Citrus Sinensis ID: 015868

---

Local Sequence Feature Prediction

Residue Number Marker
--------10--------20--------30--------40--------50--------60--------70--------80--------90-------100-------110-------120-------130-------140-------150-------160-------170-------180-------190-------200-------210-------220-------230-------240-------250-------260-------270-------280-------290-------300-------310-------320-------330-------340-------350-------360-------370-------380-------390-------40
Protein Sequence
MDMVCWVLMKVGELTSLLGEIGLNIQEAHAFSTVDGFSLDVFVVDGWPYDETEDLKNVLAKEILKSKFLIAMQDQSCSKRQPALGVPMHSKLLIESSPNCIEIPTDGTDVWEIDAKQLKIECKVASGSYGDLYKGTYCSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRLAELLERCWQHDPTQRPNFSQITDILKQMMKEVASEGENNHSNKSAGSFFSSLRRGLH
Secondary Structure (PSIPRED)
cccEEHHHHHHHHHHHHHHHHccccccccccccccccEEEEEcccccccccHHHHHHHHHHHHHccccccccccccccccccccccccccccccccccccccccccccccEEEcccccccccEEEccccccEEEEEEcccccEEEEcccccccHHHHHHHHHHHHHHHHcccccEEEEEEEEEccccEEEEEEccccccHHHHHHcccccccHHHHHHHHHHHHHHHHHHccccccccccccccEEEcccccEEEccccccEEcccccccccccccccccHHHHcccccccccccHHHHHHHHHHHHccccccccccHHHHHHHHHHccccccccccccHHHHHHHHHHccccccccccHHHHHHHHHHHHHHHccccccccccccccccccccccccc
Secondary Structure Prediction (SSPRO)
ccHHHHHHHHHHHHHHHHHHHccccEEEEEEcccccEEEEEEEcccccHHHHHHHHHHHHHHHcccccEEEEEccccccccccccccccccccccccccccccccccccEEEEcHHHEEEEEEEEcccccEEEEEEEcccEEEEEEccccccccccHHcHHHHHHHHcccccccEccEEEEccccccccEEEEcccccEHHHHHccccccccHHHHHHHHHHHHHHHHHHHHcccccccccHHHEEEcccccEEEcccccccEccccccEccccccHHHccHHHHHccccccHHHHHHHHHHHHHHHHcccccccccHHHHHHHHHHccccccccccccHHHHHHHHHHHHccHcccccHHHHHHHHHHHHHccccccccccccccccccccccccccc
Coil and Loop (DISEMBL)
MDMVCWVLMKVGELTSLLGEIGLNIqeahafstvdgfsldvfvvdgwpydeteDLKNVLAKEILKSKFLIAMQDqscskrqpalgvpmhsklliesspncieiptdgtdvwEIDAKQLKIECKVasgsygdlykgtycSQEVAIkvlkpecvntEMLKEFSQEVYIMRKIRHKNVVQFIgactrppnlcivtEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSkgmnylhqnniIHRDLKTANLLMDENGVVKVADFGVARVQAqsgvmtaetgtyrwmapeviehkpydykadVFSFGIALWELLTgelpyagltplQAAVGVVQkslrptipkhaHPRLAELLERcwqhdptqrpnfSQITDILKQMMKEVAsegennhsnksagSFFSSLRRGLH
Flexible Loop (DISEMBL)
MDMVCWVLMKVGELTSLLGEIGLNIQEAHAFSTVDGFSLDVFVVDGWPYDETEDLKNVLAKEILKSKFLIAMQDQSCSKRQPALGVPMHSKLLIESSPNCIEIPTDGTDVWEIDAKQLKIECKVASGSYGDLYKGTYCSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARvqaqsgvmtaetgtyrWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRLAELLERcwqhdptqrPNFSQITDILKQMMKEVAsegennhsnksagsffsslrrglh
Low Complexity Region (SEG)
MDMVCWVLMKVGELTSLLGEIGLNIQEAHAFSTVDGFSLDVFVVDGWPYDETEDLKNVLAKEILKSKFLIAMQDQSCSKRQPALGVPMHSKLLIESSPNCIEIPTDGTDVWEIDAKQLKIECKVASGSYGDLYKGTYCSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRLAELLERCWQHDPTQRPNFSQITDILKQMMKEVASEGENNHSNKSAGSFFSSLRRGLH
Disordered region (IsUnstruct)
**MVCWVLMKVGELTSLLGEIGLNIQEAHAFSTVDGFSLDVFVVDGWPYDETEDLKNVLAKEILKSKFLIAMQDQ********LGVPMHSKLLIESSPNCIEIPTDGTDVWEIDAKQLKIECKVASGSYGDLYKGTYCSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRLAELLERCWQH***********************************************
Disordered Region (DISOPRED)
**MVCWVLMKVGELTSLLGEIGLNIQEAHAFSTVDGFSLDVFVVDGWPY************************************************************VWEIDAKQLKIECKVASGSYGDLYKGTYCSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRLAELLERCWQHDPTQRPNFSQITDILK*******************************
Disordered Region (DISEMBL)
MDMVCWVLMKVGELTSLLGEIGLNIQEAHAFSTVDGFSLDVFVVDGWPYDETEDLKNVLAKEILKSKFLIAMQDQSCSKRQPALGVPMHSKLLIESSPNCIEIPTDGTDVWEIDAKQLKIECKVASGSYGDLYKGTYCSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRLAELLERCWQHDPTQRPNFSQITDILKQMMKE**************************
Disordered Region (DISPRO)
MDMVCWVLMKVGELTSLLGEIGLNIQEAHAFSTVDGFSLDVFVVDGWPYDETEDLKNVLAKEILKSKFLIAMQDQSCSKRQPALGVPMHSKLLIESSPNCIEIPTDGTDVWEIDAKQLKIECKVASGSYGDLYKGTYCSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRLAELLERCWQHDPTQRPNFSQITDILKQMMKEV*************************
Transmembrane Helix (TMHMM)
ooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
Transmembrane Helix (HMMTOP)
ooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
Transmembrane Helix (MEMSAT)
ooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooohhhhhhhhhhhhhhhhhhhhhhhhhiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiii
TM Helix, Signal Peptide (MEMSAT_SVM)
iiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiihhhhhhhhhhhhhhhhooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
TM Helix, Signal Peptide (Phobius)
ooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
Signal Peptide (SignalP HMM Mode)
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
Signal Peptide (SignalP NN Mode)
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
Coiled Coils (COILS)
MDMVCWVLMKVGELTSLLGEIGLNIQEAHAFSTVDGFSLDVFVVDGWPYDETEDLKNVLAKEILKSKFLIAMQDQSCSKRQPALGVPMHSKLLIESSPNCIEIPTDGTDVWEIDAKQLKIECKVASGSYGDLYKGTYCSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRLAELLERCWQHDPTQRPNFSQITDILKQMMKEVASEGENNHSNKSAGSFFSSLRRGLH
Positional Conservation
no confident homologs detected

---

Close Homologs for Annotation Transfer

Close Homologs in SWISS-PROT Database Detected by BLAST

Original result of BLAST against SWISS-PROT Database

ID	Length	Definition	RBH(Q2H)	RBH(H2Q)	Q cover	H cover	Identity	E-value
Query	399	2.2.26 [Sep-21-2011]
Q2MHE4	390	Serine/threonine-protein	no	no	0.669	0.684	0.432	3e-67
Q55GU0	916	Probable serine/threonine	yes	no	0.696	0.303	0.425	3e-67
Q05609	821	Serine/threonine-protein	no	no	0.719	0.349	0.416	2e-63
Q54H46	642	Probable serine/threonine	no	no	0.654	0.406	0.438	5e-63
Q54H45	690	Probable serine/threonine	no	no	0.654	0.378	0.430	1e-62
Q9FPR3	933	Serine/threonine-protein	no	no	0.674	0.288	0.448	4e-62
Q54TM7	1288	Probable serine/threonine	no	no	0.664	0.205	0.412	2e-57
Q54IP4	653	Dual specificity protein	no	no	0.636	0.388	0.425	9e-56
Q7T6X2	1657	Putative serine/threonine	N/A	no	0.676	0.162	0.404	1e-55
Q55A09	1331	Probable serine/threonine	no	no	0.674	0.202	0.377	2e-54

>sp|Q2MHE4|HT1_ARATH Serine/threonine-protein kinase HT1 OS=Arabidopsis thaliana GN=HT1 PE=1 SV=1

 Score =  256 bits (653), Expect = 3e-67,   Method: Compositional matrix adjust.
 Identities = 118/273 (43%), Positives = 181/273 (66%), Gaps = 6/273 (2%)

Query: 111 WEIDAKQLKIECKVASGSYGDLYKGTYCSQEVAIKVLK----PECVNTEMLKEFSQEVYI 166
           W  D  QL I  K ASG++  +Y+G Y  + VA+K+++     E    ++ ++F  EV +
Sbjct: 79  WTADLSQLFIGNKFASGAHSRIYRGIYKQRAVAVKMVRIPTHKEETRAKLEQQFKSEVAL 138

Query: 167 MRKIRHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGV-FQLTSLLKVAIDVSK 225
           + ++ H N+VQFI AC +PP  CI+TE+M++G++  +L+K++     + ++L++A+D+S+
Sbjct: 139 LSRLFHPNIVQFIAACKKPPVYCIITEYMSQGNLRMYLNKKEPYSLSIETVLRLALDISR 198

Query: 226 GMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAETGTYRWMAPEVI 285
           GM YLH   +IHRDLK+ NLL+++   VKVADFG + ++ Q        GTYRWMAPE+I
Sbjct: 199 GMEYLHSQGVIHRDLKSNNLLLNDEMRVKVADFGTSCLETQCREAKGNMGTYRWMAPEMI 258

Query: 286 EHKPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRLAEL 345
           + KPY  K DV+SFGI LWEL T  LP+ G+TP+QAA  V +K+ RP +P    P LA L
Sbjct: 259 KEKPYTRKVDVYSFGIVLWELTTALLPFQGMTPVQAAFAVAEKNERPPLPASCQPALAHL 318

Query: 346 LERCWQHDPTQRPNFSQITDILKQMMKEVASEG 378
           ++RCW  +P++RP+FS I  +L++   E   EG
Sbjct: 319 IKRCWSENPSKRPDFSNIVAVLEK-YDECVKEG 350

Serine/threonine kinase involved in the control of stomatal movement in response to CO(2). Shows a reduced response to ABA or light compared to CO(2).
Arabidopsis thaliana (taxid: 3702)
EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 1

>sp|Q55GU0|Y9955_DICDI Probable serine/threonine-protein kinase DDB_G0267514 OS=Dictyostelium discoideum GN=DDB_G0267514 PE=3 SV=1

 Score =  256 bits (653), Expect = 3e-67,   Method: Compositional matrix adjust.
 Identities = 120/282 (42%), Positives = 191/282 (67%), Gaps = 4/282 (1%)

Query: 93  LIESSPNCIEIPTDGTDVW---EIDAKQLKIECKVASGSYGDLYKGTYCSQEVAIKVLK- 148
           ++++S + +E P+     +   EI   +LKI  K+  G++G +YKG +    VAIK +K 
Sbjct: 634 ILKNSGSVVEPPSQQQQYFSDIEISFSELKISSKLGEGTFGVVYKGLWRGSSVAIKQIKI 693

Query: 149 PECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQK 208
            E VN ++L+EF +E+ I+ ++RH N+V  + ACT PPNLC +TE++  GS+YD LH +K
Sbjct: 694 NEDVNNQVLEEFRKELTILSRLRHPNIVLLMAACTAPPNLCFITEYLPGGSLYDALHSKK 753

Query: 209 GVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSG 268
               +    K+AI +++GMNYLH + +IHRD+K+ NLL+DE+  VK+ DFG+++++++S 
Sbjct: 754 IKMNMQLYKKLAIQIAQGMNYLHLSGVIHRDIKSLNLLLDEHMNVKICDFGLSKLKSKST 813

Query: 269 VMTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQK 328
            MT   G+  WM+PE++  + Y  K DV++FGI LWEL TGELPY+GL  +Q A+ V  K
Sbjct: 814 EMTKSIGSPIWMSPELLMGEDYTEKVDVYAFGIILWELGTGELPYSGLDSVQLALAVTTK 873

Query: 329 SLRPTIPKHAHPRLAELLERCWQHDPTQRPNFSQITDILKQM 370
           SLRP IP     +L+ L++ CW  DP +RP+F++I ++L ++
Sbjct: 874 SLRPPIPNAWPYQLSHLIQACWHQDPLKRPSFTEILNLLNEI 915

Dictyostelium discoideum (taxid: 44689)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q05609|CTR1_ARATH Serine/threonine-protein kinase CTR1 OS=Arabidopsis thaliana GN=CTR1 PE=1 SV=1

 Score =  243 bits (620), Expect = 2e-63,   Method: Compositional matrix adjust.
 Identities = 123/295 (41%), Positives = 193/295 (65%), Gaps = 8/295 (2%)

Query: 85  GVPMHSKLLIESSPNCI--EIPTDGTDVWEIDAKQLKIECKVASGSYGDLYKGTYCSQEV 142
             PM++  + +  PN    E+  DG D+ +I    L I+ K+ +GS+G +++  +   +V
Sbjct: 517 AAPMNAPPISQPVPNRANRELGLDGDDM-DIPWCDLNIKEKIGAGSFGTVHRAEWHGSDV 575

Query: 143 AIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVTEFMARGSIYD 202
           A+K+L  +  + E + EF +EV IM+++RH N+V F+GA T+PPNL IVTE+++RGS+Y 
Sbjct: 576 AVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYR 635

Query: 203 FLHKQKGVFQLTSL--LKVAIDVSKGMNYLHQNN--IIHRDLKTANLLMDENGVVKVADF 258
            LHK     QL     L +A DV+KGMNYLH  N  I+HRDLK+ NLL+D+   VKV DF
Sbjct: 636 LLHKSGAREQLDERRRLSMAYDVAKGMNYLHNRNPPIVHRDLKSPNLLVDKKYTVKVCDF 695

Query: 259 GVARVQAQSGVMT-AETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPYAGLT 317
           G++R++A + + + +  GT  WMAPEV+  +P + K+DV+SFG+ LWEL T + P+  L 
Sbjct: 696 GLSRLKASTFLSSKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPWGNLN 755

Query: 318 PLQAAVGVVQKSLRPTIPKHAHPRLAELLERCWQHDPTQRPNFSQITDILKQMMK 372
           P Q    V  K  R  IP++ +P++A ++E CW ++P +RP+F+ I D+L+ ++K
Sbjct: 756 PAQVVAAVGFKCKRLEIPRNLNPQVAAIIEGCWTNEPWKRPSFATIMDLLRPLIK 810

Acts as a negative regulator in the ethylene response pathway.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q54H46|DRKA_DICDI Probable serine/threonine-protein kinase drkA OS=Dictyostelium discoideum GN=drkA PE=3 SV=1

 Score =  242 bits (617), Expect = 5e-63,   Method: Compositional matrix adjust.
 Identities = 117/267 (43%), Positives = 172/267 (64%), Gaps = 6/267 (2%)

Query: 106 DGTDVWEIDAKQLKIECKVASGSYGDLYKGTYCSQEVAIKVLKPECVNTEMLKEFSQEVY 165
           DG D   ID  Q+KI  ++  G+YG++Y GT+   +VA+K L    +N  +LKEF +E+ 
Sbjct: 365 DGKD---IDIHQIKIGVRIGKGNYGEVYLGTWRGSQVAVKKLPAHNINENILKEFHREIN 421

Query: 166 IMRKIRHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSK 225
           +M+ +RH NV+QF+G+C  PP++CI TE+M RGS+Y  LH Q    Q + L+K+ ID +K
Sbjct: 422 LMKNLRHPNVIQFLGSCLIPPDICICTEYMPRGSLYSILHDQALQLQWSLLIKMMIDAAK 481

Query: 226 GMNYLHQNN--IIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAETGTYRWMAPE 283
           G+ YLH +   I+HRDLK+ NLL+DEN  VKVADFG++ ++ Q   MTA  GT  W +PE
Sbjct: 482 GVIYLHNSTPVILHRDLKSHNLLVDENWKVKVADFGLSTIEQQGATMTA-CGTPCWTSPE 540

Query: 284 VIEHKPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRLA 343
           V+  + Y  KADV+SFGI LWE  T + PY G+ P Q    V ++ +RP +P++  P+  
Sbjct: 541 VLRSQRYTEKADVYSFGIILWECATRQDPYFGIPPFQVIFAVGREGMRPPVPQNGPPKYI 600

Query: 344 ELLERCWQHDPTQRPNFSQITDILKQM 370
           +LL  C   +P+ RP   Q  + L+ +
Sbjct: 601 QLLIDCLNENPSHRPTMEQCLERLESI 627

Dictyostelium discoideum (taxid: 44689)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q54H45|DRKB_DICDI Probable serine/threonine-protein kinase drkB OS=Dictyostelium discoideum GN=drkB PE=3 SV=1

 Score =  240 bits (613), Expect = 1e-62,   Method: Compositional matrix adjust.
 Identities = 115/267 (43%), Positives = 173/267 (64%), Gaps = 6/267 (2%)

Query: 106 DGTDVWEIDAKQLKIECKVASGSYGDLYKGTYCSQEVAIKVLKPECVNTEMLKEFSQEVY 165
           DG D   ID +Q+KI  ++  G++G++Y GT+   +VA+K L    +N  +LKEF +E+ 
Sbjct: 382 DGKD---IDTQQIKIGVRIGKGNFGEVYLGTWRGSQVAVKKLPAHNINENILKEFHREIN 438

Query: 166 IMRKIRHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSK 225
           +M+ +RH NV+QF+G+C   P++CI TE+M RGS+Y  LH +K     + + ++ ID +K
Sbjct: 439 LMKNLRHPNVIQFLGSCLISPDICICTEYMPRGSLYSILHNEKIKISWSLVKRMMIDAAK 498

Query: 226 GMNYLHQNN--IIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAETGTYRWMAPE 283
           G+ YLH +   I+HRDLK+ NLL+DEN  VKVADFG++ ++ Q   MTA  GT  W +PE
Sbjct: 499 GIIYLHGSTPVILHRDLKSHNLLVDENWKVKVADFGLSTIEQQGATMTA-CGTPCWTSPE 557

Query: 284 VIEHKPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRLA 343
           V+  + Y  KADV+SFGI LWE  T + PY G+ P Q    V ++ +RP  PK+  P+  
Sbjct: 558 VLRSQRYTEKADVYSFGIILWECATRQDPYFGIPPFQVIFAVGREGMRPPTPKYGPPKYI 617

Query: 344 ELLERCWQHDPTQRPNFSQITDILKQM 370
           +LL+ C   +P+QRP   Q  +IL+ +
Sbjct: 618 QLLKDCLNENPSQRPTMEQCLEILESI 644

Dictyostelium discoideum (taxid: 44689)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q9FPR3|EDR1_ARATH Serine/threonine-protein kinase EDR1 OS=Arabidopsis thaliana GN=EDR1 PE=1 SV=1

 Score =  238 bits (608), Expect = 4e-62,   Method: Compositional matrix adjust.
 Identities = 123/274 (44%), Positives = 172/274 (62%), Gaps = 5/274 (1%)

Query: 106 DGTDVWE--IDAKQLKIECKVASGSYGDLYKGTYCSQEVAIKVLKPECVNTEMLKEFSQE 163
           D  DV E  I    L I  ++  GSYG++Y   +   EVA+K    +  +   L EF  E
Sbjct: 655 DDADVGECEIPWNDLVIAERIGLGSYGEVYHADWHGTEVAVKKFLDQDFSGAALAEFRSE 714

Query: 164 VYIMRKIRHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDV 223
           V IMR++RH NVV F+GA TRPPNL IVTEF+ RGS+Y  LH+ K        +K+A+DV
Sbjct: 715 VRIMRRLRHPNVVFFLGAVTRPPNLSIVTEFLPRGSLYRILHRPKSHIDERRRIKMALDV 774

Query: 224 SKGMNYLHQN--NIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAET-GTYRWM 280
           + GMN LH +   I+HRDLKT NLL+D N  VKV DFG++R++  + + +  T GT  WM
Sbjct: 775 AMGMNCLHTSTPTIVHRDLKTPNLLVDNNWNVKVGDFGLSRLKHNTFLSSKSTAGTPEWM 834

Query: 281 APEVIEHKPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKSLRPTIPKHAHP 340
           APEV+ ++P + K DV+SFG+ LWEL T  LP+ G+ P+Q    V  ++ R  IPK   P
Sbjct: 835 APEVLRNEPSNEKCDVYSFGVILWELATLRLPWRGMNPMQVVGAVGFQNRRLEIPKELDP 894

Query: 341 RLAELLERCWQHDPTQRPNFSQITDILKQMMKEV 374
            +  ++  CWQ DP  RP+F+Q+T++LK + + V
Sbjct: 895 VVGRIILECWQTDPNLRPSFAQLTEVLKPLNRLV 928

MAPKKK serine/threonine-protein kinase involved in the regulation of a MAP kinase cascade (probably including MPK3 and MPK6) that negatively regulates salicylic acid- (SA-) dependent defense responses, abscisic acid (ABA) signaling, and ethylene-induced senescence. Modulates also stress response (e.g. drought) signaling and cell death, in an ORE9-dependent manner. Functions at a point of cross talk between ethylene, ABA and SA signaling that impinges on senescence and cell death. In another hand, confers sensitivity to various pathogens such as the fungus Erysiphe cichoracearum, the oomycete Hyaloperonospora parasitica and the bacteria Pseudomonas syringae pv. tomato DC3000. Required for the resistance to some hemibiotrophic/necrotrophic fungal pathogens (e.g. Colletotrichum gloeosporioides, Colletotrichum higginsianum and Alternaria brassicicola) through the induction of defensins expression, probably by repressing MYC2, an inhibitor of defensin genes (PDFs). Together with KEG, may regulate endocytic trafficking and/or the formation of signaling complexes on trans-Golgi network (TGN)/ early endosome (EE) vesicles during stress responses.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q54TM7|DRKD_DICDI Probable serine/threonine-protein kinase drkD OS=Dictyostelium discoideum GN=drkD PE=2 SV=1

 Score =  223 bits (568), Expect = 2e-57,   Method: Compositional matrix adjust.
 Identities = 111/269 (41%), Positives = 170/269 (63%), Gaps = 4/269 (1%)

Query: 111  WEIDAKQLKIECKVASGSYGDLYKGTYCSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKI 170
            WE+   ++ I  ++  G YG +++G++   EVA+K+L  + VN +++ +  +EV ++ K+
Sbjct: 844  WEVPLSEIAIGARIGRGGYGQVFRGSWRGTEVAVKMLFNDNVNLKLISDLRKEVDLLCKL 903

Query: 171  RHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYL 230
            RH N+V F+GACT P + CIVTE+++RGS+ + L  +         L++  D ++GM YL
Sbjct: 904  RHPNIVLFMGACTEPSSPCIVTEYLSRGSLANILLDESIEMDWGLRLQLGFDCARGMTYL 963

Query: 231  HQNN--IIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAETGTYRWMAPEVIEHK 288
            H  N  IIHRDLKT NLL+D++  VKVADFG+A V++ +   T   GT  W+APEV+  +
Sbjct: 964  HSRNPIIIHRDLKTDNLLVDDSWQVKVADFGLATVKSHTFAKTM-CGTTGWVAPEVLAEE 1022

Query: 289  PYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRLAELLER 348
             Y  KADV+S+ I LWELLT  +PYAG   +Q  V  + +  R  +P    P+ A L+ R
Sbjct: 1023 GYTEKADVYSYAIVLWELLTRLIPYAGKNTMQ-VVRSIDRGERLPMPAWCPPKYAALMNR 1081

Query: 349  CWQHDPTQRPNFSQITDILKQMMKEVASE 377
            CW+ DPT RP+F +I  I++ M+ E   E
Sbjct: 1082 CWETDPTHRPSFPEILPIMEGMISEFQKE 1110

Dictyostelium discoideum (taxid: 44689)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q54IP4|SHKB_DICDI Dual specificity protein kinase shkB OS=Dictyostelium discoideum GN=shkB PE=3 SV=1

 Score =  218 bits (554), Expect = 9e-56,   Method: Compositional matrix adjust.
 Identities = 112/263 (42%), Positives = 163/263 (61%), Gaps = 9/263 (3%)

Query: 111 WEIDAKQLKI--ECKVASGSYGDLYKGTYCSQEVAIKVLKPECVNTEMLKEFSQEVYIMR 168
           WEID  ++    E K+ SG++G +YKG    +EVAIK L         + EF +EV +M 
Sbjct: 165 WEIDRNEISYNREAKLGSGAFGSVYKGIVRGKEVAIKKLTQTVFEENTMNEFKKEVSLMA 224

Query: 169 KIRHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLK---VAIDVSK 225
           K+R+ +++ F+GACT P +L IVTE M +GS++  L  ++      +  +   +A D   
Sbjct: 225 KLRNPHLLLFMGACTAPEDLSIVTELMPKGSVHSLLRAKEDTSDFITFKRAILIARDTVL 284

Query: 226 GMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQA--QSGVMTAETGTYRWMAPE 283
           GM +LH +NI+H DLK ANLL+D+N VVKVADFG+++         +  + G+  +MAPE
Sbjct: 285 GMTWLHASNILHLDLKPANLLVDQNWVVKVADFGLSKYMKPDSKDKLLGQAGSPLYMAPE 344

Query: 284 VIEHKPYDYKADVFSFGIALWELLTGELPYAGL--TPLQAAVGVVQKSLRPTIPKHAHPR 341
           ++ ++PYD K DVFSF I LWELLT + PY  L  +  Q   GVV K  RP IP +   R
Sbjct: 345 MLVNQPYDGKVDVFSFSILLWELLTKQEPYNKLYSSYPQLVEGVVNKKNRPIIPDYFPTR 404

Query: 342 LAELLERCWQHDPTQRPNFSQIT 364
           L +LL RCW H P++RP+F++I+
Sbjct: 405 LKDLLARCWDHYPSRRPSFAEIS 427

Required for proper chemotaxis and phagocytosis; proper spatiotemporal control of F-actin levels in chemotaxing cells. Negative regulator of the PI3K (phosphatidylinositol 3 kinase) pathway. Predominantly phosphorylates serines and threonines and tyrosines at a lower level.

Dictyostelium discoideum (taxid: 44689)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q7T6X2|YR826_MIMIV Putative serine/threonine-protein kinase/receptor R826 OS=Acanthamoeba polyphaga mimivirus GN=MIMI_R826 PE=4 SV=2

 Score =  217 bits (552), Expect = 1e-55,   Method: Compositional matrix adjust.
 Identities = 114/282 (40%), Positives = 173/282 (61%), Gaps = 12/282 (4%)

Query: 108  TDVWEIDAKQLKIECKVASGSYGDLYKGTYCSQEVAIKVLKPE-CVNTEMLKEFSQEVYI 166
            +D WEID  +L++  ++ +G++G+++KGT+   EVA+K++ P+  +  ++ + F  EV +
Sbjct: 776  SDDWEIDFHELELGEQLGTGAFGEVHKGTWRGTEVAVKMISPDKTITKDIERNFKDEVRV 835

Query: 167  MRKIRHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAI--DVS 224
            M  +RH NVV F+ A T+PP +CIV EFMA GS++D L K + +  +   LKV I    S
Sbjct: 836  MTTLRHPNVVLFMAASTKPPKMCIVMEFMALGSLHDLL-KNELIPDIPFALKVKIAYQAS 894

Query: 225  KGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAE--TGTYRWMAP 282
            KGM++LH + I HRDLK+ NLL+D    VKV+DFG+ + ++    +  E   GT +W AP
Sbjct: 895  KGMHFLHSSGITHRDLKSLNLLLDIKWNVKVSDFGLTKFKSDVKSINPEKFAGTIQWTAP 954

Query: 283  EVI-EHKPYDY-KADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKSLRPTIPKHAH- 339
            E++ E +  DY  +DV+SFGI +WEL+T + PY G++P   AV V++ + RP I      
Sbjct: 955  EILSEDREVDYILSDVYSFGIIMWELITRDQPYFGMSPAAIAVSVIRDNYRPVISDQLRS 1014

Query: 340  ---PRLAELLERCWQHDPTQRPNFSQITDILKQMMKEVASEG 378
               P   ELL  CW  DPT RP F +I   L  +M +    G
Sbjct: 1015 EVAPEYIELLTSCWHFDPTIRPTFLEIMTRLSNLMGDSGMTG 1056

Acanthamoeba polyphaga (taxid: 5757)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q55A09|Y9963_DICDI Probable serine/threonine-protein kinase DDB_G0272254 OS=Dictyostelium discoideum GN=DDB_G0272254 PE=3 SV=1

 Score =  213 bits (542), Expect = 2e-54,   Method: Compositional matrix adjust.
 Identities = 106/281 (37%), Positives = 172/281 (61%), Gaps = 12/281 (4%)

Query: 99   NCIEIPTDGTDVWEIDAKQLKIECKVASGSYGDLYKGTYCSQEVAIKVLKP--ECVNTEM 156
            N + +P   + V  I+   +KI+ ++  G +  + KG +  ++VA+K L    +    EM
Sbjct: 1055 NTVTLPISSS-VTMINYSDIKIDKEIGKGHFSKVLKGNWKGKDVAVKKLNSNKDKAREEM 1113

Query: 157  LKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLH----KQKGVFQ 212
            ++EF  EV ++  ++H N+V   G    P  +CIV EF+  G++++ +H    +Q+   +
Sbjct: 1114 IQEFKAEVELLGSLQHPNLVTCYGYSLNP--MCIVMEFLPSGNLFELIHSKPSEQQQSIK 1171

Query: 213  LTS--LLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVM 270
            L S  +L +A D+++GM +LH  NIIHRDLK++NLLMD++  +K+AD G+AR  + +  M
Sbjct: 1172 LDSTLILAIAFDIARGMQHLHTRNIIHRDLKSSNLLMDKHFNIKIADLGIARETSFTQTM 1231

Query: 271  TAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKSL 330
            T   GT  W APE++ H+ Y+ KADV+S+ I L+ELLTGE PY G+ P+ A + V  K L
Sbjct: 1232 TT-IGTVAWTAPEILRHESYNQKADVYSYAIVLYELLTGEEPYQGIPPMNAGILVASKGL 1290

Query: 331  RPTIPKHAHPRLAELLERCWQHDPTQRPNFSQITDILKQMM 371
            RP +P +  P   +L+  CW  DP +RP+F +IT+ L +  
Sbjct: 1291 RPELPDNCDPNWKKLVVWCWSEDPNKRPSFEEITNYLTKTF 1331

Dictyostelium discoideum (taxid: 44689)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

Close Homologs in the Non-Redundant Database Detected by BLAST

Original result of BLAST against Nonredundant Database

GI	Length	Definition	Q cover	H cover	Identity	E-value
Query	399
449456851	579	PREDICTED: mitogen-activated protein kin	0.959	0.661	0.743	1e-175
449495086	579	PREDICTED: mitogen-activated protein kin	0.959	0.661	0.743	1e-175
224117232	587	predicted protein [Populus trichocarpa]	0.959	0.652	0.771	1e-175
356538347	571	PREDICTED: serine/threonine-protein kina	0.947	0.661	0.748	1e-172
356496589	571	PREDICTED: serine/threonine-protein kina	0.947	0.661	0.753	1e-172
357483963	574	Dual specificity protein kinase pyk2 [Me	0.954	0.663	0.750	1e-170
365222936	562	Hop-interacting protein THI135 [Solanum	0.939	0.667	0.737	1e-170
297798344	570	kinase family protein [Arabidopsis lyrat	0.944	0.661	0.731	1e-167
224133576	579	predicted protein [Populus trichocarpa]	0.912	0.628	0.763	1e-166
22329194	570	ACT-like protein tyrosine kinase family	0.944	0.661	0.731	1e-165

>gi|449456851|ref|XP_004146162.1| PREDICTED: mitogen-activated protein kinase kinase kinase 10-like [Cucumis sativus]

 Score =  621 bits (1602), Expect = e-175,   Method: Compositional matrix adjust.
 Identities = 290/390 (74%), Positives = 341/390 (87%), Gaps = 7/390 (1%)

Query: 11  VGELTSLLGEIGLNIQEAHAFSTVDGFSLDVFVVDGWPYDETEDLKNVLAKEILKSKFLI 70
           + +LTSLL ++GLNIQEAHAFS+VDGFSLDVFV+DGWPY+ETE+LK VL KEIL  K   
Sbjct: 196 LSQLTSLLADVGLNIQEAHAFSSVDGFSLDVFVIDGWPYEETEELKRVLEKEILNFK--- 252

Query: 71  AMQDQSCSKRQPALGVPMHSKLLIESSPNCIEIPTDGTDVWEIDAKQLKIECKVASGSYG 130
              +Q  S++QP+  +  H++  +ES P+C+ IPTDGTDVWE+D  QLK E KV SGS+G
Sbjct: 253 ---EQCWSEKQPSSALGKHNQNRVESFPSCVGIPTDGTDVWEMDISQLKFENKVGSGSFG 309

Query: 131 DLYKGTYCSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCI 190
           DLY+GTYCSQEVAIKVL+PE +N EMLKEFSQEVYIMRK+RHKNVVQF+GACT+PPNLCI
Sbjct: 310 DLYRGTYCSQEVAIKVLRPERINEEMLKEFSQEVYIMRKVRHKNVVQFLGACTKPPNLCI 369

Query: 191 VTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDEN 250
           VTEFM+RGS+YDFLHKQ+GVF L SLLKVAI++S+GMNYLHQNNIIHRDLKTANLLMDEN
Sbjct: 370 VTEFMSRGSVYDFLHKQRGVFNLPSLLKVAINISRGMNYLHQNNIIHRDLKTANLLMDEN 429

Query: 251 GVVKVADFGVARVQAQSGVMTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTGE 310
            VVKVADFGVARVQ QSGVMTAETGTYRWMAPEVIEHKPYD+KADVFSFGIALWELLTGE
Sbjct: 430 MVVKVADFGVARVQTQSGVMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIALWELLTGE 489

Query: 311 LPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRLAELLERCWQHDPTQRPNFSQITDILKQM 370
           +PY+ +TPLQAAVGVVQK LRPTIPK+AHP LAELLERCW+HDPT+RPNFS+I +ILKQ+
Sbjct: 490 IPYSSMTPLQAAVGVVQKRLRPTIPKNAHPVLAELLERCWRHDPTERPNFSEILEILKQI 549

Query: 371 MKEVASEGENNH-SNKSAGSFFSSLRRGLH 399
            ++V + GEN    +K +G+ FS+ ++  H
Sbjct: 550 AEQVDNSGENRRKKDKLSGALFSAFKKRHH 579

Source: Cucumis sativus

Species: Cucumis sativus

Genus: Cucumis

Family: Cucurbitaceae

Order: Cucurbitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|449495086|ref|XP_004159730.1| PREDICTED: mitogen-activated protein kinase kinase kinase 10-like [Cucumis sativus]

 Score =  621 bits (1601), Expect = e-175,   Method: Compositional matrix adjust.
 Identities = 290/390 (74%), Positives = 341/390 (87%), Gaps = 7/390 (1%)

Query: 11  VGELTSLLGEIGLNIQEAHAFSTVDGFSLDVFVVDGWPYDETEDLKNVLAKEILKSKFLI 70
           + +LTSLL ++GLNIQEAHAFS+VDGFSLDVFV+DGWPY+ETE+LK VL KEIL  K   
Sbjct: 196 LSQLTSLLADVGLNIQEAHAFSSVDGFSLDVFVIDGWPYEETEELKRVLEKEILNFK--- 252

Query: 71  AMQDQSCSKRQPALGVPMHSKLLIESSPNCIEIPTDGTDVWEIDAKQLKIECKVASGSYG 130
              +Q  S++QP+  +  H++  +ES P+C+ IPTDGTDVWE+D  QLK E KV SGS+G
Sbjct: 253 ---EQCWSEKQPSSALGKHNQNRVESFPSCVGIPTDGTDVWEMDISQLKFENKVGSGSFG 309

Query: 131 DLYKGTYCSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCI 190
           DLY+GTYCSQEVAIKVL+PE +N EMLKEFSQEVYIMRK+RHKNVVQF+GACT+PPNLCI
Sbjct: 310 DLYRGTYCSQEVAIKVLRPERINEEMLKEFSQEVYIMRKVRHKNVVQFLGACTKPPNLCI 369

Query: 191 VTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDEN 250
           VTEFM+RGS+YDFLHKQ+GVF L SLLKVAI++S+GMNYLHQNNIIHRDLKTANLLMDEN
Sbjct: 370 VTEFMSRGSVYDFLHKQRGVFNLPSLLKVAINISRGMNYLHQNNIIHRDLKTANLLMDEN 429

Query: 251 GVVKVADFGVARVQAQSGVMTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTGE 310
            VVKVADFGVARVQ QSGVMTAETGTYRWMAPEVIEHKPYD+KADVFSFGIALWELLTGE
Sbjct: 430 MVVKVADFGVARVQTQSGVMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIALWELLTGE 489

Query: 311 LPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRLAELLERCWQHDPTQRPNFSQITDILKQM 370
           +PY+ +TPLQAAVGVVQK LRPTIPK+AHP LAELLERCW+HDPT+RPNFS+I +ILKQ+
Sbjct: 490 IPYSSMTPLQAAVGVVQKRLRPTIPKNAHPVLAELLERCWRHDPTERPNFSEILEILKQI 549

Query: 371 MKEVASEGENNH-SNKSAGSFFSSLRRGLH 399
            ++V + GEN    +K +G+ FS+ ++  H
Sbjct: 550 AEQVDNSGENRRKKDKLSGALFSAFKKRHH 579

Source: Cucumis sativus

Species: Cucumis sativus

Genus: Cucumis

Family: Cucurbitaceae

Order: Cucurbitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|224117232|ref|XP_002331754.1| predicted protein [Populus trichocarpa] gi|222874451|gb|EEF11582.1| predicted protein [Populus trichocarpa]

 Score =  620 bits (1598), Expect = e-175,   Method: Compositional matrix adjust.
 Identities = 300/389 (77%), Positives = 335/389 (86%), Gaps = 6/389 (1%)

Query: 11  VGELTSLLGEIGLNIQEAHAFSTVDGFSLDVFVVDGWPYDETEDLKNVLAKEILKSKFLI 70
           + +LTSLL EIGLNIQEAHAFSTVDGFSLDVFVVDGW  +ETE+L+N L KEILKSK   
Sbjct: 205 LSQLTSLLAEIGLNIQEAHAFSTVDGFSLDVFVVDGWLREETEELRNALEKEILKSK--- 261

Query: 71  AMQDQSCSKRQPALGVPMHSKLLIESSPNCIEIPTDGTDVWEIDAKQLKIECKVASGSYG 130
              +Q  SK+     V   +K  +ES P+C+EIP+DGTDVWEID   LK+E KVASGSYG
Sbjct: 262 ---EQCFSKQLSVSLVGEQNKTGVESLPDCVEIPSDGTDVWEIDTSLLKVENKVASGSYG 318

Query: 131 DLYKGTYCSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCI 190
           DLY+GTYCSQEVAIKVLKPE V+ EML+EFS+EVYIMRK+RHKNVVQFIGAC R PNLCI
Sbjct: 319 DLYRGTYCSQEVAIKVLKPERVSGEMLREFSREVYIMRKVRHKNVVQFIGACDRSPNLCI 378

Query: 191 VTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDEN 250
           VTEFMA+GS+Y+FLHKQKGVF+L  L+KVAIDVSKGMNYLHQNNIIHRDLKTANLLMDEN
Sbjct: 379 VTEFMAKGSLYNFLHKQKGVFKLPCLIKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDEN 438

Query: 251 GVVKVADFGVARVQAQSGVMTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTGE 310
            VVKVADFGVARVQ QSGVMTAETGTYRWMAPEVIEHKPYD+KADVFSFGI  WELLTGE
Sbjct: 439 EVVKVADFGVARVQTQSGVMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVAWELLTGE 498

Query: 311 LPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRLAELLERCWQHDPTQRPNFSQITDILKQM 370
           LPY+ LTPLQAAVGVV+K LRPTIPKH HP+LAELLE CWQ DP QRPNFSQI DIL+Q+
Sbjct: 499 LPYSYLTPLQAAVGVVRKGLRPTIPKHTHPKLAELLETCWQQDPNQRPNFSQIIDILQQI 558

Query: 371 MKEVASEGENNHSNKSAGSFFSSLRRGLH 399
           +KEV  E E+   +KS+GSFFS+L +G H
Sbjct: 559 VKEVGDEREDRCKDKSSGSFFSALIKGHH 587

Source: Populus trichocarpa

Species: Populus trichocarpa

Genus: Populus

Family: Salicaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|356538347|ref|XP_003537665.1| PREDICTED: serine/threonine-protein kinase CTR1-like [Glycine max]

 Score =  611 bits (1576), Expect = e-172,   Method: Compositional matrix adjust.
 Identities = 291/389 (74%), Positives = 333/389 (85%), Gaps = 11/389 (2%)

Query: 11  VGELTSLLGEIGLNIQEAHAFSTVDGFSLDVFVVDGWPYDETEDLKNVLAKEILKSKFLI 70
           + +LT++LGE+GLNIQEAHAFST DGFSLDVFVV+GWP +ETE+LK VL KEI K K   
Sbjct: 194 LSQLTAILGEMGLNIQEAHAFSTTDGFSLDVFVVEGWPNEETEELKGVLEKEIFKVK--- 250

Query: 71  AMQDQSCSKRQPALGVPMHSKLLIESSPNCIEIPTDGTDVWEIDAKQLKIECKVASGSYG 130
              +Q+ S +          +  +E SP+CI+IP+DG DVWEID  QLK E KV SGS+G
Sbjct: 251 ---EQNLSNQGIHYATNEQYQARMEPSPHCIQIPSDGADVWEIDTNQLKYENKVGSGSFG 307

Query: 131 DLYKGTYCSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCI 190
           DLY+GTYCSQ+VAIKVLKPE ++T+ML+EF+QEVYIMRKIRHKNVVQFIGACTRPPNLCI
Sbjct: 308 DLYRGTYCSQDVAIKVLKPERISTDMLREFAQEVYIMRKIRHKNVVQFIGACTRPPNLCI 367

Query: 191 VTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDEN 250
           VTEFM+RGS+YDFLHKQ+GVF+L SLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDEN
Sbjct: 368 VTEFMSRGSLYDFLHKQRGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDEN 427

Query: 251 GVVKVADFGVARVQAQSGVMTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTGE 310
            VVKVADFGVARVQ QSGVMTAETGTYRWMAPEVIEHKPYD KADVFSFGIALWELLTGE
Sbjct: 428 EVVKVADFGVARVQTQSGVMTAETGTYRWMAPEVIEHKPYDQKADVFSFGIALWELLTGE 487

Query: 311 LPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRLAELLERCWQHDPTQRPNFSQITDILKQM 370
           LPY+ LTPLQAAVGVVQK LRPTIPK+ HPRL+ELL+RCWQ DPTQRPNFS++ +IL+Q+
Sbjct: 488 LPYSCLTPLQAAVGVVQKGLRPTIPKNTHPRLSELLQRCWQQDPTQRPNFSEVIEILQQI 547

Query: 371 MKEVASEGENNHSNKSAGSFFSSLRRGLH 399
            KEV     N+H +K++  F S+LRR  H
Sbjct: 548 AKEV-----NDHKDKASHGFLSALRRAHH 571

Source: Glycine max

Species: Glycine max

Genus: Glycine

Family: Fabaceae

Order: Fabales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|356496589|ref|XP_003517149.1| PREDICTED: serine/threonine-protein kinase CTR1-like [Glycine max]

 Score =  610 bits (1574), Expect = e-172,   Method: Compositional matrix adjust.
 Identities = 293/389 (75%), Positives = 332/389 (85%), Gaps = 11/389 (2%)

Query: 11  VGELTSLLGEIGLNIQEAHAFSTVDGFSLDVFVVDGWPYDETEDLKNVLAKEILKSKFLI 70
           + +LT++LGE+GLNIQEAHAFST DGFSLDVFVV+GWP +ETE+LK VL KEI K K   
Sbjct: 194 LSQLTAILGEMGLNIQEAHAFSTTDGFSLDVFVVEGWPNEETEELKGVLEKEIFKVK--- 250

Query: 71  AMQDQSCSKRQPALGVPMHSKLLIESSPNCIEIPTDGTDVWEIDAKQLKIECKVASGSYG 130
              +Q+ S +          +  +E SP+CI IP+DG DVWEID  QLK E KV SGS+G
Sbjct: 251 ---EQNMSNQGIHYATNEQYQARMEPSPHCILIPSDGADVWEIDTNQLKYENKVGSGSFG 307

Query: 131 DLYKGTYCSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCI 190
           DLY+GTYCSQ+VAIKVLKPE ++T+ML+EF+QEVYIMRKIRHKNVVQFIGACTRPPNLCI
Sbjct: 308 DLYRGTYCSQDVAIKVLKPERISTDMLREFAQEVYIMRKIRHKNVVQFIGACTRPPNLCI 367

Query: 191 VTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDEN 250
           VTEFM+RGS+YDFLHKQ+GVF+L SLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDEN
Sbjct: 368 VTEFMSRGSLYDFLHKQRGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDEN 427

Query: 251 GVVKVADFGVARVQAQSGVMTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTGE 310
            VVKVADFGVARVQ QSGVMTAETGTYRWMAPEVIEHKPYD KADVFSFGIALWELLTGE
Sbjct: 428 EVVKVADFGVARVQTQSGVMTAETGTYRWMAPEVIEHKPYDQKADVFSFGIALWELLTGE 487

Query: 311 LPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRLAELLERCWQHDPTQRPNFSQITDILKQM 370
           LPY+ LTPLQAAVGVVQK LRPTIPK+ HPRL+ELL+RCWQ DPTQRPNFS+I +IL+Q+
Sbjct: 488 LPYSCLTPLQAAVGVVQKGLRPTIPKNTHPRLSELLQRCWQQDPTQRPNFSEIIEILQQI 547

Query: 371 MKEVASEGENNHSNKSAGSFFSSLRRGLH 399
            KEV     N+H +KS+  F S+LRR  H
Sbjct: 548 AKEV-----NDHKDKSSHGFLSALRRAHH 571

Source: Glycine max

Species: Glycine max

Genus: Glycine

Family: Fabaceae

Order: Fabales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|357483963|ref|XP_003612268.1| Dual specificity protein kinase pyk2 [Medicago truncatula] gi|355513603|gb|AES95226.1| Dual specificity protein kinase pyk2 [Medicago truncatula]

 Score =  605 bits (1560), Expect = e-170,   Method: Compositional matrix adjust.
 Identities = 292/389 (75%), Positives = 330/389 (84%), Gaps = 8/389 (2%)

Query: 11  VGELTSLLGEIGLNIQEAHAFSTVDGFSLDVFVVDGWPYDETEDLKNVLAKEILKSKFLI 70
           + +LTS+LGEIGLNIQEAHAFST DGFSLDVFVV+GWP +ETE+LK VL KEILK K   
Sbjct: 194 LSQLTSILGEIGLNIQEAHAFSTSDGFSLDVFVVEGWPNEETEELKGVLEKEILKVK--- 250

Query: 71  AMQDQSCSKRQPALGVPMHSKLLIESSPNCIEIPTDGTDVWEIDAKQLKIECKVASGSYG 130
              DQ  S +          +  +ESSP+CI+IP DG DVWEID  QLK E KV SGS+G
Sbjct: 251 ---DQYLSNQGTLYSSNDQYQTRMESSPDCIQIPFDGADVWEIDPSQLKYENKVGSGSFG 307

Query: 131 DLYKGTYCSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCI 190
           DL++G+YCSQ+VAIKVLKPE ++T+MLKEF+QEVYIMRKIRHKNVVQFIGACTRPPNLCI
Sbjct: 308 DLFRGSYCSQDVAIKVLKPERISTDMLKEFAQEVYIMRKIRHKNVVQFIGACTRPPNLCI 367

Query: 191 VTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDEN 250
           VTEFM+RGS+YDFLH+QKGVF+L SLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDEN
Sbjct: 368 VTEFMSRGSLYDFLHRQKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDEN 427

Query: 251 GVVKVADFGVARVQAQSGVMTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTGE 310
            +VKVADFGVARVQ QSGVMTAETGTYRWMAPEVIEHKPYD KADVFSFGIALWELLTGE
Sbjct: 428 ELVKVADFGVARVQTQSGVMTAETGTYRWMAPEVIEHKPYDQKADVFSFGIALWELLTGE 487

Query: 311 LPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRLAELLERCWQHDPTQRPNFSQITDILKQM 370
           LPY+ LTPLQAAVGVVQK LRPTIPK+ HPR++ELL+RCWQ DP +RP FS+I +IL+ +
Sbjct: 488 LPYSYLTPLQAAVGVVQKGLRPTIPKNTHPRISELLQRCWQQDPKERPAFSEIIEILQHI 547

Query: 371 MKEVASEGENNHSNKSAGSFFSSLRRGLH 399
            KEV     + H +KS+  F SSLRRG H
Sbjct: 548 AKEV--NDVDRHKDKSSHGFLSSLRRGHH 574

Source: Medicago truncatula

Species: Medicago truncatula

Genus: Medicago

Family: Fabaceae

Order: Fabales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|365222936|gb|AEW69820.1| Hop-interacting protein THI135 [Solanum lycopersicum]

 Score =  603 bits (1555), Expect = e-170,   Method: Compositional matrix adjust.
 Identities = 286/388 (73%), Positives = 328/388 (84%), Gaps = 13/388 (3%)

Query: 13  ELTSLLGEIGLNIQEAHAFSTVDGFSLDVFVVDGWPYDETEDLKNVLAKEILKSKFLIAM 72
           +LT+++ EIGLNI+EAH FST DGFSLDVFVVDGWPY+ETE LK+ + KE+++SK     
Sbjct: 187 QLTNIISEIGLNIEEAHVFSTTDGFSLDVFVVDGWPYEETELLKSEVQKEVMRSK----- 241

Query: 73  QDQSCSKRQPALGVPMHSK-LLIESSPNCIEIPTDGTDVWEIDAKQLKIECKVASGSYGD 131
                   QP +  P+       ES  + ++IPTDG+D WEID + LK E KVASGS+GD
Sbjct: 242 -------EQPQVLPPISEPGQTSESGSDSVKIPTDGSDDWEIDIRLLKFENKVASGSFGD 294

Query: 132 LYKGTYCSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIV 191
           LYKGTYCSQEVAIKVLKPE +N +M+KEFSQEV+IMRKIRHKNVVQFIGACTRPPNLCIV
Sbjct: 295 LYKGTYCSQEVAIKVLKPENLNMDMVKEFSQEVFIMRKIRHKNVVQFIGACTRPPNLCIV 354

Query: 192 TEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENG 251
           TEFM RGSIY FLHKQ+G F+L +LLKVAIDVSKGM+YLHQNNIIHRDLKTANLLMDE+G
Sbjct: 355 TEFMTRGSIYTFLHKQRGAFKLPTLLKVAIDVSKGMSYLHQNNIIHRDLKTANLLMDEHG 414

Query: 252 VVKVADFGVARVQAQSGVMTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTGEL 311
           VVKV DFGVARVQ Q+GVMTAETGTYRWMAPEVIEHKPYD+KADVFSFGI LWELLTGE+
Sbjct: 415 VVKVGDFGVARVQTQTGVMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGEI 474

Query: 312 PYAGLTPLQAAVGVVQKSLRPTIPKHAHPRLAELLERCWQHDPTQRPNFSQITDILKQMM 371
           PYA LTPLQAA+GVVQ+ LRPTIPK  HP+LAELLE+CWQ DPTQRP+FS+I DILKQ+ 
Sbjct: 475 PYAYLTPLQAAIGVVQQGLRPTIPKSTHPKLAELLEKCWQQDPTQRPDFSEILDILKQLT 534

Query: 372 KEVASEGENNHSNKSAGSFFSSLRRGLH 399
           KEV  +GE+ H +KS G FFSSLR+G H
Sbjct: 535 KEVGDDGEDRHKDKSIGGFFSSLRKGNH 562

Source: Solanum lycopersicum

Species: Solanum lycopersicum

Genus: Solanum

Family: Solanaceae

Order: Solanales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|297798344|ref|XP_002867056.1| kinase family protein [Arabidopsis lyrata subsp. lyrata] gi|297312892|gb|EFH43315.1| kinase family protein [Arabidopsis lyrata subsp. lyrata]

 Score =  592 bits (1527), Expect = e-167,   Method: Compositional matrix adjust.
 Identities = 283/387 (73%), Positives = 323/387 (83%), Gaps = 10/387 (2%)

Query: 11  VGELTSLLGEIGLNIQEAHAFSTVDGFSLDVFVVDGWPYDETEDLKNVLAKEILKSKFLI 70
           + +LTS+LGE+GLNIQEAHAFST DGFSLDVFVVDGW  +ETE LK+ L KEI K     
Sbjct: 192 LSQLTSMLGELGLNIQEAHAFSTADGFSLDVFVVDGWSQEETEGLKDALTKEIRK----- 246

Query: 71  AMQDQSCSKRQPALGVPMHSKLLIESSPNCIEIPTDGTDVWEIDAKQLKIECKVASGSYG 130
            ++DQ CSK Q ++    H K   E  P C+EIPTDGTD WEID KQLKIE KVA GSYG
Sbjct: 247 -LKDQPCSK-QKSITFFEHDKSTNELLPACVEIPTDGTDEWEIDMKQLKIEKKVACGSYG 304

Query: 131 DLYKGTYCSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCI 190
           +L++GTYCSQEVAIK+LKPE VN EML+EFSQEVYIMRK+RHKNVVQFIGACTR PNLCI
Sbjct: 305 ELFRGTYCSQEVAIKILKPERVNAEMLREFSQEVYIMRKVRHKNVVQFIGACTRSPNLCI 364

Query: 191 VTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDEN 250
           VTEFM RGSIYDFLHK KGVF++ SLLKVA+DVSKGMNYLHQNNIIHRDLKTANLLMDE+
Sbjct: 365 VTEFMTRGSIYDFLHKHKGVFKIQSLLKVALDVSKGMNYLHQNNIIHRDLKTANLLMDEH 424

Query: 251 GVVKVADFGVARVQAQSGVMTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTGE 310
            VVKVADFGVARVQ +SGVMTAETGTYRWMAPEVIEHKPYD++ADVFS+ I LWELLTGE
Sbjct: 425 EVVKVADFGVARVQTESGVMTAETGTYRWMAPEVIEHKPYDHRADVFSYAIVLWELLTGE 484

Query: 311 LPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRLAELLERCWQHDPTQRPNFSQITDILKQM 370
           LPY+ LTPLQAAVGVVQK LRP IPK  HP+L ELLE+CWQ DP QRPNF++I ++L Q+
Sbjct: 485 LPYSYLTPLQAAVGVVQKGLRPKIPKETHPKLTELLEKCWQQDPAQRPNFAEIIEMLNQL 544

Query: 371 MKEVASEGENNHSNKSAGSFFSSLRRG 397
           ++EV   G++       G +FS L++G
Sbjct: 545 IREV---GDDERHKDKHGGYFSDLKKG 568

Source: Arabidopsis lyrata subsp. lyrata

Species: Arabidopsis lyrata

Genus: Arabidopsis

Family: Brassicaceae

Order: Brassicales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|224133576|ref|XP_002327629.1| predicted protein [Populus trichocarpa] gi|222836714|gb|EEE75107.1| predicted protein [Populus trichocarpa]

 Score =  590 bits (1520), Expect = e-166,   Method: Compositional matrix adjust.
 Identities = 290/380 (76%), Positives = 322/380 (84%), Gaps = 16/380 (4%)

Query: 11  VGELTSLLGEIGLNIQEAHAFSTVDGFSLDVFVVDGWPYDETEDLKNVLAKEILKSK--- 67
           + +LTSLL EIGLNIQEAHAFSTVDGFSLDVFVVDGW  +ETE+LKN L KEILK+K   
Sbjct: 201 LSQLTSLLAEIGLNIQEAHAFSTVDGFSLDVFVVDGWLCEETEELKNALEKEILKAKDQC 260

Query: 68  -------FLIAMQDQSCSKRQ-PALGVPMHSKLLIESSPNCIEIPTDGTDVWEIDAKQLK 119
                   LI  Q+++  K     + +P    LL     + ++IP+DGTDVWEID  QLK
Sbjct: 261 FPNQLSVSLIGEQNKTGVKSLLDNVQIPSDGTLL-----DNVQIPSDGTDVWEIDTSQLK 315

Query: 120 IECKVASGSYGDLYKGTYCSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFI 179
           +E KVASGSYGDLY+G YCSQEVAIKVLKPE V+ EML+EFSQEVYIMRK+RHKNVVQ I
Sbjct: 316 VENKVASGSYGDLYRGIYCSQEVAIKVLKPERVSAEMLREFSQEVYIMRKVRHKNVVQLI 375

Query: 180 GACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRD 239
           GACTR PNLCIVTEFMA+GS+Y+FLHKQKGVF+L SL+KVAIDVSKGMNYLHQNNIIHRD
Sbjct: 376 GACTRSPNLCIVTEFMAKGSLYNFLHKQKGVFKLPSLIKVAIDVSKGMNYLHQNNIIHRD 435

Query: 240 LKTANLLMDENGVVKVADFGVARVQAQSGVMTAETGTYRWMAPEVIEHKPYDYKADVFSF 299
           LKTANLLMDEN VVKVADFGVARVQ QSGVMTAETGTYRWMAPEVIEHKPYDYKADVFSF
Sbjct: 436 LKTANLLMDENEVVKVADFGVARVQTQSGVMTAETGTYRWMAPEVIEHKPYDYKADVFSF 495

Query: 300 GIALWELLTGELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRLAELLERCWQHDPTQRPN 359
           GI +WELLTGELPY+ LTPLQAAVGVVQK LRPTIPKH +P+LAELLERCWQ DPTQRPN
Sbjct: 496 GIVMWELLTGELPYSYLTPLQAAVGVVQKGLRPTIPKHTYPKLAELLERCWQRDPTQRPN 555

Query: 360 FSQITDILKQMMKEVASEGE 379
           FSQI DIL+Q+ KE+   G+
Sbjct: 556 FSQIIDILQQIAKELEMRGK 575

Source: Populus trichocarpa

Species: Populus trichocarpa

Genus: Populus

Family: Salicaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|22329194|ref|NP_195303.2| ACT-like protein tyrosine kinase family protein [Arabidopsis thaliana] gi|20260236|gb|AAM13016.1| putative protein [Arabidopsis thaliana] gi|22136520|gb|AAM91338.1| putative protein [Arabidopsis thaliana] gi|332661163|gb|AEE86563.1| ACT-like protein tyrosine kinase family protein [Arabidopsis thaliana]

 Score =  588 bits (1516), Expect = e-165,   Method: Compositional matrix adjust.
 Identities = 283/387 (73%), Positives = 321/387 (82%), Gaps = 10/387 (2%)

Query: 11  VGELTSLLGEIGLNIQEAHAFSTVDGFSLDVFVVDGWPYDETEDLKNVLAKEILKSKFLI 70
           + +LTS+LGE+GLNIQEAHAFST DGFSLDVFVVDGW  +ETE LK+ L KEI K K   
Sbjct: 192 LSQLTSMLGELGLNIQEAHAFSTADGFSLDVFVVDGWSQEETEGLKDALKKEIRKFK--- 248

Query: 71  AMQDQSCSKRQPALGVPMHSKLLIESSPNCIEIPTDGTDVWEIDAKQLKIECKVASGSYG 130
              DQ CSK Q ++    H K   E  P C+EIPTDGTD WEID KQLKIE KVA GSYG
Sbjct: 249 ---DQPCSK-QKSITFFEHDKSTNELLPACVEIPTDGTDEWEIDMKQLKIEKKVACGSYG 304

Query: 131 DLYKGTYCSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCI 190
           +L++GTYCSQEVAIK+LKPE VN EML+EFSQEVYIMRK+RHKNVVQFIGACTR PNLCI
Sbjct: 305 ELFRGTYCSQEVAIKILKPERVNAEMLREFSQEVYIMRKVRHKNVVQFIGACTRSPNLCI 364

Query: 191 VTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDEN 250
           VTEFM RGSIYDFLHK KGVF++ SLLKVA+DVSKGMNYLHQNNIIHRDLKTANLLMDE+
Sbjct: 365 VTEFMTRGSIYDFLHKHKGVFKIQSLLKVALDVSKGMNYLHQNNIIHRDLKTANLLMDEH 424

Query: 251 GVVKVADFGVARVQAQSGVMTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTGE 310
            VVKVADFGVARVQ +SGVMTAETGTYRWMAPEVIEHKPYD++ADVFS+ I LWELLTGE
Sbjct: 425 EVVKVADFGVARVQTESGVMTAETGTYRWMAPEVIEHKPYDHRADVFSYAIVLWELLTGE 484

Query: 311 LPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRLAELLERCWQHDPTQRPNFSQITDILKQM 370
           LPY+ LTPLQAAVGVVQK LRP IPK  HP+L ELLE+CWQ DP  RPNF++I ++L Q+
Sbjct: 485 LPYSYLTPLQAAVGVVQKGLRPKIPKETHPKLTELLEKCWQQDPALRPNFAEIIEMLNQL 544

Query: 371 MKEVASEGENNHSNKSAGSFFSSLRRG 397
           ++EV   G++       G +FS L++G
Sbjct: 545 IREV---GDDERHKDKHGGYFSGLKKG 568

Source: Arabidopsis thaliana

Species: Arabidopsis thaliana

Genus: Arabidopsis

Family: Brassicaceae

Order: Brassicales

Phylum: Streptophyta

Superkingdom: Eukaryota

---

Prediction of Gene Ontology (GO) Terms

Close Homologs with Gene Ontology terms Detected by BLAST

Original result of BLAST against Gene Ontology (AMIGO)

ID	Length	Definition	Q cover	H cover	Identity	E-value
Query	399
TAIR|locus:2128043	570	STY17 "serine/threonine/tyrosi	0.944	0.661	0.733	9.8e-151
TAIR|locus:2827943	546	STY8 "serine/threonine/tyrosin	0.894	0.653	0.747	2.6e-143
TAIR|locus:2121154	575	STY46 "serine/threonine/tyrosi	0.944	0.655	0.689	1.9e-140
TAIR|locus:2126311	412	AT4G31170 [Arabidopsis thalian	0.679	0.657	0.462	9.4e-66
TAIR|locus:2061092	411	AT2G24360 [Arabidopsis thalian	0.679	0.659	0.458	3.2e-65
DICTYBASE|DDB_G0267514	916	DDB_G0267514 "protein kinase,	0.694	0.302	0.431	7.1e-63
TAIR|locus:2144613	821	CTR1 "CONSTITUTIVE TRIPLE RESP	0.714	0.347	0.419	6.4e-60
DICTYBASE|DDB_G0289709	690	drkB "DRK subfamily protein ki	0.701	0.405	0.414	1.7e-59
DICTYBASE|DDB_G0289791	642	drkA "DRK subfamily protein ki	0.654	0.406	0.438	2.2e-59
TAIR|locus:2154573	525	AT5G58950 [Arabidopsis thalian	0.726	0.552	0.39	4.5e-59

TAIR|locus:2128043 STY17 "serine/threonine/tyrosine kinase 17" [Arabidopsis thaliana (taxid:3702)]

 Score = 1471 (522.9 bits), Expect = 9.8e-151, P = 9.8e-151
 Identities = 284/387 (73%), Positives = 322/387 (83%)

Query:    11 VGELTSLLGEIGLNIQEAHAFSTVDGFSLDVFVVDGWPYDETEDLKNVLAKEILKSKFLI 70
             + +LTS+LGE+GLNIQEAHAFST DGFSLDVFVVDGW  +ETE LK+ L KEI K K   
Sbjct:   192 LSQLTSMLGELGLNIQEAHAFSTADGFSLDVFVVDGWSQEETEGLKDALKKEIRKFK--- 248

Query:    71 AMQDQSCSKRQPALGVPMHSKLLIESSPNCIEIPTDGTDVWEIDAKQLKIECKVASGSYG 130
                DQ CSK Q ++    H K   E  P C+EIPTDGTD WEID KQLKIE KVA GSYG
Sbjct:   249 ---DQPCSK-QKSITFFEHDKSTNELLPACVEIPTDGTDEWEIDMKQLKIEKKVACGSYG 304

Query:   131 DLYKGTYCSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCI 190
             +L++GTYCSQEVAIK+LKPE VN EML+EFSQEVYIMRK+RHKNVVQFIGACTR PNLCI
Sbjct:   305 ELFRGTYCSQEVAIKILKPERVNAEMLREFSQEVYIMRKVRHKNVVQFIGACTRSPNLCI 364

Query:   191 VTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDEN 250
             VTEFM RGSIYDFLHK KGVF++ SLLKVA+DVSKGMNYLHQNNIIHRDLKTANLLMDE+
Sbjct:   365 VTEFMTRGSIYDFLHKHKGVFKIQSLLKVALDVSKGMNYLHQNNIIHRDLKTANLLMDEH 424

Query:   251 GVVKVADFGVARVQAQSGVMTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTGE 310
              VVKVADFGVARVQ +SGVMTAETGTYRWMAPEVIEHKPYD++ADVFS+ I LWELLTGE
Sbjct:   425 EVVKVADFGVARVQTESGVMTAETGTYRWMAPEVIEHKPYDHRADVFSYAIVLWELLTGE 484

Query:   311 LPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRLAELLERCWQHDPTQRPNFSQITDILKQM 370
             LPY+ LTPLQAAVGVVQK LRP IPK  HP+L ELLE+CWQ DP  RPNF++I ++L Q+
Sbjct:   485 LPYSYLTPLQAAVGVVQKGLRPKIPKETHPKLTELLEKCWQQDPALRPNFAEIIEMLNQL 544

Query:   371 MKEVASEGENNHSNKSAGSFFSSLRRG 397
             ++EV  +    H +K  G +FS L++G
Sbjct:   545 IREVGDD--ERHKDKHGG-YFSGLKKG 568

GO:0004672 "protein kinase activity" evidence=IEA;ISS

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0008152 "metabolic process" evidence=IEA

GO:0016597 "amino acid binding" evidence=IEA

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0004712 "protein serine/threonine/tyrosine kinase activity" evidence=ISS

GO:0005829 "cytosol" evidence=IDA

GO:0009658 "chloroplast organization" evidence=IGI

GO:0007015 "actin filament organization" evidence=RCA

TAIR|locus:2827943 STY8 "serine/threonine/tyrosine kinase 8" [Arabidopsis thaliana (taxid:3702)]

 Score = 1401 (498.2 bits), Expect = 2.6e-143, P = 2.6e-143
 Identities = 272/364 (74%), Positives = 309/364 (84%)

Query:    11 VGELTSLLGEIGLNIQEAHAFSTVDGFSLDVFVVDGWPYDETEDLKNVLAKEILKSKFLI 70
             + +LTSLLGE+GLNIQEAHAFSTVDGFSLDVFVVDGW  +ET+ L++ L+KEILK K   
Sbjct:   186 LSQLTSLLGELGLNIQEAHAFSTVDGFSLDVFVVDGWSQEETDGLRDALSKEILKLK--- 242

Query:    71 AMQDQSCSKRQPALGVPMHSKLLIESSPNCIEIPTDGTDVWEIDAKQLKIECKVASGSYG 130
                DQ  SK Q ++    H K   E  P CIEIPTDGTD WEID  QLKIE KVASGSYG
Sbjct:   243 ---DQPGSK-QKSISFFEHDKSSNELIPACIEIPTDGTDEWEIDVTQLKIEKKVASGSYG 298

Query:   131 DLYKGTYCSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCI 190
             DL++GTYCSQEVAIK LKP+ VN EML+EFSQEV+IMRK+RHKNVVQF+GACTR P LCI
Sbjct:   299 DLHRGTYCSQEVAIKFLKPDRVNNEMLREFSQEVFIMRKVRHKNVVQFLGACTRSPTLCI 358

Query:   191 VTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDEN 250
             VTEFMARGSIYDFLHKQK  F+L +LLKVA+DV+KGM+YLHQNNIIHRDLKTANLLMDE+
Sbjct:   359 VTEFMARGSIYDFLHKQKCAFKLQTLLKVALDVAKGMSYLHQNNIIHRDLKTANLLMDEH 418

Query:   251 GVVKVADFGVARVQAQSGVMTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTGE 310
             G+VKVADFGVARVQ +SGVMTAETGTYRWMAPEVIEHKPY++KADVFS+ I LWELLTG+
Sbjct:   419 GLVKVADFGVARVQIESGVMTAETGTYRWMAPEVIEHKPYNHKADVFSYAIVLWELLTGD 478

Query:   311 LPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRLAELLERCWQHDPTQRPNFSQITDILKQM 370
             +PYA LTPLQAAVGVVQK LRP IPK  HP++  LLERCW  DP QRP F +I ++L+Q+
Sbjct:   479 IPYAFLTPLQAAVGVVQKGLRPKIPKKTHPKVKGLLERCWHQDPEQRPLFEEIIEMLQQI 538

Query:   371 MKEV 374
             MKEV
Sbjct:   539 MKEV 542

GO:0004672 "protein kinase activity" evidence=IEA;ISS

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA;IDA

GO:0005524 "ATP binding" evidence=IEA

GO:0005634 "nucleus" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0008152 "metabolic process" evidence=IEA

GO:0016597 "amino acid binding" evidence=IEA

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0004712 "protein serine/threonine/tyrosine kinase activity" evidence=ISS

GO:0005829 "cytosol" evidence=IDA

GO:0009658 "chloroplast organization" evidence=IGI

GO:0007015 "actin filament organization" evidence=RCA

TAIR|locus:2121154 STY46 "serine/threonine/tyrosine kinase 46" [Arabidopsis thaliana (taxid:3702)]

 Score = 1374 (488.7 bits), Expect = 1.9e-140, P = 1.9e-140
 Identities = 266/386 (68%), Positives = 315/386 (81%)

Query:    13 ELTSLLGEIGLNIQEAHAFSTVDGFSLDVFVVDGWPYDETEDLKNVLAKEILKSKFLIAM 72
             +LT+LL E+GLNIQEAHAFST DG+SLDVFVVDGWPY+ETE L+  L KE  K    I +
Sbjct:   192 QLTALLAELGLNIQEAHAFSTTDGYSLDVFVVDGWPYEETERLRISLEKEAAK----IEL 247

Query:    73 QDQSCSKRQPALGVPMHSKLLIESSPNCIEIPTDGTDVWEIDAKQLKIECKVASGSYGDL 132
             Q QS   +Q       + +     +   + IP DGTDVWEI+ K LK   K+ASGSYGDL
Sbjct:   248 QSQSWPMQQSFSPEKENGQT---GARTHVPIPNDGTDVWEINLKHLKFGHKIASGSYGDL 304

Query:   133 YKGTYCSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVT 192
             YKGTYCSQEVAIKVLKPE +++++ KEF+QEV+IMRK+RHKNVVQFIGACT+PP+LCIVT
Sbjct:   305 YKGTYCSQEVAIKVLKPERLDSDLEKEFAQEVFIMRKVRHKNVVQFIGACTKPPHLCIVT 364

Query:   193 EFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGV 252
             EFM  GS+YD+LHKQKGVF+L +L KVAID+ KGM+YLHQNNIIHRDLK ANLLMDEN V
Sbjct:   365 EFMPGGSVYDYLHKQKGVFKLPTLFKVAIDICKGMSYLHQNNIIHRDLKAANLLMDENEV 424

Query:   253 VKVADFGVARVQAQSGVMTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELP 312
             VKVADFGVARV+AQ+GVMTAETGTYRWMAPEVIEHKPYD+KADVFS+GI LWELLTG+LP
Sbjct:   425 VKVADFGVARVKAQTGVMTAETGTYRWMAPEVIEHKPYDHKADVFSYGIVLWELLTGKLP 484

Query:   313 YAGLTPLQAAVGVVQKSLRPTIPKHAHPRLAELLERCWQHDPTQRPNFSQITDILKQMMK 372
             Y  +TPLQAAVGVVQK LRPTIPK+ HP+LAELLER W+HD TQRP+FS+I + L+++ K
Sbjct:   485 YEYMTPLQAAVGVVQKGLRPTIPKNTHPKLAELLERLWEHDSTQRPDFSEIIEQLQEIAK 544

Query:   373 EVASEGENNHSNKSA--GSFFSSLRR 396
             EV  EGE    + +   G  F++LRR
Sbjct:   545 EVGEEGEEKKKSSTGLGGGIFAALRR 570

GO:0004672 "protein kinase activity" evidence=IEA;ISS

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0008152 "metabolic process" evidence=IEA

GO:0016597 "amino acid binding" evidence=IEA

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0004712 "protein serine/threonine/tyrosine kinase activity" evidence=ISS

GO:0005829 "cytosol" evidence=IDA

GO:0009658 "chloroplast organization" evidence=IGI

GO:0007015 "actin filament organization" evidence=RCA

TAIR|locus:2126311 AT4G31170 [Arabidopsis thaliana (taxid:3702)]

 Score = 669 (240.6 bits), Expect = 9.4e-66, P = 9.4e-66
 Identities = 129/279 (46%), Positives = 186/279 (66%)

Query:   104 PTDGT---DVWEIDAKQLKIECKVASGSYGDLYKGTYCSQEVAIKVLKPECVNTE----M 156
             PT+G    + W ID ++L +    A G++G LY+GTY  ++VAIK+L+    N E    +
Sbjct:   114 PTEGLVNYEEWTIDLRKLHMGPAFAQGAFGKLYRGTYNGEDVAIKLLERSDSNPEKAQAL 173

Query:   157 LKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHK-QKGVFQLTS 215
              ++F QEV ++  ++H N+V+FIGAC +P   CIVTE+   GS+  FL K Q     L  
Sbjct:   174 EQQFQQEVSMLAFLKHPNIVRFIGACIKPMVWCIVTEYAKGGSVRQFLTKRQNRAVPLKL 233

Query:   216 LLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAETG 275
              +  A+DV++GM Y+H+ N IHRDLK+ NLL+  +  +K+ADFGVAR++ Q+  MT ETG
Sbjct:   234 AVMQALDVARGMAYVHERNFIHRDLKSDNLLISADRSIKIADFGVARIEVQTEGMTPETG 293

Query:   276 TYRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKSLRPTIP 335
             TYRWMAPE+I+H+PY  K DV+SFGI LWEL+TG LP+  +T +QAA  VV + +RPT+P
Sbjct:   294 TYRWMAPEMIQHRPYTQKVDVYSFGIVLWELITGLLPFQNMTAVQAAFAVVNRGVRPTVP 353

Query:   336 KHAHPRLAELLERCWQHDPTQRPNFSQITDILKQMMKEV 374
                 P L E++ RCW  DP  RP F++I ++L+    E+
Sbjct:   354 ADCLPVLGEIMTRCWDADPEVRPCFAEIVNLLEAAETEI 392

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005634 "nucleus" evidence=ISM

GO:0005886 "plasma membrane" evidence=ISM

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0004712 "protein serine/threonine/tyrosine kinase activity" evidence=ISS

GO:0006499 "N-terminal protein myristoylation" evidence=RCA

GO:0006914 "autophagy" evidence=RCA

GO:0010053 "root epidermal cell differentiation" evidence=IMP

TAIR|locus:2061092 AT2G24360 [Arabidopsis thaliana (taxid:3702)]

 Score = 664 (238.8 bits), Expect = 3.2e-65, P = 3.2e-65
 Identities = 128/279 (45%), Positives = 186/279 (66%)

Query:   104 PTDGT---DVWEIDAKQLKIECKVASGSYGDLYKGTYCSQEVAIKVL-KPECVNTE---M 156
             PT+G    D W ID ++L +    A G++G LYKGTY  ++VAIK+L +PE    +   M
Sbjct:   113 PTEGLTNYDEWTIDLRKLNMGPAFAQGAFGKLYKGTYNGEDVAIKILERPENSPEKAQFM 172

Query:   157 LKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFL-HKQKGVFQLTS 215
              ++F QEV ++  ++H N+V+FIGAC +P   CIVTE+   GS+  FL  +Q     L  
Sbjct:   173 EQQFQQEVSMLANLKHPNIVRFIGACRKPMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKL 232

Query:   216 LLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAETG 275
              +K A+DV++GM Y+H  N IHRDLK+ NLL+  +  +K+ADFGVAR++ Q+  MT ETG
Sbjct:   233 AVKQALDVARGMAYVHGRNFIHRDLKSDNLLISADKSIKIADFGVARIEVQTEGMTPETG 292

Query:   276 TYRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKSLRPTIP 335
             TYRWMAPE+I+H+ Y+ K DV+SFGI LWEL+TG LP+  +T +QAA  VV + +RPT+P
Sbjct:   293 TYRWMAPEMIQHRAYNQKVDVYSFGIVLWELITGLLPFQNMTAVQAAFAVVNRGVRPTVP 352

Query:   336 KHAHPRLAELLERCWQHDPTQRPNFSQITDILKQMMKEV 374
                 P L++++ RCW  +P  RP F ++  +L+    E+
Sbjct:   353 NDCLPVLSDIMTRCWDANPEVRPCFVEVVKLLEAAETEI 391

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM;IDA

GO:0006468 "protein phosphorylation" evidence=IEA;IDA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0004712 "protein serine/threonine/tyrosine kinase activity" evidence=ISS

GO:0004713 "protein tyrosine kinase activity" evidence=IDA

GO:0006487 "protein N-linked glycosylation" evidence=RCA

GO:0006499 "N-terminal protein myristoylation" evidence=RCA

DICTYBASE|DDB_G0267514 DDB_G0267514 "protein kinase, TKL group" [Dictyostelium discoideum (taxid:44689)]

 Score = 643 (231.4 bits), Expect = 7.1e-63, P = 7.1e-63
 Identities = 122/283 (43%), Positives = 194/283 (68%)

Query:    93 LIESSPNCIEIPTDGTDVW---EIDAKQLKIECKVASGSYGDLYKGTYCSQEVAIKVLK- 148
             ++++S + +E P+     +   EI   +LKI  K+  G++G +YKG +    VAIK +K 
Sbjct:   634 ILKNSGSVVEPPSQQQQYFSDIEISFSELKISSKLGEGTFGVVYKGLWRGSSVAIKQIKI 693

Query:   149 PECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQK 208
              E VN ++L+EF +E+ I+ ++RH N+V  + ACT PPNLC +TE++  GS+YD LH +K
Sbjct:   694 NEDVNNQVLEEFRKELTILSRLRHPNIVLLMAACTAPPNLCFITEYLPGGSLYDALHSKK 753

Query:   209 GVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSG 268
                 +    K+AI +++GMNYLH + +IHRD+K+ NLL+DE+  VK+ DFG+++++++S 
Sbjct:   754 IKMNMQLYKKLAIQIAQGMNYLHLSGVIHRDIKSLNLLLDEHMNVKICDFGLSKLKSKST 813

Query:   269 VMTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQK 328
              MT   G+  WM+PE++  + Y  K DV++FGI LWEL TGELPY+GL  +Q A+ V  K
Sbjct:   814 EMTKSIGSPIWMSPELLMGEDYTEKVDVYAFGIILWELGTGELPYSGLDSVQLALAVTTK 873

Query:   329 SLRPTIPKHAHP-RLAELLERCWQHDPTQRPNFSQITDILKQM 370
             SLRP IP +A P +L+ L++ CW  DP +RP+F++I ++L ++
Sbjct:   874 SLRPPIP-NAWPYQLSHLIQACWHQDPLKRPSFTEILNLLNEI 915

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0004672 "protein kinase activity" evidence=IEA

GO:0005575 "cellular_component" evidence=ND

GO:0016740 "transferase activity" evidence=IEA

GO:0016310 "phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=IEA

GO:0000166 "nucleotide binding" evidence=IEA

TAIR|locus:2144613 CTR1 "CONSTITUTIVE TRIPLE RESPONSE 1" [Arabidopsis thaliana (taxid:3702)]

 Score = 614 (221.2 bits), Expect = 6.4e-60, P = 6.4e-60
 Identities = 123/293 (41%), Positives = 193/293 (65%)

Query:    87 PMHSKLLIESSPNCI--EIPTDGTDVWEIDAKQLKIECKVASGSYGDLYKGTYCSQEVAI 144
             PM++  + +  PN    E+  DG D+ +I    L I+ K+ +GS+G +++  +   +VA+
Sbjct:   519 PMNAPPISQPVPNRANRELGLDGDDM-DIPWCDLNIKEKIGAGSFGTVHRAEWHGSDVAV 577

Query:   145 KVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFL 204
             K+L  +  + E + EF +EV IM+++RH N+V F+GA T+PPNL IVTE+++RGS+Y  L
Sbjct:   578 KILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLL 637

Query:   205 HKQKGVFQLTSL--LKVAIDVSKGMNYLHQNN--IIHRDLKTANLLMDENGVVKVADFGV 260
             HK     QL     L +A DV+KGMNYLH  N  I+HRDLK+ NLL+D+   VKV DFG+
Sbjct:   638 HKSGAREQLDERRRLSMAYDVAKGMNYLHNRNPPIVHRDLKSPNLLVDKKYTVKVCDFGL 697

Query:   261 ARVQAQSGVMT-AETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPYAGLTPL 319
             +R++A + + + +  GT  WMAPEV+  +P + K+DV+SFG+ LWEL T + P+  L P 
Sbjct:   698 SRLKASTFLSSKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPWGNLNPA 757

Query:   320 QAAVGVVQKSLRPTIPKHAHPRLAELLERCWQHDPTQRPNFSQITDILKQMMK 372
             Q    V  K  R  IP++ +P++A ++E CW ++P +RP+F+ I D+L+ ++K
Sbjct:   758 QVVAAVGFKCKRLEIPRNLNPQVAAIIEGCWTNEPWKRPSFATIMDLLRPLIK 810

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA;IDA

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005634 "nucleus" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0009744 "response to sucrose stimulus" evidence=IMP

GO:0005515 "protein binding" evidence=IPI

GO:0010105 "negative regulation of ethylene mediated signaling pathway" evidence=TAS

GO:0010182 "sugar mediated signaling pathway" evidence=TAS

GO:0005789 "endoplasmic reticulum membrane" evidence=IDA

GO:0004712 "protein serine/threonine/tyrosine kinase activity" evidence=ISS

GO:0009686 "gibberellin biosynthetic process" evidence=IMP

GO:0048510 "regulation of timing of transition from vegetative to reproductive phase" evidence=IMP

GO:2000035 "regulation of stem cell division" evidence=IMP

GO:2000069 "regulation of post-embryonic root development" evidence=IMP

GO:0071281 "cellular response to iron ion" evidence=IEP

GO:0009750 "response to fructose stimulus" evidence=IMP

GO:0046777 "protein autophosphorylation" evidence=IDA

GO:0009723 "response to ethylene stimulus" evidence=IMP

DICTYBASE|DDB_G0289709 drkB "DRK subfamily protein kinase" [Dictyostelium discoideum (taxid:44689)]

 Score = 610 (219.8 bits), Expect = 1.7e-59, P = 1.7e-59
 Identities = 119/287 (41%), Positives = 182/287 (63%)

Query:   106 DGTDVWEIDAKQLKIECKVASGSYGDLYKGTYCSQEVAIKVLKPECVNTEMLKEFSQEVY 165
             DG D   ID +Q+KI  ++  G++G++Y GT+   +VA+K L    +N  +LKEF +E+ 
Sbjct:   382 DGKD---IDTQQIKIGVRIGKGNFGEVYLGTWRGSQVAVKKLPAHNINENILKEFHREIN 438

Query:   166 IMRKIRHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSK 225
             +M+ +RH NV+QF+G+C   P++CI TE+M RGS+Y  LH +K     + + ++ ID +K
Sbjct:   439 LMKNLRHPNVIQFLGSCLISPDICICTEYMPRGSLYSILHNEKIKISWSLVKRMMIDAAK 498

Query:   226 GMNYLHQNN--IIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAETGTYRWMAPE 283
             G+ YLH +   I+HRDLK+ NLL+DEN  VKVADFG++ ++ Q   MTA  GT  W +PE
Sbjct:   499 GIIYLHGSTPVILHRDLKSHNLLVDENWKVKVADFGLSTIEQQGATMTA-CGTPCWTSPE 557

Query:   284 VIEHKPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRLA 343
             V+  + Y  KADV+SFGI LWE  T + PY G+ P Q    V ++ +RP  PK+  P+  
Sbjct:   558 VLRSQRYTEKADVYSFGIILWECATRQDPYFGIPPFQVIFAVGREGMRPPTPKYGPPKYI 617

Query:   344 ELLERCWQHDPTQRPNFSQITDILKQM-MKEVASEGENNHSNKSAGS 389
             +LL+ C   +P+QRP   Q  +IL+ +  K       NN++N ++ +
Sbjct:   618 QLLKDCLNENPSQRPTMEQCLEILESIETKGFDDIPVNNNNNNNSNN 664

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0004672 "protein kinase activity" evidence=IEA

GO:0005575 "cellular_component" evidence=ND

GO:0016740 "transferase activity" evidence=IEA

GO:0016310 "phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=IEA

GO:0016021 "integral to membrane" evidence=IEA

GO:0016020 "membrane" evidence=IEA

GO:0000166 "nucleotide binding" evidence=IEA

DICTYBASE|DDB_G0289791 drkA "DRK subfamily protein kinase" [Dictyostelium discoideum (taxid:44689)]

 Score = 609 (219.4 bits), Expect = 2.2e-59, P = 2.2e-59
 Identities = 117/267 (43%), Positives = 172/267 (64%)

Query:   106 DGTDVWEIDAKQLKIECKVASGSYGDLYKGTYCSQEVAIKVLKPECVNTEMLKEFSQEVY 165
             DG D   ID  Q+KI  ++  G+YG++Y GT+   +VA+K L    +N  +LKEF +E+ 
Sbjct:   365 DGKD---IDIHQIKIGVRIGKGNYGEVYLGTWRGSQVAVKKLPAHNINENILKEFHREIN 421

Query:   166 IMRKIRHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSK 225
             +M+ +RH NV+QF+G+C  PP++CI TE+M RGS+Y  LH Q    Q + L+K+ ID +K
Sbjct:   422 LMKNLRHPNVIQFLGSCLIPPDICICTEYMPRGSLYSILHDQALQLQWSLLIKMMIDAAK 481

Query:   226 GMNYLHQNN--IIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAETGTYRWMAPE 283
             G+ YLH +   I+HRDLK+ NLL+DEN  VKVADFG++ ++ Q   MTA  GT  W +PE
Sbjct:   482 GVIYLHNSTPVILHRDLKSHNLLVDENWKVKVADFGLSTIEQQGATMTA-CGTPCWTSPE 540

Query:   284 VIEHKPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRLA 343
             V+  + Y  KADV+SFGI LWE  T + PY G+ P Q    V ++ +RP +P++  P+  
Sbjct:   541 VLRSQRYTEKADVYSFGIILWECATRQDPYFGIPPFQVIFAVGREGMRPPVPQNGPPKYI 600

Query:   344 ELLERCWQHDPTQRPNFSQITDILKQM 370
             +LL  C   +P+ RP   Q  + L+ +
Sbjct:   601 QLLIDCLNENPSHRPTMEQCLERLESI 627

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0004672 "protein kinase activity" evidence=IEA

GO:0005575 "cellular_component" evidence=ND

GO:0016740 "transferase activity" evidence=IEA

GO:0016310 "phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=IEA

GO:0016021 "integral to membrane" evidence=IEA

GO:0016020 "membrane" evidence=IEA

GO:0000166 "nucleotide binding" evidence=IEA

GO:0044351 "macropinocytosis" evidence=RCA

TAIR|locus:2154573 AT5G58950 [Arabidopsis thaliana (taxid:3702)]

 Score = 606 (218.4 bits), Expect = 4.5e-59, P = 4.5e-59
 Identities = 117/300 (39%), Positives = 184/300 (61%)

Query:   106 DGTDVWEIDAKQLKIECKVASGSYGDLYKGTYCSQEVAIKVLK-PE-----CVNTEMLKE 159
             + ++ + +D  +L    K A G Y  LY G Y  + VA+K++  P+     C+   + K+
Sbjct:   195 EASEEFRVDMSKLFFGLKFAHGLYSRLYHGKYEDKAVAVKLITVPDDDDNGCLGARLEKQ 254

Query:   160 FSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKG-VFQLTSLLK 218
             F++EV ++ ++ H NV++F+GA   PP  C++T+++  GS+  FLHK +     L  L++
Sbjct:   255 FTKEVTLLSRLTHPNVIKFVGAYKDPPVYCVLTQYLPEGSLRSFLHKPENRSLPLKKLIE 314

Query:   219 VAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAETGTYR 278
              AID+++GM Y+H   IIHRDLK  N+L+DE   +K+ADFG+A  +    ++  + GTYR
Sbjct:   315 FAIDIARGMEYIHSRRIIHRDLKPENVLIDEEFHLKIADFGIACEEEYCDMLADDPGTYR 374

Query:   279 WMAPEVIEHKPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKSLRPTIPKHA 338
             WMAPE+I+ KP+  KADV+SFG+ LWE++ G +PY  + P+QAA  VV K++RP IP   
Sbjct:   375 WMAPEMIKRKPHGRKADVYSFGLVLWEMVAGAIPYEDMNPIQAAFAVVHKNIRPAIPGDC 434

Query:   339 HPRLAELLERCWQHDPTQRPNFSQITDILKQMMKEVASEGENNHSNKSAGSFFSSLRRGL 398
                +  L+E+CW   P +RP F QI  +L+Q    ++ E E N  N S+       R+GL
Sbjct:   435 PVAMKALIEQCWSVAPDKRPEFWQIVKVLEQFA--ISLEREGN-LNLSSSKICKDPRKGL 491

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0004712 "protein serine/threonine/tyrosine kinase activity" evidence=ISS

GO:0005886 "plasma membrane" evidence=IDA

GO:0005829 "cytosol" evidence=IDA

---

Prediction of Enzyme Commission (EC) Number

EC Number Prediction by Annotation Transfer from SWISS-PROT Entries

Original result of BLAST against SWISS-PROT

No confident hit for EC number transfering in SWISSPROT detected by BLAST

EC Number Prediction by Ezypred Server

Original result from Ezypred Server

Fail to connect to Ezypred Server

EC Number Prediction by EFICAz Software

Prediction Level	EC number	Confidence of Prediction
4th Layer	2.7.11.1	LOW CONFIDENCE prediction!
3rd Layer	2.7.11	0.766

---

Prediction of Functionally Associated Proteins

Functionally Associated Proteins Detected by STRING

Original result from the STRING server

Your Input: eugene3.01810006 hypothetical protein (587 aa) (Populus trichocarpa)

Predicted Functional Partners:

Sorry, there are no predicted associations at the current settings.

---

Conserved Domains and Related Protein Families

Conserved Domains Detected by RPS-BLAST

Original result of RPS-BLAST against CDD database part I

ID	Length	Definition	E-value
Query	399
smart00219	257	smart00219, TyrKc, Tyrosine kinase, catalytic doma	8e-92
pfam07714	258	pfam07714, Pkinase_Tyr, Protein tyrosine kinase	1e-91
smart00221	258	smart00221, STYKc, Protein kinase; unclassified sp	4e-90
cd00192	262	cd00192, PTKc, Catalytic domain of Protein Tyrosin	2e-83
pfam00069	260	pfam00069, Pkinase, Protein kinase domain	4e-75
smart00220	254	smart00220, S_TKc, Serine/Threonine protein kinase	8e-73
cd00180	215	cd00180, PKc, Catalytic domain of Protein Kinases	4e-66
cd05122	253	cd05122, PKc_STE, Catalytic domain of STE family P	2e-64
cd05068	261	cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re	8e-64
cd06606	260	cd06606, STKc_MAPKKK, Catalytic domain of the Prot	1e-63
cd05039	256	cd05039, PTKc_Csk_like, Catalytic domain of C-term	2e-62
cd05034	261	cd05034, PTKc_Src_like, Catalytic domain of Src ki	5e-62
cd05052	263	cd05052, PTKc_Abl, Catalytic domain of the Protein	1e-61
cd05059	256	cd05059, PTKc_Tec_like, Catalytic domain of Tec-li	2e-61
cd06627	254	cd06627, STKc_Cdc7_like, Catalytic domain of Cell	9e-59
cd05148	261	cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro	9e-58
cd05041	251	cd05041, PTKc_Fes_like, Catalytic domain of Fes-li	1e-56
cd05033	266	cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec	2e-56
cd08215	258	cd08215, STKc_Nek, Catalytic domain of the Protein	1e-54
cd05082	256	cd05082, PTKc_Csk, Catalytic domain of the Protein	2e-54
cd05112	256	cd05112, PTKc_Itk, Catalytic domain of the Protein	4e-54
cd06612	256	cd06612, STKc_MST1_2, Catalytic domain of the Prot	1e-52
cd05071	262	cd05071, PTKc_Src, Catalytic domain of the Protein	2e-52
cd05069	260	cd05069, PTKc_Yes, Catalytic domain of the Protein	2e-52
cd06609	274	cd06609, STKc_MST3_like, Catalytic domain of Mamma	2e-52
cd05056	270	cd05056, PTKc_FAK, Catalytic domain of the Protein	3e-52
cd05070	260	cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro	4e-52
cd06614	286	cd06614, STKc_PAK, Catalytic domain of the Protein	3e-51
cd05067	260	cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro	4e-51
cd05040	257	cd05040, PTKc_Ack_like, Catalytic domain of the Pr	4e-51
cd05083	254	cd05083, PTKc_Chk, Catalytic domain of the Protein	7e-51
cd05038	284	cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai	9e-51
cd05114	256	cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro	1e-50
cd05072	261	cd05072, PTKc_Lyn, Catalytic domain of the Protein	1e-50
cd05032	277	cd05032, PTKc_InsR_like, Catalytic domain of Insul	3e-50
cd05085	250	cd05085, PTKc_Fer, Catalytic domain of the Protein	1e-49
cd06610	267	cd06610, STKc_OSR1_SPAK, Catalytic domain of the P	2e-49
cd05057	279	cd05057, PTKc_EGFR_like, Catalytic domain of Epide	5e-49
cd05073	260	cd05073, PTKc_Hck, Catalytic domain of the Protein	3e-48
cd06632	258	cd06632, STKc_MEKK1_plant, Catalytic domain of the	3e-48
cd05113	256	cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro	9e-48
cd05053	293	cd05053, PTKc_FGFR, Catalytic domain of the Protei	2e-47
cd05060	257	cd05060, PTKc_Syk_like, Catalytic domain of Spleen	3e-47
cd06625	263	cd06625, STKc_MEKK3_like, Catalytic domain of MAP/	2e-46
cd05055	302	cd05055, PTKc_PDGFR, Catalytic domain of the Prote	3e-46
cd05065	269	cd05065, PTKc_EphR_B, Catalytic domain of the Prot	1e-45
cd05084	252	cd05084, PTKc_Fes, Catalytic domain of the Protein	1e-45
cd06613	262	cd06613, STKc_MAP4K3_like, Catalytic domain of Mit	1e-44
cd05066	267	cd05066, PTKc_EphR_A, Catalytic domain of the Prot	2e-44
cd06623	264	cd06623, PKc_MAPKK_plant_like, Catalytic domain of	3e-44
cd05064	266	cd05064, PTKc_EphR_A10, Catalytic domain of the Pr	4e-44
cd05044	269	cd05044, PTKc_c-ros, Catalytic domain of the Prote	2e-43
cd06917	277	cd06917, STKc_NAK1_like, Catalytic domain of Funga	4e-43
cd05063	268	cd05063, PTKc_EphR_A2, Catalytic domain of the Pro	1e-42
cd08529	256	cd08529, STKc_FA2-like, Catalytic domain of the Pr	2e-42
cd06611	280	cd06611, STKc_SLK_like, Catalytic domain of Ste20-	2e-42
cd05051	296	cd05051, PTKc_DDR, Catalytic domain of the Protein	6e-42
cd05049	280	cd05049, PTKc_Trk, Catalytic domain of the Protein	5e-41
cd06605	265	cd06605, PKc_MAPKK, Catalytic domain of the dual-s	8e-41
cd05036	277	cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro	3e-40
cd06642	277	cd06642, STKc_STK25-YSK1, Catalytic domain of the	3e-40
cd05089	297	cd05089, PTKc_Tie1, Catalytic domain of the Protei	1e-39
cd05099	314	cd05099, PTKc_FGFR4, Catalytic domain of the Prote	1e-39
cd05048	283	cd05048, PTKc_Ror, Catalytic Domain of the Protein	1e-39
cd06628	267	cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o	2e-39
cd05088	303	cd05088, PTKc_Tie2, Catalytic domain of the Protei	2e-39
cd06631	265	cd06631, STKc_YSK4, Catalytic domain of the Protei	3e-39
cd05050	288	cd05050, PTKc_Musk, Catalytic domain of the Protei	5e-39
cd06641	277	cd06641, STKc_MST3, Catalytic domain of the Protei	6e-39
cd05108	316	cd05108, PTKc_EGFR, Catalytic domain of the Protei	7e-39
cd05058	262	cd05058, PTKc_Met_Ron, Catalytic domain of the Pro	1e-38
cd06608	275	cd06608, STKc_myosinIII_like, Catalytic domain of	3e-38
cd06640	277	cd06640, STKc_MST4, Catalytic domain of the Protei	3e-38
cd08530	256	cd08530, STKc_CNK2-like, Catalytic domain of the P	4e-38
cd06626	264	cd06626, STKc_MEKK4, Catalytic domain of the Prote	4e-38
cd05090	283	cd05090, PTKc_Ror1, Catalytic domain of the Protei	4e-38
cd05035	273	cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li	5e-38
cd05098	307	cd05098, PTKc_FGFR1, Catalytic domain of the Prote	6e-38
cd05100	334	cd05100, PTKc_FGFR3, Catalytic domain of the Prote	2e-37
cd05101	304	cd05101, PTKc_FGFR2, Catalytic domain of the Prote	3e-37
cd05110	303	cd05110, PTKc_HER4, Catalytic domain of the Protei	4e-37
COG0515	384	COG0515, SPS1, Serine/threonine protein kinase [Ge	5e-37
cd05047	270	cd05047, PTKc_Tie, Catalytic domain of Tie Protein	1e-36
cd05046	275	cd05046, PTK_CCK4, Pseudokinase domain of the Prot	2e-36
cd05097	295	cd05097, PTKc_DDR_like, Catalytic domain of Discoi	4e-36
cd06630	268	cd06630, STKc_MEKK1, Catalytic domain of the Prote	4e-36
cd05109	279	cd05109, PTKc_HER2, Catalytic domain of the Protei	4e-36
cd06621	287	cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of	4e-36
cd05080	283	cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma	5e-36
cd05079	284	cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma	1e-35
cd05045	290	cd05045, PTKc_RET, Catalytic domain of the Protein	2e-35
cd05074	273	cd05074, PTKc_Tyro3, Catalytic domain of the Prote	5e-35
cd05094	291	cd05094, PTKc_TrkC, Catalytic domain of the Protei	1e-34
cd06624	268	cd06624, STKc_ASK, Catalytic domain of the Protein	1e-34
cd06648	285	cd06648, STKc_PAK_II, Catalytic domain of the Prot	2e-34
cd05116	257	cd05116, PTKc_Syk, Catalytic domain of the Protein	3e-34
cd06629	272	cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o	3e-34
cd05062	277	cd05062, PTKc_IGF-1R, Catalytic domain of the Prot	4e-34
cd08221	256	cd08221, STKc_Nek9, Catalytic domain of the Protei	4e-34
cd05123	250	cd05123, STKc_AGC, Catalytic domain of AGC family	6e-34
cd05096	304	cd05096, PTKc_DDR1, Catalytic domain of the Protei	1e-33
cd06637	272	cd06637, STKc_TNIK, Catalytic domain of the Protei	2e-33
cd05115	257	cd05115, PTKc_Zap-70, Catalytic domain of the Prot	3e-33
cd05111	279	cd05111, PTK_HER3, Pseudokinase domain of the Prot	8e-33
cd05061	288	cd05061, PTKc_InsR, Catalytic domain of the Protei	9e-33
cd06636	282	cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr	1e-32
cd05081	284	cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2)	1e-32
cd05092	280	cd05092, PTKc_TrkA, Catalytic domain of the Protei	3e-32
cd06651	266	cd06651, STKc_MEKK3, Catalytic domain of the Prote	4e-32
cd06620	284	cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of	5e-32
cd07829	282	cd07829, STKc_CDK_like, Catalytic domain of Cyclin	6e-32
cd05093	288	cd05093, PTKc_TrkB, Catalytic domain of the Protei	6e-32
cd08218	256	cd08218, STKc_Nek1, Catalytic domain of the Protei	8e-32
cd06617	283	cd06617, PKc_MKK3_6, Catalytic domain of the dual-	9e-32
cd05579	265	cd05579, STKc_MAST_like, Catalytic domain of Micro	1e-31
cd08225	257	cd08225, STKc_Nek5, Catalytic domain of the Protei	1e-31
cd06652	265	cd06652, STKc_MEKK2, Catalytic domain of the Prote	1e-31
cd08224	267	cd08224, STKc_Nek6_Nek7, Catalytic domain of the P	2e-31
cd08220	256	cd08220, STKc_Nek8, Catalytic domain of the Protei	2e-31
cd08223	257	cd08223, STKc_Nek4, Catalytic domain of the Protei	2e-31
cd05075	272	cd05075, PTKc_Axl, Catalytic domain of the Protein	3e-31
cd05043	280	cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece	4e-31
cd06645	267	cd06645, STKc_MAP4K3, Catalytic domain of the Prot	5e-31
cd06643	282	cd06643, STKc_SLK, Catalytic domain of the Protein	6e-31
cd08217	265	cd08217, STKc_Nek2, Catalytic domain of the Protei	7e-31
cd05095	296	cd05095, PTKc_DDR2, Catalytic domain of the Protei	1e-30
cd05581	280	cd05581, STKc_PDK1, Catalytic domain of the Protei	1e-30
cd05580	290	cd05580, STKc_PKA, Catalytic domain of the Protein	2e-30
cd06657	292	cd06657, STKc_PAK4, Catalytic domain of the Protei	2e-30
cd06647	293	cd06647, STKc_PAK_I, Catalytic domain of the Prote	4e-30
cd08222	260	cd08222, STKc_Nek11, Catalytic domain of the Prote	5e-30
cd06618	296	cd06618, PKc_MKK7, Catalytic domain of the dual-sp	6e-30
cd06653	264	cd06653, STKc_MEKK3_like_1, Catalytic domain of MA	1e-29
cd06644	292	cd06644, STKc_STK10_LOK, Catalytic domain of the P	1e-29
cd05104	375	cd05104, PTKc_Kit, Catalytic domain of the Protein	1e-29
cd06616	288	cd06616, PKc_MKK4, Catalytic domain of the dual-sp	2e-29
cd05054	337	cd05054, PTKc_VEGFR, Catalytic domain of the Prote	2e-29
cd06659	297	cd06659, STKc_PAK6, Catalytic domain of the Protei	3e-29
cd06655	296	cd06655, STKc_PAK2, Catalytic domain of the Protei	3e-29
PLN00034	353	PLN00034, PLN00034, mitogen-activated protein kina	3e-29
cd08228	267	cd08228, STKc_Nek6, Catalytic domain of the Protei	6e-29
cd05118	283	cd05118, STKc_CMGC, Catalytic domain of CMGC famil	7e-29
cd07833	288	cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep	1e-28
cd07840	287	cd07840, STKc_CDK9_like, Catalytic domain of Cycli	2e-28
cd06658	292	cd06658, STKc_PAK5, Catalytic domain of the Protei	3e-28
cd05102	338	cd05102, PTKc_VEGFR3, Catalytic domain of the Prot	3e-28
cd08229	267	cd08229, STKc_Nek7, Catalytic domain of the Protei	5e-28
cd06656	297	cd06656, STKc_PAK3, Catalytic domain of the Protei	6e-28
cd05103	343	cd05103, PTKc_VEGFR2, Catalytic domain of the Prot	1e-27
cd06607	307	cd06607, STKc_TAO, Catalytic domain of the Protein	1e-27
cd05107	401	cd05107, PTKc_PDGFR_beta, Catalytic domain of the	2e-27
cd05572	262	cd05572, STKc_cGK_PKG, Catalytic domain of the Pro	2e-27
cd06619	279	cd06619, PKc_MKK5, Catalytic domain of the dual-sp	3e-27
cd06646	267	cd06646, STKc_MAP4K5, Catalytic domain of the Prot	3e-27
cd05105	400	cd05105, PTKc_PDGFR_alpha, Catalytic domain of the	3e-27
cd06654	296	cd06654, STKc_PAK1, Catalytic domain of the Protei	4e-27
cd05578	258	cd05578, STKc_Yank1, Catalytic domain of the Prote	5e-27
cd07841	298	cd07841, STKc_CDK7, Catalytic domain of the Serine	6e-27
cd05042	269	cd05042, PTKc_Aatyk, Catalytic domain of the Prote	6e-27
cd07846	286	cd07846, STKc_CDKL2_3, Catalytic domain of the Ser	6e-27
cd06634	308	cd06634, STKc_TAO2, Catalytic domain of the Protei	7e-27
cd08219	255	cd08219, STKc_Nek3, Catalytic domain of the Protei	1e-26
cd05037	259	cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) dom	1e-26
cd05091	283	cd05091, PTKc_Ror2, Catalytic domain of the Protei	4e-26
cd05106	374	cd05106, PTKc_CSF-1R, Catalytic domain of the Prot	5e-26
cd06635	317	cd06635, STKc_TAO1, Catalytic domain of the Protei	5e-26
cd06633	313	cd06633, STKc_TAO3, Catalytic domain of the Protei	9e-26
cd05612	291	cd05612, STKc_PRKX_like, Catalytic domain of PRKX-	3e-25
cd07830	283	cd07830, STKc_MAK_like, Catalytic domain of Male g	3e-25
cd05589	324	cd05589, STKc_PKN, Catalytic domain of the Protein	7e-25
cd06638	286	cd06638, STKc_myosinIIIA, Catalytic domain of the	1e-24
cd05611	260	cd05611, STKc_Rim15_like, Catalytic domain of fung	1e-24
PHA02988	283	PHA02988, PHA02988, hypothetical protein; Provisio	2e-24
cd06639	291	cd06639, STKc_myosinIIIB, Catalytic domain of the	2e-24
cd07832	286	cd07832, STKc_CCRK, Catalytic domain of the Serine	2e-24
cd05570	318	cd05570, STKc_PKC, Catalytic domain of the Protein	2e-24
cd08528	269	cd08528, STKc_Nek10, Catalytic domain of the Prote	4e-24
cd05577	277	cd05577, STKc_GRK, Catalytic domain of the Protein	2e-23
cd05087	269	cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t	3e-22
PTZ00263	329	PTZ00263, PTZ00263, protein kinase A catalytic sub	7e-22
cd05606	278	cd05606, STKc_beta_ARK, Catalytic domain of the Pr	8e-22
cd05592	316	cd05592, STKc_nPKC_theta_delta, Catalytic domain o	9e-22
cd05582	318	cd05582, STKc_RSK_N, N-terminal catalytic domain o	1e-21
cd05633	279	cd05633, STKc_GRK3, Catalytic domain of the Protei	2e-21
PHA03209	357	PHA03209, PHA03209, serine/threonine kinase US3; P	2e-21
cd05077	262	cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) do	3e-21
cd05602	325	cd05602, STKc_SGK1, Catalytic domain of the Protei	8e-21
PTZ00283	496	PTZ00283, PTZ00283, serine/threonine protein kinas	9e-21
cd05620	316	cd05620, STKc_nPKC_delta, Catalytic domain of the	1e-20
cd05604	325	cd05604, STKc_SGK3, Catalytic domain of the Protei	2e-20
cd07842	316	cd07842, STKc_CDK8_like, Catalytic domain of Cycli	2e-20
PTZ00426	340	PTZ00426, PTZ00426, cAMP-dependent protein kinase	2e-20
cd05595	323	cd05595, STKc_PKB_beta, Catalytic domain of the Pr	3e-20
cd06622	286	cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of	5e-20
cd07847	286	cd07847, STKc_CDKL1_4, Catalytic domain of the Ser	6e-20
cd05594	325	cd05594, STKc_PKB_alpha, Catalytic domain of the P	8e-20
cd05086	268	cd05086, PTKc_Aatyk2, Catalytic domain of the Prot	1e-19
cd05593	328	cd05593, STKc_PKB_gamma, Catalytic domain of the P	1e-19
cd07836	284	cd07836, STKc_Pho85, Catalytic domain of the Serin	1e-19
cd07851	343	cd07851, STKc_p38, Catalytic domain of the Serine/	2e-19
cd08216	314	cd08216, PK_STRAD, Pseudokinase domain of STE20-re	2e-19
cd07845	309	cd07845, STKc_CDK10, Catalytic domain of the Serin	2e-19
cd04928	68	cd04928, ACT_TyrKc, Uncharacterized, N-terminal AC	3e-19
cd07861	285	cd07861, STKc_CDK1_euk, Catalytic domain of the Se	3e-19
cd07858	337	cd07858, STKc_TEY_MAPK_plant, Catalytic domain of	3e-19
cd05600	333	cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun	4e-19
cd05616	323	cd05616, STKc_cPKC_beta, Catalytic domain of the P	5e-19
cd07865	310	cd07865, STKc_CDK9, Catalytic domain of the Serine	5e-19
cd07866	311	cd07866, STKc_BUR1, Catalytic domain of the Serine	7e-19
cd05078	258	cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat	7e-19
cd05615	323	cd05615, STKc_cPKC_alpha, Catalytic domain of the	7e-19
cd05608	280	cd05608, STKc_GRK1, Catalytic domain of the Protei	8e-19
cd05607	277	cd05607, STKc_GRK7, Catalytic domain of the Protei	8e-19
TIGR03903	1266	TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas	9e-19
cd05587	324	cd05587, STKc_cPKC, Catalytic domain of the Protei	1e-18
cd05076	274	cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) do	3e-18
cd07834	330	cd07834, STKc_MAPK, Catalytic domain of the Serine	3e-18
cd05630	285	cd05630, STKc_GRK6, Catalytic domain of the Protei	3e-18
cd05575	323	cd05575, STKc_SGK, Catalytic domain of the Protein	3e-18
cd07848	287	cd07848, STKc_CDKL5, Catalytic domain of the Serin	3e-18
PTZ00024	335	PTZ00024, PTZ00024, cyclin-dependent protein kinas	4e-18
cd07856	328	cd07856, STKc_Sty1_Hog1, Catalytic domain of the S	4e-18
cd07831	282	cd07831, STKc_MOK, Catalytic domain of the Serine/	5e-18
cd05618	329	cd05618, STKc_aPKC_iota, Catalytic domain of the P	6e-18
cd05571	323	cd05571, STKc_PKB, Catalytic domain of the Protein	6e-18
cd05583	288	cd05583, STKc_MSK_N, N-terminal catalytic domain o	8e-18
cd07843	293	cd07843, STKc_CDC2L1, Catalytic domain of the Seri	9e-18
cd05632	285	cd05632, STKc_GRK5, Catalytic domain of the Protei	9e-18
cd07849	336	cd07849, STKc_ERK1_2_like, Catalytic domain of Ext	1e-17
cd05603	321	cd05603, STKc_SGK2, Catalytic domain of the Protei	1e-17
cd05619	316	cd05619, STKc_nPKC_theta, Catalytic domain of the	1e-17
cd06615	308	cd06615, PKc_MEK, Catalytic domain of the dual-spe	2e-17
cd08226	328	cd08226, PK_STRAD_beta, Pseudokinase domain of STE	4e-17
cd05584	323	cd05584, STKc_p70S6K, Catalytic domain of the Prot	4e-17
PTZ00267	478	PTZ00267, PTZ00267, NIMA-related protein kinase; P	4e-17
cd07879	342	cd07879, STKc_p38delta_MAPK13, Catalytic domain of	7e-17
PHA03212	391	PHA03212, PHA03212, serine/threonine kinase US3; P	9e-17
cd06650	333	cd06650, PKc_MEK1, Catalytic domain of the dual-sp	2e-16
cd05605	285	cd05605, STKc_GRK4_like, Catalytic domain of G pro	3e-16
cd06649	331	cd06649, PKc_MEK2, Catalytic domain of the dual-sp	4e-16
cd07860	284	cd07860, STKc_CDK2_3, Catalytic domain of the Seri	4e-16
cd05609	305	cd05609, STKc_MAST, Catalytic domain of the Protei	4e-16
cd07877	345	cd07877, STKc_p38alpha_MAPK14, Catalytic domain of	5e-16
cd05588	329	cd05588, STKc_aPKC, Catalytic domain of the Protei	5e-16
PHA03390	267	PHA03390, pk1, serine/threonine-protein kinase 1;	5e-16
cd07862	290	cd07862, STKc_CDK6, Catalytic domain of the Serine	6e-16
cd07850	353	cd07850, STKc_JNK, Catalytic domain of the Serine/	7e-16
cd07853	372	cd07853, STKc_NLK, Catalytic domain of the Serine/	8e-16
cd05617	327	cd05617, STKc_aPKC_zeta, Catalytic domain of the P	9e-16
cd07880	343	cd07880, STKc_p38gamma_MAPK12, Catalytic domain of	1e-15
cd05590	320	cd05590, STKc_nPKC_eta, Catalytic domain of the Pr	2e-15
cd05591	321	cd05591, STKc_nPKC_epsilon, Catalytic domain of th	2e-15
cd07869	303	cd07869, STKc_PFTAIRE1, Catalytic domain of the Se	2e-15
cd07875	364	cd07875, STKc_JNK1, Catalytic domain of the Serine	2e-15
cd07855	334	cd07855, STKc_ERK5, Catalytic domain of the Serine	2e-15
cd07870	291	cd07870, STKc_PFTAIRE2, Catalytic domain of the Se	3e-15
cd05631	285	cd05631, STKc_GRK4, Catalytic domain of the Protei	3e-15
cd07839	284	cd07839, STKc_CDK5, Catalytic domain of the Serine	3e-15
cd07854	342	cd07854, STKc_MAPK4_6, Catalytic domain of the Ser	4e-15
cd07838	287	cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc	4e-15
cd05614	332	cd05614, STKc_MSK2_N, N-terminal catalytic domain	6e-15
cd07835	283	cd07835, STKc_CDK1_like, Catalytic domain of Cycli	1e-14
cd07873	301	cd07873, STKc_PCTAIRE1, Catalytic domain of the Se	1e-14
cd07876	359	cd07876, STKc_JNK2, Catalytic domain of the Serine	1e-14
cd07859	338	cd07859, STKc_TDY_MAPK_plant, Catalytic domain of	2e-14
cd05586	330	cd05586, STKc_Sck1_like, Catalytic domain of Suppr	2e-14
cd07874	355	cd07874, STKc_JNK3, Catalytic domain of the Serine	3e-14
cd08227	327	cd08227, PK_STRAD_alpha, Pseudokinase domain of ST	3e-14
cd05596	370	cd05596, STKc_ROCK, Catalytic domain of the Protei	3e-14
cd05613	290	cd05613, STKc_MSK1_N, N-terminal catalytic domain	4e-14
cd07871	288	cd07871, STKc_PCTAIRE3, Catalytic domain of the Se	5e-14
PHA03207	392	PHA03207, PHA03207, serine/threonine kinase US3; P	6e-14
cd07878	343	cd07878, STKc_p38beta_MAPK11, Catalytic domain of	7e-14
cd07863	288	cd07863, STKc_CDK4, Catalytic domain of the Serine	8e-14
cd05585	312	cd05585, STKc_YPK1_like, Catalytic domain of Yeast	1e-13
cd07872	309	cd07872, STKc_PCTAIRE2, Catalytic domain of the Se	1e-13
cd05573	350	cd05573, STKc_ROCK_NDR_like, Catalytic domain of R	1e-13
cd05621	370	cd05621, STKc_ROCK2, Catalytic domain of the Prote	1e-13
cd07864	302	cd07864, STKc_CDK12, Catalytic domain of the Serin	2e-13
cd07852	337	cd07852, STKc_MAPK15, Catalytic domain of the Seri	3e-13
cd05622	371	cd05622, STKc_ROCK1, Catalytic domain of the Prote	4e-13
cd05601	330	cd05601, STKc_CRIK, Catalytic domain of the Protei	4e-13
cd07837	295	cd07837, STKc_CdkB_plant, Catalytic domain of the	1e-12
cd07857	332	cd07857, STKc_MPK1, Catalytic domain of the Serine	1e-12
cd07844	291	cd07844, STKc_PCTAIRE_like, Catalytic domain of PC	2e-12
cd05574	316	cd05574, STKc_phototropin_like, Catalytic domain o	3e-12
PTZ00266	1021	PTZ00266, PTZ00266, NIMA-related protein kinase; P	3e-12
PLN00009	294	PLN00009, PLN00009, cyclin-dependent kinase A; Pro	7e-12
cd05628	363	cd05628, STKc_NDR1, Catalytic domain of the Protei	2e-11
cd05623	332	cd05623, STKc_MRCK_alpha, Catalytic domain of the	5e-11
cd05627	360	cd05627, STKc_NDR2, Catalytic domain of the Protei	5e-11
cd07867	317	cd07867, STKc_CDC2L6, Catalytic domain of Serine/T	6e-11
cd05624	331	cd05624, STKc_MRCK_beta, Catalytic domain of the P	6e-11
smart00750	176	smart00750, KIND, kinase non-catalytic C-lobe doma	8e-11
cd05610	669	cd05610, STKc_MASTL, Catalytic domain of the Prote	8e-11
cd05598	376	cd05598, STKc_LATS, Catalytic domain of the Protei	1e-10
PLN00113	968	PLN00113, PLN00113, leucine-rich repeat receptor-l	2e-10
cd07868	317	cd07868, STKc_CDK8, Catalytic domain of the Serine	2e-10
PTZ00036	440	PTZ00036, PTZ00036, glycogen synthase kinase; Prov	5e-10
cd05625	382	cd05625, STKc_LATS1, Catalytic domain of the Prote	1e-09
PHA03211	461	PHA03211, PHA03211, serine/threonine kinase US3; P	2e-09
PRK13184	932	PRK13184, pknD, serine/threonine-protein kinase; R	2e-09
cd05626	381	cd05626, STKc_LATS2, Catalytic domain of the Prote	2e-09
cd05107	401	cd05107, PTKc_PDGFR_beta, Catalytic domain of the	3e-09
cd05597	331	cd05597, STKc_DMPK_like, Catalytic domain of Myoto	3e-09
cd04900	73	cd04900, ACT_UUR-like_1, ACT domain family, ACT_UU	4e-09
cd05105	400	cd05105, PTKc_PDGFR_alpha, Catalytic domain of the	3e-08
cd05599	364	cd05599, STKc_NDR_like, Catalytic domain of Nuclea	1e-07
cd05576	237	cd05576, STKc_RPK118_like, Catalytic domain of the	4e-07
PHA03210	501	PHA03210, PHA03210, serine/threonine kinase US3; P	1e-06
cd05103	343	cd05103, PTKc_VEGFR2, Catalytic domain of the Prot	7e-06
cd05102	338	cd05102, PTKc_VEGFR3, Catalytic domain of the Prot	8e-06
cd05104	375	cd05104, PTKc_Kit, Catalytic domain of the Protein	2e-05
cd05106	374	cd05106, PTKc_CSF-1R, Catalytic domain of the Prot	3e-05
cd05054	337	cd05054, PTKc_VEGFR, Catalytic domain of the Prote	4e-05
PTZ00284	467	PTZ00284, PTZ00284, protein kinase; Provisional	1e-04
PLN03224	507	PLN03224, PLN03224, probable serine/threonine prot	3e-04
cd05629	377	cd05629, STKc_NDR_like_fungal, Catalytic domain of	0.001
PRK14879	211	PRK14879, PRK14879, serine/threonine protein kinas	0.001
cd04873	70	cd04873, ACT_UUR-ACR-like, ACT domains of the bact	0.002
cd05610	669	cd05610, STKc_MASTL, Catalytic domain of the Prote	0.003

>gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain

 Score =  276 bits (708), Expect = 8e-92
 Identities = 97/259 (37%), Positives = 147/259 (56%), Gaps = 11/259 (4%)

Query: 118 LKIECKVASGSYGDLYKGTY------CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIR 171
           L +  K+  G++G++YKG           EVA+K LK +  + + ++EF +E  IMRK+ 
Sbjct: 1   LTLGKKLGEGAFGEVYKGKLKGKGGKKKVEVAVKTLKEDA-SEQQIEEFLREARIMRKLD 59

Query: 172 HKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLH 231
           H NVV+ +G CT    L IV E+M  G +  +L K +    L+ LL  A+ +++GM YL 
Sbjct: 60  HPNVVKLLGVCTEEEPLYIVMEYMEGGDLLSYLRKNRPKLSLSDLLSFALQIARGMEYLE 119

Query: 232 QNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAETG--TYRWMAPEVIEHKP 289
             N IHRDL   N L+ EN VVK++DFG++R            G    RWMAPE ++   
Sbjct: 120 SKNFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYRKRGGKLPIRWMAPESLKEGK 179

Query: 290 YDYKADVFSFGIALWELLT-GELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRLAELLER 348
           +  K+DV+SFG+ LWE+ T GE PY G++  +  +  ++   R   P +  P L +L+ +
Sbjct: 180 FTSKSDVWSFGVLLWEIFTLGEQPYPGMSNEE-VLEYLKNGYRLPQPPNCPPELYDLMLQ 238

Query: 349 CWQHDPTQRPNFSQITDIL 367
           CW  DP  RP FS++ +IL
Sbjct: 239 CWAEDPEDRPTFSELVEIL 257

Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257

>gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase

 Score =  276 bits (708), Expect = 1e-91
 Identities = 97/260 (37%), Positives = 151/260 (58%), Gaps = 12/260 (4%)

Query: 118 LKIECKVASGSYGDLYKGTY------CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIR 171
           L++  K+  G++G++YKGT          +VA+K LK      E  +EF +E  IM+K+ 
Sbjct: 1   LELGKKLGEGAFGEVYKGTLKGDGEGTETKVAVKTLKEGASE-EEREEFLEEASIMKKLS 59

Query: 172 HKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLH 231
           H N+V+ +G CT+   L IVTE+M  G + DFL K      L  LL++A+ ++KGM YL 
Sbjct: 60  HPNIVRLLGVCTQGEPLYIVTEYMPGGDLLDFLRKHGEKLTLKDLLQMALQIAKGMEYLE 119

Query: 232 QNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAETGTY---RWMAPEVIEHK 288
             N +HRDL   N L+ EN VVK++DFG++R   +        G     +WMAPE ++  
Sbjct: 120 SKNFVHRDLAARNCLVTENLVVKISDFGLSRDIYEDDYYRKRGGGKLPIKWMAPESLKDG 179

Query: 289 PYDYKADVFSFGIALWELLT-GELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRLAELLE 347
            +  K+DV+SFG+ LWE+ T GE PY G++  +  + +++   R   P++    L EL+ 
Sbjct: 180 KFTSKSDVWSFGVLLWEIFTLGEQPYPGMSNEE-VLELLEDGYRLPRPENCPDELYELML 238

Query: 348 RCWQHDPTQRPNFSQITDIL 367
           +CW +DP  RP FS++ + L
Sbjct: 239 QCWAYDPEDRPTFSELVEDL 258

Length = 258

>gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity

 Score =  272 bits (697), Expect = 4e-90
 Identities = 99/260 (38%), Positives = 150/260 (57%), Gaps = 12/260 (4%)

Query: 118 LKIECKVASGSYGDLYKGTY------CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIR 171
           L +  K+  G++G++YKGT          EVA+K LK +  + + ++EF +E  IMRK+ 
Sbjct: 1   LTLGKKLGEGAFGEVYKGTLKGKGDGKEVEVAVKTLKEDA-SEQQIEEFLREARIMRKLD 59

Query: 172 HKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTS-LLKVAIDVSKGMNYL 230
           H N+V+ +G CT    L IV E+M  G + D+L K +      S LL  A+ +++GM YL
Sbjct: 60  HPNIVKLLGVCTEEEPLMIVMEYMPGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYL 119

Query: 231 HQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAETG--TYRWMAPEVIEHK 288
              N IHRDL   N L+ EN VVK++DFG++R          + G    RWMAPE ++  
Sbjct: 120 ESKNFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYKVKGGKLPIRWMAPESLKEG 179

Query: 289 PYDYKADVFSFGIALWELLT-GELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRLAELLE 347
            +  K+DV+SFG+ LWE+ T GE PY G++  +  +  ++K  R   P +  P L +L+ 
Sbjct: 180 KFTSKSDVWSFGVLLWEIFTLGEEPYPGMSNAE-VLEYLKKGYRLPKPPNCPPELYKLML 238

Query: 348 RCWQHDPTQRPNFSQITDIL 367
           +CW  DP  RP FS++ +IL
Sbjct: 239 QCWAEDPEDRPTFSELVEIL 258

Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258

>gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases

 Score =  255 bits (653), Expect = 2e-83
 Identities = 97/260 (37%), Positives = 145/260 (55%), Gaps = 19/260 (7%)

Query: 126 SGSYGDLYKGTY-----CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIG 180
            G++G++YKG        + EVA+K LK E  + E  K+F +E  +M+K+ H NVV+ +G
Sbjct: 5   EGAFGEVYKGKLKGKDGKTTEVAVKTLK-EDASEEERKDFLKEARVMKKLGHPNVVRLLG 63

Query: 181 ACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTS--------LLKVAIDVSKGMNYLHQ 232
            CT    L +V E+M  G + D+L K + VF            LL  AI ++KGM YL  
Sbjct: 64  VCTEEEPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLAS 123

Query: 233 NNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAETGTY---RWMAPEVIEHKP 289
              +HRDL   N L+ E+ VVK++DFG++R          +TG     RWMAPE ++   
Sbjct: 124 KKFVHRDLAARNCLVGEDLVVKISDFGLSRDVYDDDYYRKKTGGKLPIRWMAPESLKDGI 183

Query: 290 YDYKADVFSFGIALWELLT-GELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRLAELLER 348
           +  K+DV+SFG+ LWE+ T G  PY GL+  +  +  ++K  R   P++    L EL+  
Sbjct: 184 FTSKSDVWSFGVLLWEIFTLGATPYPGLSNEE-VLEYLRKGYRLPKPEYCPDELYELMLS 242

Query: 349 CWQHDPTQRPNFSQITDILK 368
           CWQ DP  RP FS++ + L+
Sbjct: 243 CWQLDPEDRPTFSELVERLE 262

Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262

>gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain

 Score =  233 bits (597), Expect = 4e-75
 Identities = 91/250 (36%), Positives = 144/250 (57%), Gaps = 10/250 (4%)

Query: 123 KVASGSYGDLYKGTYCS--QEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIG 180
           K+ SGS+G +YK  +    + VA+K+LK     ++  +   +E+ I+R++ H N+V+ I 
Sbjct: 6   KLGSGSFGTVYKAKHKGTGKIVAVKILKKRSEKSKKDQTARREIRILRRLSHPNIVRLID 65

Query: 181 ACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDL 240
           A     +L +V E+   G ++D+L +  G        K+A+ + +G+ YLH N IIHRDL
Sbjct: 66  AFEDKDHLYLVMEYCEGGDLFDYLSR-GGPLSEDEAKKIALQILRGLEYLHSNGIIHRDL 124

Query: 241 KTANLLMDENGVVKVADFGVARVQAQSG-VMTAETGTYRWMAPEVI-EHKPYDYKADVFS 298
           K  N+L+DENGVVK+ADFG+A+   +S   +T   GT  +MAPEV+     Y  K DV+S
Sbjct: 125 KPENILLDENGVVKIADFGLAKKLLKSSSSLTTFVGTPWYMAPEVLLGGNGYGPKVDVWS 184

Query: 299 FGIALWELLTGELPYAG---LTPLQAAVGVVQKSLRPTIPKH--AHPRLAELLERCWQHD 353
            G+ L+ELLTG+ P++G   L  LQ    ++   L    PK         +L+++C   D
Sbjct: 185 LGVILYELLTGKPPFSGENILDQLQLIRRILGPPLEFDEPKWSSGSEEAKDLIKKCLNKD 244

Query: 354 PTQRPNFSQI 363
           P++RP   +I
Sbjct: 245 PSKRPTAEEI 254

Length = 260

>gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain

 Score =  227 bits (582), Expect = 8e-73
 Identities = 78/249 (31%), Positives = 123/249 (49%), Gaps = 6/249 (2%)

Query: 119 KIECKVASGSYGDLYKGTYCS--QEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVV 176
           +I  K+  GS+G +Y        + VAIKV+K +    +  +   +E+ I++K++H N+V
Sbjct: 2   EILEKLGEGSFGKVYLARDKKTGKLVAIKVIKKK-KIKKDRERILREIKILKKLKHPNIV 60

Query: 177 QFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNII 236
           +          L +V E+   G ++D L K +G             +   + YLH   I+
Sbjct: 61  RLYDVFEDEDKLYLVMEYCEGGDLFDLLKK-RGRLSEDEARFYLRQILSALEYLHSKGIV 119

Query: 237 HRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAETGTYRWMAPEVIEHKPYDYKADV 296
           HRDLK  N+L+DE+G VK+ADFG+AR       +T   GT  +MAPEV+  K Y    D+
Sbjct: 120 HRDLKPENILLDEDGHVKLADFGLARQLDPGEKLTTFVGTPEYMAPEVLLGKGYGKAVDI 179

Query: 297 FSFGIALWELLTGELPYAGLTPLQAAVGVVQKSLRPTIPKHAH--PRLAELLERCWQHDP 354
           +S G+ L+ELLTG+ P+ G   L      + K   P  P      P   +L+ +    DP
Sbjct: 180 WSLGVILYELLTGKPPFPGDDQLLELFKKIGKPKPPFPPPEWDISPEAKDLIRKLLVKDP 239

Query: 355 TQRPNFSQI 363
            +R    + 
Sbjct: 240 EKRLTAEEA 248

Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254

>gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases

 Score =  209 bits (534), Expect = 4e-66
 Identities = 76/247 (30%), Positives = 130/247 (52%), Gaps = 39/247 (15%)

Query: 126 SGSYGDLYKGTYCS--QEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACT 183
            G +G +Y        ++VAIK++K E  ++ +L+E  +E+ I++K+ H N+V+  G   
Sbjct: 3   EGGFGTVYLARDKKTGKKVAIKIIKKE-DSSSLLEELLREIEILKKLNHPNIVKLYGVFE 61

Query: 184 RPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTA 243
              +L +V E+   GS+ D L + +G      +L++ + + +G+ YLH N IIHRDLK  
Sbjct: 62  DENHLYLVMEYCEGGSLKDLLKENEGKLSEDEILRILLQILEGLEYLHSNGIIHRDLKPE 121

Query: 244 NLLMDE-NGVVKVADFGVAR-VQAQSGVMTAETGTYRWMAPEVIEHKP-YDYKADVFSFG 300
           N+L+D  NG VK+ADFG+++ + +   ++    GT  +MAPEV+  K  Y  K+D++S G
Sbjct: 122 NILLDSDNGKVKLADFGLSKLLTSDKSLLKTIVGTPAYMAPEVLLGKGYYSEKSDIWSLG 181

Query: 301 IALWELLTGELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRLAELLERCWQHDPTQRPNF 360
           + L+EL                                 P L +L+ +  Q DP +RP+ 
Sbjct: 182 VILYEL---------------------------------PELKDLIRKMLQKDPEKRPSA 208

Query: 361 SQITDIL 367
            +I + L
Sbjct: 209 KEILEHL 215

Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215

>gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases

 Score =  205 bits (525), Expect = 2e-64
 Identities = 88/240 (36%), Positives = 137/240 (57%), Gaps = 7/240 (2%)

Query: 123 KVASGSYGDLYKGTYCS--QEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIG 180
           K+  G +G++YK  +    +EVAIKV+K E  + E  ++   E+ I++K +H N+V++ G
Sbjct: 7   KIGKGGFGEVYKARHKRTGKEVAIKVIKLE--SKEKKEKIINEIQILKKCKHPNIVKYYG 64

Query: 181 ACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDL 240
           +  +   L IV EF + GS+ D L         + +  V  ++ KG+ YLH N IIHRD+
Sbjct: 65  SYLKKDELWIVMEFCSGGSLKDLLKSTNQTLTESQIAYVCKELLKGLEYLHSNGIIHRDI 124

Query: 241 KTANLLMDENGVVKVADFGVARVQAQSGVMTAETGTYRWMAPEVIEHKPYDYKADVFSFG 300
           K AN+L+  +G VK+ DFG++   + +       GT  WMAPEVI  KPYDYKAD++S G
Sbjct: 125 KAANILLTSDGEVKLIDFGLSAQLSDTKARNTMVGTPYWMAPEVINGKPYDYKADIWSLG 184

Query: 301 IALWELLTGELPYAGLTPLQAAVGVVQKSLRPTI--PKHAHPRLAELLERCWQHDPTQRP 358
           I   EL  G+ PY+ L P++A   +      P +  P+       + L++C Q +P +RP
Sbjct: 185 ITAIELAEGKPPYSELPPMKALFKIATNGP-PGLRNPEKWSDEFKDFLKKCLQKNPEKRP 243

Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253

>gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases

 Score =  204 bits (522), Expect = 8e-64
 Identities = 94/256 (36%), Positives = 142/256 (55%), Gaps = 11/256 (4%)

Query: 111 WEIDAKQLKIECKVASGSYGDLYKGTY-CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRK 169
           WEID   +++  K+ +G +G++++G +  +  VA+K LKP    T   K+F  E  IM+K
Sbjct: 1   WEIDRTSIQLLRKLGAGQFGEVWEGLWNNTTPVAVKTLKP---GTMDPKDFLAEAQIMKK 57

Query: 170 IRHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKG-VFQLTSLLKVAIDVSKGMN 228
           +RH  ++Q    CT    + IVTE M  GS+ ++L    G   +L  L+ +A  V+ GM 
Sbjct: 58  LRHPKLIQLYAVCTLEEPIYIVTELMKYGSLLEYLQGGAGRALKLPQLIDMAAQVASGMA 117

Query: 229 YLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAETGT---YRWMAPEVI 285
           YL   N IHRDL   N+L+ EN + KVADFG+ARV  +  +  A  G     +W APE  
Sbjct: 118 YLEAQNYIHRDLAARNVLVGENNICKVADFGLARVIKED-IYEAREGAKFPIKWTAPEAA 176

Query: 286 EHKPYDYKADVFSFGIALWELLT-GELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRLAE 344
            +  +  K+DV+SFGI L E++T G +PY G+T  +  +  V +  R   P      L +
Sbjct: 177 LYNRFSIKSDVWSFGILLTEIVTYGRMPYPGMTNAE-VLQQVDQGYRMPCPPGCPKELYD 235

Query: 345 LLERCWQHDPTQRPNF 360
           ++  CW+ DP  RP F
Sbjct: 236 IMLDCWKEDPDDRPTF 251

Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261

>gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase

 Score =  204 bits (521), Expect = 1e-63
 Identities = 79/254 (31%), Positives = 130/254 (51%), Gaps = 9/254 (3%)

Query: 117 QLKIECKVASGSYGDLYKGTYCS--QEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKN 174
           +      +  GS+G +Y        + +A+K ++    + E L+   +E+ I+  ++H N
Sbjct: 1   EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPN 60

Query: 175 VVQFIGAC-TRPPN-LCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQ 232
           +V++ G+      N L I  E+++ GS+   L K  G      + K    + +G+ YLH 
Sbjct: 61  IVRYYGSERDEEKNTLNIFLEYVSGGSLSSLLKK-FGKLPEPVIRKYTRQILEGLAYLHS 119

Query: 233 NNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAET---GTYRWMAPEVIEHKP 289
           N I+HRD+K AN+L+D +GVVK+ADFG A+               GT  WMAPEVI  + 
Sbjct: 120 NGIVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETGEGTGSVRGTPYWMAPEVIRGEE 179

Query: 290 YDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKS-LRPTIPKHAHPRLAELLER 348
           Y   AD++S G  + E+ TG+ P++ L    AA+  +  S   P IP+H      + L +
Sbjct: 180 YGRAADIWSLGCTVIEMATGKPPWSELGNPMAALYKIGSSGEPPEIPEHLSEEAKDFLRK 239

Query: 349 CWQHDPTQRPNFSQ 362
           C + DP +RP   +
Sbjct: 240 CLRRDPKKRPTADE 253

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260

>gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases

 Score =  201 bits (513), Expect = 2e-62
 Identities = 98/257 (38%), Positives = 154/257 (59%), Gaps = 12/257 (4%)

Query: 111 WEIDAKQLKIECKVASGSYGDLYKGTYCSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKI 170
           W I++K+LK+   +  G +GD+  G Y  Q+VA+K LK    ++   + F  E  +M  +
Sbjct: 1   WAINSKELKLGATIGKGEFGDVMLGDYRGQKVAVKCLKD---DSTAAQAFLAEASVMTTL 57

Query: 171 RHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLH-KQKGVFQLTSLLKVAIDVSKGMNY 229
           RH N+VQ +G   +   L IVTE+MA+GS+ D+L  + + V  L   L  A+DV +GM Y
Sbjct: 58  RHPNLVQLLGVVLQGNPLYIVTEYMAKGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEY 117

Query: 230 LHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAETGTY--RWMAPEVIEH 287
           L + N +HRDL   N+L+ E+ V KV+DFG+A+ +A  G    ++G    +W APE +  
Sbjct: 118 LEEKNFVHRDLAARNVLVSEDLVAKVSDFGLAK-EASQGQ---DSGKLPVKWTAPEALRE 173

Query: 288 KPYDYKADVFSFGIALWELLT-GELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRLAELL 346
           K +  K+DV+SFGI LWE+ + G +PY  + PL+  V  V+K  R   P+   P + +++
Sbjct: 174 KKFSTKSDVWSFGILLWEIYSFGRVPYPRI-PLKDVVPHVEKGYRMEAPEGCPPEVYKVM 232

Query: 347 ERCWQHDPTQRPNFSQI 363
           + CW+ DP +RP F Q+
Sbjct: 233 KDCWELDPAKRPTFKQL 249

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256

>gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases

 Score =  200 bits (510), Expect = 5e-62
 Identities = 100/265 (37%), Positives = 154/265 (58%), Gaps = 11/265 (4%)

Query: 111 WEIDAKQLKIECKVASGSYGDLYKGTYC-SQEVAIKVLKPECVNTEMLKEFSQEVYIMRK 169
           WEI  + LK+E K+ +G +G+++ GT+  + +VA+K LKP  ++ E    F QE  IM+K
Sbjct: 1   WEIPRESLKLERKLGAGQFGEVWMGTWNGTTKVAVKTLKPGTMSPE---AFLQEAQIMKK 57

Query: 170 IRHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQ-LTSLLKVAIDVSKGMN 228
           +RH  +VQ    C+    + IVTE+M++GS+ DFL   +G    L  L+ +A  +++GM 
Sbjct: 58  LRHDKLVQLYAVCSEEEPIYIVTEYMSKGSLLDFLKSGEGKKLRLPQLVDMAAQIAEGMA 117

Query: 229 YLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAETGT---YRWMAPEVI 285
           YL   N IHRDL   N+L+ EN V K+ADFG+AR+       TA  G     +W APE  
Sbjct: 118 YLESRNYIHRDLAARNILVGENLVCKIADFGLARLIEDD-EYTAREGAKFPIKWTAPEAA 176

Query: 286 EHKPYDYKADVFSFGIALWELLT-GELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRLAE 344
            +  +  K+DV+SFGI L E++T G +PY G+T  +  +  V++  R   P +    L +
Sbjct: 177 NYGRFTIKSDVWSFGILLTEIVTYGRVPYPGMTNRE-VLEQVERGYRMPRPPNCPEELYD 235

Query: 345 LLERCWQHDPTQRPNFSQITDILKQ 369
           L+ +CW  DP +RP F  +   L+ 
Sbjct: 236 LMLQCWDKDPEERPTFEYLQSFLED 260

Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261

>gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase

 Score =  199 bits (507), Expect = 1e-61
 Identities = 98/267 (36%), Positives = 156/267 (58%), Gaps = 12/267 (4%)

Query: 111 WEIDAKQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVNTEMLKEFSQEVYIMR 168
           WE++   + ++ K+  G YG++Y+G +   S  VA+K LK +   T  ++EF +E  +M+
Sbjct: 1   WEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED---TMEVEEFLKEAAVMK 57

Query: 169 KIRHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHK-QKGVFQLTSLLKVAIDVSKGM 227
           +I+H N+VQ +G CTR P   I+TEFM  G++ D+L +  +       LL +A  +S  M
Sbjct: 58  EIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAM 117

Query: 228 NYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAETGT---YRWMAPEV 284
            YL + N IHRDL   N L+ EN +VKVADFG++R+       TA  G     +W APE 
Sbjct: 118 EYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLM-TGDTYTAHAGAKFPIKWTAPES 176

Query: 285 IEHKPYDYKADVFSFGIALWELLT-GELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRLA 343
           + +  +  K+DV++FG+ LWE+ T G  PY G+  L     +++K  R   P+   P++ 
Sbjct: 177 LAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGID-LSQVYELLEKGYRMERPEGCPPKVY 235

Query: 344 ELLERCWQHDPTQRPNFSQITDILKQM 370
           EL+  CWQ +P+ RP+F++I    + M
Sbjct: 236 ELMRACWQWNPSDRPSFAEIHQAFETM 262

Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263

>gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases

 Score =  198 bits (505), Expect = 2e-61
 Identities = 89/262 (33%), Positives = 144/262 (54%), Gaps = 14/262 (5%)

Query: 113 IDAKQLKIECKVASGSYGDLYKGTYCSQ-EVAIKVLKPECVNTEMLKEFSQEVYIMRKIR 171
           ID  +L    ++ SG +G ++ G +  + +VAIK+++   ++ +   +F +E  +M K+ 
Sbjct: 1   IDPSELTFLKELGSGQFGVVHLGKWRGKIDVAIKMIREGAMSED---DFIEEAKVMMKLS 57

Query: 172 HKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLH 231
           H N+VQ  G CT+   + IVTE+MA G + ++L ++KG      LL +  DV + M YL 
Sbjct: 58  HPNLVQLYGVCTKQRPIFIVTEYMANGCLLNYLRERKGKLGTEWLLDMCSDVCEAMEYLE 117

Query: 232 QNNIIHRDLKTANLLMDENGVVKVADFGVAR--VQAQSGVMTAETGT---YRWMAPEVIE 286
            N  IHRDL   N L+ E+ VVKV+DFG+AR  +  Q    T+  GT    +W  PEV +
Sbjct: 118 SNGFIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQ---YTSSQGTKFPVKWAPPEVFD 174

Query: 287 HKPYDYKADVFSFGIALWELLT-GELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRLAEL 345
           +  +  K+DV+SFG+ +WE+ + G++PY   +  +  V  V    R   PK A   +  +
Sbjct: 175 YSRFSSKSDVWSFGVLMWEVFSEGKMPYERFSNSE-VVESVSAGYRLYRPKLAPTEVYTI 233

Query: 346 LERCWQHDPTQRPNFSQITDIL 367
           +  CW   P  RP F ++   L
Sbjct: 234 MYSCWHEKPEDRPAFKKLLSQL 255

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256

>gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases

 Score =  191 bits (488), Expect = 9e-59
 Identities = 92/250 (36%), Positives = 141/250 (56%), Gaps = 7/250 (2%)

Query: 117 QLKIECKVASGSYGDLYKG--TYCSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKN 174
             ++   +  G++G +YKG        VAIK +  E +  E LK   QE+ +++ ++H N
Sbjct: 1   NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPN 60

Query: 175 VVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAI-DVSKGMNYLHQN 233
           +V++IG+     +L I+ E+   GS+   + K+ G F   SL+ V +  V +G+ YLH+ 
Sbjct: 61  IVKYIGSIETSDSLYIILEYAENGSLRQII-KKFGPFP-ESLVAVYVYQVLQGLAYLHEQ 118

Query: 234 NIIHRDLKTANLLMDENGVVKVADFGVA-RVQAQSGVMTAETGTYRWMAPEVIEHKPYDY 292
            +IHRD+K AN+L  ++GVVK+ADFGVA ++   S    +  GT  WMAPEVIE      
Sbjct: 119 GVIHRDIKAANILTTKDGVVKLADFGVATKLNDVSKDDASVVGTPYWMAPEVIEMSGAST 178

Query: 293 KADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRLAELLERCWQH 352
            +D++S G  + ELLTG  PY  L P+ A   +VQ    P +P+   P L + L +C+Q 
Sbjct: 179 ASDIWSLGCTVIELLTGNPPYYDLNPMAALFRIVQDD-HPPLPEGISPELKDFLMQCFQK 237

Query: 353 DPTQRPNFSQ 362
           DP  RP   Q
Sbjct: 238 DPNLRPTAKQ 247

Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254

>gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk

 Score =  189 bits (481), Expect = 9e-58
 Identities = 85/254 (33%), Positives = 146/254 (57%), Gaps = 7/254 (2%)

Query: 111 WEIDAKQLKIECKVASGSYGDLYKGTYC-SQEVAIKVLKPECVNTEMLKEFSQEVYIMRK 169
           WE   ++  +E K+ SG +G++++G +     VAIK+LK +  +    ++F +EV  +++
Sbjct: 1   WERPREEFTLERKLGSGYFGEVWEGLWKNRVRVAIKILKSD--DLLKQQDFQKEVQALKR 58

Query: 170 IRHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKG-VFQLTSLLKVAIDVSKGMN 228
           +RHK+++     C+    + I+TE M +GS+  FL   +G V  + SL+ +A  V++GM 
Sbjct: 59  LRHKHLISLFAVCSVGEPVYIITELMEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMA 118

Query: 229 YLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAETGT-YRWMAPEVIEH 287
           YL + N IHRDL   N+L+ E+ V KVADFG+AR+  +   ++++    Y+W APE   H
Sbjct: 119 YLEEQNSIHRDLAARNILVGEDLVCKVADFGLARLIKEDVYLSSDKKIPYKWTAPEAASH 178

Query: 288 KPYDYKADVFSFGIALWELLT-GELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRLAELL 346
             +  K+DV+SFGI L+E+ T G++PY G+         +    R   P      + +++
Sbjct: 179 GTFSTKSDVWSFGILLYEMFTYGQVPYPGMN-NHEVYDQITAGYRMPCPAKCPQEIYKIM 237

Query: 347 ERCWQHDPTQRPNF 360
             CW  +P  RP+F
Sbjct: 238 LECWAAEPEDRPSF 251

Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261

>gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases

 Score =  186 bits (473), Expect = 1e-56
 Identities = 87/252 (34%), Positives = 144/252 (57%), Gaps = 9/252 (3%)

Query: 123 KVASGSYGDLYKGTYCSQ-EVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGA 181
           K+  G++GD+YKG      EVA+K  +      ++ ++F QE  I+++  H N+V+ IG 
Sbjct: 2   KIGKGNFGDVYKGVLKGNTEVAVKTCRSTLPP-DLKRKFLQEAEILKQYDHPNIVKLIGV 60

Query: 182 CTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLK 241
           C +   + IV E +  GS+  FL K+K    +  LL++++D + GM YL   N IHRDL 
Sbjct: 61  CVQKQPIYIVMELVPGGSLLTFLRKKKNRLTVKKLLQMSLDAAAGMEYLESKNCIHRDLA 120

Query: 242 TANLLMDENGVVKVADFGVARVQAQSGVMTAETGT----YRWMAPEVIEHKPYDYKADVF 297
             N L+ EN V+K++DFG++R + + G+ T   G      +W APE + +  Y  ++DV+
Sbjct: 121 ARNCLVGENNVLKISDFGMSR-EEEGGIYTVSDGLKQIPIKWTAPEALNYGRYTSESDVW 179

Query: 298 SFGIALWELLT-GELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRLAELLERCWQHDPTQ 356
           S+GI LWE  + G+ PY G++  Q     ++   R   P+     +  L+ +CW +DP  
Sbjct: 180 SYGILLWETFSLGDTPYPGMSNQQTR-ERIESGYRMPAPQLCPEEIYRLMLQCWAYDPEN 238

Query: 357 RPNFSQITDILK 368
           RP+FS+I + L+
Sbjct: 239 RPSFSEIYNELQ 250

Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251

>gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases

 Score =  186 bits (473), Expect = 2e-56
 Identities = 92/267 (34%), Positives = 143/267 (53%), Gaps = 11/267 (4%)

Query: 113 IDAKQLKIECKVASGSYGDLYKGTY---CSQE--VAIKVLKPECVNTEMLKEFSQEVYIM 167
           ID   + IE  +  G +G++ +G       +E  VAIK LK    + + L +F  E  IM
Sbjct: 1   IDPSYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRL-DFLTEASIM 59

Query: 168 RKIRHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGM 227
            +  H N+++  G  T+   + I+TE+M  GS+  FL +  G F +  L+ +   ++ GM
Sbjct: 60  GQFDHPNIIRLEGVVTKSRPVMIITEYMENGSLDKFLRENDGKFTVGQLVGMLRGIASGM 119

Query: 228 NYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQS-GVMTAETG--TYRWMAPEV 284
            YL + N +HRDL   N+L++ N V KV+DFG++R    S    T + G    RW APE 
Sbjct: 120 KYLSEMNYVHRDLAARNILVNSNLVCKVSDFGLSRRLEDSEATYTTKGGKIPIRWTAPEA 179

Query: 285 IEHKPYDYKADVFSFGIALWELLT-GELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRLA 343
           I ++ +   +DV+SFGI +WE+++ GE PY  ++  Q  +  V+   R   P      L 
Sbjct: 180 IAYRKFTSASDVWSFGIVMWEVMSYGERPYWDMSN-QDVIKAVEDGYRLPPPMDCPSALY 238

Query: 344 ELLERCWQHDPTQRPNFSQITDILKQM 370
           +L+  CWQ D  +RP FSQI   L +M
Sbjct: 239 QLMLDCWQKDRNERPTFSQIVSTLDKM 265

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266

>gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase

 Score =  181 bits (461), Expect = 1e-54
 Identities = 73/254 (28%), Positives = 136/254 (53%), Gaps = 12/254 (4%)

Query: 123 KVASGSYGD--LYKGTYCSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIG 180
           ++  GS+G   L +     +   +K +    ++ +  ++   EV I++K+ H N++++  
Sbjct: 7   QIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYE 66

Query: 181 ACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTS---LLKVAIDVSKGMNYLHQNNIIH 237
           +      LCIV E+   G +   + KQK   +      +L   + +   + YLH   I+H
Sbjct: 67  SFEEKGKLCIVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSRKILH 126

Query: 238 RDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAET--GTYRWMAPEVIEHKPYDYKAD 295
           RD+K  N+ +  NG+VK+ DFG+++V + +  + A+T  GT  +++PE+ ++KPY+YK+D
Sbjct: 127 RDIKPQNIFLTSNGLVKLGDFGISKVLSSTVDL-AKTVVGTPYYLSPELCQNKPYNYKSD 185

Query: 296 VFSFGIALWELLTGELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRLAELLERCWQHDPT 355
           ++S G  L+EL T + P+ G   L+ A+ +++    P IP      L  L+    Q DP 
Sbjct: 186 IWSLGCVLYELCTLKHPFEGENLLELALKILKGQYPP-IPSQYSSELRNLVSSLLQKDPE 244

Query: 356 QRPNFSQITDILKQ 369
           +RP+   I  IL+ 
Sbjct: 245 ERPS---IAQILQS 255

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258

>gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase

 Score =  180 bits (458), Expect = 2e-54
 Identities = 94/263 (35%), Positives = 151/263 (57%), Gaps = 10/263 (3%)

Query: 111 WEIDAKQLKIECKVASGSYGDLYKGTYCSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKI 170
           W ++ K+LK+   +  G +GD+  G Y   +VA+K +K    N    + F  E  +M ++
Sbjct: 1   WALNMKELKLLQTIGKGEFGDVMLGDYRGNKVAVKCIK----NDATAQAFLAEASVMTQL 56

Query: 171 RHKNVVQFIGACTRPP-NLCIVTEFMARGSIYDFLHKQ-KGVFQLTSLLKVAIDVSKGMN 228
           RH N+VQ +G        L IVTE+MA+GS+ D+L  + + V     LLK ++DV + M 
Sbjct: 57  RHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAME 116

Query: 229 YLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAETGTYRWMAPEVIEHK 288
           YL  NN +HRDL   N+L+ E+ V KV+DFG+ + +A S   T +    +W APE +  K
Sbjct: 117 YLEANNFVHRDLAARNVLVSEDNVAKVSDFGLTK-EASSTQDTGKLPV-KWTAPEALREK 174

Query: 289 PYDYKADVFSFGIALWELLT-GELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRLAELLE 347
            +  K+DV+SFGI LWE+ + G +PY  + PL+  V  V+K  +   P    P + ++++
Sbjct: 175 KFSTKSDVWSFGILLWEIYSFGRVPYPRI-PLKDVVPRVEKGYKMDAPDGCPPVVYDVMK 233

Query: 348 RCWQHDPTQRPNFSQITDILKQM 370
           +CW  D   RP+F Q+ + L+ +
Sbjct: 234 QCWHLDAATRPSFLQLREQLEHI 256

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256

>gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase

 Score =  179 bits (456), Expect = 4e-54
 Identities = 91/256 (35%), Positives = 144/256 (56%), Gaps = 10/256 (3%)

Query: 113 IDAKQLKIECKVASGSYGDLYKGTYCSQ-EVAIKVLKPECVNTEMLKEFSQEVYIMRKIR 171
           I   +L +  ++ SG +G ++ G +  + +VAIK ++   ++ E   +F +E  +M K+ 
Sbjct: 1   IHPSELTLVQEIGSGQFGLVWLGYWLEKRKVAIKTIREGAMSEE---DFIEEAQVMMKLS 57

Query: 172 HKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLH 231
           H  +VQ  G CT    +C+V EFM  G + D+L  Q+G F   +LL + +DV +GM YL 
Sbjct: 58  HPKLVQLYGVCTERSPICLVFEFMEHGCLSDYLRAQRGKFSQETLLGMCLDVCEGMAYLE 117

Query: 232 QNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAETGT---YRWMAPEVIEHK 288
            +N+IHRDL   N L+ EN VVKV+DFG+ R        T+ TGT    +W +PEV    
Sbjct: 118 SSNVIHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQ-YTSSTGTKFPVKWSSPEVFSFS 176

Query: 289 PYDYKADVFSFGIALWELLT-GELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRLAELLE 347
            Y  K+DV+SFG+ +WE+ + G+ PY   +  +  V  +    R   P+ A   + EL++
Sbjct: 177 KYSSKSDVWSFGVLMWEVFSEGKTPYENRSNSE-VVETINAGFRLYKPRLASQSVYELMQ 235

Query: 348 RCWQHDPTQRPNFSQI 363
            CW+  P  RP+FS +
Sbjct: 236 HCWKERPEDRPSFSLL 251

Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256

>gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2

 Score =  175 bits (447), Expect = 1e-52
 Identities = 84/248 (33%), Positives = 132/248 (53%), Gaps = 18/248 (7%)

Query: 120 IECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQ 177
           I  K+  GSYG +YK  +    Q VAIKV+  E    E++KE S    I+++     +V+
Sbjct: 7   ILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEEDLQEIIKEIS----ILKQCDSPYIVK 62

Query: 178 FIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVF---QLTSLLKVAIDVSKGMNYLHQNN 234
           + G+  +  +L IV E+   GS+ D +          ++ ++L       KG+ YLH N 
Sbjct: 63  YYGSYFKNTDLWIVMEYCGAGSVSDIMKITNKTLTEEEIAAILY---QTLKGLEYLHSNK 119

Query: 235 IIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAET--GTYRWMAPEVIEHKPYDY 292
            IHRD+K  N+L++E G  K+ADFGV+  Q    +    T  GT  WMAPEVI+   Y+ 
Sbjct: 120 KIHRDIKAGNILLNEEGQAKLADFGVSG-QLTDTMAKRNTVIGTPFWMAPEVIQEIGYNN 178

Query: 293 KADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKSLRPT--IPKHAHPRLAELLERCW 350
           KAD++S GI   E+  G+ PY+ + P++A   ++     PT   P+   P   + +++C 
Sbjct: 179 KADIWSLGITAIEMAEGKPPYSDIHPMRAIF-MIPNKPPPTLSDPEKWSPEFNDFVKKCL 237

Query: 351 QHDPTQRP 358
             DP +RP
Sbjct: 238 VKDPEERP 245

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256

>gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src

 Score =  175 bits (445), Expect = 2e-52
 Identities = 98/264 (37%), Positives = 156/264 (59%), Gaps = 12/264 (4%)

Query: 111 WEIDAKQLKIECKVASGSYGDLYKGTY-CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRK 169
           WEI  + L++E K+  G +G+++ GT+  +  VAIK LKP  ++ E    F QE  +M+K
Sbjct: 1   WEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPE---AFLQEAQVMKK 57

Query: 170 IRHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVF-QLTSLLKVAIDVSKGMN 228
           +RH+ +VQ     +  P + IVTE+M++GS+ DFL  + G + +L  L+ +A  ++ GM 
Sbjct: 58  LRHEKLVQLYAVVSEEP-IYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMA 116

Query: 229 YLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAETGT---YRWMAPEVI 285
           Y+ + N +HRDL+ AN+L+ EN V KVADFG+AR+  +    TA  G     +W APE  
Sbjct: 117 YVERMNYVHRDLRAANILVGENLVCKVADFGLARL-IEDNEYTARQGAKFPIKWTAPEAA 175

Query: 286 EHKPYDYKADVFSFGIALWELLT-GELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRLAE 344
            +  +  K+DV+SFGI L EL T G +PY G+   +  +  V++  R   P      L +
Sbjct: 176 LYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVN-REVLDQVERGYRMPCPPECPESLHD 234

Query: 345 LLERCWQHDPTQRPNFSQITDILK 368
           L+ +CW+ +P +RP F  +   L+
Sbjct: 235 LMCQCWRKEPEERPTFEYLQAFLE 258

Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262

>gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes

 Score =  175 bits (444), Expect = 2e-52
 Identities = 101/264 (38%), Positives = 156/264 (59%), Gaps = 12/264 (4%)

Query: 111 WEIDAKQLKIECKVASGSYGDLYKGTY-CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRK 169
           WEI  + L+++ K+  G +G+++ GT+  + +VAIK LKP    T M + F QE  IM+K
Sbjct: 1   WEIPRESLRLDVKLGQGCFGEVWMGTWNGTTKVAIKTLKP---GTMMPEAFLQEAQIMKK 57

Query: 170 IRHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVF-QLTSLLKVAIDVSKGMN 228
           +RH  +V      +  P + IVTEFM +GS+ DFL +  G + +L  L+ +A  ++ GM 
Sbjct: 58  LRHDKLVPLYAVVSEEP-IYIVTEFMGKGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMA 116

Query: 229 YLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAETGT---YRWMAPEVI 285
           Y+ + N IHRDL+ AN+L+ +N V K+ADFG+AR+  +    TA  G     +W APE  
Sbjct: 117 YIERMNYIHRDLRAANILVGDNLVCKIADFGLARL-IEDNEYTARQGAKFPIKWTAPEAA 175

Query: 286 EHKPYDYKADVFSFGIALWELLT-GELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRLAE 344
            +  +  K+DV+SFGI L EL+T G +PY G+   +  +  V++  R   P+     L E
Sbjct: 176 LYGRFTIKSDVWSFGILLTELVTKGRVPYPGMVN-REVLEQVERGYRMPCPQGCPESLHE 234

Query: 345 LLERCWQHDPTQRPNFSQITDILK 368
           L++ CW+ DP +RP F  I   L+
Sbjct: 235 LMKLCWKKDPDERPTFEYIQSFLE 258

Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260

>gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases

 Score =  175 bits (446), Expect = 2e-52
 Identities = 86/261 (32%), Positives = 129/261 (49%), Gaps = 36/261 (13%)

Query: 116 KQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHK 173
           +   +   +  GS+G++YK      +Q VAIKV+  E    E+ ++  QE+  + + R  
Sbjct: 1   ELFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEI-EDIQQEIQFLSQCRSP 59

Query: 174 NVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQN 233
            + ++ G+  +   L I+ E+   GS  D L  + G    T +  +  +V  G+ YLH+ 
Sbjct: 60  YITKYYGSFLKGSKLWIIMEYCGGGSCLDLL--KPGKLDETYIAFILREVLLGLEYLHEE 117

Query: 234 NIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAET-------GTYRWMAPEVIE 286
             IHRD+K AN+L+ E G VK+ADFGV      SG +T+         GT  WMAPEVI+
Sbjct: 118 GKIHRDIKAANILLSEEGDVKLADFGV------SGQLTSTMSKRNTFVGTPFWMAPEVIK 171

Query: 287 HKPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRLA--- 343
              YD KAD++S GI   EL  GE P + L P+        + L   IPK+  P L    
Sbjct: 172 QSGYDEKADIWSLGITAIELAKGEPPLSDLHPM--------RVLF-LIPKNNPPSLEGNK 222

Query: 344 ------ELLERCWQHDPTQRP 358
                 + +  C   DP +RP
Sbjct: 223 FSKPFKDFVSLCLNKDPKERP 243

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274

>gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase

 Score =  175 bits (445), Expect = 3e-52
 Identities = 84/271 (30%), Positives = 138/271 (50%), Gaps = 11/271 (4%)

Query: 111 WEIDAKQLKIECKVASGSYGDLYKGTYCSQE-----VAIKVLKPECVNTEMLKEFSQEVY 165
           +EI  + + +   +  G +GD+Y+G Y S E     VA+K  K     +   K F QE Y
Sbjct: 1   YEIQREDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREK-FLQEAY 59

Query: 166 IMRKIRHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSK 225
           IMR+  H ++V+ IG  T  P + IV E    G +  +L   K    L SL+  +  +S 
Sbjct: 60  IMRQFDHPHIVKLIGVITENP-VWIVMELAPLGELRSYLQVNKYSLDLASLILYSYQLST 118

Query: 226 GMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAETGTY--RWMAPE 283
            + YL     +HRD+   N+L+     VK+ DFG++R         A  G    +WMAPE
Sbjct: 119 ALAYLESKRFVHRDIAARNVLVSSPDCVKLGDFGLSRYLEDESYYKASKGKLPIKWMAPE 178

Query: 284 VIEHKPYDYKADVFSFGIALWELLT-GELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRL 342
            I  + +   +DV+ FG+ +WE+L  G  P+ G+      +G ++   R  +P +  P L
Sbjct: 179 SINFRRFTSASDVWMFGVCMWEILMLGVKPFQGVKN-NDVIGRIENGERLPMPPNCPPTL 237

Query: 343 AELLERCWQHDPTQRPNFSQITDILKQMMKE 373
             L+ +CW +DP++RP F+++   L  +++E
Sbjct: 238 YSLMTKCWAYDPSKRPRFTELKAQLSDILQE 268

Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270

>gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk

 Score =  174 bits (442), Expect = 4e-52
 Identities = 97/264 (36%), Positives = 158/264 (59%), Gaps = 12/264 (4%)

Query: 111 WEIDAKQLKIECKVASGSYGDLYKGTY-CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRK 169
           WEI  + L++  K+ +G +G+++ GT+  + +VA+K LKP  ++ E    F +E  IM+K
Sbjct: 1   WEIPRESLQLIKKLGNGQFGEVWMGTWNGNTKVAVKTLKPGTMSPE---SFLEEAQIMKK 57

Query: 170 IRHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKG-VFQLTSLLKVAIDVSKGMN 228
           +RH  +VQ     +  P + IVTE+M++GS+ DFL   +G   +L +L+ +A  V+ GM 
Sbjct: 58  LRHDKLVQLYAVVSEEP-IYIVTEYMSKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMA 116

Query: 229 YLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAETGT---YRWMAPEVI 285
           Y+ + N IHRDL++AN+L+ +  V K+ADFG+AR+  +    TA  G     +W APE  
Sbjct: 117 YIERMNYIHRDLRSANILVGDGLVCKIADFGLARL-IEDNEYTARQGAKFPIKWTAPEAA 175

Query: 286 EHKPYDYKADVFSFGIALWELLT-GELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRLAE 344
            +  +  K+DV+SFGI L EL+T G +PY G+   +  +  V++  R   P+     L E
Sbjct: 176 LYGRFTIKSDVWSFGILLTELVTKGRVPYPGMNN-REVLEQVERGYRMPCPQDCPISLHE 234

Query: 345 LLERCWQHDPTQRPNFSQITDILK 368
           L+ +CW+ DP +RP F  +   L+
Sbjct: 235 LMLQCWKKDPEERPTFEYLQSFLE 258

Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260

>gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase

 Score =  173 bits (440), Expect = 3e-51
 Identities = 83/248 (33%), Positives = 131/248 (52%), Gaps = 13/248 (5%)

Query: 123 KVASGSYGDLYKGTYCS--QEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIG 180
           K+  G+ G++YK T  +  +EVAIK ++    N E++     E+ IM+  +H N+V +  
Sbjct: 26  KIGEGASGEVYKATDRATGKEVAIKKMRLRKQNKELII---NEILIMKDCKHPNIVDYYD 82

Query: 181 ACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDL 240
           +      L +V E+M  GS+ D + +         +  V  +V +G+ YLH  N+IHRD+
Sbjct: 83  SYLVGDELWVVMEYMDGGSLTDIITQNFVRMNEPQIAYVCREVLQGLEYLHSQNVIHRDI 142

Query: 241 KTANLLMDENGVVKVADFGVARVQAQSGVMTAET--GTYRWMAPEVIEHKPYDYKADVFS 298
           K+ N+L+ ++G VK+ADFG A  Q         +  GT  WMAPEVI+ K Y  K D++S
Sbjct: 143 KSDNILLSKDGSVKLADFGFA-AQLTKEKSKRNSVVGTPYWMAPEVIKRKDYGPKVDIWS 201

Query: 299 FGIALWELLTGELPYAGLTPLQAAVGVVQKSLRPTIPKHAH---PRLAELLERCWQHDPT 355
            GI   E+  GE PY    PL+A   +  K + P   K+     P   + L +C   DP 
Sbjct: 202 LGIMCIEMAEGEPPYLREPPLRALFLITTKGIPP--LKNPEKWSPEFKDFLNKCLVKDPE 259

Query: 356 QRPNFSQI 363
           +RP+  ++
Sbjct: 260 KRPSAEEL 267

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286

>gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk

 Score =  171 bits (436), Expect = 4e-51
 Identities = 87/263 (33%), Positives = 151/263 (57%), Gaps = 10/263 (3%)

Query: 111 WEIDAKQLKIECKVASGSYGDLYKGTY-CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRK 169
           WE+  + LK+  K+ +G +G+++ G Y    +VAIK LK   ++ E    F  E  +M++
Sbjct: 1   WEVPRETLKLVKKLGAGQFGEVWMGYYNGHTKVAIKSLKQGSMSPE---AFLAEANLMKQ 57

Query: 170 IRHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGV-FQLTSLLKVAIDVSKGMN 228
           ++H  +V+     T+ P + I+TE+M  GS+ DFL   +G+   +  L+ +A  +++GM 
Sbjct: 58  LQHPRLVRLYAVVTQEP-IYIITEYMENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMA 116

Query: 229 YLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAETGTY--RWMAPEVIE 286
           ++ + N IHRDL+ AN+L+ E    K+ADFG+AR+   +     E   +  +W APE I 
Sbjct: 117 FIERKNYIHRDLRAANILVSETLCCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAIN 176

Query: 287 HKPYDYKADVFSFGIALWELLT-GELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRLAEL 345
           +  +  K+DV+SFGI L E++T G +PY G+T  +  +  +++  R   P +    L EL
Sbjct: 177 YGTFTIKSDVWSFGILLTEIVTYGRIPYPGMTNPE-VIQNLERGYRMPRPDNCPEELYEL 235

Query: 346 LERCWQHDPTQRPNFSQITDILK 368
           +  CW+  P +RP F  +  +L+
Sbjct: 236 MRLCWKEKPEERPTFEYLRSVLE 258

Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260

>gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase

 Score =  171 bits (436), Expect = 4e-51
 Identities = 80/256 (31%), Positives = 137/256 (53%), Gaps = 13/256 (5%)

Query: 123 KVASGSYGDLYKGTYCSQ-----EVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQ 177
           K+  GS+G + +G + +       VA+K LK + + ++++ +F +E  IM  + H+N+++
Sbjct: 2   KLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKL-SDIMDDFLKEAAIMHSLDHENLIR 60

Query: 178 FIGACTRPPNLCIVTEFMARGSIYDFLHK-QKGVFQLTSLLKVAIDVSKGMNYLHQNNII 236
             G     P L +VTE    GS+ D L K   G F +++L   A+ ++ GM YL     I
Sbjct: 61  LYGVVLTHP-LMMVTELAPLGSLLDRLRKDALGHFLISTLCDYAVQIANGMRYLESKRFI 119

Query: 237 HRDLKTANLLMDENGVVKVADFGVARVQAQSG---VMTAETGT-YRWMAPEVIEHKPYDY 292
           HRDL   N+L+  +  VK+ DFG+ R   Q+    VM       + W APE +  + + +
Sbjct: 120 HRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVMEEHLKVPFAWCAPESLRTRTFSH 179

Query: 293 KADVFSFGIALWELLT-GELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRLAELLERCWQ 351
            +DV+ FG+ LWE+ T GE P+AGL+  Q    + ++  R   P+     +  ++ +CW 
Sbjct: 180 ASDVWMFGVTLWEMFTYGEEPWAGLSGSQILKKIDKEGERLERPEACPQDIYNVMLQCWA 239

Query: 352 HDPTQRPNFSQITDIL 367
           H+P  RP F+ + + L
Sbjct: 240 HNPADRPTFAALREFL 255

Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257

>gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase

 Score =  171 bits (434), Expect = 7e-51
 Identities = 87/261 (33%), Positives = 156/261 (59%), Gaps = 10/261 (3%)

Query: 111 WEIDAKQLKIECKVASGSYGDLYKGTYCSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKI 170
           W ++ ++L +   +  G +G + +G Y  Q+VA+K +K  C  T   + F +E  +M K+
Sbjct: 1   WLLNLQKLTLGEIIGEGEFGAVLQGEYTGQKVAVKNIK--CDVTA--QAFLEETAVMTKL 56

Query: 171 RHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQ-KGVFQLTSLLKVAIDVSKGMNY 229
            HKN+V+ +G       L IV E M++G++ +FL  + + +  +  LL+ ++DV++GM Y
Sbjct: 57  HHKNLVRLLGVILHN-GLYIVMELMSKGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEY 115

Query: 230 LHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAETGTYRWMAPEVIEHKP 289
           L    ++HRDL   N+L+ E+GV KV+DFG+ARV +  GV  ++    +W APE ++HK 
Sbjct: 116 LESKKLVHRDLAARNILVSEDGVAKVSDFGLARVGSM-GVDNSKLPV-KWTAPEALKHKK 173

Query: 290 YDYKADVFSFGIALWELLT-GELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRLAELLER 348
           +  K+DV+S+G+ LWE+ + G  PY  ++ L+     V+K  R   P+     +  L+  
Sbjct: 174 FSSKSDVWSYGVLLWEVFSYGRAPYPKMS-LKEVKECVEKGYRMEPPEGCPADVYVLMTS 232

Query: 349 CWQHDPTQRPNFSQITDILKQ 369
           CW+ +P +RP+F ++ + L++
Sbjct: 233 CWETEPKKRPSFHKLREKLEK 253

Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254

>gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases

 Score =  171 bits (436), Expect = 9e-51
 Identities = 76/288 (26%), Positives = 134/288 (46%), Gaps = 41/288 (14%)

Query: 116 KQLKIECKVASGSYGDLYKGTYCSQ------EVAIKVLKPECVNTEMLKEFSQEVYIMRK 169
           + LK   ++  G +G +    Y         +VA+K L           +F +E+ I+R 
Sbjct: 4   RHLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHR-SDFEREIEILRT 62

Query: 170 IRHKNVVQFIGACTRP--PNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGM 227
           + H+N+V++ G C +P   +L ++ E++  GS+ D+L + +    L  LL  +  + KGM
Sbjct: 63  LDHENIVKYKGVCEKPGGRSLRLIMEYLPSGSLRDYLQRHRDQINLKRLLLFSSQICKGM 122

Query: 228 NYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSG----VMTAETGTYRWMAPE 283
           +YL     IHRDL   N+L++   +VK++DFG+A+V  +      V         W APE
Sbjct: 123 DYLGSQRYIHRDLAARNILVESEDLVKISDFGLAKVLPEDKDYYYVKEPGESPIFWYAPE 182

Query: 284 VIEHKPYDYKADVFSFGIALWELLT-GELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRL 342
            +    +   +DV+SFG+ L+EL T G+       P Q+      + +     +    RL
Sbjct: 183 CLRTSKFSSASDVWSFGVTLYELFTYGD-------PSQSPPAEFLRMIGIAQGQMIVTRL 235

Query: 343 AELLE--------------------RCWQHDPTQRPNFSQITDILKQM 370
            ELL+                     CW+ +P  RP+F+ +  I+ ++
Sbjct: 236 LELLKEGERLPRPPSCPDEVYDLMKLCWEAEPQDRPSFADLILIVDRL 283

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284

>gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase

 Score =  170 bits (433), Expect = 1e-50
 Identities = 85/259 (32%), Positives = 141/259 (54%), Gaps = 8/259 (3%)

Query: 113 IDAKQLKIECKVASGSYGDLYKGTYCSQ-EVAIKVLKPECVNTEMLKEFSQEVYIMRKIR 171
           I+  +L    ++ SG +G ++ G + +Q +VAIK +    ++ E   +F +E  +M K+ 
Sbjct: 1   INPSELTFMKELGSGQFGVVHLGKWRAQIKVAIKAINEGAMSEE---DFIEEAKVMMKLS 57

Query: 172 HKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLH 231
           H  +VQ  G CT+   L IVTEFM  G + ++L +++G      LL +  DV +GM YL 
Sbjct: 58  HPKLVQLYGVCTQQKPLYIVTEFMENGCLLNYLRQRQGKLSKDMLLSMCQDVCEGMEYLE 117

Query: 232 QNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAETGTY--RWMAPEVIEHKP 289
           +N+ IHRDL   N L+   GVVKV+DFG+ R        ++    +  +W  PEV     
Sbjct: 118 RNSFIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDEYTSSSGAKFPVKWSPPEVFNFSK 177

Query: 290 YDYKADVFSFGIALWELLT-GELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRLAELLER 348
           Y  K+DV+SFG+ +WE+ T G++P+   +  +  V ++ +  R   PK A   + E++  
Sbjct: 178 YSSKSDVWSFGVLMWEVFTEGKMPFEKKSNYE-VVEMISRGFRLYRPKLASMTVYEVMYS 236

Query: 349 CWQHDPTQRPNFSQITDIL 367
           CW   P  RP F+++   +
Sbjct: 237 CWHEKPEGRPTFAELLRAI 255

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256

>gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn

 Score =  170 bits (432), Expect = 1e-50
 Identities = 88/263 (33%), Positives = 153/263 (58%), Gaps = 11/263 (4%)

Query: 111 WEIDAKQLKIECKVASGSYGDLYKGTY-CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRK 169
           WEI  + +K+  K+ +G +G+++ G Y  S +VA+K LKP    T  ++ F +E  +M+ 
Sbjct: 1   WEIPRESIKLVKKLGAGQFGEVWMGYYNNSTKVAVKTLKP---GTMSVQAFLEEANLMKT 57

Query: 170 IRHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGV-FQLTSLLKVAIDVSKGMN 228
           ++H  +V+     T+   + I+TE+MA+GS+ DFL   +G    L  L+  +  +++GM 
Sbjct: 58  LQHDKLVRLYAVVTKEEPIYIITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMA 117

Query: 229 YLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAETGT---YRWMAPEVI 285
           Y+ + N IHRDL+ AN+L+ E+ + K+ADFG+ARV  +    TA  G     +W APE I
Sbjct: 118 YIERKNYIHRDLRAANVLVSESLMCKIADFGLARV-IEDNEYTAREGAKFPIKWTAPEAI 176

Query: 286 EHKPYDYKADVFSFGIALWELLT-GELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRLAE 344
               +  K+DV+SFGI L+E++T G++PY G++        +Q+  R    ++    L +
Sbjct: 177 NFGSFTIKSDVWSFGILLYEIVTYGKIPYPGMSNSDVMSA-LQRGYRMPRMENCPDELYD 235

Query: 345 LLERCWQHDPTQRPNFSQITDIL 367
           +++ CW+    +RP F  +  +L
Sbjct: 236 IMKTCWKEKAEERPTFDYLQSVL 258

Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261

>gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases

 Score =  169 bits (431), Expect = 3e-50
 Identities = 83/285 (29%), Positives = 138/285 (48%), Gaps = 36/285 (12%)

Query: 111 WEIDAKQLKIECKVASGSYGDLYKGTYCS-------QEVAIKVLKPECVNTEMLKEFSQE 163
           WE+  +++ +  ++  GS+G +Y+G             VAIK +       E + EF  E
Sbjct: 1   WELPREKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERI-EFLNE 59

Query: 164 VYIMRKIRHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQK---------GVFQLT 214
             +M++    +VV+ +G  +      +V E MA+G +  +L  ++         G   L 
Sbjct: 60  ASVMKEFNCHHVVRLLGVVSTGQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQ 119

Query: 215 SLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAET 274
             +++A +++ GM YL     +HRDL   N ++ E+  VK+ DFG+ R          ET
Sbjct: 120 KFIQMAAEIADGMAYLAAKKFVHRDLAARNCMVAEDLTVKIGDFGMTR-------DIYET 172

Query: 275 GTY----------RWMAPEVIEHKPYDYKADVFSFGIALWELLT-GELPYAGLTPLQAAV 323
             Y          RWMAPE ++   +  K+DV+SFG+ LWE+ T  E PY GL+  +   
Sbjct: 173 DYYRKGGKGLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQGLSNEEVLK 232

Query: 324 GVVQKSLRPTIPKHAHPRLAELLERCWQHDPTQRPNFSQITDILK 368
            V+       +P++   +L EL+  CWQ++P  RP F +I   LK
Sbjct: 233 FVIDGGHLD-LPENCPDKLLELMRMCWQYNPKMRPTFLEIVSSLK 276

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277

>gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer

 Score =  167 bits (424), Expect = 1e-49
 Identities = 87/245 (35%), Positives = 141/245 (57%), Gaps = 8/245 (3%)

Query: 124 VASGSYGDLYKGTYCSQ-EVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGAC 182
           +  G++G+++KGT   +  VA+K  K E +  E+  +F  E  I+++  H N+V+ IG C
Sbjct: 3   LGKGNFGEVFKGTLKDKTPVAVKTCK-EDLPQELKIKFLSEARILKQYDHPNIVKLIGVC 61

Query: 183 TRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKT 242
           T+   + IV E +  G    FL K+K   +   L+K A+D + GM YL   N IHRDL  
Sbjct: 62  TQRQPIYIVMELVPGGDFLSFLRKKKDELKTKQLVKFALDAAAGMAYLESKNCIHRDLAA 121

Query: 243 ANLLMDENGVVKVADFGVARVQAQSGVMTA---ETGTYRWMAPEVIEHKPYDYKADVFSF 299
            N L+ EN V+K++DFG++R Q   G+ ++   +    +W APE + +  Y  ++DV+S+
Sbjct: 122 RNCLVGENNVLKISDFGMSR-QEDDGIYSSSGLKQIPIKWTAPEALNYGRYSSESDVWSY 180

Query: 300 GIALWELLT-GELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRLAELLERCWQHDPTQRP 358
           GI LWE  + G  PY G+T  Q A   V+K  R + P+     + ++++RCW + P  RP
Sbjct: 181 GILLWETFSLGVCPYPGMTN-QQAREQVEKGYRMSCPQKCPDDVYKVMQRCWDYKPENRP 239

Query: 359 NFSQI 363
            FS++
Sbjct: 240 KFSEL 244

Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250

>gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase

 Score =  167 bits (425), Expect = 2e-49
 Identities = 84/264 (31%), Positives = 135/264 (51%), Gaps = 19/264 (7%)

Query: 116 KQLKIECKVASGSYGDLYKGTYC---SQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRH 172
              ++   +  G+   +Y    C   +++VAIK +  E   T +  E  +EV  M +  H
Sbjct: 1   DDYELIEVIGVGATAVVYAA-ICLPNNEKVAIKRIDLEKCQTSV-DELRKEVQAMSQCNH 58

Query: 173 KNVVQFIGACTRPPNLCIVTEFMARGSIYDFL-HK-QKGVFQLTSLLKVAIDVSKGMNYL 230
            NVV++  +      L +V  +++ GS+ D +     +G      +  V  +V KG+ YL
Sbjct: 59  PNVVKYYTSFVVGDELWLVMPYLSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYL 118

Query: 231 HQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAET-----GTYRWMAPEVI 285
           H N  IHRD+K  N+L+ E+G VK+ADFGV+   A  G  T +      GT  WMAPEV+
Sbjct: 119 HSNGQIHRDIKAGNILLGEDGSVKIADFGVSASLADGGDRTRKVRKTFVGTPCWMAPEVM 178

Query: 286 E-HKPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPR--- 341
           E    YD+KAD++SFGI   EL TG  PY+   P++  +  +Q    P++   A  +   
Sbjct: 179 EQVHGYDFKADIWSFGITAIELATGAAPYSKYPPMKVLMLTLQND-PPSLETGADYKKYS 237

Query: 342 --LAELLERCWQHDPTQRPNFSQI 363
               +++  C Q DP++RP   ++
Sbjct: 238 KSFRKMISLCLQKDPSKRPTAEEL 261

Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267

>gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases

 Score =  166 bits (423), Expect = 5e-49
 Identities = 82/258 (31%), Positives = 137/258 (53%), Gaps = 13/258 (5%)

Query: 126 SGSYGDLYKGTYCSQ------EVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFI 179
           SG++G +YKG +  +       VAIKVL+ E  + +  KE   E Y+M  + H +VV+ +
Sbjct: 17  SGAFGTVYKGVWIPEGEKVKIPVAIKVLR-EETSPKANKEILDEAYVMASVDHPHVVRLL 75

Query: 180 GACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRD 239
           G C     + ++T+ M  G + D++   K       LL   + ++KGM+YL +  ++HRD
Sbjct: 76  GICL-SSQVQLITQLMPLGCLLDYVRNHKDNIGSQYLLNWCVQIAKGMSYLEEKRLVHRD 134

Query: 240 LKTANLLMDENGVVKVADFGVAR-VQAQSGVMTAETGTY--RWMAPEVIEHKPYDYKADV 296
           L   N+L+     VK+ DFG+A+ +        AE G    +WMA E I H+ Y +K+DV
Sbjct: 135 LAARNVLVKTPQHVKITDFGLAKLLDVDEKEYHAEGGKVPIKWMALESILHRIYTHKSDV 194

Query: 297 FSFGIALWELLT-GELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRLAELLERCWQHDPT 355
           +S+G+ +WEL+T G  PY G+ P      +++K  R   P      +  +L +CW  D  
Sbjct: 195 WSYGVTVWELMTFGAKPYEGI-PAVEIPDLLEKGERLPQPPICTIDVYMVLVKCWMIDAE 253

Query: 356 QRPNFSQITDILKQMMKE 373
            RP F ++ +   +M ++
Sbjct: 254 SRPTFKELINEFSKMARD 271

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279

>gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase

 Score =  164 bits (416), Expect = 3e-48
 Identities = 91/263 (34%), Positives = 153/263 (58%), Gaps = 10/263 (3%)

Query: 111 WEIDAKQLKIECKVASGSYGDLYKGTYCSQ-EVAIKVLKPECVNTEMLKEFSQEVYIMRK 169
           WEI  + LK+E K+ +G +G+++  TY    +VA+K +KP  ++ E    F  E  +M+ 
Sbjct: 1   WEIPRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGSMSVE---AFLAEANVMKT 57

Query: 170 IRHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKG-VFQLTSLLKVAIDVSKGMN 228
           ++H  +V+     T+ P + I+TEFMA+GS+ DFL   +G    L  L+  +  +++GM 
Sbjct: 58  LQHDKLVKLHAVVTKEP-IYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMA 116

Query: 229 YLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAETGTY--RWMAPEVIE 286
           ++ Q N IHRDL+ AN+L+  + V K+ADFG+ARV   +     E   +  +W APE I 
Sbjct: 117 FIEQRNYIHRDLRAANILVSASLVCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAIN 176

Query: 287 HKPYDYKADVFSFGIALWELLT-GELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRLAEL 345
              +  K+DV+SFGI L E++T G +PY G++  +  +  +++  R   P++    L  +
Sbjct: 177 FGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPE-VIRALERGYRMPRPENCPEELYNI 235

Query: 346 LERCWQHDPTQRPNFSQITDILK 368
           + RCW++ P +RP F  I  +L 
Sbjct: 236 MMRCWKNRPEERPTFEYIQSVLD 258

Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260

>gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1

 Score =  164 bits (416), Expect = 3e-48
 Identities = 81/246 (32%), Positives = 130/246 (52%), Gaps = 7/246 (2%)

Query: 124 VASGSYGDLYKGTYCSQE--VAIKV--LKPECVNT-EMLKEFSQEVYIMRKIRHKNVVQF 178
           + SGS+G +Y+G         A+K   L  +     E +K+  QE+ ++ K++H N+VQ+
Sbjct: 8   LGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQY 67

Query: 179 IGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHR 238
           +G      NL I  E +  GS+   L K  G F    +      +  G+ YLH  N +HR
Sbjct: 68  LGTEREEDNLYIFLELVPGGSLAKLLKKY-GSFPEPVIRLYTRQILLGLEYLHDRNTVHR 126

Query: 239 DLKTANLLMDENGVVKVADFGVARVQAQSGVMTAETGTYRWMAPEVIEHK-PYDYKADVF 297
           D+K AN+L+D NGVVK+ADFG+A+   +     +  G+  WMAPEVI  +  Y   AD++
Sbjct: 127 DIKGANILVDTNGVVKLADFGMAKQVVEFSFAKSFKGSPYWMAPEVIAQQGGYGLAADIW 186

Query: 298 SFGIALWELLTGELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRLAELLERCWQHDPTQR 357
           S G  + E+ TG+ P++ L  + A   + +    P IP H      + + +C Q DP+ R
Sbjct: 187 SLGCTVLEMATGKPPWSQLEGVAAVFKIGRSKELPPIPDHLSDEAKDFILKCLQRDPSLR 246

Query: 358 PNFSQI 363
           P  +++
Sbjct: 247 PTAAEL 252

Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258

>gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome

 Score =  163 bits (413), Expect = 9e-48
 Identities = 86/256 (33%), Positives = 141/256 (55%), Gaps = 10/256 (3%)

Query: 113 IDAKQLKIECKVASGSYGDLYKGTYCSQ-EVAIKVLKPECVNTEMLKEFSQEVYIMRKIR 171
           ID K L    ++ +G +G +  G +  Q +VAIK++K   ++ +   EF +E  +M K+ 
Sbjct: 1   IDPKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSED---EFIEEAKVMMKLS 57

Query: 172 HKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLH 231
           H+ +VQ  G CT+   + IVTE+M+ G + ++L +    FQ + LL++  DV +GM YL 
Sbjct: 58  HEKLVQLYGVCTKQRPIYIVTEYMSNGCLLNYLREHGKRFQPSQLLEMCKDVCEGMAYLE 117

Query: 232 QNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAETGT---YRWMAPEVIEHK 288
               IHRDL   N L+D+ G VKV+DFG++R        T+  G+    RW  PEV+ + 
Sbjct: 118 SKQFIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDE-YTSSVGSKFPVRWSPPEVLLYS 176

Query: 289 PYDYKADVFSFGIALWELLT-GELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRLAELLE 347
            +  K+DV++FG+ +WE+ + G++PY      +    V Q  LR   P  A  ++  ++ 
Sbjct: 177 KFSSKSDVWAFGVLMWEVYSLGKMPYERFNNSETVEKVSQ-GLRLYRPHLASEKVYAIMY 235

Query: 348 RCWQHDPTQRPNFSQI 363
            CW     +RP F Q+
Sbjct: 236 SCWHEKAEERPTFQQL 251

Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256

>gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors

 Score =  163 bits (414), Expect = 2e-47
 Identities = 89/296 (30%), Positives = 153/296 (51%), Gaps = 31/296 (10%)

Query: 103 IPTDGTDVWEIDAKQLKIECKVASGSYGDLYKGTYC-------SQEVAIKVLKPECVNTE 155
           +P D    WE+   +L +   +  G++G + K           +  VA+K+LK +    +
Sbjct: 1   LPLD--PEWELPRDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKD 58

Query: 156 MLKEFSQEVYIMRKI-RHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLT 214
            L +   E+ +M+ I +HKN++  +G CT+   L +V E+ A G++ DFL  ++   +  
Sbjct: 59  -LSDLVSEMEMMKMIGKHKNIINLLGVCTQEGPLYVVVEYAAHGNLRDFLRARRPPGEYA 117

Query: 215 S---------------LLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFG 259
           S               L+  A  V++GM +L     IHRDL   N+L+ E+ V+K+ADFG
Sbjct: 118 SPDDPRPPEETLTQKDLVSFAYQVARGMEFLASKKCIHRDLAARNVLVTEDHVMKIADFG 177

Query: 260 VAR-VQAQSGVMTAETG--TYRWMAPEVIEHKPYDYKADVFSFGIALWELLT-GELPYAG 315
           +AR +           G    +WMAPE +  + Y +++DV+SFG+ LWE+ T G  PY G
Sbjct: 178 LARDIHHIDYYRKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPG 237

Query: 316 LTPLQAAVGVVQKSLRPTIPKHAHPRLAELLERCWQHDPTQRPNFSQITDILKQMM 371
           + P++    ++++  R   P++    L  L+  CW   P+QRP F Q+ + L +M+
Sbjct: 238 I-PVEELFKLLKEGYRMEKPQNCTQELYHLMRDCWHEVPSQRPTFKQLVEDLDRML 292

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293

>gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases

 Score =  161 bits (410), Expect = 3e-47
 Identities = 76/254 (29%), Positives = 130/254 (51%), Gaps = 14/254 (5%)

Query: 126 SGSYGDLYKGTYCSQ-----EVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIG 180
            G++G + KG Y  +     EVA+K LK E +     KEF +E  +M ++ H  +V+ IG
Sbjct: 5   HGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGK-KEFLREASVMAQLDHPCIVRLIG 63

Query: 181 ACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDL 240
            C   P L +V E    G +  +L K++    ++ L ++A  V+ GM YL   + +HRDL
Sbjct: 64  VCKGEP-LMLVMELAPLGPLLKYL-KKRREIPVSDLKELAHQVAMGMAYLESKHFVHRDL 121

Query: 241 KTANLLMDENGVVKVADFGVAR-VQAQSGVMTAETG---TYRWMAPEVIEHKPYDYKADV 296
              N+L+      K++DFG++R + A S    A T      +W APE I +  +  K+DV
Sbjct: 122 AARNVLLVNRHQAKISDFGMSRALGAGSDYYRATTAGRWPLKWYAPECINYGKFSSKSDV 181

Query: 297 FSFGIALWELLT-GELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRLAELLERCWQHDPT 355
           +S+G+ LWE  + G  PY  +      + +++   R   P+     +  ++  CW++ P 
Sbjct: 182 WSYGVTLWEAFSYGAKPYGEMKG-AEVIAMLESGERLPRPEECPQEIYSIMLSCWKYRPE 240

Query: 356 QRPNFSQITDILKQ 369
            RP FS++    ++
Sbjct: 241 DRPTFSELESTFRR 254

Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257

>gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

 Score =  159 bits (404), Expect = 2e-46
 Identities = 80/252 (31%), Positives = 129/252 (51%), Gaps = 16/252 (6%)

Query: 124 VASGSYGDLYKGTYC-----SQEVAIKVLKPECVNTEMLKEFSQ---EVYIMRKIRHKNV 175
           +  G++G +Y    C      +E+A+K +  +  + E  KE +    E+ +++ ++H+ +
Sbjct: 10  LGQGAFGRVY---LCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERI 66

Query: 176 VQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNI 235
           VQ+ G       L I  E+M  GS+ D L K  G    T   K    + +G+ YLH N I
Sbjct: 67  VQYYGCLRDDETLSIFMEYMPGGSVKDQL-KAYGALTETVTRKYTRQILEGVEYLHSNMI 125

Query: 236 IHRDLKTANLLMDENGVVKVADFGVA-RVQA---QSGVMTAETGTYRWMAPEVIEHKPYD 291
           +HRD+K AN+L D  G VK+ DFG + R+Q        M + TGT  WM+PEVI  + Y 
Sbjct: 126 VHRDIKGANILRDSAGNVKLGDFGASKRLQTICSSGTGMKSVTGTPYWMSPEVISGEGYG 185

Query: 292 YKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRLAELLERCWQ 351
            KADV+S G  + E+LT + P+A    + A   +  +   P +P H  P     L R + 
Sbjct: 186 RKADVWSVGCTVVEMLTEKPPWAEFEAMAAIFKIATQPTNPQLPSHVSPDARNFLRRTFV 245

Query: 352 HDPTQRPNFSQI 363
            +  +RP+  ++
Sbjct: 246 ENAKKRPSAEEL 257

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263

>gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors

 Score =  160 bits (406), Expect = 3e-46
 Identities = 87/284 (30%), Positives = 148/284 (52%), Gaps = 16/284 (5%)

Query: 101 IEIPTDGTDVWEIDAKQLKIECKVASGSYGDLYKGTY-------CSQEVAIKVLKPECVN 153
            ++P D    WE     L     + +G++G + + T           +VA+K+LKP   +
Sbjct: 22  TQLPYD--LKWEFPRNNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHS 79

Query: 154 TEMLKEFSQEVYIMRKI-RHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVF- 211
           +E     S E+ IM  +  H+N+V  +GACT    + ++TE+   G + +FL +++  F 
Sbjct: 80  SEREALMS-ELKIMSHLGNHENIVNLLGACTIGGPILVITEYCCYGDLLNFLRRKRESFL 138

Query: 212 QLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMT 271
            L  LL  +  V+KGM +L   N IHRDL   N+L+    +VK+ DFG+AR         
Sbjct: 139 TLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNVLLTHGKIVKICDFGLARDIMNDSNYV 198

Query: 272 AETGTY---RWMAPEVIEHKPYDYKADVFSFGIALWELLT-GELPYAGLTPLQAAVGVVQ 327
            +       +WMAPE I +  Y +++DV+S+GI LWE+ + G  PY G+        +++
Sbjct: 199 VKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSNPYPGMPVDSKFYKLIK 258

Query: 328 KSLRPTIPKHAHPRLAELLERCWQHDPTQRPNFSQITDILKQMM 371
           +  R   P+HA   + ++++ CW  DP +RP F QI  ++ + +
Sbjct: 259 EGYRMAQPEHAPAEIYDIMKTCWDADPLKRPTFKQIVQLIGKQL 302

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302

>gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors

 Score =  158 bits (400), Expect = 1e-45
 Identities = 86/271 (31%), Positives = 139/271 (51%), Gaps = 14/271 (5%)

Query: 113 IDAKQLKIECKVASGSYGDLYKGTYC-----SQEVAIKVLKPECVNTEMLKEFSQEVYIM 167
           ID   +KIE  + +G +G++ +G           VAIK LK      +  ++F  E  IM
Sbjct: 1   IDVSCVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSG-YTEKQRRDFLSEASIM 59

Query: 168 RKIRHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGM 227
            +  H N++   G  T+   + I+TEFM  G++  FL +  G F +  L+ +   ++ GM
Sbjct: 60  GQFDHPNIIHLEGVVTKSRPVMIITEFMENGALDSFLRQNDGQFTVIQLVGMLRGIAAGM 119

Query: 228 NYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAETGTY------RWMA 281
            YL + N +HRDL   N+L++ N V KV+DFG++R           T +       RW A
Sbjct: 120 KYLSEMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSSLGGKIPIRWTA 179

Query: 282 PEVIEHKPYDYKADVFSFGIALWELLT-GELPYAGLTPLQAAVGVVQKSLRPTIPKHAHP 340
           PE I ++ +   +DV+S+GI +WE+++ GE PY  ++  Q  +  +++  R   P     
Sbjct: 180 PEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSN-QDVINAIEQDYRLPPPMDCPT 238

Query: 341 RLAELLERCWQHDPTQRPNFSQITDILKQMM 371
            L +L+  CWQ D   RP F QI   L +M+
Sbjct: 239 ALHQLMLDCWQKDRNARPKFGQIVSTLDKMI 269

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269

>gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes

 Score =  157 bits (397), Expect = 1e-45
 Identities = 81/252 (32%), Positives = 141/252 (55%), Gaps = 10/252 (3%)

Query: 123 KVASGSYGDLYKGTYCSQE--VAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIG 180
           ++  G++G+++ G   +    VA+K  + E +  ++  +F QE  I+++  H N+V+ IG
Sbjct: 2   RIGRGNFGEVFSGRLRADNTPVAVKSCR-ETLPPDLKAKFLQEARILKQYSHPNIVRLIG 60

Query: 181 ACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDL 240
            CT+   + IV E +  G    FL  +    ++  L+++  + + GM YL   + IHRDL
Sbjct: 61  VCTQKQPIYIVMELVQGGDFLTFLRTEGPRLKVKELIQMVENAAAGMEYLESKHCIHRDL 120

Query: 241 KTANLLMDENGVVKVADFGVARVQAQSGVMTAETGT----YRWMAPEVIEHKPYDYKADV 296
              N L+ E  V+K++DFG++R + + GV  +  G      +W APE + +  Y  ++DV
Sbjct: 121 AARNCLVTEKNVLKISDFGMSR-EEEDGVYASTGGMKQIPVKWTAPEALNYGRYSSESDV 179

Query: 297 FSFGIALWELLT-GELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRLAELLERCWQHDPT 355
           +SFGI LWE  + G +PYA L+  Q     +++ +R   P+     +  L+ERCW++DP 
Sbjct: 180 WSFGILLWEAFSLGAVPYANLSN-QQTREAIEQGVRLPCPELCPDAVYRLMERCWEYDPG 238

Query: 356 QRPNFSQITDIL 367
           QRP+FS +   L
Sbjct: 239 QRPSFSTVHQEL 250

Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252

>gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases

 Score =  155 bits (393), Expect = 1e-44
 Identities = 83/245 (33%), Positives = 129/245 (52%), Gaps = 11/245 (4%)

Query: 123 KVASGSYGDLYKG--TYCSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIG 180
           ++ SG+YGD+YK       + VAIKV+K E    +  +   QE+ ++++ RH N+V + G
Sbjct: 10  RIGSGTYGDVYKARDIATGELVAIKVIKLE--PGDDFEIIQQEISMLKECRHPNIVAYFG 67

Query: 181 ACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDL 240
           +  R   L IV E+   GS+ D     +G      +  V  +  KG+ YLH+   IHRD+
Sbjct: 68  SYLRRDKLWIVMEYCGGGSLQDIYQVTRGPLSELQIAYVCRETLKGLAYLHETGKIHRDI 127

Query: 241 KTANLLMDENGVVKVADFGV-ARVQAQSGVMTAETGTYRWMAPEVIEHK---PYDYKADV 296
           K AN+L+ E+G VK+ADFGV A++ A      +  GT  WMAPEV   +    YD K D+
Sbjct: 128 KGANILLTEDGDVKLADFGVSAQLTATIAKRKSFIGTPYWMAPEVAAVERKGGYDGKCDI 187

Query: 297 FSFGIALWELLTGELPYAGLTPLQAAVGVVQKSLRPTIPKHAH---PRLAELLERCWQHD 353
           ++ GI   EL   + P   L P++A   + + +  P   K      P   + +++C   D
Sbjct: 188 WALGITAIELAELQPPMFDLHPMRALFLISKSNFPPPKLKDKEKWSPVFHDFIKKCLTKD 247

Query: 354 PTQRP 358
           P +RP
Sbjct: 248 PKKRP 252

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262

>gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors

 Score =  154 bits (391), Expect = 2e-44
 Identities = 90/269 (33%), Positives = 140/269 (52%), Gaps = 12/269 (4%)

Query: 113 IDAKQLKIECKVASGSYGDLYKGTYCSQ-----EVAIKVLKPECVNTEMLKEFSQEVYIM 167
           IDA  +KIE  + +G +G++  G           VAIK LK      +  ++F  E  IM
Sbjct: 1   IDASCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQR-RDFLSEASIM 59

Query: 168 RKIRHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGM 227
            +  H N++   G  T+   + IVTE+M  GS+  FL K  G F +  L+ +   ++ GM
Sbjct: 60  GQFDHPNIIHLEGVVTKSKPVMIVTEYMENGSLDAFLRKHDGQFTVIQLVGMLRGIASGM 119

Query: 228 NYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARV--QAQSGVMTAETGT--YRWMAPE 283
            YL     +HRDL   N+L++ N V KV+DFG++RV         T   G    RW APE
Sbjct: 120 KYLSDMGYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTAPE 179

Query: 284 VIEHKPYDYKADVFSFGIALWELLT-GELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRL 342
            I ++ +   +DV+S+GI +WE+++ GE PY  ++  Q  +  +++  R   P      L
Sbjct: 180 AIAYRKFTSASDVWSYGIVMWEVMSYGERPYWEMSN-QDVIKAIEEGYRLPAPMDCPAAL 238

Query: 343 AELLERCWQHDPTQRPNFSQITDILKQMM 371
            +L+  CWQ D  +RP F QI  IL +++
Sbjct: 239 HQLMLDCWQKDRNERPKFEQIVSILDKLI 267

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267

>gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins

 Score =  153 bits (390), Expect = 3e-44
 Identities = 77/251 (30%), Positives = 122/251 (48%), Gaps = 15/251 (5%)

Query: 118 LKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNV 175
           L+    +  GS G +YK  +    +  A+K +     + E  K+  +E+  +R      V
Sbjct: 3   LERVKVLGQGSSGVVYKVRHKPTGKIYALKKIH-VDGDEEFRKQLLRELKTLRSCESPYV 61

Query: 176 VQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQN-N 234
           V+  GA  +   + IV E+M  GS+ D L K+ G      L  +A  + KG++YLH   +
Sbjct: 62  VKCYGAFYKEGEISIVLEYMDGGSLAD-LLKKVGKIPEPVLAYIARQILKGLDYLHTKRH 120

Query: 235 IIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAE-TGTYRWMAPEVIEHKPYDYK 293
           IIHRD+K +NLL++  G VK+ADFG+++V   +        GT  +M+PE I+ + Y Y 
Sbjct: 121 IIHRDIKPSNLLINSKGEVKIADFGISKVLENTLDQCNTFVGTVTYMSPERIQGESYSYA 180

Query: 294 ADVFSFGIALWELLTGELPYAGLTP------LQAAVGVVQKSLRPTIPKHAHPRLAELLE 347
           AD++S G+ L E   G+ P+           +QA       SL         P   + + 
Sbjct: 181 ADIWSLGLTLLECALGKFPFLPPGQPSFFELMQAICDGPPPSLPAE---EFSPEFRDFIS 237

Query: 348 RCWQHDPTQRP 358
            C Q DP +RP
Sbjct: 238 ACLQKDPKKRP 248

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264

>gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10

 Score =  153 bits (389), Expect = 4e-44
 Identities = 82/268 (30%), Positives = 140/268 (52%), Gaps = 10/268 (3%)

Query: 112 EIDAKQLKIECKVASGSYGDLYKGTY---CSQE--VAIKVLKPECVNTEMLKEFSQEVYI 166
           E+D K +KIE  + +G +G+L +G       +E  VAI  L+  C + +    F  E   
Sbjct: 1   ELDNKSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRG-FLAEALT 59

Query: 167 MRKIRHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKG 226
           + +  H N+V+  G  TR   + IVTE+M+ G++  FL K +G      L+ +   ++ G
Sbjct: 60  LGQFDHSNIVRLEGVITRGNTMMIVTEYMSNGALDSFLRKHEGQLVAGQLMGMLPGLASG 119

Query: 227 MNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAETG--TYRWMAPEV 284
           M YL +   +H+ L    +L++ + V K++ F   +      + T  +G     W APE 
Sbjct: 120 MKYLSEMGYVHKGLAAHKVLVNSDLVCKISGFRRLQEDKSEAIYTTMSGKSPVLWAAPEA 179

Query: 285 IEHKPYDYKADVFSFGIALWELLT-GELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRLA 343
           I++  +   +DV+SFGI +WE+++ GE PY  ++  Q  +  V+   R   P++    L 
Sbjct: 180 IQYHHFSSASDVWSFGIVMWEVMSYGERPYWDMSG-QDVIKAVEDGFRLPAPRNCPNLLH 238

Query: 344 ELLERCWQHDPTQRPNFSQITDILKQMM 371
           +L+  CWQ +  +RP FSQI  IL +M+
Sbjct: 239 QLMLDCWQKERGERPRFSQIHSILSKMV 266

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266

>gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros

 Score =  152 bits (385), Expect = 2e-43
 Identities = 88/267 (32%), Positives = 137/267 (51%), Gaps = 25/267 (9%)

Query: 124 VASGSYGDLYKGTYCS--------QEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNV 175
           + SG++G++Y+GT             VA+K L+    + E  KEF +E ++M    H N+
Sbjct: 3   LGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEK-KEFLKEAHLMSNFNHPNI 61

Query: 176 VQFIGACTRPPNLCIVTEFMARGSIYDFLHKQK------GVFQLTSLLKVAIDVSKGMNY 229
           V+ +G C       I+ E M  G +  +L   +       +  L  LL + +DV+KG  Y
Sbjct: 62  VKLLGVCLLNEPQYIIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVY 121

Query: 230 LHQNNIIHRDLKTANLLMDENG-----VVKVADFGVARVQAQSGVMTAETG---TYRWMA 281
           L Q + IHRDL   N L+ E G     VVK+ DFG+AR   +S     E       RWMA
Sbjct: 122 LEQMHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLARDIYKSDYYRKEGEGLLPVRWMA 181

Query: 282 PEVIEHKPYDYKADVFSFGIALWELLT-GELPYAGLTPLQAAVGVVQKSLRPTIPKHAHP 340
           PE +    +  ++DV+SFG+ +WE+LT G+ PY  L   +  +  V    R   P++   
Sbjct: 182 PESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPALNNQE-VLQHVTAGGRLQKPENCPD 240

Query: 341 RLAELLERCWQHDPTQRPNFSQITDIL 367
           ++ +L+  CW  DP++RP F +I +IL
Sbjct: 241 KIYQLMTNCWAQDPSERPTFDRIQEIL 267

Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269

>gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases

 Score =  151 bits (383), Expect = 4e-43
 Identities = 73/242 (30%), Positives = 130/242 (53%), Gaps = 12/242 (4%)

Query: 124 VASGSYGDLYKGTY--CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRH---KNVVQF 178
           +  G+YG +Y+G +    + VA+K++  +  + + + +  +EV ++ ++R     N+ ++
Sbjct: 9   IGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDD-VSDIQREVALLSQLRQSQPPNITKY 67

Query: 179 IGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHR 238
            G+  + P L I+ E+   GS+   +       +  S+  +  +V   + Y+H+  +IHR
Sbjct: 68  YGSYLKGPRLWIIMEYAEGGSVRTLMKAGPIAEKYISV--IIREVLVALKYIHKVGVIHR 125

Query: 239 DLKTANLLMDENGVVKVADFGV-ARVQAQSGVMTAETGTYRWMAPEVI-EHKPYDYKADV 296
           D+K AN+L+   G VK+ DFGV A +   S   +   GT  WMAPEVI E K YD KAD+
Sbjct: 126 DIKAANILVTNTGNVKLCDFGVAALLNQNSSKRSTFVGTPYWMAPEVITEGKYYDTKADI 185

Query: 297 FSFGIALWELLTGELPYAGLTPLQAAVGVVQKSLRPTIP-KHAHPRLAELLERCWQHDPT 355
           +S GI ++E+ TG  PY+ +   + A+ ++ KS  P +        L E +  C   +P 
Sbjct: 186 WSLGITIYEMATGNPPYSDVDAFR-AMMLIPKSKPPRLEDNGYSKLLREFVAACLDEEPK 244

Query: 356 QR 357
           +R
Sbjct: 245 ER 246

Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277

>gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2

 Score =  150 bits (379), Expect = 1e-42
 Identities = 81/270 (30%), Positives = 137/270 (50%), Gaps = 12/270 (4%)

Query: 112 EIDAKQLKIECKVASGSYGDLYKGTY-----CSQEVAIKVLKPECVNTEMLKEFSQEVYI 166
           EI    +  +  + +G +G++++G           VAIK LKP     +  ++F  E  I
Sbjct: 1   EIHPSHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQR-QDFLSEASI 59

Query: 167 MRKIRHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKG 226
           M +  H N+++  G  T+     I+TE+M  G++  +L    G F    L+ +   ++ G
Sbjct: 60  MGQFSHHNIIRLEGVVTKFKPAMIITEYMENGALDKYLRDHDGEFSSYQLVGMLRGIAAG 119

Query: 227 MNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQ--SGVMTAETGT--YRWMAP 282
           M YL   N +HRDL   N+L++ N   KV+DFG++RV      G  T   G    RW AP
Sbjct: 120 MKYLSDMNYVHRDLAARNILVNSNLECKVSDFGLSRVLEDDPEGTYTTSGGKIPIRWTAP 179

Query: 283 EVIEHKPYDYKADVFSFGIALWELLT-GELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPR 341
           E I ++ +   +DV+SFGI +WE+++ GE PY  ++     +  +    R   P      
Sbjct: 180 EAIAYRKFTSASDVWSFGIVMWEVMSFGERPYWDMSN-HEVMKAINDGFRLPAPMDCPSA 238

Query: 342 LAELLERCWQHDPTQRPNFSQITDILKQMM 371
           + +L+ +CWQ D  +RP F  I ++L +++
Sbjct: 239 VYQLMLQCWQQDRARRPRFVDIVNLLDKLL 268

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268

>gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains

 Score =  149 bits (377), Expect = 2e-42
 Identities = 69/252 (27%), Positives = 129/252 (51%), Gaps = 13/252 (5%)

Query: 120 IECKVASGSYGDLYKGTYCS--QEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQ 177
           I  K+  GS+G ++K    +  +  A+K +    +N    +E   E  ++ K+    +++
Sbjct: 4   ILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIR 63

Query: 178 FIGACTRPPNLCIVTEFMARGSIYDFLHKQKGV-FQLTSLLKVAIDVSKGMNYLHQNNII 236
           +  +      L IV E+   G ++  L  Q+G       + +  I +  G+ +LH   I+
Sbjct: 64  YYESFLDKGKLNIVMEYAENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHLHSKKIL 123

Query: 237 HRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAET--GTYRWMAPEVIEHKPYDYKA 294
           HRD+K+ NL +D    VK+ D GVA++ + +    A T  GT  +++PE+ E KPY+ K+
Sbjct: 124 HRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTNF-ANTIVGTPYYLSPELCEDKPYNEKS 182

Query: 295 DVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKSLR---PTIPKHAHPRLAELLERCWQ 351
           DV++ G+ L+E  TG+ P+           ++ K +R   P + +    +LA+L+++C  
Sbjct: 183 DVWALGVVLYECCTGKHPFDA----NNQGALILKIIRGVFPPVSQMYSQQLAQLIDQCLT 238

Query: 352 HDPTQRPNFSQI 363
            D  QRP+  Q+
Sbjct: 239 KDYRQRPDTFQL 250

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256

>gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases

 Score =  149 bits (378), Expect = 2e-42
 Identities = 82/269 (30%), Positives = 136/269 (50%), Gaps = 20/269 (7%)

Query: 105 TDGTDVWEIDAKQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVNTEMLKEFSQ 162
            +  D+WEI  +       +  G++G +YK  +       A K+++ E  + E L++F  
Sbjct: 1   VNPNDIWEIIGE-------LGDGAFGKVYKAQHKETGLFAAAKIIQIE--SEEELEDFMV 51

Query: 163 EVYIMRKIRHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAID 222
           E+ I+ + +H N+V    A      L I+ EF   G++   + + +       +  V   
Sbjct: 52  EIDILSECKHPNIVGLYEAYFYENKLWILIEFCDGGALDSIMLELERGLTEPQIRYVCRQ 111

Query: 223 VSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGV-ARVQAQSGVMTAETGTYRWMA 281
           + + +N+LH + +IHRDLK  N+L+  +G VK+ADFGV A+ ++         GT  WMA
Sbjct: 112 MLEALNFLHSHKVIHRDLKAGNILLTLDGDVKLADFGVSAKNKSTLQKRDTFIGTPYWMA 171

Query: 282 PEVI-----EHKPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKSLRPTI-- 334
           PEV+     +  PYDYKAD++S GI L EL   E P+  L P++  +  + KS  PT+  
Sbjct: 172 PEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELNPMRVLLK-ILKSEPPTLDQ 230

Query: 335 PKHAHPRLAELLERCWQHDPTQRPNFSQI 363
           P        + L+ C   DP  RP  +++
Sbjct: 231 PSKWSSSFNDFLKSCLVKDPDDRPTAAEL 259

Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280

>gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors

 Score =  149 bits (377), Expect = 6e-42
 Identities = 80/257 (31%), Positives = 126/257 (49%), Gaps = 38/257 (14%)

Query: 142 VAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVTEFMARGSIY 201
           VA+KVL+P+  +    ++F +EV I+ ++   N+ + +G CT  P LC++ E+M  G + 
Sbjct: 49  VAVKVLRPD-ASDNAREDFLKEVKILSRLSDPNIARLLGVCTVDPPLCMIMEYMENGDLN 107

Query: 202 DFLHKQKGVFQLTS----------LLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENG 251
            FL K        +          LL +A  ++ GM YL   N +HRDL T N L+ +N 
Sbjct: 108 QFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESLNFVHRDLATRNCLVGKNY 167

Query: 252 VVKVADFGVARVQAQSGVMTAETGTY-----------RWMAPEVIEHKPYDYKADVFSFG 300
            +K+ADFG++R           +  Y           RWMA E +    +  K+DV++FG
Sbjct: 168 TIKIADFGMSR--------NLYSSDYYRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFG 219

Query: 301 IALWELLT--GELPYAGLTPLQ----AAVGVVQKSLRPTIPK-HAHPR-LAELLERCWQH 352
           + LWE+LT   E PY  LT  Q    A         +  +P+    P+ + EL+  CW+ 
Sbjct: 220 VTLWEILTLCREQPYEHLTDQQVIENAGHFFRDDGRQIYLPRPPNCPKDIYELMLECWRR 279

Query: 353 DPTQRPNFSQITDILKQ 369
           D   RP F +I   L++
Sbjct: 280 DEEDRPTFREIHLFLQR 296

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296

>gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases

 Score =  146 bits (369), Expect = 5e-41
 Identities = 86/278 (30%), Positives = 141/278 (50%), Gaps = 42/278 (15%)

Query: 124 VASGSYGDLYKGTYCSQE-------VAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVV 176
           +  G++G ++ G     E       VA+K LK    N +  K+F +E  ++   +H+N+V
Sbjct: 13  LGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASN-DARKDFEREAELLTNFQHENIV 71

Query: 177 QFIGACTRPPNLCIVTEFMARGSIYDFL--HKQKGVF---------QLT--SLLKVAIDV 223
           +F G CT      +V E+M  G +  FL  H     F         +LT   LL++A+ +
Sbjct: 72  KFYGVCTEGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQI 131

Query: 224 SKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAETGTY------ 277
           + GM YL   + +HRDL T N L+  + VVK+ DFG++R      V T  T  Y      
Sbjct: 132 ASGMVYLASQHFVHRDLATRNCLVGYDLVVKIGDFGMSR-----DVYT--TDYYRVGGHT 184

Query: 278 ----RWMAPEVIEHKPYDYKADVFSFGIALWELLT-GELPYAGLTPLQAAVGVVQ-KSLR 331
               RWM PE I ++ +  ++DV+SFG+ LWE+ T G+ P+ GL+  +    + Q + L+
Sbjct: 185 MLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQPWYGLSNEEVIECITQGRLLQ 244

Query: 332 PTIPKHAHPRLAELLERCWQHDPTQRPNFSQITDILKQ 369
              P+     + +++  CW+ DP QR N   I + L++
Sbjct: 245 R--PRTCPSEVYDIMLGCWKRDPQQRINIKDIHERLQK 280

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280

>gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase

 Score =  145 bits (367), Expect = 8e-41
 Identities = 75/249 (30%), Positives = 129/249 (51%), Gaps = 12/249 (4%)

Query: 126 SGSYGDLYKGTY--CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACT 183
           +G+ G + K  +    + +A+K ++ E +N  + K+  +E+ I+ K     +V F GA  
Sbjct: 11  AGNSGVVSKVLHRPTGKIMAVKTIRLE-INEAIQKQILRELDILHKCNSPYIVGFYGAFY 69

Query: 184 RPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLH-QNNIIHRDLKT 242
              ++ I  E+M  GS+   L + +G      L K+A+ V KG+ YLH ++ IIHRD+K 
Sbjct: 70  NNGDISICMEYMDGGSLDKILKEVQGRIPERILGKIAVAVLKGLTYLHEKHKIIHRDVKP 129

Query: 243 ANLLMDENGVVKVADFGVARVQAQSGVMTAETGTYRWMAPEVIEHKPYDYKADVFSFGIA 302
           +N+L++  G +K+ DFGV+     S   T   GT  +MAPE I+   Y  K+D++S G++
Sbjct: 130 SNILVNSRGQIKLCDFGVSGQLVNSLAKT-FVGTSSYMAPERIQGNDYSVKSDIWSLGLS 188

Query: 303 LWELLTGELPYAG-----LTPLQAAVGVVQKSLRPTIPKHAH-PRLAELLERCWQHDPTQ 356
           L EL TG  PY           +    +V +   P +P     P   + +  C   DP +
Sbjct: 189 LIELATGRFPYPPENDPPDGIFELLQYIVNEP-PPRLPSGKFSPDFQDFVNLCLIKDPRE 247

Query: 357 RPNFSQITD 365
           RP++ ++ +
Sbjct: 248 RPSYKELLE 256

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265

>gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase

 Score =  143 bits (363), Expect = 3e-40
 Identities = 90/269 (33%), Positives = 130/269 (48%), Gaps = 36/269 (13%)

Query: 127 GSYGDLYKGTY-------CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFI 179
           G++G++Y+G Y          +VA+K L PE  + +   +F  E  IM K  H+N+V+ I
Sbjct: 17  GAFGEVYEGLYRGRDGDAVELQVAVKTL-PESCSEQDESDFLMEALIMSKFNHQNIVRLI 75

Query: 180 GACTRPPNLCIVTEFMARGSIYDFLH----KQKGVFQLT--SLLKVAIDVSKGMNYLHQN 233
           G         I+ E MA G +  FL     + +    LT   LL  A DV+KG  YL +N
Sbjct: 76  GVSFERLPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEEN 135

Query: 234 NIIHRDLKTANLLMDENG---VVKVADFGVARVQAQSGVMTAETGTYR----------WM 280
           + IHRD+   N L+   G   V K+ADFG+AR   ++         YR          WM
Sbjct: 136 HFIHRDIAARNCLLTCKGPGRVAKIADFGMARDIYRASY-------YRKGGRAMLPIKWM 188

Query: 281 APEVIEHKPYDYKADVFSFGIALWELLT-GELPYAGLTPLQAAVGVVQKSLRPTIPKHAH 339
            PE      +  K DV+SFG+ LWE+ + G +PY G T  Q  +  V    R   PK   
Sbjct: 189 PPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTN-QEVMEFVTGGGRLDPPKGCP 247

Query: 340 PRLAELLERCWQHDPTQRPNFSQITDILK 368
             +  ++  CWQH P  RPNF+ I + ++
Sbjct: 248 GPVYRIMTDCWQHTPEDRPNFATILERIQ 276

Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277

>gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1

 Score =  144 bits (363), Expect = 3e-40
 Identities = 81/244 (33%), Positives = 133/244 (54%), Gaps = 7/244 (2%)

Query: 123 KVASGSYGDLYKG--TYCSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIG 180
           ++  GS+G++YKG      + VAIK++  E    E +++  QE+ ++ +     + ++ G
Sbjct: 11  RIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDE-IEDIQQEITVLSQCDSPYITRYYG 69

Query: 181 ACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDL 240
           +  +   L I+ E++  GS  D L  + G  + T +  +  ++ KG++YLH    IHRD+
Sbjct: 70  SYLKGTKLWIIMEYLGGGSALDLL--KPGPLEETYIATILREILKGLDYLHSERKIHRDI 127

Query: 241 KTANLLMDENGVVKVADFGVARVQAQSGVM-TAETGTYRWMAPEVIEHKPYDYKADVFSF 299
           K AN+L+ E G VK+ADFGVA     + +      GT  WMAPEVI+   YD+KAD++S 
Sbjct: 128 KAANVLLSEQGDVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIKQSAYDFKADIWSL 187

Query: 300 GIALWELLTGELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRLAELLERCWQHDPTQRPN 359
           GI   EL  GE P + L P++  + ++ K+  PT+         E +E C   DP  RP 
Sbjct: 188 GITAIELAKGEPPNSDLHPMR-VLFLIPKNSPPTLEGQYSKPFKEFVEACLNKDPRFRPT 246

Query: 360 FSQI 363
             ++
Sbjct: 247 AKEL 250

Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277

>gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1

 Score =  143 bits (361), Expect = 1e-39
 Identities = 91/283 (32%), Positives = 145/283 (51%), Gaps = 27/283 (9%)

Query: 111 WEIDAKQLKIECKVASGSYGDLYKGTY----CSQEVAIKVLKPECVNTEMLKEFSQEVYI 166
           WE     +K E  +  G++G + +            AIK+LK E  +    ++F+ E+ +
Sbjct: 1   WE----DIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLK-EFASENDHRDFAGELEV 55

Query: 167 MRKI-RHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQK-------------GVFQ 212
           + K+  H N++  +GAC     L I  E+   G++ DFL K +                 
Sbjct: 56  LCKLGHHPNIINLLGACENRGYLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTAST 115

Query: 213 LTS--LLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVM 270
           LTS  LL+ A DV+ GM YL +   IHRDL   N+L+ EN   K+ADFG++R +      
Sbjct: 116 LTSQQLLQFASDVATGMQYLSEKQFIHRDLAARNVLVGENLASKIADFGLSRGEEVYVKK 175

Query: 271 TAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLT-GELPYAGLTPLQAAVGVVQKS 329
           T      RWMA E + +  Y  K+DV+SFG+ LWE+++ G  PY G+T  +    + Q  
Sbjct: 176 TMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPYCGMTCAELYEKLPQ-G 234

Query: 330 LRPTIPKHAHPRLAELLERCWQHDPTQRPNFSQITDILKQMMK 372
            R   P++    + EL+ +CW+  P +RP F+QI+  L +M++
Sbjct: 235 YRMEKPRNCDDEVYELMRQCWRDRPYERPPFAQISVQLSRMLE 277

Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297

>gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4

 Score =  143 bits (361), Expect = 1e-39
 Identities = 80/256 (31%), Positives = 136/256 (53%), Gaps = 22/256 (8%)

Query: 142 VAIKVLKPECVNTEMLKEFSQEVYIMRKI-RHKNVVQFIGACTRPPNLCIVTEFMARGSI 200
           VA+K+LK    + + L +   E+ +M+ I +HKN++  +G CT+   L ++ E+ A+G++
Sbjct: 47  VAVKMLKDNATDKD-LADLISEMELMKLIGKHKNIINLLGVCTQEGPLYVIVEYAAKGNL 105

Query: 201 YDFLHKQK---------------GVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANL 245
            +FL  ++                      L+  A  V++GM YL     IHRDL   N+
Sbjct: 106 REFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESRRCIHRDLAARNV 165

Query: 246 LMDENGVVKVADFGVARVQAQSGVMTAETG---TYRWMAPEVIEHKPYDYKADVFSFGIA 302
           L+ E+ V+K+ADFG+AR           +      +WMAPE +  + Y +++DV+SFGI 
Sbjct: 166 LVTEDNVMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGIL 225

Query: 303 LWELLT-GELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRLAELLERCWQHDPTQRPNFS 361
           +WE+ T G  PY G+ P++    ++++  R   P +    L  L+  CW   PTQRP F 
Sbjct: 226 MWEIFTLGGSPYPGI-PVEELFKLLREGHRMDKPSNCTHELYMLMRECWHAVPTQRPTFK 284

Query: 362 QITDILKQMMKEVASE 377
           Q+ + L +++  V+ E
Sbjct: 285 QLVEALDKVLAAVSEE 300

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314

>gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors

 Score =  142 bits (359), Expect = 1e-39
 Identities = 83/274 (30%), Positives = 136/274 (49%), Gaps = 40/274 (14%)

Query: 127 GSYGDLYKG-------TYCSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFI 179
           G++G +YKG          +  VAIK LK E    ++ +EF QE  +M  ++H N+V  +
Sbjct: 16  GAFGKVYKGELTGPNERLSATSVAIKTLK-ENAEPKVQQEFRQEAELMSDLQHPNIVCLL 74

Query: 180 GACTRPPNLCIVTEFMARGSIYDFL---------------HKQKGVFQLTSLLKVAIDVS 224
           G CT+    C++ E++A G +++FL                  K     +  L +AI ++
Sbjct: 75  GVCTKEQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIA 134

Query: 225 KGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVAR---------VQAQSGVMTAETG 275
            GM YL  ++ +HRDL   N L+ E   VK++DFG++R         VQ++S +      
Sbjct: 135 AGMEYLSSHHFVHRDLAARNCLVGEGLTVKISDFGLSRDIYSADYYRVQSKSLL------ 188

Query: 276 TYRWMAPEVIEHKPYDYKADVFSFGIALWELLT-GELPYAGLTPLQAAVGVVQKSLRPTI 334
             RWM PE I +  +  ++D++SFG+ LWE+ + G  PY G +  +    +  + L P  
Sbjct: 189 PVRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQPYYGFSNQEVIEMIRSRQLLPC- 247

Query: 335 PKHAHPRLAELLERCWQHDPTQRPNFSQITDILK 368
           P+    R+  L+  CW   P +RP F  I   L+
Sbjct: 248 PEDCPARVYALMIECWNEIPARRPRFKDIHTRLR 281

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283

>gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases

 Score =  141 bits (358), Expect = 2e-39
 Identities = 80/256 (31%), Positives = 143/256 (55%), Gaps = 18/256 (7%)

Query: 124 VASGSYGDLYKGTYCS--QEVAIKVLKPECVNTE-------MLKEFSQEVYIMRKIRHKN 174
           + SGS+G +Y G   S  + +A+K ++   V+         ML   ++E+ ++++++H+N
Sbjct: 8   IGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHEN 67

Query: 175 VVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNN 234
           +VQ++G+     +L I  E++  GS+   L+   G F+ T +      + KG+NYLH   
Sbjct: 68  IVQYLGSSLDADHLNIFLEYVPGGSVAALLN-NYGAFEETLVRNFVRQILKGLNYLHNRG 126

Query: 235 IIHRDLKTANLLMDENGVVKVADFGVA-RVQAQSGVMTAET------GTYRWMAPEVIEH 287
           IIHRD+K AN+L+D  G +K++DFG++ +++A S             G+  WMAPEV++ 
Sbjct: 127 IIHRDIKGANILVDNKGGIKISDFGISKKLEANSLSTKTNGARPSLQGSVFWMAPEVVKQ 186

Query: 288 KPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRLAELLE 347
             Y  KAD++S G  + E+LTG+ P+   T LQA   + +    P IP +      + LE
Sbjct: 187 TSYTRKADIWSLGCLVVEMLTGKHPFPDCTQLQAIFKIGEN-ASPEIPSNISSEAIDFLE 245

Query: 348 RCWQHDPTQRPNFSQI 363
           + ++ D  +RP  +++
Sbjct: 246 KTFEIDHNKRPTAAEL 261

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267

>gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2

 Score =  142 bits (359), Expect = 2e-39
 Identities = 85/282 (30%), Positives = 144/282 (51%), Gaps = 23/282 (8%)

Query: 113 IDAKQLKIECKVASGSYGDLYKGTY----CSQEVAIKVLKPECVNTEMLKEFSQEVYIMR 168
           ++   +K +  +  G++G + K          + AIK +K E  + +  ++F+ E+ ++ 
Sbjct: 4   LEWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMK-EYASKDDHRDFAGELEVLC 62

Query: 169 KI-RHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQK---------------GVFQ 212
           K+  H N++  +GAC     L +  E+   G++ DFL K +                   
Sbjct: 63  KLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLS 122

Query: 213 LTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTA 272
              LL  A DV++GM+YL Q   IHRDL   N+L+ EN V K+ADFG++R Q      T 
Sbjct: 123 SQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKKTM 182

Query: 273 ETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLT-GELPYAGLTPLQAAVGVVQKSLR 331
                RWMA E + +  Y   +DV+S+G+ LWE+++ G  PY G+T  +    + Q   R
Sbjct: 183 GRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQ-GYR 241

Query: 332 PTIPKHAHPRLAELLERCWQHDPTQRPNFSQITDILKQMMKE 373
              P +    + +L+ +CW+  P +RP+F+QI   L +M++E
Sbjct: 242 LEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEE 283

Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303

>gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4

 Score =  140 bits (355), Expect = 3e-39
 Identities = 78/253 (30%), Positives = 127/253 (50%), Gaps = 16/253 (6%)

Query: 127 GSYGDLYKG-TYCSQEVAIK--VLKPECVNT--EMLKEFSQEVYIMRKIRHKNVVQFIGA 181
           G+YG +Y G T   Q +A+K   L    V    +  ++  +EV +++ ++H N+VQ++G 
Sbjct: 11  GAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGT 70

Query: 182 CTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLK 241
           C     + I  EF+  GSI   L  + G        K    +  G+ YLH N ++HRD+K
Sbjct: 71  CLDDNTISIFMEFVPGGSISSIL-NRFGPLPEPVFCKYTKQILDGVAYLHNNCVVHRDIK 129

Query: 242 TANLLMDENGVVKVADFGVARVQA-------QSGVMTAETGTYRWMAPEVIEHKPYDYKA 294
             N+++  NG++K+ DFG AR  A        S ++ +  GT  WMAPEVI    Y  K+
Sbjct: 130 GNNVMLMPNGIIKLIDFGCARRLAWVGLHGTHSNMLKSMHGTPYWMAPEVINESGYGRKS 189

Query: 295 DVFSFGIALWELLTGELPYAGLTPLQA--AVGVVQKSLRPTIPKHAHPRLAELLERCWQH 352
           D++S G  ++E+ TG+ P A +  L A   +G   + L P +P        + +  C   
Sbjct: 190 DIWSIGCTVFEMATGKPPLASMDRLAAMFYIG-AHRGLMPRLPDSFSAAAIDFVTSCLTR 248

Query: 353 DPTQRPNFSQITD 365
           D  +RP+  Q+  
Sbjct: 249 DQHERPSALQLLR 261

Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265

>gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase

 Score =  141 bits (356), Expect = 5e-39
 Identities = 79/253 (31%), Positives = 130/253 (51%), Gaps = 27/253 (10%)

Query: 142 VAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVTEFMARGSIY 201
           VA+K+LK E  + +M  +F +E  +M +  H N+V+ +G C     +C++ E+MA G + 
Sbjct: 38  VAVKMLKEE-ASADMQADFQREAALMAEFDHPNIVKLLGVCAVGKPMCLLFEYMAYGDLN 96

Query: 202 DFLHKQ--KGVFQL-------------------TSLLKVAIDVSKGMNYLHQNNIIHRDL 240
           +FL  +  +    L                   T  L +A  V+ GM YL +   +HRDL
Sbjct: 97  EFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSERKFVHRDL 156

Query: 241 KTANLLMDENGVVKVADFGVAR-VQAQSGVMTAETGTY--RWMAPEVIEHKPYDYKADVF 297
            T N L+ EN VVK+ADFG++R + +      +E      RWM PE I +  Y  ++DV+
Sbjct: 157 ATRNCLVGENMVVKIADFGLSRNIYSADYYKASENDAIPIRWMPPESIFYNRYTTESDVW 216

Query: 298 SFGIALWELLT-GELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRLAELLERCWQHDPTQ 356
           ++G+ LWE+ + G  PY G+   +  +  V+     + P +    L  L+  CW   P+ 
Sbjct: 217 AYGVVLWEIFSYGMQPYYGMAHEE-VIYYVRDGNVLSCPDNCPLELYNLMRLCWSKLPSD 275

Query: 357 RPNFSQITDILKQ 369
           RP+F+ I  IL++
Sbjct: 276 RPSFASINRILQR 288

Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288

>gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3

 Score =  140 bits (354), Expect = 6e-39
 Identities = 82/244 (33%), Positives = 136/244 (55%), Gaps = 7/244 (2%)

Query: 123 KVASGSYGDLYKG--TYCSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIG 180
           K+  GS+G+++KG      + VAIK++  E    E +++  QE+ ++ +     V ++ G
Sbjct: 11  KIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDE-IEDIQQEITVLSQCDSPYVTKYYG 69

Query: 181 ACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDL 240
           +  +   L I+ E++  GS  D L  + G    T +  +  ++ KG++YLH    IHRD+
Sbjct: 70  SYLKDTKLWIIMEYLGGGSALDLL--EPGPLDETQIATILREILKGLDYLHSEKKIHRDI 127

Query: 241 KTANLLMDENGVVKVADFGVARVQAQSGVMTAE-TGTYRWMAPEVIEHKPYDYKADVFSF 299
           K AN+L+ E+G VK+ADFGVA     + +      GT  WMAPEVI+   YD KAD++S 
Sbjct: 128 KAANVLLSEHGEVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIKQSAYDSKADIWSL 187

Query: 300 GIALWELLTGELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRLAELLERCWQHDPTQRPN 359
           GI   EL  GE P++ L P++  + ++ K+  PT+  +    L E +E C   +P+ RP 
Sbjct: 188 GITAIELAKGEPPHSELHPMK-VLFLIPKNNPPTLEGNYSKPLKEFVEACLNKEPSFRPT 246

Query: 360 FSQI 363
             ++
Sbjct: 247 AKEL 250

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277

>gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor

 Score =  141 bits (356), Expect = 7e-39
 Identities = 82/272 (30%), Positives = 144/272 (52%), Gaps = 16/272 (5%)

Query: 112 EIDAKQLKIECKVASGSYGDLYKGTYCSQ------EVAIKVLKPECVNTEMLKEFSQEVY 165
           E + K++K+   + SG++G +YKG +  +       VAIK L+ E  + +  KE   E Y
Sbjct: 6   ETEFKKIKV---LGSGAFGTVYKGLWIPEGEKVKIPVAIKELR-EATSPKANKEILDEAY 61

Query: 166 IMRKIRHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSK 225
           +M  + + +V + +G C     + ++T+ M  G + D++ + K       LL   + ++K
Sbjct: 62  VMASVDNPHVCRLLGICL-TSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAK 120

Query: 226 GMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVAR-VQAQSGVMTAETGTY--RWMAP 282
           GMNYL +  ++HRDL   N+L+     VK+ DFG+A+ + A      AE G    +WMA 
Sbjct: 121 GMNYLEERRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGADEKEYHAEGGKVPIKWMAL 180

Query: 283 EVIEHKPYDYKADVFSFGIALWELLT-GELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPR 341
           E I H+ Y +++DV+S+G+ +WEL+T G  PY G+ P      +++K  R   P      
Sbjct: 181 ESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGI-PASEISSILEKGERLPQPPICTID 239

Query: 342 LAELLERCWQHDPTQRPNFSQITDILKQMMKE 373
           +  ++ +CW  D   RP F ++     +M ++
Sbjct: 240 VYMIMVKCWMIDADSRPKFRELIIEFSKMARD 271

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316

>gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron

 Score =  139 bits (352), Expect = 1e-38
 Identities = 78/256 (30%), Positives = 125/256 (48%), Gaps = 22/256 (8%)

Query: 124 VASGSYGDLYKGTYCSQE-----VAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQF 178
           +  G +G +Y GT    +      A+K L     + E +++F +E  IM+   H NV+  
Sbjct: 3   IGKGHFGCVYHGTLIDSDGQKIHCAVKSLN-RITDLEEVEQFLKEGIIMKDFSHPNVLSL 61

Query: 179 IGACTRPPNL-CIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIH 237
           +G C        +V  +M  G + +F+  +     +  L+   + V+KGM YL     +H
Sbjct: 62  LGICLPSEGSPLVVLPYMKHGDLRNFIRSETHNPTVKDLIGFGLQVAKGMEYLASKKFVH 121

Query: 238 RDLKTANLLMDENGVVKVADFGVAR---------VQAQSGVMTAETGTYRWMAPEVIEHK 288
           RDL   N ++DE+  VKVADFG+AR         V   +G         +WMA E ++ +
Sbjct: 122 RDLAARNCMLDESFTVKVADFGLARDIYDKEYYSVHNHTGAKLP----VKWMALESLQTQ 177

Query: 289 PYDYKADVFSFGIALWELLT-GELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRLAELLE 347
            +  K+DV+SFG+ LWEL+T G  PY  +      V ++Q   R   P++    L E++ 
Sbjct: 178 KFTTKSDVWSFGVLLWELMTRGAPPYPDVDSFDITVYLLQGR-RLLQPEYCPDPLYEVML 236

Query: 348 RCWQHDPTQRPNFSQI 363
            CW   P  RP FS++
Sbjct: 237 SCWHPKPEMRPTFSEL 252

Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262

>gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases

 Score =  138 bits (350), Expect = 3e-38
 Identities = 86/285 (30%), Positives = 135/285 (47%), Gaps = 45/285 (15%)

Query: 106 DGTDVWEIDAKQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVNTEMLKEFSQE 163
           D T ++E+    +++   +  G+YG +YK  +    Q VAIK++       +  +E  +E
Sbjct: 3   DPTGIFEL----VEV---IGEGTYGKVYKARHKKTGQLVAIKIMDII---EDEEEEIKEE 52

Query: 164 VYIMRKI-RHKNVVQFIGA------CTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSL 216
             I+RK   H N+  F GA            L +V E    GS+ D +   KG+ +    
Sbjct: 53  YNILRKYSNHPNIATFYGAFIKKNPPGNDDQLWLVMELCGGGSVTDLV---KGLRKKGKR 109

Query: 217 LKVAI------DVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVM 270
           LK         +  +G+ YLH+N +IHRD+K  N+L+ +N  VK+ DFGV+  Q  S + 
Sbjct: 110 LKEEWIAYILRETLRGLAYLHENKVIHRDIKGQNILLTKNAEVKLVDFGVSA-QLDSTLG 168

Query: 271 TAET--GTYRWMAPEVI--EHKP---YDYKADVFSFGIALWELLTGELPYAGLTPLQAAV 323
              T  GT  WMAPEVI  + +P   YD ++DV+S GI   EL  G+ P   + P++A  
Sbjct: 169 RRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHPMRA-- 226

Query: 324 GVVQKSLRPTIPKHAHPRL-----AELLERCWQHDPTQRPNFSQI 363
             + K  R   P    P        + +  C   +  QRP   ++
Sbjct: 227 --LFKIPRNPPPTLKSPENWSKKFNDFISECLIKNYEQRPFMEEL 269

Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275

>gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4

 Score =  138 bits (349), Expect = 3e-38
 Identities = 84/246 (34%), Positives = 135/246 (54%), Gaps = 11/246 (4%)

Query: 123 KVASGSYGDLYKG--TYCSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIG 180
           ++  GS+G+++KG      Q VAIK++  E    E +++  QE+ ++ +     V ++ G
Sbjct: 11  RIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDE-IEDIQQEITVLSQCDSPYVTKYYG 69

Query: 181 ACTRPPNLCIVTEFMARGSIYDFLHKQK-GVFQLTSLLKVAIDVSKGMNYLHQNNIIHRD 239
           +  +   L I+ E++  GS  D L       FQ+ ++LK   ++ KG++YLH    IHRD
Sbjct: 70  SYLKGTKLWIIMEYLGGGSALDLLRAGPFDEFQIATMLK---EILKGLDYLHSEKKIHRD 126

Query: 240 LKTANLLMDENGVVKVADFGVARVQAQSGVMTAET--GTYRWMAPEVIEHKPYDYKADVF 297
           +K AN+L+ E G VK+ADFGVA  Q     +   T  GT  WMAPEVI+   YD KAD++
Sbjct: 127 IKAANVLLSEQGDVKLADFGVAG-QLTDTQIKRNTFVGTPFWMAPEVIQQSAYDSKADIW 185

Query: 298 SFGIALWELLTGELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRLAELLERCWQHDPTQR 357
           S GI   EL  GE P + + P++  + ++ K+  PT+         E ++ C   DP+ R
Sbjct: 186 SLGITAIELAKGEPPNSDMHPMR-VLFLIPKNNPPTLTGEFSKPFKEFIDACLNKDPSFR 244

Query: 358 PNFSQI 363
           P   ++
Sbjct: 245 PTAKEL 250

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277

>gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains

 Score =  137 bits (347), Expect = 4e-38
 Identities = 75/252 (29%), Positives = 128/252 (50%), Gaps = 7/252 (2%)

Query: 117 QLKIECKVASGSYGDLYKGTYCS--QEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKN 174
             K+  K+  GSYG +YK    S  Q  A+K +    ++ +  ++   E+ I+  + H N
Sbjct: 1   DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPN 60

Query: 175 VVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGV---FQLTSLLKVAIDVSKGMNYLH 231
           ++ +  A      LCIV E+   G +   + K+K          + ++ I + +G+  LH
Sbjct: 61  IISYKEAFLDGNKLCIVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALH 120

Query: 232 QNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAETGTYRWMAPEVIEHKPYD 291
           +  I+HRDLK+AN+L+  N +VK+ D G+++V  +  +   + GT  +MAPEV + +PY 
Sbjct: 121 EQKILHRDLKSANILLVANDLVKIGDLGISKV-LKKNMAKTQIGTPHYMAPEVWKGRPYS 179

Query: 292 YKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRLAELLERCWQ 351
           YK+D++S G  L+E+ T   P+   + +Q     VQ+   P IP      L   +    Q
Sbjct: 180 YKSDIWSLGCLLYEMATFAPPFEARS-MQDLRYKVQRGKYPPIPPIYSQDLQNFIRSMLQ 238

Query: 352 HDPTQRPNFSQI 363
             P  RPN  +I
Sbjct: 239 VKPKLRPNCDKI 250

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256

>gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4

 Score =  137 bits (348), Expect = 4e-38
 Identities = 69/254 (27%), Positives = 126/254 (49%), Gaps = 15/254 (5%)

Query: 123 KVASGSYGDLYKG-TYCSQEV-AIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIG 180
           K+  G++G +Y      + E+ A+K ++ +  + + +KE + E+ ++  ++H N+V++ G
Sbjct: 7   KIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYG 66

Query: 181 ACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDL 240
                  + I  E+ + G++ + L     +     +    + + +G+ YLH + I+HRD+
Sbjct: 67  VEVHREKVYIFMEYCSGGTLEELLE-HGRILDEHVIRVYTLQLLEGLAYLHSHGIVHRDI 125

Query: 241 KTANLLMDENGVVKVADFGVARVQAQSGVMTAE-----TGTYRWMAPEVIEHKPYDYK-- 293
           K AN+ +D NGV+K+ DFG A     +     E      GT  +MAPEVI          
Sbjct: 126 KPANIFLDHNGVIKLGDFGCAVKLKNNTTTMGEEVQSLAGTPAYMAPEVITGGKGKGHGR 185

Query: 294 -ADVFSFGIALWELLTGELPYAGL-TPLQAAVGVVQKSLRPTIPKHAHPRLA--ELLERC 349
            AD++S G  + E+ TG+ P++ L    Q    V     +P IP          + L+RC
Sbjct: 186 AADIWSLGCVVLEMATGKRPWSELDNEFQIMFHVGAGH-KPPIPDSLQLSPEGKDFLDRC 244

Query: 350 WQHDPTQRPNFSQI 363
            + DP +RP  S++
Sbjct: 245 LESDPKKRPTASEL 258

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264

>gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1

 Score =  138 bits (349), Expect = 4e-38
 Identities = 78/262 (29%), Positives = 131/262 (50%), Gaps = 28/262 (10%)

Query: 128 SYGDLYKGTYC------SQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGA 181
           ++G +YKG         +Q VAIK LK +  N +   EF QE  +M ++ H N+V  +G 
Sbjct: 17  AFGKIYKGHLYLPGMDHAQLVAIKTLK-DINNPQQWGEFQQEASLMAELHHPNIVCLLGV 75

Query: 182 CTRPPNLCIVTEFMARGSIYDFL-----HKQ-----------KGVFQLTSLLKVAIDVSK 225
            T+   +C++ E++ +G +++FL     H             K        L +AI ++ 
Sbjct: 76  VTQEQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAA 135

Query: 226 GMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAETGTY---RWMAP 282
           GM YL  +  +H+DL   N+L+ E   VK++D G++R    +     +  +    RWM P
Sbjct: 136 GMEYLSSHFFVHKDLAARNILIGEQLHVKISDLGLSREIYSADYYRVQPKSLLPIRWMPP 195

Query: 283 EVIEHKPYDYKADVFSFGIALWELLT-GELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPR 341
           E I +  +   +D++SFG+ LWE+ + G  PY G +  +    V ++ L P   +   PR
Sbjct: 196 EAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYYGFSNQEVIEMVRKRQLLPC-SEDCPPR 254

Query: 342 LAELLERCWQHDPTQRPNFSQI 363
           +  L+  CWQ  P++RP F  I
Sbjct: 255 MYSLMTECWQEGPSRRPRFKDI 276

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283

>gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases

 Score =  138 bits (348), Expect = 5e-38
 Identities = 76/273 (27%), Positives = 131/273 (47%), Gaps = 37/273 (13%)

Query: 127 GSYGDLYKGTY-----CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGA 181
           G +G + +G          +VA+K +K +      ++EF  E   M+   H NV++ IG 
Sbjct: 10  GEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKLIGV 69

Query: 182 C------TRPPNLCIVTEFMARGSIYDFL-----HKQKGVFQLTSLLKVAIDVSKGMNYL 230
           C       + P   ++  FM  G ++ FL             L +LLK  +D++ GM YL
Sbjct: 70  CFEASSLQKIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYL 129

Query: 231 HQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAETGTY-----------RW 279
              N IHRDL   N ++ E+  V VADFG+++           +G Y           +W
Sbjct: 130 SNRNFIHRDLAARNCMLREDMTVCVADFGLSK--------KIYSGDYYRQGRIAKMPVKW 181

Query: 280 MAPEVIEHKPYDYKADVFSFGIALWELLT-GELPYAGLTPLQAAVGVVQKSLRPTIPKHA 338
           +A E +  + Y  K+DV++FG+ +WE+ T G+ PY G+   +    +   + R   P+  
Sbjct: 182 IAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPYPGVENHEIYDYLRHGN-RLKQPEDC 240

Query: 339 HPRLAELLERCWQHDPTQRPNFSQITDILKQMM 371
              L +L+  CW+ DP  RP F+++ ++L+ ++
Sbjct: 241 LDELYDLMYSCWRADPKDRPTFTKLREVLENIL 273

Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273

>gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1

 Score =  138 bits (349), Expect = 6e-38
 Identities = 84/299 (28%), Positives = 150/299 (50%), Gaps = 33/299 (11%)

Query: 102 EIPTDGTDVWEIDAKQLKIECKVASGSYGDLYKGTYCS---------QEVAIKVLKPECV 152
           E+P D    WE+   +L +   +  G +G +                 +VA+K+LK +  
Sbjct: 6   ELPEDPR--WEVPRDRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDAT 63

Query: 153 NTEMLKEFSQEVYIMRKI-RHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQK--- 208
             + L +   E+ +M+ I +HKN++  +GACT+   L ++ E+ ++G++ ++L  ++   
Sbjct: 64  EKD-LSDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPG 122

Query: 209 ------------GVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVA 256
                              L+  A  V++GM YL     IHRDL   N+L+ E+ V+K+A
Sbjct: 123 MEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIA 182

Query: 257 DFGVARVQAQSGVMTAETG---TYRWMAPEVIEHKPYDYKADVFSFGIALWELLT-GELP 312
           DFG+AR           T      +WMAPE +  + Y +++DV+SFG+ LWE+ T G  P
Sbjct: 183 DFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSP 242

Query: 313 YAGLTPLQAAVGVVQKSLRPTIPKHAHPRLAELLERCWQHDPTQRPNFSQITDILKQMM 371
           Y G+ P++    ++++  R   P +    L  ++  CW   P+QRP F Q+ + L +++
Sbjct: 243 YPGV-PVEELFKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIL 300

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307

>gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3

 Score =  138 bits (348), Expect = 2e-37
 Identities = 87/304 (28%), Positives = 158/304 (51%), Gaps = 33/304 (10%)

Query: 103 IPTDGTDVWEIDAKQLKIECKVASGSYGDLYKGTYCSQE---------VAIKVLKPECVN 153
           +P D    WE+   +L +   +  G +G +        +         VA+K+LK +  +
Sbjct: 1   LPADPK--WELSRTRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATD 58

Query: 154 TEMLKEFSQEVYIMRKI-RHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQK--GV 210
            + L +   E+ +M+ I +HKN++  +GACT+   L ++ E+ ++G++ ++L  ++  G+
Sbjct: 59  KD-LSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVLVEYASKGNLREYLRARRPPGM 117

Query: 211 -----------FQLT--SLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVAD 257
                       QLT   L+  A  V++GM YL     IHRDL   N+L+ E+ V+K+AD
Sbjct: 118 DYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQKCIHRDLAARNVLVTEDNVMKIAD 177

Query: 258 FGVARVQAQSGVMTAETG---TYRWMAPEVIEHKPYDYKADVFSFGIALWELLT-GELPY 313
           FG+AR           T      +WMAPE +  + Y +++DV+SFG+ LWE+ T G  PY
Sbjct: 178 FGLARDVHNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPY 237

Query: 314 AGLTPLQAAVGVVQKSLRPTIPKHAHPRLAELLERCWQHDPTQRPNFSQITDILKQMMKE 373
            G+ P++    ++++  R   P +    L  ++  CW   P+QRP F Q+ + L +++  
Sbjct: 238 PGI-PVEELFKLLKEGHRMDKPANCTHELYMIMRECWHAVPSQRPTFKQLVEDLDRVLTV 296

Query: 374 VASE 377
            +++
Sbjct: 297 TSTD 300

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334

>gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2

 Score =  136 bits (344), Expect = 3e-37
 Identities = 83/305 (27%), Positives = 149/305 (48%), Gaps = 33/305 (10%)

Query: 102 EIPTDGTDVWEIDAKQLKIECKVASGSYGDLYKGTYC---------SQEVAIKVLKPECV 152
           E+P D    WE    +L +   +  G +G +               +  VA+K+LK +  
Sbjct: 3   ELPED--PRWEFSRDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDAT 60

Query: 153 NTEMLKEFSQEVYIMRKI-RHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGV- 210
             + L +   E+ +M+ I +HKN++  +GACT+   L ++ E+ ++G++ ++L  ++   
Sbjct: 61  EKD-LSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPG 119

Query: 211 --------------FQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVA 256
                              L+     V++GM YL     IHRDL   N+L+ EN V+K+A
Sbjct: 120 MEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQKCIHRDLAARNVLVTENNVMKIA 179

Query: 257 DFGVARVQAQSGVMTAETG---TYRWMAPEVIEHKPYDYKADVFSFGIALWELLT-GELP 312
           DFG+AR           T      +WMAPE +  + Y +++DV+SFG+ +WE+ T G  P
Sbjct: 180 DFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSP 239

Query: 313 YAGLTPLQAAVGVVQKSLRPTIPKHAHPRLAELLERCWQHDPTQRPNFSQITDILKQMMK 372
           Y G+ P++    ++++  R   P +    L  ++  CW   P+ RP F Q+ + L +++ 
Sbjct: 240 YPGI-PVEELFKLLKEGHRMDKPANCTNELYMMMRDCWHAIPSHRPTFKQLVEDLDRILT 298

Query: 373 EVASE 377
              +E
Sbjct: 299 LTTNE 303

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304

>gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4

 Score =  136 bits (343), Expect = 4e-37
 Identities = 82/272 (30%), Positives = 145/272 (53%), Gaps = 16/272 (5%)

Query: 112 EIDAKQLKIECKVASGSYGDLYKGTYCSQ------EVAIKVLKPECVNTEMLKEFSQEVY 165
           E + K++K+   + SG++G +YKG +  +       VAIK+L  E    +   EF  E  
Sbjct: 6   ETELKRVKV---LGSGAFGTVYKGIWVPEGETVKIPVAIKILN-ETTGPKANVEFMDEAL 61

Query: 166 IMRKIRHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSK 225
           IM  + H ++V+ +G C  P  + +VT+ M  G + D++H+ K       LL   + ++K
Sbjct: 62  IMASMDHPHLVRLLGVCLSP-TIQLVTQLMPHGCLLDYVHEHKDNIGSQLLLNWCVQIAK 120

Query: 226 GMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVAR-VQAQSGVMTAETGTY--RWMAP 282
           GM YL +  ++HRDL   N+L+     VK+ DFG+AR ++       A+ G    +WMA 
Sbjct: 121 GMMYLEERRLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGGKMPIKWMAL 180

Query: 283 EVIEHKPYDYKADVFSFGIALWELLT-GELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPR 341
           E I ++ + +++DV+S+G+ +WEL+T G  PY G+ P +    +++K  R   P      
Sbjct: 181 ECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGI-PTREIPDLLEKGERLPQPPICTID 239

Query: 342 LAELLERCWQHDPTQRPNFSQITDILKQMMKE 373
           +  ++ +CW  D   RP F ++     +M ++
Sbjct: 240 VYMVMVKCWMIDADSRPKFKELAAEFSRMARD 271

Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303

>gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair]

 Score =  137 bits (346), Expect = 5e-37
 Identities = 78/273 (28%), Positives = 131/273 (47%), Gaps = 27/273 (9%)

Query: 119 KIECKVASGSYGDLYKGTYCSQEVAIKVLKPE-CVNTEMLKEFSQEVYIMRKIRH-KNVV 176
           +I  K+  GS+G++Y      + VA+KVL  +    ++ ++ F +E+ I+  + H  N+V
Sbjct: 3   RILRKLGEGSFGEVYLA-RDRKLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIV 61

Query: 177 QFIGACTRPPNLCIVTEFMARGSIYDFLHK--QKGVFQLTSLLKVAIDVSKGMNYLHQNN 234
           +         +L +V E++  GS+ D L K  +KG    +  L +   +   + YLH   
Sbjct: 62  KLYDFFQDEGSLYLVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHSKG 121

Query: 235 IIHRDLKTANLLMDENG-VVKVADFGVARVQAQSGV-------MTAETGTYRWMAPEVIE 286
           IIHRD+K  N+L+D +G VVK+ DFG+A++    G         +   GT  +MAPEV+ 
Sbjct: 122 IIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTPGYMAPEVLL 181

Query: 287 HK---PYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQK-----------SLRP 332
                     +D++S GI L+ELLTG  P+ G     A    ++             L P
Sbjct: 182 GLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILELPTPSLASPLSP 241

Query: 333 TIPKHAHPRLAELLERCWQHDPTQRPNFSQITD 365
           + P+      ++LL++    DP  R + S    
Sbjct: 242 SNPELISKAASDLLKKLLAKDPKNRLSSSSDLS 274

Length = 384

>gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases

 Score =  134 bits (337), Expect = 1e-36
 Identities = 83/270 (30%), Positives = 138/270 (51%), Gaps = 23/270 (8%)

Query: 124 VASGSYGDLYKGTY----CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKI-RHKNVVQF 178
           +  G++G + K          + AIK +K E  + +  ++F+ E+ ++ K+  H N++  
Sbjct: 3   IGEGNFGQVLKARIKKDGLRMDAAIKRMK-EYASKDDHRDFAGELEVLCKLGHHPNIINL 61

Query: 179 IGACTRPPNLCIVTEFMARGSIYDFLHKQK---------------GVFQLTSLLKVAIDV 223
           +GAC     L +  E+   G++ DFL K +                      LL  A DV
Sbjct: 62  LGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADV 121

Query: 224 SKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAETGTYRWMAPE 283
           ++GM+YL Q   IHRDL   N+L+ EN V K+ADFG++R Q      T      RWMA E
Sbjct: 122 ARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKKTMGRLPVRWMAIE 181

Query: 284 VIEHKPYDYKADVFSFGIALWELLT-GELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRL 342
            + +  Y   +DV+S+G+ LWE+++ G  PY G+T  +    + Q   R   P +    +
Sbjct: 182 SLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQ-GYRLEKPLNCDDEV 240

Query: 343 AELLERCWQHDPTQRPNFSQITDILKQMMK 372
            +L+ +CW+  P +RP+F+QI   L +M++
Sbjct: 241 YDLMRQCWREKPYERPSFAQILVSLNRMLE 270

Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270

>gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4

 Score =  133 bits (337), Expect = 2e-36
 Identities = 75/260 (28%), Positives = 128/260 (49%), Gaps = 29/260 (11%)

Query: 127 GSYGDLY----KGTYCSQE---VAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFI 179
           G +G+++    KG         V +K L+       +  EF +E+ + RK+ HKNVV+ +
Sbjct: 16  GEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDE-NLQSEFRRELDMFRKLSHKNVVRLL 74

Query: 180 GACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQ------LTSLLKVAI--DVSKGMNYLH 231
           G C       ++ E+   G +  FL   K   +      L++  KVA+   ++ GM++L 
Sbjct: 75  GLCREAEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLS 134

Query: 232 QNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAETGTY-------RWMAPEV 284
               +HRDL   N L+     VKV+   +++      V  +E           RW+APE 
Sbjct: 135 NARFVHRDLAARNCLVSSQREVKVSLLSLSK-----DVYNSEYYKLRNALIPLRWLAPEA 189

Query: 285 IEHKPYDYKADVFSFGIALWELLT-GELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRLA 343
           ++   +  K+DV+SFG+ +WE+ T GELP+ GL+  +    +    L   +P+    RL 
Sbjct: 190 VQEDDFSTKSDVWSFGVLMWEVFTQGELPFYGLSDEEVLNRLQAGKLELPVPEGCPSRLY 249

Query: 344 ELLERCWQHDPTQRPNFSQI 363
           +L+ RCW  +P  RP+FS++
Sbjct: 250 KLMTRCWAVNPKDRPSFSEL 269

Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275

>gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases

 Score =  133 bits (336), Expect = 4e-36
 Identities = 85/300 (28%), Positives = 145/300 (48%), Gaps = 47/300 (15%)

Query: 112 EIDAKQLKIECKVASGSYGDLYKGTYCSQE-------------------VAIKVLKPECV 152
           E   +QL+++ K+  G +G+++    C  E                   VA+K+L+ + V
Sbjct: 1   EFPRQQLRLKEKLGEGQFGEVH---LCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRAD-V 56

Query: 153 NTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQ 212
                 +F +E+ IM ++++ N+++ +G C     LC++TE+M  G +  FL +++    
Sbjct: 57  TKTARNDFLKEIKIMSRLKNPNIIRLLGVCVSDDPLCMITEYMENGDLNQFLSQREIEST 116

Query: 213 LT-----------SLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVA 261
            T           +LL +A+ ++ GM YL   N +HRDL T N L+  +  +K+ADFG++
Sbjct: 117 FTHANNIPSVSIANLLYMAVQIASGMKYLASLNFVHRDLATRNCLVGNHYTIKIADFGMS 176

Query: 262 RVQAQSGVMTAETG----TYRWMAPEVIEHKPYDYKADVFSFGIALWEL--LTGELPYAG 315
           R    SG      G      RWMA E I    +   +DV++FG+ LWE+  L  E PY+ 
Sbjct: 177 R-NLYSGDYYRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFTLCKEQPYSL 235

Query: 316 LTPLQAA--VGVVQKSLRPTIPKHAHP----RLAELLERCWQHDPTQRPNFSQITDILKQ 369
           L+  Q     G   ++    I     P     + +L+ RCW  D   RP F++I   L++
Sbjct: 236 LSDEQVIENTGEFFRNQGRQIYLSQTPLCPSPVFKLMMRCWSRDIKDRPTFNKIHHFLRE 295

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295

>gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1

 Score =  132 bits (334), Expect = 4e-36
 Identities = 68/219 (31%), Positives = 113/219 (51%), Gaps = 22/219 (10%)

Query: 155 EMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLT 214
           E+++   +E+ +M ++ H ++++ +GA     +  +  E+MA GS+   L K  G F+  
Sbjct: 45  EVVEALRKEIRLMARLNHPHIIRMLGATCEDSHFNLFVEWMAGGSVSHLLSKY-GAFKEA 103

Query: 215 SLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENG-VVKVADFGVARVQAQSGVMTAE 273
            ++     + +G++YLH+N IIHRD+K ANLL+D  G  +++ADFG A   A  G    E
Sbjct: 104 VIINYTEQLLRGLSYLHENQIIHRDVKGANLLIDSTGQRLRIADFGAAARLAAKGTGAGE 163

Query: 274 -----TGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELP---------YAGLTPL 319
                 GT  +MAPEV+  + Y    DV+S G  + E+ T + P          A +  +
Sbjct: 164 FQGQLLGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSNHLALIFKI 223

Query: 320 QAAVGVVQKSLRPTIPKHAHPRLAELLERCWQHDPTQRP 358
            +A         P+IP+H  P L ++  RC +  P  RP
Sbjct: 224 ASATTA------PSIPEHLSPGLRDVTLRCLELQPEDRP 256

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268

>gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2

 Score =  133 bits (335), Expect = 4e-36
 Identities = 82/272 (30%), Positives = 143/272 (52%), Gaps = 16/272 (5%)

Query: 112 EIDAKQLKIECKVASGSYGDLYKGTYCSQ------EVAIKVLKPECVNTEMLKEFSQEVY 165
           E + K++K+   + SG++G +YKG +          VAIKVL+ E  + +  KE   E Y
Sbjct: 6   ETELKKVKV---LGSGAFGTVYKGIWIPDGENVKIPVAIKVLR-ENTSPKANKEILDEAY 61

Query: 166 IMRKIRHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSK 225
           +M  +    V + +G C     + +VT+ M  G + D++ + K       LL   + ++K
Sbjct: 62  VMAGVGSPYVCRLLGICL-TSTVQLVTQLMPYGCLLDYVRENKDRIGSQDLLNWCVQIAK 120

Query: 226 GMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVAR-VQAQSGVMTAETGTY--RWMAP 282
           GM+YL +  ++HRDL   N+L+     VK+ DFG+AR +        A+ G    +WMA 
Sbjct: 121 GMSYLEEVRLVHRDLAARNVLVKSPNHVKITDFGLARLLDIDETEYHADGGKVPIKWMAL 180

Query: 283 EVIEHKPYDYKADVFSFGIALWELLT-GELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPR 341
           E I H+ + +++DV+S+G+ +WEL+T G  PY G+ P +    +++K  R   P      
Sbjct: 181 ESILHRRFTHQSDVWSYGVTVWELMTFGAKPYDGI-PAREIPDLLEKGERLPQPPICTID 239

Query: 342 LAELLERCWQHDPTQRPNFSQITDILKQMMKE 373
           +  ++ +CW  D   RP F ++ D   +M ++
Sbjct: 240 VYMIMVKCWMIDSECRPRFRELVDEFSRMARD 271

Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279

>gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases

 Score =  132 bits (335), Expect = 4e-36
 Identities = 75/244 (30%), Positives = 118/244 (48%), Gaps = 27/244 (11%)

Query: 153 NTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPP--NLCIVTEFMARGS---IYDFLHKQ 207
           N ++ K+  +E+ I +  +   +V++ GA       ++ I  E+   GS   IY  + K+
Sbjct: 39  NPDLQKQILRELEINKSCKSPYIVKYYGAFLDESSSSIGIAMEYCEGGSLDSIYKKVKKR 98

Query: 208 KGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQS 267
            G      L K+A  V KG++YLH   IIHRD+K +N+L+   G VK+ DFGV+     S
Sbjct: 99  GGRIGEKVLGKIAESVLKGLSYLHSRKIIHRDIKPSNILLTRKGQVKLCDFGVSGELVNS 158

Query: 268 GVMTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQ 327
              T  TGT  +MAPE I+ KPY   +DV+S G+ L E+     P+    P +    +  
Sbjct: 159 LAGTF-TGTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFPF----PPEGEPPLGP 213

Query: 328 KSLRPTIPKHAHPRLAE--------------LLERCWQHDPTQRPNFSQITD---ILKQM 370
             L   I    +P L +               +++C + DPT+RP    + +   I  QM
Sbjct: 214 IELLSYIVNMPNPELKDEPGNGIKWSEEFKDFIKQCLEKDPTRRPTPWDMLEHPWIKAQM 273

Query: 371 MKEV 374
            K+V
Sbjct: 274 KKKV 277

Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287

>gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

 Score =  132 bits (334), Expect = 5e-36
 Identities = 78/249 (31%), Positives = 128/249 (51%), Gaps = 23/249 (9%)

Query: 142 VAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRP--PNLCIVTEFMARGS 199
           VA+K LK EC   +    + +E+ I++ + H+N+V++ G C+      L ++ E++  GS
Sbjct: 36  VAVKTLKREC-GQQNTSGWKKEINILKTLYHENIVKYKGCCSEQGGKGLQLIMEYVPLGS 94

Query: 200 IYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFG 259
           + D+L K K    L  LL  A  + +GM YLH  + IHRDL   N+L+D + +VK+ DFG
Sbjct: 95  LRDYLPKHK--LNLAQLLLFAQQICEGMAYLHSQHYIHRDLAARNVLLDNDRLVKIGDFG 152

Query: 260 VARV--QAQSGVMTAETGTYR--WMAPEVIEHKPYDYKADVFSFGIALWELLTGELPYAG 315
           +A+   +        E G     W A E ++   + Y +DV+SFG+ L+ELLT       
Sbjct: 153 LAKAVPEGHEYYRVREDGDSPVFWYAVECLKENKFSYASDVWSFGVTLYELLTHCDSKQS 212

Query: 316 --------LTPLQAAVGVV------QKSLRPTIPKHAHPRLAELLERCWQHDPTQRPNFS 361
                   + P Q  + VV      ++ +R   PK+    +  L++ CW+ +   RP F 
Sbjct: 213 PPKKFEEMIGPKQGQMTVVRLIELLERGMRLPCPKNCPQEVYILMKNCWETEAKFRPTFR 272

Query: 362 QITDILKQM 370
            +  ILK+M
Sbjct: 273 SLIPILKEM 281

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283

>gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1

 Score =  131 bits (332), Expect = 1e-35
 Identities = 72/260 (27%), Positives = 128/260 (49%), Gaps = 25/260 (9%)

Query: 134 KGTYCSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCI--V 191
           +G    ++VA+K LKPE      + +  +E+ I+R + H+N+V++ G CT      I  +
Sbjct: 28  EGDNTGEQVAVKSLKPES-GGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGIKLI 86

Query: 192 TEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENG 251
            EF+  GS+ ++L + K    L   LK A+ + KGM+YL     +HRDL   N+L++   
Sbjct: 87  MEFLPSGSLKEYLPRNKNKINLKQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLVESEH 146

Query: 252 VVKVADFGVAR-VQAQSGVMTAE---TGTYRWMAPEVIEHKPYDYKADVFSFGIALWELL 307
            VK+ DFG+ + ++      T +        W APE +    +   +DV+SFG+ L+ELL
Sbjct: 147 QVKIGDFGLTKAIETDKEYYTVKDDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLYELL 206

Query: 308 T----------------GELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRLAELLERCWQ 351
           T                G  P  G   +   V V+++  R   P +    + +L+ +CW+
Sbjct: 207 TYCDSESSPMTLFLKMIG--PTHGQMTVTRLVRVLEEGKRLPRPPNCPEEVYQLMRKCWE 264

Query: 352 HDPTQRPNFSQITDILKQMM 371
             P++R  F  + +  + ++
Sbjct: 265 FQPSKRTTFQNLIEGFEAIL 284

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284

>gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein

 Score =  131 bits (331), Expect = 2e-35
 Identities = 78/289 (26%), Positives = 144/289 (49%), Gaps = 36/289 (12%)

Query: 117 QLKIECKVASGSYGDLYKGTYCS-------QEVAIKVLKPECVNTEMLKEFSQEVYIMRK 169
            L +   +  G +G + K T            VA+K+LK E  ++  L++   E  ++++
Sbjct: 1   NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLK-ENASSSELRDLLSEFNLLKQ 59

Query: 170 IRHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGV------------------- 210
           + H +V++  GAC++   L ++ E+   GS+  FL + + V                   
Sbjct: 60  VNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNP 119

Query: 211 ----FQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVAR-VQA 265
                 +  L+  A  +S+GM YL +  ++HRDL   N+L+ E   +K++DFG++R V  
Sbjct: 120 DERALTMGDLISFAWQISRGMQYLAEMKLVHRDLAARNVLVAEGRKMKISDFGLSRDVYE 179

Query: 266 QSGVMTAETG--TYRWMAPEVIEHKPYDYKADVFSFGIALWELLT-GELPYAGLTPLQAA 322
           +   +    G    +WMA E +    Y  ++DV+SFG+ LWE++T G  PY G+ P +  
Sbjct: 180 EDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIAP-ERL 238

Query: 323 VGVVQKSLRPTIPKHAHPRLAELLERCWQHDPTQRPNFSQITDILKQMM 371
             +++   R   P++    +  L+  CW+ +P +RP F+ I+  L++MM
Sbjct: 239 FNLLKTGYRMERPENCSEEMYNLMLTCWKQEPDKRPTFADISKELEKMM 287

Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290

>gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3

 Score =  130 bits (327), Expect = 5e-35
 Identities = 78/247 (31%), Positives = 132/247 (53%), Gaps = 18/247 (7%)

Query: 140 QEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIG------ACTRPPNLCIVTE 193
           Q+VA+K+LK +  ++  ++EF +E   M++  H NV++ IG      A  R P   ++  
Sbjct: 28  QKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRLPIPMVILP 87

Query: 194 FMARGSIYDFL-----HKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMD 248
           FM  G ++ FL      ++     L +L++  ID++ GM YL   N IHRDL   N +++
Sbjct: 88  FMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSSKNFIHRDLAARNCMLN 147

Query: 249 ENGVVKVADFGVARVQAQSGVM----TAETGTYRWMAPEVIEHKPYDYKADVFSFGIALW 304
           EN  V VADFG+++ +  SG       A     +W+A E +    Y   +DV++FG+ +W
Sbjct: 148 ENMTVCVADFGLSK-KIYSGDYYRQGCASKLPVKWLALESLADNVYTTHSDVWAFGVTMW 206

Query: 305 ELLT-GELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRLAELLERCWQHDPTQRPNFSQI 363
           E++T G+ PYAG+   +    ++ K  R   P      + EL+ +CW  +P  RP+F  +
Sbjct: 207 EIMTRGQTPYAGVENSEIYNYLI-KGNRLKQPPDCLEDVYELMCQCWSPEPKCRPSFQHL 265

Query: 364 TDILKQM 370
            D L+ +
Sbjct: 266 RDQLELI 272

Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273

>gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C

 Score =  129 bits (326), Expect = 1e-34
 Identities = 78/253 (30%), Positives = 128/253 (50%), Gaps = 28/253 (11%)

Query: 142 VAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVTEFMARGSIY 201
           VA+K LK         K+F +E  ++  ++H+++V+F G C     L +V E+M  G + 
Sbjct: 38  VAVKALKDP--TLAARKDFQREAELLTNLQHEHIVKFYGVCGDGDPLIMVFEYMKHGDLN 95

Query: 202 DFLH---------------KQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLL 246
            FL                + KG   L+ +L +A  ++ GM YL   + +HRDL T N L
Sbjct: 96  KFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQHFVHRDLATRNCL 155

Query: 247 MDENGVVKVADFGVARVQAQSGVMTAETGTY---RWMAPEVIEHKPYDYKADVFSFGIAL 303
           +  N +VK+ DFG++R    +        T    RWM PE I ++ +  ++DV+SFG+ L
Sbjct: 156 VGANLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVIL 215

Query: 304 WELLT-GELPYAGLTPLQAAVGVVQKSL--RPTI-PKHAHPRLAELLERCWQHDPTQRPN 359
           WE+ T G+ P+  L+  +    + Q  +  RP + PK  +    +++  CWQ +P QR N
Sbjct: 216 WEIFTYGKQPWFQLSNTEVIECITQGRVLERPRVCPKEVY----DIMLGCWQREPQQRLN 271

Query: 360 FSQITDILKQMMK 372
             +I  IL  + K
Sbjct: 272 IKEIYKILHALGK 284

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291

>gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase

 Score =  128 bits (324), Expect = 1e-34
 Identities = 73/246 (29%), Positives = 131/246 (53%), Gaps = 11/246 (4%)

Query: 127 GSYGDLYKGTYCSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPP 186
           G+YG +Y     S +V I + +    ++  ++   +E+ +   ++H+N+VQ++G+ +   
Sbjct: 19  GTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRNIVQYLGSDSENG 78

Query: 187 NLCIVTEFMARGSIYDFLHKQKGVFQL--TSLLKVAIDVSKGMNYLHQNNIIHRDLKTAN 244
              I  E +  GS+   L  + G  +    +++     + +G+ YLH N I+HRD+K  N
Sbjct: 79  FFKIFMEQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQILEGLKYLHDNQIVHRDIKGDN 138

Query: 245 LLMDE-NGVVKVADFGVARVQAQSGVMTAE-TGTYRWMAPEVIEHKPYDY--KADVFSFG 300
           +L++  +GVVK++DFG ++  A     T   TGT ++MAPEVI+  P  Y   AD++S G
Sbjct: 139 VLVNTYSGVVKISDFGTSKRLAGINPCTETFTGTLQYMAPEVIDKGPRGYGAPADIWSLG 198

Query: 301 IALWELLTGELPYAGLTPLQAA---VGVVQKSLRPTIPKHAHPRLAELLERCWQHDPTQR 357
             + E+ TG+ P+  L   QAA   VG+ +    P IP+         + RC++ DP +R
Sbjct: 199 CTIVEMATGKPPFIELGEPQAAMFKVGMFKI--HPEIPESLSAEAKNFILRCFEPDPDKR 256

Query: 358 PNFSQI 363
            +   +
Sbjct: 257 ASAHDL 262

Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268

>gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase

 Score =  128 bits (323), Expect = 2e-34
 Identities = 71/202 (35%), Positives = 108/202 (53%), Gaps = 14/202 (6%)

Query: 163 EVYIMRKIRHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAID 222
           EV IMR  +H N+V+   +      L +V EF+  G++ D +   +       +  V + 
Sbjct: 66  EVVIMRDYQHPNIVEMYSSYLVGDELWVVMEFLEGGALTDIVTHTR--MNEEQIATVCLA 123

Query: 223 VSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFG-VARVQAQSGVMTAETGTYRWMA 281
           V K +++LH   +IHRD+K+ ++L+  +G VK++DFG  A+V  +     +  GT  WMA
Sbjct: 124 VLKALSFLHAQGVIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEVPRRKSLVGTPYWMA 183

Query: 282 PEVIEHKPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKSLRPTIP---KHA 338
           PEVI   PY  + D++S GI + E++ GE PY    PLQA      K +R  +P   K+ 
Sbjct: 184 PEVISRLPYGTEVDIWSLGIMVIEMVDGEPPYFNEPPLQA-----MKRIRDNLPPKLKNL 238

Query: 339 H---PRLAELLERCWQHDPTQR 357
           H   PRL   L+R    DP QR
Sbjct: 239 HKVSPRLRSFLDRMLVRDPAQR 260

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285

>gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase

 Score =  127 bits (320), Expect = 3e-34
 Identities = 72/250 (28%), Positives = 135/250 (54%), Gaps = 12/250 (4%)

Query: 123 KVASGSYGDLYKGTY----CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQF 178
           ++ SG++G + KG Y      + VA+K+LK +  +  +  E  +E  +M+++ +  +V+ 
Sbjct: 2   ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRM 61

Query: 179 IGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHR 238
           IG C    +  +V E    G +  FL K K V +  ++ ++   VS GM YL + N +HR
Sbjct: 62  IGIC-EAESWMLVMELAELGPLNKFLQKNKHVTE-KNITELVHQVSMGMKYLEETNFVHR 119

Query: 239 DLKTANLLMDENGVVKVADFGVAR-VQAQSGVMTAET-GTY--RWMAPEVIEHKPYDYKA 294
           DL   N+L+      K++DFG+++ + A      A+T G +  +W APE + +  +  K+
Sbjct: 120 DLAARNVLLVTQHYAKISDFGLSKALGADENYYKAKTHGKWPVKWYAPECMNYYKFSSKS 179

Query: 295 DVFSFGIALWELLT-GELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRLAELLERCWQHD 353
           DV+SFG+ +WE  + G+ PY G+   +    +++   R   P+   P + +L++ CW + 
Sbjct: 180 DVWSFGVLMWEAFSYGQKPYKGMKGNEVTQ-MIESGERMECPQRCPPEMYDLMKLCWTYG 238

Query: 354 PTQRPNFSQI 363
             +RP F+ +
Sbjct: 239 VDERPGFAVV 248

Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257

>gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases

 Score =  127 bits (321), Expect = 3e-34
 Identities = 73/255 (28%), Positives = 118/255 (46%), Gaps = 22/255 (8%)

Query: 124 VASGSYGDLYKGTYCSQEVAIKVLKPECVNTE----------MLKEFSQEVYIMRKIRHK 173
           +  G+YG +Y     +    + V + E   T           M+K    E+  ++ + H 
Sbjct: 9   IGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHL 68

Query: 174 NVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQN 233
           N+VQ++G  T    L I  E++  GSI   L    G F+   +      V +G+ YLH  
Sbjct: 69  NIVQYLGFETTEEYLSIFLEYVPGGSIGSCLRTY-GRFEEQLVRFFTEQVLEGLAYLHSK 127

Query: 234 NIIHRDLKTANLLMDENGVVKVADFGVAR----VQAQSGVMTAETGTYRWMAPEVIE--H 287
            I+HRDLK  NLL+D +G+ K++DFG+++    +      M+ + G+  WMAPEVI    
Sbjct: 128 GILHRDLKADNLLVDADGICKISDFGISKKSDDIYDNDQNMSMQ-GSVFWMAPEVIHSYS 186

Query: 288 KPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRL----A 343
           + Y  K D++S G  + E+  G  P++    + A   +  K   P IP      L     
Sbjct: 187 QGYSAKVDIWSLGCVVLEMFAGRRPWSDEEAIAAMFKLGNKRSAPPIPPDVSMNLSPVAL 246

Query: 344 ELLERCWQHDPTQRP 358
           + L  C+  +P  RP
Sbjct: 247 DFLNACFTINPDNRP 261

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272

>gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor

 Score =  127 bits (321), Expect = 4e-34
 Identities = 80/286 (27%), Positives = 140/286 (48%), Gaps = 36/286 (12%)

Query: 111 WEIDAKQLKIECKVASGSYGDLYKGTY-------CSQEVAIKVLKPECVNTEMLKEFSQE 163
           WE+  +++ +  ++  GS+G +Y+G             VAIK +       E + EF  E
Sbjct: 1   WEVAREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERI-EFLNE 59

Query: 164 VYIMRKIRHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQ---------LT 214
             +M++    +VV+ +G  ++     ++ E M RG +  +L   +   +         L 
Sbjct: 60  ASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLK 119

Query: 215 SLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAET 274
            ++++A +++ GM YL+ N  +HRDL   N ++ E+  VK+ DFG+ R          ET
Sbjct: 120 KMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTR-------DIYET 172

Query: 275 GTY----------RWMAPEVIEHKPYDYKADVFSFGIALWELLT-GELPYAGLTPLQAAV 323
             Y          RWM+PE ++   +   +DV+SFG+ LWE+ T  E PY G++  Q   
Sbjct: 173 DYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGMSNEQVLR 232

Query: 324 GVVQKSLRPTIPKHAHPRLAELLERCWQHDPTQRPNFSQITDILKQ 369
            V++  L    P +    L EL+  CWQ++P  RP+F +I   +K+
Sbjct: 233 FVMEGGLLDK-PDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKE 277

Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277

>gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9

 Score =  127 bits (320), Expect = 4e-34
 Identities = 68/247 (27%), Positives = 131/247 (53%), Gaps = 7/247 (2%)

Query: 124 VASGSYGD--LYKGTYCSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGA 181
           +  G++G+  LY+ T     V  K +    ++ +  ++   E+ I+  ++H N++ +   
Sbjct: 8   LGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYNH 67

Query: 182 CTRPPNLCIVTEFMARGSIYDFLHKQKG-VFQLTSLLKVAIDVSKGMNYLHQNNIIHRDL 240
                 L I  E+   G++YD + +QKG +F+   +L     +   ++Y+H+  I+HRD+
Sbjct: 68  FMDDNTLLIEMEYANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIHKAGILHRDI 127

Query: 241 KTANLLMDENGVVKVADFGVARVQAQSGVMTAET--GTYRWMAPEVIEHKPYDYKADVFS 298
           KT N+ + + G++K+ DFG++++      M AET  GT  +M+PE+ +   Y++K+D+++
Sbjct: 128 KTLNIFLTKAGLIKLGDFGISKILGSEYSM-AETVVGTPYYMSPELCQGVKYNFKSDIWA 186

Query: 299 FGIALWELLTGELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRLAELLERCWQHDPTQRP 358
            G  L+ELLT +  +    PL   V +VQ +  P +       L  L+    Q DP +RP
Sbjct: 187 LGCVLYELLTLKRTFDATNPLNLVVKIVQGNYTP-VVSVYSSELISLVHSLLQQDPEKRP 245

Query: 359 NFSQITD 365
              ++ D
Sbjct: 246 TADEVLD 252

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256

>gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases

 Score =  126 bits (318), Expect = 6e-34
 Identities = 73/249 (29%), Positives = 121/249 (48%), Gaps = 17/249 (6%)

Query: 127 GSYGDLY----KGTYCSQEVAIKVL-KPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGA 181
           GS+G +     K T   +  A+KVL K + +  + ++    E  I+ +I H  +V+   A
Sbjct: 4   GSFGKVLLVRKKDT--GKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYA 61

Query: 182 CTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLK 241
                 L +V E+   G ++  L K+ G F        A ++   + YLH   II+RDLK
Sbjct: 62  FQTEEKLYLVLEYAPGGELFSHLSKE-GRFSEERARFYAAEIVLALEYLHSLGIIYRDLK 120

Query: 242 TANLLMDENGVVKVADFGVARVQAQSGVMTAET--GTYRWMAPEVIEHKPYDYKADVFSF 299
             N+L+D +G +K+ DFG+A+ +  S      T  GT  ++APEV+  K Y    D +S 
Sbjct: 121 PENILLDADGHIKLTDFGLAK-ELSSEGSRTNTFCGTPEYLAPEVLLGKGYGKAVDWWSL 179

Query: 300 GIALWELLTGELPYAGLTPLQAAVGVVQKSLR--PTIPKHAHPRLAELLERCWQHDPTQR 357
           G+ L+E+LTG+ P+      +    + +K L+     P+   P   +L+    Q DPT+R
Sbjct: 180 GVLLYEMLTGKPPFYAEDRKE----IYEKILKDPLRFPEFLSPEARDLISGLLQKDPTKR 235

Query: 358 PNFSQITDI 366
                  +I
Sbjct: 236 LGSGGAEEI 244

Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250

>gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1

 Score =  127 bits (320), Expect = 1e-33
 Identities = 82/263 (31%), Positives = 126/263 (47%), Gaps = 42/263 (15%)

Query: 142 VAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVTEFMARGSIY 201
           VA+K+L+P+  N     +F +EV I+ +++  N+++ +G C     LC++TE+M  G + 
Sbjct: 49  VAVKILRPD-ANKNARNDFLKEVKILSRLKDPNIIRLLGVCVDEDPLCMITEYMENGDLN 107

Query: 202 DFLHK------------------QKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTA 243
            FL                           +SLL VA+ ++ GM YL   N +HRDL T 
Sbjct: 108 QFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSLNFVHRDLATR 167

Query: 244 NLLMDENGVVKVADFGVA---------RVQAQSGVMTAETGTYRWMAPEVIEHKPYDYKA 294
           N L+ EN  +K+ADFG++         R+Q ++ +        RWMA E I    +   +
Sbjct: 168 NCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVL------PIRWMAWECILMGKFTTAS 221

Query: 295 DVFSFGIALWELLT--GELPYAGLTPLQA---AVGVVQKSLRPTI---PKHAHPRLAELL 346
           DV++FG+ LWE+L    E PY  LT  Q    A    +   R      P      L EL+
Sbjct: 222 DVWAFGVTLWEILMLCKEQPYGELTDEQVIENAGEFFRDQGRQVYLFRPPPCPQGLYELM 281

Query: 347 ERCWQHDPTQRPNFSQITDILKQ 369
            +CW  D  +RP+FS I   L +
Sbjct: 282 LQCWSRDCRERPSFSDIHAFLTE 304

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304

>gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase

 Score =  125 bits (316), Expect = 2e-33
 Identities = 86/265 (32%), Positives = 136/265 (51%), Gaps = 37/265 (13%)

Query: 124 VASGSYGDLYKGTYCS--QEVAIKVLKPECVNTEMLKEFSQEVYIMRKI-RHKNVVQFIG 180
           V +G+YG +YKG +    Q  AIKV+    V  +  +E  QE+ +++K   H+N+  + G
Sbjct: 14  VGNGTYGQVYKGRHVKTGQLAAIKVMD---VTGDEEEEIKQEINMLKKYSHHRNIATYYG 70

Query: 181 ACTR--PP----NLCIVTEFMARGSIYDFLHKQKG-VFQLTSLLKVAIDVSKGMNYLHQN 233
           A  +  PP     L +V EF   GS+ D +   KG   +   +  +  ++ +G+++LHQ+
Sbjct: 71  AFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQH 130

Query: 234 NIIHRDLKTANLLMDENGVVKVADFGV-ARVQAQSGVMTAETGTYRWMAPEVI--EHKP- 289
            +IHRD+K  N+L+ EN  VK+ DFGV A++    G      GT  WMAPEVI  +  P 
Sbjct: 131 KVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFIGTPYWMAPEVIACDENPD 190

Query: 290 --YDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRLA---- 343
             YD+K+D++S GI   E+  G  P   + P++A            IP++  PRL     
Sbjct: 191 ATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALF---------LIPRNPAPRLKSKKW 241

Query: 344 -----ELLERCWQHDPTQRPNFSQI 363
                  +E C   + +QRP   Q+
Sbjct: 242 SKKFQSFIESCLVKNHSQRPTTEQL 266

Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272

>gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa

 Score =  124 bits (313), Expect = 3e-33
 Identities = 75/253 (29%), Positives = 133/253 (52%), Gaps = 18/253 (7%)

Query: 123 KVASGSYGDLYKGTYCSQ----EVAIKVLKPE---CVNTEMLKEFSQEVYIMRKIRHKNV 175
           ++ SG++G + KG Y  +    +VAIKVLK E    V  EM++E      IM ++ +  +
Sbjct: 2   ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMRE----AEIMHQLDNPYI 57

Query: 176 VQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNI 235
           V+ IG C     L +V E  + G +  FL  +K    +++++++   VS GM YL   N 
Sbjct: 58  VRMIGVC-EAEALMLVMEMASGGPLNKFLSGKKDEITVSNVVELMHQVSMGMKYLEGKNF 116

Query: 236 IHRDLKTANLLMDENGVVKVADFGVAR-VQAQSGVMTAETG---TYRWMAPEVIEHKPYD 291
           +HRDL   N+L+      K++DFG+++ + A      A +      +W APE I  + + 
Sbjct: 117 VHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKARSAGKWPLKWYAPECINFRKFS 176

Query: 292 YKADVFSFGIALWELLT-GELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRLAELLERCW 350
            ++DV+S+GI +WE  + G+ PY  +   +  +  +++  R   P    P +  L++ CW
Sbjct: 177 SRSDVWSYGITMWEAFSYGQKPYKKMKGPE-VMSFIEQGKRLDCPAECPPEMYALMKDCW 235

Query: 351 QHDPTQRPNFSQI 363
            +    RPNF+++
Sbjct: 236 IYKWEDRPNFAKV 248

Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257

>gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3

 Score =  123 bits (311), Expect = 8e-33
 Identities = 71/273 (26%), Positives = 142/273 (52%), Gaps = 18/273 (6%)

Query: 112 EIDAKQLKIECKVASGSYGDLYKGTYCSQEVAIKVLKPECVNT-------EMLKEFSQEV 164
           E + ++LK+   + SG +G ++KG +  +  +IK+  P  + T       +  +E +  +
Sbjct: 6   ETELRKLKL---LGSGVFGTVHKGIWIPEGDSIKI--PVAIKTIQDRSGRQTFQEITDHM 60

Query: 165 YIMRKIRHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVS 224
             M  + H  +V+ +G C    +L +VT+    GS+ D + + +       LL   + ++
Sbjct: 61  LAMGSLDHAYIVRLLGICP-GASLQLVTQLSPLGSLLDHVRQHRDSLDPQRLLNWCVQIA 119

Query: 225 KGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARV---QAQSGVMTAETGTYRWMA 281
           KGM YL ++ ++HR+L   N+L+  + +V++ADFGVA +     +    +      +WMA
Sbjct: 120 KGMYYLEEHRMVHRNLAARNILLKSDSIVQIADFGVADLLYPDDKKYFYSEHKTPIKWMA 179

Query: 282 PEVIEHKPYDYKADVFSFGIALWELLT-GELPYAGLTPLQAAVGVVQKSLRPTIPKHAHP 340
            E I    Y +++DV+S+G+ +WE+++ G  PYAG+ P      +++K  R   P+    
Sbjct: 180 LESILFGRYTHQSDVWSYGVTVWEMMSYGAEPYAGMRP-HEVPDLLEKGERLAQPQICTI 238

Query: 341 RLAELLERCWQHDPTQRPNFSQITDILKQMMKE 373
            +  ++ +CW  D   RP F ++ +   +M ++
Sbjct: 239 DVYMVMVKCWMIDENVRPTFKELANEFTRMARD 271

Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279

>gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor

 Score =  124 bits (312), Expect = 9e-33
 Identities = 77/286 (26%), Positives = 135/286 (47%), Gaps = 36/286 (12%)

Query: 111 WEIDAKQLKIECKVASGSYGDLYKGTY-------CSQEVAIKVLKPECVNTEMLKEFSQE 163
           WE+  +++ +  ++  GS+G +Y+G             VA+K +       E + EF  E
Sbjct: 1   WEVSREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERI-EFLNE 59

Query: 164 VYIMRKIRHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQ---------LT 214
             +M+     +VV+ +G  ++     +V E MA G +  +L   +   +         L 
Sbjct: 60  ASVMKGFTCHHVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQ 119

Query: 215 SLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAET 274
            ++++A +++ GM YL+    +HRDL   N ++  +  VK+ DFG+ R          ET
Sbjct: 120 EMIQMAAEIADGMAYLNAKKFVHRDLAARNCMVAHDFTVKIGDFGMTR-------DIYET 172

Query: 275 GTYR----------WMAPEVIEHKPYDYKADVFSFGIALWELLT-GELPYAGLTPLQAAV 323
             YR          WMAPE ++   +   +D++SFG+ LWE+ +  E PY GL+  Q   
Sbjct: 173 DYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVLK 232

Query: 324 GVVQKSLRPTIPKHAHPRLAELLERCWQHDPTQRPNFSQITDILKQ 369
            V+        P +   R+ +L+  CWQ +P  RP F +I ++LK 
Sbjct: 233 FVMDGGYLDQ-PDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKD 277

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288

>gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6

 Score =  123 bits (310), Expect = 1e-32
 Identities = 82/265 (30%), Positives = 133/265 (50%), Gaps = 37/265 (13%)

Query: 124 VASGSYGDLYKGTYCS--QEVAIKVLKPECVNTEMLKEFSQEVYIMRKI-RHKNVVQFIG 180
           V +G+YG +YKG +    Q  AIKV+    V  +  +E   E+ +++K   H+N+  + G
Sbjct: 24  VGNGTYGQVYKGRHVKTGQLAAIKVMD---VTEDEEEEIKLEINMLKKYSHHRNIATYYG 80

Query: 181 ACTR--PP----NLCIVTEFMARGSIYDFLHKQKG-VFQLTSLLKVAIDVSKGMNYLHQN 233
           A  +  PP     L +V EF   GS+ D +   KG   +   +  +  ++ +G+ +LH +
Sbjct: 81  AFIKKSPPGHDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAYICREILRGLAHLHAH 140

Query: 234 NIIHRDLKTANLLMDENGVVKVADFGV-ARVQAQSGVMTAETGTYRWMAPEVI--EHKP- 289
            +IHRD+K  N+L+ EN  VK+ DFGV A++    G      GT  WMAPEVI  +  P 
Sbjct: 141 KVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFIGTPYWMAPEVIACDENPD 200

Query: 290 --YDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRLA---- 343
             YDY++D++S GI   E+  G  P   + P++A            IP++  P+L     
Sbjct: 201 ATYDYRSDIWSLGITAIEMAEGAPPLCDMHPMRALF---------LIPRNPPPKLKSKKW 251

Query: 344 -----ELLERCWQHDPTQRPNFSQI 363
                + +E C   +   RP+  Q+
Sbjct: 252 SKKFIDFIEGCLVKNYLSRPSTEQL 276

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282

>gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

 Score =  123 bits (311), Expect = 1e-32
 Identities = 74/251 (29%), Positives = 126/251 (50%), Gaps = 23/251 (9%)

Query: 142 VAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRP--PNLCIVTEFMARGS 199
           VA+K L+      E L++F +E+ I++ ++H N+V++ G C      NL +V E++  GS
Sbjct: 36  VAVKKLQHS--TAEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLRLVMEYLPYGS 93

Query: 200 IYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFG 259
           + D+L K +       LL  A  + KGM YL     +HRDL T N+L++    VK+ DFG
Sbjct: 94  LRDYLQKHRERLDHRKLLLYASQICKGMEYLGSKRYVHRDLATRNILVESENRVKIGDFG 153

Query: 260 VARV--QAQSGVMTAETGTYR--WMAPEVIEHKPYDYKADVFSFGIALWELLT----GEL 311
           + +V  Q +      E G     W APE +    +   +DV+SFG+ L+EL T       
Sbjct: 154 LTKVLPQDKEYYKVREPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYSDKSCS 213

Query: 312 PYA-----------GLTPLQAAVGVVQKSLRPTIPKHAHPRLAELLERCWQHDPTQRPNF 360
           P A           G   +   + +++ + R   P      +  +++ CW +DP+QRP+F
Sbjct: 214 PPAEFMRMMGNDKQGQMIVYHLIELLKNNGRLPAPPGCPAEIYAIMKECWNNDPSQRPSF 273

Query: 361 SQITDILKQMM 371
           S++   ++ + 
Sbjct: 274 SELALQVEAIR 284

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284

>gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A

 Score =  122 bits (308), Expect = 3e-32
 Identities = 74/244 (30%), Positives = 123/244 (50%), Gaps = 26/244 (10%)

Query: 142 VAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVTEFMARGSIY 201
           VA+K LK    +    ++F +E  ++  ++H+++V+F G CT    L +V E+M  G + 
Sbjct: 38  VAVKALKE--ASESARQDFQREAELLTVLQHQHIVRFYGVCTEGRPLLMVFEYMRHGDLN 95

Query: 202 DFLHKQK--------------GVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLM 247
            FL                  G   L  +L +A  ++ GM YL   + +HRDL T N L+
Sbjct: 96  RFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLASLHFVHRDLATRNCLV 155

Query: 248 DENGVVKVADFGVARVQAQSGVMTAETGTY---RWMAPEVIEHKPYDYKADVFSFGIALW 304
            +  VVK+ DFG++R    +        T    RWM PE I ++ +  ++D++SFG+ LW
Sbjct: 156 GQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDIWSFGVVLW 215

Query: 305 ELLT-GELPYAGLTPLQAAVGVVQ-KSLRPTIPKHAHPRLAELLERCWQHDPTQRPNFSQ 362
           E+ T G+ P+  L+  +A   + Q + L    P+   P +  +++ CWQ +P QR     
Sbjct: 216 EIFTYGKQPWYQLSNTEAIECITQGRELER--PRTCPPEVYAIMQGCWQREPQQR---MV 270

Query: 363 ITDI 366
           I DI
Sbjct: 271 IKDI 274

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280

>gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3

 Score =  122 bits (306), Expect = 4e-32
 Identities = 82/252 (32%), Positives = 131/252 (51%), Gaps = 15/252 (5%)

Query: 124 VASGSYGDLY--KGTYCSQEVAIKVLKPECVNTEMLKEFSQ---EVYIMRKIRHKNVVQF 178
           +  G++G +Y        +E+A K ++ +  + E  KE S    E+ +++ ++H+ +VQ+
Sbjct: 10  LGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQY 69

Query: 179 IGACTR---PPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNI 235
            G C R      L I  E+M  GS+ D L K  G    +   K    + +GM+YLH N I
Sbjct: 70  YG-CLRDRAEKTLTIFMEYMPGGSVKDQL-KAYGALTESVTRKYTRQILEGMSYLHSNMI 127

Query: 236 IHRDLKTANLLMDENGVVKVADFGVA-RVQA--QSGV-MTAETGTYRWMAPEVIEHKPYD 291
           +HRD+K AN+L D  G VK+ DFG + R+Q    SG  + + TGT  WM+PEVI  + Y 
Sbjct: 128 VHRDIKGANILRDSAGNVKLGDFGASKRLQTICMSGTGIRSVTGTPYWMSPEVISGEGYG 187

Query: 292 YKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRLAELLERCWQ 351
            KADV+S G  + E+LT + P+A    + A   +  +   P +P H      + L  C  
Sbjct: 188 RKADVWSLGCTVVEMLTEKPPWAEYEAMAAIFKIATQPTNPQLPSHISEHARDFL-GCIF 246

Query: 352 HDPTQRPNFSQI 363
            +   RP+  ++
Sbjct: 247 VEARHRPSAEEL 258

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266

>gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases

 Score =  122 bits (307), Expect = 5e-32
 Identities = 72/225 (32%), Positives = 116/225 (51%), Gaps = 18/225 (8%)

Query: 155 EMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLT 214
            + K+  +E+ IM + R   +V F GA     N+C+  EFM  GS+ D ++K+ G   + 
Sbjct: 45  SVRKQILRELQIMHECRSPYIVSFYGAFLNENNICMCMEFMDCGSL-DRIYKKGGPIPVE 103

Query: 215 SLLKVAIDVSKGMNYLH-QNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAE 273
            L K+A+ V +G+ YL+  + I+HRD+K +N+L++  G +K+ DFGV+     S    A+
Sbjct: 104 ILGKIAVAVVEGLTYLYNVHRIMHRDIKPSNILVNSRGQIKLCDFGVSGELINS---IAD 160

Query: 274 T--GTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPYA---GLTPLQAAVGVVQK 328
           T  GT  +M+PE I+   Y  K+DV+S GI++ EL  G+ P+A        Q     +  
Sbjct: 161 TFVGTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILD 220

Query: 329 SLR-------PTIPKHAHPRLAELL-ERCWQHDPTQRPNFSQITD 365
            L+       P +P    P       + C   DPT+RP   Q+  
Sbjct: 221 LLQQIVQEPPPRLPSSDFPEDLRDFVDACLLKDPTERPTPQQLCA 265

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284

>gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases

 Score =  121 bits (307), Expect = 6e-32
 Identities = 59/206 (28%), Positives = 106/206 (51%), Gaps = 26/206 (12%)

Query: 119 KIECKVASGSYGDLYKGT--YCSQEVAIKVLKPECVNTEMLKE-FSQ----EVYIMRKIR 171
           K+E K+  G+YG +YK       + VA+K ++      +  +E        E+ ++++++
Sbjct: 3   KLE-KLGEGTYGVVYKARDKKTGEIVALKKIR-----LDNEEEGIPSTALREISLLKELK 56

Query: 172 HKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLH 231
           H N+V+ +        L +V E+     +  +L K+ G      +  +   + +G+ Y H
Sbjct: 57  HPNIVKLLDVIHTERKLYLVFEYCDM-DLKKYLDKRPGPLSPNLIKSIMYQLLRGLAYCH 115

Query: 232 QNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGV----MTAETGT--YRWMAPEVI 285
            + I+HRDLK  N+L++ +GV+K+ADFG+AR     G+     T E  T  YR  APE++
Sbjct: 116 SHRILHRDLKPQNILINRDGVLKLADFGLAR---AFGIPLRTYTHEVVTLWYR--APEIL 170

Query: 286 -EHKPYDYKADVFSFGIALWELLTGE 310
              K Y    D++S G    E++TG+
Sbjct: 171 LGSKHYSTAVDIWSVGCIFAEMITGK 196

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282

>gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B

 Score =  122 bits (306), Expect = 6e-32
 Identities = 83/276 (30%), Positives = 140/276 (50%), Gaps = 32/276 (11%)

Query: 123 KVASGSYGDLYKG---TYCSQE----VAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNV 175
           ++  G++G ++       C ++    VA+K LK    N    K+F +E  ++  ++H+++
Sbjct: 12  ELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNAR--KDFHREAELLTNLQHEHI 69

Query: 176 VQFIGACTRPPNLCIVTEFMARGSIYDFL--HKQKGVF--------QLTS--LLKVAIDV 223
           V+F G C     L +V E+M  G +  FL  H    V         +LT   +L +A  +
Sbjct: 70  VKFYGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQI 129

Query: 224 SKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAETGTY---RWM 280
           + GM YL   + +HRDL T N L+ EN +VK+ DFG++R    +        T    RWM
Sbjct: 130 AAGMVYLASQHFVHRDLATRNCLVGENLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWM 189

Query: 281 APEVIEHKPYDYKADVFSFGIALWELLT-GELPYAGLTPLQAAVGVVQKSL--RP-TIPK 336
            PE I ++ +  ++DV+S G+ LWE+ T G+ P+  L+  +    + Q  +  RP T PK
Sbjct: 190 PPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNEVIECITQGRVLQRPRTCPK 249

Query: 337 HAHPRLAELLERCWQHDPTQRPNFSQITDILKQMMK 372
             +    +L+  CWQ +P  R N  +I  +L+ + K
Sbjct: 250 EVY----DLMLGCWQREPHMRLNIKEIHSLLQNLAK 281

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288

>gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1

 Score =  120 bits (303), Expect = 8e-32
 Identities = 67/248 (27%), Positives = 134/248 (54%), Gaps = 7/248 (2%)

Query: 123 KVASGSYGD--LYKGTYCSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIG 180
           K+  GS+G   L K     ++  IK +    ++ +  +E  +EV ++  ++H N+VQ+  
Sbjct: 7   KIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQE 66

Query: 181 ACTRPPNLCIVTEFMARGSIYDFLHKQKGV-FQLTSLLKVAIDVSKGMNYLHQNNIIHRD 239
           +     NL IV ++   G +Y  ++ Q+GV F    +L   + +   + ++H   I+HRD
Sbjct: 67  SFEENGNLYIVMDYCEGGDLYKKINAQRGVLFPEDQILDWFVQICLALKHVHDRKILHRD 126

Query: 240 LKTANLLMDENGVVKVADFGVARVQAQSGVMTAET--GTYRWMAPEVIEHKPYDYKADVF 297
           +K+ N+ + ++G +K+ DFG+ARV   S V  A T  GT  +++PE+ E++PY+ K+D++
Sbjct: 127 IKSQNIFLTKDGTIKLGDFGIARV-LNSTVELARTCIGTPYYLSPEICENRPYNNKSDIW 185

Query: 298 SFGIALWELLTGELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRLAELLERCWQHDPTQR 357
           + G  L+E+ T +  +         + +++ S  P +  H    L  L+ + ++ +P  R
Sbjct: 186 ALGCVLYEMCTLKHAFEAGNMKNLVLKIIRGSY-PPVSSHYSYDLRNLVSQLFKRNPRDR 244

Query: 358 PNFSQITD 365
           P+ + I +
Sbjct: 245 PSVNSILE 252

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256

>gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6

 Score =  121 bits (305), Expect = 9e-32
 Identities = 81/258 (31%), Positives = 131/258 (50%), Gaps = 14/258 (5%)

Query: 118 LKIECKVASGSYGDLYKGTYCSQEVAIKVLK-PECVNTEMLKEFSQEVYI-MRKIRHKNV 175
           L++  ++  G+YG + K  +      + V +    VN++  K    ++ I MR +     
Sbjct: 3   LEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQKRLLMDLDISMRSVDCPYT 62

Query: 176 VQFIGACTRPPNLCIVTEFMARGSIYDFLHK--QKGVFQLTSLL-KVAIDVSKGMNYLHQ 232
           V F GA  R  ++ I  E M   S+  F  K   KG+     +L K+A+ + K + YLH 
Sbjct: 63  VTFYGALFREGDVWICMEVMDT-SLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHS 121

Query: 233 N-NIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAETGTYRWMAPEVI----EH 287
             ++IHRD+K +N+L++ NG VK+ DFG++     S   T + G   +MAPE I      
Sbjct: 122 KLSVIHRDVKPSNVLINRNGQVKLCDFGISGYLVDSVAKTIDAGCKPYMAPERINPELNQ 181

Query: 288 KPYDYKADVFSFGIALWELLTGELPYAGL-TPLQAAVGVVQKSLRPTIPKHA-HPRLAEL 345
           K YD K+DV+S GI + EL TG  PY    TP Q    VV++   P +P     P   + 
Sbjct: 182 KGYDVKSDVWSLGITMIELATGRFPYDSWKTPFQQLKQVVEEP-SPQLPAEKFSPEFQDF 240

Query: 346 LERCWQHDPTQRPNFSQI 363
           + +C + +  +RPN+ ++
Sbjct: 241 VNKCLKKNYKERPNYPEL 258

Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283

>gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins

 Score =  120 bits (304), Expect = 1e-31
 Identities = 67/253 (26%), Positives = 110/253 (43%), Gaps = 13/253 (5%)

Query: 126 SGSYGDLY--KGTYCSQEVAIKVL-KPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGAC 182
            G+YG ++  K        AIKV+ K + +    + +   E  I+ + +   VV+   + 
Sbjct: 3   KGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSF 62

Query: 183 TRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKT 242
               NL +V E++  G +   L    G            ++   + YLH N IIHRDLK 
Sbjct: 63  QGKKNLYLVMEYLPGGDLASLLE-NVGSLDEDVARIYIAEIVLALEYLHSNGIIHRDLKP 121

Query: 243 ANLLMDENGVVKVADFGVARV-----QAQSGVMTAET----GTYRWMAPEVIEHKPYDYK 293
            N+L+D NG +K+ DFG+++V     Q        E     GT  ++APEVI  + +   
Sbjct: 122 DNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKEDKRIVGTPDYIAPEVILGQGHSKT 181

Query: 294 ADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRLAELLERCWQHD 353
            D +S G  L+E L G  P+ G TP +    ++   +             +L+ +    D
Sbjct: 182 VDWWSLGCILYEFLVGIPPFHGETPEEIFQNILNGKIEWPEDVEVSDEAIDLISKLLVPD 241

Query: 354 PTQRPNFSQITDI 366
           P +R     I +I
Sbjct: 242 PEKRLGAKSIEEI 254

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265

>gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5

 Score =  120 bits (302), Expect = 1e-31
 Identities = 77/253 (30%), Positives = 136/253 (53%), Gaps = 11/253 (4%)

Query: 123 KVASGSYGDLY--KGTYCSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIG 180
           K+  GS+G +Y  K    S+   IK +    +  +  +   +EV ++ K++H N+V F  
Sbjct: 7   KIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFA 66

Query: 181 ACTRPPNLCIVTEFMARGSIYDFLHKQKGV-FQLTSLLKVAIDVSKGMNYLHQNNIIHRD 239
           +      L IV E+   G +   +++Q+GV F    +L   + +S G+ ++H   I+HRD
Sbjct: 67  SFQENGRLFIVMEYCDGGDLMKRINRQRGVLFSEDQILSWFVQISLGLKHIHDRKILHRD 126

Query: 240 LKTANLLMDENGVV-KVADFGVARVQAQSGVMTAET--GTYRWMAPEVIEHKPYDYKADV 296
           +K+ N+ + +NG+V K+ DFG+AR    S +  A T  GT  +++PE+ +++PY+ K D+
Sbjct: 127 IKSQNIFLSKNGMVAKLGDFGIARQLNDS-MELAYTCVGTPYYLSPEICQNRPYNNKTDI 185

Query: 297 FSFGIALWELLTGELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRLAELLERCWQHDPTQ 356
           +S G  L+EL T + P+ G    Q  + + Q    P  P  +   L  L+ + ++  P  
Sbjct: 186 WSLGCVLYELCTLKHPFEGNNLHQLVLKICQGYFAPISPNFSR-DLRSLISQLFKVSPRD 244

Query: 357 RPNFSQITDILKQ 369
           RP+   IT ILK+
Sbjct: 245 RPS---ITSILKR 254

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257

>gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2

 Score =  120 bits (303), Expect = 1e-31
 Identities = 80/251 (31%), Positives = 130/251 (51%), Gaps = 13/251 (5%)

Query: 124 VASGSYGDLY--KGTYCSQEVAIKVLKPECVNTEMLKEFSQ---EVYIMRKIRHKNVVQF 178
           +  G++G +Y        +E+A+K ++ +  + E  KE +    E+ +++ + H+ +VQ+
Sbjct: 10  LGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQY 69

Query: 179 IGACTRPP--NLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNII 236
            G    P    L I  E M  GSI D L K  G        K    + +G++YLH N I+
Sbjct: 70  YGCLRDPMERTLSIFMEHMPGGSIKDQL-KSYGALTENVTRKYTRQILEGVSYLHSNMIV 128

Query: 237 HRDLKTANLLMDENGVVKVADFGVA-RVQA--QSGV-MTAETGTYRWMAPEVIEHKPYDY 292
           HRD+K AN+L D  G VK+ DFG + R+Q    SG  M + TGT  WM+PEVI  + Y  
Sbjct: 129 HRDIKGANILRDSVGNVKLGDFGASKRLQTICLSGTGMKSVTGTPYWMSPEVISGEGYGR 188

Query: 293 KADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRLAELLERCWQH 352
           KAD++S G  + E+LT + P+A    + A   +  +   P +P H      + L+R +  
Sbjct: 189 KADIWSVGCTVVEMLTEKPPWAEFEAMAAIFKIATQPTNPVLPPHVSDHCRDFLKRIFV- 247

Query: 353 DPTQRPNFSQI 363
           +   RP+  ++
Sbjct: 248 EAKLRPSADEL 258

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265

>gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7

 Score =  120 bits (302), Expect = 2e-31
 Identities = 72/262 (27%), Positives = 135/262 (51%), Gaps = 11/262 (4%)

Query: 119 KIECKVASGSYGDLYKG--TYCSQEVAIKVLKP-ECVNTEMLKEFSQEVYIMRKIRHKNV 175
           KIE K+  G +  +YK       + VA+K ++  E ++ +  ++  +E+ +++++ H NV
Sbjct: 5   KIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNV 64

Query: 176 VQFIGACTRPPNLCIVTEFMARGSIYDFL---HKQKGVFQLTSLLKVAIDVSKGMNYLHQ 232
           ++++ +      L IV E    G +   +    KQK +    ++ K  + +   + ++H 
Sbjct: 65  IKYLASFIENNELNIVLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHS 124

Query: 233 NNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAET--GTYRWMAPEVIEHKPY 290
             I+HRD+K AN+ +   GVVK+ D G+ R    S    A +  GT  +M+PE I    Y
Sbjct: 125 KRIMHRDIKPANVFITATGVVKLGDLGLGR-FFSSKTTAAHSLVGTPYYMSPERIHENGY 183

Query: 291 DYKADVFSFGIALWELLTGELPYAG-LTPLQAAVGVVQKSLRPTIPK-HAHPRLAELLER 348
           ++K+D++S G  L+E+   + P+ G    L +    ++K   P +P  H    L +L+ R
Sbjct: 184 NFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEKCDYPPLPADHYSEELRDLVSR 243

Query: 349 CWQHDPTQRPNFSQITDILKQM 370
           C   DP +RP+ S +  + K+M
Sbjct: 244 CINPDPEKRPDISYVLQVAKEM 265

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267

>gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8

 Score =  119 bits (300), Expect = 2e-31
 Identities = 62/244 (25%), Positives = 124/244 (50%), Gaps = 5/244 (2%)

Query: 124 VASGSYGDLY--KGTYCSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGA 181
           V  G++G ++  +     + V IK +  E +  +       E  +++ + H N++++   
Sbjct: 8   VGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYEN 67

Query: 182 CTRPPNLCIVTEFMARGSIYDFLHKQ-KGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDL 240
                 L IV E+   G++ +++ K+   +    ++L   + +   ++++H   I+HRDL
Sbjct: 68  FLEDKALMIVMEYAPGGTLAEYIQKRCNSLLDEDTILHFFVQILLALHHVHTKLILHRDL 127

Query: 241 KTANLLMDENG-VVKVADFGVARVQAQSGVMTAETGTYRWMAPEVIEHKPYDYKADVFSF 299
           KT N+L+D++  VVK+ DFG++++ +         GT  +++PE+ E KPY+ K+D+++ 
Sbjct: 128 KTQNILLDKHKMVVKIGDFGISKILSSKSKAYTVVGTPCYISPELCEGKPYNQKSDIWAL 187

Query: 300 GIALWELLTGELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRLAELLERCWQHDPTQRPN 359
           G  L+EL + +  +     L A V  +       I     P L +L+      DP++RP 
Sbjct: 188 GCVLYELASLKRAFEAAN-LPALVLKIMSGTFAPISDRYSPDLRQLILSMLNLDPSKRPQ 246

Query: 360 FSQI 363
            SQI
Sbjct: 247 LSQI 250

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256

>gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4

 Score =  119 bits (300), Expect = 2e-31
 Identities = 71/245 (28%), Positives = 125/245 (51%), Gaps = 6/245 (2%)

Query: 124 VASGSYGD--LYKGTYCSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGA 181
           V  GSYG+  L +     ++  IK L     +    K   QE  ++ +++H N+V +  +
Sbjct: 8   VGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRES 67

Query: 182 CTRPPN-LCIVTEFMARGSIYDFLHKQKGVFQLTS-LLKVAIDVSKGMNYLHQNNIIHRD 239
                  L IV  F   G +Y  L +QKG     + +++  + ++  + YLH+ +I+HRD
Sbjct: 68  WEGEDGLLYIVMGFCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYLHEKHILHRD 127

Query: 240 LKTANLLMDENGVVKVADFGVARV-QAQSGVMTAETGTYRWMAPEVIEHKPYDYKADVFS 298
           LKT N+ +    ++KV D G+ARV + Q  + +   GT  +M+PE+  +KPY+YK+DV++
Sbjct: 128 LKTQNVFLTRTNIIKVGDLGIARVLENQCDMASTLIGTPYYMSPELFSNKPYNYKSDVWA 187

Query: 299 FGIALWELLTGELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRLAELLERCWQHDPTQRP 358
            G  ++E+ T +  +           +++  L P +PK   P L EL+       P +RP
Sbjct: 188 LGCCVYEMATLKHAFNAKDMNSLVYRIIEGKL-PPMPKDYSPELGELIATMLSKRPEKRP 246

Query: 359 NFSQI 363
           +   I
Sbjct: 247 SVKSI 251

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257

>gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl

 Score =  119 bits (300), Expect = 3e-31
 Identities = 76/273 (27%), Positives = 129/273 (47%), Gaps = 32/273 (11%)

Query: 124 VASGSYGDLYKGTYCSQE----VAIKVLKPE-CVNTEMLKEFSQEVYIMRKIRHKNVVQF 178
           +  G +G + +G     +    VA+K +K   C  +EM ++F  E   M++  H NV++ 
Sbjct: 7   LGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEM-EDFLSEAVCMKEFDHPNVMRL 65

Query: 179 IGACTRP------PNLCIVTEFMARGSIYDFL-----HKQKGVFQLTSLLKVAIDVSKGM 227
           IG C +       P+  ++  FM  G ++ FL                L+K   D++ GM
Sbjct: 66  IGVCLQTVESEGYPSPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGM 125

Query: 228 NYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARV--------QAQSGVMTAETGTYRW 279
            YL   + IHRDL   N +++EN  V VADFG+++         Q +   M       +W
Sbjct: 126 EYLSSKSFIHRDLAARNCMLNENMNVCVADFGLSKKIYNGDYYRQGRIAKMPV-----KW 180

Query: 280 MAPEVIEHKPYDYKADVFSFGIALWELLT-GELPYAGLTPLQAAVGVVQKSLRPTIPKHA 338
           +A E +  + Y  K+DV+SFG+ +WE+ T G+ PY G+   +     +++  R   P   
Sbjct: 181 IAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPGVENSE-IYDYLRQGNRLKQPPDC 239

Query: 339 HPRLAELLERCWQHDPTQRPNFSQITDILKQMM 371
              L  L+  CW  +P  RP+F  +   L++ +
Sbjct: 240 LDGLYSLMSSCWLLNPKDRPSFETLRCELEKAL 272

Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272

>gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase)

 Score =  119 bits (300), Expect = 4e-31
 Identities = 72/262 (27%), Positives = 125/262 (47%), Gaps = 24/262 (9%)

Query: 122 CKVASGSYGDLYKGTY------CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNV 175
             +  G++G ++ G          +EV +K +K      + +    QE  ++  + H+N+
Sbjct: 12  DLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQ-VTLLLQESCLLYGLSHQNI 70

Query: 176 VQFIGACTR---PPNLCIVTEFMARGSIYDFL----HKQKGVFQLTS---LLKVAIDVSK 225
           +  +  C     PP +     +M  G++  FL      +    Q  S   L+ +AI ++ 
Sbjct: 71  LPILHVCIEDGEPPFVLY--PYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIAC 128

Query: 226 GMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAETGTYR---WMAP 282
           GM+YLH+  +IH+D+   N ++DE   VK+ D  ++R               R   WMA 
Sbjct: 129 GMSYLHKRGVIHKDIAARNCVIDEELQVKITDNALSRDLFPMDYHCLGDNENRPVKWMAL 188

Query: 283 EVIEHKPYDYKADVFSFGIALWELLT-GELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPR 341
           E + +K Y   +DV+SFG+ LWEL+T G+ PY  + P + A   ++   R   P +    
Sbjct: 189 ESLVNKEYSSASDVWSFGVLLWELMTLGQTPYVEIDPFEMA-AYLKDGYRLAQPINCPDE 247

Query: 342 LAELLERCWQHDPTQRPNFSQI 363
           L  ++  CW  DP +RP+FSQ+
Sbjct: 248 LFAVMACCWALDPEERPSFSQL 269

Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280

>gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3

 Score =  119 bits (298), Expect = 5e-31
 Identities = 75/216 (34%), Positives = 117/216 (54%), Gaps = 9/216 (4%)

Query: 123 KVASGSYGDLYKGTYCS--QEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIG 180
           ++ SG+YGD+YK    +  +  AIKV+K E    E      QE+ +M+  +H N+V + G
Sbjct: 16  RIGSGTYGDVYKARNVNTGELAAIKVIKLE--PGEDFAVVQQEIIMMKDCKHSNIVAYFG 73

Query: 181 ACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDL 240
           +  R   L I  EF   GS+ D  H   G    + +  V+ +  +G+ YLH    +HRD+
Sbjct: 74  SYLRRDKLWICMEFCGGGSLQDIYH-VTGPLSESQIAYVSRETLQGLYYLHSKGKMHRDI 132

Query: 241 KTANLLMDENGVVKVADFGV-ARVQAQSGVMTAETGTYRWMAPEV--IEHK-PYDYKADV 296
           K AN+L+ +NG VK+ADFGV A++ A      +  GT  WMAPEV  +E K  Y+   D+
Sbjct: 133 KGANILLTDNGHVKLADFGVSAQITATIAKRKSFIGTPYWMAPEVAAVERKGGYNQLCDI 192

Query: 297 FSFGIALWELLTGELPYAGLTPLQAAVGVVQKSLRP 332
           ++ GI   EL   + P   L P++A   + + + +P
Sbjct: 193 WAVGITAIELAELQPPMFDLHPMRALFLMTKSNFQP 228

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267

>gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase

 Score =  119 bits (299), Expect = 6e-31
 Identities = 82/265 (30%), Positives = 135/265 (50%), Gaps = 20/265 (7%)

Query: 109 DVWEIDAKQLKIECKVASGSYGDLYKGTYCSQEV--AIKVLKPECVNTEMLKEFSQEVYI 166
           + WEI  +       +  G++G +YK       V  A KV+  +  + E L+++  E+ I
Sbjct: 5   EFWEIIGE-------LGDGAFGKVYKAQNKETGVLAAAKVIDTK--SEEELEDYMVEIDI 55

Query: 167 MRKIRHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKG 226
           +    H N+V+ + A     NL I+ EF A G++   + + +       +  V     + 
Sbjct: 56  LASCDHPNIVKLLDAFYYENNLWILIEFCAGGAVDAVMLELERPLTEPQIRVVCKQTLEA 115

Query: 227 MNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQS-GVMTAETGTYRWMAPEVI 285
           +NYLH+N IIHRDLK  N+L   +G +K+ADFGV+    ++     +  GT  WMAPEV+
Sbjct: 116 LNYLHENKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDSFIGTPYWMAPEVV 175

Query: 286 -----EHKPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKSLRPTI--PKHA 338
                + +PYDYKADV+S GI L E+   E P+  L P++  + +  KS  PT+  P   
Sbjct: 176 MCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELNPMRVLLKIA-KSEPPTLAQPSRW 234

Query: 339 HPRLAELLERCWQHDPTQRPNFSQI 363
                + L++C + +   R   +Q+
Sbjct: 235 SSEFKDFLKKCLEKNVDARWTTTQL 259

Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282

>gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2

 Score =  118 bits (298), Expect = 7e-31
 Identities = 69/258 (26%), Positives = 121/258 (46%), Gaps = 22/258 (8%)

Query: 123 KVASGSYGDLYKGTYCS--QEVAIKVLKPECVNTEMLKEFSQ---EVYIMRKIRHKNVVQ 177
            +  GS+G + K    S  + +  K +    +     KE  Q   EV I+R+++H N+V+
Sbjct: 7   TIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTE---KEKQQLVSEVNILRELKHPNIVR 63

Query: 178 FIGACTRPPN--LCIVTEFMARGSIYDFLHK---QKGVFQLTSLLKVAIDVSKGMNYLH- 231
           +        N  L IV E+   G +   + K   ++   +   + ++   +   +   H 
Sbjct: 64  YYDRIIDRSNQTLYIVMEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHN 123

Query: 232 ----QNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAET--GTYRWMAPEVI 285
                N ++HRDLK AN+ +D N  VK+ DFG+A++        A+T  GT  +M+PE +
Sbjct: 124 RSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKI-LGHDSSFAKTYVGTPYYMSPEQL 182

Query: 286 EHKPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRLAEL 345
            H  YD K+D++S G  ++EL     P+     LQ A  + +   R  IP      L E+
Sbjct: 183 NHMSYDEKSDIWSLGCLIYELCALSPPFTARNQLQLASKIKEGKFRR-IPYRYSSELNEV 241

Query: 346 LERCWQHDPTQRPNFSQI 363
           ++     DP +RP+  ++
Sbjct: 242 IKSMLNVDPDKRPSTEEL 259

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265

>gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2

 Score =  118 bits (298), Expect = 1e-30
 Identities = 76/250 (30%), Positives = 130/250 (52%), Gaps = 24/250 (9%)

Query: 142 VAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVTEFMARGSIY 201
           VA+K+L+ +  N     +F +E+ IM +++  N+++ +  C     LC++TE+M  G + 
Sbjct: 49  VAVKMLRED-ANKNARNDFLKEIKIMSRLKDPNIIRLLAVCITSDPLCMITEYMENGDLN 107

Query: 202 DFL--HKQKG--------VFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENG 251
            FL  H+ +             ++L+ +A  ++ GM YL   N +HRDL T N L+ +N 
Sbjct: 108 QFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSLNFVHRDLATRNCLVGKNY 167

Query: 252 VVKVADFGVARVQAQSGVMTAETG----TYRWMAPEVIEHKPYDYKADVFSFGIALWELL 307
            +K+ADFG++R    SG      G      RWM+ E I    +   +DV++FG+ LWE+L
Sbjct: 168 TIKIADFGMSR-NLYSGDYYRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEIL 226

Query: 308 T--GELPYAGLTPLQAAVGVVQ----KSLRPTIPKHAH-PR-LAELLERCWQHDPTQRPN 359
           T   E PY+ L+  Q      +    +  +  +PK A  P  L +L+  CW+ +  +RP+
Sbjct: 227 TLCKEQPYSQLSDEQVIENTGEFFRDQGRQVYLPKPALCPDSLYKLMLSCWRRNAKERPS 286

Query: 360 FSQITDILKQ 369
           F +I   L +
Sbjct: 287 FQEIHATLLE 296

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296

>gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1

 Score =  118 bits (297), Expect = 1e-30
 Identities = 66/281 (23%), Positives = 118/281 (41%), Gaps = 38/281 (13%)

Query: 119 KIECKVASGSYGDLYKGT--YCSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKI-----R 171
           K    +  GS+  +        ++E AIK+L    +  E  K   + V I +++      
Sbjct: 4   KFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEK-KV--KYVKIEKEVLTRLNG 60

Query: 172 HKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLH 231
           H  +++         NL  V E+   G +  ++ K  G          A ++   + YLH
Sbjct: 61  HPGIIKLYYTFQDEENLYFVLEYAPNGELLQYIRKY-GSLDEKCTRFYAAEILLALEYLH 119

Query: 232 QNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAET----------------- 274
              IIHRDLK  N+L+D++  +K+ DFG A+V   +    +                   
Sbjct: 120 SKGIIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPESNKGDATNIDSQIEKNRRRF 179

Query: 275 ----GTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQK-- 328
               GT  +++PE++  KP    +D+++ G  ++++LTG+ P+ G           QK  
Sbjct: 180 ASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFRGSNEYL----TFQKIL 235

Query: 329 SLRPTIPKHAHPRLAELLERCWQHDPTQRPNFSQITDILKQ 369
            L  + P +  P   +L+E+    DP  R   ++  D LK 
Sbjct: 236 KLEYSFPPNFPPDAKDLIEKLLVLDPQDRLGVNEGYDELKA 276

Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280

>gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase

 Score =  118 bits (297), Expect = 2e-30
 Identities = 72/239 (30%), Positives = 120/239 (50%), Gaps = 16/239 (6%)

Query: 126 SGSYGD----LYKGTYCSQEVAIKVL-KPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIG 180
           +GS+G      +KG+   +  A+K+L K + V  + ++    E  I++ IRH  +V   G
Sbjct: 11  TGSFGRVMLVRHKGSG--KYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYG 68

Query: 181 ACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDL 240
           +     NL +V E++  G ++  L ++ G F        A  V   + YLH  +I++RDL
Sbjct: 69  SFQDDSNLYLVMEYVPGGELFSHL-RKSGRFPEPVARFYAAQVVLALEYLHSLDIVYRDL 127

Query: 241 KTANLLMDENGVVKVADFGVARVQAQSGVMTAETGTYRWMAPEVIEHKPYDYKADVFSFG 300
           K  NLL+D +G +K+ DFG A+   +    T   GT  ++APE+I  K Y    D ++ G
Sbjct: 128 KPENLLLDSDGYIKITDFGFAKR-VKGRTYTL-CGTPEYLAPEIILSKGYGKAVDWWALG 185

Query: 301 IALWELLTGELPYAGLTPLQAAVGVVQKSL--RPTIPKHAHPRLAELLERCWQHDPTQR 357
           I ++E+L G  P+    P+Q    + +K L  +   P    P   +L+    Q D T+R
Sbjct: 186 ILIYEMLAGYPPFFDDNPIQ----IYEKILEGKVRFPSFFSPDAKDLIRNLLQVDLTKR 240

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290

>gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4

 Score =  117 bits (295), Expect = 2e-30
 Identities = 78/246 (31%), Positives = 130/246 (52%), Gaps = 10/246 (4%)

Query: 123 KVASGSYGDLYKGTYCSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGAC 182
           K+  GS G +   T  S    + V K +    +  +    EV IMR  +H+NVV+   + 
Sbjct: 27  KIGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSY 86

Query: 183 TRPPNLCIVTEFMARGSIYDFL-HKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLK 241
                L +V EF+  G++ D + H +    Q+ +   V + V K ++ LH   +IHRD+K
Sbjct: 87  LVGDELWVVMEFLEGGALTDIVTHTRMNEEQIAA---VCLAVLKALSVLHAQGVIHRDIK 143

Query: 242 TANLLMDENGVVKVADFG-VARVQAQSGVMTAETGTYRWMAPEVIEHKPYDYKADVFSFG 300
           + ++L+  +G VK++DFG  A+V  +     +  GT  WMAPE+I   PY  + D++S G
Sbjct: 144 SDSILLTHDGRVKLSDFGFCAQVSKEVPRRKSLVGTPYWMAPELISRLPYGPEVDIWSLG 203

Query: 301 IALWELLTGELPYAGLTPLQAAVGVVQKSLRPTIPKHAH---PRLAELLERCWQHDPTQR 357
           I + E++ GE PY    PL+ A+ +++ +L P + K+ H   P L   L+R    DP QR
Sbjct: 204 IMVIEMVDGEPPYFNEPPLK-AMKMIRDNLPPKL-KNLHKVSPSLKGFLDRLLVRDPAQR 261

Query: 358 PNFSQI 363
              +++
Sbjct: 262 ATAAEL 267

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292

>gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase

 Score =  117 bits (294), Expect = 4e-30
 Identities = 75/256 (29%), Positives = 131/256 (51%), Gaps = 13/256 (5%)

Query: 114 DAKQLKIECKVASGSYGDLYKGTYCS--QEVAIKVLKPECVNTEMLKEFS-QEVYIMRKI 170
             K  + E K+  G+ G +Y     +  QEVAIK +    +  +  KE    E+ +MR+ 
Sbjct: 18  KKKYTRFE-KIGQGASGTVYTAIDVATGQEVAIKQMN---LQQQPKKELIINEILVMREN 73

Query: 171 RHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYL 230
           +H N+V ++ +      L +V E++A GS+ D +   +       +  V  +  + + +L
Sbjct: 74  KHPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVV--TETCMDEGQIAAVCRECLQALEFL 131

Query: 231 HQNNIIHRDLKTANLLMDENGVVKVADFG-VARVQAQSGVMTAETGTYRWMAPEVIEHKP 289
           H N +IHRD+K+ N+L+  +G VK+ DFG  A++  +    +   GT  WMAPEV+  K 
Sbjct: 132 HSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKA 191

Query: 290 YDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKSLRPTI--PKHAHPRLAELLE 347
           Y  K D++S GI   E++ GE PY    PL+ A+ ++  +  P +  P+       + L 
Sbjct: 192 YGPKVDIWSLGIMAIEMVEGEPPYLNENPLR-ALYLIATNGTPELQNPEKLSAIFRDFLN 250

Query: 348 RCWQHDPTQRPNFSQI 363
           RC + D  +R +  ++
Sbjct: 251 RCLEMDVEKRGSAKEL 266

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293

>gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11

 Score =  116 bits (291), Expect = 5e-30
 Identities = 72/254 (28%), Positives = 129/254 (50%), Gaps = 13/254 (5%)

Query: 120 IECKVASGSYGDLY--KGTYCSQEVAIKVLKPECV---NTEMLKEFSQEVYIMRKIRHKN 174
           ++ ++  GS+G +Y  K      E  +KVLK   V   N     + +QE  ++ K+ H  
Sbjct: 4   LQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPA 63

Query: 175 VVQFIGACTRPPNLCIVTEFMARGSIYDF----LHKQKGVFQLTSLLKVAIDVSKGMNYL 230
           +V+F  +       CI+TE+   G   D     L           + +  I +  G++Y+
Sbjct: 64  IVKFHASFLERDAFCIITEY-CEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYM 122

Query: 231 HQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQS-GVMTAETGTYRWMAPEVIEHKP 289
           HQ  I+HRDLK  N+ +  N ++K+ DFGV+R+   S  + T  TGT  +M+PE ++H+ 
Sbjct: 123 HQRRILHRDLKAKNIFLKNN-LLKIGDFGVSRLLMGSCDLATTFTGTPYYMSPEALKHQG 181

Query: 290 YDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRLAELLERC 349
           YD K+D++S G  L+E+      + G   L   + +V+    P++P+    +L  +++  
Sbjct: 182 YDSKSDIWSLGCILYEMCCLAHAFEGQNFLSVVLRIVEGP-TPSLPETYSRQLNSIMQSM 240

Query: 350 WQHDPTQRPNFSQI 363
              DP+ RP+ ++I
Sbjct: 241 LNKDPSLRPSAAEI 254

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260

>gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7

 Score =  116 bits (293), Expect = 6e-30
 Identities = 73/265 (27%), Positives = 128/265 (48%), Gaps = 16/265 (6%)

Query: 111 WEIDAKQLKIECKVASGSYGDLYKGTYCSQEVAIKVLK-PECVNTEMLKEFSQEVYIMRK 169
           +  D   L+   ++ SG+ G +YK  +      + V +     N E  K    ++ ++ K
Sbjct: 10  YPADLNDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEENKRILMDLDVVLK 69

Query: 170 IRH--KNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQ-KGVFQLTSLLKVAIDVSKG 226
             H    +V+  G      ++ I  E M+  +  D L K+ +G      L K+ + + K 
Sbjct: 70  -SHDCPYIVKCYGYFITDSDVFICMELMS--TCLDKLLKRIQGPIPEDILGKMTVAIVKA 126

Query: 227 MNYLHQN-NIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAETGTYRWMAPEVI 285
           ++YL +   +IHRD+K +N+L+D +G VK+ DFG++     S   T   G   +MAPE I
Sbjct: 127 LHYLKEKHGVIHRDVKPSNILLDASGNVKLCDFGISGRLVDSKAKTRSAGCAAYMAPERI 186

Query: 286 EHKP----YDYKADVFSFGIALWELLTGELPYAGL-TPLQAAVGVVQKSLRPTIPKHAH- 339
           +       YD +ADV+S GI+L EL TG+ PY    T  +    ++Q+   P++P +   
Sbjct: 187 DPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTEFEVLTKILQEEP-PSLPPNEGF 245

Query: 340 -PRLAELLERCWQHDPTQRPNFSQI 363
            P     ++ C   D  +RP + ++
Sbjct: 246 SPDFCSFVDLCLTKDHRKRPKYREL 270

Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296

>gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

 Score =  115 bits (289), Expect = 1e-29
 Identities = 75/221 (33%), Positives = 119/221 (53%), Gaps = 14/221 (6%)

Query: 127 GSYGDLY--KGTYCSQEVAIKVL--KPECVNT-EMLKEFSQEVYIMRKIRHKNVVQFIGA 181
           G++G++Y        +E+A+K +   P+   T + +     E+ +++ +RH  +VQ+ G 
Sbjct: 13  GAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYG- 71

Query: 182 CTRPP---NLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHR 238
           C R P    L I  E+M  GSI D L K  G        +    + +G++YLH N I+HR
Sbjct: 72  CLRDPEEKKLSIFVEYMPGGSIKDQL-KAYGALTENVTRRYTRQILQGVSYLHSNMIVHR 130

Query: 239 DLKTANLLMDENGVVKVADFGVA-RVQA--QSGV-MTAETGTYRWMAPEVIEHKPYDYKA 294
           D+K AN+L D  G VK+ DFG + R+Q    SG  + + TGT  WM+PEVI  + Y  KA
Sbjct: 131 DIKGANILRDSAGNVKLGDFGASKRIQTICMSGTGIKSVTGTPYWMSPEVISGEGYGRKA 190

Query: 295 DVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKSLRPTIP 335
           DV+S    + E+LT + P+A    + A   +  +  +P +P
Sbjct: 191 DVWSVACTVVEMLTEKPPWAEYEAMAAIFKIATQPTKPMLP 231

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264

>gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase

 Score =  115 bits (290), Expect = 1e-29
 Identities = 79/268 (29%), Positives = 130/268 (48%), Gaps = 20/268 (7%)

Query: 106 DGTDVWEIDAKQLKIECKVASGSYGDLYKGTYCSQEV--AIKVLKPECVNTEMLKEFSQE 163
           D  +VWEI  +       +  G++G +YK          A KV+  E  + E L+++  E
Sbjct: 9   DPNEVWEIIGE-------LGDGAFGKVYKAKNKETGALAAAKVI--ETKSEEELEDYMVE 59

Query: 164 VYIMRKIRHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDV 223
           + I+    H  +V+ +GA      L I+ EF   G++   + +         +  +   +
Sbjct: 60  IEILATCNHPYIVKLLGAFYWDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVICRQM 119

Query: 224 SKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQS-GVMTAETGTYRWMAP 282
            + + YLH   IIHRDLK  N+L+  +G +K+ADFGV+    ++     +  GT  WMAP
Sbjct: 120 LEALQYLHSMKIIHRDLKAGNVLLTLDGDIKLADFGVSAKNVKTLQRRDSFIGTPYWMAP 179

Query: 283 EVI-----EHKPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKSLRPTI--P 335
           EV+     +  PYDYKAD++S GI L E+   E P+  L P++  + +  KS  PT+  P
Sbjct: 180 EVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIA-KSEPPTLSQP 238

Query: 336 KHAHPRLAELLERCWQHDPTQRPNFSQI 363
                   + L+      P  RP+ +Q+
Sbjct: 239 SKWSMEFRDFLKTALDKHPETRPSAAQL 266

Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292

>gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit

 Score =  117 bits (295), Expect = 1e-29
 Identities = 54/160 (33%), Positives = 91/160 (56%), Gaps = 4/160 (2%)

Query: 216 LLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVAR-VQAQSGVMTAET 274
           LL  +  V+KGM++L   N IHRDL   N+L+    + K+ DFG+AR ++  S  +    
Sbjct: 216 LLSFSYQVAKGMSFLASKNCIHRDLAARNILLTHGRITKICDFGLARDIRNDSNYVVKGN 275

Query: 275 GTY--RWMAPEVIEHKPYDYKADVFSFGIALWELLT-GELPYAGLTPLQAAVGVVQKSLR 331
                +WMAPE I +  Y +++DV+S+GI LWE+ + G  PY G+        ++++  R
Sbjct: 276 ARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPYPGMPVDSKFYKMIKEGYR 335

Query: 332 PTIPKHAHPRLAELLERCWQHDPTQRPNFSQITDILKQMM 371
              P+ A   + ++++ CW  DP +RP F QI  +++Q +
Sbjct: 336 MLSPECAPSEMYDIMKSCWDADPLKRPTFKQIVQLIEQQL 375

Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375

>gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4

 Score =  115 bits (290), Expect = 2e-29
 Identities = 72/259 (27%), Positives = 122/259 (47%), Gaps = 17/259 (6%)

Query: 127 GSYGDLYKGTY--CSQEVAIKVLKPECVNTEMLKEFSQEV-YIMRKIRHKNVVQFIGACT 183
           G++G + K  +      +A+K ++      E  K    ++  +MR      +V+F GA  
Sbjct: 15  GAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQ-KRLLMDLDVVMRSSDCPYIVKFYGALF 73

Query: 184 RPPNLCIVTEFM--ARGSIYDFLH-KQKGVFQLTSLLKVAIDVSKGMNYLHQN-NIIHRD 239
           R  +  I  E M  +    Y +++   K V     L K+A+   K +NYL +   IIHRD
Sbjct: 74  REGDCWICMELMDISLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEELKIIHRD 133

Query: 240 LKTANLLMDENGVVKVADFGVARVQAQSGVMTAETGTYRWMAPEVIE---HKPYDYKADV 296
           +K +N+L+D NG +K+ DFG++     S   T + G   +MAPE I+      YD ++DV
Sbjct: 134 VKPSNILLDRNGNIKLCDFGISGQLVDSIAKTRDAGCRPYMAPERIDPSARDGYDVRSDV 193

Query: 297 FSFGIALWELLTGELPYAGLTPLQAAVGVVQKS----LRPTIPKHAHPRLAELLERCWQH 352
           +S GI L+E+ TG+ PY     +   +  V K     L  +  +   P     +  C   
Sbjct: 194 WSLGITLYEVATGKFPYPKWNSVFDQLTQVVKGDPPILSNSEEREFSPSFVNFINLCLIK 253

Query: 353 DPTQRPNFSQI--TDILKQ 369
           D ++RP + ++     +K 
Sbjct: 254 DESKRPKYKELLEHPFIKD 272

Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288

>gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors

 Score =  116 bits (291), Expect = 2e-29
 Identities = 58/170 (34%), Positives = 94/170 (55%), Gaps = 14/170 (8%)

Query: 213 LTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVAR--------VQ 264
           L  L+  +  V++GM +L     IHRDL   N+L+ EN VVK+ DFG+AR        V+
Sbjct: 172 LEDLISYSFQVARGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVR 231

Query: 265 AQSGVMTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLT-GELPYAGLTPLQAAV 323
                +       +WMAPE I  K Y  ++DV+SFG+ LWE+ + G  PY G+   +   
Sbjct: 232 KGDARL-----PLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQIDEEFC 286

Query: 324 GVVQKSLRPTIPKHAHPRLAELLERCWQHDPTQRPNFSQITDILKQMMKE 373
             +++  R   P++A P +  ++  CW ++P  RP FS++ +IL  +++E
Sbjct: 287 RRLKEGTRMRAPEYATPEIYSIMLDCWHNNPEDRPTFSELVEILGDLLQE 336

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337

>gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6

 Score =  115 bits (288), Expect = 3e-29
 Identities = 78/253 (30%), Positives = 132/253 (52%), Gaps = 20/253 (7%)

Query: 123 KVASGSYGD--LYKGTYCSQEVAIKVLKPECVNTEMLKEF-SQEVYIMRKIRHKNVVQFI 179
           K+  GS G   + +  +  ++VA+K++    +  +  +E    EV IMR  +H+NVV+  
Sbjct: 28  KIGEGSTGIVCIAREKHSGRQVAVKMMD---LRKQQRRELLFNEVVIMRDYQHQNVVEMY 84

Query: 180 GACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRD 239
            +      L ++ EF+  G++ D + + +       +  V   V + + YLH   +IHRD
Sbjct: 85  KSYLVGEELWVLMEFLQGGALTDIVSQTR--LNEEQIATVCESVLQALCYLHSQGVIHRD 142

Query: 240 LKTANLLMDENGVVKVADFG-VARVQAQSGVMTAETGTYRWMAPEVIEHKPYDYKADVFS 298
           +K+ ++L+  +G VK++DFG  A++        +  GT  WMAPEVI   PY  + D++S
Sbjct: 143 IKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKSLVGTPYWMAPEVISRTPYGTEVDIWS 202

Query: 299 FGIALWELLTGELPYAGLTPLQAAVGVVQKSLRPTIP---KHAH---PRLAELLERCWQH 352
            GI + E++ GE PY   +P+QA      K LR + P   K+AH   P L + LER    
Sbjct: 203 LGIMVIEMVDGEPPYFSDSPVQA-----MKRLRDSPPPKLKNAHKISPVLRDFLERMLTR 257

Query: 353 DPTQRPNFSQITD 365
           +P +R    ++ D
Sbjct: 258 EPQERATAQELLD 270

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297

>gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2

 Score =  115 bits (288), Expect = 3e-29
 Identities = 72/241 (29%), Positives = 127/241 (52%), Gaps = 12/241 (4%)

Query: 123 KVASGSYGDLYKGTYCS--QEVAIKVLKPECVNTEMLKEFS-QEVYIMRKIRHKNVVQFI 179
           K+  G+ G ++     +  QEVAIK +    +  +  KE    E+ +M+++++ N+V F+
Sbjct: 26  KIGQGASGTVFTAIDVATGQEVAIKQIN---LQKQPKKELIINEILVMKELKNPNIVNFL 82

Query: 180 GACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRD 239
            +      L +V E++A GS+ D +   +       +  V  +  + + +LH N +IHRD
Sbjct: 83  DSFLVGDELFVVMEYLAGGSLTDVV--TETCMDEAQIAAVCRECLQALEFLHANQVIHRD 140

Query: 240 LKTANLLMDENGVVKVADFG-VARVQAQSGVMTAETGTYRWMAPEVIEHKPYDYKADVFS 298
           +K+ N+L+  +G VK+ DFG  A++  +    +   GT  WMAPEV+  K Y  K D++S
Sbjct: 141 IKSDNVLLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWS 200

Query: 299 FGIALWELLTGELPYAGLTPLQAAVGVVQKSLRPTI--PKHAHPRLAELLERCWQHDPTQ 356
            GI   E++ GE PY    PL+ A+ ++  +  P +  P+   P   + L RC + D  +
Sbjct: 201 LGIMAIEMVEGEPPYLNENPLR-ALYLIATNGTPELQNPEKLSPIFRDFLNRCLEMDVEK 259

Query: 357 R 357
           R
Sbjct: 260 R 260

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296

>gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional

 Score =  116 bits (291), Expect = 3e-29
 Identities = 85/303 (28%), Positives = 145/303 (47%), Gaps = 31/303 (10%)

Query: 79  KRQPALGVPMHSKLLIESSPNCIEIPTDGTDVWEIDAK---QLKIECKVASGSYGDLYKG 135
           +R P+L VP+   L   SS +     +  +      AK   +L+   ++ SG+ G +YK 
Sbjct: 36  QRDPSLAVPL--PLPPPSSSSSSSSSSSASGSAPSAAKSLSELERVNRIGSGAGGTVYKV 93

Query: 136 TY--CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVTE 193
            +    +  A+KV+     +T + ++  +E+ I+R + H NVV+          + ++ E
Sbjct: 94  IHRPTGRLYALKVIYGNHEDT-VRRQICREIEILRDVNHPNVVKCHDMFDHNGEIQVLLE 152

Query: 194 FMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVV 253
           FM  GS+     +   +     L  VA  +  G+ YLH+ +I+HRD+K +NLL++    V
Sbjct: 153 FMDGGSL-----EGTHIADEQFLADVARQILSGIAYLHRRHIVHRDIKPSNLLINSAKNV 207

Query: 254 KVADFGVARVQAQSGVM---TAETGTYRWMAPEVI----EHKPYD-YKADVFSFGIALWE 305
           K+ADFGV+R+ AQ+  M    +  GT  +M+PE I     H  YD Y  D++S G+++ E
Sbjct: 208 KIADFGVSRILAQT--MDPCNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILE 265

Query: 306 LLTGELPYA-----GLTPLQAAVGVVQKSLRPTIPKHAHPRLAELLERCWQHDPTQRPNF 360
              G  P+          L  A+ + Q    P  P  A       +  C Q +P +R + 
Sbjct: 266 FYLGRFPFGVGRQGDWASLMCAICMSQP---PEAPATASREFRHFISCCLQREPAKRWSA 322

Query: 361 SQI 363
            Q+
Sbjct: 323 MQL 325

Length = 353

>gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6

 Score =  113 bits (284), Expect = 6e-29
 Identities = 70/263 (26%), Positives = 137/263 (52%), Gaps = 11/263 (4%)

Query: 118 LKIECKVASGSYGDLYKGTYC---SQEVAIKVLKP-ECVNTEMLKEFSQEVYIMRKIRHK 173
            +IE K+  G + ++Y+ T C    + VA+K ++  E ++ +  ++  +E+ +++++ H 
Sbjct: 4   FQIEKKIGRGQFSEVYRAT-CLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHP 62

Query: 174 NVVQFIGACTRPPNLCIVTEFMARGSIYD---FLHKQKGVFQLTSLLKVAIDVSKGMNYL 230
           NV++++ +      L IV E    G +     +  KQK +    ++ K  + +   + ++
Sbjct: 63  NVIKYLDSFIEDNELNIVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHM 122

Query: 231 HQNNIIHRDLKTANLLMDENGVVKVADFGVAR-VQAQSGVMTAETGTYRWMAPEVIEHKP 289
           H   ++HRD+K AN+ +   GVVK+ D G+ R   +++    +  GT  +M+PE I    
Sbjct: 123 HSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPERIHENG 182

Query: 290 YDYKADVFSFGIALWELLTGELP-YAGLTPLQAAVGVVQKSLRPTIPK-HAHPRLAELLE 347
           Y++K+D++S G  L+E+   + P Y     L +    +++   P +P  H   +L EL+ 
Sbjct: 183 YNFKSDIWSLGCLLYEMAALQSPFYGDKMNLFSLCQKIEQCDYPPLPTEHYSEKLRELVS 242

Query: 348 RCWQHDPTQRPNFSQITDILKQM 370
            C   DP QRP+   +  I KQM
Sbjct: 243 MCIYPDPDQRPDIGYVHQIAKQM 265

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267

>gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases

 Score =  113 bits (285), Expect = 7e-29
 Identities = 66/273 (24%), Positives = 113/273 (41%), Gaps = 35/273 (12%)

Query: 123 KVASGSYGDLYKG--TYCSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIG 180
           K+  G+YG +YK       + VAIK +K    +  + K   +E+ +++++ H N+++ + 
Sbjct: 6   KIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLD 65

Query: 181 ACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDL 240
                 +L +V EFM    +Y  +  ++     + +      + +G+ + H + I+HRDL
Sbjct: 66  VFRHKGDLYLVFEFM-DTDLYKLIKDRQRGLPESLIKSYLYQLLQGLAFCHSHGILHRDL 124

Query: 241 KTANLLMDENGVVKVADFGVARVQA-QSGVMTAETGTYRWM-APEVI-EHKPYDYKADVF 297
           K  NLL++  GV+K+ADFG+AR         T    T RW  APE++   K Y    D++
Sbjct: 125 KPENLLINTEGVLKLADFGLARSFGSPVRPYTHYVVT-RWYRAPELLLGDKGYSTPVDIW 183

Query: 298 SFGIALWELLTGELPYAG------------------------LTPLQAAVGVVQKSLRPT 333
           S G    ELL+    + G                         T L              
Sbjct: 184 SVGCIFAELLSRRPLFPGKSEIDQLFKIFRTLGTPDPEVWPKFTSLARNYKFSFPKKAGM 243

Query: 334 IPKHAHPRLAE----LLERCWQHDPTQRPNFSQ 362
                 P  +     LL +   +DP +R    Q
Sbjct: 244 PLPKLFPNASPQALDLLSQMLHYDPHKRITAEQ 276

Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283

>gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases

 Score =  113 bits (284), Expect = 1e-28
 Identities = 84/287 (29%), Positives = 133/287 (46%), Gaps = 66/287 (22%)

Query: 122 CKVASGSYGDLYKGTYC-----SQEVAIKVLKPECVNTEMLKEFSQ-EVYIMRKIRHKNV 175
             V  G+YG + K   C      + VAIK  K E  + E +K+ +  EV ++R++RH+N+
Sbjct: 7   GVVGEGAYGVVLK---CRNKATGEIVAIKKFK-ESEDDEDVKKTALREVKVLRQLRHENI 62

Query: 176 VQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKG----------VFQLTSLLKVAIDVSK 225
           V    A  R   L +V E++ R ++ + L    G          ++QL           +
Sbjct: 63  VNLKEAFRRKGRLYLVFEYVER-TLLELLEASPGGLPPDAVRSYIWQLL----------Q 111

Query: 226 GMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVAR-VQAQSGVMTAETGTYRWM-APE 283
            + Y H +NIIHRD+K  N+L+ E+GV+K+ DFG AR ++A+      +    RW  APE
Sbjct: 112 AIAYCHSHNIIHRDIKPENILVSESGVLKLCDFGFARALRARPASPLTDYVATRWYRAPE 171

Query: 284 V-IEHKPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKSLRPTIPKH----- 337
           + +    Y    DV++ G  + ELL GE  + G + +   + ++QK L P  P H     
Sbjct: 172 LLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGDSDID-QLYLIQKCLGPLPPSHQELFS 230

Query: 338 AHPRLA----------ELLER----------------CWQHDPTQRP 358
           ++PR A          E LER                C + DP +R 
Sbjct: 231 SNPRFAGVAFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERL 277

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288

>gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases

 Score =  112 bits (283), Expect = 2e-28
 Identities = 65/215 (30%), Positives = 104/215 (48%), Gaps = 36/215 (16%)

Query: 122 CKVASGSYGDLYKG--TYCSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFI 179
            ++  G+YG +YK       + VA+K ++ E           +E+ +++K+RH N+V+  
Sbjct: 5   AQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLK 64

Query: 180 GACTRPPNLCIVTEFMARGSIY--------DF--LHKQKGV-F---QLTSLLKVAIDVSK 225
                     IVT    +GSIY        D   L     V F   Q+   +K  +   +
Sbjct: 65  ---------EIVTS-KGKGSIYMVFEYMDHDLTGLLDSPEVKFTESQIKCYMKQLL---E 111

Query: 226 GMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQA--QSGVMTAETGT--YRWMA 281
           G+ YLH N I+HRD+K +N+L++ +GV+K+ADFG+AR      S   T    T  YR   
Sbjct: 112 GLQYLHSNGILHRDIKGSNILINNDGVLKLADFGLARPYTKRNSADYTNRVITLWYR--P 169

Query: 282 PEVIEH-KPYDYKADVFSFGIALWELLTGELPYAG 315
           PE++     Y  + D++S G  L EL  G+  + G
Sbjct: 170 PELLLGATRYGPEVDMWSVGCILAELFLGKPIFQG 204

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287

>gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5

 Score =  112 bits (280), Expect = 3e-28
 Identities = 72/227 (31%), Positives = 119/227 (52%), Gaps = 18/227 (7%)

Query: 123 KVASGSYGDLYKGT--YCSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIG 180
           K+  GS G +   T  +  ++VA+K  K +    +  +    EV IMR   H+NVV    
Sbjct: 29  KIGEGSTGIVCIATEKHTGKQVAVK--KMDLRKQQRRELLFNEVVIMRDYHHENVVDMYN 86

Query: 181 ACTRPPNLCIVTEFMARGSIYDFL-HKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRD 239
           +      L +V EF+  G++ D + H +    Q+ +   V + V + ++YLH   +IHRD
Sbjct: 87  SYLVGDELWVVMEFLEGGALTDIVTHTRMNEEQIAT---VCLSVLRALSYLHNQGVIHRD 143

Query: 240 LKTANLLMDENGVVKVADFG-VARVQAQSGVMTAETGTYRWMAPEVIEHKPYDYKADVFS 298
           +K+ ++L+  +G +K++DFG  A+V  +     +  GT  WMAPEVI   PY  + D++S
Sbjct: 144 IKSDSILLTSDGRIKLSDFGFCAQVSKEVPKRKSLVGTPYWMAPEVISRLPYGTEVDIWS 203

Query: 299 FGIALWELLTGELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRLAEL 345
            GI + E++ GE PY    PLQA      + +R  +P    PR+ + 
Sbjct: 204 LGIMVIEMIDGEPPYFNEPPLQA-----MRRIRDNLP----PRVKDS 241

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292

>gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3

 Score =  112 bits (282), Expect = 3e-28
 Identities = 60/170 (35%), Positives = 94/170 (55%), Gaps = 14/170 (8%)

Query: 213 LTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVAR--------VQ 264
           +  L+  +  V++GM +L     IHRDL   N+L+ EN VVK+ DFG+AR        V+
Sbjct: 173 MEDLICYSFQVARGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVR 232

Query: 265 AQSGVMTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLT-GELPYAGLTPLQAAV 323
             S  +       +WMAPE I  K Y  ++DV+SFG+ LWE+ + G  PY G+   +   
Sbjct: 233 KGSARL-----PLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQINEEFC 287

Query: 324 GVVQKSLRPTIPKHAHPRLAELLERCWQHDPTQRPNFSQITDILKQMMKE 373
             ++   R   P++A P +  ++  CWQ DP +RP FS + +IL  +++E
Sbjct: 288 QRLKDGTRMRAPENATPEIYRIMLACWQGDPKERPTFSALVEILGDLLQE 337

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338

>gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7

 Score =  110 bits (277), Expect = 5e-28
 Identities = 64/262 (24%), Positives = 133/262 (50%), Gaps = 9/262 (3%)

Query: 118 LKIECKVASGSYGDLYKGTYCSQEVAIKVLKPEC---VNTEMLKEFSQEVYIMRKIRHKN 174
            +IE K+  G + ++Y+ T     V + + K +    ++ +   +  +E+ +++++ H N
Sbjct: 4   FRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPN 63

Query: 175 VVQFIGACTRPPNLCIVTEFMARGSIYDFLH---KQKGVFQLTSLLKVAIDVSKGMNYLH 231
           V+++  +      L IV E    G +   +    KQK +    ++ K  + +   + ++H
Sbjct: 64  VIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMH 123

Query: 232 QNNIIHRDLKTANLLMDENGVVKVADFGVAR-VQAQSGVMTAETGTYRWMAPEVIEHKPY 290
              ++HRD+K AN+ +   GVVK+ D G+ R   +++    +  GT  +M+PE I    Y
Sbjct: 124 SRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPERIHENGY 183

Query: 291 DYKADVFSFGIALWELLTGELPYAG-LTPLQAAVGVVQKSLRPTIPK-HAHPRLAELLER 348
           ++K+D++S G  L+E+   + P+ G    L +    +++   P +P  H    L +L+  
Sbjct: 184 NFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQCDYPPLPSDHYSEELRQLVNM 243

Query: 349 CWQHDPTQRPNFSQITDILKQM 370
           C   DP +RP+ + + D+ K+M
Sbjct: 244 CINPDPEKRPDITYVYDVAKRM 265

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267

>gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3

 Score =  111 bits (278), Expect = 6e-28
 Identities = 72/241 (29%), Positives = 125/241 (51%), Gaps = 12/241 (4%)

Query: 123 KVASGSYGDLYKG--TYCSQEVAIKVLKPECVNTEMLKEFS-QEVYIMRKIRHKNVVQFI 179
           K+  G+ G +Y        QEVAIK +    +  +  KE    E+ +MR+ ++ N+V ++
Sbjct: 26  KIGQGASGTVYTAIDIATGQEVAIKQMN---LQQQPKKELIINEILVMRENKNPNIVNYL 82

Query: 180 GACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRD 239
            +      L +V E++A GS+ D +   +       +  V  +  + +++LH N +IHRD
Sbjct: 83  DSYLVGDELWVVMEYLAGGSLTDVV--TETCMDEGQIAAVCRECLQALDFLHSNQVIHRD 140

Query: 240 LKTANLLMDENGVVKVADFG-VARVQAQSGVMTAETGTYRWMAPEVIEHKPYDYKADVFS 298
           +K+ N+L+  +G VK+ DFG  A++  +    +   GT  WMAPEV+  K Y  K D++S
Sbjct: 141 IKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWS 200

Query: 299 FGIALWELLTGELPYAGLTPLQAAVGVVQKSLRPTI--PKHAHPRLAELLERCWQHDPTQ 356
            GI   E++ GE PY    PL+ A+ ++  +  P +  P+       + L RC + D  +
Sbjct: 201 LGIMAIEMVEGEPPYLNENPLR-ALYLIATNGTPELQNPERLSAVFRDFLNRCLEMDVDR 259

Query: 357 R 357
           R
Sbjct: 260 R 260

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297

>gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2

 Score =  111 bits (279), Expect = 1e-27
 Identities = 58/169 (34%), Positives = 93/169 (55%), Gaps = 4/169 (2%)

Query: 208 KGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVAR--VQA 265
           K V  L  L+  +  V+KGM +L     IHRDL   N+L+ EN VVK+ DFG+AR   + 
Sbjct: 173 KKVLTLEDLICYSFQVAKGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKD 232

Query: 266 QSGVMTAETG-TYRWMAPEVIEHKPYDYKADVFSFGIALWELLT-GELPYAGLTPLQAAV 323
              V   +     +WMAPE I  + Y  ++DV+SFG+ LWE+ + G  PY G+   +   
Sbjct: 233 PDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFC 292

Query: 324 GVVQKSLRPTIPKHAHPRLAELLERCWQHDPTQRPNFSQITDILKQMMK 372
             +++  R   P +  P + + +  CW  +P+QRP FS++ + L  +++
Sbjct: 293 RRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQ 341

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343

>gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins

 Score =  110 bits (277), Expect = 1e-27
 Identities = 76/245 (31%), Positives = 116/245 (47%), Gaps = 16/245 (6%)

Query: 123 KVASGSYGDLY--KGTYCSQEVAIKVLKPEC-VNTEMLKEFSQEVYIMRKIRHKNVVQFI 179
           ++  GS+G +Y  +    ++ VAIK +      + E  ++  +EV  ++++RH N +++ 
Sbjct: 22  EIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYK 81

Query: 180 GACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRD 239
           G   R     +V E+   GS  D L   K   Q   +  +     +G+ YLH +  IHRD
Sbjct: 82  GCYLREHTAWLVMEYCL-GSASDILEVHKKPLQEVEIAAICHGALQGLAYLHSHERIHRD 140

Query: 240 LKTANLLMDENGVVKVADFGVARVQ--AQSGVMTAETGTYRWMAPEVI---EHKPYDYKA 294
           +K  N+L+ E G VK+ADFG A +   A S V     GT  WMAPEVI   +   YD K 
Sbjct: 141 IKAGNILLTEPGTVKLADFGSASLVSPANSFV-----GTPYWMAPEVILAMDEGQYDGKV 195

Query: 295 DVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKSLRPTIPK-HAHPRLAELLERCWQHD 353
           DV+S GI   EL   + P   +  + A   + Q    PT+            ++ C Q  
Sbjct: 196 DVWSLGITCIELAERKPPLFNMNAMSALYHIAQND-SPTLSSNDWSDYFRNFVDSCLQKI 254

Query: 354 PTQRP 358
           P  RP
Sbjct: 255 PQDRP 259

Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307

>gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta

 Score =  112 bits (280), Expect = 2e-27
 Identities = 54/160 (33%), Positives = 89/160 (55%), Gaps = 4/160 (2%)

Query: 216 LLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAETG 275
           L+  +  V+ GM +L   N +HRDL   N+L+ E  +VK+ DFG+AR   +     ++  
Sbjct: 241 LVGFSYQVANGMEFLASKNCVHRDLAARNVLICEGKLVKICDFGLARDIMRDSNYISKGS 300

Query: 276 TY---RWMAPEVIEHKPYDYKADVFSFGIALWELLT-GELPYAGLTPLQAAVGVVQKSLR 331
           T+   +WMAPE I +  Y   +DV+SFGI LWE+ T G  PY  L   +     +++  R
Sbjct: 301 TFLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFTLGGTPYPELPMNEQFYNAIKRGYR 360

Query: 332 PTIPKHAHPRLAELLERCWQHDPTQRPNFSQITDILKQMM 371
              P HA   + E++++CW+     RP+FSQ+  ++  ++
Sbjct: 361 MAKPAHASDEIYEIMQKCWEEKFEIRPDFSQLVHLVGDLL 400

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401

>gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase

 Score =  108 bits (273), Expect = 2e-27
 Identities = 64/197 (32%), Positives = 100/197 (50%), Gaps = 8/197 (4%)

Query: 124 VASGSYGDLYKGTYCSQEV--AIKVL-KPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIG 180
           +  G +G +      S+    A+K + K   V T   +    E  I+ +  H  +V+   
Sbjct: 1   LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYR 60

Query: 181 ACTRPPNLCIVTEFMARGSIYDFLHKQKGVF-QLTSLLKVAIDVSKGMNYLHQNNIIHRD 239
                  + ++ E+   G ++  L   +G+F + T+   +A  V     YLH   II+RD
Sbjct: 61  TFKDKKYIYMLMEYCLGGELWTILRD-RGLFDEYTARFYIACVVL-AFEYLHNRGIIYRD 118

Query: 240 LKTANLLMDENGVVKVADFGVARVQAQSGVMTAE-TGTYRWMAPEVIEHKPYDYKADVFS 298
           LK  NLL+D NG VK+ DFG A+ + +SG  T    GT  ++APE+I +K YD+  D +S
Sbjct: 119 LKPENLLLDSNGYVKLVDFGFAK-KLKSGQKTWTFCGTPEYVAPEIILNKGYDFSVDYWS 177

Query: 299 FGIALWELLTGELPYAG 315
            GI L+ELLTG  P+  
Sbjct: 178 LGILLYELLTGRPPFGE 194

Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262

>gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5

 Score =  108 bits (272), Expect = 3e-27
 Identities = 76/249 (30%), Positives = 121/249 (48%), Gaps = 18/249 (7%)

Query: 127 GSYGDLYKGTYCSQE--VAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTR 184
           G+ G +YK  +      +A+KV+ P  +  E+ K+   E+ I+ K     ++ F GA   
Sbjct: 12  GNGGTVYKAYHLLTRRILAVKVI-PLDITVELQKQIMSELEILYKCDSPYIIGFYGAFFV 70

Query: 185 PPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTAN 244
              + I TEFM  GS+  +    + V     L ++A+ V KG+ YL    I+HRD+K +N
Sbjct: 71  ENRISICTEFMDGGSLDVYRKIPEHV-----LGRIAVAVVKGLTYLWSLKILHRDVKPSN 125

Query: 245 LLMDENGVVKVADFGVARVQAQSGVMTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALW 304
           +L++  G VK+ DFGV+  Q  + +     GT  +MAPE I  + Y   +DV+S GI+  
Sbjct: 126 MLVNTRGQVKLCDFGVST-QLVNSIAKTYVGTNAYMAPERISGEQYGIHSDVWSLGISFM 184

Query: 305 ELLTGELPY-------AGLTPLQAAVGVVQKSLRPTIPKHA-HPRLAELLERCWQHDPTQ 356
           EL  G  PY         L PLQ    +V +   P +P      +    + +C +  P +
Sbjct: 185 ELALGRFPYPQIQKNQGSLMPLQLLQCIVDED-PPVLPVGQFSEKFVHFITQCMRKQPKE 243

Query: 357 RPNFSQITD 365
           RP    + D
Sbjct: 244 RPAPENLMD 252

Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279

>gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5

 Score =  108 bits (271), Expect = 3e-27
 Identities = 73/245 (29%), Positives = 126/245 (51%), Gaps = 12/245 (4%)

Query: 123 KVASGSYGDLYKG--TYCSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIG 180
           +V SG+YGD+YK    +  +  A+K++K E  +   L    QE++++++ +H N+V + G
Sbjct: 16  RVGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSL--IQQEIFMVKECKHCNIVAYFG 73

Query: 181 ACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDL 240
           +      L I  E+   GS+ D  H    + +L  +  V  +  +G+ YLH    +HRD+
Sbjct: 74  SYLSREKLWICMEYCGGGSLQDIYHVTGPLSEL-QIAYVCRETLQGLAYLHSKGKMHRDI 132

Query: 241 KTANLLMDENGVVKVADFGV-ARVQAQSGVMTAETGTYRWMAPEVI---EHKPYDYKADV 296
           K AN+L+ +NG VK+ADFGV A++ A      +  GT  WMAPEV    ++  Y+   D+
Sbjct: 133 KGANILLTDNGDVKLADFGVAAKITATIAKRKSFIGTPYWMAPEVAAVEKNGGYNQLCDI 192

Query: 297 FSFGIALWELLTGELPYAGLTPLQAAVGVVQKSLRPTIPKHA---HPRLAELLERCWQHD 353
           ++ GI   EL   + P   L P++A   + + + +P   K            ++     +
Sbjct: 193 WAVGITAIELAELQPPMFDLHPMRALFLMSKSNFQPPKLKDKTKWSSTFHNFVKISLTKN 252

Query: 354 PTQRP 358
           P +RP
Sbjct: 253 PKKRP 257

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267

>gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha

 Score =  111 bits (278), Expect = 3e-27
 Identities = 52/163 (31%), Positives = 88/163 (53%), Gaps = 4/163 (2%)

Query: 213 LTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTA 272
              LL     V++GM +L   N +HRDL   N+L+ +  +VK+ DFG+AR         +
Sbjct: 236 TLDLLSFTYQVARGMEFLASKNCVHRDLAARNVLLAQGKIVKICDFGLARDIMHDSNYVS 295

Query: 273 ETGTY---RWMAPEVIEHKPYDYKADVFSFGIALWELLT-GELPYAGLTPLQAAVGVVQK 328
           +  T+   +WMAPE I    Y   +DV+S+GI LWE+ + G  PY G+         ++ 
Sbjct: 296 KGSTFLPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFSLGGTPYPGMIVDSTFYNKIKS 355

Query: 329 SLRPTIPKHAHPRLAELLERCWQHDPTQRPNFSQITDILKQMM 371
             R   P HA   + +++ +CW  +P +RP+F  ++DI++ ++
Sbjct: 356 GYRMAKPDHATQEVYDIMVKCWNSEPEKRPSFLHLSDIVESLL 398

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400

>gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1

 Score =  109 bits (272), Expect = 4e-27
 Identities = 77/276 (27%), Positives = 135/276 (48%), Gaps = 20/276 (7%)

Query: 123 KVASGSYGDLYKG--TYCSQEVAIKVLKPECVNTEMLKEFS-QEVYIMRKIRHKNVVQFI 179
           K+  G+ G +Y        QEVAI+ +    +  +  KE    E+ +MR+ ++ N+V ++
Sbjct: 27  KIGQGASGTVYTAMDVATGQEVAIRQMN---LQQQPKKELIINEILVMRENKNPNIVNYL 83

Query: 180 GACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRD 239
            +      L +V E++A GS+ D +   +       +  V  +  + + +LH N +IHRD
Sbjct: 84  DSYLVGDELWVVMEYLAGGSLTDVV--TETCMDEGQIAAVCRECLQALEFLHSNQVIHRD 141

Query: 240 LKTANLLMDENGVVKVADFG-VARVQAQSGVMTAETGTYRWMAPEVIEHKPYDYKADVFS 298
           +K+ N+L+  +G VK+ DFG  A++  +    +   GT  WMAPEV+  K Y  K D++S
Sbjct: 142 IKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWS 201

Query: 299 FGIALWELLTGELPYAGLTPLQAAVGVVQKSLRPTI--PKHAHPRLAELLERCWQHDPTQ 356
            GI   E++ GE PY    PL+ A+ ++  +  P +  P+       + L RC   D  +
Sbjct: 202 LGIMAIEMIEGEPPYLNENPLR-ALYLIATNGTPELQNPEKLSAIFRDFLNRCLDMDVEK 260

Query: 357 RPN--------FSQITDILKQMMKEVASEGENNHSN 384
           R +        F +I   L  +   +A+  E   +N
Sbjct: 261 RGSAKELLQHQFLKIAKPLSSLTPLIAAAKEATKNN 296

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296

>gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1

 Score =  107 bits (270), Expect = 5e-27
 Identities = 56/221 (25%), Positives = 101/221 (45%), Gaps = 4/221 (1%)

Query: 148 KPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQ 207
           K +CV    ++    E  I++++ H  +V    +     N+ +V + +  G +   L  Q
Sbjct: 35  KQKCVEKGSVRNVLNERRILQELNHPFLVNLWYSFQDEENMYLVVDLLLGGDLRYHL-SQ 93

Query: 208 KGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQS 267
           K  F    +     ++   + YLH   IIHRD+K  N+L+DE G V + DF +A      
Sbjct: 94  KVKFSEEQVKFWICEIVLALEYLHSKGIIHRDIKPDNILLDEQGHVHITDFNIATKVTPD 153

Query: 268 GVMTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPYAG-LTPLQAAVGVV 326
            + T+ +GT  +MAPEV+  + Y    D +S G+  +E L G+ PY G    ++  +   
Sbjct: 154 TLTTSTSGTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRPYRGHSRTIRDQIRAK 213

Query: 327 QKSLRPTIPKHAHPRLAELLERCWQHDPTQR--PNFSQITD 365
           Q++     P        + + +  + DP +R   N   + +
Sbjct: 214 QETADVLYPATWSTEAIDAINKLLERDPQKRLGDNLKDLKN 254

Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258

>gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7

 Score =  108 bits (272), Expect = 6e-27
 Identities = 63/208 (30%), Positives = 103/208 (49%), Gaps = 32/208 (15%)

Query: 119 KIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVNTEMLKE---FS--QEVYIMRKIR 171
           +   K+  G+Y  +YK       + VAIK +K      +  K+   F+  +E+ ++++++
Sbjct: 3   EKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLG--ERKEAKDGINFTALREIKLLQELK 60

Query: 172 HKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVS------- 224
           H N++  +       N+ +V EFM      D     + V +  S++    D+        
Sbjct: 61  HPNIIGLLDVFGHKSNINLVFEFME----TDL----EKVIKDKSIVLTPADIKSYMLMTL 112

Query: 225 KGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSG-VMTAETGTYRWM-AP 282
           +G+ YLH N I+HRDLK  NLL+  +GV+K+ADFG+AR        MT +  T RW  AP
Sbjct: 113 RGLEYLHSNWILHRDLKPNNLLIASDGVLKLADFGLARSFGSPNRKMTHQVVT-RWYRAP 171

Query: 283 EVI---EHKPYDYKADVFSFGIALWELL 307
           E++    H  Y    D++S G    ELL
Sbjct: 172 ELLFGARH--YGVGVDMWSVGCIFAELL 197

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298

>gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases

 Score =  108 bits (270), Expect = 6e-27
 Identities = 76/257 (29%), Positives = 129/257 (50%), Gaps = 22/257 (8%)

Query: 130 GDLYKGTYCSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLC 189
           G+ ++G   ++ V +K L+      E L  F QEV   R++ H NV+Q +G C       
Sbjct: 14  GEAHRGMSKAR-VVVKELRASATPDEQL-LFLQEVQPYRELNHPNVLQCLGQCIESIPYL 71

Query: 190 IVTEFMARGSIYDFLHKQKGVF----QLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANL 245
           +V EF   G + ++L   +G+     Q   L ++A +V+ G+ +LHQ + IH DL   N 
Sbjct: 72  LVLEFCPLGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQADFIHSDLALRNC 131

Query: 246 LMDENGVVKVADFGVARVQ-AQSGVMTAETGTY--RWMAPEVIEH-----KPYDY--KAD 295
            +  +  VK+ D+G+A  Q  +   +T +      RW+APE++E       P D   K++
Sbjct: 132 QLTADLSVKIGDYGLALEQYPEDYYITKDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSN 191

Query: 296 VFSFGIALWELLT-GELPYAGLTPLQAAVGVVQ----KSLRPTIPKHAHPRLAELLERCW 350
           ++S G+ +WEL T  + PY  L+  Q    VV+    K  +P +      R  E+++ CW
Sbjct: 192 IWSLGVTMWELFTAADQPYPDLSDEQVLKQVVREQDIKLPKPQLDLKYSDRWYEVMQFCW 251

Query: 351 QHDPTQRPNFSQITDIL 367
             DP  RP   ++ ++L
Sbjct: 252 L-DPETRPTAEEVHELL 267

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269

>gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3

 Score =  108 bits (271), Expect = 6e-27
 Identities = 80/279 (28%), Positives = 134/279 (48%), Gaps = 44/279 (15%)

Query: 123 KVASGSYGDLYKGTYC-----SQEVAIKVLKPECVNTEMLKEFS-QEVYIMRKIRHKNVV 176
            V  GSYG + K   C      Q VAIK    E  + +M+K+ + +E+ +++++RH+N+V
Sbjct: 8   LVGEGSYGMVMK---CKHKETGQIVAIKKFL-ESEDDKMVKKIAMREIRMLKQLRHENLV 63

Query: 177 QFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNII 236
             I    R   L +V EF+   ++ D L K       + + K    + +G+ + H +NII
Sbjct: 64  NLIEVFRRKKRLYLVFEFVDH-TVLDDLEKYPNGLDESRVRKYLFQILRGIEFCHSHNII 122

Query: 237 HRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAETGTYRWM-APEVIEHKP-YDYKA 294
           HRD+K  N+L+ ++GVVK+ DFG AR  A  G +  +    RW  APE++     Y    
Sbjct: 123 HRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYTDYVATRWYRAPELLVGDTKYGRAV 182

Query: 295 DVFSFGIALWELLTGELPYAG--------------------------LTPLQAAVGVVQ- 327
           D+++ G  + E+LTGE  + G                            PL A + + + 
Sbjct: 183 DIWAVGCLVTEMLTGEPLFPGDSDIDQLYHIIKCLGNLIPRHQEIFQKNPLFAGMRLPEV 242

Query: 328 ---KSLRPTIPKHAHPRLAELLERCWQHDPTQRPNFSQI 363
              + L    PK +   + +L ++C + DP  RP+ SQ+
Sbjct: 243 KEIEPLEKRFPKLS-GLVLDLAKQCLRIDPDDRPSSSQL 280

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286

>gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2

 Score =  108 bits (271), Expect = 7e-27
 Identities = 77/242 (31%), Positives = 115/242 (47%), Gaps = 10/242 (4%)

Query: 123 KVASGSYGDLY--KGTYCSQEVAIKVLKPECVNT-EMLKEFSQEVYIMRKIRHKNVVQFI 179
           ++  GS+G +Y  +    S+ VAIK +      + E  ++  +EV  ++K+RH N +Q+ 
Sbjct: 22  EIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYR 81

Query: 180 GACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRD 239
           G   R     +V E+   GS  D L   K   Q   +  V     +G+ YLH +N+IHRD
Sbjct: 82  GCYLREHTAWLVMEY-CLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRD 140

Query: 240 LKTANLLMDENGVVKVADFGVARVQAQSGVMTAETGTYRWMAPEVI---EHKPYDYKADV 296
           +K  N+L+ E G+VK+ DFG A + A +       GT  WMAPEVI   +   YD K DV
Sbjct: 141 VKAGNILLSEPGLVKLGDFGSASIMAPANXF---VGTPYWMAPEVILAMDEGQYDGKVDV 197

Query: 297 FSFGIALWELLTGELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRLAELLERCWQHDPTQ 356
           +S GI   EL   + P   +  + A   + Q         H        ++ C Q  P  
Sbjct: 198 WSLGITCIELAERKPPLFNMNAMSALYHIAQNESPALQSGHWSEYFRNFVDSCLQKIPQD 257

Query: 357 RP 358
           RP
Sbjct: 258 RP 259

Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308

>gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3

 Score =  106 bits (266), Expect = 1e-26
 Identities = 60/204 (29%), Positives = 114/204 (55%), Gaps = 3/204 (1%)

Query: 162 QEVYIMRKIRHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKG-VFQLTSLLKVA 220
           +E  ++ K++H N+V F  +     +L IV E+   G +   +  Q+G +F   ++L+  
Sbjct: 47  KEAVLLAKMKHPNIVAFKESFEADGHLYIVMEYCDGGDLMQKIKLQRGKLFPEDTILQWF 106

Query: 221 IDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAE-TGTYRW 279
           + +  G+ ++H+  ++HRD+K+ N+ + +NG VK+ DFG AR+    G       GT  +
Sbjct: 107 VQMCLGVQHIHEKRVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGAYACTYVGTPYY 166

Query: 280 MAPEVIEHKPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKSLRPTIPKHAH 339
           + PE+ E+ PY+ K+D++S G  L+EL T + P+   +     + V Q S +P +P H  
Sbjct: 167 VPPEIWENMPYNNKSDIWSLGCILYELCTLKHPFQANSWKNLILKVCQGSYKP-LPSHYS 225

Query: 340 PRLAELLERCWQHDPTQRPNFSQI 363
             L  L+++ ++ +P  RP+ + I
Sbjct: 226 YELRSLIKQMFKRNPRSRPSATTI 249

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255

>gnl|CDD|173627 cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases

 Score =  106 bits (267), Expect = 1e-26
 Identities = 67/235 (28%), Positives = 116/235 (49%), Gaps = 24/235 (10%)

Query: 141 EVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVTEFMARGSI 200
            V +KVL  +  ++     F +   +M ++ HK++V+  G C R  N+ +V E++  G +
Sbjct: 32  SVVLKVLGSDHRDSL---AFFETASLMSQLSHKHLVKLYGVCVRDENI-MVEEYVKFGPL 87

Query: 201 YDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGV-------V 253
             FLH++K    L   L VA  ++  ++YL    ++H ++   N+L+   G+       +
Sbjct: 88  DVFLHREKNNVSLHWKLDVAKQLASALHYLEDKKLVHGNVCGKNILVARYGLNEGYVPFI 147

Query: 254 KVADFGVARVQAQSGVMTAETGTYR--WMAPEVIE--HKPYDYKADVFSFGIALWELLT- 308
           K++D G+        V++ E    R  W+APE I          AD +SFG  L E+ + 
Sbjct: 148 KLSDPGIPI-----TVLSREERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSN 202

Query: 309 GELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRLAELLERCWQHDPTQRPNFSQI 363
           GE P + L+  +       +   P +P  A   LA L+ +CW +DPT+RP+F  I
Sbjct: 203 GEEPLSTLSSSEKERFYQDQHRLP-MPDCA--ELANLINQCWTYDPTKRPSFRAI 254

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 259

>gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2

 Score =  105 bits (264), Expect = 4e-26
 Identities = 70/283 (24%), Positives = 133/283 (46%), Gaps = 28/283 (9%)

Query: 112 EIDAKQLKIECKVASGSYGDLYKGTYC-------SQEVAIKVLKPECVNTEMLKEFSQEV 164
           EI+   ++   ++    +G +YKG          +Q VAIK LK +     + +EF  E 
Sbjct: 1   EINLSTVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDK-AEGPLREEFKHEA 59

Query: 165 YIMRKIRHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFL-----HKQ----------KG 209
            +  +++H N+V  +G  T+   L ++  + +   +++FL     H            K 
Sbjct: 60  MMRSRLQHPNIVCLLGVVTKEQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKS 119

Query: 210 VFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVAR-VQAQS- 267
             +    + +   ++ GM +L  ++++H+DL T N+L+ +   VK++D G+ R V A   
Sbjct: 120 TLEPADFVHIVTQIAAGMEFLSSHHVVHKDLATRNVLVFDKLNVKISDLGLFREVYAADY 179

Query: 268 -GVMTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLT-GELPYAGLTPLQAAVGV 325
             +M       RWM+PE I +  +   +D++S+G+ LWE+ + G  PY G +  Q  + +
Sbjct: 180 YKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSN-QDVIEM 238

Query: 326 VQKSLRPTIPKHAHPRLAELLERCWQHDPTQRPNFSQITDILK 368
           ++       P      +  L+  CW   P++RP F  I   L+
Sbjct: 239 IRNRQVLPCPDDCPAWVYTLMLECWNEFPSRRPRFKDIHSRLR 281

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283

>gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor

 Score =  107 bits (269), Expect = 5e-26
 Identities = 57/165 (34%), Positives = 96/165 (58%), Gaps = 8/165 (4%)

Query: 213 LTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVAR-VQAQSGVMT 271
           L  LL+ +  V++GM++L   N IHRD+   N+L+ +  V K+ DFG+AR +   S  + 
Sbjct: 211 LDDLLRFSSQVAQGMDFLASKNCIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNYVV 270

Query: 272 AETGTYR----WMAPEVIEHKPYDYKADVFSFGIALWELLT-GELPYAGLTPLQAAVGVV 326
              G  R    WMAPE I    Y  ++DV+S+GI LWE+ + G+ PY G+        +V
Sbjct: 271 --KGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSPYPGILVNSKFYKMV 328

Query: 327 QKSLRPTIPKHAHPRLAELLERCWQHDPTQRPNFSQITDILKQMM 371
           ++  + + P  A P +  +++ CW  +PT+RP FSQI+ ++++ +
Sbjct: 329 KRGYQMSRPDFAPPEIYSIMKMCWNLEPTERPTFSQISQLIQRQL 373

Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374

>gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1

 Score =  106 bits (266), Expect = 5e-26
 Identities = 77/255 (30%), Positives = 123/255 (48%), Gaps = 15/255 (5%)

Query: 123 KVASGSYGDLY--KGTYCSQEVAIKVLKPEC-VNTEMLKEFSQEVYIMRKIRHKNVVQFI 179
           ++  GS+G +Y  +    ++ VAIK +      + E  ++  +EV  +++I+H N +++ 
Sbjct: 32  EIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYK 91

Query: 180 GACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRD 239
           G   R     +V E+   GS  D L   K   Q   +  +     +G+ YLH +N+IHRD
Sbjct: 92  GCYLREHTAWLVMEY-CLGSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNMIHRD 150

Query: 240 LKTANLLMDENGVVKVADFGVARVQAQSGVMTAETGTYRWMAPEVI---EHKPYDYKADV 296
           +K  N+L+ E G VK+ADFG A + + +       GT  WMAPEVI   +   YD K DV
Sbjct: 151 IKAGNILLTEPGQVKLADFGSASIASPANSF---VGTPYWMAPEVILAMDEGQYDGKVDV 207

Query: 297 FSFGIALWELLTGELPYAGLTPLQAAVGVVQKSLRPTIPKHA-HPRLAELLERCWQHDPT 355
           +S GI   EL   + P   +  + A   + Q    PT+  +         ++ C Q  P 
Sbjct: 208 WSLGITCIELAERKPPLFNMNAMSALYHIAQNE-SPTLQSNEWSDYFRNFVDSCLQKIPQ 266

Query: 356 QRPNFSQITDILKQM 370
            RP   +   +LK M
Sbjct: 267 DRPTSEE---LLKHM 278

Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317

>gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3

 Score =  105 bits (264), Expect = 9e-26
 Identities = 73/248 (29%), Positives = 122/248 (49%), Gaps = 12/248 (4%)

Query: 123 KVASGSYGDLYKGT--YCSQEVAIKVLKPECVNT-EMLKEFSQEVYIMRKIRHKNVVQFI 179
           ++  GS+G +Y  T  + ++ VA+K +      T E  ++  +EV  +++++H N +++ 
Sbjct: 28  EIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYK 87

Query: 180 GACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRD 239
           G   +     +V E+   GS  D L   K   Q   +  +     +G+ YLH +N+IHRD
Sbjct: 88  GCYLKEHTAWLVMEY-CLGSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNMIHRD 146

Query: 240 LKTANLLMDENGVVKVADFGVARVQAQSGVMTAETGTYRWMAPEVI---EHKPYDYKADV 296
           +K  N+L+ E G VK+ADFG A   + +       GT  WMAPEVI   +   YD K DV
Sbjct: 147 IKAGNILLTEPGQVKLADFGSASKSSPANSF---VGTPYWMAPEVILAMDEGQYDGKVDV 203

Query: 297 FSFGIALWELLTGELPYAGLTPLQAAVGVVQKSLRPTIPKHA-HPRLAELLERCWQHDPT 355
           +S GI   EL   + P   +  + A   + Q    PT+  +         ++ C Q  P 
Sbjct: 204 WSLGITCIELAERKPPLFNMNAMSALYHIAQND-SPTLQSNEWTDSFRGFVDYCLQKIPQ 262

Query: 356 QRPNFSQI 363
           +RP  +++
Sbjct: 263 ERPASAEL 270

Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313

>gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases

 Score =  103 bits (259), Expect = 3e-25
 Identities = 62/251 (24%), Positives = 127/251 (50%), Gaps = 22/251 (8%)

Query: 117 QLKIECKVASGSYGDLYK------GTYCSQEVAIKVLK-PECVNTEMLKEFSQEVYIMRK 169
            L+    V +G++G ++         Y     A+KV+  PE +  +  +    E  ++++
Sbjct: 2   DLERIKTVGTGTFGRVHLVRDRISEHYY----ALKVMAIPEVIRLKQEQHVHNEKRVLKE 57

Query: 170 IRHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNY 229
           + H  +++          L ++ E++  G ++ +L +  G F  ++ L  A ++   + Y
Sbjct: 58  VSHPFIIRLFWTEHDQRFLYMLMEYVPGGELFSYL-RNSGRFSNSTGLFYASEIVCALEY 116

Query: 230 LHQNNIIHRDLKTANLLMDENGVVKVADFGVAR-VQAQSGVMTAETGTYRWMAPEVIEHK 288
           LH   I++RDLK  N+L+D+ G +K+ DFG A+ ++ ++  +    GT  ++APEVI+ K
Sbjct: 117 LHSKEIVYRDLKPENILLDKEGHIKLTDFGFAKKLRDRTWTL---CGTPEYLAPEVIQSK 173

Query: 289 PYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKSLRPTI--PKHAHPRLAELL 346
            ++   D ++ GI ++E+L G  P+    P     G+ +K L   +  P+H      +L+
Sbjct: 174 GHNKAVDWWALGILIYEMLVGYPPFFDDNPF----GIYEKILAGKLEFPRHLDLYAKDLI 229

Query: 347 ERCWQHDPTQR 357
           ++    D T+R
Sbjct: 230 KKLLVVDRTRR 240

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291

>gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases

 Score =  103 bits (259), Expect = 3e-25
 Identities = 79/298 (26%), Positives = 124/298 (41%), Gaps = 71/298 (23%)

Query: 119 KIECKVASGSYGDLYKGTY--CSQEVAIKVLK------PECVNTEMLKEFSQEVYIMRKI 170
           K+  ++  G++G +Y        + VAIK +K       EC+N   L+E    V  +RK+
Sbjct: 2   KVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEECMN---LRE----VKSLRKL 54

Query: 171 -RHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKG-----------VFQLTSLLK 218
             H N+V+          L  V E+M  G++Y  +  +KG           ++Q+     
Sbjct: 55  NEHPNIVKLKEVFRENDELYFVFEYM-EGNLYQLMKDRKGKPFSESVIRSIIYQILQ--- 110

Query: 219 VAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAETGTYR 278
                  G+ ++H++   HRDLK  NLL+    VVK+ADFG+AR        T    T R
Sbjct: 111 -------GLAHIHKHGFFHRDLKPENLLVSGPEVVKIADFGLAREIRSRPPYTDYVST-R 162

Query: 279 WM-APEVIEHKP-YDYKADVFSFGIALWELLTGELPYAGL--------------TP---- 318
           W  APE++     Y    D+++ G  + EL T    + G               TP    
Sbjct: 163 WYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQLYKICSVLGTPTKQD 222

Query: 319 ------LQAAVG-----VVQKSLRPTIPKHAHPRLAELLERCWQHDPTQRPNFSQITD 365
                 L + +G         SL   IP +A P   +L++   + DP +RP  SQ   
Sbjct: 223 WPEGYKLASKLGFRFPQFAPTSLHQLIP-NASPEAIDLIKDMLRWDPKKRPTASQALQ 279

Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283

>gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N

 Score =  103 bits (258), Expect = 7e-25
 Identities = 61/188 (32%), Positives = 89/188 (47%), Gaps = 9/188 (4%)

Query: 133 YKGTYCSQEVAIKVLKPECV----NTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNL 188
           YK T   +  AIK LK   +      E L    +        RH  +V          ++
Sbjct: 20  YKKT--GELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACFQTEDHV 77

Query: 189 CIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMD 248
           C V E+ A G +   +H    VF     +  A  V  G+ YLH+N I++RDLK  NLL+D
Sbjct: 78  CFVMEYAAGGDL--MMHIHTDVFSEPRAVFYAACVVLGLQYLHENKIVYRDLKLDNLLLD 135

Query: 249 ENGVVKVADFGVARVQAQSGVMTAE-TGTYRWMAPEVIEHKPYDYKADVFSFGIALWELL 307
             G VK+ADFG+ +     G  T+   GT  ++APEV+    Y    D +  G+ ++E+L
Sbjct: 136 TEGFVKIADFGLCKEGMGFGDRTSTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIYEML 195

Query: 308 TGELPYAG 315
            GE P+ G
Sbjct: 196 VGESPFPG 203

Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324

>gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin

 Score =  102 bits (255), Expect = 1e-24
 Identities = 86/283 (30%), Positives = 128/283 (45%), Gaps = 42/283 (14%)

Query: 106 DGTDVWEIDAKQLKIECKVASGSYGDLYK--GTYCSQEVAIKVLKPECVNTEMLKEFSQE 163
           D +D WEI      IE  +  G+YG ++K        + A+K+L P     ++ +E   E
Sbjct: 15  DPSDTWEI------IE-TIGKGTYGKVFKVLNKKNGSKAAVKILDPI---HDIDEEIEAE 64

Query: 164 VYIMRKIR-HKNVVQFIGACTRPP-----NLCIVTEFMARGSIYDFLHKQKGVFQLTSLL 217
             I++ +  H NVV+F G   +        L +V E    GS+ D +   KG  +    +
Sbjct: 65  YNILKALSDHPNVVKFYGMYYKKDVKNGDQLWLVLELCNGGSVTDLV---KGFLKRGERM 121

Query: 218 KVAI------DVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGV-ARVQAQSGVM 270
           +  I      +   G+ +LH N  IHRD+K  N+L+   G VK+ DFGV A++ +     
Sbjct: 122 EEPIIAYILHEALMGLQHLHVNKTIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLRR 181

Query: 271 TAETGTYRWMAPEVIE-----HKPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGV 325
               GT  WMAPEVI         YD + DV+S GI   EL  G+ P A L P++A    
Sbjct: 182 NTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHPMRALF-- 239

Query: 326 VQKSLRPTIPKHAHPRL-----AELLERCWQHDPTQRPNFSQI 363
             K  R   P    P L      + + +C   D  +RP  S +
Sbjct: 240 --KIPRNPPPTLHQPELWSNEFNDFIRKCLTKDYEKRPTVSDL 280

Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286

>gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases

 Score =  101 bits (253), Expect = 1e-24
 Identities = 67/245 (27%), Positives = 103/245 (42%), Gaps = 20/245 (8%)

Query: 124 VASGSYGDLY--KGTYCSQEVAIKVL-KPECVNTEMLKEFSQEVYIMRKIRHK-NVVQFI 179
           ++ G++G +Y  K        AIKVL K + +    +     E  IM        V +  
Sbjct: 4   ISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLY 63

Query: 180 GACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRD 239
            +      L +V E++  G     + K  G        +   +V  G+  LHQ  IIHRD
Sbjct: 64  YSFQSKDYLYLVMEYLNGGDCASLI-KTLGGLPEDWAKQYIAEVVLGVEDLHQRGIIHRD 122

Query: 240 LKTANLLMDENGVVKVADFGVARVQAQSGVMTAE-TGTYRWMAPEVIEHKPYDYKADVFS 298
           +K  NLL+D+ G +K+ DFG++R     G+   +  GT  ++APE I     D  +D +S
Sbjct: 123 IKPENLLIDQTGHLKLTDFGLSRN----GLENKKFVGTPDYLAPETILGVGDDKMSDWWS 178

Query: 299 FGIALWELLTGELPYAGLTPLQAAVGVVQKSLRPTIPKHAH------PRLAELLERCWQH 352
            G  ++E L G  P+   TP      V    L   I           P   +L+ R    
Sbjct: 179 LGCVIFEFLFGYPPFHAETPDA----VFDNILSRRINWPEEVKEFCSPEAVDLINRLLCM 234

Query: 353 DPTQR 357
           DP +R
Sbjct: 235 DPAKR 239

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260

>gnl|CDD|165291 PHA02988, PHA02988, hypothetical protein; Provisional

 Score =  101 bits (253), Expect = 2e-24
 Identities = 60/246 (24%), Positives = 119/246 (48%), Gaps = 11/246 (4%)

Query: 132 LYKGTYCSQEVAIKVLKPECVNTEMLKE-FSQEVYIMRKIRHKNVVQ----FIGACTRPP 186
           +YKG + ++EV I+  K      ++L +    E+  +R+I   N+++     I      P
Sbjct: 36  IYKGIFNNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDLP 95

Query: 187 NLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQ-NNIIHRDLKTANL 245
            L ++ E+  RG + + L K+K +    + L +AID  KG+  L++  N  +++L + + 
Sbjct: 96  RLSLILEYCTRGYLREVLDKEKDL-SFKTKLDMAIDCCKGLYNLYKYTNKPYKNLTSVSF 154

Query: 246 LMDENGVVKVADFGVARVQAQSGVMTAETGTYRWMAPEVIEH--KPYDYKADVFSFGIAL 303
           L+ EN  +K+   G+ ++ +           Y   + +++      Y  K D++S G+ L
Sbjct: 155 LVTENYKLKIICHGLEKILSSPPFKNVNFMVYF--SYKMLNDIFSEYTIKDDIYSLGVVL 212

Query: 304 WELLTGELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRLAELLERCWQHDPTQRPNFSQI 363
           WE+ TG++P+  LT  +    ++ K+    +P      +  ++E C  HD  +RPN  +I
Sbjct: 213 WEIFTGKIPFENLTTKEIYDLIINKNNSLKLPLDCPLEIKCIVEACTSHDSIKRPNIKEI 272

Query: 364 TDILKQ 369
              L  
Sbjct: 273 LYNLSL 278

Length = 283

>gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin

 Score =  101 bits (253), Expect = 2e-24
 Identities = 87/283 (30%), Positives = 133/283 (46%), Gaps = 38/283 (13%)

Query: 106 DGTDVWEIDAKQLKIECKVASGSYGDLYKGTYC--SQEVAIKVLKPECVNTEMLKEFSQE 163
           D TD WEI      IE  +  G+YG +YK T        A+K+L P    +++ +E   E
Sbjct: 19  DPTDTWEI------IE-TIGKGTYGKVYKVTNKKDGSLAAVKILDPI---SDVDEEIEAE 68

Query: 164 VYIMRKI-RHKNVVQFIGACTRPPN-----LCIVTEFMARGSIYDFLHKQKGVFQLTSLL 217
             I++ +  H NVV+F G   +        L +V E    GS+ + +   KG+      L
Sbjct: 69  YNILQSLPNHPNVVKFYGMFYKADKLVGGQLWLVLELCNGGSVTELV---KGLLICGQRL 125

Query: 218 KVAI------DVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMT 271
             A+          G+ +LH N IIHRD+K  N+L+   G VK+ DFGV+  Q  S  + 
Sbjct: 126 DEAMISYILYGALLGLQHLHNNRIIHRDVKGNNILLTTEGGVKLVDFGVS-AQLTSTRLR 184

Query: 272 AET--GTYRWMAPEVIE-HKPYDY----KADVFSFGIALWELLTGELPYAGLTPLQAAVG 324
             T  GT  WMAPEVI   + YDY    + DV+S GI   EL  G+ P   + P++    
Sbjct: 185 RNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHPVKTLFK 244

Query: 325 VVQKSLRPTI--PKHAHPRLAELLERCWQHDPTQRPNFSQITD 365
            + ++  PT+  P+         + +C   D   RP+ + + +
Sbjct: 245 -IPRNPPPTLLHPEKWCRSFNHFISQCLIKDFEARPSVTHLLE 286

Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291

>gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase

 Score =  101 bits (253), Expect = 2e-24
 Identities = 48/177 (27%), Positives = 88/177 (49%), Gaps = 12/177 (6%)

Query: 140 QEVAIKVL----KPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVTEFM 195
           + VA+K +        +  + L+E    +  ++  +H  VV+ +          +V E+M
Sbjct: 26  ETVALKKVALRRLEGGIPNQALRE----IKALQACQHPYVVKLLDVFPHGSGFVLVMEYM 81

Query: 196 ARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKV 255
               + + L  ++       +      + KG+ Y+H N I+HRDLK ANLL+  +GV+K+
Sbjct: 82  PS-DLSEVLRDEERPLPEAQVKSYMRMLLKGVAYMHANGIMHRDLKPANLLISADGVLKI 140

Query: 256 ADFGVARVQA--QSGVMTAETGTYRWMAPEVIEHKP-YDYKADVFSFGIALWELLTG 309
           ADFG+AR+ +  +  + + +  T  + APE++     YD   D+++ G    ELL G
Sbjct: 141 ADFGLARLFSEEEPRLYSHQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNG 197

Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286

>gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C

 Score =  102 bits (255), Expect = 2e-24
 Identities = 62/241 (25%), Positives = 116/241 (48%), Gaps = 18/241 (7%)

Query: 127 GSYGDL----YKGTYCSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKI-----RHKNVVQ 177
           GS+G +     KGT   +  A+KVLK + +  +   E +      +++     +H  + Q
Sbjct: 6   GSFGKVLLAELKGT--DELYAVKVLKKDVILQDDDVECTM---TEKRVLALAGKHPFLTQ 60

Query: 178 FIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIH 237
                     L  V E++  G +   + +  G F        A ++  G+ +LH+  II+
Sbjct: 61  LHSCFQTKDRLFFVMEYVNGGDLMFHIQRS-GRFDEPRARFYAAEIVLGLQFLHERGIIY 119

Query: 238 RDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAE-TGTYRWMAPEVIEHKPYDYKADV 296
           RDLK  N+L+D  G +K+ADFG+ +     GV T+   GT  ++APE++ ++PY    D 
Sbjct: 120 RDLKLDNVLLDSEGHIKIADFGMCKEGILGGVTTSTFCGTPDYIAPEILSYQPYGPAVDW 179

Query: 297 FSFGIALWELLTGELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRLAELLERCWQHDPTQ 356
           ++ G+ L+E+L G+ P+ G    +    +++  +R   P+        +L+     +P +
Sbjct: 180 WALGVLLYEMLAGQSPFEGDDEDELFQSILEDEVR--YPRWLSKEAKSILKSFLTKNPEK 237

Query: 357 R 357
           R
Sbjct: 238 R 238

Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318

>gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10

 Score = 99.9 bits (249), Expect = 4e-24
 Identities = 62/255 (24%), Positives = 122/255 (47%), Gaps = 16/255 (6%)

Query: 126 SGSYGDLYKGTYCSQEVAIKVLK------PECVNTEMLKEFS-----QEVYIMRK-IRHK 173
           SG++G +YK    +    +  LK      P     +  ++ S      EV I+++ +RH 
Sbjct: 10  SGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHP 69

Query: 174 NVVQFIGACTRPPNLCIVTEFMARGSIYDF---LHKQKGVFQLTSLLKVAIDVSKGMNYL 230
           N+V++         L IV + +    + +    L ++K  F    +  + + +   + YL
Sbjct: 70  NIVRYYKTFLENDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYL 129

Query: 231 H-QNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAETGTYRWMAPEVIEHKP 289
           H +  I+HRDL   N+++ E+  V + DFG+A+ +     +T+  GT  +  PE+++++P
Sbjct: 130 HKEKRIVHRDLTPNNIMLGEDDKVTITDFGLAKQKQPESKLTSVVGTILYSCPEIVKNEP 189

Query: 290 YDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRLAELLERC 349
           Y  KADV++FG  L+++ T + P+     L  A  +V+    P         + +++  C
Sbjct: 190 YGEKADVWAFGCILYQMCTLQPPFYSTNMLSLATKIVEAVYEPLPEGMYSEDVTDVITSC 249

Query: 350 WQHDPTQRPNFSQIT 364
              D   RP+  Q++
Sbjct: 250 LTPDAEARPDIIQVS 264

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269

>gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase

 Score = 98.7 bits (246), Expect = 2e-23
 Identities = 57/204 (27%), Positives = 96/204 (47%), Gaps = 15/204 (7%)

Query: 163 EVYIMRKIRHKNVVQFIGACTRPPNLCIVTEFMARGSI-YDFLHKQKGVFQLTSLLKVAI 221
           E  I+ K+  + +V    A     +LC+V   M  G + Y   +  +  F     +  A 
Sbjct: 43  EKKILEKVSSRFIVSLAYAFETKDDLCLVMTLMNGGDLKYHIYNVGEPGFPEARAIFYAA 102

Query: 222 DVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAETGTYRWMA 281
            +  G+ +LHQ  I++RDLK  N+L+D++G V+++D G+A        +    GT  +MA
Sbjct: 103 QIICGLEHLHQRRIVYRDLKPENVLLDDHGNVRISDLGLAVELKGGKKIKGRAGTPGYMA 162

Query: 282 PEVIEHKPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQK--------SLRPT 333
           PEV++ + YD+  D F+ G  L+E++      AG +P +     V+K         +   
Sbjct: 163 PEVLQGEVYDFSVDWFALGCTLYEMI------AGRSPFRQRKEKVEKEELKRRTLEMAVE 216

Query: 334 IPKHAHPRLAELLERCWQHDPTQR 357
            P    P   +L E   Q DP +R
Sbjct: 217 YPDKFSPEAKDLCEALLQKDPEKR 240

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277

>gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3

 Score = 94.6 bits (235), Expect = 3e-22
 Identities = 69/264 (26%), Positives = 129/264 (48%), Gaps = 25/264 (9%)

Query: 123 KVASGSYGDLYKGT----YCSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQF 178
           ++ +G +G +  G     Y   +V +K L+      E +K F +E    R ++H N++Q 
Sbjct: 2   EIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMK-FLEEAQPYRSLQHSNLLQC 60

Query: 179 IGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLT----SLLKVAIDVSKGMNYLHQNN 234
           +G CT      +V EF   G +  +L   +    +T    +L ++A +++ G+ +LH+NN
Sbjct: 61  LGQCTEVTPYLLVMEFCPLGDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKNN 120

Query: 235 IIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAETGTY---RWMAPEVIEHKPYD 291
            IH DL   N L+  +  VK+ D+G++  + +          +   RW+APE+++    +
Sbjct: 121 FIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYVTPDQLWVPLRWIAPELVDEVHGN 180

Query: 292 Y-------KADVFSFGIALWELLT-GELPYAGLTPLQAAVGVV-QKSLRPTIPKHAHP-- 340
                   +++V+S G+ +WEL   G  PY  L+  Q     V ++ L+   P+   P  
Sbjct: 181 LLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDEQVLTYTVREQQLKLPKPRLKLPLS 240

Query: 341 -RLAELLERCWQHDPTQRPNFSQI 363
            R  E+++ CW   P QRP+  ++
Sbjct: 241 DRWYEVMQFCWLQ-PEQRPSAEEV 263

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269

>gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional

 Score = 94.9 bits (236), Expect = 7e-22
 Identities = 71/248 (28%), Positives = 120/248 (48%), Gaps = 30/248 (12%)

Query: 124 VASGSYGDL----YKGTYCSQEVAIKVLKP-ECVNTEMLKEFSQEVYIMRKIRHKNVVQF 178
           + +GS+G +    +KGT   +  AIK LK  E +  + ++  +QE  I+ ++ H  +V  
Sbjct: 26  LGTGSFGRVRIAKHKGT--GEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNM 83

Query: 179 IGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSK--------GMNYL 230
           + +      +  + EF+  G ++  L K           +   DV+K           YL
Sbjct: 84  MCSFQDENRVYFLLEFVVGGELFTHLRKAG---------RFPNDVAKFYHAELVLAFEYL 134

Query: 231 HQNNIIHRDLKTANLLMDENGVVKVADFGVA-RVQAQSGVMTAETGTYRWMAPEVIEHKP 289
           H  +II+RDLK  NLL+D  G VKV DFG A +V  ++  +    GT  ++APEVI+ K 
Sbjct: 135 HSKDIIYRDLKPENLLLDNKGHVKVTDFGFAKKVPDRTFTL---CGTPEYLAPEVIQSKG 191

Query: 290 YDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRLAELLERC 349
           +    D ++ G+ L+E + G  P+   TP +    ++   L+   P     R  +L++  
Sbjct: 192 HGKAVDWWTMGVLLYEFIAGYPPFFDDTPFRIYEKILAGRLK--FPNWFDGRARDLVKGL 249

Query: 350 WQHDPTQR 357
            Q D T+R
Sbjct: 250 LQTDHTKR 257

Length = 329

>gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase

 Score = 93.8 bits (233), Expect = 8e-22
 Identities = 56/175 (32%), Positives = 90/175 (51%), Gaps = 4/175 (2%)

Query: 185 PPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTAN 244
           P  L  + + M  G ++  L  Q GVF    +   A ++  G+ ++H   +++RDLK AN
Sbjct: 69  PDKLSFILDLMNGGDLHYHL-SQHGVFSEAEMRFYAAEIILGLEHMHNRFVVYRDLKPAN 127

Query: 245 LLMDENGVVKVADFGVARVQAQSGVMTAETGTYRWMAPEVIEHK-PYDYKADVFSFGIAL 303
           +L+DE+G V+++D G+A          A  GT+ +MAPEV++    YD  AD FS G  L
Sbjct: 128 ILLDEHGHVRISDLGLA-CDFSKKKPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCML 186

Query: 304 WELLTGELPYAGL-TPLQAAVGVVQKSLRPTIPKHAHPRLAELLERCWQHDPTQR 357
           ++LL G  P+    T  +  +  +  ++   +P    P L  LLE   Q D  +R
Sbjct: 187 FKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELPDSFSPELRSLLEGLLQRDVNRR 241

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278

>gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta

 Score = 94.5 bits (235), Expect = 9e-22
 Identities = 72/248 (29%), Positives = 123/248 (49%), Gaps = 32/248 (12%)

Query: 127 GSYGDLY----KGTYCSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKI-----RHKNVVQ 177
           GS+G +     KGT  ++  AIK LK + V   +  +  +   + R++      H  +  
Sbjct: 6   GSFGKVMLAELKGT--NEFFAIKALKKDVV---LEDDDVECTMVERRVLALAWEHPFLTH 60

Query: 178 FIGACTRPPNLCIVTEFMARGSIYDFLH--KQKGVFQLTSLLKVAIDVSKGMNYLHQNNI 235
                    +L  V E++  G   D +   +  G F        A ++  G+ +LH+  I
Sbjct: 61  LFCTFQTKEHLFFVMEYLNGG---DLMFHIQSSGRFDEARARFYAAEIICGLQFLHKKGI 117

Query: 236 IHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAET--GTYRWMAPEVIEHKPYDYK 293
           I+RDLK  N+L+D++G +K+ADFG+ +    +G   A T  GT  ++APE+++ + Y+  
Sbjct: 118 IYRDLKLDNVLLDKDGHIKIADFGMCKENM-NGEGKASTFCGTPDYIAPEILKGQKYNES 176

Query: 294 ADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKSLRP----TIPKHAHPRLAELLERC 349
            D +SFG+ L+E+L G+ P+ G    +    ++    RP     I K A   L++L ER 
Sbjct: 177 VDWWSFGVLLYEMLIGQSPFHGEDEDELFDSILND--RPHFPRWISKEAKDCLSKLFER- 233

Query: 350 WQHDPTQR 357
              DPT+R
Sbjct: 234 ---DPTKR 238

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316

>gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase

 Score = 94.5 bits (235), Expect = 1e-21
 Identities = 65/238 (27%), Positives = 120/238 (50%), Gaps = 11/238 (4%)

Query: 127 GSYGDLY-----KGTYCSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGA 181
           GS+G ++      G    Q  A+KVLK   +          E  I+ ++ H  +V+   A
Sbjct: 7   GSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVKLHYA 66

Query: 182 CTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLK 241
                 L ++ +F+  G ++  L K+  +F    +     +++  +++LH   II+RDLK
Sbjct: 67  FQTEGKLYLILDFLRGGDLFTRLSKEV-MFTEEDVKFYLAELALALDHLHSLGIIYRDLK 125

Query: 242 TANLLMDENGVVKVADFGVARVQAQSGVMTAET--GTYRWMAPEVIEHKPYDYKADVFSF 299
             N+L+DE G +K+ DFG+++ ++      A +  GT  +MAPEV+  + +   AD +SF
Sbjct: 126 PENILLDEEGHIKLTDFGLSK-ESIDHEKKAYSFCGTVEYMAPEVVNRRGHTQSADWWSF 184

Query: 300 GIALWELLTGELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRLAELLERCWQHDPTQR 357
           G+ ++E+LTG LP+ G    +    +++  L   +P+   P    LL   ++ +P  R
Sbjct: 185 GVLMFEMLTGSLPFQGKDRKETMTMILKAKL--GMPQFLSPEAQSLLRALFKRNPANR 240

Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318

>gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3

 Score = 92.8 bits (230), Expect = 2e-21
 Identities = 70/245 (28%), Positives = 117/245 (47%), Gaps = 16/245 (6%)

Query: 124 VASGSYGDLYKGTYCSQEVAIKVLKPECVNTEMLKEFSQEVY-----IMRKIRHKNVVQF 178
           +  G +G++Y    C +    K+   +C++ + +K    E       IM  +       F
Sbjct: 2   IGRGGFGEVYG---CRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPF 58

Query: 179 IGACT----RPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNN 234
           I   T     P  LC + + M  G ++  L  Q GVF    +   A ++  G+ ++H   
Sbjct: 59  IVCMTYAFHTPDKLCFILDLMNGGDLHYHL-SQHGVFSEKEMRFYATEIILGLEHMHNRF 117

Query: 235 IIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAETGTYRWMAPEVIEH-KPYDYK 293
           +++RDLK AN+L+DE+G V+++D G+A          A  GT+ +MAPEV++    YD  
Sbjct: 118 VVYRDLKPANILLDEHGHVRISDLGLA-CDFSKKKPHASVGTHGYMAPEVLQKGTAYDSS 176

Query: 294 ADVFSFGIALWELLTGELPY-AGLTPLQAAVGVVQKSLRPTIPKHAHPRLAELLERCWQH 352
           AD FS G  L++LL G  P+    T  +  +  +  ++   +P    P L  LLE   Q 
Sbjct: 177 ADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTVNVELPDSFSPELKSLLEGLLQR 236

Query: 353 DPTQR 357
           D ++R
Sbjct: 237 DVSKR 241

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279

>gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional

 Score = 93.8 bits (233), Expect = 2e-21
 Identities = 41/145 (28%), Positives = 71/145 (48%), Gaps = 1/145 (0%)

Query: 163 EVYIMRKIRHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAID 222
           E  +++ + H +V++           C+V        +Y +L K+     +   L +   
Sbjct: 107 EAMLLQNVNHPSVIRMKDTLVSGAITCMVLPHY-SSDLYTYLTKRSRPLPIDQALIIEKQ 165

Query: 223 VSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAETGTYRWMAP 282
           + +G+ YLH   IIHRD+KT N+ +++   V + D G A+    +       GT    AP
Sbjct: 166 ILEGLRYLHAQRIIHRDVKTENIFINDVDQVCIGDLGAAQFPVVAPAFLGLAGTVETNAP 225

Query: 283 EVIEHKPYDYKADVFSFGIALWELL 307
           EV+    Y+ KAD++S GI L+E+L
Sbjct: 226 EVLARDKYNSKADIWSAGIVLFEML 250

Length = 357

>gnl|CDD|173643 cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1

 Score = 91.9 bits (228), Expect = 3e-21
 Identities = 67/234 (28%), Positives = 113/234 (48%), Gaps = 21/234 (8%)

Query: 141 EVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVTEFMARGSI 200
           +V +KVL P   + ++   F +   +MR++ HK++V   G C R     +V EF+  G +
Sbjct: 34  KVILKVLDPS--HRDISLAFFETASMMRQVSHKHIVLLYGVCVRDVENIMVEEFVEFGPL 91

Query: 201 YDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGV-------V 253
             F+H++  V       KVA  ++  ++YL   +++H ++ T N+L+   G+       +
Sbjct: 92  DLFMHRKSDVLTTPWKFKVAKQLASALSYLEDKDLVHGNVCTKNILLAREGIDGECGPFI 151

Query: 254 KVADFGVARVQAQSGVMTAETGTYR--WMAPEVIE-HKPYDYKADVFSFGIALWEL-LTG 309
           K++D G+        V++ +    R  W+APE +E  K     AD +SFG  LWE+   G
Sbjct: 152 KLSDPGIPIT-----VLSRQECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNG 206

Query: 310 ELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRLAELLERCWQHDPTQRPNFSQI 363
           E+P    T L       +       P  +   LA+L+  C  +DP QRP F  I
Sbjct: 207 EIPLKDKT-LAEKERFYEGQCMLVTP--SCKELADLMTHCMNYDPNQRPFFRAI 257

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 262

>gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1

 Score = 92.0 bits (228), Expect = 8e-21
 Identities = 62/245 (25%), Positives = 118/245 (48%), Gaps = 12/245 (4%)

Query: 124 VASGSYGDLYKGTYCSQEV--AIKVLKPECV--NTEMLKEFSQEVYIMRKIRHKNVVQFI 179
           +  GS+G +    + ++E   A+KVL+ + +    E     S+   +++ ++H  +V   
Sbjct: 3   IGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLH 62

Query: 180 GACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRD 239
            +      L  V +++  G ++  L +++   +  +    A +++  + YLH  NI++RD
Sbjct: 63  FSFQTADKLYFVLDYINGGELFYHLQRERCFLEPRARFYAA-EIASALGYLHSLNIVYRD 121

Query: 240 LKTANLLMDENGVVKVADFGVARVQAQ-SGVMTAETGTYRWMAPEVIEHKPYDYKADVFS 298
           LK  N+L+D  G + + DFG+ +   + +G  +   GT  ++APEV+  +PYD   D + 
Sbjct: 122 LKPENILLDSQGHIVLTDFGLCKENIEHNGTTSTFCGTPEYLAPEVLHKQPYDRTVDWWC 181

Query: 299 FGIALWELLTGELPYAGLTPLQAAVGVVQK--SLRPTIPKHAHPRLAELLERCWQHDPTQ 356
            G  L+E+L G  P+      +    ++ K   L+P I   A      LLE   Q D T+
Sbjct: 182 LGAVLYEMLYGLPPFYSRNTAEMYDNILNKPLQLKPNITNSAR----HLLEGLLQKDRTK 237

Query: 357 RPNFS 361
           R    
Sbjct: 238 RLGAK 242

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325

>gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional

 Score = 93.4 bits (232), Expect = 9e-21
 Identities = 52/152 (34%), Positives = 89/152 (58%), Gaps = 10/152 (6%)

Query: 221 IDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQS---GVMTAETGTY 277
           I V   ++++H  ++IHRD+K+AN+L+  NG+VK+ DFG +++ A +    V     GT 
Sbjct: 150 IQVLLAVHHVHSKHMIHRDIKSANILLCSNGLVKLGDFGFSKMYAATVSDDVGRTFCGTP 209

Query: 278 RWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKSLR---PTI 334
            ++APE+   KPY  KAD+FS G+ L+ELLT + P+ G    +    V+ K+L      +
Sbjct: 210 YYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFDGENMEE----VMHKTLAGRYDPL 265

Query: 335 PKHAHPRLAELLERCWQHDPTQRPNFSQITDI 366
           P    P + E++      DP +RP+ S++ ++
Sbjct: 266 PPSISPEMQEIVTALLSSDPKRRPSSSKLLNM 297

Length = 496

>gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta

 Score = 91.2 bits (226), Expect = 1e-20
 Identities = 55/173 (31%), Positives = 95/173 (54%), Gaps = 6/173 (3%)

Query: 187 NLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLL 246
           +L  V EF+  G +  F  + KG F L      A ++  G+ +LH   II+RDLK  N++
Sbjct: 70  HLFFVMEFLNGGDLM-FHIQDKGRFDLYRATFYAAEIVCGLQFLHSKGIIYRDLKLDNVM 128

Query: 247 MDENGVVKVADFGVARVQAQSGVMTAET--GTYRWMAPEVIEHKPYDYKADVFSFGIALW 304
           +D +G +K+ADFG+ + +   G   A T  GT  ++APE+++   Y +  D +SFG+ L+
Sbjct: 129 LDRDGHIKIADFGMCK-ENVFGDNRASTFCGTPDYIAPEILQGLKYTFSVDWWSFGVLLY 187

Query: 305 ELLTGELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRLAELLERCWQHDPTQR 357
           E+L G+ P+ G    +    +   +  P  P+       ++LE+ ++ DPT+R
Sbjct: 188 EMLIGQSPFHGDDEDELFESIRVDT--PHYPRWITKESKDILEKLFERDPTRR 238

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316

>gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3

 Score = 90.8 bits (225), Expect = 2e-20
 Identities = 70/249 (28%), Positives = 120/249 (48%), Gaps = 8/249 (3%)

Query: 124 VASGSYGD--LYKGTYCSQEVAIKVLKPECV--NTEMLKEFSQEVYIMRKIRHKNVVQFI 179
           +  GS+G   L K     +  A+KVL+ + V    E     ++   +++ ++H  +V   
Sbjct: 3   IGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLH 62

Query: 180 GACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRD 239
            +      L  V +F+  G ++  L +++   +  +    A +++  + YLH  NI++RD
Sbjct: 63  YSFQTTEKLYFVLDFVNGGELFFHLQRERSFPEPRARFYAA-EIASALGYLHSINIVYRD 121

Query: 240 LKTANLLMDENGVVKVADFGVARVQ-AQSGVMTAETGTYRWMAPEVIEHKPYDYKADVFS 298
           LK  N+L+D  G V + DFG+ +   AQS   T   GT  ++APEVI  +PYD   D + 
Sbjct: 122 LKPENILLDSQGHVVLTDFGLCKEGIAQSDTTTTFCGTPEYLAPEVIRKQPYDNTVDWWC 181

Query: 299 FGIALWELLTGELPYAGLTPLQAAVGVVQKSL--RPTIPKHAHPRLAELLERCWQHDPTQ 356
            G  L+E+L G  P+      +    ++ K L  RP     A   L ELLE+  Q     
Sbjct: 182 LGAVLYEMLYGLPPFYCRDVAEMYDNILHKPLVLRPGASLTAWSILEELLEKDRQRRLGA 241

Query: 357 RPNFSQITD 365
           + +F +I +
Sbjct: 242 KEDFLEIQE 250

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325

>gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases

 Score = 90.4 bits (225), Expect = 2e-20
 Identities = 62/225 (27%), Positives = 106/225 (47%), Gaps = 37/225 (16%)

Query: 119 KIECKVASGSYGDLYKG----TYCSQEVAIKVLKPECVNTEMLKEFSQ----EVYIMRKI 170
           +IE  +  G+YG +YK         +E AIK  K +          SQ    E+ ++R++
Sbjct: 3   EIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYT---GISQSACREIALLREL 59

Query: 171 RHKNVVQFIGACTRPPNLCI--VTEFMARGSIYDFL-----HKQKGVFQL-TSLLKVAI- 221
           +H+NVV  +       +  +  + ++    + +D       H+Q     +  S++K  + 
Sbjct: 60  KHENVVSLVEVFLEHADKSVYLLFDY----AEHDLWQIIKFHRQAKRVSIPPSMVKSLLW 115

Query: 222 DVSKGMNYLHQNNIIHRDLKTANLLM----DENGVVKVADFGVARV-QAQSGVMTAETG- 275
            +  G++YLH N ++HRDLK AN+L+     E GVVK+ D G+AR+  A    +      
Sbjct: 116 QILNGVHYLHSNWVLHRDLKPANILVMGEGPERGVVKIGDLGLARLFNAPLKPLADLDPV 175

Query: 276 --TYRWMAPEVI---EHKPYDYKADVFSFGIALWELLTGELPYAG 315
             T  + APE++    H  Y    D+++ G    ELLT E  + G
Sbjct: 176 VVTIWYRAPELLLGARH--YTKAIDIWAIGCIFAELLTLEPIFKG 218

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316

>gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional

 Score = 90.8 bits (225), Expect = 2e-20
 Identities = 72/246 (29%), Positives = 118/246 (47%), Gaps = 25/246 (10%)

Query: 124 VASGSYGDLYKGTYCSQE---VAIKVL-KPECVNTEMLKEFSQEVYIMRKIRHKNVVQFI 179
           + +GS+G +   TY +++   VAIK   K + +  + +     E  I+  I H   V   
Sbjct: 38  LGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLY 97

Query: 180 GACTRPPNLCIVTEFMARGSIYDFLHKQK------GVFQLTSLLKVAIDVSKGMNYLHQN 233
           G+      L +V EF+  G  + FL + K      G F    ++ +         YL   
Sbjct: 98  GSFKDESYLYLVLEFVIGGEFFTFLRRNKRFPNDVGCFYAAQIVLI-------FEYLQSL 150

Query: 234 NIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAETGTYRWMAPEVIEHKPYDYK 293
           NI++RDLK  NLL+D++G +K+ DFG A+V   +   T   GT  ++APE++ +  +   
Sbjct: 151 NIVYRDLKPENLLLDKDGFIKMTDFGFAKV-VDTRTYTL-CGTPEYIAPEILLNVGHGKA 208

Query: 294 ADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKSLRPTI--PKHAHPRLAELLERCWQ 351
           AD ++ GI ++E+L G  P+    PL     + QK L   I  PK        L+++   
Sbjct: 209 ADWWTLGIFIYEILVGCPPFYANEPLL----IYQKILEGIIYFPKFLDNNCKHLMKKLLS 264

Query: 352 HDPTQR 357
           HD T+R
Sbjct: 265 HDLTKR 270

Length = 340

>gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta

 Score = 90.5 bits (224), Expect = 3e-20
 Identities = 55/217 (25%), Positives = 104/217 (47%), Gaps = 5/217 (2%)

Query: 143 AIKVLKPECV-NTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVTEFMARGSIY 201
           A+K+L+ E +   + +     E  +++  RH  +     A      LC V E+   G ++
Sbjct: 24  AMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGGELF 83

Query: 202 DFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVA 261
             L +++ VF          ++   + YLH  ++++RD+K  NL++D++G +K+ DFG+ 
Sbjct: 84  FHLSRER-VFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLC 142

Query: 262 RVQAQSG-VMTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPYAGLTPLQ 320
           +     G  M    GT  ++APEV+E   Y    D +  G+ ++E++ G LP+      +
Sbjct: 143 KEGISDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHER 202

Query: 321 AAVGVVQKSLRPTIPKHAHPRLAELLERCWQHDPTQR 357
               ++ + +R   P+   P    LL    + DP QR
Sbjct: 203 LFELILMEEIR--FPRTLSPEAKSLLAGLLKKDPKQR 237

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323

>gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases

 Score = 89.1 bits (221), Expect = 5e-20
 Identities = 68/253 (26%), Positives = 123/253 (48%), Gaps = 17/253 (6%)

Query: 127 GSYGDLYKGTYCSQEV--AIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTR 184
           G+YG +YK  +    V  A+K ++ E ++     +   E+ I+ K     +V F GA   
Sbjct: 12  GNYGSVYKVLHRPTGVTMAMKEIRLE-LDESKFNQIIMELDILHKAVSPYIVDFYGAFFI 70

Query: 185 PPNLCIVTEFMARGS---IYDFLHKQKGVFQLTSLLKVAIDVSKGMNYL-HQNNIIHRDL 240
              + +  E+M  GS   +Y      +G+ +   L ++   V KG+ +L  ++NIIHRD+
Sbjct: 71  EGAVYMCMEYMDAGSLDKLYAGGVATEGIPE-DVLRRITYAVVKGLKFLKEEHNIIHRDV 129

Query: 241 KTANLLMDENGVVKVADFGVARVQAQSGVMTAETGTYRWMAPEVI------EHKPYDYKA 294
           K  N+L++ NG VK+ DFGV+     + +     G   +MAPE I      ++  Y  ++
Sbjct: 130 KPTNVLVNGNGQVKLCDFGVSG-NLVASLAKTNIGCQSYMAPERIKSGGPNQNPTYTVQS 188

Query: 295 DVFSFGIALWELLTGELPYA--GLTPLQAAVGVVQKSLRPTIPKHAHPRLAELLERCWQH 352
           DV+S G+++ E+  G  PY       + A +  +     PT+P        + + +C   
Sbjct: 189 DVWSLGLSILEMALGRYPYPPETYANIFAQLSAIVDGDPPTLPSGYSDDAQDFVAKCLNK 248

Query: 353 DPTQRPNFSQITD 365
            P +RP ++Q+ +
Sbjct: 249 IPNRRPTYAQLLE 261

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286

>gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4

 Score = 88.6 bits (220), Expect = 6e-20
 Identities = 72/285 (25%), Positives = 131/285 (45%), Gaps = 50/285 (17%)

Query: 122 CKVASGSYGDLYKGTYC-----SQEVAIKVLKPECVNTE---MLKEFS-QEVYIMRKIRH 172
            K+  GSYG ++K   C      Q VAIK    + V +E   ++K+ + +E+ ++++++H
Sbjct: 7   SKIGEGSYGVVFK---CRNRETGQIVAIK----KFVESEDDPVIKKIALREIRMLKQLKH 59

Query: 173 KNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQ 232
            N+V  I    R   L +V E+     + +     +GV +   + K+     + +N+ H+
Sbjct: 60  PNLVNLIEVFRRKRKLHLVFEYCDHTVLNELEKNPRGVPEH-LIKKIIWQTLQAVNFCHK 118

Query: 233 NNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAETGTYRWM-APEVI-EHKPY 290
           +N IHRD+K  N+L+ + G +K+ DFG AR+    G    +    RW  APE++     Y
Sbjct: 119 HNCIHRDVKPENILITKQGQIKLCDFGFARILTGPGDDYTDYVATRWYRAPELLVGDTQY 178

Query: 291 DYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKSLRPTIPKH------------- 337
               DV++ G    ELLTG+  + G + +   + +++K+L   IP+H             
Sbjct: 179 GPPVDVWAIGCVFAELLTGQPLWPGKSDVD-QLYLIRKTLGDLIPRHQQIFSTNQFFKGL 237

Query: 338 -----------------AHPRLAELLERCWQHDPTQRPNFSQITD 365
                                    L+ C Q DPT+R +  ++ +
Sbjct: 238 SIPEPETREPLESKFPNISSPALSFLKGCLQMDPTERLSCEELLE 282

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286

>gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha

 Score = 88.9 bits (220), Expect = 8e-20
 Identities = 62/239 (25%), Positives = 115/239 (48%), Gaps = 8/239 (3%)

Query: 124 VASGSYGD--LYKGTYCSQEVAIKVLKPEC-VNTEMLKEFSQEVYIMRKIRHKNVVQFIG 180
           +  G++G   L K     +  A+K+LK E  V  + +     E  +++  RH  +     
Sbjct: 3   LGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKY 62

Query: 181 ACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLH-QNNIIHRD 239
           +      LC V E+   G ++  L +++ VF          ++   ++YLH + N+++RD
Sbjct: 63  SFQTHDRLCFVMEYANGGELFFHLSRER-VFSEDRARFYGAEIVSALDYLHSEKNVVYRD 121

Query: 240 LKTANLLMDENGVVKVADFGVARVQAQSG-VMTAETGTYRWMAPEVIEHKPYDYKADVFS 298
           LK  NL++D++G +K+ DFG+ +   + G  M    GT  ++APEV+E   Y    D + 
Sbjct: 122 LKLENLMLDKDGHIKITDFGLCKEGIKDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWG 181

Query: 299 FGIALWELLTGELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRLAELLERCWQHDPTQR 357
            G+ ++E++ G LP+      +    ++ + +R   P+   P    LL    + DP QR
Sbjct: 182 LGVVMYEMMCGRLPFYNQDHEKLFELILMEEIR--FPRTLSPEAKSLLSGLLKKDPKQR 238

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325

>gnl|CDD|133217 cd05086, PTKc_Aatyk2, Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2

 Score = 87.6 bits (217), Expect = 1e-19
 Identities = 64/260 (24%), Positives = 123/260 (47%), Gaps = 29/260 (11%)

Query: 130 GDLYKGTYCSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLC 189
            ++Y  T  ++ V +K LK    + E   EF Q+    R ++H N++Q +G C       
Sbjct: 14  SEIYTDTGVARVV-VKELKANASSKEQ-NEFLQQGDPYRILQHPNILQCLGQCVEAIPYL 71

Query: 190 IVTEFMARGSIYDFLHKQKGVF---QLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLL 246
           +V E+   G +  +L +++      QL  L ++A +++ G+ ++H++N +H DL   N  
Sbjct: 72  LVFEYCELGDLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHKHNFLHSDLALRNCF 131

Query: 247 MDENGVVKVADFGVARVQAQSGVMTAETGTY---RWMAPEVI-----------EHKPYDY 292
           +  +  VKV D+G+   + +   +  E       RW+APE++           + KP   
Sbjct: 132 LTSDLTVKVGDYGIGPSRYKEDYIETEDDKCVPLRWLAPELVGEFHGGLITAEQTKP--- 188

Query: 293 KADVFSFGIALWELL-TGELPYAGLTPLQAAVGVVQ----KSLRPTIPKHAHPRLAELLE 347
            ++V++ G+ LWEL      PY+ L+  +    V++    K  +P +      R  E+L+
Sbjct: 189 -SNVWALGVTLWELFENAAQPYSHLSDREVLNHVIKDQQVKLFKPQLELPYSERWYEVLQ 247

Query: 348 RCWQHDPTQRPNFSQITDIL 367
            CW   P +R    ++  +L
Sbjct: 248 FCWL-SPEKRATAEEVHRLL 266

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage spermatogenesis. Although it is classified as a tyr kinase based on sequence similarity and the phylogenetic tree, Aatyk2 has been characterized as a serine/threonine kinase. Length = 268

>gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma

 Score = 88.6 bits (219), Expect = 1e-19
 Identities = 50/194 (25%), Positives = 97/194 (50%), Gaps = 5/194 (2%)

Query: 124 VASGSYGD--LYKGTYCSQEVAIKVLKPECV-NTEMLKEFSQEVYIMRKIRHKNVVQFIG 180
           +  G++G   L +     +  A+K+LK E +   + +     E  +++  RH  +     
Sbjct: 3   LGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKY 62

Query: 181 ACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDL 240
           +      LC V E++  G ++  L +++ VF          ++   ++YLH   I++RDL
Sbjct: 63  SFQTKDRLCFVMEYVNGGELFFHLSRER-VFSEDRTRFYGAEIVSALDYLHSGKIVYRDL 121

Query: 241 KTANLLMDENGVVKVADFGVARVQ-AQSGVMTAETGTYRWMAPEVIEHKPYDYKADVFSF 299
           K  NL++D++G +K+ DFG+ +     +  M    GT  ++APEV+E   Y    D +  
Sbjct: 122 KLENLMLDKDGHIKITDFGLCKEGITDAATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGL 181

Query: 300 GIALWELLTGELPY 313
           G+ ++E++ G LP+
Sbjct: 182 GVVMYEMMCGRLPF 195

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328

>gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85

 Score = 87.5 bits (217), Expect = 1e-19
 Identities = 74/280 (26%), Positives = 130/280 (46%), Gaps = 48/280 (17%)

Query: 116 KQLKIECKVASGSYGDLYKG--TYCSQEVAIKVLK---PECVNTEMLKEFSQEVYIMRKI 170
           KQL+   K+  G+Y  +YKG      + VA+K +     E   +  ++E S    +M+++
Sbjct: 3   KQLE---KLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREIS----LMKEL 55

Query: 171 RHKNVVQFIGACTRPPNLCIVTEFMARG-SIYDFLHKQKGVFQLTSLLKVAIDVSKGMNY 229
           +H+N+V+          L +V E+M +    Y   H  +G     ++      + KG+ +
Sbjct: 56  KHENIVRLHDVIHTENKLMLVFEYMDKDLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAF 115

Query: 230 LHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGV----MTAETGTYRWMAPEVI 285
            H+N ++HRDLK  NLL+++ G +K+ADFG+AR     G+     + E  T  + AP+V+
Sbjct: 116 CHENRVLHRDLKPQNLLINKRGELKLADFGLARA---FGIPVNTFSNEVVTLWYRAPDVL 172

Query: 286 -EHKPYDYKADVFSFGIALWELLTGELPYAGL--------------TPLQAAVGVVQKS- 329
              + Y    D++S G  + E++TG   + G               TP ++    + +  
Sbjct: 173 LGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQLLKIFRIMGTPTESTWPGISQLP 232

Query: 330 -LRPTIPK-----------HAHPRLAELLERCWQHDPTQR 357
             +PT P+           HA P   +LL R  Q +P  R
Sbjct: 233 EYKPTFPRYPPQDLQQLFPHADPLGIDLLHRLLQLNPELR 272

Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284

>gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase

 Score = 88.1 bits (219), Expect = 2e-19
 Identities = 82/298 (27%), Positives = 136/298 (45%), Gaps = 58/298 (19%)

Query: 110 VWEIDAKQLKIECKVASGSYGDLYKG--TYCSQEVAIKVLKPECVNTEMLKEFSQEVYIM 167
           VWE+  +   +   V SG+YG +     T   ++VAIK L     +    K   +E+ ++
Sbjct: 10  VWEVPDRYQNLS-PVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLL 68

Query: 168 RKIRHKNVVQFIGACTRPPNL------CIVTEFMARGSIYDFLHKQK-----GVFQLTSL 216
           + + H+NV+  +   T   +L       +VT  M    + + +  QK       F +  +
Sbjct: 69  KHMDHENVIGLLDVFTPASSLEDFQDVYLVTHLMGA-DLNNIVKCQKLSDDHIQFLVYQI 127

Query: 217 LKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAETGT 276
           L+       G+ Y+H   IIHRDLK +N+ ++E+  +K+ DFG+AR       MT    T
Sbjct: 128 LR-------GLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLAR-HTDDE-MTGYVAT 178

Query: 277 YRW-MAPEVIEHK-PYDYKADVFSFGIALWELLTGELPYAG------LTPLQAAVG---- 324
            RW  APE++ +   Y+   D++S G  + ELLTG+  + G      L  +   VG    
Sbjct: 179 -RWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDHIDQLKRIMNLVGTPDE 237

Query: 325 -VVQK-----------SLRPTIPKH--------AHPRLAELLERCWQHDPTQRPNFSQ 362
            ++QK           SL P +PK         A+P   +LLE+    DP +R   ++
Sbjct: 238 ELLQKISSESARNYIQSL-PQMPKKDFKEVFSGANPLAIDLLEKMLVLDPDKRITAAE 294

Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343

>gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein

 Score = 87.8 bits (218), Expect = 2e-19
 Identities = 72/288 (25%), Positives = 122/288 (42%), Gaps = 53/288 (18%)

Query: 132 LYKGTYCSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIV 191
           L K    +  VA+K +  +  + E LK   QE+   R+++H N++ ++ +      L +V
Sbjct: 18  LAKHKPTNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSFIVDSELYVV 77

Query: 192 TEFMARGSIYDFLHKQKGVFQLTSLLKVAI-----DVSKGMNYLHQNNIIHRDLKTANLL 246
           +  MA GS  D L   K  F    L ++AI     DV   ++Y+H    IHR +K +++L
Sbjct: 78  SPLMAYGSCEDLL---KTHFP-EGLPELAIAFILKDVLNALDYIHSKGFIHRSVKASHIL 133

Query: 247 MDENGVVKVADFGVARVQAQSGVMTA--------ETGTYRWMAPEVIEH--KPYDYKADV 296
           +  +G V ++    +    + G                  W++PEV++   + Y+ K+D+
Sbjct: 134 LSGDGKVVLSGLRYSVSMIKHGKRQRVVHDFPKSSVKNLPWLSPEVLQQNLQGYNEKSDI 193

Query: 297 FSFGIALWELLTGELPYAGLTP----LQAAVGVVQKSL-RPTIP---------------- 335
           +S GI   EL  G +P+  +      L+   G V   L + T P                
Sbjct: 194 YSVGITACELANGHVPFKDMPATQMLLEKVRGTVPCLLDKSTYPLYEDSMSQSRSSNEHP 253

Query: 336 ----KHAHP---RLAE----LLERCWQHDPTQRPNFSQITD--ILKQM 370
                  HP     +E     +E C Q DP  RP+ SQ+ +    KQ 
Sbjct: 254 NNRDSVDHPYTRTFSEHFHQFVELCLQRDPESRPSASQLLNHSFFKQC 301

Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314

>gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10

 Score = 87.4 bits (217), Expect = 2e-19
 Identities = 54/198 (27%), Positives = 101/198 (51%), Gaps = 15/198 (7%)

Query: 123 KVASGSYGDLYKG--TYCSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQF-- 178
           ++  G+YG +Y+   T   + VA+K ++ +     +     +E+ ++  +RH N+V+   
Sbjct: 14  RIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNIVELKE 73

Query: 179 IGACTRPPNLCIVTEF----MARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNN 234
           +       ++ +V E+    +A       L      F  + +  + + + +G+ YLH+N 
Sbjct: 74  VVVGKHLDSIFLVMEYCEQDLAS-----LLDNMPTPFSESQVKCLMLQLLRGLQYLHENF 128

Query: 235 IIHRDLKTANLLMDENGVVKVADFGVARV-QAQSGVMTAETGTYRWMAPEVI-EHKPYDY 292
           IIHRDLK +NLL+ + G +K+ADFG+AR     +  MT +  T  + APE++     Y  
Sbjct: 129 IIHRDLKVSNLLLTDKGCLKIADFGLARTYGLPAKPMTPKVVTLWYRAPELLLGCTTYTT 188

Query: 293 KADVFSFGIALWELLTGE 310
             D+++ G  L ELL  +
Sbjct: 189 AIDMWAVGCILAELLAHK 206

Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309

>gnl|CDD|153200 cd04928, ACT_TyrKc, Uncharacterized, N-terminal ACT domain of an Arabidopsis/Oryza predicted tyrosine kinase and other related ACT domains

 Score = 81.1 bits (200), Expect = 3e-19
 Identities = 32/52 (61%), Positives = 39/52 (75%)

Query: 13 ELTSLLGEIGLNIQEAHAFSTVDGFSLDVFVVDGWPYDETEDLKNVLAKEIL 64
          +L+SLLG++GLNI EAHAFST DG +LD+FVV GW   ET  L + L KEI 
Sbjct: 17 QLSSLLGDLGLNIAEAHAFSTDDGLALDIFVVTGWKRGETAALGHALQKEID 68

This CD includes a novel, yet uncharacterized, N-terminal ACT domain of an Arabidopsis/Oryza predicted tyrosine kinase and other related ACT domains. Members of this CD belong to the superfamily of ACT regulatory domains. Length = 68

>gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like

 Score = 87.1 bits (216), Expect = 3e-19
 Identities = 64/198 (32%), Positives = 101/198 (51%), Gaps = 10/198 (5%)

Query: 118 LKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNV 175
            KIE K+  G+YG +YKG      Q VA+K ++ E     +     +E+ ++++++H N+
Sbjct: 3   TKIE-KIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNI 61

Query: 176 VQFIGACTRPPNLCIVTEF--MARGSIYDFLHKQKGVFQLTSLLKVAI-DVSKGMNYLHQ 232
           V       +   L ++ EF  M      D L   KG +    L+K  +  + +G+ + H 
Sbjct: 62  VCLQDVLMQESRLYLIFEFLSMDLKKYLDSL--PKGQYMDAELVKSYLYQILQGILFCHS 119

Query: 233 NNIIHRDLKTANLLMDENGVVKVADFGVAR-VQAQSGVMTAETGTYRWMAPEVIEHKP-Y 290
             ++HRDLK  NLL+D  GV+K+ADFG+AR       V T E  T  + APEV+   P Y
Sbjct: 120 RRVLHRDLKPQNLLIDNKGVIKLADFGLARAFGIPVRVYTHEVVTLWYRAPEVLLGSPRY 179

Query: 291 DYKADVFSFGIALWELLT 308
               D++S G    E+ T
Sbjct: 180 STPVDIWSIGTIFAEMAT 197

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285

>gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants

 Score = 87.8 bits (218), Expect = 3e-19
 Identities = 81/300 (27%), Positives = 134/300 (44%), Gaps = 73/300 (24%)

Query: 112 EIDAKQLKIECKVASGSYGDLYKGTYCS-------QEVAIKVLKPECVNTEMLKEFSQEV 164
           E+D K + I+  +  G+YG       CS       ++VAIK +     N    K   +E+
Sbjct: 2   EVDTKYVPIKP-IGRGAYG-----IVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREI 55

Query: 165 YIMRKIRHKNVVQFIGACTRPPN------LCIVTEFMARGSIYDFL---------HKQKG 209
            ++R + H+NV+  I     PP+      + IV E M    ++  +         H Q  
Sbjct: 56  KLLRHLDHENVIA-IKDIMPPPHREAFNDVYIVYELMDT-DLHQIIRSSQTLSDDHCQYF 113

Query: 210 VFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSG- 268
           ++QL           +G+ Y+H  N++HRDLK +NLL++ N  +K+ DFG+AR  ++ G 
Sbjct: 114 LYQLL----------RGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARTTSEKGD 163

Query: 269 VMTAETGTYRWMAPEVI-EHKPYDYKADVFSFGIALWELLTGELPYAGL----------- 316
            MT    T  + APE++     Y    DV+S G    ELL  +  + G            
Sbjct: 164 FMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKDYVHQLKLITE 223

Query: 317 ---TPLQAAVGVVQ--------KSLRPTIPK--------HAHPRLAELLERCWQHDPTQR 357
              +P +  +G ++        +SL P  P+        HA+P   +LLE+    DP++R
Sbjct: 224 LLGSPSEEDLGFIRNEKARRYIRSL-PYTPRQSFARLFPHANPLAIDLLEKMLVFDPSKR 282

Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337

>gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases

 Score = 87.1 bits (216), Expect = 4e-19
 Identities = 63/220 (28%), Positives = 104/220 (47%), Gaps = 34/220 (15%)

Query: 116 KQLKIECKVASGSYGDLY----KGTYCSQEVAIKVLKPECV-NTEMLKEFSQEVYIMRKI 170
           K  +I  +V  G YG ++    K T   + VA+K +K   +     ++    E  I+   
Sbjct: 1   KDFQILTQVGQGGYGQVFLAKKKDT--GEIVALKRMKKSLLFKLNEVRHVLTERDILTTT 58

Query: 171 RHKNVVQFIGACTRPPNLCIVTEFMARGSIYDF---------LHKQKGVFQLTSLLKVAI 221
           + + +V+ + A      L +  E++  G   DF         L +    F +  +   A+
Sbjct: 59  KSEWLVKLLYAFQDDEYLYLAMEYVPGG---DFRTLLNNLGVLSEDHARFYMAEMF-EAV 114

Query: 222 DVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMT---AETGTYR 278
           D       LH+   IHRDLK  N L+D +G +K+ DFG++      G++T   +  G+  
Sbjct: 115 DA------LHELGYIHRDLKPENFLIDASGHIKLTDFGLS-----KGIVTYANSVVGSPD 163

Query: 279 WMAPEVIEHKPYDYKADVFSFGIALWELLTGELPYAGLTP 318
           +MAPEV+  K YD+  D +S G  L+E L G  P++G TP
Sbjct: 164 YMAPEVLRGKGYDFTVDYWSLGCMLYEFLCGFPPFSGSTP 203

Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333

>gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta

 Score = 86.6 bits (214), Expect = 5e-19
 Identities = 45/129 (34%), Positives = 77/129 (59%), Gaps = 2/129 (1%)

Query: 188 LCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLM 247
           L  V E++  G +  +  +Q G F+    +  A +++ G+ +LH   II+RDLK  N+++
Sbjct: 76  LYFVMEYVNGGDLM-YQIQQVGRFKEPHAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVML 134

Query: 248 DENGVVKVADFGVARVQAQSGVMTAE-TGTYRWMAPEVIEHKPYDYKADVFSFGIALWEL 306
           D  G +K+ADFG+ +     GV T    GT  ++APE+I ++PY    D ++FG+ L+E+
Sbjct: 135 DSEGHIKIADFGMCKENMWDGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEM 194

Query: 307 LTGELPYAG 315
           L G+ P+ G
Sbjct: 195 LAGQAPFEG 203

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323

>gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9

 Score = 86.7 bits (215), Expect = 5e-19
 Identities = 59/210 (28%), Positives = 102/210 (48%), Gaps = 33/210 (15%)

Query: 123 KVASGSYGDLYKG--TYCSQEVAIKVLKPECVNTEMLKE-FS----QEVYIMRKIRHKNV 175
           K+  G++G+++K       Q VA+K      V  E  KE F     +E+ I++ ++H+NV
Sbjct: 19  KIGQGTFGEVFKARHKKTKQIVALKK-----VLMENEKEGFPITALREIKILQLLKHENV 73

Query: 176 VQFIGACTRPPNLCIVTEFMARGSIY---DF--------LHKQKGVFQLTSLLKVAIDVS 224
           V  I  C              +GS Y   +F        L  +   F L+ + KV   + 
Sbjct: 74  VNLIEICRTKAT----PYNRYKGSFYLVFEFCEHDLAGLLSNKNVKFTLSEIKKVMKMLL 129

Query: 225 KGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARV-----QAQSGVMTAETGTYRW 279
            G+ Y+H+N I+HRD+K AN+L+ ++G++K+ADFG+AR       ++    T    T  +
Sbjct: 130 NGLYYIHRNKILHRDMKAANILITKDGILKLADFGLARAFSLSKNSKPNRYTNRVVTLWY 189

Query: 280 MAPEV-IEHKPYDYKADVFSFGIALWELLT 308
             PE+ +  + Y    D++  G  + E+ T
Sbjct: 190 RPPELLLGERDYGPPIDMWGAGCIMAEMWT 219

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310

>gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins

 Score = 86.2 bits (214), Expect = 7e-19
 Identities = 55/174 (31%), Positives = 83/174 (47%), Gaps = 34/174 (19%)

Query: 163 EVYIMRKIRHKNVVQFIG-ACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLL---K 218
           E+ I++K++H NVV  I  A  RP           RGS+Y           L+ LL    
Sbjct: 57  EIKILKKLKHPNVVPLIDMAVERPDK-----SKRKRGSVYMVTPYM--DHDLSGLLENPS 109

Query: 219 VAIDVSK----------GMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARV----- 263
           V +  S+          G+NYLH+N+I+HRD+K AN+L+D  G++K+ADFG+AR      
Sbjct: 110 VKLTESQIKCYMLQLLEGINYLHENHILHRDIKAANILIDNQGILKIADFGLARPYDGPP 169

Query: 264 ---QAQSGVMTAE-TG--TYRWM-APEVIEH-KPYDYKADVFSFGIALWELLTG 309
              +   G  T + T     RW   PE++   + Y    D++  G    E+ T 
Sbjct: 170 PNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTR 223

Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311

>gnl|CDD|133209 cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

 Score = 85.3 bits (211), Expect = 7e-19
 Identities = 67/259 (25%), Positives = 120/259 (46%), Gaps = 37/259 (14%)

Query: 122 CKVASGSYGDLYKGTYCSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGA 181
            +   G YG+L+K      EV +KVL  +  +    + F +   +M ++ HK++V   G 
Sbjct: 15  IRREVGDYGELHK-----TEVLLKVL--DKSHRNYSESFFEAASMMSQLSHKHLVLNYGV 67

Query: 182 CTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLK 241
           C       +V E++  GS+  +L K K +  ++  L+VA  ++  +++L    + H ++ 
Sbjct: 68  CVCGDESIMVQEYVKFGSLDTYLKKNKNLINISWKLEVAKQLAWALHFLEDKGLTHGNVC 127

Query: 242 TANLLMDENG--------VVKVADFGVARVQAQSGVMTAETGTYR--WMAPEVIEH-KPY 290
             N+L+             +K++D G++       V+  E    R  W+ PE IE+ +  
Sbjct: 128 AKNVLLIREEDRKTGNPPFIKLSDPGISIT-----VLPKEILLERIPWVPPECIENPQNL 182

Query: 291 DYKADVFSFGIALWELLTG-ELPYAGLTPLQAAVGVVQKSLRPTIPKHAHP-----RLAE 344
              AD +SFG  LWE+ +G + P + L          QK L+    +H  P      LA 
Sbjct: 183 SLAADKWSFGTTLWEIFSGGDKPLSALDS--------QKKLQFYEDRHQLPAPKWTELAN 234

Query: 345 LLERCWQHDPTQRPNFSQI 363
           L+ +C  ++P  RP+F  I
Sbjct: 235 LINQCMDYEPDFRPSFRAI 253

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 258

>gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha

 Score = 86.2 bits (213), Expect = 7e-19
 Identities = 45/129 (34%), Positives = 78/129 (60%), Gaps = 2/129 (1%)

Query: 188 LCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLM 247
           L  V E++  G +   + +Q G F+    +  A ++S G+ +LH+  II+RDLK  N+++
Sbjct: 76  LYFVMEYVNGGDLMYHI-QQVGKFKEPQAVFYAAEISVGLFFLHRRGIIYRDLKLDNVML 134

Query: 248 DENGVVKVADFGVARVQAQSGVMTAE-TGTYRWMAPEVIEHKPYDYKADVFSFGIALWEL 306
           D  G +K+ADFG+ +     GV T    GT  ++APE+I ++PY    D +++G+ L+E+
Sbjct: 135 DSEGHIKIADFGMCKEHMVDGVTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEM 194

Query: 307 LTGELPYAG 315
           L G+ P+ G
Sbjct: 195 LAGQPPFDG 203

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323

>gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1

 Score = 85.7 bits (212), Expect = 8e-19
 Identities = 48/157 (30%), Positives = 82/157 (52%), Gaps = 8/157 (5%)

Query: 163 EVYIMRKIRHKNVVQFIGACTRPPNLCIVTEFMARGS----IYDFLHKQKGVFQLTSLLK 218
           E  I+ K+  + +V    A     +LC+V   M  G     IY+   +  G F       
Sbjct: 43  EKRILAKVHSRFIVSLAYAFQTKTDLCLVMTIMNGGDLRYHIYNVDEENPG-FPEPRACF 101

Query: 219 VAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAE--TGT 276
               +  G+ +LHQ  II+RDLK  N+L+D +G V+++D G+A V+ + G    +   GT
Sbjct: 102 YTAQIISGLEHLHQRRIIYRDLKPENVLLDNDGNVRISDLGLA-VELKDGQSKTKGYAGT 160

Query: 277 YRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPY 313
             +MAPE+++ + YD+  D F+ G+ L+E++    P+
Sbjct: 161 PGFMAPELLQGEEYDFSVDYFALGVTLYEMIAARGPF 197

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280

>gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7

 Score = 85.4 bits (211), Expect = 8e-19
 Identities = 43/153 (28%), Positives = 86/153 (56%), Gaps = 3/153 (1%)

Query: 163 EVYIMRKIRHKNVVQFIGACTRPPNLCIVTEFMARGSI-YDFLHKQKGVFQLTSLLKVAI 221
           E  I+ K+    +V    A     +LC+V   M  G + Y   +  +   ++  ++  + 
Sbjct: 43  EKEILEKVNSPFIVNLAYAFESKTHLCLVMSLMNGGDLKYHIYNVGERGLEMERVIHYSA 102

Query: 222 DVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSG-VMTAETGTYRWM 280
            ++ G+ +LH  +I++RD+K  N+L+D+ G  +++D G+A V+ + G  +T   GT  +M
Sbjct: 103 QITCGILHLHSMDIVYRDMKPENVLLDDQGNCRLSDLGLA-VELKDGKTITQRAGTNGYM 161

Query: 281 APEVIEHKPYDYKADVFSFGIALWELLTGELPY 313
           APE+++ +PY Y  D F+ G +++E++ G  P+
Sbjct: 162 APEILKEEPYSYPVDWFAMGCSIYEMVAGRTPF 194

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277

>gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein

 Score = 88.4 bits (219), Expect = 9e-19
 Identities = 64/235 (27%), Positives = 106/235 (45%), Gaps = 20/235 (8%)

Query: 139 SQEVAIKVLKPECVNTEML-KEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCI-VTEFMA 196
             EVAIK+L+ +    E     F +E  +  ++ H N+V  + +   PP L   V E++ 
Sbjct: 3   GHEVAIKLLRTDAPEEEHQRARFRRETALCARLYHPNIVALLDSGEAPPGLLFAVFEYVP 62

Query: 197 RGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGV---V 253
             ++ + L    G        ++ + V   +   H   I+HRDLK  N+++ + GV    
Sbjct: 63  GRTLREVLAAD-GALPAGETGRLMLQVLDALACAHNQGIVHRDLKPQNIMVSQTGVRPHA 121

Query: 254 KVADFGVARV-----QAQSGVMTAET---GTYRWMAPEVIEHKPYDYKADVFSFGIALWE 305
           KV DFG+  +      A    +T  T   GT  + APE +  +P    +D++++G+   E
Sbjct: 122 KVLDFGIGTLLPGVRDADVATLTRTTEVLGTPTYCAPEQLRGEPVTPNSDLYAWGLIFLE 181

Query: 306 LLTGELPYAGLTP---LQAAVGVVQKSLRPTIPKHAHPRLAELLERCWQHDPTQR 357
            LTG+    G +    L   +  V  SL P I  H    L ++L +    DP QR
Sbjct: 182 CLTGQRVVQGASVAEILYQQLSPVDVSLPPWIAGH---PLGQVLRKALNKDPRQR 233

This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266

>gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C

 Score = 85.6 bits (212), Expect = 1e-18
 Identities = 44/129 (34%), Positives = 76/129 (58%), Gaps = 2/129 (1%)

Query: 188 LCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLM 247
           L  V E++  G +  +  +Q G F+    +  A +++ G+ +LH   II+RDLK  N+++
Sbjct: 76  LYFVMEYVNGGDLM-YHIQQVGKFKEPHAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVML 134

Query: 248 DENGVVKVADFGVARVQAQSGVMTAE-TGTYRWMAPEVIEHKPYDYKADVFSFGIALWEL 306
           D  G +K+ADFG+ +     G  T    GT  ++APE+I ++PY    D ++FG+ L+E+
Sbjct: 135 DAEGHIKIADFGMCKENIFGGKTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEM 194

Query: 307 LTGELPYAG 315
           L G+ P+ G
Sbjct: 195 LAGQPPFDG 203

Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324

>gnl|CDD|133207 cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

 Score = 83.8 bits (207), Expect = 3e-18
 Identities = 64/233 (27%), Positives = 112/233 (48%), Gaps = 21/233 (9%)

Query: 142 VAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVTEFMARGSIY 201
           V +KVL P   + ++   F +   +M ++ H ++    G C R     +V EF+  G + 
Sbjct: 47  VVLKVLDPS--HRDIALAFFETASLMSQVSHIHLAFVHGVCVRGSENIMVEEFVEHGPLD 104

Query: 202 DFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGV-------VK 254
             L K+KG   +   + VA  ++  ++YL   N++H ++   N+L+   G+       +K
Sbjct: 105 VCLRKEKGRVPVAWKITVAQQLASALSYLEDKNLVHGNVCAKNILLARLGLAEGTSPFIK 164

Query: 255 VADFGVARVQAQSGVMTAETGTYR--WMAPEVIEH-KPYDYKADVFSFGIALWEL-LTGE 310
           ++D GV+        ++ E    R  W+APE +         AD +SFG  L E+   GE
Sbjct: 165 LSDPGVS-----FTALSREERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGE 219

Query: 311 LPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRLAELLERCWQHDPTQRPNFSQI 363
           +P    TP +      +K  R  +P+ +   LA L+ +C  ++PTQRP+F  I
Sbjct: 220 VPLKERTPSEKE-RFYEKKHR--LPEPSCKELATLISQCLTYEPTQRPSFRTI 269

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 274

>gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase

 Score = 84.5 bits (210), Expect = 3e-18
 Identities = 61/209 (29%), Positives = 98/209 (46%), Gaps = 36/209 (17%)

Query: 124 VASGSYGDLYKGTY--CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGA 181
           + SG+YG +         ++VAIK +     +    K   +E+ ++R +RH+N++  +  
Sbjct: 8   IGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHENIIGLLDI 67

Query: 182 CTRPP------NLCIVTEFMA--------RGSIYDFLHKQKGVFQLTSLLKVAIDVSKGM 227
             RPP      ++ IVTE M                 H Q  ++Q+           +G+
Sbjct: 68  -LRPPSPEDFNDVYIVTELMETDLHKVIKSPQPLTDDHIQYFLYQIL----------RGL 116

Query: 228 NYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQ----AQSGVMTAETGT--YRWMA 281
            YLH  N+IHRDLK +N+L++ N  +K+ DFG+AR       + G +T    T  YR  A
Sbjct: 117 KYLHSANVIHRDLKPSNILVNSNCDLKICDFGLARGVDPDEDEKGFLTEYVVTRWYR--A 174

Query: 282 PEVI-EHKPYDYKADVFSFGIALWELLTG 309
           PE++     Y    D++S G    ELLT 
Sbjct: 175 PELLLSSSRYTKAIDIWSVGCIFAELLTR 203

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330

>gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6

 Score = 83.9 bits (207), Expect = 3e-18
 Identities = 44/152 (28%), Positives = 82/152 (53%), Gaps = 1/152 (0%)

Query: 163 EVYIMRKIRHKNVVQFIGACTRPPNLCIVTEFMARGSI-YDFLHKQKGVFQLTSLLKVAI 221
           E  I+ K+  + VV    A      LC+V   M  G + +   H  +  F+    +  A 
Sbjct: 50  EKQILEKVNSRFVVSLAYAYETKDALCLVLTLMNGGDLKFHIYHMGEAGFEEGRAVFYAA 109

Query: 222 DVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAETGTYRWMA 281
           ++  G+  LHQ  I++RDLK  N+L+D++G ++++D G+A    +   +    GT  +MA
Sbjct: 110 EICCGLEDLHQERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQTIKGRVGTVGYMA 169

Query: 282 PEVIEHKPYDYKADVFSFGIALWELLTGELPY 313
           PEV++++ Y +  D ++ G  L+E++ G+ P+
Sbjct: 170 PEVVKNERYTFSPDWWALGCLLYEMIAGQSPF 201

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285

>gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase

 Score = 84.5 bits (209), Expect = 3e-18
 Identities = 60/239 (25%), Positives = 114/239 (47%), Gaps = 8/239 (3%)

Query: 124 VASGSYGDLYKGTYCSQEV--AIKVLKPECV--NTEMLKEFSQEVYIMRKIRHKNVVQFI 179
           +  GS+G +    + +     A+KVL+ + +    E     ++   +++ ++H  +V   
Sbjct: 3   IGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLH 62

Query: 180 GACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRD 239
            +      L  V +++  G ++  L +++   +  +    A +++  + YLH  NII+RD
Sbjct: 63  YSFQTADKLYFVLDYVNGGELFFHLQRERSFPEPRARFYAA-EIASALGYLHSLNIIYRD 121

Query: 240 LKTANLLMDENGVVKVADFGVARVQAQ-SGVMTAETGTYRWMAPEVIEHKPYDYKADVFS 298
           LK  N+L+D  G V + DFG+ +   + S   +   GT  ++APEV+  +PYD   D + 
Sbjct: 122 LKPENILLDSQGHVVLTDFGLCKEGIEHSKTTSTFCGTPEYLAPEVLRKQPYDRTVDWWC 181

Query: 299 FGIALWELLTGELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRLAELLERCWQHDPTQR 357
            G  L+E+L G  P+      +    ++ K LR  +  +       LLE   Q D T+R
Sbjct: 182 LGAVLYEMLYGLPPFYSRDTAEMYDNILNKPLR--LKPNISVSARHLLEGLLQKDRTKR 238

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323

>gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5

 Score = 83.9 bits (207), Expect = 3e-18
 Identities = 67/261 (25%), Positives = 127/261 (48%), Gaps = 12/261 (4%)

Query: 124 VASGSYGDLYKGTY--CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGA 181
           V  G+YG + K  +    + VAIK  K    N E+ +   +E+ ++R ++ +N+V+   A
Sbjct: 9   VGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKEA 68

Query: 182 CTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLK 241
             R   L +V E++ + ++ + L +         +      + K +++ H+N+I+HRD+K
Sbjct: 69  FRRRGKLYLVFEYVEK-NMLELLEEMPNGVPPEKVRSYIYQLIKAIHWCHKNDIVHRDIK 127

Query: 242 TANLLMDENGVVKVADFGVAR--VQAQSGVMTAETGTYRWMAPEVIEHKPYDYKADVFSF 299
             NLL+  N V+K+ DFG AR   +  +   T    T  + +PE++   PY    D++S 
Sbjct: 128 PENLLISHNDVLKLCDFGFARNLSEGSNANYTEYVATRWYRSPELLLGAPYGKAVDMWSV 187

Query: 300 GIALWELLTGELPYAGLTPLQAAVGVVQKSLRPTIPK-----HAHPRLAELLERCWQHDP 354
           G  L EL  G+  + G + +   +  +QK L P   +     +++PR   L      H  
Sbjct: 188 GCILGELSDGQPLFPGESEID-QLFTIQKVLGPLPAEQMKLFYSNPRFHGLRFPAVNHPQ 246

Query: 355 T-QRPNFSQITDILKQMMKEV 374
           + +R     ++ +L  +MK +
Sbjct: 247 SLERRYLGILSGVLLDLMKNL 267

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287

>gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional

 Score = 84.4 bits (209), Expect = 4e-18
 Identities = 57/223 (25%), Positives = 96/223 (43%), Gaps = 52/223 (23%)

Query: 127 GSYGDLYKG--TYCSQEVAIKVLKPECVNTEMLKEFS----------------QEVYIMR 168
           G+YG + K   T   + VAIK +K      E+  + +                +E+ IM 
Sbjct: 20  GTYGKVEKAYDTLTGKIVAIKKVK----IIEISNDVTKDRQLVGMCGIHFTTLRELKIMN 75

Query: 169 KIRHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVA------ID 222
           +I+H+N++  +        + +V + MA     D     K V      L  +      + 
Sbjct: 76  EIKHENIMGLVDVYVEGDFINLVMDIMA----SDL----KKVVDRKIRLTESQVKCILLQ 127

Query: 223 VSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGV------------- 269
           +  G+N LH+   +HRDL  AN+ ++  G+ K+ADFG+AR                    
Sbjct: 128 ILNGLNVLHKWYFMHRDLSPANIFINSKGICKIADFGLARRYGYPPYSDTLSKDETMQRR 187

Query: 270 --MTAETGTYRWMAPEVI-EHKPYDYKADVFSFGIALWELLTG 309
             MT++  T  + APE++   + Y +  D++S G    ELLTG
Sbjct: 188 EEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTG 230

Length = 335

>gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1

 Score = 84.1 bits (208), Expect = 4e-18
 Identities = 65/252 (25%), Positives = 116/252 (46%), Gaps = 40/252 (15%)

Query: 139 SQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRP-PNLCIVTEFMAR 197
            Q VAIK +        + K   +E+ +++ +RH+N++        P  ++  VTE +  
Sbjct: 35  GQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHENIISLSDIFISPLEDIYFVTELLGT 94

Query: 198 GSIYDFLHK--QKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKV 255
                 LH+       +   +      + +G+ Y+H   ++HRDLK +N+L++EN  +K+
Sbjct: 95  D-----LHRLLTSRPLEKQFIQYFLYQILRGLKYVHSAGVVHRDLKPSNILINENCDLKI 149

Query: 256 ADFGVARVQAQSGVMTAETGTYRWMAPEV-IEHKPYDYKADVFSFGIALWELLTGELPYA 314
            DFG+AR+Q     MT    T  + APE+ +  + YD + D++S G    E+L G+  + 
Sbjct: 150 CDFGLARIQDPQ--MTGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFP 207

Query: 315 GLTPL-QAAV----------GVVQ-----------KSL--RPTIP-----KHAHPRLAEL 345
           G   + Q ++           V+            +SL  R  +P     K+A P   +L
Sbjct: 208 GKDHVNQFSIITDLLGTPPDDVINTICSENTLRFVQSLPKREPVPFSEKFKNADPSAIDL 267

Query: 346 LERCWQHDPTQR 357
           LE+    DP +R
Sbjct: 268 LEKMLVFDPQKR 279

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328

>gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase

 Score = 83.1 bits (206), Expect = 5e-18
 Identities = 50/197 (25%), Positives = 95/197 (48%), Gaps = 11/197 (5%)

Query: 119 KIECKVASGSYGDLYKG--TYCSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIR-HKNV 175
           KI  K+  G++ ++ K       +  AIK +K    + E +     E+  +R++  H N+
Sbjct: 2   KILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNNLR-EIQALRRLSPHPNI 60

Query: 176 VQFIGACTRPPN--LCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQN 233
           ++ I          L +V E M   ++Y+ +  +K       +      + K ++++H+N
Sbjct: 61  LRLIEVLFDRKTGRLALVFELM-DMNLYELIKGRKRPLPEKRVKSYMYQLLKSLDHMHRN 119

Query: 234 NIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAETGTYRWM-APE-VIEHKPYD 291
            I HRD+K  N+L+ ++ ++K+ADFG  R        T    T RW  APE ++    Y 
Sbjct: 120 GIFHRDIKPENILIKDD-ILKLADFGSCRGIYSKPPYTEYIST-RWYRAPECLLTDGYYG 177

Query: 292 YKADVFSFGIALWELLT 308
            K D+++ G   +E+L+
Sbjct: 178 PKMDIWAVGCVFFEILS 194

Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282

>gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota

 Score = 84.0 bits (207), Expect = 6e-18
 Identities = 58/227 (25%), Positives = 119/227 (52%), Gaps = 15/227 (6%)

Query: 143 AIKVLKPECVNTEMLKEFSQ-EVYIMRKIRHKNVVQFIGACTRPPN-LCIVTEFMARGSI 200
           A+KV+K E VN +   ++ Q E ++  +  +   +  + +C +  + L  V E++  G +
Sbjct: 24  AMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNGGDL 83

Query: 201 YDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGV 260
              + +Q+ + +  +    A ++S  +NYLH+  II+RDLK  N+L+D  G +K+ D+G+
Sbjct: 84  MFHMQRQRKLPEEHARFYSA-EISLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGM 142

Query: 261 ARVQAQSGVMTAE-TGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPY----AG 315
            +   + G  T+   GT  ++APE++  + Y +  D ++ G+ ++E++ G  P+    + 
Sbjct: 143 CKEGLRPGDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSS 202

Query: 316 LTPLQAAVG-----VVQKSLRPTIPKHAHPRLAELLERCWQHDPTQR 357
             P Q         +++K +R  IP+    + A +L+     DP +R
Sbjct: 203 DNPDQNTEDYLFQVILEKQIR--IPRSLSVKAASVLKSFLNKDPKER 247

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329

>gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B

 Score = 83.7 bits (207), Expect = 6e-18
 Identities = 56/217 (25%), Positives = 103/217 (47%), Gaps = 5/217 (2%)

Query: 143 AIKVLKPEC-VNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVTEFMARGSIY 201
           A+K+LK E  +  + +     E  +++  RH  +     +      LC V E+   G ++
Sbjct: 24  AMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYSFQTHDRLCFVMEYANGGELF 83

Query: 202 DFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVA 261
             L ++  VF          ++   + YLH  ++++RDLK  NL++D++G +K+ DFG+ 
Sbjct: 84  FHLSRE-RVFSEDRARFYGAEIVSALGYLHSCDVVYRDLKLENLMLDKDGHIKITDFGLC 142

Query: 262 RVQAQSG-VMTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPYAGLTPLQ 320
           +     G  M    GT  ++APEV+E   Y    D +  G+ ++E++ G LP+      +
Sbjct: 143 KEGISDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEK 202

Query: 321 AAVGVVQKSLRPTIPKHAHPRLAELLERCWQHDPTQR 357
               ++ + +R   P+   P    LL    + DP QR
Sbjct: 203 LFELILMEEIR--FPRTLSPEAKSLLAGLLKKDPKQR 237

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323

>gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase

 Score = 82.9 bits (205), Expect = 8e-18
 Identities = 48/176 (27%), Positives = 88/176 (50%), Gaps = 7/176 (3%)

Query: 188 LCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLM 247
           L ++ +++  G ++  L+ Q+  F  + +     ++   +++LHQ  II+RD+K  N+L+
Sbjct: 80  LHLILDYVNGGELFTHLY-QREHFTESEVRVYIAEIVLALDHLHQLGIIYRDIKLENILL 138

Query: 248 DENGVVKVADFGVARVQAQSGVMTAET--GTYRWMAPEVIEHKP--YDYKADVFSFGIAL 303
           D  G V + DFG+++         A +  GT  +MAPEVI      +D   D +S G+  
Sbjct: 139 DSEGHVVLTDFGLSKEFLAEEEERAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLT 198

Query: 304 WELLTGELPYA--GLTPLQAAVGVVQKSLRPTIPKHAHPRLAELLERCWQHDPTQR 357
           +ELLTG  P+   G    Q+ +       +P  PK       + +++  + DP +R
Sbjct: 199 FELLTGASPFTVDGEQNSQSEISRRILKSKPPFPKTMSAEARDFIQKLLEKDPKKR 254

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288

>gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1

 Score = 82.7 bits (205), Expect = 9e-18
 Identities = 58/203 (28%), Positives = 99/203 (48%), Gaps = 25/203 (12%)

Query: 123 KVASGSYGDLYKGTYCSQE--VAIKVLKPECVNTEMLKEFS-------QEVYIMRKIRHK 173
           ++  G+YG +Y+         VA+K LK       M KE         +E+ I+ K++H 
Sbjct: 12  RIEEGTYGVVYRARDKKTGEIVALKKLK-------MEKEKEGFPITSLREINILLKLQHP 64

Query: 174 NVVQF--IGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLH 231
           N+V    +   +    + +V E++    +   +   K  F  + +  + + +  G+ +LH
Sbjct: 65  NIVTVKEVVVGSNLDKIYMVMEYVEH-DLKSLMETMKQPFLQSEVKCLMLQLLSGVAHLH 123

Query: 232 QNNIIHRDLKTANLLMDENGVVKVADFGVAR-VQAQSGVMTAETGT--YRWMAPEVIEHK 288
            N I+HRDLKT+NLL++  G++K+ DFG+AR   +     T    T  YR  APE++   
Sbjct: 124 DNWILHRDLKTSNLLLNNRGILKICDFGLAREYGSPLKPYTQLVVTLWYR--APELLLGA 181

Query: 289 P-YDYKADVFSFGIALWELLTGE 310
             Y    D++S G    ELLT +
Sbjct: 182 KEYSTAIDMWSVGCIFAELLTKK 204

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293

>gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5

 Score = 82.3 bits (203), Expect = 9e-18
 Identities = 43/154 (27%), Positives = 78/154 (50%), Gaps = 1/154 (0%)

Query: 163 EVYIMRKIRHKNVVQFIGACTRPPNLCIVTEFMARGSI-YDFLHKQKGVFQLTSLLKVAI 221
           E  I+ K+  + VV    A      LC+V   M  G + +   +     F+    L  A 
Sbjct: 50  EKQILEKVNSQFVVNLAYAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFEEERALFYAA 109

Query: 222 DVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAETGTYRWMA 281
           ++  G+  LH+ N ++RDLK  N+L+D+ G ++++D G+A    +   +    GT  +MA
Sbjct: 110 EILCGLEDLHRENTVYRDLKPENILLDDYGHIRISDLGLAVKIPEGESIRGRVGTVGYMA 169

Query: 282 PEVIEHKPYDYKADVFSFGIALWELLTGELPYAG 315
           PEV+ ++ Y    D +  G  ++E++ G+ P+ G
Sbjct: 170 PEVLNNQRYTLSPDYWGLGCLIYEMIEGQSPFRG 203

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285

>gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases

 Score = 83.1 bits (206), Expect = 1e-17
 Identities = 63/218 (28%), Positives = 104/218 (47%), Gaps = 36/218 (16%)

Query: 115 AKQLKIECKVASGSYGDLYKGTYC--SQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRH 172
             + +    +  G+YG +   T+     +VAIK + P    T   +   +E+ I+R+ +H
Sbjct: 4   GPRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTL-REIKILRRFKH 62

Query: 173 KNVVQFIGACTRPPNLC------IVTEFMARGSIYDFL--------HKQKGVFQLTSLLK 218
           +N++  I    RPP+        IV E M    +Y  +        H Q  ++Q+   LK
Sbjct: 63  ENIIG-ILDIIRPPSFESFNDVYIVQELM-ETDLYKLIKTQHLSNDHIQYFLYQILRGLK 120

Query: 219 VAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQ----SGVMTAET 274
                     Y+H  N++HRDLK +NLL++ N  +K+ DFG+AR+       +G +T   
Sbjct: 121 ----------YIHSANVLHRDLKPSNLLLNTNCDLKICDFGLARIADPEHDHTGFLTEYV 170

Query: 275 GTYRWM-APEV-IEHKPYDYKADVFSFGIALWELLTGE 310
            T RW  APE+ +  K Y    D++S G  L E+L+  
Sbjct: 171 AT-RWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNR 207

Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336

>gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2

 Score = 82.7 bits (204), Expect = 1e-17
 Identities = 67/254 (26%), Positives = 115/254 (45%), Gaps = 18/254 (7%)

Query: 124 VASGSYGD--LYKGTYCSQEVAIKVLKPECV--NTEMLKEFSQEVYIMRKIRHKNVVQFI 179
           +  GS+G   L K        A+KVL+ + +    E     ++   +++ ++H  +V   
Sbjct: 3   IGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLH 62

Query: 180 GACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRD 239
            +      L  V +++  G ++  L +++   +  +    A +V+  + YLH  NII+RD
Sbjct: 63  YSFQTAEKLYFVLDYVNGGELFFHLQRERCFLEPRARFYAA-EVASAIGYLHSLNIIYRD 121

Query: 240 LKTANLLMDENGVVKVADFGVARVQAQSGVMTAET-----GTYRWMAPEVIEHKPYDYKA 294
           LK  N+L+D  G V + DFG+ +     GV   ET     GT  ++APEV+  +PYD   
Sbjct: 122 LKPENILLDSQGHVVLTDFGLCK----EGVEPEETTSTFCGTPEYLAPEVLRKEPYDRTV 177

Query: 295 DVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRLAELLERCWQHDP 354
           D +  G  L+E+L G  P+      Q    ++ K L+  +P        +LL      D 
Sbjct: 178 DWWCLGAVLYEMLYGLPPFYSRDVSQMYDNILHKPLQ--LPGGKTVAACDLLVGLLHKD- 234

Query: 355 TQRPNFSQITDILK 368
            QR       D L+
Sbjct: 235 -QRRRLGAKADFLE 247

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321

>gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta

 Score = 82.3 bits (203), Expect = 1e-17
 Identities = 59/206 (28%), Positives = 106/206 (51%), Gaps = 24/206 (11%)

Query: 124 VASGSYGDLY----KGTYCSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKI-----RHKN 174
           +  GS+G ++    KGT  +Q  AIK LK + V   ++ +  +   + +++      H  
Sbjct: 3   LGKGSFGKVFLAELKGT--NQFFAIKALKKDVV---LMDDDVECTMVEKRVLSLAWEHPF 57

Query: 175 VVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQK-GVFQLTSLLKVAIDVSKGMNYLHQN 233
           +           NL  V E++  G +    H Q    F L      A ++  G+ +LH  
Sbjct: 58  LTHLYCTFQTKENLFFVMEYLNGGDL--MFHIQSCHKFDLPRATFYAAEIICGLQFLHSK 115

Query: 234 NIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAET----GTYRWMAPEVIEHKP 289
            I++RDLK  N+L+D +G +K+ADFG+ +   ++ +  A+T    GT  ++APE++  + 
Sbjct: 116 GIVYRDLKLDNILLDTDGHIKIADFGMCK---ENMLGDAKTCTFCGTPDYIAPEILLGQK 172

Query: 290 YDYKADVFSFGIALWELLTGELPYAG 315
           Y+   D +SFG+ L+E+L G+ P+ G
Sbjct: 173 YNTSVDWWSFGVLLYEMLIGQSPFHG 198

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316

>gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase

 Score = 82.1 bits (203), Expect = 2e-17
 Identities = 47/162 (29%), Positives = 87/162 (53%), Gaps = 3/162 (1%)

Query: 152 VNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVF 211
           +   +  +  +E+ ++ +     +V F GA      + I  E M  GS+ D + K+ G  
Sbjct: 38  IKPAIRNQIIRELKVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSL-DQVLKKAGRI 96

Query: 212 QLTSLLKVAIDVSKGMNYLHQN-NIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVM 270
               L K++I V +G+ YL +   I+HRD+K +N+L++  G +K+ DFGV+  Q    + 
Sbjct: 97  PENILGKISIAVLRGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSG-QLIDSMA 155

Query: 271 TAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELP 312
            +  GT  +M+PE ++   Y  ++D++S G++L E+  G  P
Sbjct: 156 NSFVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYP 197

Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308

>gnl|CDD|173766 cd08226, PK_STRAD_beta, Pseudokinase domain of STE20-related kinase adapter protein beta

 Score = 81.2 bits (200), Expect = 4e-17
 Identities = 72/303 (23%), Positives = 124/303 (40%), Gaps = 64/303 (21%)

Query: 132 LYKGTYCSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIV 191
           L + T     V +++   E    E LK    EV +    RH N++      T    L ++
Sbjct: 18  LARHTPTGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVI 77

Query: 192 TEFMARGSIYDFL--HKQKGVFQ--LTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLM 247
           + FMA GS    L  +  +G+ +  + ++L  A+   +G+NYLHQN  IHR++K +++L+
Sbjct: 78  SPFMAYGSANSLLKTYFPEGMSEALIGNILFGAL---RGLNYLHQNGYIHRNIKASHILI 134

Query: 248 DENGVVKVADFGVARVQAQSGVMTA--------ETGTYRWMAPEVIEHKPYDY--KADVF 297
             +G+V ++         ++G             T    W++PE++    Y Y  K+D++
Sbjct: 135 SGDGLVSLSGLSHLYSLVRNGQKAKVVYDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIY 194

Query: 298 SFGIALWELLTGELPYAGL---------------TPLQAAV------------------- 323
           S GI   EL TG +P+  +               +PL                       
Sbjct: 195 SVGITACELATGRVPFQDMLRTQMLLQKLKGPPYSPLDITTFPCEESRMKNSQSGVDSGI 254

Query: 324 --GVVQKSLRPTI---------PKHAHPRLAELLERCWQHDPTQRPNFSQITD--ILKQM 370
              VV   +  T+          K   P    L+E C Q DP +RP+ S +      KQ+
Sbjct: 255 GESVVAAGMTQTMTSERLRTPSSKTFSPAFQNLVELCLQQDPEKRPSASSLLSHAFFKQV 314

Query: 371 MKE 373
            ++
Sbjct: 315 KEQ 317

Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. STRAD-beta is also referred to as ALS2CR2 (Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 2 protein), since the human gene encoding it is located within the juvenile ALS2 critical region on chromosome 2q33-q34. It is not linked to the development of ALS2. Length = 328

>gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase

 Score = 81.0 bits (200), Expect = 4e-17
 Identities = 64/240 (26%), Positives = 120/240 (50%), Gaps = 13/240 (5%)

Query: 127 GSYGDLYK-----GTYCSQEVAIKVLKPECV--NTEMLKEFSQEVYIMRKIRHKNVVQFI 179
           G YG +++     G    +  A+KVLK   +  N +       E  I+  ++H  +V  I
Sbjct: 7   GGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLI 66

Query: 180 GACTRPPNLCIVTEFMARGSIYDFLH-KQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHR 238
            A      L ++ E+++ G +  F+H +++G+F   +      ++S  + +LHQ  II+R
Sbjct: 67  YAFQTGGKLYLILEYLSGGEL--FMHLEREGIFMEDTACFYLSEISLALEHLHQQGIIYR 124

Query: 239 DLKTANLLMDENGVVKVADFGVARVQAQSGVMTAE-TGTYRWMAPEVIEHKPYDYKADVF 297
           DLK  N+L+D  G VK+ DFG+ +     G +T    GT  +MAPE++    +    D +
Sbjct: 125 DLKPENILLDAQGHVKLTDFGLCKESIHEGTVTHTFCGTIEYMAPEILMRSGHGKAVDWW 184

Query: 298 SFGIALWELLTGELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRLAELLERCWQHDPTQR 357
           S G  ++++LTG  P+      +    +++  L   +P +  P   +LL++  + +P+ R
Sbjct: 185 SLGALMYDMLTGAPPFTAENRKKTIDKILKGKL--NLPPYLTPEARDLLKKLLKRNPSSR 242

Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323

>gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional

 Score = 82.4 bits (203), Expect = 4e-17
 Identities = 47/153 (30%), Positives = 82/153 (53%), Gaps = 6/153 (3%)

Query: 227 MNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQS---GVMTAETGTYRWMAPE 283
           ++ +H   ++HRDLK+AN+ +   G++K+ DFG ++  + S    V ++  GT  ++APE
Sbjct: 182 LDEVHSRKMMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSVSLDVASSFCGTPYYLAPE 241

Query: 284 VIEHKPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRLA 343
           + E K Y  KAD++S G+ L+ELLT   P+ G +  +    V+     P  P      + 
Sbjct: 242 LWERKRYSKKADMWSLGVILYELLTLHRPFKGPSQREIMQQVLYGKYDP-FPCPVSSGMK 300

Query: 344 ELLERCWQHDPTQRPNFSQITDILKQMMKEVAS 376
            LL+     +P  RP   Q+  +  + +K VA+
Sbjct: 301 ALLDPLLSKNPALRPTTQQL--LHTEFLKYVAN 331

Length = 478

>gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase

 Score = 80.7 bits (199), Expect = 7e-17
 Identities = 83/311 (26%), Positives = 132/311 (42%), Gaps = 68/311 (21%)

Query: 110 VWEIDAKQLKIECKVASGSYGDLYKGTYCS-------QEVAIKVLKPECVNTEMLKEFSQ 162
           VWE+  +   +  +V SG+YG +     CS       ++VAIK L     +    K   +
Sbjct: 10  VWELPERYTSL-KQVGSGAYGSV-----CSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYR 63

Query: 163 EVYIMRKIRHKNVVQFIGACTRPP------NLCIVTEFMARGSIYDFLHKQKGV-FQLTS 215
           E+ +++ ++H+NV+  +   T         +  +V  +M        L K  G       
Sbjct: 64  ELTLLKHMQHENVIGLLDVFTSAVSGDEFQDFYLVMPYMQTD-----LQKIMGHPLSEDK 118

Query: 216 LLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAETG 275
           +  +   +  G+ Y+H   IIHRDLK  NL ++E+  +K+ DFG+AR       MT    
Sbjct: 119 VQYLVYQMLCGLKYIHSAGIIHRDLKPGNLAVNEDCELKILDFGLAR--HADAEMTGYVV 176

Query: 276 TYRWMAPEVIEH-KPYDYKADVFSFGIALWELLTGELPYAG------LTPLQAAVGV--- 325
           T  + APEVI +   Y+   D++S G  + E+LTG+  + G      LT +    GV   
Sbjct: 177 TRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGP 236

Query: 326 --VQK-----------SLRPTIPK--------HAHPRLAELLERCWQHDPTQR------- 357
             VQK           SL P  P+         A P+  +LLE+  + D  +R       
Sbjct: 237 EFVQKLEDKAAKSYIKSL-PKYPRKDFSTLFPKASPQAVDLLEKMLELDVDKRLTATEAL 295

Query: 358 --PNFSQITDI 366
             P F    D 
Sbjct: 296 EHPYFDSFRDA 306

Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342

>gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional

 Score = 80.8 bits (199), Expect = 9e-17
 Identities = 45/150 (30%), Positives = 76/150 (50%), Gaps = 4/150 (2%)

Query: 163 EVYIMRKIRHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAID 222
           E +I+R I H +++Q  G  T     C++     +  +Y +L  ++ +  +  +L +   
Sbjct: 133 EAHILRAINHPSIIQLKGTFTYNKFTCLILP-RYKTDLYCYLAAKRNI-AICDILAIERS 190

Query: 223 VSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVA--RVQAQSGVMTAETGTYRWM 280
           V + + YLH+N IIHRD+K  N+ ++  G V + DFG A   V   +       GT    
Sbjct: 191 VLRAIQYLHENRIIHRDIKAENIFINHPGDVCLGDFGAACFPVDINANKYYGWAGTIATN 250

Query: 281 APEVIEHKPYDYKADVFSFGIALWELLTGE 310
           APE++   PY    D++S GI L+E+ T  
Sbjct: 251 APELLARDPYGPAVDIWSAGIVLFEMATCH 280

Length = 391

>gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1

 Score = 79.3 bits (195), Expect = 2e-16
 Identities = 49/152 (32%), Positives = 85/152 (55%), Gaps = 3/152 (1%)

Query: 162 QEVYIMRKIRHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAI 221
           +E+ ++ +     +V F GA      + I  E M  GS+ D + K+ G      L KV+I
Sbjct: 52  RELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSL-DQVLKKAGRIPEQILGKVSI 110

Query: 222 DVSKGMNYLHQNN-IIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAETGTYRWM 280
            V KG+ YL + + I+HRD+K +N+L++  G +K+ DFGV+  Q    +  +  GT  +M
Sbjct: 111 AVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSG-QLIDSMANSFVGTRSYM 169

Query: 281 APEVIEHKPYDYKADVFSFGIALWELLTGELP 312
           +PE ++   Y  ++D++S G++L E+  G  P
Sbjct: 170 SPERLQGTHYSVQSDIWSMGLSLVEMAIGRYP 201

Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333

>gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases

 Score = 77.9 bits (192), Expect = 3e-16
 Identities = 43/155 (27%), Positives = 81/155 (52%), Gaps = 3/155 (1%)

Query: 163 EVYIMRKIRHKNVVQFIGACTRPPNLCIVTEFMARGSI-YDFLHKQKGVFQLTSLLKVAI 221
           E  I+ K+  + VV    A      LC+V   M  G + +   +     F     +  A 
Sbjct: 50  EKQILEKVNSRFVVSLAYAYETKDALCLVLTLMNGGDLKFHIYNMGNPGFDEERAVFYAA 109

Query: 222 DVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSG-VMTAETGTYRWM 280
           +++ G+  LH+  I++RDLK  N+L+D+ G ++++D G+A V+   G  +    GT  +M
Sbjct: 110 EITCGLEDLHRERIVYRDLKPENILLDDYGHIRISDLGLA-VEIPEGETIRGRVGTVGYM 168

Query: 281 APEVIEHKPYDYKADVFSFGIALWELLTGELPYAG 315
           APEV++++ Y +  D +  G  ++E++ G+ P+  
Sbjct: 169 APEVVKNERYTFSPDWWGLGCLIYEMIEGKSPFRQ 203

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285

>gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2

 Score = 78.6 bits (193), Expect = 4e-16
 Identities = 48/152 (31%), Positives = 85/152 (55%), Gaps = 3/152 (1%)

Query: 162 QEVYIMRKIRHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAI 221
           +E+ ++ +     +V F GA      + I  E M  GS+   L + K + +   L KV+I
Sbjct: 52  RELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKEAKRIPE-EILGKVSI 110

Query: 222 DVSKGMNYLHQ-NNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAETGTYRWM 280
            V +G+ YL + + I+HRD+K +N+L++  G +K+ DFGV+  Q    +  +  GT  +M
Sbjct: 111 AVLRGLAYLREKHQIMHRDVKPSNILVNSRGEIKLCDFGVSG-QLIDSMANSFVGTRSYM 169

Query: 281 APEVIEHKPYDYKADVFSFGIALWELLTGELP 312
           +PE ++   Y  ++D++S G++L EL  G  P
Sbjct: 170 SPERLQGTHYSVQSDIWSMGLSLVELAIGRYP 201

Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331

>gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3

 Score = 77.5 bits (191), Expect = 4e-16
 Identities = 74/277 (26%), Positives = 127/277 (45%), Gaps = 46/277 (16%)

Query: 119 KIECKVASGSYGDLYKG--TYCSQEVAIKVLKPECVNTEMLKEFS---QEVYIMRKIRHK 173
           K+E K+  G+YG +YK       + VA+K ++   ++TE     S   +E+ +++++ H 
Sbjct: 4   KVE-KIGEGTYGVVYKARNKLTGEVVALKKIR---LDTETEGVPSTAIREISLLKELNHP 59

Query: 174 NVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAI-DVSKGMNYLHQ 232
           N+V+ +        L +V EF+ +  +  F+           L+K  +  + +G+ + H 
Sbjct: 60  NIVKLLDVIHTENKLYLVFEFLHQ-DLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFCHS 118

Query: 233 NNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGV----MTAETGTYRWMAPEV-IEH 287
           + ++HRDLK  NLL++  G +K+ADFG+AR     GV     T E  T  + APE+ +  
Sbjct: 119 HRVLHRDLKPQNLLINTEGAIKLADFGLARA---FGVPVRTYTHEVVTLWYRAPEILLGC 175

Query: 288 KPYDYKADVFSFGIALWELLTGELPYAGL--------------TPLQAA-VGVVQ-KSLR 331
           K Y    D++S G    E++T    + G               TP +    GV      +
Sbjct: 176 KYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSLPDYK 235

Query: 332 PTIPK-------HAHPRLAE----LLERCWQHDPTQR 357
           P+ PK          P L E    LL +   +DP +R
Sbjct: 236 PSFPKWARQDFSKVVPPLDEDGRDLLSQMLHYDPNKR 272

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284

>gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase

 Score = 77.9 bits (192), Expect = 4e-16
 Identities = 71/262 (27%), Positives = 120/262 (45%), Gaps = 37/262 (14%)

Query: 124 VASGSYGDLY--KGTYCSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKI----RHKNVVQ 177
           +++G+YG +Y  +     Q  A+K +        +L+   Q+V++ R I     +  VV 
Sbjct: 9   ISNGAYGAVYLVRHKETRQRFAMKKI---NKQNLILRNQIQQVFVERDILTFAENPFVVS 65

Query: 178 FIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQL-TSLLKVAIDVSKGMNYLHQNNII 236
              +     +LC+V E++  G     L K  G   +  + +  A  V   + YLH   I+
Sbjct: 66  MFCSFETKRHLCMVMEYVEGGDCATLL-KNIGALPVDMARMYFAETVL-ALEYLHNYGIV 123

Query: 237 HRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAET--------------------GT 276
           HRDLK  NLL+   G +K+ DFG++++    G+M+  T                    GT
Sbjct: 124 HRDLKPDNLLITSMGHIKLTDFGLSKI----GLMSLTTNLYEGHIEKDTREFLDKQVCGT 179

Query: 277 YRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKSLRPTIPK 336
             ++APEVI  + Y    D ++ GI L+E L G +P+ G TP +    V+   +      
Sbjct: 180 PEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQVISDDIEWPEGD 239

Query: 337 HAHPRLA-ELLERCWQHDPTQR 357
            A P  A +L+ R  + +P +R
Sbjct: 240 EALPADAQDLISRLLRQNPLER 261

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305

>gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase

 Score = 78.5 bits (193), Expect = 5e-16
 Identities = 75/287 (26%), Positives = 125/287 (43%), Gaps = 39/287 (13%)

Query: 110 VWEIDAKQLKIECKVASGSYGDLYKG--TYCSQEVAIKVLKPECVNTEMLKEFSQEVYIM 167
           +WE+  +   +   V SG+YG +     T     VA+K L     +    K   +E+ ++
Sbjct: 12  IWEVPERYQNLS-PVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLL 70

Query: 168 RKIRHKNVVQFIGACTRPPNL------CIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAI 221
           + ++H+NV+  +   T   +L       +VT  M    + + +  QK        L   I
Sbjct: 71  KHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMG-ADLNNIVKCQKLTDDHVQFLIYQI 129

Query: 222 DVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAETGTYRWMA 281
              +G+ Y+H  +IIHRDLK +NL ++E+  +K+ DFG+AR       MT    T  + A
Sbjct: 130 --LRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE--MTGYVATRWYRA 185

Query: 282 PEV-IEHKPYDYKADVFSFGIALWELLTGELPYAG------LTPLQAAVGVVQKSLRPTI 334
           PE+ +    Y+   D++S G  + ELLTG   + G      L  +   VG     L   I
Sbjct: 186 PEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKI 245

Query: 335 PKHAHPRLAELLERCWQHDPTQRP--NFS--------QITDILKQMM 371
              +         R +    TQ P  NF+           D+L++M+
Sbjct: 246 SSES--------ARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKML 284

Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345

>gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C

 Score = 77.9 bits (192), Expect = 5e-16
 Identities = 61/251 (24%), Positives = 127/251 (50%), Gaps = 23/251 (9%)

Query: 124 VASGSYGD--LYKGTYCSQEVAIKVLKPECVNTEMLKEFSQ-EVYIMRKIRHKNVVQFIG 180
           +  GSY    L +     +  A+KV+K E VN +   ++ Q E ++     +   +  + 
Sbjct: 3   IGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLH 62

Query: 181 ACTRPPN-LCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRD 239
           +C +  + L  V EF++ G +   + +Q+ + +  +    A ++S  +N+LH+  II+RD
Sbjct: 63  SCFQTESRLFFVIEFVSGGDLMFHMQRQRKLPEEHARFYSA-EISLALNFLHERGIIYRD 121

Query: 240 LKTANLLMDENGVVKVADFGVARVQAQSGVMTAE-TGTYRWMAPEVIEHKPYDYKADVFS 298
           LK  N+L+D  G +K+ D+G+ +   + G  T+   GT  ++APE++  + Y +  D ++
Sbjct: 122 LKLDNVLLDAEGHIKLTDYGMCKEGIRPGDTTSTFCGTPNYIAPEILRGEDYGFSVDWWA 181

Query: 299 FGIALWELLTGELPY--AGLTP----------LQAAVGVVQKSLRPTIPKHAHPRLAELL 346
            G+ ++E++ G  P+   G++            Q    +++K +R  IP+    + + +L
Sbjct: 182 LGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLFQV---ILEKQIR--IPRSLSVKASSVL 236

Query: 347 ERCWQHDPTQR 357
           +     DP +R
Sbjct: 237 KGFLNKDPKER 247

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329

>gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional

 Score = 77.2 bits (191), Expect = 5e-16
 Identities = 48/208 (23%), Positives = 96/208 (46%), Gaps = 25/208 (12%)

Query: 116 KQLKIEC--KVASGSYG--DLYKGTYCSQEVAIKVLKPECVNTEMLKEFSQEVY---IMR 168
           K  +I    K+  G +G   + K     +    K++K +  N       + E     +M+
Sbjct: 14  KNCEIVKKLKLIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFN-------AIEPMVHQLMK 66

Query: 169 KIRHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLL--KVAIDVSKG 226
              + N ++   + T      ++ +++  G ++D L K+    +L+     K+   + + 
Sbjct: 67  D--NPNFIKLYYSVTTLKGHVLIMDYIKDGDLFDLLKKEG---KLSEAEVKKIIRQLVEA 121

Query: 227 MNYLHQNNIIHRDLKTANLLMDENGV-VKVADFGVARVQAQSGVMTAETGTYRWMAPEVI 285
           +N LH++NIIH D+K  N+L D     + + D+G+ ++           GT  + +PE I
Sbjct: 122 LNDLHKHNIIHNDIKLENVLYDRAKDRIYLCDYGLCKIIGTPSCYD---GTLDYFSPEKI 178

Query: 286 EHKPYDYKADVFSFGIALWELLTGELPY 313
           +   YD   D ++ G+  +ELLTG+ P+
Sbjct: 179 KGHNYDVSFDWWAVGVLTYELLTGKHPF 206

Length = 267

>gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6

 Score = 77.4 bits (190), Expect = 6e-16
 Identities = 56/205 (27%), Positives = 104/205 (50%), Gaps = 15/205 (7%)

Query: 116 KQLKIECKVASGSYGDLYKG---TYCSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIR- 171
           +Q +   ++  G+YG ++K        + VA+K ++ +     M     +EV ++R +  
Sbjct: 1   QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLET 60

Query: 172 --HKNVVQFIGACT-----RPPNLCIVTEFMARGSIYDFLHK--QKGVFQLTSLLKVAID 222
             H NVV+    CT     R   L +V E + +  +  +L K  + GV   T +  +   
Sbjct: 61  FEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQ-DLTTYLDKVPEPGVPTET-IKDMMFQ 118

Query: 223 VSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAETGTYRWMAP 282
           + +G+++LH + ++HRDLK  N+L+  +G +K+ADFG+AR+ +    +T+   T  + AP
Sbjct: 119 LLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTSVVVTLWYRAP 178

Query: 283 EVIEHKPYDYKADVFSFGIALWELL 307
           EV+    Y    D++S G    E+ 
Sbjct: 179 EVLLQSSYATPVDLWSVGCIFAEMF 203

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290

>gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase

 Score = 77.8 bits (192), Expect = 7e-16
 Identities = 54/186 (29%), Positives = 85/186 (45%), Gaps = 18/186 (9%)

Query: 140 QEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNL------CIVTE 193
           Q VAIK L     N    K   +E+ +M+ + HKN++  +   T   +L       +V E
Sbjct: 42  QNVAIKKLSRPFQNVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSLEEFQDVYLVME 101

Query: 194 FMARGSI----YDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDE 249
            M          D  H++        L         G+ +LH   IIHRDLK +N+++  
Sbjct: 102 LMDANLCQVIQMDLDHERMSYLLYQMLC--------GIKHLHSAGIIHRDLKPSNIVVKS 153

Query: 250 NGVVKVADFGVARVQAQSGVMTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTG 309
           +  +K+ DFG+AR    S +MT    T  + APEVI    Y    D++S G  + E++ G
Sbjct: 154 DCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRG 213

Query: 310 ELPYAG 315
            + + G
Sbjct: 214 TVLFPG 219

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353

>gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase

 Score = 77.9 bits (192), Expect = 8e-16
 Identities = 38/99 (38%), Positives = 58/99 (58%), Gaps = 3/99 (3%)

Query: 225 KGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQA--QSGVMTAETGTYRWMAP 282
           +G+ YLH   I+HRD+K  NLL++ N V+K+ DFG+ARV+   +S  MT E  T  + AP
Sbjct: 114 RGLKYLHSAGILHRDIKPGNLLVNSNCVLKICDFGLARVEEPDESKHMTQEVVTQYYRAP 173

Query: 283 EVIEHKP-YDYKADVFSFGIALWELLTGELPYAGLTPLQ 320
           E++     Y    D++S G    ELL   + +   +P+Q
Sbjct: 174 EILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQ 212

Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372

>gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta

 Score = 77.4 bits (190), Expect = 9e-16
 Identities = 59/249 (23%), Positives = 125/249 (50%), Gaps = 21/249 (8%)

Query: 124 VASGSYGD--LYKGTYCSQEVAIKVLKPECVNTEMLKEFSQ-EVYIMRKIRHKNVVQFIG 180
           +  GSY    L +     Q  A+KV+K E V+ +   ++ Q E ++  +      +  + 
Sbjct: 3   IGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLH 62

Query: 181 ACTRPPN-LCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRD 239
           +C +  + L +V E++  G +   + +Q+ + +  +    A ++   +N+LH+  II+RD
Sbjct: 63  SCFQTTSRLFLVIEYVNGGDLMFHMQRQRKLPEEHARFYAA-EICIALNFLHERGIIYRD 121

Query: 240 LKTANLLMDENGVVKVADFGVARVQAQSGVMTAE-TGTYRWMAPEVIEHKPYDYKADVFS 298
           LK  N+L+D +G +K+ D+G+ +     G  T+   GT  ++APE++  + Y +  D ++
Sbjct: 122 LKLDNVLLDADGHIKLTDYGMCKEGLGPGDTTSTFCGTPNYIAPEILRGEEYGFSVDWWA 181

Query: 299 FGIALWELLTGELPYAGLTP----------LQAAVGVVQKSLRPTIPKHAHPRLAELLER 348
            G+ ++E++ G  P+  +T            Q    +++K +R  IP+    + + +L+ 
Sbjct: 182 LGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQV---ILEKPIR--IPRFLSVKASHVLKG 236

Query: 349 CWQHDPTQR 357
               DP +R
Sbjct: 237 FLNKDPKER 245

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327

>gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase

 Score = 76.9 bits (189), Expect = 1e-15
 Identities = 84/314 (26%), Positives = 135/314 (42%), Gaps = 73/314 (23%)

Query: 110 VWEIDAKQLKIECKVASGSYGDLYKGTYCSQ-------EVAIKVLKPECVNTEMLKEFSQ 162
           +WE+  +   ++ +V SG+YG     T CS        +VAIK L     +    K   +
Sbjct: 10  IWEVPDRYRDLK-QVGSGAYG-----TVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYR 63

Query: 163 EVYIMRKIRHKNVVQFIGACTRPPNL------CIVTEFMAR--GSI--YDFLHKQKGVFQ 212
           E+ +++ ++H+NV+  +   T   +L       +V  FM    G +  ++ L + +  F 
Sbjct: 64  ELRLLKHMKHENVIGLLDVFTPDLSLDRFHDFYLVMPFMGTDLGKLMKHEKLSEDRIQFL 123

Query: 213 LTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTA 272
           +  +LK       G+ Y+H   IIHRDLK  NL ++E+  +K+ DFG+AR Q  S  MT 
Sbjct: 124 VYQMLK-------GLKYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLAR-QTDSE-MTG 174

Query: 273 ETGTYRWMAPEVI-EHKPYDYKADVFSFGIALWELLTGELPYAGL--------------T 317
              T  + APEVI     Y    D++S G  + E+LTG+  + G               T
Sbjct: 175 YVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLDQLMEIMKVTGT 234

Query: 318 PLQAAVGVVQ----------------KSLRPTIPKHAHPRLAELLERCWQHDPTQR---- 357
           P +  V  +Q                K  R  +P +A+P    +LE+    D   R    
Sbjct: 235 PSKEFVQKLQSEDAKNYVKKLPRFRKKDFRSLLP-NANPLAVNVLEKMLVLDAESRITAA 293

Query: 358 -----PNFSQITDI 366
                P F +  D 
Sbjct: 294 EALAHPYFEEFHDP 307

Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343

>gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta

 Score = 76.5 bits (188), Expect = 2e-15
 Identities = 57/197 (28%), Positives = 93/197 (47%), Gaps = 16/197 (8%)

Query: 127 GSYGD--LYKGTYCSQEVAIKVLKPECVNTEMLKEFSQEVYIMRK------IRHKNVVQF 178
           GS+G   L +     +  A+KVLK + +    L++   E  +  K        H  + Q 
Sbjct: 6   GSFGKVMLARLKESGRLYAVKVLKKDVI----LQDDDVECTMTEKRILSLARNHPFLTQL 61

Query: 179 IGACTRPPNLCIVTEFMARGSIYDFLHKQKGV-FQLTSLLKVAIDVSKGMNYLHQNNIIH 237
                 P  L  V EF+  G +    H QK   F        A +++  + +LH   II+
Sbjct: 62  YCCFQTPDRLFFVMEFVNGGDL--MFHIQKSRRFDEARARFYAAEITSALMFLHDKGIIY 119

Query: 238 RDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAE-TGTYRWMAPEVIEHKPYDYKADV 296
           RDLK  N+L+D  G  K+ADFG+ +    +G  T+   GT  ++APE+++   Y    D 
Sbjct: 120 RDLKLDNVLLDHEGHCKLADFGMCKEGIFNGKTTSTFCGTPDYIAPEILQEMLYGPSVDW 179

Query: 297 FSFGIALWELLTGELPY 313
           ++ G+ L+E+L G  P+
Sbjct: 180 WAMGVLLYEMLCGHAPF 196

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320

>gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon

 Score = 76.4 bits (188), Expect = 2e-15
 Identities = 32/95 (33%), Positives = 60/95 (63%), Gaps = 1/95 (1%)

Query: 220 AIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAE-TGTYR 278
           A +V+  + +LH++ +I+RDLK  N+L+D  G  K+ADFG+ +    +GV T    GT  
Sbjct: 102 AAEVTLALMFLHRHGVIYRDLKLDNILLDAEGHCKLADFGMCKEGILNGVTTTTFCGTPD 161

Query: 279 WMAPEVIEHKPYDYKADVFSFGIALWELLTGELPY 313
           ++APE+++   Y    D ++ G+ ++E++ G+ P+
Sbjct: 162 YIAPEILQELEYGPSVDWWALGVLMYEMMAGQPPF 196

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321

>gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase

 Score = 76.3 bits (187), Expect = 2e-15
 Identities = 55/204 (26%), Positives = 102/204 (50%), Gaps = 10/204 (4%)

Query: 123 KVASGSYGDLYKGT--YCSQEVAIKVLKPECVNTEMLKEFS--QEVYIMRKIRHKNVVQF 178
           K+  GSY  +YKG      + VA+KV++   +  E    F+  +E  +++ ++H N+V  
Sbjct: 12  KLGEGSYATVYKGKSKVNGKLVALKVIR---LQEEEGTPFTAIREASLLKGLKHANIVLL 68

Query: 179 IGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHR 238
                    L +V E++    +  ++ K  G     ++      + +G++Y+HQ  I+HR
Sbjct: 69  HDIIHTKETLTLVFEYV-HTDLCQYMDKHPGGLHPENVKLFLFQLLRGLSYIHQRYILHR 127

Query: 239 DLKTANLLMDENGVVKVADFGVARVQA-QSGVMTAETGTYRWMAPEV-IEHKPYDYKADV 296
           DLK  NLL+ + G +K+ADFG+AR ++  S   + E  T  +  P+V +    Y    D+
Sbjct: 128 DLKPQNLLISDTGELKLADFGLARAKSVPSHTYSNEVVTLWYRPPDVLLGSTEYSTCLDM 187

Query: 297 FSFGIALWELLTGELPYAGLTPLQ 320
           +  G    E++ G   + G+  +Q
Sbjct: 188 WGVGCIFVEMIQGVAAFPGMKDIQ 211

Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303

>gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1

 Score = 76.6 bits (188), Expect = 2e-15
 Identities = 59/218 (27%), Positives = 102/218 (46%), Gaps = 20/218 (9%)

Query: 140 QEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNL------CIVTE 193
           + VAIK L     N    K   +E+ +M+ + HKN++  +   T   +L       IV E
Sbjct: 50  RNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVME 109

Query: 194 FMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVV 253
            M   ++   +  +    +++ LL     +  G+ +LH   IIHRDLK +N+++  +  +
Sbjct: 110 LM-DANLCQVIQMELDHERMSYLL---YQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTL 165

Query: 254 KVADFGVARVQAQSGVMTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPY 313
           K+ DFG+AR    S +MT    T  + APEVI    Y    D++S G  + E++ G + +
Sbjct: 166 KILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLF 225

Query: 314 AGLTPLQAAVGVVQ----------KSLRPTIPKHAHPR 341
            G   +     V++          K L+PT+  +   R
Sbjct: 226 PGTDHIDQWNKVIEQLGTPCPEFMKKLQPTVRTYVENR 263

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364

>gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5

 Score = 76.2 bits (188), Expect = 2e-15
 Identities = 62/214 (28%), Positives = 102/214 (47%), Gaps = 40/214 (18%)

Query: 119 KIECKVASGSYGDLYKGTYCS-------QEVAIKVLKPECVNTEMLKEFSQEVYIMRKIR 171
           K    + SG+YG       CS       ++VAIK +        + K   +E+ I+R  +
Sbjct: 8   KPIENIGSGAYG-----VVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFK 62

Query: 172 HKNVVQFIGACTRPP-----NLCIVTEFMARGSIYDFLHKQKGV------FQLTSLLKVA 220
           H N++  I    RPP     ++ +V + M    ++  +H  + +      + L  LL+  
Sbjct: 63  HDNIIA-IRDILRPPGADFKDVYVVMDLM-ESDLHHIIHSDQPLTEEHIRYFLYQLLR-- 118

Query: 221 IDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQS-----GVMTAETG 275
                G+ Y+H  N+IHRDLK +NLL++E+  +++ DFG+AR  + S       MT    
Sbjct: 119 -----GLKYIHSANVIHRDLKPSNLLVNEDCELRIGDFGMARGLSSSPTEHKYFMTEYVA 173

Query: 276 TYRWM-APEVIEHKP-YDYKADVFSFGIALWELL 307
           T RW  APE++   P Y    D++S G    E+L
Sbjct: 174 T-RWYRAPELLLSLPEYTTAIDMWSVGCIFAEML 206

Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334

>gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase

 Score = 75.4 bits (185), Expect = 3e-15
 Identities = 56/201 (27%), Positives = 100/201 (49%), Gaps = 10/201 (4%)

Query: 123 KVASGSYGDLYKGT--YCSQEVAIKVLKPECVNTEMLKEFS--QEVYIMRKIRHKNVVQF 178
           K+  GSY  +YKG      Q VA+KV+    + TE    F+  +E  +++ ++H N+V  
Sbjct: 12  KLGEGSYATVYKGISRINGQLVALKVIS---MKTEEGVPFTAIREASLLKGLKHANIVLL 68

Query: 179 IGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHR 238
                    L  V E+M    +  ++ +  G     ++      + +G+ Y+H  +I+HR
Sbjct: 69  HDIIHTKETLTFVFEYM-HTDLAQYMIQHPGGLHPYNVRLFMFQLLRGLAYIHGQHILHR 127

Query: 239 DLKTANLLMDENGVVKVADFGVARVQA-QSGVMTAETGTYRWMAPEVI-EHKPYDYKADV 296
           DLK  NLL+   G +K+ADFG+AR ++  S   ++E  T  +  P+V+     Y    D+
Sbjct: 128 DLKPQNLLISYLGELKLADFGLARAKSIPSQTYSSEVVTLWYRPPDVLLGATDYSSALDI 187

Query: 297 FSFGIALWELLTGELPYAGLT 317
           +  G    E+L G+  + G++
Sbjct: 188 WGAGCIFIEMLQGQPAFPGVS 208

Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291

>gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4

 Score = 75.0 bits (184), Expect = 3e-15
 Identities = 44/159 (27%), Positives = 79/159 (49%), Gaps = 15/159 (9%)

Query: 163 EVYIMRKIRHKNVVQFIGACTRPPNLCIVTEFMARGS----IYDF----LHKQKGVFQLT 214
           E  I+ K+  + VV    A      LC+V   M  G     IY+       +Q+ +F   
Sbjct: 50  EKRILEKVNSRFVVSLAYAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFDEQRAIF--- 106

Query: 215 SLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAET 274
                A ++  G+  L +  I++RDLK  N+L+D+ G ++++D G+A    +   +    
Sbjct: 107 ----YAAELCCGLEDLQRERIVYRDLKPENILLDDRGHIRISDLGLAVQIPEGETVRGRV 162

Query: 275 GTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPY 313
           GT  +MAPEVI ++ Y +  D +  G  ++E++ G+ P+
Sbjct: 163 GTVGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSPF 201

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285

>gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5

 Score = 74.8 bits (184), Expect = 3e-15
 Identities = 60/212 (28%), Positives = 103/212 (48%), Gaps = 34/212 (16%)

Query: 119 KIECKVASGSYGDLYKGT--YCSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVV 176
           K+E K+  G+YG ++K       + VA+K ++ +  +  +     +E+ ++++++HKN+V
Sbjct: 4   KLE-KIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIV 62

Query: 177 QFIGACTRPPNLCIVTEFM----------ARGSIYDFLHKQKGVFQLTSLLKVAIDVSKG 226
           +          L +V E+             G I D    +  +FQL           KG
Sbjct: 63  RLYDVLHSDKKLTLVFEYCDQDLKKYFDSCNGDI-DPEIVKSFMFQLL----------KG 111

Query: 227 MNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVAR-----VQAQSGVMTAETGTYRWMA 281
           + + H +N++HRDLK  NLL+++NG +K+ADFG+AR     V+  S    AE  T  +  
Sbjct: 112 LAFCHSHNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVRCYS----AEVVTLWYRP 167

Query: 282 PEVI-EHKPYDYKADVFSFGIALWELLTGELP 312
           P+V+   K Y    D++S G    EL     P
Sbjct: 168 PDVLFGAKLYSTSIDMWSAGCIFAELANAGRP 199

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284

>gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6

 Score = 75.6 bits (186), Expect = 4e-15
 Identities = 52/199 (26%), Positives = 101/199 (50%), Gaps = 27/199 (13%)

Query: 138 CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQF--------------IGACT 183
           C + VA+K  K    + + +K   +E+ I+R++ H N+V+               +G+ T
Sbjct: 29  CDKRVAVK--KIVLTDPQSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTEDVGSLT 86

Query: 184 RPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTA 243
              ++ IV E+M    + + L +     +   L      + +G+ Y+H  N++HRDLK A
Sbjct: 87  ELNSVYIVQEYM-ETDLANVLEQGPLSEEHARLF--MYQLLRGLKYIHSANVLHRDLKPA 143

Query: 244 NLLMD-ENGVVKVADFGVARV----QAQSGVMTAETGTYRWMAPEVIEHKPYDYK--ADV 296
           N+ ++ E+ V+K+ DFG+AR+     +  G ++    T  + +P ++   P +Y    D+
Sbjct: 144 NVFINTEDLVLKIGDFGLARIVDPHYSHKGYLSEGLVTKWYRSPRLLLS-PNNYTKAIDM 202

Query: 297 FSFGIALWELLTGELPYAG 315
           ++ G    E+LTG+  +AG
Sbjct: 203 WAAGCIFAEMLTGKPLFAG 221

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342

>gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases

 Score = 74.6 bits (184), Expect = 4e-15
 Identities = 72/288 (25%), Positives = 122/288 (42%), Gaps = 71/288 (24%)

Query: 124 VASGSYGDLYKG--TYCSQEVAIK-VLKPEC---VNTEMLKEFSQEVYIMRKIR---HKN 174
           +  G+YG +YK       + VA+K V  P     +    L+E +    +++++    H N
Sbjct: 7   IGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIA----LLKQLESFEHPN 62

Query: 175 VVQFIGACTRPPN-----LCIVTEFMARGSIYDFLHK--QKGVFQLTSLLKVAI-DVSK- 225
           +V+ +  C  P       L +V E + +  +  +L K  + G      L    I D+ + 
Sbjct: 63  IVRLLDVCHGPRTDRELKLTLVFEHVDQ-DLATYLSKCPKPG------LPPETIKDLMRQ 115

Query: 226 ---GMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAETGT--YRWM 280
              G+++LH + I+HRDLK  N+L+  +G VK+ADFG+AR+ +    +T+   T  YR  
Sbjct: 116 LLRGVDFLHSHRIVHRDLKPQNILVTSDGQVKIADFGLARIYSFEMALTSVVVTLWYR-- 173

Query: 281 APEVIEHKPYDYKADVFSFGIALWEL---------------------LTGELPYAGLTPL 319
           APEV+    Y    D++S G    EL                     + G LP     P 
Sbjct: 174 APEVLLQSSYATPVDMWSVGCIFAELFRRRPLFRGTSEADQLDKIFDVIG-LPSEEEWPR 232

Query: 320 QAAV---------GVVQKSLRPTIPKHAHPRLAELLERCWQHDPTQRP 358
             ++             KS  P I +       +LL++    +P +R 
Sbjct: 233 NVSLPRSSFPSYTPRSFKSFVPEICEEGL----DLLKKMLTFNPHKRI 276

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287

>gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2

 Score = 75.0 bits (184), Expect = 6e-15
 Identities = 65/247 (26%), Positives = 118/247 (47%), Gaps = 14/247 (5%)

Query: 124 VASGSYGDLY-----KGTYCSQEVAIKVL-KPECVNTEMLKEFSQ-EVYIMRKIRHKN-V 175
           + +G+YG ++      G    +  A+KVL K   V      E ++ E  ++  +R    +
Sbjct: 8   LGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFL 67

Query: 176 VQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNI 235
           V    A      L ++ ++++ G ++  L+ Q+  F    +   + ++   + +LH+  I
Sbjct: 68  VTLHYAFQTEAKLHLILDYVSGGEMFTHLY-QRDNFSEDEVRFYSGEIILALEHLHKLGI 126

Query: 236 IHRDLKTANLLMDENGVVKVADFGVAR--VQAQSGVMTAETGTYRWMAPEVIEHKPYDYK 293
           ++RD+K  N+L+D  G V + DFG+++  +  +     +  GT  +MAPE+I  K    K
Sbjct: 127 VYRDIKLENILLDSEGHVVLTDFGLSKEFLSEEKERTYSFCGTIEYMAPEIIRGKGGHGK 186

Query: 294 A-DVFSFGIALWELLTGELPYA--GLTPLQAAVGVVQKSLRPTIPKHAHPRLAELLERCW 350
           A D +S GI ++ELLTG  P+   G    Q+ V        P  P    P   +LL +  
Sbjct: 187 AVDWWSLGILIFELLTGASPFTLEGERNTQSEVSRRILKCDPPFPSFIGPEAQDLLHKLL 246

Query: 351 QHDPTQR 357
           + DP +R
Sbjct: 247 RKDPKKR 253

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332

>gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases

 Score = 73.5 bits (181), Expect = 1e-14
 Identities = 60/207 (28%), Positives = 100/207 (48%), Gaps = 31/207 (14%)

Query: 119 KIECKVASGSYGDLYKG--TYCSQEVAIKVLK----PECVNTEMLKEFSQEVYIMRKIRH 172
           K+E K+  G+YG +YK       + VA+K ++     E V +  ++E S    +++++ H
Sbjct: 3   KVE-KIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREIS----LLKELNH 57

Query: 173 KNVVQFIGACTRPPNLCIVTEFMARGSIYDF-LHK---QKGVFQLTSLL--KVAIDVSKG 226
            N+V+ +        L +V EF+      D  L K      +  L   L       + +G
Sbjct: 58  PNIVRLLDVVHSENKLYLVFEFL------DLDLKKYMDSSPLTGLDPPLIKSYLYQLLQG 111

Query: 227 MNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGV----MTAETGTYRWMAP 282
           + Y H + ++HRDLK  NLL+D  G +K+ADFG+AR     GV     T E  T  + AP
Sbjct: 112 IAYCHSHRVLHRDLKPQNLLIDREGALKLADFGLARA---FGVPVRTYTHEVVTLWYRAP 168

Query: 283 EV-IEHKPYDYKADVFSFGIALWELLT 308
           E+ +  + Y    D++S G    E++ 
Sbjct: 169 EILLGSRQYSTPVDIWSIGCIFAEMVN 195

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283

>gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase

 Score = 73.5 bits (180), Expect = 1e-14
 Identities = 51/199 (25%), Positives = 100/199 (50%), Gaps = 6/199 (3%)

Query: 123 KVASGSYGDLYKGTYCSQE--VAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIG 180
           K+  G+Y  +YKG     +  VA+K ++ E           +EV +++ ++H N+V    
Sbjct: 13  KLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAI-REVSLLKDLKHANIVTLHD 71

Query: 181 ACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDL 240
                 +L +V E++ +  +  +L        + ++      + +G+NY H+  ++HRDL
Sbjct: 72  IIHTEKSLTLVFEYLDK-DLKQYLDDCGNSINMHNVKLFLFQLLRGLNYCHRRKVLHRDL 130

Query: 241 KTANLLMDENGVVKVADFGVARVQA-QSGVMTAETGTYRWMAPEV-IEHKPYDYKADVFS 298
           K  NLL++E G +K+ADFG+AR ++  +   + E  T  +  P++ +    Y  + D++ 
Sbjct: 131 KPQNLLINERGELKLADFGLARAKSIPTKTYSNEVVTLWYRPPDILLGSTDYSTQIDMWG 190

Query: 299 FGIALWELLTGELPYAGLT 317
            G   +E+ TG   + G T
Sbjct: 191 VGCIFYEMSTGRPLFPGST 209

Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301

>gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2

 Score = 74.3 bits (182), Expect = 1e-14
 Identities = 51/180 (28%), Positives = 90/180 (50%), Gaps = 10/180 (5%)

Query: 142 VAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNL------CIVTEFM 195
           VA+K L     N    K   +E+ +++ + HKN++  +   T   +L       +V E M
Sbjct: 49  VAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEEFQDVYLVMELM 108

Query: 196 ARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKV 255
              ++   +H +    +++ LL     +  G+ +LH   IIHRDLK +N+++  +  +K+
Sbjct: 109 -DANLCQVIHMELDHERMSYLL---YQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKI 164

Query: 256 ADFGVARVQAQSGVMTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPYAG 315
            DFG+AR    + +MT    T  + APEVI    Y    D++S G  + EL+ G + + G
Sbjct: 165 LDFGLARTACTNFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKGSVIFQG 224

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359

>gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants

 Score = 73.7 bits (181), Expect = 2e-14
 Identities = 75/290 (25%), Positives = 119/290 (41%), Gaps = 56/290 (19%)

Query: 117 QLKIECKVASGSYGDL--YKGTYCSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKN 174
           + KI+  +  GSYG +     T+  ++VAIK +     +        +E+ ++R +RH +
Sbjct: 1   RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPD 60

Query: 175 VVQFIGACTRPPN------LCIVTEFMARG-----SIYDFLHKQKGVFQLTSLLKVAIDV 223
           +V+ I     PP+      + +V E M           D L  +   F L  LL+     
Sbjct: 61  IVE-IKHIMLPPSRREFKDIYVVFELMESDLHQVIKANDDLTPEHHQFFLYQLLR----- 114

Query: 224 SKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARV---QAQSGVMTAETGTYRWM 280
              + Y+H  N+ HRDLK  N+L + +  +K+ DFG+ARV      + +   +    RW 
Sbjct: 115 --ALKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWY 172

Query: 281 -APEVIE--HKPYDYKADVFSFGIALWELLTGELPYAGL--------------TPLQAAV 323
            APE+       Y    D++S G    E+LTG+  + G               TP    +
Sbjct: 173 RAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLITDLLGTPSPETI 232

Query: 324 GVVQ--------KSLRPTIP-------KHAHPRLAELLERCWQHDPTQRP 358
             V+         S+R   P        +A P    LLER    DP  RP
Sbjct: 233 SRVRNEKARRYLSSMRKKQPVPFSQKFPNADPLALRLLERLLAFDPKDRP 282

Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338

>gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases

 Score = 73.4 bits (180), Expect = 2e-14
 Identities = 40/132 (30%), Positives = 71/132 (53%), Gaps = 5/132 (3%)

Query: 185 PPNLCIVTEFMARGSIYDFLHKQK-GVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTA 243
             +L +VT++M+ G +  F H QK G F          ++   + +LH+ +I++RDLK  
Sbjct: 68  DSDLYLVTDYMSGGEL--FWHLQKEGRFSEDRAKFYIAELVLALEHLHKYDIVYRDLKPE 125

Query: 244 NLLMDENGVVKVADFGVARVQAQSGVMTAE-TGTYRWMAPEV-IEHKPYDYKADVFSFGI 301
           N+L+D  G + + DFG+++        T    GT  ++APEV ++ K Y    D +S G+
Sbjct: 126 NILLDATGHIALCDFGLSKANLTDNKTTNTFCGTTEYLAPEVLLDEKGYTKHVDFWSLGV 185

Query: 302 ALWELLTGELPY 313
            ++E+  G  P+
Sbjct: 186 LVFEMCCGWSPF 197

Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330

>gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3

 Score = 73.2 bits (179), Expect = 3e-14
 Identities = 67/264 (25%), Positives = 119/264 (45%), Gaps = 43/264 (16%)

Query: 140 QEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVTEFMARGS 199
           + VAIK L     N    K   +E+ +M+ + HKN++  +   T   +L    EF     
Sbjct: 43  RNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSL---EEFQDVYL 99

Query: 200 IYDFLHKQKGVFQLTSLLKVAIDVSK----------GMNYLHQNNIIHRDLKTANLLMDE 249
           + + +        L  ++++ +D  +          G+ +LH   IIHRDLK +N+++  
Sbjct: 100 VMELMDAN-----LCQVIQMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKS 154

Query: 250 NGVVKVADFGVARVQAQSGVMTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTG 309
           +  +K+ DFG+AR    S +MT    T  + APEVI    Y    D++S G  + E++  
Sbjct: 155 DCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRH 214

Query: 310 ELPYAGLTPLQAAVGVVQ----------KSLRPTI-------PKHA---HPRL--AELLE 347
           ++ + G   +     V++          K L+PT+       PK+A    P+L    L  
Sbjct: 215 KILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFP 274

Query: 348 RCWQHDPTQRPNFSQITDILKQMM 371
              +H+  +    SQ  D+L +M+
Sbjct: 275 ADSEHNKLKA---SQARDLLSKML 295

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355

>gnl|CDD|173767 cd08227, PK_STRAD_alpha, Pseudokinase domain of STE20-related kinase adapter protein alpha

 Score = 72.7 bits (178), Expect = 3e-14
 Identities = 69/304 (22%), Positives = 125/304 (41%), Gaps = 64/304 (21%)

Query: 133 YKGTYCSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVT 192
           YK T   + V ++ +  E    EM+     E+++ +   H N+V +         L +VT
Sbjct: 21  YKPT--GEYVTVRRINLEACTNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVT 78

Query: 193 EFMARGSIYDFL--HKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDEN 250
            FMA GS  D +  H   G+ +L  +  +   V K ++Y+H    +HR +K +++L+  +
Sbjct: 79  SFMAYGSAKDLICTHFMDGMSELA-IAYILQGVLKALDYIHHMGYVHRSVKASHILISVD 137

Query: 251 GVVKV----ADFGVARVQAQSGVMTAETGTYR-----WMAPEVIEH--KPYDYKADVFSF 299
           G V +    ++  +     Q   +  +   Y      W++PEV++   + YD K+D++S 
Sbjct: 138 GKVYLSGLRSNLSMIN-HGQRLRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSV 196

Query: 300 GIALWELLTGELPYAGLTPLQAAVGVVQKSL-----RPTIPKH----------------- 337
           GI   EL  G +P+  +   Q  +  +  ++       TIP                   
Sbjct: 197 GITACELANGHVPFKDMPATQMLLEKLNGTVPCLLDTTTIPAEELTMKPSRSGANSGLGE 256

Query: 338 ---------------AHP-------RLAELLERCWQHDPTQRPNFSQITD--ILKQMMKE 373
                          +HP            +E+C Q +P  RP+ S + +    KQ +K 
Sbjct: 257 STTVSTPRPSNGESSSHPYNRTFSPHFHHFVEQCLQRNPDARPSASTLLNHSFFKQ-IKR 315

Query: 374 VASE 377
            ASE
Sbjct: 316 RASE 319

Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha, stabilized through ATP and MO25, may be needed to activate LKB1. A mutation which results in a truncation of a C-terminal part of the human STRAD-alpha pseudokinase domain and disrupts its association with LKB1, leads to PMSE (polyhydramnios, megalencephaly, symptomatic epilepsy) syndrome. Several splice variants of STRAD-alpha exist which exhibit different effects on the localization and activation of LKB1. Length = 327

>gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase

 Score = 72.9 bits (179), Expect = 3e-14
 Identities = 61/219 (27%), Positives = 106/219 (48%), Gaps = 34/219 (15%)

Query: 114 DAKQLKIECKVASGSYGD--LYKGTYCSQEVAIKVLKPECVNTEMLKE-----FSQEVYI 166
           D   +K+   +  G++G+  L +     Q  A+K+L       EM+K      F +E  I
Sbjct: 44  DFDVIKV---IGRGAFGEVQLVRHKSSKQVYAMKLLS----KFEMIKRSDSAFFWEERDI 96

Query: 167 MRKIRHKNVVQFIGACTRPPNLCIVTEFMARGSI------YDFLHKQKGVFQLTSLLKVA 220
           M     + +VQ   A      L +V E+M  G +      YD   K    +  T+ + +A
Sbjct: 97  MAHANSEWIVQLHYAFQDDKYLYMVMEYMPGGDLVNLMSNYDIPEKWARFY--TAEVVLA 154

Query: 221 IDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAET--GTYR 278
           +D       +H    IHRD+K  N+L+D++G +K+ADFG       +G++  +T  GT  
Sbjct: 155 LDA------IHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMDANGMVRCDTAVGTPD 208

Query: 279 WMAPEVIE----HKPYDYKADVFSFGIALWELLTGELPY 313
           +++PEV++       Y  + D +S G+ L+E+L G+ P+
Sbjct: 209 YISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPF 247

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370

>gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1

 Score = 72.0 bits (176), Expect = 4e-14
 Identities = 61/248 (24%), Positives = 117/248 (47%), Gaps = 15/248 (6%)

Query: 124 VASGSYGDLY-----KGTYCSQEVAIKVLKPECV--NTEMLKEFSQEVYIMRKIRHKN-V 175
           + +G+YG ++      G    +  A+KVLK   +    +  +    E  ++  IR    +
Sbjct: 8   LGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFL 67

Query: 176 VQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNI 235
           V    A      L ++ +++  G ++  L  Q+  F+   +   + ++   + +LH+  I
Sbjct: 68  VTLHYAFQTDTKLHLILDYINGGELFTHL-SQRERFKEQEVQIYSGEIVLALEHLHKLGI 126

Query: 236 IHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAET--GTYRWMAPEVIE--HKPYD 291
           I+RD+K  N+L+D NG V + DFG+++   +  V  A +  GT  +MAP+++      +D
Sbjct: 127 IYRDIKLENILLDSNGHVVLTDFGLSKEFHEDEVERAYSFCGTIEYMAPDIVRGGDGGHD 186

Query: 292 YKADVFSFGIALWELLTGELPYA--GLTPLQAAVGVVQKSLRPTIPKHAHPRLAELLERC 349
              D +S G+ ++ELLTG  P+   G    QA +        P  P+       ++++R 
Sbjct: 187 KAVDWWSMGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPPYPQEMSALAKDIIQRL 246

Query: 350 WQHDPTQR 357
              DP +R
Sbjct: 247 LMKDPKKR 254

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290

>gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase

 Score = 71.6 bits (175), Expect = 5e-14
 Identities = 58/208 (27%), Positives = 99/208 (47%), Gaps = 24/208 (11%)

Query: 123 KVASGSYGDLYKGTYCSQE--VAIKVLKPE------CVNTEMLKEFSQEVYIMRKIRHKN 174
           K+  G+Y  ++KG     E  VA+K ++ E      C          +EV +++ ++H N
Sbjct: 12  KLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAI-------REVSLLKNLKHAN 64

Query: 175 VVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAI---DVSKGMNYLH 231
           +V           L +V E++      D          L S+  V I    + +G++Y H
Sbjct: 65  IVTLHDIIHTERCLTLVFEYLDS----DLKQYLDNCGNLMSMHNVKIFMFQLLRGLSYCH 120

Query: 232 QNNIIHRDLKTANLLMDENGVVKVADFGVARVQA-QSGVMTAETGTYRWMAPEV-IEHKP 289
           +  I+HRDLK  NLL++E G +K+ADFG+AR ++  +   + E  T  +  P+V +    
Sbjct: 121 KRKILHRDLKPQNLLINEKGELKLADFGLARAKSVPTKTYSNEVVTLWYRPPDVLLGSTE 180

Query: 290 YDYKADVFSFGIALWELLTGELPYAGLT 317
           Y    D++  G  L+E+ TG   + G T
Sbjct: 181 YSTPIDMWGVGCILYEMATGRPMFPGST 208

Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288

>gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional

 Score = 72.2 bits (177), Expect = 6e-14
 Identities = 44/168 (26%), Positives = 71/168 (42%), Gaps = 19/168 (11%)

Query: 158 KEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLL 217
           K   +E+ I++ I H+ ++  I A      +C+V          D          L   L
Sbjct: 131 KTPGREIDILKTISHRAIINLIHAYRWKSTVCMVM----PKYKCDLFTYVDRSGPLP--L 184

Query: 218 KVAIDVSKGM----NYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAE 273
           + AI + + +     YLH   IIHRD+KT N+ +DE     + DFG A    +       
Sbjct: 185 EQAITIQRRLLEALAYLHGRGIIHRDVKTENIFLDEPENAVLGDFGAA---CKLDAHPDT 241

Query: 274 TGTYRWM------APEVIEHKPYDYKADVFSFGIALWELLTGELPYAG 315
              Y W       +PE++   PY  K D++S G+ L+E+    +   G
Sbjct: 242 PQCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTLFG 289

Length = 392

>gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase

 Score = 72.0 bits (176), Expect = 7e-14
 Identities = 61/222 (27%), Positives = 107/222 (48%), Gaps = 29/222 (13%)

Query: 110 VWEIDAKQLKIECKVASGSYGDLYKG--TYCSQEVAIKVLKPECVNTEMLKEFSQEVYIM 167
           VWE+  +   +   V SG+YG +     T   Q+VA+K L     +    +   +E+ ++
Sbjct: 10  VWEVPERYQNLT-PVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLL 68

Query: 168 RKIRHKNVVQFIGACTRPPNL------CIVTEFMAR--GSIYDFL-----HKQKGVFQLT 214
           + ++H+NV+  +   T   ++       +VT  M     +I         H Q  ++QL 
Sbjct: 69  KHMKHENVIGLLDVFTPATSIENFNEVYLVTNLMGADLNNIVKCQKLSDEHVQFLIYQLL 128

Query: 215 SLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAET 274
                     +G+ Y+H   IIHRDLK +N+ ++E+  +++ DFG+AR QA    MT   
Sbjct: 129 ----------RGLKYIHSAGIIHRDLKPSNVAVNEDCELRILDFGLAR-QADDE-MTGYV 176

Query: 275 GTYRWMAPEV-IEHKPYDYKADVFSFGIALWELLTGELPYAG 315
            T  + APE+ +    Y+   D++S G  + ELL G+  + G
Sbjct: 177 ATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPG 218

Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343

>gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4

 Score = 71.1 bits (174), Expect = 8e-14
 Identities = 59/241 (24%), Positives = 113/241 (46%), Gaps = 27/241 (11%)

Query: 123 KVASGSYGDLYKGT--YCSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIR---HKNVVQ 177
           ++  G+YG +YK    +    VA+K ++ +     +     +EV +++++    H N+V+
Sbjct: 7   EIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVR 66

Query: 178 FIGACT-----RPPNLCIVTEFMARGSIYDFLHKQKG----VFQLTSLLKVAIDVSKGMN 228
            +  C      R   + +V E + +  +  +L K          +  L++  +   +G++
Sbjct: 67  LMDVCATSRTDRETKVTLVFEHVDQ-DLRTYLDKVPPPGLPAETIKDLMRQFL---RGLD 122

Query: 229 YLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAETGTYRWMAPEVIEHK 288
           +LH N I+HRDLK  N+L+   G VK+ADFG+AR+ +    +T    T  + APEV+   
Sbjct: 123 FLHANCIVHRDLKPENILVTSGGQVKLADFGLARIYSCQMALTPVVVTLWYRAPEVLLQS 182

Query: 289 PYDYKADVFSFGIALWELLTGELPYAG------LTPLQAAVGVVQKSLRP---TIPKHAH 339
            Y    D++S G    E+   +  + G      L  +   +G+  +   P   T+P+ A 
Sbjct: 183 TYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDWPRDVTLPRGAF 242

Query: 340 P 340
            
Sbjct: 243 S 243

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288

>gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases

 Score = 70.7 bits (173), Expect = 1e-13
 Identities = 51/185 (27%), Positives = 90/185 (48%), Gaps = 8/185 (4%)

Query: 185 PPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTAN 244
           P  L +V  F+  G ++  L ++ G F L+       ++   +  LH+ N+I+RDLK  N
Sbjct: 65  PEKLYLVLAFINGGELFHHLQRE-GRFDLSRARFYTAELLCALENLHKFNVIYRDLKPEN 123

Query: 245 LLMDENGVVKVADFGVARVQ-AQSGVMTAETGTYRWMAPEVIEHKPYDYKADVFSFGIAL 303
           +L+D  G + + DFG+ ++            GT  ++APE++    Y    D ++ G+ L
Sbjct: 124 ILLDYQGHIALCDFGLCKLNMKDDDKTNTFCGTPEYLAPELLLGHGYTKAVDWWTLGVLL 183

Query: 304 WELLTGELPYAGLTPLQAAVGVVQKSLR--PTIPKHAHPRLAELLERCWQHDPTQRPNFS 361
           +E+LTG  P+      +    ++Q+ LR      + A   L  LL R    DPT+R  ++
Sbjct: 184 YEMLTGLPPFYDENVNEMYRKILQEPLRFPDGFDRDAKDLLIGLLSR----DPTRRLGYN 239

Query: 362 QITDI 366
              +I
Sbjct: 240 GAQEI 244

Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312

>gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase

 Score = 70.8 bits (173), Expect = 1e-13
 Identities = 51/204 (25%), Positives = 104/204 (50%), Gaps = 7/204 (3%)

Query: 118 LKIECKVASGSYGDLYKGTYCSQE--VAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNV 175
           +K+E K+  G+Y  ++KG     E  VA+K ++ E           +EV +++ ++H N+
Sbjct: 9   IKLE-KLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAI-REVSLLKDLKHANI 66

Query: 176 VQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNI 235
           V          +L +V E++ +  +  ++     +  + ++      + +G+ Y H+  +
Sbjct: 67  VTLHDIVHTDKSLTLVFEYLDK-DLKQYMDDCGNIMSMHNVKIFLYQILRGLAYCHRRKV 125

Query: 236 IHRDLKTANLLMDENGVVKVADFGVARVQA-QSGVMTAETGTYRWMAPEV-IEHKPYDYK 293
           +HRDLK  NLL++E G +K+ADFG+AR ++  +   + E  T  +  P+V +    Y  +
Sbjct: 126 LHRDLKPQNLLINERGELKLADFGLARAKSVPTKTYSNEVVTLWYRPPDVLLGSSEYSTQ 185

Query: 294 ADVFSFGIALWELLTGELPYAGLT 317
            D++  G   +E+ +G   + G T
Sbjct: 186 IDMWGVGCIFFEMASGRPLFPGST 209

Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309

>gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases

 Score = 71.2 bits (175), Expect = 1e-13
 Identities = 71/292 (24%), Positives = 120/292 (41%), Gaps = 63/292 (21%)

Query: 124 VASGSYGD--LYKGTYCSQEVAIKVLKPECVNTEMLKE-----FSQEVYIMRKIRHKNVV 176
           +  G++G+  L +     Q  A+KVL+      +M+K         E  I+       +V
Sbjct: 9   IGRGAFGEVWLVRDKDTGQVYAMKVLRKS----DMIKRNQIAHVRAERDILADADSPWIV 64

Query: 177 QFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQ------LTSLLKVAIDVSKGMNYL 230
           +   +     +L +V E+M  G + + L + K VF         + L +A+D       +
Sbjct: 65  KLYYSFQDEEHLYLVMEYMPGGDLMNLLIR-KDVFPEETARFYIAELVLALD------SV 117

Query: 231 HQNNIIHRDLKTANLLMDENGVVKVADFGVA----------------------------- 261
           H+   IHRD+K  N+L+D +G +K+ADFG+                              
Sbjct: 118 HKLGFIHRDIKPDNILIDADGHIKLADFGLCKKMNKAKDREYYLNDSHNLLFRDNVLVRR 177

Query: 262 RVQAQSGVMT-AETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPYAGLTPLQ 320
           R   Q  V   +  GT  ++APEV+   PY  + D +S G+ L+E+L G  P+   T  +
Sbjct: 178 RDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFPPFYSDTLQE 237

Query: 321 AAVGVV--QKSLRPTIPKHAH--PRLAELLERCWQHDPTQRPNFSQITDILK 368
               ++  ++SLR   P      P   +L+ R    DP  R       +I  
Sbjct: 238 TYNKIINWKESLR--FPPDPPVSPEAIDLICRLLC-DPEDR--LGSFEEIKS 284

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350

>gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2

 Score = 71.2 bits (174), Expect = 1e-13
 Identities = 59/209 (28%), Positives = 104/209 (49%), Gaps = 31/209 (14%)

Query: 124 VASGSYGDLYKGTY-CSQEV-AIKVLKPECVNTEMLKE-----FSQEVYIMRKIRHKNVV 176
           +  G++G++    +  SQ+V A+K+L       EM+K      F +E  IM       VV
Sbjct: 51  IGRGAFGEVQLVRHKSSQKVYAMKLLS----KFEMIKRSDSAFFWEERDIMAFANSPWVV 106

Query: 177 QFIGACTRPPNLCIVTEFMARGSI------YDFLHKQKGVFQLTSLLKVAIDVSKGMNYL 230
           Q   A      L +V E+M  G +      YD   K    +    +L         ++ +
Sbjct: 107 QLFCAFQDDKYLYMVMEYMPGGDLVNLMSNYDVPEKWAKFYTAEVVL--------ALDAI 158

Query: 231 HQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAET--GTYRWMAPEVIEHK 288
           H   +IHRD+K  N+L+D++G +K+ADFG      ++G++  +T  GT  +++PEV++ +
Sbjct: 159 HSMGLIHRDVKPDNMLLDKHGHLKLADFGTCMKMDETGMVRCDTAVGTPDYISPEVLKSQ 218

Query: 289 P----YDYKADVFSFGIALWELLTGELPY 313
                Y  + D +S G+ L+E+L G+ P+
Sbjct: 219 GGDGYYGRECDWWSVGVFLFEMLVGDTPF 247

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370

>gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12

 Score = 70.2 bits (172), Expect = 2e-13
 Identities = 64/221 (28%), Positives = 102/221 (46%), Gaps = 58/221 (26%)

Query: 124 VASGSYGDLYKG--TYCSQEVAIKVLKPECVNTEMLKE-FS----QEVYIMRKIRHKNVV 176
           +  G+YG +YK       + VA+K      V  +  KE F     +E+ I+R++ H+N+V
Sbjct: 15  IGEGTYGQVYKARDKDTGELVALKK-----VRLDNEKEGFPITAIREIKILRQLNHRNIV 69

Query: 177 QFIGACTRPPNLC-IVTEFMARGSIYDFLHKQKGVF------------------------ 211
                     NL  IVT+   +    DF  K KG F                        
Sbjct: 70  ----------NLKEIVTD---KQDALDFK-KDKGAFYLVFEYMDHDLMGLLESGLVHFSE 115

Query: 212 -QLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARV--QAQSG 268
             + S +K  ++   G+NY H+ N +HRD+K +N+L++  G +K+ADFG+AR+    +S 
Sbjct: 116 DHIKSFMKQLLE---GLNYCHKKNFLHRDIKCSNILLNNKGQIKLADFGLARLYNSEESR 172

Query: 269 VMTAETGTYRWMAPE-VIEHKPYDYKADVFSFGIALWELLT 308
             T +  T  +  PE ++  + Y    DV+S G  L EL T
Sbjct: 173 PYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFT 213

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302

>gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15

 Score = 69.5 bits (171), Expect = 3e-13
 Identities = 63/227 (27%), Positives = 108/227 (47%), Gaps = 57/227 (25%)

Query: 116 KQLKIECKVASGSYGDLYKGT--YCSQEVAIKVLKPECVNTEMLKEF--------SQ--- 162
           ++ +I  K+  G+YG ++K       + VA+K            K F        +Q   
Sbjct: 7   RKYEILQKLGKGAYGIVWKAIDRRTKEVVALK------------KIFDAFRNATDAQRTF 54

Query: 163 -EVYIMRKIR-HKNVVQFIGACTRPPN---LCIVTEFMA-------RGSIYDFLHKQKGV 210
            E+  ++++  H N+V+ +    +  N   + +V E+M        R +I + +HK+  +
Sbjct: 55  REIMFLQELGDHPNIVKLL-NVIKAENDKDIYLVFEYMETDLHAVIRANILEDVHKRYIM 113

Query: 211 FQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSG-- 268
           +QL   LK          Y+H  N+IHRDLK +N+L++ +  VK+ADFG+AR  ++    
Sbjct: 114 YQLLKALK----------YIHSGNVIHRDLKPSNILLNSDCRVKLADFGLARSLSELEEN 163

Query: 269 ----VMTAETGTYRWM-APEV-IEHKPYDYKADVFSFGIALWELLTG 309
               V+T    T RW  APE+ +    Y    D++S G  L E+L G
Sbjct: 164 PENPVLTDYVAT-RWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLG 209

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337

>gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1

 Score = 69.7 bits (170), Expect = 4e-13
 Identities = 57/207 (27%), Positives = 102/207 (49%), Gaps = 27/207 (13%)

Query: 124 VASGSYGD--LYKGTYCSQEVAIKVLKPECVNTEMLKE-----FSQEVYIMRKIRHKNVV 176
           +  G++G+  L +     +  A+K+L       EM+K      F +E  IM       VV
Sbjct: 51  IGRGAFGEVQLVRHKSTRKVYAMKLLS----KFEMIKRSDSAFFWEERDIMAFANSPWVV 106

Query: 177 QFIGACTRPPNLCIVTEFMARGSIYDFLHK----QKGVFQLTSLLKVAIDVSKGMNYLHQ 232
           Q   A      L +V E+M  G + + +      +K     T+ + +A+D       +H 
Sbjct: 107 QLFYAFQDDRYLYMVMEYMPGGDLVNLMSNYDVPEKWARFYTAEVVLALDA------IHS 160

Query: 233 NNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAET--GTYRWMAPEVIEHKP- 289
              IHRD+K  N+L+D++G +K+ADFG      + G++  +T  GT  +++PEV++ +  
Sbjct: 161 MGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAVGTPDYISPEVLKSQGG 220

Query: 290 ---YDYKADVFSFGIALWELLTGELPY 313
              Y  + D +S G+ L+E+L G+ P+
Sbjct: 221 DGYYGRECDWWSVGVFLYEMLVGDTPF 247

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371

>gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase

 Score = 69.5 bits (170), Expect = 4e-13
 Identities = 52/194 (26%), Positives = 88/194 (45%), Gaps = 18/194 (9%)

Query: 130 GDLYKGTYCSQEVAIKVLKPECV-NTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNL 188
           GD+Y         A+KV+K   +   E +  F +E  I+       + Q   A     NL
Sbjct: 26  GDIY---------AMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAFQDKDNL 76

Query: 189 CIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMD 248
            +V E+   G +   L++ +  F          ++   ++ +HQ   +HRD+K  N+L+D
Sbjct: 77  YLVMEYQPGGDLLSLLNRYEDQFDEDMAQFYLAELVLAIHSVHQMGYVHRDIKPENVLID 136

Query: 249 ENGVVKVADFG-VARVQAQSGVM-TAETGTYRWMAPEVIE------HKPYDYKADVFSFG 300
             G +K+ADFG  AR+ A   V      GT  ++APEV+          Y  + D +S G
Sbjct: 137 RTGHIKLADFGSAARLTANKMVNSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLG 196

Query: 301 IALWELLTGELPYA 314
           +  +E++ G  P+ 
Sbjct: 197 VIAYEMIYGRSPFH 210

Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330

>gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase

 Score = 67.9 bits (166), Expect = 1e-12
 Identities = 61/230 (26%), Positives = 105/230 (45%), Gaps = 43/230 (18%)

Query: 119 KIECKVASGSYGDLYKGTYCS--QEVAIKVLKPECVN----------TEMLKEFSQEVYI 166
           K+E K+  G+YG +YK    +  + VA+K  + E               +L+  S+ +YI
Sbjct: 5   KLE-KIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYI 63

Query: 167 MRKIRHKNVVQFIGACTRPPNLCIVTEFM-----------ARGSIYDFLHK--QKGVFQL 213
           +R +  ++V +  G     P+L +V E++            RG       K  +  ++QL
Sbjct: 64  VRLLDVEHVEEKNGK----PSLYLVFEYLDSDLKKFMDSNGRGPGRPLPAKTIKSFMYQL 119

Query: 214 TSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMD-ENGVVKVADFGVARV-QAQSGVMT 271
                      KG+ + H++ ++HRDLK  NLL+D + G++K+AD G+ R         T
Sbjct: 120 L----------KGVAHCHKHGVMHRDLKPQNLLVDKQKGLLKIADLGLGRAFSIPVKSYT 169

Query: 272 AETGTYRWMAPEV-IEHKPYDYKADVFSFGIALWELLTGELPYAGLTPLQ 320
            E  T  + APEV +    Y    D++S G    E+   +  + G + LQ
Sbjct: 170 HEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQ 219

Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295

>gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1

 Score = 68.2 bits (167), Expect = 1e-12
 Identities = 54/168 (32%), Positives = 79/168 (47%), Gaps = 37/168 (22%)

Query: 226 GMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVAR-----VQAQSGVMTAETGTYRWM 280
           G+ Y+H  N++HRDLK  NLL++ +  +K+ DFG+AR         +G MT    T RW 
Sbjct: 117 GLKYIHSANVLHRDLKPGNLLVNADCELKICDFGLARGFSENPGENAGFMTEYVAT-RWY 175

Query: 281 -APEV-IEHKPYDYKADVFSFGIALWELLTGELPYAG------LTPLQAAVGV------- 325
            APE+ +  + Y    DV+S G  L ELL  +  + G      L  +   +G        
Sbjct: 176 RAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDYVDQLNQILQVLGTPDEETLS 235

Query: 326 ------VQKSLR--PTIPK--------HAHPRLAELLERCWQHDPTQR 357
                  Q  +R  P IPK        +A+P   +LLE+    DPT+R
Sbjct: 236 RIGSPKAQNYIRSLPNIPKKPFESIFPNANPLALDLLEKLLAFDPTKR 283

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332

>gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases

 Score = 67.0 bits (164), Expect = 2e-12
 Identities = 58/211 (27%), Positives = 97/211 (45%), Gaps = 28/211 (13%)

Query: 122 CKVASGSYGDLYKGTYC--SQEVAIKVLKPECVNTEMLKEFS--QEVYIMRKIRHKNVVQ 177
            K+  GSY  +YKG      Q VA+K ++   +  E    F+  +E  +++ ++H N+V 
Sbjct: 11  DKLGEGSYATVYKGRSKLTGQLVALKEIR---LEHEEGAPFTAIREASLLKDLKHANIVT 67

Query: 178 FIGACTRPPNLCIVTEFMAR---------GSIYDFLHKQKGVFQLTSLLKVAIDVSKGMN 228
                     L +V E++           G      + +  +FQL           +G+ 
Sbjct: 68  LHDIIHTKKTLTLVFEYLDTDLKQYMDDCGGGLSMHNVRLFLFQLL----------RGLA 117

Query: 229 YLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQA-QSGVMTAETGTYRWMAPEVI-E 286
           Y HQ  ++HRDLK  NLL+ E G +K+ADFG+AR ++  S   + E  T  +  P+V+  
Sbjct: 118 YCHQRRVLHRDLKPQNLLISERGELKLADFGLARAKSVPSKTYSNEVVTLWYRPPDVLLG 177

Query: 287 HKPYDYKADVFSFGIALWELLTGELPYAGLT 317
              Y    D++  G   +E+ TG   + G T
Sbjct: 178 STEYSTSLDMWGVGCIFYEMATGRPLFPGST 208

Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291

>gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases

 Score = 66.9 bits (164), Expect = 3e-12
 Identities = 57/250 (22%), Positives = 100/250 (40%), Gaps = 38/250 (15%)

Query: 143 AIKVLKPECVNTE-MLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVTEFMARGSIY 201
           A+KVL  + +     +K    E  I+  + H  +     +      LC+V ++   G ++
Sbjct: 30  ALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYASFQTETYLCLVMDYCPGGELF 89

Query: 202 DFLHKQKG-VFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADF-- 258
             L +Q G           A +V   + YLH   I++RDLK  N+L+ E+G + ++DF  
Sbjct: 90  RLLQRQPGKCLSEEVARFYAAEVLLALEYLHLLGIVYRDLKPENILLHESGHIMLSDFDL 149

Query: 259 -------GVARVQAQSG-------------VMTAET--------GTYRWMAPEVIEHKPY 290
                       +A                  + E         GT  ++APEVI    +
Sbjct: 150 SKQSDVEPPPVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGH 209

Query: 291 DYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRLAE---LLE 347
               D ++ GI L+E+L G  P+ G    +    +++K    T P    P  +    L+ 
Sbjct: 210 GSAVDWWTLGILLYEMLYGTTPFKGSNRDETFSNILKKE--VTFPGS-PPVSSSARDLIR 266

Query: 348 RCWQHDPTQR 357
           +    DP++R
Sbjct: 267 KLLVKDPSKR 276

Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316

>gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional

 Score = 67.8 bits (165), Expect = 3e-12
 Identities = 57/232 (24%), Positives = 111/232 (47%), Gaps = 49/232 (21%)

Query: 123 KVASGSYGDLY----KGT---YCSQEVAIKVLKPECVNTEMLKEFSQ---EVYIMRKIRH 172
           K+ +G +G+++    K T   +C + ++ + LK         +E SQ   EV +MR+++H
Sbjct: 20  KIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKE--------REKSQLVIEVNVMRELKH 71

Query: 173 KNVVQFIGACTRPPN--LCIVTEFMARGSIYDFL---HKQKGVFQLTSLLKVAIDVSKGM 227
           KN+V++I       N  L I+ EF   G +   +   +K  G  +  +++ +   +   +
Sbjct: 72  KNIVRYIDRFLNKANQKLYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHAL 131

Query: 228 NYLHQ-------NNIIHRDLKTANLLMDE---------------NG--VVKVADFGVARV 263
            Y H          ++HRDLK  N+ +                 NG  + K+ DFG+++ 
Sbjct: 132 AYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITAQANNLNGRPIAKIGDFGLSKN 191

Query: 264 QAQSGVMTAETGTYRWMAPEVIEH--KPYDYKADVFSFGIALWELLTGELPY 313
                +  +  GT  + +PE++ H  K YD K+D+++ G  ++EL +G+ P+
Sbjct: 192 IGIESMAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTPF 243

Length = 1021

>gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional

 Score = 65.2 bits (159), Expect = 7e-12
 Identities = 56/221 (25%), Positives = 101/221 (45%), Gaps = 58/221 (26%)

Query: 119 KIECKVASGSYGDLYKGT--YCSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVV 176
           K+E K+  G+YG +YK      ++ +A+K ++ E  +  +     +E+ ++++++H N+V
Sbjct: 6   KVE-KIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIV 64

Query: 177 QFIGACTRPPNLCIVTEFMARGSIYDFLHKQKG---VFQLTSL-LKVAIDVS-------- 224
           +                      + D +H +K    VF+   L LK  +D S        
Sbjct: 65  R----------------------LQDVVHSEKRLYLVFEYLDLDLKKHMDSSPDFAKNPR 102

Query: 225 ----------KGMNYLHQNNIIHRDLKTANLLMDE-NGVVKVADFGVAR-----VQAQSG 268
                     +G+ Y H + ++HRDLK  NLL+D     +K+ADFG+AR     V+    
Sbjct: 103 LIKTYLYQILRGIAYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRT--- 159

Query: 269 VMTAETGTYRWMAPEV-IEHKPYDYKADVFSFGIALWELLT 308
             T E  T  + APE+ +  + Y    D++S G    E++ 
Sbjct: 160 -FTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVN 199

Length = 294

>gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1

 Score = 64.3 bits (156), Expect = 2e-11
 Identities = 60/244 (24%), Positives = 104/244 (42%), Gaps = 43/244 (17%)

Query: 114 DAKQLKIECKVASGSYGD--LYKGTYCSQEVAIKVL-KPECVNTEMLKEFSQEVYIMRKI 170
           D + LK+   +  G++G+  L +        A+K+L K + +  E +     E  I+ + 
Sbjct: 2   DFESLKV---IGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEA 58

Query: 171 RHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYL 230
               VV+   +     NL ++ EF+  G +   L K+  + +  +   +A +    ++ +
Sbjct: 59  DSLWVVKMFYSFQDKLNLYLIMEFLPGGDMMTLLMKKDTLTEEETQFYIA-ETVLAIDSI 117

Query: 231 HQNNIIHRDLKTANLLMDENGVVKVADFGVA-----------------------RVQAQS 267
           HQ   IHRD+K  NLL+D  G VK++DFG+                          Q  +
Sbjct: 118 HQLGFIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHRTEFYRNLNHSLPSDFTFQNMN 177

Query: 268 GVMTAET-------------GTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPYA 314
               AET             GT  ++APEV     Y+   D +S G+ ++E+L G  P+ 
Sbjct: 178 SKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPFC 237

Query: 315 GLTP 318
             TP
Sbjct: 238 SETP 241

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363

>gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha

 Score = 63.2 bits (153), Expect = 5e-11
 Identities = 54/211 (25%), Positives = 99/211 (46%), Gaps = 32/211 (15%)

Query: 124 VASGSYGDL--YKGTYCSQEVAIKVLKPECVNTEMLKE-----FSQEVYIMRKIRHKNVV 176
           +  G++G++   K     +  A+K+L       EMLK      F +E  ++    ++ + 
Sbjct: 9   IGRGAFGEVAVVKLKNADKVFAMKILN----KWEMLKRAETACFREERDVLVNGDNQWIT 64

Query: 177 QFIGACTRPPNLCIVTEFMARGSIYDFLHK-------QKGVFQLTSLLKVAIDVSKGMNY 229
               A     NL +V ++   G +   L K           F L  ++ +AID       
Sbjct: 65  TLHYAFQDENNLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMV-IAIDS------ 117

Query: 230 LHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVM--TAETGTYRWMAPEVIEH 287
           +HQ + +HRD+K  N+LMD NG +++ADFG      + G +  +   GT  +++PE+++ 
Sbjct: 118 VHQLHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSVAVGTPDYISPEILQA 177

Query: 288 KP-----YDYKADVFSFGIALWELLTGELPY 313
                  Y  + D +S G+ ++E+L GE P+
Sbjct: 178 MEDGKGKYGPECDWWSLGVCMYEMLYGETPF 208

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332

>gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2

 Score = 63.1 bits (153), Expect = 5e-11
 Identities = 61/244 (25%), Positives = 104/244 (42%), Gaps = 43/244 (17%)

Query: 114 DAKQLKIECKVASGSYGD--LYKGTYCSQEVAIKVL-KPECVNTEMLKEFSQEVYIMRKI 170
           D + LK+   +  G++G+  L +        A+K+L K + +  E +     E  I+ + 
Sbjct: 2   DFESLKV---IGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEA 58

Query: 171 RHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYL 230
               VV+   +     NL ++ EF+  G +   L K+  + +  +   +A  V   ++ +
Sbjct: 59  DGAWVVKMFYSFQDKRNLYLIMEFLPGGDMMTLLMKKDTLSEEATQFYIAETVL-AIDAI 117

Query: 231 HQNNIIHRDLKTANLLMDENGVVKVADFGVA-----------------------RVQAQS 267
           HQ   IHRD+K  NLL+D  G VK++DFG+                          Q  +
Sbjct: 118 HQLGFIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAHRTEFYRNLTHNPPSDFSFQNMN 177

Query: 268 GVMTAET-------------GTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPYA 314
               AET             GT  ++APEV     Y+   D +S G+ ++E+L G  P+ 
Sbjct: 178 SKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPFC 237

Query: 315 GLTP 318
             TP
Sbjct: 238 SETP 241

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360

>gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6

 Score = 62.8 bits (152), Expect = 6e-11
 Identities = 63/215 (29%), Positives = 102/215 (47%), Gaps = 34/215 (15%)

Query: 122 CKVASGSYGDLYKGTYC----SQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQ 177
           CKV  G+YG +YK         +E A+K ++     T +     +E+ ++R+++H NV+ 
Sbjct: 7   CKVGRGTYGHVYKAKRKDGKDEKEYALKQIE----GTGISMSACREIALLRELKHPNVIA 62

Query: 178 ----FIGACTRP---------PNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVS 224
               F+    R           +L  + +F  R S  +    Q     + SLL   +D  
Sbjct: 63  LQKVFLSHSDRKVWLLFDYAEHDLWHIIKFH-RASKANKKPMQLPRSMVKSLLYQILD-- 119

Query: 225 KGMNYLHQNNIIHRDLKTANLLM----DENGVVKVADFGVARVQAQSGVMTAETG----T 276
            G++YLH N ++HRDLK AN+L+     E G VK+AD G AR+        A+      T
Sbjct: 120 -GIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVT 178

Query: 277 YRWMAPE-VIEHKPYDYKADVFSFGIALWELLTGE 310
           + + APE ++  + Y    D+++ G    ELLT E
Sbjct: 179 FWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSE 213

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317

>gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta

 Score = 62.7 bits (152), Expect = 6e-11
 Identities = 33/119 (27%), Positives = 64/119 (53%), Gaps = 7/119 (5%)

Query: 226 GMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVM--TAETGTYRWMAPE 283
            ++ +HQ + +HRD+K  N+L+D NG +++ADFG      Q G +  +   GT  +++PE
Sbjct: 114 AIHSIHQLHYVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQDGTVQSSVAVGTPDYISPE 173

Query: 284 VIEHK-----PYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKSLRPTIPKH 337
           +++        Y  + D +S G+ ++E+L GE P+   + ++    ++    R   P H
Sbjct: 174 ILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHEERFQFPSH 232

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331

>gnl|CDD|214801 smart00750, KIND, kinase non-catalytic C-lobe domain

 Score = 60.1 bits (146), Expect = 8e-11
 Identities = 38/167 (22%), Positives = 62/167 (37%), Gaps = 20/167 (11%)

Query: 219 VAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAETGTYR 278
           V +     +  LH+       L T + L+  +G V           A      +    Y 
Sbjct: 22  VCLQCLGALRELHRQAKSGNILLTWDGLLKLDGSV-----------AFKTPEQSRPDPY- 69

Query: 279 WMAPEVIEHKPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKSLRPTIPKH- 337
           +MAPEVI+ + Y  KAD++S GI L+E L  ELPY     L A + ++   +    P+  
Sbjct: 70  FMAPEVIQGQSYTEKADIYSLGITLYEALDYELPYNEERELSAILEILLNGMPADDPRDR 129

Query: 338 -------AHPRLAELLERCWQHDPTQRPNFSQITDILKQMMKEVASE 377
                  A     + +  C    P +R   +      + +  E    
Sbjct: 130 SNLEGVSAARSFEDFMRLCASRLPQRREAANHYLAHCRALFAETLEL 176

It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features. Length = 176

>gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase

 Score = 63.4 bits (154), Expect = 8e-11
 Identities = 41/143 (28%), Positives = 76/143 (53%), Gaps = 4/143 (2%)

Query: 124 VASGSYGDLYKG--TYCSQEVAIKVL-KPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIG 180
           ++ G++G +Y G     S+  A+KV+ K + +N  M+ +   E   +   +   +V    
Sbjct: 12  ISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYY 71

Query: 181 ACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDL 240
           +     N+ +V E++  G +   LH   G F     +K   +V+  ++YLH++ IIHRDL
Sbjct: 72  SLQSANNVYLVMEYLIGGDVKSLLHIY-GYFDEEMAVKYISEVALALDYLHRHGIIHRDL 130

Query: 241 KTANLLMDENGVVKVADFGVARV 263
           K  N+L+   G +K+ DFG+++V
Sbjct: 131 KPDNMLISNEGHIKLTDFGLSKV 153

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669

>gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor

 Score = 62.1 bits (151), Expect = 1e-10
 Identities = 49/204 (24%), Positives = 84/204 (41%), Gaps = 61/204 (29%)

Query: 187 NLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAI-DVSKGMNYLHQNNIIHRDLKTANL 245
           NL  V +++  G +   L  + G+F+   L +  I +++  +  +H+   IHRD+K  N+
Sbjct: 75  NLYFVMDYIPGGDMMSLL-IRLGIFE-EDLARFYIAELTCAIESVHKMGFIHRDIKPDNI 132

Query: 246 LMDENGVVKVADFGVA-------------------------------------------- 261
           L+D +G +K+ DFG+                                             
Sbjct: 133 LIDRDGHIKLTDFGLCTGFRWTHDSKYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRR 192

Query: 262 -----RVQAQSGVMTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPYAGL 316
                R  A S V     GT  ++APEV+    Y    D +S G+ L+E+L G+ P+   
Sbjct: 193 KRQHQRCLAHSLV-----GTPNYIAPEVLLRTGYTQLCDWWSVGVILYEMLVGQPPFLAD 247

Query: 317 TPLQAAVGVV--QKSLRPTIPKHA 338
           TP +  + V+  + +L   IP  A
Sbjct: 248 TPAETQLKVINWETTLH--IPSQA 269

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376

>gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional

 Score = 62.6 bits (152), Expect = 2e-10
 Identities = 64/286 (22%), Positives = 110/286 (38%), Gaps = 47/286 (16%)

Query: 118 LKIECKVASGSYGDLYKGTYCSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQ 177
           LK E  ++ G  G  YKG      +   V +   VN+    E +     M K++H N+V+
Sbjct: 692 LKEENVISRGKKGASYKGKSIKNGMQFVVKEINDVNSIPSSEIAD----MGKLQHPNIVK 747

Query: 178 FIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQN---N 234
            IG C       ++ E++   ++ + L             K+AI ++K + +LH      
Sbjct: 748 LIGLCRSEKGAYLIHEYIEGKNLSEVLRN----LSWERRRKIAIGIAKALRFLHCRCSPA 803

Query: 235 IIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAETGTYR--WMAPEVIEHKPYDY 292
           ++         L  E  ++   D    R+     + T         ++APE  E K    
Sbjct: 804 VV------VGNLSPEKIIIDGKDEPHLRLSLPGLLCTDTKCFISSAYVAPETRETKDITE 857

Query: 293 KADVFSFGIALWELLTGELPYAGLTPLQAAVGV----------------VQKSLRPTIPK 336
           K+D++ FG+ L ELLTG+      +P  A  GV                +   + P+I  
Sbjct: 858 KSDIYGFGLILIELLTGK------SPADAEFGVHGSIVEWARYCYSDCHLDMWIDPSIRG 911

Query: 337 HAHPRLAELLE------RCWQHDPTQRPNFSQITDILKQMMKEVAS 376
                  E++E       C   DPT RP  + +   L+   +  +S
Sbjct: 912 DVSVNQNEIVEVMNLALHCTATDPTARPCANDVLKTLESASRSSSS 957

Length = 968

>gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8

 Score = 61.2 bits (148), Expect = 2e-10
 Identities = 62/215 (28%), Positives = 102/215 (47%), Gaps = 34/215 (15%)

Query: 122 CKVASGSYGDLYKGTYCS----QEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQ 177
           CKV  G+YG +YK         ++ A+K ++     T +     +E+ ++R+++H NV+ 
Sbjct: 7   CKVGRGTYGHVYKAKRKDGKDDRDYALKQIE----GTGISMSACREIALLRELKHPNVIS 62

Query: 178 ----FIGACTRP---------PNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVS 224
               F+    R           +L  + +F  R S  +    Q     + SLL   +D  
Sbjct: 63  LQKVFLSHADRKVWLLFDYAEHDLWHIIKFH-RASKANKKPVQLPRGMVKSLLYQILD-- 119

Query: 225 KGMNYLHQNNIIHRDLKTANLLM----DENGVVKVADFGVARVQAQSGVMTAETG----T 276
            G++YLH N ++HRDLK AN+L+     E G VK+AD G AR+        A+      T
Sbjct: 120 -GIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVT 178

Query: 277 YRWMAPE-VIEHKPYDYKADVFSFGIALWELLTGE 310
           + + APE ++  + Y    D+++ G    ELLT E
Sbjct: 179 FWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSE 213

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317

>gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional

 Score = 60.4 bits (146), Expect = 5e-10
 Identities = 65/238 (27%), Positives = 114/238 (47%), Gaps = 32/238 (13%)

Query: 116 KQLKIECKVASGSYGDLYKGTYC---SQEVAIK-VLK-PECVNTEMLKEFSQEVYIMRKI 170
           K  K+   + +GS+G +Y+   C   S++VAIK VL+ P+  N E+L        IM+ +
Sbjct: 66  KSYKLGNIIGNGSFGVVYEAI-CIDTSEKVAIKKVLQDPQYKNRELL--------IMKNL 116

Query: 171 RHKNVV----QFIGACTRPPN----LCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAI- 221
            H N++     +   C +       L +V EF+ + +++ ++           L  V + 
Sbjct: 117 NHINIIFLKDYYYTECFKKNEKNIFLNVVMEFIPQ-TVHKYMKHYARNNHALPLFLVKLY 175

Query: 222 --DVSKGMNYLHQNNIIHRDLKTANLLMDENG-VVKVADFGVAR--VQAQSGVMTAETGT 276
              + + + Y+H   I HRDLK  NLL+D N   +K+ DFG A+  +  Q  V    +  
Sbjct: 176 SYQLCRALAYIHSKFICHRDLKPQNLLIDPNTHTLKLCDFGSAKNLLAGQRSVSYICSRF 235

Query: 277 YRWMAPEV-IEHKPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKSLRPT 333
           YR  APE+ +    Y    D++S G  + E++ G   ++G + +   V ++Q    PT
Sbjct: 236 YR--APELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVDQLVRIIQVLGTPT 291

Length = 440

>gnl|CDD|173714 cd05625, STKc_LATS1, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1

 Score = 59.2 bits (143), Expect = 1e-09
 Identities = 50/211 (23%), Positives = 87/211 (41%), Gaps = 53/211 (25%)

Query: 187 NLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAI-DVSKGMNYLHQNNIIHRDLKTANL 245
           NL  V +++  G +   L +  G+F    L +  I +++  +  +H+   IHRD+K  N+
Sbjct: 75  NLYFVMDYIPGGDMMSLLIRM-GIFP-EDLARFYIAELTCAVESVHKMGFIHRDIKPDNI 132

Query: 246 LMDENGVVKVADFGV--------------------------------------------- 260
           L+D +G +K+ DFG+                                             
Sbjct: 133 LIDRDGHIKLTDFGLCTGFRWTHDSKYYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPL 192

Query: 261 ---ARVQAQSGVMTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPYAGLT 317
              A  Q Q  +  +  GT  ++APEV+    Y    D +S G+ L+E+L G+ P+   T
Sbjct: 193 ERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYEMLVGQPPFLAQT 252

Query: 318 PLQAAVGVVQKSLRPTIPKHAH--PRLAELL 346
           PL+  + V+       IP  A   P  ++L+
Sbjct: 253 PLETQMKVINWQTSLHIPPQAKLSPEASDLI 283

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype and poor prognosis. LATS1 induces G2 arrest and promotes cytokinesis. It may be a component of the mitotic exit network in higher eukaryotes. Length = 382

>gnl|CDD|223009 PHA03211, PHA03211, serine/threonine kinase US3; Provisional

 Score = 58.8 bits (142), Expect = 2e-09
 Identities = 43/153 (28%), Positives = 71/153 (46%), Gaps = 14/153 (9%)

Query: 161 SQEVYIMRKIRHKNV-----VQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTS 215
             E  ++R++ H  V     V+ +G  T     C+V     R  +Y +L  +     L  
Sbjct: 208 VHEARLLRRLSHPAVLALLDVRVVGGLT-----CLVLP-KYRSDLYTYLGARLRPLGLAQ 261

Query: 216 LLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVA---RVQAQSGVMTA 272
           +  VA  +   ++Y+H   IIHRD+KT N+L++    + + DFG A   R    +     
Sbjct: 262 VTAVARQLLSAIDYIHGEGIIHRDIKTENVLVNGPEDICLGDFGAACFARGSWSTPFHYG 321

Query: 273 ETGTYRWMAPEVIEHKPYDYKADVFSFGIALWE 305
             GT    APEV+   PY    D++S G+ ++E
Sbjct: 322 IAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFE 354

Length = 461

>gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed

 Score = 59.4 bits (144), Expect = 2e-09
 Identities = 53/226 (23%), Positives = 91/226 (40%), Gaps = 38/226 (16%)

Query: 123 KVASGSYGDLYKG--TYCSQEVAIKVLKPECVNTEMLKE-FSQEVYIMRKIRHKNVVQFI 179
            +  G  G++Y      CS+ VA+K ++ +     +LK+ F +E  I   + H  +V   
Sbjct: 9   LIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVY 68

Query: 180 GACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSL-------------LKVAIDVSKG 226
             C+       V   M     Y      K V+Q  SL             L +   +   
Sbjct: 69  SICSDGD---PVYYTMPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICAT 125

Query: 227 MNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQ------------AQSGVMTAE- 273
           + Y+H   ++HRDLK  N+L+   G V + D+G A  +             +  +  +  
Sbjct: 126 IEYVHSKGVLHRDLKPDNILLGLFGEVVILDWGAAIFKKLEEEDLLDIDVDERNICYSSM 185

Query: 274 ------TGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPY 313
                  GT  +MAPE +   P     D+++ G+ L+++LT   PY
Sbjct: 186 TIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFPY 231

Length = 932

>gnl|CDD|173715 cd05626, STKc_LATS2, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2

 Score = 58.1 bits (140), Expect = 2e-09
 Identities = 51/233 (21%), Positives = 98/233 (42%), Gaps = 50/233 (21%)

Query: 143 AIKVL-KPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVTEFMARGSIY 201
           A+K L K + +N   +     E  I+ +  ++ VV+   +     NL  V +++  G + 
Sbjct: 30  AMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMDYIPGGDMM 89

Query: 202 DFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGV- 260
             L + +   ++ +   +A +++  +  +H+   IHRD+K  N+L+D +G +K+ DFG+ 
Sbjct: 90  SLLIRMEVFPEVLARFYIA-ELTLAIESVHKMGFIHRDIKPDNILIDLDGHIKLTDFGLC 148

Query: 261 -----------------------------------------------ARVQAQSGVMTAE 273
                                                          A  Q Q  +  + 
Sbjct: 149 TGFRWTHNSKYYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSL 208

Query: 274 TGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVV 326
            GT  ++APEV+  K Y    D +S G+ L+E+L G+ P+   TP +  + V+
Sbjct: 209 VGTPNYIAPEVLLRKGYTQLCDWWSVGVILFEMLVGQPPFLAPTPTETQLKVI 261

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with poor prognosis in acute lymphoblastic leukemia and breast cancer. Length = 381

>gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta

 Score = 57.7 bits (139), Expect = 3e-09
 Identities = 34/119 (28%), Positives = 62/119 (52%), Gaps = 11/119 (9%)

Query: 101 IEIPTDGTDVWEIDAKQLKIECKVASGSYGDLYKGT-------YCSQEVAIKVLKPECVN 153
           +++P D    WE+    L +   + SG++G + + T         + +VA+K+LK    +
Sbjct: 24  MQLPYDSA--WEMPRDNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTARS 81

Query: 154 TEMLKEFSQEVYIMRKI-RHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVF 211
           +E  +    E+ IM  +  H N+V  +GACT+   + I+TE+   G + D+LH+ K  F
Sbjct: 82  SEK-QALMSELKIMSHLGPHLNIVNLLGACTKGGPIYIITEYCRYGDLVDYLHRNKHTF 139

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401

>gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases

 Score = 57.9 bits (140), Expect = 3e-09
 Identities = 31/94 (32%), Positives = 57/94 (60%), Gaps = 7/94 (7%)

Query: 227 MNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVA-RVQAQSGVMTA-ETGTYRWMAPEV 284
           ++ +HQ   +HRD+K  N+L+D+NG +++ADFG   R+ A   V +    GT  +++PE+
Sbjct: 115 IDSVHQLGYVHRDIKPDNVLLDKNGHIRLADFGSCLRLLADGTVQSNVAVGTPDYISPEI 174

Query: 285 IE-----HKPYDYKADVFSFGIALWELLTGELPY 313
           ++        Y  + D +S G+ ++E+L GE P+
Sbjct: 175 LQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPF 208

Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331

>gnl|CDD|153172 cd04900, ACT_UUR-like_1, ACT domain family, ACT_UUR-like_1, includes the first of two C-terminal ACT domains of the bacterial signal-transducing uridylyltransferase /uridylyl-removing (UUR) enzyme, GlnD and related domains

 Score = 52.5 bits (127), Expect = 4e-09
 Identities = 21/48 (43%), Positives = 29/48 (60%), Gaps = 3/48 (6%)

Query: 14 LTSLLGEIGLNIQEAHAFSTVDGFSLDVFVV---DGWPYDETEDLKNV 58
          +   L ++GLNI +A  F+T DG++LD FVV   DG P  E E L  +
Sbjct: 18 IAGALDQLGLNILDARIFTTRDGYALDTFVVLDPDGEPIGERERLARI 65

This ACT domain family, ACT_UUR-like_1, includes the first of two C-terminal ACT domains of the bacterial signal-transducing uridylyltransferase /uridylyl-removing (UUR) enzyme, GlnD; including those enzymes similar to the GlnD found in enteric Escherichia coli and those found in photosynthetic, nitrogen-fixing bacterium Rhodospirillum rubrum. Also included in this CD is the N-terminal ACT domain of a yet characterized Arabidopsis/Oryza predicted tyrosine kinase. Members of this CD belong to the superfamily of ACT regulatory domains. Length = 73

>gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha

 Score = 55.0 bits (132), Expect = 3e-08
 Identities = 37/120 (30%), Positives = 64/120 (53%), Gaps = 11/120 (9%)

Query: 101 IEIPTDGTDVWEIDAKQLKIECKVASGSYGDLYKGTYC----SQ---EVAIKVLKPECVN 153
           +++P D    WE     L +   + SG++G + +GT      SQ   +VA+K+LKP   +
Sbjct: 24  MQLPYDSR--WEFPRDGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTARS 81

Query: 154 TEMLKEFSQEVYIMRKI-RHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQ 212
           +E  +    E+ IM  +  H N+V  +GACT+   + I+TE+   G + ++LHK +  F 
Sbjct: 82  SEK-QALMSELKIMTHLGPHLNIVNLLGACTKSGPIYIITEYCFYGDLVNYLHKNRDNFL 140

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400

>gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

 Score = 53.1 bits (128), Expect = 1e-07
 Identities = 42/184 (22%), Positives = 72/184 (39%), Gaps = 62/184 (33%)

Query: 187 NLCIVTEFMARGSI------YDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDL 240
            L ++ E++  G +       D   +++  F +   + +AID       +H+   IHRD+
Sbjct: 75  YLYLIMEYLPGGDMMTLLMKKDTFTEEETRFYIAETI-LAID------SIHKLGYIHRDI 127

Query: 241 KTANLLMDENGVVKVADFGVA--------------------------------------- 261
           K  NLL+D  G +K++DFG+                                        
Sbjct: 128 KPDNLLLDAKGHIKLSDFGLCTGLKKSHRTEFYRILSHALPSNFLDFISKPMSSKRKAET 187

Query: 262 -----RVQAQSGVMTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPYAGL 316
                R  A S V     GT  ++APEV     Y+ + D +S G+ ++E+L G  P+   
Sbjct: 188 WKRNRRALAYSTV-----GTPDYIAPEVFLQTGYNKECDWWSLGVIMYEMLVGYPPFCSD 242

Query: 317 TPLQ 320
            P +
Sbjct: 243 NPQE 246

Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364

>gnl|CDD|173667 cd05576, STKc_RPK118_like, Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins

 Score = 50.2 bits (120), Expect = 4e-07
 Identities = 49/212 (23%), Positives = 88/212 (41%), Gaps = 23/212 (10%)

Query: 161 SQEVYIMRKIRHKNVVQFIGACTRP---PNL-CIVTEFMARGSIYDFL-HKQKGVF--QL 213
           +Q+ +I++ +R  +          P   PN+ C+    ++  S++  L H + G     +
Sbjct: 17  TQQTFILKGLRKSSEYSRERLTIIPHCVPNMVCLHKYIVSEDSVFLVLQHAEGGKLWSHI 76

Query: 214 TSLLKV--------AIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQA 265
           +  L +        A ++   ++ LH+  I+ RDL   N+L+D+ G +++  F       
Sbjct: 77  SKFLNIPEECVKRWAAEMVVALDALHREGIVCRDLNPNNILLDDRGHIQLTYFSRWSEVE 136

Query: 266 QSGVMTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGV 325
            S    A    Y   APEV          D +S G  L+ELLT      G T ++     
Sbjct: 137 DSCDGEAVENMY--CAPEVGGISEETEACDWWSLGAILFELLT------GKTLVECHPSG 188

Query: 326 VQKSLRPTIPKHAHPRLAELLERCWQHDPTQR 357
           +       IP+        LL++  Q +PT+R
Sbjct: 189 INTHTTLNIPEWVSEEARSLLQQLLQFNPTER 220

Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phosphate (SPP), a lipid messenger involved in many cellular events. RPK118 may be involved in transmitting SPP-mediated signaling. RPK118 also binds the antioxidant peroxiredoxin-3 (PRDX3). RPK118 may be involved in the transport of PRDX3 from the cytoplasm to its site of function in the mitochondria. Length = 237

>gnl|CDD|165476 PHA03210, PHA03210, serine/threonine kinase US3; Provisional

 Score = 50.5 bits (120), Expect = 1e-06
 Identities = 41/191 (21%), Positives = 83/191 (43%), Gaps = 20/191 (10%)

Query: 154 TEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQL 213
           +    +   E+  + ++ H+N+++         N  ++T+      +Y F++ +   ++ 
Sbjct: 204 SRAAIQLENEILALGRLNHENILKIEEILRSEANTYMITQ-KYDFDLYSFMYDEAFDWKD 262

Query: 214 TSLLKVAIDVSK----GMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVA------RV 263
             LLK    + K     + Y+H   +IHRD+K  N+ ++ +G + + DFG A      R 
Sbjct: 263 RPLLKQTRAIMKQLLCAVEYIHDKKLIHRDIKLENIFLNCDGKIVLGDFGTAMPFEKERE 322

Query: 264 QAQSGVMTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAV 323
               G +    GT    +PE++    Y    D++S G+ L ++L+ +       P+    
Sbjct: 323 AFDYGWV----GTVATNSPEILAGDGYCEITDIWSCGLILLDMLSHD-----FCPIGDGG 373

Query: 324 GVVQKSLRPTI 334
           G   K L   I
Sbjct: 374 GKPGKQLLKII 384

Length = 501

>gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2

 Score = 47.3 bits (112), Expect = 7e-06
 Identities = 32/110 (29%), Positives = 57/110 (51%), Gaps = 10/110 (9%)

Query: 111 WEIDAKQLKIECKVASGSYGDLYKG-------TYCSQEVAIKVLKPECVNTEMLKEFSQE 163
           WE    +LK+   +  G++G + +        T   + VA+K+LK    ++E  +    E
Sbjct: 2   WEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEH-RALMSE 60

Query: 164 VYIMRKI-RHKNVVQFIGACTRPPN-LCIVTEFMARGSIYDFLHKQKGVF 211
           + I+  I  H NVV  +GACT+P   L ++ EF   G++ ++L  ++G F
Sbjct: 61  LKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSNYLRSKRGEF 110

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343

>gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3

 Score = 46.9 bits (111), Expect = 8e-06
 Identities = 33/111 (29%), Positives = 55/111 (49%), Gaps = 12/111 (10%)

Query: 111 WEIDAKQLKIECKVASGSYGDL--------YKGTYCSQEVAIKVLKPECVNTEMLKEFSQ 162
           WE    +L++   +  G++G +         K + C   VA+K+LK     +E  K    
Sbjct: 2   WEFPRDRLRLGKVLGHGAFGKVVEASAFGIDKKSSC-NTVAVKMLKEGATASEH-KALMS 59

Query: 163 EVYIMRKI-RHKNVVQFIGACTRPPN-LCIVTEFMARGSIYDFLHKQKGVF 211
           E+ I+  I  H NVV  +GACT+P   L ++ EF   G++ +FL  ++  F
Sbjct: 60  ELKILIHIGNHLNVVNLLGACTKPNGPLMVIVEFCKYGNLSNFLRAKREFF 110

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338

>gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit

 Score = 45.7 bits (108), Expect = 2e-05
 Identities = 29/111 (26%), Positives = 52/111 (46%), Gaps = 13/111 (11%)

Query: 111 WEIDAKQLKIECKVASGSYGDLYKGTY-------CSQEVAIKVLKPECVNTE---MLKEF 160
           WE    +L     + +G++G + + T         +  VA+K+LKP    TE   ++ E 
Sbjct: 30  WEFPRNRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAHLTEREALMSEL 89

Query: 161 SQEVYIMRKIRHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVF 211
               Y+     H N+V  +GACT      ++TE+   G + +FL +++  F
Sbjct: 90  KVLSYLGN---HINIVNLLGACTVGGPTLVITEYCCYGDLLNFLRRKRDSF 137

Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375

>gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor

 Score = 45.6 bits (108), Expect = 3e-05
 Identities = 29/111 (26%), Positives = 55/111 (49%), Gaps = 9/111 (8%)

Query: 109 DVWEIDAKQLKIECKVASGSYGDLYKGTY-------CSQEVAIKVLKPECVNTEMLKEFS 161
           + WE     L+    + +G++G + + T            VA+K+LK    +T+  +   
Sbjct: 31  EKWEFPRDNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKAS-AHTDEREALM 89

Query: 162 QEVYIMRKI-RHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVF 211
            E+ I+  + +HKN+V  +GACT    + ++TE+   G + +FL K+   F
Sbjct: 90  SELKILSHLGQHKNIVNLLGACTHGGPVLVITEYCCYGDLLNFLRKKAETF 140

Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374

>gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors

 Score = 44.8 bits (106), Expect = 4e-05
 Identities = 32/114 (28%), Positives = 55/114 (48%), Gaps = 12/114 (10%)

Query: 111 WEIDAKQLKIECKVASGSYG--------DLYKGTYCSQEVAIKVLKPECVNTEMLKEFSQ 162
           WE    +LK+   +  G++G         + K   C + VA+K+LK     +E  K    
Sbjct: 2   WEFPRDRLKLGKPLGRGAFGKVIQASAFGIEKSASC-RTVAVKMLKEGATASEY-KALMT 59

Query: 163 EVYIMRKI-RHKNVVQFIGACTRPPN-LCIVTEFMARGSIYDFLHKQKGVFQLT 214
           E+ I+  I  H NVV  +GACT+P   L ++ E+   G++ ++L  ++  F   
Sbjct: 60  ELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEYCKFGNLSNYLRSKRECFSPY 113

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337

>gnl|CDD|140307 PTZ00284, PTZ00284, protein kinase; Provisional

 Score = 43.8 bits (103), Expect = 1e-04
 Identities = 34/129 (26%), Positives = 57/129 (44%), Gaps = 20/129 (15%)

Query: 202 DFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQN-NIIHRDLKTANLLMDENGV-------- 252
           D++ K  G F    L ++       ++Y H   +++H DLK  N+LM+ +          
Sbjct: 220 DWIMKH-GPFSHRHLAQIIFQTGVALDYFHTELHLMHTDLKPENILMETSDTVVDPVTNR 278

Query: 253 --------VKVADFGVARVQAQSGVMTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALW 304
                   V++ D G    +  S      T  YR  +PEV+    + Y  D++S G  ++
Sbjct: 279 ALPPDPCRVRICDLGGCCDERHSRTAIVSTRHYR--SPEVVLGLGWMYSTDMWSMGCIIY 336

Query: 305 ELLTGELPY 313
           EL TG+L Y
Sbjct: 337 ELYTGKLLY 345

Length = 467

>gnl|CDD|178763 PLN03224, PLN03224, probable serine/threonine protein kinase; Provisional

 Score = 42.4 bits (99), Expect = 3e-04
 Identities = 27/70 (38%), Positives = 38/70 (54%), Gaps = 3/70 (4%)

Query: 193 EFMARGS-IYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENG 251
           EFM  G  I D + + K    +  +  V   V  G+  LH+  I+HRD+K  NLL+  +G
Sbjct: 289 EFMMAGKKIPDNMPQDKR--DINVIKGVMRQVLTGLRKLHRIGIVHRDIKPENLLVTVDG 346

Query: 252 VVKVADFGVA 261
            VK+ DFG A
Sbjct: 347 QVKIIDFGAA 356

Length = 507

>gnl|CDD|173718 cd05629, STKc_NDR_like_fungal, Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

 Score = 40.6 bits (95), Expect = 0.001
 Identities = 29/137 (21%), Positives = 52/137 (37%), Gaps = 48/137 (35%)

Query: 230 LHQNNIIHRDLKTANLLMDENGVVKVADFGVA-----------------------RVQAQ 266
           +H+   IHRD+K  N+L+D  G +K++DFG++                       R+  +
Sbjct: 117 VHKLGFIHRDIKPDNILIDRGGHIKLSDFGLSTGFHKQHDSAYYQKLLQGKSNKNRIDNR 176

Query: 267 SGVMT-------------------------AETGTYRWMAPEVIEHKPYDYKADVFSFGI 301
           + V                           +  GT  ++APE+   + Y  + D +S G 
Sbjct: 177 NSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQECDWWSLGA 236

Query: 302 ALWELLTGELPYAGLTP 318
            ++E L G  P+     
Sbjct: 237 IMFECLIGWPPFCSENS 253

Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of Ace2p activity and cellular morphogenesis) network. CBK1 and Orb6 play similar roles in coordinating cell morphology with cell cycle progression. Ukc1 is involved in morphogenesis, pathogenicity, and pigment formation. Cot1 plays a role in polar tip extension. Length = 377

>gnl|CDD|237847 PRK14879, PRK14879, serine/threonine protein kinase; Provisional

 Score = 39.9 bits (94), Expect = 0.001
 Identities = 14/47 (29%), Positives = 28/47 (59%), Gaps = 1/47 (2%)

Query: 216 LLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVAR 262
            L+++ ++ + +  LH   IIH DL T+N+++    +  + DFG+A 
Sbjct: 97  ELELSREIGRLVGKLHSAGIIHGDLTTSNMILSGGKIY-LIDFGLAE 142

Length = 211

>gnl|CDD|153145 cd04873, ACT_UUR-ACR-like, ACT domains of the bacterial signal-transducing uridylyltransferase /uridylyl-removing (UUR) enzyme, GlnD

 Score = 36.0 bits (84), Expect = 0.002
 Identities = 16/55 (29%), Positives = 27/55 (49%), Gaps = 2/55 (3%)

Query: 13 ELTSLLGEIGLNIQEAHAFSTVDGFSLDVFVV-DGWPYDETEDLKNVLAKEILKS 66
          ++T +L ++GLNI +A   ST    +LDVF V D        +    L + +  +
Sbjct: 16 DITRVLADLGLNIHDAR-ISTTGERALDVFYVTDSDGRPLDPERIARLEEALEDA 69

This ACT domain family, ACT_UUR_ACR-like, includes the two C-terminal ACT domains of the bacterial signal-transducing uridylyltransferase /uridylyl-removing (UUR) enzyme, GlnD; including those enzymes similar to the GlnD found in enteric Escherichia coli and those found in photosynthetic, nitrogen-fixing bacterium Rhodospirillum rubrum. Also included in this CD are the four ACT domains of a novel protein composed almost entirely of ACT domain repeats (the ACR protein) and like proteins. These ACR proteins, found in Arabidopsis and Oryza, are proposed to function as novel regulatory or sensor proteins in plants. This CD also includes the first of the two ACT domains that comprise the Glycine Cleavage System Transcriptional Repressor (GcvR) protein and related domains, as well as, the N-terminal ACT domain of a yet characterized Arabidopsis/Oryza predicted tyrosine kinase. Members of this CD belong to the superfamily of ACT regulatory domains. Length = 70

>gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase

 Score = 39.5 bits (92), Expect = 0.003
 Identities = 23/61 (37%), Positives = 33/61 (54%), Gaps = 4/61 (6%)

Query: 275 GTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKSLRPTI 334
           GT  ++APE++  KP+    D ++ G+ L+E LTG  P+   TP Q    V Q  L   I
Sbjct: 542 GTPDYLAPELLLGKPHGPAVDWWALGVCLFEFLTGIPPFNDETPQQ----VFQNILNRDI 597

Query: 335 P 335
           P
Sbjct: 598 P 598

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669

Conserved Domains Detected by HHsearch

Original result of HHsearch against CDD database

ID	Length	Definition	Probability
Query	399
KOG0192	362	consensus Tyrosine kinase specific for activated (	100.0
KOG0581	364	consensus Mitogen-activated protein kinase kinase	100.0
KOG0199	1039	consensus ACK and related non-receptor tyrosine ki	100.0
KOG0197	468	consensus Tyrosine kinases [Signal transduction me	100.0
KOG0595	429	consensus Serine/threonine-protein kinase involved	100.0
KOG0575	592	consensus Polo-like serine/threonine protein kinas	100.0
KOG0193	678	consensus Serine/threonine protein kinase RAF [Sig	100.0
KOG0591	375	consensus NIMA (never in mitosis)-related G2-speci	100.0
KOG0615	475	consensus Serine/threonine protein kinase Chk2 and	100.0
KOG4721	904	consensus Serine/threonine protein kinase, contain	100.0
KOG0598	357	consensus Ribosomal protein S6 kinase and related	100.0
cd05102	338	PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi	100.0
KOG0198	313	consensus MEKK and related serine/threonine protei	100.0
KOG0582	516	consensus Ste20-like serine/threonine protein kina	100.0
KOG0593	396	consensus Predicted protein kinase KKIAMRE [Genera	100.0
KOG0194	474	consensus Protein tyrosine kinase [Signal transduc	100.0
KOG0583	370	consensus Serine/threonine protein kinase [Signal	100.0
KOG0592	604	consensus 3-phosphoinositide-dependent protein kin	100.0
PHA02988	283	hypothetical protein; Provisional	100.0
KOG0661	538	consensus MAPK related serine/threonine protein ki	100.0
KOG0588	786	consensus Serine/threonine protein kinase [Cell cy	100.0
KOG0616	355	consensus cAMP-dependent protein kinase catalytic	100.0
cd05064	266	PTKc_EphR_A10 Catalytic domain of the Protein Tyro	100.0
KOG0578	550	consensus p21-activated serine/threonine protein k	100.0
cd05104	375	PTKc_Kit Catalytic domain of the Protein Tyrosine	100.0
KOG0600	560	consensus Cdc2-related protein kinase [Cell cycle	100.0
KOG0659	318	consensus Cdk activating kinase (CAK)/RNA polymera	100.0
cd05106	374	PTKc_CSF-1R Catalytic domain of the Protein Tyrosi	100.0
KOG1026	774	consensus Nerve growth factor receptor TRKA and re	100.0
KOG0597	808	consensus Serine-threonine protein kinase FUSED [G	100.0
KOG4257	974	consensus Focal adhesion tyrosine kinase FAK, cont	100.0
KOG0201	467	consensus Serine/threonine protein kinase [Signal	100.0
cd05096	304	PTKc_DDR1 Catalytic domain of the Protein Tyrosine	100.0
KOG0605	550	consensus NDR and related serine/threonine kinases	100.0
PF07714	259	Pkinase_Tyr: Protein tyrosine kinase Protein kinas	100.0
KOG1095	1025	consensus Protein tyrosine kinase [Signal transduc	100.0
cd05612	291	STKc_PRKX_like Catalytic domain of PRKX-like Prote	100.0
PTZ00263	329	protein kinase A catalytic subunit; Provisional	100.0
cd05631	285	STKc_GRK4 Catalytic domain of the Protein Serine/T	100.0
cd05054	337	PTKc_VEGFR Catalytic domain of the Protein Tyrosin	100.0
cd05105	400	PTKc_PDGFR_alpha Catalytic domain of the Protein T	100.0
cd05600	333	STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p-	100.0
cd05048	283	PTKc_Ror Catalytic Domain of the Protein Tyrosine	100.0
cd05571	323	STKc_PKB Catalytic domain of the Protein Serine/Th	100.0
cd05107	401	PTKc_PDGFR_beta Catalytic domain of the Protein Ty	100.0
cd05072	261	PTKc_Lyn Catalytic domain of the Protein Tyrosine	100.0
cd05114	256	PTKc_Tec_Rlk Catalytic domain of the Protein Tyros	100.0
cd05052	263	PTKc_Abl Catalytic domain of the Protein Tyrosine	100.0
PTZ00426	340	cAMP-dependent protein kinase catalytic subunit; P	100.0
KOG0589	426	consensus Serine/threonine protein kinase [General	100.0
cd05108	316	PTKc_EGFR Catalytic domain of the Protein Tyrosine	100.0
cd05573	350	STKc_ROCK_NDR_like Catalytic domain of ROCK- and N	100.0
cd07871	288	STKc_PCTAIRE3 Catalytic domain of the Serine/Threo	100.0
cd06649	331	PKc_MEK2 Catalytic domain of the dual-specificity	100.0
KOG0585	576	consensus Ca2+/calmodulin-dependent protein kinase	100.0
cd05033	266	PTKc_EphR Catalytic domain of Ephrin Receptor Prot	100.0
cd07848	287	STKc_CDKL5 Catalytic domain of the Serine/Threonin	100.0
cd05082	256	PTKc_Csk Catalytic domain of the Protein Tyrosine	100.0
cd07862	290	STKc_CDK6 Catalytic domain of the Serine/Threonine	100.0
cd05585	312	STKc_YPK1_like Catalytic domain of Yeast Protein K	100.0
cd05039	256	PTKc_Csk_like Catalytic domain of C-terminal Src k	100.0
cd05089	297	PTKc_Tie1 Catalytic domain of the Protein Tyrosine	100.0
cd05068	261	PTKc_Frk_like Catalytic domain of Fyn-related kina	100.0
cd05595	323	STKc_PKB_beta Catalytic domain of the Protein Seri	100.0
cd05062	277	PTKc_IGF-1R Catalytic domain of the Protein Tyrosi	100.0
cd07869	303	STKc_PFTAIRE1 Catalytic domain of the Serine/Threo	100.0
cd05055	302	PTKc_PDGFR Catalytic domain of the Protein Tyrosin	100.0
cd05113	256	PTKc_Btk_Bmx Catalytic domain of the Protein Tyros	100.0
cd05032	277	PTKc_InsR_like Catalytic domain of Insulin Recepto	100.0
cd05098	307	PTKc_FGFR1 Catalytic domain of the Protein Tyrosin	100.0
PTZ00283	496	serine/threonine protein kinase; Provisional	100.0
cd05116	257	PTKc_Syk Catalytic domain of the Protein Tyrosine	100.0
cd05093	288	PTKc_TrkB Catalytic domain of the Protein Tyrosine	100.0
cd05593	328	STKc_PKB_gamma Catalytic domain of the Protein Ser	100.0
cd05599	364	STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel	100.0
cd08228	267	STKc_Nek6 Catalytic domain of the Protein Serine/T	100.0
cd05088	303	PTKc_Tie2 Catalytic domain of the Protein Tyrosine	100.0
KOG0611	668	consensus Predicted serine/threonine protein kinas	100.0
cd05628	363	STKc_NDR1 Catalytic domain of the Protein Serine/T	100.0
cd05626	381	STKc_LATS2 Catalytic domain of the Protein Serine/	100.0
cd05059	256	PTKc_Tec_like Catalytic domain of Tec-like Protein	100.0
cd05601	330	STKc_CRIK Catalytic domain of the Protein Serine/T	100.0
KOG4278	1157	consensus Protein tyrosine kinase [Signal transduc	100.0
cd05148	261	PTKc_Srm_Brk Catalytic domain of the Protein Tyros	100.0
cd05584	323	STKc_p70S6K Catalytic domain of the Protein Serine	100.0
cd05090	283	PTKc_Ror1 Catalytic domain of the Protein Tyrosine	100.0
cd05109	279	PTKc_HER2 Catalytic domain of the Protein Tyrosine	100.0
KOG0663	419	consensus Protein kinase PITSLRE and related kinas	100.0
cd05103	343	PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi	100.0
cd05071	262	PTKc_Src Catalytic domain of the Protein Tyrosine	100.0
cd05589	324	STKc_PKN Catalytic domain of the Protein Serine/Th	100.0
KOG0694	694	consensus Serine/threonine protein kinase [Signal	100.0
cd05111	279	PTK_HER3 Pseudokinase domain of the Protein Tyrosi	100.0
cd05035	273	PTKc_Axl_like Catalytic Domain of Axl-like Protein	100.0
cd05049	280	PTKc_Trk Catalytic domain of the Protein Tyrosine	100.0
cd05084	252	PTKc_Fes Catalytic domain of the Protein Tyrosine	100.0
cd05629	377	STKc_NDR_like_fungal Catalytic domain of Fungal Nu	100.0
cd05115	257	PTKc_Zap-70 Catalytic domain of the Protein Tyrosi	100.0
cd07859	338	STKc_TDY_MAPK_plant Catalytic domain of the Serine	100.0
cd05582	318	STKc_RSK_N N-terminal catalytic domain of the Prot	100.0
PTZ00267	478	NIMA-related protein kinase; Provisional	100.0
cd06625	263	STKc_MEKK3_like Catalytic domain of MAP/ERK kinase	100.0
cd05587	324	STKc_cPKC Catalytic domain of the Protein Serine/T	100.0
cd05596	370	STKc_ROCK Catalytic domain of the Protein Serine/T	100.0
cd05070	260	PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros	100.0
cd05066	267	PTKc_EphR_A Catalytic domain of the Protein Tyrosi	100.0
cd05605	285	STKc_GRK4_like Catalytic domain of G protein-coupl	100.0
cd07876	359	STKc_JNK2 Catalytic domain of the Serine/Threonine	100.0
cd05094	291	PTKc_TrkC Catalytic domain of the Protein Tyrosine	100.0
cd05061	288	PTKc_InsR Catalytic domain of the Protein Tyrosine	100.0
cd05053	293	PTKc_FGFR Catalytic domain of the Protein Tyrosine	100.0
cd05075	272	PTKc_Axl Catalytic domain of the Protein Tyrosine	100.0
cd05091	283	PTKc_Ror2 Catalytic domain of the Protein Tyrosine	100.0
cd08529	256	STKc_FA2-like Catalytic domain of the Protein Seri	100.0
KOG0580	281	consensus Serine/threonine protein kinase [Cell cy	100.0
cd05099	314	PTKc_FGFR4 Catalytic domain of the Protein Tyrosin	100.0
KOG1187	361	consensus Serine/threonine protein kinase [Signal	100.0
cd06650	333	PKc_MEK1 Catalytic domain of the dual-specificity	100.0
cd05101	304	PTKc_FGFR2 Catalytic domain of the Protein Tyrosin	100.0
cd05598	376	STKc_LATS Catalytic domain of the Protein Serine/T	100.0
cd05045	290	PTKc_RET Catalytic domain of the Protein Tyrosine	100.0
cd05625	382	STKc_LATS1 Catalytic domain of the Protein Serine/	100.0
PLN00034	353	mitogen-activated protein kinase kinase; Provision	100.0
cd05590	320	STKc_nPKC_eta Catalytic domain of the Protein Seri	100.0
cd05592	316	STKc_nPKC_theta_delta Catalytic domain of the Prot	100.0
cd05056	270	PTKc_FAK Catalytic domain of the Protein Tyrosine	100.0
cd05594	325	STKc_PKB_alpha Catalytic domain of the Protein Ser	100.0
KOG0196	996	consensus Tyrosine kinase, EPH (ephrin) receptor f	100.0
cd05065	269	PTKc_EphR_B Catalytic domain of the Protein Tyrosi	100.0
cd05591	321	STKc_nPKC_epsilon Catalytic domain of the Protein	100.0
cd05067	260	PTKc_Lck_Blk Catalytic domain of the Protein Tyros	100.0
cd05092	280	PTKc_TrkA Catalytic domain of the Protein Tyrosine	100.0
cd05043	280	PTK_Ryk Pseudokinase domain of Ryk (Receptor relat	100.0
cd05034	261	PTKc_Src_like Catalytic domain of Src kinase-like	100.0
cd05080	283	PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the	100.0
cd05614	332	STKc_MSK2_N N-terminal catalytic domain of the Pro	100.0
cd05616	323	STKc_cPKC_beta Catalytic domain of the Protein Ser	100.0
cd00192	262	PTKc Catalytic domain of Protein Tyrosine Kinases.	100.0
PTZ00036	440	glycogen synthase kinase; Provisional	100.0
cd05069	260	PTKc_Yes Catalytic domain of the Protein Tyrosine	100.0
cd05588	329	STKc_aPKC Catalytic domain of the Protein Serine/T	100.0
cd07874	355	STKc_JNK3 Catalytic domain of the Serine/Threonine	100.0
cd05570	318	STKc_PKC Catalytic domain of the Protein Serine/Th	100.0
cd05036	277	PTKc_ALK_LTK Catalytic domain of the Protein Tyros	100.0
cd05621	370	STKc_ROCK2 Catalytic domain of the Protein Serine/	100.0
KOG1989	738	consensus ARK protein kinase family [Signal transd	100.0
cd05063	268	PTKc_EphR_A2 Catalytic domain of the Protein Tyros	100.0
cd05607	277	STKc_GRK7 Catalytic domain of the Protein Serine/T	100.0
cd07875	364	STKc_JNK1 Catalytic domain of the Serine/Threonine	100.0
cd05620	316	STKc_nPKC_delta Catalytic domain of the Protein Se	100.0
cd08219	255	STKc_Nek3 Catalytic domain of the Protein Serine/T	100.0
cd05057	279	PTKc_EGFR_like Catalytic domain of Epidermal Growt	100.0
cd05619	316	STKc_nPKC_theta Catalytic domain of the Protein Se	100.0
cd05050	288	PTKc_Musk Catalytic domain of the Protein Tyrosine	100.0
cd05097	295	PTKc_DDR_like Catalytic domain of Discoidin Domain	100.0
cd08224	267	STKc_Nek6_Nek7 Catalytic domain of the Protein Ser	100.0
cd05622	371	STKc_ROCK1 Catalytic domain of the Protein Serine/	100.0
cd05081	284	PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of	100.0
cd05575	323	STKc_SGK Catalytic domain of the Protein Serine/Th	100.0
cd05100	334	PTKc_FGFR3 Catalytic domain of the Protein Tyrosin	100.0
cd05051	296	PTKc_DDR Catalytic domain of the Protein Tyrosine	100.0
cd06646	267	STKc_MAP4K5 Catalytic domain of the Protein Serine	100.0
cd05083	254	PTKc_Chk Catalytic domain of the Protein Tyrosine	100.0
cd05060	257	PTKc_Syk_like Catalytic domain of Spleen Tyrosine	100.0
KOG0594	323	consensus Protein kinase PCTAIRE and related kinas	100.0
cd07863	288	STKc_CDK4 Catalytic domain of the Serine/Threonine	100.0
KOG4717	864	consensus Serine/threonine protein kinase [Signal	100.0
cd05602	325	STKc_SGK1 Catalytic domain of the Protein Serine/T	100.0
cd05627	360	STKc_NDR2 Catalytic domain of the Protein Serine/T	100.0
cd05040	257	PTKc_Ack_like Catalytic domain of the Protein Tyro	100.0
cd05597	331	STKc_DMPK_like Catalytic domain of Myotonic Dystro	100.0
cd06613	262	STKc_MAP4K3_like Catalytic domain of Mitogen-activ	100.0
cd05608	280	STKc_GRK1 Catalytic domain of the Protein Serine/T	100.0
cd08229	267	STKc_Nek7 Catalytic domain of the Protein Serine/T	100.0
KOG0660	359	consensus Mitogen-activated protein kinase [Signal	100.0
cd05047	270	PTKc_Tie Catalytic domain of Tie Protein Tyrosine	100.0
cd05085	250	PTKc_Fer Catalytic domain of the Protein Tyrosine	100.0
cd05079	284	PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the	100.0
cd05618	329	STKc_aPKC_iota Catalytic domain of the Protein Ser	100.0
cd07853	372	STKc_NLK Catalytic domain of the Serine/Threonine	100.0
cd05073	260	PTKc_Hck Catalytic domain of the Protein Tyrosine	100.0
cd05630	285	STKc_GRK6 Catalytic domain of the Protein Serine/T	100.0
cd05112	256	PTKc_Itk Catalytic domain of the Protein Tyrosine	100.0
cd07872	309	STKc_PCTAIRE2 Catalytic domain of the Serine/Threo	100.0
cd06644	292	STKc_STK10_LOK Catalytic domain of the Protein Ser	100.0
cd05632	285	STKc_GRK5 Catalytic domain of the Protein Serine/T	100.0
cd08221	256	STKc_Nek9 Catalytic domain of the Protein Serine/T	100.0
KOG0658	364	consensus Glycogen synthase kinase-3 [Carbohydrate	100.0
PF00069	260	Pkinase: Protein kinase domain Protein kinase; unc	100.0
cd06611	280	STKc_SLK_like Catalytic domain of Ste20-like kinas	100.0
cd05095	296	PTKc_DDR2 Catalytic domain of the Protein Tyrosine	100.0
cd06628	267	STKc_MAPKKK_Byr2_like Catalytic domain of fungal B	100.0
cd05624	331	STKc_MRCK_beta Catalytic domain of the Protein Ser	100.0
cd06631	265	STKc_YSK4 Catalytic domain of the Protein Serine/T	100.0
cd05604	325	STKc_SGK3 Catalytic domain of the Protein Serine/T	100.0
cd05058	262	PTKc_Met_Ron Catalytic domain of the Protein Tyros	100.0
cd08223	257	STKc_Nek4 Catalytic domain of the Protein Serine/T	100.0
cd08220	256	STKc_Nek8 Catalytic domain of the Protein Serine/T	100.0
cd05615	323	STKc_cPKC_alpha Catalytic domain of the Protein Se	100.0
cd06632	258	STKc_MEKK1_plant Catalytic domain of the Protein S	100.0
cd05623	332	STKc_MRCK_alpha Catalytic domain of the Protein Se	100.0
cd05603	321	STKc_SGK2 Catalytic domain of the Protein Serine/T	100.0
cd06643	282	STKc_SLK Catalytic domain of the Protein Serine/Th	100.0
cd05617	327	STKc_aPKC_zeta Catalytic domain of the Protein Ser	100.0
KOG0579	1187	consensus Ste20-like serine/threonine protein kina	100.0
PTZ00266	1021	NIMA-related protein kinase; Provisional	100.0
cd08217	265	STKc_Nek2 Catalytic domain of the Protein Serine/T	100.0
KOG0577	948	consensus Serine/threonine protein kinase [Signal	100.0
cd07861	285	STKc_CDK1_euk Catalytic domain of the Serine/Threo	100.0
cd06609	274	STKc_MST3_like Catalytic domain of Mammalian Ste20	100.0
KOG0032	382	consensus Ca2+/calmodulin-dependent protein kinase	100.0
cd06637	272	STKc_TNIK Catalytic domain of the Protein Serine/T	100.0
KOG1094	807	consensus Discoidin domain receptor DDR1 [Signal t	100.0
KOG0033	355	consensus Ca2+/calmodulin-dependent protein kinase	100.0
cd06645	267	STKc_MAP4K3 Catalytic domain of the Protein Serine	100.0
PHA03212	391	serine/threonine kinase US3; Provisional	100.0
cd05110	303	PTKc_HER4 Catalytic domain of the Protein Tyrosine	100.0
cd06612	256	STKc_MST1_2 Catalytic domain of the Protein Serine	100.0
cd08227	327	PK_STRAD_alpha Pseudokinase domain of STE20-relate	100.0
KOG0667	586	consensus Dual-specificity tyrosine-phosphorylatio	100.0
KOG0610	459	consensus Putative serine/threonine protein kinase	100.0
cd05041	251	PTKc_Fes_like Catalytic domain of Fes-like Protein	100.0
cd06626	264	STKc_MEKK4 Catalytic domain of the Protein Serine/	100.0
cd05076	274	PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th	100.0
cd06619	279	PKc_MKK5 Catalytic domain of the dual-specificity	100.0
KOG0983	391	consensus Mitogen-activated protein kinase (MAPK)	100.0
cd06654	296	STKc_PAK1 Catalytic domain of the Protein Serine/T	100.0
cd05038	284	PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P	100.0
cd08218	256	STKc_Nek1 Catalytic domain of the Protein Serine/T	100.0
cd05042	269	PTKc_Aatyk Catalytic domain of the Protein Tyrosin	100.0
cd06652	265	STKc_MEKK2 Catalytic domain of the Protein Serine/	100.0
KOG0574	502	consensus STE20-like serine/threonine kinase MST [	100.0
cd07873	301	STKc_PCTAIRE1 Catalytic domain of the Serine/Threo	100.0
smart00219	258	TyrKc Tyrosine kinase, catalytic domain. Phosphotr	100.0
cd06617	283	PKc_MKK3_6 Catalytic domain of the dual-specificit	100.0
cd05046	275	PTK_CCK4 Pseudokinase domain of the Protein Tyrosi	100.0
cd07847	286	STKc_CDKL1_4 Catalytic domain of the Serine/Threon	100.0
cd06651	266	STKc_MEKK3 Catalytic domain of the Protein Serine/	100.0
cd05077	262	PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th	100.0
cd05580	290	STKc_PKA Catalytic domain of the Protein Serine/Th	100.0
cd07832	286	STKc_CCRK Catalytic domain of the Serine/Threonine	100.0
cd08528	269	STKc_Nek10 Catalytic domain of the Protein Serine/	100.0
cd06605	265	PKc_MAPKK Catalytic domain of the dual-specificity	100.0
PRK13184	932	pknD serine/threonine-protein kinase; Reviewed	100.0
cd07839	284	STKc_CDK5 Catalytic domain of the Serine/Threonine	100.0
cd05574	316	STKc_phototropin_like Catalytic domain of Phototro	100.0
cd06640	277	STKc_MST4 Catalytic domain of the Protein Serine/T	100.0
cd05087	269	PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein	100.0
cd06615	308	PKc_MEK Catalytic domain of the dual-specificity P	100.0
cd05609	305	STKc_MAST Catalytic domain of the Protein Serine/T	100.0
PTZ00284	467	protein kinase; Provisional	100.0
cd05078	258	PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain	100.0
cd07878	343	STKc_p38beta_MAPK11 Catalytic domain of the Serine	100.0
KOG2345	302	consensus Serine/threonine protein kinase/TGF-beta	100.0
cd06622	286	PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS	100.0
cd05578	258	STKc_Yank1 Catalytic domain of the Protein Serine/	100.0
cd06610	267	STKc_OSR1_SPAK Catalytic domain of the Protein Ser	100.0
cd06624	268	STKc_ASK Catalytic domain of the Protein Serine/Th	100.0
KOG0200	609	consensus Fibroblast/platelet-derived growth facto	100.0
cd06655	296	STKc_PAK2 Catalytic domain of the Protein Serine/T	100.0
cd05074	273	PTKc_Tyro3 Catalytic domain of the Protein Tyrosin	100.0
cd06636	282	STKc_MAP4K4_6 Catalytic domain of the Protein Seri	100.0
cd05572	262	STKc_cGK_PKG Catalytic domain of the Protein Serin	100.0
cd06620	284	PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr	100.0
cd06623	264	PKc_MAPKK_plant_like Catalytic domain of Plant dua	100.0
cd05586	330	STKc_Sck1_like Catalytic domain of Suppressor of l	100.0
KOG4279	1226	consensus Serine/threonine protein kinase [Signal	100.0
KOG0586	596	consensus Serine/threonine protein kinase [General	100.0
cd06656	297	STKc_PAK3 Catalytic domain of the Protein Serine/T	100.0
cd08215	258	STKc_Nek Catalytic domain of the Protein Serine/Th	100.0
cd05037	259	PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the	100.0
cd06630	268	STKc_MEKK1 Catalytic domain of the Protein Serine/	100.0
cd06606	260	STKc_MAPKKK Catalytic domain of the Protein Serine	100.0
PHA03209	357	serine/threonine kinase US3; Provisional	100.0
cd05044	269	PTKc_c-ros Catalytic domain of the Protein Tyrosin	100.0
cd06638	286	STKc_myosinIIIA Catalytic domain of the Protein Se	100.0
cd07843	293	STKc_CDC2L1 Catalytic domain of the Serine/Threoni	100.0
PHA03207	392	serine/threonine kinase US3; Provisional	100.0
cd06607	307	STKc_TAO Catalytic domain of the Protein Serine/Th	100.0
cd06642	277	STKc_STK25-YSK1 Catalytic domain of the Protein Se	100.0
cd05086	268	PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi	100.0
KOG0596	677	consensus Dual specificity; serine/threonine and t	100.0
cd06629	272	STKc_MAPKKK_Bck1_like Catalytic domain of fungal B	100.0
cd07833	288	STKc_CDKL Catalytic domain of Cyclin-Dependent pro	100.0
cd07850	353	STKc_JNK Catalytic domain of the Serine/Threonine	100.0
cd06616	288	PKc_MKK4 Catalytic domain of the dual-specificity	100.0
cd07845	309	STKc_CDK10 Catalytic domain of the Serine/Threonin	100.0
cd05122	253	PKc_STE Catalytic domain of STE family Protein Kin	100.0
cd07846	286	STKc_CDKL2_3 Catalytic domain of the Serine/Threon	100.0
cd06653	264	STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina	100.0
cd07831	282	STKc_MOK Catalytic domain of the Serine/Threonine	100.0
cd06641	277	STKc_MST3 Catalytic domain of the Protein Serine/T	100.0
cd06608	275	STKc_myosinIII_like Catalytic domain of Class III	100.0
cd07841	298	STKc_CDK7 Catalytic domain of the Serine/Threonine	100.0
cd08225	257	STKc_Nek5 Catalytic domain of the Protein Serine/T	100.0
cd06627	254	STKc_Cdc7_like Catalytic domain of Cell division c	100.0
cd06618	296	PKc_MKK7 Catalytic domain of the dual-specificity	100.0
cd08530	256	STKc_CNK2-like Catalytic domain of the Protein Ser	100.0
cd06917	277	STKc_NAK1_like Catalytic domain of Fungal Nak1-lik	100.0
cd07868	317	STKc_CDK8 Catalytic domain of the Serine/Threonine	100.0
cd06639	291	STKc_myosinIIIB Catalytic domain of the Protein Se	100.0
KOG0599	411	consensus Phosphorylase kinase gamma subunit [Carb	100.0
cd06635	317	STKc_TAO1 Catalytic domain of the Protein Serine/T	100.0
cd07860	284	STKc_CDK2_3 Catalytic domain of the Serine/Threoni	100.0
cd07844	291	STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like	100.0
cd05577	277	STKc_GRK Catalytic domain of the Protein Serine/Th	100.0
PHA03211	461	serine/threonine kinase US3; Provisional	100.0
cd06614	286	STKc_PAK Catalytic domain of the Protein Serine/Th	100.0
cd06648	285	STKc_PAK_II Catalytic domain of the Protein Serine	100.0
cd06658	292	STKc_PAK5 Catalytic domain of the Protein Serine/T	100.0
cd07835	283	STKc_CDK1_like Catalytic domain of Cyclin-Dependen	100.0
cd06621	287	PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek	100.0
cd07837	295	STKc_CdkB_plant Catalytic domain of the Serine/Thr	100.0
cd07870	291	STKc_PFTAIRE2 Catalytic domain of the Serine/Threo	100.0
cd06659	297	STKc_PAK6 Catalytic domain of the Protein Serine/T	100.0
PLN00009	294	cyclin-dependent kinase A; Provisional	100.0
cd07840	287	STKc_CDK9_like Catalytic domain of Cyclin-Dependen	100.0
cd07864	302	STKc_CDK12 Catalytic domain of the Serine/Threonin	100.0
cd07865	310	STKc_CDK9 Catalytic domain of the Serine/Threonine	100.0
cd08226	328	PK_STRAD_beta Pseudokinase domain of STE20-related	100.0
cd05579	265	STKc_MAST_like Catalytic domain of Microtubule-ass	100.0
cd05611	260	STKc_Rim15_like Catalytic domain of fungal Rim15-l	100.0
cd06647	293	STKc_PAK_I Catalytic domain of the Protein Serine/	100.0
cd05118	283	STKc_CMGC Catalytic domain of CMGC family Serine/T	100.0
cd07836	284	STKc_Pho85 Catalytic domain of the Serine/Threonin	100.0
cd06634	308	STKc_TAO2 Catalytic domain of the Protein Serine/T	100.0
cd07867	317	STKc_CDC2L6 Catalytic domain of Serine/Threonine K	100.0
cd05633	279	STKc_GRK3 Catalytic domain of the Protein Serine/T	100.0
PHA02882	294	putative serine/threonine kinase; Provisional	100.0
cd06633	313	STKc_TAO3 Catalytic domain of the Protein Serine/T	100.0
cd07838	287	STKc_CDK4_6_like Catalytic domain of Cyclin-Depend	100.0
cd08216	314	PK_STRAD Pseudokinase domain of STE20-related kina	100.0
cd07842	316	STKc_CDK8_like Catalytic domain of Cyclin-Dependen	100.0
cd07858	337	STKc_TEY_MAPK_plant Catalytic domain of the Serine	100.0
cd05581	280	STKc_PDK1 Catalytic domain of the Protein Serine/T	100.0
KOG0690	516	consensus Serine/threonine protein kinase [Signal	100.0
KOG1025	1177	consensus Epidermal growth factor receptor EGFR an	100.0
cd07834	330	STKc_MAPK Catalytic domain of the Serine/Threonine	100.0
KOG1006	361	consensus Mitogen-activated protein kinase (MAPK)	100.0
cd05606	278	STKc_beta_ARK Catalytic domain of the Protein Seri	100.0
PHA03210	501	serine/threonine kinase US3; Provisional	100.0
cd08222	260	STKc_Nek11 Catalytic domain of the Protein Serine/	100.0
cd07849	336	STKc_ERK1_2_like Catalytic domain of Extracellular	100.0
cd07830	283	STKc_MAK_like Catalytic domain of Male germ cell-A	100.0
PHA03390	267	pk1 serine/threonine-protein kinase 1; Provisional	100.0
cd07855	334	STKc_ERK5 Catalytic domain of the Serine/Threonine	100.0
cd05613	290	STKc_MSK1_N N-terminal catalytic domain of the Pro	100.0
cd07866	311	STKc_BUR1 Catalytic domain of the Serine/Threonine	100.0
cd06657	292	STKc_PAK4 Catalytic domain of the Protein Serine/T	100.0
cd07852	337	STKc_MAPK15 Catalytic domain of the Serine/Threoni	100.0
cd07829	282	STKc_CDK_like Catalytic domain of Cyclin-Dependent	100.0
cd07880	343	STKc_p38gamma_MAPK12 Catalytic domain of the Serin	100.0
cd07879	342	STKc_p38delta_MAPK13 Catalytic domain of the Serin	100.0
cd05123	250	STKc_AGC Catalytic domain of AGC family Protein Se	100.0
KOG4645	1509	consensus MAPKKK (MAP kinase kinase kinase) SSK2 a	100.0
cd05583	288	STKc_MSK_N N-terminal catalytic domain of the Prot	100.0
KOG4236	888	consensus Serine/threonine protein kinase PKC mu/P	100.0
cd07856	328	STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre	100.0
PTZ00024	335	cyclin-dependent protein kinase; Provisional	100.0
cd07851	343	STKc_p38 Catalytic domain of the Serine/Threonine	100.0
KOG0604	400	consensus MAP kinase-activated protein kinase 2 [S	100.0
cd07854	342	STKc_MAPK4_6 Catalytic domain of the Serine/Threon	100.0
cd07857	332	STKc_MPK1 Catalytic domain of the Serine/Threonine	100.0
KOG0584	632	consensus Serine/threonine protein kinase [General	100.0
cd07877	345	STKc_p38alpha_MAPK14 Catalytic domain of the Serin	100.0
KOG0614	732	consensus cGMP-dependent protein kinase [Signal tr	100.0
cd05610	669	STKc_MASTL Catalytic domain of the Protein Serine/	100.0
KOG2052	513	consensus Activin A type IB receptor, serine/threo	100.0
KOG4250	732	consensus TANK binding protein kinase TBK1 [Signal	100.0
KOG3653	534	consensus Transforming growth factor beta/activin	100.0
KOG0612	1317	consensus Rho-associated, coiled-coil containing p	100.0
KOG1035	1351	consensus eIF-2alpha kinase GCN2 [Translation, rib	100.0
KOG0696	683	consensus Serine/threonine protein kinase [Signal	100.0
KOG0662	292	consensus Cyclin-dependent kinase CDK5 [Intracellu	100.0
KOG0986	591	consensus G protein-coupled receptor kinase [Signa	100.0
KOG0607	463	consensus MAP kinase-interacting kinase and relate	100.0
cd05576	237	STKc_RPK118_like Catalytic domain of the Protein S	100.0
KOG0603	612	consensus Ribosomal protein S6 kinase [Signal tran	100.0
smart00220	244	S_TKc Serine/Threonine protein kinases, catalytic	100.0
KOG0587	953	consensus Traf2- and Nck-interacting kinase and re	100.0
PLN00113	968	leucine-rich repeat receptor-like protein kinase;	100.0
KOG0666	438	consensus Cyclin C-dependent kinase CDK8 [Transcri	100.0
KOG0984	282	consensus Mitogen-activated protein kinase (MAPK)	100.0
KOG0671	415	consensus LAMMER dual specificity kinases [Signal	100.0
KOG0669	376	consensus Cyclin T-dependent kinase CDK9 [Cell cyc	100.0
KOG1024	563	consensus Receptor-like protein tyrosine kinase RY	100.0
KOG0608	1034	consensus Warts/lats-like serine threonine kinases	100.0
KOG1290	590	consensus Serine/threonine protein kinase [Signal	100.0
KOG1027	903	consensus Serine/threonine protein kinase and endo	100.0
PLN03224	507	probable serine/threonine protein kinase; Provisio	100.0
PLN03225	566	Serine/threonine-protein kinase SNT7; Provisional	100.0
KOG0695	593	consensus Serine/threonine protein kinase [Signal	100.0
KOG1151	775	consensus Tousled-like protein kinase [Signal tran	100.0
cd00180	215	PKc Catalytic domain of Protein Kinases. Protein K	100.0
KOG0664	449	consensus Nemo-like MAPK-related serine/threonine	100.0
KOG0576	829	consensus Mitogen-activated protein kinase kinase	100.0
KOG0665	369	consensus Jun-N-terminal kinase (JNK) [Signal tran	99.98
KOG0670	752	consensus U4/U6-associated splicing factor PRP4 [R	99.97
smart00221	225	STYKc Protein kinase; unclassified specificity. Ph	99.97
KOG0668	338	consensus Casein kinase II, alpha subunit [Signal	99.97
KOG1152	772	consensus Signal transduction serine/threonine kin	99.97
KOG0195	448	consensus Integrin-linked kinase [Signal transduct	99.96
smart00750	176	KIND kinase non-catalytic C-lobe domain. It is an	99.96
KOG1345	378	consensus Serine/threonine kinase [Signal transduc	99.96
PLN00181	793	protein SPA1-RELATED; Provisional	99.96
KOG1164	322	consensus Casein kinase (serine/threonine/tyrosine	99.96
KOG1163	341	consensus Casein kinase (serine/threonine/tyrosine	99.95
KOG1165	449	consensus Casein kinase (serine/threonine/tyrosine	99.95
KOG1167	418	consensus Serine/threonine protein kinase of the C	99.95
COG0515	384	SPS1 Serine/threonine protein kinase [General func	99.94
PRK09188	365	serine/threonine protein kinase; Provisional	99.93
PRK10359	232	lipopolysaccharide core biosynthesis protein; Prov	99.9
cd05147	190	RIO1_euk RIO kinase family; eukaryotic RIO1, catal	99.9
KOG0590	601	consensus Checkpoint kinase and related serine/thr	99.9
PF14531	288	Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_	99.89
KOG1240	1431	consensus Protein kinase containing WD40 repeats [	99.89
cd05145	190	RIO1_like RIO kinase family; RIO1, RIO3 and simila	99.88
KOG0603	612	consensus Ribosomal protein S6 kinase [Signal tran	99.88
KOG4158	598	consensus BRPK/PTEN-induced protein kinase [Signal	99.88
PRK12274	218	serine/threonine protein kinase; Provisional	99.87
KOG1166	974	consensus Mitotic checkpoint serine/threonine prot	99.85
PRK14879	211	serine/threonine protein kinase; Provisional	99.85
PRK10345	210	hypothetical protein; Provisional	99.84
KOG1023	484	consensus Natriuretic peptide receptor, guanylate	99.83
TIGR03724	199	arch_bud32 Kae1-associated kinase Bud32. Members o	99.82
KOG0606	1205	consensus Microtubule-associated serine/threonine	99.81
smart00090	237	RIO RIO-like kinase.	99.8
KOG1033	516	consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati	99.8
PRK09605	535	bifunctional UGMP family protein/serine/threonine	99.79
cd05144	198	RIO2_C RIO kinase family; RIO2, C-terminal catalyt	99.78
cd05119	187	RIO RIO kinase family, catalytic domain. The RIO k	99.73
PRK01723	239	3-deoxy-D-manno-octulosonic-acid kinase; Reviewed	99.73
cd05120	155	APH_ChoK_like Aminoglycoside 3'-phosphotransferase	99.71
KOG0590	601	consensus Checkpoint kinase and related serine/thr	99.69
TIGR01982	437	UbiB 2-polyprenylphenol 6-hydroxylase. This model	99.57
KOG0601	524	consensus Cyclin-dependent kinase WEE1 [Cell cycle	99.55
PRK04750	537	ubiB putative ubiquinone biosynthesis protein UbiB	99.54
cd05151	170	ChoK Choline Kinase (ChoK). The ChoK subfamily is	99.47
cd05146	197	RIO3_euk RIO kinase family; eukaryotic RIO3, catal	99.44
KOG0606	1205	consensus Microtubule-associated serine/threonine	99.44
KOG1243	690	consensus Protein kinase [General function predict	99.41
COG3642	204	Mn2+-dependent serine/threonine protein kinase [Si	99.4
KOG0601	524	consensus Cyclin-dependent kinase WEE1 [Cell cycle	99.35
KOG1266	458	consensus Protein kinase [Signal transduction mech	99.33
KOG3087	229	consensus Serine/threonine protein kinase [General	99.32
cd05154	223	ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an	99.26
cd04928	68	ACT_TyrKc Uncharacterized, N-terminal ACT domain o	99.25
PRK15123	268	lipopolysaccharide core heptose(I) kinase RfaP; Pr	99.22
KOG3741	655	consensus Poly(A) ribonuclease subunit [RNA proces	99.15
COG4248	637	Uncharacterized protein with protein kinase and he	99.13
PF01163	188	RIO1: RIO1 family; InterPro: IPR018934 Protein pho	99.11
PF06293	206	Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family;	98.97
COG0661	517	AarF Predicted unusual protein kinase [General fun	98.95
COG0478	304	RIO-like serine/threonine protein kinase fused to	98.93
PRK09902	216	hypothetical protein; Provisional	98.79
KOG2137	700	consensus Protein kinase [Signal transduction mech	98.78
PF06176	229	WaaY: Lipopolysaccharide core biosynthesis protein	98.76
TIGR02172	226	Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou	98.63
PF01636	239	APH: Phosphotransferase enzyme family This family	98.59
COG1718	268	RIO1 Serine/threonine protein kinase involved in c	98.5
cd05150	244	APH Aminoglycoside 3'-phosphotransferase (APH). Th	98.48
COG2112	201	Predicted Ser/Thr protein kinase [Signal transduct	98.44
KOG1235	538	consensus Predicted unusual protein kinase [Genera	98.42
KOG1035	1351	consensus eIF-2alpha kinase GCN2 [Translation, rib	98.42
cd04900	73	ACT_UUR-like_1 ACT domain family, ACT_UUR-like_1,	98.41
KOG0576	829	consensus Mitogen-activated protein kinase kinase	98.34
PF13095	207	FTA2: Kinetochore Sim4 complex subunit FTA2	98.23
PLN02876	822	acyl-CoA dehydrogenase	98.21
cd04927	76	ACT_ACR-like_2 Second ACT domain, of a novel type	98.17
PF12260	188	PIP49_C: Protein-kinase domain of FAM69; InterPro:	98.16
PF10707	199	YrbL-PhoP_reg: PhoP regulatory network protein Yrb	98.08
cd05155	235	APH_ChoK_like_1 Uncharacterized bacterial proteins	98.05
PRK10593	297	hypothetical protein; Provisional	97.94
PRK05231	319	homoserine kinase; Provisional	97.84
cd04925	74	ACT_ACR_2 ACT domain-containing protein which is c	97.84
TIGR02721	256	ycfN_thiK thiamine kinase. Members of this family	97.82
TIGR00938	307	thrB_alt homoserine kinase, Neisseria type. Homose	97.68
KOG1826	2724	consensus Ras GTPase activating protein RasGAP/neu	97.68
cd05157	235	ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes.	97.65
cd05153	296	HomoserineK_II Homoserine Kinase, type II. Homoser	97.64
KOG2268	465	consensus Serine/threonine protein kinase [Signal	97.6
PRK09550	401	mtnK methylthioribose kinase; Reviewed	97.52
cd05156	302	ChoK_euk Choline Kinase (ChoK) in eukaryotes. The	97.36
KOG2270	520	consensus Serine/threonine protein kinase involved	97.25
COG3173	321	Predicted aminoglycoside phosphotransferase [Gener	97.15
cd04926	72	ACT_ACR_4 C-terminal ACT domain, of a novel type o	97.1
PLN02756	418	S-methyl-5-thioribose kinase	97.1
TIGR02906	313	spore_CotS spore coat protein, CotS family. Member	97.07
PLN02236	344	choline kinase	97.03
PLN02421	330	phosphotransferase, alcohol group as acceptor/kina	96.84
cd05152	276	MPH2' Macrolide 2'-Phosphotransferase (MPH2'). MPH	96.8
PRK05092	931	PII uridylyl-transferase; Provisional	96.72
PF03881	288	Fructosamin_kin: Fructosamine kinase; InterPro: IP	96.65
KOG1093	725	consensus Predicted protein kinase (contains TBC a	96.62
TIGR02904	309	spore_ysxE spore coat protein YsxE. Members of thi	96.56
PRK00275	895	glnD PII uridylyl-transferase; Provisional	96.55
cd04899	70	ACT_ACR-UUR-like_2 C-terminal ACT domains of the b	96.46
cd04895	72	ACT_ACR_1 ACT domain-containing protein which is c	96.45
PRK03059	856	PII uridylyl-transferase; Provisional	96.45
cd04873	70	ACT_UUR-ACR-like ACT domains of the bacterial sign	96.36

>KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms]

Probab=100.00  E-value=5.6e-57  Score=436.64  Aligned_cols=269  Identities=48%  Similarity=0.889  Sum_probs=252.9

Q ss_pred             CCceeecccccceeceeceeCceEEEEEEECCee-EEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCceeeEEeEEecCC
Q 015868          108 TDVWEIDAKQLKIECKVASGSYGDLYKGTYCSQE-VAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPP  186 (399)
Q Consensus       108 ~~~~~i~~~~~~i~~~lg~G~~g~Vy~~~~~~~~-vAvK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~nIv~~~~~~~~~~  186 (399)
                      ...|.|+...+.+.+.||.|+||+||+|.|.++. ||+|++..........+.|.+|+.+|.+++|||||+|+|+|..++
T Consensus        33 ~~~~~i~~~~l~~~~~iG~G~~g~V~~~~~~g~~~vavK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~f~G~~~~~~  112 (362)
T KOG0192|consen   33 LPEEEIDPDELPIEEVLGSGSFGTVYKGKWRGTDVVAVKIISDPDFDDESRKAFRREASLLSRLRHPNIVQFYGACTSPP  112 (362)
T ss_pred             ccceecChHHhhhhhhcccCCceeEEEEEeCCceeEEEEEecchhcChHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCC
Confidence            4668999999999999999999999999999999 999999987666655889999999999999999999999999998


Q ss_pred             -cEEEEEecCCCCCHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHHCC-cccCCCCCCceeecCCC-cEEEeecccee
Q 015868          187 -NLCIVTEFMARGSIYDFLHK-QKGVFQLTSLLKVAIDVSKGMNYLHQNN-IIHRDLKTANLLMDENG-VVKVADFGVAR  262 (399)
Q Consensus       187 -~~~lV~E~~~ggsL~~~l~~-~~~~l~~~~~~~i~~~i~~~L~~LH~~g-iiHrDlkp~NILl~~~~-~vkl~DFG~a~  262 (399)
                       .++|||||+++|+|.++++. ....++...+..++.||++||.|||+++ ||||||||+|||++.++ ++||+|||+++
T Consensus       113 ~~~~iVtEy~~~GsL~~~l~~~~~~~l~~~~~l~~aldiArGm~YLH~~~~iIHrDLK~~NiLv~~~~~~~KI~DFGlsr  192 (362)
T KOG0192|consen  113 GSLCIVTEYMPGGSLSVLLHKKRKRKLPLKVRLRIALDIARGMEYLHSEGPIIHRDLKSDNILVDLKGKTLKIADFGLSR  192 (362)
T ss_pred             CceEEEEEeCCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcCCCeeecccChhhEEEcCCCCEEEECCCccce
Confidence             79999999999999999988 4788999999999999999999999999 99999999999999998 99999999999


Q ss_pred             eccCC-CccccCCCCcccccccccC--CCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhccCCCCCCCCCc
Q 015868          263 VQAQS-GVMTAETGTYRWMAPEVIE--HKPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKSLRPTIPKHAH  339 (399)
Q Consensus       263 ~~~~~-~~~~~~~gt~~y~aPE~l~--~~~~~~~~Dv~slG~vl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~  339 (399)
                      ..... ..++...||++|||||++.  ...|+.|+||||||+++|||+||+.||.+..+.+.+..++....+|.+|..++
T Consensus       193 ~~~~~~~~~~~~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl~t~~~Pf~~~~~~~~~~~v~~~~~Rp~~p~~~~  272 (362)
T KOG0192|consen  193 EKVISKTSMTSVAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWELLTGEIPFEDLAPVQVASAVVVGGLRPPIPKECP  272 (362)
T ss_pred             eeccccccccCCCCCccccChhhhcCCCCcCCccchhhhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcCCCCCCCccCC
Confidence            87765 4566689999999999999  66999999999999999999999999999999999999999999999999999


Q ss_pred             HHHHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHh
Q 015868          340 PRLAELLERCWQHDPTQRPNFSQITDILKQMMKEVAS  376 (399)
Q Consensus       340 ~~l~~ll~~cl~~dP~~Rps~~ell~~L~~l~~~~~~  376 (399)
                      +.+..+|.+||..||..||+|.+++..|+.+......
T Consensus       273 ~~l~~l~~~CW~~dp~~RP~f~ei~~~l~~~~~~~~~  309 (362)
T KOG0192|consen  273 PHLSSLMERCWLVDPSRRPSFLEIVSRLESIMSHISS  309 (362)
T ss_pred             HHHHHHHHHhCCCCCCcCCCHHHHHHHHHHHHHhhcc
Confidence            9999999999999999999999999999999887754

>KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms]

Probab=100.00  E-value=1.6e-53  Score=396.40  Aligned_cols=251  Identities=31%  Similarity=0.538  Sum_probs=227.6

Q ss_pred             eeecccccceeceeceeCceEEEEEEE--CCeeEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCceeeEEeEEecCCc-
Q 015868          111 WEIDAKQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPN-  187 (399)
Q Consensus       111 ~~i~~~~~~i~~~lg~G~~g~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~nIv~~~~~~~~~~~-  187 (399)
                      ..+..++++....||+|+.|+||++.+  +++.+|+|++.. ..+....+.+.+|++++++++|||||.+||+|..+.. 
T Consensus        74 ~~i~~~dle~~~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~~-~~~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~~~~~~  152 (364)
T KOG0581|consen   74 NGISLSDLERLGVLGSGNGGTVYKVRHKPTGKIYALKVILL-NIDPALQKQILRELEILRSCQSPYIVGFYGAFYSNGEE  152 (364)
T ss_pred             cccCHHHhhhhhhcccCCCcEEEEEEEcCCCeEEEEEeecc-cCCHHHHHHHHHHHHHHhhCCCCCeeeEeEEEEeCCce
Confidence            346667899999999999999999988  588999999943 3467778899999999999999999999999999995 


Q ss_pred             EEEEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH-CCcccCCCCCCceeecCCCcEEEeeccceeeccC
Q 015868          188 LCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQ-NNIIHRDLKTANLLMDENGVVKVADFGVARVQAQ  266 (399)
Q Consensus       188 ~~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~-~giiHrDlkp~NILl~~~~~vkl~DFG~a~~~~~  266 (399)
                      .+|+||||.||||.+++... +++++..+.+++.+|++||.|||. ++||||||||+|||++..|.|||||||+++....
T Consensus       153 isI~mEYMDgGSLd~~~k~~-g~i~E~~L~~ia~~VL~GL~YLh~~~~IIHRDIKPsNlLvNskGeVKicDFGVS~~lvn  231 (364)
T KOG0581|consen  153 ISICMEYMDGGSLDDILKRV-GRIPEPVLGKIARAVLRGLSYLHEERKIIHRDIKPSNLLVNSKGEVKICDFGVSGILVN  231 (364)
T ss_pred             EEeehhhcCCCCHHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHhhccCeeeccCCHHHeeeccCCCEEeccccccHHhhh
Confidence            99999999999999999764 789999999999999999999995 9999999999999999999999999999987776


Q ss_pred             CCccccCCCCcccccccccCCCCCCChhhHHHHHHHHHHHHcCCCCCCCC-----CHHHHHHHHHhccCCCCCCCC-CcH
Q 015868          267 SGVMTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPYAGL-----TPLQAAVGVVQKSLRPTIPKH-AHP  340 (399)
Q Consensus       267 ~~~~~~~~gt~~y~aPE~l~~~~~~~~~Dv~slG~vl~elltg~~P~~~~-----~~~~~~~~~~~~~~~~~~~~~-~~~  340 (399)
                      + ...+.+||..|||||.+.+..|+.++||||||++++|+++|+.||...     .+.+....++. ...|.+|.. +|+
T Consensus       232 S-~a~tfvGT~~YMsPERi~g~~Ys~~sDIWSLGLsllE~a~GrfP~~~~~~~~~~~~~Ll~~Iv~-~ppP~lP~~~fS~  309 (364)
T KOG0581|consen  232 S-IANTFVGTSAYMSPERISGESYSVKSDIWSLGLSLLELAIGRFPYPPPNPPYLDIFELLCAIVD-EPPPRLPEGEFSP  309 (364)
T ss_pred             h-hcccccccccccChhhhcCCcCCcccceecccHHHHHHhhCCCCCCCcCCCCCCHHHHHHHHhc-CCCCCCCcccCCH
Confidence            6 557789999999999999999999999999999999999999999774     56666655554 567888887 999


Q ss_pred             HHHHHHHHHhhhcCCCCCCHHHHHH
Q 015868          341 RLAELLERCWQHDPTQRPNFSQITD  365 (399)
Q Consensus       341 ~l~~ll~~cl~~dP~~Rps~~ell~  365 (399)
                      ++++|+..||++||.+|||+.|+++
T Consensus       310 ef~~FV~~CL~Kdp~~R~s~~qLl~  334 (364)
T KOG0581|consen  310 EFRSFVSCCLRKDPSERPSAKQLLQ  334 (364)
T ss_pred             HHHHHHHHHhcCCcccCCCHHHHhc
Confidence            9999999999999999999999976

>KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=1.1e-53  Score=420.78  Aligned_cols=346  Identities=27%  Similarity=0.488  Sum_probs=295.2

Q ss_pred             HHHHHHHH--HHHHHhhh--hCCCeeeeceeccCCCceeeEEEecCCCCcchHHHHHHHHHHHhhhhHHHhhhccCcCCC
Q 015868            5 CWVLMKVG--ELTSLLGE--IGLNIQEAHAFSTVDGFSLDVFVVDGWPYDETEDLKNVLAKEILKSKFLIAMQDQSCSKR   80 (399)
Q Consensus         5 ~~~~~~~~--~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~g~~~~~~~~l~~~l~~~~~~~~~~~~~~~~~~s~~   80 (399)
                      .|+|-||+  ||....++  -.||++++.||++++..+|+.+   |++++++++|++++++.....+      +.+|.++
T Consensus        10 ~wLleLLr~aqL~qf~s~lr~~lnvrr~~hf~yVk~eDLl~I---GMgRp~qRRLrea~kkm~~~~k------~kswvkK   80 (1039)
T KOG0199|consen   10 DWLLELLRKAQLDQFISQLRFLLNVRRFDHFSYVKDEDLLEI---GMGRPQQRRLREAIKKMSREMK------NKSWVKK   80 (1039)
T ss_pred             HHHHHHHHHHHHHHHHHHHHHHhccCchhhhhhcchhhhhhh---ccCcHHHHHHHHHHHHhhhhcc------ccchHHH
Confidence            59999986  56666665  4799999999999999999999   9999999999999999887766      6666655


Q ss_pred             CCCCCCCCcccccccCCCCccccCCCCCCceeecccccceeceeceeCceEEEEEEECC-----eeEEEEEecCCCCCHH
Q 015868           81 QPALGVPMHSKLLIESSPNCIEIPTDGTDVWEIDAKQLKIECKVASGSYGDLYKGTYCS-----QEVAIKVLKPECVNTE  155 (399)
Q Consensus        81 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~i~~~lg~G~~g~Vy~~~~~~-----~~vAvK~~~~~~~~~~  155 (399)
                      .-.-..|.+......     .. ..+......|..++.++.++||+|+||+|++|.|+.     -.||||+++....+. 
T Consensus        81 vf~ga~p~h~~~t~~-----~~-~p~~~lkclIpee~i~l~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~~-  153 (1039)
T KOG0199|consen   81 VFIGADPSHPAQTNS-----VA-NPSIDLKCLIPEEQIKLYELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLNA-  153 (1039)
T ss_pred             HhccCCccccccccC-----CC-CcCCCcceeccHHHHHHHHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccch-
Confidence            433333322221110     11 123345567889999999999999999999999953     469999999876555 


Q ss_pred             HHHHHHHHHHHHHhcCCCceeeEEeEEecCCcEEEEEecCCCCCHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHHCC
Q 015868          156 MLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHK-QKGVFQLTSLLKVAIDVSKGMNYLHQNN  234 (399)
Q Consensus       156 ~~~~~~~Ei~~l~~l~h~nIv~~~~~~~~~~~~~lV~E~~~ggsL~~~l~~-~~~~l~~~~~~~i~~~i~~~L~~LH~~g  234 (399)
                      ...+|.+|+.+|.+|+|+|++++||+..+ ..+.||||.+++|||.+.|++ ....|....+..++.||+.||.||..++
T Consensus       154 ~mddflrEas~M~~L~H~hliRLyGvVl~-qp~mMV~ELaplGSLldrLrka~~~~llv~~Lcdya~QiA~aM~YLeskr  232 (1039)
T KOG0199|consen  154 IMDDFLREASHMLKLQHPHLIRLYGVVLD-QPAMMVFELAPLGSLLDRLRKAKKAILLVSRLCDYAMQIAKAMQYLESKR  232 (1039)
T ss_pred             hHHHHHHHHHHHHhccCcceeEEeeeecc-chhhHHhhhcccchHHHHHhhccccceeHHHHHHHHHHHHHHHHHHhhhh
Confidence            67899999999999999999999999988 458899999999999999988 5678999999999999999999999999


Q ss_pred             cccCCCCCCceeecCCCcEEEeeccceeeccCCCccccC----CCCcccccccccCCCCCCChhhHHHHHHHHHHHHc-C
Q 015868          235 IIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAE----TGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLT-G  309 (399)
Q Consensus       235 iiHrDlkp~NILl~~~~~vkl~DFG~a~~~~~~~~~~~~----~gt~~y~aPE~l~~~~~~~~~Dv~slG~vl~ellt-g  309 (399)
                      +|||||.++|+|+-....|||+|||+++.......+...    ...+.|+|||.+++..+++++|||+||+++|||+| |
T Consensus       233 lvHRDLAARNlllasprtVKI~DFGLmRaLg~ned~Yvm~p~rkvPfAWCaPEsLrh~kFShaSDvWmyGVTiWEMFtyG  312 (1039)
T KOG0199|consen  233 LVHRDLAARNLLLASPRTVKICDFGLMRALGENEDMYVMAPQRKVPFAWCAPESLRHRKFSHASDVWMYGVTIWEMFTYG  312 (1039)
T ss_pred             hhhhhhhhhhheecccceeeeecccceeccCCCCcceEecCCCcCcccccCHhHhccccccccchhhhhhhhHHhhhccC
Confidence            999999999999999999999999999987765543322    24778999999999999999999999999999999 8


Q ss_pred             CCCCCCCCHHHHHHHHHhccCCCCCCCCCcHHHHHHHHHHhhhcCCCCCCHHHHHHHHH
Q 015868          310 ELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRLAELLERCWQHDPTQRPNFSQITDILK  368 (399)
Q Consensus       310 ~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~cl~~dP~~Rps~~ell~~L~  368 (399)
                      +.||.+....+.+..+- .+.+.+-|+.++.++.+++.+||..+|.+||||..|.+.+-
T Consensus       313 EePW~G~~g~qIL~~iD-~~erLpRPk~csedIY~imk~cWah~paDRptFsair~~~~  370 (1039)
T KOG0199|consen  313 EEPWVGCRGIQILKNID-AGERLPRPKYCSEDIYQIMKNCWAHNPADRPTFSAIREDLV  370 (1039)
T ss_pred             CCCCCCCCHHHHHHhcc-ccccCCCCCCChHHHHHHHHHhccCCccccccHHHHHHhHH
Confidence            99999999999877655 78888899999999999999999999999999999985544

>KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=2.4e-53  Score=411.67  Aligned_cols=261  Identities=36%  Similarity=0.749  Sum_probs=236.4

Q ss_pred             CCceeecccccceeceeceeCceEEEEEEECCe-eEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCceeeEEeEEecCC
Q 015868          108 TDVWEIDAKQLKIECKVASGSYGDLYKGTYCSQ-EVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPP  186 (399)
Q Consensus       108 ~~~~~i~~~~~~i~~~lg~G~~g~Vy~~~~~~~-~vAvK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~nIv~~~~~~~~~~  186 (399)
                      .+.|+|+.+.+++.++||+|-||.||.|.|.++ +||+|.++.....   ...|.+|+++|++|+|+|||+++++|..+.
T Consensus       198 ~d~wei~r~~l~l~~~LG~G~FG~V~~g~~~~~~~vavk~ik~~~m~---~~~f~~Ea~iMk~L~H~~lV~l~gV~~~~~  274 (468)
T KOG0197|consen  198 RDPWEIPREELKLIRELGSGQFGEVWLGKWNGSTKVAVKTIKEGSMS---PEAFLREAQIMKKLRHEKLVKLYGVCTKQE  274 (468)
T ss_pred             cCCeeecHHHHHHHHHhcCCccceEEEEEEcCCCcccceEEeccccC---hhHHHHHHHHHHhCcccCeEEEEEEEecCC
Confidence            578999999999999999999999999999887 9999999976333   257889999999999999999999999988


Q ss_pred             cEEEEEecCCCCCHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceeecCCCcEEEeeccceeecc
Q 015868          187 NLCIVTEFMARGSIYDFLHK-QKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQA  265 (399)
Q Consensus       187 ~~~lV~E~~~ggsL~~~l~~-~~~~l~~~~~~~i~~~i~~~L~~LH~~giiHrDlkp~NILl~~~~~vkl~DFG~a~~~~  265 (399)
                      .+|||||||+.|+|.++|+. ....+...+++.++.|||+||+||+++++|||||.++|||++++..+||+|||+|+...
T Consensus       275 piyIVtE~m~~GsLl~yLr~~~~~~l~~~~Ll~~a~qIaeGM~YLes~~~IHRDLAARNiLV~~~~~vKIsDFGLAr~~~  354 (468)
T KOG0197|consen  275 PIYIVTEYMPKGSLLDYLRTREGGLLNLPQLLDFAAQIAEGMAYLESKNYIHRDLAARNILVDEDLVVKISDFGLARLIG  354 (468)
T ss_pred             ceEEEEEecccCcHHHHhhhcCCCccchHHHHHHHHHHHHHHHHHHhCCccchhhhhhheeeccCceEEEcccccccccC
Confidence            99999999999999999987 56789999999999999999999999999999999999999999999999999999544


Q ss_pred             CCCccccC--CCCcccccccccCCCCCCChhhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHHhccCCCCCCCCCcHHH
Q 015868          266 QSGVMTAE--TGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLT-GELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRL  342 (399)
Q Consensus       266 ~~~~~~~~--~gt~~y~aPE~l~~~~~~~~~Dv~slG~vl~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  342 (399)
                      .+......  .-+..|.|||.++...++.||||||||++|||++| |+.||.+++..+... .+.++.|.+-|..+|+++
T Consensus       355 d~~Y~~~~~~kfPIkWtAPEa~~~~~FS~kSDVWSFGVlL~E~fT~G~~py~~msn~ev~~-~le~GyRlp~P~~CP~~v  433 (468)
T KOG0197|consen  355 DDEYTASEGGKFPIKWTAPEALNYGKFSSKSDVWSFGVLLWELFTYGRVPYPGMSNEEVLE-LLERGYRLPRPEGCPDEV  433 (468)
T ss_pred             CCceeecCCCCCCceecCHHHHhhCCcccccceeehhhhHHHHhccCCCCCCCCCHHHHHH-HHhccCcCCCCCCCCHHH
Confidence            43322222  23668999999999999999999999999999999 999999999988665 467789999999999999


Q ss_pred             HHHHHHHhhhcCCCCCCHHHHHHHHHHHHH
Q 015868          343 AELLERCWQHDPTQRPNFSQITDILKQMMK  372 (399)
Q Consensus       343 ~~ll~~cl~~dP~~Rps~~ell~~L~~l~~  372 (399)
                      .++|..||..+|++||||+.+...++++..
T Consensus       434 Y~lM~~CW~~~P~~RPtF~~L~~~l~~~~~  463 (468)
T KOG0197|consen  434 YELMKSCWHEDPEDRPTFETLREVLEDFFT  463 (468)
T ss_pred             HHHHHHHhhCCcccCCCHHHHHHHHHHhhh
Confidence            999999999999999999999988888753

>KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms]

Probab=100.00  E-value=3.7e-51  Score=383.75  Aligned_cols=249  Identities=30%  Similarity=0.547  Sum_probs=226.7

Q ss_pred             ccccceeceeceeCceEEEEEEE--CCeeEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCceeeEEeEEecCCcEEEEE
Q 015868          115 AKQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVT  192 (399)
Q Consensus       115 ~~~~~i~~~lg~G~~g~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~nIv~~~~~~~~~~~~~lV~  192 (399)
                      ..+|.+.++||.|+||+||+|++  .+..||||.+.....+....+-+..|+.+|+.++|||||++++++..++.+|+||
T Consensus         9 ~~~y~~~~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~~~~~~i~lVM   88 (429)
T KOG0595|consen    9 VGDYELSREIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKLNKKLVELLLSEIKILKELKHPNIVRLLDCIEDDDFIYLVM   88 (429)
T ss_pred             cccceehhhccCcceEEEEEeEeccCCceEEeeeehhhccCHHHHHHHHHHHHHHHhcCCcceeeEEEEEecCCeEEEEE
Confidence            35899999999999999999987  5789999999988778888899999999999999999999999999999999999


Q ss_pred             ecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceeecCC------CcEEEeeccceeeccC
Q 015868          193 EFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDEN------GVVKVADFGVARVQAQ  266 (399)
Q Consensus       193 E~~~ggsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~giiHrDlkp~NILl~~~------~~vkl~DFG~a~~~~~  266 (399)
                      |||.||+|.++|+. .+.+++..+..++.|++.||++||+++||||||||.|||++..      -.+||+|||+|+....
T Consensus        89 EyC~gGDLs~yi~~-~~~l~e~t~r~Fm~QLA~alq~L~~~~IiHRDLKPQNiLLs~~~~~~~~~~LKIADFGfAR~L~~  167 (429)
T KOG0595|consen   89 EYCNGGDLSDYIRR-RGRLPEATARHFMQQLASALQFLHENNIIHRDLKPQNILLSTTARNDTSPVLKIADFGFARFLQP  167 (429)
T ss_pred             EeCCCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCcceEEeccCCCCCCCceEEecccchhhhCCc
Confidence            99999999999987 4689999999999999999999999999999999999999865      4689999999999887


Q ss_pred             CCccccCCCCcccccccccCCCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhc-cCCCCCCCCCcHHHHHH
Q 015868          267 SGVMTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQK-SLRPTIPKHAHPRLAEL  345 (399)
Q Consensus       267 ~~~~~~~~gt~~y~aPE~l~~~~~~~~~Dv~slG~vl~elltg~~P~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~l~~l  345 (399)
                      .....+-+|++.|||||++....|+.|+|+||+|+++|++++|+.||+..++.+......+. ...|.++...++.+.++
T Consensus       168 ~~~a~tlcGSplYMAPEV~~~~~YdAKADLWSiG~Ilyq~l~g~~Pf~a~t~~eL~~~~~k~~~~~~~~~~~~s~~~~~L  247 (429)
T KOG0595|consen  168 GSMAETLCGSPLYMAPEVIMSQQYDAKADLWSIGTILYQCLTGKPPFDAETPKELLLYIKKGNEIVPVLPAELSNPLREL  247 (429)
T ss_pred             hhHHHHhhCCccccCHHHHHhccccchhhHHHHHHHHHHHHhCCCCccccCHHHHHHHHhccccccCchhhhccCchhhh
Confidence            77777789999999999999999999999999999999999999999999999887755433 34566777788889999


Q ss_pred             HHHHhhhcCCCCCCHHHHH
Q 015868          346 LERCWQHDPTQRPNFSQIT  364 (399)
Q Consensus       346 l~~cl~~dP~~Rps~~ell  364 (399)
                      +...++.+|.+|-++.+-.
T Consensus       248 l~~ll~~~~~~~~~~~~~~  266 (429)
T KOG0595|consen  248 LISLLQRNPKDRISFEDFF  266 (429)
T ss_pred             hhHHHhcCccccCchHHhh
Confidence            9999999999998887653

>KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=1.4e-50  Score=396.52  Aligned_cols=249  Identities=27%  Similarity=0.461  Sum_probs=227.1

Q ss_pred             cccccceeceeceeCceEEEEEEE--CCeeEEEEEecCCC-CCHHHHHHHHHHHHHHHhcCCCceeeEEeEEecCCcEEE
Q 015868          114 DAKQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPEC-VNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCI  190 (399)
Q Consensus       114 ~~~~~~i~~~lg~G~~g~Vy~~~~--~~~~vAvK~~~~~~-~~~~~~~~~~~Ei~~l~~l~h~nIv~~~~~~~~~~~~~l  190 (399)
                      ...+|+..+.||+|+|+.+|.+++  +++.||+|++.... ......+.+.+||+|.++|+|||||+++++|++..+.||
T Consensus        16 ~~~~Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~HpnIV~f~~~FEDs~nVYi   95 (592)
T KOG0575|consen   16 RSKRYKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLKHPNIVQFYHFFEDSNNVYI   95 (592)
T ss_pred             CcceeeeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhcCCCcEEeeeeEeecCCceEE
Confidence            346899999999999999999987  78999999997543 345566789999999999999999999999999999999


Q ss_pred             EEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceeecCCCcEEEeeccceeeccCC-Cc
Q 015868          191 VTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQS-GV  269 (399)
Q Consensus       191 V~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~giiHrDlkp~NILl~~~~~vkl~DFG~a~~~~~~-~~  269 (399)
                      |.|+|..++|..+++ +...+++.++..++.||+.||.|||+++|||||||..|++++++-+|||+|||+|...... ..
T Consensus        96 vLELC~~~sL~el~K-rrk~ltEpEary~l~QIv~GlkYLH~~~IiHRDLKLGNlfL~~~~~VKIgDFGLAt~le~~~Er  174 (592)
T KOG0575|consen   96 VLELCHRGSLMELLK-RRKPLTEPEARYFLRQIVEGLKYLHSLGIIHRDLKLGNLFLNENMNVKIGDFGLATQLEYDGER  174 (592)
T ss_pred             EEEecCCccHHHHHH-hcCCCCcHHHHHHHHHHHHHHHHHHhcCceecccchhheeecCcCcEEecccceeeeecCcccc
Confidence            999999999999997 5788999999999999999999999999999999999999999999999999999877644 45


Q ss_pred             cccCCCCcccccccccCCCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhccCCCCCCCCCcHHHHHHHHHH
Q 015868          270 MTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRLAELLERC  349 (399)
Q Consensus       270 ~~~~~gt~~y~aPE~l~~~~~~~~~Dv~slG~vl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~c  349 (399)
                      ..+.+|||.|.|||++....++..+||||+||+||.||+|++||...+-.+....+....  -.+|..++.+..+||.++
T Consensus       175 k~TlCGTPNYIAPEVl~k~gHsfEvDiWSlGcvmYtLL~G~PPFetk~vkety~~Ik~~~--Y~~P~~ls~~A~dLI~~l  252 (592)
T KOG0575|consen  175 KKTLCGTPNYIAPEVLNKSGHSFEVDIWSLGCVMYTLLVGRPPFETKTVKETYNKIKLNE--YSMPSHLSAEAKDLIRKL  252 (592)
T ss_pred             cceecCCCcccChhHhccCCCCCchhhhhhhhHHHhhhhCCCCcccchHHHHHHHHHhcC--cccccccCHHHHHHHHHH
Confidence            667799999999999999999999999999999999999999999988777777766543  357789999999999999


Q ss_pred             hhhcCCCCCCHHHHHH
Q 015868          350 WQHDPTQRPNFSQITD  365 (399)
Q Consensus       350 l~~dP~~Rps~~ell~  365 (399)
                      |+.||.+|||+++++.
T Consensus       253 L~~~P~~Rpsl~~vL~  268 (592)
T KOG0575|consen  253 LRPNPSERPSLDEVLD  268 (592)
T ss_pred             hcCCcccCCCHHHHhc
Confidence            9999999999999975

>KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms]

Probab=100.00  E-value=1.4e-50  Score=395.18  Aligned_cols=266  Identities=36%  Similarity=0.730  Sum_probs=237.8

Q ss_pred             CCCceeecccccceeceeceeCceEEEEEEECCeeEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCceeeEEeEEecCC
Q 015868          107 GTDVWEIDAKQLKIECKVASGSYGDLYKGTYCSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPP  186 (399)
Q Consensus       107 ~~~~~~i~~~~~~i~~~lg~G~~g~Vy~~~~~~~~vAvK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~nIv~~~~~~~~~~  186 (399)
                      ....|+|..++..+..+||+|+||+||+|.|.| +||||+++....+.+..+.|++|+.++++-+|.||+-|.|+|..++
T Consensus       383 s~~~WeIp~~ev~l~~rIGsGsFGtV~Rg~whG-dVAVK~Lnv~~pt~~qlqaFKnEVa~lkkTRH~NIlLFMG~~~~p~  461 (678)
T KOG0193|consen  383 SLEEWEIPPEEVLLGERIGSGSFGTVYRGRWHG-DVAVKLLNVDDPTPEQLQAFKNEVAVLKKTRHENILLFMGACMNPP  461 (678)
T ss_pred             cccccccCHHHhhccceeccccccceeeccccc-ceEEEEEecCCCCHHHHHHHHHHHHHHhhcchhhheeeehhhcCCc
Confidence            347899999999999999999999999999976 8999999999889999999999999999999999999999999988


Q ss_pred             cEEEEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceeecCCCcEEEeeccceeeccC
Q 015868          187 NLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQ  266 (399)
Q Consensus       187 ~~~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~giiHrDlkp~NILl~~~~~vkl~DFG~a~~~~~  266 (399)
                      . .||+.+|+|-+|+.+++.....|.+...+.|+.||++||.|||.++|||||||..||++.+++.|||+|||++.....
T Consensus       462 ~-AIiTqwCeGsSLY~hlHv~etkfdm~~~idIAqQiaqGM~YLHAK~IIHrDLKSnNIFl~~~~kVkIgDFGLatvk~~  540 (678)
T KOG0193|consen  462 L-AIITQWCEGSSLYTHLHVQETKFDMNTTIDIAQQIAQGMDYLHAKNIIHRDLKSNNIFLHEDLKVKIGDFGLATVKTR  540 (678)
T ss_pred             e-eeeehhccCchhhhhccchhhhhhHHHHHHHHHHHHHhhhhhhhhhhhhhhccccceEEccCCcEEEecccceeeeee
Confidence            6 999999999999999999889999999999999999999999999999999999999999999999999999975432


Q ss_pred             ---CCccccCCCCcccccccccCC---CCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhccCCCCC---CCC
Q 015868          267 ---SGVMTAETGTYRWMAPEVIEH---KPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKSLRPTI---PKH  337 (399)
Q Consensus       267 ---~~~~~~~~gt~~y~aPE~l~~---~~~~~~~Dv~slG~vl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~---~~~  337 (399)
                         ........|...|||||++..   .+|++.+||||||+++|||+||.+||......+.+..+-+..++|..   -..
T Consensus       541 w~g~~q~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~lPysi~~~dqIifmVGrG~l~pd~s~~~s~  620 (678)
T KOG0193|consen  541 WSGEQQLEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGELPYSIQNRDQIIFMVGRGYLMPDLSKIRSN  620 (678)
T ss_pred             eccccccCCCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCcCCcCCCChhheEEEecccccCccchhhhcc
Confidence               233455678899999999964   47999999999999999999999999976666665554444344443   356


Q ss_pred             CcHHHHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHH
Q 015868          338 AHPRLAELLERCWQHDPTQRPNFSQITDILKQMMKEV  374 (399)
Q Consensus       338 ~~~~l~~ll~~cl~~dP~~Rps~~ell~~L~~l~~~~  374 (399)
                      ++.++.+|+..||.+++++||.|.+|+..|+.++...
T Consensus       621 ~pk~mk~Ll~~C~~~~~~eRP~F~~il~~l~~l~~~~  657 (678)
T KOG0193|consen  621 CPKAMKRLLSDCWKFDREERPLFPQLLSKLEELLPSL  657 (678)
T ss_pred             CHHHHHHHHHHHHhcCcccCccHHHHHHHHHHhhhcc
Confidence            7889999999999999999999999999999887653

>KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=6.7e-51  Score=365.03  Aligned_cols=254  Identities=27%  Similarity=0.501  Sum_probs=222.8

Q ss_pred             cccccceeceeceeCceEEEEEEE--CCeeEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCceeeEEe-EEecCCc-EE
Q 015868          114 DAKQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIG-ACTRPPN-LC  189 (399)
Q Consensus       114 ~~~~~~i~~~lg~G~~g~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~nIv~~~~-~~~~~~~-~~  189 (399)
                      ...+|+|+++||.|+||.||+++.  ++..+|.|-++-+..+.........|+.+|++|+|||||++++ .+.+... ++
T Consensus        17 ~l~~y~Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~f~~md~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~~~~evln   96 (375)
T KOG0591|consen   17 TLADYQILKKIGRGSFGEVYKVQCLLDGKLVALKKIQFGMMDAKARQDCVKEISLLKQLNHPNIVQYYAHSFIEDNEVLN   96 (375)
T ss_pred             cHHHHHHHHHHcCCcchheEEeeeccCcchhhhhhcchhhccHHHHHHHHHHHHHHHhcCCchHHHHHHHhhhccchhhH
Confidence            356899999999999999999976  7889999999987778888899999999999999999999999 4555444 89


Q ss_pred             EEEecCCCCCHHHHHH---hcCCCCCHHHHHHHHHHHHHHHHHHHH--CC--cccCCCCCCceeecCCCcEEEeecccee
Q 015868          190 IVTEFMARGSIYDFLH---KQKGVFQLTSLLKVAIDVSKGMNYLHQ--NN--IIHRDLKTANLLMDENGVVKVADFGVAR  262 (399)
Q Consensus       190 lV~E~~~ggsL~~~l~---~~~~~l~~~~~~~i~~~i~~~L~~LH~--~g--iiHrDlkp~NILl~~~~~vkl~DFG~a~  262 (399)
                      ||||+|.+|+|...++   ++...+++..+|+++.|++.||.++|+  .+  |+||||||.||+++.+|.|||+|||+++
T Consensus        97 ivmE~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRDIKPaNIFl~~~gvvKLGDfGL~r  176 (375)
T KOG0591|consen   97 IVMELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKIPRGTVMHRDIKPANIFLTANGVVKLGDFGLGR  176 (375)
T ss_pred             HHHHhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhccccccceeeccCcchheEEcCCCceeeccchhHh
Confidence            9999999999999985   356789999999999999999999999  45  9999999999999999999999999999


Q ss_pred             eccCCCc-cccCCCCcccccccccCCCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhccCCCCCC-CCCcH
Q 015868          263 VQAQSGV-MTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKSLRPTIP-KHAHP  340 (399)
Q Consensus       263 ~~~~~~~-~~~~~gt~~y~aPE~l~~~~~~~~~Dv~slG~vl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~-~~~~~  340 (399)
                      ....... ....+|||.||+||++...+|+.++||||+||++|||+.-+.||.+.+-.+.-. .+.++.-|++| ..+|.
T Consensus       177 ~l~s~~tfA~S~VGTPyYMSPE~i~~~~Y~~kSDiWslGCllyEMcaL~~PF~g~n~~~L~~-KI~qgd~~~~p~~~YS~  255 (375)
T KOG0591|consen  177 FLSSKTTFAHSLVGTPYYMSPERIHESGYNFKSDIWSLGCLLYEMCALQSPFYGDNLLSLCK-KIEQGDYPPLPDEHYST  255 (375)
T ss_pred             HhcchhHHHHhhcCCCcccCHHHHhcCCCCcchhHHHHHHHHHHHHhcCCCcccccHHHHHH-HHHcCCCCCCcHHHhhh
Confidence            8776543 345689999999999999999999999999999999999999999986555444 44456667777 78999


Q ss_pred             HHHHHHHHHhhhcCCCCCCHHHHHHHHH
Q 015868          341 RLAELLERCWQHDPTQRPNFSQITDILK  368 (399)
Q Consensus       341 ~l~~ll~~cl~~dP~~Rps~~ell~~L~  368 (399)
                      ++..++..|+..||+.||+...+++.++
T Consensus       256 ~l~~li~~ci~vd~~~RP~t~~~v~di~  283 (375)
T KOG0591|consen  256 DLRELINMCIAVDPEQRPDTVPYVQDIQ  283 (375)
T ss_pred             HHHHHHHHHccCCcccCCCcchHHHHHH
Confidence            9999999999999999998655544444

>KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=2.1e-50  Score=378.34  Aligned_cols=250  Identities=24%  Similarity=0.392  Sum_probs=216.1

Q ss_pred             ccccceeceeceeCceEEEEEEE--CCeeEEEEEecCCCCCH-----HHHHHHHHHHHHHHhcCCCceeeEEeEEecCCc
Q 015868          115 AKQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVNT-----EMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPN  187 (399)
Q Consensus       115 ~~~~~i~~~lg~G~~g~Vy~~~~--~~~~vAvK~~~~~~~~~-----~~~~~~~~Ei~~l~~l~h~nIv~~~~~~~~~~~  187 (399)
                      .+.|.+.+.||+|+||.|-+|..  +++.||||+++......     .......+|+++|++++|||||+++++|..+..
T Consensus       171 ~d~yii~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~~d~f~~~ds  250 (475)
T KOG0615|consen  171 NDYYIISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRIKDFFEVPDS  250 (475)
T ss_pred             cceeEeeeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEEeeeeecCCc
Confidence            46788899999999999999965  78999999998543221     123446799999999999999999999999999


Q ss_pred             EEEEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceeecCC---CcEEEeeccceeec
Q 015868          188 LCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDEN---GVVKVADFGVARVQ  264 (399)
Q Consensus       188 ~~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~giiHrDlkp~NILl~~~---~~vkl~DFG~a~~~  264 (399)
                      .||||||++||.|.+.+-. ++.+.+..-+.++.|++.|+.|||++||+||||||+|||+..+   -.+||+|||+|+..
T Consensus       251 ~YmVlE~v~GGeLfd~vv~-nk~l~ed~~K~~f~Qll~avkYLH~~GI~HRDiKPeNILl~~~~e~~llKItDFGlAK~~  329 (475)
T KOG0615|consen  251 SYMVLEYVEGGELFDKVVA-NKYLREDLGKLLFKQLLTAVKYLHSQGIIHRDIKPENILLSNDAEDCLLKITDFGLAKVS  329 (475)
T ss_pred             eEEEEEEecCccHHHHHHh-ccccccchhHHHHHHHHHHHHHHHHcCcccccCCcceEEeccCCcceEEEecccchhhcc
Confidence            9999999999999999976 5678888889999999999999999999999999999999876   58999999999999


Q ss_pred             cCCCccccCCCCcccccccccCCCCC---CChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcc---CCCCCCCCC
Q 015868          265 AQSGVMTAETGTYRWMAPEVIEHKPY---DYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKS---LRPTIPKHA  338 (399)
Q Consensus       265 ~~~~~~~~~~gt~~y~aPE~l~~~~~---~~~~Dv~slG~vl~elltg~~P~~~~~~~~~~~~~~~~~---~~~~~~~~~  338 (399)
                      +....|.+.+||+.|.|||++.++.+   ..+.|+||+||+||-+++|.+||++..........+.++   ..|.....+
T Consensus       330 g~~sfm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~~~~sl~eQI~~G~y~f~p~~w~~I  409 (475)
T KOG0615|consen  330 GEGSFMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSEEYTDPSLKEQILKGRYAFGPLQWDRI  409 (475)
T ss_pred             ccceehhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCCcccccCCccHHHHHhcCcccccChhhhhh
Confidence            88888999999999999999987754   347799999999999999999998866655233333333   234455678


Q ss_pred             cHHHHHHHHHHhhhcCCCCCCHHHHHH
Q 015868          339 HPRLAELLERCWQHDPTQRPNFSQITD  365 (399)
Q Consensus       339 ~~~l~~ll~~cl~~dP~~Rps~~ell~  365 (399)
                      +.+..+||.+||..||++|||+.|+++
T Consensus       410 seea~dlI~~mL~VdP~~R~s~~eaL~  436 (475)
T KOG0615|consen  410 SEEALDLINWMLVVDPENRPSADEALN  436 (475)
T ss_pred             hHHHHHHHHHhhEeCcccCcCHHHHhc
Confidence            999999999999999999999999976

>KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms]

Probab=100.00  E-value=3.4e-50  Score=388.62  Aligned_cols=262  Identities=35%  Similarity=0.663  Sum_probs=241.0

Q ss_pred             cccCCCCCCceeecccccceeceeceeCceEEEEEEECCeeEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCceeeEEe
Q 015868          101 IEIPTDGTDVWEIDAKQLKIECKVASGSYGDLYKGTYCSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIG  180 (399)
Q Consensus       101 ~~~~~~~~~~~~i~~~~~~i~~~lg~G~~g~Vy~~~~~~~~vAvK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~nIv~~~~  180 (399)
                      .+......+.|+|..+...-++-||+|+.|.||+|+..++.||||.++..       +  ..+|+-|++|+||||+.|.|
T Consensus       109 ~e~k~qq~e~WeiPFe~IsELeWlGSGaQGAVF~Grl~netVAVKKV~el-------k--ETdIKHLRkLkH~NII~FkG  179 (904)
T KOG4721|consen  109 TEHKQQQEELWEIPFEEISELEWLGSGAQGAVFLGRLHNETVAVKKVREL-------K--ETDIKHLRKLKHPNIITFKG  179 (904)
T ss_pred             eehhhhhhhhccCCHHHhhhhhhhccCcccceeeeeccCceehhHHHhhh-------h--hhhHHHHHhccCcceeeEee
Confidence            34445566889999999999999999999999999999999999987522       1  14788999999999999999


Q ss_pred             EEecCCcEEEEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceeecCCCcEEEeeccc
Q 015868          181 ACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGV  260 (399)
Q Consensus       181 ~~~~~~~~~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~giiHrDlkp~NILl~~~~~vkl~DFG~  260 (399)
                      +|...+.+|||||||..|-|+..|+. ...+....+..|..+|+.||.|||.+.|||||||.-||||+.+..|||+|||-
T Consensus       180 VCtqsPcyCIiMEfCa~GqL~~VLka-~~~itp~llv~Wsk~IA~GM~YLH~hKIIHRDLKSPNiLIs~~d~VKIsDFGT  258 (904)
T KOG4721|consen  180 VCTQSPCYCIIMEFCAQGQLYEVLKA-GRPITPSLLVDWSKGIAGGMNYLHLHKIIHRDLKSPNILISYDDVVKISDFGT  258 (904)
T ss_pred             eecCCceeEEeeeccccccHHHHHhc-cCccCHHHHHHHHHHhhhhhHHHHHhhHhhhccCCCceEeeccceEEeccccc
Confidence            99999999999999999999999976 56788899999999999999999999999999999999999999999999999


Q ss_pred             eeeccCCCccccCCCCcccccccccCCCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhccCCCCCCCCCcH
Q 015868          261 ARVQAQSGVMTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKSLRPTIPKHAHP  340 (399)
Q Consensus       261 a~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~Dv~slG~vl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~  340 (399)
                      ++....-..+....||..|||||+|.+.+.++|.||||||||||||+||..||...+....++++-.+.+...+|..++.
T Consensus       259 S~e~~~~STkMSFaGTVaWMAPEvIrnePcsEKVDIwSfGVVLWEmLT~EiPYkdVdssAIIwGVGsNsL~LpvPstcP~  338 (904)
T KOG4721|consen  259 SKELSDKSTKMSFAGTVAWMAPEVIRNEPCSEKVDIWSFGVVLWEMLTGEIPYKDVDSSAIIWGVGSNSLHLPVPSTCPD  338 (904)
T ss_pred             hHhhhhhhhhhhhhhhHhhhCHHHhhcCCcccccceehhHHHHHHHHhcCCCccccchheeEEeccCCcccccCcccCch
Confidence            98877766777789999999999999999999999999999999999999999999988888888888889999999999


Q ss_pred             HHHHHHHHHhhhcCCCCCCHHHHHHHHHHHHH
Q 015868          341 RLAELLERCWQHDPTQRPNFSQITDILKQMMK  372 (399)
Q Consensus       341 ~l~~ll~~cl~~dP~~Rps~~ell~~L~~l~~  372 (399)
                      .|.-||++||+..|..||+|++++..|.-+-.
T Consensus       339 GfklL~Kqcw~sKpRNRPSFrqil~HldIa~p  370 (904)
T KOG4721|consen  339 GFKLLLKQCWNSKPRNRPSFRQILLHLDIASP  370 (904)
T ss_pred             HHHHHHHHHHhcCCCCCccHHHHHHHHhhcCH
Confidence            99999999999999999999999998875433

>KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms]

Probab=100.00  E-value=5.3e-49  Score=365.98  Aligned_cols=246  Identities=28%  Similarity=0.478  Sum_probs=220.7

Q ss_pred             eecccccceeceeceeCceEEEEEEE--CCeeEEEEEecCCCC-CHHHHHHHHHHHHHHHhcCCCceeeEEeEEecCCcE
Q 015868          112 EIDAKQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECV-NTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNL  188 (399)
Q Consensus       112 ~i~~~~~~i~~~lg~G~~g~Vy~~~~--~~~~vAvK~~~~~~~-~~~~~~~~~~Ei~~l~~l~h~nIv~~~~~~~~~~~~  188 (399)
                      .+..++|++.+.||.|+||.||+++.  +++.+|+|++++... .....+....|..+|.+++||.||.++..|+++.++
T Consensus        21 ~~~~~dF~~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~hPFiv~l~ysFQt~~kL  100 (357)
T KOG0598|consen   21 MVGPDDFEILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIKHPFIVKLIYSFQTEEKL  100 (357)
T ss_pred             cCChhheeeeeeeeccCCceEEEEEEcccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCCCCcEeeeEEecccCCeE
Confidence            34567899999999999999999976  788999999986543 334678899999999999999999999999999999


Q ss_pred             EEEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceeecCCCcEEEeeccceeeccCCC
Q 015868          189 CIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSG  268 (399)
Q Consensus       189 ~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~giiHrDlkp~NILl~~~~~vkl~DFG~a~~~~~~~  268 (399)
                      |+|+||+.||.|.-.|.+ .+.|++..+..++.+|+.||.|||++|||||||||+|||+|.+|+++|+|||+++.....+
T Consensus       101 ylVld~~~GGeLf~hL~~-eg~F~E~~arfYlaEi~lAL~~LH~~gIiyRDlKPENILLd~~GHi~LtDFgL~k~~~~~~  179 (357)
T KOG0598|consen  101 YLVLDYLNGGELFYHLQR-EGRFSEDRARFYLAEIVLALGYLHSKGIIYRDLKPENILLDEQGHIKLTDFGLCKEDLKDG  179 (357)
T ss_pred             EEEEeccCCccHHHHHHh-cCCcchhHHHHHHHHHHHHHHHHHhCCeeeccCCHHHeeecCCCcEEEeccccchhcccCC
Confidence            999999999999999976 6889999999999999999999999999999999999999999999999999998655443


Q ss_pred             -ccccCCCCcccccccccCCCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhccCCCCCCCCCcHHHHHHHH
Q 015868          269 -VMTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRLAELLE  347 (399)
Q Consensus       269 -~~~~~~gt~~y~aPE~l~~~~~~~~~Dv~slG~vl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~  347 (399)
                       .....+||+.|||||++.+.+|+..+|.||||+++|||++|.+||.+.+..+....+.+.. .+..|..++.+.+++++
T Consensus       180 ~~t~tfcGT~eYmAPEil~~~gy~~~vDWWsLGillYeML~G~pPF~~~~~~~~~~~I~~~k-~~~~p~~ls~~ardll~  258 (357)
T KOG0598|consen  180 DATRTFCGTPEYMAPEILLGKGYDKAVDWWSLGILLYEMLTGKPPFYAEDVKKMYDKILKGK-LPLPPGYLSEEARDLLK  258 (357)
T ss_pred             CccccccCCccccChHHHhcCCCCcccchHhHHHHHHHHhhCCCCCcCccHHHHHHHHhcCc-CCCCCccCCHHHHHHHH
Confidence             3444699999999999999999999999999999999999999999998888777666543 45667779999999999


Q ss_pred             HHhhhcCCCCCC
Q 015868          348 RCWQHDPTQRPN  359 (399)
Q Consensus       348 ~cl~~dP~~Rps  359 (399)
                      ++|+.||++|..
T Consensus       259 ~LL~rdp~~RLg  270 (357)
T KOG0598|consen  259 KLLKRDPRQRLG  270 (357)
T ss_pred             HHhccCHHHhcC
Confidence            999999999963

>cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3

Probab=100.00  E-value=1.6e-47  Score=371.74  Aligned_cols=261  Identities=33%  Similarity=0.659  Sum_probs=222.4

Q ss_pred             eeecccccceeceeceeCceEEEEEEE-------CCeeEEEEEecCCCCCHHHHHHHHHHHHHHHhc-CCCceeeEEeEE
Q 015868          111 WEIDAKQLKIECKVASGSYGDLYKGTY-------CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKI-RHKNVVQFIGAC  182 (399)
Q Consensus       111 ~~i~~~~~~i~~~lg~G~~g~Vy~~~~-------~~~~vAvK~~~~~~~~~~~~~~~~~Ei~~l~~l-~h~nIv~~~~~~  182 (399)
                      |++..++|++.++||.|+||.||+|.+       .+..||+|+++... .......+.+|+.+++++ +||||+++++++
T Consensus         2 ~~~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~   80 (338)
T cd05102           2 WEFPRDRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGA-TASEHKALMSELKILIHIGNHLNVVNLLGAC   80 (338)
T ss_pred             cccchhHceeeeEeccCCcceEEEEEEeccCCcccchhhheecccccc-chHHHHHHHHHHHHHHHhccCcceeeEEeEe
Confidence            788899999999999999999999974       23579999997543 334456799999999999 899999999998


Q ss_pred             ecCC-cEEEEEecCCCCCHHHHHHhcC-----------------------------------------------------
Q 015868          183 TRPP-NLCIVTEFMARGSIYDFLHKQK-----------------------------------------------------  208 (399)
Q Consensus       183 ~~~~-~~~lV~E~~~ggsL~~~l~~~~-----------------------------------------------------  208 (399)
                      .... .+++||||+++|+|.+++....                                                     
T Consensus        81 ~~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  160 (338)
T cd05102          81 TKPNGPLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPP  160 (338)
T ss_pred             cCCCCceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccc
Confidence            7644 5899999999999999997532                                                     


Q ss_pred             --------CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceeecCCCcEEEeeccceeeccCCCc---cccCCCCc
Q 015868          209 --------GVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGV---MTAETGTY  277 (399)
Q Consensus       209 --------~~l~~~~~~~i~~~i~~~L~~LH~~giiHrDlkp~NILl~~~~~vkl~DFG~a~~~~~~~~---~~~~~gt~  277 (399)
                              ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.......   .....++.
T Consensus       161 ~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~  240 (338)
T cd05102         161 QETDDLWKSPLTMEDLICYSFQVARGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLPL  240 (338)
T ss_pred             hhccccccCCCCHHHHHHHHHHHHHHHHHHHHCCEECCCCccceEEEcCCCcEEEeecccccccccCcchhcccCCCCCc
Confidence                    2477788999999999999999999999999999999999999999999999975433211   11234567


Q ss_pred             ccccccccCCCCCCChhhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHHhccCCCCCCCCCcHHHHHHHHHHhhhcCCC
Q 015868          278 RWMAPEVIEHKPYDYKADVFSFGIALWELLT-GELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRLAELLERCWQHDPTQ  356 (399)
Q Consensus       278 ~y~aPE~l~~~~~~~~~Dv~slG~vl~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~cl~~dP~~  356 (399)
                      .|+|||++.+..++.++||||||+++|||++ |..||.+....+..........++..|..+++++.+++.+||+.||.+
T Consensus       241 ~y~aPE~~~~~~~~~~sDiwslG~il~el~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~  320 (338)
T cd05102         241 KWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQINEEFCQRLKDGTRMRAPENATPEIYRIMLACWQGDPKE  320 (338)
T ss_pred             cccCcHHhhcCCCCcccCHHHHHHHHHHHHhCCCCCCCCCCccHHHHHHHhcCCCCCCCCCCCHHHHHHHHHHccCChhh
Confidence            8999999999999999999999999999997 999998876555555555556666677889999999999999999999


Q ss_pred             CCCHHHHHHHHHHHHH
Q 015868          357 RPNFSQITDILKQMMK  372 (399)
Q Consensus       357 Rps~~ell~~L~~l~~  372 (399)
                      |||+.++++.|++++.
T Consensus       321 RPs~~el~~~l~~~~~  336 (338)
T cd05102         321 RPTFSALVEILGDLLQ  336 (338)
T ss_pred             CcCHHHHHHHHHHHHh
Confidence            9999999999999875

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V

>KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=2.6e-48  Score=366.10  Aligned_cols=252  Identities=27%  Similarity=0.504  Sum_probs=218.7

Q ss_pred             ccccceeceeceeCceEEEEEEEC--CeeEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCceeeEEeEEecCC--cEEE
Q 015868          115 AKQLKIECKVASGSYGDLYKGTYC--SQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPP--NLCI  190 (399)
Q Consensus       115 ~~~~~i~~~lg~G~~g~Vy~~~~~--~~~vAvK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~nIv~~~~~~~~~~--~~~l  190 (399)
                      ..++...+.||+|+||.||+++..  +...|||.....  +....+.+.+|+.+|++++|||||+++|......  .+++
T Consensus        16 ~~~~~~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~--~~~~~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~~~~~~i   93 (313)
T KOG0198|consen   16 ISNWSKGKLLGRGSFGSVYLATNKKTGELMAVKSVELE--DSPTSESLEREIRILSRLNHPNIVQYYGSSSSRENDEYNI   93 (313)
T ss_pred             cchhhhhccccCccceEEEEEEecCCCcceeeeeeecc--cchhHHHHHHHHHHHHhCCCCCEEeeCCccccccCeeeEe
Confidence            456888999999999999999985  589999998765  2222677899999999999999999999854444  6999


Q ss_pred             EEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceeecC-CCcEEEeeccceeeccC---
Q 015868          191 VTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDE-NGVVKVADFGVARVQAQ---  266 (399)
Q Consensus       191 V~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~giiHrDlkp~NILl~~-~~~vkl~DFG~a~~~~~---  266 (399)
                      .|||+++|||.+++.+..+.++++.+..++.||++||+|||++||+||||||+|||++. ++.+||+|||.++....   
T Consensus        94 ~mEy~~~GsL~~~~~~~g~~l~E~~v~~ytr~iL~GL~ylHs~g~vH~DiK~~NiLl~~~~~~~KlaDFG~a~~~~~~~~  173 (313)
T KOG0198|consen   94 FMEYAPGGSLSDLIKRYGGKLPEPLVRRYTRQILEGLAYLHSKGIVHCDIKPANILLDPSNGDVKLADFGLAKKLESKGT  173 (313)
T ss_pred             eeeccCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCEeccCcccceEEEeCCCCeEEeccCccccccccccc
Confidence            99999999999999887668999999999999999999999999999999999999999 79999999999986553   


Q ss_pred             -CCccccCCCCcccccccccCCCC-CCChhhHHHHHHHHHHHHcCCCCCCC-CCHHHHHHHHHhccCCCCCCCCCcHHHH
Q 015868          267 -SGVMTAETGTYRWMAPEVIEHKP-YDYKADVFSFGIALWELLTGELPYAG-LTPLQAAVGVVQKSLRPTIPKHAHPRLA  343 (399)
Q Consensus       267 -~~~~~~~~gt~~y~aPE~l~~~~-~~~~~Dv~slG~vl~elltg~~P~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~l~  343 (399)
                       ........||+.|||||++.+.. ...++|||||||++.||+||+.||.. ................|.+|..++.+..
T Consensus       174 ~~~~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~~~~~~~~~~~ig~~~~~P~ip~~ls~~a~  253 (313)
T KOG0198|consen  174 KSDSELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLTGKPPWSEFFEEAEALLLIGREDSLPEIPDSLSDEAK  253 (313)
T ss_pred             cccccccccCCccccCchhhcCCCcCCccchhhhcCCEEEeccCCCCcchhhcchHHHHHHHhccCCCCCCCcccCHHHH
Confidence             12234567999999999999632 33589999999999999999999998 5666666666666677899999999999


Q ss_pred             HHHHHHhhhcCCCCCCHHHHHHHHH
Q 015868          344 ELLERCWQHDPTQRPNFSQITDILK  368 (399)
Q Consensus       344 ~ll~~cl~~dP~~Rps~~ell~~L~  368 (399)
                      +|+.+|+..+|++|||++++++.--
T Consensus       254 ~Fl~~C~~~~p~~Rpta~eLL~hpf  278 (313)
T KOG0198|consen  254 DFLRKCFKRDPEKRPTAEELLEHPF  278 (313)
T ss_pred             HHHHHHhhcCcccCcCHHHHhhChh
Confidence            9999999999999999999987544

>KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.4e-47  Score=362.58  Aligned_cols=256  Identities=32%  Similarity=0.559  Sum_probs=226.0

Q ss_pred             CceeecccccceeceeceeCceEEEEEEE--CCeeEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCceeeEEeEEecCC
Q 015868          109 DVWEIDAKQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPP  186 (399)
Q Consensus       109 ~~~~i~~~~~~i~~~lg~G~~g~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~nIv~~~~~~~~~~  186 (399)
                      ..|-++.+.|++.+.||.|..++||+|.+  .+..||||++.-+..+.+ .+.+.+|+..|+.++||||++++..|..+.
T Consensus        19 ~~~p~n~~~YeL~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEkc~~~-ld~l~kE~~~msl~~HPNIv~~~~sFvv~~   97 (516)
T KOG0582|consen   19 KEFPLNAKDYELQEVIGVGASAVVYLARCIPTNEVVAIKIINLEKCNND-LDALRKEVQTMSLIDHPNIVTYHCSFVVDS   97 (516)
T ss_pred             ccCCCCccceeEEEEEeccceeEeeeeeecccCCEEEEEEeehhhhhhh-HHHHHHHHHHhhhcCCCCcceEEEEEEecc
Confidence            45777889999999999999999999987  678999999998876666 789999999999999999999999999999


Q ss_pred             cEEEEEecCCCCCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceeecCCCcEEEeeccceeecc
Q 015868          187 NLCIVTEFMARGSIYDFLHKQ-KGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQA  265 (399)
Q Consensus       187 ~~~lV~E~~~ggsL~~~l~~~-~~~l~~~~~~~i~~~i~~~L~~LH~~giiHrDlkp~NILl~~~~~vkl~DFG~a~~~~  265 (399)
                      .+++||.||.+||+.++++.. ...+++..+..++.++++||.|||++|.||||||+.|||++++|.|||+|||++-...
T Consensus        98 ~LWvVmpfMa~GS~ldIik~~~~~Gl~E~~Ia~iLre~LkaL~YLH~~G~IHRdvKAgnILi~~dG~VkLadFgvsa~l~  177 (516)
T KOG0582|consen   98 ELWVVMPFMAGGSLLDIIKTYYPDGLEEASIATILREVLKALDYLHQNGHIHRDVKAGNILIDSDGTVKLADFGVSASLF  177 (516)
T ss_pred             eeEEeehhhcCCcHHHHHHHHccccccHHHHHHHHHHHHHHHHHHHhcCceecccccccEEEcCCCcEEEcCceeeeeec
Confidence            999999999999999999763 4669999999999999999999999999999999999999999999999999986655


Q ss_pred             CCCc-----cccCCCCcccccccccCC--CCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhccCCC----CC
Q 015868          266 QSGV-----MTAETGTYRWMAPEVIEH--KPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKSLRP----TI  334 (399)
Q Consensus       266 ~~~~-----~~~~~gt~~y~aPE~l~~--~~~~~~~Dv~slG~vl~elltg~~P~~~~~~~~~~~~~~~~~~~~----~~  334 (399)
                      ..+.     .....||+.|||||++..  ..|+.|+||||||++..||.+|..||..+.|.+.+...++...+.    .+
T Consensus       178 ~~G~R~~~rf~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~G~aPf~k~pPmkvLl~tLqn~pp~~~t~~~  257 (516)
T KOG0582|consen  178 DSGDRQVTRFNTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACELAHGHAPFSKYPPMKVLLLTLQNDPPTLLTSGL  257 (516)
T ss_pred             ccCceeeEeeccccCcccccChHHhhhcccCccchhhhhhhhHHHHHHhcCCCCcccCChHHHHHHHhcCCCCCcccccC
Confidence            4432     144579999999999643  479999999999999999999999999999999888777654321    11


Q ss_pred             ----CCCCcHHHHHHHHHHhhhcCCCCCCHHHHHH
Q 015868          335 ----PKHAHPRLAELLERCWQHDPTQRPNFSQITD  365 (399)
Q Consensus       335 ----~~~~~~~l~~ll~~cl~~dP~~Rps~~ell~  365 (399)
                          ....+..+++++..||++||.+|||++++++
T Consensus       258 ~~d~~k~~~ksf~e~i~~CL~kDP~kRptAskLlk  292 (516)
T KOG0582|consen  258 DKDEDKKFSKSFREMIALCLVKDPSKRPTASKLLK  292 (516)
T ss_pred             ChHHhhhhcHHHHHHHHHHhhcCcccCCCHHHHhc
Confidence                1336678999999999999999999999976

>KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only]

Probab=100.00  E-value=1.1e-48  Score=353.90  Aligned_cols=249  Identities=28%  Similarity=0.433  Sum_probs=218.7

Q ss_pred             cccceeceeceeCceEEEEEEE--CCeeEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCceeeEEeEEecCCcEEEEEe
Q 015868          116 KQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVTE  193 (399)
Q Consensus       116 ~~~~i~~~lg~G~~g~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~nIv~~~~~~~~~~~~~lV~E  193 (399)
                      +.|+.+.++|+|+||+||+++.  +|+.||||.+.....+....+-..+|+++|++++|+|+|.++++|.....+++|+|
T Consensus         2 ekYE~LgkvGEGSYGvV~KCrnk~TgqIVAIKkF~Esedd~~VkKIAlREIrmLKqLkH~NLVnLiEVFrrkrklhLVFE   81 (396)
T KOG0593|consen    2 EKYEKLGKVGEGSYGVVMKCRNKDTGQIVAIKKFVESEDDPVVKKIALREIRMLKQLKHENLVNLIEVFRRKRKLHLVFE   81 (396)
T ss_pred             cHHhhhhccccCcceEEEEeccCCcccEEEEEeeccCCccHHHHHHHHHHHHHHHhcccchHHHHHHHHHhcceeEEEee
Confidence            4688899999999999999976  78999999998776667777889999999999999999999999999999999999


Q ss_pred             cCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceeecCCCcEEEeeccceeecc-CCCcccc
Q 015868          194 FMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQA-QSGVMTA  272 (399)
Q Consensus       194 ~~~ggsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~giiHrDlkp~NILl~~~~~vkl~DFG~a~~~~-~~~~~~~  272 (399)
                      ||+. ++.+-+......++...+.+++.|++.|+.|+|++++|||||||+|||++.+|.+||||||+|+... .....|.
T Consensus        82 ~~dh-TvL~eLe~~p~G~~~~~vk~~l~Q~l~ai~~cHk~n~IHRDIKPENILit~~gvvKLCDFGFAR~L~~pgd~YTD  160 (396)
T KOG0593|consen   82 YCDH-TVLHELERYPNGVPSELVKKYLYQLLKAIHFCHKNNCIHRDIKPENILITQNGVVKLCDFGFARTLSAPGDNYTD  160 (396)
T ss_pred             ecch-HHHHHHHhccCCCCHHHHHHHHHHHHHHhhhhhhcCeecccCChhheEEecCCcEEeccchhhHhhcCCcchhhh
Confidence            9987 7778888888889999999999999999999999999999999999999999999999999999887 4456777


Q ss_pred             CCCCcccccccccCC-CCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhc-------------------cCC-
Q 015868          273 ETGTYRWMAPEVIEH-KPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQK-------------------SLR-  331 (399)
Q Consensus       273 ~~gt~~y~aPE~l~~-~~~~~~~Dv~slG~vl~elltg~~P~~~~~~~~~~~~~~~~-------------------~~~-  331 (399)
                      ++.|..|.|||.+.+ ..|....||||+||++.||++|++.|.+.+..+.+..+...                   +.+ 
T Consensus       161 YVATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~G~pL~PG~SDiDQLy~I~ktLG~L~prhq~iF~~N~~F~Gv~l  240 (396)
T KOG0593|consen  161 YVATRWYRAPELLVGDTQYGKPVDIWAIGCVFAELLTGEPLWPGRSDIDQLYLIRKTLGNLIPRHQSIFSSNPFFHGVRL  240 (396)
T ss_pred             hhhhhhccChhhhcccCcCCCcccchhhhHHHHHHhcCCcCCCCcchHHHHHHHHHHHcccCHHHHHHhccCCceeeeec
Confidence            889999999999988 68999999999999999999999999988776655443210                   111 


Q ss_pred             CCCC---------CCCcHHHHHHHHHHhhhcCCCCCCHHHHHH
Q 015868          332 PTIP---------KHAHPRLAELLERCWQHDPTQRPNFSQITD  365 (399)
Q Consensus       332 ~~~~---------~~~~~~l~~ll~~cl~~dP~~Rps~~ell~  365 (399)
                      |..+         +.++.-+.+|+++||..||++|++-+|++.
T Consensus       241 P~~~~~epLe~k~p~~s~~~ld~~k~cL~~dP~~R~sc~qll~  283 (396)
T KOG0593|consen  241 PEPEHPEPLERKYPKISNVLLDLLKKCLKMDPDDRLSCEQLLH  283 (396)
T ss_pred             CCCCCccchhhhcccchHHHHHHHHHHhcCCccccccHHHHhc
Confidence            1111         346678999999999999999999999975

>KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.8e-47  Score=375.93  Aligned_cols=267  Identities=33%  Similarity=0.665  Sum_probs=243.0

Q ss_pred             CceeecccccceeceeceeCceEEEEEEECC-----ee-EEEEEecC-CCCCHHHHHHHHHHHHHHHhcCCCceeeEEeE
Q 015868          109 DVWEIDAKQLKIECKVASGSYGDLYKGTYCS-----QE-VAIKVLKP-ECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGA  181 (399)
Q Consensus       109 ~~~~i~~~~~~i~~~lg~G~~g~Vy~~~~~~-----~~-vAvK~~~~-~~~~~~~~~~~~~Ei~~l~~l~h~nIv~~~~~  181 (399)
                      ..|++..++..+.++||+|+||.||+|+..-     .. ||+|..+. .....+...+|.+|.++|+.++||||+++||+
T Consensus       150 ~~Wel~H~~v~l~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l~H~NVVr~yGV  229 (474)
T KOG0194|consen  150 QKWELSHSDIELGKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQLNHPNVVRFYGV  229 (474)
T ss_pred             cccEEeccCccccceeecccccEEEEEEEEecCCceeeeeEEEeecccccccHHHHHHHHHHHHHHHhCCCCCEEEEEEE
Confidence            4599999999999999999999999998621     23 89999986 33578889999999999999999999999999


Q ss_pred             EecCCcEEEEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceeecCCCcEEEeeccce
Q 015868          182 CTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVA  261 (399)
Q Consensus       182 ~~~~~~~~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~giiHrDlkp~NILl~~~~~vkl~DFG~a  261 (399)
                      +.....+++|||+|.||+|.++|++..+.++..+...++.+.+.||+|||++++|||||.++|+|++.++.+||+|||++
T Consensus       230 a~~~~Pl~ivmEl~~gGsL~~~L~k~~~~v~~~ek~~~~~~AA~Gl~YLh~k~~IHRDIAARNcL~~~~~~vKISDFGLs  309 (474)
T KOG0194|consen  230 AVLEEPLMLVMELCNGGSLDDYLKKNKKSLPTLEKLRFCYDAARGLEYLHSKNCIHRDIAARNCLYSKKGVVKISDFGLS  309 (474)
T ss_pred             EcCCCccEEEEEecCCCcHHHHHHhCCCCCCHHHHHHHHHHHHhHHHHHHHCCCcchhHhHHHheecCCCeEEeCccccc
Confidence            99999999999999999999999998778999999999999999999999999999999999999999999999999999


Q ss_pred             eeccCCCccc-cCCCCcccccccccCCCCCCChhhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHHhccCCCCCCCCCc
Q 015868          262 RVQAQSGVMT-AETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLT-GELPYAGLTPLQAAVGVVQKSLRPTIPKHAH  339 (399)
Q Consensus       262 ~~~~~~~~~~-~~~gt~~y~aPE~l~~~~~~~~~Dv~slG~vl~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~  339 (399)
                      +......... ...-+.+|+|||.+...-|+.++|||||||++||+++ |..||.+++..+....++....+...|...+
T Consensus       310 ~~~~~~~~~~~~~klPirWLAPEtl~~~~~s~kTDV~sfGV~~~Eif~~g~~Py~g~~~~~v~~kI~~~~~r~~~~~~~p  389 (474)
T KOG0194|consen  310 RAGSQYVMKKFLKKLPIRWLAPETLNTGIFSFKTDVWSFGVLLWEIFENGAEPYPGMKNYEVKAKIVKNGYRMPIPSKTP  389 (474)
T ss_pred             cCCcceeeccccccCcceecChhhhccCccccccchhheeeeEEeeeccCCCCCCCCCHHHHHHHHHhcCccCCCCCCCH
Confidence            8655322222 2235789999999999999999999999999999999 8999999999999999888899999999999


Q ss_pred             HHHHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHH
Q 015868          340 PRLAELLERCWQHDPTQRPNFSQITDILKQMMKEVA  375 (399)
Q Consensus       340 ~~l~~ll~~cl~~dP~~Rps~~ell~~L~~l~~~~~  375 (399)
                      .++..++.+||..+|++||++.++.+.++.+.....
T Consensus       390 ~~~~~~~~~c~~~~p~~R~tm~~i~~~l~~~~~~~~  425 (474)
T KOG0194|consen  390 KELAKVMKQCWKKDPEDRPTMSTIKKKLEALEKKKE  425 (474)
T ss_pred             HHHHHHHHHhccCChhhccCHHHHHHHHHHHHhccc
Confidence            999999999999999999999999999999987654

>KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=8.1e-47  Score=368.53  Aligned_cols=254  Identities=27%  Similarity=0.506  Sum_probs=224.9

Q ss_pred             ecccccceeceeceeCceEEEEEEE--CCeeEEEEEecCCCCC---HHHHHHHHHHHHHHHhcC-CCceeeEEeEEecCC
Q 015868          113 IDAKQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVN---TEMLKEFSQEVYIMRKIR-HKNVVQFIGACTRPP  186 (399)
Q Consensus       113 i~~~~~~i~~~lg~G~~g~Vy~~~~--~~~~vAvK~~~~~~~~---~~~~~~~~~Ei~~l~~l~-h~nIv~~~~~~~~~~  186 (399)
                      ...+.|.+.+.||+|+||.|++|.+  ++..||+|++......   ....+.+.+|+.+++.++ ||||+++++++....
T Consensus        14 ~~~g~y~~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t~~   93 (370)
T KOG0583|consen   14 LSIGKYELGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFATPT   93 (370)
T ss_pred             cccCceeeeeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEecCC
Confidence            4467999999999999999999977  6799999988765222   234566778999999999 999999999999999


Q ss_pred             cEEEEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceeecCC-CcEEEeeccceeec-
Q 015868          187 NLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDEN-GVVKVADFGVARVQ-  264 (399)
Q Consensus       187 ~~~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~giiHrDlkp~NILl~~~-~~vkl~DFG~a~~~-  264 (399)
                      .+|+||||+.||+|.+++.. .+++.+..+..++.|+++|++|+|++||+||||||+|||++.+ +.+||+|||++... 
T Consensus        94 ~~~ivmEy~~gGdL~~~i~~-~g~l~E~~ar~~F~Qlisav~y~H~~gi~HRDLK~ENilld~~~~~~Kl~DFG~s~~~~  172 (370)
T KOG0583|consen   94 KIYIVMEYCSGGDLFDYIVN-KGRLKEDEARKYFRQLISAVAYCHSRGIVHRDLKPENILLDGNEGNLKLSDFGLSAISP  172 (370)
T ss_pred             eEEEEEEecCCccHHHHHHH-cCCCChHHHHHHHHHHHHHHHHHHhCCEeeCCCCHHHEEecCCCCCEEEeccccccccC
Confidence            99999999999999999988 7899999999999999999999999999999999999999999 99999999999987 


Q ss_pred             cCCCccccCCCCcccccccccCCCC-CC-ChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhccCCCCCCCCC-cHH
Q 015868          265 AQSGVMTAETGTYRWMAPEVIEHKP-YD-YKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKSLRPTIPKHA-HPR  341 (399)
Q Consensus       265 ~~~~~~~~~~gt~~y~aPE~l~~~~-~~-~~~Dv~slG~vl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~  341 (399)
                      .........+||+.|+|||++.+.. |+ .++||||+|++||.|++|..||+..+.......+..  ....+|..+ +++
T Consensus       173 ~~~~~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d~~~~~l~~ki~~--~~~~~p~~~~S~~  250 (370)
T KOG0583|consen  173 GEDGLLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPFDDSNVPNLYRKIRK--GEFKIPSYLLSPE  250 (370)
T ss_pred             CCCCcccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCCCccHHHHHHHHhc--CCccCCCCcCCHH
Confidence            4556678889999999999999988 97 679999999999999999999999777666655332  345677778 999


Q ss_pred             HHHHHHHHhhhcCCCCCCHHHHHHHHHHH
Q 015868          342 LAELLERCWQHDPTQRPNFSQITDILKQM  370 (399)
Q Consensus       342 l~~ll~~cl~~dP~~Rps~~ell~~L~~l  370 (399)
                      +..|+.+||..||.+|+++.+++ .-.-+
T Consensus       251 ~~~Li~~mL~~~P~~R~t~~~i~-~h~w~  278 (370)
T KOG0583|consen  251 ARSLIEKMLVPDPSTRITLLEIL-EHPWF  278 (370)
T ss_pred             HHHHHHHHcCCCcccCCCHHHHh-hChhh
Confidence            99999999999999999999998 44434

>KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms]

Probab=100.00  E-value=1.6e-47  Score=369.63  Aligned_cols=249  Identities=25%  Similarity=0.448  Sum_probs=222.5

Q ss_pred             cccccceeceeceeCceEEEEEEE--CCeeEEEEEecCCCC-CHHHHHHHHHHHHHHHhc-CCCceeeEEeEEecCCcEE
Q 015868          114 DAKQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECV-NTEMLKEFSQEVYIMRKI-RHKNVVQFIGACTRPPNLC  189 (399)
Q Consensus       114 ~~~~~~i~~~lg~G~~g~Vy~~~~--~~~~vAvK~~~~~~~-~~~~~~~~~~Ei~~l~~l-~h~nIv~~~~~~~~~~~~~  189 (399)
                      ...+|++++.||.|+|++|++|+.  +++.||||++.+... .+...+.+..|-.+|.+| .||.|++++-.|.+...+|
T Consensus        71 ~~~DF~Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TFQD~~sLY  150 (604)
T KOG0592|consen   71 TPNDFKFGKILGEGSYSTVVLAREKATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFTFQDEESLY  150 (604)
T ss_pred             ChhhcchhheeccccceeEEEeeecCCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEEeecccceE
Confidence            457899999999999999999986  678999999975433 334456688899999999 8999999999999999999


Q ss_pred             EEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceeecCCCcEEEeeccceeeccCCCc
Q 015868          190 IVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGV  269 (399)
Q Consensus       190 lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~giiHrDlkp~NILl~~~~~vkl~DFG~a~~~~~~~~  269 (399)
                      +|+||+++|+|.++|++ -+.|++.....++.+|+.||+|||++|||||||||+|||+++++++||+|||.|+.......
T Consensus       151 FvLe~A~nGdll~~i~K-~Gsfde~caR~YAAeIldAleylH~~GIIHRDlKPENILLd~dmhikITDFGsAK~l~~~~~  229 (604)
T KOG0592|consen  151 FVLEYAPNGDLLDLIKK-YGSFDETCARFYAAEILDALEYLHSNGIIHRDLKPENILLDKDGHIKITDFGSAKILSPSQK  229 (604)
T ss_pred             EEEEecCCCcHHHHHHH-hCcchHHHHHHHHHHHHHHHHHHHhcCceeccCChhheeEcCCCcEEEeeccccccCChhhc
Confidence            99999999999999987 58899999999999999999999999999999999999999999999999999987554221


Q ss_pred             --------------cccCCCCcccccccccCCCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhccCCCCCC
Q 015868          270 --------------MTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKSLRPTIP  335 (399)
Q Consensus       270 --------------~~~~~gt~~y~aPE~l~~~~~~~~~Dv~slG~vl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~  335 (399)
                                    ....+||-.|.+||++.....+..+|+|+|||++|+|+.|++||.+.++-..+..++..  .-.+|
T Consensus       230 ~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~~~~~~~sDiWAlGCilyQmlaG~PPFra~NeyliFqkI~~l--~y~fp  307 (604)
T KOG0592|consen  230 SQENPVDPNQASSRRSSFVGTAEYVSPELLNDSPAGPSSDLWALGCILYQMLAGQPPFRAANEYLIFQKIQAL--DYEFP  307 (604)
T ss_pred             cccCccCcccccCcccceeeeecccCHHHhcCCCCCcccchHHHHHHHHHHhcCCCCCccccHHHHHHHHHHh--cccCC
Confidence                          13467999999999999999999999999999999999999999999887777776653  34578


Q ss_pred             CCCcHHHHHHHHHHhhhcCCCCCCHHHHHH
Q 015868          336 KHAHPRLAELLERCWQHDPTQRPNFSQITD  365 (399)
Q Consensus       336 ~~~~~~l~~ll~~cl~~dP~~Rps~~ell~  365 (399)
                      +..++...+|++++|..||.+|+|..||.+
T Consensus       308 ~~fp~~a~dLv~KLLv~dp~~Rlt~~qIk~  337 (604)
T KOG0592|consen  308 EGFPEDARDLIKKLLVRDPSDRLTSQQIKA  337 (604)
T ss_pred             CCCCHHHHHHHHHHHccCccccccHHHHhh
Confidence            889999999999999999999999988865

>PHA02988 hypothetical protein; Provisional

Probab=100.00  E-value=3e-46  Score=354.38  Aligned_cols=259  Identities=22%  Similarity=0.418  Sum_probs=225.8

Q ss_pred             ceeeccccccee--ceeceeCceEEEEEEECCeeEEEEEecCCCCC-HHHHHHHHHHHHHHHhcCCCceeeEEeEEec--
Q 015868          110 VWEIDAKQLKIE--CKVASGSYGDLYKGTYCSQEVAIKVLKPECVN-TEMLKEFSQEVYIMRKIRHKNVVQFIGACTR--  184 (399)
Q Consensus       110 ~~~i~~~~~~i~--~~lg~G~~g~Vy~~~~~~~~vAvK~~~~~~~~-~~~~~~~~~Ei~~l~~l~h~nIv~~~~~~~~--  184 (399)
                      ...|+.+++...  ..||+|++|.||+|.+.++.||+|.++..... ....+.+.+|+.+|++++||||+++++++.+  
T Consensus        12 ~~~i~~~~i~~~~~~~i~~g~~~~v~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~~~   91 (283)
T PHA02988         12 IKCIESDDIDKYTSVLIKENDQNSIYKGIFNNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIV   91 (283)
T ss_pred             ceecCHHHcCCCCCeEEeeCCceEEEEEEECCEEEEEEeccccccccHHHHHHHHHHHHHHHhcCCCCEEEEeeeEEecc
Confidence            344555555555  67899999999999999999999999865433 3345788999999999999999999999876  


Q ss_pred             --CCcEEEEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC-CcccCCCCCCceeecCCCcEEEeeccce
Q 015868          185 --PPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQN-NIIHRDLKTANLLMDENGVVKVADFGVA  261 (399)
Q Consensus       185 --~~~~~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~-giiHrDlkp~NILl~~~~~vkl~DFG~a  261 (399)
                        ...+++||||+.+|+|.+++.+ ...+++.....++.+++.||.|||+. +++||||||+||++++++.+||+|||++
T Consensus        92 ~~~~~~~lv~Ey~~~g~L~~~l~~-~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~Hrdlkp~nill~~~~~~kl~dfg~~  170 (283)
T PHA02988         92 DDLPRLSLILEYCTRGYLREVLDK-EKDLSFKTKLDMAIDCCKGLYNLYKYTNKPYKNLTSVSFLVTENYKLKIICHGLE  170 (283)
T ss_pred             cCCCceEEEEEeCCCCcHHHHHhh-CCCCChhHHHHHHHHHHHHHHHHHhcCCCCCCcCChhhEEECCCCcEEEcccchH
Confidence              4578999999999999999976 45788999999999999999999984 9999999999999999999999999998


Q ss_pred             eeccCCCccccCCCCcccccccccCC--CCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhccCCCCCCCCCc
Q 015868          262 RVQAQSGVMTAETGTYRWMAPEVIEH--KPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKSLRPTIPKHAH  339 (399)
Q Consensus       262 ~~~~~~~~~~~~~gt~~y~aPE~l~~--~~~~~~~Dv~slG~vl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~  339 (399)
                      +.....  .....++..|+|||.+.+  ..++.++||||||+++|||++|+.||...+..+....+.....++.+|..++
T Consensus       171 ~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~  248 (283)
T PHA02988        171 KILSSP--PFKNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENLTTKEIYDLIINKNNSLKLPLDCP  248 (283)
T ss_pred             hhhccc--cccccCcccccCHHHhhhccccccchhhhhHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcCCCCCCCCcCc
Confidence            764432  234568899999999976  6899999999999999999999999999988887777766777777887899


Q ss_pred             HHHHHHHHHHhhhcCCCCCCHHHHHHHHHHHH
Q 015868          340 PRLAELLERCWQHDPTQRPNFSQITDILKQMM  371 (399)
Q Consensus       340 ~~l~~ll~~cl~~dP~~Rps~~ell~~L~~l~  371 (399)
                      +++.+++.+||+.||++|||+.++++.|+++.
T Consensus       249 ~~l~~li~~cl~~dp~~Rps~~ell~~l~~~~  280 (283)
T PHA02988        249 LEIKCIVEACTSHDSIKRPNIKEILYNLSLYK  280 (283)
T ss_pred             HHHHHHHHHHhcCCcccCcCHHHHHHHHHHHH
Confidence            99999999999999999999999999999874

>KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=6.6e-48  Score=367.19  Aligned_cols=250  Identities=26%  Similarity=0.414  Sum_probs=220.9

Q ss_pred             cccccceeceeceeCceEEEEEEE--CCeeEEEEEecCCCCCHHHHHHHHHHHHHHHhcC-CCceeeEEeEEecCC-cEE
Q 015868          114 DAKQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIR-HKNVVQFIGACTRPP-NLC  189 (399)
Q Consensus       114 ~~~~~~i~~~lg~G~~g~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~Ei~~l~~l~-h~nIv~~~~~~~~~~-~~~  189 (399)
                      ..++|++.++||.|+||.||+|+.  .+..||||.++......+. -.-.+|+..|++++ ||||+++.+++.+.. .+|
T Consensus         8 ~m~RY~~i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf~s~ee-~~nLREvksL~kln~hpniikL~Evi~d~~~~L~   86 (538)
T KOG0661|consen    8 FMDRYTVIRKLGDGTFGSVYLAKSKETGELVAIKKMKKKFYSWEE-CMNLREVKSLRKLNPHPNIIKLKEVIRDNDRILY   86 (538)
T ss_pred             HHHHHHHHHHhcCCcceeEEEeeecCCCceeeHHHHHhhhccHHH-HHHHHHHHHHHhcCCCCcchhhHHHhhccCceEe
Confidence            457999999999999999999976  6788999999876544332 23468999999998 999999999998888 899


Q ss_pred             EEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceeecCCCcEEEeeccceeeccCCCc
Q 015868          190 IVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGV  269 (399)
Q Consensus       190 lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~giiHrDlkp~NILl~~~~~vkl~DFG~a~~~~~~~~  269 (399)
                      +|||||+. +|+++++.++..|+++.+..|+.||++||+|+|++|+.|||+||+|||+..+..|||+|||+||.......
T Consensus        87 fVfE~Md~-NLYqLmK~R~r~fse~~irnim~QilqGL~hiHk~GfFHRDlKPENiLi~~~~~iKiaDFGLARev~SkpP  165 (538)
T KOG0661|consen   87 FVFEFMDC-NLYQLMKDRNRLFSESDIRNIMYQILQGLAHIHKHGFFHRDLKPENILISGNDVIKIADFGLAREVRSKPP  165 (538)
T ss_pred             eeHHhhhh-hHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHHhcCcccccCChhheEecccceeEecccccccccccCCC
Confidence            99999976 99999999999999999999999999999999999999999999999999999999999999999888888


Q ss_pred             cccCCCCcccccccccCC-CCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcc-----------------C-
Q 015868          270 MTAETGTYRWMAPEVIEH-KPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKS-----------------L-  330 (399)
Q Consensus       270 ~~~~~gt~~y~aPE~l~~-~~~~~~~Dv~slG~vl~elltg~~P~~~~~~~~~~~~~~~~~-----------------~-  330 (399)
                      .|.++.|..|.|||++.. ..|+.+.|+|++||+++|+.+-++.|.+.+..+.+..++.-.                 + 
T Consensus       166 YTeYVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~sE~Dqi~KIc~VLGtP~~~~~~eg~~La~~mn  245 (538)
T KOG0661|consen  166 YTEYVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLRPLFPGASEIDQIYKICEVLGTPDKDSWPEGYNLASAMN  245 (538)
T ss_pred             cchhhhcccccchHHhhhccccCCchHHHHHHHHHHHHHHhcccCCCCcHHHHHHHHHHHhCCCccccchhHHHHHHHhc
Confidence            999999999999999864 568999999999999999999999999988877777654210                 0 


Q ss_pred             --CCC--------CCCCCcHHHHHHHHHHhhhcCCCCCCHHHHHH
Q 015868          331 --RPT--------IPKHAHPRLAELLERCWQHDPTQRPNFSQITD  365 (399)
Q Consensus       331 --~~~--------~~~~~~~~l~~ll~~cl~~dP~~Rps~~ell~  365 (399)
                        .|.        +-+.+++++.++|.+|+.+||.+|||+.|+++
T Consensus       246 f~~P~~~~~~l~~L~p~~s~~~~~li~~ll~WDP~kRpTA~~al~  290 (538)
T KOG0661|consen  246 FRFPQVKPSPLKDLLPNASSEAASLIERLLAWDPDKRPTASQALQ  290 (538)
T ss_pred             cCCCcCCCCChHHhCcccCHHHHHHHHHHhcCCCccCccHHHHhc
Confidence              011        11348899999999999999999999999987

>KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=1.2e-46  Score=370.43  Aligned_cols=248  Identities=28%  Similarity=0.477  Sum_probs=228.2

Q ss_pred             cccceeceeceeCceEEEEEEE--CCeeEEEEEecCC-CCCHHHHHHHHHHHHHHHhcCCCceeeEEeEEecCCcEEEEE
Q 015868          116 KQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPE-CVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVT  192 (399)
Q Consensus       116 ~~~~i~~~lg~G~~g~Vy~~~~--~~~~vAvK~~~~~-~~~~~~~~~~~~Ei~~l~~l~h~nIv~~~~~~~~~~~~~lV~  192 (399)
                      .-|++++-||.|+.|.|.+|++  +|+.+|||++... .........+.+||.||+-+.||||+++|++|+...++|+|.
T Consensus        12 GpwkLgkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi~HpnVl~LydVwe~~~~lylvl   91 (786)
T KOG0588|consen   12 GPWKLGKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLIEHPNVLRLYDVWENKQHLYLVL   91 (786)
T ss_pred             cceeccccccCCCCceehhhhcccccceeEEEeeccccccccccccchhhhhHHHHHhcCCCeeeeeeeeccCceEEEEE
Confidence            3578899999999999999987  7999999999765 445555678889999999999999999999999999999999


Q ss_pred             ecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceeecCCCcEEEeeccceeeccCCCcccc
Q 015868          193 EFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTA  272 (399)
Q Consensus       193 E~~~ggsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~giiHrDlkp~NILl~~~~~vkl~DFG~a~~~~~~~~~~~  272 (399)
                      ||++||.|.+++-. .+++++.++.+++.||+.|+.|+|..+|+|||+||+|+|++..+.+||+|||.|..........+
T Consensus        92 Eyv~gGELFdylv~-kG~l~e~eaa~ff~QIi~gv~yCH~~~icHRDLKpENlLLd~~~nIKIADFGMAsLe~~gklLeT  170 (786)
T KOG0588|consen   92 EYVPGGELFDYLVR-KGPLPEREAAHFFRQILDGVSYCHAFNICHRDLKPENLLLDVKNNIKIADFGMASLEVPGKLLET  170 (786)
T ss_pred             EecCCchhHHHHHh-hCCCCCHHHHHHHHHHHHHHHHHhhhcceeccCCchhhhhhcccCEeeeccceeecccCCccccc
Confidence            99999999999976 68899999999999999999999999999999999999999999999999999999888888899


Q ss_pred             CCCCcccccccccCCCCCC-ChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhccCCCCCCCCCcHHHHHHHHHHhh
Q 015868          273 ETGTYRWMAPEVIEHKPYD-YKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRLAELLERCWQ  351 (399)
Q Consensus       273 ~~gt~~y~aPE~l~~~~~~-~~~Dv~slG~vl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~cl~  351 (399)
                      .+|++.|.+||++.|.+|+ .++||||+|++||.||||++||++.+-...+..+.+..  ..+|..++++.++||.+|+.
T Consensus       171 SCGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~LPFdDdNir~LLlKV~~G~--f~MPs~Is~eaQdLLr~ml~  248 (786)
T KOG0588|consen  171 SCGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGKLPFDDDNIRVLLLKVQRGV--FEMPSNISSEAQDLLRRMLD  248 (786)
T ss_pred             cCCCcccCCchhhcCCCCCCCccccchhHHHHHHHHhCCCCCCCccHHHHHHHHHcCc--ccCCCcCCHHHHHHHHHHhc
Confidence            9999999999999999996 67999999999999999999999888887777765543  35789999999999999999


Q ss_pred             hcCCCCCCHHHHHHH
Q 015868          352 HDPTQRPNFSQITDI  366 (399)
Q Consensus       352 ~dP~~Rps~~ell~~  366 (399)
                      .||+.|.|.+||++.
T Consensus       249 VDp~~RiT~~eI~kH  263 (786)
T KOG0588|consen  249 VDPSTRITTEEILKH  263 (786)
T ss_pred             cCccccccHHHHhhC
Confidence            999999999999763

>KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms]

Probab=100.00  E-value=5.5e-46  Score=335.63  Aligned_cols=239  Identities=27%  Similarity=0.472  Sum_probs=219.4

Q ss_pred             cccccceeceeceeCceEEEEEEE--CCeeEEEEEecCCC-CCHHHHHHHHHHHHHHHhcCCCceeeEEeEEecCCcEEE
Q 015868          114 DAKQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPEC-VNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCI  190 (399)
Q Consensus       114 ~~~~~~i~~~lg~G~~g~Vy~~~~--~~~~vAvK~~~~~~-~~~~~~~~~~~Ei~~l~~l~h~nIv~~~~~~~~~~~~~l  190 (399)
                      ..++|++.+.||.|+||.|.+++.  .+..+|+|++..+. ......+...+|..+|+.+.||.++++++.|.+..++||
T Consensus        42 ~l~dfe~~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~~PFlv~l~~t~~d~~~lym  121 (355)
T KOG0616|consen   42 SLQDFERLKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVSHPFLVKLYGTFKDNSNLYM  121 (355)
T ss_pred             chhhhhheeeeccCccceEEEEEEccCCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhccCceeEEEEEeeccCCeEEE
Confidence            356899999999999999999976  67889999998653 345567788999999999999999999999999999999


Q ss_pred             EEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceeecCCCcEEEeeccceeeccCCCcc
Q 015868          191 VTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVM  270 (399)
Q Consensus       191 V~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~giiHrDlkp~NILl~~~~~vkl~DFG~a~~~~~~~~~  270 (399)
                      ||||.+||.|..++++ .++|+++.+..++.+|+.|++|||+++|++||+||+|||+|.+|.+||+|||+|+.....  .
T Consensus       122 vmeyv~GGElFS~Lrk-~~rF~e~~arFYAAeivlAleylH~~~iiYRDLKPENiLlD~~G~iKitDFGFAK~v~~r--T  198 (355)
T KOG0616|consen  122 VMEYVPGGELFSYLRK-SGRFSEPHARFYAAEIVLALEYLHSLDIIYRDLKPENLLLDQNGHIKITDFGFAKRVSGR--T  198 (355)
T ss_pred             EEeccCCccHHHHHHh-cCCCCchhHHHHHHHHHHHHHHHHhcCeeeccCChHHeeeccCCcEEEEeccceEEecCc--E
Confidence            9999999999999987 578999999999999999999999999999999999999999999999999999876554  4


Q ss_pred             ccCCCCcccccccccCCCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhccCCCCCCCCCcHHHHHHHHHHh
Q 015868          271 TAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRLAELLERCW  350 (399)
Q Consensus       271 ~~~~gt~~y~aPE~l~~~~~~~~~Dv~slG~vl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~cl  350 (399)
                      -+-+|||.|+|||++..++|..++|.|+||+++|||+.|.+||...++.+....++....  .+|...++++++|+.++|
T Consensus       199 ~TlCGTPeYLAPEii~sk~ynkavDWWalGVLIYEMlaG~pPF~~~~~~~iY~KI~~~~v--~fP~~fs~~~kdLl~~LL  276 (355)
T KOG0616|consen  199 WTLCGTPEYLAPEIIQSKGYNKAVDWWALGVLIYEMLAGYPPFYDDNPIQIYEKILEGKV--KFPSYFSSDAKDLLKKLL  276 (355)
T ss_pred             EEecCCccccChHHhhcCCCCcchhHHHHHHHHHHHHcCCCCCcCCChHHHHHHHHhCcc--cCCcccCHHHHHHHHHHH
Confidence            556899999999999999999999999999999999999999999999998888887654  478889999999999999


Q ss_pred             hhcCCCC
Q 015868          351 QHDPTQR  357 (399)
Q Consensus       351 ~~dP~~R  357 (399)
                      +.|-.+|
T Consensus       277 ~vD~t~R  283 (355)
T KOG0616|consen  277 QVDLTKR  283 (355)
T ss_pred             hhhhHhh
Confidence            9999988

>cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10

Probab=100.00  E-value=3.5e-45  Score=343.41  Aligned_cols=256  Identities=30%  Similarity=0.599  Sum_probs=221.7

Q ss_pred             ecccccceeceeceeCceEEEEEEE-----CCeeEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCceeeEEeEEecCCc
Q 015868          113 IDAKQLKIECKVASGSYGDLYKGTY-----CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPN  187 (399)
Q Consensus       113 i~~~~~~i~~~lg~G~~g~Vy~~~~-----~~~~vAvK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~nIv~~~~~~~~~~~  187 (399)
                      |+.++|++.+.||+|+||.||+|.+     .+..||+|.++... .....+.+.+|+.++++++||||+++++++..++.
T Consensus         2 i~~~~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~   80 (266)
T cd05064           2 LDNKSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGC-SDKQRRGFLAEALTLGQFDHSNIVRLEGVITRGNT   80 (266)
T ss_pred             CchHHeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCC-CHHHHHHHHHHHHHHhcCCCCCcCeEEEEEecCCC
Confidence            5677899999999999999999975     35689999998653 34445789999999999999999999999999999


Q ss_pred             EEEEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceeecCCCcEEEeeccceeeccCC
Q 015868          188 LCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQS  267 (399)
Q Consensus       188 ~~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~giiHrDlkp~NILl~~~~~vkl~DFG~a~~~~~~  267 (399)
                      .++||||+++|+|.+++......+++..++.++.|++.||+|||++|++||||||+||+++.++.++++|||.+......
T Consensus        81 ~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~i~~al~~lH~~~iiH~dikp~nili~~~~~~~l~dfg~~~~~~~~  160 (266)
T cd05064          81 MMIVTEYMSNGALDSFLRKHEGQLVAGQLMGMLPGLASGMKYLSEMGYVHKGLAAHKVLVNSDLVCKISGFRRLQEDKSE  160 (266)
T ss_pred             cEEEEEeCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeeccccHhhEEEcCCCcEEECCCccccccccc
Confidence            99999999999999999876678999999999999999999999999999999999999999999999999987643322


Q ss_pred             Cccc--cCCCCcccccccccCCCCCCChhhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHHhccCCCCCCCCCcHHHHH
Q 015868          268 GVMT--AETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLT-GELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRLAE  344 (399)
Q Consensus       268 ~~~~--~~~gt~~y~aPE~l~~~~~~~~~Dv~slG~vl~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~  344 (399)
                      ....  ...++..|+|||.+.+..++.++||||||+++|++++ |..||...+..+.... +....+++.|..++..+.+
T Consensus       161 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~p~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~  239 (266)
T cd05064         161 AIYTTMSGKSPVLWAAPEAIQYHHFSSASDVWSFGIVMWEVMSYGERPYWDMSGQDVIKA-VEDGFRLPAPRNCPNLLHQ  239 (266)
T ss_pred             chhcccCCCCceeecCHHHHhhCCccchhHHHHHHHHHHHHhcCCCCCcCcCCHHHHHHH-HHCCCCCCCCCCCCHHHHH
Confidence            1111  2234678999999999999999999999999999875 9999998887665444 3445566678889999999


Q ss_pred             HHHHHhhhcCCCCCCHHHHHHHHHHH
Q 015868          345 LLERCWQHDPTQRPNFSQITDILKQM  370 (399)
Q Consensus       345 ll~~cl~~dP~~Rps~~ell~~L~~l  370 (399)
                      ++.+||+.+|.+||++.+|.+.|..+
T Consensus       240 li~~c~~~~p~~RP~~~~i~~~l~~~  265 (266)
T cd05064         240 LMLDCWQKERGERPRFSQIHSILSKM  265 (266)
T ss_pred             HHHHHcCCCchhCCCHHHHHHHHHhh
Confidence            99999999999999999999988765

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor

>KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.2e-46  Score=364.35  Aligned_cols=247  Identities=30%  Similarity=0.524  Sum_probs=221.4

Q ss_pred             ccccceeceeceeCceEEEEEEE--CCeeEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCceeeEEeEEecCCcEEEEE
Q 015868          115 AKQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVT  192 (399)
Q Consensus       115 ~~~~~i~~~lg~G~~g~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~nIv~~~~~~~~~~~~~lV~  192 (399)
                      ...|.-..+||+|+.|.||.|+.  +++.||||.+......  ..+-+.+|+.+|+..+|+|||.+++.|...+.++.||
T Consensus       272 ~~~y~~~~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~~Q~--~keLilnEi~Vm~~~~H~NiVnfl~Sylv~deLWVVM  349 (550)
T KOG0578|consen  272 RSKYTDFKKIGQGATGGVYVARKISTKQEVAIKRMDLRKQP--KKELLLNEILVMRDLHHPNIVNFLDSYLVGDELWVVM  349 (550)
T ss_pred             hhhhcchhhhccccccceeeeeeccCCceEEEEEEEeccCC--chhhhHHHHHHHHhccchHHHHHHHHhcccceeEEEE
Confidence            35678889999999999999976  5788999998765322  3367889999999999999999999999889999999


Q ss_pred             ecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceeecCCCcEEEeeccceeeccCCC-ccc
Q 015868          193 EFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSG-VMT  271 (399)
Q Consensus       193 E~~~ggsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~giiHrDlkp~NILl~~~~~vkl~DFG~a~~~~~~~-~~~  271 (399)
                      |||+||+|.|.+..  ..+++.++..++.++++||+|||.+||||||||.+|||++.+|.|||+|||++....... ...
T Consensus       350 Eym~ggsLTDvVt~--~~~~E~qIA~Icre~l~aL~fLH~~gIiHrDIKSDnILL~~~g~vKltDFGFcaqi~~~~~KR~  427 (550)
T KOG0578|consen  350 EYMEGGSLTDVVTK--TRMTEGQIAAICREILQGLKFLHARGIIHRDIKSDNILLTMDGSVKLTDFGFCAQISEEQSKRS  427 (550)
T ss_pred             eecCCCchhhhhhc--ccccHHHHHHHHHHHHHHHHHHHhcceeeeccccceeEeccCCcEEEeeeeeeeccccccCccc
Confidence            99999999999965  458999999999999999999999999999999999999999999999999998766554 566


Q ss_pred             cCCCCcccccccccCCCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhccCC-CCCCCCCcHHHHHHHHHHh
Q 015868          272 AETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKSLR-PTIPKHAHPRLAELLERCW  350 (399)
Q Consensus       272 ~~~gt~~y~aPE~l~~~~~~~~~Dv~slG~vl~elltg~~P~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~l~~ll~~cl  350 (399)
                      +.+||+.|||||++..+.|..+.||||||++++||+.|++||-.-+|.++...+...+.. ...+..+|+.|++|+.+||
T Consensus       428 TmVGTPYWMAPEVvtrk~YG~KVDIWSLGIMaIEMveGEPPYlnE~PlrAlyLIa~ng~P~lk~~~klS~~~kdFL~~cL  507 (550)
T KOG0578|consen  428 TMVGTPYWMAPEVVTRKPYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPKLKNPEKLSPELKDFLDRCL  507 (550)
T ss_pred             cccCCCCccchhhhhhcccCccccchhhhhHHHHHhcCCCCccCCChHHHHHHHhhcCCCCcCCccccCHHHHHHHHHHh
Confidence            778999999999999999999999999999999999999999999999988877665532 2235679999999999999


Q ss_pred             hhcCCCCCCHHHHHH
Q 015868          351 QHDPTQRPNFSQITD  365 (399)
Q Consensus       351 ~~dP~~Rps~~ell~  365 (399)
                      +.|+++|+++.||++
T Consensus       508 ~~dv~~RasA~eLL~  522 (550)
T KOG0578|consen  508 VVDVEQRASAKELLE  522 (550)
T ss_pred             hcchhcCCCHHHHhc
Confidence            999999999999986

>cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit

Probab=100.00  E-value=2.2e-45  Score=362.19  Aligned_cols=261  Identities=30%  Similarity=0.615  Sum_probs=224.4

Q ss_pred             CceeecccccceeceeceeCceEEEEEEE-------CCeeEEEEEecCCCCCHHHHHHHHHHHHHHHhc-CCCceeeEEe
Q 015868          109 DVWEIDAKQLKIECKVASGSYGDLYKGTY-------CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKI-RHKNVVQFIG  180 (399)
Q Consensus       109 ~~~~i~~~~~~i~~~lg~G~~g~Vy~~~~-------~~~~vAvK~~~~~~~~~~~~~~~~~Ei~~l~~l-~h~nIv~~~~  180 (399)
                      ..|.+..++|++.++||+|+||.||+|++       .+..||+|+++.... ....+.+.+|+.+++.+ +||||+++++
T Consensus        28 ~~~~~~~~~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~~-~~~~~~~~~Ei~il~~l~~HpnIv~l~~  106 (375)
T cd05104          28 HKWEFPRNRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAH-LTEREALMSELKVLSYLGNHINIVNLLG  106 (375)
T ss_pred             cccccchHHeehhheecCCccceEEEEEEeccccCccceeEEEEeccCCcC-cHHHHHHHHHHHHHHHhcCCcceeeeee
Confidence            45788888999999999999999999974       345799999986532 33456788999999999 8999999999


Q ss_pred             EEecCCcEEEEEecCCCCCHHHHHHhcC----------------------------------------------------
Q 015868          181 ACTRPPNLCIVTEFMARGSIYDFLHKQK----------------------------------------------------  208 (399)
Q Consensus       181 ~~~~~~~~~lV~E~~~ggsL~~~l~~~~----------------------------------------------------  208 (399)
                      ++..+...++||||+++|+|.+++....                                                    
T Consensus       107 ~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~  186 (375)
T cd05104         107 ACTVGGPTLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKR  186 (375)
T ss_pred             eeccCCcceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCcccccccccccc
Confidence            9999999999999999999999986532                                                    


Q ss_pred             ----------------------CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceeecCCCcEEEeeccceeeccC
Q 015868          209 ----------------------GVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQ  266 (399)
Q Consensus       209 ----------------------~~l~~~~~~~i~~~i~~~L~~LH~~giiHrDlkp~NILl~~~~~vkl~DFG~a~~~~~  266 (399)
                                            ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++....
T Consensus       187 ~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~~~  266 (375)
T cd05104         187 RSVRSGSYIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLASKNCIHRDLAARNILLTHGRITKICDFGLARDIRN  266 (375)
T ss_pred             cccccceecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCchhhEEEECCCcEEEecCccceeccC
Confidence                                  1467788999999999999999999999999999999999999999999999976543


Q ss_pred             CCcc---ccCCCCcccccccccCCCCCCChhhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHHhccCCCCCCCCCcHHH
Q 015868          267 SGVM---TAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLT-GELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRL  342 (399)
Q Consensus       267 ~~~~---~~~~gt~~y~aPE~l~~~~~~~~~Dv~slG~vl~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  342 (399)
                      ....   ....++..|+|||.+.+..++.++||||||+++|+|++ |..||............+....++..|...+.++
T Consensus       267 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDi~slG~~l~ellt~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  346 (375)
T cd05104         267 DSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPYPGMPVDSKFYKMIKEGYRMLSPECAPSEM  346 (375)
T ss_pred             cccccccCCCCCCcceeChhHhcCCCCCCCCCHHHHHHHHHHHHhcCCCCCCCCCchHHHHHHHHhCccCCCCCCCCHHH
Confidence            3211   12234668999999999999999999999999999998 8999988776666666677666777777788999


Q ss_pred             HHHHHHHhhhcCCCCCCHHHHHHHHHHH
Q 015868          343 AELLERCWQHDPTQRPNFSQITDILKQM  370 (399)
Q Consensus       343 ~~ll~~cl~~dP~~Rps~~ell~~L~~l  370 (399)
                      .+++.+||+.||++|||+.++++.|++.
T Consensus       347 ~~li~~cl~~dP~~RPs~~eil~~l~~~  374 (375)
T cd05104         347 YDIMKSCWDADPLKRPTFKQIVQLIEQQ  374 (375)
T ss_pred             HHHHHHHccCChhHCcCHHHHHHHHHhh
Confidence            9999999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce

>KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=4e-46  Score=357.34  Aligned_cols=252  Identities=26%  Similarity=0.419  Sum_probs=222.3

Q ss_pred             ecccccceeceeceeCceEEEEEEE--CCeeEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCceeeEEeEEecC--CcE
Q 015868          113 IDAKQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRP--PNL  188 (399)
Q Consensus       113 i~~~~~~i~~~lg~G~~g~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~nIv~~~~~~~~~--~~~  188 (399)
                      ...+.|+..++||+|.||.||+|++  +++.||+|.++-+....+......+||.||++|+||||+++.+.....  ..+
T Consensus       114 r~~~~feki~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~~~~~~~~t~~REI~ILr~l~HpNIikL~eivt~~~~~si  193 (560)
T KOG0600|consen  114 RRADSFEKIEKIGEGTYGQVYKARDLETGKIVALKKVRFDNEKEGFPITAIREIKILRRLDHPNIIKLEEIVTSKLSGSI  193 (560)
T ss_pred             cchHHHHHHHHhcCcchhheeEeeecccCcEEEEEEeecccCCCcchHHHHHHHHHHHhcCCCcccceeeEEEecCCceE
Confidence            3467899999999999999999987  678899999998877788888999999999999999999999999876  689


Q ss_pred             EEEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceeecCCCcEEEeeccceeeccCCC
Q 015868          189 CIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSG  268 (399)
Q Consensus       189 ~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~giiHrDlkp~NILl~~~~~vkl~DFG~a~~~~~~~  268 (399)
                      |||+|||+. +|.-++....-.|++.+++.++.|++.||+|+|.+||+|||||..|||||.+|.+||+|||+|+++....
T Consensus       194 YlVFeYMdh-DL~GLl~~p~vkft~~qIKc~mkQLl~Gl~~cH~~gvlHRDIK~SNiLidn~G~LKiaDFGLAr~y~~~~  272 (560)
T KOG0600|consen  194 YLVFEYMDH-DLSGLLSSPGVKFTEPQIKCYMKQLLEGLEYCHSRGVLHRDIKGSNILIDNNGVLKIADFGLARFYTPSG  272 (560)
T ss_pred             EEEEecccc-hhhhhhcCCCcccChHHHHHHHHHHHHHHHHHhhcCeeeccccccceEEcCCCCEEeccccceeeccCCC
Confidence            999999988 9999998767789999999999999999999999999999999999999999999999999999766543


Q ss_pred             --ccccCCCCcccccccccCCC-CCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcc----------------
Q 015868          269 --VMTAETGTYRWMAPEVIEHK-PYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKS----------------  329 (399)
Q Consensus       269 --~~~~~~gt~~y~aPE~l~~~-~~~~~~Dv~slG~vl~elltg~~P~~~~~~~~~~~~~~~~~----------------  329 (399)
                        .+|..+.|..|.|||.+.+. .|+.+.|+||.||+|.||++|++.|.+.+..+....+...-                
T Consensus       273 ~~~~T~rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~gkPI~~G~tEveQl~kIfklcGSP~e~~W~~~kLP~~  352 (560)
T KOG0600|consen  273 SAPYTSRVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELFLGKPILQGRTEVEQLHKIFKLCGSPTEDYWPVSKLPHA  352 (560)
T ss_pred             CcccccceEEeeccChHHhcCCcccccceeehhhhHHHHHHHcCCCCcCCccHHHHHHHHHHHhCCCChhccccccCCcc
Confidence              57888899999999999886 79999999999999999999999999998877666554210                


Q ss_pred             --CCCCC---------CCCCcHHHHHHHHHHhhhcCCCCCCHHHHHH
Q 015868          330 --LRPTI---------PKHAHPRLAELLERCWQHDPTQRPNFSQITD  365 (399)
Q Consensus       330 --~~~~~---------~~~~~~~l~~ll~~cl~~dP~~Rps~~ell~  365 (399)
                        +.|..         ....++...+|+.++|..||.+|.|+.+.++
T Consensus       353 ~~~kp~~~y~r~l~E~~~~~~~~~l~Ll~~lL~ldP~kR~tA~~aL~  399 (560)
T KOG0600|consen  353 TIFKPQQPYKRRLRETFKDFPASALDLLEKLLSLDPDKRGTASSALQ  399 (560)
T ss_pred             cccCCCCcccchHHHHhccCCHHHHHHHHHHhccCccccccHHHHhc
Confidence              11111         1357788999999999999999999999864

>KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair]

Probab=100.00  E-value=8.1e-46  Score=330.07  Aligned_cols=250  Identities=25%  Similarity=0.387  Sum_probs=218.5

Q ss_pred             cccceeceeceeCceEEEEEEE--CCeeEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCceeeEEeEEecCCcEEEEEe
Q 015868          116 KQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVTE  193 (399)
Q Consensus       116 ~~~~i~~~lg~G~~g~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~nIv~~~~~~~~~~~~~lV~E  193 (399)
                      .+|...+++|+|.||.||+|++  +++.||||.++.....+.......+||..|+.++|+||+.++++|....++.||+|
T Consensus         2 ~rY~~~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~kdGi~~talREIK~Lqel~h~nIi~LiD~F~~~~~l~lVfE   81 (318)
T KOG0659|consen    2 DRYEKLEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNAKDGINRTALREIKLLQELKHPNIIELIDVFPHKSNLSLVFE   81 (318)
T ss_pred             chhhhhhhhcCcceEEEEEEEecCCCcEEEEEEeeccccccCccHHHHHHHHHHHHccCcchhhhhhhccCCCceEEEEE
Confidence            4788899999999999999987  68999999999776555556778899999999999999999999999999999999


Q ss_pred             cCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceeecCCCcEEEeeccceeeccCCCc-ccc
Q 015868          194 FMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGV-MTA  272 (399)
Q Consensus       194 ~~~ggsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~giiHrDlkp~NILl~~~~~vkl~DFG~a~~~~~~~~-~~~  272 (399)
                      ||+. +|+..++.....++...++.++.++++|++|||++.|+||||||.|+|++++|.+||+|||+|+....... .+.
T Consensus        82 fm~t-dLe~vIkd~~i~l~pa~iK~y~~m~LkGl~y~H~~~IlHRDlKPnNLLis~~g~lKiADFGLAr~f~~p~~~~~~  160 (318)
T KOG0659|consen   82 FMPT-DLEVVIKDKNIILSPADIKSYMLMTLKGLAYCHSKWILHRDLKPNNLLISSDGQLKIADFGLARFFGSPNRIQTH  160 (318)
T ss_pred             eccc-cHHHHhcccccccCHHHHHHHHHHHHHHHHHHHhhhhhcccCCccceEEcCCCcEEeecccchhccCCCCccccc
Confidence            9987 99999999889999999999999999999999999999999999999999999999999999998776544 344


Q ss_pred             CCCCcccccccccCCC-CCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhccCC--------------------
Q 015868          273 ETGTYRWMAPEVIEHK-PYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKSLR--------------------  331 (399)
Q Consensus       273 ~~gt~~y~aPE~l~~~-~~~~~~Dv~slG~vl~elltg~~P~~~~~~~~~~~~~~~~~~~--------------------  331 (399)
                      .+.|..|.|||.+.|. .|....|+||.||++.||+-+.+.|.+.+..+....+....-.                    
T Consensus       161 ~V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr~P~fpG~sDidQL~~If~~LGTP~~~~WP~~~~lpdY~~~~~  240 (318)
T KOG0659|consen  161 QVVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLRVPFFPGDSDIDQLSKIFRALGTPTPDQWPEMTSLPDYVKIQQ  240 (318)
T ss_pred             ceeeeeccChHHhccchhcCCcchhhhHHHHHHHHHccCCCCCCCchHHHHHHHHHHcCCCCcccCccccccccHHHHhc
Confidence            4789999999998765 7999999999999999999999999998877665554321100                    


Q ss_pred             -CC-----CCCCCcHHHHHHHHHHhhhcCCCCCCHHHHHHH
Q 015868          332 -PT-----IPKHAHPRLAELLERCWQHDPTQRPNFSQITDI  366 (399)
Q Consensus       332 -~~-----~~~~~~~~l~~ll~~cl~~dP~~Rps~~ell~~  366 (399)
                       |.     +-+..+.+..+|+.+||..||.+|.++.|+++.
T Consensus       241 ~P~~~~~~lf~aas~d~ldLl~~m~~ynP~~Rita~qaL~~  281 (318)
T KOG0659|consen  241 FPKPPLNNLFPAASSDALDLLSKMLTYNPKKRITASQALKH  281 (318)
T ss_pred             CCCCccccccccccHHHHHHHHhhhccCchhcccHHHHhcc
Confidence             00     123467788999999999999999999999763

>cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor

Probab=100.00  E-value=2.7e-45  Score=361.37  Aligned_cols=262  Identities=31%  Similarity=0.643  Sum_probs=225.1

Q ss_pred             CceeecccccceeceeceeCceEEEEEEEC-------CeeEEEEEecCCCCCHHHHHHHHHHHHHHHhc-CCCceeeEEe
Q 015868          109 DVWEIDAKQLKIECKVASGSYGDLYKGTYC-------SQEVAIKVLKPECVNTEMLKEFSQEVYIMRKI-RHKNVVQFIG  180 (399)
Q Consensus       109 ~~~~i~~~~~~i~~~lg~G~~g~Vy~~~~~-------~~~vAvK~~~~~~~~~~~~~~~~~Ei~~l~~l-~h~nIv~~~~  180 (399)
                      ..|.+..++|++.+.||+|+||.||+|.+.       ...||+|+++... ..+....+.+|+.+++.+ +|+||+++++
T Consensus        31 ~~~~~~~~~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~il~~l~~h~nIv~~~~  109 (374)
T cd05106          31 EKWEFPRDNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASA-HTDEREALMSELKILSHLGQHKNIVNLLG  109 (374)
T ss_pred             ccccccHHHceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCC-CHHHHHHHHHHHHHHHhhccCCceeeEee
Confidence            568888999999999999999999998752       2479999998653 334456789999999999 8999999999


Q ss_pred             EEecCCcEEEEEecCCCCCHHHHHHhcC----------------------------------------------------
Q 015868          181 ACTRPPNLCIVTEFMARGSIYDFLHKQK----------------------------------------------------  208 (399)
Q Consensus       181 ~~~~~~~~~lV~E~~~ggsL~~~l~~~~----------------------------------------------------  208 (399)
                      ++...+..++||||+++|+|.+++....                                                    
T Consensus       110 ~~~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  189 (374)
T cd05106         110 ACTHGGPVLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSS  189 (374)
T ss_pred             EecCCCCeEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCccc
Confidence            9999999999999999999999986431                                                    


Q ss_pred             -----------------CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceeecCCCcEEEeeccceeeccCCCcc-
Q 015868          209 -----------------GVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVM-  270 (399)
Q Consensus       209 -----------------~~l~~~~~~~i~~~i~~~L~~LH~~giiHrDlkp~NILl~~~~~vkl~DFG~a~~~~~~~~~-  270 (399)
                                       ..+++..+++++.||+.||+|||++||+||||||+|||+++++.+||+|||+++........ 
T Consensus       190 ~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~giiHrDLkp~Nil~~~~~~~kL~DfGla~~~~~~~~~~  269 (374)
T cd05106         190 SSSQSSDSKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLASKNCIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNYV  269 (374)
T ss_pred             cccccccccchhccCCCCCcCHHHHHHHHHHHHHHHHHHHHCCEEeccCchheEEEeCCCeEEEeeceeeeeccCCccee
Confidence                             24678889999999999999999999999999999999999999999999999765433211 


Q ss_pred             --ccCCCCcccccccccCCCCCCChhhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHHhccCCCCCCCCCcHHHHHHHH
Q 015868          271 --TAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLT-GELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRLAELLE  347 (399)
Q Consensus       271 --~~~~gt~~y~aPE~l~~~~~~~~~Dv~slG~vl~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~  347 (399)
                        ....++..|+|||++.+..++.++||||||+++|+|++ |+.||..................+..+...++++.+++.
T Consensus       270 ~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt~G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~  349 (374)
T cd05106         270 VKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSPYPGILVNSKFYKMVKRGYQMSRPDFAPPEIYSIMK  349 (374)
T ss_pred             eccCCCCccceeCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCccccccHHHHHHHHcccCccCCCCCCHHHHHHHH
Confidence              12234668999999998899999999999999999997 999998877665555666666666677778999999999


Q ss_pred             HHhhhcCCCCCCHHHHHHHHHHHH
Q 015868          348 RCWQHDPTQRPNFSQITDILKQMM  371 (399)
Q Consensus       348 ~cl~~dP~~Rps~~ell~~L~~l~  371 (399)
                      +||+.||.+|||+.++++.|++++
T Consensus       350 ~cl~~dp~~RPs~~~l~~~l~~~~  373 (374)
T cd05106         350 MCWNLEPTERPTFSQISQLIQRQL  373 (374)
T ss_pred             HHcCCChhhCcCHHHHHHHHHHHh
Confidence            999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti

>KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport]

Probab=100.00  E-value=4.4e-46  Score=377.50  Aligned_cols=264  Identities=30%  Similarity=0.609  Sum_probs=233.9

Q ss_pred             CCCceeecccccceeceeceeCceEEEEEEEC-------CeeEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCceeeEE
Q 015868          107 GTDVWEIDAKQLKIECKVASGSYGDLYKGTYC-------SQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFI  179 (399)
Q Consensus       107 ~~~~~~i~~~~~~i~~~lg~G~~g~Vy~~~~~-------~~~vAvK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~nIv~~~  179 (399)
                      .....+|...+.++.++||+|+||.||+|+..       ...||||.++... +.....+|.+|+.++..++|||||+++
T Consensus       477 ~~~~~~i~r~~i~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~a-~~~~~~dF~REaeLla~l~H~nIVrLl  555 (774)
T KOG1026|consen  477 DLKVLEIPRSDIVFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDKA-ENQARQDFRREAELLAELQHPNIVRLL  555 (774)
T ss_pred             ccceeEechhheeehhhhcCchhhhhhhhhccCCCCCccceehhHhhhcccc-cHHHHHHHHHHHHHHHhccCCCeEEEE
Confidence            44678899999999999999999999999764       3569999998763 444778999999999999999999999


Q ss_pred             eEEecCCcEEEEEecCCCCCHHHHHHhcC-------------CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcee
Q 015868          180 GACTRPPNLCIVTEFMARGSIYDFLHKQK-------------GVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLL  246 (399)
Q Consensus       180 ~~~~~~~~~~lV~E~~~ggsL~~~l~~~~-------------~~l~~~~~~~i~~~i~~~L~~LH~~giiHrDlkp~NIL  246 (399)
                      |+|..++.+|||+|||..|+|.++|+.+.             .+++..+.+.|+.||+.||.||-++.++||||.++|.|
T Consensus       556 GVC~~~~P~~MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~~~FVHRDLATRNCL  635 (774)
T KOG1026|consen  556 GVCREGDPLCMVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSSHHFVHRDLATRNCL  635 (774)
T ss_pred             EEEccCCeeEEEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCcccccchhhhhce
Confidence            99999999999999999999999996532             23778899999999999999999999999999999999


Q ss_pred             ecCCCcEEEeeccceeeccCCCcc---ccCCCCcccccccccCCCCCCChhhHHHHHHHHHHHHc-CCCCCCCCCHHHHH
Q 015868          247 MDENGVVKVADFGVARVQAQSGVM---TAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLT-GELPYAGLTPLQAA  322 (399)
Q Consensus       247 l~~~~~vkl~DFG~a~~~~~~~~~---~~~~gt~~y~aPE~l~~~~~~~~~Dv~slG~vl~ellt-g~~P~~~~~~~~~~  322 (399)
                      |+++-.|||+|||+++..-.....   ....-+.+|||||.|...+|+.+||||||||+|||+++ |+.||.+++..+..
T Consensus       636 Vge~l~VKIsDfGLsRdiYssDYYk~~~~t~lPIRWMppEsIly~kFTteSDVWs~GVvLWEIFsyG~QPy~glSn~EVI  715 (774)
T KOG1026|consen  636 VGENLVVKISDFGLSRDIYSSDYYKVRGNTLLPIRWMPPESILYGKFTTESDVWSFGVVLWEIFSYGKQPYYGLSNQEVI  715 (774)
T ss_pred             eccceEEEecccccchhhhhhhhhcccCCceeeeecCCHHHhhcCcccchhhhhhhhhhhhhhhccccCcccccchHHHH
Confidence            999999999999999854333221   12345789999999999999999999999999999999 99999999999987


Q ss_pred             HHHHhccCCCCCCCCCcHHHHHHHHHHhhhcCCCCCCHHHHHHHHHHHHH
Q 015868          323 VGVVQKSLRPTIPKHAHPRLAELLERCWQHDPTQRPNFSQITDILKQMMK  372 (399)
Q Consensus       323 ~~~~~~~~~~~~~~~~~~~l~~ll~~cl~~dP~~Rps~~ell~~L~~l~~  372 (399)
                      ..+.+... .+-|..+|.++.+||..||+.+|.+||+|.||-..|+...+
T Consensus       716 e~i~~g~l-L~~Pe~CP~~vY~LM~~CW~~~P~~RPsF~eI~~~L~~~~~  764 (774)
T KOG1026|consen  716 ECIRAGQL-LSCPENCPTEVYSLMLECWNENPKRRPSFKEIHSRLQAWAQ  764 (774)
T ss_pred             HHHHcCCc-ccCCCCCCHHHHHHHHHHhhcCcccCCCHHHHHHHHHHHHh
Confidence            76665555 77899999999999999999999999999999999998764

>KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only]

Probab=100.00  E-value=2.9e-46  Score=361.55  Aligned_cols=246  Identities=31%  Similarity=0.574  Sum_probs=223.3

Q ss_pred             cccceeceeceeCceEEEEEEE--CCeeEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCceeeEEeEEecCCcEEEEEe
Q 015868          116 KQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVTE  193 (399)
Q Consensus       116 ~~~~i~~~lg~G~~g~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~nIv~~~~~~~~~~~~~lV~E  193 (399)
                      ++|.+.+.||+|+||.||+|+.  +.+.||+|.+.+.+.++...+.+.+|++|+++++||||+.+++.|+...++++|+|
T Consensus         2 e~yhv~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~gr~~k~l~~l~~ev~i~r~lkHpniv~m~esfEt~~~~~vVte   81 (808)
T KOG0597|consen    2 EQYHVYEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSGRNEKELKNLRQEVRILRSLKHPNIVEMLESFETSAHLWVVTE   81 (808)
T ss_pred             cchhHHHHhcCCccceeeecccccceeEEEEEEehhcCCchHHHHHHHHHHHHHHhcCCcchhhHHHhhcccceEEEEeh
Confidence            5789999999999999999964  67899999998888788889999999999999999999999999999999999999


Q ss_pred             cCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceeecCCCcEEEeeccceeeccCCCc-ccc
Q 015868          194 FMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGV-MTA  272 (399)
Q Consensus       194 ~~~ggsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~giiHrDlkp~NILl~~~~~vkl~DFG~a~~~~~~~~-~~~  272 (399)
                      |+.| +|..++.. .+.++++.+..++.++++||.|||+++|+|||+||.|||++.+|++|+||||+|+.+..... .+.
T Consensus        82 ~a~g-~L~~il~~-d~~lpEe~v~~~a~~LVsaL~yLhs~rilhrd~kPqniLl~~~~~~KlcdFg~Ar~m~~~t~vlts  159 (808)
T KOG0597|consen   82 YAVG-DLFTILEQ-DGKLPEEQVRAIAYDLVSALYYLHSNRILHRDMKPQNILLEKGGTLKLCDFGLARAMSTNTSVLTS  159 (808)
T ss_pred             hhhh-hHHHHHHh-ccCCCHHHHHHHHHHHHHHHHHHHhcCcccccCCcceeeecCCCceeechhhhhhhcccCceeeee
Confidence            9988 99999966 68899999999999999999999999999999999999999999999999999998776543 345


Q ss_pred             CCCCcccccccccCCCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhccCCCCCCCCCcHHHHHHHHHHhhh
Q 015868          273 ETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRLAELLERCWQH  352 (399)
Q Consensus       273 ~~gt~~y~aPE~l~~~~~~~~~Dv~slG~vl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~cl~~  352 (399)
                      -.|||.|||||+..+.+|++.+|+||+||++||+++|++||....-.+....+....  ...|...+..+.+|++.+|.+
T Consensus       160 ikGtPlYmAPElv~e~pyd~~sDlWslGcilYE~~~G~PPF~a~si~~Lv~~I~~d~--v~~p~~~S~~f~nfl~gLL~k  237 (808)
T KOG0597|consen  160 IKGTPLYMAPELVEEQPYDHTSDLWSLGCILYELYVGQPPFYARSITQLVKSILKDP--VKPPSTASSSFVNFLQGLLIK  237 (808)
T ss_pred             ccCcccccCHHHHcCCCccchhhHHHHHHHHHHHhcCCCCchHHHHHHHHHHHhcCC--CCCcccccHHHHHHHHHHhhc
Confidence            579999999999999999999999999999999999999998777766665555443  334558999999999999999


Q ss_pred             cCCCCCCHHHHHH
Q 015868          353 DPTQRPNFSQITD  365 (399)
Q Consensus       353 dP~~Rps~~ell~  365 (399)
                      ||.+|.+-.+++.
T Consensus       238 dP~~RltW~~Ll~  250 (808)
T KOG0597|consen  238 DPAQRLTWTDLLG  250 (808)
T ss_pred             ChhhcccHHHHhc
Confidence            9999999999865

>KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms]

Probab=100.00  E-value=1e-45  Score=360.64  Aligned_cols=262  Identities=31%  Similarity=0.694  Sum_probs=238.4

Q ss_pred             CceeecccccceeceeceeCceEEEEEEECC------eeEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCceeeEEeEE
Q 015868          109 DVWEIDAKQLKIECKVASGSYGDLYKGTYCS------QEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGAC  182 (399)
Q Consensus       109 ~~~~i~~~~~~i~~~lg~G~~g~Vy~~~~~~------~~vAvK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~nIv~~~~~~  182 (399)
                      ...+++.....+.+.||.|-||.||+|.|+.      -.||||..+.+....+ .+.|.+|..+|+.++||||++++|+|
T Consensus       382 rnyel~Re~Itl~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~t~d~-tekflqEa~iMrnfdHphIikLIGv~  460 (974)
T KOG4257|consen  382 RNYELRRELITLKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDCTPDD-TEKFLQEASIMRNFDHPHIIKLIGVC  460 (974)
T ss_pred             CcceeehhhccHHHhhcCCcccceeeeEecccccCcceeeeeehhccCCChhh-HHHHHHHHHHHHhCCCcchhheeeee
Confidence            4567788888889999999999999999854      2599999998764444 78999999999999999999999999


Q ss_pred             ecCCcEEEEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceeecCCCcEEEeecccee
Q 015868          183 TRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVAR  262 (399)
Q Consensus       183 ~~~~~~~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~giiHrDlkp~NILl~~~~~vkl~DFG~a~  262 (399)
                      .+.+ .+||||.++-|.|..|+..+...++...+..++.||+.+|+|||+++++||||.++|||+.+..-|||+|||+++
T Consensus       461 ~e~P-~WivmEL~~~GELr~yLq~nk~sL~l~tL~ly~~Qi~talaYLeSkrfVHRDIAaRNiLVsSp~CVKLaDFGLSR  539 (974)
T KOG4257|consen  461 VEQP-MWIVMELAPLGELREYLQQNKDSLPLRTLTLYCYQICTALAYLESKRFVHRDIAARNILVSSPQCVKLADFGLSR  539 (974)
T ss_pred             eccc-eeEEEecccchhHHHHHHhccccchHHHHHHHHHHHHHHHHHHHhhchhhhhhhhhheeecCcceeeecccchhh
Confidence            9886 899999999999999999999999999999999999999999999999999999999999999999999999999


Q ss_pred             eccCCCccccCCC--CcccccccccCCCCCCChhhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHHhccCCCCCCCCCc
Q 015868          263 VQAQSGVMTAETG--TYRWMAPEVIEHKPYDYKADVFSFGIALWELLT-GELPYAGLTPLQAAVGVVQKSLRPTIPKHAH  339 (399)
Q Consensus       263 ~~~~~~~~~~~~g--t~~y~aPE~l~~~~~~~~~Dv~slG~vl~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~  339 (399)
                      .........+..|  +..|||||.++-..++.++|||+||+.+||++. |..||.+..+.+. .+.+.++.|++.|+.|+
T Consensus       540 ~~ed~~yYkaS~~kLPIKWmaPESINfRrFTtASDVWMFgVCmWEIl~lGvkPfqgvkNsDV-I~~iEnGeRlP~P~nCP  618 (974)
T KOG4257|consen  540 YLEDDAYYKASRGKLPIKWMAPESINFRRFTTASDVWMFGVCMWEILSLGVKPFQGVKNSDV-IGHIENGERLPCPPNCP  618 (974)
T ss_pred             hccccchhhccccccceeecCccccchhcccchhhHHHHHHHHHHHHHhcCCccccccccce-EEEecCCCCCCCCCCCC
Confidence            8887766666555  668999999999999999999999999999988 9999999887664 44577899999999999


Q ss_pred             HHHHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHH
Q 015868          340 PRLAELLERCWQHDPTQRPNFSQITDILKQMMKE  373 (399)
Q Consensus       340 ~~l~~ll~~cl~~dP~~Rps~~ell~~L~~l~~~  373 (399)
                      +.|..|+.+||.++|.+||+|.+|...|.+++++
T Consensus       619 p~LYslmskcWayeP~kRPrftei~~~lsdv~qe  652 (974)
T KOG4257|consen  619 PALYSLMSKCWAYEPSKRPRFTEIKAILSDVLQE  652 (974)
T ss_pred             hHHHHHHHHHhccCcccCCcHHHHHHHHHHHHHH
Confidence            9999999999999999999999999999998773

>KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=4.6e-47  Score=358.67  Aligned_cols=247  Identities=32%  Similarity=0.563  Sum_probs=219.9

Q ss_pred             cccceeceeceeCceEEEEEEE--CCeeEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCceeeEEeEEecCCcEEEEEe
Q 015868          116 KQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVTE  193 (399)
Q Consensus       116 ~~~~i~~~lg~G~~g~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~nIv~~~~~~~~~~~~~lV~E  193 (399)
                      ..|+..+.||+|+||.||+|.+  +++.||+|++..+. ..+...++.+|+.++.+++++||.++|+.+..+..++++||
T Consensus        13 ~~~~~~~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le~-~~deIediqqei~~Ls~~~~~~it~yygsyl~g~~LwiiMe   91 (467)
T KOG0201|consen   13 LLYTKLELIGRGSFGEVYKAIDNKTKKVVAIKIIDLEE-AEDEIEDIQQEISVLSQCDSPNITEYYGSYLKGTKLWIIME   91 (467)
T ss_pred             cccccchhccccccceeeeeeeccccceEEEEEechhh-cchhhHHHHHHHHHHHhcCcchHHhhhhheeecccHHHHHH
Confidence            4677779999999999999987  67899999998764 44557889999999999999999999999999999999999


Q ss_pred             cCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceeecCCCcEEEeeccceeeccCCCc-ccc
Q 015868          194 FMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGV-MTA  272 (399)
Q Consensus       194 ~~~ggsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~giiHrDlkp~NILl~~~~~vkl~DFG~a~~~~~~~~-~~~  272 (399)
                      ||.||++.+.++. ...+.+..+..++.+++.|+.|||.++.+|||||+.|||+..+|.|||+|||++-....... ...
T Consensus        92 y~~gGsv~~lL~~-~~~~~E~~i~~ilre~l~~l~ylH~~~kiHrDIKaanil~s~~g~vkl~DfgVa~ql~~~~~rr~t  170 (467)
T KOG0201|consen   92 YCGGGSVLDLLKS-GNILDEFEIAVILREVLKGLDYLHSEKKIHRDIKAANILLSESGDVKLADFGVAGQLTNTVKRRKT  170 (467)
T ss_pred             HhcCcchhhhhcc-CCCCccceeeeehHHHHHHhhhhhhcceecccccccceeEeccCcEEEEecceeeeeechhhcccc
Confidence            9999999999965 45558899999999999999999999999999999999999999999999999976655433 356


Q ss_pred             CCCCcccccccccCCCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhccCCCCCCCCCcHHHHHHHHHHhhh
Q 015868          273 ETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRLAELLERCWQH  352 (399)
Q Consensus       273 ~~gt~~y~aPE~l~~~~~~~~~Dv~slG~vl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~cl~~  352 (399)
                      ..||+.|||||++.+..|+.|+||||||++.+||++|.+||....|..... .+.+..+|.+...+++.+++|+..||.+
T Consensus       171 fvGTPfwMAPEVI~~~~Y~~KADIWSLGITaiEla~GePP~s~~hPmrvlf-lIpk~~PP~L~~~~S~~~kEFV~~CL~k  249 (467)
T KOG0201|consen  171 FVGTPFWMAPEVIKQSGYDTKADIWSLGITAIELAKGEPPHSKLHPMRVLF-LIPKSAPPRLDGDFSPPFKEFVEACLDK  249 (467)
T ss_pred             ccccccccchhhhccccccchhhhhhhhHHHHHHhcCCCCCcccCcceEEE-eccCCCCCccccccCHHHHHHHHHHhhc
Confidence            789999999999999999999999999999999999999999999854332 2344556777778999999999999999


Q ss_pred             cCCCCCCHHHHHH
Q 015868          353 DPTQRPNFSQITD  365 (399)
Q Consensus       353 dP~~Rps~~ell~  365 (399)
                      ||+.||++.++++
T Consensus       250 ~P~~RpsA~~LLK  262 (467)
T KOG0201|consen  250 NPEFRPSAKELLK  262 (467)
T ss_pred             CcccCcCHHHHhh
Confidence            9999999999976

>cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1

Probab=100.00  E-value=2.8e-44  Score=343.73  Aligned_cols=255  Identities=33%  Similarity=0.598  Sum_probs=212.2

Q ss_pred             ecccccceeceeceeCceEEEEEEEC------------------CeeEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCc
Q 015868          113 IDAKQLKIECKVASGSYGDLYKGTYC------------------SQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKN  174 (399)
Q Consensus       113 i~~~~~~i~~~lg~G~~g~Vy~~~~~------------------~~~vAvK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~n  174 (399)
                      +..++|++.++||+|+||.||++.+.                  +..||+|+++... .......+.+|+.++++++|||
T Consensus         2 ~~~~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~h~n   80 (304)
T cd05096           2 FPRGHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDA-NKNARNDFLKEVKILSRLKDPN   80 (304)
T ss_pred             CchhhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCC-CHHHHHHHHHHHHHHhhcCCCC
Confidence            34678999999999999999999752                  2469999998653 4455678999999999999999


Q ss_pred             eeeEEeEEecCCcEEEEEecCCCCCHHHHHHhcC------------------CCCCHHHHHHHHHHHHHHHHHHHHCCcc
Q 015868          175 VVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQK------------------GVFQLTSLLKVAIDVSKGMNYLHQNNII  236 (399)
Q Consensus       175 Iv~~~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~------------------~~l~~~~~~~i~~~i~~~L~~LH~~gii  236 (399)
                      |+++++++......++||||+++++|.+++....                  ..++...++.++.||+.||.|||+.||+
T Consensus        81 iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~iv  160 (304)
T cd05096          81 IIRLLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSLNFV  160 (304)
T ss_pred             eeEEEEEEecCCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHCCcc
Confidence            9999999999999999999999999999986532                  2367788999999999999999999999


Q ss_pred             cCCCCCCceeecCCCcEEEeeccceeeccCCCc---cccCCCCcccccccccCCCCCCChhhHHHHHHHHHHHHc--CCC
Q 015868          237 HRDLKTANLLMDENGVVKVADFGVARVQAQSGV---MTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLT--GEL  311 (399)
Q Consensus       237 HrDlkp~NILl~~~~~vkl~DFG~a~~~~~~~~---~~~~~gt~~y~aPE~l~~~~~~~~~Dv~slG~vl~ellt--g~~  311 (399)
                      ||||||+|||++.++.+||+|||+++.......   .....++..|+|||++.+..++.++||||||+++|+|++  +..
T Consensus       161 H~dlkp~Nill~~~~~~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~  240 (304)
T cd05096         161 HRDLATRNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEILMLCKEQ  240 (304)
T ss_pred             ccCcchhheEEcCCccEEECCCccceecccCceeEecCcCCCCccccCHHHHhcCCCCchhhhHHHHHHHHHHHHccCCC
Confidence            999999999999999999999999975433221   122345788999999998889999999999999999986  668


Q ss_pred             CCCCCCHHHHHHHHHh------ccCCCCCCCCCcHHHHHHHHHHhhhcCCCCCCHHHHHHHHH
Q 015868          312 PYAGLTPLQAAVGVVQ------KSLRPTIPKHAHPRLAELLERCWQHDPTQRPNFSQITDILK  368 (399)
Q Consensus       312 P~~~~~~~~~~~~~~~------~~~~~~~~~~~~~~l~~ll~~cl~~dP~~Rps~~ell~~L~  368 (399)
                      ||...+..+.......      ....+..+..+++.+.+++.+||+.+|.+|||+.+|.+.|+
T Consensus       241 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~~i~~~l~  303 (304)
T cd05096         241 PYGELTDEQVIENAGEFFRDQGRQVYLFRPPPCPQGLYELMLQCWSRDCRERPSFSDIHAFLT  303 (304)
T ss_pred             CCCcCCHHHHHHHHHHHhhhccccccccCCCCCCHHHHHHHHHHccCCchhCcCHHHHHHHHh
Confidence            8988776665443321      11122345668899999999999999999999999988775

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k

>KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only]

Probab=100.00  E-value=5.6e-45  Score=352.16  Aligned_cols=251  Identities=22%  Similarity=0.368  Sum_probs=218.0

Q ss_pred             eecccccceeceeceeCceEEEEEEE--CCeeEEEEEecCCC-CCHHHHHHHHHHHHHHHhcCCCceeeEEeEEecCCcE
Q 015868          112 EIDAKQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPEC-VNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNL  188 (399)
Q Consensus       112 ~i~~~~~~i~~~lg~G~~g~Vy~~~~--~~~~vAvK~~~~~~-~~~~~~~~~~~Ei~~l~~l~h~nIv~~~~~~~~~~~~  188 (399)
                      .+..++|+++..||+|+||.||+|+.  +|..+|+|++++.. ...+..+.+..|-.+|...+.|+||+++..|.+..++
T Consensus       137 r~~~~DFe~Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~ds~~vVKLyYsFQD~~~L  216 (550)
T KOG0605|consen  137 RLSLDDFELLKVIGKGAFGEVRLARKKDTGEIYAMKILKKSEMLKKNQVEHVRAERDILAEVDSPWVVKLYYSFQDKEYL  216 (550)
T ss_pred             cCCcccchhheeeccccceeEEEEEEccCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhcCCCcEEEEEEEecCCCee
Confidence            34567999999999999999999975  78999999998653 3456678899999999999999999999999999999


Q ss_pred             EEEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceeecCCCcEEEeeccceeeccC--
Q 015868          189 CIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQ--  266 (399)
Q Consensus       189 ~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~giiHrDlkp~NILl~~~~~vkl~DFG~a~~~~~--  266 (399)
                      ||||||.+||++..+|.+ .+.+++..+..++.+++-|++.||+.|||||||||+|+|||..|++||+|||++.....  
T Consensus       217 YLiMEylPGGD~mTLL~~-~~~L~e~~arfYiaE~vlAI~~iH~~gyIHRDIKPdNlLiD~~GHiKLSDFGLs~gl~~~~  295 (550)
T KOG0605|consen  217 YLIMEYLPGGDMMTLLMR-KDTLTEDWARFYIAETVLAIESIHQLGYIHRDIKPDNLLIDAKGHIKLSDFGLSTGLDKKH  295 (550)
T ss_pred             EEEEEecCCccHHHHHHh-cCcCchHHHHHHHHHHHHHHHHHHHcCcccccCChhheeecCCCCEeeccccccchhhhhh
Confidence            999999999999999976 68899999999999999999999999999999999999999999999999999852111  


Q ss_pred             -------------------CCcc---------------------------ccCCCCcccccccccCCCCCCChhhHHHHH
Q 015868          267 -------------------SGVM---------------------------TAETGTYRWMAPEVIEHKPYDYKADVFSFG  300 (399)
Q Consensus       267 -------------------~~~~---------------------------~~~~gt~~y~aPE~l~~~~~~~~~Dv~slG  300 (399)
                                         ....                           ...+|||.|||||++.+++|+..+|.||||
T Consensus       296 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~kgY~~~cDwWSLG  375 (550)
T KOG0605|consen  296 RIESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLGKGYGKECDWWSLG  375 (550)
T ss_pred             hhhhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhcCCCCccccHHHHH
Confidence                               0000                           012499999999999999999999999999


Q ss_pred             HHHHHHHcCCCCCCCCCHHHHHHHHHhcc--CCCCCCCCCcHHHHHHHHHHhhhcCCCCCC---HHHHH
Q 015868          301 IALWELLTGELPYAGLTPLQAAVGVVQKS--LRPTIPKHAHPRLAELLERCWQHDPTQRPN---FSQIT  364 (399)
Q Consensus       301 ~vl~elltg~~P~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~l~~ll~~cl~~dP~~Rps---~~ell  364 (399)
                      |++||||.|.+||.+.++.+....++...  +..+-...++++..+||.+|+. ||++|..   ++||.
T Consensus       376 ~ImyEmLvGyPPF~s~tp~~T~rkI~nwr~~l~fP~~~~~s~eA~DLI~rll~-d~~~RLG~~G~~EIK  443 (550)
T KOG0605|consen  376 CIMYEMLVGYPPFCSETPQETYRKIVNWRETLKFPEEVDLSDEAKDLITRLLC-DPENRLGSKGAEEIK  443 (550)
T ss_pred             HHHHHHHhCCCCCCCCCHHHHHHHHHHHhhhccCCCcCcccHHHHHHHHHHhc-CHHHhcCcccHHHHh
Confidence            99999999999999999999888876554  3333334578999999999999 9999965   55554

>PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity

Probab=100.00  E-value=9.6e-45  Score=339.48  Aligned_cols=247  Identities=36%  Similarity=0.701  Sum_probs=211.7

Q ss_pred             ceeceeceeCceEEEEEEEC------CeeEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCceeeEEeEEecCCcEEEEE
Q 015868          119 KIECKVASGSYGDLYKGTYC------SQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVT  192 (399)
Q Consensus       119 ~i~~~lg~G~~g~Vy~~~~~------~~~vAvK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~nIv~~~~~~~~~~~~~lV~  192 (399)
                      ++.+.||.|+||.||+|++.      +..|+||+++.. ...+..+.+.+|+..+++++||||++++|++......++||
T Consensus         2 ~~~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~~-~~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~~~~~~lv~   80 (259)
T PF07714_consen    2 KLIKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKPS-SSEEEEEEFLNEIQILRKLRHPNIVKLYGFCIENEPLFLVM   80 (259)
T ss_dssp             EEEEEEEEESSEEEEEEEEESTTTSSEEEEEEEEESTT-SSHHHHHHHHHHHHHHHTHSBTTBE-EEEEEESSSSEEEEE
T ss_pred             EEeeEEccCCCcEEEEEEEEcccCCCCEEEEEEEeccc-cccccceeeeecccccccccccccccccccccccccccccc
Confidence            46789999999999999987      678999999764 35556789999999999999999999999999888899999


Q ss_pred             ecCCCCCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceeecCCCcEEEeeccceeeccCCC---
Q 015868          193 EFMARGSIYDFLHKQ-KGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSG---  268 (399)
Q Consensus       193 E~~~ggsL~~~l~~~-~~~l~~~~~~~i~~~i~~~L~~LH~~giiHrDlkp~NILl~~~~~vkl~DFG~a~~~~~~~---  268 (399)
                      ||+++|+|.+++... ...+++..++.++.||+.||.|||+++++|+||+++||++++++.+||+|||++.......   
T Consensus        81 e~~~~g~L~~~L~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~iiH~~l~~~nill~~~~~~Kl~~f~~~~~~~~~~~~~  160 (259)
T PF07714_consen   81 EYCPGGSLDDYLKSKNKEPLSEQQRLSIAIQIAEALSYLHSNNIIHGNLSPSNILLDSNGQVKLSDFGLSRPISEKSKYK  160 (259)
T ss_dssp             E--TTEBHHHHHHHTCTTTSBHHHHHHHHHHHHHHHHHHHHTTEEEST-SGGGEEEETTTEEEEESTTTGEETTTSSSEE
T ss_pred             cccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccc
Confidence            999999999999886 6789999999999999999999999999999999999999999999999999998763221   


Q ss_pred             ccccCCCCcccccccccCCCCCCChhhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHHhccCCCCCCCCCcHHHHHHHH
Q 015868          269 VMTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLT-GELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRLAELLE  347 (399)
Q Consensus       269 ~~~~~~gt~~y~aPE~l~~~~~~~~~Dv~slG~vl~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~  347 (399)
                      ..........|+|||.+....++.++||||||+++||+++ |+.||...+..+..... ....++..+..++..+.+++.
T Consensus       161 ~~~~~~~~~~~~aPE~~~~~~~~~ksDVysfG~~l~ei~~~~~~p~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~li~  239 (259)
T PF07714_consen  161 NDSSQQLPLRYLAPEVLKDGEYTKKSDVYSFGMLLYEILTLGKFPFSDYDNEEIIEKL-KQGQRLPIPDNCPKDIYSLIQ  239 (259)
T ss_dssp             ESTTSESGGGGS-HHHHHHSEESHHHHHHHHHHHHHHHHTTSSGTTTTSCHHHHHHHH-HTTEETTSBTTSBHHHHHHHH
T ss_pred             cccccccccccccccccccccccccccccccccccccccccccccccccccccccccc-cccccceeccchhHHHHHHHH
Confidence            1233346789999999998889999999999999999999 78999999887766555 556667788889999999999


Q ss_pred             HHhhhcCCCCCCHHHHHHHH
Q 015868          348 RCWQHDPTQRPNFSQITDIL  367 (399)
Q Consensus       348 ~cl~~dP~~Rps~~ell~~L  367 (399)
                      +||..+|++|||+.++++.|
T Consensus       240 ~C~~~~p~~RPs~~~i~~~L  259 (259)
T PF07714_consen  240 QCWSHDPEKRPSFQEILQEL  259 (259)
T ss_dssp             HHT-SSGGGS--HHHHHHHH
T ss_pred             HHcCCChhhCcCHHHHHhcC
Confidence            99999999999999999876

Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A ....

>KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=100.00  E-value=6.7e-45  Score=380.83  Aligned_cols=262  Identities=34%  Similarity=0.650  Sum_probs=233.7

Q ss_pred             eeecccccceeceeceeCceEEEEEEECC-------eeEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCceeeEEeEEe
Q 015868          111 WEIDAKQLKIECKVASGSYGDLYKGTYCS-------QEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACT  183 (399)
Q Consensus       111 ~~i~~~~~~i~~~lg~G~~g~Vy~~~~~~-------~~vAvK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~nIv~~~~~~~  183 (399)
                      .++.....++.+.||+|.||.||.|++.+       ..||+|.++... +.....+|.+|..+|++++||||++++|++.
T Consensus       687 p~v~~~~v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~~-~~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l  765 (1025)
T KOG1095|consen  687 PEVPRKNVTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRLS-SEQEVSDFLKEALLMSKFDHPNIVSLIGVCL  765 (1025)
T ss_pred             ccCChhheEeeeeeccccccceEEEEEecCCCCccceEEEEEeccccC-CHHHHHHHHHHHHHHhcCCCcceeeEEEeec
Confidence            34668889999999999999999998843       248889887653 5666789999999999999999999999999


Q ss_pred             cCCcEEEEEecCCCCCHHHHHHhc------CCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceeecCCCcEEEee
Q 015868          184 RPPNLCIVTEFMARGSIYDFLHKQ------KGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVAD  257 (399)
Q Consensus       184 ~~~~~~lV~E~~~ggsL~~~l~~~------~~~l~~~~~~~i~~~i~~~L~~LH~~giiHrDlkp~NILl~~~~~vkl~D  257 (399)
                      +....+|++|||.||+|..+|++.      ...++...++.++.||++|+.||+++++|||||.++|+|++....|||+|
T Consensus       766 ~~~~~~i~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~~~fvHRDLAaRNCLL~~~r~VKIaD  845 (1025)
T KOG1095|consen  766 DSGPPLILLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLESKHFVHRDLAARNCLLDERRVVKIAD  845 (1025)
T ss_pred             CCCCcEEEehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHhCCCcCcchhhhheeecccCcEEEcc
Confidence            999999999999999999999987      67789999999999999999999999999999999999999999999999


Q ss_pred             ccceeeccCCCcc--ccC-CCCcccccccccCCCCCCChhhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHHhccCCCC
Q 015868          258 FGVARVQAQSGVM--TAE-TGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLT-GELPYAGLTPLQAAVGVVQKSLRPT  333 (399)
Q Consensus       258 FG~a~~~~~~~~~--~~~-~gt~~y~aPE~l~~~~~~~~~Dv~slG~vl~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~  333 (399)
                      ||+|+-.......  ... .-+.+|||||.+....++.|+|||||||++||++| |..||...++.+...-+...+ |..
T Consensus       846 FGlArDiy~~~yyr~~~~a~lPvkWm~PEsl~d~iFtskSDvWsFGVllWEifslG~~PY~~~~n~~v~~~~~~gg-RL~  924 (1025)
T KOG1095|consen  846 FGLARDIYDKDYYRKHGEAMLPVKWMPPESLKDGIFTSKSDVWSFGVLLWEIFSLGATPYPSRSNFEVLLDVLEGG-RLD  924 (1025)
T ss_pred             cchhHhhhhchheeccCccccceecCCHHHHhhcccccccchhhhHHHHHHHHhCCCCCCCCcchHHHHHHHHhCC-ccC
Confidence            9999933322211  112 33579999999999999999999999999999999 999999999999888777766 888


Q ss_pred             CCCCCcHHHHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHH
Q 015868          334 IPKHAHPRLAELLERCWQHDPTQRPNFSQITDILKQMMKEV  374 (399)
Q Consensus       334 ~~~~~~~~l~~ll~~cl~~dP~~Rps~~ell~~L~~l~~~~  374 (399)
                      .|..++..+.++|.+||+.+|++||+|..|++.+.++.+..
T Consensus       925 ~P~~CP~~ly~lM~~CW~~~pe~RP~F~~i~~q~~~i~~~~  965 (1025)
T KOG1095|consen  925 PPSYCPEKLYQLMLQCWKHDPEDRPSFRTIVEQDPAISNAA  965 (1025)
T ss_pred             CCCCCChHHHHHHHHHccCChhhCccHHHHHhhhhhhhhhh
Confidence            99999999999999999999999999999999999887755

>cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=8.3e-45  Score=345.64  Aligned_cols=245  Identities=23%  Similarity=0.408  Sum_probs=214.4

Q ss_pred             cccceeceeceeCceEEEEEEEC--CeeEEEEEecCCCC-CHHHHHHHHHHHHHHHhcCCCceeeEEeEEecCCcEEEEE
Q 015868          116 KQLKIECKVASGSYGDLYKGTYC--SQEVAIKVLKPECV-NTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVT  192 (399)
Q Consensus       116 ~~~~i~~~lg~G~~g~Vy~~~~~--~~~vAvK~~~~~~~-~~~~~~~~~~Ei~~l~~l~h~nIv~~~~~~~~~~~~~lV~  192 (399)
                      ++|++.+.||+|+||.||+|...  ++.||+|++..... .......+.+|+.++++++||||+++++++.+...+++||
T Consensus         1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~   80 (291)
T cd05612           1 DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFWTEHDQRFLYMLM   80 (291)
T ss_pred             CCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCCCCcHhhhHhhhccCCeEEEEE
Confidence            36889999999999999999874  78999999975322 2334567889999999999999999999999999999999


Q ss_pred             ecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceeecCCCcEEEeeccceeeccCCCcccc
Q 015868          193 EFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTA  272 (399)
Q Consensus       193 E~~~ggsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~giiHrDlkp~NILl~~~~~vkl~DFG~a~~~~~~~~~~~  272 (399)
                      ||+++++|.+++.. .+.+++..+..++.|++.||+|||++||+||||||+||+++.++.+||+|||+++.....  ...
T Consensus        81 e~~~~~~L~~~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~NIli~~~~~~kl~Dfg~~~~~~~~--~~~  157 (291)
T cd05612          81 EYVPGGELFSYLRN-SGRFSNSTGLFYASEIVCALEYLHSKEIVYRDLKPENILLDKEGHIKLTDFGFAKKLRDR--TWT  157 (291)
T ss_pred             eCCCCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECCCCCEEEEecCcchhccCC--ccc
Confidence            99999999999976 457899999999999999999999999999999999999999999999999999765432  234


Q ss_pred             CCCCcccccccccCCCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhccCCCCCCCCCcHHHHHHHHHHhhh
Q 015868          273 ETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRLAELLERCWQH  352 (399)
Q Consensus       273 ~~gt~~y~aPE~l~~~~~~~~~Dv~slG~vl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~cl~~  352 (399)
                      ..|++.|+|||++.+..++.++||||||+++|+|++|..||.+.+..+....+...  ...+|...++.+.+++.+||+.
T Consensus       158 ~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~i~~~--~~~~~~~~~~~~~~li~~~l~~  235 (291)
T cd05612         158 LCGTPEYLAPEVIQSKGHNKAVDWWALGILIYEMLVGYPPFFDDNPFGIYEKILAG--KLEFPRHLDLYAKDLIKKLLVV  235 (291)
T ss_pred             ccCChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhC--CcCCCccCCHHHHHHHHHHcCC
Confidence            56899999999999999999999999999999999999999988877666555443  3456777899999999999999


Q ss_pred             cCCCCCC-----HHHHHH
Q 015868          353 DPTQRPN-----FSQITD  365 (399)
Q Consensus       353 dP~~Rps-----~~ell~  365 (399)
                      ||.+||+     ++++++
T Consensus       236 dp~~R~~~~~~~~~~~l~  253 (291)
T cd05612         236 DRTRRLGNMKNGADDVKN  253 (291)
T ss_pred             CHHHccCCccCCHHHHhc
Confidence            9999995     787765

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt

>PTZ00263 protein kinase A catalytic subunit; Provisional

Probab=100.00  E-value=1.1e-44  Score=350.83  Aligned_cols=247  Identities=26%  Similarity=0.435  Sum_probs=216.1

Q ss_pred             cccccceeceeceeCceEEEEEEE--CCeeEEEEEecCCC-CCHHHHHHHHHHHHHHHhcCCCceeeEEeEEecCCcEEE
Q 015868          114 DAKQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPEC-VNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCI  190 (399)
Q Consensus       114 ~~~~~~i~~~lg~G~~g~Vy~~~~--~~~~vAvK~~~~~~-~~~~~~~~~~~Ei~~l~~l~h~nIv~~~~~~~~~~~~~l  190 (399)
                      ..++|++.+.||+|+||.||+|+.  +++.||+|+++... ......+.+.+|+.+++.++||||+++++++..+...|+
T Consensus        16 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~l   95 (329)
T PTZ00263         16 KLSDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQDENRVYF   95 (329)
T ss_pred             CchheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCcEEEEEEcCCEEEE
Confidence            357899999999999999999987  56889999997532 123345678999999999999999999999999999999


Q ss_pred             EEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceeecCCCcEEEeeccceeeccCCCcc
Q 015868          191 VTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVM  270 (399)
Q Consensus       191 V~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~giiHrDlkp~NILl~~~~~vkl~DFG~a~~~~~~~~~  270 (399)
                      ||||+.|++|.+++.. .+.+++..+..++.|++.||+|||++||+||||||+|||++.++.+||+|||+++.....  .
T Consensus        96 v~e~~~~~~L~~~l~~-~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~--~  172 (329)
T PTZ00263         96 LLEFVVGGELFTHLRK-AGRFPNDVAKFYHAELVLAFEYLHSKDIIYRDLKPENLLLDNKGHVKVTDFGFAKKVPDR--T  172 (329)
T ss_pred             EEcCCCCChHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHEEECCCCCEEEeeccCceEcCCC--c
Confidence            9999999999999976 467899999999999999999999999999999999999999999999999999865433  2


Q ss_pred             ccCCCCcccccccccCCCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhccCCCCCCCCCcHHHHHHHHHHh
Q 015868          271 TAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRLAELLERCW  350 (399)
Q Consensus       271 ~~~~gt~~y~aPE~l~~~~~~~~~Dv~slG~vl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~cl  350 (399)
                      ....||+.|+|||++.+..++.++|||||||++|+|++|..||.+.++.+....+...  ...+|..++..+.+|+.+||
T Consensus       173 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~--~~~~p~~~~~~~~~li~~~L  250 (329)
T PTZ00263        173 FTLCGTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPPFFDDTPFRIYEKILAG--RLKFPNWFDGRARDLVKGLL  250 (329)
T ss_pred             ceecCChhhcCHHHHcCCCCCCcceeechHHHHHHHHcCCCCCCCCCHHHHHHHHhcC--CcCCCCCCCHHHHHHHHHHh
Confidence            3457899999999999999999999999999999999999999988877666554432  35567779999999999999


Q ss_pred             hhcCCCCCC-----HHHHHH
Q 015868          351 QHDPTQRPN-----FSQITD  365 (399)
Q Consensus       351 ~~dP~~Rps-----~~ell~  365 (399)
                      +.||.+||+     +++++.
T Consensus       251 ~~dP~~R~~~~~~~~~~ll~  270 (329)
T PTZ00263        251 QTDHTKRLGTLKGGVADVKN  270 (329)
T ss_pred             hcCHHHcCCCCCCCHHHHhc
Confidence            999999987     577763

>cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4

Probab=100.00  E-value=3.1e-44  Score=340.54  Aligned_cols=248  Identities=20%  Similarity=0.336  Sum_probs=209.5

Q ss_pred             cceeceeceeCceEEEEEEE--CCeeEEEEEecCCCCC-HHHHHHHHHHHHHHHhcCCCceeeEEeEEecCCcEEEEEec
Q 015868          118 LKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVN-TEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVTEF  194 (399)
Q Consensus       118 ~~i~~~lg~G~~g~Vy~~~~--~~~~vAvK~~~~~~~~-~~~~~~~~~Ei~~l~~l~h~nIv~~~~~~~~~~~~~lV~E~  194 (399)
                      |++.+.||+|+||.||++..  +++.||+|++...... ......+.+|+.++++++|+||+++++++......++||||
T Consensus         2 f~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~iv~~~~~~~~~~~~~lv~e~   81 (285)
T cd05631           2 FRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAYAYETKDALCLVLTI   81 (285)
T ss_pred             ceEEEEEecCCCEEEEEEEEecCCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcCCCcEEEEEEEEccCCeEEEEEEe
Confidence            77889999999999999976  6889999998754322 23335678999999999999999999999999999999999


Q ss_pred             CCCCCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceeecCCCcEEEeeccceeeccCCCccccC
Q 015868          195 MARGSIYDFLHKQ-KGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAE  273 (399)
Q Consensus       195 ~~ggsL~~~l~~~-~~~l~~~~~~~i~~~i~~~L~~LH~~giiHrDlkp~NILl~~~~~vkl~DFG~a~~~~~~~~~~~~  273 (399)
                      +++|+|.+++... ...+++..+..++.|++.||+|||++||+||||||+|||+++++.++|+|||++............
T Consensus        82 ~~~g~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~  161 (285)
T cd05631          82 MNGGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDLQRERIVYRDLKPENILLDDRGHIRISDLGLAVQIPEGETVRGR  161 (285)
T ss_pred             cCCCcHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHEEECCCCCEEEeeCCCcEEcCCCCeecCC
Confidence            9999999888653 346899999999999999999999999999999999999999999999999999875544344456


Q ss_pred             CCCcccccccccCCCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHH--hccCCCCCCCCCcHHHHHHHHHHhh
Q 015868          274 TGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVV--QKSLRPTIPKHAHPRLAELLERCWQ  351 (399)
Q Consensus       274 ~gt~~y~aPE~l~~~~~~~~~Dv~slG~vl~elltg~~P~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~l~~ll~~cl~  351 (399)
                      .||..|+|||++.+..++.++|||||||++|+|++|+.||...+.........  .......++..+++++.+|+++||+
T Consensus       162 ~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~l~  241 (285)
T cd05631         162 VGTVGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSPFRKRKERVKREEVDRRVKEDQEEYSEKFSEDAKSICRMLLT  241 (285)
T ss_pred             CCCCCccCHhhhcCCCCCcccCchhHHHHHHHHHhCCCCCCCCCcchhHHHHHHHhhcccccCCccCCHHHHHHHHHHhh
Confidence            78999999999999999999999999999999999999998765432221111  1122345667789999999999999


Q ss_pred             hcCCCCCC-----HHHHHH
Q 015868          352 HDPTQRPN-----FSQITD  365 (399)
Q Consensus       352 ~dP~~Rps-----~~ell~  365 (399)
                      .||.+||+     ++++++
T Consensus       242 ~~P~~R~~~~~~~~~~~~~  260 (285)
T cd05631         242 KNPKERLGCRGNGAAGVKQ  260 (285)
T ss_pred             cCHHHhcCCCCCCHHHHhc
Confidence            99999997     677765

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i

>cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors

Probab=100.00  E-value=3.8e-44  Score=348.37  Aligned_cols=261  Identities=32%  Similarity=0.642  Sum_probs=223.1

Q ss_pred             eeecccccceeceeceeCceEEEEEEEC-------CeeEEEEEecCCCCCHHHHHHHHHHHHHHHhc-CCCceeeEEeEE
Q 015868          111 WEIDAKQLKIECKVASGSYGDLYKGTYC-------SQEVAIKVLKPECVNTEMLKEFSQEVYIMRKI-RHKNVVQFIGAC  182 (399)
Q Consensus       111 ~~i~~~~~~i~~~lg~G~~g~Vy~~~~~-------~~~vAvK~~~~~~~~~~~~~~~~~Ei~~l~~l-~h~nIv~~~~~~  182 (399)
                      |++..++|++.+.||.|+||.||+|...       ++.||+|+++... .......+.+|+.+++++ +|+||+++++++
T Consensus         2 ~~~~~~~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~-~~~~~~~~~~E~~~~~~l~~h~niv~~~~~~   80 (337)
T cd05054           2 WEFPRDRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGA-TASEYKALMTELKILIHIGHHLNVVNLLGAC   80 (337)
T ss_pred             cccCHHHhhhhcccccCcCceEEeccccccccccccceeeeeeccCCC-CHHHHHHHHHHHHHHHhhccCcchhheeeeE
Confidence            7888899999999999999999999642       3679999998543 234456788999999999 799999999988


Q ss_pred             ec-CCcEEEEEecCCCCCHHHHHHhcC-----------------------------------------------------
Q 015868          183 TR-PPNLCIVTEFMARGSIYDFLHKQK-----------------------------------------------------  208 (399)
Q Consensus       183 ~~-~~~~~lV~E~~~ggsL~~~l~~~~-----------------------------------------------------  208 (399)
                      .. ...++++|||+++++|.+++....                                                     
T Consensus        81 ~~~~~~~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  160 (337)
T cd05054          81 TKPGGPLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDE  160 (337)
T ss_pred             ecCCCCEEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccch
Confidence            64 456899999999999999986422                                                     


Q ss_pred             -------CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceeecCCCcEEEeeccceeeccCCCc---cccCCCCcc
Q 015868          209 -------GVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGV---MTAETGTYR  278 (399)
Q Consensus       209 -------~~l~~~~~~~i~~~i~~~L~~LH~~giiHrDlkp~NILl~~~~~vkl~DFG~a~~~~~~~~---~~~~~gt~~  278 (399)
                             ..+++..+..++.||+.||+|||++||+||||||+||++++++.++|+|||+++.......   .....++..
T Consensus       161 ~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~~ivHrDikp~Nill~~~~~vkL~DfG~a~~~~~~~~~~~~~~~~~~~~  240 (337)
T cd05054         161 EGDELYKEPLTLEDLISYSFQVARGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLK  240 (337)
T ss_pred             hhhHHhhcCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCcceEEEeCCCcEEEeccccchhcccCcchhhccCCCCCcc
Confidence                   2578899999999999999999999999999999999999999999999999986433221   122345678


Q ss_pred             cccccccCCCCCCChhhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHHhccCCCCCCCCCcHHHHHHHHHHhhhcCCCC
Q 015868          279 WMAPEVIEHKPYDYKADVFSFGIALWELLT-GELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRLAELLERCWQHDPTQR  357 (399)
Q Consensus       279 y~aPE~l~~~~~~~~~Dv~slG~vl~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~cl~~dP~~R  357 (399)
                      |+|||++.+..++.++|||||||++|+|++ |..||.+....+..........++..+...++++.+++.+||+.+|++|
T Consensus       241 y~aPE~~~~~~~~~~~Di~SlGv~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~R  320 (337)
T cd05054         241 WMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQIDEEFCRRLKEGTRMRAPEYATPEIYSIMLDCWHNNPEDR  320 (337)
T ss_pred             ccCcHHhcCCCCCccccHHHHHHHHHHHHHcCCCCCCCCCccHHHHHHHhccCCCCCCccCCHHHHHHHHHHccCChhhC
Confidence            999999999999999999999999999998 9999987666555555666666777778889999999999999999999


Q ss_pred             CCHHHHHHHHHHHHH
Q 015868          358 PNFSQITDILKQMMK  372 (399)
Q Consensus       358 ps~~ell~~L~~l~~  372 (399)
                      |++.++++.|.++++
T Consensus       321 Ps~~ell~~l~~~~~  335 (337)
T cd05054         321 PTFSELVEILGDLLQ  335 (337)
T ss_pred             cCHHHHHHHHHHHHh
Confidence            999999999999875

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto

>cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha

Probab=100.00  E-value=6e-44  Score=354.21  Aligned_cols=263  Identities=31%  Similarity=0.638  Sum_probs=225.9

Q ss_pred             CceeecccccceeceeceeCceEEEEEEECC-------eeEEEEEecCCCCCHHHHHHHHHHHHHHHhcC-CCceeeEEe
Q 015868          109 DVWEIDAKQLKIECKVASGSYGDLYKGTYCS-------QEVAIKVLKPECVNTEMLKEFSQEVYIMRKIR-HKNVVQFIG  180 (399)
Q Consensus       109 ~~~~i~~~~~~i~~~lg~G~~g~Vy~~~~~~-------~~vAvK~~~~~~~~~~~~~~~~~Ei~~l~~l~-h~nIv~~~~  180 (399)
                      ..|+++.++|.+.++||+|+||.||+|++.+       ..||||+++... .......+.+|+.+++++. ||||+++++
T Consensus        30 ~~~~~~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~-~~~~~~~~~~Ei~~l~~l~~HpnIv~l~~  108 (400)
T cd05105          30 SRWEFPRDGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTA-RSSEKQALMSELKIMTHLGPHLNIVNLLG  108 (400)
T ss_pred             CceeccccceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCC-ChHHHHHHHHHHHHHHhcCCCCCeeeEEE
Confidence            5689999999999999999999999998632       369999997643 3444568999999999996 999999999


Q ss_pred             EEecCCcEEEEEecCCCCCHHHHHHhcC----------------------------------------------------
Q 015868          181 ACTRPPNLCIVTEFMARGSIYDFLHKQK----------------------------------------------------  208 (399)
Q Consensus       181 ~~~~~~~~~lV~E~~~ggsL~~~l~~~~----------------------------------------------------  208 (399)
                      ++......|+||||+++|+|.+++....                                                    
T Consensus       109 ~~~~~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  188 (400)
T cd05105         109 ACTKSGPIYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQY  188 (400)
T ss_pred             EEccCCceEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhccccccccccccccccc
Confidence            9999999999999999999999986531                                                    


Q ss_pred             -------------------------------------------CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCce
Q 015868          209 -------------------------------------------GVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANL  245 (399)
Q Consensus       209 -------------------------------------------~~l~~~~~~~i~~~i~~~L~~LH~~giiHrDlkp~NI  245 (399)
                                                                 ..+++..+..++.|++.||+|||++||+||||||+||
T Consensus       189 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivH~dikp~Ni  268 (400)
T cd05105         189 VPMLEIKEASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLASKNCVHRDLAARNV  268 (400)
T ss_pred             chhhhhhhhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChHhE
Confidence                                                       2367788899999999999999999999999999999


Q ss_pred             eecCCCcEEEeeccceeeccCCCc---cccCCCCcccccccccCCCCCCChhhHHHHHHHHHHHHc-CCCCCCCCCHHHH
Q 015868          246 LMDENGVVKVADFGVARVQAQSGV---MTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLT-GELPYAGLTPLQA  321 (399)
Q Consensus       246 Ll~~~~~vkl~DFG~a~~~~~~~~---~~~~~gt~~y~aPE~l~~~~~~~~~Dv~slG~vl~ellt-g~~P~~~~~~~~~  321 (399)
                      +++.++.+||+|||+++.......   .....++..|+|||.+.+..++.++||||||+++|+|++ |..||........
T Consensus       269 ll~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt~g~~P~~~~~~~~~  348 (400)
T cd05105         269 LLAQGKIVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFSLGGTPYPGMIVDST  348 (400)
T ss_pred             EEeCCCEEEEEeCCcceeccccccccccCCcCCCcceEChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCcccchhHH
Confidence            999999999999999986543222   122346778999999999999999999999999999997 9999988766555


Q ss_pred             HHHHHhccCCCCCCCCCcHHHHHHHHHHhhhcCCCCCCHHHHHHHHHHHHH
Q 015868          322 AVGVVQKSLRPTIPKHAHPRLAELLERCWQHDPTQRPNFSQITDILKQMMK  372 (399)
Q Consensus       322 ~~~~~~~~~~~~~~~~~~~~l~~ll~~cl~~dP~~Rps~~ell~~L~~l~~  372 (399)
                      ....+....++..+..++.++.+++.+||+.+|++||++.++.+.|+++++
T Consensus       349 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~l~~l~~  399 (400)
T cd05105         349 FYNKIKSGYRMAKPDHATQEVYDIMVKCWNSEPEKRPSFLHLSDIVESLLP  399 (400)
T ss_pred             HHHHHhcCCCCCCCccCCHHHHHHHHHHCccCHhHCcCHHHHHHHHHHHcC
Confidence            555566666677778899999999999999999999999999999998753

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-

>cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.5e-44  Score=348.83  Aligned_cols=248  Identities=24%  Similarity=0.402  Sum_probs=213.7

Q ss_pred             cccceeceeceeCceEEEEEEE--CCeeEEEEEecCCCC-CHHHHHHHHHHHHHHHhcCCCceeeEEeEEecCCcEEEEE
Q 015868          116 KQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECV-NTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVT  192 (399)
Q Consensus       116 ~~~~i~~~lg~G~~g~Vy~~~~--~~~~vAvK~~~~~~~-~~~~~~~~~~Ei~~l~~l~h~nIv~~~~~~~~~~~~~lV~  192 (399)
                      ++|++.++||+|+||.||+|++  +++.||+|+++.... .......+.+|+.+++.++||||+++++++..+...|+||
T Consensus         1 ~~y~~~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~   80 (333)
T cd05600           1 KDFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYAFQDDEYLYLAM   80 (333)
T ss_pred             CCcEEEEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCCCCCCccEEEEEEcCCEEEEEE
Confidence            4789999999999999999987  578999999975422 2334567889999999999999999999999999999999


Q ss_pred             ecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceeecCCCcEEEeeccceeeccCCCcccc
Q 015868          193 EFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTA  272 (399)
Q Consensus       193 E~~~ggsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~giiHrDlkp~NILl~~~~~vkl~DFG~a~~~~~~~~~~~  272 (399)
                      ||++|++|.+++.. .+.+++..+..++.|++.||.|||++||+||||||+||+++.++.+||+|||+++....  ....
T Consensus        81 e~~~g~~L~~~l~~-~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kL~Dfg~a~~~~~--~~~~  157 (333)
T cd05600          81 EYVPGGDFRTLLNN-LGVLSEDHARFYMAEMFEAVDALHELGYIHRDLKPENFLIDASGHIKLTDFGLSKGIVT--YANS  157 (333)
T ss_pred             eCCCCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECCCCCEEEEeCcCCccccc--ccCC
Confidence            99999999999975 45789999999999999999999999999999999999999999999999999975543  2344


Q ss_pred             CCCCcccccccccCCCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhccC---CCCCC---CCCcHHHHHHH
Q 015868          273 ETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKSL---RPTIP---KHAHPRLAELL  346 (399)
Q Consensus       273 ~~gt~~y~aPE~l~~~~~~~~~Dv~slG~vl~elltg~~P~~~~~~~~~~~~~~~~~~---~~~~~---~~~~~~l~~ll  346 (399)
                      ..||+.|+|||.+.+..++.++|||||||++|+|++|..||...++.+..........   .|...   ..+++++.+++
T Consensus       158 ~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~s~~~~~li  237 (333)
T cd05600         158 VVGSPDYMAPEVLRGKGYDFTVDYWSLGCMLYEFLCGFPPFSGSTPNETWENLKYWKETLQRPVYDDPRFNLSDEAWDLI  237 (333)
T ss_pred             cccCccccChhHhcCCCCCCccceecchHHHhhhhhCCCCCCCCCHHHHHHHHHhccccccCCCCCccccccCHHHHHHH
Confidence            5789999999999999999999999999999999999999998887765554433221   12111   24689999999


Q ss_pred             HHHhhhcCCCCCCHHHHHHH
Q 015868          347 ERCWQHDPTQRPNFSQITDI  366 (399)
Q Consensus       347 ~~cl~~dP~~Rps~~ell~~  366 (399)
                      .+||..+|.+||++.++++.
T Consensus       238 ~~~l~~~~~rr~s~~~ll~h  257 (333)
T cd05600         238 TKLINDPSRRFGSLEDIKNH  257 (333)
T ss_pred             HHHhhChhhhcCCHHHHHhC
Confidence            99999999999999999863

Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis.

>cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors

Probab=100.00  E-value=7.3e-44  Score=336.73  Aligned_cols=255  Identities=31%  Similarity=0.634  Sum_probs=220.2

Q ss_pred             ecccccceeceeceeCceEEEEEEECC-------eeEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCceeeEEeEEecC
Q 015868          113 IDAKQLKIECKVASGSYGDLYKGTYCS-------QEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRP  185 (399)
Q Consensus       113 i~~~~~~i~~~lg~G~~g~Vy~~~~~~-------~~vAvK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~nIv~~~~~~~~~  185 (399)
                      ++.++|++.+.||.|+||.||+|...+       ..||+|.++... .......+.+|+.+++.++||||+++++++...
T Consensus         2 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~-~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~   80 (283)
T cd05048           2 IPLSAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENA-EPKVQQEFRQEAELMSDLQHPNIVCLLGVCTKE   80 (283)
T ss_pred             CChHHcchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCC-CHHHHHHHHHHHHHHHhcCCcccceEEEEEcCC
Confidence            456789999999999999999998633       569999987543 345567799999999999999999999999998


Q ss_pred             CcEEEEEecCCCCCHHHHHHhcC---------------CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceeecCC
Q 015868          186 PNLCIVTEFMARGSIYDFLHKQK---------------GVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDEN  250 (399)
Q Consensus       186 ~~~~lV~E~~~ggsL~~~l~~~~---------------~~l~~~~~~~i~~~i~~~L~~LH~~giiHrDlkp~NILl~~~  250 (399)
                      ...+++|||+++++|.+++....               ..+++..++.++.|++.||.|||++|++|+||||+||+++++
T Consensus        81 ~~~~~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~~~i~H~dlkp~Nil~~~~  160 (283)
T cd05048          81 QPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSSHHFVHRDLAARNCLVGEG  160 (283)
T ss_pred             CceEEEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccccceEEEcCC
Confidence            89999999999999999997532               457889999999999999999999999999999999999999


Q ss_pred             CcEEEeeccceeeccCCC---ccccCCCCcccccccccCCCCCCChhhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHH
Q 015868          251 GVVKVADFGVARVQAQSG---VMTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLT-GELPYAGLTPLQAAVGVV  326 (399)
Q Consensus       251 ~~vkl~DFG~a~~~~~~~---~~~~~~gt~~y~aPE~l~~~~~~~~~Dv~slG~vl~ellt-g~~P~~~~~~~~~~~~~~  326 (399)
                      +.++|+|||+++......   ......+++.|+|||.+.+..++.++||||||+++|||++ |..||.+.++.+.... +
T Consensus       161 ~~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~slG~il~el~~~g~~p~~~~~~~~~~~~-i  239 (283)
T cd05048         161 LTVKISDFGLSRDIYSADYYRVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQPYYGFSNQEVIEM-I  239 (283)
T ss_pred             CcEEECCCcceeeccccccccccCCCcccccccCHHHhccCcCchhhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH-H
Confidence            999999999997643322   1233456788999999998889999999999999999998 9999998887665444 4


Q ss_pred             hccCCCCCCCCCcHHHHHHHHHHhhhcCCCCCCHHHHHHHHHH
Q 015868          327 QKSLRPTIPKHAHPRLAELLERCWQHDPTQRPNFSQITDILKQ  369 (399)
Q Consensus       327 ~~~~~~~~~~~~~~~l~~ll~~cl~~dP~~Rps~~ell~~L~~  369 (399)
                      .....+..+..+++++.+++.+||+.||.+||++.++++.|+.
T Consensus       240 ~~~~~~~~~~~~~~~~~~l~~~c~~~~p~~Rp~~~~i~~~l~~  282 (283)
T cd05048         240 RSRQLLPCPEDCPARVYALMIECWNEIPARRPRFKDIHTRLRS  282 (283)
T ss_pred             HcCCcCCCcccCCHHHHHHHHHHccCChhhCcCHHHHHHHHhc
Confidence            4455566788899999999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer

>cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B

Probab=100.00  E-value=1.9e-44  Score=348.35  Aligned_cols=241  Identities=24%  Similarity=0.449  Sum_probs=209.3

Q ss_pred             ceeceeCceEEEEEEE--CCeeEEEEEecCCC-CCHHHHHHHHHHHHHHHhcCCCceeeEEeEEecCCcEEEEEecCCCC
Q 015868          122 CKVASGSYGDLYKGTY--CSQEVAIKVLKPEC-VNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVTEFMARG  198 (399)
Q Consensus       122 ~~lg~G~~g~Vy~~~~--~~~~vAvK~~~~~~-~~~~~~~~~~~Ei~~l~~l~h~nIv~~~~~~~~~~~~~lV~E~~~gg  198 (399)
                      +.||+|+||.||+++.  +++.||+|+++... ........+.+|+.++++++||||+++++++..+..+|+||||++++
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~   80 (323)
T cd05571           1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYSFQTHDRLCFVMEYANGG   80 (323)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCCEEEEEEcCCEEEEEEeCCCCC
Confidence            3689999999999986  57899999997542 23344567889999999999999999999999999999999999999


Q ss_pred             CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceeecCCCcEEEeeccceeeccCC-CccccCCCCc
Q 015868          199 SIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQS-GVMTAETGTY  277 (399)
Q Consensus       199 sL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~giiHrDlkp~NILl~~~~~vkl~DFG~a~~~~~~-~~~~~~~gt~  277 (399)
                      +|.+++.. .+.+++..+..++.||+.||+|||++||+||||||+||+++.++.+||+|||+++..... .......||+
T Consensus        81 ~L~~~l~~-~~~~~~~~~~~~~~qi~~~L~~lH~~~ivHrDlkp~NIll~~~~~~kl~DfG~a~~~~~~~~~~~~~~gt~  159 (323)
T cd05571          81 ELFFHLSR-ERVFSEDRARFYGAEIVSALGYLHSCDVVYRDLKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGTP  159 (323)
T ss_pred             cHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHEEECCCCCEEEeeCCCCcccccCCCcccceecCc
Confidence            99999976 467899999999999999999999999999999999999999999999999998753322 2234456899


Q ss_pred             ccccccccCCCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhccCCCCCCCCCcHHHHHHHHHHhhhcCCCC
Q 015868          278 RWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRLAELLERCWQHDPTQR  357 (399)
Q Consensus       278 ~y~aPE~l~~~~~~~~~Dv~slG~vl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~cl~~dP~~R  357 (399)
                      .|+|||++.+..++.++|||||||++|+|++|..||...+...........  ...+|..+++++.++|.+||+.||++|
T Consensus       160 ~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~~~~~--~~~~p~~~~~~~~~li~~~L~~dP~~R  237 (323)
T cd05571         160 EYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILME--EIRFPRTLSPEAKSLLAGLLKKDPKQR  237 (323)
T ss_pred             cccChhhhcCCCCCccccCcccchhhhhhhcCCCCCCCCCHHHHHHHHHcC--CCCCCCCCCHHHHHHHHHHccCCHHHc
Confidence            999999999999999999999999999999999999887776655544432  346778899999999999999999999


Q ss_pred             C-----CHHHHHH
Q 015868          358 P-----NFSQITD  365 (399)
Q Consensus       358 p-----s~~ell~  365 (399)
                      |     ++.++++
T Consensus       238 ~~~~~~~~~~ll~  250 (323)
T cd05571         238 LGGGPEDAKEIME  250 (323)
T ss_pred             CCCCCCCHHHHHc
Confidence            9     7888865

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be

>cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta

Probab=100.00  E-value=1.8e-43  Score=350.83  Aligned_cols=262  Identities=32%  Similarity=0.623  Sum_probs=227.2

Q ss_pred             CceeecccccceeceeceeCceEEEEEEEC-------CeeEEEEEecCCCCCHHHHHHHHHHHHHHHhcC-CCceeeEEe
Q 015868          109 DVWEIDAKQLKIECKVASGSYGDLYKGTYC-------SQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIR-HKNVVQFIG  180 (399)
Q Consensus       109 ~~~~i~~~~~~i~~~lg~G~~g~Vy~~~~~-------~~~vAvK~~~~~~~~~~~~~~~~~Ei~~l~~l~-h~nIv~~~~  180 (399)
                      ..|++..++|.+.++||+|+||.||+|++.       ++.||+|+++... .......+.+|+.+|.++. ||||+++++
T Consensus        30 ~~~~~~~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~-~~~~~~~~~~E~~~l~~l~~H~niv~~~~  108 (401)
T cd05107          30 SAWEMPRDNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTA-RSSEKQALMSELKIMSHLGPHLNIVNLLG  108 (401)
T ss_pred             CcceecHHHeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCC-ChhHHHHHHHHHHHHHhcCCCCCeEEEEE
Confidence            459999999999999999999999999864       3579999998653 3334457889999999997 999999999


Q ss_pred             EEecCCcEEEEEecCCCCCHHHHHHhcC----------------------------------------------------
Q 015868          181 ACTRPPNLCIVTEFMARGSIYDFLHKQK----------------------------------------------------  208 (399)
Q Consensus       181 ~~~~~~~~~lV~E~~~ggsL~~~l~~~~----------------------------------------------------  208 (399)
                      ++......++||||+++|+|.++++...                                                    
T Consensus       109 ~~~~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  188 (401)
T cd05107         109 ACTKGGPIYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESAD  188 (401)
T ss_pred             EEccCCCcEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccccC
Confidence            9999999999999999999999996532                                                    


Q ss_pred             ---------------------------------------------CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCC
Q 015868          209 ---------------------------------------------GVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTA  243 (399)
Q Consensus       209 ---------------------------------------------~~l~~~~~~~i~~~i~~~L~~LH~~giiHrDlkp~  243 (399)
                                                                   ..++...+..++.|++.||+|||+++++||||||+
T Consensus       189 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrdlkp~  268 (401)
T cd05107         189 YVPMQDMKGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLASKNCVHRDLAAR  268 (401)
T ss_pred             ccchhcchhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCcCcccCCcc
Confidence                                                         13566778899999999999999999999999999


Q ss_pred             ceeecCCCcEEEeeccceeeccCCCc---cccCCCCcccccccccCCCCCCChhhHHHHHHHHHHHHc-CCCCCCCCCHH
Q 015868          244 NLLMDENGVVKVADFGVARVQAQSGV---MTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLT-GELPYAGLTPL  319 (399)
Q Consensus       244 NILl~~~~~vkl~DFG~a~~~~~~~~---~~~~~gt~~y~aPE~l~~~~~~~~~Dv~slG~vl~ellt-g~~P~~~~~~~  319 (399)
                      |||+++++.+||+|||+++.......   .....++..|+|||.+.+..++.++||||||+++|||++ |..||......
T Consensus       269 NiLl~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~e~l~~g~~P~~~~~~~  348 (401)
T cd05107         269 NVLICEGKLVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFTLGGTPYPELPMN  348 (401)
T ss_pred             eEEEeCCCEEEEEecCcceecccccccccCCCcCCCCceeChHHhcCCCCCcHhHHHHHHHHHHHHHHcCCCCCCCCCch
Confidence            99999999999999999986433221   122346788999999998889999999999999999998 89999887776


Q ss_pred             HHHHHHHhccCCCCCCCCCcHHHHHHHHHHhhhcCCCCCCHHHHHHHHHHHH
Q 015868          320 QAAVGVVQKSLRPTIPKHAHPRLAELLERCWQHDPTQRPNFSQITDILKQMM  371 (399)
Q Consensus       320 ~~~~~~~~~~~~~~~~~~~~~~l~~ll~~cl~~dP~~Rps~~ell~~L~~l~  371 (399)
                      +.....+....++..|..++.++.+++.+||..+|.+||++.+|++.|++++
T Consensus       349 ~~~~~~~~~~~~~~~p~~~~~~l~~li~~cl~~~P~~RPs~~ell~~L~~~~  400 (401)
T cd05107         349 EQFYNAIKRGYRMAKPAHASDEIYEIMQKCWEEKFEIRPDFSQLVHLVGDLL  400 (401)
T ss_pred             HHHHHHHHcCCCCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHh
Confidence            6666666777777788889999999999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D

>cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn

Probab=100.00  E-value=1.3e-43  Score=331.22  Aligned_cols=255  Identities=33%  Similarity=0.685  Sum_probs=221.1

Q ss_pred             eeecccccceeceeceeCceEEEEEEE-CCeeEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCceeeEEeEEecCCcEE
Q 015868          111 WEIDAKQLKIECKVASGSYGDLYKGTY-CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLC  189 (399)
Q Consensus       111 ~~i~~~~~~i~~~lg~G~~g~Vy~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~nIv~~~~~~~~~~~~~  189 (399)
                      |.|..++|++.++||+|+||.||+|.. .+..||+|.+....   ...+.+.+|+.+++.++|+||+++++.+......+
T Consensus         1 ~~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~v~iK~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~   77 (261)
T cd05072           1 WEIPRESIKLVKKLGAGQFGEVWMGYYNNSTKVAVKTLKPGT---MSVQAFLEEANLMKTLQHDKLVRLYAVVTKEEPIY   77 (261)
T ss_pred             CcCchHHeEEeeecCCcCCceEEEEEecCCceEEEEEccCCc---hhHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCcE
Confidence            678899999999999999999999987 45679999987542   23467899999999999999999999999999999


Q ss_pred             EEEecCCCCCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceeecCCCcEEEeeccceeeccCCC
Q 015868          190 IVTEFMARGSIYDFLHKQ-KGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSG  268 (399)
Q Consensus       190 lV~E~~~ggsL~~~l~~~-~~~l~~~~~~~i~~~i~~~L~~LH~~giiHrDlkp~NILl~~~~~vkl~DFG~a~~~~~~~  268 (399)
                      ++|||+++++|.+++... ...+++..+..++.|++.||+|||+++++||||||+||++++++.++|+|||.++......
T Consensus        78 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~LH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~  157 (261)
T cd05072          78 IITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIERKNYIHRDLRAANVLVSESLMCKIADFGLARVIEDNE  157 (261)
T ss_pred             EEEecCCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhhEEecCCCcEEECCCccceecCCCc
Confidence            999999999999999764 3568889999999999999999999999999999999999999999999999998654432


Q ss_pred             c--cccCCCCcccccccccCCCCCCChhhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHHhccCCCCCCCCCcHHHHHH
Q 015868          269 V--MTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLT-GELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRLAEL  345 (399)
Q Consensus       269 ~--~~~~~gt~~y~aPE~l~~~~~~~~~Dv~slG~vl~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l  345 (399)
                      .  .....++..|+|||.+.+..++.++||||||+++|+|++ |..||...+..+..... ....+.+.+..++.++.++
T Consensus       158 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~l  236 (261)
T cd05072         158 YTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLYEIVTYGKIPYPGMSNSDVMSAL-QRGYRMPRMENCPDELYDI  236 (261)
T ss_pred             eeccCCCccceecCCHHHhccCCCChhhhhhhhHHHHHHHHccCCCCCCCCCHHHHHHHH-HcCCCCCCCCCCCHHHHHH
Confidence            2  122345678999999998889999999999999999998 99999888776655443 3344555556788999999


Q ss_pred             HHHHhhhcCCCCCCHHHHHHHHHH
Q 015868          346 LERCWQHDPTQRPNFSQITDILKQ  369 (399)
Q Consensus       346 l~~cl~~dP~~Rps~~ell~~L~~  369 (399)
                      +.+||..+|++||+++++.+.|++
T Consensus       237 i~~~l~~~p~~Rp~~~~i~~~l~~  260 (261)
T cd05072         237 MKTCWKEKAEERPTFDYLQSVLDD  260 (261)
T ss_pred             HHHHccCCcccCcCHHHHHHHHhc
Confidence            999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa

>cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase

Probab=100.00  E-value=1.8e-43  Score=329.38  Aligned_cols=250  Identities=32%  Similarity=0.636  Sum_probs=216.3

Q ss_pred             cccccceeceeceeCceEEEEEEECC-eeEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCceeeEEeEEecCCcEEEEE
Q 015868          114 DAKQLKIECKVASGSYGDLYKGTYCS-QEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVT  192 (399)
Q Consensus       114 ~~~~~~i~~~lg~G~~g~Vy~~~~~~-~~vAvK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~nIv~~~~~~~~~~~~~lV~  192 (399)
                      +.++|++.+.||+|+||.||++++.. ..+|+|.++.....   ...+.+|+.+++.++||||+++++++......++||
T Consensus         2 ~~~~~~~~~~lg~G~~~~vy~~~~~~~~~~a~K~~~~~~~~---~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~   78 (256)
T cd05114           2 NPSELTFMKELGSGQFGVVHLGKWRAQIKVAIKAINEGAMS---EEDFIEEAKVMMKLSHPKLVQLYGVCTQQKPLYIVT   78 (256)
T ss_pred             CHHHcEEeeEecCCcCceEEEEEeccCceEEEEecccCCcc---HHHHHHHHHHHHHCCCCCceeEEEEEccCCCEEEEE
Confidence            45789999999999999999998854 58999998754322   356889999999999999999999999999999999


Q ss_pred             ecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceeecCCCcEEEeeccceeeccCCCc--c
Q 015868          193 EFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGV--M  270 (399)
Q Consensus       193 E~~~ggsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~giiHrDlkp~NILl~~~~~vkl~DFG~a~~~~~~~~--~  270 (399)
                      ||+++|+|.+++....+.+++..++.++.|++.||+|||++||+||||+|+||++++++.+||+|||.++.......  .
T Consensus        79 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~i~~~~~~kl~d~g~~~~~~~~~~~~~  158 (256)
T cd05114          79 EFMENGCLLNYLRQRQGKLSKDMLLSMCQDVCEGMEYLERNSFIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDEYTSS  158 (256)
T ss_pred             EcCCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCCccccccCcceEEEcCCCeEEECCCCCccccCCCceecc
Confidence            99999999999987666789999999999999999999999999999999999999999999999999875433221  1


Q ss_pred             ccCCCCcccccccccCCCCCCChhhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHHhccCCCCCCCCCcHHHHHHHHHH
Q 015868          271 TAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLT-GELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRLAELLERC  349 (399)
Q Consensus       271 ~~~~gt~~y~aPE~l~~~~~~~~~Dv~slG~vl~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~c  349 (399)
                      ....++..|+|||.+.+..++.++|+||||+++|+|++ |+.||...+..+....+.+ ..++..|...+.++.+++.+|
T Consensus       159 ~~~~~~~~y~aPE~~~~~~~~~~~Di~s~G~~l~el~~~g~~p~~~~~~~~~~~~i~~-~~~~~~~~~~~~~~~~li~~c  237 (256)
T cd05114         159 SGAKFPVKWSPPEVFNFSKYSSKSDVWSFGVLMWEVFTEGKMPFEKKSNYEVVEMISR-GFRLYRPKLASMTVYEVMYSC  237 (256)
T ss_pred             CCCCCchhhCChhhcccCccchhhhhHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHC-CCCCCCCCCCCHHHHHHHHHH
Confidence            22245678999999998899999999999999999999 9999998887766555443 445556777889999999999


Q ss_pred             hhhcCCCCCCHHHHHHHH
Q 015868          350 WQHDPTQRPNFSQITDIL  367 (399)
Q Consensus       350 l~~dP~~Rps~~ell~~L  367 (399)
                      |+.+|++||++.++++.|
T Consensus       238 ~~~~p~~Rps~~~l~~~l  255 (256)
T cd05114         238 WHEKPEGRPTFAELLRAI  255 (256)
T ss_pred             ccCCcccCcCHHHHHHhh
Confidence            999999999999999876

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h

>cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase

Probab=100.00  E-value=1.8e-43  Score=330.92  Aligned_cols=256  Identities=37%  Similarity=0.738  Sum_probs=222.5

Q ss_pred             eeecccccceeceeceeCceEEEEEEE--CCeeEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCceeeEEeEEecCCcE
Q 015868          111 WEIDAKQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNL  188 (399)
Q Consensus       111 ~~i~~~~~~i~~~lg~G~~g~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~nIv~~~~~~~~~~~~  188 (399)
                      |+++..+|.+.++||.|+||.||+|.+  .++.||+|+++..   ......+.+|+.+++.++||||+++++++.....+
T Consensus         1 ~~~~~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~   77 (263)
T cd05052           1 WEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED---TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPF   77 (263)
T ss_pred             CCCchHHeEEeeecCCcccceEEEEEEecCCceEEEEEecCC---chHHHHHHHHHHHHHhCCCCChhheEEEEcCCCCc
Confidence            678888999999999999999999987  4788999998754   23356788999999999999999999999999999


Q ss_pred             EEEEecCCCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceeecCCCcEEEeeccceeeccCC
Q 015868          189 CIVTEFMARGSIYDFLHKQK-GVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQS  267 (399)
Q Consensus       189 ~lV~E~~~ggsL~~~l~~~~-~~l~~~~~~~i~~~i~~~L~~LH~~giiHrDlkp~NILl~~~~~vkl~DFG~a~~~~~~  267 (399)
                      ++||||+++++|.+++.... ..++...+..++.|++.||+|||++|++||||||+||++++++.+||+|||.+......
T Consensus        78 ~lv~e~~~~~~L~~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~nil~~~~~~~kl~df~~~~~~~~~  157 (263)
T cd05052          78 YIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGD  157 (263)
T ss_pred             EEEEEeCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccCcceEEEcCCCcEEeCCCccccccccc
Confidence            99999999999999997643 46899999999999999999999999999999999999999999999999999765433


Q ss_pred             Ccc--ccCCCCcccccccccCCCCCCChhhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHHhccCCCCCCCCCcHHHHH
Q 015868          268 GVM--TAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLT-GELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRLAE  344 (399)
Q Consensus       268 ~~~--~~~~gt~~y~aPE~l~~~~~~~~~Dv~slG~vl~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~  344 (399)
                      ...  ....++..|+|||.+.+..++.++||||||+++|+|++ |..||.+.+..+... .......+..+..++.++.+
T Consensus       158 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~  236 (263)
T cd05052         158 TYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYE-LLEKGYRMERPEGCPPKVYE  236 (263)
T ss_pred             eeeccCCCCCccccCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH-HHHCCCCCCCCCCCCHHHHH
Confidence            211  11223568999999999999999999999999999998 999998877655443 34455667778889999999


Q ss_pred             HHHHHhhhcCCCCCCHHHHHHHHHHH
Q 015868          345 LLERCWQHDPTQRPNFSQITDILKQM  370 (399)
Q Consensus       345 ll~~cl~~dP~~Rps~~ell~~L~~l  370 (399)
                      ++.+||+.+|++||++.++++.|+++
T Consensus       237 li~~cl~~~p~~Rp~~~~l~~~l~~~  262 (263)
T cd05052         237 LMRACWQWNPSDRPSFAEIHQAFETM  262 (263)
T ss_pred             HHHHHccCCcccCCCHHHHHHHHHhh
Confidence            99999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays

>PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional

Probab=100.00  E-value=4.5e-44  Score=348.30  Aligned_cols=250  Identities=26%  Similarity=0.410  Sum_probs=217.2

Q ss_pred             eeecccccceeceeceeCceEEEEEEECC---eeEEEEEecCCC-CCHHHHHHHHHHHHHHHhcCCCceeeEEeEEecCC
Q 015868          111 WEIDAKQLKIECKVASGSYGDLYKGTYCS---QEVAIKVLKPEC-VNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPP  186 (399)
Q Consensus       111 ~~i~~~~~~i~~~lg~G~~g~Vy~~~~~~---~~vAvK~~~~~~-~~~~~~~~~~~Ei~~l~~l~h~nIv~~~~~~~~~~  186 (399)
                      ..+..++|++.+.||.|+||.||+|.+.+   ..||+|++.... ........+.+|+.+++.++||||+++++++..+.
T Consensus        25 ~~~~~~~y~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~  104 (340)
T PTZ00426         25 NKMKYEDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFKDES  104 (340)
T ss_pred             CCCChhhcEEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCCcceEEEEEeCC
Confidence            45667899999999999999999998632   579999986432 23344567889999999999999999999999999


Q ss_pred             cEEEEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceeecCCCcEEEeeccceeeccC
Q 015868          187 NLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQ  266 (399)
Q Consensus       187 ~~~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~giiHrDlkp~NILl~~~~~vkl~DFG~a~~~~~  266 (399)
                      .+|+||||+.||+|.+++.. ...+++..+..++.|++.||.|||++||+||||||+|||++.++.+||+|||+++....
T Consensus       105 ~~~lv~Ey~~~g~L~~~i~~-~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~~~ikL~DFG~a~~~~~  183 (340)
T PTZ00426        105 YLYLVLEFVIGGEFFTFLRR-NKRFPNDVGCFYAAQIVLIFEYLQSLNIVYRDLKPENLLLDKDGFIKMTDFGFAKVVDT  183 (340)
T ss_pred             EEEEEEeCCCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCeEccCCCHHHEEECCCCCEEEecCCCCeecCC
Confidence            99999999999999999976 45789999999999999999999999999999999999999999999999999986543


Q ss_pred             CCccccCCCCcccccccccCCCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhccCCCCCCCCCcHHHHHHH
Q 015868          267 SGVMTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRLAELL  346 (399)
Q Consensus       267 ~~~~~~~~gt~~y~aPE~l~~~~~~~~~Dv~slG~vl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll  346 (399)
                      .  .....||+.|+|||++.+..++.++|||||||++|+|++|..||...++......+...  ...+|..+++.+.+++
T Consensus       184 ~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~~~i~~~--~~~~p~~~~~~~~~li  259 (340)
T PTZ00426        184 R--TYTLCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPPFYANEPLLIYQKILEG--IIYFPKFLDNNCKHLM  259 (340)
T ss_pred             C--cceecCChhhcCHHHHhCCCCCccccccchhhHHHHHhcCCCCCCCCCHHHHHHHHhcC--CCCCCCCCCHHHHHHH
Confidence            2  23457899999999999988999999999999999999999999988877655555443  2346778899999999


Q ss_pred             HHHhhhcCCCCC-----CHHHHHH
Q 015868          347 ERCWQHDPTQRP-----NFSQITD  365 (399)
Q Consensus       347 ~~cl~~dP~~Rp-----s~~ell~  365 (399)
                      .+||+.||++|+     +++++++
T Consensus       260 ~~~l~~dp~~R~~~~~~~~~~~~~  283 (340)
T PTZ00426        260 KKLLSHDLTKRYGNLKKGAQNVKE  283 (340)
T ss_pred             HHHcccCHHHcCCCCCCCHHHHHc
Confidence            999999999995     7888866

>KOG0589 consensus Serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=1e-44  Score=350.41  Aligned_cols=251  Identities=24%  Similarity=0.442  Sum_probs=231.8

Q ss_pred             ccccceeceeceeCceEEEEEEE--CCeeEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCceeeEEeEEecCCc-EEEE
Q 015868          115 AKQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPN-LCIV  191 (399)
Q Consensus       115 ~~~~~i~~~lg~G~~g~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~nIv~~~~~~~~~~~-~~lV  191 (399)
                      .+.|...+++|.|+||.+++.++  .++.+++|.+..........+...+|+.+++++.|||||.+.+.|..++. .|||
T Consensus         3 m~~Ye~~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t~~~r~~A~~E~~lis~~~hP~iv~y~ds~~~~~~~l~Iv   82 (426)
T KOG0589|consen    3 MDNYEVLRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLTEPERRSAIQEMDLLSKLLHPNIVEYKDSFEEDGQLLCIV   82 (426)
T ss_pred             cchhhhhhhcCccccchhhhhhhccCCceEEEEEEeccccCchhhHHHHHHHHHHHhccCCCeeeeccchhcCCceEEEE
Confidence            35789999999999999988765  56789999999888788888899999999999999999999999998888 9999


Q ss_pred             EecCCCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceeecCCCcEEEeeccceeeccCCC-c
Q 015868          192 TEFMARGSIYDFLHKQK-GVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSG-V  269 (399)
Q Consensus       192 ~E~~~ggsL~~~l~~~~-~~l~~~~~~~i~~~i~~~L~~LH~~giiHrDlkp~NILl~~~~~vkl~DFG~a~~~~~~~-~  269 (399)
                      |+|++||++.+.|.+++ ..+++..+..|+.|++.|+.|||+++|.|||||+.||+++.++.|+|+|||+|+...... .
T Consensus        83 m~Y~eGg~l~~~i~~~k~~~f~E~~i~~~~~Q~~~av~ylH~~~iLHRDlK~~Nifltk~~~VkLgDfGlaK~l~~~~~~  162 (426)
T KOG0589|consen   83 MEYCEGGDLAQLIKEQKGVLFPEERILKWFVQILLAVNYLHENRVLHRDLKCANIFLTKDKKVKLGDFGLAKILNPEDSL  162 (426)
T ss_pred             EeecCCCCHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHhhhhhcccchhhhhhccccCceeecchhhhhhcCCchhh
Confidence            99999999999998876 679999999999999999999999999999999999999999999999999999877765 5


Q ss_pred             cccCCCCcccccccccCCCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhccCCCCCCCCCcHHHHHHHHHH
Q 015868          270 MTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRLAELLERC  349 (399)
Q Consensus       270 ~~~~~gt~~y~aPE~l~~~~~~~~~Dv~slG~vl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~c  349 (399)
                      .....||+.||+||.+.+.+|..|+|||||||++|||++-+++|...+.......+.+.. ..++|..++.+++.++..|
T Consensus       163 a~tvvGTp~YmcPEil~d~pYn~KSDiWsLGC~~yEm~~lk~aF~a~~m~~Li~ki~~~~-~~Plp~~ys~el~~lv~~~  241 (426)
T KOG0589|consen  163 ASTVVGTPYYMCPEILSDIPYNEKSDIWSLGCCLYEMCTLKPAFKASNMSELILKINRGL-YSPLPSMYSSELRSLVKSM  241 (426)
T ss_pred             hheecCCCcccCHHHhCCCCCCccCcchhhcchHHHHHhcccccCccchHHHHHHHhhcc-CCCCCccccHHHHHHHHHH
Confidence            566789999999999999999999999999999999999999999999888887776654 6678999999999999999


Q ss_pred             hhhcCCCCCCHHHHHHH
Q 015868          350 WQHDPTQRPNFSQITDI  366 (399)
Q Consensus       350 l~~dP~~Rps~~ell~~  366 (399)
                      +..+|+.||++.+++..
T Consensus       242 l~~~P~~RPsa~~LL~~  258 (426)
T KOG0589|consen  242 LRKNPEHRPSALELLRR  258 (426)
T ss_pred             hhcCCccCCCHHHHhhC
Confidence            99999999999999986

>cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor

Probab=100.00  E-value=1.7e-43  Score=340.43  Aligned_cols=259  Identities=29%  Similarity=0.585  Sum_probs=221.7

Q ss_pred             ecccccceeceeceeCceEEEEEEE--CCe----eEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCceeeEEeEEecCC
Q 015868          113 IDAKQLKIECKVASGSYGDLYKGTY--CSQ----EVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPP  186 (399)
Q Consensus       113 i~~~~~~i~~~lg~G~~g~Vy~~~~--~~~----~vAvK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~nIv~~~~~~~~~~  186 (399)
                      +...+|++.+.||+|+||.||+|++  .+.    .||+|+++... .....+++.+|+.+++.++||||+++++++... 
T Consensus         4 ~~~~~f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~~-   81 (316)
T cd05108           4 LKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREAT-SPKANKEILDEAYVMASVDNPHVCRLLGICLTS-   81 (316)
T ss_pred             cchhhceeeeeeecCCCceEEEEEEecCCCccceeEEEEeccccC-CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEcCC-
Confidence            4567899999999999999999986  333    48999987542 345567899999999999999999999999875 


Q ss_pred             cEEEEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceeecCCCcEEEeeccceeeccC
Q 015868          187 NLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQ  266 (399)
Q Consensus       187 ~~~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~giiHrDlkp~NILl~~~~~vkl~DFG~a~~~~~  266 (399)
                      ..++|+||+.+|+|.+++......++...++.++.||+.||+|||++||+||||||+||+++.++.+||+|||+++....
T Consensus        82 ~~~~v~e~~~~g~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~iiH~dlkp~Nill~~~~~~kl~DfG~a~~~~~  161 (316)
T cd05108          82 TVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEERRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGA  161 (316)
T ss_pred             CceeeeecCCCCCHHHHHHhccccCCHHHHHHHHHHHHHHHHHHHhcCeeccccchhheEecCCCcEEEccccccccccC
Confidence            57899999999999999988777789999999999999999999999999999999999999999999999999986543


Q ss_pred             CCcc---ccCCCCcccccccccCCCCCCChhhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHHhccCCCCCCCCCcHHH
Q 015868          267 SGVM---TAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLT-GELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRL  342 (399)
Q Consensus       267 ~~~~---~~~~gt~~y~aPE~l~~~~~~~~~Dv~slG~vl~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  342 (399)
                      ....   ....++..|+|||.+.+..++.++||||||+++|||++ |..||.+....+. .........+..+..++.++
T Consensus       162 ~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slGv~l~el~t~g~~p~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~  240 (316)
T cd05108         162 DEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEI-SSILEKGERLPQPPICTIDV  240 (316)
T ss_pred             CCcceeccCCccceeecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHHHH-HHHHhCCCCCCCCCCCCHHH
Confidence            3221   12234678999999999999999999999999999998 9999988776554 34455555666677789999


Q ss_pred             HHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHH
Q 015868          343 AELLERCWQHDPTQRPNFSQITDILKQMMKEV  374 (399)
Q Consensus       343 ~~ll~~cl~~dP~~Rps~~ell~~L~~l~~~~  374 (399)
                      .+++.+||+.+|.+||++.+++..+.++.++.
T Consensus       241 ~~li~~cl~~~p~~Rps~~~l~~~l~~~~~~~  272 (316)
T cd05108         241 YMIMVKCWMIDADSRPKFRELIIEFSKMARDP  272 (316)
T ss_pred             HHHHHHHccCChhhCcCHHHHHHHHHHHHcCC
Confidence            99999999999999999999999999887654

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor

>cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.8e-44  Score=351.63  Aligned_cols=248  Identities=24%  Similarity=0.422  Sum_probs=215.3

Q ss_pred             cccceeceeceeCceEEEEEEEC--CeeEEEEEecCCCC-CHHHHHHHHHHHHHHHhcCCCceeeEEeEEecCCcEEEEE
Q 015868          116 KQLKIECKVASGSYGDLYKGTYC--SQEVAIKVLKPECV-NTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVT  192 (399)
Q Consensus       116 ~~~~i~~~lg~G~~g~Vy~~~~~--~~~vAvK~~~~~~~-~~~~~~~~~~Ei~~l~~l~h~nIv~~~~~~~~~~~~~lV~  192 (399)
                      ++|++.+.||+|+||.||+|+..  ++.||+|+++.... .......+.+|+.+++.++||||+++++++..+...|+||
T Consensus         1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~   80 (350)
T cd05573           1 DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYYSFQDEEHLYLVM   80 (350)
T ss_pred             CCceEEEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcCCCCccchhhheecCCeEEEEE
Confidence            47899999999999999999885  88999999975422 2244567899999999999999999999999999999999


Q ss_pred             ecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceeecCCCcEEEeeccceeeccCCC----
Q 015868          193 EFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSG----  268 (399)
Q Consensus       193 E~~~ggsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~giiHrDlkp~NILl~~~~~vkl~DFG~a~~~~~~~----  268 (399)
                      ||+++++|.+++... +.+++..++.++.||+.||+|||++||+||||||+||+++.++.+||+|||+++......    
T Consensus        81 e~~~~~~L~~~l~~~-~~l~~~~~~~i~~qi~~aL~~LH~~giiH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~  159 (350)
T cd05573          81 EYMPGGDLMNLLIRK-DVFPEETARFYIAELVLALDSVHKLGFIHRDIKPDNILIDADGHIKLADFGLCKKMNKAKDREY  159 (350)
T ss_pred             cCCCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEeecCCCCccCcccCcccc
Confidence            999999999999775 779999999999999999999999999999999999999999999999999997654332    


Q ss_pred             --------------------------ccccCCCCcccccccccCCCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHH
Q 015868          269 --------------------------VMTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPYAGLTPLQAA  322 (399)
Q Consensus       269 --------------------------~~~~~~gt~~y~aPE~l~~~~~~~~~Dv~slG~vl~elltg~~P~~~~~~~~~~  322 (399)
                                                ......||+.|+|||++.+..++.++|||||||++|+|++|+.||...+..+..
T Consensus       160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~~~~~  239 (350)
T cd05573         160 YLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFPPFYSDTLQETY  239 (350)
T ss_pred             cccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCceeeEecchhhhhhccCCCCCCCCCHHHHH
Confidence                                      223446899999999999999999999999999999999999999998877766


Q ss_pred             HHHHhccCCCCCC--CCCcHHHHHHHHHHhhhcCCCCCC-HHHHHH
Q 015868          323 VGVVQKSLRPTIP--KHAHPRLAELLERCWQHDPTQRPN-FSQITD  365 (399)
Q Consensus       323 ~~~~~~~~~~~~~--~~~~~~l~~ll~~cl~~dP~~Rps-~~ell~  365 (399)
                      ..+........+|  ..+++++.++|.+||. +|.+||+ +.++++
T Consensus       240 ~~i~~~~~~~~~p~~~~~~~~~~~li~~ll~-dp~~R~~s~~~ll~  284 (350)
T cd05573         240 NKIINWKESLRFPPDPPVSPEAIDLICRLLC-DPEDRLGSFEEIKS  284 (350)
T ss_pred             HHHhccCCcccCCCCCCCCHHHHHHHHHHcc-ChhhcCCCHHHHhc
Confidence            6655522222233  3369999999999998 9999999 999987

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the

>cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase

Probab=100.00  E-value=1.6e-43  Score=336.27  Aligned_cols=249  Identities=22%  Similarity=0.360  Sum_probs=207.9

Q ss_pred             ccccceeceeceeCceEEEEEEE--CCeeEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCceeeEEeEEecCCcEEEEE
Q 015868          115 AKQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVT  192 (399)
Q Consensus       115 ~~~~~i~~~lg~G~~g~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~nIv~~~~~~~~~~~~~lV~  192 (399)
                      .++|++.++||.|+||.||+|..  +++.||+|+++.... ......+.+|+.++++++||||+++++++......++||
T Consensus         4 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~   82 (288)
T cd07871           4 LETYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHE-EGAPCTAIREVSLLKNLKHANIVTLHDIIHTERCLTLVF   82 (288)
T ss_pred             cccceEeeEEecCCCEEEEEEEECCCCCEEEEEEeccccc-CCcchhHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEEEE
Confidence            46799999999999999999977  578999999975432 222356778999999999999999999999999999999


Q ss_pred             ecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceeecCCCcEEEeeccceeeccCCC-ccc
Q 015868          193 EFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSG-VMT  271 (399)
Q Consensus       193 E~~~ggsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~giiHrDlkp~NILl~~~~~vkl~DFG~a~~~~~~~-~~~  271 (399)
                      ||+.+ +|.+++......+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+++...... ...
T Consensus        83 e~~~~-~l~~~l~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~Nil~~~~~~~kl~DfG~~~~~~~~~~~~~  161 (288)
T cd07871          83 EYLDS-DLKQYLDNCGNLMSMHNVKIFMFQLLRGLSYCHKRKILHRDLKPQNLLINEKGELKLADFGLARAKSVPTKTYS  161 (288)
T ss_pred             eCCCc-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEECcCcceeeccCCCcccc
Confidence            99986 9999997766678999999999999999999999999999999999999999999999999997643322 233


Q ss_pred             cCCCCcccccccccCC-CCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhccC--------------------
Q 015868          272 AETGTYRWMAPEVIEH-KPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKSL--------------------  330 (399)
Q Consensus       272 ~~~gt~~y~aPE~l~~-~~~~~~~Dv~slG~vl~elltg~~P~~~~~~~~~~~~~~~~~~--------------------  330 (399)
                      ...+++.|+|||.+.+ ..++.++||||+|+++|+|+||+.||.+.+..+..........                    
T Consensus       162 ~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  241 (288)
T cd07871         162 NEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTVKEELHLIFRLLGTPTEETWPGITSNEEFRSYL  241 (288)
T ss_pred             CceecccccChHHhcCCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhccccchhhhccc
Confidence            4567999999999875 5689999999999999999999999988776655443322110                    


Q ss_pred             CCC--------CCCCCcHHHHHHHHHHhhhcCCCCCCHHHHHH
Q 015868          331 RPT--------IPKHAHPRLAELLERCWQHDPTQRPNFSQITD  365 (399)
Q Consensus       331 ~~~--------~~~~~~~~l~~ll~~cl~~dP~~Rps~~ell~  365 (399)
                      .+.        .....++++.+||.+||+.||.+|||++|+++
T Consensus       242 ~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dp~~R~t~~~~l~  284 (288)
T cd07871         242 FPQYRAQPLINHAPRLDTDGIDLLSSLLLYETKSRISAEAALR  284 (288)
T ss_pred             cCccCCCchHHhCCCCCHHHHHHHHHhcCcCcccCCCHHHHhc
Confidence            000        11246789999999999999999999999974

Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament

>cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2

Probab=100.00  E-value=3.2e-43  Score=340.97  Aligned_cols=251  Identities=24%  Similarity=0.431  Sum_probs=212.0

Q ss_pred             ecccccceeceeceeCceEEEEEEE--CCeeEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCceeeEEeEEecCCcEEE
Q 015868          113 IDAKQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCI  190 (399)
Q Consensus       113 i~~~~~~i~~~lg~G~~g~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~nIv~~~~~~~~~~~~~l  190 (399)
                      +..++|++.++||.|+||.||++++  ++..+|+|+++... .......+.+|+.++++++||||+++++++...+..++
T Consensus         2 l~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l   80 (331)
T cd06649           2 LKDDDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEI-KPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISI   80 (331)
T ss_pred             CCcccceEEEeecCCCCEEEEEEEECCCCcEEEEEEeeccc-CHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEE
Confidence            4567999999999999999999988  47789999998653 34556789999999999999999999999999999999


Q ss_pred             EEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC-CcccCCCCCCceeecCCCcEEEeeccceeeccCCCc
Q 015868          191 VTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQN-NIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGV  269 (399)
Q Consensus       191 V~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~-giiHrDlkp~NILl~~~~~vkl~DFG~a~~~~~~~~  269 (399)
                      ||||+++++|.+++.. ...+++..+..++.|++.||.|||++ +|+||||||+||+++.++.+||+|||++...... .
T Consensus        81 v~e~~~~~~L~~~l~~-~~~~~~~~~~~~~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~-~  158 (331)
T cd06649          81 CMEHMDGGSLDQVLKE-AKRIPEEILGKVSIAVLRGLAYLREKHQIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS-M  158 (331)
T ss_pred             EeecCCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHhhcCCEEcCCCChhhEEEcCCCcEEEccCccccccccc-c
Confidence            9999999999999976 35689999999999999999999986 6999999999999999999999999998755432 2


Q ss_pred             cccCCCCcccccccccCCCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHH------------------------
Q 015868          270 MTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGV------------------------  325 (399)
Q Consensus       270 ~~~~~gt~~y~aPE~l~~~~~~~~~Dv~slG~vl~elltg~~P~~~~~~~~~~~~~------------------------  325 (399)
                      .....|++.|+|||.+.+..++.++|||||||++|+|++|+.||...+..+.....                        
T Consensus       159 ~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (331)
T cd06649         159 ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYPIPPPDAKELEAIFGRPVVDGEEGEPHSISPRPRPPGR  238 (331)
T ss_pred             cccCCCCcCcCCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccccccccCCccccCcccccccc
Confidence            34457899999999999999999999999999999999999999766554322111                        


Q ss_pred             ---------------------HhccCCCCCC-CCCcHHHHHHHHHHhhhcCCCCCCHHHHHHH
Q 015868          326 ---------------------VQKSLRPTIP-KHAHPRLAELLERCWQHDPTQRPNFSQITDI  366 (399)
Q Consensus       326 ---------------------~~~~~~~~~~-~~~~~~l~~ll~~cl~~dP~~Rps~~ell~~  366 (399)
                                           +....++..+ ..+++++.+||.+||+.||++|||+.++++.
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~~P~~Rpt~~ell~h  301 (331)
T cd06649         239 PVSGHGMDSRPAMAIFELLDYIVNEPPPKLPNGVFTPDFQEFVNKCLIKNPAERADLKMLMNH  301 (331)
T ss_pred             cccccccccccchhHHHHHHHHHhCCCcCCCCccccHHHHHHHHHHccCCcccCCCHHHHhcC
Confidence                                 0111122222 2468899999999999999999999999764

Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst

>KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=1.6e-44  Score=343.70  Aligned_cols=251  Identities=28%  Similarity=0.465  Sum_probs=212.5

Q ss_pred             ecccccceeceeceeCceEEEEEEE--CCeeEEEEEecCCCCCH-------H-----HHHHHHHHHHHHHhcCCCceeeE
Q 015868          113 IDAKQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVNT-------E-----MLKEFSQEVYIMRKIRHKNVVQF  178 (399)
Q Consensus       113 i~~~~~~i~~~lg~G~~g~Vy~~~~--~~~~vAvK~~~~~~~~~-------~-----~~~~~~~Ei~~l~~l~h~nIv~~  178 (399)
                      .-.++|++.+.||+|.||.|.+|..  .++.||||++.+.....       .     ..+...+||.+|+++.|||||++
T Consensus        94 k~lNqy~l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H~nVV~L  173 (576)
T KOG0585|consen   94 KQLNQYELIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHHPNVVKL  173 (576)
T ss_pred             eehhheehhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCCcCeeEE
Confidence            3467999999999999999999987  67899999997432211       1     13588999999999999999999


Q ss_pred             EeEEecC--CcEEEEEecCCCCCHHHHHHhcCCC-CCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceeecCCCcEEE
Q 015868          179 IGACTRP--PNLCIVTEFMARGSIYDFLHKQKGV-FQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKV  255 (399)
Q Consensus       179 ~~~~~~~--~~~~lV~E~~~ggsL~~~l~~~~~~-l~~~~~~~i~~~i~~~L~~LH~~giiHrDlkp~NILl~~~~~vkl  255 (399)
                      +++..++  .++|||+|||..|.+...=  .... +++.++++++.+++.||+|||.+|||||||||.|+|++++|+|||
T Consensus       174 iEvLDDP~s~~~YlVley~s~G~v~w~p--~d~~els~~~Ar~ylrDvv~GLEYLH~QgiiHRDIKPsNLLl~~~g~VKI  251 (576)
T KOG0585|consen  174 IEVLDDPESDKLYLVLEYCSKGEVKWCP--PDKPELSEQQARKYLRDVVLGLEYLHYQGIIHRDIKPSNLLLSSDGTVKI  251 (576)
T ss_pred             EEeecCcccCceEEEEEeccCCccccCC--CCcccccHHHHHHHHHHHHHHHHHHHhcCeeccccchhheEEcCCCcEEe
Confidence            9998765  4699999999988776532  1233 899999999999999999999999999999999999999999999


Q ss_pred             eeccceeeccCC------CccccCCCCcccccccccCCC---CC-CChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHH
Q 015868          256 ADFGVARVQAQS------GVMTAETGTYRWMAPEVIEHK---PY-DYKADVFSFGIALWELLTGELPYAGLTPLQAAVGV  325 (399)
Q Consensus       256 ~DFG~a~~~~~~------~~~~~~~gt~~y~aPE~l~~~---~~-~~~~Dv~slG~vl~elltg~~P~~~~~~~~~~~~~  325 (399)
                      +|||++...++.      .......||+.|+|||...+.   .+ +.+.||||+|++||.|+.|+.||-+....+....+
T Consensus       252 sDFGVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG~~PF~~~~~~~l~~KI  331 (576)
T KOG0585|consen  252 SDFGVSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFGQLPFFDDFELELFDKI  331 (576)
T ss_pred             eccceeeecccCCccccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhhccCCcccchHHHHHHHH
Confidence            999999865332      123345799999999998763   33 46789999999999999999999999999999998


Q ss_pred             HhccCCCCCCCCCcHHHHHHHHHHhhhcCCCCCCHHHHHH
Q 015868          326 VQKSLRPTIPKHAHPRLAELLERCWQHDPTQRPNFSQITD  365 (399)
Q Consensus       326 ~~~~~~~~~~~~~~~~l~~ll~~cl~~dP~~Rps~~ell~  365 (399)
                      +...+..+..+.+..++++||.+||++||++|.+..+|..
T Consensus       332 vn~pL~fP~~pe~~e~~kDli~~lL~KdP~~Ri~l~~ik~  371 (576)
T KOG0585|consen  332 VNDPLEFPENPEINEDLKDLIKRLLEKDPEQRITLPDIKL  371 (576)
T ss_pred             hcCcccCCCcccccHHHHHHHHHHhhcChhheeehhhhee
Confidence            8877664444568899999999999999999999988854

>cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases

Probab=100.00  E-value=3.7e-43  Score=329.12  Aligned_cols=255  Identities=33%  Similarity=0.621  Sum_probs=221.0

Q ss_pred             cccccceeceeceeCceEEEEEEEC-----CeeEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCceeeEEeEEecCCcE
Q 015868          114 DAKQLKIECKVASGSYGDLYKGTYC-----SQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNL  188 (399)
Q Consensus       114 ~~~~~~i~~~lg~G~~g~Vy~~~~~-----~~~vAvK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~nIv~~~~~~~~~~~~  188 (399)
                      +.++|++.+.||+|+||.||+|...     ...||+|+++... .......+.+|+.+++.++||||+++++.+......
T Consensus         2 ~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~   80 (266)
T cd05033           2 DPSYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGS-SDKQRLDFLTEASIMGQFDHPNIIRLEGVVTKSRPV   80 (266)
T ss_pred             ChHHceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCCC-ChHHHHHHHHHHHHHHhCCCCCcceEeEEEecCCce
Confidence            4578999999999999999999873     3479999987653 344567789999999999999999999999999999


Q ss_pred             EEEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceeecCCCcEEEeeccceeeccC-C
Q 015868          189 CIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQ-S  267 (399)
Q Consensus       189 ~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~giiHrDlkp~NILl~~~~~vkl~DFG~a~~~~~-~  267 (399)
                      ++||||+++++|.+++....+.++...+..++.|++.|+.|||++||+|+||||+||++++++.++|+|||.++.... .
T Consensus        81 ~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~~~i~H~di~p~nili~~~~~~~l~dfg~~~~~~~~~  160 (266)
T cd05033          81 MIITEYMENGSLDKFLRENDGKFTVGQLVGMLRGIASGMKYLSEMNYVHRDLAARNILVNSNLVCKVSDFGLSRRLEDSE  160 (266)
T ss_pred             EEEEEcCCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEEcCCCCEEECccchhhcccccc
Confidence            999999999999999988777899999999999999999999999999999999999999999999999999987642 1


Q ss_pred             Ccc--ccCCCCcccccccccCCCCCCChhhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHHhccCCCCCCCCCcHHHHH
Q 015868          268 GVM--TAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLT-GELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRLAE  344 (399)
Q Consensus       268 ~~~--~~~~gt~~y~aPE~l~~~~~~~~~Dv~slG~vl~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~  344 (399)
                      ...  ....++..|+|||.+.+..++.++||||||+++|+|++ |..||...+..+..... ....+...+..++..+.+
T Consensus       161 ~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Dv~slG~~l~~l~~~g~~p~~~~~~~~~~~~~-~~~~~~~~~~~~~~~l~~  239 (266)
T cd05033         161 ATYTTKGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSYGERPYWDMSNQDVIKAV-EDGYRLPPPMDCPSALYQ  239 (266)
T ss_pred             cceeccCCCCCccccChhhhccCCCccccchHHHHHHHHHHHccCCCCCCCCCHHHHHHHH-HcCCCCCCCCCCCHHHHH
Confidence            111  12234678999999999899999999999999999998 99999887776654443 344455566788999999


Q ss_pred             HHHHHhhhcCCCCCCHHHHHHHHHHH
Q 015868          345 LLERCWQHDPTQRPNFSQITDILKQM  370 (399)
Q Consensus       345 ll~~cl~~dP~~Rps~~ell~~L~~l  370 (399)
                      ++.+||+.+|++||++.++++.|.++
T Consensus       240 li~~cl~~~p~~Rp~~~ei~~~l~~~  265 (266)
T cd05033         240 LMLDCWQKDRNERPTFSQIVSTLDKM  265 (266)
T ss_pred             HHHHHcCCCcccCcCHHHHHHHHHhh
Confidence            99999999999999999999999876

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment

>cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5

Probab=100.00  E-value=1e-43  Score=336.63  Aligned_cols=249  Identities=24%  Similarity=0.365  Sum_probs=207.9

Q ss_pred             cccceeceeceeCceEEEEEEE--CCeeEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCceeeEEeEEecCCcEEEEEe
Q 015868          116 KQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVTE  193 (399)
Q Consensus       116 ~~~~i~~~lg~G~~g~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~nIv~~~~~~~~~~~~~lV~E  193 (399)
                      ++|++.+.||+|+||.||++++  +++.||+|+++.........+.+.+|+.+++.++||||+++++++...+..++|||
T Consensus         1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e   80 (287)
T cd07848           1 NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKEAFRRRGKLYLVFE   80 (287)
T ss_pred             CCceEEEEecccCCEEEEEEEECCCCcEEEEEEEecccccccchhhHHHHHHHHHhCCCccccchhhhEecCCEEEEEEe
Confidence            4789999999999999999988  46789999998665455556778899999999999999999999999999999999


Q ss_pred             cCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceeecCCCcEEEeeccceeeccCCC--ccc
Q 015868          194 FMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSG--VMT  271 (399)
Q Consensus       194 ~~~ggsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~giiHrDlkp~NILl~~~~~vkl~DFG~a~~~~~~~--~~~  271 (399)
                      |++++++..+ ......+++..++.++.|++.||.|||+.||+||||||+||+++.++.+||+|||+++......  ...
T Consensus        81 ~~~~~~l~~~-~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~  159 (287)
T cd07848          81 YVEKNMLELL-EEMPNGVPPEKVRSYIYQLIKAIHWCHKNDIVHRDIKPENLLISHNDVLKLCDFGFARNLSEGSNANYT  159 (287)
T ss_pred             cCCCCHHHHH-HhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCcEEEeeccCccccccccccccc
Confidence            9998666554 4445678999999999999999999999999999999999999999999999999998654322  223


Q ss_pred             cCCCCcccccccccCCCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcc--------------------CC
Q 015868          272 AETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKS--------------------LR  331 (399)
Q Consensus       272 ~~~gt~~y~aPE~l~~~~~~~~~Dv~slG~vl~elltg~~P~~~~~~~~~~~~~~~~~--------------------~~  331 (399)
                      ...|++.|+|||++.+..++.++|||||||++|+|++|+.||...+..+.........                    ..
T Consensus       160 ~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (287)
T cd07848         160 EYVATRWYRSPELLLGAPYGKAVDMWSVGCILGELSDGQPLFPGESEIDQLFTIQKVLGPLPAEQMKLFYSNPRFHGLRF  239 (287)
T ss_pred             ccccccccCCcHHHcCCCCCCchhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCHHHHHhhhccchhccccc
Confidence            4568999999999999899999999999999999999999998876554433221100                    00


Q ss_pred             CC----------CCCCCcHHHHHHHHHHhhhcCCCCCCHHHHHH
Q 015868          332 PT----------IPKHAHPRLAELLERCWQHDPTQRPNFSQITD  365 (399)
Q Consensus       332 ~~----------~~~~~~~~l~~ll~~cl~~dP~~Rps~~ell~  365 (399)
                      +.          ....+++++.+|+.+||+.||++|||++|+++
T Consensus       240 ~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~~P~~R~s~~~~l~  283 (287)
T cd07848         240 PAVNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQCLN  283 (287)
T ss_pred             CcccCcccHHHhhhcccCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence            00          01236788999999999999999999999875

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes

>cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase

Probab=100.00  E-value=2.8e-43  Score=328.08  Aligned_cols=253  Identities=34%  Similarity=0.696  Sum_probs=219.3

Q ss_pred             eeecccccceeceeceeCceEEEEEEECCeeEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCceeeEEeEEe-cCCcEE
Q 015868          111 WEIDAKQLKIECKVASGSYGDLYKGTYCSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACT-RPPNLC  189 (399)
Q Consensus       111 ~~i~~~~~~i~~~lg~G~~g~Vy~~~~~~~~vAvK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~nIv~~~~~~~-~~~~~~  189 (399)
                      |.++.++|++.+.||+|+||.||++...+..||+|.++..    ...+.+.+|+.++++++|+|++++++++. .+...+
T Consensus         1 ~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~k~~~~~----~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~   76 (256)
T cd05082           1 WALNMKELKLLQTIGKGEFGDVMLGDYRGNKVAVKCIKND----ATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLY   76 (256)
T ss_pred             CCccHHhCeeeeeecccCCCeEEEEEEcCCcEEEEEeCCC----chHHHHHHHHHHHHhCCCCCeeeEEEEEEcCCCceE
Confidence            6778899999999999999999999999999999998753    23467889999999999999999999764 456789


Q ss_pred             EEEecCCCCCHHHHHHhcCC-CCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceeecCCCcEEEeeccceeeccCCC
Q 015868          190 IVTEFMARGSIYDFLHKQKG-VFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSG  268 (399)
Q Consensus       190 lV~E~~~ggsL~~~l~~~~~-~l~~~~~~~i~~~i~~~L~~LH~~giiHrDlkp~NILl~~~~~vkl~DFG~a~~~~~~~  268 (399)
                      +||||+++++|.+++..... .+++..+..++.|++.||+|||++|++||||||+||++++++.+||+|||.++......
T Consensus        77 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~  156 (256)
T cd05082          77 IVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEANNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ  156 (256)
T ss_pred             EEEECCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeccccchheEEEcCCCcEEecCCccceeccccC
Confidence            99999999999999976443 48899999999999999999999999999999999999999999999999987543321


Q ss_pred             ccccCCCCcccccccccCCCCCCChhhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHHhccCCCCCCCCCcHHHHHHHH
Q 015868          269 VMTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLT-GELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRLAELLE  347 (399)
Q Consensus       269 ~~~~~~gt~~y~aPE~l~~~~~~~~~Dv~slG~vl~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~  347 (399)
                        ....++..|+|||.+.+..++.++||||||+++|+|++ |+.||...+..+.... +.....+..+..+++.+.+++.
T Consensus       157 --~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~~l~~~g~~p~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~li~  233 (256)
T cd05082         157 --DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPR-VEKGYKMDAPDGCPPVVYDVMK  233 (256)
T ss_pred             --CCCccceeecCHHHHccCCCCchhhhHHHHHHHHHHHhCCCCCCCCCCHHHHHHH-HhcCCCCCCCCCCCHHHHHHHH
Confidence              23345668999999999899999999999999999997 9999987776554443 3445566777789999999999


Q ss_pred             HHhhhcCCCCCCHHHHHHHHHHH
Q 015868          348 RCWQHDPTQRPNFSQITDILKQM  370 (399)
Q Consensus       348 ~cl~~dP~~Rps~~ell~~L~~l  370 (399)
                      +||+.+|++|||+.++++.|+++
T Consensus       234 ~~l~~~p~~Rpt~~~l~~~l~~~  256 (256)
T cd05082         234 QCWHLDAATRPSFLQLREQLEHI  256 (256)
T ss_pred             HHhcCChhhCcCHHHHHHHHhcC
Confidence            99999999999999999988753

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re

>cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6

Probab=100.00  E-value=1.8e-43  Score=335.48  Aligned_cols=249  Identities=24%  Similarity=0.430  Sum_probs=205.5

Q ss_pred             cccceeceeceeCceEEEEEEE---CCeeEEEEEecCCCCCHHHHHHHHHHHHHHHhc---CCCceeeEEeEEe-----c
Q 015868          116 KQLKIECKVASGSYGDLYKGTY---CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKI---RHKNVVQFIGACT-----R  184 (399)
Q Consensus       116 ~~~~i~~~lg~G~~g~Vy~~~~---~~~~vAvK~~~~~~~~~~~~~~~~~Ei~~l~~l---~h~nIv~~~~~~~-----~  184 (399)
                      ++|++.+.||+|+||.||+|++   .++.||+|+++...........+.+|+.+++.+   +||||+++++++.     .
T Consensus         1 ~~Y~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~~   80 (290)
T cd07862           1 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDR   80 (290)
T ss_pred             CCcceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCCCCchHHHHHHHHHHHhhcccCCCCcceEEEEEecccCCC
Confidence            3789999999999999999986   357899999876543443345566777777766   6999999999985     3


Q ss_pred             CCcEEEEEecCCCCCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceeecCCCcEEEeeccceee
Q 015868          185 PPNLCIVTEFMARGSIYDFLHKQ-KGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARV  263 (399)
Q Consensus       185 ~~~~~lV~E~~~ggsL~~~l~~~-~~~l~~~~~~~i~~~i~~~L~~LH~~giiHrDlkp~NILl~~~~~vkl~DFG~a~~  263 (399)
                      ...+++||||+.+ +|.+++... ...+++..++.++.|++.||.|||++||+||||||+|||++.++.+||+|||+++.
T Consensus        81 ~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~iiH~dlkp~Nil~~~~~~~kl~Dfg~~~~  159 (290)
T cd07862          81 ETKLTLVFEHVDQ-DLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLARI  159 (290)
T ss_pred             CCcEEEEEccCCC-CHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEEcCCCCEEEccccceEe
Confidence            4568999999974 999998764 34589999999999999999999999999999999999999999999999999987


Q ss_pred             ccCCCccccCCCCcccccccccCCCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhccCCC-----------
Q 015868          264 QAQSGVMTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKSLRP-----------  332 (399)
Q Consensus       264 ~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~Dv~slG~vl~elltg~~P~~~~~~~~~~~~~~~~~~~~-----------  332 (399)
                      ...........|++.|+|||.+.+..++.++||||||+++|+|++|.+||.+.+..+....+......+           
T Consensus       160 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~  239 (290)
T cd07862         160 YSFQMALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRDVAL  239 (290)
T ss_pred             ccCCcccccccccccccChHHHhCCCCCCccchHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCCCChhhchhhhcc
Confidence            655444455678999999999999899999999999999999999999999887766554443211000           


Q ss_pred             --------------CCCCCCcHHHHHHHHHHhhhcCCCCCCHHHHHH
Q 015868          333 --------------TIPKHAHPRLAELLERCWQHDPTQRPNFSQITD  365 (399)
Q Consensus       333 --------------~~~~~~~~~l~~ll~~cl~~dP~~Rps~~ell~  365 (399)
                                    .+...+++.+.+++.+||+.||++|||+.++++
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~  286 (290)
T cd07862         240 PRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS  286 (290)
T ss_pred             cchhccCCCCCCHHHHccCCCHHHHHHHHHHhccCchhcCCHHHHhc
Confidence                          011346788999999999999999999999974

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla

>cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=6e-44  Score=343.17  Aligned_cols=237  Identities=23%  Similarity=0.406  Sum_probs=205.4

Q ss_pred             eceeCceEEEEEEE--CCeeEEEEEecCCC-CCHHHHHHHHHHHHHHHhcCCCceeeEEeEEecCCcEEEEEecCCCCCH
Q 015868          124 VASGSYGDLYKGTY--CSQEVAIKVLKPEC-VNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVTEFMARGSI  200 (399)
Q Consensus       124 lg~G~~g~Vy~~~~--~~~~vAvK~~~~~~-~~~~~~~~~~~Ei~~l~~l~h~nIv~~~~~~~~~~~~~lV~E~~~ggsL  200 (399)
                      ||+|+||.||++++  +++.||+|+++... ........+.+|+.++++++||||+++++++..+...++||||+++|+|
T Consensus         1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L   80 (312)
T cd05585           1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQSPEKLYLVLAFINGGEL   80 (312)
T ss_pred             CCcCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCcEeceeeEEecCCeEEEEEcCCCCCcH
Confidence            69999999999987  46789999987532 2334456788999999999999999999999999999999999999999


Q ss_pred             HHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceeecCCCcEEEeeccceeeccCC-CccccCCCCccc
Q 015868          201 YDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQS-GVMTAETGTYRW  279 (399)
Q Consensus       201 ~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~giiHrDlkp~NILl~~~~~vkl~DFG~a~~~~~~-~~~~~~~gt~~y  279 (399)
                      .+++.. .+.+++..+..++.|++.||.|||++||+||||||+||+++.++.+||+|||+++..... .......||+.|
T Consensus        81 ~~~l~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~i~HrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y  159 (312)
T cd05585          81 FHHLQR-EGRFDLSRARFYTAELLCALENLHKFNVIYRDLKPENILLDYQGHIALCDFGLCKLNMKDDDKTNTFCGTPEY  159 (312)
T ss_pred             HHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHeEECCCCcEEEEECcccccCccCCCccccccCCccc
Confidence            999976 467899999999999999999999999999999999999999999999999999754322 223445689999


Q ss_pred             ccccccCCCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhccCCCCCCCCCcHHHHHHHHHHhhhcCCCCCC
Q 015868          280 MAPEVIEHKPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRLAELLERCWQHDPTQRPN  359 (399)
Q Consensus       280 ~aPE~l~~~~~~~~~Dv~slG~vl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~cl~~dP~~Rps  359 (399)
                      +|||++.+..++.++|||||||++|+|++|..||...+..+........  ...+|..+++++.+++.+||+.||.+||+
T Consensus       160 ~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~li~~~L~~dp~~R~~  237 (312)
T cd05585         160 LAPELLLGHGYTKAVDWWTLGVLLYEMLTGLPPFYDENVNEMYRKILQE--PLRFPDGFDRDAKDLLIGLLSRDPTRRLG  237 (312)
T ss_pred             CCHHHHcCCCCCCccceechhHHHHHHHhCCCCcCCCCHHHHHHHHHcC--CCCCCCcCCHHHHHHHHHHcCCCHHHcCC
Confidence            9999999999999999999999999999999999988777665554433  44567789999999999999999999986


Q ss_pred             HHHH
Q 015868          360 FSQI  363 (399)
Q Consensus       360 ~~el  363 (399)
                      +..+
T Consensus       238 ~~~~  241 (312)
T cd05585         238 YNGA  241 (312)
T ss_pred             CCCH
Confidence            5433

Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl

>cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=4.7e-43  Score=326.44  Aligned_cols=253  Identities=37%  Similarity=0.721  Sum_probs=222.7

Q ss_pred             eeecccccceeceeceeCceEEEEEEECCeeEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCceeeEEeEEecCCcEEE
Q 015868          111 WEIDAKQLKIECKVASGSYGDLYKGTYCSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCI  190 (399)
Q Consensus       111 ~~i~~~~~~i~~~lg~G~~g~Vy~~~~~~~~vAvK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~nIv~~~~~~~~~~~~~l  190 (399)
                      |.++.++|++.+.||.|+||.||+|...++.||+|.++....   ..+.+.+|+.+++.++|+||+++++++......++
T Consensus         1 ~~~~~~~~~~~~~ig~g~~g~v~~~~~~~~~v~iK~~~~~~~---~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~   77 (256)
T cd05039           1 WAINSKELKLGATIGKGEFGDVMLGDYRGQKVAVKCLKDDST---AAQAFLAEASVMTTLRHPNLVQLLGVVLQGNPLYI   77 (256)
T ss_pred             CccChhhccceeeeecCCCceEEEEEecCcEEEEEEeccchh---HHHHHHHHHHHHHhcCCcceeeeEEEEcCCCCeEE
Confidence            556788999999999999999999999999999999986532   46789999999999999999999999998889999


Q ss_pred             EEecCCCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceeecCCCcEEEeeccceeeccCCCc
Q 015868          191 VTEFMARGSIYDFLHKQK-GVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGV  269 (399)
Q Consensus       191 V~E~~~ggsL~~~l~~~~-~~l~~~~~~~i~~~i~~~L~~LH~~giiHrDlkp~NILl~~~~~vkl~DFG~a~~~~~~~~  269 (399)
                      ||||+++++|.+++.... ..+++..++.++.|++.|+.|||++|++|+||||+||+++.++.++|+|||.++...... 
T Consensus        78 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~p~Nili~~~~~~~l~d~g~~~~~~~~~-  156 (256)
T cd05039          78 VTEYMAKGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYLEEKNFVHRDLAARNVLVSEDLVAKVSDFGLAKEASQGQ-  156 (256)
T ss_pred             EEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccchhcccceEEEeCCCCEEEccccccccccccc-
Confidence            999999999999997644 368999999999999999999999999999999999999999999999999998663322 


Q ss_pred             cccCCCCcccccccccCCCCCCChhhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHHhccCCCCCCCCCcHHHHHHHHH
Q 015868          270 MTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLT-GELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRLAELLER  348 (399)
Q Consensus       270 ~~~~~gt~~y~aPE~l~~~~~~~~~Dv~slG~vl~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~  348 (399)
                       .....+..|+|||.+.+..++.++|+||||+++|++++ |..||...+..+... .+....++..+..+++++.+++.+
T Consensus       157 -~~~~~~~~~~ape~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~li~~  234 (256)
T cd05039         157 -DSGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVP-HVEKGYRMEAPEGCPPEVYKVMKD  234 (256)
T ss_pred             -ccCCCcccccCchhhcCCcCCcHHHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH-HHhcCCCCCCccCCCHHHHHHHHH
Confidence             23345678999999998889999999999999999997 999998877665444 344445666777889999999999


Q ss_pred             HhhhcCCCCCCHHHHHHHHHH
Q 015868          349 CWQHDPTQRPNFSQITDILKQ  369 (399)
Q Consensus       349 cl~~dP~~Rps~~ell~~L~~  369 (399)
                      ||..+|++||++.++++.|++
T Consensus       235 ~l~~~p~~Rp~~~~l~~~l~~  255 (256)
T cd05039         235 CWELDPAKRPTFKQLREQLAL  255 (256)
T ss_pred             HhccChhhCcCHHHHHHHHhc
Confidence            999999999999999999875

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk

>cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1

Probab=100.00  E-value=5e-43  Score=334.13  Aligned_cols=259  Identities=32%  Similarity=0.598  Sum_probs=219.1

Q ss_pred             ccccceeceeceeCceEEEEEEEC--C--eeEEEEEecCCCCCHHHHHHHHHHHHHHHhc-CCCceeeEEeEEecCCcEE
Q 015868          115 AKQLKIECKVASGSYGDLYKGTYC--S--QEVAIKVLKPECVNTEMLKEFSQEVYIMRKI-RHKNVVQFIGACTRPPNLC  189 (399)
Q Consensus       115 ~~~~~i~~~lg~G~~g~Vy~~~~~--~--~~vAvK~~~~~~~~~~~~~~~~~Ei~~l~~l-~h~nIv~~~~~~~~~~~~~  189 (399)
                      +++|++.+.||.|+||.||+|...  +  ..+++|.++.. ......+.+.+|+.++.++ +||||+++++++......+
T Consensus         1 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~-~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~   79 (297)
T cd05089           1 WEDIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEF-ASENDHRDFAGELEVLCKLGHHPNIINLLGACENRGYLY   79 (297)
T ss_pred             CccceeeeeecCCCcceEEEEEecCCCCcceeEEEEcccc-CCHHHHHHHHHHHHHHHhhcCCCchhheEEEEccCCcce
Confidence            368999999999999999999763  2  24788888743 2344457789999999999 7999999999999999999


Q ss_pred             EEEecCCCCCHHHHHHhcC---------------CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceeecCCCcEE
Q 015868          190 IVTEFMARGSIYDFLHKQK---------------GVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVK  254 (399)
Q Consensus       190 lV~E~~~ggsL~~~l~~~~---------------~~l~~~~~~~i~~~i~~~L~~LH~~giiHrDlkp~NILl~~~~~vk  254 (399)
                      +||||+++++|.+++....               ..+++..++.++.|++.||+|||++||+||||||+||++++++.+|
T Consensus        80 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~ivH~dlkp~Nill~~~~~~k  159 (297)
T cd05089          80 IAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSEKQFIHRDLAARNVLVGENLASK  159 (297)
T ss_pred             EEEEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHHCCcccCcCCcceEEECCCCeEE
Confidence            9999999999999997532               3588899999999999999999999999999999999999999999


Q ss_pred             EeeccceeeccCCCccccCCCCcccccccccCCCCCCChhhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHHhccCCCC
Q 015868          255 VADFGVARVQAQSGVMTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLT-GELPYAGLTPLQAAVGVVQKSLRPT  333 (399)
Q Consensus       255 l~DFG~a~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~Dv~slG~vl~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~  333 (399)
                      |+|||++..............+..|+|||.+.+..++.++||||||+++|+|++ |..||...+..+..... .....+.
T Consensus       160 l~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~el~t~g~~pf~~~~~~~~~~~~-~~~~~~~  238 (297)
T cd05089         160 IADFGLSRGEEVYVKKTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPYCGMTCAELYEKL-PQGYRME  238 (297)
T ss_pred             ECCcCCCccccceeccCCCCcCccccCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHH-hcCCCCC
Confidence            999999864332211222233567999999999899999999999999999997 99999988877655543 3445566


Q ss_pred             CCCCCcHHHHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHH
Q 015868          334 IPKHAHPRLAELLERCWQHDPTQRPNFSQITDILKQMMKEVA  375 (399)
Q Consensus       334 ~~~~~~~~l~~ll~~cl~~dP~~Rps~~ell~~L~~l~~~~~  375 (399)
                      .+..++.++.+++.+||+.+|.+|||++++++.|..++....
T Consensus       239 ~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~~~~~~  280 (297)
T cd05089         239 KPRNCDDEVYELMRQCWRDRPYERPPFAQISVQLSRMLEARK  280 (297)
T ss_pred             CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhhc
Confidence            777899999999999999999999999999999999886553

Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations.

>cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=5.5e-43  Score=327.07  Aligned_cols=255  Identities=36%  Similarity=0.665  Sum_probs=220.4

Q ss_pred             eeecccccceeceeceeCceEEEEEEE-CCeeEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCceeeEEeEEecCCcEE
Q 015868          111 WEIDAKQLKIECKVASGSYGDLYKGTY-CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLC  189 (399)
Q Consensus       111 ~~i~~~~~~i~~~lg~G~~g~Vy~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~nIv~~~~~~~~~~~~~  189 (399)
                      |++..++|++.+.||.|++|.||+|.+ .++.||+|.++.....   .+.+.+|+.++++++||||+++++++...+..+
T Consensus         1 ~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~v~iK~~~~~~~~---~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~   77 (261)
T cd05068           1 WEIDRTSIQLLRKLGAGQFGEVWEGLWNNTTPVAVKTLKPGTMD---PKDFLAEAQIMKKLRHPKLIQLYAVCTLEEPIY   77 (261)
T ss_pred             CccchhheeeEEEecccCCccEEEEEecCCeEEEEEeeCCCccc---HHHHHHHHHHHHHCCCCCccceeEEEecCCCee
Confidence            567888999999999999999999987 4568999999865322   456889999999999999999999999999999


Q ss_pred             EEEecCCCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceeecCCCcEEEeeccceeeccCCC
Q 015868          190 IVTEFMARGSIYDFLHKQK-GVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSG  268 (399)
Q Consensus       190 lV~E~~~ggsL~~~l~~~~-~~l~~~~~~~i~~~i~~~L~~LH~~giiHrDlkp~NILl~~~~~vkl~DFG~a~~~~~~~  268 (399)
                      +||||+.+++|.+++.... ..++...+..++.|++.|+.|||++|++||||||+||++++++.++|+|||.++......
T Consensus        78 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~  157 (261)
T cd05068          78 IVTELMKYGSLLEYLQGGAGRALKLPQLIDMAAQVASGMAYLEAQNYIHRDLAARNVLVGENNICKVADFGLARVIKEDI  157 (261)
T ss_pred             eeeecccCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCcceEEEcCCCCEEECCcceEEEccCCc
Confidence            9999999999999997643 468999999999999999999999999999999999999999999999999998765332


Q ss_pred             ccc--cCCCCcccccccccCCCCCCChhhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHHhccCCCCCCCCCcHHHHHH
Q 015868          269 VMT--AETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLT-GELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRLAEL  345 (399)
Q Consensus       269 ~~~--~~~gt~~y~aPE~l~~~~~~~~~Dv~slG~vl~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l  345 (399)
                      ...  ....+..|+|||.+.+..++.++|+||||+++|+|++ |+.||.+.+..+....+. .......+..++..+.++
T Consensus       158 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~l  236 (261)
T cd05068         158 YEAREGAKFPIKWTAPEAALYNRFSIKSDVWSFGILLTEIVTYGRMPYPGMTNAEVLQQVD-QGYRMPCPPGCPKELYDI  236 (261)
T ss_pred             ccccCCCcCceeccCccccccCCCCchhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHH-cCCCCCCCCcCCHHHHHH
Confidence            111  1122457999999999899999999999999999999 999999888776555443 344455667789999999


Q ss_pred             HHHHhhhcCCCCCCHHHHHHHHHH
Q 015868          346 LERCWQHDPTQRPNFSQITDILKQ  369 (399)
Q Consensus       346 l~~cl~~dP~~Rps~~ell~~L~~  369 (399)
                      +.+||+.+|.+||++.++.+.|++
T Consensus       237 i~~~l~~~P~~Rp~~~~l~~~l~~  260 (261)
T cd05068         237 MLDCWKEDPDDRPTFETLQWKLED  260 (261)
T ss_pred             HHHHhhcCcccCCCHHHHHHHHhc
Confidence            999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a

>cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta

Probab=100.00  E-value=1.3e-43  Score=342.65  Aligned_cols=241  Identities=23%  Similarity=0.452  Sum_probs=208.3

Q ss_pred             ceeceeCceEEEEEEE--CCeeEEEEEecCCCC-CHHHHHHHHHHHHHHHhcCCCceeeEEeEEecCCcEEEEEecCCCC
Q 015868          122 CKVASGSYGDLYKGTY--CSQEVAIKVLKPECV-NTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVTEFMARG  198 (399)
Q Consensus       122 ~~lg~G~~g~Vy~~~~--~~~~vAvK~~~~~~~-~~~~~~~~~~Ei~~l~~l~h~nIv~~~~~~~~~~~~~lV~E~~~gg  198 (399)
                      +.||+|+||.||+++.  .++.||+|+++.... .......+.+|+.+++.++||||+++++++.....+|+||||++++
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~E~~~~~   80 (323)
T cd05595           1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGG   80 (323)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCcceeeEEecCCEEEEEEeCCCCC
Confidence            4689999999999986  578999999975422 3344567888999999999999999999999999999999999999


Q ss_pred             CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceeecCCCcEEEeeccceeeccC-CCccccCCCCc
Q 015868          199 SIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQ-SGVMTAETGTY  277 (399)
Q Consensus       199 sL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~giiHrDlkp~NILl~~~~~vkl~DFG~a~~~~~-~~~~~~~~gt~  277 (399)
                      +|.+++.. ...+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.... ........||+
T Consensus        81 ~L~~~l~~-~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~gt~  159 (323)
T cd05595          81 ELFFHLSR-ERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGTP  159 (323)
T ss_pred             cHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEEcCCCCEEecccHHhccccCCCCccccccCCc
Confidence            99998866 45789999999999999999999999999999999999999999999999999875322 22234456899


Q ss_pred             ccccccccCCCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhccCCCCCCCCCcHHHHHHHHHHhhhcCCCC
Q 015868          278 RWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRLAELLERCWQHDPTQR  357 (399)
Q Consensus       278 ~y~aPE~l~~~~~~~~~Dv~slG~vl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~cl~~dP~~R  357 (399)
                      .|+|||.+.+..++.++|||||||++|+|++|+.||...+...........  ...+|..+++++.++|.+||+.||.+|
T Consensus       160 ~y~aPE~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~~~~~--~~~~p~~~~~~~~~li~~~L~~dP~~R  237 (323)
T cd05595         160 EYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILME--EIRFPRTLSPEAKSLLAGLLKKDPKQR  237 (323)
T ss_pred             CcCCcccccCCCCCchhchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHhcC--CCCCCCCCCHHHHHHHHHHccCCHHHh
Confidence            999999999999999999999999999999999999888776655544432  345677899999999999999999999


Q ss_pred             C-----CHHHHHH
Q 015868          358 P-----NFSQITD  365 (399)
Q Consensus       358 p-----s~~ell~  365 (399)
                      |     ++.++++
T Consensus       238 ~~~~~~~~~~~l~  250 (323)
T cd05595         238 LGGGPSDAKEVME  250 (323)
T ss_pred             CCCCCCCHHHHHc
Confidence            8     7888765

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in

>cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor

Probab=100.00  E-value=5.1e-43  Score=330.35  Aligned_cols=256  Identities=29%  Similarity=0.561  Sum_probs=216.8

Q ss_pred             eeecccccceeceeceeCceEEEEEEEC-------CeeEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCceeeEEeEEe
Q 015868          111 WEIDAKQLKIECKVASGSYGDLYKGTYC-------SQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACT  183 (399)
Q Consensus       111 ~~i~~~~~~i~~~lg~G~~g~Vy~~~~~-------~~~vAvK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~nIv~~~~~~~  183 (399)
                      |.+..++|++.++||.|+||.||+|.+.       +..||+|.++... .......+.+|+.+++.++||||+++++++.
T Consensus         1 ~~~~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~-~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~   79 (277)
T cd05062           1 WEVAREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAA-SMRERIEFLNEASVMKEFNCHHVVRLLGVVS   79 (277)
T ss_pred             CcccHHHceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccC-CHHHHHHHHHHHHHHHhCCCCCeeeEEEEEc
Confidence            6778889999999999999999998763       3579999986542 3344567899999999999999999999999


Q ss_pred             cCCcEEEEEecCCCCCHHHHHHhcC---------CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceeecCCCcEE
Q 015868          184 RPPNLCIVTEFMARGSIYDFLHKQK---------GVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVK  254 (399)
Q Consensus       184 ~~~~~~lV~E~~~ggsL~~~l~~~~---------~~l~~~~~~~i~~~i~~~L~~LH~~giiHrDlkp~NILl~~~~~vk  254 (399)
                      .+...++||||+++++|.+++....         ..++...+..++.|++.||.|||++|++|+||||+||++++++.++
T Consensus        80 ~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~vH~dlkp~Nil~~~~~~~~  159 (277)
T cd05062          80 QGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVK  159 (277)
T ss_pred             CCCCeEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCcchheEEEcCCCCEE
Confidence            9999999999999999999997532         2356778899999999999999999999999999999999999999


Q ss_pred             EeeccceeeccCCCc---cccCCCCcccccccccCCCCCCChhhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHHhccC
Q 015868          255 VADFGVARVQAQSGV---MTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLT-GELPYAGLTPLQAAVGVVQKSL  330 (399)
Q Consensus       255 l~DFG~a~~~~~~~~---~~~~~gt~~y~aPE~l~~~~~~~~~Dv~slG~vl~ellt-g~~P~~~~~~~~~~~~~~~~~~  330 (399)
                      |+|||+++.......   .....++..|+|||.+.+..++.++||||||+++|+|++ |..||.+.+..+...... ...
T Consensus       160 l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~p~~~~~~~~~~~~~~-~~~  238 (277)
T cd05062         160 IGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGMSNEQVLRFVM-EGG  238 (277)
T ss_pred             ECCCCCccccCCcceeecCCCCccCHhhcChhHhhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHH-cCC
Confidence            999999875433221   112345778999999999899999999999999999999 789998887765554433 344


Q ss_pred             CCCCCCCCcHHHHHHHHHHhhhcCCCCCCHHHHHHHHH
Q 015868          331 RPTIPKHAHPRLAELLERCWQHDPTQRPNFSQITDILK  368 (399)
Q Consensus       331 ~~~~~~~~~~~l~~ll~~cl~~dP~~Rps~~ell~~L~  368 (399)
                      .+..+..++..+.+++.+||+.+|++|||+.++++.|+
T Consensus       239 ~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~  276 (277)
T cd05062         239 LLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIK  276 (277)
T ss_pred             cCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHhh
Confidence            45667788999999999999999999999999998875

Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh

>cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase

Probab=100.00  E-value=2.8e-43  Score=336.77  Aligned_cols=249  Identities=24%  Similarity=0.406  Sum_probs=203.8

Q ss_pred             ccccceeceeceeCceEEEEEEE--CCeeEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCceeeEEeEEecCCcEEEEE
Q 015868          115 AKQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVT  192 (399)
Q Consensus       115 ~~~~~i~~~lg~G~~g~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~nIv~~~~~~~~~~~~~lV~  192 (399)
                      .++|++.++||.|+||.||+|+.  +++.||+|+++.... ......+.+|+.+++.++||||+++++++..+...++||
T Consensus         4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~   82 (303)
T cd07869           4 ADSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEE-EGTPFTAIREASLLKGLKHANIVLLHDIIHTKETLTLVF   82 (303)
T ss_pred             cccceEeeeEEecCCEEEEEEEECCCCCEEEEEEeccccc-cccchhHHHHHHHHhhCCCCCcCeEEEEEecCCeEEEEE
Confidence            46899999999999999999987  578899999975432 222346778999999999999999999999999999999


Q ss_pred             ecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceeecCCCcEEEeeccceeeccCC-Cccc
Q 015868          193 EFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQS-GVMT  271 (399)
Q Consensus       193 E~~~ggsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~giiHrDlkp~NILl~~~~~vkl~DFG~a~~~~~~-~~~~  271 (399)
                      ||+. ++|.+++....+.+++..+..++.|++.||+|||++||+||||||+||+++.++.+||+|||.++..... ....
T Consensus        83 e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~  161 (303)
T cd07869          83 EYVH-TDLCQYMDKHPGGLHPENVKLFLFQLLRGLSYIHQRYILHRDLKPQNLLISDTGELKLADFGLARAKSVPSHTYS  161 (303)
T ss_pred             ECCC-cCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEECCCCcceeccCCCccCC
Confidence            9996 5899988877778999999999999999999999999999999999999999999999999998754332 2234


Q ss_pred             cCCCCcccccccccCC-CCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhccC-C----------------CC
Q 015868          272 AETGTYRWMAPEVIEH-KPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKSL-R----------------PT  333 (399)
Q Consensus       272 ~~~gt~~y~aPE~l~~-~~~~~~~Dv~slG~vl~elltg~~P~~~~~~~~~~~~~~~~~~-~----------------~~  333 (399)
                      ...+++.|+|||++.+ ..++.++|||||||++|+|++|..||.+............... .                +.
T Consensus       162 ~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  241 (303)
T cd07869         162 NEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDIQDQLERIFLVLGTPNEDTWPGVHSLPHFKPE  241 (303)
T ss_pred             CCcccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHHhCCCChhhccchhhccccccc
Confidence            4568999999999875 4588999999999999999999999987654332221111000 0                00


Q ss_pred             -----CC---------CCCcHHHHHHHHHHhhhcCCCCCCHHHHHH
Q 015868          334 -----IP---------KHAHPRLAELLERCWQHDPTQRPNFSQITD  365 (399)
Q Consensus       334 -----~~---------~~~~~~l~~ll~~cl~~dP~~Rps~~ell~  365 (399)
                           .+         ...++++.+|+.+||+.||.+|||+.|+++
T Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dp~~R~s~~~~l~  287 (303)
T cd07869         242 RFTLYSPKNLRQAWNKLSYVNHAEDLASKLLQCFPKNRLSAQAALS  287 (303)
T ss_pred             cccccCCccHHHHhhccCCChHHHHHHHHHhccCchhccCHHHHhc
Confidence                 00         124568899999999999999999999975

Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an

>cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors

Probab=100.00  E-value=5.8e-43  Score=334.77  Aligned_cols=260  Identities=32%  Similarity=0.655  Sum_probs=224.1

Q ss_pred             ceeecccccceeceeceeCceEEEEEEE-------CCeeEEEEEecCCCCCHHHHHHHHHHHHHHHhc-CCCceeeEEeE
Q 015868          110 VWEIDAKQLKIECKVASGSYGDLYKGTY-------CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKI-RHKNVVQFIGA  181 (399)
Q Consensus       110 ~~~i~~~~~~i~~~lg~G~~g~Vy~~~~-------~~~~vAvK~~~~~~~~~~~~~~~~~Ei~~l~~l-~h~nIv~~~~~  181 (399)
                      .|.+..++|.+.+.||.|+||.||+++.       .+..||+|+++... .....+.+.+|+.+++++ +||||++++++
T Consensus        29 ~~~~~~~~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~  107 (302)
T cd05055          29 KWEFPRNNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTA-HSSEREALMSELKIMSHLGNHENIVNLLGA  107 (302)
T ss_pred             cccccHHHeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccC-ChHHHHHHHHHHHHHHhccCCCCcceEEEE
Confidence            4678888999999999999999999975       23579999987653 234456889999999999 79999999999


Q ss_pred             EecCCcEEEEEecCCCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceeecCCCcEEEeeccc
Q 015868          182 CTRPPNLCIVTEFMARGSIYDFLHKQK-GVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGV  260 (399)
Q Consensus       182 ~~~~~~~~lV~E~~~ggsL~~~l~~~~-~~l~~~~~~~i~~~i~~~L~~LH~~giiHrDlkp~NILl~~~~~vkl~DFG~  260 (399)
                      +...+..++||||+.+++|.++++... ..+++..+..++.+++.||.|||+++|+|+||||+||+++.++.++++|||.
T Consensus       108 ~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~~l~dfg~  187 (302)
T cd05055         108 CTIGGPILVITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNVLLTHGKIVKICDFGL  187 (302)
T ss_pred             EecCCceEEEEEcCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeehhhhccceEEEcCCCeEEECCCcc
Confidence            999999999999999999999997643 3489999999999999999999999999999999999999999999999999


Q ss_pred             eeeccCCCc---cccCCCCcccccccccCCCCCCChhhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHHhccCCCCCCC
Q 015868          261 ARVQAQSGV---MTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLT-GELPYAGLTPLQAAVGVVQKSLRPTIPK  336 (399)
Q Consensus       261 a~~~~~~~~---~~~~~gt~~y~aPE~l~~~~~~~~~Dv~slG~vl~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~  336 (399)
                      ++.......   .....++..|+|||.+.+..++.++||||||+++|+|++ |..||.................++..+.
T Consensus       188 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~  267 (302)
T cd05055         188 ARDIMNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSNPYPGMPVDSKFYKLIKEGYRMAQPE  267 (302)
T ss_pred             cccccCCCceeecCCCCcccccCCHhhhccCCCCcHhHHHHHHHHHHHHHhCCCCCcCCCCchHHHHHHHHcCCcCCCCC
Confidence            975443221   122345778999999999999999999999999999998 9999988776665555565565666667


Q ss_pred             CCcHHHHHHHHHHhhhcCCCCCCHHHHHHHHHHH
Q 015868          337 HAHPRLAELLERCWQHDPTQRPNFSQITDILKQM  370 (399)
Q Consensus       337 ~~~~~l~~ll~~cl~~dP~~Rps~~ell~~L~~l  370 (399)
                      ..++++.+++.+||..+|++|||+.|+++.|+++
T Consensus       268 ~~~~~~~~li~~cl~~~p~~Rpt~~ell~~l~~~  301 (302)
T cd05055         268 HAPAEIYDIMKTCWDADPLKRPTFKQIVQLIGKQ  301 (302)
T ss_pred             CCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHhh
Confidence            7899999999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept

>cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome

Probab=100.00  E-value=5.3e-43  Score=326.77  Aligned_cols=251  Identities=33%  Similarity=0.647  Sum_probs=216.1

Q ss_pred             ecccccceeceeceeCceEEEEEEECCe-eEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCceeeEEeEEecCCcEEEE
Q 015868          113 IDAKQLKIECKVASGSYGDLYKGTYCSQ-EVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIV  191 (399)
Q Consensus       113 i~~~~~~i~~~lg~G~~g~Vy~~~~~~~-~vAvK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~nIv~~~~~~~~~~~~~lV  191 (399)
                      ++.++|++.+.||+|+||.||+|++.+. .+|+|.++.....   ...+.+|+.++++++||||+++++++......++|
T Consensus         1 ~~~~~~~~~~~lg~G~~~~vy~~~~~~~~~~aik~~~~~~~~---~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   77 (256)
T cd05113           1 IDPKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMS---EDEFIEEAKVMMKLSHEKLVQLYGVCTKQRPIYIV   77 (256)
T ss_pred             CChHHeEEeeEecCcccceEEEEEecCCCcEEEEEcCCCccc---HHHHHHHHHHHhcCCCCCeeeEEEEEccCCCcEEE
Confidence            3457899999999999999999987554 5999998754332   35688999999999999999999999988889999


Q ss_pred             EecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceeecCCCcEEEeeccceeeccCCCcc-
Q 015868          192 TEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVM-  270 (399)
Q Consensus       192 ~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~giiHrDlkp~NILl~~~~~vkl~DFG~a~~~~~~~~~-  270 (399)
                      |||+.+++|.+++......+++..++.++.|++.||.|||++|++|+||||.||++++++.+||+|||.++........ 
T Consensus        78 ~e~~~~~~l~~~i~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~nili~~~~~~kl~d~g~~~~~~~~~~~~  157 (256)
T cd05113          78 TEYMSNGCLLNYLREHGKRFQPSQLLEMCKDVCEGMAYLESKQFIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDEYTS  157 (256)
T ss_pred             EEcCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccCcceEEEcCCCCEEECCCccceecCCCceee
Confidence            9999999999999876667899999999999999999999999999999999999999999999999998755433211 


Q ss_pred             -ccCCCCcccccccccCCCCCCChhhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHHhccCCCCCCCCCcHHHHHHHHH
Q 015868          271 -TAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLT-GELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRLAELLER  348 (399)
Q Consensus       271 -~~~~gt~~y~aPE~l~~~~~~~~~Dv~slG~vl~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~  348 (399)
                       ....++..|+|||.+.+..++.++||||||+++|+|++ |..||...+..+...... ...++..+...+..+.+++.+
T Consensus       158 ~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~li~~  236 (256)
T cd05113         158 SVGSKFPVRWSPPEVLLYSKFSSKSDVWAFGVLMWEVYSLGKMPYERFNNSETVEKVS-QGLRLYRPHLASEKVYAIMYS  236 (256)
T ss_pred             cCCCccChhhCCHHHHhcCcccchhHHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHh-cCCCCCCCCCCCHHHHHHHHH
Confidence             12235678999999998889999999999999999999 999998887766555443 345556667788999999999


Q ss_pred             HhhhcCCCCCCHHHHHHHH
Q 015868          349 CWQHDPTQRPNFSQITDIL  367 (399)
Q Consensus       349 cl~~dP~~Rps~~ell~~L  367 (399)
                      ||+.+|.+||++.++++.|
T Consensus       237 cl~~~p~~Rp~~~~ll~~~  255 (256)
T cd05113         237 CWHEKAEERPTFQQLLSSI  255 (256)
T ss_pred             HcCCCcccCCCHHHHHHhh
Confidence            9999999999999998766

Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds

>cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases

Probab=100.00  E-value=5.2e-43  Score=329.70  Aligned_cols=256  Identities=31%  Similarity=0.595  Sum_probs=221.1

Q ss_pred             eeecccccceeceeceeCceEEEEEEECC-------eeEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCceeeEEeEEe
Q 015868          111 WEIDAKQLKIECKVASGSYGDLYKGTYCS-------QEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACT  183 (399)
Q Consensus       111 ~~i~~~~~~i~~~lg~G~~g~Vy~~~~~~-------~~vAvK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~nIv~~~~~~~  183 (399)
                      |+++.++|++.+.||.|+||.||+|...+       ..||+|.+.... .......+.+|+.+++.++||||+++++++.
T Consensus         1 ~~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~-~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~   79 (277)
T cd05032           1 WELPREKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENA-SMRERIEFLNEASVMKEFNCHHVVRLLGVVS   79 (277)
T ss_pred             CccchHHeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCcc-CHHHHHHHHHHHHHHHhCCCCceeEEEEEEc
Confidence            67888999999999999999999997642       679999987543 3344567889999999999999999999999


Q ss_pred             cCCcEEEEEecCCCCCHHHHHHhcC---------CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceeecCCCcEE
Q 015868          184 RPPNLCIVTEFMARGSIYDFLHKQK---------GVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVK  254 (399)
Q Consensus       184 ~~~~~~lV~E~~~ggsL~~~l~~~~---------~~l~~~~~~~i~~~i~~~L~~LH~~giiHrDlkp~NILl~~~~~vk  254 (399)
                      .....++||||+++++|.+++....         ..+++..+..++.|++.||.|||++|++||||||+||+++.++.+|
T Consensus        80 ~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~di~p~nill~~~~~~k  159 (277)
T cd05032          80 TGQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAAKKFVHRDLAARNCMVAEDLTVK  159 (277)
T ss_pred             CCCCcEEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccccChheEEEcCCCCEE
Confidence            9999999999999999999996532         2467888999999999999999999999999999999999999999


Q ss_pred             EeeccceeeccCCCc---cccCCCCcccccccccCCCCCCChhhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHHhccC
Q 015868          255 VADFGVARVQAQSGV---MTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLT-GELPYAGLTPLQAAVGVVQKSL  330 (399)
Q Consensus       255 l~DFG~a~~~~~~~~---~~~~~gt~~y~aPE~l~~~~~~~~~Dv~slG~vl~ellt-g~~P~~~~~~~~~~~~~~~~~~  330 (399)
                      |+|||.++.......   .....++..|+|||.+.+..++.++||||||+++|++++ |..||...++.+...... ...
T Consensus       160 l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~~~-~~~  238 (277)
T cd05032         160 IGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQGLSNEEVLKFVI-DGG  238 (277)
T ss_pred             ECCcccchhhccCcccccCCCCCccccccCHHHHhcCCCCcccchHHHHHHHHHhhccCCCCCccCCHHHHHHHHh-cCC
Confidence            999999875443321   223346788999999988889999999999999999998 999999888777655544 455


Q ss_pred             CCCCCCCCcHHHHHHHHHHhhhcCCCCCCHHHHHHHHH
Q 015868          331 RPTIPKHAHPRLAELLERCWQHDPTQRPNFSQITDILK  368 (399)
Q Consensus       331 ~~~~~~~~~~~l~~ll~~cl~~dP~~Rps~~ell~~L~  368 (399)
                      .+..|..++.++.+++.+||+.+|++|||+.++++.|+
T Consensus       239 ~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~  276 (277)
T cd05032         239 HLDLPENCPDKLLELMRMCWQYNPKMRPTFLEIVSSLK  276 (277)
T ss_pred             CCCCCCCCCHHHHHHHHHHcCCChhhCCCHHHHHHHhc
Confidence            66778888999999999999999999999999998875

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological

>cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1

Probab=100.00  E-value=1.1e-42  Score=333.22  Aligned_cols=264  Identities=30%  Similarity=0.628  Sum_probs=225.2

Q ss_pred             CceeecccccceeceeceeCceEEEEEEEC---------CeeEEEEEecCCCCCHHHHHHHHHHHHHHHhc-CCCceeeE
Q 015868          109 DVWEIDAKQLKIECKVASGSYGDLYKGTYC---------SQEVAIKVLKPECVNTEMLKEFSQEVYIMRKI-RHKNVVQF  178 (399)
Q Consensus       109 ~~~~i~~~~~~i~~~lg~G~~g~Vy~~~~~---------~~~vAvK~~~~~~~~~~~~~~~~~Ei~~l~~l-~h~nIv~~  178 (399)
                      ..|++..++|.+.++||+|+||.||++++.         ...+|+|+++... .......+.+|+.+++.+ +||||+++
T Consensus        11 ~~~~~~~~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~-~~~~~~~~~~e~~~l~~l~~h~~i~~~   89 (307)
T cd05098          11 PRWEVPRDRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDA-TEKDLSDLISEMEMMKMIGKHKNIINL   89 (307)
T ss_pred             CcceeehHHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCC-ChHHHHHHHHHHHHHHHhcCCCCEeeE
Confidence            457888899999999999999999999753         2469999998653 344456788999999999 79999999


Q ss_pred             EeEEecCCcEEEEEecCCCCCHHHHHHhcC---------------CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCC
Q 015868          179 IGACTRPPNLCIVTEFMARGSIYDFLHKQK---------------GVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTA  243 (399)
Q Consensus       179 ~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~---------------~~l~~~~~~~i~~~i~~~L~~LH~~giiHrDlkp~  243 (399)
                      ++++......++||||+++++|.+++....               ..++...++.++.|++.||+|||++|++||||||+
T Consensus        90 ~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~gi~H~dlkp~  169 (307)
T cd05098          90 LGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASKKCIHRDLAAR  169 (307)
T ss_pred             EEEEecCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCCcccccccHH
Confidence            999999999999999999999999997642               24788899999999999999999999999999999


Q ss_pred             ceeecCCCcEEEeeccceeeccCCCc---cccCCCCcccccccccCCCCCCChhhHHHHHHHHHHHHc-CCCCCCCCCHH
Q 015868          244 NLLMDENGVVKVADFGVARVQAQSGV---MTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLT-GELPYAGLTPL  319 (399)
Q Consensus       244 NILl~~~~~vkl~DFG~a~~~~~~~~---~~~~~gt~~y~aPE~l~~~~~~~~~Dv~slG~vl~ellt-g~~P~~~~~~~  319 (399)
                      ||+++.++.++|+|||.++.......   .....++..|+|||.+.+..++.++|+||||+++|+|++ |..||...+..
T Consensus       170 Nill~~~~~~kL~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~~g~~p~~~~~~~  249 (307)
T cd05098         170 NVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVE  249 (307)
T ss_pred             heEEcCCCcEEECCCcccccccccchhhccccCCCccceeChHHhccCCCCcHHHHHHHHHHHHHHHcCCCCCCCcCCHH
Confidence            99999999999999999875443211   122234578999999999889999999999999999998 88999876665


Q ss_pred             HHHHHHHhccCCCCCCCCCcHHHHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHH
Q 015868          320 QAAVGVVQKSLRPTIPKHAHPRLAELLERCWQHDPTQRPNFSQITDILKQMMKEV  374 (399)
Q Consensus       320 ~~~~~~~~~~~~~~~~~~~~~~l~~ll~~cl~~dP~~Rps~~ell~~L~~l~~~~  374 (399)
                      +.. ..+....++..+..++.++.+++.+||..+|.+|||+.++++.|.+++...
T Consensus       250 ~~~-~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~~l~~~~~~~  303 (307)
T cd05098         250 ELF-KLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILALT  303 (307)
T ss_pred             HHH-HHHHcCCCCCCCCcCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHHHHh
Confidence            443 344455566777889999999999999999999999999999999997653

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>PTZ00283 serine/threonine protein kinase; Provisional

Probab=100.00  E-value=6.3e-43  Score=355.96  Aligned_cols=253  Identities=26%  Similarity=0.407  Sum_probs=219.6

Q ss_pred             eecccccceeceeceeCceEEEEEEE--CCeeEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCceeeEEeEEecCC---
Q 015868          112 EIDAKQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPP---  186 (399)
Q Consensus       112 ~i~~~~~~i~~~lg~G~~g~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~nIv~~~~~~~~~~---  186 (399)
                      ....++|++.+.||+|+||.||+++.  +++.||||++.....+......+.+|+.++..++|+||+++++.+....   
T Consensus        28 ~~~~~rY~i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~~~~~  107 (496)
T PTZ00283         28 KEQAKKYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSIVKCHEDFAKKDPRN  107 (496)
T ss_pred             cccCCCEEEEEEEecCCCEEEEEEEEcCCCCEEEEEEEecccCCHHHHHHHHHHHHHHhcCCCCcEEEeecceecccccC
Confidence            34467999999999999999999976  6889999999877666777788999999999999999999998775432   


Q ss_pred             -----cEEEEEecCCCCCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceeecCCCcEEEeec
Q 015868          187 -----NLCIVTEFMARGSIYDFLHKQ---KGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADF  258 (399)
Q Consensus       187 -----~~~lV~E~~~ggsL~~~l~~~---~~~l~~~~~~~i~~~i~~~L~~LH~~giiHrDlkp~NILl~~~~~vkl~DF  258 (399)
                           .+++||||+++|+|.+++...   ...+++..+..++.|++.||.|||++||+||||||+|||++.++.+||+||
T Consensus       108 ~~~~~~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH~~~IiHrDLKP~NILl~~~~~vkL~DF  187 (496)
T PTZ00283        108 PENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHSKHMIHRDIKSANILLCSNGLVKLGDF  187 (496)
T ss_pred             cccceEEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEeCCCCEEEEec
Confidence                 368999999999999998653   356899999999999999999999999999999999999999999999999


Q ss_pred             cceeeccCC---CccccCCCCcccccccccCCCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhccCCCCCC
Q 015868          259 GVARVQAQS---GVMTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKSLRPTIP  335 (399)
Q Consensus       259 G~a~~~~~~---~~~~~~~gt~~y~aPE~l~~~~~~~~~Dv~slG~vl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~  335 (399)
                      |+++.....   .......||+.|+|||.+.+..++.++||||||+++|+|++|+.||...+..+....... ...+.+|
T Consensus       188 Gls~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~k~DVwSlGvilyeLltG~~Pf~~~~~~~~~~~~~~-~~~~~~~  266 (496)
T PTZ00283        188 GFSKMYAATVSDDVGRTFCGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFDGENMEEVMHKTLA-GRYDPLP  266 (496)
T ss_pred             ccCeeccccccccccccccCCcceeCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhc-CCCCCCC
Confidence            999765432   123345789999999999999999999999999999999999999998877665555443 3445577


Q ss_pred             CCCcHHHHHHHHHHhhhcCCCCCCHHHHHH
Q 015868          336 KHAHPRLAELLERCWQHDPTQRPNFSQITD  365 (399)
Q Consensus       336 ~~~~~~l~~ll~~cl~~dP~~Rps~~ell~  365 (399)
                      ..+++++.+++.+||+.||.+||++.++++
T Consensus       267 ~~~~~~l~~li~~~L~~dP~~RPs~~ell~  296 (496)
T PTZ00283        267 PSISPEMQEIVTALLSSDPKRRPSSSKLLN  296 (496)
T ss_pred             CCCCHHHHHHHHHHcccChhhCcCHHHHHh
Confidence            889999999999999999999999999875

>cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase

Probab=100.00  E-value=8.3e-43  Score=325.31  Aligned_cols=245  Identities=28%  Similarity=0.584  Sum_probs=212.3

Q ss_pred             eeceeCceEEEEEEE----CCeeEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCceeeEEeEEecCCcEEEEEecCCCC
Q 015868          123 KVASGSYGDLYKGTY----CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVTEFMARG  198 (399)
Q Consensus       123 ~lg~G~~g~Vy~~~~----~~~~vAvK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~nIv~~~~~~~~~~~~~lV~E~~~gg  198 (399)
                      +||+|+||.||+|.+    ++..+|+|+++....+....+.+.+|+.+++.++||||+++++++.. ...++||||++++
T Consensus         2 ~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~lv~e~~~~~   80 (257)
T cd05116           2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMIGICEA-ESWMLVMELAELG   80 (257)
T ss_pred             cCCCcCCcceEEeEEecCCCceEEEEEEccCCCCcHHHHHHHHHHHHHHHhCCCCCcceEEEEEcC-CCcEEEEecCCCC
Confidence            689999999999965    46789999998765566677889999999999999999999998864 4679999999999


Q ss_pred             CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceeecCCCcEEEeeccceeeccCCCc----cccCC
Q 015868          199 SIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGV----MTAET  274 (399)
Q Consensus       199 sL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~giiHrDlkp~NILl~~~~~vkl~DFG~a~~~~~~~~----~~~~~  274 (399)
                      +|.+++.. ...+++..+..++.|++.||+|||++||+||||||.||++++++.+||+|||.++.......    .....
T Consensus        81 ~L~~~l~~-~~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dlkp~nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~  159 (257)
T cd05116          81 PLNKFLQK-NKHVTEKNITELVHQVSMGMKYLEETNFVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKAKTHGK  159 (257)
T ss_pred             cHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccchhhEEEcCCCeEEECCCccccccCCCCCeeeecCCCC
Confidence            99999975 35689999999999999999999999999999999999999999999999999976543321    12223


Q ss_pred             CCcccccccccCCCCCCChhhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHHhccCCCCCCCCCcHHHHHHHHHHhhhc
Q 015868          275 GTYRWMAPEVIEHKPYDYKADVFSFGIALWELLT-GELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRLAELLERCWQHD  353 (399)
Q Consensus       275 gt~~y~aPE~l~~~~~~~~~Dv~slG~vl~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~cl~~d  353 (399)
                      ++..|+|||.+....++.++|+||||+++|||++ |..||...+..+... .+.+...+..|..+++++.++|.+||+.|
T Consensus       160 ~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~-~i~~~~~~~~~~~~~~~l~~li~~~~~~~  238 (257)
T cd05116         160 WPVKWYAPECMNYYKFSSKSDVWSFGVLMWEAFSYGQKPYKGMKGNEVTQ-MIESGERMECPQRCPPEMYDLMKLCWTYG  238 (257)
T ss_pred             CCccccCHhHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHH-HHHCCCCCCCCCCCCHHHHHHHHHHhccC
Confidence            4578999999988889999999999999999998 999998877765444 45556667788889999999999999999


Q ss_pred             CCCCCCHHHHHHHHHHH
Q 015868          354 PTQRPNFSQITDILKQM  370 (399)
Q Consensus       354 P~~Rps~~ell~~L~~l  370 (399)
                      |++||++.+|.+.|++.
T Consensus       239 p~~Rp~~~~i~~~l~~~  255 (257)
T cd05116         239 VDERPGFAVVELRLRNY  255 (257)
T ss_pred             chhCcCHHHHHHHHhcc
Confidence            99999999999998764

Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio

>cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B

Probab=100.00  E-value=1e-42  Score=330.45  Aligned_cols=258  Identities=28%  Similarity=0.558  Sum_probs=221.4

Q ss_pred             ecccccceeceeceeCceEEEEEEE-------CCeeEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCceeeEEeEEecC
Q 015868          113 IDAKQLKIECKVASGSYGDLYKGTY-------CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRP  185 (399)
Q Consensus       113 i~~~~~~i~~~lg~G~~g~Vy~~~~-------~~~~vAvK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~nIv~~~~~~~~~  185 (399)
                      |++.+|.+.+.||.|+||.||++..       .+..+|+|.+...  .......+.+|+.++++++||||+++++++...
T Consensus         2 ~~~~~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~   79 (288)
T cd05093           2 IKRHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDA--SDNARKDFHREAELLTNLQHEHIVKFYGVCVEG   79 (288)
T ss_pred             CchHHeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCc--CHHHHHHHHHHHHHHHhCCCCCcceEEEEEecC
Confidence            5678899999999999999999974       2356899988754  345567899999999999999999999999999


Q ss_pred             CcEEEEEecCCCCCHHHHHHhcC------------CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceeecCCCcE
Q 015868          186 PNLCIVTEFMARGSIYDFLHKQK------------GVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVV  253 (399)
Q Consensus       186 ~~~~lV~E~~~ggsL~~~l~~~~------------~~l~~~~~~~i~~~i~~~L~~LH~~giiHrDlkp~NILl~~~~~v  253 (399)
                      ...++||||+++++|.+++....            ..+++..++.++.|++.||+|||++|++||||||+||++++++.+
T Consensus        80 ~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~~~i~H~dlkp~Nili~~~~~~  159 (288)
T cd05093          80 DPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQHFVHRDLATRNCLVGENLLV  159 (288)
T ss_pred             CccEEEEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccCcceEEEccCCcE
Confidence            99999999999999999997542            248999999999999999999999999999999999999999999


Q ss_pred             EEeeccceeeccCCCc---cccCCCCcccccccccCCCCCCChhhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHHhcc
Q 015868          254 KVADFGVARVQAQSGV---MTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLT-GELPYAGLTPLQAAVGVVQKS  329 (399)
Q Consensus       254 kl~DFG~a~~~~~~~~---~~~~~gt~~y~aPE~l~~~~~~~~~Dv~slG~vl~ellt-g~~P~~~~~~~~~~~~~~~~~  329 (399)
                      +|+|||.++.......   .....++..|+|||.+.+..++.++|+||||+++|+|++ |..||.............. .
T Consensus       160 kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t~g~~p~~~~~~~~~~~~i~~-~  238 (288)
T cd05093         160 KIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNEVIECITQ-G  238 (288)
T ss_pred             EeccCCccccccCCceeecCCCCCccccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHc-C
Confidence            9999999975433221   122345778999999999999999999999999999998 9999988877665554443 4


Q ss_pred             CCCCCCCCCcHHHHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHH
Q 015868          330 LRPTIPKHAHPRLAELLERCWQHDPTQRPNFSQITDILKQMMKE  373 (399)
Q Consensus       330 ~~~~~~~~~~~~l~~ll~~cl~~dP~~Rps~~ell~~L~~l~~~  373 (399)
                      ..+..+..+++++.+++.+||+.||.+|||+.++.+.|+++.+.
T Consensus       239 ~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~v~~~l~~~~~~  282 (288)
T cd05093         239 RVLQRPRTCPKEVYDLMLGCWQREPHMRLNIKEIHSLLQNLAKA  282 (288)
T ss_pred             CcCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHHHh
Confidence            44456667899999999999999999999999999999988753

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly

>cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma

Probab=100.00  E-value=1.8e-43  Score=342.34  Aligned_cols=241  Identities=23%  Similarity=0.434  Sum_probs=209.1

Q ss_pred             ceeceeCceEEEEEEE--CCeeEEEEEecCCC-CCHHHHHHHHHHHHHHHhcCCCceeeEEeEEecCCcEEEEEecCCCC
Q 015868          122 CKVASGSYGDLYKGTY--CSQEVAIKVLKPEC-VNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVTEFMARG  198 (399)
Q Consensus       122 ~~lg~G~~g~Vy~~~~--~~~~vAvK~~~~~~-~~~~~~~~~~~Ei~~l~~l~h~nIv~~~~~~~~~~~~~lV~E~~~gg  198 (399)
                      +.||+|+||.||++..  .++.||+|+++... ........+.+|+.+++.++||||+++++++.....+|+||||+++|
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~Ey~~~g   80 (328)
T cd05593           1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQTKDRLCFVMEYVNGG   80 (328)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCEEEEEEeCCCCC
Confidence            3689999999999986  57899999997543 23345577889999999999999999999999999999999999999


Q ss_pred             CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceeecCCCcEEEeeccceeeccC-CCccccCCCCc
Q 015868          199 SIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQ-SGVMTAETGTY  277 (399)
Q Consensus       199 sL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~giiHrDlkp~NILl~~~~~vkl~DFG~a~~~~~-~~~~~~~~gt~  277 (399)
                      +|.+++.. ...+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+++.... ........||+
T Consensus        81 ~L~~~l~~-~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~NIll~~~~~~kL~DfG~~~~~~~~~~~~~~~~gt~  159 (328)
T cd05593          81 ELFFHLSR-ERVFSEDRTRFYGAEIVSALDYLHSGKIVYRDLKLENLMLDKDGHIKITDFGLCKEGITDAATMKTFCGTP  159 (328)
T ss_pred             CHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCeEecccCHHHeEECCCCcEEEecCcCCccCCCcccccccccCCc
Confidence            99998865 45789999999999999999999999999999999999999999999999999875332 22234457899


Q ss_pred             ccccccccCCCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhccCCCCCCCCCcHHHHHHHHHHhhhcCCCC
Q 015868          278 RWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRLAELLERCWQHDPTQR  357 (399)
Q Consensus       278 ~y~aPE~l~~~~~~~~~Dv~slG~vl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~cl~~dP~~R  357 (399)
                      .|+|||++.+..++.++|||||||++|+|++|+.||...+..+.......  ....+|..+++++.+++.+||+.||.+|
T Consensus       160 ~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~~~~~~~~~~~--~~~~~p~~~~~~~~~li~~~L~~dP~~R  237 (328)
T cd05593         160 EYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILM--EDIKFPRTLSADAKSLLSGLLIKDPNKR  237 (328)
T ss_pred             CccChhhhcCCCCCccCCccccchHHHHHhhCCCCCCCCCHHHHHHHhcc--CCccCCCCCCHHHHHHHHHHcCCCHHHc
Confidence            99999999999999999999999999999999999988777665544332  2345778899999999999999999999


Q ss_pred             C-----CHHHHHH
Q 015868          358 P-----NFSQITD  365 (399)
Q Consensus       358 p-----s~~ell~  365 (399)
                      |     ++.++++
T Consensus       238 ~~~~~~~~~~il~  250 (328)
T cd05593         238 LGGGPDDAKEIMR  250 (328)
T ss_pred             CCCCCCCHHHHhc
Confidence            7     8888875

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate

>cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.6e-43  Score=347.21  Aligned_cols=248  Identities=22%  Similarity=0.374  Sum_probs=211.6

Q ss_pred             cccceeceeceeCceEEEEEEE--CCeeEEEEEecCCC-CCHHHHHHHHHHHHHHHhcCCCceeeEEeEEecCCcEEEEE
Q 015868          116 KQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPEC-VNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVT  192 (399)
Q Consensus       116 ~~~~i~~~lg~G~~g~Vy~~~~--~~~~vAvK~~~~~~-~~~~~~~~~~~Ei~~l~~l~h~nIv~~~~~~~~~~~~~lV~  192 (399)
                      ++|++.+.||.|+||.||+++.  +++.||||+++... ........+.+|+.+++.++||||+++++++..+..+|+||
T Consensus         1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~   80 (364)
T cd05599           1 DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLYYSFQDENYLYLIM   80 (364)
T ss_pred             CCceEEEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCeEEEEE
Confidence            4789999999999999999987  57899999997532 23344567889999999999999999999999999999999


Q ss_pred             ecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceeecCCCcEEEeeccceeeccCCC----
Q 015868          193 EFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSG----  268 (399)
Q Consensus       193 E~~~ggsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~giiHrDlkp~NILl~~~~~vkl~DFG~a~~~~~~~----  268 (399)
                      ||++||+|.+++.. .+.+++..+..++.|++.||+|||++||+||||||+|||++.++.++|+|||+++......    
T Consensus        81 E~~~~g~L~~~l~~-~~~l~~~~~~~~~~qi~~aL~~lH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~  159 (364)
T cd05599          81 EYLPGGDMMTLLMK-KDTFTEEETRFYIAETILAIDSIHKLGYIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSHRTEF  159 (364)
T ss_pred             CCCCCcHHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCCCCEEEeecccceeccccccccc
Confidence            99999999999976 4578999999999999999999999999999999999999999999999999986532211    


Q ss_pred             -----------------------------------ccccCCCCcccccccccCCCCCCChhhHHHHHHHHHHHHcCCCCC
Q 015868          269 -----------------------------------VMTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPY  313 (399)
Q Consensus       269 -----------------------------------~~~~~~gt~~y~aPE~l~~~~~~~~~Dv~slG~vl~elltg~~P~  313 (399)
                                                         ......||+.|+|||++.+..++.++|||||||++|+|++|..||
T Consensus       160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~G~~Pf  239 (364)
T cd05599         160 YRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIMYEMLVGYPPF  239 (364)
T ss_pred             cccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcCCCCCCeeeeecchhHHHHhhcCCCCC
Confidence                                               001235899999999999999999999999999999999999999


Q ss_pred             CCCCHHHHHHHHHhccCCCCCCC--CCcHHHHHHHHHHhhhcCCCCCC---HHHHHH
Q 015868          314 AGLTPLQAAVGVVQKSLRPTIPK--HAHPRLAELLERCWQHDPTQRPN---FSQITD  365 (399)
Q Consensus       314 ~~~~~~~~~~~~~~~~~~~~~~~--~~~~~l~~ll~~cl~~dP~~Rps---~~ell~  365 (399)
                      ...++.+....+.........|.  .+++++.++|.+|+. +|.+|++   +.++++
T Consensus       240 ~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~ll~-~p~~R~~~~~~~~ll~  295 (364)
T cd05599         240 CSDNPQETYRKIINWKETLQFPDEVPLSPEAKDLIKRLCC-EAERRLGNNGVNEIKS  295 (364)
T ss_pred             CCCCHHHHHHHHHcCCCccCCCCCCCCCHHHHHHHHHHcc-CHhhcCCCCCHHHHhc
Confidence            99888776665554333333333  468999999999997 9999998   888766

Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica

>cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6

Probab=100.00  E-value=1.1e-42  Score=325.69  Aligned_cols=254  Identities=26%  Similarity=0.504  Sum_probs=215.1

Q ss_pred             cccceeceeceeCceEEEEEEE--CCeeEEEEEecCCC-CCHHHHHHHHHHHHHHHhcCCCceeeEEeEEecCCcEEEEE
Q 015868          116 KQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPEC-VNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVT  192 (399)
Q Consensus       116 ~~~~i~~~lg~G~~g~Vy~~~~--~~~~vAvK~~~~~~-~~~~~~~~~~~Ei~~l~~l~h~nIv~~~~~~~~~~~~~lV~  192 (399)
                      ++|++.+.||.|+||.||+|+.  +++.||||.++... ........+.+|+.+++.++||||+++++++...+..++|+
T Consensus         2 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~   81 (267)
T cd08228           2 ANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLDSFIEDNELNIVL   81 (267)
T ss_pred             cceeeeeeeccCCCeeEEEEEEeCCCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCcceeeeeeeEEECCeEEEEE
Confidence            5799999999999999999986  67899999886532 34555678899999999999999999999999999999999


Q ss_pred             ecCCCCCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceeecCCCcEEEeeccceeeccCCCc
Q 015868          193 EFMARGSIYDFLHK---QKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGV  269 (399)
Q Consensus       193 E~~~ggsL~~~l~~---~~~~l~~~~~~~i~~~i~~~L~~LH~~giiHrDlkp~NILl~~~~~vkl~DFG~a~~~~~~~~  269 (399)
                      ||+++++|.+++..   ....+++..+..++.|++.||+|||++|++|+||+|+||+++.++.++|+|||.+........
T Consensus        82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~~~nil~~~~~~~~l~d~g~~~~~~~~~~  161 (267)
T cd08228          82 ELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTT  161 (267)
T ss_pred             EecCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCCHHHEEEcCCCCEEECccccceeccchhH
Confidence            99999999998853   235588999999999999999999999999999999999999999999999999876543321


Q ss_pred             -cccCCCCcccccccccCCCCCCChhhHHHHHHHHHHHHcCCCCCCCCCH--HHHHHHHHhccCCCCC-CCCCcHHHHHH
Q 015868          270 -MTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPYAGLTP--LQAAVGVVQKSLRPTI-PKHAHPRLAEL  345 (399)
Q Consensus       270 -~~~~~gt~~y~aPE~l~~~~~~~~~Dv~slG~vl~elltg~~P~~~~~~--~~~~~~~~~~~~~~~~-~~~~~~~l~~l  345 (399)
                       .....++..|+|||.+.+..++.++|+||||+++|+|++|..||.....  .... ..+.....+.. +..++..+.++
T Consensus       162 ~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~l  240 (267)
T cd08228         162 AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLFSLC-QKIEQCDYPPLPTEHYSEKLREL  240 (267)
T ss_pred             HHhcCCCCccccChhhhccCCCCchhhHHHHHHHHHHHhcCCCCCccccccHHHHH-HHHhcCCCCCCChhhcCHHHHHH
Confidence             2334688899999999988899999999999999999999999865432  2322 23333233333 34678899999


Q ss_pred             HHHHhhhcCCCCCCHHHHHHHHHHH
Q 015868          346 LERCWQHDPTQRPNFSQITDILKQM  370 (399)
Q Consensus       346 l~~cl~~dP~~Rps~~ell~~L~~l  370 (399)
                      +.+||+.+|++||++.++++.++++
T Consensus       241 i~~cl~~~p~~Rp~~~~vl~~~~~~  265 (267)
T cd08228         241 VSMCIYPDPDQRPDIGYVHQIAKQM  265 (267)
T ss_pred             HHHHCCCCcccCcCHHHHHHHHHHh
Confidence            9999999999999999999999876

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase

>cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2

Probab=100.00  E-value=6.2e-43  Score=334.63  Aligned_cols=261  Identities=32%  Similarity=0.609  Sum_probs=219.0

Q ss_pred             ecccccceeceeceeCceEEEEEEEC--Ce--eEEEEEecCCCCCHHHHHHHHHHHHHHHhc-CCCceeeEEeEEecCCc
Q 015868          113 IDAKQLKIECKVASGSYGDLYKGTYC--SQ--EVAIKVLKPECVNTEMLKEFSQEVYIMRKI-RHKNVVQFIGACTRPPN  187 (399)
Q Consensus       113 i~~~~~~i~~~lg~G~~g~Vy~~~~~--~~--~vAvK~~~~~~~~~~~~~~~~~Ei~~l~~l-~h~nIv~~~~~~~~~~~  187 (399)
                      +..++|++.+.||.|+||.||+|.+.  +.  .+|+|.++.. ........+.+|+.++.++ +||||+++++++.....
T Consensus         4 ~~~~~~~~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~~-~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~~~~   82 (303)
T cd05088           4 LEWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEY-ASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGY   82 (303)
T ss_pred             cchhhceeeeeecCCCCceEEEEEEccCCceeeEEEEEeccc-CCHHHHHHHHHHHHHHHHhcCCCCcceEEEEECCCCC
Confidence            45678999999999999999999863  33  4577776643 2345567889999999999 89999999999999999


Q ss_pred             EEEEEecCCCCCHHHHHHhcC---------------CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceeecCCCc
Q 015868          188 LCIVTEFMARGSIYDFLHKQK---------------GVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGV  252 (399)
Q Consensus       188 ~~lV~E~~~ggsL~~~l~~~~---------------~~l~~~~~~~i~~~i~~~L~~LH~~giiHrDlkp~NILl~~~~~  252 (399)
                      +++||||+++++|.+++....               ..+++..++.++.|++.|++|||++|++||||||+|||++.++.
T Consensus        83 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~gi~H~dlkp~Nili~~~~~  162 (303)
T cd05088          83 LYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYV  162 (303)
T ss_pred             ceEEEEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHhCCccccccchheEEecCCCc
Confidence            999999999999999997542               25789999999999999999999999999999999999999999


Q ss_pred             EEEeeccceeeccCCCccccCCCCcccccccccCCCCCCChhhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHHhccCC
Q 015868          253 VKVADFGVARVQAQSGVMTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLT-GELPYAGLTPLQAAVGVVQKSLR  331 (399)
Q Consensus       253 vkl~DFG~a~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~Dv~slG~vl~ellt-g~~P~~~~~~~~~~~~~~~~~~~  331 (399)
                      +||+|||++.............++..|+|||.+.+..++.++||||||+++|+|+| |..||...+..+.... .....+
T Consensus       163 ~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~-~~~~~~  241 (303)
T cd05088         163 AKIADFGLSRGQEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEK-LPQGYR  241 (303)
T ss_pred             EEeCccccCcccchhhhcccCCCcccccCHHHHhccCCcccccchhhhhHHHHHHhcCCCCcccCChHHHHHH-HhcCCc
Confidence            99999999864322211222334678999999988889999999999999999998 9999988777655443 333445


Q ss_pred             CCCCCCCcHHHHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHH
Q 015868          332 PTIPKHAHPRLAELLERCWQHDPTQRPNFSQITDILKQMMKEVA  375 (399)
Q Consensus       332 ~~~~~~~~~~l~~ll~~cl~~dP~~Rps~~ell~~L~~l~~~~~  375 (399)
                      +..+...++++.+++.+||+.+|++||++.++++.+.+++.+-.
T Consensus       242 ~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~l~~~~~~~~  285 (303)
T cd05088         242 LEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEERK  285 (303)
T ss_pred             CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhhh
Confidence            55667788999999999999999999999999999998876543

Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A

>KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=3.4e-44  Score=335.35  Aligned_cols=247  Identities=23%  Similarity=0.490  Sum_probs=222.3

Q ss_pred             ccccceeceeceeCceEEEEEEE--CCeeEEEEEecCCCC-CHHHHHHHHHHHHHHHhcCCCceeeEEeEEecCCcEEEE
Q 015868          115 AKQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECV-NTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIV  191 (399)
Q Consensus       115 ~~~~~i~~~lg~G~~g~Vy~~~~--~~~~vAvK~~~~~~~-~~~~~~~~~~Ei~~l~~l~h~nIv~~~~~~~~~~~~~lV  191 (399)
                      ..+|++.+.||.|.||.|-+|..  .++.||||.++.+.. ++...-.+.+||+||..|+||||+++|.+|+..+.+.||
T Consensus        52 kHRyE~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLNHPhII~IyEVFENkdKIviv  131 (668)
T KOG0611|consen   52 KHRYEITETLGKGTYGKVKLAYEHKSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSLNHPHIIQIYEVFENKDKIVIV  131 (668)
T ss_pred             hhHHHHHHHhcCCcccceeehhhccCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhcCCCceeehhhhhcCCceEEEE
Confidence            46899999999999999999975  689999999987655 344566799999999999999999999999999999999


Q ss_pred             EecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceeecCCCcEEEeeccceeeccCCCccc
Q 015868          192 TEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMT  271 (399)
Q Consensus       192 ~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~giiHrDlkp~NILl~~~~~vkl~DFG~a~~~~~~~~~~  271 (399)
                      |||..+|.|+||+.. .+.+++.+...++.||++|+.|+|+++++|||||.+|||+|.|+.+||+|||++..+......+
T Consensus       132 MEYaS~GeLYDYiSe-r~~LsErEaRhfFRQIvSAVhYCHknrVvHRDLKLENILLD~N~NiKIADFGLSNly~~~kfLq  210 (668)
T KOG0611|consen  132 MEYASGGELYDYISE-RGSLSEREARHFFRQIVSAVHYCHKNRVVHRDLKLENILLDQNNNIKIADFGLSNLYADKKFLQ  210 (668)
T ss_pred             EEecCCccHHHHHHH-hccccHHHHHHHHHHHHHHHHHHhhccceecccchhheeecCCCCeeeeccchhhhhccccHHH
Confidence            999999999999977 5789999999999999999999999999999999999999999999999999999998888889


Q ss_pred             cCCCCcccccccccCCCCCC-ChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhccCCCCCCCCCcHHHHHHHHHHh
Q 015868          272 AETGTYRWMAPEVIEHKPYD-YKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRLAELLERCW  350 (399)
Q Consensus       272 ~~~gt~~y~aPE~l~~~~~~-~~~Dv~slG~vl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~cl  350 (399)
                      +.+|++-|.+||++++.+|. +..|-||||++||.|..|..||++.+-.....++-....+   .+..+.+..-||+.||
T Consensus       211 TFCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyGtMPFDG~Dhk~lvrQIs~GaYr---EP~~PSdA~gLIRwmL  287 (668)
T KOG0611|consen  211 TFCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYGTMPFDGRDHKRLVRQISRGAYR---EPETPSDASGLIRWML  287 (668)
T ss_pred             HhcCCcccCCccccCCCCCCCCccchhhHHHHHHHHhhcccccCCchHHHHHHHhhccccc---CCCCCchHHHHHHHHH
Confidence            99999999999999999995 7799999999999999999999998876655554443333   2334567899999999


Q ss_pred             hhcCCCCCCHHHHHH
Q 015868          351 QHDPTQRPNFSQITD  365 (399)
Q Consensus       351 ~~dP~~Rps~~ell~  365 (399)
                      ..||+.|.|+++|..
T Consensus       288 mVNP~RRATieDiAs  302 (668)
T KOG0611|consen  288 MVNPERRATIEDIAS  302 (668)
T ss_pred             hcCcccchhHHHHhh
Confidence            999999999999865

>cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1

Probab=100.00  E-value=4e-43  Score=344.56  Aligned_cols=250  Identities=23%  Similarity=0.357  Sum_probs=209.9

Q ss_pred             cccceeceeceeCceEEEEEEE--CCeeEEEEEecCCCC-CHHHHHHHHHHHHHHHhcCCCceeeEEeEEecCCcEEEEE
Q 015868          116 KQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECV-NTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVT  192 (399)
Q Consensus       116 ~~~~i~~~lg~G~~g~Vy~~~~--~~~~vAvK~~~~~~~-~~~~~~~~~~Ei~~l~~l~h~nIv~~~~~~~~~~~~~lV~  192 (399)
                      ++|++.+.||+|+||.||+++.  +++.||+|+++.... .......+.+|+.++++++|+||+++++.+.+...+|+||
T Consensus         1 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~~~~~~~~lv~   80 (363)
T cd05628           1 EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFYSFQDKLNLYLIM   80 (363)
T ss_pred             CCceEeEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCCCCCcceEEEEEecCCeEEEEE
Confidence            4789999999999999999987  578999999975321 2344567889999999999999999999999999999999


Q ss_pred             ecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceeecCCCcEEEeeccceeeccCCC----
Q 015868          193 EFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSG----  268 (399)
Q Consensus       193 E~~~ggsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~giiHrDlkp~NILl~~~~~vkl~DFG~a~~~~~~~----  268 (399)
                      ||++||+|.+++.. .+.+++..+..++.|++.||+|||++||+||||||+|||++.++.+||+|||+++......    
T Consensus        81 E~~~gg~L~~~l~~-~~~l~~~~~~~~~~qi~~aL~~lH~~givHrDlKp~NILi~~~~~vkL~DFGla~~~~~~~~~~~  159 (363)
T cd05628          81 EFLPGGDMMTLLMK-KDTLTEEETQFYIAETVLAIDSIHQLGFIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHRTEF  159 (363)
T ss_pred             cCCCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCeEecCCCHHHeEECCCCCEEEeeccCcccccccccccc
Confidence            99999999999976 4678999999999999999999999999999999999999999999999999987432110    


Q ss_pred             --------------------------------ccccCCCCcccccccccCCCCCCChhhHHHHHHHHHHHHcCCCCCCCC
Q 015868          269 --------------------------------VMTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPYAGL  316 (399)
Q Consensus       269 --------------------------------~~~~~~gt~~y~aPE~l~~~~~~~~~Dv~slG~vl~elltg~~P~~~~  316 (399)
                                                      ......||+.|+|||++.+..++.++|||||||++|||++|..||.+.
T Consensus       160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~ell~G~~Pf~~~  239 (363)
T cd05628         160 YRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPFCSE  239 (363)
T ss_pred             cccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcCCCCCCchhhhhhHHHHHHHHhCCCCCCCC
Confidence                                            012346899999999999999999999999999999999999999998


Q ss_pred             CHHHHHHHHHhccCCCCCCC--CCcHHHHHHHHHHhhh--cCCCCCCHHHHHHH
Q 015868          317 TPLQAAVGVVQKSLRPTIPK--HAHPRLAELLERCWQH--DPTQRPNFSQITDI  366 (399)
Q Consensus       317 ~~~~~~~~~~~~~~~~~~~~--~~~~~l~~ll~~cl~~--dP~~Rps~~ell~~  366 (399)
                      ++.+....+........+|.  .+++++.+++.+|+..  ++..||+++|+++.
T Consensus       240 ~~~~~~~~i~~~~~~~~~p~~~~~s~~~~~li~~l~~~~~~r~~r~~~~ei~~h  293 (363)
T cd05628         240 TPQETYKKVMNWKETLIFPPEVPISEKAKDLILRFCCEWEHRIGAPGVEEIKTN  293 (363)
T ss_pred             CHHHHHHHHHcCcCcccCCCcCCCCHHHHHHHHHHcCChhhcCCCCCHHHHhCC
Confidence            88776666554333333343  4689999999997652  33356899999874

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus

>cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2

Probab=100.00  E-value=3e-43  Score=347.67  Aligned_cols=248  Identities=23%  Similarity=0.371  Sum_probs=209.3

Q ss_pred             ccceeceeceeCceEEEEEEE--CCeeEEEEEecCCC-CCHHHHHHHHHHHHHHHhcCCCceeeEEeEEecCCcEEEEEe
Q 015868          117 QLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPEC-VNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVTE  193 (399)
Q Consensus       117 ~~~i~~~lg~G~~g~Vy~~~~--~~~~vAvK~~~~~~-~~~~~~~~~~~Ei~~l~~l~h~nIv~~~~~~~~~~~~~lV~E  193 (399)
                      .|++.++||+|+||.||+|+.  +++.||+|+++... .+......+.+|+.+++.++||||+++++++.....+|+|||
T Consensus         2 ~f~~~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lv~E   81 (381)
T cd05626           2 MFVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMD   81 (381)
T ss_pred             CceEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcCCCCeeeeEEEEecCCEEEEEEe
Confidence            688999999999999999987  56889999997543 234556789999999999999999999999999999999999


Q ss_pred             cCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceeecCCCcEEEeeccceeeccCC------
Q 015868          194 FMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQS------  267 (399)
Q Consensus       194 ~~~ggsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~giiHrDlkp~NILl~~~~~vkl~DFG~a~~~~~~------  267 (399)
                      |++||+|.+++.. ...+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.....      
T Consensus        82 ~~~gg~L~~~l~~-~~~~~e~~~~~~~~qi~~aL~~LH~~givHrDlKp~Nili~~~~~~kL~DFGl~~~~~~~~~~~~~  160 (381)
T cd05626          82 YIPGGDMMSLLIR-MEVFPEVLARFYIAELTLAIESVHKMGFIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTHNSKYY  160 (381)
T ss_pred             cCCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCcHHHEEECCCCCEEEeeCcCCcccccccccccc
Confidence            9999999999976 456899999999999999999999999999999999999999999999999987532100      


Q ss_pred             ------------------------------------------CccccCCCCcccccccccCCCCCCChhhHHHHHHHHHH
Q 015868          268 ------------------------------------------GVMTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWE  305 (399)
Q Consensus       268 ------------------------------------------~~~~~~~gt~~y~aPE~l~~~~~~~~~Dv~slG~vl~e  305 (399)
                                                                .......||+.|+|||++.+..++.++|||||||++||
T Consensus       161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlG~il~e  240 (381)
T cd05626         161 QKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWSVGVILFE  240 (381)
T ss_pred             cccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcCCCCCCccceeehhhHHHH
Confidence                                                      00123468999999999999999999999999999999


Q ss_pred             HHcCCCCCCCCCHHHHHHHHHhccCCCCCCC--CCcHHHHHHHHHHh--hhcCCCCCCHHHHHH
Q 015868          306 LLTGELPYAGLTPLQAAVGVVQKSLRPTIPK--HAHPRLAELLERCW--QHDPTQRPNFSQITD  365 (399)
Q Consensus       306 lltg~~P~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~l~~ll~~cl--~~dP~~Rps~~ell~  365 (399)
                      |++|..||...++.+.............+|.  .+++++.++|.+|+  ..+|..||++.+++.
T Consensus       241 lltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~dli~~ll~~~~~~~~R~~~~~~l~  304 (381)
T cd05626         241 MLVGQPPFLAPTPTETQLKVINWENTLHIPPQVKLSPEAVDLITKLCCSAEERLGRNGADDIKA  304 (381)
T ss_pred             HHhCCCCCcCCCHHHHHHHHHccccccCCCCCCCCCHHHHHHHHHHccCcccccCCCCHHHHhc
Confidence            9999999998887666555544332333333  57899999999955  455666999999976

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po

>cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases

Probab=100.00  E-value=1e-42  Score=324.52  Aligned_cols=251  Identities=33%  Similarity=0.641  Sum_probs=216.5

Q ss_pred             ecccccceeceeceeCceEEEEEEEC-CeeEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCceeeEEeEEecCCcEEEE
Q 015868          113 IDAKQLKIECKVASGSYGDLYKGTYC-SQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIV  191 (399)
Q Consensus       113 i~~~~~~i~~~lg~G~~g~Vy~~~~~-~~~vAvK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~nIv~~~~~~~~~~~~~lV  191 (399)
                      |+..+|++.+.||+|+||.||++.+. +..+|+|++......   ...+.+|+.+++.++||||+++++++......++|
T Consensus         1 ~~~~~~~~~~~lg~G~~~~v~~~~~~~~~~~~iK~~~~~~~~---~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv   77 (256)
T cd05059           1 IDPSELTFLKELGSGQFGVVHLGKWRGKIDVAIKMIREGAMS---EDDFIEEAKVMMKLSHPNLVQLYGVCTKQRPIFIV   77 (256)
T ss_pred             CChHHcchhhhhccCCCceEEEeEecCCccEEEEEeccCCCC---HHHHHHHHHHHHhCCCCCEEEEEEEEcCCCceEEE
Confidence            34567999999999999999999874 457999998754332   24678899999999999999999999999999999


Q ss_pred             EecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceeecCCCcEEEeeccceeeccCCCcc-
Q 015868          192 TEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVM-  270 (399)
Q Consensus       192 ~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~giiHrDlkp~NILl~~~~~vkl~DFG~a~~~~~~~~~-  270 (399)
                      |||++|++|.+++......+++..+..++.|++.|++|||++|++||||||+||++++++.+||+|||.++........ 
T Consensus        78 ~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~ni~i~~~~~~kl~dfg~~~~~~~~~~~~  157 (256)
T cd05059          78 TEYMANGCLLNYLRERKGKLGTEWLLDMCSDVCEAMEYLESNGFIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQYTS  157 (256)
T ss_pred             EecCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCcccccccHhhEEECCCCcEEECCcccceecccccccc
Confidence            9999999999999876678899999999999999999999999999999999999999999999999998765432211 


Q ss_pred             -ccCCCCcccccccccCCCCCCChhhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHHhccCCCCCCCCCcHHHHHHHHH
Q 015868          271 -TAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLT-GELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRLAELLER  348 (399)
Q Consensus       271 -~~~~gt~~y~aPE~l~~~~~~~~~Dv~slG~vl~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~  348 (399)
                       ....++..|+|||.+.+..++.++|+||||+++|+|++ |..||...++.+.... .....++..+..++.++.+++.+
T Consensus       158 ~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~li~~  236 (256)
T cd05059         158 SQGTKFPVKWAPPEVFDYSRFSSKSDVWSFGVLMWEVFSEGKMPYERFSNSEVVES-VSAGYRLYRPKLAPTEVYTIMYS  236 (256)
T ss_pred             cCCCCCCccccCHHHhccCCCCchhhHHHHHHHHHHHhccCCCCCCCCCHHHHHHH-HHcCCcCCCCCCCCHHHHHHHHH
Confidence             11223567999999999899999999999999999999 8999988777665544 44455667777899999999999


Q ss_pred             HhhhcCCCCCCHHHHHHHH
Q 015868          349 CWQHDPTQRPNFSQITDIL  367 (399)
Q Consensus       349 cl~~dP~~Rps~~ell~~L  367 (399)
                      ||..+|++|||+.++++.|
T Consensus       237 cl~~~p~~Rpt~~~~l~~l  255 (256)
T cd05059         237 CWHEKPEDRPAFKKLLSQL  255 (256)
T ss_pred             HhcCChhhCcCHHHHHHHh
Confidence            9999999999999999876

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows

>cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase

Probab=100.00  E-value=8.7e-44  Score=344.51  Aligned_cols=249  Identities=22%  Similarity=0.354  Sum_probs=214.4

Q ss_pred             cccceeceeceeCceEEEEEEE--CCeeEEEEEecCCCC-CHHHHHHHHHHHHHHHhcCCCceeeEEeEEecCCcEEEEE
Q 015868          116 KQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECV-NTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVT  192 (399)
Q Consensus       116 ~~~~i~~~lg~G~~g~Vy~~~~--~~~~vAvK~~~~~~~-~~~~~~~~~~Ei~~l~~l~h~nIv~~~~~~~~~~~~~lV~  192 (399)
                      ++|++.+.||+|+||.||++..  +++.||+|+++.... ..+....+.+|+.+++.++||||+++++++......++||
T Consensus         1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~~~~~~~lv~   80 (330)
T cd05601           1 KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAFQDKDNLYLVM   80 (330)
T ss_pred             CCceEEEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceeeEEecCCeEEEEE
Confidence            4689999999999999999987  578999999985432 3345567889999999999999999999999999999999


Q ss_pred             ecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceeecCCCcEEEeeccceeeccCCCc--c
Q 015868          193 EFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGV--M  270 (399)
Q Consensus       193 E~~~ggsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~giiHrDlkp~NILl~~~~~vkl~DFG~a~~~~~~~~--~  270 (399)
                      ||+++++|.+++......+++..+..++.|++.||.|||++||+||||||+||+++.++.+||+|||++........  .
T Consensus        81 e~~~~~~L~~~l~~~~~~l~~~~~~~~~~qi~~aL~~lH~~~i~H~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~  160 (330)
T cd05601          81 EYQPGGDLLSLLNRYEDQFDEDMAQFYLAELVLAIHSVHQMGYVHRDIKPENVLIDRTGHIKLADFGSAARLTANKMVNS  160 (330)
T ss_pred             CCCCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEcccCchHheEECCCCCEEeccCCCCeECCCCCceee
Confidence            99999999999988767899999999999999999999999999999999999999999999999999986544322  2


Q ss_pred             ccCCCCcccccccccC------CCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhccCCCCCC--CCCcHHH
Q 015868          271 TAETGTYRWMAPEVIE------HKPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKSLRPTIP--KHAHPRL  342 (399)
Q Consensus       271 ~~~~gt~~y~aPE~l~------~~~~~~~~Dv~slG~vl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~l  342 (399)
                      ....||+.|+|||++.      ...++.++||||||+++|+|++|..||...+..+....+.........|  ..+++++
T Consensus       161 ~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~  240 (330)
T cd05601         161 KLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSAKTYNNIMNFQRFLKFPEDPKVSSDF  240 (330)
T ss_pred             ecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCCCCCCHHHHHHHHHcCCCccCCCCCCCCCHHH
Confidence            3346899999999987      4567899999999999999999999999888777666555433222233  3578999


Q ss_pred             HHHHHHHhhhcCCCCCCHHHHHH
Q 015868          343 AELLERCWQHDPTQRPNFSQITD  365 (399)
Q Consensus       343 ~~ll~~cl~~dP~~Rps~~ell~  365 (399)
                      .+|+.+||+ +|.+|||+.++++
T Consensus       241 ~~li~~ll~-~p~~R~t~~~l~~  262 (330)
T cd05601         241 LDLIQSLLC-GQKERLGYEGLCC  262 (330)
T ss_pred             HHHHHHHcc-ChhhCCCHHHHhC
Confidence            999999998 9999999999875

Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor

>KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=100.00  E-value=5.5e-44  Score=348.27  Aligned_cols=259  Identities=38%  Similarity=0.760  Sum_probs=235.6

Q ss_pred             CceeecccccceeceeceeCceEEEEEEEC--CeeEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCceeeEEeEEecCC
Q 015868          109 DVWEIDAKQLKIECKVASGSYGDLYKGTYC--SQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPP  186 (399)
Q Consensus       109 ~~~~i~~~~~~i~~~lg~G~~g~Vy~~~~~--~~~vAvK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~nIv~~~~~~~~~~  186 (399)
                      +.|+++..+.....+||-|.||.||.|.|.  .-.||||.++.+   .-...+|..|..+|+.++|||+|+++|+|+.++
T Consensus       260 DkWEmeRtdItMkhKLGGGQYGeVYeGvWKkyslTvAVKtLKED---tMeveEFLkEAAvMKeikHpNLVqLLGVCT~Ep  336 (1157)
T KOG4278|consen  260 DKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED---TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTHEP  336 (1157)
T ss_pred             chhhccchheeeeeccCCCcccceeeeeeeccceeeehhhhhhc---chhHHHHHHHHHHHHhhcCccHHHHhhhhccCC
Confidence            789999999999999999999999999884  567999999864   344689999999999999999999999999999


Q ss_pred             cEEEEEecCCCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceeecCCCcEEEeeccceeecc
Q 015868          187 NLCIVTEFMARGSIYDFLHKQK-GVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQA  265 (399)
Q Consensus       187 ~~~lV~E~~~ggsL~~~l~~~~-~~l~~~~~~~i~~~i~~~L~~LH~~giiHrDlkp~NILl~~~~~vkl~DFG~a~~~~  265 (399)
                      .+|||+|||..|+|.+||++.+ ..++.-.++.++.||.+||.||..+++|||||.++|.|+.++..|||+|||+++.+.
T Consensus       337 PFYIiTEfM~yGNLLdYLRecnr~ev~avvLlyMAtQIsSaMeYLEkknFIHRDLAARNCLVgEnhiVKvADFGLsRlMt  416 (1157)
T KOG4278|consen  337 PFYIITEFMCYGNLLDYLRECNRSEVPAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHIVKVADFGLSRLMT  416 (1157)
T ss_pred             CeEEEEecccCccHHHHHHHhchhhcchhHHHHHHHHHHHHHHHHHHhhhhhhhhhhhhccccccceEEeeccchhhhhc
Confidence            9999999999999999998854 446667788999999999999999999999999999999999999999999999876


Q ss_pred             CCCccccCCC---CcccccccccCCCCCCChhhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHHhccCCCCCCCCCcHH
Q 015868          266 QSGVMTAETG---TYRWMAPEVIEHKPYDYKADVFSFGIALWELLT-GELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPR  341 (399)
Q Consensus       266 ~~~~~~~~~g---t~~y~aPE~l~~~~~~~~~Dv~slG~vl~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  341 (399)
                      .. ..++..|   +..|.|||-+.-..++.|+|||+||++|||+.| |--||.+.+-.+. .+.+.++.|...|..|++.
T Consensus       417 gD-TYTAHAGAKFPIKWTAPEsLAyNtFSiKSDVWAFGVLLWEIATYGMsPYPGidlSqV-Y~LLEkgyRM~~PeGCPpk  494 (1157)
T KOG4278|consen  417 GD-TYTAHAGAKFPIKWTAPESLAYNTFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQV-YGLLEKGYRMDGPEGCPPK  494 (1157)
T ss_pred             CC-ceecccCccCcccccCcccccccccccchhhHHHHHHHHHHHhcCCCCCCCccHHHH-HHHHhccccccCCCCCCHH
Confidence            54 3555555   668999999999999999999999999999999 8899999887774 5678889999999999999


Q ss_pred             HHHHHHHHhhhcCCCCCCHHHHHHHHHHHHH
Q 015868          342 LAELLERCWQHDPTQRPNFSQITDILKQMMK  372 (399)
Q Consensus       342 l~~ll~~cl~~dP~~Rps~~ell~~L~~l~~  372 (399)
                      ..+||+.||++.|.+||+|.|+-+.++.|..
T Consensus       495 VYeLMraCW~WsPsDRPsFaeiHqafEtmf~  525 (1157)
T KOG4278|consen  495 VYELMRACWNWSPSDRPSFAEIHQAFETMFS  525 (1157)
T ss_pred             HHHHHHHHhcCCcccCccHHHHHHHHHHHhc
Confidence            9999999999999999999999999999865

>cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk

Probab=100.00  E-value=3.8e-43  Score=327.73  Aligned_cols=256  Identities=33%  Similarity=0.679  Sum_probs=222.0

Q ss_pred             eeecccccceeceeceeCceEEEEEEEC-CeeEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCceeeEEeEEecCCcEE
Q 015868          111 WEIDAKQLKIECKVASGSYGDLYKGTYC-SQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLC  189 (399)
Q Consensus       111 ~~i~~~~~~i~~~lg~G~~g~Vy~~~~~-~~~vAvK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~nIv~~~~~~~~~~~~~  189 (399)
                      |+....+|++.++||.|+||.||+|.+. +..+|+|+++..  .......+.+|+.+++.++||||+++++++......+
T Consensus         1 ~~~~~~~y~~~~~ig~g~~~~vy~~~~~~~~~~~~k~~~~~--~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~   78 (261)
T cd05148           1 WERPREEFTLERKLGSGYFGEVWEGLWKNRVRVAIKILKSD--DLLKQQDFQKEVQALKRLRHKHLISLFAVCSVGEPVY   78 (261)
T ss_pred             CcCcHHHHHHhhhhccCCCccEEEeEecCCCcEEEEecccc--chhhHHHHHHHHHHHhcCCCcchhheeeeEecCCCeE
Confidence            3445678999999999999999999874 578999998765  2334567889999999999999999999999999999


Q ss_pred             EEEecCCCCCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceeecCCCcEEEeeccceeeccCCC
Q 015868          190 IVTEFMARGSIYDFLHKQ-KGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSG  268 (399)
Q Consensus       190 lV~E~~~ggsL~~~l~~~-~~~l~~~~~~~i~~~i~~~L~~LH~~giiHrDlkp~NILl~~~~~vkl~DFG~a~~~~~~~  268 (399)
                      +||||+++++|.+++... ...++...+..++.|++.|+.|||++|++|+||+|+||++++++.+||+|||.+.......
T Consensus        79 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~h~dl~~~nilv~~~~~~kl~d~g~~~~~~~~~  158 (261)
T cd05148          79 IITELMEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLEEQNSIHRDLAARNILVGEDLVCKVADFGLARLIKEDV  158 (261)
T ss_pred             EEEeecccCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccCcceEEEcCCceEEEccccchhhcCCcc
Confidence            999999999999999764 3568999999999999999999999999999999999999999999999999997654322


Q ss_pred             c-cccCCCCcccccccccCCCCCCChhhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHHhccCCCCCCCCCcHHHHHHH
Q 015868          269 V-MTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLT-GELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRLAELL  346 (399)
Q Consensus       269 ~-~~~~~gt~~y~aPE~l~~~~~~~~~Dv~slG~vl~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll  346 (399)
                      . .....++..|+|||.+.+..++.++|+||||+++|+|++ |+.||...+..+...... ...++..+..+++++.+++
T Consensus       159 ~~~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~~l~~l~~~g~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~i  237 (261)
T cd05148         159 YLSSDKKIPYKWTAPEAASHGTFSTKSDVWSFGILLYEMFTYGQVPYPGMNNHEVYDQIT-AGYRMPCPAKCPQEIYKIM  237 (261)
T ss_pred             ccccCCCCceEecCHHHHccCCCCchhhHHHHHHHHHHHHcCCCCCCCcCCHHHHHHHHH-hCCcCCCCCCCCHHHHHHH
Confidence            1 223345778999999998899999999999999999998 899998887766555444 4556677788999999999


Q ss_pred             HHHhhhcCCCCCCHHHHHHHHHH
Q 015868          347 ERCWQHDPTQRPNFSQITDILKQ  369 (399)
Q Consensus       347 ~~cl~~dP~~Rps~~ell~~L~~  369 (399)
                      .+||+.+|.+|||+.++++.|+.
T Consensus       238 ~~~l~~~p~~Rpt~~~l~~~L~~  260 (261)
T cd05148         238 LECWAAEPEDRPSFKALREELDN  260 (261)
T ss_pred             HHHcCCCchhCcCHHHHHHHHhc
Confidence            99999999999999999999975

Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom

>cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase

Probab=100.00  E-value=2.9e-43  Score=340.09  Aligned_cols=241  Identities=25%  Similarity=0.468  Sum_probs=208.0

Q ss_pred             ceeceeCceEEEEEEE-----CCeeEEEEEecCCCC--CHHHHHHHHHHHHHHHhcCCCceeeEEeEEecCCcEEEEEec
Q 015868          122 CKVASGSYGDLYKGTY-----CSQEVAIKVLKPECV--NTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVTEF  194 (399)
Q Consensus       122 ~~lg~G~~g~Vy~~~~-----~~~~vAvK~~~~~~~--~~~~~~~~~~Ei~~l~~l~h~nIv~~~~~~~~~~~~~lV~E~  194 (399)
                      +.||+|+||.||+++.     .++.||+|+++....  +......+.+|+.+++.++||||+++++++..++.+|+||||
T Consensus         2 ~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~e~   81 (323)
T cd05584           2 KVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAFQTGGKLYLILEY   81 (323)
T ss_pred             ceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCchhceeeEEecCCeEEEEEeC
Confidence            5799999999999975     467899999975321  223345678999999999999999999999999999999999


Q ss_pred             CCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceeecCCCcEEEeeccceeeccCCC-ccccC
Q 015868          195 MARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSG-VMTAE  273 (399)
Q Consensus       195 ~~ggsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~giiHrDlkp~NILl~~~~~vkl~DFG~a~~~~~~~-~~~~~  273 (399)
                      ++|++|.+++.. .+.+++..+..++.|++.||.|||++||+||||||+|||++.++.+||+|||+++...... .....
T Consensus        82 ~~~~~L~~~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~  160 (323)
T cd05584          82 LSGGELFMHLER-EGIFMEDTACFYLSEISLALEHLHQQGIIYRDLKPENILLDAQGHVKLTDFGLCKESIHEGTVTHTF  160 (323)
T ss_pred             CCCchHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCCEEEeeCcCCeecccCCCccccc
Confidence            999999999976 4668889999999999999999999999999999999999999999999999987543322 23345


Q ss_pred             CCCcccccccccCCCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhccCCCCCCCCCcHHHHHHHHHHhhhc
Q 015868          274 TGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRLAELLERCWQHD  353 (399)
Q Consensus       274 ~gt~~y~aPE~l~~~~~~~~~Dv~slG~vl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~cl~~d  353 (399)
                      .|++.|+|||++.+..++.++||||||+++|+|++|+.||...+..+........  ...+|..+++++.++|.+||+.+
T Consensus       161 ~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~pf~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~li~~~l~~~  238 (323)
T cd05584         161 CGTIEYMAPEILMRSGHGKAVDWWSLGALMYDMLTGAPPFTAENRKKTIDKILKG--KLNLPPYLTPEARDLLKKLLKRN  238 (323)
T ss_pred             CCCccccChhhccCCCCCCcceecccHHHHHHHhcCCCCCCCCCHHHHHHHHHcC--CCCCCCCCCHHHHHHHHHHcccC
Confidence            6899999999999988999999999999999999999999988877665554432  34567788999999999999999


Q ss_pred             CCCCC-----CHHHHHH
Q 015868          354 PTQRP-----NFSQITD  365 (399)
Q Consensus       354 P~~Rp-----s~~ell~  365 (399)
                      |++||     ++.++++
T Consensus       239 p~~R~~~~~~~~~~l~~  255 (323)
T cd05584         239 PSSRLGAGPGDAAEVQS  255 (323)
T ss_pred             HhHcCCCCCCCHHHHhc
Confidence            99999     7888766

Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in

>cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1

Probab=100.00  E-value=1.5e-42  Score=328.14  Aligned_cols=254  Identities=30%  Similarity=0.609  Sum_probs=216.1

Q ss_pred             ecccccceeceeceeCceEEEEEEE------CCeeEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCceeeEEeEEecCC
Q 015868          113 IDAKQLKIECKVASGSYGDLYKGTY------CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPP  186 (399)
Q Consensus       113 i~~~~~~i~~~lg~G~~g~Vy~~~~------~~~~vAvK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~nIv~~~~~~~~~~  186 (399)
                      ++.++|++.++||+|+||.||+|..      .+..||+|.++... .......+.+|+.+++.++||||+++++++..+.
T Consensus         2 ~~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~   80 (283)
T cd05090           2 LPLSAVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDIN-NPQQWGEFQQEASLMAELHHPNIVCLLGVVTQEQ   80 (283)
T ss_pred             CChhhceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCCC-CHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCC
Confidence            4457899999999999999999974      34689999998543 3445578899999999999999999999999999


Q ss_pred             cEEEEEecCCCCCHHHHHHhcC----------------CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceeecCC
Q 015868          187 NLCIVTEFMARGSIYDFLHKQK----------------GVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDEN  250 (399)
Q Consensus       187 ~~~lV~E~~~ggsL~~~l~~~~----------------~~l~~~~~~~i~~~i~~~L~~LH~~giiHrDlkp~NILl~~~  250 (399)
                      ..|+||||+++++|.+++....                ..+++..+..++.|++.||+|||++|++||||||+||+++++
T Consensus        81 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~nili~~~  160 (283)
T cd05090          81 PVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSHFFVHKDLAARNILIGEQ  160 (283)
T ss_pred             ceEEEEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHhcCeehhccccceEEEcCC
Confidence            9999999999999999986421                247788899999999999999999999999999999999999


Q ss_pred             CcEEEeeccceeeccCCC---ccccCCCCcccccccccCCCCCCChhhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHH
Q 015868          251 GVVKVADFGVARVQAQSG---VMTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLT-GELPYAGLTPLQAAVGVV  326 (399)
Q Consensus       251 ~~vkl~DFG~a~~~~~~~---~~~~~~gt~~y~aPE~l~~~~~~~~~Dv~slG~vl~ellt-g~~P~~~~~~~~~~~~~~  326 (399)
                      +.+||+|||+++......   ......++..|+|||.+.+..++.++|+||||+++|+|++ |..||.+.++..... .+
T Consensus       161 ~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~g~~p~~~~~~~~~~~-~~  239 (283)
T cd05090         161 LHVKISDLGLSREIYSADYYRVQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYYGFSNQEVIE-MV  239 (283)
T ss_pred             CcEEeccccccccccCCcceecccCCCccceecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHHHHHH-HH
Confidence            999999999997643321   1223345678999999998889999999999999999998 999998877654433 34


Q ss_pred             hccCCCCCCCCCcHHHHHHHHHHhhhcCCCCCCHHHHHHHHH
Q 015868          327 QKSLRPTIPKHAHPRLAELLERCWQHDPTQRPNFSQITDILK  368 (399)
Q Consensus       327 ~~~~~~~~~~~~~~~l~~ll~~cl~~dP~~Rps~~ell~~L~  368 (399)
                      .....+..+..+++++.+++.+||+.+|.+||++.++.+.|.
T Consensus       240 ~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~  281 (283)
T cd05090         240 RKRQLLPCSEDCPPRMYSLMTECWQEGPSRRPRFKDIHTRLR  281 (283)
T ss_pred             HcCCcCCCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHhh
Confidence            444455677789999999999999999999999999998875

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly

>cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2

Probab=100.00  E-value=1.5e-42  Score=327.37  Aligned_cols=257  Identities=30%  Similarity=0.602  Sum_probs=219.4

Q ss_pred             ecccccceeceeceeCceEEEEEEE--CCe----eEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCceeeEEeEEecCC
Q 015868          113 IDAKQLKIECKVASGSYGDLYKGTY--CSQ----EVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPP  186 (399)
Q Consensus       113 i~~~~~~i~~~lg~G~~g~Vy~~~~--~~~----~vAvK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~nIv~~~~~~~~~~  186 (399)
                      +..++|++.++||.|+||.||+|++  .++    .||+|+++... .......+.+|+.+++.+.||||+++++++... 
T Consensus         4 l~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~-~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-   81 (279)
T cd05109           4 LKETELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENT-SPKANKEILDEAYVMAGVGSPYVCRLLGICLTS-   81 (279)
T ss_pred             cchhheeeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCCC-CHHHHHHHHHHHHHHHhcCCCCCceEEEEEcCC-
Confidence            4567899999999999999999986  333    48999987543 445567899999999999999999999998764 


Q ss_pred             cEEEEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceeecCCCcEEEeeccceeeccC
Q 015868          187 NLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQ  266 (399)
Q Consensus       187 ~~~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~giiHrDlkp~NILl~~~~~vkl~DFG~a~~~~~  266 (399)
                      ..++++||+++|+|.+++....+.+++..+..++.|++.||+|||++||+||||||+||++++++.+||+|||+++....
T Consensus        82 ~~~l~~~~~~~g~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~iiH~dlkp~Nil~~~~~~~kL~dfG~~~~~~~  161 (279)
T cd05109          82 TVQLVTQLMPYGCLLDYVRENKDRIGSQDLLNWCVQIAKGMSYLEEVRLVHRDLAARNVLVKSPNHVKITDFGLARLLDI  161 (279)
T ss_pred             CcEEEEEcCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccccceEEEcCCCcEEECCCCceeeccc
Confidence            57899999999999999987667899999999999999999999999999999999999999999999999999986543


Q ss_pred             CCc---cccCCCCcccccccccCCCCCCChhhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHHhccCCCCCCCCCcHHH
Q 015868          267 SGV---MTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLT-GELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRL  342 (399)
Q Consensus       267 ~~~---~~~~~gt~~y~aPE~l~~~~~~~~~Dv~slG~vl~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  342 (399)
                      ...   .....++..|+|||.+.+..++.++||||||+++|||++ |..||......... ..+.....+..+..++.++
T Consensus       162 ~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~  240 (279)
T cd05109         162 DETEYHADGGKVPIKWMALESILHRRFTHQSDVWSYGVTVWELMTFGAKPYDGIPAREIP-DLLEKGERLPQPPICTIDV  240 (279)
T ss_pred             ccceeecCCCccchhhCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHH-HHHHCCCcCCCCccCCHHH
Confidence            222   122234678999999999999999999999999999998 99999877665543 3455555666677899999


Q ss_pred             HHHHHHHhhhcCCCCCCHHHHHHHHHHHHH
Q 015868          343 AELLERCWQHDPTQRPNFSQITDILKQMMK  372 (399)
Q Consensus       343 ~~ll~~cl~~dP~~Rps~~ell~~L~~l~~  372 (399)
                      .+++.+||..||++||++.++++.|.++.+
T Consensus       241 ~~li~~~l~~dp~~Rp~~~~l~~~l~~~~~  270 (279)
T cd05109         241 YMIMVKCWMIDSECRPRFRELVDEFSRMAR  270 (279)
T ss_pred             HHHHHHHcCCChhhCcCHHHHHHHHHHhhc
Confidence            999999999999999999999998877743

Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve

>KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only]

Probab=100.00  E-value=6.5e-44  Score=326.79  Aligned_cols=250  Identities=26%  Similarity=0.387  Sum_probs=216.4

Q ss_pred             ccccceeceeceeCceEEEEEEE--CCeeEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCceeeEEeEEecC--CcEEE
Q 015868          115 AKQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRP--PNLCI  190 (399)
Q Consensus       115 ~~~~~i~~~lg~G~~g~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~nIv~~~~~~~~~--~~~~l  190 (399)
                      .++|+++.+|++|+||.||+|++  +++.||+|.++.+.......-...+||.+|.+++|||||.+-.+....  +.+||
T Consensus        75 v~efe~lnrI~EGtyGiVYRakdk~t~eIVALKr~kmekek~GFPItsLREIniLl~~~H~NIV~vkEVVvG~~~d~iy~  154 (419)
T KOG0663|consen   75 VEEFEKLNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEKEKEGFPITSLREINILLKARHPNIVEVKEVVVGSNMDKIYI  154 (419)
T ss_pred             HHHHHHHhhcccCcceeEEEeccCCcceeEEeeecccccccCCCcchhHHHHHHHHhcCCCCeeeeEEEEeccccceeee
Confidence            56899999999999999999987  578899999997754444445678999999999999999999988654  46999


Q ss_pred             EEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceeecCCCcEEEeeccceeeccCC-Cc
Q 015868          191 VTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQS-GV  269 (399)
Q Consensus       191 V~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~giiHrDlkp~NILl~~~~~vkl~DFG~a~~~~~~-~~  269 (399)
                      |||||+. +|..++..-..+|...+++.++.|+++|++|||.+.|+||||||+|+|++..|.+||+|||+||.+..+ ..
T Consensus       155 VMe~~Eh-DLksl~d~m~q~F~~~evK~L~~QlL~glk~lH~~wilHRDLK~SNLLm~~~G~lKiaDFGLAR~ygsp~k~  233 (419)
T KOG0663|consen  155 VMEYVEH-DLKSLMETMKQPFLPGEVKTLMLQLLRGLKHLHDNWILHRDLKTSNLLLSHKGILKIADFGLAREYGSPLKP  233 (419)
T ss_pred             eHHHHHh-hHHHHHHhccCCCchHHHHHHHHHHHHHHHHHhhceeEecccchhheeeccCCcEEecccchhhhhcCCccc
Confidence            9999987 999999988889999999999999999999999999999999999999999999999999999987765 34


Q ss_pred             cccCCCCcccccccccCCC-CCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcc-------------------
Q 015868          270 MTAETGTYRWMAPEVIEHK-PYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKS-------------------  329 (399)
Q Consensus       270 ~~~~~gt~~y~aPE~l~~~-~~~~~~Dv~slG~vl~elltg~~P~~~~~~~~~~~~~~~~~-------------------  329 (399)
                      ++..+.|..|.|||.+.+. .|+...|+||+||++.||+++++.|.+.........+.+..                   
T Consensus       234 ~T~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~kPlf~G~sE~dQl~~If~llGtPte~iwpg~~~lp~~k~  313 (419)
T KOG0663|consen  234 YTPLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQKPLFPGKSEIDQLDKIFKLLGTPSEAIWPGYSELPAVKK  313 (419)
T ss_pred             CcceEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHhcCCCCCCCchHHHHHHHHHHhCCCccccCCCccccchhhc
Confidence            7777889999999999875 68999999999999999999999999988776666554311                   


Q ss_pred             ----------CCCCCCCC-CcHHHHHHHHHHhhhcCCCCCCHHHHHH
Q 015868          330 ----------LRPTIPKH-AHPRLAELLERCWQHDPTQRPNFSQITD  365 (399)
Q Consensus       330 ----------~~~~~~~~-~~~~l~~ll~~cl~~dP~~Rps~~ell~  365 (399)
                                ++..++.. ++..-.+|+..+|..||.+|.|++|.++
T Consensus       314 ~~f~~~pyn~lr~kF~~~~lse~g~~Lln~llt~dP~kR~tA~~~L~  360 (419)
T KOG0663|consen  314 MTFSEHPYNNLRKKFGALSLSEQGFDLLNKLLTYDPGKRITAEDGLK  360 (419)
T ss_pred             cccCCCCchhhhhhccccccchhHHHHHHHHhccCccccccHHHhhc
Confidence                      11111222 5688899999999999999999999875

>cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2

Probab=100.00  E-value=7.1e-43  Score=340.20  Aligned_cols=261  Identities=32%  Similarity=0.644  Sum_probs=220.9

Q ss_pred             eeecccccceeceeceeCceEEEEEEE-------CCeeEEEEEecCCCCCHHHHHHHHHHHHHHHhc-CCCceeeEEeEE
Q 015868          111 WEIDAKQLKIECKVASGSYGDLYKGTY-------CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKI-RHKNVVQFIGAC  182 (399)
Q Consensus       111 ~~i~~~~~~i~~~lg~G~~g~Vy~~~~-------~~~~vAvK~~~~~~~~~~~~~~~~~Ei~~l~~l-~h~nIv~~~~~~  182 (399)
                      |.+..++|++.+.||.|+||.||+|.+       .++.||||+++... .......+.+|+.+++++ +||||+++++++
T Consensus         2 ~~~~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~   80 (343)
T cd05103           2 WEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA-THSEHRALMSELKILIHIGHHLNVVNLLGAC   80 (343)
T ss_pred             cccchhHhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCC-ChHHHHHHHHHHHHHHhccCCccHhhhccee
Confidence            778888999999999999999999974       35789999998653 234456788999999999 689999999988


Q ss_pred             ecC-CcEEEEEecCCCCCHHHHHHhcC-----------------------------------------------------
Q 015868          183 TRP-PNLCIVTEFMARGSIYDFLHKQK-----------------------------------------------------  208 (399)
Q Consensus       183 ~~~-~~~~lV~E~~~ggsL~~~l~~~~-----------------------------------------------------  208 (399)
                      ... ...++||||+++|+|.+++....                                                     
T Consensus        81 ~~~~~~~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  160 (343)
T cd05103          81 TKPGGPLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSD  160 (343)
T ss_pred             ecCCCceEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCcccc
Confidence            654 46899999999999999986532                                                     


Q ss_pred             -------------CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceeecCCCcEEEeeccceeeccCCCc---ccc
Q 015868          209 -------------GVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGV---MTA  272 (399)
Q Consensus       209 -------------~~l~~~~~~~i~~~i~~~L~~LH~~giiHrDlkp~NILl~~~~~vkl~DFG~a~~~~~~~~---~~~  272 (399)
                                   ..++...+..++.|++.||+|||++||+||||||.||+++.++.+||+|||+++.......   ...
T Consensus       161 ~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~  240 (343)
T cd05103         161 VEEEEAEQEDLYKKVLTLEDLICYSFQVAKGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGD  240 (343)
T ss_pred             chhhhhhhhhhhhccCCHHHHHHHHHHHHHHHHHHHhCCeecCCCccCeEEEcCCCcEEEEecccccccccCcchhhcCC
Confidence                         2367778889999999999999999999999999999999999999999999875433221   112


Q ss_pred             CCCCcccccccccCCCCCCChhhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHHhccCCCCCCCCCcHHHHHHHHHHhh
Q 015868          273 ETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLT-GELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRLAELLERCWQ  351 (399)
Q Consensus       273 ~~gt~~y~aPE~l~~~~~~~~~Dv~slG~vl~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~cl~  351 (399)
                      ..+++.|+|||.+.+..++.++||||||+++|+|++ |..||......+..........++..|...++++.+++.+||+
T Consensus       241 ~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~cl~  320 (343)
T cd05103         241 ARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWH  320 (343)
T ss_pred             CCCCcceECcHHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCccccHHHHHHHhccCCCCCCCCCCHHHHHHHHHHcc
Confidence            235678999999999899999999999999999997 9999987665555555566666677777788999999999999


Q ss_pred             hcCCCCCCHHHHHHHHHHHHH
Q 015868          352 HDPTQRPNFSQITDILKQMMK  372 (399)
Q Consensus       352 ~dP~~Rps~~ell~~L~~l~~  372 (399)
                      .+|.+|||+.++++.|+.+++
T Consensus       321 ~~p~~Rps~~eil~~l~~~~~  341 (343)
T cd05103         321 GEPSQRPTFSELVEHLGNLLQ  341 (343)
T ss_pred             CChhhCcCHHHHHHHHHHHHh
Confidence            999999999999999999875

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp

>cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src

Probab=100.00  E-value=1.7e-42  Score=324.40  Aligned_cols=256  Identities=36%  Similarity=0.680  Sum_probs=217.3

Q ss_pred             eeecccccceeceeceeCceEEEEEEECC-eeEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCceeeEEeEEecCCcEE
Q 015868          111 WEIDAKQLKIECKVASGSYGDLYKGTYCS-QEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLC  189 (399)
Q Consensus       111 ~~i~~~~~~i~~~lg~G~~g~Vy~~~~~~-~~vAvK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~nIv~~~~~~~~~~~~~  189 (399)
                      |.+..++|++.++||+|+||.||+|++.+ ..||+|+++.....   .+.+.+|+.++++++||||+++++.+.. ...+
T Consensus         1 ~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~valK~~~~~~~~---~~~~~~E~~~l~~l~~~~i~~~~~~~~~-~~~~   76 (262)
T cd05071           1 WEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMS---PEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIY   76 (262)
T ss_pred             CCCChHHeeEeeecCCCCCCcEEEEEecCCceEEEEecccCccC---HHHHHHHHHHHHhCCCCCcceEEEEECC-CCcE
Confidence            56778899999999999999999998743 57999999864332   2568899999999999999999998754 4589


Q ss_pred             EEEecCCCCCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceeecCCCcEEEeeccceeeccCCC
Q 015868          190 IVTEFMARGSIYDFLHKQ-KGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSG  268 (399)
Q Consensus       190 lV~E~~~ggsL~~~l~~~-~~~l~~~~~~~i~~~i~~~L~~LH~~giiHrDlkp~NILl~~~~~vkl~DFG~a~~~~~~~  268 (399)
                      +||||+++++|.+++... ...+++..+..++.|++.||+|||++|++||||||+||++++++.++|+|||.++......
T Consensus        77 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~Nill~~~~~~~L~dfg~~~~~~~~~  156 (262)
T cd05071          77 IVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNE  156 (262)
T ss_pred             EEEEcCCCCcHHHHHhhccccCCCHHHHHHHHHHHHHHHHHHHHCCccccccCcccEEEcCCCcEEeccCCceeeccccc
Confidence            999999999999999764 3457899999999999999999999999999999999999999999999999997654432


Q ss_pred             cc--ccCCCCcccccccccCCCCCCChhhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHHhccCCCCCCCCCcHHHHHH
Q 015868          269 VM--TAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLT-GELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRLAEL  345 (399)
Q Consensus       269 ~~--~~~~gt~~y~aPE~l~~~~~~~~~Dv~slG~vl~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l  345 (399)
                      ..  ....++..|+|||.+.+..++.++||||||+++|+|++ |..||...++.+...... .......+..++..+.++
T Consensus       157 ~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~ellt~g~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~~~l~~l  235 (262)
T cd05071         157 YTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVE-RGYRMPCPPECPESLHDL  235 (262)
T ss_pred             cccccCCcccceecCHhHhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCChHHHHHHHh-cCCCCCCccccCHHHHHH
Confidence            21  12345678999999998899999999999999999999 889998887766544433 333445566789999999


Q ss_pred             HHHHhhhcCCCCCCHHHHHHHHHHHH
Q 015868          346 LERCWQHDPTQRPNFSQITDILKQMM  371 (399)
Q Consensus       346 l~~cl~~dP~~Rps~~ell~~L~~l~  371 (399)
                      +.+||+.+|++||++.++++.|++..
T Consensus       236 i~~~l~~~p~~Rp~~~~~~~~l~~~~  261 (262)
T cd05071         236 MCQCWRKEPEERPTFEYLQAFLEDYF  261 (262)
T ss_pred             HHHHccCCcccCCCHHHHHHHHHHhc
Confidence            99999999999999999999998764

Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo

>cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N

Probab=100.00  E-value=4e-43  Score=339.17  Aligned_cols=244  Identities=26%  Similarity=0.468  Sum_probs=207.4

Q ss_pred             cceeceeceeCceEEEEEEE--CCeeEEEEEecCCC-CCHHHHHHHHHHHHHH---HhcCCCceeeEEeEEecCCcEEEE
Q 015868          118 LKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPEC-VNTEMLKEFSQEVYIM---RKIRHKNVVQFIGACTRPPNLCIV  191 (399)
Q Consensus       118 ~~i~~~lg~G~~g~Vy~~~~--~~~~vAvK~~~~~~-~~~~~~~~~~~Ei~~l---~~l~h~nIv~~~~~~~~~~~~~lV  191 (399)
                      |++.+.||+|+||.||+|.+  +++.||||+++... ......+.+.+|+.++   +.++||||+++++++..+...|+|
T Consensus         1 y~i~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv   80 (324)
T cd05589           1 FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACFQTEDHVCFV   80 (324)
T ss_pred             CeEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEEEcCCEEEEE
Confidence            67889999999999999987  57899999997542 1233345677776665   466799999999999999999999


Q ss_pred             EecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceeecCCCcEEEeeccceeeccCC-Ccc
Q 015868          192 TEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQS-GVM  270 (399)
Q Consensus       192 ~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~giiHrDlkp~NILl~~~~~vkl~DFG~a~~~~~~-~~~  270 (399)
                      |||++|++|..++..  +.+++..++.++.||+.||.|||++||+||||||+||+++.++.+||+|||+++..... ...
T Consensus        81 ~E~~~~~~L~~~~~~--~~l~~~~~~~~~~qi~~al~~lH~~~ivHrdlkp~Nill~~~~~~kL~Dfg~~~~~~~~~~~~  158 (324)
T cd05589          81 MEYAAGGDLMMHIHT--DVFSEPRAVFYAACVVLGLQYLHENKIVYRDLKLDNLLLDTEGFVKIADFGLCKEGMGFGDRT  158 (324)
T ss_pred             EcCCCCCcHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHHhCCeEecCCCHHHeEECCCCcEEeCcccCCccCCCCCCcc
Confidence            999999999988854  56899999999999999999999999999999999999999999999999998753322 223


Q ss_pred             ccCCCCcccccccccCCCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhccCCCCCCCCCcHHHHHHHHHHh
Q 015868          271 TAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRLAELLERCW  350 (399)
Q Consensus       271 ~~~~gt~~y~aPE~l~~~~~~~~~Dv~slG~vl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~cl  350 (399)
                      ....|++.|+|||.+.+..++.++||||||+++|+|++|+.||.+.+..+........  .+..|..+++++.++|.+||
T Consensus       159 ~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~G~~pf~~~~~~~~~~~i~~~--~~~~p~~~~~~~~~li~~~L  236 (324)
T cd05589         159 STFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGESPFPGDDEEEVFDSIVND--EVRYPRFLSREAISIMRRLL  236 (324)
T ss_pred             cccccCccccCHhHhcCCCCCcccchhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhC--CCCCCCCCCHHHHHHHHHHh
Confidence            4457899999999999999999999999999999999999999988877766555443  34567788999999999999


Q ss_pred             hhcCCCCC-----CHHHHHH
Q 015868          351 QHDPTQRP-----NFSQITD  365 (399)
Q Consensus       351 ~~dP~~Rp-----s~~ell~  365 (399)
                      +.||.+||     ++.++++
T Consensus       237 ~~dP~~R~~~~~~~~~~l~~  256 (324)
T cd05589         237 RRNPERRLGSGEKDAEDVKK  256 (324)
T ss_pred             hcCHhHcCCCCCCCHHHHhh
Confidence            99999999     4666554

Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved

>KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=3.1e-43  Score=348.61  Aligned_cols=245  Identities=27%  Similarity=0.456  Sum_probs=221.4

Q ss_pred             eecccccceeceeceeCceEEEEEEE--CCeeEEEEEecCCCC-CHHHHHHHHHHHHHHHhcC-CCceeeEEeEEecCCc
Q 015868          112 EIDAKQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECV-NTEMLKEFSQEVYIMRKIR-HKNVVQFIGACTRPPN  187 (399)
Q Consensus       112 ~i~~~~~~i~~~lg~G~~g~Vy~~~~--~~~~vAvK~~~~~~~-~~~~~~~~~~Ei~~l~~l~-h~nIv~~~~~~~~~~~  187 (399)
                      .+..++|.+.+.||.|+||.|+++..  +++.+|||++++... ..+..+..+.|..|+.... ||.+++++..|.++.+
T Consensus       364 ~~~l~~F~~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~fQT~~~  443 (694)
T KOG0694|consen  364 PLTLDDFRLLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSCFQTKEH  443 (694)
T ss_pred             cccccceEEEEEeccCcCceEEEEEEcCCCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeecccccccCCe
Confidence            56678999999999999999999987  567899999997653 5566788889999988885 9999999999999999


Q ss_pred             EEEEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceeecCCCcEEEeeccceeecc-C
Q 015868          188 LCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQA-Q  266 (399)
Q Consensus       188 ~~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~giiHrDlkp~NILl~~~~~vkl~DFG~a~~~~-~  266 (399)
                      +|+||||+.||++..++  +.+.|++..+..++..|+.||.|||++|||+||||.+|||+|.+|.+||+|||+++... .
T Consensus       444 l~fvmey~~Ggdm~~~~--~~~~F~e~rarfyaAev~l~L~fLH~~~IIYRDlKLdNiLLD~eGh~kiADFGlcKe~m~~  521 (694)
T KOG0694|consen  444 LFFVMEYVAGGDLMHHI--HTDVFSEPRARFYAAEVVLGLQFLHENGIIYRDLKLDNLLLDTEGHVKIADFGLCKEGMGQ  521 (694)
T ss_pred             EEEEEEecCCCcEEEEE--ecccccHHHHHHHHHHHHHHHHHHHhcCceeeecchhheEEcccCcEEecccccccccCCC
Confidence            99999999999944433  35789999999999999999999999999999999999999999999999999998655 4


Q ss_pred             CCccccCCCCcccccccccCCCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhccCCCCCCCCCcHHHHHHH
Q 015868          267 SGVMTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRLAELL  346 (399)
Q Consensus       267 ~~~~~~~~gt~~y~aPE~l~~~~~~~~~Dv~slG~vl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll  346 (399)
                      .....+.+||+.|||||++.+..|+.+.|.|+|||+||||+.|+.||.+.+..+....++..  .+..|..++.+..++|
T Consensus       522 g~~TsTfCGTpey~aPEil~e~~Yt~aVDWW~lGVLlyeML~Gq~PF~gddEee~FdsI~~d--~~~yP~~ls~ea~~il  599 (694)
T KOG0694|consen  522 GDRTSTFCGTPEFLAPEVLTEQSYTRAVDWWGLGVLLYEMLVGESPFPGDDEEEVFDSIVND--EVRYPRFLSKEAIAIM  599 (694)
T ss_pred             CCccccccCChhhcChhhhccCcccchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcC--CCCCCCcccHHHHHHH
Confidence            44567789999999999999999999999999999999999999999999999998888754  5678889999999999


Q ss_pred             HHHhhhcCCCCCCH
Q 015868          347 ERCWQHDPTQRPNF  360 (399)
Q Consensus       347 ~~cl~~dP~~Rps~  360 (399)
                      +++|..+|++|...
T Consensus       600 ~~ll~k~p~kRLG~  613 (694)
T KOG0694|consen  600 RRLLRKNPEKRLGS  613 (694)
T ss_pred             HHHhccCcccccCC
Confidence            99999999999755

>cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3

Probab=100.00  E-value=2e-42  Score=327.02  Aligned_cols=257  Identities=27%  Similarity=0.590  Sum_probs=218.2

Q ss_pred             ecccccceeceeceeCceEEEEEEE--CCe----eEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCceeeEEeEEecCC
Q 015868          113 IDAKQLKIECKVASGSYGDLYKGTY--CSQ----EVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPP  186 (399)
Q Consensus       113 i~~~~~~i~~~lg~G~~g~Vy~~~~--~~~----~vAvK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~nIv~~~~~~~~~~  186 (399)
                      +..++|++.+.||.|+||.||+|.+  .++    .+++|.+... .......++..|+.++++++||||+++++++.. .
T Consensus         4 ~~~~~~~~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~-~~~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~~-~   81 (279)
T cd05111           4 LKETELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDR-SGRQTFQEITDHMLAMGSLDHAYIVRLLGICPG-A   81 (279)
T ss_pred             CCHhhceeccccCccCCcceEEEEEcCCCCceeeEEEEeecccc-cchHHHHHHHHHHHHHhcCCCCCcceEEEEECC-C
Confidence            3456899999999999999999987  343    4778887533 223445678889999999999999999998764 4


Q ss_pred             cEEEEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceeecCCCcEEEeeccceeeccC
Q 015868          187 NLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQ  266 (399)
Q Consensus       187 ~~~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~giiHrDlkp~NILl~~~~~vkl~DFG~a~~~~~  266 (399)
                      ..++++||+++|+|.+++....+.+++..+..++.||+.||+|||++|++||||||+||++++++.+||+|||.++....
T Consensus        82 ~~~~i~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~nili~~~~~~kl~Dfg~~~~~~~  161 (279)
T cd05111          82 SLQLVTQLSPLGSLLDHVRQHRDSLDPQRLLNWCVQIAKGMYYLEEHRMVHRNLAARNILLKSDSIVQIADFGVADLLYP  161 (279)
T ss_pred             ccEEEEEeCCCCcHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCEeccccCcceEEEcCCCcEEEcCCccceeccC
Confidence            57899999999999999987777899999999999999999999999999999999999999999999999999986543


Q ss_pred             CC---ccccCCCCcccccccccCCCCCCChhhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHHhccCCCCCCCCCcHHH
Q 015868          267 SG---VMTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLT-GELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRL  342 (399)
Q Consensus       267 ~~---~~~~~~gt~~y~aPE~l~~~~~~~~~Dv~slG~vl~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  342 (399)
                      ..   ......++..|+|||.+.+..++.++||||||+++||+++ |..||.+..+... ...+....++..+..++.++
T Consensus       162 ~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~  240 (279)
T cd05111         162 DDKKYFYSEHKTPIKWMALESILFGRYTHQSDVWSYGVTVWEMMSYGAEPYAGMRPHEV-PDLLEKGERLAQPQICTIDV  240 (279)
T ss_pred             CCcccccCCCCCcccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHH-HHHHHCCCcCCCCCCCCHHH
Confidence            22   1223346778999999998899999999999999999998 9999988876553 34455666666677788999


Q ss_pred             HHHHHHHhhhcCCCCCCHHHHHHHHHHHHH
Q 015868          343 AELLERCWQHDPTQRPNFSQITDILKQMMK  372 (399)
Q Consensus       343 ~~ll~~cl~~dP~~Rps~~ell~~L~~l~~  372 (399)
                      .+++.+||..+|.+|||+.++++.|..+.+
T Consensus       241 ~~li~~c~~~~p~~Rps~~el~~~l~~~~~  270 (279)
T cd05111         241 YMVMVKCWMIDENVRPTFKELANEFTRMAR  270 (279)
T ss_pred             HHHHHHHcCCCcccCcCHHHHHHHHHHHHh
Confidence            999999999999999999999999988765

Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r

>cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases

Probab=100.00  E-value=1.8e-42  Score=324.86  Aligned_cols=252  Identities=30%  Similarity=0.591  Sum_probs=216.9

Q ss_pred             cceeceeceeCceEEEEEEEC-----CeeEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCceeeEEeEEecCCc-----
Q 015868          118 LKIECKVASGSYGDLYKGTYC-----SQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPN-----  187 (399)
Q Consensus       118 ~~i~~~lg~G~~g~Vy~~~~~-----~~~vAvK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~nIv~~~~~~~~~~~-----  187 (399)
                      |++.+.||+|+||.||+|+..     +..||+|+++...........+.+|+.+++.++||||+++++++.....     
T Consensus         1 ~~~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~   80 (273)
T cd05035           1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQKIP   80 (273)
T ss_pred             CccccccCcCCCceEEEEEEecCCCCcceEEEEEeccCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCccccCc
Confidence            578899999999999999863     3679999998766566667789999999999999999999998866554     


Q ss_pred             -EEEEEecCCCCCHHHHHHhc-----CCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceeecCCCcEEEeeccce
Q 015868          188 -LCIVTEFMARGSIYDFLHKQ-----KGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVA  261 (399)
Q Consensus       188 -~~lV~E~~~ggsL~~~l~~~-----~~~l~~~~~~~i~~~i~~~L~~LH~~giiHrDlkp~NILl~~~~~vkl~DFG~a  261 (399)
                       .++|+||+++++|..++...     ...+++..+..++.|++.||+|||++|++||||||+||++++++.+||+|||.+
T Consensus        81 ~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~  160 (273)
T cd05035          81 KPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSNRNFIHRDLAARNCMLREDMTVCVADFGLS  160 (273)
T ss_pred             ccEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCCeeccccchheEEECCCCeEEECCccce
Confidence             79999999999999998543     246889999999999999999999999999999999999999999999999999


Q ss_pred             eeccCCCc---cccCCCCcccccccccCCCCCCChhhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHHhccCCCCCCCC
Q 015868          262 RVQAQSGV---MTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLT-GELPYAGLTPLQAAVGVVQKSLRPTIPKH  337 (399)
Q Consensus       262 ~~~~~~~~---~~~~~gt~~y~aPE~l~~~~~~~~~Dv~slG~vl~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~  337 (399)
                      +.......   .....++..|+|||.+.+..++.++||||||+++|||++ |..||.+.++.+..... .....+..+..
T Consensus       161 ~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~SlG~il~el~~~g~~p~~~~~~~~~~~~~-~~~~~~~~~~~  239 (273)
T cd05035         161 KKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPYPGVENHEIYDYL-RHGNRLKQPED  239 (273)
T ss_pred             eeccccccccccccccCCccccCHhhcccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCHHHHHHHH-HcCCCCCCCcC
Confidence            86543321   112235678999999998899999999999999999999 99999888777655443 44456667888


Q ss_pred             CcHHHHHHHHHHhhhcCCCCCCHHHHHHHHHHH
Q 015868          338 AHPRLAELLERCWQHDPTQRPNFSQITDILKQM  370 (399)
Q Consensus       338 ~~~~l~~ll~~cl~~dP~~Rps~~ell~~L~~l  370 (399)
                      +++++.+++.+||+.||.+||++.++++.|+++
T Consensus       240 ~~~~~~~li~~~l~~~p~~Rp~~~e~~~~l~~~  272 (273)
T cd05035         240 CLDELYDLMYSCWRADPKDRPTFTKLREVLENI  272 (273)
T ss_pred             CCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence            999999999999999999999999999999876

Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu

>cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases

Probab=100.00  E-value=9.5e-43  Score=328.41  Aligned_cols=254  Identities=30%  Similarity=0.613  Sum_probs=217.7

Q ss_pred             ecccccceeceeceeCceEEEEEEEC-------CeeEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCceeeEEeEEecC
Q 015868          113 IDAKQLKIECKVASGSYGDLYKGTYC-------SQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRP  185 (399)
Q Consensus       113 i~~~~~~i~~~lg~G~~g~Vy~~~~~-------~~~vAvK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~nIv~~~~~~~~~  185 (399)
                      +..++|.+.+.||.|+||.||+|+..       +..||+|+++... ..+....+.+|+.+++.++||||+++++++...
T Consensus         2 ~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~   80 (280)
T cd05049           2 VQRDTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETA-SNDARKDFEREAELLTNFQHENIVKFYGVCTEG   80 (280)
T ss_pred             CChHHhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccC-CHHHHHHHHHHHHHHHhcCCCCchheeeEEecC
Confidence            34568999999999999999999753       3679999997653 334567899999999999999999999999999


Q ss_pred             CcEEEEEecCCCCCHHHHHHhcC-------------CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceeecCCCc
Q 015868          186 PNLCIVTEFMARGSIYDFLHKQK-------------GVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGV  252 (399)
Q Consensus       186 ~~~~lV~E~~~ggsL~~~l~~~~-------------~~l~~~~~~~i~~~i~~~L~~LH~~giiHrDlkp~NILl~~~~~  252 (399)
                      ...++||||+++++|.+++....             ..+++..+..++.|++.|+.|||++|++||||||+||+++.++.
T Consensus        81 ~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~h~dlkp~nili~~~~~  160 (280)
T cd05049          81 DPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLASQHFVHRDLATRNCLVGYDLV  160 (280)
T ss_pred             CCeEEEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhhCCeeccccccceEEEcCCCe
Confidence            99999999999999999997542             34788899999999999999999999999999999999999999


Q ss_pred             EEEeeccceeeccCCC---ccccCCCCcccccccccCCCCCCChhhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHHhc
Q 015868          253 VKVADFGVARVQAQSG---VMTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLT-GELPYAGLTPLQAAVGVVQK  328 (399)
Q Consensus       253 vkl~DFG~a~~~~~~~---~~~~~~gt~~y~aPE~l~~~~~~~~~Dv~slG~vl~ellt-g~~P~~~~~~~~~~~~~~~~  328 (399)
                      ++|+|||.++......   ......+++.|+|||.+.+..++.++||||||+++|+|++ |..||...+..+..... ..
T Consensus       161 ~kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~e~~~~g~~p~~~~~~~~~~~~~-~~  239 (280)
T cd05049         161 VKIGDFGMSRDVYTTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQPWYGLSNEEVIECI-TQ  239 (280)
T ss_pred             EEECCcccceecccCcceecCCCCcccceecChhhhccCCcchhhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHH-Hc
Confidence            9999999987543221   1223345788999999999999999999999999999998 99999887776654443 34


Q ss_pred             cCCCCCCCCCcHHHHHHHHHHhhhcCCCCCCHHHHHHHHH
Q 015868          329 SLRPTIPKHAHPRLAELLERCWQHDPTQRPNFSQITDILK  368 (399)
Q Consensus       329 ~~~~~~~~~~~~~l~~ll~~cl~~dP~~Rps~~ell~~L~  368 (399)
                      +..+..+..++..+.+++.+||+.||++||++.|+++.|+
T Consensus       240 ~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~l~  279 (280)
T cd05049         240 GRLLQRPRTCPSEVYDIMLGCWKRDPQQRINIKDIHERLQ  279 (280)
T ss_pred             CCcCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhh
Confidence            4455566779999999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt

>cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes

Probab=100.00  E-value=1.6e-42  Score=322.15  Aligned_cols=245  Identities=31%  Similarity=0.641  Sum_probs=210.8

Q ss_pred             ceeceeCceEEEEEEE--CCeeEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCceeeEEeEEecCCcEEEEEecCCCCC
Q 015868          122 CKVASGSYGDLYKGTY--CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVTEFMARGS  199 (399)
Q Consensus       122 ~~lg~G~~g~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~nIv~~~~~~~~~~~~~lV~E~~~ggs  199 (399)
                      ++||+|+||.||+|+.  .++.||+|.+.... ..+....+.+|+.+++.++||||+++++++......++||||+++++
T Consensus         1 ~~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~   79 (252)
T cd05084           1 ERIGRGNFGEVFSGRLRADNTPVAVKSCRETL-PPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGD   79 (252)
T ss_pred             CccCcccCccEEEEEEecCCceEEEEecCccC-CHHHHHHHHHHHHHHHhCCCCCcceEEEEEcCCCCeEEEEeeccCCc
Confidence            4689999999999987  67889999987542 45556789999999999999999999999999999999999999999


Q ss_pred             HHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceeecCCCcEEEeeccceeeccCCCcc---ccCCCC
Q 015868          200 IYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVM---TAETGT  276 (399)
Q Consensus       200 L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~giiHrDlkp~NILl~~~~~vkl~DFG~a~~~~~~~~~---~~~~gt  276 (399)
                      |.+++......+++..++.++.|++.||.|||++|++||||||.||+++.++.+||+|||.+.........   .....+
T Consensus        80 L~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~  159 (252)
T cd05084          80 FLTFLRTEGPRLKVKELIQMVENAAAGMEYLESKHCIHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYASTGGMKQIP  159 (252)
T ss_pred             HHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccccchheEEEcCCCcEEECccccCcccccccccccCCCCCCc
Confidence            99999776667899999999999999999999999999999999999999999999999998754322111   111234


Q ss_pred             cccccccccCCCCCCChhhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHHhccCCCCCCCCCcHHHHHHHHHHhhhcCC
Q 015868          277 YRWMAPEVIEHKPYDYKADVFSFGIALWELLT-GELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRLAELLERCWQHDPT  355 (399)
Q Consensus       277 ~~y~aPE~l~~~~~~~~~Dv~slG~vl~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~cl~~dP~  355 (399)
                      ..|+|||.+.+..++.++||||||+++|+|++ |..||...++...... .....++..+..++..+.+++.+||+.+|+
T Consensus       160 ~~y~aPE~~~~~~~~~~~Dv~slG~il~e~~~~~~~p~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~li~~~l~~~p~  238 (252)
T cd05084         160 VKWTAPEALNYGRYSSESDVWSFGILLWEAFSLGAVPYANLSNQQTREA-IEQGVRLPCPELCPDAVYRLMERCWEYDPG  238 (252)
T ss_pred             eeecCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccCHHHHHHH-HHcCCCCCCcccCCHHHHHHHHHHcCCChh
Confidence            67999999999889999999999999999998 9999988777654443 334455667778899999999999999999


Q ss_pred             CCCCHHHHHHHHH
Q 015868          356 QRPNFSQITDILK  368 (399)
Q Consensus       356 ~Rps~~ell~~L~  368 (399)
                      +|||+.++++.|+
T Consensus       239 ~Rps~~~~~~~l~  251 (252)
T cd05084         239 QRPSFSTVHQELQ  251 (252)
T ss_pred             hCcCHHHHHHHHh
Confidence            9999999998875

Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular

>cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.5e-43  Score=347.72  Aligned_cols=249  Identities=20%  Similarity=0.318  Sum_probs=209.1

Q ss_pred             cccceeceeceeCceEEEEEEE--CCeeEEEEEecCCC-CCHHHHHHHHHHHHHHHhcCCCceeeEEeEEecCCcEEEEE
Q 015868          116 KQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPEC-VNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVT  192 (399)
Q Consensus       116 ~~~~i~~~lg~G~~g~Vy~~~~--~~~~vAvK~~~~~~-~~~~~~~~~~~Ei~~l~~l~h~nIv~~~~~~~~~~~~~lV~  192 (399)
                      ++|++.++||+|+||.||++..  +++.||||++.... ...+..+.+.+|+.++++++||||+++++++..+..+|+||
T Consensus         1 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~   80 (377)
T cd05629           1 EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLYYSFQDAQYLYLIM   80 (377)
T ss_pred             CCceEeEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCeeEEEE
Confidence            3789999999999999999976  67899999986432 23345577899999999999999999999999999999999


Q ss_pred             ecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceeecCCCcEEEeeccceeeccCCC----
Q 015868          193 EFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSG----  268 (399)
Q Consensus       193 E~~~ggsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~giiHrDlkp~NILl~~~~~vkl~DFG~a~~~~~~~----  268 (399)
                      ||++||+|.+++.. .+.+++..+..++.|++.||+|||++||+||||||+|||++.++.+||+|||+++......    
T Consensus        81 E~~~gg~L~~~l~~-~~~~~~~~~~~~~~ql~~aL~~LH~~givHrDlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~~  159 (377)
T cd05629          81 EFLPGGDLMTMLIK-YDTFSEDVTRFYMAECVLAIEAVHKLGFIHRDIKPDNILIDRGGHIKLSDFGLSTGFHKQHDSAY  159 (377)
T ss_pred             eCCCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEECCCCCEEEeeccccccccccccccc
Confidence            99999999999976 4678999999999999999999999999999999999999999999999999986321100    


Q ss_pred             --------------------------------------------ccccCCCCcccccccccCCCCCCChhhHHHHHHHHH
Q 015868          269 --------------------------------------------VMTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALW  304 (399)
Q Consensus       269 --------------------------------------------~~~~~~gt~~y~aPE~l~~~~~~~~~Dv~slG~vl~  304 (399)
                                                                  ......||+.|+|||++.+..++.++|||||||++|
T Consensus       160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~  239 (377)
T cd05629         160 YQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQECDWWSLGAIMF  239 (377)
T ss_pred             ccccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHccCCCCCceeeEecchhhh
Confidence                                                        001235899999999999999999999999999999


Q ss_pred             HHHcCCCCCCCCCHHHHHHHHHhccCCCCCCC--CCcHHHHHHHHHHhhhcCCCC---CCHHHHHHH
Q 015868          305 ELLTGELPYAGLTPLQAAVGVVQKSLRPTIPK--HAHPRLAELLERCWQHDPTQR---PNFSQITDI  366 (399)
Q Consensus       305 elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~l~~ll~~cl~~dP~~R---ps~~ell~~  366 (399)
                      ||++|..||...++.+.............+|.  .+++++.+||.+||. +|.+|   +++.+++..
T Consensus       240 elltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dli~~lL~-~~~~r~~r~~~~~~l~h  305 (377)
T cd05629         240 ECLIGWPPFCSENSHETYRKIINWRETLYFPDDIHLSVEAEDLIRRLIT-NAENRLGRGGAHEIKSH  305 (377)
T ss_pred             hhhcCCCCCCCCCHHHHHHHHHccCCccCCCCCCCCCHHHHHHHHHHhc-CHhhcCCCCCHHHHhcC
Confidence            99999999998887666555544322333333  478999999999998 77765   599888763

Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of

>cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa

Probab=100.00  E-value=2e-42  Score=323.12  Aligned_cols=245  Identities=29%  Similarity=0.608  Sum_probs=210.9

Q ss_pred             eeceeCceEEEEEEEC----CeeEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCceeeEEeEEecCCcEEEEEecCCCC
Q 015868          123 KVASGSYGDLYKGTYC----SQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVTEFMARG  198 (399)
Q Consensus       123 ~lg~G~~g~Vy~~~~~----~~~vAvK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~nIv~~~~~~~~~~~~~lV~E~~~gg  198 (399)
                      .||+|+||.||+|.+.    +..||+|++.... .....+.+.+|+.++++++||||+++++++.. +..++||||++++
T Consensus         2 ~ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~~-~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~-~~~~lv~e~~~~~   79 (257)
T cd05115           2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNEN-EKSVRDEMMREAEIMHQLDNPYIVRMIGVCEA-EALMLVMEMASGG   79 (257)
T ss_pred             ccCCCCcccEEEEEEecCCCceeEEEEEccccc-ChHHHHHHHHHHHHHHhcCCCCeEEEEEEEcC-CCeEEEEEeCCCC
Confidence            4899999999999763    4469999997653 34455789999999999999999999998864 4689999999999


Q ss_pred             CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceeecCCCcEEEeeccceeeccCCCc----cccCC
Q 015868          199 SIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGV----MTAET  274 (399)
Q Consensus       199 sL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~giiHrDlkp~NILl~~~~~vkl~DFG~a~~~~~~~~----~~~~~  274 (399)
                      +|.+++......+++..++.++.|++.||.|||++|++||||||+||+++.++.+||+|||++........    .+...
T Consensus        80 ~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~  159 (257)
T cd05115          80 PLNKFLSGKKDEITVSNVVELMHQVSMGMKYLEGKNFVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKARSAGK  159 (257)
T ss_pred             CHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhcCeeecccchheEEEcCCCcEEeccCCccccccCCccceeccCCCC
Confidence            99999987677899999999999999999999999999999999999999999999999999975433221    12223


Q ss_pred             CCcccccccccCCCCCCChhhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHHhccCCCCCCCCCcHHHHHHHHHHhhhc
Q 015868          275 GTYRWMAPEVIEHKPYDYKADVFSFGIALWELLT-GELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRLAELLERCWQHD  353 (399)
Q Consensus       275 gt~~y~aPE~l~~~~~~~~~Dv~slG~vl~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~cl~~d  353 (399)
                      ++..|+|||.+.+..++.++||||||+++|++++ |..||....+.... ..+....++..+..+++++.+++.+||+.+
T Consensus       160 ~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~-~~~~~~~~~~~~~~~~~~l~~li~~c~~~~  238 (257)
T cd05115         160 WPLKWYAPECINFRKFSSRSDVWSYGITMWEAFSYGQKPYKKMKGPEVM-SFIEQGKRLDCPAECPPEMYALMKDCWIYK  238 (257)
T ss_pred             CCcccCCHHHHccCCCCchhhHHHHHHHHHHHhcCCCCCcCcCCHHHHH-HHHHCCCCCCCCCCCCHHHHHHHHHHcCCC
Confidence            3578999999998889999999999999999996 99999988776644 445556677788889999999999999999


Q ss_pred             CCCCCCHHHHHHHHHHH
Q 015868          354 PTQRPNFSQITDILKQM  370 (399)
Q Consensus       354 P~~Rps~~ell~~L~~l  370 (399)
                      |++||++.++.+.|+.+
T Consensus       239 ~~~Rp~~~~i~~~l~~~  255 (257)
T cd05115         239 WEDRPNFAKVEERMRTY  255 (257)
T ss_pred             hhhCcCHHHHHHHHhhh
Confidence            99999999999998865

Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho

>cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants

Probab=100.00  E-value=8.3e-43  Score=338.03  Aligned_cols=247  Identities=25%  Similarity=0.399  Sum_probs=200.9

Q ss_pred             ccceeceeceeCceEEEEEEE--CCeeEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCceeeEEeEEecCC-----cEE
Q 015868          117 QLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPP-----NLC  189 (399)
Q Consensus       117 ~~~i~~~lg~G~~g~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~nIv~~~~~~~~~~-----~~~  189 (399)
                      +|++.++||+|+||.||+|..  +++.||+|+++...........+.+|+.++++++||||+++++++....     .+|
T Consensus         1 ry~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~   80 (338)
T cd07859           1 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIY   80 (338)
T ss_pred             CeEEEEEEeecCCeEEEEEEECCCCCEEEEEEechhhccchhHHHHHHHHHHHHhCCCCCEeeecceEeccCCCCCceEE
Confidence            588999999999999999986  5789999998754333444567889999999999999999999885432     489


Q ss_pred             EEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceeecCCCcEEEeeccceeeccCCC-
Q 015868          190 IVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSG-  268 (399)
Q Consensus       190 lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~giiHrDlkp~NILl~~~~~vkl~DFG~a~~~~~~~-  268 (399)
                      +||||+. ++|.+++.. ...+++..+..++.||++||.|||++||+||||||+|||++.++.+||+|||+++...... 
T Consensus        81 lv~e~~~-~~L~~~l~~-~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~  158 (338)
T cd07859          81 VVFELME-SDLHQVIKA-NDDLTPEHHQFFLYQLLRALKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTP  158 (338)
T ss_pred             EEEecCC-CCHHHHHHh-cccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCcEEEccCccccccccccC
Confidence            9999995 599998865 4568999999999999999999999999999999999999999999999999997543221 


Q ss_pred             ---ccccCCCCcccccccccCC--CCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHh----------------
Q 015868          269 ---VMTAETGTYRWMAPEVIEH--KPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQ----------------  327 (399)
Q Consensus       269 ---~~~~~~gt~~y~aPE~l~~--~~~~~~~Dv~slG~vl~elltg~~P~~~~~~~~~~~~~~~----------------  327 (399)
                         ......||+.|+|||++.+  ..++.++|||||||++|+|++|+.||.+.+.......+..                
T Consensus       159 ~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~  238 (338)
T cd07859         159 TAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLITDLLGTPSPETISRVRNE  238 (338)
T ss_pred             ccccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhhhh
Confidence               1234568999999999876  6789999999999999999999999987654332111100                


Q ss_pred             ------ccCCCCC-------CCCCcHHHHHHHHHHhhhcCCCCCCHHHHHH
Q 015868          328 ------KSLRPTI-------PKHAHPRLAELLERCWQHDPTQRPNFSQITD  365 (399)
Q Consensus       328 ------~~~~~~~-------~~~~~~~l~~ll~~cl~~dP~~Rps~~ell~  365 (399)
                            .......       .+..++++.+++.+||+.||++|||++|+++
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~e~l~  289 (338)
T cd07859         239 KARRYLSSMRKKQPVPFSQKFPNADPLALRLLERLLAFDPKDRPTAEEALA  289 (338)
T ss_pred             hHHHHHHhhcccCCCchHHhcCCCChHHHHHHHHHcCcCcccCCCHHHHhc
Confidence                  0000000       1246788999999999999999999999986

Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos

>cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase

Probab=100.00  E-value=7.9e-44  Score=343.15  Aligned_cols=238  Identities=26%  Similarity=0.443  Sum_probs=206.8

Q ss_pred             ceeceeCceEEEEEEE-----CCeeEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCceeeEEeEEecCCcEEEEEecCC
Q 015868          122 CKVASGSYGDLYKGTY-----CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVTEFMA  196 (399)
Q Consensus       122 ~~lg~G~~g~Vy~~~~-----~~~~vAvK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~nIv~~~~~~~~~~~~~lV~E~~~  196 (399)
                      +.||+|+||.||+++.     .++.||+|+++...........+.+|+.++++++||||+++++++..+..+|+||||++
T Consensus         2 ~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~   81 (318)
T cd05582           2 KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVKLHYAFQTEGKLYLILDFLR   81 (318)
T ss_pred             ceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhCCCCCcccEEEEEEcCCEEEEEEcCCC
Confidence            5799999999999864     56889999998643333344567889999999999999999999999999999999999


Q ss_pred             CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceeecCCCcEEEeeccceeeccCC-CccccCCC
Q 015868          197 RGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQS-GVMTAETG  275 (399)
Q Consensus       197 ggsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~giiHrDlkp~NILl~~~~~vkl~DFG~a~~~~~~-~~~~~~~g  275 (399)
                      +++|.+++.+ ...+++..++.++.||+.||.|||++||+||||||+||+++.++.+||+|||+++..... .......|
T Consensus        82 ~~~L~~~l~~-~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~~~~~~~~g  160 (318)
T cd05582          82 GGDLFTRLSK-EVMFTEEDVKFYLAELALALDHLHSLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYSFCG  160 (318)
T ss_pred             CCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHeEECCCCcEEEeeccCCcccCCCCCceecccC
Confidence            9999999966 457899999999999999999999999999999999999999999999999998765433 22334578


Q ss_pred             CcccccccccCCCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhccCCCCCCCCCcHHHHHHHHHHhhhcCC
Q 015868          276 TYRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRLAELLERCWQHDPT  355 (399)
Q Consensus       276 t~~y~aPE~l~~~~~~~~~Dv~slG~vl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~cl~~dP~  355 (399)
                      ++.|+|||.+.+..++.++||||||+++|+|++|+.||...+..+........  ...+|..+++++.+++.+||+.||+
T Consensus       161 ~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~i~~~--~~~~p~~~~~~~~~li~~~l~~~P~  238 (318)
T cd05582         161 TVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLPFQGKDRKETMTMILKA--KLGMPQFLSPEAQSLLRALFKRNPA  238 (318)
T ss_pred             ChhhcCHHHHcCCCCCCccceeccceEeeeeccCCCCCCCCCHHHHHHHHHcC--CCCCCCCCCHHHHHHHHHHhhcCHh
Confidence            99999999999999999999999999999999999999988877666554432  3456778899999999999999999


Q ss_pred             CCCCHHH
Q 015868          356 QRPNFSQ  362 (399)
Q Consensus       356 ~Rps~~e  362 (399)
                      +||++.+
T Consensus       239 ~R~~a~~  245 (318)
T cd05582         239 NRLGAGP  245 (318)
T ss_pred             HcCCCCC
Confidence            9999655

Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate

>PTZ00267 NIMA-related protein kinase; Provisional

Probab=100.00  E-value=1.6e-42  Score=352.06  Aligned_cols=248  Identities=22%  Similarity=0.353  Sum_probs=214.6

Q ss_pred             ccccceeceeceeCceEEEEEEEC---CeeEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCceeeEEeEEecCCcEEEE
Q 015868          115 AKQLKIECKVASGSYGDLYKGTYC---SQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIV  191 (399)
Q Consensus       115 ~~~~~i~~~lg~G~~g~Vy~~~~~---~~~vAvK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~nIv~~~~~~~~~~~~~lV  191 (399)
                      ...|.+.+.||.|++|.||+|...   ++.||+|.+...  .......+.+|+.+++.++||||+++++++..++..|+|
T Consensus        66 ~~~y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~--~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv  143 (478)
T PTZ00267         66 EHMYVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLN--DERQAAYARSELHCLAACDHFGIVKHFDDFKSDDKLLLI  143 (478)
T ss_pred             ceeEEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccC--CHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEECCEEEEE
Confidence            445999999999999999999763   567888877543  344456788899999999999999999999999999999


Q ss_pred             EecCCCCCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceeecCCCcEEEeeccceeeccCCC
Q 015868          192 TEFMARGSIYDFLHKQ---KGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSG  268 (399)
Q Consensus       192 ~E~~~ggsL~~~l~~~---~~~l~~~~~~~i~~~i~~~L~~LH~~giiHrDlkp~NILl~~~~~vkl~DFG~a~~~~~~~  268 (399)
                      |||++||+|.+++...   ...+++..+..++.|++.||.|||++||+||||||+|||++.++.+||+|||+++......
T Consensus       144 ~E~~~gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDlkp~NIll~~~~~~kL~DFgla~~~~~~~  223 (478)
T PTZ00267        144 MEYGSGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHSRKMMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSV  223 (478)
T ss_pred             EECCCCCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCEEECCcCHHhEEECCCCcEEEEeCcCceecCCcc
Confidence            9999999999988542   4568899999999999999999999999999999999999999999999999998654432


Q ss_pred             ---ccccCCCCcccccccccCCCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhccCCCCCCCCCcHHHHHH
Q 015868          269 ---VMTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRLAEL  345 (399)
Q Consensus       269 ---~~~~~~gt~~y~aPE~l~~~~~~~~~Dv~slG~vl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l  345 (399)
                         ......||+.|+|||++.+..++.++|||||||++|+|++|+.||...+..+....... ...+..|..+++++.++
T Consensus       224 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~Pf~~~~~~~~~~~~~~-~~~~~~~~~~s~~~~~l  302 (478)
T PTZ00267        224 SLDVASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRPFKGPSQREIMQQVLY-GKYDPFPCPVSSGMKAL  302 (478)
T ss_pred             ccccccccCCCccccCHhHhCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHh-CCCCCCCccCCHHHHHH
Confidence               13345689999999999999999999999999999999999999998877665555444 33445677789999999


Q ss_pred             HHHHhhhcCCCCCCHHHHHH
Q 015868          346 LERCWQHDPTQRPNFSQITD  365 (399)
Q Consensus       346 l~~cl~~dP~~Rps~~ell~  365 (399)
                      |.+||+.+|++||++.+++.
T Consensus       303 i~~~L~~dP~~Rps~~~~l~  322 (478)
T PTZ00267        303 LDPLLSKNPALRPTTQQLLH  322 (478)
T ss_pred             HHHHhccChhhCcCHHHHHh
Confidence            99999999999999999864

>cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.3e-42  Score=322.60  Aligned_cols=249  Identities=29%  Similarity=0.509  Sum_probs=217.9

Q ss_pred             cccceeceeceeCceEEEEEEE--CCeeEEEEEecCCCCCH---HHHHHHHHHHHHHHhcCCCceeeEEeEEecCCcEEE
Q 015868          116 KQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVNT---EMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCI  190 (399)
Q Consensus       116 ~~~~i~~~lg~G~~g~Vy~~~~--~~~~vAvK~~~~~~~~~---~~~~~~~~Ei~~l~~l~h~nIv~~~~~~~~~~~~~l  190 (399)
                      +.|++.+.||+|++|.||++..  +++.||+|.++......   .....+.+|+.++++++||||+++++++......++
T Consensus         2 ~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~   81 (263)
T cd06625           2 TNWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCLRDDETLSI   81 (263)
T ss_pred             CcccccceecCCCceEEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEccCCeEEE
Confidence            4688899999999999999975  57899999987543222   234678999999999999999999999999999999


Q ss_pred             EEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceeecCCCcEEEeeccceeeccCCCcc
Q 015868          191 VTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVM  270 (399)
Q Consensus       191 V~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~giiHrDlkp~NILl~~~~~vkl~DFG~a~~~~~~~~~  270 (399)
                      |+||+++++|.+++.. ...+++..+..++.|++.||.|||+.|++||||+|+||++++++.++|+|||.++........
T Consensus        82 v~e~~~~~~l~~~~~~-~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nilv~~~~~~~l~dfg~~~~~~~~~~~  160 (263)
T cd06625          82 FMEYMPGGSVKDQLKA-YGALTETVTRKYTRQILEGVEYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICSS  160 (263)
T ss_pred             EEEECCCCcHHHHHHH-hCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEeecccceeccccccc
Confidence            9999999999999976 356889999999999999999999999999999999999999999999999998754332111


Q ss_pred             ----ccCCCCcccccccccCCCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhccCCCCCCCCCcHHHHHHH
Q 015868          271 ----TAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRLAELL  346 (399)
Q Consensus       271 ----~~~~gt~~y~aPE~l~~~~~~~~~Dv~slG~vl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll  346 (399)
                          ....++..|+|||.+.+..++.++||||||+++|+|++|+.||...+..............+.++..++..+.+++
T Consensus       161 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li  240 (263)
T cd06625         161 GTGMKSVTGTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLTEKPPWAEFEAMAAIFKIATQPTNPQLPSHVSPDARNFL  240 (263)
T ss_pred             cccccCCCcCccccCcceeccCCCCchhhhHHHHHHHHHHHhCCCCccccchHHHHHHHhccCCCCCCCccCCHHHHHHH
Confidence                2345788999999999998999999999999999999999999887777666666666667778888999999999


Q ss_pred             HHHhhhcCCCCCCHHHHHH
Q 015868          347 ERCWQHDPTQRPNFSQITD  365 (399)
Q Consensus       347 ~~cl~~dP~~Rps~~ell~  365 (399)
                      .+||..+|.+|||+.++++
T Consensus       241 ~~~l~~~p~~Rpt~~~ll~  259 (263)
T cd06625         241 RRTFVENAKKRPSAEELLR  259 (263)
T ss_pred             HHHhhcCcccCCCHHHHhh
Confidence            9999999999999999976

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t

>cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C

Probab=100.00  E-value=7.9e-43  Score=337.12  Aligned_cols=241  Identities=23%  Similarity=0.405  Sum_probs=208.0

Q ss_pred             ccceeceeceeCceEEEEEEEC--CeeEEEEEecCCCC-CHHHHHHHHHHHHHHHhcCC-CceeeEEeEEecCCcEEEEE
Q 015868          117 QLKIECKVASGSYGDLYKGTYC--SQEVAIKVLKPECV-NTEMLKEFSQEVYIMRKIRH-KNVVQFIGACTRPPNLCIVT  192 (399)
Q Consensus       117 ~~~i~~~lg~G~~g~Vy~~~~~--~~~vAvK~~~~~~~-~~~~~~~~~~Ei~~l~~l~h-~nIv~~~~~~~~~~~~~lV~  192 (399)
                      +|++.+.||+|+||.||+|+..  ++.||+|+++.... .....+.+..|+.+++.+.| ++|+.+++++...+.+|+||
T Consensus         1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~   80 (324)
T cd05587           1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVM   80 (324)
T ss_pred             CceEEEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCEEEEEE
Confidence            5889999999999999999874  57899999975422 23445678889999999976 46889999999999999999


Q ss_pred             ecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceeecCCCcEEEeeccceeecc-CCCccc
Q 015868          193 EFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQA-QSGVMT  271 (399)
Q Consensus       193 E~~~ggsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~giiHrDlkp~NILl~~~~~vkl~DFG~a~~~~-~~~~~~  271 (399)
                      ||++||+|.+++.. ...+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++... ......
T Consensus        81 E~~~~g~L~~~~~~-~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~~~~~~  159 (324)
T cd05587          81 EYVNGGDLMYHIQQ-VGKFKEPHAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDAEGHIKIADFGMCKENIFGGKTTR  159 (324)
T ss_pred             cCCCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEEcCCCCEEEeecCcceecCCCCCcee
Confidence            99999999999976 4568999999999999999999999999999999999999999999999999987432 222334


Q ss_pred             cCCCCcccccccccCCCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhccCCCCCCCCCcHHHHHHHHHHhh
Q 015868          272 AETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRLAELLERCWQ  351 (399)
Q Consensus       272 ~~~gt~~y~aPE~l~~~~~~~~~Dv~slG~vl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~cl~  351 (399)
                      ...||+.|+|||++.+..++.++|||||||++|+|+||+.||.+.+..+....+..  ..+.+|..+++++.+++.+||.
T Consensus       160 ~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~~~~~~i~~--~~~~~~~~~~~~~~~li~~~l~  237 (324)
T cd05587         160 TFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQSIME--HNVSYPKSLSKEAVSICKGLLT  237 (324)
T ss_pred             eecCCccccChhhhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHc--CCCCCCCCCCHHHHHHHHHHhh
Confidence            45689999999999999999999999999999999999999998887766655443  3456678899999999999999


Q ss_pred             hcCCCCCCH
Q 015868          352 HDPTQRPNF  360 (399)
Q Consensus       352 ~dP~~Rps~  360 (399)
                      .||.+|++.
T Consensus       238 ~~P~~R~~~  246 (324)
T cd05587         238 KHPAKRLGC  246 (324)
T ss_pred             cCHHHcCCC
Confidence            999999976

Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory

>cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase

Probab=100.00  E-value=4.9e-43  Score=344.82  Aligned_cols=253  Identities=22%  Similarity=0.343  Sum_probs=214.9

Q ss_pred             eeecccccceeceeceeCceEEEEEEE--CCeeEEEEEecCCCC-CHHHHHHHHHHHHHHHhcCCCceeeEEeEEecCCc
Q 015868          111 WEIDAKQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECV-NTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPN  187 (399)
Q Consensus       111 ~~i~~~~~~i~~~lg~G~~g~Vy~~~~--~~~~vAvK~~~~~~~-~~~~~~~~~~Ei~~l~~l~h~nIv~~~~~~~~~~~  187 (399)
                      +.+..++|++.++||+|+||.||+++.  +++.||+|+++.... .......+.+|+.+++.++||||+++++++..+..
T Consensus        38 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~h~~iv~~~~~~~~~~~  117 (370)
T cd05596          38 LRMKAEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHYAFQDDKY  117 (370)
T ss_pred             CCCCHHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCcceEEEEEecCCE
Confidence            456678999999999999999999987  578899999974321 22334567899999999999999999999999999


Q ss_pred             EEEEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceeecCCCcEEEeeccceeeccCC
Q 015868          188 LCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQS  267 (399)
Q Consensus       188 ~~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~giiHrDlkp~NILl~~~~~vkl~DFG~a~~~~~~  267 (399)
                      +|+||||++||+|.+++..  ..+++..+..++.|++.||+|||++||+||||||+|||++.++.+||+|||+++.....
T Consensus       118 ~~lv~Ey~~gg~L~~~l~~--~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~~~~kL~DfG~~~~~~~~  195 (370)
T cd05596         118 LYMVMEYMPGGDLVNLMSN--YDIPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMDAN  195 (370)
T ss_pred             EEEEEcCCCCCcHHHHHHh--cCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEcCCCCEEEEeccceeeccCC
Confidence            9999999999999999865  45889999999999999999999999999999999999999999999999999865433


Q ss_pred             Cc--cccCCCCcccccccccCCC----CCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhccCCCCCCC--CCc
Q 015868          268 GV--MTAETGTYRWMAPEVIEHK----PYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKSLRPTIPK--HAH  339 (399)
Q Consensus       268 ~~--~~~~~gt~~y~aPE~l~~~----~~~~~~Dv~slG~vl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~--~~~  339 (399)
                      ..  .....||+.|+|||++.+.    .++.++|||||||++|+|++|+.||...+.......+.........|.  .++
T Consensus       196 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s  275 (370)
T cd05596         196 GMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMDHKNSLTFPDDIEIS  275 (370)
T ss_pred             CcccCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCCCCHHHHHHHHHcCCCcCCCCCcCCCC
Confidence            22  2345689999999998754    378899999999999999999999998887766665554333333443  579


Q ss_pred             HHHHHHHHHHhhhcCCC--CCCHHHHHH
Q 015868          340 PRLAELLERCWQHDPTQ--RPNFSQITD  365 (399)
Q Consensus       340 ~~l~~ll~~cl~~dP~~--Rps~~ell~  365 (399)
                      .++.++|.+||+.+|.+  |+++.++++
T Consensus       276 ~~~~~li~~~L~~~p~r~~R~s~~ell~  303 (370)
T cd05596         276 KQAKDLICAFLTDREVRLGRNGVDEIKS  303 (370)
T ss_pred             HHHHHHHHHHccChhhccCCCCHHHHhc
Confidence            99999999999999987  999999975

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in

>cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk

Probab=100.00  E-value=2.3e-42  Score=322.63  Aligned_cols=254  Identities=36%  Similarity=0.688  Sum_probs=218.1

Q ss_pred             eeecccccceeceeceeCceEEEEEEE-CCeeEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCceeeEEeEEecCCcEE
Q 015868          111 WEIDAKQLKIECKVASGSYGDLYKGTY-CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLC  189 (399)
Q Consensus       111 ~~i~~~~~~i~~~lg~G~~g~Vy~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~nIv~~~~~~~~~~~~~  189 (399)
                      |++..++|++.++||.|+||.||+|.. .+..+|+|.++......   ..+.+|+.++++++|+|++++++++.. ...+
T Consensus         1 ~~~~~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~k~~~~~~~~~---~~~~~E~~~l~~l~~~~i~~~~~~~~~-~~~~   76 (260)
T cd05070           1 WEIPRESLQLIKKLGNGQFGEVWMGTWNGNTKVAVKTLKPGTMSP---ESFLEEAQIMKKLRHDKLVQLYAVVSE-EPIY   76 (260)
T ss_pred             CCCchHHhhhhheeccccCceEEEEEecCCceeEEEEecCCCCCH---HHHHHHHHHHHhcCCCceEEEEeEECC-CCcE
Confidence            677888999999999999999999986 45679999998754433   468899999999999999999998854 5688


Q ss_pred             EEEecCCCCCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceeecCCCcEEEeeccceeeccCCC
Q 015868          190 IVTEFMARGSIYDFLHKQ-KGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSG  268 (399)
Q Consensus       190 lV~E~~~ggsL~~~l~~~-~~~l~~~~~~~i~~~i~~~L~~LH~~giiHrDlkp~NILl~~~~~vkl~DFG~a~~~~~~~  268 (399)
                      ++|||+++++|.+++... ...+++..+..++.+++.||.|||++|++||||||+||++++++.++|+|||.+.......
T Consensus        77 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~di~p~Nili~~~~~~~l~dfg~~~~~~~~~  156 (260)
T cd05070          77 IVTEYMSKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIERMNYIHRDLRSANILVGDGLVCKIADFGLARLIEDNE  156 (260)
T ss_pred             EEEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCccceEEEeCCceEEeCCceeeeeccCcc
Confidence            999999999999999764 3458999999999999999999999999999999999999999999999999998654432


Q ss_pred             cc--ccCCCCcccccccccCCCCCCChhhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHHhccCCCCCCCCCcHHHHHH
Q 015868          269 VM--TAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLT-GELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRLAEL  345 (399)
Q Consensus       269 ~~--~~~~gt~~y~aPE~l~~~~~~~~~Dv~slG~vl~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l  345 (399)
                      ..  ....++..|+|||.+.+..++.++|+||||+++|+|++ |..||...+..+..... .....+..+...+..+.++
T Consensus       157 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~l  235 (260)
T cd05070         157 YTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMNNREVLEQV-ERGYRMPCPQDCPISLHEL  235 (260)
T ss_pred             cccccCCCCCccccChHHHhcCCCcchhhhHHHHHHHHHHHhcCCCCCCCCCHHHHHHHH-HcCCCCCCCCcCCHHHHHH
Confidence            11  12235678999999988889999999999999999999 89999888776655543 3345566777889999999


Q ss_pred             HHHHhhhcCCCCCCHHHHHHHHHH
Q 015868          346 LERCWQHDPTQRPNFSQITDILKQ  369 (399)
Q Consensus       346 l~~cl~~dP~~Rps~~ell~~L~~  369 (399)
                      +.+||..+|.+|||+.++.+.|++
T Consensus       236 i~~~l~~~p~~Rpt~~~l~~~l~~  259 (260)
T cd05070         236 MLQCWKKDPEERPTFEYLQSFLED  259 (260)
T ss_pred             HHHHcccCcccCcCHHHHHHHHhc
Confidence            999999999999999999988874

Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r

>cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors

Probab=100.00  E-value=1.7e-42  Score=324.93  Aligned_cols=256  Identities=34%  Similarity=0.632  Sum_probs=219.5

Q ss_pred             ecccccceeceeceeCceEEEEEEEC-----CeeEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCceeeEEeEEecCCc
Q 015868          113 IDAKQLKIECKVASGSYGDLYKGTYC-----SQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPN  187 (399)
Q Consensus       113 i~~~~~~i~~~lg~G~~g~Vy~~~~~-----~~~vAvK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~nIv~~~~~~~~~~~  187 (399)
                      |+..+|++.+.||+|+||.||+|...     ...+|+|.++... .....+.+.+|+.++++++||||+++++++..+..
T Consensus         1 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~   79 (267)
T cd05066           1 IDASCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGY-TEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSKP   79 (267)
T ss_pred             CCHHHeEeeeeecccCCCceEEEEEecCCCCceEEEEEECCCCC-CHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCc
Confidence            34678999999999999999999762     2369999987643 34456789999999999999999999999999999


Q ss_pred             EEEEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceeecCCCcEEEeeccceeeccCC
Q 015868          188 LCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQS  267 (399)
Q Consensus       188 ~~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~giiHrDlkp~NILl~~~~~vkl~DFG~a~~~~~~  267 (399)
                      .++||||+++++|.+++......++...+..++.|++.|++|||++|++||||||+||+++.++.++++|||.+......
T Consensus        80 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~h~dlkp~nili~~~~~~~l~dfg~~~~~~~~  159 (267)
T cd05066          80 VMIVTEYMENGSLDAFLRKHDGQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDD  159 (267)
T ss_pred             cEEEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEeehhhchhcEEECCCCeEEeCCCCcccccccc
Confidence            99999999999999999876677899999999999999999999999999999999999999999999999999765432


Q ss_pred             Cc--c--ccCCCCcccccccccCCCCCCChhhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHHhccCCCCCCCCCcHHH
Q 015868          268 GV--M--TAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLT-GELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRL  342 (399)
Q Consensus       268 ~~--~--~~~~gt~~y~aPE~l~~~~~~~~~Dv~slG~vl~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  342 (399)
                      ..  .  ....++..|+|||.+.+..++.++|+||||+++|++++ |..||...+..+..... ....++..+..+++.+
T Consensus       160 ~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~ell~~g~~p~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~  238 (267)
T cd05066         160 PEAAYTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWEMSNQDVIKAI-EEGYRLPAPMDCPAAL  238 (267)
T ss_pred             cceeeecCCCccceeecCHhHhccCccCchhhhHHHHHHHHHHhcCCCCCcccCCHHHHHHHH-hCCCcCCCCCCCCHHH
Confidence            21  1  11223568999999998889999999999999999887 99999888776654443 3445556667789999


Q ss_pred             HHHHHHHhhhcCCCCCCHHHHHHHHHHH
Q 015868          343 AELLERCWQHDPTQRPNFSQITDILKQM  370 (399)
Q Consensus       343 ~~ll~~cl~~dP~~Rps~~ell~~L~~l  370 (399)
                      .+++.+||+.+|.+||++.++++.|+++
T Consensus       239 ~~li~~~l~~~p~~Rp~~~~i~~~l~~~  266 (267)
T cd05066         239 HQLMLDCWQKDRNERPKFEQIVSILDKL  266 (267)
T ss_pred             HHHHHHHcccCchhCCCHHHHHHHHHhh
Confidence            9999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul

>cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=7.8e-43  Score=330.99  Aligned_cols=249  Identities=20%  Similarity=0.347  Sum_probs=210.5

Q ss_pred             ccceeceeceeCceEEEEEEE--CCeeEEEEEecCCCCC-HHHHHHHHHHHHHHHhcCCCceeeEEeEEecCCcEEEEEe
Q 015868          117 QLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVN-TEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVTE  193 (399)
Q Consensus       117 ~~~i~~~lg~G~~g~Vy~~~~--~~~~vAvK~~~~~~~~-~~~~~~~~~Ei~~l~~l~h~nIv~~~~~~~~~~~~~lV~E  193 (399)
                      .|++.+.||+|+||.||++..  +++.||+|++...... ......+.+|+.+++.++||||+++++.+..+...++|||
T Consensus         1 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e   80 (285)
T cd05605           1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLT   80 (285)
T ss_pred             CceEEEEEecCCCeEEEEEEEcCCCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcCCCCEeeeeeeecCCCeEEEEEe
Confidence            478899999999999999987  5789999999754322 2233567889999999999999999999999999999999


Q ss_pred             cCCCCCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceeecCCCcEEEeeccceeeccCCCcccc
Q 015868          194 FMARGSIYDFLHKQ-KGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTA  272 (399)
Q Consensus       194 ~~~ggsL~~~l~~~-~~~l~~~~~~~i~~~i~~~L~~LH~~giiHrDlkp~NILl~~~~~vkl~DFG~a~~~~~~~~~~~  272 (399)
                      |+.+++|.+++... ...+++..+..++.|++.||.|||++||+||||||+||++++++.++|+|||+++..........
T Consensus        81 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~~~~~  160 (285)
T cd05605          81 LMNGGDLKFHIYNMGNPGFDEERAVFYAAEITCGLEDLHRERIVYRDLKPENILLDDYGHIRISDLGLAVEIPEGETIRG  160 (285)
T ss_pred             ccCCCcHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCHHHEEECCCCCEEEeeCCCceecCCCCcccc
Confidence            99999999988654 35689999999999999999999999999999999999999999999999999987554433345


Q ss_pred             CCCCcccccccccCCCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHh--ccCCCCCCCCCcHHHHHHHHHHh
Q 015868          273 ETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQ--KSLRPTIPKHAHPRLAELLERCW  350 (399)
Q Consensus       273 ~~gt~~y~aPE~l~~~~~~~~~Dv~slG~vl~elltg~~P~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~l~~ll~~cl  350 (399)
                      ..|+..|+|||.+.+..++.++||||+|+++|+|++|..||.+.+..........  ....+..+..+++.+.+++.+||
T Consensus       161 ~~~~~~y~aPE~~~~~~~~~~~Diws~G~~l~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l  240 (285)
T cd05605         161 RVGTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSPFRQRKEKVKREEVERRVKEDQEEYSEKFSEAARSICRQLL  240 (285)
T ss_pred             ccCCCCccCcHHhcCCCCCccccchhHHHHHHHHHHCCCCCCCCchhhHHHHHHHHhhhcccccCcccCHHHHHHHHHHc
Confidence            5789999999999999999999999999999999999999987665332222111  12344566778999999999999


Q ss_pred             hhcCCCCC-----CHHHHHH
Q 015868          351 QHDPTQRP-----NFSQITD  365 (399)
Q Consensus       351 ~~dP~~Rp-----s~~ell~  365 (399)
                      ..||.+||     ++.++++
T Consensus       241 ~~~P~~R~~~~~~~~~~l~~  260 (285)
T cd05605         241 TKDPGFRLGCRGEGAEEVKA  260 (285)
T ss_pred             cCCHHHhcCCCCCCHHHHhc
Confidence            99999999     7777755

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5,

>cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2

Probab=100.00  E-value=1.4e-42  Score=339.99  Aligned_cols=247  Identities=25%  Similarity=0.368  Sum_probs=205.3

Q ss_pred             ccccceeceeceeCceEEEEEEE--CCeeEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCceeeEEeEEecCC------
Q 015868          115 AKQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPP------  186 (399)
Q Consensus       115 ~~~~~i~~~lg~G~~g~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~nIv~~~~~~~~~~------  186 (399)
                      .++|++.+.||+|+||.||++..  .++.||+|++............+.+|+.+++.++||||+++++++....      
T Consensus        20 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~   99 (359)
T cd07876          20 LKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEEFQ   99 (359)
T ss_pred             hhceEEEEEeecCCCEEEEEEEEcCCCceeEEEEecccccchhHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCCccccc
Confidence            47899999999999999999976  5789999999866545556678889999999999999999999986543      


Q ss_pred             cEEEEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceeecCCCcEEEeeccceeeccC
Q 015868          187 NLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQ  266 (399)
Q Consensus       187 ~~~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~giiHrDlkp~NILl~~~~~vkl~DFG~a~~~~~  266 (399)
                      .+|+||||+.+ +|.+.+.   ..++...+..++.|++.||.|||++||+||||||+||+++.++.+||+|||+++....
T Consensus       100 ~~~lv~e~~~~-~l~~~~~---~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~NIl~~~~~~~kl~Dfg~a~~~~~  175 (359)
T cd07876         100 DVYLVMELMDA-NLCQVIH---MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTACT  175 (359)
T ss_pred             eeEEEEeCCCc-CHHHHHh---ccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEEecCCCcccccc
Confidence            47999999976 6777663   3478899999999999999999999999999999999999999999999999976554


Q ss_pred             CCccccCCCCcccccccccCCCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcc-----------------
Q 015868          267 SGVMTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKS-----------------  329 (399)
Q Consensus       267 ~~~~~~~~gt~~y~aPE~l~~~~~~~~~Dv~slG~vl~elltg~~P~~~~~~~~~~~~~~~~~-----------------  329 (399)
                      ........+|+.|+|||++.+..++.++||||||+++|+|++|+.||.+.+............                 
T Consensus       176 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  255 (359)
T cd07876         176 NFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKGSVIFQGTDHIDQWNKVIEQLGTPSAEFMNRLQPTVRN  255 (359)
T ss_pred             CccCCCCcccCCCCCchhccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCcHHHHHHHHHHHHH
Confidence            444455678999999999999999999999999999999999999998766543222111100                 


Q ss_pred             ---CCCC--------------------CCCCCcHHHHHHHHHHhhhcCCCCCCHHHHHH
Q 015868          330 ---LRPT--------------------IPKHAHPRLAELLERCWQHDPTQRPNFSQITD  365 (399)
Q Consensus       330 ---~~~~--------------------~~~~~~~~l~~ll~~cl~~dP~~Rps~~ell~  365 (399)
                         .++.                    .+...++++.+||.+||+.||++|||+.|+++
T Consensus       256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~  314 (359)
T cd07876         256 YVENRPQYPGISFEELFPDWIFPSESERDKLKTSQARDLLSKMLVIDPDKRISVDEALR  314 (359)
T ss_pred             HHhhCCCCCCcchhhhccccccccccccccccchhHHHHHHHHhccCcccCCCHHHHhc
Confidence               0000                    11224678999999999999999999999987

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn

>cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C

Probab=100.00  E-value=2.3e-42  Score=328.43  Aligned_cols=257  Identities=29%  Similarity=0.573  Sum_probs=220.3

Q ss_pred             ecccccceeceeceeCceEEEEEEEC-------CeeEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCceeeEEeEEecC
Q 015868          113 IDAKQLKIECKVASGSYGDLYKGTYC-------SQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRP  185 (399)
Q Consensus       113 i~~~~~~i~~~lg~G~~g~Vy~~~~~-------~~~vAvK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~nIv~~~~~~~~~  185 (399)
                      +...+|.+.+.||.|+||.||++...       ...+++|.++..  .....+.+.+|+.++++++||||+++++++...
T Consensus         2 ~~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~   79 (291)
T cd05094           2 IKRRDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDP--TLAARKDFQREAELLTNLQHEHIVKFYGVCGDG   79 (291)
T ss_pred             CchHHeEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCc--cHHHHHHHHHHHHHHhcCCCCCcceEEEEEccC
Confidence            34568999999999999999999752       356889998754  344456789999999999999999999999999


Q ss_pred             CcEEEEEecCCCCCHHHHHHhcC---------------CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceeecCC
Q 015868          186 PNLCIVTEFMARGSIYDFLHKQK---------------GVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDEN  250 (399)
Q Consensus       186 ~~~~lV~E~~~ggsL~~~l~~~~---------------~~l~~~~~~~i~~~i~~~L~~LH~~giiHrDlkp~NILl~~~  250 (399)
                      ...++||||+++++|.+++....               +.+++..++.++.||+.|++|||++||+||||||+||+++.+
T Consensus        80 ~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~Nil~~~~  159 (291)
T cd05094          80 DPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQHFVHRDLATRNCLVGAN  159 (291)
T ss_pred             CceEEEEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccCcceEEEccC
Confidence            99999999999999999997532               347889999999999999999999999999999999999999


Q ss_pred             CcEEEeeccceeeccCCCc---cccCCCCcccccccccCCCCCCChhhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHH
Q 015868          251 GVVKVADFGVARVQAQSGV---MTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLT-GELPYAGLTPLQAAVGVV  326 (399)
Q Consensus       251 ~~vkl~DFG~a~~~~~~~~---~~~~~gt~~y~aPE~l~~~~~~~~~Dv~slG~vl~ellt-g~~P~~~~~~~~~~~~~~  326 (399)
                      +.++|+|||+++.......   .....++..|+|||.+.+..++.++||||||+++|+|+| |..||...++.+.... .
T Consensus       160 ~~~~l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~-~  238 (291)
T cd05094         160 LLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSNTEVIEC-I  238 (291)
T ss_pred             CcEEECCCCcccccCCCceeecCCCCCcceeecChHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHH-H
Confidence            9999999999975443221   223346788999999999999999999999999999999 9999988777665443 4


Q ss_pred             hccCCCCCCCCCcHHHHHHHHHHhhhcCCCCCCHHHHHHHHHHHHH
Q 015868          327 QKSLRPTIPKHAHPRLAELLERCWQHDPTQRPNFSQITDILKQMMK  372 (399)
Q Consensus       327 ~~~~~~~~~~~~~~~l~~ll~~cl~~dP~~Rps~~ell~~L~~l~~  372 (399)
                      .....+..+..++..+.+++.+||+.+|.+||++.++++.|.++.+
T Consensus       239 ~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~v~~~l~~~~~  284 (291)
T cd05094         239 TQGRVLERPRVCPKEVYDIMLGCWQREPQQRLNIKEIYKILHALGK  284 (291)
T ss_pred             hCCCCCCCCccCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHHh
Confidence            4455556667789999999999999999999999999999999865

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n

>cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor

Probab=100.00  E-value=2.7e-42  Score=327.47  Aligned_cols=259  Identities=28%  Similarity=0.566  Sum_probs=218.4

Q ss_pred             eeecccccceeceeceeCceEEEEEEEC-------CeeEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCceeeEEeEEe
Q 015868          111 WEIDAKQLKIECKVASGSYGDLYKGTYC-------SQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACT  183 (399)
Q Consensus       111 ~~i~~~~~~i~~~lg~G~~g~Vy~~~~~-------~~~vAvK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~nIv~~~~~~~  183 (399)
                      |+++.++|++.++||+|+||.||+|...       +..||+|.++... .......+.+|+.+++.++||||+++++++.
T Consensus         1 ~~~~~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~   79 (288)
T cd05061           1 WEVSREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESA-SLRERIEFLNEASVMKGFTCHHVVRLLGVVS   79 (288)
T ss_pred             CcccHHHceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcC-CHHHHHHHHHHHHHHHhCCCCCeeeEEEEEc
Confidence            7888999999999999999999998653       3479999987543 2333456889999999999999999999999


Q ss_pred             cCCcEEEEEecCCCCCHHHHHHhcC---------CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceeecCCCcEE
Q 015868          184 RPPNLCIVTEFMARGSIYDFLHKQK---------GVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVK  254 (399)
Q Consensus       184 ~~~~~~lV~E~~~ggsL~~~l~~~~---------~~l~~~~~~~i~~~i~~~L~~LH~~giiHrDlkp~NILl~~~~~vk  254 (399)
                      .+...++||||+++|+|.+++....         ..++...+..++.|++.||.|||++||+||||||+||++++++.++
T Consensus        80 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dikp~nili~~~~~~~  159 (288)
T cd05061          80 KGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAKKFVHRDLAARNCMVAHDFTVK  159 (288)
T ss_pred             CCCCcEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCcCCCCChheEEEcCCCcEE
Confidence            9999999999999999999997532         2345678899999999999999999999999999999999999999


Q ss_pred             EeeccceeeccCCCc---cccCCCCcccccccccCCCCCCChhhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHHhccC
Q 015868          255 VADFGVARVQAQSGV---MTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLT-GELPYAGLTPLQAAVGVVQKSL  330 (399)
Q Consensus       255 l~DFG~a~~~~~~~~---~~~~~gt~~y~aPE~l~~~~~~~~~Dv~slG~vl~ellt-g~~P~~~~~~~~~~~~~~~~~~  330 (399)
                      |+|||+++.......   .....++..|+|||.+.+..++.++|+||||+++|||++ |..||.+.+..+...... ...
T Consensus       160 L~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~DvwslG~~l~el~~~~~~p~~~~~~~~~~~~~~-~~~  238 (288)
T cd05061         160 IGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVLKFVM-DGG  238 (288)
T ss_pred             ECcCCccccccccccccccCCCcccccccCHHHhccCCCChHhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHH-cCC
Confidence            999999875433221   122345678999999998889999999999999999998 789998877766544333 344


Q ss_pred             CCCCCCCCcHHHHHHHHHHhhhcCCCCCCHHHHHHHHHHHH
Q 015868          331 RPTIPKHAHPRLAELLERCWQHDPTQRPNFSQITDILKQMM  371 (399)
Q Consensus       331 ~~~~~~~~~~~l~~ll~~cl~~dP~~Rps~~ell~~L~~l~  371 (399)
                      .+..+..+++.+.+++.+||+.+|++|||+.++++.|+..+
T Consensus       239 ~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~~~  279 (288)
T cd05061         239 YLDQPDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKDDL  279 (288)
T ss_pred             CCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHhhc
Confidence            45566778899999999999999999999999998888764

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta

>cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors

Probab=100.00  E-value=1.7e-42  Score=329.30  Aligned_cols=261  Identities=33%  Similarity=0.648  Sum_probs=224.2

Q ss_pred             CceeecccccceeceeceeCceEEEEEEECC-------eeEEEEEecCCCCCHHHHHHHHHHHHHHHhc-CCCceeeEEe
Q 015868          109 DVWEIDAKQLKIECKVASGSYGDLYKGTYCS-------QEVAIKVLKPECVNTEMLKEFSQEVYIMRKI-RHKNVVQFIG  180 (399)
Q Consensus       109 ~~~~i~~~~~~i~~~lg~G~~g~Vy~~~~~~-------~~vAvK~~~~~~~~~~~~~~~~~Ei~~l~~l-~h~nIv~~~~  180 (399)
                      ..|+++.++|++.+.||+|+||.||++...+       ..+|+|+++... .......+.+|+.+++++ +|+||+++++
T Consensus         5 ~~~~~~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~-~~~~~~~~~~E~~~l~~l~~h~~i~~~~~   83 (293)
T cd05053           5 PEWELPRDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDA-TEKDLSDLVSEMEMMKMIGKHKNIINLLG   83 (293)
T ss_pred             cccccCHhHeEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCC-CHHHHHHHHHHHHHHHhhcCCCCeeeEEE
Confidence            3478889999999999999999999998632       579999998653 334456789999999999 7999999999


Q ss_pred             EEecCCcEEEEEecCCCCCHHHHHHhc---------------CCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCce
Q 015868          181 ACTRPPNLCIVTEFMARGSIYDFLHKQ---------------KGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANL  245 (399)
Q Consensus       181 ~~~~~~~~~lV~E~~~ggsL~~~l~~~---------------~~~l~~~~~~~i~~~i~~~L~~LH~~giiHrDlkp~NI  245 (399)
                      ++.....++++|||+++++|.+++...               ...+++..+..++.|++.||+|||++||+||||||+||
T Consensus        84 ~~~~~~~~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivH~dlkp~Ni  163 (293)
T cd05053          84 VCTQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASKKCIHRDLAARNV  163 (293)
T ss_pred             EEcCCCCeEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHCCccccccceeeE
Confidence            999999999999999999999999642               34688999999999999999999999999999999999


Q ss_pred             eecCCCcEEEeeccceeeccCCCc---cccCCCCcccccccccCCCCCCChhhHHHHHHHHHHHHc-CCCCCCCCCHHHH
Q 015868          246 LMDENGVVKVADFGVARVQAQSGV---MTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLT-GELPYAGLTPLQA  321 (399)
Q Consensus       246 Ll~~~~~vkl~DFG~a~~~~~~~~---~~~~~gt~~y~aPE~l~~~~~~~~~Dv~slG~vl~ellt-g~~P~~~~~~~~~  321 (399)
                      +++.++.+||+|||.++.......   .....++..|+|||.+.+..++.++||||||+++|+|++ |..||...+..+.
T Consensus       164 l~~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~  243 (293)
T cd05053         164 LVTEDHVMKIADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEEL  243 (293)
T ss_pred             EEcCCCeEEeCccccccccccccceeccCCCCCCccccCHHHhccCCcCcccceeehhhHHHHHhcCCCCCCCCCCHHHH
Confidence            999999999999999986543321   122234678999999999999999999999999999998 9999988776665


Q ss_pred             HHHHHhccCCCCCCCCCcHHHHHHHHHHhhhcCCCCCCHHHHHHHHHHHH
Q 015868          322 AVGVVQKSLRPTIPKHAHPRLAELLERCWQHDPTQRPNFSQITDILKQMM  371 (399)
Q Consensus       322 ~~~~~~~~~~~~~~~~~~~~l~~ll~~cl~~dP~~Rps~~ell~~L~~l~  371 (399)
                      ... ......+..+..++.++.+|+.+||..+|++|||+.++++.|+.++
T Consensus       244 ~~~-~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~eil~~l~~~~  292 (293)
T cd05053         244 FKL-LKEGYRMEKPQNCTQELYHLMRDCWHEVPSQRPTFKQLVEDLDRML  292 (293)
T ss_pred             HHH-HHcCCcCCCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHHHHhh
Confidence            443 4444556677788999999999999999999999999999998875

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation,

>cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl

Probab=100.00  E-value=2.6e-42  Score=324.08  Aligned_cols=252  Identities=29%  Similarity=0.554  Sum_probs=212.6

Q ss_pred             cceeceeceeCceEEEEEEECC----eeEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCceeeEEeEEecC------Cc
Q 015868          118 LKIECKVASGSYGDLYKGTYCS----QEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRP------PN  187 (399)
Q Consensus       118 ~~i~~~lg~G~~g~Vy~~~~~~----~~vAvK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~nIv~~~~~~~~~------~~  187 (399)
                      +.+.++||+|+||.||+|.+..    ..||+|.++.........+.+.+|+.+++.++||||+++++++...      ..
T Consensus         1 ~~i~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~   80 (272)
T cd05075           1 LALGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYPS   80 (272)
T ss_pred             CccccccCcccCceEEEeEEccCCCeeeEEEEecccCcCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCcccCCCC
Confidence            3567899999999999998743    2589999987655666778899999999999999999999987432      24


Q ss_pred             EEEEEecCCCCCHHHHHHhc-----CCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceeecCCCcEEEeecccee
Q 015868          188 LCIVTEFMARGSIYDFLHKQ-----KGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVAR  262 (399)
Q Consensus       188 ~~lV~E~~~ggsL~~~l~~~-----~~~l~~~~~~~i~~~i~~~L~~LH~~giiHrDlkp~NILl~~~~~vkl~DFG~a~  262 (399)
                      .+++|||+.+|+|.+++...     ...++...+..++.|++.||+|||++||+||||||+||++++++.++|+|||+++
T Consensus        81 ~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~  160 (272)
T cd05075          81 PVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSSKSFIHRDLAARNCMLNENMNVCVADFGLSK  160 (272)
T ss_pred             cEEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhheEEcCCCCEEECCCCccc
Confidence            78999999999999987432     2457899999999999999999999999999999999999999999999999998


Q ss_pred             eccCCCc---cccCCCCcccccccccCCCCCCChhhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHHhccCCCCCCCCC
Q 015868          263 VQAQSGV---MTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLT-GELPYAGLTPLQAAVGVVQKSLRPTIPKHA  338 (399)
Q Consensus       263 ~~~~~~~---~~~~~gt~~y~aPE~l~~~~~~~~~Dv~slG~vl~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~  338 (399)
                      .......   .....+++.|+|||.+.+..++.++||||||+++|+|++ |..||......+.... +.....+..+..+
T Consensus       161 ~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~-~~~~~~~~~~~~~  239 (272)
T cd05075         161 KIYNGDYYRQGRIAKMPVKWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPGVENSEIYDY-LRQGNRLKQPPDC  239 (272)
T ss_pred             ccCcccceecCCcccCCcccCCHHHccCCCcChHHHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH-HHcCCCCCCCCCC
Confidence            6543321   122245778999999999999999999999999999999 8999988777654443 4444555667788


Q ss_pred             cHHHHHHHHHHhhhcCCCCCCHHHHHHHHHHH
Q 015868          339 HPRLAELLERCWQHDPTQRPNFSQITDILKQM  370 (399)
Q Consensus       339 ~~~l~~ll~~cl~~dP~~Rps~~ell~~L~~l  370 (399)
                      +..+.+++.+||+.+|++|||+.++++.|+++
T Consensus       240 ~~~~~~li~~~l~~~p~~Rps~~~l~~~l~~~  271 (272)
T cd05075         240 LDGLYSLMSSCWLLNPKDRPSFETLRCELEKA  271 (272)
T ss_pred             CHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence            99999999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor

>cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2

Probab=100.00  E-value=1.1e-42  Score=328.89  Aligned_cols=255  Identities=25%  Similarity=0.544  Sum_probs=217.8

Q ss_pred             ecccccceeceeceeCceEEEEEEEC-------CeeEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCceeeEEeEEecC
Q 015868          113 IDAKQLKIECKVASGSYGDLYKGTYC-------SQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRP  185 (399)
Q Consensus       113 i~~~~~~i~~~lg~G~~g~Vy~~~~~-------~~~vAvK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~nIv~~~~~~~~~  185 (399)
                      ++..+|++.++||.|+||.||+|...       ++.||+|+++... .....+.+.+|+.++..++||||+++++++...
T Consensus         2 i~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~   80 (283)
T cd05091           2 INLSTVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKA-EGPLREEFKHEAMMRSRLQHPNIVCLLGVVTKE   80 (283)
T ss_pred             CCHHHHHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCC-CHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcCC
Confidence            55678999999999999999999863       3679999998543 344557789999999999999999999999999


Q ss_pred             CcEEEEEecCCCCCHHHHHHhc---------------CCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceeecCC
Q 015868          186 PNLCIVTEFMARGSIYDFLHKQ---------------KGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDEN  250 (399)
Q Consensus       186 ~~~~lV~E~~~ggsL~~~l~~~---------------~~~l~~~~~~~i~~~i~~~L~~LH~~giiHrDlkp~NILl~~~  250 (399)
                      ...++++||+.+++|.+++...               ...+++..+..++.|++.||.|||++||+||||||.||+++++
T Consensus        81 ~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~~gi~H~dlkp~Nil~~~~  160 (283)
T cd05091          81 QPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSHHVVHKDLATRNVLVFDK  160 (283)
T ss_pred             CceEEEEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHcCccccccchhheEecCC
Confidence            9999999999999999998532               2357888899999999999999999999999999999999999


Q ss_pred             CcEEEeeccceeeccCCCc---cccCCCCcccccccccCCCCCCChhhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHH
Q 015868          251 GVVKVADFGVARVQAQSGV---MTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLT-GELPYAGLTPLQAAVGVV  326 (399)
Q Consensus       251 ~~vkl~DFG~a~~~~~~~~---~~~~~gt~~y~aPE~l~~~~~~~~~Dv~slG~vl~ellt-g~~P~~~~~~~~~~~~~~  326 (399)
                      +.+||+|||+++.......   .....+++.|+|||.+.+..++.++||||||+++|||++ |..||.+.+..+......
T Consensus       161 ~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~i~  240 (283)
T cd05091         161 LNVKISDLGLFREVYAADYYKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDVIEMIR  240 (283)
T ss_pred             CceEecccccccccccchheeeccCccCCccccCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHH
Confidence            9999999999875433221   223345778999999988889999999999999999998 889998888776555443


Q ss_pred             hccCCCCCCCCCcHHHHHHHHHHhhhcCCCCCCHHHHHHHHHH
Q 015868          327 QKSLRPTIPKHAHPRLAELLERCWQHDPTQRPNFSQITDILKQ  369 (399)
Q Consensus       327 ~~~~~~~~~~~~~~~l~~ll~~cl~~dP~~Rps~~ell~~L~~  369 (399)
                       ....+..+..++..+.+++.+||+.+|.+||++.+|+..|+.
T Consensus       241 -~~~~~~~~~~~~~~~~~li~~cl~~~p~~RP~~~~i~~~l~~  282 (283)
T cd05091         241 -NRQVLPCPDDCPAWVYTLMLECWNEFPSRRPRFKDIHSRLRT  282 (283)
T ss_pred             -cCCcCCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHhhC
Confidence             344455677899999999999999999999999999998864

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly

>cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains

Probab=100.00  E-value=3.1e-42  Score=320.25  Aligned_cols=248  Identities=26%  Similarity=0.459  Sum_probs=218.5

Q ss_pred             ccceeceeceeCceEEEEEEE--CCeeEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCceeeEEeEEecCCcEEEEEec
Q 015868          117 QLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVTEF  194 (399)
Q Consensus       117 ~~~i~~~lg~G~~g~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~nIv~~~~~~~~~~~~~lV~E~  194 (399)
                      +|.+.+.||+|++|.||+++.  +++.|++|.+............+.+|+.+++.++||||+++++++...+..++||||
T Consensus         1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   80 (256)
T cd08529           1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYESFLDKGKLNIVMEY   80 (256)
T ss_pred             CceEeEEecCCCCeEEEEEEEcCCCcEEEEEEeehhhCCHHHHHHHHHHHHHHHhcCCCCeehheeeeccCCEEEEEEEe
Confidence            478889999999999999987  578999999986655566678899999999999999999999999999999999999


Q ss_pred             CCCCCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceeecCCCcEEEeeccceeeccCCC-cccc
Q 015868          195 MARGSIYDFLHKQ-KGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSG-VMTA  272 (399)
Q Consensus       195 ~~ggsL~~~l~~~-~~~l~~~~~~~i~~~i~~~L~~LH~~giiHrDlkp~NILl~~~~~vkl~DFG~a~~~~~~~-~~~~  272 (399)
                      ++|++|.+++... ...++...++.++.+++.||.|||++|++|+||+|+||+++.++.++|+|||.++...... ....
T Consensus        81 ~~~~~L~~~l~~~~~~~~~~~~~~~i~~~l~~al~~lH~~~i~h~dl~~~nili~~~~~~~l~df~~~~~~~~~~~~~~~  160 (256)
T cd08529          81 AENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHLHSKKILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTNFANT  160 (256)
T ss_pred             CCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEEeCCCCEEEcccccceeccCccchhhc
Confidence            9999999999774 4678999999999999999999999999999999999999999999999999988654432 2234


Q ss_pred             CCCCcccccccccCCCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhccCCCCCCCCCcHHHHHHHHHHhhh
Q 015868          273 ETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRLAELLERCWQH  352 (399)
Q Consensus       273 ~~gt~~y~aPE~l~~~~~~~~~Dv~slG~vl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~cl~~  352 (399)
                      ..+++.|+|||++.+..++.++|+||||+++|+|++|+.||...+..+..... .....+.++..++.++.+++.+||+.
T Consensus       161 ~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~i~~~l~~  239 (256)
T cd08529         161 IVGTPYYLSPELCEDKPYNEKSDVWALGVVLYECCTGKHPFDANNQGALILKI-IRGVFPPVSQMYSQQLAQLIDQCLTK  239 (256)
T ss_pred             cccCccccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHH-HcCCCCCCccccCHHHHHHHHHHccC
Confidence            46889999999999999999999999999999999999999888765544443 33455667778899999999999999


Q ss_pred             cCCCCCCHHHHHH
Q 015868          353 DPTQRPNFSQITD  365 (399)
Q Consensus       353 dP~~Rps~~ell~  365 (399)
                      +|++||++.++++
T Consensus       240 ~p~~Rp~~~~ll~  252 (256)
T cd08529         240 DYRQRPDTFQLLR  252 (256)
T ss_pred             CcccCcCHHHHhh
Confidence            9999999999875

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc

>KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=5.9e-44  Score=313.91  Aligned_cols=248  Identities=24%  Similarity=0.435  Sum_probs=221.2

Q ss_pred             ccccceeceeceeCceEEEEEEE--CCeeEEEEEecCCCC-CHHHHHHHHHHHHHHHhcCCCceeeEEeEEecCCcEEEE
Q 015868          115 AKQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECV-NTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIV  191 (399)
Q Consensus       115 ~~~~~i~~~lg~G~~g~Vy~~~~--~~~~vAvK~~~~~~~-~~~~~~~~~~Ei~~l~~l~h~nIv~~~~~~~~~~~~~lV  191 (399)
                      .++|.+++.||.|-||.||+|+.  ++-.||+|++..... .......+.+|++|-..|+||||.++|++|.+....|++
T Consensus        21 l~dfeigr~LgkgkFG~vYlarekks~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~hpnilrlY~~fhd~~riyLi  100 (281)
T KOG0580|consen   21 LDDFEIGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQILKTQVEHQLRREIEIQSHLRHPNILRLYGYFHDSKRIYLI  100 (281)
T ss_pred             hhhccccccccCCccccEeEeeeccCCcEEEEeeeeHHHHHHhcchhhhhheeEeecccCCccHHhhhhheeccceeEEE
Confidence            45899999999999999999987  456799999875432 233446789999999999999999999999999999999


Q ss_pred             EecCCCCCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceeecCCCcEEEeeccceeeccCCCcc
Q 015868          192 TEFMARGSIYDFLHKQ-KGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVM  270 (399)
Q Consensus       192 ~E~~~ggsL~~~l~~~-~~~l~~~~~~~i~~~i~~~L~~LH~~giiHrDlkp~NILl~~~~~vkl~DFG~a~~~~~~~~~  270 (399)
                      +||..+|+++..|... ...++++..+.++.|++.|+.|+|.++||||||||+|+|++..|.+|++|||.+...+ .+..
T Consensus       101 lEya~~gel~k~L~~~~~~~f~e~~~a~Yi~q~A~Al~y~h~k~VIhRdiKpenlLlg~~~~lkiAdfGwsV~~p-~~kR  179 (281)
T KOG0580|consen  101 LEYAPRGELYKDLQEGRMKRFDEQRAATYIKQLANALLYCHLKRVIHRDIKPENLLLGSAGELKIADFGWSVHAP-SNKR  179 (281)
T ss_pred             EEecCCchHHHHHHhcccccccccchhHHHHHHHHHHHHhccCCcccCCCCHHHhccCCCCCeeccCCCceeecC-CCCc
Confidence            9999999999999854 4569999999999999999999999999999999999999999999999999997655 5566


Q ss_pred             ccCCCCcccccccccCCCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhccCCCCCCCCCcHHHHHHHHHHh
Q 015868          271 TAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRLAELLERCW  350 (399)
Q Consensus       271 ~~~~gt~~y~aPE~l~~~~~~~~~Dv~slG~vl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~cl  350 (399)
                      .+.+||..|.+||+..+..++...|+|++|++.||++.|.+||...+..+....+..  .+-.+|..++.+..++|.+|+
T Consensus       180 ~tlcgt~dyl~pEmv~~~~hd~~Vd~w~lgvl~yeflvg~ppFes~~~~etYkrI~k--~~~~~p~~is~~a~dlI~~ll  257 (281)
T KOG0580|consen  180 KTLCGTLDYLPPEMVEGRGHDKFVDLWSLGVLCYEFLVGLPPFESQSHSETYKRIRK--VDLKFPSTISGGAADLISRLL  257 (281)
T ss_pred             eeeecccccCCHhhcCCCCccchhhHHHHHHHHHHHHhcCCchhhhhhHHHHHHHHH--ccccCCcccChhHHHHHHHHh
Confidence            778999999999999999999999999999999999999999999886666555443  345677899999999999999


Q ss_pred             hhcCCCCCCHHHHHH
Q 015868          351 QHDPTQRPNFSQITD  365 (399)
Q Consensus       351 ~~dP~~Rps~~ell~  365 (399)
                      ..+|.+|.+..|+++
T Consensus       258 ~~~p~~r~~l~~v~~  272 (281)
T KOG0580|consen  258 VKNPIERLALTEVMD  272 (281)
T ss_pred             ccCccccccHHHHhh
Confidence            999999999999875

>cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4

Probab=100.00  E-value=3.5e-42  Score=330.97  Aligned_cols=264  Identities=31%  Similarity=0.634  Sum_probs=224.4

Q ss_pred             CceeecccccceeceeceeCceEEEEEEEC---------CeeEEEEEecCCCCCHHHHHHHHHHHHHHHhc-CCCceeeE
Q 015868          109 DVWEIDAKQLKIECKVASGSYGDLYKGTYC---------SQEVAIKVLKPECVNTEMLKEFSQEVYIMRKI-RHKNVVQF  178 (399)
Q Consensus       109 ~~~~i~~~~~~i~~~lg~G~~g~Vy~~~~~---------~~~vAvK~~~~~~~~~~~~~~~~~Ei~~l~~l-~h~nIv~~  178 (399)
                      ..|.+...+|++.++||+|+||.||+++..         ...+|+|+++... .......+.+|+.+++++ +||||+++
T Consensus         5 ~~~~~~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~-~~~~~~~~~~E~~~l~~l~~h~~iv~~   83 (314)
T cd05099           5 PKWEFPRDRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNA-TDKDLADLISEMELMKLIGKHKNIINL   83 (314)
T ss_pred             ccccccHHHeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCC-ChHHHHHHHHHHHHHHhccCCCCeeeE
Confidence            347788899999999999999999999752         3569999988543 344567789999999999 69999999


Q ss_pred             EeEEecCCcEEEEEecCCCCCHHHHHHhcC---------------CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCC
Q 015868          179 IGACTRPPNLCIVTEFMARGSIYDFLHKQK---------------GVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTA  243 (399)
Q Consensus       179 ~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~---------------~~l~~~~~~~i~~~i~~~L~~LH~~giiHrDlkp~  243 (399)
                      ++++.....+++||||+++|+|.+++....               ..++...+..++.|++.||.|||++|++||||||+
T Consensus        84 ~~~~~~~~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~gi~H~dlkp~  163 (314)
T cd05099          84 LGVCTQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESRRCIHRDLAAR  163 (314)
T ss_pred             EEEEccCCceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHHCCeeeccccce
Confidence            999999889999999999999999997632               34788899999999999999999999999999999


Q ss_pred             ceeecCCCcEEEeeccceeeccCCCc---cccCCCCcccccccccCCCCCCChhhHHHHHHHHHHHHc-CCCCCCCCCHH
Q 015868          244 NLLMDENGVVKVADFGVARVQAQSGV---MTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLT-GELPYAGLTPL  319 (399)
Q Consensus       244 NILl~~~~~vkl~DFG~a~~~~~~~~---~~~~~gt~~y~aPE~l~~~~~~~~~Dv~slG~vl~ellt-g~~P~~~~~~~  319 (399)
                      ||+++.++.+||+|||.++.......   .....++..|+|||.+.+..++.++||||||+++|+|++ |..||...+..
T Consensus       164 Nill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~  243 (314)
T cd05099         164 NVLVTEDNVMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSPYPGIPVE  243 (314)
T ss_pred             eEEEcCCCcEEEccccccccccccccccccccCCCCccccCHHHHccCCcCccchhhHHHHHHHHHHhCCCCCCCCCCHH
Confidence            99999999999999999976543211   122234568999999999899999999999999999999 89999888776


Q ss_pred             HHHHHHHhccCCCCCCCCCcHHHHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHH
Q 015868          320 QAAVGVVQKSLRPTIPKHAHPRLAELLERCWQHDPTQRPNFSQITDILKQMMKEV  374 (399)
Q Consensus       320 ~~~~~~~~~~~~~~~~~~~~~~l~~ll~~cl~~dP~~Rps~~ell~~L~~l~~~~  374 (399)
                      +.... ......+..+..++.++.+++.+||..+|++|||+.++++.|.++....
T Consensus       244 ~~~~~-~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~l~~~~~~~  297 (314)
T cd05099         244 ELFKL-LREGHRMDKPSNCTHELYMLMRECWHAVPTQRPTFKQLVEALDKVLAAV  297 (314)
T ss_pred             HHHHH-HHcCCCCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHHHh
Confidence            65544 3444455667788999999999999999999999999999999987654

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=4.9e-43  Score=341.11  Aligned_cols=256  Identities=32%  Similarity=0.590  Sum_probs=211.4

Q ss_pred             cccccceeceeceeCceEEEEEEECC-eeEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCceeeEEeEEecCC-cEEEE
Q 015868          114 DAKQLKIECKVASGSYGDLYKGTYCS-QEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPP-NLCIV  191 (399)
Q Consensus       114 ~~~~~~i~~~lg~G~~g~Vy~~~~~~-~~vAvK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~nIv~~~~~~~~~~-~~~lV  191 (399)
                      ..++|.-...||+|+||.||+|...+ ..||||.+.......  .++|.+|+.++.+++|||+++++|+|.+.. ..+||
T Consensus        73 AT~~Fs~~~~ig~Ggfg~VYkG~l~~~~~vAVK~~~~~~~~~--~~eF~~Ei~~ls~l~H~Nlv~LlGyC~e~~~~~~LV  150 (361)
T KOG1187|consen   73 ATNNFSESNLIGEGGFGTVYKGVLSDGTVVAVKRLSSNSGQG--EREFLNEVEILSRLRHPNLVKLLGYCLEGGEHRLLV  150 (361)
T ss_pred             HHhCCchhcceecCCCeEEEEEEECCCCEEEEEEecCCCCcc--hhHHHHHHHHHhcCCCcCcccEEEEEecCCceEEEE
Confidence            34677778899999999999999865 899999888654332  456999999999999999999999999988 49999


Q ss_pred             EecCCCCCHHHHHHhcCC-CCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCCCceeecCCCcEEEeeccceeeccC-
Q 015868          192 TEFMARGSIYDFLHKQKG-VFQLTSLLKVAIDVSKGMNYLHQNN---IIHRDLKTANLLMDENGVVKVADFGVARVQAQ-  266 (399)
Q Consensus       192 ~E~~~ggsL~~~l~~~~~-~l~~~~~~~i~~~i~~~L~~LH~~g---iiHrDlkp~NILl~~~~~vkl~DFG~a~~~~~-  266 (399)
                      +|||++|||.+.|+.... .+++..+.+|+.++++||+|||...   ||||||||.|||+|++...||+|||+|+..+. 
T Consensus       151 YEym~nGsL~d~L~~~~~~~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD~~~~aKlsDFGLa~~~~~~  230 (361)
T KOG1187|consen  151 YEYMPNGSLEDHLHGKKGEPLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLDEDFNAKLSDFGLAKLGPEG  230 (361)
T ss_pred             EEccCCCCHHHHhCCCCCCCCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeECCCCCEEccCccCcccCCcc
Confidence            999999999999988766 8999999999999999999999854   99999999999999999999999999976654 


Q ss_pred             CCccccC-CCCcccccccccCCCCCCChhhHHHHHHHHHHHHcCCCCCCCCC------HHHHHHHHHh-----ccCCCCC
Q 015868          267 SGVMTAE-TGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPYAGLT------PLQAAVGVVQ-----KSLRPTI  334 (399)
Q Consensus       267 ~~~~~~~-~gt~~y~aPE~l~~~~~~~~~Dv~slG~vl~elltg~~P~~~~~------~~~~~~~~~~-----~~~~~~~  334 (399)
                      ....... .||.+|+|||.+.....+.|+||||||++|.||+||+.|.+...      -.+.+...+.     ....|.+
T Consensus       231 ~~~~~~~~~gt~gY~~PEy~~~g~lt~KsDVySFGVvllElitgr~~~d~~~~~~~~~l~~w~~~~~~~~~~~eiiD~~l  310 (361)
T KOG1187|consen  231 DTSVSTTVMGTFGYLAPEYASTGKLTEKSDVYSFGVVLLELITGRKAVDQSRPRGELSLVEWAKPLLEEGKLREIVDPRL  310 (361)
T ss_pred             ccceeeecCCCCccCChhhhccCCcCcccccccchHHHHHHHhCCcccCCCCCcccccHHHHHHHHHHCcchhheeCCCc
Confidence            3322223 79999999999999889999999999999999999998877532      1121122222     2233444


Q ss_pred             C-CCCc-----HHHHHHHHHHhhhcCCCCCCHHHHHHHHHHHH
Q 015868          335 P-KHAH-----PRLAELLERCWQHDPTQRPNFSQITDILKQMM  371 (399)
Q Consensus       335 ~-~~~~-----~~l~~ll~~cl~~dP~~Rps~~ell~~L~~l~  371 (399)
                      . ...+     ..+..+..+|++.+|..||++.|+++.|+.+.
T Consensus       311 ~~~~~~~~~~~~~~~~~a~~C~~~~~~~RP~m~~Vv~~L~~~~  353 (361)
T KOG1187|consen  311 KEGEYPDEKEVKKLAELALRCLRPDPKERPTMSQVVKELEGIL  353 (361)
T ss_pred             cCCCCChHHHHHHHHHHHHHHcCcCCCcCcCHHHHHHHHHhhc
Confidence            3 2223     23678888999999999999999988886554

>cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1

Probab=100.00  E-value=2.1e-42  Score=335.54  Aligned_cols=250  Identities=24%  Similarity=0.451  Sum_probs=209.4

Q ss_pred             ecccccceeceeceeCceEEEEEEE--CCeeEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCceeeEEeEEecCCcEEE
Q 015868          113 IDAKQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCI  190 (399)
Q Consensus       113 i~~~~~~i~~~lg~G~~g~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~nIv~~~~~~~~~~~~~l  190 (399)
                      +..++|++.++||.|+||.||++..  ++..+|+|+++... .......+.+|+.++++++||||+++++++.....+++
T Consensus         2 l~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l   80 (333)
T cd06650           2 LKDDDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEI-KPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISI   80 (333)
T ss_pred             cchhhhheeccccCCCCEEEEEEEECCCCcEEEEEEeeccc-CHHHHHHHHHHHHHHHHCCCCcccceeEEEEECCEEEE
Confidence            5568999999999999999999988  46789999987653 34455779999999999999999999999999999999


Q ss_pred             EEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC-CcccCCCCCCceeecCCCcEEEeeccceeeccCCCc
Q 015868          191 VTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQN-NIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGV  269 (399)
Q Consensus       191 V~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~-giiHrDlkp~NILl~~~~~vkl~DFG~a~~~~~~~~  269 (399)
                      ||||+.+++|.+++.. .+.+++..+..++.+++.||.|||++ +|+||||||+|||+++++.+||+|||++...... .
T Consensus        81 v~e~~~~~~L~~~l~~-~~~~~~~~~~~~~~~l~~~l~~lH~~~~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~-~  158 (333)
T cd06650          81 CMEHMDGGSLDQVLKK-AGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS-M  158 (333)
T ss_pred             EEecCCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHhcCCEEecCCChhhEEEcCCCCEEEeeCCcchhhhhh-c
Confidence            9999999999999976 45689999999999999999999985 7999999999999999999999999998754332 2


Q ss_pred             cccCCCCcccccccccCCCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHH-------------------------
Q 015868          270 MTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVG-------------------------  324 (399)
Q Consensus       270 ~~~~~gt~~y~aPE~l~~~~~~~~~Dv~slG~vl~elltg~~P~~~~~~~~~~~~-------------------------  324 (399)
                      .....|+..|+|||.+.+..++.++|+|||||++|+|++|+.||......+....                         
T Consensus       159 ~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (333)
T cd06650         159 ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYPIPPPDAKELELMFGCPVEGDPAESETSPRPRPPGRPL  238 (333)
T ss_pred             cccCCCCccccCHHHhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcchhHHHHHhcCcccCCccccccCcccCCccchh
Confidence            2345689999999999998999999999999999999999999976544322110                         


Q ss_pred             ------------------HHhccCCCCCCC-CCcHHHHHHHHHHhhhcCCCCCCHHHHHH
Q 015868          325 ------------------VVQKSLRPTIPK-HAHPRLAELLERCWQHDPTQRPNFSQITD  365 (399)
Q Consensus       325 ------------------~~~~~~~~~~~~-~~~~~l~~ll~~cl~~dP~~Rps~~ell~  365 (399)
                                        .+.....+.++. ..+.++.+|+.+||+.||++|||+.|+++
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~P~~Rpt~~ell~  298 (333)
T cd06650         239 SSYGPDSRPPMAIFELLDYIVNEPPPKLPSGVFGAEFQDFVNKCLIKNPAERADLKQLMV  298 (333)
T ss_pred             hhhcccccccccHHHHHHHHhcCCCccCCCCCcCHHHHHHHHHhccCCcccCcCHHHHhh
Confidence                              011111222222 36789999999999999999999999965

Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst

>cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2

Probab=100.00  E-value=3.4e-42  Score=329.37  Aligned_cols=262  Identities=30%  Similarity=0.624  Sum_probs=224.1

Q ss_pred             eeecccccceeceeceeCceEEEEEEEC---------CeeEEEEEecCCCCCHHHHHHHHHHHHHHHhc-CCCceeeEEe
Q 015868          111 WEIDAKQLKIECKVASGSYGDLYKGTYC---------SQEVAIKVLKPECVNTEMLKEFSQEVYIMRKI-RHKNVVQFIG  180 (399)
Q Consensus       111 ~~i~~~~~~i~~~lg~G~~g~Vy~~~~~---------~~~vAvK~~~~~~~~~~~~~~~~~Ei~~l~~l-~h~nIv~~~~  180 (399)
                      |++...+|++.+.||+|+||.||++++.         +..||+|.++... .....+.+.+|+.+++.+ +||||+++++
T Consensus        10 ~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~-~~~~~~~~~~E~~~l~~l~~h~~i~~~~~   88 (304)
T cd05101          10 WEFSRDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDA-TEKDLSDLVSEMEMMKMIGKHKNIINLLG   88 (304)
T ss_pred             ccccHHHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeeccccc-chHHHHHHHHHHHHHHhhccCCCchheeE
Confidence            6788899999999999999999999752         3469999987542 344467899999999999 8999999999


Q ss_pred             EEecCCcEEEEEecCCCCCHHHHHHhcC---------------CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCce
Q 015868          181 ACTRPPNLCIVTEFMARGSIYDFLHKQK---------------GVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANL  245 (399)
Q Consensus       181 ~~~~~~~~~lV~E~~~ggsL~~~l~~~~---------------~~l~~~~~~~i~~~i~~~L~~LH~~giiHrDlkp~NI  245 (399)
                      ++......++||||+++++|.+++....               ..++...+..++.||+.||.|||++|++||||||+||
T Consensus        89 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~givH~dlkp~Ni  168 (304)
T cd05101          89 ACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQKCIHRDLAARNV  168 (304)
T ss_pred             EEecCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHHCCeeecccccceE
Confidence            9999999999999999999999997632               3467888999999999999999999999999999999


Q ss_pred             eecCCCcEEEeeccceeeccCCCc---cccCCCCcccccccccCCCCCCChhhHHHHHHHHHHHHc-CCCCCCCCCHHHH
Q 015868          246 LMDENGVVKVADFGVARVQAQSGV---MTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLT-GELPYAGLTPLQA  321 (399)
Q Consensus       246 Ll~~~~~vkl~DFG~a~~~~~~~~---~~~~~gt~~y~aPE~l~~~~~~~~~Dv~slG~vl~ellt-g~~P~~~~~~~~~  321 (399)
                      ++++++.+||+|||.++.......   .....+++.|+|||++.+..++.++||||||+++|+|++ |..||...+..+.
T Consensus       169 li~~~~~~kl~D~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~  248 (304)
T cd05101         169 LVTENNVMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEEL  248 (304)
T ss_pred             EEcCCCcEEECCCccceecccccccccccCCCCCceeeCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCHHHH
Confidence            999999999999999986543221   222345678999999998889999999999999999998 8899988877665


Q ss_pred             HHHHHhccCCCCCCCCCcHHHHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHH
Q 015868          322 AVGVVQKSLRPTIPKHAHPRLAELLERCWQHDPTQRPNFSQITDILKQMMKEV  374 (399)
Q Consensus       322 ~~~~~~~~~~~~~~~~~~~~l~~ll~~cl~~dP~~Rps~~ell~~L~~l~~~~  374 (399)
                      ... +....+...+..++.++.+++.+||..+|.+|||+.++++.|++++...
T Consensus       249 ~~~-~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~l~~l~~~~~~~  300 (304)
T cd05101         249 FKL-LKEGHRMDKPANCTNELYMMMRDCWHAIPSHRPTFKQLVEDLDRILTLT  300 (304)
T ss_pred             HHH-HHcCCcCCCCCCCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHHHHhh
Confidence            444 3444555667788999999999999999999999999999999987643

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor

Probab=100.00  E-value=3.3e-43  Score=346.65  Aligned_cols=249  Identities=22%  Similarity=0.354  Sum_probs=208.7

Q ss_pred             cccceeceeceeCceEEEEEEE--CCeeEEEEEecCCCC-CHHHHHHHHHHHHHHHhcCCCceeeEEeEEecCCcEEEEE
Q 015868          116 KQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECV-NTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVT  192 (399)
Q Consensus       116 ~~~~i~~~lg~G~~g~Vy~~~~--~~~~vAvK~~~~~~~-~~~~~~~~~~Ei~~l~~l~h~nIv~~~~~~~~~~~~~lV~  192 (399)
                      ++|++.++||+|+||.||+++.  +++.||+|++..... .......+.+|+.++++++||||+++++.+..++.+|+||
T Consensus         1 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~   80 (376)
T cd05598           1 SMFVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVM   80 (376)
T ss_pred             CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCCCCCcceEEEEEEcCCEEEEEE
Confidence            4799999999999999999986  578999999864321 2233567889999999999999999999999999999999


Q ss_pred             ecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceeecCCCcEEEeeccceeeccCC-----
Q 015868          193 EFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQS-----  267 (399)
Q Consensus       193 E~~~ggsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~giiHrDlkp~NILl~~~~~vkl~DFG~a~~~~~~-----  267 (399)
                      ||++||+|.+++.. .+.+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||++......     
T Consensus        81 E~~~~g~L~~~i~~-~~~~~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nill~~~~~ikL~DFG~a~~~~~~~~~~~  159 (376)
T cd05598          81 DYIPGGDMMSLLIR-LGIFEEDLARFYIAELTCAIESVHKMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKY  159 (376)
T ss_pred             eCCCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHEEECCCCCEEEEeCCCCccccccccccc
Confidence            99999999999976 457899999999999999999999999999999999999999999999999997422100     


Q ss_pred             ---------------------------------------CccccCCCCcccccccccCCCCCCChhhHHHHHHHHHHHHc
Q 015868          268 ---------------------------------------GVMTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLT  308 (399)
Q Consensus       268 ---------------------------------------~~~~~~~gt~~y~aPE~l~~~~~~~~~Dv~slG~vl~ellt  308 (399)
                                                             .......||+.|+|||++.+..++.++|||||||++|+|++
T Consensus       160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyell~  239 (376)
T cd05598         160 YQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYEMLV  239 (376)
T ss_pred             cccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcCCCCCcceeeeeccceeeehhh
Confidence                                                   00112368999999999999999999999999999999999


Q ss_pred             CCCCCCCCCHHHHHHHHHhccCCCCCC--CCCcHHHHHHHHHHhhhcCCCCC---CHHHHHHH
Q 015868          309 GELPYAGLTPLQAAVGVVQKSLRPTIP--KHAHPRLAELLERCWQHDPTQRP---NFSQITDI  366 (399)
Q Consensus       309 g~~P~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~l~~ll~~cl~~dP~~Rp---s~~ell~~  366 (399)
                      |+.||...++.+....+........++  ..+++++.++|.+|+ .+|.+|+   ++.++++.
T Consensus       240 G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~l~-~~p~~R~~~~t~~ell~h  301 (376)
T cd05598         240 GQPPFLADTPAETQLKVINWETTLHIPSQAKLSREASDLILRLC-CGAEDRLGKNGADEIKAH  301 (376)
T ss_pred             CCCCCCCCCHHHHHHHHhccCccccCCCCCCCCHHHHHHHHHHh-cCHhhcCCCCCHHHHhCC
Confidence            999999888776555444322222232  357899999999976 5999999   88998763

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation.

>cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein

Probab=100.00  E-value=4.4e-42  Score=326.25  Aligned_cols=254  Identities=29%  Similarity=0.617  Sum_probs=217.3

Q ss_pred             ccceeceeceeCceEEEEEEECC-------eeEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCceeeEEeEEecCCcEE
Q 015868          117 QLKIECKVASGSYGDLYKGTYCS-------QEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLC  189 (399)
Q Consensus       117 ~~~i~~~lg~G~~g~Vy~~~~~~-------~~vAvK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~nIv~~~~~~~~~~~~~  189 (399)
                      +|++.+.||+|+||.||+|....       ..+++|.+.... .......+.+|+.+++.++||||+++++.+......+
T Consensus         1 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~   79 (290)
T cd05045           1 NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENA-SSSELRDLLSEFNLLKQVNHPHVIKLYGACSQDGPLL   79 (290)
T ss_pred             CccccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCC-CHHHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCCcE
Confidence            47888999999999999998632       468999987653 2344578999999999999999999999999999999


Q ss_pred             EEEecCCCCCHHHHHHhcC-----------------------CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcee
Q 015868          190 IVTEFMARGSIYDFLHKQK-----------------------GVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLL  246 (399)
Q Consensus       190 lV~E~~~ggsL~~~l~~~~-----------------------~~l~~~~~~~i~~~i~~~L~~LH~~giiHrDlkp~NIL  246 (399)
                      +|+||+.+++|.+++....                       ..++...++.++.|++.||.|||++|++||||||+||+
T Consensus        80 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~dikp~nil  159 (290)
T cd05045          80 LIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAEMKLVHRDLAARNVL  159 (290)
T ss_pred             EEEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHHCCeehhhhhhheEE
Confidence            9999999999999986421                       34788899999999999999999999999999999999


Q ss_pred             ecCCCcEEEeeccceeeccCCCc---cccCCCCcccccccccCCCCCCChhhHHHHHHHHHHHHc-CCCCCCCCCHHHHH
Q 015868          247 MDENGVVKVADFGVARVQAQSGV---MTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLT-GELPYAGLTPLQAA  322 (399)
Q Consensus       247 l~~~~~vkl~DFG~a~~~~~~~~---~~~~~gt~~y~aPE~l~~~~~~~~~Dv~slG~vl~ellt-g~~P~~~~~~~~~~  322 (399)
                      +++++.+||+|||+++.......   .....++..|+|||.+.+..++.++||||||+++|+|++ |..||.+..+.+..
T Consensus       160 l~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~  239 (290)
T cd05045         160 VAEGRKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIAPERLF  239 (290)
T ss_pred             EcCCCcEEeccccccccccCccchhcccCCCCCccccCHHHHccCCcchHhHHHHHHHHHHHHHhcCCCCCCCCCHHHHH
Confidence            99999999999999975433221   122345678999999988889999999999999999998 99999888776644


Q ss_pred             HHHHhccCCCCCCCCCcHHHHHHHHHHhhhcCCCCCCHHHHHHHHHHHHH
Q 015868          323 VGVVQKSLRPTIPKHAHPRLAELLERCWQHDPTQRPNFSQITDILKQMMK  372 (399)
Q Consensus       323 ~~~~~~~~~~~~~~~~~~~l~~ll~~cl~~dP~~Rps~~ell~~L~~l~~  372 (399)
                      . .......+..+..++.++.+++.+||+.+|++||++.++++.|++++.
T Consensus       240 ~-~~~~~~~~~~~~~~~~~~~~~i~~cl~~~P~~Rp~~~~i~~~l~~~~~  288 (290)
T cd05045         240 N-LLKTGYRMERPENCSEEMYNLMLTCWKQEPDKRPTFADISKELEKMMV  288 (290)
T ss_pred             H-HHhCCCCCCCCCCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHHHHh
Confidence            4 344455666778899999999999999999999999999999999874

Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi

>cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1

Probab=100.00  E-value=7.1e-43  Score=345.03  Aligned_cols=247  Identities=23%  Similarity=0.393  Sum_probs=209.1

Q ss_pred             ccceeceeceeCceEEEEEEE--CCeeEEEEEecCCC-CCHHHHHHHHHHHHHHHhcCCCceeeEEeEEecCCcEEEEEe
Q 015868          117 QLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPEC-VNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVTE  193 (399)
Q Consensus       117 ~~~i~~~lg~G~~g~Vy~~~~--~~~~vAvK~~~~~~-~~~~~~~~~~~Ei~~l~~l~h~nIv~~~~~~~~~~~~~lV~E  193 (399)
                      +|++.++||+|+||.||+|..  +++.||+|++.... ........+.+|+.++++++||||+++++.+..+..+|+|||
T Consensus         2 ~f~~~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~~~~~~~lv~E   81 (382)
T cd05625           2 MFVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMD   81 (382)
T ss_pred             CcEEEEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEEeCCEEEEEEe
Confidence            688999999999999999987  56889999987532 233455678999999999999999999999999999999999


Q ss_pred             cCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceeecCCCcEEEeeccceeeccCC------
Q 015868          194 FMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQS------  267 (399)
Q Consensus       194 ~~~ggsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~giiHrDlkp~NILl~~~~~vkl~DFG~a~~~~~~------  267 (399)
                      |++||+|.+++.. .+.+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+++.....      
T Consensus        82 ~~~gg~L~~~l~~-~~~~~e~~~~~~~~qi~~al~~lH~~~ivHrDlKp~NILl~~~g~~kL~DFGla~~~~~~~~~~~~  160 (382)
T cd05625          82 YIPGGDMMSLLIR-MGIFPEDLARFYIAELTCAVESVHKMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYY  160 (382)
T ss_pred             CCCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEEeECCCCcccccccccccc
Confidence            9999999999976 357899999999999999999999999999999999999999999999999997522100      


Q ss_pred             ------------------------------------------CccccCCCCcccccccccCCCCCCChhhHHHHHHHHHH
Q 015868          268 ------------------------------------------GVMTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWE  305 (399)
Q Consensus       268 ------------------------------------------~~~~~~~gt~~y~aPE~l~~~~~~~~~Dv~slG~vl~e  305 (399)
                                                                .......||+.|+|||++.+..|+.++|||||||++||
T Consensus       161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvil~e  240 (382)
T cd05625         161 QSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYE  240 (382)
T ss_pred             ccccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcCCCCCCeeeEEechHHHHH
Confidence                                                      00112358999999999999999999999999999999


Q ss_pred             HHcCCCCCCCCCHHHHHHHHHhccCCCCCC--CCCcHHHHHHHHHHhhhcCCCCCC---HHHHHH
Q 015868          306 LLTGELPYAGLTPLQAAVGVVQKSLRPTIP--KHAHPRLAELLERCWQHDPTQRPN---FSQITD  365 (399)
Q Consensus       306 lltg~~P~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~l~~ll~~cl~~dP~~Rps---~~ell~  365 (399)
                      |++|+.||...++.+..............|  ..+++++.++|.+|+ .+|.+|++   +.++++
T Consensus       241 lltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~~li~~l~-~~p~~R~~~~~~~ei~~  304 (382)
T cd05625         241 MLVGQPPFLAQTPLETQMKVINWQTSLHIPPQAKLSPEASDLIIKLC-RGPEDRLGKNGADEIKA  304 (382)
T ss_pred             HHhCCCCCCCCCHHHHHHHHHccCCCcCCCCcccCCHHHHHHHHHHc-cCHhHcCCCCCHHHHhc
Confidence            999999999988877666655433333333  457899999999976 59999987   777764

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an

>PLN00034 mitogen-activated protein kinase kinase; Provisional

Probab=100.00  E-value=3.4e-42  Score=336.62  Aligned_cols=248  Identities=27%  Similarity=0.452  Sum_probs=206.2

Q ss_pred             eecccccceeceeceeCceEEEEEEE--CCeeEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCceeeEEeEEecCCcEE
Q 015868          112 EIDAKQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLC  189 (399)
Q Consensus       112 ~i~~~~~~i~~~lg~G~~g~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~nIv~~~~~~~~~~~~~  189 (399)
                      ....++|++.++||.|+||.||+|++  +++.||||++.... .......+.+|+.+++.++|+||+++++++.....++
T Consensus        70 ~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~  148 (353)
T PLN00034         70 AKSLSELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNH-EDTVRRQICREIEILRDVNHPNVVKCHDMFDHNGEIQ  148 (353)
T ss_pred             CCCHHHHhhhhhccCCCCeEEEEEEECCCCCEEEEEEEecCC-cHHHHHHHHHHHHHHHhCCCCCcceeeeEeccCCeEE
Confidence            34457899999999999999999987  47899999997543 3445678999999999999999999999999999999


Q ss_pred             EEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceeecCCCcEEEeeccceeeccCCC-
Q 015868          190 IVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSG-  268 (399)
Q Consensus       190 lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~giiHrDlkp~NILl~~~~~vkl~DFG~a~~~~~~~-  268 (399)
                      +||||+.+++|.+.     ...++..+..++.||+.||.|||++||+||||||+|||+++++.+||+|||+++...... 
T Consensus       149 lv~e~~~~~~L~~~-----~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kL~DfG~~~~~~~~~~  223 (353)
T PLN00034        149 VLLEFMDGGSLEGT-----HIADEQFLADVARQILSGIAYLHRRHIVHRDIKPSNLLINSAKNVKIADFGVSRILAQTMD  223 (353)
T ss_pred             EEEecCCCCccccc-----ccCCHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcCCCCEEEcccccceecccccc
Confidence            99999999998653     335677888999999999999999999999999999999999999999999998654332 


Q ss_pred             ccccCCCCcccccccccCC-----CCCCChhhHHHHHHHHHHHHcCCCCCCCCCHH--HHHHHHHhccCCCCCCCCCcHH
Q 015868          269 VMTAETGTYRWMAPEVIEH-----KPYDYKADVFSFGIALWELLTGELPYAGLTPL--QAAVGVVQKSLRPTIPKHAHPR  341 (399)
Q Consensus       269 ~~~~~~gt~~y~aPE~l~~-----~~~~~~~Dv~slG~vl~elltg~~P~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~  341 (399)
                      ......||..|+|||++..     ...+.++|||||||++|+|++|+.||......  ............+..+..++.+
T Consensus       224 ~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  303 (353)
T PLN00034        224 PCNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQGDWASLMCAICMSQPPEAPATASRE  303 (353)
T ss_pred             cccccccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCCCCCccHHHHHHHHhccCCCCCCCccCHH
Confidence            2344578999999999853     23356899999999999999999999743221  2222223334456667789999


Q ss_pred             HHHHHHHHhhhcCCCCCCHHHHHH
Q 015868          342 LAELLERCWQHDPTQRPNFSQITD  365 (399)
Q Consensus       342 l~~ll~~cl~~dP~~Rps~~ell~  365 (399)
                      +.+||.+||+.||++|||+.|+++
T Consensus       304 l~~li~~~l~~~P~~Rpt~~ell~  327 (353)
T PLN00034        304 FRHFISCCLQREPAKRWSAMQLLQ  327 (353)
T ss_pred             HHHHHHHHccCChhhCcCHHHHhc
Confidence            999999999999999999999976

>cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta

Probab=100.00  E-value=8.2e-43  Score=336.57  Aligned_cols=236  Identities=24%  Similarity=0.395  Sum_probs=204.1

Q ss_pred             ceeceeCceEEEEEEE--CCeeEEEEEecCCCC-CHHHHHHHHHHHHHHHhc-CCCceeeEEeEEecCCcEEEEEecCCC
Q 015868          122 CKVASGSYGDLYKGTY--CSQEVAIKVLKPECV-NTEMLKEFSQEVYIMRKI-RHKNVVQFIGACTRPPNLCIVTEFMAR  197 (399)
Q Consensus       122 ~~lg~G~~g~Vy~~~~--~~~~vAvK~~~~~~~-~~~~~~~~~~Ei~~l~~l-~h~nIv~~~~~~~~~~~~~lV~E~~~g  197 (399)
                      +.||+|+||.||+|+.  +++.||+|+++.... .....+.+.+|..++..+ +||||+++++++.....+|+||||++|
T Consensus         1 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~iv~Ey~~~   80 (320)
T cd05590           1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQTPDRLFFVMEFVNG   80 (320)
T ss_pred             CeeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEEEcCCEEEEEEcCCCC
Confidence            4689999999999987  467899999975421 233456778888888876 699999999999999999999999999


Q ss_pred             CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceeecCCCcEEEeeccceeeccC-CCccccCCCC
Q 015868          198 GSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQ-SGVMTAETGT  276 (399)
Q Consensus       198 gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~giiHrDlkp~NILl~~~~~vkl~DFG~a~~~~~-~~~~~~~~gt  276 (399)
                      |+|.+++.. ...+++..+..++.|++.||+|||++||+||||||+|||++.++.+||+|||+++.... ........||
T Consensus        81 g~L~~~i~~-~~~l~~~~~~~~~~ql~~~L~~lH~~~ivH~dlkp~NIli~~~~~~kL~DfG~~~~~~~~~~~~~~~~gt  159 (320)
T cd05590          81 GDLMFHIQK-SRRFDEARARFYAAEITSALMFLHDKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNGKTTSTFCGT  159 (320)
T ss_pred             chHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHeEECCCCcEEEeeCCCCeecCcCCCcccccccC
Confidence            999999876 45789999999999999999999999999999999999999999999999999875332 2233445789


Q ss_pred             cccccccccCCCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhccCCCCCCCCCcHHHHHHHHHHhhhcCCC
Q 015868          277 YRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRLAELLERCWQHDPTQ  356 (399)
Q Consensus       277 ~~y~aPE~l~~~~~~~~~Dv~slG~vl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~cl~~dP~~  356 (399)
                      +.|+|||++.+..++.++||||||+++|+|++|+.||...+..+....+...  ....|..+++++.+++.+||+.||.+
T Consensus       160 ~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~i~~~--~~~~~~~~~~~~~~li~~~L~~dP~~  237 (320)
T cd05590         160 PDYIAPEILQEMLYGPSVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILND--EVVYPTWLSQDAVDILKAFMTKNPTM  237 (320)
T ss_pred             ccccCHHHHcCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHHHHHHHHhcC--CCCCCCCCCHHHHHHHHHHcccCHHH
Confidence            9999999999999999999999999999999999999988877766555432  34566778999999999999999999


Q ss_pred             CCCH
Q 015868          357 RPNF  360 (399)
Q Consensus       357 Rps~  360 (399)
                      ||++
T Consensus       238 R~~~  241 (320)
T cd05590         238 RLGS  241 (320)
T ss_pred             CCCC
Confidence            9998

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal

>cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta

Probab=100.00  E-value=1.3e-42  Score=334.70  Aligned_cols=240  Identities=26%  Similarity=0.470  Sum_probs=204.1

Q ss_pred             ceeceeCceEEEEEEE--CCeeEEEEEecCCCC-CHHHHHHHHHHHHHHHhc-CCCceeeEEeEEecCCcEEEEEecCCC
Q 015868          122 CKVASGSYGDLYKGTY--CSQEVAIKVLKPECV-NTEMLKEFSQEVYIMRKI-RHKNVVQFIGACTRPPNLCIVTEFMAR  197 (399)
Q Consensus       122 ~~lg~G~~g~Vy~~~~--~~~~vAvK~~~~~~~-~~~~~~~~~~Ei~~l~~l-~h~nIv~~~~~~~~~~~~~lV~E~~~g  197 (399)
                      +.||+|+||.||+|+.  +++.||+|+++.... .....+.+..|..++... +||||+++++++..+..+++||||++|
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~g   80 (316)
T cd05592           1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTFQTKEHLFFVMEYLNG   80 (316)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence            4689999999999987  467899999985422 223344556677777654 899999999999999999999999999


Q ss_pred             CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceeecCCCcEEEeeccceeeccCC-CccccCCCC
Q 015868          198 GSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQS-GVMTAETGT  276 (399)
Q Consensus       198 gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~giiHrDlkp~NILl~~~~~vkl~DFG~a~~~~~~-~~~~~~~gt  276 (399)
                      |+|.+++.. ...+++..+..++.|++.||.|||++||+||||||+||+++.++.+||+|||+++..... .......||
T Consensus        81 g~L~~~~~~-~~~~~~~~~~~~~~qi~~al~~LH~~~ivH~dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~~~~~~~~gt  159 (316)
T cd05592          81 GDLMFHIQS-SGRFDEARARFYAAEIICGLQFLHKKGIIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGEGKASTFCGT  159 (316)
T ss_pred             CcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCEEeCCCCHHHeEECCCCCEEEccCcCCeECCCCCCccccccCC
Confidence            999999876 457899999999999999999999999999999999999999999999999999754322 233445789


Q ss_pred             cccccccccCCCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhccCCCCCCCCCcHHHHHHHHHHhhhcCCC
Q 015868          277 YRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRLAELLERCWQHDPTQ  356 (399)
Q Consensus       277 ~~y~aPE~l~~~~~~~~~Dv~slG~vl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~cl~~dP~~  356 (399)
                      +.|+|||++.+..++.++|||||||++|+|++|..||.+.+..+....+..  ..+.+|..++.++.+++.+||+.||.+
T Consensus       160 ~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~Pf~~~~~~~~~~~i~~--~~~~~~~~~~~~~~~ll~~~l~~~P~~  237 (316)
T cd05592         160 PDYIAPEILKGQKYNESVDWWSFGVLLYEMLIGQSPFHGEDEDELFDSILN--DRPHFPRWISKEAKDCLSKLFERDPTK  237 (316)
T ss_pred             ccccCHHHHcCCCCCCcccchhHHHHHHHHHhCCCCCCCCCHHHHHHHHHc--CCCCCCCCCCHHHHHHHHHHccCCHHH
Confidence            999999999999999999999999999999999999998887766555433  456678889999999999999999999


Q ss_pred             CCCHH-HHH
Q 015868          357 RPNFS-QIT  364 (399)
Q Consensus       357 Rps~~-ell  364 (399)
                      ||++. +++
T Consensus       238 R~~~~~~l~  246 (316)
T cd05592         238 RLGVDGDIR  246 (316)
T ss_pred             cCCChHHHH
Confidence            99875 443

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp

>cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase

Probab=100.00  E-value=5.4e-42  Score=321.94  Aligned_cols=259  Identities=30%  Similarity=0.624  Sum_probs=221.8

Q ss_pred             eecccccceeceeceeCceEEEEEEECC-----eeEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCceeeEEeEEecCC
Q 015868          112 EIDAKQLKIECKVASGSYGDLYKGTYCS-----QEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPP  186 (399)
Q Consensus       112 ~i~~~~~~i~~~lg~G~~g~Vy~~~~~~-----~~vAvK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~nIv~~~~~~~~~~  186 (399)
                      ++..++|.+.+.||.|+||.||+|.+..     ..||+|...... .....+.+.+|+.+++.++||||+++++++... 
T Consensus         2 ~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~-~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~-   79 (270)
T cd05056           2 EIQREDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCT-SPSVREKFLQEAYIMRQFDHPHIVKLIGVITEN-   79 (270)
T ss_pred             eechhhceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCcC-CHHHHHHHHHHHHHHHhCCCCchhceeEEEcCC-
Confidence            4566789999999999999999998643     368999887543 345567899999999999999999999998765 


Q ss_pred             cEEEEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceeecCCCcEEEeeccceeeccC
Q 015868          187 NLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQ  266 (399)
Q Consensus       187 ~~~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~giiHrDlkp~NILl~~~~~vkl~DFG~a~~~~~  266 (399)
                      ..++||||+++++|.+++......++...+..++.+++.||+|||+.|++|+||||+||+++.++.++|+|||+++....
T Consensus        80 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~  159 (270)
T cd05056          80 PVWIVMELAPLGELRSYLQVNKYSLDLASLILYSYQLSTALAYLESKRFVHRDIAARNVLVSSPDCVKLGDFGLSRYLED  159 (270)
T ss_pred             CcEEEEEcCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccChheEEEecCCCeEEccCceeeeccc
Confidence            47899999999999999987666789999999999999999999999999999999999999999999999999986544


Q ss_pred             CCcc--ccCCCCcccccccccCCCCCCChhhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHHhccCCCCCCCCCcHHHH
Q 015868          267 SGVM--TAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLT-GELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRLA  343 (399)
Q Consensus       267 ~~~~--~~~~gt~~y~aPE~l~~~~~~~~~Dv~slG~vl~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~  343 (399)
                      ....  +...++..|+|||.+....++.++||||||+++|++++ |..||...+..+.... .....++..+..++.++.
T Consensus       160 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~  238 (270)
T cd05056         160 ESYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMLGVKPFQGVKNNDVIGR-IENGERLPMPPNCPPTLY  238 (270)
T ss_pred             ccceecCCCCccccccChhhhccCCCCchhhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHH-HHcCCcCCCCCCCCHHHH
Confidence            3221  12234568999999998889999999999999999986 9999988877665543 444556677788999999


Q ss_pred             HHHHHHhhhcCCCCCCHHHHHHHHHHHHHH
Q 015868          344 ELLERCWQHDPTQRPNFSQITDILKQMMKE  373 (399)
Q Consensus       344 ~ll~~cl~~dP~~Rps~~ell~~L~~l~~~  373 (399)
                      +++.+||..+|.+|||+.++++.|.++..+
T Consensus       239 ~li~~~l~~~P~~Rpt~~~~~~~l~~~~~~  268 (270)
T cd05056         239 SLMTKCWAYDPSKRPRFTELKAQLSDILQE  268 (270)
T ss_pred             HHHHHHcCCChhhCcCHHHHHHHHHHHHhc
Confidence            999999999999999999999999988653

Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions

>cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha

Probab=100.00  E-value=3.7e-43  Score=339.55  Aligned_cols=241  Identities=24%  Similarity=0.454  Sum_probs=208.1

Q ss_pred             ceeceeCceEEEEEEE--CCeeEEEEEecCCCC-CHHHHHHHHHHHHHHHhcCCCceeeEEeEEecCCcEEEEEecCCCC
Q 015868          122 CKVASGSYGDLYKGTY--CSQEVAIKVLKPECV-NTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVTEFMARG  198 (399)
Q Consensus       122 ~~lg~G~~g~Vy~~~~--~~~~vAvK~~~~~~~-~~~~~~~~~~Ei~~l~~l~h~nIv~~~~~~~~~~~~~lV~E~~~gg  198 (399)
                      +.||+|+||.||+++.  +++.||+|+++.... .......+.+|+.+++.++||||+++++++..+..+|+||||+++|
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~~   80 (325)
T cd05594           1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGG   80 (325)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCCceEEEEEcCCEEEEEEeCCCCC
Confidence            4689999999999986  678999999975432 2344567788999999999999999999999999999999999999


Q ss_pred             CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH-CCcccCCCCCCceeecCCCcEEEeeccceeeccC-CCccccCCCC
Q 015868          199 SIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQ-NNIIHRDLKTANLLMDENGVVKVADFGVARVQAQ-SGVMTAETGT  276 (399)
Q Consensus       199 sL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~-~giiHrDlkp~NILl~~~~~vkl~DFG~a~~~~~-~~~~~~~~gt  276 (399)
                      +|.+++.. ...+++..+..++.||+.||.|||+ +||+||||||+|||++.++.+||+|||+++.... ........||
T Consensus        81 ~L~~~l~~-~~~l~~~~~~~~~~qi~~aL~~lH~~~~ivHrDikp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~gt  159 (325)
T cd05594          81 ELFFHLSR-ERVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKTFCGT  159 (325)
T ss_pred             cHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhcCCEEecCCCCCeEEECCCCCEEEecCCCCeecCCCCcccccccCC
Confidence            99998865 4578999999999999999999997 7999999999999999999999999999875332 2223445799


Q ss_pred             cccccccccCCCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhccCCCCCCCCCcHHHHHHHHHHhhhcCCC
Q 015868          277 YRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRLAELLERCWQHDPTQ  356 (399)
Q Consensus       277 ~~y~aPE~l~~~~~~~~~Dv~slG~vl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~cl~~dP~~  356 (399)
                      +.|+|||++.+..++.++||||||+++|+|++|..||...+..+........  ...+|..+++++.+++.+||+.||++
T Consensus       160 ~~y~aPE~~~~~~~~~~~DiwslG~il~el~tG~~Pf~~~~~~~~~~~i~~~--~~~~p~~~~~~~~~li~~~L~~dP~~  237 (325)
T cd05594         160 PEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILME--EIRFPRTLSPEAKSLLSGLLKKDPKQ  237 (325)
T ss_pred             cccCCHHHHccCCCCCccccccccceeeeeccCCCCCCCCCHHHHHHHHhcC--CCCCCCCCCHHHHHHHHHHhhcCHHH
Confidence            9999999999999999999999999999999999999888776655444332  34567789999999999999999999


Q ss_pred             CC-----CHHHHHH
Q 015868          357 RP-----NFSQITD  365 (399)
Q Consensus       357 Rp-----s~~ell~  365 (399)
                      |+     ++.++++
T Consensus       238 R~~~~~~~~~~il~  251 (325)
T cd05594         238 RLGGGPDDAKEIMQ  251 (325)
T ss_pred             hCCCCCCCHHHHhc
Confidence            96     8888875

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien

>KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms]

Probab=100.00  E-value=8.3e-44  Score=355.20  Aligned_cols=263  Identities=33%  Similarity=0.612  Sum_probs=238.1

Q ss_pred             ceeecccccceeceeceeCceEEEEEEEC-----CeeEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCceeeEEeEEec
Q 015868          110 VWEIDAKQLKIECKVASGSYGDLYKGTYC-----SQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTR  184 (399)
Q Consensus       110 ~~~i~~~~~~i~~~lg~G~~g~Vy~~~~~-----~~~vAvK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~nIv~~~~~~~~  184 (399)
                      ..+|+.+..+|.+.||.|.||.||+|+..     ...||||.+|... .+...++|..|..||-+.+||||+++.|+.++
T Consensus       623 akEId~s~i~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~Gy-tekqrrdFL~EAsIMGQFdHPNIIrLEGVVTk  701 (996)
T KOG0196|consen  623 AKEIDPSCVKIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAGY-TEKQRRDFLSEASIMGQFDHPNIIRLEGVVTK  701 (996)
T ss_pred             hhhcChhheEEEEEEecccccceecccccCCCCcceeEEEeeeccCc-cHHHHhhhhhhhhhcccCCCCcEEEEEEEEec
Confidence            36788999999999999999999999762     3579999999764 56778899999999999999999999999999


Q ss_pred             CCcEEEEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceeecCCCcEEEeeccceeec
Q 015868          185 PPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQ  264 (399)
Q Consensus       185 ~~~~~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~giiHrDlkp~NILl~~~~~vkl~DFG~a~~~  264 (399)
                      .....||+|||++|+|+.+|+++.+.|...++..++..|+.||.||-+.|++||||.++|||++.+-..|++|||++|..
T Consensus       702 s~PvMIiTEyMENGsLDsFLR~~DGqftviQLVgMLrGIAsGMkYLsdm~YVHRDLAARNILVNsnLvCKVsDFGLSRvl  781 (996)
T KOG0196|consen  702 SKPVMIITEYMENGSLDSFLRQNDGQFTVIQLVGMLRGIASGMKYLSDMNYVHRDLAARNILVNSNLVCKVSDFGLSRVL  781 (996)
T ss_pred             CceeEEEhhhhhCCcHHHHHhhcCCceEeehHHHHHHHHHHHhHHHhhcCchhhhhhhhheeeccceEEEeccccceeec
Confidence            99999999999999999999999999999999999999999999999999999999999999999999999999999977


Q ss_pred             cCCCc--cccCC--CCcccccccccCCCCCCChhhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHHhccCCCCCCCCCc
Q 015868          265 AQSGV--MTAET--GTYRWMAPEVIEHKPYDYKADVFSFGIALWELLT-GELPYAGLTPLQAAVGVVQKSLRPTIPKHAH  339 (399)
Q Consensus       265 ~~~~~--~~~~~--gt~~y~aPE~l~~~~~~~~~Dv~slG~vl~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~  339 (399)
                      .....  .+..-  -+.+|.|||.|...+++.++||||+|++|||.+. |..||=.+++.+.... +.++.|.+.|.+++
T Consensus       782 edd~~~~ytt~GGKIPiRWTAPEAIa~RKFTsASDVWSyGIVmWEVmSyGERPYWdmSNQdVIka-Ie~gyRLPpPmDCP  860 (996)
T KOG0196|consen  782 EDDPEAAYTTLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVIKA-IEQGYRLPPPMDCP  860 (996)
T ss_pred             ccCCCccccccCCccceeecChhHhhhcccCchhhccccceEEEEecccCCCcccccchHHHHHH-HHhccCCCCCCCCc
Confidence            55431  11111  2679999999999999999999999999999887 9999999998887665 55678888899999


Q ss_pred             HHHHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHH
Q 015868          340 PRLAELLERCWQHDPTQRPNFSQITDILKQMMKEV  374 (399)
Q Consensus       340 ~~l~~ll~~cl~~dP~~Rps~~ell~~L~~l~~~~  374 (399)
                      ..|.+||..||++|-.+||.|.||+..|.++++.-
T Consensus       861 ~aL~qLMldCWqkdR~~RP~F~qiV~~lDklIrnP  895 (996)
T KOG0196|consen  861 AALYQLMLDCWQKDRNRRPKFAQIVSTLDKLIRNP  895 (996)
T ss_pred             HHHHHHHHHHHHHHhhcCCCHHHHHHHHHHHhcCc
Confidence            99999999999999999999999999999998644

>cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors

Probab=100.00  E-value=4e-42  Score=322.69  Aligned_cols=255  Identities=33%  Similarity=0.619  Sum_probs=217.9

Q ss_pred             cccccceeceeceeCceEEEEEEEC--C---eeEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCceeeEEeEEecCCcE
Q 015868          114 DAKQLKIECKVASGSYGDLYKGTYC--S---QEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNL  188 (399)
Q Consensus       114 ~~~~~~i~~~lg~G~~g~Vy~~~~~--~---~~vAvK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~nIv~~~~~~~~~~~~  188 (399)
                      +...|++.+.||.|+||.||+|...  +   ..||+|+++... .......|..|+.+++.++||||+++++++..+...
T Consensus         2 ~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~   80 (269)
T cd05065           2 DVSCVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGY-TEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSRPV   80 (269)
T ss_pred             ChHHeEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCCC-CHHHHHHHHHHHHHHHhCCCcCcceEEEEECCCCce
Confidence            3467899999999999999999863  2   359999987643 455567899999999999999999999999999999


Q ss_pred             EEEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceeecCCCcEEEeeccceeeccCCC
Q 015868          189 CIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSG  268 (399)
Q Consensus       189 ~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~giiHrDlkp~NILl~~~~~vkl~DFG~a~~~~~~~  268 (399)
                      ++||||+++++|.+++....+.++...+..++.|++.|++|||++|++|+||||+||++++++.++|+|||++.......
T Consensus        81 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~l~~al~~lH~~g~~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~~  160 (269)
T cd05065          81 MIITEFMENGALDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLSEMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDT  160 (269)
T ss_pred             EEEEecCCCCcHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccChheEEEcCCCcEEECCCccccccccCc
Confidence            99999999999999998766778999999999999999999999999999999999999999999999999987544322


Q ss_pred             cc---ccC---CCCcccccccccCCCCCCChhhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHHhccCCCCCCCCCcHH
Q 015868          269 VM---TAE---TGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLT-GELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPR  341 (399)
Q Consensus       269 ~~---~~~---~gt~~y~aPE~l~~~~~~~~~Dv~slG~vl~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  341 (399)
                      ..   ...   ..+..|+|||.+.+..++.++||||||+++||+++ |..||...........+ ....+...+..++..
T Consensus       161 ~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~e~l~~g~~p~~~~~~~~~~~~i-~~~~~~~~~~~~~~~  239 (269)
T cd05065         161 SDPTYTSSLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVINAI-EQDYRLPPPMDCPTA  239 (269)
T ss_pred             cccccccccCCCcceeecCHhHhccCcccchhhhhhhHHHHHHHhcCCCCCCCCCCHHHHHHHH-HcCCcCCCcccCCHH
Confidence            11   111   12457999999999999999999999999999887 99999887776654443 334444556678999


Q ss_pred             HHHHHHHHhhhcCCCCCCHHHHHHHHHHH
Q 015868          342 LAELLERCWQHDPTQRPNFSQITDILKQM  370 (399)
Q Consensus       342 l~~ll~~cl~~dP~~Rps~~ell~~L~~l  370 (399)
                      +.+++.+||+.+|.+||++.+++..|+++
T Consensus       240 ~~~li~~~l~~~p~~Rp~~~~i~~~l~~~  268 (269)
T cd05065         240 LHQLMLDCWQKDRNARPKFGQIVSTLDKM  268 (269)
T ss_pred             HHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence            99999999999999999999999988765

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr

>cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon

Probab=100.00  E-value=1.1e-42  Score=335.82  Aligned_cols=241  Identities=22%  Similarity=0.361  Sum_probs=206.4

Q ss_pred             ceeceeCceEEEEEEE--CCeeEEEEEecCCCC-CHHHHHHHHHHHHHHHhc-CCCceeeEEeEEecCCcEEEEEecCCC
Q 015868          122 CKVASGSYGDLYKGTY--CSQEVAIKVLKPECV-NTEMLKEFSQEVYIMRKI-RHKNVVQFIGACTRPPNLCIVTEFMAR  197 (399)
Q Consensus       122 ~~lg~G~~g~Vy~~~~--~~~~vAvK~~~~~~~-~~~~~~~~~~Ei~~l~~l-~h~nIv~~~~~~~~~~~~~lV~E~~~g  197 (399)
                      +.||+|+||.||+|+.  +++.||+|+++.... ..+..+.+..|..+++.+ +||||+++++++..+..+|+||||+++
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~   80 (321)
T cd05591           1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQTKDRLFFVMEYVNG   80 (321)
T ss_pred             CccccCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCeEEEEEeCCCC
Confidence            4689999999999987  467899999975422 234456677899998876 799999999999999999999999999


Q ss_pred             CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceeecCCCcEEEeeccceeeccCC-CccccCCCC
Q 015868          198 GSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQS-GVMTAETGT  276 (399)
Q Consensus       198 gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~giiHrDlkp~NILl~~~~~vkl~DFG~a~~~~~~-~~~~~~~gt  276 (399)
                      ++|.+++.. ...+++..+..++.||+.||.|||++||+||||||+||+++.++.+||+|||+++..... .......||
T Consensus        81 ~~L~~~l~~-~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~Nill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~gt  159 (321)
T cd05591          81 GDLMFQIQR-SRKFDEPRSRFYAAEVTLALMFLHRHGVIYRDLKLDNILLDAEGHCKLADFGMCKEGILNGVTTTTFCGT  159 (321)
T ss_pred             CcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEEeecccceecccCCccccccccC
Confidence            999999876 457899999999999999999999999999999999999999999999999998754322 223445689


Q ss_pred             cccccccccCCCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhccCCCCCCCCCcHHHHHHHHHHhhhcCCC
Q 015868          277 YRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRLAELLERCWQHDPTQ  356 (399)
Q Consensus       277 ~~y~aPE~l~~~~~~~~~Dv~slG~vl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~cl~~dP~~  356 (399)
                      +.|+|||++.+..++.++||||||+++|+|++|+.||...+..+........  ....|..+++++.+++.+||+.||++
T Consensus       160 ~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~~~~~~~~~i~~~--~~~~p~~~~~~~~~ll~~~L~~dp~~  237 (321)
T cd05591         160 PDYIAPEILQELEYGPSVDWWALGVLMYEMMAGQPPFEADNEDDLFESILHD--DVLYPVWLSKEAVSILKAFMTKNPNK  237 (321)
T ss_pred             ccccCHHHHcCCCCCCccceechhHHHHHHhcCCCCCCCCCHHHHHHHHHcC--CCCCCCCCCHHHHHHHHHHhccCHHH
Confidence            9999999999999999999999999999999999999998877766555443  23456678999999999999999999


Q ss_pred             CC-------CHHHHHH
Q 015868          357 RP-------NFSQITD  365 (399)
Q Consensus       357 Rp-------s~~ell~  365 (399)
                      ||       ++.++++
T Consensus       238 R~~~~~~~~~~~~~~~  253 (321)
T cd05591         238 RLGCVASQGGEDAIKQ  253 (321)
T ss_pred             cCCCCCCCCCHHHHhc
Confidence            99       6777764

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to

>cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk

Probab=100.00  E-value=4.8e-42  Score=320.56  Aligned_cols=254  Identities=33%  Similarity=0.658  Sum_probs=218.5

Q ss_pred             eeecccccceeceeceeCceEEEEEEE-CCeeEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCceeeEEeEEecCCcEE
Q 015868          111 WEIDAKQLKIECKVASGSYGDLYKGTY-CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLC  189 (399)
Q Consensus       111 ~~i~~~~~~i~~~lg~G~~g~Vy~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~nIv~~~~~~~~~~~~~  189 (399)
                      |+|..++|++.++||+|+||.||+|.. .++.||+|.+......   ...+.+|+.++++++|+||+++++++.. ...+
T Consensus         1 ~~~~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~a~K~~~~~~~~---~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~~   76 (260)
T cd05067           1 WEVPRETLKLVKKLGAGQFGEVWMGYYNGHTKVAIKSLKQGSMS---PEAFLAEANLMKQLQHPRLVRLYAVVTQ-EPIY   76 (260)
T ss_pred             CccchHHceeeeeeccCccceEEeeecCCCceEEEEEecCCCCc---HHHHHHHHHHHHhcCCcCeeeEEEEEcc-CCcE
Confidence            678889999999999999999999987 5688999999865433   3578899999999999999999998754 5689


Q ss_pred             EEEecCCCCCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceeecCCCcEEEeeccceeeccCCC
Q 015868          190 IVTEFMARGSIYDFLHKQ-KGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSG  268 (399)
Q Consensus       190 lV~E~~~ggsL~~~l~~~-~~~l~~~~~~~i~~~i~~~L~~LH~~giiHrDlkp~NILl~~~~~vkl~DFG~a~~~~~~~  268 (399)
                      ++|||+.+++|.+++... ...++...+..++.|++.||+|||+.|++||||||+||++++++.++|+|||.+.......
T Consensus        77 ~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~  156 (260)
T cd05067          77 IITEYMENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIERKNYIHRDLRAANILVSETLCCKIADFGLARLIEDNE  156 (260)
T ss_pred             EEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCeecccccHHhEEEcCCCCEEEccCcceeecCCCC
Confidence            999999999999998654 3468899999999999999999999999999999999999999999999999997655322


Q ss_pred             cc--ccCCCCcccccccccCCCCCCChhhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHHhccCCCCCCCCCcHHHHHH
Q 015868          269 VM--TAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLT-GELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRLAEL  345 (399)
Q Consensus       269 ~~--~~~~gt~~y~aPE~l~~~~~~~~~Dv~slG~vl~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l  345 (399)
                      ..  ....++..|+|||.+.+..++.++||||||+++|++++ |..||.+.+..+.... .....++..+...+.++.++
T Consensus       157 ~~~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~l  235 (260)
T cd05067         157 YTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTYGRIPYPGMTNPEVIQN-LERGYRMPRPDNCPEELYEL  235 (260)
T ss_pred             cccccCCcccccccCHHHhccCCcCcccchHHHHHHHHHHHhCCCCCCCCCChHHHHHH-HHcCCCCCCCCCCCHHHHHH
Confidence            21  22345678999999998889999999999999999999 9999988776654443 34455666777889999999


Q ss_pred             HHHHhhhcCCCCCCHHHHHHHHHH
Q 015868          346 LERCWQHDPTQRPNFSQITDILKQ  369 (399)
Q Consensus       346 l~~cl~~dP~~Rps~~ell~~L~~  369 (399)
                      +.+||..+|++||+++++.+.|+.
T Consensus       236 i~~~l~~~p~~Rp~~~~l~~~l~~  259 (260)
T cd05067         236 MRLCWKEKPEERPTFEYLRSVLED  259 (260)
T ss_pred             HHHHccCChhhCCCHHHHHHHhhc
Confidence            999999999999999999998875

Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr

>cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A

Probab=100.00  E-value=5.9e-42  Score=323.86  Aligned_cols=253  Identities=29%  Similarity=0.578  Sum_probs=217.3

Q ss_pred             ecccccceeceeceeCceEEEEEEE-------CCeeEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCceeeEEeEEecC
Q 015868          113 IDAKQLKIECKVASGSYGDLYKGTY-------CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRP  185 (399)
Q Consensus       113 i~~~~~~i~~~lg~G~~g~Vy~~~~-------~~~~vAvK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~nIv~~~~~~~~~  185 (399)
                      |+.++|.+.++||.|+||.||+++.       .+..+|+|.++..  .......+.+|+.+++.++|+||+++++++...
T Consensus         2 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~   79 (280)
T cd05092           2 IKRRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEA--SESARQDFQREAELLTVLQHQHIVRFYGVCTEG   79 (280)
T ss_pred             CChHhceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcC--CHHHHHHHHHHHHHHhcCCCCCCceEEEEEecC
Confidence            5678899999999999999999964       3457899988754  455567899999999999999999999999999


Q ss_pred             CcEEEEEecCCCCCHHHHHHhcC--------------CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceeecCCC
Q 015868          186 PNLCIVTEFMARGSIYDFLHKQK--------------GVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENG  251 (399)
Q Consensus       186 ~~~~lV~E~~~ggsL~~~l~~~~--------------~~l~~~~~~~i~~~i~~~L~~LH~~giiHrDlkp~NILl~~~~  251 (399)
                      ...+++|||+++++|.+++....              ..+++..+..++.|++.|++|||++|++||||||+||++++++
T Consensus        80 ~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~i~H~dlkp~nil~~~~~  159 (280)
T cd05092          80 RPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLASLHFVHRDLATRNCLVGQGL  159 (280)
T ss_pred             CceEEEEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHHCCeecccccHhhEEEcCCC
Confidence            99999999999999999997643              3478899999999999999999999999999999999999999


Q ss_pred             cEEEeeccceeeccCCCc---cccCCCCcccccccccCCCCCCChhhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHHh
Q 015868          252 VVKVADFGVARVQAQSGV---MTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLT-GELPYAGLTPLQAAVGVVQ  327 (399)
Q Consensus       252 ~vkl~DFG~a~~~~~~~~---~~~~~gt~~y~aPE~l~~~~~~~~~Dv~slG~vl~ellt-g~~P~~~~~~~~~~~~~~~  327 (399)
                      .+||+|||+++.......   .....+++.|+|||.+.+..++.++||||||+++|+|++ |.+||...+........ .
T Consensus       160 ~~kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~-~  238 (280)
T cd05092         160 VVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQPWYQLSNTEAIECI-T  238 (280)
T ss_pred             CEEECCCCceeEcCCCceeecCCCccccccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCccCCHHHHHHHH-H
Confidence            999999999975433221   122234678999999999999999999999999999998 99999887776655443 3


Q ss_pred             ccCCCCCCCCCcHHHHHHHHHHhhhcCCCCCCHHHHHHHHH
Q 015868          328 KSLRPTIPKHAHPRLAELLERCWQHDPTQRPNFSQITDILK  368 (399)
Q Consensus       328 ~~~~~~~~~~~~~~l~~ll~~cl~~dP~~Rps~~ell~~L~  368 (399)
                      ....+..+..+++.+.+++.+||+.||.+||++.++.+.|+
T Consensus       239 ~~~~~~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~l~~~l~  279 (280)
T cd05092         239 QGRELERPRTCPPEVYAIMQGCWQREPQQRMVIKDIHSRLQ  279 (280)
T ss_pred             cCccCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHh
Confidence            34455667789999999999999999999999999998875

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory

>cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase)

Probab=100.00  E-value=5.8e-42  Score=323.44  Aligned_cols=260  Identities=27%  Similarity=0.540  Sum_probs=221.8

Q ss_pred             eecccccceeceeceeCceEEEEEEEC------CeeEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCceeeEEeEEec-
Q 015868          112 EIDAKQLKIECKVASGSYGDLYKGTYC------SQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTR-  184 (399)
Q Consensus       112 ~i~~~~~~i~~~lg~G~~g~Vy~~~~~------~~~vAvK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~nIv~~~~~~~~-  184 (399)
                      .++.++|++.+.||+|+||.||+|.+.      +..|++|.++.. ........+.+|+.++++++||||+++++++.. 
T Consensus         2 ~~~~~~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~-~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~   80 (280)
T cd05043           2 AISRDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDH-ASEIQVTLLLQESCLLYGLSHQNILPILHVCIED   80 (280)
T ss_pred             ccchhheEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccCC-CCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecC
Confidence            356789999999999999999999874      478999998754 345556789999999999999999999998766 


Q ss_pred             CCcEEEEEecCCCCCHHHHHHhcC-------CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceeecCCCcEEEee
Q 015868          185 PPNLCIVTEFMARGSIYDFLHKQK-------GVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVAD  257 (399)
Q Consensus       185 ~~~~~lV~E~~~ggsL~~~l~~~~-------~~l~~~~~~~i~~~i~~~L~~LH~~giiHrDlkp~NILl~~~~~vkl~D  257 (399)
                      +...++++||+++++|.+++....       ..++...++.++.+++.||+|||+++++||||||+||++++++.+||+|
T Consensus        81 ~~~~~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~di~p~nil~~~~~~~kl~d  160 (280)
T cd05043          81 GEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHKRGVIHKDIAARNCVIDEELQVKITD  160 (280)
T ss_pred             CCCCEEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHHCCEeecccCHhhEEEcCCCcEEECC
Confidence            467899999999999999996632       4588999999999999999999999999999999999999999999999


Q ss_pred             ccceeeccCCCc---cccCCCCcccccccccCCCCCCChhhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHHhccCCCC
Q 015868          258 FGVARVQAQSGV---MTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLT-GELPYAGLTPLQAAVGVVQKSLRPT  333 (399)
Q Consensus       258 FG~a~~~~~~~~---~~~~~gt~~y~aPE~l~~~~~~~~~Dv~slG~vl~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~  333 (399)
                      ||+++.......   .....++..|+|||.+.+..++.++||||||+++|++++ |+.||...++.+.... .....++.
T Consensus       161 ~g~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~-~~~~~~~~  239 (280)
T cd05043         161 NALSRDLFPMDYHCLGDNENRPVKWMALESLVNKEYSSASDVWSFGVLLWELMTLGQTPYVEIDPFEMAAY-LKDGYRLA  239 (280)
T ss_pred             CCCcccccCCceEEeCCCCCcchhccCHHHHhcCCCCchhhHHHhHHHHHHHhcCCCCCcCcCCHHHHHHH-HHcCCCCC
Confidence            999975433211   122345778999999998899999999999999999999 9999988877665433 34455555


Q ss_pred             CCCCCcHHHHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHH
Q 015868          334 IPKHAHPRLAELLERCWQHDPTQRPNFSQITDILKQMMKE  373 (399)
Q Consensus       334 ~~~~~~~~l~~ll~~cl~~dP~~Rps~~ell~~L~~l~~~  373 (399)
                      .+..+++++.+++.+||..+|++|||+.++++.|.++.++
T Consensus       240 ~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~~~~~~  279 (280)
T cd05043         240 QPINCPDELFAVMACCWALDPEERPSFSQLVQCLTDFHAQ  279 (280)
T ss_pred             CCCcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHhc
Confidence            6667899999999999999999999999999999998753

Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It

>cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=6.6e-42  Score=319.39  Aligned_cols=255  Identities=37%  Similarity=0.711  Sum_probs=220.4

Q ss_pred             eeecccccceeceeceeCceEEEEEEEC-CeeEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCceeeEEeEEecCCcEE
Q 015868          111 WEIDAKQLKIECKVASGSYGDLYKGTYC-SQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLC  189 (399)
Q Consensus       111 ~~i~~~~~~i~~~lg~G~~g~Vy~~~~~-~~~vAvK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~nIv~~~~~~~~~~~~~  189 (399)
                      |+++.++|++.++||.|+||.||+|... ++.||+|.++.....   ...+.+|+.++++++|+||+++++++......+
T Consensus         1 ~~~~~~~~~i~~~ig~g~~~~v~~~~~~~~~~~~vK~~~~~~~~---~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~   77 (261)
T cd05034           1 WEIPRESLKLERKLGAGQFGEVWMGTWNGTTKVAVKTLKPGTMS---PEAFLQEAQIMKKLRHDKLVQLYAVCSEEEPIY   77 (261)
T ss_pred             CccchhheeeeeeeccCcceEEEEEEEcCCceEEEEEecCCccC---HHHHHHHHHHHhhCCCCCEeeeeeeeecCCceE
Confidence            6788899999999999999999999863 467999999865332   357889999999999999999999999888999


Q ss_pred             EEEecCCCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceeecCCCcEEEeeccceeeccCCC
Q 015868          190 IVTEFMARGSIYDFLHKQK-GVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSG  268 (399)
Q Consensus       190 lV~E~~~ggsL~~~l~~~~-~~l~~~~~~~i~~~i~~~L~~LH~~giiHrDlkp~NILl~~~~~vkl~DFG~a~~~~~~~  268 (399)
                      +||||+++++|.+++.... ..++...+..++.+++.|+.|||++|++|+||+|+||++++++.++|+|||.++......
T Consensus        78 ~v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~i~~al~~lh~~~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~  157 (261)
T cd05034          78 IVTEYMSKGSLLDFLKSGEGKKLRLPQLVDMAAQIAEGMAYLESRNYIHRDLAARNILVGENLVCKIADFGLARLIEDDE  157 (261)
T ss_pred             EEEeccCCCCHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcchheEEEcCCCCEEECccccceeccchh
Confidence            9999999999999997644 468999999999999999999999999999999999999999999999999987654321


Q ss_pred             c--cccCCCCcccccccccCCCCCCChhhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHHhccCCCCCCCCCcHHHHHH
Q 015868          269 V--MTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLT-GELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRLAEL  345 (399)
Q Consensus       269 ~--~~~~~gt~~y~aPE~l~~~~~~~~~Dv~slG~vl~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l  345 (399)
                      .  .....++..|+|||.+.+..++.++|+||||+++|++++ |+.||.+.+........ ....+...+...+.++.++
T Consensus       158 ~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~  236 (261)
T cd05034         158 YTAREGAKFPIKWTAPEAANYGRFTIKSDVWSFGILLTEIVTYGRVPYPGMTNREVLEQV-ERGYRMPRPPNCPEELYDL  236 (261)
T ss_pred             hhhhhccCCCccccCHHHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHH-HcCCCCCCCCCCCHHHHHH
Confidence            1  122234668999999999889999999999999999998 99999888776655443 3344556677789999999


Q ss_pred             HHHHhhhcCCCCCCHHHHHHHHHH
Q 015868          346 LERCWQHDPTQRPNFSQITDILKQ  369 (399)
Q Consensus       346 l~~cl~~dP~~Rps~~ell~~L~~  369 (399)
                      +.+||+.+|.+||++.++.+.|+.
T Consensus       237 i~~~l~~~p~~Rp~~~~l~~~l~~  260 (261)
T cd05034         237 MLQCWDKDPEERPTFEYLQSFLED  260 (261)
T ss_pred             HHHHcccCcccCCCHHHHHHHHhc
Confidence            999999999999999999998874

Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t

>cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

Probab=100.00  E-value=7.1e-42  Score=323.51  Aligned_cols=251  Identities=30%  Similarity=0.586  Sum_probs=207.7

Q ss_pred             cceeceeceeCceEEEEEEE------CCeeEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCceeeEEeEEecC--CcEE
Q 015868          118 LKIECKVASGSYGDLYKGTY------CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRP--PNLC  189 (399)
Q Consensus       118 ~~i~~~lg~G~~g~Vy~~~~------~~~~vAvK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~nIv~~~~~~~~~--~~~~  189 (399)
                      |++.+.||.|+||.||++.+      .++.||+|+++... .......+.+|+.++++++||||+++++++...  ...+
T Consensus         6 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~   84 (283)
T cd05080           6 LKKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKREC-GQQNTSGWKKEINILKTLYHENIVKYKGCCSEQGGKGLQ   84 (283)
T ss_pred             ceeceecccCCCcEEEEeeEccccCCCCceEEEEEecccc-ChHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCceEE
Confidence            48999999999999988764      45689999998653 233456788999999999999999999988653  3589


Q ss_pred             EEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceeecCCCcEEEeeccceeeccCCCc
Q 015868          190 IVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGV  269 (399)
Q Consensus       190 lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~giiHrDlkp~NILl~~~~~vkl~DFG~a~~~~~~~~  269 (399)
                      +||||+++++|.+++..  ..+++..++.++.|++.||.|||++||+||||||+||++++++.++|+|||+++.......
T Consensus        85 lv~e~~~~~~l~~~~~~--~~l~~~~~~~i~~~l~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~  162 (283)
T cd05080          85 LIMEYVPLGSLRDYLPK--HKLNLAQLLLFAQQICEGMAYLHSQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHE  162 (283)
T ss_pred             EEecCCCCCCHHHHHHH--cCCCHHHHHHHHHHHHHHHHHHHHCCeeccccChheEEEcCCCcEEEeecccccccCCcch
Confidence            99999999999999965  3589999999999999999999999999999999999999999999999999976543221


Q ss_pred             ----cccCCCCcccccccccCCCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHH--------------HHHHHHHhccCC
Q 015868          270 ----MTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPYAGLTPL--------------QAAVGVVQKSLR  331 (399)
Q Consensus       270 ----~~~~~gt~~y~aPE~l~~~~~~~~~Dv~slG~vl~elltg~~P~~~~~~~--------------~~~~~~~~~~~~  331 (399)
                          .....++..|+|||.+.+..++.++||||||+++|+|+||..||......              ............
T Consensus       163 ~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  242 (283)
T cd05080         163 YYRVREDGDSPVFWYAVECLKENKFSYASDVWSFGVTLYELLTHCDSKQSPPKKFEEMIGPKQGQMTVVRLIELLERGMR  242 (283)
T ss_pred             hhccCCCCCCCceeeCHhHhcccCCCcccccHHHHHHHHHHHhCCCCCCCCcchhhhhhcccccccchhhhhhhhhcCCC
Confidence                12234566799999999888999999999999999999999998643321              011112223344


Q ss_pred             CCCCCCCcHHHHHHHHHHhhhcCCCCCCHHHHHHHHHHHH
Q 015868          332 PTIPKHAHPRLAELLERCWQHDPTQRPNFSQITDILKQMM  371 (399)
Q Consensus       332 ~~~~~~~~~~l~~ll~~cl~~dP~~Rps~~ell~~L~~l~  371 (399)
                      +..+..++.++.+++.+||+.+|++|||+.++++.|+++.
T Consensus       243 ~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~i~~~l~~~~  282 (283)
T cd05080         243 LPCPKNCPQEVYILMKNCWETEAKFRPTFRSLIPILKEMH  282 (283)
T ss_pred             CCCCCCCCHHHHHHHHHHhccChhhCCCHHHHHHHHHHhh
Confidence            4567778999999999999999999999999999998874

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign

>cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2

Probab=100.00  E-value=1.2e-42  Score=336.91  Aligned_cols=247  Identities=23%  Similarity=0.400  Sum_probs=205.6

Q ss_pred             ccceeceeceeCceEEEEEEE-----CCeeEEEEEecCCCC--CHHHHHHHHHHHHHHHhcC-CCceeeEEeEEecCCcE
Q 015868          117 QLKIECKVASGSYGDLYKGTY-----CSQEVAIKVLKPECV--NTEMLKEFSQEVYIMRKIR-HKNVVQFIGACTRPPNL  188 (399)
Q Consensus       117 ~~~i~~~lg~G~~g~Vy~~~~-----~~~~vAvK~~~~~~~--~~~~~~~~~~Ei~~l~~l~-h~nIv~~~~~~~~~~~~  188 (399)
                      +|++.++||+|+||.||+++.     .++.||+|+++....  .....+.+.+|+.+++.++ ||||+++++++.....+
T Consensus         1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~   80 (332)
T cd05614           1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQTEAKL   80 (332)
T ss_pred             CceEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEEecCCEE
Confidence            488999999999999999875     468899999874321  2234567889999999994 89999999999999999


Q ss_pred             EEEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceeecCCCcEEEeeccceeeccCCC
Q 015868          189 CIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSG  268 (399)
Q Consensus       189 ~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~giiHrDlkp~NILl~~~~~vkl~DFG~a~~~~~~~  268 (399)
                      ++||||+++|+|.+++.. ...+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++......
T Consensus        81 ~lv~e~~~~g~L~~~l~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~ivHrDlkp~Nili~~~~~~kl~DfG~~~~~~~~~  159 (332)
T cd05614          81 HLILDYVSGGEMFTHLYQ-RDNFSEDEVRFYSGEIILALEHLHKLGIVYRDIKLENILLDSEGHVVLTDFGLSKEFLSEE  159 (332)
T ss_pred             EEEEeCCCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCHHHeEECCCCCEEEeeCcCCccccccC
Confidence            999999999999999976 4568999999999999999999999999999999999999999999999999997543221


Q ss_pred             --ccccCCCCcccccccccCCC-CCCChhhHHHHHHHHHHHHcCCCCCCCCCH---HHHHHHHHhccCCCCCCCCCcHHH
Q 015868          269 --VMTAETGTYRWMAPEVIEHK-PYDYKADVFSFGIALWELLTGELPYAGLTP---LQAAVGVVQKSLRPTIPKHAHPRL  342 (399)
Q Consensus       269 --~~~~~~gt~~y~aPE~l~~~-~~~~~~Dv~slG~vl~elltg~~P~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~l  342 (399)
                        ......||..|+|||++.+. .++.++|||||||++|+|+||+.||.....   ........ ....+.++..+++.+
T Consensus       160 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~  238 (332)
T cd05614         160 KERTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERNTQSEVSRRI-LKCDPPFPSFIGPEA  238 (332)
T ss_pred             CCccccccCCccccCHHHhcCCCCCCCccccccchhhhhhhhcCCCCCCCCCCCCCHHHHHHHH-hcCCCCCCCCCCHHH
Confidence              22345689999999999875 478899999999999999999999964322   11121112 234566778899999


Q ss_pred             HHHHHHHhhhcCCCCC-----CHHHHHH
Q 015868          343 AELLERCWQHDPTQRP-----NFSQITD  365 (399)
Q Consensus       343 ~~ll~~cl~~dP~~Rp-----s~~ell~  365 (399)
                      .+++.+||+.||++||     +++++++
T Consensus       239 ~~li~~~l~~dp~~R~~~~~~~~~~~l~  266 (332)
T cd05614         239 QDLLHKLLRKDPKKRLGAGPQGASEIKE  266 (332)
T ss_pred             HHHHHHHcCCCHHHcCCCCCCCHHHHHc
Confidence            9999999999999999     6777765

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph

>cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta

Probab=100.00  E-value=2.4e-42  Score=333.60  Aligned_cols=241  Identities=23%  Similarity=0.406  Sum_probs=207.7

Q ss_pred             ccceeceeceeCceEEEEEEE--CCeeEEEEEecCCCC-CHHHHHHHHHHHHHHHhc-CCCceeeEEeEEecCCcEEEEE
Q 015868          117 QLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECV-NTEMLKEFSQEVYIMRKI-RHKNVVQFIGACTRPPNLCIVT  192 (399)
Q Consensus       117 ~~~i~~~lg~G~~g~Vy~~~~--~~~~vAvK~~~~~~~-~~~~~~~~~~Ei~~l~~l-~h~nIv~~~~~~~~~~~~~lV~  192 (399)
                      +|.+.+.||+|+||.||+|..  +++.||+|+++.... .......+..|..++..+ .|++|+++++++...+.+++||
T Consensus         1 df~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~   80 (323)
T cd05616           1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQTMDRLYFVM   80 (323)
T ss_pred             CceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEecCCEEEEEE
Confidence            478899999999999999987  457899999985432 233345677788888877 5899999999999999999999


Q ss_pred             ecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceeecCCCcEEEeeccceeeccCC-Cccc
Q 015868          193 EFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQS-GVMT  271 (399)
Q Consensus       193 E~~~ggsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~giiHrDlkp~NILl~~~~~vkl~DFG~a~~~~~~-~~~~  271 (399)
                      ||+++|+|.+++.. .+.+++..+..++.|++.||+|||++||+||||||+|||++.++.+||+|||+++..... ....
T Consensus        81 E~~~~g~L~~~~~~-~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~kL~DfG~~~~~~~~~~~~~  159 (323)
T cd05616          81 EYVNGGDLMYQIQQ-VGRFKEPHAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENMWDGVTTK  159 (323)
T ss_pred             cCCCCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCEEecCCCHHHeEECCCCcEEEccCCCceecCCCCCccc
Confidence            99999999999866 456899999999999999999999999999999999999999999999999999754322 2233


Q ss_pred             cCCCCcccccccccCCCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhccCCCCCCCCCcHHHHHHHHHHhh
Q 015868          272 AETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRLAELLERCWQ  351 (399)
Q Consensus       272 ~~~gt~~y~aPE~l~~~~~~~~~Dv~slG~vl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~cl~  351 (399)
                      ...||+.|+|||++.+..++.++|||||||++|+|+||+.||.+.+..+....+...  ...+|..++.++.+++.+||+
T Consensus       160 ~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~--~~~~p~~~s~~~~~li~~~l~  237 (323)
T cd05616         160 TFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEH--NVAYPKSMSKEAVAICKGLMT  237 (323)
T ss_pred             cCCCChhhcCHHHhcCCCCCCccchhchhHHHHHHHhCCCCCCCCCHHHHHHHHHhC--CCCCCCcCCHHHHHHHHHHcc
Confidence            457899999999999999999999999999999999999999988877766555443  345677899999999999999


Q ss_pred             hcCCCCCCH
Q 015868          352 HDPTQRPNF  360 (399)
Q Consensus       352 ~dP~~Rps~  360 (399)
                      .+|.+|++.
T Consensus       238 ~~p~~R~~~  246 (323)
T cd05616         238 KHPGKRLGC  246 (323)
T ss_pred             cCHHhcCCC
Confidence            999999985

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and

>cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases

Probab=100.00  E-value=5.2e-42  Score=318.76  Aligned_cols=245  Identities=39%  Similarity=0.707  Sum_probs=216.3

Q ss_pred             ceeceeCceEEEEEEEC-----CeeEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCceeeEEeEEecCCcEEEEEecCC
Q 015868          122 CKVASGSYGDLYKGTYC-----SQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVTEFMA  196 (399)
Q Consensus       122 ~~lg~G~~g~Vy~~~~~-----~~~vAvK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~nIv~~~~~~~~~~~~~lV~E~~~  196 (399)
                      +.||.|+||.||+|...     +..|++|+++...... ..+.+.+|+.+++.++|+||+++++++.....+++||||++
T Consensus         1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~-~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~   79 (262)
T cd00192           1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEE-ERKDFLKEARVMKKLGHPNVVRLLGVCTEEEPLYLVLEYME   79 (262)
T ss_pred             CccccCCceEEEEEEEecCCCCCceEEeEeeccccchh-HHHHHHHHHHHHhhcCCCChheeeeeecCCCceEEEEEecc
Confidence            46899999999999885     7789999998764333 56789999999999999999999999999999999999999


Q ss_pred             CCCHHHHHHhc--------CCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceeecCCCcEEEeeccceeeccCCC
Q 015868          197 RGSIYDFLHKQ--------KGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSG  268 (399)
Q Consensus       197 ggsL~~~l~~~--------~~~l~~~~~~~i~~~i~~~L~~LH~~giiHrDlkp~NILl~~~~~vkl~DFG~a~~~~~~~  268 (399)
                      +++|.+++...        ...+++..++.++.|++.||+|||++|++|+||+|+||++++++.++|+|||.+.......
T Consensus        80 ~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~di~p~nili~~~~~~~l~dfg~~~~~~~~~  159 (262)
T cd00192          80 GGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASKKFVHRDLAARNCLVGEDLVVKISDFGLSRDVYDDD  159 (262)
T ss_pred             CCcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHcCCcccCccCcceEEECCCCcEEEccccccccccccc
Confidence            99999999876        4779999999999999999999999999999999999999999999999999998765432


Q ss_pred             ---ccccCCCCcccccccccCCCCCCChhhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHHhccCCCCCCCCCcHHHHH
Q 015868          269 ---VMTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLT-GELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRLAE  344 (399)
Q Consensus       269 ---~~~~~~gt~~y~aPE~l~~~~~~~~~Dv~slG~vl~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~  344 (399)
                         ......++..|+|||.+....++.++||||||+++|+|++ |..||...++.+...... ...+...+..+++++.+
T Consensus       160 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~  238 (262)
T cd00192         160 YYRKKTGGKLPIRWMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLSNEEVLEYLR-KGYRLPKPEYCPDELYE  238 (262)
T ss_pred             ccccccCCCcCccccCHHHhccCCcchhhccHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHH-cCCCCCCCccCChHHHH
Confidence               2233457889999999998889999999999999999999 699999987766555444 35667778889999999


Q ss_pred             HHHHHhhhcCCCCCCHHHHHHHHH
Q 015868          345 LLERCWQHDPTQRPNFSQITDILK  368 (399)
Q Consensus       345 ll~~cl~~dP~~Rps~~ell~~L~  368 (399)
                      ++.+||+.+|.+|||+.|+++.|+
T Consensus       239 li~~~l~~~p~~Rps~~~l~~~l~  262 (262)
T cd00192         239 LMLSCWQLDPEDRPTFSELVERLE  262 (262)
T ss_pred             HHHHHccCCcccCcCHHHHHHhhC
Confidence            999999999999999999998763

Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan

>PTZ00036 glycogen synthase kinase; Provisional

Probab=100.00  E-value=1.9e-42  Score=347.94  Aligned_cols=246  Identities=23%  Similarity=0.380  Sum_probs=201.9

Q ss_pred             ecccccceeceeceeCceEEEEEEE--CCeeEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCceeeEEeEEecC-----
Q 015868          113 IDAKQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRP-----  185 (399)
Q Consensus       113 i~~~~~~i~~~lg~G~~g~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~nIv~~~~~~~~~-----  185 (399)
                      ....+|++.+.||+|+||.||+|..  .++.||||.+....      ....+|+.+|+.++||||+++++++...     
T Consensus        63 ~~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~------~~~~~Ei~il~~l~h~niv~l~~~~~~~~~~~~  136 (440)
T PTZ00036         63 SPNKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDP------QYKNRELLIMKNLNHINIIFLKDYYYTECFKKN  136 (440)
T ss_pred             CcCCeEEEeEEEEeCCCEEEEEEEECCCCCEEEEEEEecCc------chHHHHHHHHHhcCCCCCcceeeeEeecccccC
Confidence            3456899999999999999999987  57899999886431      2234799999999999999999887432     


Q ss_pred             ---CcEEEEEecCCCCCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceeecCCC-cEEEeec
Q 015868          186 ---PNLCIVTEFMARGSIYDFLHK---QKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENG-VVKVADF  258 (399)
Q Consensus       186 ---~~~~lV~E~~~ggsL~~~l~~---~~~~l~~~~~~~i~~~i~~~L~~LH~~giiHrDlkp~NILl~~~~-~vkl~DF  258 (399)
                         ..+++||||+++ +|.+++..   ....+++..++.++.||+.||+|||++||+||||||+|||++.++ .+||+||
T Consensus       137 ~~~~~l~lvmE~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH~~~IiHrDLKp~NILl~~~~~~vkL~DF  215 (440)
T PTZ00036        137 EKNIFLNVVMEFIPQ-TVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHSKFICHRDLKPQNLLIDPNTHTLKLCDF  215 (440)
T ss_pred             CCceEEEEEEecCCc-cHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCcCHHHEEEcCCCCceeeecc
Confidence               246799999976 78777653   356789999999999999999999999999999999999998665 7999999


Q ss_pred             cceeeccCCCccccCCCCcccccccccCCC-CCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcc--------
Q 015868          259 GVARVQAQSGVMTAETGTYRWMAPEVIEHK-PYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKS--------  329 (399)
Q Consensus       259 G~a~~~~~~~~~~~~~gt~~y~aPE~l~~~-~~~~~~Dv~slG~vl~elltg~~P~~~~~~~~~~~~~~~~~--------  329 (399)
                      |+++............||+.|+|||++.+. .|+.++|||||||++|+|++|.+||.+.+..+......+..        
T Consensus       216 Gla~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~p~~~~~  295 (440)
T PTZ00036        216 GSAKNLLAGQRSVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVDQLVRIIQVLGTPTEDQL  295 (440)
T ss_pred             ccchhccCCCCcccCCCCcCccCHHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHH
Confidence            999866554444556789999999998764 68999999999999999999999999877655544433211        


Q ss_pred             -------------------CCCCCCCCCcHHHHHHHHHHhhhcCCCCCCHHHHHH
Q 015868          330 -------------------LRPTIPKHAHPRLAELLERCWQHDPTQRPNFSQITD  365 (399)
Q Consensus       330 -------------------~~~~~~~~~~~~l~~ll~~cl~~dP~~Rps~~ell~  365 (399)
                                         +...+|...++++.+||.+||+.||.+|||+.|+++
T Consensus       296 ~~~~~~~~~~~~~~~~~~~l~~~~p~~~~~~~~~li~~~L~~dP~~R~ta~e~l~  350 (440)
T PTZ00036        296 KEMNPNYADIKFPDVKPKDLKKVFPKGTPDDAINFISQFLKYEPLKRLNPIEALA  350 (440)
T ss_pred             HHhchhhhcccCCccCchhHHHHhccCCCHHHHHHHHHHCCCChhHCcCHHHHhC
Confidence                               011234457889999999999999999999999985

>cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes

Probab=100.00  E-value=9.6e-42  Score=318.68  Aligned_cols=254  Identities=37%  Similarity=0.707  Sum_probs=216.0

Q ss_pred             eeecccccceeceeceeCceEEEEEEECC-eeEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCceeeEEeEEecCCcEE
Q 015868          111 WEIDAKQLKIECKVASGSYGDLYKGTYCS-QEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLC  189 (399)
Q Consensus       111 ~~i~~~~~~i~~~lg~G~~g~Vy~~~~~~-~~vAvK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~nIv~~~~~~~~~~~~~  189 (399)
                      |++..++|.+.++||+|++|.||++...+ ..+|+|.+.....   ..+.+.+|+.+++.++|+|++++++++.. ...+
T Consensus         1 ~~~~~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~lK~~~~~~~---~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~~   76 (260)
T cd05069           1 WEIPRESLRLDVKLGQGCFGEVWMGTWNGTTKVAIKTLKPGTM---MPEAFLQEAQIMKKLRHDKLVPLYAVVSE-EPIY   76 (260)
T ss_pred             CcCChHHeeeeeeecCcCCCeEEEEEEcCCceEEEEEcccCCc---cHHHHHHHHHHHHhCCCCCeeeEEEEEcC-CCcE
Confidence            56777889999999999999999998744 4799999875432   23568889999999999999999998754 4588


Q ss_pred             EEEecCCCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceeecCCCcEEEeeccceeeccCCC
Q 015868          190 IVTEFMARGSIYDFLHKQK-GVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSG  268 (399)
Q Consensus       190 lV~E~~~ggsL~~~l~~~~-~~l~~~~~~~i~~~i~~~L~~LH~~giiHrDlkp~NILl~~~~~vkl~DFG~a~~~~~~~  268 (399)
                      +||||+.+++|.+++.... ..+++..+..++.|++.||.|||+.|++|+||||+||++++++.++|+|||.++......
T Consensus        77 ~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~dl~~~Nill~~~~~~~l~dfg~~~~~~~~~  156 (260)
T cd05069          77 IVTEFMGKGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYIERMNYIHRDLRAANILVGDNLVCKIADFGLARLIEDNE  156 (260)
T ss_pred             EEEEcCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccCcceEEEcCCCeEEECCCccceEccCCc
Confidence            9999999999999997643 457899999999999999999999999999999999999999999999999997654332


Q ss_pred             cc--ccCCCCcccccccccCCCCCCChhhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHHhccCCCCCCCCCcHHHHHH
Q 015868          269 VM--TAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLT-GELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRLAEL  345 (399)
Q Consensus       269 ~~--~~~~gt~~y~aPE~l~~~~~~~~~Dv~slG~vl~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l  345 (399)
                      ..  ....++..|+|||.+.+..++.++|+||||+++|+|++ |..||.+.++.+..... .....+..+...+..+.++
T Consensus       157 ~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~l  235 (260)
T cd05069         157 YTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMVNREVLEQV-ERGYRMPCPQGCPESLHEL  235 (260)
T ss_pred             ccccCCCccchhhCCHHHhccCCcChHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHH-HcCCCCCCCcccCHHHHHH
Confidence            11  22345678999999998889999999999999999999 99999988776655443 3344556677889999999


Q ss_pred             HHHHhhhcCCCCCCHHHHHHHHHH
Q 015868          346 LERCWQHDPTQRPNFSQITDILKQ  369 (399)
Q Consensus       346 l~~cl~~dP~~Rps~~ell~~L~~  369 (399)
                      +.+||..+|.+||++.++++.|++
T Consensus       236 i~~~l~~~p~~Rp~~~~i~~~l~~  259 (260)
T cd05069         236 MKLCWKKDPDERPTFEYIQSFLED  259 (260)
T ss_pred             HHHHccCCcccCcCHHHHHHHHhc
Confidence            999999999999999999998875

Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an

>cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C

Probab=100.00  E-value=1.7e-42  Score=335.57  Aligned_cols=242  Identities=23%  Similarity=0.418  Sum_probs=202.7

Q ss_pred             ceeceeCceEEEEEEE--CCeeEEEEEecCCCC-CHHHHHHHHHHHHHHHhc-CCCceeeEEeEEecCCcEEEEEecCCC
Q 015868          122 CKVASGSYGDLYKGTY--CSQEVAIKVLKPECV-NTEMLKEFSQEVYIMRKI-RHKNVVQFIGACTRPPNLCIVTEFMAR  197 (399)
Q Consensus       122 ~~lg~G~~g~Vy~~~~--~~~~vAvK~~~~~~~-~~~~~~~~~~Ei~~l~~l-~h~nIv~~~~~~~~~~~~~lV~E~~~g  197 (399)
                      +.||+|+||.||+++.  +++.||+|+++.... .....+.+.+|..+++.+ +||||+++++++.....+|+||||++|
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~~~~~lv~e~~~~   80 (329)
T cd05588           1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQTESRLFFVIEFVSG   80 (329)
T ss_pred             CeEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEcCCEEEEEEeCCCC
Confidence            4689999999999987  578899999986432 233456788999999998 699999999999999999999999999


Q ss_pred             CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceeecCCCcEEEeeccceeeccC-CCccccCCCC
Q 015868          198 GSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQ-SGVMTAETGT  276 (399)
Q Consensus       198 gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~giiHrDlkp~NILl~~~~~vkl~DFG~a~~~~~-~~~~~~~~gt  276 (399)
                      |+|.+++.. .+.+++..+..++.|++.||.|||++||+||||||+||+++.++.+||+|||+++.... ........||
T Consensus        81 g~L~~~~~~-~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~~~~~~~~~gt  159 (329)
T cd05588          81 GDLMFHMQR-QRKLPEEHARFYSAEISLALNFLHERGIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRPGDTTSTFCGT  159 (329)
T ss_pred             CCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCCCCEEECcCccccccccCCCccccccCC
Confidence            999998865 46799999999999999999999999999999999999999999999999999874322 2233445789


Q ss_pred             cccccccccCCCCCCChhhHHHHHHHHHHHHcCCCCCCCCC--------HHHHHHHHHhccCCCCCCCCCcHHHHHHHHH
Q 015868          277 YRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPYAGLT--------PLQAAVGVVQKSLRPTIPKHAHPRLAELLER  348 (399)
Q Consensus       277 ~~y~aPE~l~~~~~~~~~Dv~slG~vl~elltg~~P~~~~~--------~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~  348 (399)
                      +.|+|||++.+..++.++|+||||+++|+|++|+.||....        .......... .....+|..++.++.+++.+
T Consensus       160 ~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~-~~~~~~p~~~~~~~~~li~~  238 (329)
T cd05588         160 PNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLFQVIL-EKQIRIPRSLSVKASSVLKG  238 (329)
T ss_pred             ccccCHHHHcCCCCCCccceechHHHHHHHHHCCCCcccccccccccccchHHHHHHHH-cCCCCCCCCCCHHHHHHHHH
Confidence            99999999999999999999999999999999999996321        1111222222 23445778899999999999


Q ss_pred             HhhhcCCCCCC------HHHHHH
Q 015868          349 CWQHDPTQRPN------FSQITD  365 (399)
Q Consensus       349 cl~~dP~~Rps------~~ell~  365 (399)
                      ||+.||.+||+      ++++++
T Consensus       239 ~L~~dP~~R~~~~~~~~~~~i~~  261 (329)
T cd05588         239 FLNKDPKERLGCHPQTGFRDIKS  261 (329)
T ss_pred             HhccCHHHcCCCCCCCCHHHHhc
Confidence            99999999997      566653

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl

>cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3

Probab=100.00  E-value=3.5e-42  Score=336.68  Aligned_cols=248  Identities=24%  Similarity=0.340  Sum_probs=207.2

Q ss_pred             ccccceeceeceeCceEEEEEEE--CCeeEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCceeeEEeEEecC------C
Q 015868          115 AKQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRP------P  186 (399)
Q Consensus       115 ~~~~~i~~~lg~G~~g~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~nIv~~~~~~~~~------~  186 (399)
                      .++|++.+.||+|+||.||++..  .++.||+|++............+.+|+.+++.++||||+++++++...      .
T Consensus        16 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~   95 (355)
T cd07874          16 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSLEEFQ   95 (355)
T ss_pred             hhceeEEEEeeecCCEEEEEEEecCCCceEEEEEeCCcccChHHHHHHHHHHHHHHHhCCCchhceeeeeeccccccccc
Confidence            56899999999999999999976  578999999987655566677888999999999999999999988643      3


Q ss_pred             cEEEEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceeecCCCcEEEeeccceeeccC
Q 015868          187 NLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQ  266 (399)
Q Consensus       187 ~~~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~giiHrDlkp~NILl~~~~~vkl~DFG~a~~~~~  266 (399)
                      ..|+||||+.+ ++.+.+..   .++...+..++.|++.||+|||++||+||||||+||+++.++.+||+|||+++....
T Consensus        96 ~~~lv~e~~~~-~l~~~~~~---~l~~~~~~~~~~qi~~aL~~LH~~givHrDikp~Nill~~~~~~kl~Dfg~~~~~~~  171 (355)
T cd07874          96 DVYLVMELMDA-NLCQVIQM---ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGT  171 (355)
T ss_pred             eeEEEhhhhcc-cHHHHHhh---cCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHHEEECCCCCEEEeeCcccccCCC
Confidence            47999999976 77777643   478899999999999999999999999999999999999999999999999987655


Q ss_pred             CCccccCCCCcccccccccCCCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhccC----------------
Q 015868          267 SGVMTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKSL----------------  330 (399)
Q Consensus       267 ~~~~~~~~gt~~y~aPE~l~~~~~~~~~Dv~slG~vl~elltg~~P~~~~~~~~~~~~~~~~~~----------------  330 (399)
                      ........+|..|+|||++.+..++.++|||||||++|+|++|+.||.+.+..+..........                
T Consensus       172 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  251 (355)
T cd07874         172 SFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRN  251 (355)
T ss_pred             ccccCCccccCCccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhhcHHHHH
Confidence            5445556789999999999999999999999999999999999999988765443332211100                


Q ss_pred             ------------------------CCCCCCCCcHHHHHHHHHHhhhcCCCCCCHHHHHHH
Q 015868          331 ------------------------RPTIPKHAHPRLAELLERCWQHDPTQRPNFSQITDI  366 (399)
Q Consensus       331 ------------------------~~~~~~~~~~~l~~ll~~cl~~dP~~Rps~~ell~~  366 (399)
                                              ....+...+.++.+||.+||+.||++|||+.|+++.
T Consensus       252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rps~~ell~h  311 (355)
T cd07874         252 YVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDEALQH  311 (355)
T ss_pred             HHhcCCccccccchhhccccccccccccccccchHHHHHHHHHhcCCchhcCCHHHHhcC
Confidence                                    001112245678999999999999999999999873

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok

>cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C

Probab=100.00  E-value=2e-42  Score=333.58  Aligned_cols=241  Identities=23%  Similarity=0.428  Sum_probs=206.7

Q ss_pred             ceeceeCceEEEEEEE--CCeeEEEEEecCCCC-CHHHHHHHHHHHHHHHhc-CCCceeeEEeEEecCCcEEEEEecCCC
Q 015868          122 CKVASGSYGDLYKGTY--CSQEVAIKVLKPECV-NTEMLKEFSQEVYIMRKI-RHKNVVQFIGACTRPPNLCIVTEFMAR  197 (399)
Q Consensus       122 ~~lg~G~~g~Vy~~~~--~~~~vAvK~~~~~~~-~~~~~~~~~~Ei~~l~~l-~h~nIv~~~~~~~~~~~~~lV~E~~~g  197 (399)
                      +.||+|+||.||++..  +++.||+|+++.... .......+.+|+.+++.+ +||||+++++++.....+|+||||++|
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~   80 (318)
T cd05570           1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQTKDRLFFVMEYVNG   80 (318)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence            4689999999999987  467899999975421 233456678899999888 699999999999999999999999999


Q ss_pred             CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceeecCCCcEEEeeccceeeccCC-CccccCCCC
Q 015868          198 GSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQS-GVMTAETGT  276 (399)
Q Consensus       198 gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~giiHrDlkp~NILl~~~~~vkl~DFG~a~~~~~~-~~~~~~~gt  276 (399)
                      ++|.+++.. .+.+++..+..++.|++.||.|||++||+||||||+||++++++.+||+|||+++..... .......|+
T Consensus        81 ~~L~~~~~~-~~~l~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~g~  159 (318)
T cd05570          81 GDLMFHIQR-SGRFDEPRARFYAAEIVLGLQFLHERGIIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGGVTTSTFCGT  159 (318)
T ss_pred             CCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHhCCeEccCCCHHHeEECCCCcEEecccCCCeecCcCCCcccceecC
Confidence            999999876 457999999999999999999999999999999999999999999999999998753222 223334689


Q ss_pred             cccccccccCCCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhccCCCCCCCCCcHHHHHHHHHHhhhcCCC
Q 015868          277 YRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRLAELLERCWQHDPTQ  356 (399)
Q Consensus       277 ~~y~aPE~l~~~~~~~~~Dv~slG~vl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~cl~~dP~~  356 (399)
                      +.|+|||++.+..++.++|+|||||++|+|++|+.||...+..+........  .+.+|..++.++.++|.+||+.||.+
T Consensus       160 ~~y~aPE~~~~~~~~~~~DiwslGvil~~l~~G~~pf~~~~~~~~~~~i~~~--~~~~~~~~~~~~~~li~~~l~~dP~~  237 (318)
T cd05570         160 PDYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQSPFEGDDEDELFQSILED--EVRYPRWLSKEAKSILKSFLTKNPEK  237 (318)
T ss_pred             ccccCHHHhcCCCCCcchhhhhHHHHHHHHhhCCCCCCCCCHHHHHHHHHcC--CCCCCCcCCHHHHHHHHHHccCCHHH
Confidence            9999999999999999999999999999999999999888776655544433  34567788999999999999999999


Q ss_pred             CCCH-----HHHHH
Q 015868          357 RPNF-----SQITD  365 (399)
Q Consensus       357 Rps~-----~ell~  365 (399)
                      ||++     .++++
T Consensus       238 R~s~~~~~~~~ll~  251 (318)
T cd05570         238 RLGCLPTGEQDIKG  251 (318)
T ss_pred             cCCCCCCCHHHHhc
Confidence            9999     77654

Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re

>cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase

Probab=100.00  E-value=6.1e-42  Score=323.14  Aligned_cols=254  Identities=33%  Similarity=0.615  Sum_probs=214.9

Q ss_pred             ecccccceeceeceeCceEEEEEEEC-------CeeEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCceeeEEeEEecC
Q 015868          113 IDAKQLKIECKVASGSYGDLYKGTYC-------SQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRP  185 (399)
Q Consensus       113 i~~~~~~i~~~lg~G~~g~Vy~~~~~-------~~~vAvK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~nIv~~~~~~~~~  185 (399)
                      +..++|++.+.||.|+||.||+|.+.       +..||+|.+.... .......+.+|+.+++.++|+||+++++++...
T Consensus         3 ~~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~   81 (277)
T cd05036           3 VPRDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESC-SEQDESDFLMEALIMSKFNHQNIVRLIGVSFER   81 (277)
T ss_pred             CCHHHcEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCC-CHHHHHHHHHHHHHHHhCCCCCEeeEEEEEccC
Confidence            44678999999999999999999874       4678999886542 344456789999999999999999999999988


Q ss_pred             CcEEEEEecCCCCCHHHHHHhcC------CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceeecCCC---cEEEe
Q 015868          186 PNLCIVTEFMARGSIYDFLHKQK------GVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENG---VVKVA  256 (399)
Q Consensus       186 ~~~~lV~E~~~ggsL~~~l~~~~------~~l~~~~~~~i~~~i~~~L~~LH~~giiHrDlkp~NILl~~~~---~vkl~  256 (399)
                      ...++||||++|++|.+++....      ..+++..+.+++.||+.||.|||+++++||||||+||+++.++   .+||+
T Consensus        82 ~~~~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~nil~~~~~~~~~~kl~  161 (277)
T cd05036          82 LPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEENHFIHRDIAARNCLLTCKGPGRVAKIA  161 (277)
T ss_pred             CCcEEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccchheEEEeccCCCcceEec
Confidence            89999999999999999997643      2588999999999999999999999999999999999998765   69999


Q ss_pred             eccceeeccCCCc---cccCCCCcccccccccCCCCCCChhhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHHhccCCC
Q 015868          257 DFGVARVQAQSGV---MTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLT-GELPYAGLTPLQAAVGVVQKSLRP  332 (399)
Q Consensus       257 DFG~a~~~~~~~~---~~~~~gt~~y~aPE~l~~~~~~~~~Dv~slG~vl~ellt-g~~P~~~~~~~~~~~~~~~~~~~~  332 (399)
                      |||.++.......   ......+..|+|||++.+..++.++|||||||++|+|++ |..||...+..+... .+....++
T Consensus       162 dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~~g~~pf~~~~~~~~~~-~~~~~~~~  240 (277)
T cd05036         162 DFGMARDIYRASYYRKGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTNQEVME-FVTGGGRL  240 (277)
T ss_pred             cCccccccCCccceecCCCCCccHhhCCHHHHhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH-HHHcCCcC
Confidence            9999976532211   112233568999999998889999999999999999997 999999877765443 34444556


Q ss_pred             CCCCCCcHHHHHHHHHHhhhcCCCCCCHHHHHHHHH
Q 015868          333 TIPKHAHPRLAELLERCWQHDPTQRPNFSQITDILK  368 (399)
Q Consensus       333 ~~~~~~~~~l~~ll~~cl~~dP~~Rps~~ell~~L~  368 (399)
                      ..|..++..+.+++.+||+.+|++||++.++++.|+
T Consensus       241 ~~~~~~~~~~~~~i~~cl~~~p~~Rps~~~vl~~l~  276 (277)
T cd05036         241 DPPKGCPGPVYRIMTDCWQHTPEDRPNFATILERIQ  276 (277)
T ss_pred             CCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHhh
Confidence            677889999999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well

>cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2

Probab=100.00  E-value=1.8e-42  Score=340.82  Aligned_cols=253  Identities=21%  Similarity=0.340  Sum_probs=212.6

Q ss_pred             eecccccceeceeceeCceEEEEEEE--CCeeEEEEEecCCC-CCHHHHHHHHHHHHHHHhcCCCceeeEEeEEecCCcE
Q 015868          112 EIDAKQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPEC-VNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNL  188 (399)
Q Consensus       112 ~i~~~~~~i~~~lg~G~~g~Vy~~~~--~~~~vAvK~~~~~~-~~~~~~~~~~~Ei~~l~~l~h~nIv~~~~~~~~~~~~  188 (399)
                      .+..++|++.+.||+|+||.||++++  +++.||+|++.... ........+.+|+.+++.++||||+++++++..+..+
T Consensus        39 ~~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~~  118 (370)
T cd05621          39 QMKAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAFQDDKYL  118 (370)
T ss_pred             CCCHHHCeEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEE
Confidence            34467899999999999999999987  46789999986422 2233345688999999999999999999999999999


Q ss_pred             EEEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceeecCCCcEEEeeccceeeccCCC
Q 015868          189 CIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSG  268 (399)
Q Consensus       189 ~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~giiHrDlkp~NILl~~~~~vkl~DFG~a~~~~~~~  268 (399)
                      |+||||++||+|.+++..  ..+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||++.......
T Consensus       119 ~lv~Ey~~gg~L~~~l~~--~~~~~~~~~~~~~qil~aL~~LH~~~IvHrDLKp~NILl~~~~~~kL~DFG~a~~~~~~~  196 (370)
T cd05621         119 YMVMEYMPGGDLVNLMSN--YDVPEKWAKFYTAEVVLALDAIHSMGLIHRDVKPDNMLLDKHGHLKLADFGTCMKMDETG  196 (370)
T ss_pred             EEEEcCCCCCcHHHHHHh--cCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEECCCCCEEEEecccceecccCC
Confidence            999999999999999965  358999999999999999999999999999999999999999999999999998654332


Q ss_pred             c--cccCCCCcccccccccCCCC----CCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhccCCCCCCC--CCcH
Q 015868          269 V--MTAETGTYRWMAPEVIEHKP----YDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKSLRPTIPK--HAHP  340 (399)
Q Consensus       269 ~--~~~~~gt~~y~aPE~l~~~~----~~~~~Dv~slG~vl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~--~~~~  340 (399)
                      .  .....||+.|+|||++.+..    ++.++|+|||||++|+|++|..||...+.......+........+|.  .++.
T Consensus       197 ~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~s~  276 (370)
T cd05621         197 MVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSLVGTYSKIMDHKNSLNFPEDVEISK  276 (370)
T ss_pred             ceecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCCCCHHHHHHHHHhCCcccCCCCcccCCH
Confidence            2  23456999999999997643    78899999999999999999999998887776666655443344444  4689


Q ss_pred             HHHHHHHHHhhhcCC--CCCCHHHHHHH
Q 015868          341 RLAELLERCWQHDPT--QRPNFSQITDI  366 (399)
Q Consensus       341 ~l~~ll~~cl~~dP~--~Rps~~ell~~  366 (399)
                      .+.+++.+||+.++.  .|+++.|+++.
T Consensus       277 ~~~~li~~~L~~~~~r~~R~~~~e~l~h  304 (370)
T cd05621         277 HAKNLICAFLTDREVRLGRNGVEEIKQH  304 (370)
T ss_pred             HHHHHHHHHccCchhccCCCCHHHHhcC
Confidence            999999999985544  38899998774

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found

>KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms]

Probab=100.00  E-value=7.5e-43  Score=355.35  Aligned_cols=259  Identities=25%  Similarity=0.429  Sum_probs=219.2

Q ss_pred             CCceeecccccceeceeceeCceEEEEEEEC--CeeEEEEEecCCCCCHHHHHHHHHHHHHHHhcC-CCceeeEEeE-Ee
Q 015868          108 TDVWEIDAKQLKIECKVASGSYGDLYKGTYC--SQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIR-HKNVVQFIGA-CT  183 (399)
Q Consensus       108 ~~~~~i~~~~~~i~~~lg~G~~g~Vy~~~~~--~~~vAvK~~~~~~~~~~~~~~~~~Ei~~l~~l~-h~nIv~~~~~-~~  183 (399)
                      +.+++|...+++|.+.|++|||+.||+|+..  +..||+|++-..  ++...+.+.+||.+|++|. |+|||.+++. ..
T Consensus        29 G~~~~Vg~~~v~V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~~--de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~  106 (738)
T KOG1989|consen   29 GQTFTVGSHRVTVEKVLAEGGFAQVYLAQDVKGGKKYALKRMYVN--DEEALNAVKREIDIMKLLSGHKNIVSYIDSSAI  106 (738)
T ss_pred             ceEEEECCEEEEEEEEEccCCcEEEEEEEecCCCceeeeeeeecC--CHHHHHHHHHHHHHHHHhcCCCceeeEeccccc
Confidence            4678999999999999999999999999883  379999998765  7888999999999999997 9999999993 22


Q ss_pred             c------CCcEEEEEecCCCCCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCCCceeecCCCcEE
Q 015868          184 R------PPNLCIVTEFMARGSIYDFLHKQ-KGVFQLTSLLKVAIDVSKGMNYLHQNN--IIHRDLKTANLLMDENGVVK  254 (399)
Q Consensus       184 ~------~~~~~lV~E~~~ggsL~~~l~~~-~~~l~~~~~~~i~~~i~~~L~~LH~~g--iiHrDlkp~NILl~~~~~vk  254 (399)
                      .      ...+.|.||||.||+|-|+++++ ...|++.++++|+.|+++|+++||...  |||||||-+|||++.+|..|
T Consensus       107 ~~~~~~~~~EvllLmEyC~gg~Lvd~mn~Rlq~~lte~eVLkIf~dv~~AVa~mH~~~pPiIHRDLKiENvLls~~g~~K  186 (738)
T KOG1989|consen  107 NRSSNNGVWEVLLLMEYCKGGSLVDFMNTRLQTRLTEDEVLKIFYDVCEAVAAMHYLKPPIIHRDLKIENVLLSADGNYK  186 (738)
T ss_pred             cccCCCceeEEEeehhhccCCcHHHHHHHHHhccCChHHHHHHHHHHHHHHHHHhcCCCccchhhhhhhheEEcCCCCEE
Confidence            1      13578999999999999999753 355999999999999999999999997  99999999999999999999


Q ss_pred             EeeccceeeccCCCccc----------cCCCCcccccccccC---CCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHH
Q 015868          255 VADFGVARVQAQSGVMT----------AETGTYRWMAPEVIE---HKPYDYKADVFSFGIALWELLTGELPYAGLTPLQA  321 (399)
Q Consensus       255 l~DFG~a~~~~~~~~~~----------~~~gt~~y~aPE~l~---~~~~~~~~Dv~slG~vl~elltg~~P~~~~~~~~~  321 (399)
                      |||||.|+.........          ...-|+.|+|||+++   +.+.++|+|||+|||+||.|+....||+.-.....
T Consensus       187 LCDFGSatt~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eKsDIWALGclLYkLCy~t~PFe~sg~laI  266 (738)
T KOG1989|consen  187 LCDFGSATTKILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEKSDIWALGCLLYKLCYFTTPFEESGKLAI  266 (738)
T ss_pred             eCcccccccccCCCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCCcchhHHHHHHHHHHHHHHhCCCcCcCcceeE
Confidence            99999997544332111          113589999999985   67889999999999999999999999987655443


Q ss_pred             HHHHHhccCCCCCCCCCcHHHHHHHHHHhhhcCCCCCCHHHHHHHHHHHHH
Q 015868          322 AVGVVQKSLRPTIPKHAHPRLAELLERCWQHDPTQRPNFSQITDILKQMMK  372 (399)
Q Consensus       322 ~~~~~~~~~~~~~~~~~~~~l~~ll~~cl~~dP~~Rps~~ell~~L~~l~~  372 (399)
                      ..+    .+..+..+.++..+.+||+.||+.||.+||++.|++..+..|..
T Consensus       267 lng----~Y~~P~~p~ys~~l~~LI~~mL~~nP~~RPnI~Qv~~~~~~l~~  313 (738)
T KOG1989|consen  267 LNG----NYSFPPFPNYSDRLKDLIRTMLQPNPDERPNIYQVLEEIFELAN  313 (738)
T ss_pred             Eec----cccCCCCccHHHHHHHHHHHHhccCcccCCCHHHHHHHHHHHhc
Confidence            322    22222224689999999999999999999999999999998864

>cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2

Probab=100.00  E-value=1.2e-41  Score=318.98  Aligned_cols=257  Identities=30%  Similarity=0.608  Sum_probs=219.0

Q ss_pred             ecccccceeceeceeCceEEEEEEEC--C---eeEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCceeeEEeEEecCCc
Q 015868          113 IDAKQLKIECKVASGSYGDLYKGTYC--S---QEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPN  187 (399)
Q Consensus       113 i~~~~~~i~~~lg~G~~g~Vy~~~~~--~---~~vAvK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~nIv~~~~~~~~~~~  187 (399)
                      |..++|+..+.||+|+||.||+|...  +   ..+|+|.++... .....+.+.+|+.++++++||||+++++++.....
T Consensus         2 i~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~   80 (268)
T cd05063           2 IHPSHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGY-TEKQRQDFLSEASIMGQFSHHNIIRLEGVVTKFKP   80 (268)
T ss_pred             CChHHceEeeEecCCCCccEEEEEEecCCCCceEEEEEeccccC-CHHHHHHHHHHHHHHhcCCCCCeeEEEEEEccCCC
Confidence            45668889999999999999999863  2   368999987543 34445789999999999999999999999999999


Q ss_pred             EEEEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceeecCCCcEEEeeccceeeccCC
Q 015868          188 LCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQS  267 (399)
Q Consensus       188 ~~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~giiHrDlkp~NILl~~~~~vkl~DFG~a~~~~~~  267 (399)
                      .++||||+++++|.+++....+.+++..+..++.|++.|++|||+.|++|+||||+||++++++.+||+|||++......
T Consensus        81 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~  160 (268)
T cd05063          81 AMIITEYMENGALDKYLRDHDGEFSSYQLVGMLRGIAAGMKYLSDMNYVHRDLAARNILVNSNLECKVSDFGLSRVLEDD  160 (268)
T ss_pred             cEEEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhhEEEcCCCcEEECCCccceecccc
Confidence            99999999999999999876778999999999999999999999999999999999999999999999999998765432


Q ss_pred             Ccc----ccCCCCcccccccccCCCCCCChhhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHHhccCCCCCCCCCcHHH
Q 015868          268 GVM----TAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLT-GELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRL  342 (399)
Q Consensus       268 ~~~----~~~~gt~~y~aPE~l~~~~~~~~~Dv~slG~vl~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  342 (399)
                      ...    .....+..|+|||.+.+..++.++||||||+++|++++ |..||...+..+....+ ....+.+.+..++.++
T Consensus       161 ~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~il~ell~~g~~p~~~~~~~~~~~~i-~~~~~~~~~~~~~~~~  239 (268)
T cd05063         161 PEGTYTTSGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGERPYWDMSNHEVMKAI-NDGFRLPAPMDCPSAV  239 (268)
T ss_pred             cccceeccCCCcCceecCHHHhhcCCcChHhHHHHHHHHHHHHHhCCCCCCCcCCHHHHHHHH-hcCCCCCCCCCCCHHH
Confidence            211    11223567999999998889999999999999999998 99999887776544443 3344555566788999


Q ss_pred             HHHHHHHhhhcCCCCCCHHHHHHHHHHHH
Q 015868          343 AELLERCWQHDPTQRPNFSQITDILKQMM  371 (399)
Q Consensus       343 ~~ll~~cl~~dP~~Rps~~ell~~L~~l~  371 (399)
                      .+++.+||+.+|.+||++.++++.|.+++
T Consensus       240 ~~li~~c~~~~p~~Rp~~~~i~~~l~~~~  268 (268)
T cd05063         240 YQLMLQCWQQDRARRPRFVDIVNLLDKLL  268 (268)
T ss_pred             HHHHHHHcCCCcccCcCHHHHHHHHHhhC
Confidence            99999999999999999999999998763

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored

>cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7

Probab=100.00  E-value=3.7e-42  Score=325.05  Aligned_cols=244  Identities=21%  Similarity=0.366  Sum_probs=200.9

Q ss_pred             eceeCceEEEEEEE--CCeeEEEEEecCCCCCH-HHHHHHHHHHHHHHhcCCCceeeEEeEEecCCcEEEEEecCCCCCH
Q 015868          124 VASGSYGDLYKGTY--CSQEVAIKVLKPECVNT-EMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVTEFMARGSI  200 (399)
Q Consensus       124 lg~G~~g~Vy~~~~--~~~~vAvK~~~~~~~~~-~~~~~~~~Ei~~l~~l~h~nIv~~~~~~~~~~~~~lV~E~~~ggsL  200 (399)
                      ||+|+||.||+++.  +++.||+|.+....... .....+..|+.++++++||||+++++.+..+...++||||++|++|
T Consensus         1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~hp~i~~~~~~~~~~~~~~lv~e~~~g~~L   80 (277)
T cd05607           1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAYAFESKTHLCLVMSLMNGGDL   80 (277)
T ss_pred             CCCCCceEEEEEEEccCCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhcCCCcEEEEEEEEecCCeEEEEEecCCCCCH
Confidence            69999999999976  57899999987432221 2234566799999999999999999999999999999999999999


Q ss_pred             HHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceeecCCCcEEEeeccceeeccCCCccccCCCCccc
Q 015868          201 YDFLHKQK-GVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAETGTYRW  279 (399)
Q Consensus       201 ~~~l~~~~-~~l~~~~~~~i~~~i~~~L~~LH~~giiHrDlkp~NILl~~~~~vkl~DFG~a~~~~~~~~~~~~~gt~~y  279 (399)
                      .+++.... ..+++..+..++.|++.||+|||++||+||||||+||+++.++.++|+|||.+.............|+..|
T Consensus        81 ~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~y  160 (277)
T cd05607          81 KYHIYNVGERGLEMERVIHYSAQITCGILHLHSMDIVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGKTITQRAGTNGY  160 (277)
T ss_pred             HHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCCEEEccCChHhEEEcCCCCEEEeeceeeeecCCCceeeccCCCCCc
Confidence            98886533 45888999999999999999999999999999999999999999999999999866554444456789999


Q ss_pred             ccccccCCCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhccC---CCCCCCCCcHHHHHHHHHHhhhcCCC
Q 015868          280 MAPEVIEHKPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKSL---RPTIPKHAHPRLAELLERCWQHDPTQ  356 (399)
Q Consensus       280 ~aPE~l~~~~~~~~~Dv~slG~vl~elltg~~P~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~l~~ll~~cl~~dP~~  356 (399)
                      +|||.+.+..++.++||||+||++|+|++|+.||.................   .+.....+++++.+++.+||+.||++
T Consensus       161 ~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~P~~  240 (277)
T cd05607         161 MAPEILKEEPYSYPVDWFAMGCSIYEMVAGRTPFKDHKEKVAKEELKRRTLEDEVKFEHQNFTEESKDICRLFLAKKPED  240 (277)
T ss_pred             cCHHHHccCCCCCchhHHHHHHHHHHHHhCCCCCCCCcchhhHHHHHHHhhccccccccccCCHHHHHHHHHHhccCHhh
Confidence            999999998899999999999999999999999976543222222222111   12222468899999999999999999


Q ss_pred             CCCHHHHHHHH
Q 015868          357 RPNFSQITDIL  367 (399)
Q Consensus       357 Rps~~ell~~L  367 (399)
                      ||++.|+++.+
T Consensus       241 R~~~~~~~~~~  251 (277)
T cd05607         241 RLGSREKNDDP  251 (277)
T ss_pred             CCCCccchhhh
Confidence            99998776433

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr

>cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1

Probab=100.00  E-value=4.7e-42  Score=336.94  Aligned_cols=247  Identities=25%  Similarity=0.358  Sum_probs=207.5

Q ss_pred             ccccceeceeceeCceEEEEEEE--CCeeEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCceeeEEeEEecC------C
Q 015868          115 AKQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRP------P  186 (399)
Q Consensus       115 ~~~~~i~~~lg~G~~g~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~nIv~~~~~~~~~------~  186 (399)
                      .++|++.+.||+|+||.||++..  .++.||||++............+.+|+.+++.++||||+++++++...      .
T Consensus        23 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~~~~~  102 (364)
T cd07875          23 LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQ  102 (364)
T ss_pred             hcceeEEEEeecCCCeEEEEEEECCCCcEEEEEEeCccccCchhHHHHHHHHHHHHhcCCCCccccceeecccccccccC
Confidence            56899999999999999999986  578899999986655555667888999999999999999999987543      3


Q ss_pred             cEEEEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceeecCCCcEEEeeccceeeccC
Q 015868          187 NLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQ  266 (399)
Q Consensus       187 ~~~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~giiHrDlkp~NILl~~~~~vkl~DFG~a~~~~~  266 (399)
                      ..|+||||+.+ +|.+.+..   .++...+..++.|++.||+|||++||+||||||+||+++.++.+||+|||+++....
T Consensus       103 ~~~lv~e~~~~-~l~~~~~~---~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~  178 (364)
T cd07875         103 DVYIVMELMDA-NLCQVIQM---ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGT  178 (364)
T ss_pred             eEEEEEeCCCC-CHHHHHHh---cCCHHHHHHHHHHHHHHHHHHhhCCeecCCCCHHHEEECCCCcEEEEeCCCccccCC
Confidence            57999999976 78877743   478899999999999999999999999999999999999999999999999987655


Q ss_pred             CCccccCCCCcccccccccCCCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhccCC---------------
Q 015868          267 SGVMTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKSLR---------------  331 (399)
Q Consensus       267 ~~~~~~~~gt~~y~aPE~l~~~~~~~~~Dv~slG~vl~elltg~~P~~~~~~~~~~~~~~~~~~~---------------  331 (399)
                      ........+|..|+|||++.+..++.++|||||||++|+|++|+.||.+.+..+....++.....               
T Consensus       179 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  258 (364)
T cd07875         179 SFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKLQPTVRT  258 (364)
T ss_pred             CCcccCCcccCCcCCHHHHhCCCCCchhhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHhhhHHHHH
Confidence            44445567899999999999999999999999999999999999999887765554443321100               


Q ss_pred             -----C--------------------CCCCCCcHHHHHHHHHHhhhcCCCCCCHHHHHH
Q 015868          332 -----P--------------------TIPKHAHPRLAELLERCWQHDPTQRPNFSQITD  365 (399)
Q Consensus       332 -----~--------------------~~~~~~~~~l~~ll~~cl~~dP~~Rps~~ell~  365 (399)
                           +                    ......+.++.+||.+||+.||.+|||+.|+++
T Consensus       259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~R~t~~e~L~  317 (364)
T cd07875         259 YVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQ  317 (364)
T ss_pred             HHhhCCCcCCCChHhhCccccccccccccccccHHHHHHHHHhcCcCcccCCCHHHHhc
Confidence                 0                    011123467899999999999999999999987

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn

>cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta

Probab=100.00  E-value=2.3e-42  Score=332.91  Aligned_cols=240  Identities=25%  Similarity=0.445  Sum_probs=204.0

Q ss_pred             ceeceeCceEEEEEEE--CCeeEEEEEecCCCC-CHHHHHHHHHHHHHHHhc-CCCceeeEEeEEecCCcEEEEEecCCC
Q 015868          122 CKVASGSYGDLYKGTY--CSQEVAIKVLKPECV-NTEMLKEFSQEVYIMRKI-RHKNVVQFIGACTRPPNLCIVTEFMAR  197 (399)
Q Consensus       122 ~~lg~G~~g~Vy~~~~--~~~~vAvK~~~~~~~-~~~~~~~~~~Ei~~l~~l-~h~nIv~~~~~~~~~~~~~lV~E~~~g  197 (399)
                      +.||+|+||.||+|++  +++.||+|+++.... .......+..|..++... +||||+++++++...+.+|+||||+.|
T Consensus         1 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~~   80 (316)
T cd05620           1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQTKEHLFFVMEFLNG   80 (316)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEEEeCCEEEEEECCCCC
Confidence            4699999999999987  577899999975421 122345567788888754 899999999999999999999999999


Q ss_pred             CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceeecCCCcEEEeeccceeeccC-CCccccCCCC
Q 015868          198 GSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQ-SGVMTAETGT  276 (399)
Q Consensus       198 gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~giiHrDlkp~NILl~~~~~vkl~DFG~a~~~~~-~~~~~~~~gt  276 (399)
                      ++|.+++.. ...+++..+..++.|++.||+|||++||+||||||+||+++.++.++|+|||+++.... ........||
T Consensus        81 g~L~~~i~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~ivHrDlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt  159 (316)
T cd05620          81 GDLMFHIQD-KGRFDLYRATFYAAEIVCGLQFLHSKGIIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGDNRASTFCGT  159 (316)
T ss_pred             CcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCCCCEEeCccCCCeecccCCCceeccCCC
Confidence            999999876 46789999999999999999999999999999999999999999999999999874322 2233455789


Q ss_pred             cccccccccCCCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhccCCCCCCCCCcHHHHHHHHHHhhhcCCC
Q 015868          277 YRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRLAELLERCWQHDPTQ  356 (399)
Q Consensus       277 ~~y~aPE~l~~~~~~~~~Dv~slG~vl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~cl~~dP~~  356 (399)
                      +.|+|||++.+..++.++||||||+++|+|++|..||...+..+......  ...+.+|..++.++.+++.+||+.||++
T Consensus       160 ~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~Pf~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~li~~~l~~dP~~  237 (316)
T cd05620         160 PDYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQSPFHGDDEDELFESIR--VDTPHYPRWITKESKDILEKLFERDPTR  237 (316)
T ss_pred             cCccCHHHHcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHH--hCCCCCCCCCCHHHHHHHHHHccCCHHH
Confidence            99999999999999999999999999999999999998887766554433  2346677789999999999999999999


Q ss_pred             CCCHH-HHH
Q 015868          357 RPNFS-QIT  364 (399)
Q Consensus       357 Rps~~-ell  364 (399)
                      ||++. +++
T Consensus       238 R~~~~~~~~  246 (316)
T cd05620         238 RLGVVGNIR  246 (316)
T ss_pred             cCCChHHHH
Confidence            99984 554

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I

>cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3

Probab=100.00  E-value=9e-42  Score=317.59  Aligned_cols=248  Identities=26%  Similarity=0.468  Sum_probs=216.0

Q ss_pred             ccceeceeceeCceEEEEEEE--CCeeEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCceeeEEeEEecCCcEEEEEec
Q 015868          117 QLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVTEF  194 (399)
Q Consensus       117 ~~~i~~~lg~G~~g~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~nIv~~~~~~~~~~~~~lV~E~  194 (399)
                      +|++.++||.|+||.||+++.  +++.+|+|.++... .....+.+.+|+.+++.++|+||+++++.+.....+++||||
T Consensus         1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   79 (255)
T cd08219           1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPK-SSSAVEDSRKEAVLLAKMKHPNIVAFKESFEADGHLYIVMEY   79 (255)
T ss_pred             CceEEEEeeccCCeEEEEEEEcCCCceEEEEEEEcCc-chHHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEee
Confidence            478899999999999999987  57889999986543 234457788999999999999999999999999999999999


Q ss_pred             CCCCCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceeecCCCcEEEeeccceeeccCCCc-ccc
Q 015868          195 MARGSIYDFLHKQ-KGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGV-MTA  272 (399)
Q Consensus       195 ~~ggsL~~~l~~~-~~~l~~~~~~~i~~~i~~~L~~LH~~giiHrDlkp~NILl~~~~~vkl~DFG~a~~~~~~~~-~~~  272 (399)
                      +++++|.+++... ...+++..+..++.|++.||.|||++||+|+||||.||++++++.++++|||.++....... ...
T Consensus        80 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~~~~~  159 (255)
T cd08219          80 CDGGDLMQKIKLQRGKLFPEDTILQWFVQMCLGVQHIHEKRVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGAYACT  159 (255)
T ss_pred             CCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCcceEEECCCCcEEEcccCcceeeccccccccc
Confidence            9999999998653 35689999999999999999999999999999999999999999999999999986554332 234


Q ss_pred             CCCCcccccccccCCCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhccCCCCCCCCCcHHHHHHHHHHhhh
Q 015868          273 ETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRLAELLERCWQH  352 (399)
Q Consensus       273 ~~gt~~y~aPE~l~~~~~~~~~Dv~slG~vl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~cl~~  352 (399)
                      ..++..|+|||++.+..++.++|+||||+++|+|++|..||...+......... ....+.++..++..+.+++.+||+.
T Consensus       160 ~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~li~~~l~~  238 (255)
T cd08219         160 YVGTPYYVPPEIWENMPYNNKSDIWSLGCILYELCTLKHPFQANSWKNLILKVC-QGSYKPLPSHYSYELRSLIKQMFKR  238 (255)
T ss_pred             ccCCccccCHHHHccCCcCchhhhhhhchhheehhhccCCCCCCCHHHHHHHHh-cCCCCCCCcccCHHHHHHHHHHHhC
Confidence            568899999999999889999999999999999999999999877766554443 3445557778899999999999999


Q ss_pred             cCCCCCCHHHHHHH
Q 015868          353 DPTQRPNFSQITDI  366 (399)
Q Consensus       353 dP~~Rps~~ell~~  366 (399)
                      ||++||++.+++..
T Consensus       239 ~P~~Rp~~~~il~~  252 (255)
T cd08219         239 NPRSRPSATTILSR  252 (255)
T ss_pred             CcccCCCHHHHhhc
Confidence            99999999999764

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati

>cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases

Probab=100.00  E-value=1.1e-41  Score=321.54  Aligned_cols=258  Identities=31%  Similarity=0.607  Sum_probs=221.2

Q ss_pred             ecccccceeceeceeCceEEEEEEEC--C----eeEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCceeeEEeEEecCC
Q 015868          113 IDAKQLKIECKVASGSYGDLYKGTYC--S----QEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPP  186 (399)
Q Consensus       113 i~~~~~~i~~~lg~G~~g~Vy~~~~~--~----~~vAvK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~nIv~~~~~~~~~~  186 (399)
                      +...+|++.+.||+|+||.||+|.+.  +    ..+|+|.++... .......+.+|+.++++++||||+++++++.. .
T Consensus         4 ~~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~   81 (279)
T cd05057           4 LKETELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREET-SPKANKEILDEAYVMASVDHPHVVRLLGICLS-S   81 (279)
T ss_pred             cCHHHcEEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCC-CHHHHHHHHHHHHHHHhCCCCCcceEEEEEec-C
Confidence            45678999999999999999999762  2    358999887653 24456788999999999999999999999987 6


Q ss_pred             cEEEEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceeecCCCcEEEeeccceeeccC
Q 015868          187 NLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQ  266 (399)
Q Consensus       187 ~~~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~giiHrDlkp~NILl~~~~~vkl~DFG~a~~~~~  266 (399)
                      ..++||||+++|+|.+++......+++..+..++.|++.||+|||++|++||||||+||++++++.+||+|||.++....
T Consensus        82 ~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~i~H~di~p~nil~~~~~~~kL~dfg~~~~~~~  161 (279)
T cd05057          82 QVQLITQLMPLGCLLDYVRNHKDNIGSQYLLNWCVQIAKGMSYLEEKRLVHRDLAARNVLVKTPQHVKITDFGLAKLLDV  161 (279)
T ss_pred             ceEEEEecCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCEEecccCcceEEEcCCCeEEECCCcccccccC
Confidence            79999999999999999988777799999999999999999999999999999999999999999999999999976543


Q ss_pred             CCccc---cCCCCcccccccccCCCCCCChhhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHHhccCCCCCCCCCcHHH
Q 015868          267 SGVMT---AETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLT-GELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRL  342 (399)
Q Consensus       267 ~~~~~---~~~gt~~y~aPE~l~~~~~~~~~Dv~slG~vl~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  342 (399)
                      .....   ...++..|+|||.+.+..++.++|+||||+++|++++ |..||......+.... +........|..++.++
T Consensus       162 ~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~  240 (279)
T cd05057         162 DEKEYHAEGGKVPIKWMALESILHRIYTHKSDVWSYGVTVWELMTFGAKPYEGIPAVEIPDL-LEKGERLPQPPICTIDV  240 (279)
T ss_pred             cccceecCCCcccccccCHHHhhcCCcCchhhHHHHHHHHHHHhcCCCCCCCCCCHHHHHHH-HhCCCCCCCCCCCCHHH
Confidence            22111   1223568999999988889999999999999999999 9999998877665443 33444556677788999


Q ss_pred             HHHHHHHhhhcCCCCCCHHHHHHHHHHHHHH
Q 015868          343 AELLERCWQHDPTQRPNFSQITDILKQMMKE  373 (399)
Q Consensus       343 ~~ll~~cl~~dP~~Rps~~ell~~L~~l~~~  373 (399)
                      .+++.+||..+|..||++.++++.|.++.++
T Consensus       241 ~~~~~~~l~~~p~~Rp~~~~l~~~l~~~~~~  271 (279)
T cd05057         241 YMVLVKCWMIDAESRPTFKELINEFSKMARD  271 (279)
T ss_pred             HHHHHHHcCCChhhCCCHHHHHHHHHHHHhC
Confidence            9999999999999999999999999998653

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea

>cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta

Probab=100.00  E-value=3.2e-42  Score=331.95  Aligned_cols=241  Identities=24%  Similarity=0.427  Sum_probs=203.8

Q ss_pred             ceeceeCceEEEEEEE--CCeeEEEEEecCCCC-CHHHHHHHHHHHHHHHh-cCCCceeeEEeEEecCCcEEEEEecCCC
Q 015868          122 CKVASGSYGDLYKGTY--CSQEVAIKVLKPECV-NTEMLKEFSQEVYIMRK-IRHKNVVQFIGACTRPPNLCIVTEFMAR  197 (399)
Q Consensus       122 ~~lg~G~~g~Vy~~~~--~~~~vAvK~~~~~~~-~~~~~~~~~~Ei~~l~~-l~h~nIv~~~~~~~~~~~~~lV~E~~~g  197 (399)
                      +.||+|+||.||+|+.  +++.||+|+++.... .......+..|..++.. ++||||+++++++.....+++||||++|
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ey~~~   80 (316)
T cd05619           1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQTKENLFFVMEYLNG   80 (316)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEEeCCEEEEEEeCCCC
Confidence            4689999999999987  467899999985422 12334556677888876 4899999999999999999999999999


Q ss_pred             CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceeecCCCcEEEeeccceeeccC-CCccccCCCC
Q 015868          198 GSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQ-SGVMTAETGT  276 (399)
Q Consensus       198 gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~giiHrDlkp~NILl~~~~~vkl~DFG~a~~~~~-~~~~~~~~gt  276 (399)
                      |+|.+++.. ...+++..+..++.|++.||.|||++||+||||||+||+++.++.+||+|||+++.... ........||
T Consensus        81 g~L~~~l~~-~~~~~~~~~~~~~~qi~~al~~LH~~~ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt  159 (316)
T cd05619          81 GDLMFHIQS-CHKFDLPRATFYAAEIICGLQFLHSKGIVYRDLKLDNILLDTDGHIKIADFGMCKENMLGDAKTCTFCGT  159 (316)
T ss_pred             CcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHEEECCCCCEEEccCCcceECCCCCCceeeecCC
Confidence            999999976 45789999999999999999999999999999999999999999999999999875322 2223345689


Q ss_pred             cccccccccCCCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhccCCCCCCCCCcHHHHHHHHHHhhhcCCC
Q 015868          277 YRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRLAELLERCWQHDPTQ  356 (399)
Q Consensus       277 ~~y~aPE~l~~~~~~~~~Dv~slG~vl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~cl~~dP~~  356 (399)
                      +.|+|||++.+..++.++|||||||++|+|++|..||...+..+.......  ..+.+|..++.++.+++.+||+.||.+
T Consensus       160 ~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~~~~~~i~~--~~~~~~~~~~~~~~~li~~~l~~~P~~  237 (316)
T cd05619         160 PDYIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQSPFHGHDEEELFQSIRM--DNPCYPRWLTREAKDILVKLFVREPER  237 (316)
T ss_pred             ccccCHHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHh--CCCCCCccCCHHHHHHHHHHhccCHhh
Confidence            999999999999999999999999999999999999998887665544332  235567778999999999999999999


Q ss_pred             CCCHH-HHHH
Q 015868          357 RPNFS-QITD  365 (399)
Q Consensus       357 Rps~~-ell~  365 (399)
                      ||++. ++++
T Consensus       238 R~~~~~~l~~  247 (316)
T cd05619         238 RLGVKGDIRQ  247 (316)
T ss_pred             cCCChHHHHc
Confidence            99997 5543

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in

>cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase

Probab=100.00  E-value=9.5e-42  Score=323.48  Aligned_cols=254  Identities=31%  Similarity=0.601  Sum_probs=216.1

Q ss_pred             ecccccceeceeceeCceEEEEEEE-------CCeeEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCceeeEEeEEecC
Q 015868          113 IDAKQLKIECKVASGSYGDLYKGTY-------CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRP  185 (399)
Q Consensus       113 i~~~~~~i~~~lg~G~~g~Vy~~~~-------~~~~vAvK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~nIv~~~~~~~~~  185 (399)
                      ++.++|++.++||.|+||.||++..       .+..||+|+++... .......+.+|+.++++++||||+++++++..+
T Consensus         2 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~-~~~~~~~~~~ei~~l~~l~h~~iv~~~~~~~~~   80 (288)
T cd05050           2 YPRNNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEA-SADMQADFQREAALMAEFDHPNIVKLLGVCAVG   80 (288)
T ss_pred             CChHhceecccccccccccEEEEEEcccCCCCcceeEEEEecCCCc-CHHHHHHHHHHHHHHHhcCCCchheEEEEEcCC
Confidence            4567899999999999999999976       35789999987543 344567799999999999999999999999999


Q ss_pred             CcEEEEEecCCCCCHHHHHHhcC---------------------CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCc
Q 015868          186 PNLCIVTEFMARGSIYDFLHKQK---------------------GVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTAN  244 (399)
Q Consensus       186 ~~~~lV~E~~~ggsL~~~l~~~~---------------------~~l~~~~~~~i~~~i~~~L~~LH~~giiHrDlkp~N  244 (399)
                      ...++||||+++++|.+++....                     ..+++..++.++.|++.||+|||++|++||||||+|
T Consensus        81 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~~~i~H~dl~p~n  160 (288)
T cd05050          81 KPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSERKFVHRDLATRN  160 (288)
T ss_pred             CccEEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCCeecccccHhh
Confidence            99999999999999999997532                     246788899999999999999999999999999999


Q ss_pred             eeecCCCcEEEeeccceeeccCCCc---cccCCCCcccccccccCCCCCCChhhHHHHHHHHHHHHc-CCCCCCCCCHHH
Q 015868          245 LLMDENGVVKVADFGVARVQAQSGV---MTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLT-GELPYAGLTPLQ  320 (399)
Q Consensus       245 ILl~~~~~vkl~DFG~a~~~~~~~~---~~~~~gt~~y~aPE~l~~~~~~~~~Dv~slG~vl~ellt-g~~P~~~~~~~~  320 (399)
                      |++++++.++|+|||.++.......   ......+..|+|||.+.+..++.++||||||+++|+|++ |..||.+.+..+
T Consensus       161 il~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~~~~p~~~~~~~~  240 (288)
T cd05050         161 CLVGENMVVKIADFGLSRNIYSADYYKASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQPYYGMAHEE  240 (288)
T ss_pred             eEecCCCceEECccccceecccCccccccCCCccChhhcCHHHHhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCHHH
Confidence            9999999999999999875432211   122344678999999998899999999999999999998 888998887766


Q ss_pred             HHHHHHhccCCCCCCCCCcHHHHHHHHHHhhhcCCCCCCHHHHHHHHH
Q 015868          321 AAVGVVQKSLRPTIPKHAHPRLAELLERCWQHDPTQRPNFSQITDILK  368 (399)
Q Consensus       321 ~~~~~~~~~~~~~~~~~~~~~l~~ll~~cl~~dP~~Rps~~ell~~L~  368 (399)
                      .... ......+..+..++.++.+++.+||+.+|.+|||+.|+++.|+
T Consensus       241 ~~~~-~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~el~~~l~  287 (288)
T cd05050         241 VIYY-VRDGNVLSCPDNCPLELYNLMRLCWSKLPSDRPSFASINRILQ  287 (288)
T ss_pred             HHHH-HhcCCCCCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHhh
Confidence            5544 3334444556778899999999999999999999999999886

Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M

>cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases

Probab=100.00  E-value=7.8e-42  Score=325.46  Aligned_cols=255  Identities=29%  Similarity=0.573  Sum_probs=212.2

Q ss_pred             ecccccceeceeceeCceEEEEEEECC----------------eeEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCcee
Q 015868          113 IDAKQLKIECKVASGSYGDLYKGTYCS----------------QEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVV  176 (399)
Q Consensus       113 i~~~~~~i~~~lg~G~~g~Vy~~~~~~----------------~~vAvK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~nIv  176 (399)
                      +..++|++.++||+|+||.||+++..+                ..||+|.++... .......+.+|++++++++|+|++
T Consensus         2 ~~~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~ei~~l~~l~h~~i~   80 (295)
T cd05097           2 FPRQQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADV-TKTARNDFLKEIKIMSRLKNPNII   80 (295)
T ss_pred             CchHhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCC-CHHHHHHHHHHHHHHHhCCCCCcC
Confidence            456799999999999999999987532                358999998653 345566799999999999999999


Q ss_pred             eEEeEEecCCcEEEEEecCCCCCHHHHHHhcC-----------CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCce
Q 015868          177 QFIGACTRPPNLCIVTEFMARGSIYDFLHKQK-----------GVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANL  245 (399)
Q Consensus       177 ~~~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~-----------~~l~~~~~~~i~~~i~~~L~~LH~~giiHrDlkp~NI  245 (399)
                      ++++++......++||||+.+++|.+++....           ..+++..++.++.|++.||.|||++|++||||||+||
T Consensus        81 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~Ni  160 (295)
T cd05097          81 RLLGVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASLNFVHRDLATRNC  160 (295)
T ss_pred             eEEEEEcCCCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHhcCeeccccChhhE
Confidence            99999999999999999999999999986532           2367888999999999999999999999999999999


Q ss_pred             eecCCCcEEEeeccceeeccCCCc---cccCCCCcccccccccCCCCCCChhhHHHHHHHHHHHHc--CCCCCCCCCHHH
Q 015868          246 LMDENGVVKVADFGVARVQAQSGV---MTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLT--GELPYAGLTPLQ  320 (399)
Q Consensus       246 Ll~~~~~vkl~DFG~a~~~~~~~~---~~~~~gt~~y~aPE~l~~~~~~~~~Dv~slG~vl~ellt--g~~P~~~~~~~~  320 (399)
                      ++++++.+||+|||+++.......   .....++..|+|||.+.+..++.++|+||||+++|+|++  +..||...+..+
T Consensus       161 ll~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~~l~el~~~~~~~p~~~~~~~~  240 (295)
T cd05097         161 LVGNHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFTLCKEQPYSLLSDEQ  240 (295)
T ss_pred             EEcCCCcEEecccccccccccCcceeccCcCcCceeecChhhhccCCcCchhhHHHHHHHHHHHHHcCCCCCCcccChHH
Confidence            999999999999999875433221   122345778999999998889999999999999999988  678998877665


Q ss_pred             HHHHHHh------ccCCCCCCCCCcHHHHHHHHHHhhhcCCCCCCHHHHHHHHH
Q 015868          321 AAVGVVQ------KSLRPTIPKHAHPRLAELLERCWQHDPTQRPNFSQITDILK  368 (399)
Q Consensus       321 ~~~~~~~------~~~~~~~~~~~~~~l~~ll~~cl~~dP~~Rps~~ell~~L~  368 (399)
                      ......+      .......+...++.+.+++.+||+.+|++||++.++++.|+
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~~l~  294 (295)
T cd05097         241 VIENTGEFFRNQGRQIYLSQTPLCPSPVFKLMMRCWSRDIKDRPTFNKIHHFLR  294 (295)
T ss_pred             HHHHHHHhhhhccccccCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHh
Confidence            4443322      11223345567899999999999999999999999998876

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including

>cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7

Probab=100.00  E-value=1.6e-41  Score=317.38  Aligned_cols=255  Identities=27%  Similarity=0.512  Sum_probs=216.3

Q ss_pred             cccceeceeceeCceEEEEEEE--CCeeEEEEEecCCC-CCHHHHHHHHHHHHHHHhcCCCceeeEEeEEecCCcEEEEE
Q 015868          116 KQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPEC-VNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVT  192 (399)
Q Consensus       116 ~~~~i~~~lg~G~~g~Vy~~~~--~~~~vAvK~~~~~~-~~~~~~~~~~~Ei~~l~~l~h~nIv~~~~~~~~~~~~~lV~  192 (399)
                      ++|++.+.||.|+||.||+|..  +++.||+|.++... ........+.+|+.++++++|+|++++++.+...+..++||
T Consensus         2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~~~~~~~lv~   81 (267)
T cd08224           2 GNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLASFIENNELNIVL   81 (267)
T ss_pred             CceeeeeeeccCCceEEEEEEEcCCCCEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEEE
Confidence            5799999999999999999988  58899999987532 23444678999999999999999999999999999999999


Q ss_pred             ecCCCCCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceeecCCCcEEEeeccceeeccCCC-
Q 015868          193 EFMARGSIYDFLHK---QKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSG-  268 (399)
Q Consensus       193 E~~~ggsL~~~l~~---~~~~l~~~~~~~i~~~i~~~L~~LH~~giiHrDlkp~NILl~~~~~vkl~DFG~a~~~~~~~-  268 (399)
                      ||+++++|.+++..   ....++...++.++.+++.||.|||+.|++||||+|+||+++.++.++|+|||.+....... 
T Consensus        82 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~nil~~~~~~~~l~d~~~~~~~~~~~~  161 (267)
T cd08224          82 ELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHSKRIMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTT  161 (267)
T ss_pred             ecCCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHHhCCEecCCcChhhEEECCCCcEEEeccceeeeccCCCc
Confidence            99999999999864   24568999999999999999999999999999999999999999999999999987654322 


Q ss_pred             ccccCCCCcccccccccCCCCCCChhhHHHHHHHHHHHHcCCCCCCCCCH-HHHHHHHHhccCCCCCCC-CCcHHHHHHH
Q 015868          269 VMTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPYAGLTP-LQAAVGVVQKSLRPTIPK-HAHPRLAELL  346 (399)
Q Consensus       269 ~~~~~~gt~~y~aPE~l~~~~~~~~~Dv~slG~vl~elltg~~P~~~~~~-~~~~~~~~~~~~~~~~~~-~~~~~l~~ll  346 (399)
                      ......++..|+|||.+.+..++.++|+||||+++|+|++|+.||..... .............+..|. ..+..+.+++
T Consensus       162 ~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i  241 (267)
T cd08224         162 AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEKCDYPPLPADHYSEELRDLV  241 (267)
T ss_pred             ccceecCCccccCHHHhccCCCCchhcHHHHHHHHHHHHHCCCCcccCCccHHHHHhhhhcCCCCCCChhhcCHHHHHHH
Confidence            22334688899999999998999999999999999999999999965432 122222233334444554 7888999999


Q ss_pred             HHHhhhcCCCCCCHHHHHHHHHHH
Q 015868          347 ERCWQHDPTQRPNFSQITDILKQM  370 (399)
Q Consensus       347 ~~cl~~dP~~Rps~~ell~~L~~l  370 (399)
                      .+||..+|++|||+.+|++.|+++
T Consensus       242 ~~cl~~~p~~Rp~~~~il~~~~~~  265 (267)
T cd08224         242 SRCINPDPEKRPDISYVLQVAKEM  265 (267)
T ss_pred             HHHcCCCcccCCCHHHHHHHHHHh
Confidence            999999999999999999999876

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a

>cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1

Probab=100.00  E-value=3.3e-42  Score=339.09  Aligned_cols=253  Identities=22%  Similarity=0.334  Sum_probs=212.0

Q ss_pred             eeecccccceeceeceeCceEEEEEEE--CCeeEEEEEecCCC-CCHHHHHHHHHHHHHHHhcCCCceeeEEeEEecCCc
Q 015868          111 WEIDAKQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPEC-VNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPN  187 (399)
Q Consensus       111 ~~i~~~~~~i~~~lg~G~~g~Vy~~~~--~~~~vAvK~~~~~~-~~~~~~~~~~~Ei~~l~~l~h~nIv~~~~~~~~~~~  187 (399)
                      ..+..++|++.+.||+|+||.||+++.  +++.||+|++.... ........+.+|+.+++.++||||+++++.+..+..
T Consensus        38 ~~~~~~~y~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~  117 (371)
T cd05622          38 LRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRY  117 (371)
T ss_pred             cCcchhhcEEEEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCE
Confidence            355668999999999999999999987  57889999986422 223344568899999999999999999999999999


Q ss_pred             EEEEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceeecCCCcEEEeeccceeeccCC
Q 015868          188 LCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQS  267 (399)
Q Consensus       188 ~~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~giiHrDlkp~NILl~~~~~vkl~DFG~a~~~~~~  267 (399)
                      +|+||||++||+|.+++..  ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.....
T Consensus       118 ~~lv~Ey~~gg~L~~~~~~--~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NIll~~~~~ikL~DfG~a~~~~~~  195 (371)
T cd05622         118 LYMVMEYMPGGDLVNLMSN--YDVPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKE  195 (371)
T ss_pred             EEEEEcCCCCCcHHHHHHh--cCCCHHHHHHHHHHHHHHHHHHHHCCEEeCCCCHHHEEECCCCCEEEEeCCceeEcCcC
Confidence            9999999999999999965  35889999999999999999999999999999999999999999999999999866543


Q ss_pred             Cc--cccCCCCcccccccccCCCC----CCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhccCCCCCC--CCCc
Q 015868          268 GV--MTAETGTYRWMAPEVIEHKP----YDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKSLRPTIP--KHAH  339 (399)
Q Consensus       268 ~~--~~~~~gt~~y~aPE~l~~~~----~~~~~Dv~slG~vl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~--~~~~  339 (399)
                      ..  .....||+.|+|||++.+..    ++.++|||||||++|+|++|..||...+.......+........+|  ..++
T Consensus       196 ~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s  275 (371)
T cd05622         196 GMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKNSLTFPDDNDIS  275 (371)
T ss_pred             CcccccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCcccCCCcCCCC
Confidence            22  23456899999999997643    7889999999999999999999999888776666555433222333  4689


Q ss_pred             HHHHHHHHHHhhhcCCC---CCCHHHHHHH
Q 015868          340 PRLAELLERCWQHDPTQ---RPNFSQITDI  366 (399)
Q Consensus       340 ~~l~~ll~~cl~~dP~~---Rps~~ell~~  366 (399)
                      ..+.+++.+||. +|..   |++++++++.
T Consensus       276 ~~~~~li~~~L~-~~~~r~~r~~~~ei~~h  304 (371)
T cd05622         276 KEAKNLICAFLT-DREVRLGRNGVEEIKRH  304 (371)
T ss_pred             HHHHHHHHHHcC-ChhhhcCCCCHHHHhcC
Confidence            999999999998 4444   6788888773

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an

>cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

Probab=100.00  E-value=1.6e-41  Score=321.18  Aligned_cols=254  Identities=29%  Similarity=0.574  Sum_probs=209.8

Q ss_pred             ccccceeceeceeCceEEEEEEE------CCeeEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCceeeEEeEEec--CC
Q 015868          115 AKQLKIECKVASGSYGDLYKGTY------CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTR--PP  186 (399)
Q Consensus       115 ~~~~~i~~~lg~G~~g~Vy~~~~------~~~~vAvK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~nIv~~~~~~~~--~~  186 (399)
                      ..+|++.+.||+|+||.||++.+      .+..||+|.++..  .....+.+.+|+.+++.++||||+++++++..  ..
T Consensus         3 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~   80 (284)
T cd05081           3 ERHLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHS--TAEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRR   80 (284)
T ss_pred             cccceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccC--CHHHHHHHHHHHHHHHhCCCCCeeEEEEEEccCCCC
Confidence            45789999999999999999875      4678999998754  45556789999999999999999999998754  34


Q ss_pred             cEEEEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceeecCCCcEEEeeccceeeccC
Q 015868          187 NLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQ  266 (399)
Q Consensus       187 ~~~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~giiHrDlkp~NILl~~~~~vkl~DFG~a~~~~~  266 (399)
                      .+++||||+++++|.+++......+++..++.++.|++.||+|||++||+||||||+||++++++.+||+|||+++....
T Consensus        81 ~~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~l~~aL~~LH~~~i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~  160 (284)
T cd05081          81 NLRLVMEYLPYGSLRDYLQKHRERLDHRKLLLYASQICKGMEYLGSKRYVHRDLATRNILVESENRVKIGDFGLTKVLPQ  160 (284)
T ss_pred             ceEEEEEecCCCCHHHHHHhcCcCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCHhhEEECCCCeEEECCCcccccccC
Confidence            68999999999999999977666789999999999999999999999999999999999999999999999999986544


Q ss_pred             CCcc----ccCCCCcccccccccCCCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHH---------------HHHHHHh
Q 015868          267 SGVM----TAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPYAGLTPLQ---------------AAVGVVQ  327 (399)
Q Consensus       267 ~~~~----~~~~gt~~y~aPE~l~~~~~~~~~Dv~slG~vl~elltg~~P~~~~~~~~---------------~~~~~~~  327 (399)
                      ....    ....++..|+|||.+.+..++.++|+||||+++|||++|..|+.......               .....+.
T Consensus       161 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (284)
T cd05081         161 DKEYYKVREPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYSDKSCSPPAEFMRMMGNDKQGQMIVYHLIELLK  240 (284)
T ss_pred             CCcceeecCCCCCceEeeCHHHhccCCcChHHHHHHHHHHHHHHhhcCCcCCCcchhhhhhcccccccccchHHHHHHHh
Confidence            3211    11223456999999998899999999999999999999876654322110               0112233


Q ss_pred             ccCCCCCCCCCcHHHHHHHHHHhhhcCCCCCCHHHHHHHHHHH
Q 015868          328 KSLRPTIPKHAHPRLAELLERCWQHDPTQRPNFSQITDILKQM  370 (399)
Q Consensus       328 ~~~~~~~~~~~~~~l~~ll~~cl~~dP~~Rps~~ell~~L~~l  370 (399)
                      ...++..+..++.++.+++.+||..+|++|||+.++++.|+.+
T Consensus       241 ~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~~  283 (284)
T cd05081         241 NNGRLPAPPGCPAEIYAIMKECWNNDPSQRPSFSELALQVEAI  283 (284)
T ss_pred             cCCcCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHhc
Confidence            3344455667889999999999999999999999999998865

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th

>cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase

Probab=100.00  E-value=1.7e-42  Score=334.61  Aligned_cols=237  Identities=25%  Similarity=0.417  Sum_probs=201.1

Q ss_pred             ceeceeCceEEEEEEE--CCeeEEEEEecCCCC-CHHHHHHHHHHHH-HHHhcCCCceeeEEeEEecCCcEEEEEecCCC
Q 015868          122 CKVASGSYGDLYKGTY--CSQEVAIKVLKPECV-NTEMLKEFSQEVY-IMRKIRHKNVVQFIGACTRPPNLCIVTEFMAR  197 (399)
Q Consensus       122 ~~lg~G~~g~Vy~~~~--~~~~vAvK~~~~~~~-~~~~~~~~~~Ei~-~l~~l~h~nIv~~~~~~~~~~~~~lV~E~~~g  197 (399)
                      +.||+|+||.||+|..  +++.||+|++..... .......+.+|.. +++.++||||+++++.+......++||||+++
T Consensus         1 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~   80 (323)
T cd05575           1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTADKLYFVLDYVNG   80 (323)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEEEeCCEEEEEEcCCCC
Confidence            4689999999999988  578999999975321 2222344555544 56789999999999999999999999999999


Q ss_pred             CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceeecCCCcEEEeeccceeeccC-CCccccCCCC
Q 015868          198 GSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQ-SGVMTAETGT  276 (399)
Q Consensus       198 gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~giiHrDlkp~NILl~~~~~vkl~DFG~a~~~~~-~~~~~~~~gt  276 (399)
                      |+|.+++.. ...+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.... ........||
T Consensus        81 g~L~~~l~~-~~~~~~~~~~~~~~qi~~~l~~lH~~givH~dikp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt  159 (323)
T cd05575          81 GELFFHLQR-ERSFPEPRARFYAAEIASALGYLHSLNIIYRDLKPENILLDSQGHVVLTDFGLCKEGIEHSKTTSTFCGT  159 (323)
T ss_pred             CCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHeEECCCCcEEEeccCCCcccccCCCccccccCC
Confidence            999999876 46789999999999999999999999999999999999999999999999999875322 2233445689


Q ss_pred             cccccccccCCCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhccCCCCCCCCCcHHHHHHHHHHhhhcCCC
Q 015868          277 YRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRLAELLERCWQHDPTQ  356 (399)
Q Consensus       277 ~~y~aPE~l~~~~~~~~~Dv~slG~vl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~cl~~dP~~  356 (399)
                      +.|+|||++.+..++.++||||||+++|+|++|..||...+..+........  ...++..+++++.++|.+||+.||.+
T Consensus       160 ~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~i~~~--~~~~~~~~~~~~~~li~~~l~~~p~~  237 (323)
T cd05575         160 PEYLAPEVLRKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRDTAEMYDNILNK--PLRLKPNISVSARHLLEGLLQKDRTK  237 (323)
T ss_pred             hhhcChhhhcCCCCCccccccccchhhhhhhcCCCCCCCCCHHHHHHHHHcC--CCCCCCCCCHHHHHHHHHHhhcCHHh
Confidence            9999999999999999999999999999999999999988877766555543  23456678999999999999999999


Q ss_pred             CCCHH
Q 015868          357 RPNFS  361 (399)
Q Consensus       357 Rps~~  361 (399)
                      ||++.
T Consensus       238 R~~~~  242 (323)
T cd05575         238 RLGAK  242 (323)
T ss_pred             CCCCC
Confidence            99885

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr

>cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3

Probab=100.00  E-value=1.4e-41  Score=329.73  Aligned_cols=262  Identities=31%  Similarity=0.628  Sum_probs=223.6

Q ss_pred             CceeecccccceeceeceeCceEEEEEEEC---------CeeEEEEEecCCCCCHHHHHHHHHHHHHHHhc-CCCceeeE
Q 015868          109 DVWEIDAKQLKIECKVASGSYGDLYKGTYC---------SQEVAIKVLKPECVNTEMLKEFSQEVYIMRKI-RHKNVVQF  178 (399)
Q Consensus       109 ~~~~i~~~~~~i~~~lg~G~~g~Vy~~~~~---------~~~vAvK~~~~~~~~~~~~~~~~~Ei~~l~~l-~h~nIv~~  178 (399)
                      ..|++...+|++.+.||+|+||.||++++.         ...||+|+++... .....+.+.+|+.+++++ +||||+++
T Consensus         5 ~~~~~~~~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~~h~~iv~~   83 (334)
T cd05100           5 PKWELSRTRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDA-TDKDLSDLVSEMEMMKMIGKHKNIINL   83 (334)
T ss_pred             cccccCHhHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEccccc-CHHHHHHHHHHHHHHHhhcCCCCeeee
Confidence            348888899999999999999999999752         2368999887542 344567899999999999 79999999


Q ss_pred             EeEEecCCcEEEEEecCCCCCHHHHHHhcC---------------CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCC
Q 015868          179 IGACTRPPNLCIVTEFMARGSIYDFLHKQK---------------GVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTA  243 (399)
Q Consensus       179 ~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~---------------~~l~~~~~~~i~~~i~~~L~~LH~~giiHrDlkp~  243 (399)
                      ++++......++++||+++|+|.+++....               ..++...+..++.|++.||+|||++|++||||||+
T Consensus        84 ~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~givH~dlkp~  163 (334)
T cd05100          84 LGACTQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQKCIHRDLAAR  163 (334)
T ss_pred             eEEEccCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCCeeccccccc
Confidence            999999999999999999999999997532               24677888999999999999999999999999999


Q ss_pred             ceeecCCCcEEEeeccceeeccCCCc---cccCCCCcccccccccCCCCCCChhhHHHHHHHHHHHHc-CCCCCCCCCHH
Q 015868          244 NLLMDENGVVKVADFGVARVQAQSGV---MTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLT-GELPYAGLTPL  319 (399)
Q Consensus       244 NILl~~~~~vkl~DFG~a~~~~~~~~---~~~~~gt~~y~aPE~l~~~~~~~~~Dv~slG~vl~ellt-g~~P~~~~~~~  319 (399)
                      ||+++.++.+||+|||.++.......   .....++..|+|||++.+..++.++||||||+++|+|++ |..||.+.+..
T Consensus       164 Nill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~  243 (334)
T cd05100         164 NVLVTEDNVMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVE  243 (334)
T ss_pred             eEEEcCCCcEEECCcccceecccccccccccCCCcCceEcCHHHhccCCcCchhhhHHHHHHHHHHHhcCCCCCCCCCHH
Confidence            99999999999999999976543221   222334568999999999999999999999999999998 88999888766


Q ss_pred             HHHHHHHhccCCCCCCCCCcHHHHHHHHHHhhhcCCCCCCHHHHHHHHHHHHH
Q 015868          320 QAAVGVVQKSLRPTIPKHAHPRLAELLERCWQHDPTQRPNFSQITDILKQMMK  372 (399)
Q Consensus       320 ~~~~~~~~~~~~~~~~~~~~~~l~~ll~~cl~~dP~~Rps~~ell~~L~~l~~  372 (399)
                      +.... +.....+..+..++.++.+++.+||+.+|++||++.++++.|.++..
T Consensus       244 ~~~~~-~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~ell~~l~~~~~  295 (334)
T cd05100         244 ELFKL-LKEGHRMDKPANCTHELYMIMRECWHAVPSQRPTFKQLVEDLDRVLT  295 (334)
T ss_pred             HHHHH-HHcCCCCCCCCCCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHhh
Confidence            65444 44455666777889999999999999999999999999999998874

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors

Probab=100.00  E-value=1.3e-41  Score=323.33  Aligned_cols=254  Identities=33%  Similarity=0.593  Sum_probs=213.5

Q ss_pred             cccccceeceeceeCceEEEEEEECC------------------eeEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCce
Q 015868          114 DAKQLKIECKVASGSYGDLYKGTYCS------------------QEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNV  175 (399)
Q Consensus       114 ~~~~~~i~~~lg~G~~g~Vy~~~~~~------------------~~vAvK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~nI  175 (399)
                      ..++|++.++||+|+||.||+++...                  ..||+|.+.... .......+.+|+.++++++||||
T Consensus         3 ~~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~-~~~~~~~~~~e~~~l~~l~~~~i   81 (296)
T cd05051           3 PRQPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDA-SDNAREDFLKEVKILSRLSDPNI   81 (296)
T ss_pred             chhhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCcc-CHHHHHHHHHHHHHHHhcCCCCE
Confidence            45689999999999999999987532                  468999988653 34556789999999999999999


Q ss_pred             eeEEeEEecCCcEEEEEecCCCCCHHHHHHhcC----------CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCce
Q 015868          176 VQFIGACTRPPNLCIVTEFMARGSIYDFLHKQK----------GVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANL  245 (399)
Q Consensus       176 v~~~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~----------~~l~~~~~~~i~~~i~~~L~~LH~~giiHrDlkp~NI  245 (399)
                      +++++++...+..++|||++.+++|.+++....          ..+++..++.++.|++.||+|||++|++||||||+||
T Consensus        82 ~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~i~H~dlkp~Ni  161 (296)
T cd05051          82 ARLLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESLNFVHRDLATRNC  161 (296)
T ss_pred             eEEEEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHHcCccccccchhce
Confidence            999999999999999999999999999997643          2689999999999999999999999999999999999


Q ss_pred             eecCCCcEEEeeccceeeccCCC---ccccCCCCcccccccccCCCCCCChhhHHHHHHHHHHHHc--CCCCCCCCCHHH
Q 015868          246 LMDENGVVKVADFGVARVQAQSG---VMTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLT--GELPYAGLTPLQ  320 (399)
Q Consensus       246 Ll~~~~~vkl~DFG~a~~~~~~~---~~~~~~gt~~y~aPE~l~~~~~~~~~Dv~slG~vl~ellt--g~~P~~~~~~~~  320 (399)
                      ++++++.++|+|||.++......   ......++..|+|||.+.+..++.++||||||+++|+|++  +..||...+..+
T Consensus       162 li~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p~~~~~~~~  241 (296)
T cd05051         162 LVGKNYTIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILTLCREQPYEHLTDQQ  241 (296)
T ss_pred             eecCCCceEEccccceeecccCcceeecCcCCCCceecCHHHhhcCCCCccchhhhhHHHHHHHHhcCCCCCCCCcChHH
Confidence            99999999999999987543322   1223345778999999988889999999999999999998  778998877666


Q ss_pred             HHHHHHhc------cCCCCCCCCCcHHHHHHHHHHhhhcCCCCCCHHHHHHHHH
Q 015868          321 AAVGVVQK------SLRPTIPKHAHPRLAELLERCWQHDPTQRPNFSQITDILK  368 (399)
Q Consensus       321 ~~~~~~~~------~~~~~~~~~~~~~l~~ll~~cl~~dP~~Rps~~ell~~L~  368 (399)
                      ........      ......+..++.++.+++.+||+.||.+|||+.++++.|+
T Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~el~~~L~  295 (296)
T cd05051         242 VIENAGHFFRDDGRQIYLPRPPNCPKDIYELMLECWRRDEEDRPTFREIHLFLQ  295 (296)
T ss_pred             HHHHHHhccccccccccCCCccCCCHHHHHHHHHHhccChhcCCCHHHHHHHhc
Confidence            54443321      1112234567889999999999999999999999998875

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke

>cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5

Probab=100.00  E-value=4.6e-42  Score=321.71  Aligned_cols=249  Identities=28%  Similarity=0.492  Sum_probs=208.1

Q ss_pred             ccccceeceeceeCceEEEEEEE--CCeeEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCceeeEEeEEecCCcEEEEE
Q 015868          115 AKQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVT  192 (399)
Q Consensus       115 ~~~~~i~~~lg~G~~g~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~nIv~~~~~~~~~~~~~lV~  192 (399)
                      .++|++.++||+|+||.||+|+.  +++.||+|+++...  ......+.+|+.++++++||||+++++++..+...++||
T Consensus         8 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~--~~~~~~~~~e~~~l~~~~h~~ii~~~~~~~~~~~~~iv~   85 (267)
T cd06646           8 QHDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEP--GDDFSLIQQEIFMVKECKHCNIVAYFGSYLSREKLWICM   85 (267)
T ss_pred             hhhcchhheeecCCCeEEEEEEECCCCeEEEEEEEecCc--cchHHHHHHHHHHHHhcCCCCeeeeeEEEEeCCEEEEEE
Confidence            46899999999999999999986  57889999997542  223456889999999999999999999999999999999


Q ss_pred             ecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceeecCCCcEEEeeccceeeccCCC-ccc
Q 015868          193 EFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSG-VMT  271 (399)
Q Consensus       193 E~~~ggsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~giiHrDlkp~NILl~~~~~vkl~DFG~a~~~~~~~-~~~  271 (399)
                      ||+++++|.+++.. .+.+++..+..++.|++.||.|||++||+||||+|+||+++.++.++|+|||.+....... ...
T Consensus        86 e~~~~~~L~~~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~~~~~  164 (267)
T cd06646          86 EYCGGGSLQDIYHV-TGPLSELQIAYVCRETLQGLAYLHSKGKMHRDIKGANILLTDNGDVKLADFGVAAKITATIAKRK  164 (267)
T ss_pred             eCCCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECCCCCEEECcCccceeecccccccC
Confidence            99999999999865 4578999999999999999999999999999999999999999999999999998654322 223


Q ss_pred             cCCCCcccccccccC---CCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhccCCCCC---CCCCcHHHHHH
Q 015868          272 AETGTYRWMAPEVIE---HKPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKSLRPTI---PKHAHPRLAEL  345 (399)
Q Consensus       272 ~~~gt~~y~aPE~l~---~~~~~~~~Dv~slG~vl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~l~~l  345 (399)
                      ...++..|+|||.+.   ...++.++|+||||+++|+|++|+.||....+.+...........+..   +..++..+.++
T Consensus       165 ~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  244 (267)
T cd06646         165 SFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMSKSNFQPPKLKDKTKWSSTFHNF  244 (267)
T ss_pred             ccccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCccccchhhhheeeecCCCCCCCCccccccCHHHHHH
Confidence            456889999999985   345788999999999999999999999776655443322222222221   23468899999


Q ss_pred             HHHHhhhcCCCCCCHHHHHHH
Q 015868          346 LERCWQHDPTQRPNFSQITDI  366 (399)
Q Consensus       346 l~~cl~~dP~~Rps~~ell~~  366 (399)
                      +.+||+.+|++|||++++++.
T Consensus       245 i~~~l~~~P~~Rp~~~~il~~  265 (267)
T cd06646         245 VKISLTKNPKKRPTAERLLTH  265 (267)
T ss_pred             HHHHhhCChhhCcCHHHHhcC
Confidence            999999999999999999864

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated

>cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase

Probab=100.00  E-value=7.6e-42  Score=318.08  Aligned_cols=250  Identities=33%  Similarity=0.705  Sum_probs=215.8

Q ss_pred             eeecccccceeceeceeCceEEEEEEECCeeEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCceeeEEeEEecCCcEEE
Q 015868          111 WEIDAKQLKIECKVASGSYGDLYKGTYCSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCI  190 (399)
Q Consensus       111 ~~i~~~~~~i~~~lg~G~~g~Vy~~~~~~~~vAvK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~nIv~~~~~~~~~~~~~l  190 (399)
                      |-+..++|++.+.||.|+||.||++...++.||+|.++...    ....+.+|+.++++++|||++++++++... ..++
T Consensus         1 ~~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~iK~~~~~~----~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~~~~   75 (254)
T cd05083           1 WLLNLQKLTLGEIIGEGEFGAVLQGEYTGQKVAVKNIKCDV----TAQAFLEETAVMTKLHHKNLVRLLGVILHN-GLYI   75 (254)
T ss_pred             CcccHHHceeeeeeccCCCCceEecccCCCceEEEeecCcc----hHHHHHHHHHHHHhCCCCCcCeEEEEEcCC-CcEE
Confidence            44567889999999999999999999999999999987532    235788999999999999999999998765 4799


Q ss_pred             EEecCCCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceeecCCCcEEEeeccceeeccCCCc
Q 015868          191 VTEFMARGSIYDFLHKQK-GVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGV  269 (399)
Q Consensus       191 V~E~~~ggsL~~~l~~~~-~~l~~~~~~~i~~~i~~~L~~LH~~giiHrDlkp~NILl~~~~~vkl~DFG~a~~~~~~~~  269 (399)
                      ||||+.+++|.+++.... ..++...++.++.|++.|+.|||++|++||||||+||+++.++.++|+|||.+......  
T Consensus        76 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~H~dl~p~nili~~~~~~kl~Dfg~~~~~~~~--  153 (254)
T cd05083          76 VMELMSKGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLESKKLVHRDLAARNILVSEDGVAKVSDFGLARVGSMG--  153 (254)
T ss_pred             EEECCCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccCcceEEEcCCCcEEECCCccceecccc--
Confidence            999999999999997643 35889999999999999999999999999999999999999999999999998754322  


Q ss_pred             cccCCCCcccccccccCCCCCCChhhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHHhccCCCCCCCCCcHHHHHHHHH
Q 015868          270 MTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLT-GELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRLAELLER  348 (399)
Q Consensus       270 ~~~~~gt~~y~aPE~l~~~~~~~~~Dv~slG~vl~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~  348 (399)
                      ......+..|+|||.+.+..++.++|+||||+++|+|++ |..||...+..+.... .....++..+..++..+.+++.+
T Consensus       154 ~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~li~~  232 (254)
T cd05083         154 VDNSKLPVKWTAPEALKHKKFSSKSDVWSYGVLLWEVFSYGRAPYPKMSLKEVKEC-VEKGYRMEPPEGCPADVYVLMTS  232 (254)
T ss_pred             CCCCCCCceecCHHHhccCCcCchhhHHHHHHHHHHHHhCCCCCCccCCHHHHHHH-HhCCCCCCCCCcCCHHHHHHHHH
Confidence            222344678999999998889999999999999999997 9999988877665443 34455566667789999999999


Q ss_pred             HhhhcCCCCCCHHHHHHHHH
Q 015868          349 CWQHDPTQRPNFSQITDILK  368 (399)
Q Consensus       349 cl~~dP~~Rps~~ell~~L~  368 (399)
                      ||+.+|++||++.++++.|+
T Consensus       233 ~l~~~p~~Rp~~~~l~~~l~  252 (254)
T cd05083         233 CWETEPKKRPSFHKLREKLE  252 (254)
T ss_pred             HcCCChhhCcCHHHHHHHHc
Confidence            99999999999999998875

Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki

>cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=1.8e-41  Score=316.19  Aligned_cols=245  Identities=30%  Similarity=0.592  Sum_probs=209.1

Q ss_pred             ceeceeCceEEEEEEECC-----eeEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCceeeEEeEEecCCcEEEEEecCC
Q 015868          122 CKVASGSYGDLYKGTYCS-----QEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVTEFMA  196 (399)
Q Consensus       122 ~~lg~G~~g~Vy~~~~~~-----~~vAvK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~nIv~~~~~~~~~~~~~lV~E~~~  196 (399)
                      ++||+|+||.||+|.+..     ..+|+|.++..... ...+.+.+|+.+++.++||||+++++++.. ...++||||+.
T Consensus         1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~-~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~v~e~~~   78 (257)
T cd05060           1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIA-AGKKEFLREASVMAQLDHPCIVRLIGVCKG-EPLMLVMELAP   78 (257)
T ss_pred             CccCccCceeEEEeEeeccCCCcceEEEEecccccch-HHHHHHHHHHHHHHhcCCCCeeeEEEEEcC-CceEEEEEeCC
Confidence            479999999999997632     57999999865433 455789999999999999999999998764 46899999999


Q ss_pred             CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceeecCCCcEEEeeccceeeccCCCcc----cc
Q 015868          197 RGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVM----TA  272 (399)
Q Consensus       197 ggsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~giiHrDlkp~NILl~~~~~vkl~DFG~a~~~~~~~~~----~~  272 (399)
                      +++|.+++... ..+++..+..++.|++.||+|||.+|++|+||||+||+++.++.+||+|||.++........    ..
T Consensus        79 ~~~L~~~l~~~-~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~p~nili~~~~~~kl~df~~~~~~~~~~~~~~~~~~  157 (257)
T cd05060          79 LGPLLKYLKKR-REIPVSDLKELAHQVAMGMAYLESKHFVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYRATTA  157 (257)
T ss_pred             CCcHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHhhcCeeccCcccceEEEcCCCcEEeccccccceeecCCcccccccC
Confidence            99999999764 37899999999999999999999999999999999999999999999999999865433221    11


Q ss_pred             CCCCcccccccccCCCCCCChhhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHHhccCCCCCCCCCcHHHHHHHHHHhh
Q 015868          273 ETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLT-GELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRLAELLERCWQ  351 (399)
Q Consensus       273 ~~gt~~y~aPE~l~~~~~~~~~Dv~slG~vl~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~cl~  351 (399)
                      ..++..|+|||.+.+..++.++||||||+++|++++ |..||...++.+.... +........+..++..+.+++.+||.
T Consensus       158 ~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~~g~~p~~~~~~~~~~~~-~~~~~~~~~~~~~~~~l~~li~~cl~  236 (257)
T cd05060         158 GRWPLKWYAPECINYGKFSSKSDVWSYGVTLWEAFSYGAKPYGEMKGAEVIAM-LESGERLPRPEECPQEIYSIMLSCWK  236 (257)
T ss_pred             ccccccccCHHHhcCCCCCccchHHHHHHHHHHHHcCCCCCcccCCHHHHHHH-HHcCCcCCCCCCCCHHHHHHHHHHhc
Confidence            223467999999999999999999999999999998 9999998887665443 34445556777889999999999999


Q ss_pred             hcCCCCCCHHHHHHHHHHH
Q 015868          352 HDPTQRPNFSQITDILKQM  370 (399)
Q Consensus       352 ~dP~~Rps~~ell~~L~~l  370 (399)
                      .+|.+||++.++.+.|+.+
T Consensus       237 ~~p~~Rp~~~~l~~~l~~~  255 (257)
T cd05060         237 YRPEDRPTFSELESTFRRD  255 (257)
T ss_pred             CChhhCcCHHHHHHHHHhc
Confidence            9999999999999999875

Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi

>KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only]

Probab=100.00  E-value=2.2e-42  Score=321.32  Aligned_cols=251  Identities=25%  Similarity=0.415  Sum_probs=213.9

Q ss_pred             ccccceeceeceeCceEEEEEEE--CCeeEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCc-eeeEEeEEecCC-----
Q 015868          115 AKQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKN-VVQFIGACTRPP-----  186 (399)
Q Consensus       115 ~~~~~i~~~lg~G~~g~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~n-Iv~~~~~~~~~~-----  186 (399)
                      ...|...++||+|+||+||+|+.  +++.||+|.++.+...+.......+|+.+|+.++|+| |+++++++....     
T Consensus        10 ~~~~~~~eklGeGtyg~Vykar~~~~g~~VALKkirl~~~~EG~P~taiREisllk~L~~~~~iv~L~dv~~~~~~~~~~   89 (323)
T KOG0594|consen   10 MFDYEKVEKLGEGTYGVVYKARSKRTGKFVALKKIRLEFEEEGVPSTAIREISLLKRLSHANHIVRLHDVIHTSNNHRGI   89 (323)
T ss_pred             HHHHHHHHHhCCCCceEEEEEEEecCCCEEEEEEEeccccccCCCchhhHHHHHHHHhCCCcceEEEEeeeeeccccccc
Confidence            45788889999999999999976  6889999999876444444566789999999999999 999999998776     


Q ss_pred             -cEEEEEecCCCCCHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceeecCCCcEEEeecccee
Q 015868          187 -NLCIVTEFMARGSIYDFLHKQK---GVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVAR  262 (399)
Q Consensus       187 -~~~lV~E~~~ggsL~~~l~~~~---~~l~~~~~~~i~~~i~~~L~~LH~~giiHrDlkp~NILl~~~~~vkl~DFG~a~  262 (399)
                       .+++|+||+.. +|..++....   ..++...++.++.||+.||+|||++||+||||||.|||++++|.+||+|||+|+
T Consensus        90 ~~l~lvfe~~d~-DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H~~~IlHRDLKPQNlLi~~~G~lKlaDFGlAr  168 (323)
T KOG0594|consen   90 GKLYLVFEFLDR-DLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLHSHGILHRDLKPQNLLISSSGVLKLADFGLAR  168 (323)
T ss_pred             ceEEEEEEeecc-cHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCcceEEECCCCcEeeeccchHH
Confidence             79999999976 9999998765   468889999999999999999999999999999999999999999999999999


Q ss_pred             eccCC-CccccCCCCcccccccccCCC-CCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhccCCC--------
Q 015868          263 VQAQS-GVMTAETGTYRWMAPEVIEHK-PYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKSLRP--------  332 (399)
Q Consensus       263 ~~~~~-~~~~~~~gt~~y~aPE~l~~~-~~~~~~Dv~slG~vl~elltg~~P~~~~~~~~~~~~~~~~~~~~--------  332 (399)
                      ....+ ...+.+.+|..|.|||++.+. .|+...||||+||++.||++++..|.+....+....+....-.|        
T Consensus       169 a~~ip~~~yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfaEm~~~~~LFpG~se~~ql~~If~~lGtP~e~~Wp~v  248 (323)
T KOG0594|consen  169 AFSIPMRTYTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFAEMFTRRPLFPGDSEIDQLFRIFRLLGTPNEKDWPGV  248 (323)
T ss_pred             HhcCCcccccccEEEeeccCHHHhcCCCcCCCCcchHhHHHHHHHHHhCCCCCCCCcHHHHHHHHHHHcCCCCccCCCCc
Confidence            76633 347788899999999999887 79999999999999999999999999988866665544311111        


Q ss_pred             --------CC-----C-------CCCcHHHHHHHHHHhhhcCCCCCCHHHHHHH
Q 015868          333 --------TI-----P-------KHAHPRLAELLERCWQHDPTQRPNFSQITDI  366 (399)
Q Consensus       333 --------~~-----~-------~~~~~~l~~ll~~cl~~dP~~Rps~~ell~~  366 (399)
                              ..     +       +..+++..+++.+||+.+|.+|.|+...++.
T Consensus       249 ~~~~~~k~~f~~~~~~~~l~~~~~~~~~~~~dll~~~L~y~p~~R~Sa~~al~h  302 (323)
T KOG0594|consen  249 SSLPDYKAPFPKWPGPKDLSSILPKLDPDGIELLSKLLQYDPAKRISAKGALTH  302 (323)
T ss_pred             cccccccccCcCCCCccchHHhccccCccHHHHHHHHhccCcccCcCHHHHhcC
Confidence                    01     1       2233589999999999999999999998875

>cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4

Probab=100.00  E-value=7e-42  Score=323.99  Aligned_cols=248  Identities=23%  Similarity=0.401  Sum_probs=201.6

Q ss_pred             ccceeceeceeCceEEEEEEE--CCeeEEEEEecCCCCCHHHHHHHHHHHHHHHhc---CCCceeeEEeEEec-----CC
Q 015868          117 QLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKI---RHKNVVQFIGACTR-----PP  186 (399)
Q Consensus       117 ~~~i~~~lg~G~~g~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~Ei~~l~~l---~h~nIv~~~~~~~~-----~~  186 (399)
                      +|++.+.||+|+||.||+|+.  +++.||+|+++...........+.+|+.+++.+   +||||+++++++..     ..
T Consensus         1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~~~   80 (288)
T cd07863           1 QYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDRET   80 (288)
T ss_pred             CceEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCcCCCCCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCCCc
Confidence            588999999999999999987  578899999875433332233455677777665   79999999998864     24


Q ss_pred             cEEEEEecCCCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceeecCCCcEEEeeccceeecc
Q 015868          187 NLCIVTEFMARGSIYDFLHKQK-GVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQA  265 (399)
Q Consensus       187 ~~~lV~E~~~ggsL~~~l~~~~-~~l~~~~~~~i~~~i~~~L~~LH~~giiHrDlkp~NILl~~~~~vkl~DFG~a~~~~  265 (399)
                      ..++||||+.+ +|.+++.... ..+++..+..++.|++.||.|||++||+||||||+||+++.++.+||+|||+++...
T Consensus        81 ~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dikp~Nili~~~~~~kl~dfg~~~~~~  159 (288)
T cd07863          81 KVTLVFEHVDQ-DLRTYLDKVPPPGLPAETIKDLMRQFLRGLDFLHANCIVHRDLKPENILVTSGGQVKLADFGLARIYS  159 (288)
T ss_pred             eEEEEEccccc-CHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEECccCcccccc
Confidence            58999999985 8999887643 458999999999999999999999999999999999999999999999999998665


Q ss_pred             CCCccccCCCCcccccccccCCCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhccC---------------
Q 015868          266 QSGVMTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKSL---------------  330 (399)
Q Consensus       266 ~~~~~~~~~gt~~y~aPE~l~~~~~~~~~Dv~slG~vl~elltg~~P~~~~~~~~~~~~~~~~~~---------------  330 (399)
                      .........++..|+|||++.+..++.++|||||||++|+|++|.+||.................               
T Consensus       160 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (288)
T cd07863         160 CQMALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDWPRDVTLPR  239 (288)
T ss_pred             CcccCCCccccccccCchHhhCCCCCCcchhhhHHHHHHHHHhCCcCcCCCCHHHHHHHHHHHhCCCChhhCcccccccc
Confidence            44444455689999999999988999999999999999999999999987766554433322100               


Q ss_pred             ---CC-------CCCCCCcHHHHHHHHHHhhhcCCCCCCHHHHHH
Q 015868          331 ---RP-------TIPKHAHPRLAELLERCWQHDPTQRPNFSQITD  365 (399)
Q Consensus       331 ---~~-------~~~~~~~~~l~~ll~~cl~~dP~~Rps~~ell~  365 (399)
                         .+       ...+.++.++.+++.+||+.||++|||+.|++.
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~l~  284 (288)
T cd07863         240 GAFSPRGPRPVQSVVPEIEESGAQLLLEMLTFNPHKRISAFRALQ  284 (288)
T ss_pred             cccCCCCCCchHHhCcCcCHHHHHHHHHHhccCcccCCCHHHHhc
Confidence               00       011356788999999999999999999999874

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou

>KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=8.2e-43  Score=334.20  Aligned_cols=249  Identities=23%  Similarity=0.440  Sum_probs=228.5

Q ss_pred             ccccceeceeceeCceEEEEEEE--CCeeEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCceeeEEeEEecCCcEEEEE
Q 015868          115 AKQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVT  192 (399)
Q Consensus       115 ~~~~~i~~~lg~G~~g~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~nIv~~~~~~~~~~~~~lV~  192 (399)
                      ..-|.+.+.||+|-|.+|-+|++  +|..||||++.+...+.-....+++|+..|+.++|||||++|++......+|+|+
T Consensus        17 AGLYDLekTlG~GHFAVVKLArHVFTGekVAVKviDKTKlD~~st~hlfqEVRCMKLVQHpNiVRLYEViDTQTKlyLiL   96 (864)
T KOG4717|consen   17 AGLYDLEKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDTLSTGHLFQEVRCMKLVQHPNIVRLYEVIDTQTKLYLIL   96 (864)
T ss_pred             eeeehhhhhhcCCceehhhhhhhhcccceeEEEEecccccchhhhhHHHHHHHHHHHhcCcCeeeeeehhcccceEEEEE
Confidence            45788999999999999999986  8999999999988888888889999999999999999999999999999999999


Q ss_pred             ecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceee-cCCCcEEEeeccceeeccCCCccc
Q 015868          193 EFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLM-DENGVVKVADFGVARVQAQSGVMT  271 (399)
Q Consensus       193 E~~~ggsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~giiHrDlkp~NILl-~~~~~vkl~DFG~a~~~~~~~~~~  271 (399)
                      |.-.+|+|+|||-++...+.++...+++.||+.|+.|+|+..++||||||+||.+ ..-|.|||.|||++..+......+
T Consensus        97 ELGD~GDl~DyImKHe~Gl~E~La~kYF~QI~~AI~YCHqLHVVHRDLKPENVVFFEKlGlVKLTDFGFSNkf~PG~kL~  176 (864)
T KOG4717|consen   97 ELGDGGDLFDYIMKHEEGLNEDLAKKYFAQIVHAISYCHQLHVVHRDLKPENVVFFEKLGLVKLTDFGFSNKFQPGKKLT  176 (864)
T ss_pred             EecCCchHHHHHHhhhccccHHHHHHHHHHHHHHHHHHhhhhhhcccCCcceeEEeeecCceEeeeccccccCCCcchhh
Confidence            9999999999999999999999999999999999999999999999999999865 567999999999998877777888


Q ss_pred             cCCCCcccccccccCCCCCC-ChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhccCCCCCCCCCcHHHHHHHHHHh
Q 015868          272 AETGTYRWMAPEVIEHKPYD-YKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRLAELLERCW  350 (399)
Q Consensus       272 ~~~gt~~y~aPE~l~~~~~~-~~~Dv~slG~vl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~cl  350 (399)
                      ..+|+..|.|||++.+..|+ ++.||||||++||.|.||++||...+..+.+-.+..  ..-.+|..++.+.++||..||
T Consensus       177 TsCGSLAYSAPEILLGDsYDAPAVDiWSLGVILyMLVCGq~PFqeANDSETLTmImD--CKYtvPshvS~eCrdLI~sML  254 (864)
T KOG4717|consen  177 TSCGSLAYSAPEILLGDSYDAPAVDIWSLGVILYMLVCGQPPFQEANDSETLTMIMD--CKYTVPSHVSKECRDLIQSML  254 (864)
T ss_pred             cccchhhccCchhhhcCccCCcchhhhHHHHHHHHHHhCCCccccccchhhhhhhhc--ccccCchhhhHHHHHHHHHHH
Confidence            99999999999999999997 567999999999999999999998887776654443  234688999999999999999


Q ss_pred             hhcCCCCCCHHHHHH
Q 015868          351 QHDPTQRPNFSQITD  365 (399)
Q Consensus       351 ~~dP~~Rps~~ell~  365 (399)
                      ..||.+|.+.++|..
T Consensus       255 vRdPkkRAslEeI~s  269 (864)
T KOG4717|consen  255 VRDPKKRASLEEIVS  269 (864)
T ss_pred             hcCchhhccHHHHhc
Confidence            999999999999853

>cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1

Probab=100.00  E-value=2e-42  Score=334.43  Aligned_cols=240  Identities=24%  Similarity=0.417  Sum_probs=201.0

Q ss_pred             ceeceeCceEEEEEEE--CCeeEEEEEecCCCC-CHHHHHHHHHHH-HHHHhcCCCceeeEEeEEecCCcEEEEEecCCC
Q 015868          122 CKVASGSYGDLYKGTY--CSQEVAIKVLKPECV-NTEMLKEFSQEV-YIMRKIRHKNVVQFIGACTRPPNLCIVTEFMAR  197 (399)
Q Consensus       122 ~~lg~G~~g~Vy~~~~--~~~~vAvK~~~~~~~-~~~~~~~~~~Ei-~~l~~l~h~nIv~~~~~~~~~~~~~lV~E~~~g  197 (399)
                      +.||+|+||.||++++  .++.||+|++..... .......+..|. .+++.++||||+++++++...+.+|+||||++|
T Consensus         1 ~~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~~~~~~lv~e~~~~   80 (325)
T cd05602           1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYING   80 (325)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCCCCCCCceeEEEEcCCeEEEEEeCCCC
Confidence            4689999999999987  467899999975321 112223444444 457888999999999999999999999999999


Q ss_pred             CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceeecCCCcEEEeeccceeeccC-CCccccCCCC
Q 015868          198 GSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQ-SGVMTAETGT  276 (399)
Q Consensus       198 gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~giiHrDlkp~NILl~~~~~vkl~DFG~a~~~~~-~~~~~~~~gt  276 (399)
                      ++|.+++.. ...+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.... ........||
T Consensus        81 ~~L~~~~~~-~~~~~~~~~~~~~~qi~~~L~~lH~~giiHrDlkp~Nili~~~~~~kl~DfG~a~~~~~~~~~~~~~~gt  159 (325)
T cd05602          81 GELFYHLQR-ERCFLEPRARFYAAEIASALGYLHSLNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNGTTSTFCGT  159 (325)
T ss_pred             CcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCCCCEEEccCCCCcccccCCCCcccccCC
Confidence            999999976 45688899999999999999999999999999999999999999999999999875332 2233445789


Q ss_pred             cccccccccCCCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhccCCCCCCCCCcHHHHHHHHHHhhhcCCC
Q 015868          277 YRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRLAELLERCWQHDPTQ  356 (399)
Q Consensus       277 ~~y~aPE~l~~~~~~~~~Dv~slG~vl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~cl~~dP~~  356 (399)
                      +.|+|||++.+..++.++|||||||++|+|++|..||...+..+........  ...++..+++.+.+++.+||+.+|.+
T Consensus       160 ~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~--~~~~~~~~~~~~~~li~~~l~~~p~~  237 (325)
T cd05602         160 PEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNILNK--PLQLKPNITNSARHLLEGLLQKDRTK  237 (325)
T ss_pred             ccccCHHHHcCCCCCCccccccccHHHHHHhcCCCCCCCCCHHHHHHHHHhC--CcCCCCCCCHHHHHHHHHHcccCHHH
Confidence            9999999999999999999999999999999999999988877765555443  23455678999999999999999999


Q ss_pred             CCCHHHHH
Q 015868          357 RPNFSQIT  364 (399)
Q Consensus       357 Rps~~ell  364 (399)
                      ||++.+.+
T Consensus       238 R~~~~~~~  245 (325)
T cd05602         238 RLGAKDDF  245 (325)
T ss_pred             CCCCCCCH
Confidence            99887543

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt

>cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2

Probab=100.00  E-value=2.1e-42  Score=338.97  Aligned_cols=248  Identities=23%  Similarity=0.375  Sum_probs=208.9

Q ss_pred             cccceeceeceeCceEEEEEEE--CCeeEEEEEecCCC-CCHHHHHHHHHHHHHHHhcCCCceeeEEeEEecCCcEEEEE
Q 015868          116 KQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPEC-VNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVT  192 (399)
Q Consensus       116 ~~~~i~~~lg~G~~g~Vy~~~~--~~~~vAvK~~~~~~-~~~~~~~~~~~Ei~~l~~l~h~nIv~~~~~~~~~~~~~lV~  192 (399)
                      ++|++.+.||+|+||.||+++.  +++.||+|+++... ...+....+.+|+.++..++||||+++++.+.....+|+||
T Consensus         1 ~~f~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~   80 (360)
T cd05627           1 DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFYSFQDKRNLYLIM   80 (360)
T ss_pred             CCceEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence            3688999999999999999987  57899999997432 23344567889999999999999999999999999999999


Q ss_pred             ecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceeecCCCcEEEeeccceeeccCCC----
Q 015868          193 EFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSG----  268 (399)
Q Consensus       193 E~~~ggsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~giiHrDlkp~NILl~~~~~vkl~DFG~a~~~~~~~----  268 (399)
                      ||++||+|.+++.+ .+.+++..+..++.|++.||.|||++||+||||||+|||++.++.++|+|||+++......    
T Consensus        81 E~~~gg~L~~~l~~-~~~l~~~~~~~~~~qi~~~L~~lH~~givHrDLkp~NIli~~~~~vkL~DfG~~~~~~~~~~~~~  159 (360)
T cd05627          81 EFLPGGDMMTLLMK-KDTLSEEATQFYIAETVLAIDAIHQLGFIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAHRTEF  159 (360)
T ss_pred             eCCCCccHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCeEccCCCHHHEEECCCCCEEEeeccCCccccccccccc
Confidence            99999999999976 4678999999999999999999999999999999999999999999999999986432110    


Q ss_pred             --------------------------------ccccCCCCcccccccccCCCCCCChhhHHHHHHHHHHHHcCCCCCCCC
Q 015868          269 --------------------------------VMTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPYAGL  316 (399)
Q Consensus       269 --------------------------------~~~~~~gt~~y~aPE~l~~~~~~~~~Dv~slG~vl~elltg~~P~~~~  316 (399)
                                                      ......||+.|+|||++.+..++.++|||||||++|+|++|+.||...
T Consensus       160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvilyel~tG~~Pf~~~  239 (360)
T cd05627         160 YRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPFCSE  239 (360)
T ss_pred             ccccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcCCCCCCcceeccccceeeecccCCCCCCCC
Confidence                                            011346899999999999999999999999999999999999999998


Q ss_pred             CHHHHHHHHHhccCCCCCCC--CCcHHHHHHHHHHhhhcCCCCCC---HHHHHH
Q 015868          317 TPLQAAVGVVQKSLRPTIPK--HAHPRLAELLERCWQHDPTQRPN---FSQITD  365 (399)
Q Consensus       317 ~~~~~~~~~~~~~~~~~~~~--~~~~~l~~ll~~cl~~dP~~Rps---~~ell~  365 (399)
                      ++......+........+|.  .+++++.++|.+|+. +|.+|++   +.++++
T Consensus       240 ~~~~~~~~i~~~~~~~~~p~~~~~s~~~~~li~~l~~-~p~~R~~~~~~~ei~~  292 (360)
T cd05627         240 TPQETYRKVMNWKETLVFPPEVPISEKAKDLILRFCT-DSENRIGSNGVEEIKS  292 (360)
T ss_pred             CHHHHHHHHHcCCCceecCCCCCCCHHHHHHHHHhcc-ChhhcCCCCCHHHHhc
Confidence            88776666554332333333  378999999999774 9999985   555554

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul

>cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase

Probab=100.00  E-value=1.1e-41  Score=317.06  Aligned_cols=245  Identities=31%  Similarity=0.646  Sum_probs=213.1

Q ss_pred             ceeceeCceEEEEEEECC-----eeEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCceeeEEeEEecCCcEEEEEecCC
Q 015868          122 CKVASGSYGDLYKGTYCS-----QEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVTEFMA  196 (399)
Q Consensus       122 ~~lg~G~~g~Vy~~~~~~-----~~vAvK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~nIv~~~~~~~~~~~~~lV~E~~~  196 (399)
                      ++||+|++|.||+|.+..     ..||+|.++..... ...+.+.+|+.++++++||||+++++.+.. ...++||||++
T Consensus         1 ~~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~v~e~~~   78 (257)
T cd05040           1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLS-DIMDDFLKEAAIMHSLDHENLIRLYGVVLT-HPLMMVTELAP   78 (257)
T ss_pred             CcCCccCcccEEeeeEecCCCCceEEEEeecCCcccH-HHHHHHHHHHHHHhhcCCCCccceeEEEcC-CeEEEEEEecC
Confidence            468999999999998632     36899999876543 667889999999999999999999999988 88999999999


Q ss_pred             CCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceeecCCCcEEEeeccceeeccCCC----ccc
Q 015868          197 RGSIYDFLHKQK-GVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSG----VMT  271 (399)
Q Consensus       197 ggsL~~~l~~~~-~~l~~~~~~~i~~~i~~~L~~LH~~giiHrDlkp~NILl~~~~~vkl~DFG~a~~~~~~~----~~~  271 (399)
                      +++|.+++.... ..+++..++.++.|++.||.|||++|++|+||+|+||+++.++.+||+|||.++......    ...
T Consensus        79 ~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~di~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~  158 (257)
T cd05040          79 LGSLLDRLRKDALGHFLISTLCDYAVQIANGMRYLESKRFIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVMEE  158 (257)
T ss_pred             CCcHHHHHHhcccccCcHHHHHHHHHHHHHHHHHHHhCCccccccCcccEEEecCCEEEeccccccccccccccceeccc
Confidence            999999997755 578999999999999999999999999999999999999999999999999997654421    112


Q ss_pred             cCCCCcccccccccCCCCCCChhhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHHhccCCCCCCCCCcHHHHHHHHHHh
Q 015868          272 AETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLT-GELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRLAELLERCW  350 (399)
Q Consensus       272 ~~~gt~~y~aPE~l~~~~~~~~~Dv~slG~vl~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~cl  350 (399)
                      ...++..|+|||.+.+..++.++||||||+++|+|++ |..||...+..+..............+...+..+.+++.+||
T Consensus       159 ~~~~~~~y~~pE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l  238 (257)
T cd05040         159 HLKVPFAWCAPESLRTRTFSHASDVWMFGVTLWEMFTYGEEPWAGLSGSQILKKIDKEGERLERPEACPQDIYNVMLQCW  238 (257)
T ss_pred             CCCCCceecCHHHhcccCcCchhhhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhcCCcCCCCccCCHHHHHHHHHHC
Confidence            3456788999999999999999999999999999998 999998888877665555445555566778899999999999


Q ss_pred             hhcCCCCCCHHHHHHHHH
Q 015868          351 QHDPTQRPNFSQITDILK  368 (399)
Q Consensus       351 ~~dP~~Rps~~ell~~L~  368 (399)
                      +.+|++||++.++++.|.
T Consensus       239 ~~~p~~Rps~~~~~~~l~  256 (257)
T cd05040         239 AHNPADRPTFAALREFLP  256 (257)
T ss_pred             CCCcccCCCHHHHHHHhc
Confidence            999999999999998875

Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and

>cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=6.2e-42  Score=331.96  Aligned_cols=251  Identities=20%  Similarity=0.342  Sum_probs=209.0

Q ss_pred             cccceeceeceeCceEEEEEEE--CCeeEEEEEecCCC-CCHHHHHHHHHHHHHHHhcCCCceeeEEeEEecCCcEEEEE
Q 015868          116 KQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPEC-VNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVT  192 (399)
Q Consensus       116 ~~~~i~~~lg~G~~g~Vy~~~~--~~~~vAvK~~~~~~-~~~~~~~~~~~Ei~~l~~l~h~nIv~~~~~~~~~~~~~lV~  192 (399)
                      ++|++.+.||+|+||.||+++.  +++.||+|+++... ........+.+|+.+++.++|+||+++++++..+..+|+||
T Consensus         1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~   80 (331)
T cd05597           1 DDFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLHYAFQDENNLYLVM   80 (331)
T ss_pred             CCceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCceEEEEecCCeEEEEE
Confidence            4789999999999999999987  57889999997421 22334566889999999999999999999999999999999


Q ss_pred             ecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceeecCCCcEEEeeccceeeccCCCc--c
Q 015868          193 EFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGV--M  270 (399)
Q Consensus       193 E~~~ggsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~giiHrDlkp~NILl~~~~~vkl~DFG~a~~~~~~~~--~  270 (399)
                      ||+.||+|.+++.+....+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||++........  .
T Consensus        81 e~~~g~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~  160 (331)
T cd05597          81 DYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVLAIDSVHQLGYVHRDIKPDNVLLDKNGHIRLADFGSCLRLLADGTVQS  160 (331)
T ss_pred             ecCCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEECCCCHHHEEECCCCCEEEEECCceeecCCCCCccc
Confidence            99999999999987667899999999999999999999999999999999999999999999999999876543322  2


Q ss_pred             ccCCCCcccccccccCC-----CCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhccCCCCCC---CCCcHHH
Q 015868          271 TAETGTYRWMAPEVIEH-----KPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKSLRPTIP---KHAHPRL  342 (399)
Q Consensus       271 ~~~~gt~~y~aPE~l~~-----~~~~~~~Dv~slG~vl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~l  342 (399)
                      ....||+.|+|||++.+     ..++.++|||||||++|+|++|+.||...+..+.............++   ..++.++
T Consensus       161 ~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~  240 (331)
T cd05597         161 NVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKEHFQFPPDVTDVSEEA  240 (331)
T ss_pred             cceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCCCCCHHHHHHHHHcCCCcccCCCccCCCCHHH
Confidence            23468999999999963     457889999999999999999999998887766655554433222222   3478999


Q ss_pred             HHHHHHHhhhcCC--CCCCHHHHHHH
Q 015868          343 AELLERCWQHDPT--QRPNFSQITDI  366 (399)
Q Consensus       343 ~~ll~~cl~~dP~--~Rps~~ell~~  366 (399)
                      .+++++|+..+++  .||++.++++.
T Consensus       241 ~~li~~ll~~~~~r~~r~~~~~~l~h  266 (331)
T cd05597         241 KDLIRRLICSPETRLGRNGLQDFKDH  266 (331)
T ss_pred             HHHHHHHccCcccccCCCCHHHHhcC
Confidence            9999998865433  37788888764

Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy,

>cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.3e-41  Score=317.24  Aligned_cols=249  Identities=32%  Similarity=0.557  Sum_probs=214.4

Q ss_pred             ccccceeceeceeCceEEEEEEE--CCeeEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCceeeEEeEEecCCcEEEEE
Q 015868          115 AKQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVT  192 (399)
Q Consensus       115 ~~~~~i~~~lg~G~~g~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~nIv~~~~~~~~~~~~~lV~  192 (399)
                      .++|++.+.||.|+||.||+|..  .++.+++|++....  ....+.+.+|+.++++++||||+++++++.....++++|
T Consensus         2 ~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~--~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~l~~   79 (262)
T cd06613           2 QEDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEP--GDDFEIIQQEISMLKECRHPNIVAYFGSYLRRDKLWIVM   79 (262)
T ss_pred             ccceEEEEEecCCCceEEEEeEecCCCCEEEEEEEEcCc--hhhHHHHHHHHHHHHhCCCCChhceEEEEEeCCEEEEEE
Confidence            46899999999999999999987  46789999998653  335678999999999999999999999999999999999


Q ss_pred             ecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceeecCCCcEEEeeccceeeccCCC-ccc
Q 015868          193 EFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSG-VMT  271 (399)
Q Consensus       193 E~~~ggsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~giiHrDlkp~NILl~~~~~vkl~DFG~a~~~~~~~-~~~  271 (399)
                      ||+++++|.+++......+++..++.++.|++.||.|||++|++|+||+|+||+++.++.++|+|||.+....... ...
T Consensus        80 e~~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~~~~  159 (262)
T cd06613          80 EYCGGGSLQDIYQVTRGPLSELQIAYVCRETLKGLAYLHETGKIHRDIKGANILLTEDGDVKLADFGVSAQLTATIAKRK  159 (262)
T ss_pred             eCCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCceecCCChhhEEECCCCCEEECccccchhhhhhhhccc
Confidence            9999999999998766789999999999999999999999999999999999999999999999999987654332 233


Q ss_pred             cCCCCcccccccccCCC---CCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhccCCCC---CCCCCcHHHHHH
Q 015868          272 AETGTYRWMAPEVIEHK---PYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKSLRPT---IPKHAHPRLAEL  345 (399)
Q Consensus       272 ~~~gt~~y~aPE~l~~~---~~~~~~Dv~slG~vl~elltg~~P~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~l~~l  345 (399)
                      ...++..|+|||.+.+.   .++.++|+||||+++|+|++|+.||...++.+...........+.   .+..++.++.++
T Consensus       160 ~~~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  239 (262)
T cd06613         160 SFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDLHPMRALFLISKSNFPPPKLKDKEKWSPVFHDF  239 (262)
T ss_pred             cccCCccccCchhhcccccCCcCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCccccchhhhhHHHHHH
Confidence            45678899999999876   889999999999999999999999998877665554443322222   233467889999


Q ss_pred             HHHHhhhcCCCCCCHHHHHH
Q 015868          346 LERCWQHDPTQRPNFSQITD  365 (399)
Q Consensus       346 l~~cl~~dP~~Rps~~ell~  365 (399)
                      +.+||..+|.+|||+.+++.
T Consensus       240 i~~~l~~~p~~Rpt~~~il~  259 (262)
T cd06613         240 IKKCLTKDPKKRPTATKLLQ  259 (262)
T ss_pred             HHHHcCCChhhCCCHHHHhc
Confidence            99999999999999999874

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ

>cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1

Probab=100.00  E-value=8.6e-42  Score=322.99  Aligned_cols=242  Identities=24%  Similarity=0.389  Sum_probs=200.0

Q ss_pred             eceeCceEEEEEEE--CCeeEEEEEecCCCCC-HHHHHHHHHHHHHHHhcCCCceeeEEeEEecCCcEEEEEecCCCCCH
Q 015868          124 VASGSYGDLYKGTY--CSQEVAIKVLKPECVN-TEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVTEFMARGSI  200 (399)
Q Consensus       124 lg~G~~g~Vy~~~~--~~~~vAvK~~~~~~~~-~~~~~~~~~Ei~~l~~l~h~nIv~~~~~~~~~~~~~lV~E~~~ggsL  200 (399)
                      ||+|+||.||++.+  +++.||+|.+...... ....+.+..|+.+++.++|+||+++++++......++||||++||+|
T Consensus         1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~g~L   80 (280)
T cd05608           1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAYAFQTKTDLCLVMTIMNGGDL   80 (280)
T ss_pred             CCCCCceeEEEEEEccCCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCCCCcEeeeeEEEcCCCeEEEEEeCCCCCCH
Confidence            69999999999976  5789999998754322 22345678899999999999999999999999999999999999999


Q ss_pred             HHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceeecCCCcEEEeeccceeeccCCCc-cccCCCC
Q 015868          201 YDFLHK---QKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGV-MTAETGT  276 (399)
Q Consensus       201 ~~~l~~---~~~~l~~~~~~~i~~~i~~~L~~LH~~giiHrDlkp~NILl~~~~~vkl~DFG~a~~~~~~~~-~~~~~gt  276 (399)
                      .+++..   ....+++..++.++.||+.||.|||++||+||||||+||+++.++.++|+|||.+........ .....|+
T Consensus        81 ~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~g~  160 (280)
T cd05608          81 RYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQRRIIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQSKTKGYAGT  160 (280)
T ss_pred             HHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEeeCccceecCCCCccccccCCC
Confidence            988753   345689999999999999999999999999999999999999999999999999976543322 2335689


Q ss_pred             cccccccccCCCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhc--cCCCCCCCCCcHHHHHHHHHHhhhcC
Q 015868          277 YRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQK--SLRPTIPKHAHPRLAELLERCWQHDP  354 (399)
Q Consensus       277 ~~y~aPE~l~~~~~~~~~Dv~slG~vl~elltg~~P~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~l~~ll~~cl~~dP  354 (399)
                      +.|+|||.+.+..++.++|+||||+++|+|++|+.||...............  .....++..+++++.+++.+||+.||
T Consensus       161 ~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P  240 (280)
T cd05608         161 PGFMAPELLQGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRILNDSVTYPDKFSPASKSFCEALLAKDP  240 (280)
T ss_pred             cCccCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCcchhHHHHHHhhcccCCCCcccCCHHHHHHHHHHhcCCH
Confidence            9999999999999999999999999999999999999765432111111111  12234566789999999999999999


Q ss_pred             CCCC-----CHHHHHH
Q 015868          355 TQRP-----NFSQITD  365 (399)
Q Consensus       355 ~~Rp-----s~~ell~  365 (399)
                      ++||     +++++++
T Consensus       241 ~~R~~~~~~~~~~~l~  256 (280)
T cd05608         241 EKRLGFRDGNCDGLRT  256 (280)
T ss_pred             HHhcCCCCCCHHHHhc
Confidence            9999     5566654

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g

>cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7

Probab=100.00  E-value=9.8e-42  Score=319.30  Aligned_cols=256  Identities=24%  Similarity=0.474  Sum_probs=214.8

Q ss_pred             cccceeceeceeCceEEEEEEE--CCeeEEEEEecCCC-CCHHHHHHHHHHHHHHHhcCCCceeeEEeEEecCCcEEEEE
Q 015868          116 KQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPEC-VNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVT  192 (399)
Q Consensus       116 ~~~~i~~~lg~G~~g~Vy~~~~--~~~~vAvK~~~~~~-~~~~~~~~~~~Ei~~l~~l~h~nIv~~~~~~~~~~~~~lV~  192 (399)
                      ++|++.+.||.|+||.||+++.  +++.+|||.+.... .+......+.+|+.+++.++||||+++++++..++..+++|
T Consensus         2 ~~y~~~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~   81 (267)
T cd08229           2 ANFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVL   81 (267)
T ss_pred             chhhhhhhhcccCCeEEEEEeecCCCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHccCCchhhhhheeEeCCeEEEEE
Confidence            4788999999999999999986  68899999886532 23445578999999999999999999999999999999999


Q ss_pred             ecCCCCCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceeecCCCcEEEeeccceeeccCCC-
Q 015868          193 EFMARGSIYDFLHK---QKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSG-  268 (399)
Q Consensus       193 E~~~ggsL~~~l~~---~~~~l~~~~~~~i~~~i~~~L~~LH~~giiHrDlkp~NILl~~~~~vkl~DFG~a~~~~~~~-  268 (399)
                      ||+++++|.+++..   ....+++..++.++.|++.||.|||++|++|+||+|+||+++.++.++|+|||.+....... 
T Consensus        82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~  161 (267)
T cd08229          82 ELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTT  161 (267)
T ss_pred             EecCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCCEEECcchhhhccccCCc
Confidence            99999999999864   24568999999999999999999999999999999999999999999999999987654322 


Q ss_pred             ccccCCCCcccccccccCCCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHH-HHHHHHHhccCCC-CCCCCCcHHHHHHH
Q 015868          269 VMTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPYAGLTPL-QAAVGVVQKSLRP-TIPKHAHPRLAELL  346 (399)
Q Consensus       269 ~~~~~~gt~~y~aPE~l~~~~~~~~~Dv~slG~vl~elltg~~P~~~~~~~-~~~~~~~~~~~~~-~~~~~~~~~l~~ll  346 (399)
                      ......++..|+|||.+.+..++.++|+||||+++|+|++|..||.+.... ......+.....+ ..+...++++.+++
T Consensus       162 ~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li  241 (267)
T cd08229         162 AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQCDYPPLPSDHYSEELRQLV  241 (267)
T ss_pred             ccccccCCcCccCHHHhcCCCccchhhHHHHHHHHHHHHhCCCCcccccchHHHHhhhhhcCCCCCCCcccccHHHHHHH
Confidence            223446888999999999988999999999999999999999999754432 2222222222223 33345889999999


Q ss_pred             HHHhhhcCCCCCCHHHHHHHHHHHH
Q 015868          347 ERCWQHDPTQRPNFSQITDILKQMM  371 (399)
Q Consensus       347 ~~cl~~dP~~Rps~~ell~~L~~l~  371 (399)
                      .+||..+|++|||+.++.+.++++.
T Consensus       242 ~~~l~~~p~~Rpt~~~i~~~~~~~~  266 (267)
T cd08229         242 NMCINPDPEKRPDITYVYDVAKRMH  266 (267)
T ss_pred             HHhcCCCcccCCCHHHHHHHHhhhc
Confidence            9999999999999999999988763

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase.

>KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.5e-42  Score=321.81  Aligned_cols=249  Identities=25%  Similarity=0.409  Sum_probs=211.4

Q ss_pred             cccceeceeceeCceEEEEEEE--CCeeEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCceeeEEeEEec-----CCcE
Q 015868          116 KQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTR-----PPNL  188 (399)
Q Consensus       116 ~~~~i~~~lg~G~~g~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~nIv~~~~~~~~-----~~~~  188 (399)
                      ..|...+.||.|+||.|+.+.+  +++.||||.+.....+.-..++..+|+.+|+.++|+||+.+.+++..     -..+
T Consensus        22 ~~y~~~~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~~F~~~~~akRtlRElklLr~~~HeNIi~l~di~~p~~~~~f~Dv  101 (359)
T KOG0660|consen   22 RYYVLIEPIGRGAYGVVCSAKDKRTGEKVAIKKILNPFENQIDAKRTLRELKLLRHLRHENIIGLLDIFRPPSRDKFNDV  101 (359)
T ss_pred             ceecccccccCcceeeEEEEEEcCCCCEeehhhhhhhhhchHHHHHHHHHHHHHHHhcCCCcceEEeeccccccccccee
Confidence            4566689999999999999977  67899999988666677778899999999999999999999999866     2358


Q ss_pred             EEEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceeecCCCcEEEeeccceeeccC--
Q 015868          189 CIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQ--  266 (399)
Q Consensus       189 ~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~giiHrDlkp~NILl~~~~~vkl~DFG~a~~~~~--  266 (399)
                      |+|+|+|+ -+|...++. +..++...+..+++|+++||.|+|+.||+|||+||.|++++.+..+||+|||+|+....  
T Consensus       102 YiV~elMe-tDL~~iik~-~~~L~d~H~q~f~YQiLrgLKyiHSAnViHRDLKPsNll~n~~c~lKI~DFGLAR~~~~~~  179 (359)
T KOG0660|consen  102 YLVFELME-TDLHQIIKS-QQDLTDDHAQYFLYQILRGLKYIHSANVIHRDLKPSNLLLNADCDLKICDFGLARYLDKFF  179 (359)
T ss_pred             EEehhHHh-hHHHHHHHc-CccccHHHHHHHHHHHHHhcchhhcccccccccchhheeeccCCCEEeccccceeeccccC
Confidence            99999995 489998865 45599999999999999999999999999999999999999999999999999998764  


Q ss_pred             -CCccccCCCCcccccccccC-CCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHh-----------------
Q 015868          267 -SGVMTAETGTYRWMAPEVIE-HKPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQ-----------------  327 (399)
Q Consensus       267 -~~~~~~~~gt~~y~aPE~l~-~~~~~~~~Dv~slG~vl~elltg~~P~~~~~~~~~~~~~~~-----------------  327 (399)
                       .+.+|.+..|..|.|||++. ...|+.+.||||.||++.||++|++-|.+.+.......+..                 
T Consensus       180 ~~~~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL~gkplFpG~d~v~Ql~lI~~~lGtP~~e~l~~i~s~~  259 (359)
T KOG0660|consen  180 EDGFMTEYVATRWYRAPELLLNSSEYTKAIDIWSVGCILAEMLTGKPLFPGKDYVHQLQLILELLGTPSEEDLQKIRSEK  259 (359)
T ss_pred             cccchhcceeeeeecCHHHHhccccccchhhhhhhhHHHHHHHcCCCCCCCCchHHHHHHHHHhcCCCCHHHHHHhccHH
Confidence             56678889999999999985 45799999999999999999999999988654333222211                 


Q ss_pred             -------ccCCCCCC-----CCCcHHHHHHHHHHhhhcCCCCCCHHHHHHH
Q 015868          328 -------KSLRPTIP-----KHAHPRLAELLERCWQHDPTQRPNFSQITDI  366 (399)
Q Consensus       328 -------~~~~~~~~-----~~~~~~l~~ll~~cl~~dP~~Rps~~ell~~  366 (399)
                             ....|..|     ++.++...+|+++||..||.+|+|++|.++.
T Consensus       260 ar~yi~slp~~p~~~f~~~fp~a~p~AidLlekmL~fdP~kRita~eAL~h  310 (359)
T KOG0660|consen  260 ARPYIKSLPQIPKQPFSSIFPNANPLAIDLLEKMLVFDPKKRITAEEALAH  310 (359)
T ss_pred             HHHHHHhCCCCCCCCHHHHcCCCCHHHHHHHHHHhccCccccCCHHHHhcC
Confidence                   11122222     5788999999999999999999999999763

>cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases

Probab=100.00  E-value=2e-41  Score=318.42  Aligned_cols=247  Identities=33%  Similarity=0.630  Sum_probs=207.8

Q ss_pred             eeceeCceEEEEEEEC--C--eeEEEEEecCCCCCHHHHHHHHHHHHHHHhc-CCCceeeEEeEEecCCcEEEEEecCCC
Q 015868          123 KVASGSYGDLYKGTYC--S--QEVAIKVLKPECVNTEMLKEFSQEVYIMRKI-RHKNVVQFIGACTRPPNLCIVTEFMAR  197 (399)
Q Consensus       123 ~lg~G~~g~Vy~~~~~--~--~~vAvK~~~~~~~~~~~~~~~~~Ei~~l~~l-~h~nIv~~~~~~~~~~~~~lV~E~~~g  197 (399)
                      .||.|+||.||+|...  +  ..+++|.++... .......+.+|+.+++++ +||||+++++++......++||||+++
T Consensus         2 ~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~~-~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~   80 (270)
T cd05047           2 VIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYA-SKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPH   80 (270)
T ss_pred             cCCCCCCceEEEEEEcCCCCeeEEEEEEccccC-CHHHHHHHHHHHHHHHhhccCCCeeeEEEEEecCCCceEEEEeCCC
Confidence            5899999999999863  3  356888887432 344556889999999999 799999999999999999999999999


Q ss_pred             CCHHHHHHhcC---------------CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceeecCCCcEEEeecccee
Q 015868          198 GSIYDFLHKQK---------------GVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVAR  262 (399)
Q Consensus       198 gsL~~~l~~~~---------------~~l~~~~~~~i~~~i~~~L~~LH~~giiHrDlkp~NILl~~~~~vkl~DFG~a~  262 (399)
                      ++|.+++....               ..++++.+..++.|++.||+|||++|++||||||+||++++++.+||+|||++.
T Consensus        81 ~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~~~i~H~dikp~nili~~~~~~kl~dfgl~~  160 (270)
T cd05047          81 GNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSR  160 (270)
T ss_pred             CcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccccceEEEcCCCeEEECCCCCcc
Confidence            99999997532               247889999999999999999999999999999999999999999999999986


Q ss_pred             eccCCCccccCCCCcccccccccCCCCCCChhhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHHhccCCCCCCCCCcHH
Q 015868          263 VQAQSGVMTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLT-GELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPR  341 (399)
Q Consensus       263 ~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~Dv~slG~vl~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  341 (399)
                      .............+..|+|||.+.+..++.++|+||||+++|+|++ |..||...+..+.... .....+...+..++.+
T Consensus       161 ~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~~~~~-~~~~~~~~~~~~~~~~  239 (270)
T cd05047         161 GQEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEK-LPQGYRLEKPLNCDDE  239 (270)
T ss_pred             ccchhhhccCCCCccccCChHHHccCCCCchhhHHHHHHHHHHHHcCCCCCccccCHHHHHHH-HhCCCCCCCCCcCCHH
Confidence            3322211122234667999999998899999999999999999997 9999988776654443 3334455566778899


Q ss_pred             HHHHHHHHhhhcCCCCCCHHHHHHHHHHHH
Q 015868          342 LAELLERCWQHDPTQRPNFSQITDILKQMM  371 (399)
Q Consensus       342 l~~ll~~cl~~dP~~Rps~~ell~~L~~l~  371 (399)
                      +.+++.+||..+|.+|||+.++++.|.+++
T Consensus       240 ~~~li~~~l~~~p~~Rps~~~il~~l~~~~  269 (270)
T cd05047         240 VYDLMRQCWREKPYERPSFAQILVSLNRML  269 (270)
T ss_pred             HHHHHHHHcccChhhCCCHHHHHHHHHHhh
Confidence            999999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l

>cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer

Probab=100.00  E-value=3.3e-41  Score=312.68  Aligned_cols=245  Identities=35%  Similarity=0.655  Sum_probs=211.5

Q ss_pred             ceeceeCceEEEEEEE-CCeeEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCceeeEEeEEecCCcEEEEEecCCCCCH
Q 015868          122 CKVASGSYGDLYKGTY-CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVTEFMARGSI  200 (399)
Q Consensus       122 ~~lg~G~~g~Vy~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~nIv~~~~~~~~~~~~~lV~E~~~ggsL  200 (399)
                      +.||+|+||.||+|.. .++.+|+|+++... .......+.+|+.+++.++||||+++++++......++||||+++++|
T Consensus         1 ~~ig~g~~g~vy~~~~~~~~~~a~K~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L   79 (250)
T cd05085           1 ELLGKGNFGEVFKGTLKDKTPVAVKTCKEDL-PQELKIKFLSEARILKQYDHPNIVKLIGVCTQRQPIYIVMELVPGGDF   79 (250)
T ss_pred             CccCCCCCceEEEEEecCCcEEEEEecCCcC-CHHHHHHHHHHHHHHHhCCCCCcCeEEEEEecCCccEEEEECCCCCcH
Confidence            3689999999999976 46789999987653 344456789999999999999999999999999999999999999999


Q ss_pred             HHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceeecCCCcEEEeeccceeeccCCCc--cccCCCCcc
Q 015868          201 YDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGV--MTAETGTYR  278 (399)
Q Consensus       201 ~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~giiHrDlkp~NILl~~~~~vkl~DFG~a~~~~~~~~--~~~~~gt~~  278 (399)
                      .+++......+++..+..++.+++.+|.|||++|++||||+|+||+++.++.+||+|||++........  .....++..
T Consensus        80 ~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~  159 (250)
T cd05085          80 LSFLRKKKDELKTKQLVKFALDAAAGMAYLESKNCIHRDLAARNCLVGENNVLKISDFGMSRQEDDGIYSSSGLKQIPIK  159 (250)
T ss_pred             HHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccChheEEEcCCCeEEECCCccceeccccccccCCCCCCccc
Confidence            999987666789999999999999999999999999999999999999999999999999875433221  112234667


Q ss_pred             cccccccCCCCCCChhhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHHhccCCCCCCCCCcHHHHHHHHHHhhhcCCCC
Q 015868          279 WMAPEVIEHKPYDYKADVFSFGIALWELLT-GELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRLAELLERCWQHDPTQR  357 (399)
Q Consensus       279 y~aPE~l~~~~~~~~~Dv~slG~vl~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~cl~~dP~~R  357 (399)
                      |+|||.+.+..++.++||||||+++|++++ |..||...+....... .....+...+..++..+.+++.+||+.+|++|
T Consensus       160 y~aPE~~~~~~~~~~~Di~slG~ll~~~~~~g~~p~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R  238 (250)
T cd05085         160 WTAPEALNYGRYSSESDVWSYGILLWETFSLGVCPYPGMTNQQAREQ-VEKGYRMSCPQKCPDDVYKVMQRCWDYKPENR  238 (250)
T ss_pred             ccCHHHhccCCCCchhHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHH-HHcCCCCCCCCCCCHHHHHHHHHHcccCcccC
Confidence            999999998889999999999999999998 9999988877665443 44555666777899999999999999999999


Q ss_pred             CCHHHHHHHHH
Q 015868          358 PNFSQITDILK  368 (399)
Q Consensus       358 ps~~ell~~L~  368 (399)
                      |++.++.+.|.
T Consensus       239 p~~~~l~~~l~  249 (250)
T cd05085         239 PKFSELQKELA  249 (250)
T ss_pred             CCHHHHHHHhc
Confidence            99999998874

Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c

>cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1

Probab=100.00  E-value=1.3e-41  Score=322.02  Aligned_cols=255  Identities=28%  Similarity=0.555  Sum_probs=211.9

Q ss_pred             ccccceeceeceeCceEEEEEEE------CCeeEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCceeeEEeEEecC--C
Q 015868          115 AKQLKIECKVASGSYGDLYKGTY------CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRP--P  186 (399)
Q Consensus       115 ~~~~~i~~~lg~G~~g~Vy~~~~------~~~~vAvK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~nIv~~~~~~~~~--~  186 (399)
                      ..-|++.+.||+|+||.||++++      .+..||+|.++... .......+.+|+.+++.++||||+++++++...  .
T Consensus         3 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~   81 (284)
T cd05079           3 KRFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPES-GGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGN   81 (284)
T ss_pred             hhhhhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCccc-cHHHHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCC
Confidence            45689999999999999999974      46789999987653 344557899999999999999999999998775  5


Q ss_pred             cEEEEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceeecCCCcEEEeeccceeeccC
Q 015868          187 NLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQ  266 (399)
Q Consensus       187 ~~~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~giiHrDlkp~NILl~~~~~vkl~DFG~a~~~~~  266 (399)
                      ..++||||++|++|.+++......+++..+..++.|++.||+|||++|++||||||+||+++.++.++|+|||+++....
T Consensus        82 ~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~i~~~i~~aL~~lH~~gi~H~dlkp~Nil~~~~~~~~l~dfg~~~~~~~  161 (284)
T cd05079          82 GIKLIMEFLPSGSLKEYLPRNKNKINLKQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIET  161 (284)
T ss_pred             ceEEEEEccCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeecccchheEEEcCCCCEEECCCcccccccc
Confidence            68999999999999999977656789999999999999999999999999999999999999999999999999986543


Q ss_pred             CCc----cccCCCCcccccccccCCCCCCChhhHHHHHHHHHHHHcCCCCCCCCC--------------HHHHHHHHHhc
Q 015868          267 SGV----MTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPYAGLT--------------PLQAAVGVVQK  328 (399)
Q Consensus       267 ~~~----~~~~~gt~~y~aPE~l~~~~~~~~~Dv~slG~vl~elltg~~P~~~~~--------------~~~~~~~~~~~  328 (399)
                      ...    .....++..|+|||.+.+..++.++||||||+++|+|+++..|+....              ...........
T Consensus       162 ~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~ellt~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  241 (284)
T cd05079         162 DKEYYTVKDDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLYELLTYCDSESSPMTLFLKMIGPTHGQMTVTRLVRVLEE  241 (284)
T ss_pred             CccceeecCCCCCCccccCHHHhccCCCCccccchhhhhhhhhhhcCCCCCccccchhhhhcccccccccHHHHHHHHHc
Confidence            221    122345678999999998889999999999999999999776542210              11112223334


Q ss_pred             cCCCCCCCCCcHHHHHHHHHHhhhcCCCCCCHHHHHHHHHHH
Q 015868          329 SLRPTIPKHAHPRLAELLERCWQHDPTQRPNFSQITDILKQM  370 (399)
Q Consensus       329 ~~~~~~~~~~~~~l~~ll~~cl~~dP~~Rps~~ell~~L~~l  370 (399)
                      ..+...+..++.++.+|+.+||+.+|.+||++.++++.++++
T Consensus       242 ~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~~~  283 (284)
T cd05079         242 GKRLPRPPNCPEEVYQLMRKCWEFQPSKRTTFQNLIEGFEAI  283 (284)
T ss_pred             CccCCCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHHHHhh
Confidence            445556777899999999999999999999999999999876

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a

>cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota

Probab=100.00  E-value=5e-42  Score=332.39  Aligned_cols=237  Identities=23%  Similarity=0.411  Sum_probs=198.9

Q ss_pred             ceeceeCceEEEEEEE--CCeeEEEEEecCCCC-CHHHHHHHHHHHHHHHhc-CCCceeeEEeEEecCCcEEEEEecCCC
Q 015868          122 CKVASGSYGDLYKGTY--CSQEVAIKVLKPECV-NTEMLKEFSQEVYIMRKI-RHKNVVQFIGACTRPPNLCIVTEFMAR  197 (399)
Q Consensus       122 ~~lg~G~~g~Vy~~~~--~~~~vAvK~~~~~~~-~~~~~~~~~~Ei~~l~~l-~h~nIv~~~~~~~~~~~~~lV~E~~~g  197 (399)
                      +.||+|+||.||+++.  +++.||+|+++.... .......+.+|+.++.++ +||||+++++++.....+++||||+++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~~~   80 (329)
T cd05618           1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNG   80 (329)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEeCCEEEEEEeCCCC
Confidence            4689999999999987  567899999986532 334456788899998877 799999999999999999999999999


Q ss_pred             CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceeecCCCcEEEeeccceeeccCC-CccccCCCC
Q 015868          198 GSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQS-GVMTAETGT  276 (399)
Q Consensus       198 gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~giiHrDlkp~NILl~~~~~vkl~DFG~a~~~~~~-~~~~~~~gt  276 (399)
                      ++|.+++.. ...+++..+..++.|++.||.|||++||+||||||+||+++.++.+||+|||+++..... .......||
T Consensus        81 ~~L~~~~~~-~~~l~~~~~~~i~~qi~~~l~~lH~~~ivH~Dikp~Nili~~~~~~kL~DfG~~~~~~~~~~~~~~~~gt  159 (329)
T cd05618          81 GDLMFHMQR-QRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSTFCGT  159 (329)
T ss_pred             CCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEECCCCCEEEeeCCccccccCCCCccccccCC
Confidence            999998865 467899999999999999999999999999999999999999999999999998753222 223345789


Q ss_pred             cccccccccCCCCCCChhhHHHHHHHHHHHHcCCCCCCCCC--------HHHHHHHHHhccCCCCCCCCCcHHHHHHHHH
Q 015868          277 YRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPYAGLT--------PLQAAVGVVQKSLRPTIPKHAHPRLAELLER  348 (399)
Q Consensus       277 ~~y~aPE~l~~~~~~~~~Dv~slG~vl~elltg~~P~~~~~--------~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~  348 (399)
                      +.|+|||++.+..++.++||||||+++|+|++|+.||....        .......... .....+|...+.++.++|.+
T Consensus       160 ~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~i~-~~~~~~p~~~~~~~~~ll~~  238 (329)
T cd05618         160 PNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVIL-EKQIRIPRSLSVKAASVLKS  238 (329)
T ss_pred             ccccCHHHHcCCCCCCccceecccHHHHHHhhCCCCCccCCCcCCcccccHHHHHHHHh-cCCCCCCCCCCHHHHHHHHH
Confidence            99999999999999999999999999999999999995311        1111222222 23456788899999999999


Q ss_pred             HhhhcCCCCCCH
Q 015868          349 CWQHDPTQRPNF  360 (399)
Q Consensus       349 cl~~dP~~Rps~  360 (399)
                      ||+.||.+||++
T Consensus       239 ~L~~dP~~R~~~  250 (329)
T cd05618         239 FLNKDPKERLGC  250 (329)
T ss_pred             HhcCCHHHcCCC
Confidence            999999999984

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o

>cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase

Probab=100.00  E-value=1e-41  Score=335.63  Aligned_cols=247  Identities=26%  Similarity=0.405  Sum_probs=206.5

Q ss_pred             ccceeceeceeCceEEEEEEE--CCeeEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCceeeEEeEEecCC-----cEE
Q 015868          117 QLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPP-----NLC  189 (399)
Q Consensus       117 ~~~i~~~lg~G~~g~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~nIv~~~~~~~~~~-----~~~  189 (399)
                      +|++.++||+|+||.||++..  +++.||+|.+.....+....+.+.+|+.+++.++||||+++++++..+.     ..|
T Consensus         1 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~   80 (372)
T cd07853           1 DVEPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFEEIY   80 (372)
T ss_pred             CCcccceeeeCCCEEEEEEEECCCCCEEEEEeccccccchHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCccccceEE
Confidence            477889999999999999986  6789999998765445555678899999999999999999999998776     789


Q ss_pred             EEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceeecCCCcEEEeeccceeeccCC--
Q 015868          190 IVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQS--  267 (399)
Q Consensus       190 lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~giiHrDlkp~NILl~~~~~vkl~DFG~a~~~~~~--  267 (399)
                      +||||+.+ +|.+++.. ...+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.....  
T Consensus        81 lv~e~~~~-~l~~~~~~-~~~l~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~Nili~~~~~~kL~Dfg~a~~~~~~~~  158 (372)
T cd07853          81 VVTELMQS-DLHKIIVS-PQPLSSDHVKVFLYQILRGLKYLHSAGILHRDIKPGNLLVNSNCVLKICDFGLARVEEPDES  158 (372)
T ss_pred             EEeecccc-CHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChHHEEECCCCCEEeccccceeecccCcc
Confidence            99999974 88888755 467899999999999999999999999999999999999999999999999999865432  


Q ss_pred             CccccCCCCcccccccccCCC-CCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHh-------------------
Q 015868          268 GVMTAETGTYRWMAPEVIEHK-PYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQ-------------------  327 (399)
Q Consensus       268 ~~~~~~~gt~~y~aPE~l~~~-~~~~~~Dv~slG~vl~elltg~~P~~~~~~~~~~~~~~~-------------------  327 (399)
                      .......+++.|+|||.+.+. .++.++|||||||++|+|++|+.||.+.++.+....+..                   
T Consensus       159 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~  238 (372)
T cd07853         159 KHMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQQLDLITDLLGTPSLEAMRSACEGARA  238 (372)
T ss_pred             ccCCCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCCCCHHHHHHhhHHHHH
Confidence            223445678999999999874 579999999999999999999999988776554333221                   


Q ss_pred             ----ccCCC-------CCCCCCcHHHHHHHHHHhhhcCCCCCCHHHHHH
Q 015868          328 ----KSLRP-------TIPKHAHPRLAELLERCWQHDPTQRPNFSQITD  365 (399)
Q Consensus       328 ----~~~~~-------~~~~~~~~~l~~ll~~cl~~dP~~Rps~~ell~  365 (399)
                          ....+       ......++++.+||.+||+.||++|||+.|+++
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~  287 (372)
T cd07853         239 HILRGPHKPPSLPVLYTLSSQATHEAVHLLCRMLVFDPDKRISAADALA  287 (372)
T ss_pred             HHHhCCCCCCchHHhcccCCCCCHHHHHHHHHhCCCChhhCcCHHHHhc
Confidence                01111       123456889999999999999999999999976

Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription

>cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase

Probab=100.00  E-value=2.7e-41  Score=315.62  Aligned_cols=254  Identities=34%  Similarity=0.690  Sum_probs=217.5

Q ss_pred             eeecccccceeceeceeCceEEEEEEE-CCeeEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCceeeEEeEEecCCcEE
Q 015868          111 WEIDAKQLKIECKVASGSYGDLYKGTY-CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLC  189 (399)
Q Consensus       111 ~~i~~~~~~i~~~lg~G~~g~Vy~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~nIv~~~~~~~~~~~~~  189 (399)
                      |++..++|++.++||+|+||.||++.. .+..+|+|.++..   ......+.+|+.+++.++|+||+++++.+.. ...+
T Consensus         1 ~~~~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~iK~~~~~---~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~   76 (260)
T cd05073           1 WEIPRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPG---SMSVEAFLAEANVMKTLQHDKLVKLHAVVTK-EPIY   76 (260)
T ss_pred             CcccccceeEEeEecCccceEEEEEEecCCccEEEEecCCC---hhHHHHHHHHHHHHHhcCCCCcceEEEEEcC-CCeE
Confidence            678889999999999999999999986 4467999998753   3345678899999999999999999999887 6789


Q ss_pred             EEEecCCCCCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceeecCCCcEEEeeccceeeccCCC
Q 015868          190 IVTEFMARGSIYDFLHKQ-KGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSG  268 (399)
Q Consensus       190 lV~E~~~ggsL~~~l~~~-~~~l~~~~~~~i~~~i~~~L~~LH~~giiHrDlkp~NILl~~~~~vkl~DFG~a~~~~~~~  268 (399)
                      ++|||+++++|.+++... ...++...+..++.|++.||.|||++|++|+||+|+||+++.++.+||+|||.+.......
T Consensus        77 ~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~  156 (260)
T cd05073          77 IITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDLRAANILVSASLVCKIADFGLARVIEDNE  156 (260)
T ss_pred             EEEEeCCCCcHHHHHHhCCccccCHHHHHHHHHHHHHHHHHHHhCCccccccCcceEEEcCCCcEEECCCcceeeccCCC
Confidence            999999999999999764 3457888999999999999999999999999999999999999999999999997654322


Q ss_pred             c--cccCCCCcccccccccCCCCCCChhhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHHhccCCCCCCCCCcHHHHHH
Q 015868          269 V--MTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLT-GELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRLAEL  345 (399)
Q Consensus       269 ~--~~~~~gt~~y~aPE~l~~~~~~~~~Dv~slG~vl~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l  345 (399)
                      .  .....++..|+|||.+.+..++.++|+||||+++|++++ |..||...+....... .........+...+.++.++
T Consensus       157 ~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~  235 (260)
T cd05073         157 YTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRA-LERGYRMPRPENCPEELYNI  235 (260)
T ss_pred             cccccCCcccccccCHhHhccCCcCccccchHHHHHHHHHHhcCCCCCCCCCHHHHHHH-HhCCCCCCCcccCCHHHHHH
Confidence            1  122345678999999998889999999999999999999 9999988776654443 33444555667788999999


Q ss_pred             HHHHhhhcCCCCCCHHHHHHHHHH
Q 015868          346 LERCWQHDPTQRPNFSQITDILKQ  369 (399)
Q Consensus       346 l~~cl~~dP~~Rps~~ell~~L~~  369 (399)
                      +.+||+.+|++||++.++.+.|+.
T Consensus       236 i~~~l~~~p~~Rp~~~~l~~~L~~  259 (260)
T cd05073         236 MMRCWKNRPEERPTFEYIQSVLDD  259 (260)
T ss_pred             HHHHcccCcccCcCHHHHHHHHhc
Confidence            999999999999999999998875

Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa

>cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6

Probab=100.00  E-value=1.1e-41  Score=323.13  Aligned_cols=247  Identities=22%  Similarity=0.396  Sum_probs=208.6

Q ss_pred             cceeceeceeCceEEEEEEE--CCeeEEEEEecCCCCC-HHHHHHHHHHHHHHHhcCCCceeeEEeEEecCCcEEEEEec
Q 015868          118 LKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVN-TEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVTEF  194 (399)
Q Consensus       118 ~~i~~~lg~G~~g~Vy~~~~--~~~~vAvK~~~~~~~~-~~~~~~~~~Ei~~l~~l~h~nIv~~~~~~~~~~~~~lV~E~  194 (399)
                      |++.+.||.|+||.||++.+  +++.||+|.+...... ......+.+|+.+++.++|+||+.+++.+......++||||
T Consensus         2 f~~~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~   81 (285)
T cd05630           2 FRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLTL   81 (285)
T ss_pred             ceeeEEeecCCCeEEEEEEEcCCCceEEEEEEehhhccchHHHHHHHHHHHHHHhCCCCCeeeeeEEEecCCEEEEEEEe
Confidence            67788999999999999987  5789999998754322 23345678899999999999999999999999999999999


Q ss_pred             CCCCCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceeecCCCcEEEeeccceeeccCCCccccC
Q 015868          195 MARGSIYDFLHKQ-KGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAE  273 (399)
Q Consensus       195 ~~ggsL~~~l~~~-~~~l~~~~~~~i~~~i~~~L~~LH~~giiHrDlkp~NILl~~~~~vkl~DFG~a~~~~~~~~~~~~  273 (399)
                      ++|++|.+++... ...+++..+..++.|++.||.|||+.||+||||||+||++++++.++|+|||++............
T Consensus        82 ~~g~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~iiH~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~  161 (285)
T cd05630          82 MNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDLHQERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQTIKGR  161 (285)
T ss_pred             cCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHEEECCCCCEEEeeccceeecCCCccccCC
Confidence            9999999998653 346899999999999999999999999999999999999999999999999999765444333445


Q ss_pred             CCCcccccccccCCCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHH---HHHHHHHhccCCCCCCCCCcHHHHHHHHHHh
Q 015868          274 TGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPYAGLTPL---QAAVGVVQKSLRPTIPKHAHPRLAELLERCW  350 (399)
Q Consensus       274 ~gt~~y~aPE~l~~~~~~~~~Dv~slG~vl~elltg~~P~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~l~~ll~~cl  350 (399)
                      .|+..|+|||.+.+..++.++||||||+++|+|++|+.||......   ....... .......+..+++++.+|+.+||
T Consensus       162 ~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~li~~~l  240 (285)
T cd05630         162 VGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLV-KEVQEEYSEKFSPDARSLCKMLL  240 (285)
T ss_pred             CCCccccChHHHcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCccchHHHHHhhh-hhhhhhcCccCCHHHHHHHHHHh
Confidence            7899999999999999999999999999999999999999865432   1111211 12233456778999999999999


Q ss_pred             hhcCCCCCC-----HHHHHH
Q 015868          351 QHDPTQRPN-----FSQITD  365 (399)
Q Consensus       351 ~~dP~~Rps-----~~ell~  365 (399)
                      +.||++|||     +.|+++
T Consensus       241 ~~~p~~R~s~~~~~~~~~~~  260 (285)
T cd05630         241 CKDPKERLGCQGGGAREVKE  260 (285)
T ss_pred             hcCHHHccCCCCCchHHHHc
Confidence            999999999     788877

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as

>cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase

Probab=100.00  E-value=3.6e-41  Score=313.51  Aligned_cols=250  Identities=34%  Similarity=0.689  Sum_probs=214.9

Q ss_pred             cccccceeceeceeCceEEEEEEEC-CeeEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCceeeEEeEEecCCcEEEEE
Q 015868          114 DAKQLKIECKVASGSYGDLYKGTYC-SQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVT  192 (399)
Q Consensus       114 ~~~~~~i~~~lg~G~~g~Vy~~~~~-~~~vAvK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~nIv~~~~~~~~~~~~~lV~  192 (399)
                      +..+|++.+.||.|+||.||++.+. +..+|+|+++......   ..+.+|+.++++++|||++++++++......++||
T Consensus         2 ~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~k~~~~~~~~~---~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~   78 (256)
T cd05112           2 HPSELTLVQEIGSGQFGLVWLGYWLEKRKVAIKTIREGAMSE---EDFIEEAQVMMKLSHPKLVQLYGVCTERSPICLVF   78 (256)
T ss_pred             ChhHeEEEeeecCcccceEEEEEEeCCCeEEEEECCCCCCCH---HHHHHHHHHHHhCCCCCeeeEEEEEccCCceEEEE
Confidence            4568999999999999999999874 7889999987654332   46888999999999999999999999999999999


Q ss_pred             ecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceeecCCCcEEEeeccceeeccCCCc--c
Q 015868          193 EFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGV--M  270 (399)
Q Consensus       193 E~~~ggsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~giiHrDlkp~NILl~~~~~vkl~DFG~a~~~~~~~~--~  270 (399)
                      ||+.+++|.+++....+.+++..++.++.+++.+++|||++|++|+||||+||+++.++.++|+|||.++.......  .
T Consensus        79 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~~~~  158 (256)
T cd05112          79 EFMEHGCLSDYLRAQRGKFSQETLLGMCLDVCEGMAYLESSNVIHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQYTSS  158 (256)
T ss_pred             EcCCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCCccccccccceEEEcCCCeEEECCCcceeecccCccccc
Confidence            99999999999987667789999999999999999999999999999999999999999999999999875543221  1


Q ss_pred             ccCCCCcccccccccCCCCCCChhhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHHhccCCCCCCCCCcHHHHHHHHHH
Q 015868          271 TAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLT-GELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRLAELLERC  349 (399)
Q Consensus       271 ~~~~gt~~y~aPE~l~~~~~~~~~Dv~slG~vl~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~c  349 (399)
                      ....++..|+|||.+.+..++.++|+||||+++|+|++ |..||........... .....++..+...+..+.+++.+|
T Consensus       159 ~~~~~~~~~~aPe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~l~~~~  237 (256)
T cd05112         159 TGTKFPVKWSSPEVFSFSKYSSKSDVWSFGVLMWEVFSEGKTPYENRSNSEVVET-INAGFRLYKPRLASQSVYELMQHC  237 (256)
T ss_pred             CCCccchhhcCHhHhccCCcChHHHHHHHHHHHHHHHcCCCCCCCcCCHHHHHHH-HhCCCCCCCCCCCCHHHHHHHHHH
Confidence            12234678999999998889999999999999999998 9999987766554433 333445555666889999999999


Q ss_pred             hhhcCCCCCCHHHHHHHH
Q 015868          350 WQHDPTQRPNFSQITDIL  367 (399)
Q Consensus       350 l~~dP~~Rps~~ell~~L  367 (399)
                      |+.+|++||++.++++.|
T Consensus       238 l~~~p~~Rp~~~~~l~~l  255 (256)
T cd05112         238 WKERPEDRPSFSLLLHQL  255 (256)
T ss_pred             cccChhhCCCHHHHHHhh
Confidence            999999999999999876

Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ

>cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase

Probab=100.00  E-value=1.2e-41  Score=326.54  Aligned_cols=249  Identities=21%  Similarity=0.380  Sum_probs=206.7

Q ss_pred             ccccceeceeceeCceEEEEEEE--CCeeEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCceeeEEeEEecCCcEEEEE
Q 015868          115 AKQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVT  192 (399)
Q Consensus       115 ~~~~~i~~~lg~G~~g~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~nIv~~~~~~~~~~~~~lV~  192 (399)
                      .++|++.++||+|+||.||+|+.  +++.||+|.++.... ......+.+|+.++++++||||+++++++..++..++||
T Consensus         5 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~   83 (309)
T cd07872           5 METYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHE-EGAPCTAIREVSLLKDLKHANIVTLHDIVHTDKSLTLVF   83 (309)
T ss_pred             CCceEEEEEecccCCEEEEEEEecCCCCeEEEEEeecccc-CCcchhHHHHHHHHHhCCCCCcceEEEEEeeCCeEEEEE
Confidence            46799999999999999999986  567899999875432 222345778999999999999999999999999999999


Q ss_pred             ecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceeecCCCcEEEeeccceeeccCCC-ccc
Q 015868          193 EFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSG-VMT  271 (399)
Q Consensus       193 E~~~ggsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~giiHrDlkp~NILl~~~~~vkl~DFG~a~~~~~~~-~~~  271 (399)
                      ||+++ +|.+++......++...+..++.|++.||+|||++||+||||||+||+++.++.+||+|||+++...... ...
T Consensus        84 e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~  162 (309)
T cd07872          84 EYLDK-DLKQYMDDCGNIMSMHNVKIFLYQILRGLAYCHRRKVLHRDLKPQNLLINERGELKLADFGLARAKSVPTKTYS  162 (309)
T ss_pred             eCCCC-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEECccccceecCCCccccc
Confidence            99976 8999987766778999999999999999999999999999999999999999999999999997644322 233


Q ss_pred             cCCCCcccccccccCC-CCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcc---------------------
Q 015868          272 AETGTYRWMAPEVIEH-KPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKS---------------------  329 (399)
Q Consensus       272 ~~~gt~~y~aPE~l~~-~~~~~~~Dv~slG~vl~elltg~~P~~~~~~~~~~~~~~~~~---------------------  329 (399)
                      ...+++.|+|||.+.+ ..++.++||||||+++|+|+||+.||.+.+..+.........                     
T Consensus       163 ~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  242 (309)
T cd07872         163 NEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDELHLIFRLLGTPTEETWPGISSNDEFKNYN  242 (309)
T ss_pred             cccccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhhcchhhhhhhh
Confidence            4567899999999865 468999999999999999999999998877654433322110                     


Q ss_pred             CCC-------CCCCCCcHHHHHHHHHHhhhcCCCCCCHHHHHH
Q 015868          330 LRP-------TIPKHAHPRLAELLERCWQHDPTQRPNFSQITD  365 (399)
Q Consensus       330 ~~~-------~~~~~~~~~l~~ll~~cl~~dP~~Rps~~ell~  365 (399)
                      ..+       .....+++++.++|.+||+.||.+|||+.|+++
T Consensus       243 ~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~  285 (309)
T cd07872         243 FPKYKPQPLINHAPRLDTEGIELLTKFLQYESKKRISAEEAMK  285 (309)
T ss_pred             cCccCCCchhhhccCCCHHHHHHHHHhccCChhhCCCHHHHhc
Confidence            000       011346889999999999999999999999976

Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play

>cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase

Probab=100.00  E-value=2.6e-41  Score=321.30  Aligned_cols=249  Identities=29%  Similarity=0.514  Sum_probs=213.3

Q ss_pred             cccccceeceeceeCceEEEEEEE--CCeeEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCceeeEEeEEecCCcEEEE
Q 015868          114 DAKQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIV  191 (399)
Q Consensus       114 ~~~~~~i~~~lg~G~~g~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~nIv~~~~~~~~~~~~~lV  191 (399)
                      ..+.|++.++||.|+||.||+|+.  .++.|++|++...  +......+.+|+.+++.++||||+++++.+..+..+++|
T Consensus        10 ~~~~y~i~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   87 (292)
T cd06644          10 PNEVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETK--SEEELEDYMVEIEILATCNHPYIVKLLGAFYWDGKLWIM   87 (292)
T ss_pred             cchhhhhhheecCCCCeEEEEEEECCCCceEEEEEeccC--CHHHHHHHHHHHHHHHhCCCCcEeeeEEEEEeCCeEEEE
Confidence            346799999999999999999987  4688999998764  455677899999999999999999999999999999999


Q ss_pred             EecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceeecCCCcEEEeeccceeeccCC-Ccc
Q 015868          192 TEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQS-GVM  270 (399)
Q Consensus       192 ~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~giiHrDlkp~NILl~~~~~vkl~DFG~a~~~~~~-~~~  270 (399)
                      |||+++++|..++.+....+++..+..++.|++.++.|||+.|++||||||+||+++.++.++|+|||.+...... ...
T Consensus        88 ~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~~~~~  167 (292)
T cd06644          88 IEFCPGGAVDAIMLELDRGLTEPQIQVICRQMLEALQYLHSMKIIHRDLKAGNVLLTLDGDIKLADFGVSAKNVKTLQRR  167 (292)
T ss_pred             EecCCCCcHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhcCCeeecCCCcceEEEcCCCCEEEccCccceecccccccc
Confidence            9999999999988776677999999999999999999999999999999999999999999999999988653322 222


Q ss_pred             ccCCCCcccccccccC-----CCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhccCCC--CCCCCCcHHHH
Q 015868          271 TAETGTYRWMAPEVIE-----HKPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKSLRP--TIPKHAHPRLA  343 (399)
Q Consensus       271 ~~~~gt~~y~aPE~l~-----~~~~~~~~Dv~slG~vl~elltg~~P~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~l~  343 (399)
                      ....+++.|+|||.+.     ...++.++|+||||+++|+|++|..||...++.+....... ...+  ..+..++.++.
T Consensus       168 ~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~  246 (292)
T cd06644         168 DSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAK-SEPPTLSQPSKWSMEFR  246 (292)
T ss_pred             ceecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCccccHHHHHHHHhc-CCCccCCCCcccCHHHH
Confidence            3456788999999984     34578899999999999999999999988777665544432 2222  23556889999


Q ss_pred             HHHHHHhhhcCCCCCCHHHHHH
Q 015868          344 ELLERCWQHDPTQRPNFSQITD  365 (399)
Q Consensus       344 ~ll~~cl~~dP~~Rps~~ell~  365 (399)
                      +++.+||..+|++||+++++++
T Consensus       247 ~li~~~l~~~p~~Rp~~~~il~  268 (292)
T cd06644         247 DFLKTALDKHPETRPSAAQLLE  268 (292)
T ss_pred             HHHHHHhcCCcccCcCHHHHhc
Confidence            9999999999999999999965

Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types.

>cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5

Probab=100.00  E-value=1.9e-41  Score=321.49  Aligned_cols=248  Identities=21%  Similarity=0.348  Sum_probs=209.0

Q ss_pred             cceeceeceeCceEEEEEEE--CCeeEEEEEecCCCCC-HHHHHHHHHHHHHHHhcCCCceeeEEeEEecCCcEEEEEec
Q 015868          118 LKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVN-TEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVTEF  194 (399)
Q Consensus       118 ~~i~~~lg~G~~g~Vy~~~~--~~~~vAvK~~~~~~~~-~~~~~~~~~Ei~~l~~l~h~nIv~~~~~~~~~~~~~lV~E~  194 (399)
                      |+..+.||.|+||.||++++  +++.||+|++...... ......+.+|+.+++.++|+||+.+++.+..++..++||||
T Consensus         2 ~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~   81 (285)
T cd05632           2 FRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYAYETKDALCLVLTI   81 (285)
T ss_pred             ceEEEEEecCCCeEEEEEEECCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCcCceeEEEEEecCCEEEEEEEe
Confidence            67788999999999999987  5789999999764322 23345678899999999999999999999999999999999


Q ss_pred             CCCCCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceeecCCCcEEEeeccceeeccCCCccccC
Q 015868          195 MARGSIYDFLHKQ-KGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAE  273 (399)
Q Consensus       195 ~~ggsL~~~l~~~-~~~l~~~~~~~i~~~i~~~L~~LH~~giiHrDlkp~NILl~~~~~vkl~DFG~a~~~~~~~~~~~~  273 (399)
                      +.+++|.+++... ...+++..+..++.|++.||.|||++||+||||||+||++++++.++|+|||++............
T Consensus        82 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~iiH~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~  161 (285)
T cd05632          82 MNGGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLHRENTVYRDLKPENILLDDYGHIRISDLGLAVKIPEGESIRGR  161 (285)
T ss_pred             ccCccHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCHHHEEECCCCCEEEecCCcceecCCCCcccCC
Confidence            9999999988654 346999999999999999999999999999999999999999999999999999765443334455


Q ss_pred             CCCcccccccccCCCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHh--ccCCCCCCCCCcHHHHHHHHHHhh
Q 015868          274 TGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQ--KSLRPTIPKHAHPRLAELLERCWQ  351 (399)
Q Consensus       274 ~gt~~y~aPE~l~~~~~~~~~Dv~slG~vl~elltg~~P~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~l~~ll~~cl~  351 (399)
                      .|+..|+|||.+.+..++.++|+||||+++|+|++|..||..............  ....+.++..+++++.+|+.+||+
T Consensus       162 ~g~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~  241 (285)
T cd05632         162 VGTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSPFRGRKEKVKREEVDRRVLETEEVYSAKFSEEAKSICKMLLT  241 (285)
T ss_pred             CCCcCccChHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhhccccccCccCCHHHHHHHHHHcc
Confidence            789999999999999999999999999999999999999987765433222221  112234566788999999999999


Q ss_pred             hcCCCCCC-----HHHHHH
Q 015868          352 HDPTQRPN-----FSQITD  365 (399)
Q Consensus       352 ~dP~~Rps-----~~ell~  365 (399)
                      .||++||+     +.++++
T Consensus       242 ~~P~~R~~~~~~~~~~l~~  260 (285)
T cd05632         242 KDPKQRLGCQEEGAGEVKR  260 (285)
T ss_pred             CCHhHcCCCcccChHHHHc
Confidence            99999999     556554

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with

>cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9

Probab=100.00  E-value=4.6e-41  Score=312.82  Aligned_cols=249  Identities=23%  Similarity=0.432  Sum_probs=218.3

Q ss_pred             ccceeceeceeCceEEEEEEE--CCeeEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCceeeEEeEEecCCcEEEEEec
Q 015868          117 QLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVTEF  194 (399)
Q Consensus       117 ~~~i~~~lg~G~~g~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~nIv~~~~~~~~~~~~~lV~E~  194 (399)
                      +|++.+.||.|+||.||.++.  .++.+++|.+.....+......+.+|+.++++++|+||+++++++......+++|||
T Consensus         1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~~~e~   80 (256)
T cd08221           1 HYIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYNHFMDDNTLLIEMEY   80 (256)
T ss_pred             CceEeeEecccCCceEEEEEEcCCCcEEEEEEEeecccchhHHHHHHHHHHHHHhCCCCCeeEEEeEEecCCeEEEEEEe
Confidence            588999999999998887765  678899999886655666677899999999999999999999999999999999999


Q ss_pred             CCCCCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceeecCCCcEEEeeccceeeccCCC-cccc
Q 015868          195 MARGSIYDFLHKQ-KGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSG-VMTA  272 (399)
Q Consensus       195 ~~ggsL~~~l~~~-~~~l~~~~~~~i~~~i~~~L~~LH~~giiHrDlkp~NILl~~~~~vkl~DFG~a~~~~~~~-~~~~  272 (399)
                      +++++|.+++... ...+++..+..++.|++.||.|||+.|++|+||+|+||+++.++.+||+|||.+....... ....
T Consensus        81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~ni~~~~~~~~kl~d~~~~~~~~~~~~~~~~  160 (256)
T cd08221          81 ANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIHKAGILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYSMAET  160 (256)
T ss_pred             cCCCcHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCCccccCCChHhEEEeCCCCEEECcCcceEEcccccccccc
Confidence            9999999999765 4568999999999999999999999999999999999999999999999999998654433 2344


Q ss_pred             CCCCcccccccccCCCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhccCCCCCCCCCcHHHHHHHHHHhhh
Q 015868          273 ETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRLAELLERCWQH  352 (399)
Q Consensus       273 ~~gt~~y~aPE~l~~~~~~~~~Dv~slG~vl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~cl~~  352 (399)
                      ..+++.|+|||.+.+..++.++|+||||+++|+|++|..||...+..+....... ...+..+..++.++.+++.+||..
T Consensus       161 ~~~~~~y~ape~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~i~~~l~~  239 (256)
T cd08221         161 VVGTPYYMSPELCQGVKYNFKSDIWALGCVLYELLTLKRTFDATNPLNLVVKIVQ-GNYTPVVSVYSSELISLVHSLLQQ  239 (256)
T ss_pred             cCCCccccCHhhcCCCCCCCcchhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHc-CCCCCCccccCHHHHHHHHHHccc
Confidence            5689999999999988899999999999999999999999988777665555443 334445567899999999999999


Q ss_pred             cCCCCCCHHHHHHH
Q 015868          353 DPTQRPNFSQITDI  366 (399)
Q Consensus       353 dP~~Rps~~ell~~  366 (399)
                      +|.+||++.++++.
T Consensus       240 ~p~~R~s~~~ll~~  253 (256)
T cd08221         240 DPEKRPTADEVLDQ  253 (256)
T ss_pred             CcccCCCHHHHhhC
Confidence            99999999999864

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa

>KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism]

Probab=100.00  E-value=8.1e-43  Score=324.12  Aligned_cols=242  Identities=28%  Similarity=0.440  Sum_probs=205.2

Q ss_pred             ccceeceeceeCceEEEEEEE--CCeeEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCceeeEEeEEecCC-----cEE
Q 015868          117 QLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPP-----NLC  189 (399)
Q Consensus       117 ~~~i~~~lg~G~~g~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~nIv~~~~~~~~~~-----~~~  189 (399)
                      .|.-.+.+|+|+||.||+|..  .++.||||..-.+..      .--+|..+|+.++|||||+++-+|....     ...
T Consensus        25 ~~~~~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~r------~knrEl~im~~l~HpNIV~L~~~f~~~~~~d~~~ln   98 (364)
T KOG0658|consen   25 SYEAVRLIGSGSFGVVYQAKLRETEEEVAIKKVLQDKR------YKNRELQIMRKLDHPNIVRLLYFFSSSTESDEVYLN   98 (364)
T ss_pred             EEEeeEEEeecccceEEEEEEcCCCceeEEEEecCCCC------cCcHHHHHHHhcCCcCeeeEEEEEEecCCCchhHHH
Confidence            567788999999999999976  568999998765421      2236999999999999999999885432     357


Q ss_pred             EEEecCCCCCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceeecCC-CcEEEeeccceeecc
Q 015868          190 IVTEFMARGSIYDFLHK---QKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDEN-GVVKVADFGVARVQA  265 (399)
Q Consensus       190 lV~E~~~ggsL~~~l~~---~~~~l~~~~~~~i~~~i~~~L~~LH~~giiHrDlkp~NILl~~~-~~vkl~DFG~a~~~~  265 (399)
                      +|||||+. +|++.++.   .+..++.-.++-+..||++||+|||+.||+||||||.|+|+|.+ |.+||||||.|+...
T Consensus        99 lVleymP~-tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh~~~IcHRDIKPqNlLvD~~tg~LKicDFGSAK~L~  177 (364)
T KOG0658|consen   99 LVLEYMPE-TLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLHSHGICHRDIKPQNLLVDPDTGVLKICDFGSAKVLV  177 (364)
T ss_pred             HHHHhchH-HHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHHhcCcccCCCChheEEEcCCCCeEEeccCCcceeec
Confidence            99999987 99999974   35778889999999999999999999999999999999999976 999999999999988


Q ss_pred             CCCccccCCCCcccccccccCCC-CCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcc---------------
Q 015868          266 QSGVMTAETGTYRWMAPEVIEHK-PYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKS---------------  329 (399)
Q Consensus       266 ~~~~~~~~~gt~~y~aPE~l~~~-~~~~~~Dv~slG~vl~elltg~~P~~~~~~~~~~~~~~~~~---------------  329 (399)
                      .......+..|..|.|||.+.+. .|+.+.||||.||++.||+-|++-|.+.+....+..+++-.               
T Consensus       178 ~~epniSYicSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl~g~plFpG~s~~dQL~eIik~lG~Pt~e~I~~mn~~y  257 (364)
T KOG0658|consen  178 KGEPNISYICSRYYRAPELIFGATEYTTSIDIWSAGCVMAELLKGQPLFPGDSSVDQLVEIIKVLGTPTREDIKSMNPNY  257 (364)
T ss_pred             cCCCceeEEEeccccCHHHHcCccccCceeEEhhhhHHHHHHhcCCcccCCCCHHHHHHHHHHHhCCCCHHHHhhcCccc
Confidence            88777888999999999999875 79999999999999999999999999987766655543210               


Q ss_pred             ---CCCC---------CCCCCcHHHHHHHHHHhhhcCCCCCCHHHHHH
Q 015868          330 ---LRPT---------IPKHAHPRLAELLERCWQHDPTQRPNFSQITD  365 (399)
Q Consensus       330 ---~~~~---------~~~~~~~~l~~ll~~cl~~dP~~Rps~~ell~  365 (399)
                         ..|.         .....++++.+|+.++|+++|.+|.++.|++.
T Consensus       258 ~~~~~p~ik~~~~~~~~~~~~~~d~~dll~~~L~Y~P~~R~~~~~~l~  305 (364)
T KOG0658|consen  258 TEFKFPQIKAHPWHKVFFKRLPPDALDLLSKLLQYSPSKRLSALEALA  305 (364)
T ss_pred             ccccCcccccccceeecccCCCHHHHHHHHHHhccChhhcCCHHHHhc
Confidence               0011         33567899999999999999999999999875

>PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity

Probab=100.00  E-value=3.2e-42  Score=320.61  Aligned_cols=247  Identities=33%  Similarity=0.589  Sum_probs=207.5

Q ss_pred             cceeceeceeCceEEEEEEEC--CeeEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCceeeEEeEEecCCcEEEEEecC
Q 015868          118 LKIECKVASGSYGDLYKGTYC--SQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVTEFM  195 (399)
Q Consensus       118 ~~i~~~lg~G~~g~Vy~~~~~--~~~vAvK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~nIv~~~~~~~~~~~~~lV~E~~  195 (399)
                      |++.+.||+|+||.||++...  ++.||+|++..............+|+.++++++||||+++++++......++|||++
T Consensus         1 y~~~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~v~~~~   80 (260)
T PF00069_consen    1 YRLVKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEIEEEEREENIREIKILRRLRHPNIVQILDVFQDDNYLYIVMEYC   80 (260)
T ss_dssp             EEEEEEEEEESSEEEEEEEETTTTEEEEEEEEESTTHHHHHHHHHHHHHHHHHHHTBTTBCHEEEEEEESSEEEEEEEEE
T ss_pred             CEEeEEEEeCCCEEEEEEEECCCCeEEEEEEeccccccccccchhhhhhhcccccccccccccccccccccccccccccc
Confidence            788999999999999999984  567999999987544444445567999999999999999999999999999999999


Q ss_pred             CCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceeecCCCcEEEeeccceeec-cCCCccccCC
Q 015868          196 ARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQ-AQSGVMTAET  274 (399)
Q Consensus       196 ~ggsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~giiHrDlkp~NILl~~~~~vkl~DFG~a~~~-~~~~~~~~~~  274 (399)
                      .+++|.+++.. ...+++..++.++.|++.||.+||++||+|+||||+||+++.++.++|+|||.+... ..........
T Consensus        81 ~~~~L~~~l~~-~~~~~~~~~~~~~~qi~~~L~~Lh~~~i~H~dikp~NIl~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~  159 (260)
T PF00069_consen   81 PGGSLQDYLQK-NKPLSEEEILKIAYQILEALAYLHSKGIVHRDIKPENILLDENGEVKLIDFGSSVKLSENNENFNPFV  159 (260)
T ss_dssp             TTEBHHHHHHH-HSSBBHHHHHHHHHHHHHHHHHHHHTTEEESSBSGGGEEESTTSEEEESSGTTTEESTSTTSEBSSSS
T ss_pred             ccccccccccc-cccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccc
Confidence            99999999983 567899999999999999999999999999999999999999999999999999763 2333455667


Q ss_pred             CCcccccccccC-CCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHH---HHHHHHhccCCCC--CCCCCcHHHHHHHHH
Q 015868          275 GTYRWMAPEVIE-HKPYDYKADVFSFGIALWELLTGELPYAGLTPLQ---AAVGVVQKSLRPT--IPKHAHPRLAELLER  348 (399)
Q Consensus       275 gt~~y~aPE~l~-~~~~~~~~Dv~slG~vl~elltg~~P~~~~~~~~---~~~~~~~~~~~~~--~~~~~~~~l~~ll~~  348 (399)
                      ++..|+|||.+. +..++.++|+||+|+++|+|++|..||.......   .............  .....+.++.+++.+
T Consensus       160 ~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~  239 (260)
T PF00069_consen  160 GTPEYMAPEVLQQGKKYTRKSDIWSLGIILYELLTGKLPFEESNSDDQLEIIEKILKRPLPSSSQQSREKSEELRDLIKK  239 (260)
T ss_dssp             SSGGGSCHHHHTTTSSBSTHHHHHHHHHHHHHHHHSSSSSTTSSHHHHHHHHHHHHHTHHHHHTTSHTTSHHHHHHHHHH
T ss_pred             ccccccccccccccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccccccchhHHHHHHHHHH
Confidence            899999999998 8889999999999999999999999999873322   2222222111111  112234899999999


Q ss_pred             HhhhcCCCCCCHHHHHH
Q 015868          349 CWQHDPTQRPNFSQITD  365 (399)
Q Consensus       349 cl~~dP~~Rps~~ell~  365 (399)
                      ||+.||++||++.++++
T Consensus       240 ~l~~~p~~R~~~~~l~~  256 (260)
T PF00069_consen  240 MLSKDPEQRPSAEELLK  256 (260)
T ss_dssp             HSSSSGGGSTTHHHHHT
T ss_pred             HccCChhHCcCHHHHhc
Confidence            99999999999999875

Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A ....

>cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.4e-41  Score=320.74  Aligned_cols=248  Identities=31%  Similarity=0.541  Sum_probs=213.8

Q ss_pred             ccccceeceeceeCceEEEEEEE--CCeeEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCceeeEEeEEecCCcEEEEE
Q 015868          115 AKQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVT  192 (399)
Q Consensus       115 ~~~~~i~~~lg~G~~g~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~nIv~~~~~~~~~~~~~lV~  192 (399)
                      .++|++.++||.|+||.||++..  ++..+|+|+++..  .......+.+|+.++++++||||+++++++..+...++||
T Consensus         4 ~~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   81 (280)
T cd06611           4 NDIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIE--SEEELEDFMVEIDILSECKHPNIVGLYEAYFYENKLWILI   81 (280)
T ss_pred             hhHHHHHHHhcCCCCceEEEEEEcCCCcEEEEEEEeeC--CHHHHHHHHHHHHHHHhCCCCceeEEEEEEecCCeEEEEe
Confidence            45799999999999999999987  4788999998754  4555678999999999999999999999999999999999


Q ss_pred             ecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceeecCCCcEEEeeccceeeccCC-Cccc
Q 015868          193 EFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQS-GVMT  271 (399)
Q Consensus       193 E~~~ggsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~giiHrDlkp~NILl~~~~~vkl~DFG~a~~~~~~-~~~~  271 (399)
                      ||+++++|.+++......+++..+..++.|++.||.|||++||+|+||+|+||+++.++.++|+|||.+...... ....
T Consensus        82 e~~~~~~L~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~  161 (280)
T cd06611          82 EFCDGGALDSIMLELERGLTEPQIRYVCRQMLEALNFLHSHKVIHRDLKAGNILLTLDGDVKLADFGVSAKNKSTLQKRD  161 (280)
T ss_pred             eccCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEECCCCCEEEccCccchhhcccccccc
Confidence            999999999999876678999999999999999999999999999999999999999999999999988654332 2233


Q ss_pred             cCCCCcccccccccC-----CCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhccCCCC--CCCCCcHHHHH
Q 015868          272 AETGTYRWMAPEVIE-----HKPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKSLRPT--IPKHAHPRLAE  344 (399)
Q Consensus       272 ~~~gt~~y~aPE~l~-----~~~~~~~~Dv~slG~vl~elltg~~P~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~l~~  344 (399)
                      ...+++.|+|||.+.     ..+++.++|+||||+++|+|++|..||...++.+...... ....+.  .+..++.++.+
T Consensus       162 ~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~  240 (280)
T cd06611         162 TFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELNPMRVLLKIL-KSEPPTLDQPSKWSSSFND  240 (280)
T ss_pred             eeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCcccCCHHHHHHHHh-cCCCCCcCCcccCCHHHHH
Confidence            446889999999975     3457889999999999999999999999887766554433 333222  35568899999


Q ss_pred             HHHHHhhhcCCCCCCHHHHHH
Q 015868          345 LLERCWQHDPTQRPNFSQITD  365 (399)
Q Consensus       345 ll~~cl~~dP~~Rps~~ell~  365 (399)
                      ++.+||+.+|.+||++.++++
T Consensus       241 li~~~l~~~p~~Rps~~~il~  261 (280)
T cd06611         241 FLKSCLVKDPDDRPTAAELLK  261 (280)
T ss_pred             HHHHHhccChhhCcCHHHHhc
Confidence            999999999999999999966

Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti

>cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2

Probab=100.00  E-value=2.1e-41  Score=322.65  Aligned_cols=254  Identities=29%  Similarity=0.563  Sum_probs=210.5

Q ss_pred             cccccceeceeceeCceEEEEEEEC------------------CeeEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCce
Q 015868          114 DAKQLKIECKVASGSYGDLYKGTYC------------------SQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNV  175 (399)
Q Consensus       114 ~~~~~~i~~~lg~G~~g~Vy~~~~~------------------~~~vAvK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~nI  175 (399)
                      ..++|++.++||+|+||.||++.+.                  ...||+|+++... .......+.+|+.+++.++|+||
T Consensus         3 ~~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~-~~~~~~~~~~E~~~l~~l~~~~i   81 (296)
T cd05095           3 PRKRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDA-NKNARNDFLKEIKIMSRLKDPNI   81 (296)
T ss_pred             ChhhceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccC-CHHHHHHHHHHHHHHHhCCCCCc
Confidence            4568999999999999999998542                  2368999987542 34456789999999999999999


Q ss_pred             eeEEeEEecCCcEEEEEecCCCCCHHHHHHhcC----------CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCce
Q 015868          176 VQFIGACTRPPNLCIVTEFMARGSIYDFLHKQK----------GVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANL  245 (399)
Q Consensus       176 v~~~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~----------~~l~~~~~~~i~~~i~~~L~~LH~~giiHrDlkp~NI  245 (399)
                      +++++++......++||||+.+++|.+++....          ..+++..+..++.|++.||+|||++|++|+||||+||
T Consensus        82 ~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dlkp~Ni  161 (296)
T cd05095          82 IRLLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSLNFVHRDLATRNC  161 (296)
T ss_pred             ceEEEEEecCCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHHCCeecccCChheE
Confidence            999999999999999999999999999997642          2366788999999999999999999999999999999


Q ss_pred             eecCCCcEEEeeccceeeccCCCc---cccCCCCcccccccccCCCCCCChhhHHHHHHHHHHHHc--CCCCCCCCCHHH
Q 015868          246 LMDENGVVKVADFGVARVQAQSGV---MTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLT--GELPYAGLTPLQ  320 (399)
Q Consensus       246 Ll~~~~~vkl~DFG~a~~~~~~~~---~~~~~gt~~y~aPE~l~~~~~~~~~Dv~slG~vl~ellt--g~~P~~~~~~~~  320 (399)
                      +++.++.++|+|||.++.......   .....++..|++||...+..++.++|+||||+++|||++  |..||...+..+
T Consensus       162 li~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~DiwSlG~~l~el~~~~~~~p~~~~~~~~  241 (296)
T cd05095         162 LVGKNYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILTLCKEQPYSQLSDEQ  241 (296)
T ss_pred             EEcCCCCEEeccCcccccccCCcceeccCcCcCccccCCHHHHhcCCccchhhhhHHHHHHHHHHHhCCCCCccccChHH
Confidence            999999999999999875433221   122234678999999888889999999999999999998  778998777655


Q ss_pred             HHHHHHh------ccCCCCCCCCCcHHHHHHHHHHhhhcCCCCCCHHHHHHHHH
Q 015868          321 AAVGVVQ------KSLRPTIPKHAHPRLAELLERCWQHDPTQRPNFSQITDILK  368 (399)
Q Consensus       321 ~~~~~~~------~~~~~~~~~~~~~~l~~ll~~cl~~dP~~Rps~~ell~~L~  368 (399)
                      .......      .......+..+++.+.+++.+||+.||.+||++.++.+.|+
T Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~  295 (296)
T cd05095         242 VIENTGEFFRDQGRQVYLPKPALCPDSLYKLMLSCWRRNAKERPSFQEIHATLL  295 (296)
T ss_pred             HHHHHHHHHhhccccccCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHHh
Confidence            4433211      11122345568899999999999999999999999999886

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit

>cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases

Probab=100.00  E-value=3e-41  Score=315.97  Aligned_cols=247  Identities=31%  Similarity=0.608  Sum_probs=212.9

Q ss_pred             ccceeceeceeCceEEEEEEE--CCeeEEEEEecCCCCC-------HHHHHHHHHHHHHHHhcCCCceeeEEeEEecCCc
Q 015868          117 QLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVN-------TEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPN  187 (399)
Q Consensus       117 ~~~i~~~lg~G~~g~Vy~~~~--~~~~vAvK~~~~~~~~-------~~~~~~~~~Ei~~l~~l~h~nIv~~~~~~~~~~~  187 (399)
                      +|.+...||.|++|.||+|..  .++.||+|.+......       ....+.+.+|+.++++++||||+++++++.....
T Consensus         1 ~~~~~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~   80 (267)
T cd06628           1 KWIKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSLDADH   80 (267)
T ss_pred             CccccceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCc
Confidence            467888999999999999986  5688999988754322       1234678899999999999999999999999999


Q ss_pred             EEEEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceeecCCCcEEEeeccceeeccCC
Q 015868          188 LCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQS  267 (399)
Q Consensus       188 ~~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~giiHrDlkp~NILl~~~~~vkl~DFG~a~~~~~~  267 (399)
                      .++||||+++++|.+++... +.+++..+..++.|++.||+|||++|++||||+|+||++++++.++|+|||.++.....
T Consensus        81 ~~lv~e~~~~~~L~~~l~~~-~~l~~~~~~~~~~~l~~~l~~lH~~~ivH~di~p~nil~~~~~~~~l~dfg~~~~~~~~  159 (267)
T cd06628          81 LNIFLEYVPGGSVAALLNNY-GAFEETLVRNFVRQILKGLNYLHNRGIIHRDIKGANILVDNKGGIKISDFGISKKLEAN  159 (267)
T ss_pred             cEEEEEecCCCCHHHHHHhc-cCccHHHHHHHHHHHHHHHHHHHhcCcccccCCHHHEEEcCCCCEEecccCCCcccccc
Confidence            99999999999999999764 67899999999999999999999999999999999999999999999999998765422


Q ss_pred             C-------ccccCCCCcccccccccCCCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhccCCCCCCCCCcH
Q 015868          268 G-------VMTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKSLRPTIPKHAHP  340 (399)
Q Consensus       268 ~-------~~~~~~gt~~y~aPE~l~~~~~~~~~Dv~slG~vl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~  340 (399)
                      .       ......++..|+|||.+.+..++.++|+||||+++|+|++|+.||...+..+..... .....+.++..++.
T Consensus       160 ~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~-~~~~~~~~~~~~~~  238 (267)
T cd06628         160 SLSTKTNGARPSLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPDCTQLQAIFKI-GENASPEIPSNISS  238 (267)
T ss_pred             cccCCccccccccCCCcCccChhHhccCCCCchhhhHHHHHHHHHHhhCCCCCCCccHHHHHHHH-hccCCCcCCcccCH
Confidence            1       112235788999999999888999999999999999999999999887766544433 33556778888999


Q ss_pred             HHHHHHHHHhhhcCCCCCCHHHHHH
Q 015868          341 RLAELLERCWQHDPTQRPNFSQITD  365 (399)
Q Consensus       341 ~l~~ll~~cl~~dP~~Rps~~ell~  365 (399)
                      .+.++|.+||+.+|.+||++.++++
T Consensus       239 ~~~~li~~~l~~~p~~Rp~~~~il~  263 (267)
T cd06628         239 EAIDFLEKTFEIDHNKRPTAAELLK  263 (267)
T ss_pred             HHHHHHHHHccCCchhCcCHHHHhh
Confidence            9999999999999999999999875

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate

>cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta

Probab=100.00  E-value=6.5e-42  Score=331.85  Aligned_cols=250  Identities=19%  Similarity=0.339  Sum_probs=209.8

Q ss_pred             cccceeceeceeCceEEEEEEE--CCeeEEEEEecCCC-CCHHHHHHHHHHHHHHHhcCCCceeeEEeEEecCCcEEEEE
Q 015868          116 KQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPEC-VNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVT  192 (399)
Q Consensus       116 ~~~~i~~~lg~G~~g~Vy~~~~--~~~~vAvK~~~~~~-~~~~~~~~~~~Ei~~l~~l~h~nIv~~~~~~~~~~~~~lV~  192 (399)
                      ++|++.++||+|+||.||+++.  .++.||+|++.... ........+.+|+.++..++|+||+++++++..++..|+||
T Consensus         1 d~y~i~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~~~~~~~lv~   80 (331)
T cd05624           1 DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHYAFQDENYLYLVM   80 (331)
T ss_pred             CCceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence            4789999999999999999987  56789999987421 12333456889999999999999999999999999999999


Q ss_pred             ecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceeecCCCcEEEeeccceeeccCCCcc--
Q 015868          193 EFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVM--  270 (399)
Q Consensus       193 E~~~ggsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~giiHrDlkp~NILl~~~~~vkl~DFG~a~~~~~~~~~--  270 (399)
                      ||+.||+|.+++......+++..+..++.|++.||.|||++||+||||||+|||++.++.+||+|||+++........  
T Consensus        81 Ey~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~~L~~lH~~~iiHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~~  160 (331)
T cd05624          81 DYYVGGDLLTLLSKFEDRLPEDMARFYIAEMVLAIHSIHQLHYVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQDGTVQS  160 (331)
T ss_pred             eCCCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCchHHEEEcCCCCEEEEeccceeeccCCCceee
Confidence            999999999999876678999999999999999999999999999999999999999999999999999765543322  


Q ss_pred             ccCCCCcccccccccCC-----CCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhccCCCCCC---CCCcHHH
Q 015868          271 TAETGTYRWMAPEVIEH-----KPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKSLRPTIP---KHAHPRL  342 (399)
Q Consensus       271 ~~~~gt~~y~aPE~l~~-----~~~~~~~Dv~slG~vl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~l  342 (399)
                      ....||+.|+|||++.+     ..++.++|+||||+++|+|++|+.||...+..+..........+..+|   ..++.++
T Consensus       161 ~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~~~~~  240 (331)
T cd05624         161 SVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHEERFQFPSHITDVSEEA  240 (331)
T ss_pred             ccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCccCCCHHHHHHHHHcCCCcccCCCccccCCHHH
Confidence            23468999999999876     467889999999999999999999999888777666555444333333   3468999


Q ss_pred             HHHHHHHhhhcCCC--CCCHHHHHH
Q 015868          343 AELLERCWQHDPTQ--RPNFSQITD  365 (399)
Q Consensus       343 ~~ll~~cl~~dP~~--Rps~~ell~  365 (399)
                      .+++.+|+..++..  |++++++++
T Consensus       241 ~~li~~ll~~~~~~~~~~~~~~~~~  265 (331)
T cd05624         241 KDLIQRLICSRERRLGQNGIEDFKK  265 (331)
T ss_pred             HHHHHHHccCchhhcCCCCHHHHhc
Confidence            99999999865543  457877765

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues.

>cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4

Probab=100.00  E-value=3.5e-41  Score=315.38  Aligned_cols=248  Identities=29%  Similarity=0.554  Sum_probs=212.8

Q ss_pred             ccceeceeceeCceEEEEEEE-CCeeEEEEEecCCCC----CHHHHHHHHHHHHHHHhcCCCceeeEEeEEecCCcEEEE
Q 015868          117 QLKIECKVASGSYGDLYKGTY-CSQEVAIKVLKPECV----NTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIV  191 (399)
Q Consensus       117 ~~~i~~~lg~G~~g~Vy~~~~-~~~~vAvK~~~~~~~----~~~~~~~~~~Ei~~l~~l~h~nIv~~~~~~~~~~~~~lV  191 (399)
                      +|++.+.||.|+||.||+|.. .++.+|+|.++....    .......+.+|+.++++++|+||+++++++......++|
T Consensus         1 ~~~~~~~ig~g~~~~v~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv   80 (265)
T cd06631           1 EWTKGEVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLDDNTISIF   80 (265)
T ss_pred             CccccceEeccCCeEEEEEEEcCCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEeecCCeEEEE
Confidence            478899999999999999976 677899999875432    223446789999999999999999999999999999999


Q ss_pred             EecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceeecCCCcEEEeeccceeeccCC----
Q 015868          192 TEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQS----  267 (399)
Q Consensus       192 ~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~giiHrDlkp~NILl~~~~~vkl~DFG~a~~~~~~----  267 (399)
                      +||++|++|.+++... ..+++..+..++.|++.||+|||+.||+|+||+|+||++++++.++|+|||.+......    
T Consensus        81 ~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~  159 (265)
T cd06631          81 MEFVPGGSISSILNRF-GPLPEPVFCKYTKQILDGVAYLHNNCVVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLHG  159 (265)
T ss_pred             EecCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcCHHhEEECCCCeEEeccchhhHhhhhccccc
Confidence            9999999999999763 56899999999999999999999999999999999999999999999999998754221    


Q ss_pred             ---CccccCCCCcccccccccCCCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhc-cCCCCCCCCCcHHHH
Q 015868          268 ---GVMTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQK-SLRPTIPKHAHPRLA  343 (399)
Q Consensus       268 ---~~~~~~~gt~~y~aPE~l~~~~~~~~~Dv~slG~vl~elltg~~P~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~l~  343 (399)
                         .......++..|+|||.+.+..++.++|+||||+++|+|++|..||...+........... ...+.++..++.++.
T Consensus       160 ~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (265)
T cd06631         160 THSNMLKSMHGTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGKPPLASMDRLAAMFYIGAHRGLMPRLPDSFSAAAI  239 (265)
T ss_pred             cccccccccCCCccccChhhhcCCCCcchhhHHHHHHHHHHHHhCCCccccCChHHHHHHhhhccCCCCCCCCCCCHHHH
Confidence               1123346889999999999988999999999999999999999999887765544433322 345667888999999


Q ss_pred             HHHHHHhhhcCCCCCCHHHHHH
Q 015868          344 ELLERCWQHDPTQRPNFSQITD  365 (399)
Q Consensus       344 ~ll~~cl~~dP~~Rps~~ell~  365 (399)
                      +++++||+.+|.+||++.++++
T Consensus       240 ~~i~~~l~~~p~~Rp~~~~~l~  261 (265)
T cd06631         240 DFVTSCLTRDQHERPSALQLLR  261 (265)
T ss_pred             HHHHHHhcCCcccCCCHHHHhc
Confidence            9999999999999999999875

Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals.

>cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3

Probab=100.00  E-value=3.7e-42  Score=332.58  Aligned_cols=239  Identities=26%  Similarity=0.404  Sum_probs=201.9

Q ss_pred             ceeceeCceEEEEEEE--CCeeEEEEEecCCCC-CHHHHHHHHHHHH-HHHhcCCCceeeEEeEEecCCcEEEEEecCCC
Q 015868          122 CKVASGSYGDLYKGTY--CSQEVAIKVLKPECV-NTEMLKEFSQEVY-IMRKIRHKNVVQFIGACTRPPNLCIVTEFMAR  197 (399)
Q Consensus       122 ~~lg~G~~g~Vy~~~~--~~~~vAvK~~~~~~~-~~~~~~~~~~Ei~-~l~~l~h~nIv~~~~~~~~~~~~~lV~E~~~g  197 (399)
                      +.||+|+||.||+++.  +++.||+|++..... +......+.+|.. +++.++||||+++++++......++||||++|
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~~~~~~lv~e~~~~   80 (325)
T cd05604           1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTTEKLYFVLDFVNG   80 (325)
T ss_pred             CceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCCCCCCccEEEEEecCCEEEEEEcCCCC
Confidence            4689999999999987  578999999975321 2233345555654 56789999999999999999999999999999


Q ss_pred             CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceeecCCCcEEEeeccceeeccC-CCccccCCCC
Q 015868          198 GSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQ-SGVMTAETGT  276 (399)
Q Consensus       198 gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~giiHrDlkp~NILl~~~~~vkl~DFG~a~~~~~-~~~~~~~~gt  276 (399)
                      ++|..++.. ...+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+++.... ........||
T Consensus        81 ~~L~~~l~~-~~~~~~~~~~~~~~qi~~al~~lH~~givH~Dlkp~NIll~~~~~~kL~DfG~~~~~~~~~~~~~~~~gt  159 (325)
T cd05604          81 GELFFHLQR-ERSFPEPRARFYAAEIASALGYLHSINIVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQSDTTTTFCGT  159 (325)
T ss_pred             CCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECCCCCEEEeecCCcccCCCCCCCcccccCC
Confidence            999998865 46789999999999999999999999999999999999999999999999999875322 2233445689


Q ss_pred             cccccccccCCCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhccCCCCCCCCCcHHHHHHHHHHhhhcCCC
Q 015868          277 YRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRLAELLERCWQHDPTQ  356 (399)
Q Consensus       277 ~~y~aPE~l~~~~~~~~~Dv~slG~vl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~cl~~dP~~  356 (399)
                      +.|+|||++.+..++.++|||||||++|+|++|..||...+..+........  ...++...+..+.+++.+||+.+|.+
T Consensus       160 ~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~ll~~ll~~~p~~  237 (325)
T cd05604         160 PEYLAPEVIRKQPYDNTVDWWCLGAVLYEMLYGLPPFYCRDVAEMYDNILHK--PLVLRPGASLTAWSILEELLEKDRQR  237 (325)
T ss_pred             hhhCCHHHHcCCCCCCcCccccccceehhhhcCCCCCCCCCHHHHHHHHHcC--CccCCCCCCHHHHHHHHHHhccCHHh
Confidence            9999999999999999999999999999999999999988877766555443  23445568899999999999999999


Q ss_pred             CCCHHHH
Q 015868          357 RPNFSQI  363 (399)
Q Consensus       357 Rps~~el  363 (399)
                      ||++.+.
T Consensus       238 R~~~~~~  244 (325)
T cd05604         238 RLGAKED  244 (325)
T ss_pred             cCCCCCC
Confidence            9988643

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels,

>cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron

Probab=100.00  E-value=4.9e-41  Score=313.66  Aligned_cols=249  Identities=31%  Similarity=0.579  Sum_probs=207.8

Q ss_pred             ceeceeCceEEEEEEEC-----CeeEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCceeeEEeEEe-cCCcEEEEEecC
Q 015868          122 CKVASGSYGDLYKGTYC-----SQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACT-RPPNLCIVTEFM  195 (399)
Q Consensus       122 ~~lg~G~~g~Vy~~~~~-----~~~vAvK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~nIv~~~~~~~-~~~~~~lV~E~~  195 (399)
                      +.||+|+||.||+|...     ...||+|.+.... .......+.+|+.+++.++||||+++++++. .++..++||||+
T Consensus         1 ~~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~~   79 (262)
T cd05058           1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRIT-DLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPSEGSPLVVLPYM   79 (262)
T ss_pred             CcccccCCceEEEEEEecCCCceEEEEEEecCccC-CHHHHHHHHHHHHHHccCCCCCcceEEEEeecCCCCcEEEEecC
Confidence            36899999999999852     3569999986432 3445678899999999999999999999875 455689999999


Q ss_pred             CCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceeecCCCcEEEeeccceeeccCCC-----cc
Q 015868          196 ARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSG-----VM  270 (399)
Q Consensus       196 ~ggsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~giiHrDlkp~NILl~~~~~vkl~DFG~a~~~~~~~-----~~  270 (399)
                      .+++|.+++.......+...+..++.|+++||+|||+.+++||||||+||++++++.+||+|||.++......     ..
T Consensus        80 ~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlk~~nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~  159 (262)
T cd05058          80 KHGDLRNFIRSETHNPTVKDLIGFGLQVAKGMEYLASKKFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSVHNH  159 (262)
T ss_pred             CCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCccccccCcceEEEcCCCcEEECCccccccccCCcceeeccc
Confidence            9999999998766667888889999999999999999999999999999999999999999999987543221     11


Q ss_pred             ccCCCCcccccccccCCCCCCChhhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHHhccCCCCCCCCCcHHHHHHHHHH
Q 015868          271 TAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLT-GELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRLAELLERC  349 (399)
Q Consensus       271 ~~~~gt~~y~aPE~l~~~~~~~~~Dv~slG~vl~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~c  349 (399)
                      ....++..|+|||.+.+..++.++||||||+++|||++ |.+||...+..+.... +.....+..+...++.+.+++.+|
T Consensus       160 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~li~~c  238 (262)
T cd05058         160 TGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVDSFDITVY-LLQGRRLLQPEYCPDPLYEVMLSC  238 (262)
T ss_pred             ccCcCCccccChhHhccCccchHHHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH-HhcCCCCCCCCcCCHHHHHHHHHH
Confidence            22345778999999998899999999999999999999 5678887776654443 334445556667889999999999


Q ss_pred             hhhcCCCCCCHHHHHHHHHHHHH
Q 015868          350 WQHDPTQRPNFSQITDILKQMMK  372 (399)
Q Consensus       350 l~~dP~~Rps~~ell~~L~~l~~  372 (399)
                      |+.+|++||++.++++.|+++..
T Consensus       239 l~~~p~~Rp~~~~il~~l~~~~~  261 (262)
T cd05058         239 WHPKPEMRPTFSELVSRIEQIFS  261 (262)
T ss_pred             cCCChhhCCCHHHHHHHHHHHhc
Confidence            99999999999999999998753

Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca

>cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4

Probab=100.00  E-value=7.3e-41  Score=311.39  Aligned_cols=248  Identities=27%  Similarity=0.477  Sum_probs=214.1

Q ss_pred             ccceeceeceeCceEEEEEEE--CCeeEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCceeeEEeEEec-CCcEEEEEe
Q 015868          117 QLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTR-PPNLCIVTE  193 (399)
Q Consensus       117 ~~~i~~~lg~G~~g~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~nIv~~~~~~~~-~~~~~lV~E  193 (399)
                      .|++.+.||.|++|.||++..  .++.||+|.+..........+.+.+|+.++++++|+|++++++.+.. ...+++|||
T Consensus         1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e   80 (257)
T cd08223           1 AYCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRESWEGEDGLLYIVMG   80 (257)
T ss_pred             CceEEEEecCCCCeEEEEEEEcCCCcEEEEEEEehhhcCHHHHHHHHHHHHHHHhCCCCCeeeeeeeecCCCCEEEEEec
Confidence            488999999999999999976  56789999997665555666789999999999999999999998764 445799999


Q ss_pred             cCCCCCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceeecCCCcEEEeeccceeeccCC-Cccc
Q 015868          194 FMARGSIYDFLHKQ-KGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQS-GVMT  271 (399)
Q Consensus       194 ~~~ggsL~~~l~~~-~~~l~~~~~~~i~~~i~~~L~~LH~~giiHrDlkp~NILl~~~~~vkl~DFG~a~~~~~~-~~~~  271 (399)
                      |+++++|.+++... ...+++.+++.++.+++.|+++||++|++||||+|+||+++.++.++|+|||.+...... ....
T Consensus        81 ~~~~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~l~~lH~~~i~H~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~  160 (257)
T cd08223          81 FCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYLHEKHILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQCDMAS  160 (257)
T ss_pred             ccCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCchhEEEecCCcEEEecccceEEecccCCccc
Confidence            99999999999764 346899999999999999999999999999999999999999999999999999765432 2233


Q ss_pred             cCCCCcccccccccCCCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhccCCCCCCCCCcHHHHHHHHHHhh
Q 015868          272 AETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRLAELLERCWQ  351 (399)
Q Consensus       272 ~~~gt~~y~aPE~l~~~~~~~~~Dv~slG~vl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~cl~  351 (399)
                      ...+++.|+|||.+.+..++.++|+||||+++++|++|+.||...+......... ....+..+...++++.+++.+||+
T Consensus       161 ~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~li~~~l~  239 (257)
T cd08223         161 TLIGTPYYMSPELFSNKPYNYKSDVWALGCCVYEMATLKHAFNAKDMNSLVYRII-EGKLPPMPKDYSPELGELIATMLS  239 (257)
T ss_pred             cccCCcCccChhHhcCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCHHHHHHHHH-hcCCCCCccccCHHHHHHHHHHhc
Confidence            4568899999999999999999999999999999999999998877655444333 344556777899999999999999


Q ss_pred             hcCCCCCCHHHHHH
Q 015868          352 HDPTQRPNFSQITD  365 (399)
Q Consensus       352 ~dP~~Rps~~ell~  365 (399)
                      .+|++||++.++++
T Consensus       240 ~~p~~Rp~~~~~l~  253 (257)
T cd08223         240 KRPEKRPSVKSILR  253 (257)
T ss_pred             cCcccCCCHHHHhc
Confidence            99999999999875

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown.

>cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8

Probab=100.00  E-value=3.9e-41  Score=312.82  Aligned_cols=248  Identities=24%  Similarity=0.428  Sum_probs=217.1

Q ss_pred             ccceeceeceeCceEEEEEEE--CCeeEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCceeeEEeEEecCCcEEEEEec
Q 015868          117 QLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVTEF  194 (399)
Q Consensus       117 ~~~i~~~lg~G~~g~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~nIv~~~~~~~~~~~~~lV~E~  194 (399)
                      +|++.+.||.|+||.||++..  .++.+|+|.+.....+......+.+|+.+++.++||||+++++.+...+..++||||
T Consensus         1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~   80 (256)
T cd08220           1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYENFLEDKALMIVMEY   80 (256)
T ss_pred             CceEEEEecccCceEEEEEEEcCCCcEEEEEEEeccccccHHHHHHHHHHHHHhhCCCCchhheeeeEecCCEEEEEEec
Confidence            588899999999999999876  678899999987655666678899999999999999999999999999999999999


Q ss_pred             CCCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceeecCC-CcEEEeeccceeeccCCCcccc
Q 015868          195 MARGSIYDFLHKQK-GVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDEN-GVVKVADFGVARVQAQSGVMTA  272 (399)
Q Consensus       195 ~~ggsL~~~l~~~~-~~l~~~~~~~i~~~i~~~L~~LH~~giiHrDlkp~NILl~~~-~~vkl~DFG~a~~~~~~~~~~~  272 (399)
                      +++++|.+++.... ..+++..+..++.+++.+|.|||++|++|+||+|+||+++++ +.++|+|||.+...........
T Consensus        81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~~~~~  160 (256)
T cd08220          81 APGGTLAEYIQKRCNSLLDEDTILHFFVQILLALHHVHTKLILHRDLKTQNILLDKHKMVVKIGDFGISKILSSKSKAYT  160 (256)
T ss_pred             CCCCCHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEEccCCCceecCCCccccc
Confidence            99999999997753 458999999999999999999999999999999999999865 4689999999987665444445


Q ss_pred             CCCCcccccccccCCCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhccCCCCCCCCCcHHHHHHHHHHhhh
Q 015868          273 ETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRLAELLERCWQH  352 (399)
Q Consensus       273 ~~gt~~y~aPE~l~~~~~~~~~Dv~slG~vl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~cl~~  352 (399)
                      ..++..|+|||.+.+..++.++|+||||+++|+|++|..||...+.......... ...+.++..+++++.+++.+||+.
T Consensus       161 ~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~l~~li~~~l~~  239 (256)
T cd08220         161 VVGTPCYISPELCEGKPYNQKSDIWALGCVLYELASLKRAFEAANLPALVLKIMS-GTFAPISDRYSPDLRQLILSMLNL  239 (256)
T ss_pred             cccCCcccCchhccCCCCCcccchHHHHHHHHHHHhCCCCcccCchHHHHHHHHh-cCCCCCCCCcCHHHHHHHHHHccC
Confidence            5788999999999998899999999999999999999999988776665544443 334456677899999999999999


Q ss_pred             cCCCCCCHHHHHH
Q 015868          353 DPTQRPNFSQITD  365 (399)
Q Consensus       353 dP~~Rps~~ell~  365 (399)
                      +|.+|||+.|+++
T Consensus       240 ~p~~Rpt~~~ll~  252 (256)
T cd08220         240 DPSKRPQLSQIMA  252 (256)
T ss_pred             ChhhCCCHHHHhh
Confidence            9999999999975

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with

>cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha

Probab=100.00  E-value=1.5e-41  Score=328.16  Aligned_cols=242  Identities=24%  Similarity=0.425  Sum_probs=207.1

Q ss_pred             ccceeceeceeCceEEEEEEE--CCeeEEEEEecCCCC-CHHHHHHHHHHHHHHHhcC-CCceeeEEeEEecCCcEEEEE
Q 015868          117 QLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECV-NTEMLKEFSQEVYIMRKIR-HKNVVQFIGACTRPPNLCIVT  192 (399)
Q Consensus       117 ~~~i~~~lg~G~~g~Vy~~~~--~~~~vAvK~~~~~~~-~~~~~~~~~~Ei~~l~~l~-h~nIv~~~~~~~~~~~~~lV~  192 (399)
                      +|.+.+.||+|+||.||+|..  +++.||+|+++.... .....+.+..|..+++.+. |++|+++++++...+.+|+||
T Consensus         1 ~f~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~   80 (323)
T cd05615           1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQTVDRLYFVM   80 (323)
T ss_pred             CceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEEecCCEEEEEE
Confidence            367889999999999999987  578999999975422 2334566788999998886 577888999999999999999


Q ss_pred             ecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceeecCCCcEEEeeccceeeccCCC-ccc
Q 015868          193 EFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSG-VMT  271 (399)
Q Consensus       193 E~~~ggsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~giiHrDlkp~NILl~~~~~vkl~DFG~a~~~~~~~-~~~  271 (399)
                      ||++||+|.+++.. .+.+++..+..++.|++.||.|||++||+||||||+|||++.++.+||+|||+++...... ...
T Consensus        81 Ey~~~g~L~~~i~~-~~~l~~~~~~~i~~qi~~al~~lH~~~ivHrDikp~Nill~~~~~ikL~Dfg~~~~~~~~~~~~~  159 (323)
T cd05615          81 EYVNGGDLMYHIQQ-VGKFKEPQAVFYAAEISVGLFFLHRRGIIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVDGVTTR  159 (323)
T ss_pred             cCCCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEEeccccccccCCCCcccc
Confidence            99999999999865 4679999999999999999999999999999999999999999999999999987543222 223


Q ss_pred             cCCCCcccccccccCCCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhccCCCCCCCCCcHHHHHHHHHHhh
Q 015868          272 AETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRLAELLERCWQ  351 (399)
Q Consensus       272 ~~~gt~~y~aPE~l~~~~~~~~~Dv~slG~vl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~cl~  351 (399)
                      ...||+.|+|||++.+..++.++|+||||+++|+|++|..||.+.++.+........  ....|..+++++.+++.+||+
T Consensus       160 ~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~~~~~~i~~~--~~~~p~~~~~~~~~li~~~l~  237 (323)
T cd05615         160 TFCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGEDEDELFQSIMEH--NVSYPKSLSKEAVSICKGLMT  237 (323)
T ss_pred             CccCCccccCHHHHcCCCCCCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhC--CCCCCccCCHHHHHHHHHHcc
Confidence            346899999999999999999999999999999999999999998887766655543  345677889999999999999


Q ss_pred             hcCCCCCCHH
Q 015868          352 HDPTQRPNFS  361 (399)
Q Consensus       352 ~dP~~Rps~~  361 (399)
                      .+|.+|++..
T Consensus       238 ~~p~~R~~~~  247 (323)
T cd05615         238 KHPSKRLGCG  247 (323)
T ss_pred             cCHhhCCCCC
Confidence            9999999853

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a

>cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1

Probab=100.00  E-value=4.8e-41  Score=312.38  Aligned_cols=248  Identities=32%  Similarity=0.577  Sum_probs=217.4

Q ss_pred             ccceeceeceeCceEEEEEEE--CCeeEEEEEecCCC---CCHHHHHHHHHHHHHHHhcCCCceeeEEeEEecCCcEEEE
Q 015868          117 QLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPEC---VNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIV  191 (399)
Q Consensus       117 ~~~i~~~lg~G~~g~Vy~~~~--~~~~vAvK~~~~~~---~~~~~~~~~~~Ei~~l~~l~h~nIv~~~~~~~~~~~~~lV  191 (399)
                      +|+..+.||+|++|.||+|..  .++.|++|.+....   ...+..+.+.+|+.+++.++|+||+++++++.....+++|
T Consensus         1 ~~~~~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv   80 (258)
T cd06632           1 RWRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTEREEDNLYIF   80 (258)
T ss_pred             CccccceeeecCCceEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeEecCCeEEEE
Confidence            467788999999999999987  57899999986532   2344567899999999999999999999999999999999


Q ss_pred             EecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceeecCCCcEEEeeccceeeccCCCccc
Q 015868          192 TEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMT  271 (399)
Q Consensus       192 ~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~giiHrDlkp~NILl~~~~~vkl~DFG~a~~~~~~~~~~  271 (399)
                      +||+++++|.+++... ..+++..+..++.|++.|++|||+.|++|+||+|+||+++.++.+||+|||.+..........
T Consensus        81 ~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~~~ni~~~~~~~~kl~d~~~~~~~~~~~~~~  159 (258)
T cd06632          81 LELVPGGSLAKLLKKY-GSFPEPVIRLYTRQILLGLEYLHDRNTVHRDIKGANILVDTNGVVKLADFGMAKQVVEFSFAK  159 (258)
T ss_pred             EEecCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEccCccceecccccccc
Confidence            9999999999999764 568899999999999999999999999999999999999999999999999998765544345


Q ss_pred             cCCCCcccccccccCCCC-CCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhccCCCCCCCCCcHHHHHHHHHHh
Q 015868          272 AETGTYRWMAPEVIEHKP-YDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRLAELLERCW  350 (399)
Q Consensus       272 ~~~gt~~y~aPE~l~~~~-~~~~~Dv~slG~vl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~cl  350 (399)
                      ...++..|+|||.+.+.. ++.++|+||||+++|+|++|..||....+.+...........+.++..+++++.+++.+||
T Consensus       160 ~~~~~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l  239 (258)
T cd06632         160 SFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLEGVAAVFKIGRSKELPPIPDHLSDEAKDFILKCL  239 (258)
T ss_pred             ccCCCcceeCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcccCcHHHHHHHHHhcccCCCcCCCcCHHHHHHHHHHh
Confidence            567889999999998776 8999999999999999999999998877666555555445567778889999999999999


Q ss_pred             hhcCCCCCCHHHHHH
Q 015868          351 QHDPTQRPNFSQITD  365 (399)
Q Consensus       351 ~~dP~~Rps~~ell~  365 (399)
                      +.+|.+||++.+++.
T Consensus       240 ~~~p~~Rp~~~~~l~  254 (258)
T cd06632         240 QRDPSLRPTAAELLE  254 (258)
T ss_pred             hcCcccCcCHHHHhc
Confidence            999999999999874

Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops

>cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha

Probab=100.00  E-value=1e-41  Score=330.58  Aligned_cols=251  Identities=20%  Similarity=0.344  Sum_probs=210.6

Q ss_pred             cccceeceeceeCceEEEEEEE--CCeeEEEEEecCCC-CCHHHHHHHHHHHHHHHhcCCCceeeEEeEEecCCcEEEEE
Q 015868          116 KQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPEC-VNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVT  192 (399)
Q Consensus       116 ~~~~i~~~lg~G~~g~Vy~~~~--~~~~vAvK~~~~~~-~~~~~~~~~~~Ei~~l~~l~h~nIv~~~~~~~~~~~~~lV~  192 (399)
                      ++|++.++||+|+||.||+++.  .++.+|+|++.... ........+.+|+.++..++|+||+++++.+.....+++||
T Consensus         1 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~   80 (332)
T cd05623           1 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHYAFQDENNLYLVM   80 (332)
T ss_pred             CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCEEEEEE
Confidence            4789999999999999999987  46789999986421 12233456889999999999999999999999999999999


Q ss_pred             ecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceeecCCCcEEEeeccceeeccCCCc--c
Q 015868          193 EFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGV--M  270 (399)
Q Consensus       193 E~~~ggsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~giiHrDlkp~NILl~~~~~vkl~DFG~a~~~~~~~~--~  270 (399)
                      ||+++|+|.+++.+....+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++........  .
T Consensus        81 ey~~~g~L~~~l~~~~~~l~~~~~~~~~~qi~~al~~lH~~~iiHrDlkp~Nili~~~~~~kL~DfG~a~~~~~~~~~~~  160 (332)
T cd05623          81 DYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVIAIDSVHQLHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQS  160 (332)
T ss_pred             eccCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEECCCCCEEEeecchheecccCCccee
Confidence            99999999999987667899999999999999999999999999999999999999999999999999875433322  2


Q ss_pred             ccCCCCcccccccccC-----CCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhccCCCCCC---CCCcHHH
Q 015868          271 TAETGTYRWMAPEVIE-----HKPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKSLRPTIP---KHAHPRL  342 (399)
Q Consensus       271 ~~~~gt~~y~aPE~l~-----~~~~~~~~Dv~slG~vl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~l  342 (399)
                      ....||+.|+|||++.     ...++.++|||||||++|+|++|+.||...+..+....+.....+..+|   ..+++++
T Consensus       161 ~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~s~~~  240 (332)
T cd05623         161 SVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKERFQFPAQVTDVSEDA  240 (332)
T ss_pred             cccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCCCCHHHHHHHHhCCCccccCCCccccCCHHH
Confidence            2346899999999986     3468899999999999999999999999888877766665544333333   4579999


Q ss_pred             HHHHHHHhhhcCCC--CCCHHHHHHH
Q 015868          343 AELLERCWQHDPTQ--RPNFSQITDI  366 (399)
Q Consensus       343 ~~ll~~cl~~dP~~--Rps~~ell~~  366 (399)
                      .+|+.+|+..++..  |++++++++.
T Consensus       241 ~~li~~ll~~~~~r~~r~~~~~~~~h  266 (332)
T cd05623         241 KDLIRRLICSREHRLGQNGIEDFKQH  266 (332)
T ss_pred             HHHHHHHccChhhhcCCCCHHHHhCC
Confidence            99999999654443  6889988765

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw

>cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2

Probab=100.00  E-value=5.6e-42  Score=330.70  Aligned_cols=237  Identities=24%  Similarity=0.407  Sum_probs=200.7

Q ss_pred             ceeceeCceEEEEEEE--CCeeEEEEEecCCCC-CHHHHHHHHHHH-HHHHhcCCCceeeEEeEEecCCcEEEEEecCCC
Q 015868          122 CKVASGSYGDLYKGTY--CSQEVAIKVLKPECV-NTEMLKEFSQEV-YIMRKIRHKNVVQFIGACTRPPNLCIVTEFMAR  197 (399)
Q Consensus       122 ~~lg~G~~g~Vy~~~~--~~~~vAvK~~~~~~~-~~~~~~~~~~Ei-~~l~~l~h~nIv~~~~~~~~~~~~~lV~E~~~g  197 (399)
                      +.||.|+||.||+|+.  .++.||+|++..... .......+.+|. .+++.++||||+++++++......|+||||++|
T Consensus         1 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~~~   80 (321)
T cd05603           1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQTAEKLYFVLDYVNG   80 (321)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence            4689999999999987  578899999875321 222334455555 467889999999999999999999999999999


Q ss_pred             CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceeecCCCcEEEeeccceeeccC-CCccccCCCC
Q 015868          198 GSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQ-SGVMTAETGT  276 (399)
Q Consensus       198 gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~giiHrDlkp~NILl~~~~~vkl~DFG~a~~~~~-~~~~~~~~gt  276 (399)
                      ++|...+.. ...+++..+..++.||+.||.|||++||+||||||+||+++.++.+||+|||+++.... ........||
T Consensus        81 ~~L~~~l~~-~~~~~~~~~~~~~~qi~~~L~~lH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt  159 (321)
T cd05603          81 GELFFHLQR-ERCFLEPRARFYAAEVASAIGYLHSLNIIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPEETTSTFCGT  159 (321)
T ss_pred             CCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCCCCEEEccCCCCccCCCCCCccccccCC
Confidence            999998865 46689999999999999999999999999999999999999999999999999875322 2223445689


Q ss_pred             cccccccccCCCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhccCCCCCCCCCcHHHHHHHHHHhhhcCCC
Q 015868          277 YRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRLAELLERCWQHDPTQ  356 (399)
Q Consensus       277 ~~y~aPE~l~~~~~~~~~Dv~slG~vl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~cl~~dP~~  356 (399)
                      +.|+|||++.+..++.++|||||||++|+|++|..||...+..+....+...  ...+|...+.++.+++.+||+.+|.+
T Consensus       160 ~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~--~~~~~~~~~~~~~~li~~~l~~~p~~  237 (321)
T cd05603         160 PEYLAPEVLRKEPYDRTVDWWCLGAVLYEMLYGLPPFYSRDVSQMYDNILHK--PLQLPGGKTVAACDLLVGLLHKDQRR  237 (321)
T ss_pred             cccCCHHHhcCCCCCCcCcccccchhhhhhhcCCCCCCCCCHHHHHHHHhcC--CCCCCCCCCHHHHHHHHHHccCCHhh
Confidence            9999999999999999999999999999999999999988876665555443  34567778999999999999999999


Q ss_pred             CCCHH
Q 015868          357 RPNFS  361 (399)
Q Consensus       357 Rps~~  361 (399)
                      ||++.
T Consensus       238 R~~~~  242 (321)
T cd05603         238 RLGAK  242 (321)
T ss_pred             cCCCC
Confidence            99764

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1.

>cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase

Probab=100.00  E-value=4e-41  Score=318.26  Aligned_cols=247  Identities=30%  Similarity=0.516  Sum_probs=210.2

Q ss_pred             ccceeceeceeCceEEEEEEE--CCeeEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCceeeEEeEEecCCcEEEEEec
Q 015868          117 QLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVTEF  194 (399)
Q Consensus       117 ~~~i~~~lg~G~~g~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~nIv~~~~~~~~~~~~~lV~E~  194 (399)
                      .|++.++||.|+||.||+|..  ++..+++|.+...  .......+.+|+.+++.++||||+++++++..+...++|+||
T Consensus         6 ~~~i~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~--~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~~v~e~   83 (282)
T cd06643           6 FWEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTK--SEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEF   83 (282)
T ss_pred             HHHHHhhcccCCCeEEEEEEECCCCeEEEEEEeCCC--CHHHHHHHHHHHHHHHHCCCCCeeeEEEEEeeCCEEEEEEEe
Confidence            468889999999999999987  4678899998654  355567889999999999999999999999999999999999


Q ss_pred             CCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceeecCCCcEEEeeccceeeccCC-CccccC
Q 015868          195 MARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQS-GVMTAE  273 (399)
Q Consensus       195 ~~ggsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~giiHrDlkp~NILl~~~~~vkl~DFG~a~~~~~~-~~~~~~  273 (399)
                      +++++|..++......+++..+..++.|++.||.|||+.|++||||||+||+++.++.++|+|||++...... ......
T Consensus        84 ~~~~~l~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~~~~~~~~  163 (282)
T cd06643          84 CAGGAVDAVMLELERPLTEPQIRVVCKQTLEALNYLHENKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDSF  163 (282)
T ss_pred             cCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCcccEEEccCCCEEEccccccccccccccccccc
Confidence            9999999988776678999999999999999999999999999999999999999999999999998654322 122334


Q ss_pred             CCCcccccccccC-----CCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcc-CCCCCCCCCcHHHHHHHH
Q 015868          274 TGTYRWMAPEVIE-----HKPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKS-LRPTIPKHAHPRLAELLE  347 (399)
Q Consensus       274 ~gt~~y~aPE~l~-----~~~~~~~~Dv~slG~vl~elltg~~P~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~l~~ll~  347 (399)
                      .++..|+|||++.     +..++.++|+||||+++|+|++|..||...++.+......... .....+..++.++.++|.
T Consensus       164 ~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~  243 (282)
T cd06643         164 IGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSEPPTLAQPSRWSSEFKDFLK  243 (282)
T ss_pred             cccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCCccccCHHHHHHHHhhcCCCCCCCccccCHHHHHHHH
Confidence            6889999999984     4557889999999999999999999998887766555443321 122345668899999999


Q ss_pred             HHhhhcCCCCCCHHHHHH
Q 015868          348 RCWQHDPTQRPNFSQITD  365 (399)
Q Consensus       348 ~cl~~dP~~Rps~~ell~  365 (399)
                      +||+.+|.+||++.++++
T Consensus       244 ~~l~~~p~~Rp~~~~il~  261 (282)
T cd06643         244 KCLEKNVDARWTTTQLLQ  261 (282)
T ss_pred             HHccCChhhCcCHHHHhc
Confidence            999999999999998864

Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration.

>cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta

Probab=100.00  E-value=1.5e-41  Score=328.72  Aligned_cols=237  Identities=22%  Similarity=0.398  Sum_probs=200.4

Q ss_pred             ceeceeCceEEEEEEE--CCeeEEEEEecCCCC-CHHHHHHHHHHHHHHHhc-CCCceeeEEeEEecCCcEEEEEecCCC
Q 015868          122 CKVASGSYGDLYKGTY--CSQEVAIKVLKPECV-NTEMLKEFSQEVYIMRKI-RHKNVVQFIGACTRPPNLCIVTEFMAR  197 (399)
Q Consensus       122 ~~lg~G~~g~Vy~~~~--~~~~vAvK~~~~~~~-~~~~~~~~~~Ei~~l~~l-~h~nIv~~~~~~~~~~~~~lV~E~~~g  197 (399)
                      +.||+|+||.||+++.  .++.||+|+++.... .....+.+.+|+.++.++ +||||+++++++.....+|+||||++|
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~   80 (327)
T cd05617           1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTTSRLFLVIEYVNG   80 (327)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeCCEEEEEEeCCCC
Confidence            4699999999999987  568899999986532 234456788999999888 699999999999999999999999999


Q ss_pred             CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceeecCCCcEEEeeccceeeccC-CCccccCCCC
Q 015868          198 GSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQ-SGVMTAETGT  276 (399)
Q Consensus       198 gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~giiHrDlkp~NILl~~~~~vkl~DFG~a~~~~~-~~~~~~~~gt  276 (399)
                      ++|.+++.. .+.+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+++.... ........||
T Consensus        81 ~~L~~~~~~-~~~l~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt  159 (327)
T cd05617          81 GDLMFHMQR-QRKLPEEHARFYAAEICIALNFLHERGIIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGPGDTTSTFCGT  159 (327)
T ss_pred             CcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEeCCCCEEEeccccceeccCCCCceecccCC
Confidence            999998865 45799999999999999999999999999999999999999999999999999875322 2233446789


Q ss_pred             cccccccccCCCCCCChhhHHHHHHHHHHHHcCCCCCCCC------CHHHHHHHHHhccCCCCCCCCCcHHHHHHHHHHh
Q 015868          277 YRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPYAGL------TPLQAAVGVVQKSLRPTIPKHAHPRLAELLERCW  350 (399)
Q Consensus       277 ~~y~aPE~l~~~~~~~~~Dv~slG~vl~elltg~~P~~~~------~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~cl  350 (399)
                      +.|+|||.+.+..++.++||||||+++|+|++|..||...      ...+....... .....+|..++..+.+++.+||
T Consensus       160 ~~y~aPE~~~~~~~~~~~DiwslGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~-~~~~~~p~~~~~~~~~li~~~L  238 (327)
T cd05617         160 PNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQVIL-EKPIRIPRFLSVKASHVLKGFL  238 (327)
T ss_pred             cccCCHHHHCCCCCCchheeehhHHHHHHHHhCCCCCCccCCCcccccHHHHHHHHH-hCCCCCCCCCCHHHHHHHHHHh
Confidence            9999999999999999999999999999999999999642      22222223222 2244577889999999999999


Q ss_pred             hhcCCCCCCH
Q 015868          351 QHDPTQRPNF  360 (399)
Q Consensus       351 ~~dP~~Rps~  360 (399)
                      +.||.+|+++
T Consensus       239 ~~dP~~R~~~  248 (327)
T cd05617         239 NKDPKERLGC  248 (327)
T ss_pred             ccCHHHcCCC
Confidence            9999999984

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways

>KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=3.1e-43  Score=343.60  Aligned_cols=245  Identities=32%  Similarity=0.563  Sum_probs=216.2

Q ss_pred             cceeceeceeCceEEEEEEEC--CeeEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCceeeEEeEEecCCcEEEEEecC
Q 015868          118 LKIECKVASGSYGDLYKGTYC--SQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVTEFM  195 (399)
Q Consensus       118 ~~i~~~lg~G~~g~Vy~~~~~--~~~vAvK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~nIv~~~~~~~~~~~~~lV~E~~  195 (399)
                      |.|...||.|+||.||+|...  +-..|-|++...  ..+.++++.-||.||..++||+|++++++|...+.++|+.|||
T Consensus        34 WeIiGELGDGAFGKVyKA~nket~~lAAaKvIetk--seEELEDylVEIeILa~CdHP~ivkLl~ayy~enkLwiliEFC  111 (1187)
T KOG0579|consen   34 WEIIGELGDGAFGKVYKAVNKETKLLAAAKVIETK--SEEELEDYLVEIEILAECDHPVIVKLLSAYYFENKLWILIEFC  111 (1187)
T ss_pred             HHHHhhhcCccchhhhhhhcccchhhhhhhhhccc--chhHHhhhhhhhhhhhcCCChHHHHHHHHHhccCceEEEEeec
Confidence            455678999999999999764  334577887654  5777899999999999999999999999999999999999999


Q ss_pred             CCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceeecCCCcEEEeeccceee-ccCCCccccCC
Q 015868          196 ARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARV-QAQSGVMTAET  274 (399)
Q Consensus       196 ~ggsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~giiHrDlkp~NILl~~~~~vkl~DFG~a~~-~~~~~~~~~~~  274 (399)
                      .||.+..++-.-...+.++++..+++|++.||.|||+++|||||||+.|||++-+|.|+|+|||++.. ...........
T Consensus       112 ~GGAVDaimlEL~r~LtE~QIqvvc~q~ldALn~LHs~~iIHRDLKAGNiL~TldGdirLADFGVSAKn~~t~qkRDsFI  191 (1187)
T KOG0579|consen  112 GGGAVDAIMLELGRVLTEDQIQVVCYQVLDALNWLHSQNIIHRDLKAGNILLTLDGDIRLADFGVSAKNKSTRQKRDSFI  191 (1187)
T ss_pred             CCchHhHHHHHhccccchHHHHHHHHHHHHHHHHHhhcchhhhhccccceEEEecCcEeeecccccccchhHHhhhcccc
Confidence            99999999988889999999999999999999999999999999999999999999999999998743 22333456678


Q ss_pred             CCcccccccccC-----CCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhccCCCCC--CCCCcHHHHHHHH
Q 015868          275 GTYRWMAPEVIE-----HKPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKSLRPTI--PKHAHPRLAELLE  347 (399)
Q Consensus       275 gt~~y~aPE~l~-----~~~~~~~~Dv~slG~vl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~l~~ll~  347 (399)
                      |||+|||||++.     ..+|+.++||||||++|.||..+.+|....++...+..+.. ..+|.+  |..++..+.+++.
T Consensus       192 GTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMAqiEPPHhelnpMRVllKiaK-SePPTLlqPS~Ws~~F~DfLk  270 (1187)
T KOG0579|consen  192 GTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAK-SEPPTLLQPSHWSRSFSDFLK  270 (1187)
T ss_pred             CCcccccchheeeccccCCCchhhhhHHhhhhHHHHHhccCCCccccchHHHHHHHhh-cCCCcccCcchhhhHHHHHHH
Confidence            999999999974     56899999999999999999999999999999887776544 444443  7889999999999


Q ss_pred             HHhhhcCCCCCCHHHHHH
Q 015868          348 RCWQHDPTQRPNFSQITD  365 (399)
Q Consensus       348 ~cl~~dP~~Rps~~ell~  365 (399)
                      +||.+||..||++++|++
T Consensus       271 ~cL~Knp~~Rp~aaqll~  288 (1187)
T KOG0579|consen  271 RCLVKNPRNRPPAAQLLK  288 (1187)
T ss_pred             HHHhcCCccCCCHHHHhh
Confidence            999999999999999964

>PTZ00266 NIMA-related protein kinase; Provisional

Probab=100.00  E-value=2.2e-41  Score=357.80  Aligned_cols=253  Identities=22%  Similarity=0.436  Sum_probs=213.3

Q ss_pred             eeecccccceeceeceeCceEEEEEEE--CCeeEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCceeeEEeEEec--CC
Q 015868          111 WEIDAKQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTR--PP  186 (399)
Q Consensus       111 ~~i~~~~~~i~~~lg~G~~g~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~nIv~~~~~~~~--~~  186 (399)
                      .+...++|++.++||.|+||.||++++  .+..||+|++............+.+|+.+++.++||||++++++|..  ..
T Consensus         8 ge~~l~~YeIl~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l~e~~~~~~~~EI~IL~~L~HPNIVrl~d~f~de~~~   87 (1021)
T PTZ00266          8 GESRLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKHKNIVRYIDRFLNKANQ   87 (1021)
T ss_pred             CccccCCEEEEEEEecCCCeEEEEEEECCCCeEEEEEEEeccccCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEecCCC
Confidence            455667999999999999999999987  56789999998766666677889999999999999999999998854  35


Q ss_pred             cEEEEEecCCCCCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHC-------CcccCCCCCCceeecC-------
Q 015868          187 NLCIVTEFMARGSIYDFLHKQ---KGVFQLTSLLKVAIDVSKGMNYLHQN-------NIIHRDLKTANLLMDE-------  249 (399)
Q Consensus       187 ~~~lV~E~~~ggsL~~~l~~~---~~~l~~~~~~~i~~~i~~~L~~LH~~-------giiHrDlkp~NILl~~-------  249 (399)
                      .+||||||+++++|.++|...   .+.+++..++.|+.||+.||.|||+.       +||||||||+|||++.       
T Consensus        88 ~lyIVMEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~~lg~  167 (1021)
T PTZ00266         88 KLYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGK  167 (1021)
T ss_pred             EEEEEEeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCcccccc
Confidence            689999999999999999653   35799999999999999999999984       4999999999999964       


Q ss_pred             ----------CCcEEEeeccceeeccCCCccccCCCCcccccccccCC--CCCCChhhHHHHHHHHHHHHcCCCCCCCCC
Q 015868          250 ----------NGVVKVADFGVARVQAQSGVMTAETGTYRWMAPEVIEH--KPYDYKADVFSFGIALWELLTGELPYAGLT  317 (399)
Q Consensus       250 ----------~~~vkl~DFG~a~~~~~~~~~~~~~gt~~y~aPE~l~~--~~~~~~~Dv~slG~vl~elltg~~P~~~~~  317 (399)
                                .+.+||+|||++.............||+.|+|||++.+  ..++.++|||||||++|+|+||..||....
T Consensus       168 i~~~~~n~ng~~iVKLsDFGlAr~l~~~s~~~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~ILYELLTGk~PF~~~~  247 (1021)
T PTZ00266        168 ITAQANNLNGRPIAKIGDFGLSKNIGIESMAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTPFHKAN  247 (1021)
T ss_pred             ccccccccCCCCceEEccCCccccccccccccccCCCccccCHHHHhccCCCCCchhHHHHHHHHHHHHHHCCCCCCcCC
Confidence                      33589999999986654444445578999999999864  458899999999999999999999998766


Q ss_pred             HHHHHHHHHhccCCCCCC-CCCcHHHHHHHHHHhhhcCCCCCCHHHHHH
Q 015868          318 PLQAAVGVVQKSLRPTIP-KHAHPRLAELLERCWQHDPTQRPNFSQITD  365 (399)
Q Consensus       318 ~~~~~~~~~~~~~~~~~~-~~~~~~l~~ll~~cl~~dP~~Rps~~ell~  365 (399)
                      ........+...  +.++ ...++++.+||.+||+.+|.+||++.|++.
T Consensus       248 ~~~qli~~lk~~--p~lpi~~~S~eL~dLI~~~L~~dPeeRPSa~QlL~  294 (1021)
T PTZ00266        248 NFSQLISELKRG--PDLPIKGKSKELNILIKNLLNLSAKERPSALQCLG  294 (1021)
T ss_pred             cHHHHHHHHhcC--CCCCcCCCCHHHHHHHHHHhcCChhHCcCHHHHhc
Confidence            655544444433  2222 357899999999999999999999999984

>cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2

Probab=100.00  E-value=5.7e-41  Score=312.56  Aligned_cols=248  Identities=24%  Similarity=0.437  Sum_probs=216.8

Q ss_pred             ccceeceeceeCceEEEEEEE--CCeeEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCceeeEEeEEec--CCcEEEEE
Q 015868          117 QLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTR--PPNLCIVT  192 (399)
Q Consensus       117 ~~~i~~~lg~G~~g~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~nIv~~~~~~~~--~~~~~lV~  192 (399)
                      +|++.+.||.|+||.||++..  .++.||+|+++.........+.+.+|+.+++.++||||+++++++..  +...+++|
T Consensus         1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~   80 (265)
T cd08217           1 DYEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYDRIIDRSNQTLYIVM   80 (265)
T ss_pred             CceeeeeeccCCCeEEEEeeecCCCCEEEEEEEecccCCHHHHHHHHHHHHHHHhcCCCccceeeeeeecCCCCEEEEEe
Confidence            478899999999999999976  56889999998766666667789999999999999999999998754  44689999


Q ss_pred             ecCCCCCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHH-----HCCcccCCCCCCceeecCCCcEEEeeccceeec
Q 015868          193 EFMARGSIYDFLHKQ---KGVFQLTSLLKVAIDVSKGMNYLH-----QNNIIHRDLKTANLLMDENGVVKVADFGVARVQ  264 (399)
Q Consensus       193 E~~~ggsL~~~l~~~---~~~l~~~~~~~i~~~i~~~L~~LH-----~~giiHrDlkp~NILl~~~~~vkl~DFG~a~~~  264 (399)
                      ||+++++|.+++...   ...+++..++.++.+++.||+|||     +.+++|+||+|+||++++++.+||+|||.+...
T Consensus        81 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~i~h~dl~p~nili~~~~~~kl~d~g~~~~~  160 (265)
T cd08217          81 EYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKIL  160 (265)
T ss_pred             hhccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCccccCcceecCCCHHHEEEecCCCEEEecccccccc
Confidence            999999999999654   467899999999999999999999     899999999999999999999999999999876


Q ss_pred             cCCCc-cccCCCCcccccccccCCCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhccCCCCCCCCCcHHHH
Q 015868          265 AQSGV-MTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRLA  343 (399)
Q Consensus       265 ~~~~~-~~~~~gt~~y~aPE~l~~~~~~~~~Dv~slG~vl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~  343 (399)
                      ..... .....++..|+|||.+.+..++.++|+||||+++|+|++|+.||...+..+ ....+.....+.++..++.++.
T Consensus       161 ~~~~~~~~~~~~~~~~~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~  239 (265)
T cd08217         161 GHDSSFAKTYVGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPPFTARNQLQ-LASKIKEGKFRRIPYRYSSELN  239 (265)
T ss_pred             cCCcccccccccCCCccChhhhcCCCCCchhHHHHHHHHHHHHHHCCCcccCcCHHH-HHHHHhcCCCCCCccccCHHHH
Confidence            55433 344568999999999998889999999999999999999999998877544 3344555556677888999999


Q ss_pred             HHHHHHhhhcCCCCCCHHHHHH
Q 015868          344 ELLERCWQHDPTQRPNFSQITD  365 (399)
Q Consensus       344 ~ll~~cl~~dP~~Rps~~ell~  365 (399)
                      +++.+||+.+|.+||++.++++
T Consensus       240 ~l~~~~l~~~p~~Rp~~~~il~  261 (265)
T cd08217         240 EVIKSMLNVDPDKRPSTEELLQ  261 (265)
T ss_pred             HHHHHHccCCcccCCCHHHHhh
Confidence            9999999999999999999976

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi

>KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=7e-43  Score=339.21  Aligned_cols=245  Identities=31%  Similarity=0.509  Sum_probs=219.6

Q ss_pred             cccceeceeceeCceEEEEEEE--CCeeEEEEEecCCC-CCHHHHHHHHHHHHHHHhcCCCceeeEEeEEecCCcEEEEE
Q 015868          116 KQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPEC-VNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVT  192 (399)
Q Consensus       116 ~~~~i~~~lg~G~~g~Vy~~~~--~~~~vAvK~~~~~~-~~~~~~~~~~~Ei~~l~~l~h~nIv~~~~~~~~~~~~~lV~  192 (399)
                      ..|.-++.||.|+||.||-|++  +.+.||||.+...+ ...+...++..|+..|++++|||++.+-|+|......++||
T Consensus        26 klf~dLrEIGHGSFGAVYfArd~~n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~HPntieYkgCyLre~TaWLVM  105 (948)
T KOG0577|consen   26 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLRHPNTIEYKGCYLREHTAWLVM  105 (948)
T ss_pred             HHHHHHHHhcCCccceeEEeeccCccceeeeeeccccccccHHHHHHHHHHHHHHHhccCCCcccccceeeccchHHHHH
Confidence            4577789999999999999987  67889999998554 35566788999999999999999999999999999999999


Q ss_pred             ecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceeecCCCcEEEeeccceeeccCCCcccc
Q 015868          193 EFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTA  272 (399)
Q Consensus       193 E~~~ggsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~giiHrDlkp~NILl~~~~~vkl~DFG~a~~~~~~~~~~~  272 (399)
                      |||-| |-.|++.-+..++.+.++..|+.+.+.||+|||+.+.||||||+.|||+++.|.|||+|||.|......   ..
T Consensus       106 EYClG-SAsDlleVhkKplqEvEIAAi~~gaL~gLaYLHS~~~IHRDiKAGNILLse~g~VKLaDFGSAsi~~PA---ns  181 (948)
T KOG0577|consen  106 EYCLG-SASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNRIHRDIKAGNILLSEPGLVKLADFGSASIMAPA---NS  181 (948)
T ss_pred             HHHhc-cHHHHHHHHhccchHHHHHHHHHHHHHHHHHHHHhhHHhhhccccceEecCCCeeeeccccchhhcCch---hc
Confidence            99966 999999888889999999999999999999999999999999999999999999999999999876543   46


Q ss_pred             CCCCcccccccccC---CCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhccCCCCC-CCCCcHHHHHHHHH
Q 015868          273 ETGTYRWMAPEVIE---HKPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKSLRPTI-PKHAHPRLAELLER  348 (399)
Q Consensus       273 ~~gt~~y~aPE~l~---~~~~~~~~Dv~slG~vl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~l~~ll~~  348 (399)
                      .+|||.|||||++.   .+.|+-+.||||||++..||...++|+-.++...++.-+.++. .|.+ ...++..|++|+..
T Consensus       182 FvGTPywMAPEVILAMDEGqYdgkvDvWSLGITCIELAERkPPlFnMNAMSALYHIAQNe-sPtLqs~eWS~~F~~Fvd~  260 (948)
T KOG0577|consen  182 FVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNE-SPTLQSNEWSDYFRNFVDS  260 (948)
T ss_pred             ccCCccccchhHheeccccccCCccceeeccchhhhhhhcCCCccCchHHHHHHHHHhcC-CCCCCCchhHHHHHHHHHH
Confidence            78999999999984   5679999999999999999999999999999988888777654 4444 45699999999999


Q ss_pred             HhhhcCCCCCCHHHHHH
Q 015868          349 CWQHDPTQRPNFSQITD  365 (399)
Q Consensus       349 cl~~dP~~Rps~~ell~  365 (399)
                      ||++-|.+|||.++++.
T Consensus       261 CLqKipqeRptse~ll~  277 (948)
T KOG0577|consen  261 CLQKIPQERPTSEELLK  277 (948)
T ss_pred             HHhhCcccCCcHHHHhh
Confidence            99999999999998753

>cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like

Probab=100.00  E-value=4.4e-41  Score=317.88  Aligned_cols=248  Identities=25%  Similarity=0.390  Sum_probs=205.3

Q ss_pred             ccceeceeceeCceEEEEEEE--CCeeEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCceeeEEeEEecCCcEEEEEec
Q 015868          117 QLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVTEF  194 (399)
Q Consensus       117 ~~~i~~~lg~G~~g~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~nIv~~~~~~~~~~~~~lV~E~  194 (399)
                      +|++.+.||+|++|.||+|+.  +++.||+|+++....+......+.+|+.++++++||||+++++++..+...++||||
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~   80 (285)
T cd07861           1 DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQDVLMQESRLYLIFEF   80 (285)
T ss_pred             CceEeeEecccCceEEEEEEECCCCcEEEEEEeccccccCCchHHHHHHHHHHHhcCCCCEeeeEEEEeeCCeEEEEEec
Confidence            478899999999999999987  578999999876544444456788999999999999999999999999999999999


Q ss_pred             CCCCCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceeecCCCcEEEeeccceeeccCCC-ccc
Q 015868          195 MARGSIYDFLHKQK--GVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSG-VMT  271 (399)
Q Consensus       195 ~~ggsL~~~l~~~~--~~l~~~~~~~i~~~i~~~L~~LH~~giiHrDlkp~NILl~~~~~vkl~DFG~a~~~~~~~-~~~  271 (399)
                      ++ ++|.+++....  ..+++..++.++.|++.||+|||++|++|+||+|+||++++++.++|+|||++....... ...
T Consensus        81 ~~-~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~  159 (285)
T cd07861          81 LS-MDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHSRRVLHRDLKPQNLLIDNKGVIKLADFGLARAFGIPVRVYT  159 (285)
T ss_pred             CC-CCHHHHHhcCCCCCcCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCHHHEEEcCCCcEEECcccceeecCCCccccc
Confidence            97 48988886533  568999999999999999999999999999999999999999999999999997544322 223


Q ss_pred             cCCCCcccccccccCCC-CCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhccC--------------------
Q 015868          272 AETGTYRWMAPEVIEHK-PYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKSL--------------------  330 (399)
Q Consensus       272 ~~~gt~~y~aPE~l~~~-~~~~~~Dv~slG~vl~elltg~~P~~~~~~~~~~~~~~~~~~--------------------  330 (399)
                      ...+++.|+|||.+.+. .++.++|+||||+++|+|+||+.||.+.+.............                    
T Consensus       160 ~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (285)
T cd07861         160 HEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDSEIDQLFRIFRILGTPTEDVWPGVTSLPDYKNTF  239 (285)
T ss_pred             CCcccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhcchhhHHHHhhc
Confidence            44678899999998654 578999999999999999999999987765443332221100                    


Q ss_pred             -------CCCCCCCCcHHHHHHHHHHhhhcCCCCCCHHHHHH
Q 015868          331 -------RPTIPKHAHPRLAELLERCWQHDPTQRPNFSQITD  365 (399)
Q Consensus       331 -------~~~~~~~~~~~l~~ll~~cl~~dP~~Rps~~ell~  365 (399)
                             .......+++++.++|.+||+.||.+|||+.++++
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~ll~  281 (285)
T cd07861         240 PKWKKGSLRSAVKNLDEDGLDLLEKMLIYDPAKRISAKKALN  281 (285)
T ss_pred             cccCcchhHHhcCCCCHHHHHHHHHHhcCChhhCCCHHHHhc
Confidence                   00112347889999999999999999999999875

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2

>cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=4.8e-41  Score=316.17  Aligned_cols=246  Identities=31%  Similarity=0.547  Sum_probs=214.9

Q ss_pred             cccceeceeceeCceEEEEEEE--CCeeEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCceeeEEeEEecCCcEEEEEe
Q 015868          116 KQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVTE  193 (399)
Q Consensus       116 ~~~~i~~~lg~G~~g~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~nIv~~~~~~~~~~~~~lV~E  193 (399)
                      ++|++.+.||.|++|.||+|..  +++.||+|++.... .......+.+|+.+++.++|+||+++++++..+...++|+|
T Consensus         1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e   79 (274)
T cd06609           1 ELFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEE-AEDEIEDIQQEIQFLSQCRSPYITKYYGSFLKGSKLWIIME   79 (274)
T ss_pred             ChhhhhhhhcCCCCeEEEEEEECCCCeEEEEEEeeccc-cchHHHHHHHHHHHHHHcCCCCeeeeeEEEEECCeEEEEEE
Confidence            3688999999999999999987  57899999987553 23445678899999999999999999999999999999999


Q ss_pred             cCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceeecCCCcEEEeeccceeeccCC-Ccccc
Q 015868          194 FMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQS-GVMTA  272 (399)
Q Consensus       194 ~~~ggsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~giiHrDlkp~NILl~~~~~vkl~DFG~a~~~~~~-~~~~~  272 (399)
                      |+++++|.+++...  .+++..++.++.|++.|+.|||+++++|+||+|+||++++++.++|+|||.++..... .....
T Consensus        80 ~~~~~~L~~~~~~~--~~~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~~~~~  157 (274)
T cd06609          80 YCGGGSCLDLLKPG--KLDETYIAFILREVLLGLEYLHEEGKIHRDIKAANILLSEEGDVKLADFGVSGQLTSTMSKRNT  157 (274)
T ss_pred             eeCCCcHHHHHhhc--CCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEEcccccceeeccccccccc
Confidence            99999999999763  7899999999999999999999999999999999999999999999999999876543 23344


Q ss_pred             CCCCcccccccccCCCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhccCCCCCCCC-CcHHHHHHHHHHhh
Q 015868          273 ETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKSLRPTIPKH-AHPRLAELLERCWQ  351 (399)
Q Consensus       273 ~~gt~~y~aPE~l~~~~~~~~~Dv~slG~vl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~l~~ll~~cl~  351 (399)
                      ..++..|+|||.+.+..++.++|+||||+++|+|+||..||...++.+.... ......+.++.. ++.++.+++.+||.
T Consensus       158 ~~~~~~y~~PE~~~~~~~~~~sDv~slG~il~~l~tg~~p~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~l~~~l~  236 (274)
T cd06609         158 FVGTPFWMAPEVIKQSGYDEKADIWSLGITAIELAKGEPPLSDLHPMRVLFL-IPKNNPPSLEGNKFSKPFKDFVSLCLN  236 (274)
T ss_pred             ccCCccccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccCchHHHHHH-hhhcCCCCCcccccCHHHHHHHHHHhh
Confidence            5688899999999988899999999999999999999999988776554433 334455556655 88999999999999


Q ss_pred             hcCCCCCCHHHHHH
Q 015868          352 HDPTQRPNFSQITD  365 (399)
Q Consensus       352 ~dP~~Rps~~ell~  365 (399)
                      .+|++|||++++++
T Consensus       237 ~~p~~Rpt~~~il~  250 (274)
T cd06609         237 KDPKERPSAKELLK  250 (274)
T ss_pred             CChhhCcCHHHHhh
Confidence            99999999999976

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN)

>KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms]

Probab=100.00  E-value=2.8e-41  Score=329.71  Aligned_cols=250  Identities=25%  Similarity=0.461  Sum_probs=222.8

Q ss_pred             cccccceeceeceeCceEEEEEEE--CCeeEEEEEecCCCC-CHHHHHHHHHHHHHHHhcC-CCceeeEEeEEecCCcEE
Q 015868          114 DAKQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECV-NTEMLKEFSQEVYIMRKIR-HKNVVQFIGACTRPPNLC  189 (399)
Q Consensus       114 ~~~~~~i~~~lg~G~~g~Vy~~~~--~~~~vAvK~~~~~~~-~~~~~~~~~~Ei~~l~~l~-h~nIv~~~~~~~~~~~~~  189 (399)
                      ....|++.+.||.|.||.||+++.  +++.+|+|+++.... .......+.+|+.+|+++. ||||++++++|+....++
T Consensus        33 ~~~~Y~l~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~e~~~~~~  112 (382)
T KOG0032|consen   33 IKEKYELGRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDAFEDPDSVY  112 (382)
T ss_pred             ccccEEehhhhCCCCceEEEEEEecCCCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEEEEcCCeEE
Confidence            356899999999999999999987  578999999976543 2334578999999999998 999999999999999999


Q ss_pred             EEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceeecCC----CcEEEeeccceeecc
Q 015868          190 IVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDEN----GVVKVADFGVARVQA  265 (399)
Q Consensus       190 lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~giiHrDlkp~NILl~~~----~~vkl~DFG~a~~~~  265 (399)
                      +|||++.||.|.+.+...  .+++..+..++.|++.++.|||+.||+|||+||+|+|+...    +.+|++|||++....
T Consensus       113 lvmEL~~GGeLfd~i~~~--~~sE~da~~~~~~il~av~~lH~~gvvHrDlKpEN~L~~~~~~~~~~ik~~DFGla~~~~  190 (382)
T KOG0032|consen  113 LVMELCEGGELFDRIVKK--HYSERDAAGIIRQILEAVKYLHSLGVVHRDLKPENLLLASKDEGSGRIKLIDFGLAKFIK  190 (382)
T ss_pred             EEEEecCCchHHHHHHHc--cCCHHHHHHHHHHHHHHHHHHHhCCceeccCCHHHeeeccccCCCCcEEEeeCCCceEcc
Confidence            999999999999999776  39999999999999999999999999999999999999643    479999999999877


Q ss_pred             CCCccccCCCCcccccccccCCCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhccCC--CCCCCCCcHHHH
Q 015868          266 QSGVMTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKSLR--PTIPKHAHPRLA  343 (399)
Q Consensus       266 ~~~~~~~~~gt~~y~aPE~l~~~~~~~~~Dv~slG~vl~elltg~~P~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~l~  343 (399)
                      ........+||+.|+|||++...+|+..+|+||+|+++|.|++|..||.+.+.......+......  ......++..+.
T Consensus       191 ~~~~~~~~~Gtp~y~APEvl~~~~y~~~~DiWS~Gvi~yiLL~G~~PF~~~~~~~~~~~i~~~~~~f~~~~w~~is~~ak  270 (382)
T KOG0032|consen  191 PGERLHTIVGTPEYVAPEVLGGRPYGDEVDVWSIGVILYILLSGVPPFWGETEFEIFLAILRGDFDFTSEPWDDISESAK  270 (382)
T ss_pred             CCceEeeecCCccccCchhhcCCCCCcccchhHHHHHHHHHhhCCCCCcCCChhHHHHHHHcCCCCCCCCCccccCHHHH
Confidence            765677789999999999999999999999999999999999999999999988877766655432  222345799999


Q ss_pred             HHHHHHhhhcCCCCCCHHHHHH
Q 015868          344 ELLERCWQHDPTQRPNFSQITD  365 (399)
Q Consensus       344 ~ll~~cl~~dP~~Rps~~ell~  365 (399)
                      +++++|+..||..|+|+.++++
T Consensus       271 d~i~~ll~~dp~~R~ta~~~L~  292 (382)
T KOG0032|consen  271 DFIRKLLEFDPRKRLTAAQALQ  292 (382)
T ss_pred             HHHHHhcccCcccCCCHHHHhc
Confidence            9999999999999999999988

>cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase

Probab=100.00  E-value=3.7e-41  Score=316.24  Aligned_cols=248  Identities=31%  Similarity=0.550  Sum_probs=209.2

Q ss_pred             ccccceeceeceeCceEEEEEEE--CCeeEEEEEecCCCCCHHHHHHHHHHHHHHHhc-CCCceeeEEeEEecC------
Q 015868          115 AKQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKI-RHKNVVQFIGACTRP------  185 (399)
Q Consensus       115 ~~~~~i~~~lg~G~~g~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~Ei~~l~~l-~h~nIv~~~~~~~~~------  185 (399)
                      .+.|++.+.||.|+||.||+|..  .++.||+|++....   .....+.+|+.+++++ +||||+++++++...      
T Consensus         5 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~---~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~   81 (272)
T cd06637           5 AGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG---DEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMD   81 (272)
T ss_pred             hhhhhHHHheeecCCeEEEEEEEcCCCcEEEEEEEEcCC---ccHHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCCCCC
Confidence            35788899999999999999987  56889999987542   2235678899999998 699999999998653      


Q ss_pred             CcEEEEEecCCCCCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceeecCCCcEEEeeccceeec
Q 015868          186 PNLCIVTEFMARGSIYDFLHKQ-KGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQ  264 (399)
Q Consensus       186 ~~~~lV~E~~~ggsL~~~l~~~-~~~l~~~~~~~i~~~i~~~L~~LH~~giiHrDlkp~NILl~~~~~vkl~DFG~a~~~  264 (399)
                      ..+++||||+++++|.+++... ...+++..+..++.|++.||+|||+++|+|+||+|+||++++++.++|+|||++...
T Consensus        82 ~~~~iv~e~~~~~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~ivh~dl~~~nili~~~~~~~l~Dfg~~~~~  161 (272)
T cd06637          82 DQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQL  161 (272)
T ss_pred             cEEEEEEEcCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHEEECCCCCEEEccCCCceec
Confidence            4589999999999999999764 356899999999999999999999999999999999999999999999999999765


Q ss_pred             cCC-CccccCCCCcccccccccC-----CCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhccCCCCCCCCC
Q 015868          265 AQS-GVMTAETGTYRWMAPEVIE-----HKPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKSLRPTIPKHA  338 (399)
Q Consensus       265 ~~~-~~~~~~~gt~~y~aPE~l~-----~~~~~~~~Dv~slG~vl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~  338 (399)
                      ... .......|+..|+|||++.     +..++.++|+||||+++|+|++|..||....+............+...+..+
T Consensus       162 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  241 (272)
T cd06637         162 DRTVGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNPAPRLKSKKW  241 (272)
T ss_pred             ccccccCCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhCCCCccccCHHHHHHHHhcCCCCCCCCCCc
Confidence            432 2334456899999999986     3468889999999999999999999998877766555444444444455668


Q ss_pred             cHHHHHHHHHHhhhcCCCCCCHHHHHH
Q 015868          339 HPRLAELLERCWQHDPTQRPNFSQITD  365 (399)
Q Consensus       339 ~~~l~~ll~~cl~~dP~~Rps~~ell~  365 (399)
                      +.++.+|+.+||..+|.+|||+.++++
T Consensus       242 ~~~~~~li~~~l~~~p~~Rpt~~~il~  268 (272)
T cd06637         242 SKKFQSFIESCLVKNHSQRPTTEQLMK  268 (272)
T ss_pred             CHHHHHHHHHHcCCChhhCCCHHHHhh
Confidence            899999999999999999999999875

Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ

>KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms]

Probab=100.00  E-value=9.6e-42  Score=331.13  Aligned_cols=262  Identities=29%  Similarity=0.563  Sum_probs=224.7

Q ss_pred             CCceeecccccceeceeceeCceEEEEEEECC-eeEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCceeeEEeEEecCC
Q 015868          108 TDVWEIDAKQLKIECKVASGSYGDLYKGTYCS-QEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPP  186 (399)
Q Consensus       108 ~~~~~i~~~~~~i~~~lg~G~~g~Vy~~~~~~-~~vAvK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~nIv~~~~~~~~~~  186 (399)
                      ....++..+.+.+.++||+|-||.|.+++..+ ..||||.++++. +.+..++|..|+++|.+++||||++++|+|..++
T Consensus       530 ~al~EfPRs~L~~~ekiGeGqFGEVhLCeveg~lkVAVK~Lr~~a-~~~~r~~F~kEIkiLsqLkhPNIveLvGVC~~De  608 (807)
T KOG1094|consen  530 PALVEFPRSRLRFKEKIGEGQFGEVHLCEVEGPLKVAVKILRPDA-TKNARNDFLKEIKILSRLKHPNIVELLGVCVQDD  608 (807)
T ss_pred             cchhhcchhheehhhhhcCcccceeEEEEecCceEEEEeecCccc-chhHHHHHHHHHHHHhccCCCCeeEEEeeeecCC
Confidence            34567888999999999999999999998876 899999999874 4555789999999999999999999999999999


Q ss_pred             cEEEEEecCCCCCHHHHHHhcCCCC-CHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceeecCCCcEEEeeccceeecc
Q 015868          187 NLCIVTEFMARGSIYDFLHKQKGVF-QLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQA  265 (399)
Q Consensus       187 ~~~lV~E~~~ggsL~~~l~~~~~~l-~~~~~~~i~~~i~~~L~~LH~~giiHrDlkp~NILl~~~~~vkl~DFG~a~~~~  265 (399)
                      .+|+|+|||+.|+|..++.++..+. .-.....++.||++||+||.+.+++|||+.+.|+|++.++++||+|||.++..-
T Consensus       609 PicmI~EYmEnGDLnqFl~aheapt~~t~~~vsi~tqiasgmaYLes~nfVHrd~a~rNcLv~~e~~iKiadfgmsR~ly  688 (807)
T KOG1094|consen  609 PLCMITEYMENGDLNQFLSAHELPTAETAPGVSICTQIASGMAYLESLNFVHRDLATRNCLVDGEFTIKIADFGMSRNLY  688 (807)
T ss_pred             chHHHHHHHhcCcHHHHHHhccCcccccchhHHHHHHHHHHHHHHHhhchhhccccccceeecCcccEEecCcccccccc
Confidence            9999999999999999998864333 445566799999999999999999999999999999999999999999998543


Q ss_pred             CCCc---cccCCCCcccccccccCCCCCCChhhHHHHHHHHHHHHc--CCCCCCCCCHHHHHHHHHh---c---cCCCCC
Q 015868          266 QSGV---MTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLT--GELPYAGLTPLQAAVGVVQ---K---SLRPTI  334 (399)
Q Consensus       266 ~~~~---~~~~~gt~~y~aPE~l~~~~~~~~~Dv~slG~vl~ellt--g~~P~~~~~~~~~~~~~~~---~---~~~~~~  334 (399)
                      ....   .....-+.+|||||.+...+++.++|+|+||+++||+++  .+.||+.++..+.......   .   ..-+..
T Consensus       689 sg~yy~vqgr~vlpiRwmawEsillgkFttaSDvWafgvTlwE~~~~C~e~Py~~lt~e~vven~~~~~~~~~~~~~l~~  768 (807)
T KOG1094|consen  689 SGDYYRVQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEVFMLCREQPYSQLTDEQVVENAGEFFRDQGRQVVLSR  768 (807)
T ss_pred             cCCceeeecceeeeeeehhHHHHHhccccchhhhhhhHHHHHHHHHHHhhCchhhhhHHHHHHhhhhhcCCCCcceeccC
Confidence            3221   222345789999999999999999999999999999776  7789999998886654321   1   122445


Q ss_pred             CCCCcHHHHHHHHHHhhhcCCCCCCHHHHHHHHHHH
Q 015868          335 PKHAHPRLAELLERCWQHDPTQRPNFSQITDILKQM  370 (399)
Q Consensus       335 ~~~~~~~l~~ll~~cl~~dP~~Rps~~ell~~L~~l  370 (399)
                      |.-++.++.++|.+||..+-.+||+|+++-..|++.
T Consensus       769 P~~cp~~lyelml~Cw~~es~~RPsFe~lh~~lq~~  804 (807)
T KOG1094|consen  769 PPACPQGLYELMLRCWRRESEQRPSFEQLHLFLQED  804 (807)
T ss_pred             CCcCcHHHHHHHHHHhchhhhcCCCHHHHHHHHHHh
Confidence            677999999999999999999999999998888764

>KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms]

Probab=100.00  E-value=1.9e-43  Score=311.53  Aligned_cols=250  Identities=20%  Similarity=0.378  Sum_probs=221.0

Q ss_pred             ccccceeceeceeCceEEEEEEE--CCeeEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCceeeEEeEEecCCcEEEEE
Q 015868          115 AKQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVT  192 (399)
Q Consensus       115 ~~~~~i~~~lg~G~~g~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~nIv~~~~~~~~~~~~~lV~  192 (399)
                      .+.|.+.+.||+|.|+.||++..  +++.+|+|++..........+++.+|+.|-+.++||||+++.+.+......|||+
T Consensus        10 ~d~y~l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~~~~~e~l~rEarIC~~LqHP~IvrL~~ti~~~~~~ylvF   89 (355)
T KOG0033|consen   10 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVF   89 (355)
T ss_pred             chhhhHHHHHccCchHHHHHHHhccchHHHHHHHhhhhhhccccHHHHHHHHHHHHhcCCCcEeehhhhhcccceeEEEE
Confidence            56899999999999999999854  7899999998766555556788999999999999999999999999999999999


Q ss_pred             ecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceeecC---CCcEEEeeccceeeccCCCc
Q 015868          193 EFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDE---NGVVKVADFGVARVQAQSGV  269 (399)
Q Consensus       193 E~~~ggsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~giiHrDlkp~NILl~~---~~~vkl~DFG~a~~~~~~~~  269 (399)
                      |+|.|++|..-|-.+ ..+++..+...+.||+.+|+|+|.+||||||+||+|+++.+   ..-+||+|||+|........
T Consensus        90 e~m~G~dl~~eIV~R-~~ySEa~aSH~~rQiLeal~yCH~n~IvHRDvkP~nllLASK~~~A~vKL~~FGvAi~l~~g~~  168 (355)
T KOG0033|consen   90 DLVTGGELFEDIVAR-EFYSEADASHCIQQILEALAYCHSNGIVHRDLKPENLLLASKAKGAAVKLADFGLAIEVNDGEA  168 (355)
T ss_pred             ecccchHHHHHHHHH-HHHHHHHHHHHHHHHHHHHHHHHhcCceeccCChhheeeeeccCCCceeecccceEEEeCCccc
Confidence            999999998777553 56788889999999999999999999999999999999964   34799999999988775555


Q ss_pred             cccCCCCcccccccccCCCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhccCC--CCCCCCCcHHHHHHHH
Q 015868          270 MTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKSLR--PTIPKHAHPRLAELLE  347 (399)
Q Consensus       270 ~~~~~gt~~y~aPE~l~~~~~~~~~Dv~slG~vl~elltg~~P~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~l~~ll~  347 (399)
                      .....|||.|||||++...+|+..+|||+.|++||-|+.|.+||.+.+......++.+....  ++.-.+++++.++|++
T Consensus       169 ~~G~~GtP~fmaPEvvrkdpy~kpvDiW~cGViLfiLL~G~~PF~~~~~~rlye~I~~g~yd~~~~~w~~is~~Ak~Lvr  248 (355)
T KOG0033|consen  169 WHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYEQIKAGAYDYPSPEWDTVTPEAKSLIR  248 (355)
T ss_pred             cccccCCCcccCHHHhhcCCCCCcchhhhhhHHHHHHHhCCCCCCCccHHHHHHHHhccccCCCCcccCcCCHHHHHHHH
Confidence            66678999999999999999999999999999999999999999998888877777765443  3344678999999999


Q ss_pred             HHhhhcCCCCCCHHHHHH
Q 015868          348 RCWQHDPTQRPNFSQITD  365 (399)
Q Consensus       348 ~cl~~dP~~Rps~~ell~  365 (399)
                      +||..||.+|.|+.|.++
T Consensus       249 rML~~dP~kRIta~EAL~  266 (355)
T KOG0033|consen  249 RMLTVNPKKRITADEALK  266 (355)
T ss_pred             HHhccChhhhccHHHHhC
Confidence            999999999999999864

>cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3

Probab=100.00  E-value=3.7e-41  Score=315.61  Aligned_cols=248  Identities=30%  Similarity=0.518  Sum_probs=208.4

Q ss_pred             ccccceeceeceeCceEEEEEEE--CCeeEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCceeeEEeEEecCCcEEEEE
Q 015868          115 AKQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVT  192 (399)
Q Consensus       115 ~~~~~i~~~lg~G~~g~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~nIv~~~~~~~~~~~~~lV~  192 (399)
                      .++|++.++||+|+||.||+|+.  +++.||+|+++...  ......+.+|+.+++.++||||+++++.+.....+++||
T Consensus         8 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~--~~~~~~~~~e~~~~~~l~h~~ii~~~~~~~~~~~~~lv~   85 (267)
T cd06645           8 QEDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEP--GEDFAVVQQEIIMMKDCKHSNIVAYFGSYLRRDKLWICM   85 (267)
T ss_pred             HHHHHHHHHhCCCCCeEEEEEEEcCCCcEEEEEEEecCc--hhHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEEEE
Confidence            46899999999999999999987  57899999997652  333456889999999999999999999999999999999


Q ss_pred             ecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceeecCCCcEEEeeccceeeccCC-Cccc
Q 015868          193 EFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQS-GVMT  271 (399)
Q Consensus       193 E~~~ggsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~giiHrDlkp~NILl~~~~~vkl~DFG~a~~~~~~-~~~~  271 (399)
                      ||+++++|.+++.. .+.+++..++.++.|++.|+.|||++|++|+||||+||+++.++.++|+|||.+...... ....
T Consensus        86 e~~~~~~L~~~~~~-~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~~~~~~~  164 (267)
T cd06645          86 EFCGGGSLQDIYHV-TGPLSESQIAYVSRETLQGLYYLHSKGKMHRDIKGANILLTDNGHVKLADFGVSAQITATIAKRK  164 (267)
T ss_pred             eccCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEECcceeeeEccCcccccc
Confidence            99999999999865 457899999999999999999999999999999999999999999999999998754432 1223


Q ss_pred             cCCCCcccccccccC---CCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhccCCCCC---CCCCcHHHHHH
Q 015868          272 AETGTYRWMAPEVIE---HKPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKSLRPTI---PKHAHPRLAEL  345 (399)
Q Consensus       272 ~~~gt~~y~aPE~l~---~~~~~~~~Dv~slG~vl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~l~~l  345 (399)
                      ...|+..|+|||.+.   ...++.++|+||||+++|+|++|..||....+.............+..   ...++..+.++
T Consensus       165 ~~~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  244 (267)
T cd06645         165 SFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMTKSNFQPPKLKDKMKWSNSFHHF  244 (267)
T ss_pred             cccCcccccChhhhccccCCCCCchhhhHHHHHHHHHHhcCCCCcccccchhhHHhhhccCCCCCcccccCCCCHHHHHH
Confidence            457899999999984   456889999999999999999999999766654443333322222221   12467899999


Q ss_pred             HHHHhhhcCCCCCCHHHHHH
Q 015868          346 LERCWQHDPTQRPNFSQITD  365 (399)
Q Consensus       346 l~~cl~~dP~~Rps~~ell~  365 (399)
                      +.+||+.+|++||++.++++
T Consensus       245 i~~~l~~~P~~R~~~~~ll~  264 (267)
T cd06645         245 VKMALTKNPKKRPTAEKLLQ  264 (267)
T ss_pred             HHHHccCCchhCcCHHHHhc
Confidence            99999999999999999875

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated

>PHA03212 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=3.1e-41  Score=334.15  Aligned_cols=243  Identities=26%  Similarity=0.379  Sum_probs=197.6

Q ss_pred             ecccccceeceeceeCceEEEEEEE--CCeeEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCceeeEEeEEecCCcEEE
Q 015868          113 IDAKQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCI  190 (399)
Q Consensus       113 i~~~~~~i~~~lg~G~~g~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~nIv~~~~~~~~~~~~~l  190 (399)
                      +...+|++.++||+|+||.||++.+  +++.||+|....        ..+.+|+.++++++||||+++++++..+...++
T Consensus        89 ~~~~~y~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~~--------~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~l  160 (391)
T PHA03212         89 IEKAGFSILETFTPGAEGFAFACIDNKTCEHVVIKAGQR--------GGTATEAHILRAINHPSIIQLKGTFTYNKFTCL  160 (391)
T ss_pred             cccCCcEEEEEEcCCCCeEEEEEEECCCCCEEEEechhh--------hhhHHHHHHHHhCCCCCCCCEeEEEEECCeeEE
Confidence            4567899999999999999999987  578899997542        346789999999999999999999999999999


Q ss_pred             EEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceeecCCCcEEEeeccceeeccCC--C
Q 015868          191 VTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQS--G  268 (399)
Q Consensus       191 V~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~giiHrDlkp~NILl~~~~~vkl~DFG~a~~~~~~--~  268 (399)
                      |+|++. ++|.+++.. ...+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.....  .
T Consensus       161 v~e~~~-~~L~~~l~~-~~~l~~~~~~~i~~qi~~aL~ylH~~~IvHrDiKP~NIll~~~~~vkL~DFG~a~~~~~~~~~  238 (391)
T PHA03212        161 ILPRYK-TDLYCYLAA-KRNIAICDILAIERSVLRAIQYLHENRIIHRDIKAENIFINHPGDVCLGDFGAACFPVDINAN  238 (391)
T ss_pred             EEecCC-CCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHhEEEcCCCCEEEEeCCccccccccccc
Confidence            999995 589988865 356899999999999999999999999999999999999999999999999999753321  2


Q ss_pred             ccccCCCCcccccccccCCCCCCChhhHHHHHHHHHHHHcCCCCCCCCCH-------HHHHHHH----------------
Q 015868          269 VMTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPYAGLTP-------LQAAVGV----------------  325 (399)
Q Consensus       269 ~~~~~~gt~~y~aPE~l~~~~~~~~~Dv~slG~vl~elltg~~P~~~~~~-------~~~~~~~----------------  325 (399)
                      ......||+.|+|||++.+..++.++|||||||++|+|++|..||.....       ......+                
T Consensus       239 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~l~~i~~~~g~~p~~~~~~~~  318 (391)
T PHA03212        239 KYYGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSLFEKDGLDGDCDSDRQIKLIIRRSGTHPNEFPIDAQ  318 (391)
T ss_pred             ccccccCccCCCChhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCcCCcccccccCchhHHHHHHHHHhcCChhhcCcchh
Confidence            23345799999999999999999999999999999999999977643210       0000000                


Q ss_pred             ----------HhccCC-CC-CC-----CCCcHHHHHHHHHHhhhcCCCCCCHHHHHH
Q 015868          326 ----------VQKSLR-PT-IP-----KHAHPRLAELLERCWQHDPTQRPNFSQITD  365 (399)
Q Consensus       326 ----------~~~~~~-~~-~~-----~~~~~~l~~ll~~cl~~dP~~Rps~~ell~  365 (399)
                                ...... +. .+     ...+.++.+||.+||+.||.+|||+.|+++
T Consensus       319 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~mL~~dP~~Rpta~elL~  375 (391)
T PHA03212        319 ANLDEIYIGLAKKSSRKPGSRPLWTNLYELPIDLEYLICKMLAFDAHHRPSAEALLD  375 (391)
T ss_pred             HHHHHHHHHHHhccCCCCCCCCCHHHHhhhhhhHHHHHHHHhcCChhhCCCHHHHhc
Confidence                      000000 00 00     124668999999999999999999999985

>cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4

Probab=100.00  E-value=7e-41  Score=320.35  Aligned_cols=260  Identities=30%  Similarity=0.607  Sum_probs=219.0

Q ss_pred             ecccccceeceeceeCceEEEEEEE--CCe----eEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCceeeEEeEEecCC
Q 015868          113 IDAKQLKIECKVASGSYGDLYKGTY--CSQ----EVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPP  186 (399)
Q Consensus       113 i~~~~~~i~~~lg~G~~g~Vy~~~~--~~~----~vAvK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~nIv~~~~~~~~~~  186 (399)
                      +..++|+..+.||+|+||.||+|.+  .+.    .||+|++.... ......++.+|+.+++.++||||+++++++..+ 
T Consensus         4 ~~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~-   81 (303)
T cd05110           4 LKETELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETT-GPKANVEFMDEALIMASMDHPHLVRLLGVCLSP-   81 (303)
T ss_pred             cchhhceeccccccCCCccEEEEEEecCCCcceeeEEEEeccccC-CHHHHHHHHHHHHHHHhCCCCCcccEEEEEcCC-
Confidence            4567889999999999999999976  333    57899887543 334445789999999999999999999998764 


Q ss_pred             cEEEEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceeecCCCcEEEeeccceeeccC
Q 015868          187 NLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQ  266 (399)
Q Consensus       187 ~~~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~giiHrDlkp~NILl~~~~~vkl~DFG~a~~~~~  266 (399)
                      ..++++||+++|+|.+++......++...++.++.|++.||.|||++||+||||||+||+++.++.+||+|||.++....
T Consensus        82 ~~~~v~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~dikp~Nill~~~~~~kL~Dfg~~~~~~~  161 (303)
T cd05110          82 TIQLVTQLMPHGCLLDYVHEHKDNIGSQLLLNWCVQIAKGMMYLEERRLVHRDLAARNVLVKSPNHVKITDFGLARLLEG  161 (303)
T ss_pred             CceeeehhcCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHhhcCeeccccccceeeecCCCceEEccccccccccC
Confidence            47799999999999999987767789999999999999999999999999999999999999999999999999986543


Q ss_pred             CCc---cccCCCCcccccccccCCCCCCChhhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHHhccCCCCCCCCCcHHH
Q 015868          267 SGV---MTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLT-GELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRL  342 (399)
Q Consensus       267 ~~~---~~~~~gt~~y~aPE~l~~~~~~~~~Dv~slG~vl~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  342 (399)
                      ...   .....++..|+|||.+.+..++.++||||||+++|+|++ |..||.+....+. .........+..+..++..+
T Consensus       162 ~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~el~t~g~~p~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~  240 (303)
T cd05110         162 DEKEYNADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGIPTREI-PDLLEKGERLPQPPICTIDV  240 (303)
T ss_pred             cccccccCCCccccccCCHHHhccCCCChHHHHHHHHHHHHHHHhCCCCCCCCCCHHHH-HHHHHCCCCCCCCCCCCHHH
Confidence            222   122335678999999999999999999999999999997 9999988765543 34445555555667788999


Q ss_pred             HHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHH
Q 015868          343 AELLERCWQHDPTQRPNFSQITDILKQMMKEVA  375 (399)
Q Consensus       343 ~~ll~~cl~~dP~~Rps~~ell~~L~~l~~~~~  375 (399)
                      .+++.+||..+|++||++.++++.|.++..+..
T Consensus       241 ~~li~~c~~~~p~~Rp~~~~l~~~l~~~~~~~~  273 (303)
T cd05110         241 YMVMVKCWMIDADSRPKFKELAAEFSRMARDPQ  273 (303)
T ss_pred             HHHHHHHcCCChhhCcCHHHHHHHHHHHHhchh
Confidence            999999999999999999999999998865543

Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin

>cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2

Probab=100.00  E-value=5.1e-41  Score=312.04  Aligned_cols=247  Identities=33%  Similarity=0.573  Sum_probs=213.3

Q ss_pred             ccccceeceeceeCceEEEEEEEC--CeeEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCceeeEEeEEecCCcEEEEE
Q 015868          115 AKQLKIECKVASGSYGDLYKGTYC--SQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVT  192 (399)
Q Consensus       115 ~~~~~i~~~lg~G~~g~Vy~~~~~--~~~vAvK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~nIv~~~~~~~~~~~~~lV~  192 (399)
                      .++|++.++||+|+||.||+|...  ++.+++|.++..    .....+.+|+.++++++||||+++++.+.....+|+++
T Consensus         2 ~~~y~~~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~----~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~   77 (256)
T cd06612           2 EEVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVE----EDLQEIIKEISILKQCDSPYIVKYYGSYFKNTDLWIVM   77 (256)
T ss_pred             cccchhhhhhcCCCCeEEEEEEEcCCCcEEEEEEeecH----HHHHHHHHHHHHHHhCCCCcEeeeeeeeecCCcEEEEE
Confidence            368999999999999999999874  688999998753    22678999999999999999999999999999999999


Q ss_pred             ecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceeecCCCcEEEeeccceeeccCCC-ccc
Q 015868          193 EFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSG-VMT  271 (399)
Q Consensus       193 E~~~ggsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~giiHrDlkp~NILl~~~~~vkl~DFG~a~~~~~~~-~~~  271 (399)
                      ||+++++|.+++......+++..+..++.|++.||.|||+.|++|+||+|.||+++.++.++|+|||.+....... ...
T Consensus        78 e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~l~~~l~~lh~~~i~H~dl~~~ni~~~~~~~~~l~dfg~~~~~~~~~~~~~  157 (256)
T cd06612          78 EYCGAGSVSDIMKITNKTLTEEEIAAILYQTLKGLEYLHSNKKIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTMAKRN  157 (256)
T ss_pred             ecCCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEECCCCcEEEcccccchhcccCccccc
Confidence            9999999999998777789999999999999999999999999999999999999999999999999987654432 233


Q ss_pred             cCCCCcccccccccCCCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhccC-CCCCCCCCcHHHHHHHHHHh
Q 015868          272 AETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKSL-RPTIPKHAHPRLAELLERCW  350 (399)
Q Consensus       272 ~~~gt~~y~aPE~l~~~~~~~~~Dv~slG~vl~elltg~~P~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~l~~ll~~cl  350 (399)
                      ...++..|+|||.+.+..++.++||||||+++|+|++|+.||....+.+.......... ....+..++.++.+++.+||
T Consensus       158 ~~~~~~~y~~PE~~~~~~~~~~~Di~s~G~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l  237 (256)
T cd06612         158 TVIGTPFWMAPEVIQEIGYNNKADIWSLGITAIEMAEGKPPYSDIHPMRAIFMIPNKPPPTLSDPEKWSPEFNDFVKKCL  237 (256)
T ss_pred             cccCCccccCHHHHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCcchhhhhhhhccCCCCCCCchhhcCHHHHHHHHHHH
Confidence            34578899999999999999999999999999999999999988776654433322111 11234457789999999999


Q ss_pred             hhcCCCCCCHHHHHH
Q 015868          351 QHDPTQRPNFSQITD  365 (399)
Q Consensus       351 ~~dP~~Rps~~ell~  365 (399)
                      +.+|.+|||+.|+++
T Consensus       238 ~~~P~~Rps~~~il~  252 (256)
T cd06612         238 VKDPEERPSAIQLLQ  252 (256)
T ss_pred             hcChhhCcCHHHHhc
Confidence            999999999999875

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a

>cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha

Probab=100.00  E-value=5e-41  Score=324.90  Aligned_cols=251  Identities=22%  Similarity=0.438  Sum_probs=203.9

Q ss_pred             eeceecee--CceEEEEEEE--CCeeEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCceeeEEeEEecCCcEEEEEecC
Q 015868          120 IECKVASG--SYGDLYKGTY--CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVTEFM  195 (399)
Q Consensus       120 i~~~lg~G--~~g~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~nIv~~~~~~~~~~~~~lV~E~~  195 (399)
                      +.++||+|  +||+||++..  +++.||+|+++.........+.+.+|+.+++.++||||+++++++..++..++||||+
T Consensus         2 ~~~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~   81 (327)
T cd08227           2 LLTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEACTNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSFM   81 (327)
T ss_pred             hhhhccccccceEEEEEEeecccCcEEEEEEechhhccHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEECCEEEEEEecc
Confidence            56789999  7889999976  5789999999876555666678889999999999999999999999999999999999


Q ss_pred             CCCCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceeecCCCcEEEeeccceeeccCCC------
Q 015868          196 ARGSIYDFLHKQ-KGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSG------  268 (399)
Q Consensus       196 ~ggsL~~~l~~~-~~~l~~~~~~~i~~~i~~~L~~LH~~giiHrDlkp~NILl~~~~~vkl~DFG~a~~~~~~~------  268 (399)
                      ++++|.+++... ...+++..++.++.|++.||+|||++||+||||||+||+++.++.++++||+.+......+      
T Consensus        82 ~~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~dlkp~Nil~~~~~~~~l~~~~~~~~~~~~~~~~~~~  161 (327)
T cd08227          82 AYGSAKDLICTHFMDGMSELAIAYILQGVLKALDYIHHMGYVHRSVKASHILISVDGKVYLSGLRSNLSMINHGQRLRVV  161 (327)
T ss_pred             CCCcHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCChhhEEEecCCcEEEcccchhhcccccccccccc
Confidence            999999999754 3458999999999999999999999999999999999999999999999998654322111      


Q ss_pred             --ccccCCCCcccccccccCC--CCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhccCC-------------
Q 015868          269 --VMTAETGTYRWMAPEVIEH--KPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKSLR-------------  331 (399)
Q Consensus       269 --~~~~~~gt~~y~aPE~l~~--~~~~~~~Dv~slG~vl~elltg~~P~~~~~~~~~~~~~~~~~~~-------------  331 (399)
                        ......++..|+|||++.+  ..++.++|||||||++|+|++|+.||......+...........             
T Consensus       162 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  241 (327)
T cd08227         162 HDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVPCLLDTTTIPAEEL  241 (327)
T ss_pred             ccccccccceecccChHHhhcccCCCCchhhHHHHHHHHHHHHHCCCCCCCcchhHHHHHHhcCCccccccccchhhhhc
Confidence              1122346778999999976  46899999999999999999999999876654433332211100             


Q ss_pred             -------------------------------CCCCCCCcHHHHHHHHHHhhhcCCCCCCHHHHHH--HHHHH
Q 015868          332 -------------------------------PTIPKHAHPRLAELLERCWQHDPTQRPNFSQITD--ILKQM  370 (399)
Q Consensus       332 -------------------------------~~~~~~~~~~l~~ll~~cl~~dP~~Rps~~ell~--~L~~l  370 (399)
                                                     ......+++++.+|+.+||+.||++|||+.|+++  .++++
T Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~ell~~p~f~~~  313 (327)
T cd08227         242 TMKPSRSGANSGLGESTTVSTPRPSNGESSSHPYNRTFSPHFHHFVEQCLQRNPDARPSASTLLNHSFFKQI  313 (327)
T ss_pred             ccCCcccCCcCCCCcccccCCcCccccCCcccccccccCHHHHHHHHHHHhhCchhcCCHHHHhcChhhhhc
Confidence                                           0011235778999999999999999999999986  34443

Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype

>KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only]

Probab=100.00  E-value=1.2e-41  Score=336.91  Aligned_cols=244  Identities=29%  Similarity=0.464  Sum_probs=208.0

Q ss_pred             cccceeceeceeCceEEEEEEE--CCeeEEEEEecCCCCCHHHHHHHHHHHHHHHhcC-C-----CceeeEEeEEecCCc
Q 015868          116 KQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIR-H-----KNVVQFIGACTRPPN  187 (399)
Q Consensus       116 ~~~~i~~~lg~G~~g~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~Ei~~l~~l~-h-----~nIv~~~~~~~~~~~  187 (399)
                      .+|.+.+.||+|+||+|-+|.+  +++.||||+++..   ....+....|+.+|..++ |     -|+|+++++|...++
T Consensus       186 ~rY~V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN~---k~f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F~fr~H  262 (586)
T KOG0667|consen  186 YRYEVLEVLGKGSFGQVVKAYDHKTGEIVAIKIIKNK---KRFLRQAQIEIRILELLNKHDPDDKYNIVRMLDYFYFRNH  262 (586)
T ss_pred             EEEEEEEEecccccceeEEEEecCCCcEEEEEeeccC---hHHHHHHHHHHHHHHHHhccCCCCCeeEEEeeeccccccc
Confidence            4889999999999999999987  6799999999964   566677888999999997 4     589999999999999


Q ss_pred             EEEEEecCCCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceeecCCC--cEEEeeccceeec
Q 015868          188 LCIVTEFMARGSIYDFLHKQK-GVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENG--VVKVADFGVARVQ  264 (399)
Q Consensus       188 ~~lV~E~~~ggsL~~~l~~~~-~~l~~~~~~~i~~~i~~~L~~LH~~giiHrDlkp~NILl~~~~--~vkl~DFG~a~~~  264 (399)
                      +|||+|.++. +|+++|+.++ .+++...+..++.||+.||.+||+.||||+||||+|||+.+-+  .|||+|||.++..
T Consensus       263 lciVfELL~~-NLYellK~n~f~Glsl~~ir~~~~Qil~~L~~L~~l~IIHcDLKPENILL~~~~r~~vKVIDFGSSc~~  341 (586)
T KOG0667|consen  263 LCIVFELLST-NLYELLKNNKFRGLSLPLVRKFAQQILTALLFLHELGIIHCDLKPENILLKDPKRSRIKVIDFGSSCFE  341 (586)
T ss_pred             eeeeehhhhh-hHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCChhheeeccCCcCceeEEeccccccc
Confidence            9999999865 9999998754 5799999999999999999999999999999999999997543  7999999999877


Q ss_pred             cCCCccccCCCCcccccccccCCCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHh-----------------
Q 015868          265 AQSGVMTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQ-----------------  327 (399)
Q Consensus       265 ~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~Dv~slG~vl~elltg~~P~~~~~~~~~~~~~~~-----------------  327 (399)
                      .+...  .+..+..|.|||++.+-+|+.+.|+|||||+++||++|.+.|.+.+..+.+..++.                 
T Consensus       342 ~q~vy--tYiQSRfYRAPEVILGlpY~~~IDmWSLGCIlAEL~tG~PLfpG~ne~DQl~~I~e~lG~Pp~~mL~~~~~~~  419 (586)
T KOG0667|consen  342 SQRVY--TYIQSRFYRAPEVILGLPYDTAIDMWSLGCILAELFTGEPLFPGDNEYDQLARIIEVLGLPPPKMLDTAKKAH  419 (586)
T ss_pred             CCcce--eeeeccccccchhhccCCCCCccceeehhhhHHhHhcCccccCCCCHHHHHHHHHHHhCCCCHHHHHhccccc
Confidence            66533  77889999999999999999999999999999999999999988777655544331                 


Q ss_pred             ----c-c----------------------------CCCCCC-----------CCCcHHHHHHHHHHhhhcCCCCCCHHHH
Q 015868          328 ----K-S----------------------------LRPTIP-----------KHAHPRLAELLERCWQHDPTQRPNFSQI  363 (399)
Q Consensus       328 ----~-~----------------------------~~~~~~-----------~~~~~~l~~ll~~cl~~dP~~Rps~~el  363 (399)
                          . .                            .....|           ......+.+||.+||.+||.+|+|..|.
T Consensus       420 kff~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~P~~~~~l~~~~~~~~~~~F~dflk~~L~~dP~~R~tp~qa  499 (586)
T KOG0667|consen  420 KFFTSLKGFPRLCVETSAPRGTKSPEVRKYYRKARLERRGPPGSRSLESGLPKADDKLFIDFLKRCLEWDPAERITPAQA  499 (586)
T ss_pred             eehhccCCceeeeeeecccccccchhhhhhhhhhcccccCCCCCcccchhcccccHHHHHHHHHHHhccCchhcCCHHHH
Confidence                0 0                            000011           1233578999999999999999999998


Q ss_pred             HH
Q 015868          364 TD  365 (399)
Q Consensus       364 l~  365 (399)
                      ++
T Consensus       500 l~  501 (586)
T KOG0667|consen  500 LN  501 (586)
T ss_pred             hc
Confidence            76

>KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=1.5e-41  Score=319.25  Aligned_cols=255  Identities=24%  Similarity=0.370  Sum_probs=223.1

Q ss_pred             eeecccccceeceeceeCceEEEEEEECC--eeEEEEEecCCCC-CHHHHHHHHHHHHHHHhcCCCceeeEEeEEecCCc
Q 015868          111 WEIDAKQLKIECKVASGSYGDLYKGTYCS--QEVAIKVLKPECV-NTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPN  187 (399)
Q Consensus       111 ~~i~~~~~~i~~~lg~G~~g~Vy~~~~~~--~~vAvK~~~~~~~-~~~~~~~~~~Ei~~l~~l~h~nIv~~~~~~~~~~~  187 (399)
                      ..+..+.|++.++||.|.-|+||+++..+  ..+|+|++.++.. ..+...+...|-.||+.++||.++.+|..|+....
T Consensus        72 ~~l~l~~f~llk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~lDHPFlPTLYa~fet~~~  151 (459)
T KOG0610|consen   72 GSLGLRHFRLLKRLGCGDIGTVYLVELRGTNCLFAMKVMDKESLASRKKLKRAQTEREILSLLDHPFLPTLYASFETDKY  151 (459)
T ss_pred             CccCHHHHHHHHHcCCCCceeEEEEEecCCCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhcCCCccchhhheeeccce
Confidence            45677899999999999999999998855  7899999976543 34556788899999999999999999999999999


Q ss_pred             EEEEEecCCCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceeecCCCcEEEeeccceeeccC
Q 015868          188 LCIVTEFMARGSIYDFLHKQK-GVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQ  266 (399)
Q Consensus       188 ~~lV~E~~~ggsL~~~l~~~~-~~l~~~~~~~i~~~i~~~L~~LH~~giiHrDlkp~NILl~~~~~vkl~DFG~a~~~~~  266 (399)
                      .|+|||||+||+|..+++++. ..|+++.+..++.+|+-||+|||-.|||.|||||+|||+.++|+|-|+||.++.....
T Consensus       152 ~cl~meyCpGGdL~~LrqkQp~~~fse~~aRFYaAEvl~ALEYLHmlGivYRDLKPENILvredGHIMLsDFDLS~~~~~  231 (459)
T KOG0610|consen  152 SCLVMEYCPGGDLHSLRQKQPGKRFSESAARFYAAEVLLALEYLHMLGIVYRDLKPENILVREDGHIMLSDFDLSLRCPV  231 (459)
T ss_pred             eEEEEecCCCccHHHHHhhCCCCccchhhHHHHHHHHHHHHHHHHhhceeeccCCcceeEEecCCcEEeeeccccccCCC
Confidence            999999999999999998864 5799999999999999999999999999999999999999999999999998742110


Q ss_pred             ---------------------------------C-C-----------------------ccccCCCCcccccccccCCCC
Q 015868          267 ---------------------------------S-G-----------------------VMTAETGTYRWMAPEVIEHKP  289 (399)
Q Consensus       267 ---------------------------------~-~-----------------------~~~~~~gt~~y~aPE~l~~~~  289 (399)
                                                       . .                       .....+||-.|+|||++.+..
T Consensus       232 ~Pt~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYlAPEvI~G~G  311 (459)
T KOG0610|consen  232 SPTLVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYLAPEVIRGEG  311 (459)
T ss_pred             CCeeeccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCccccccccccccccceeeecCC
Confidence                                             0 0                       001124888999999999999


Q ss_pred             CCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhccCCCCCCCCCcHHHHHHHHHHhhhcCCCCCC----HHHHHH
Q 015868          290 YDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRLAELLERCWQHDPTQRPN----FSQITD  365 (399)
Q Consensus       290 ~~~~~Dv~slG~vl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~cl~~dP~~Rps----~~ell~  365 (399)
                      .+.+.|.|+||+++|||+.|.-||.+.+..+.+..++.+.....-.+.++..+++||+++|.+||.+|..    +.||.+
T Consensus       312 HgsAVDWWtfGIflYEmLyG~TPFKG~~~~~Tl~NIv~~~l~Fp~~~~vs~~akDLIr~LLvKdP~kRlg~~rGA~eIK~  391 (459)
T KOG0610|consen  312 HGSAVDWWTFGIFLYEMLYGTTPFKGSNNKETLRNIVGQPLKFPEEPEVSSAAKDLIRKLLVKDPSKRLGSKRGAAEIKR  391 (459)
T ss_pred             CCchhhHHHHHHHHHHHHhCCCCcCCCCchhhHHHHhcCCCcCCCCCcchhHHHHHHHHHhccChhhhhccccchHHhhc
Confidence            9999999999999999999999999999999999999877664444578899999999999999999988    666643

>cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases

Probab=100.00  E-value=1.1e-40  Score=309.23  Aligned_cols=245  Identities=34%  Similarity=0.675  Sum_probs=210.9

Q ss_pred             ceeceeCceEEEEEEEC-CeeEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCceeeEEeEEecCCcEEEEEecCCCCCH
Q 015868          122 CKVASGSYGDLYKGTYC-SQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVTEFMARGSI  200 (399)
Q Consensus       122 ~~lg~G~~g~Vy~~~~~-~~~vAvK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~nIv~~~~~~~~~~~~~lV~E~~~ggsL  200 (399)
                      ++||.|+||.||++... ++.||+|+++..... .....+.+|+.++++++|+||+++++++......++||||+.+++|
T Consensus         1 ~~lg~g~~g~v~~~~~~~~~~v~~K~~~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~l   79 (251)
T cd05041           1 EKIGKGNFGDVYKGVLKGNTEVAVKTCRSTLPP-DLKRKFLQEAEILKQYDHPNIVKLIGVCVQKQPIYIVMELVPGGSL   79 (251)
T ss_pred             CccccCCCceEEEEEEeCCCcEEEEeccccCCH-HHHHHHHHHHHHHHhCCCCCeEEEEEEEecCCCeEEEEEcCCCCcH
Confidence            47899999999999875 789999998865433 4567899999999999999999999999999999999999999999


Q ss_pred             HHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceeecCCCcEEEeeccceeeccCCCcc---ccCCCCc
Q 015868          201 YDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVM---TAETGTY  277 (399)
Q Consensus       201 ~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~giiHrDlkp~NILl~~~~~vkl~DFG~a~~~~~~~~~---~~~~gt~  277 (399)
                      .+++......++...+..++.+++.++.|||++|++||||+|+||+++.++.++|+|||.++........   .....+.
T Consensus        80 ~~~l~~~~~~~~~~~~~~~~~~~~~~l~~lH~~~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~  159 (251)
T cd05041          80 LTFLRKKKNRLTVKKLLQMSLDAAAGMEYLESKNCIHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDGLKQIPI  159 (251)
T ss_pred             HHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCEehhhcCcceEEEcCCCcEEEeeccccccccCCcceeccccCccee
Confidence            9999776667899999999999999999999999999999999999999999999999999754422111   1123356


Q ss_pred             ccccccccCCCCCCChhhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHHhccCCCCCCCCCcHHHHHHHHHHhhhcCCC
Q 015868          278 RWMAPEVIEHKPYDYKADVFSFGIALWELLT-GELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRLAELLERCWQHDPTQ  356 (399)
Q Consensus       278 ~y~aPE~l~~~~~~~~~Dv~slG~vl~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~cl~~dP~~  356 (399)
                      .|+|||.+.+..++.++|+||||+++|+|+| |..||........... .........+...+.++.+++.+||..+|.+
T Consensus       160 ~y~~PE~~~~~~~~~~~Di~slG~i~~~l~t~~~~p~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~  238 (251)
T cd05041         160 KWTAPEALNYGRYTSESDVWSYGILLWETFSLGDTPYPGMSNQQTRER-IESGYRMPAPQLCPEEIYRLMLQCWAYDPEN  238 (251)
T ss_pred             ccCChHhhccCCCCcchhHHHHHHHHHHHHhccCCCCccCCHHHHHHH-HhcCCCCCCCccCCHHHHHHHHHHhccChhh
Confidence            7999999998889999999999999999999 8899988876554443 3333455567778999999999999999999


Q ss_pred             CCCHHHHHHHHH
Q 015868          357 RPNFSQITDILK  368 (399)
Q Consensus       357 Rps~~ell~~L~  368 (399)
                      ||++.|+++.|+
T Consensus       239 Rp~~~ell~~l~  250 (251)
T cd05041         239 RPSFSEIYNELQ  250 (251)
T ss_pred             CcCHHHHHHHhh
Confidence            999999999875

Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k

>cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4

Probab=100.00  E-value=1e-40  Score=311.36  Aligned_cols=248  Identities=27%  Similarity=0.525  Sum_probs=212.7

Q ss_pred             ccceeceeceeCceEEEEEEE--CCeeEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCceeeEEeEEecCCcEEEEEec
Q 015868          117 QLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVTEF  194 (399)
Q Consensus       117 ~~~i~~~lg~G~~g~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~nIv~~~~~~~~~~~~~lV~E~  194 (399)
                      +|++.+.||+|+||.||+|..  +++.|++|+++.........+.+.+|+.+++.++|+||+++++.+.....+++|+||
T Consensus         1 ~y~~~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~lv~e~   80 (264)
T cd06626           1 RWQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYGVEVHREKVYIFMEY   80 (264)
T ss_pred             CceeeeEeecCCCcEEEEEEECCCCcEEEEEEEECcccchHHHHHHHHHHHHHHhCCCCChhheeeeEecCCEEEEEEec
Confidence            588999999999999999986  578999999987655556778999999999999999999999999999999999999


Q ss_pred             CCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceeecCCCcEEEeeccceeeccCCCcc----
Q 015868          195 MARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVM----  270 (399)
Q Consensus       195 ~~ggsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~giiHrDlkp~NILl~~~~~vkl~DFG~a~~~~~~~~~----  270 (399)
                      +++++|.+++.. ...+++..+..++.+++.||.|||++|++|+||+|+||++++++.+||+|||.+.........    
T Consensus        81 ~~~~~L~~~~~~-~~~~~~~~~~~i~~~i~~~l~~lh~~~i~H~dl~~~nil~~~~~~~kl~d~g~~~~~~~~~~~~~~~  159 (264)
T cd06626          81 CSGGTLEELLEH-GRILDEHVIRVYTLQLLEGLAYLHSHGIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTMGEE  159 (264)
T ss_pred             CCCCcHHHHHhh-cCCCChHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEcccccccccCCCCCccccc
Confidence            999999999976 355889999999999999999999999999999999999999999999999998765443221    


Q ss_pred             -ccCCCCcccccccccCCCC---CCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhccCCCCCCCCC--cHHHHH
Q 015868          271 -TAETGTYRWMAPEVIEHKP---YDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKSLRPTIPKHA--HPRLAE  344 (399)
Q Consensus       271 -~~~~gt~~y~aPE~l~~~~---~~~~~Dv~slG~vl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~l~~  344 (399)
                       ....++..|+|||.+.+..   ++.++||||||+++|++++|..||..................+.+|...  ++.+.+
T Consensus       160 ~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (264)
T cd06626         160 VQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDNEFQIMFHVGAGHKPPIPDSLQLSPEGKD  239 (264)
T ss_pred             ccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCccCCcchHHHHHHHhcCCCCCCCcccccCHHHHH
Confidence             1245788999999998766   8899999999999999999999997764333222223334455666554  899999


Q ss_pred             HHHHHhhhcCCCCCCHHHHHH
Q 015868          345 LLERCWQHDPTQRPNFSQITD  365 (399)
Q Consensus       345 ll~~cl~~dP~~Rps~~ell~  365 (399)
                      ++.+||+.+|.+||++.+++.
T Consensus       240 li~~~l~~~p~~R~~~~~i~~  260 (264)
T cd06626         240 FLDRCLESDPKKRPTASELLQ  260 (264)
T ss_pred             HHHHHccCCcccCCCHHHHhc
Confidence            999999999999999999864

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4

>cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

Probab=100.00  E-value=5.7e-41  Score=316.49  Aligned_cols=237  Identities=27%  Similarity=0.513  Sum_probs=197.4

Q ss_pred             eeceeCceEEEEEEEC--------------------------CeeEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCcee
Q 015868          123 KVASGSYGDLYKGTYC--------------------------SQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVV  176 (399)
Q Consensus       123 ~lg~G~~g~Vy~~~~~--------------------------~~~vAvK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~nIv  176 (399)
                      +||+|+||.||+|...                          ...|++|++...  .......+.+|+.+++.++||||+
T Consensus         2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~--~~~~~~~~~~~~~~~~~l~h~niv   79 (274)
T cd05076           2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPS--HRDIALAFFETASLMSQVSHIHLA   79 (274)
T ss_pred             CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChH--HHHHHHHHHHHHHHHhcCCCCCee
Confidence            6999999999998641                          135889998754  234456789999999999999999


Q ss_pred             eEEeEEecCCcEEEEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceeecCCC-----
Q 015868          177 QFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENG-----  251 (399)
Q Consensus       177 ~~~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~giiHrDlkp~NILl~~~~-----  251 (399)
                      ++++++......++||||+++++|..++....+.+++..+..++.|+++||+|||++||+||||||+||+++..+     
T Consensus        80 ~~~~~~~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~Nill~~~~~~~~~  159 (274)
T cd05076          80 FVHGVCVRGSENIMVEEFVEHGPLDVCLRKEKGRVPVAWKITVAQQLASALSYLEDKNLVHGNVCAKNILLARLGLAEGT  159 (274)
T ss_pred             eEEEEEEeCCceEEEEecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCccCCCCCcccEEEeccCcccCc
Confidence            999999999999999999999999999987677899999999999999999999999999999999999997644     


Q ss_pred             --cEEEeeccceeeccCCCccccCCCCcccccccccCC-CCCCChhhHHHHHHHHHHHH-cCCCCCCCCCHHHHHHHHHh
Q 015868          252 --VVKVADFGVARVQAQSGVMTAETGTYRWMAPEVIEH-KPYDYKADVFSFGIALWELL-TGELPYAGLTPLQAAVGVVQ  327 (399)
Q Consensus       252 --~vkl~DFG~a~~~~~~~~~~~~~gt~~y~aPE~l~~-~~~~~~~Dv~slG~vl~ell-tg~~P~~~~~~~~~~~~~~~  327 (399)
                        .+|++|||.+.....   .....++..|+|||.+.+ ..++.++||||||+++||++ +|+.||...++.+... ...
T Consensus       160 ~~~~kl~d~g~~~~~~~---~~~~~~~~~~~aPe~~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~-~~~  235 (274)
T cd05076         160 SPFIKLSDPGVSFTALS---REERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPLKERTPSEKER-FYE  235 (274)
T ss_pred             cceeeecCCcccccccc---ccccccCCcccCchhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCccccChHHHHH-HHH
Confidence              489999998754322   122356788999998865 56899999999999999985 6999998877655432 222


Q ss_pred             ccCCCCCCCCCcHHHHHHHHHHhhhcCCCCCCHHHHHHHH
Q 015868          328 KSLRPTIPKHAHPRLAELLERCWQHDPTQRPNFSQITDIL  367 (399)
Q Consensus       328 ~~~~~~~~~~~~~~l~~ll~~cl~~dP~~Rps~~ell~~L  367 (399)
                      .  ....|...++++.+++.+||+.+|++|||+.++++.|
T Consensus       236 ~--~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~il~~L  273 (274)
T cd05076         236 K--KHRLPEPSCKELATLISQCLTYEPTQRPSFRTILRDL  273 (274)
T ss_pred             h--ccCCCCCCChHHHHHHHHHcccChhhCcCHHHHHHhh
Confidence            2  2334555678899999999999999999999999876

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt

>cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5

Probab=100.00  E-value=1.1e-40  Score=315.05  Aligned_cols=243  Identities=29%  Similarity=0.497  Sum_probs=203.7

Q ss_pred             cccceeceeceeCceEEEEEEE--CCeeEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCceeeEEeEEecCCcEEEEEe
Q 015868          116 KQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVTE  193 (399)
Q Consensus       116 ~~~~i~~~lg~G~~g~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~nIv~~~~~~~~~~~~~lV~E  193 (399)
                      ++|++.+.||+|+||.||+|.+  +++.||+|++.... .......+.+|+.++++++||||+++++++......++|||
T Consensus         1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e   79 (279)
T cd06619           1 QDIQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDI-TVELQKQIMSELEILYKCDSPYIIGFYGAFFVENRISICTE   79 (279)
T ss_pred             CcchheeeeccCCCeEEEEEEEcCCCcEEEEEEEecCC-ChHHHHHHHHHHHHHHhCCCCCeeeEEEEEEECCEEEEEEe
Confidence            3678899999999999999986  67889999987543 34455789999999999999999999999999999999999


Q ss_pred             cCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceeecCCCcEEEeeccceeeccCCCccccC
Q 015868          194 FMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAE  273 (399)
Q Consensus       194 ~~~ggsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~giiHrDlkp~NILl~~~~~vkl~DFG~a~~~~~~~~~~~~  273 (399)
                      |+++++|..+     ..+++..+..++.|++.||.|||+.||+|+||||+||+++.++.++|+|||++...... .....
T Consensus        80 ~~~~~~l~~~-----~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nill~~~~~~~l~dfg~~~~~~~~-~~~~~  153 (279)
T cd06619          80 FMDGGSLDVY-----RKIPEHVLGRIAVAVVKGLTYLWSLKILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNS-IAKTY  153 (279)
T ss_pred             cCCCCChHHh-----hcCCHHHHHHHHHHHHHHHHHHHHCCEeeCCCCHHHEEECCCCCEEEeeCCcceecccc-cccCC
Confidence            9999998754     34688899999999999999999999999999999999999999999999999765432 23445


Q ss_pred             CCCcccccccccCCCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHH-------HHHHHHHhccCCCCC-CCCCcHHHHHH
Q 015868          274 TGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPYAGLTPL-------QAAVGVVQKSLRPTI-PKHAHPRLAEL  345 (399)
Q Consensus       274 ~gt~~y~aPE~l~~~~~~~~~Dv~slG~vl~elltg~~P~~~~~~~-------~~~~~~~~~~~~~~~-~~~~~~~l~~l  345 (399)
                      .++..|+|||.+.+..++.++|+||||+++|+|++|+.||......       +...... ....+.. ....++++.++
T Consensus       154 ~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~l  232 (279)
T cd06619         154 VGTNAYMAPERISGEQYGIHSDVWSLGISFMELALGRFPYPQIQKNQGSLMPLQLLQCIV-DEDPPVLPVGQFSEKFVHF  232 (279)
T ss_pred             CCChhhcCceeecCCCCCCcchHHHHHHHHHHHHhCCCCchhhcccccccchHHHHHHHh-ccCCCCCCCCcCCHHHHHH
Confidence            7899999999999999999999999999999999999999653321       1111111 1222222 23478899999


Q ss_pred             HHHHhhhcCCCCCCHHHHHHH
Q 015868          346 LERCWQHDPTQRPNFSQITDI  366 (399)
Q Consensus       346 l~~cl~~dP~~Rps~~ell~~  366 (399)
                      +.+||+.+|++||+++++++.
T Consensus       233 i~~~l~~~P~~Rp~~~eil~~  253 (279)
T cd06619         233 ITQCMRKQPKERPAPENLMDH  253 (279)
T ss_pred             HHHHhhCChhhCCCHHHHhcC
Confidence            999999999999999998763

Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p

>KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms]

Probab=100.00  E-value=3.2e-42  Score=308.02  Aligned_cols=252  Identities=29%  Similarity=0.524  Sum_probs=216.6

Q ss_pred             eeecccccceeceeceeCceEEEEEEEC--CeeEEEEEecCCCCCHHHHHHHHHHHHHHHhc-CCCceeeEEeEEecCCc
Q 015868          111 WEIDAKQLKIECKVASGSYGDLYKGTYC--SQEVAIKVLKPECVNTEMLKEFSQEVYIMRKI-RHKNVVQFIGACTRPPN  187 (399)
Q Consensus       111 ~~i~~~~~~i~~~lg~G~~g~Vy~~~~~--~~~vAvK~~~~~~~~~~~~~~~~~Ei~~l~~l-~h~nIv~~~~~~~~~~~  187 (399)
                      ...+.++++++..||+|+.|+|+++++.  +...|||.+.... |.+..+++...+.++... +.|+||+.+|+|..+..
T Consensus        87 ~~~dindl~~l~dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt~-Nkee~kRILmDldvv~~s~dcpyIV~c~GyFi~n~d  165 (391)
T KOG0983|consen   87 YQADINDLENLGDLGSGTCGQVWKMRFRSTGHIIAVKQMRRTG-NKEENKRILMDLDVVLKSHDCPYIVQCFGYFITNTD  165 (391)
T ss_pred             cccChHHhhhHHhhcCCCccceEEEEEcccceEEEEEeecccC-CHHHHHHHHHhhhHHhhccCCCeeeeeeeEEeeCch
Confidence            4456678889999999999999999885  4889999998775 555566777777776665 48999999999999999


Q ss_pred             EEEEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC-CcccCCCCCCceeecCCCcEEEeeccceeeccC
Q 015868          188 LCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQN-NIIHRDLKTANLLMDENGVVKVADFGVARVQAQ  266 (399)
Q Consensus       188 ~~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~-giiHrDlkp~NILl~~~~~vkl~DFG~a~~~~~  266 (399)
                      .++.||.|.. -+..+++.-.+++++..+-++...+++||.||..+ ||||||+||+|||+|+.|++|+||||.+.....
T Consensus       166 V~IcMelMs~-C~ekLlkrik~piPE~ilGk~tva~v~AL~YLKeKH~viHRDvKPSNILlDe~GniKlCDFGIsGrlvd  244 (391)
T KOG0983|consen  166 VFICMELMST-CAEKLLKRIKGPIPERILGKMTVAIVKALYYLKEKHGVIHRDVKPSNILLDERGNIKLCDFGISGRLVD  244 (391)
T ss_pred             HHHHHHHHHH-HHHHHHHHhcCCchHHhhhhhHHHHHHHHHHHHHhcceeecccCccceEEccCCCEEeecccccceeec
Confidence            9999999854 56666666678899999999999999999999975 999999999999999999999999999988887


Q ss_pred             CCccccCCCCcccccccccCC---CCCCChhhHHHHHHHHHHHHcCCCCCCCCCH-HHHHHHHHhccCCCCCCCC--CcH
Q 015868          267 SGVMTAETGTYRWMAPEVIEH---KPYDYKADVFSFGIALWELLTGELPYAGLTP-LQAAVGVVQKSLRPTIPKH--AHP  340 (399)
Q Consensus       267 ~~~~~~~~gt~~y~aPE~l~~---~~~~~~~Dv~slG~vl~elltg~~P~~~~~~-~~~~~~~~~~~~~~~~~~~--~~~  340 (399)
                      +.-.+...|.+.|||||.+.-   ..|+.++||||||++++||.||+.||.+.+. .+..-.+++ .++|.++..  .++
T Consensus       245 SkAhtrsAGC~~YMaPERidp~~~~kYDiRaDVWSlGITlveLaTg~yPy~~c~tdFe~ltkvln-~ePP~L~~~~gFSp  323 (391)
T KOG0983|consen  245 SKAHTRSAGCAAYMAPERIDPPDKPKYDIRADVWSLGITLVELATGQYPYKGCKTDFEVLTKVLN-EEPPLLPGHMGFSP  323 (391)
T ss_pred             ccccccccCCccccCccccCCCCCCccchhhhhhhhccchhhhhcccCCCCCCCccHHHHHHHHh-cCCCCCCcccCcCH
Confidence            777788899999999999964   4799999999999999999999999998654 444444444 556777643  799


Q ss_pred             HHHHHHHHHhhhcCCCCCCHHHHHH
Q 015868          341 RLAELLERCWQHDPTQRPNFSQITD  365 (399)
Q Consensus       341 ~l~~ll~~cl~~dP~~Rps~~ell~  365 (399)
                      .+.+|+..||++|+.+||.+.++++
T Consensus       324 ~F~~fv~~CL~kd~r~RP~Y~~Ll~  348 (391)
T KOG0983|consen  324 DFQSFVKDCLTKDHRKRPKYNKLLE  348 (391)
T ss_pred             HHHHHHHHHhhcCcccCcchHHHhc
Confidence            9999999999999999999999976

>cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1

Probab=100.00  E-value=9.1e-41  Score=318.62  Aligned_cols=247  Identities=28%  Similarity=0.484  Sum_probs=211.1

Q ss_pred             ccccceeceeceeCceEEEEEEE--CCeeEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCceeeEEeEEecCCcEEEEE
Q 015868          115 AKQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVT  192 (399)
Q Consensus       115 ~~~~~i~~~lg~G~~g~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~nIv~~~~~~~~~~~~~lV~  192 (399)
                      ..+|++.+.||+|+||.||+|..  .++.||+|.+......  ....+.+|+.+++.++|+||+++++.+..+...|+||
T Consensus        19 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~--~~~~~~~e~~~l~~~~h~~v~~~~~~~~~~~~~~lv~   96 (296)
T cd06654          19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQP--KKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVM   96 (296)
T ss_pred             ccceeeEEEecCCCCeEEEEEEECCCCcEEEEEEEecCCcc--hHHHHHHHHHHHHhCCCCCEeeEEEEEEeCCEEEEee
Confidence            35899999999999999999976  5789999998765332  3467889999999999999999999999999999999


Q ss_pred             ecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceeecCCCcEEEeeccceeeccCCC-ccc
Q 015868          193 EFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSG-VMT  271 (399)
Q Consensus       193 E~~~ggsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~giiHrDlkp~NILl~~~~~vkl~DFG~a~~~~~~~-~~~  271 (399)
                      ||+++++|.+++..  ..++...+..++.|++.||+|||++||+||||||+||+++.++.++|+|||.+....... ...
T Consensus        97 e~~~~~~L~~~~~~--~~~~~~~~~~i~~ql~~aL~~LH~~gi~H~dLkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~~  174 (296)
T cd06654          97 EYLAGGSLTDVVTE--TCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRS  174 (296)
T ss_pred             cccCCCCHHHHHHh--cCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEcCCCCEEECccccchhccccccccC
Confidence            99999999999864  457899999999999999999999999999999999999999999999999987543322 223


Q ss_pred             cCCCCcccccccccCCCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhccC-CCCCCCCCcHHHHHHHHHHh
Q 015868          272 AETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKSL-RPTIPKHAHPRLAELLERCW  350 (399)
Q Consensus       272 ~~~gt~~y~aPE~l~~~~~~~~~Dv~slG~vl~elltg~~P~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~l~~ll~~cl  350 (399)
                      ...+++.|+|||.+.+..++.++||||||+++|+|++|+.||...++............ ....+..+++.+.+++.+||
T Consensus       175 ~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l  254 (296)
T cd06654         175 TMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIFRDFLNRCL  254 (296)
T ss_pred             cccCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCHHHhHHHHhcCCCCCCCCccccCHHHHHHHHHHC
Confidence            45688999999999988899999999999999999999999988777554433332221 12235568899999999999


Q ss_pred             hhcCCCCCCHHHHHH
Q 015868          351 QHDPTQRPNFSQITD  365 (399)
Q Consensus       351 ~~dP~~Rps~~ell~  365 (399)
                      ..+|++||++.++++
T Consensus       255 ~~~p~~Rpt~~eil~  269 (296)
T cd06654         255 DMDVEKRGSAKELLQ  269 (296)
T ss_pred             cCCcccCcCHHHHhh
Confidence            999999999999986

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases

Probab=100.00  E-value=5.7e-41  Score=316.50  Aligned_cols=255  Identities=27%  Similarity=0.575  Sum_probs=214.9

Q ss_pred             ccccceeceeceeCceEEEEEEEC------CeeEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCceeeEEeEEec--CC
Q 015868          115 AKQLKIECKVASGSYGDLYKGTYC------SQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTR--PP  186 (399)
Q Consensus       115 ~~~~~i~~~lg~G~~g~Vy~~~~~------~~~vAvK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~nIv~~~~~~~~--~~  186 (399)
                      .+.|++.+.||+|+||.||++++.      +..+|+|+++..... .....+.+|+.+++.+.||||+++++++..  ..
T Consensus         3 ~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~-~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~~~~~   81 (284)
T cd05038           3 KRHLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEE-QHRSDFEREIEILRTLDHENIVKYKGVCEKPGGR   81 (284)
T ss_pred             hhhchhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccch-HHHHHHHHHHHHHHhCCCCChheEEeeeecCCCC
Confidence            457888999999999999999863      578999999866433 456789999999999999999999999877  55


Q ss_pred             cEEEEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceeecCCCcEEEeeccceeeccC
Q 015868          187 NLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQ  266 (399)
Q Consensus       187 ~~~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~giiHrDlkp~NILl~~~~~vkl~DFG~a~~~~~  266 (399)
                      ..++||||+++++|.+++......++...+..++.|++.||+|||++|++|+||||+||+++.++.++|+|||.+.....
T Consensus        82 ~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~  161 (284)
T cd05038          82 SLRLIMEYLPSGSLRDYLQRHRDQINLKRLLLFSSQICKGMDYLGSQRYIHRDLAARNILVESEDLVKISDFGLAKVLPE  161 (284)
T ss_pred             ceEEEEecCCCCCHHHHHHhCccccCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHhEEEcCCCCEEEccccccccccc
Confidence            79999999999999999987666799999999999999999999999999999999999999999999999999986653


Q ss_pred             CCc----cccCCCCcccccccccCCCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHH--------------HHHHHHHhc
Q 015868          267 SGV----MTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPYAGLTPL--------------QAAVGVVQK  328 (399)
Q Consensus       267 ~~~----~~~~~gt~~y~aPE~l~~~~~~~~~Dv~slG~vl~elltg~~P~~~~~~~--------------~~~~~~~~~  328 (399)
                      ...    .....++..|+|||.+.+..++.++||||||+++|+|++|..|+......              .........
T Consensus       162 ~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  241 (284)
T cd05038         162 DKDYYYVKEPGESPIFWYAPECLRTSKFSSASDVWSFGVTLYELFTYGDPSQSPPAEFLRMIGIAQGQMIVTRLLELLKE  241 (284)
T ss_pred             CCcceeccCCCCCcccccCcHHHccCCCCcccchHHHhhhhheeeccCCCcccccchhccccccccccccHHHHHHHHHc
Confidence            221    11223456799999998888999999999999999999999988653221              112223334


Q ss_pred             cCCCCCCCCCcHHHHHHHHHHhhhcCCCCCCHHHHHHHHHHH
Q 015868          329 SLRPTIPKHAHPRLAELLERCWQHDPTQRPNFSQITDILKQM  370 (399)
Q Consensus       329 ~~~~~~~~~~~~~l~~ll~~cl~~dP~~Rps~~ell~~L~~l  370 (399)
                      ..+...+..++.++.+++.+||+.+|.+|||+.+++++|+.+
T Consensus       242 ~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~i  283 (284)
T cd05038         242 GERLPRPPSCPDEVYDLMKLCWEAEPQDRPSFADLILIVDRL  283 (284)
T ss_pred             CCcCCCCccCCHHHHHHHHHHhccChhhCCCHHHHHHHHhhc
Confidence            444555667889999999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut

>cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1

Probab=100.00  E-value=1.4e-40  Score=309.48  Aligned_cols=248  Identities=23%  Similarity=0.466  Sum_probs=216.9

Q ss_pred             ccceeceeceeCceEEEEEEE--CCeeEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCceeeEEeEEecCCcEEEEEec
Q 015868          117 QLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVTEF  194 (399)
Q Consensus       117 ~~~i~~~lg~G~~g~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~nIv~~~~~~~~~~~~~lV~E~  194 (399)
                      +|++.++||.|+||.+|+++.  .++.||+|.+..........+.+.+|+.++++++||||+++++.+......++||||
T Consensus         1 ~y~~~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~   80 (256)
T cd08218           1 KYVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQESFEENGNLYIVMDY   80 (256)
T ss_pred             CceEEEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhCChHHHHHHHHHHHHHHhCCCCCeeeeEeeecCCCeEEEEEec
Confidence            588999999999999999976  678999999876544555667899999999999999999999999999999999999


Q ss_pred             CCCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceeecCCCcEEEeeccceeeccCCCc-ccc
Q 015868          195 MARGSIYDFLHKQK-GVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGV-MTA  272 (399)
Q Consensus       195 ~~ggsL~~~l~~~~-~~l~~~~~~~i~~~i~~~L~~LH~~giiHrDlkp~NILl~~~~~vkl~DFG~a~~~~~~~~-~~~  272 (399)
                      +.+++|.+++.... ..+++..+..++.|++.|+.|||++|++|+||+|+||+++.++.++|+|||.+........ ...
T Consensus        81 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~~l~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~  160 (256)
T cd08218          81 CEGGDLYKKINAQRGVLFPEDQILDWFVQICLALKHVHDRKILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTVELART  160 (256)
T ss_pred             CCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCEEEeeccceeecCcchhhhhh
Confidence            99999999997643 4688999999999999999999999999999999999999999999999999976544322 223


Q ss_pred             CCCCcccccccccCCCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhccCCCCCCCCCcHHHHHHHHHHhhh
Q 015868          273 ETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRLAELLERCWQH  352 (399)
Q Consensus       273 ~~gt~~y~aPE~l~~~~~~~~~Dv~slG~vl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~cl~~  352 (399)
                      ..+++.|+|||.+.+..++.++|+||||+++++|++|..||...+..+...... ....+..+...+.++.+++.+||+.
T Consensus       161 ~~~~~~~~~pe~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~li~~~l~~  239 (256)
T cd08218         161 CIGTPYYLSPEICENRPYNNKSDIWALGCVLYEMCTLKHAFEAGNMKNLVLKII-RGSYPPVSSHYSYDLRNLVSQLFKR  239 (256)
T ss_pred             ccCCccccCHHHhCCCCCCCccchhHHHHHHHHHHcCCCCccCCCHHHHHHHHh-cCCCCCCcccCCHHHHHHHHHHhhC
Confidence            457889999999999889999999999999999999999998777666555444 3445667778899999999999999


Q ss_pred             cCCCCCCHHHHHH
Q 015868          353 DPTQRPNFSQITD  365 (399)
Q Consensus       353 dP~~Rps~~ell~  365 (399)
                      +|.+||++.++++
T Consensus       240 ~p~~Rp~~~~vl~  252 (256)
T cd08218         240 NPRDRPSVNSILE  252 (256)
T ss_pred             ChhhCcCHHHHhh
Confidence            9999999999976

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti

>cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases

Probab=100.00  E-value=1.4e-40  Score=312.21  Aligned_cols=245  Identities=29%  Similarity=0.550  Sum_probs=200.5

Q ss_pred             ceeceeCceEEEEEEEC----CeeEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCceeeEEeEEecCCcEEEEEecCCC
Q 015868          122 CKVASGSYGDLYKGTYC----SQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVTEFMAR  197 (399)
Q Consensus       122 ~~lg~G~~g~Vy~~~~~----~~~vAvK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~nIv~~~~~~~~~~~~~lV~E~~~g  197 (399)
                      ++||+|+||.||+|+..    ...+|+|.+.... .......+.+|+.+++.++||||+++++.+.....+++||||+++
T Consensus         1 ~~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~~-~~~~~~~~~~e~~~~~~l~h~nii~~~~~~~~~~~~~lv~e~~~~   79 (269)
T cd05042           1 DEIGNGWFGKVLLGEAHRGMSKARVVVKELRASA-TPDEQLLFLQEVQPYRELNHPNVLQCLGQCIESIPYLLVLEFCPL   79 (269)
T ss_pred             CcCCccCCceEEEEEEecCCCCeEEEEeecCccC-ChHHHHHHHHHHHHHHhCCCCCcceEEEEECCCCceEEEEEeCCC
Confidence            36899999999999752    3468888876442 344456789999999999999999999999999999999999999


Q ss_pred             CCHHHHHHhcCC----CCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceeecCCCcEEEeeccceeeccCCCc---c
Q 015868          198 GSIYDFLHKQKG----VFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGV---M  270 (399)
Q Consensus       198 gsL~~~l~~~~~----~l~~~~~~~i~~~i~~~L~~LH~~giiHrDlkp~NILl~~~~~vkl~DFG~a~~~~~~~~---~  270 (399)
                      |+|.+++.....    ..++..+..++.||+.||+|||++||+||||||+||++++++.+||+|||++........   .
T Consensus        80 g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~~~  159 (269)
T cd05042          80 GDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQADFIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYITK  159 (269)
T ss_pred             CcHHHHHHhccccccccccHHHHHHHHHHHHHHHHHHHhcCEecccccHhheEecCCCcEEEeccccccccccchheecc
Confidence            999999976432    346778899999999999999999999999999999999999999999999865433211   1


Q ss_pred             ccCCCCcccccccccCC-------CCCCChhhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHHhccC----CCCCCCCC
Q 015868          271 TAETGTYRWMAPEVIEH-------KPYDYKADVFSFGIALWELLT-GELPYAGLTPLQAAVGVVQKSL----RPTIPKHA  338 (399)
Q Consensus       271 ~~~~gt~~y~aPE~l~~-------~~~~~~~Dv~slG~vl~ellt-g~~P~~~~~~~~~~~~~~~~~~----~~~~~~~~  338 (399)
                      ....++..|+|||++..       ..++.++||||||+++|+|++ |..||...++.+..........    .+.++..+
T Consensus       160 ~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (269)
T cd05042         160 DCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDEQVLKQVVREQDIKLPKPQLDLKY  239 (269)
T ss_pred             CCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCCcCCHHHHHHHHhhccCccCCCCcccccC
Confidence            22345678999999743       456889999999999999999 8899988887766555444332    24455678


Q ss_pred             cHHHHHHHHHHhhhcCCCCCCHHHHHHHHH
Q 015868          339 HPRLAELLERCWQHDPTQRPNFSQITDILK  368 (399)
Q Consensus       339 ~~~l~~ll~~cl~~dP~~Rps~~ell~~L~  368 (399)
                      ++.+.+++..||. ||++|||+.++++.|.
T Consensus       240 ~~~~~~~~~~~~~-dp~~Rpt~~~v~~~l~  268 (269)
T cd05042         240 SDRWYEVMQFCWL-DPETRPTAEEVHELLT  268 (269)
T ss_pred             CHHHHHHHHHHhc-CcccccCHHHHHHHhc
Confidence            8999999999994 9999999999998763

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina

>cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2

Probab=100.00  E-value=1.9e-40  Score=310.68  Aligned_cols=248  Identities=29%  Similarity=0.512  Sum_probs=210.9

Q ss_pred             cccceeceeceeCceEEEEEEE--CCeeEEEEEecCCCC---CHHHHHHHHHHHHHHHhcCCCceeeEEeEEecC--CcE
Q 015868          116 KQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECV---NTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRP--PNL  188 (399)
Q Consensus       116 ~~~~i~~~lg~G~~g~Vy~~~~--~~~~vAvK~~~~~~~---~~~~~~~~~~Ei~~l~~l~h~nIv~~~~~~~~~--~~~  188 (399)
                      ++|++.+.||+|+||.||+|..  +++.||+|.+.....   .....+.+.+|+.++++++||||+++++++...  ..+
T Consensus         2 ~~~~~~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~   81 (265)
T cd06652           2 TNWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRDPMERTL   81 (265)
T ss_pred             CcceEeeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEeccCCCceE
Confidence            4789999999999999999986  578899999864321   234567889999999999999999999988764  458


Q ss_pred             EEEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceeecCCCcEEEeeccceeeccCC-
Q 015868          189 CIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQS-  267 (399)
Q Consensus       189 ~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~giiHrDlkp~NILl~~~~~vkl~DFG~a~~~~~~-  267 (399)
                      ++||||+++++|.+++... ..+++..+..++.|++.||.|||++|++|+||+|+||+++.++.++|+|||.++..... 
T Consensus        82 ~~v~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~l~Dfg~~~~~~~~~  160 (265)
T cd06652          82 SIFMEHMPGGSIKDQLKSY-GALTENVTRKYTRQILEGVSYLHSNMIVHRDIKGANILRDSVGNVKLGDFGASKRLQTIC  160 (265)
T ss_pred             EEEEEecCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEecCCCCEEECcCcccccccccc
Confidence            8999999999999998764 56888999999999999999999999999999999999999999999999998754321 


Q ss_pred             ---CccccCCCCcccccccccCCCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhccCCCCCCCCCcHHHHH
Q 015868          268 ---GVMTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRLAE  344 (399)
Q Consensus       268 ---~~~~~~~gt~~y~aPE~l~~~~~~~~~Dv~slG~vl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~  344 (399)
                         .......++..|+|||.+.+..++.++|+||||+++|+|++|+.||..................+..|...+..+.+
T Consensus       161 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (265)
T cd06652         161 LSGTGMKSVTGTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEKPPWAEFEAMAAIFKIATQPTNPVLPPHVSDHCRD  240 (265)
T ss_pred             ccccccccCCCCccccChhhhcCCCCCcchhHHHHHHHHHHHhhCCCCCCccchHHHHHHHhcCCCCCCCchhhCHHHHH
Confidence               12233468889999999998889999999999999999999999998877666555544444556677788899999


Q ss_pred             HHHHHhhhcCCCCCCHHHHHH
Q 015868          345 LLERCWQHDPTQRPNFSQITD  365 (399)
Q Consensus       345 ll~~cl~~dP~~Rps~~ell~  365 (399)
                      ++.+||. +|.+||+++++++
T Consensus       241 ~i~~~l~-~p~~Rp~~~~il~  260 (265)
T cd06652         241 FLKRIFV-EAKLRPSADELLR  260 (265)
T ss_pred             HHHHHhc-ChhhCCCHHHHhc
Confidence            9999995 9999999999874

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re

>KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms]

Probab=100.00  E-value=5.3e-44  Score=323.14  Aligned_cols=245  Identities=32%  Similarity=0.560  Sum_probs=215.3

Q ss_pred             cccceeceeceeCceEEEEEEE--CCeeEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCceeeEEeEEecCCcEEEEEe
Q 015868          116 KQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVTE  193 (399)
Q Consensus       116 ~~~~i~~~lg~G~~g~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~nIv~~~~~~~~~~~~~lV~E  193 (399)
                      +-|.++.+||+|+||.||+|.+  .|+.+|||.+..+    ..+.++..|+.+|++++.|++|++||.|.+...++||||
T Consensus        33 EVFDi~~KLGEGSYGSV~KAIH~EsG~v~AIK~VPV~----sDLQEIIKEISIMQQC~S~yVVKYYGSYFK~sDLWIVME  108 (502)
T KOG0574|consen   33 EVFDIVGKLGEGSYGSVHKAIHRESGHVLAIKKVPVD----TDLQEIIKEISIMQQCKSKYVVKYYGSYFKHSDLWIVME  108 (502)
T ss_pred             HHHHHHHHhcCCcchHHHHHHHhccCcEEEEEecCcc----chHHHHHHHHHHHHHcCCchhhhhhhhhccCCceEeehh
Confidence            4577899999999999999965  7899999998743    346788899999999999999999999999999999999


Q ss_pred             cCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceeecCCCcEEEeeccceeeccCC-Ccccc
Q 015868          194 FMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQS-GVMTA  272 (399)
Q Consensus       194 ~~~ggsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~giiHrDlkp~NILl~~~~~vkl~DFG~a~~~~~~-~~~~~  272 (399)
                      ||..||+.|.++.++.+++++++..++...++||.|||...-||||||+.|||++.+|..||+|||+|...... ....+
T Consensus       109 YCGAGSiSDI~R~R~K~L~E~EIs~iL~~TLKGL~YLH~~~KIHRDIKAGNILLNT~G~AKLADFGVAGQLTDTMAKRNT  188 (502)
T KOG0574|consen  109 YCGAGSISDIMRARRKPLSEQEISAVLRDTLKGLQYLHDLKKIHRDIKAGNILLNTDGIAKLADFGVAGQLTDTMAKRNT  188 (502)
T ss_pred             hcCCCcHHHHHHHhcCCccHHHHHHHHHHHHhHHHHHHHHHHHHhhcccccEEEcccchhhhhhccccchhhhhHHhhCc
Confidence            99999999999999999999999999999999999999999999999999999999999999999999654332 22345


Q ss_pred             CCCCcccccccccCCCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhccCCCC--CCCCCcHHHHHHHHHHh
Q 015868          273 ETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKSLRPT--IPKHAHPRLAELLERCW  350 (399)
Q Consensus       273 ~~gt~~y~aPE~l~~~~~~~~~Dv~slG~vl~elltg~~P~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~l~~ll~~cl  350 (399)
                      ..||+.|||||++..-.|+.++||||||++..||..|++||....|..+..-+ ....+|.  -|..++.++.+++++||
T Consensus       189 VIGTPFWMAPEVI~EIGY~~~ADIWSLGITaIEMAEG~PPYsDIHPMRAIFMI-PT~PPPTF~KPE~WS~~F~DFi~~CL  267 (502)
T KOG0574|consen  189 VIGTPFWMAPEVIEEIGYDTKADIWSLGITAIEMAEGRPPYSDIHPMRAIFMI-PTKPPPTFKKPEEWSSEFNDFIRSCL  267 (502)
T ss_pred             cccCcccccHHHHHHhccchhhhHhhhcchhhhhhcCCCCcccccccceeEec-cCCCCCCCCChHhhhhHHHHHHHHHh
Confidence            67999999999999999999999999999999999999999998886543322 1222222  24568999999999999


Q ss_pred             hhcCCCCCCHHHHHH
Q 015868          351 QHDPTQRPNFSQITD  365 (399)
Q Consensus       351 ~~dP~~Rps~~ell~  365 (399)
                      -++|++|.|+.++++
T Consensus       268 iK~PE~R~TA~~L~~  282 (502)
T KOG0574|consen  268 IKKPEERKTALRLCE  282 (502)
T ss_pred             cCCHHHHHHHHHHhh
Confidence            999999999999875

>cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase

Probab=100.00  E-value=9.8e-41  Score=318.81  Aligned_cols=249  Identities=23%  Similarity=0.387  Sum_probs=206.4

Q ss_pred             ccccceeceeceeCceEEEEEEE--CCeeEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCceeeEEeEEecCCcEEEEE
Q 015868          115 AKQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVT  192 (399)
Q Consensus       115 ~~~~~i~~~lg~G~~g~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~nIv~~~~~~~~~~~~~lV~  192 (399)
                      .++|++.++||.|+||.||+|++  +++.||+|.++.... ......+.+|+.+++.++||||+++++++..+...++||
T Consensus         5 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~lv~   83 (301)
T cd07873           5 LETYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHE-EGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVF   83 (301)
T ss_pred             ccceEEeeEeccCcCEEEEEEEEcCCCcEEEEEEEecccc-cCchhHHHHHHHHHHhcCCCCcceEEEEEecCCeEEEEE
Confidence            46899999999999999999987  578899999875432 222346778999999999999999999999999999999


Q ss_pred             ecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceeecCCCcEEEeeccceeeccCCC-ccc
Q 015868          193 EFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSG-VMT  271 (399)
Q Consensus       193 E~~~ggsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~giiHrDlkp~NILl~~~~~vkl~DFG~a~~~~~~~-~~~  271 (399)
                      ||+.+ +|.+++......+++..+..++.|++.||.|||++||+|+||||+||++++++.++|+|||.+....... ...
T Consensus        84 e~~~~-~l~~~l~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~  162 (301)
T cd07873          84 EYLDK-DLKQYLDDCGNSINMHNVKLFLFQLLRGLNYCHRRKVLHRDLKPQNLLINERGELKLADFGLARAKSIPTKTYS  162 (301)
T ss_pred             ecccc-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHHHEEECCCCcEEECcCcchhccCCCCCccc
Confidence            99975 9999998777778999999999999999999999999999999999999999999999999987543322 223


Q ss_pred             cCCCCcccccccccCCC-CCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhccC--------------------
Q 015868          272 AETGTYRWMAPEVIEHK-PYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKSL--------------------  330 (399)
Q Consensus       272 ~~~gt~~y~aPE~l~~~-~~~~~~Dv~slG~vl~elltg~~P~~~~~~~~~~~~~~~~~~--------------------  330 (399)
                      ...+++.|+|||.+.+. .++.++||||||+++|+|++|++||...+..+..........                    
T Consensus       163 ~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  242 (301)
T cd07873         163 NEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSNEEFKSYN  242 (301)
T ss_pred             ccceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChhhchhhhccccccccc
Confidence            44678899999998754 578899999999999999999999988776544332211000                    


Q ss_pred             CCC--------CCCCCcHHHHHHHHHHhhhcCCCCCCHHHHHH
Q 015868          331 RPT--------IPKHAHPRLAELLERCWQHDPTQRPNFSQITD  365 (399)
Q Consensus       331 ~~~--------~~~~~~~~l~~ll~~cl~~dP~~Rps~~ell~  365 (399)
                      .+.        ....+++++.+||.+||+.||.+|||+.|+++
T Consensus       243 ~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~eil~  285 (301)
T cd07873         243 YPKYRADCLHNHAPRLDSDGAELLSKLLQFEGRKRISAEEAMK  285 (301)
T ss_pred             cCccccccHHhhcCCCCHHHHHHHHHHhcCCcccCcCHHHHhc
Confidence            010        11357889999999999999999999999876

Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl

>smart00219 TyrKc Tyrosine kinase, catalytic domain

Probab=100.00  E-value=1.4e-40  Score=308.87  Aligned_cols=248  Identities=39%  Similarity=0.757  Sum_probs=214.1

Q ss_pred             cceeceeceeCceEEEEEEECC------eeEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCceeeEEeEEecCCcEEEE
Q 015868          118 LKIECKVASGSYGDLYKGTYCS------QEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIV  191 (399)
Q Consensus       118 ~~i~~~lg~G~~g~Vy~~~~~~------~~vAvK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~nIv~~~~~~~~~~~~~lV  191 (399)
                      +++.+.||.|+||.||++....      ..||+|+++... .....+.+.+|+.+++.++|+||+++++.+......+++
T Consensus         1 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~i   79 (258)
T smart00219        1 LTLGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDA-DEQQIEEFLREARIMRKLDHPNIVKLLGVCTEEEPLMIV   79 (258)
T ss_pred             CcccceeccCCCcceEEEEecCCCCCCCceEEEEEccCCC-ChHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCeeEEE
Confidence            3567899999999999998854      789999997653 233567899999999999999999999999999999999


Q ss_pred             EecCCCCCHHHHHHhcCCC-CCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceeecCCCcEEEeeccceeeccCCCcc
Q 015868          192 TEFMARGSIYDFLHKQKGV-FQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVM  270 (399)
Q Consensus       192 ~E~~~ggsL~~~l~~~~~~-l~~~~~~~i~~~i~~~L~~LH~~giiHrDlkp~NILl~~~~~vkl~DFG~a~~~~~~~~~  270 (399)
                      |||+++++|.+++...... +++..+..++.|++.|++|||++|++|+||+|+||++++++.++|+|||.++........
T Consensus        80 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~~~~h~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~~~  159 (258)
T smart00219       80 MEYMEGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYLESKNFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYY  159 (258)
T ss_pred             EeccCCCCHHHHHHhhhhccCCHHHHHHHHHHHHHHHHHHhcCCeeecccccceEEEccCCeEEEcccCCceeccccccc
Confidence            9999999999999765444 899999999999999999999999999999999999999999999999999765543222


Q ss_pred             c--cCCCCcccccccccCCCCCCChhhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHHhccCCCCCCCCCcHHHHHHHH
Q 015868          271 T--AETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLT-GELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRLAELLE  347 (399)
Q Consensus       271 ~--~~~gt~~y~aPE~l~~~~~~~~~Dv~slG~vl~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~  347 (399)
                      .  ...+++.|+|||.+.+..++.++|+||||+++|+|++ |..||...+..+..... .....+..+..++.++.+++.
T Consensus       160 ~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~i~~~l~~~g~~p~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~i~  238 (258)
T smart00219      160 KKKGGKLPIRWMAPESLKDGKFTSKSDVWSFGVLLWEIFTLGESPYPGMSNEEVLEYL-KKGYRLPKPENCPPEIYKLML  238 (258)
T ss_pred             ccccCCCcccccChHHhccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHH-hcCCCCCCCCcCCHHHHHHHH
Confidence            2  1236789999999988889999999999999999998 88999887776655543 344556667779999999999


Q ss_pred             HHhhhcCCCCCCHHHHHHHH
Q 015868          348 RCWQHDPTQRPNFSQITDIL  367 (399)
Q Consensus       348 ~cl~~dP~~Rps~~ell~~L  367 (399)
                      +||..+|++|||+.|+++.|
T Consensus       239 ~~l~~~p~~Rpt~~~ll~~l  258 (258)
T smart00219      239 QCWAEDPEDRPTFSELVEIL  258 (258)
T ss_pred             HHCcCChhhCcCHHHHHhhC
Confidence            99999999999999998764

Phosphotransferases. Tyrosine-specific kinase subfamily.

>cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6

Probab=100.00  E-value=1.2e-40  Score=314.52  Aligned_cols=247  Identities=31%  Similarity=0.545  Sum_probs=202.4

Q ss_pred             cccceeceeceeCceEEEEEEE--CCeeEEEEEecCCCCCHHHHHHHHHHHH-HHHhcCCCceeeEEeEEecCCcEEEEE
Q 015868          116 KQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVNTEMLKEFSQEVY-IMRKIRHKNVVQFIGACTRPPNLCIVT  192 (399)
Q Consensus       116 ~~~~i~~~lg~G~~g~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~Ei~-~l~~l~h~nIv~~~~~~~~~~~~~lV~  192 (399)
                      ++|++.+.||+|+||.||++.+  +++.||+|+++........ ..+..|+. .++..+||||+++++++..+...|+||
T Consensus         1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~-~~~~~e~~~~~~~~~~~~iv~~~~~~~~~~~~~lv~   79 (283)
T cd06617           1 DDLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQ-KRLLMDLDISMRSVDCPYTVTFYGALFREGDVWICM   79 (283)
T ss_pred             CCceEEEEecccCCeEEEEEEEcCCCcEEEEEEEecCCCcHHH-HHHHHHHHHHHHHcCCCCeeeeeEEEecCCcEEEEh
Confidence            4688999999999999999987  5789999999865433333 34455555 467778999999999999999999999


Q ss_pred             ecCCCCCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHC-CcccCCCCCCceeecCCCcEEEeeccceeeccCCC
Q 015868          193 EFMARGSIYDFLHK---QKGVFQLTSLLKVAIDVSKGMNYLHQN-NIIHRDLKTANLLMDENGVVKVADFGVARVQAQSG  268 (399)
Q Consensus       193 E~~~ggsL~~~l~~---~~~~l~~~~~~~i~~~i~~~L~~LH~~-giiHrDlkp~NILl~~~~~vkl~DFG~a~~~~~~~  268 (399)
                      ||++ ++|.+++..   ....+++..++.++.|++.||+|||++ +++||||||+||+++.++.+||+|||.++......
T Consensus        80 e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~i~h~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~  158 (283)
T cd06617          80 EVMD-TSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSKLSVIHRDVKPSNVLINRNGQVKLCDFGISGYLVDSV  158 (283)
T ss_pred             hhhc-ccHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhcCCeecCCCCHHHEEECCCCCEEEeeccccccccccc
Confidence            9997 488888754   235689999999999999999999998 99999999999999999999999999998654443


Q ss_pred             ccccCCCCcccccccccCC----CCCCChhhHHHHHHHHHHHHcCCCCCCCCC-HHHHHHHHHhccCCCCCC-CCCcHHH
Q 015868          269 VMTAETGTYRWMAPEVIEH----KPYDYKADVFSFGIALWELLTGELPYAGLT-PLQAAVGVVQKSLRPTIP-KHAHPRL  342 (399)
Q Consensus       269 ~~~~~~gt~~y~aPE~l~~----~~~~~~~Dv~slG~vl~elltg~~P~~~~~-~~~~~~~~~~~~~~~~~~-~~~~~~l  342 (399)
                      ..+...++..|+|||.+.+    ..++.++|+||||+++|+|++|+.||.... ..+....... ...+.++ ..++.++
T Consensus       159 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~l  237 (283)
T cd06617         159 AKTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKTPFQQLKQVVE-EPSPQLPAEKFSPEF  237 (283)
T ss_pred             ccccccCCccccChhhcCCcccccccCccccchhhHHHHHHHHhCCCCCCccccCHHHHHHHHh-cCCCCCCccccCHHH
Confidence            3344568899999999865    457889999999999999999999997543 3333333333 3334444 3578999


Q ss_pred             HHHHHHHhhhcCCCCCCHHHHHH
Q 015868          343 AELLERCWQHDPTQRPNFSQITD  365 (399)
Q Consensus       343 ~~ll~~cl~~dP~~Rps~~ell~  365 (399)
                      .+++.+||..+|.+||++.++++
T Consensus       238 ~~li~~~l~~~p~~Rp~~~~il~  260 (283)
T cd06617         238 QDFVNKCLKKNYKERPNYPELLQ  260 (283)
T ss_pred             HHHHHHHccCChhhCcCHHHHhc
Confidence            99999999999999999999976

Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs

>cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4

Probab=100.00  E-value=1.6e-40  Score=312.69  Aligned_cols=254  Identities=28%  Similarity=0.551  Sum_probs=214.6

Q ss_pred             cccccceeceeceeCceEEEEEEEC-------CeeEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCceeeEEeEEecCC
Q 015868          114 DAKQLKIECKVASGSYGDLYKGTYC-------SQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPP  186 (399)
Q Consensus       114 ~~~~~~i~~~lg~G~~g~Vy~~~~~-------~~~vAvK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~nIv~~~~~~~~~~  186 (399)
                      ..++|++.+.||.|+||.||+|+..       .+.|++|.+.... .......+.+|+.++++++|+||+++++++....
T Consensus         3 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~   81 (275)
T cd05046           3 PRSNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTK-DENLQSEFRRELDMFRKLSHKNVVRLLGLCREAE   81 (275)
T ss_pred             ChHhceeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCcc-chHHHHHHHHHHHHHHhcCCcceeeeEEEECCCC
Confidence            4568999999999999999999852       4679999987542 2335678999999999999999999999999988


Q ss_pred             cEEEEEecCCCCCHHHHHHhcC--------CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceeecCCCcEEEeec
Q 015868          187 NLCIVTEFMARGSIYDFLHKQK--------GVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADF  258 (399)
Q Consensus       187 ~~~lV~E~~~ggsL~~~l~~~~--------~~l~~~~~~~i~~~i~~~L~~LH~~giiHrDlkp~NILl~~~~~vkl~DF  258 (399)
                      ..++||||+++++|.+++....        ..+++..+..++.|++.||.|||++||+||||||+||+++.++.++++||
T Consensus        82 ~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~i~H~dlkp~Nili~~~~~~~l~~~  161 (275)
T cd05046          82 PHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSNARFVHRDLAARNCLVSSQREVKVSLL  161 (275)
T ss_pred             cceEEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhhcCcccCcCccceEEEeCCCcEEEccc
Confidence            9999999999999999997643        15899999999999999999999999999999999999999999999999


Q ss_pred             cceeeccCCC--ccccCCCCcccccccccCCCCCCChhhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHHhccCCCCCC
Q 015868          259 GVARVQAQSG--VMTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLT-GELPYAGLTPLQAAVGVVQKSLRPTIP  335 (399)
Q Consensus       259 G~a~~~~~~~--~~~~~~gt~~y~aPE~l~~~~~~~~~Dv~slG~vl~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~  335 (399)
                      |++.......  ......++..|+|||.+.+..++.++||||||+++|++++ |..||......+..............+
T Consensus       162 ~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~  241 (275)
T cd05046         162 SLSKDVYNSEYYKLRNALIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYGLSDEEVLNRLQAGKLELPVP  241 (275)
T ss_pred             ccccccCcccccccCCceeEEeecChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCccccchHHHHHHHHcCCcCCCCC
Confidence            9986433221  1223345778999999988888999999999999999999 889998777666555444333334455


Q ss_pred             CCCcHHHHHHHHHHhhhcCCCCCCHHHHHHHHH
Q 015868          336 KHAHPRLAELLERCWQHDPTQRPNFSQITDILK  368 (399)
Q Consensus       336 ~~~~~~l~~ll~~cl~~dP~~Rps~~ell~~L~  368 (399)
                      ..++..+.+++.+||+.+|.+|||+.++++.|.
T Consensus       242 ~~~~~~l~~~i~~~l~~~p~~Rp~~~~~l~~l~  274 (275)
T cd05046         242 EGCPSRLYKLMTRCWAVNPKDRPSFSELVSALG  274 (275)
T ss_pred             CCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhc
Confidence            678899999999999999999999999998875

Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s

>cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4

Probab=100.00  E-value=1.2e-40  Score=314.78  Aligned_cols=249  Identities=25%  Similarity=0.398  Sum_probs=206.4

Q ss_pred             cccceeceeceeCceEEEEEEE--CCeeEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCceeeEEeEEecCCcEEEEEe
Q 015868          116 KQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVTE  193 (399)
Q Consensus       116 ~~~~i~~~lg~G~~g~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~nIv~~~~~~~~~~~~~lV~E  193 (399)
                      ++|++.+.||+|+||.||+|+.  .++.||+|++..........+.+.+|+.++++++|||++++++++......++|||
T Consensus         1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~e   80 (286)
T cd07847           1 EKYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIEVFRRKRKLHLVFE   80 (286)
T ss_pred             CceeeeeeecccCCeEEEEEEECCCCcEEEEEEEeecccCccccHHHHHHHHHHHhCCCCCEeeeeeEEeeCCEEEEEEe
Confidence            4688999999999999999987  47899999987543333344668899999999999999999999999999999999


Q ss_pred             cCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceeecCCCcEEEeeccceeeccCCC-cccc
Q 015868          194 FMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSG-VMTA  272 (399)
Q Consensus       194 ~~~ggsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~giiHrDlkp~NILl~~~~~vkl~DFG~a~~~~~~~-~~~~  272 (399)
                      |+++++|..++.. ...+++..+..++.|++.||.|||++|++|+||||+||++++++.++|+|||.+....... ....
T Consensus        81 ~~~~~~l~~~~~~-~~~~~~~~~~~~~~ql~~~l~~LH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~  159 (286)
T cd07847          81 YCDHTVLNELEKN-PRGVPEHLIKKIIWQTLQAVNFCHKHNCIHRDVKPENILITKQGQIKLCDFGFARILTGPGDDYTD  159 (286)
T ss_pred             ccCccHHHHHHhC-CCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCChhhEEEcCCCcEEECccccceecCCCcccccC
Confidence            9999888777654 4568999999999999999999999999999999999999999999999999998665433 2334


Q ss_pred             CCCCcccccccccCC-CCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcc--------------------CC
Q 015868          273 ETGTYRWMAPEVIEH-KPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKS--------------------LR  331 (399)
Q Consensus       273 ~~gt~~y~aPE~l~~-~~~~~~~Dv~slG~vl~elltg~~P~~~~~~~~~~~~~~~~~--------------------~~  331 (399)
                      ..++..|+|||.+.+ ..++.++|+||||+++|+|++|..||.+.++.+.........                    ..
T Consensus       160 ~~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (286)
T cd07847         160 YVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQLYLIRKTLGDLIPRHQQIFSTNQFFKGLSI  239 (286)
T ss_pred             cccccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChHHhhhcccccccccccC
Confidence            467889999999876 457899999999999999999999998877655443322100                    00


Q ss_pred             CC---------CCCCCcHHHHHHHHHHhhhcCCCCCCHHHHHH
Q 015868          332 PT---------IPKHAHPRLAELLERCWQHDPTQRPNFSQITD  365 (399)
Q Consensus       332 ~~---------~~~~~~~~l~~ll~~cl~~dP~~Rps~~ell~  365 (399)
                      +.         ....++..+.+|+.+||+.+|++||++.|++.
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~  282 (286)
T cd07847         240 PEPETREPLESKFPNISSPALSFLKGCLQMDPTERLSCEELLE  282 (286)
T ss_pred             CCcccccCHHHHhccCCHHHHHHHHHHhcCCccccCCHHHHhc
Confidence            00         01246788999999999999999999999874

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio

>cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3

Probab=100.00  E-value=1.7e-40  Score=311.26  Aligned_cols=248  Identities=29%  Similarity=0.499  Sum_probs=211.2

Q ss_pred             cccceeceeceeCceEEEEEEE--CCeeEEEEEecCCCC---CHHHHHHHHHHHHHHHhcCCCceeeEEeEEec--CCcE
Q 015868          116 KQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECV---NTEMLKEFSQEVYIMRKIRHKNVVQFIGACTR--PPNL  188 (399)
Q Consensus       116 ~~~~i~~~lg~G~~g~Vy~~~~--~~~~vAvK~~~~~~~---~~~~~~~~~~Ei~~l~~l~h~nIv~~~~~~~~--~~~~  188 (399)
                      .+|++.+.||+|+||.||+|..  ++..||+|.++....   .......+.+|+.++++++||||+++++.+..  ...+
T Consensus         2 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~   81 (266)
T cd06651           2 INWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRDRAEKTL   81 (266)
T ss_pred             CCccccceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEcCCCCEE
Confidence            3688899999999999999986  578999999875422   23445678999999999999999999998865  3568


Q ss_pred             EEEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceeecCCCcEEEeeccceeeccCC-
Q 015868          189 CIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQS-  267 (399)
Q Consensus       189 ~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~giiHrDlkp~NILl~~~~~vkl~DFG~a~~~~~~-  267 (399)
                      ++++||+++++|.+++... ..++...++.++.|++.||+|||+++|+||||+|+||+++.++.++|+|||+++..... 
T Consensus        82 ~l~~e~~~~~~L~~~l~~~-~~l~~~~~~~~~~qi~~~l~~LH~~~i~H~~l~p~nil~~~~~~~~l~dfg~~~~~~~~~  160 (266)
T cd06651          82 TIFMEYMPGGSVKDQLKAY-GALTESVTRKYTRQILEGMSYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTIC  160 (266)
T ss_pred             EEEEeCCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEECCCCCEEEccCCCcccccccc
Confidence            9999999999999999763 46889999999999999999999999999999999999999999999999998754321 


Q ss_pred             ---CccccCCCCcccccccccCCCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhccCCCCCCCCCcHHHHH
Q 015868          268 ---GVMTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRLAE  344 (399)
Q Consensus       268 ---~~~~~~~gt~~y~aPE~l~~~~~~~~~Dv~slG~vl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~  344 (399)
                         .......++..|+|||.+.+..++.++|+||||+++|+|++|+.||......+...........+.+|..+++.+.+
T Consensus       161 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (266)
T cd06651         161 MSGTGIRSVTGTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPPWAEYEAMAAIFKIATQPTNPQLPSHISEHARD  240 (266)
T ss_pred             ccCCccccCCccccccCHHHhCCCCCCchhhhHHHHHHHHHHHHCCCCccccchHHHHHHHhcCCCCCCCchhcCHHHHH
Confidence               11223457889999999999889999999999999999999999998887766655555555567778888999999


Q ss_pred             HHHHHhhhcCCCCCCHHHHHH
Q 015868          345 LLERCWQHDPTQRPNFSQITD  365 (399)
Q Consensus       345 ll~~cl~~dP~~Rps~~ell~  365 (399)
                      ++ +||..+|++||++.|+++
T Consensus       241 li-~~~~~~p~~Rp~~~eil~  260 (266)
T cd06651         241 FL-GCIFVEARHRPSAEELLR  260 (266)
T ss_pred             HH-HHhcCChhhCcCHHHHhc
Confidence            99 688899999999999964

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development

>cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1

Probab=100.00  E-value=9.1e-41  Score=312.99  Aligned_cols=238  Identities=28%  Similarity=0.524  Sum_probs=197.1

Q ss_pred             ceeceeCceEEEEEEEC--------------CeeEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCceeeEEeEEecCCc
Q 015868          122 CKVASGSYGDLYKGTYC--------------SQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPN  187 (399)
Q Consensus       122 ~~lg~G~~g~Vy~~~~~--------------~~~vAvK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~nIv~~~~~~~~~~~  187 (399)
                      +.||.|+||.||+|+..              ...|++|++...  ..+....+.+|+.+++.++||||+++++++.....
T Consensus         1 ~~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~--~~~~~~~~~~~~~~l~~l~hp~iv~~~~~~~~~~~   78 (262)
T cd05077           1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPS--HRDISLAFFETASMMRQVSHKHIVLLYGVCVRDVE   78 (262)
T ss_pred             CccccCCcceEeeeecccCCCccccccchhhceeEEEeecChh--hhhHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCC
Confidence            46899999999999752              235889988764  34455678999999999999999999999999989


Q ss_pred             EEEEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceeecCCCc-------EEEeeccc
Q 015868          188 LCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGV-------VKVADFGV  260 (399)
Q Consensus       188 ~~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~giiHrDlkp~NILl~~~~~-------vkl~DFG~  260 (399)
                      .++||||+++++|..++......+++..++.++.||++||+|||++||+||||||+|||++.++.       ++++|||.
T Consensus        79 ~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~~~~~~~~~~~l~d~g~  158 (262)
T cd05077          79 NIMVEEFVEFGPLDLFMHRKSDVLTTPWKFKVAKQLASALSYLEDKDLVHGNVCTKNILLAREGIDGECGPFIKLSDPGI  158 (262)
T ss_pred             CEEEEecccCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhCCeECCCCCcccEEEecCCccCCCCceeEeCCCCC
Confidence            99999999999999999876677999999999999999999999999999999999999987664       89999999


Q ss_pred             eeeccCCCccccCCCCcccccccccC-CCCCCChhhHHHHHHHHHHHH-cCCCCCCCCCHHHHHHHHHhccCCCCCCCCC
Q 015868          261 ARVQAQSGVMTAETGTYRWMAPEVIE-HKPYDYKADVFSFGIALWELL-TGELPYAGLTPLQAAVGVVQKSLRPTIPKHA  338 (399)
Q Consensus       261 a~~~~~~~~~~~~~gt~~y~aPE~l~-~~~~~~~~Dv~slG~vl~ell-tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~  338 (399)
                      +.....   .....++..|+|||.+. +..++.++||||||+++|+|+ +|..||......+... .....  .......
T Consensus       159 ~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~-~~~~~--~~~~~~~  232 (262)
T cd05077         159 PITVLS---RQECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKDKTLAEKER-FYEGQ--CMLVTPS  232 (262)
T ss_pred             CccccC---cccccccccccChhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCcchhHHHH-HHhcC--ccCCCCC
Confidence            865432   22345788899999987 567899999999999999997 5889998765544322 12211  1223345


Q ss_pred             cHHHHHHHHHHhhhcCCCCCCHHHHHHHH
Q 015868          339 HPRLAELLERCWQHDPTQRPNFSQITDIL  367 (399)
Q Consensus       339 ~~~l~~ll~~cl~~dP~~Rps~~ell~~L  367 (399)
                      ++++.+++.+||+.||.+||++.+|++.+
T Consensus       233 ~~~~~~li~~cl~~dp~~Rp~~~~il~~~  261 (262)
T cd05077         233 CKELADLMTHCMNYDPNQRPFFRAIMRDI  261 (262)
T ss_pred             hHHHHHHHHHHcCCChhhCcCHHHHHHhc
Confidence            67899999999999999999999998865

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom

>cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase

Probab=100.00  E-value=1.4e-40  Score=316.16  Aligned_cols=245  Identities=27%  Similarity=0.460  Sum_probs=213.5

Q ss_pred             cccceeceeceeCceEEEEEEE--CCeeEEEEEecCCCC-CHHHHHHHHHHHHHHHhcCCCceeeEEeEEecCCcEEEEE
Q 015868          116 KQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECV-NTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVT  192 (399)
Q Consensus       116 ~~~~i~~~lg~G~~g~Vy~~~~--~~~~vAvK~~~~~~~-~~~~~~~~~~Ei~~l~~l~h~nIv~~~~~~~~~~~~~lV~  192 (399)
                      ++|++.+.||.|+||.||++.+  .++.||+|+++.... .......+.+|+.++++++||||+++++.+..+...++||
T Consensus         1 ~~y~~~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~   80 (290)
T cd05580           1 DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQDDSNLYLVM   80 (290)
T ss_pred             CceEEEEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCccceeeEEEcCCeEEEEE
Confidence            4789999999999999999987  578999999875432 2344577899999999999999999999999999999999


Q ss_pred             ecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceeecCCCcEEEeeccceeeccCCCcccc
Q 015868          193 EFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTA  272 (399)
Q Consensus       193 E~~~ggsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~giiHrDlkp~NILl~~~~~vkl~DFG~a~~~~~~~~~~~  272 (399)
                      ||+++++|.+++... +.+++..+..++.|++.||.|||++|++|+||+|.||+++.++.+||+|||++......  ...
T Consensus        81 e~~~~~~L~~~~~~~-~~l~~~~~~~~~~qil~~l~~lH~~~i~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~--~~~  157 (290)
T cd05580          81 EYVPGGELFSHLRKS-GRFPEPVARFYAAQVVLALEYLHSLDIVYRDLKPENLLLDSDGYIKITDFGFAKRVKGR--TYT  157 (290)
T ss_pred             ecCCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEECCCCCEEEeeCCCccccCCC--CCC
Confidence            999999999999764 67899999999999999999999999999999999999999999999999999765443  334


Q ss_pred             CCCCcccccccccCCCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhccCCCCCCCCCcHHHHHHHHHHhhh
Q 015868          273 ETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRLAELLERCWQH  352 (399)
Q Consensus       273 ~~gt~~y~aPE~l~~~~~~~~~Dv~slG~vl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~cl~~  352 (399)
                      ..+++.|+|||.+.+..++.++|+||||+++|+|++|..||...+..+......  ...+.+|...+..+.+++.+||+.
T Consensus       158 ~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~--~~~~~~~~~~~~~l~~li~~~l~~  235 (290)
T cd05580         158 LCGTPEYLAPEIILSKGYGKAVDWWALGILIYEMLAGYPPFFDDNPIQIYEKIL--EGKVRFPSFFSPDAKDLIRNLLQV  235 (290)
T ss_pred             CCCCccccChhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHh--cCCccCCccCCHHHHHHHHHHccC
Confidence            468899999999988888999999999999999999999998877655444433  234567778899999999999999


Q ss_pred             cCCCCC-----CHHHHHH
Q 015868          353 DPTQRP-----NFSQITD  365 (399)
Q Consensus       353 dP~~Rp-----s~~ell~  365 (399)
                      ||.+|+     +++++++
T Consensus       236 ~p~~R~~~~~~~~~~l~~  253 (290)
T cd05580         236 DLTKRLGNLKNGVNDIKN  253 (290)
T ss_pred             CHHHccCcccCCHHHHHc
Confidence            999998     6777753

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi

>cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase

Probab=100.00  E-value=1.6e-40  Score=313.98  Aligned_cols=248  Identities=25%  Similarity=0.414  Sum_probs=210.4

Q ss_pred             ccceeceeceeCceEEEEEEE--CCeeEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCceeeEEeEEecCCcEEEEEec
Q 015868          117 QLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVTEF  194 (399)
Q Consensus       117 ~~~i~~~lg~G~~g~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~nIv~~~~~~~~~~~~~lV~E~  194 (399)
                      +|++.+.||.|+||.||+|++  .++.||+|++............+.+|+.++++++||||+++++++..+...++||||
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~   80 (286)
T cd07832           1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDVFPHGSGFVLVMEY   80 (286)
T ss_pred             CceEEeecccCCCcEEEEEEECCCCceEEEEEEEcccccchhhHHHHHHHHHHHhCCCCCCcceeeEEecCCeeEEEecc
Confidence            588999999999999999987  578999999987655455567899999999999999999999999999999999999


Q ss_pred             CCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceeecCCCcEEEeeccceeeccCCCc--ccc
Q 015868          195 MARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGV--MTA  272 (399)
Q Consensus       195 ~~ggsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~giiHrDlkp~NILl~~~~~vkl~DFG~a~~~~~~~~--~~~  272 (399)
                      + +++|.+++......+++..++.++.||+.||+|||+.|++|+||||+||++++++.++|+|||.+........  ...
T Consensus        81 ~-~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~~~~~~~~~l~dfg~~~~~~~~~~~~~~~  159 (286)
T cd07832          81 M-PSDLSEVLRDEERPLPEAQVKSYMRMLLKGVAYMHANGIMHRDLKPANLLISADGVLKIADFGLARLFSEEEPRLYSH  159 (286)
T ss_pred             c-CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCcCHHHEEEcCCCcEEEeeeeecccccCCCCCcccc
Confidence            9 9999999987677899999999999999999999999999999999999999999999999999986654331  334


Q ss_pred             CCCCcccccccccCCC-CCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhccCCC-------------------
Q 015868          273 ETGTYRWMAPEVIEHK-PYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKSLRP-------------------  332 (399)
Q Consensus       273 ~~gt~~y~aPE~l~~~-~~~~~~Dv~slG~vl~elltg~~P~~~~~~~~~~~~~~~~~~~~-------------------  332 (399)
                      ..++..|+|||.+.+. .++.++||||+|+++|+|++|.+||.+.+..............+                   
T Consensus       160 ~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (286)
T cd07832         160 QVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPGENDIEQLAIVFRTLGTPNEETWPGLTSLPDYNKITF  239 (286)
T ss_pred             ccCcccccCceeeeccccCCchhHHHHHHHHHHHHHcCCcCcCCCCHHHHHHHHHHHcCCCChHHHhhccCcchhhcccC
Confidence            5688999999998654 46899999999999999999999998776554433332211100                   


Q ss_pred             ---------CCCCCCcHHHHHHHHHHhhhcCCCCCCHHHHHH
Q 015868          333 ---------TIPKHAHPRLAELLERCWQHDPTQRPNFSQITD  365 (399)
Q Consensus       333 ---------~~~~~~~~~l~~ll~~cl~~dP~~Rps~~ell~  365 (399)
                               ......+.++.+++.+||+.+|++||++++++.
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~l~  281 (286)
T cd07832         240 PESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRLSAAEALR  281 (286)
T ss_pred             CCCCcchHHHhCCCccHHHHHHHHHHhccChhhCCCHHHHhh
Confidence                     011346789999999999999999999999875

Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea

>cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10

Probab=100.00  E-value=1.7e-40  Score=311.35  Aligned_cols=252  Identities=23%  Similarity=0.477  Sum_probs=214.7

Q ss_pred             ccceeceeceeCceEEEEEEEC---CeeEEEEEecCCC--------CCHHHHHHHHHHHHHHHh-cCCCceeeEEeEEec
Q 015868          117 QLKIECKVASGSYGDLYKGTYC---SQEVAIKVLKPEC--------VNTEMLKEFSQEVYIMRK-IRHKNVVQFIGACTR  184 (399)
Q Consensus       117 ~~~i~~~lg~G~~g~Vy~~~~~---~~~vAvK~~~~~~--------~~~~~~~~~~~Ei~~l~~-l~h~nIv~~~~~~~~  184 (399)
                      .|++.+.||+|+||.||++...   ++.+|+|.+....        ........+.+|+.++.+ ++||||+++++++..
T Consensus         1 ~y~~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~   80 (269)
T cd08528           1 EYAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLE   80 (269)
T ss_pred             CchhhhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEcc
Confidence            4788899999999999999874   4789999886432        233455678889998875 799999999999999


Q ss_pred             CCcEEEEEecCCCCCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHH-CCcccCCCCCCceeecCCCcEEEeeccc
Q 015868          185 PPNLCIVTEFMARGSIYDFLHK---QKGVFQLTSLLKVAIDVSKGMNYLHQ-NNIIHRDLKTANLLMDENGVVKVADFGV  260 (399)
Q Consensus       185 ~~~~~lV~E~~~ggsL~~~l~~---~~~~l~~~~~~~i~~~i~~~L~~LH~-~giiHrDlkp~NILl~~~~~vkl~DFG~  260 (399)
                      .+..++||||++|++|.+++..   ....+++..++.++.|++.||.|||+ .|++|+||+|+||++++++.++|+|||.
T Consensus        81 ~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~i~H~dl~~~nil~~~~~~~~l~dfg~  160 (269)
T cd08528          81 NDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHKEKRIVHRDLTPNNIMLGEDDKVTITDFGL  160 (269)
T ss_pred             CCeEEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhccCCceeecCCCHHHEEECCCCcEEEecccc
Confidence            9999999999999999998743   35678999999999999999999996 7899999999999999999999999999


Q ss_pred             eeeccCCCccccCCCCcccccccccCCCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhccCCCCCCCCCcH
Q 015868          261 ARVQAQSGVMTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKSLRPTIPKHAHP  340 (399)
Q Consensus       261 a~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~Dv~slG~vl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~  340 (399)
                      +.............++..|+|||.+.+..++.++|+||||+++|+|++|+.||..................+.....+++
T Consensus       161 ~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (269)
T cd08528         161 AKQKQPESKLTSVVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYSTNMLSLATKIVEAVYEPLPEGMYSE  240 (269)
T ss_pred             eeecccccccccccCcccCcChhhhcCCCCchHHHHHHHHHHHHHHHhCCCcccccCHHHHHHHHhhccCCcCCcccCCH
Confidence            98765544445567899999999999988999999999999999999999999877766655555544444433446889


Q ss_pred             HHHHHHHHHhhhcCCCCCCHHHHHHHHH
Q 015868          341 RLAELLERCWQHDPTQRPNFSQITDILK  368 (399)
Q Consensus       341 ~l~~ll~~cl~~dP~~Rps~~ell~~L~  368 (399)
                      ++.+++.+||+.||++||++.|+..++.
T Consensus       241 ~l~~li~~cl~~~p~~Rp~~~e~~~~~~  268 (269)
T cd08528         241 DVTDVITSCLTPDAEARPDIIQVSAMIS  268 (269)
T ss_pred             HHHHHHHHHCCCCCccCCCHHHHHHHhc
Confidence            9999999999999999999999998775

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24.

>cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase

Probab=100.00  E-value=5.5e-41  Score=313.67  Aligned_cols=247  Identities=30%  Similarity=0.512  Sum_probs=212.0

Q ss_pred             cccceeceeceeCceEEEEEEEC--CeeEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCceeeEEeEEecCCcEEEEEe
Q 015868          116 KQLKIECKVASGSYGDLYKGTYC--SQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVTE  193 (399)
Q Consensus       116 ~~~~i~~~lg~G~~g~Vy~~~~~--~~~vAvK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~nIv~~~~~~~~~~~~~lV~E  193 (399)
                      ++|++.+.||.|+||.||++...  ++.+|+|.+..... ......+.+|+.+++.++||||+++++.+.....+++++|
T Consensus         1 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~~-~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e   79 (265)
T cd06605           1 DDLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEIN-EAIQKQILRELDILHKCNSPYIVGFYGAFYNNGDISICME   79 (265)
T ss_pred             CcchHHHHhcCCCCeEEEEEEEcCCCcEEEEEEEecccC-hHHHHHHHHHHHHHHHCCCCchhhhheeeecCCEEEEEEE
Confidence            36788899999999999999884  78899999876542 3556788999999999999999999999999999999999


Q ss_pred             cCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH-CCcccCCCCCCceeecCCCcEEEeeccceeeccCCCcccc
Q 015868          194 FMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQ-NNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTA  272 (399)
Q Consensus       194 ~~~ggsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~-~giiHrDlkp~NILl~~~~~vkl~DFG~a~~~~~~~~~~~  272 (399)
                      |+++++|.+++......+++..+..++.|++.||+|||+ .|++|+||+|+||+++.++.++|+|||.+......... .
T Consensus        80 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~i~H~dl~~~ni~~~~~~~~~l~d~g~~~~~~~~~~~-~  158 (265)
T cd06605          80 YMDGGSLDKILKEVQGRIPERILGKIAVAVLKGLTYLHEKHKIIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNSLAK-T  158 (265)
T ss_pred             ecCCCcHHHHHHHccCCCCHHHHHHHHHHHHHHHHHHcCCCCeecCCCCHHHEEECCCCCEEEeecccchhhHHHHhh-c
Confidence            999999999998766789999999999999999999999 99999999999999999999999999998755432222 2


Q ss_pred             CCCCcccccccccCCCCCCChhhHHHHHHHHHHHHcCCCCCCCCC-----HHHHHHHHHhccCCCCCCCC-CcHHHHHHH
Q 015868          273 ETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPYAGLT-----PLQAAVGVVQKSLRPTIPKH-AHPRLAELL  346 (399)
Q Consensus       273 ~~gt~~y~aPE~l~~~~~~~~~Dv~slG~vl~elltg~~P~~~~~-----~~~~~~~~~~~~~~~~~~~~-~~~~l~~ll  346 (399)
                      ..++..|+|||.+.+..++.++|+||||+++|+|++|..||....     ..+.... ......+..+.. ++.++.++|
T Consensus       159 ~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~li  237 (265)
T cd06605         159 FVGTSSYMAPERIQGNDYSVKSDIWSLGLSLIELATGRFPYPPENDPPDGIFELLQY-IVNEPPPRLPSGKFSPDFQDFV  237 (265)
T ss_pred             ccCChhccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCccccccccHHHHHHH-HhcCCCCCCChhhcCHHHHHHH
Confidence            678889999999999999999999999999999999999997642     2222222 223344555555 889999999


Q ss_pred             HHHhhhcCCCCCCHHHHHH
Q 015868          347 ERCWQHDPTQRPNFSQITD  365 (399)
Q Consensus       347 ~~cl~~dP~~Rps~~ell~  365 (399)
                      .+||..+|++|||+.+++.
T Consensus       238 ~~~l~~~p~~Rpt~~~ll~  256 (265)
T cd06605         238 NLCLIKDPRERPSYKELLE  256 (265)
T ss_pred             HHHcCCCchhCcCHHHHhh
Confidence            9999999999999999875

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity

>PRK13184 pknD serine/threonine-protein kinase; Reviewed

Probab=100.00  E-value=1.5e-40  Score=350.03  Aligned_cols=258  Identities=21%  Similarity=0.378  Sum_probs=211.5

Q ss_pred             cccceeceeceeCceEEEEEEE--CCeeEEEEEecCCCC-CHHHHHHHHHHHHHHHhcCCCceeeEEeEEecCCcEEEEE
Q 015868          116 KQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECV-NTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVT  192 (399)
Q Consensus       116 ~~~~i~~~lg~G~~g~Vy~~~~--~~~~vAvK~~~~~~~-~~~~~~~~~~Ei~~l~~l~h~nIv~~~~~~~~~~~~~lV~  192 (399)
                      ++|++.++||+|+||.||+|.+  +++.||+|+++.... +....+++.+|+.++++++||||+++++++..++..++||
T Consensus         2 grYeIi~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~d~~~lyLVM   81 (932)
T PRK13184          2 QRYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYSICSDGDPVYYTM   81 (932)
T ss_pred             CCeEEEEEEecCCCEEEEEEEECCCCcEEEEEEECcccccCHHHHHHHHHHHHHHHhCCCcCcCeEEEEEeeCCEEEEEE
Confidence            5799999999999999999987  578999999976432 3445678999999999999999999999999999999999


Q ss_pred             ecCCCCCHHHHHHhc----------CCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceeecCCCcEEEeecccee
Q 015868          193 EFMARGSIYDFLHKQ----------KGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVAR  262 (399)
Q Consensus       193 E~~~ggsL~~~l~~~----------~~~l~~~~~~~i~~~i~~~L~~LH~~giiHrDlkp~NILl~~~~~vkl~DFG~a~  262 (399)
                      ||++|++|.+++...          ....+...+..++.||++||+|||++||+||||||+||+++.++.++|+|||+++
T Consensus        82 EY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs~GIIHRDLKPeNILLd~dg~vKLiDFGLAk  161 (932)
T PRK13184         82 PYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHSKGVLHRDLKPDNILLGLFGEVVILDWGAAI  161 (932)
T ss_pred             EcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHHCCccccCCchheEEEcCCCCEEEEecCcce
Confidence            999999999998642          1235567788999999999999999999999999999999999999999999997


Q ss_pred             eccCCC-------------------ccccCCCCcccccccccCCCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHH
Q 015868          263 VQAQSG-------------------VMTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAV  323 (399)
Q Consensus       263 ~~~~~~-------------------~~~~~~gt~~y~aPE~l~~~~~~~~~Dv~slG~vl~elltg~~P~~~~~~~~~~~  323 (399)
                      ......                   ......||+.|+|||.+.+..++.++|||||||++|+|+||..||..........
T Consensus       162 ~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~~~S~kSDIWSLGVILyELLTG~~PF~~~~~~ki~~  241 (932)
T PRK13184        162 FKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFPYRRKKGRKISY  241 (932)
T ss_pred             ecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcCCCCCcHhHHHHHHHHHHHHHHCCCCCCCcchhhhhh
Confidence            652110                   0112368999999999999999999999999999999999999998765543322


Q ss_pred             HHH-hccCCCCCCCCCcHHHHHHHHHHhhhcCCCCC-CHHHHHHHHHHHHHH
Q 015868          324 GVV-QKSLRPTIPKHAHPRLAELLERCWQHDPTQRP-NFSQITDILKQMMKE  373 (399)
Q Consensus       324 ~~~-~~~~~~~~~~~~~~~l~~ll~~cl~~dP~~Rp-s~~ell~~L~~l~~~  373 (399)
                      ... ...........+++.+.+++.+||+.||++|| +++++++.|+..++.
T Consensus       242 ~~~i~~P~~~~p~~~iP~~L~~LI~rcL~~DP~kR~ss~eeLl~~Le~~lq~  293 (932)
T PRK13184        242 RDVILSPIEVAPYREIPPFLSQIAMKALAVDPAERYSSVQELKQDLEPHLQG  293 (932)
T ss_pred             hhhccChhhccccccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhc
Confidence            211 11101111235788999999999999999995 677888888877653

>cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5

Probab=100.00  E-value=4.4e-41  Score=317.89  Aligned_cols=248  Identities=23%  Similarity=0.386  Sum_probs=202.6

Q ss_pred             ccceeceeceeCceEEEEEEE--CCeeEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCceeeEEeEEecCCcEEEEEec
Q 015868          117 QLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVTEF  194 (399)
Q Consensus       117 ~~~i~~~lg~G~~g~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~nIv~~~~~~~~~~~~~lV~E~  194 (399)
                      +|++.+.||.|+||.||+|++  +++.||+|.++...........+.+|+.++++++||||+++++++.....+++|+||
T Consensus         1 ~y~~~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   80 (284)
T cd07839           1 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDVLHSDKKLTLVFEY   80 (284)
T ss_pred             CceeEEEecccCCeEEEEEEECCCCcEEEEEEeecccccccCccchhHHHHHHHhcCCCCeeeHHHHhccCCceEEEEec
Confidence            488899999999999999987  578999999976543444446678899999999999999999999999999999999


Q ss_pred             CCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceeecCCCcEEEeeccceeeccCC-CccccC
Q 015868          195 MARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQS-GVMTAE  273 (399)
Q Consensus       195 ~~ggsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~giiHrDlkp~NILl~~~~~vkl~DFG~a~~~~~~-~~~~~~  273 (399)
                      +++ +|.+++....+.+++..++.++.||++||.|||++||+||||||+||+++.++.++|+|||.++..... ......
T Consensus        81 ~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~  159 (284)
T cd07839          81 CDQ-DLKKYFDSCNGDIDPEIVKSFMFQLLKGLAFCHSHNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVRCYSAE  159 (284)
T ss_pred             CCC-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEEcCCCcEEECccchhhccCCCCCCcCCC
Confidence            975 898888776678999999999999999999999999999999999999999999999999998754432 223345


Q ss_pred             CCCcccccccccCCC-CCCChhhHHHHHHHHHHHHcCCCCC-CCCCHHHHHHHHHhc------------------cCCC-
Q 015868          274 TGTYRWMAPEVIEHK-PYDYKADVFSFGIALWELLTGELPY-AGLTPLQAAVGVVQK------------------SLRP-  332 (399)
Q Consensus       274 ~gt~~y~aPE~l~~~-~~~~~~Dv~slG~vl~elltg~~P~-~~~~~~~~~~~~~~~------------------~~~~-  332 (399)
                      .++..|+|||.+.+. .++.++||||||+++|+|+||..|+ .+.+..+........                  ...+ 
T Consensus       160 ~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (284)
T cd07839         160 VVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEESWPGVSKLPDYKPYPM  239 (284)
T ss_pred             ccccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHhcCCCCcCCCCHHHHHHHHHHHhCCCChHHhHHhhhcccccccCC
Confidence            678899999998764 4789999999999999999988875 433332222111100                  0000 


Q ss_pred             --------CCCCCCcHHHHHHHHHHhhhcCCCCCCHHHHHH
Q 015868          333 --------TIPKHAHPRLAELLERCWQHDPTQRPNFSQITD  365 (399)
Q Consensus       333 --------~~~~~~~~~l~~ll~~cl~~dP~~Rps~~ell~  365 (399)
                              ...+.+++++.+++.+||+.||.+|||++++++
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~il~  280 (284)
T cd07839         240 YPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEALQ  280 (284)
T ss_pred             CCCcchhhhhcccCCHHHHHHHHHHhcCChhhcCCHHHHhc
Confidence                    112346789999999999999999999999875

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also

>cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.8e-40  Score=318.98  Aligned_cols=250  Identities=22%  Similarity=0.367  Sum_probs=212.2

Q ss_pred             cccceeceeceeCceEEEEEEE--CCeeEEEEEecCCCCCH-HHHHHHHHHHHHHHhcCCCceeeEEeEEecCCcEEEEE
Q 015868          116 KQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVNT-EMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVT  192 (399)
Q Consensus       116 ~~~~i~~~lg~G~~g~Vy~~~~--~~~~vAvK~~~~~~~~~-~~~~~~~~Ei~~l~~l~h~nIv~~~~~~~~~~~~~lV~  192 (399)
                      ++|++.+.||+|+||.||++..  .++.||+|.+....... ...+.+.+|+.+++.++|+||+++++.+......|+||
T Consensus         1 ~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~   80 (316)
T cd05574           1 KHFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYASFQTETYLCLVM   80 (316)
T ss_pred             CceEEeeeecCCccEEEEEEEEcCCCcEEEEEEEeccccchHHHHHHHHHHHHHHHhCCCCCchhheeeeecCCEEEEEE
Confidence            3688999999999999999987  46899999998654332 45678999999999999999999999999999999999


Q ss_pred             ecCCCCCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceeecCCCcEEEeeccceeeccCCCc--
Q 015868          193 EFMARGSIYDFLHKQ-KGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGV--  269 (399)
Q Consensus       193 E~~~ggsL~~~l~~~-~~~l~~~~~~~i~~~i~~~L~~LH~~giiHrDlkp~NILl~~~~~vkl~DFG~a~~~~~~~~--  269 (399)
                      ||+.|++|.+++... ...+++..+..++.|++.||+|||++|++|+||||+||+++.++.++|+|||.+........  
T Consensus        81 e~~~~~~L~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~~~  160 (316)
T cd05574          81 DYCPGGELFRLLQRQPGKCLSEEVARFYAAEVLLALEYLHLLGIVYRDLKPENILLHESGHIMLSDFDLSKQSDVEPPPV  160 (316)
T ss_pred             EecCCCCHHHHHHhCCCCccCHHHHHHHHHHHHHHHHHHHHCCeeccCCChHHeEEcCCCCEEEeecchhhccccccccc
Confidence            999999999999764 35789999999999999999999999999999999999999999999999999864332110  


Q ss_pred             ----------------------------cccCCCCcccccccccCCCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHH
Q 015868          270 ----------------------------MTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPYAGLTPLQA  321 (399)
Q Consensus       270 ----------------------------~~~~~gt~~y~aPE~l~~~~~~~~~Dv~slG~vl~elltg~~P~~~~~~~~~  321 (399)
                                                  .....|+..|+|||.+.+..++.++||||||+++|+|++|+.||.+.+....
T Consensus       161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~  240 (316)
T cd05574         161 SKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYGTTPFKGSNRDET  240 (316)
T ss_pred             ccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcCCCCCchHHHHHHHHHHHHHhhCCCCCCCCchHHH
Confidence                                        1123578899999999998899999999999999999999999998887766


Q ss_pred             HHHHHhccCCCCCCCCCcHHHHHHHHHHhhhcCCCCCC----HHHHHH
Q 015868          322 AVGVVQKSLRPTIPKHAHPRLAELLERCWQHDPTQRPN----FSQITD  365 (399)
Q Consensus       322 ~~~~~~~~~~~~~~~~~~~~l~~ll~~cl~~dP~~Rps----~~ell~  365 (399)
                      .................++++.+++.+||+.+|++||+    +.++++
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~ll~  288 (316)
T cd05574         241 FSNILKKEVTFPGSPPVSSSARDLIRKLLVKDPSKRLGSKRGAAEIKQ  288 (316)
T ss_pred             HHHHhcCCccCCCccccCHHHHHHHHHHccCCHhHCCCchhhHHHHHc
Confidence            66555443332222337899999999999999999999    666655

Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin

>cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4

Probab=100.00  E-value=2.2e-40  Score=312.54  Aligned_cols=247  Identities=32%  Similarity=0.575  Sum_probs=214.7

Q ss_pred             cccceeceeceeCceEEEEEEE--CCeeEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCceeeEEeEEecCCcEEEEEe
Q 015868          116 KQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVTE  193 (399)
Q Consensus       116 ~~~~i~~~lg~G~~g~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~nIv~~~~~~~~~~~~~lV~E  193 (399)
                      ..|+..++||.|+||.||+|.+  +++.||+|+++... .......+.+|+.++++++||||+++++.+..+...++|||
T Consensus         4 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   82 (277)
T cd06640           4 ELFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEE-AEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKGTKLWIIME   82 (277)
T ss_pred             HhhhhhhhcccCCCeEEEEEEEccCCEEEEEEEEeccc-cHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEEe
Confidence            4678889999999999999986  57899999987543 23456789999999999999999999999999999999999


Q ss_pred             cCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceeecCCCcEEEeeccceeeccCCC-cccc
Q 015868          194 FMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSG-VMTA  272 (399)
Q Consensus       194 ~~~ggsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~giiHrDlkp~NILl~~~~~vkl~DFG~a~~~~~~~-~~~~  272 (399)
                      |++|++|.+++..  +.++...+..++.|++.||+|||+++++|+||+|+||+++.++.++|+|||.+....... ....
T Consensus        83 ~~~~~~L~~~i~~--~~l~~~~~~~~~~~l~~~l~~lh~~~ivH~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~~~~~  160 (277)
T cd06640          83 YLGGGSALDLLRA--GPFDEFQIATMLKEILKGLDYLHSEKKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNT  160 (277)
T ss_pred             cCCCCcHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCccCcCCChhhEEEcCCCCEEEcccccceeccCCcccccc
Confidence            9999999999864  468899999999999999999999999999999999999999999999999997654332 1233


Q ss_pred             CCCCcccccccccCCCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhccCCCCCCCCCcHHHHHHHHHHhhh
Q 015868          273 ETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRLAELLERCWQH  352 (399)
Q Consensus       273 ~~gt~~y~aPE~l~~~~~~~~~Dv~slG~vl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~cl~~  352 (399)
                      ..++..|+|||.+.+..++.++|+||||+++|+|+||+.||...++...... ......+.++..++..+.+++.+||+.
T Consensus       161 ~~~~~~y~apE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~li~~~l~~  239 (277)
T cd06640         161 FVGTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKGEPPNSDMHPMRVLFL-IPKNNPPTLTGEFSKPFKEFIDACLNK  239 (277)
T ss_pred             ccCcccccCHhHhccCCCccHHHHHHHHHHHHHHHHCCCCCCCcChHhHhhh-hhcCCCCCCchhhhHHHHHHHHHHccc
Confidence            4578899999999988899999999999999999999999998877665443 334445667777899999999999999


Q ss_pred             cCCCCCCHHHHHHH
Q 015868          353 DPTQRPNFSQITDI  366 (399)
Q Consensus       353 dP~~Rps~~ell~~  366 (399)
                      +|++||++.++++.
T Consensus       240 ~p~~Rp~~~~il~~  253 (277)
T cd06640         240 DPSFRPTAKELLKH  253 (277)
T ss_pred             CcccCcCHHHHHhC
Confidence            99999999999664

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter

>cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3

Probab=100.00  E-value=3e-40  Score=310.11  Aligned_cols=245  Identities=27%  Similarity=0.499  Sum_probs=198.8

Q ss_pred             ceeceeCceEEEEEEEC----CeeEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCceeeEEeEEecCCcEEEEEecCCC
Q 015868          122 CKVASGSYGDLYKGTYC----SQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVTEFMAR  197 (399)
Q Consensus       122 ~~lg~G~~g~Vy~~~~~----~~~vAvK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~nIv~~~~~~~~~~~~~lV~E~~~g  197 (399)
                      +.||+|+||.||+|...    +..+|+|.++.... ......+.+|+.++++++||||+++++++......++||||+++
T Consensus         1 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~   79 (269)
T cd05087           1 KEIGNGWFGKVILGEVNSGYTPAQVVVKELRVSAS-VQEQMKFLEEAQPYRSLQHSNLLQCLGQCTEVTPYLLVMEFCPL   79 (269)
T ss_pred             CcccccCCceEEEEEEcCCCCceEEEEEecCCCCC-hHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCCcEEEEECCCC
Confidence            36899999999999763    35689999876542 33345788999999999999999999999998899999999999


Q ss_pred             CCHHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceeecCCCcEEEeeccceeeccCCCc---c
Q 015868          198 GSIYDFLHKQK----GVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGV---M  270 (399)
Q Consensus       198 gsL~~~l~~~~----~~l~~~~~~~i~~~i~~~L~~LH~~giiHrDlkp~NILl~~~~~vkl~DFG~a~~~~~~~~---~  270 (399)
                      |+|.+++....    ...+...+..++.|++.|++|||++|++||||||+||+++.++.++|+|||.++.......   .
T Consensus        80 g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~~~~~~~~~  159 (269)
T cd05087          80 GDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKNNFIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYVTP  159 (269)
T ss_pred             CcHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCCEeccccCcceEEEcCCCcEEECCccccccccCcceeecC
Confidence            99999997532    2456677889999999999999999999999999999999999999999999875433221   1


Q ss_pred             ccCCCCcccccccccCCC-------CCCChhhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHHhcc----CCCCCCCCC
Q 015868          271 TAETGTYRWMAPEVIEHK-------PYDYKADVFSFGIALWELLT-GELPYAGLTPLQAAVGVVQKS----LRPTIPKHA  338 (399)
Q Consensus       271 ~~~~gt~~y~aPE~l~~~-------~~~~~~Dv~slG~vl~ellt-g~~P~~~~~~~~~~~~~~~~~----~~~~~~~~~  338 (399)
                      ....++..|+|||++.+.       .++.++|+||||+++|+|++ |..||...++.+.....+...    ..+.+....
T Consensus       160 ~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (269)
T cd05087         160 DQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDEQVLTYTVREQQLKLPKPRLKLPL  239 (269)
T ss_pred             CCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCCCChHHHHHHHhhcccCCCCCCccCCCC
Confidence            223567889999998643       35789999999999999996 999998877766544333221    123333457


Q ss_pred             cHHHHHHHHHHhhhcCCCCCCHHHHHHHHH
Q 015868          339 HPRLAELLERCWQHDPTQRPNFSQITDILK  368 (399)
Q Consensus       339 ~~~l~~ll~~cl~~dP~~Rps~~ell~~L~  368 (399)
                      ++.+.+++.+|| .+|++|||+.+|...|.
T Consensus       240 ~~~~~~l~~~c~-~~P~~Rpt~~~l~~~l~  268 (269)
T cd05087         240 SDRWYEVMQFCW-LQPEQRPSAEEVHLLLS  268 (269)
T ss_pred             ChHHHHHHHHHh-cCcccCCCHHHHHHHhc
Confidence            789999999999 58999999999998764

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells

>cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase

Probab=100.00  E-value=2.2e-40  Score=317.76  Aligned_cols=248  Identities=24%  Similarity=0.446  Sum_probs=207.3

Q ss_pred             cccceeceeceeCceEEEEEEE--CCeeEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCceeeEEeEEecCCcEEEEEe
Q 015868          116 KQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVTE  193 (399)
Q Consensus       116 ~~~~i~~~lg~G~~g~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~nIv~~~~~~~~~~~~~lV~E  193 (399)
                      ++|++.++||+|+||.||++.+  ++..+|+|.++... .......+.+|+.++++++||||+++++.+..++.+++|||
T Consensus         1 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e   79 (308)
T cd06615           1 DDFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEI-KPAIRNQIIRELKVLHECNSPYIVGFYGAFYSDGEISICME   79 (308)
T ss_pred             CCceEEeeccCCCCeEEEEEEEcCCCeEEEEEEecccc-CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCEEEEEee
Confidence            3689999999999999999987  56789999987542 34556678999999999999999999999999999999999


Q ss_pred             cCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH-CCcccCCCCCCceeecCCCcEEEeeccceeeccCCCcccc
Q 015868          194 FMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQ-NNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTA  272 (399)
Q Consensus       194 ~~~ggsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~-~giiHrDlkp~NILl~~~~~vkl~DFG~a~~~~~~~~~~~  272 (399)
                      |+++++|.+++... +.+++..+..++.|+++||.|||+ .+++|+||||+||+++.++.++|+|||.+...... ....
T Consensus        80 y~~~~~L~~~l~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~-~~~~  157 (308)
T cd06615          80 HMDGGSLDQVLKKA-GRIPENILGKISIAVLRGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS-MANS  157 (308)
T ss_pred             ccCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhhCCEEECCCChHHEEEecCCcEEEccCCCccccccc-cccc
Confidence            99999999999764 678999999999999999999997 59999999999999999999999999998754332 2234


Q ss_pred             CCCCcccccccccCCCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHH---------------------------
Q 015868          273 ETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGV---------------------------  325 (399)
Q Consensus       273 ~~gt~~y~aPE~l~~~~~~~~~Dv~slG~vl~elltg~~P~~~~~~~~~~~~~---------------------------  325 (399)
                      ..++..|+|||.+.+..++.++|+||||+++|+|++|..||...+........                           
T Consensus       158 ~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (308)
T cd06615         158 FVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPIPPPDAKELEAMFGRPVSEGEAKESHRPVSGHPPDSPRPM  237 (308)
T ss_pred             CCCCcCccChhHhcCCCCCccchHHHHHHHHHHHHhCCCCCCCcchhhHHHhhcCccccccccCCcccccCCCCCccchh
Confidence            56889999999998888999999999999999999999999755432221111                           


Q ss_pred             --------HhccCCCCCCC-CCcHHHHHHHHHHhhhcCCCCCCHHHHHHH
Q 015868          326 --------VQKSLRPTIPK-HAHPRLAELLERCWQHDPTQRPNFSQITDI  366 (399)
Q Consensus       326 --------~~~~~~~~~~~-~~~~~l~~ll~~cl~~dP~~Rps~~ell~~  366 (399)
                              .....+|..|. .++.++.+++.+||..+|++||++.++++.
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~  287 (308)
T cd06615         238 AIFELLDYIVNEPPPKLPSGAFSDEFQDFVDKCLKKNPKERADLKELTKH  287 (308)
T ss_pred             hHHHHHHHHhcCCCccCcCcccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence                    00111222222 367899999999999999999999998764

Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down

>cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase

Probab=100.00  E-value=2.7e-40  Score=316.46  Aligned_cols=253  Identities=24%  Similarity=0.398  Sum_probs=212.3

Q ss_pred             cccceeceeceeCceEEEEEEE--CCeeEEEEEecCCCC-CHHHHHHHHHHHHHHHhcCCCceeeEEeEEecCCcEEEEE
Q 015868          116 KQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECV-NTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVT  192 (399)
Q Consensus       116 ~~~~i~~~lg~G~~g~Vy~~~~--~~~~vAvK~~~~~~~-~~~~~~~~~~Ei~~l~~l~h~nIv~~~~~~~~~~~~~lV~  192 (399)
                      ++|++.+.||.|+||.||++..  .++.||+|.+..... .......+.+|+.+++.++||||+++++.+..+...++||
T Consensus         1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~   80 (305)
T cd05609           1 EDFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMFCSFETKRHLCMVM   80 (305)
T ss_pred             CCceEeeEeecCCCeeEEEEEECCCCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEecCCEEEEEE
Confidence            3688999999999999999987  467899999875432 2334567889999999999999999999999999999999


Q ss_pred             ecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceeecCCCcEEEeeccceeeccCCC----
Q 015868          193 EFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSG----  268 (399)
Q Consensus       193 E~~~ggsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~giiHrDlkp~NILl~~~~~vkl~DFG~a~~~~~~~----  268 (399)
                      ||++|++|.+++... +.+++..+..++.|++.||.|||++|++||||||+||+++.++.++|+|||.++......    
T Consensus        81 e~~~g~~L~~~l~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~NIll~~~~~~~l~dfg~~~~~~~~~~~~~  159 (305)
T cd05609          81 EYVEGGDCATLLKNI-GALPVDMARMYFAETVLALEYLHNYGIVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLTTNL  159 (305)
T ss_pred             ecCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCchHHEEECCCCCEEEeeCCCccccCcCccccc
Confidence            999999999999764 578999999999999999999999999999999999999999999999999886421100    


Q ss_pred             ------------ccccCCCCcccccccccCCCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcc-CCCCCC
Q 015868          269 ------------VMTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKS-LRPTIP  335 (399)
Q Consensus       269 ------------~~~~~~gt~~y~aPE~l~~~~~~~~~Dv~slG~vl~elltg~~P~~~~~~~~~~~~~~~~~-~~~~~~  335 (399)
                                  ......++..|+|||.+.+..++.++|+||||+++|+|++|..||.+.++.+......... ..+..+
T Consensus       160 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~vl~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~  239 (305)
T cd05609         160 YEGHIEKDTREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQVISDDIEWPEGD  239 (305)
T ss_pred             cccccccchhhccccCCccCccccCchhccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccCCCCcc
Confidence                        0112346788999999998889999999999999999999999999888776655544432 223334


Q ss_pred             CCCcHHHHHHHHHHhhhcCCCCCCHHHHHHHHHH
Q 015868          336 KHAHPRLAELLERCWQHDPTQRPNFSQITDILKQ  369 (399)
Q Consensus       336 ~~~~~~l~~ll~~cl~~dP~~Rps~~ell~~L~~  369 (399)
                      ..+++++.++|.+||+.+|++||++.++.+.|+.
T Consensus       240 ~~~~~~~~~li~~~l~~~P~~R~~~~~~~~ll~~  273 (305)
T cd05609         240 EALPADAQDLISRLLRQNPLERLGTGGAFEVKQH  273 (305)
T ss_pred             ccCCHHHHHHHHHHhccChhhccCccCHHHHHhC
Confidence            4678999999999999999999997766665554

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a

>PTZ00284 protein kinase; Provisional

Probab=100.00  E-value=2.5e-40  Score=335.32  Aligned_cols=246  Identities=23%  Similarity=0.388  Sum_probs=196.5

Q ss_pred             ecccccceeceeceeCceEEEEEEE--CCeeEEEEEecCCCCCHHHHHHHHHHHHHHHhcCC------CceeeEEeEEec
Q 015868          113 IDAKQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRH------KNVVQFIGACTR  184 (399)
Q Consensus       113 i~~~~~~i~~~lg~G~~g~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~Ei~~l~~l~h------~nIv~~~~~~~~  184 (399)
                      +..++|++.++||+|+||.||+|.+  .++.||||+++..   ....+.+..|+.+++.++|      .+++.+++++..
T Consensus       126 ~~~~~y~i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~---~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~~~~  202 (467)
T PTZ00284        126 VSTQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNV---PKYTRDAKIEIQFMEKVRQADPADRFPLMKIQRYFQN  202 (467)
T ss_pred             cCCCcEEEEEEEEeccCEEEEEEEEcCCCeEEEEEEEecc---hhhHHHHHHHHHHHHHHhhcCcccCcceeeeEEEEEc
Confidence            4457899999999999999999987  5788999999743   2334456678888877754      458899998876


Q ss_pred             C-CcEEEEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH-CCcccCCCCCCceeecCCC-----------
Q 015868          185 P-PNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQ-NNIIHRDLKTANLLMDENG-----------  251 (399)
Q Consensus       185 ~-~~~~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~-~giiHrDlkp~NILl~~~~-----------  251 (399)
                      . .++|+|||++ |++|.+++.+ .+.+++..+..++.||+.||+|||+ .|||||||||+|||++.++           
T Consensus       203 ~~~~~~iv~~~~-g~~l~~~l~~-~~~l~~~~~~~i~~qi~~aL~yLH~~~gIiHrDlKP~NILl~~~~~~~~~~~~~~~  280 (467)
T PTZ00284        203 ETGHMCIVMPKY-GPCLLDWIMK-HGPFSHRHLAQIIFQTGVALDYFHTELHLMHTDLKPENILMETSDTVVDPVTNRAL  280 (467)
T ss_pred             CCceEEEEEecc-CCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCHHHEEEecCCccccccccccc
Confidence            4 4689999988 6699998876 4679999999999999999999998 5999999999999998765           


Q ss_pred             -----cEEEeeccceeeccCCCccccCCCCcccccccccCCCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHH
Q 015868          252 -----VVKVADFGVARVQAQSGVMTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVV  326 (399)
Q Consensus       252 -----~vkl~DFG~a~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~Dv~slG~vl~elltg~~P~~~~~~~~~~~~~~  326 (399)
                           .+||+|||.+.....  ..+...||+.|+|||++.+..|+.++|||||||++|||++|+.||.+.+..+....+.
T Consensus       281 ~~~~~~vkl~DfG~~~~~~~--~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~  358 (467)
T PTZ00284        281 PPDPCRVRICDLGGCCDERH--SRTAIVSTRHYRSPEVVLGLGWMYSTDMWSMGCIIYELYTGKLLYDTHDNLEHLHLME  358 (467)
T ss_pred             CCCCceEEECCCCccccCcc--ccccccCCccccCcHHhhcCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHH
Confidence                 499999998864322  2345678999999999999999999999999999999999999998877654333221


Q ss_pred             hcc-------------------------CCCCC---------------CCCCcHHHHHHHHHHhhhcCCCCCCHHHHHH
Q 015868          327 QKS-------------------------LRPTI---------------PKHAHPRLAELLERCWQHDPTQRPNFSQITD  365 (399)
Q Consensus       327 ~~~-------------------------~~~~~---------------~~~~~~~l~~ll~~cl~~dP~~Rps~~ell~  365 (399)
                      ...                         .++..               ....++.+.+||.+||++||++|||++|+++
T Consensus       359 ~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R~ta~e~L~  437 (467)
T PTZ00284        359 KTLGRLPSEWAGRCGTEEARLLYNSAGQLRPCTDPKHLARIARARPVREVIRDDLLCDLIYGLLHYDRQKRLNARQMTT  437 (467)
T ss_pred             HHcCCCCHHHHhhccchhHHHHhhhcccccccCCHHHHHhhhcccchhhhhchHHHHHHHHHhCCcChhhCCCHHHHhc
Confidence            100                         00000               0012456889999999999999999999986

>cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

Probab=100.00  E-value=4.1e-41  Score=314.22  Aligned_cols=238  Identities=25%  Similarity=0.480  Sum_probs=199.9

Q ss_pred             ceeceeCceEEEEEEEC---------CeeEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCceeeEEeEEecCCcEEEEE
Q 015868          122 CKVASGSYGDLYKGTYC---------SQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVT  192 (399)
Q Consensus       122 ~~lg~G~~g~Vy~~~~~---------~~~vAvK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~nIv~~~~~~~~~~~~~lV~  192 (399)
                      +.||.|+||.||+|...         ...+|+|.+...  .....+.+.+|+.+++.++||||+++++++..+...++||
T Consensus         1 ~~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~--~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~   78 (258)
T cd05078           1 ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKS--HRNYSESFFEAASMMSQLSHKHLVLNYGVCVCGDESIMVQ   78 (258)
T ss_pred             CCCCcccchhheeeeecccccccccccchhhHHhhcch--hHHHHHHHHHHHHHHHhCCCCChhheeeEEEeCCCcEEEE
Confidence            46899999999999763         234888887643  2344567899999999999999999999999989999999


Q ss_pred             ecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceeecCCCc--------EEEeeccceeec
Q 015868          193 EFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGV--------VKVADFGVARVQ  264 (399)
Q Consensus       193 E~~~ggsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~giiHrDlkp~NILl~~~~~--------vkl~DFG~a~~~  264 (399)
                      ||+++|+|.+++......+++..+..++.||+.||+|||++||+||||||+||+++.++.        ++++|||.+...
T Consensus        79 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiH~dlkp~nili~~~~~~~~~~~~~~~l~d~g~~~~~  158 (258)
T cd05078          79 EYVKFGSLDTYLKKNKNLINISWKLEVAKQLAWALHFLEDKGLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGISITV  158 (258)
T ss_pred             ecCCCCcHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCccceEEEecccccccCCCceEEeccccccccc
Confidence            999999999999876667899999999999999999999999999999999999987765        699999988644


Q ss_pred             cCCCccccCCCCcccccccccCC-CCCCChhhHHHHHHHHHHHHcC-CCCCCCCCHHHHHHHHHhccCCCCCCCCCcHHH
Q 015868          265 AQSGVMTAETGTYRWMAPEVIEH-KPYDYKADVFSFGIALWELLTG-ELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRL  342 (399)
Q Consensus       265 ~~~~~~~~~~gt~~y~aPE~l~~-~~~~~~~Dv~slG~vl~elltg-~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  342 (399)
                      ..   .....++..|+|||.+.+ ..++.++||||||+++|+|++| ..||...++..... ...  .++.+|...+.++
T Consensus       159 ~~---~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~~~~~~~~~~~~~~-~~~--~~~~~~~~~~~~~  232 (258)
T cd05078         159 LP---KEILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALDSQKKLQ-FYE--DRHQLPAPKWTEL  232 (258)
T ss_pred             CC---chhccccCCccCchhccCCCCCCchhhHHHHHHHHHHHHcCCCCChhhccHHHHHH-HHH--ccccCCCCCcHHH
Confidence            32   233467889999999986 4579999999999999999998 57777766654332 222  2455667778899


Q ss_pred             HHHHHHHhhhcCCCCCCHHHHHHHH
Q 015868          343 AELLERCWQHDPTQRPNFSQITDIL  367 (399)
Q Consensus       343 ~~ll~~cl~~dP~~Rps~~ell~~L  367 (399)
                      .+++.+||+.+|++|||++++++.|
T Consensus       233 ~~li~~~l~~~p~~Rps~~~il~~l  257 (258)
T cd05078         233 ANLINQCMDYEPDFRPSFRAIIRDL  257 (258)
T ss_pred             HHHHHHHhccChhhCCCHHHHHHhc
Confidence            9999999999999999999999876

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity

>cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase

Probab=100.00  E-value=6.2e-41  Score=326.23  Aligned_cols=250  Identities=25%  Similarity=0.426  Sum_probs=204.5

Q ss_pred             ceeecccccceeceeceeCceEEEEEEE--CCeeEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCceeeEEeEEecC--
Q 015868          110 VWEIDAKQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRP--  185 (399)
Q Consensus       110 ~~~i~~~~~~i~~~lg~G~~g~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~nIv~~~~~~~~~--  185 (399)
                      .|++ .++|++.+.||.|+||.||+|..  +++.||+|++............+.+|+.++++++||||+++++++...  
T Consensus        10 ~~~~-~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~   88 (343)
T cd07878          10 VWEV-PERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLDVFTPATS   88 (343)
T ss_pred             Hhhh-hhhhhhheecccCCCeEEEEEEECCCCCEEEEEEeCchhhhhHHHHHHHHHHHHHHhcCCCchhhhhhhhccccc
Confidence            3444 46899999999999999999976  567899999986543444556788999999999999999999987543  


Q ss_pred             ----CcEEEEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceeecCCCcEEEeeccce
Q 015868          186 ----PNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVA  261 (399)
Q Consensus       186 ----~~~~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~giiHrDlkp~NILl~~~~~vkl~DFG~a  261 (399)
                          ...|+++|++ +++|.+++..  ..+++..+..++.||+.||.|||++||+||||||+||+++.++.+||+|||++
T Consensus        89 ~~~~~~~~~~~~~~-~~~l~~~~~~--~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrdikp~Nil~~~~~~~kl~Dfg~~  165 (343)
T cd07878          89 IENFNEVYLVTNLM-GADLNNIVKC--QKLSDEHVQFLIYQLLRGLKYIHSAGIIHRDLKPSNVAVNEDCELRILDFGLA  165 (343)
T ss_pred             ccccCcEEEEeecC-CCCHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCeecccCChhhEEECCCCCEEEcCCccc
Confidence                3479999988 6799988753  56899999999999999999999999999999999999999999999999999


Q ss_pred             eeccCCCccccCCCCcccccccccCC-CCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcc-----------
Q 015868          262 RVQAQSGVMTAETGTYRWMAPEVIEH-KPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKS-----------  329 (399)
Q Consensus       262 ~~~~~~~~~~~~~gt~~y~aPE~l~~-~~~~~~~Dv~slG~vl~elltg~~P~~~~~~~~~~~~~~~~~-----------  329 (399)
                      +.....  .....||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+..+.........           
T Consensus       166 ~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  243 (343)
T cd07878         166 RQADDE--MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDYIDQLKRIMEVVGTPSPEVLKKI  243 (343)
T ss_pred             eecCCC--cCCccccccccCchHhcCCccCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhc
Confidence            865432  345578999999999977 568999999999999999999999998766544333221100           


Q ss_pred             ----------CCCCC--------CCCCcHHHHHHHHHHhhhcCCCCCCHHHHHH
Q 015868          330 ----------LRPTI--------PKHAHPRLAELLERCWQHDPTQRPNFSQITD  365 (399)
Q Consensus       330 ----------~~~~~--------~~~~~~~l~~ll~~cl~~dP~~Rps~~ell~  365 (399)
                                ..+..        ....++.+.+|+.+||+.||.+|||+.|+++
T Consensus       244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dp~~R~s~~ell~  297 (343)
T cd07878         244 SSEHARKYIQSLPHMPQQDLKKIFRGANPLAIDLLEKMLVLDSDKRISASEALA  297 (343)
T ss_pred             chhhHHHHhhccccccchhHHHhccCCCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence                      00111        1235677899999999999999999999985

Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is

>KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms]

Probab=100.00  E-value=6.1e-42  Score=302.52  Aligned_cols=261  Identities=22%  Similarity=0.365  Sum_probs=214.5

Q ss_pred             CceeecccccceeceeceeCceEEEEEEE--CCeeEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCceeeEEeEEecCC
Q 015868          109 DVWEIDAKQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPP  186 (399)
Q Consensus       109 ~~~~i~~~~~~i~~~lg~G~~g~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~nIv~~~~~~~~~~  186 (399)
                      .+..|+.++|+|.++||+|+|+-||+++.  ++..+|+|.+...  +.+..+..++|++..++++|||+++++++...+.
T Consensus        14 ~tv~In~~Ryri~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~--~~~~~e~~~rEid~~rkf~s~~vl~l~dh~l~~~   91 (302)
T KOG2345|consen   14 GTVIINNKRYRIQRLLGEGGFSFVDLVKGLSTGHLYALKKILCH--SQEDIEEALREIDNHRKFNSPNVLRLVDHQLREE   91 (302)
T ss_pred             CcEEEcCceEEEeeeecCCCceeeeeecccCcccchhhheeecc--chHHHHHHHHHHHHHHhhCCcchHHHHHHHHHhh
Confidence            45679999999999999999999999984  6788999998866  3566788999999999999999999999875443


Q ss_pred             -----cEEEEEecCCCCCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCCCceeecCCCcEEEe
Q 015868          187 -----NLCIVTEFMARGSIYDFLHKQ---KGVFQLTSLLKVAIDVSKGMNYLHQNN--IIHRDLKTANLLMDENGVVKVA  256 (399)
Q Consensus       187 -----~~~lV~E~~~ggsL~~~l~~~---~~~l~~~~~~~i~~~i~~~L~~LH~~g--iiHrDlkp~NILl~~~~~vkl~  256 (399)
                           ..||+++|+..|||.+.+...   +..+++.++++|+.+|++||.+||...  ++||||||.|||+++.+.+++.
T Consensus        92 ~D~~~~~yll~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH~~~~~yAH~DiKP~NILls~~~~~vl~  171 (302)
T KOG2345|consen   92 KDGKHEAYLLLPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALHEKEPPYAHRDIKPANILLSDSGLPVLM  171 (302)
T ss_pred             ccCceeEEEEeehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHhccCCcccccCCCcceeEecCCCceEEE
Confidence                 389999999999999998653   357999999999999999999999998  9999999999999999999999


Q ss_pred             eccceeeccCC----------CccccCCCCcccccccccCCC---CCCChhhHHHHHHHHHHHHcCCCCCCCCCHH--HH
Q 015868          257 DFGVARVQAQS----------GVMTAETGTYRWMAPEVIEHK---PYDYKADVFSFGIALWELLTGELPYAGLTPL--QA  321 (399)
Q Consensus       257 DFG~a~~~~~~----------~~~~~~~gt~~y~aPE~l~~~---~~~~~~Dv~slG~vl~elltg~~P~~~~~~~--~~  321 (399)
                      |||.++...-.          +....+..|..|.|||.++-+   ..++++|||||||++|.|+.|.-||+..-..  ..
T Consensus       172 D~GS~~~a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~mf~~sPfe~~~~~GgSl  251 (302)
T KOG2345|consen  172 DLGSATQAPIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLYAMMFGESPFERIYQQGGSL  251 (302)
T ss_pred             eccCccccceEeechHHHHHHHHHHHHhCCCcccCchheecccCcccccccchhhhhHHHHHHHHcCCcchHHhhcCCeE
Confidence            99998753321          123445689999999999755   4578999999999999999999999642210  01


Q ss_pred             HHHHHhccCCCCCCCCCcHHHHHHHHHHhhhcCCCCCCHHHHHHHHHHHH
Q 015868          322 AVGVVQKSLRPTIPKHAHPRLAELLERCWQHDPTQRPNFSQITDILKQMM  371 (399)
Q Consensus       322 ~~~~~~~~~~~~~~~~~~~~l~~ll~~cl~~dP~~Rps~~ell~~L~~l~  371 (399)
                      +..+......-+-...+|..+.++++.|++.||.+||++.+++..+..+.
T Consensus       252 aLAv~n~q~s~P~~~~yse~l~~lik~mlqvdP~qRP~i~~ll~~~d~Li  301 (302)
T KOG2345|consen  252 ALAVQNAQISIPNSSRYSEALHQLIKSMLQVDPNQRPTIPELLSKLDDLI  301 (302)
T ss_pred             EEeeeccccccCCCCCccHHHHHHHHHHhcCCcccCCCHHHHHHHHHhhc
Confidence            11111211111122348999999999999999999999999999988764

>cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases

Probab=100.00  E-value=1.3e-40  Score=315.08  Aligned_cols=248  Identities=27%  Similarity=0.484  Sum_probs=210.7

Q ss_pred             cccceeceeceeCceEEEEEEE--CCeeEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCceeeEEeEEecCCcEEEEEe
Q 015868          116 KQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVTE  193 (399)
Q Consensus       116 ~~~~i~~~lg~G~~g~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~nIv~~~~~~~~~~~~~lV~E  193 (399)
                      ++|++.+.||+|+||.||++..  .+..||+|.++... +......+.+|+.++++++||||+++++.+..++.+++|||
T Consensus         1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~-~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e   79 (286)
T cd06622           1 DEIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLEL-DESKFNQIIMELDILHKAVSPYIVDFYGAFFIEGAVYMCME   79 (286)
T ss_pred             ChhhhhhhhcccCCeEEEEEEEcCCCcEEEEEEeeccc-CHHHHHHHHHHHHHHHhcCCCcHHhhhhheecCCeEEEEEe
Confidence            3688999999999999999987  48899999987542 44445789999999999999999999999999999999999


Q ss_pred             cCCCCCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHH-CCcccCCCCCCceeecCCCcEEEeeccceeeccCCCcc
Q 015868          194 FMARGSIYDFLHKQ--KGVFQLTSLLKVAIDVSKGMNYLHQ-NNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVM  270 (399)
Q Consensus       194 ~~~ggsL~~~l~~~--~~~l~~~~~~~i~~~i~~~L~~LH~-~giiHrDlkp~NILl~~~~~vkl~DFG~a~~~~~~~~~  270 (399)
                      |+++++|..++...  ...+++..+..++.+++.||.|||+ .||+|+||||+||+++.++.++|+|||.+...... ..
T Consensus        80 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~-~~  158 (286)
T cd06622          80 YMDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEEHNIIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVAS-LA  158 (286)
T ss_pred             ecCCCCHHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCEeeCCCCHHHEEECCCCCEEEeecCCcccccCC-cc
Confidence            99999999998763  2478999999999999999999997 59999999999999999999999999998754332 23


Q ss_pred             ccCCCCcccccccccCCC------CCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHH--HHhccCCCCCCCCCcHHH
Q 015868          271 TAETGTYRWMAPEVIEHK------PYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVG--VVQKSLRPTIPKHAHPRL  342 (399)
Q Consensus       271 ~~~~gt~~y~aPE~l~~~------~~~~~~Dv~slG~vl~elltg~~P~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~l  342 (399)
                      ....+++.|+|||.+.+.      .++.++|+||||+++|+|++|+.||...+.......  .......+.++..++.++
T Consensus       159 ~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (286)
T cd06622         159 KTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETYANIFAQLSAIVDGDPPTLPSGYSDDA  238 (286)
T ss_pred             ccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCCcchhhHHHHHHHHhhcCCCCCCcccCHHH
Confidence            345678899999998544      357899999999999999999999976554433222  223345567777899999


Q ss_pred             HHHHHHHhhhcCCCCCCHHHHHH
Q 015868          343 AELLERCWQHDPTQRPNFSQITD  365 (399)
Q Consensus       343 ~~ll~~cl~~dP~~Rps~~ell~  365 (399)
                      .++|.+||+.+|.+||++.++++
T Consensus       239 ~~li~~~l~~~p~~Rp~~~~l~~  261 (286)
T cd06622         239 QDFVAKCLNKIPNRRPTYAQLLE  261 (286)
T ss_pred             HHHHHHHcccCcccCCCHHHHhc
Confidence            99999999999999999999876

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1

Probab=100.00  E-value=4.7e-41  Score=313.31  Aligned_cols=246  Identities=22%  Similarity=0.387  Sum_probs=213.5

Q ss_pred             ccceeceeceeCceEEEEEEE--CCeeEEEEEecCCCC-CHHHHHHHHHHHHHHHhcCCCceeeEEeEEecCCcEEEEEe
Q 015868          117 QLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECV-NTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVTE  193 (399)
Q Consensus       117 ~~~i~~~lg~G~~g~Vy~~~~--~~~~vAvK~~~~~~~-~~~~~~~~~~Ei~~l~~l~h~nIv~~~~~~~~~~~~~lV~E  193 (399)
                      +|++.+.||.|+||.||++..  +++.||+|++..... .....+.+.+|+.++++++||||+++++.+..+...++|+|
T Consensus         1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   80 (258)
T cd05578           1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYSFQDEENMYLVVD   80 (258)
T ss_pred             CceEEEEeccCCCceEEEEEEccCCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhCCCCChHHHHHhhcCCCeEEEEEe
Confidence            488999999999999999987  478999999975432 33556789999999999999999999999999999999999


Q ss_pred             cCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceeecCCCcEEEeeccceeeccCCCccccC
Q 015868          194 FMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAE  273 (399)
Q Consensus       194 ~~~ggsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~giiHrDlkp~NILl~~~~~vkl~DFG~a~~~~~~~~~~~~  273 (399)
                      |+.|++|.+++... ..+++..+..++.|++.||.|||++|++|+||+|.||++++++.++|+|||.+............
T Consensus        81 ~~~~~~L~~~l~~~-~~l~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~  159 (258)
T cd05578          81 LLLGGDLRYHLSQK-VKFSEEQVKFWICEIVLALEYLHSKGIIHRDIKPDNILLDEQGHVHITDFNIATKVTPDTLTTST  159 (258)
T ss_pred             CCCCCCHHHHHHhc-CCcCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeEEcCCCCEEEeecccccccCCCcccccc
Confidence            99999999999764 67899999999999999999999999999999999999999999999999999866554444556


Q ss_pred             CCCcccccccccCCCCCCChhhHHHHHHHHHHHHcCCCCCCCCCH--HHHHHHHHhccCCCCCCCCCcHHHHHHHHHHhh
Q 015868          274 TGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPYAGLTP--LQAAVGVVQKSLRPTIPKHAHPRLAELLERCWQ  351 (399)
Q Consensus       274 ~gt~~y~aPE~l~~~~~~~~~Dv~slG~vl~elltg~~P~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~cl~  351 (399)
                      .++..|+|||.+.+..++.++|+||||+++|+|++|..||...+.  ......... ...+..|..++.++.++|.+||+
T Consensus       160 ~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~i~~~l~  238 (258)
T cd05578         160 SGTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRPYRGHSRTIRDQIRAKQE-TADVLYPATWSTEAIDAINKLLE  238 (258)
T ss_pred             CCChhhcCHHHHcccCCCCcccchhhHHHHHHHHhCCCCCCCCCccHHHHHHHHhc-cccccCcccCcHHHHHHHHHHcc
Confidence            788899999999988899999999999999999999999987764  222222222 24566778899999999999999


Q ss_pred             hcCCCCCCH--HHHH
Q 015868          352 HDPTQRPNF--SQIT  364 (399)
Q Consensus       352 ~dP~~Rps~--~ell  364 (399)
                      .||.+||++  .|++
T Consensus       239 ~~p~~R~~~~~~~l~  253 (258)
T cd05578         239 RDPQKRLGDNLKDLK  253 (258)
T ss_pred             CChhHcCCccHHHHh
Confidence            999999999  5543

Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A.

>cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase

Probab=100.00  E-value=2.8e-40  Score=308.73  Aligned_cols=248  Identities=33%  Similarity=0.582  Sum_probs=213.1

Q ss_pred             cccceeceeceeCceEEEEEEE--CCeeEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCceeeEEeEEecCCcEEEEEe
Q 015868          116 KQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVTE  193 (399)
Q Consensus       116 ~~~~i~~~lg~G~~g~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~nIv~~~~~~~~~~~~~lV~E  193 (399)
                      ++|++.+.||.|+||.||+|..  .+..+|+|++....... ....+.+|+.+++.++|+||+++++.+......++|||
T Consensus         1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e   79 (267)
T cd06610           1 DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQT-SVDELRKEVQAMSQCNHPNVVKYYTSFVVGDELWLVMP   79 (267)
T ss_pred             CcceeeeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCcch-HHHHHHHHHHHHHhcCCCCEEEEEEEEeeCCEEEEEEe
Confidence            4789999999999999999986  56789999997654334 56789999999999999999999999999999999999


Q ss_pred             cCCCCCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceeecCCCcEEEeeccceeeccCCCcc-
Q 015868          194 FMARGSIYDFLHKQ--KGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVM-  270 (399)
Q Consensus       194 ~~~ggsL~~~l~~~--~~~l~~~~~~~i~~~i~~~L~~LH~~giiHrDlkp~NILl~~~~~vkl~DFG~a~~~~~~~~~-  270 (399)
                      ++++++|.+++...  ...+++..+..++.|++.||+|||++|++|+||+|+||++++++.++|+|||.+......... 
T Consensus        80 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lh~~~i~h~~l~p~ni~~~~~~~~~l~df~~~~~~~~~~~~~  159 (267)
T cd06610          80 YLSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHSNGQIHRDIKAGNILLGEDGSVKIADFGVSASLADGGDRT  159 (267)
T ss_pred             ccCCCcHHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHhEEEcCCCCEEEcccchHHHhccCcccc
Confidence            99999999999764  256899999999999999999999999999999999999999999999999998755443221 


Q ss_pred             ----ccCCCCcccccccccCCC-CCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhccCCCCCC-----CCCcH
Q 015868          271 ----TAETGTYRWMAPEVIEHK-PYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKSLRPTIP-----KHAHP  340 (399)
Q Consensus       271 ----~~~~gt~~y~aPE~l~~~-~~~~~~Dv~slG~vl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~-----~~~~~  340 (399)
                          ....++..|+|||.+... .++.++|+||||+++|+|++|+.||...++.+......+.. .+..+     ..+++
T Consensus       160 ~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~  238 (267)
T cd06610         160 RKVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPPMKVLMLTLQND-PPSLETGADYKKYSK  238 (267)
T ss_pred             ccccccccCChhhcChHHHccccCcCcccchHhHhHHHHHHHhCCCCccccChhhhHHHHhcCC-CCCcCCccccccccH
Confidence                233578899999998877 78999999999999999999999999888776666555432 22222     25678


Q ss_pred             HHHHHHHHHhhhcCCCCCCHHHHHH
Q 015868          341 RLAELLERCWQHDPTQRPNFSQITD  365 (399)
Q Consensus       341 ~l~~ll~~cl~~dP~~Rps~~ell~  365 (399)
                      ++.+++.+||+.||++||++.++++
T Consensus       239 ~~~~li~~~l~~~p~~Rp~~~~ll~  263 (267)
T cd06610         239 SFRKMISLCLQKDPSKRPTAEELLK  263 (267)
T ss_pred             HHHHHHHHHcCCChhhCcCHHHHhh
Confidence            9999999999999999999999875

Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1

>cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase

Probab=100.00  E-value=4.4e-40  Score=308.67  Aligned_cols=251  Identities=28%  Similarity=0.514  Sum_probs=207.9

Q ss_pred             ecccccceeceeceeCceEEEEEEE--CCeeEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCceeeEEeEEecCCcEEE
Q 015868          113 IDAKQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCI  190 (399)
Q Consensus       113 i~~~~~~i~~~lg~G~~g~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~nIv~~~~~~~~~~~~~l  190 (399)
                      ++.+.......||+|+||.||+|++  ++..||+|.+...  .....+.+.+|+.+++.++|+||+++++++..++..++
T Consensus         5 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l   82 (268)
T cd06624           5 YEYDENGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPER--DSRYVQPLHEEIALHSYLKHRNIVQYLGSDSENGFFKI   82 (268)
T ss_pred             cccccCCceEEEecCCceEEEEeEecCCCcEEEEEEecCC--CHHHHHHHHHHHHHHHhcCCCCeeeeeeeeccCCEEEE
Confidence            3344455556899999999999986  4578999998754  34456789999999999999999999999999999999


Q ss_pred             EEecCCCCCHHHHHHhcCCCC--CHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceeecC-CCcEEEeeccceeeccCC
Q 015868          191 VTEFMARGSIYDFLHKQKGVF--QLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDE-NGVVKVADFGVARVQAQS  267 (399)
Q Consensus       191 V~E~~~ggsL~~~l~~~~~~l--~~~~~~~i~~~i~~~L~~LH~~giiHrDlkp~NILl~~-~~~vkl~DFG~a~~~~~~  267 (399)
                      |+||+++++|.+++......+  +...+..++.|++.||+|||++||+||||||.||+++. ++.++|+|||.+......
T Consensus        83 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~h~dl~p~nil~~~~~~~~~l~dfg~~~~~~~~  162 (268)
T cd06624          83 FMEQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQILEGLKYLHDNQIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGI  162 (268)
T ss_pred             EEecCCCCCHHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcCCCCeEEEecchhheecccC
Confidence            999999999999998755555  78889999999999999999999999999999999976 679999999998754432


Q ss_pred             C-ccccCCCCcccccccccCCC--CCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHH-HHHhccCCCCCCCCCcHHHH
Q 015868          268 G-VMTAETGTYRWMAPEVIEHK--PYDYKADVFSFGIALWELLTGELPYAGLTPLQAAV-GVVQKSLRPTIPKHAHPRLA  343 (399)
Q Consensus       268 ~-~~~~~~gt~~y~aPE~l~~~--~~~~~~Dv~slG~vl~elltg~~P~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~l~  343 (399)
                      . ......++..|+|||.+.+.  .++.++|+||||+++|+|++|..||.......... ........+.+|..+++++.
T Consensus       163 ~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  242 (268)
T cd06624         163 NPCTETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEPQAAMFKVGMFKIHPEIPESLSAEAK  242 (268)
T ss_pred             CCccccCCCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCccccChhhhHhhhhhhccCCCCCcccCHHHH
Confidence            2 23334678999999998654  37889999999999999999999997654332222 22222345667888999999


Q ss_pred             HHHHHHhhhcCCCCCCHHHHHH
Q 015868          344 ELLERCWQHDPTQRPNFSQITD  365 (399)
Q Consensus       344 ~ll~~cl~~dP~~Rps~~ell~  365 (399)
                      +++.+||+.+|.+|||+.+++.
T Consensus       243 ~li~~~l~~~p~~Rpt~~~ll~  264 (268)
T cd06624         243 NFILRCFEPDPDKRASAHDLLQ  264 (268)
T ss_pred             HHHHHHcCCCchhCCCHHHHHh
Confidence            9999999999999999999875

Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina

>KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=2.2e-40  Score=343.90  Aligned_cols=263  Identities=32%  Similarity=0.676  Sum_probs=235.1

Q ss_pred             ceeecccccceeceeceeCceEEEEEEEC---------CeeEEEEEecCCCCCHHHHHHHHHHHHHHHhc-CCCceeeEE
Q 015868          110 VWEIDAKQLKIECKVASGSYGDLYKGTYC---------SQEVAIKVLKPECVNTEMLKEFSQEVYIMRKI-RHKNVVQFI  179 (399)
Q Consensus       110 ~~~i~~~~~~i~~~lg~G~~g~Vy~~~~~---------~~~vAvK~~~~~~~~~~~~~~~~~Ei~~l~~l-~h~nIv~~~  179 (399)
                      .|+++.+++++.+.||+|.||.|++|...         ...||||.++..... ...+.+..|+.+|+.+ .|+||+.++
T Consensus       290 ~~e~~~~~l~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~~-~~~~~~~~El~~m~~~g~H~niv~ll  368 (609)
T KOG0200|consen  290 KWEIPRENLKLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENASS-SEKKDLMSELNVLKELGKHPNIVNLL  368 (609)
T ss_pred             ceeechhhccccceeecccccceEeEEEeecccccccceEEEEEEecccccCc-HHHHHHHHHHHHHHHhcCCcchhhhe
Confidence            79999999999999999999999999642         457999999977645 6678999999999999 599999999


Q ss_pred             eEEecCCcEEEEEecCCCCCHHHHHHhcC---------------CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCc
Q 015868          180 GACTRPPNLCIVTEFMARGSIYDFLHKQK---------------GVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTAN  244 (399)
Q Consensus       180 ~~~~~~~~~~lV~E~~~ggsL~~~l~~~~---------------~~l~~~~~~~i~~~i~~~L~~LH~~giiHrDlkp~N  244 (399)
                      |+|.+....++|+||+..|+|.++++...               ..++...++.++.||+.||+||++++++||||.++|
T Consensus       369 G~~t~~~~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~~~~vHRDLAaRN  448 (609)
T KOG0200|consen  369 GACTQDGPLYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLASVPCVHRDLAARN  448 (609)
T ss_pred             eeeccCCceEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhhCCccchhhhhhh
Confidence            99999889999999999999999998766               348889999999999999999999999999999999


Q ss_pred             eeecCCCcEEEeeccceeeccCCCcccc--CC--CCcccccccccCCCCCCChhhHHHHHHHHHHHHc-CCCCCCCCCHH
Q 015868          245 LLMDENGVVKVADFGVARVQAQSGVMTA--ET--GTYRWMAPEVIEHKPYDYKADVFSFGIALWELLT-GELPYAGLTPL  319 (399)
Q Consensus       245 ILl~~~~~vkl~DFG~a~~~~~~~~~~~--~~--gt~~y~aPE~l~~~~~~~~~Dv~slG~vl~ellt-g~~P~~~~~~~  319 (399)
                      ||++.+..+||+|||+|+..........  ..  -+..|||||.+....|+.++||||||++|||+++ |..||.+..+.
T Consensus       449 VLi~~~~~~kIaDFGlar~~~~~~~y~~~~~~~~LP~kWmApEsl~~~~ft~kSDVWSfGI~L~EifsLG~~PYp~~~~~  528 (609)
T KOG0200|consen  449 VLITKNKVIKIADFGLARDHYNKDYYRTKSSAGTLPVKWMAPESLFDRVFTSKSDVWSFGILLWEIFTLGGTPYPGIPPT  528 (609)
T ss_pred             EEecCCCEEEEccccceeccCCCCceEecCCCCccceeecCHHHhccCcccccchhhHHHHHHHHHhhCCCCCCCCCCcH
Confidence            9999999999999999996554433321  12  3567999999999999999999999999999999 99999997744


Q ss_pred             HHHHHHHhccCCCCCCCCCcHHHHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHH
Q 015868          320 QAAVGVVQKSLRPTIPKHAHPRLAELLERCWQHDPTQRPNFSQITDILKQMMKE  373 (399)
Q Consensus       320 ~~~~~~~~~~~~~~~~~~~~~~l~~ll~~cl~~dP~~Rps~~ell~~L~~l~~~  373 (399)
                      +.....+..+.+...|..+++++.++|+.||..+|++||+|.++.+.+...+.+
T Consensus       529 ~~l~~~l~~G~r~~~P~~c~~eiY~iM~~CW~~~p~~RP~F~~~~~~~~~~l~~  582 (609)
T KOG0200|consen  529 EELLEFLKEGNRMEQPEHCSDEIYDLMKSCWNADPEDRPTFSECVEFFEKHLQD  582 (609)
T ss_pred             HHHHHHHhcCCCCCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHHHHHHHH
Confidence            445668899999999999999999999999999999999999999999997654

>cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2

Probab=100.00  E-value=3.8e-40  Score=314.46  Aligned_cols=247  Identities=28%  Similarity=0.500  Sum_probs=212.0

Q ss_pred             ccccceeceeceeCceEEEEEEE--CCeeEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCceeeEEeEEecCCcEEEEE
Q 015868          115 AKQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVT  192 (399)
Q Consensus       115 ~~~~~i~~~lg~G~~g~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~nIv~~~~~~~~~~~~~lV~  192 (399)
                      ..+|++.++||.|+||.||+|..  .++.||+|.+.....  .....+.+|+.+++.++||||+++++.+.....+++|+
T Consensus        18 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~--~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~   95 (296)
T cd06655          18 KKKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQ--PKKELIINEILVMKELKNPNIVNFLDSFLVGDELFVVM   95 (296)
T ss_pred             cceEEEEEEEecCCCeEEEEEEEcCCCcEEEEEEEecccC--chHHHHHHHHHHHHhcCCCceeeeeeeEecCceEEEEE
Confidence            45799999999999999999975  678999999875432  23467889999999999999999999999999999999


Q ss_pred             ecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceeecCCCcEEEeeccceeeccCCCc-cc
Q 015868          193 EFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGV-MT  271 (399)
Q Consensus       193 E~~~ggsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~giiHrDlkp~NILl~~~~~vkl~DFG~a~~~~~~~~-~~  271 (399)
                      ||+.+++|.+++..  ..+++..+..++.+++.|++|||++|++|+||+|+||+++.++.++|+|||++........ ..
T Consensus        96 e~~~~~~L~~~~~~--~~l~~~~~~~i~~~l~~al~~LH~~~i~H~dL~p~Nili~~~~~~kl~dfg~~~~~~~~~~~~~  173 (296)
T cd06655          96 EYLAGGSLTDVVTE--TCMDEAQIAAVCRECLQALEFLHANQVIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQSKRS  173 (296)
T ss_pred             EecCCCcHHHHHHh--cCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEccCccchhcccccccCC
Confidence            99999999999865  4589999999999999999999999999999999999999999999999999875443221 23


Q ss_pred             cCCCCcccccccccCCCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhccC-CCCCCCCCcHHHHHHHHHHh
Q 015868          272 AETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKSL-RPTIPKHAHPRLAELLERCW  350 (399)
Q Consensus       272 ~~~gt~~y~aPE~l~~~~~~~~~Dv~slG~vl~elltg~~P~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~l~~ll~~cl  350 (399)
                      ...++..|+|||.+.+..++.++|+||||+++|+|++|+.||...++............ ....+..+++.+.++|.+||
T Consensus       174 ~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l  253 (296)
T cd06655         174 TMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPELQNPEKLSPIFRDFLNRCL  253 (296)
T ss_pred             CcCCCccccCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCcccCCcccCCHHHHHHHHHHh
Confidence            34688899999999998899999999999999999999999988877655444332221 22345678899999999999


Q ss_pred             hhcCCCCCCHHHHHH
Q 015868          351 QHDPTQRPNFSQITD  365 (399)
Q Consensus       351 ~~dP~~Rps~~ell~  365 (399)
                      ..+|.+||++.++++
T Consensus       254 ~~dp~~Rpt~~~il~  268 (296)
T cd06655         254 EMDVEKRGSAKELLQ  268 (296)
T ss_pred             hcChhhCCCHHHHhh
Confidence            999999999999975

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3

Probab=100.00  E-value=3.8e-40  Score=309.53  Aligned_cols=252  Identities=30%  Similarity=0.574  Sum_probs=211.9

Q ss_pred             cceeceeceeCceEEEEEEE-----CCeeEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCceeeEEeEEecCC------
Q 015868          118 LKIECKVASGSYGDLYKGTY-----CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPP------  186 (399)
Q Consensus       118 ~~i~~~lg~G~~g~Vy~~~~-----~~~~vAvK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~nIv~~~~~~~~~~------  186 (399)
                      |++.+.||+|+||.||+|..     .++.||+|+++.........+.+.+|+.+++.++||||+++++++....      
T Consensus         1 ~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~   80 (273)
T cd05074           1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRLP   80 (273)
T ss_pred             CcchhcccCCCCCCEEeeEeeccCCCceEEEEEEeccccCChHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCCCCccc
Confidence            56788999999999999975     3578999999877666666788999999999999999999999886532      


Q ss_pred             cEEEEEecCCCCCHHHHHHhc-----CCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceeecCCCcEEEeeccce
Q 015868          187 NLCIVTEFMARGSIYDFLHKQ-----KGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVA  261 (399)
Q Consensus       187 ~~~lV~E~~~ggsL~~~l~~~-----~~~l~~~~~~~i~~~i~~~L~~LH~~giiHrDlkp~NILl~~~~~vkl~DFG~a  261 (399)
                      ..++++||+.+|+|.+++...     ...++...+..++.|++.||+|||++||+||||||+||++++++.+||+|||.+
T Consensus        81 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~nili~~~~~~kl~dfg~~  160 (273)
T cd05074          81 IPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSSKNFIHRDLAARNCMLNENMTVCVADFGLS  160 (273)
T ss_pred             ceEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccchhhEEEcCCCCEEECccccc
Confidence            247899999999999887532     135788999999999999999999999999999999999999999999999999


Q ss_pred             eeccCCC---ccccCCCCcccccccccCCCCCCChhhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHHhccCCCCCCCC
Q 015868          262 RVQAQSG---VMTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLT-GELPYAGLTPLQAAVGVVQKSLRPTIPKH  337 (399)
Q Consensus       262 ~~~~~~~---~~~~~~gt~~y~aPE~l~~~~~~~~~Dv~slG~vl~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~  337 (399)
                      +......   ......+++.|++||.+....++.++||||||+++|+|++ |+.||...+......... .......+..
T Consensus       161 ~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~sDi~slG~il~el~~~g~~p~~~~~~~~~~~~~~-~~~~~~~~~~  239 (273)
T cd05074         161 KKIYSGDYYRQGCASKLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGVENSEIYNYLI-KGNRLKQPPD  239 (273)
T ss_pred             ccccCCcceecCCCccCchhhcCHhHHhcCccchhhhhHHHHHHHHHHhhCCCCCCCCCCHHHHHHHHH-cCCcCCCCCC
Confidence            8654322   1223345678999999999999999999999999999999 899998877765544433 3334445567


Q ss_pred             CcHHHHHHHHHHhhhcCCCCCCHHHHHHHHHHH
Q 015868          338 AHPRLAELLERCWQHDPTQRPNFSQITDILKQM  370 (399)
Q Consensus       338 ~~~~l~~ll~~cl~~dP~~Rps~~ell~~L~~l  370 (399)
                      .+..+.+++.+||+.+|++||++.++++.|+++
T Consensus       240 ~~~~~~~l~~~~l~~~p~~Rps~~~~~~~l~~~  272 (273)
T cd05074         240 CLEDVYELMCQCWSPEPKCRPSFQHLRDQLELI  272 (273)
T ss_pred             CCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence            889999999999999999999999999999865

Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac

>cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6

Probab=100.00  E-value=2.4e-40  Score=312.78  Aligned_cols=248  Identities=29%  Similarity=0.535  Sum_probs=206.6

Q ss_pred             ccccceeceeceeCceEEEEEEE--CCeeEEEEEecCCCCCHHHHHHHHHHHHHHHhc-CCCceeeEEeEEec------C
Q 015868          115 AKQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKI-RHKNVVQFIGACTR------P  185 (399)
Q Consensus       115 ~~~~~i~~~lg~G~~g~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~Ei~~l~~l-~h~nIv~~~~~~~~------~  185 (399)
                      .+.|++.+.||.|+||.||+|..  .++.+|+|++...   ......+..|+.+++++ +|+||+++++++..      .
T Consensus        15 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~---~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~   91 (282)
T cd06636          15 AGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVT---EDEEEEIKLEINMLKKYSHHRNIATYYGAFIKKSPPGHD   91 (282)
T ss_pred             hhhhhhheeeccCCCeEEEEEEEcCCCcEEEEEEEecC---hHHHHHHHHHHHHHHHhcCCCcEEEEeeehhcccccCCC
Confidence            46889999999999999999987  5688999998653   33446788999999998 69999999999853      4


Q ss_pred             CcEEEEEecCCCCCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceeecCCCcEEEeeccceeec
Q 015868          186 PNLCIVTEFMARGSIYDFLHKQ-KGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQ  264 (399)
Q Consensus       186 ~~~~lV~E~~~ggsL~~~l~~~-~~~l~~~~~~~i~~~i~~~L~~LH~~giiHrDlkp~NILl~~~~~vkl~DFG~a~~~  264 (399)
                      ..++++|||+++++|.+++... ...+++..+..++.|++.||+|||+.||+|+||+|+||++++++.++|+|||.+...
T Consensus        92 ~~~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~ivH~dl~~~nili~~~~~~~l~dfg~~~~~  171 (282)
T cd06636          92 DQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAYICREILRGLAHLHAHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQL  171 (282)
T ss_pred             CEEEEEEEeCCCCcHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEeeCcchhhh
Confidence            5689999999999999999764 345888899999999999999999999999999999999999999999999998754


Q ss_pred             cCC-CccccCCCCcccccccccC-----CCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhccCCCCCCCCC
Q 015868          265 AQS-GVMTAETGTYRWMAPEVIE-----HKPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKSLRPTIPKHA  338 (399)
Q Consensus       265 ~~~-~~~~~~~gt~~y~aPE~l~-----~~~~~~~~Dv~slG~vl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~  338 (399)
                      ... .......++..|+|||.+.     +..++.++|+||||+++|+|++|..||....+................+..+
T Consensus       172 ~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  251 (282)
T cd06636         172 DRTVGRRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNPPPKLKSKKW  251 (282)
T ss_pred             hccccCCCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHHhCCCCccccCHHhhhhhHhhCCCCCCccccc
Confidence            322 2233456889999999986     3468889999999999999999999998877655544433333333334568


Q ss_pred             cHHHHHHHHHHhhhcCCCCCCHHHHHH
Q 015868          339 HPRLAELLERCWQHDPTQRPNFSQITD  365 (399)
Q Consensus       339 ~~~l~~ll~~cl~~dP~~Rps~~ell~  365 (399)
                      +.++.++|.+||+.||.+|||+.|+++
T Consensus       252 ~~~~~~li~~cl~~~p~~Rp~~~ell~  278 (282)
T cd06636         252 SKKFIDFIEGCLVKNYLSRPSTEQLLK  278 (282)
T ss_pred             CHHHHHHHHHHhCCChhhCcCHHHHhc
Confidence            899999999999999999999999874

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea

>cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase

Probab=100.00  E-value=3.6e-40  Score=308.06  Aligned_cols=241  Identities=26%  Similarity=0.443  Sum_probs=209.5

Q ss_pred             eceeCceEEEEEEEC--CeeEEEEEecCCCC-CHHHHHHHHHHHHHHHhcCCCceeeEEeEEecCCcEEEEEecCCCCCH
Q 015868          124 VASGSYGDLYKGTYC--SQEVAIKVLKPECV-NTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVTEFMARGSI  200 (399)
Q Consensus       124 lg~G~~g~Vy~~~~~--~~~vAvK~~~~~~~-~~~~~~~~~~Ei~~l~~l~h~nIv~~~~~~~~~~~~~lV~E~~~ggsL  200 (399)
                      ||.|++|.||+++..  ++.||+|++..... .....+.+.+|+.+++.++||||+++++.+..+...++|+||+++++|
T Consensus         1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L   80 (262)
T cd05572           1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTFKDKKYIYMLMEYCLGGEL   80 (262)
T ss_pred             CCCCCceEEEEEEECCCCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhCCCCCEeeeeeeEEcCCccEEEEecCCCCcH
Confidence            689999999999986  88999999975432 334557899999999999999999999999999999999999999999


Q ss_pred             HHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceeecCCCcEEEeeccceeeccCCCccccCCCCcccc
Q 015868          201 YDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAETGTYRWM  280 (399)
Q Consensus       201 ~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~giiHrDlkp~NILl~~~~~vkl~DFG~a~~~~~~~~~~~~~gt~~y~  280 (399)
                      .+++.+. ..++...+..++.|++.||.|||++|++|+||+|.||++++++.++|+|||.+.............++..|+
T Consensus        81 ~~~l~~~-~~l~~~~~~~~~~~i~~~l~~lH~~~~~h~dl~~~nilv~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~  159 (262)
T cd05572          81 WTILRDR-GLFDEYTARFYIACVVLAFEYLHNRGIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQKTWTFCGTPEYV  159 (262)
T ss_pred             HHHHhhc-CCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCHHHEEEcCCCCEEEeeCCcccccCcccccccccCCcCcc
Confidence            9999763 568999999999999999999999999999999999999999999999999998665543334456788999


Q ss_pred             cccccCCCCCCChhhHHHHHHHHHHHHcCCCCCCCCC--HHHHHHHHHhccCCCCCCCCCcHHHHHHHHHHhhhcCCCCC
Q 015868          281 APEVIEHKPYDYKADVFSFGIALWELLTGELPYAGLT--PLQAAVGVVQKSLRPTIPKHAHPRLAELLERCWQHDPTQRP  358 (399)
Q Consensus       281 aPE~l~~~~~~~~~Dv~slG~vl~elltg~~P~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~cl~~dP~~Rp  358 (399)
                      +||.+.+..++.++|+||||+++|+|++|..||....  +.+...........+..|...++++.++|.+||+.+|++||
T Consensus       160 ~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~  239 (262)
T cd05572         160 APEIILNKGYDFSVDYWSLGILLYELLTGRPPFGEDDEDPMEIYNDILKGNGKLEFPNYIDKAAKDLIKQLLRRNPEERL  239 (262)
T ss_pred             ChhHhcCCCCCChhhhhhhHHHHHHHHhCCCCcCCCCCCHHHHHHHHhccCCCCCCCcccCHHHHHHHHHHccCChhhCc
Confidence            9999988889999999999999999999999998777  55555544443556677777899999999999999999999


Q ss_pred             C-----HHHHHH
Q 015868          359 N-----FSQITD  365 (399)
Q Consensus       359 s-----~~ell~  365 (399)
                      +     +.|+++
T Consensus       240 ~~~~~~~~~l~~  251 (262)
T cd05572         240 GNLKGGIKDIKK  251 (262)
T ss_pred             CCcccCHHHHhc
Confidence            9     666654

Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi

>cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases

Probab=100.00  E-value=2.1e-40  Score=313.73  Aligned_cols=250  Identities=30%  Similarity=0.502  Sum_probs=210.9

Q ss_pred             ecccccceeceeceeCceEEEEEEEC--CeeEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCceeeEEeEEecCCcEEE
Q 015868          113 IDAKQLKIECKVASGSYGDLYKGTYC--SQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCI  190 (399)
Q Consensus       113 i~~~~~~i~~~lg~G~~g~Vy~~~~~--~~~vAvK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~nIv~~~~~~~~~~~~~l  190 (399)
                      +..++|++.+.||+|+||.||++...  ++.||+|++.... .....+.+.+|+.+++.++||||+++++++.....+++
T Consensus         2 l~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~-~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~l   80 (284)
T cd06620           2 LRNEDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGA-KSSVRKQILRELQIMHECRSPYIVSFYGAFLNENNICM   80 (284)
T ss_pred             ccHHHHHHHHHcCCCCCeEEEEEEEcCCCcEEEEEEEEecC-cchHHHHHHHHHHHHHHcCCCCcceEeeeEecCCEEEE
Confidence            45678999999999999999999874  7899999987543 34456789999999999999999999999999999999


Q ss_pred             EEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH-CCcccCCCCCCceeecCCCcEEEeeccceeeccCCCc
Q 015868          191 VTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQ-NNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGV  269 (399)
Q Consensus       191 V~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~-~giiHrDlkp~NILl~~~~~vkl~DFG~a~~~~~~~~  269 (399)
                      ||||+++++|.+++.+ .+.++...+..++.+++.+|.|||+ .+++||||+|+||++++++.++|+|||++....... 
T Consensus        81 v~e~~~~~~L~~~~~~-~~~~~~~~~~~~~~~i~~~l~~LH~~~~i~H~dl~p~nil~~~~~~~~l~d~gl~~~~~~~~-  158 (284)
T cd06620          81 CMEFMDCGSLDRIYKK-GGPIPVEILGKIAVAVVEGLTYLYNVHRIMHRDIKPSNILVNSRGQIKLCDFGVSGELINSI-  158 (284)
T ss_pred             EEecCCCCCHHHHHHh-ccCCCHHHHHHHHHHHHHHHHHHHHhcCeeccCCCHHHEEECCCCcEEEccCCcccchhhhc-
Confidence            9999999999999876 4578999999999999999999997 599999999999999999999999999986543221 


Q ss_pred             cccCCCCcccccccccCCCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHH-----------HHHHHHHhccCCCCCCCC-
Q 015868          270 MTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPYAGLTPL-----------QAAVGVVQKSLRPTIPKH-  337 (399)
Q Consensus       270 ~~~~~gt~~y~aPE~l~~~~~~~~~Dv~slG~vl~elltg~~P~~~~~~~-----------~~~~~~~~~~~~~~~~~~-  337 (399)
                      .....++..|+|||++.+..++.++|+|||||++|++++|..||......           ........ ...+.++.. 
T Consensus       159 ~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~  237 (284)
T cd06620         159 ADTFVGTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILDLLQQIVQ-EPPPRLPSSD  237 (284)
T ss_pred             cCccccCcccCCHHHHccCCCCccchHHHHHHHHHHHHhCCCCCcccchhhhhhhhhhHHHHHHHHHhh-ccCCCCCchh
Confidence            22346899999999998888999999999999999999999999865542           11222222 223333333 


Q ss_pred             CcHHHHHHHHHHhhhcCCCCCCHHHHHHH
Q 015868          338 AHPRLAELLERCWQHDPTQRPNFSQITDI  366 (399)
Q Consensus       338 ~~~~l~~ll~~cl~~dP~~Rps~~ell~~  366 (399)
                      ++.++.+|+.+||+.||.+|||+.|+++.
T Consensus       238 ~~~~~~~li~~~l~~dp~~Rpt~~e~~~~  266 (284)
T cd06620         238 FPEDLRDFVDACLLKDPTERPTPQQLCAM  266 (284)
T ss_pred             cCHHHHHHHHHHhcCCcccCcCHHHHhcC
Confidence            78899999999999999999999999875

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins

Probab=100.00  E-value=6.5e-40  Score=305.79  Aligned_cols=248  Identities=30%  Similarity=0.528  Sum_probs=215.0

Q ss_pred             cccceeceeceeCceEEEEEEE--CCeeEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCceeeEEeEEecCCcEEEEEe
Q 015868          116 KQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVTE  193 (399)
Q Consensus       116 ~~~~i~~~lg~G~~g~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~nIv~~~~~~~~~~~~~lV~E  193 (399)
                      ++|++.+.||.|++|.||+++.  +++.|++|++...... .....+.+|+.++++++|+|++++++++..+...++|||
T Consensus         1 ~~~~~~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e   79 (264)
T cd06623           1 SDLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDE-EFRKQLLRELKTLRSCESPYVVKCYGAFYKEGEISIVLE   79 (264)
T ss_pred             CcceeeeeeeecCCeEEEEEEEcCCCcEEEEEEeccCcch-HHHHHHHHHHHHHHhcCCCCeeeEEEEEccCCeEEEEEE
Confidence            3688899999999999999987  4789999999865432 556789999999999999999999999999999999999


Q ss_pred             cCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH-CCcccCCCCCCceeecCCCcEEEeeccceeeccCCCcc-c
Q 015868          194 FMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQ-NNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVM-T  271 (399)
Q Consensus       194 ~~~ggsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~-~giiHrDlkp~NILl~~~~~vkl~DFG~a~~~~~~~~~-~  271 (399)
                      |+++++|.+++... ..+++..++.++.|++.|++|||+ +|++|+||+|+||+++.++.++|+|||.+......... .
T Consensus        80 ~~~~~~L~~~l~~~-~~l~~~~~~~~~~~l~~~l~~lh~~~~~~H~~l~~~ni~~~~~~~~~l~df~~~~~~~~~~~~~~  158 (264)
T cd06623          80 YMDGGSLADLLKKV-GKIPEPVLAYIARQILKGLDYLHTKRHIIHRDIKPSNLLINSKGEVKIADFGISKVLENTLDQCN  158 (264)
T ss_pred             ecCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHhccCCCccCCCCHHHEEECCCCCEEEccCccceecccCCCccc
Confidence            99999999999764 678999999999999999999999 99999999999999999999999999999866543322 2


Q ss_pred             cCCCCcccccccccCCCCCCChhhHHHHHHHHHHHHcCCCCCCCCC--HHHHHHHHHhccCCCCCCCC-CcHHHHHHHHH
Q 015868          272 AETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPYAGLT--PLQAAVGVVQKSLRPTIPKH-AHPRLAELLER  348 (399)
Q Consensus       272 ~~~gt~~y~aPE~l~~~~~~~~~Dv~slG~vl~elltg~~P~~~~~--~~~~~~~~~~~~~~~~~~~~-~~~~l~~ll~~  348 (399)
                      ...++..|+|||.+.+..++.++|+||||+++|+|++|..||....  ..............+..+.. ++..+.+++.+
T Consensus       159 ~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~  238 (264)
T cd06623         159 TFVGTVTYMSPERIQGESYSYAADIWSLGLTLLECALGKFPFLPPGQPSFFELMQAICDGPPPSLPAEEFSPEFRDFISA  238 (264)
T ss_pred             ceeecccccCHhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCccccccCHHHHHHHHhcCCCCCCCcccCCHHHHHHHHH
Confidence            4467889999999999999999999999999999999999998774  32223333334444556666 88999999999


Q ss_pred             HhhhcCCCCCCHHHHHH
Q 015868          349 CWQHDPTQRPNFSQITD  365 (399)
Q Consensus       349 cl~~dP~~Rps~~ell~  365 (399)
                      ||..+|++||++.++++
T Consensus       239 ~l~~~p~~R~~~~~ll~  255 (264)
T cd06623         239 CLQKDPKKRPSAAELLQ  255 (264)
T ss_pred             HccCChhhCCCHHHHHh
Confidence            99999999999999987

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of

>cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=3e-41  Score=326.84  Aligned_cols=239  Identities=21%  Similarity=0.379  Sum_probs=196.8

Q ss_pred             eceeCceEEEEEEE--CCeeEEEEEecCCC-CCHHHHHHHHHHHHHHHhc---CCCceeeEEeEEecCCcEEEEEecCCC
Q 015868          124 VASGSYGDLYKGTY--CSQEVAIKVLKPEC-VNTEMLKEFSQEVYIMRKI---RHKNVVQFIGACTRPPNLCIVTEFMAR  197 (399)
Q Consensus       124 lg~G~~g~Vy~~~~--~~~~vAvK~~~~~~-~~~~~~~~~~~Ei~~l~~l---~h~nIv~~~~~~~~~~~~~lV~E~~~g  197 (399)
                      ||+|+||.||+|+.  .++.||+|++.... ........+..|..++...   +||||+++++.+.....+|+||||+++
T Consensus         1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~~~~~lv~e~~~~   80 (330)
T cd05586           1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTDSDLYLVTDYMSG   80 (330)
T ss_pred             CCCCCceEEEEEEECCCCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEecCCeEEEEEcCCCC
Confidence            69999999999987  57899999986432 1223334556677777665   699999999999999999999999999


Q ss_pred             CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceeecCCCcEEEeeccceeeccCC-CccccCCCC
Q 015868          198 GSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQS-GVMTAETGT  276 (399)
Q Consensus       198 gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~giiHrDlkp~NILl~~~~~vkl~DFG~a~~~~~~-~~~~~~~gt  276 (399)
                      |+|.+++.. .+.+++..+..++.||+.||+|||++||+||||||+|||++.++.++|+|||+++..... .......||
T Consensus        81 g~L~~~l~~-~~~~~~~~~~~~~~qil~al~~LH~~~ivHrDlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~~~~~~~gt  159 (330)
T cd05586          81 GELFWHLQK-EGRFSEDRAKFYIAELVLALEHLHKYDIVYRDLKPENILLDATGHIALCDFGLSKANLTDNKTTNTFCGT  159 (330)
T ss_pred             ChHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCCCCEEEecCCcCcCCCCCCCCccCccCC
Confidence            999999875 567899999999999999999999999999999999999999999999999998753322 223445789


Q ss_pred             cccccccccCCC-CCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhccCCCCCC-CCCcHHHHHHHHHHhhhcC
Q 015868          277 YRWMAPEVIEHK-PYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKSLRPTIP-KHAHPRLAELLERCWQHDP  354 (399)
Q Consensus       277 ~~y~aPE~l~~~-~~~~~~Dv~slG~vl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~l~~ll~~cl~~dP  354 (399)
                      +.|+|||++.+. .++.++|||||||++|+|++|..||...+..+..........  .++ ..+++++.+++.+||+.||
T Consensus       160 ~~y~aPE~~~~~~~~~~~~DvwslGvil~elltG~~Pf~~~~~~~~~~~i~~~~~--~~~~~~~~~~~~~li~~~L~~~P  237 (330)
T cd05586         160 TEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAEDTQQMYRNIAFGKV--RFPKNVLSDEGRQFVKGLLNRNP  237 (330)
T ss_pred             ccccCHHHHcCCCCCCCccceeccccEEEEeccCCCCCCCCCHHHHHHHHHcCCC--CCCCccCCHHHHHHHHHHcCCCH
Confidence            999999999764 589999999999999999999999988777665544433222  233 3478999999999999999


Q ss_pred             CCCCC----HHHHHH
Q 015868          355 TQRPN----FSQITD  365 (399)
Q Consensus       355 ~~Rps----~~ell~  365 (399)
                      .+||+    +.++++
T Consensus       238 ~~R~~~~~~~~~ll~  252 (330)
T cd05586         238 QHRLGAHRDAVELKE  252 (330)
T ss_pred             HHCCCCCCCHHHHhc
Confidence            99984    555544

Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of

>KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=3.9e-42  Score=338.89  Aligned_cols=241  Identities=30%  Similarity=0.565  Sum_probs=213.7

Q ss_pred             eeceeCceEEEEEEEC--CeeEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCceeeEEeEEecCCcEEEEEecCCCCCH
Q 015868          123 KVASGSYGDLYKGTYC--SQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVTEFMARGSI  200 (399)
Q Consensus       123 ~lg~G~~g~Vy~~~~~--~~~vAvK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~nIv~~~~~~~~~~~~~lV~E~~~ggsL  200 (399)
                      .||.|.||+||.|++.  ....|||-+...  +.....-+.+||.+.++++|.|||+++|.+.+++.+-|.||..+||||
T Consensus       582 VLGKGTYG~VYA~RD~~tqvrIaIKEIpek--dsr~~QPLhEEIaLH~~LrHkNIVrYLGs~senGf~kIFMEqVPGGSL  659 (1226)
T KOG4279|consen  582 VLGKGTYGTVYAARDMDTQVRIAIKEIPEK--DSREVQPLHEEIALHSTLRHKNIVRYLGSVSENGFFKIFMEQVPGGSL  659 (1226)
T ss_pred             EeecCceeEEEeeccccceeEEEeeecccc--cchhhccHHHHHHHHHHHhhHhHHHHhhccCCCCeEEEEeecCCCCcH
Confidence            6899999999999884  456788887643  445567789999999999999999999999999999999999999999


Q ss_pred             HHHHHhcCCCC--CHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceeecC-CCcEEEeeccceeeccCCC-ccccCCCC
Q 015868          201 YDFLHKQKGVF--QLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDE-NGVVKVADFGVARVQAQSG-VMTAETGT  276 (399)
Q Consensus       201 ~~~l~~~~~~l--~~~~~~~i~~~i~~~L~~LH~~giiHrDlkp~NILl~~-~~~vkl~DFG~a~~~~~~~-~~~~~~gt  276 (399)
                      .++++..=+++  .++.+..+..||+.||.|||.+.|+|||||-+|||++. .|.+||+|||-++....-+ ...+.+||
T Consensus       660 SsLLrskWGPlKDNEstm~fYtkQILeGLkYLHen~IVHRDIKGDNVLvNTySGvlKISDFGTsKRLAginP~TETFTGT  739 (1226)
T KOG4279|consen  660 SSLLRSKWGPLKDNESTMNFYTKQILEGLKYLHENKIVHRDIKGDNVLVNTYSGVLKISDFGTSKRLAGINPCTETFTGT  739 (1226)
T ss_pred             HHHHHhccCCCccchhHHHHHHHHHHHHhhhhhhcceeeccccCCcEEEeeccceEEecccccchhhccCCccccccccc
Confidence            99998877777  78899999999999999999999999999999999974 7899999999998766544 45667999


Q ss_pred             cccccccccCCC--CCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHh-ccCCCCCCCCCcHHHHHHHHHHhhhc
Q 015868          277 YRWMAPEVIEHK--PYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQ-KSLRPTIPKHAHPRLAELLERCWQHD  353 (399)
Q Consensus       277 ~~y~aPE~l~~~--~~~~~~Dv~slG~vl~elltg~~P~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~l~~ll~~cl~~d  353 (399)
                      ..|||||++..+  .|..++|||||||++.||.||++||-.+...++++-.+. -...|++|..++.+.+.+|.+|+.++
T Consensus       740 LQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~ElgspqAAMFkVGmyKvHP~iPeelsaeak~FilrcFepd  819 (1226)
T KOG4279|consen  740 LQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFVELGSPQAAMFKVGMYKVHPPIPEELSAEAKNFILRCFEPD  819 (1226)
T ss_pred             hhhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCeeecCChhHhhhhhcceecCCCCcHHHHHHHHHHHHHHcCCC
Confidence            999999999865  589999999999999999999999998887777664443 23469999999999999999999999


Q ss_pred             CCCCCCHHHHHH
Q 015868          354 PTQRPNFSQITD  365 (399)
Q Consensus       354 P~~Rps~~ell~  365 (399)
                      |..||++.++++
T Consensus       820 ~~~R~sA~~LL~  831 (1226)
T KOG4279|consen  820 PCDRPSAKDLLQ  831 (1226)
T ss_pred             cccCccHHHhcc
Confidence            999999999976

>KOG0586 consensus Serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=4.5e-41  Score=329.98  Aligned_cols=251  Identities=27%  Similarity=0.465  Sum_probs=229.4

Q ss_pred             eecccccceeceeceeCceEEEEEEE--CCeeEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCceeeEEeEEecCCcEE
Q 015868          112 EIDAKQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLC  189 (399)
Q Consensus       112 ~i~~~~~~i~~~lg~G~~g~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~nIv~~~~~~~~~~~~~  189 (399)
                      ......|.+.+.||+|.|+.|.+|++  ++..||||++.....+....+.+.+|+++|+.++|||||+++.+......+|
T Consensus        52 ~~~vg~y~i~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~ln~~~~~k~~rev~imk~l~HPnIvkl~~v~~t~~~ly  131 (596)
T KOG0586|consen   52 SNSVGLYVIIKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQLNPSKRQKLGREVDIMKSLNHPNIVKLFSVIETEATLY  131 (596)
T ss_pred             cccccceeeeeeeccceeEEEEeeEecCCCceEEEEEehhcccChHHHHHHHHHHHHHHhcCCcceeeeeeeeeecceeE
Confidence            34456899999999999999999987  6889999999998888888888999999999999999999999999999999


Q ss_pred             EEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceeecCCCcEEEeeccceeeccCCCc
Q 015868          190 IVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGV  269 (399)
Q Consensus       190 lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~giiHrDlkp~NILl~~~~~vkl~DFG~a~~~~~~~~  269 (399)
                      +||||+.+|.+++++.++ +...+..+..+..|++++++|||+++|+|||||++|||++.+-.+||+|||++........
T Consensus       132 lV~eya~~ge~~~yl~~~-gr~~e~~ar~~F~q~vsaveYcH~k~ivHrdLk~eNilL~~~mnikIaDfgfS~~~~~~~~  210 (596)
T KOG0586|consen  132 LVMEYASGGELFDYLVKH-GRMKEKEARAKFRQIVSAVEYCHSKNIVHRDLKAENILLDENMNIKIADFGFSTFFDYGLM  210 (596)
T ss_pred             EEEEeccCchhHHHHHhc-ccchhhhhhhhhHHHHHHHHHHhhcceeccccchhhcccccccceeeeccccceeeccccc
Confidence            999999999999999885 5566699999999999999999999999999999999999999999999999999888777


Q ss_pred             cccCCCCcccccccccCCCCCC-ChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhccCCCCCCCCCcHHHHHHHHH
Q 015868          270 MTAETGTYRWMAPEVIEHKPYD-YKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRLAELLER  348 (399)
Q Consensus       270 ~~~~~gt~~y~aPE~l~~~~~~-~~~Dv~slG~vl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~  348 (399)
                      ..+.+|++.|.|||++.+..|+ +.+|+||+|+++|-|++|.+||++.+-.+....++....+  +|..++.++.++|++
T Consensus       211 lqt~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~GsLPFDG~~lk~Lr~rvl~gk~r--Ip~~ms~dce~lLrk  288 (596)
T KOG0586|consen  211 LQTFCGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVEGSLPFDGQNLKELRPRVLRGKYR--IPFYMSCDCEDLLRK  288 (596)
T ss_pred             ccccCCCCCccChHhhcCcccCCcceehhhhhhhheeeeecccccCCcccccccchheeeeec--ccceeechhHHHHHH
Confidence            8889999999999999999885 7899999999999999999999988776666666655444  667788899999999


Q ss_pred             HhhhcCCCCCCHHHHHH
Q 015868          349 CWQHDPTQRPNFSQITD  365 (399)
Q Consensus       349 cl~~dP~~Rps~~ell~  365 (399)
                      +|-.+|.+|++..++++
T Consensus       289 ~lvl~Pskr~~~dqim~  305 (596)
T KOG0586|consen  289 FLVLNPSKRGPCDQIMK  305 (596)
T ss_pred             hhccCccccCCHHHhhh
Confidence            99999999999999976

>cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3

Probab=100.00  E-value=2.7e-40  Score=315.51  Aligned_cols=246  Identities=28%  Similarity=0.490  Sum_probs=210.0

Q ss_pred             cccceeceeceeCceEEEEEEE--CCeeEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCceeeEEeEEecCCcEEEEEe
Q 015868          116 KQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVTE  193 (399)
Q Consensus       116 ~~~~i~~~lg~G~~g~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~nIv~~~~~~~~~~~~~lV~E  193 (399)
                      .+|++.++||+|+||.||++..  .++.||+|.+......  ..+.+.+|+.+++.++|+||+++++++..+...++|||
T Consensus        19 ~~y~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e   96 (297)
T cd06656          19 KKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQP--KKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVME   96 (297)
T ss_pred             hhceeeeeeccCCCeEEEEEEECCCCCEEEEEEEecCccc--hHHHHHHHHHHHHhCCCCCEeeEEEEEecCCEEEEeec
Confidence            6899999999999999999986  6789999999754322  34668899999999999999999999999999999999


Q ss_pred             cCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceeecCCCcEEEeeccceeeccCCCc-ccc
Q 015868          194 FMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGV-MTA  272 (399)
Q Consensus       194 ~~~ggsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~giiHrDlkp~NILl~~~~~vkl~DFG~a~~~~~~~~-~~~  272 (399)
                      |+++++|.+++.+  ..+++..+..++.|++.||.|||+.|++||||||+||+++.++.++|+|||.+........ ...
T Consensus        97 ~~~~~~L~~~~~~--~~~~~~~~~~~~~~l~~~L~~LH~~~i~H~dL~p~Nili~~~~~~~l~Dfg~~~~~~~~~~~~~~  174 (297)
T cd06656          97 YLAGGSLTDVVTE--TCMDEGQIAAVCRECLQALDFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRST  174 (297)
T ss_pred             ccCCCCHHHHHHh--CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEECcCccceEccCCccCcCc
Confidence            9999999999865  4578899999999999999999999999999999999999999999999999876543322 234


Q ss_pred             CCCCcccccccccCCCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhccC-CCCCCCCCcHHHHHHHHHHhh
Q 015868          273 ETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKSL-RPTIPKHAHPRLAELLERCWQ  351 (399)
Q Consensus       273 ~~gt~~y~aPE~l~~~~~~~~~Dv~slG~vl~elltg~~P~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~l~~ll~~cl~  351 (399)
                      ..+++.|+|||.+.+..++.++|+||||+++|++++|..||...++............ ....+..+++.+.+++.+||.
T Consensus       175 ~~~~~~y~aPE~~~~~~~~~~~Di~slGvil~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~  254 (297)
T cd06656         175 MVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPELQNPERLSAVFRDFLNRCLE  254 (297)
T ss_pred             ccCCccccCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcchheeeeccCCCCCCCCccccCHHHHHHHHHHcc
Confidence            5688899999999998899999999999999999999999987666443332222111 122456688899999999999


Q ss_pred             hcCCCCCCHHHHHH
Q 015868          352 HDPTQRPNFSQITD  365 (399)
Q Consensus       352 ~dP~~Rps~~ell~  365 (399)
                      .+|++||++.++++
T Consensus       255 ~~p~~Rps~~~il~  268 (297)
T cd06656         255 MDVDRRGSAKELLQ  268 (297)
T ss_pred             CChhhCcCHHHHhc
Confidence            99999999999977

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase

Probab=100.00  E-value=6.5e-40  Score=303.94  Aligned_cols=248  Identities=29%  Similarity=0.556  Sum_probs=220.9

Q ss_pred             ccceeceeceeCceEEEEEEEC--CeeEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCceeeEEeEEecCCcEEEEEec
Q 015868          117 QLKIECKVASGSYGDLYKGTYC--SQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVTEF  194 (399)
Q Consensus       117 ~~~i~~~lg~G~~g~Vy~~~~~--~~~vAvK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~nIv~~~~~~~~~~~~~lV~E~  194 (399)
                      +|++.+.||.|+||.||++.+.  ++.|++|++............+.+|+++++.++|||++++++.+......++|+|+
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~lv~e~   80 (258)
T cd08215           1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYESFEEKGKLCIVMEY   80 (258)
T ss_pred             CceEEeeeccCCCeEEEEEEEcCCCcEEEEEEeecccCChHHHHHHHHHHHHHHhcCCCChhheEEEEecCCEEEEEEEe
Confidence            5788999999999999999885  78999999987766666778899999999999999999999999999999999999


Q ss_pred             CCCCCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceeecCCCcEEEeeccceeeccCCC-cc
Q 015868          195 MARGSIYDFLHKQ---KGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSG-VM  270 (399)
Q Consensus       195 ~~ggsL~~~l~~~---~~~l~~~~~~~i~~~i~~~L~~LH~~giiHrDlkp~NILl~~~~~vkl~DFG~a~~~~~~~-~~  270 (399)
                      +++++|.+++...   ...+++..+..++.+++.||.|||++|++|+||+|+||++++++.++|+|||.+....... ..
T Consensus        81 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~  160 (258)
T cd08215          81 ADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSRKILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTVDLA  160 (258)
T ss_pred             cCCCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHHhCCEecccCChHHeEEcCCCcEEECCccceeecccCccee
Confidence            9999999999775   3789999999999999999999999999999999999999999999999999998655443 23


Q ss_pred             ccCCCCcccccccccCCCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhccCCCCCCCCCcHHHHHHHHHHh
Q 015868          271 TAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRLAELLERCW  350 (399)
Q Consensus       271 ~~~~gt~~y~aPE~l~~~~~~~~~Dv~slG~vl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~cl  350 (399)
                      ....+++.|+|||.+.+..++.++|+||+|+++|+|++|..||...+..+....... ...+.++..++.++.+++.+||
T Consensus       161 ~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~i~~~l  239 (258)
T cd08215         161 KTVVGTPYYLSPELCQNKPYNYKSDIWSLGCVLYELCTLKHPFEGENLLELALKILK-GQYPPIPSQYSSELRNLVSSLL  239 (258)
T ss_pred             cceeeeecccChhHhccCCCCccccHHHHHHHHHHHHcCCCCCCCCcHHHHHHHHhc-CCCCCCCCCCCHHHHHHHHHHc
Confidence            334678899999999999999999999999999999999999988876665555443 3456677789999999999999


Q ss_pred             hhcCCCCCCHHHHHH
Q 015868          351 QHDPTQRPNFSQITD  365 (399)
Q Consensus       351 ~~dP~~Rps~~ell~  365 (399)
                      ..+|++|||+.++++
T Consensus       240 ~~~p~~Rp~~~~ll~  254 (258)
T cd08215         240 QKDPEERPSIAQILQ  254 (258)
T ss_pred             CCChhhCcCHHHHhc
Confidence            999999999999975

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They

>cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases

Probab=100.00  E-value=2.4e-40  Score=308.07  Aligned_cols=236  Identities=28%  Similarity=0.526  Sum_probs=196.5

Q ss_pred             ceeceeCceEEEEEEECCe------------eEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCceeeEEeEEecCCcEE
Q 015868          122 CKVASGSYGDLYKGTYCSQ------------EVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLC  189 (399)
Q Consensus       122 ~~lg~G~~g~Vy~~~~~~~------------~vAvK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~nIv~~~~~~~~~~~~~  189 (399)
                      +.||+|+||.||+|.....            .+++|++....   .....+.+|+.++++++||||+++++++.. ...+
T Consensus         1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~   76 (259)
T cd05037           1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDH---RDSLAFFETASLMSQLSHKHLVKLYGVCVR-DENI   76 (259)
T ss_pred             CcccccccceEEEEEEeccCCccccCCccceeeeeeccccch---hhHHHHHHHHHHHHcCCCcchhheeeEEec-CCcE
Confidence            4689999999999988543            37888876542   115788999999999999999999999988 7789


Q ss_pred             EEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceeecCCC-------cEEEeecccee
Q 015868          190 IVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENG-------VVKVADFGVAR  262 (399)
Q Consensus       190 lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~giiHrDlkp~NILl~~~~-------~vkl~DFG~a~  262 (399)
                      +||||+++++|.+++......++...+..++.||+.||+|||++||+||||||+||+++.++       .+||+|||.+.
T Consensus        77 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dlkp~Nill~~~~~~~~~~~~~kl~Dfg~a~  156 (259)
T cd05037          77 MVEEYVKFGPLDVFLHREKNNVSLHWKLDVAKQLASALHYLEDKKLVHGNVCGKNILVARYGLNEGYVPFIKLSDPGIPI  156 (259)
T ss_pred             EEEEcCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhhCCeecccCccceEEEecCccccCCceeEEeCCCCccc
Confidence            99999999999999987665789999999999999999999999999999999999999887       79999999997


Q ss_pred             eccCCCccccCCCCcccccccccCCC--CCCChhhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHHhccCCCCCCCCCc
Q 015868          263 VQAQSGVMTAETGTYRWMAPEVIEHK--PYDYKADVFSFGIALWELLT-GELPYAGLTPLQAAVGVVQKSLRPTIPKHAH  339 (399)
Q Consensus       263 ~~~~~~~~~~~~gt~~y~aPE~l~~~--~~~~~~Dv~slG~vl~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~  339 (399)
                      ....   .....++..|+|||.+.+.  .++.++|+||||+++|+|++ |..||...++........ .  ....+....
T Consensus       157 ~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~~p~~~~~~~~~~~~~~-~--~~~~~~~~~  230 (259)
T cd05037         157 TVLS---REERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSSSEKERFYQ-D--QHRLPMPDC  230 (259)
T ss_pred             cccc---ccccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCCCCCcccCCchhHHHHHh-c--CCCCCCCCc
Confidence            6443   2234567789999999876  78999999999999999999 688887776443322222 1  122233334


Q ss_pred             HHHHHHHHHHhhhcCCCCCCHHHHHHHH
Q 015868          340 PRLAELLERCWQHDPTQRPNFSQITDIL  367 (399)
Q Consensus       340 ~~l~~ll~~cl~~dP~~Rps~~ell~~L  367 (399)
                      ..+.+++.+||..+|.+|||+.++++.|
T Consensus       231 ~~~~~li~~~l~~~p~~Rpt~~~il~~l  258 (259)
T cd05037         231 AELANLINQCWTYDPTKRPSFRAILRDL  258 (259)
T ss_pred             hHHHHHHHHHhccChhhCCCHHHHHHhc
Confidence            8999999999999999999999999876

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki

>cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1

Probab=100.00  E-value=3.5e-40  Score=308.73  Aligned_cols=248  Identities=28%  Similarity=0.535  Sum_probs=209.5

Q ss_pred             ccceeceeceeCceEEEEEEE--CCeeEEEEEecCCCC----CHHHHHHHHHHHHHHHhcCCCceeeEEeEEecCCcEEE
Q 015868          117 QLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECV----NTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCI  190 (399)
Q Consensus       117 ~~~i~~~lg~G~~g~Vy~~~~--~~~~vAvK~~~~~~~----~~~~~~~~~~Ei~~l~~l~h~nIv~~~~~~~~~~~~~l  190 (399)
                      +|+..+.||+|++|.||++..  +++.||+|+++....    .....+.+.+|+.+++.++|+||+++++++..++.+++
T Consensus         1 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~   80 (268)
T cd06630           1 EWLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATCEDSHFNL   80 (268)
T ss_pred             CccccceecCcCceEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhceeccCCeEEE
Confidence            477889999999999999976  678999999875432    12345789999999999999999999999999999999


Q ss_pred             EEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceeecCCC-cEEEeeccceeeccCCCc
Q 015868          191 VTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENG-VVKVADFGVARVQAQSGV  269 (399)
Q Consensus       191 V~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~giiHrDlkp~NILl~~~~-~vkl~DFG~a~~~~~~~~  269 (399)
                      |+||+.|++|.+++.. .+.+++..++.++.|++.||.|||++|++|+||+|+||+++.++ .++|+|||.+........
T Consensus        81 v~e~~~~~~L~~~l~~-~~~~~~~~~~~~~~ql~~al~~LH~~~i~H~~i~~~nil~~~~~~~~~l~dfg~~~~~~~~~~  159 (268)
T cd06630          81 FVEWMAGGSVSHLLSK-YGAFKEAVIINYTEQLLRGLSYLHENQIIHRDVKGANLLIDSTGQRLRIADFGAAARLAAKGT  159 (268)
T ss_pred             EEeccCCCcHHHHHHH-hCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEEcccccccccccccc
Confidence            9999999999999976 45789999999999999999999999999999999999998776 699999999876543211


Q ss_pred             -----cccCCCCcccccccccCCCCCCChhhHHHHHHHHHHHHcCCCCCCCCCH---HHHHHHHHhccCCCCCCCCCcHH
Q 015868          270 -----MTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPYAGLTP---LQAAVGVVQKSLRPTIPKHAHPR  341 (399)
Q Consensus       270 -----~~~~~gt~~y~aPE~l~~~~~~~~~Dv~slG~vl~elltg~~P~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~  341 (399)
                           .....++..|+|||.+.+..++.++|+||+|+++|+|++|..||.....   .............+.++...+++
T Consensus       160 ~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (268)
T cd06630         160 GAGEFQGQLLGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSNHLALIFKIASATTAPSIPEHLSPG  239 (268)
T ss_pred             cCCccccccccccceeCHhHhccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcchHHHHHHHhccCCCCCCchhhCHH
Confidence                 1234578899999999988899999999999999999999999975432   22222222334456777788999


Q ss_pred             HHHHHHHHhhhcCCCCCCHHHHHH
Q 015868          342 LAELLERCWQHDPTQRPNFSQITD  365 (399)
Q Consensus       342 l~~ll~~cl~~dP~~Rps~~ell~  365 (399)
                      +.+++.+||+.+|.+||++.++++
T Consensus       240 ~~~~i~~~l~~~p~~R~~~~~ll~  263 (268)
T cd06630         240 LRDVTLRCLELQPEDRPPSRELLK  263 (268)
T ss_pred             HHHHHHHHcCCCcccCcCHHHHhc
Confidence            999999999999999999999975

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their

>cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase

Probab=100.00  E-value=1.1e-39  Score=302.18  Aligned_cols=248  Identities=31%  Similarity=0.548  Sum_probs=218.4

Q ss_pred             ccceeceeceeCceEEEEEEEC--CeeEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCceeeEEeEEecC--CcEEEEE
Q 015868          117 QLKIECKVASGSYGDLYKGTYC--SQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRP--PNLCIVT  192 (399)
Q Consensus       117 ~~~i~~~lg~G~~g~Vy~~~~~--~~~vAvK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~nIv~~~~~~~~~--~~~~lV~  192 (399)
                      +|++.+.||+|++|.||+|...  ++.|++|+++.........+.+.+|+.++++++||||+++++.+...  ..+++|+
T Consensus         1 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~   80 (260)
T cd06606           1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYYGSERDEEKNTLNIFL   80 (260)
T ss_pred             CceeeeEeeecCceEEEEEEECCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHcCCCCEeeEEEEEecCCCCeEEEEE
Confidence            4778899999999999999885  88999999987655556678899999999999999999999999888  8899999


Q ss_pred             ecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceeecCCCcEEEeeccceeeccCCCc---
Q 015868          193 EFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGV---  269 (399)
Q Consensus       193 E~~~ggsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~giiHrDlkp~NILl~~~~~vkl~DFG~a~~~~~~~~---  269 (399)
                      ||+++++|.+++.... .+++..++.++.+++.||.|||+.|++|+||+|+||+++.++.++|+|||.+........   
T Consensus        81 e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~l~~~l~~lh~~~~~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~~~  159 (260)
T cd06606          81 EYVSGGSLSSLLKKFG-KLPEPVIRKYTRQILEGLAYLHSNGIVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETGEG  159 (260)
T ss_pred             EecCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEcCCCCEEEcccccEEeccccccccc
Confidence            9999999999997754 889999999999999999999999999999999999999999999999999987666543   


Q ss_pred             cccCCCCcccccccccCCCCCCChhhHHHHHHHHHHHHcCCCCCCCCC-HHHHHHHHHhccCCCCCCCCCcHHHHHHHHH
Q 015868          270 MTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPYAGLT-PLQAAVGVVQKSLRPTIPKHAHPRLAELLER  348 (399)
Q Consensus       270 ~~~~~gt~~y~aPE~l~~~~~~~~~Dv~slG~vl~elltg~~P~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~  348 (399)
                      .....++..|+|||.+.+..++.++|+||||+++++|++|..||.... ..............+.++...++.+.+++.+
T Consensus       160 ~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~i~~  239 (260)
T cd06606         160 TGSVRGTPYWMAPEVIRGEEYGRAADIWSLGCTVIEMATGKPPWSELGNPMAALYKIGSSGEPPEIPEHLSEEAKDFLRK  239 (260)
T ss_pred             ccCCCCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHhccccCCCcCCCcccCHHHHHHHHH
Confidence            345678899999999998889999999999999999999999998776 3333333333345567788889999999999


Q ss_pred             HhhhcCCCCCCHHHHHH
Q 015868          349 CWQHDPTQRPNFSQITD  365 (399)
Q Consensus       349 cl~~dP~~Rps~~ell~  365 (399)
                      ||+.+|.+||++.++++
T Consensus       240 ~l~~~p~~Rp~~~~ll~  256 (260)
T cd06606         240 CLRRDPKKRPTADELLQ  256 (260)
T ss_pred             hCcCChhhCCCHHHHhh
Confidence            99999999999999975

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK

>PHA03209 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=1.7e-40  Score=325.27  Aligned_cols=243  Identities=22%  Similarity=0.384  Sum_probs=196.3

Q ss_pred             cccccceeceeceeCceEEEEEEEC--CeeEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCceeeEEeEEecCCcEEEE
Q 015868          114 DAKQLKIECKVASGSYGDLYKGTYC--SQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIV  191 (399)
Q Consensus       114 ~~~~~~i~~~lg~G~~g~Vy~~~~~--~~~vAvK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~nIv~~~~~~~~~~~~~lV  191 (399)
                      ...+|++.+.||+|+||.||+|+..  ++.||+|+....        ....|+.++++++||||+++++++......++|
T Consensus        64 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~~--------~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv  135 (357)
T PHA03209         64 ASLGYTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQKG--------TTLIEAMLLQNVNHPSVIRMKDTLVSGAITCMV  135 (357)
T ss_pred             hhcCcEEEEEecCCCCeEEEEEEECCCCceEEEEeCCcc--------ccHHHHHHHHhCCCCCCcChhheEEeCCeeEEE
Confidence            3457999999999999999999884  568999986533        234689999999999999999999999999999


Q ss_pred             EecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceeecCCCcEEEeeccceeeccCCCccc
Q 015868          192 TEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMT  271 (399)
Q Consensus       192 ~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~giiHrDlkp~NILl~~~~~vkl~DFG~a~~~~~~~~~~  271 (399)
                      ||++. ++|.+++......+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||.++.........
T Consensus       136 ~e~~~-~~l~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~  214 (357)
T PHA03209        136 LPHYS-SDLYTYLTKRSRPLPIDQALIIEKQILEGLRYLHAQRIIHRDVKTENIFINDVDQVCIGDLGAAQFPVVAPAFL  214 (357)
T ss_pred             EEccC-CcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEEecCccccccccCcccc
Confidence            99996 49999998777789999999999999999999999999999999999999999999999999997544433344


Q ss_pred             cCCCCcccccccccCCCCCCChhhHHHHHHHHHHHHcCC-CCCCCCCHH--H-------HHHHHHhc-cC-CCCCC----
Q 015868          272 AETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTGE-LPYAGLTPL--Q-------AAVGVVQK-SL-RPTIP----  335 (399)
Q Consensus       272 ~~~gt~~y~aPE~l~~~~~~~~~Dv~slG~vl~elltg~-~P~~~~~~~--~-------~~~~~~~~-~~-~~~~~----  335 (399)
                      ...||+.|+|||++.+..++.++|||||||++|||+++. .+|......  .       ........ .. ...++    
T Consensus       215 ~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvvl~ell~~~~~~f~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~  294 (357)
T PHA03209        215 GLAGTVETNAPEVLARDKYNSKADIWSAGIVLFEMLAYPSTIFEDPPSTPEEYVKSCHSHLLKIISTLKVHPEEFPRDPG  294 (357)
T ss_pred             cccccccccCCeecCCCCCCchhhHHHHHHHHHHHHHcCCccccCCCCcHHHHHHHHHHHHHHHHHHhccChhhcCCCCc
Confidence            567899999999999999999999999999999999854 444432111  0       00000100 00 00011    


Q ss_pred             --------------------------CCCcHHHHHHHHHHhhhcCCCCCCHHHHHH
Q 015868          336 --------------------------KHAHPRLAELLERCWQHDPTQRPNFSQITD  365 (399)
Q Consensus       336 --------------------------~~~~~~l~~ll~~cl~~dP~~Rps~~ell~  365 (399)
                                                ..++.++.+||.+||+.||.+|||+.|+++
T Consensus       295 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rpta~e~l~  350 (357)
T PHA03209        295 SRLVRGFIEYASLERQPYTRYPCFQRVNLPIDGEFLVHKMLTFDAAMRPSAEEILN  350 (357)
T ss_pred             cHHHHHHHhhcccCCCcccccHHHhccCCCchHHHHHHHHHcCCcccCcCHHHHhc
Confidence                                      135667888999999999999999999875

>cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros

Probab=100.00  E-value=2.8e-40  Score=309.79  Aligned_cols=245  Identities=35%  Similarity=0.664  Sum_probs=207.0

Q ss_pred             ceeceeCceEEEEEEECC--------eeEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCceeeEEeEEecCCcEEEEEe
Q 015868          122 CKVASGSYGDLYKGTYCS--------QEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVTE  193 (399)
Q Consensus       122 ~~lg~G~~g~Vy~~~~~~--------~~vAvK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~nIv~~~~~~~~~~~~~lV~E  193 (399)
                      +.||.|+||.||+|+...        +.+|+|.+.... .......+.+|+.+++.++||||+++++++......++|||
T Consensus         1 ~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e   79 (269)
T cd05044           1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGA-TDQEKKEFLKEAHLMSNFNHPNIVKLLGVCLLNEPQYIIME   79 (269)
T ss_pred             CccccccceeEEeeeecccccCcccceeehhhhhhccc-chhhHHHHHHHHHHHHhcCCCCeeeEeeeecCCCCeEEEEe
Confidence            368999999999998642        579999886542 23445678899999999999999999999999999999999


Q ss_pred             cCCCCCHHHHHHhc------CCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceeecCCC-----cEEEeecccee
Q 015868          194 FMARGSIYDFLHKQ------KGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENG-----VVKVADFGVAR  262 (399)
Q Consensus       194 ~~~ggsL~~~l~~~------~~~l~~~~~~~i~~~i~~~L~~LH~~giiHrDlkp~NILl~~~~-----~vkl~DFG~a~  262 (399)
                      |+++++|.+++...      ...+++..+..++.|++.||.|||+++++|+||+|+||+++.++     .++++|||+++
T Consensus        80 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~~~~~~l~dfg~~~  159 (269)
T cd05044          80 LMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQMHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLAR  159 (269)
T ss_pred             ccCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHhCCcccCCCChheEEEecCCCCCCcceEECCccccc
Confidence            99999999999752      23478899999999999999999999999999999999999887     89999999987


Q ss_pred             eccCCCc---cccCCCCcccccccccCCCCCCChhhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHHhccCCCCCCCCC
Q 015868          263 VQAQSGV---MTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLT-GELPYAGLTPLQAAVGVVQKSLRPTIPKHA  338 (399)
Q Consensus       263 ~~~~~~~---~~~~~gt~~y~aPE~l~~~~~~~~~Dv~slG~vl~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~  338 (399)
                      .......   .....++..|+|||.+.+..++.++||||||+++|+|++ |..||...+..+.... +....++..+..+
T Consensus       160 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt~g~~p~~~~~~~~~~~~-~~~~~~~~~~~~~  238 (269)
T cd05044         160 DIYKSDYYRKEGEGLLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPALNNQEVLQH-VTAGGRLQKPENC  238 (269)
T ss_pred             ccccccccccCcccCCCccccCHHHHccCCcccchhHHHHHHHHHHHHHcCCCCCcccCHHHHHHH-HhcCCccCCcccc
Confidence            5432211   122345678999999999899999999999999999998 9999988777665443 3334455667788


Q ss_pred             cHHHHHHHHHHhhhcCCCCCCHHHHHHHHH
Q 015868          339 HPRLAELLERCWQHDPTQRPNFSQITDILK  368 (399)
Q Consensus       339 ~~~l~~ll~~cl~~dP~~Rps~~ell~~L~  368 (399)
                      +..+.+++.+||..+|.+||++.++.+.|+
T Consensus       239 ~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~  268 (269)
T cd05044         239 PDKIYQLMTNCWAQDPSERPTFDRIQEILQ  268 (269)
T ss_pred             hHHHHHHHHHHcCCCcccCCCHHHHHHHHh
Confidence            999999999999999999999999999876

Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male

>cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin

Probab=100.00  E-value=5.1e-40  Score=310.94  Aligned_cols=251  Identities=29%  Similarity=0.481  Sum_probs=205.6

Q ss_pred             ecccccceeceeceeCceEEEEEEE--CCeeEEEEEecCCCCCHHHHHHHHHHHHHHHhc-CCCceeeEEeEEe-----c
Q 015868          113 IDAKQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKI-RHKNVVQFIGACT-----R  184 (399)
Q Consensus       113 i~~~~~~i~~~lg~G~~g~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~Ei~~l~~l-~h~nIv~~~~~~~-----~  184 (399)
                      ...++|++.+.||+|+||.||++..  .++.+|+|+++...   .....+.+|+.+++.+ +||||+++++++.     .
T Consensus        15 ~~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~---~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~   91 (286)
T cd06638          15 DPSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIH---DIDEEIEAEYNILKALSDHPNVVKFYGMYYKKDVKN   91 (286)
T ss_pred             CcccceeeeeeeccCCCcEEEEEEECCCCceeEEEeecccc---chHHHHHHHHHHHHHHhcCCCeeeeeeeeeecccCC
Confidence            3467899999999999999999977  57889999987532   2235678899999999 6999999999874     3


Q ss_pred             CCcEEEEEecCCCCCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceeecCCCcEEEeeccce
Q 015868          185 PPNLCIVTEFMARGSIYDFLHK---QKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVA  261 (399)
Q Consensus       185 ~~~~~lV~E~~~ggsL~~~l~~---~~~~l~~~~~~~i~~~i~~~L~~LH~~giiHrDlkp~NILl~~~~~vkl~DFG~a  261 (399)
                      ++..++||||++|++|.+++..   ....+++..++.++.|++.||.|||+++++||||||+||++++++.++|+|||.+
T Consensus        92 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nili~~~~~~kl~dfg~~  171 (286)
T cd06638          92 GDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHVNKTIHRDVKGNNILLTTEGGVKLVDFGVS  171 (286)
T ss_pred             CCeEEEEEeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHHhCCccccCCCHHhEEECCCCCEEEccCCce
Confidence            4568999999999999998863   2356889999999999999999999999999999999999999999999999998


Q ss_pred             eeccCCC-ccccCCCCcccccccccCC-----CCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcc-CCCCC
Q 015868          262 RVQAQSG-VMTAETGTYRWMAPEVIEH-----KPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKS-LRPTI  334 (399)
Q Consensus       262 ~~~~~~~-~~~~~~gt~~y~aPE~l~~-----~~~~~~~Dv~slG~vl~elltg~~P~~~~~~~~~~~~~~~~~-~~~~~  334 (399)
                      +...... ......|++.|+|||.+..     ..++.++||||||+++|+|++|+.||....+........... .....
T Consensus       172 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~  251 (286)
T cd06638         172 AQLTSTRLRRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHPMRALFKIPRNPPPTLHQ  251 (286)
T ss_pred             eecccCCCccccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHhcCCCCCCCCchhHHHhhccccCCCcccC
Confidence            7654322 2233468999999999853     457889999999999999999999998877655443322211 11123


Q ss_pred             CCCCcHHHHHHHHHHhhhcCCCCCCHHHHHHH
Q 015868          335 PKHAHPRLAELLERCWQHDPTQRPNFSQITDI  366 (399)
Q Consensus       335 ~~~~~~~l~~ll~~cl~~dP~~Rps~~ell~~  366 (399)
                      +..++.++.+++.+||+.+|++|||+.++++.
T Consensus       252 ~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~  283 (286)
T cd06638         252 PELWSNEFNDFIRKCLTKDYEKRPTVSDLLQH  283 (286)
T ss_pred             CCCcCHHHHHHHHHHccCCcccCCCHHHHhhc
Confidence            45578899999999999999999999999864

Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear

>cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1

Probab=100.00  E-value=3.6e-40  Score=313.40  Aligned_cols=250  Identities=26%  Similarity=0.393  Sum_probs=208.5

Q ss_pred             ccccceeceeceeCceEEEEEEE--CCeeEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCceeeEEeEEecC--CcEEE
Q 015868          115 AKQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRP--PNLCI  190 (399)
Q Consensus       115 ~~~~~i~~~lg~G~~g~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~nIv~~~~~~~~~--~~~~l  190 (399)
                      .++|++.+.||.|+||.||+|++  +++.+|+|.++...........+.+|+.++++++||||+++++++...  ...|+
T Consensus         4 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~l   83 (293)
T cd07843           4 VDEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREINILLKLQHPNIVTVKEVVVGSNLDKIYM   83 (293)
T ss_pred             hhhhhhhhhhcCCCCeEEEEEEECCCCcEEEEEEEeeccccccchhhHHHHHHHHHhcCCCCEEEEEEEEEecCCCcEEE
Confidence            35799999999999999999998  478899999986544444445678899999999999999999998877  78999


Q ss_pred             EEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceeecCCCcEEEeeccceeeccCC-Cc
Q 015868          191 VTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQS-GV  269 (399)
Q Consensus       191 V~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~giiHrDlkp~NILl~~~~~vkl~DFG~a~~~~~~-~~  269 (399)
                      ||||+.+ +|.+++......+++..++.++.|++.||+|||++|++|+||||+||+++.++.++|+|||.+...... ..
T Consensus        84 v~e~~~~-~L~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~i~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~  162 (293)
T cd07843          84 VMEYVEH-DLKSLMETMKQPFLQSEVKCLMLQLLSGVAHLHDNWILHRDLKTSNLLLNNRGILKICDFGLAREYGSPLKP  162 (293)
T ss_pred             EehhcCc-CHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCHHHEEECCCCcEEEeecCceeeccCCccc
Confidence            9999975 999999876667999999999999999999999999999999999999999999999999999865543 22


Q ss_pred             cccCCCCcccccccccCCC-CCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcc-------------------
Q 015868          270 MTAETGTYRWMAPEVIEHK-PYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKS-------------------  329 (399)
Q Consensus       270 ~~~~~gt~~y~aPE~l~~~-~~~~~~Dv~slG~vl~elltg~~P~~~~~~~~~~~~~~~~~-------------------  329 (399)
                      .....+++.|+|||.+.+. .++.++|+||||+++|+|++|..||...+..+.........                   
T Consensus       163 ~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  242 (293)
T cd07843         163 YTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEIDQLNKIFKLLGTPTEKIWPGFSELPGAKK  242 (293)
T ss_pred             cccccccccccCchhhcCCccccchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchHHHHHhhccchhcc
Confidence            3345678899999998754 46899999999999999999999998876655443322110                   


Q ss_pred             ----------CCCCCCCC-CcHHHHHHHHHHhhhcCCCCCCHHHHHH
Q 015868          330 ----------LRPTIPKH-AHPRLAELLERCWQHDPTQRPNFSQITD  365 (399)
Q Consensus       330 ----------~~~~~~~~-~~~~l~~ll~~cl~~dP~~Rps~~ell~  365 (399)
                                ....++.. +++.+.++|.+||+.+|++|||+.|+++
T Consensus       243 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~ell~  289 (293)
T cd07843         243 KTFTKYPYNQLRKKFPALSLSDNGFDLLNRLLTYDPAKRISAEDALK  289 (293)
T ss_pred             cccccccchhhhccccccCCChHHHHHHHHHhccCccccCCHHHHhc
Confidence                      01122232 5888999999999999999999999975

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the

>PHA03207 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=8.4e-40  Score=324.29  Aligned_cols=246  Identities=24%  Similarity=0.416  Sum_probs=200.6

Q ss_pred             eecccccceeceeceeCceEEEEEEEC----CeeEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCceeeEEeEEecCCc
Q 015868          112 EIDAKQLKIECKVASGSYGDLYKGTYC----SQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPN  187 (399)
Q Consensus       112 ~i~~~~~~i~~~lg~G~~g~Vy~~~~~----~~~vAvK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~nIv~~~~~~~~~~~  187 (399)
                      .+...+|++.++||.|+||.||++...    +..||+|.+...       ....+|+.++++++||||+++++++.....
T Consensus        88 ~~~~~~y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~-------~~~~~E~~il~~l~h~~iv~~~~~~~~~~~  160 (392)
T PHA03207         88 SVVRMQYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGG-------KTPGREIDILKTISHRAIINLIHAYRWKST  160 (392)
T ss_pred             hhccCceEEEEeecCCCCeEEEEEEEcCCccceeEEEEecccc-------ccHHHHHHHHHhcCCCCccceeeeEeeCCE
Confidence            344568999999999999999999753    467999988643       234579999999999999999999999999


Q ss_pred             EEEEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceeecCCCcEEEeeccceeeccCC
Q 015868          188 LCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQS  267 (399)
Q Consensus       188 ~~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~giiHrDlkp~NILl~~~~~vkl~DFG~a~~~~~~  267 (399)
                      .|+|||++. ++|.+++. ....+++..++.++.||+.||.|||++||+||||||+|||++.++.++|+|||+++.....
T Consensus       161 ~~lv~e~~~-~~l~~~l~-~~~~l~~~~~~~i~~ql~~aL~~LH~~givHrDlkp~Nill~~~~~~~l~DfG~a~~~~~~  238 (392)
T PHA03207        161 VCMVMPKYK-CDLFTYVD-RSGPLPLEQAITIQRRLLEALAYLHGRGIIHRDVKTENIFLDEPENAVLGDFGAACKLDAH  238 (392)
T ss_pred             EEEEehhcC-CCHHHHHH-hcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEcCCCCEEEccCccccccCcc
Confidence            999999996 58999884 3577999999999999999999999999999999999999999999999999999754432


Q ss_pred             Cc---cccCCCCcccccccccCCCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHH---HHHHHHHh--------------
Q 015868          268 GV---MTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPYAGLTPL---QAAVGVVQ--------------  327 (399)
Q Consensus       268 ~~---~~~~~gt~~y~aPE~l~~~~~~~~~Dv~slG~vl~elltg~~P~~~~~~~---~~~~~~~~--------------  327 (399)
                      ..   .....||+.|+|||++.+..|+.++|||||||++|+|++|+.||.+....   .....+..              
T Consensus       239 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~l~~i~~~~~~~~~~~~~~~~  318 (392)
T PHA03207        239 PDTPQCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTLFGKQVKSSSSQLRSIIRCMQVHPLEFPQNGS  318 (392)
T ss_pred             cccccccccccccCccCHhHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCCCCcHHHHHHHHHHhccCccccCCccc
Confidence            21   22456899999999999999999999999999999999999999664321   11111110              


Q ss_pred             -----------ccCCCCC--C-----CCCcHHHHHHHHHHhhhcCCCCCCHHHHHHH
Q 015868          328 -----------KSLRPTI--P-----KHAHPRLAELLERCWQHDPTQRPNFSQITDI  366 (399)
Q Consensus       328 -----------~~~~~~~--~-----~~~~~~l~~ll~~cl~~dP~~Rps~~ell~~  366 (399)
                                 ...++..  +     ...+.++.++|.+||+.||++|||+.+++..
T Consensus       319 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~Rpsa~e~l~~  375 (392)
T PHA03207        319 TNLCKHFKQYAIVLRPPYTIPPVIRKYGMHMDVEYLIAKMLTFDQEFRPSAQDILSL  375 (392)
T ss_pred             hhHHHHHHhhcccccCCccccchhhccCcchhHHHHHHHHhccChhhCCCHHHHhhC
Confidence                       0011111  1     2356789999999999999999999999763

>cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins

Probab=100.00  E-value=1.1e-39  Score=312.63  Aligned_cols=245  Identities=30%  Similarity=0.486  Sum_probs=209.1

Q ss_pred             cccceeceeceeCceEEEEEEE--CCeeEEEEEecCCC-CCHHHHHHHHHHHHHHHhcCCCceeeEEeEEecCCcEEEEE
Q 015868          116 KQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPEC-VNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVT  192 (399)
Q Consensus       116 ~~~~i~~~lg~G~~g~Vy~~~~--~~~~vAvK~~~~~~-~~~~~~~~~~~Ei~~l~~l~h~nIv~~~~~~~~~~~~~lV~  192 (399)
                      +.|++.+.||+|+||.||+|..  .++.||+|++.... ...+....+.+|+.+++.++||||+++++++......++||
T Consensus        15 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~lv~   94 (307)
T cd06607          15 KLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLREHTAWLVM   94 (307)
T ss_pred             hhhhhheeecCCCCeEEEEEEEcCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhCCCCCEEEEEEEEEeCCeEEEEH
Confidence            5689999999999999999986  57899999986432 34455578899999999999999999999999999999999


Q ss_pred             ecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceeecCCCcEEEeeccceeeccCCCcccc
Q 015868          193 EFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTA  272 (399)
Q Consensus       193 E~~~ggsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~giiHrDlkp~NILl~~~~~vkl~DFG~a~~~~~~~~~~~  272 (399)
                      ||+.| ++.+++......+++..+..++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||++......   ..
T Consensus        95 e~~~g-~l~~~~~~~~~~l~~~~~~~~~~ql~~~L~~LH~~~i~H~dl~p~nIl~~~~~~~kL~dfg~~~~~~~~---~~  170 (307)
T cd06607          95 EYCLG-SASDILEVHKKPLQEVEIAAICHGALQGLAYLHSHERIHRDIKAGNILLTEPGTVKLADFGSASLVSPA---NS  170 (307)
T ss_pred             HhhCC-CHHHHHHHcccCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcccEEECCCCCEEEeecCcceecCCC---CC
Confidence            99975 888888766677999999999999999999999999999999999999999999999999998754332   33


Q ss_pred             CCCCcccccccccC---CCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhccCCCCC-CCCCcHHHHHHHHH
Q 015868          273 ETGTYRWMAPEVIE---HKPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKSLRPTI-PKHAHPRLAELLER  348 (399)
Q Consensus       273 ~~gt~~y~aPE~l~---~~~~~~~~Dv~slG~vl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~l~~ll~~  348 (399)
                      ..+++.|+|||++.   ...++.++||||||+++|+|++|+.||...+........... ..+.. +..++.++.+++.+
T Consensus       171 ~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~li~~  249 (307)
T cd06607         171 FVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQN-DSPTLSSNDWSDYFRNFVDS  249 (307)
T ss_pred             ccCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCCCccHHHHHHHHhcC-CCCCCCchhhCHHHHHHHHH
Confidence            46788999999984   456889999999999999999999999887776654443332 22333 34578899999999


Q ss_pred             HhhhcCCCCCCHHHHHH
Q 015868          349 CWQHDPTQRPNFSQITD  365 (399)
Q Consensus       349 cl~~dP~~Rps~~ell~  365 (399)
                      ||+.+|++||++.+++.
T Consensus       250 ~l~~~p~~Rp~~~~il~  266 (307)
T cd06607         250 CLQKIPQDRPSSEELLK  266 (307)
T ss_pred             HhcCChhhCcCHHHHhc
Confidence            99999999999999976

Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily

>cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1

Probab=100.00  E-value=2.7e-40  Score=311.75  Aligned_cols=246  Identities=33%  Similarity=0.597  Sum_probs=212.7

Q ss_pred             cccceeceeceeCceEEEEEEE--CCeeEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCceeeEEeEEecCCcEEEEEe
Q 015868          116 KQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVTE  193 (399)
Q Consensus       116 ~~~~i~~~lg~G~~g~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~nIv~~~~~~~~~~~~~lV~E  193 (399)
                      +.|+..+.||.|+||.||+|..  .+..||+|+++... .......+.+|+.++++++||||+++++.+..+...++|||
T Consensus         4 ~~y~~~~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   82 (277)
T cd06642           4 ELFTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEE-AEDEIEDIQQEITVLSQCDSPYITRYYGSYLKGTKLWIIME   82 (277)
T ss_pred             HHHHHHHHhcCCCCeeEEEEEEcCCCeEEEEEEecccc-chHHHHHHHHHHHHHHcCCCCccHhhhcccccCCceEEEEE
Confidence            4677889999999999999976  56789999987543 23455789999999999999999999999999999999999


Q ss_pred             cCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceeecCCCcEEEeeccceeeccCCCc-ccc
Q 015868          194 FMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGV-MTA  272 (399)
Q Consensus       194 ~~~ggsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~giiHrDlkp~NILl~~~~~vkl~DFG~a~~~~~~~~-~~~  272 (399)
                      |+++++|.+++..  +.+++..+..++.|++.|+.|||++|++|+||+|+||++++++.++|+|||++........ ...
T Consensus        83 ~~~~~~L~~~~~~--~~~~~~~~~~~~~~i~~~l~~lH~~~ivH~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~~~~~  160 (277)
T cd06642          83 YLGGGSALDLLKP--GPLEETYIATILREILKGLDYLHSERKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNT  160 (277)
T ss_pred             ccCCCcHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHhcCCeeccCCChheEEEeCCCCEEEccccccccccCcchhhhc
Confidence            9999999999854  5689999999999999999999999999999999999999999999999999876543321 223


Q ss_pred             CCCCcccccccccCCCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhccCCCCCCCCCcHHHHHHHHHHhhh
Q 015868          273 ETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRLAELLERCWQH  352 (399)
Q Consensus       273 ~~gt~~y~aPE~l~~~~~~~~~Dv~slG~vl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~cl~~  352 (399)
                      ..++..|+|||.+.+..++.++|+||||+++|+|++|..||....+...... ......+.++..++.++.+++.+||+.
T Consensus       161 ~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~li~~~l~~  239 (277)
T cd06642         161 FVGTPFWMAPEVIKQSAYDFKADIWSLGITAIELAKGEPPNSDLHPMRVLFL-IPKNSPPTLEGQYSKPFKEFVEACLNK  239 (277)
T ss_pred             ccCcccccCHHHhCcCCCchhhhHHHHHHHHHHHHhCCCCCcccchhhHHhh-hhcCCCCCCCcccCHHHHHHHHHHccC
Confidence            4578899999999998999999999999999999999999987766554433 333445666677889999999999999


Q ss_pred             cCCCCCCHHHHHH
Q 015868          353 DPTQRPNFSQITD  365 (399)
Q Consensus       353 dP~~Rps~~ell~  365 (399)
                      +|++||++.++++
T Consensus       240 ~p~~Rp~~~~il~  252 (277)
T cd06642         240 DPRFRPTAKELLK  252 (277)
T ss_pred             CcccCcCHHHHHH
Confidence            9999999999987

Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25

>cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2

Probab=100.00  E-value=1.6e-39  Score=305.36  Aligned_cols=245  Identities=24%  Similarity=0.497  Sum_probs=198.9

Q ss_pred             ceeceeCceEEEEEEE-CC---eeEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCceeeEEeEEecCCcEEEEEecCCC
Q 015868          122 CKVASGSYGDLYKGTY-CS---QEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVTEFMAR  197 (399)
Q Consensus       122 ~~lg~G~~g~Vy~~~~-~~---~~vAvK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~nIv~~~~~~~~~~~~~lV~E~~~g  197 (399)
                      ++||+|+||.||+|.. .+   ..+++|.++... .....+.+.+|+.+++.++||||+++++.+......|+||||+++
T Consensus         1 ~~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~~-~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~   79 (268)
T cd05086           1 QEIGNGWFGKVLLSEIYTDTGVARVVVKELKANA-SSKEQNEFLQQGDPYRILQHPNILQCLGQCVEAIPYLLVFEYCEL   79 (268)
T ss_pred             CcCCCCcCceEEEEEEEcCCCcceEEEEEecCCC-ChHHHHHHHHHHHHHhccCCcchhheEEEecCCCccEEEEecCCC
Confidence            3689999999999975 22   245667665432 234467899999999999999999999999999999999999999


Q ss_pred             CCHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceeecCCCcEEEeeccceeeccCCC---ccc
Q 015868          198 GSIYDFLHKQK---GVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSG---VMT  271 (399)
Q Consensus       198 gsL~~~l~~~~---~~l~~~~~~~i~~~i~~~L~~LH~~giiHrDlkp~NILl~~~~~vkl~DFG~a~~~~~~~---~~~  271 (399)
                      |+|.+++....   ...+...+..++.||+.||+|||+++++||||||+|||++.++.++|+|||++.......   ...
T Consensus        80 ~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dikp~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~~  159 (268)
T cd05086          80 GDLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHKHNFLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIETED  159 (268)
T ss_pred             CcHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCCeeccCCccceEEEcCCccEEecccccccccCcchhhhccc
Confidence            99999997642   346677888999999999999999999999999999999999999999999986432211   123


Q ss_pred             cCCCCcccccccccCC-------CCCCChhhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHHhcc----CCCCCCCCCc
Q 015868          272 AETGTYRWMAPEVIEH-------KPYDYKADVFSFGIALWELLT-GELPYAGLTPLQAAVGVVQKS----LRPTIPKHAH  339 (399)
Q Consensus       272 ~~~gt~~y~aPE~l~~-------~~~~~~~Dv~slG~vl~ellt-g~~P~~~~~~~~~~~~~~~~~----~~~~~~~~~~  339 (399)
                      ...++..|+|||++..       ..++.++||||||+++|||++ |..||...++.+.........    .+|.++..++
T Consensus       160 ~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (268)
T cd05086         160 DKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSDREVLNHVIKDQQVKLFKPQLELPYS  239 (268)
T ss_pred             CCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhhcccccCCCccCCCCc
Confidence            3467889999999853       245789999999999999997 678998877766555544332    3455666789


Q ss_pred             HHHHHHHHHHhhhcCCCCCCHHHHHHHHH
Q 015868          340 PRLAELLERCWQHDPTQRPNFSQITDILK  368 (399)
Q Consensus       340 ~~l~~ll~~cl~~dP~~Rps~~ell~~L~  368 (399)
                      +.+.+++..|| .+|++||++.++++.|.
T Consensus       240 ~~~~~l~~~c~-~~P~~Rp~~~~i~~~l~  267 (268)
T cd05086         240 ERWYEVLQFCW-LSPEKRATAEEVHRLLT  267 (268)
T ss_pred             HHHHHHHHHHh-hCcccCCCHHHHHHHhc
Confidence            99999999999 67999999999988763

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage

>KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=1.2e-40  Score=322.18  Aligned_cols=253  Identities=23%  Similarity=0.397  Sum_probs=212.6

Q ss_pred             CceeecccccceeceeceeCceEEEEEEEC-CeeEEEEEecCCCCCHHHHHHHHHHHHHHHhcC-CCceeeEEeEEecCC
Q 015868          109 DVWEIDAKQLKIECKVASGSYGDLYKGTYC-SQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIR-HKNVVQFIGACTRPP  186 (399)
Q Consensus       109 ~~~~i~~~~~~i~~~lg~G~~g~Vy~~~~~-~~~vAvK~~~~~~~~~~~~~~~~~Ei~~l~~l~-h~nIv~~~~~~~~~~  186 (399)
                      ....|....|++.++||+|+.+.||++... .+.||+|.+.-...+......|.+|+..|.+++ |.+|+++|+|-..++
T Consensus       354 ~~i~Vkg~~Yeilk~iG~GGSSkV~kV~~s~~~iyalkkv~~~~~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv~d~  433 (677)
T KOG0596|consen  354 EIIKVKGREYEILKQIGSGGSSKVFKVLNSDKQIYALKKVVLLEADNQTLDGYRNEIALLNKLKGHDKIIQLYDYEVTDG  433 (677)
T ss_pred             eeEEECcchhhHHHhhcCCCcceeeeeecCCCcchhhhHHHHhhcCHHHHHHHHHHHHHHHHhcCCceEEEEeeeeccCc
Confidence            567789999999999999999999999874 467888877766667888899999999999995 899999999999999


Q ss_pred             cEEEEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceeecCCCcEEEeeccceeeccC
Q 015868          187 NLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQ  266 (399)
Q Consensus       187 ~~~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~giiHrDlkp~NILl~~~~~vkl~DFG~a~~~~~  266 (399)
                      .+|||||+-+ -+|..+|++.....+...+..+..||+.++.++|+.||||.||||.|+|+- .|.+||+|||.|.....
T Consensus       434 ~lYmvmE~Gd-~DL~kiL~k~~~~~~~~~lk~ywkqML~aV~~IH~~gIVHSDLKPANFLlV-kG~LKLIDFGIA~aI~~  511 (677)
T KOG0596|consen  434 YLYMVMECGD-IDLNKILKKKKSIDPDWFLKFYWKQMLLAVKTIHQHGIVHSDLKPANFLLV-KGRLKLIDFGIANAIQP  511 (677)
T ss_pred             eEEEEeeccc-ccHHHHHHhccCCCchHHHHHHHHHHHHHHHHHHHhceeecCCCcccEEEE-eeeEEeeeechhcccCc
Confidence            9999999754 499999988777677678999999999999999999999999999999994 68999999999986654


Q ss_pred             CC---ccccCCCCcccccccccCCC-----------CCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcc---
Q 015868          267 SG---VMTAETGTYRWMAPEVIEHK-----------PYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKS---  329 (399)
Q Consensus       267 ~~---~~~~~~gt~~y~aPE~l~~~-----------~~~~~~Dv~slG~vl~elltg~~P~~~~~~~~~~~~~~~~~---  329 (399)
                      ..   .....+||+.||+||.+..-           ..+.++|||||||+||+|+.|+.||............+...   
T Consensus       512 DTTsI~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~~~~n~~aKl~aI~~P~~~  591 (677)
T KOG0596|consen  512 DTTSIVKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFGQIINQIAKLHAITDPNHE  591 (677)
T ss_pred             cccceeeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCchHHHHHHHHHHHhhcCCCcc
Confidence            32   34556899999999998532           24578999999999999999999998776555554444433   


Q ss_pred             -CCCCCCCCCcHHHHHHHHHHhhhcCCCCCCHHHHHH
Q 015868          330 -LRPTIPKHAHPRLAELLERCWQHDPTQRPNFSQITD  365 (399)
Q Consensus       330 -~~~~~~~~~~~~l~~ll~~cl~~dP~~Rps~~ell~  365 (399)
                       .-|.+|+.  .++.++|+.||++||.+||+..++++
T Consensus       592 Iefp~~~~~--~~li~~mK~CL~rdPkkR~si~eLLq  626 (677)
T KOG0596|consen  592 IEFPDIPEN--DELIDVMKCCLARDPKKRWSIPELLQ  626 (677)
T ss_pred             ccccCCCCc--hHHHHHHHHHHhcCcccCCCcHHHhc
Confidence             22333332  23999999999999999999999976

>cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases

Probab=100.00  E-value=8.3e-40  Score=307.26  Aligned_cols=248  Identities=29%  Similarity=0.532  Sum_probs=207.0

Q ss_pred             ccceeceeceeCceEEEEEEE--CCeeEEEEEecCCCC--------CHHHHHHHHHHHHHHHhcCCCceeeEEeEEecCC
Q 015868          117 QLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECV--------NTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPP  186 (399)
Q Consensus       117 ~~~i~~~lg~G~~g~Vy~~~~--~~~~vAvK~~~~~~~--------~~~~~~~~~~Ei~~l~~l~h~nIv~~~~~~~~~~  186 (399)
                      +|.+.+.||.|+||.||+|..  +++.||+|.++....        .....+.+.+|+.+++.++|||++++++++..+.
T Consensus         2 ~~~~~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~   81 (272)
T cd06629           2 KWVKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFETTEE   81 (272)
T ss_pred             ceeecceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEeccCC
Confidence            578889999999999999975  578999998864211        1123457889999999999999999999999999


Q ss_pred             cEEEEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceeecCCCcEEEeeccceeeccC
Q 015868          187 NLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQ  266 (399)
Q Consensus       187 ~~~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~giiHrDlkp~NILl~~~~~vkl~DFG~a~~~~~  266 (399)
                      ..++||||+.+++|.+++... +.++...+..++.|++.||.|||++|++||||+|+||+++.++.++|+|||.++....
T Consensus        82 ~~~lv~e~~~~~~L~~~l~~~-~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~  160 (272)
T cd06629          82 YLSIFLEYVPGGSIGSCLRTY-GRFEEQLVRFFTEQVLEGLAYLHSKGILHRDLKADNLLVDADGICKISDFGISKKSDD  160 (272)
T ss_pred             ceEEEEecCCCCcHHHHHhhc-cCCCHHHHHHHHHHHHHHHHHHhhCCeeecCCChhhEEEcCCCeEEEeeccccccccc
Confidence            999999999999999999774 6789999999999999999999999999999999999999999999999999875432


Q ss_pred             CC---ccccCCCCcccccccccCCCC--CCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhccCCCCCC----CC
Q 015868          267 SG---VMTAETGTYRWMAPEVIEHKP--YDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKSLRPTIP----KH  337 (399)
Q Consensus       267 ~~---~~~~~~gt~~y~aPE~l~~~~--~~~~~Dv~slG~vl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~----~~  337 (399)
                      ..   ......++..|+|||.+....  ++.++|+||||+++|++++|..||......+...........+.++    ..
T Consensus       161 ~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (272)
T cd06629         161 IYDNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEAIAAMFKLGNKRSAPPIPPDVSMN  240 (272)
T ss_pred             cccccccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCcCcchHHHHHHhhccccCCcCCcccccc
Confidence            21   122345788999999987654  7899999999999999999999998766655444433333333333    34


Q ss_pred             CcHHHHHHHHHHhhhcCCCCCCHHHHHH
Q 015868          338 AHPRLAELLERCWQHDPTQRPNFSQITD  365 (399)
Q Consensus       338 ~~~~l~~ll~~cl~~dP~~Rps~~ell~  365 (399)
                      ++.++.+++.+||..+|.+||++.++++
T Consensus       241 ~~~~~~~li~~~l~~~p~~Rps~~~il~  268 (272)
T cd06629         241 LSPVALDFLNACFTINPDNRPTARELLQ  268 (272)
T ss_pred             CCHHHHHHHHHHhcCChhhCCCHHHHhh
Confidence            6889999999999999999999999875

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte

>cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases

Probab=100.00  E-value=6.2e-40  Score=310.26  Aligned_cols=249  Identities=27%  Similarity=0.420  Sum_probs=207.4

Q ss_pred             cccceeceeceeCceEEEEEEE--CCeeEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCceeeEEeEEecCCcEEEEEe
Q 015868          116 KQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVTE  193 (399)
Q Consensus       116 ~~~~i~~~lg~G~~g~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~nIv~~~~~~~~~~~~~lV~E  193 (399)
                      ++|++.+.||+|+||.||+|..  +++.||+|+++....+......+.+|+.++++++|+||+++++.+..++..++|||
T Consensus         1 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e   80 (288)
T cd07833           1 NKYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKEAFRRKGRLYLVFE   80 (288)
T ss_pred             CceeEEEEecccCCeeEEEEEeCCCCcEEEEehhhhhcccccchhHHHHHHHHHHhcCCCCeeehhheEEECCEEEEEEe
Confidence            3689999999999999999987  47889999998655455556789999999999999999999999999999999999


Q ss_pred             cCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceeecCCCcEEEeeccceeeccCCC--ccc
Q 015868          194 FMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSG--VMT  271 (399)
Q Consensus       194 ~~~ggsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~giiHrDlkp~NILl~~~~~vkl~DFG~a~~~~~~~--~~~  271 (399)
                      |++++.+..+. .....+++..++.++.||+.||.|||++|++|+||+|+||++++++.+||+|||.+.......  ...
T Consensus        81 ~~~~~~l~~~~-~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~~~ni~~~~~~~~kl~d~g~~~~~~~~~~~~~~  159 (288)
T cd07833          81 YVERTLLELLE-ASPGGLPPDAVRSYIWQLLQAIAYCHSHNIIHRDIKPENILVSESGVLKLCDFGFARALRARPASPLT  159 (288)
T ss_pred             cCCCCHHHHHH-hcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCCEEEEeeecccccCCCcccccc
Confidence            99986666555 445668999999999999999999999999999999999999999999999999987655433  334


Q ss_pred             cCCCCcccccccccCCC-CCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcc---------------------
Q 015868          272 AETGTYRWMAPEVIEHK-PYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKS---------------------  329 (399)
Q Consensus       272 ~~~gt~~y~aPE~l~~~-~~~~~~Dv~slG~vl~elltg~~P~~~~~~~~~~~~~~~~~---------------------  329 (399)
                      ...++..|+|||.+.+. .++.++|+||||+++|+|++|+.||.+.+............                     
T Consensus       160 ~~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (288)
T cd07833         160 DYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGDSDIDQLYLIQKCLGPLPPSHQELFSSNPRFAGVA  239 (288)
T ss_pred             CcccccCCcCCchhcCCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHhhhcccCccccccc
Confidence            45678899999999887 88999999999999999999999998765544332211100                     


Q ss_pred             C---------CCCCCCCCcHHHHHHHHHHhhhcCCCCCCHHHHHH
Q 015868          330 L---------RPTIPKHAHPRLAELLERCWQHDPTQRPNFSQITD  365 (399)
Q Consensus       330 ~---------~~~~~~~~~~~l~~ll~~cl~~dP~~Rps~~ell~  365 (399)
                      .         ....+..++.++.+++++||..+|++||+++++++
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~  284 (288)
T cd07833         240 FPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQ  284 (288)
T ss_pred             cCCCCCcHHHHHhcCCccchHHHHHHHHHhccCchhcccHHHHhc
Confidence            0         00122335889999999999999999999999875

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning

>cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase

Probab=100.00  E-value=9e-40  Score=319.49  Aligned_cols=247  Identities=25%  Similarity=0.373  Sum_probs=205.2

Q ss_pred             ccccceeceeceeCceEEEEEEE--CCeeEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCceeeEEeEEecC------C
Q 015868          115 AKQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRP------P  186 (399)
Q Consensus       115 ~~~~~i~~~lg~G~~g~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~nIv~~~~~~~~~------~  186 (399)
                      .++|++.+.||.|+||.||+|..  +++.||+|++.....+......+.+|+.+++.++||||+++++++...      .
T Consensus        15 ~~~y~~~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~   94 (353)
T cd07850          15 LKRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSLEEFQ   94 (353)
T ss_pred             hcceEEEEEeccCCCEEEEEEEECCCCCEEEEEecCccccChhHHHHHHHHHHHHHhcCCCCCcceeeeeccCCCccccC
Confidence            47899999999999999999986  678999999876544555567788999999999999999999988644      3


Q ss_pred             cEEEEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceeecCCCcEEEeeccceeeccC
Q 015868          187 NLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQ  266 (399)
Q Consensus       187 ~~~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~giiHrDlkp~NILl~~~~~vkl~DFG~a~~~~~  266 (399)
                      ..|+||||+.+ +|.+.+...   ++...+..++.|++.||+|||++||+||||||+||+++.++.+||+|||.++....
T Consensus        95 ~~~lv~e~~~~-~l~~~~~~~---l~~~~~~~~~~ql~~aL~~LH~~gi~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~  170 (353)
T cd07850          95 DVYLVMELMDA-NLCQVIQMD---LDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGT  170 (353)
T ss_pred             cEEEEEeccCC-CHHHHHhhc---CCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEECCCCCEEEccCccceeCCC
Confidence            57999999965 888888543   88999999999999999999999999999999999999999999999999987655


Q ss_pred             CCccccCCCCcccccccccCCCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhccCC---------------
Q 015868          267 SGVMTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKSLR---------------  331 (399)
Q Consensus       267 ~~~~~~~~gt~~y~aPE~l~~~~~~~~~Dv~slG~vl~elltg~~P~~~~~~~~~~~~~~~~~~~---------------  331 (399)
                      ........++..|+|||.+.+..++.++||||||+++|+|++|+.||...+.......+......               
T Consensus       171 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  250 (353)
T cd07850         171 SFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGTVLFPGTDHIDQWNKIIEQLGTPSDEFMSRLQPTVRN  250 (353)
T ss_pred             CCCCCCCcccccccCHHHHhCCCCCCchhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHhhhhhhH
Confidence            44444556889999999999999999999999999999999999999876543322222110000               


Q ss_pred             -----C---------------------CCCCCCcHHHHHHHHHHhhhcCCCCCCHHHHHH
Q 015868          332 -----P---------------------TIPKHAHPRLAELLERCWQHDPTQRPNFSQITD  365 (399)
Q Consensus       332 -----~---------------------~~~~~~~~~l~~ll~~cl~~dP~~Rps~~ell~  365 (399)
                           +                     ..+...++.+.++|.+||+.||++|||+.|+++
T Consensus       251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eiL~  310 (353)
T cd07850         251 YVENRPKYAGYSFEELFPDVLFPPDSESHNKLKASQARDLLSKMLVIDPEKRISVDDALQ  310 (353)
T ss_pred             HhhcCCCCCCcchhhhCcccccCcccccccccchhHHHHHHHHHcCCChhhCcCHHHHhc
Confidence                 0                     001234667899999999999999999999985

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK

>cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4

Probab=100.00  E-value=6.4e-40  Score=310.78  Aligned_cols=249  Identities=29%  Similarity=0.504  Sum_probs=203.0

Q ss_pred             ccccceeceeceeCceEEEEEEE--CCeeEEEEEecCCCCCHHHHHHHHHHHHHHHhcC-CCceeeEEeEEecCCcEEEE
Q 015868          115 AKQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIR-HKNVVQFIGACTRPPNLCIV  191 (399)
Q Consensus       115 ~~~~~i~~~lg~G~~g~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~Ei~~l~~l~-h~nIv~~~~~~~~~~~~~lV  191 (399)
                      .++|...++||+|+||.||++..  +++.||+|.+...... .....+.+|+.++.++. |+||+++++++..+...+++
T Consensus         3 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~-~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~~~~~~~   81 (288)
T cd06616           3 AEDLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDE-KEQKRLLMDLDVVMRSSDCPYIVKFYGALFREGDCWIC   81 (288)
T ss_pred             HHHhHHHHHhCCCCceEEEEEEECCCCCEEEEEEehhccCh-HHHHHHHHHHHHHHHhcCCCCEeeeeeEEecCCcEEEE
Confidence            45777889999999999999987  5689999998754323 44567889999999996 99999999999999999999


Q ss_pred             EecCCCCCHHHHHH---h-cCCCCCHHHHHHHHHHHHHHHHHHHHC-CcccCCCCCCceeecCCCcEEEeeccceeeccC
Q 015868          192 TEFMARGSIYDFLH---K-QKGVFQLTSLLKVAIDVSKGMNYLHQN-NIIHRDLKTANLLMDENGVVKVADFGVARVQAQ  266 (399)
Q Consensus       192 ~E~~~ggsL~~~l~---~-~~~~l~~~~~~~i~~~i~~~L~~LH~~-giiHrDlkp~NILl~~~~~vkl~DFG~a~~~~~  266 (399)
                      |||+.+ ++.++..   . ....+++..+..++.+++.||+|||+. |++||||||+||+++.++.++|+|||+++....
T Consensus        82 ~e~~~~-~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~  160 (288)
T cd06616          82 MELMDI-SLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEELKIIHRDVKPSNILLDRNGNIKLCDFGISGQLVD  160 (288)
T ss_pred             EecccC-CHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhcCCeeccCCCHHHEEEccCCcEEEeecchhHHhcc
Confidence            999865 6655432   2 246789999999999999999999985 999999999999999999999999999976554


Q ss_pred             CCccccCCCCcccccccccCCC---CCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhccCCCCC----CCCCc
Q 015868          267 SGVMTAETGTYRWMAPEVIEHK---PYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKSLRPTI----PKHAH  339 (399)
Q Consensus       267 ~~~~~~~~gt~~y~aPE~l~~~---~~~~~~Dv~slG~vl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~----~~~~~  339 (399)
                      ........++..|+|||.+.+.   .++.++||||||+++|+|++|+.||..................+.+    +..++
T Consensus       161 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (288)
T cd06616         161 SIAKTRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWNSVFDQLTQVVKGDPPILSNSEEREFS  240 (288)
T ss_pred             CCccccccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCCCchhcchHHHHHhhhcCCCCCcCCCcCCCccC
Confidence            4444455788999999999876   6899999999999999999999999776532222111111222222    23478


Q ss_pred             HHHHHHHHHHhhhcCCCCCCHHHHHH
Q 015868          340 PRLAELLERCWQHDPTQRPNFSQITD  365 (399)
Q Consensus       340 ~~l~~ll~~cl~~dP~~Rps~~ell~  365 (399)
                      .++.+|+.+||+.+|.+|||+.++++
T Consensus       241 ~~l~~li~~~l~~~p~~Rpt~~~i~~  266 (288)
T cd06616         241 PSFVNFINLCLIKDESKRPKYKELLE  266 (288)
T ss_pred             HHHHHHHHHHccCChhhCcCHHHHhc
Confidence            99999999999999999999999876

Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates

>cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10

Probab=100.00  E-value=1e-39  Score=312.93  Aligned_cols=251  Identities=24%  Similarity=0.391  Sum_probs=207.7

Q ss_pred             cccccceeceeceeCceEEEEEEE--CCeeEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCceeeEEeEEecC--CcEE
Q 015868          114 DAKQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRP--PNLC  189 (399)
Q Consensus       114 ~~~~~~i~~~lg~G~~g~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~nIv~~~~~~~~~--~~~~  189 (399)
                      ..++|++.+.||.|+||.||+|..  +++.||+|+++...........+.+|+.++++++|+||+++++++...  ..++
T Consensus         5 ~~~~y~~~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~   84 (309)
T cd07845           5 SVTEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNIVELKEVVVGKHLDSIF   84 (309)
T ss_pred             cccceeEeeeeeecCCEEEEEEEECCCCcEEEEEEEEeccCCCCCcchhhHHHHHHHhCCCCCCcceEEEEecCCCCeEE
Confidence            456899999999999999999987  578999999975543333334567899999999999999999998755  4689


Q ss_pred             EEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceeecCCCcEEEeeccceeeccCC-C
Q 015868          190 IVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQS-G  268 (399)
Q Consensus       190 lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~giiHrDlkp~NILl~~~~~vkl~DFG~a~~~~~~-~  268 (399)
                      +||||+.+ +|.+++......+++..++.++.|++.||.|||+.|++||||||+||+++.++.+||+|||.+...... .
T Consensus        85 lv~e~~~~-~l~~~l~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~~~~kL~dfg~~~~~~~~~~  163 (309)
T cd07845          85 LVMEYCEQ-DLASLLDNMPTPFSESQVKCLMLQLLRGLQYLHENFIIHRDLKVSNLLLTDKGCLKIADFGLARTYGLPAK  163 (309)
T ss_pred             EEEecCCC-CHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEECccceeeecCCccC
Confidence            99999975 899998776677999999999999999999999999999999999999999999999999999865443 2


Q ss_pred             ccccCCCCcccccccccCC-CCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhccCCC---------------
Q 015868          269 VMTAETGTYRWMAPEVIEH-KPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKSLRP---------------  332 (399)
Q Consensus       269 ~~~~~~gt~~y~aPE~l~~-~~~~~~~Dv~slG~vl~elltg~~P~~~~~~~~~~~~~~~~~~~~---------------  332 (399)
                      ..+...++..|+|||.+.+ ..++.++||||||+++|+|++|..||...++.+...........+               
T Consensus       164 ~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  243 (309)
T cd07845         164 PMTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKSEIEQLDLIIQLLGTPNESIWPGFSDLPLVG  243 (309)
T ss_pred             CCCcccccccccChhhhcCCCCcCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChhhchhhhcccccc
Confidence            2333446788999999865 567899999999999999999999999888777655444311000               


Q ss_pred             --CC-----------CCCCcHHHHHHHHHHhhhcCCCCCCHHHHHH
Q 015868          333 --TI-----------PKHAHPRLAELLERCWQHDPTQRPNFSQITD  365 (399)
Q Consensus       333 --~~-----------~~~~~~~l~~ll~~cl~~dP~~Rps~~ell~  365 (399)
                        .+           ....++++.++|.+||+.||++|||+.+++.
T Consensus       244 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~~il~  289 (309)
T cd07845         244 KFTLPKQPYNNLKHKFPWLSEAGLRLLNFLLMYDPKKRATAEEALE  289 (309)
T ss_pred             cccccCCCCCchHHhccccCHHHHHHHHHHhcCChhhCcCHHHHhc
Confidence              00           0125788999999999999999999999875

Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing

>cd05122 PKc_STE Catalytic domain of STE family Protein Kinases

Probab=100.00  E-value=2.5e-39  Score=298.56  Aligned_cols=246  Identities=36%  Similarity=0.649  Sum_probs=213.8

Q ss_pred             ccceeceeceeCceEEEEEEEC--CeeEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCceeeEEeEEecCCcEEEEEec
Q 015868          117 QLKIECKVASGSYGDLYKGTYC--SQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVTEF  194 (399)
Q Consensus       117 ~~~i~~~lg~G~~g~Vy~~~~~--~~~vAvK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~nIv~~~~~~~~~~~~~lV~E~  194 (399)
                      +|.+.+.||+|++|.||++...  ++.+++|+++....  .....+.+|+.+++.++|+|++++++.+......++++||
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l~~e~   78 (253)
T cd05122           1 LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESK--EKKEKIINEIQILKKCKHPNIVKYYGSYLKKDELWIVMEF   78 (253)
T ss_pred             CceeeeeeccCCceEEEEEEECCCCcEEEEEEecccch--hHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEec
Confidence            4778899999999999999884  78899999986532  4567899999999999999999999999999999999999


Q ss_pred             CCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceeecCCCcEEEeeccceeeccCCCccccCC
Q 015868          195 MARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAET  274 (399)
Q Consensus       195 ~~ggsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~giiHrDlkp~NILl~~~~~vkl~DFG~a~~~~~~~~~~~~~  274 (399)
                      +++++|.+++......+++..+..++.+++.++.+||++|++|+||+|.||++++++.++|+|||.+.............
T Consensus        79 ~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~i~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~~~~~  158 (253)
T cd05122          79 CSGGSLKDLLKSTNQTLTESQIAYVCKELLKGLEYLHSNGIIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKARNTMV  158 (253)
T ss_pred             CCCCcHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCEecCCCCHHHEEEccCCeEEEeecccccccccccccccee
Confidence            99999999998765789999999999999999999999999999999999999999999999999997665443234556


Q ss_pred             CCcccccccccCCCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhccCCCCCCCC--CcHHHHHHHHHHhhh
Q 015868          275 GTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKSLRPTIPKH--AHPRLAELLERCWQH  352 (399)
Q Consensus       275 gt~~y~aPE~l~~~~~~~~~Dv~slG~vl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~l~~ll~~cl~~  352 (399)
                      ++..|+|||.+.+..++.++|+||||+++|+|++|..||...+..+....... ...+..+..  ++..+.+++.+||+.
T Consensus       159 ~~~~~~~PE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~i~~~l~~  237 (253)
T cd05122         159 GTPYWMAPEVINGKPYDYKADIWSLGITAIELAEGKPPYSELPPMKALFKIAT-NGPPGLRNPEKWSDEFKDFLKKCLQK  237 (253)
T ss_pred             cCCcccCHHHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHh-cCCCCcCcccccCHHHHHHHHHHccC
Confidence            88999999999988889999999999999999999999988766555444333 333444433  389999999999999


Q ss_pred             cCCCCCCHHHHHH
Q 015868          353 DPTQRPNFSQITD  365 (399)
Q Consensus       353 dP~~Rps~~ell~  365 (399)
                      ||++|||+.++++
T Consensus       238 ~p~~R~t~~~~l~  250 (253)
T cd05122         238 NPEKRPTAEQLLK  250 (253)
T ss_pred             ChhhCCCHHHHhc
Confidence            9999999999875

Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core

>cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3

Probab=100.00  E-value=6.5e-40  Score=310.02  Aligned_cols=249  Identities=29%  Similarity=0.438  Sum_probs=205.7

Q ss_pred             cccceeceeceeCceEEEEEEE--CCeeEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCceeeEEeEEecCCcEEEEEe
Q 015868          116 KQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVTE  193 (399)
Q Consensus       116 ~~~~i~~~lg~G~~g~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~nIv~~~~~~~~~~~~~lV~E  193 (399)
                      ++|++.++||+|+||.||+|.+  .++.||+|++..........+.+.+|+.+++.++||||+++++++..+...++|||
T Consensus         1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   80 (286)
T cd07846           1 EKYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIEVFRRKKRLYLVFE   80 (286)
T ss_pred             CceeEeeeeccCCCeEEEEEEECCCCCEEEEEeHhhccCcchhhHHHHHHHHHHHhcCCcchhhHHHhcccCCeEEEEEe
Confidence            3688999999999999999988  47899999987654444455678899999999999999999999999999999999


Q ss_pred             cCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceeecCCCcEEEeeccceeeccCCC-cccc
Q 015868          194 FMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSG-VMTA  272 (399)
Q Consensus       194 ~~~ggsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~giiHrDlkp~NILl~~~~~vkl~DFG~a~~~~~~~-~~~~  272 (399)
                      |+++++|..+... ...+++..++.++.|++.||+|||+.|++|+||+|+||++++++.++|+|||++....... ....
T Consensus        81 ~~~~~~l~~~~~~-~~~~~~~~~~~~~~~i~~~l~~LH~~~i~h~~l~p~ni~~~~~~~~~l~dfg~~~~~~~~~~~~~~  159 (286)
T cd07846          81 FVDHTVLDDLEKY-PNGLDESRVRKYLFQILRGIEFCHSHNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYTD  159 (286)
T ss_pred             cCCccHHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECCCCcEEEEeeeeeeeccCCccccCc
Confidence            9999888887654 4558999999999999999999999999999999999999999999999999987654332 2334


Q ss_pred             CCCCcccccccccCC-CCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhc--------------------cCC
Q 015868          273 ETGTYRWMAPEVIEH-KPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQK--------------------SLR  331 (399)
Q Consensus       273 ~~gt~~y~aPE~l~~-~~~~~~~Dv~slG~vl~elltg~~P~~~~~~~~~~~~~~~~--------------------~~~  331 (399)
                      ..++..|+|||.+.+ ..++.++||||||+++|+|++|.+||...+..+........                    ...
T Consensus       160 ~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (286)
T cd07846         160 YVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDIDQLYHIIKCLGNLIPRHQEIFQKNPLFAGMRL  239 (286)
T ss_pred             ccceeeccCcHHhccccccCchHhHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHHHhCCCchhhHHHhccchHhhcccc
Confidence            567889999999875 45788999999999999999999999766543322221110                    000


Q ss_pred             CC---------CCCCCcHHHHHHHHHHhhhcCCCCCCHHHHHH
Q 015868          332 PT---------IPKHAHPRLAELLERCWQHDPTQRPNFSQITD  365 (399)
Q Consensus       332 ~~---------~~~~~~~~l~~ll~~cl~~dP~~Rps~~ell~  365 (399)
                      +.         ..+.++..+.+++.+||+.+|++||++.++++
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~  282 (286)
T cd07846         240 PEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLH  282 (286)
T ss_pred             ccccCcchHHHhCCCcCHHHHHHHHHHhcCCcccchhHHHHhc
Confidence            00         12357889999999999999999999999875

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI

>cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=3e-39  Score=302.48  Aligned_cols=248  Identities=28%  Similarity=0.500  Sum_probs=213.3

Q ss_pred             cccceeceeceeCceEEEEEEE--CCeeEEEEEecCCC---CCHHHHHHHHHHHHHHHhcCCCceeeEEeEEecC--CcE
Q 015868          116 KQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPEC---VNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRP--PNL  188 (399)
Q Consensus       116 ~~~~i~~~lg~G~~g~Vy~~~~--~~~~vAvK~~~~~~---~~~~~~~~~~~Ei~~l~~l~h~nIv~~~~~~~~~--~~~  188 (399)
                      .+|++.+.||+|+||.||+|+.  +++.||+|++....   ........+.+|+.++++++|+||+++++.+...  ..+
T Consensus         2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~   81 (264)
T cd06653           2 VNWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDPEEKKL   81 (264)
T ss_pred             CceeeeeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEcCCCCEE
Confidence            4788999999999999999986  57899999875321   1334557899999999999999999999998764  458


Q ss_pred             EEEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceeecCCCcEEEeeccceeeccCC-
Q 015868          189 CIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQS-  267 (399)
Q Consensus       189 ~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~giiHrDlkp~NILl~~~~~vkl~DFG~a~~~~~~-  267 (399)
                      ++++||+++++|.+++... +.+++..+..++.|++.||.|||++|++|+||+|+||+++.++.++|+|||+++..... 
T Consensus        82 ~~v~e~~~~~~L~~~~~~~-~~l~~~~~~~~~~~i~~al~~LH~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~  160 (264)
T cd06653          82 SIFVEYMPGGSIKDQLKAY-GALTENVTRRYTRQILQGVSYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRIQTIC  160 (264)
T ss_pred             EEEEEeCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCEEECcccccccccccc
Confidence            8999999999999998763 45889999999999999999999999999999999999999999999999999754321 


Q ss_pred             ---CccccCCCCcccccccccCCCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhccCCCCCCCCCcHHHHH
Q 015868          268 ---GVMTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRLAE  344 (399)
Q Consensus       268 ---~~~~~~~gt~~y~aPE~l~~~~~~~~~Dv~slG~vl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~  344 (399)
                         ...+...++..|+|||.+.+..++.++|+||||+++|+|++|+.||...+..+..........++.+|...++++.+
T Consensus       161 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~  240 (264)
T cd06653         161 MSGTGIKSVTGTPYWMSPEVISGEGYGRKADVWSVACTVVEMLTEKPPWAEYEAMAAIFKIATQPTKPMLPDGVSDACRD  240 (264)
T ss_pred             ccCccccccCCcccccCHhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCccCHHHHHHHHHcCCCCCCCCcccCHHHHH
Confidence               11233468899999999998889999999999999999999999999887777666666556677888999999999


Q ss_pred             HHHHHhhhcCCCCCCHHHHHH
Q 015868          345 LLERCWQHDPTQRPNFSQITD  365 (399)
Q Consensus       345 ll~~cl~~dP~~Rps~~ell~  365 (399)
                      ++.+||+ +|..||++.+++.
T Consensus       241 ~i~~~l~-~~~~r~~~~~~~~  260 (264)
T cd06653         241 FLKQIFV-EEKRRPTAEFLLR  260 (264)
T ss_pred             HHHHHhc-CcccCccHHHHhc
Confidence            9999999 5799999998764

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho

>cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase

Probab=100.00  E-value=2.1e-39  Score=305.66  Aligned_cols=245  Identities=23%  Similarity=0.361  Sum_probs=201.3

Q ss_pred             cceeceeceeCceEEEEEEE--CCeeEEEEEecCCCCCHHHHHHHHHHHHHHHhcC-CCceeeEEeEEecC--CcEEEEE
Q 015868          118 LKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIR-HKNVVQFIGACTRP--PNLCIVT  192 (399)
Q Consensus       118 ~~i~~~lg~G~~g~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~Ei~~l~~l~-h~nIv~~~~~~~~~--~~~~lV~  192 (399)
                      |++.++||+|+||.||+|..  +++.||+|+++........ ....+|+.+++++. |+|++++++++..+  +..++||
T Consensus         1 y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~-~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv~   79 (282)
T cd07831           1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQ-VNNLREIQALRRLSPHPNILRLIEVLFDRKTGRLALVF   79 (282)
T ss_pred             CceEeeccccccceEEEEEEcCCCcEEEEEEehhccCCchh-hhHHHHHHHHhhcCCCCCccceEEEEecCCCCcEEEEE
Confidence            67889999999999999987  5788999998764323322 34457888999885 99999999999887  8899999


Q ss_pred             ecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceeecCCCcEEEeeccceeeccCCCcccc
Q 015868          193 EFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTA  272 (399)
Q Consensus       193 E~~~ggsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~giiHrDlkp~NILl~~~~~vkl~DFG~a~~~~~~~~~~~  272 (399)
                      ||+++ +|.+.+......+++..++.++.|++.||.|||++|++||||+|+||+++. +.+||+|||.++..........
T Consensus        80 e~~~~-~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dl~p~ni~l~~-~~~kl~dfg~~~~~~~~~~~~~  157 (282)
T cd07831          80 ELMDM-NLYELIKGRKRPLPEKRVKSYMYQLLKSLDHMHRNGIFHRDIKPENILIKD-DILKLADFGSCRGIYSKPPYTE  157 (282)
T ss_pred             ecCCc-cHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCceecccCHHHEEEcC-CCeEEEecccccccccCCCcCC
Confidence            99975 899888776677999999999999999999999999999999999999999 9999999999986654444445


Q ss_pred             CCCCcccccccccCC-CCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcc----------------CCCCC-
Q 015868          273 ETGTYRWMAPEVIEH-KPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKS----------------LRPTI-  334 (399)
Q Consensus       273 ~~gt~~y~aPE~l~~-~~~~~~~Dv~slG~vl~elltg~~P~~~~~~~~~~~~~~~~~----------------~~~~~-  334 (399)
                      ..++..|+|||.+.. ..++.++|+||||+++|+|++|..||.+.++.+.........                ..... 
T Consensus       158 ~~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (282)
T cd07831         158 YISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTNELDQIAKIHDVLGTPDAEVLKKFRKSRHMNYNFP  237 (282)
T ss_pred             CCCCcccCChhHhhcCCCCCcchhHHHHHHHHHHHHcCCcCCCCCCHHHHHHHHHHHcCCCCHHHHHhhcccccccccCc
Confidence            567899999998754 457889999999999999999999998877654333221100                00001 


Q ss_pred             ----------CCCCcHHHHHHHHHHhhhcCCCCCCHHHHHH
Q 015868          335 ----------PKHAHPRLAELLERCWQHDPTQRPNFSQITD  365 (399)
Q Consensus       335 ----------~~~~~~~l~~ll~~cl~~dP~~Rps~~ell~  365 (399)
                                ...++.++.+++.+||+.+|++||++.++++
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~  278 (282)
T cd07831         238 SKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERITAKQALR  278 (282)
T ss_pred             ccccccHHHHcccccHHHHHHHHHHhccCcccccCHHHHhh
Confidence                      1346789999999999999999999999875

Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation.

>cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3

Probab=100.00  E-value=3.2e-39  Score=304.60  Aligned_cols=246  Identities=33%  Similarity=0.583  Sum_probs=213.1

Q ss_pred             cccceeceeceeCceEEEEEEE--CCeeEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCceeeEEeEEecCCcEEEEEe
Q 015868          116 KQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVTE  193 (399)
Q Consensus       116 ~~~~i~~~lg~G~~g~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~nIv~~~~~~~~~~~~~lV~E  193 (399)
                      +-|++.++||.|+||.||+|..  .+..||+|++.... .......+.+|+.++++++||||+++++++..+...++|||
T Consensus         4 ~~~~~~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e   82 (277)
T cd06641           4 ELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEE-AEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIME   82 (277)
T ss_pred             HhhhhheeEeecCCeEEEEEEECCCCcEEEEEEecccc-chHHHHHHHHHHHHHHhcCCCCEeEEEEEEEeCCeEEEEEE
Confidence            3577888999999999999976  56889999986543 23445688999999999999999999999999999999999


Q ss_pred             cCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceeecCCCcEEEeeccceeeccCCC-cccc
Q 015868          194 FMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSG-VMTA  272 (399)
Q Consensus       194 ~~~ggsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~giiHrDlkp~NILl~~~~~vkl~DFG~a~~~~~~~-~~~~  272 (399)
                      |+++++|.+++..  ..++...+..++.+++.++.|||++|++|+||+|.||+++.++.++|+|||.+....... ....
T Consensus        83 ~~~~~~l~~~i~~--~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~Ni~i~~~~~~~l~dfg~~~~~~~~~~~~~~  160 (277)
T cd06641          83 YLGGGSALDLLEP--GPLDETQIATILREILKGLDYLHSEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNT  160 (277)
T ss_pred             eCCCCcHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHccCCeecCCCCHHhEEECCCCCEEEeecccceecccchhhhcc
Confidence            9999999999864  468899999999999999999999999999999999999999999999999987544322 1233


Q ss_pred             CCCCcccccccccCCCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhccCCCCCCCCCcHHHHHHHHHHhhh
Q 015868          273 ETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRLAELLERCWQH  352 (399)
Q Consensus       273 ~~gt~~y~aPE~l~~~~~~~~~Dv~slG~vl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~cl~~  352 (399)
                      ..++..|+|||.+.+..++.++|+||||+++|+|++|..||...++...... +.....+.++..++.++.+++.+||+.
T Consensus       161 ~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~i~~~l~~  239 (277)
T cd06641         161 FVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPHSELHPMKVLFL-IPKNNPPTLEGNYSKPLKEFVEACLNK  239 (277)
T ss_pred             ccCCccccChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCccchHHHHHH-HhcCCCCCCCcccCHHHHHHHHHHccC
Confidence            4678899999999988889999999999999999999999988776554443 334455667778899999999999999


Q ss_pred             cCCCCCCHHHHHH
Q 015868          353 DPTQRPNFSQITD  365 (399)
Q Consensus       353 dP~~Rps~~ell~  365 (399)
                      +|.+||++.++++
T Consensus       240 ~p~~Rp~~~~~l~  252 (277)
T cd06641         240 EPSFRPTAKELLK  252 (277)
T ss_pred             ChhhCcCHHHHHh
Confidence            9999999999988

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int

>cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.4e-39  Score=305.11  Aligned_cols=247  Identities=30%  Similarity=0.540  Sum_probs=205.8

Q ss_pred             ccccceeceeceeCceEEEEEEE--CCeeEEEEEecCCCCCHHHHHHHHHHHHHHHhc-CCCceeeEEeEEecCC-----
Q 015868          115 AKQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKI-RHKNVVQFIGACTRPP-----  186 (399)
Q Consensus       115 ~~~~~i~~~lg~G~~g~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~Ei~~l~~l-~h~nIv~~~~~~~~~~-----  186 (399)
                      .++|++.+.||.|++|.||+|..  .++.+++|++....   .....+.+|+.+++++ .|+||+++++++....     
T Consensus         5 ~~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~---~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~   81 (275)
T cd06608           5 TGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIE---DEEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPPGND   81 (275)
T ss_pred             hhheeheeeecCCCCeEEEEEEECCCCcEEEEEEEecCc---hhHHHHHHHHHHHHHhcCCCChheEEEEEEecCCCCcc
Confidence            46899999999999999999987  46789999987642   2346789999999999 6999999999997644     


Q ss_pred             -cEEEEEecCCCCCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceeecCCCcEEEeecccee
Q 015868          187 -NLCIVTEFMARGSIYDFLHKQ---KGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVAR  262 (399)
Q Consensus       187 -~~~lV~E~~~ggsL~~~l~~~---~~~l~~~~~~~i~~~i~~~L~~LH~~giiHrDlkp~NILl~~~~~vkl~DFG~a~  262 (399)
                       .+++||||+++++|.+++...   ...+++..+..++.|++.||.|||++|++|+||+|+||+++.++.++|+|||.+.
T Consensus        82 ~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~i~H~~l~p~ni~~~~~~~~~l~d~~~~~  161 (275)
T cd06608          82 DQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLHENKVIHRDIKGQNILLTKNAEVKLVDFGVSA  161 (275)
T ss_pred             eEEEEEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHHHEEEccCCeEEECCCccce
Confidence             489999999999999998653   3678999999999999999999999999999999999999999999999999987


Q ss_pred             eccCC-CccccCCCCcccccccccCC-----CCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhccCCCCC--
Q 015868          263 VQAQS-GVMTAETGTYRWMAPEVIEH-----KPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKSLRPTI--  334 (399)
Q Consensus       263 ~~~~~-~~~~~~~gt~~y~aPE~l~~-----~~~~~~~Dv~slG~vl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~--  334 (399)
                      ..... .......++..|+|||.+..     ..++.++||||||+++|+|++|..||....+.......... ..+.+  
T Consensus       162 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~-~~~~~~~  240 (275)
T cd06608         162 QLDSTLGRRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHPMRALFKIPRN-PPPTLKS  240 (275)
T ss_pred             ecccchhhhcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhCCCCccccchHHHHHHhhcc-CCCCCCc
Confidence            54432 22334568889999999853     35778999999999999999999999876665544443322 22222  


Q ss_pred             CCCCcHHHHHHHHHHhhhcCCCCCCHHHHHH
Q 015868          335 PKHAHPRLAELLERCWQHDPTQRPNFSQITD  365 (399)
Q Consensus       335 ~~~~~~~l~~ll~~cl~~dP~~Rps~~ell~  365 (399)
                      +..++.++.+++.+||..||++|||+.++++
T Consensus       241 ~~~~~~~~~~li~~~l~~dp~~Rpt~~~ll~  271 (275)
T cd06608         241 PENWSKKFNDFISECLIKNYEQRPFMEELLE  271 (275)
T ss_pred             hhhcCHHHHHHHHHHhhcChhhCcCHHHHhc
Confidence            2337789999999999999999999999975

Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I

>cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7

Probab=100.00  E-value=1.5e-39  Score=309.70  Aligned_cols=248  Identities=26%  Similarity=0.384  Sum_probs=205.5

Q ss_pred             ccceeceeceeCceEEEEEEE--CCeeEEEEEecCCCCC---HHHHHHHHHHHHHHHhcCCCceeeEEeEEecCCcEEEE
Q 015868          117 QLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVN---TEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIV  191 (399)
Q Consensus       117 ~~~i~~~lg~G~~g~Vy~~~~--~~~~vAvK~~~~~~~~---~~~~~~~~~Ei~~l~~l~h~nIv~~~~~~~~~~~~~lV  191 (399)
                      +|++.+.||.|+||.||+|..  .++.||+|.++.....   ......+.+|+.++++++|+||+++++++......++|
T Consensus         1 ~y~~~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv   80 (298)
T cd07841           1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVFGHKSNINLV   80 (298)
T ss_pred             CceeeeeeeeccccEEEEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhheeecCCEEEEE
Confidence            478889999999999999987  4789999999865433   33445678899999999999999999999999999999


Q ss_pred             EecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceeecCCCcEEEeeccceeeccCCC-cc
Q 015868          192 TEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSG-VM  270 (399)
Q Consensus       192 ~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~giiHrDlkp~NILl~~~~~vkl~DFG~a~~~~~~~-~~  270 (399)
                      |||+ +++|.+++......+++..+..++.||++||.|||++|++|+||+|+||+++.++.++|+|||.++...... ..
T Consensus        81 ~e~~-~~~L~~~i~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~~~~  159 (298)
T cd07841          81 FEFM-ETDLEKVIKDKSIVLTPADIKSYMLMTLRGLEYLHSNWILHRDLKPNNLLIASDGVLKLADFGLARSFGSPNRKM  159 (298)
T ss_pred             Eccc-CCCHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCChhhEEEcCCCCEEEccceeeeeccCCCccc
Confidence            9999 889999997654479999999999999999999999999999999999999999999999999998655432 23


Q ss_pred             ccCCCCcccccccccCC-CCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhccCC------------------
Q 015868          271 TAETGTYRWMAPEVIEH-KPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKSLR------------------  331 (399)
Q Consensus       271 ~~~~gt~~y~aPE~l~~-~~~~~~~Dv~slG~vl~elltg~~P~~~~~~~~~~~~~~~~~~~------------------  331 (399)
                      ....++..|+|||.+.+ ..++.++|+||||+++|+|++|.+||...++.............                  
T Consensus       160 ~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (298)
T cd07841         160 THQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSDIDQLGKIFEALGTPTEENWPGVTSLPDYVEF  239 (298)
T ss_pred             cccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHcCCccccCCccHHHHHHHHHHcCCCchhhhhhcccccccccc
Confidence            33456888999999865 46789999999999999999998888776654433322211000                  


Q ss_pred             ---CC-----CCCCCcHHHHHHHHHHhhhcCCCCCCHHHHHH
Q 015868          332 ---PT-----IPKHAHPRLAELLERCWQHDPTQRPNFSQITD  365 (399)
Q Consensus       332 ---~~-----~~~~~~~~l~~ll~~cl~~dP~~Rps~~ell~  365 (399)
                         +.     .....+.++.+++.+||+.+|.+|||+.|+++
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~e~l~  281 (298)
T cd07841         240 KPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQALE  281 (298)
T ss_pred             cccCCcchhhhcccccHHHHHHHHHHhcCCcccCcCHHHHhh
Confidence               00     11345788999999999999999999999976

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is

>cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5

Probab=100.00  E-value=1.2e-39  Score=302.91  Aligned_cols=248  Identities=27%  Similarity=0.501  Sum_probs=212.6

Q ss_pred             ccceeceeceeCceEEEEEEE--CCeeEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCceeeEEeEEecCCcEEEEEec
Q 015868          117 QLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVTEF  194 (399)
Q Consensus       117 ~~~i~~~lg~G~~g~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~nIv~~~~~~~~~~~~~lV~E~  194 (399)
                      +|++.+.||.|+||.||++..  .+..+|+|.+..........+.+.+|+.+++.++|+||+++++.+......++|+||
T Consensus         1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~   80 (257)
T cd08225           1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFASFQENGRLFIVMEY   80 (257)
T ss_pred             CceEEEEecCCCcceEEEEEEcCCCceEEEEEeeHhhccchhhHHHHHHHHHHHhCCCCChhhhhheeccCCeEEEEEec
Confidence            478899999999999999987  568899999876543444456788999999999999999999999999999999999


Q ss_pred             CCCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceeecCCC-cEEEeeccceeeccCCCc-cc
Q 015868          195 MARGSIYDFLHKQK-GVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENG-VVKVADFGVARVQAQSGV-MT  271 (399)
Q Consensus       195 ~~ggsL~~~l~~~~-~~l~~~~~~~i~~~i~~~L~~LH~~giiHrDlkp~NILl~~~~-~vkl~DFG~a~~~~~~~~-~~  271 (399)
                      +++++|.+++.... ..+++..+..++.+++.||.|||+++++|+||+|.||++++++ .++|+|||.+........ ..
T Consensus        81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~H~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~~~~~  160 (257)
T cd08225          81 CDGGDLMKRINRQRGVLFSEDQILSWFVQISLGLKHIHDRKILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSMELAY  160 (257)
T ss_pred             CCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEEcCCCCeEEecccccchhccCCccccc
Confidence            99999999997643 3578999999999999999999999999999999999999886 469999999876543322 22


Q ss_pred             cCCCCcccccccccCCCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhccCCCCCCCCCcHHHHHHHHHHhh
Q 015868          272 AETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRLAELLERCWQ  351 (399)
Q Consensus       272 ~~~gt~~y~aPE~l~~~~~~~~~Dv~slG~vl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~cl~  351 (399)
                      ...|++.|+|||.+.+..++.++|+||||+++|++++|..||...+..+....... ...+.++...+.++.+++.+||+
T Consensus       161 ~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~i~~~l~  239 (257)
T cd08225         161 TCVGTPYYLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHPFEGNNLHQLVLKICQ-GYFAPISPNFSRDLRSLISQLFK  239 (257)
T ss_pred             ccCCCccccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHhc-ccCCCCCCCCCHHHHHHHHHHhc
Confidence            34588899999999888899999999999999999999999988777665555443 33445566788999999999999


Q ss_pred             hcCCCCCCHHHHHH
Q 015868          352 HDPTQRPNFSQITD  365 (399)
Q Consensus       352 ~dP~~Rps~~ell~  365 (399)
                      .+|++|||+.++++
T Consensus       240 ~~p~~Rpt~~~ll~  253 (257)
T cd08225         240 VSPRDRPSITSILK  253 (257)
T ss_pred             cChhhCcCHHHHhh
Confidence            99999999999975

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown.

>cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=4.8e-39  Score=297.96  Aligned_cols=247  Identities=35%  Similarity=0.627  Sum_probs=218.0

Q ss_pred             ccceeceeceeCceEEEEEEE--CCeeEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCceeeEEeEEecCCcEEEEEec
Q 015868          117 QLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVTEF  194 (399)
Q Consensus       117 ~~~i~~~lg~G~~g~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~nIv~~~~~~~~~~~~~lV~E~  194 (399)
                      +|++.+.||+|++|.||++..  .++.|++|.+............+.+|+.++++++|||++++++++......++||||
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~   80 (254)
T cd06627           1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIGSIETSDSLYIILEY   80 (254)
T ss_pred             CceeeeEEcccCCeEEEEEEEcCCCcEEEEEEecccccCHHHHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEEEEec
Confidence            478899999999999999977  567899999987765556678899999999999999999999999999999999999


Q ss_pred             CCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceeecCCCcEEEeeccceeeccCCCc-cccC
Q 015868          195 MARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGV-MTAE  273 (399)
Q Consensus       195 ~~ggsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~giiHrDlkp~NILl~~~~~vkl~DFG~a~~~~~~~~-~~~~  273 (399)
                      +++++|.+++... ..+++..++.++.|++.|+.|||++||+||||+|+||+++.++.++|+|||.+........ ....
T Consensus        81 ~~~~~L~~~~~~~-~~l~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~~~~~  159 (254)
T cd06627          81 AENGSLRQIIKKF-GPFPESLVAVYVYQVLQGLAYLHEQGVIHRDIKAANILTTKDGVVKLADFGVATKLNDVSKDDASV  159 (254)
T ss_pred             CCCCcHHHHHHhc-cCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCHHHEEECCCCCEEEeccccceecCCCccccccc
Confidence            9999999999764 6789999999999999999999999999999999999999999999999999986654332 2334


Q ss_pred             CCCcccccccccCCCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhccCCCCCCCCCcHHHHHHHHHHhhhc
Q 015868          274 TGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRLAELLERCWQHD  353 (399)
Q Consensus       274 ~gt~~y~aPE~l~~~~~~~~~Dv~slG~vl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~cl~~d  353 (399)
                      .++..|+|||...+..++.++|+|++|+++|+|++|..||...++........ ....+.++..++..+.+++.+||..+
T Consensus       160 ~~~~~y~~pe~~~~~~~~~~~Dv~~lG~~l~~l~~g~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~i~~~l~~~  238 (254)
T cd06627         160 VGTPYWMAPEVIEMSGASTASDIWSLGCTVIELLTGNPPYYDLNPMAALFRIV-QDDHPPLPEGISPELKDFLMQCFQKD  238 (254)
T ss_pred             ccchhhcCHhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHh-ccCCCCCCCCCCHHHHHHHHHHHhCC
Confidence            67889999999988888999999999999999999999998877655554443 34556677889999999999999999


Q ss_pred             CCCCCCHHHHHH
Q 015868          354 PTQRPNFSQITD  365 (399)
Q Consensus       354 P~~Rps~~ell~  365 (399)
                      |++|||+.+++.
T Consensus       239 p~~R~~~~~~l~  250 (254)
T cd06627         239 PNLRPTAKQLLK  250 (254)
T ss_pred             hhhCcCHHHHhc
Confidence            999999999874

Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast

>cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7

Probab=100.00  E-value=1.8e-39  Score=309.38  Aligned_cols=255  Identities=27%  Similarity=0.491  Sum_probs=209.2

Q ss_pred             CceeecccccceeceeceeCceEEEEEEEC--CeeEEEEEecCCCCCHHHHHHHHHHHHHHHhc-CCCceeeEEeEEecC
Q 015868          109 DVWEIDAKQLKIECKVASGSYGDLYKGTYC--SQEVAIKVLKPECVNTEMLKEFSQEVYIMRKI-RHKNVVQFIGACTRP  185 (399)
Q Consensus       109 ~~~~i~~~~~~i~~~lg~G~~g~Vy~~~~~--~~~vAvK~~~~~~~~~~~~~~~~~Ei~~l~~l-~h~nIv~~~~~~~~~  185 (399)
                      ..|.++.++|++.+.||+|+||.||+|.+.  ++.||||+++.... ......+.+|+.++.+. +||||+++++++...
T Consensus         8 ~~~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~-~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~   86 (296)
T cd06618           8 QKYPADLNDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGN-KEENKRILMDLDVVLKSHDCPYIVKCYGYFITD   86 (296)
T ss_pred             eeccCCcchheeeeEeeccCCeEEEEEEECCCCeEEEEEEEeccCC-hHHHHHHHHHHHHHHhccCCCchHhhheeeecC
Confidence            346677889999999999999999999985  88999999976532 23345666677766666 499999999999999


Q ss_pred             CcEEEEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH-CCcccCCCCCCceeecCCCcEEEeeccceeec
Q 015868          186 PNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQ-NNIIHRDLKTANLLMDENGVVKVADFGVARVQ  264 (399)
Q Consensus       186 ~~~~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~-~giiHrDlkp~NILl~~~~~vkl~DFG~a~~~  264 (399)
                      ...|+||||+.+ ++.+++......+++..+..++.|++.||+|||+ .||+||||+|+||++++++.+||+|||.+...
T Consensus        87 ~~~~~v~e~~~~-~l~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~i~H~dl~p~nill~~~~~~kL~dfg~~~~~  165 (296)
T cd06618          87 SDVFICMELMST-CLDKLLKRIQGPIPEDILGKMTVAIVKALHYLKEKHGVIHRDVKPSNILLDASGNVKLCDFGISGRL  165 (296)
T ss_pred             CeEEEEeeccCc-CHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhhCCEecCCCcHHHEEEcCCCCEEECccccchhc
Confidence            999999999854 8888887666789999999999999999999997 59999999999999999999999999998765


Q ss_pred             cCCCccccCCCCcccccccccCCCC----CCChhhHHHHHHHHHHHHcCCCCCCCCCHH-HHHHHHHhccCCCCCCC--C
Q 015868          265 AQSGVMTAETGTYRWMAPEVIEHKP----YDYKADVFSFGIALWELLTGELPYAGLTPL-QAAVGVVQKSLRPTIPK--H  337 (399)
Q Consensus       265 ~~~~~~~~~~gt~~y~aPE~l~~~~----~~~~~Dv~slG~vl~elltg~~P~~~~~~~-~~~~~~~~~~~~~~~~~--~  337 (399)
                      ..........++..|+|||.+.+..    ++.++|+||||+++|+|++|+.||...... +....... ...+..+.  .
T Consensus       166 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~-~~~~~~~~~~~  244 (296)
T cd06618         166 VDSKAKTRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTEFEVLTKILQ-EEPPSLPPNEG  244 (296)
T ss_pred             cCCCcccCCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCCcchhHHHHHHHHhc-CCCCCCCCCCC
Confidence            5444444456788999999997553    788999999999999999999999764432 33333332 22333332  4


Q ss_pred             CcHHHHHHHHHHhhhcCCCCCCHHHHHHH
Q 015868          338 AHPRLAELLERCWQHDPTQRPNFSQITDI  366 (399)
Q Consensus       338 ~~~~l~~ll~~cl~~dP~~Rps~~ell~~  366 (399)
                      ++.++.+++.+||..||.+||++.++++.
T Consensus       245 ~~~~l~~li~~~l~~~p~~Rp~~~~il~~  273 (296)
T cd06618         245 FSPDFCSFVDLCLTKDHRKRPKYRELLQH  273 (296)
T ss_pred             CCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence            78899999999999999999999999753

Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it

>cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains

Probab=100.00  E-value=1.5e-39  Score=301.92  Aligned_cols=247  Identities=29%  Similarity=0.520  Sum_probs=217.4

Q ss_pred             ccceeceeceeCceEEEEEEE--CCeeEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCceeeEEeEEecCCcEEEEEec
Q 015868          117 QLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVTEF  194 (399)
Q Consensus       117 ~~~i~~~lg~G~~g~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~nIv~~~~~~~~~~~~~lV~E~  194 (399)
                      +|++.++||.|+||.||+++.  +++.+|+|.+............+.+|+.+++.++|+||+++++++......++||||
T Consensus         1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~   80 (256)
T cd08530           1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKEAFLDGNKLCIVMEY   80 (256)
T ss_pred             CceEeeeecCCCceeEEEEEECCCCCEEEEEEEehhhccHHHHHHHHHHHHHHHhCCCCCchhhhhhhccCCEEEEEehh
Confidence            478899999999999999976  577899999987655556667888999999999999999999999999999999999


Q ss_pred             CCCCCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceeecCCCcEEEeeccceeeccCCCccc
Q 015868          195 MARGSIYDFLHKQ---KGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMT  271 (399)
Q Consensus       195 ~~ggsL~~~l~~~---~~~l~~~~~~~i~~~i~~~L~~LH~~giiHrDlkp~NILl~~~~~vkl~DFG~a~~~~~~~~~~  271 (399)
                      +++++|.+++...   ...+++..++.++.+++.||+|||+.|++|+||+|.||++++++.+||+|||.+...... ...
T Consensus        81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh~~~i~h~~l~~~ni~~~~~~~~kl~d~g~~~~~~~~-~~~  159 (256)
T cd08530          81 APFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQKILHRDLKSANILLVANDLVKIGDLGISKVLKKN-MAK  159 (256)
T ss_pred             cCCCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCcceEEEecCCcEEEeeccchhhhccC-Ccc
Confidence            9999999998652   356899999999999999999999999999999999999999999999999999876554 333


Q ss_pred             cCCCCcccccccccCCCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhccCCCCCCCCCcHHHHHHHHHHhh
Q 015868          272 AETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRLAELLERCWQ  351 (399)
Q Consensus       272 ~~~gt~~y~aPE~l~~~~~~~~~Dv~slG~vl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~cl~  351 (399)
                      ...++..|+|||.+.+..++.++|+||||+++|+|++|+.||...+........ .....+.++..++.++.+++.+||+
T Consensus       160 ~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~li~~~l~  238 (256)
T cd08530         160 TQIGTPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPPFEARSMQDLRYKV-QRGKYPPIPPIYSQDLQNFIRSMLQ  238 (256)
T ss_pred             cccCCccccCHHHHCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH-hcCCCCCCchhhCHHHHHHHHHHcC
Confidence            456889999999999999999999999999999999999999988876554443 3445566677889999999999999


Q ss_pred             hcCCCCCCHHHHHH
Q 015868          352 HDPTQRPNFSQITD  365 (399)
Q Consensus       352 ~dP~~Rps~~ell~  365 (399)
                      .+|++||++.++++
T Consensus       239 ~~p~~Rp~~~~~l~  252 (256)
T cd08530         239 VKPKLRPNCDKILA  252 (256)
T ss_pred             CCcccCCCHHHHhc
Confidence            99999999999875

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an

>cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2e-39  Score=305.44  Aligned_cols=245  Identities=29%  Similarity=0.564  Sum_probs=208.4

Q ss_pred             ccceeceeceeCceEEEEEEE--CCeeEEEEEecCCCCCHHHHHHHHHHHHHHHhcC---CCceeeEEeEEecCCcEEEE
Q 015868          117 QLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIR---HKNVVQFIGACTRPPNLCIV  191 (399)
Q Consensus       117 ~~~i~~~lg~G~~g~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~Ei~~l~~l~---h~nIv~~~~~~~~~~~~~lV  191 (399)
                      .|++.+.||.|+||.||+|.+  .++.||+|+++... .......+.+|+.+++.++   |||++++++++..++..++|
T Consensus         2 ~y~~~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~-~~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~~~~~~lv   80 (277)
T cd06917           2 LYQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDT-PDDDVSDIQREVALLSQLRQSQPPNITKYYGSYLKGPRLWII   80 (277)
T ss_pred             hhhhhhheeccCCceEEEEEEcCCCcEEEEEEecCCC-CchhHHHHHHHHHHHHHhccCCCCCeeeEeeeeeeCCEEEEE
Confidence            578889999999999999987  57889999987543 3344567889999999997   99999999999999999999


Q ss_pred             EecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceeecCCCcEEEeeccceeeccCCC-cc
Q 015868          192 TEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSG-VM  270 (399)
Q Consensus       192 ~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~giiHrDlkp~NILl~~~~~vkl~DFG~a~~~~~~~-~~  270 (399)
                      |||+++++|.+++..  +.+++..++.++.+++.||.|||+.|++|+||+|+||++++++.++|+|||.+....... ..
T Consensus        81 ~e~~~~~~L~~~~~~--~~l~~~~~~~i~~~i~~~l~~lh~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~~~  158 (277)
T cd06917          81 MEYAEGGSVRTLMKA--GPIAEKYISVIIREVLVALKYIHKVGVIHRDIKAANILVTNTGNVKLCDFGVAALLNQNSSKR  158 (277)
T ss_pred             EecCCCCcHHHHHHc--cCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcCHHHEEEcCCCCEEEccCCceeecCCCcccc
Confidence            999999999999865  478999999999999999999999999999999999999999999999999997655432 23


Q ss_pred             ccCCCCcccccccccCC-CCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhccCCCCCCCC-CcHHHHHHHHH
Q 015868          271 TAETGTYRWMAPEVIEH-KPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKSLRPTIPKH-AHPRLAELLER  348 (399)
Q Consensus       271 ~~~~gt~~y~aPE~l~~-~~~~~~~Dv~slG~vl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~l~~ll~~  348 (399)
                      ....|+..|+|||.+.+ ..++.++|+||||+++|+|++|..||...+....... ......+.++.. ++.++.+++.+
T Consensus       159 ~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~i~~  237 (277)
T cd06917         159 STFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDAFRAMML-IPKSKPPRLEDNGYSKLLREFVAA  237 (277)
T ss_pred             ccccCCcceeCHHHhccCCccccchhHHHHHHHHHHHHhCCCCCCCCChhhhhhc-cccCCCCCCCcccCCHHHHHHHHH
Confidence            34468889999999865 4578999999999999999999999988776554432 222233444443 78899999999


Q ss_pred             HhhhcCCCCCCHHHHHH
Q 015868          349 CWQHDPTQRPNFSQITD  365 (399)
Q Consensus       349 cl~~dP~~Rps~~ell~  365 (399)
                      ||+.||.+||++.+++.
T Consensus       238 ~l~~~p~~R~~~~~il~  254 (277)
T cd06917         238 CLDEEPKERLSAEELLK  254 (277)
T ss_pred             HcCCCcccCcCHHHHhh
Confidence            99999999999999976

Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent

>cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8

Probab=100.00  E-value=1.2e-39  Score=313.47  Aligned_cols=240  Identities=23%  Similarity=0.402  Sum_probs=187.0

Q ss_pred             eceeceeCceEEEEEEE----CCeeEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCceeeEEeEEec--CCcEEEEEec
Q 015868          121 ECKVASGSYGDLYKGTY----CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTR--PPNLCIVTEF  194 (399)
Q Consensus       121 ~~~lg~G~~g~Vy~~~~----~~~~vAvK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~nIv~~~~~~~~--~~~~~lV~E~  194 (399)
                      .++||+|+||.||+|+.    .++.||+|.++.....    ..+.+|+.++++++||||+++++++..  ...+++||||
T Consensus         6 ~~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~~~~----~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~   81 (317)
T cd07868           6 GCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTGIS----MSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDY   81 (317)
T ss_pred             ccccccCCCeEEEEEEEccCCCCceEEEEEECCCCCc----HHHHHHHHHHHhcCCCCCcceeeeEecCCCcEEEEEEec
Confidence            46899999999999985    3478999999765322    346789999999999999999999854  4568999999


Q ss_pred             CCCCCHHHHHHhc--------CCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceee----cCCCcEEEeecccee
Q 015868          195 MARGSIYDFLHKQ--------KGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLM----DENGVVKVADFGVAR  262 (399)
Q Consensus       195 ~~ggsL~~~l~~~--------~~~l~~~~~~~i~~~i~~~L~~LH~~giiHrDlkp~NILl----~~~~~vkl~DFG~a~  262 (399)
                      +.+ +|.+++...        ...+++..+..++.||+.||.|||++||+||||||+|||+    +.++.+||+|||+++
T Consensus        82 ~~~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivHrDlkp~Nil~~~~~~~~~~~kl~DfG~a~  160 (317)
T cd07868          82 AEH-DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFAR  160 (317)
T ss_pred             cCC-CHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHhCCEEcCCCCHHHEEEecCCCCcCcEEEeecCcee
Confidence            865 898887532        2358899999999999999999999999999999999999    456799999999998


Q ss_pred             eccCCC----ccccCCCCcccccccccCC-CCCCChhhHHHHHHHHHHHHcCCCCCCCCCHH---------HHHHHHHhc
Q 015868          263 VQAQSG----VMTAETGTYRWMAPEVIEH-KPYDYKADVFSFGIALWELLTGELPYAGLTPL---------QAAVGVVQK  328 (399)
Q Consensus       263 ~~~~~~----~~~~~~gt~~y~aPE~l~~-~~~~~~~Dv~slG~vl~elltg~~P~~~~~~~---------~~~~~~~~~  328 (399)
                      ......    ......+|+.|+|||++.+ ..++.++||||+||++|+|++|++||......         .........
T Consensus       161 ~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~  240 (317)
T cd07868         161 LFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRIFNV  240 (317)
T ss_pred             ccCCCCccccccCCccccccccCCHHHcCCCCcCchhhHHHHHHHHHHHHhCCCCccCCcccccccccccHHHHHHHHHh
Confidence            654322    2234568999999999977 45899999999999999999999999643210         001111000


Q ss_pred             c-----------------------C-CC------------CCCCCCcHHHHHHHHHHhhhcCCCCCCHHHHHH
Q 015868          329 S-----------------------L-RP------------TIPKHAHPRLAELLERCWQHDPTQRPNFSQITD  365 (399)
Q Consensus       329 ~-----------------------~-~~------------~~~~~~~~~l~~ll~~cl~~dP~~Rps~~ell~  365 (399)
                      .                       . +.            ......+.++.+||.+||+.||.+|||++|+++
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R~t~~e~l~  313 (317)
T cd07868         241 MGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITSEQAMQ  313 (317)
T ss_pred             cCCCChHHhHHHhhccchhhhhhhhhccccCcccccchHHhcCCCCChHHHHHHHHHhccCcccCCCHHHHhc
Confidence            0                       0 00            001123567899999999999999999999875

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p

>cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin

Probab=100.00  E-value=3.5e-39  Score=306.27  Aligned_cols=247  Identities=29%  Similarity=0.494  Sum_probs=205.5

Q ss_pred             ccccceeceeceeCceEEEEEEE--CCeeEEEEEecCCCCCHHHHHHHHHHHHHHHhc-CCCceeeEEeEEecC-----C
Q 015868          115 AKQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKI-RHKNVVQFIGACTRP-----P  186 (399)
Q Consensus       115 ~~~~~i~~~lg~G~~g~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~Ei~~l~~l-~h~nIv~~~~~~~~~-----~  186 (399)
                      .++|++.+.||+|+||.||++..  .++.+|+|++....   .....+.+|+.+++++ +|||++++++++...     .
T Consensus        21 ~~~y~~~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~~---~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~~~~~~~~   97 (291)
T cd06639          21 TDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPIS---DVDEEIEAEYNILQSLPNHPNVVKFYGMFYKADKLVGG   97 (291)
T ss_pred             CCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEecccc---cHHHHHHHHHHHHHHhcCCCCeEEEEEEEEeccccCCC
Confidence            56899999999999999999987  57889999987532   2235677899999999 799999999998654     3


Q ss_pred             cEEEEEecCCCCCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceeecCCCcEEEeeccceee
Q 015868          187 NLCIVTEFMARGSIYDFLHK---QKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARV  263 (399)
Q Consensus       187 ~~~lV~E~~~ggsL~~~l~~---~~~~l~~~~~~~i~~~i~~~L~~LH~~giiHrDlkp~NILl~~~~~vkl~DFG~a~~  263 (399)
                      ..++||||++|++|.++++.   ....+++..++.++.|++.||.|||+.|++||||||+||+++.++.+||+|||.+..
T Consensus        98 ~~~lv~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~nili~~~~~~kl~dfg~~~~  177 (291)
T cd06639          98 QLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHNNRIIHRDVKGNNILLTTEGGVKLVDFGVSAQ  177 (291)
T ss_pred             eeEEEEEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEEcCCCCEEEeecccchh
Confidence            58999999999999998864   345789999999999999999999999999999999999999999999999999875


Q ss_pred             ccCCC-ccccCCCCcccccccccCCC-----CCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhccCCC--CCC
Q 015868          264 QAQSG-VMTAETGTYRWMAPEVIEHK-----PYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKSLRP--TIP  335 (399)
Q Consensus       264 ~~~~~-~~~~~~gt~~y~aPE~l~~~-----~~~~~~Dv~slG~vl~elltg~~P~~~~~~~~~~~~~~~~~~~~--~~~  335 (399)
                      ..... ......++..|+|||.+...     .++.++|+||||+++|+|++|+.||...++.+........ ..+  ..+
T Consensus       178 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~~~~~~~~~~~~~~~~-~~~~~~~~  256 (291)
T cd06639         178 LTSTRLRRNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHPVKTLFKIPRN-PPPTLLHP  256 (291)
T ss_pred             cccccccccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCCCCCCCcHHHHHHHHhcC-CCCCCCcc
Confidence            44322 22334678899999998643     3678999999999999999999999888776655443322 222  224


Q ss_pred             CCCcHHHHHHHHHHhhhcCCCCCCHHHHHH
Q 015868          336 KHAHPRLAELLERCWQHDPTQRPNFSQITD  365 (399)
Q Consensus       336 ~~~~~~l~~ll~~cl~~dP~~Rps~~ell~  365 (399)
                      ..++..+.+++.+||+.+|++||++.++++
T Consensus       257 ~~~~~~l~~li~~~l~~~p~~Rps~~~il~  286 (291)
T cd06639         257 EKWCRSFNHFISQCLIKDFEARPSVTHLLE  286 (291)
T ss_pred             cccCHHHHHHHHHHhhcChhhCcCHHHHhc
Confidence            457789999999999999999999999975

Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre

>KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism]

Probab=100.00  E-value=1e-40  Score=298.23  Aligned_cols=256  Identities=24%  Similarity=0.407  Sum_probs=215.3

Q ss_pred             cccceeceeceeCceEEEEEEE--CCeeEEEEEecCCCC------CHHHHHHHHHHHHHHHhc-CCCceeeEEeEEecCC
Q 015868          116 KQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECV------NTEMLKEFSQEVYIMRKI-RHKNVVQFIGACTRPP  186 (399)
Q Consensus       116 ~~~~i~~~lg~G~~g~Vy~~~~--~~~~vAvK~~~~~~~------~~~~~~~~~~Ei~~l~~l-~h~nIv~~~~~~~~~~  186 (399)
                      ..|.-.+.||.|..++|.++..  +++.+|+|++.....      ..+..+.-.+|+.||+++ .||+|+++.++|+.+.
T Consensus        17 ~~y~pkeilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~yes~s   96 (411)
T KOG0599|consen   17 AKYEPKEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDVYESDA   96 (411)
T ss_pred             hhcChHHHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeeeccCcc
Confidence            4677778899999999998855  688999999853211      234456678899999999 5999999999999999


Q ss_pred             cEEEEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceeecCCCcEEEeeccceeeccC
Q 015868          187 NLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQ  266 (399)
Q Consensus       187 ~~~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~giiHrDlkp~NILl~~~~~vkl~DFG~a~~~~~  266 (399)
                      .+++|+|.|+.|.|.|++.. .-.+++....+++.|++.|+.|||.++|+||||||+|||++++.++||+|||+++....
T Consensus        97 F~FlVFdl~prGELFDyLts-~VtlSEK~tR~iMrqlfegVeylHa~~IVHRDLKpENILlddn~~i~isDFGFa~~l~~  175 (411)
T KOG0599|consen   97 FVFLVFDLMPRGELFDYLTS-KVTLSEKETRRIMRQLFEGVEYLHARNIVHRDLKPENILLDDNMNIKISDFGFACQLEP  175 (411)
T ss_pred             hhhhhhhhcccchHHHHhhh-heeecHHHHHHHHHHHHHHHHHHHHhhhhhcccChhheeeccccceEEeccceeeccCC
Confidence            99999999999999999976 56789999999999999999999999999999999999999999999999999998888


Q ss_pred             CCccccCCCCcccccccccC------CCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcc--CCCCCCCCC
Q 015868          267 SGVMTAETGTYRWMAPEVIE------HKPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKS--LRPTIPKHA  338 (399)
Q Consensus       267 ~~~~~~~~gt~~y~aPE~l~------~~~~~~~~Dv~slG~vl~elltg~~P~~~~~~~~~~~~~~~~~--~~~~~~~~~  338 (399)
                      ......-+|||+|+|||.+.      +..|+...|+|++|++||.|+.|.+||-.....-.+..+.+..  ++.+-..++
T Consensus       176 GekLrelCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPFwHRkQmlMLR~ImeGkyqF~speWadi  255 (411)
T KOG0599|consen  176 GEKLRELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPFWHRKQMLMLRMIMEGKYQFRSPEWADI  255 (411)
T ss_pred             chhHHHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCchhHHHHHHHHHHHHhcccccCCcchhhc
Confidence            77778889999999999985      4578889999999999999999999996544333333333222  233334568


Q ss_pred             cHHHHHHHHHHhhhcCCCCCCHHHHHH--HHHHHHH
Q 015868          339 HPRLAELLERCWQHDPTQRPNFSQITD--ILKQMMK  372 (399)
Q Consensus       339 ~~~l~~ll~~cl~~dP~~Rps~~ell~--~L~~l~~  372 (399)
                      +....+||.+||+.||++|.|+.|++.  .+.++..
T Consensus       256 s~~~KdLIsrlLqVdp~~Ritake~LaHpff~q~~~  291 (411)
T KOG0599|consen  256 SATVKDLISRLLQVDPTKRITAKEALAHPFFIQIAQ  291 (411)
T ss_pred             cccHHHHHHHHHeeCchhcccHHHHhcChHHHHHHH
Confidence            889999999999999999999999986  4555544

>cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1

Probab=100.00  E-value=6.1e-39  Score=308.96  Aligned_cols=248  Identities=29%  Similarity=0.471  Sum_probs=213.0

Q ss_pred             cccceeceeceeCceEEEEEEE--CCeeEEEEEecCCC-CCHHHHHHHHHHHHHHHhcCCCceeeEEeEEecCCcEEEEE
Q 015868          116 KQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPEC-VNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVT  192 (399)
Q Consensus       116 ~~~~i~~~lg~G~~g~Vy~~~~--~~~~vAvK~~~~~~-~~~~~~~~~~~Ei~~l~~l~h~nIv~~~~~~~~~~~~~lV~  192 (399)
                      ..|...+.||+|+||.||++..  .+..||+|++.... ...+....+.+|+.+++.++|||++++++++..+...++||
T Consensus        25 ~~f~~~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~  104 (317)
T cd06635          25 KLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLREHTAWLVM  104 (317)
T ss_pred             hhhhhhheeccCCCeEEEEEEEcCCCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCeEEEEE
Confidence            4588899999999999999986  57889999987542 23455678999999999999999999999999999999999


Q ss_pred             ecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceeecCCCcEEEeeccceeeccCCCcccc
Q 015868          193 EFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTA  272 (399)
Q Consensus       193 E~~~ggsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~giiHrDlkp~NILl~~~~~vkl~DFG~a~~~~~~~~~~~  272 (399)
                      ||+.| ++.+.+......+++..+..++.+++.||.|||++||+||||+|+||+++.++.++|+|||.+.....   ...
T Consensus       105 e~~~g-~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~i~H~dL~p~Nil~~~~~~~kl~dfg~~~~~~~---~~~  180 (317)
T cd06635         105 EYCLG-SASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNMIHRDIKAGNILLTEPGQVKLADFGSASIASP---ANS  180 (317)
T ss_pred             eCCCC-CHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcccEEECCCCCEEEecCCCccccCC---ccc
Confidence            99975 88888877677799999999999999999999999999999999999999999999999998865432   234


Q ss_pred             CCCCcccccccccC---CCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhccCCCCCCCCCcHHHHHHHHHH
Q 015868          273 ETGTYRWMAPEVIE---HKPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRLAELLERC  349 (399)
Q Consensus       273 ~~gt~~y~aPE~l~---~~~~~~~~Dv~slG~vl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~c  349 (399)
                      ..+++.|+|||.+.   ...++.++|+||||+++|+|++|..||...+..............+..+..+++.+.+++.+|
T Consensus       181 ~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~  260 (317)
T cd06635         181 FVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPTLQSNEWSDYFRNFVDSC  260 (317)
T ss_pred             ccCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhccCCCCCCccccHHHHHHHHHH
Confidence            56888999999973   456889999999999999999999999887776665555554444444556889999999999


Q ss_pred             hhhcCCCCCCHHHHHHHH
Q 015868          350 WQHDPTQRPNFSQITDIL  367 (399)
Q Consensus       350 l~~dP~~Rps~~ell~~L  367 (399)
                      |+.+|.+||++.++++..
T Consensus       261 l~~~p~~Rpt~~~il~~~  278 (317)
T cd06635         261 LQKIPQDRPTSEELLKHM  278 (317)
T ss_pred             ccCCcccCcCHHHHHhCh
Confidence            999999999999998754

Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron

>cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3

Probab=100.00  E-value=1.7e-39  Score=307.07  Aligned_cols=248  Identities=23%  Similarity=0.400  Sum_probs=204.7

Q ss_pred             ccceeceeceeCceEEEEEEE--CCeeEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCceeeEEeEEecCCcEEEEEec
Q 015868          117 QLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVTEF  194 (399)
Q Consensus       117 ~~~i~~~lg~G~~g~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~nIv~~~~~~~~~~~~~lV~E~  194 (399)
                      +|++.+.||.|++|.||+|..  +++.||||.++...........+.+|+.++++++||||+++++++......++||||
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~   80 (284)
T cd07860           1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEF   80 (284)
T ss_pred             CceeeeeecCCCceEEEEEEECCCCCEEEEEEccccccccccchHHHHHHHHHHhcCCCCCcchhhhcccCCcEEEEeec
Confidence            478899999999999999987  578999999876544444456788999999999999999999999999999999999


Q ss_pred             CCCCCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceeecCCCcEEEeeccceeeccCCC-cccc
Q 015868          195 MARGSIYDFLHKQ-KGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSG-VMTA  272 (399)
Q Consensus       195 ~~ggsL~~~l~~~-~~~l~~~~~~~i~~~i~~~L~~LH~~giiHrDlkp~NILl~~~~~vkl~DFG~a~~~~~~~-~~~~  272 (399)
                      +. ++|.+++... ...+++..++.++.|++.||+|||+.|++|+||+|+||+++.++.++|+|||.++...... ....
T Consensus        81 ~~-~~l~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~i~H~~l~p~nill~~~~~~~l~dfg~~~~~~~~~~~~~~  159 (284)
T cd07860          81 LH-QDLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTH  159 (284)
T ss_pred             cc-cCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEEeeccchhhcccCcccccc
Confidence            96 5899988653 3568999999999999999999999999999999999999999999999999987544321 2233


Q ss_pred             CCCCcccccccccCCCC-CCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhccCCC-------------------
Q 015868          273 ETGTYRWMAPEVIEHKP-YDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKSLRP-------------------  332 (399)
Q Consensus       273 ~~gt~~y~aPE~l~~~~-~~~~~Dv~slG~vl~elltg~~P~~~~~~~~~~~~~~~~~~~~-------------------  332 (399)
                      ..++..|+|||.+.+.. ++.++||||||+++|+|+||+.||...+..............+                   
T Consensus       160 ~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (284)
T cd07860         160 EVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSLPDYKPSFP  239 (284)
T ss_pred             ccccccccCCeEEecCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhhhhHHHHHHhhcc
Confidence            45688999999887644 6889999999999999999999998766544433322211110                   


Q ss_pred             --------CCCCCCcHHHHHHHHHHhhhcCCCCCCHHHHHH
Q 015868          333 --------TIPKHAHPRLAELLERCWQHDPTQRPNFSQITD  365 (399)
Q Consensus       333 --------~~~~~~~~~l~~ll~~cl~~dP~~Rps~~ell~  365 (399)
                              .+...+++++.++|.+||+.||.+|||++++++
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~  280 (284)
T cd07860         240 KWARQDFSKVVPPLDEDGRDLLSQMLHYDPNKRISAKAALA  280 (284)
T ss_pred             cccccCHHHHcccCCHHHHHHHHHhcCCCcccCCCHHHHhc
Confidence                    012346789999999999999999999999874

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex

>cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases

Probab=100.00  E-value=3.1e-39  Score=306.52  Aligned_cols=249  Identities=24%  Similarity=0.393  Sum_probs=200.9

Q ss_pred             ccccceeceeceeCceEEEEEEE--CCeeEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCceeeEEeEEecCCcEEEEE
Q 015868          115 AKQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVT  192 (399)
Q Consensus       115 ~~~~~i~~~lg~G~~g~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~nIv~~~~~~~~~~~~~lV~  192 (399)
                      .++|++.+.||.|++|.||+|..  .++.||+|.+...... .....+.+|+.+++.++|+||+++++++......++||
T Consensus         4 ~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   82 (291)
T cd07844           4 LETYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEE-GAPFTAIREASLLKDLKHANIVTLHDIIHTKKTLTLVF   82 (291)
T ss_pred             ccceeEEEEEeecCCeEEEEEEEcCCCcEEEEEEEeccccc-CCchhHHHHHHHHhhCCCcceeeEEEEEecCCeEEEEE
Confidence            36899999999999999999987  5788999998754322 22345678999999999999999999999999999999


Q ss_pred             ecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceeecCCCcEEEeeccceeeccCCC-ccc
Q 015868          193 EFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSG-VMT  271 (399)
Q Consensus       193 E~~~ggsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~giiHrDlkp~NILl~~~~~vkl~DFG~a~~~~~~~-~~~  271 (399)
                      ||+.+ +|.+++......+++..++.++.|++.||.|||++||+||||||+||+++.++.+||+|||.++...... ...
T Consensus        83 e~~~~-~L~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~  161 (291)
T cd07844          83 EYLDT-DLKQYMDDCGGGLSMHNVRLFLFQLLRGLAYCHQRRVLHRDLKPQNLLISERGELKLADFGLARAKSVPSKTYS  161 (291)
T ss_pred             ecCCC-CHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCHHHEEEcCCCCEEECccccccccCCCCcccc
Confidence            99985 9999998766788999999999999999999999999999999999999999999999999987543221 122


Q ss_pred             cCCCCcccccccccCC-CCCCChhhHHHHHHHHHHHHcCCCCCCCCC-HHHHHHHHHhccC-------------------
Q 015868          272 AETGTYRWMAPEVIEH-KPYDYKADVFSFGIALWELLTGELPYAGLT-PLQAAVGVVQKSL-------------------  330 (399)
Q Consensus       272 ~~~gt~~y~aPE~l~~-~~~~~~~Dv~slG~vl~elltg~~P~~~~~-~~~~~~~~~~~~~-------------------  330 (399)
                      ...++..|+|||.+.+ ..++.++||||+|+++|+|++|..||...+ ..+..........                   
T Consensus       162 ~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  241 (291)
T cd07844         162 NEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGSTDVEDQLHKIFRVLGTPTEETWPGVSSNPEFKPY  241 (291)
T ss_pred             ccccccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHhcCCCChhhhhhhhhccccccc
Confidence            3356889999999875 468899999999999999999999997665 2221111110000                   


Q ss_pred             --C----C---CCCCCCc--HHHHHHHHHHhhhcCCCCCCHHHHHH
Q 015868          331 --R----P---TIPKHAH--PRLAELLERCWQHDPTQRPNFSQITD  365 (399)
Q Consensus       331 --~----~---~~~~~~~--~~l~~ll~~cl~~dP~~Rps~~ell~  365 (399)
                        .    .   .....++  .++.+++.+||+.+|++|||+.++++
T Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~p~~Rps~~e~l~  287 (291)
T cd07844         242 SFPFYPPRPLINHAPRLDRIPHGEELALKFLQYEPKKRISAAEAMK  287 (291)
T ss_pred             cccccCChhHHHhCcCCCCchhHHHHHHHHhccCcccccCHHHHhc
Confidence              0    0   0001233  78899999999999999999999864

Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the

>cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase

Probab=100.00  E-value=2.4e-39  Score=305.38  Aligned_cols=239  Identities=24%  Similarity=0.391  Sum_probs=199.3

Q ss_pred             eceeCceEEEEEEE--CCeeEEEEEecCCCCC-HHHHHHHHHHHHHHHhcCCCceeeEEeEEecCCcEEEEEecCCCCCH
Q 015868          124 VASGSYGDLYKGTY--CSQEVAIKVLKPECVN-TEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVTEFMARGSI  200 (399)
Q Consensus       124 lg~G~~g~Vy~~~~--~~~~vAvK~~~~~~~~-~~~~~~~~~Ei~~l~~l~h~nIv~~~~~~~~~~~~~lV~E~~~ggsL  200 (399)
                      ||+|+||.||++..  +++.||+|++...... ......+.+|+.+++.++||||+++++.+...+..|+||||+++++|
T Consensus         1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L   80 (277)
T cd05577           1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAYAFETKDDLCLVMTLMNGGDL   80 (277)
T ss_pred             CCCCCceeEEEEEEcCCCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhCCCCCEeeeeeEEecCCeEEEEEecCCCCcH
Confidence            68999999999976  5789999998754322 23345677899999999999999999999999999999999999999


Q ss_pred             HHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceeecCCCcEEEeeccceeeccCCCccccCCCCccc
Q 015868          201 YDFLHKQK-GVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAETGTYRW  279 (399)
Q Consensus       201 ~~~l~~~~-~~l~~~~~~~i~~~i~~~L~~LH~~giiHrDlkp~NILl~~~~~vkl~DFG~a~~~~~~~~~~~~~gt~~y  279 (399)
                      .+++.... ..+++..+..++.|++.||.|||++|++||||+|+||++++++.++|+|||.+.............++..|
T Consensus        81 ~~~l~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~di~p~Nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~y  160 (277)
T cd05577          81 KYHIYNVGEPGFPEARAIFYAAQIICGLEHLHQRRIVYRDLKPENVLLDDHGNVRISDLGLAVELKGGKKIKGRAGTPGY  160 (277)
T ss_pred             HHHHHHcCcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEEccCcchhhhccCCccccccCCCCc
Confidence            99997644 36899999999999999999999999999999999999999999999999998765543334445678899


Q ss_pred             ccccccCCCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHH--HHhccCCCCCCCCCcHHHHHHHHHHhhhcCCCC
Q 015868          280 MAPEVIEHKPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVG--VVQKSLRPTIPKHAHPRLAELLERCWQHDPTQR  357 (399)
Q Consensus       280 ~aPE~l~~~~~~~~~Dv~slG~vl~elltg~~P~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~l~~ll~~cl~~dP~~R  357 (399)
                      +|||.+.+..++.++|+||||+++|+|++|+.||...........  ..........+..+++++.++|.+||+.+|.+|
T Consensus       161 ~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R  240 (277)
T cd05577         161 MAPEVLQGEVYDFSVDWFALGCTLYEMIAGRSPFRQRKEKVEKEELKRRTLEMAVEYPDKFSPEAKDLCEALLQKDPEKR  240 (277)
T ss_pred             CCHHHhcCCCCCchhhhHHHHHHHHHHhhCCCCCCCCcccccHHHHHhccccccccCCccCCHHHHHHHHHHccCChhHc
Confidence            999999888899999999999999999999999977543111111  111123445667789999999999999999999


Q ss_pred             CCHHH
Q 015868          358 PNFSQ  362 (399)
Q Consensus       358 ps~~e  362 (399)
                      |++++
T Consensus       241 ~~~~~  245 (277)
T cd05577         241 LGCRG  245 (277)
T ss_pred             cCCCc
Confidence            95444

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of

>PHA03211 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=2e-39  Score=326.18  Aligned_cols=241  Identities=22%  Similarity=0.347  Sum_probs=196.4

Q ss_pred             ccccceeceeceeCceEEEEEEE--CCeeEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCceeeEEeEEecCCcEEEEE
Q 015868          115 AKQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVT  192 (399)
Q Consensus       115 ~~~~~i~~~lg~G~~g~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~nIv~~~~~~~~~~~~~lV~  192 (399)
                      ...|.+.+.||.|+||.||++.+  .++.||||....        ..+.+|+.++++++|+||+++++++..+...++||
T Consensus       168 ~~gy~i~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~~--------~~~~~E~~iL~~L~HpnIv~l~~~~~~~~~~~lv~  239 (461)
T PHA03211        168 GLGFAIHRALTPGSEGCVFESSHPDYPQRVVVKAGWY--------ASSVHEARLLRRLSHPAVLALLDVRVVGGLTCLVL  239 (461)
T ss_pred             cCCeEEEEEEccCCCeEEEEEEECCCCCEEEEecccc--------cCHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEE
Confidence            45799999999999999999988  467899996432        23568999999999999999999999999999999


Q ss_pred             ecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceeecCCCcEEEeeccceeeccCCCc---
Q 015868          193 EFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGV---  269 (399)
Q Consensus       193 E~~~ggsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~giiHrDlkp~NILl~~~~~vkl~DFG~a~~~~~~~~---  269 (399)
                      |++. ++|.+++......+++..++.++.|++.||.|||++||+||||||+|||++.++.+||+|||+++.......   
T Consensus       240 e~~~-~~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIvHrDLKP~NILl~~~~~vkL~DFGla~~~~~~~~~~~  318 (461)
T PHA03211        240 PKYR-SDLYTYLGARLRPLGLAQVTAVARQLLSAIDYIHGEGIIHRDIKTENVLVNGPEDICLGDFGAACFARGSWSTPF  318 (461)
T ss_pred             EccC-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEEECcCCHHHEEECCCCCEEEcccCCceeccccccccc
Confidence            9995 599999877667899999999999999999999999999999999999999999999999999976543221   


Q ss_pred             cccCCCCcccccccccCCCCCCChhhHHHHHHHHHHHHcCCCCCCCC--------CHHHHHHHHHhccC-----------
Q 015868          270 MTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPYAGL--------TPLQAAVGVVQKSL-----------  330 (399)
Q Consensus       270 ~~~~~gt~~y~aPE~l~~~~~~~~~Dv~slG~vl~elltg~~P~~~~--------~~~~~~~~~~~~~~-----------  330 (399)
                      .....||..|+|||++.+..++.++|||||||++|||++|..|+-..        ...+. ...++...           
T Consensus       319 ~~~~~GT~~Y~APE~~~~~~~~~~sDvwSlGviL~El~~g~~~lf~~~~~~~~~~~~~~l-~~~i~~~~~~~~~~~~~~~  397 (461)
T PHA03211        319 HYGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFEAAVHTASLFSASRGDERRPYDAQI-LRIIRQAQVHVDEFPQHAG  397 (461)
T ss_pred             ccccCCCcCCcCHHHHcCCCCCchHHHHHHHHHHHHHHHcCCCcccCCcccccCCcHHHH-HHHHHhhccccccCCCCcc
Confidence            22346899999999999999999999999999999999977554221        11121 11111100           


Q ss_pred             ---------------CCCCC-------CCCcHHHHHHHHHHhhhcCCCCCCHHHHHH
Q 015868          331 ---------------RPTIP-------KHAHPRLAELLERCWQHDPTQRPNFSQITD  365 (399)
Q Consensus       331 ---------------~~~~~-------~~~~~~l~~ll~~cl~~dP~~Rps~~ell~  365 (399)
                                     ++...       ...+.++.+||.+||+.||.+|||+.|+++
T Consensus       398 ~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~DP~~RPsa~elL~  454 (461)
T PHA03211        398 SRLVSQYRHRAARNRRPAYTRPAWTRYYKLDLDVEYLVCRALTFDGARRPSAAELLR  454 (461)
T ss_pred             hHHHHHHHhhhhcccCCccCCcchhhhccccchHHHHHHHHcccChhhCcCHHHHhh
Confidence                           00000       134568999999999999999999999986

>cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase

Probab=100.00  E-value=4.4e-39  Score=304.88  Aligned_cols=248  Identities=33%  Similarity=0.555  Sum_probs=212.1

Q ss_pred             ccccceeceeceeCceEEEEEEEC--CeeEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCceeeEEeEEecCCcEEEEE
Q 015868          115 AKQLKIECKVASGSYGDLYKGTYC--SQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVT  192 (399)
Q Consensus       115 ~~~~~i~~~lg~G~~g~Vy~~~~~--~~~vAvK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~nIv~~~~~~~~~~~~~lV~  192 (399)
                      .+.|++...||+|++|.||++.+.  ++.|++|+++....   ....+.+|+.+++.++|+|++++++.+......++|+
T Consensus        18 ~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~---~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~   94 (286)
T cd06614          18 RELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQ---NKELIINEILIMKDCKHPNIVDYYDSYLVGDELWVVM   94 (286)
T ss_pred             cccchHhHhccCCCCeEEEEEEEccCCcEEEEEEEecCch---hHHHHHHHHHHHHHCCCCCeeEEEEEEEECCEEEEEE
Confidence            456888899999999999999885  78999999986532   4567889999999999999999999999999999999


Q ss_pred             ecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceeecCCCcEEEeeccceeeccCCC-ccc
Q 015868          193 EFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSG-VMT  271 (399)
Q Consensus       193 E~~~ggsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~giiHrDlkp~NILl~~~~~vkl~DFG~a~~~~~~~-~~~  271 (399)
                      ||+++++|.+++......++...+..++.+++.||.|||+.|++|+||+|+||+++.++.++|+|||.+....... ...
T Consensus        95 e~~~~~~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~lH~~gi~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~~~  174 (286)
T cd06614          95 EYMDGGSLTDIITQNFVRMNEPQIAYVCREVLQGLEYLHSQNVIHRDIKSDNILLSKDGSVKLADFGFAAQLTKEKSKRN  174 (286)
T ss_pred             eccCCCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCChhhEEEcCCCCEEECccchhhhhccchhhhc
Confidence            9999999999998765579999999999999999999999999999999999999999999999999886543321 123


Q ss_pred             cCCCCcccccccccCCCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhccCCCC-CCCCCcHHHHHHHHHHh
Q 015868          272 AETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKSLRPT-IPKHAHPRLAELLERCW  350 (399)
Q Consensus       272 ~~~gt~~y~aPE~l~~~~~~~~~Dv~slG~vl~elltg~~P~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~l~~ll~~cl  350 (399)
                      ...++..|+|||.+.+..++.++|+||||+++|+|++|..||....+.............+. .+..++.++.+++.+||
T Consensus       175 ~~~~~~~y~~PE~~~~~~~~~~~Dv~slGvil~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l  254 (286)
T cd06614         175 SVVGTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEGEPPYLREPPLRALFLITTKGIPPLKNPEKWSPEFKDFLNKCL  254 (286)
T ss_pred             cccCCcccCCHhHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCcchhhCCHHHHHHHHHHh
Confidence            34578899999999988899999999999999999999999988777655444333322221 22337899999999999


Q ss_pred             hhcCCCCCCHHHHHH
Q 015868          351 QHDPTQRPNFSQITD  365 (399)
Q Consensus       351 ~~dP~~Rps~~ell~  365 (399)
                      +.+|.+||++.++++
T Consensus       255 ~~~p~~Rpt~~~il~  269 (286)
T cd06614         255 VKDPEKRPSAEELLQ  269 (286)
T ss_pred             ccChhhCcCHHHHhh
Confidence            999999999999975

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou

>cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase

Probab=100.00  E-value=5.9e-39  Score=304.40  Aligned_cols=244  Identities=31%  Similarity=0.523  Sum_probs=207.2

Q ss_pred             ccceeceeceeCceEEEEEEE--CCeeEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCceeeEEeEEecCCcEEEEEec
Q 015868          117 QLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVTEF  194 (399)
Q Consensus       117 ~~~i~~~lg~G~~g~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~nIv~~~~~~~~~~~~~lV~E~  194 (399)
                      .|.-.+.||.|++|.||++..  .++.+++|.++..  .....+.+.+|+.+++.++||||+++++++..+...++|+||
T Consensus        20 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~--~~~~~~~~~~e~~~l~~~~h~~vv~~~~~~~~~~~~~~v~e~   97 (285)
T cd06648          20 YLDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLR--KQQRRELLFNEVVIMRDYQHPNIVEMYSSYLVGDELWVVMEF   97 (285)
T ss_pred             hhhcceEeccCCCeEEEEEEECCCCCEEEEEEEecc--chhHHHHHHHHHHHHHHcCCCChheEEEEEEcCCeEEEEEec
Confidence            455567999999999999976  5688999998643  333456788999999999999999999999999999999999


Q ss_pred             CCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceeecCCCcEEEeeccceeeccCCC-ccccC
Q 015868          195 MARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSG-VMTAE  273 (399)
Q Consensus       195 ~~ggsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~giiHrDlkp~NILl~~~~~vkl~DFG~a~~~~~~~-~~~~~  273 (399)
                      +.|++|.+++..  ..++...+..++.|++.||+|||++|++||||+|+||+++.++.++|+|||.+....... .....
T Consensus        98 ~~~~~L~~~~~~--~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~l~d~g~~~~~~~~~~~~~~~  175 (285)
T cd06648          98 LEGGALTDIVTH--TRMNEEQIATVCLAVLKALSFLHAQGVIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEVPRRKSL  175 (285)
T ss_pred             cCCCCHHHHHHh--CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCChhhEEEcCCCcEEEcccccchhhccCCcccccc
Confidence            999999999876  568999999999999999999999999999999999999999999999999886543321 22334


Q ss_pred             CCCcccccccccCCCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhccCCCCC--CCCCcHHHHHHHHHHhh
Q 015868          274 TGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKSLRPTI--PKHAHPRLAELLERCWQ  351 (399)
Q Consensus       274 ~gt~~y~aPE~l~~~~~~~~~Dv~slG~vl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~l~~ll~~cl~  351 (399)
                      .|++.|+|||.+.+..++.++|+||||+++|+|++|+.||...++.+....... ...+..  +..++..+.+++.+||+
T Consensus       176 ~~~~~y~aPE~~~~~~~~~~~Dv~slGv~l~ell~g~~p~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~l~~li~~~l~  254 (285)
T cd06648         176 VGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGEPPYFNEPPLQAMKRIRD-NLPPKLKNLHKVSPRLRSFLDRMLV  254 (285)
T ss_pred             cCCccccCHHHhcCCCCCCcccHHHHHHHHHHHHhCCCCCcCCCHHHHHHHHHh-cCCCCCcccccCCHHHHHHHHHHcc
Confidence            688999999999988899999999999999999999999988777665544333 222232  23378899999999999


Q ss_pred             hcCCCCCCHHHHHH
Q 015868          352 HDPTQRPNFSQITD  365 (399)
Q Consensus       352 ~dP~~Rps~~ell~  365 (399)
                      .+|++||++.++++
T Consensus       255 ~~p~~Rpt~~~il~  268 (285)
T cd06648         255 RDPAQRATAAELLN  268 (285)
T ss_pred             cChhhCcCHHHHcc
Confidence            99999999999875

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun

>cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5

Probab=100.00  E-value=1.4e-39  Score=309.82  Aligned_cols=244  Identities=29%  Similarity=0.499  Sum_probs=206.8

Q ss_pred             ccceeceeceeCceEEEEEEE--CCeeEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCceeeEEeEEecCCcEEEEEec
Q 015868          117 QLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVTEF  194 (399)
Q Consensus       117 ~~~i~~~lg~G~~g~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~nIv~~~~~~~~~~~~~lV~E~  194 (399)
                      .|.....||.|+||.||++..  ++..||||.+...  .....+.+.+|+.+++.++|+||+++++.+..++..++||||
T Consensus        23 ~~~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~lv~e~  100 (292)
T cd06658          23 YLDSFIKIGEGSTGIVCIATEKHTGKQVAVKKMDLR--KQQRRELLFNEVVIMRDYHHENVVDMYNSYLVGDELWVVMEF  100 (292)
T ss_pred             HHhhhhcccCCCCeEEEEEEECCCCCEEEEEEEecc--hHHHHHHHHHHHHHHHhCCCCcHHHHHHheecCCeEEEEEeC
Confidence            455567899999999999986  5788999998653  344456789999999999999999999999999999999999


Q ss_pred             CCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceeecCCCcEEEeeccceeeccCCC-ccccC
Q 015868          195 MARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSG-VMTAE  273 (399)
Q Consensus       195 ~~ggsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~giiHrDlkp~NILl~~~~~vkl~DFG~a~~~~~~~-~~~~~  273 (399)
                      +++++|.+++..  +.+++..++.++.||+.||+|||++||+||||||+||++++++.++|+|||++....... .....
T Consensus       101 ~~~~~L~~~~~~--~~l~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~~kL~dfg~~~~~~~~~~~~~~~  178 (292)
T cd06658         101 LEGGALTDIVTH--TRMNEEQIATVCLSVLRALSYLHNQGVIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEVPKRKSL  178 (292)
T ss_pred             CCCCcHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcCCCCEEEccCcchhhcccccccCcee
Confidence            999999998854  468999999999999999999999999999999999999999999999999986543221 22335


Q ss_pred             CCCcccccccccCCCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhccCCCCC--CCCCcHHHHHHHHHHhh
Q 015868          274 TGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKSLRPTI--PKHAHPRLAELLERCWQ  351 (399)
Q Consensus       274 ~gt~~y~aPE~l~~~~~~~~~Dv~slG~vl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~l~~ll~~cl~  351 (399)
                      .++..|+|||.+.+..++.++|+||||+++|+|++|+.||...++.+...... ....+..  ...++..+.+++.+||.
T Consensus       179 ~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~li~~~l~  257 (292)
T cd06658         179 VGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEPPYFNEPPLQAMRRIR-DNLPPRVKDSHKVSSVLRGFLDLMLV  257 (292)
T ss_pred             ecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH-hcCCCccccccccCHHHHHHHHHHcc
Confidence            68899999999998889999999999999999999999998877765444322 2222222  23578899999999999


Q ss_pred             hcCCCCCCHHHHHH
Q 015868          352 HDPTQRPNFSQITD  365 (399)
Q Consensus       352 ~dP~~Rps~~ell~  365 (399)
                      .+|.+|||++++++
T Consensus       258 ~~P~~Rpt~~~il~  271 (292)
T cd06658         258 REPSQRATAQELLQ  271 (292)
T ss_pred             CChhHCcCHHHHhh
Confidence            99999999999986

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express

>cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases

Probab=100.00  E-value=3.2e-39  Score=305.00  Aligned_cols=247  Identities=22%  Similarity=0.380  Sum_probs=205.1

Q ss_pred             cceeceeceeCceEEEEEEE--CCeeEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCceeeEEeEEecCCcEEEEEecC
Q 015868          118 LKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVTEFM  195 (399)
Q Consensus       118 ~~i~~~lg~G~~g~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~nIv~~~~~~~~~~~~~lV~E~~  195 (399)
                      |++.+.||.|++|.||+|..  ++..||+|++............+.+|+.+++.++|||++++++++..+...+++|||+
T Consensus         1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~~~~iv~~~~~~~~~~~~~iv~e~~   80 (283)
T cd07835           1 YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLDVVHSENKLYLVFEFL   80 (283)
T ss_pred             CchheEecCCCCeEEEEEEEcCCCCEEEEEEeecccccccchhHHHHHHHHHHhcCCCCccCHhheeccCCeEEEEEecc
Confidence            57788999999999999986  6889999999865444444567889999999999999999999999999999999999


Q ss_pred             CCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceeecCCCcEEEeeccceeeccCCC-ccccC
Q 015868          196 ARGSIYDFLHKQK-GVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSG-VMTAE  273 (399)
Q Consensus       196 ~ggsL~~~l~~~~-~~l~~~~~~~i~~~i~~~L~~LH~~giiHrDlkp~NILl~~~~~vkl~DFG~a~~~~~~~-~~~~~  273 (399)
                      + ++|.+++.... ..+++..+..++.|++.||+|||+++++||||+|+||+++.++.++|+|||.++...... .....
T Consensus        81 ~-~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~~~~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~  159 (283)
T cd07835          81 D-LDLKKYMDSSPLTGLDPPLIKSYLYQLLQGIAYCHSHRVLHRDLKPQNLLIDREGALKLADFGLARAFGVPVRTYTHE  159 (283)
T ss_pred             C-cCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCHHHEEEcCCCcEEEeecccccccCCCccccCcc
Confidence            5 59999987644 468999999999999999999999999999999999999999999999999997543321 22334


Q ss_pred             CCCcccccccccCCC-CCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhccC----------------------
Q 015868          274 TGTYRWMAPEVIEHK-PYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKSL----------------------  330 (399)
Q Consensus       274 ~gt~~y~aPE~l~~~-~~~~~~Dv~slG~vl~elltg~~P~~~~~~~~~~~~~~~~~~----------------------  330 (399)
                      .++..|+|||.+.+. .++.++|+||||+++|+|++|+.||...+.............                      
T Consensus       160 ~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (283)
T cd07835         160 VVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEIDQLFRIFRTLGTPDEDVWPGVTSLPDYKPTFPK  239 (283)
T ss_pred             ccccCCCCCceeecCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhhhhhchhhhhhccc
Confidence            568899999988664 578999999999999999999999988776544333222100                      


Q ss_pred             -----CCCCCCCCcHHHHHHHHHHhhhcCCCCCCHHHHHH
Q 015868          331 -----RPTIPKHAHPRLAELLERCWQHDPTQRPNFSQITD  365 (399)
Q Consensus       331 -----~~~~~~~~~~~l~~ll~~cl~~dP~~Rps~~ell~  365 (399)
                           .......++.++.+++.+||+.+|.+|||+.|+++
T Consensus       240 ~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~  279 (283)
T cd07835         240 WARQDLSKVVPNLDEDGLDLLSKMLVYDPAKRISAKAALQ  279 (283)
T ss_pred             ccccchhhhcCCCCHHHHHHHHHHhcCChhhCcCHHHHhc
Confidence                 01123457789999999999999999999999874

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc

>cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases

Probab=100.00  E-value=9.9e-39  Score=302.89  Aligned_cols=247  Identities=28%  Similarity=0.485  Sum_probs=203.8

Q ss_pred             cccceeceeceeCceEEEEEEE--CCeeEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCceeeEEeEEecC--CcEEEE
Q 015868          116 KQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRP--PNLCIV  191 (399)
Q Consensus       116 ~~~~i~~~lg~G~~g~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~nIv~~~~~~~~~--~~~~lV  191 (399)
                      ++|.+.++||.|++|.||++..  +++.+|+|++.... .......+.+|+++++.++||||+++++++...  ..+++|
T Consensus         1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv   79 (287)
T cd06621           1 EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDP-NPDLQKQILRELEINKSCKSPYIVKYYGAFLDESSSSIGIA   79 (287)
T ss_pred             CceEEEEEeccCCceEEEEEEECCCCeEEEEEEEecCC-chHHHHHHHHHHHHHHhCCCCCeeeeeeEEEccCCCeEEEE
Confidence            3688899999999999999987  57899999987543 234567899999999999999999999998653  468999


Q ss_pred             EecCCCCCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceeecCCCcEEEeeccceeeccCCC
Q 015868          192 TEFMARGSIYDFLHK---QKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSG  268 (399)
Q Consensus       192 ~E~~~ggsL~~~l~~---~~~~l~~~~~~~i~~~i~~~L~~LH~~giiHrDlkp~NILl~~~~~vkl~DFG~a~~~~~~~  268 (399)
                      |||+++++|.+++..   ....+++..+..++.|++.||+|||+.|++|+||+|.||+++.++.++|+|||++.......
T Consensus        80 ~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~  159 (287)
T cd06621          80 MEYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHSRKIIHRDIKPSNILLTRKGQVKLCDFGVSGELVNSL  159 (287)
T ss_pred             EEecCCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEecCCeEEEeeccccccccccc
Confidence            999999999988753   34568899999999999999999999999999999999999999999999999986543322


Q ss_pred             ccccCCCCcccccccccCCCCCCChhhHHHHHHHHHHHHcCCCCCCCC-----CHHHHHHHHHhccCCCCCC------CC
Q 015868          269 VMTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPYAGL-----TPLQAAVGVVQKSLRPTIP------KH  337 (399)
Q Consensus       269 ~~~~~~gt~~y~aPE~l~~~~~~~~~Dv~slG~vl~elltg~~P~~~~-----~~~~~~~~~~~~~~~~~~~------~~  337 (399)
                       .....++..|+|||.+.+..++.++|+||||+++|+|++|+.||...     .+.+...... ....+.++      ..
T Consensus       160 -~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~  237 (287)
T cd06621         160 -AGTFTGTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFPFPPEGEPPLGPIELLSYIV-NMPNPELKDEPGNGIK  237 (287)
T ss_pred             -cccccCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCcccCCCCChHHHHHHHh-cCCchhhccCCCCCCc
Confidence             22345788999999999999999999999999999999999999765     2233222222 21222222      23


Q ss_pred             CcHHHHHHHHHHhhhcCCCCCCHHHHHH
Q 015868          338 AHPRLAELLERCWQHDPTQRPNFSQITD  365 (399)
Q Consensus       338 ~~~~l~~ll~~cl~~dP~~Rps~~ell~  365 (399)
                      +++.+.+++.+||..+|.+|||+.|+++
T Consensus       238 ~~~~~~~li~~~l~~~p~~Rpt~~eil~  265 (287)
T cd06621         238 WSEEFKDFIKQCLEKDPTRRPTPWDMLE  265 (287)
T ss_pred             hHHHHHHHHHHHcCCCcccCCCHHHHHh
Confidence            5688999999999999999999999877

Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase

Probab=100.00  E-value=4e-39  Score=306.21  Aligned_cols=249  Identities=22%  Similarity=0.359  Sum_probs=203.2

Q ss_pred             cccceeceeceeCceEEEEEEE--CCeeEEEEEecCCCCCHHHHHHHHHHHHHHHhcC-CCceeeEEeEEecCCc-----
Q 015868          116 KQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIR-HKNVVQFIGACTRPPN-----  187 (399)
Q Consensus       116 ~~~~i~~~lg~G~~g~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~Ei~~l~~l~-h~nIv~~~~~~~~~~~-----  187 (399)
                      ++|++.+.||+|+||.||+|.+  +++.||+|+++...........+.+|+.+++.+. ||||+++++++.....     
T Consensus         1 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~~   80 (295)
T cd07837           1 DAYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGKPS   80 (295)
T ss_pred             CCceEeeEecccCCeEEEEEEECCCCcEEEEEeehhhccccCCchHHHHHHHHHHHccCCCCccceeeeEeecCCCCCce
Confidence            3688999999999999999987  5789999998765433334467888999999995 6999999999877665     


Q ss_pred             EEEEEecCCCCCHHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceeecC-CCcEEEeecccee
Q 015868          188 LCIVTEFMARGSIYDFLHKQK----GVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDE-NGVVKVADFGVAR  262 (399)
Q Consensus       188 ~~lV~E~~~ggsL~~~l~~~~----~~l~~~~~~~i~~~i~~~L~~LH~~giiHrDlkp~NILl~~-~~~vkl~DFG~a~  262 (399)
                      .|+||||+++ +|.+++....    ..+++..++.++.||+.||.|||++||+||||+|+||+++. ++.+||+|||.++
T Consensus        81 ~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dl~~~nil~~~~~~~~kl~dfg~~~  159 (295)
T cd07837          81 LYLVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHKHGVMHRDLKPQNLLVDKQKGLLKIADLGLGR  159 (295)
T ss_pred             EEEEeeccCc-CHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChHHEEEecCCCeEEEeecccce
Confidence            8999999986 8988886532    45899999999999999999999999999999999999998 8999999999987


Q ss_pred             eccCC-CccccCCCCcccccccccCC-CCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhccCCC--------
Q 015868          263 VQAQS-GVMTAETGTYRWMAPEVIEH-KPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKSLRP--------  332 (399)
Q Consensus       263 ~~~~~-~~~~~~~gt~~y~aPE~l~~-~~~~~~~Dv~slG~vl~elltg~~P~~~~~~~~~~~~~~~~~~~~--------  332 (399)
                      ..... ...+...+++.|+|||.+.+ ..++.++|+||||+++|+|++|..||.+.++.+...........+        
T Consensus       160 ~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (295)
T cd07837         160 AFSIPVKSYTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQQLLHIFKLLGTPTEQVWPGV  239 (295)
T ss_pred             ecCCCccccCCcccccCCCChHHhhCCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHhCCCChhhCcch
Confidence            54332 22334457889999998865 457899999999999999999999998877665544332211100        


Q ss_pred             ------------------CCCCCCcHHHHHHHHHHhhhcCCCCCCHHHHHH
Q 015868          333 ------------------TIPKHAHPRLAELLERCWQHDPTQRPNFSQITD  365 (399)
Q Consensus       333 ------------------~~~~~~~~~l~~ll~~cl~~dP~~Rps~~ell~  365 (399)
                                        ...+.+++++.++|.+||..||.+||++.+++.
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~R~~~~eil~  290 (295)
T cd07837         240 SKLRDWHEFPQWKPQDLSRAVPDLSPEGLDLLQKMLRYDPAKRISAKAALT  290 (295)
T ss_pred             hhccchhhcCcccchhHHHhccccCHHHHHHHHHHccCChhhcCCHHHHhc
Confidence                              011347889999999999999999999999874

Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm

>cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase

Probab=100.00  E-value=6.9e-39  Score=304.28  Aligned_cols=249  Identities=24%  Similarity=0.383  Sum_probs=199.9

Q ss_pred             ccccceeceeceeCceEEEEEEE--CCeeEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCceeeEEeEEecCCcEEEEE
Q 015868          115 AKQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVT  192 (399)
Q Consensus       115 ~~~~~i~~~lg~G~~g~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~nIv~~~~~~~~~~~~~lV~  192 (399)
                      .++|++.+.||+|+||.||+|..  +++.||+|+++.... ......+.+|+.+++.++|+||+++++++..+...|+||
T Consensus         4 ~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~   82 (291)
T cd07870           4 ATSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTE-EGVPFTAIREASLLKGLKHANIVLLHDIIHTKETLTFVF   82 (291)
T ss_pred             cceeEEEEEEEecCCEEEEEEEEcCCCcEEEEEEecccCc-CCCcHHHHHHHHHHHhcCCCCEeEEEEEEecCCeEEEEE
Confidence            36899999999999999999976  578999999875432 222345678999999999999999999999999999999


Q ss_pred             ecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceeecCCCcEEEeeccceeeccCCC-ccc
Q 015868          193 EFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSG-VMT  271 (399)
Q Consensus       193 E~~~ggsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~giiHrDlkp~NILl~~~~~vkl~DFG~a~~~~~~~-~~~  271 (399)
                      ||+. +++.+++......++...+..++.|++.||.|||++||+|+||||+||+++.++.++|+|||.++...... ...
T Consensus        83 e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~~~~~  161 (291)
T cd07870          83 EYMH-TDLAQYMIQHPGGLHPYNVRLFMFQLLRGLAYIHGQHILHRDLKPQNLLISYLGELKLADFGLARAKSIPSQTYS  161 (291)
T ss_pred             eccc-CCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHHEEEcCCCcEEEeccccccccCCCCCCCC
Confidence            9996 58888876656678889999999999999999999999999999999999999999999999987543322 223


Q ss_pred             cCCCCcccccccccCCC-CCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHH-HHHhc---------------------
Q 015868          272 AETGTYRWMAPEVIEHK-PYDYKADVFSFGIALWELLTGELPYAGLTPLQAAV-GVVQK---------------------  328 (399)
Q Consensus       272 ~~~gt~~y~aPE~l~~~-~~~~~~Dv~slG~vl~elltg~~P~~~~~~~~~~~-~~~~~---------------------  328 (399)
                      ...++..|+|||.+.+. .++.++||||||+++|+|++|..||.......... ..+..                     
T Consensus       162 ~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  241 (291)
T cd07870         162 SEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVSDVFEQLEKIWTVLGVPTEDTWPGVSKLPNYKPE  241 (291)
T ss_pred             CccccccccCCceeecCCCCCcHHHHHHHHHHHHHHHhCCCCCCCchhHHHHHHHHHHHcCCCChhhhhhhhhcccccch
Confidence            34578899999998764 57889999999999999999999998765432211 11100                     


Q ss_pred             cCCCCCC---------CCCcHHHHHHHHHHhhhcCCCCCCHHHHHH
Q 015868          329 SLRPTIP---------KHAHPRLAELLERCWQHDPTQRPNFSQITD  365 (399)
Q Consensus       329 ~~~~~~~---------~~~~~~l~~ll~~cl~~dP~~Rps~~ell~  365 (399)
                      ......+         ...++++.+++.+|++.||.+|||+.|++.
T Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dp~~R~t~~~~l~  287 (291)
T cd07870         242 WFLPCKPQQLRVVWKRLSRPPKAEDLASQMLMMFPKDRISAQDALL  287 (291)
T ss_pred             hccccCCcchhhhccccCCChHHHHHHHHHhCcCcccCcCHHHHhc
Confidence            0000000         113578999999999999999999999864

Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess

>cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6

Probab=100.00  E-value=2.9e-39  Score=308.45  Aligned_cols=246  Identities=28%  Similarity=0.474  Sum_probs=206.7

Q ss_pred             ccceeceeceeCceEEEEEEE--CCeeEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCceeeEEeEEecCCcEEEEEec
Q 015868          117 QLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVTEF  194 (399)
Q Consensus       117 ~~~i~~~lg~G~~g~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~nIv~~~~~~~~~~~~~lV~E~  194 (399)
                      .|....+||.|+||.||++..  .++.||+|++....  ....+.+.+|+.+++.++||||+++++.+..+...++|+||
T Consensus        22 ~~~~~~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~--~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~iv~e~   99 (297)
T cd06659          22 LLENYIKIGEGSTGIVCIAREKHSGRQVAVKMMDLRK--QQRRELLFNEVVIMRDYQHQNVVEMYKSYLVGEELWVLMEF   99 (297)
T ss_pred             hHHhhhhcCCCCceeEEEEEEcCCCCEEEEEEEEecc--cchHHHHHHHHHHHHhCCCCchhhhhhheeeCCeEEEEEec
Confidence            344556899999999999976  57899999986542  22346688999999999999999999999999999999999


Q ss_pred             CCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceeecCCCcEEEeeccceeeccCCC-ccccC
Q 015868          195 MARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSG-VMTAE  273 (399)
Q Consensus       195 ~~ggsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~giiHrDlkp~NILl~~~~~vkl~DFG~a~~~~~~~-~~~~~  273 (399)
                      +++++|.+++..  ..+++..++.++.|++.||+|||++|++||||+|+||+++.++.++|+|||++....... .....
T Consensus       100 ~~~~~L~~~~~~--~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~dl~p~Nill~~~~~~kL~dfg~~~~~~~~~~~~~~~  177 (297)
T cd06659         100 LQGGALTDIVSQ--TRLNEEQIATVCESVLQALCYLHSQGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKSL  177 (297)
T ss_pred             CCCCCHHHHHhh--cCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHeEEccCCcEEEeechhHhhcccccccccce
Confidence            999999998754  468999999999999999999999999999999999999999999999999986543322 22345


Q ss_pred             CCCcccccccccCCCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcc-CCCCCCCCCcHHHHHHHHHHhhh
Q 015868          274 TGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKS-LRPTIPKHAHPRLAELLERCWQH  352 (399)
Q Consensus       274 ~gt~~y~aPE~l~~~~~~~~~Dv~slG~vl~elltg~~P~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~l~~ll~~cl~~  352 (399)
                      .++..|+|||.+.+..++.++|+||||+++|+|++|+.||...++.+......... .....+..++..+.+++.+||+.
T Consensus       178 ~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~i~~~l~~  257 (297)
T cd06659         178 VGTPYWMAPEVISRTPYGTEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRLRDSPPPKLKNAHKISPVLRDFLERMLTR  257 (297)
T ss_pred             ecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhccCCCCccccCCCCHHHHHHHHHHhcC
Confidence            68899999999998889999999999999999999999998877666544332211 11223345788999999999999


Q ss_pred             cCCCCCCHHHHHHH
Q 015868          353 DPTQRPNFSQITDI  366 (399)
Q Consensus       353 dP~~Rps~~ell~~  366 (399)
                      +|.+||++.++++.
T Consensus       258 ~P~~Rps~~~ll~~  271 (297)
T cd06659         258 EPQERATAQELLDH  271 (297)
T ss_pred             CcccCcCHHHHhhC
Confidence            99999999999873

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i

>PLN00009 cyclin-dependent kinase A; Provisional

Probab=100.00  E-value=7.8e-39  Score=304.35  Aligned_cols=249  Identities=22%  Similarity=0.389  Sum_probs=203.9

Q ss_pred             cccceeceeceeCceEEEEEEE--CCeeEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCceeeEEeEEecCCcEEEEEe
Q 015868          116 KQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVTE  193 (399)
Q Consensus       116 ~~~~i~~~lg~G~~g~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~nIv~~~~~~~~~~~~~lV~E  193 (399)
                      ++|++.++||.|++|.||+|..  +++.||+|.++....+....+.+.+|+.++++++||||+++++++......++|||
T Consensus         2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   81 (294)
T PLN00009          2 DQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKRLYLVFE   81 (294)
T ss_pred             CceEEEEEecCCCCEEEEEEEecCCCcEEEEEehhhccccccchHHHHHHHHHHHhccCCCEeeEEEEEecCCeEEEEEe
Confidence            5789999999999999999986  57889999987654444455678899999999999999999999999999999999


Q ss_pred             cCCCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceeecC-CCcEEEeeccceeeccCC-Ccc
Q 015868          194 FMARGSIYDFLHKQK-GVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDE-NGVVKVADFGVARVQAQS-GVM  270 (399)
Q Consensus       194 ~~~ggsL~~~l~~~~-~~l~~~~~~~i~~~i~~~L~~LH~~giiHrDlkp~NILl~~-~~~vkl~DFG~a~~~~~~-~~~  270 (399)
                      |+++ +|.+++.... ..+++..++.++.||+.||+|||++|++|+||+|+||+++. ++.+||+|||.+...... ...
T Consensus        82 ~~~~-~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~i~H~dl~p~nill~~~~~~~kl~dfg~~~~~~~~~~~~  160 (294)
T PLN00009         82 YLDL-DLKKHMDSSPDFAKNPRLIKTYLYQILRGIAYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTF  160 (294)
T ss_pred             cccc-cHHHHHHhCCCCCcCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCcceEEEECCCCEEEEcccccccccCCCcccc
Confidence            9965 8888875533 33678889999999999999999999999999999999985 567999999999754332 122


Q ss_pred             ccCCCCcccccccccCC-CCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhccCC------------------
Q 015868          271 TAETGTYRWMAPEVIEH-KPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKSLR------------------  331 (399)
Q Consensus       271 ~~~~gt~~y~aPE~l~~-~~~~~~~Dv~slG~vl~elltg~~P~~~~~~~~~~~~~~~~~~~------------------  331 (399)
                      ....+++.|+|||.+.+ ..++.++||||||+++|+|+||..||...+..............                  
T Consensus       161 ~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (294)
T PLN00009        161 THEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEIDELFKIFRILGTPNEETWPGVTSLPDYKSA  240 (294)
T ss_pred             ccCceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhccccccchhhhhh
Confidence            34467889999999876 45789999999999999999999999887765554433221000                  


Q ss_pred             -CC--------CCCCCcHHHHHHHHHHhhhcCCCCCCHHHHHH
Q 015868          332 -PT--------IPKHAHPRLAELLERCWQHDPTQRPNFSQITD  365 (399)
Q Consensus       332 -~~--------~~~~~~~~l~~ll~~cl~~dP~~Rps~~ell~  365 (399)
                       +.        .....++++.+++.+||+.+|++||++.++++
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~~l~  283 (294)
T PLN00009        241 FPKWPPKDLATVVPTLEPAGVDLLSKMLRLDPSKRITARAALE  283 (294)
T ss_pred             cccCCCCCHHHhCcCCChHHHHHHHHHccCChhhCcCHHHHhc
Confidence             00        12356789999999999999999999999986

>cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases

Probab=100.00  E-value=8.2e-39  Score=302.00  Aligned_cols=247  Identities=26%  Similarity=0.436  Sum_probs=205.8

Q ss_pred             cceeceeceeCceEEEEEEEC--CeeEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCceeeEEeEEecC--CcEEEEEe
Q 015868          118 LKIECKVASGSYGDLYKGTYC--SQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRP--PNLCIVTE  193 (399)
Q Consensus       118 ~~i~~~lg~G~~g~Vy~~~~~--~~~vAvK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~nIv~~~~~~~~~--~~~~lV~E  193 (399)
                      |++.++||.|+||.||+|...  ++.+|+|+++...........+.+|+.+++.++|||++++++++...  ...++|+|
T Consensus         1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e   80 (287)
T cd07840           1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKGKGSIYMVFE   80 (287)
T ss_pred             CeeeEEeccCCCeEEEEEEECCCCeEEEEEEEecccccccchHHHHHHHHHHHhccCCCeeeheeeEecCCCCcEEEEec
Confidence            678899999999999999874  58999999987643444556788999999999999999999999888  78999999


Q ss_pred             cCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceeecCCCcEEEeeccceeeccCCC--ccc
Q 015868          194 FMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSG--VMT  271 (399)
Q Consensus       194 ~~~ggsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~giiHrDlkp~NILl~~~~~vkl~DFG~a~~~~~~~--~~~  271 (399)
                      |+++ +|.+++......+++..++.++.|++.||+|||+.|++|+||+|+||++++++.++|+|||.+.......  ..+
T Consensus        81 ~~~~-~l~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~~h~dl~p~nil~~~~~~~~l~d~g~~~~~~~~~~~~~~  159 (287)
T cd07840          81 YMDH-DLTGLLDSPEVKFTESQIKCYMKQLLEGLQYLHSNGILHRDIKGSNILINNDGVLKLADFGLARPYTKRNSADYT  159 (287)
T ss_pred             cccc-cHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCcHHHeEEcCCCCEEEccccceeeccCCCccccc
Confidence            9975 9999987765689999999999999999999999999999999999999999999999999998665443  233


Q ss_pred             cCCCCcccccccccCC-CCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhccCCC------------------
Q 015868          272 AETGTYRWMAPEVIEH-KPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKSLRP------------------  332 (399)
Q Consensus       272 ~~~gt~~y~aPE~l~~-~~~~~~~Dv~slG~vl~elltg~~P~~~~~~~~~~~~~~~~~~~~------------------  332 (399)
                      ...++..|+|||.+.+ ..++.++||||||+++|+|++|+.||...+..............+                  
T Consensus       160 ~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (287)
T cd07840         160 NRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGSTELEQLEKIFELCGSPTDENWPGVSKLPWFENLK  239 (287)
T ss_pred             ccccccccCCceeeEccccCChHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchhhccccccchhhhhcc
Confidence            4456888999998765 457899999999999999999999998877655443332211000                  


Q ss_pred             -----------CCCCCCcHHHHHHHHHHhhhcCCCCCCHHHHHH
Q 015868          333 -----------TIPKHAHPRLAELLERCWQHDPTQRPNFSQITD  365 (399)
Q Consensus       333 -----------~~~~~~~~~l~~ll~~cl~~dP~~Rps~~ell~  365 (399)
                                 .+...+++++.+++.+||+.+|.+||+++++++
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~  283 (287)
T cd07840         240 PKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQALQ  283 (287)
T ss_pred             ccccchhHHHHHhcccCCHHHHHHHHHHcCCChhhCcCHHHHhh
Confidence                       001113789999999999999999999999875

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po

>cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12

Probab=100.00  E-value=5e-39  Score=306.50  Aligned_cols=252  Identities=24%  Similarity=0.375  Sum_probs=206.3

Q ss_pred             ecccccceeceeceeCceEEEEEEE--CCeeEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCceeeEEeEEecCC----
Q 015868          113 IDAKQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPP----  186 (399)
Q Consensus       113 i~~~~~~i~~~lg~G~~g~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~nIv~~~~~~~~~~----  186 (399)
                      ...++|++.+.||+|+||.||+|..  .++.||+|+++...........+.+|+.+++.++||||+++++++....    
T Consensus         4 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~~   83 (302)
T cd07864           4 RCVDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNIVNLKEIVTDKQDALD   83 (302)
T ss_pred             hhhhhhheeeeecccCCEEEEEEEECCCCcEEEEEEEeecccccCchHHHHHHHHHHHhCCCCCeeeeeheecCcchhhh
Confidence            3457899999999999999999987  5788999999765433344456788999999999999999999987654    


Q ss_pred             ------cEEEEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceeecCCCcEEEeeccc
Q 015868          187 ------NLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGV  260 (399)
Q Consensus       187 ------~~~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~giiHrDlkp~NILl~~~~~vkl~DFG~  260 (399)
                            .+++|+||+++ ++.+.+......+++..+..++.|++.||.|||+.||+|+||+|+||++++++.+||+|||.
T Consensus        84 ~~~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~i~H~dl~p~nili~~~~~~kl~dfg~  162 (302)
T cd07864          84 FKKDKGAFYLVFEYMDH-DLMGLLESGLVHFSEDHIKSFMKQLLEGLNYCHKKNFLHRDIKCSNILLNNKGQIKLADFGL  162 (302)
T ss_pred             ccccCCcEEEEEcccCc-cHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCcEEeCcccc
Confidence                  79999999986 88888876666799999999999999999999999999999999999999999999999999


Q ss_pred             eeeccCCC--ccccCCCCcccccccccCCC-CCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhccCCC-----
Q 015868          261 ARVQAQSG--VMTAETGTYRWMAPEVIEHK-PYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKSLRP-----  332 (399)
Q Consensus       261 a~~~~~~~--~~~~~~gt~~y~aPE~l~~~-~~~~~~Dv~slG~vl~elltg~~P~~~~~~~~~~~~~~~~~~~~-----  332 (399)
                      +.......  ......++..|+|||.+.+. .++.++||||||+++|+|++|++||...+..+....+......+     
T Consensus       163 ~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~~~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~  242 (302)
T cd07864         163 ARLYNSEESRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQELAQLELISRLCGSPCPAVW  242 (302)
T ss_pred             cccccCCcccccccceeccCccChHHhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhhc
Confidence            97654332  12233467889999988654 57889999999999999999999998766655443332211000     


Q ss_pred             -----------------------CCCCCCcHHHHHHHHHHhhhcCCCCCCHHHHHH
Q 015868          333 -----------------------TIPKHAHPRLAELLERCWQHDPTQRPNFSQITD  365 (399)
Q Consensus       333 -----------------------~~~~~~~~~l~~ll~~cl~~dP~~Rps~~ell~  365 (399)
                                             .....++..+.+++.+||+.+|.+||++.+++.
T Consensus       243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~  298 (302)
T cd07864         243 PDVIKLPYFNTMKPKKQYRRRLREEFSFIPTPALDLLDHMLTLDPSKRCTAEEALN  298 (302)
T ss_pred             ccccccccccccccccccccchhhhcCCCCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence                                   011246889999999999999999999999874

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely

>cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9

Probab=100.00  E-value=6.4e-39  Score=306.51  Aligned_cols=251  Identities=26%  Similarity=0.442  Sum_probs=201.5

Q ss_pred             cccccceeceeceeCceEEEEEEE--CCeeEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCceeeEEeEEecCC-----
Q 015868          114 DAKQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPP-----  186 (399)
Q Consensus       114 ~~~~~~i~~~lg~G~~g~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~nIv~~~~~~~~~~-----  186 (399)
                      +.++|++.++||.|+||.||+|..  +++.||+|.+............+.+|+.++++++||||+++++++....     
T Consensus        10 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~   89 (310)
T cd07865          10 EVSKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPYNR   89 (310)
T ss_pred             hhhheEEEEEeecCCCEEEEEEEECCCCcEEEEEEEeccCCcCCchhHHHHHHHHHHhCCCCCccceEEEEecccccccC
Confidence            356899999999999999999987  5789999998754333333445678999999999999999999986654     


Q ss_pred             ---cEEEEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceeecCCCcEEEeeccceee
Q 015868          187 ---NLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARV  263 (399)
Q Consensus       187 ---~~~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~giiHrDlkp~NILl~~~~~vkl~DFG~a~~  263 (399)
                         ..++||||+.+ +|.+++......+++..++.++.|++.||.|||++|++|+||||+||+++.++.+||+|||.+..
T Consensus        90 ~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~  168 (310)
T cd07865          90 YKGSFYLVFEFCEH-DLAGLLSNKNVKFTLSEIKKVMKMLLNGLYYIHRNKILHRDMKAANILITKDGILKLADFGLARA  168 (310)
T ss_pred             CCceEEEEEcCCCc-CHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEECCCCcEEECcCCCccc
Confidence               35999999965 89998877666799999999999999999999999999999999999999999999999999975


Q ss_pred             ccCCC-----ccccCCCCcccccccccCCC-CCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhc--cCCCC--
Q 015868          264 QAQSG-----VMTAETGTYRWMAPEVIEHK-PYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQK--SLRPT--  333 (399)
Q Consensus       264 ~~~~~-----~~~~~~gt~~y~aPE~l~~~-~~~~~~Dv~slG~vl~elltg~~P~~~~~~~~~~~~~~~~--~~~~~--  333 (399)
                      .....     ......++..|+|||.+.+. .++.++|+||||+++|+|++|..||...++.........-  ...+.  
T Consensus       169 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~el~t~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  248 (310)
T cd07865         169 FSLSKNSKPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQHQLTLISQLCGSITPEVW  248 (310)
T ss_pred             ccCCcccCCCCccCcccCccccCcHHhcCCcccCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhc
Confidence            54322     12234568889999988664 4788999999999999999999999877665433221110  00000  


Q ss_pred             -------------C-------------CCCCcHHHHHHHHHHhhhcCCCCCCHHHHHH
Q 015868          334 -------------I-------------PKHAHPRLAELLERCWQHDPTQRPNFSQITD  365 (399)
Q Consensus       334 -------------~-------------~~~~~~~l~~ll~~cl~~dP~~Rps~~ell~  365 (399)
                                   .             +...+..+.++|.+||..||.+|||++++++
T Consensus       249 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~dli~~~l~~~P~~R~t~~e~l~  306 (310)
T cd07865         249 PGVDKLELFKKMELPQGQKRKVKERLKPYVKDPHALDLIDKLLVLDPAKRIDADTALN  306 (310)
T ss_pred             ccccchhhhhhccCCCccchhhHHhcccccCCHHHHHHHHHHhcCChhhccCHHHHhc
Confidence                         0             1123567889999999999999999999874

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl

>cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta

Probab=100.00  E-value=6.1e-39  Score=310.45  Aligned_cols=251  Identities=26%  Similarity=0.473  Sum_probs=202.6

Q ss_pred             ceecee--CceEEEEEEE--CCeeEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCceeeEEeEEecCCcEEEEEecCCC
Q 015868          122 CKVASG--SYGDLYKGTY--CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVTEFMAR  197 (399)
Q Consensus       122 ~~lg~G--~~g~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~nIv~~~~~~~~~~~~~lV~E~~~g  197 (399)
                      ..||.|  +||+||++++  .++.||+|++.......+..+.+.+|+.+++.++||||+++++++..+...++|+||+.+
T Consensus         4 ~~ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~~v~e~~~~   83 (328)
T cd08226           4 VEIGRGFCNLTSVYLARHTPTGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPFMAY   83 (328)
T ss_pred             HHhCCcccCceeEEEEEEcCCCcEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceEeeeEecCCceEEEEecccC
Confidence            456666  9999999987  789999999987655666678899999999999999999999999999999999999999


Q ss_pred             CCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceeecCCCcEEEeeccceeeccCCCc-------
Q 015868          198 GSIYDFLHKQ-KGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGV-------  269 (399)
Q Consensus       198 gsL~~~l~~~-~~~l~~~~~~~i~~~i~~~L~~LH~~giiHrDlkp~NILl~~~~~vkl~DFG~a~~~~~~~~-------  269 (399)
                      +++.+++... ...+++..+..++.|++.||+|||++||+||||||+||+++.++.++++||+.+........       
T Consensus        84 ~~l~~~l~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivHrDlkp~Nill~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  163 (328)
T cd08226          84 GSANSLLKTYFPEGMSEALIGNILFGALRGLNYLHQNGYIHRNIKASHILISGDGLVSLSGLSHLYSLVRNGQKAKVVYD  163 (328)
T ss_pred             CCHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEeCCCcEEEechHHHhhhhccCcccccccc
Confidence            9999998764 34589999999999999999999999999999999999999999999999986543221111       


Q ss_pred             -cccCCCCcccccccccCCC--CCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcc-----------------
Q 015868          270 -MTAETGTYRWMAPEVIEHK--PYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKS-----------------  329 (399)
Q Consensus       270 -~~~~~gt~~y~aPE~l~~~--~~~~~~Dv~slG~vl~elltg~~P~~~~~~~~~~~~~~~~~-----------------  329 (399)
                       .....++..|+|||++.+.  .++.++||||||+++|+|++|..||......+.........                 
T Consensus       164 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  243 (328)
T cd08226         164 FPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDMLRTQMLLQKLKGPPYSPLDITTFPCEESRM  243 (328)
T ss_pred             ccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcChHHHHHHHhcCCCCCCccccccchhhhhh
Confidence             1112346679999999764  57899999999999999999999998776544433322110                 


Q ss_pred             ----------------------------CCCCCCCCCcHHHHHHHHHHhhhcCCCCCCHHHHHH--HHHHHHH
Q 015868          330 ----------------------------LRPTIPKHAHPRLAELLERCWQHDPTQRPNFSQITD--ILKQMMK  372 (399)
Q Consensus       330 ----------------------------~~~~~~~~~~~~l~~ll~~cl~~dP~~Rps~~ell~--~L~~l~~  372 (399)
                                                  .+...+..+++.+.+|+.+||+.||++|||+.|+++  .+..+.+
T Consensus       244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpta~e~l~~~~~~~~~~  316 (328)
T cd08226         244 KNSQSGVDSGIGESVVAAGMTQTMTSERLRTPSSKTFSPAFQNLVELCLQQDPEKRPSASSLLSHAFFKQVKE  316 (328)
T ss_pred             ccchhhhhcccccchhccccccccccccccchhhhhhhHHHHHHHHHHccCCcccCCCHHHHhhCHHHHHHHH
Confidence                                        011122346778999999999999999999999975  4555544

Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig

>cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins

Probab=100.00  E-value=3.8e-39  Score=300.23  Aligned_cols=241  Identities=27%  Similarity=0.439  Sum_probs=205.1

Q ss_pred             eceeCceEEEEEEEC--CeeEEEEEecCCCC-CHHHHHHHHHHHHHHHhcCCCceeeEEeEEecCCcEEEEEecCCCCCH
Q 015868          124 VASGSYGDLYKGTYC--SQEVAIKVLKPECV-NTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVTEFMARGSI  200 (399)
Q Consensus       124 lg~G~~g~Vy~~~~~--~~~vAvK~~~~~~~-~~~~~~~~~~Ei~~l~~l~h~nIv~~~~~~~~~~~~~lV~E~~~ggsL  200 (399)
                      ||.|+||.||++++.  ++.+++|++..... .......+.+|+.++++++||||+++++.+..+...|+|+||+.+++|
T Consensus         1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L   80 (265)
T cd05579           1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQGKKNLYLVMEYLPGGDL   80 (265)
T ss_pred             CCCCCceEEEEEEECCCCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhCCCcchhHHHHheecCcEEEEEEecCCCCcH
Confidence            689999999999984  88999999976532 234567899999999999999999999999999999999999999999


Q ss_pred             HHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceeecCCCcEEEeeccceeeccCCC---------ccc
Q 015868          201 YDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSG---------VMT  271 (399)
Q Consensus       201 ~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~giiHrDlkp~NILl~~~~~vkl~DFG~a~~~~~~~---------~~~  271 (399)
                      .+++... +.+++..+..++.||+.||+|||++|++|+||+|+||++++++.++|+|||++.......         ...
T Consensus        81 ~~~l~~~-~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~di~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~  159 (265)
T cd05579          81 ASLLENV-GSLDEDVARIYIAEIVLALEYLHSNGIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKEDK  159 (265)
T ss_pred             HHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHcCeecCCCCHHHeEEcCCCCEEEEecccchhcccCccccccccccccc
Confidence            9999764 478999999999999999999999999999999999999999999999999987544321         122


Q ss_pred             cCCCCcccccccccCCCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhccCCCCCCCC--CcHHHHHHHHHH
Q 015868          272 AETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKSLRPTIPKH--AHPRLAELLERC  349 (399)
Q Consensus       272 ~~~gt~~y~aPE~l~~~~~~~~~Dv~slG~vl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~l~~ll~~c  349 (399)
                      ...++..|+|||.+.+..++.++|+||||+++|+|++|..||....+.+..........  ..+..  .+..+.+++.+|
T Consensus       160 ~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~i~~~  237 (265)
T cd05579         160 RIVGTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLVGIPPFHGETPEEIFQNILNGKI--EWPEDVEVSDEAIDLISKL  237 (265)
T ss_pred             CcccCccccCHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCc--CCCccccCCHHHHHHHHHH
Confidence            34578899999999888899999999999999999999999998887776655544222  23333  489999999999


Q ss_pred             hhhcCCCCCCHHHHHHHH
Q 015868          350 WQHDPTQRPNFSQITDIL  367 (399)
Q Consensus       350 l~~dP~~Rps~~ell~~L  367 (399)
                      |+.+|.+|||+..+.+.|
T Consensus       238 l~~~p~~Rpt~~~~~~~l  255 (265)
T cd05579         238 LVPDPEKRLGAKSIEEIK  255 (265)
T ss_pred             hcCCHhhcCCCccHHHHh
Confidence            999999999995555443

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re

>cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=8.8e-39  Score=298.29  Aligned_cols=241  Identities=26%  Similarity=0.393  Sum_probs=199.4

Q ss_pred             ceeceeCceEEEEEEE--CCeeEEEEEecCCCC-CHHHHHHHHHHHHHH-HhcCCCceeeEEeEEecCCcEEEEEecCCC
Q 015868          122 CKVASGSYGDLYKGTY--CSQEVAIKVLKPECV-NTEMLKEFSQEVYIM-RKIRHKNVVQFIGACTRPPNLCIVTEFMAR  197 (399)
Q Consensus       122 ~~lg~G~~g~Vy~~~~--~~~~vAvK~~~~~~~-~~~~~~~~~~Ei~~l-~~l~h~nIv~~~~~~~~~~~~~lV~E~~~g  197 (399)
                      +.||.|+||.||+|..  .++.||+|+++.... .......+..|..++ ...+|+|++++++++.....+++|+||+++
T Consensus         2 ~~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~   81 (260)
T cd05611           2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQSKDYLYLVMEYLNG   81 (260)
T ss_pred             ccCCcCCCeeEEEEEecCCCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEcCCeEEEEEeccCC
Confidence            5789999999999987  578999999875432 122233445555544 455899999999999999999999999999


Q ss_pred             CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceeecCCCcEEEeeccceeeccCCCccccCCCCc
Q 015868          198 GSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAETGTY  277 (399)
Q Consensus       198 gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~giiHrDlkp~NILl~~~~~vkl~DFG~a~~~~~~~~~~~~~gt~  277 (399)
                      ++|.+++.. .+.+++..+..++.|++.||.|||+.|++|+||+|.||++++++.++|+|||+++....   .....++.
T Consensus        82 ~~L~~~l~~-~~~~~~~~~~~i~~qi~~aL~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~---~~~~~~~~  157 (260)
T cd05611          82 GDCASLIKT-LGGLPEDWAKQYIAEVVLGVEDLHQRGIIHRDIKPENLLIDQTGHLKLTDFGLSRNGLE---NKKFVGTP  157 (260)
T ss_pred             CCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCcEEEeecccceeccc---cccCCCCc
Confidence            999999976 45689999999999999999999999999999999999999999999999999875433   23346788


Q ss_pred             ccccccccCCCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhccC--CCCCCCCCcHHHHHHHHHHhhhcCC
Q 015868          278 RWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKSL--RPTIPKHAHPRLAELLERCWQHDPT  355 (399)
Q Consensus       278 ~y~aPE~l~~~~~~~~~Dv~slG~vl~elltg~~P~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~l~~ll~~cl~~dP~  355 (399)
                      .|+|||.+.+..++.++||||||+++|+|++|..||...+..+..........  .+..+..+++++.+++.+||+.+|+
T Consensus       158 ~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~  237 (260)
T cd05611         158 DYLAPETILGVGDDKMSDWWSLGCVIFEFLFGYPPFHAETPDAVFDNILSRRINWPEEVKEFCSPEAVDLINRLLCMDPA  237 (260)
T ss_pred             CccChhhhcCCCCcchhhhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcccCCCCcccccCCHHHHHHHHHHccCCHH
Confidence            99999999888899999999999999999999999998887665554433222  2334456889999999999999999


Q ss_pred             CCCCHHHHHHH
Q 015868          356 QRPNFSQITDI  366 (399)
Q Consensus       356 ~Rps~~ell~~  366 (399)
                      +||++.++.+.
T Consensus       238 ~R~~~~~~~~~  248 (260)
T cd05611         238 KRLGANGYQEI  248 (260)
T ss_pred             HccCCCcHHHH
Confidence            99977655443

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do

>cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase

Probab=100.00  E-value=5.2e-39  Score=306.07  Aligned_cols=247  Identities=29%  Similarity=0.498  Sum_probs=208.1

Q ss_pred             ccccceeceeceeCceEEEEEEE--CCeeEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCceeeEEeEEecCCcEEEEE
Q 015868          115 AKQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVT  192 (399)
Q Consensus       115 ~~~~~i~~~lg~G~~g~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~nIv~~~~~~~~~~~~~lV~  192 (399)
                      .++|++.+.||+|+||.||++..  +++.||+|.+....  ....+.+.+|+.+++.++||||+++++.+......++|+
T Consensus        18 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~--~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~   95 (293)
T cd06647          18 KKKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQ--QPKKELIINEILVMRENKHPNIVNYLDSYLVGDELWVVM   95 (293)
T ss_pred             hhhceeeeEecCCCCeEEEEEEEcCCCCEEEEEEecccc--chHHHHHHHHHHHHhhcCCCCeeehhheeeeCCcEEEEE
Confidence            46899999999999999999975  67889999986442  233467889999999999999999999999999999999


Q ss_pred             ecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceeecCCCcEEEeeccceeeccCCC-ccc
Q 015868          193 EFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSG-VMT  271 (399)
Q Consensus       193 E~~~ggsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~giiHrDlkp~NILl~~~~~vkl~DFG~a~~~~~~~-~~~  271 (399)
                      ||+++++|.+++.+  ..++...+..++.|++.||.|||++|++|+||+|+||+++.++.++|+|||++....... ...
T Consensus        96 e~~~~~~L~~~~~~--~~l~~~~~~~i~~~l~~al~~LH~~gi~H~dL~p~Nili~~~~~~kL~dfg~~~~~~~~~~~~~  173 (293)
T cd06647          96 EYLAGGSLTDVVTE--TCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRS  173 (293)
T ss_pred             ecCCCCcHHHHHhh--cCCCHHHHHHHHHHHHHHHHHHHhCCEeeccCCHHHEEEcCCCCEEEccCcceecccccccccc
Confidence            99999999999865  357889999999999999999999999999999999999999999999999887544332 223


Q ss_pred             cCCCCcccccccccCCCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhccCCCC--CCCCCcHHHHHHHHHH
Q 015868          272 AETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKSLRPT--IPKHAHPRLAELLERC  349 (399)
Q Consensus       272 ~~~gt~~y~aPE~l~~~~~~~~~Dv~slG~vl~elltg~~P~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~l~~ll~~c  349 (399)
                      ...+++.|+|||.+.+..++.++|+||||+++|++++|+.||...++......... ...+.  .+..++..+.+++.+|
T Consensus       174 ~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~ll~~ll~g~~pf~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~l~~li~~~  252 (293)
T cd06647         174 TMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIAT-NGTPELQNPEKLSAIFRDFLNRC  252 (293)
T ss_pred             cccCChhhcCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhhheeehhc-CCCCCCCCccccCHHHHHHHHHH
Confidence            34688899999999988899999999999999999999999987766543322221 11222  2344678999999999


Q ss_pred             hhhcCCCCCCHHHHHHH
Q 015868          350 WQHDPTQRPNFSQITDI  366 (399)
Q Consensus       350 l~~dP~~Rps~~ell~~  366 (399)
                      |+.+|++||++.+++..
T Consensus       253 l~~~p~~Rp~~~~il~h  269 (293)
T cd06647         253 LEMDVEKRGSAKELLQH  269 (293)
T ss_pred             ccCChhhCcCHHHHhcC
Confidence            99999999999999753

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi

>cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases

Probab=100.00  E-value=6.1e-39  Score=302.50  Aligned_cols=247  Identities=26%  Similarity=0.427  Sum_probs=209.2

Q ss_pred             cceeceeceeCceEEEEEEE--CCeeEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCceeeEEeEEecCCcEEEEEecC
Q 015868          118 LKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVTEFM  195 (399)
Q Consensus       118 ~~i~~~lg~G~~g~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~nIv~~~~~~~~~~~~~lV~E~~  195 (399)
                      |++.+.||.|++|.||++..  .++.+++|.++...........+.+|+.++++++|+||+++++++..+...++|+||+
T Consensus         1 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~   80 (283)
T cd05118           1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDVFRHKGDLYLVFEFM   80 (283)
T ss_pred             CccceeeecCCCceEEEEEcCCCCcEEEEEEeccccccchhHHHHHHHHHHHHHhcCCCcchHHHhhccCCCEEEEEecc
Confidence            56778999999999999987  5788999999876545455678889999999999999999999999999999999999


Q ss_pred             CCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceeecCCCcEEEeeccceeeccCCC-ccccCC
Q 015868          196 ARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSG-VMTAET  274 (399)
Q Consensus       196 ~ggsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~giiHrDlkp~NILl~~~~~vkl~DFG~a~~~~~~~-~~~~~~  274 (399)
                      ++ ++.+++......+++..+..++.+++.||.|||+.||+|+||+|+||+++.++.++|+|||.+....... ......
T Consensus        81 ~~-~l~~~l~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~p~nili~~~~~~~l~df~~~~~~~~~~~~~~~~~  159 (283)
T cd05118          81 DT-DLYKLIKDRQRGLPESLIKSYLYQLLQGLAFCHSHGILHRDLKPENLLINTEGVLKLADFGLARSFGSPVRPYTHYV  159 (283)
T ss_pred             CC-CHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHHCCeeecCcCHHHEEECCCCcEEEeeeeeeEecCCCcccccCcc
Confidence            76 9999887766789999999999999999999999999999999999999999999999999998765543 233456


Q ss_pred             CCcccccccccCCC-CCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhccCC----------------------
Q 015868          275 GTYRWMAPEVIEHK-PYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKSLR----------------------  331 (399)
Q Consensus       275 gt~~y~aPE~l~~~-~~~~~~Dv~slG~vl~elltg~~P~~~~~~~~~~~~~~~~~~~----------------------  331 (399)
                      ++..|+|||.+.+. .++.++|+||||+++|+|+||+.||...+..+...........                      
T Consensus       160 ~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (283)
T cd05118         160 VTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSEIDQLFKIFRTLGTPDPEVWPKFTSLARNYKFSFPK  239 (283)
T ss_pred             CcccccCcHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCchHhcccchhhhhhhhhhhcc
Confidence            78899999999876 7899999999999999999999999887765543333221100                      


Q ss_pred             ------CCCCCCCcHHHHHHHHHHhhhcCCCCCCHHHHHH
Q 015868          332 ------PTIPKHAHPRLAELLERCWQHDPTQRPNFSQITD  365 (399)
Q Consensus       332 ------~~~~~~~~~~l~~ll~~cl~~dP~~Rps~~ell~  365 (399)
                            +.+...++.++.++|.+||+.||.+||++.+++.
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~ll~  279 (283)
T cd05118         240 KAGMPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQALA  279 (283)
T ss_pred             ccccCHHHhhhhhCHHHHHHHHHHhccCcccCcCHHHHhh
Confidence                  0112346789999999999999999999999875

Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They

>cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85

Probab=100.00  E-value=1e-38  Score=301.60  Aligned_cols=247  Identities=26%  Similarity=0.457  Sum_probs=203.6

Q ss_pred             ccceeceeceeCceEEEEEEE--CCeeEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCceeeEEeEEecCCcEEEEEec
Q 015868          117 QLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVTEF  194 (399)
Q Consensus       117 ~~~i~~~lg~G~~g~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~nIv~~~~~~~~~~~~~lV~E~  194 (399)
                      +|++.++||.|++|.||+|+.  +++.||+|+++.... ......+.+|+.++++++||||+++++++...+..++||||
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   79 (284)
T cd07836           1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAE-EGTPSTAIREISLMKELKHENIVRLHDVIHTENKLMLVFEY   79 (284)
T ss_pred             CceEeeeeccCCceEEEEEEECCCCeEEEEEEeccccc-ccchHHHHHHHHHHHhhcCCCEeeeeeeEeeCCcEEEEEec
Confidence            488999999999999999987  578899999875532 22235677899999999999999999999999999999999


Q ss_pred             CCCCCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceeecCCCcEEEeeccceeeccCCC-ccc
Q 015868          195 MARGSIYDFLHKQK--GVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSG-VMT  271 (399)
Q Consensus       195 ~~ggsL~~~l~~~~--~~l~~~~~~~i~~~i~~~L~~LH~~giiHrDlkp~NILl~~~~~vkl~DFG~a~~~~~~~-~~~  271 (399)
                      +++ +|.+++....  ..+++..+..++.|++.||.|||+.|++||||+|+||++++++.++|+|||.++...... ...
T Consensus        80 ~~~-~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~h~dl~p~ni~~~~~~~~~l~d~g~~~~~~~~~~~~~  158 (284)
T cd07836          80 MDK-DLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHENRVLHRDLKPQNLLINKRGELKLADFGLARAFGIPVNTFS  158 (284)
T ss_pred             CCc-cHHHHHHhcCCCCCcCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEECCCCcEEEeecchhhhhcCCccccc
Confidence            986 8999886543  568999999999999999999999999999999999999999999999999997543321 223


Q ss_pred             cCCCCcccccccccCCC-CCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhccC----------------CCC-
Q 015868          272 AETGTYRWMAPEVIEHK-PYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKSL----------------RPT-  333 (399)
Q Consensus       272 ~~~gt~~y~aPE~l~~~-~~~~~~Dv~slG~vl~elltg~~P~~~~~~~~~~~~~~~~~~----------------~~~-  333 (399)
                      ...++..|++||.+.+. .++.++|+||||+++|+|++|+.||.+.+..+..........                ... 
T Consensus       159 ~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (284)
T cd07836         159 NEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQLLKIFRIMGTPTESTWPGISQLPEYKPTF  238 (284)
T ss_pred             cccccccccChHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhHHHHhcCchhcccc
Confidence            44578899999998664 578999999999999999999999988766544333221110                000 


Q ss_pred             ----------CCCCCcHHHHHHHHHHhhhcCCCCCCHHHHHH
Q 015868          334 ----------IPKHAHPRLAELLERCWQHDPTQRPNFSQITD  365 (399)
Q Consensus       334 ----------~~~~~~~~l~~ll~~cl~~dP~~Rps~~ell~  365 (399)
                                +.+..++.+.+++.+||+.||.+||++.++++
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~  280 (284)
T cd07836         239 PRYPPQDLQQLFPHADPLGIDLLHRLLQLNPELRISAHDALQ  280 (284)
T ss_pred             cCCChHHHHHHhhhcCcHHHHHHHHHhcCCcccCCCHHHHhc
Confidence                      11346788999999999999999999999874

Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment.

>cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2

Probab=100.00  E-value=1.4e-38  Score=305.26  Aligned_cols=248  Identities=31%  Similarity=0.483  Sum_probs=209.8

Q ss_pred             ccccceeceeceeCceEEEEEEE--CCeeEEEEEecCCC-CCHHHHHHHHHHHHHHHhcCCCceeeEEeEEecCCcEEEE
Q 015868          115 AKQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPEC-VNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIV  191 (399)
Q Consensus       115 ~~~~~i~~~lg~G~~g~Vy~~~~--~~~~vAvK~~~~~~-~~~~~~~~~~~Ei~~l~~l~h~nIv~~~~~~~~~~~~~lV  191 (399)
                      ...|+..+.||.|+||.||+|..  +++.+|+|.+.... ........+.+|+.+++.++|+|++++++++......++|
T Consensus        14 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   93 (308)
T cd06634          14 EKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLV   93 (308)
T ss_pred             HHHHHHHHheeeCCCEEEEEEEEcCCCcEEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCcccEEEEEEcCCeeEEE
Confidence            34588889999999999999987  56889999987532 2344556788999999999999999999999999999999


Q ss_pred             EecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceeecCCCcEEEeeccceeeccCCCccc
Q 015868          192 TEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMT  271 (399)
Q Consensus       192 ~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~giiHrDlkp~NILl~~~~~vkl~DFG~a~~~~~~~~~~  271 (399)
                      |||+. +++.+++......+++..+..++.+++.|+.|||+++++||||+|.||+++.++.++|+|||.+.....   ..
T Consensus        94 ~e~~~-~~l~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~---~~  169 (308)
T cd06634          94 MEYCL-GSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAP---AN  169 (308)
T ss_pred             EEccC-CCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHhEEECCCCcEEECCcccceeecC---cc
Confidence            99997 588888876667789999999999999999999999999999999999999999999999999876543   23


Q ss_pred             cCCCCcccccccccC---CCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhccCCCCCCCCCcHHHHHHHHH
Q 015868          272 AETGTYRWMAPEVIE---HKPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRLAELLER  348 (399)
Q Consensus       272 ~~~gt~~y~aPE~l~---~~~~~~~~Dv~slG~vl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~  348 (399)
                      ...++..|+|||.+.   ...++.++||||||+++|+|++|..||...+.................+..++..+.++|.+
T Consensus       170 ~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~  249 (308)
T cd06634         170 XFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPALQSGHWSEYFRNFVDS  249 (308)
T ss_pred             cccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCccccHHHHHHHHhhcCCCCcCcccccHHHHHHHHH
Confidence            456788999999974   35678899999999999999999999988776655544444333333345688999999999


Q ss_pred             HhhhcCCCCCCHHHHHHH
Q 015868          349 CWQHDPTQRPNFSQITDI  366 (399)
Q Consensus       349 cl~~dP~~Rps~~ell~~  366 (399)
                      ||+.+|.+||++.++++.
T Consensus       250 cl~~~P~~Rp~~~~ll~~  267 (308)
T cd06634         250 CLQKIPQDRPTSEVLLKH  267 (308)
T ss_pred             HhhCCcccCCCHHHHhhC
Confidence            999999999999999764

Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin

>cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6

Probab=100.00  E-value=5.3e-39  Score=308.62  Aligned_cols=240  Identities=25%  Similarity=0.396  Sum_probs=186.2

Q ss_pred             eceeceeCceEEEEEEEC----CeeEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCceeeEEeEEec--CCcEEEEEec
Q 015868          121 ECKVASGSYGDLYKGTYC----SQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTR--PPNLCIVTEF  194 (399)
Q Consensus       121 ~~~lg~G~~g~Vy~~~~~----~~~vAvK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~nIv~~~~~~~~--~~~~~lV~E~  194 (399)
                      ..+||+|+||.||+|+..    +..||+|.++....    ...+.+|+.+++.++||||+++++++..  ....++||||
T Consensus         6 g~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~~~----~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~   81 (317)
T cd07867           6 GCKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTGI----SMSACREIALLRELKHPNVIALQKVFLSHSDRKVWLLFDY   81 (317)
T ss_pred             ceEeccCCCeeEEEEEecCCCccceEEEEEecCCCC----cHHHHHHHHHHHhCCCCCeeeEEEEEeccCCCeEEEEEee
Confidence            358999999999999863    46899999875432    2356789999999999999999999853  4578999999


Q ss_pred             CCCCCHHHHHHhc--------CCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceee----cCCCcEEEeecccee
Q 015868          195 MARGSIYDFLHKQ--------KGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLM----DENGVVKVADFGVAR  262 (399)
Q Consensus       195 ~~ggsL~~~l~~~--------~~~l~~~~~~~i~~~i~~~L~~LH~~giiHrDlkp~NILl----~~~~~vkl~DFG~a~  262 (399)
                      +.+ +|.+++...        ...+++..+..++.||+.||.|||++||+||||||+||++    +.++.+||+|||+++
T Consensus        82 ~~~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~~kl~DfG~a~  160 (317)
T cd07867          82 AEH-DLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFAR  160 (317)
T ss_pred             eCC-cHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCCEEcCCCCHHHEEEccCCCCCCcEEEeecccee
Confidence            875 888887532        2357889999999999999999999999999999999999    566799999999998


Q ss_pred             eccCCC----ccccCCCCcccccccccCCC-CCCChhhHHHHHHHHHHHHcCCCCCCCCCHHH---------HHHHHHh-
Q 015868          263 VQAQSG----VMTAETGTYRWMAPEVIEHK-PYDYKADVFSFGIALWELLTGELPYAGLTPLQ---------AAVGVVQ-  327 (399)
Q Consensus       263 ~~~~~~----~~~~~~gt~~y~aPE~l~~~-~~~~~~Dv~slG~vl~elltg~~P~~~~~~~~---------~~~~~~~-  327 (399)
                      ......    ......+|+.|+|||.+.+. .++.++||||||+++|+|+||++||.......         ....... 
T Consensus       161 ~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~  240 (317)
T cd07867         161 LFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPFHHDQLDRIFSV  240 (317)
T ss_pred             ccCCCcccccccCcceecccccCcHHhcCCCccCcHHHHHhHHHHHHHHHhCCCCcccccccccccccccHHHHHHHHHh
Confidence            654322    12334678999999999764 58999999999999999999999996532110         0000000 


Q ss_pred             ----------------------c-cCC------------CCCCCCCcHHHHHHHHHHhhhcCCCCCCHHHHHH
Q 015868          328 ----------------------K-SLR------------PTIPKHAHPRLAELLERCWQHDPTQRPNFSQITD  365 (399)
Q Consensus       328 ----------------------~-~~~------------~~~~~~~~~~l~~ll~~cl~~dP~~Rps~~ell~  365 (399)
                                            . ...            .......+..+.+|+.+||+.||.+|||+.|+++
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dP~~R~t~~e~l~  313 (317)
T cd07867         241 MGFPADKDWEDIRKMPEYPTLQKDFRRTTYANSSLIKYMEKHKVKPDSKVFLLLQKLLTMDPTKRITSEQALQ  313 (317)
T ss_pred             cCCCChhhhhhhhhcccchhhhhhhcccccCCchhhhhhhcccCCCChHHHHHHHHHhccCcccccCHHHHhc
Confidence                                  0 000            0011124567899999999999999999999975

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as

>cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3

Probab=100.00  E-value=1.3e-38  Score=301.09  Aligned_cols=241  Identities=27%  Similarity=0.435  Sum_probs=194.6

Q ss_pred             eeceeCceEEEEEEE--CCeeEEEEEecCCCCCHH-HHHHHHHHHHHHHh---cCCCceeeEEeEEecCCcEEEEEecCC
Q 015868          123 KVASGSYGDLYKGTY--CSQEVAIKVLKPECVNTE-MLKEFSQEVYIMRK---IRHKNVVQFIGACTRPPNLCIVTEFMA  196 (399)
Q Consensus       123 ~lg~G~~g~Vy~~~~--~~~~vAvK~~~~~~~~~~-~~~~~~~Ei~~l~~---l~h~nIv~~~~~~~~~~~~~lV~E~~~  196 (399)
                      .||+|+||.||++..  +++.+|+|++........ ....+.+|..+++.   .+||||+.+++++..++..++||||+.
T Consensus         1 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~   80 (279)
T cd05633           1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHTPDKLCFILDLMN   80 (279)
T ss_pred             CcccCCCeEEEEEEECCCCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEecCCeEEEEEecCC
Confidence            489999999999987  578999999976543222 22334455444443   479999999999999999999999999


Q ss_pred             CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceeecCCCcEEEeeccceeeccCCCccccCCCC
Q 015868          197 RGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAETGT  276 (399)
Q Consensus       197 ggsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~giiHrDlkp~NILl~~~~~vkl~DFG~a~~~~~~~~~~~~~gt  276 (399)
                      +++|.+++.. .+.+++..+..++.|++.||+|||++||+||||||+||++++++.++|+|||++...... ......|+
T Consensus        81 ~~~L~~~i~~-~~~l~~~~~~~i~~qi~~al~~lH~~~ivH~dikp~Nil~~~~~~~~l~dfg~~~~~~~~-~~~~~~~~  158 (279)
T cd05633          81 GGDLHYHLSQ-HGVFSEKEMRFYATEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKK-KPHASVGT  158 (279)
T ss_pred             CCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCcCCCCCCHHHEEECCCCCEEEccCCcceecccc-CccCcCCC
Confidence            9999999876 456999999999999999999999999999999999999999999999999998754332 22345689


Q ss_pred             cccccccccC-CCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHH-HHHHHHHhccCCCCCCCCCcHHHHHHHHHHhhhcC
Q 015868          277 YRWMAPEVIE-HKPYDYKADVFSFGIALWELLTGELPYAGLTPL-QAAVGVVQKSLRPTIPKHAHPRLAELLERCWQHDP  354 (399)
Q Consensus       277 ~~y~aPE~l~-~~~~~~~~Dv~slG~vl~elltg~~P~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~l~~ll~~cl~~dP  354 (399)
                      ..|+|||.+. +..++.++|+||+|+++|+|++|..||...... ..............++..+++++.+++.+||..||
T Consensus       159 ~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p  238 (279)
T cd05633         159 HGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTVNVELPDSFSPELKSLLEGLLQRDV  238 (279)
T ss_pred             cCccCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcCCCCCcCHHHHHHHhhcCCcCCccccCHHHHHHHHHHhcCCH
Confidence            9999999986 456899999999999999999999999754321 11111222234556777899999999999999999


Q ss_pred             CCCC-----CHHHHHH
Q 015868          355 TQRP-----NFSQITD  365 (399)
Q Consensus       355 ~~Rp-----s~~ell~  365 (399)
                      .+||     ++.++++
T Consensus       239 ~~R~~~~~~~~~~~~~  254 (279)
T cd05633         239 SKRLGCLGRGAQEVKE  254 (279)
T ss_pred             HHhcCCCCCCHHHHHh
Confidence            9999     5777765

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi

>PHA02882 putative serine/threonine kinase; Provisional

Probab=100.00  E-value=1e-38  Score=304.31  Aligned_cols=255  Identities=17%  Similarity=0.264  Sum_probs=193.1

Q ss_pred             eeecccccceeceeceeCceEEEEEEECC-----eeEEEEEecCCCCCH--HH-------HHHHHHHHHHHHhcCCCcee
Q 015868          111 WEIDAKQLKIECKVASGSYGDLYKGTYCS-----QEVAIKVLKPECVNT--EM-------LKEFSQEVYIMRKIRHKNVV  176 (399)
Q Consensus       111 ~~i~~~~~~i~~~lg~G~~g~Vy~~~~~~-----~~vAvK~~~~~~~~~--~~-------~~~~~~Ei~~l~~l~h~nIv  176 (399)
                      .++..++|++.++||+|+||.||+|...+     ..+|+|+........  +.       .....++...++.+.|+|++
T Consensus         7 ~~i~~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i~   86 (294)
T PHA02882          7 IDITGKEWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLGIP   86 (294)
T ss_pred             eccCCCceEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCCCC
Confidence            35667899999999999999999998743     356777644322111  10       01122344456667899999


Q ss_pred             eEEeEEecCC----cEEEEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceeecCCCc
Q 015868          177 QFIGACTRPP----NLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGV  252 (399)
Q Consensus       177 ~~~~~~~~~~----~~~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~giiHrDlkp~NILl~~~~~  252 (399)
                      ++++.+....    ..++++|++.. ++.+.+.. ....++..+..++.|++.||+|||+++|+||||||+|||++.++.
T Consensus        87 ~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~-~~~~~~~~~~~i~~qi~~~l~~lH~~~iiHrDiKp~Nill~~~~~  164 (294)
T PHA02882         87 KYYGCGSFKRCRMYYRFILLEKLVE-NTKEIFKR-IKCKNKKLIKNIMKDMLTTLEYIHEHGISHGDIKPENIMVDGNNR  164 (294)
T ss_pred             cEEEeeeEecCCceEEEEEEehhcc-CHHHHHHh-hccCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCc
Confidence            9999765443    34788887754 77777654 344678889999999999999999999999999999999999999


Q ss_pred             EEEeeccceeeccCCC--------ccccCCCCcccccccccCCCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHH-
Q 015868          253 VKVADFGVARVQAQSG--------VMTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAV-  323 (399)
Q Consensus       253 vkl~DFG~a~~~~~~~--------~~~~~~gt~~y~aPE~l~~~~~~~~~Dv~slG~vl~elltg~~P~~~~~~~~~~~-  323 (399)
                      ++|+|||+++......        ......||+.|+|||++.+..++.++|||||||++|+|++|+.||.+........ 
T Consensus       165 ~~l~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~~~~~~~~DiwSlG~~l~el~~g~~P~~~~~~~~~~~~  244 (294)
T PHA02882        165 GYIIDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNGACVTRRGDLESLGYCMLKWAGIKLPWKGFGHNGNLIH  244 (294)
T ss_pred             EEEEEcCCceeeccCCcccccccccccccCCCccccCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCccccchHHHH
Confidence            9999999997653221        1223468999999999999999999999999999999999999998774322111 


Q ss_pred             ----HHHhccCCC-CCCCCCcHHHHHHHHHHhhhcCCCCCCHHHHHHHH
Q 015868          324 ----GVVQKSLRP-TIPKHAHPRLAELLERCWQHDPTQRPNFSQITDIL  367 (399)
Q Consensus       324 ----~~~~~~~~~-~~~~~~~~~l~~ll~~cl~~dP~~Rps~~ell~~L  367 (399)
                          ........+ .....+++.+.+++..||..+|++||++.++.+.+
T Consensus       245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~rp~~~~l~~~~  293 (294)
T PHA02882        245 AAKCDFIKRLHEGKIKIKNANKFIYDFIECVTKLSYEEKPDYDALIKIF  293 (294)
T ss_pred             HhHHHHHHHhhhhhhccCCCCHHHHHHHHHHHhCCCCCCCCHHHHHHhh
Confidence                111111111 12345688999999999999999999999999876

>cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3

Probab=100.00  E-value=3.1e-38  Score=303.65  Aligned_cols=245  Identities=28%  Similarity=0.458  Sum_probs=208.4

Q ss_pred             ccceeceeceeCceEEEEEEE--CCeeEEEEEecCCCC-CHHHHHHHHHHHHHHHhcCCCceeeEEeEEecCCcEEEEEe
Q 015868          117 QLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECV-NTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVTE  193 (399)
Q Consensus       117 ~~~i~~~lg~G~~g~Vy~~~~--~~~~vAvK~~~~~~~-~~~~~~~~~~Ei~~l~~l~h~nIv~~~~~~~~~~~~~lV~E  193 (399)
                      .|...++||.|+||.||+|+.  +++.|++|++..... .......+.+|+.+++.++|||++++++++......++|||
T Consensus        22 ~~~~~~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e  101 (313)
T cd06633          22 IFVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLKEHTAWLVME  101 (313)
T ss_pred             HhhcceeeccCCCeEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEEe
Confidence            366678899999999999986  678999999875432 34455678899999999999999999999999999999999


Q ss_pred             cCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceeecCCCcEEEeeccceeeccCCCccccC
Q 015868          194 FMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAE  273 (399)
Q Consensus       194 ~~~ggsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~giiHrDlkp~NILl~~~~~vkl~DFG~a~~~~~~~~~~~~  273 (399)
                      |+.+ ++.+++......+++..+..++.|++.++.|||++|++|+||+|+||+++.++.++|+|||.+....   .....
T Consensus       102 ~~~~-~l~~~l~~~~~~l~~~~~~~~~~qi~~al~~LH~~gi~H~dl~p~nili~~~~~~kL~dfg~~~~~~---~~~~~  177 (313)
T cd06633         102 YCLG-SASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNMIHRDIKAGNILLTEPGQVKLADFGSASKSS---PANSF  177 (313)
T ss_pred             cCCC-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCChhhEEECCCCCEEEeecCCCcccC---CCCCc
Confidence            9965 8888887767789999999999999999999999999999999999999999999999999886432   22345


Q ss_pred             CCCcccccccccC---CCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhccCCCCCCCCCcHHHHHHHHHHh
Q 015868          274 TGTYRWMAPEVIE---HKPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRLAELLERCW  350 (399)
Q Consensus       274 ~gt~~y~aPE~l~---~~~~~~~~Dv~slG~vl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~cl  350 (399)
                      .++..|+|||.+.   ...++.++||||||+++|+|++|..||...+....................++..+.+++.+||
T Consensus       178 ~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l  257 (313)
T cd06633         178 VGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNDSPTLQSNEWTDSFRGFVDYCL  257 (313)
T ss_pred             cccccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCccccCHHHHHHHHHHc
Confidence            6888999999984   4568899999999999999999999998887766555544433333334467889999999999


Q ss_pred             hhcCCCCCCHHHHHH
Q 015868          351 QHDPTQRPNFSQITD  365 (399)
Q Consensus       351 ~~dP~~Rps~~ell~  365 (399)
                      +.+|.+||++.+++.
T Consensus       258 ~~~P~~Rp~~~~~l~  272 (313)
T cd06633         258 QKIPQERPASAELLR  272 (313)
T ss_pred             cCChhhCcCHHHHhc
Confidence            999999999999985

Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co

>cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases

Probab=100.00  E-value=2e-38  Score=299.58  Aligned_cols=247  Identities=23%  Similarity=0.392  Sum_probs=204.6

Q ss_pred             cceeceeceeCceEEEEEEEC--CeeEEEEEecCCCCCHHHHHHHHHHHHHHHhc---CCCceeeEEeEEecCCc-----
Q 015868          118 LKIECKVASGSYGDLYKGTYC--SQEVAIKVLKPECVNTEMLKEFSQEVYIMRKI---RHKNVVQFIGACTRPPN-----  187 (399)
Q Consensus       118 ~~i~~~lg~G~~g~Vy~~~~~--~~~vAvK~~~~~~~~~~~~~~~~~Ei~~l~~l---~h~nIv~~~~~~~~~~~-----  187 (399)
                      |++.+.||.|+||.||+|++.  ++.||+|+++...........+.+|+.+++++   +|||++++++++.....     
T Consensus         1 y~~~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~~   80 (287)
T cd07838           1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDRELK   80 (287)
T ss_pred             CeEEEEecccCceEEEEEEECCCCCEEEEEEeccccccchhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCCce
Confidence            678899999999999999984  78999999986544444445677788887766   59999999999988776     


Q ss_pred             EEEEEecCCCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceeecCCCcEEEeeccceeeccC
Q 015868          188 LCIVTEFMARGSIYDFLHKQK-GVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQ  266 (399)
Q Consensus       188 ~~lV~E~~~ggsL~~~l~~~~-~~l~~~~~~~i~~~i~~~L~~LH~~giiHrDlkp~NILl~~~~~vkl~DFG~a~~~~~  266 (399)
                      .+++|||+.+ +|.+++.... ..+++..++.++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||.+.....
T Consensus        81 ~~l~~e~~~~-~l~~~l~~~~~~~l~~~~~~~~~~~i~~al~~LH~~~i~h~~l~~~nili~~~~~~~l~dfg~~~~~~~  159 (287)
T cd07838          81 LTLVFEHVDQ-DLATYLSKCPKPGLPPETIKDLMRQLLRGVDFLHSHRIVHRDLKPQNILVTSDGQVKIADFGLARIYSF  159 (287)
T ss_pred             eEEEehhccc-CHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCChhhEEEccCCCEEEeccCcceeccC
Confidence            9999999975 8999887643 3689999999999999999999999999999999999999999999999999987655


Q ss_pred             CCccccCCCCcccccccccCCCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhccCC---------------
Q 015868          267 SGVMTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKSLR---------------  331 (399)
Q Consensus       267 ~~~~~~~~gt~~y~aPE~l~~~~~~~~~Dv~slG~vl~elltg~~P~~~~~~~~~~~~~~~~~~~---------------  331 (399)
                      ........++..|+|||.+.+..++.++|+||||+++|+|++|.+||...+..+....+......               
T Consensus       160 ~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~s~G~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (287)
T cd07838         160 EMALTSVVVTLWYRAPEVLLQSSYATPVDMWSVGCIFAELFRRRPLFRGTSEADQLDKIFDVIGLPSEEEWPRNVSLPRS  239 (287)
T ss_pred             CcccccccccccccChHHhccCCCCCcchhhhHHHHHHHHHhCCCcccCCChHHHHHHHHHHcCCCChHhcCCCcccchh
Confidence            44344445788999999999999999999999999999999999999887766554444321100               


Q ss_pred             ----------CCCCCCCcHHHHHHHHHHhhhcCCCCCCHHHHHH
Q 015868          332 ----------PTIPKHAHPRLAELLERCWQHDPTQRPNFSQITD  365 (399)
Q Consensus       332 ----------~~~~~~~~~~l~~ll~~cl~~dP~~Rps~~ell~  365 (399)
                                .......++.+.+++.+||+.||.+||++.+++.
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~il~  283 (287)
T cd07838         240 SFPSYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRISAFEALQ  283 (287)
T ss_pred             hcccccccchhhhhhhhhHHHHHHHHHHhccCCccCCCHHHHhc
Confidence                      0001234678899999999999999999999874

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both

>cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein

Probab=100.00  E-value=9.3e-39  Score=306.67  Aligned_cols=248  Identities=24%  Similarity=0.419  Sum_probs=203.9

Q ss_pred             cceeceeceeCceEEEEEEECCeeEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCceeeEEeEEecCCcEEEEEecCCC
Q 015868          118 LKIECKVASGSYGDLYKGTYCSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVTEFMAR  197 (399)
Q Consensus       118 ~~i~~~lg~G~~g~Vy~~~~~~~~vAvK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~nIv~~~~~~~~~~~~~lV~E~~~g  197 (399)
                      +.+.+.+|.|+++.||+++.+++.||+|+++.........+.+.+|+.+++.++|+||+++++++......+++|||+++
T Consensus         4 ~~i~~~~~~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~e~~~~   83 (314)
T cd08216           4 TLIGKCFEDLMIVHLAKHKPTNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSFIVDSELYVVSPLMAY   83 (314)
T ss_pred             hhhhHhhcCCceEEEEEecCCCCEEEEEEEeccccchhHHHHHHHHHHHHHhcCCcchhhhhheeecCCeEEEEEeccCC
Confidence            45566677778888888888899999999987655566678899999999999999999999999999999999999999


Q ss_pred             CCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceeecCCCcEEEeeccceeeccCCC--------
Q 015868          198 GSIYDFLHKQ-KGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSG--------  268 (399)
Q Consensus       198 gsL~~~l~~~-~~~l~~~~~~~i~~~i~~~L~~LH~~giiHrDlkp~NILl~~~~~vkl~DFG~a~~~~~~~--------  268 (399)
                      ++|.+++... ...+++..+..++.|++.||+|||++||+||||||+||+++.++.+||+|||.+.......        
T Consensus        84 ~~l~~~l~~~~~~~~~~~~~~~~~~~l~~~L~~LH~~~ivH~dlk~~Nili~~~~~~kl~d~~~~~~~~~~~~~~~~~~~  163 (314)
T cd08216          84 GSCEDLLKTHFPEGLPELAIAFILKDVLNALDYIHSKGFIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRVVHD  163 (314)
T ss_pred             CCHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCcceEEEecCCceEEecCccceeecccccccccccc
Confidence            9999999764 3568999999999999999999999999999999999999999999999999886443221        


Q ss_pred             ccccCCCCcccccccccCC--CCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhccC----------------
Q 015868          269 VMTAETGTYRWMAPEVIEH--KPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKSL----------------  330 (399)
Q Consensus       269 ~~~~~~gt~~y~aPE~l~~--~~~~~~~Dv~slG~vl~elltg~~P~~~~~~~~~~~~~~~~~~----------------  330 (399)
                      ......++..|+|||.+.+  ..++.++|+||||+++|+|++|+.||.................                
T Consensus       164 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~Diws~G~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  243 (314)
T cd08216         164 FPKSSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMPATQMLLEKVRGTVPCLLDKSTYPLYEDSM  243 (314)
T ss_pred             ccccccccccccCHHHhcCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCccccccCchhhhcCCc
Confidence            1233456778999999976  3588999999999999999999999987665544332221110                


Q ss_pred             ----------------CCCCCCCCcHHHHHHHHHHhhhcCCCCCCHHHHHH
Q 015868          331 ----------------RPTIPKHAHPRLAELLERCWQHDPTQRPNFSQITD  365 (399)
Q Consensus       331 ----------------~~~~~~~~~~~l~~ll~~cl~~dP~~Rps~~ell~  365 (399)
                                      ....+...+.++.+++.+||+.||++|||+.++++
T Consensus       244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~  294 (314)
T cd08216         244 SQSRSSNEHPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPESRPSASQLLN  294 (314)
T ss_pred             CcccccccccchhhhhhcchhhHHHHHHHHHHHHHhhcCCCcCcCHHHHhc
Confidence                            00111234568999999999999999999999987

Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc

>cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases

Probab=100.00  E-value=1e-38  Score=306.06  Aligned_cols=248  Identities=25%  Similarity=0.412  Sum_probs=197.7

Q ss_pred             ccceeceeceeCceEEEEEEE----CCeeEEEEEecCCC-CCHHHHHHHHHHHHHHHhcCCCceeeEEeEEecC--CcEE
Q 015868          117 QLKIECKVASGSYGDLYKGTY----CSQEVAIKVLKPEC-VNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRP--PNLC  189 (399)
Q Consensus       117 ~~~i~~~lg~G~~g~Vy~~~~----~~~~vAvK~~~~~~-~~~~~~~~~~~Ei~~l~~l~h~nIv~~~~~~~~~--~~~~  189 (399)
                      +|++.++||+|+||.||+|..    .++.||+|++.... ........+.+|+.+++.++||||+++++++...  ..++
T Consensus         1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~   80 (316)
T cd07842           1 KYEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLVEVFLEHADKSVY   80 (316)
T ss_pred             CceEEEEeccCCcEEEEEEEecCCCCCCeEEEEEeccccccccCccHHHHHHHHHHHhcCCCCccceEEEEeCCCCceEE
Confidence            478899999999999999987    46899999998643 1233345678899999999999999999999888  7899


Q ss_pred             EEEecCCCCCHHHHHHhc----CCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceeecC----CCcEEEeeccce
Q 015868          190 IVTEFMARGSIYDFLHKQ----KGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDE----NGVVKVADFGVA  261 (399)
Q Consensus       190 lV~E~~~ggsL~~~l~~~----~~~l~~~~~~~i~~~i~~~L~~LH~~giiHrDlkp~NILl~~----~~~vkl~DFG~a  261 (399)
                      +||||+++ ++.+++...    ...+++..++.++.|++.||.|||+++|+||||||+||+++.    ++.+||+|||++
T Consensus        81 lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~h~dlkp~Nil~~~~~~~~~~~kl~Dfg~~  159 (316)
T cd07842          81 LLFDYAEH-DLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHSNWVLHRDLKPANILVMGEGPERGVVKIGDLGLA  159 (316)
T ss_pred             EEEeCCCc-CHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHHhCCEeeCCCCHHHEEEcCCCCccceEEECCCccc
Confidence            99999975 777776432    236899999999999999999999999999999999999999    999999999998


Q ss_pred             eeccCCCc----cccCCCCcccccccccCC-CCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHH---------HHHHHHh
Q 015868          262 RVQAQSGV----MTAETGTYRWMAPEVIEH-KPYDYKADVFSFGIALWELLTGELPYAGLTPLQ---------AAVGVVQ  327 (399)
Q Consensus       262 ~~~~~~~~----~~~~~gt~~y~aPE~l~~-~~~~~~~Dv~slG~vl~elltg~~P~~~~~~~~---------~~~~~~~  327 (399)
                      +.......    .....++..|+|||.+.+ ..++.++|+||||+++|+|++|..||.+.....         .....+.
T Consensus       160 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (316)
T cd07842         160 RLFNAPLKPLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGREAKIKKSNPFQRDQLERIFE  239 (316)
T ss_pred             cccCCCcccccccCCccccccccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhcCCCCcCCcccccccchhHHHHHHHHHH
Confidence            86543321    123356889999998876 457899999999999999999999997654322         0000000


Q ss_pred             ------------------------ccCCCCCC-----------CCCcHHHHHHHHHHhhhcCCCCCCHHHHHH
Q 015868          328 ------------------------KSLRPTIP-----------KHAHPRLAELLERCWQHDPTQRPNFSQITD  365 (399)
Q Consensus       328 ------------------------~~~~~~~~-----------~~~~~~l~~ll~~cl~~dP~~Rps~~ell~  365 (399)
                                              .......+           ...+.++.+++.+||+.||++|||+.|+++
T Consensus       240 ~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~eil~  312 (316)
T cd07842         240 VLGTPTEKDWPDIKKMPEYDTLMKDFKTKTYPSNSLAKWMEKHKKPDSQGFDLLRKLLEYDPTKRITAEEALE  312 (316)
T ss_pred             HhCCCchhHHHHHhhcccchhhhhhccCCCCCCccHHHHHHhccCCCHHHHHHHHHHhcCCcccCcCHHHHhc
Confidence                                    00011111           156678999999999999999999999875

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the

>cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants

Probab=100.00  E-value=1.1e-38  Score=309.85  Aligned_cols=253  Identities=25%  Similarity=0.390  Sum_probs=205.7

Q ss_pred             cccceeceeceeCceEEEEEEE--CCeeEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCceeeEEeEEecC-----CcE
Q 015868          116 KQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRP-----PNL  188 (399)
Q Consensus       116 ~~~~i~~~lg~G~~g~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~nIv~~~~~~~~~-----~~~  188 (399)
                      ++|++.+.||.|+||.||++..  +++.||||.++...........+.+|+.+++.++|+||+++++++...     ...
T Consensus         5 ~~y~~~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~~~~~   84 (337)
T cd07858           5 TKYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIAIKDIMPPPHREAFNDV   84 (337)
T ss_pred             cceeEEEEeccCCCeEEEEEEecCCCCeEEEEEecccccccchhHHHHHHHHHHHhcCCCCccchHHheecccccccCcE
Confidence            4799999999999999999986  578999999876543444456778899999999999999999988654     348


Q ss_pred             EEEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceeecCCCcEEEeeccceeeccCC-
Q 015868          189 CIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQS-  267 (399)
Q Consensus       189 ~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~giiHrDlkp~NILl~~~~~vkl~DFG~a~~~~~~-  267 (399)
                      |+|+||+. ++|.+++.. .+.+++..+..++.|++.||.|||+++++||||||+||+++.++.+||+|||+++..... 
T Consensus        85 ~lv~e~~~-~~L~~~~~~-~~~l~~~~~~~i~~qi~~aL~~LH~~~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~  162 (337)
T cd07858          85 YIVYELMD-TDLHQIIRS-SQTLSDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARTTSEKG  162 (337)
T ss_pred             EEEEeCCC-CCHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCEEECcCccccccCCCc
Confidence            99999996 589998865 467999999999999999999999999999999999999999999999999999865443 


Q ss_pred             CccccCCCCcccccccccCC-CCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHh-------------------
Q 015868          268 GVMTAETGTYRWMAPEVIEH-KPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQ-------------------  327 (399)
Q Consensus       268 ~~~~~~~gt~~y~aPE~l~~-~~~~~~~Dv~slG~vl~elltg~~P~~~~~~~~~~~~~~~-------------------  327 (399)
                      .......++..|+|||.+.+ ..++.++|+||||+++|+|++|+.||.+.+..........                   
T Consensus       163 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  242 (337)
T cd07858         163 DFMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKDYVHQLKLITELLGSPSEEDLGFIRNEKAR  242 (337)
T ss_pred             ccccccccccCccChHHHhcCCCCCCcccHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCChHHhhhcCchhhh
Confidence            23344568889999998865 4688999999999999999999999977654322211110                   


Q ss_pred             ----cc---CC---CCCCCCCcHHHHHHHHHHhhhcCCCCCCHHHHHHH--HHHH
Q 015868          328 ----KS---LR---PTIPKHAHPRLAELLERCWQHDPTQRPNFSQITDI--LKQM  370 (399)
Q Consensus       328 ----~~---~~---~~~~~~~~~~l~~ll~~cl~~dP~~Rps~~ell~~--L~~l  370 (399)
                          ..   .+   ....+.+++++.+++.+||+.+|++|||+.++++.  +..+
T Consensus       243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rps~~ell~h~~~~~~  297 (337)
T cd07858         243 RYIRSLPYTPRQSFARLFPHANPLAIDLLEKMLVFDPSKRITVEEALAHPYLASL  297 (337)
T ss_pred             HHHHhcCcccccCHHHHcccCCHHHHHHHHHHhcCChhhccCHHHHHcCcchhhh
Confidence                00   00   01224578999999999999999999999999875  5443

Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati

>cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1

Probab=100.00  E-value=1.4e-38  Score=299.33  Aligned_cols=247  Identities=24%  Similarity=0.467  Sum_probs=212.7

Q ss_pred             cccceeceeceeCceEEEEEEE--CCeeEEEEEecCCCC-CHHHHHHHHHHHHHHHhcC-CCceeeEEeEEecCCcEEEE
Q 015868          116 KQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECV-NTEMLKEFSQEVYIMRKIR-HKNVVQFIGACTRPPNLCIV  191 (399)
Q Consensus       116 ~~~~i~~~lg~G~~g~Vy~~~~--~~~~vAvK~~~~~~~-~~~~~~~~~~Ei~~l~~l~-h~nIv~~~~~~~~~~~~~lV  191 (399)
                      ++|++.+.||+|+||.||+++.  +++.||+|++..... .....+.+.+|..++++++ ||||+++++.+......++|
T Consensus         1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv   80 (280)
T cd05581           1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQDEENLYFV   80 (280)
T ss_pred             CCceEeeeecCCCceEEEEEEEcCCCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHhcCCceEEEE
Confidence            4789999999999999999987  678999999976432 3344577889999999998 99999999999999999999


Q ss_pred             EecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceeecCCCcEEEeeccceeeccCCCc--
Q 015868          192 TEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGV--  269 (399)
Q Consensus       192 ~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~giiHrDlkp~NILl~~~~~vkl~DFG~a~~~~~~~~--  269 (399)
                      ||++++++|.+++.+. +.+++..++.++.|++.||.|||+.|++|+||+|+||+++.++.++++|||.+........  
T Consensus        81 ~e~~~~~~L~~~l~~~-~~l~~~~~~~i~~ql~~~l~~Lh~~~~~H~dl~~~ni~i~~~~~~~l~df~~~~~~~~~~~~~  159 (280)
T cd05581          81 LEYAPNGELLQYIRKY-GSLDEKCTRFYAAEILLALEYLHSKGIIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPE  159 (280)
T ss_pred             EcCCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECCCCCEEecCCccccccCCccccc
Confidence            9999999999999764 5799999999999999999999999999999999999999999999999999875443221  


Q ss_pred             -------------------cccCCCCcccccccccCCCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhccC
Q 015868          270 -------------------MTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKSL  330 (399)
Q Consensus       270 -------------------~~~~~gt~~y~aPE~l~~~~~~~~~Dv~slG~vl~elltg~~P~~~~~~~~~~~~~~~~~~  330 (399)
                                         .....++..|+|||.+.+..++.++|+||||++++++++|..||...+..+......  ..
T Consensus       160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~--~~  237 (280)
T cd05581         160 SNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFRGSNEYLTFQKIL--KL  237 (280)
T ss_pred             cCCCCCccccccccccccccccccCCccccCHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHH--hc
Confidence                               112346789999999988889999999999999999999999999887665554444  23


Q ss_pred             CCCCCCCCcHHHHHHHHHHhhhcCCCCCCH----HHHHH
Q 015868          331 RPTIPKHAHPRLAELLERCWQHDPTQRPNF----SQITD  365 (399)
Q Consensus       331 ~~~~~~~~~~~l~~ll~~cl~~dP~~Rps~----~ell~  365 (399)
                      ...++..+++.+.+++.+||+.+|.+||++    +++++
T Consensus       238 ~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~ll~  276 (280)
T cd05581         238 EYSFPPNFPPDAKDLIEKLLVLDPQDRLGVNEGYDELKA  276 (280)
T ss_pred             CCCCCCccCHHHHHHHHHHhcCCHhhCCCcccCHHHHhc
Confidence            345677789999999999999999999999    77653

Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto

>KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2e-39  Score=296.21  Aligned_cols=251  Identities=23%  Similarity=0.432  Sum_probs=221.5

Q ss_pred             eecccccceeceeceeCceEEEEEEE--CCeeEEEEEecCCCC-CHHHHHHHHHHHHHHHhcCCCceeeEEeEEecCCcE
Q 015868          112 EIDAKQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECV-NTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNL  188 (399)
Q Consensus       112 ~i~~~~~~i~~~lg~G~~g~Vy~~~~--~~~~vAvK~~~~~~~-~~~~~~~~~~Ei~~l~~l~h~nIv~~~~~~~~~~~~  188 (399)
                      .+..++|.+++.||.|.||.|-+++.  +++.+|+|+++++.. ..+....-..|-++|+..+||.+..+.-.|.....+
T Consensus       164 kvTm~dFdfLKvLGkGTFGKVIL~rEKat~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~HPFLt~LKYsFQt~drl  243 (516)
T KOG0690|consen  164 KVTMEDFDFLKVLGKGTFGKVILCREKATGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNCRHPFLTSLKYSFQTQDRL  243 (516)
T ss_pred             eeccchhhHHHHhcCCccceEEEEeecccCceeehhhhhhhheeehHHhhhhhhHHHHHHhccCcHHHHhhhhhccCceE
Confidence            45567899999999999999999876  688999999998753 555667778899999999999999999999999999


Q ss_pred             EEEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceeecCCCcEEEeeccceeeccCC-
Q 015868          189 CIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQS-  267 (399)
Q Consensus       189 ~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~giiHrDlkp~NILl~~~~~vkl~DFG~a~~~~~~-  267 (399)
                      |+||||..||.|.-.+.. ...+++.....+...|+.||.|||+++||.||+|.+|+|+|.+|++||+|||+++..... 
T Consensus       244 CFVMeyanGGeLf~HLsr-er~FsE~RtRFYGaEIvsAL~YLHs~~ivYRDlKLENLlLDkDGHIKitDFGLCKE~I~~g  322 (516)
T KOG0690|consen  244 CFVMEYANGGELFFHLSR-ERVFSEDRTRFYGAEIVSALGYLHSRNIVYRDLKLENLLLDKDGHIKITDFGLCKEEIKYG  322 (516)
T ss_pred             EEEEEEccCceEeeehhh-hhcccchhhhhhhHHHHHHhhhhhhCCeeeeechhhhheeccCCceEeeecccchhccccc
Confidence            999999999999988865 567999999999999999999999999999999999999999999999999999865443 


Q ss_pred             CccccCCCCcccccccccCCCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhccCCCCCCCCCcHHHHHHHH
Q 015868          268 GVMTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRLAELLE  347 (399)
Q Consensus       268 ~~~~~~~gt~~y~aPE~l~~~~~~~~~Dv~slG~vl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~  347 (399)
                      ..+...+|||.|+|||++....|....|.|.+|+++|||+||++||...+....+.-+.-..  ..+|..++++...|+.
T Consensus       323 ~t~kTFCGTPEYLAPEVleDnDYgraVDWWG~GVVMYEMmCGRLPFyn~dh~kLFeLIl~ed--~kFPr~ls~eAktLLs  400 (516)
T KOG0690|consen  323 DTTKTFCGTPEYLAPEVLEDNDYGRAVDWWGVGVVMYEMMCGRLPFYNKDHEKLFELILMED--LKFPRTLSPEAKTLLS  400 (516)
T ss_pred             ceeccccCChhhcCchhhccccccceeehhhhhHHHHHHHhccCcccccchhHHHHHHHhhh--ccCCccCCHHHHHHHH
Confidence            34667899999999999999999999999999999999999999999988877776655443  3478899999999999


Q ss_pred             HHhhhcCCCCC--CHHHHHH
Q 015868          348 RCWQHDPTQRP--NFSQITD  365 (399)
Q Consensus       348 ~cl~~dP~~Rp--s~~ell~  365 (399)
                      .+|.+||.+|.  ...+..+
T Consensus       401 GLL~kdP~kRLGgGpdDakE  420 (516)
T KOG0690|consen  401 GLLKKDPKKRLGGGPDDAKE  420 (516)
T ss_pred             HHhhcChHhhcCCCchhHHH
Confidence            99999999994  3344443

>KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=1.2e-39  Score=326.65  Aligned_cols=258  Identities=30%  Similarity=0.601  Sum_probs=229.5

Q ss_pred             ccccceeceeceeCceEEEEEEEC------CeeEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCceeeEEeEEecCCcE
Q 015868          115 AKQLKIECKVASGSYGDLYKGTYC------SQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNL  188 (399)
Q Consensus       115 ~~~~~i~~~lg~G~~g~Vy~~~~~------~~~vAvK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~nIv~~~~~~~~~~~~  188 (399)
                      ...++..++||+|+||+||+|.|.      .-+||+|++.... ......++.+|+.+|.+++|||++++++++.... +
T Consensus       695 Etelkk~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~t-~~~~s~e~LdeAl~masldHpnl~RLLgvc~~s~-~  772 (1177)
T KOG1025|consen  695 ETELKKDKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEFT-SPKASIELLDEALRMASLDHPNLLRLLGVCMLST-L  772 (1177)
T ss_pred             hhhhhhhceeccccceeEEeeeEecCCceecceeEEEEeeccC-CchhhHHHHHHHHHHhcCCCchHHHHhhhcccch-H
Confidence            345677789999999999999872      3579999987553 3444578999999999999999999999998776 8


Q ss_pred             EEEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceeecCCCcEEEeeccceeeccCCC
Q 015868          189 CIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSG  268 (399)
Q Consensus       189 ~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~giiHrDlkp~NILl~~~~~vkl~DFG~a~~~~~~~  268 (399)
                      .||++|+++|+|.|+++.+++.+-.+.++.|..||++||.|||.++++||||.++|||+.+-..|||.|||+++......
T Consensus       773 qlvtq~mP~G~LlDyvr~hr~~igsq~lLnw~~QIAkgM~YLe~qrlVHrdLaaRNVLVksP~hvkitdfgla~ll~~d~  852 (1177)
T KOG1025|consen  773 QLVTQLMPLGCLLDYVREHRDNIGSQDLLNWCYQIAKGMKYLEEQRLVHRDLAARNVLVKSPNHVKITDFGLAKLLAPDE  852 (1177)
T ss_pred             HHHHHhcccchHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHhcchhhhhhhhhheeecCCCeEEEEecchhhccCccc
Confidence            89999999999999999999999999999999999999999999999999999999999999999999999999876654


Q ss_pred             c-cccCCC--CcccccccccCCCCCCChhhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHHhccCCCCCCCCCcHHHHH
Q 015868          269 V-MTAETG--TYRWMAPEVIEHKPYDYKADVFSFGIALWELLT-GELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRLAE  344 (399)
Q Consensus       269 ~-~~~~~g--t~~y~aPE~l~~~~~~~~~Dv~slG~vl~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~  344 (399)
                      . ..+..|  .+.|||-|.+....|++++||||||+++||++| |..||.+....+ ....+..+.|...|+.++.++..
T Consensus       853 ~ey~~~~gK~pikwmale~i~~~~~thqSDVWsfGVtiWElmTFGa~Py~gi~~~e-I~dlle~geRLsqPpiCtiDVy~  931 (1177)
T KOG1025|consen  853 KEYSAPGGKVPIKWMALESIRIRKYTHQSDVWSFGVTIWELMTFGAKPYDGIPAEE-IPDLLEKGERLSQPPICTIDVYM  931 (1177)
T ss_pred             ccccccccccCcHHHHHHHhhccCCCchhhhhhhhhhHHHHHhcCCCccCCCCHHH-hhHHHhccccCCCCCCccHHHHH
Confidence            3 233333  678999999999999999999999999999999 999999987665 55667888999999999999999


Q ss_pred             HHHHHhhhcCCCCCCHHHHHHHHHHHHHHHH
Q 015868          345 LLERCWQHDPTQRPNFSQITDILKQMMKEVA  375 (399)
Q Consensus       345 ll~~cl~~dP~~Rps~~ell~~L~~l~~~~~  375 (399)
                      +|.+||..|+..||+|+++..++.++.++.+
T Consensus       932 ~mvkCwmid~~~rp~fkel~~~fs~~ardpq  962 (1177)
T KOG1025|consen  932 VMVKCWMIDADSRPTFKELAEEFSRMARDPQ  962 (1177)
T ss_pred             HHHHHhccCcccCccHHHHHHHHHHHhcCcc
Confidence            9999999999999999999999999987664

>cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase

Probab=100.00  E-value=1.6e-38  Score=307.27  Aligned_cols=247  Identities=26%  Similarity=0.397  Sum_probs=208.8

Q ss_pred             ccceeceeceeCceEEEEEEE--CCeeEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCceeeEEeEEecCC-----cEE
Q 015868          117 QLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPP-----NLC  189 (399)
Q Consensus       117 ~~~i~~~lg~G~~g~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~nIv~~~~~~~~~~-----~~~  189 (399)
                      +|++.+.||.|++|.||+|+.  .++.||+|.+..........+.+.+|+.+++.++|+||+++++++....     ..|
T Consensus         1 ~y~i~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~   80 (330)
T cd07834           1 RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFNDVY   80 (330)
T ss_pred             CceeeeeecCCCCeEEEEEEeCCCCcEEEEEeeccccccchhhhhHHHHHHHHHhcCCcchhhhhhhhcccCcccccceE
Confidence            588999999999999999987  4689999999865434555678999999999999999999999998775     789


Q ss_pred             EEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceeecCCCcEEEeeccceeeccCCC-
Q 015868          190 IVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSG-  268 (399)
Q Consensus       190 lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~giiHrDlkp~NILl~~~~~vkl~DFG~a~~~~~~~-  268 (399)
                      +||||+++ +|.+++.. ...+++..++.++.+++.||+|||++||+||||||.||+++.++.++|+|||.+....... 
T Consensus        81 lv~e~~~~-~l~~~l~~-~~~l~~~~~~~i~~~l~~~l~~LH~~gi~H~dlkp~nili~~~~~~~L~dfg~~~~~~~~~~  158 (330)
T cd07834          81 IVTELMET-DLHKVIKS-PQPLTDDHIQYFLYQILRGLKYLHSANVIHRDLKPSNILVNSNCDLKICDFGLARGVDPDED  158 (330)
T ss_pred             EEecchhh-hHHHHHhC-CCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEcccCceEeeccccc
Confidence            99999975 89998865 3489999999999999999999999999999999999999999999999999998765543 


Q ss_pred             ---ccccCCCCcccccccccCCC-CCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhccCC-------------
Q 015868          269 ---VMTAETGTYRWMAPEVIEHK-PYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKSLR-------------  331 (399)
Q Consensus       269 ---~~~~~~gt~~y~aPE~l~~~-~~~~~~Dv~slG~vl~elltg~~P~~~~~~~~~~~~~~~~~~~-------------  331 (399)
                         ......++..|+|||.+.+. .++.++|+||||+++|+|++|..||...+..+....+......             
T Consensus       159 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~  238 (330)
T cd07834         159 EKGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYIDQLNLIVEVLGTPSEEDLKFITSEK  238 (330)
T ss_pred             ccccccccccccCcCCceeeecccCCCcchhHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHhcCCCChhHhhhccccc
Confidence               23445678899999999887 7899999999999999999999999887765544333221100             


Q ss_pred             ----------------CCCCCCCcHHHHHHHHHHhhhcCCCCCCHHHHHH
Q 015868          332 ----------------PTIPKHAHPRLAELLERCWQHDPTQRPNFSQITD  365 (399)
Q Consensus       332 ----------------~~~~~~~~~~l~~ll~~cl~~dP~~Rps~~ell~  365 (399)
                                      .......++++.+++.+||+.+|.+||+++++++
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~  288 (330)
T cd07834         239 ARNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRITADEALA  288 (330)
T ss_pred             hhhHHhhcccCCcchhHHhcccCCHHHHHHHHHHccCChhhCCCHHHHHh
Confidence                            0012346789999999999999999999999986

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and

>KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms]

Probab=100.00  E-value=1.4e-40  Score=296.57  Aligned_cols=258  Identities=26%  Similarity=0.451  Sum_probs=218.1

Q ss_pred             CCCCceeecccccceeceeceeCceEEEEEEE--CCeeEEEEEecCCCCCHHHHHHHHHHHH-HHHhcCCCceeeEEeEE
Q 015868          106 DGTDVWEIDAKQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVNTEMLKEFSQEVY-IMRKIRHKNVVQFIGAC  182 (399)
Q Consensus       106 ~~~~~~~i~~~~~~i~~~lg~G~~g~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~Ei~-~l~~l~h~nIv~~~~~~  182 (399)
                      ++...|.+..++++-+..||.|+||+|++-.+  .++..|||.++..... ....++..|.. ++++-+.||||++||++
T Consensus        54 ~~~~~~~F~~~~Lqdlg~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n~~-keq~rll~e~d~~mks~~cp~IVkfyGa~  132 (361)
T KOG1006|consen   54 DDAHLHTFTSDNLQDLGEIGNGAFGTVNKMLHKPSGKLMAVKRIRSNNIE-KEQKRLLMEHDTVMKSSNCPNIVKFYGAL  132 (361)
T ss_pred             CcccccccccchHHHHHHhcCCcchhhhhhhcCccCcEEEEEEeeeccch-HHHHHHHHHHHHHHhhcCCcHHHHHhhhh
Confidence            44567888899999999999999999999876  5788999999987543 34456666665 45556799999999999


Q ss_pred             ecCCcEEEEEecCCCCCHHHHHH----hcCCCCCHHHHHHHHHHHHHHHHHHHH-CCcccCCCCCCceeecCCCcEEEee
Q 015868          183 TRPPNLCIVTEFMARGSIYDFLH----KQKGVFQLTSLLKVAIDVSKGMNYLHQ-NNIIHRDLKTANLLMDENGVVKVAD  257 (399)
Q Consensus       183 ~~~~~~~lV~E~~~ggsL~~~l~----~~~~~l~~~~~~~i~~~i~~~L~~LH~-~giiHrDlkp~NILl~~~~~vkl~D  257 (399)
                      ..++.++|.||.|.- |+..+-.    .++..++++.+-.|....+.||+||.. ..|||||+||+|||++..|.|||||
T Consensus       133 F~EGdcWiCMELMd~-SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~~lkiIHRDvKPSNILldr~G~vKLCD  211 (361)
T KOG1006|consen  133 FSEGDCWICMELMDI-SLDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKEELKIIHRDVKPSNILLDRHGDVKLCD  211 (361)
T ss_pred             hcCCceeeeHHHHhh-hHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHHHhhhhhccCChhheEEecCCCEeeec
Confidence            999999999999965 7765542    245789999999999999999999986 5999999999999999999999999


Q ss_pred             ccceeeccCCCccccCCCCcccccccccCC--CCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhccCCCCCC
Q 015868          258 FGVARVQAQSGVMTAETGTYRWMAPEVIEH--KPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKSLRPTIP  335 (399)
Q Consensus       258 FG~a~~~~~~~~~~~~~gt~~y~aPE~l~~--~~~~~~~Dv~slG~vl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~  335 (399)
                      ||.+.....+--.+...|...|||||.+..  ..|+.++||||||++|+|+.||+.||.+.+..-.....+..+..|.+.
T Consensus       212 FGIcGqLv~SiAkT~daGCrpYmAPERi~p~~~gyDiRSDvWSLGITL~EvAtG~fPyr~w~svfeql~~Vv~gdpp~l~  291 (361)
T KOG1006|consen  212 FGICGQLVDSIAKTVDAGCRPYMAPERIDPSDKGYDIRSDVWSLGITLYEVATGNFPYRKWDSVFEQLCQVVIGDPPILL  291 (361)
T ss_pred             ccchHhHHHHHHhhhccCCccccChhccCCccCCcchhhhhhhhcceEeeeecCCCCcchHHHHHHHHHHHHcCCCCeec
Confidence            999987766666778889999999999964  469999999999999999999999999988755555555556655553


Q ss_pred             C-----CCcHHHHHHHHHHhhhcCCCCCCHHHHHH
Q 015868          336 K-----HAHPRLAELLERCWQHDPTQRPNFSQITD  365 (399)
Q Consensus       336 ~-----~~~~~l~~ll~~cl~~dP~~Rps~~ell~  365 (399)
                      .     +.+..+..++.-||.+|-..||.+.++++
T Consensus       292 ~~~~~~~~s~~~~~fintCl~Kd~~~Rpky~~Lk~  326 (361)
T KOG1006|consen  292 FDKECVHYSFSMVRFINTCLIKDRSDRPKYDDLKK  326 (361)
T ss_pred             CcccccccCHHHHHHHHHHhhcccccCcchhhhhc
Confidence            2     37889999999999999999999999876

>cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase

Probab=100.00  E-value=4.3e-38  Score=297.39  Aligned_cols=241  Identities=26%  Similarity=0.417  Sum_probs=195.6

Q ss_pred             eeceeCceEEEEEEE--CCeeEEEEEecCCCCCH-HHHHHHHHHH---HHHHhcCCCceeeEEeEEecCCcEEEEEecCC
Q 015868          123 KVASGSYGDLYKGTY--CSQEVAIKVLKPECVNT-EMLKEFSQEV---YIMRKIRHKNVVQFIGACTRPPNLCIVTEFMA  196 (399)
Q Consensus       123 ~lg~G~~g~Vy~~~~--~~~~vAvK~~~~~~~~~-~~~~~~~~Ei---~~l~~l~h~nIv~~~~~~~~~~~~~lV~E~~~  196 (399)
                      .||+|+||.||++..  +++.||+|++....... .....+.+|.   ..++...||||+.+++++...+..++||||+.
T Consensus         1 ~ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~   80 (278)
T cd05606           1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMN   80 (278)
T ss_pred             CcccCCCeEEEEEEEecCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecCCEEEEEEecCC
Confidence            379999999999876  57899999987643322 1122233443   34445579999999999999999999999999


Q ss_pred             CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceeecCCCcEEEeeccceeeccCCCccccCCCC
Q 015868          197 RGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAETGT  276 (399)
Q Consensus       197 ggsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~giiHrDlkp~NILl~~~~~vkl~DFG~a~~~~~~~~~~~~~gt  276 (399)
                      |++|.+++.. .+.+++..+..++.|++.||.|||+.+|+||||||+||+++.++.++|+|||.+...... ......|+
T Consensus        81 g~~L~~~l~~-~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~di~p~nili~~~~~~kl~dfg~~~~~~~~-~~~~~~~~  158 (278)
T cd05606          81 GGDLHYHLSQ-HGVFSEAEMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKK-KPHASVGT  158 (278)
T ss_pred             CCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCEEcCCCCHHHEEECCCCCEEEccCcCccccCcc-CCcCcCCC
Confidence            9999998865 467999999999999999999999999999999999999999999999999998754332 22345789


Q ss_pred             cccccccccCCC-CCCChhhHHHHHHHHHHHHcCCCCCCCCCHHH-HHHHHHhccCCCCCCCCCcHHHHHHHHHHhhhcC
Q 015868          277 YRWMAPEVIEHK-PYDYKADVFSFGIALWELLTGELPYAGLTPLQ-AAVGVVQKSLRPTIPKHAHPRLAELLERCWQHDP  354 (399)
Q Consensus       277 ~~y~aPE~l~~~-~~~~~~Dv~slG~vl~elltg~~P~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~l~~ll~~cl~~dP  354 (399)
                      ..|+|||.+.+. .++.++||||+|+++|+|++|..||....... ...........+.+|..+++++.+++.+||..+|
T Consensus       159 ~~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p  238 (278)
T cd05606         159 HGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELPDSFSPELRSLLEGLLQRDV  238 (278)
T ss_pred             cCCcCcHHhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCccchHHHHHHhhccCCCCCCcCCHHHHHHHHHHhhcCH
Confidence            999999999754 68999999999999999999999997763211 1111222334566777789999999999999999


Q ss_pred             CCCC-----CHHHHHH
Q 015868          355 TQRP-----NFSQITD  365 (399)
Q Consensus       355 ~~Rp-----s~~ell~  365 (399)
                      .+||     ++.++++
T Consensus       239 ~~R~~~~~~~~~~ll~  254 (278)
T cd05606         239 NRRLGCLGRGAQEVKE  254 (278)
T ss_pred             HhccCCCCCCHHHHHh
Confidence            9999     8888874

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co

>PHA03210 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=1.6e-38  Score=324.33  Aligned_cols=250  Identities=16%  Similarity=0.286  Sum_probs=190.1

Q ss_pred             ccccceeceeceeCceEEEEEEECC---eeEEEEE---------------ecCCCCCHHHHHHHHHHHHHHHhcCCCcee
Q 015868          115 AKQLKIECKVASGSYGDLYKGTYCS---QEVAIKV---------------LKPECVNTEMLKEFSQEVYIMRKIRHKNVV  176 (399)
Q Consensus       115 ~~~~~i~~~lg~G~~g~Vy~~~~~~---~~vAvK~---------------~~~~~~~~~~~~~~~~Ei~~l~~l~h~nIv  176 (399)
                      .++|++.++||+|+||.||++....   ..++.|.               .+...........+.+|+.+|++++||||+
T Consensus       147 ~~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~Ei~il~~l~HpnIv  226 (501)
T PHA03210        147 LAHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKAGSRAAIQLENEILALGRLNHENIL  226 (501)
T ss_pred             hhccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhhcchHHHHHHHHHHHHHHhCCCCCcC
Confidence            4689999999999999999986522   1122221               111111233456788999999999999999


Q ss_pred             eEEeEEecCCcEEEEEecCCCCCHHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceeecCCCc
Q 015868          177 QFIGACTRPPNLCIVTEFMARGSIYDFLHKQK----GVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGV  252 (399)
Q Consensus       177 ~~~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~----~~l~~~~~~~i~~~i~~~L~~LH~~giiHrDlkp~NILl~~~~~  252 (399)
                      ++++++......|+|+|++.+ +|.+++....    .......+..++.||+.||.|||++||+||||||+|||++.++.
T Consensus       227 ~l~~~~~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH~~gIiHrDLKP~NILl~~~~~  305 (501)
T PHA03210        227 KIEEILRSEANTYMITQKYDF-DLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHDKKLIHRDIKLENIFLNCDGK  305 (501)
T ss_pred             cEeEEEEECCeeEEEEecccc-CHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCC
Confidence            999999999999999999854 8888775422    23345678889999999999999999999999999999999999


Q ss_pred             EEEeeccceeeccCCCc--cccCCCCcccccccccCCCCCCChhhHHHHHHHHHHHHcCCC-CCCCC--CHHHHHHHHHh
Q 015868          253 VKVADFGVARVQAQSGV--MTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTGEL-PYAGL--TPLQAAVGVVQ  327 (399)
Q Consensus       253 vkl~DFG~a~~~~~~~~--~~~~~gt~~y~aPE~l~~~~~~~~~Dv~slG~vl~elltg~~-P~~~~--~~~~~~~~~~~  327 (399)
                      +||+|||+++.......  .....||..|+|||++.+..++.++|||||||++|||++|.. ||...  .+......++.
T Consensus       306 vkL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~~~~~p~~~~~~~~~~~~~~~~~  385 (501)
T PHA03210        306 IVLGDFGTAMPFEKEREAFDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLSHDFCPIGDGGGKPGKQLLKIID  385 (501)
T ss_pred             EEEEeCCCceecCcccccccccccCCcCCCCchhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCccCCCCCHHHHHHHHHH
Confidence            99999999986544322  233578999999999999999999999999999999999875 45432  22222222111


Q ss_pred             ccC---------------------CCCC---------CCCCcHHHHHHHHHHhhhcCCCCCCHHHHHH
Q 015868          328 KSL---------------------RPTI---------PKHAHPRLAELLERCWQHDPTQRPNFSQITD  365 (399)
Q Consensus       328 ~~~---------------------~~~~---------~~~~~~~l~~ll~~cl~~dP~~Rps~~ell~  365 (399)
                      ...                     ....         ...++.++.+++.+||+.||.+|||+.|+++
T Consensus       386 ~~~~~~~~~p~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~li~kmL~~DP~~Rpsa~elL~  453 (501)
T PHA03210        386 SLSVCDEEFPDPPCKLFDYIDSAEIDHAGHSVPPLIRNLGLPADFEYPLVKMLTFDWHLRPGAAELLA  453 (501)
T ss_pred             hcccChhhcCCcHHHHHHHhhhhhcccCccchhhHHHhcCCChHHHHHHHHHhccCcccCcCHHHHhh
Confidence            000                     0000         1135667889999999999999999999986

>cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11

Probab=100.00  E-value=2e-38  Score=295.84  Aligned_cols=247  Identities=27%  Similarity=0.485  Sum_probs=207.9

Q ss_pred             ccceeceeceeCceEEEEEEEC--CeeEEEEEecCCC---CCHHHHHHHHHHHHHHHhcCCCceeeEEeEEecCCcEEEE
Q 015868          117 QLKIECKVASGSYGDLYKGTYC--SQEVAIKVLKPEC---VNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIV  191 (399)
Q Consensus       117 ~~~i~~~lg~G~~g~Vy~~~~~--~~~vAvK~~~~~~---~~~~~~~~~~~Ei~~l~~l~h~nIv~~~~~~~~~~~~~lV  191 (399)
                      +|.+.++||+|+||.||++.+.  +..+++|+++...   ........+.+|+.+++.++||||+++++++......++|
T Consensus         1 ~y~i~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   80 (260)
T cd08222           1 RYILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASFLERDAFCII   80 (260)
T ss_pred             CceeeeeecCCCCceEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHHhcCCceEEE
Confidence            5889999999999999999874  4456777766422   1223345677899999999999999999999999999999


Q ss_pred             EecCCCCCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceeecCCCcEEEeeccceeeccCCC
Q 015868          192 TEFMARGSIYDFLHK---QKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSG  268 (399)
Q Consensus       192 ~E~~~ggsL~~~l~~---~~~~l~~~~~~~i~~~i~~~L~~LH~~giiHrDlkp~NILl~~~~~vkl~DFG~a~~~~~~~  268 (399)
                      |||+++++|.+++..   ....+++..++.++.|++.|+.|||++|++|+||+|+||++++ +.++|+|||.+.......
T Consensus        81 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~h~~l~~~nili~~-~~~~l~d~g~~~~~~~~~  159 (260)
T cd08222          81 TEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQRRILHRDLKAKNIFLKN-NLLKIGDFGVSRLLMGSC  159 (260)
T ss_pred             EEeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHcCccccCCChhheEeec-CCEeecccCceeecCCCc
Confidence            999999999998864   3467899999999999999999999999999999999999975 679999999987654332


Q ss_pred             -ccccCCCCcccccccccCCCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhccCCCCCCCCCcHHHHHHHH
Q 015868          269 -VMTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRLAELLE  347 (399)
Q Consensus       269 -~~~~~~gt~~y~aPE~l~~~~~~~~~Dv~slG~vl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~  347 (399)
                       ......+++.|+|||.+.+..++.++|+||||+++|+|++|..||......+...... ....+..+..++.++.++|.
T Consensus       160 ~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~li~  238 (260)
T cd08222         160 DLATTFTGTPYYMSPEALKHQGYDSKSDIWSLGCILYEMCCLAHAFEGQNFLSVVLRIV-EGPTPSLPETYSRQLNSIMQ  238 (260)
T ss_pred             ccccCCCCCcCccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHH-cCCCCCCcchhcHHHHHHHH
Confidence             2234567889999999988889999999999999999999999998776655544433 35566677788999999999


Q ss_pred             HHhhhcCCCCCCHHHHHH
Q 015868          348 RCWQHDPTQRPNFSQITD  365 (399)
Q Consensus       348 ~cl~~dP~~Rps~~ell~  365 (399)
                      +||..+|++||++.++++
T Consensus       239 ~~l~~~p~~Rp~~~~il~  256 (260)
T cd08222         239 SMLNKDPSLRPSAAEILR  256 (260)
T ss_pred             HHhcCChhhCcCHHHHhh
Confidence            999999999999999875

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check

>cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases

Probab=100.00  E-value=2.9e-38  Score=306.74  Aligned_cols=252  Identities=25%  Similarity=0.462  Sum_probs=201.3

Q ss_pred             ccccceeceeceeCceEEEEEEE--CCeeEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCceeeEEeEEecCC-----c
Q 015868          115 AKQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPP-----N  187 (399)
Q Consensus       115 ~~~~~i~~~lg~G~~g~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~nIv~~~~~~~~~~-----~  187 (399)
                      .++|++.++||+|+||.||+|..  +++.||+|+++... .......+.+|+.++++++||||+++++++....     .
T Consensus         4 ~~~y~i~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~   82 (336)
T cd07849           4 GPRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFE-HQTFCQRTLREIKILRRFKHENIIGILDIIRPPSFESFND   82 (336)
T ss_pred             ccceEEEEEEEecCCeEEEEEEEcCCCCeEEEEEecccc-cchhHHHHHHHHHHHHhCCCCCcCchhheeecccccccce
Confidence            36899999999999999999976  67899999987532 2334567889999999999999999999875443     4


Q ss_pred             EEEEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceeecCCCcEEEeeccceeeccCC
Q 015868          188 LCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQS  267 (399)
Q Consensus       188 ~~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~giiHrDlkp~NILl~~~~~vkl~DFG~a~~~~~~  267 (399)
                      .++|+||+.+ +|.+++..  ..+++..++.++.|++.||.|||++||+||||||+||+++.++.+||+|||+++.....
T Consensus        83 ~~lv~e~~~~-~l~~~~~~--~~l~~~~~~~i~~ql~~aL~~LH~~~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~  159 (336)
T cd07849          83 VYIVQELMET-DLYKLIKT--QHLSNDHIQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTNCDLKICDFGLARIADPE  159 (336)
T ss_pred             EEEEehhccc-CHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEECCCCCEEECcccceeecccc
Confidence            7999999975 88888754  56899999999999999999999999999999999999999999999999998764432


Q ss_pred             C----ccccCCCCcccccccccCC-CCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhc--------------
Q 015868          268 G----VMTAETGTYRWMAPEVIEH-KPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQK--------------  328 (399)
Q Consensus       268 ~----~~~~~~gt~~y~aPE~l~~-~~~~~~~Dv~slG~vl~elltg~~P~~~~~~~~~~~~~~~~--------------  328 (399)
                      .    ......++..|+|||.+.+ ..++.++||||||+++|+|++|+.||.+.+...........              
T Consensus       160 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil~el~~G~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (336)
T cd07849         160 HDHTGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDYLHQLNLILGVLGTPSQEDLNCIIS  239 (336)
T ss_pred             ccccCCcCCcCcCCCccChHHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCHHHHHHhhc
Confidence            2    1223467899999998754 56899999999999999999999999765543222111100              


Q ss_pred             ----------cCCCC-----CCCCCcHHHHHHHHHHhhhcCCCCCCHHHHHHH--HHHH
Q 015868          329 ----------SLRPT-----IPKHAHPRLAELLERCWQHDPTQRPNFSQITDI--LKQM  370 (399)
Q Consensus       329 ----------~~~~~-----~~~~~~~~l~~ll~~cl~~dP~~Rps~~ell~~--L~~l  370 (399)
                                ...+.     ..+..++++.+++.+||+.+|++|||+.++++.  +.+.
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~e~l~hp~~~~~  298 (336)
T cd07849         240 LRARNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRITVEEALAHPYLEQY  298 (336)
T ss_pred             hhhhhHHhhcCcCCcccHHHHhcccCcHHHHHHHHHcCCChhhCcCHHHHhcCcccccc
Confidence                      00011     113467889999999999999999999999875  5444

Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase

>cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases

Probab=100.00  E-value=4.3e-38  Score=297.14  Aligned_cols=246  Identities=26%  Similarity=0.421  Sum_probs=202.3

Q ss_pred             cceeceeceeCceEEEEEEE--CCeeEEEEEecCCCCCHHHHHHHHHHHHHHHhcC-CCceeeEEeEEecCCcEEEEEec
Q 015868          118 LKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIR-HKNVVQFIGACTRPPNLCIVTEF  194 (399)
Q Consensus       118 ~~i~~~lg~G~~g~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~Ei~~l~~l~-h~nIv~~~~~~~~~~~~~lV~E~  194 (399)
                      |++.+.||+|++|.||+|..  +++.|++|.+.......+ .....+|+..+++++ |+||+++++++..+...++||||
T Consensus         1 y~~~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~-~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e~   79 (283)
T cd07830           1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYSWE-ECMNLREVKSLRKLNEHPNIVKLKEVFRENDELYFVFEY   79 (283)
T ss_pred             CeeheeeccCCceEEEEEEECCCCcEEEEEEehhhccchh-HHHHHHHHHHHHhccCCCCchhHHHHhhcCCcEEEEEec
Confidence            67889999999999999988  568899999875433222 234557999999999 99999999999999999999999


Q ss_pred             CCCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceeecCCCcEEEeeccceeeccCCCccccC
Q 015868          195 MARGSIYDFLHKQK-GVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAE  273 (399)
Q Consensus       195 ~~ggsL~~~l~~~~-~~l~~~~~~~i~~~i~~~L~~LH~~giiHrDlkp~NILl~~~~~vkl~DFG~a~~~~~~~~~~~~  273 (399)
                      + +++|.+++.... ..+++..+..++.|++.+|.|||++|++|+||+|.||++++++.++|+|||.+............
T Consensus        80 ~-~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~~~i~H~dl~~~ni~i~~~~~~~l~d~~~~~~~~~~~~~~~~  158 (283)
T cd07830          80 M-EGNLYQLMKDRKGKPFSESVIRSIIYQILQGLAHIHKHGFFHRDLKPENLLVSGPEVVKIADFGLAREIRSRPPYTDY  158 (283)
T ss_pred             C-CCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEEcCCCCEEEeecccceeccCCCCcCCC
Confidence            9 779999987754 57899999999999999999999999999999999999999999999999999876554444556


Q ss_pred             CCCcccccccccC-CCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhccCC---------------------
Q 015868          274 TGTYRWMAPEVIE-HKPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKSLR---------------------  331 (399)
Q Consensus       274 ~gt~~y~aPE~l~-~~~~~~~~Dv~slG~vl~elltg~~P~~~~~~~~~~~~~~~~~~~---------------------  331 (399)
                      .++..|+|||.+. +..++.++|+||||+++|+|++|+.||...+..............                     
T Consensus       159 ~~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (283)
T cd07830         159 VSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQLYKICSVLGTPTKQDWPEGYKLASKLGFRFP  238 (283)
T ss_pred             CCcccccCceeeecCcCcCCccchhhHHHHHHHHHhCCCccCCCChHHHHHHHHHhcCCCChhhhhhHhhhhcccccccc
Confidence            7889999999885 455789999999999999999999999877654433322210000                     


Q ss_pred             -------CCCCCCCcHHHHHHHHHHhhhcCCCCCCHHHHHH
Q 015868          332 -------PTIPKHAHPRLAELLERCWQHDPTQRPNFSQITD  365 (399)
Q Consensus       332 -------~~~~~~~~~~l~~ll~~cl~~dP~~Rps~~ell~  365 (399)
                             .......+.++.+++++||+.+|++|||+.|++.
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~  279 (283)
T cd07830         239 QFAPTSLHQLIPNASPEAIDLIKDMLRWDPKKRPTASQALQ  279 (283)
T ss_pred             ccccccHHHHcccCCHHHHHHHHHhcccCcccCCCHHHHhh
Confidence                   0011233688999999999999999999999864

Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili

>PHA03390 pk1 serine/threonine-protein kinase 1; Provisional

Probab=100.00  E-value=5.6e-38  Score=294.97  Aligned_cols=239  Identities=21%  Similarity=0.393  Sum_probs=194.4

Q ss_pred             cccceecee--ceeCceEEEEEEE--CCeeEEEEEecCCCCCHHHHHHHHHHHHHHHhc-CCCceeeEEeEEecCCcEEE
Q 015868          116 KQLKIECKV--ASGSYGDLYKGTY--CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKI-RHKNVVQFIGACTRPPNLCI  190 (399)
Q Consensus       116 ~~~~i~~~l--g~G~~g~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~Ei~~l~~l-~h~nIv~~~~~~~~~~~~~l  190 (399)
                      +.|.+.+.+  |+|+||.||++..  ++..+|+|+++.......       |+.....+ +||||+++++.+..+...++
T Consensus        14 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~-------e~~~~~~~~~h~~iv~~~~~~~~~~~~~i   86 (267)
T PHA03390         14 KNCEIVKKLKLIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFNAI-------EPMVHQLMKDNPNFIKLYYSVTTLKGHVL   86 (267)
T ss_pred             HhhccccceeecCCCceEEEEEEEcCCCcEEEEEEEehhhcchh-------hHHHHHHhhcCCCEEEEEEEEecCCeeEE
Confidence            456666665  9999999999976  578899999875432221       22222222 79999999999999999999


Q ss_pred             EEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceeecCCC-cEEEeeccceeeccCCCc
Q 015868          191 VTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENG-VVKVADFGVARVQAQSGV  269 (399)
Q Consensus       191 V~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~giiHrDlkp~NILl~~~~-~vkl~DFG~a~~~~~~~~  269 (399)
                      ||||+++++|.+++... ..+++..+..++.|+++||.|||+.|++||||||+||+++.++ .++|+|||.++.....  
T Consensus        87 v~e~~~~~~L~~~l~~~-~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~~l~dfg~~~~~~~~--  163 (267)
T PHA03390         87 IMDYIKDGDLFDLLKKE-GKLSEAEVKKIIRQLVEALNDLHKHNIIHNDIKLENVLYDRAKDRIYLCDYGLCKIIGTP--  163 (267)
T ss_pred             EEEcCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEEeCCCCeEEEecCccceecCCC--
Confidence            99999999999999764 4889999999999999999999999999999999999999998 9999999998765432  


Q ss_pred             cccCCCCcccccccccCCCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHH--hccCCCCCCCCCcHHHHHHHH
Q 015868          270 MTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVV--QKSLRPTIPKHAHPRLAELLE  347 (399)
Q Consensus       270 ~~~~~gt~~y~aPE~l~~~~~~~~~Dv~slG~vl~elltg~~P~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~l~~ll~  347 (399)
                       ....++..|+|||.+.+..++.++|+||||+++|+|++|..||.............  ........+..+++.+.++|.
T Consensus       164 -~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~  242 (267)
T PHA03390        164 -SCYDGTLDYFSPEKIKGHNYDVSFDWWAVGVLTYELLTGKHPFKEDEDEELDLESLLKRQQKKLPFIKNVSKNANDFVQ  242 (267)
T ss_pred             -ccCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCcchhhHHHHHHhhcccCCcccccCHHHHHHHH
Confidence             23468899999999999999999999999999999999999998654332211111  112233455678999999999


Q ss_pred             HHhhhcCCCCCC-HHHHHH
Q 015868          348 RCWQHDPTQRPN-FSQITD  365 (399)
Q Consensus       348 ~cl~~dP~~Rps-~~ell~  365 (399)
                      +||+.+|.+||+ ++++++
T Consensus       243 ~~l~~~p~~R~~~~~~~l~  261 (267)
T PHA03390        243 SMLKYNINYRLTNYNEIIK  261 (267)
T ss_pred             HHhccChhhCCchHHHHhc
Confidence            999999999995 688864

>cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5

Probab=100.00  E-value=1.7e-38  Score=308.14  Aligned_cols=248  Identities=24%  Similarity=0.388  Sum_probs=202.5

Q ss_pred             cccceeceeceeCceEEEEEEE--CCeeEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCceeeEEeEEec----CCcEE
Q 015868          116 KQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTR----PPNLC  189 (399)
Q Consensus       116 ~~~~i~~~lg~G~~g~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~nIv~~~~~~~~----~~~~~  189 (399)
                      ++|++.+.||.|+||.||+|..  +++.||+|++............+.+|+.++++++||||+++++++..    ....+
T Consensus         5 ~~y~~~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~   84 (334)
T cd07855           5 SRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDNIIAIRDILRPPGADFKDVY   84 (334)
T ss_pred             hceeeeeeeecCCCeEEEEEEEcCCCCEEEEEEeccccccccchHHHHHHHHHHHhcCCCCccCHHHhccccCCCCceEE
Confidence            6899999999999999999976  58899999998654444456778889999999999999999998753    34689


Q ss_pred             EEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceeecCCCcEEEeeccceeeccCCC-
Q 015868          190 IVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSG-  268 (399)
Q Consensus       190 lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~giiHrDlkp~NILl~~~~~vkl~DFG~a~~~~~~~-  268 (399)
                      +||||+. ++|.+++.. ...+++..++.++.||+.||.|||++||+||||||+||+++.++.+||+|||.+....... 
T Consensus        85 lv~e~~~-~~l~~~~~~-~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~  162 (334)
T cd07855          85 VVMDLME-SDLHHIIHS-DQPLTEEHIRYFLYQLLRGLKYIHSANVIHRDLKPSNLLVNEDCELRIGDFGMARGLSSSPT  162 (334)
T ss_pred             EEEehhh-hhHHHHhcc-CCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCcEEecccccceeecccCc
Confidence            9999996 589998865 4558999999999999999999999999999999999999999999999999997543322 


Q ss_pred             ----ccccCCCCcccccccccCC-CCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHh----------------
Q 015868          269 ----VMTAETGTYRWMAPEVIEH-KPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQ----------------  327 (399)
Q Consensus       269 ----~~~~~~gt~~y~aPE~l~~-~~~~~~~Dv~slG~vl~elltg~~P~~~~~~~~~~~~~~~----------------  327 (399)
                          ......++..|+|||.+.+ ..++.++||||||+++|+|++|+.||...+..........                
T Consensus       163 ~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~~~~~~~~~~~~~~g~~~~~~~~~~~~~  242 (334)
T cd07855         163 EHKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVHQLKLILSVLGSPSEEVLNRIGSD  242 (334)
T ss_pred             CCCcccccccccccccChHHhcCCcccccccchHHHHHHHHHHHcCCCccCCCChHHHHHHHHHHhCCChhHhhhhhchh
Confidence                1234468889999999865 4688999999999999999999999987654332211111                


Q ss_pred             --------ccCCCCC-----CCCCcHHHHHHHHHHhhhcCCCCCCHHHHHH
Q 015868          328 --------KSLRPTI-----PKHAHPRLAELLERCWQHDPTQRPNFSQITD  365 (399)
Q Consensus       328 --------~~~~~~~-----~~~~~~~l~~ll~~cl~~dP~~Rps~~ell~  365 (399)
                              ....+..     ....++++.++|.+||+.+|++||++.+++.
T Consensus       243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~  293 (334)
T cd07855         243 RVRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERITVEQALQ  293 (334)
T ss_pred             hHHHHHhhcccCCCCCHHHHcccCCHHHHHHHHHHccCChhhCcCHHHHHh
Confidence                    0011111     1446889999999999999999999998876

Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the

>cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1

Probab=100.00  E-value=4.7e-38  Score=298.45  Aligned_cols=247  Identities=22%  Similarity=0.389  Sum_probs=202.5

Q ss_pred             ccceeceeceeCceEEEEEEE-----CCeeEEEEEecCCCC--CHHHHHHHHHHHHHHHhc-CCCceeeEEeEEecCCcE
Q 015868          117 QLKIECKVASGSYGDLYKGTY-----CSQEVAIKVLKPECV--NTEMLKEFSQEVYIMRKI-RHKNVVQFIGACTRPPNL  188 (399)
Q Consensus       117 ~~~i~~~lg~G~~g~Vy~~~~-----~~~~vAvK~~~~~~~--~~~~~~~~~~Ei~~l~~l-~h~nIv~~~~~~~~~~~~  188 (399)
                      .|++.+.||.|+||.||+++.     ++..||+|+++....  .....+.+.+|+.+++++ +|+||+.+++.+..+...
T Consensus         1 ~y~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~   80 (290)
T cd05613           1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTDTKL   80 (290)
T ss_pred             CceeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEeecCCeE
Confidence            478899999999999999976     578899999975322  123346788899999999 589999999999999999


Q ss_pred             EEEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceeecCCCcEEEeeccceeeccCCC
Q 015868          189 CIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSG  268 (399)
Q Consensus       189 ~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~giiHrDlkp~NILl~~~~~vkl~DFG~a~~~~~~~  268 (399)
                      |+||||+++++|.+++.. ...+++..+..++.|++.||.|||++|++||||+|+||+++.++.++|+|||+++......
T Consensus        81 ~lv~e~~~~~~L~~~l~~-~~~l~~~~~~~~~~qi~~al~~lH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~  159 (290)
T cd05613          81 HLILDYINGGELFTHLSQ-RERFKEQEVQIYSGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFHEDE  159 (290)
T ss_pred             EEEEecCCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeEECCCCCEEEeeCccceeccccc
Confidence            999999999999999976 4568899999999999999999999999999999999999999999999999997654322


Q ss_pred             --ccccCCCCcccccccccCCC--CCCChhhHHHHHHHHHHHHcCCCCCCCCCHH---HHHHHHHhccCCCCCCCCCcHH
Q 015868          269 --VMTAETGTYRWMAPEVIEHK--PYDYKADVFSFGIALWELLTGELPYAGLTPL---QAAVGVVQKSLRPTIPKHAHPR  341 (399)
Q Consensus       269 --~~~~~~gt~~y~aPE~l~~~--~~~~~~Dv~slG~vl~elltg~~P~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~  341 (399)
                        ......|+..|+|||.+.+.  .++.++||||||+++|+|++|..||......   ........ ...+..+..+++.
T Consensus       160 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~  238 (290)
T cd05613         160 VERAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEKNSQAEISRRIL-KSEPPYPQEMSAL  238 (290)
T ss_pred             ccccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCCcCCccccHHHHHHHhh-ccCCCCCccCCHH
Confidence              12234588999999998753  4678999999999999999999999643221   11111111 2235567778999


Q ss_pred             HHHHHHHHhhhcCCCCC-----CHHHHHH
Q 015868          342 LAELLERCWQHDPTQRP-----NFSQITD  365 (399)
Q Consensus       342 l~~ll~~cl~~dP~~Rp-----s~~ell~  365 (399)
                      +.+++.+||+.+|.+||     +..++++
T Consensus       239 ~~~ll~~~l~~~p~~R~~~~~~~~~~l~~  267 (290)
T cd05613         239 AKDIIQRLLMKDPKKRLGCGPSDADEIKK  267 (290)
T ss_pred             HHHHHHHHhcCCHHHhcCCCCCCHHHHHc
Confidence            99999999999999997     6666654

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph

>cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins

Probab=100.00  E-value=2.9e-38  Score=302.16  Aligned_cols=250  Identities=26%  Similarity=0.433  Sum_probs=201.2

Q ss_pred             ccccceeceeceeCceEEEEEEE--CCeeEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCceeeEEeEEecCC------
Q 015868          115 AKQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPP------  186 (399)
Q Consensus       115 ~~~~~i~~~lg~G~~g~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~nIv~~~~~~~~~~------  186 (399)
                      .++|++.++||+|+||.||+|++  +++.+|+|++............+.+|+.+++.++||||+++++++....      
T Consensus         7 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~   86 (311)
T cd07866           7 LRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKLKHPNVVPLIDMAVERPDKSKRK   86 (311)
T ss_pred             cccEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEEeccCCCCcchhHHHHHHHHHhcCCCCccchhhheeccccccccc
Confidence            57899999999999999999987  5788999998654333333346678999999999999999999875433      


Q ss_pred             --cEEEEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceeecCCCcEEEeeccceeec
Q 015868          187 --NLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQ  264 (399)
Q Consensus       187 --~~~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~giiHrDlkp~NILl~~~~~vkl~DFG~a~~~  264 (399)
                        .+++|+||+.+ ++...+......+++..+..++.|+++||+|||++||+|+||||+||++++++.++|+|||+++..
T Consensus        87 ~~~~~lv~~~~~~-~l~~~~~~~~~~~~~~~~~~i~~~l~~al~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~  165 (311)
T cd07866          87 RGSVYMVTPYMDH-DLSGLLENPSVKLTESQIKCYMLQLLEGINYLHENHILHRDIKAANILIDNQGILKIADFGLARPY  165 (311)
T ss_pred             CceEEEEEecCCc-CHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEECcCccchhc
Confidence              46999999975 788888766678999999999999999999999999999999999999999999999999999754


Q ss_pred             cCCCc------------cccCCCCcccccccccCC-CCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhccCC
Q 015868          265 AQSGV------------MTAETGTYRWMAPEVIEH-KPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKSLR  331 (399)
Q Consensus       265 ~~~~~------------~~~~~gt~~y~aPE~l~~-~~~~~~~Dv~slG~vl~elltg~~P~~~~~~~~~~~~~~~~~~~  331 (399)
                      .....            .+...+++.|+|||.+.+ ..++.++||||||+++|+|++|++||.+.+..............
T Consensus       166 ~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~~g~~~~~~~~~~~~~~~~~~~~~~  245 (311)
T cd07866         166 DGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKSDIDQLHLIFKLCGT  245 (311)
T ss_pred             cCCCcccccCCcccccccccceeccCcCChHHhhCCCccCchhHhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCC
Confidence            33211            122346788999998865 45889999999999999999999999887765544433221100


Q ss_pred             C---------------------CCC-------CCCcHHHHHHHHHHhhhcCCCCCCHHHHHH
Q 015868          332 P---------------------TIP-------KHAHPRLAELLERCWQHDPTQRPNFSQITD  365 (399)
Q Consensus       332 ~---------------------~~~-------~~~~~~l~~ll~~cl~~dP~~Rps~~ell~  365 (399)
                      +                     ..+       ...++.+.+++.+||+.+|.+|||+.+++.
T Consensus       246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~t~~ell~  307 (311)
T cd07866         246 PTEETWPGWRSLPGCEGVHSFTNYPRTLEERFGKLGPEGLDLLSKLLSLDPYKRLTASDALE  307 (311)
T ss_pred             CChhhchhhhhcccccccccCCCCCccHHHHcccCChhHHHHHHHHcccCcccCcCHHHHhc
Confidence            0                     000       234578999999999999999999999864

Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic

>cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4

Probab=100.00  E-value=9.8e-38  Score=297.30  Aligned_cols=243  Identities=30%  Similarity=0.494  Sum_probs=204.8

Q ss_pred             cceeceeceeCceEEEEEEE--CCeeEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCceeeEEeEEecCCcEEEEEecC
Q 015868          118 LKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVTEFM  195 (399)
Q Consensus       118 ~~i~~~lg~G~~g~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~nIv~~~~~~~~~~~~~lV~E~~  195 (399)
                      |....+||+|+||.||++..  +++.||+|.+...  .......+.+|+.+++.++|+||+++++.+..+...++||||+
T Consensus        22 ~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~   99 (292)
T cd06657          22 LDNFIKIGEGSTGIVCIATVKSSGKLVAVKKMDLR--KQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFL   99 (292)
T ss_pred             hhhHHHcCCCCCeEEEEEEEcCCCeEEEEEEeccc--chhHHHHHHHHHHHHHhcCCcchhheeeEEEeCCEEEEEEecC
Confidence            44457899999999999977  6789999998643  2344567899999999999999999999999999999999999


Q ss_pred             CCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceeecCCCcEEEeeccceeeccCCC-ccccCC
Q 015868          196 ARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSG-VMTAET  274 (399)
Q Consensus       196 ~ggsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~giiHrDlkp~NILl~~~~~vkl~DFG~a~~~~~~~-~~~~~~  274 (399)
                      ++++|.+++..  ..+++..+..++.|++.|++|||++|++|+||+|+||+++.++.++|+|||.+....... ......
T Consensus       100 ~~~~L~~~~~~--~~~~~~~~~~~~~ql~~~l~~lH~~givH~dl~p~Nilv~~~~~~~l~dfg~~~~~~~~~~~~~~~~  177 (292)
T cd06657         100 EGGALTDIVTH--TRMNEEQIAAVCLAVLKALSVLHAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKSLV  177 (292)
T ss_pred             CCCcHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEEcccccceecccccccccccc
Confidence            99999998754  468999999999999999999999999999999999999999999999999886543321 223356


Q ss_pred             CCcccccccccCCCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhccCCCC--CCCCCcHHHHHHHHHHhhh
Q 015868          275 GTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKSLRPT--IPKHAHPRLAELLERCWQH  352 (399)
Q Consensus       275 gt~~y~aPE~l~~~~~~~~~Dv~slG~vl~elltg~~P~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~l~~ll~~cl~~  352 (399)
                      +++.|+|||.+.+..++.++|+||+|+++|+|++|..||.+....+..... .....+.  ....+++.+.+++.+||+.
T Consensus       178 ~~~~y~~pE~~~~~~~~~~~Dv~slGvil~el~tg~~p~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~l~~li~~~l~~  256 (292)
T cd06657         178 GTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMI-RDNLPPKLKNLHKVSPSLKGFLDRLLVR  256 (292)
T ss_pred             cCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH-HhhCCcccCCcccCCHHHHHHHHHHHhC
Confidence            889999999998888899999999999999999999999877665543332 2222222  2245788999999999999


Q ss_pred             cCCCCCCHHHHHH
Q 015868          353 DPTQRPNFSQITD  365 (399)
Q Consensus       353 dP~~Rps~~ell~  365 (399)
                      +|.+||++.++++
T Consensus       257 ~P~~R~~~~~ll~  269 (292)
T cd06657         257 DPAQRATAAELLK  269 (292)
T ss_pred             CcccCcCHHHHhc
Confidence            9999999999876

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo

>cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15

Probab=100.00  E-value=5e-38  Score=305.05  Aligned_cols=249  Identities=23%  Similarity=0.395  Sum_probs=202.7

Q ss_pred             ccccceeceeceeCceEEEEEEE--CCeeEEEEEecCCCCCHHHHHHHHHHHHHHHhc-CCCceeeEEeEEecC--CcEE
Q 015868          115 AKQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKI-RHKNVVQFIGACTRP--PNLC  189 (399)
Q Consensus       115 ~~~~~i~~~lg~G~~g~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~Ei~~l~~l-~h~nIv~~~~~~~~~--~~~~  189 (399)
                      .++|++.+.||+|+||.||+|.+  +++.+|+|.+.....+......+.+|+.+++++ +||||+++++++...  ...+
T Consensus         6 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~~~~~~~   85 (337)
T cd07852           6 LRKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFREIMFLQELGDHPNIVKLLNVIKAENDKDIY   85 (337)
T ss_pred             hhHHHHhHhhcCCCCeeEEEEEEcCCCeEEEEEeeccccCcchhhhhhhHHHHHHHHhcCCCCccceeeeeccCCCceEE
Confidence            46899999999999999999987  578899999865433444556788899999999 999999999998643  3689


Q ss_pred             EEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceeecCCCcEEEeeccceeeccCCC-
Q 015868          190 IVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSG-  268 (399)
Q Consensus       190 lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~giiHrDlkp~NILl~~~~~vkl~DFG~a~~~~~~~-  268 (399)
                      +||||+.+ +|.+++...  .+++..+..++.||+.||.|||++||+||||||+||+++.++.+||+|||.+....... 
T Consensus        86 lv~e~~~~-~L~~~~~~~--~~~~~~~~~i~~qi~~~L~~LH~~~i~H~dl~p~nill~~~~~~kl~d~g~~~~~~~~~~  162 (337)
T cd07852          86 LVFEYMET-DLHAVIRAN--ILEDVHKRYIMYQLLKALKYIHSGNVIHRDLKPSNILLNSDCRVKLADFGLARSLSELEE  162 (337)
T ss_pred             EEeccccc-CHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCcEEEeeccchhccccccc
Confidence            99999975 999988653  77888999999999999999999999999999999999999999999999997544322 


Q ss_pred             -----ccccCCCCcccccccccCC-CCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhccC------------
Q 015868          269 -----VMTAETGTYRWMAPEVIEH-KPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKSL------------  330 (399)
Q Consensus       269 -----~~~~~~gt~~y~aPE~l~~-~~~~~~~Dv~slG~vl~elltg~~P~~~~~~~~~~~~~~~~~~------------  330 (399)
                           ......++..|+|||.+.+ ..++.++|+||||+++|+|++|+.||.+..+............            
T Consensus       163 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  242 (337)
T cd07852         163 NPENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQLEKIIEVIGPPSAEDIESIKS  242 (337)
T ss_pred             cccCcchhcccccccccCceeeeccccccccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHHHh
Confidence                 2233467889999998765 4578899999999999999999999987655443222211100            


Q ss_pred             -----------------CCCCCCCCcHHHHHHHHHHhhhcCCCCCCHHHHHHH
Q 015868          331 -----------------RPTIPKHAHPRLAELLERCWQHDPTQRPNFSQITDI  366 (399)
Q Consensus       331 -----------------~~~~~~~~~~~l~~ll~~cl~~dP~~Rps~~ell~~  366 (399)
                                       .....+.++.++.+++.+||+.+|.+|||+.++++.
T Consensus       243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rps~~~il~~  295 (337)
T cd07852         243 PFAATMLDSLPSRPRKPLDELLPKASDDALDLLKKLLVFNPNKRLTAEEALEH  295 (337)
T ss_pred             hhHHHhhhhcccccccchhhhccCCCHHHHHHHHHhccCCcccccCHHHHhhC
Confidence                             011123378899999999999999999999999873

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul

>cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases

Probab=100.00  E-value=4.9e-38  Score=296.14  Aligned_cols=247  Identities=25%  Similarity=0.438  Sum_probs=206.3

Q ss_pred             cceeceeceeCceEEEEEEE--CCeeEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCceeeEEeEEecCCcEEEEEecC
Q 015868          118 LKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVTEFM  195 (399)
Q Consensus       118 ~~i~~~lg~G~~g~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~nIv~~~~~~~~~~~~~lV~E~~  195 (399)
                      |++.+.||+|++|.||+|+.  +++.||+|+++...........+.+|+.++++++|+|++++++++......++||||+
T Consensus         1 y~~~~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~~   80 (282)
T cd07829           1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKELKHPNIVKLLDVIHTERKLYLVFEYC   80 (282)
T ss_pred             CeeehcccccCcceEEEeeecCCCcEEEEEEeccccccccccHHHHHHHHHHHhcCCCCHHHHHhhhhcCCceEEEecCc
Confidence            56778999999999999987  4789999999876444445577889999999999999999999999999999999999


Q ss_pred             CCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceeecCCCcEEEeeccceeeccCCC-ccccCC
Q 015868          196 ARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSG-VMTAET  274 (399)
Q Consensus       196 ~ggsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~giiHrDlkp~NILl~~~~~vkl~DFG~a~~~~~~~-~~~~~~  274 (399)
                      ++ +|.+++......+++..+..++.+++.||.|||++||+||||+|+||++++++.++|+|||.++...... ......
T Consensus        81 ~~-~l~~~i~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~~l~~~ni~~~~~~~~~l~d~g~~~~~~~~~~~~~~~~  159 (282)
T cd07829          81 DM-DLKKYLDKRPGPLSPNLIKSIMYQLLRGLAYCHSHRILHRDLKPQNILINRDGVLKLADFGLARAFGIPLRTYTHEV  159 (282)
T ss_pred             Cc-CHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChheEEEcCCCCEEEecCCcccccCCCccccCccc
Confidence            85 9999998765679999999999999999999999999999999999999999999999999997654432 233445


Q ss_pred             CCcccccccccCCC-CCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcc-------------------CCC--
Q 015868          275 GTYRWMAPEVIEHK-PYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKS-------------------LRP--  332 (399)
Q Consensus       275 gt~~y~aPE~l~~~-~~~~~~Dv~slG~vl~elltg~~P~~~~~~~~~~~~~~~~~-------------------~~~--  332 (399)
                      ++..|+|||.+.+. .++.++|+||||+++|++++|..||...+..+.........                   ..+  
T Consensus       160 ~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (282)
T cd07829         160 VTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDSEIDQLFKIFQILGTPTEESWPGVTKLPDYKPTFPKF  239 (282)
T ss_pred             cCcCcCChHHhcCCcCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHHHhCCCcHHHHHhhccccccccccccc
Confidence            67889999998776 78999999999999999999999998876554433322110                   000  


Q ss_pred             ------CCCCCCcHHHHHHHHHHhhhcCCCCCCHHHHHH
Q 015868          333 ------TIPKHAHPRLAELLERCWQHDPTQRPNFSQITD  365 (399)
Q Consensus       333 ------~~~~~~~~~l~~ll~~cl~~dP~~Rps~~ell~  365 (399)
                            ...+..+.++.+++.+||+.+|++||++++++.
T Consensus       240 ~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~  278 (282)
T cd07829         240 PPKDLEKVLPRLDPEGIDLLSKMLQYNPAKRISAKEALK  278 (282)
T ss_pred             CccchHHhcccccHHHHHHHHHhhccCcccCCCHHHHhh
Confidence                  011234788999999999999999999999875

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the

>cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase

Probab=100.00  E-value=1.4e-37  Score=303.05  Aligned_cols=251  Identities=26%  Similarity=0.418  Sum_probs=205.7

Q ss_pred             CceeecccccceeceeceeCceEEEEEEE--CCeeEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCceeeEEeEEecCC
Q 015868          109 DVWEIDAKQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPP  186 (399)
Q Consensus       109 ~~~~i~~~~~~i~~~lg~G~~g~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~nIv~~~~~~~~~~  186 (399)
                      ..|.+ .++|++.+.||.|+||.||++..  ++..||+|+++...........+.+|+.++++++||||+++++++....
T Consensus         9 ~~~~~-~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~   87 (343)
T cd07880           9 TIWEV-PDRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLLDVFTPDL   87 (343)
T ss_pred             hhhcc-ccceEEEEEeeecCCeEEEEEEECCCCcEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCccceeeeecCCc
Confidence            34555 45799999999999999999976  5788999999765444555667889999999999999999999987654


Q ss_pred             ------cEEEEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceeecCCCcEEEeeccc
Q 015868          187 ------NLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGV  260 (399)
Q Consensus       187 ------~~~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~giiHrDlkp~NILl~~~~~vkl~DFG~  260 (399)
                            .+++||||+ |++|.+++..  ..+++..+..++.|++.||.|||+.||+||||||+||++++++.++|+|||.
T Consensus        88 ~~~~~~~~~lv~e~~-~~~l~~~~~~--~~l~~~~~~~i~~qi~~al~~LH~~gi~H~dlkp~Nill~~~~~~kl~dfg~  164 (343)
T cd07880          88 SLDRFHDFYLVMPFM-GTDLGKLMKH--EKLSEDRIQFLVYQMLKGLKYIHAAGIIHRDLKPGNLAVNEDCELKILDFGL  164 (343)
T ss_pred             cccccceEEEEEecC-CCCHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEeeccc
Confidence                  358999998 6799988854  5689999999999999999999999999999999999999999999999999


Q ss_pred             eeeccCCCccccCCCCcccccccccCC-CCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhccC---------
Q 015868          261 ARVQAQSGVMTAETGTYRWMAPEVIEH-KPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKSL---------  330 (399)
Q Consensus       261 a~~~~~~~~~~~~~gt~~y~aPE~l~~-~~~~~~~Dv~slG~vl~elltg~~P~~~~~~~~~~~~~~~~~~---------  330 (399)
                      +......  .....+++.|+|||.+.+ ..++.++|+||||+++|+|++|..||...+.............         
T Consensus       165 ~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  242 (343)
T cd07880         165 ARQTDSE--MTGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLDQLMEIMKVTGTPSKEFVQK  242 (343)
T ss_pred             ccccccC--ccccccCCcccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHh
Confidence            9754332  233467889999999876 4578999999999999999999999987665433322211100         


Q ss_pred             --------------------CCCCCCCCcHHHHHHHHHHhhhcCCCCCCHHHHHH
Q 015868          331 --------------------RPTIPKHAHPRLAELLERCWQHDPTQRPNFSQITD  365 (399)
Q Consensus       331 --------------------~~~~~~~~~~~l~~ll~~cl~~dP~~Rps~~ell~  365 (399)
                                          .......+++++.+++.+|++.||.+|||+.+++.
T Consensus       243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~t~~~~l~  297 (343)
T cd07880         243 LQSEDAKNYVKKLPRFRKKDFRSLLPNANPLAVNVLEKMLVLDAESRITAAEALA  297 (343)
T ss_pred             hcchhHHHHHHhccccCcchHHHhccCCChHHHHHHHHHcCCChhhCCCHHHHhc
Confidence                                00122457888999999999999999999999984

Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12

>cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase

Probab=100.00  E-value=5.7e-38  Score=305.54  Aligned_cols=255  Identities=26%  Similarity=0.432  Sum_probs=205.8

Q ss_pred             CceeecccccceeceeceeCceEEEEEEE--CCeeEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCceeeEEeEEecCC
Q 015868          109 DVWEIDAKQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPP  186 (399)
Q Consensus       109 ~~~~i~~~~~~i~~~lg~G~~g~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~nIv~~~~~~~~~~  186 (399)
                      ..|++. .+|.+.+.||+|+||.||+|..  +++.||+|+++...........+.+|+.+++.++||||+++++++....
T Consensus         9 ~~~~~~-~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~   87 (342)
T cd07879           9 TVWELP-ERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLLDVFTSAV   87 (342)
T ss_pred             hhhccc-cceEEEEEeeecCCeEEEEEEeCCCCcEEEEEEecCccccccchhHHHHHHHHHHhcCCCCccchhheecccc
Confidence            456663 5899999999999999999986  5789999998765434444567889999999999999999999986543


Q ss_pred             ------cEEEEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceeecCCCcEEEeeccc
Q 015868          187 ------NLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGV  260 (399)
Q Consensus       187 ------~~~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~giiHrDlkp~NILl~~~~~vkl~DFG~  260 (399)
                            .+++|+||+.. +|.+++   ...+++..+..++.|++.||+|||++|++||||||+||+++.++.++|+|||+
T Consensus        88 ~~~~~~~~~lv~e~~~~-~l~~~~---~~~~~~~~~~~~~~qi~~aL~~LH~~~i~H~dlkp~NIll~~~~~~kL~dfg~  163 (342)
T cd07879          88 SGDEFQDFYLVMPYMQT-DLQKIM---GHPLSEDKVQYLVYQMLCGLKYIHSAGIIHRDLKPGNLAVNEDCELKILDFGL  163 (342)
T ss_pred             cCCCCceEEEEeccccc-CHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEeeCCC
Confidence                  46999999965 777765   34689999999999999999999999999999999999999999999999999


Q ss_pred             eeeccCCCccccCCCCcccccccccCC-CCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcc----------
Q 015868          261 ARVQAQSGVMTAETGTYRWMAPEVIEH-KPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKS----------  329 (399)
Q Consensus       261 a~~~~~~~~~~~~~gt~~y~aPE~l~~-~~~~~~~Dv~slG~vl~elltg~~P~~~~~~~~~~~~~~~~~----------  329 (399)
                      ++....  ......++..|+|||.+.+ ..++.++|+||||+++|+|++|+.||.+.+............          
T Consensus       164 ~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  241 (342)
T cd07879         164 ARHADA--EMTGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGPEFVQK  241 (342)
T ss_pred             CcCCCC--CCCCceeeecccChhhhcCccccCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHH
Confidence            875432  2234467889999999876 468899999999999999999999998876544333222100          


Q ss_pred             -----------CCCCC--------CCCCcHHHHHHHHHHhhhcCCCCCCHHHHHH--HHHHH
Q 015868          330 -----------LRPTI--------PKHAHPRLAELLERCWQHDPTQRPNFSQITD--ILKQM  370 (399)
Q Consensus       330 -----------~~~~~--------~~~~~~~l~~ll~~cl~~dP~~Rps~~ell~--~L~~l  370 (399)
                                 ..+..        .+..++++.++|.+||+.||.+||++.+++.  .++.+
T Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~~~~e~l~h~~f~~~  303 (342)
T cd07879         242 LEDKAAKSYIKSLPKYPRKDFSTLFPKASPQAVDLLEKMLELDVDKRLTATEALEHPYFDSF  303 (342)
T ss_pred             hcccchHHHHhhcCCcccchHHHHhcCCCHHHHHHHHHHcCCChhhCcCHHHHhcCcchhhc
Confidence                       00111        1246788999999999999999999999984  35554

Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13

>cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases

Probab=100.00  E-value=1e-37  Score=288.84  Aligned_cols=236  Identities=28%  Similarity=0.441  Sum_probs=205.3

Q ss_pred             eceeCceEEEEEEEC--CeeEEEEEecCCCC-CHHHHHHHHHHHHHHHhcCCCceeeEEeEEecCCcEEEEEecCCCCCH
Q 015868          124 VASGSYGDLYKGTYC--SQEVAIKVLKPECV-NTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVTEFMARGSI  200 (399)
Q Consensus       124 lg~G~~g~Vy~~~~~--~~~vAvK~~~~~~~-~~~~~~~~~~Ei~~l~~l~h~nIv~~~~~~~~~~~~~lV~E~~~ggsL  200 (399)
                      ||.|+||.||++...  ++.+|+|+++.... .......+..|+.++++++||||+++++.+..+...++||||+++++|
T Consensus         1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L   80 (250)
T cd05123           1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYAFQTEEKLYLVLEYAPGGEL   80 (250)
T ss_pred             CCCCCceEEEEEEECCCCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHcCCCcHHHHHHHeecCCeeEEEEecCCCCcH
Confidence            689999999999874  78999999876533 233567899999999999999999999999999999999999999999


Q ss_pred             HHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceeecCCCcEEEeeccceeeccCC-CccccCCCCccc
Q 015868          201 YDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQS-GVMTAETGTYRW  279 (399)
Q Consensus       201 ~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~giiHrDlkp~NILl~~~~~vkl~DFG~a~~~~~~-~~~~~~~gt~~y  279 (399)
                      .+++... ..+++..++.++.|++.|+.|||+.+++|+||+|.||+++.++.++|+|||.+...... .......++..|
T Consensus        81 ~~~l~~~-~~l~~~~~~~~~~qi~~~l~~lh~~~~~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~  159 (250)
T cd05123          81 FSHLSKE-GRFSEERARFYAAEIVLALEYLHSLGIIYRDLKPENILLDADGHIKLTDFGLAKELSSEGSRTNTFCGTPEY  159 (250)
T ss_pred             HHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcceEEEcCCCcEEEeecCcceecccCCCcccCCcCCccc
Confidence            9999764 46899999999999999999999999999999999999999999999999999765443 223445678899


Q ss_pred             ccccccCCCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhccCCCCCCCCCcHHHHHHHHHHhhhcCCCCCC
Q 015868          280 MAPEVIEHKPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRLAELLERCWQHDPTQRPN  359 (399)
Q Consensus       280 ~aPE~l~~~~~~~~~Dv~slG~vl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~cl~~dP~~Rps  359 (399)
                      +|||.+.+..++.++|+||||+++|++++|..||...+..+.......  ....++...+.++.+++.+||..||++||+
T Consensus       160 ~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~--~~~~~~~~~~~~l~~~i~~~l~~~p~~R~~  237 (250)
T cd05123         160 LAPEVLLGKGYGKAVDWWSLGVLLYEMLTGKPPFYAEDRKEIYEKILK--DPLRFPEFLSPEARDLISGLLQKDPTKRLG  237 (250)
T ss_pred             cChHHhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhc--CCCCCCCCCCHHHHHHHHHHhcCCHhhCCC
Confidence            999999988889999999999999999999999988776554444443  345677788999999999999999999999


Q ss_pred             HHH
Q 015868          360 FSQ  362 (399)
Q Consensus       360 ~~e  362 (399)
                      +.+
T Consensus       238 ~~~  240 (250)
T cd05123         238 SGG  240 (250)
T ss_pred             ccc
Confidence            944

Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the

>KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=3.2e-40  Score=344.57  Aligned_cols=248  Identities=27%  Similarity=0.456  Sum_probs=217.0

Q ss_pred             ccceeceeceeCceEEEEEEE--CCeeEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCceeeEEeEEecCCcEEEEEec
Q 015868          117 QLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVTEF  194 (399)
Q Consensus       117 ~~~i~~~lg~G~~g~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~nIv~~~~~~~~~~~~~lV~E~  194 (399)
                      +++-..+||.|.||.||-|..  +|...|+|-++-............+|..++..++|||+|+++|+-.+....+|.|||
T Consensus      1236 rWqrg~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~~k~~~~i~eEm~vlE~lnHpNlV~YyGVEvHRekv~IFMEy 1315 (1509)
T KOG4645|consen 1236 RWQRGNFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSDHKTFKLIAEEMKVLEGLNHPNLVRYYGVEVHREKVYIFMEY 1315 (1509)
T ss_pred             eeccccccCCcceeeeEEeecCCccchhhhhhhhcCccccccCcchHHHHHHHHhccCccccccCceeecHHHHHHHHHH
Confidence            456677899999999999865  678899998886655555667789999999999999999999999999999999999


Q ss_pred             CCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceeecCCCcEEEeeccceeeccCCC-----c
Q 015868          195 MARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSG-----V  269 (399)
Q Consensus       195 ~~ggsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~giiHrDlkp~NILl~~~~~vkl~DFG~a~~~~~~~-----~  269 (399)
                      |+||+|.+.+.. .+-.++.....+..|++.|++|||+.|||||||||+||+++.+|.+|++|||.|.....+.     .
T Consensus      1316 C~~GsLa~ll~~-gri~dE~vt~vyt~qll~gla~LH~~gIVHRDIK~aNI~Ld~~g~iK~~DFGsa~ki~~~~~~~~~e 1394 (1509)
T KOG4645|consen 1316 CEGGSLASLLEH-GRIEDEMVTRVYTKQLLEGLAYLHEHGIVHRDIKPANILLDFNGLIKYGDFGSAVKIKNNAQTMPGE 1394 (1509)
T ss_pred             hccCcHHHHHHh-cchhhhhHHHHHHHHHHHHHHHHHhcCceecCCCccceeeecCCcEEeecccceeEecCchhcCCHH
Confidence            999999999854 4455666777788999999999999999999999999999999999999999997654432     2


Q ss_pred             cccCCCCcccccccccCCC---CCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhccCCCCCCCCCcHHHHHHH
Q 015868          270 MTAETGTYRWMAPEVIEHK---PYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRLAELL  346 (399)
Q Consensus       270 ~~~~~gt~~y~aPE~l~~~---~~~~~~Dv~slG~vl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll  346 (399)
                      .....||+.|||||++.+.   ....++||||+|||+.||+||+.||..++..=+.+-.+..+-.|.+|..++++-.+||
T Consensus      1395 l~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~~dne~aIMy~V~~gh~Pq~P~~ls~~g~dFl 1474 (1509)
T KOG4645|consen 1395 LQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWAELDNEWAIMYHVAAGHKPQIPERLSSEGRDFL 1474 (1509)
T ss_pred             HHhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCchhhccchhHHHhHHhccCCCCCchhhhHhHHHHH
Confidence            2345799999999999764   4567899999999999999999999999888878888888889999999999999999


Q ss_pred             HHHhhhcCCCCCCHHHHHH
Q 015868          347 ERCWQHDPTQRPNFSQITD  365 (399)
Q Consensus       347 ~~cl~~dP~~Rps~~ell~  365 (399)
                      .+||+.||..|.++.||++
T Consensus      1475 e~Cl~~dP~~Rw~~~qlle 1493 (1509)
T KOG4645|consen 1475 EHCLEQDPKMRWTASQLLE 1493 (1509)
T ss_pred             HHHHhcCchhhhHHHHHHH
Confidence            9999999999988887654

>cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase

Probab=100.00  E-value=6.2e-38  Score=297.29  Aligned_cols=251  Identities=23%  Similarity=0.386  Sum_probs=205.6

Q ss_pred             ccceeceeceeCceEEEEEEE-----CCeeEEEEEecCCCC--CHHHHHHHHHHHHHHHhc-CCCceeeEEeEEecCCcE
Q 015868          117 QLKIECKVASGSYGDLYKGTY-----CSQEVAIKVLKPECV--NTEMLKEFSQEVYIMRKI-RHKNVVQFIGACTRPPNL  188 (399)
Q Consensus       117 ~~~i~~~lg~G~~g~Vy~~~~-----~~~~vAvK~~~~~~~--~~~~~~~~~~Ei~~l~~l-~h~nIv~~~~~~~~~~~~  188 (399)
                      +|++.+.||.|+||.||+++.     .++.||+|+++....  .......+.+|+.+++++ +||||+++++.+..+...
T Consensus         1 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~~~~~   80 (288)
T cd05583           1 NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQTDTKL   80 (288)
T ss_pred             CceEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheeeecCCEE
Confidence            478899999999999999875     457899999875322  123346788999999999 599999999999999999


Q ss_pred             EEEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceeecCCCcEEEeeccceeeccCCC
Q 015868          189 CIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSG  268 (399)
Q Consensus       189 ~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~giiHrDlkp~NILl~~~~~vkl~DFG~a~~~~~~~  268 (399)
                      ++||||+.+++|.+++.. ...+++..+..++.|++++|.|||+.|++||||+|.||+++.++.++|+|||+++......
T Consensus        81 ~lv~e~~~~~~L~~~~~~-~~~~~~~~~~~~~~ql~~~l~~lH~~~~~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~  159 (288)
T cd05583          81 HLILDYVNGGELFTHLYQ-REHFTESEVRVYIAEIVLALDHLHQLGIIYRDIKLENILLDSEGHVVLTDFGLSKEFLAEE  159 (288)
T ss_pred             EEEEecCCCCcHHHHHhh-cCCcCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEEEECcccccccccc
Confidence            999999999999999876 3568999999999999999999999999999999999999999999999999987644332


Q ss_pred             c--cccCCCCcccccccccCCCC--CCChhhHHHHHHHHHHHHcCCCCCCCCCH---HHHHHHHHhccCCCCCCCCCcHH
Q 015868          269 V--MTAETGTYRWMAPEVIEHKP--YDYKADVFSFGIALWELLTGELPYAGLTP---LQAAVGVVQKSLRPTIPKHAHPR  341 (399)
Q Consensus       269 ~--~~~~~gt~~y~aPE~l~~~~--~~~~~Dv~slG~vl~elltg~~P~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~  341 (399)
                      .  .....++..|+|||.+.+..  .+.++|+||||+++|+|++|..||.....   ......... ...+..+..++++
T Consensus       160 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~  238 (288)
T cd05583         160 EERAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQNSQSEISRRIL-KSKPPFPKTMSAE  238 (288)
T ss_pred             ccccccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCcccCcccchHHHHHHHHH-ccCCCCCcccCHH
Confidence            1  12235788999999987654  68899999999999999999999964321   111111121 2235567778999


Q ss_pred             HHHHHHHHhhhcCCCCCCHHHHHHHHHH
Q 015868          342 LAELLERCWQHDPTQRPNFSQITDILKQ  369 (399)
Q Consensus       342 l~~ll~~cl~~dP~~Rps~~ell~~L~~  369 (399)
                      +.+++.+||+.+|++|||+.++.+.|..
T Consensus       239 l~~li~~~l~~~p~~R~t~~~~~~~l~~  266 (288)
T cd05583         239 ARDFIQKLLEKDPKKRLGANGADEIKNH  266 (288)
T ss_pred             HHHHHHHHhcCCHhhccCcchHHHHhcC
Confidence            9999999999999999998887766554

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines

>KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms]

Probab=100.00  E-value=3e-39  Score=310.40  Aligned_cols=249  Identities=24%  Similarity=0.395  Sum_probs=213.9

Q ss_pred             ccce--eceeceeCceEEEEEEE--CCeeEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCceeeEEeEEecCCcEEEEE
Q 015868          117 QLKI--ECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVT  192 (399)
Q Consensus       117 ~~~i--~~~lg~G~~g~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~nIv~~~~~~~~~~~~~lV~  192 (399)
                      -|+|  .+.||+|.||+||-|++  +|+.||||++.+..........+.+|+.||+.+.||.||.+...|+.++..+.||
T Consensus       563 vYQif~devLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp~kqesqlR~EVaILq~l~HPGiV~le~M~ET~ervFVVM  642 (888)
T KOG4236|consen  563 VYQIFADEVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFPTKQESQLRNEVAILQNLHHPGIVNLECMFETPERVFVVM  642 (888)
T ss_pred             HHHhhhHhhccCCcceeeecceecccCceeeeeeeecccCCCchHHHHHHHHHHHHhcCCCCeeEEEEeecCCceEEEEe
Confidence            3444  46899999999999976  7999999999887766666688999999999999999999999999999999999


Q ss_pred             ecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceeecCC---CcEEEeeccceeeccCCCc
Q 015868          193 EFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDEN---GVVKVADFGVARVQAQSGV  269 (399)
Q Consensus       193 E~~~ggsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~giiHrDlkp~NILl~~~---~~vkl~DFG~a~~~~~~~~  269 (399)
                      |.+.|.-|.-++....+++++..-+.++.||+.||.|||-+||+|+||||+|||+.+.   -++||||||+|+..+....
T Consensus       643 EKl~GDMLEMILSsEkgRL~er~TkFlvtQIL~ALr~LH~knIvHCDLKPENVLLas~~~FPQvKlCDFGfARiIgEksF  722 (888)
T KOG4236|consen  643 EKLHGDMLEMILSSEKGRLPERITKFLVTQILVALRYLHFKNIVHCDLKPENVLLASASPFPQVKLCDFGFARIIGEKSF  722 (888)
T ss_pred             hhhcchHHHHHHHhhcccchHHHHHHHHHHHHHHHHHhhhcceeeccCCchheeeccCCCCCceeeccccceeecchhhh
Confidence            9997755555556677999999999999999999999999999999999999999754   4799999999999998877


Q ss_pred             cccCCCCcccccccccCCCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhccCCCCCCCCCcHHHHHHHHHH
Q 015868          270 MTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRLAELLERC  349 (399)
Q Consensus       270 ~~~~~gt~~y~aPE~l~~~~~~~~~Dv~slG~vl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~c  349 (399)
                      .....||+.|+|||++.++.|...-|+||.|+++|--+.|-.||..........+...--.+|.....++++..+||..+
T Consensus       723 RrsVVGTPAYLaPEVLrnkGyNrSLDMWSVGVIiYVsLSGTFPFNEdEdIndQIQNAaFMyPp~PW~eis~~AidlIn~L  802 (888)
T KOG4236|consen  723 RRSVVGTPAYLAPEVLRNKGYNRSLDMWSVGVIIYVSLSGTFPFNEDEDINDQIQNAAFMYPPNPWSEISPEAIDLINNL  802 (888)
T ss_pred             hhhhcCCccccCHHHHhhccccccccceeeeEEEEEEecccccCCCccchhHHhhccccccCCCchhhcCHHHHHHHHHH
Confidence            78889999999999999999999999999999999999999999765443322222222234444567899999999999


Q ss_pred             hhhcCCCCCCHHHHHH
Q 015868          350 WQHDPTQRPNFSQITD  365 (399)
Q Consensus       350 l~~dP~~Rps~~ell~  365 (399)
                      |+..-.+|-|....+.
T Consensus       803 LqVkm~kRysvdk~ls  818 (888)
T KOG4236|consen  803 LQVKMRKRYSVDKSLS  818 (888)
T ss_pred             HHHHHHHhcchHhhcc
Confidence            9999999999887643

>cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1

Probab=100.00  E-value=2.6e-37  Score=299.28  Aligned_cols=246  Identities=25%  Similarity=0.405  Sum_probs=200.7

Q ss_pred             ccccceeceeceeCceEEEEEEE--CCeeEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCceeeEEeEEec-CCcEEEE
Q 015868          115 AKQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTR-PPNLCIV  191 (399)
Q Consensus       115 ~~~~~i~~~lg~G~~g~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~nIv~~~~~~~~-~~~~~lV  191 (399)
                      .++|++.+.||.|+||.||++..  +++.||+|++..........+.+.+|+.+++.++||||+++++++.. ....++|
T Consensus         9 ~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~lv   88 (328)
T cd07856           9 TNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHENIISLSDIFISPLEDIYFV   88 (328)
T ss_pred             ccceEEEEeecccCCeEEEEEEECCCCCEEEEEEecccccccchhHHHHHHHHHHHhcCCCCeeeEeeeEecCCCcEEEE
Confidence            45799999999999999999976  57889999987544344455778899999999999999999999865 5578999


Q ss_pred             EecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceeecCCCcEEEeeccceeeccCCCccc
Q 015868          192 TEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMT  271 (399)
Q Consensus       192 ~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~giiHrDlkp~NILl~~~~~vkl~DFG~a~~~~~~~~~~  271 (399)
                      +||+ +++|.++++.  ..+++..+..++.|+++||.|||++||+||||+|.||++++++.++|+|||.+.....  ...
T Consensus        89 ~e~~-~~~L~~~~~~--~~~~~~~~~~~~~ql~~aL~~LH~~~iiH~dl~p~Nili~~~~~~~l~dfg~~~~~~~--~~~  163 (328)
T cd07856          89 TELL-GTDLHRLLTS--RPLEKQFIQYFLYQILRGLKYVHSAGVVHRDLKPSNILINENCDLKICDFGLARIQDP--QMT  163 (328)
T ss_pred             eehh-ccCHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEeECCCCCEEeCccccccccCC--CcC
Confidence            9998 4589988854  4578889999999999999999999999999999999999999999999999875432  223


Q ss_pred             cCCCCcccccccccCC-CCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHh-----------------------
Q 015868          272 AETGTYRWMAPEVIEH-KPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQ-----------------------  327 (399)
Q Consensus       272 ~~~gt~~y~aPE~l~~-~~~~~~~Dv~slG~vl~elltg~~P~~~~~~~~~~~~~~~-----------------------  327 (399)
                      ...++..|+|||.+.+ ..++.++|+||||+++|+|++|+.||...++.........                       
T Consensus       164 ~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  243 (328)
T cd07856         164 GYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQFSIITDLLGTPPDDVINTICSENTLRFVQ  243 (328)
T ss_pred             CCcccccccCceeeeccCCcCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhccchhhHHHHh
Confidence            4467889999999866 5689999999999999999999999987765332211110                       


Q ss_pred             cc-CCCC-----CCCCCcHHHHHHHHHHhhhcCCCCCCHHHHHH
Q 015868          328 KS-LRPT-----IPKHAHPRLAELLERCWQHDPTQRPNFSQITD  365 (399)
Q Consensus       328 ~~-~~~~-----~~~~~~~~l~~ll~~cl~~dP~~Rps~~ell~  365 (399)
                      .. ....     ....+++++.++|.+||+.+|++||++.+++.
T Consensus       244 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~ell~  287 (328)
T cd07856         244 SLPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAAEALA  287 (328)
T ss_pred             hccccCCCcHHHHcCCCCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence            00 0001     11346789999999999999999999998865

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U

>PTZ00024 cyclin-dependent protein kinase; Provisional

Probab=100.00  E-value=1.7e-37  Score=300.99  Aligned_cols=248  Identities=25%  Similarity=0.391  Sum_probs=200.6

Q ss_pred             cccc-eeceeceeCceEEEEEEE--CCeeEEEEEecCCCCCHH------------HHHHHHHHHHHHHhcCCCceeeEEe
Q 015868          116 KQLK-IECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVNTE------------MLKEFSQEVYIMRKIRHKNVVQFIG  180 (399)
Q Consensus       116 ~~~~-i~~~lg~G~~g~Vy~~~~--~~~~vAvK~~~~~~~~~~------------~~~~~~~Ei~~l~~l~h~nIv~~~~  180 (399)
                      ++|. +.+.||.|+||.||+|..  .++.||+|+++.......            ....+.+|+.+++.++|+||+++++
T Consensus         8 ~ry~~~~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~   87 (335)
T PTZ00024          8 ERYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIMGLVD   87 (335)
T ss_pred             cchhhhhhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcceeeeeE
Confidence            3554 567799999999999976  578999999875422210            0125778999999999999999999


Q ss_pred             EEecCCcEEEEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceeecCCCcEEEeeccc
Q 015868          181 ACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGV  260 (399)
Q Consensus       181 ~~~~~~~~~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~giiHrDlkp~NILl~~~~~vkl~DFG~  260 (399)
                      ++......++||||+.+ +|.+++.. ...+++..+..++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||.
T Consensus        88 ~~~~~~~~~lv~e~~~~-~l~~~l~~-~~~~~~~~~~~~~~ql~~aL~~LH~~~i~H~dl~~~nill~~~~~~kl~dfg~  165 (335)
T PTZ00024         88 VYVEGDFINLVMDIMAS-DLKKVVDR-KIRLTESQVKCILLQILNGLNVLHKWYFMHRDLSPANIFINSKGICKIADFGL  165 (335)
T ss_pred             EEecCCcEEEEEecccc-CHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCeecccccHHHeEECCCCCEEECCccc
Confidence            99999999999999974 99999865 45689999999999999999999999999999999999999999999999999


Q ss_pred             eeeccCC---------------CccccCCCCcccccccccCCC-CCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHH
Q 015868          261 ARVQAQS---------------GVMTAETGTYRWMAPEVIEHK-PYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVG  324 (399)
Q Consensus       261 a~~~~~~---------------~~~~~~~gt~~y~aPE~l~~~-~~~~~~Dv~slG~vl~elltg~~P~~~~~~~~~~~~  324 (399)
                      ++.....               .......++..|+|||.+.+. .++.++|+||||+++|+|++|+.||...++.+....
T Consensus       166 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~  245 (335)
T PTZ00024        166 ARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPGENEIDQLGR  245 (335)
T ss_pred             eeecccccccccccccccccccccccccccccCCCCChhcccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHH
Confidence            9765411               112233467889999998764 468999999999999999999999988876654433


Q ss_pred             HHhccCCC--------------------------CCCCCCcHHHHHHHHHHhhhcCCCCCCHHHHHH
Q 015868          325 VVQKSLRP--------------------------TIPKHAHPRLAELLERCWQHDPTQRPNFSQITD  365 (399)
Q Consensus       325 ~~~~~~~~--------------------------~~~~~~~~~l~~ll~~cl~~dP~~Rps~~ell~  365 (399)
                      +......+                          ......+.++.+++.+||+.+|++||+++|++.
T Consensus       246 i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~  312 (335)
T PTZ00024        246 IFELLGTPNEDNWPQAKKLPLYTEFTPRKPKDLKTIFPNASDDAIDLLQSLLKLNPLERISAKEALK  312 (335)
T ss_pred             HHHHhCCCchhhCcchhhcccccccCcCCcccHHHhCcCCChHHHHHHHHHcCCCchhccCHHHHhc
Confidence            32211000                          011345788999999999999999999999975

>cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase

Probab=100.00  E-value=5.9e-38  Score=305.52  Aligned_cols=250  Identities=26%  Similarity=0.444  Sum_probs=206.2

Q ss_pred             ceeecccccceeceeceeCceEEEEEEE--CCeeEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCceeeEEeEEecCCc
Q 015868          110 VWEIDAKQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPN  187 (399)
Q Consensus       110 ~~~i~~~~~~i~~~lg~G~~g~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~nIv~~~~~~~~~~~  187 (399)
                      .|++ .++|++.+.||+|++|.||+|..  +++.||+|++............+.+|+.++++++|||++++++++.....
T Consensus        10 ~~~~-~~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~   88 (343)
T cd07851          10 VWEV-PDRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHENVIGLLDVFTPASS   88 (343)
T ss_pred             eecc-cCceEEEEEeccCCceEEEEEEECCCCcEEEEEecccccchhhHHHHHHHHHHHHHhccCCCHHHHHHHhhcccc
Confidence            3444 45799999999999999999987  47889999987654444555678899999999999999999998766554


Q ss_pred             ------EEEEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceeecCCCcEEEeeccce
Q 015868          188 ------LCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVA  261 (399)
Q Consensus       188 ------~~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~giiHrDlkp~NILl~~~~~vkl~DFG~a  261 (399)
                            .++|+||+ +++|.+++..  ..+++..++.++.|++.||.|||+.||+||||+|+||++++++.++|+|||.+
T Consensus        89 ~~~~~~~~lv~e~~-~~~L~~~~~~--~~l~~~~~~~~~~ql~~aL~~LH~~gi~H~dlkp~Nill~~~~~~kL~dfg~~  165 (343)
T cd07851          89 LEDFQDVYLVTHLM-GADLNNIVKC--QKLSDDHIQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLA  165 (343)
T ss_pred             ccccccEEEEEecC-CCCHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCCEEEcccccc
Confidence                  89999998 5699999865  56899999999999999999999999999999999999999999999999999


Q ss_pred             eeccCCCccccCCCCcccccccccCC-CCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhccCCC--------
Q 015868          262 RVQAQSGVMTAETGTYRWMAPEVIEH-KPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKSLRP--------  332 (399)
Q Consensus       262 ~~~~~~~~~~~~~gt~~y~aPE~l~~-~~~~~~~Dv~slG~vl~elltg~~P~~~~~~~~~~~~~~~~~~~~--------  332 (399)
                      ......  .....++..|+|||.+.+ ..++.++||||||+++|+|++|+.||...+..+...........+        
T Consensus       166 ~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~  243 (343)
T cd07851         166 RHTDDE--MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDHIDQLKRIMNLVGTPDEELLQKI  243 (343)
T ss_pred             cccccc--ccCCcccccccCHHHHhCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHHHhhc
Confidence            765432  344567889999999865 367899999999999999999999998776654433322211000        


Q ss_pred             ---------------------CCCCCCcHHHHHHHHHHhhhcCCCCCCHHHHHH
Q 015868          333 ---------------------TIPKHAHPRLAELLERCWQHDPTQRPNFSQITD  365 (399)
Q Consensus       333 ---------------------~~~~~~~~~l~~ll~~cl~~dP~~Rps~~ell~  365 (399)
                                           ......++++.+++.+||+.+|.+|||+.++++
T Consensus       244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dli~~~l~~~P~~Rpt~~ell~  297 (343)
T cd07851         244 SSESARNYIQSLPQMPKKDFKEVFSGANPLAIDLLEKMLVLDPDKRITAAEALA  297 (343)
T ss_pred             cchhHHHHHHhccccCCCCHHHHhccCCHHHHHHHHHhCCCChhhCCCHHHHhc
Confidence                                 111246889999999999999999999999875

Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK

>KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms]

Probab=100.00  E-value=8.5e-39  Score=289.29  Aligned_cols=243  Identities=25%  Similarity=0.412  Sum_probs=201.1

Q ss_pred             ccccee-ceeceeCceEEEEEEE--CCeeEEEEEecCCCCCHHHHHHHHHHHHHHHhc-CCCceeeEEeEEec----CCc
Q 015868          116 KQLKIE-CKVASGSYGDLYKGTY--CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKI-RHKNVVQFIGACTR----PPN  187 (399)
Q Consensus       116 ~~~~i~-~~lg~G~~g~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~Ei~~l~~l-~h~nIv~~~~~~~~----~~~  187 (399)
                      ++|++. ++||-|-.|.|-.+..  +++.+|+|++...       ....+|+++.-.. .|||||+++++|..    ...
T Consensus        61 edY~is~qvLG~GinGkV~~C~~k~T~ekfALKvL~Ds-------~KARrEVeLHw~~s~h~~iV~IidVyeNs~~~rkc  133 (400)
T KOG0604|consen   61 EDYSISWQVLGAGINGKVVQCVHKRTQEKFALKVLLDS-------PKARREVELHWMASGHPHIVSIIDVYENSYQGRKC  133 (400)
T ss_pred             hhheehhhhhccccCCceEEEEeccchhhhHHHHHhcC-------HHHHhHhhhhhhhcCCCceEEeehhhhhhccCcee
Confidence            456663 5789999999998865  7889999998743       3455788776555 59999999999854    345


Q ss_pred             EEEEEecCCCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceeecC---CCcEEEeeccceee
Q 015868          188 LCIVTEFMARGSIYDFLHKQK-GVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDE---NGVVKVADFGVARV  263 (399)
Q Consensus       188 ~~lV~E~~~ggsL~~~l~~~~-~~l~~~~~~~i~~~i~~~L~~LH~~giiHrDlkp~NILl~~---~~~vkl~DFG~a~~  263 (399)
                      +.+|||.|+||.|...+..+. ..|++.++..|+.||..|+.|||+.+|.||||||+|+|.+.   |..+||+|||+|+.
T Consensus       134 LLiVmE~meGGeLfsriq~~g~~afTErea~eI~~qI~~Av~~lH~~nIAHRDlKpENLLyt~t~~na~lKLtDfGFAK~  213 (400)
T KOG0604|consen  134 LLIVMECMEGGELFSRIQDRGDQAFTEREASEIMKQIGLAVRYLHSMNIAHRDLKPENLLYTTTSPNAPLKLTDFGFAKE  213 (400)
T ss_pred             eEeeeecccchHHHHHHHHcccccchHHHHHHHHHHHHHHHHHHHhcchhhccCChhheeeecCCCCcceEecccccccc
Confidence            789999999999999998753 56999999999999999999999999999999999999974   55899999999998


Q ss_pred             ccCCCccccCCCCcccccccccCCCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhccCC--CCCC----CC
Q 015868          264 QAQSGVMTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKSLR--PTIP----KH  337 (399)
Q Consensus       264 ~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~Dv~slG~vl~elltg~~P~~~~~~~~~~~~~~~~~~~--~~~~----~~  337 (399)
                      -...+...+.+.|+.|.|||++....|+..+|+||+|+++|-|+||.+||........-.+...+...  -.+|    ..
T Consensus       214 t~~~~~L~TPc~TPyYvaPevlg~eKydkscdmwSlgVimYIlLCGyPPFYS~hg~aispgMk~rI~~gqy~FP~pEWs~  293 (400)
T KOG0604|consen  214 TQEPGDLMTPCFTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKRRIRTGQYEFPEPEWSC  293 (400)
T ss_pred             cCCCccccCCcccccccCHHHhCchhcCCCCCccchhHHHHHhhcCCCcccccCCccCChhHHhHhhccCccCCChhHhH
Confidence            77777788889999999999999999999999999999999999999999876553322222221111  1122    34


Q ss_pred             CcHHHHHHHHHHhhhcCCCCCCHHHHHH
Q 015868          338 AHPRLAELLERCWQHDPTQRPNFSQITD  365 (399)
Q Consensus       338 ~~~~l~~ll~~cl~~dP~~Rps~~ell~  365 (399)
                      +|.+.+++|+++|..+|++|.|++++++
T Consensus       294 VSe~aKdlIR~LLkt~PteRlTI~~~m~  321 (400)
T KOG0604|consen  294 VSEAAKDLIRKLLKTEPTERLTIEEVMD  321 (400)
T ss_pred             HHHHHHHHHHHHhcCCchhheeHHHhhc
Confidence            7889999999999999999999999864

>cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6

Probab=100.00  E-value=1.5e-37  Score=302.48  Aligned_cols=246  Identities=23%  Similarity=0.396  Sum_probs=199.3

Q ss_pred             ccccceeceeceeCceEEEEEEE--CCeeEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCceeeEEeEEecC-------
Q 015868          115 AKQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRP-------  185 (399)
Q Consensus       115 ~~~~~i~~~lg~G~~g~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~nIv~~~~~~~~~-------  185 (399)
                      ..+|.+.+.||.|+||.||+|..  +++.||+|.+....  ....+.+.+|+.++++++||||+++++.+...       
T Consensus         4 ~~~y~~~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~--~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~   81 (342)
T cd07854           4 GSRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTD--PQSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTED   81 (342)
T ss_pred             CcceEEEEEecCCCCEEEEEEEECCCCcEEEEEEEecCC--CchHHHHHHHHHHHHhcCCCcchhhHhhhcccccccccc
Confidence            36899999999999999999987  57899999987553  24456788999999999999999999876543       


Q ss_pred             -------CcEEEEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceeecC-CCcEEEee
Q 015868          186 -------PNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDE-NGVVKVAD  257 (399)
Q Consensus       186 -------~~~~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~giiHrDlkp~NILl~~-~~~vkl~D  257 (399)
                             ...|+||||+++ +|.+++..  +.+++..++.++.||+.||.|||+.||+||||||+||+++. ++.++++|
T Consensus        82 ~~~~~~~~~~~lv~e~~~~-~L~~~~~~--~~l~~~~~~~~~~qi~~aL~~LH~~givH~dikp~Nili~~~~~~~kl~d  158 (342)
T cd07854          82 VGSLTELNSVYIVQEYMET-DLANVLEQ--GPLSEEHARLFMYQLLRGLKYIHSANVLHRDLKPANVFINTEDLVLKIGD  158 (342)
T ss_pred             cccccccceEEEEeecccc-cHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEcCCCceEEECC
Confidence                   357999999975 99988854  46899999999999999999999999999999999999974 56789999


Q ss_pred             ccceeeccCCC----ccccCCCCcccccccccCC-CCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcc---
Q 015868          258 FGVARVQAQSG----VMTAETGTYRWMAPEVIEH-KPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKS---  329 (399)
Q Consensus       258 FG~a~~~~~~~----~~~~~~gt~~y~aPE~l~~-~~~~~~~Dv~slG~vl~elltg~~P~~~~~~~~~~~~~~~~~---  329 (399)
                      ||.++......    ......++..|+|||.+.+ ..++.++|||||||++|+|++|..||...++...........   
T Consensus       159 fg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~  238 (342)
T cd07854         159 FGLARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQMQLILESVPVV  238 (342)
T ss_pred             cccceecCCccccccccccccccccccCHHHHhCccccCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCC
Confidence            99997643221    1223457889999998754 567889999999999999999999998877655444332210   


Q ss_pred             --------------------CCCC-----CCCCCcHHHHHHHHHHhhhcCCCCCCHHHHHH
Q 015868          330 --------------------LRPT-----IPKHAHPRLAELLERCWQHDPTQRPNFSQITD  365 (399)
Q Consensus       330 --------------------~~~~-----~~~~~~~~l~~ll~~cl~~dP~~Rps~~ell~  365 (399)
                                          ..+.     ..+..+.++.+++.+||+.||.+|||+.+++.
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~  299 (342)
T cd07854         239 REEDRNELLNVIPSFVRNDGGEPRRPLRDLLPGVNPEALDFLEQILTFNPMDRLTAEEALM  299 (342)
T ss_pred             ChHHhhhhhhhhhhhhhhcccccCCCHHHHccCCCHHHHHHHHHHhCCCchhccCHHHHhC
Confidence                                0010     12357789999999999999999999999974

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi

>cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1

Probab=100.00  E-value=4.6e-37  Score=297.81  Aligned_cols=247  Identities=25%  Similarity=0.377  Sum_probs=198.1

Q ss_pred             ccceeceeceeCceEEEEEEEC----CeeEEEEEecCCCCCHHHHHHHHHHHHHHHhc-CCCceeeEEeEEecC----Cc
Q 015868          117 QLKIECKVASGSYGDLYKGTYC----SQEVAIKVLKPECVNTEMLKEFSQEVYIMRKI-RHKNVVQFIGACTRP----PN  187 (399)
Q Consensus       117 ~~~i~~~lg~G~~g~Vy~~~~~----~~~vAvK~~~~~~~~~~~~~~~~~Ei~~l~~l-~h~nIv~~~~~~~~~----~~  187 (399)
                      +|++.+.||.|+||.||++.+.    +..||+|++............+.+|+.+++++ +||||+++++.+...    ..
T Consensus         1 ~y~~~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~   80 (332)
T cd07857           1 RYELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNITCLYDMDIVFPGNFNE   80 (332)
T ss_pred             CceEEEEccccCCeEEEEEEeCCCCcCceEEEEEeccccccchhHHHHHHHHHHHHHhcCCCChheeeeeeeeccccCCc
Confidence            4788999999999999999885    55899999875443444456788999999999 599999999975432    45


Q ss_pred             EEEEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceeecCCCcEEEeeccceeeccCC
Q 015868          188 LCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQS  267 (399)
Q Consensus       188 ~~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~giiHrDlkp~NILl~~~~~vkl~DFG~a~~~~~~  267 (399)
                      .++++|++. ++|.+++.. ...+++..++.++.||+.||.|||++||+||||||+||+++.++.++|+|||.++.....
T Consensus        81 ~~~~~e~~~-~~L~~~l~~-~~~~~~~~~~~~~~qi~~aL~~LH~~givH~dlkp~Nili~~~~~~kl~Dfg~a~~~~~~  158 (332)
T cd07857          81 LYLYEELME-ADLHQIIRS-GQPLTDAHFQSFIYQILCGLKYIHSANVLHRDLKPGNLLVNADCELKICDFGLARGFSEN  158 (332)
T ss_pred             EEEEEeccc-CCHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHeEEcCCCCEEeCcCCCceecccc
Confidence            789999986 599998865 467899999999999999999999999999999999999999999999999999754432


Q ss_pred             C-----ccccCCCCcccccccccCC-CCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhc-------------
Q 015868          268 G-----VMTAETGTYRWMAPEVIEH-KPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQK-------------  328 (399)
Q Consensus       268 ~-----~~~~~~gt~~y~aPE~l~~-~~~~~~~Dv~slG~vl~elltg~~P~~~~~~~~~~~~~~~~-------------  328 (399)
                      .     ......|+..|+|||.+.+ ..++.++|+||||+++|+|++|..||...+...........             
T Consensus       159 ~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (332)
T cd07857         159 PGENAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDYVDQLNQILQVLGTPDEETLSRIG  238 (332)
T ss_pred             cccccccccCcccCccccCcHHHhCCCCCCcHHHHHHHHHHHHHHHhCCcCCCCCCHHHHHHHHHHHhCCCCHHHHHhhh
Confidence            1     1233468899999998765 56899999999999999999999999876543322221110             


Q ss_pred             -----------cCC-----CCCCCCCcHHHHHHHHHHhhhcCCCCCCHHHHHH
Q 015868          329 -----------SLR-----PTIPKHAHPRLAELLERCWQHDPTQRPNFSQITD  365 (399)
Q Consensus       329 -----------~~~-----~~~~~~~~~~l~~ll~~cl~~dP~~Rps~~ell~  365 (399)
                                 ...     +......+..+.+++.+||+.||.+|||+.++++
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~ll~  291 (332)
T cd07857         239 SPKAQNYIRSLPNIPKKPFESIFPNANPLALDLLEKLLAFDPTKRISVEEALE  291 (332)
T ss_pred             hhhHHHHHHhccccCCcchHhhCCCCCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence                       000     1112346789999999999999999999999865

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co

>KOG0584 consensus Serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=2e-38  Score=311.74  Aligned_cols=245  Identities=28%  Similarity=0.501  Sum_probs=205.4

Q ss_pred             ccceeceeceeCceEEEEEEE--CCeeEEEEEec--CCCCCHHHHHHHHHHHHHHHhcCCCceeeEEeEEecCCc--EEE
Q 015868          117 QLKIECKVASGSYGDLYKGTY--CSQEVAIKVLK--PECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPN--LCI  190 (399)
Q Consensus       117 ~~~i~~~lg~G~~g~Vy~~~~--~~~~vAvK~~~--~~~~~~~~~~~~~~Ei~~l~~l~h~nIv~~~~~~~~~~~--~~l  190 (399)
                      -.++...||+|+|-+||+|-+  .|-.||--.++  .-....+...+|+.|+.+|+.|+||||+++|.+|.+..+  +.+
T Consensus        41 y~k~~evLGrGafKtVYka~De~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~~n~~in~  120 (632)
T KOG0584|consen   41 YLKFDEVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLKHPNIIRFYDSWVDTDNKTINF  120 (632)
T ss_pred             eeehhhhcccccceeeeeccccccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCCCCceeeeeeheecCCCceeee
Confidence            346678999999999999976  45566643322  112255667899999999999999999999999987665  889


Q ss_pred             EEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC--CcccCCCCCCceeecC-CCcEEEeeccceeeccCC
Q 015868          191 VTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQN--NIIHRDLKTANLLMDE-NGVVKVADFGVARVQAQS  267 (399)
Q Consensus       191 V~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~--giiHrDlkp~NILl~~-~~~vkl~DFG~a~~~~~~  267 (399)
                      |+|.+..|+|..|+++. +..+...++.|+.||++||.|||++  -|||||||-+||+|+. .|.|||+|+|+|+....+
T Consensus       121 iTEL~TSGtLr~Y~kk~-~~vn~kaik~W~RQILkGL~yLHs~~PPIIHRDLKCDNIFinG~~G~VKIGDLGLAtl~r~s  199 (632)
T KOG0584|consen  121 ITELFTSGTLREYRKKH-RRVNIKAIKSWCRQILKGLVYLHSQDPPIIHRDLKCDNIFVNGNLGEVKIGDLGLATLLRKS  199 (632)
T ss_pred             eeecccCCcHHHHHHHh-ccCCHHHHHHHHHHHHHHhhhhhcCCCCccccccccceEEEcCCcCceeecchhHHHHhhcc
Confidence            99999999999999874 6688899999999999999999998  5999999999999975 589999999999987665


Q ss_pred             CccccCCCCcccccccccCCCCCCChhhHHHHHHHHHHHHcCCCCCCCCC-HHHHHHHHHhccCCCCCCCCCcHHHHHHH
Q 015868          268 GVMTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPYAGLT-PLQAAVGVVQKSLRPTIPKHAHPRLAELL  346 (399)
Q Consensus       268 ~~~~~~~gt~~y~aPE~l~~~~~~~~~Dv~slG~vl~elltg~~P~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~l~~ll  346 (399)
                      .- ..-.|||.|||||+.. ..|++..||||||+.|.||+|+..||+..+ +.|....+.....+..+.+--++++++||
T Consensus       200 ~a-ksvIGTPEFMAPEmYE-E~YnE~VDVYaFGMCmLEMvT~eYPYsEC~n~AQIYKKV~SGiKP~sl~kV~dPevr~fI  277 (632)
T KOG0584|consen  200 HA-KSVIGTPEFMAPEMYE-ENYNELVDVYAFGMCMLEMVTSEYPYSECTNPAQIYKKVTSGIKPAALSKVKDPEVREFI  277 (632)
T ss_pred             cc-ceeccCccccChHHHh-hhcchhhhhhhhhHHHHHHHhccCChhhhCCHHHHHHHHHcCCCHHHhhccCCHHHHHHH
Confidence            32 2368999999999998 779999999999999999999999998754 55555555544433344555689999999


Q ss_pred             HHHhhhcCCCCCCHHHHHH
Q 015868          347 ERCWQHDPTQRPNFSQITD  365 (399)
Q Consensus       347 ~~cl~~dP~~Rps~~ell~  365 (399)
                      .+|+.. ..+|||+.||++
T Consensus       278 ekCl~~-~~~R~sa~eLL~  295 (632)
T KOG0584|consen  278 EKCLAT-KSERLSAKELLK  295 (632)
T ss_pred             HHHhcC-chhccCHHHHhh
Confidence            999999 899999999976

>cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase

Probab=100.00  E-value=3.5e-37  Score=300.35  Aligned_cols=251  Identities=25%  Similarity=0.407  Sum_probs=203.1

Q ss_pred             ceeecccccceeceeceeCceEEEEEEE--CCeeEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCceeeEEeEEecC--
Q 015868          110 VWEIDAKQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRP--  185 (399)
Q Consensus       110 ~~~i~~~~~~i~~~lg~G~~g~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~nIv~~~~~~~~~--  185 (399)
                      .|.+ .++|.+.+.||+|+||.||++..  +++.||+|+++.........+.+.+|+.++++++||||+++++++...  
T Consensus        12 ~~~~-~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~iv~~~~~~~~~~~   90 (345)
T cd07877          12 IWEV-PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARS   90 (345)
T ss_pred             Hhhc-cCceEEEEEeeecCCeEEEEEEEcCCCeEEEEEEecCcchhhHHHHHHHHHHHHHHHcCCCcccceeeeeeeccc
Confidence            3444 36899999999999999999975  678999999986543444456788999999999999999999988543  


Q ss_pred             ----CcEEEEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceeecCCCcEEEeeccce
Q 015868          186 ----PNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVA  261 (399)
Q Consensus       186 ----~~~~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~giiHrDlkp~NILl~~~~~vkl~DFG~a  261 (399)
                          ...|++++++ |++|.+++..  ..+++..++.++.|++.||+|||++||+||||||+||+++.++.++|+|||++
T Consensus        91 ~~~~~~~~lv~~~~-~~~L~~~~~~--~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIll~~~~~~kl~dfg~~  167 (345)
T cd07877          91 LEEFNDVYLVTHLM-GADLNNIVKC--QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLA  167 (345)
T ss_pred             ccccccEEEEehhc-ccCHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChHHEEEcCCCCEEEeccccc
Confidence                3478899887 6799988854  45899999999999999999999999999999999999999999999999998


Q ss_pred             eeccCCCccccCCCCcccccccccCC-CCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhccC----------
Q 015868          262 RVQAQSGVMTAETGTYRWMAPEVIEH-KPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKSL----------  330 (399)
Q Consensus       262 ~~~~~~~~~~~~~gt~~y~aPE~l~~-~~~~~~~Dv~slG~vl~elltg~~P~~~~~~~~~~~~~~~~~~----------  330 (399)
                      +....  ......++..|+|||.+.+ ..++.++||||||+++|+|++|+.||...+.............          
T Consensus       168 ~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  245 (345)
T cd07877         168 RHTDD--EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKI  245 (345)
T ss_pred             ccccc--cccccccCCCccCHHHHhCccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHhhc
Confidence            75432  2334567889999999866 5688999999999999999999999987665443322211100          


Q ss_pred             -----------CCCC--------CCCCcHHHHHHHHHHhhhcCCCCCCHHHHHHH
Q 015868          331 -----------RPTI--------PKHAHPRLAELLERCWQHDPTQRPNFSQITDI  366 (399)
Q Consensus       331 -----------~~~~--------~~~~~~~l~~ll~~cl~~dP~~Rps~~ell~~  366 (399)
                                 .+..        ....++++.++|.+||+.||.+||++.+++..
T Consensus       246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h  300 (345)
T cd07877         246 SSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAH  300 (345)
T ss_pred             ccHhHHHHHHHhcccCCcchhhhcCCCCHHHHHHHHHHcCCChhhcCCHHHHhcC
Confidence                       0011        12357889999999999999999999998764

Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14

>KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=3.6e-39  Score=308.86  Aligned_cols=247  Identities=27%  Similarity=0.434  Sum_probs=229.7

Q ss_pred             eecccccceeceeceeCceEEEEEEECCee--EEEEEecCCC-CCHHHHHHHHHHHHHHHhcCCCceeeEEeEEecCCcE
Q 015868          112 EIDAKQLKIECKVASGSYGDLYKGTYCSQE--VAIKVLKPEC-VNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNL  188 (399)
Q Consensus       112 ~i~~~~~~i~~~lg~G~~g~Vy~~~~~~~~--vAvK~~~~~~-~~~~~~~~~~~Ei~~l~~l~h~nIv~~~~~~~~~~~~  188 (399)
                      ++..+++++...||-|+||.|=+.+..++.  +|+|++++.. .+....+.+..|-.+|..++.|.||++|..|.+.++.
T Consensus       416 ~v~l~dl~~iaTLGvGgFGRVELV~~~~~~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~s~fIvrLYrTfrd~kyv  495 (732)
T KOG0614|consen  416 QVKLSDLKRIATLGVGGFGRVELVKVNSQKATFALKILKKKHIVDTKQQEHVFSERNIMMECRSDFIVRLYRTFRDSKYV  495 (732)
T ss_pred             ccchhhhhhhhhcccCccceEEEEEecccchHHHHHHHhHhhccchhHHHHHHhHHHHHHhcCchHHHHHHHHhccchhh
Confidence            345678889999999999999999988777  7999997543 4566678899999999999999999999999999999


Q ss_pred             EEEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceeecCCCcEEEeeccceeeccCCC
Q 015868          189 CIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSG  268 (399)
Q Consensus       189 ~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~giiHrDlkp~NILl~~~~~vkl~DFG~a~~~~~~~  268 (399)
                      ||+||-|-||.|...+++ .+.|.......++..++.|++|||++|||.|||||+|++++.+|.+||.|||+|+......
T Consensus       496 YmLmEaClGGElWTiLrd-Rg~Fdd~tarF~~acv~EAfeYLH~k~iIYRDLKPENllLd~~Gy~KLVDFGFAKki~~g~  574 (732)
T KOG0614|consen  496 YMLMEACLGGELWTILRD-RGSFDDYTARFYVACVLEAFEYLHRKGIIYRDLKPENLLLDNRGYLKLVDFGFAKKIGSGR  574 (732)
T ss_pred             hhhHHhhcCchhhhhhhh-cCCcccchhhhhHHHHHHHHHHHHhcCceeccCChhheeeccCCceEEeehhhHHHhccCC
Confidence            999999999999999987 5789999999999999999999999999999999999999999999999999999988887


Q ss_pred             ccccCCCCcccccccccCCCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhccCCCCCCCCCcHHHHHHHHH
Q 015868          269 VMTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRLAELLER  348 (399)
Q Consensus       269 ~~~~~~gt~~y~aPE~l~~~~~~~~~Dv~slG~vl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~  348 (399)
                      ..-+.+||+.|.|||++.++..+.+.|.||||+++|||++|.+||++.+|.+....++.....-.+|..++....+||++
T Consensus       575 KTwTFcGTpEYVAPEIILnKGHD~avDyWaLGIli~ELL~G~pPFs~~dpmktYn~ILkGid~i~~Pr~I~k~a~~Lik~  654 (732)
T KOG0614|consen  575 KTWTFCGTPEYVAPEIILNKGHDRAVDYWALGILIYELLTGSPPFSGVDPMKTYNLILKGIDKIEFPRRITKTATDLIKK  654 (732)
T ss_pred             ceeeecCCcccccchhhhccCcchhhHHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHhhhhhhhcccccchhHHHHHHH
Confidence            77788999999999999999999999999999999999999999999999999999888877788899999999999999


Q ss_pred             HhhhcCCCCCC
Q 015868          349 CWQHDPTQRPN  359 (399)
Q Consensus       349 cl~~dP~~Rps  359 (399)
                      +...+|.+|..
T Consensus       655 LCr~~P~ERLG  665 (732)
T KOG0614|consen  655 LCRDNPTERLG  665 (732)
T ss_pred             HHhcCcHhhhc
Confidence            99999999976

>cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase

Probab=100.00  E-value=1.1e-36  Score=320.26  Aligned_cols=147  Identities=28%  Similarity=0.506  Sum_probs=134.1

Q ss_pred             ccccceeceeceeCceEEEEEEEC--CeeEEEEEecCCC-CCHHHHHHHHHHHHHHHhcCCCceeeEEeEEecCCcEEEE
Q 015868          115 AKQLKIECKVASGSYGDLYKGTYC--SQEVAIKVLKPEC-VNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIV  191 (399)
Q Consensus       115 ~~~~~i~~~lg~G~~g~Vy~~~~~--~~~vAvK~~~~~~-~~~~~~~~~~~Ei~~l~~l~h~nIv~~~~~~~~~~~~~lV  191 (399)
                      .++|++.++||+|+||.||+|.+.  ++.||||+++... .+......+.+|+.+++.++||||+++++.+.....+|+|
T Consensus         3 ~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lV   82 (669)
T cd05610           3 IEEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSLQSANNVYLV   82 (669)
T ss_pred             cCCEEEEEEEecCCCeEEEEEEECCCCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhcCCCCcCeEEEEEEECCEEEEE
Confidence            468999999999999999999985  7899999997542 3455567899999999999999999999999999999999


Q ss_pred             EecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceeecCCCcEEEeecccee
Q 015868          192 TEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVAR  262 (399)
Q Consensus       192 ~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~giiHrDlkp~NILl~~~~~vkl~DFG~a~  262 (399)
                      |||+.|++|.+++.. .+.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++
T Consensus        83 mEy~~g~~L~~li~~-~~~l~~~~~~~i~~qil~aL~yLH~~gIiHrDLKP~NILl~~~g~vkL~DFGls~  152 (669)
T cd05610          83 MEYLIGGDVKSLLHI-YGYFDEEMAVKYISEVALALDYLHRHGIIHRDLKPDNMLISNEGHIKLTDFGLSK  152 (669)
T ss_pred             EeCCCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCccHHHEEEcCCCCEEEEeCCCCc
Confidence            999999999999976 4568899999999999999999999999999999999999999999999999875

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481

>KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.7e-37  Score=293.87  Aligned_cols=251  Identities=31%  Similarity=0.647  Sum_probs=207.7

Q ss_pred             ccccceeceeceeCceEEEEEEECCeeEEEEEecCCCCCHHHHHHHHHHHHHHHhc--CCCceeeEEeEEecCC----cE
Q 015868          115 AKQLKIECKVASGSYGDLYKGTYCSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKI--RHKNVVQFIGACTRPP----NL  188 (399)
Q Consensus       115 ~~~~~i~~~lg~G~~g~Vy~~~~~~~~vAvK~~~~~~~~~~~~~~~~~Ei~~l~~l--~h~nIv~~~~~~~~~~----~~  188 (399)
                      .++..+.+.||+|.||.||+|.|.|+.||||++...     ..+.+.+|.+|++.+  +|+||+.|+++-....    .+
T Consensus       210 arqI~L~e~IGkGRyGEVwrG~wrGe~VAVKiF~sr-----dE~SWfrEtEIYqTvmLRHENILgFIaaD~~~~gs~TQL  284 (513)
T KOG2052|consen  210 ARQIVLQEIIGKGRFGEVWRGRWRGEDVAVKIFSSR-----DERSWFRETEIYQTVMLRHENILGFIAADNKDNGSWTQL  284 (513)
T ss_pred             hheeEEEEEecCccccceeeccccCCceEEEEeccc-----chhhhhhHHHHHHHHHhccchhhhhhhccccCCCceEEE
Confidence            467889999999999999999999999999999743     235678888888875  9999999999865443    48


Q ss_pred             EEEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC--------CcccCCCCCCceeecCCCcEEEeeccc
Q 015868          189 CIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQN--------NIIHRDLKTANLLMDENGVVKVADFGV  260 (399)
Q Consensus       189 ~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~--------giiHrDlkp~NILl~~~~~vkl~DFG~  260 (399)
                      +||++|.+.|||+|||..  ..++.....+++..++.||+|||..        .|.|||||..|||+..+|+.-|+|+|+
T Consensus       285 wLvTdYHe~GSL~DyL~r--~tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILVKkn~~C~IADLGL  362 (513)
T KOG2052|consen  285 WLVTDYHEHGSLYDYLNR--NTVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGL  362 (513)
T ss_pred             EEeeecccCCcHHHHHhh--ccCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEEccCCcEEEeecee
Confidence            999999999999999976  6789999999999999999999952        599999999999999999999999999


Q ss_pred             eeeccCCC-----ccccCCCCcccccccccCCC----CCC--ChhhHHHHHHHHHHHHcC----------CCCCCCCCH-
Q 015868          261 ARVQAQSG-----VMTAETGTYRWMAPEVIEHK----PYD--YKADVFSFGIALWELLTG----------ELPYAGLTP-  318 (399)
Q Consensus       261 a~~~~~~~-----~~~~~~gt~~y~aPE~l~~~----~~~--~~~Dv~slG~vl~elltg----------~~P~~~~~~-  318 (399)
                      |-......     .....+||-+|||||++...    .++  ..+||||||.++||++..          ++||.+..+ 
T Consensus       363 Av~h~~~t~~idi~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVlWEiarRc~~ggi~eey~~Pyyd~Vp~  442 (513)
T KOG2052|consen  363 AVRHDSDTDTIDIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVLWEIARRCESGGIVEEYQLPYYDVVPS  442 (513)
T ss_pred             eEEecccCCcccCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHHHHHHHHhhcCCEehhhcCCcccCCCC
Confidence            97665542     23456899999999999654    222  248999999999999762          578876433 


Q ss_pred             ----HHHHHHHHhccCCCCCCCCCcH-----HHHHHHHHHhhhcCCCCCCHHHHHHHHHHHHH
Q 015868          319 ----LQAAVGVVQKSLRPTIPKHAHP-----RLAELLERCWQHDPTQRPNFSQITDILKQMMK  372 (399)
Q Consensus       319 ----~~~~~~~~~~~~~~~~~~~~~~-----~l~~ll~~cl~~dP~~Rps~~ell~~L~~l~~  372 (399)
                          .+...-+..+..||.+|..++.     .+..+|+.||..||..|.|+--+.+.|.++.+
T Consensus       443 DPs~eeMrkVVCv~~~RP~ipnrW~s~~~l~~m~klMkeCW~~Np~aRltALriKKtl~~l~~  505 (513)
T KOG2052|consen  443 DPSFEEMRKVVCVQKLRPNIPNRWKSDPALRVMAKLMKECWYANPAARLTALRIKKTLAKLSN  505 (513)
T ss_pred             CCCHHHHhcceeecccCCCCCcccccCHHHHHHHHHHHHhhcCCchhhhHHHHHHHHHHHHhc
Confidence                2222233457789999977653     57889999999999999999999999988853

>KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms]

Probab=100.00  E-value=5.8e-38  Score=311.98  Aligned_cols=253  Identities=26%  Similarity=0.499  Sum_probs=207.2

Q ss_pred             ceeceeceeCceEEEEEEE--CCeeEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCceeeEEeEEecCC------cEEE
Q 015868          119 KIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPP------NLCI  190 (399)
Q Consensus       119 ~i~~~lg~G~~g~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~nIv~~~~~~~~~~------~~~l  190 (399)
                      ...+.||.|+||.||+|+.  +|+.||||.++... +....+...+|+++|++++|||||++.++-.+..      ...+
T Consensus        16 ~~~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~-~~r~~e~~~~EieilkKLnh~NIVk~f~iee~~~~~~~~~~~vl   94 (732)
T KOG4250|consen   16 EMDERLGKGAFGNVYRGRNKETGRLVAVKTFNKES-SLRPRERWCREIEILKKLNHPNIVKLFDIEETKFLGLVTRLPVL   94 (732)
T ss_pred             eehhhhcCCccceeeeecccccccchhHHhhhhhc-ccchHHHHHHHHHHHHHcCchhhhhhcccCCccccCcccccceE
Confidence            3456899999999999975  78999999998754 3444577889999999999999999999865443      4689


Q ss_pred             EEecCCCCCHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceeec--CCC--cEEEeeccceeec
Q 015868          191 VTEFMARGSIYDFLHK--QKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMD--ENG--VVKVADFGVARVQ  264 (399)
Q Consensus       191 V~E~~~ggsL~~~l~~--~~~~l~~~~~~~i~~~i~~~L~~LH~~giiHrDlkp~NILl~--~~~--~vkl~DFG~a~~~  264 (399)
                      |||||.||||+..++.  +...+++.+++.++.+++.||.|||++||+||||||.||++-  .+|  ..||+|||.|+-.
T Consensus        95 vmEyC~gGsL~~~L~~PEN~~GLpE~e~l~lL~d~~~al~~LrEn~IvHRDlKP~NIvl~~Gedgq~IyKLtDfG~Arel  174 (732)
T KOG4250|consen   95 VMEYCSGGSLRKVLNSPENAYGLPESEFLDLLSDLVSALRHLRENGIVHRDLKPGNIVLQIGEDGQSIYKLTDFGAAREL  174 (732)
T ss_pred             EEeecCCCcHHHHhcCcccccCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEeecCCCceEEeeecccccccC
Confidence            9999999999999975  346799999999999999999999999999999999999883  333  4799999999999


Q ss_pred             cCCCccccCCCCcccccccccCC-CCCCChhhHHHHHHHHHHHHcCCCCCCCCCHH----HHHHHHHhc-----------
Q 015868          265 AQSGVMTAETGTYRWMAPEVIEH-KPYDYKADVFSFGIALWELLTGELPYAGLTPL----QAAVGVVQK-----------  328 (399)
Q Consensus       265 ~~~~~~~~~~gt~~y~aPE~l~~-~~~~~~~Dv~slG~vl~elltg~~P~~~~~~~----~~~~~~~~~-----------  328 (399)
                      +++...+...||..|++||+... +.|+...|.|||||++|+++||..||......    +.......+           
T Consensus       175 ~d~s~~~S~vGT~~YLhPel~E~q~~y~~tVDLWS~GvtlY~caTG~lPF~p~~~pk~~~~~~~~~~tkkp~~v~i~~~~  254 (732)
T KOG4250|consen  175 DDNSLFTSLVGTEEYLHPELYERQKKYTATVDLWSFGVTLYECATGELPFIPFGGPKNNKEIMWHIITKKPSGVAIGAQE  254 (732)
T ss_pred             CCCCeeeeecCchhhcChHHHhhccCcCceeehhhhhhHHHHHhccCCCCCcCCCccccchhhhhhhccCCCceeEeeec
Confidence            99888899999999999999984 88999999999999999999999999654322    122221111           


Q ss_pred             --------cCCCCCCCCCcHH----HHHHHHHHhhhcCCCCC--CHHHHHHHHHHHHH
Q 015868          329 --------SLRPTIPKHAHPR----LAELLERCWQHDPTQRP--NFSQITDILKQMMK  372 (399)
Q Consensus       329 --------~~~~~~~~~~~~~----l~~ll~~cl~~dP~~Rp--s~~ell~~L~~l~~  372 (399)
                              ....+.|.+.++.    +...+..+|.++|++|-  .+.+....+..|++
T Consensus       255 ~eNgpv~~s~~lP~p~~Ls~~l~~~~~kwLa~~L~~~~~~~~~~~~~~~Fa~~~dIL~  312 (732)
T KOG4250|consen  255 EENGPVEWSSTLPQPNHLSRGLATRLTKWLASMLEWNPRKRGHEGFDRFFAEVDDILN  312 (732)
T ss_pred             ccCCceeeeccCCCcccccHHHHhhhhHHHHHHHhhhHHHhCCCCcchHHHHHHHHHh
Confidence                    1112234455554    45667778999999998  88888888888875

>KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=9.2e-37  Score=290.88  Aligned_cols=255  Identities=31%  Similarity=0.541  Sum_probs=212.3

Q ss_pred             ecccccceeceeceeCceEEEEEEECCeeEEEEEecCCCCCHHHHHHHHHHHHHHHhc--CCCceeeEEeEEecCC----
Q 015868          113 IDAKQLKIECKVASGSYGDLYKGTYCSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKI--RHKNVVQFIGACTRPP----  186 (399)
Q Consensus       113 i~~~~~~i~~~lg~G~~g~Vy~~~~~~~~vAvK~~~~~~~~~~~~~~~~~Ei~~l~~l--~h~nIv~~~~~~~~~~----  186 (399)
                      .+...+++.+.+|+|.||.||+|+..++.||||++.     ....+.|..|-.|+...  +|+||++|+++-....    
T Consensus       207 ~~l~pl~l~eli~~Grfg~V~KaqL~~~~VAVKifp-----~~~kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~~~~  281 (534)
T KOG3653|consen  207 LELDPLQLLELIGRGRFGCVWKAQLDNRLVAVKIFP-----EQEKQSFQNEKNIYSLPGMKHENILQFIGAEKRGTADRM  281 (534)
T ss_pred             ccCCchhhHHHhhcCccceeehhhccCceeEEEecC-----HHHHHHHHhHHHHHhccCccchhHHHhhchhccCCcccc
Confidence            445678889999999999999999999999999996     44567788888877754  7999999999887666    


Q ss_pred             cEEEEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC---------CcccCCCCCCceeecCCCcEEEee
Q 015868          187 NLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQN---------NIIHRDLKTANLLMDENGVVKVAD  257 (399)
Q Consensus       187 ~~~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~---------giiHrDlkp~NILl~~~~~vkl~D  257 (399)
                      .+.||+||.+.|||.+||..  ..+++....+++..+++||+|||+.         .|+|||||..|||+.+|++.-|+|
T Consensus       282 eywLVt~fh~kGsL~dyL~~--ntisw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~DlTccIaD  359 (534)
T KOG3653|consen  282 EYWLVTEFHPKGSLCDYLKA--NTISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDLTCCIAD  359 (534)
T ss_pred             ceeEEeeeccCCcHHHHHHh--ccccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCCcEEeec
Confidence            79999999999999999976  5689999999999999999999962         699999999999999999999999


Q ss_pred             ccceeeccCC---CccccCCCCcccccccccCCCC-CC-----ChhhHHHHHHHHHHHHcCC------------CCCC--
Q 015868          258 FGVARVQAQS---GVMTAETGTYRWMAPEVIEHKP-YD-----YKADVFSFGIALWELLTGE------------LPYA--  314 (399)
Q Consensus       258 FG~a~~~~~~---~~~~~~~gt~~y~aPE~l~~~~-~~-----~~~Dv~slG~vl~elltg~------------~P~~--  314 (399)
                      ||+|......   +.....+||.+|||||++.+.- +.     .+.||||+|.+|||+++..            .||.  
T Consensus       360 FGLAl~~~p~~~~~d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~SRC~~~~~~~vp~Yqlpfe~e  439 (534)
T KOG3653|consen  360 FGLALRLEPGKPQGDTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIASRCTDADPGPVPEYQLPFEAE  439 (534)
T ss_pred             cceeEEecCCCCCcchhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHHhhcccccCCCCCcccCchhHH
Confidence            9999866532   2233468999999999997752 22     3579999999999999842            2333  


Q ss_pred             ---CCCHHHHHHHHHhccCCCCCCCCC-----cHHHHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHH
Q 015868          315 ---GLTPLQAAVGVVQKSLRPTIPKHA-----HPRLAELLERCWQHDPTQRPNFSQITDILKQMMKEV  374 (399)
Q Consensus       315 ---~~~~~~~~~~~~~~~~~~~~~~~~-----~~~l~~ll~~cl~~dP~~Rps~~ell~~L~~l~~~~  374 (399)
                         ..+-.+....++++..||.+|..+     ...+.+.+..||..||+.|.|+.=+.+++.++....
T Consensus       440 vG~hPt~e~mq~~VV~kK~RP~~p~~W~~h~~~~~l~et~EeCWDhDaeARLTA~Cv~eR~~~l~~~~  507 (534)
T KOG3653|consen  440 VGNHPTLEEMQELVVRKKQRPKIPDAWRKHAGMAVLCETIEECWDHDAEARLTAGCVEERMAELMMLW  507 (534)
T ss_pred             hcCCCCHHHHHHHHHhhccCCCChhhhhcCccHHHHHHHHHHHcCCchhhhhhhHHHHHHHHHHhccC
Confidence               123344555678888999998643     356899999999999999999999999999986544

>KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=6.1e-38  Score=323.91  Aligned_cols=253  Identities=22%  Similarity=0.347  Sum_probs=218.3

Q ss_pred             eeecccccceeceeceeCceEEEEEEE--CCeeEEEEEecCCC-CCHHHHHHHHHHHHHHHhcCCCceeeEEeEEecCCc
Q 015868          111 WEIDAKQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPEC-VNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPN  187 (399)
Q Consensus       111 ~~i~~~~~~i~~~lg~G~~g~Vy~~~~--~~~~vAvK~~~~~~-~~~~~~~~~~~Ei~~l~~l~h~nIv~~~~~~~~~~~  187 (399)
                      .....++|.|.+.||.|+||.|.+++.  +++.||+|++.... .......-|..|-.+|..-+.+-|++++-+|.++.+
T Consensus        70 lrl~~~DfeilKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~ns~Wiv~LhyAFQD~~~  149 (1317)
T KOG0612|consen   70 LRLKAEDFEILKVIGRGAFGEVALVRHKSTEKVYAMKILNKWEMLKRAETACFREERDIMVFGNSEWIVQLHYAFQDERY  149 (1317)
T ss_pred             HhCCHHhhHHHHHhcccccceeEEEEeeccccchhHHHhhHHHHhhchhHHHHHHHhHHHHcCCcHHHHHHHHHhcCccc
Confidence            345678999999999999999999987  57889999997521 122334678999999999999999999999999999


Q ss_pred             EEEEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceeecCCCcEEEeeccceeeccCC
Q 015868          188 LCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQS  267 (399)
Q Consensus       188 ~~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~giiHrDlkp~NILl~~~~~vkl~DFG~a~~~~~~  267 (399)
                      +|+|||||+||+|..++.+.. ++|+..+..++..|+-||+.||+.|+|||||||+|||+|..|+|||+|||.+-.+...
T Consensus       150 LYlVMdY~pGGDlltLlSk~~-~~pE~~ArFY~aEiVlAldslH~mgyVHRDiKPDNvLld~~GHikLADFGsClkm~~d  228 (1317)
T KOG0612|consen  150 LYLVMDYMPGGDLLTLLSKFD-RLPEDWARFYTAEIVLALDSLHSMGYVHRDIKPDNVLLDKSGHIKLADFGSCLKMDAD  228 (1317)
T ss_pred             eEEEEecccCchHHHHHhhcC-CChHHHHHHHHHHHHHHHHHHHhccceeccCCcceeEecccCcEeeccchhHHhcCCC
Confidence            999999999999999998865 8999999999999999999999999999999999999999999999999998766654


Q ss_pred             Cc--cccCCCCcccccccccC----C-CCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhccCCCCCC--CCC
Q 015868          268 GV--MTAETGTYRWMAPEVIE----H-KPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKSLRPTIP--KHA  338 (399)
Q Consensus       268 ~~--~~~~~gt~~y~aPE~l~----~-~~~~~~~Dv~slG~vl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~--~~~  338 (399)
                      +.  ....+|||.|.+||++.    + +.|...+|.||+||++|||+.|.-||...+-.+....+........+|  ..+
T Consensus       229 G~V~s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFYadslveTY~KIm~hk~~l~FP~~~~V  308 (1317)
T KOG0612|consen  229 GTVRSSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFYADSLVETYGKIMNHKESLSFPDETDV  308 (1317)
T ss_pred             CcEEeccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcchHHHHHHHHHHHhchhhhcCCCccccc
Confidence            43  34568999999999995    3 468899999999999999999999998887777777776655455555  569


Q ss_pred             cHHHHHHHHHHhhhcCCCCCC---HHHHHH
Q 015868          339 HPRLAELLERCWQHDPTQRPN---FSQITD  365 (399)
Q Consensus       339 ~~~l~~ll~~cl~~dP~~Rps---~~ell~  365 (399)
                      |.+..+||++.+. +|+.|..   ++++..
T Consensus       309 SeeakdLI~~ll~-~~e~RLgrngiedik~  337 (1317)
T KOG0612|consen  309 SEEAKDLIEALLC-DREVRLGRNGIEDIKN  337 (1317)
T ss_pred             CHHHHHHHHHHhc-ChhhhcccccHHHHHh
Confidence            9999999999887 6888987   777754

>KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis]

Probab=100.00  E-value=3.9e-37  Score=320.18  Aligned_cols=243  Identities=27%  Similarity=0.495  Sum_probs=194.6

Q ss_pred             cccceeceeceeCceEEEEEEE--CCeeEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCceeeEEeEEec---------
Q 015868          116 KQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTR---------  184 (399)
Q Consensus       116 ~~~~i~~~lg~G~~g~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~nIv~~~~~~~~---------  184 (399)
                      ++|+..+.||+|+||.||+++.  .|+.||||.+.... .......+.+|+..+.+++|||||+++.+|.+         
T Consensus       479 ~DFEEL~lLGkGGFG~VvkVRNKlDGr~YAIKKIpl~~-s~~~~skI~rEVk~LArLnHpNVVRYysAWVEs~~~~~~~e  557 (1351)
T KOG1035|consen  479 NDFEELELLGKGGFGSVVKVRNKLDGREYAIKKIPLKA-SDKLYSKILREVKLLARLNHPNVVRYYSAWVESTAELTVLE  557 (1351)
T ss_pred             hhhHHHHHhcCCCCceEEEEeecccchhhhhhhccCch-HHHHHHHHHHHHHHHhhcCCcceeeeehhhhccCCcccccc
Confidence            5678889999999999999976  79999999998765 56667889999999999999999999975310         


Q ss_pred             ---------------------------------------------------------------------C----------
Q 015868          185 ---------------------------------------------------------------------P----------  185 (399)
Q Consensus       185 ---------------------------------------------------------------------~----------  185 (399)
                                                                                           +          
T Consensus       558 i~~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S~tS~~e  637 (1351)
T KOG1035|consen  558 IVASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLSNTSDSE  637 (1351)
T ss_pred             ccccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCcccccccccccccccccccC
Confidence                                                                                 0          


Q ss_pred             -------------------------------CcEEEEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC
Q 015868          186 -------------------------------PNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNN  234 (399)
Q Consensus       186 -------------------------------~~~~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~g  234 (399)
                                                     ..+||-||||+.-++.++++.+...-.....|+++.+|+.||+|+|++|
T Consensus       638 ~~~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~~~~~~d~~wrLFreIlEGLaYIH~~g  717 (1351)
T KOG1035|consen  638 GSVILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNHFNSQRDEAWRLFREILEGLAYIHDQG  717 (1351)
T ss_pred             CccccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhcccchhhHHHHHHHHHHHHHHHHHHhCc
Confidence                                           1268999999997778877664322257889999999999999999999


Q ss_pred             cccCCCCCCceeecCCCcEEEeeccceeecc-------------------CCCccccCCCCcccccccccCCC---CCCC
Q 015868          235 IIHRDLKTANLLMDENGVVKVADFGVARVQA-------------------QSGVMTAETGTYRWMAPEVIEHK---PYDY  292 (399)
Q Consensus       235 iiHrDlkp~NILl~~~~~vkl~DFG~a~~~~-------------------~~~~~~~~~gt~~y~aPE~l~~~---~~~~  292 (399)
                      ||||||||.||++++++.|||+|||+|+...                   ..+..|...||.-|+|||++.+.   +|+.
T Consensus       718 iIHRDLKP~NIFLd~~~~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEll~~~~~~~Yn~  797 (1351)
T KOG1035|consen  718 IIHRDLKPRNIFLDSRNSVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPELLSDTSSNKYNS  797 (1351)
T ss_pred             eeeccCCcceeEEcCCCCeeecccccchhhhhhhhhHhhccCccccccCCCCcccccccceeeeecHHHhcccccccccc
Confidence            9999999999999999999999999998511                   11245667899999999999765   4999


Q ss_pred             hhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhccCCCCCCCC------CcHHHHHHHHHHhhhcCCCCCCHHHHHH
Q 015868          293 KADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKSLRPTIPKH------AHPRLAELLERCWQHDPTQRPNFSQITD  365 (399)
Q Consensus       293 ~~Dv~slG~vl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~------~~~~l~~ll~~cl~~dP~~Rps~~ell~  365 (399)
                      |+|+||||++++||+.   ||...-..-.....++   .+.+|..      -.+.-..+|+.|++.||.+|||+.|+++
T Consensus       798 KiDmYSLGIVlFEM~y---PF~TsMERa~iL~~LR---~g~iP~~~~f~~~~~~~e~slI~~Ll~hdP~kRPtA~eLL~  870 (1351)
T KOG1035|consen  798 KIDMYSLGIVLFEMLY---PFGTSMERASILTNLR---KGSIPEPADFFDPEHPEEASLIRWLLSHDPSKRPTATELLN  870 (1351)
T ss_pred             hhhhHHHHHHHHHHhc---cCCchHHHHHHHHhcc---cCCCCCCcccccccchHHHHHHHHHhcCCCccCCCHHHHhh
Confidence            9999999999999984   4644322222222233   3334433      3456789999999999999999999975

>KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.9e-37  Score=289.51  Aligned_cols=244  Identities=24%  Similarity=0.428  Sum_probs=212.2

Q ss_pred             eecccccceeceeceeCceEEEEEEECC--eeEEEEEecCCCC-CHHHHHHHHHHHHHHHhc-CCCceeeEEeEEecCCc
Q 015868          112 EIDAKQLKIECKVASGSYGDLYKGTYCS--QEVAIKVLKPECV-NTEMLKEFSQEVYIMRKI-RHKNVVQFIGACTRPPN  187 (399)
Q Consensus       112 ~i~~~~~~i~~~lg~G~~g~Vy~~~~~~--~~vAvK~~~~~~~-~~~~~~~~~~Ei~~l~~l-~h~nIv~~~~~~~~~~~  187 (399)
                      .|...+|.++..||.|+||.|-+|...+  +.+|||+++.+.. ..+..+--+.|-++|... +-|.+++++..|..-+.
T Consensus       345 ~i~~tDFnFl~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHScFQTmDR  424 (683)
T KOG0696|consen  345 RIKATDFNFLMVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSCFQTMDR  424 (683)
T ss_pred             ceeecccceEEEeccCccceeeeecccCcchhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHHhhhhhh
Confidence            6778899999999999999999998754  6699999997653 223333344566666655 46889999999999999


Q ss_pred             EEEEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceeecCCCcEEEeeccceeeccCC
Q 015868          188 LCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQS  267 (399)
Q Consensus       188 ~~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~giiHrDlkp~NILl~~~~~vkl~DFG~a~~~~~~  267 (399)
                      +|+||||+.||+|--.|+. -+.+.++.+..++..|+-||-+||++|||.||||.+|||++.+|+|||+|||.++.....
T Consensus       425 LyFVMEyvnGGDLMyhiQQ-~GkFKEp~AvFYAaEiaigLFFLh~kgIiYRDLKLDNvmLd~eGHiKi~DFGmcKEni~~  503 (683)
T KOG0696|consen  425 LYFVMEYVNGGDLMYHIQQ-VGKFKEPVAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIFD  503 (683)
T ss_pred             eeeEEEEecCchhhhHHHH-hcccCCchhhhhhHHHHHHhhhhhcCCeeeeeccccceEeccCCceEeeecccccccccC
Confidence            9999999999999887755 578999999999999999999999999999999999999999999999999999854444


Q ss_pred             C-ccccCCCCcccccccccCCCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhccCCCCCCCCCcHHHHHHH
Q 015868          268 G-VMTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRLAELL  346 (399)
Q Consensus       268 ~-~~~~~~gt~~y~aPE~l~~~~~~~~~Dv~slG~vl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll  346 (399)
                      + ...+.+||+.|+|||++.-.+|....|.||+|++||||+.|++||++.+..+.+..+....  -..|+.+|.+..++.
T Consensus       504 ~~TTkTFCGTPdYiAPEIi~YqPYgksvDWWa~GVLLyEmlaGQpPFdGeDE~elF~aI~ehn--vsyPKslSkEAv~ic  581 (683)
T KOG0696|consen  504 GVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQAIMEHN--VSYPKSLSKEAVAIC  581 (683)
T ss_pred             CcceeeecCCCcccccceEEecccccchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHcc--CcCcccccHHHHHHH
Confidence            3 3445789999999999999999999999999999999999999999999998887776543  457899999999999


Q ss_pred             HHHhhhcCCCCC
Q 015868          347 ERCWQHDPTQRP  358 (399)
Q Consensus       347 ~~cl~~dP~~Rp  358 (399)
                      ...|.+.|.+|.
T Consensus       582 kg~ltK~P~kRL  593 (683)
T KOG0696|consen  582 KGLLTKHPGKRL  593 (683)
T ss_pred             HHHhhcCCcccc
Confidence            999999999994

>KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms]

Probab=100.00  E-value=4.8e-37  Score=259.72  Aligned_cols=248  Identities=23%  Similarity=0.396  Sum_probs=212.2

Q ss_pred             ccceeceeceeCceEEEEEEE--CCeeEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCceeeEEeEEecCCcEEEEEec
Q 015868          117 QLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVTEF  194 (399)
Q Consensus       117 ~~~i~~~lg~G~~g~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~nIv~~~~~~~~~~~~~lV~E~  194 (399)
                      +|.-.++||+|.||+||+|+.  +.+.||+|.++.+..++.......+|+-+++.++|.||++++++....+.+.+|+||
T Consensus         3 ~ydkmekigegtygtvfkarn~~t~eivalkrvrlddddegvpssalreicllkelkhknivrl~dvlhsdkkltlvfe~   82 (292)
T KOG0662|consen    3 KYDKMEKIGEGTYGTVFKARNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEF   82 (292)
T ss_pred             chHHHHhhcCCcceeeEecccCCccceEEEEEEeccCCCCCCcHHHHHHHHHHHHhhhcceeehhhhhccCceeEEeHHH
Confidence            466678999999999999975  678899999987766666667788999999999999999999999999999999999


Q ss_pred             CCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceeecCCCcEEEeeccceeeccCCC-ccccC
Q 015868          195 MARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSG-VMTAE  273 (399)
Q Consensus       195 ~~ggsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~giiHrDlkp~NILl~~~~~vkl~DFG~a~~~~~~~-~~~~~  273 (399)
                      |.. +|..+....++.++.+.+..++.|+++|+.+.|++++.|||+||.|+|++.+|.+|++|||+++..+-+. ...++
T Consensus        83 cdq-dlkkyfdslng~~d~~~~rsfmlqllrgl~fchshnvlhrdlkpqnllin~ngelkladfglarafgipvrcysae  161 (292)
T KOG0662|consen   83 CDQ-DLKKYFDSLNGDLDPEIVRSFMLQLLRGLGFCHSHNVLHRDLKPQNLLINRNGELKLADFGLARAFGIPVRCYSAE  161 (292)
T ss_pred             hhH-HHHHHHHhcCCcCCHHHHHHHHHHHHhhhhhhhhhhhhhccCCcceEEeccCCcEEecccchhhhcCCceEeeece
Confidence            965 9999998888999999999999999999999999999999999999999999999999999999766554 56788


Q ss_pred             CCCcccccccccCCC-CCCChhhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHHhccC------C------------CC
Q 015868          274 TGTYRWMAPEVIEHK-PYDYKADVFSFGIALWELLT-GELPYAGLTPLQAAVGVVQKSL------R------------PT  333 (399)
Q Consensus       274 ~gt~~y~aPE~l~~~-~~~~~~Dv~slG~vl~ellt-g~~P~~~~~~~~~~~~~~~~~~------~------------~~  333 (399)
                      ..|..|.+|.++.+. -|+...|+||.||++.|+.. |.+.|.+.+-......+....-      .            |.
T Consensus       162 vvtlwyrppdvlfgakly~tsidmwsagcifaelanagrplfpg~dvddqlkrif~~lg~p~ed~wps~t~lpdyk~yp~  241 (292)
T KOG0662|consen  162 VVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEDQWPSMTKLPDYKPYPI  241 (292)
T ss_pred             eeeeeccCcceeeeeehhccchHhhhcchHHHHHhhcCCCCCCCCcHHHHHHHHHHHhCCCccccCCccccCCCCcccCC
Confidence            899999999999875 58999999999999999998 7888888776665555432110      0            11


Q ss_pred             CC---------CCCcHHHHHHHHHHhhhcCCCCCCHHHHHH
Q 015868          334 IP---------KHAHPRLAELLERCWQHDPTQRPNFSQITD  365 (399)
Q Consensus       334 ~~---------~~~~~~l~~ll~~cl~~dP~~Rps~~ell~  365 (399)
                      .|         +.++..-+++++++|..+|.+|.++++.++
T Consensus       242 ypattswsqivp~lns~grdllqkll~cnp~qrisaeaalq  282 (292)
T KOG0662|consen  242 YPATTSWSQIVPKLNSTGRDLLQKLLKCNPAQRISAEAALQ  282 (292)
T ss_pred             ccccchHHHHhhhhcchhHHHHHHHhccCcccccCHHHHhc
Confidence            11         223445689999999999999999988764

>KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.8e-37  Score=294.06  Aligned_cols=249  Identities=22%  Similarity=0.350  Sum_probs=213.1

Q ss_pred             eecccccceeceeceeCceEEEEEEE--CCeeEEEEEecCCCCCHH-HHHHHHHHHHHHHhcCCCceeeEEeEEecCCcE
Q 015868          112 EIDAKQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVNTE-MLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNL  188 (399)
Q Consensus       112 ~i~~~~~~i~~~lg~G~~g~Vy~~~~--~~~~vAvK~~~~~~~~~~-~~~~~~~Ei~~l~~l~h~nIv~~~~~~~~~~~~  188 (399)
                      .+..+.|+.-+.||.|+||.||.++.  +|+-+|+|.+........ ......+|-.||.+++.+.||.+--+|++++.+
T Consensus       181 pvt~n~F~~~RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~s~FiVslaYAfeTkd~L  260 (591)
T KOG0986|consen  181 PVTKNTFRVYRVLGKGGFGEVCACQVRATGKMYACKKLDKKRIKKRKGETMALNEKQILEKVSSPFIVSLAYAFETKDAL  260 (591)
T ss_pred             hccccceeeeEEEecccccceeEEEEecchhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhccCcEEEEeeeecCCCce
Confidence            45567888899999999999998754  789999998864433222 234578899999999999999999999999999


Q ss_pred             EEEEecCCCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceeecCCCcEEEeeccceeeccCC
Q 015868          189 CIVTEFMARGSIYDFLHKQK-GVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQS  267 (399)
Q Consensus       189 ~lV~E~~~ggsL~~~l~~~~-~~l~~~~~~~i~~~i~~~L~~LH~~giiHrDlkp~NILl~~~~~vkl~DFG~a~~~~~~  267 (399)
                      |+|+..|.||+|.-.|.+.. ..|+++.+..++.+|+.||.+||+.+|+.||+||+|||+|+.|+|.|+|+|+|......
T Consensus       261 ClVLtlMNGGDLkfHiyn~g~~gF~e~ra~FYAAEi~cGLehlH~~~iVYRDLKPeNILLDd~GhvRISDLGLAvei~~g  340 (591)
T KOG0986|consen  261 CLVLTLMNGGDLKFHIYNHGNPGFDEQRARFYAAEIICGLEHLHRRRIVYRDLKPENILLDDHGHVRISDLGLAVEIPEG  340 (591)
T ss_pred             EEEEEeecCCceeEEeeccCCCCCchHHHHHHHHHHHhhHHHHHhcceeeccCChhheeeccCCCeEeeccceEEecCCC
Confidence            99999999999988886643 57999999999999999999999999999999999999999999999999999988887


Q ss_pred             CccccCCCCcccccccccCCCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHH---HHHHHHHhccCCCCCCCCCcHHHHH
Q 015868          268 GVMTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPYAGLTPL---QAAVGVVQKSLRPTIPKHAHPRLAE  344 (399)
Q Consensus       268 ~~~~~~~gt~~y~aPE~l~~~~~~~~~Dv~slG~vl~elltg~~P~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~l~~  344 (399)
                      .......||.+|||||++++..|+...|.|+|||++|||+.|+-||......   +..... .....-.++...|++.++
T Consensus       341 ~~~~~rvGT~GYMAPEvl~ne~Y~~s~Dwf~lGCllYemi~G~sPFr~~KeKvk~eEvdrr-~~~~~~ey~~kFS~eaks  419 (591)
T KOG0986|consen  341 KPIRGRVGTVGYMAPEVLQNEVYDFSPDWFSLGCLLYEMIAGHSPFRQRKEKVKREEVDRR-TLEDPEEYSDKFSEEAKS  419 (591)
T ss_pred             CccccccCcccccCHHHHcCCcccCCccHHHHHhHHHHHHcccCchhhhhhhhhHHHHHHH-HhcchhhcccccCHHHHH
Confidence            7777779999999999999999999999999999999999999999764332   122221 122344567889999999


Q ss_pred             HHHHHhhhcCCCCCCHH
Q 015868          345 LLERCWQHDPTQRPNFS  361 (399)
Q Consensus       345 ll~~cl~~dP~~Rps~~  361 (399)
                      +.+.+|+.||.+|....
T Consensus       420 lc~~LL~Kdp~~RLGcr  436 (591)
T KOG0986|consen  420 LCEGLLTKDPEKRLGCR  436 (591)
T ss_pred             HHHHHHccCHHHhccCC
Confidence            99999999999997554

>KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=3.8e-37  Score=280.67  Aligned_cols=246  Identities=24%  Similarity=0.417  Sum_probs=203.0

Q ss_pred             ccccee-ceeceeCceEEEEEE--ECCeeEEEEEecCCCCCHHHHHHHHHHHHHHHhcC-CCceeeEEeEEecCCcEEEE
Q 015868          116 KQLKIE-CKVASGSYGDLYKGT--YCSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIR-HKNVVQFIGACTRPPNLCIV  191 (399)
Q Consensus       116 ~~~~i~-~~lg~G~~g~Vy~~~--~~~~~vAvK~~~~~~~~~~~~~~~~~Ei~~l~~l~-h~nIv~~~~~~~~~~~~~lV  191 (399)
                      +-|++. +.||+|+|+.|--+.  .++..+|||++.+.  ......++.+|++++.+++ |+||++++++|+++..+|+|
T Consensus        77 d~YkLt~e~LGeGAyasVqtcv~i~t~~EYAVKiidKq--~gHsR~RvfREVe~f~~Cqgh~nilqLiefFEdd~~FYLV  154 (463)
T KOG0607|consen   77 DMYKLTSELLGEGAYASVQTCVSIQTGKEYAVKIIDKQ--PGHSRSRVFREVETFYQCQGHKNILQLIEFFEDDTRFYLV  154 (463)
T ss_pred             HHHHhHHHHhcCccceeeeeeeeeccchhhhhhhhhcC--CchHHHHHHHHHHHHHHhcCCccHHHHHHHhcccceEEEE
Confidence            456664 568999999997654  58999999999876  4455678999999999995 99999999999999999999


Q ss_pred             EecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceeecCCC---cEEEeeccceeeccCCC
Q 015868          192 TEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENG---VVKVADFGVARVQAQSG  268 (399)
Q Consensus       192 ~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~giiHrDlkp~NILl~~~~---~vkl~DFG~a~~~~~~~  268 (399)
                      ||.|.||+|...|.+ ...|++.++.++..+|+.||++||.+||.|||+||+|||....+   .||||||.+........
T Consensus       155 fEKm~GGplLshI~~-~~~F~E~EAs~vvkdia~aLdFlH~kgIAHRDlKPENiLC~~pn~vsPvKiCDfDLgSg~k~~~  233 (463)
T KOG0607|consen  155 FEKMRGGPLLSHIQK-RKHFNEREASRVVKDIASALDFLHTKGIAHRDLKPENILCESPNKVSPVKICDFDLGSGIKLNN  233 (463)
T ss_pred             EecccCchHHHHHHH-hhhccHHHHHHHHHHHHHHHHHHhhcCcccccCCccceeecCCCCcCceeeeccccccccccCC
Confidence            999999999999987 46799999999999999999999999999999999999997655   58999999876433221


Q ss_pred             --------ccccCCCCcccccccccC-----CCCCCChhhHHHHHHHHHHHHcCCCCCCCCC--------------HHHH
Q 015868          269 --------VMTAETGTYRWMAPEVIE-----HKPYDYKADVFSFGIALWELLTGELPYAGLT--------------PLQA  321 (399)
Q Consensus       269 --------~~~~~~gt~~y~aPE~l~-----~~~~~~~~Dv~slG~vl~elltg~~P~~~~~--------------~~~~  321 (399)
                              ...+.+|+..|||||+..     .-.|+.++|.||||+++|-|+.|.+||.+.=              -.+.
T Consensus       234 ~~spastP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG~Cg~dCGWdrGe~Cr~CQ~~  313 (463)
T KOG0607|consen  234 DCSPASTPELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNK  313 (463)
T ss_pred             CCCCCCCccccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCCccCccCCcCCccCCCccHHHHHH
Confidence                    234457888999999874     2358999999999999999999999996531              2333


Q ss_pred             HHHHHhccCCCCCC----CCCcHHHHHHHHHHhhhcCCCCCCHHHHHH
Q 015868          322 AVGVVQKSLRPTIP----KHAHPRLAELLERCWQHDPTQRPNFSQITD  365 (399)
Q Consensus       322 ~~~~~~~~~~~~~~----~~~~~~l~~ll~~cl~~dP~~Rps~~ell~  365 (399)
                      +...++.+.- ++|    ..+|.+..+++..+|..++.+|.++.++++
T Consensus       314 LFesIQEGkY-eFPdkdWahIS~eakdlisnLlvrda~~rlsa~~vln  360 (463)
T KOG0607|consen  314 LFESIQEGKY-EFPDKDWAHISSEAKDLISNLLVRDAKQRLSAAQVLN  360 (463)
T ss_pred             HHHHHhccCC-cCChhhhHHhhHHHHHHHHHHHhccHHhhhhhhhccC
Confidence            3334454432 233    347899999999999999999999999876

>cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins

Probab=100.00  E-value=3.6e-36  Score=277.66  Aligned_cols=218  Identities=22%  Similarity=0.267  Sum_probs=183.0

Q ss_pred             eCceEEEEEEE--CCeeEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCceeeEEeEEecCCcEEEEEecCCCCCHHHHH
Q 015868          127 GSYGDLYKGTY--CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFL  204 (399)
Q Consensus       127 G~~g~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~nIv~~~~~~~~~~~~~lV~E~~~ggsL~~~l  204 (399)
                      |.+|.||++.+  +++.||+|.++...       .+.+|...+....||||+++++++......++||||++|++|.+++
T Consensus         4 g~~~~v~~~~~~~~~~~~~~K~i~~~~-------~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l   76 (237)
T cd05576           4 GVIDKVLLVMDTRTQQTFILKGLRKSS-------EYSRERLTIIPHCVPNMVCLHKYIVSEDSVFLVLQHAEGGKLWSHI   76 (237)
T ss_pred             cccceEEEEEEccCCcEEEEEeecchh-------hhhhHHHHHHhcCCCceeehhhheecCCeEEEEEecCCCCCHHHHH
Confidence            89999999987  67889999997542       2334555556667999999999999999999999999999999999


Q ss_pred             HhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceeecCCCcEEEeeccceeeccCCCccccCCCCcccccccc
Q 015868          205 HKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAETGTYRWMAPEV  284 (399)
Q Consensus       205 ~~~~~~l~~~~~~~i~~~i~~~L~~LH~~giiHrDlkp~NILl~~~~~vkl~DFG~a~~~~~~~~~~~~~gt~~y~aPE~  284 (399)
                      ... ..+++..+..++.|++.||+|||++||+||||||+||+++.++.++++|||.+......  .....++..|+|||.
T Consensus        77 ~~~-~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~l~df~~~~~~~~~--~~~~~~~~~y~aPE~  153 (237)
T cd05576          77 SKF-LNIPEECVKRWAAEMVVALDALHREGIVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDS--CDGEAVENMYCAPEV  153 (237)
T ss_pred             HHh-cCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEEcCCCCEEEecccchhccccc--cccCCcCccccCCcc
Confidence            764 46899999999999999999999999999999999999999999999999987654332  233456778999999


Q ss_pred             cCCCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhccCCCCCCCCCcHHHHHHHHHHhhhcCCCCCCH
Q 015868          285 IEHKPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRLAELLERCWQHDPTQRPNF  360 (399)
Q Consensus       285 l~~~~~~~~~Dv~slG~vl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~cl~~dP~~Rps~  360 (399)
                      +.+..++.++|+||+|+++|+|++|..|+......      ........+|..+++.+.+++.+||+.||.+||++
T Consensus       154 ~~~~~~~~~~DvwslG~il~el~~g~~~~~~~~~~------~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~~~  223 (237)
T cd05576         154 GGISEETEACDWWSLGAILFELLTGKTLVECHPSG------INTHTTLNIPEWVSEEARSLLQQLLQFNPTERLGA  223 (237)
T ss_pred             cCCCCCCchhhHHHHHHHHHHHHHCcchhhcCchh------cccccccCCcccCCHHHHHHHHHHccCCHHHhcCC
Confidence            98888999999999999999999999887543211      11122334667789999999999999999999996

Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha

>KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms]

Probab=100.00  E-value=7e-37  Score=301.94  Aligned_cols=238  Identities=22%  Similarity=0.376  Sum_probs=201.4

Q ss_pred             ccccceeceeceeCceEEEEEEE--CCeeEEEEEecCCCCCHHHHHHHHHHHHHHHhc-CCCceeeEEeEEecCCcEEEE
Q 015868          115 AKQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKI-RHKNVVQFIGACTRPPNLCIV  191 (399)
Q Consensus       115 ~~~~~i~~~lg~G~~g~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~Ei~~l~~l-~h~nIv~~~~~~~~~~~~~lV  191 (399)
                      ...|.+...+|.|+|+.|..+..  +++..++|++....      ....+|+.++... +||||+++.+.+.++.+.|+|
T Consensus       321 ~~~y~~~~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~~------~~~~~e~~~~~~~~~h~niv~~~~v~~~~~~~~~v  394 (612)
T KOG0603|consen  321 TESYEFREELGEGSFSAVKYCESSPTDQEPAVKIISKRA------DDNQDEIPISLLVRDHPNIVKSHDVYEDGKEIYLV  394 (612)
T ss_pred             chhhccccccCCCCccceeeeeccccccchhheeccccc------cccccccchhhhhcCCCcceeecceecCCceeeee
Confidence            56888999999999999999876  67889999997652      2233466555444 799999999999999999999


Q ss_pred             EecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceee-cCCCcEEEeeccceeeccCCCcc
Q 015868          192 TEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLM-DENGVVKVADFGVARVQAQSGVM  270 (399)
Q Consensus       192 ~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~giiHrDlkp~NILl-~~~~~vkl~DFG~a~~~~~~~~~  270 (399)
                      ||.+.|+-+.+.+.... .+. .++..|+.+|+.++.|||.+|++|||+||+|||+ ++.|+++|+|||.++.....  .
T Consensus       395 ~e~l~g~ell~ri~~~~-~~~-~e~~~w~~~lv~Av~~LH~~gvvhRDLkp~NIL~~~~~g~lrltyFG~a~~~~~~--~  470 (612)
T KOG0603|consen  395 MELLDGGELLRRIRSKP-EFC-SEASQWAAELVSAVDYLHEQGVVHRDLKPGNILLDGSAGHLRLTYFGFWSELERS--C  470 (612)
T ss_pred             ehhccccHHHHHHHhcc-hhH-HHHHHHHHHHHHHHHHHHhcCeeecCCChhheeecCCCCcEEEEEechhhhCchh--h
Confidence            99999999888886633 223 7888899999999999999999999999999999 69999999999999866544  4


Q ss_pred             ccCCCCcccccccccCCCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhccCCCCCCCCCcHHHHHHHHHHh
Q 015868          271 TAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRLAELLERCW  350 (399)
Q Consensus       271 ~~~~gt~~y~aPE~l~~~~~~~~~Dv~slG~vl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~cl  350 (399)
                      ...+-|..|.|||++....|++++|+||||++||+|++|+.||........+..   ....+.....+|.+.++|+++||
T Consensus       471 ~tp~~t~~y~APEvl~~~~yt~acD~WSLGvlLy~ML~G~tp~~~~P~~~ei~~---~i~~~~~s~~vS~~AKdLl~~LL  547 (612)
T KOG0603|consen  471 DTPALTLQYVAPEVLAIQEYTEACDWWSLGVLLYEMLTGRTLFAAHPAGIEIHT---RIQMPKFSECVSDEAKDLLQQLL  547 (612)
T ss_pred             cccchhhcccChhhhccCCCCcchhhHHHHHHHHHHHhCCCccccCCchHHHHH---hhcCCccccccCHHHHHHHHHhc
Confidence            455678899999999999999999999999999999999999977655533333   33345566889999999999999


Q ss_pred             hhcCCCCCCHHHHHH
Q 015868          351 QHDPTQRPNFSQITD  365 (399)
Q Consensus       351 ~~dP~~Rps~~ell~  365 (399)
                      +.||.+||++.++..
T Consensus       548 ~~dP~~Rl~~~~i~~  562 (612)
T KOG0603|consen  548 QVDPALRLGADEIGA  562 (612)
T ss_pred             cCChhhCcChhhhcc
Confidence            999999999999864

>smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain

Probab=100.00  E-value=1.6e-35  Score=271.04  Aligned_cols=236  Identities=34%  Similarity=0.563  Sum_probs=202.7

Q ss_pred             CceEEEEEEEC--CeeEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCceeeEEeEEecCCcEEEEEecCCCCCHHHHHH
Q 015868          128 SYGDLYKGTYC--SQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLH  205 (399)
Q Consensus       128 ~~g~Vy~~~~~--~~~vAvK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~nIv~~~~~~~~~~~~~lV~E~~~ggsL~~~l~  205 (399)
                      +||.||+|...  ++.+|+|++........ .+.+.+|+..+++++|+||+++++.+......++++|++++++|.+++.
T Consensus         1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~-~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~~~   79 (244)
T smart00220        1 SFGKVYLARDKKTGKLVAIKVIKKEKIKKK-RERILREISILKKLKHPNIVRLYDVFEDEDKLYLVMEYCDGGDLFDLLK   79 (244)
T ss_pred             CceEEEEEEECCCCcEEEEEEecccccccH-HHHHHHHHHHHHhCCCCcHHHHHhheeeCCEEEEEEeCCCCCCHHHHHH
Confidence            58999999884  58999999986543322 5789999999999999999999999999889999999999999999997


Q ss_pred             hcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceeecCCCcEEEeeccceeeccCCCccccCCCCccccccccc
Q 015868          206 KQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAETGTYRWMAPEVI  285 (399)
Q Consensus       206 ~~~~~l~~~~~~~i~~~i~~~L~~LH~~giiHrDlkp~NILl~~~~~vkl~DFG~a~~~~~~~~~~~~~gt~~y~aPE~l  285 (399)
                      ... .++...++.++.+++.++.|||+.+++|+||+|.||++++++.++|+|||.+.............++..|++||.+
T Consensus        80 ~~~-~~~~~~~~~~~~~l~~~l~~lh~~~i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~pE~~  158 (244)
T smart00220       80 KRG-RLSEDEARFYARQILSALEYLHSNGIIHRDLKPENILLDEDGHVKLADFGLARQLDPGGLLTTFVGTPEYMAPEVL  158 (244)
T ss_pred             hcc-CCCHHHHHHHHHHHHHHHHHHHHcCeecCCcCHHHeEECCCCcEEEccccceeeeccccccccccCCcCCCCHHHH
Confidence            643 3899999999999999999999999999999999999999999999999999877665455566788999999999


Q ss_pred             CCCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhccCCCCCCCC--CcHHHHHHHHHHhhhcCCCCCCHHHH
Q 015868          286 EHKPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKSLRPTIPKH--AHPRLAELLERCWQHDPTQRPNFSQI  363 (399)
Q Consensus       286 ~~~~~~~~~Dv~slG~vl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~l~~ll~~cl~~dP~~Rps~~el  363 (399)
                      .+..++.++|+|+||+++|++++|..||..................+..+..  ++.++.+++.+||..+|.+||++.++
T Consensus       159 ~~~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~  238 (244)
T smart00220      159 LGKGYGKAVDVWSLGVILYELLTGKPPFPGDDQLLELFKKIGKPKPPFPPPEWKISPEAKDLIRKLLVKDPEKRLTAEEA  238 (244)
T ss_pred             ccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhccCCCCccccccCCHHHHHHHHHHccCCchhccCHHHH
Confidence            9888999999999999999999999999874444444444444433333222  88899999999999999999999999


Q ss_pred             HH
Q 015868          364 TD  365 (399)
Q Consensus       364 l~  365 (399)
                      ++
T Consensus       239 ~~  240 (244)
T smart00220      239 LQ  240 (244)
T ss_pred             hh
Confidence            86

Phosphotransferases. Serine or threonine-specific kinase subfamily.

>KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=4.4e-36  Score=303.82  Aligned_cols=246  Identities=31%  Similarity=0.569  Sum_probs=209.8

Q ss_pred             cccceeceeceeCceEEEEEEE--CCeeEEEEEecCCCCCHHHHHHHHHHHHHHHhc-CCCceeeEEeEEec-----CCc
Q 015868          116 KQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKI-RHKNVVQFIGACTR-----PPN  187 (399)
Q Consensus       116 ~~~~i~~~lg~G~~g~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~Ei~~l~~l-~h~nIv~~~~~~~~-----~~~  187 (399)
                      ..++|...||.|.+|.||+++.  .++.+|+||+.+..   +..++...|..+++.. .|||++.++|+|..     ++.
T Consensus        19 d~~ei~evig~Gtygkv~k~k~~~~~~~aa~kI~~~~~---d~deEiE~eynil~~~~~hpnv~~fyg~~~k~~~~~~Dq   95 (953)
T KOG0587|consen   19 DIFEIIEVIGNGTYGKVYKGRHVKTGQLAAIKIMDPTE---DEEEEIELEYNMLKKYSHHPNVATFYGAFIKKDPGNGDQ   95 (953)
T ss_pred             CccEEEEEEeeccceeEEEEeeeecCceeeeEeecCCc---cccHHHHHHHHHHHhccCCCCcceEEEEEEEecCCCCCe
Confidence            3456688999999999998864  78999999998753   3345667788899887 59999999999853     456


Q ss_pred             EEEEEecCCCCCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceeecCCCcEEEeeccceeeccC
Q 015868          188 LCIVTEFMARGSIYDFLHKQ-KGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQ  266 (399)
Q Consensus       188 ~~lV~E~~~ggsL~~~l~~~-~~~l~~~~~~~i~~~i~~~L~~LH~~giiHrDlkp~NILl~~~~~vkl~DFG~a~~~~~  266 (399)
                      +++|||||.|||+-|++++. ...+.+..+..|+..++.|+.+||++.+||||||-.|||++.++.||++|||++.....
T Consensus        96 LWLVMEfC~gGSVTDLVKn~~g~rl~E~~IaYI~re~lrgl~HLH~nkviHRDikG~NiLLT~e~~VKLvDFGvSaQlds  175 (953)
T KOG0587|consen   96 LWLVMEFCGGGSVTDLVKNTKGNRLKEEWIAYILREILRGLAHLHNNKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDS  175 (953)
T ss_pred             EEEEeeccCCccHHHHHhhhcccchhhHHHHHHHHHHHHHHHHHhhcceeeecccCceEEEeccCcEEEeeeeeeeeeec
Confidence            99999999999999999764 56789999999999999999999999999999999999999999999999999876554


Q ss_pred             C-CccccCCCCcccccccccCCC-----CCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhccCCCCC--CCCC
Q 015868          267 S-GVMTAETGTYRWMAPEVIEHK-----PYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKSLRPTI--PKHA  338 (399)
Q Consensus       267 ~-~~~~~~~gt~~y~aPE~l~~~-----~~~~~~Dv~slG~vl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~--~~~~  338 (399)
                      . +...+.+||+.|||||++...     .|+.++|+||||++..||..|.+|+..+.|..++..+.... +|.+  |+.+
T Consensus       176 T~grRnT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIEladG~PPl~DmHPmraLF~IpRNP-PPkLkrp~kW  254 (953)
T KOG0587|consen  176 TVGRRNTFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNP-PPKLKRPKKW  254 (953)
T ss_pred             ccccccCcCCCcccccceeeecccCCCCCcccccchhhccceeehhcCCCCCccCcchhhhhccCCCCC-CccccchhhH
Confidence            3 345667899999999999643     47889999999999999999999999999988766544432 2222  5678


Q ss_pred             cHHHHHHHHHHhhhcCCCCCCHHHHHH
Q 015868          339 HPRLAELLERCWQHDPTQRPNFSQITD  365 (399)
Q Consensus       339 ~~~l~~ll~~cl~~dP~~Rps~~ell~  365 (399)
                      +.++.++|..||.+|.++||+..++++
T Consensus       255 s~~FndFIs~cL~Kd~e~RP~~~~ll~  281 (953)
T KOG0587|consen  255 SKKFNDFISTCLVKDYEQRPSTEELLK  281 (953)
T ss_pred             HHHHHHHHHHHHhhccccCcchhhhcc
Confidence            999999999999999999999999864

>PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional

Probab=100.00  E-value=7.7e-36  Score=327.55  Aligned_cols=243  Identities=23%  Similarity=0.382  Sum_probs=193.1

Q ss_pred             ccceeceeceeCceEEEEEEE--CCeeEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCceeeEEeEEecCCcEEEEEec
Q 015868          117 QLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVTEF  194 (399)
Q Consensus       117 ~~~i~~~lg~G~~g~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~nIv~~~~~~~~~~~~~lV~E~  194 (399)
                      .++....||+|+||.||+|+.  .+..||+|.++....      ....|+..+++++||||+++++++..+...++||||
T Consensus       691 ~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~------~~~~~~~~l~~l~HpnIv~~~~~~~~~~~~~lv~Ey  764 (968)
T PLN00113        691 SLKEENVISRGKKGASYKGKSIKNGMQFVVKEINDVNS------IPSSEIADMGKLQHPNIVKLIGLCRSEKGAYLIHEY  764 (968)
T ss_pred             hCCcccEEccCCCeeEEEEEECCCCcEEEEEEccCCcc------ccHHHHHHHhhCCCCCcceEEEEEEcCCCCEEEEeC
Confidence            466677899999999999986  678999999874321      112468899999999999999999999999999999


Q ss_pred             CCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCCCceeecCCCcEEEeeccceeeccCCCccc
Q 015868          195 MARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLH---QNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMT  271 (399)
Q Consensus       195 ~~ggsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH---~~giiHrDlkp~NILl~~~~~vkl~DFG~a~~~~~~~~~~  271 (399)
                      +++|+|.++++.    +++..+.+++.|+++||+|||   +.+|+||||||+||+++.++..++. ||.......   ..
T Consensus       765 ~~~g~L~~~l~~----l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~~~~~~~~~-~~~~~~~~~---~~  836 (968)
T PLN00113        765 IEGKNLSEVLRN----LSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LSLPGLLCT---DT  836 (968)
T ss_pred             CCCCcHHHHHhc----CCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEECCCCceEEE-ecccccccc---CC
Confidence            999999999953    788999999999999999999   6799999999999999998888775 665543221   22


Q ss_pred             cCCCCcccccccccCCCCCCChhhHHHHHHHHHHHHcCCCCCCCCCH-----HHHHHHH-----HhccCCCCCC------
Q 015868          272 AETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPYAGLTP-----LQAAVGV-----VQKSLRPTIP------  335 (399)
Q Consensus       272 ~~~gt~~y~aPE~l~~~~~~~~~Dv~slG~vl~elltg~~P~~~~~~-----~~~~~~~-----~~~~~~~~~~------  335 (399)
                      ...+++.|+|||++.+..++.++|||||||++|||+||+.||+....     .+.....     ......+.+.      
T Consensus       837 ~~~~t~~y~aPE~~~~~~~~~~sDv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  916 (968)
T PLN00113        837 KCFISSAYVAPETRETKDITEKSDIYGFGLILIELLTGKSPADAEFGVHGSIVEWARYCYSDCHLDMWIDPSIRGDVSVN  916 (968)
T ss_pred             CccccccccCcccccCCCCCcccchhhHHHHHHHHHhCCCCCCcccCCCCcHHHHHHHhcCccchhheeCccccCCCCcc
Confidence            34678999999999999999999999999999999999999854211     1111000     0011112221      


Q ss_pred             CCCcHHHHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHH
Q 015868          336 KHAHPRLAELLERCWQHDPTQRPNFSQITDILKQMMKE  373 (399)
Q Consensus       336 ~~~~~~l~~ll~~cl~~dP~~Rps~~ell~~L~~l~~~  373 (399)
                      .....++.+++.+||+.+|++||++.|+++.|+++.+.
T Consensus       917 ~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~L~~~~~~  954 (968)
T PLN00113        917 QNEIVEVMNLALHCTATDPTARPCANDVLKTLESASRS  954 (968)
T ss_pred             HHHHHHHHHHHHhhCcCCchhCcCHHHHHHHHHHhhcc
Confidence            12234678899999999999999999999999988653

>KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription]

Probab=100.00  E-value=1.3e-36  Score=276.39  Aligned_cols=252  Identities=26%  Similarity=0.407  Sum_probs=198.0

Q ss_pred             ccccceeceeceeCceEEEEEEEC------CeeEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCceeeEEeEEec-CCc
Q 015868          115 AKQLKIECKVASGSYGDLYKGTYC------SQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTR-PPN  187 (399)
Q Consensus       115 ~~~~~i~~~lg~G~~g~Vy~~~~~------~~~vAvK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~nIv~~~~~~~~-~~~  187 (399)
                      ...|++..+||+|.||.||+|...      ...+|+|.++.+..........-+|+.+++.++|||++.+..++.. ...
T Consensus        23 l~~ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~tGiS~SAcREiaL~REl~h~nvi~Lv~Vfl~~d~~  102 (438)
T KOG0666|consen   23 LFEYEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDGTGISMSACREIALLRELKHPNVISLVKVFLSHDKK  102 (438)
T ss_pred             HHHhhccceecccccceeeEeeeccCCcccchhhHHHHHhccCCCCCcCHHHHHHHHHHHHhcCCcchhHHHHHhccCce
Confidence            457899999999999999999432      2478999998763333333456689999999999999999999977 778


Q ss_pred             EEEEEecCCCCCHHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceeecCC----CcEEEeecc
Q 015868          188 LCIVTEFMARGSIYDFLHKQK----GVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDEN----GVVKVADFG  259 (399)
Q Consensus       188 ~~lV~E~~~ggsL~~~l~~~~----~~l~~~~~~~i~~~i~~~L~~LH~~giiHrDlkp~NILl~~~----~~vkl~DFG  259 (399)
                      +++++||.+. +|...|+.+.    ..++...++.++.||+.|+.|||++-|+||||||.|||+..+    |.|||+|||
T Consensus       103 v~l~fdYAEh-DL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~NWvlHRDLKPaNIlvmgdgperG~VKIaDlG  181 (438)
T KOG0666|consen  103 VWLLFDYAEH-DLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHSNWVLHRDLKPANILVMGDGPERGRVKIADLG  181 (438)
T ss_pred             EEEEehhhhh-hHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhhhheeeccCCcceEEEeccCCccCeeEeeccc
Confidence            9999999987 9999986542    468999999999999999999999999999999999999887    899999999


Q ss_pred             ceeeccCCCcc----ccCCCCcccccccccCCC-CCCChhhHHHHHHHHHHHHcCCCCCCCCC-------HHHH--HHHH
Q 015868          260 VARVQAQSGVM----TAETGTYRWMAPEVIEHK-PYDYKADVFSFGIALWELLTGELPYAGLT-------PLQA--AVGV  325 (399)
Q Consensus       260 ~a~~~~~~~~~----~~~~gt~~y~aPE~l~~~-~~~~~~Dv~slG~vl~elltg~~P~~~~~-------~~~~--~~~~  325 (399)
                      +++.....-..    ...+.|..|.|||.+.+. .|+.+.|||+.||++.||+|-++.|.+..       |.+.  ...+
T Consensus       182 laR~~~~plkpl~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIfaElLtl~PlF~g~E~k~~~~~Pfq~dQl~rI  261 (438)
T KOG0666|consen  182 LARLFNNPLKPLASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCIFAELLTLEPLFKGREEKIKTKNPFQHDQLDRI  261 (438)
T ss_pred             HHHHhhccccccccCCceEEEEEecChHHhcccccccchhhhHHHHHHHHHHHccCccccchhhhcccCCCchHHHHHHH
Confidence            99977654221    223468999999999875 68999999999999999999888775431       2111  0111


Q ss_pred             Hh------ccCCCC---CC--------------------------CCCcHHHHHHHHHHhhhcCCCCCCHHHHHHHH
Q 015868          326 VQ------KSLRPT---IP--------------------------KHAHPRLAELLERCWQHDPTQRPNFSQITDIL  367 (399)
Q Consensus       326 ~~------~~~~~~---~~--------------------------~~~~~~l~~ll~~cl~~dP~~Rps~~ell~~L  367 (399)
                      ..      ....|.   +|                          ..-++...+|+.+||+.||.+|.|++|.++..
T Consensus       262 f~vLG~Pt~~~Wp~lkk~Pe~q~~ls~f~~~~~~n~sL~~~~~~~k~k~~~a~~LL~klL~yDP~kRIta~qAleh~  338 (438)
T KOG0666|consen  262 FEVLGTPTDKDWPDLKKMPEYQTLLSDFRRHYYDNVSLHKYYHKHKVKDPSALDLLQKLLTYDPIKRITAEQALEHP  338 (438)
T ss_pred             HHHcCCCccccchhhhhCcchHHHHHHhHHhhcCcchHHHHHHHhcCCCchHHHHHHHHhccCchhhccHHHHhccc
Confidence            10      000000   00                          11345588999999999999999999987754

>KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms]

Probab=100.00  E-value=9.6e-36  Score=256.85  Aligned_cols=222  Identities=31%  Similarity=0.496  Sum_probs=188.2

Q ss_pred             eeecccccceeceeceeCceEEEEEE--ECCeeEEEEEecCCCCCHHHHHHHHHHHHHHH-hcCCCceeeEEeEEecCCc
Q 015868          111 WEIDAKQLKIECKVASGSYGDLYKGT--YCSQEVAIKVLKPECVNTEMLKEFSQEVYIMR-KIRHKNVVQFIGACTRPPN  187 (399)
Q Consensus       111 ~~i~~~~~~i~~~lg~G~~g~Vy~~~--~~~~~vAvK~~~~~~~~~~~~~~~~~Ei~~l~-~l~h~nIv~~~~~~~~~~~  187 (399)
                      ++++.+++.-...||+|+||.|-+.+  +.|...|+|.++.... ....+...+|+.+.. ...+|.+|.|+|.......
T Consensus        41 ~eV~ad~L~~i~elGrGayG~vekmrh~~sg~imAvKri~~tvn-~q~q~r~L~dldi~~r~~~CPf~V~FyGa~~regd  119 (282)
T KOG0984|consen   41 FEVPADDLVGIEELGRGAYGVVEKMRHIQSGTIMAVKRIRATVN-SQEQKRLLMDLDIIMRTVDCPFTVHFYGALFREGD  119 (282)
T ss_pred             cccchhhhhhhhhhcCCccchhhheeeccCCeEEEEeeehhhcC-hHHHHHHHHhhhhhccCCCCCeEEEeehhhhcccc
Confidence            78888899999999999999986655  4789999999987754 444566667777654 4579999999999999999


Q ss_pred             EEEEEecCCCCCHHHHHH---hcCCCCCHHHHHHHHHHHHHHHHHHHHC-CcccCCCCCCceeecCCCcEEEeeccceee
Q 015868          188 LCIVTEFMARGSIYDFLH---KQKGVFQLTSLLKVAIDVSKGMNYLHQN-NIIHRDLKTANLLMDENGVVKVADFGVARV  263 (399)
Q Consensus       188 ~~lV~E~~~ggsL~~~l~---~~~~~l~~~~~~~i~~~i~~~L~~LH~~-giiHrDlkp~NILl~~~~~vkl~DFG~a~~  263 (399)
                      .+|.||.|.- ||..+-+   ++++.+++..+-+++..+++||.|||++ .+||||+||.|||++.+|+||+||||.+..
T Consensus       120 vwIcME~M~t-Sldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~kL~vIHRDvKPsNiLIn~~GqVKiCDFGIsG~  198 (282)
T KOG0984|consen  120 VWICMELMDT-SLDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHSKLSVIHRDVKPSNILINYDGQVKICDFGISGY  198 (282)
T ss_pred             EEEeHHHhhh-hHHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHHHhhhhhccCCcceEEEccCCcEEEccccccee
Confidence            9999999965 8877654   3578899999999999999999999986 999999999999999999999999999987


Q ss_pred             ccCCCccccCCCCcccccccccCC----CCCCChhhHHHHHHHHHHHHcCCCCCCC-CCHHHHHHHHHhccCCCCCC
Q 015868          264 QAQSGVMTAETGTYRWMAPEVIEH----KPYDYKADVFSFGIALWELLTGELPYAG-LTPLQAAVGVVQKSLRPTIP  335 (399)
Q Consensus       264 ~~~~~~~~~~~gt~~y~aPE~l~~----~~~~~~~Dv~slG~vl~elltg~~P~~~-~~~~~~~~~~~~~~~~~~~~  335 (399)
                      ...+--.+-..|...|||||.++.    ..|+-++||||||+++.||.++..||+. .+|.+.+.+++... .|.+|
T Consensus       199 L~dSiAkt~daGCkpYmaPEri~~e~n~~gY~vksDvWSLGItmiElA~lr~PY~~w~tpF~qLkqvVeep-~P~Lp  274 (282)
T KOG0984|consen  199 LVDSIAKTMDAGCKPYMAPERINPELNQKGYSVKSDVWSLGITMIEMAILRFPYESWGTPFQQLKQVVEEP-SPQLP  274 (282)
T ss_pred             ehhhhHHHHhcCCCccCChhhcCcccCcccceeehhhhhhhhhhhhhhhccccccccCCHHHHHHHHhcCC-CCCCc
Confidence            776655666789999999999863    4799999999999999999999999976 57888877777643 34444

>KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms]

Probab=100.00  E-value=8.2e-36  Score=278.06  Aligned_cols=246  Identities=25%  Similarity=0.390  Sum_probs=198.3

Q ss_pred             cccccceeceeceeCceEEEEEEE--CCeeEEEEEecCCCCCHHHHHHHHHHHHHHHhcCC--C----ceeeEEeEEecC
Q 015868          114 DAKQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRH--K----NVVQFIGACTRP  185 (399)
Q Consensus       114 ~~~~~~i~~~lg~G~~g~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~Ei~~l~~l~h--~----nIv~~~~~~~~~  185 (399)
                      ...+|++...+|+|.||.|-.+.+  .+..||||+++..   ....+..+-|+.+++++.+  |    -++++.++|.-.
T Consensus        87 l~~Ry~i~~~lGeGtFGkV~ec~D~~~~~~vAlKIik~V---~kYreAa~iEi~vLqki~~~DP~g~~rcv~m~~wFdyr  163 (415)
T KOG0671|consen   87 LTNRYEIVDLLGEGTFGKVVECWDRETKEHVALKIIKNV---DKYREAALIEIEVLQKINESDPNGKFRCVQMRDWFDYR  163 (415)
T ss_pred             cccceehhhhhcCCcccceEEEeecCCCceehHHHHHHH---HHHhhHHHHHHHHHHHHHhcCCCCceEEEeeehhhhcc
Confidence            367999999999999999999876  4678999999853   3444556779999999943  2    278888889999


Q ss_pred             CcEEEEEecCCCCCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceeecC---------------
Q 015868          186 PNLCIVTEFMARGSIYDFLHKQ-KGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDE---------------  249 (399)
Q Consensus       186 ~~~~lV~E~~~ggsL~~~l~~~-~~~l~~~~~~~i~~~i~~~L~~LH~~giiHrDlkp~NILl~~---------------  249 (399)
                      ++.|||+|.+ |.|+++++..+ -.+++...+..++.|+++++++||+.+++|.||||+|||+.+               
T Consensus       164 ghiCivfell-G~S~~dFlk~N~y~~fpi~~ir~m~~QL~~sv~fLh~~kl~HTDLKPENILfvss~~~~~~~~k~~~~~  242 (415)
T KOG0671|consen  164 GHICIVFELL-GLSTFDFLKENNYIPFPIDHIRHMGYQLLESVAFLHDLKLTHTDLKPENILFVSSEYFKTYNPKKKVCF  242 (415)
T ss_pred             CceEEEEecc-ChhHHHHhccCCccccchHHHHHHHHHHHHHHHHHHhcceeecCCChheEEEeccceEEEeccCCccce
Confidence            9999999988 66999999874 367999999999999999999999999999999999999842               


Q ss_pred             -----CCcEEEeeccceeeccCCCccccCCCCcccccccccCCCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHH--
Q 015868          250 -----NGVVKVADFGVARVQAQSGVMTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPYAGLTPLQAA--  322 (399)
Q Consensus       250 -----~~~vkl~DFG~a~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~Dv~slG~vl~elltg~~P~~~~~~~~~~--  322 (399)
                           +-.|+|+|||.|+...+.  .+.-+.|..|.|||++.+-+++..+||||+||+|+||.||...|...+..+-+  
T Consensus       243 ~r~~ks~~I~vIDFGsAtf~~e~--hs~iVsTRHYRAPEViLgLGwS~pCDvWSiGCIL~ElytG~~LFqtHen~EHLaM  320 (415)
T KOG0671|consen  243 IRPLKSTAIKVIDFGSATFDHEH--HSTIVSTRHYRAPEVILGLGWSQPCDVWSIGCILVELYTGETLFQTHENLEHLAM  320 (415)
T ss_pred             eccCCCcceEEEecCCcceeccC--cceeeeccccCCchheeccCcCCccCceeeeeEEEEeeccceecccCCcHHHHHH
Confidence                 236899999999876554  25557799999999999999999999999999999999999988776644421  


Q ss_pred             HHHHhccCC----------------------------------CCCC--------CCCcHHHHHHHHHHhhhcCCCCCCH
Q 015868          323 VGVVQKSLR----------------------------------PTIP--------KHAHPRLAELLERCWQHDPTQRPNF  360 (399)
Q Consensus       323 ~~~~~~~~~----------------------------------~~~~--------~~~~~~l~~ll~~cl~~dP~~Rps~  360 (399)
                      +..+-...+                                  +..|        .....+|.+||++||..||.+|+|+
T Consensus       321 MerIlGp~P~~mi~r~~~~Kyf~~~rldw~e~~~~~~~k~v~~~ckpl~~~~~~~d~e~~~LfDLl~~mL~fDP~~RiTl  400 (415)
T KOG0671|consen  321 MERILGPIPSRMIKKTRKEKYFRRGRLDWPEVSSKGKSKYVFEPCKPLKKYMLQDDLEHVQLFDLLRRMLEFDPARRITL  400 (415)
T ss_pred             HHHhhCCCcHHHhhhhhhHhhhhcccccCccccccccchhhhcCCccHHHHhccCcHHHhHHHHHHHHHHccCccccccH
Confidence            111100000                                  0000        1123469999999999999999999


Q ss_pred             HHHHH
Q 015868          361 SQITD  365 (399)
Q Consensus       361 ~ell~  365 (399)
                      .|++.
T Consensus       401 ~EAL~  405 (415)
T KOG0671|consen  401 REALS  405 (415)
T ss_pred             HHHhc
Confidence            99865

>KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=5.2e-37  Score=271.83  Aligned_cols=254  Identities=27%  Similarity=0.430  Sum_probs=208.3

Q ss_pred             eeecccccceeceeceeCceEEEEEEE--CCeeEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCceeeEEeEEecC---
Q 015868          111 WEIDAKQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRP---  185 (399)
Q Consensus       111 ~~i~~~~~~i~~~lg~G~~g~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~nIv~~~~~~~~~---  185 (399)
                      +.+..+.|.-..++|+|.||.||+|+.  +++.||+|+.--+...+.......+|+.+|+.++|+|++.+++.|...   
T Consensus        12 ~~~~~~~yek~~kigqGtfgeVFkAr~~n~~kkvalkkvlmeneKeGfpitalreikiL~~lkHenv~nliEic~tk~Tp   91 (376)
T KOG0669|consen   12 FCDEVSKYEKLAKIGQGTFGEVFKARSKNTGKKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATP   91 (376)
T ss_pred             ceecchHHHHHHhcCCchHHHHHHHhhcCccchhHHHHHHHhccccCCcHHHHHHHHHHHHhcchhHHHHHHHHhhccCC
Confidence            455677888899999999999999976  567889887644332333445677899999999999999999988432   


Q ss_pred             -----CcEEEEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceeecCCCcEEEeeccc
Q 015868          186 -----PNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGV  260 (399)
Q Consensus       186 -----~~~~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~giiHrDlkp~NILl~~~~~vkl~DFG~  260 (399)
                           ..+|+||.+|+. +|.-++.+...+++..++.+++.++..||.|+|...|+|||+||+|+||+.+|.+||+|||+
T Consensus        92 ~~r~r~t~ylVf~~ceh-DLaGlLsn~~vr~sls~Ikk~Mk~Lm~GL~~iHr~kilHRDmKaaNvLIt~dgilklADFGl  170 (376)
T KOG0669|consen   92 TNRDRATFYLVFDFCEH-DLAGLLSNRKVRFSLSEIKKVMKGLMNGLYYIHRNKILHRDMKAANVLITKDGILKLADFGL  170 (376)
T ss_pred             cccccceeeeeHHHhhh-hHHHHhcCccccccHHHHHHHHHHHHHHHHHHHHhhHHhhcccHhhEEEcCCceEEeecccc
Confidence                 248999999987 99999988778899999999999999999999999999999999999999999999999999


Q ss_pred             eeeccCCC-----ccccCCCCcccccccccCCC-CCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHh-------
Q 015868          261 ARVQAQSG-----VMTAETGTYRWMAPEVIEHK-PYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQ-------  327 (399)
Q Consensus       261 a~~~~~~~-----~~~~~~gt~~y~aPE~l~~~-~~~~~~Dv~slG~vl~elltg~~P~~~~~~~~~~~~~~~-------  327 (399)
                      ++....+.     ..+..+.|..|.+||.+.+. .|..+.|||..||++.||+|+.+.+.+.+..+....+.+       
T Consensus       171 ar~fs~~~n~~kprytnrvvTLwYrppEllLG~r~yg~~iDiWgAgCimaeMwtrspimqgnteqqql~~Is~LcGs~tk  250 (376)
T KOG0669|consen  171 ARAFSTSKNVVKPRYTNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIMAEMWTRSPIMQGNTEQQQLHLISQLCGSITK  250 (376)
T ss_pred             ccceecccccCCCCcccceeeeecCCHHHhhcccccCCcchhHhHHHHHHHHHccCccccCChHHHHHHHHHHHhccCCc
Confidence            98655432     24555679999999999875 689999999999999999999999999888776554321       


Q ss_pred             -------------ccCCCCCCC-------------CCcHHHHHHHHHHhhhcCCCCCCHHHHHH
Q 015868          328 -------------KSLRPTIPK-------------HAHPRLAELLERCWQHDPTQRPNFSQITD  365 (399)
Q Consensus       328 -------------~~~~~~~~~-------------~~~~~l~~ll~~cl~~dP~~Rps~~ell~  365 (399)
                                   ....+++|+             .-+++..+|+.+++..||.+|+++.+++.
T Consensus       251 evWP~~d~lpL~~sie~ePl~~~~~rkv~n~~kp~~kd~~a~dLle~ll~~DP~kR~~ad~aln  314 (376)
T KOG0669|consen  251 EVWPNVDNLPLYQSIELEPLPKGQKRKVKNRLKPYVKDDEALDLLEKLLKLDPTKRIDADQALN  314 (376)
T ss_pred             ccCCCcccchHHHhccCCCCCcchhhhhhhhcccccCChhHHHHHHHHhccCcccCcchHhhhc
Confidence                         010111221             12457889999999999999999999864

>KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms]

Probab=100.00  E-value=1.8e-34  Score=269.24  Aligned_cols=262  Identities=25%  Similarity=0.503  Sum_probs=222.5

Q ss_pred             eecccccceeceeceeCceEEEEEEECC-------eeEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCceeeEEeEEec
Q 015868          112 EIDAKQLKIECKVASGSYGDLYKGTYCS-------QEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTR  184 (399)
Q Consensus       112 ~i~~~~~~i~~~lg~G~~g~Vy~~~~~~-------~~vAvK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~nIv~~~~~~~~  184 (399)
                      .+...++++...+-+|.||.||+|.+..       +.|-+|.++... +.-....+.+|.-++..+.|||+.++.+++..
T Consensus       280 ~v~r~Rv~l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~A-S~iQv~~~L~es~lly~~sH~nll~V~~V~ie  358 (563)
T KOG1024|consen  280 TVQRCRVRLSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQHA-SQIQVNLLLQESMLLYGASHPNLLSVLGVSIE  358 (563)
T ss_pred             hhhhhheechhhhhcCchhheeeeeecccCCcchHHHHHHHHHHhcc-cHHHHHHHHHHHHHHhcCcCCCccceeEEEee
Confidence            3445567788889999999999995532       456677776542 44556789999999999999999999999854


Q ss_pred             -CCcEEEEEecCCCCCHHHHHHhc-------CCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceeecCCCcEEEe
Q 015868          185 -PPNLCIVTEFMARGSIYDFLHKQ-------KGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVA  256 (399)
Q Consensus       185 -~~~~~lV~E~~~ggsL~~~l~~~-------~~~l~~~~~~~i~~~i~~~L~~LH~~giiHrDlkp~NILl~~~~~vkl~  256 (399)
                       ....+.++.++.-|+|..++...       ...++-.++..++.|++.||+|||+.|+||.||.++|.+|++.-+|||+
T Consensus       359 ~~~~P~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~~~ViHkDiAaRNCvIdd~LqVklt  438 (563)
T KOG1024|consen  359 DYATPFVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHNHGVIHKDIAARNCVIDDQLQVKLT  438 (563)
T ss_pred             ccCcceEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHhcCcccchhhhhcceehhheeEEec
Confidence             44578889999999999999732       2346667788899999999999999999999999999999999999999


Q ss_pred             eccceeeccCCC---ccccCCCCcccccccccCCCCCCChhhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHHhccCCC
Q 015868          257 DFGVARVQAQSG---VMTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLT-GELPYAGLTPLQAAVGVVQKSLRP  332 (399)
Q Consensus       257 DFG~a~~~~~~~---~~~~~~gt~~y~aPE~l~~~~~~~~~Dv~slG~vl~ellt-g~~P~~~~~~~~~~~~~~~~~~~~  332 (399)
                      |=.++|-.-...   ....+-.+..||+||.+.+..|+.++|+||||++||||+| |+.||...+|.+.. ..+..+.|.
T Consensus       439 DsaLSRDLFP~DYhcLGDnEnRPvkWMslEal~n~~yssasDvWsfGVllWELmtlg~~PyaeIDPfEm~-~ylkdGyRl  517 (563)
T KOG1024|consen  439 DSALSRDLFPGDYHCLGDNENRPVKWMSLEALQNSHYSSASDVWSFGVLLWELMTLGKLPYAEIDPFEME-HYLKDGYRL  517 (563)
T ss_pred             cchhccccCcccccccCCCCCCcccccCHHHHhhhhhcchhhhHHHHHHHHHHHhcCCCCccccCHHHHH-HHHhcccee
Confidence            999998544332   2334456789999999999999999999999999999999 99999999998865 457778999


Q ss_pred             CCCCCCcHHHHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHH
Q 015868          333 TIPKHAHPRLAELLERCWQHDPTQRPNFSQITDILKQMMKEVA  375 (399)
Q Consensus       333 ~~~~~~~~~l~~ll~~cl~~dP~~Rps~~ell~~L~~l~~~~~  375 (399)
                      ..|.+++++|..+|.-||...|++||+|+|+..-|.++-.++.
T Consensus       518 aQP~NCPDeLf~vMacCWallpeeRPsf~Qlv~cLseF~~qlt  560 (563)
T KOG1024|consen  518 AQPFNCPDELFTVMACCWALLPEERPSFSQLVICLSEFHTQLT  560 (563)
T ss_pred             cCCCCCcHHHHHHHHHHHhcCcccCCCHHHHHHHHHHHHHHHh
Confidence            9999999999999999999999999999999999999876653

>KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=1.1e-34  Score=284.07  Aligned_cols=245  Identities=22%  Similarity=0.377  Sum_probs=205.6

Q ss_pred             eecccccceeceeceeCceEEEEEEE--CCeeEEEEEecC-CCCCHHHHHHHHHHHHHHHhcCCCceeeEEeEEecCCcE
Q 015868          112 EIDAKQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKP-ECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNL  188 (399)
Q Consensus       112 ~i~~~~~~i~~~lg~G~~g~Vy~~~~--~~~~vAvK~~~~-~~~~~~~~~~~~~Ei~~l~~l~h~nIv~~~~~~~~~~~~  188 (399)
                      ..+.+.|...+.||-|+||.|.+++.  +...+|+|.+++ +....+.....+.|-.||..-+.+-||++|-.|.+.+++
T Consensus       625 KMdKSmFvkik~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEADn~WVVrLyySFQDkdnL  704 (1034)
T KOG0608|consen  625 KMDKSMFVKIKTIGVGAFGEVCLVRKVDTRALYAMKTLRKADVLMRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNL  704 (1034)
T ss_pred             hccccceEEEeeecccccceeEEEeecchhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhcCCcceEEEEEEeccCCce
Confidence            35567888899999999999999975  556789999874 344566677899999999999999999999999999999


Q ss_pred             EEEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceeecCCCcEEEeeccceeecc---
Q 015868          189 CIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQA---  265 (399)
Q Consensus       189 ~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~giiHrDlkp~NILl~~~~~vkl~DFG~a~~~~---  265 (399)
                      |+||+|++||++-.+|-+ -+.|++..+..++.++..|+++.|..|+|||||||+|||||.+|+|||.|||+++-..   
T Consensus       705 YFVMdYIPGGDmMSLLIr-mgIFeE~LARFYIAEltcAiesVHkmGFIHRDiKPDNILIDrdGHIKLTDFGLCTGfRWTH  783 (1034)
T KOG0608|consen  705 YFVMDYIPGGDMMSLLIR-MGIFEEDLARFYIAELTCAIESVHKMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTH  783 (1034)
T ss_pred             EEEEeccCCccHHHHHHH-hccCHHHHHHHHHHHHHHHHHHHHhccceecccCccceEEccCCceeeeeccccccceecc
Confidence            999999999999998866 5789999999999999999999999999999999999999999999999999986211   


Q ss_pred             -----CCCc-----------------------------------cccCCCCcccccccccCCCCCCChhhHHHHHHHHHH
Q 015868          266 -----QSGV-----------------------------------MTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWE  305 (399)
Q Consensus       266 -----~~~~-----------------------------------~~~~~gt~~y~aPE~l~~~~~~~~~Dv~slG~vl~e  305 (399)
                           +.+.                                   ....+||+.|+|||++....|+..+|.||.|++|||
T Consensus       784 dskYYq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r~g~~q~cdwws~gvil~e  863 (1034)
T KOG0608|consen  784 DSKYYQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLARTGYTQLCDWWSVGVILYE  863 (1034)
T ss_pred             ccccccCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhcccCccccchhhHhhHHHHH
Confidence                 0000                                   011248999999999999999999999999999999


Q ss_pred             HHcCCCCCCCCCHHHHHHHHHh--ccCCCCCCCCCcHHHHHHHHHHhhhcCCCCC
Q 015868          306 LLTGELPYAGLTPLQAAVGVVQ--KSLRPTIPKHAHPRLAELLERCWQHDPTQRP  358 (399)
Q Consensus       306 lltg~~P~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~l~~ll~~cl~~dP~~Rp  358 (399)
                      |+.|++||-..++.+....++.  ..+.-.....++++..++|.++.. .++.|.
T Consensus       864 m~~g~~pf~~~tp~~tq~kv~nw~~~l~~~~~~~ls~e~~~li~kLc~-sad~RL  917 (1034)
T KOG0608|consen  864 MLVGQPPFLADTPGETQYKVINWRNFLHIPYQGNLSKEALDLIQKLCC-SADSRL  917 (1034)
T ss_pred             HhhCCCCccCCCCCcceeeeeehhhccccccccccCHHHHHHHHHHhc-Chhhhh
Confidence            9999999998888776655543  333333445689999999998543 567774

>KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=3e-33  Score=267.50  Aligned_cols=246  Identities=23%  Similarity=0.400  Sum_probs=193.8

Q ss_pred             cccccceeceeceeCceEEEEEEE--CCeeEEEEEecCCCCCHHHHHHHHHHHHHHHhcC-----C---CceeeEEeEEe
Q 015868          114 DAKQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIR-----H---KNVVQFIGACT  183 (399)
Q Consensus       114 ~~~~~~i~~~lg~G~~g~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~Ei~~l~~l~-----h---~nIv~~~~~~~  183 (399)
                      ...+|.+.++||+|-|++||++.+  ..+.||+|+.+..   ....+....||.+|++++     |   .+||++++.|.
T Consensus        76 ~~gRY~v~rKLGWGHFSTVWLawDtq~~r~VAlKVvKSA---qhYtEaAlDEIklL~~v~~~Dp~~~~~~~VV~LlD~Fk  152 (590)
T KOG1290|consen   76 NGGRYHVQRKLGWGHFSTVWLAWDTQNKRYVALKVVKSA---QHYTEAALDEIKLLQQVREGDPNDPGKKCVVQLLDHFK  152 (590)
T ss_pred             cCceEEEEEeccccccceeEEEeeccCCeEEEEEEEehh---hHHHHHHHHHHHHHHHHHhcCCCCCCCceeeeeeccce
Confidence            347999999999999999999987  4688999999863   455667889999999984     2   46999999996


Q ss_pred             c----CCcEEEEEecCCCCCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHC-CcccCCCCCCceeecCCC------
Q 015868          184 R----PPNLCIVTEFMARGSIYDFLHKQ-KGVFQLTSLLKVAIDVSKGMNYLHQN-NIIHRDLKTANLLMDENG------  251 (399)
Q Consensus       184 ~----~~~~~lV~E~~~ggsL~~~l~~~-~~~l~~~~~~~i~~~i~~~L~~LH~~-giiHrDlkp~NILl~~~~------  251 (399)
                      .    +.++|||+|++ |-+|..+|... -..++...+++|+.||+.||.|||.. ||||.||||+|||+..+.      
T Consensus       153 hsGpNG~HVCMVfEvL-GdnLLklI~~s~YrGlpl~~VK~I~~qvL~GLdYLH~ecgIIHTDlKPENvLl~~~e~~~~~~  231 (590)
T KOG1290|consen  153 HSGPNGQHVCMVFEVL-GDNLLKLIKYSNYRGLPLSCVKEICRQVLTGLDYLHRECGIIHTDLKPENVLLCSTEIDPAKD  231 (590)
T ss_pred             ecCCCCcEEEEEehhh-hhHHHHHHHHhCCCCCcHHHHHHHHHHHHHHHHHHHHhcCccccCCCcceeeeeccccchhhh
Confidence            4    45799999998 55999998764 46799999999999999999999975 999999999999982000      


Q ss_pred             --------------------------------------------------------------------------------
Q 015868          252 --------------------------------------------------------------------------------  251 (399)
Q Consensus       252 --------------------------------------------------------------------------------  251 (399)
                                                                                                      
T Consensus       232 ~~~a~e~~~~~p~~s~s~~~t~~d~~~~~~~~~~s~~~~k~~~kk~~r~~~~~~~~l~~~~~~~~~~~~~s~n~~~~~n~  311 (590)
T KOG1290|consen  232 AREAGEATTSLPKMSPSAVSTRPDALQRMAAEPMSKSKFKKMKKKLKRQAKKLEASLAGLEGIEEEPNQESYNNEPRING  311 (590)
T ss_pred             hhhhccccccCCCCCcccccccccccchhhccccchhhHHHHHHHHhhhhhhhhhhhcccccccccccccccccccCCCc
Confidence                                                                                            


Q ss_pred             --------------------------------------------------------------------------------
Q 015868          252 --------------------------------------------------------------------------------  251 (399)
Q Consensus       252 --------------------------------------------------------------------------------  251 (399)
                                                                                                      
T Consensus       312 ~~~~v~~~~~~~~~~~~~~~~n~~~k~~e~~~~~~~sl~~~~~~~~~t~~~~~~~s~~s~~~~~~n~~v~p~~~~~~~di  391 (590)
T KOG1290|consen  312 NESTVERSTLEEDSNENGNRENLPIKSPENFRGNNTSLPESQLRDSATPSDGSLSSPSSPGTIASNPLVNPDIPLPECDI  391 (590)
T ss_pred             cccchhhcccccccccccCCccccccCccccccccccccchhcccccccccccccCcCCccccccccccCCCCCCCccce
Confidence                                                                                            


Q ss_pred             cEEEeeccceeeccCCCccccCCCCcccccccccCCCCCCChhhHHHHHHHHHHHHcCCCCCCCC-----CHHHHHHHHH
Q 015868          252 VVKVADFGVARVQAQSGVMTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPYAGL-----TPLQAAVGVV  326 (399)
Q Consensus       252 ~vkl~DFG~a~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~Dv~slG~vl~elltg~~P~~~~-----~~~~~~~~~~  326 (399)
                      .+||+|||.|+....  ..+....|..|.|||++.+..|+..+||||++|++|||+||...|+..     +..+.-...+
T Consensus       392 ~vKIaDlGNACW~~k--hFT~DIQTRQYRapEVllGsgY~~~ADiWS~AC~~FELaTGDyLFePhsG~~Y~rDEDHiA~i  469 (590)
T KOG1290|consen  392 RVKIADLGNACWVHK--HFTEDIQTRQYRAPEVLLGSGYSTSADIWSTACMAFELATGDYLFEPHSGENYSRDEDHIALI  469 (590)
T ss_pred             eEEEeeccchhhhhh--hhchhhhhhhccCcceeecCCCCCchhHHHHHHHHHHhhcCceeecCCCCCCCCccHHHHHHH
Confidence            257777777765433  356677899999999999999999999999999999999999887532     1111111110


Q ss_pred             ----h-------------------ccC-C-----------------CCCCCCCcHHHHHHHHHHhhhcCCCCCCHHHHHH
Q 015868          327 ----Q-------------------KSL-R-----------------PTIPKHAHPRLAELLERCWQHDPTQRPNFSQITD  365 (399)
Q Consensus       327 ----~-------------------~~~-~-----------------~~~~~~~~~~l~~ll~~cl~~dP~~Rps~~ell~  365 (399)
                          .                   .+. +                 -..+.....++.+|+.-||+.+|++|||+.++++
T Consensus       470 ~ELLG~iPr~ia~~Gk~SRdFFnr~G~LrhI~~LK~WpL~~VL~eKY~~s~e~A~~fsdFL~PmLef~PeKR~tA~~cl~  549 (590)
T KOG1290|consen  470 MELLGKIPRKIALGGKYSRDFFNRRGELRHIRRLKPWPLYEVLIEKYEWSEEDAQQFSDFLSPMLEFDPEKRPTAAQCLK  549 (590)
T ss_pred             HHHHhhccHHHHhcCcchHhhhccccceecccccCCCcHHHHHHHHhCCCHHHHHHHHHHHHHHHhcCccccccHHHHhc
Confidence                0                   000 0                 0012233457999999999999999999999974

>KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms]

Probab=100.00  E-value=1.7e-34  Score=291.18  Aligned_cols=240  Identities=25%  Similarity=0.403  Sum_probs=191.3

Q ss_pred             cceeceeceeCceE-EEEEEECCeeEEEEEecCCCCCHHHHHHHHHHHHHHHhcC-CCceeeEEeEEecCCcEEEEEecC
Q 015868          118 LKIECKVASGSYGD-LYKGTYCSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIR-HKNVVQFIGACTRPPNLCIVTEFM  195 (399)
Q Consensus       118 ~~i~~~lg~G~~g~-Vy~~~~~~~~vAvK~~~~~~~~~~~~~~~~~Ei~~l~~l~-h~nIv~~~~~~~~~~~~~lV~E~~  195 (399)
                      |.-.+.+|.|+.|+ ||+|.+.++.||||.+-     .+......+|+..|+..+ |||||++++.-.+....||..|.|
T Consensus       511 ~~~~eilG~Gs~Gt~Vf~G~ye~R~VAVKrll-----~e~~~~A~rEi~lL~eSD~H~NviRyyc~E~d~qF~YIalELC  585 (903)
T KOG1027|consen  511 FSPKEILGYGSNGTVVFRGVYEGREVAVKRLL-----EEFFDFAQREIQLLQESDEHPNVIRYYCSEQDRQFLYIALELC  585 (903)
T ss_pred             eccHHHcccCCCCcEEEEEeeCCceehHHHHh-----hHhHHHHHHHHHHHHhccCCCceEEEEeeccCCceEEEEehHh
Confidence            33456688999986 89999999999999985     344567789999999984 999999999999999999999999


Q ss_pred             CCCCHHHHHHhcCCCC---CHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceeecC---C--CcEEEeeccceeeccCC
Q 015868          196 ARGSIYDFLHKQKGVF---QLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDE---N--GVVKVADFGVARVQAQS  267 (399)
Q Consensus       196 ~ggsL~~~l~~~~~~l---~~~~~~~i~~~i~~~L~~LH~~giiHrDlkp~NILl~~---~--~~vkl~DFG~a~~~~~~  267 (399)
                      .. +|.|++.......   .....+.++.|+++||++||+.+||||||||.||||+.   +  ..++|+|||+++..+..
T Consensus       586 ~~-sL~dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHLHsl~iVHRDLkPQNILI~~~~~~~~~ra~iSDfglsKkl~~~  664 (903)
T KOG1027|consen  586 AC-SLQDLIESSGLDVEMQSDIDPISVLSQIASGLAHLHSLKIVHRDLKPQNILISVPSADGTLRAKISDFGLSKKLAGG  664 (903)
T ss_pred             hh-hHHHHHhccccchhhcccccHHHHHHHHHHHHHHHHhcccccccCCCceEEEEccCCCcceeEEecccccccccCCC
Confidence            76 9999997631111   11345778899999999999999999999999999976   2  47899999999876543


Q ss_pred             Cc----cccCCCCcccccccccCCCCCCChhhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHHhccCCCCCCCCCcHHH
Q 015868          268 GV----MTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLT-GELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRL  342 (399)
Q Consensus       268 ~~----~~~~~gt~~y~aPE~l~~~~~~~~~Dv~slG~vl~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  342 (399)
                      ..    .....||.+|+|||++....-+.+.||||+||++|+.++ |..||...-..++..-.-... .-.+.+..+.+.
T Consensus       665 ~sS~~r~s~~sGt~GW~APE~L~~~~~~~avDiFslGCvfyYvltgG~HpFGd~~~R~~NIl~~~~~-L~~L~~~~d~eA  743 (903)
T KOG1027|consen  665 KSSFSRLSGGSGTSGWQAPEQLREDRKTQAVDIFSLGCVFYYVLTGGSHPFGDSLERQANILTGNYT-LVHLEPLPDCEA  743 (903)
T ss_pred             cchhhcccCCCCcccccCHHHHhccccCcccchhhcCceEEEEecCCccCCCchHHhhhhhhcCccc-eeeeccCchHHH
Confidence            22    344579999999999998888889999999999999999 589998766655432211111 111112222289


Q ss_pred             HHHHHHHhhhcCCCCCCHHHHH
Q 015868          343 AELLERCWQHDPTQRPNFSQIT  364 (399)
Q Consensus       343 ~~ll~~cl~~dP~~Rps~~ell  364 (399)
                      .+||.+|+..+|..||++.+++
T Consensus       744 ~dLI~~ml~~dP~~RPsa~~VL  765 (903)
T KOG1027|consen  744 KDLISRMLNPDPQLRPSATDVL  765 (903)
T ss_pred             HHHHHHhcCCCcccCCCHHHHh
Confidence            9999999999999999999995

>PLN03224 probable serine/threonine protein kinase; Provisional

Probab=100.00  E-value=5e-33  Score=280.43  Aligned_cols=253  Identities=20%  Similarity=0.285  Sum_probs=184.8

Q ss_pred             eeecccccceeceeceeCceEEEEEEE------------------CCeeEEEEEecCCCCCHHHH--------------H
Q 015868          111 WEIDAKQLKIECKVASGSYGDLYKGTY------------------CSQEVAIKVLKPECVNTEML--------------K  158 (399)
Q Consensus       111 ~~i~~~~~~i~~~lg~G~~g~Vy~~~~------------------~~~~vAvK~~~~~~~~~~~~--------------~  158 (399)
                      .....++|.+.++||+|+||.||+|..                  .++.||||.++...  ....              +
T Consensus       140 ~r~~~d~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~--~~~~~~fl~e~~~~~~~~e  217 (507)
T PLN03224        140 SRWSSDDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDR--QGVRQDFLKTGTLAKGSAE  217 (507)
T ss_pred             CCccccCceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccc--hhhHHHHHhhhhhhhcccc
Confidence            345678999999999999999999963                  24579999987542  1111              2


Q ss_pred             HHHHHHHHHHhcCCCce-----eeEEeEEec--------CCcEEEEEecCCCCCHHHHHHhcCC----------------
Q 015868          159 EFSQEVYIMRKIRHKNV-----VQFIGACTR--------PPNLCIVTEFMARGSIYDFLHKQKG----------------  209 (399)
Q Consensus       159 ~~~~Ei~~l~~l~h~nI-----v~~~~~~~~--------~~~~~lV~E~~~ggsL~~~l~~~~~----------------  209 (399)
                      ....|+.++.+++|.++     ++++++|..        ....++||||+++++|.++++...+                
T Consensus       218 ~~~vE~~~l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l  297 (507)
T PLN03224        218 TGMVEAYMCAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKI  297 (507)
T ss_pred             hhHHHHHHHHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCch
Confidence            23457777777766554     677777653        3468999999999999999875321                


Q ss_pred             -------CCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceeecCCCcEEEeeccceeeccCCCccc--cCCCCcccc
Q 015868          210 -------VFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMT--AETGTYRWM  280 (399)
Q Consensus       210 -------~l~~~~~~~i~~~i~~~L~~LH~~giiHrDlkp~NILl~~~~~vkl~DFG~a~~~~~~~~~~--~~~gt~~y~  280 (399)
                             .+++..++.++.|++.+|.|||+++|+||||||+||+++.++.+||+|||+++.........  ...+++.|+
T Consensus       298 ~~~~~~~~~~~~~~~~i~~ql~~aL~~lH~~~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~g~~tp~Y~  377 (507)
T PLN03224        298 PDNMPQDKRDINVIKGVMRQVLTGLRKLHRIGIVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTGINFNPLYGMLDPRYS  377 (507)
T ss_pred             hhhcccccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCchHhEEECCCCcEEEEeCcCccccccCCccCccccCCCccee
Confidence                   23456788999999999999999999999999999999999999999999997544322222  223478999


Q ss_pred             cccccCCCC--------------------C--CChhhHHHHHHHHHHHHcCCC-CCCCCCHHHHHHH-----------HH
Q 015868          281 APEVIEHKP--------------------Y--DYKADVFSFGIALWELLTGEL-PYAGLTPLQAAVG-----------VV  326 (399)
Q Consensus       281 aPE~l~~~~--------------------~--~~~~Dv~slG~vl~elltg~~-P~~~~~~~~~~~~-----------~~  326 (399)
                      |||.+....                    |  ..+.|+||+||++++|++|.. ||...........           ..
T Consensus       378 aPE~l~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~~~~~f~~~~~~~~~~~~~~r~~~  457 (507)
T PLN03224        378 PPEELVMPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVANIRLFNTELRQYDNDLNRWRMYK  457 (507)
T ss_pred             ChhhhcCCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCccchhhhhhHHhhccchHHHHHhhc
Confidence            999986432                    1  124699999999999999876 7764322211111           00


Q ss_pred             hccCCCCCCCCCcHHHHHHHHHHhhhcC---CCCCCHHHHHH
Q 015868          327 QKSLRPTIPKHAHPRLAELLERCWQHDP---TQRPNFSQITD  365 (399)
Q Consensus       327 ~~~~~~~~~~~~~~~l~~ll~~cl~~dP---~~Rps~~ell~  365 (399)
                      ............++...+|+.+||..+|   .+|+|+.|+++
T Consensus       458 ~~~~~~~~~d~~s~~~~dLi~~LL~~~~~~~~~RlSa~eaL~  499 (507)
T PLN03224        458 GQKYDFSLLDRNKEAGWDLACKLITKRDQANRGRLSVGQALS  499 (507)
T ss_pred             ccCCCcccccccChHHHHHHHHHhccCCCCcccCCCHHHHhC
Confidence            1111122234578899999999999866   68999999875

>PLN03225 Serine/threonine-protein kinase SNT7; Provisional

Probab=100.00  E-value=4e-33  Score=287.04  Aligned_cols=246  Identities=16%  Similarity=0.231  Sum_probs=169.0

Q ss_pred             eecccccceeceeceeCceEEEEEEEC------CeeEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCceeeEEeE----
Q 015868          112 EIDAKQLKIECKVASGSYGDLYKGTYC------SQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGA----  181 (399)
Q Consensus       112 ~i~~~~~~i~~~lg~G~~g~Vy~~~~~------~~~vAvK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~nIv~~~~~----  181 (399)
                      ....++|.+.++||+|+||.||+|++.      +..||+|.++.....+    ....|  .++...+.++..++..    
T Consensus       128 ~~~~~~y~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~~~e----~~~~e--~l~~~~~~~~~~~~~~~~~~  201 (566)
T PLN03225        128 SFKKDDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYGAVE----IWMNE--RVRRACPNSCADFVYGFLEP  201 (566)
T ss_pred             CCccCCeEEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccchhH----HHHHH--HHHhhchhhHHHHHHhhhcc
Confidence            345679999999999999999999874      5789999986432111    11111  1111122222222221    


Q ss_pred             --EecCCcEEEEEecCCCCCHHHHHHhcCCCC-------------------CHHHHHHHHHHHHHHHHHHHHCCcccCCC
Q 015868          182 --CTRPPNLCIVTEFMARGSIYDFLHKQKGVF-------------------QLTSLLKVAIDVSKGMNYLHQNNIIHRDL  240 (399)
Q Consensus       182 --~~~~~~~~lV~E~~~ggsL~~~l~~~~~~l-------------------~~~~~~~i~~~i~~~L~~LH~~giiHrDl  240 (399)
                        ......+++|+||+.+++|.+++.......                   ....+..++.||+.||.|||++||+||||
T Consensus       202 ~~~~~~~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~~gIiHRDL  281 (566)
T PLN03225        202 VSSKKEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHSTGIVHRDV  281 (566)
T ss_pred             cccccCCceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHHCCEEeCcC
Confidence              245567999999999999999987543211                   13346689999999999999999999999


Q ss_pred             CCCceeecC-CCcEEEeeccceeeccCC--CccccCCCCcccccccccCCC----------------------CCCChhh
Q 015868          241 KTANLLMDE-NGVVKVADFGVARVQAQS--GVMTAETGTYRWMAPEVIEHK----------------------PYDYKAD  295 (399)
Q Consensus       241 kp~NILl~~-~~~vkl~DFG~a~~~~~~--~~~~~~~gt~~y~aPE~l~~~----------------------~~~~~~D  295 (399)
                      ||+|||+++ ++.+||+|||+++.....  .......+++.|+|||.+...                      .++.++|
T Consensus       282 KP~NILl~~~~~~~KL~DFGlA~~l~~~~~~~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~~~k~D  361 (566)
T PLN03225        282 KPQNIIFSEGSGSFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFD  361 (566)
T ss_pred             CHHHEEEeCCCCcEEEEeCCCccccccccccCCcccccCCCccChHHhhccCCCCCCccccccccccchhccccCCCCcc
Confidence            999999985 589999999999754322  223445789999999976422                      2345679


Q ss_pred             HHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhc----------cCCCCCC----------CCCcHHHHHHHHHHhhhcCC
Q 015868          296 VFSFGIALWELLTGELPYAGLTPLQAAVGVVQK----------SLRPTIP----------KHAHPRLAELLERCWQHDPT  355 (399)
Q Consensus       296 v~slG~vl~elltg~~P~~~~~~~~~~~~~~~~----------~~~~~~~----------~~~~~~l~~ll~~cl~~dP~  355 (399)
                      ||||||++|||+++..|++..  .......+..          ...+...          ...+....+||.+||+.||+
T Consensus       362 VwSlGviL~el~~~~~~~~~~--~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~dLi~~mL~~dP~  439 (566)
T PLN03225        362 IYSAGLIFLQMAFPNLRSDSN--LIQFNRQLKRNDYDLVAWRKLVEPRASPDLRRGFEVLDLDGGAGWELLKSMMRFKGR  439 (566)
T ss_pred             cHHHHHHHHHHHhCcCCCchH--HHHHHHHHHhcCCcHHHHHHhhccccchhhhhhhhhccccchHHHHHHHHHccCCcc
Confidence            999999999999977665431  1111111110          0011110          11223456899999999999


Q ss_pred             CCCCHHHHHH
Q 015868          356 QRPNFSQITD  365 (399)
Q Consensus       356 ~Rps~~ell~  365 (399)
                      +|||+.|+++
T Consensus       440 kR~ta~e~L~  449 (566)
T PLN03225        440 QRISAKAALA  449 (566)
T ss_pred             cCCCHHHHhC
Confidence            9999999976

>KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.9e-33  Score=257.93  Aligned_cols=247  Identities=21%  Similarity=0.398  Sum_probs=209.1

Q ss_pred             CceeecccccceeceeceeCceEEEEEEE--CCeeEEEEEecCCCCCHH-HHHHHHHHHHHHHhc-CCCceeeEEeEEec
Q 015868          109 DVWEIDAKQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVNTE-MLKEFSQEVYIMRKI-RHKNVVQFIGACTR  184 (399)
Q Consensus       109 ~~~~i~~~~~~i~~~lg~G~~g~Vy~~~~--~~~~vAvK~~~~~~~~~~-~~~~~~~Ei~~l~~l-~h~nIv~~~~~~~~  184 (399)
                      ..|.+..++|.+++.||.|+|..|.+++.  +.+.+|+|+++++..+++ ...-...|-.+..+. +||.+|.++..|..
T Consensus       243 ~~~~l~l~df~ll~vigrgsyakvl~~~~~~t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhscfqt  322 (593)
T KOG0695|consen  243 ISQGLGLQDFDLLRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHSCFQT  322 (593)
T ss_pred             cccccccccceeeeeecCcchhhhhheehcccceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhhhhcc
Confidence            45777888999999999999999999876  678899999998765543 344455666666554 79999999999999


Q ss_pred             CCcEEEEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceeecCCCcEEEeeccceeec
Q 015868          185 PPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQ  264 (399)
Q Consensus       185 ~~~~~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~giiHrDlkp~NILl~~~~~vkl~DFG~a~~~  264 (399)
                      +..+++|.||.+||+|--.+.. +..+|++.+..+...|+-||.|||++|||.||+|..|||++..|++|+.|+|.++..
T Consensus       323 esrlffvieyv~ggdlmfhmqr-qrklpeeharfys~ei~lal~flh~rgiiyrdlkldnvlldaeghikltdygmcke~  401 (593)
T KOG0695|consen  323 ESRLFFVIEYVNGGDLMFHMQR-QRKLPEEHARFYSAEICLALNFLHERGIIYRDLKLDNVLLDAEGHIKLTDYGMCKEG  401 (593)
T ss_pred             cceEEEEEEEecCcceeeehhh-hhcCcHHHhhhhhHHHHHHHHHHhhcCeeeeeccccceEEccCCceeecccchhhcC
Confidence            9999999999999999887765 567999999999999999999999999999999999999999999999999999865


Q ss_pred             cCCC-ccccCCCCcccccccccCCCCCCChhhHHHHHHHHHHHHcCCCCCCC-------CCHHH-HHHHHHhccCCCCCC
Q 015868          265 AQSG-VMTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPYAG-------LTPLQ-AAVGVVQKSLRPTIP  335 (399)
Q Consensus       265 ~~~~-~~~~~~gt~~y~aPE~l~~~~~~~~~Dv~slG~vl~elltg~~P~~~-------~~~~~-~~~~~~~~~~~~~~~  335 (399)
                      -.++ ...+.+||+.|.|||.+.+..|....|.|+||++++||+.|.-||+-       .+... .+.-++.++.  .+|
T Consensus       402 l~~gd~tstfcgtpnyiapeilrgeeygfsvdwwalgvlmfemmagrspfdivgm~n~d~ntedylfqvilekqi--rip  479 (593)
T KOG0695|consen  402 LGPGDTTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIVGMDNPDMNTEDYLFQVILEKQI--RIP  479 (593)
T ss_pred             CCCCcccccccCCCcccchhhhcccccCceehHHHHHHHHHHHHcCCCCcceecCCCcccchhHHHHHHHhhhcc--ccc
Confidence            5444 35567899999999999999999999999999999999999999962       22222 2222333333  478


Q ss_pred             CCCcHHHHHHHHHHhhhcCCCCC
Q 015868          336 KHAHPRLAELLERCWQHDPTQRP  358 (399)
Q Consensus       336 ~~~~~~l~~ll~~cl~~dP~~Rp  358 (399)
                      ...+-....+++..|.+||.+|.
T Consensus       480 rslsvkas~vlkgflnkdp~erl  502 (593)
T KOG0695|consen  480 RSLSVKASHVLKGFLNKDPKERL  502 (593)
T ss_pred             ceeehhhHHHHHHhhcCCcHHhc
Confidence            88899999999999999999994

>KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.2e-33  Score=267.35  Aligned_cols=250  Identities=19%  Similarity=0.370  Sum_probs=202.7

Q ss_pred             ccccceeceeceeCceEEEEEEE--CCeeEEEEEecCCCCC-----HHHHHHHHHHHHHHHhcCCCceeeEEeEEe-cCC
Q 015868          115 AKQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVN-----TEMLKEFSQEVYIMRKIRHKNVVQFIGACT-RPP  186 (399)
Q Consensus       115 ~~~~~i~~~lg~G~~g~Vy~~~~--~~~~vAvK~~~~~~~~-----~~~~~~~~~Ei~~l~~l~h~nIv~~~~~~~-~~~  186 (399)
                      .++|-++..||.|+|+.||+|-+  ..+.||||+-......     .+..+...+|..|.+.|+||.||++|++|. +..
T Consensus       462 n~RYLlLhLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVKlYDyfslDtd  541 (775)
T KOG1151|consen  462 NDRYLLLHLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKLYDYFSLDTD  541 (775)
T ss_pred             HHHHHHHHHhccccHHHHHHhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeeeeeeeeeeccc
Confidence            46788999999999999999976  5678999997643322     234566889999999999999999999996 455


Q ss_pred             cEEEEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC--CcccCCCCCCceeec---CCCcEEEeeccce
Q 015868          187 NLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQN--NIIHRDLKTANLLMD---ENGVVKVADFGVA  261 (399)
Q Consensus       187 ~~~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~--giiHrDlkp~NILl~---~~~~vkl~DFG~a  261 (399)
                      .+|-|+|||+|.+|.-||+. ...+++.++..|+.||+.||.||...  .|||-||||.|||+-   .-|.+||.|||++
T Consensus       542 sFCTVLEYceGNDLDFYLKQ-hklmSEKEARSIiMQiVnAL~YLNEikpPIIHYDLKPgNILLv~GtacGeIKITDFGLS  620 (775)
T KOG1151|consen  542 SFCTVLEYCEGNDLDFYLKQ-HKLMSEKEARSIIMQIVNALKYLNEIKPPIIHYDLKPGNILLVNGTACGEIKITDFGLS  620 (775)
T ss_pred             cceeeeeecCCCchhHHHHh-hhhhhHHHHHHHHHHHHHHHHHHhccCCCeeeeccCCccEEEecCcccceeEeeecchh
Confidence            79999999999999999966 56789999999999999999999986  699999999999995   3478999999999


Q ss_pred             eeccCCCc--------cccCCCCcccccccccCC----CCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHH---HH
Q 015868          262 RVQAQSGV--------MTAETGTYRWMAPEVIEH----KPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVG---VV  326 (399)
Q Consensus       262 ~~~~~~~~--------~~~~~gt~~y~aPE~l~~----~~~~~~~Dv~slG~vl~elltg~~P~~~~~~~~~~~~---~~  326 (399)
                      +.+.....        .....||+.|++||.+.-    ...+.|.||||.|+++|.++.|+.||...-..+....   ++
T Consensus       621 KIMdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClYGrKPFGhnqsQQdILqeNTIl  700 (775)
T KOG1151|consen  621 KIMDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRKPFGHNQSQQDILQENTIL  700 (775)
T ss_pred             hhccCCccCcccceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhhccCCCCCCchhHHHHHhhhchh
Confidence            98765432        244579999999998853    3468899999999999999999999977654443322   11


Q ss_pred             hcc-CCCCCCCCCcHHHHHHHHHHhhhcCCCCCCHHHHHH
Q 015868          327 QKS-LRPTIPKHAHPRLAELLERCWQHDPTQRPNFSQITD  365 (399)
Q Consensus       327 ~~~-~~~~~~~~~~~~l~~ll~~cl~~dP~~Rps~~ell~  365 (399)
                      ... ...+..+.++++..+||++||++.-++|.+..++..
T Consensus       701 kAtEVqFP~KPvVsseAkaFIRRCLaYRKeDR~DV~qLA~  740 (775)
T KOG1151|consen  701 KATEVQFPPKPVVSSEAKAFIRRCLAYRKEDRIDVQQLAC  740 (775)
T ss_pred             cceeccCCCCCccCHHHHHHHHHHHHhhhhhhhhHHHHcc
Confidence            111 111122458899999999999999999999888865

>cd00180 PKc Catalytic domain of Protein Kinases

Probab=100.00  E-value=1.9e-31  Score=237.85  Aligned_cols=209  Identities=36%  Similarity=0.688  Sum_probs=186.6

Q ss_pred             eceeCceEEEEEEEC--CeeEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCceeeEEeEEecCCcEEEEEecCCCCCHH
Q 015868          124 VASGSYGDLYKGTYC--SQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVTEFMARGSIY  201 (399)
Q Consensus       124 lg~G~~g~Vy~~~~~--~~~vAvK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~nIv~~~~~~~~~~~~~lV~E~~~ggsL~  201 (399)
                      ||+|++|.||+++..  ++.+++|++....... ....+.+|+..++.+.|++|+++++++......++++|++.|++|.
T Consensus         1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~-~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~~~e~~~~~~l~   79 (215)
T cd00180           1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSS-LLEELLREIEILKKLNHPNIVKLYGVFEDENHLYLVMEYCEGGSLK   79 (215)
T ss_pred             CCcCCceEEEEEEecCCCcEEEEEEeccccchh-HHHHHHHHHHHHHhcCCCCeeeEeeeeecCCeEEEEEecCCCCcHH
Confidence            689999999999986  8999999998764332 4567999999999999999999999999989999999999999999


Q ss_pred             HHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceeecC-CCcEEEeeccceeeccCCC-ccccCCCCccc
Q 015868          202 DFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDE-NGVVKVADFGVARVQAQSG-VMTAETGTYRW  279 (399)
Q Consensus       202 ~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~giiHrDlkp~NILl~~-~~~vkl~DFG~a~~~~~~~-~~~~~~gt~~y  279 (399)
                      +++......++...++.++.++++++.+||+.|++|+||+|.||+++. ++.++|+|||.+....... ......+...|
T Consensus        80 ~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~  159 (215)
T cd00180          80 DLLKENEGKLSEDEILRILLQILEGLEYLHSNGIIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKSLLKTIVGTPAY  159 (215)
T ss_pred             HHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHhhEEEeCCCCcEEEecCCceEEccCCcchhhcccCCCCc
Confidence            999775457899999999999999999999999999999999999999 8999999999998665442 23345678899


Q ss_pred             ccccccCCC-CCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhccCCCCCCCCCcHHHHHHHHHHhhhcCCCCC
Q 015868          280 MAPEVIEHK-PYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRLAELLERCWQHDPTQRP  358 (399)
Q Consensus       280 ~aPE~l~~~-~~~~~~Dv~slG~vl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~cl~~dP~~Rp  358 (399)
                      ++||.+... .++.++|+|++|++++++                                 ..+.+++.+|++.+|.+||
T Consensus       160 ~~pe~~~~~~~~~~~~D~~~lg~~~~~l---------------------------------~~~~~~l~~~l~~~p~~R~  206 (215)
T cd00180         160 MAPEVLLGKGYYSEKSDIWSLGVILYEL---------------------------------PELKDLIRKMLQKDPEKRP  206 (215)
T ss_pred             cChhHhcccCCCCchhhhHHHHHHHHHH---------------------------------HHHHHHHHHHhhCCcccCc
Confidence            999999887 788999999999999999                                 5799999999999999999


Q ss_pred             CHHHHHHH
Q 015868          359 NFSQITDI  366 (399)
Q Consensus       359 s~~ell~~  366 (399)
                      ++.++++.
T Consensus       207 ~~~~l~~~  214 (215)
T cd00180         207 SAKEILEH  214 (215)
T ss_pred             CHHHHhhC
Confidence            99999764

Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which

>KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.3e-34  Score=259.15  Aligned_cols=248  Identities=25%  Similarity=0.422  Sum_probs=203.0

Q ss_pred             cceeceeceeCceEEEEEEE--CCeeEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCceeeEEeEEecCC-----cEEE
Q 015868          118 LKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPP-----NLCI  190 (399)
Q Consensus       118 ~~i~~~lg~G~~g~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~nIv~~~~~~~~~~-----~~~l  190 (399)
                      .+-.+.||.|+||+||..++  .++.||+|.+..-..+-...+.+.+|+.+|...+|.|+...+++...+.     .+|.
T Consensus        55 i~PDRPIGYGAFGVVWsVTDPRdgrrvalkK~pnvfq~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~dfFqEiYV  134 (449)
T KOG0664|consen   55 IQPDRPIGYGAFGVVWSVTDPRSGKRVALKKMPNVFQNLASCKRVFREIKMLSSFRHDNVLSLLDILQPANPSFFQELYV  134 (449)
T ss_pred             CCCCCcccccceeEEEeccCCCCccchhHhhcchHHHHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCchHHHHHHH
Confidence            34467899999999999987  6899999998766556667789999999999999999999998765443     3688


Q ss_pred             EEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceeecCCCcEEEeeccceeeccC--CC
Q 015868          191 VTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQ--SG  268 (399)
Q Consensus       191 V~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~giiHrDlkp~NILl~~~~~vkl~DFG~a~~~~~--~~  268 (399)
                      ++|.|.. +|..+|-. ...++.+.++-+++||++||.|||+.||.||||||.|+|+++|-.+||||||+++....  ..
T Consensus       135 ~TELmQS-DLHKIIVS-PQ~Ls~DHvKVFlYQILRGLKYLHsA~ILHRDIKPGNLLVNSNCvLKICDFGLARvee~d~~~  212 (449)
T KOG0664|consen  135 LTELMQS-DLHKIIVS-PQALTPDHVKVFVYQILRGLKYLHTANILHRDIKPGNLLVNSNCILKICDFGLARTWDQRDRL  212 (449)
T ss_pred             HHHHHHh-hhhheecc-CCCCCcchhhhhHHHHHhhhHHHhhcchhhccCCCccEEeccCceEEecccccccccchhhhh
Confidence            8998865 77776643 57788899999999999999999999999999999999999999999999999997554  34


Q ss_pred             ccccCCCCcccccccccCCC-CCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHh--------------------
Q 015868          269 VMTAETGTYRWMAPEVIEHK-PYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQ--------------------  327 (399)
Q Consensus       269 ~~~~~~gt~~y~aPE~l~~~-~~~~~~Dv~slG~vl~elltg~~P~~~~~~~~~~~~~~~--------------------  327 (399)
                      .|+.+..|..|.|||.+.+. .|+.+.||||.||++.||+..+..|...+|.+...-+..                    
T Consensus       213 hMTqEVVTQYYRAPEiLMGaRhYs~AvDiWSVGCIFaELLgRrILFQAq~PiqQL~lItdLLGTPs~EaMr~ACEGAk~H  292 (449)
T KOG0664|consen  213 NMTHEVVTQYYRAPELLMGARRYTGAVDIWSVGCIFAELLQRKILFQAAGPIEQLQMIIDLLGTPSQEAMKYACEGAKNH  292 (449)
T ss_pred             hhHHHHHHHHhccHHHhhcchhhcCccceehhhHHHHHHHhhhhhhhccChHHHHHHHHHHhCCCcHHHHHHHhhhhHHH
Confidence            68888899999999999875 689999999999999999999999988777665443321                    


Q ss_pred             ---ccCC-CCCC--------CCCcHHHHHHHHHHhhhcCCCCCCHHHHHHHH
Q 015868          328 ---KSLR-PTIP--------KHAHPRLAELLERCWQHDPTQRPNFSQITDIL  367 (399)
Q Consensus       328 ---~~~~-~~~~--------~~~~~~l~~ll~~cl~~dP~~Rps~~ell~~L  367 (399)
                         ...+ |..+        .....+...++.+++..||+.|.+.++.+...
T Consensus       293 ~LR~~~k~Ps~~vLYtlsS~~~~~heav~~~~~~l~~d~dkris~~~A~~~~  344 (449)
T KOG0664|consen  293 VLRAGLRAPDTQRLYKIASPDDKNHEAVDLLQKLLHFDPDKRISVEEALQHR  344 (449)
T ss_pred             hhccCCCCCCccceeeecCCcccchHHHHHHHHHhCCCCcccccHhhhcccc
Confidence               1111 1111        12335678899999999999999988876543

>KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms]

Probab=100.00  E-value=4.8e-34  Score=281.47  Aligned_cols=248  Identities=29%  Similarity=0.504  Sum_probs=215.5

Q ss_pred             ccccceeceeceeCceEEEEEEE--CCeeEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCceeeEEeEEecCCcEEEEE
Q 015868          115 AKQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVT  192 (399)
Q Consensus       115 ~~~~~i~~~lg~G~~g~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~nIv~~~~~~~~~~~~~lV~  192 (399)
                      ..+|.+..++|+|+||.||++++  .++..|+|+++.+.  .+......+|+-+++.++||||+.++|.+.....+++.|
T Consensus        14 ~ddyellqrvgsgTygdvyKaRd~~s~elaavkvVkLep--~dd~~~iqqei~~~~dc~h~nivay~gsylr~dklwicM   91 (829)
T KOG0576|consen   14 QDDYELLQRVGSGTYGDVYKARDKRSGELAAVKVVKLEP--GDDFSGIQQEIGMLRDCRHPNIVAYFGSYLRRDKLWICM   91 (829)
T ss_pred             ccchhheeeecCCcccchhhhcccccCchhhheeeeccC--CccccccccceeeeecCCCcChHHHHhhhhhhcCcEEEE
Confidence            45899999999999999999987  67899999999763  344567889999999999999999999999999999999


Q ss_pred             ecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceeecCCCcEEEeeccceeeccCC-Cccc
Q 015868          193 EFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQS-GVMT  271 (399)
Q Consensus       193 E~~~ggsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~giiHrDlkp~NILl~~~~~vkl~DFG~a~~~~~~-~~~~  271 (399)
                      |||.||+|.+.-+- .+.+++.++..++...++|++|||+.|-+|||||-.||++++.|.||++|||.+...... ....
T Consensus        92 EycgggslQdiy~~-TgplselqiayvcRetl~gl~ylhs~gk~hRdiKGanilltd~gDvklaDfgvsaqitati~Krk  170 (829)
T KOG0576|consen   92 EYCGGGSLQDIYHV-TGPLSELQIAYVCRETLQGLKYLHSQGKIHRDIKGANILLTDEGDVKLADFGVSAQITATIAKRK  170 (829)
T ss_pred             EecCCCcccceeee-cccchhHHHHHHHhhhhccchhhhcCCcccccccccceeecccCceeecccCchhhhhhhhhhhh
Confidence            99999999997654 578999999999999999999999999999999999999999999999999998644332 2345


Q ss_pred             cCCCCcccccccccC---CCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhccCCCCC---CCCCcHHHHHH
Q 015868          272 AETGTYRWMAPEVIE---HKPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKSLRPTI---PKHAHPRLAEL  345 (399)
Q Consensus       272 ~~~gt~~y~aPE~l~---~~~~~~~~Dv~slG~vl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~l~~l  345 (399)
                      ...||+.|||||+..   ...|...+|||++|++..|+-.-++|.-...+.+...-.-.....|.-   +..+++.|.+|
T Consensus       171 sfiGtpywmapEvaaverkggynqlcdiwa~gitAiel~eLqpplfdlhpmr~l~LmTkS~~qpp~lkDk~kws~~fh~f  250 (829)
T KOG0576|consen  171 SFIGTPYWMAPEVAAVERKGGYNQLCDIWALGITAIELGELQPPLFDLHPMRALFLMTKSGFQPPTLKDKTKWSEFFHNF  250 (829)
T ss_pred             cccCCccccchhHHHHHhcccccccccccccccchhhhhhcCCcccccchHHHHHHhhccCCCCCcccCCccchHHHHHH
Confidence            568999999999974   457999999999999999999999998888888877665555544432   34588999999


Q ss_pred             HHHHhhhcCCCCCCHHHHHH
Q 015868          346 LERCWQHDPTQRPNFSQITD  365 (399)
Q Consensus       346 l~~cl~~dP~~Rps~~ell~  365 (399)
                      ++.++.++|.+||+++-+++
T Consensus       251 vK~altknpKkRptaeklL~  270 (829)
T KOG0576|consen  251 VKGALTKNPKKRPTAEKLLQ  270 (829)
T ss_pred             HHHHhcCCCccCCChhhhee
Confidence            99999999999999998865

>KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms]

Probab=99.98  E-value=1.3e-32  Score=251.40  Aligned_cols=246  Identities=24%  Similarity=0.327  Sum_probs=203.8

Q ss_pred             ccccceeceeceeCceEEEEEEE--CCeeEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCceeeEEeEEecCC------
Q 015868          115 AKQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPP------  186 (399)
Q Consensus       115 ~~~~~i~~~lg~G~~g~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~nIv~~~~~~~~~~------  186 (399)
                      ..+|.-++.+|.|.- .|.-+-+  .+++||+|.+.....+....++..+|..++..+.|+||++++.+|+...      
T Consensus        16 ~~Ry~nL~p~~~g~~-~v~~a~D~v~~~~v~ikk~~~pf~n~~~akra~rel~l~~~v~~~nii~l~n~ftP~~~l~~~~   94 (369)
T KOG0665|consen   16 PKRYVNLKPIGSGAQ-IVVAAFDQVLGRPVAIKKLSRPFQNQTHAKRAYRELKLMKCVNHKNIISLLNVFTPQKTLEEFQ   94 (369)
T ss_pred             eeeeeeecccCCCCc-eEEecchhhccCceehhhhcCccccCccchhhhhhhhhhhhhcccceeeeeeccCccccHHHHH
Confidence            457777888999888 5655543  6899999998776767777889999999999999999999999997654      


Q ss_pred             cEEEEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceeecCCCcEEEeeccceeeccC
Q 015868          187 NLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQ  266 (399)
Q Consensus       187 ~~~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~giiHrDlkp~NILl~~~~~vkl~DFG~a~~~~~  266 (399)
                      ..|+|||+|.+ +|...+..   .+.-..+..+..|++.|+.|||+.||+||||||+||++..+..+||.|||+|+....
T Consensus        95 e~y~v~e~m~~-nl~~vi~~---elDH~tis~i~yq~~~~ik~lhs~~IihRdLkPsnivv~~~~~lKi~dfg~ar~e~~  170 (369)
T KOG0665|consen   95 EVYLVMELMDA-NLCQVILM---ELDHETISYILYQMLCGIKHLHSAGIIHRDLKPSNIVVNSDCTLKILDFGLARTEDT  170 (369)
T ss_pred             hHHHHHHhhhh-HHHHHHHH---hcchHHHHHHHHHHHHHHHHHHhcceeecccCcccceecchhheeeccchhhcccCc
Confidence            47999999976 99998863   356678999999999999999999999999999999999999999999999998776


Q ss_pred             CCccccCCCCcccccccccCCCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhccC----------------
Q 015868          267 SGVMTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKSL----------------  330 (399)
Q Consensus       267 ~~~~~~~~gt~~y~aPE~l~~~~~~~~~Dv~slG~vl~elltg~~P~~~~~~~~~~~~~~~~~~----------------  330 (399)
                      .-.++....|..|.|||++.+-.|.+..||||+||++.||++|..-|.+.+.......+.....                
T Consensus       171 ~~~mtpyVvtRyyrapevil~~~~ke~vdiwSvGci~gEli~~~Vlf~g~d~idQ~~ki~~~lgtpd~~F~~qL~~~~r~  250 (369)
T KOG0665|consen  171 DFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELILGTVLFPGKDHIDQWNKIIEQLGTPDPSFMKQLQPTVRN  250 (369)
T ss_pred             ccccCchhheeeccCchheeccCCcccchhhhhhhHHHHHhhceEEecCchHHHHHHHHHHHhcCCCHHHHHHhhHHHHH
Confidence            6567888999999999999988899999999999999999999998887654443333221100                


Q ss_pred             ----------------------CCC--CCCCCcHHHHHHHHHHhhhcCCCCCCHHHHHH
Q 015868          331 ----------------------RPT--IPKHAHPRLAELLERCWQHDPTQRPNFSQITD  365 (399)
Q Consensus       331 ----------------------~~~--~~~~~~~~l~~ll~~cl~~dP~~Rps~~ell~  365 (399)
                                            +..  -++.....+++++.+||..||++|-++.+++.
T Consensus       251 yv~~~~~y~~~~f~~~fpD~~f~~~~e~~~~~~~~ardll~~MLvi~pe~Risv~daL~  309 (369)
T KOG0665|consen  251 YVENRPQYQAISFSELFPDSLFPVVLEGSKLDCSLARDLLSKMLVIDPEKRISVDDALR  309 (369)
T ss_pred             HhhcChHhhccchhhhCCcccccccccCCccchHHHHHHHHHhhccChhhcccHHHHhc
Confidence                                  000  01123456899999999999999999999865

>KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification]

Probab=99.97  E-value=1.1e-32  Score=265.01  Aligned_cols=249  Identities=25%  Similarity=0.423  Sum_probs=206.5

Q ss_pred             eecccccceeceeceeCceEEEEEEE--CCeeEEEEEecCCCCCHHHHHHHHHHHHHHHhcC------CCceeeEEeEEe
Q 015868          112 EIDAKQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIR------HKNVVQFIGACT  183 (399)
Q Consensus       112 ~i~~~~~~i~~~lg~G~~g~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~Ei~~l~~l~------h~nIv~~~~~~~  183 (399)
                      ++..++|.+..-.|.|-|++|.+|.+  .++.|||||++.   ++-+.+.=..|+.+|++|+      .-|+++++..|.
T Consensus       428 E~LD~RY~V~~~~GkGvFs~Vvra~D~~r~~~vAiKIIRn---NE~M~KtGl~EleiLkKL~~AD~Edk~Hclrl~r~F~  504 (752)
T KOG0670|consen  428 ELLDSRYEVQGYTGKGVFSTVVRARDQARGQEVAIKIIRN---NEVMHKTGLKELEILKKLNDADPEDKFHCLRLFRHFK  504 (752)
T ss_pred             hhhcceeEEEeccccceeeeeeeccccCCCCeeEEEEeec---chHHhhhhhHHHHHHHHhhccCchhhhHHHHHHHHhh
Confidence            34457889999999999999999987  578999999985   4556677788999999995      358999999999


Q ss_pred             cCCcEEEEEecCCCCCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceeecCC-CcEEEeeccc
Q 015868          184 RPPNLCIVTEFMARGSIYDFLHKQ--KGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDEN-GVVKVADFGV  260 (399)
Q Consensus       184 ~~~~~~lV~E~~~ggsL~~~l~~~--~~~l~~~~~~~i~~~i~~~L~~LH~~giiHrDlkp~NILl~~~-~~vkl~DFG~  260 (399)
                      ..+++|||+|.+.. +|.+.|++-  +-.+....+..++.|++-||..|.+.||+|.||||.|||+++. ..+||||||.
T Consensus       505 hknHLClVFE~Lsl-NLRevLKKyG~nvGL~ikaVRsYaqQLflALklLK~c~vlHaDIKPDNiLVNE~k~iLKLCDfGS  583 (752)
T KOG0670|consen  505 HKNHLCLVFEPLSL-NLREVLKKYGRNVGLHIKAVRSYAQQLFLALKLLKKCGVLHADIKPDNILVNESKNILKLCDFGS  583 (752)
T ss_pred             hcceeEEEehhhhc-hHHHHHHHhCcccceeehHHHHHHHHHHHHHHHHHhcCeeecccCccceEeccCcceeeeccCcc
Confidence            99999999998854 999999874  3467888999999999999999999999999999999999865 5789999999


Q ss_pred             eeeccCCCccccCCCCcccccccccCCCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHh-----------cc
Q 015868          261 ARVQAQSGVMTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQ-----------KS  329 (399)
Q Consensus       261 a~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~Dv~slG~vl~elltg~~P~~~~~~~~~~~~~~~-----------~~  329 (399)
                      |...... ..+.+..+..|.|||++.|.+|+...|+||.||+||||.||+..|.+.++.+.+.-...           ++
T Consensus       584 A~~~~en-eitPYLVSRFYRaPEIiLG~~yd~~iD~WSvgctLYElYtGkIlFpG~TNN~MLrl~me~KGk~p~KmlRKg  662 (752)
T KOG0670|consen  584 ASFASEN-EITPYLVSRFYRAPEIILGLPYDYPIDTWSVGCTLYELYTGKILFPGRTNNQMLRLFMELKGKFPNKMLRKG  662 (752)
T ss_pred             ccccccc-cccHHHHHHhccCcceeecCcccCCccceeeceeeEEeeccceecCCCCcHHHHHHHHHhcCCCcHHHhhhc
Confidence            9766554 34556678899999999999999999999999999999999999999888776543321           00


Q ss_pred             --------------------------------CC------------CCCCC---CCcHHHHHHHHHHhhhcCCCCCCHHH
Q 015868          330 --------------------------------LR------------PTIPK---HAHPRLAELLERCWQHDPTQRPNFSQ  362 (399)
Q Consensus       330 --------------------------------~~------------~~~~~---~~~~~l~~ll~~cl~~dP~~Rps~~e  362 (399)
                                                      ..            +.+|.   ..-..|.+|+.+||..||++|.|..|
T Consensus       663 qF~dqHFD~d~nf~~~e~D~vT~r~~~~vm~~vkPtkdl~s~l~~~q~~~deq~~~~~~~rdLLdkml~LdP~KRit~nq  742 (752)
T KOG0670|consen  663 QFKDQHFDQDLNFLYIEVDKVTEREKRTVMVNVKPTKDLGSELIAVQRLPDEQPKIVQQLRDLLDKMLILDPEKRITVNQ  742 (752)
T ss_pred             chhhhhcccccceEEEeccccccceeEEEecccCcchhHHHHHhccCCCCchhHHHHHHHHHHHHHHhccChhhcCCHHH
Confidence                                            00            00111   12246899999999999999999999


Q ss_pred             HHH
Q 015868          363 ITD  365 (399)
Q Consensus       363 ll~  365 (399)
                      .++
T Consensus       743 AL~  745 (752)
T KOG0670|consen  743 ALK  745 (752)
T ss_pred             Hhc
Confidence            875

>smart00221 STYKc Protein kinase; unclassified specificity

Probab=99.97  E-value=2.2e-30  Score=235.08  Aligned_cols=212  Identities=32%  Similarity=0.554  Sum_probs=182.9

Q ss_pred             cceeceeceeCceEEEEEEEC--CeeEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCceeeEEeEEecCCcEEEEEecC
Q 015868          118 LKIECKVASGSYGDLYKGTYC--SQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVTEFM  195 (399)
Q Consensus       118 ~~i~~~lg~G~~g~Vy~~~~~--~~~vAvK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~nIv~~~~~~~~~~~~~lV~E~~  195 (399)
                      |.+.+.||.|++|.||++...  ++.+|+|.+...... ...+.+.+|+..++.++|+|++++++++......++++|++
T Consensus         1 ~~~~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~-~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~   79 (225)
T smart00221        1 YELGKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTE-KQREEFLREIRILKKLKHPNIVKLYGVFEDPEPLYLVMEYC   79 (225)
T ss_pred             CceeeEeecCCCeEEEEEEEcCCCcEEEEEeeccccch-HHHHHHHHHHHHHHhCCCCChhhheeeeecCCceEEEEecc
Confidence            567889999999999999884  589999999865433 25678999999999999999999999999989999999999


Q ss_pred             CCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceeecCCCcEEEeeccceeeccCCC--ccccC
Q 015868          196 ARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSG--VMTAE  273 (399)
Q Consensus       196 ~ggsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~giiHrDlkp~NILl~~~~~vkl~DFG~a~~~~~~~--~~~~~  273 (399)
                      ++++|.+++......+++..+..++.+++.++.+||+.+++|+|++|.||+++.++.++|+|||.+.......  .....
T Consensus        80 ~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~di~~~ni~v~~~~~~~l~d~g~~~~~~~~~~~~~~~~  159 (225)
T smart00221       80 EGGDLFDYLRKKGGKLSEEEARFYLRQILEALEYLHSLGIVHRDLKPENILLGMDGLVKLADFGLARFIHRDLAALLKTV  159 (225)
T ss_pred             CCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEeeCceeeEecCcccccccce
Confidence            9999999997754338899999999999999999999999999999999999999999999999998765543  33445


Q ss_pred             CCCccccccccc-CCCCCCChhhHHHHHHHHHHHHcCCCCCCC-CCHHHHHHHHHhccC
Q 015868          274 TGTYRWMAPEVI-EHKPYDYKADVFSFGIALWELLTGELPYAG-LTPLQAAVGVVQKSL  330 (399)
Q Consensus       274 ~gt~~y~aPE~l-~~~~~~~~~Dv~slG~vl~elltg~~P~~~-~~~~~~~~~~~~~~~  330 (399)
                      .++..|++||.+ ....++.++|+|+||+++++|++|+.||.. ..+.......+..+.
T Consensus       160 ~~~~~~~~pe~~~~~~~~~~~~Dv~~lG~~~~~l~~g~~pf~~~~~~~~~~~~~~~~~~  218 (225)
T smart00221      160 KGTPFYLAPEVLLGGKGYGEAVDIWSLGVILYELLWGPEPFSGEGEFTSLLSDVWSFGV  218 (225)
T ss_pred             eccCCcCCHhHhcCCCCCCchhhHHHHHHHHHHHHHCCCCccccchhHHHHHHHHhcCC
Confidence            678899999999 677788899999999999999999999987 566655555555543

Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase.

>KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription]

Probab=99.97  E-value=1.1e-31  Score=235.09  Aligned_cols=243  Identities=21%  Similarity=0.427  Sum_probs=196.1

Q ss_pred             cccccceeceeceeCceEEEEEEE--CCeeEEEEEecCCCCCHHHHHHHHHHHHHHHhcC-CCceeeEEeEEecCC--cE
Q 015868          114 DAKQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIR-HKNVVQFIGACTRPP--NL  188 (399)
Q Consensus       114 ~~~~~~i~~~lg~G~~g~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~Ei~~l~~l~-h~nIv~~~~~~~~~~--~~  188 (399)
                      ..++|++.+++|+|.|+.||.|..  +.+.++||++++.     ..+.+.+|+.||+.+. ||||+.++++..++.  ..
T Consensus        36 ~~ddYeivrk~GRGKYSEVFeg~~~~~~eK~ViKiLKPV-----kkkKIkREikIL~nL~gg~NIi~L~DiV~Dp~Sktp  110 (338)
T KOG0668|consen   36 NQDDYEIVRKVGRGKYSEVFEGINITNNEKCVIKILKPV-----KKKKIKREIKILQNLRGGPNIIKLLDIVKDPESKTP  110 (338)
T ss_pred             ccchHHHHHHHcCccHhhHhcccccCCCceEEEeeechH-----HHHHHHHHHHHHHhccCCCCeeehhhhhcCccccCc
Confidence            467899999999999999999974  6789999999864     3467899999999997 999999999987654  57


Q ss_pred             EEEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceeecCC-CcEEEeeccceeeccCC
Q 015868          189 CIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDEN-GVVKVADFGVARVQAQS  267 (399)
Q Consensus       189 ~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~giiHrDlkp~NILl~~~-~~vkl~DFG~a~~~~~~  267 (399)
                      .+|+||+.+.+...+-    ..++...+..++.++++||.|+|+.||+|||+||.|++++.. -.++|+|+|+|......
T Consensus       111 aLiFE~v~n~Dfk~ly----~tl~d~dIryY~~elLkALdyCHS~GImHRDVKPhNvmIdh~~rkLrlIDWGLAEFYHp~  186 (338)
T KOG0668|consen  111 SLIFEYVNNTDFKQLY----PTLTDYDIRYYIYELLKALDYCHSMGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPG  186 (338)
T ss_pred             hhHhhhhccccHHHHh----hhhchhhHHHHHHHHHHHHhHHHhcCcccccCCcceeeechhhceeeeeecchHhhcCCC
Confidence            8999999886665544    446778899999999999999999999999999999999854 57999999999988776


Q ss_pred             CccccCCCCcccccccccCC-CCCCChhhHHHHHHHHHHHHcCCCCC-CCCCHHHHHHHHH------------hc---cC
Q 015868          268 GVMTAETGTYRWMAPEVIEH-KPYDYKADVFSFGIALWELLTGELPY-AGLTPLQAAVGVV------------QK---SL  330 (399)
Q Consensus       268 ~~~~~~~gt~~y~aPE~l~~-~~~~~~~Dv~slG~vl~elltg~~P~-~~~~~~~~~~~~~------------~~---~~  330 (399)
                      ....-...+..|-.||.+-. +.|+..-|+|||||++..|+..+.|| .+.++...+..+.            .+   .+
T Consensus       187 ~eYnVRVASRyfKGPELLVdy~~YDYSLD~WS~GcmlA~miFrkepFFhG~dN~DQLVkIakVLGt~el~~Yl~KY~i~L  266 (338)
T KOG0668|consen  187 KEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVKIAKVLGTDELYAYLNKYQIDL  266 (338)
T ss_pred             ceeeeeeehhhcCCchheeechhccccHHHHHHHHHHHHHHhccCcccCCCCCHHHHHHHHHHhChHHHHHHHHHHccCC
Confidence            66565667788899999865 45889999999999999999988776 3333322222221            00   01


Q ss_pred             CCC--------------------CCCCCcHHHHHHHHHHhhhcCCCCCCHHHHHH
Q 015868          331 RPT--------------------IPKHAHPRLAELLERCWQHDPTQRPNFSQITD  365 (399)
Q Consensus       331 ~~~--------------------~~~~~~~~l~~ll~~cl~~dP~~Rps~~ell~  365 (399)
                      .|.                    -..-.+++..+|+.++|..|-.+|+|+.|.+.
T Consensus       267 dp~~~~i~~~~~rk~w~~Fi~~~n~hl~~peaiDlldklLrYDHqeRlTakEam~  321 (338)
T KOG0668|consen  267 DPQFEDILGRHSRKPWSRFINSENQHLVSPEAIDLLDKLLRYDHQERLTAKEAMA  321 (338)
T ss_pred             ChhHhhHhhccccccHHHhCCccccccCChHHHHHHHHHHhhccccccchHHHhc
Confidence            111                    11225689999999999999999999999875

>KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms]

Probab=99.97  E-value=9.3e-32  Score=261.58  Aligned_cols=199  Identities=27%  Similarity=0.431  Sum_probs=173.9

Q ss_pred             ccccceeceeceeCceEEEEEEEC--CeeEEEEEecCCCCCH------HHHHHHHHHHHHHHhcC---CCceeeEEeEEe
Q 015868          115 AKQLKIECKVASGSYGDLYKGTYC--SQEVAIKVLKPECVNT------EMLKEFSQEVYIMRKIR---HKNVVQFIGACT  183 (399)
Q Consensus       115 ~~~~~i~~~lg~G~~g~Vy~~~~~--~~~vAvK~~~~~~~~~------~~~~~~~~Ei~~l~~l~---h~nIv~~~~~~~  183 (399)
                      ..+|...+.+|+|+||.|++|.+.  ...|+||.+.+++.=.      ...-.+-.||+||..++   |+||++++++|+
T Consensus       560 ~s~yttlq~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlLdfFE  639 (772)
T KOG1152|consen  560 FSDYTTLQPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKLLDFFE  639 (772)
T ss_pred             cccceeeeeccccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhhhheee
Confidence            456899999999999999999884  4679999988764322      22334677999999997   999999999999


Q ss_pred             cCCcEEEEEecC-CCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceeecCCCcEEEeecccee
Q 015868          184 RPPNLCIVTEFM-ARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVAR  262 (399)
Q Consensus       184 ~~~~~~lV~E~~-~ggsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~giiHrDlkp~NILl~~~~~vkl~DFG~a~  262 (399)
                      +++++||+||-. +|-+|.++|.. ...+++.+...|..||+.|+++||+.||||||||-+||.++.+|-+||+|||.+.
T Consensus       640 ddd~yyl~te~hg~gIDLFd~IE~-kp~m~E~eAk~IFkQV~agi~hlh~~~ivhrdikdenvivd~~g~~klidfgsaa  718 (772)
T KOG1152|consen  640 DDDYYYLETEVHGEGIDLFDFIEF-KPRMDEPEAKLIFKQVVAGIKHLHDQGIVHRDIKDENVIVDSNGFVKLIDFGSAA  718 (772)
T ss_pred             cCCeeEEEecCCCCCcchhhhhhc-cCccchHHHHHHHHHHHhccccccccCceecccccccEEEecCCeEEEeeccchh
Confidence            999999999975 45599999976 5678999999999999999999999999999999999999999999999999986


Q ss_pred             eccCCCccccCCCCcccccccccCCCCCCC-hhhHHHHHHHHHHHHcCCCCCCC
Q 015868          263 VQAQSGVMTAETGTYRWMAPEVIEHKPYDY-KADVFSFGIALWELLTGELPYAG  315 (399)
Q Consensus       263 ~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~-~~Dv~slG~vl~elltg~~P~~~  315 (399)
                      . ..++......||..|.|||++.+.+|-- ..|||++|++||.+.....||..
T Consensus       719 ~-~ksgpfd~f~gtv~~aapevl~g~~y~gk~qdiwalgillytivykenpyyn  771 (772)
T KOG1152|consen  719 Y-TKSGPFDVFVGTVDYAAPEVLGGEKYLGKPQDIWALGILLYTIVYKENPYYN  771 (772)
T ss_pred             h-hcCCCcceeeeeccccchhhhCCCccCCCcchhhhhhheeeEEEeccCCCcC
Confidence            4 4566777889999999999999999964 47999999999999998888853

>KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms]

Probab=99.96  E-value=5e-30  Score=229.77  Aligned_cols=255  Identities=31%  Similarity=0.636  Sum_probs=220.6

Q ss_pred             eeecccccceeceeceeCceEEEEEEECCeeEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCceeeEEeEEecCCcEEE
Q 015868          111 WEIDAKQLKIECKVASGSYGDLYKGTYCSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCI  190 (399)
Q Consensus       111 ~~i~~~~~~i~~~lg~G~~g~Vy~~~~~~~~vAvK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~nIv~~~~~~~~~~~~~l  190 (399)
                      ..|+.+.+.+..+|....+|..|+|+|.+.+++.|+++.........++|.+|.-.|+-..||||+.++++|..++++.+
T Consensus       185 ~gid~~~lnl~tkl~e~hsgelwrgrwqgndivakil~vr~~t~risrdfneefp~lrifshpnilpvlgacnsppnlv~  264 (448)
T KOG0195|consen  185 TGIDVSSLNLITKLAESHSGELWRGRWQGNDIVAKILNVREVTARISRDFNEEFPALRIFSHPNILPVLGACNSPPNLVI  264 (448)
T ss_pred             cCcchhhhhhhhhhccCCCcccccccccCcchhhhhhhhhhcchhhcchhhhhCcceeeecCCchhhhhhhccCCCCceE
Confidence            35677888899999999999999999999999999998776666777899999999999999999999999999999999


Q ss_pred             EEecCCCCCHHHHHHhcCC-CCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCCCceeecCCCcEEEe--eccceeecc
Q 015868          191 VTEFMARGSIYDFLHKQKG-VFQLTSLLKVAIDVSKGMNYLHQNN--IIHRDLKTANLLMDENGVVKVA--DFGVARVQA  265 (399)
Q Consensus       191 V~E~~~ggsL~~~l~~~~~-~l~~~~~~~i~~~i~~~L~~LH~~g--iiHrDlkp~NILl~~~~~vkl~--DFG~a~~~~  265 (399)
                      +..||+-|||+..++.+.+ ..+-.++.+++.++++||+|||+..  |----+....+++|++-+.+|.  |--++..  
T Consensus       265 isq~mp~gslynvlhe~t~vvvd~sqav~faldiargmaflhslep~ipr~~lns~hvmidedltarismad~kfsfq--  342 (448)
T KOG0195|consen  265 ISQYMPFGSLYNVLHEQTSVVVDHSQAVRFALDIARGMAFLHSLEPMIPRFYLNSKHVMIDEDLTARISMADTKFSFQ--  342 (448)
T ss_pred             eeeeccchHHHHHHhcCccEEEecchHHHHHHHHHhhHHHHhhcchhhhhhhcccceEEecchhhhheecccceeeee--
Confidence            9999999999999987543 3566789999999999999999974  3334578889999988766554  4222211  


Q ss_pred             CCCccccCCCCcccccccccCCCCCC---ChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhccCCCCCCCCCcHHH
Q 015868          266 QSGVMTAETGTYRWMAPEVIEHKPYD---YKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRL  342 (399)
Q Consensus       266 ~~~~~~~~~gt~~y~aPE~l~~~~~~---~~~Dv~slG~vl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  342 (399)
                          .......+.||+||.+..++-+   .++|+|||++++|||-|...||....+.+.-+.+.-+++++.+|+.++..+
T Consensus       343 ----e~gr~y~pawmspealqrkped~n~raadmwsfaillwel~trevpfadlspmecgmkialeglrv~ippgis~hm  418 (448)
T KOG0195|consen  343 ----EVGRAYSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNTREVPFADLSPMECGMKIALEGLRVHIPPGISRHM  418 (448)
T ss_pred             ----ccccccCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhccccccccCCchhhhhhhhhccccccCCCCccHHH
Confidence                1122347899999999887655   468999999999999999999999999999999999999999999999999


Q ss_pred             HHHHHHHhhhcCCCCCCHHHHHHHHHHHH
Q 015868          343 AELLERCWQHDPTQRPNFSQITDILKQMM  371 (399)
Q Consensus       343 ~~ll~~cl~~dP~~Rps~~ell~~L~~l~  371 (399)
                      ..|+.-|+..||.+||.|..++-.|+.+.
T Consensus       419 ~klm~icmnedpgkrpkfdmivpilekm~  447 (448)
T KOG0195|consen  419 NKLMNICMNEDPGKRPKFDMIVPILEKMI  447 (448)
T ss_pred             HHHHHHHhcCCCCcCCCcceehhhHHHhc
Confidence            99999999999999999999999988763

>smart00750 KIND kinase non-catalytic C-lobe domain

Probab=99.96  E-value=1.1e-28  Score=216.80  Aligned_cols=164  Identities=24%  Similarity=0.397  Sum_probs=134.1

Q ss_pred             CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceeecCCCcEEEeeccceeeccCCCccccCCCCc
Q 015868          198 GSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAETGTY  277 (399)
Q Consensus       198 gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~giiHrDlkp~NILl~~~~~vkl~DFG~a~~~~~~~~~~~~~gt~  277 (399)
                      |+|.+++......+++..++.++.|++.||.|||+++      ||+||+++.++.+|+  ||.++.....    ...|++
T Consensus         1 GsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~------kp~Nil~~~~~~~~~--fG~~~~~~~~----~~~g~~   68 (176)
T smart00750        1 VSLADILEVRGRPLNEEEIWAVCLQCLRALRELHRQA------KSGNILLTWDGLLKL--DGSVAFKTPE----QSRVDP   68 (176)
T ss_pred             CcHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcC------CcccEeEcCccceee--ccceEeeccc----cCCCcc
Confidence            6899999876778999999999999999999999998      999999999999999  9999865442    236899


Q ss_pred             ccccccccCCCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhccCCCC------CCCCCcH--HHHHHHHHH
Q 015868          278 RWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKSLRPT------IPKHAHP--RLAELLERC  349 (399)
Q Consensus       278 ~y~aPE~l~~~~~~~~~Dv~slG~vl~elltg~~P~~~~~~~~~~~~~~~~~~~~~------~~~~~~~--~l~~ll~~c  349 (399)
                      .|||||++.+..|+.++||||||+++|||+||+.||............+.....+.      .+..++.  ++.+++.+|
T Consensus        69 ~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~c  148 (176)
T smart00750       69 YFMAPEVIQGQSYTEKADIYSLGITLYEALDYELPYNEERELSAILEILLNGMPADDPRDRSNLESVSAARSFADFMRVC  148 (176)
T ss_pred             cccChHHhcCCCCcchhhHHHHHHHHHHHHhCCCCccccchhcHHHHHHHHHhccCCccccccHHHHHhhhhHHHHHHHH
Confidence            99999999999999999999999999999999999976554332222222222221      1222333  699999999


Q ss_pred             hhhcCCCCCCHHHHHHHHHHHHHH
Q 015868          350 WQHDPTQRPNFSQITDILKQMMKE  373 (399)
Q Consensus       350 l~~dP~~Rps~~ell~~L~~l~~~  373 (399)
                      |..+|.+||++.++++.+..+..+
T Consensus       149 l~~~p~~Rp~~~~ll~~~~~~~~~  172 (176)
T smart00750      149 ASRLPQRREAANHYLAHCRALFAE  172 (176)
T ss_pred             HhcccccccCHHHHHHHHHHHHHH
Confidence            999999999999999988776543

It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features

>KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms]

Probab=99.96  E-value=2.5e-29  Score=225.17  Aligned_cols=248  Identities=19%  Similarity=0.301  Sum_probs=195.4

Q ss_pred             ccccceeceeceeCceEEEEEEEC--CeeEEEEEecCCCCCHHHHHHHHHHHHHHHhc-CCCceeeEEeE-EecCCcEEE
Q 015868          115 AKQLKIECKVASGSYGDLYKGTYC--SQEVAIKVLKPECVNTEMLKEFSQEVYIMRKI-RHKNVVQFIGA-CTRPPNLCI  190 (399)
Q Consensus       115 ~~~~~i~~~lg~G~~g~Vy~~~~~--~~~vAvK~~~~~~~~~~~~~~~~~Ei~~l~~l-~h~nIv~~~~~-~~~~~~~~l  190 (399)
                      .+.|.|.+.||+|.||.+-++++.  .+.+++|.++..   ....++|.+|..---.| .|.||+.-|++ |+..+.+.+
T Consensus        23 ~d~y~I~k~lgeG~FgkIlL~eHr~s~t~ivlKavp~p---~tt~~dF~rEfhY~~~Ls~H~hIi~tY~vaFqt~d~YvF   99 (378)
T KOG1345|consen   23 EDVYTINKQLGEGRFGKILLAEHRQSKTRIVLKAVPRP---QTTQADFVREFHYSFFLSPHQHIIDTYEVAFQTSDAYVF   99 (378)
T ss_pred             hhhhhHHHHhcccceeeEEeeeccCCceEEEeeccCcc---hhhHHHHHHHhccceeeccchhhhHHHHHHhhcCceEEE
Confidence            467999999999999999999884  578999999865   33457888888765555 48999987764 677778999


Q ss_pred             EEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceeec--CCCcEEEeeccceeeccCCC
Q 015868          191 VTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMD--ENGVVKVADFGVARVQAQSG  268 (399)
Q Consensus       191 V~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~giiHrDlkp~NILl~--~~~~vkl~DFG~a~~~~~~~  268 (399)
                      ++||++.|+|.+-+..  ..+-+...++++.|+++|+.|+|+++++|||||.+|||+-  +.-.|||||||..+..+...
T Consensus       100 ~qE~aP~gdL~snv~~--~GigE~~~K~v~~ql~SAi~fMHsknlVHRdlK~eNiLif~~df~rvKlcDFG~t~k~g~tV  177 (378)
T KOG1345|consen  100 VQEFAPRGDLRSNVEA--AGIGEANTKKVFAQLLSAIEFMHSKNLVHRDLKAENILIFDADFYRVKLCDFGLTRKVGTTV  177 (378)
T ss_pred             eeccCccchhhhhcCc--ccccHHHHHHHHHHHHHHHHHhhccchhhcccccceEEEecCCccEEEeeecccccccCcee
Confidence            9999999999998754  5578888999999999999999999999999999999994  34489999999997654332


Q ss_pred             ccccCCCCcccccccccCCC-----CCCChhhHHHHHHHHHHHHcCCCCCCC---CCHHHHHHHHHhccCCCCCCC---C
Q 015868          269 VMTAETGTYRWMAPEVIEHK-----PYDYKADVFSFGIALWELLTGELPYAG---LTPLQAAVGVVQKSLRPTIPK---H  337 (399)
Q Consensus       269 ~~~~~~gt~~y~aPE~l~~~-----~~~~~~Dv~slG~vl~elltg~~P~~~---~~~~~~~~~~~~~~~~~~~~~---~  337 (399)
                      ..  .-.+..|.+||+....     ..++.+|+|.||+++|.++||++||..   +++.......+.+...+..|.   .
T Consensus       178 ~~--~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQka~~~d~~Y~~~~~w~~rk~~~~P~~F~~  255 (378)
T KOG1345|consen  178 KY--LEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQKASIMDKPYWEWEQWLKRKNPALPKKFNP  255 (378)
T ss_pred             hh--hhhhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcchhhhccCchHHHHHHHhcccCccCchhhcc
Confidence            11  1235578899987543     235778999999999999999999974   334444444455556666654   4


Q ss_pred             CcHHHHHHHHHHhhhcCCCCCCHHHHHHHHHH
Q 015868          338 AHPRLAELLERCWQHDPTQRPNFSQITDILKQ  369 (399)
Q Consensus       338 ~~~~l~~ll~~cl~~dP~~Rps~~ell~~L~~  369 (399)
                      .++.+..+.++-|..+|++|--..+..+....
T Consensus       256 fs~~a~r~Fkk~lt~~~~drcki~~~kk~rk~  287 (378)
T KOG1345|consen  256 FSEKALRLFKKSLTPRFKDRCKIWTAKKMRKC  287 (378)
T ss_pred             cCHHHHHHHHHhcCCcccccchhHHHHHHHHH
Confidence            78899999999999999999666666554443

>PLN00181 protein SPA1-RELATED; Provisional

Probab=99.96  E-value=1.8e-29  Score=271.22  Aligned_cols=192  Identities=15%  Similarity=0.223  Sum_probs=143.8

Q ss_pred             cCC-CceeeEEeEE-------ecCCcEEEEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCC
Q 015868          170 IRH-KNVVQFIGAC-------TRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLK  241 (399)
Q Consensus       170 l~h-~nIv~~~~~~-------~~~~~~~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~giiHrDlk  241 (399)
                      ++| +||.+++++|       .....++.++|++ +++|.+++......+++..++.++.||++||+|||++||+|||||
T Consensus        29 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~-~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~gIvHrDlK  107 (793)
T PLN00181         29 LSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECE-DVSLRQWLDNPDRSVDAFECFHVFRQIVEIVNAAHSQGIVVHNVR  107 (793)
T ss_pred             hhHHHHHHHhhcccCCccccccccchhhhhhccC-CccHHHHHhcccccccHHHHHHHHHHHHHHHHHHHhCCeeeccCC
Confidence            455 5888888877       2334578889987 559999998766779999999999999999999999999999999


Q ss_pred             CCceeecCC-------------------CcEEEeeccceeeccCCC-----------------ccccCCCCccccccccc
Q 015868          242 TANLLMDEN-------------------GVVKVADFGVARVQAQSG-----------------VMTAETGTYRWMAPEVI  285 (399)
Q Consensus       242 p~NILl~~~-------------------~~vkl~DFG~a~~~~~~~-----------------~~~~~~gt~~y~aPE~l  285 (399)
                      |+|||++..                   +.+|++|||+++......                 ......||+.|||||++
T Consensus       108 P~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~  187 (793)
T PLN00181        108 PSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMSWYTSPEED  187 (793)
T ss_pred             chhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCCcceEChhhh
Confidence            999999654                   455666666665321100                 01123578889999999


Q ss_pred             CCCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhccCCCCCCCCCcHHHHHHHHHHhhhcCCCCCCHHHHHH
Q 015868          286 EHKPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRLAELLERCWQHDPTQRPNFSQITD  365 (399)
Q Consensus       286 ~~~~~~~~~Dv~slG~vl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~cl~~dP~~Rps~~ell~  365 (399)
                      .+..|+.++|||||||+||||++|..|+.....  ......... .+.......+...+++.+||+.+|.+||++.|+++
T Consensus       188 ~~~~~~~~sDVwSlGviL~ELl~~~~~~~~~~~--~~~~~~~~~-~~~~~~~~~~~~~~~~~~~L~~~P~~Rps~~eil~  264 (793)
T PLN00181        188 NGSSSNCASDVYRLGVLLFELFCPVSSREEKSR--TMSSLRHRV-LPPQILLNWPKEASFCLWLLHPEPSCRPSMSELLQ  264 (793)
T ss_pred             ccCCCCchhhhhhHHHHHHHHhhCCCchhhHHH--HHHHHHHhh-cChhhhhcCHHHHHHHHHhCCCChhhCcChHHHhh
Confidence            999999999999999999999999888754322  111111111 22221223456789999999999999999999975

>KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.96  E-value=1.4e-27  Score=230.52  Aligned_cols=255  Identities=23%  Similarity=0.342  Sum_probs=204.0

Q ss_pred             ccceeceeceeCceEEEEEEECC---eeEEEEEecCCCCCHHHHHHHHHHHHHHHhcCC----CceeeEEeEE-ecCCcE
Q 015868          117 QLKIECKVASGSYGDLYKGTYCS---QEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRH----KNVVQFIGAC-TRPPNL  188 (399)
Q Consensus       117 ~~~i~~~lg~G~~g~Vy~~~~~~---~~vAvK~~~~~~~~~~~~~~~~~Ei~~l~~l~h----~nIv~~~~~~-~~~~~~  188 (399)
                      +|++.++||+|+||.||++....   ..+|+|+.........  ..+..|..++..+..    ++++.+++.. ..+...
T Consensus        19 ~~~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~~--~~l~~E~~vl~~l~~~~~~~~~~~~~~~G~~~~~~~   96 (322)
T KOG1164|consen   19 RYKLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSKP--SVLKIEIQVLKKLEKKNGPSHFPKLLDHGRSTEDFN   96 (322)
T ss_pred             ceEEeeeccccCCceEEEEEecCCCCeeEEEEEEEecccCCC--ccchhHHHHHHHHhhhcCCCCCCEEEEeccCCCcee
Confidence            89999999999999999998754   3689998775422211  156678888888863    6899999999 577788


Q ss_pred             EEEEecCCCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceeecCC-----CcEEEeecccee
Q 015868          189 CIVTEFMARGSIYDFLHKQK-GVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDEN-----GVVKVADFGVAR  262 (399)
Q Consensus       189 ~lV~E~~~ggsL~~~l~~~~-~~l~~~~~~~i~~~i~~~L~~LH~~giiHrDlkp~NILl~~~-----~~vkl~DFG~a~  262 (399)
                      +|||+.+ |.+|.++..... +.++..++.+++.|++.+|.+||+.|++||||||.|+++...     ..+.|.|||+++
T Consensus        97 ~iVM~l~-G~sL~dl~~~~~~~~fs~~T~l~ia~q~l~~l~~lH~~G~iHRDiKp~N~~~g~~~~~~~~~~~llDfGlar  175 (322)
T KOG1164|consen   97 FIVMSLL-GPSLEDLRKRNPPGRFSRKTVLRIAIQNLNALEDLHSKGFIHRDIKPENFVVGQSSRSEVRTLYLLDFGLAR  175 (322)
T ss_pred             EEEEecc-CccHHHHHHhCCCCCcCHhHHHHHHHHHHHHHHHHHhcCcccCCcCHHHeeecCCCCcccceEEEEecCCCc
Confidence            9999977 779999886655 789999999999999999999999999999999999999865     469999999998


Q ss_pred             --eccC-CC-------c-cccCCCCcccccccccCCCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhccCC
Q 015868          263 --VQAQ-SG-------V-MTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKSLR  331 (399)
Q Consensus       263 --~~~~-~~-------~-~~~~~gt~~y~aPE~l~~~~~~~~~Dv~slG~vl~elltg~~P~~~~~~~~~~~~~~~~~~~  331 (399)
                        .... .+       . .....||.+|+++....+...+.+.|+||++.++.+++.|.+||.............+....
T Consensus       176 ~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~~e~~r~DDles~~Y~l~el~~g~LPW~~~~~~~~~~~~~~~~~~  255 (322)
T KOG1164|consen  176 RFKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLGIEQGRRDDLESLFYMLLELLKGSLPWEALEMTDLKSKFEKDPRK  255 (322)
T ss_pred             cccccCCCCcccccCCCCccCCCCccccccHHHhCCCccCCchhhhhHHHHHHHHhcCCCCCccccccchHHHHHHHhhh
Confidence              3211 11       1 12345999999999999999999999999999999999999999876643322222222111


Q ss_pred             CC---CCCCCcHHHHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHH
Q 015868          332 PT---IPKHAHPRLAELLERCWQHDPTQRPNFSQITDILKQMMKEV  374 (399)
Q Consensus       332 ~~---~~~~~~~~l~~ll~~cl~~dP~~Rps~~ell~~L~~l~~~~  374 (399)
                      ..   .....+.++..++..+-..+...+|....+...+++.....
T Consensus       256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pdy~~~~~~l~~~~~~~  301 (322)
T KOG1164|consen  256 LLTDRFGDLKPEEFAKILEYIDSLDYEDKPDYEKLAELLKDVFDSE  301 (322)
T ss_pred             hccccccCCChHHHHHHHHHhhccCCcCCCCHHHHHHHHHHHHHhc
Confidence            11   23445678899988888899999999999999988887654

>KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.95  E-value=1.2e-27  Score=211.15  Aligned_cols=258  Identities=22%  Similarity=0.337  Sum_probs=211.7

Q ss_pred             eecccccceeceeceeCceEEEEEEE--CCeeEEEEEecCCCCCHHHHHHHHHHHHHHHhcCC-CceeeEEeEEecCCcE
Q 015868          112 EIDAKQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRH-KNVVQFIGACTRPPNL  188 (399)
Q Consensus       112 ~i~~~~~~i~~~lg~G~~g~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~Ei~~l~~l~h-~nIv~~~~~~~~~~~~  188 (399)
                      .|....|++.++||+|+||.+|+|..  .+..||||+-+.....    -.+.-|..+++.+++ ..|+.+..+..+...-
T Consensus        11 ~iv~gky~lvrkiGsGSFGdIy~~~~i~~ge~VAiK~Es~~a~h----pqL~yEskvY~iL~~g~GiP~i~~y~~e~~yn   86 (341)
T KOG1163|consen   11 LIVGGKYKLVRKIGSGSFGDIYLGISITSGEEVAIKLESSKAKH----PQLLYESKVYRILQGGVGIPHIRHYGTEKDYN   86 (341)
T ss_pred             heeccceEEEEeecCCchhheeeeeeccCCceEEEEeecccCCC----cchhHHHHHHHHhccCCCCchhhhhccccccc
Confidence            45678999999999999999999986  6899999997644222    245568888888875 7899999999998889


Q ss_pred             EEEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceeecC---CCcEEEeeccceeecc
Q 015868          189 CIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDE---NGVVKVADFGVARVQA  265 (399)
Q Consensus       189 ~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~giiHrDlkp~NILl~~---~~~vkl~DFG~a~~~~  265 (399)
                      .+||+.. |.||.++..-....++..+++-++-|++.-++|+|.+++|||||||+|+|+.-   ...+.++|||+|+..-
T Consensus        87 vlVMdLL-GPsLEdLfnfC~R~ftmkTvLMLaDQml~RiEyvH~r~fiHRDIKPdNFLMGlgrh~~kl~LIDFGLaKky~  165 (341)
T KOG1163|consen   87 VLVMDLL-GPSLEDLFNFCSRRFTMKTVLMLADQMLSRIEYVHLRNFIHRDIKPDNFLMGLGRHCNKLYLIDFGLAKKYR  165 (341)
T ss_pred             eeeeecc-CccHHHHHHHHhhhhhHHhHHHHHHHHHHHHHHHHhhccccccCCccceeeccccccceEEEEeccchhhhc
Confidence            9999987 78999999888889999999999999999999999999999999999999963   3579999999997543


Q ss_pred             CC--------CccccCCCCcccccccccCCCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHH---HHHHHHhccCCCC-
Q 015868          266 QS--------GVMTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPYAGLTPLQ---AAVGVVQKSLRPT-  333 (399)
Q Consensus       266 ~~--------~~~~~~~gt~~y~aPE~l~~~~~~~~~Dv~slG~vl~elltg~~P~~~~~~~~---~~~~~~~~~~~~~-  333 (399)
                      ..        ......+||.+|.+-....+...+.+.|+-|+|.+|.++.-|.+||.+..+..   ....+......-. 
T Consensus       166 d~~t~~HIpyre~r~ltGTaRYASinAh~g~eqSRRDDmeSvgYvLmYfnrG~LPWQglka~tk~QKyEkI~EkK~s~~i  245 (341)
T KOG1163|consen  166 DIRTRQHIPYREDRNLTGTARYASINAHLGIEQSRRDDMESVGYVLMYFNRGSLPWQGLKAATKKQKYEKISEKKMSTPI  245 (341)
T ss_pred             cccccccCccccCCccceeeeehhhhhhhhhhhhhhhhhhhhcceeeeeecCCCcccccchhhHHHHHHHHHHhhcCCCH
Confidence            32        12344579999999888888888899999999999999999999999876533   2333332222111 


Q ss_pred             --CCCCCcHHHHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHH
Q 015868          334 --IPKHAHPRLAELLERCWQHDPTQRPNFSQITDILKQMMKEV  374 (399)
Q Consensus       334 --~~~~~~~~l~~ll~~cl~~dP~~Rps~~ell~~L~~l~~~~  374 (399)
                        +-+..|.++...+.-|-..--++-|+..-+.+.+.-+.+.+
T Consensus       246 e~LC~G~P~EF~myl~Y~R~L~F~E~Pdy~ylrqlFriLfr~l  288 (341)
T KOG1163|consen  246 EVLCKGFPAEFAMYLNYCRGLGFEEKPDYMYLRQLFRILFRTL  288 (341)
T ss_pred             HHHhCCCcHHHHHHHHHHhhcCCCCCCcHHHHHHHHHHHHhhc
Confidence              22568899999999999999999999999988888776544

>KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.95  E-value=1.6e-26  Score=212.42  Aligned_cols=259  Identities=19%  Similarity=0.317  Sum_probs=212.5

Q ss_pred             eecccccceeceeceeCceEEEEEEE--CCeeEEEEEecCCCCCHHHHHHHHHHHHHHHhcC-CCceeeEEeEEecCCcE
Q 015868          112 EIDAKQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIR-HKNVVQFIGACTRPPNL  188 (399)
Q Consensus       112 ~i~~~~~~i~~~lg~G~~g~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~Ei~~l~~l~-h~nIv~~~~~~~~~~~~  188 (399)
                      .+-.-.|++.++||+|+||.++.|+.  ++++||||.-....    ..-.+..|...++.|. .++|++.|-+...+.+-
T Consensus        24 ~~VG~hyrVGkKIGeGsFG~lf~G~Nl~nne~VAIKfEPrkS----~APQLrdEYr~YKlL~g~~GIP~vYYFGqeG~~N   99 (449)
T KOG1165|consen   24 LMVGPHYRVGKKIGEGSFGVLFLGKNLYNNEPVAIKFEPRKS----EAPQLRDEYRTYKLLGGTEGIPQVYYFGQEGKYN   99 (449)
T ss_pred             eEecccceeccccccCcceeeecccccccCceEEEEeccccC----CcchHHHHHHHHHHHcCCCCCCceeeeccccchh
Confidence            45567899999999999999999975  89999999865321    1234556777888775 69999999998999889


Q ss_pred             EEEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceeecC-----CCcEEEeeccceee
Q 015868          189 CIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDE-----NGVVKVADFGVARV  263 (399)
Q Consensus       189 ~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~giiHrDlkp~NILl~~-----~~~vkl~DFG~a~~  263 (399)
                      .||+|.+ |.||.|+..-....|+..++..++.|++.-++|+|++.+|.|||||+|+||..     ...|.|+|||+|+.
T Consensus       100 iLVidLL-GPSLEDLFD~CgR~FSvKTV~miA~Qmi~rie~vH~k~LIYRDIKPdNFLIGrp~~k~~n~IhiiDFGmAK~  178 (449)
T KOG1165|consen  100 ILVIDLL-GPSLEDLFDLCGRRFSVKTVAMIAKQMITRIEYVHEKDLIYRDIKPDNFLIGRPGTKDANVIHIIDFGMAKE  178 (449)
T ss_pred             hhhhhhh-CcCHHHHHHHhcCcccHHhHHHHHHHHHHHHHHHHhcceeecccCccceeecCCCCCCCceEEEEeccchhh
Confidence            9999988 77999999888899999999999999999999999999999999999999974     34799999999986


Q ss_pred             ccCCC--------ccccCCCCcccccccccCCCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHH--HHHHHhccCCCC
Q 015868          264 QAQSG--------VMTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPYAGLTPLQA--AVGVVQKSLRPT  333 (399)
Q Consensus       264 ~~~~~--------~~~~~~gt~~y~aPE~l~~~~~~~~~Dv~slG~vl~elltg~~P~~~~~~~~~--~~~~~~~~~~~~  333 (399)
                      +..+.        ....-+||.+||+-....++..+.+.|+-|||.++.++|-|.+||.++.....  ....+....+..
T Consensus       179 YrDp~TkqHIPYrE~KSLsGTARYMSINTHlGrEQSRRDDLEaLGHvFmYFLRGsLPWQGLKA~tnK~kYeKIGe~Kr~T  258 (449)
T KOG1165|consen  179 YRDPKTKQHIPYREHKSLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKADTNKEKYEKIGETKRST  258 (449)
T ss_pred             hcCccccccCccccccccccceeeeEeeccccchhhhhhhHHHhhhhhhhhccCCCccccccCcchHHHHHHhccccccC
Confidence            55432        12334799999999999999999999999999999999999999988643222  222222111211


Q ss_pred             ----CCCCCcHHHHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHH
Q 015868          334 ----IPKHAHPRLAELLERCWQHDPTQRPNFSQITDILKQMMKEVA  375 (399)
Q Consensus       334 ----~~~~~~~~l~~ll~~cl~~dP~~Rps~~ell~~L~~l~~~~~  375 (399)
                          +-...+.++..-|+-.-..+-.+-|+++-+...+.+++....
T Consensus       259 ~i~~Lc~g~P~efa~Yl~yvR~L~F~E~PDYdylr~Lf~dvldr~g  304 (449)
T KOG1165|consen  259 PIEVLCEGFPEEFATYLRYVRRLDFFETPDYDYLRKLFDDVLDRLG  304 (449)
T ss_pred             CHHHHHhcCHHHHHHHHHHHHhcCcccCCCHHHHHHHHHHHHHhcC
Confidence                224578899999999999999999999999999999988664

>KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair]

Probab=99.95  E-value=1.1e-27  Score=226.57  Aligned_cols=243  Identities=24%  Similarity=0.383  Sum_probs=188.9

Q ss_pred             ccccceeceeceeCceEEEEEEE-----CCeeEEEEEecCCCCCHHHHHHHHHHHHHHHhcC-CCceeeEEeEEecCCcE
Q 015868          115 AKQLKIECKVASGSYGDLYKGTY-----CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIR-HKNVVQFIGACTRPPNL  188 (399)
Q Consensus       115 ~~~~~i~~~lg~G~~g~Vy~~~~-----~~~~vAvK~~~~~~~~~~~~~~~~~Ei~~l~~l~-h~nIv~~~~~~~~~~~~  188 (399)
                      .+.|++.++||.|+|++||+++.     ..+.||+|.+....    ....+..|+++|..+. +.||+.+.+.+..++..
T Consensus        35 ~~~~~~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~ts----~p~ri~~El~~L~~~gG~~ni~~~~~~~rnnd~v  110 (418)
T KOG1167|consen   35 SNAYKVVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRTS----SPSRILNELEMLYRLGGSDNIIKLNGCFRNNDQV  110 (418)
T ss_pred             hhhhhhhccccccchhhhhhhhHhhhccccceEeeeeccccc----CchHHHHHHHHHHHhccchhhhcchhhhccCCee
Confidence            45789999999999999999965     35689999987542    2346889999999995 89999999999999999


Q ss_pred             EEEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceeecC-CCcEEEeeccceeeccC-
Q 015868          189 CIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDE-NGVVKVADFGVARVQAQ-  266 (399)
Q Consensus       189 ~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~giiHrDlkp~NILl~~-~~~vkl~DFG~a~~~~~-  266 (399)
                      ++|+||++.....++...    ++...+..++..++.||.++|.+|||||||||.|+|.+. .+.-.|+|||+|..... 
T Consensus       111 ~ivlp~~~H~~f~~l~~~----l~~~~i~~Yl~~ll~Al~~~h~~GIvHRDiKpsNFL~n~~t~rg~LvDFgLA~~~d~~  186 (418)
T KOG1167|consen  111 AIVLPYFEHDRFRDLYRS----LSLAEIRWYLRNLLKALAHLHKNGIVHRDIKPSNFLYNRRTQRGVLVDFGLAQRYDGY  186 (418)
T ss_pred             EEEecccCccCHHHHHhc----CCHHHHHHHHHHHHHHhhhhhccCccccCCCccccccccccCCceEEechhHHHHHhh
Confidence            999999999888888754    678999999999999999999999999999999999974 56789999999961110 


Q ss_pred             ---------------C--C---------------------------ccccCCCCcccccccccCCC-CCCChhhHHHHHH
Q 015868          267 ---------------S--G---------------------------VMTAETGTYRWMAPEVIEHK-PYDYKADVFSFGI  301 (399)
Q Consensus       267 ---------------~--~---------------------------~~~~~~gt~~y~aPE~l~~~-~~~~~~Dv~slG~  301 (399)
                                     .  +                           ......||++|.|||++... ..+.+.||||.|+
T Consensus       187 ~~~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k~~~QttaiDiws~GV  266 (418)
T KOG1167|consen  187 QQTEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFRCPRQTTAIDIWSAGV  266 (418)
T ss_pred             hhhhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhhccCcCCccceeeccc
Confidence                           0  0                           00112489999999999765 4578899999999


Q ss_pred             HHHHHHcCCCCCCCCC-HHHHHHHH---------------------Hhcc--------------C-------------CC
Q 015868          302 ALWELLTGELPYAGLT-PLQAAVGV---------------------VQKS--------------L-------------RP  332 (399)
Q Consensus       302 vl~elltg~~P~~~~~-~~~~~~~~---------------------~~~~--------------~-------------~~  332 (399)
                      ++.-++++..||-... ........                     +++.              .             ..
T Consensus       267 I~Lslls~~~PFf~a~dd~~al~ei~tifG~~~mrk~A~l~g~~~l~~ksn~~~~~e~~~~f~s~~~~~~~~~~q~n~~~  346 (418)
T KOG1167|consen  267 ILLSLLSRRYPFFKAKDDADALAEIATIFGSAEMRKCAALPGRILLWQKSNIPTIPELRVNFETLHIESIYKSRQPNTER  346 (418)
T ss_pred             eeehhhccccccccCccccchHHHHHHHhChHHHHHHhhcCCceeeeccccccccHHHHhchhccChhhcccccccceee
Confidence            9999999999983221 11111000                     0000              0             00


Q ss_pred             CC-CCCCcHHHHHHHHHHhhhcCCCCCCHHHHHH
Q 015868          333 TI-PKHAHPRLAELLERCWQHDPTQRPNFSQITD  365 (399)
Q Consensus       333 ~~-~~~~~~~l~~ll~~cl~~dP~~Rps~~ell~  365 (399)
                      .. ....+..+.+|+.+|+..||.+|.|+++.++
T Consensus       347 ~~~~d~~~~~~~dlLdk~le~np~kRitAEeALk  380 (418)
T KOG1167|consen  347 EIGSDVFPALLLDLLDKCLELNPQKRITAEDALK  380 (418)
T ss_pred             ccccccccHHHHHHHHHHccCChhhcccHHHHhc
Confidence            00 0123458999999999999999999999976

>COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair]

Probab=99.94  E-value=4.5e-25  Score=208.53  Aligned_cols=248  Identities=30%  Similarity=0.511  Sum_probs=205.6

Q ss_pred             cceeceeceeCceEEEEEEECCeeEEEEEecCCCCCHH-HHHHHHHHHHHHHhcCCC-ceeeEEeEEecCCcEEEEEecC
Q 015868          118 LKIECKVASGSYGDLYKGTYCSQEVAIKVLKPECVNTE-MLKEFSQEVYIMRKIRHK-NVVQFIGACTRPPNLCIVTEFM  195 (399)
Q Consensus       118 ~~i~~~lg~G~~g~Vy~~~~~~~~vAvK~~~~~~~~~~-~~~~~~~Ei~~l~~l~h~-nIv~~~~~~~~~~~~~lV~E~~  195 (399)
                      |.+.+.||.|+||.||++... ..+++|.+........ ....+.+|+.+++.+.|+ +++++.+.+......+++++++
T Consensus         2 ~~~~~~l~~g~~~~v~~~~~~-~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~   80 (384)
T COG0515           2 YRILRKLGEGSFGEVYLARDR-KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFFQDEGSLYLVMEYV   80 (384)
T ss_pred             ceeEEeecCCCCeEEEEEEec-cEEEEEeechhhccchhHHHHHHHHHHHHHHccCCcceeeEEEEEecCCEEEEEEecC
Confidence            678889999999999999887 8899999987654443 678899999999999988 7999999997777789999999


Q ss_pred             CCCCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceeecCCC-cEEEeeccceeeccCCC----
Q 015868          196 ARGSIYDFLHKQK--GVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENG-VVKVADFGVARVQAQSG----  268 (399)
Q Consensus       196 ~ggsL~~~l~~~~--~~l~~~~~~~i~~~i~~~L~~LH~~giiHrDlkp~NILl~~~~-~vkl~DFG~a~~~~~~~----  268 (399)
                      .++++.+++....  ..++......++.|++.++.|+|+.+++|||+||+||+++..+ .++++|||.++......    
T Consensus        81 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~H~~~~~hrd~kp~nil~~~~~~~~~l~dfg~~~~~~~~~~~~~  160 (384)
T COG0515          81 DGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHSKGIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSS  160 (384)
T ss_pred             CCCcHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeeecCCCCeEEEeccCcceecCCCCcccc
Confidence            9999997776643  2789999999999999999999999999999999999999988 79999999998555433    


Q ss_pred             ---ccccCCCCcccccccccCC---CCCCChhhHHHHHHHHHHHHcCCCCCCCCCH---HHHHHHHHhccCCC----CCC
Q 015868          269 ---VMTAETGTYRWMAPEVIEH---KPYDYKADVFSFGIALWELLTGELPYAGLTP---LQAAVGVVQKSLRP----TIP  335 (399)
Q Consensus       269 ---~~~~~~gt~~y~aPE~l~~---~~~~~~~Dv~slG~vl~elltg~~P~~~~~~---~~~~~~~~~~~~~~----~~~  335 (399)
                         ......|+..|++||.+.+   ..+....|+|++|++++++++|..||.....   .............+    ...
T Consensus       161 ~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (384)
T COG0515         161 IPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILELPTPSLASPLS  240 (384)
T ss_pred             ccccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCccccHHHHHHHHHhcCCcccccccC
Confidence               2356679999999999988   5788999999999999999999999877763   23333333322222    122


Q ss_pred             CCC----cHHHHHHHHHHhhhcCCCCCCHHHHHHH
Q 015868          336 KHA----HPRLAELLERCWQHDPTQRPNFSQITDI  366 (399)
Q Consensus       336 ~~~----~~~l~~ll~~cl~~dP~~Rps~~ell~~  366 (399)
                      ...    ...+.+++.+|+..+|..|.+..+....
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~~~~~  275 (384)
T COG0515         241 PSNPELISKAASDLLKKLLAKDPKNRLSSSSDLSH  275 (384)
T ss_pred             ccccchhhHHHHHHHHHHHhcCchhcCCHHHHhhc
Confidence            222    2579999999999999999998887765

>PRK09188 serine/threonine protein kinase; Provisional

Probab=99.93  E-value=2.9e-25  Score=215.46  Aligned_cols=165  Identities=17%  Similarity=0.207  Sum_probs=130.0

Q ss_pred             eecccccceeceeceeCceEEEEEEE---CCeeEEEEEecCCCC---CHHHHHHHHHHHHHHHhcCCCceee-EEeEEec
Q 015868          112 EIDAKQLKIECKVASGSYGDLYKGTY---CSQEVAIKVLKPECV---NTEMLKEFSQEVYIMRKIRHKNVVQ-FIGACTR  184 (399)
Q Consensus       112 ~i~~~~~~i~~~lg~G~~g~Vy~~~~---~~~~vAvK~~~~~~~---~~~~~~~~~~Ei~~l~~l~h~nIv~-~~~~~~~  184 (399)
                      ..-..+|.+.+.||+|+||.||+|.+   .++.||||++.....   .......+.+|+.+|++++|+|++. +++.   
T Consensus        14 ~~~~~~Y~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~l~~~---   90 (365)
T PRK09188         14 PALSARFVETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQLLAT---   90 (365)
T ss_pred             ccccCCceEccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcEEEEc---
Confidence            34467899999999999999999976   456789998764311   2344567999999999999999985 5432   


Q ss_pred             CCcEEEEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCC-CCCceeecCCCcEEEeeccceee
Q 015868          185 PPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDL-KTANLLMDENGVVKVADFGVARV  263 (399)
Q Consensus       185 ~~~~~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~giiHrDl-kp~NILl~~~~~vkl~DFG~a~~  263 (399)
                       ...|+||||++|++|.. +.. .   .   ...++.+++++|.|||++||+|||| ||+|||++.++.+||+|||+++.
T Consensus        91 -~~~~LVmE~~~G~~L~~-~~~-~---~---~~~~~~~i~~aL~~lH~~gIiHrDL~KP~NILv~~~~~ikLiDFGlA~~  161 (365)
T PRK09188         91 -GKDGLVRGWTEGVPLHL-ARP-H---G---DPAWFRSAHRALRDLHRAGITHNDLAKPQNWLMGPDGEAAVIDFQLASV  161 (365)
T ss_pred             -CCcEEEEEccCCCCHHH-hCc-c---c---hHHHHHHHHHHHHHHHHCCCeeCCCCCcceEEEcCCCCEEEEECcccee
Confidence             35899999999999973 211 1   1   1467889999999999999999999 99999999999999999999986


Q ss_pred             ccCCCcc---------ccCCCCcccccccccCCC
Q 015868          264 QAQSGVM---------TAETGTYRWMAPEVIEHK  288 (399)
Q Consensus       264 ~~~~~~~---------~~~~gt~~y~aPE~l~~~  288 (399)
                      ....+..         +...+++.|+|||.+...
T Consensus       162 ~~~~~~~~~~~~~~d~~~~~~~~~~~~pe~~~~~  195 (365)
T PRK09188        162 FRRRGALYRIAAYEDLRHLLKHKRTYAPDALTPR  195 (365)
T ss_pred             cccCcchhhhhhhhhhhhhhccCccCCcccCChh
Confidence            5543311         233578889999998643

>PRK10359 lipopolysaccharide core biosynthesis protein; Provisional

Probab=99.90  E-value=1e-23  Score=191.25  Aligned_cols=173  Identities=16%  Similarity=0.214  Sum_probs=137.5

Q ss_pred             cccccceeceeceeCceEEEEEEECCeeEEEEEecCCCCCHHH-HHH------HHHHHHHHHhcCCCceeeEEeEEecC-
Q 015868          114 DAKQLKIECKVASGSYGDLYKGTYCSQEVAIKVLKPECVNTEM-LKE------FSQEVYIMRKIRHKNVVQFIGACTRP-  185 (399)
Q Consensus       114 ~~~~~~i~~~lg~G~~g~Vy~~~~~~~~vAvK~~~~~~~~~~~-~~~------~~~Ei~~l~~l~h~nIv~~~~~~~~~-  185 (399)
                      -.++|++.+.+|.|+||.||+....+..+|+|++++.....+. ...      +.+|+..+.++.|++|+.+.+++... 
T Consensus        29 l~~~y~~~~~l~~~~f~~v~l~~~~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~~~~d~~~~~~  108 (232)
T PRK10359         29 LSYNIKTIKVFRNIDDTKVSLIDTDYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVRSEGLASLNDFYLLAE  108 (232)
T ss_pred             hhCceEEEEEecCCCceEEEEEecCCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHHHCCCCcceEeeeecc
Confidence            4679999999999999999998888889999999876543332 223      67999999999999999999886533 


Q ss_pred             -------CcEEEEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceeecCCCcEEEeec
Q 015868          186 -------PNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADF  258 (399)
Q Consensus       186 -------~~~~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~giiHrDlkp~NILl~~~~~vkl~DF  258 (399)
                             ...++||||++|.+|.++..     +++    ....+++.++..+|+.|++|||++|+||+++++| ++|+||
T Consensus       109 ~~~~~~~~~~~lvmEyi~G~tL~~~~~-----~~~----~~~~~i~~~l~~lH~~gi~H~Dikp~Nili~~~g-i~liDf  178 (232)
T PRK10359        109 RKTLRYAHTYIMLIEYIEGVELNDMPE-----ISE----DVKAKIKASIESLHQHGMVSGDPHKGNFIVSKNG-LRIIDL  178 (232)
T ss_pred             cccccccCCeEEEEEEECCccHHHhhh-----ccH----HHHHHHHHHHHHHHHcCCccCCCChHHEEEeCCC-EEEEEC
Confidence                   35789999999999988732     233    2456999999999999999999999999999988 999999


Q ss_pred             cceeeccCCCccccCCCCcccccccccCCCCCCChhhHHHHHHHHHHHH
Q 015868          259 GVARVQAQSGVMTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELL  307 (399)
Q Consensus       259 G~a~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~Dv~slG~vl~ell  307 (399)
                      |..+........           ...+....|+.++|+|+||+++..+.
T Consensus       179 g~~~~~~e~~a~-----------d~~vler~y~~~~di~~lg~~~~~~~  216 (232)
T PRK10359        179 SGKRCTAQRKAK-----------DRIDLERHYGIKNEIKDLGYYLLIYK  216 (232)
T ss_pred             CCcccccchhhH-----------HHHHHHhHhcccccccceeEeehHHH
Confidence            988654322111           11334456778999999999986654

>cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain

Probab=99.90  E-value=1.7e-23  Score=186.63  Aligned_cols=142  Identities=17%  Similarity=0.200  Sum_probs=110.8

Q ss_pred             eceeceeCceEEEEEEE-CCeeEEEEEecCCCCCHHH------------------------HHHHHHHHHHHHhcCCCce
Q 015868          121 ECKVASGSYGDLYKGTY-CSQEVAIKVLKPECVNTEM------------------------LKEFSQEVYIMRKIRHKNV  175 (399)
Q Consensus       121 ~~~lg~G~~g~Vy~~~~-~~~~vAvK~~~~~~~~~~~------------------------~~~~~~Ei~~l~~l~h~nI  175 (399)
                      ...||+|++|.||+|.. +++.||+|++++.......                        .....+|+.++.++.++++
T Consensus         2 ~~~ig~G~~~~Vy~a~~~~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~v   81 (190)
T cd05147           2 NGCISTGKEANVYHATTANGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTAGI   81 (190)
T ss_pred             CCccccccceEEEEEECCCCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHCCC
Confidence            46799999999999987 5899999999865321111                        1123459999999988776


Q ss_pred             eeEEeEEecCCcEEEEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHH-HHCCcccCCCCCCceeecCCCcEE
Q 015868          176 VQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYL-HQNNIIHRDLKTANLLMDENGVVK  254 (399)
Q Consensus       176 v~~~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~L-H~~giiHrDlkp~NILl~~~~~vk  254 (399)
                      .....+...  ..+|||||++|+++...+.. ...++...+..++.|++.+|.++ |+.||+||||||+||+++ ++.++
T Consensus        82 ~~p~~~~~~--~~~iVmE~i~g~~l~~~~~~-~~~~~~~~~~~i~~qi~~~L~~l~H~~giiHrDlkP~NIli~-~~~v~  157 (190)
T cd05147          82 PCPEPILLK--SHVLVMEFIGDDGWAAPRLK-DAPLSESKARELYLQVIQIMRILYQDCRLVHADLSEYNLLYH-DGKLY  157 (190)
T ss_pred             CCCcEEEec--CCEEEEEEeCCCCCcchhhh-cCCCCHHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEE-CCcEE
Confidence            443333222  23899999999877655433 46789999999999999999999 799999999999999998 57899


Q ss_pred             EeeccceeeccC
Q 015868          255 VADFGVARVQAQ  266 (399)
Q Consensus       255 l~DFG~a~~~~~  266 (399)
                      |+|||+|.....
T Consensus       158 LiDFG~a~~~~~  169 (190)
T cd05147         158 IIDVSQSVEHDH  169 (190)
T ss_pred             EEEccccccCCC
Confidence            999999975433

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c

>KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=99.90  E-value=3.1e-24  Score=221.11  Aligned_cols=245  Identities=23%  Similarity=0.337  Sum_probs=187.7

Q ss_pred             ceeceeceeCceEEEEEEEC--CeeEEEEEec----CCCCCHHHHHHHHHHHHHHHhcCCCceeeEEeEEecCCcEEEEE
Q 015868          119 KIECKVASGSYGDLYKGTYC--SQEVAIKVLK----PECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVT  192 (399)
Q Consensus       119 ~i~~~lg~G~~g~Vy~~~~~--~~~vAvK~~~----~~~~~~~~~~~~~~Ei~~l~~l~h~nIv~~~~~~~~~~~~~lV~  192 (399)
                      .....+|.|++|.|+.....  .+..+.|..+    +..........+..|.-+-..+.|+|++..+..+.+.....-+|
T Consensus       321 ~~~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~~~~~~~~~m  400 (601)
T KOG0590|consen  321 KPGRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQEIDGILQSM  400 (601)
T ss_pred             CccceeeecccCceEEEEecCCCccchhhhhhcccCCcccHHHHhhhhhhheeecccccCCchhhhHHHHhhcccchhhh
Confidence            56778999999988776542  2233333322    22222222333777888888899999988888777766666669


Q ss_pred             ecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceeecCCCcEEEeeccceeeccCCC----
Q 015868          193 EFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSG----  268 (399)
Q Consensus       193 E~~~ggsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~giiHrDlkp~NILl~~~~~vkl~DFG~a~~~~~~~----  268 (399)
                      ||+++ +|..++.. .+.+....+-.++.|++.|++|+|..||.|||+|++|++++.+|.+||+|||.+.......    
T Consensus       401 E~~~~-Dlf~~~~~-~~~~~~~e~~c~fKqL~~Gv~y~h~~GiahrdlK~enll~~~~g~lki~Dfg~~~vf~~~~e~~~  478 (601)
T KOG0590|consen  401 EYCPY-DLFSLVMS-NGKLTPLEADCFFKQLLRGVKYLHSMGLAHRDLKLENLLVTENGILKIIDFGAASVFRYPWEKNI  478 (601)
T ss_pred             hcccH-HHHHHHhc-ccccchhhhhHHHHHHHHHHHHHHhcCceeccCccccEEEecCCceEEeecCcceeeccCcchhh
Confidence            99999 99999865 3578889999999999999999999999999999999999999999999999997654332    


Q ss_pred             -ccccCCCCcccccccccCCCCCCCh-hhHHHHHHHHHHHHcCCCCCCCCCHHHHH-HHHHhcc------CCCCCCCCCc
Q 015868          269 -VMTAETGTYRWMAPEVIEHKPYDYK-ADVFSFGIALWELLTGELPYAGLTPLQAA-VGVVQKS------LRPTIPKHAH  339 (399)
Q Consensus       269 -~~~~~~gt~~y~aPE~l~~~~~~~~-~Dv~slG~vl~elltg~~P~~~~~~~~~~-~~~~~~~------~~~~~~~~~~  339 (399)
                       ......|+..|+|||++.+..|++. .||||.|+++..|.+|+.||......+.. .......      ....+...++
T Consensus       479 ~~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~~~~~Wk~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~lp  558 (601)
T KOG0590|consen  479 HESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMILGRFPWKVAKKSDNSFKTNNYSDQRNIFEGPNRLLSLLP  558 (601)
T ss_pred             hhhcCcccCCcCcCcccccccccCcchhhhhhccceEEEEecCCCccccccccccchhhhccccccccccChHHHHHhch
Confidence             2344578999999999999999876 69999999999999999999765443321 0000000      0011223467


Q ss_pred             HHHHHHHHHHhhhcCCCCCCHHHHHH
Q 015868          340 PRLAELLERCWQHDPTQRPNFSQITD  365 (399)
Q Consensus       340 ~~l~~ll~~cl~~dP~~Rps~~ell~  365 (399)
                      ..-+.+|.+||+.+|.+|.|+++|++
T Consensus       559 ~~~~~~~~~~l~~~P~~R~ti~~i~~  584 (601)
T KOG0590|consen  559 RETRIIIYRMLQLDPTKRITIEQILN  584 (601)
T ss_pred             hhHHHHHHHHccCChhheecHHHHhh
Confidence            78999999999999999999999976

>PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A

Probab=99.89  E-value=2.6e-23  Score=194.07  Aligned_cols=233  Identities=18%  Similarity=0.292  Sum_probs=154.1

Q ss_pred             cccceeceeceeCceEEEEEEE--CCeeEEEEEecCCC-CCHHHHHHHHHHHHHHHhcCC----------CceeeEEeEE
Q 015868          116 KQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPEC-VNTEMLKEFSQEVYIMRKIRH----------KNVVQFIGAC  182 (399)
Q Consensus       116 ~~~~i~~~lg~G~~g~Vy~~~~--~~~~vAvK~~~~~~-~~~~~~~~~~~Ei~~l~~l~h----------~nIv~~~~~~  182 (399)
                      ..+...+.||.|+++.||.+++  +++++|+|++.... ......+.+.+|......+.+          -.++-.++..
T Consensus        12 r~l~~~~~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~d~~   91 (288)
T PF14531_consen   12 RTLVRGRIIGKGGFSIVFEVTDVETGEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPLDLL   91 (288)
T ss_dssp             EEEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---SEEE
T ss_pred             eEEEEccccccCCceEEEEEEEccCCceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeeeEEE
Confidence            3567788999999999999999  46999999986433 233356777777766655322          1222222222


Q ss_pred             e---------cC---C-----cEEEEEecCCCCCHHHHHHh---cCCC---CCHHHHHHHHHHHHHHHHHHHHCCcccCC
Q 015868          183 T---------RP---P-----NLCIVTEFMARGSIYDFLHK---QKGV---FQLTSLLKVAIDVSKGMNYLHQNNIIHRD  239 (399)
Q Consensus       183 ~---------~~---~-----~~~lV~E~~~ggsL~~~l~~---~~~~---l~~~~~~~i~~~i~~~L~~LH~~giiHrD  239 (399)
                      .         ..   .     +.+++|+-+.+ +|.+++..   ....   +.......+..|+++.+++||..|++|+|
T Consensus        92 ~i~~~~~~~~~~~~~~~~~v~n~~~l~P~~~~-dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh~~GlVHgd  170 (288)
T PF14531_consen   92 RIPGKPPFFERGPGQSIYWVLNRFLLMPRAQG-DLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLHSYGLVHGD  170 (288)
T ss_dssp             EETTS-SEEEECETTEEEEEESEEEEEE--SE-EHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTTEEEST
T ss_pred             EEcCCCcceecCCCCccceeehhhhccchhhh-cHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHhhcceEecc
Confidence            1         11   1     35788998855 88887642   2221   22334456668999999999999999999


Q ss_pred             CCCCceeecCCCcEEEeeccceeeccCCCccccCCCCcccccccccCC--------CCCCChhhHHHHHHHHHHHHcCCC
Q 015868          240 LKTANLLMDENGVVKVADFGVARVQAQSGVMTAETGTYRWMAPEVIEH--------KPYDYKADVFSFGIALWELLTGEL  311 (399)
Q Consensus       240 lkp~NILl~~~~~vkl~DFG~a~~~~~~~~~~~~~gt~~y~aPE~l~~--------~~~~~~~Dv~slG~vl~elltg~~  311 (399)
                      |+|+|++++.+|.++|+||+.....+.....  ...+..|.+||....        -.++.+.|.|+||+++|.|.|+..
T Consensus       171 i~~~nfll~~~G~v~Lg~F~~~~r~g~~~~~--~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~LG~~ly~lWC~~l  248 (288)
T PF14531_consen  171 IKPENFLLDQDGGVFLGDFSSLVRAGTRYRC--SEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQLGITLYSLWCGRL  248 (288)
T ss_dssp             -SGGGEEE-TTS-EEE--GGGEEETTEEEEG--GGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHHHHHHHHHHHSS-
T ss_pred             cceeeEEEcCCCCEEEcChHHHeecCceeec--cCCCcccCChhhhhhhcccCcccceeeeccCHHHHHHHHHHHHHccC
Confidence            9999999999999999999988765543222  445678899998743        257889999999999999999999


Q ss_pred             CCCCCCHHHHHHHHHhccCCCCCCCCCcHHHHHHHHHHhhhcCCCC
Q 015868          312 PYAGLTPLQAAVGVVQKSLRPTIPKHAHPRLAELLERCWQHDPTQR  357 (399)
Q Consensus       312 P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~cl~~dP~~R  357 (399)
                      ||...++........     ..-. +++..++.||..+|+.||++|
T Consensus       249 Pf~~~~~~~~~~~~f-----~~C~-~~Pe~v~~LI~~lL~~~~~~R  288 (288)
T PF14531_consen  249 PFGLSSPEADPEWDF-----SRCR-DMPEPVQFLIRGLLQRNPEDR  288 (288)
T ss_dssp             STCCCGGGSTSGGGG-----TTSS----HHHHHHHHHHT-SSGGGS
T ss_pred             CCCCCCccccccccc-----hhcC-CcCHHHHHHHHHHccCCcccC
Confidence            998765433211101     1122 678899999999999999987

>KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms]

Probab=99.89  E-value=2.5e-24  Score=223.01  Aligned_cols=244  Identities=18%  Similarity=0.240  Sum_probs=182.5

Q ss_pred             ccceeceeceeCceEEEEEEECCeeEEEEEecCCCC--CHHHHHHHHHHHHHHHhcCCCceeeEEeEEecCCcEEEEEec
Q 015868          117 QLKIECKVASGSYGDLYKGTYCSQEVAIKVLKPECV--NTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVTEF  194 (399)
Q Consensus       117 ~~~i~~~lg~G~~g~Vy~~~~~~~~vAvK~~~~~~~--~~~~~~~~~~Ei~~l~~l~h~nIv~~~~~~~~~~~~~lV~E~  194 (399)
                      ++...+.||++.|=.|.+|++....|+||++-....  +-....+-..|++ ...+++||++.+.-+-...+..|||-+|
T Consensus        24 e~~~~~~LGstRFlKv~r~k~~eG~vVvKVFvk~~p~~sL~~~~qrL~~ik-~~l~~~pn~lPfqk~~~t~kAAylvRqy  102 (1431)
T KOG1240|consen   24 ECHYVENLGSTRFLKVARAKDREGLVVVKVFVKQDPTISLRPFKQRLEEIK-FALMKAPNCLPFQKVLVTDKAAYLVRQY  102 (1431)
T ss_pred             ceeeecccCchhhhhhhhccCCCceEEEEEEeccCCCCCchHHHHHHHHHH-HHhhcCCcccchHHHHHhhHHHHHHHHH
Confidence            678889999999999999999777799999865432  2222333334444 5556899999999888888889999999


Q ss_pred             CCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceeecCCCcEEEeeccceee--ccCC--Ccc
Q 015868          195 MARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARV--QAQS--GVM  270 (399)
Q Consensus       195 ~~ggsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~giiHrDlkp~NILl~~~~~vkl~DFG~a~~--~~~~--~~~  270 (399)
                      ... +|+|.+.. +.-+.+-+.++|+.|++.|+..+|..||+|||||.+|||+++-+.+.|+||..-+.  .+..  ...
T Consensus       103 vkh-nLyDRlST-RPFL~~iEKkWiaFQLL~al~qcH~~gVcHGDIKsENILiTSWNW~~LtDFAsFKPtYLPeDNPadf  180 (1431)
T KOG1240|consen  103 VKH-NLYDRLST-RPFLVLIEKKWIAFQLLKALSQCHKLGVCHGDIKSENILITSWNWLYLTDFASFKPTYLPEDNPADF  180 (1431)
T ss_pred             Hhh-hhhhhhcc-chHHHHHHHHHHHHHHHHHHHHHHHcCccccccccceEEEeeechhhhhcccccCCccCCCCCcccc
Confidence            977 99999976 34567778899999999999999999999999999999999999999999987653  2221  111


Q ss_pred             ccC----CCCcccccccccCCC----------C-CCChhhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHHhccCCC--
Q 015868          271 TAE----TGTYRWMAPEVIEHK----------P-YDYKADVFSFGIALWELLT-GELPYAGLTPLQAAVGVVQKSLRP--  332 (399)
Q Consensus       271 ~~~----~gt~~y~aPE~l~~~----------~-~~~~~Dv~slG~vl~ellt-g~~P~~~~~~~~~~~~~~~~~~~~--  332 (399)
                      +-.    ..--.|.|||.+...          + .+++.||||+||++.||++ |.+||.-..-.....+   ....+  
T Consensus       181 ~fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~LSQL~aYr~~---~~~~~e~  257 (1431)
T KOG1240|consen  181 TFFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFTLSQLLAYRSG---NADDPEQ  257 (1431)
T ss_pred             eEEEecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCcccHHHHHhHhcc---CccCHHH
Confidence            111    223469999998541          2 5678899999999999999 8898842111100000   00000  


Q ss_pred             CCCCCCcHHHHHHHHHHhhhcCCCCCCHHHHHHH
Q 015868          333 TIPKHAHPRLAELLERCWQHDPTQRPNFSQITDI  366 (399)
Q Consensus       333 ~~~~~~~~~l~~ll~~cl~~dP~~Rps~~ell~~  366 (399)
                      .+..--+..+++++..|++.||.+|.++++.++.
T Consensus       258 ~Le~Ied~~~Rnlil~Mi~rdPs~RlSAedyL~~  291 (1431)
T KOG1240|consen  258 LLEKIEDVSLRNLILSMIQRDPSKRLSAEDYLQK  291 (1431)
T ss_pred             HHHhCcCccHHHHHHHHHccCchhccCHHHHHHh
Confidence            0111234479999999999999999999999987

>cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain

Probab=99.88  E-value=3.7e-22  Score=178.24  Aligned_cols=143  Identities=17%  Similarity=0.185  Sum_probs=112.8

Q ss_pred             eeceeceeCceEEEEEEE-CCeeEEEEEecCCCCCH------------------------HHHHHHHHHHHHHHhcCCCc
Q 015868          120 IECKVASGSYGDLYKGTY-CSQEVAIKVLKPECVNT------------------------EMLKEFSQEVYIMRKIRHKN  174 (399)
Q Consensus       120 i~~~lg~G~~g~Vy~~~~-~~~~vAvK~~~~~~~~~------------------------~~~~~~~~Ei~~l~~l~h~n  174 (399)
                      +...||+|++|.||+|.. +++.||||++++.....                        .....+.+|...+.++.|++
T Consensus         1 ~~~~ig~G~~~~Vy~a~~~~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~   80 (190)
T cd05145           1 INGCISTGKEANVYHARTGDGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYEAG   80 (190)
T ss_pred             CCceeecCCCcEEEEEEcCCCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHhCC
Confidence            356899999999999987 58999999998653210                        00123468999999999998


Q ss_pred             eeeEEeEEecCCcEEEEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH-CCcccCCCCCCceeecCCCcE
Q 015868          175 VVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQ-NNIIHRDLKTANLLMDENGVV  253 (399)
Q Consensus       175 Iv~~~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~-~giiHrDlkp~NILl~~~~~v  253 (399)
                      +.....+....  .++||||++|+++...... ...++...+..++.+++.++.++|+ +||+||||||+||+++ ++.+
T Consensus        81 i~~p~~~~~~~--~~lVmE~~~g~~~~~~~l~-~~~~~~~~~~~i~~~l~~~l~~lH~~~givHrDlkP~NIll~-~~~~  156 (190)
T cd05145          81 VPVPEPILLKK--NVLVMEFIGDDGSPAPRLK-DVPLEEEEAEELYEQVVEQMRRLYQEAGLVHGDLSEYNILYH-DGKP  156 (190)
T ss_pred             CCCceEEEecC--CEEEEEEecCCCchhhhhh-hccCCHHHHHHHHHHHHHHHHHHHHhCCEecCCCChhhEEEE-CCCE
Confidence            75544444332  4899999998755443222 3567888999999999999999999 9999999999999998 8999


Q ss_pred             EEeeccceeeccC
Q 015868          254 KVADFGVARVQAQ  266 (399)
Q Consensus       254 kl~DFG~a~~~~~  266 (399)
                      +|+|||+++....
T Consensus       157 ~liDFG~a~~~~~  169 (190)
T cd05145         157 YIIDVSQAVELDH  169 (190)
T ss_pred             EEEEcccceecCC
Confidence            9999999986543

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro

>KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms]

Probab=99.88  E-value=1.1e-23  Score=208.57  Aligned_cols=225  Identities=25%  Similarity=0.435  Sum_probs=188.8

Q ss_pred             eceeCceEEEEEE-----ECCeeEEEEEecCCCCCHHHHHHHHHHHHHHHhcC-CCceeeEEeEEecCCcEEEEEecCCC
Q 015868          124 VASGSYGDLYKGT-----YCSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIR-HKNVVQFIGACTRPPNLCIVTEFMAR  197 (399)
Q Consensus       124 lg~G~~g~Vy~~~-----~~~~~vAvK~~~~~~~~~~~~~~~~~Ei~~l~~l~-h~nIv~~~~~~~~~~~~~lV~E~~~g  197 (399)
                      +|.|+||.|++.+     +.+.-+|+|+++..............|..++..++ ||.+++++-++..+...++++++..|
T Consensus         2 lg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~~~t~~er~il~~~~~~~f~v~lhyafqt~~kl~l~ld~~rg   81 (612)
T KOG0603|consen    2 LGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDRTHTKQERIILAFVHNTPFLVKLHYAFQTDGKLYLILDFLRG   81 (612)
T ss_pred             CCcCCCcchHHHHHhccccccchhhhhcccccccccccccccccHHHHHhhccCCCceeeeeeeeccccchhHhhhhccc
Confidence            6899999999754     35677899998755432222226667888888887 99999999999999999999999999


Q ss_pred             CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceeecCCCcEEEeeccceeeccCCCccccCCCCc
Q 015868          198 GSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAETGTY  277 (399)
Q Consensus       198 gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~giiHrDlkp~NILl~~~~~vkl~DFG~a~~~~~~~~~~~~~gt~  277 (399)
                      |.|...+.+ ...+.+.....+...++-+++++|+.+|+|||+|++||+++.+|++++.|||.++.......   .+||.
T Consensus        82 g~lft~l~~-~~~f~~~~~~~~~aelaLald~lh~l~iiyrd~k~enilld~~Ghi~~tdfglske~v~~~~---~cgt~  157 (612)
T KOG0603|consen   82 GDLFTRLSK-EVMFDELDVAFYLAELALALDHLHKLGIAYRDYKLENVLLLLEGHIKLTDFGLSKEAVKEKI---ACGTY  157 (612)
T ss_pred             chhhhcccc-CCchHHHHHHHHHHHHHHHHhhcchhHHHHhcccccceeecccCccccCCchhhhHhHhhhh---cccch
Confidence            999888755 46678888889999999999999999999999999999999999999999999986554332   28999


Q ss_pred             ccccccccCCCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhccCCCCCCCCCcHHHHHHHHHHhhhcCCCC
Q 015868          278 RWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRLAELLERCWQHDPTQR  357 (399)
Q Consensus       278 ~y~aPE~l~~~~~~~~~Dv~slG~vl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~cl~~dP~~R  357 (399)
                      -|||||+++  .....+|.||||+++++|+||..||..    +....+..  ..+..|...+....+++.+++..+|..|
T Consensus       158 eymApEI~~--gh~~a~D~ws~gvl~felltg~~pf~~----~~~~~Il~--~~~~~p~~l~~~a~~~~~~l~~r~p~nr  229 (612)
T KOG0603|consen  158 EYRAPEIIN--GHLSAADWWSFGVLAFELLTGTLPFGG----DTMKRILK--AELEMPRELSAEARSLFRQLFKRNPENR  229 (612)
T ss_pred             hhhhhHhhh--ccCCcccchhhhhhHHHHhhCCCCCch----HHHHHHhh--hccCCchhhhHHHHHHHHHHHhhCHHHH
Confidence            999999999  578889999999999999999999987    22222222  2356788899999999999999999999


Q ss_pred             CCH
Q 015868          358 PNF  360 (399)
Q Consensus       358 ps~  360 (399)
                      ...
T Consensus       230 Lg~  232 (612)
T KOG0603|consen  230 LGA  232 (612)
T ss_pred             hcc
Confidence            655

>KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms]

Probab=99.88  E-value=3.7e-22  Score=187.66  Aligned_cols=254  Identities=22%  Similarity=0.361  Sum_probs=184.1

Q ss_pred             eecccccceeceeceeCceEEEEEEECC-------------------------------------eeEEEEEecC---CC
Q 015868          112 EIDAKQLKIECKVASGSYGDLYKGTYCS-------------------------------------QEVAIKVLKP---EC  151 (399)
Q Consensus       112 ~i~~~~~~i~~~lg~G~~g~Vy~~~~~~-------------------------------------~~vAvK~~~~---~~  151 (399)
                      .+..++|.|.+.||+|....||.++..+                                     =+.|||.+-.   +.
T Consensus       153 kFtiddyeiG~~igkGC~AaVY~A~~~~dg~~le~~~~t~~~pgf~p~ts~p~e~~q~~~p~~~aFPLAiKmMfN~~~~s  232 (598)
T KOG4158|consen  153 KFTIDDYEIGEFIGKGCNAAVYSARLANDGSDLESSGNTHYGPGFNPVTSIPAEIPQVSKPAQKAFPLAIKMMFNFEHDS  232 (598)
T ss_pred             ccchhhhcccchhhccchhhhhhhhcCCCcccccccCCCCcCCCcCCCcCCcccCCcccCccccccchHHHHhcccccCC
Confidence            4456789999999999999999875311                                     0245665432   11


Q ss_pred             CCHHHHHHHHHHHH------HH--------Hh--------cCCCceeeEEeEEec-------------------------
Q 015868          152 VNTEMLKEFSQEVY------IM--------RK--------IRHKNVVQFIGACTR-------------------------  184 (399)
Q Consensus       152 ~~~~~~~~~~~Ei~------~l--------~~--------l~h~nIv~~~~~~~~-------------------------  184 (399)
                      .+....+.+.+|..      ++        +.        -+|||||++.++|.+                         
T Consensus       233 ~~~~iL~sM~~ElvPa~~~a~~~e~~~~t~R~l~nqtvhLa~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~  312 (598)
T KOG4158|consen  233 GDAHILKSMGNELVPAPNAAKLLEGQMGTFRPLPNQTVHLAKHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGA  312 (598)
T ss_pred             chHHHHHHhhhhccCcchhhhhcccccceeeeCCCCCcccCCCCCEEeehhhhhhhhccCCchhhhCcccccceeccccc
Confidence            12233344444432      11        11        259999999998743                         


Q ss_pred             --CCcEEEEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceeec--CCC--cEEEeec
Q 015868          185 --PPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMD--ENG--VVKVADF  258 (399)
Q Consensus       185 --~~~~~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~giiHrDlkp~NILl~--~~~--~vkl~DF  258 (399)
                        +..+|+||.-+.. +|..++-.+  ..+.....-++.|+++|+.|||++||.|||+|.+|||+.  +++  .+.|+||
T Consensus       313 g~~~tlylvMkrY~~-tLr~yl~~~--~~s~r~~~~~laQlLEav~hL~~hgvAhRDlKSDNiL~ElddD~~P~LVvaDF  389 (598)
T KOG4158|consen  313 GEPKTLYLVMKRYRQ-TLREYLWTR--HRSYRTGRVILAQLLEAVTHLHKHGVAHRDLKSDNILLELDDDEIPQLVVADF  389 (598)
T ss_pred             CCCceEEEehhcchh-hHHHHHhcC--CCchHHHHHHHHHHHHHHHHHHHccchhhcccccceEEEecCCCCcEEEEccc
Confidence              2358999998866 999999653  356677778899999999999999999999999999984  333  6899999


Q ss_pred             cceeeccCCC-------ccccCCCCcccccccccCCCCC------CChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHH
Q 015868          259 GVARVQAQSG-------VMTAETGTYRWMAPEVIEHKPY------DYKADVFSFGIALWELLTGELPYAGLTPLQAAVGV  325 (399)
Q Consensus       259 G~a~~~~~~~-------~~~~~~gt~~y~aPE~l~~~~~------~~~~Dv~slG~vl~elltg~~P~~~~~~~~~~~~~  325 (399)
                      |.+---...+       .....-|.-..||||+.+..+-      -.++|.|+.|.+.||+++...||.+..........
T Consensus       390 GCcLAd~~hGlqlpy~S~~Vd~GGNa~lmAPEi~ta~PGp~avvny~kAD~WA~GalaYEIfg~~NPFY~rGem~L~~r~  469 (598)
T KOG4158|consen  390 GCCLADDNHGLQLPYESDEVDLGGNAKLMAPEIATAVPGPNAVVNYEKADTWAAGALAYEIFGRSNPFYKRGEMLLDTRT  469 (598)
T ss_pred             ceeeeccccccccccccccccCCCcceecchhhhhcCCCCceeeccchhhhhhhhhhHHHHhccCCcccccchheechhh
Confidence            9873221111       1122235667899999875431      25799999999999999999999874443333334


Q ss_pred             HhccCCCCCCCCCcHHHHHHHHHHhhhcCCCCCCHHHHHHHHH
Q 015868          326 VQKSLRPTIPKHAHPRLAELLERCWQHDPTQRPNFSQITDILK  368 (399)
Q Consensus       326 ~~~~~~~~~~~~~~~~l~~ll~~cl~~dP~~Rps~~ell~~L~  368 (399)
                      .++...|.+|..+++.+++++...|+.||.+|++..-....|.
T Consensus       470 Yqe~qLPalp~~vpp~~rqlV~~lL~r~pskRvsp~iAANvl~  512 (598)
T KOG4158|consen  470 YQESQLPALPSRVPPVARQLVFDLLKRDPSKRVSPNIAANVLN  512 (598)
T ss_pred             hhhhhCCCCcccCChHHHHHHHHHhcCCccccCCccHHHhHHH
Confidence            5566678899999999999999999999999999877666554

>PRK12274 serine/threonine protein kinase; Provisional

Probab=99.87  E-value=1.2e-21  Score=174.27  Aligned_cols=184  Identities=15%  Similarity=0.126  Sum_probs=140.7

Q ss_pred             eeceeceeCceEEEEEEECCeeEEEEEecCCCCCH--HHHHHHHHHHHHHHhcC-CCceeeEEeEEecCCcEEEEEecCC
Q 015868          120 IECKVASGSYGDLYKGTYCSQEVAIKVLKPECVNT--EMLKEFSQEVYIMRKIR-HKNVVQFIGACTRPPNLCIVTEFMA  196 (399)
Q Consensus       120 i~~~lg~G~~g~Vy~~~~~~~~vAvK~~~~~~~~~--~~~~~~~~Ei~~l~~l~-h~nIv~~~~~~~~~~~~~lV~E~~~  196 (399)
                      +...|++|+||+||.+...+.+++.+.+.......  -....+.+|+++|+++. |+++++++++    ...+++|||+.
T Consensus         6 ~~~~l~~~~f~~v~~~~~~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~----~~~~lvmeyI~   81 (218)
T PRK12274          6 VNEPLKSDTFGRILLVRGGERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHW----DGRHLDRSYLA   81 (218)
T ss_pred             cceeecCCCcceEEEeecCCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEE----cCEEEEEeeec
Confidence            45689999999999998888899888887543311  12336889999999995 5889999886    34799999999


Q ss_pred             CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCC-CCCceeecCCCcEEEeeccceeeccCCCcc-----
Q 015868          197 RGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDL-KTANLLMDENGVVKVADFGVARVQAQSGVM-----  270 (399)
Q Consensus       197 ggsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~giiHrDl-kp~NILl~~~~~vkl~DFG~a~~~~~~~~~-----  270 (399)
                      |.+|...+..       . ...++.+++.+|.++|++||+|||| ||.|||++.++.++|+|||++.........     
T Consensus        82 G~~L~~~~~~-------~-~~~~~~qi~~~L~~lH~~GIvHrDL~kp~NILv~~~g~i~LIDFG~A~~~~~~~~~~r~L~  153 (218)
T PRK12274         82 GAAMYQRPPR-------G-DLAYFRAARRLLQQLHRCGVAHNDLAKEANWLVQEDGSPAVIDFQLAVRGNPRARWMRLLA  153 (218)
T ss_pred             CccHHhhhhh-------h-hHHHHHHHHHHHHHHHHCcCccCCCCCcceEEEcCCCCEEEEECCCceecCCcchHHHHHH
Confidence            9998764421       1 1357789999999999999999999 799999999999999999999865543310     


Q ss_pred             ---------ccCCCCcccccccccCCC-CCC-ChhhHHHHHHHHHHHHcCCCCCCC
Q 015868          271 ---------TAETGTYRWMAPEVIEHK-PYD-YKADVFSFGIALWELLTGELPYAG  315 (399)
Q Consensus       271 ---------~~~~gt~~y~aPE~l~~~-~~~-~~~Dv~slG~vl~elltg~~P~~~  315 (399)
                               .....++.|++|+...-- ..+ .+.+.++.|+.+|.++|+..|.-+
T Consensus       154 ~rDl~~llk~~~~y~~~~l~~~~~~~l~~~~~~~~~w~~~g~~~~~~~~~~~~~~~  209 (218)
T PRK12274        154 REDLRHLLKHKRMYCPAALTPVERRVLKRTSWIRELWFATGKPVYRFVTRRVLHWE  209 (218)
T ss_pred             HHHHHHHHHHHHhcCCCCCCHHHHhhhccchhHHHHHHHhcchHHHHHhccCCccc
Confidence                     011256677777764322 223 567999999999999998887643

>KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=99.85  E-value=4.8e-21  Score=201.91  Aligned_cols=251  Identities=20%  Similarity=0.317  Sum_probs=189.7

Q ss_pred             CCceeecccccceeceeceeCceEEEEEEE-CCeeEEEEEecCCCCCHHHHHHHHHHHHHHHhcC---CCceeeEEeEEe
Q 015868          108 TDVWEIDAKQLKIECKVASGSYGDLYKGTY-CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIR---HKNVVQFIGACT  183 (399)
Q Consensus       108 ~~~~~i~~~~~~i~~~lg~G~~g~Vy~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~Ei~~l~~l~---h~nIv~~~~~~~  183 (399)
                      ...+++....|.|.+.+|.|+||.||+|+. .++.||+|+-++....+-     +=-.+++.+|+   -+.|..+..++.
T Consensus       690 ~~~~~~~~~~~~I~~e~G~g~y~~vy~a~~~~~~~~alK~e~P~~~WEf-----YI~~q~~~RLk~~~~~~~~~~~~a~~  764 (974)
T KOG1166|consen  690 NTEFEVGGEKFCISKEIGEGSYGSVYVATHSNGKLVALKVEKPPNPWEF-----YICLQVMERLKPQMLPSIMHISSAHV  764 (974)
T ss_pred             cceeeecceeEEEEeeeccccceEEEEeecCCCcEEEEEeecCCCceee-----eehHHHHHhhchhhhcchHHHHHHHc
Confidence            456788899999999999999999999986 578899999987754432     22233444444   245555666666


Q ss_pred             cCCcEEEEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceeec-------CCCcEEEe
Q 015868          184 RPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMD-------ENGVVKVA  256 (399)
Q Consensus       184 ~~~~~~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~giiHrDlkp~NILl~-------~~~~vkl~  256 (399)
                      -.+..++|+||.+-|+|.++++ ..+.+++..+..++.|++..+++||..+|||+||||+|+|+.       ++-.++|+
T Consensus       765 ~~~~S~lv~ey~~~Gtlld~~N-~~~~m~e~lv~~~~~qml~ive~lH~~~IIHgDiKPDNfll~~~~~~~~~~~~l~lI  843 (974)
T KOG1166|consen  765 FQNASVLVSEYSPYGTLLDLIN-TNKVMDEYLVMFFSCQMLRIVEHLHAMGIIHGDIKPDNFLLRREICADSDSKGLYLI  843 (974)
T ss_pred             cCCcceeeeeccccccHHHhhc-cCCCCCchhhhHHHHHHHHHHHHHHhcceecccCCcceeEeecccCCCCcccceEEE
Confidence            6677899999999999999997 467789999999999999999999999999999999999995       23479999


Q ss_pred             ecccee---eccCCCccccCCCCcccccccccCCCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcc---C
Q 015868          257 DFGVAR---VQAQSGVMTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKS---L  330 (399)
Q Consensus       257 DFG~a~---~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~Dv~slG~vl~elltg~~P~~~~~~~~~~~~~~~~~---~  330 (399)
                      |||.+.   ...........++|-.+-.+|+..|++++...|.|.++.+++-|+.|+.--           +....   .
T Consensus       844 DfG~siDm~lfp~~~~F~~~~~td~f~C~EM~~grpWtYq~DyfGlAa~~h~mLFG~y~q-----------~~~g~~~~~  912 (974)
T KOG1166|consen  844 DFGRSIDMKLFPDGTKFKAVWHTDLFDCIEMREGRPWTYQIDYFGLAATVHVMLFGKYME-----------VKNGSSWMV  912 (974)
T ss_pred             ecccceeeeEcCCCcEEeeeeccccchhHHHhcCCCCchhhhhHHHHHHHHHHHHHHHHH-----------hcCCcceec
Confidence            999885   344444566677899999999999999999999999999999999986421           11110   0


Q ss_pred             CCCCCCCCcH-HHHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHH
Q 015868          331 RPTIPKHAHP-RLAELLERCWQHDPTQRPNFSQITDILKQMMKEVA  375 (399)
Q Consensus       331 ~~~~~~~~~~-~l~~ll~~cl~~dP~~Rps~~ell~~L~~l~~~~~  375 (399)
                      ...++..+.. -..+++..+|..|-..=|...+|...++..+.+..
T Consensus       913 ~~~~~Ry~~~~~W~~~F~~lLN~~~~~~p~l~~lr~~~~~~~~~~~  958 (974)
T KOG1166|consen  913 KTNFPRYWKRDMWNKFFDLLLNPDCDTLPNLQELRTELEEVLAEHF  958 (974)
T ss_pred             cccchhhhhHHHHHHHHHHHhCcCcccchhHHHHHHHHHHHHHHHH
Confidence            1112222222 35577777888444444778888887777766543

>PRK14879 serine/threonine protein kinase; Provisional

Probab=99.85  E-value=4.6e-20  Score=167.00  Aligned_cols=136  Identities=24%  Similarity=0.395  Sum_probs=116.8

Q ss_pred             ceeceeCceEEEEEEECCeeEEEEEecCCCCCHH------HHHHHHHHHHHHHhcCCCceeeEEeEEecCCcEEEEEecC
Q 015868          122 CKVASGSYGDLYKGTYCSQEVAIKVLKPECVNTE------MLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVTEFM  195 (399)
Q Consensus       122 ~~lg~G~~g~Vy~~~~~~~~vAvK~~~~~~~~~~------~~~~~~~Ei~~l~~l~h~nIv~~~~~~~~~~~~~lV~E~~  195 (399)
                      +.||+|++|.||+|.+.+..|++|+..+......      ....+.+|+.++..+.|++++....++......++||||+
T Consensus         2 ~~l~~G~~~~vy~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~~   81 (211)
T PRK14879          2 KLIKRGAEAEIYLGDFLGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVDPENFIIVMEYI   81 (211)
T ss_pred             cccccCceEEEEEEeeCCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEeCCCCEEEEEEe
Confidence            5789999999999999999999998775433211      1246888999999999999888777777777889999999


Q ss_pred             CCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceeecCCCcEEEeeccceee
Q 015868          196 ARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARV  263 (399)
Q Consensus       196 ~ggsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~giiHrDlkp~NILl~~~~~vkl~DFG~a~~  263 (399)
                      +|++|.+++....    . ....++.+++.+|.++|+.|++|+|++|.||+++ ++.++|+|||.++.
T Consensus        82 ~G~~L~~~~~~~~----~-~~~~i~~~i~~~l~~lH~~~i~H~Dl~p~Nil~~-~~~~~liDf~~a~~  143 (211)
T PRK14879         82 EGEPLKDLINSNG----M-EELELSREIGRLVGKLHSAGIIHGDLTTSNMILS-GGKIYLIDFGLAEF  143 (211)
T ss_pred             CCcCHHHHHHhcc----H-HHHHHHHHHHHHHHHHHhCCcccCCCCcccEEEE-CCCEEEEECCcccC
Confidence            9999999986532    1 7889999999999999999999999999999998 78999999998864

>PRK10345 hypothetical protein; Provisional

Probab=99.84  E-value=2.3e-20  Score=168.50  Aligned_cols=134  Identities=16%  Similarity=0.224  Sum_probs=104.5

Q ss_pred             eceeceeCceEEEEEEECCeeEEEEEecCCCCCHHHHHHHHHHHHHHHhc-----CCCceeeEEeEEecCC---c-EEEE
Q 015868          121 ECKVASGSYGDLYKGTYCSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKI-----RHKNVVQFIGACTRPP---N-LCIV  191 (399)
Q Consensus       121 ~~~lg~G~~g~Vy~~~~~~~~vAvK~~~~~~~~~~~~~~~~~Ei~~l~~l-----~h~nIv~~~~~~~~~~---~-~~lV  191 (399)
                      .+.||+|+||.||.-..... .+||++....  ....+.+.+|+.+++.+     +||||++++|++.++.   . +.+|
T Consensus         7 ~~~LG~G~~~~Vy~hp~~~~-k~IKv~~~~~--~~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~g~v~~~I   83 (210)
T PRK10345          7 QSPLGTGRHRKCYAHPEDAQ-RCIKIVYHRG--DGGDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGTGYVYDVI   83 (210)
T ss_pred             cceecCCCceEEEECCCCcC-eEEEEEeccc--cchHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCCeEEEEEE
Confidence            56899999999997322333 4688887642  22346799999999999     5799999999998874   3 3378


Q ss_pred             Eec--CCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHH-HHHHHCCcccCCCCCCceeecC----CCcEEEeeccce
Q 015868          192 TEF--MARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGM-NYLHQNNIIHRDLKTANLLMDE----NGVVKVADFGVA  261 (399)
Q Consensus       192 ~E~--~~ggsL~~~l~~~~~~l~~~~~~~i~~~i~~~L-~~LH~~giiHrDlkp~NILl~~----~~~vkl~DFG~a  261 (399)
                      +||  +.+++|.+++.+  +.+++.  ..++.+++.++ +|||+++|+||||||+|||++.    ++.++|+||+.+
T Consensus        84 ~e~~G~~~~tL~~~l~~--~~~~e~--~~~~~~~L~~l~~yLh~~~IvhrDlKp~NILl~~~~~~~~~~~LiDg~G~  156 (210)
T PRK10345         84 ADFDGKPSITLTEFAEQ--CRYEED--VAQLRQLLKKLKRYLLDNRIVTMELKPQNILCQRISESEVIPVVCDNIGE  156 (210)
T ss_pred             ecCCCCcchhHHHHHHc--ccccHh--HHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEeccCCCCCcEEEEECCCC
Confidence            999  557899999965  346655  35677888777 9999999999999999999974    348999994433

>KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms]

Probab=99.83  E-value=1.1e-20  Score=187.17  Aligned_cols=206  Identities=32%  Similarity=0.582  Sum_probs=166.4

Q ss_pred             HHhcCCCceeeEEeEEecCCcEEEEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCc-ccCCCCCCce
Q 015868          167 MRKIRHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNI-IHRDLKTANL  245 (399)
Q Consensus       167 l~~l~h~nIv~~~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~gi-iHrDlkp~NI  245 (399)
                      |+.+.|.|+.+|+|.+..++..++|.+||..|+|.|.+......++.--...++.+|++||.|||.-.| .|+.+++.|.
T Consensus         1 l~~l~h~n~~~f~g~~~~~~~~~~i~~~c~rGsl~D~i~~~~~~~d~~F~~s~~rdi~~Gl~ylh~s~i~~hg~l~s~nC   80 (484)
T KOG1023|consen    1 LRQLDHDNLNKFIGASVDGPEMIVIWEYCSRGSLLDILSNEDIKLDYFFILSFIRDISKGLAYLHNSPIGYHGALKSSNC   80 (484)
T ss_pred             CcccchhhhhhheeeEecCCceEEEEeeecCccHHhHHhccccCccHHHHHHHHHHHHHHHHHHhcCcceeeeeeccccc
Confidence            467899999999999999999999999999999999998877777888888899999999999998766 9999999999


Q ss_pred             eecCCCcEEEeeccceeeccCC---CccccCCCCcccccccccCCCC-------CCChhhHHHHHHHHHHHHcCCCCCCC
Q 015868          246 LMDENGVVKVADFGVARVQAQS---GVMTAETGTYRWMAPEVIEHKP-------YDYKADVFSFGIALWELLTGELPYAG  315 (399)
Q Consensus       246 Ll~~~~~vkl~DFG~a~~~~~~---~~~~~~~gt~~y~aPE~l~~~~-------~~~~~Dv~slG~vl~elltg~~P~~~  315 (399)
                      +++....+|++|||+.......   .......-..-|.|||.+....       .+.+.|+||||++++|+++.+.||+.
T Consensus        81 lvd~~w~lklt~~Gl~~~~~~~~~~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~ei~~r~~~~~~  160 (484)
T KOG1023|consen   81 LVDSRWVLKLTDFGLNSLLEETAEPEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMYEILFRSGPFDL  160 (484)
T ss_pred             eeeeeEEEEechhhhcccccccccccccchhHHHHhccCHHHhcccccccccccccccCCeehHHHHHHHHHhccCcccc
Confidence            9999999999999998766431   1112222456799999997642       35668999999999999999999975


Q ss_pred             C----CHHHHHHHHHh---ccCCCCCCC--CCcHHHHHHHHHHhhhcCCCCCCHHHHHHHHHHHHH
Q 015868          316 L----TPLQAAVGVVQ---KSLRPTIPK--HAHPRLAELLERCWQHDPTQRPNFSQITDILKQMMK  372 (399)
Q Consensus       316 ~----~~~~~~~~~~~---~~~~~~~~~--~~~~~l~~ll~~cl~~dP~~Rps~~ell~~L~~l~~  372 (399)
                      .    .+.+....+..   ...+|.++.  ..++++..++++||..+|..||+++++...++.+..
T Consensus       161 ~~~~~~~~eii~~~~~~~~~~~rP~i~~~~e~~~~l~~l~~~cw~e~P~~rPs~~~i~~~~~~~~~  226 (484)
T KOG1023|consen  161 RNLVEDPDEIILRVKKGGSNPFRPSIELLNELPPELLLLVARCWEEIPEKRPSIEQIRSKLLTINK  226 (484)
T ss_pred             ccccCChHHHHHHHHhcCCCCcCcchhhhhhcchHHHHHHHHhcccChhhCccHHHHHhhhhhhcc
Confidence            2    33233333222   224555542  355689999999999999999999999888877653

>TIGR03724 arch_bud32 Kae1-associated kinase Bud32

Probab=99.82  E-value=1.1e-19  Score=163.10  Aligned_cols=131  Identities=21%  Similarity=0.365  Sum_probs=109.3

Q ss_pred             eceeCceEEEEEEECCeeEEEEEecCCCCCH------HHHHHHHHHHHHHHhcCCCceeeEEeEEecCCcEEEEEecCCC
Q 015868          124 VASGSYGDLYKGTYCSQEVAIKVLKPECVNT------EMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVTEFMAR  197 (399)
Q Consensus       124 lg~G~~g~Vy~~~~~~~~vAvK~~~~~~~~~------~~~~~~~~Ei~~l~~l~h~nIv~~~~~~~~~~~~~lV~E~~~g  197 (399)
                      ||+|+||.||+|.+.+..|++|+........      .....+.+|+.+++.+.|+++.....++......++||||++|
T Consensus         2 ig~G~~~~vy~~~~~~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~~~g   81 (199)
T TIGR03724         2 IAKGAEAIIYLGDFLGLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDVDPDNKTIVMEYIEG   81 (199)
T ss_pred             CCCCceEEEEEeecCCccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEECCCCEEEEEEECC
Confidence            7999999999999999999999976432211      1235688999999999988766555555566678999999999


Q ss_pred             CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceeecCCCcEEEeeccceee
Q 015868          198 GSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARV  263 (399)
Q Consensus       198 gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~giiHrDlkp~NILl~~~~~vkl~DFG~a~~  263 (399)
                      ++|.+++.....        .++.+++.+|.+||+.|++|+|++|.||+++ ++.++++|||.++.
T Consensus        82 ~~l~~~~~~~~~--------~~~~~i~~~l~~lH~~gi~H~Dl~~~Nil~~-~~~~~liDfg~a~~  138 (199)
T TIGR03724        82 KPLKDVIEEGND--------ELLREIGRLVGKLHKAGIVHGDLTTSNIIVR-DDKLYLIDFGLGKY  138 (199)
T ss_pred             ccHHHHHhhcHH--------HHHHHHHHHHHHHHHCCeecCCCCcceEEEE-CCcEEEEECCCCcC
Confidence            999998754211        7889999999999999999999999999999 89999999999865

Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine.

>KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only]

Probab=99.81  E-value=4.4e-20  Score=191.58  Aligned_cols=203  Identities=31%  Similarity=0.490  Sum_probs=156.7

Q ss_pred             cccceeceeceeCceEEEEEEEC--CeeEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCceeeEEeEEecCCcEEEEEe
Q 015868          116 KQLKIECKVASGSYGDLYKGTYC--SQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVTE  193 (399)
Q Consensus       116 ~~~~i~~~lg~G~~g~Vy~~~~~--~~~vAvK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~nIv~~~~~~~~~~~~~lV~E  193 (399)
                      .+|...+.+..|+||.||..++.  .+++|+|+=+..    -          |++     ||..+-+      +.+.|  
T Consensus        83 ~df~~IklisngAygavylvrh~~trqrfa~kiNkq~----l----------ilR-----nilt~a~------npfvv--  135 (1205)
T KOG0606|consen   83 SDFNTIKLISNGAYGAVYLVRHKETRQRFAMKINKQN----L----------ILR-----NILTFAG------NPFVV--  135 (1205)
T ss_pred             cccceeEeeccCCCCceeeeeccccccchhhcccccc----h----------hhh-----ccccccC------Cccee--
Confidence            56778889999999999999764  788998663321    0          111     2222221      22233  


Q ss_pred             cCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceeecCCCcEEEeeccceeeccCCC-----
Q 015868          194 FMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSG-----  268 (399)
Q Consensus       194 ~~~ggsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~giiHrDlkp~NILl~~~~~vkl~DFG~a~~~~~~~-----  268 (399)
                          |+....++. .+.++...        +.+++|||+.||+|||+||+|++|+.-|++|+.|||+++......     
T Consensus       136 ----gDc~tllk~-~g~lPvdm--------vla~Eylh~ygivhrdlkpdnllIT~mGhiKlTDfgLsk~GLms~atnl~  202 (1205)
T KOG0606|consen  136 ----GDCATLLKN-IGPLPVDM--------VLAVEYLHSYGIVHRDLKPDNLLITSMGHIKLTDFGLSKKGLMSLATNLK  202 (1205)
T ss_pred             ----chhhhhccc-CCCCcchh--------hHHhHhhccCCeecCCCCCCcceeeecccccccchhhhhhhhhhccchhh
Confidence                566666643 45566544        779999999999999999999999999999999999987422110     


Q ss_pred             -----------ccccCCCCcccccccccCCCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhc-cCCCCCCC
Q 015868          269 -----------VMTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQK-SLRPTIPK  336 (399)
Q Consensus       269 -----------~~~~~~gt~~y~aPE~l~~~~~~~~~Dv~slG~vl~elltg~~P~~~~~~~~~~~~~~~~-~~~~~~~~  336 (399)
                                 .....+||+.|.|||++..+.|....|.|++|+++|+++.|+.||.+.++.+.+-.++.. ...|+-..
T Consensus       203 eg~I~k~t~Ef~dKqvcgTPeyiaPeVilrqgygkpvdwwamGiIlyeFLVgcvpffGdtpeelfg~visd~i~wpE~de  282 (1205)
T KOG0606|consen  203 EGHIEKDTHEFQDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQVISDDIEWPEEDE  282 (1205)
T ss_pred             hcchHHHHHHhhhccccCCccccChhhhhhhccCCCccHHHHHHHHHHHheeeeeccCCCHHHHHhhhhhhhccccccCc
Confidence                       012236899999999999999999999999999999999999999999999988877653 23455556


Q ss_pred             CCcHHHHHHHHHHhhhcCCCCC
Q 015868          337 HAHPRLAELLERCWQHDPTQRP  358 (399)
Q Consensus       337 ~~~~~l~~ll~~cl~~dP~~Rp  358 (399)
                      ..+++.++++.++|+.+|..|-
T Consensus       283 a~p~Ea~dli~~LL~qnp~~Rl  304 (1205)
T KOG0606|consen  283 ALPPEAQDLIEQLLRQNPLCRL  304 (1205)
T ss_pred             CCCHHHHHHHHHHHHhChHhhc
Confidence            6889999999999999999994

>smart00090 RIO RIO-like kinase

Probab=99.80  E-value=1.7e-19  Score=166.42  Aligned_cols=144  Identities=17%  Similarity=0.171  Sum_probs=113.6

Q ss_pred             cccceeceeceeCceEEEEEE---ECCeeEEEEEecCCCCCH----------------------HHHHHHHHHHHHHHhc
Q 015868          116 KQLKIECKVASGSYGDLYKGT---YCSQEVAIKVLKPECVNT----------------------EMLKEFSQEVYIMRKI  170 (399)
Q Consensus       116 ~~~~i~~~lg~G~~g~Vy~~~---~~~~~vAvK~~~~~~~~~----------------------~~~~~~~~Ei~~l~~l  170 (399)
                      ..|++.+.||.|++|.||+|.   ..++.||+|+++......                      .....+..|+.+++++
T Consensus        28 ~~~~i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L~~L  107 (237)
T smart00090       28 ILSAIGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNLQRL  107 (237)
T ss_pred             chHHhCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHHHHH
Confidence            468899999999999999998   378999999998543210                      0123467899999999


Q ss_pred             CCC--ceeeEEeEEecCCcEEEEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC-cccCCCCCCceee
Q 015868          171 RHK--NVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNN-IIHRDLKTANLLM  247 (399)
Q Consensus       171 ~h~--nIv~~~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~g-iiHrDlkp~NILl  247 (399)
                      .+.  .++++++.   . ..++||||++|.+|...... ...+....+..++.|++.++.+||+.| ++||||||+||++
T Consensus       108 ~~~~i~~p~~~~~---~-~~~lV~E~~~g~~L~~~~~~-~~~~~~~~~~~i~~qi~~~l~~LH~~g~iiH~Dikp~NIli  182 (237)
T smart00090      108 YEAGVPVPKPIAW---R-RNVLVMEFIGGDGLPAPRLK-DVEPEEEEEFELYDDILEEMRKLYKEGELVHGDLSEYNILV  182 (237)
T ss_pred             HhcCCCCCeeeEe---c-CceEEEEEecCCcccccccc-cCCcchHHHHHHHHHHHHHHHHHHhcCCEEeCCCChhhEEE
Confidence            753  34555543   2 35899999999888765433 344566677899999999999999999 9999999999999


Q ss_pred             cCCCcEEEeeccceeecc
Q 015868          248 DENGVVKVADFGVARVQA  265 (399)
Q Consensus       248 ~~~~~vkl~DFG~a~~~~  265 (399)
                      + ++.++|+|||.+....
T Consensus       183 ~-~~~i~LiDFg~a~~~~  199 (237)
T smart00090      183 H-DGKVVIIDVSQSVELD  199 (237)
T ss_pred             E-CCCEEEEEChhhhccC
Confidence            9 8899999999987543

>KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis]

Probab=99.80  E-value=2.3e-20  Score=181.93  Aligned_cols=168  Identities=25%  Similarity=0.460  Sum_probs=135.2

Q ss_pred             cEEEEEecCCCCCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceeecCCCcEEEeeccceeec
Q 015868          187 NLCIVTEFMARGSIYDFLHKQ--KGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQ  264 (399)
Q Consensus       187 ~~~lV~E~~~ggsL~~~l~~~--~~~l~~~~~~~i~~~i~~~L~~LH~~giiHrDlkp~NILl~~~~~vkl~DFG~a~~~  264 (399)
                      ++||.|++|.-.+|.++|...  ....+....+.++.|++.|++|   +|.+|+|+||.||+...+..+||.|||+....
T Consensus       330 ~lyI~Mn~c~~~tledWl~rr~~~e~~s~s~~~~~~~q~~~~~~y---k~~ihrdlkp~nif~~~d~q~kIgDFgl~ts~  406 (516)
T KOG1033|consen  330 YLYIQMNLCEKETLEDWLRRRRTGEERSLSLMLDIFKQIAPAVEY---KGLIHRDLKPSNIFFSDDDQLKIGDFGLVTSQ  406 (516)
T ss_pred             chhhhhhhhhhhhHHHHhhCCCcccccchhHHHHHHHhhccchhh---ccchhhhccccccccccchhhhhhhhhheeec
Confidence            589999999999999999643  3456778899999999999999   99999999999999999999999999999876


Q ss_pred             cCCC-------ccccCCCCcccccccccCCCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhccCCCCCCCC
Q 015868          265 AQSG-------VMTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKSLRPTIPKH  337 (399)
Q Consensus       265 ~~~~-------~~~~~~gt~~y~aPE~l~~~~~~~~~Dv~slG~vl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~  337 (399)
                      ....       .++...||..||+||.+.+..|+.++|||+||++++||+.   +|...-........++.+..|+....
T Consensus       407 ~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g~~y~~kvdIyaLGlil~EL~~---~f~T~~er~~t~~d~r~g~ip~~~~~  483 (516)
T KOG1033|consen  407 DKDETVAPAAASHTQQVGTLLYMSPEQIRGQQYSEKVDIYALGLILAELLI---QFSTQFERIATLTDIRDGIIPPEFLQ  483 (516)
T ss_pred             ccCCcccchhhhhhhcccccccCCHHHHhhhhhhhhcchhhHHHHHHHHHH---HhccHHHHHHhhhhhhcCCCChHHhh
Confidence            6554       5777889999999999999999999999999999999986   22222222222333344433332233


Q ss_pred             CcHHHHHHHHHHhhhcCCCCCCH
Q 015868          338 AHPRLAELLERCWQHDPTQRPNF  360 (399)
Q Consensus       338 ~~~~l~~ll~~cl~~dP~~Rps~  360 (399)
                      -.++-..|+.+++...|.+||++
T Consensus       484 d~p~e~~ll~~lls~~p~~RP~~  506 (516)
T KOG1033|consen  484 DYPEEYTLLQQLLSPSPEERPSA  506 (516)
T ss_pred             cCcHHHHHHHHhcCCCcccCchH
Confidence            44566799999999999999943

>PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated

Probab=99.79  E-value=9.3e-19  Score=180.30  Aligned_cols=136  Identities=21%  Similarity=0.320  Sum_probs=114.9

Q ss_pred             cceeceeceeCceEEEEEEECCeeEEEEEecCCCCC------HHHHHHHHHHHHHHHhcCCCceeeEEeEEecCCcEEEE
Q 015868          118 LKIECKVASGSYGDLYKGTYCSQEVAIKVLKPECVN------TEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIV  191 (399)
Q Consensus       118 ~~i~~~lg~G~~g~Vy~~~~~~~~vAvK~~~~~~~~------~~~~~~~~~Ei~~l~~l~h~nIv~~~~~~~~~~~~~lV  191 (399)
                      |...+.||+|+||.||+|.+.+..+++|+.......      ......+.+|+.+++.++|++++..+.++......++|
T Consensus       335 ~~~~~~iG~G~~g~Vy~~~~~~~~~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv  414 (535)
T PRK09605        335 KIPDHLIGKGAEADIKKGEYLGRDAVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPTPVIYDVDPEEKTIV  414 (535)
T ss_pred             cCccceeccCCcEEEEEEeecCccceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCeeEEEEEeCCCCEEE
Confidence            455889999999999999998888777764322111      11235688999999999999999888888777778999


Q ss_pred             EecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceeecCCCcEEEeeccceee
Q 015868          192 TEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARV  263 (399)
Q Consensus       192 ~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~giiHrDlkp~NILl~~~~~vkl~DFG~a~~  263 (399)
                      |||++|++|.+++.         ....++.+++.+|.+||+.|++|||+||+|||+ +++.++|+|||+++.
T Consensus       415 ~E~~~g~~L~~~l~---------~~~~~~~~i~~~L~~lH~~giiHrDlkp~NILl-~~~~~~liDFGla~~  476 (535)
T PRK09605        415 MEYIGGKDLKDVLE---------GNPELVRKVGEIVAKLHKAGIVHGDLTTSNFIV-RDDRLYLIDFGLGKY  476 (535)
T ss_pred             EEecCCCcHHHHHH---------HHHHHHHHHHHHHHHHHhCCCccCCCChHHEEE-ECCcEEEEeCccccc
Confidence            99999999999885         346789999999999999999999999999999 678999999999975

>cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain

Probab=99.78  E-value=1.3e-18  Score=156.31  Aligned_cols=138  Identities=16%  Similarity=0.170  Sum_probs=109.1

Q ss_pred             ccceeceeceeCceEEEEEEE-CCeeEEEEEecCCCCCH--------------------HHHHHHHHHHHHHHhcCCC--
Q 015868          117 QLKIECKVASGSYGDLYKGTY-CSQEVAIKVLKPECVNT--------------------EMLKEFSQEVYIMRKIRHK--  173 (399)
Q Consensus       117 ~~~i~~~lg~G~~g~Vy~~~~-~~~~vAvK~~~~~~~~~--------------------~~~~~~~~Ei~~l~~l~h~--  173 (399)
                      .|.+.+.||.|+||.||++.. +++.||||+++......                    .....+.+|..++.++.|+  
T Consensus        16 ~~~~~~~i~~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i   95 (198)
T cd05144          16 VESLGNQIGVGKESDVYLALDPDGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAALKALYEEGF   95 (198)
T ss_pred             hhhcCCccccCcceEEEEEEcCCCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHHHHHHHcCC
Confidence            377789999999999999987 68999999977542110                    0112367899999999877  


Q ss_pred             ceeeEEeEEecCCcEEEEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceeecCCCcE
Q 015868          174 NVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVV  253 (399)
Q Consensus       174 nIv~~~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~giiHrDlkp~NILl~~~~~v  253 (399)
                      .++..++.    ...++||||++|++|.+....       .....++.+++.++.++|+.|++||||+|+||++++++.+
T Consensus        96 ~v~~~~~~----~~~~lv~e~~~g~~L~~~~~~-------~~~~~~~~~i~~~l~~lh~~gi~H~Dl~p~Nill~~~~~~  164 (198)
T cd05144          96 PVPKPIDW----NRHAVVMEYIDGVELYRVRVL-------EDPEEVLDEILEEIVKAYKHGIIHGDLSEFNILVDDDEKI  164 (198)
T ss_pred             CCCceeec----CCceEEEEEeCCcchhhcccc-------ccHHHHHHHHHHHHHHHHHCCCCcCCCCcccEEEcCCCcE
Confidence            45555542    345899999999998775421       3456788999999999999999999999999999999999


Q ss_pred             EEeeccceeecc
Q 015868          254 KVADFGVARVQA  265 (399)
Q Consensus       254 kl~DFG~a~~~~  265 (399)
                      +|+|||.+....
T Consensus       165 ~liDfg~~~~~~  176 (198)
T cd05144         165 YIIDWPQMVSTD  176 (198)
T ss_pred             EEEECCccccCC
Confidence            999999996443

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom

>cd05119 RIO RIO kinase family, catalytic domain

Probab=99.73  E-value=2e-17  Score=146.87  Aligned_cols=137  Identities=20%  Similarity=0.227  Sum_probs=100.0

Q ss_pred             eceeceeCceEEEEEEEC-CeeEEEEEecCCCCCHHHHHH----------------------HHHHHHHHHhcCCCc--e
Q 015868          121 ECKVASGSYGDLYKGTYC-SQEVAIKVLKPECVNTEMLKE----------------------FSQEVYIMRKIRHKN--V  175 (399)
Q Consensus       121 ~~~lg~G~~g~Vy~~~~~-~~~vAvK~~~~~~~~~~~~~~----------------------~~~Ei~~l~~l~h~n--I  175 (399)
                      .+.||+|+||.||+|... ++.||||++++..........                      ...|...+.++.+.+  +
T Consensus         2 ~~~lg~G~~g~Vy~a~~~~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~   81 (187)
T cd05119           2 GGPIGTGKEADVYLALDGDGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGVPV   81 (187)
T ss_pred             CcccccccceeEEEEECCCCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCCCC
Confidence            567999999999999875 899999998865332222111                      135666666665433  5


Q ss_pred             eeEEeEEecCCcEEEEEecCCCCCHHH-HHHhcCCCCCHHHHHHHHHHHHHHHHHHHH-CCcccCCCCCCceeecCCCcE
Q 015868          176 VQFIGACTRPPNLCIVTEFMARGSIYD-FLHKQKGVFQLTSLLKVAIDVSKGMNYLHQ-NNIIHRDLKTANLLMDENGVV  253 (399)
Q Consensus       176 v~~~~~~~~~~~~~lV~E~~~ggsL~~-~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~-~giiHrDlkp~NILl~~~~~v  253 (399)
                      +++++..    ..++||||++|+++.. .+.....  . ..+..++.+++.++.++|. .||+|+||||+||+++ ++.+
T Consensus        82 ~~~~~~~----~~~lv~e~~~g~~~~~~~l~~~~~--~-~~~~~~~~~~~~~l~~lh~~~~ivH~Dl~p~Nili~-~~~~  153 (187)
T cd05119          82 PKPIDLN----RHVLVMEFIGGDGIPAPRLKDVRL--L-EDPEELYDQILELMRKLYREAGLVHGDLSEYNILVD-DGKV  153 (187)
T ss_pred             CceEecC----CCEEEEEEeCCCCccChhhhhhhh--c-ccHHHHHHHHHHHHHHHhhccCcCcCCCChhhEEEE-CCcE
Confidence            5555432    3589999999853321 1211111  1 5678899999999999999 9999999999999999 8999


Q ss_pred             EEeeccceeecc
Q 015868          254 KVADFGVARVQA  265 (399)
Q Consensus       254 kl~DFG~a~~~~  265 (399)
                      +++|||.+....
T Consensus       154 ~liDfg~a~~~~  165 (187)
T cd05119         154 YIIDVPQAVEID  165 (187)
T ss_pred             EEEECccccccc
Confidence            999999997543

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct

>PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed

Probab=99.73  E-value=6.4e-17  Score=149.43  Aligned_cols=136  Identities=13%  Similarity=0.142  Sum_probs=107.5

Q ss_pred             ceec-eeCceEEEEEEECCeeEEEEEecCCCC-----------CHHHHHHHHHHHHHHHhcCCCce--eeEEeEEecCC-
Q 015868          122 CKVA-SGSYGDLYKGTYCSQEVAIKVLKPECV-----------NTEMLKEFSQEVYIMRKIRHKNV--VQFIGACTRPP-  186 (399)
Q Consensus       122 ~~lg-~G~~g~Vy~~~~~~~~vAvK~~~~~~~-----------~~~~~~~~~~Ei~~l~~l~h~nI--v~~~~~~~~~~-  186 (399)
                      ..|| .|+.|+||.++..+..++||.+.....           .......+.+|+.++.++.|++|  +..+++..... 
T Consensus        37 ~~lg~~~g~gtv~~v~~~~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl~~~~~~~~  116 (239)
T PRK01723         37 RVVGSAKGRGTTWFVQTPGVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPIAARVVRHG  116 (239)
T ss_pred             ceeecCCCCccEEEEEeCCceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeEeeeeeecC
Confidence            4577 788899999988899999998864321           11223568899999999998875  77777654322 


Q ss_pred             c---EEEEEecCCC-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceeecCCCcEEEeecccee
Q 015868          187 N---LCIVTEFMAR-GSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVAR  262 (399)
Q Consensus       187 ~---~~lV~E~~~g-gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~giiHrDlkp~NILl~~~~~vkl~DFG~a~  262 (399)
                      .   .++|||+++| .+|.+++..  ..+++..    +.+++.++.+||++||+||||||.|||++.++.++|+|||.++
T Consensus       117 ~~~~~~lV~e~l~G~~~L~~~l~~--~~l~~~~----~~~i~~~l~~lH~~GI~HrDlkp~NILv~~~~~v~LIDfg~~~  190 (239)
T PRK01723        117 LFYRADILIERIEGARDLVALLQE--APLSEEQ----WQAIGQLIARFHDAGVYHADLNAHNILLDPDGKFWLIDFDRGE  190 (239)
T ss_pred             cceeeeEEEEecCCCCCHHHHHhc--CCCCHHH----HHHHHHHHHHHHHCCCCCCCCCchhEEEcCCCCEEEEECCCcc
Confidence            2   3599999997 699998854  3455443    5689999999999999999999999999999999999999887


Q ss_pred             e
Q 015868          263 V  263 (399)
Q Consensus       263 ~  263 (399)
                      .
T Consensus       191 ~  191 (239)
T PRK01723        191 L  191 (239)
T ss_pred             c
Confidence            5

>cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family

Probab=99.71  E-value=6.9e-17  Score=136.82  Aligned_cols=132  Identities=15%  Similarity=0.181  Sum_probs=114.4

Q ss_pred             eeceeceeCceEEEEEEECCeeEEEEEecCCCCCHHHHHHHHHHHHHHHhcCC--CceeeEEeEEecCCcEEEEEecCCC
Q 015868          120 IECKVASGSYGDLYKGTYCSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRH--KNVVQFIGACTRPPNLCIVTEFMAR  197 (399)
Q Consensus       120 i~~~lg~G~~g~Vy~~~~~~~~vAvK~~~~~~~~~~~~~~~~~Ei~~l~~l~h--~nIv~~~~~~~~~~~~~lV~E~~~g  197 (399)
                      +.+.||.|.++.||+++..+..+++|+.+....    ...+.+|+.+++.+.|  .++++++.+....+..+++|||++|
T Consensus         2 ~~~~i~~g~~~~v~~~~~~~~~~~iK~~~~~~~----~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~~~~~~~v~e~~~g   77 (155)
T cd05120           2 SIKLLKGGLTNRVYLLGTKDEDYVLKINPSREK----GADREREVAILQLLARKGLPVPKVLASGESDGWSYLLMEWIEG   77 (155)
T ss_pred             cceecccccccceEEEEecCCeEEEEecCCCCc----hhHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCccEEEEEecCC
Confidence            457899999999999999889999999876532    4678899999999976  5999999988888889999999998


Q ss_pred             CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCCCceeecCCCcEEEeeccceee
Q 015868          198 GSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQN---NIIHRDLKTANLLMDENGVVKVADFGVARV  263 (399)
Q Consensus       198 gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~---giiHrDlkp~NILl~~~~~vkl~DFG~a~~  263 (399)
                      +++..+        +......++.+++.++++||..   +++|+|++|.||++++.+.++++|||.++.
T Consensus        78 ~~~~~~--------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~~~~l~Df~~~~~  138 (155)
T cd05120          78 ETLDEV--------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKILGIIDWEYAGY  138 (155)
T ss_pred             eecccC--------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCcEEEEEecccccC
Confidence            777654        4456677889999999999985   799999999999999989999999998864

The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves

>KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=99.69  E-value=1.6e-18  Score=178.88  Aligned_cols=251  Identities=24%  Similarity=0.389  Sum_probs=199.8

Q ss_pred             ccccceeceeceeCceEEEEEEE---CCeeEEEEEecCCCCCHHHHHHHHHHHHHHHhcC-CCceeeEEeEEecCCcEEE
Q 015868          115 AKQLKIECKVASGSYGDLYKGTY---CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIR-HKNVVQFIGACTRPPNLCI  190 (399)
Q Consensus       115 ~~~~~i~~~lg~G~~g~Vy~~~~---~~~~vAvK~~~~~~~~~~~~~~~~~Ei~~l~~l~-h~nIv~~~~~~~~~~~~~l  190 (399)
                      ...|.+.+.||.|+|+.|-....   ....+|+|.+...............|..+-+.+. |+|++.+++....+...++
T Consensus        19 ~~~~~~~~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~~~~~~~~   98 (601)
T KOG0590|consen   19 NSQYKLSRSIGKGSFSSSALASNSRDPESSSATKPISIPPKSEDSSEHIDTETDIQKKLSKHSNTVHMIEPSSSPRSYLL   98 (601)
T ss_pred             cccccccccccccccchhhhhhhcCCCcceeeccCCCCCCCccchhhhcCccccccccccccccccccCCccCCCccccc
Confidence            34677777899999999987654   3345677766654434455566667888888887 9999999999999999999


Q ss_pred             EEecCCCCCHHHHH-HhcCCCCCHHHHHHHHHHHHHHHHHHH-HCCcccCCCCCCceeecCCC-cEEEeeccceeeccC-
Q 015868          191 VTEFMARGSIYDFL-HKQKGVFQLTSLLKVAIDVSKGMNYLH-QNNIIHRDLKTANLLMDENG-VVKVADFGVARVQAQ-  266 (399)
Q Consensus       191 V~E~~~ggsL~~~l-~~~~~~l~~~~~~~i~~~i~~~L~~LH-~~giiHrDlkp~NILl~~~~-~vkl~DFG~a~~~~~-  266 (399)
                      ++++..|+++.+.+ .......+......++.|+..++.|+| ..++.|+|+||+|.+++..+ .++++|||+|..... 
T Consensus        99 ~~~~s~g~~~f~~i~~~~~~~~~~~~~~~~~~ql~s~l~~~H~~~~~~h~~ikP~n~~l~~s~~~l~~~df~~At~~~~~  178 (601)
T KOG0590|consen   99 SLSYSDGGSLFSKISHPDSTGTSSSSASRYLPQLNSGLSYLHPENGVTHRDIKPSNSLLDESGSALKIADFGLATAYRNK  178 (601)
T ss_pred             ccCcccccccccccccCCccCCCCcchhhhhhhhccCccccCcccccccCCCCCccchhccCCCcccCCCchhhcccccc
Confidence            99999999999998 544336777888899999999999999 99999999999999999999 999999999986655 


Q ss_pred             CC---ccccCCC-CcccccccccCCCCC-CChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHH-HHhccC--CCCCCCCC
Q 015868          267 SG---VMTAETG-TYRWMAPEVIEHKPY-DYKADVFSFGIALWELLTGELPYAGLTPLQAAVG-VVQKSL--RPTIPKHA  338 (399)
Q Consensus       267 ~~---~~~~~~g-t~~y~aPE~l~~~~~-~~~~Dv~slG~vl~elltg~~P~~~~~~~~~~~~-~~~~~~--~~~~~~~~  338 (399)
                      .+   ......| ++.|+|||...+..| ....|+||.|+++.-+++|..||........... ......  ........
T Consensus       179 ~g~~~~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  258 (601)
T KOG0590|consen  179 NGAERSLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVLSAMLTGELPWDFPSRKDGRYSSWKSNKGRFTQLPWNSI  258 (601)
T ss_pred             CCcceeeecccCCCCCCCCcccccchhhcCCCcccccccccccccccCCCCccccccccccceeecccccccccCccccC
Confidence            32   2334567 999999999998655 5678999999999999999999976554432211 111111  13344668


Q ss_pred             cHHHHHHHHHHhhhcCCCCCCHHHHHH
Q 015868          339 HPRLAELLERCWQHDPTQRPNFSQITD  365 (399)
Q Consensus       339 ~~~l~~ll~~cl~~dP~~Rps~~ell~  365 (399)
                      +....+++.+++..+|..|.+.+++..
T Consensus       259 ~~~~~~~l~k~l~~~~~~r~s~~~~~~  285 (601)
T KOG0590|consen  259 SDQAHDLLHKILKENPSNRLSIEELKL  285 (601)
T ss_pred             ChhhhhcccccccCCchhccccccccc
Confidence            889999999999999999999998854

>TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase

Probab=99.57  E-value=1.7e-14  Score=144.42  Aligned_cols=140  Identities=19%  Similarity=0.299  Sum_probs=99.7

Q ss_pred             ceeceeCceEEEEEEE-CCeeEEEEEecCCCCCH----------------------------HHH----------HHHHH
Q 015868          122 CKVASGSYGDLYKGTY-CSQEVAIKVLKPECVNT----------------------------EML----------KEFSQ  162 (399)
Q Consensus       122 ~~lg~G~~g~Vy~~~~-~~~~vAvK~~~~~~~~~----------------------------~~~----------~~~~~  162 (399)
                      +.||+|++|+||+|+. .|+.||||+.++.....                            +..          -+|.+
T Consensus       123 ~plasaSigQVh~A~l~~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~Eldf~~  202 (437)
T TIGR01982       123 KPLAAASIAQVHRARLVDGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRRELDLRR  202 (437)
T ss_pred             cceeeeehhheEEEEecCCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHHHHCHHH
Confidence            5799999999999987 68999999998753110                            000          02455


Q ss_pred             HHHHHHhcC-----CCc--eeeEEeEEecCCcEEEEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHH-HHHHHHHCC
Q 015868          163 EVYIMRKIR-----HKN--VVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSK-GMNYLHQNN  234 (399)
Q Consensus       163 Ei~~l~~l~-----h~n--Iv~~~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~~i~~-~L~~LH~~g  234 (399)
                      |...+.++.     +++  |++++.  ......++||||++|++|.++........+   ...++..++. .+..+|..|
T Consensus       203 Ea~n~~~~~~~~~~~~~v~vP~v~~--~~~~~~vLvmE~i~G~~L~~~~~~~~~~~~---~~~ia~~~~~~~l~ql~~~g  277 (437)
T TIGR01982       203 EAANASELGENFKNDPGVYVPEVYW--DRTSERVLTMEWIDGIPLSDIAALDEAGLD---RKALAENLARSFLNQVLRDG  277 (437)
T ss_pred             HHHHHHHHHHhcCCCCCEEeCCEeh--hhcCCceEEEEeECCcccccHHHHHhcCCC---HHHHHHHHHHHHHHHHHhCC
Confidence            666666552     233  233332  223346899999999999988754322222   2345555555 478899999


Q ss_pred             cccCCCCCCceeecCCCcEEEeeccceeeccC
Q 015868          235 IIHRDLKTANLLMDENGVVKVADFGVARVQAQ  266 (399)
Q Consensus       235 iiHrDlkp~NILl~~~~~vkl~DFG~a~~~~~  266 (399)
                      ++|+|++|.||+++.++.++++|||.+.....
T Consensus       278 ~~H~D~hPgNilv~~~g~i~liDfG~~~~l~~  309 (437)
T TIGR01982       278 FFHADLHPGNIFVLKDGKIIALDFGIVGRLSE  309 (437)
T ss_pred             ceeCCCCcccEEECCCCcEEEEeCCCeeECCH
Confidence            99999999999999999999999999976543

This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species.

>KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning]

Probab=99.55  E-value=7.3e-15  Score=146.08  Aligned_cols=246  Identities=23%  Similarity=0.260  Sum_probs=189.3

Q ss_pred             cccccceeceece--eCceEEEEEEE----CCeeEEEEEecCCCCCHHHHHHHHHHHHHHHhcC-CCceeeEEeEEecCC
Q 015868          114 DAKQLKIECKVAS--GSYGDLYKGTY----CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIR-HKNVVQFIGACTRPP  186 (399)
Q Consensus       114 ~~~~~~i~~~lg~--G~~g~Vy~~~~----~~~~vAvK~~~~~~~~~~~~~~~~~Ei~~l~~l~-h~nIv~~~~~~~~~~  186 (399)
                      ....+.+.+.+|.  |.+|.||.+..    .+..+|+|.-+...........=.+|....++++ |+|.++.+..+...+
T Consensus       112 ~~~~~~~~~~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p~s~p~~~~~k~~~~~s~~~i~~~~~~v~~~~~~e~~~  191 (524)
T KOG0601|consen  112 FDQRFPISSRTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIPFSPPLDSKRKLREFLSHHKIDSHENPVRDSPAWEGSG  191 (524)
T ss_pred             hhhhcccccccccCCCCCceeecccCCcccCCcccccccccCCCCCccccccccchhhcccccCccccccccCcccccCC
Confidence            3456778889999  99999999865    4677888874422211222233345666666664 999999999999999


Q ss_pred             cEEEEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHH----HHHHHHHCCcccCCCCCCceeecCC-CcEEEeeccce
Q 015868          187 NLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSK----GMNYLHQNNIIHRDLKTANLLMDEN-GVVKVADFGVA  261 (399)
Q Consensus       187 ~~~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~~i~~----~L~~LH~~giiHrDlkp~NILl~~~-~~vkl~DFG~a  261 (399)
                      ..++-+|.+. .+|..+.+.....++...++....+...    |+.++|..+++|-|+||.||++.++ ...+++|||+.
T Consensus       192 ~lfiqtE~~~-~sl~~~~~~~~~~~p~~~l~~~~~~~~~~~~~al~~~hs~~~~~~~~kp~~i~~~~~~~s~~~~df~~v  270 (524)
T KOG0601|consen  192 ILFIQTELCG-ESLQSYCHTPCNFLPDNLLWNSLRDWLSRDVTALSHLHSNNIVHDDLKPANIFTTSDWTSCKLTDFGLV  270 (524)
T ss_pred             cceeeecccc-chhHHhhhcccccCCchhhhhHHhhhhhcccccccccCCCcccccccchhheecccccceeecCCccee
Confidence            9999999885 6999999887777999999999999999    9999999999999999999999999 88999999999


Q ss_pred             eeccCCCc------cccCCCCcccccccccCCCCCCChhhHHHHHHHHHHHHcCCCCCCCC---CHHHHHHHHHhccCCC
Q 015868          262 RVQAQSGV------MTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPYAGL---TPLQAAVGVVQKSLRP  332 (399)
Q Consensus       262 ~~~~~~~~------~~~~~gt~~y~aPE~l~~~~~~~~~Dv~slG~vl~elltg~~P~~~~---~~~~~~~~~~~~~~~~  332 (399)
                      ........      .....|...|++||..++- ++..+|+|++|.++.+-.++..+...-   .+.+..    +.....
T Consensus       271 ~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l-~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~~r----~~~ip~  345 (524)
T KOG0601|consen  271 SKISDGNFSSVFKVSKRPEGDCIYAAKELLNGL-ATFASDIFSLGEVILEAILGSHLPSVGKNSSWSQLR----QGYIPL  345 (524)
T ss_pred             EEccCCccccceeeeecCCCCceEeChhhhccc-cchHhhhcchhhhhHhhHhhcccccCCCCCCccccc----cccCch
Confidence            87665432      1222578899999998765 788999999999999988876544322   122111    111223


Q ss_pred             CCCCCCcHHHHHHHHHHhhhcCCCCCCHHHHHH
Q 015868          333 TIPKHAHPRLAELLERCWQHDPTQRPNFSQITD  365 (399)
Q Consensus       333 ~~~~~~~~~l~~ll~~cl~~dP~~Rps~~ell~  365 (399)
                      ++-...+.++...+.+|++.+|..|++++.+..
T Consensus       346 e~~~~~s~~l~~~~~~~~d~~~~~~~~~q~~~~  378 (524)
T KOG0601|consen  346 EFCEGGSSSLRSVTSQMLDEDPRLRLTAQILTA  378 (524)
T ss_pred             hhhcCcchhhhhHHHHhcCcchhhhhHHHHHhc
Confidence            333456678888999999999999998887754

>PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed

Probab=99.54  E-value=1.8e-13  Score=139.01  Aligned_cols=148  Identities=17%  Similarity=0.213  Sum_probs=91.8

Q ss_pred             ccccceeceeceeCceEEEEEEEC--CeeEEEEEecCCCCC----------------------------H----HHHHH-
Q 015868          115 AKQLKIECKVASGSYGDLYKGTYC--SQEVAIKVLKPECVN----------------------------T----EMLKE-  159 (399)
Q Consensus       115 ~~~~~i~~~lg~G~~g~Vy~~~~~--~~~vAvK~~~~~~~~----------------------------~----~~~~~-  159 (399)
                      ...|.. +.||+|++|+||+|+..  |+.||||+.++....                            .    +..+. 
T Consensus       119 F~~fd~-~PlasaSiaQVh~A~l~~~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~~~~l  197 (537)
T PRK04750        119 FDDFDI-KPLASASIAQVHFARLKDNGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEFEKTL  197 (537)
T ss_pred             HHhcCh-hhhcCCCccEEEEEEECCCCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHHHHHH
Confidence            345665 78999999999999873  899999999875210                            0    11122 


Q ss_pred             -----HHHHHHHHHhcC----CCceeeEEeEEe-cCCcEEEEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHH
Q 015868          160 -----FSQEVYIMRKIR----HKNVVQFIGACT-RPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNY  229 (399)
Q Consensus       160 -----~~~Ei~~l~~l~----h~nIv~~~~~~~-~~~~~~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~  229 (399)
                           +.+|...+.++.    +.+.+.+-.++. -....+|||||+.|+.+.++-.-.....+...+.....+  .-+..
T Consensus       198 ~~ElD~~~Ea~N~~~~~~~f~~~~~v~VP~v~~d~st~~VLvmE~i~G~~l~d~~~l~~~g~d~~~la~~~v~--~~~~Q  275 (537)
T PRK04750        198 HDELDLMREAANASQLRRNFEDSDMLYVPEVYWDYCSETVMVMERMYGIPVSDVAALRAAGTDMKLLAERGVE--VFFTQ  275 (537)
T ss_pred             HHhhCHHHHHHHHHHHHHHccCCCCeecceeecccCCCceEEEeeecCccHHhHHHHHhcCCCHHHHHHHHHH--HHHHH
Confidence                 333444444442    222222222221 123467999999999998753211222222222221111  12333


Q ss_pred             HHHCCcccCCCCCCceeecCCC----cEEEeeccceeecc
Q 015868          230 LHQNNIIHRDLKTANLLMDENG----VVKVADFGVARVQA  265 (399)
Q Consensus       230 LH~~giiHrDlkp~NILl~~~~----~vkl~DFG~a~~~~  265 (399)
                      +...|++|+|++|.||+++.+|    .++++|||.+...+
T Consensus       276 if~~GffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l~  315 (537)
T PRK04750        276 VFRDGFFHADMHPGNIFVSYDPPENPRYIALDFGIVGSLN  315 (537)
T ss_pred             HHhCCeeeCCCChHHeEEecCCCCCCeEEEEecceEEECC
Confidence            4569999999999999999888    99999999997654

>cd05151 ChoK Choline Kinase (ChoK)

Probab=99.47  E-value=1.9e-13  Score=118.98  Aligned_cols=128  Identities=16%  Similarity=0.190  Sum_probs=98.1

Q ss_pred             eceeceeCceEEEEEEECCeeEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCc-eeeEEeEEecCCcEEEEEecCCCCC
Q 015868          121 ECKVASGSYGDLYKGTYCSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKN-VVQFIGACTRPPNLCIVTEFMARGS  199 (399)
Q Consensus       121 ~~~lg~G~~g~Vy~~~~~~~~vAvK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~n-Iv~~~~~~~~~~~~~lV~E~~~ggs  199 (399)
                      .+.++.|.++.||+++..+..|++|+......   ....+..|..+++.+.+.+ +++++....  ...++||||++|.+
T Consensus         3 ~~~l~~G~~~~vy~~~~~~~~~~lK~~~~~~~---~~~~~~~E~~~l~~l~~~~~~P~~~~~~~--~~~~lv~e~i~G~~   77 (170)
T cd05151           3 ISPLKGGMTNKNYRVEVANKKYVVRIPGNGTE---LLINRENEAENSKLAAEAGIGPKLYYFDP--ETGVLITEFIEGSE   77 (170)
T ss_pred             eeecCCcccCceEEEEECCeEEEEEeCCCCcc---cccCHHHHHHHHHHHHHhCCCCceEEEeC--CCCeEEEEecCCCc
Confidence            35688999999999999999999999865421   1234568899999886544 455665443  23579999999987


Q ss_pred             HHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCc-----ccCCCCCCceeecCCCcEEEeeccceee
Q 015868          200 IYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNI-----IHRDLKTANLLMDENGVVKVADFGVARV  263 (399)
Q Consensus       200 L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~gi-----iHrDlkp~NILl~~~~~vkl~DFG~a~~  263 (399)
                      +.+.      ..   ....++.+++++|+.||+.++     +|+|++|.||+++ ++.++++|||.+..
T Consensus        78 l~~~------~~---~~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~-~~~~~liDf~~a~~  136 (170)
T cd05151          78 LLTE------DF---SDPENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLD-DGRLWLIDWEYAGM  136 (170)
T ss_pred             cccc------cc---cCHHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEE-CCeEEEEecccccC
Confidence            7653      01   112456789999999999985     9999999999998 67899999998863

The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph

>cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain

Probab=99.44  E-value=1.1e-12  Score=116.78  Aligned_cols=139  Identities=17%  Similarity=0.208  Sum_probs=101.5

Q ss_pred             eceeceeCceEEEEEEEC--------CeeEEEEEecCCCCC--------------------HHHHHHH----HHHHHHHH
Q 015868          121 ECKVASGSYGDLYKGTYC--------SQEVAIKVLKPECVN--------------------TEMLKEF----SQEVYIMR  168 (399)
Q Consensus       121 ~~~lg~G~~g~Vy~~~~~--------~~~vAvK~~~~~~~~--------------------~~~~~~~----~~Ei~~l~  168 (399)
                      ...||.|-=+.||.|...        +..+|||+.+....+                    ....+.+    .+|...|+
T Consensus         2 ~g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~   81 (197)
T cd05146           2 NGCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLK   81 (197)
T ss_pred             CCccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHH
Confidence            346899999999999754        368999997632110                    0112233    38999999


Q ss_pred             hcCC--CceeeEEeEEecCCcEEEEEecCCCCCHHH-HHHhcCCCCCHHHHHHHHHHHHHHHHHH-HHCCcccCCCCCCc
Q 015868          169 KIRH--KNVVQFIGACTRPPNLCIVTEFMARGSIYD-FLHKQKGVFQLTSLLKVAIDVSKGMNYL-HQNNIIHRDLKTAN  244 (399)
Q Consensus       169 ~l~h--~nIv~~~~~~~~~~~~~lV~E~~~ggsL~~-~l~~~~~~l~~~~~~~i~~~i~~~L~~L-H~~giiHrDlkp~N  244 (399)
                      ++..  -+++.++++    ..-++||||+.+..+.. .++.  ..++...+..+..+++.+|..| |+.|++|+|+++.|
T Consensus        82 rl~~~Gv~vP~pi~~----~~~~lvME~Ig~~~~~~~~Lkd--~~~~~~~~~~i~~~i~~~l~~l~H~~glVHGDLs~~N  155 (197)
T cd05146          82 RMQKAGIPCPEVVVL----KKHVLVMSFIGDDQVPAPKLKD--AKLNDEEMKNAYYQVLSMMKQLYKECNLVHADLSEYN  155 (197)
T ss_pred             HHHHcCCCCCeEEEe----cCCEEEEEEcCCCCccchhhhc--cccCHHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHH
Confidence            9853  467777764    34689999997754422 2222  2355566778889999999999 89999999999999


Q ss_pred             eeecCCCcEEEeeccceeeccC
Q 015868          245 LLMDENGVVKVADFGVARVQAQ  266 (399)
Q Consensus       245 ILl~~~~~vkl~DFG~a~~~~~  266 (399)
                      |+++ ++.++|+|||.+-....
T Consensus       156 IL~~-~~~v~iIDF~qav~~~h  176 (197)
T cd05146         156 MLWH-DGKVWFIDVSQSVEPTH  176 (197)
T ss_pred             EEEE-CCcEEEEECCCceeCCC
Confidence            9996 57899999998865543

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown.

>KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only]

Probab=99.44  E-value=1e-13  Score=144.86  Aligned_cols=248  Identities=23%  Similarity=0.309  Sum_probs=186.8

Q ss_pred             ecccccceeceeceeCceEEEEEEEC--CeeEEEEEecCCC-CCHHHHHHHHHHHHHHHhcCCCceeeEEeEEecCCcEE
Q 015868          113 IDAKQLKIECKVASGSYGDLYKGTYC--SQEVAIKVLKPEC-VNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLC  189 (399)
Q Consensus       113 i~~~~~~i~~~lg~G~~g~Vy~~~~~--~~~vAvK~~~~~~-~~~~~~~~~~~Ei~~l~~l~h~nIv~~~~~~~~~~~~~  189 (399)
                      ...+.+.+.+.+-+|+++.++.++-.  +...+.|+..... ......+...++-.++-...+|-+++....+......+
T Consensus       801 sS~d~~~i~~p~qS~sp~ss~p~~pa~sgh~~~~~v~~~ap~i~~~~~~s~r~~s~~~i~p~~P~v~~~~~s~~~rsP~~  880 (1205)
T KOG0606|consen  801 SSPDGFEITKPSQSGSPSSSFPASPAGSGHTRPSKVHGLAPKIRTNDYESIRSKSNILITPRSPAVVRSFPSFPCRSPLP  880 (1205)
T ss_pred             CCCccceecccccCCCCcccccCCccccccccchhhhccchhhccccccccCCccCccccCCCCceecccCCCCCCCCcc
Confidence            34456777778999999999987653  3334444433210 01111233344445555556677777766666667799


Q ss_pred             EEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceeecCCCcEEEeeccceeeccC---
Q 015868          190 IVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQ---  266 (399)
Q Consensus       190 lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~giiHrDlkp~NILl~~~~~vkl~DFG~a~~~~~---  266 (399)
                      ++++|..|++|...++... ..+..........+..+.+|||...+.|+|++|.|++...+|..++.|||......-   
T Consensus       881 L~~~~~~~~~~~Skl~~~~-~~saepaRs~i~~~vqs~e~L~s~~r~h~~~~p~~~l~~~~gh~~l~~~~t~~~vg~~~p  959 (1205)
T KOG0606|consen  881 LVGHYLNGGDLPSKLHNSG-CLSAEPARSPILERVQSLESLHSSLRKHRDLKPDSLLIAYDGHRPLTDFGTLSKVGLIPP  959 (1205)
T ss_pred             hhhHHhccCCchhhhhcCC-CcccccccchhHHHHhhhhccccchhhcccccccchhhcccCCcccCccccccccccccC
Confidence            9999999999999998743 455556667778889999999999999999999999999999999999984321100   


Q ss_pred             -------C----------------------CccccCCCCcccccccccCCCCCCChhhHHHHHHHHHHHHcCCCCCCCCC
Q 015868          267 -------S----------------------GVMTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPYAGLT  317 (399)
Q Consensus       267 -------~----------------------~~~~~~~gt~~y~aPE~l~~~~~~~~~Dv~slG~vl~elltg~~P~~~~~  317 (399)
                             .                      .......+|+.|.+||...+......+|.|++|++++|.++|.+||...+
T Consensus       960 ~~~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg~~hgs~ad~~~~g~~l~e~l~g~pp~na~t 1039 (1205)
T KOG0606|consen  960 TTDLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLGRRHGSAADWWSSGVCLFEVLTGIPPFNAET 1039 (1205)
T ss_pred             cCCcccccccCccccccccccccccccchhhccccccCCCcccCCcccccccCCCcchhhhhhhhhhhhhcCCCCCCCcc
Confidence                   0                      00122358999999999999999999999999999999999999999999


Q ss_pred             HHHHHHHHHhccC-CCCCCCCCcHHHHHHHHHHhhhcCCCCCCHH
Q 015868          318 PLQAAVGVVQKSL-RPTIPKHAHPRLAELLERCWQHDPTQRPNFS  361 (399)
Q Consensus       318 ~~~~~~~~~~~~~-~~~~~~~~~~~l~~ll~~cl~~dP~~Rps~~  361 (399)
                      +.+.+..+..... .|..+...+++..+++.+.+..+|.+|..+.
T Consensus      1040 pq~~f~ni~~~~~~~p~g~~~~s~~aq~~~~~ll~~~~~qr~~a~ 1084 (1205)
T KOG0606|consen 1040 PQQIFENILNRDIPWPEGPEEGSYEAQDLINRLLTEEPTQRLGAK 1084 (1205)
T ss_pred             hhhhhhccccCCCCCCCCccccChhhhhhhhhhhccCchhccCcc
Confidence            9998876655433 3566777899999999999999999997665

>KOG1243 consensus Protein kinase [General function prediction only]

Probab=99.41  E-value=1.3e-11  Score=124.41  Aligned_cols=162  Identities=17%  Similarity=0.273  Sum_probs=126.4

Q ss_pred             CCeeEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCceeeEEeEEecCCcEEEEEecCCCCCHHHHHHhcCCCCCHHHHH
Q 015868          138 CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLL  217 (399)
Q Consensus       138 ~~~~vAvK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~nIv~~~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~~~l~~~~~~  217 (399)
                      .+.+|.|.+.+...  ........+-++-|+.++||||++++..++..+..|+|+|-+.  .|..++++..    ...+.
T Consensus        36 ~~~~vsVF~~~~~~--~~~~~~~~~A~k~lKtlRHP~Il~yL~t~e~~~~~ylvTErV~--Pl~~~lk~l~----~~~v~  107 (690)
T KOG1243|consen   36 DGGPVSVFVYKRSN--GEVTELAKRAVKRLKTLRHPNILSYLDTTEEEGTLYLVTERVR--PLETVLKELG----KEEVC  107 (690)
T ss_pred             cCCceEEEEEeCCC--chhhHHHHHHHHHhhhccCchhhhhhhhhcccCceEEEeeccc--cHHHHHHHhH----HHHHH
Confidence            56788888887653  2445567788999999999999999999999999999999874  7888886643    56777


Q ss_pred             HHHHHHHHHHHHHH-HCCcccCCCCCCceeecCCCcEEEeeccceeeccCCCccc-cCCCCcccccccccCCCCCCChhh
Q 015868          218 KVAIDVSKGMNYLH-QNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMT-AETGTYRWMAPEVIEHKPYDYKAD  295 (399)
Q Consensus       218 ~i~~~i~~~L~~LH-~~giiHrDlkp~NILl~~~~~vkl~DFG~a~~~~~~~~~~-~~~gt~~y~aPE~l~~~~~~~~~D  295 (399)
                      .-+.||+.||.||| ..+++|++|....|+++..|..||++|..+......+.+. ...--..|..|+.+....  -..|
T Consensus       108 ~Gl~qIl~AL~FL~~d~~lvHgNv~~~SVfVn~~GeWkLggle~v~~~~~~~~~~~~~~~~~s~~~P~~~~~s~--~s~D  185 (690)
T KOG1243|consen  108 LGLFQILAALSFLNDDCNLVHGNVCKDSVFVNESGEWKLGGLELVSKASGFNAPAKSLYLIESFDDPEEIDPSE--WSID  185 (690)
T ss_pred             HHHHHHHHHHHHHhccCCeeeccEeeeeEEEcCCCcEEEeeeEEEeccccCCcccccchhhhcccChhhcCccc--cchh
Confidence            88899999999998 5689999999999999999999999999987554433211 111112345566553332  3569


Q ss_pred             HHHHHHHHHHHHcC
Q 015868          296 VFSFGIALWELLTG  309 (399)
Q Consensus       296 v~slG~vl~elltg  309 (399)
                      .|.||+++|+++.|
T Consensus       186 ~~~Lg~li~el~ng  199 (690)
T KOG1243|consen  186 SWGLGCLIEELFNG  199 (690)
T ss_pred             hhhHHHHHHHHhCc
Confidence            99999999999998

>COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.40  E-value=3.9e-12  Score=109.92  Aligned_cols=132  Identities=22%  Similarity=0.303  Sum_probs=105.2

Q ss_pred             eeceeCceEEEEEEECCeeEEEEEecCCCCCHHH------HHHHHHHHHHHHhcCCCceeeEEeEEecCCcEEEEEecCC
Q 015868          123 KVASGSYGDLYKGTYCSQEVAIKVLKPECVNTEM------LKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVTEFMA  196 (399)
Q Consensus       123 ~lg~G~~g~Vy~~~~~~~~vAvK~~~~~~~~~~~------~~~~~~Ei~~l~~l~h~nIv~~~~~~~~~~~~~lV~E~~~  196 (399)
                      .+++|+=+.+|.+.+.+.++.+|.=.+.......      .....+|..++.+++--.|...+=+..++.+..|+|||++
T Consensus         3 ~i~~GAEa~i~~~~~~g~~av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~dvD~~~~~I~me~I~   82 (204)
T COG3642           3 LIKQGAEAIIYLTDFLGLPAVVKERIPKRYRHPELDEKLRRERTRREARILAKAREAGVPVPIVYDVDPDNGLIVMEYIE   82 (204)
T ss_pred             hhhCCcceeEEeeeccCcceEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCEEEEEEeC
Confidence            5788999999999998888888875443332221      2457789999999987777777777788888999999999


Q ss_pred             CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceeecCCCcEEEeeccceee
Q 015868          197 RGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARV  263 (399)
Q Consensus       197 ggsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~giiHrDlkp~NILl~~~~~vkl~DFG~a~~  263 (399)
                      |..|.+.+...    .    ..++..+=.-+.-||..||+|+|+.++||++..++ +.++|||++..
T Consensus        83 G~~lkd~l~~~----~----~~~~r~vG~~vg~lH~~givHGDLTtsNiIl~~~~-i~~IDfGLg~~  140 (204)
T COG3642          83 GELLKDALEEA----R----PDLLREVGRLVGKLHKAGIVHGDLTTSNIILSGGR-IYFIDFGLGEF  140 (204)
T ss_pred             ChhHHHHHHhc----c----hHHHHHHHHHHHHHHhcCeecCCCccceEEEeCCc-EEEEECCcccc
Confidence            99999998764    2    34555666667779999999999999999997654 99999999974

>KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning]

Probab=99.35  E-value=4.2e-13  Score=133.60  Aligned_cols=247  Identities=20%  Similarity=0.217  Sum_probs=184.0

Q ss_pred             ecccccceeceeceeCceEEEEEEE---CCeeEEEEEecCCCCCHHHHHHHHHHHHHHHhc-CCCceeeEEeEEecCCcE
Q 015868          113 IDAKQLKIECKVASGSYGDLYKGTY---CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKI-RHKNVVQFIGACTRPPNL  188 (399)
Q Consensus       113 i~~~~~~i~~~lg~G~~g~Vy~~~~---~~~~vAvK~~~~~~~~~~~~~~~~~Ei~~l~~l-~h~nIv~~~~~~~~~~~~  188 (399)
                      ....++.....||.|.|+.|+....   .+..+++|-+............-..|+.+...+ .|.++++.+..|...+..
T Consensus       262 ~~~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~~r~~  341 (524)
T KOG0601|consen  262 CKLTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFASDIFSLGEVILEAILGSHLPSVGKNSSWSQLRQG  341 (524)
T ss_pred             eecCCcceeEEccCCccccceeeeecCCCCceEeChhhhccccchHhhhcchhhhhHhhHhhcccccCCCCCCccccccc
Confidence            3456888999999999999998754   356788887765544333334455677777777 489999999999888889


Q ss_pred             EEEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceeecCC-CcEEEeeccceeeccCC
Q 015868          189 CIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDEN-GVVKVADFGVARVQAQS  267 (399)
Q Consensus       189 ~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~giiHrDlkp~NILl~~~-~~vkl~DFG~a~~~~~~  267 (399)
                      |+--||+.++++...+. -...+.+...+++..|++.++.++|+..++|+|++|.||++..+ +.-++.|||........
T Consensus       342 ~ip~e~~~~~s~~l~~~-~~~~~d~~~~~~~~~q~~~~l~~i~s~~~~~~d~~psni~i~~~~~~~~~~~~~~~t~~~~~  420 (524)
T KOG0601|consen  342 YIPLEFCEGGSSSLRSV-TSQMLDEDPRLRLTAQILTALNVIHSKLFVHLDVKPSNILISNDGFFSKLGDFGCWTRLAFS  420 (524)
T ss_pred             cCchhhhcCcchhhhhH-HHHhcCcchhhhhHHHHHhccccccchhhhcccccccceeeccchhhhhcccccccccccee
Confidence            99999999998877663 24567888899999999999999999999999999999999876 78899999998643222


Q ss_pred             CccccCCCCccc-ccccccCCCCCCChhhHHHHHHHHHHHHcCCC-CCCCCCHHHHHHHHHhccCCCCCCCCCcHHHHHH
Q 015868          268 GVMTAETGTYRW-MAPEVIEHKPYDYKADVFSFGIALWELLTGEL-PYAGLTPLQAAVGVVQKSLRPTIPKHAHPRLAEL  345 (399)
Q Consensus       268 ~~~~~~~gt~~y-~aPE~l~~~~~~~~~Dv~slG~vl~elltg~~-P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l  345 (399)
                      . ......+..| .+|.......+..+.|+|+||..+.+.+++.+ +..+...     ..+..+..+..+. ...++..+
T Consensus       421 ~-~~~~~~~r~~p~~~~~~e~~~~~~~~~~~sl~~~~~e~~~~~~ls~~~~~~-----~~i~~~~~p~~~~-~~~~~q~~  493 (524)
T KOG0601|consen  421 S-GVFHHIDRLYPIAEILLEDYPHLSKADIFSLGLSVDEAITGSPLSESGVQS-----LTIRSGDTPNLPG-LKLQLQVL  493 (524)
T ss_pred             c-ccccccccccccchhhccccccccccccccccccccccccCcccCcccccc-----eeeecccccCCCc-hHHhhhhh
Confidence            1 1122233334 35566667788899999999999999999764 3322211     1223333344443 33889999


Q ss_pred             HHHHhhhcCCCCCCHHHHHHHH
Q 015868          346 LERCWQHDPTQRPNFSQITDIL  367 (399)
Q Consensus       346 l~~cl~~dP~~Rps~~ell~~L  367 (399)
                      .+.+...++..||.+.++....
T Consensus       494 ~kv~~~~~~~~~~l~~~l~~~~  515 (524)
T KOG0601|consen  494 LKVMINPDRKRRPSAVELSLHS  515 (524)
T ss_pred             hhhhcCCccccchhhhhhcccc
Confidence            9999999999999988876543

>KOG1266 consensus Protein kinase [Signal transduction mechanisms]

Probab=99.33  E-value=1.9e-12  Score=120.06  Aligned_cols=191  Identities=19%  Similarity=0.339  Sum_probs=139.6

Q ss_pred             HHHhcCCCceeeEEeEEecCC-----cEEEEEecCCCCCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHC--Cc
Q 015868          166 IMRKIRHKNVVQFIGACTRPP-----NLCIVTEFMARGSIYDFLHK---QKGVFQLTSLLKVAIDVSKGMNYLHQN--NI  235 (399)
Q Consensus       166 ~l~~l~h~nIv~~~~~~~~~~-----~~~lV~E~~~ggsL~~~l~~---~~~~l~~~~~~~i~~~i~~~L~~LH~~--gi  235 (399)
                      -+-++.|.|+++++.||.+.+     ...+++|||+-|++..+|++   ....+......+|+.||+.||.|||+-  -|
T Consensus       120 nllqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLhs~~Ppi  199 (458)
T KOG1266|consen  120 NLLQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKKNQKALFQKAWKKWCTQILSALSYLHSCDPPI  199 (458)
T ss_pred             HHHHHHHHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhhccCCcc
Confidence            344557999999999986543     47899999999999999965   345678888899999999999999986  59


Q ss_pred             ccCCCCCCceeecCCCcEEEeeccceeeccCC-----CccccCCCCcccccccccCCCCCCChhhHHHHHHHHHHHHcCC
Q 015868          236 IHRDLKTANLLMDENGVVKVADFGVARVQAQS-----GVMTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTGE  310 (399)
Q Consensus       236 iHrDlkp~NILl~~~~~vkl~DFG~a~~~~~~-----~~~~~~~gt~~y~aPE~l~~~~~~~~~Dv~slG~vl~elltg~  310 (399)
                      +|+++..+.|++..+|-+|+.--........-     ......++-++|.+||.=.....+..+|||+||....+|.-+.
T Consensus       200 ihgnlTc~tifiq~ngLIkig~~ap~s~h~s~~~~~~~Ek~~~~~~~g~~a~~sg~~tn~~~a~dIy~fgmcAlemailE  279 (458)
T KOG1266|consen  200 IHGNLTCDTIFIQHNGLIKIGSVAPDSTHPSVNSTREAEKSVNTSLPGFSAPESGTTTNTTGASDIYKFGMCALEMAILE  279 (458)
T ss_pred             ccCCcchhheeecCCceEEecccCccccchhhhhhhHhhhhccccCCccccCCcCcccccccchhhhhhhHHHHHHHHhe
Confidence            99999999999999999988643222111110     1122345678899999877777788899999999999998876


Q ss_pred             CCCCCCC----HHHHHHHHHhccCCCCCCCCCcHHHHHHHHHHhhhcCCCCCCHHHHH
Q 015868          311 LPYAGLT----PLQAAVGVVQKSLRPTIPKHAHPRLAELLERCWQHDPTQRPNFSQIT  364 (399)
Q Consensus       311 ~P~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~cl~~dP~~Rps~~ell  364 (399)
                      .--...+    +.+....+...        ....-=++++.+|++..|..||++.+++
T Consensus       280 iq~tnseS~~~~ee~ia~~i~~--------len~lqr~~i~kcl~~eP~~rp~ar~ll  329 (458)
T KOG1266|consen  280 IQSTNSESKVEVEENIANVIIG--------LENGLQRGSITKCLEGEPNGRPDARLLL  329 (458)
T ss_pred             eccCCCcceeehhhhhhhheee--------ccCccccCcCcccccCCCCCCcchhhhh
Confidence            5422211    11111111111        1112246789999999999999999985

>KOG3087 consensus Serine/threonine protein kinase [General function prediction only]

Probab=99.32  E-value=2.4e-11  Score=104.70  Aligned_cols=144  Identities=22%  Similarity=0.269  Sum_probs=111.4

Q ss_pred             eeceeceeCceEEEEEEECCeeEEEEEecCCCCCHH------HHHHHHHHHHHHHhcCCCceeeEEeEEecCCcEEEEEe
Q 015868          120 IECKVASGSYGDLYKGTYCSQEVAIKVLKPECVNTE------MLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVTE  193 (399)
Q Consensus       120 i~~~lg~G~~g~Vy~~~~~~~~vAvK~~~~~~~~~~------~~~~~~~Ei~~l~~l~h~nIv~~~~~~~~~~~~~lV~E  193 (399)
                      ....+-+|+-+.|+++.+.|+...||.=.+......      ...+..+|+.++.++.--.|.-..=++.+...-+|+||
T Consensus        11 ~l~likQGAEArv~~~~~~Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~~D~~~~~i~ME   90 (229)
T KOG3087|consen   11 SLELIKQGAEARVPRGSFSGEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLIFIDTYGGQIYME   90 (229)
T ss_pred             cceeeeccceeeEeeeccCCceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEEEEecCCCeEEEE
Confidence            455778899999999999999988886443333222      24578899999999976666655556666677889999


Q ss_pred             cCCC-CCHHHHHHhcCCC-CCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceeecCCC---cEEEeeccceee
Q 015868          194 FMAR-GSIYDFLHKQKGV-FQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENG---VVKVADFGVARV  263 (399)
Q Consensus       194 ~~~g-gsL~~~l~~~~~~-l~~~~~~~i~~~i~~~L~~LH~~giiHrDlkp~NILl~~~~---~vkl~DFG~a~~  263 (399)
                      |++| .++.+++...... ........++.+|=+.+.-||.++|||+||..+||++.+++   .+.++|||++..
T Consensus        91 ~~~g~~~vk~~i~~~~~~~~~d~~~~~~~~~iG~~igklH~ndiiHGDLTTSNill~~~~~~~~~~lIdfgls~~  165 (229)
T KOG3087|consen   91 FIDGASTVKDFILSTMEDESEDEGLAELARRIGELIGKLHDNDIIHGDLTTSNILLRSDGNQITPILIDFGLSSV  165 (229)
T ss_pred             eccchhHHHHHHHHHccCcccchhHHHHHHHHHHHHHHhhhCCeecccccccceEEecCCCcCceEEEeecchhc
Confidence            9987 5888888765433 33333478888999999999999999999999999997655   458999999864

>cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins

Probab=99.26  E-value=2.7e-11  Score=109.90  Aligned_cols=139  Identities=18%  Similarity=0.263  Sum_probs=105.9

Q ss_pred             ceeceeCceEEEEEEECC-eeEEEEEecCCCCCHHHHHHHHHHHHHHHhcCC--CceeeEEeEEecCC---cEEEEEecC
Q 015868          122 CKVASGSYGDLYKGTYCS-QEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRH--KNVVQFIGACTRPP---NLCIVTEFM  195 (399)
Q Consensus       122 ~~lg~G~~g~Vy~~~~~~-~~vAvK~~~~~~~~~~~~~~~~~Ei~~l~~l~h--~nIv~~~~~~~~~~---~~~lV~E~~  195 (399)
                      +.|+.|.++.||+++..+ +.+++|+....... .....+.+|..+++.+.+  .++++++.+.....   ..++||||+
T Consensus         4 ~~l~~G~~n~~~~v~~~~g~~~ilK~~~~~~~~-~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~~~~~~v~e~i   82 (223)
T cd05154           4 RQLSGGQSNLTYLLTAGGGRRLVLRRPPPGALL-PSAHDVAREYRVLRALAGTGVPVPKVLALCEDPSVLGTPFYVMERV   82 (223)
T ss_pred             eecCCCccceEEEEEecCCcceEEEeCCCcccC-cccccHHHHHHHHHHhhCCCCCCCCEEEECCCCCccCCceEEEEEe
Confidence            568999999999998865 89999998754321 234578899999999976  34677887766542   578999999


Q ss_pred             CCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH-------------------------------------------
Q 015868          196 ARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQ-------------------------------------------  232 (399)
Q Consensus       196 ~ggsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~-------------------------------------------  232 (399)
                      +|.++.+.+..  ..++......++.+++++|.+||+                                           
T Consensus        83 ~G~~l~~~~~~--~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  160 (223)
T cd05154          83 DGRVLRDRLLR--PELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDEPPAMERL  160 (223)
T ss_pred             CCEecCCCCCC--CCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhcccccHHHHHH
Confidence            99888765421  345666666777777777777773                                           


Q ss_pred             -------------CCcccCCCCCCceeecC--CCcEEEeeccceee
Q 015868          233 -------------NNIIHRDLKTANLLMDE--NGVVKVADFGVARV  263 (399)
Q Consensus       233 -------------~giiHrDlkp~NILl~~--~~~vkl~DFG~a~~  263 (399)
                                   ..++|+|+.|.||+++.  ++.+.|+||+.+..
T Consensus       161 ~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~~  206 (223)
T cd05154         161 LRWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELATL  206 (223)
T ss_pred             HHHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEecccccc
Confidence                         23589999999999998  67789999998864

This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain

>cd04928 ACT_TyrKc Uncharacterized, N-terminal ACT domain of an Arabidopsis/Oryza predicted tyrosine kinase and other related ACT domains

Probab=99.25  E-value=1.7e-11  Score=89.10  Aligned_cols=55  Identities=58%  Similarity=0.925  Sum_probs=52.6

Q ss_pred             HHHHHHHHHhhhhCCCeeeeceeccCCCceeeEEEecCCCCcchHHHHHHHHHHH
Q 015868            9 MKVGELTSLLGEIGLNIQEAHAFSTVDGFSLDVFVVDGWPYDETEDLKNVLAKEI   63 (399)
Q Consensus         9 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~~~~~~l~~~l~~~~   63 (399)
                      .++++++.+|+..||||.+|.+|+|.|||.||+|+|.+|.++|+++|.++|.+++
T Consensus        13 gLFa~iag~L~~~~LnI~~A~i~tt~dG~~LDtF~V~d~~~~~~~~~~~~~~~~~   67 (68)
T cd04928          13 KLLSQLSSLLGDLGLNIAEAHAFSTDDGLALDIFVVTGWKRGETAALGHALQKEI   67 (68)
T ss_pred             chHHHHHHHHHHCCCceEEEEEEEcCCCeEEEEEEEecCCccchHHHHHHHHHhh
Confidence            3789999999999999999999999999999999999999999999999998875

This CD includes a novel, yet uncharacterized, N-terminal ACT domain of an Arabidopsis/Oryza predicted tyrosine kinase and other related ACT domains. Members of this CD belong to the superfamily of ACT regulatory domains.

>PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional

Probab=99.22  E-value=2.7e-10  Score=106.70  Aligned_cols=134  Identities=15%  Similarity=0.093  Sum_probs=98.9

Q ss_pred             eEEEEEEECCeeEEEEEecCCCCCHHH---------HHHHHHHHHHHHhcCCCcee--eEEeEEec-----CCcEEEEEe
Q 015868          130 GDLYKGTYCSQEVAIKVLKPECVNTEM---------LKEFSQEVYIMRKIRHKNVV--QFIGACTR-----PPNLCIVTE  193 (399)
Q Consensus       130 g~Vy~~~~~~~~vAvK~~~~~~~~~~~---------~~~~~~Ei~~l~~l~h~nIv--~~~~~~~~-----~~~~~lV~E  193 (399)
                      ..|++.+..|+.+.||.........-.         ...+.+|...+.++...+|.  .++++...     ....++|||
T Consensus        36 rrvvr~~~~g~~~~vKr~~~~~~~~~~k~l~~~~~p~~~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~~~~~s~LVte  115 (268)
T PRK15123         36 RRTLRFELAGKSYFLKWHRGTGWGEIFKNLLSLRMPVLGADREWRAIHRLHEVGVDTMTGVAFGERGSNPATRTSFIITE  115 (268)
T ss_pred             ceEEEEEECCEEEEEEEecCCcHHHHhhhhcccccccHHHHHHHHHHHHHHHcCCCCCCeeEEEEecCCCccceeEEEEe
Confidence            346678888899999977543311100         11477899999888544433  44555532     224789999


Q ss_pred             cCCCC-CHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceeecC-------CCcEEEeeccceee
Q 015868          194 FMARG-SIYDFLHKQ-KGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDE-------NGVVKVADFGVARV  263 (399)
Q Consensus       194 ~~~gg-sL~~~l~~~-~~~l~~~~~~~i~~~i~~~L~~LH~~giiHrDlkp~NILl~~-------~~~vkl~DFG~a~~  263 (399)
                      ++++. +|.+++... ....+......++.+++..+.-||+.||+|+|+++.|||++.       +..+.++||+.++.
T Consensus       116 ~l~~~~sL~~~~~~~~~~~~~~~~~~~ll~~la~~i~~LH~~Gi~HgDL~~~NiLl~~~~~~~~~~~~~~LIDl~r~~~  194 (268)
T PRK15123        116 DLAPTISLEDYCADWATNPPDPRLKRMLIKRVATMVRDMHAAGINHRDCYICHFLLHLPFPGREEDLKLSVIDLHRAQI  194 (268)
T ss_pred             eCCCCccHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHHCcCccCCCChhhEEEeccccCCCCCceEEEEECCcccc
Confidence            99886 899998542 244566777889999999999999999999999999999975       46899999998853

>KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification]

Probab=99.15  E-value=2.6e-09  Score=105.03  Aligned_cols=213  Identities=15%  Similarity=0.202  Sum_probs=156.9

Q ss_pred             ceEEEEEEE--CCeeEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCceeeEEeEEec----CCcEEEEEecCCC-CCHH
Q 015868          129 YGDLYKGTY--CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTR----PPNLCIVTEFMAR-GSIY  201 (399)
Q Consensus       129 ~g~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~nIv~~~~~~~~----~~~~~lV~E~~~g-gsL~  201 (399)
                      ..+.|+++.  +|..|.+|+++......  ......-+++++++.|+|||++.+++..    ...+++|++|+++ ++|+
T Consensus       289 ~~Ttyk~~s~~DG~~YvLkRlhg~r~~~--~nk~t~lve~wkkl~h~NvV~frevf~t~tF~D~SlvlvYDYyP~s~TL~  366 (655)
T KOG3741|consen  289 SITTYKATSNVDGNAYVLKRLHGDRDQS--TNKDTSLVEAWKKLCHTNVVPFREVFLTYTFGDLSLVLVYDYYPSSPTLY  366 (655)
T ss_pred             cceeEeeeeccCCceeeeeeeccccccC--cccchHHHHHHHHhccCceeehhhhhhhhccCcceEEEEEecCCCCchHH
Confidence            356888865  68899999995432111  1223345788999999999999999863    3458999999886 5888


Q ss_pred             HHHHhc--------------CCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceeecCCCcEEEeeccceeeccCC
Q 015868          202 DFLHKQ--------------KGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQS  267 (399)
Q Consensus       202 ~~l~~~--------------~~~l~~~~~~~i~~~i~~~L~~LH~~giiHrDlkp~NILl~~~~~vkl~DFG~a~~~~~~  267 (399)
                      ++.-..              +...++..+|.++.|+..||.++|+.|+.-+-|.|.+|+++.+.+++|.-.|........
T Consensus       367 d~~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHssGLAck~L~~~kIlv~G~~RIriS~C~i~Dvl~~d  446 (655)
T KOG3741|consen  367 DLYFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHSSGLACKTLDLKKILVTGKMRIRISGCGIMDVLQED  446 (655)
T ss_pred             HHHccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHHhcCceeecccHhHeEeeCcceEEEecccceeeecCC
Confidence            875321              235678999999999999999999999999999999999999989999988888765443


Q ss_pred             CccccCCCCcccccccccCCCCCCChhhHHHHHHHHHHHHcCCCC-CCCCCHHHHHHHHHhccCCCCCCCCCcHHHHHHH
Q 015868          268 GVMTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELP-YAGLTPLQAAVGVVQKSLRPTIPKHAHPRLAELL  346 (399)
Q Consensus       268 ~~~~~~~gt~~y~aPE~l~~~~~~~~~Dv~slG~vl~elltg~~P-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll  346 (399)
                      .      +       +.+..   ..+-|.=.||.++..|.||..- +......+....        .+...++.++++++
T Consensus       447 ~------~-------~~le~---~Qq~D~~~lG~ll~aLAt~~~ns~~~d~~~~s~~~--------~I~~~yS~D~rn~v  502 (655)
T KOG3741|consen  447 P------T-------EPLES---QQQNDLRDLGLLLLALATGTENSNRTDSTQSSHLT--------RITTTYSTDLRNVV  502 (655)
T ss_pred             C------C-------cchhH---HhhhhHHHHHHHHHHHhhcccccccccchHHHHHH--------HhhhhhhHHHHHHH
Confidence            2      0       11111   2356999999999999998542 322223322122        23456888999999


Q ss_pred             HHHhhhcCCCCCCHHHHHHHHH
Q 015868          347 ERCWQHDPTQRPNFSQITDILK  368 (399)
Q Consensus       347 ~~cl~~dP~~Rps~~ell~~L~  368 (399)
                      .-....++++ -++.+++..+-
T Consensus       503 ~yl~s~~~~~-ksI~~llp~~~  523 (655)
T KOG3741|consen  503 EYLESLNFRE-KSIQDLLPMIG  523 (655)
T ss_pred             HHHHhcCccc-ccHHHHHHHHH
Confidence            9999998887 77787766543

>COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only]

Probab=99.13  E-value=4.2e-09  Score=101.29  Aligned_cols=253  Identities=17%  Similarity=0.278  Sum_probs=170.9

Q ss_pred             cceeceeceeCceEEEEEEECCeeEEEEEecCCCCCHHHHHHHHHHHHHHHhc-CCCceeeEEeEE-------ecCCcEE
Q 015868          118 LKIECKVASGSYGDLYKGTYCSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKI-RHKNVVQFIGAC-------TRPPNLC  189 (399)
Q Consensus       118 ~~i~~~lg~G~~g~Vy~~~~~~~~vAvK~~~~~~~~~~~~~~~~~Ei~~l~~l-~h~nIv~~~~~~-------~~~~~~~  189 (399)
                      ....+.||+|+-+.+|-.-.-... +-|+.+........     +-+..|... .||-+-.-+.+-       ..+....
T Consensus        13 i~~gr~LgqGgea~ly~l~e~~d~-VAKIYh~Pppa~~a-----qk~a~la~~p~~p~~~~rvaWPqa~L~G~~~~~~iG   86 (637)
T COG4248          13 IPPGRPLGQGGEADLYTLGEVRDQ-VAKIYHAPPPAAQA-----QKVAELAATPDAPLLNYRVAWPQATLHGGRRGKVIG   86 (637)
T ss_pred             cCCCccccCCccceeeecchhhch-hheeecCCCchHHH-----HHHHHhccCCCCcchhhhhcccHHHhhCCCccceeE
Confidence            345678999999999964332223 34666544222211     123334333 455433311110       1122367


Q ss_pred             EEEecCCCC-CHHHHHH-----hcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceeecCCCcEEEeeccceee
Q 015868          190 IVTEFMARG-SIYDFLH-----KQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARV  263 (399)
Q Consensus       190 lV~E~~~gg-sL~~~l~-----~~~~~l~~~~~~~i~~~i~~~L~~LH~~giiHrDlkp~NILl~~~~~vkl~DFG~a~~  263 (399)
                      +.|..++|. .+.++.+     .......++.+.+++..++.+.+.||..|.+-+|+.++|+|+++++.|.|+|-..-..
T Consensus        87 flmP~v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH~~Gh~vGDVn~~~~lVsd~~~V~LVdsDsfqi  166 (637)
T COG4248          87 FLMPKVSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLHEHGHVVGDVNQNSFLVSDDSKVVLVDSDSFQI  166 (637)
T ss_pred             EecccCCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHHhcCCcccccCccceeeecCceEEEEcccceee
Confidence            888888775 3333332     1224467888999999999999999999999999999999999999999998766555


Q ss_pred             ccCCCccccCCCCcccccccccCC-----CCCCChhhHHHHHHHHHHHHcC-CCCCCCC-------CHHHHHHHH-----
Q 015868          264 QAQSGVMTAETGTYRWMAPEVIEH-----KPYDYKADVFSFGIALWELLTG-ELPYAGL-------TPLQAAVGV-----  325 (399)
Q Consensus       264 ~~~~~~~~~~~gt~~y~aPE~l~~-----~~~~~~~Dv~slG~vl~elltg-~~P~~~~-------~~~~~~~~~-----  325 (399)
                      ........-..|...|.+||.-+-     -.-+...|.|.||+++++++.| ..||++.       ++.+.....     
T Consensus       167 ~~ng~~~~cpVg~~eftPPElQ~~~sf~g~~r~~~hD~FGLavLiF~lL~ggrHPysGI~~~~~ap~p~E~~Ia~g~f~y  246 (637)
T COG4248         167 NANGTLHLCPVGVSEFTPPELQTLPSFVGFERTANHDNFGLAVLIFHLLFGGRHPYSGIPLISDAPNPLETDIAHGRFAY  246 (637)
T ss_pred             ccCCceEecccCccccCCHHHhccccccccCCCccccchhHHHHHHHHHhcCCCCCCcccccCCCCCcchhhhhcceeee
Confidence            555555666789999999998762     3345678999999999999885 8999763       333322211     


Q ss_pred             ---HhccCCCC---CC-CCCcHHHHHHHHHHhhhc--CCCCCCHHHHHHHHHHHHHHHHh
Q 015868          326 ---VQKSLRPT---IP-KHAHPRLAELLERCWQHD--PTQRPNFSQITDILKQMMKEVAS  376 (399)
Q Consensus       326 ---~~~~~~~~---~~-~~~~~~l~~ll~~cl~~d--P~~Rps~~ell~~L~~l~~~~~~  376 (399)
                         .+.+.+|.   +| .-+++++..|..+|+..-  +.-|||++..+..|.++.+++..
T Consensus       247 a~~~~~g~~p~P~~~P~~~Lpp~vqAlF~qaF~~~~~~~~RP~a~aW~aAl~al~~~L~~  306 (637)
T COG4248         247 ASDQRRGLKPPPRSIPLSMLPPDVQALFQQAFTESGVATPRPTAKAWVAALDALRQQLKK  306 (637)
T ss_pred             chhccCCCCCCCCCCChhhcCHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHHHHhhhh
Confidence               11111111   11 236789999999999763  67899999999999999887743

>PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases

Probab=99.11  E-value=7.1e-10  Score=98.26  Aligned_cols=127  Identities=20%  Similarity=0.262  Sum_probs=83.6

Q ss_pred             EEEEEEE-CCeeEEEEEecCCCCC------------------------HHHHHHHHHHHHHHHhcCCC--ceeeEEeEEe
Q 015868          131 DLYKGTY-CSQEVAIKVLKPECVN------------------------TEMLKEFSQEVYIMRKIRHK--NVVQFIGACT  183 (399)
Q Consensus       131 ~Vy~~~~-~~~~vAvK~~~~~~~~------------------------~~~~~~~~~Ei~~l~~l~h~--nIv~~~~~~~  183 (399)
                      .||.|.. .+..+|+|+.+....+                        .-......+|...|.++...  ++++++++. 
T Consensus         1 ~Vy~~~~~~~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p~~~~-   79 (188)
T PF01163_consen    1 DVYHAIDPDGEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPKPYDYN-   79 (188)
T ss_dssp             EEEEEEECTTEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--EEEEE-
T ss_pred             CEEEEECCCCCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCcEEEEe-
Confidence            4888886 6789999997643211                        11134578899999999765  577777553 


Q ss_pred             cCCcEEEEEecCC--CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHH-HHHCCcccCCCCCCceeecCCCcEEEeeccc
Q 015868          184 RPPNLCIVTEFMA--RGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNY-LHQNNIIHRDLKTANLLMDENGVVKVADFGV  260 (399)
Q Consensus       184 ~~~~~~lV~E~~~--ggsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~-LH~~giiHrDlkp~NILl~~~~~vkl~DFG~  260 (399)
                         .-+|||||++  |..+..+....   ++......++.+++..+.. +|..||+|+|+.+.||+++++ .+.|+|||.
T Consensus        80 ---~~~ivME~I~~~G~~~~~l~~~~---~~~~~~~~~~~~il~~~~~~~~~~givHGDLs~~NIlv~~~-~~~iIDf~q  152 (188)
T PF01163_consen   80 ---RNVIVMEYIGEDGVPLPRLKDVD---LSPEEPKELLEEILEEIIKMLHKAGIVHGDLSEYNILVDDG-KVYIIDFGQ  152 (188)
T ss_dssp             ---TTEEEEE--EETTEEGGCHHHCG---GGGSTHHHHHHHHHHHHHHHHHCTTEEESS-STTSEEEETT-CEEE--GTT
T ss_pred             ---CCEEEEEecCCCccchhhHHhcc---ccchhHHHHHHHHHHHHHHHHHhcCceecCCChhhEEeecc-eEEEEecCc
Confidence               3479999998  65554433221   1134456677788885555 579999999999999999877 999999999


Q ss_pred             eeecc
Q 015868          261 ARVQA  265 (399)
Q Consensus       261 a~~~~  265 (399)
                      +....
T Consensus       153 av~~~  157 (188)
T PF01163_consen  153 AVDSS  157 (188)
T ss_dssp             EEETT
T ss_pred             ceecC
Confidence            87544

Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A.

>PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases

Probab=98.97  E-value=7.8e-09  Score=93.39  Aligned_cols=106  Identities=17%  Similarity=0.266  Sum_probs=83.7

Q ss_pred             HHHHHHHHHHHhcCCCc--eeeEEeEEecC----CcEEEEEecCCCC-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHH
Q 015868          158 KEFSQEVYIMRKIRHKN--VVQFIGACTRP----PNLCIVTEFMARG-SIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYL  230 (399)
Q Consensus       158 ~~~~~Ei~~l~~l~h~n--Iv~~~~~~~~~----~~~~lV~E~~~gg-sL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~L  230 (399)
                      ....+|...+..+...+  ++..+++....    ...++|||++++. +|.+++..... .+......++.+++..++-|
T Consensus        56 ~ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~~~~~~s~lite~l~~~~~L~~~~~~~~~-~~~~~~~~ll~~l~~~i~~l  134 (206)
T PF06293_consen   56 SRAKREWRNLQRLREAGIPTPEPVAYGERRKGGGYRSYLITEALPGAQDLRDLLQQWEQ-LDPSQRRELLRALARLIAKL  134 (206)
T ss_pred             hHHHHHHHHHHHHHHcCCCCCcEEEEEEEcCCCceeEEEEEEeCCCcccHHHHHHhhcc-cchhhHHHHHHHHHHHHHHH
Confidence            35777888877775333  44555555442    2358999999884 89999876333 56677889999999999999


Q ss_pred             HHCCcccCCCCCCceeecCCC---cEEEeeccceeec
Q 015868          231 HQNNIIHRDLKTANLLMDENG---VVKVADFGVARVQ  264 (399)
Q Consensus       231 H~~giiHrDlkp~NILl~~~~---~vkl~DFG~a~~~  264 (399)
                      |.+||+|+|+++.|||++.++   .+.++||+-++..
T Consensus       135 H~~gi~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~~  171 (206)
T PF06293_consen  135 HDAGIYHGDLNPSNILVDPDDGQYRFYLIDLDRMRFR  171 (206)
T ss_pred             HHCcCCCCCCCcccEEEeCCCCceeEEEEcchhceeC
Confidence            999999999999999999887   8999999988754

Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane

>COG0661 AarF Predicted unusual protein kinase [General function prediction only]

Probab=98.95  E-value=6.4e-08  Score=98.16  Aligned_cols=142  Identities=19%  Similarity=0.259  Sum_probs=97.2

Q ss_pred             ceeceeCceEEEEEEEC-CeeEEEEEecCCCCCH--------------------------------HHHH------HHHH
Q 015868          122 CKVASGSYGDLYKGTYC-SQEVAIKVLKPECVNT--------------------------------EMLK------EFSQ  162 (399)
Q Consensus       122 ~~lg~G~~g~Vy~~~~~-~~~vAvK~~~~~~~~~--------------------------------~~~~------~~~~  162 (399)
                      ..|+.+|-|+||+|+.. |+.||||+.+|.....                                +..+      ++.+
T Consensus       131 ~PiAsASIaQVH~A~L~sG~~VAVKVqrPgi~~~i~~DL~il~~~a~~~~~~~~~~~~l~~~~vv~e~~~~l~~ElDy~~  210 (517)
T COG0661         131 EPIASASIAQVHRAVLKSGEEVAVKVQRPGIRERIEADLKLLRRLARLIKRLPPGGRRLDLVEVVDEFEKRLREELDYRR  210 (517)
T ss_pred             CchhhhhHhhheeEEecCCCEEEEEecCCChHHHHHHHHHHHHHHHHHHHHcCCccccCChHHHHHHHHHHHHHHhCHHH
Confidence            57899999999999986 8999999988753210                                0011      2444


Q ss_pred             HHHHHHhcC-----CCceeeEEeEEecCCcEEEEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccc
Q 015868          163 EVYIMRKIR-----HKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIH  237 (399)
Q Consensus       163 Ei~~l~~l~-----h~nIv~~~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~giiH  237 (399)
                      |...+.+++     .+++.=..=++.-...-.|+|||++|-.+.+........++...+.....++  -+..+-..|++|
T Consensus       211 EA~n~~~~~~nf~~~~~v~VP~V~we~t~~~VLtmE~i~Gi~i~d~~~l~~~g~d~k~ia~~~~~~--f~~q~~~dgffH  288 (517)
T COG0661         211 EAANAERFRENFKDDPDVYVPKVYWEYTTRRVLTMEWIDGIKISDIAALKSAGIDRKELAELLVRA--FLRQLLRDGFFH  288 (517)
T ss_pred             HHHHHHHHHHHcCCCCCeEeceeehhccCCcEEEEEeeCCEecccHHHHHhcCCCHHHHHHHHHHH--HHHHHHhcCccc
Confidence            555555552     2433222222333334679999999999988854434556655554444443  234444589999


Q ss_pred             CCCCCCceeecCCCcEEEeeccceeecc
Q 015868          238 RDLKTANLLMDENGVVKVADFGVARVQA  265 (399)
Q Consensus       238 rDlkp~NILl~~~~~vkl~DFG~a~~~~  265 (399)
                      .|..|.||+++.+|.+.+.|||.....+
T Consensus       289 aDpHpGNi~v~~~g~i~~lDfGi~g~l~  316 (517)
T COG0661         289 ADPHPGNILVRSDGRIVLLDFGIVGRLD  316 (517)
T ss_pred             cCCCccceEEecCCcEEEEcCcceecCC
Confidence            9999999999999999999999987544

>COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms]

Probab=98.93  E-value=8.3e-09  Score=94.57  Aligned_cols=138  Identities=18%  Similarity=0.231  Sum_probs=103.5

Q ss_pred             cceeceeceeCceEEEEEEE-CCeeEEEEEecCCCCC--------------------HHHHHHHHHHHHHHHhcCCC--c
Q 015868          118 LKIECKVASGSYGDLYKGTY-CSQEVAIKVLKPECVN--------------------TEMLKEFSQEVYIMRKIRHK--N  174 (399)
Q Consensus       118 ~~i~~~lg~G~~g~Vy~~~~-~~~~vAvK~~~~~~~~--------------------~~~~~~~~~Ei~~l~~l~h~--n  174 (399)
                      ..+..+||-|-=+.||.|.. .+.++|||.-+....+                    .-......+|..+|+++...  .
T Consensus        93 e~iG~~IGvGKEsdVY~~~~~~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~~~G~~  172 (304)
T COG0478          93 EAIGTKIGVGKESDVYVAIDPKGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLYPEGVK  172 (304)
T ss_pred             HhhccccccCccceEEEEECCCCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhhhcCCC
Confidence            46678999999999999987 5899999985533221                    11234577899999999654  7


Q ss_pred             eeeEEeEEecCCcEEEEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceeecCCCcEE
Q 015868          175 VVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVK  254 (399)
Q Consensus       175 Iv~~~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~giiHrDlkp~NILl~~~~~vk  254 (399)
                      |+..+++    +.-.+|||+++|-.|+..-      +.......++..|+.-+.-+-..||||+|+++-||+++++|.+.
T Consensus       173 VP~P~~~----nRHaVvMe~ieG~eL~~~r------~~~en~~~il~~il~~~~~~~~~GiVHGDlSefNIlV~~dg~~~  242 (304)
T COG0478         173 VPKPIAW----NRHAVVMEYIEGVELYRLR------LDVENPDEILDKILEEVRKAYRRGIVHGDLSEFNILVTEDGDIV  242 (304)
T ss_pred             CCCcccc----ccceeeeehcccceeeccc------CcccCHHHHHHHHHHHHHHHHHcCccccCCchheEEEecCCCEE
Confidence            7777763    3467999999997766542      12334445566666666666689999999999999999999999


Q ss_pred             Eeeccceeecc
Q 015868          255 VADFGVARVQA  265 (399)
Q Consensus       255 l~DFG~a~~~~  265 (399)
                      ++||-.+....
T Consensus       243 vIDwPQ~v~~~  253 (304)
T COG0478         243 VIDWPQAVPIS  253 (304)
T ss_pred             EEeCcccccCC
Confidence            99998775433

>PRK09902 hypothetical protein; Provisional

Probab=98.79  E-value=1e-07  Score=85.29  Aligned_cols=139  Identities=14%  Similarity=0.089  Sum_probs=101.5

Q ss_pred             ceeCceEEEEEEECCeeEEEEEecCCCCC----HHHHHHHHHHHHHHHhcCCC--ceeeEEeEEec--C--CcEEEEEec
Q 015868          125 ASGSYGDLYKGTYCSQEVAIKVLKPECVN----TEMLKEFSQEVYIMRKIRHK--NVVQFIGACTR--P--PNLCIVTEF  194 (399)
Q Consensus       125 g~G~~g~Vy~~~~~~~~vAvK~~~~~~~~----~~~~~~~~~Ei~~l~~l~h~--nIv~~~~~~~~--~--~~~~lV~E~  194 (399)
                      |.|+-+-|++-...|+.+=+|.-......    ..-...|.+|...++++...  .+++++.....  +  -..+||+|-
T Consensus        27 ~rgG~SgV~r~~~~g~~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~GvPVP~pvf~~~~k~~~~~rA~LVTe~  106 (216)
T PRK09902         27 RRNGMSGVQCVERNGKKLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERAGVIVPKIVFGEAVKIEGEWRALLVTED  106 (216)
T ss_pred             CCCCcceEEEEEeCCcEEEEEeccCcccccccCCCCchHHHHHHHHHHHHHHcCCCCCccceeeeeccCCceEEEEEEEe
Confidence            55777888988888887888875411100    11246789999999998532  25555522211  1  136899997


Q ss_pred             CCC-CCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceeecCCCc--EEEeeccceee
Q 015868          195 MAR-GSIYDFLHKQK-GVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGV--VKVADFGVARV  263 (399)
Q Consensus       195 ~~g-gsL~~~l~~~~-~~l~~~~~~~i~~~i~~~L~~LH~~giiHrDlkp~NILl~~~~~--vkl~DFG~a~~  263 (399)
                      ++| .+|.+++.+.. .+.+......++.++++.+.-||+.|+.|+|+.+.||+++.+|.  |+++||.-++.
T Consensus       107 L~g~~~L~~~l~~~~~~~~~~~~k~~il~~va~~ia~LH~~Gv~Hgdly~khIll~~~g~~~v~lIDlEk~r~  179 (216)
T PRK09902        107 MAGFISIADWYAQHAVSPYSDEVRQAMLKAVALAFKKMHSVNRQHGCCYVRHIYVKTEGKAEAGFLDLEKSRR  179 (216)
T ss_pred             CCCCccHHHHHhcCCcCCcchHHHHHHHHHHHHHHHHHHHCCCcCCCCCHhheeecCCCCeeEEEEEhhccch
Confidence            764 48999885532 34566777889999999999999999999999999999987777  99999987764

>KOG2137 consensus Protein kinase [Signal transduction mechanisms]

Probab=98.78  E-value=2.1e-09  Score=109.07  Aligned_cols=143  Identities=19%  Similarity=0.307  Sum_probs=105.8

Q ss_pred             HHHHHHHHHHHC-CcccCCCCCCceeecCCCcEEEeeccceeeccCCCcc-----c-----cCCCCcccccccccCCCCC
Q 015868          222 DVSKGMNYLHQN-NIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVM-----T-----AETGTYRWMAPEVIEHKPY  290 (399)
Q Consensus       222 ~i~~~L~~LH~~-giiHrDlkp~NILl~~~~~vkl~DFG~a~~~~~~~~~-----~-----~~~gt~~y~aPE~l~~~~~  290 (399)
                      +++.|+.|+|+. ++||++|.|++|.++.++.+||+.|+++.........     +     .......|.|||.+.+...
T Consensus       107 ~v~dgl~flh~sAk~VH~ni~p~~i~~na~~~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~apE~~~~~~~  186 (700)
T KOG2137|consen  107 NVADGLAFLHRSAKVVHGNIQPEAIVVNANGDWKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLAPEYLLGTTN  186 (700)
T ss_pred             cccchhhhhccCcceeecccchhheeeccCcceeeccchhhhccCCCCccccccCCCCCChhhccCcccccchhhccccc
Confidence            444899999975 9999999999999999999999999987543331111     1     1123557999999999888


Q ss_pred             CChhhHHHHHHHHHHHH-cCCCCCCCCCHHHHHHH--HHhccCCCCCCCCCcHHHHHHHHHHhhhcCCCCCCHHHHH
Q 015868          291 DYKADVFSFGIALWELL-TGELPYAGLTPLQAAVG--VVQKSLRPTIPKHAHPRLAELLERCWQHDPTQRPNFSQIT  364 (399)
Q Consensus       291 ~~~~Dv~slG~vl~ell-tg~~P~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~l~~ll~~cl~~dP~~Rps~~ell  364 (399)
                      +.++|+||+|+++|.+. .|+.-+...........  .....-....+..+++++++=+.+++..++..||++.++.
T Consensus       187 ~~~sd~fSlG~li~~i~~~gk~i~~a~~~~~~~~~~~~~~~~~~~~~s~~~p~el~~~l~k~l~~~~~~rp~~~~l~  263 (700)
T KOG2137|consen  187 TPASDVFSLGVLIYTIYNGGKSIIAANGGLLSYSFSRNLLNAGAFGYSNNLPSELRESLKKLLNGDSAVRPTLDLLL  263 (700)
T ss_pred             cccccceeeeeEEEEEecCCcchhhccCCcchhhhhhcccccccccccccCcHHHHHHHHHHhcCCcccCcchhhhh
Confidence            89999999999999998 46666654432222111  1111222334577899999999999999999999776664

>PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY)

Probab=98.76  E-value=1.2e-07  Score=85.12  Aligned_cols=140  Identities=17%  Similarity=0.199  Sum_probs=94.8

Q ss_pred             ecccccceeceeceeCceEEEEEEECCeeEEEEEecCCCCCHHH-H------HHHHHHHHHHHhcCC---CceeeEEeEE
Q 015868          113 IDAKQLKIECKVASGSYGDLYKGTYCSQEVAIKVLKPECVNTEM-L------KEFSQEVYIMRKIRH---KNVVQFIGAC  182 (399)
Q Consensus       113 i~~~~~~i~~~lg~G~~g~Vy~~~~~~~~vAvK~~~~~~~~~~~-~------~~~~~Ei~~l~~l~h---~nIv~~~~~~  182 (399)
                      +-..+|++.+.+-.....-|.+-...++.+.+|..++.....+. .      ....+++..+.++..   -....++-+.
T Consensus        28 i~~~~~~~~kv~k~~~r~~ValIei~~~kyIlK~pr~~~~r~er~~~sf~kg~~~~~l~~~~~~i~~~g~~~~~~~yl~~  107 (229)
T PF06176_consen   28 ILDNNYKIIKVFKNTKRNYVALIEIDGKKYILKEPREENRRPERRFKSFFKGSEYSRLINNTDKIRNEGFTEPADPYLAA  107 (229)
T ss_pred             HHhCCceEEEeecCCCccEEEEEEECCcEEEEeccchhhhhHHHHHHHHhccHHHHHHHHHHHHHHHcCccccccceeee
Confidence            34567888888888888888888899999999998865322111 1      112334444444432   2333333333


Q ss_pred             ec-----CCcEEEEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceeecCCCcEEEee
Q 015868          183 TR-----PPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVAD  257 (399)
Q Consensus       183 ~~-----~~~~~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~giiHrDlkp~NILl~~~~~vkl~D  257 (399)
                      ..     ....+++|||++|..|.+...     +++    .++..+..++.-||+.|++|+|..|.|++++++ .++++|
T Consensus       108 ekk~~~~~~~~~ll~EYIeG~~l~d~~~-----i~e----~~~~ki~~~ikqlH~~G~~HGD~hpgNFlv~~~-~i~iID  177 (229)
T PF06176_consen  108 EKKIFRYTSSYVLLMEYIEGVELNDIED-----IDE----DLAEKIVEAIKQLHKHGFYHGDPHPGNFLVSNN-GIRIID  177 (229)
T ss_pred             eeeeccceeEEEEEEEEecCeecccchh-----cCH----HHHHHHHHHHHHHHHcCCccCCCCcCcEEEECC-cEEEEE
Confidence            22     234679999999988776532     222    244567788999999999999999999999855 599999


Q ss_pred             cccee
Q 015868          258 FGVAR  262 (399)
Q Consensus       258 FG~a~  262 (399)
                      |+..+
T Consensus       178 ~~~k~  182 (229)
T PF06176_consen  178 TQGKR  182 (229)
T ss_pred             Ccccc
Confidence            98765

The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process

>TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172

Probab=98.63  E-value=4.2e-07  Score=83.31  Aligned_cols=135  Identities=16%  Similarity=0.257  Sum_probs=86.0

Q ss_pred             ceeceeCceEEEEEEECCeeEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCc--eeeEEeEEecCCcEEEEEecCCCCC
Q 015868          122 CKVASGSYGDLYKGTYCSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKN--VVQFIGACTRPPNLCIVTEFMARGS  199 (399)
Q Consensus       122 ~~lg~G~~g~Vy~~~~~~~~vAvK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~n--Iv~~~~~~~~~~~~~lV~E~~~ggs  199 (399)
                      ..||.|..+.||+.  .+..+++|+.++.. .   .....+|.++++.+..-+  +++.+++........+|||+++|..
T Consensus         7 ~~i~~G~t~~~y~~--~~~~~VlR~~~~~~-~---~~~i~~E~~~l~~l~~~glpvP~~~~~~~~~~~~glv~e~i~G~~   80 (226)
T TIGR02172         7 TQTGEGGNGESYTH--KTGKWMLKLYNPGF-D---KETIKREFDASRKVFSLGIPTPHPFDLVEDGGRLGLIYELIVGKR   80 (226)
T ss_pred             eeecCCCCcceeEe--cCCCEEEEeCCCCC-C---HHHHHHHHHHHHHHHHcCCCCCceEEEEecCCeeeeeeeecCCcc
Confidence            57899999999984  35678889987543 1   234578999999886433  5788888877777899999999963


Q ss_pred             -HHHH---------------------HHhcC-CCCCHHHHHH-HHH----------HHHH-HHHHHH----HCCcccCCC
Q 015868          200 -IYDF---------------------LHKQK-GVFQLTSLLK-VAI----------DVSK-GMNYLH----QNNIIHRDL  240 (399)
Q Consensus       200 -L~~~---------------------l~~~~-~~l~~~~~~~-i~~----------~i~~-~L~~LH----~~giiHrDl  240 (399)
                       +...                     ++... ...+...... +..          .+.. ...+|.    ...++|+|+
T Consensus        81 ~~~~~~~~~~~~~~~l~~~la~~l~~lH~~~~~~~~l~~~~~~~~~~l~~~~~~~~~~~~~l~~~l~~~~~~~~~~HgD~  160 (226)
T TIGR02172        81 SFSRIISDNPSRLEEIAKIFAEMAKKLHSTKCDTSTFQSYKEKIRKFIEEKDFVPKDYKEKARAFIKEVPDTSTCLHGDF  160 (226)
T ss_pred             chhhhhcCCHHHHHHHHHHHHHHHHHHhCCCCCCCcHHHHHHHHHHHHHhccCCCHHHHHHHHHHHHhCCCCCceEecCC
Confidence             1111                     11100 1111111111 100          0111 122222    124789999


Q ss_pred             CCCceeecCCCcEEEeeccceee
Q 015868          241 KTANLLMDENGVVKVADFGVARV  263 (399)
Q Consensus       241 kp~NILl~~~~~vkl~DFG~a~~  263 (399)
                      .|.||++++++ +.|+||+.+..
T Consensus       161 ~~~Nii~~~~~-~~iIDwe~a~~  182 (226)
T TIGR02172       161 QIGNLITSGKG-TYWIDLGDFGY  182 (226)
T ss_pred             CCCcEEEcCCC-cEEEechhcCc
Confidence            99999999888 99999998863

This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636.

>PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily

Probab=98.59  E-value=6.2e-07  Score=81.58  Aligned_cols=139  Identities=19%  Similarity=0.281  Sum_probs=86.3

Q ss_pred             eceeceeCceEEEEEEECCeeEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCC--ceeeEEeEEec---CCcEEEEEecC
Q 015868          121 ECKVASGSYGDLYKGTYCSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHK--NVVQFIGACTR---PPNLCIVTEFM  195 (399)
Q Consensus       121 ~~~lg~G~~g~Vy~~~~~~~~vAvK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~--nIv~~~~~~~~---~~~~~lV~E~~  195 (399)
                      .+.++.|..+.||+.+..+..+++|+....    .....+.+|..+++.+...  .+++++.....   ....+++|+++
T Consensus         2 i~~l~~G~~n~~~~v~~~~~~~vlK~~~~~----~~~~~~~~e~~~~~~l~~~~~pvP~~~~~~~~~~~~~~~~~~~~~i   77 (239)
T PF01636_consen    2 IRPLSGGFSNRVYRVTTDDGRYVLKFYRPP----DAAERLRREAAVLRQLAEHGIPVPRVLAFDTSDEFNGFPYLLMEYI   77 (239)
T ss_dssp             EEEEEESSSSEEEEEEETTSEEEEEEESSH----HHHHHHHHHHHHHHHHHHTTSBS--EEEEEEETEETSEEEEEEEEE
T ss_pred             CccCCCCCeeeEEEEEECCcEEEEEEeCCC----CCHHHHHHHHHHHHHHHhcCCCCceEEeecccccccccceEEEEEe
Confidence            357899999999999998889999997643    4567788899999888533  35677764422   33478999999


Q ss_pred             CCCCHHH----------------HH---HhcC---CCCCHHH---------HHHH------------HHHHHH-HHHHHH
Q 015868          196 ARGSIYD----------------FL---HKQK---GVFQLTS---------LLKV------------AIDVSK-GMNYLH  231 (399)
Q Consensus       196 ~ggsL~~----------------~l---~~~~---~~l~~~~---------~~~i------------~~~i~~-~L~~LH  231 (399)
                      +|.++..                .+   +...   ..+....         ....            ...+.. .+..++
T Consensus        78 ~g~~~~~~~~~~~~~~~~~~~~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  157 (239)
T PF01636_consen   78 PGRPLDDELSPEQRPELLRQLGRALAQLHQVPPPFSPFADWPEWRLEFLRQLESWTARLRASELFDDLEELEERLLQELE  157 (239)
T ss_dssp             SSEEHHHTSTHHHHHHHHHHHHHHHHHHHHSHTTCCCHTHHHHHHHHHHHHHHHHHHHHHHHCCHHHHHHHHHHHHHHHH
T ss_pred             ccccccccccccccccccccchhhhhhcccccccccccccccccccccccccccccccccchhhhhhhHHHHHHHHHHHH
Confidence            9987777                11   1110   1111000         0000            111222 333333


Q ss_pred             H-------CCcccCCCCCCceeec-CCCcEEEeeccceee
Q 015868          232 Q-------NNIIHRDLKTANLLMD-ENGVVKVADFGVARV  263 (399)
Q Consensus       232 ~-------~giiHrDlkp~NILl~-~~~~vkl~DFG~a~~  263 (399)
                      +       ..++|+|+.|.||+++ +++.+.|+||+.+..
T Consensus       158 ~~~~~~~~~~~~HgD~~~~Nil~~~~~~~i~iID~e~a~~  197 (239)
T PF01636_consen  158 ALLPKPLPPVLIHGDLHPGNILVDPSDGRIGIIDFEDAGW  197 (239)
T ss_dssp             HHHHCCSCEEEE-SS-SGGGEEEESSTTEEEE--GTT-EE
T ss_pred             hhhccCCCcEEEEeccccccceeeeccceeEEEecccceE
Confidence            2       4699999999999999 667778999998864

; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B ....

>COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning]

Probab=98.50  E-value=1.1e-06  Score=79.95  Aligned_cols=138  Identities=19%  Similarity=0.200  Sum_probs=94.1

Q ss_pred             eeceeCceEEEEEEE-CCeeEEEEEecCCCCCHHH----------------------HHHHHHHHHHHHhcC--CCceee
Q 015868          123 KVASGSYGDLYKGTY-CSQEVAIKVLKPECVNTEM----------------------LKEFSQEVYIMRKIR--HKNVVQ  177 (399)
Q Consensus       123 ~lg~G~~g~Vy~~~~-~~~~vAvK~~~~~~~~~~~----------------------~~~~~~Ei~~l~~l~--h~nIv~  177 (399)
                      .|.+|--+.||+|.. .+..+|+|+.+........                      ..-...|...|+++.  +=.+++
T Consensus        55 ~istGKEA~Vy~a~~~~~~~~avKiyr~~t~~fk~~~~Yi~gd~Rf~~~~~~rr~lv~~W~~kEf~NL~R~~eAGVrvP~  134 (268)
T COG1718          55 CISTGKEANVYLAETGDGRYVAVKIYRTSTSEFKRIRRYIQGDPRFRNSRSNRRKLVFAWARKEFRNLKRAYEAGVRVPE  134 (268)
T ss_pred             eecCCcceEEEeeccCCCceEEEEEEehhhhhhhhHHHHHhcChhhhcCCCCHHHHHHHHHHHHHHHHHHHHHcCCCCCC
Confidence            556666678999875 5889999998754322111                      112345667777664  334555


Q ss_pred             EEeEEecCCcEEEEEecCCCC-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH-CCcccCCCCCCceeecCCCcEEE
Q 015868          178 FIGACTRPPNLCIVTEFMARG-SIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQ-NNIIHRDLKTANLLMDENGVVKV  255 (399)
Q Consensus       178 ~~~~~~~~~~~~lV~E~~~gg-sL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~-~giiHrDlkp~NILl~~~~~vkl  255 (399)
                      .+.+.    +-.|||||+... .-.-.|.  .-++.......+..++++.|.-|-. .++||+||+.=|||+. ++.+.|
T Consensus       135 Pi~~~----~nVLvMEfIg~~g~pAP~Lk--Dv~~e~~e~~~~~~~~v~~~~~l~~~a~LVHgDLSEyNiL~~-~~~p~i  207 (268)
T COG1718         135 PIAFR----NNVLVMEFIGDDGLPAPRLK--DVPLELEEAEGLYEDVVEYMRRLYKEAGLVHGDLSEYNILVH-DGEPYI  207 (268)
T ss_pred             ceeec----CCeEEEEeccCCCCCCCCcc--cCCcCchhHHHHHHHHHHHHHHHHHhcCcccccchhhheEEE-CCeEEE
Confidence            55543    356999999653 1111121  1223333677788899999999988 8999999999999998 889999


Q ss_pred             eeccceeeccCC
Q 015868          256 ADFGVARVQAQS  267 (399)
Q Consensus       256 ~DFG~a~~~~~~  267 (399)
                      +|||.|....++
T Consensus       208 ID~~QaV~~~hp  219 (268)
T COG1718         208 IDVSQAVTIDHP  219 (268)
T ss_pred             EECccccccCCC
Confidence            999998755443

>cd05150 APH Aminoglycoside 3'-phosphotransferase (APH)

Probab=98.48  E-value=1.6e-06  Score=80.21  Aligned_cols=136  Identities=15%  Similarity=0.144  Sum_probs=86.3

Q ss_pred             eeceeCc-eEEEEEEECCeeEEEEEecCCCCCHHHHHHHHHHHHHHHhcC-CCceeeEEeEEecCCcEEEEEecCCCCCH
Q 015868          123 KVASGSY-GDLYKGTYCSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIR-HKNVVQFIGACTRPPNLCIVTEFMARGSI  200 (399)
Q Consensus       123 ~lg~G~~-g~Vy~~~~~~~~vAvK~~~~~~~~~~~~~~~~~Ei~~l~~l~-h~nIv~~~~~~~~~~~~~lV~E~~~ggsL  200 (399)
                      .|..|.+ ..||+....+..+.+|+.....     ...+.+|+.+++.+. +--+++++++...++..++|||+++|.++
T Consensus         5 ~~~~g~~~~~v~~~~~~~~~~~vk~~~~~~-----~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e~i~G~~l   79 (244)
T cd05150           5 RVTEGQSGATVYRLDGKNPGLYLKIAPSGP-----TYELEREAERLRWLAGKLPVPEVIDYGSDDGRAWLLTSAVPGVPA   79 (244)
T ss_pred             ecCCCCCcCeEEEEcCCCCcEEEEecCCCc-----ccchHHHHHHHHHHHhcCCCCeEEEEEecCCccEEEEEeeCCccH
Confidence            3444555 7899998777788899986542     235667888888874 34577888887776678999999999776


Q ss_pred             HHHH-------------------HhcC---CCCCHH---HHHHHHH-------------------HHHHHHHHHH-----
Q 015868          201 YDFL-------------------HKQK---GVFQLT---SLLKVAI-------------------DVSKGMNYLH-----  231 (399)
Q Consensus       201 ~~~l-------------------~~~~---~~l~~~---~~~~i~~-------------------~i~~~L~~LH-----  231 (399)
                      ....                   +...   ..+...   .+.....                   .+......|-     
T Consensus        80 ~~~~~~~~~~~~~~~l~~~l~~lH~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~  159 (244)
T cd05150          80 AALWEELEPERLVDALAEALRRLHALPVADCPFDRRLDRRLAEARARVENGLVDEDDFDDERRGWSAEELYAELEATRPA  159 (244)
T ss_pred             hHhhcccCHHHHHHHHHHHHHHHhcCCcccCCcchhHHHHHHHHHHHHhcCCcChhhCcHhhcCCCHHHHHHHHHhhCCC
Confidence            5431                   1100   011100   0000000                   0111122221     


Q ss_pred             --HCCcccCCCCCCceeecCCCcEEEeeccceee
Q 015868          232 --QNNIIHRDLKTANLLMDENGVVKVADFGVARV  263 (399)
Q Consensus       232 --~~giiHrDlkp~NILl~~~~~vkl~DFG~a~~  263 (399)
                        ...++|+|+.|.|||+++++.+.|+||+.+..
T Consensus       160 ~~~~~l~HgD~~~~Nil~~~~~~~~iIDwe~a~~  193 (244)
T cd05150         160 EEDLVVTHGDACLPNIIVDPGKFSGFIDLGRLGV  193 (244)
T ss_pred             cCceEEECCCCCCccEEEeCCcEEEEEEcccccc
Confidence              23589999999999999988889999997753

The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio

>COG2112 Predicted Ser/Thr protein kinase [Signal transduction mechanisms]

Probab=98.44  E-value=1.5e-06  Score=75.11  Aligned_cols=137  Identities=19%  Similarity=0.231  Sum_probs=98.5

Q ss_pred             ccccceeceeceeCceEEEEEEECCeeEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCce-eeEEeEEecCCcEEEEEe
Q 015868          115 AKQLKIECKVASGSYGDLYKGTYCSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNV-VQFIGACTRPPNLCIVTE  193 (399)
Q Consensus       115 ~~~~~i~~~lg~G~~g~Vy~~~~~~~~vAvK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~nI-v~~~~~~~~~~~~~lV~E  193 (399)
                      ....+..+.||.|.+|.||++.+.+.++|+|+-+.+.    ....+..|.++|..+.-.++ ++++.+..    -++.||
T Consensus        21 ~~~~~v~~~L~KG~~s~Vyl~~~~~~~~a~Kvrr~ds----~r~~l~kEakiLeil~g~~~~p~vy~yg~----~~i~me   92 (201)
T COG2112          21 KYELRVEKELAKGTTSVVYLGEWRGGEVALKVRRRDS----PRRNLEKEAKILEILAGEGVTPEVYFYGE----DFIRME   92 (201)
T ss_pred             chhhhhhhhhhcccccEEEEeeccCceEEEEEecCCc----chhhHHHHHHHHHHhhhcCCCceEEEech----hhhhhh
Confidence            3455667889999999999999999999999987542    34567789999999976554 45555443    345699


Q ss_pred             cCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCC-CCceeecCCCcEEEeeccceeeccCC
Q 015868          194 FMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLK-TANLLMDENGVVKVADFGVARVQAQS  267 (399)
Q Consensus       194 ~~~ggsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~giiHrDlk-p~NILl~~~~~vkl~DFG~a~~~~~~  267 (399)
                      |+.|.+|.+.-...    +...+    ..++..---|-..||-|+.|. |...++.+++.+.|+||..|+....+
T Consensus        93 ~i~G~~L~~~~~~~----~rk~l----~~vlE~a~~LD~~GI~H~El~~~~k~vlv~~~~~~iIDFd~At~k~~p  159 (201)
T COG2112          93 YIDGRPLGKLEIGG----DRKHL----LRVLEKAYKLDRLGIEHGELSRPWKNVLVNDRDVYIIDFDSATFKKKP  159 (201)
T ss_pred             hhcCcchhhhhhcc----cHHHH----HHHHHHHHHHHHhccchhhhcCCceeEEecCCcEEEEEccchhhccCC
Confidence            99998888765321    22333    344455555677899999986 44445545669999999999854433

>KOG1235 consensus Predicted unusual protein kinase [General function prediction only]

Probab=98.42  E-value=1.5e-06  Score=88.08  Aligned_cols=141  Identities=17%  Similarity=0.255  Sum_probs=94.5

Q ss_pred             ceeceeCceEEEEEEE-CCeeEEEEEecCCCCCH-----------------------------HHHH------HHHHHHH
Q 015868          122 CKVASGSYGDLYKGTY-CSQEVAIKVLKPECVNT-----------------------------EMLK------EFSQEVY  165 (399)
Q Consensus       122 ~~lg~G~~g~Vy~~~~-~~~~vAvK~~~~~~~~~-----------------------------~~~~------~~~~Ei~  165 (399)
                      +.||..+.|+||+|+. .|+.||||+-++.....                             +..+      +|.+|.+
T Consensus       167 ~piaaASlaQVhrA~L~~G~~VaVKVQ~P~l~~~~~~Dl~~~~~~~~~l~k~~p~~~~~~lvdE~~~~L~~ELDF~~EA~  246 (538)
T KOG1235|consen  167 EPIAAASLAQVHRARLKNGEDVAVKVQHPGLEKLIMLDLRNLRLLAKVLQKFFPDFDLVWLVDEIAKSLPQELDFTKEAK  246 (538)
T ss_pred             chhhhcchhheEEEEecCCCEEEEEecCcChHHHHHHHHHHHHHHHHHHHHhCcCCchhhHHHHHHhhhHhhcchHHHHH
Confidence            5799999999999986 67889999988753221                             1111      2344444


Q ss_pred             HHHhc----CCCc------eeeEEeEEecCCcEEEEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCc
Q 015868          166 IMRKI----RHKN------VVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNI  235 (399)
Q Consensus       166 ~l~~l----~h~n------Iv~~~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~gi  235 (399)
                      ...+.    .|-+      |++++-.+..  .-.|+||||+|..+.|.-.-....++...+..-+.+...  .-+=..|+
T Consensus       247 Nae~~~~~f~~~~~~~~V~VP~Vy~~~st--~RVLtME~~~G~~i~Dl~~i~~~gi~~~~i~~~l~~~~~--~qIf~~Gf  322 (538)
T KOG1235|consen  247 NAERFRENFKDFSLLTYVLVPKVYWDLST--KRVLTMEYVDGIKINDLDAIDKRGISPHDILNKLVEAYL--EQIFKTGF  322 (538)
T ss_pred             hHHHHHHHHHhcccccceeCCeehhhcCc--ceEEEEEecCCccCCCHHHHHHcCCCHHHHHHHHHHHHH--HHHHhcCC
Confidence            44333    3444      6666654443  357999999998776654333455666655544444322  22334689


Q ss_pred             ccCCCCCCceeecC----CCcEEEeeccceeeccC
Q 015868          236 IHRDLKTANLLMDE----NGVVKVADFGVARVQAQ  266 (399)
Q Consensus       236 iHrDlkp~NILl~~----~~~vkl~DFG~a~~~~~  266 (399)
                      +|+|-.|.||++++    ++.+.+.|||+.....+
T Consensus       323 fHaDPHPGNilv~~~~~~~~~ivllDhGl~~~is~  357 (538)
T KOG1235|consen  323 FHADPHPGNILVRPNPEGDEEIVLLDHGLYAVISH  357 (538)
T ss_pred             ccCCCCCCcEEEecCCCCCccEEEEcccccccccH
Confidence            99999999999984    67899999999875543

>KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis]

Probab=98.42  E-value=1e-05  Score=87.08  Aligned_cols=231  Identities=17%  Similarity=0.230  Sum_probs=160.6

Q ss_pred             eceeCceEEEEEEECCe------eEEEEE--ecCCCCCHHHHHHHHHHHHHHHhcCCCceeeEEeEEecCCcE----EEE
Q 015868          124 VASGSYGDLYKGTYCSQ------EVAIKV--LKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNL----CIV  191 (399)
Q Consensus       124 lg~G~~g~Vy~~~~~~~------~vAvK~--~~~~~~~~~~~~~~~~Ei~~l~~l~h~nIv~~~~~~~~~~~~----~lV  191 (399)
                      +..-.+|+++..++..+      ++-++-  ..... .........-|...+.+..|+|+.+++.+.......    .+.
T Consensus       186 ls~~~~~~l~l~k~~~~~qs~~~~~~~s~~~~~~~~-~k~~i~~~E~e~~~l~k~~~~n~~~~~~~~le~~~~g~~~~v~  264 (1351)
T KOG1035|consen  186 LSHLTQGTLLLVKWVEQAQSLSEPIEISHDYESTPC-GKKEIQTTEIELESLSKIAHDNLGGYFVYGLERLFRGIVLDVL  264 (1351)
T ss_pred             eccccCceEEEEehhhhHHhhcCcccccCcccCccc-hHHHHHHHHHHHHHHHhhccccccceeEEeehhhcchHHHHHH
Confidence            55567778888766321      111111  11110 112234445577788888999999999987654433    344


Q ss_pred             EecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCC---ceeecCCCcEEEe--eccceeeccC
Q 015868          192 TEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTA---NLLMDENGVVKVA--DFGVARVQAQ  266 (399)
Q Consensus       192 ~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~giiHrDlkp~---NILl~~~~~vkl~--DFG~a~~~~~  266 (399)
                      .|++...++...+.. -+..+...+..+..++.+|++|+|+....|.-+...   +.-++..+.+.+.  ||+.+...+.
T Consensus       265 ~~~~s~~~~~~~~q~-v~~i~~~~~r~~~~~~~~GL~~~h~~~l~~v~L~~s~~~~~~~~~e~~~~~sl~~~~ss~~l~d  343 (1351)
T KOG1035|consen  265 QEICSKVELRSLLQS-VGSIPLETLRILHQKLLEGLAYLHSLSLEHVVLSASSSKESTVDGEGVVAISLSDFDSSKPLPD  343 (1351)
T ss_pred             HhhcCccchHHHHhh-ccccCHHHHHHHHHHHhhhHHHHHHhccceeEEecccccccccCccceeecchhhhcccccCCC
Confidence            567877788887754 577899999999999999999999997777666655   5556677788888  9999887776


Q ss_pred             CCccccCCCCcccccccccCCCCCCCh--hhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhccCCCCCCCCCcHHHHH
Q 015868          267 SGVMTAETGTYRWMAPEVIEHKPYDYK--ADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRLAE  344 (399)
Q Consensus       267 ~~~~~~~~gt~~y~aPE~l~~~~~~~~--~Dv~slG~vl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~  344 (399)
                      .........+..|.+||......++.+  .|+|++|.....+..|..+-.....       ..    +.++......+.+
T Consensus       344 ~~~~~~~~~~~~~~~~e~~~~~~~~~~r~~dL~~lgll~~~~~~~~~i~~~~~~-------~~----~~l~~~~~~~~~d  412 (1351)
T KOG1035|consen  344 NEKSFSDLLAEIRNADEDLKENTAKKSRLTDLWCLGLLLLQLSQGEDISEKSAV-------PV----SLLDVLSTSELLD  412 (1351)
T ss_pred             cccchhhcCccccccccccccccchhhhhhHHHHHHHHHhhhhhcCcccccccc-------hh----hhhccccchhhhh
Confidence            666666667778889999887766554  7999999999998886543221110       11    1112222227899


Q ss_pred             HHHHHhhhcCCCCCCHHHHHHHH
Q 015868          345 LLERCWQHDPTQRPNFSQITDIL  367 (399)
Q Consensus       345 ll~~cl~~dP~~Rps~~ell~~L  367 (399)
                      .+.+|+..++++|+++.+++...
T Consensus       413 ~~~~~~~~~~~~Rl~~~~ll~~~  435 (1351)
T KOG1035|consen  413 ALPKCLDEDSEERLSALELLTHP  435 (1351)
T ss_pred             hhhhhcchhhhhccchhhhhhch
Confidence            99999999999999999997743

>cd04900 ACT_UUR-like_1 ACT domain family, ACT_UUR-like_1, includes the first of two C-terminal ACT domains of the bacterial signal-transducing uridylyltransferase /uridylyl-removing (UUR) enzyme, GlnD and related domains

Probab=98.41  E-value=1e-06  Score=65.70  Aligned_cols=56  Identities=27%  Similarity=0.392  Sum_probs=45.0

Q ss_pred             HHHHHHHHHhhhhCCCeeeeceeccCCCceeeEEEecCCCCcc--hHHHHHHHHHHHh
Q 015868            9 MKVGELTSLLGEIGLNIQEAHAFSTVDGFSLDVFVVDGWPYDE--TEDLKNVLAKEIL   64 (399)
Q Consensus         9 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~~~--~~~l~~~l~~~~~   64 (399)
                      .||++++.+|++.||||..|++|++.||+.+|+|.|..+....  .++.++.+++.+.
T Consensus        13 gLl~~i~~~l~~~~l~I~~A~i~T~~~~~v~D~F~v~~~~~~~~~~~~~~~~l~~~L~   70 (73)
T cd04900          13 GLFARIAGALDQLGLNILDARIFTTRDGYALDTFVVLDPDGEPIGERERLARIREALE   70 (73)
T ss_pred             CHHHHHHHHHHHCCCCeEEeEEEEeCCCeEEEEEEEECCCCCCCChHHHHHHHHHHHH
Confidence            4789999999999999999999999999999999997654332  3455566666553

This ACT domain family, ACT_UUR-like_1, includes the first of two C-terminal ACT domains of the bacterial signal-transducing uridylyltransferase /uridylyl-removing (UUR) enzyme, GlnD; including those enzymes similar to the GlnD found in enteric Escherichia coli and those found in photosynthetic, nitrogen-fixing bacterium Rhodospirillum rubrum. Also included in this CD is the N-terminal ACT domain of a yet characterized Arabidopsis/Oryza predicted tyrosine kinase. Members of this CD belong to the superfamily of ACT regulatory domains.

>KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms]

Probab=98.34  E-value=2e-08  Score=101.16  Aligned_cols=187  Identities=18%  Similarity=0.177  Sum_probs=136.8

Q ss_pred             ccceeceeceeCceEEEEEEECCe-eEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCc-eeeEEeEEecCCcEEEEEec
Q 015868          117 QLKIECKVASGSYGDLYKGTYCSQ-EVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKN-VVQFIGACTRPPNLCIVTEF  194 (399)
Q Consensus       117 ~~~i~~~lg~G~~g~Vy~~~~~~~-~vAvK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~n-Iv~~~~~~~~~~~~~lV~E~  194 (399)
                      -+....-++.|+++.+++.+...+ ....+.+...       ....-++++|.+++||| .+..++-+..+....+++++
T Consensus       243 ws~~fh~fvK~altknpKkRptaeklL~h~fvs~~-------l~~rl~~eLLdK~n~P~~~v~~~~d~~~E~~~~i~~~i  315 (829)
T KOG0576|consen  243 WSEFFHNFVKGALTKNPKKRPTAEKLLQHPFVSQT-------LSRRLAIELLDKVNNPNPVVRYLEDYDGEDYLWIPMRI  315 (829)
T ss_pred             chHHHHHHHHHHhcCCCccCCChhhheeceeeccc-------hhhHHHHHHHHHccCCCCcccccccCCcccccchhhhh
Confidence            355567789999999999765332 2223433321       33445889999999999 77888888888889999999


Q ss_pred             CCCC-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceeecCCCcEEEeeccceeeccCCCccccC
Q 015868          195 MARG-SIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAE  273 (399)
Q Consensus       195 ~~gg-sL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~giiHrDlkp~NILl~~~~~vkl~DFG~a~~~~~~~~~~~~  273 (399)
                      +.++ +....+....-.+..-+...+...-++++++||+.-=+|+|    ||+.. ++.++..||+........-.....
T Consensus       316 ~s~~rs~~~~~~~se~~~~~~~~~~~~r~et~~l~~l~~~~~~~~d----~~l~s-~~~~~~~~~~v~~~L~~~~~~~t~  390 (829)
T KOG0576|consen  316 CSTGRSSALEMTVSEIALEQYQFAYPLRKETRPLAELHSSYKVHRD----NILGS-EEEVKLLDFAVPPQLTRTMKPRTA  390 (829)
T ss_pred             hcCCccccccCChhhHhhhhhhhhhhhhhhcccccccccccccCcc----ccccc-ccccccccccCCcccCcccccccC
Confidence            9887 33333222222334445556667778899999998778998    77765 478999999998766554444556


Q ss_pred             CCCcccccccccCCCCCCChhhHHHHHHHHHHHHcCCCCCCC
Q 015868          274 TGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPYAG  315 (399)
Q Consensus       274 ~gt~~y~aPE~l~~~~~~~~~Dv~slG~vl~elltg~~P~~~  315 (399)
                      .+++.|+|||+.....++..-|+|++|.--.++.-|.+|-..
T Consensus       391 ~~~~~~~~pev~~~~~~~~~p~~~~~~~~~~~~ap~~pPr~~  432 (829)
T KOG0576|consen  391 IGTPEPLAPEVIQENTIDGCPDSGSLAVSAIQMAPGLPPRSS  432 (829)
T ss_pred             CCCCCCCCchhhcccccccCCCccCCCcchhhcCCCCCCCCC
Confidence            789999999999999999999999999876677767666543

>PF13095 FTA2: Kinetochore Sim4 complex subunit FTA2

Probab=98.23  E-value=4.7e-05  Score=67.79  Aligned_cols=127  Identities=20%  Similarity=0.293  Sum_probs=92.9

Q ss_pred             cccceeceeceeCc-eEEEEEEECCeeEEEEEecC---CCC-------C--H-------HHHHHHHHHHHHHHhcC---C
Q 015868          116 KQLKIECKVASGSY-GDLYKGTYCSQEVAIKVLKP---ECV-------N--T-------EMLKEFSQEVYIMRKIR---H  172 (399)
Q Consensus       116 ~~~~i~~~lg~G~~-g~Vy~~~~~~~~vAvK~~~~---~~~-------~--~-------~~~~~~~~Ei~~l~~l~---h  172 (399)
                      .+++..+.||.|+- |.||+++..++.+|+|+++.   ...       .  .       ....-|..|.+...+++   +
T Consensus        37 ~~I~flefLg~g~~~~~V~kv~I~g~~YALKlf~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PF~~ECRAfgRLke~~~  116 (207)
T PF13095_consen   37 DDIEFLEFLGHGSHDGYVFKVEIDGRIYALKLFRFWDYTEPDYTRERFAGHETSLSTPAHYADPFNCECRAFGRLKEAGR  116 (207)
T ss_pred             CcEeeeeecCCCCceeEEEEEEECCeEEEEEEeeccccCCCccccccccccccccchhhhhcChHHHHHHhhHHHHhccc
Confidence            68899999999999 99999999999999999431   110       0  0       22345788888877775   4


Q ss_pred             Cce--eeEEeEEecC------------------CcEEEEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH
Q 015868          173 KNV--VQFIGACTRP------------------PNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQ  232 (399)
Q Consensus       173 ~nI--v~~~~~~~~~------------------~~~~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~  232 (399)
                      .++  ++++|+..-.                  +...||.||.+...          .+...    -+.+|.+-|..+|.
T Consensus       117 e~~~Avkc~Gyl~L~~~~q~~~~~~~~~~~~~~~~~aIVKD~v~~~~----------~~~~~----~~~~~~~dl~~~~k  182 (207)
T PF13095_consen  117 EGLWAVKCHGYLLLTEDQQFEQLRQRGSDHRPLPIRAIVKDFVPDDP----------PLQIR----DIPQMLRDLKILHK  182 (207)
T ss_pred             cCceEEEeeEEEEEchHHHHHHhhcccccCCCCccEEEEEeecCCcc----------ccchh----HHHHHHHHHHHHHH
Confidence            455  9999987221                  23578888876633          22333    33466677788999


Q ss_pred             CCcccCCCCCCceeecCCCcEEEeeccce
Q 015868          233 NNIIHRDLKTANLLMDENGVVKVADFGVA  261 (399)
Q Consensus       233 ~giiHrDlkp~NILl~~~~~vkl~DFG~a  261 (399)
                      .||+-+|+++.|.. +.    +|+|||.+
T Consensus       183 ~gI~~~Dv~~~ny~-~G----~lvDfs~~  206 (207)
T PF13095_consen  183 LGIVPRDVKPRNYR-GG----KLVDFSSS  206 (207)
T ss_pred             CCeeeccCcccccc-CC----EEEecccC
Confidence            99999999999988 22    89999864

>PLN02876 acyl-CoA dehydrogenase

Probab=98.21  E-value=1.8e-05  Score=86.02  Aligned_cols=144  Identities=15%  Similarity=0.267  Sum_probs=91.8

Q ss_pred             eceeceeCceEEEEEEECC----eeEEEEEecCCCCCHHHHHHHHHHHHHHHhcC-CCce--eeEEeEEecC---CcEEE
Q 015868          121 ECKVASGSYGDLYKGTYCS----QEVAIKVLKPECVNTEMLKEFSQEVYIMRKIR-HKNV--VQFIGACTRP---PNLCI  190 (399)
Q Consensus       121 ~~~lg~G~~g~Vy~~~~~~----~~vAvK~~~~~~~~~~~~~~~~~Ei~~l~~l~-h~nI--v~~~~~~~~~---~~~~l  190 (399)
                      .++++.|.+..+|+.+..+    ..+++|+..+.... .....+.+|..+|+.+. |.++  ++++.++.+.   +..|+
T Consensus        43 v~~l~gG~sn~ty~l~~~~~~~~~~~VLR~~p~~~~~-~~~~~~~rE~~~l~~L~~~~~vpVP~v~~~~~d~~v~G~~fl  121 (822)
T PLN02876         43 VSQFGHGQSNPTFLLEVGNGGSVKRYVLRKKPPGKLL-QSAHAVEREYQVLRALGEHTDVPVPKVYCLCTDASVIGTAFY  121 (822)
T ss_pred             EEEeCCCCcCceEEEEECCCCcceeEEEEeCCCCccC-ccHHHHHHHHHHHHHHhhcCCCCCCcEEEEecCCCcCCCceE
Confidence            4567889999999987654    46788876543211 12346789999999995 6665  8888888764   35789


Q ss_pred             EEecCCCCCHHH--------------------H---HHhcCC---CC---------CHHHHHHHHHH-------------
Q 015868          191 VTEFMARGSIYD--------------------F---LHKQKG---VF---------QLTSLLKVAID-------------  222 (399)
Q Consensus       191 V~E~~~ggsL~~--------------------~---l~~~~~---~l---------~~~~~~~i~~~-------------  222 (399)
                      ||||++|..+.+                    .   |+....   .+         ...++..|..+             
T Consensus       122 VME~v~G~~~~~~~~~~~~~~~r~~l~~~l~~~La~LH~vd~~~~gl~~~g~~~~~~~~~l~~w~~~~~~~~~~~~~~~~  201 (822)
T PLN02876        122 IMEYLEGRIFVDPKLPGVAPERRRAIYRATAKVLAALHSADVDAIGLGKYGRRDNYCKRQVERWAKQYLASTGEGKPPRN  201 (822)
T ss_pred             EEEecCCcccCCccCCCCCHHHHHHHHHHHHHHHHHHhCCCchhcChhhcCCCCchHHHHHHHHHHHHHHhhcccCCCCC
Confidence            999999864321                    1   111100   00         01223222211             


Q ss_pred             --HHHHHHHHHH-----------CCcccCCCCCCceeecCC--CcEEEeeccceeecc
Q 015868          223 --VSKGMNYLHQ-----------NNIIHRDLKTANLLMDEN--GVVKVADFGVARVQA  265 (399)
Q Consensus       223 --i~~~L~~LH~-----------~giiHrDlkp~NILl~~~--~~vkl~DFG~a~~~~  265 (399)
                        +...+.+|..           ..++|+|+++.||+++.+  ..+-|.||+.+...+
T Consensus       202 ~~~~~l~~wL~~~~P~~~~~~~~~~LvHGD~~~~Nvl~~~~~~~v~aVLDWE~a~~Gd  259 (822)
T PLN02876        202 PKMLELIDWLRENIPAEDSTGAGTGIVHGDFRIDNLVFHPTEDRVIGILDWELSTLGN  259 (822)
T ss_pred             hhHHHHHHHHHhcCCCccccCCCcceEecCcccccEEEcCCCCeEEEEEeeeccccCC
Confidence              2334566632           249999999999999853  346899999987544

>cd04927 ACT_ACR-like_2 Second ACT domain, of a novel type of ACT domain-containing protein which is composed almost entirely of four ACT domain repeats (the "ACR" protein)

Probab=98.17  E-value=6.9e-06  Score=61.66  Aligned_cols=54  Identities=22%  Similarity=0.258  Sum_probs=42.1

Q ss_pred             HHHHHHHHhhhhCCCeeeeceeccCCCceeeEEEecCCCCc-chHHHHHHHHHHH
Q 015868           10 KVGELTSLLGEIGLNIQEAHAFSTVDGFSLDVFVVDGWPYD-ETEDLKNVLAKEI   63 (399)
Q Consensus        10 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~~-~~~~l~~~l~~~~   63 (399)
                      ||++++.+|++.||||..|++++|.+|+.+|+|.|.-.... ..++.++.+++.+
T Consensus        13 Lfa~i~~~l~~~~l~I~~A~I~Tt~~~~v~D~F~V~d~~~~~~~~~~~~~l~~~L   67 (76)
T cd04927          13 LLHDVTEVLYELELTIERVKVSTTPDGRVLDLFFITDARELLHTKKRREETYDYL   67 (76)
T ss_pred             HHHHHHHHHHHCCCeEEEEEEEECCCCEEEEEEEEeCCCCCCCCHHHHHHHHHHH
Confidence            78999999999999999999999999999999999544433 1233444444444

This CD includes the second ACT domain, of a novel type of ACT domain-containing protein which is composed almost entirely of four ACT domain repeats (the "ACR" protein). ACR proteins, found only in Arabidopsis and Oryza, as yet, are proposed to function as novel regulatory or sensor proteins in plants. Nine ACR gene products (ACR1-8 in Arabidopsis and OsARC1-9 in Oryza) have been described, however, the ACR-like sequences in this CD are distinct from those characterized. This CD includes the Oryza sativa ACR-like protein (Os05g0113000) encoded on chromosome 5 and the Arabidopsis thaliana predicted gene product, At2g39570. Members of this CD belong to the superfamily of ACT regulatory domains.

>PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C)

Probab=98.16  E-value=2.7e-05  Score=69.15  Aligned_cols=100  Identities=18%  Similarity=0.310  Sum_probs=80.5

Q ss_pred             HHHHHHHhcCC-CceeeEEeEEecCCcEEEEEecCCCCCHHHHHH--hcCCCCCHHHHHHHHHHHHHHHHHHHH---CCc
Q 015868          162 QEVYIMRKIRH-KNVVQFIGACTRPPNLCIVTEFMARGSIYDFLH--KQKGVFQLTSLLKVAIDVSKGMNYLHQ---NNI  235 (399)
Q Consensus       162 ~Ei~~l~~l~h-~nIv~~~~~~~~~~~~~lV~E~~~ggsL~~~l~--~~~~~l~~~~~~~i~~~i~~~L~~LH~---~gi  235 (399)
                      .|.-+++.+.+ +++++++|+|-    -++|+||...+++...-.  .+-...++..+.+++.+++..+.+|+.   ..+
T Consensus         8 ~E~lll~~l~~~~~~pk~lG~CG----~~~v~E~~~~~~~~~~~~~l~~~~~~~w~~R~~iA~~lL~~l~~l~~~~~~~~   83 (188)
T PF12260_consen    8 NEPLLLQLLQGSEPFPKLLGSCG----RFYVVEYVGAGSLYGIYRPLSQFLQSPWEQRAKIALQLLELLEELDHGPLGFF   83 (188)
T ss_pred             cHHHHHHHcCCCCCCCCeeeECC----CEEEEEeecCccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCCCCcE
Confidence            57888999976 69999999994    367999998776643200  011235889999999999999999998   458


Q ss_pred             ccCCCCCCceeecCCCcEEEeeccceeecc
Q 015868          236 IHRDLKTANLLMDENGVVKVADFGVARVQA  265 (399)
Q Consensus       236 iHrDlkp~NILl~~~~~vkl~DFG~a~~~~  265 (399)
                      .-.|++|+|+-++++|.+|++|...+....
T Consensus        84 ~lcDv~~~nfgv~~~~~lk~iDld~v~~~~  113 (188)
T PF12260_consen   84 YLCDVSPDNFGVNDDGRLKLIDLDDVFVED  113 (188)
T ss_pred             EEeecchHHeEEeCCCcEEEEechhcchhH
Confidence            899999999999999999999999876543

Proteins in this uncharacterised family are described as transmembrane proteins.

>PF10707 YrbL-PhoP_reg: PhoP regulatory network protein YrbL; InterPro: IPR019647 This entry represents proteins that are activated by the protein PhoP

Probab=98.08  E-value=7.4e-05  Score=66.84  Aligned_cols=130  Identities=20%  Similarity=0.359  Sum_probs=92.9

Q ss_pred             eceeceeCceEEEEEEECCeeEEEEEecCCC--------------CCHHHHHHHHHHHHHHHhcC------CCceeeEEe
Q 015868          121 ECKVASGSYGDLYKGTYCSQEVAIKVLKPEC--------------VNTEMLKEFSQEVYIMRKIR------HKNVVQFIG  180 (399)
Q Consensus       121 ~~~lg~G~~g~Vy~~~~~~~~vAvK~~~~~~--------------~~~~~~~~~~~Ei~~l~~l~------h~nIv~~~~  180 (399)
                      ...||+|+.=.||.-- ......||+.++..              ......++..+|+.-...+.      +.+|.+++|
T Consensus         6 ~~~i~~G~~R~cy~HP-~dp~~cIKV~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~E~~~y~~l~~~~~~~~~~i~r~~G   84 (199)
T PF10707_consen    6 SDLIAQGGERDCYQHP-DDPNLCIKVMRPDRGERRRPFKRWLKRLRPKSRYRQNRRELRYYKQLSLRRGVDWSHIPRFYG   84 (199)
T ss_pred             CcccccCCCceEEECC-CCCCeEEEEEccccccccccchhHHHhhcccchhHHHHHHHHHHHHHhhccCCcccccccEeE
Confidence            3468999988888621 34567889888764              01122456667777666665      789999999


Q ss_pred             EEecCCcEEEEEecCCC------CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceeecCCC---
Q 015868          181 ACTRPPNLCIVTEFMAR------GSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENG---  251 (399)
Q Consensus       181 ~~~~~~~~~lV~E~~~g------gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~giiHrDlkp~NILl~~~~---  251 (399)
                      ..+++.-..+|+|.+..      .+|.+++..  +.++. .+.+.   +-.-..||-+.+|+.+|++|.||++...+   
T Consensus        85 ~veT~~G~Glv~e~I~d~dG~~s~TL~~~l~~--~~~~~-~~~~~---L~~f~~~l~~~~Iv~~dl~~~NIv~~~~~~~~  158 (199)
T PF10707_consen   85 FVETNLGLGLVVELIRDADGNISPTLEDYLKE--GGLTE-ELRQA---LDEFKRYLLDHHIVIRDLNPHNIVVQRRDSGE  158 (199)
T ss_pred             EEecCCceEEEEEEEECCCCCcCccHHHHHHc--CCccH-HHHHH---HHHHHHHHHHcCCeecCCCcccEEEEecCCCc
Confidence            99999889999997643      378999854  44555 34333   34456688899999999999999996432   


Q ss_pred             -cEEEee
Q 015868          252 -VVKVAD  257 (399)
Q Consensus       252 -~vkl~D  257 (399)
                       .+.|+|
T Consensus       159 ~~lvlID  165 (199)
T PF10707_consen  159 FRLVLID  165 (199)
T ss_pred             eEEEEEe
Confidence             577887

PhoP controls the expression of a large number of genes that mediate adaptation to low Mg2+ environments and/or virulence in several bacterial species. YbrL is proposed to be acting in a loop activity with PhoP and PrmA analogous to the multi-component loop in Salmonella sp., where the PhoP-dependent PmrD protein activates the regulatory protein PmrA, and the activated PmrA then represses transcription from the PmrD promoter which harbours binding sites for both the PhoP and PmrA proteins. Expression of YrbL is induced in low Mg2+ in a PhoP-dependent fashion and repressed by Fe3+ in a PmrA-dependent manner [].

>cd05155 APH_ChoK_like_1 Uncharacterized bacterial proteins with similarity to Aminoglycoside 3'-phosphotransferase (APH) and Choline kinase (ChoK) family members

Probab=98.05  E-value=2e-05  Score=72.56  Aligned_cols=72  Identities=11%  Similarity=0.163  Sum_probs=46.5

Q ss_pred             ceeceeCce-EEEEEEECCeeEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCC---ceeeEEeEEecC---CcEEEEEec
Q 015868          122 CKVASGSYG-DLYKGTYCSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHK---NVVQFIGACTRP---PNLCIVTEF  194 (399)
Q Consensus       122 ~~lg~G~~g-~Vy~~~~~~~~vAvK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~---nIv~~~~~~~~~---~~~~lV~E~  194 (399)
                      +.++.|+.. .||+.   +..+++|+.+..    .....+.+|..+++.+...   -++++++.....   ...+++|++
T Consensus         3 ~~~~~gG~~n~vy~~---~~~~VlR~~~~~----~~~~~~~~E~~~l~~L~~~~~v~vP~~~~~~~~~~~~~~~~~l~~~   75 (235)
T cd05155           3 EPVDSGGTDNATFRL---GDDMSVRLPSAA----GYAGQVRKEQRWLPRLAPHLPLPVPEPLGKGEPGEGYPWPWSVYRW   75 (235)
T ss_pred             eeccCCCcccceEEc---CCceEEEcCCcc----chHHHHHHHHHHHHHHhccCCCCCCceeecCCCccCCCcceEEEEe
Confidence            356666665 58875   346778876542    1234788899999888532   355555544332   235889999


Q ss_pred             CCCCCH
Q 015868          195 MARGSI  200 (399)
Q Consensus       195 ~~ggsL  200 (399)
                      ++|.++
T Consensus        76 i~G~~l   81 (235)
T cd05155          76 LEGETA   81 (235)
T ss_pred             ecCCCC
Confidence            999765

The APH/ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates, such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides, and macrolides leads to their inactivation and to bacterial antibiotic resista

>PRK10593 hypothetical protein; Provisional

Probab=97.94  E-value=0.00012  Score=69.89  Aligned_cols=76  Identities=11%  Similarity=0.031  Sum_probs=57.7

Q ss_pred             eceeceeCceEEEEEEECCeeEEEEEecCCCCCHHHHHHHHHHHHHHHhcCC---CceeeEEeEEecC---CcEEEEEec
Q 015868          121 ECKVASGSYGDLYKGTYCSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRH---KNVVQFIGACTRP---PNLCIVTEF  194 (399)
Q Consensus       121 ~~~lg~G~~g~Vy~~~~~~~~vAvK~~~~~~~~~~~~~~~~~Ei~~l~~l~h---~nIv~~~~~~~~~---~~~~lV~E~  194 (399)
                      .+.||.|..+.||+....+..+.+|..+..    .....+..|...|+.+..   -.++++++.+..+   +..++|||+
T Consensus        19 ~~~i~~G~~~~vy~~~~~~~~~~~k~~~~~----~~~~~~~~Ea~~L~~L~~~~~vpVP~V~~~~~~~~~~g~~~LVmE~   94 (297)
T PRK10593         19 VECISEQPYAALWALYDSQGNPMPLMARSF----STPGVAQQEAWKLSMLARSGTVRMPTVYGVMTHEQSPGPDVLLLER   94 (297)
T ss_pred             eeecCCccceeEEEEEcCCCCEEEEEeccc----ccchHHHHHHHHHHHHccCCCCCcCcEEEEeccCCcCCCeEEEEec
Confidence            457899999999998876667888886531    112578889999998853   3688899887543   568999999


Q ss_pred             CCCCCH
Q 015868          195 MARGSI  200 (399)
Q Consensus       195 ~~ggsL  200 (399)
                      ++|.++
T Consensus        95 i~G~~~  100 (297)
T PRK10593         95 LRGVSV  100 (297)
T ss_pred             cCCEec
Confidence            998754

>PRK05231 homoserine kinase; Provisional

Probab=97.84  E-value=0.00049  Score=66.27  Aligned_cols=137  Identities=16%  Similarity=0.206  Sum_probs=76.9

Q ss_pred             ceeceeCceEEEEEEECCeeEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCC--ceeeEEeE------EecCCcEEEEEe
Q 015868          122 CKVASGSYGDLYKGTYCSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHK--NVVQFIGA------CTRPPNLCIVTE  193 (399)
Q Consensus       122 ~~lg~G~~g~Vy~~~~~~~~vAvK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~--nIv~~~~~------~~~~~~~~lV~E  193 (399)
                      +.++.|....+|+.+..+..+++|+.. . ...+   .+..|..+++.+...  .+++++..      ....+..++++|
T Consensus        28 ~~l~~G~~n~~y~v~t~~g~~vLK~~~-~-~~~~---~l~~~~~~l~~L~~~glpvP~~i~~~~G~~~~~~~g~~~~l~~  102 (319)
T PRK05231         28 KGIAEGIENSNFFLTTTQGEYVLTLFE-R-LTAE---DLPFFLGLMQHLAARGVPVPAPVARRDGAALGELAGKPAAIVT  102 (319)
T ss_pred             chhccccccceEEEEeCCCcEEEEEec-c-CChH---HhHHHHHHHHHHHHCCCCCCcceeCCCCCEeeeeCCEEEEEEE
Confidence            456777778899988777789999986 2 1222   233355555555321  23444421      122445789999


Q ss_pred             cCCCCCHH-----------HHH---HhcCCCC--------CH---HH-HHH-----------HHHH-HHHHHHHHH----
Q 015868          194 FMARGSIY-----------DFL---HKQKGVF--------QL---TS-LLK-----------VAID-VSKGMNYLH----  231 (399)
Q Consensus       194 ~~~ggsL~-----------~~l---~~~~~~l--------~~---~~-~~~-----------i~~~-i~~~L~~LH----  231 (399)
                      |++|..+.           ..+   +.....+        ..   .. ..+           .+.+ +...++.+.    
T Consensus       103 ~l~G~~~~~~~~~~~~~~G~~LA~lH~~~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~  182 (319)
T PRK05231        103 FLEGKWPRAPTAAHCAEVGEMLARMHLAGRDFPLERPNLRGLAWWRELAPRLLPFLADEQAALLEAELAAQLAFLASAAW  182 (319)
T ss_pred             ecCCCCCCCCCHHHHHHHHHHHHHHHhhhhcCCccCCCCCChHHHHHHHHHHhhccChhHHHHHHHHHHHHHHhhhcccc
Confidence            99986431           111   1111111        00   00 000           1111 112223332    


Q ss_pred             ---HCCcccCCCCCCceeecCCCcEEEeeccceee
Q 015868          232 ---QNNIIHRDLKTANLLMDENGVVKVADFGVARV  263 (399)
Q Consensus       232 ---~~giiHrDlkp~NILl~~~~~vkl~DFG~a~~  263 (399)
                         ..++||+|+.|.||+++++...-|+||+.+..
T Consensus       183 ~~lp~~liHgD~~~~Nil~~~~~~~~iIDf~~~~~  217 (319)
T PRK05231        183 PALPRGVIHADLFRDNVLFEGDRLSGFIDFYFACN  217 (319)
T ss_pred             ccCCcccCCCCCCCCcEEEECCceEEEEecccccC
Confidence               24899999999999998776668999998853

>cd04925 ACT_ACR_2 ACT domain-containing protein which is composed almost entirely of four ACT domain repeats (the "ACR" protein)

Probab=97.84  E-value=4.3e-05  Score=56.98  Aligned_cols=36  Identities=28%  Similarity=0.314  Sum_probs=33.2

Q ss_pred             HHHHHHHHHhhhhCCCeeeeceeccCCCceeeEEEec
Q 015868            9 MKVGELTSLLGEIGLNIQEAHAFSTVDGFSLDVFVVD   45 (399)
Q Consensus         9 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~   45 (399)
                      .+|+.++.+|++.|+||..|+.+ |.+|+.+|+|.|.
T Consensus        12 gLl~~i~~~l~~~~lnI~~A~i~-t~~~~~~d~f~V~   47 (74)
T cd04925          12 GLLSEVFAVLADLHCNVVEARAW-THNGRLACVIYVR   47 (74)
T ss_pred             CHHHHHHHHHHHCCCcEEEEEEE-EECCEEEEEEEEE
Confidence            37899999999999999999999 5599999999995

This CD includes the second ACT domain, of a novel type of ACT domain-containing protein which is composed almost entirely of four ACT domain repeats (the "ACR" protein). ACR proteins, found only in Arabidopsis and Oryza, as yet, are proposed to function as novel regulatory or sensor proteins in plants. Nine ACR gene products have been described (ACR1-8 in Arabidopsis and OsARC1-9 in Oryza) and are represented in this CD. Members of this CD belong to the superfamily of ACT regulatory domains.

>TIGR02721 ycfN_thiK thiamine kinase

Probab=97.82  E-value=8.7e-05  Score=69.19  Aligned_cols=134  Identities=15%  Similarity=0.184  Sum_probs=79.6

Q ss_pred             eeceeCceEEEEEEECCeeEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCc-eeeEEeEEecCCcEEEEEecCCCCCHH
Q 015868          123 KVASGSYGDLYKGTYCSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKN-VVQFIGACTRPPNLCIVTEFMARGSIY  201 (399)
Q Consensus       123 ~lg~G~~g~Vy~~~~~~~~vAvK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~n-Iv~~~~~~~~~~~~~lV~E~~~ggsL~  201 (399)
                      .+..|-.+.+|+.+..++.+++|+.......  ..-...+|..+++.+...+ .++++....    -++||||++|..+.
T Consensus         3 ~~~~G~tn~~y~~~~~~~~~vlR~~~~~~~~--~~~~r~~E~~~l~~l~~~g~~P~~i~~~~----~~~v~e~i~G~~~~   76 (256)
T TIGR02721         3 TLSGGLTNRSWRIEHPGISFVWRPQSPVCKA--LGVDRQREYQILQALSALGLAPKPILVNE----HWLLVEWLEGEVIT   76 (256)
T ss_pred             cCCCcCcCCeEEEEeCCccEEEeeCCccccc--ccCcHHHHHHHHHHHHhcCCCCceEEEeC----CEEEEEeccCcccc
Confidence            3456778889999888888999986543111  1013467888898886432 355555432    36899999986543


Q ss_pred             H--------------HH---HhcC---CCCCHH-HHHHHHHHH---------HHHHHHHHH--------CCcccCCCCCC
Q 015868          202 D--------------FL---HKQK---GVFQLT-SLLKVAIDV---------SKGMNYLHQ--------NNIIHRDLKTA  243 (399)
Q Consensus       202 ~--------------~l---~~~~---~~l~~~-~~~~i~~~i---------~~~L~~LH~--------~giiHrDlkp~  243 (399)
                      .              .+   +...   .+++.. .+..+..++         ...+..+-.        ..++|+|+.|.
T Consensus        77 ~~~~~~~~~~~~la~~l~~lH~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~H~Dl~~~  156 (256)
T TIGR02721        77 LDQFVALDLLLELAALLHQLHSQPRFGYPLSLKARIAHYWLQIDPARRTPEWLRLYKQFRSAPEPAPLPLAPLHMDVHAY  156 (256)
T ss_pred             cccccCchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHHhcccccCChHHHHHHHHHHhccCCCCCCCeeecCCCCcC
Confidence            1              11   1111   111111 111211111         111222221        25899999999


Q ss_pred             ceeecCCCcEEEeeccceee
Q 015868          244 NLLMDENGVVKVADFGVARV  263 (399)
Q Consensus       244 NILl~~~~~vkl~DFG~a~~  263 (399)
                      ||++++++ +.|+||..+..
T Consensus       157 Nil~~~~~-~~lIDwE~a~~  175 (256)
T TIGR02721       157 NLVVTPQG-LKLIDWEYASD  175 (256)
T ss_pred             cEEEeCCC-CEEEeccccCc
Confidence            99999877 78999998864

Members of this family are the ycfN gene product of Escherichia coli, now identified as the salvage enzyme thiamine kinase (thiK), and additional proteobacterial homologs taken to be orthologs with equivalent function.

>TIGR00938 thrB_alt homoserine kinase, Neisseria type

Probab=97.68  E-value=0.00058  Score=65.50  Aligned_cols=138  Identities=21%  Similarity=0.276  Sum_probs=82.8

Q ss_pred             eceeceeCceEEEEEEECCeeEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCC--ceeeEEeEE------ecCCcEEEEE
Q 015868          121 ECKVASGSYGDLYKGTYCSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHK--NVVQFIGAC------TRPPNLCIVT  192 (399)
Q Consensus       121 ~~~lg~G~~g~Vy~~~~~~~~vAvK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~--nIv~~~~~~------~~~~~~~lV~  192 (399)
                      .+.++.|....+|+.+..+..+.+|+.+... ..   .....|..++..+...  .+++++...      ...+..++++
T Consensus        27 i~~~~~G~~n~~y~v~t~~~~~vLK~~~~~~-~~---~~i~~e~~~l~~L~~~g~pvp~~i~t~~g~~~~~~~g~~~~l~  102 (307)
T TIGR00938        27 LKGIAEGVENSNYLLTTDVGRYILTLYEKRV-KA---EELPFFLALTTHLAARGLPVPKPVKSRDGRQLSTLAGKPACLV  102 (307)
T ss_pred             ccccCCccccceEEEEeCCCcEEEEEecCCC-CH---HHHHHHHHHHHHHHHCCCCCCccccCCCCCeehhcCCeEEEEE
Confidence            4566777778899987766788899876532 12   2344566777776422  244554421      1234578999


Q ss_pred             ecCCCCCHH-----------HH---HHhcCCCC--------CHHH---H--H----------HHHHHHHHHHHHHHH---
Q 015868          193 EFMARGSIY-----------DF---LHKQKGVF--------QLTS---L--L----------KVAIDVSKGMNYLHQ---  232 (399)
Q Consensus       193 E~~~ggsL~-----------~~---l~~~~~~l--------~~~~---~--~----------~i~~~i~~~L~~LH~---  232 (399)
                      ||++|..+.           ..   ++.....+        ....   .  .          .....+.+.++++..   
T Consensus       103 e~i~G~~~~~~~~~~~~~~G~~LA~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~l~~~~~~~l~~~~~~l~~~~~  182 (307)
T TIGR00938       103 EFLQGLSVGRPTAMHCRPVGEVLAWMHLAGAHFPENRKNSLRLEAWHILAEKCFEAAPQLEAHMGAELDKELDYLDKFWP  182 (307)
T ss_pred             EeCCCCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCCCCCCChHHHHHHHHhhhhcccccCHHHHHHHHHHHHHHHhhhh
Confidence            999985431           11   12111111        0000   0  0          001123345555542   


Q ss_pred             ----CCcccCCCCCCceeecCCCcEEEeecccee
Q 015868          233 ----NNIIHRDLKTANLLMDENGVVKVADFGVAR  262 (399)
Q Consensus       233 ----~giiHrDlkp~NILl~~~~~vkl~DFG~a~  262 (399)
                          .+++|+|+.+.||++++++.+.|+||+.+.
T Consensus       183 ~~~~~~l~HgD~~~~Nvl~~~~~~~~vIDfd~~~  216 (307)
T TIGR00938       183 RDLPRGVIHADLFPDNVLFDGDSVKGVIDFYFAC  216 (307)
T ss_pred             hcCCCccCCCCCCcCcEEEECCceEEEeeccccc
Confidence                689999999999999998877999999875

Homoserine kinase is required in the biosynthesis of threonine from aspartate.The member of this family from Pseudomonas aeruginosa was shown by direct assay and complementation to act specifically as a homoserine kinase.

>KOG1826 consensus Ras GTPase activating protein RasGAP/neurofibromin [Defense mechanisms]

Probab=97.68  E-value=8.1e-06  Score=89.66  Aligned_cols=210  Identities=11%  Similarity=0.051  Sum_probs=144.7

Q ss_pred             HHHHHHHHHHHHHHHhcCCCceeeEEeEEec--CCcEEEEEecCCCCCHHHHHHhcCCC---CCHHHHHHHHHHHHHHHH
Q 015868          154 TEMLKEFSQEVYIMRKIRHKNVVQFIGACTR--PPNLCIVTEFMARGSIYDFLHKQKGV---FQLTSLLKVAIDVSKGMN  228 (399)
Q Consensus       154 ~~~~~~~~~Ei~~l~~l~h~nIv~~~~~~~~--~~~~~lV~E~~~ggsL~~~l~~~~~~---l~~~~~~~i~~~i~~~L~  228 (399)
                      +...+....|..-++...|+++.....-...  ...-+.+++++.+|.+.+.|-+.-..   +...-+.....+.+....
T Consensus      1270 ePlkemll~e~de~~~~~h~~~~~~p~rI~ps~s~ee~~r~~~~~~g~~f~iIikg~ee~~~ld~~~v~~~~kvsvl~~~ 1349 (2724)
T KOG1826|consen 1270 EPLKEMLLSERDELREAKHYLTEVDPLRIPPSESTEEYIRSLYVEFGKLFSIIIKGLEESPDLDRSPVHLRHKVSVLNRN 1349 (2724)
T ss_pred             hHHHHhhhhhhhhhhhhhceeeecccccCCCCCChHHHHHHHHHHHhHHHHHHHhccccCCcchhchHHHHHHHHHhccc
Confidence            4445666777777777889988776654432  23468999999999999998664322   333334444444355566


Q ss_pred             HHHHC-C----cccCCCCCCceeecCCCcEEEeeccceeeccC-CCccccCCCCcccccccccCCCCCCChhhHHHHHHH
Q 015868          229 YLHQN-N----IIHRDLKTANLLMDENGVVKVADFGVARVQAQ-SGVMTAETGTYRWMAPEVIEHKPYDYKADVFSFGIA  302 (399)
Q Consensus       229 ~LH~~-g----iiHrDlkp~NILl~~~~~vkl~DFG~a~~~~~-~~~~~~~~gt~~y~aPE~l~~~~~~~~~Dv~slG~v  302 (399)
                      -.|+. +    .+|+++|+.|.++..+..+|++++|+.+.... ........+++.|+.|+..+.-.++.++|+|..|+-
T Consensus      1350 ~~ls~tnlg~T~v~~~Lkf~lpmIVtny~v~~gk~gLdKIknp~~sf~Gl~l~sp~~v~qli~N~ik~t~rsdilr~s~~ 1429 (2724)
T KOG1826|consen 1350 VILSLTNLGNTNVSKSLKFTLPMIVTNYNVKLGKGGLDKIKNPVLSFFGLELCSPIYVLQLIKNEIKFTKRSDILRRSLS 1429 (2724)
T ss_pred             hhhhcccCCccchhhhhhhhccceecCCcccccccccccccCchHhhhhhhhCCHHHHHHHHHHHHhhhhHHHHHHHHHH
Confidence            65643 2    68999999999999999999999999994333 333455678889999999999999999999999999


Q ss_pred             HHHHHcCCCCCCCCCHHHHHHHHHhccCCCCCCCCCcHHHHHHHHHHhhhcCCCCCCHHHHH
Q 015868          303 LWELLTGELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRLAELLERCWQHDPTQRPNFSQIT  364 (399)
Q Consensus       303 l~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~cl~~dP~~Rps~~ell  364 (399)
                      +|.+..|..+|-... ..+..+.++.+....++.-.|.+.-.....++-+.-..||.-....
T Consensus      1430 ly~rs~~n~~fi~fl-q~~Lkgiidn~tf~sIe~l~pgdaNve~~~~Ll~K~~~rp~q~isl 1490 (2724)
T KOG1826|consen 1430 LYLRSDGNAYFIFFL-QPALKGIIDNHTFFSIEKLKPGDANVEALHRLLWKYMERPGQYISL 1490 (2724)
T ss_pred             HHHHhcccHHHHHHH-HHHHcCcccccccccccccCCCcccHHHHHHHHHHhhhcchhhhhc
Confidence            999988877763321 2222333444444555555555555555666666666777655553

>cd05157 ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes

Probab=97.65  E-value=0.00034  Score=64.17  Aligned_cols=72  Identities=13%  Similarity=0.201  Sum_probs=47.7

Q ss_pred             ceeceeCceEEEEEEEC---CeeEEEEEecCCCCCHHHHHHHHHHHHHHHhcCC-CceeeEEeEEecCCcEEEEEecCCC
Q 015868          122 CKVASGSYGDLYKGTYC---SQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRH-KNVVQFIGACTRPPNLCIVTEFMAR  197 (399)
Q Consensus       122 ~~lg~G~~g~Vy~~~~~---~~~vAvK~~~~~~~~~~~~~~~~~Ei~~l~~l~h-~nIv~~~~~~~~~~~~~lV~E~~~g  197 (399)
                      +.|..|-...+|+.+..   ++.|++|+......   ..-...+|..+++.+.. .-.+++++.+. +   .++|||++|
T Consensus         4 ~~l~gG~tN~~~~v~~~~~~~~~~vlR~~~~~~~---~~~d~~~E~~~~~~l~~~gl~P~v~~~~~-~---~~l~e~i~G   76 (235)
T cd05157           4 KRFTGGITNKLVKVSNKEDNQDAVLVRVYGNKTE---LIIDRERELRIHKLLSKHGLAPKLYATFQ-N---GLIYEFIPG   76 (235)
T ss_pred             EEcCCcccceEEEEEcCCCCCCeEEEEEccCCcc---ceecHHHHHHHHHHHHhCCCCCeEEEEeC-C---cEEEEeeCC
Confidence            46777888899998765   47899998764311   11233478888888853 33455555433 2   389999998


Q ss_pred             CCH
Q 015868          198 GSI  200 (399)
Q Consensus       198 gsL  200 (399)
                      .++
T Consensus        77 ~~l   79 (235)
T cd05157          77 RTL   79 (235)
T ss_pred             CcC
Confidence            764

ETNK is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major phospholipid, phosphatidylethanolamine (PtdEtn). Unlike ChoK, ETNK shows specific activity for its substrate, and displays negligible activity towards N-methylated derivatives of Etn. The Drosophila ETNK is implicated in development and neuronal function. Mammals contain two ETNK proteins, ETNK1 and ETNK2. ETNK1 selectively increases Etn uptake and phosphorylation, as well as PtdEtn synthesis. ETNK2 is found primarily in the liver and reproductive tissues. It plays a critical role in regulating placental hemostasis to support late embryo

>cd05153 HomoserineK_II Homoserine Kinase, type II

Probab=97.64  E-value=0.00078  Score=64.07  Aligned_cols=138  Identities=18%  Similarity=0.192  Sum_probs=84.6

Q ss_pred             eceeceeCceEEEEEEECCeeEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCc--eeeEEeE------EecCCcEEEEE
Q 015868          121 ECKVASGSYGDLYKGTYCSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKN--VVQFIGA------CTRPPNLCIVT  192 (399)
Q Consensus       121 ~~~lg~G~~g~Vy~~~~~~~~vAvK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~n--Iv~~~~~------~~~~~~~~lV~  192 (399)
                      .+.+..|....+|+....+..+++|+....  +   ...+..|+.+++.+.+.+  +++++..      ...++..++|+
T Consensus        19 i~~i~~G~~n~~y~v~~~~~~~vLr~~~~~--~---~~~~~~e~~~l~~L~~~g~~vp~~i~~~~g~~~~~~~~~~~~l~   93 (296)
T cd05153          19 FEGISAGIENTNYFVTTDSGRYVLTLFEKV--S---AEELPFFLALLDHLAERGLPVPRPIADRDGEYLSELAGKPAALV   93 (296)
T ss_pred             eecccCccccceEEEEeCCCcEEEEEcCCC--C---hHhccHHHHHHHHHHHCCCCCCccccCCCCcEeeeeCCceEEEE
Confidence            345677777889998877778999998641  2   234566788787774322  4555442      12334578999


Q ss_pred             ecCCCCCHHH-----------H---HHhcCCCCC--------HHHHH------------HHHHHHHHHHHHHHH------
Q 015868          193 EFMARGSIYD-----------F---LHKQKGVFQ--------LTSLL------------KVAIDVSKGMNYLHQ------  232 (399)
Q Consensus       193 E~~~ggsL~~-----------~---l~~~~~~l~--------~~~~~------------~i~~~i~~~L~~LH~------  232 (399)
                      ++++|..+..           .   ++.....+.        .....            .....+..++.++.+      
T Consensus        94 ~~i~G~~~~~~~~~~~~~lg~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~~~~~~  173 (296)
T cd05153          94 EFLAGEHLTRPTAAHCRQIGEALARLHLAAQSFPGERNNLRGLAWIRELGKDLLPLLSAEDRALLADELARQDAFDPSDL  173 (296)
T ss_pred             EeCCCCCCCCCCHHHHHHHHHHHHHHHHHhccCCccCCCcCCcHHHHHHHHHhccccCHHHHHHHHHHHHHHHhhhhhcC
Confidence            9999865421           0   111110000        00000            011112334445443      


Q ss_pred             -CCcccCCCCCCceeecCCCcEEEeeccceee
Q 015868          233 -NNIIHRDLKTANLLMDENGVVKVADFGVARV  263 (399)
Q Consensus       233 -~giiHrDlkp~NILl~~~~~vkl~DFG~a~~  263 (399)
                       .+++|+|+.|.||++++++.+.|+||+.+..
T Consensus       174 ~~~l~HgD~~~~Nil~~~~~~~~iIDfe~a~~  205 (296)
T cd05153         174 PRGVIHADLFRDNVLFDGDELSGVIDFYFACT  205 (296)
T ss_pred             CCcCCccCcCcccEEEeCCceEEEeehhhhcC
Confidence             4799999999999999887789999998853

Homoserine kinase is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of unusual homoserine kinases, from a subset of bacteria, which have a PK fold. These proteins do not bear any similarity to the GHMP family homoserine kinases present in most bacteria and eukaryotes. Homoserine kinase catalyzes the transfer of the gamma-phosphoryl group from ATP to L-homoserine producing L-homoserine phosphate, an intermediate in the production of the amino acids threonine, methionine, and isoleucine.

>KOG2268 consensus Serine/threonine protein kinase [Signal transduction mechanisms; General function prediction only]

Probab=97.60  E-value=6e-05  Score=71.23  Aligned_cols=136  Identities=15%  Similarity=0.193  Sum_probs=96.6

Q ss_pred             ccceeceeceeCceEEEEEEEC-CeeEEEEEecCCCCCHHH--------------------HHHHHHHHHHHHhcCC--C
Q 015868          117 QLKIECKVASGSYGDLYKGTYC-SQEVAIKVLKPECVNTEM--------------------LKEFSQEVYIMRKIRH--K  173 (399)
Q Consensus       117 ~~~i~~~lg~G~~g~Vy~~~~~-~~~vAvK~~~~~~~~~~~--------------------~~~~~~Ei~~l~~l~h--~  173 (399)
                      -+.++.+||-|--+.+|.+-+. |++.++|+-+....+-..                    .-...+|...|+.+..  -
T Consensus        93 v~svGnqIGVGKESDIY~v~d~~G~~~~lK~HRLGRtSFR~Vk~kRDY~r~r~~~sWlyLSRlaa~kEfafmkaL~e~gf  172 (465)
T KOG2268|consen   93 VESVGNQIGVGKESDIYVVADEEGNPLILKLHRLGRTSFRNVKNKRDYLRKRKSGSWLYLSRLAATKEFAFMKALYERGF  172 (465)
T ss_pred             hhhhccccccccccceEEEecCCCCchhHHHHhhhhhhHHHhhhhhhhHhcCCccchhhhHHHHHHHHHHHHHHHHHcCC
Confidence            4567789999999999998774 888888875433221110                    1234568888888743  2


Q ss_pred             ceeeEEeEEecCCcEEEEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceeecCCCcE
Q 015868          174 NVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVV  253 (399)
Q Consensus       174 nIv~~~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~giiHrDlkp~NILl~~~~~v  253 (399)
                      -++..+++.    ..|+|||++.|..|....+-.    ..+   .+...+..-+--|-..|+||+|..--||++++++.+
T Consensus       173 pVPkpiD~~----RH~Vvmelv~g~Pl~~v~~v~----d~~---~ly~~lm~~Iv~la~~GlIHgDFNEFNimv~dd~~i  241 (465)
T KOG2268|consen  173 PVPKPIDHN----RHCVVMELVDGYPLRQVRHVE----DPP---TLYDDLMGLIVRLANHGLIHGDFNEFNIMVKDDDKI  241 (465)
T ss_pred             CCCCccccc----ceeeHHHhhcccceeeeeecC----ChH---HHHHHHHHHHHHHHHcCceecccchheeEEecCCCE
Confidence            355555533    468999999998887654221    223   344455555666888999999999999999999999


Q ss_pred             EEeeccceee
Q 015868          254 KVADFGVARV  263 (399)
Q Consensus       254 kl~DFG~a~~  263 (399)
                      +++||-.+-.
T Consensus       242 ~vIDFPQmvS  251 (465)
T KOG2268|consen  242 VVIDFPQMVS  251 (465)
T ss_pred             EEeechHhhc
Confidence            9999987643

>PRK09550 mtnK methylthioribose kinase; Reviewed

Probab=97.52  E-value=0.002  Score=63.89  Aligned_cols=75  Identities=12%  Similarity=0.060  Sum_probs=53.5

Q ss_pred             ceeceeCceEEEEEEECC--eeEEEEEecCCCC---C--HHHHHHHHHHHHHHHhcC---CCceeeEEeEEecCCcEEEE
Q 015868          122 CKVASGSYGDLYKGTYCS--QEVAIKVLKPECV---N--TEMLKEFSQEVYIMRKIR---HKNVVQFIGACTRPPNLCIV  191 (399)
Q Consensus       122 ~~lg~G~~g~Vy~~~~~~--~~vAvK~~~~~~~---~--~~~~~~~~~Ei~~l~~l~---h~nIv~~~~~~~~~~~~~lV  191 (399)
                      +.||.|.+..||+++..+  +.+.||.-.+...   .  .-..+++..|...|+.+.   ..++++++.+  ++...++|
T Consensus        32 ~elggGn~N~VyrV~~~~g~~svIVKqa~p~~r~~g~~wpl~~eR~~~Eae~L~~l~~~~p~~VPkV~~~--D~~~~~lV  109 (401)
T PRK09550         32 REIGDGNLNLVFRVSDTEGGKSVIVKQALPYVRVVGESWPLTLDRARIEAEALKIQAKYVPDLVPKVYHY--DEELAVTV  109 (401)
T ss_pred             eEcCCCceEEEEEEEeCCCCeEEEEEecCcccccccccccccHHHHHHHHHHHHHHHhhCCCCCCeEEEE--CCCCCEEE
Confidence            468999999999998855  4899998653211   0  123456777888888763   3568888876  33557899


Q ss_pred             EecCCCC
Q 015868          192 TEFMARG  198 (399)
Q Consensus       192 ~E~~~gg  198 (399)
                      ||++++.
T Consensus       110 ME~L~~~  116 (401)
T PRK09550        110 MEDLSDH  116 (401)
T ss_pred             EecCCCc
Confidence            9999864

>cd05156 ChoK_euk Choline Kinase (ChoK) in eukaryotes

Probab=97.36  E-value=0.001  Score=63.58  Aligned_cols=134  Identities=19%  Similarity=0.290  Sum_probs=80.3

Q ss_pred             ceeceeCceEEEEEEEC--------CeeEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCC-ceeeEEeEEecCCcEEEEE
Q 015868          122 CKVASGSYGDLYKGTYC--------SQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHK-NVVQFIGACTRPPNLCIVT  192 (399)
Q Consensus       122 ~~lg~G~~g~Vy~~~~~--------~~~vAvK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~-nIv~~~~~~~~~~~~~lV~  192 (399)
                      +.+..|-...+|+.+..        ++.+++|+.....   .......+|..+++.+... -.+++++.+..    .+|+
T Consensus         4 ~~l~gGltN~~y~v~~~~~~~~~~~~~~~vlRi~~~~~---~~~~~r~~E~~~~~~l~~~g~~P~~~~~~~~----~~v~   76 (302)
T cd05156           4 SKISGGLTNAVYKVSLPDEDALSDEPRKVLLRVYGQSV---ELLIDRERELVVFARLSERNLGPKLYGIFPN----GRIE   76 (302)
T ss_pred             EEecCcccceeEEEEcCCcccccCCCCeEEEEEecCCC---cceechHHHHHHHHHHHhCCCCCceEEEeCC----Cchh
Confidence            34556777788888764        3789999976542   1223456788888888532 24556665542    3689


Q ss_pred             ecCCCCCHHHH-----------------HHhcCCCC------CHHHHH----H--------------------------H
Q 015868          193 EFMARGSIYDF-----------------LHKQKGVF------QLTSLL----K--------------------------V  219 (399)
Q Consensus       193 E~~~ggsL~~~-----------------l~~~~~~l------~~~~~~----~--------------------------i  219 (399)
                      ||++|.++...                 ++......      ....++    .                          +
T Consensus        77 e~i~G~~l~~~~~~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  156 (302)
T cd05156          77 EFIPSRTLTTEELRDPDISAEIARRMAKLHSIVVPLSPEERDLTPAIWKLLKQWLDLAETVIEIVDSDSEKLLEVELSLF  156 (302)
T ss_pred             heeCCCcCCHhHcCCcHHHHHHHHHHHHhhCCCCCCCCCcCcccchHHHHHHHHHHHhhhhhhhcccchhhhhhhhHHHH
Confidence            99988765321                 11111110      011111    1                          1


Q ss_pred             HHHHHHHHHHHHH---------CCcccCCCCCCceeecCC----CcEEEeecccee
Q 015868          220 AIDVSKGMNYLHQ---------NNIIHRDLKTANLLMDEN----GVVKVADFGVAR  262 (399)
Q Consensus       220 ~~~i~~~L~~LH~---------~giiHrDlkp~NILl~~~----~~vkl~DFG~a~  262 (399)
                      ...+...+..|-.         ..++|+|+.|.||+++++    +.+.++||..+.
T Consensus       157 ~~~~~~~~~~l~~~~~~~~~~~~~lcH~Dl~~~Nil~~~~~~~~~~i~lIDwEya~  212 (302)
T cd05156         157 LEDEAKYLRFLLESTSEESGSPVVFCHNDLQEGNILLLNPSSETKKLVLIDFEYAS  212 (302)
T ss_pred             HHHHHHHHHHHHhhccCCCCCCceEEecCCCcCeEEecCCCCCCCcEEEEeeCCCC
Confidence            1122233334432         258999999999999985    889999999885

The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC) and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. ChoK plays an important role in cell signaling pathways and the regulation of cell growth. Along with PCho, it is involved in malignant transformation through Ras oncogenes in various human cancer

>KOG2270 consensus Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning]

Probab=97.25  E-value=0.0025  Score=61.56  Aligned_cols=142  Identities=21%  Similarity=0.292  Sum_probs=97.0

Q ss_pred             eeceeceeCceEEEEEEE-CCeeEEEEEecCCCC----------------------C-HHHHH-HHHHHHHHHHhcCCCc
Q 015868          120 IECKVASGSYGDLYKGTY-CSQEVAIKVLKPECV----------------------N-TEMLK-EFSQEVYIMRKIRHKN  174 (399)
Q Consensus       120 i~~~lg~G~~g~Vy~~~~-~~~~vAvK~~~~~~~----------------------~-~~~~~-~~~~Ei~~l~~l~h~n  174 (399)
                      |...|..|--+.||.++. .|..+|||+.+....                      + ....+ -...|+.-|++++...
T Consensus       148 inGCiSTGKEANVYHat~~dG~~~AIKIYKTSILvFKDRdRYV~GEfRFRhgyck~NPRKMVk~WAEKE~RNLkRl~~aG  227 (520)
T KOG2270|consen  148 INGCISTGKEANVYHATEEDGSEFAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKHNPRKMVKTWAEKEMRNLKRLNNAG  227 (520)
T ss_pred             cccccccCccceeEeeecCCCceEEEEEEeeeEEEEechhhhccceeeeecccccCCcHHHHHHHHHHHHHHHHHHHhcC
Confidence            334566777788999976 678899999864311                      1 11122 2456888888887666


Q ss_pred             eeeEEeEEecCCcEEEEEecCCCCCHH-HHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC-CcccCCCCCCceeecCCCc
Q 015868          175 VVQFIGACTRPPNLCIVTEFMARGSIY-DFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQN-NIIHRDLKTANLLMDENGV  252 (399)
Q Consensus       175 Iv~~~~~~~~~~~~~lV~E~~~ggsL~-~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~-giiHrDlkp~NILl~~~~~  252 (399)
                      |+-.--+...  .-.|||+|+.+...- -.|  ....++...+..+-.+++.-|.-|.+. ++||.||.--|+|+. +|.
T Consensus       228 IP~PePIlLk--~hVLVM~FlGrdgw~aPkL--Kd~~ls~~ka~~~Y~~~v~~MR~lY~~c~LVHADLSEfN~Lyh-dG~  302 (520)
T KOG2270|consen  228 IPCPEPILLK--NHVLVMEFLGRDGWAAPKL--KDASLSTSKARELYQQCVRIMRRLYQKCRLVHADLSEFNLLYH-DGK  302 (520)
T ss_pred             CCCCCceeee--cceEeeeeccCCCCcCccc--ccccCChHHHHHHHHHHHHHHHHHHHHhceeccchhhhhheEE-CCE
Confidence            5433322222  357999999643221 112  134567778888888999999888764 899999999999995 689


Q ss_pred             EEEeeccceeeccC
Q 015868          253 VKVADFGVARVQAQ  266 (399)
Q Consensus       253 vkl~DFG~a~~~~~  266 (399)
                      +.|+|.+.+--...
T Consensus       303 lyiIDVSQSVE~DH  316 (520)
T KOG2270|consen  303 LYIIDVSQSVEHDH  316 (520)
T ss_pred             EEEEEccccccCCC
Confidence            99999987754443

>COG3173 Predicted aminoglycoside phosphotransferase [General function prediction only]

Probab=97.15  E-value=0.0034  Score=60.14  Aligned_cols=144  Identities=17%  Similarity=0.291  Sum_probs=86.5

Q ss_pred             ceeceeCceEEEEEEECCeeEEEEEecCCCCCHHHHHHHHHHHHHHHhcCC--CceeeEEeEEecCC--cEEEEEecCCC
Q 015868          122 CKVASGSYGDLYKGTYCSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRH--KNVVQFIGACTRPP--NLCIVTEFMAR  197 (399)
Q Consensus       122 ~~lg~G~~g~Vy~~~~~~~~vAvK~~~~~~~~~~~~~~~~~Ei~~l~~l~h--~nIv~~~~~~~~~~--~~~lV~E~~~g  197 (399)
                      +.+..|..-.+|.....++.+++. ..+............+|..+++.+.-  --+...++.|..+.  ..+.||+|.+|
T Consensus        31 ~~~~~G~sn~t~~~~~~~~~~vlR-~P~~~~~~~~~~~~~re~~~i~~l~~~~vP~p~~~~~~~~~~~g~pf~v~~~veG  109 (321)
T COG3173          31 EEISGGWSNDTFRLGDTGQKYVLR-KPPRGDPVESAHDEKREYRVIAALLDVDVPVPRAFGLCGEGYLGTPFYVMEWVEG  109 (321)
T ss_pred             eeccCCcccceEEEecCCceEEEe-cCCccccchhhhHHHhHHHHHHHhcCCCCCCcccccccccCCCCCceEEEEEecc
Confidence            344445555567666668888888 44333345556677788888888753  23445556665554  67999999998


Q ss_pred             CCHH------------------HHHHhc---C----------CCCCHHHHHHHHHH--------------HHHHHHHHHH
Q 015868          198 GSIY------------------DFLHKQ---K----------GVFQLTSLLKVAID--------------VSKGMNYLHQ  232 (399)
Q Consensus       198 gsL~------------------~~l~~~---~----------~~l~~~~~~~i~~~--------------i~~~L~~LH~  232 (399)
                      ..+.                  ++|..-   .          +.....++..+..+              ...-..+|+.
T Consensus       110 e~~~~~~~~~~~~~~~~~~~l~~~La~LH~ida~~~~~~g~~~~~~~rql~~~~~~~~~~~~~~~~~~p~~~~~~~Wl~~  189 (321)
T COG3173         110 EVVWSALPPESLGRQFALDALADFLAELHSIDAAGLPDPGKPNAYRGRQLARWDDEYRRAKKELGGRIPLADRLIKWLEA  189 (321)
T ss_pred             eeccCcCCcccchHHHHHHHHHHHHHHHhCCCCcCCCCCCccCccccchhhHHHHHHHHHHHhccCCCchHHHHHHHHHh
Confidence            4221                  111100   0          00011111122111              2233445544


Q ss_pred             C--------CcccCCCCCCceeecCCCcEEEeeccceeeccC
Q 015868          233 N--------NIIHRDLKTANLLMDENGVVKVADFGVARVQAQ  266 (399)
Q Consensus       233 ~--------giiHrDlkp~NILl~~~~~vkl~DFG~a~~~~~  266 (399)
                      +        .++|+|+.+.|+++++++.+-|+||+.+...+.
T Consensus       190 ~~p~~~~~~~lvHGD~~~gNlii~~~~~~gVlDwe~~~lGDP  231 (321)
T COG3173         190 NRPPWAGPPVLVHGDYRPGNLIIDPGRPTGVLDWELATLGDP  231 (321)
T ss_pred             cCCCcCCCceeeeCCcccCCEEEeCCCeeEEEeccccccCCc
Confidence            3        369999999999999999999999999976443

>cd04926 ACT_ACR_4 C-terminal ACT domain, of a novel type of ACT domain-containing protein which is composed almost entirely of four ACT domain repeats (the "ACR" protein)

Probab=97.10  E-value=0.0019  Score=47.75  Aligned_cols=53  Identities=19%  Similarity=0.276  Sum_probs=38.5

Q ss_pred             HHHHHHHHhhhhCCCeeeeceeccCCCceeeEEEecCCCCc-chHHHHHHHHHHH
Q 015868           10 KVGELTSLLGEIGLNIQEAHAFSTVDGFSLDVFVVDGWPYD-ETEDLKNVLAKEI   63 (399)
Q Consensus        10 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~~-~~~~l~~~l~~~~   63 (399)
                      +|.+++.+|++.|+||..|.+|. .+|+.+|+|.|.-.... ..++.++++++.+
T Consensus        14 ll~~i~~~l~~~~lnI~sa~i~t-~~~~~~d~f~v~~~~~~~~~~~~~~~l~~~l   67 (72)
T cd04926          14 LLSDVTRVFRENGLTVTRAEIST-QGDMAVNVFYVTDANGNPVDPKTIEAVRQEI   67 (72)
T ss_pred             HHHHHHHHHHHCCcEEEEEEEec-CCCeEEEEEEEECCCCCcCCHHHHHHHHHHh
Confidence            78999999999999999999985 48899999998432211 1223444554443

This CD includes the C-terminal ACT domain, of a novel type of ACT domain-containing protein which is composed almost entirely of four ACT domain repeats (the "ACR" protein). ACR proteins, found only in Arabidopsis and Oryza, as yet, are proposed to function as novel regulatory or sensor proteins in plants. Nine ACR gene products have been described (ACR1-8 in Arabidopsis and OsARC1-9 in Oryza) and are represented in this CD. Members of this CD belong to the superfamily of ACT regulatory domains.

>PLN02756 S-methyl-5-thioribose kinase

Probab=97.10  E-value=0.0054  Score=60.71  Aligned_cols=75  Identities=15%  Similarity=0.034  Sum_probs=52.6

Q ss_pred             eceeceeCceEEEEEEECCeeEEEEEecCCCC--CH---HHHHHHHHHHHHHHhcC---CCceeeEEeEEecCCcEEEEE
Q 015868          121 ECKVASGSYGDLYKGTYCSQEVAIKVLKPECV--NT---EMLKEFSQEVYIMRKIR---HKNVVQFIGACTRPPNLCIVT  192 (399)
Q Consensus       121 ~~~lg~G~~g~Vy~~~~~~~~vAvK~~~~~~~--~~---~~~~~~~~Ei~~l~~l~---h~nIv~~~~~~~~~~~~~lV~  192 (399)
                      .+.||.|....||+.+..++.++||.-.+...  ..   -...+-..|...|+.+.   ...+++++.++.+  ..+++|
T Consensus        37 ~~eiggGn~N~VyrV~~~~~svVVKqa~p~~r~vga~wpl~~~R~~~Ea~aL~~~~~~~p~~VPkVy~~ded--~~vlvM  114 (418)
T PLN02756         37 IKEVGDGNLNFVYIVVSSSGSFVIKQALPYIRCIGESWPMTKERAYFEATALREHGRLCPDHVPEVYHFDRT--MALIGM  114 (418)
T ss_pred             EEEcCCCceeeEEEEEcCCccEEEEeCCccccCCCccccCCccHHHHHHHHHHHhhhcCCCCCCeEEEECCC--CCEEEE
Confidence            45789999999999988777899998663211  00   12344445577776654   3588899988874  467899


Q ss_pred             ecCCC
Q 015868          193 EFMAR  197 (399)
Q Consensus       193 E~~~g  197 (399)
                      |++++
T Consensus       115 E~L~~  119 (418)
T PLN02756        115 RYLEP  119 (418)
T ss_pred             eecCC
Confidence            99977

>TIGR02906 spore_CotS spore coat protein, CotS family

Probab=97.07  E-value=0.013  Score=56.01  Aligned_cols=29  Identities=28%  Similarity=0.457  Sum_probs=25.8

Q ss_pred             CCcccCCCCCCceeecCCCcEEEeecccee
Q 015868          233 NNIIHRDLKTANLLMDENGVVKVADFGVAR  262 (399)
Q Consensus       233 ~giiHrDlkp~NILl~~~~~vkl~DFG~a~  262 (399)
                      .+++|+|+.+.||+++. +.+.|+||+.+.
T Consensus       187 ~~liHgD~~~~Nil~~~-~~i~lIDfd~~~  215 (313)
T TIGR02906       187 RGFCHQDYAYHNILLKD-NEVYVIDFDYCT  215 (313)
T ss_pred             CceEcCCCCcccEEEeC-CcEEEEECcccc
Confidence            57899999999999987 678999999775

Members of this family include the spore coat proteins CotS and YtaA from Bacillus subtilis and, from other endospore-forming bacteria, homologs that are more closely related to these two than to the spore coat proteins YutH and YsxE. The CotS family is more broadly distributed than YutH or YsxE, but still is not universal among spore-formers.

>PLN02236 choline kinase

Probab=97.03  E-value=0.0049  Score=60.13  Aligned_cols=134  Identities=14%  Similarity=0.261  Sum_probs=77.0

Q ss_pred             eeceeCceEEEEEEEC------CeeEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCc-eeeEEeEEecCCcEEEEEecC
Q 015868          123 KVASGSYGDLYKGTYC------SQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKN-VVQFIGACTRPPNLCIVTEFM  195 (399)
Q Consensus       123 ~lg~G~~g~Vy~~~~~------~~~vAvK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~n-Iv~~~~~~~~~~~~~lV~E~~  195 (399)
                      .+..|-.-.+|+.+..      ++.|.+|+.....  .. .-.-.+|..+++.+...+ -+++++.+..+    .|+||+
T Consensus        43 ~l~gGlTN~~y~v~~~~~~~~~~~~~v~Ri~g~~t--~~-~idR~~E~~~~~~l~~~gl~P~~~~~~~~g----~v~efi  115 (344)
T PLN02236         43 PLKGAMTNEVFQIKWPTKEGNLGRKVLVRIYGEGV--EL-FFDRDDEIRTFECMSRHGQGPRLLGRFPNG----RVEEFI  115 (344)
T ss_pred             EcCCcccceeEEEEeCCCCCCCCCeEEEEEccCCC--Ce-eechHHHHHHHHHHHHcCCCCceEEEECCc----eEEEee
Confidence            3444666778887642      3578899876542  11 122367888888885433 34566655332    689999


Q ss_pred             CCCCHHHH-----------------HHhcCC-----CCCHHHHHHHHHHH-----------------HHHHHHHH-----
Q 015868          196 ARGSIYDF-----------------LHKQKG-----VFQLTSLLKVAIDV-----------------SKGMNYLH-----  231 (399)
Q Consensus       196 ~ggsL~~~-----------------l~~~~~-----~l~~~~~~~i~~~i-----------------~~~L~~LH-----  231 (399)
                      +|.++...                 ++....     ......+.++..++                 ...+..|.     
T Consensus       116 ~g~~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~~~~~~~~l~~~~~~~~~~~~~l~~~~~~L~~~~~~  195 (344)
T PLN02236        116 HARTLSAADLRDPEISALIAAKLREFHSLDMPGPKNVLLWDRLRNWLKEAKNLCSPEEAKEFRLDSLEDEINLLEKELSG  195 (344)
T ss_pred             CCCCCCHHHcCChHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhhcCcchhhhcCHHHHHHHHHHHHHHhcc
Confidence            87665311                 111110     01112232332111                 11122221     


Q ss_pred             ---HCCcccCCCCCCceeecC-CCcEEEeeccceee
Q 015868          232 ---QNNIIHRDLKTANLLMDE-NGVVKVADFGVARV  263 (399)
Q Consensus       232 ---~~giiHrDlkp~NILl~~-~~~vkl~DFG~a~~  263 (399)
                         ...++|+|+++.||++++ ++.+.++||..+..
T Consensus       196 ~~~~~~~cH~Dl~~~Nil~~~~~~~~~lID~Eya~~  231 (344)
T PLN02236        196 DDQEIGFCHNDLQYGNIMIDEETRAITIIDYEYASY  231 (344)
T ss_pred             cCCCceEEeCCCCcCcEEEeCCCCcEEEEeehhccc
Confidence               235899999999999986 47899999998853

>PLN02421 phosphotransferase, alcohol group as acceptor/kinase

Probab=96.84  E-value=0.0059  Score=59.24  Aligned_cols=139  Identities=17%  Similarity=0.250  Sum_probs=78.6

Q ss_pred             ccceeceeceeCceEEEEEEECC-----eeEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCce-eeEEeEEecCCcEEE
Q 015868          117 QLKIECKVASGSYGDLYKGTYCS-----QEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNV-VQFIGACTRPPNLCI  190 (399)
Q Consensus       117 ~~~i~~~lg~G~~g~Vy~~~~~~-----~~vAvK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~nI-v~~~~~~~~~~~~~l  190 (399)
                      .+++....| |=...+|+.+..+     ..|.+|+......   ..-.-.+|..+++.+..-++ +++++++. ++   +
T Consensus        16 ~i~i~~l~g-GlTN~~~~v~~~~~~~~~~~~v~Ri~g~~t~---~~IdR~~E~~il~~l~~~gl~P~~l~~~~-~G---~   87 (330)
T PLN02421         16 DFSVERISG-GITNLLLKVSVKEENGNEVSVTVRLFGPNTD---YVIDRERELQAIKYLSAAGFGAKLLGVFG-NG---M   87 (330)
T ss_pred             ceEEEEeCC-cccceEEEEEecCCCCCCceEEEEEecCCcC---eEechHHHHHHHHHHHhcCCCCceeEEeC-Cc---E
Confidence            444444433 6667788886543     2788998765321   12233578888888865444 45666553 22   5


Q ss_pred             EEecCCCCCHHH--------------HH---HhcCCC----CC-HHHHHHHHHHH----------------------HHH
Q 015868          191 VTEFMARGSIYD--------------FL---HKQKGV----FQ-LTSLLKVAIDV----------------------SKG  226 (399)
Q Consensus       191 V~E~~~ggsL~~--------------~l---~~~~~~----l~-~~~~~~i~~~i----------------------~~~  226 (399)
                      |.+|++|..+..              .+   +....+    .+ ...+.++..++                      ..-
T Consensus        88 i~~fi~g~~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~y~~~~~~~~~~~~~~~~~~~~~~~~~l~~~  167 (330)
T PLN02421         88 IQSFINARTLTPSDMRKPKVAAEIAKELRRLHQVEIPGSKEPQLWNDIFKFYEKASTVKFEDPEKQKKYETISFEELRDE  167 (330)
T ss_pred             eehhhcCCCCChHHCCCHHHHHHHHHHHHHHhCCCCCCCCCCcHHHHHHHHHHHhhhcccCcHHHhhhhcccCHHHHHHH
Confidence            899998765421              11   111100    11 12222222221                      111


Q ss_pred             HHHHH----HC----CcccCCCCCCceeecC-CCcEEEeeccceee
Q 015868          227 MNYLH----QN----NIIHRDLKTANLLMDE-NGVVKVADFGVARV  263 (399)
Q Consensus       227 L~~LH----~~----giiHrDlkp~NILl~~-~~~vkl~DFG~a~~  263 (399)
                      +..+.    ..    -++|.|+.+.|||+++ ++.++++||..|..
T Consensus       168 ~~~l~~~~~~~~~~~v~CHnDl~~~NiL~~~~~~~l~lID~EYag~  213 (330)
T PLN02421        168 IVELKEITDSLKAPVVFAHNDLLSGNLMLNEDEGKLYFIDFEYGSY  213 (330)
T ss_pred             HHHHHHHhccCCCCeEEEECCCCcccEEEeCCCCcEEEEcccccCC
Confidence            22222    11    2799999999999974 57899999998853

>cd05152 MPH2' Macrolide 2'-Phosphotransferase (MPH2')

Probab=96.80  E-value=0.0087  Score=56.51  Aligned_cols=31  Identities=29%  Similarity=0.547  Sum_probs=25.9

Q ss_pred             CcccCCCCCCceeecCCCc-EEEeeccceeec
Q 015868          234 NIIHRDLKTANLLMDENGV-VKVADFGVARVQ  264 (399)
Q Consensus       234 giiHrDlkp~NILl~~~~~-vkl~DFG~a~~~  264 (399)
                      .++|+|+.|.||++++++. .-|+||+.+...
T Consensus       186 ~lvHGD~~~~Nilv~~~~~~~gviDWe~a~iG  217 (276)
T cd05152         186 VLVHGDLHPGHILIDEDARVTGLIDWTEAKVG  217 (276)
T ss_pred             eeEeCCCCCCcEEEeCCCCEEEEECcHhcccC
Confidence            4899999999999997555 569999988653

MPH2' is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). MPH2' catalyzes the transfer of the gamma-phosphoryl group from ATP to the 2'-hydroxyl of macrolide antibiotics such as erythromycin, clarithromycin, and azithromycin, among others. Macrolides penetrate the bacterial cell and bind to ribosomes, where it interrupts protein elongation, leading ultimately to the demise of the bacterium. Phosphorylation of macrolides leads to their inactivation. Based on substrate specificity and amino acid sequence, MPH2' is divided into types I and II, encoded by mphA and mphB genes, respectively. MPH2'I inactivates 14-membered ring macrolides while MPH2'II inactivates both 14- and 16-membered ring macrolides. Enzymatic inactivation of macrolides has been reported

>PRK05092 PII uridylyl-transferase; Provisional

Probab=96.72  E-value=0.0023  Score=70.49  Aligned_cols=55  Identities=25%  Similarity=0.367  Sum_probs=44.0

Q ss_pred             HHHHHHHHHhhhhCCCeeeeceeccCCCceeeEEEe---cCCCCc---chHHHHHHHHHHH
Q 015868            9 MKVGELTSLLGEIGLNIQEAHAFSTVDGFSLDVFVV---DGWPYD---ETEDLKNVLAKEI   63 (399)
Q Consensus         9 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~g~~~~---~~~~l~~~l~~~~   63 (399)
                      .+|++++.+|+..|+||.+|++|+|.||+.+|+|+|   +|.+..   ..+++.++|...+
T Consensus       744 GLfa~i~~~L~~~glnI~~A~I~t~~dg~alD~F~V~~~~g~~~~~~~~~~~l~~~L~~~l  804 (931)
T PRK05092        744 GLFSRIAGACAAAGANIVDARIFTTTDGRALDTFWIQDAFGRDEDEPRRLARLAKAIEDAL  804 (931)
T ss_pred             cHHHHHHHHHHHCCCcEEEEEEEEecCCeEEEEEEEECCCCCCCCCHHHHHHHHHHHHHHH
Confidence            378999999999999999999999999999999999   675432   3445555554443

>PF03881 Fructosamin_kin: Fructosamine kinase; InterPro: IPR016477 Ketosamines derive from a non-enzymatic reaction between a sugar and a protein []

Probab=96.65  E-value=0.0092  Score=56.62  Aligned_cols=73  Identities=16%  Similarity=0.144  Sum_probs=49.0

Q ss_pred             eceeceeCceEEEEEEECCeeEEEEEecCCCCCHHHHHHHHHHHHHHHhcC---CCceeeEEeEEecCCcEEEEEecCCC
Q 015868          121 ECKVASGSYGDLYKGTYCSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIR---HKNVVQFIGACTRPPNLCIVTEFMAR  197 (399)
Q Consensus       121 ~~~lg~G~~g~Vy~~~~~~~~vAvK~~~~~~~~~~~~~~~~~Ei~~l~~l~---h~nIv~~~~~~~~~~~~~lV~E~~~g  197 (399)
                      .+.++-|....+|+.+..++.+.||+-..     .....|..|..-|+.|.   .-.+++++++.......++||||++.
T Consensus        22 ~~~v~GG~i~~a~~~~~~~~~~FvK~~~~-----~~~~~f~~Ea~gL~~L~~~~~~~vP~vi~~G~~~~~~fLlle~l~~   96 (288)
T PF03881_consen   22 IEPVSGGDINEAYRLDTDGGSYFVKVNSE-----SGRDMFEGEAEGLKALAEANPIRVPKVIAWGEYDDDAFLLLEFLEM   96 (288)
T ss_dssp             EEEE--SSSSEEEEEETTS-EEEEEEEEG-----GGCCHHHHHHHHHHHHCHTTTSBS--EEEEEE-SSCCEEEEE----
T ss_pred             eEecCCCChhheEEEECCCccEEEEecCh-----hhHHHHHHHHHHHHHHHhcCCCCCCeEEEEEeecCCceEEEEeecC
Confidence            45688899999999998889999999762     22346778888888884   45688999988777778999999977


Q ss_pred             C
Q 015868          198 G  198 (399)
Q Consensus       198 g  198 (399)
                      +
T Consensus        97 ~   97 (288)
T PF03881_consen   97 G   97 (288)
T ss_dssp             -
T ss_pred             C
Confidence            6

Ketosamine-3-kinases (KT3K), of which fructosamine-3-kinase (FN3K) is the best-known example, catalyse the phosphorylation of the ketosamine moiety of glycated proteins. The instability of a phosphorylated ketosamine leads to its degradation, and KT3K is thus thought to be involved in protein repair []. The function of the prokaryotic members of this group has not been established. However, several lines of evidence indicate that they may function as fructosamine-3-kinases (FN3K). First, they are similar to characterised FN3K from mouse and human. Second, the Escherichia coli members are found in close proximity on the genome to fructose-6-phosphate kinase (PfkB). Last, FN3K activity has been found in a Anacystis montana (Gloeocapsa montana Kutzing 1843) [], indicating such activity-directly demonstrated in eukaryotes-is nonetheless not confined to eukaryotes. This family includes eukaryotic fructosamine-3-kinase enzymes [] which may initiate a process leading to the deglycation of fructoselysine and of glycated proteins and in the phosphorylation of 1-deoxy-1-morpholinofructose, fructoselysine, fructoseglycine, fructose and glycated lysozyme. The family also includes bacterial members that have not been characterised but probably have a similar or identical function. For additional information please see [].; PDB: 3JR1_B 3F7W_A.

>KOG1093 consensus Predicted protein kinase (contains TBC and RHOD domains) [General function prediction only]

Probab=96.62  E-value=0.008  Score=60.42  Aligned_cols=156  Identities=22%  Similarity=0.315  Sum_probs=95.4

Q ss_pred             HHHHHHHHHHHhcCCCceeeEEeEEecC-CcEEEEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcc
Q 015868          158 KEFSQEVYIMRKIRHKNVVQFIGACTRP-PNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNII  236 (399)
Q Consensus       158 ~~~~~Ei~~l~~l~h~nIv~~~~~~~~~-~~~~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~gii  236 (399)
                      ..+.-..++++.+.|+|..+++++-... ....+|+|++. .||+|++..+.  +......              .+|+.
T Consensus        27 ~~ilgr~~~lktl~~~~l~~yl~~~r~~~~r~IVV~e~~~-~Sled~~~~~~--l~~~s~~--------------~~~~~   89 (725)
T KOG1093|consen   27 IQILGRFQYLKSLQHDNLCQYLDFSRGKHERVIVVMEHYT-MSLEDILKTGN--LKDESLL--------------AHGVL   89 (725)
T ss_pred             HHHhhhhHHHHhhcCccceeeEeeecCccceEEEEehhhc-cchHHHHHhcc--cchhhhc--------------ccccc
Confidence            3455567889999999999999876543 34788999884 59999987643  2111111              12222


Q ss_pred             cCCCCCCceeecCCCcEEEeeccceeeccCCCccccCCCCcccccccccCCCCCCChhhHHHHHHHHHHHHcCCCCCCCC
Q 015868          237 HRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPYAGL  316 (399)
Q Consensus       237 HrDlkp~NILl~~~~~vkl~DFG~a~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~Dv~slG~vl~elltg~~P~~~~  316 (399)
                      |     -|+       ++.+| -++...                 |-.+     .+|+|||++|.++.++.-|..-+...
T Consensus        90 ~-----~~~-------~~~td-~~~t~~-----------------~~~~-----~pKsdVwsl~~i~~el~L~~~l~~~~  134 (725)
T KOG1093|consen   90 H-----LNI-------IYITD-HFLTKY-----------------PSPI-----GPKSDVWSLGFIILELYLGISLEAEL  134 (725)
T ss_pred             e-----ehh-------hhccc-cccccC-----------------CCCC-----CcchhhhhHHHHHHHHHHhhHHHHHH
Confidence            2     222       23333 111100                 1111     13999999999999999887766655


Q ss_pred             CHHHHHHHHHhccCCC----------CCCCCCcHHHHHHHHHHhhhcCCCCCCHHHHHH
Q 015868          317 TPLQAAVGVVQKSLRP----------TIPKHAHPRLAELLERCWQHDPTQRPNFSQITD  365 (399)
Q Consensus       317 ~~~~~~~~~~~~~~~~----------~~~~~~~~~l~~ll~~cl~~dP~~Rps~~ell~  365 (399)
                      +..+.......-...+          .+...++..+.++..+|+...|..||.+.++.+
T Consensus       135 ~~s~~l~~i~k~~~~d~~~~~~a~e~~~~~~~d~~~~~~~~~c~~~~~~ir~l~~~~~k  193 (725)
T KOG1093|consen  135 TESEYLEILLKYYTDDQELLSTAMEHLIQLLADKKRLPLLKKCLWLEPIIRPLPMELSK  193 (725)
T ss_pred             HHHHHHHHHHHhccCchhHHHHHHHHHHHHhhhHhHHHHhccCCccccccccchhHHhc
Confidence            5544443332211111          122346677889999999999999887766543

>TIGR02904 spore_ysxE spore coat protein YsxE

Probab=96.56  E-value=0.043  Score=52.61  Aligned_cols=30  Identities=23%  Similarity=0.307  Sum_probs=27.9

Q ss_pred             CcccCCCCCCceeecCCCcEEEeeccceee
Q 015868          234 NIIHRDLKTANLLMDENGVVKVADFGVARV  263 (399)
Q Consensus       234 giiHrDlkp~NILl~~~~~vkl~DFG~a~~  263 (399)
                      +++|+|+.+.|+++++++.+.++||..++.
T Consensus       197 ~lcHgD~~~~Nvl~~~~~~~~iIDfd~~~~  226 (309)
T TIGR02904       197 VLVHGKLSLSHFLYDETRGGYFINFEKASF  226 (309)
T ss_pred             eeeCCCCcHHhEEEcCCCCEEEEEhhhccc
Confidence            799999999999999999999999998864

Members of this family are homologs of the Bacillus subtilis spore coat protein CotS. Members of this family, designated YsxE, are found only in the family Bacillaceae, from among the endospore-forming members of the Firmicutes branch of the Bacteria. As a rule, the ysxE gene is found immediately downstream of spoVID, a gene necessary for spore coat assembly. The protein has been shown to be part of the spore coat.

>PRK00275 glnD PII uridylyl-transferase; Provisional

Probab=96.55  E-value=0.0049  Score=67.51  Aligned_cols=40  Identities=20%  Similarity=0.336  Sum_probs=36.3

Q ss_pred             HHHHHHHHHhhhhCCCeeeeceeccCCCceeeEEEecCCC
Q 015868            9 MKVGELTSLLGEIGLNIQEAHAFSTVDGFSLDVFVVDGWP   48 (399)
Q Consensus         9 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~   48 (399)
                      .+++.++.+|+..||||..|.+|+|.|||.||+|+|.-..
T Consensus       716 gLFa~i~g~L~~~~lnI~~A~I~Tt~dg~alD~F~V~d~~  755 (895)
T PRK00275        716 DFFAATVAAMDQLNLNIHDARIITSSSQFTLDTYIVLDDD  755 (895)
T ss_pred             cHHHHHHHHHHHCCCeEEEEEEEEcCCCeEEEEEEEeCCC
Confidence            3789999999999999999999999999999999995433

>cd04899 ACT_ACR-UUR-like_2 C-terminal ACT domains of the bacterial signal-transducing uridylyltransferase /uridylyl-removing (UUR) enzyme, GlnD and related domains

Probab=96.46  E-value=0.0073  Score=43.98  Aligned_cols=54  Identities=24%  Similarity=0.265  Sum_probs=39.3

Q ss_pred             HHHHHHHHHhhhhCCCeeeeceeccCCCceeeEEEecCCCCc-chHHHHHHHHHHH
Q 015868            9 MKVGELTSLLGEIGLNIQEAHAFSTVDGFSLDVFVVDGWPYD-ETEDLKNVLAKEI   63 (399)
Q Consensus         9 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~~-~~~~l~~~l~~~~   63 (399)
                      .+|++++.++++.|+||.+|+++++. ++.+|.|+|.+-... ..++.++.+++.+
T Consensus        12 gll~~i~~~l~~~~~~I~~~~~~~~~-~~~~~~f~i~~~~~~~~~~~~~~~i~~~l   66 (70)
T cd04899          12 GLLADVTRVLAELGLNIHSAKIATLG-ERAEDVFYVTDADGQPLDPERQEALRAAL   66 (70)
T ss_pred             cHHHHHHHHHHHCCCeEEEEEEEecC-CEEEEEEEEECCCCCcCCHHHHHHHHHHH
Confidence            37899999999999999999998654 599999998642221 1224455555554

This ACT domain family, ACT_ACR-UUR-like_2, includes the second of two C-terminal ACT domains of the bacterial signal-transducing uridylyltransferase /uridylyl-removing (UUR) enzyme, GlnD; including those enzymes similar to the GlnD found in enteric Escherichia coli and those found in photosynthetic, nitrogen-fixing bacterium Rhodospirillum rubrum. Also included in this CD are the second and fourth ACT domains of a novel protein composed almost entirely of ACT domain repeats, the ACR protein. These ACR proteins, found in Arabidopsis and Oryza, are proposed to function as novel regulatory or sensor proteins in plants. Members of this CD belong to the superfamily of ACT regulatory domains.

>cd04895 ACT_ACR_1 ACT domain-containing protein which is composed almost entirely of four ACT domain repeats (the "ACR" protein)

Probab=96.45  E-value=0.01  Score=43.80  Aligned_cols=39  Identities=28%  Similarity=0.294  Sum_probs=34.3

Q ss_pred             HHHHHHHHHhhhhCCCeeeeceeccCCCceeeEEEecCCC
Q 015868            9 MKVGELTSLLGEIGLNIQEAHAFSTVDGFSLDVFVVDGWP   48 (399)
Q Consensus         9 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~   48 (399)
                      -||..++.+|.++||+|+-|++ +|-.+..-|+|.|..-.
T Consensus        13 GLL~~i~~~l~~~gl~I~~AkI-sT~Gerv~DvFyV~d~~   51 (72)
T cd04895          13 GILLEAVQVLTDLDLCITKAYI-SSDGGWFMDVFHVTDQL   51 (72)
T ss_pred             CHHHHHHHHHHHCCcEEEEEEE-eecCCeEEEEEEEECCC
Confidence            4799999999999999999986 77888999999996544

This CD includes the N-terminal ACT domain, of a novel type of ACT domain-containing protein which is composed almost entirely of four ACT domain repeats (the "ACR" protein). ACR proteins, found only in Arabidopsis and Oryza, as yet, are proposed to function as novel regulatory or sensor proteins in plants. Nine ACR gene products have been described (ACR1-8 in Arabidopsis and OsARC1-9 in Oryza) and are represented in this CD. Members of this CD belong to the superfamily of ACT regulatory domains.

>PRK03059 PII uridylyl-transferase; Provisional

Probab=96.45  E-value=0.0062  Score=66.40  Aligned_cols=37  Identities=24%  Similarity=0.422  Sum_probs=35.1

Q ss_pred             HHHHHHHHHhhhhCCCeeeeceeccCCCceeeEEEec
Q 015868            9 MKVGELTSLLGEIGLNIQEAHAFSTVDGFSLDVFVVD   45 (399)
Q Consensus         9 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~   45 (399)
                      .|+++++.+|+..||||..|.+|+|.||+.||+|+|-
T Consensus       690 gLFa~i~g~l~~~~l~I~~A~i~t~~~g~~ld~f~V~  726 (856)
T PRK03059        690 DLFARICGYFDRAGFSILDARVHTTRHGYALDTFQVL  726 (856)
T ss_pred             cHHHHHHHHHHHCCCceeeeEEEEcCCCeEEEEEEEe
Confidence            4789999999999999999999999999999999994

>cd04873 ACT_UUR-ACR-like ACT domains of the bacterial signal-transducing uridylyltransferase /uridylyl-removing (UUR) enzyme, GlnD

Probab=96.36  E-value=0.016  Score=41.91  Aligned_cols=53  Identities=26%  Similarity=0.359  Sum_probs=41.1

Q ss_pred             HHHHHHHHhhhhCCCeeeeceeccCCCceeeEEEecCCCCc-chHHHHHHHHHHH
Q 015868           10 KVGELTSLLGEIGLNIQEAHAFSTVDGFSLDVFVVDGWPYD-ETEDLKNVLAKEI   63 (399)
Q Consensus        10 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~~-~~~~l~~~l~~~~   63 (399)
                      +|+.++.+|++.|+||..++++++.+ +..++|.|++.... ..++-++.+++.+
T Consensus        13 ~l~~i~~~l~~~~~~I~~~~~~~~~~-~~~~~~~v~~~~~~~~~~~~~~~l~~~l   66 (70)
T cd04873          13 LLADITRVLADLGLNIHDARISTTGE-RALDVFYVTDSDGRPLDPERIARLEEAL   66 (70)
T ss_pred             HHHHHHHHHHHCCCeEEEEEEeecCC-EEEEEEEEECCCCCcCCHHHHHHHHHHH
Confidence            68899999999999999999998877 99999999875433 3334555555444

This ACT domain family, ACT_UUR_ACR-like, includes the two C-terminal ACT domains of the bacterial signal-transducing uridylyltransferase /uridylyl-removing (UUR) enzyme, GlnD; including those enzymes similar to the GlnD found in enteric Escherichia coli and those found in photosynthetic, nitrogen-fixing bacterium Rhodospirillum rubrum. Also included in this CD are the four ACT domains of a novel protein composed almost entirely of ACT domain repeats (the ACR protein) and like proteins. These ACR proteins, found in Arabidopsis and Oryza, are proposed to function as novel regulatory or sensor proteins in plants. This CD also includes the first of the two ACT domains that comprise the Glycine Cleavage System Transcriptional Repressor (GcvR) protein and related domains, as well as, the N-terminal ACT domain of a yet characterized Arabidopsis/Oryza predicted t

---

Homologous Structure Templates

Structure Templates Detected by BLAST

Original result of BLAST against Protein Data Bank

ID	Length	Definition	E-value
Query	399
3ppz_A	309	Crystal Structure Of Ctr1 Kinase Domain In Complex		3e-63
3p86_A	309	Crystal Structure Of Ctr1 Kinase Domain Mutant D676		4e-63
3c4c_A	280	B-Raf Kinase In Complex With Plx4720 Length = 280		1e-49
4fk3_A	292	B-Raf Kinase V600e Oncogenic Mutant In Complex With		6e-49
3dk3_A	293	Crystal Structure Of Mutant Abl Kinase Domain In Co		1e-48
3og7_A	289	B-Raf Kinase V600e Oncogenic Mutant In Complex With		3e-48
3dk6_A	293	Crystal Structure Of Mutant Abl Kinase Domain In Co		4e-48
2hzi_A	277	Abl Kinase Domain In Complex With Pd180970 Length =		4e-48
3pyy_A	298	Discovery And Characterization Of A Cell-Permeable,		6e-48
3dk7_A	277	Crystal Structure Of Mutant Abl Kinase Domain In Co		6e-48
2e2b_A	293	Crystal Structure Of The C-Abl Kinase Domain In Com		1e-47
1fpu_A	293	Crystal Structure Of Abl Kinase Domain In Complex W		1e-47
3qri_A	277	The Crystal Structure Of Human Abl1 Kinase Domain I		1e-47
2gqg_A	278	X-Ray Crystal Structure Of Dasatinib (Bms-354825) B		1e-47
2v7a_A	286	Crystal Structure Of The T315i Abl Mutant In Comple		2e-47
3oxz_A	284	Crystal Structure Of Abl Kinase Domain Bound With A		2e-47
2hyy_A	273	Human Abl Kinase Domain In Complex With Imatinib (S		2e-47
2g1t_A	287	A Src-Like Inactive Conformation In The Abl Tyrosin		2e-47
2hiw_A	287	Crystal Structure Of Inactive Conformation Abl Kina		2e-47
2qoh_A	288	Crystal Structure Of Abl Kinase Bound With Ppy-a Le		2e-47
2f4j_A	287	Structure Of The Kinase Domain Of An Imatinib-Resis		2e-47
2g2f_A	287	A Src-Like Inactive Conformation In The Abl Tyrosin		2e-47
3omv_A	307	Crystal Structure Of C-Raf (Raf-1) Length = 307		3e-47
3qrj_A	277	The Crystal Structure Of Human Abl1 Kinase Domain T		5e-47
1opk_A	495	Structural Basis For The Auto-Inhibition Of C-Abl T		6e-47
3oy3_A	284	Crystal Structure Of Abl T315i Mutant Kinase Domain		7e-47
2fo0_A	495	Organization Of The Sh3-Sh2 Unit In Active And Inac		8e-47
2z60_A	288	Crystal Structure Of The T315i Mutant Of Abl Kinase		8e-47
1opl_A	537	Structural Basis For The Auto-Inhibition Of C-Abl T		8e-47
2hz0_A	270	Abl Kinase Domain In Complex With Nvp-Aeg082 Length		1e-46
2fb8_A	281	Structure Of The B-Raf Kinase Domain Bound To Sb-59		3e-46
3dtc_A	271	Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp		3e-46
4dbn_A	284	Crystal Structure Of The Kinase Domain Of Human B-R		3e-46
3ii5_A	306	The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi		4e-46
3d4q_A	307	Pyrazole-Based Inhibitors Of B-Raf Kinase Length =		5e-46
4g9r_A	307	B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr		3e-45
3q96_A	282	B-Raf Kinase Domain In Complex With A Tetrahydronap		3e-45
3idp_A	300	B-Raf V600e Kinase Domain In Complex With An Aminoi		3e-45
3gvu_A	292	The Crystal Structure Of Human Abl2 In Complex With		3e-45
4h58_A	275	Braf In Complex With Compound 3 Length = 275		4e-45
3oez_A	286	Crystal Structure Of The L317i Mutant Of The Chicke		4e-45
2oiq_A	286	Crystal Structure Of Chicken C-Src Kinase Domain In		8e-45
1uwh_A	276	The Complex Of Wild Type B-Raf And Bay439006 Length		8e-45
3d7u_B	277	Structural Basis For The Recognition Of C-Src By It		9e-45
1fmk_A	452	Crystal Structure Of Human Tyrosine-Protein Kinase		1e-44
1y57_A	452	Structure Of Unphosphorylated C-Src In Complex With		2e-44
1yi6_A	276	C-Term Tail Segment Of Human Tyrosine Kinase (258-5		2e-44
3geq_A	286	Structural Basis For The Chemical Rescue Of Src Kin		2e-44
2h8h_A	535	Src Kinase In Complex With A Quinazoline Inhibitor		2e-44
2bdf_A	279	Src Kinase In Complex With Inhibitor Ap23451 Length		2e-44
1qcf_A	454	Crystal Structure Of Hck In Complex With A Src Fami		2e-44
1uwj_A	276	The Complex Of Mutant V599e B-raf And Bay439006 Len		2e-44
2ptk_A	453	Chicken Src Tyrosine Kinase Length = 453		3e-44
2hwo_A	286	Crystal Structure Of Src Kinase Domain In Complex W		3e-44
3g6h_A	286	Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma		4e-44
3dqw_A	286	C-Src Kinase Domain Thr338ile Mutant In Complex Wit		4e-44
3svv_A	286	Crystal Structure Of T338c C-Src Covalently Bound T		4e-44
3u4w_A	275	Src In Complex With Dna-Templated Macrocyclic Inhib		4e-44
2hk5_A	270	Hck Kinase In Complex With Lck Targetted Inhibitor		5e-44
1byg_A	278	Kinase Domain Of Human C-Terminal Src Kinase (Csk)		7e-44
1ksw_A	452	Structure Of Human C-Src Tyrosine Kinase (Thr338gly		8e-44
3d7u_A	263	Structural Basis For The Recognition Of C-Src By It		8e-44
1ad5_A	438	Src Family Kinase Hck-Amp-Pnp Complex Length = 438		8e-44
1yoj_A	283	Crystal Structure Of Src Kinase Domain Length = 283		8e-44
1yol_A	283	Crystal Structure Of Src Kinase Domain In Complex W		9e-44
2qq7_A	286	Crystal Structure Of Drug Resistant Src Kinase Doma		1e-43
3d7t_A	269	Structural Basis For The Recognition Of C-Src By It		3e-43
1k9a_A	450	Crystal Structure Analysis Of Full-Length Carboxyl-		4e-43
3t9t_A	267	Crystal Structure Of Btk Mutant (F435t,K596r) Compl		7e-43
4hct_A	269	Crystal Structure Of Itk In Complex With Compound 5		2e-42
2dq7_X	283	Crystal Structure Of Fyn Kinase Domain Complexed Wi		3e-42
3miy_A	266	X-Ray Crystal Structure Of Itk Complexed With Sunit		2e-41
3v5j_A	266	Crystal Structure Of Interleukin-2 Inducible T-Cell		3e-41
3a4o_X	286	Lyn Kinase Domain Length = 286		3e-41
1sm2_A	264	Crystal Structure Of The Phosphorylated Interleukin		3e-41
3qgw_A	286	Crystal Structure Of Itk Kinase Bound To An Inhibit		5e-41
2zv7_A	279	Lyn Tyrosine Kinase Domain, Apo Form Length = 279		8e-40
3pix_A	274	Crystal Structure Of Btk Kinase Domain Complexed Wi		2e-39
3oct_A	265	Crystal Structure Of Bruton's Tyrosine Kinase Mutan		3e-39
3gen_A	283	The 1.6 A Crystal Structure Of Human Bruton's Tyros		3e-39
3p08_A	267	Crystal Structure Of The Human Btk Kinase Domain Le		4e-39
3ocs_A	271	Crystal Structure Of Bruton's Tyrosine Kinase In Co		4e-39
3k54_A	283	Structures Of Human Bruton's Tyrosine Kinase In Act		4e-39
4gs6_A	315	Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz		6e-39
2eva_A	307	Structural Basis For The Interaction Of Tak1 Kinase		6e-39
1qpe_A	279	Structural Analysis Of The Lymphocyte-Specific Kina		6e-39
3kmm_A	288	Structure Of Human Lck Kinase With A Small Molecule		6e-39
2zm1_A	285	Crystal Structure Of Imidazo Pyrazin 1 Bound To The		6e-39
3kxz_A	287	The Complex Crystal Structure Of Lck With A Probe M		7e-39
3pxk_A	282	Focal Adhesion Kinase Catalytic Domain In Complex W		7e-39
2pl0_A	289	Lck Bound To Imatinib Length = 289		7e-39
3kmw_A	271	Crystal Structure Of The IlkALPHA-Parvin Core Compl		7e-39
2etm_A	281	Crystal Structure Of Focal Adhesion Kinase Domain C		8e-39
1qpd_A	279	Structural Analysis Of The Lymphocyte-specific Kina		1e-38
3bz3_A	276	Crystal Structure Analysis Of Focal Adhesion Kinase		1e-38
2j0l_A	276	Crystal Structure Of A The Active Conformation Of T		1e-38
1mp8_A	281	Crystal Structure Of Focal Adhesion Kinase (Fak) Le		1e-38
4ebw_A	304	Structure Of Focal Adhesion Kinase Catalytic Domain		1e-38
2jkm_A	276	Focal Adhesion Kinase Catalytic Domain In Complex W		2e-38
2j0m_B	276	Crystal Structure A Two-Chain Complex Between The F		2e-38
2j0j_A	656	Crystal Structure Of A Fragment Of Focal Adhesion K		2e-38
3lck_A	271	The Kinase Domain Of Human Lymphocyte Kinase (Lck),		2e-38
3bym_A	272	X-Ray Co-Crystal Structure Aminobenzimidazole Triaz		2e-38
2of2_A	271	Crystal Structure Of Furanopyrimidine 8 Bound To Lc		2e-38
2og8_A	265	Crystal Structure Of Aminoquinazoline 36 Bound To L		2e-38
2ofu_A	273	X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam		2e-38
2ofv_A	277	Crystal Structure Of Aminoquinazoline 1 Bound To Lc		2e-38
1jpa_A	312	Crystal Structure Of Unphosphorylated Ephb2 Recepto		2e-38
3bys_A	277	Co-Crystal Structure Of Lck And Aminopyrimidine Ami		3e-38
3cd3_A	377	Crystal Structure Of Phosphorylated Human Feline Sa		6e-38
3bkb_A	377	Crystal Structure Of Human Feline Sarcoma Viral Onc		7e-38
2rei_A	318	Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep		9e-38
2jkk_A	276	Focal Adhesion Kinase Catalytic Domain In Complex W		1e-37
2vwu_A	302	Ephb4 Kinase Domain Inhibitor Complex Length = 302		1e-37
2qok_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		1e-37
2j0k_A	656	Crystal Structure Of A Fragment Of Focal Adhesion K		1e-37
4f0f_A	287	Crystal Structure Of The Roco4 Kinase Domain Bound		1e-37
4f1o_A	287	Crystal Structure Of The L1180t Mutant Roco4 Kinase		1e-37
2qoo_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		2e-37
2hen_A	286	Crystal Structure Of The Ephb2 Receptor Kinase Doma		2e-37
3mpm_A	267	Lck Complexed With A Pyrazolopyrimidine Length = 26		2e-37
1k2p_A	263	Crystal Structure Of Bruton's Tyrosine Kinase Domai		2e-37
2qoi_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		3e-37
2qod_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y602f		3e-37
2qol_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596:y		3e-37
2y4i_B	319	Ksr2-Mek1 Heterodimer Length = 319		4e-37
3kul_B	325	Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep		4e-37
2qof_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f		4e-37
2gsf_A	373	The Human Epha3 Receptor Tyrosine Kinase And Juxtam		4e-37
2xyu_A	285	Crystal Structure Of Epha4 Kinase Domain In Complex		4e-37
3fxx_A	371	Human Epha3 Kinase And Juxtamembrane Region Bound T		4e-37
2qoc_A	344	Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp		5e-37
3kul_A	325	Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep		5e-37
2y6m_A	291	Crystal Structure Of Epha4 Kinase Domain Length = 2		5e-37
3dzq_A	361	Human Epha3 Kinase Domain In Complex With Inhibitor		6e-37
2hel_A	306	Crystal Structure Of A Mutant Epha4 Kinase Domain (		6e-37
4f1m_A	287	Crystal Structure Of The G1179s Roco4 Kinase Domain		6e-37
1u46_A	291	Crystal Structure Of The Unphosphorylated Kinase Do		8e-37
4aw5_A	291	Complex Of The Ephb4 Kinase Domain With An Oxindole		8e-37
2qon_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		8e-37
1u54_A	291	Crystal Structures Of The Phosphorylated And Unphos		8e-37
4hzr_A	277	Crystal Structure Of Ack1 Kinase Domain Length = 27		9e-37
4hzs_A	341	Crystal Structure Of Ack1 Kinase Domain With C-term		9e-37
3eqp_B	276	Crystal Structure Of Ack1 With Compound T95 Length		9e-37
4id7_A	273	Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-		1e-36
4ewh_B	275	Co-Crystal Structure Of Ack1 With Inhibitor Length		1e-36
2qob_A	344	Human Epha3 Kinase Domain, Base Structure Length =		1e-36
2qo7_A	373	Human Epha3 Kinase And Juxtamembrane Region, Dephos		2e-36
1mqb_A	333	Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro		3e-36
2r2p_A	295	Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep		9e-36
3c7q_A	316	Structure Of Vegfr2 Kinase Domain In Complex With B		3e-35
3u6j_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		5e-35
1ywn_A	316	Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p		1e-34
1vr2_A	316	Human Vascular Endothelial Growth Factor Receptor 2		1e-34
3cjf_A	309	Crystal Structure Of Vegfr2 In Complex With A 3,4,5		1e-34
3kmu_A	271	Crystal Structure Of The IlkALPHA-Parvin Core Compl		2e-34
2xir_A	316	Crystal Structure Of The Vegfr2 Kinase Domain In Co		2e-34
4agc_A	353	Crystal Structure Of Vegfr2 (Juxtamembrane And Kina		2e-34
3vnt_A	318	Crystal Structure Of The Kinase Domain Of Human Veg		2e-34
2p2h_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		2e-34
3cjg_A	309	Crystal Structure Of Vegfr2 In Complex With A 3,4,5		3e-34
3ewh_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		3e-34
2oo8_X	317	Synthesis, Structural Analysis, And Sar Studies Of		3e-34
1fvr_A	327	Tie2 Kinase Domain Length = 327		4e-34
2oh4_A	316	Crystal Structure Of Vegfr2 With A Benzimidazole-Ur		4e-34
1t46_A	313	Structural Basis For The Autoinhibition And Sti-571		4e-34
1t45_A	331	Structural Basis For The Autoinhibition And Sti-571		5e-34
1pkg_A	329	Structure Of A C-kit Kinase Product Complex Length		6e-34
3g0e_A	336	Kit Kinase Domain In Complex With Sunitinib Length		6e-34
3g0f_A	336	Kit Kinase Domain Mutant D816h In Complex With Suni		6e-34
3sxr_A	268	Crystal Structure Of Bmx Non-Receptor Tyrosine Kina		7e-34
2p2i_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		8e-34
2wqb_A	324	Structure Of The Tie2 Kinase Domain In Complex With		1e-33
3gqi_A	326	Crystal Structure Of Activated Receptor Tyrosine Ki		2e-33
3gql_A	326	Crystal Structure Of Activated Receptor Tyrosine Ki		4e-33
4f63_A	309	Crystal Structure Of Human Fibroblast Growth Factor		4e-33
3c4f_A	302	Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M		4e-33
3js2_A	317	Crystal Structure Of Minimal Kinase Domain Of Fibro		4e-33
1fgk_A	310	Crystal Structure Of The Tyrosine Kinase Domain Of		5e-33
3kxx_A	317	Structure Of The Mutant Fibroblast Growth Factor Re		5e-33
3tt0_A	382	Co-Structure Of Fibroblast Growth Factor Receptor 1		5e-33
3rhx_B	306	Crystal Structure Of The Catalytic Domain Of Fgfr1		5e-33
2pvf_A	334	Crystal Structure Of Tyrosine Phosphorylated Activa		6e-33
2pzp_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		6e-33
3cly_A	334	Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase		6e-33
2pwl_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		7e-33
2pvy_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		9e-33
2xik_A	294	Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K		9e-33
2pz5_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		1e-32
2r4b_A	321	Erbb4 Kinase Domain Complexed With A Thienopyrimidi		1e-32
3ggf_A	301	Crystal Structure Of Human SerineTHREONINE-Protein		1e-32
3bbt_B	328	Crystal Structure Of The Erbb4 Kinase In Complex Wi		1e-32
4h1j_A	293	Crystal Structure Of Pyk2 With The Pyrazole 13a Len		1e-32
1oec_A	316	The Fgfr2 Tyrosine Kinase Domain Length = 316		1e-32
3fzo_A	277	Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin		1e-32
2pzr_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		1e-32
3cc6_A	281	Crystal Structure Of Kinase Domain Of Protein Tyros		1e-32
3ri1_A	313	Crystal Structure Of The Catalytic Domain Of Fgfr2		1e-32
2psq_A	370	Crystal Structure Of Unphosphorylated Unactivated W		2e-32
3b2t_A	311	Structure Of Phosphotransferase Length = 311		3e-32
3zhp_C	294	Human Mst3 (stk24) In Complex With Mo25beta Length		3e-32
2q0b_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		3e-32
3a7f_A	303	Human Mst3 Kinase Length = 303		4e-32
3ckw_A	304	Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3		4e-32
3ckx_A	304	Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3		5e-32
2py3_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		5e-32
2vwi_A	303	Structure Of The Osr1 Kinase, A Hypertension Drug T		9e-32
2zm3_A	308	Complex Structure Of Insulin-Like Growth Factor Rec		9e-32
1k3a_A	299	Structure Of The Insulin-Like Growth Factor 1 Recep		1e-31
3dak_A	290	Crystal Structure Of Domain-Swapped Osr1 Kinase Dom		1e-31
2gs7_A	330	Crystal Structure Of The Inactive Egfr Kinase Domai		1e-31
4hjo_A	337	Crystal Structure Of The Inactive Egfr Tyrosine Kin		1e-31
3lzb_A	327	Egfr Kinase Domain Complexed With An Imidazo[2,1-B]		2e-31
2eb2_A	334	Crystal Structure Of Mutated Egfr Kinase Domain (G7		2e-31
1jqh_A	308	Igf-1 Receptor Kinase Domain Length = 308		2e-31
3o23_A	305	Human Unphosphorylated Igf1-R Kinase Domain In Comp		2e-31
2oj9_A	307	Structure Of Igf-1r Kinase Domain Complexed With A		2e-31
3qqu_A	301	Cocrystal Structure Of Unphosphorylated Igf With Py		2e-31
3i81_A	315	Crystal Structure Of Insulin-Like Growth Factor 1 R		2e-31
3lvp_A	336	Crystal Structure Of Bisphosphorylated Igf1-R Kinas		2e-31
2itn_A	327	Crystal Structure Of Egfr Kinase Domain G719s Mutat		2e-31
1p4o_A	322	Structure Of Apo Unactivated Igf-1r Kinase Domain A		3e-31
3lw0_A	304	Igf-1rk In Complex With Ligand Msc1609119a-1 Length		3e-31
4i23_A	329	Crystal Structure Of The Wild-type Egfr Kinase Doma		3e-31
3vjo_A	334	Crystal Structure Of The Wild-Type Egfr Kinase Doma		3e-31
1m7n_A	322	Crystal Structure Of Unactivated Apo Insulin-Like G		3e-31
2j5e_A	327	Crystal Structure Of Egfr Kinase Domain In Complex		3e-31
1m14_A	333	Tyrosine Kinase Domain From Epidermal Growth Factor		3e-31
3bel_A	315	X-Ray Structure Of Egfr In Complex With Oxime Inhib		3e-31
2gs2_A	330	Crystal Structure Of The Active Egfr Kinase Domain		3e-31
4g5j_A	330	Crystal Structure Of Egfr Kinase In Complex With Bi		3e-31
4i20_A	329	Crystal Structure Of Monomeric (v948r) Primary Onco		3e-31
2j5f_A	327	Crystal Structure Of Egfr Kinase Domain In Complex		3e-31
1xkk_A	352	Egfr Kinase Domain Complexed With A Quinazoline Inh		3e-31
2ivv_A	314	Crystal Structure Of Phosphorylated Ret Tyrosine Ki		5e-31
3d94_A	301	Crystal Structure Of The Insulin-Like Growth Factor		5e-31
2ivt_A	314	Crystal Structure Of Phosphorylated Ret Tyrosine Ki		6e-31
2ivs_A	314	Crystal Structure Of Non-Phosphorylated Ret Tyrosin		6e-31
2itt_A	327	Crystal Structure Of Egfr Kinase Domain L858r Mutat		6e-31
2eb3_A	334	Crystal Structure Of Mutated Egfr Kinase Domain (L8		7e-31
2ogv_A	317	Crystal Structure Of The Autoinhibited Human C-Fms		7e-31
2rfd_A	324	Crystal Structure Of The Complex Between The Egfr K		9e-31
3ug1_A	334	Crystal Structure Of The Mutated Egfr Kinase Domain		9e-31
3lcd_A	329	Inhibitor Bound To A Dfg-In Structure Of The Kinase		1e-30
4i24_A	329	Structure Of T790m Egfr Kinase Domain Co-crystalliz		1e-30
3ika_A	331	Crystal Structure Of Egfr 696-1022 T790m Mutant Cov		1e-30
4g5p_A	330	Crystal Structure Of Egfr Kinase T790m In Complex W		1e-30
2jiv_A	328	Crystal Structure Of Egfr Kinase Domain T790m Mutat		1e-30
2jiu_A	328	Crystal Structure Of Egfr Kinase Domain T790m Mutat		1e-30
4i1z_A	329	Crystal Structure Of The Monomeric (v948r) Form Of		1e-30
2jit_A	327	Crystal Structure Of Egfr Kinase Domain T790m Mutat		1e-30
3lct_A	344	Crystal Structure Of The Anaplastic Lymphoma Kinase		2e-30
3l9p_A	367	Crystal Structure Of The Anaplastic Lymphoma Kinase		2e-30
3gop_A	361	Crystal Structure Of The Egf Receptor Juxtamembrane		2e-30
2yjr_A	342	Structure Of F1174l Mutant Anaplastic Lymphoma Kina		2e-30
3bea_A	333	Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P		3e-30
2i1m_A	333	Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An		3e-30
4i21_A	329	Crystal Structure Of L858r + T790m Egfr Kinase Doma		3e-30
2yhv_A	342	Structure Of L1196m Mutant Anaplastic Lymphoma Kina		3e-30
3w2o_A	331	Egfr Kinase Domain T790m/l858r Mutant With Tak-285		3e-30
2nry_A	307	Crystal Structure Of Irak-4 Length = 307		3e-30
3pls_A	298	Ron In Complex With Ligand Amp-Pnp Length = 298		5e-30
2yjs_A	342	Structure Of C1156y Mutant Anaplastic Lymphoma Kina		5e-30
2nru_A	307	Crystal Structure Of Irak-4 Length = 307		6e-30
3aox_A	344	X-Ray Crystal Structure Of Human Anaplastic Lymphom		1e-29
2i0v_A	335	C-Fms Tyrosine Kinase In Complex With A Quinolone I		1e-29
3v5q_A	297	Discovery Of A Selective Trk Inhibitor With Efficac		1e-29
2oib_A	301	Crystal Structure Of Irak4 Kinase Domain Apo Form L		1e-29
4fnw_A	327	Crystal Structure Of The Apo F1174l Anaplastic Lymp		1e-29
3lco_A	324	Inhibitor Bound To A Dfg-Out Structure Of The Kinas		2e-29
2yfx_A	327	Structure Of L1196m Mutant Anaplastic Lymphoma Kina		2e-29
4dce_A	333	Crystal Structure Of Human Anaplastic Lymphoma Kina		2e-29
2xb7_A	315	Structure Of Human Anaplastic Lymphoma Kinase In Co		2e-29
2xp2_A	327	Structure Of The Human Anaplastic Lymphoma Kinase I		2e-29
4fnz_A	327	Crystal Structure Of Human Anaplastic Lymphoma Kina		2e-29
2x7f_A	326	Crystal Structure Of The Kinase Domain Of Human Tra		2e-29
3lq8_A	302	Structure Of The Kinase Domain Of C-Met Bound To Xl		2e-29
1rqq_A	306	Crystal Structure Of The Insulin Receptor Kinase In		2e-29
4fob_A	353	Crystal Structure Of Human Anaplastic Lymphoma Kina		2e-29
3s95_A	310	Crystal Structure Of The Human Limk1 Kinase Domain		3e-29
3lmg_A	344	Crystal Structure Of The Erbb3 Kinase Domain In Com		3e-29
3kex_A	325	Crystal Structure Of The Catalytically Inactive Kin		3e-29
1ir3_A	306	Phosphorylated Insulin Receptor Tyrosine Kinase In		3e-29
3q6w_A	307	Structure Of Dually-phosphorylated Met Receptor Kin		4e-29
1luf_A	343	Crystal Structure Of The Musk Tyrosine Kinase: Insi		4e-29
3q6u_A	308	Structure Of The Apo Met Receptor Kinase In The Dua		5e-29
2rfn_A	310	X-ray Structure Of C-met With Inhibitor. Length = 3		5e-29
3f66_A	298	Human C-Met Kinase In Complex With Quinoxaline Inhi		5e-29
2wgj_A	306	X-Ray Structure Of Pf-02341066 Bound To The Kinase		5e-29
2z8c_A	303	Phosphorylated Insulin Receptor Tyrosine Kinase In		6e-29
4gg5_A	319	Crystal Structure Of Cmet In Complex With Novel Inh		6e-29
1i44_A	306	Crystallographic Studies Of An Activation Loop Muta		6e-29
3i5n_A	309	Crystal Structure Of C-Met With Triazolopyridazine		6e-29
2g15_A	318	Structural Characterization Of Autoinhibited C-Met		7e-29
2wd1_A	292	Human C-Met Kinase In Complex With Azaindole Inhibi		7e-29
1rjb_A	344	Crystal Structure Of Flt3 Length = 344		8e-29
1irk_A	306	Crystal Structure Of The Tyrosine Kinase Domain Of		8e-29
4fnx_A	327	Crystal Structure Of The Apo R1275q Anaplastic Lymp		8e-29
2uv2_A	287	Crystal Structure Of Human Ste20-Like Kinase Bound		1e-28
3dkg_A	317	Sgx Clone 5698a109kfg1h1 Length = 317		1e-28
3ekk_A	307	Insulin Receptor Kinase Complexed With An Inhibitor		1e-28
1p14_A	306	Crystal Structure Of A Catalytic-Loop Mutant Of The		2e-28
3c1x_A	373	Crystal Structure Of The Tyrosine Kinase Domain Of		2e-28
3dkc_A	317	Sgx Clone 5698a65kfg1h1 Length = 317		2e-28
1r0p_A	312	Crystal Structure Of The Tyrosine Kinase Domain Of		2e-28
2j51_A	325	Crystal Structure Of Human Ste20-Like Kinase Bound		2e-28
3cth_A	314	Crystal Structure Of The Tyrosine Kinase Domain Of		2e-28
3qti_A	314	C-Met Kinase In Complex With Nvp-Bvu972 Length = 31		2e-28
3a4p_A	319	Human C-Met Kinase Domain Complexed With 6-Benzylox		2e-28
3pp0_A	338	Crystal Structure Of The Kinase Domain Of Human Her		2e-28
2jfm_A	325	Crystal Structure Of Human Ste20-Like Kinase (Unlig		2e-28
4asz_A	299	Crystal Structure Of Apo Trkb Kinase Domain Length		3e-28
4f4p_A	273	Syk In Complex With Ligand Lasw836 Length = 273		4e-28
4e4l_A	302	Jak1 Kinase (Jh1 Domain) In Complex With Compound 3		4e-28
1xba_A	291	Crystal Structure Of Apo Syk Tyrosine Kinase Domain		4e-28
2jfl_A	325	Crystal Structure Of Human Ste20-Like Kinase ( Diph		4e-28
3eyg_A	290	Crystal Structures Of Jak1 And Jak2 Inhibitor Compl		4e-28
3com_A	314	Crystal Structure Of Mst1 Kinase Length = 314		5e-28
4aoj_A	329	Human Trka In Complex With The Inhibitor Az-23 Leng		1e-27
4f0i_A	300	Crystal Structure Of Apo Trka Length = 300		1e-27
3qup_A	323	Inhibitor Bound Structure Of The Kinase Domain Of T		1e-27
4gt5_A	306	Crystal Structure Of The Inactive Trka Kinase Domai		1e-27
1u59_A	287	Crystal Structure Of The Zap-70 Kinase Domain In Co		2e-27
4dfl_A	274	Crystal Structure Of Spleen Tyrosine Kinase Complex		2e-27
2o8y_A	298	Apo Irak4 Kinase Domain Length = 298		2e-27
3lpb_A	295	Crystal Structure Of Jak2 Complexed With A Potent 2		3e-27
4apc_A	350	Crystal Structure Of Human Nima-Related Kinase 1 (N		3e-27
3ugc_A	295	Structural Basis Of Jak2 Inhibition By The Type Ii		4e-27
3iok_A	313	2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel		6e-27
3eta_A	317	Kinase Domain Of Insulin Receptor Complexed With A		6e-27
3srv_B	277	Crystal Structure Of Spleen Tyrosine Kinase (Syk) I		7e-27
3srv_A	277	Crystal Structure Of Spleen Tyrosine Kinase (Syk) I		7e-27
3tub_A	293	Crystal Structure Of Syk Kinase Domain With 1-(5-(6		9e-27
3vf8_A	299	Crystal Structure Of Spleen Tyrosine Kinase Syk Cat		9e-27
3emg_A	291	Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami		9e-27
2ozo_A	613	Autoinhibited Intact Human Zap-70 Length = 613		9e-27
2p0c_A	313	Catalytic Domain Of The Proto-Oncogene Tyrosine-Pro		9e-27
3jy9_A	311	Janus Kinase 2 Inhibitors Length = 311		1e-26
4fl2_A	636	Structural And Biophysical Characterization Of The		2e-26
4fl3_A	635	Structural And Biophysical Characterization Of The		2e-26
2w1i_A	326	Structure Determination Of Aurora Kinase In Complex		2e-26
3tjc_A	298	Co-Crystal Structure Of Jak2 With Thienopyridine 8		2e-26
2b7a_A	293	The Structural Basis Of Janus Kinase 2 Inhibition B		2e-26
2clq_A	295	Structure Of Mitogen-Activated Protein Kinase Kinas		2e-26
4e4m_A	302	Jak2 Kinase (Jh1 Domain) In Complex With Compound 3		2e-26
1u5q_A	348	Crystal Structure Of The Tao2 Kinase Domain: Activa		2e-26
2gcd_A	309	Tao2 Kinase Domain-Staurosporine Structure Length =		2e-26
3mdy_A	337	Crystal Structure Of The Cytoplasmic Domain Of The		3e-26
3e62_A	293	Fragment Based Discovery Of Jak-2 Inhibitors Length		3e-26
4hge_A	300	Jak2 Kinase (Jh1 Domain) In Complex With Compound 8		3e-26
3q32_A	301	Structure Of Janus Kinase 2 With A Pyrrolotriazine		3e-26
4aqc_A	301	Triazolopyridine-Based Inhibitor Of Janus Kinase 2		3e-26
3vw6_A	269	Crystal Structure Of Human Apoptosis Signal-Regulat		3e-26
3rvg_A	303	Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido		3e-26
4bbe_A	298	Aminoalkylpyrimidine Inhibitor Complexes With Jak2		4e-26
4e6d_A	298	Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W		4e-26
2x4z_A	296	Crystal Structure Of The Human P21-Activated Kinase		5e-26
3hng_A	360	Crystal Structure Of Vegfr1 In Complex With N-(4-ch		5e-26
2bva_A	292	Crystal Structure Of The Human P21-Activated Kinase		6e-26
2qlu_A	314	Crystal Structure Of Activin Receptor Type Ii Kinas		7e-26
3nyx_A	302	Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T		7e-26
2cdz_A	303	Crystal Structure Of The Human P21-Activated Kinase		7e-26
2q0n_A	301	Structure Of Human P21 Activating Kinase 4 (Pak4) I		8e-26
3q4t_A	322	Crystal Structure Of Activin Receptor Type-Iia (Acv		8e-26
3nz0_A	302	Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3		9e-26
3lxn_A	318	Structural And Thermodynamic Characterization Of Th		1e-25
4fif_A	346	Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid		1e-25
1b6c_B	342	Crystal Structure Of The Cytoplasmic Domain Of The		1e-25
3tzm_A	309	Tgf-Beta Receptor Type 1 In Complex With Sb431542 L		1e-25
1py5_A	326	Crystal Structure Of Tgf-Beta Receptor I Kinase Wit		1e-25
1rw8_A	301	Crystal Structure Of Tgf-Beta Receptor I Kinase Wit		1e-25
2wot_A	306	Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)		1e-25
1vjy_A	303	Crystal Structure Of A Naphthyridine Inhibitor Of H		1e-25
4fie_A	423	Full-Length Human Pak4 Length = 423		2e-25
3q52_A	306	Structure Of Phosphorylated Pak1 Kinase Domain Leng		3e-25
4e1z_A	291	Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda		3e-25
4e20_A	290	Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda		4e-25
3fxz_A	297	Crystal Structure Of Pak1 Kinase Domain With Ruthen		4e-25
2j7t_A	302	Crystal Structure Of Human Serine Threonine Kinase-		4e-25
4bc6_A	293	Crystal Structure Of Human Serine Threonine Kinase-		4e-25
2xa4_A	298	Inhibitors Of Jak2 Kinase Domain Length = 298		5e-25
1f3m_C	297	Crystal Structure Of Human SerineTHREONINE KINASE P		5e-25
3fe3_A	328	Crystal Structure Of The Kinase Mark3PAR-1: T211a-S		5e-25
1yhv_A	297	Crystal Structure Of Pak1 Kinase Domain With Two Po		6e-25
3q4z_A	306	Structure Of Unphosphorylated Pak1 Kinase Domain Le		1e-24
2qnj_A	328	Kinase And Ubiquitin-Associated Domains Of Mark3PAR		1e-24
2c30_A	321	Crystal Structure Of The Human P21-Activated Kinase		1e-24
2f57_A	317	Crystal Structure Of The Human P21-activated Kinase		1e-24
2rku_A	294	Structure Of Plk1 In Complex With Bi2536 Length = 2		1e-24
2yac_A	311	Crystal Structure Of Polo-Like Kinase 1 In Complex		1e-24
2wqm_A	310	Structure Of Apo Human Nek7 Length = 310		1e-24
3kb7_A	311	Crystal Structure Of Polo-Like Kinase 1 In Complex		2e-24
3f69_A	311	Crystal Structure Of The Mycobacterium Tuberculosis		2e-24
2v5q_A	315	Crystal Structure Of Wild-type Plk-1 Kinase Domain		2e-24
4gt4_A	308	Structure Of Unliganded, Inactive Ror2 Kinase Domai		2e-24
3zzw_A	289	Crystal Structure Of The Kinase Domain Of Ror2 Leng		2e-24
2ou7_A	335	Structure Of The Catalytic Domain Of Human Polo-Lik		2e-24
3thb_A	333	Structure Of Plk1 Kinase Domain In Complex With A B		2e-24
2wtw_A	285	Aurora-A Inhibitor Structure (2nd Crystal Form) Len		2e-24
3ori_A	311	Mycobacterium Tuberculosis Pknb Kinase Domain L33d		3e-24
1mru_A	311	Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob		4e-24
3orm_A	311	Mycobacterium Tuberculosis Pknb Kinase Domain D76a		4e-24
3aln_A	327	Crystal Structure Of Human Non-Phosphorylated Mkk4		4e-24
3lij_A	494	Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820)		5e-24
1o6y_A	299	Catalytic Domain Of Pknb Kinase From Mycobacterium		5e-24
1y6a_A	366	Crystal Structure Of Vegfr2 In Complex With A 2-Ani		5e-24
3vhk_A	368	Crystal Structure Of The Vegfr2 Kinase Domain In Co		6e-24
1zmw_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		6e-24
3vhe_A	359	Crystal Structure Of Human Vegfr2 Kinase Domain Wit		6e-24
3vid_A	356	Crystal Structure Of Human Vegfr2 Kinase Domain Wit		7e-24
3nrm_A	283	Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito		7e-24
3h9r_A	330	Crystal Structure Of The Kinase Domain Of Type I Ac		7e-24
3f61_A	311	Crystal Structure Of M. Tuberculosis Pknb Leu33aspV		9e-24
2j50_A	280	Structure Of Aurora-2 In Complex With Pha-739358 Le		1e-23
2wtv_A	285	Aurora-A Inhibitor Structure Length = 285		1e-23
2r0i_A	327	Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len		1e-23
1zmu_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		1e-23
3mtf_A	301	Crystal Structure Of The Acvr1 Kinase In Complex Wi		1e-23
4dym_A	301	Crystal Structure Of The Acvr1 Kinase Domain In Com		1e-23
2xru_A	280	Aurora-A T288e Complexed With Pha-828300 Length = 2		1e-23
3iec_A	319	Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K		1e-23
3qbn_A	281	Structure Of Human Aurora A In Complex With A Diami		2e-23
2x6d_A	285	Aurora-A Bound To An Inhibitor Length = 285		2e-23
2xng_A	283	Structure Of Aurora-A Bound To A Selective Imidazop		2e-23
1muo_A	297	Crystal Structure Of Aurora-2, An Oncogenic Serine-		2e-23
2dwb_A	285	Aurora-A Kinase Complexed With Amppnp Length = 285		2e-23
2j4z_A	306	Structure Of Aurora-2 In Complex With Pha-680626 Le		2e-23
1zmv_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		2e-23
3fdn_A	279	Structure-Based Drug Design Of Novel Aurora Kinase		2e-23
1y8g_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		3e-23
2c6e_A	283	Aurora A Kinase Activated Mutant (T287d) In Complex		3e-23
2wzj_A	327	Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82		3e-23
2wqe_A	262	Structure Of S155r Aurora-A Somatic Mutant Length =		3e-23
3e5a_A	268	Crystal Structure Of Aurora A In Complex With Vx-68		3e-23
3igo_A	486	Crystal Structure Of Cryptosporidium Parvum Cdpk1,		4e-23
4eqm_A	294	Structural Analysis Of Staphylococcus Aureus Serine		4e-23
2w1d_A	275	Structure Determination Of Aurora Kinase In Complex		4e-23
1fot_A	318	Structure Of The Unliganded Camp-Dependent Protein		5e-23
1mq4_A	272	Crystal Structure Of Aurora-A Protein Kinase Length		5e-23
3o50_A	267	Crystal Structure Of Benzamide 9 Bound To Auroraa L		5e-23
3lau_A	287	Crystal Structure Of Aurora2 Kinase In Complex With		5e-23
3h0y_A	268	Aurora A In Complex With A Bisanilinopyrimidine Len		6e-23
1ol6_A	282	Structure Of Unphosphorylated D274n Mutant Of Auror		6e-23
2c6d_A	275	Aurora A Kinase Activated Mutant (T287d) In Complex		6e-23
3coh_A	268	Crystal Structure Of Aurora-A In Complex With A Pen		7e-23
2wei_A	287	Crystal Structure Of The Kinase Domain Of Cryptospo		7e-23
3unz_A	279	Aurora A In Complex With Rpm1679 Length = 279		8e-23
3dfa_A	286	Crystal Structure Of Kinase Domain Of Calcium-depen		8e-23
1ol5_A	282	Structure Of Aurora-A 122-403, Phosphorylated On Th		8e-23
3r21_A	271	Design, Synthesis, And Biological Evaluation Of Pyr		9e-23
1yvj_A	290	Crystal Structure Of The Jak3 Kinase Domain In Comp		1e-22
3ha6_A	268	Crystal Structure Of Aurora A In Complex With Tpx2		1e-22
2xne_A	272	Structure Of Aurora-A Bound To An Imidazopyrazine I		2e-22
3tl8_A	349	The Avrptob-Bak1 Complex Reveals Two Structurally S		2e-22
2bmc_A	306	Aurora-2 T287d T288d Complexed With Pha-680632 Leng		2e-22
2w1c_A	275	Structure Determination Of Aurora Kinase In Complex		2e-22
3hzt_A	467	Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4		2e-22
3uim_A	326	Structural Basis For The Impact Of Phosphorylation		3e-22
3my0_A	305	Crystal Structure Of The Acvrl1 (Alk1) Kinase Domai		3e-22
3h4j_B	336	Crystal Structure Of Pombe Ampk Kdaid Fragment Leng		4e-22
3dxn_A	287	Crystal Structure Of The Calcium-dependent Kinase F		4e-22
3ubd_A	304	Structure Of N-Terminal Domain Of Rsk2 Kinase In Co		5e-22
4el9_A	305	Structure Of N-Terminal Kinase Domain Of Rsk2 With		6e-22
3g51_A	325	Structural Diversity Of The Active Conformation Of		6e-22
2hak_A	328	Catalytic And Ubiqutin-Associated Domains Of Mark1P		7e-22
3d14_A	272	Crystal Structure Of Mouse Aurora A (Asn186->gly, L		9e-22
4hvd_A	314	Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h		1e-21
3pjc_A	315	Crystal Structure Of Jak3 Complexed With A Potent A		1e-21
3lxk_A	327	Structural And Thermodynamic Characterization Of Th		2e-21
3fpq_A	290	Crystal Structure Of The Kinase Domain Of Wnk1 Leng		2e-21
2y94_A	476	Structure Of An Active Form Of Mammalian Ampk Lengt		2e-21
2gng_A	350	Protein Kinase A Fivefold Mutant Model Of Rho-Kinas		2e-21
2h6d_A	276	Protein Kinase Domain Of The Human 5'-Amp-Activated		2e-21
2gnf_A	350	Protein Kinase A Fivefold Mutant Model Of Rho-Kinas		2e-21
2yza_A	276	Crystal Structure Of Kinase Domain Of Human 5'-Amp-		3e-21
3daj_A	272	Crystal Structure Of Aurora A Complexed With An Inh		4e-21
2jc6_A	334	Crystal Structure Of Human Calmodulin-Dependent Pro		4e-21
3d5u_A	317	Crystal Structure Of A Wildtype Polo-Like Kinase 1		5e-21
3d5w_A	317	Crystal Structure Of A Phosphorylated Polo-Like Kin		5e-21
3db6_A	301	Crystal Structure Of An Activated (Thr->asp) Polo-L		6e-21
3d5v_A	317	Crystal Structure Of An Activated (Thr->asp) Polo-L		7e-21
2gnj_A	350	Pka Three Fold Mutant Model Of Rho-Kinase With Y-27		8e-21
3vn9_A	340	Rifined Crystal Structure Of Non-Phosphorylated Map		9e-21
2gu8_A	337	Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel		1e-20
3fhi_A	350	Crystal Structure Of A Complex Between The Catalyti		2e-20
1j3h_A	350	Crystal Structure Of Apoenzyme Camp-Dependent Prote		2e-20
3a60_A	327	Crystal Structure Of Unphosphorylated P70s6k1 (Form		2e-20
3a62_A	327	Crystal Structure Of Phosphorylated P70s6k1 Length		2e-20
1ydt_E	350	Structure Of Camp-Dependent Protein Kinase, Alpha-C		2e-20
1fmo_E	350	Crystal Structure Of A Polyhistidine-Tagged Recombi		3e-20
3pvb_A	345	Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca		3e-20
2erz_E	351	Crystal Structure Of C-amp Dependent Kinase (pka) B		3e-20
1jbp_E	350	Crystal Structure Of The Catalytic Subunit Of Camp-		3e-20
2qur_A	350	Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe		3e-20
4dg3_E	371	Crystal Structure Of R336a Mutant Of Camp-dependent		3e-20
1bkx_A	350	A Binary Complex Of The Catalytic Subunit Of Camp-D		3e-20
4dfx_E	350	Crystal Structure Of Myristoylated K7c Catalytic Su		3e-20
2qcs_A	350	A Complex Structure Between The Catalytic And Regul		3e-20
1apm_E	350	2.0 Angstrom Refined Crystal Structure Of The Catal		3e-20
3dae_A	283	Crystal Structure Of Phosphorylated Snf1 Kinase Dom		3e-20
3ku2_A	507	Crystal Structure Of Inactivated Form Of Cdpk1 From		3e-20
1l3r_E	350	Crystal Structure Of A Transition State Mimic Of Th		3e-20
4dfy_A	371	Crystal Structure Of R194a Mutant Of Camp-Dependent		3e-20
3i79_A	484	Calcium-Dependent Protein Kinase 1 From Toxoplasma		4e-20
3hyh_A	275	Crystal Structure Of The Protein Kinase Domain Of Y		4e-20
3hx4_A	508	Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg		4e-20
2jam_A	304	Crystal Structure Of Human Calmodulin-Dependent Pro		4e-20
2fh9_A	274	Structure And Dimerization Of The Kinase Domain Fro		4e-20
3mn3_A	271	An Inhibited Conformation For The Protein Kinase Do		4e-20
3ama_A	351	Protein Kinase A Sixfold Mutant Model Of Aurora B W		5e-20
3ma6_A	298	Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr		5e-20
3o7l_B	350	Crystal Structure Of Phospholamban (1-19):pka C-Sub		5e-20
2uzt_A	336	Pka Structures Of Akt, Indazole-Pyridine Inhibitors		7e-20
1syk_A	350	Crystal Structure Of E230q Mutant Of Camp-Dependent		7e-20
4gv1_A	340	Pkb Alpha In Complex With Azd5363 Length = 340		7e-20
1cdk_A	350	Camp-Dependent Protein Kinase Catalytic Subunit (E.		7e-20
2jdo_A	342	Structure Of Pkb-Beta (Akt2) Complexed With Isoquin		7e-20
2f7e_E	351	Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu		8e-20
1cmk_E	350	Crystal Structures Of The Myristylated Catalytic Su		8e-20
1gzk_A	315	Molecular Mechanism For The Regulation Of Protein K		8e-20
1o6l_A	337	Crystal Structure Of An Activated Akt/protein Kinas		8e-20
1ctp_E	350	Structure Of The Mammalian Catalytic Subunit Of Cam		8e-20
3dnd_A	350	Camp-Dependent Protein Kinase Pka Catalytic Subunit		8e-20
3ocb_A	341	Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor		8e-20
1gzn_A	335	Structure Of Pkb Kinase Domain Length = 335		8e-20
1mrv_A	339	Crystal Structure Of An Inactive Akt2 Kinase Domain		9e-20
4ae6_A	343	Structure And Function Of The Human Sperm-specific		9e-20
3o96_A	446	Crystal Structure Of Human Akt1 With An Allosteric		9e-20
4ae9_A	343	Structure And Function Of The Human Sperm-specific		9e-20
4ejn_A	446	Crystal Structure Of Autoinhibited Form Of Akt1 In		9e-20
3cqu_A	342	Crystal Structure Of Akt-1 Complexed With Substrate		9e-20
3agm_A	351	Complex Of Pka With The Bisubstrate Protein Kinase		9e-20
2r5t_A	373	Crystal Structure Of Inactive Serum And Glucocortic		9e-20
3nx8_A	351	Human Camp Dependent Protein Kinase In Complex With		1e-19
3l9m_A	351	Crystal Structure Of Pkab3 (Pka Triple Mutant V123a		1e-19
3mvj_A	371	Human Cyclic Amp-Dependent Protein Kinase Pka Inhib		1e-19
1o6k_A	336	Structure Of Activated Form Of Pkb Kinase Domain S4		1e-19
1svh_A	350	Crystal Structure Of Protein Kinase A In Complex Wi		1e-19
1q61_A	350	Pka Triple Mutant Model Of Pkb Length = 350		1e-19
2c1a_A	351	Structure Of Camp-Dependent Protein Kinase Complexe		1e-19
3agl_A	351	Complex Of Pka With The Bisubstrate Protein Kinase		1e-19
3e87_A	335	Crystal Structures Of The Kinase Domain Of Akt2 In		1e-19
2vrx_A	285	Structure Of Aurora B Kinase In Complex With Zm4474		1e-19
1xh9_A	350	Crystal Structures Of Protein Kinase B Selective In		1e-19
1rdq_E	350	Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of		1e-19
2jds_A	351	Structure Of Camp-Dependent Protein Kinase Complexe		1e-19
2bfx_B	284	Mechanism Of Aurora-B Activation By Incenp And Inhi		1e-19
1szm_A	350	Dual Binding Mode Of Bisindolylmaleimide 2 To Prote		1e-19
1stc_E	350	Camp-Dependent Protein Kinase, Alpha-Catalytic Subu		1e-19
2bfy_A	284	Complex Of Aurora-B With Incenp And Hesperidin. Len		1e-19
3qal_E	350	Crystal Structure Of Arg280ala Mutant Of Catalytic		1e-19
1q8w_A	350	The Catalytic Subunit Of Camp-Dependent Protein Kin		1e-19
1xh7_A	350	Crystal Structures Of Protein Kinase B Selective In		1e-19
3qam_E	350	Crystal Structure Of Glu208ala Mutant Of Catalytic		1e-19
4fr4_A	384	Crystal Structure Of Human SerineTHREONINE-Protein		1e-19
2z7q_A	321	Crystal Structure Of The N-Terminal Kinase Domain O		2e-19
4fg7_A	293	Crystal Structure Of Human Calcium/calmodulin-depen		2e-19
3qc9_A	543	Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4		3e-19
4aaa_A	331	Crystal Structure Of The Human Cdkl2 Kinase Domain		3e-19
3t8o_A	543	Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu		3e-19
1q24_A	350	Pka Double Mutant Model Of Pkb In Complex With Mgat		3e-19
2jdt_A	351	Structure Of Pka-Pkb Chimera Complexed With Isoquin		3e-19
3udb_A	317	Crystal Structure Of Snrk2.6 Length = 317		3e-19
2qr8_A	342	2.0a X-ray Structure Of C-terminal Kinase Domain Of		3e-19
3c4x_A	543	Crystal Structure Of G Protein Coupled Receptor Kin		3e-19
3c4w_A	543	Crystal Structure Of G Protein Coupled Receptor Kin		3e-19
2vo0_A	351	Structure Of Pka-Pkb Chimera Complexed With C-(4-(4		3e-19
1smh_A	350	Protein Kinase A Variant Complex With Completely Or		3e-19
4fg8_A	315	Crystal Structure Of Human Calcium/calmodulin-depen		3e-19
2uvy_A	351	Structure Of Pka-pkb Chimera Complexed With Methyl-		3e-19
3bhy_A	283	Crystal Structure Of Human Death Associated Protein		3e-19
4fg9_A	320	Crystal Structure Of Human Calcium/calmodulin-depen		4e-19
1yrp_A	278	Catalytic Domain Of Human Zip Kinase Phosphorylated		4e-19
2j90_A	304	Crystal Structure Of Human Zip Kinase In Complex Wi		4e-19
3uc4_A	362	The Crystal Structure Of Snf1-Related Kinase 2.6 Le		5e-19
3ujg_A	361	Crystal Structure Of Snrk2.6 In Complex With Hab1 L		6e-19
3iw4_A	360	Crystal Structure Of Pkc Alpha In Complex With Nvp-		6e-19
3i7c_A	484	Calcium-Dependent Protein Kinase 1 From Toxoplasma		8e-19
1a06_A	332	Calmodulin-Dependent Protein Kinase From Rat Length		9e-19
3uc3_A	361	The Crystal Structure Of Snf1-Related Kinase 2.3 Le		9e-19
3hgk_A	327	Crystal Structure Of Effect Protein Avrptob Complex		1e-18
3q5i_A	504	Crystal Structure Of Pbanka_031420 Length = 504		1e-18
2jed_A	352	The Crystal Structure Of The Kinase Domain Of The P		1e-18
2qkw_B	321	Structural Basis For Activation Of Plant Immunity B		1e-18
3niz_A	311	Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5		2e-18
2qkr_A	313	Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5		2e-18
3rzf_A	677	Crystal Structure Of Inhibitor Of Kappab Kinase Bet		2e-18
3qa8_A	676	Crystal Structure Of Inhibitor Of Kappa B Kinase Be		2e-18
1zws_A	288	Crystal Structure Of The Catalytic Domain Of Human		2e-18
3cik_A	689	Human Grk2 In Complex With Gbetagamma Subunits Leng		3e-18
1z9x_A	321	Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal		3e-18
3krw_A	688	Human Grk2 In Complex With Gbetgamma Subunits And B		3e-18
2a2a_A	321	High-resolution Crystallographic Analysis Of The Au		3e-18
1omw_A	689	Crystal Structure Of The Complex Between G Protein-		3e-18
3psc_A	695	Bovine Grk2 In Complex With Gbetagamma Subunits Len		3e-18
2qr7_A	342	2.0a X-Ray Structure Of C-Terminal Kinase Domain Of		3e-18
3rny_A	346	Crystal Structure Of Human Rsk1 C-Terminal Kinase D		3e-18
2a27_A	321	Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal		3e-18
2ya9_A	361	Crystal Structure Of The Autoinhibited Form Of Mous		4e-18
2wnt_A	330	Crystal Structure Of The Human Ribosomal Protein S6		4e-18
1wmk_A	321	Human Death-Associated Kinase Drp-1, Mutant S308d D		4e-18
3is5_A	285	Crystal Structure Of Cdpk Kinase Domain From Toxopl		4e-18
2dyl_A	318	Crystal Structure Of Human Mitogen-Activated Protei		4e-18
3mfr_A	351	Cask-4m Cam Kinase Domain, Native Length = 351		5e-18
3zut_A	362	The Structure Of Ost1 (D160a) Kinase Length = 362		5e-18
3fme_A	290	Crystal Structure Of Human Mitogen-Activated Protei		6e-18
1xjd_A	345	Crystal Structure Of Pkc-Theta Complexed With Staur		6e-18
4fvp_A	289	Crystal Structure Of The Jak2 Pseudokinase Domain (		8e-18
3zuu_A	362	The Structure Of Ost1 (D160a, S175d) Kinase In Comp		1e-17
2a19_B	284	Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng		2e-17
2zv2_A	298	Crystal Structure Of Human CalciumCALMODULIN-Depend		2e-17
4fvr_A	289	Crystal Structure Of The Jak2 Pseudokinase Domain M		2e-17
3pfq_A	674	Crystal Structure And Allosteric Activation Of Prot		2e-17
1zrz_A	364	Crystal Structure Of The Catalytic Domain Of Atypic		4e-17
3uiu_A	306	Crystal Structure Of Apo-Pkr Kinase Domain Length =		4e-17
4agu_A	311	Crystal Structure Of The Human Cdkl1 Kinase Domain		4e-17
3nyn_A	576	Crystal Structure Of G Protein-Coupled Receptor Kin		4e-17
2i0e_A	353	Structure Of Catalytic Domain Of Human Protein Kina		4e-17
2acx_A	576	Crystal Structure Of G Protein Coupled Receptor Kin		4e-17
3zh8_A	349	A Novel Small Molecule Apkc Inhibitor Length = 349		5e-17
3sls_A	304	Crystal Structure Of Human Mek-1 Kinase In Complex		5e-17
3a8w_A	345	Crystal Structure Of Pkciota Kinase Domain Length =		5e-17
2w4j_A	277	X-Ray Structure Of A Dap-Kinase 2-277 Length = 277		9e-17
4dc2_A	396	Structure Of Pkc In Complex With A Substrate Peptid		9e-17
2yak_A	285	Structure Of Death-Associated Protein Kinase 1 (Dap		9e-17
1wvw_A	278	Crystal Structures Of Kinase Domain Of Dap Kinase I		9e-17
2y0a_A	326	Structure Of Dapk1 Construct Residues 1-304 Length		9e-17
4an2_A	301	Crystal Structures Of Human Mek1 With Carboxamide-B		9e-17
3gu4_A	295	Crystal Structure Of Dapkq23v-Amppnp Length = 295		9e-17
3zgw_A	347	Crystal Structure Of Maternal Embryonic Leucine Zip		9e-17
2x0g_A	334	X-ray Structure Of A Dap-kinase Calmodulin Complex		9e-17
3dfc_B	295	Crystal Structure Of A Glycine-Rich Loop Mutant Of		1e-16
1p4f_A	293	Death Associated Protein Kinase Catalytic Domain Wi		1e-16
1ig1_A	294	1.8a X-Ray Structure Of Ternary Complex Of A Cataly		1e-16
3f5u_A	295	Crystal Structure Of The Death Associated Protein K		1e-16
3f3z_A	277	Crystal Structure Of Cryptosporidium Parvum Calcium		1e-16
2xzs_A	312	Death Associated Protein Kinase 1 Residues 1-312 Le		1e-16
3gu8_A	295	Crystal Structure Of Dapkl93g With N6-Cyclopentylad		1e-16
2w4k_A	302	X-Ray Structure Of A Dap-Kinase 2-302 Length = 302		1e-16
2qg5_A	294	Cryptosporidium Parvum Calcium Dependent Protein Ki		1e-16
2xuu_A	334	Crystal Structure Of A Dap-Kinase 1 Mutant Length =		1e-16
3cok_A	278	Crystal Structure Of Plk4 Kinase Length = 278		2e-16
2w4o_A	349	Crystal Structure Of Human Camk4 In Complex With 4-		2e-16
4af3_A	292	Human Aurora B Kinase In Complex With Incenp And Vx		2e-16
2y7j_A	365	Structure Of Human Phosphorylase Kinase, Gamma 2 Le		2e-16
4eut_A	396	Structure Of Bx-795 Complexed With Unphosphorylated		3e-16
3g2f_A	336	Crystal Structure Of The Kinase Domain Of Bone Morp		3e-16
3tac_A	361	Crystal Structure Of The Liprin-AlphaCASK COMPLEX L		4e-16
2jav_A	279	Human Kinase With Pyrrole-Indolinone Ligand Length		4e-16
3c0g_A	351	Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Len		4e-16
4fsz_A	279	Crystal Structure Of The Chk1 Length = 279		5e-16
2x4f_A	373	The Crystal Structure Of The Human Myosin Light Cha		5e-16
2ydj_A	276	Discovery Of Checkpoint Kinase Inhibitor Azd7762 By		5e-16
4fsy_A	279	Crystal Structure Of The Chk1 Length = 279		5e-16
2br1_A	297	Structure-Based Design Of Novel Chk1 Inhibitors: In		6e-16
1ia8_A	289	The 1.7 A Crystal Structure Of Human Cell Cycle Che		6e-16
1zlt_A	295	Crystal Structure Of Chk1 Complexed With A Hymenald		6e-16
4a4x_A	279	Nek2-Ede Bound To Cct248662 Length = 279		6e-16
2r0u_A	323	Crystal Structure Of Chek1 In Complex With Inhibito		6e-16
2hog_A	322	Crystal Structure Of Chek1 In Complex With Inhibito		6e-16
2ghg_A	269	H-Chk1 Complexed With A431994 Length = 269		6e-16
4fst_A	269	Crystal Structure Of The Chk1 Length = 269		7e-16
4ft3_A	279	Crystal Structure Of The Chk1 Length = 279		7e-16
4fsn_A	278	Crystal Structure Of The Chk1 Length = 278		7e-16
3ot3_A	273	X-Ray Crystal Structure Of Compound 22k Bound To Hu		7e-16
2ayp_A	269	Crystal Structure Of Chk1 With An Indol Inhibitor L		7e-16
4fsw_A	279	Crystal Structure Of The Chk1 Length = 279		7e-16
2e9v_A	268	Structure Of H-Chk1 Complexed With A859017 Length =		7e-16
2p55_A	333	X-Ray Structure Of The Human Mitogen-Activated Prot		7e-16
3jvr_A	271	Characterization Of The Chk1 Allosteric Inhibitor B		7e-16
2x8e_A	276	Discovery Of A Novel Class Of Triazolones As Checkp		7e-16
4fsm_A	279	Crystal Structure Of The Chk1 Length = 279		7e-16
1s9j_A	341	X-Ray Structure Of The Human Mitogen-Activated Prot		8e-16
1kob_A	387	Twitchin Kinase Fragment (Aplysia), Autoregulated P		8e-16
2y4i_C	395	Ksr2-Mek1 Heterodimer Length = 395		8e-16
3mbl_A	328	Crystal Structure Of The Human Mitogen-Activated Pr		8e-16
3dv3_A	322	Mek1 With Pf-04622664 Bound Length = 322		8e-16
1ua2_A	346	Crystal Structure Of Human Cdk7 Length = 346		8e-16
4ec8_A	373	Structure Of Full Length Cdk9 In Complex With Cycli		9e-16
3mi9_A	351	Crystal Structure Of Hiv-1 Tat Complexed With Human		9e-16
2biy_A	310	Structure Of Pdk1-S241a Mutant Kinase Domain Length		9e-16
3orn_A	307	Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In		9e-16
3eqc_A	360	X-Ray Structure Of The Human Mitogen-Activated Prot		9e-16
3pwy_A	311	Crystal Structure Of An Extender (Spd28345)-Modifie		9e-16
4bcf_A	331	Structure Of Cdk9 In Complex With Cyclin T And A 2-		1e-15
3blh_A	331	Crystal Structure Of Human Cdk9CYCLINT1 Length = 33		1e-15
3txo_A	353	Pkc Eta Kinase In Complex With A Naphthyridine Leng		1e-15
2pk9_A	317	Structure Of The Pho85-pho80 Cdk-cyclin Complex Of		1e-15
2w5a_A	279	Human Nek2 Kinase Adp-Bound Length = 279		1e-15
4euu_A	319	Structure Of Bx-795 Complexed With Human Tbk1 Kinas		1e-15
1koa_A	491	Twitchin Kinase Fragment (C.Elegans), Autoregulated		1e-15
1zy4_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		1e-15
3nax_A	311	Pdk1 In Complex With Inhibitor Mp7 Length = 311		2e-15
3uto_A	573	Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-		2e-15
1s9i_A	354	X-Ray Structure Of The Human Mitogen-Activated Prot		2e-15
1zys_A	273	Co-Crystal Structure Of Checkpoint Kinase Chk1 With		2e-15
2r7b_A	312	Crystal Structure Of The Phosphoinositide-Dependent		2e-15
2fsl_X	367	Mitogen Activated Protein Kinase P38alpha (D176a+f3		2e-15
2fso_X	367	Mitogen Activated Protein Kinase P38alpha (D176a) A		3e-15
2fst_X	367	Mitogen Activated Protein Kinase P38alpha (d176a+f3		3e-15
3nay_A	311	Pdk1 In Complex With Inhibitor Mp6 Length = 311		3e-15
3nun_A	292	Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea		3e-15
2xck_A	309	Crystal Structure Of Pdk1 In Complex With A Pyrazol		3e-15
1uu3_A	310	Structure Of Human Pdk1 Kinase Domain In Complex Wi		3e-15
2xch_A	309	Crystal Structure Of Pdk1 In Complex With A Pyrazol		3e-15
3rwp_A	311	Discovery Of A Novel, Potent And Selective Inhibito		3e-15
3nus_A	286	Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra		3e-15
3sc1_A	311	Novel Isoquinolone Pdk1 Inhibitors Discovered Throu		3e-15
1z5m_A	286	Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr		3e-15
3orx_A	316	Pdk1 Mutant Bound To Allosteric Disulfide Fragment		3e-15
3h9o_A	311	Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1)		3e-15
2v7o_A	336	Crystal Structure Of Human Calcium-Calmodulin-Depen		3e-15
1bi8_A	326	Mechanism Of G1 Cyclin Dependent Kinase Inhibition		3e-15
3vum_A	370	Crystal Structure Of A Cysteine-deficient Mutant M7		3e-15
3iop_A	312	Pdk-1 In Complex With The Inhibitor Compound-8i Len		3e-15
3vul_A	370	Crystal Structure Of A Cysteine-deficient Mutant M1		3e-15
1uu9_A	286	Structure Of Human Pdk1 Kinase Domain In Complex Wi		3e-15
1jow_B	308	Crystal Structure Of A Complex Of Human Cdk6 And A		3e-15
3d83_A	360	Crystal Structure Of P38 Kinase In Complex With A B		4e-15
3enm_A	316	The Structure Of The Map2k Mek6 Reveals An Autoinhi		4e-15
1h1w_A	289	High Resolution Crystal Structure Of The Human Pdk1		4e-15
4fsu_A	279	Crystal Structure Of The Chk1 Length = 279		4e-15
3nup_A	307	Cdk6 (Monomeric) In Complex With Inhibitor Length =		4e-15
2oza_B	366	Structure Of P38alpha Complex Length = 366		4e-15
1ove_A	366	The Structure Of P38 Alpha In Complex With A Dihydr		4e-15
4a07_A	311	Human Pdk1 Kinase Domain In Complex With Allosteric		4e-15
3p4k_A	370	The Third Conformation Of P38a Map Kinase Observed		4e-15
3tg1_A	380	Crystal Structure Of P38alpha In Complex With A Map		5e-15
3d7z_A	360	Crystal Structure Of P38 Kinase In Complex With A B		5e-15
1bmk_A	379	The Complex Structure Of The Map Kinase P38SB218655		5e-15
1lew_A	360	Crystal Structure Of Map Kinase P38 Complexed To Th		5e-15
2gtm_A	348	Mutated Mouse P38 Map Kinase Domain In Complex With		5e-15
2y8o_A	362	Crystal Structure Of Human P38alpha Complexed With		5e-15
3qc4_A	314	Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length =		5e-15
3v3v_A	379	Structural And Functional Analysis Of Quercetagetin		5e-15
2buj_A	317	Crystal Structure Of The Human Serine-Threonine Kin		6e-15
2ac5_A	316	Structure Of Human Mnk2 Kinase Domain Mutant D228g		7e-15
3nnx_A	354	Crystal Structure Of Phosphorylated P38 Alpha In Co		7e-15
4e5a_X	360	The W197a Mutant Of P38a Map Kinase Length = 360		7e-15
3e92_A	371	Crystal Structure Of P38 Kinase In Complex With A B		8e-15
1ql6_A	298	The Catalytic Mechanism Of Phosphorylase Kinase Pro		8e-15
2bal_A	365	P38alpha Map Kinase Bound To Pyrazoloamine Length =		8e-15
4exu_A	371	Mapk13, Inactive Form Length = 371		8e-15
3fi4_A	372	P38 Kinase Crystal Structure In Complex With Ro4499		8e-15
1phk_A	298	Two Structures Of The Catalytic Domain Of Phosphory		8e-15
3gcp_A	360	Human P38 Map Kinase In Complex With Sb203580 Lengt		8e-15
3hrc_A	311	Crystal Structure Of A Mutant Of Human Pdk1 Kinase		8e-15
3kq7_A	380	Structure Of Human P38alpha With N-[4-Methyl-3-(6-{		9e-15
3coi_A	353	Crystal Structure Of P38delta Kinase Length = 353		9e-15
2phk_A	277	The Crystal Structure Of A Phosphorylase Kinase Pep		9e-15
3dt1_A	383	P38 Complexed With A Quinazoline Inhibitor Length =		9e-15
3od6_X	360	Crystal Structure Of P38alpha Y323t Active Mutant L		9e-15
2lgc_A	359	Joint Nmr And X-Ray Refinement Reveals The Structur		9e-15
1ian_A	366	Human P38 Map Kinase Inhibitor Complex Length = 366		1e-14
1oz1_A	372	P38 Mitogen-Activated Kinase In Complex With 4-Azai		1e-14
3hvc_A	362	Crystal Structure Of Human P38alpha Map Kinase Leng		1e-14
2gfs_A	372	P38 Kinase Crystal Structure In Complex With Ro3201		1e-14
3mpt_A	371	Crystal Structure Of P38 Kinase In Complex With A P		1e-14
1m7q_A	366	Crystal Structure Of P38 Map Kinase In Complex With		1e-14
3ody_X	360	Crystal Structure Of P38alpha Y323q Active Mutant L		1e-14
1bl6_A	379	The Complex Structure Of The Map Kinase P38SB216995		1e-14
3zsg_A	362	X-Ray Structure Of P38alpha Bound To Tak-715 Length		1e-14
3odz_X	360	Crystal Structure Of P38alpha Y323r Active Mutant L		1e-14
2wtk_C	305	Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2		1e-14
1zzl_A	351	Crystal Structure Of P38 With Triazolopyridine Leng		1e-14
3nnu_A	354	Crystal Structure Of P38 Alpha In Complex With Dp13		1e-14
3gcu_A	360	Human P38 Map Kinase In Complex With Rl48 Length =		1e-14
3k3i_A	350	P38alpha Bound To Novel Dgf-Out Compound Pf-0021595		1e-14
3hec_A	348	P38 In Complex With Imatinib Length = 348		1e-14
2baj_A	365	P38alpha Bound To Pyrazolourea Length = 365		1e-14
3oef_X	360	Crystal Structure Of Y323f Inactive Mutant Of P38al		1e-14
3k3j_A	362	P38alpha Bound To Novel Dfg-Out Compound Pf-0041612		1e-14
3hrb_A	359	P38 Kinase Crystal Structure In Complex With Small		1e-14
3vuk_A	370	Crystal Structure Of A Cysteine-deficient Mutant M5		1e-14
2baq_A	365	P38alpha Bound To Ro3201195 Length = 365		1e-14
3s3i_A	349	P38 Kinase Crystal Structure In Complex With Small		1e-14
1di9_A	360	The Structure Of P38 Mitogen-Activated Protein Kina		1e-14
2npq_A	367	A Novel Lipid Binding Site In The P38 Alpha Map Kin		1e-14
3vui_A	370	Crystal Structure Of A Cysteine-deficient Mutant M2		1e-14
3py3_A	380	Crystal Structure Of Phosphorylated P38alpha Map Ki		1e-14
1zyc_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		1e-14
2puu_A	348	Crystal Structure Of P38 Complex With 1-(5-Tert-But		2e-14
1v0o_A	288	Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho		2e-14
3vuh_A	370	Crystal Structure Of A Cysteine-deficient Mutant M3		2e-14
1v0b_A	288	Crystal Structure Of The T198a Mutant Of Pfpk5 Leng		2e-14
1cm8_A	367	Phosphorylated Map Kinase P38-Gamma Length = 367		2e-14
1ob3_A	288	Structure Of P. Falciparum Pfpk5 Length = 288		2e-14
1yw2_A	360	Mutated Mus Musculus P38 Kinase (Mp38) Length = 360		2e-14
1ywr_A	360	Crystal Structure Analysis Of Inactive P38 Kinase D		2e-14
2ghl_A	348	Mutant Mus Musculus P38 Kinase Domain In Complex Wi		2e-14
2pml_X	348	Crystal Structure Of Pfpk7 In Complex With An Atp A		2e-14
4eoj_A	302	Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma		2e-14
3oht_A	389	Crystal Structure Of Salmo Salar P38alpha Length =		3e-14
3lm0_A	327	Crystal Structure Of Human SerineTHREONINE KINASE 1		3e-14
3e7o_A	360	Crystal Structure Of Jnk2 Length = 360		3e-14
4eok_A	300	Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma		3e-14
3mh2_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		3e-14
4azf_A	417	Human Dyrk2 In Complex With Leucettine L41 Length =		3e-14
2ac3_A	316	Structure Of Human Mnk2 Kinase Domain Length = 316		3e-14
1oit_A	299	Imidazopyridines: A Potent And Selective Class Of C		3e-14
3gni_B	389	Structure Of Strad And Mo25 Length = 389		3e-14
2wtk_B	373	Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2		3e-14
3vug_A	370	Crystal Structure Of A Cysteine-deficient Mutant M2		3e-14
1ukh_A	369	Structural Basis For The Selective Inhibition Of Jn		3e-14
3kvw_A	429	Crystal Structure Of Dual-Specificity Tyrosine Phos		3e-14
4eoi_A	299	Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc		3e-14
1pme_A	380	Structure Of Penta Mutant Human Erk2 Map Kinase Com		3e-14
2xrw_A	371	Linear Binding Motifs For Jnk And For Calcineurin A		3e-14
1vyw_A	309	Structure Of Cdk2CYCLIN A WITH PNU-292137 Length =		3e-14
4erw_A	306	Cdk2 In Complex With Staurosporine Length = 306		3e-14
1gz8_A	299	Human Cyclin Dependent Kinase 2 Complexed With The		3e-14
3vud_A	370	Crystal Structure Of A Cysteine-deficient Mutant M1		4e-14
1h4l_A	292	Structure And Regulation Of The Cdk5-P25(Nck5a) Com		4e-14
2cn5_A	329	Crystal Structure Of Human Chk2 In Complex With Adp		4e-14
2w0j_A	323	Crystal Structure Of Chk2 In Complex With Nsc 10955		4e-14
2xk9_A	322	Structural Analysis Of Checkpoint Kinase 2 (Chk2) I		4e-14
4ewq_A	383	Human P38 Alpha Mapk In Complex With A Pyridazine B		4e-14
3npc_A	364	Crystal Structure Of Jnk2 Complexed With Birb796 Le		4e-14
2vn9_A	301	Crystal Structure Of Human Calcium Calmodulin Depen		4e-14
2ycf_A	322	Crystal Structure Of Checkpoint Kinase 2 In Complex		4e-14
2wel_A	327	Crystal Structure Of Su6656-Bound CalciumCALMODULIN		4e-14
2ycr_A	323	Crystal Structure Of Checkpoint Kinase 2 In Complex		4e-14
3pxf_A	306	Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N		4e-14
3g33_A	308	Crystal Structure Of Cdk4CYCLIN D3 Length = 308		5e-14
3fi3_A	364	Crystal Structure Of Jnk3 With Indazole Inhibitor,		5e-14
3ezr_A	300	Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ		5e-14
2w17_A	299	Cdk2 In Complex With The Imidazole Pyrimidine Amide		5e-14
1fin_A	298	Cyclin A-Cyclin-Dependent Kinase 2 Complex Length =		5e-14
3pj8_A	299	Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]		5e-14
1pf8_A	298	Crystal Structure Of Human Cyclin-dependent Kinase		5e-14
1vzo_A	355	The Structure Of The N-Terminal Kinase Domain Of Ms		6e-14
3gi3_A	360	Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana		6e-14
3kk8_A	284	Camkii Substrate Complex A Length = 284		6e-14
3kl8_A	269	Camkiintide Inhibitor Complex Length = 269		6e-14
3i6w_A	443	Structure And Activation Mechanism Of The Chk2 Dna-		6e-14
3i6u_A	419	Structure And Activation Mechanism Of The Chk2 Dna-		6e-14
2bdw_A	362	Crystal Structure Of The Auto-Inhibited Kinase Doma		6e-14
3kk9_A	282	Camkii Substrate Complex B Length = 282		6e-14
3mtl_A	324	Crystal Structure Of The Pctaire1 Kinase In Complex		7e-14
3fv8_A	355	Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le		7e-14
4gsb_A	364	Monoclinic Crystal Form Of The Apo-Erk2 Length = 36		8e-14
3gc9_A	370	The Structure Of P38beta C119s, C162s In Complex Wi		8e-14
2w99_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		8e-14
3fi2_A	353	Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib		8e-14
1zxe_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		9e-14
3o8p_A	360	Conformational Plasticity Of P38 Map Kinase Dfg Mot		9e-14
3qyw_A	364	Crystal Structure Of Erk2 In Complex With An Inhibi		9e-14
3o17_A	370	Crystal Structure Of Jnk1-Alpha1 Isoform Length = 3		9e-14
3kvx_A	364	Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le		9e-14
4fux_A	360	Crystal Structure Of The Erk2 Complexed With E75 Le		1e-13
3k2l_A	429	Crystal Structure Of Dual-Specificity Tyrosine Phos		1e-13
4fv7_A	360	Crystal Structure Of The Erk2 Complexed With E94 Le		1e-13
3r1n_A	317	Mk3 Kinase Bound To Compound 5b Length = 317		1e-13
3zu7_A	365	Crystal Structure Of A Designed Selected Ankyrin Re		1e-13
3sa0_A	360	Complex Of Erk2 With Norathyriol Length = 360		1e-13
2z7l_A	366	Unphosphorylated Mitogen Activated Protein Kinase E		1e-13
3c9w_A	357	Crystal Structure Of Erk-2 With Hypothemycin Covale		1e-13
2fys_B	364	Crystal Structure Of Erk2 Complex With Kim Peptide		1e-13
2r9s_A	356	C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu		1e-13
3fhr_A	336	High Resolution Crystal Structure Of Mitogen-Activa		1e-13
1wzy_A	368	Crystal Structure Of Human Erk2 Complexed With A Py		1e-13
1tvo_A	368	The Structure Of Erk2 In Complex With A Small Molec		1e-13
3p23_A	432	Crystal Structure Of The Human Kinase And Rnase Dom		1e-13
3mh0_A	360	Mutagenesis Of P38 Map Kinase Eshtablishes Key Role		1e-13
3o71_A	358	Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length		1e-13
4fv6_A	360	Crystal Structure Of The Erk2 Complexed With E57 Le		1e-13
2ojg_A	380	Crystal Structure Of Erk2 In Complex With N,n-dimet		1e-13
3r63_A	358	Structure Of Erk2 (Spe) Mutant (S246e) Length = 358		1e-13
2y9q_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		1e-13
2w96_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		1e-13
3mh3_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		1e-13
3ttj_A	464	Crystal Structure Of Jnk3 Complexed With Cc-359, A		1e-13
1ung_A	292	Structural Mechanism For The Inhibition Of Cdk5-P25		1e-13
3mh1_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		1e-13
4h3q_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		1e-13
2w9f_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		2e-13
2iw6_A	302	Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com		2e-13
4eom_A	301	Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum		2e-13
4eon_A	300	Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum		2e-13
1gol_A	364	Coordinates Of Rat Map Kinase Erk2 With An Arginine		2e-13
3gc8_A	370	The Structure Of P38beta C162s In Complex With A Di		2e-13
1jnk_A	423	The C-Jun N-Terminal Kinase (Jnk3s) Complexed With		2e-13
2gph_A	364	Docking Motif Interactions In The Map Kinase Erk2 L		2e-13
1ogu_A	302	Structure Of Human Thr160-phospho Cdk2/cyclin A Com		2e-13
2g01_A	370	Pyrazoloquinolones As Novel, Selective Jnk1 Inhibit		2e-13
1h1p_A	303	Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP		2e-13
2xs0_A	386	Linear Binding Motifs For Jnk And For Calcineurin A		2e-13
4eoq_A	301	Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co		2e-13
4bcq_A	301	Structure Of Cdk2 In Complex With Cyclin A And A 2-		2e-13
1pmn_A	364	Crystal Structure Of Jnk3 In Complex With An Imidaz		2e-13
1oir_A	299	Imidazopyridines: A Potent And Selective Class Of C		2e-13
1h01_A	298	Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili		2e-13
3oxi_A	362	Design And Synthesis Of Disubstituted Thiophene And		2e-13
2ok1_A	365	Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3		2e-13
2o0u_A	364	Crystal Structure Of Human Jnk3 Complexed With N-{3		2e-13
1w98_A	298	The Structural Basis Of Cdk2 Activation By Cyclin E		2e-13
3ptg_A	363	Design And Synthesis Of A Novel, Orally Efficacious		2e-13
4eop_A	300	Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3		2e-13
1qmz_A	299	Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com		2e-13
1e9h_A	297	Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex		2e-13
4eoo_A	299	Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3		2e-13
4i3z_A	296	Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES		2e-13
1jst_A	298	Phosphorylated Cyclin-Dependent Kinase-2 Bound To C		2e-13
4eos_A	300	Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co		2e-13
2b1p_A	355	Inhibitor Complex Of Jnk3 Length = 355		2e-13
3bht_A	300	Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN		2e-13
4h36_A	356	Crystal Structure Of Jnk3 In Complex With Atf2 Pept		2e-13
2jgz_A	289	Crystal Structure Of Phospho-Cdk2 In Complex With C		2e-13
3qhr_A	298	Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic		2e-13
2exc_X	356	Inhibitor Complex Of Jnk3 Length = 356		2e-13
3ll6_A	337	Crystal Structure Of The Human Cyclin G Associated		3e-13
3tei_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		3e-13
2zoq_A	382	Structural Dissection Of Human Mitogen-Activated Ki		3e-13
3elj_A	369	Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine		3e-13
3pze_A	358	Jnk1 In Complex With Inhibitor Length = 358		3e-13
3zuv_A	364	Crystal Structure Of A Designed Selected Ankyrin Re		3e-13
2erk_A	365	Phosphorylated Map Kinase Erk2 Length = 365		3e-13
3hko_A	345	Crystal Structure Of A Cdpk Kinase Domain From Cryp		4e-13
3gp0_A	348	Crystal Structure Of Human Mitogen Activated Protei		4e-13
3qd2_B	332	Crsytal Structure Of Mouse Perk Kinase Domain Lengt		6e-13
1gii_A	298	Human Cyclin Dependent Kinase 2 Complexed With The		7e-13
4g31_A	299	Crystal Structure Of Gsk6414 Bound To Perk (R587-R1		8e-13
1yxs_A	293	Crystal Structure Of Kinase Pim1 With P123m Mutatio		8e-13
2vz6_A	313	Structure Of Human Calcium Calmodulin Dependent Pro		9e-13
2f2u_A	402	Crystal Structure Of The Rho-Kinase Kinase Domain L		2e-12
2i6l_A	320	Crystal Structure Of Human Mitogen Activated Protei		2e-12
3kn5_A	325	Crystal Structure Of The C-Terminal Kinase Domain O		3e-12
2iw8_A	302	Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82		3e-12
2p3g_X	327	Crystal Structure Of A Pyrrolopyridine Inhibitor Bo		4e-12
2jbo_A	326	Protein Kinase Mk2 In Complex With An Inhibitor (Cr		4e-12
3gok_A	334	Binding Site Mapping Of Protein Ligands Length = 33		4e-12
2onl_C	406	Crystal Structure Of The P38a-Mapkap Kinase 2 Heter		4e-12
3r2y_A	319	Mk2 Kinase Bound To Compound 1 Length = 319		4e-12
3r2b_A	318	Mk2 Kinase Bound To Compound 5b Length = 318		4e-12
2pzy_A	324	Structure Of Mk2 Complexed With Compound 76 Length		4e-12
3fpm_A	325	Crystal Structure Of A Squarate Inhibitor Bound To		4e-12
2hw6_A	307	Crystal Structure Of Mnk1 Catalytic Domain Length =		4e-12
1kwp_A	400	Crystal Structure Of Mapkap2 Length = 400		4e-12
2oza_A	356	Structure Of P38alpha Complex Length = 356		4e-12
4as0_A	273	Cyclometalated Phthalimides As Protein Kinase Inhib		4e-12
2esm_A	415	Crystal Structure Of Rock 1 Bound To Fasudil Length		4e-12
3v8s_A	410	Human Rho-Associated Protein Kinase 1 (Rock 1) In C		4e-12
2v55_A	406	Mechanism Of Multi-site Phosphorylation From A Rock		5e-12
3ka0_A	320	Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4		5e-12
3jpv_A	313	Crystal Structure Of Human Proto-Oncogene Serine Th		5e-12
2bil_B	313	The Human Protein Kinase Pim1 In Complex With Its C		5e-12
2j2i_B	312	Crystal Structure Of The Humab Pim1 In Complex With		5e-12
3cxw_A	314	Crystal Structure Of Human Proto-Oncogene Serine Th		5e-12
1yhs_A	273	Crystal Structure Of Pim-1 Bound To Staurosporine L		5e-12
3cy3_A	314	Crystal Structure Of Human Proto-Oncogene Serine Th		6e-12
3ma3_A	313	Crystal Structure Of Human Proto-Oncogene Serine Th		6e-12
2bik_B	313	Human Pim1 Phosphorylated On Ser261 Length = 313		6e-12
3jxw_A	294	Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-		7e-12
3c4e_A	273	Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7		7e-12
1ywv_A	293	Crystal Structures Of Proto-Oncogene Kinase Pim1: A		7e-12
1nxk_A	400	Crystal Structure Of Staurosporine Bound To Map Kap		8e-12
4dtk_A	276	Novel And Selective Pan-Pim Kinase Inhibitor Length		8e-12
3r00_A	299	The Discovery Of Novel Benzofuran-2-Carboxylic Acid		8e-12
3uix_A	298	Crystal Structure Of Pim1 Kinase In Complex With Sm		8e-12
4alv_A	328	Benzofuropyrimidinone Inhibitors Of Pim-1 Length =		8e-12
3a99_A	320	Structure Of Pim-1 Kinase Crystallized In The Prese		8e-12
1xws_A	313	Crystal Structure Of The Human Pim1 Kinase Domain L		9e-12
2xj0_A	301	Protein Kinase Pim-1 In Complex With Fragment-4 Fro		9e-12
3oz6_A	388	Crystal Structure Of Mapk From Cryptosporidium Parv		9e-12
1xqz_A	300	Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolut		9e-12
4a7c_A	308	Crystal Structure Of Pim1 Kinase With Etp46546 Leng		9e-12
3dcv_A	328	Crystal Structure Of Human Pim1 Kinase Complexed Wi		9e-12
3bhh_A	295	Crystal Structure Of Human Calcium/calmodulin-depen		1e-11
2xiy_A	301	Protein Kinase Pim-1 In Complex With Fragment-2 Fro		1e-11
2obj_A	333	Crystal Structure Of Human Pim-1 Kinase In Complex		1e-11
3f2a_A	300	Crystal Structure Of Human Pim-1 In Complex With Da		1e-11
3gbz_A	329	Structure Of The Cmgc Cdk Kinase From Giardia Lambl		1e-11
3uys_A	296	Crystal Structure Of Apo Human Ck1d Length = 296		2e-11
4g3f_A	336	Crystal Structure Of Murine Nf-kappab Inducing Kina		2e-11
4b99_A	398	Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le		2e-11
1ckj_A	317	Casein Kinase I Delta Truncation Mutant Containing		2e-11
3soa_A	444	Full-Length Human Camkii Length = 444		2e-11
4g3c_A	352	Crystal Structure Of Apo Murine Nf-kappab Inducing		2e-11
3dls_A	335	Crystal Structure Of Human Pas Kinase Bound To Adp		2e-11
2xix_A	301	Protein Kinase Pim-1 In Complex With Fragment-1 Fro		2e-11
4e7w_A	394	Structure Of Gsk3 From Ustilago Maydis Length = 394		2e-11
4ic7_A	442	Crystal Structure Of The Erk5 Kinase Domain In Comp		2e-11
4dn5_A	356	Crystal Structure Of Nf-kb-inducing Kinase (nik) Le		3e-11
4g3d_A	371	Crystal Structure Of Human Nf-kappab Inducing Kinas		3e-11
4g3g_A	350	Crystal Structure Of Murine Nf-kappab Inducing Kina		4e-11
2f9g_A	353	Crystal Structure Of Fus3 Phosphorylated On Tyr182		5e-11
2iwi_A	312	Crystal Structure Of The Human Pim2 In Complex With		6e-11
2b9f_A	353	Crystal Structure Of Non-Phosphorylated Fus3 Length		6e-11
4aw2_A	437	Crystal Structure Of Cdc42 Binding Protein Kinase A		7e-11
3f7z_A	350	X-ray Co-crystal Structure Of Glycogen Synthase Kin		8e-11
3zdi_A	350	Glycogen Synthase Kinase 3 Beta Complexed With Axin		8e-11
2ow3_A	352	Glycogen Synthase Kinase-3 Beta In Complex With Bis		8e-11
3gb2_A	353	Gsk3beta Inhibitor Complex Length = 353		8e-11
3zrk_A	371	Identification Of 2-(4-Pyridyl)thienopyridinones As		1e-10
1gng_A	378	Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With		1e-10
4afj_A	367	5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec		1e-10
3f88_A	349	Glycogen Synthase Kinase 3beta Inhibitor Complex Le		1e-10
4dit_A	382	Crystal Structure Of Gsk3beta In Complex With A Imi		1e-10
3sd0_A	350	Identification Of A Glycogen Synthase Kinase-3b Inh		1e-10
1uv5_A	350	Glycogen Synthase Kinase 3 Beta Complexed With 6-Br		1e-10

>pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309

Iteration: 1
 Score =  238 bits (608), Expect = 3e-63,   Method: Compositional matrix adjust.
 Identities = 118/272 (43%), Positives = 181/272 (66%), Gaps = 6/272 (2%)
Query: 106 DGTDVWEIDAKQLKIECKVASGSYGDLYKGTYCSQEVAIKVLKPECVNTEMLKEFSQEVY 165
           DG D+ +I    L I+ K+ +GS+G +++  +   +VA+K+L  +  + E + EF +EV 
Sbjct: 28  DGDDM-DIPWCDLNIKEKIGAGSFGTVHRAEWHGSDVAVKILMEQDFHAERVNEFLREVA 86
Query: 166 IMRKIRHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSL--LKVAIDV 223
           IM+++RH N+V F+GA T+PPNL IVTE+++RGS+Y  LHK     QL     L +A DV
Sbjct: 87  IMKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDV 146
Query: 224 SKGMNYLHQNN--IIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMT-AETGTYRWM 280
           +KGMNYLH  N  I+HRDLK+ NLL+D+   VKV DFG++R++A   + +    GT  WM
Sbjct: 147 AKGMNYLHNRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKASXFLXSKXAAGTPEWM 206
Query: 281 APEVIEHKPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKSLRPTIPKHAHP 340
           APEV+  +P + K+DV+SFG+ LWEL T + P+  L P Q    V  K  R  IP++ +P
Sbjct: 207 APEVLRDEPSNEKSDVYSFGVILWELATLQQPWGNLNPAQVVAAVGFKCKRLEIPRNLNP 266
Query: 341 RLAELLERCWQHDPTQRPNFSQITDILKQMMK 372
           ++A ++E CW ++P +RP+F+ I D+L+ ++K
Sbjct: 267 QVAAIIEGCWTNEPWKRPSFATIMDLLRPLIK 298

>pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309

Iteration: 1
 Score =  238 bits (607), Expect = 4e-63,   Method: Compositional matrix adjust.
 Identities = 117/272 (43%), Positives = 183/272 (67%), Gaps = 6/272 (2%)
Query: 106 DGTDVWEIDAKQLKIECKVASGSYGDLYKGTYCSQEVAIKVLKPECVNTEMLKEFSQEVY 165
           DG D+ +I    L I+ K+ +GS+G +++  +   +VA+K+L  +  + E + EF +EV 
Sbjct: 28  DGDDM-DIPWCDLNIKEKIGAGSFGTVHRAEWHGSDVAVKILMEQDFHAERVNEFLREVA 86
Query: 166 IMRKIRHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSL--LKVAIDV 223
           IM+++RH N+V F+GA T+PPNL IVTE+++RGS+Y  LHK     QL     L +A DV
Sbjct: 87  IMKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDV 146
Query: 224 SKGMNYLHQNN--IIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMT-AETGTYRWM 280
           +KGMNYLH  N  I+HR+LK+ NLL+D+   VKV DFG++R++A + + + +  GT  WM
Sbjct: 147 AKGMNYLHNRNPPIVHRNLKSPNLLVDKKYTVKVCDFGLSRLKASTFLSSKSAAGTPEWM 206
Query: 281 APEVIEHKPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKSLRPTIPKHAHP 340
           APEV+  +P + K+DV+SFG+ LWEL T + P+  L P Q    V  K  R  IP++ +P
Sbjct: 207 APEVLRDEPSNEKSDVYSFGVILWELATLQQPWGNLNPAQVVAAVGFKCKRLEIPRNLNP 266
Query: 341 RLAELLERCWQHDPTQRPNFSQITDILKQMMK 372
           ++A ++E CW ++P +RP+F+ I D+L+ ++K
Sbjct: 267 QVAAIIEGCWTNEPWKRPSFATIMDLLRPLIK 298

>pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280

Iteration: 1
 Score =  194 bits (492), Expect = 1e-49,   Method: Compositional matrix adjust.
 Identities = 101/280 (36%), Positives = 172/280 (61%), Gaps = 12/280 (4%)
Query: 106 DGTDVWEIDAKQLKIECKVASGSYGDLYKGTYCSQEVAIKVLKPECVNTEMLKEFSQEVY 165
           D +D WEI   Q+ +  ++ SGS+G +YKG +   +VA+K+L       + L+ F  EV 
Sbjct: 2   DSSDDWEIPDGQITVGQRIGSGSFGTVYKGKWHG-DVAVKMLNVTAPTPQQLQAFKNEVG 60
Query: 166 IMRKIRHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSK 225
           ++RK RH N++ F+G  T+P  L IVT++    S+Y  LH  +  F++  L+ +A   ++
Sbjct: 61  VLRKTRHVNILLFMGYSTKP-QLAIVTQWCEGSSLYHHLHASETKFEMKKLIDIARQTAR 119
Query: 226 GMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQ-SGVMTAE--TGTYRWMAP 282
           GM+YLH  +IIHRDLK+ N+ + E+  VK+ DFG+A V+++ SG    E  +G+  WMAP
Sbjct: 120 GMDYLHAKSIIHRDLKSNNIFLHEDNTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAP 179
Query: 283 EVI---EHKPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQK-SLRPTIPK-- 336
           EVI   +  PY +++DV++FGI L+EL+TG+LPY+ +      + +V + SL P + K  
Sbjct: 180 EVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIEMVGRGSLSPDLSKVR 239
Query: 337 -HAHPRLAELLERCWQHDPTQRPNFSQITDILKQMMKEVA 375
            +   R+  L+  C +    +RP+F +I   ++++ +E++
Sbjct: 240 SNCPKRMKRLMAECLKKKRDERPSFPRILAEIEELARELS 279

>pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292

Iteration: 1
 Score =  191 bits (485), Expect = 6e-49,   Method: Compositional matrix adjust.
 Identities = 100/280 (35%), Positives = 171/280 (61%), Gaps = 12/280 (4%)
Query: 106 DGTDVWEIDAKQLKIECKVASGSYGDLYKGTYCSQEVAIKVLKPECVNTEMLKEFSQEVY 165
           D +D WEI   Q+ +  ++ SGS+G +YKG +   +VA+K+L       + L+ F  EV 
Sbjct: 14  DSSDDWEIPDGQITVGQRIGSGSFGTVYKGKWHG-DVAVKMLNVTAPTPQQLQAFKNEVG 72
Query: 166 IMRKIRHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSK 225
           ++RK RH N++ F+G  T+P  L IVT++    S+Y  LH  +  F++  L+ +A   ++
Sbjct: 73  VLRKTRHVNILLFMGYSTKP-QLAIVTQWCEGSSLYHHLHASETKFEMKKLIDIARQTAR 131
Query: 226 GMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQ-SGVMTAE--TGTYRWMAP 282
           GM+YLH  +IIHRDLK+ N+ + E+  VK+ DFG+A  +++ SG    E  +G+  WMAP
Sbjct: 132 GMDYLHAKSIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAP 191
Query: 283 EVI---EHKPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQK-SLRPTIPK-- 336
           EVI   +  PY +++DV++FGI L+EL+TG+LPY+ +      + +V + SL P + K  
Sbjct: 192 EVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIEMVGRGSLSPDLSKVR 251
Query: 337 -HAHPRLAELLERCWQHDPTQRPNFSQITDILKQMMKEVA 375
            +   R+  L+  C +    +RP+F +I   ++++ +E++
Sbjct: 252 SNCPKRMKRLMAECLKKKRDERPSFPRILAEIEELARELS 291

>pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293

Iteration: 1
 Score =  190 bits (483), Expect = 1e-48,   Method: Compositional matrix adjust.
 Identities = 103/289 (35%), Positives = 164/289 (56%), Gaps = 14/289 (4%)
Query: 109 DVWEIDAKQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVNTEMLKEFSQEVYI 166
           D WE++   + ++ K+  G YG++Y+G +   S  VA+K LK + +  E   EF +E  +
Sbjct: 4   DKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE---EFLKEAAV 60
Query: 167 MRKIRHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHK-QKGVFQLTSLLKVAIDVSK 225
           M++I+H N+VQ +G CTR P   I+TEFM  G++ D+L +  +       LL +A  +S 
Sbjct: 61  MKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISS 120
Query: 226 GMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAETGT---YRWMAP 282
            M YL + N IHRDL   N L+ EN +VKVADFG++R+       TA  G     +W AP
Sbjct: 121 AMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMT-GDTFTAHAGAKFPIKWTAP 179
Query: 283 EVIEHKPYDYKADVFSFGIALWELLT-GELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPR 341
           E + +  +  K+DV++FG+ LWE+ T G  PY G+ P Q    +++K  R   P+    +
Sbjct: 180 ESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDPSQ-VYELLEKDYRMERPEGCPEK 238
Query: 342 LAELLERCWQHDPTQRPNFSQITDILKQMMKE--VASEGENNHSNKSAG 388
           + EL+  CWQ +P+ RP+F++I    + M +E  ++ E E     +  G
Sbjct: 239 VYELMRACWQWNPSDRPSFAEIHQAFETMFQESSISDEVEKELGKRGEG 287

>pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289

Iteration: 1
 Score =  189 bits (479), Expect = 3e-48,   Method: Compositional matrix adjust.
 Identities = 100/278 (35%), Positives = 167/278 (60%), Gaps = 12/278 (4%)
Query: 106 DGTDVWEIDAKQLKIECKVASGSYGDLYKGTYCSQEVAIKVLKPECVNTEMLKEFSQEVY 165
           D  D WEI   Q+ +  ++ SGS+G +YKG +   +VA+K+L       + L+ F  EV 
Sbjct: 14  DAADDWEIPDGQITVGQRIGSGSFGTVYKGKWHG-DVAVKMLNVTAPTPQQLQAFKNEVG 72
Query: 166 IMRKIRHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSK 225
           ++RK RH N++ F+G  T  P L IVT++    S+Y  LH  +  F++  L+ +A   ++
Sbjct: 73  VLRKTRHVNILLFMGYST-APQLAIVTQWCEGSSLYHHLHASETKFEMKKLIDIARQTAR 131
Query: 226 GMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQ-SGVMTAE--TGTYRWMAP 282
           GM+YLH  +IIHRDLK+ N+ + E+  VK+ DFG+A  +++ SG    E  +G+  WMAP
Sbjct: 132 GMDYLHAKSIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAP 191
Query: 283 EVI---EHKPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQK-SLRPTIPK-- 336
           EVI   +  PY +++DV++FGI L+EL+TG+LPY+ +      + +V + SL P + K  
Sbjct: 192 EVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIEMVGRGSLSPDLSKVR 251
Query: 337 -HAHPRLAELLERCWQHDPTQRPNFSQITDILKQMMKE 373
            +   R+  L+  C +    +RP+F +I   ++++ +E
Sbjct: 252 SNCPKRMKRLMAECLKKKRDERPSFPRILAEIEELARE 289

>pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293

Iteration: 1
 Score =  188 bits (478), Expect = 4e-48,   Method: Compositional matrix adjust.
 Identities = 102/289 (35%), Positives = 164/289 (56%), Gaps = 14/289 (4%)
Query: 109 DVWEIDAKQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVNTEMLKEFSQEVYI 166
           D WE++   + ++ K+  G +G++Y+G +   S  VA+K LK + +  E   EF +E  +
Sbjct: 4   DKWEMERTDITMKHKLGGGQFGEVYEGVWKKYSLTVAVKTLKEDTMEVE---EFLKEAAV 60
Query: 167 MRKIRHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHK-QKGVFQLTSLLKVAIDVSK 225
           M++I+H N+VQ +G CTR P   I+TEFM  G++ D+L +  +       LL +A  +S 
Sbjct: 61  MKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISS 120
Query: 226 GMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAETGT---YRWMAP 282
            M YL + N IHRDL   N L+ EN +VKVADFG++R+       TA  G     +W AP
Sbjct: 121 AMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMT-GDTXTAHAGAKFPIKWTAP 179
Query: 283 EVIEHKPYDYKADVFSFGIALWELLT-GELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPR 341
           E + +  +  K+DV++FG+ LWE+ T G  PY G+ P Q    +++K  R   P+    +
Sbjct: 180 ESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDPSQ-VYELLEKDYRMERPEGCPEK 238
Query: 342 LAELLERCWQHDPTQRPNFSQITDILKQMMKE--VASEGENNHSNKSAG 388
           + EL+  CWQ +P+ RP+F++I    + M +E  ++ E E     +  G
Sbjct: 239 VYELMRACWQWNPSDRPSFAEIHQAFETMFQESSISDEVEKELGKRGEG 287

>pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277

Iteration: 1
 Score =  188 bits (478), Expect = 4e-48,   Method: Compositional matrix adjust.
 Identities = 100/277 (36%), Positives = 159/277 (57%), Gaps = 12/277 (4%)
Query: 104 PTDGTDVWEIDAKQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVNTEMLKEFS 161
           P+   D WE++   + ++ K+  G YG++Y+G +   S  VA+K LK + +  E   EF 
Sbjct: 5   PSPNYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE---EFL 61
Query: 162 QEVYIMRKIRHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHK-QKGVFQLTSLLKVA 220
           +E  +M++I+H N+VQ +G CTR P   I+TEFM  G++ D+L +  +       LL +A
Sbjct: 62  KEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMA 121
Query: 221 IDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAETGT---Y 277
             +S  M YL + N IHRDL   N L+ EN +VKVADFG++R+       TA  G     
Sbjct: 122 TQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMT-GDTYTAHAGAKFPI 180
Query: 278 RWMAPEVIEHKPYDYKADVFSFGIALWELLT-GELPYAGLTPLQAAVGVVQKSLRPTIPK 336
           +W APE + +  +  K+DV++FG+ LWE+ T G  PY G+  L     +++K  R   P+
Sbjct: 181 KWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGID-LSQVYELLEKDYRMERPE 239
Query: 337 HAHPRLAELLERCWQHDPTQRPNFSQITDILKQMMKE 373
               ++ EL+  CWQ +P+ RP+F++I    + M +E
Sbjct: 240 GCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQE 276

>pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298

Iteration: 1
 Score =  187 bits (476), Expect = 6e-48,   Method: Compositional matrix adjust.
 Identities = 103/289 (35%), Positives = 162/289 (56%), Gaps = 20/289 (6%)
Query: 92  LLIESSPNCIEIPTDGTDVWEIDAKQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKP 149
           L  + SPN         D WE++   + ++ K+  G YG++Y+G +   S  VA+K LK 
Sbjct: 10  LYFQGSPN--------YDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKE 61
Query: 150 ECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHK-QK 208
           + +  E   EF +E  +M++I+H N+VQ +G CTR P   I+TEFM  G++ D+L +  +
Sbjct: 62  DTMEVE---EFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNR 118
Query: 209 GVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSG 268
                  LL +A  +S  M YL + N IHRDL   N L+ EN +VKVADFG++R+     
Sbjct: 119 QEVNAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMT-GD 177
Query: 269 VMTAETGT---YRWMAPEVIEHKPYDYKADVFSFGIALWELLT-GELPYAGLTPLQAAVG 324
             TA  G     +W APE + +  +  K+DV++FG+ LWE+ T G  PY G+  L     
Sbjct: 178 TYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGID-LSQVYE 236
Query: 325 VVQKSLRPTIPKHAHPRLAELLERCWQHDPTQRPNFSQITDILKQMMKE 373
           +++K  R   P+    ++ EL+  CWQ +P+ RP+F++I    + M +E
Sbjct: 237 LLEKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQE 285

>pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277

Iteration: 1
 Score =  187 bits (476), Expect = 6e-48,   Method: Compositional matrix adjust.
 Identities = 101/279 (36%), Positives = 161/279 (57%), Gaps = 14/279 (5%)
Query: 109 DVWEIDAKQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVNTEMLKEFSQEVYI 166
           D WE++   + ++ K+  G YG++Y+G +   S  VA+K LK + +  E   EF +E  +
Sbjct: 4   DKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE---EFLKEAAV 60
Query: 167 MRKIRHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHK-QKGVFQLTSLLKVAIDVSK 225
           M++I+H N+VQ +G CTR P   I+ EFM  G++ D+L +  +       LL +A  +S 
Sbjct: 61  MKEIKHPNLVQLLGVCTREPPFYIIIEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISS 120
Query: 226 GMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAETGT---YRWMAP 282
            M YL + N IHRDL   N L+ EN +VKVADFG++R+       TA  G     +W AP
Sbjct: 121 AMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMT-GDTXTAHAGAKFPIKWTAP 179
Query: 283 EVIEHKPYDYKADVFSFGIALWELLT-GELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPR 341
           E + +  +  K+DV++FG+ LWE+ T G  PY G+ P Q    +++K  R   P+    +
Sbjct: 180 ESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDPSQV-YELLEKDYRMERPEGCPEK 238
Query: 342 LAELLERCWQHDPTQRPNFSQITDILKQMMKE--VASEG 378
           + EL+  CWQ +P+ RP+F++I    + M +E  ++ EG
Sbjct: 239 VYELMRACWQWNPSDRPSFAEIHQAFETMFQESSISDEG 277

>pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293

Iteration: 1
 Score =  187 bits (474), Expect = 1e-47,   Method: Compositional matrix adjust.
 Identities = 103/285 (36%), Positives = 161/285 (56%), Gaps = 20/285 (7%)
Query: 96  SSPNCIEIPTDGTDVWEIDAKQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVN 153
           SSPN         D WE++   + ++ K+  G YG++Y+G +   S  VA+K LK + + 
Sbjct: 6   SSPN--------YDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME 57
Query: 154 TEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHK-QKGVFQ 212
            E   EF +E  +M++I+H N+VQ +G CTR P   I+TEFM  G++ D+L +  +    
Sbjct: 58  VE---EFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVN 114
Query: 213 LTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTA 272
              LL +A  +S  M YL + N IHRDL   N L+ EN +VKVADFG++R+       TA
Sbjct: 115 AVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMT-GDTYTA 173
Query: 273 ETGT---YRWMAPEVIEHKPYDYKADVFSFGIALWELLT-GELPYAGLTPLQAAVGVVQK 328
             G     +W APE + +  +  K+DV++FG+ LWE+ T G  PY G+  L     +++K
Sbjct: 174 HAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGID-LSQVYELLEK 232
Query: 329 SLRPTIPKHAHPRLAELLERCWQHDPTQRPNFSQITDILKQMMKE 373
             R   P+    ++ EL+  CWQ +P+ RP+F++I    + M +E
Sbjct: 233 DYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQE 277

>pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293

Iteration: 1
 Score =  187 bits (474), Expect = 1e-47,   Method: Compositional matrix adjust.
 Identities = 103/285 (36%), Positives = 161/285 (56%), Gaps = 20/285 (7%)
Query: 96  SSPNCIEIPTDGTDVWEIDAKQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVN 153
           SSPN         D WE++   + ++ K+  G YG++Y+G +   S  VA+K LK + + 
Sbjct: 6   SSPN--------YDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME 57
Query: 154 TEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHK-QKGVFQ 212
            E   EF +E  +M++I+H N+VQ +G CTR P   I+TEFM  G++ D+L +  +    
Sbjct: 58  VE---EFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVS 114
Query: 213 LTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTA 272
              LL +A  +S  M YL + N IHRDL   N L+ EN +VKVADFG++R+       TA
Sbjct: 115 AVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMT-GDTYTA 173
Query: 273 ETGT---YRWMAPEVIEHKPYDYKADVFSFGIALWELLT-GELPYAGLTPLQAAVGVVQK 328
             G     +W APE + +  +  K+DV++FG+ LWE+ T G  PY G+  L     +++K
Sbjct: 174 HAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGID-LSQVYELLEK 232
Query: 329 SLRPTIPKHAHPRLAELLERCWQHDPTQRPNFSQITDILKQMMKE 373
             R   P+    ++ EL+  CWQ +P+ RP+F++I    + M +E
Sbjct: 233 DYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQE 277

>pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277

Iteration: 1
 Score =  187 bits (474), Expect = 1e-47,   Method: Compositional matrix adjust.
 Identities = 103/285 (36%), Positives = 161/285 (56%), Gaps = 20/285 (7%)
Query: 96  SSPNCIEIPTDGTDVWEIDAKQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVN 153
           SSPN         D WE++   + ++ K+  G YG++Y+G +   S  VA+K LK + + 
Sbjct: 6   SSPN--------YDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME 57
Query: 154 TEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHK-QKGVFQ 212
            E   EF +E  +M++I+H N+VQ +G CTR P   I+TEFM  G++ D+L +  +    
Sbjct: 58  VE---EFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVN 114
Query: 213 LTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTA 272
              LL +A  +S  M YL + N IHRDL   N L+ EN +VKVADFG++R+       TA
Sbjct: 115 AVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMT-GDTYTA 173
Query: 273 ETGT---YRWMAPEVIEHKPYDYKADVFSFGIALWELLT-GELPYAGLTPLQAAVGVVQK 328
             G     +W APE + +  +  K+DV++FG+ LWE+ T G  PY G+  L     +++K
Sbjct: 174 HAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGID-LSQVYELLEK 232
Query: 329 SLRPTIPKHAHPRLAELLERCWQHDPTQRPNFSQITDILKQMMKE 373
             R   P+    ++ EL+  CWQ +P+ RP+F++I    + M +E
Sbjct: 233 DYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQE 277

>pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278

Iteration: 1
 Score =  187 bits (474), Expect = 1e-47,   Method: Compositional matrix adjust.
 Identities = 103/285 (36%), Positives = 161/285 (56%), Gaps = 20/285 (7%)
Query: 96  SSPNCIEIPTDGTDVWEIDAKQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVN 153
           SSPN         D WE++   + ++ K+  G YG++Y+G +   S  VA+K LK + + 
Sbjct: 6   SSPN--------YDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME 57
Query: 154 TEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHK-QKGVFQ 212
            E   EF +E  +M++I+H N+VQ +G CTR P   I+TEFM  G++ D+L +  +    
Sbjct: 58  VE---EFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVN 114
Query: 213 LTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTA 272
              LL +A  +S  M YL + N IHRDL   N L+ EN +VKVADFG++R+       TA
Sbjct: 115 AVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMT-GDTXTA 173
Query: 273 ETGT---YRWMAPEVIEHKPYDYKADVFSFGIALWELLT-GELPYAGLTPLQAAVGVVQK 328
             G     +W APE + +  +  K+DV++FG+ LWE+ T G  PY G+  L     +++K
Sbjct: 174 HAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGID-LSQVYELLEK 232
Query: 329 SLRPTIPKHAHPRLAELLERCWQHDPTQRPNFSQITDILKQMMKE 373
             R   P+    ++ EL+  CWQ +P+ RP+F++I    + M +E
Sbjct: 233 DYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQE 277

>pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286

Iteration: 1
 Score =  186 bits (473), Expect = 2e-47,   Method: Compositional matrix adjust.
 Identities = 99/277 (35%), Positives = 158/277 (57%), Gaps = 12/277 (4%)
Query: 104 PTDGTDVWEIDAKQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVNTEMLKEFS 161
           P+   D WE++   + ++ K+  G YG++Y+G +   S  VA+K LK + +  E   EF 
Sbjct: 2   PSPNYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE---EFL 58
Query: 162 QEVYIMRKIRHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHK-QKGVFQLTSLLKVA 220
           +E  +M++I+H N+VQ +G CTR P   I+ EFM  G++ D+L +  +       LL +A
Sbjct: 59  KEAAVMKEIKHPNLVQLLGVCTREPPFYIIIEFMTYGNLLDYLRECNRQEVNAVVLLYMA 118
Query: 221 IDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAETGT---Y 277
             +S  M YL + N IHRDL   N L+ EN +VKVADFG++R+       TA  G     
Sbjct: 119 TQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMT-GDTXTAHAGAKFPI 177
Query: 278 RWMAPEVIEHKPYDYKADVFSFGIALWELLT-GELPYAGLTPLQAAVGVVQKSLRPTIPK 336
           +W APE + +  +  K+DV++FG+ LWE+ T G  PY G+  L     +++K  R   P+
Sbjct: 178 KWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGID-LSQVYELLEKDYRMERPE 236
Query: 337 HAHPRLAELLERCWQHDPTQRPNFSQITDILKQMMKE 373
               ++ EL+  CWQ +P+ RP+F++I    + M +E
Sbjct: 237 GCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQE 273

>pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284

Iteration: 1
 Score =  186 bits (473), Expect = 2e-47,   Method: Compositional matrix adjust.
 Identities = 99/272 (36%), Positives = 157/272 (57%), Gaps = 12/272 (4%)
Query: 109 DVWEIDAKQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVNTEMLKEFSQEVYI 166
           D WE++   + ++ K+  G YG++Y+G +   S  VA+K LK + +  E   EF +E  +
Sbjct: 6   DKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE---EFLKEAAV 62
Query: 167 MRKIRHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHK-QKGVFQLTSLLKVAIDVSK 225
           M++I+H N+VQ +G CTR P   I+TEFM  G++ D+L +  +       LL +A  +S 
Sbjct: 63  MKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISS 122
Query: 226 GMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAETGT---YRWMAP 282
            M YL + N IHRDL   N L+ EN +VKVADFG++R+       TA  G     +W AP
Sbjct: 123 AMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMT-GDTYTAHAGAKFPIKWTAP 181
Query: 283 EVIEHKPYDYKADVFSFGIALWELLT-GELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPR 341
           E + +  +  K+DV++FG+ LWE+ T G  PY G+  L     +++K  R   P+    +
Sbjct: 182 ESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGID-LSQVYELLEKDYRMERPEGCPEK 240
Query: 342 LAELLERCWQHDPTQRPNFSQITDILKQMMKE 373
           + EL+  CWQ +P+ RP+F++I    + M +E
Sbjct: 241 VYELMRACWQWNPSDRPSFAEIHQAFETMFQE 272

>pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273

Iteration: 1
 Score =  186 bits (472), Expect = 2e-47,   Method: Compositional matrix adjust.
 Identities = 99/272 (36%), Positives = 157/272 (57%), Gaps = 12/272 (4%)
Query: 109 DVWEIDAKQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVNTEMLKEFSQEVYI 166
           D WE++   + ++ K+  G YG++Y+G +   S  VA+K LK + +  E   EF +E  +
Sbjct: 6   DKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE---EFLKEAAV 62
Query: 167 MRKIRHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHK-QKGVFQLTSLLKVAIDVSK 225
           M++I+H N+VQ +G CTR P   I+TEFM  G++ D+L +  +       LL +A  +S 
Sbjct: 63  MKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISS 122
Query: 226 GMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAETGT---YRWMAP 282
            M YL + N IHRDL   N L+ EN +VKVADFG++R+       TA  G     +W AP
Sbjct: 123 AMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMT-GDTYTAHAGAKFPIKWTAP 181
Query: 283 EVIEHKPYDYKADVFSFGIALWELLT-GELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPR 341
           E + +  +  K+DV++FG+ LWE+ T G  PY G+  L     +++K  R   P+    +
Sbjct: 182 ESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGID-LSQVYELLEKDYRMERPEGCPEK 240
Query: 342 LAELLERCWQHDPTQRPNFSQITDILKQMMKE 373
           + EL+  CWQ +P+ RP+F++I    + M +E
Sbjct: 241 VYELMRACWQWNPSDRPSFAEIHQAFETMFQE 272

>pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287

Iteration: 1
 Score =  186 bits (472), Expect = 2e-47,   Method: Compositional matrix adjust.
 Identities = 99/272 (36%), Positives = 157/272 (57%), Gaps = 12/272 (4%)
Query: 109 DVWEIDAKQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVNTEMLKEFSQEVYI 166
           D WE++   + ++ K+  G YG++Y+G +   S  VA+K LK + +  E   EF +E  +
Sbjct: 8   DKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE---EFLKEAAV 64
Query: 167 MRKIRHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHK-QKGVFQLTSLLKVAIDVSK 225
           M++I+H N+VQ +G CTR P   I+TEFM  G++ D+L +  +       LL +A  +S 
Sbjct: 65  MKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISS 124
Query: 226 GMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAETGT---YRWMAP 282
            M YL + N IHRDL   N L+ EN +VKVADFG++R+       TA  G     +W AP
Sbjct: 125 AMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMT-GDTYTAHAGAKFPIKWTAP 183
Query: 283 EVIEHKPYDYKADVFSFGIALWELLT-GELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPR 341
           E + +  +  K+DV++FG+ LWE+ T G  PY G+  L     +++K  R   P+    +
Sbjct: 184 ESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGID-LSQVYELLEKDYRMERPEGCPEK 242
Query: 342 LAELLERCWQHDPTQRPNFSQITDILKQMMKE 373
           + EL+  CWQ +P+ RP+F++I    + M +E
Sbjct: 243 VYELMRACWQWNPSDRPSFAEIHQAFETMFQE 274

>pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287

Iteration: 1
 Score =  186 bits (472), Expect = 2e-47,   Method: Compositional matrix adjust.
 Identities = 99/272 (36%), Positives = 157/272 (57%), Gaps = 12/272 (4%)
Query: 109 DVWEIDAKQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVNTEMLKEFSQEVYI 166
           D WE++   + ++ K+  G YG++Y+G +   S  VA+K LK + +  E   EF +E  +
Sbjct: 8   DKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE---EFLKEAAV 64
Query: 167 MRKIRHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHK-QKGVFQLTSLLKVAIDVSK 225
           M++I+H N+VQ +G CTR P   I+TEFM  G++ D+L +  +       LL +A  +S 
Sbjct: 65  MKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISS 124
Query: 226 GMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAETGT---YRWMAP 282
            M YL + N IHRDL   N L+ EN +VKVADFG++R+       TA  G     +W AP
Sbjct: 125 AMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMT-GDTYTAHAGAKFPIKWTAP 183
Query: 283 EVIEHKPYDYKADVFSFGIALWELLT-GELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPR 341
           E + +  +  K+DV++FG+ LWE+ T G  PY G+  L     +++K  R   P+    +
Sbjct: 184 ESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGID-LSQVYELLEKDYRMERPEGCPEK 242
Query: 342 LAELLERCWQHDPTQRPNFSQITDILKQMMKE 373
           + EL+  CWQ +P+ RP+F++I    + M +E
Sbjct: 243 VYELMRACWQWNPSDRPSFAEIHQAFETMFQE 274

>pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288

Iteration: 1
 Score =  186 bits (472), Expect = 2e-47,   Method: Compositional matrix adjust.
 Identities = 99/272 (36%), Positives = 157/272 (57%), Gaps = 12/272 (4%)
Query: 109 DVWEIDAKQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVNTEMLKEFSQEVYI 166
           D WE++   + ++ K+  G YG++Y+G +   S  VA+K LK + +  E   EF +E  +
Sbjct: 6   DKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE---EFLKEAAV 62
Query: 167 MRKIRHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHK-QKGVFQLTSLLKVAIDVSK 225
           M++I+H N+VQ +G CTR P   I+TEFM  G++ D+L +  +       LL +A  +S 
Sbjct: 63  MKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISS 122
Query: 226 GMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAETGT---YRWMAP 282
            M YL + N IHRDL   N L+ EN +VKVADFG++R+       TA  G     +W AP
Sbjct: 123 AMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMT-GDTYTAHAGAKFPIKWTAP 181
Query: 283 EVIEHKPYDYKADVFSFGIALWELLT-GELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPR 341
           E + +  +  K+DV++FG+ LWE+ T G  PY G+  L     +++K  R   P+    +
Sbjct: 182 ESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGID-LSQVYELLEKDYRMERPEGCPEK 240
Query: 342 LAELLERCWQHDPTQRPNFSQITDILKQMMKE 373
           + EL+  CWQ +P+ RP+F++I    + M +E
Sbjct: 241 VYELMRACWQWNPSDRPSFAEIHQAFETMFQE 272

>pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287

Iteration: 1
 Score =  186 bits (472), Expect = 2e-47,   Method: Compositional matrix adjust.
 Identities = 99/272 (36%), Positives = 157/272 (57%), Gaps = 12/272 (4%)
Query: 109 DVWEIDAKQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVNTEMLKEFSQEVYI 166
           D WE++   + ++ K+  G YG++Y+G +   S  VA+K LK + +  E   EF +E  +
Sbjct: 7   DKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE---EFLKEAAV 63
Query: 167 MRKIRHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHK-QKGVFQLTSLLKVAIDVSK 225
           M++I+H N+VQ +G CTR P   I+TEFM  G++ D+L +  +       LL +A  +S 
Sbjct: 64  MKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISS 123
Query: 226 GMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAETGT---YRWMAP 282
            M YL + N IHRDL   N L+ EN +VKVADFG++R+       TA  G     +W AP
Sbjct: 124 AMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMT-GDTYTAPAGAKFPIKWTAP 182
Query: 283 EVIEHKPYDYKADVFSFGIALWELLT-GELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPR 341
           E + +  +  K+DV++FG+ LWE+ T G  PY G+  L     +++K  R   P+    +
Sbjct: 183 ESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGID-LSQVYELLEKDYRMERPEGCPEK 241
Query: 342 LAELLERCWQHDPTQRPNFSQITDILKQMMKE 373
           + EL+  CWQ +P+ RP+F++I    + M +E
Sbjct: 242 VYELMRACWQWNPSDRPSFAEIHQAFETMFQE 273

>pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287

Iteration: 1
 Score =  186 bits (471), Expect = 2e-47,   Method: Compositional matrix adjust.
 Identities = 99/272 (36%), Positives = 157/272 (57%), Gaps = 12/272 (4%)
Query: 109 DVWEIDAKQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVNTEMLKEFSQEVYI 166
           D WE++   + ++ K+  G YG++Y+G +   S  VA+K LK + +  E   EF +E  +
Sbjct: 8   DKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE---EFLKEAAV 64
Query: 167 MRKIRHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHK-QKGVFQLTSLLKVAIDVSK 225
           M++I+H N+VQ +G CTR P   I+TEFM  G++ D+L +  +       LL +A  +S 
Sbjct: 65  MKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISS 124
Query: 226 GMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAETGT---YRWMAP 282
            M YL + N IHRDL   N L+ EN +VKVADFG++R+       TA  G     +W AP
Sbjct: 125 AMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMT-GDTYTAPAGAKFPIKWTAP 183
Query: 283 EVIEHKPYDYKADVFSFGIALWELLT-GELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPR 341
           E + +  +  K+DV++FG+ LWE+ T G  PY G+  L     +++K  R   P+    +
Sbjct: 184 ESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGID-LSQVYELLEKDYRMERPEGCPEK 242
Query: 342 LAELLERCWQHDPTQRPNFSQITDILKQMMKE 373
           + EL+  CWQ +P+ RP+F++I    + M +E
Sbjct: 243 VYELMRACWQWNPSDRPSFAEIHQAFETMFQE 274

>pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307

Iteration: 1
 Score =  185 bits (470), Expect = 3e-47,   Method: Compositional matrix adjust.
 Identities = 97/250 (38%), Positives = 156/250 (62%), Gaps = 15/250 (6%)
Query: 106 DGTDVWEIDAKQLKIECKVASGSYGDLYKGTYCSQEVAIKVLKPECVNTEMLKEFSQEVY 165
           D +  WEI+A ++ +  ++ SGS+G +YKG +   +VA+K+LK      E  + F  EV 
Sbjct: 26  DSSYYWEIEASEVMLSTRIGSGSFGTVYKGKWHG-DVAVKILKVVDPTPEQFQAFRNEVA 84
Query: 166 IMRKIRHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSK 225
           ++RK RH N++ F+G  T+  NL IVT++    S+Y  LH Q+  FQ+  L+ +A   ++
Sbjct: 85  VLRKTRHVNILLFMGYMTKD-NLAIVTQWCEGSSLYKHLHVQETKFQMFQLIDIARQTAQ 143
Query: 226 GMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQ-SGVMTAE--TGTYRWMAP 282
           GM+YLH  NIIHRD+K+ N+ + E   VK+ DFG+A V+++ SG    E  TG+  WMAP
Sbjct: 144 GMDYLHAKNIIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRWSGSQQVEQPTGSVLWMAP 203
Query: 283 EVI---EHKPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKSLRPTIPKHAH 339
           EVI   ++ P+ +++DV+S+GI L+EL+TGELPY+ +      + +V +        +A 
Sbjct: 204 EVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNRDQIIFMVGRG-------YAS 256
Query: 340 PRLAELLERC 349
           P L++L + C
Sbjct: 257 PDLSKLYKNC 266

>pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277

Iteration: 1
 Score =  184 bits (468), Expect = 5e-47,   Method: Compositional matrix adjust.
 Identities = 102/285 (35%), Positives = 160/285 (56%), Gaps = 20/285 (7%)
Query: 96  SSPNCIEIPTDGTDVWEIDAKQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVN 153
           SSPN         D WE++   + ++ K+  G YG++Y+G +   S  VA+K LK + + 
Sbjct: 6   SSPN--------YDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME 57
Query: 154 TEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHK-QKGVFQ 212
            E   EF +E  +M++I+H N+VQ +G CTR P   I+ EFM  G++ D+L +  +    
Sbjct: 58  VE---EFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIIIEFMTYGNLLDYLRECNRQEVN 114
Query: 213 LTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTA 272
              LL +A  +S  M YL + N IHRDL   N L+ EN +VKVADFG++R+       TA
Sbjct: 115 AVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMT-GDTYTA 173
Query: 273 ETGT---YRWMAPEVIEHKPYDYKADVFSFGIALWELLT-GELPYAGLTPLQAAVGVVQK 328
             G     +W APE + +  +  K+DV++FG+ LWE+ T G  PY G+  L     +++K
Sbjct: 174 HAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGID-LSQVYELLEK 232
Query: 329 SLRPTIPKHAHPRLAELLERCWQHDPTQRPNFSQITDILKQMMKE 373
             R   P+    ++ EL+  CWQ +P+ RP+F++I    + M +E
Sbjct: 233 DYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQE 277

>pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495

Iteration: 1
 Score =  184 bits (468), Expect = 6e-47,   Method: Compositional matrix adjust.
 Identities = 98/272 (36%), Positives = 157/272 (57%), Gaps = 12/272 (4%)
Query: 109 DVWEIDAKQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVNTEMLKEFSQEVYI 166
           D WE++   + ++ K+  G YG++Y+G +   S  VA+K LK + +  E   EF +E  +
Sbjct: 213 DKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE---EFLKEAAV 269
Query: 167 MRKIRHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHK-QKGVFQLTSLLKVAIDVSK 225
           M++I+H N+VQ +G CTR P   I+TEFM  G++ D+L +  +       LL +A  +S 
Sbjct: 270 MKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISS 329
Query: 226 GMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAETGT---YRWMAP 282
            M YL + N IHR+L   N L+ EN +VKVADFG++R+       TA  G     +W AP
Sbjct: 330 AMEYLEKKNFIHRNLAARNCLVGENHLVKVADFGLSRLMT-GDTYTAHAGAKFPIKWTAP 388
Query: 283 EVIEHKPYDYKADVFSFGIALWELLT-GELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPR 341
           E + +  +  K+DV++FG+ LWE+ T G  PY G+  L     +++K  R   P+    +
Sbjct: 389 ESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGID-LSQVYELLEKDYRMERPEGCPEK 447
Query: 342 LAELLERCWQHDPTQRPNFSQITDILKQMMKE 373
           + EL+  CWQ +P+ RP+F++I    + M +E
Sbjct: 448 VYELMRACWQWNPSDRPSFAEIHQAFETMFQE 479

>pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284

Iteration: 1
 Score =  184 bits (467), Expect = 7e-47,   Method: Compositional matrix adjust.
 Identities = 98/272 (36%), Positives = 156/272 (57%), Gaps = 12/272 (4%)
Query: 109 DVWEIDAKQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVNTEMLKEFSQEVYI 166
           D WE++   + ++ K+  G YG++Y+G +   S  VA+K LK + +  E   EF +E  +
Sbjct: 6   DKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE---EFLKEAAV 62
Query: 167 MRKIRHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHK-QKGVFQLTSLLKVAIDVSK 225
           M++I+H N+VQ +G CTR P   I+ EFM  G++ D+L +  +       LL +A  +S 
Sbjct: 63  MKEIKHPNLVQLLGVCTREPPFYIIIEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISS 122
Query: 226 GMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAETGT---YRWMAP 282
            M YL + N IHRDL   N L+ EN +VKVADFG++R+       TA  G     +W AP
Sbjct: 123 AMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMT-GDTYTAHAGAKFPIKWTAP 181
Query: 283 EVIEHKPYDYKADVFSFGIALWELLT-GELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPR 341
           E + +  +  K+DV++FG+ LWE+ T G  PY G+  L     +++K  R   P+    +
Sbjct: 182 ESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGID-LSQVYELLEKDYRMERPEGCPEK 240
Query: 342 LAELLERCWQHDPTQRPNFSQITDILKQMMKE 373
           + EL+  CWQ +P+ RP+F++I    + M +E
Sbjct: 241 VYELMRACWQWNPSDRPSFAEIHQAFETMFQE 272

>pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288

Iteration: 1
 Score =  184 bits (467), Expect = 8e-47,   Method: Compositional matrix adjust.
 Identities = 98/272 (36%), Positives = 156/272 (57%), Gaps = 12/272 (4%)
Query: 109 DVWEIDAKQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVNTEMLKEFSQEVYI 166
           D WE++   + ++ K+  G YG++Y+G +   S  VA+K LK + +  E   EF +E  +
Sbjct: 6   DKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE---EFLKEAAV 62
Query: 167 MRKIRHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHK-QKGVFQLTSLLKVAIDVSK 225
           M++I+H N+VQ +G CTR P   I+ EFM  G++ D+L +  +       LL +A  +S 
Sbjct: 63  MKEIKHPNLVQLLGVCTREPPFYIIIEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISS 122
Query: 226 GMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAETGT---YRWMAP 282
            M YL + N IHRDL   N L+ EN +VKVADFG++R+       TA  G     +W AP
Sbjct: 123 AMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMT-GDTYTAHAGAKFPIKWTAP 181
Query: 283 EVIEHKPYDYKADVFSFGIALWELLT-GELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPR 341
           E + +  +  K+DV++FG+ LWE+ T G  PY G+  L     +++K  R   P+    +
Sbjct: 182 ESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGID-LSQVYELLEKDYRMERPEGCPEK 240
Query: 342 LAELLERCWQHDPTQRPNFSQITDILKQMMKE 373
           + EL+  CWQ +P+ RP+F++I    + M +E
Sbjct: 241 VYELMRACWQWNPSDRPSFAEIHQAFETMFQE 272

>pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537

Iteration: 1
 Score =  184 bits (467), Expect = 8e-47,   Method: Compositional matrix adjust.
 Identities = 98/272 (36%), Positives = 157/272 (57%), Gaps = 12/272 (4%)
Query: 109 DVWEIDAKQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVNTEMLKEFSQEVYI 166
           D WE++   + ++ K+  G YG++Y+G +   S  VA+K LK + +  E   EF +E  +
Sbjct: 252 DKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE---EFLKEAAV 308
Query: 167 MRKIRHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHK-QKGVFQLTSLLKVAIDVSK 225
           M++I+H N+VQ +G CTR P   I+TEFM  G++ D+L +  +       LL +A  +S 
Sbjct: 309 MKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISS 368
Query: 226 GMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAETGT---YRWMAP 282
            M YL + N IHR+L   N L+ EN +VKVADFG++R+       TA  G     +W AP
Sbjct: 369 AMEYLEKKNFIHRNLAARNCLVGENHLVKVADFGLSRLMT-GDTYTAHAGAKFPIKWTAP 427
Query: 283 EVIEHKPYDYKADVFSFGIALWELLT-GELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPR 341
           E + +  +  K+DV++FG+ LWE+ T G  PY G+  L     +++K  R   P+    +
Sbjct: 428 ESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGID-LSQVYELLEKDYRMERPEGCPEK 486
Query: 342 LAELLERCWQHDPTQRPNFSQITDILKQMMKE 373
           + EL+  CWQ +P+ RP+F++I    + M +E
Sbjct: 487 VYELMRACWQWNPSDRPSFAEIHQAFETMFQE 518

>pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270

Iteration: 1
 Score =  184 bits (466), Expect = 1e-46,   Method: Compositional matrix adjust.
 Identities = 98/270 (36%), Positives = 155/270 (57%), Gaps = 12/270 (4%)
Query: 109 DVWEIDAKQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVNTEMLKEFSQEVYI 166
           D WE++   + ++ K+  G YG++Y+G +   S  VA+K LK + +  E   EF +E  +
Sbjct: 6   DKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE---EFLKEAAV 62
Query: 167 MRKIRHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHK-QKGVFQLTSLLKVAIDVSK 225
           M++I+H N+VQ +G CTR P   I+TEFM  G++ D+L +  +       LL +A  +S 
Sbjct: 63  MKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISS 122
Query: 226 GMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAETGT---YRWMAP 282
            M YL + N IHRDL   N L+ EN +VKVADFG++R+       TA  G     +W AP
Sbjct: 123 AMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMT-GDTYTAHAGAKFPIKWTAP 181
Query: 283 EVIEHKPYDYKADVFSFGIALWELLT-GELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPR 341
           E + +  +  K+DV++FG+ LWE+ T G  PY G+  L     +++K  R   P+    +
Sbjct: 182 ESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGID-LSQVYELLEKDYRMERPEGCPEK 240
Query: 342 LAELLERCWQHDPTQRPNFSQITDILKQMM 371
           + EL+  CWQ +P+ RP+F++I    + M 
Sbjct: 241 VYELMRACWQWNPSDRPSFAEIHQAFETMF 270

>pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281

Iteration: 1
 Score =  182 bits (462), Expect = 3e-46,   Method: Compositional matrix adjust.
 Identities = 99/269 (36%), Positives = 162/269 (60%), Gaps = 12/269 (4%)
Query: 105 TDGTDVWEIDAKQLKIECKVASGSYGDLYKGTYCSQEVAIKVLKPECVNTEMLKEFSQEV 164
           +D +D WEI   Q+ +  ++ SGS+G +YKG +   +VA+K+L       + L+ F  EV
Sbjct: 2   SDSSDDWEIPDGQITVGQRIGSGSFGTVYKGKWHG-DVAVKMLNVTAPTPQQLQAFKNEV 60
Query: 165 YIMRKIRHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVS 224
            ++RK RH N++ F+G  T+P  L IVT++    S+Y  LH  +  F++  L+ +A   +
Sbjct: 61  GVLRKTRHVNILLFMGYSTKP-QLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTA 119
Query: 225 KGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQ-SGVMTAE--TGTYRWMA 281
           +GM+YLH  +IIHRDLK+ N+ + E+  VK+ DFG+A V+++ SG    E  +G+  WMA
Sbjct: 120 QGMDYLHAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMA 179
Query: 282 PEVI---EHKPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKS-LRPTIPK- 336
           PEVI   +  PY +++DV++FGI L+EL+TG+LPY+ +      + +V +  L P + K 
Sbjct: 180 PEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPDLSKV 239
Query: 337 --HAHPRLAELLERCWQHDPTQRPNFSQI 363
             +    +  L+  C +    +RP F QI
Sbjct: 240 RSNCPKAMKRLMAECLKKKRDERPLFPQI 268

>pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271

Iteration: 1
 Score =  182 bits (462), Expect = 3e-46,   Method: Compositional matrix adjust.
 Identities = 99/272 (36%), Positives = 152/272 (55%), Gaps = 16/272 (5%)
Query: 112 EIDAKQLKIECKVASGSYGDLYKGTYCSQEVAIKVLK--PECVNTEMLKEFSQEVYIMRK 169
           EID  +L +E  +  G +G +Y+  +   EVA+K  +  P+   ++ ++   QE  +   
Sbjct: 3   EIDFAELTLEEIIGIGGFGKVYRAFWIGDEVAVKAARHDPDEDISQTIENVRQEAKLFAM 62
Query: 170 IRHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNY 229
           ++H N++   G C + PNLC+V EF   G +   L  ++       L+  A+ +++GMNY
Sbjct: 63  LKHPNIIALRGVCLKEPNLCLVMEFARGGPLNRVLSGKR--IPPDILVNWAVQIARGMNY 120
Query: 230 LHQNNI---IHRDLKTANLLM---DENG-----VVKVADFGVARVQAQSGVMTAETGTYR 278
           LH   I   IHRDLK++N+L+    ENG     ++K+ DFG+AR   ++  M+A  G Y 
Sbjct: 121 LHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAREWHRTTKMSA-AGAYA 179
Query: 279 WMAPEVIEHKPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKSLRPTIPKHA 338
           WMAPEVI    +   +DV+S+G+ LWELLTGE+P+ G+  L  A GV    L   IP   
Sbjct: 180 WMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGIDGLAVAYGVAMNKLALPIPSTC 239
Query: 339 HPRLAELLERCWQHDPTQRPNFSQITDILKQM 370
               A+L+E CW  DP  RP+F+ I D L  +
Sbjct: 240 PEPFAKLMEDCWNPDPHSRPSFTNILDQLTTI 271

>pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284

Iteration: 1
 Score =  182 bits (461), Expect = 3e-46,   Method: Compositional matrix adjust.
 Identities = 99/269 (36%), Positives = 162/269 (60%), Gaps = 12/269 (4%)
Query: 105 TDGTDVWEIDAKQLKIECKVASGSYGDLYKGTYCSQEVAIKVLKPECVNTEMLKEFSQEV 164
           +D +D WEI   Q+ +  ++ SGS+G +YKG +   +VA+K+L       + L+ F  EV
Sbjct: 2   SDSSDDWEIPDGQITVGQRIGSGSFGTVYKGKWHG-DVAVKMLNVTAPTPQQLQAFKNEV 60
Query: 165 YIMRKIRHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVS 224
            ++RK RH N++ F+G  T+P  L IVT++    S+Y  LH  +  F++  L+ +A   +
Sbjct: 61  GVLRKTRHVNILLFMGYSTKP-QLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTA 119
Query: 225 KGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQ-SGVMTAE--TGTYRWMA 281
           +GM+YLH  +IIHRDLK+ N+ + E+  VK+ DFG+A V+++ SG    E  +G+  WMA
Sbjct: 120 QGMDYLHAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMA 179
Query: 282 PEVI---EHKPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKS-LRPTIPK- 336
           PEVI   +  PY +++DV++FGI L+EL+TG+LPY+ +      + +V +  L P + K 
Sbjct: 180 PEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPDLSKV 239
Query: 337 --HAHPRLAELLERCWQHDPTQRPNFSQI 363
             +    +  L+  C +    +RP F QI
Sbjct: 240 RSNCPKAMKRLMAECLKKKRDERPLFPQI 268

>pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306

Iteration: 1
 Score =  181 bits (460), Expect = 4e-46,   Method: Compositional matrix adjust.
 Identities = 99/268 (36%), Positives = 161/268 (60%), Gaps = 12/268 (4%)
Query: 106 DGTDVWEIDAKQLKIECKVASGSYGDLYKGTYCSQEVAIKVLKPECVNTEMLKEFSQEVY 165
           D +D WEI   Q+ +  ++ SGS+G +YKG +   +VA+K+L       + L+ F  EV 
Sbjct: 25  DSSDDWEIPDGQITVGQRIGSGSFGTVYKGKWHG-DVAVKMLNVTAPTPQQLQAFKNEVG 83
Query: 166 IMRKIRHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSK 225
           ++RK RH N++ F+G  T+P  L IVT++    S+Y  LH  +  F++  L+ +A   ++
Sbjct: 84  VLRKTRHVNILLFMGYSTKP-QLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQ 142
Query: 226 GMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQ-SGVMTAE--TGTYRWMAP 282
           GM+YLH  +IIHRDLK+ N+ + E+  VK+ DFG+A V+++ SG    E  +G+  WMAP
Sbjct: 143 GMDYLHAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAP 202
Query: 283 EVI---EHKPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKS-LRPTIPK-- 336
           EVI   +  PY +++DV++FGI L+EL+TG+LPY+ +      + +V +  L P + K  
Sbjct: 203 EVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPDLSKVR 262
Query: 337 -HAHPRLAELLERCWQHDPTQRPNFSQI 363
            +    +  L+  C +    +RP F QI
Sbjct: 263 SNCPKAMKRLMAECLKKKRDERPLFPQI 290

>pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307

Iteration: 1
 Score =  181 bits (460), Expect = 5e-46,   Method: Compositional matrix adjust.
 Identities = 99/268 (36%), Positives = 161/268 (60%), Gaps = 12/268 (4%)
Query: 106 DGTDVWEIDAKQLKIECKVASGSYGDLYKGTYCSQEVAIKVLKPECVNTEMLKEFSQEVY 165
           D +D WEI   Q+ +  ++ SGS+G +YKG +   +VA+K+L       + L+ F  EV 
Sbjct: 26  DSSDDWEIPDGQITVGQRIGSGSFGTVYKGKWHG-DVAVKMLNVTAPTPQQLQAFKNEVG 84
Query: 166 IMRKIRHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSK 225
           ++RK RH N++ F+G  T+P  L IVT++    S+Y  LH  +  F++  L+ +A   ++
Sbjct: 85  VLRKTRHVNILLFMGYSTKP-QLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQ 143
Query: 226 GMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQ-SGVMTAE--TGTYRWMAP 282
           GM+YLH  +IIHRDLK+ N+ + E+  VK+ DFG+A V+++ SG    E  +G+  WMAP
Sbjct: 144 GMDYLHAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAP 203
Query: 283 EVI---EHKPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKS-LRPTIPK-- 336
           EVI   +  PY +++DV++FGI L+EL+TG+LPY+ +      + +V +  L P + K  
Sbjct: 204 EVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPDLSKVR 263
Query: 337 -HAHPRLAELLERCWQHDPTQRPNFSQI 363
            +    +  L+  C +    +RP F QI
Sbjct: 264 SNCPKAMKRLMAECLKKKRDERPLFPQI 291

>pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307

Iteration: 1
 Score =  179 bits (454), Expect = 3e-45,   Method: Compositional matrix adjust.
 Identities = 98/268 (36%), Positives = 160/268 (59%), Gaps = 12/268 (4%)
Query: 106 DGTDVWEIDAKQLKIECKVASGSYGDLYKGTYCSQEVAIKVLKPECVNTEMLKEFSQEVY 165
           D +D WEI   Q+ +  ++ SGS+G +YKG +   +VA+K+L       + L+ F  EV 
Sbjct: 26  DSSDDWEIPDGQITVGQRIGSGSFGTVYKGKWHG-DVAVKMLNVTAPTPQQLQAFKNEVG 84
Query: 166 IMRKIRHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSK 225
           ++RK RH N++ F+G  T+P  L IVT++    S+Y  LH  +  F++  L+ +A   ++
Sbjct: 85  VLRKTRHVNILLFMGYSTKP-QLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQ 143
Query: 226 GMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQ-SGVMTAE--TGTYRWMAP 282
           GM+YLH  +IIHRDLK+ N+ + E+  VK+ DFG+A  +++ SG    E  +G+  WMAP
Sbjct: 144 GMDYLHAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAP 203
Query: 283 EVI---EHKPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKS-LRPTIPK-- 336
           EVI   +  PY +++DV++FGI L+EL+TG+LPY+ +      + +V +  L P + K  
Sbjct: 204 EVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPDLSKVR 263
Query: 337 -HAHPRLAELLERCWQHDPTQRPNFSQI 363
            +    +  L+  C +    +RP F QI
Sbjct: 264 SNCPKAMKRLMAECLKKKRDERPLFPQI 291

>pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282

Iteration: 1
 Score =  179 bits (454), Expect = 3e-45,   Method: Compositional matrix adjust.
 Identities = 98/266 (36%), Positives = 160/266 (60%), Gaps = 12/266 (4%)
Query: 108 TDVWEIDAKQLKIECKVASGSYGDLYKGTYCSQEVAIKVLKPECVNTEMLKEFSQEVYIM 167
           +D WEI   Q+ +  ++ SGS+G +YKG +   +VA+K+L       + L+ F  EV ++
Sbjct: 2   SDDWEIPDGQITVGQRIGSGSFGTVYKGKWHG-DVAVKMLNVTAPTPQQLQAFKNEVGVL 60
Query: 168 RKIRHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGM 227
           RK RH N++ F+G  T+P  L IVT++    S+Y  LH  +  F++  L+ +A   ++GM
Sbjct: 61  RKTRHVNILLFMGYSTKP-QLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGM 119
Query: 228 NYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQ-SGVMTAE--TGTYRWMAPEV 284
           +YLH  +IIHRDLK+ N+ + E+  VK+ DFG+A V+++ SG    E  +G+  WMAPEV
Sbjct: 120 DYLHAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEV 179
Query: 285 I---EHKPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKS-LRPTIPK---H 337
           I   +  PY +++DV++FGI L+EL+TG+LPY+ +      + +V +  L P + K   +
Sbjct: 180 IRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPDLSKVRSN 239
Query: 338 AHPRLAELLERCWQHDPTQRPNFSQI 363
               +  L+  C +    +RP F QI
Sbjct: 240 CPKAMKRLMAECLKKKRDERPLFPQI 265

>pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300

Iteration: 1
 Score =  179 bits (453), Expect = 3e-45,   Method: Compositional matrix adjust.
 Identities = 98/268 (36%), Positives = 160/268 (59%), Gaps = 12/268 (4%)
Query: 106 DGTDVWEIDAKQLKIECKVASGSYGDLYKGTYCSQEVAIKVLKPECVNTEMLKEFSQEVY 165
           D +D WEI   Q+ +  ++ SGS+G +YKG +   +VA+K+L       + L+ F  EV 
Sbjct: 18  DSSDDWEIPDGQITVGQRIGSGSFGTVYKGKWHG-DVAVKMLNVTAPTPQQLQAFKNEVG 76
Query: 166 IMRKIRHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSK 225
           ++RK RH N++ F+G  T+P  L IVT++    S+Y  LH  +  F++  L+ +A   ++
Sbjct: 77  VLRKTRHVNILLFMGYSTKP-QLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQ 135
Query: 226 GMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQ-SGVMTAE--TGTYRWMAP 282
           GM+YLH  +IIHRDLK+ N+ + E+  VK+ DFG+A  +++ SG    E  +G+  WMAP
Sbjct: 136 GMDYLHAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAP 195
Query: 283 EVI---EHKPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKS-LRPTIPK-- 336
           EVI   +  PY +++DV++FGI L+EL+TG+LPY+ +      + +V +  L P + K  
Sbjct: 196 EVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPDLSKVR 255
Query: 337 -HAHPRLAELLERCWQHDPTQRPNFSQI 363
            +    +  L+  C +    +RP F QI
Sbjct: 256 SNCPKAMKRLMAECLKKKRDERPLFPQI 283

>pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292

Iteration: 1
 Score =  179 bits (453), Expect = 3e-45,   Method: Compositional matrix adjust.
 Identities = 97/272 (35%), Positives = 152/272 (55%), Gaps = 12/272 (4%)
Query: 109 DVWEIDAKQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVNTEMLKEFSQEVYI 166
           D WE++   + ++ K+  G YG++Y G +   S  VA+K LK + +  E   EF +E  +
Sbjct: 25  DKWEMERTDITMKHKLGGGQYGEVYVGVWKKYSLTVAVKTLKEDTMEVE---EFLKEAAV 81
Query: 167 MRKIRHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHK-QKGVFQLTSLLKVAIDVSK 225
           M++I+H N+VQ +G CT  P   IVTE+M  G++ D+L +  +       LL +A  +S 
Sbjct: 82  MKEIKHPNLVQLLGVCTLEPPFYIVTEYMPYGNLLDYLRECNREEVTAVVLLYMATQISS 141
Query: 226 GMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAETGT---YRWMAP 282
            M YL + N IHRDL   N L+ EN VVKVADFG++R+       TA  G     +W AP
Sbjct: 142 AMEYLEKKNFIHRDLAARNCLVGENHVVKVADFGLSRLMT-GDTYTAHAGAKFPIKWTAP 200
Query: 283 EVIEHKPYDYKADVFSFGIALWELLT-GELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPR 341
           E + +  +  K+DV++FG+ LWE+ T G  PY G+  L     +++K  R   P+   P+
Sbjct: 201 ESLAYNTFSIKSDVWAFGVLLWEIATYGMSPYPGID-LSQVYDLLEKGYRMEQPEGCPPK 259
Query: 342 LAELLERCWQHDPTQRPNFSQITDILKQMMKE 373
           + EL+  CW+  P  RP+F++     + M  +
Sbjct: 260 VYELMRACWKWSPADRPSFAETHQAFETMFHD 291

>pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275

Iteration: 1
 Score =  178 bits (452), Expect = 4e-45,   Method: Compositional matrix adjust.
 Identities = 98/265 (36%), Positives = 159/265 (60%), Gaps = 12/265 (4%)
Query: 109 DVWEIDAKQLKIECKVASGSYGDLYKGTYCSQEVAIKVLKPECVNTEMLKEFSQEVYIMR 168
           D WEI   Q+ +  ++ SGS+G +YKG +   +VA+K+L       + L+ F  EV ++R
Sbjct: 1   DDWEIPDGQITVGQRIGSGSFGTVYKGKWHG-DVAVKMLNVTAPTPQQLQAFKNEVGVLR 59
Query: 169 KIRHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMN 228
           K RH N++ F+G  T+P  L IVT++    S+Y  LH  +  F++  L+ +A   ++GM+
Sbjct: 60  KTRHVNILLFMGYSTKP-QLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMD 118
Query: 229 YLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQ-SGVMTAE--TGTYRWMAPEVI 285
           YLH  +IIHRDLK+ N+ + E+  VK+ DFG+A V+++ SG    E  +G+  WMAPEVI
Sbjct: 119 YLHAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVI 178
Query: 286 ---EHKPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKS-LRPTIPK---HA 338
              +  PY +++DV++FGI L+EL+TG+LPY+ +      + +V +  L P + K   + 
Sbjct: 179 RMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPDLSKVRSNC 238
Query: 339 HPRLAELLERCWQHDPTQRPNFSQI 363
              +  L+  C +    +RP F QI
Sbjct: 239 PKAMKRLMAECLKKKRDERPLFPQI 263

>pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286

Iteration: 1
 Score =  178 bits (452), Expect = 4e-45,   Method: Compositional matrix adjust.
 Identities = 104/281 (37%), Positives = 161/281 (57%), Gaps = 15/281 (5%)
Query: 109 DVWEIDAKQLKIECKVASGSYGDLYKGTY-CSQEVAIKVLKPECVNTEMLKEFSQEVYIM 167
           D WEI  + L++E K+  G +G+++ GT+  +  VAIK LKP  ++ E    F QE  +M
Sbjct: 11  DAWEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEA---FLQEAQVM 67
Query: 168 RKIRHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVF-QLTSLLKVAIDVSKG 226
           +KIRH+ +VQ     +  P + IVTE+M++GS+ DFL  + G + +L  L+ +A  ++ G
Sbjct: 68  KKIRHEKLVQLYAVVSEEP-IYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASG 126
Query: 227 MNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAETGT---YRWMAPE 283
           M Y+ + N +HRDL+ AN+L+ EN V KVADFG+AR+  +    TA  G     +W APE
Sbjct: 127 MAYVERMNYVHRDLRAANILVGENLVCKVADFGLARL-IEDNEYTARQGAKFPIKWTAPE 185
Query: 284 VIEHKPYDYKADVFSFGIALWELLT-GELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRL 342
              +  +  K+DV+SFGI L EL T G +PY G+   +  +  V++  R   P      L
Sbjct: 186 AALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVN-REVLDQVERGYRMPCPPECPESL 244
Query: 343 AELLERCWQHDPTQRPNFSQITDILKQMMKEVASE---GEN 380
            +L+ +CW+ DP +RP F  +   L+        +   GEN
Sbjct: 245 HDLMCQCWRKDPEERPTFEYLQAFLEDYFTSTEPQYQPGEN 285

>pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286

Iteration: 1
 Score =  177 bits (450), Expect = 8e-45,   Method: Compositional matrix adjust.
 Identities = 103/281 (36%), Positives = 161/281 (57%), Gaps = 15/281 (5%)
Query: 109 DVWEIDAKQLKIECKVASGSYGDLYKGTY-CSQEVAIKVLKPECVNTEMLKEFSQEVYIM 167
           D WEI  + L++E K+  G +G+++ GT+  +  VAIK LKP  ++ E    F QE  +M
Sbjct: 11  DAWEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEA---FLQEAQVM 67
Query: 168 RKIRHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVF-QLTSLLKVAIDVSKG 226
           +K+RH+ +VQ     +  P + IVTE+M++GS+ DFL  + G + +L  L+ +A  ++ G
Sbjct: 68  KKLRHEKLVQLYAVVSEEP-IYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASG 126
Query: 227 MNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAETGT---YRWMAPE 283
           M Y+ + N +HRDL+ AN+L+ EN V KVADFG+AR+  +    TA  G     +W APE
Sbjct: 127 MAYVERMNYVHRDLRAANILVGENLVCKVADFGLARL-IEDNEYTARQGAKFPIKWTAPE 185
Query: 284 VIEHKPYDYKADVFSFGIALWELLT-GELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRL 342
              +  +  K+DV+SFGI L EL T G +PY G+   +  +  V++  R   P      L
Sbjct: 186 AALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVN-REVLDQVERGYRMPCPPECPESL 244
Query: 343 AELLERCWQHDPTQRPNFSQITDILKQMMKEVASE---GEN 380
            +L+ +CW+ DP +RP F  +   L+        +   GEN
Sbjct: 245 HDLMCQCWRKDPEERPTFEYLQAFLEDYFTSTEPQYQPGEN 285

>pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276

Iteration: 1
 Score =  177 bits (449), Expect = 8e-45,   Method: Compositional matrix adjust.
 Identities = 98/265 (36%), Positives = 158/265 (59%), Gaps = 12/265 (4%)
Query: 109 DVWEIDAKQLKIECKVASGSYGDLYKGTYCSQEVAIKVLKPECVNTEMLKEFSQEVYIMR 168
           D WEI   Q+ +  ++ SGS+G +YKG +   +VA+K+L       + L+ F  EV ++R
Sbjct: 1   DDWEIPDGQITVGQRIGSGSFGTVYKGKWHG-DVAVKMLNVTAPTPQQLQAFKNEVGVLR 59
Query: 169 KIRHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMN 228
           K RH N++ F+G  T  P L IVT++    S+Y  LH  +  F++  L+ +A   ++GM+
Sbjct: 60  KTRHVNILLFMGYST-APQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMD 118
Query: 229 YLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQ-SGVMTAE--TGTYRWMAPEVI 285
           YLH  +IIHRDLK+ N+ + E+  VK+ DFG+A V+++ SG    E  +G+  WMAPEVI
Sbjct: 119 YLHAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVI 178
Query: 286 ---EHKPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKS-LRPTIPK---HA 338
              +  PY +++DV++FGI L+EL+TG+LPY+ +      + +V +  L P + K   + 
Sbjct: 179 RMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPDLSKVRSNC 238
Query: 339 HPRLAELLERCWQHDPTQRPNFSQI 363
              +  L+  C +    +RP F QI
Sbjct: 239 PKAMKRLMAECLKKKRDERPLFPQI 263

>pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277

Iteration: 1
 Score =  177 bits (449), Expect = 9e-45,   Method: Compositional matrix adjust.
 Identities = 103/281 (36%), Positives = 161/281 (57%), Gaps = 15/281 (5%)
Query: 109 DVWEIDAKQLKIECKVASGSYGDLYKGTY-CSQEVAIKVLKPECVNTEMLKEFSQEVYIM 167
           D WEI  + L++E K+  G +G+++ GT+  +  VAIK LKP  ++ E    F QE  +M
Sbjct: 2   DAWEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEA---FLQEAQVM 58
Query: 168 RKIRHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVF-QLTSLLKVAIDVSKG 226
           +K+RH+ +VQ     +  P + IVTE+M++GS+ DFL  + G + +L  L+ +A  ++ G
Sbjct: 59  KKLRHEKLVQLYAVVSEEP-IYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASG 117
Query: 227 MNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAETGT---YRWMAPE 283
           M Y+ + N +HRDL+ AN+L+ EN V KVADFG+AR+  +    TA  G     +W APE
Sbjct: 118 MAYVERMNYVHRDLRAANILVGENLVCKVADFGLARL-IEDNEYTARQGAKFPIKWTAPE 176
Query: 284 VIEHKPYDYKADVFSFGIALWELLT-GELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRL 342
              +  +  K+DV+SFGI L EL T G +PY G+   +  +  V++  R   P      L
Sbjct: 177 AALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVN-REVLDQVERGYRMPCPPECPESL 235
Query: 343 AELLERCWQHDPTQRPNFSQITDILKQMMKEVASE---GEN 380
            +L+ +CW+ DP +RP F  +   L+        +   GEN
Sbjct: 236 HDLMCQCWRKDPEERPTFEYLQAFLEDYFTSTEPQYQPGEN 276

>pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452

Iteration: 1
 Score =  176 bits (447), Expect = 1e-44,   Method: Compositional matrix adjust.
 Identities = 102/281 (36%), Positives = 161/281 (57%), Gaps = 15/281 (5%)
Query: 109 DVWEIDAKQLKIECKVASGSYGDLYKGTY-CSQEVAIKVLKPECVNTEMLKEFSQEVYIM 167
           D WEI  + L++E K+  G +G+++ GT+  +  VAIK LKP  ++ E    F QE  +M
Sbjct: 177 DAWEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEA---FLQEAQVM 233
Query: 168 RKIRHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVF-QLTSLLKVAIDVSKG 226
           +K+RH+ +VQ     +  P + IVTE+M++GS+ DFL  + G + +L  L+ +A  ++ G
Sbjct: 234 KKLRHEKLVQLYAVVSEEP-IYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASG 292
Query: 227 MNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAETGT---YRWMAPE 283
           M Y+ + N +HRDL+ AN+L+ EN V KVADFG+AR+  +    TA  G     +W APE
Sbjct: 293 MAYVERMNYVHRDLRAANILVGENLVCKVADFGLARL-IEDNEYTARQGAKFPIKWTAPE 351
Query: 284 VIEHKPYDYKADVFSFGIALWELLT-GELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRL 342
              +  +  K+DV+SFGI L EL T G +PY G+   +  +  V++  R   P      L
Sbjct: 352 AALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVN-REVLDQVERGYRMPCPPECPESL 410
Query: 343 AELLERCWQHDPTQRPNFSQITDILKQMMKEVASE---GEN 380
            +L+ +CW+ +P +RP F  +   L+        +   GEN
Sbjct: 411 HDLMCQCWRKEPEERPTFEYLQAFLEDYFTSTEPQXQPGEN 451

>pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452

Iteration: 1
 Score =  176 bits (447), Expect = 2e-44,   Method: Compositional matrix adjust.
 Identities = 102/281 (36%), Positives = 161/281 (57%), Gaps = 15/281 (5%)
Query: 109 DVWEIDAKQLKIECKVASGSYGDLYKGTY-CSQEVAIKVLKPECVNTEMLKEFSQEVYIM 167
           D WEI  + L++E K+  G +G+++ GT+  +  VAIK LKP  ++ E    F QE  +M
Sbjct: 177 DAWEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEA---FLQEAQVM 233
Query: 168 RKIRHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVF-QLTSLLKVAIDVSKG 226
           +K+RH+ +VQ     +  P + IVTE+M++GS+ DFL  + G + +L  L+ +A  ++ G
Sbjct: 234 KKLRHEKLVQLYAVVSEEP-IYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASG 292
Query: 227 MNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAETGT---YRWMAPE 283
           M Y+ + N +HRDL+ AN+L+ EN V KVADFG+AR+  +    TA  G     +W APE
Sbjct: 293 MAYVERMNYVHRDLRAANILVGENLVCKVADFGLARL-IEDNEYTARQGAKFPIKWTAPE 351
Query: 284 VIEHKPYDYKADVFSFGIALWELLT-GELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRL 342
              +  +  K+DV+SFGI L EL T G +PY G+   +  +  V++  R   P      L
Sbjct: 352 AALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVN-REVLDQVERGYRMPCPPECPESL 410
Query: 343 AELLERCWQHDPTQRPNFSQITDILKQMMKEVASE---GEN 380
            +L+ +CW+ +P +RP F  +   L+        +   GEN
Sbjct: 411 HDLMCQCWRKEPEERPTFEYLQAFLEDYFTSTEPQYQPGEN 451

>pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276

Iteration: 1
 Score =  176 bits (447), Expect = 2e-44,   Method: Compositional matrix adjust.
 Identities = 102/281 (36%), Positives = 161/281 (57%), Gaps = 15/281 (5%)
Query: 109 DVWEIDAKQLKIECKVASGSYGDLYKGTY-CSQEVAIKVLKPECVNTEMLKEFSQEVYIM 167
           D WEI  + L++E K+  G +G+++ GT+  +  VAIK LKP  ++ E    F QE  +M
Sbjct: 1   DAWEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEA---FLQEAQVM 57
Query: 168 RKIRHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVF-QLTSLLKVAIDVSKG 226
           +K+RH+ +VQ     +  P + IVTE+M++GS+ DFL  + G + +L  L+ +A  ++ G
Sbjct: 58  KKLRHEKLVQLYAVVSEEP-IXIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASG 116
Query: 227 MNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAETGT---YRWMAPE 283
           M Y+ + N +HRDL+ AN+L+ EN V KVADFG+AR+  +    TA  G     +W APE
Sbjct: 117 MAYVERMNYVHRDLRAANILVGENLVCKVADFGLARL-IEDNEXTARQGAKFPIKWTAPE 175
Query: 284 VIEHKPYDYKADVFSFGIALWELLT-GELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRL 342
              +  +  K+DV+SFGI L EL T G +PY G+   +  +  V++  R   P      L
Sbjct: 176 AALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVN-REVLDQVERGYRMPCPPECPESL 234
Query: 343 AELLERCWQHDPTQRPNFSQITDILKQMMKEVASE---GEN 380
            +L+ +CW+ +P +RP F  +   L+        +   GEN
Sbjct: 235 HDLMCQCWRKEPEERPTFEYLQAFLEDYFTSTEPQYQPGEN 275

>pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286

Iteration: 1
 Score =  176 bits (446), Expect = 2e-44,   Method: Compositional matrix adjust.
 Identities = 103/281 (36%), Positives = 160/281 (56%), Gaps = 15/281 (5%)
Query: 109 DVWEIDAKQLKIECKVASGSYGDLYKGTY-CSQEVAIKVLKPECVNTEMLKEFSQEVYIM 167
           D WEI  + L++E K+  G +G+++ GT+  +  VAIK LKP  ++ E    F QE  +M
Sbjct: 11  DAWEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEA---FLQEAQVM 67
Query: 168 RKIRHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVF-QLTSLLKVAIDVSKG 226
           +K+RH+ +VQ     +  P + IVTE+M++GS+ DFL  + G + +L  L+ +A  ++ G
Sbjct: 68  KKLRHEKLVQLYAVVSEEP-IYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASG 126
Query: 227 MNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAETGT---YRWMAPE 283
           M Y+ + N +HRDL  AN+L+ EN V KVADFG+AR+  +    TA  G     +W APE
Sbjct: 127 MAYVERMNYVHRDLAAANILVGENLVCKVADFGLARL-IEDNEYTARQGAKFPIKWTAPE 185
Query: 284 VIEHKPYDYKADVFSFGIALWELLT-GELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRL 342
              +  +  K+DV+SFGI L EL T G +PY G+   +  +  V++  R   P      L
Sbjct: 186 AALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVN-REVLDQVERGYRMPCPPECPESL 244
Query: 343 AELLERCWQHDPTQRPNFSQITDILKQMMKEVASE---GEN 380
            +L+ +CW+ DP +RP F  +   L+        +   GEN
Sbjct: 245 HDLMCQCWRKDPEERPTFEYLQAFLEDYFTSTEPQYQPGEN 285

>pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535

Iteration: 1
 Score =  176 bits (446), Expect = 2e-44,   Method: Compositional matrix adjust.
 Identities = 102/281 (36%), Positives = 161/281 (57%), Gaps = 15/281 (5%)
Query: 109 DVWEIDAKQLKIECKVASGSYGDLYKGTY-CSQEVAIKVLKPECVNTEMLKEFSQEVYIM 167
           D WEI  + L++E K+  G +G+++ GT+  +  VAIK LKP  ++ E    F QE  +M
Sbjct: 260 DAWEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEA---FLQEAQVM 316
Query: 168 RKIRHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVF-QLTSLLKVAIDVSKG 226
           +K+RH+ +VQ     +  P + IVTE+M++GS+ DFL  + G + +L  L+ +A  ++ G
Sbjct: 317 KKLRHEKLVQLYAVVSEEP-IYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASG 375
Query: 227 MNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAETGT---YRWMAPE 283
           M Y+ + N +HRDL+ AN+L+ EN V KVADFG+AR+  +    TA  G     +W APE
Sbjct: 376 MAYVERMNYVHRDLRAANILVGENLVCKVADFGLARL-IEDNEYTARQGAKFPIKWTAPE 434
Query: 284 VIEHKPYDYKADVFSFGIALWELLT-GELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRL 342
              +  +  K+DV+SFGI L EL T G +PY G+   +  +  V++  R   P      L
Sbjct: 435 AALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNRE-VLDQVERGYRMPCPPECPESL 493
Query: 343 AELLERCWQHDPTQRPNFSQITDILKQMMKEVASE---GEN 380
            +L+ +CW+ +P +RP F  +   L+        +   GEN
Sbjct: 494 HDLMCQCWRKEPEERPTFEYLQAFLEDYFTSTEPQXQPGEN 534

>pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279

Iteration: 1
 Score =  176 bits (446), Expect = 2e-44,   Method: Compositional matrix adjust.
 Identities = 102/281 (36%), Positives = 161/281 (57%), Gaps = 15/281 (5%)
Query: 109 DVWEIDAKQLKIECKVASGSYGDLYKGTY-CSQEVAIKVLKPECVNTEMLKEFSQEVYIM 167
           D WEI  + L++E K+  G +G+++ GT+  +  VAIK LKP  ++ E    F QE  +M
Sbjct: 4   DAWEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEA---FLQEAQVM 60
Query: 168 RKIRHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVF-QLTSLLKVAIDVSKG 226
           +K+RH+ +VQ     +  P + IVTE+M++GS+ DFL  + G + +L  L+ +A  ++ G
Sbjct: 61  KKLRHEKLVQLYAVVSEEP-IYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASG 119
Query: 227 MNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAETGT---YRWMAPE 283
           M Y+ + N +HRDL+ AN+L+ EN V KVADFG+AR+  +    TA  G     +W APE
Sbjct: 120 MAYVERMNYVHRDLRAANILVGENLVCKVADFGLARL-IEDNEYTARQGAKFPIKWTAPE 178
Query: 284 VIEHKPYDYKADVFSFGIALWELLT-GELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRL 342
              +  +  K+DV+SFGI L EL T G +PY G+   +  +  V++  R   P      L
Sbjct: 179 AALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVN-REVLDQVERGYRMPCPPECPESL 237
Query: 343 AELLERCWQHDPTQRPNFSQITDILKQMMKEVASE---GEN 380
            +L+ +CW+ +P +RP F  +   L+        +   GEN
Sbjct: 238 HDLMCQCWRKEPEERPTFEYLQAFLEDYFTSTEPQYQPGEN 278

>pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454

Iteration: 1
 Score =  176 bits (446), Expect = 2e-44,   Method: Compositional matrix adjust.
 Identities = 95/276 (34%), Positives = 158/276 (57%), Gaps = 10/276 (3%)
Query: 109 DVWEIDAKQLKIECKVASGSYGDLYKGTYCSQ-EVAIKVLKPECVNTEMLKEFSQEVYIM 167
           D WEI  + LK+E K+ +G +G+++  TY    +VA+K +KP  ++ E    F  E  +M
Sbjct: 181 DAWEIPRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGSMSVEA---FLAEANVM 237
Query: 168 RKIRHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQ-LTSLLKVAIDVSKG 226
           + ++H  +V+     T+ P + I+TEFMA+GS+ DFL   +G  Q L  L+  +  +++G
Sbjct: 238 KTLQHDKLVKLHAVVTKEP-IYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEG 296
Query: 227 MNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAETGTY--RWMAPEV 284
           M ++ Q N IHRDL+ AN+L+  + V K+ADFG+ARV   +     E   +  +W APE 
Sbjct: 297 MAFIEQRNYIHRDLRAANILVSASLVCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEA 356
Query: 285 IEHKPYDYKADVFSFGIALWELLT-GELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRLA 343
           I    +  K+DV+SFGI L E++T G +PY G++  +  +  +++  R   P++    L 
Sbjct: 357 INFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPE-VIRALERGYRMPRPENCPEELY 415
Query: 344 ELLERCWQHDPTQRPNFSQITDILKQMMKEVASEGE 379
            ++ RCW++ P +RP F  I  +L        S+ E
Sbjct: 416 NIMMRCWKNRPEERPTFEYIQSVLDDFYTATESQXE 451

>pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276

Iteration: 1
 Score =  176 bits (446), Expect = 2e-44,   Method: Compositional matrix adjust.
 Identities = 97/265 (36%), Positives = 158/265 (59%), Gaps = 12/265 (4%)
Query: 109 DVWEIDAKQLKIECKVASGSYGDLYKGTYCSQEVAIKVLKPECVNTEMLKEFSQEVYIMR 168
           D WEI   Q+ +  ++ SGS+G +YKG +   +VA+K+L       + L+ F  EV ++R
Sbjct: 1   DDWEIPDGQITVGQRIGSGSFGTVYKGKWHG-DVAVKMLNVTAPTPQQLQAFKNEVGVLR 59
Query: 169 KIRHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMN 228
           K RH N++ F+G  T+P  L IVT++    S+Y  LH  +  F++  L+ +A   ++GM+
Sbjct: 60  KTRHVNILLFMGYSTKP-QLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMD 118
Query: 229 YLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQ-SGVMTAE--TGTYRWMAPEVI 285
           YLH  +IIHRDLK+ N+ + E+  VK+ DFG+A  +++ SG    E  +G+  WMAPEVI
Sbjct: 119 YLHAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVI 178
Query: 286 ---EHKPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKS-LRPTIPK---HA 338
              +  PY +++DV++FGI L+EL+TG+LPY+ +      + +V +  L P + K   + 
Sbjct: 179 RMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPDLSKVRSNC 238
Query: 339 HPRLAELLERCWQHDPTQRPNFSQI 363
              +  L+  C +    +RP F QI
Sbjct: 239 PKAMKRLMAECLKKKRDERPLFPQI 263

>pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453

Iteration: 1
 Score =  176 bits (445), Expect = 3e-44,   Method: Compositional matrix adjust.
 Identities = 102/281 (36%), Positives = 160/281 (56%), Gaps = 15/281 (5%)
Query: 109 DVWEIDAKQLKIECKVASGSYGDLYKGTY-CSQEVAIKVLKPECVNTEMLKEFSQEVYIM 167
           D WEI  + L++E K+  G +G+++ GT+  +  VAIK LKP  ++ E    F QE  +M
Sbjct: 178 DAWEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGNMSPEA---FLQEAQVM 234
Query: 168 RKIRHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVF-QLTSLLKVAIDVSKG 226
           +K+RH+ +VQ     +  P + IVTE+M++GS+ DFL  + G + +L  L+ +A  ++ G
Sbjct: 235 KKLRHEKLVQLYAVVSEEP-IYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASG 293
Query: 227 MNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAETGT---YRWMAPE 283
           M Y+ + N +HRDL+ AN+L+ EN V KVADFG+ R+  +    TA  G     +W APE
Sbjct: 294 MAYVERMNYVHRDLRAANILVGENLVCKVADFGLGRL-IEDNEYTARQGAKFPIKWTAPE 352
Query: 284 VIEHKPYDYKADVFSFGIALWELLT-GELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRL 342
              +  +  K+DV+SFGI L EL T G +PY G+   +  +  V++  R   P      L
Sbjct: 353 AALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVN-REVLDQVERGYRMPCPPECPESL 411
Query: 343 AELLERCWQHDPTQRPNFSQITDILKQMMKEVASE---GEN 380
            +L+ +CW+ DP +RP F  +   L+        +   GEN
Sbjct: 412 HDLMCQCWRKDPEERPTFEYLQAFLEDYFTSTEPQXQPGEN 452

>pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286

Iteration: 1
 Score =  175 bits (444), Expect = 3e-44,   Method: Compositional matrix adjust.
 Identities = 102/281 (36%), Positives = 160/281 (56%), Gaps = 15/281 (5%)
Query: 109 DVWEIDAKQLKIECKVASGSYGDLYKGTY-CSQEVAIKVLKPECVNTEMLKEFSQEVYIM 167
           D WEI  + L++E K+  G +G+++ GT+  +  VAIK LKP  ++ E    F QE  +M
Sbjct: 11  DAWEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEA---FLQEAQVM 67
Query: 168 RKIRHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVF-QLTSLLKVAIDVSKG 226
           +K+RH+ +VQ     +  P + IVTE+M++G + DFL  + G + +L  L+ +A  ++ G
Sbjct: 68  KKLRHEKLVQLYAVVSEEP-IYIVTEYMSKGCLLDFLKGEMGKYLRLPQLVDMAAQIASG 126
Query: 227 MNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAETGT---YRWMAPE 283
           M Y+ + N +HRDL+ AN+L+ EN V KVADFG+AR+  +    TA  G     +W APE
Sbjct: 127 MAYVERMNYVHRDLRAANILVGENLVCKVADFGLARL-IEDNEYTARQGAKFPIKWTAPE 185
Query: 284 VIEHKPYDYKADVFSFGIALWELLT-GELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRL 342
              +  +  K+DV+SFGI L EL T G +PY G+   +  +  V++  R   P      L
Sbjct: 186 AALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVN-REVLDQVERGYRMPCPPECPESL 244
Query: 343 AELLERCWQHDPTQRPNFSQITDILKQMMKEVASE---GEN 380
            +L+ +CW+ DP +RP F  +   L+        +   GEN
Sbjct: 245 HDLMCQCWRKDPEERPTFEYLQAFLEDYFTSTEPQYQPGEN 285

>pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286

Iteration: 1
 Score =  175 bits (444), Expect = 4e-44,   Method: Compositional matrix adjust.
 Identities = 102/281 (36%), Positives = 160/281 (56%), Gaps = 15/281 (5%)
Query: 109 DVWEIDAKQLKIECKVASGSYGDLYKGTY-CSQEVAIKVLKPECVNTEMLKEFSQEVYIM 167
           D WEI  + L++E K+  G +G+++ GT+  +  VAIK LKP  ++ E    F QE  +M
Sbjct: 11  DAWEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEA---FLQEAQVM 67
Query: 168 RKIRHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVF-QLTSLLKVAIDVSKG 226
           +K+RH+ +VQ     +  P + IV E+M++GS+ DFL  + G + +L  L+ +A  ++ G
Sbjct: 68  KKLRHEKLVQLYAVVSEEP-IYIVIEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASG 126
Query: 227 MNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAETGT---YRWMAPE 283
           M Y+ + N +HRDL+ AN+L+ EN V KVADFG+AR+  +    TA  G     +W APE
Sbjct: 127 MAYVERMNYVHRDLRAANILVGENLVCKVADFGLARL-IEDNEYTARQGAKFPIKWTAPE 185
Query: 284 VIEHKPYDYKADVFSFGIALWELLT-GELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRL 342
              +  +  K+DV+SFGI L EL T G +PY G+   +  +  V++  R   P      L
Sbjct: 186 AALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVN-REVLDQVERGYRMPCPPECPESL 244
Query: 343 AELLERCWQHDPTQRPNFSQITDILKQMMKEVASE---GEN 380
            +L+ +CW+ DP +RP F  +   L+        +   GEN
Sbjct: 245 HDLMCQCWRKDPEERPTFEYLQAFLEDYFTSTEPQYQPGEN 285

>pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286

Iteration: 1
 Score =  175 bits (444), Expect = 4e-44,   Method: Compositional matrix adjust.
 Identities = 102/281 (36%), Positives = 160/281 (56%), Gaps = 15/281 (5%)
Query: 109 DVWEIDAKQLKIECKVASGSYGDLYKGTY-CSQEVAIKVLKPECVNTEMLKEFSQEVYIM 167
           D WEI  + L++E K+  G +G+++ GT+  +  VAIK LKP  ++ E    F QE  +M
Sbjct: 11  DAWEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEA---FLQEAQVM 67
Query: 168 RKIRHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVF-QLTSLLKVAIDVSKG 226
           +K+RH+ +VQ     +  P + IV E+M++GS+ DFL  + G + +L  L+ +A  ++ G
Sbjct: 68  KKLRHEKLVQLYAVVSEEP-IYIVIEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASG 126
Query: 227 MNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAETGT---YRWMAPE 283
           M Y+ + N +HRDL+ AN+L+ EN V KVADFG+AR+  +    TA  G     +W APE
Sbjct: 127 MAYVERMNYVHRDLRAANILVGENLVCKVADFGLARL-IEDNEXTARQGAKFPIKWTAPE 185
Query: 284 VIEHKPYDYKADVFSFGIALWELLT-GELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRL 342
              +  +  K+DV+SFGI L EL T G +PY G+   +  +  V++  R   P      L
Sbjct: 186 AALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVN-REVLDQVERGYRMPCPPECPESL 244
Query: 343 AELLERCWQHDPTQRPNFSQITDILKQMMKEVASE---GEN 380
            +L+ +CW+ DP +RP F  +   L+        +   GEN
Sbjct: 245 HDLMCQCWRKDPEERPTFEYLQAFLEDYFTSTEPQYQPGEN 285

>pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286

Iteration: 1
 Score =  175 bits (444), Expect = 4e-44,   Method: Compositional matrix adjust.
 Identities = 102/281 (36%), Positives = 160/281 (56%), Gaps = 15/281 (5%)
Query: 109 DVWEIDAKQLKIECKVASGSYGDLYKGTY-CSQEVAIKVLKPECVNTEMLKEFSQEVYIM 167
           D WEI  + L++E K+  G +G+++ GT+  +  VAIK LKP  ++ E    F QE  +M
Sbjct: 11  DAWEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEA---FLQEAQVM 67
Query: 168 RKIRHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVF-QLTSLLKVAIDVSKG 226
           +K+RH+ +VQ     +  P + IV E+M++GS+ DFL  + G + +L  L+ +A  ++ G
Sbjct: 68  KKLRHEKLVQLYAVVSEEP-IYIVCEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASG 126
Query: 227 MNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAETGT---YRWMAPE 283
           M Y+ + N +HRDL+ AN+L+ EN V KVADFG+AR+  +    TA  G     +W APE
Sbjct: 127 MAYVERMNYVHRDLRAANILVGENLVCKVADFGLARL-IEDNEYTARQGAKFPIKWTAPE 185
Query: 284 VIEHKPYDYKADVFSFGIALWELLT-GELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRL 342
              +  +  K+DV+SFGI L EL T G +PY G+   +  +  V++  R   P      L
Sbjct: 186 AALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVN-REVLDQVERGYRMPCPPECPESL 244
Query: 343 AELLERCWQHDPTQRPNFSQITDILKQMMKEVASE---GEN 380
            +L+ +CW+ DP +RP F  +   L+        +   GEN
Sbjct: 245 HDLMCQCWRKDPEERPTFEYLQAFLEDYFTSTEPQYQPGEN 285

>pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275

Iteration: 1
 Score =  175 bits (444), Expect = 4e-44,   Method: Compositional matrix adjust.
 Identities = 102/280 (36%), Positives = 160/280 (57%), Gaps = 15/280 (5%)
Query: 110 VWEIDAKQLKIECKVASGSYGDLYKGTY-CSQEVAIKVLKPECVNTEMLKEFSQEVYIMR 168
            WEI  + L++E K+  G +G+++ GT+  +  VAIK LKP  ++ E    F QE  +M+
Sbjct: 1   AWEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEA---FLQEAQVMK 57
Query: 169 KIRHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVF-QLTSLLKVAIDVSKGM 227
           K+RH+ +VQ     +  P + IVTE+M++GS+ DFL  + G + +L  L+ +A  ++ GM
Sbjct: 58  KLRHEKLVQLYAVVSEEP-IYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGM 116
Query: 228 NYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAETGT---YRWMAPEV 284
            Y+ + N +HRDL+ AN+L+ EN V KVADFG+AR+  +    TA  G     +W APE 
Sbjct: 117 AYVERMNYVHRDLRAANILVGENLVCKVADFGLARL-IEDNEYTARQGAKFPIKWTAPEA 175
Query: 285 IEHKPYDYKADVFSFGIALWELLT-GELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRLA 343
             +  +  K+DV+SFGI L EL T G +PY G+   +  +  V++  R   P      L 
Sbjct: 176 ALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVN-REVLDQVERGYRMPCPPECPESLH 234
Query: 344 ELLERCWQHDPTQRPNFSQITDILKQMMKEVASE---GEN 380
           +L+ +CW+ DP +RP F  +   L+        +   GEN
Sbjct: 235 DLMCQCWRKDPEERPTFEYLQAFLEDYFTSTEPQYQPGEN 274

>pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270

Iteration: 1
 Score =  174 bits (442), Expect = 5e-44,   Method: Compositional matrix adjust.
 Identities = 93/264 (35%), Positives = 155/264 (58%), Gaps = 10/264 (3%)
Query: 109 DVWEIDAKQLKIECKVASGSYGDLYKGTYCSQ-EVAIKVLKPECVNTEMLKEFSQEVYIM 167
           D WEI  + LK+E K+ +G +G+++  TY    +VA+K +KP  ++ E    F  E  +M
Sbjct: 8   DAWEIPRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGSMSVEA---FLAEANVM 64
Query: 168 RKIRHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQ-LTSLLKVAIDVSKG 226
           + ++H  +V+     T+ P + I+TEFMA+GS+ DFL   +G  Q L  L+  +  +++G
Sbjct: 65  KTLQHDKLVKLHAVVTKEP-IYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEG 123
Query: 227 MNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAETGTY--RWMAPEV 284
           M ++ Q N IHRDL+ AN+L+  + V K+ADFG+ARV   +     E   +  +W APE 
Sbjct: 124 MAFIEQRNYIHRDLRAANILVSASLVCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEA 183
Query: 285 IEHKPYDYKADVFSFGIALWELLT-GELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRLA 343
           I    +  K+DV+SFGI L E++T G +PY G++  +  +  +++  R   P++    L 
Sbjct: 184 INFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPE-VIRALERGYRMPRPENCPEELY 242
Query: 344 ELLERCWQHDPTQRPNFSQITDIL 367
            ++ RCW++ P +RP F  I  +L
Sbjct: 243 NIMMRCWKNRPEERPTFEYIQSVL 266

>pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278

Iteration: 1
 Score =  174 bits (441), Expect = 7e-44,   Method: Compositional matrix adjust.
 Identities = 97/265 (36%), Positives = 152/265 (57%), Gaps = 14/265 (5%)
Query: 111 WEIDAKQLKIECKVASGSYGDLYKGTYCSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKI 170
           W ++ K+LK+   +  G +GD+  G Y   +VA+K +K    N    + F  E  +M ++
Sbjct: 16  WALNMKELKLLQTIGKGEFGDVMLGDYRGNKVAVKCIK----NDATAQAFLAEASVMTQL 71
Query: 171 RHKNVVQFIGACTRPPN-LCIVTEFMARGSIYDFLHKQ-KGVFQLTSLLKVAIDVSKGMN 228
           RH N+VQ +G        L IVTE+MA+GS+ D+L  + + V     LLK ++DV + M 
Sbjct: 72  RHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAME 131
Query: 229 YLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAETGTY--RWMAPEVIE 286
           YL  NN +HRDL   N+L+ E+ V KV+DFG+ + +A S   T +TG    +W APE + 
Sbjct: 132 YLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTK-EASS---TQDTGKLPVKWTAPEALR 187
Query: 287 HKPYDYKADVFSFGIALWELLT-GELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRLAEL 345
            K +  K+DV+SFGI LWE+ + G +PY  + PL+  V  V+K  +   P    P + E+
Sbjct: 188 EKKFSTKSDVWSFGILLWEIYSFGRVPYPRI-PLKDVVPRVEKGYKMDAPDGCPPAVYEV 246
Query: 346 LERCWQHDPTQRPNFSQITDILKQM 370
           ++ CW  D   RP+F Q+ + L+ +
Sbjct: 247 MKNCWHLDAAMRPSFLQLREQLEHI 271

>pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452

Iteration: 1
 Score =  174 bits (441), Expect = 8e-44,   Method: Compositional matrix adjust.
 Identities = 101/281 (35%), Positives = 160/281 (56%), Gaps = 15/281 (5%)
Query: 109 DVWEIDAKQLKIECKVASGSYGDLYKGTY-CSQEVAIKVLKPECVNTEMLKEFSQEVYIM 167
           D WEI  + L++E K+  G +G+++ GT+  +  VAIK LKP  ++ E    F QE  +M
Sbjct: 177 DAWEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEA---FLQEAQVM 233
Query: 168 RKIRHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVF-QLTSLLKVAIDVSKG 226
           +K+RH+ +VQ     +  P + IV E+M++GS+ DFL  + G + +L  L+ +A  ++ G
Sbjct: 234 KKLRHEKLVQLYAVVSEEP-IYIVGEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASG 292
Query: 227 MNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAETGT---YRWMAPE 283
           M Y+ + N +HRDL+ AN+L+ EN V KVADFG+AR+  +    TA  G     +W APE
Sbjct: 293 MAYVERMNYVHRDLRAANILVGENLVCKVADFGLARL-IEDNEYTARQGAKFPIKWTAPE 351
Query: 284 VIEHKPYDYKADVFSFGIALWELLT-GELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRL 342
              +  +  K+DV+SFGI L EL T G +PY G+   +  +  V++  R   P      L
Sbjct: 352 AALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVN-REVLDQVERGYRMPCPPECPESL 410
Query: 343 AELLERCWQHDPTQRPNFSQITDILKQMMKEVASE---GEN 380
            +L+ +CW+ +P +RP F  +   L+        +   GEN
Sbjct: 411 HDLMCQCWRKEPEERPTFEYLQAFLEDYFTSTEPQXQPGEN 451

>pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263

Iteration: 1
 Score =  174 bits (441), Expect = 8e-44,   Method: Compositional matrix adjust.
 Identities = 97/265 (36%), Positives = 152/265 (57%), Gaps = 14/265 (5%)
Query: 111 WEIDAKQLKIECKVASGSYGDLYKGTYCSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKI 170
           W ++ K+LK+   +  G +GD+  G Y   +VA+K +K    N    + F  E  +M ++
Sbjct: 1   WALNMKELKLLQTIGKGEFGDVMLGDYRGNKVAVKCIK----NDATAQAFLAEASVMTQL 56
Query: 171 RHKNVVQFIGACTRPPN-LCIVTEFMARGSIYDFLHKQ-KGVFQLTSLLKVAIDVSKGMN 228
           RH N+VQ +G        L IVTE+MA+GS+ D+L  + + V     LLK ++DV + M 
Sbjct: 57  RHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAME 116
Query: 229 YLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAETGTY--RWMAPEVIE 286
           YL  NN +HRDL   N+L+ E+ V KV+DFG+ + +A S   T +TG    +W APE + 
Sbjct: 117 YLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTK-EASS---TQDTGKLPVKWTAPEALR 172
Query: 287 HKPYDYKADVFSFGIALWELLT-GELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRLAEL 345
            K +  K+DV+SFGI LWE+ + G +PY  + PL+  V  V+K  +   P    P + E+
Sbjct: 173 EKKFSTKSDVWSFGILLWEIYSFGRVPYPRI-PLKDVVPRVEKGYKMDAPDGCPPAVYEV 231
Query: 346 LERCWQHDPTQRPNFSQITDILKQM 370
           ++ CW  D   RP+F Q+ + L+ +
Sbjct: 232 MKNCWHLDAAMRPSFLQLREQLEHI 256

>pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438

Iteration: 1
 Score =  174 bits (441), Expect = 8e-44,   Method: Compositional matrix adjust.
 Identities = 94/276 (34%), Positives = 158/276 (57%), Gaps = 16/276 (5%)
Query: 109 DVWEIDAKQLKIECKVASGSYGDLYKGTYCSQ-EVAIKVLKPECVNTEMLKEFSQEVYIM 167
           D WEI  + LK+E K+ +G +G+++  TY    +VA+K +KP  ++ E    F  E  +M
Sbjct: 175 DAWEIPRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGSMSVEA---FLAEANVM 231
Query: 168 RKIRHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQ-LTSLLKVAIDVSKG 226
           + ++H  +V+     T+ P + I+TEFMA+GS+ DFL   +G  Q L  L+  +  +++G
Sbjct: 232 KTLQHDKLVKLHAVVTKEP-IYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEG 290
Query: 227 MNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAETGTYRWMAPEVIE 286
           M ++ Q N IHRDL+ AN+L+  + V K+ADFG+ARV A+  +        +W APE I 
Sbjct: 291 MAFIEQRNYIHRDLRAANILVSASLVCKIADFGLARVGAKFPI--------KWTAPEAIN 342
Query: 287 HKPYDYKADVFSFGIALWELLT-GELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRLAEL 345
              +  K+DV+SFGI L E++T G +PY G++  +  +  +++  R   P++    L  +
Sbjct: 343 FGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPE-VIRALERGYRMPRPENCPEELYNI 401
Query: 346 LERCWQHDPTQRPNFSQITDILKQMMKEVASEGENN 381
           + RCW++ P +RP F  I  +L        S+ +  
Sbjct: 402 MMRCWKNRPEERPTFEYIQSVLDDFYTATESQXQQQ 437

>pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283

Iteration: 1
 Score =  174 bits (441), Expect = 8e-44,   Method: Compositional matrix adjust.
 Identities = 101/281 (35%), Positives = 160/281 (56%), Gaps = 15/281 (5%)
Query: 109 DVWEIDAKQLKIECKVASGSYGDLYKGTY-CSQEVAIKVLKPECVNTEMLKEFSQEVYIM 167
           D WEI  + L++E K+  G +G+++ GT+  +  VAIK LKP  ++ E    F QE  +M
Sbjct: 8   DAWEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEA---FLQEAQVM 64
Query: 168 RKIRHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVF-QLTSLLKVAIDVSKG 226
           +K+RH+ +VQ     +  P + IVTE+M +GS+ DFL  + G + +L  L+ ++  ++ G
Sbjct: 65  KKLRHEKLVQLYAVVSEEP-IYIVTEYMNKGSLLDFLKGETGKYLRLPQLVDMSAQIASG 123
Query: 227 MNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAETGT---YRWMAPE 283
           M Y+ + N +HRDL+ AN+L+ EN V KVADFG+AR+  +    TA  G     +W APE
Sbjct: 124 MAYVERMNYVHRDLRAANILVGENLVCKVADFGLARL-IEDNEWTARQGAKFPIKWTAPE 182
Query: 284 VIEHKPYDYKADVFSFGIALWELLT-GELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRL 342
              +  +  K+DV+SFGI L EL T G +PY G+   +  +  V++  R   P      L
Sbjct: 183 AALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVN-REVLDQVERGYRMPCPPECPESL 241
Query: 343 AELLERCWQHDPTQRPNFSQITDILKQMMKEVASE---GEN 380
            +L+ +CW+ +P +RP F  +   L+        +   GEN
Sbjct: 242 HDLMCQCWRKEPEERPTFEYLQAFLEDYFTSTEPQYQPGEN 282

>pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283

Iteration: 1
 Score =  174 bits (441), Expect = 9e-44,   Method: Compositional matrix adjust.
 Identities = 101/281 (35%), Positives = 160/281 (56%), Gaps = 15/281 (5%)
Query: 109 DVWEIDAKQLKIECKVASGSYGDLYKGTY-CSQEVAIKVLKPECVNTEMLKEFSQEVYIM 167
           D WEI  + L++E K+  G +G+++ GT+  +  VAIK LKP  ++ E    F QE  +M
Sbjct: 8   DAWEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEA---FLQEAQVM 64
Query: 168 RKIRHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVF-QLTSLLKVAIDVSKG 226
           +K+RH+ +VQ     +  P + IVTE+M +GS+ DFL  + G + +L  L+ ++  ++ G
Sbjct: 65  KKLRHEKLVQLYAVVSEEP-IYIVTEYMNKGSLLDFLKGETGKYLRLPQLVDMSAQIASG 123
Query: 227 MNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAETGT---YRWMAPE 283
           M Y+ + N +HRDL+ AN+L+ EN V KVADFG+AR+  +    TA  G     +W APE
Sbjct: 124 MAYVERMNYVHRDLRAANILVGENLVCKVADFGLARL-IEDNEYTARQGAKFPIKWTAPE 182
Query: 284 VIEHKPYDYKADVFSFGIALWELLT-GELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRL 342
              +  +  K+DV+SFGI L EL T G +PY G+   +  +  V++  R   P      L
Sbjct: 183 AALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVN-REVLDQVERGYRMPCPPECPESL 241
Query: 343 AELLERCWQHDPTQRPNFSQITDILKQMMKEVASE---GEN 380
            +L+ +CW+ +P +RP F  +   L+        +   GEN
Sbjct: 242 HDLMCQCWRKEPEERPTFEYLQAFLEDYFTSTEPQYQPGEN 282

>pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286

Iteration: 1
 Score =  173 bits (439), Expect = 1e-43,   Method: Compositional matrix adjust.
 Identities = 101/281 (35%), Positives = 159/281 (56%), Gaps = 15/281 (5%)
Query: 109 DVWEIDAKQLKIECKVASGSYGDLYKGTY-CSQEVAIKVLKPECVNTEMLKEFSQEVYIM 167
           D WEI  + L++E K+  G +G+++ GT+  +  VAIK LKP  ++ E    F QE  +M
Sbjct: 11  DAWEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEA---FLQEAQVM 67
Query: 168 RKIRHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVF-QLTSLLKVAIDVSKG 226
           +K+RH+ +VQ     +  P + IV E+M++G + DFL  + G + +L  L+ +A  ++ G
Sbjct: 68  KKLRHEKLVQLYAVVSEEP-IYIVMEYMSKGCLLDFLKGEMGKYLRLPQLVDMAAQIASG 126
Query: 227 MNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAETGT---YRWMAPE 283
           M Y+ + N +HRDL+ AN+L+ EN V KVADFG+AR+  +    TA  G     +W APE
Sbjct: 127 MAYVERMNYVHRDLRAANILVGENLVCKVADFGLARL-IEDNEYTARQGAKFPIKWTAPE 185
Query: 284 VIEHKPYDYKADVFSFGIALWELLT-GELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRL 342
              +  +  K+DV+SFGI L EL T G +PY G+   +  +  V++  R   P      L
Sbjct: 186 AALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVN-REVLDQVERGYRMPCPPECPESL 244
Query: 343 AELLERCWQHDPTQRPNFSQITDILKQMMKEVASE---GEN 380
            +L+ +CW+ DP +RP F  +   L+        +   GEN
Sbjct: 245 HDLMCQCWRKDPEERPTFEYLQAFLEDYFTSTEPQYQPGEN 285

>pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269

Iteration: 1
 Score =  172 bits (436), Expect = 3e-43,   Method: Compositional matrix adjust.
 Identities = 96/265 (36%), Positives = 151/265 (56%), Gaps = 14/265 (5%)
Query: 111 WEIDAKQLKIECKVASGSYGDLYKGTYCSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKI 170
           W ++ K+LK+   +  G +GD+  G Y   +VA+K +K    N    + F  E  +M ++
Sbjct: 7   WALNMKELKLLQTIGKGEFGDVMLGDYRGNKVAVKCIK----NDATAQAFLAEASVMTQL 62
Query: 171 RHKNVVQFIGACTRPPN-LCIVTEFMARGSIYDFLHKQ-KGVFQLTSLLKVAIDVSKGMN 228
           RH N+VQ +G        L IVTE+MA+GS+ D+L  + + V     LLK ++DV + M 
Sbjct: 63  RHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAME 122
Query: 229 YLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAETGTY--RWMAPEVIE 286
           YL  NN +HRDL   N+L+ E+ V KV+DFG+ + +A S   T +TG    +W APE + 
Sbjct: 123 YLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTK-EASS---TQDTGKLPVKWTAPEALR 178
Query: 287 HKPYDYKADVFSFGIALWELLT-GELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRLAEL 345
              +  K+DV+SFGI LWE+ + G +PY  + PL+  V  V+K  +   P    P + E+
Sbjct: 179 EAAFSTKSDVWSFGILLWEIYSFGRVPYPRI-PLKDVVPRVEKGYKMDAPDGCPPAVYEV 237
Query: 346 LERCWQHDPTQRPNFSQITDILKQM 370
           ++ CW  D   RP+F Q+ + L+ +
Sbjct: 238 MKNCWHLDAAMRPSFLQLREQLEHI 262

>pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450

Iteration: 1
 Score =  172 bits (435), Expect = 4e-43,   Method: Compositional matrix adjust.
 Identities = 96/265 (36%), Positives = 151/265 (56%), Gaps = 14/265 (5%)
Query: 111 WEIDAKQLKIECKVASGSYGDLYKGTYCSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKI 170
           W ++ K+LK+   +  G +GD+  G Y   +VA+K +K    N    + F  E  +M ++
Sbjct: 188 WALNMKELKLLQTIGKGEFGDVMLGDYRGNKVAVKCIK----NDATAQAFLAEASVMTQL 243
Query: 171 RHKNVVQFIGACTRPPN-LCIVTEFMARGSIYDFLHKQ-KGVFQLTSLLKVAIDVSKGMN 228
           RH N+VQ +G        L IVTE+MA+GS+ D+L  + + V     LLK ++DV + M 
Sbjct: 244 RHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAME 303
Query: 229 YLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAETGTY--RWMAPEVIE 286
           YL  NN +HRDL   N+L+ E+ V KV+DFG+ + +A S   T +TG    +W APE + 
Sbjct: 304 YLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTK-EASS---TQDTGKLPVKWTAPEALR 359
Query: 287 HKPYDYKADVFSFGIALWELLT-GELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRLAEL 345
            K +  K+DV+SFGI LWE+ + G +PY  + PL+  V  V+K  +   P    P + ++
Sbjct: 360 EKKFSTKSDVWSFGILLWEIYSFGRVPYPRI-PLKDVVPRVEKGYKMDAPDGCPPAVYDV 418
Query: 346 LERCWQHDPTQRPNFSQITDILKQM 370
           ++ CW  D   RP F Q+ + L+ +
Sbjct: 419 MKNCWHLDAATRPTFLQLREQLEHI 443

>pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267

Iteration: 1
 Score =  171 bits (433), Expect = 7e-43,   Method: Compositional matrix adjust.
 Identities = 94/273 (34%), Positives = 154/273 (56%), Gaps = 14/273 (5%)
Query: 111 WEIDAKQLKIECKVASGSYGDLYKGTYCSQE-VAIKVLKPECVNTEMLKEFSQEVYIMRK 169
           W ID  +L    ++ SG +G ++ G + +++ VAIK ++   ++ E   +F +E  +M K
Sbjct: 3   WVIDPSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSEE---DFIEEAEVMMK 59
Query: 170 IRHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNY 229
           + H  +VQ  G C     +C+VTEFM  G + D+L  Q+G+F   +LL + +DV +GM Y
Sbjct: 60  LSHPKLVQLYGVCLEQAPICLVTEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAY 119
Query: 230 LHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAETGT---YRWMAPEVIE 286
           L +  +IHRDL   N L+ EN V+KV+DFG+ R        T+ TGT    +W +PEV  
Sbjct: 120 LEEACVIHRDLAARNCLVGENQVIKVSDFGMTRF-VLDDQYTSSTGTKFPVKWASPEVFS 178
Query: 287 HKPYDYKADVFSFGIALWELLT-GELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRLAEL 345
              Y  K+DV+SFG+ +WE+ + G++PY   +  +  V  +    R   P+ A   + ++
Sbjct: 179 FSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSE-VVEDISTGFRLYKPRLASTHVYQI 237
Query: 346 LERCWQHDPTQRPNFSQITDILKQMMKEVASEG 378
           +  CW+  P  RP FS+   +L+Q + E+A  G
Sbjct: 238 MNHCWRERPEDRPAFSR---LLRQ-LAEIAESG 266

>pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269

Iteration: 1
 Score =  170 bits (430), Expect = 2e-42,   Method: Compositional matrix adjust.
 Identities = 94/277 (33%), Positives = 155/277 (55%), Gaps = 14/277 (5%)
Query: 107 GTDVWEIDAKQLKIECKVASGSYGDLYKGTYCSQE-VAIKVLKPECVNTEMLKEFSQEVY 165
           G+  W ID  +L    ++ SG +G ++ G + +++ VAIK ++   ++ E   +F +E  
Sbjct: 1   GSGKWVIDPSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSEE---DFIEEAE 57
Query: 166 IMRKIRHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSK 225
           +M K+ H  +VQ  G C     +C+V EFM  G + D+L  Q+G+F   +LL + +DV +
Sbjct: 58  VMMKLSHPKLVQLYGVCLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCE 117
Query: 226 GMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAETGT---YRWMAP 282
           GM YL +  +IHRDL   N L+ EN V+KV+DFG+ R        T+ TGT    +W +P
Sbjct: 118 GMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQ-YTSSTGTKFPVKWASP 176
Query: 283 EVIEHKPYDYKADVFSFGIALWELLT-GELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPR 341
           EV     Y  K+DV+SFG+ +WE+ + G++PY   +  +  V  +    R   P+ A   
Sbjct: 177 EVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSE-VVEDISTGFRLYKPRLASTH 235
Query: 342 LAELLERCWQHDPTQRPNFSQITDILKQMMKEVASEG 378
           + +++  CW+  P  RP FS+   +L+Q + E+A  G
Sbjct: 236 VYQIMNHCWRERPEDRPAFSR---LLRQ-LAEIAESG 268

>pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283

Iteration: 1
 Score =  169 bits (428), Expect = 3e-42,   Method: Compositional matrix adjust.
 Identities = 97/266 (36%), Positives = 157/266 (59%), Gaps = 12/266 (4%)
Query: 109 DVWEIDAKQLKIECKVASGSYGDLYKGTY-CSQEVAIKVLKPECVNTEMLKEFSQEVYIM 167
           DVWEI  + L++  ++ +G +G+++ GT+  + +VAIK LKP  ++ E    F +E  IM
Sbjct: 2   DVWEIPRESLQLIKRLGNGQFGEVWMGTWNGNTKVAIKTLKPGTMSPE---SFLEEAQIM 58
Query: 168 RKIRHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKG-VFQLTSLLKVAIDVSKG 226
           +K++H  +VQ     +  P + IVTE+M +GS+ DFL   +G   +L +L+ +A  V+ G
Sbjct: 59  KKLKHDKLVQLYAVVSEEP-IYIVTEYMNKGSLLDFLKDGEGRALKLPNLVDMAAQVAAG 117
Query: 227 MNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAETGT---YRWMAPE 283
           M Y+ + N IHRDL++AN+L+    + K+ADFG+AR+  +    TA  G     +W APE
Sbjct: 118 MAYIERMNYIHRDLRSANILVGNGLICKIADFGLARL-IEDNEXTARQGAKFPIKWTAPE 176
Query: 284 VIEHKPYDYKADVFSFGIALWELLT-GELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRL 342
              +  +  K+DV+SFGI L EL+T G +PY G+   +  +  V++  R   P+     L
Sbjct: 177 AALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMNN-REVLEQVERGYRMPCPQDCPISL 235
Query: 343 AELLERCWQHDPTQRPNFSQITDILK 368
            EL+  CW+ DP +RP F  +   L+
Sbjct: 236 HELMIHCWKKDPEERPTFEYLQSFLE 261

>pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266

Iteration: 1
 Score =  166 bits (420), Expect = 2e-41,   Method: Compositional matrix adjust.
 Identities = 91/269 (33%), Positives = 151/269 (56%), Gaps = 13/269 (4%)
Query: 113 IDAKQLKIECKVASGSYGDLYKGTYCSQE-VAIKVLKPECVNTEMLKEFSQEVYIMRKIR 171
           ID  +L    ++ SG +G ++ G + +++ VAIK ++   ++ E   +F +E  +M K+ 
Sbjct: 4   IDPSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSEE---DFIEEAEVMMKLS 60
Query: 172 HKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLH 231
           H  +VQ  G C     +C+V EFM  G + D+L  Q+G+F   +LL + +DV +GM YL 
Sbjct: 61  HPKLVQLYGVCLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLE 120
Query: 232 QNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAETGT---YRWMAPEVIEHK 288
           + ++IHRDL   N L+ EN V+KV+DFG+ R        T+ TGT    +W +PEV    
Sbjct: 121 EASVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQ-YTSSTGTKFPVKWASPEVFSFS 179
Query: 289 PYDYKADVFSFGIALWELLT-GELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRLAELLE 347
            Y  K+DV+SFG+ +WE+ + G++PY   +  +  V  +    R   P+ A   + +++ 
Sbjct: 180 RYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSE-VVEDISTGFRLYKPRLASTHVYQIMN 238
Query: 348 RCWQHDPTQRPNFSQITDILKQMMKEVAS 376
            CW+  P  RP FS+   +L+Q+    AS
Sbjct: 239 HCWKERPEDRPAFSR---LLRQLAAIAAS 264

>pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266

Iteration: 1
 Score =  166 bits (419), Expect = 3e-41,   Method: Compositional matrix adjust.
 Identities = 92/271 (33%), Positives = 152/271 (56%), Gaps = 14/271 (5%)
Query: 113 IDAKQLKIECKVASGSYGDLYKGTYCSQE-VAIKVLKPECVNTEMLKEFSQEVYIMRKIR 171
           ID  +L    ++ SG +G ++ G + +++ VAIK ++   ++ E   +F +E  +M K+ 
Sbjct: 4   IDPSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSEE---DFIEEAEVMMKLS 60
Query: 172 HKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLH 231
           H  +VQ  G C     +C+V EFM  G + D+L  Q+G+F   +LL + +DV +GM YL 
Sbjct: 61  HPKLVQLYGVCLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLE 120
Query: 232 QNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAETGT---YRWMAPEVIEHK 288
           +  +IHRDL   N L+ EN V+KV+DFG+ R        T+ TGT    +W +PEV    
Sbjct: 121 EACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQ-YTSSTGTKFPVKWASPEVFSFS 179
Query: 289 PYDYKADVFSFGIALWELLT-GELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRLAELLE 347
            Y  K+DV+SFG+ +WE+ + G++PY   +  +  V  +    R   P+ A   + +++ 
Sbjct: 180 RYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSE-VVEDISTGFRLYKPRLASTHVYQIMN 238
Query: 348 RCWQHDPTQRPNFSQITDILKQMMKEVASEG 378
            CW+  P  RP FS+   +L+Q + E+A  G
Sbjct: 239 HCWKERPEDRPAFSR---LLRQ-LAEIAESG 265

>pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286

Iteration: 1
 Score =  166 bits (419), Expect = 3e-41,   Method: Compositional matrix adjust.
 Identities = 91/276 (32%), Positives = 157/276 (56%), Gaps = 11/276 (3%)
Query: 109 DVWEIDAKQLKIECKVASGSYGDLYKGTYC-SQEVAIKVLKPECVNTEMLKEFSQEVYIM 167
           D WEI  + +K+  ++ +G +G+++ G Y  S +VA+K LKP    T  ++ F +E  +M
Sbjct: 6   DAWEIPRESIKLVKRLGAGQFGEVWMGYYNNSTKVAVKTLKP---GTMSVQAFLEEANLM 62
Query: 168 RKIRHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKG-VFQLTSLLKVAIDVSKG 226
           + ++H  +V+     TR   + I+TE+MA+GS+ DFL   +G    L  L+  +  +++G
Sbjct: 63  KTLQHDKLVRLYAVVTREEPIYIITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEG 122
Query: 227 MNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAETGTY--RWMAPEV 284
           M Y+ + N IHRDL+ AN+L+ E+ + K+ADFG+ARV   +     E   +  +W APE 
Sbjct: 123 MAYIERKNYIHRDLRAANVLVSESLMCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEA 182
Query: 285 IEHKPYDYKADVFSFGIALWELLT-GELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRLA 343
           I    +  K+DV+SFGI L+E++T G++PY G T       + Q    P + ++    L 
Sbjct: 183 INFGCFTIKSDVWSFGILLYEIVTYGKIPYPGRTNADVMTALSQGYRMPRV-ENCPDELY 241
Query: 344 ELLERCWQHDPTQRPNFSQITDILKQMMKEVASEGE 379
           ++++ CW+    +RP F  +  +L       A+EG+
Sbjct: 242 DIMKMCWKEKAEERPTFDYLQSVLDDFY--TATEGQ 275

>pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264

Iteration: 1
 Score =  165 bits (418), Expect = 3e-41,   Method: Compositional matrix adjust.
 Identities = 92/271 (33%), Positives = 152/271 (56%), Gaps = 14/271 (5%)
Query: 113 IDAKQLKIECKVASGSYGDLYKGTYCSQE-VAIKVLKPECVNTEMLKEFSQEVYIMRKIR 171
           ID  +L    ++ SG +G ++ G + +++ VAIK ++   ++ E   +F +E  +M K+ 
Sbjct: 2   IDPSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSEE---DFIEEAEVMMKLS 58
Query: 172 HKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLH 231
           H  +VQ  G C     +C+V EFM  G + D+L  Q+G+F   +LL + +DV +GM YL 
Sbjct: 59  HPKLVQLYGVCLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLE 118
Query: 232 QNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAETGT---YRWMAPEVIEHK 288
           +  +IHRDL   N L+ EN V+KV+DFG+ R        T+ TGT    +W +PEV    
Sbjct: 119 EACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQ-YTSSTGTKFPVKWASPEVFSFS 177
Query: 289 PYDYKADVFSFGIALWELLT-GELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRLAELLE 347
            Y  K+DV+SFG+ +WE+ + G++PY   +  +  V  +    R   P+ A   + +++ 
Sbjct: 178 RYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSE-VVEDISTGFRLYKPRLASTHVYQIMN 236
Query: 348 RCWQHDPTQRPNFSQITDILKQMMKEVASEG 378
            CW+  P  RP FS+   +L+Q + E+A  G
Sbjct: 237 HCWKERPEDRPAFSR---LLRQ-LAEIAESG 263

>pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286

Iteration: 1
 Score =  165 bits (417), Expect = 5e-41,   Method: Compositional matrix adjust.
 Identities = 92/271 (33%), Positives = 152/271 (56%), Gaps = 14/271 (5%)
Query: 113 IDAKQLKIECKVASGSYGDLYKGTYCSQE-VAIKVLKPECVNTEMLKEFSQEVYIMRKIR 171
           ID  +L    ++ SG +G ++ G + +++ VAIK +K   ++ +   +F +E  +M K+ 
Sbjct: 24  IDPSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIKEGSMSED---DFIEEAEVMMKLS 80
Query: 172 HKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLH 231
           H  +VQ  G C     +C+V EFM  G + D+L  Q+G+F   +LL + +DV +GM YL 
Sbjct: 81  HPKLVQLYGVCLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLE 140
Query: 232 QNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAETGT---YRWMAPEVIEHK 288
           +  +IHRDL   N L+ EN V+KV+DFG+ R        T+ TGT    +W +PEV    
Sbjct: 141 EACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQ-YTSSTGTKFPVKWASPEVFSFS 199
Query: 289 PYDYKADVFSFGIALWELLT-GELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRLAELLE 347
            Y  K+DV+SFG+ +WE+ + G++PY   +  +  V  +    R   P+ A   + +++ 
Sbjct: 200 RYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSE-VVEDISTGFRLYKPRLASTHVYQIMN 258
Query: 348 RCWQHDPTQRPNFSQITDILKQMMKEVASEG 378
            CW+  P  RP FS+   +L+Q + E+A  G
Sbjct: 259 HCWKERPEDRPAFSR---LLRQ-LAEIAESG 285

>pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279

Iteration: 1
 Score =  160 bits (406), Expect = 8e-40,   Method: Compositional matrix adjust.
 Identities = 90/274 (32%), Positives = 156/274 (56%), Gaps = 11/274 (4%)
Query: 111 WEIDAKQLKIECKVASGSYGDLYKGTYC-SQEVAIKVLKPECVNTEMLKEFSQEVYIMRK 169
           WEI  + +K+  K+ +G +G+++ G Y  S +VA+K LKP    T  ++ F +E  +M+ 
Sbjct: 7   WEIPRESIKLVKKLGAGQFGEVWMGYYNNSTKVAVKTLKP---GTMSVQAFLEEANLMKT 63
Query: 170 IRHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHK-QKGVFQLTSLLKVAIDVSKGMN 228
           ++H  +V+     T+   + I+TEFMA+GS+ DFL   + G   L  L+  +  +++GM 
Sbjct: 64  LQHDKLVRLYAVVTKEEPIYIITEFMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMA 123
Query: 229 YLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAETGTY--RWMAPEVIE 286
           Y+ + N IHRDL+ AN+L+ E+ + K+ADFG+ARV   +     E   +  +W APE I 
Sbjct: 124 YIERKNYIHRDLRAANVLVSESLMCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAIN 183
Query: 287 HKPYDYKADVFSFGIALWELLT-GELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRLAEL 345
              +  K++V+SFGI L+E++T G++PY G T       + Q    P + ++    L ++
Sbjct: 184 FGCFTIKSNVWSFGILLYEIVTYGKIPYPGRTNADVMSALSQGYRMPRM-ENCPDELYDI 242
Query: 346 LERCWQHDPTQRPNFSQITDILKQMMKEVASEGE 379
           ++ CW+    +RP F  +  +L       A+EG+
Sbjct: 243 MKMCWKEKAEERPTFDYLQSVLDDFY--TATEGQ 274

>pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274

Iteration: 1
 Score =  159 bits (403), Expect = 2e-39,   Method: Compositional matrix adjust.
 Identities = 86/271 (31%), Positives = 148/271 (54%), Gaps = 12/271 (4%)
Query: 107 GTDVWEIDAKQLKIECKVASGSYGDLYKGTYCSQ-EVAIKVLKPECVNTEMLKEFSQEVY 165
           G   WEID K L    ++ +G +G +  G +  Q +VAIK++K   ++ +   EF +E  
Sbjct: 6   GYGSWEIDPKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSED---EFIEEAK 62
Query: 166 IMRKIRHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSK 225
           +M  + H+ +VQ  G CT+   + I+TE+MA G + ++L + +  FQ   LL++  DV +
Sbjct: 63  VMMNLSHEKLVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCE 122
Query: 226 GMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAETGTY--RWMAPE 283
            M YL     +HRDL   N L+++ GVVKV+DFG++R        ++    +  RW  PE
Sbjct: 123 AMEYLESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPE 182
Query: 284 VIEHKPYDYKADVFSFGIALWELLT-GELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRL 342
           V+ +  +  K+D+++FG+ +WE+ + G++PY   T  + A  + Q  LR   P  A  ++
Sbjct: 183 VLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQ-GLRLYRPHLASEKV 241
Query: 343 AELLERCWQHDPTQRPNF----SQITDILKQ 369
             ++  CW     +RP F    S I D++ +
Sbjct: 242 YTIMYSCWHEKADERPTFKILLSNILDVMDE 272

>pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265

Iteration: 1
 Score =  159 bits (402), Expect = 3e-39,   Method: Compositional matrix adjust.
 Identities = 85/265 (32%), Positives = 146/265 (55%), Gaps = 12/265 (4%)
Query: 111 WEIDAKQLKIECKVASGSYGDLYKGTYCSQ-EVAIKVLKPECVNTEMLKEFSQEVYIMRK 169
           WEID K L    ++ +G +G +  G +  Q +VAIK++K   ++ +   EF +E  +M  
Sbjct: 4   WEIDPKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSED---EFIEEAKVMMN 60
Query: 170 IRHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNY 229
           + H+ +VQ  G CT+   + I+TE+MA G + ++L + +  FQ   LL++  DV + M Y
Sbjct: 61  LSHEKLVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEY 120
Query: 230 LHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAETGTY--RWMAPEVIEH 287
           L     +HRDL   N L+++ GVVKV+DFG++R        ++    +  RW  PEV+ +
Sbjct: 121 LESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSRGSKFPVRWSPPEVLMY 180
Query: 288 KPYDYKADVFSFGIALWELLT-GELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRLAELL 346
             +  K+D+++FG+ +WE+ + G++PY   T  + A  + Q  LR   P  A  ++  ++
Sbjct: 181 SKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQ-GLRLYRPHLASEKVYTIM 239
Query: 347 ERCWQHDPTQRPNF----SQITDIL 367
             CW     +RP F    S I D++
Sbjct: 240 YSCWHEKADERPTFKILLSNILDVM 264

>pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283

Iteration: 1
 Score =  159 bits (402), Expect = 3e-39,   Method: Compositional matrix adjust.
 Identities = 86/271 (31%), Positives = 148/271 (54%), Gaps = 12/271 (4%)
Query: 107 GTDVWEIDAKQLKIECKVASGSYGDLYKGTYCSQ-EVAIKVLKPECVNTEMLKEFSQEVY 165
           G   WEID K L    ++ +G +G +  G +  Q +VAIK++K   ++ +   EF +E  
Sbjct: 15  GYGSWEIDPKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSED---EFIEEAK 71
Query: 166 IMRKIRHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSK 225
           +M  + H+ +VQ  G CT+   + I+TE+MA G + ++L + +  FQ   LL++  DV +
Sbjct: 72  VMMNLSHEKLVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCE 131
Query: 226 GMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAETGTY--RWMAPE 283
            M YL     +HRDL   N L+++ GVVKV+DFG++R        ++    +  RW  PE
Sbjct: 132 AMEYLESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPE 191
Query: 284 VIEHKPYDYKADVFSFGIALWELLT-GELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRL 342
           V+ +  +  K+D+++FG+ +WE+ + G++PY   T  + A  + Q  LR   P  A  ++
Sbjct: 192 VLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQ-GLRLYRPHLASEKV 250
Query: 343 AELLERCWQHDPTQRPNF----SQITDILKQ 369
             ++  CW     +RP F    S I D++ +
Sbjct: 251 YTIMYSCWHEKADERPTFKILLSNILDVMDE 281

>pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267

Iteration: 1
 Score =  159 bits (401), Expect = 4e-39,   Method: Compositional matrix adjust.
 Identities = 85/267 (31%), Positives = 147/267 (55%), Gaps = 12/267 (4%)
Query: 111 WEIDAKQLKIECKVASGSYGDLYKGTYCSQ-EVAIKVLKPECVNTEMLKEFSQEVYIMRK 169
           WEID K L    ++ +G +G +  G +  Q +VAIK++K   ++ +   EF +E  +M  
Sbjct: 3   WEIDPKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSED---EFIEEAKVMMN 59
Query: 170 IRHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNY 229
           + H+ +VQ  G CT+   + I+TE+MA G + ++L + +  FQ   LL++  DV + M Y
Sbjct: 60  LSHEKLVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEY 119
Query: 230 LHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAETGTY--RWMAPEVIEH 287
           L     +HRDL   N L+++ GVVKV+DFG++R        ++    +  RW  PEV+ +
Sbjct: 120 LESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMY 179
Query: 288 KPYDYKADVFSFGIALWELLT-GELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRLAELL 346
             +  K+D+++FG+ +WE+ + G++PY   T  + A  + Q  LR   P  A  ++  ++
Sbjct: 180 SKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQ-GLRLYRPHLASEKVYTIM 238
Query: 347 ERCWQHDPTQRPNF----SQITDILKQ 369
             CW     +RP F    S I D++ +
Sbjct: 239 YSCWHEKADERPTFKILLSNILDVMDE 265

>pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271

Iteration: 1
 Score =  158 bits (400), Expect = 4e-39,   Method: Compositional matrix adjust.
 Identities = 85/267 (31%), Positives = 147/267 (55%), Gaps = 12/267 (4%)
Query: 111 WEIDAKQLKIECKVASGSYGDLYKGTYCSQ-EVAIKVLKPECVNTEMLKEFSQEVYIMRK 169
           WEID K L    ++ +G +G +  G +  Q +VAIK++K   ++ +   EF +E  +M  
Sbjct: 4   WEIDPKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSED---EFIEEAKVMMN 60
Query: 170 IRHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNY 229
           + H+ +VQ  G CT+   + I+TE+MA G + ++L + +  FQ   LL++  DV + M Y
Sbjct: 61  LSHEKLVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEY 120
Query: 230 LHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAETGTY--RWMAPEVIEH 287
           L     +HRDL   N L+++ GVVKV+DFG++R        ++    +  RW  PEV+ +
Sbjct: 121 LESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMY 180
Query: 288 KPYDYKADVFSFGIALWELLT-GELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRLAELL 346
             +  K+D+++FG+ +WE+ + G++PY   T  + A  + Q  LR   P  A  ++  ++
Sbjct: 181 SKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQ-GLRLYRPHLASEKVYTIM 239
Query: 347 ERCWQHDPTQRPNF----SQITDILKQ 369
             CW     +RP F    S I D++ +
Sbjct: 240 YSCWHEKADERPTFKILLSNILDVMDE 266

>pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283

Iteration: 1
 Score =  158 bits (400), Expect = 4e-39,   Method: Compositional matrix adjust.
 Identities = 86/271 (31%), Positives = 148/271 (54%), Gaps = 12/271 (4%)
Query: 107 GTDVWEIDAKQLKIECKVASGSYGDLYKGTYCSQ-EVAIKVLKPECVNTEMLKEFSQEVY 165
           G   WEID K L    ++ +G +G +  G +  Q +VAIK++K   ++ +   EF +E  
Sbjct: 15  GYGSWEIDPKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSED---EFIEEAK 71
Query: 166 IMRKIRHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSK 225
           +M  + H+ +VQ  G CT+   + I+TE+MA G + ++L + +  FQ   LL++  DV +
Sbjct: 72  VMMNLSHEKLVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCE 131
Query: 226 GMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAETGTY--RWMAPE 283
            M YL     +HRDL   N L+++ GVVKV+DFG++R        ++    +  RW  PE
Sbjct: 132 AMEYLESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEETSSVGSKFPVRWSPPE 191
Query: 284 VIEHKPYDYKADVFSFGIALWELLT-GELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRL 342
           V+ +  +  K+D+++FG+ +WE+ + G++PY   T  + A  + Q  LR   P  A  ++
Sbjct: 192 VLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQ-GLRLYRPHLASEKV 250
Query: 343 AELLERCWQHDPTQRPNF----SQITDILKQ 369
             ++  CW     +RP F    S I D++ +
Sbjct: 251 YTIMYSCWHEKADERPTFKILLSNILDVMDE 281

>pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315

Iteration: 1
 Score =  158 bits (399), Expect = 6e-39,   Method: Compositional matrix adjust.
 Identities = 93/268 (34%), Positives = 146/268 (54%), Gaps = 17/268 (6%)
Query: 113 IDAKQLKIECKVASGSYGDLYKGTYCSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRH 172
           ID K++++E  V  G++G + K  + +++VAIK ++ E      + E  Q    + ++ H
Sbjct: 6   IDYKEIEVEEVVGRGAFGVVCKAKWRAKDVAIKQIESESERKAFIVELRQ----LSRVNH 61
Query: 173 KNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSL--LKVAIDVSKGMNYL 230
            N+V+  GAC  P  +C+V E+   GS+Y+ LH  + +   T+   +   +  S+G+ YL
Sbjct: 62  PNIVKLYGACLNP--VCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYL 119
Query: 231 HQ---NNIIHRDLKTANLLMDENG-VVKVADFGVA-RVQAQSGVMTAETGTYRWMAPEVI 285
           H      +IHRDLK  NLL+   G V+K+ DFG A  +Q     MT   G+  WMAPEV 
Sbjct: 120 HSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQTH---MTNNKGSAAWMAPEVF 176
Query: 286 EHKPYDYKADVFSFGIALWELLTGELPYAGL-TPLQAAVGVVQKSLRPTIPKHAHPRLAE 344
           E   Y  K DVFS+GI LWE++T   P+  +  P    +  V    RP + K+    +  
Sbjct: 177 EGSNYSEKCDVFSWGIILWEVITRRKPFDEIGGPAFRIMWAVHNGTRPPLIKNLPKPIES 236
Query: 345 LLERCWQHDPTQRPNFSQITDILKQMMK 372
           L+ RCW  DP+QRP+  +I  I+  +M+
Sbjct: 237 LMTRCWSKDPSQRPSMEEIVKIMTHLMR 264

>pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307

Iteration: 1
 Score =  158 bits (399), Expect = 6e-39,   Method: Compositional matrix adjust.
 Identities = 93/268 (34%), Positives = 146/268 (54%), Gaps = 17/268 (6%)
Query: 113 IDAKQLKIECKVASGSYGDLYKGTYCSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRH 172
           ID K++++E  V  G++G + K  + +++VAIK ++ E      + E  Q    + ++ H
Sbjct: 5   IDYKEIEVEEVVGRGAFGVVCKAKWRAKDVAIKQIESESERKAFIVELRQ----LSRVNH 60
Query: 173 KNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSL--LKVAIDVSKGMNYL 230
            N+V+  GAC  P  +C+V E+   GS+Y+ LH  + +   T+   +   +  S+G+ YL
Sbjct: 61  PNIVKLYGACLNP--VCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYL 118
Query: 231 HQ---NNIIHRDLKTANLLMDENG-VVKVADFGVA-RVQAQSGVMTAETGTYRWMAPEVI 285
           H      +IHRDLK  NLL+   G V+K+ DFG A  +Q     MT   G+  WMAPEV 
Sbjct: 119 HSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQTH---MTNNKGSAAWMAPEVF 175
Query: 286 EHKPYDYKADVFSFGIALWELLTGELPYAGL-TPLQAAVGVVQKSLRPTIPKHAHPRLAE 344
           E   Y  K DVFS+GI LWE++T   P+  +  P    +  V    RP + K+    +  
Sbjct: 176 EGSNYSEKCDVFSWGIILWEVITRRKPFDEIGGPAFRIMWAVHNGTRPPLIKNLPKPIES 235
Query: 345 LLERCWQHDPTQRPNFSQITDILKQMMK 372
           L+ RCW  DP+QRP+  +I  I+  +M+
Sbjct: 236 LMTRCWSKDPSQRPSMEEIVKIMTHLMR 263

>pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279

Iteration: 1
 Score =  158 bits (399), Expect = 6e-39,   Method: Compositional matrix adjust.
 Identities = 87/276 (31%), Positives = 156/276 (56%), Gaps = 12/276 (4%)
Query: 109 DVWEIDAKQLKIECKVASGSYGDLYKGTYCSQ-EVAIKVLKPECVNTEMLKEFSQEVYIM 167
           D WE+  + LK+  ++ +G +G+++ G Y    +VA+K LK   ++ +    F  E  +M
Sbjct: 6   DEWEVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDA---FLAEANLM 62
Query: 168 RKIRHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGV-FQLTSLLKVAIDVSKG 226
           ++++H+ +V+     T+ P + I+TE+M  GS+ DFL    G+   +  LL +A  +++G
Sbjct: 63  KQLQHQRLVRLYAVVTQEP-IYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEG 121
Query: 227 MNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAETGTY--RWMAPEV 284
           M ++ + N IHRDL+ AN+L+ +    K+ADFG+AR+   +     E   +  +W APE 
Sbjct: 122 MAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEXTAREGAKFPIKWTAPEA 181
Query: 285 IEHKPYDYKADVFSFGIALWELLT-GELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRLA 343
           I +  +  K+DV+SFGI L E++T G +PY G+T  +  +  +++  R   P +    L 
Sbjct: 182 INYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPE-VIQNLERGYRMVRPDNCPEELY 240
Query: 344 ELLERCWQHDPTQRPNFSQITDILKQMMKEVASEGE 379
           +L+  CW+  P  RP F  +  +L+      A+EG+
Sbjct: 241 QLMRLCWKERPEDRPTFDYLRSVLEDFF--TATEGQ 274

>pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288

Iteration: 1
 Score =  158 bits (399), Expect = 6e-39,   Method: Compositional matrix adjust.
 Identities = 87/276 (31%), Positives = 156/276 (56%), Gaps = 12/276 (4%)
Query: 109 DVWEIDAKQLKIECKVASGSYGDLYKGTYCSQ-EVAIKVLKPECVNTEMLKEFSQEVYIM 167
           D WE+  + LK+  ++ +G +G+++ G Y    +VA+K LK   ++ +    F  E  +M
Sbjct: 15  DEWEVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDA---FLAEANLM 71
Query: 168 RKIRHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGV-FQLTSLLKVAIDVSKG 226
           ++++H+ +V+     T+ P + I+TE+M  GS+ DFL    G+   +  LL +A  +++G
Sbjct: 72  KQLQHQRLVRLYAVVTQEP-IYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEG 130
Query: 227 MNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAETGTY--RWMAPEV 284
           M ++ + N IHRDL+ AN+L+ +    K+ADFG+AR+   +     E   +  +W APE 
Sbjct: 131 MAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEXTAREGAKFPIKWTAPEA 190
Query: 285 IEHKPYDYKADVFSFGIALWELLT-GELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRLA 343
           I +  +  K+DV+SFGI L E++T G +PY G+T  +  +  +++  R   P +    L 
Sbjct: 191 INYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPE-VIQNLERGYRMVRPDNCPEELY 249
Query: 344 ELLERCWQHDPTQRPNFSQITDILKQMMKEVASEGE 379
           +L+  CW+  P  RP F  +  +L+      A+EG+
Sbjct: 250 QLMRLCWKERPEDRPTFDYLRSVLEDFF--TATEGQ 283

>pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285

Iteration: 1
 Score =  158 bits (399), Expect = 6e-39,   Method: Compositional matrix adjust.
 Identities = 87/276 (31%), Positives = 156/276 (56%), Gaps = 12/276 (4%)
Query: 109 DVWEIDAKQLKIECKVASGSYGDLYKGTYCSQ-EVAIKVLKPECVNTEMLKEFSQEVYIM 167
           D WE+  + LK+  ++ +G +G+++ G Y    +VA+K LK   ++ +    F  E  +M
Sbjct: 12  DEWEVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDA---FLAEANLM 68
Query: 168 RKIRHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGV-FQLTSLLKVAIDVSKG 226
           ++++H+ +V+     T+ P + I+TE+M  GS+ DFL    G+   +  LL +A  +++G
Sbjct: 69  KQLQHQRLVRLYAVVTQEP-IYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEG 127
Query: 227 MNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAETGTY--RWMAPEV 284
           M ++ + N IHRDL+ AN+L+ +    K+ADFG+AR+   +     E   +  +W APE 
Sbjct: 128 MAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEXTAREGAKFPIKWTAPEA 187
Query: 285 IEHKPYDYKADVFSFGIALWELLT-GELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRLA 343
           I +  +  K+DV+SFGI L E++T G +PY G+T  +  +  +++  R   P +    L 
Sbjct: 188 INYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPE-VIQNLERGYRMVRPDNCPEELY 246
Query: 344 ELLERCWQHDPTQRPNFSQITDILKQMMKEVASEGE 379
           +L+  CW+  P  RP F  +  +L+      A+EG+
Sbjct: 247 QLMRLCWKERPEDRPTFDYLRSVLEDFF--TATEGQ 280

>pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287

Iteration: 1
 Score =  158 bits (399), Expect = 7e-39,   Method: Compositional matrix adjust.
 Identities = 87/276 (31%), Positives = 156/276 (56%), Gaps = 12/276 (4%)
Query: 109 DVWEIDAKQLKIECKVASGSYGDLYKGTYCSQ-EVAIKVLKPECVNTEMLKEFSQEVYIM 167
           D WE+  + LK+  ++ +G +G+++ G Y    +VA+K LK   ++ +    F  E  +M
Sbjct: 14  DEWEVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDA---FLAEANLM 70
Query: 168 RKIRHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGV-FQLTSLLKVAIDVSKG 226
           ++++H+ +V+     T+ P + I+TE+M  GS+ DFL    G+   +  LL +A  +++G
Sbjct: 71  KQLQHQRLVRLYAVVTQEP-IYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEG 129
Query: 227 MNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAETGTY--RWMAPEV 284
           M ++ + N IHRDL+ AN+L+ +    K+ADFG+AR+   +     E   +  +W APE 
Sbjct: 130 MAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEXTAREGAKFPIKWTAPEA 189
Query: 285 IEHKPYDYKADVFSFGIALWELLT-GELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRLA 343
           I +  +  K+DV+SFGI L E++T G +PY G+T  +  +  +++  R   P +    L 
Sbjct: 190 INYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPE-VIQNLERGYRMVRPDNCPEELY 248
Query: 344 ELLERCWQHDPTQRPNFSQITDILKQMMKEVASEGE 379
           +L+  CW+  P  RP F  +  +L+      A+EG+
Sbjct: 249 QLMRLCWKERPEDRPTFDYLRSVLEDFF--TATEGQ 282

>pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282

Iteration: 1
 Score =  157 bits (398), Expect = 7e-39,   Method: Compositional matrix adjust.
 Identities = 87/283 (30%), Positives = 149/283 (52%), Gaps = 11/283 (3%)
Query: 105 TDGTDVWEIDAKQLKIECKVASGSYGDLYKGTYCSQE-----VAIKVLKPECVNTEMLKE 159
           +  T  +EI  +++++   +  G +GD+++G Y S E     VAIK  K  C +  + ++
Sbjct: 2   SGSTRDYEIQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCK-NCTSDSVREK 60
Query: 160 FSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKV 219
           F QE   MR+  H ++V+ IG  T  P + I+ E    G +  FL  +K    L SL+  
Sbjct: 61  FLQEALTMRQFDHPHIVKLIGVITENP-VWIIMELCTLGELRSFLQVRKYSLDLASLILY 119
Query: 220 AIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAETGTY-- 277
           A  +S  + YL     +HRD+   N+L+  N  VK+ DFG++R    S    A  G    
Sbjct: 120 AYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPI 179
Query: 278 RWMAPEVIEHKPYDYKADVFSFGIALWELLT-GELPYAGLTPLQAAVGVVQKSLRPTIPK 336
           +WMAPE I  + +   +DV+ FG+ +WE+L  G  P+ G+      +G ++   R  +P 
Sbjct: 180 KWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKN-NDVIGRIENGERLPMPP 238
Query: 337 HAHPRLAELLERCWQHDPTQRPNFSQITDILKQMMKEVASEGE 379
           +  P L  L+ +CW +DP++RP F+++   L  +++E  ++ E
Sbjct: 239 NCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILEEEKAQQE 281

>pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289

Iteration: 1
 Score =  157 bits (398), Expect = 7e-39,   Method: Compositional matrix adjust.
 Identities = 87/276 (31%), Positives = 156/276 (56%), Gaps = 12/276 (4%)
Query: 109 DVWEIDAKQLKIECKVASGSYGDLYKGTYCSQ-EVAIKVLKPECVNTEMLKEFSQEVYIM 167
           D WE+  + LK+  ++ +G +G+++ G Y    +VA+K LK   ++ +    F  E  +M
Sbjct: 16  DEWEVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDA---FLAEANLM 72
Query: 168 RKIRHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGV-FQLTSLLKVAIDVSKG 226
           ++++H+ +V+     T+ P + I+TE+M  GS+ DFL    G+   +  LL +A  +++G
Sbjct: 73  KQLQHQRLVRLYAVVTQEP-IYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEG 131
Query: 227 MNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAETGTY--RWMAPEV 284
           M ++ + N IHRDL+ AN+L+ +    K+ADFG+AR+   +     E   +  +W APE 
Sbjct: 132 MAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEA 191
Query: 285 IEHKPYDYKADVFSFGIALWELLT-GELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRLA 343
           I +  +  K+DV+SFGI L E++T G +PY G+T  +  +  +++  R   P +    L 
Sbjct: 192 INYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPE-VIQNLERGYRMVRPDNCPEELY 250
Query: 344 ELLERCWQHDPTQRPNFSQITDILKQMMKEVASEGE 379
           +L+  CW+  P  RP F  +  +L+      A+EG+
Sbjct: 251 QLMRLCWKERPEDRPTFDYLRSVLEDFF--TATEGQ 284

>pdb|3KMW|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Mgatp) Length = 271

Iteration: 1
 Score =  157 bits (398), Expect = 7e-39,   Method: Compositional matrix adjust.
 Identities = 88/266 (33%), Positives = 149/266 (56%), Gaps = 12/266 (4%)
Query: 113 IDAKQLKIECKVASGSYGDLYKGTYCSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRH 172
           ID KQL    K+     G+L+KG +   ++ +KVLK    +T   ++F++E   +R   H
Sbjct: 7   IDFKQLNFLTKLNENHSGELWKGRWQGNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSH 66
Query: 173 KNVVQFIGACTRPP--NLCIVTEFMARGSIYDFLHKQKG-VFQLTSLLKVAIDVSKGMNY 229
            NV+  +GAC  PP  +  ++T +M  GS+Y+ LH+    V   +  +K A+D+++GM +
Sbjct: 67  PNVLPVLGACQSPPAPHPTLITHWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAF 126
Query: 230 LH--QNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAETGTYRWMAPEVIEH 287
           LH  +  I    L + ++++DE+   +++   V       G M A      W+APE ++ 
Sbjct: 127 LHTLEPLIPRHALNSRSVMIDEDMTARISMADVKFSFQSPGRMYAPA----WVAPEALQK 182
Query: 288 KPYDYK---ADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRLAE 344
           KP D     AD++SF + LWEL+T E+P+A L+ ++  + V  + LRPTIP    P +++
Sbjct: 183 KPEDTNRRSADMWSFAVLLWELVTREVPFADLSNMEIGMKVALEGLRPTIPPGISPHVSK 242
Query: 345 LLERCWQHDPTQRPNFSQITDILKQM 370
           L++ C   DP +RP F  I  IL++M
Sbjct: 243 LMKICMNEDPAKRPKFDMIVPILEKM 268

>pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281

Iteration: 1
 Score =  157 bits (398), Expect = 8e-39,   Method: Compositional matrix adjust.
 Identities = 87/280 (31%), Positives = 148/280 (52%), Gaps = 11/280 (3%)
Query: 108 TDVWEIDAKQLKIECKVASGSYGDLYKGTYCSQE-----VAIKVLKPECVNTEMLKEFSQ 162
           T  +EI  +++++   +  G +GD+++G Y S E     VAIK  K  C +  + ++F Q
Sbjct: 4   TRDYEIQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCK-NCTSDSVREKFLQ 62
Query: 163 EVYIMRKIRHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAID 222
           E   MR+  H ++V+ IG  T  P + I+ E    G +  FL  +K    L SL+  A  
Sbjct: 63  EALTMRQFDHPHIVKLIGVITENP-VWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQ 121
Query: 223 VSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAETGTY--RWM 280
           +S  + YL     +HRD+   N+L+  N  VK+ DFG++R    S    A  G    +WM
Sbjct: 122 LSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWM 181
Query: 281 APEVIEHKPYDYKADVFSFGIALWELLT-GELPYAGLTPLQAAVGVVQKSLRPTIPKHAH 339
           APE I  + +   +DV+ FG+ +WE+L  G  P+ G+      +G ++   R  +P +  
Sbjct: 182 APESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKN-NDVIGRIENGERLPMPPNCP 240
Query: 340 PRLAELLERCWQHDPTQRPNFSQITDILKQMMKEVASEGE 379
           P L  L+ +CW +DP++RP F+++   L  +++E  ++ E
Sbjct: 241 PTLYSLMTKCWAYDPSRRPRFTELKAQLSTILEEEKAQQE 280

>pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279

Iteration: 1
 Score =  157 bits (397), Expect = 1e-38,   Method: Compositional matrix adjust.
 Identities = 87/276 (31%), Positives = 155/276 (56%), Gaps = 12/276 (4%)
Query: 109 DVWEIDAKQLKIECKVASGSYGDLYKGTYCSQ-EVAIKVLKPECVNTEMLKEFSQEVYIM 167
           D WE+  + LK+  ++ +G  G+++ G Y    +VA+K LK   ++ +    F  E  +M
Sbjct: 6   DAWEVPRETLKLVERLGAGQAGEVWMGYYNGHTKVAVKSLKQGSMSPDA---FLAEANLM 62
Query: 168 RKIRHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGV-FQLTSLLKVAIDVSKG 226
           ++++H+ +V+     T+ P + I+TE+M  GS+ DFL    G+   +  LL +A  +++G
Sbjct: 63  KQLQHQRLVRLYAVVTQEP-IYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEG 121
Query: 227 MNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAETGTY--RWMAPEV 284
           M ++ + N IHRDL+ AN+L+ +    K+ADFG+AR+   +     E   +  +W APE 
Sbjct: 122 MAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDAEXTAREGAKFPIKWTAPEA 181
Query: 285 IEHKPYDYKADVFSFGIALWELLT-GELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRLA 343
           I +  +  K+DV+SFGI L E++T G +PY G+T  +  +  +++  R   P +    L 
Sbjct: 182 INYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPE-VIQNLERGYRMVRPDNCPEELY 240
Query: 344 ELLERCWQHDPTQRPNFSQITDILKQMMKEVASEGE 379
           +L+  CW+  P  RP F  +  +L+      A+EG+
Sbjct: 241 QLMRLCWKERPEDRPTFDYLRSVLEDFF--TATEGQ 274

>pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276

Iteration: 1
 Score =  157 bits (397), Expect = 1e-38,   Method: Compositional matrix adjust.
 Identities = 86/277 (31%), Positives = 147/277 (53%), Gaps = 11/277 (3%)
Query: 111 WEIDAKQLKIECKVASGSYGDLYKGTYCSQE-----VAIKVLKPECVNTEMLKEFSQEVY 165
           +EI  +++++   +  G +GD+++G Y S E     VAIK  K  C +  + ++F QE  
Sbjct: 2   YEIQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCK-NCTSDSVREKFLQEAL 60
Query: 166 IMRKIRHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSK 225
            MR+  H ++V+ IG  T  P + I+ E    G +  FL  +K    L SL+  A  +S 
Sbjct: 61  TMRQFDHPHIVKLIGVITENP-VWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLST 119
Query: 226 GMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAETGTY--RWMAPE 283
            + YL     +HRD+   N+L+  N  VK+ DFG++R    S    A  G    +WMAPE
Sbjct: 120 ALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPE 179
Query: 284 VIEHKPYDYKADVFSFGIALWELLT-GELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRL 342
            I  + +   +DV+ FG+ +WE+L  G  P+ G+      +G ++   R  +P +  P L
Sbjct: 180 SINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKN-NDVIGRIENGERLPMPPNCPPTL 238
Query: 343 AELLERCWQHDPTQRPNFSQITDILKQMMKEVASEGE 379
             L+ +CW +DP++RP F+++   L  +++E  ++ E
Sbjct: 239 YSLMTKCWAYDPSRRPRFTELKAQLSTILEEEKAQQE 275

>pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276

Iteration: 1
 Score =  157 bits (396), Expect = 1e-38,   Method: Compositional matrix adjust.
 Identities = 86/275 (31%), Positives = 145/275 (52%), Gaps = 11/275 (4%)
Query: 107 GTDVWEIDAKQLKIECKVASGSYGDLYKGTYCSQE-----VAIKVLKPECVNTEMLKEFS 161
            T  +EI  +++++   +  G +GD+++G Y S E     VAIK  K  C +  + ++F 
Sbjct: 1   STRDYEIQRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCK-NCTSDSVREKFL 59
Query: 162 QEVYIMRKIRHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAI 221
           QE   MR+  H ++V+ IG  T  P + I+ E    G +  FL  +K    L SL+  A 
Sbjct: 60  QEALTMRQFDHPHIVKLIGVITENP-VWIIMELCTLGELRSFLQVRKFSLDLASLILYAY 118
Query: 222 DVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAETGTY--RW 279
            +S  + YL     +HRD+   N+L+  N  VK+ DFG++R    S    A  G    +W
Sbjct: 119 QLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTXXKASKGKLPIKW 178
Query: 280 MAPEVIEHKPYDYKADVFSFGIALWELLT-GELPYAGLTPLQAAVGVVQKSLRPTIPKHA 338
           MAPE I  + +   +DV+ FG+ +WE+L  G  P+ G+      +G ++   R  +P + 
Sbjct: 179 MAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKN-NDVIGRIENGERLPMPPNC 237
Query: 339 HPRLAELLERCWQHDPTQRPNFSQITDILKQMMKE 373
            P L  L+ +CW +DP++RP F+++   L  +++E
Sbjct: 238 PPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILEE 272

>pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281

Iteration: 1
 Score =  157 bits (396), Expect = 1e-38,   Method: Compositional matrix adjust.
 Identities = 86/274 (31%), Positives = 145/274 (52%), Gaps = 11/274 (4%)
Query: 108 TDVWEIDAKQLKIECKVASGSYGDLYKGTYCSQE-----VAIKVLKPECVNTEMLKEFSQ 162
           T  +EI  +++++   +  G +GD+++G Y S E     VAIK  K  C +  + ++F Q
Sbjct: 7   TRDYEIQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCK-NCTSDSVREKFLQ 65
Query: 163 EVYIMRKIRHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAID 222
           E   MR+  H ++V+ IG  T  P + I+ E    G +  FL  +K    L SL+  A  
Sbjct: 66  EALTMRQFDHPHIVKLIGVITENP-VWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQ 124
Query: 223 VSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAETGTY--RWM 280
           +S  + YL     +HRD+   N+L+  N  VK+ DFG++R    S    A  G    +WM
Sbjct: 125 LSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWM 184
Query: 281 APEVIEHKPYDYKADVFSFGIALWELLT-GELPYAGLTPLQAAVGVVQKSLRPTIPKHAH 339
           APE I  + +   +DV+ FG+ +WE+L  G  P+ G+      +G ++   R  +P +  
Sbjct: 185 APESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKN-NDVIGRIENGERLPMPPNCP 243
Query: 340 PRLAELLERCWQHDPTQRPNFSQITDILKQMMKE 373
           P L  L+ +CW +DP++RP F+++   L  +++E
Sbjct: 244 PTLYSLMTKCWAYDPSRRPRFTELKAQLSTILEE 277

>pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304

Iteration: 1
 Score =  157 bits (396), Expect = 1e-38,   Method: Compositional matrix adjust.
 Identities = 86/274 (31%), Positives = 145/274 (52%), Gaps = 11/274 (4%)
Query: 108 TDVWEIDAKQLKIECKVASGSYGDLYKGTYCSQE-----VAIKVLKPECVNTEMLKEFSQ 162
           T  +EI  +++++   +  G +GD+++G Y S E     VAIK  K  C +  + ++F Q
Sbjct: 30  TRDYEIQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCK-NCTSDSVREKFLQ 88
Query: 163 EVYIMRKIRHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAID 222
           E   MR+  H ++V+ IG  T  P + I+ E    G +  FL  +K    L SL+  A  
Sbjct: 89  EALTMRQFDHPHIVKLIGVITENP-VWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQ 147
Query: 223 VSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAETGTY--RWM 280
           +S  + YL     +HRD+   N+L+  N  VK+ DFG++R    S    A  G    +WM
Sbjct: 148 LSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWM 207
Query: 281 APEVIEHKPYDYKADVFSFGIALWELLT-GELPYAGLTPLQAAVGVVQKSLRPTIPKHAH 339
           APE I  + +   +DV+ FG+ +WE+L  G  P+ G+      +G ++   R  +P +  
Sbjct: 208 APESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKN-NDVIGRIENGERLPMPPNCP 266
Query: 340 PRLAELLERCWQHDPTQRPNFSQITDILKQMMKE 373
           P L  L+ +CW +DP++RP F+++   L  +++E
Sbjct: 267 PTLYSLMTKCWAYDPSRRPRFTELKAQLSTILEE 300

>pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276

Iteration: 1
 Score =  156 bits (395), Expect = 2e-38,   Method: Compositional matrix adjust.
 Identities = 86/275 (31%), Positives = 145/275 (52%), Gaps = 11/275 (4%)
Query: 107 GTDVWEIDAKQLKIECKVASGSYGDLYKGTYCSQE-----VAIKVLKPECVNTEMLKEFS 161
            T  +EI  +++++   +  G +GD+++G Y S E     VAIK  K  C +  + ++F 
Sbjct: 1   STRDYEIQRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCK-NCTSDSVREKFL 59
Query: 162 QEVYIMRKIRHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAI 221
           QE   MR+  H ++V+ IG  T  P + I+ E    G +  FL  +K    L SL+  A 
Sbjct: 60  QEALTMRQFDHPHIVKLIGVITENP-VWIIMELCTLGELRSFLQVRKYSLDLASLILYAY 118
Query: 222 DVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAETGTY--RW 279
            +S  + YL     +HRD+   N+L+  N  VK+ DFG++R    S    A  G    +W
Sbjct: 119 QLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKW 178
Query: 280 MAPEVIEHKPYDYKADVFSFGIALWELLT-GELPYAGLTPLQAAVGVVQKSLRPTIPKHA 338
           MAPE I  + +   +DV+ FG+ +WE+L  G  P+ G+      +G ++   R  +P + 
Sbjct: 179 MAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKN-NDVIGRIENGERLPMPPNC 237
Query: 339 HPRLAELLERCWQHDPTQRPNFSQITDILKQMMKE 373
            P L  L+ +CW +DP++RP F+++   L  +++E
Sbjct: 238 PPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILEE 272

>pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276

Iteration: 1
 Score =  156 bits (395), Expect = 2e-38,   Method: Compositional matrix adjust.
 Identities = 86/275 (31%), Positives = 145/275 (52%), Gaps = 11/275 (4%)
Query: 107 GTDVWEIDAKQLKIECKVASGSYGDLYKGTYCSQE-----VAIKVLKPECVNTEMLKEFS 161
            T  +EI  +++++   +  G +GD+++G Y S E     VAIK  K  C +  + ++F 
Sbjct: 1   STRDYEIQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCK-NCTSDSVREKFL 59
Query: 162 QEVYIMRKIRHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAI 221
           QE   MR+  H ++V+ IG  T  P + I+ E    G +  FL  +K    L SL+  A 
Sbjct: 60  QEALTMRQFDHPHIVKLIGVITENP-VWIIMELCTLGELRSFLQVRKYSLDLASLILYAY 118
Query: 222 DVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAETGTY--RW 279
            +S  + YL     +HRD+   N+L+  N  VK+ DFG++R    S    A  G    +W
Sbjct: 119 QLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKW 178
Query: 280 MAPEVIEHKPYDYKADVFSFGIALWELLT-GELPYAGLTPLQAAVGVVQKSLRPTIPKHA 338
           MAPE I  + +   +DV+ FG+ +WE+L  G  P+ G+      +G ++   R  +P + 
Sbjct: 179 MAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKN-NDVIGRIENGERLPMPPNC 237
Query: 339 HPRLAELLERCWQHDPTQRPNFSQITDILKQMMKE 373
            P L  L+ +CW +DP++RP F+++   L  +++E
Sbjct: 238 PPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILEE 272

>pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656

Iteration: 1
 Score =  156 bits (395), Expect = 2e-38,   Method: Compositional matrix adjust.
 Identities = 86/275 (31%), Positives = 145/275 (52%), Gaps = 11/275 (4%)
Query: 107 GTDVWEIDAKQLKIECKVASGSYGDLYKGTYCSQE-----VAIKVLKPECVNTEMLKEFS 161
            T  +EI  +++++   +  G +GD+++G Y S E     VAIK  K  C +  + ++F 
Sbjct: 381 STRDYEIQRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCK-NCTSDSVREKFL 439
Query: 162 QEVYIMRKIRHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAI 221
           QE   MR+  H ++V+ IG  T  P + I+ E    G +  FL  +K    L SL+  A 
Sbjct: 440 QEALTMRQFDHPHIVKLIGVITENP-VWIIMELCTLGELRSFLQVRKFSLDLASLILYAY 498
Query: 222 DVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAETGTY--RW 279
            +S  + YL     +HRD+   N+L+  N  VK+ DFG++R    S    A  G    +W
Sbjct: 499 QLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKW 558
Query: 280 MAPEVIEHKPYDYKADVFSFGIALWELLT-GELPYAGLTPLQAAVGVVQKSLRPTIPKHA 338
           MAPE I  + +   +DV+ FG+ +WE+L  G  P+ G+      +G ++   R  +P + 
Sbjct: 559 MAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKN-NDVIGRIENGERLPMPPNC 617
Query: 339 HPRLAELLERCWQHDPTQRPNFSQITDILKQMMKE 373
            P L  L+ +CW +DP++RP F+++   L  +++E
Sbjct: 618 PPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILEE 652

>pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271

Iteration: 1
 Score =  156 bits (395), Expect = 2e-38,   Method: Compositional matrix adjust.
 Identities = 84/268 (31%), Positives = 151/268 (56%), Gaps = 10/268 (3%)
Query: 109 DVWEIDAKQLKIECKVASGSYGDLYKGTYCSQ-EVAIKVLKPECVNTEMLKEFSQEVYIM 167
           D WE+  + LK+  ++ +G +G+++ G Y    +VA+K LK   ++ +    F  E  +M
Sbjct: 6   DEWEVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDA---FLAEANLM 62
Query: 168 RKIRHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGV-FQLTSLLKVAIDVSKG 226
           ++++H+ +V+     T+ P + I+TE+M  GS+ DFL    G+   +  LL +A  +++G
Sbjct: 63  KQLQHQRLVRLYAVVTQEP-IYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEG 121
Query: 227 MNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAETGTY--RWMAPEV 284
           M ++ + N IHRDL+ AN+L+ +    K+ADFG+AR+   +     E   +  +W APE 
Sbjct: 122 MAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEXTAREGAKFPIKWTAPEA 181
Query: 285 IEHKPYDYKADVFSFGIALWELLT-GELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRLA 343
           I +  +  K+DV+SFGI L E++T G +PY G+T  +  +  +++  R   P +    L 
Sbjct: 182 INYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPE-VIQNLERGYRMVRPDNCPEELY 240
Query: 344 ELLERCWQHDPTQRPNFSQITDILKQMM 371
           +L+  CW+  P  RP F  +  +L+   
Sbjct: 241 QLMRLCWKERPEDRPTFDYLRSVLEDFF 268

>pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272

Iteration: 1
 Score =  156 bits (394), Expect = 2e-38,   Method: Compositional matrix adjust.
 Identities = 84/268 (31%), Positives = 151/268 (56%), Gaps = 10/268 (3%)
Query: 109 DVWEIDAKQLKIECKVASGSYGDLYKGTYCSQ-EVAIKVLKPECVNTEMLKEFSQEVYIM 167
           D WE+  + LK+  ++ +G +G+++ G Y    +VA+K LK   ++ +    F  E  +M
Sbjct: 7   DEWEVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDA---FLAEANLM 63
Query: 168 RKIRHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGV-FQLTSLLKVAIDVSKG 226
           ++++H+ +V+     T+ P + I+TE+M  GS+ DFL    G+   +  LL +A  +++G
Sbjct: 64  KQLQHQRLVRLYAVVTQEP-IYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEG 122
Query: 227 MNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAETGTY--RWMAPEV 284
           M ++ + N IHRDL+ AN+L+ +    K+ADFG+AR+   +     E   +  +W APE 
Sbjct: 123 MAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEXTAREGAKFPIKWTAPEA 182
Query: 285 IEHKPYDYKADVFSFGIALWELLT-GELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRLA 343
           I +  +  K+DV+SFGI L E++T G +PY G+T  +  +  +++  R   P +    L 
Sbjct: 183 INYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPE-VIQNLERGYRMVRPDNCPEELY 241
Query: 344 ELLERCWQHDPTQRPNFSQITDILKQMM 371
           +L+  CW+  P  RP F  +  +L+   
Sbjct: 242 QLMRLCWKERPEDRPTFDYLRSVLEDFF 269

>pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271

Iteration: 1
 Score =  156 bits (394), Expect = 2e-38,   Method: Compositional matrix adjust.
 Identities = 84/268 (31%), Positives = 151/268 (56%), Gaps = 10/268 (3%)
Query: 109 DVWEIDAKQLKIECKVASGSYGDLYKGTYCSQ-EVAIKVLKPECVNTEMLKEFSQEVYIM 167
           D WE+  + LK+  ++ +G +G+++ G Y    +VA+K LK   ++ +    F  E  +M
Sbjct: 6   DEWEVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDA---FLAEANLM 62
Query: 168 RKIRHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGV-FQLTSLLKVAIDVSKG 226
           ++++H+ +V+     T+ P + I+TE+M  GS+ DFL    G+   +  LL +A  +++G
Sbjct: 63  KQLQHQRLVRLYAVVTQEP-IYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEG 121
Query: 227 MNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAETGTY--RWMAPEV 284
           M ++ + N IHRDL+ AN+L+ +    K+ADFG+AR+   +     E   +  +W APE 
Sbjct: 122 MAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEA 181
Query: 285 IEHKPYDYKADVFSFGIALWELLT-GELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRLA 343
           I +  +  K+DV+SFGI L E++T G +PY G+T  +  +  +++  R   P +    L 
Sbjct: 182 INYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPE-VIQNLERGYRMVRPDNCPEELY 240
Query: 344 ELLERCWQHDPTQRPNFSQITDILKQMM 371
           +L+  CW+  P  RP F  +  +L+   
Sbjct: 241 QLMRLCWKERPEDRPTFDYLRSVLEDFF 268

>pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265

Iteration: 1
 Score =  156 bits (394), Expect = 2e-38,   Method: Compositional matrix adjust.
 Identities = 84/268 (31%), Positives = 151/268 (56%), Gaps = 10/268 (3%)
Query: 109 DVWEIDAKQLKIECKVASGSYGDLYKGTYCSQ-EVAIKVLKPECVNTEMLKEFSQEVYIM 167
           D WE+  + LK+  ++ +G +G+++ G Y    +VA+K LK   ++ +    F  E  +M
Sbjct: 1   DEWEVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDA---FLAEANLM 57
Query: 168 RKIRHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGV-FQLTSLLKVAIDVSKG 226
           ++++H+ +V+     T+ P + I+TE+M  GS+ DFL    G+   +  LL +A  +++G
Sbjct: 58  KQLQHQRLVRLYAVVTQEP-IYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEG 116
Query: 227 MNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAETGTY--RWMAPEV 284
           M ++ + N IHRDL+ AN+L+ +    K+ADFG+AR+   +     E   +  +W APE 
Sbjct: 117 MAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEA 176
Query: 285 IEHKPYDYKADVFSFGIALWELLT-GELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRLA 343
           I +  +  K+DV+SFGI L E++T G +PY G+T  +  +  +++  R   P +    L 
Sbjct: 177 INYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPE-VIQNLERGYRMVRPDNCPEELY 235
Query: 344 ELLERCWQHDPTQRPNFSQITDILKQMM 371
           +L+  CW+  P  RP F  +  +L+   
Sbjct: 236 QLMRLCWKERPEDRPTFDYLRSVLEDFF 263

>pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273

Iteration: 1
 Score =  156 bits (394), Expect = 2e-38,   Method: Compositional matrix adjust.
 Identities = 84/268 (31%), Positives = 151/268 (56%), Gaps = 10/268 (3%)
Query: 109 DVWEIDAKQLKIECKVASGSYGDLYKGTYCSQ-EVAIKVLKPECVNTEMLKEFSQEVYIM 167
           D WE+  + LK+  ++ +G +G+++ G Y    +VA+K LK   ++ +    F  E  +M
Sbjct: 8   DEWEVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDA---FLAEANLM 64
Query: 168 RKIRHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGV-FQLTSLLKVAIDVSKG 226
           ++++H+ +V+     T+ P + I+TE+M  GS+ DFL    G+   +  LL +A  +++G
Sbjct: 65  KQLQHQRLVRLYAVVTQEP-IYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEG 123
Query: 227 MNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAETGTY--RWMAPEV 284
           M ++ + N IHRDL+ AN+L+ +    K+ADFG+AR+   +     E   +  +W APE 
Sbjct: 124 MAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEXTAREGAKFPIKWTAPEA 183
Query: 285 IEHKPYDYKADVFSFGIALWELLT-GELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRLA 343
           I +  +  K+DV+SFGI L E++T G +PY G+T  +  +  +++  R   P +    L 
Sbjct: 184 INYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPE-VIQNLERGYRMVRPDNCPEELY 242
Query: 344 ELLERCWQHDPTQRPNFSQITDILKQMM 371
           +L+  CW+  P  RP F  +  +L+   
Sbjct: 243 QLMRLCWKERPEDRPTFDYLRSVLEDFF 270

>pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277

Iteration: 1
 Score =  156 bits (394), Expect = 2e-38,   Method: Compositional matrix adjust.
 Identities = 84/268 (31%), Positives = 151/268 (56%), Gaps = 10/268 (3%)
Query: 109 DVWEIDAKQLKIECKVASGSYGDLYKGTYCSQ-EVAIKVLKPECVNTEMLKEFSQEVYIM 167
           D WE+  + LK+  ++ +G +G+++ G Y    +VA+K LK   ++ +    F  E  +M
Sbjct: 11  DEWEVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDA---FLAEANLM 67
Query: 168 RKIRHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGV-FQLTSLLKVAIDVSKG 226
           ++++H+ +V+     T+ P + I+TE+M  GS+ DFL    G+   +  LL +A  +++G
Sbjct: 68  KQLQHQRLVRLYAVVTQEP-IYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEG 126
Query: 227 MNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAETGTY--RWMAPEV 284
           M ++ + N IHRDL+ AN+L+ +    K+ADFG+AR+   +     E   +  +W APE 
Sbjct: 127 MAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEA 186
Query: 285 IEHKPYDYKADVFSFGIALWELLT-GELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRLA 343
           I +  +  K+DV+SFGI L E++T G +PY G+T  +  +  +++  R   P +    L 
Sbjct: 187 INYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPE-VIQNLERGYRMVRPDNCPEELY 245
Query: 344 ELLERCWQHDPTQRPNFSQITDILKQMM 371
           +L+  CW+  P  RP F  +  +L+   
Sbjct: 246 QLMRLCWKERPEDRPTFDYLRSVLEDFF 273

>pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312

Iteration: 1
 Score =  156 bits (394), Expect = 2e-38,   Method: Compositional matrix adjust.
 Identities = 93/277 (33%), Positives = 145/277 (52%), Gaps = 14/277 (5%)
Query: 112 EIDAKQLKIECKVASGSYGDLYKGTY---CSQE--VAIKVLKPECVNTEMLKEFSQEVYI 166
           EID   +KIE  + +G +G++  G       +E  VAIK LK      +  ++F  E  I
Sbjct: 29  EIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQR-RDFLSEASI 87
Query: 167 MRKIRHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKG 226
           M +  H NV+   G  T+   + I+TEFM  GS+  FL +  G F +  L+ +   ++ G
Sbjct: 88  MGQFDHPNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQNDGQFTVIQLVGMLRGIAAG 147
Query: 227 MNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARV---QAQSGVMTAETG---TYRWM 280
           M YL   N +HRDL   N+L++ N V KV+DFG++R           T+  G     RW 
Sbjct: 148 MKYLADMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSALGGKIPIRWT 207
Query: 281 APEVIEHKPYDYKADVFSFGIALWELLT-GELPYAGLTPLQAAVGVVQKSLRPTIPKHAH 339
           APE I+++ +   +DV+S+GI +WE+++ GE PY  +T  Q  +  +++  R   P    
Sbjct: 208 APEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTN-QDVINAIEQDYRLPPPMDCP 266
Query: 340 PRLAELLERCWQHDPTQRPNFSQITDILKQMMKEVAS 376
             L +L+  CWQ D   RP F QI + L +M++   S
Sbjct: 267 SALHQLMLDCWQKDRNHRPKFGQIVNTLDKMIRNPNS 303

>pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277

Iteration: 1
 Score =  155 bits (393), Expect = 3e-38,   Method: Compositional matrix adjust.
 Identities = 84/268 (31%), Positives = 151/268 (56%), Gaps = 10/268 (3%)
Query: 109 DVWEIDAKQLKIECKVASGSYGDLYKGTYCSQ-EVAIKVLKPECVNTEMLKEFSQEVYIM 167
           D WE+  + LK+  ++ +G +G+++ G Y    +VA+K LK   ++ +    F  E  +M
Sbjct: 12  DEWEVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDA---FLAEANLM 68
Query: 168 RKIRHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGV-FQLTSLLKVAIDVSKG 226
           ++++H+ +V+     T+ P + I+TE+M  GS+ DFL    G+   +  LL +A  +++G
Sbjct: 69  KQLQHQRLVRLYAVVTQEP-IYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEG 127
Query: 227 MNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAETGTY--RWMAPEV 284
           M ++ + N IHRDL+ AN+L+ +    K+ADFG+AR+   +     E   +  +W APE 
Sbjct: 128 MAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEA 187
Query: 285 IEHKPYDYKADVFSFGIALWELLT-GELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRLA 343
           I +  +  K+DV+SFGI L E++T G +PY G+T  +  +  +++  R   P +    L 
Sbjct: 188 INYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPE-VIQNLERGYRMVRPDNCPEELY 246
Query: 344 ELLERCWQHDPTQRPNFSQITDILKQMM 371
           +L+  CW+  P  RP F  +  +L+   
Sbjct: 247 QLMRLCWKERPEDRPTFDYLRSVLEDFF 274

>pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377

Iteration: 1
 Score =  154 bits (390), Expect = 6e-38,   Method: Compositional matrix adjust.
 Identities = 89/271 (32%), Positives = 147/271 (54%), Gaps = 10/271 (3%)
Query: 109 DVWEIDAKQLKIECKVASGSYGDLYKGTYCSQE--VAIKVLKPECVNTEMLKEFSQEVYI 166
           D W ++ + L +  ++  G++G+++ G   +    VA+K  + E +  ++  +F QE  I
Sbjct: 107 DKWVLNHEDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCR-ETLPPDLKAKFLQEARI 165
Query: 167 MRKIRHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKG 226
           +++  H N+V+ IG CT+   + IV E +  G    FL  +    ++ +LL++  D + G
Sbjct: 166 LKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDFLTFLRTEGARLRVKTLLQMVGDAAAG 225
Query: 227 MNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAETG----TYRWMAP 282
           M YL     IHRDL   N L+ E  V+K++DFG++R +A  GV  A  G      +W AP
Sbjct: 226 MEYLESKCCIHRDLAARNCLVTEKNVLKISDFGMSREEA-DGVXAASGGLRQVPVKWTAP 284
Query: 283 EVIEHKPYDYKADVFSFGIALWELLT-GELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPR 341
           E + +  Y  ++DV+SFGI LWE  + G  PY  L+  Q     V+K  R   P+     
Sbjct: 285 EALNYGRYSSESDVWSFGILLWETFSLGASPYPNLSN-QQTREFVEKGGRLPCPELCPDA 343
Query: 342 LAELLERCWQHDPTQRPNFSQITDILKQMMK 372
           +  L+E+CW ++P QRP+FS I   L+ + K
Sbjct: 344 VFRLMEQCWAYEPGQRPSFSTIYQELQSIRK 374

>pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377

Iteration: 1
 Score =  154 bits (390), Expect = 7e-38,   Method: Compositional matrix adjust.
 Identities = 89/271 (32%), Positives = 147/271 (54%), Gaps = 10/271 (3%)
Query: 109 DVWEIDAKQLKIECKVASGSYGDLYKGTYCSQE--VAIKVLKPECVNTEMLKEFSQEVYI 166
           D W ++ + L +  ++  G++G+++ G   +    VA+K  + E +  ++  +F QE  I
Sbjct: 107 DKWVLNHEDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCR-ETLPPDLKAKFLQEARI 165
Query: 167 MRKIRHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKG 226
           +++  H N+V+ IG CT+   + IV E +  G    FL  +    ++ +LL++  D + G
Sbjct: 166 LKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDFLTFLRTEGARLRVKTLLQMVGDAAAG 225
Query: 227 MNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAETG----TYRWMAP 282
           M YL     IHRDL   N L+ E  V+K++DFG++R +A  GV  A  G      +W AP
Sbjct: 226 MEYLESKCCIHRDLAARNCLVTEKNVLKISDFGMSREEA-DGVYAASGGLRQVPVKWTAP 284
Query: 283 EVIEHKPYDYKADVFSFGIALWELLT-GELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPR 341
           E + +  Y  ++DV+SFGI LWE  + G  PY  L+  Q     V+K  R   P+     
Sbjct: 285 EALNYGRYSSESDVWSFGILLWETFSLGASPYPNLSN-QQTREFVEKGGRLPCPELCPDA 343
Query: 342 LAELLERCWQHDPTQRPNFSQITDILKQMMK 372
           +  L+E+CW ++P QRP+FS I   L+ + K
Sbjct: 344 VFRLMEQCWAYEPGQRPSFSTIYQELQSIRK 374

>pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318

Iteration: 1
 Score =  154 bits (389), Expect = 9e-38,   Method: Compositional matrix adjust.
 Identities = 93/271 (34%), Positives = 143/271 (52%), Gaps = 12/271 (4%)
Query: 112 EIDAKQLKIECKVASGSYGDLYKGTYC-----SQEVAIKVLKPECVNTEMLKEFSQEVYI 166
           E+DA  +KIE  + +G +G++  G           VAIK LK      +  ++F  E  I
Sbjct: 39  ELDASCIKIERVIGAGEFGEVCSGRLKLPGKRDVAVAIKTLKVGYTEKQR-RDFLCEASI 97
Query: 167 MRKIRHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKG 226
           M +  H NVV   G  TR   + IV EFM  G++  FL K  G F +  L+ +   ++ G
Sbjct: 98  MGQFDHPNVVHLEGVVTRGKPVMIVIEFMENGALDAFLRKHDGQFTVIQLVGMLRGIAAG 157
Query: 227 MNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARV--QAQSGVMTAETGT--YRWMAP 282
           M YL     +HRDL   N+L++ N V KV+DFG++RV       V T   G    RW AP
Sbjct: 158 MRYLADMGYVHRDLAARNILVNSNLVCKVSDFGLSRVIEDDPEAVYTTTGGKIPVRWTAP 217
Query: 283 EVIEHKPYDYKADVFSFGIALWELLT-GELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPR 341
           E I+++ +   +DV+S+GI +WE+++ GE PY  ++  Q  +  +++  R   P      
Sbjct: 218 EAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSN-QDVIKAIEEGYRLPAPMDCPAG 276
Query: 342 LAELLERCWQHDPTQRPNFSQITDILKQMMK 372
           L +L+  CWQ +  +RP F QI  IL +M++
Sbjct: 277 LHQLMLDCWQKERAERPKFEQIVGILDKMIR 307

>pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276

Iteration: 1
 Score =  154 bits (388), Expect = 1e-37,   Method: Compositional matrix adjust.
 Identities = 85/275 (30%), Positives = 144/275 (52%), Gaps = 11/275 (4%)
Query: 107 GTDVWEIDAKQLKIECKVASGSYGDLYKGTYCSQE-----VAIKVLKPECVNTEMLKEFS 161
            T  +EI  +++++   +  G +GD+++G Y S E     VAIK  K  C +  + ++F 
Sbjct: 1   STRDYEIQRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCK-NCTSDSVREKFL 59
Query: 162 QEVYIMRKIRHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAI 221
           QE   MR+  H ++V+ IG  T  P + I+ E    G +  FL  +K    L SL+  A 
Sbjct: 60  QEALTMRQFDHPHIVKLIGVITENP-VWIIMELCTLGELRSFLQVRKFSLDLASLILYAY 118
Query: 222 DVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAETGTY--RW 279
            +S  + YL     +HRD+   N+L+     VK+ DFG++R    S    A  G    +W
Sbjct: 119 QLSTALAYLESKRFVHRDIAARNVLVSATDCVKLGDFGLSRYMEDSTYYKASKGKLPIKW 178
Query: 280 MAPEVIEHKPYDYKADVFSFGIALWELLT-GELPYAGLTPLQAAVGVVQKSLRPTIPKHA 338
           MAPE I  + +   +DV+ FG+ +WE+L  G  P+ G+      +G ++   R  +P + 
Sbjct: 179 MAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKN-NDVIGRIENGERLPMPPNC 237
Query: 339 HPRLAELLERCWQHDPTQRPNFSQITDILKQMMKE 373
            P L  L+ +CW +DP++RP F+++   L  +++E
Sbjct: 238 PPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILEE 272

>pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302

Iteration: 1
 Score =  154 bits (388), Expect = 1e-37,   Method: Compositional matrix adjust.
 Identities = 88/277 (31%), Positives = 144/277 (51%), Gaps = 14/277 (5%)
Query: 112 EIDAKQLKIECKVASGSYGDLYKGTYCSQE-----VAIKVLKPECVNTEMLKEFSQEVYI 166
           EID   +KIE  + +G +G++ +G   +       VAIK LK      +  +EF  E  I
Sbjct: 12  EIDVSYVKIEEVIGAGEFGEVCRGRLKAPGKKESCVAIKTLKGGYTERQR-REFLSEASI 70
Query: 167 MRKIRHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKG 226
           M +  H N+++  G  T    + I+TEFM  G++  FL    G F +  L+ +   ++ G
Sbjct: 71  MGQFEHPNIIRLEGVVTNSMPVMILTEFMENGALDSFLRLNDGQFTVIQLVGMLRGIASG 130
Query: 227 MNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAETGTY------RWM 280
           M YL + + +HRDL   N+L++ N V KV+DFG++R   ++     ET +       RW 
Sbjct: 131 MRYLAEMSYVHRDLAARNILVNSNLVCKVSDFGLSRFLEENSSDPTETSSLGGKIPIRWT 190
Query: 281 APEVIEHKPYDYKADVFSFGIALWELLT-GELPYAGLTPLQAAVGVVQKSLRPTIPKHAH 339
           APE I  + +   +D +S+GI +WE+++ GE PY  ++  Q  +  +++  R   P    
Sbjct: 191 APEAIAFRKFTSASDAWSYGIVMWEVMSFGERPYWDMSN-QDVINAIEQDYRLPPPPDCP 249
Query: 340 PRLAELLERCWQHDPTQRPNFSQITDILKQMMKEVAS 376
             L +L+  CWQ D   RP F Q+   L +M++  AS
Sbjct: 250 TSLHQLMLDCWQKDRNARPRFPQVVSALDKMIRNPAS 286

>pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373

Iteration: 1
 Score =  154 bits (388), Expect = 1e-37,   Method: Compositional matrix adjust.
 Identities = 95/291 (32%), Positives = 147/291 (50%), Gaps = 14/291 (4%)
Query: 98  PNCIEIPTDGTDVW--EIDAKQLKIECKVASGSYGDLYKG-----TYCSQEVAIKVLKPE 150
           P+  E PT     +  E+DA  + I+  V +G +G++  G     +     VAIK LK  
Sbjct: 25  PHTFEDPTQTVHEFAKELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVG 84
Query: 151 CVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGV 210
               +  ++F  E  IM +  H N+++  G  T+   + IVTE+M  GS+  FL K    
Sbjct: 85  YTEKQR-RDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQ 143
Query: 211 FQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARV--QAQSG 268
           F +  L+ +   ++ GM YL     +HRDL   N+L++ N V KV+DFG+ARV       
Sbjct: 144 FTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILINSNLVCKVSDFGLARVLEDDPEA 203
Query: 269 VMTAETGT--YRWMAPEVIEHKPYDYKADVFSFGIALWELLT-GELPYAGLTPLQAAVGV 325
             T   G    RW +PE I ++ +   +DV+S+GI LWE+++ GE PY  ++  Q  +  
Sbjct: 204 AYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSN-QDVIKA 262
Query: 326 VQKSLRPTIPKHAHPRLAELLERCWQHDPTQRPNFSQITDILKQMMKEVAS 376
           V +  R   P      L +L+  CWQ D   RP F QI  IL ++++   S
Sbjct: 263 VDEGYRLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKLIRNPGS 313

>pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656

Iteration: 1
 Score =  154 bits (388), Expect = 1e-37,   Method: Compositional matrix adjust.
 Identities = 85/275 (30%), Positives = 144/275 (52%), Gaps = 11/275 (4%)
Query: 107 GTDVWEIDAKQLKIECKVASGSYGDLYKGTYCSQE-----VAIKVLKPECVNTEMLKEFS 161
            T  +EI  +++++   +  G +GD+++G Y S E     VAIK  K  C +  + ++F 
Sbjct: 381 STRDYEIQRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCK-NCTSDSVREKFL 439
Query: 162 QEVYIMRKIRHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAI 221
           QE   MR+  H ++V+ IG  T  P + I+ E    G +  FL  +K    L SL+  A 
Sbjct: 440 QEALTMRQFDHPHIVKLIGVITENP-VWIIMELCTLGELRSFLQVRKFSLDLASLILYAY 498
Query: 222 DVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAETGTY--RW 279
            +S  + YL     +HRD+   N+L+     VK+ DFG++R    S    A  G    +W
Sbjct: 499 QLSTALAYLESKRFVHRDIAARNVLVSATDCVKLGDFGLSRYMEDSTYYKASKGKLPIKW 558
Query: 280 MAPEVIEHKPYDYKADVFSFGIALWELLT-GELPYAGLTPLQAAVGVVQKSLRPTIPKHA 338
           MAPE I  + +   +DV+ FG+ +WE+L  G  P+ G+      +G ++   R  +P + 
Sbjct: 559 MAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKN-NDVIGRIENGERLPMPPNC 617
Query: 339 HPRLAELLERCWQHDPTQRPNFSQITDILKQMMKE 373
            P L  L+ +CW +DP++RP F+++   L  +++E
Sbjct: 618 PPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILEE 652

>pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287

Iteration: 1
 Score =  154 bits (388), Expect = 1e-37,   Method: Compositional matrix adjust.
 Identities = 94/274 (34%), Positives = 155/274 (56%), Gaps = 26/274 (9%)
Query: 117 QLKIECKVASGSYGDLYKGTYCSQE--VAIKVL-----KPECVNTEMLKEFSQEVYIMRK 169
           +++ E ++  G +G ++KG     +  VAIK L     + E    E  +EF +EV+IM  
Sbjct: 20  EIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSN 79
Query: 170 IRHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNY 229
           + H N+V+  G    PP +  V EF+  G +Y  L  +    + +  L++ +D++ G+ Y
Sbjct: 80  LNHPNIVKLYGLMHNPPRM--VMEFVPCGDLYHRLLDKAHPIKWSVKLRLMLDIALGIEY 137
Query: 230 LHQNN--IIHRDLKTANLLM---DENGVV--KVADFGVAR--VQAQSGVMTAETGTYRWM 280
           +   N  I+HRDL++ N+ +   DEN  V  KVADFG+++  V + SG++    G ++WM
Sbjct: 138 MQNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQQSVHSVSGLL----GNFQWM 193
Query: 281 APEVI--EHKPYDYKADVFSFGIALWELLTGELPYAGLT--PLQAAVGVVQKSLRPTIPK 336
           APE I  E + Y  KAD +SF + L+ +LTGE P+   +   ++    + ++ LRPTIP+
Sbjct: 194 APETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKIKFINMIREEGLRPTIPE 253
Query: 337 HAHPRLAELLERCWQHDPTQRPNFSQITDILKQM 370
              PRL  ++E CW  DP +RP+FS I   L ++
Sbjct: 254 DCPPRLRNVIELCWSGDPKKRPHFSYIVKELSEL 287

>pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287

Iteration: 1
 Score =  153 bits (387), Expect = 1e-37,   Method: Compositional matrix adjust.
 Identities = 94/274 (34%), Positives = 154/274 (56%), Gaps = 26/274 (9%)
Query: 117 QLKIECKVASGSYGDLYKGTYCSQE--VAIKVL-----KPECVNTEMLKEFSQEVYIMRK 169
           +++ E ++  G +G ++KG     +  VAIK L     + E    E  +EF +EV+IM  
Sbjct: 20  EIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSN 79
Query: 170 IRHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNY 229
           + H N+V+  G    PP +  V EF+  G +Y  L  +    + +  L++ +D++ G+ Y
Sbjct: 80  LNHPNIVKLYGLMHNPPRM--VMEFVPCGDLYHRLLDKAHPIKWSVKLRLMLDIALGIEY 137
Query: 230 LHQNN--IIHRDLKTANLLM---DENGVV--KVADFGVAR--VQAQSGVMTAETGTYRWM 280
           +   N  I+HRDL++ N+ +   DEN  V  KVADFG ++  V + SG++    G ++WM
Sbjct: 138 MQNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGTSQQSVHSVSGLL----GNFQWM 193
Query: 281 APEVI--EHKPYDYKADVFSFGIALWELLTGELPYAGLT--PLQAAVGVVQKSLRPTIPK 336
           APE I  E + Y  KAD +SF + L+ +LTGE P+   +   ++    + ++ LRPTIP+
Sbjct: 194 APETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKIKFINMIREEGLRPTIPE 253
Query: 337 HAHPRLAELLERCWQHDPTQRPNFSQITDILKQM 370
              PRL  ++E CW  DP +RP+FS I   L ++
Sbjct: 254 DCPPRLRNVIELCWSGDPKKRPHFSYIVKELSEL 287

>pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373

Iteration: 1
 Score =  153 bits (386), Expect = 2e-37,   Method: Compositional matrix adjust.
 Identities = 94/291 (32%), Positives = 147/291 (50%), Gaps = 14/291 (4%)
Query: 98  PNCIEIPTDGTDVW--EIDAKQLKIECKVASGSYGDLYKG-----TYCSQEVAIKVLKPE 150
           P+  E PT     +  E+DA  + I+  V +G +G++  G     +     VAIK LK  
Sbjct: 25  PHTFEDPTQTVHEFAKELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVG 84
Query: 151 CVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGV 210
               +  ++F  E  IM +  H N+++  G  T+   + IVTE+M  GS+  FL K    
Sbjct: 85  YTEKQR-RDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQ 143
Query: 211 FQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARV--QAQSG 268
           F +  L+ +   ++ GM YL     +HRDL   N+L++ N V KV+DFG++RV       
Sbjct: 144 FTVIQLVGMLRGIASGMKYLSDMGFVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEA 203
Query: 269 VMTAETGT--YRWMAPEVIEHKPYDYKADVFSFGIALWELLT-GELPYAGLTPLQAAVGV 325
             T   G    RW +PE I ++ +   +DV+S+GI LWE+++ GE PY  ++  Q  +  
Sbjct: 204 AYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSN-QDVIKA 262
Query: 326 VQKSLRPTIPKHAHPRLAELLERCWQHDPTQRPNFSQITDILKQMMKEVAS 376
           V +  R   P      L +L+  CWQ D   RP F QI  IL ++++   S
Sbjct: 263 VDEGYRLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKLIRNPGS 313

>pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286

Iteration: 1
 Score =  153 bits (386), Expect = 2e-37,   Method: Compositional matrix adjust.
 Identities = 92/277 (33%), Positives = 144/277 (51%), Gaps = 14/277 (5%)
Query: 112 EIDAKQLKIECKVASGSYGDLYKGTY---CSQE--VAIKVLKPECVNTEMLKEFSQEVYI 166
           EID   +KIE  + +G +G++  G       +E  VAIK LK      +  ++F  E  I
Sbjct: 3   EIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQR-RDFLSEASI 61
Query: 167 MRKIRHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKG 226
           M +  H NV+   G  T+   + I+TEFM  GS+  FL +  G F +  L+ +   ++ G
Sbjct: 62  MGQFDHPNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQNDGQFTVIQLVGMLRGIAAG 121
Query: 227 MNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARV---QAQSGVMTAETG---TYRWM 280
           M YL   N +HR L   N+L++ N V KV+DFG++R           T+  G     RW 
Sbjct: 122 MKYLADMNYVHRALAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSALGGKIPIRWT 181
Query: 281 APEVIEHKPYDYKADVFSFGIALWELLT-GELPYAGLTPLQAAVGVVQKSLRPTIPKHAH 339
           APE I+++ +   +DV+S+GI +WE+++ GE PY  +T  Q  +  +++  R   P    
Sbjct: 182 APEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTN-QDVINAIEQDYRLPPPMDCP 240
Query: 340 PRLAELLERCWQHDPTQRPNFSQITDILKQMMKEVAS 376
             L +L+  CWQ D   RP F QI + L +M++   S
Sbjct: 241 SALHQLMLDCWQKDRNHRPKFGQIVNTLDKMIRNPNS 277

>pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267

Iteration: 1
 Score =  153 bits (386), Expect = 2e-37,   Method: Compositional matrix adjust.
 Identities = 82/266 (30%), Positives = 150/266 (56%), Gaps = 10/266 (3%)
Query: 111 WEIDAKQLKIECKVASGSYGDLYKGTYCSQ-EVAIKVLKPECVNTEMLKEFSQEVYIMRK 169
           WE+  + LK+  ++ +G +G+++ G Y    +VA+K LK   ++ +    F  E  +M++
Sbjct: 4   WEVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDA---FLAEANLMKQ 60
Query: 170 IRHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGV-FQLTSLLKVAIDVSKGMN 228
           ++H+ +V+     T+ P + I+TE+M  GS+ DFL    G+   +  LL +A  +++GM 
Sbjct: 61  LQHQRLVRLYAVVTQEP-IYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMA 119
Query: 229 YLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAETGTY--RWMAPEVIE 286
           ++ + N IHR+L+ AN+L+ +    K+ADFG+AR+   +     E   +  +W APE I 
Sbjct: 120 FIEERNYIHRNLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAIN 179
Query: 287 HKPYDYKADVFSFGIALWELLT-GELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRLAEL 345
           +  +  K+DV+SFGI L E++T G +PY G+T  +  +  +++  R   P +    L +L
Sbjct: 180 YGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPE-VIQNLERGYRMVRPDNCPEELYQL 238
Query: 346 LERCWQHDPTQRPNFSQITDILKQMM 371
           +  CW+  P  RP F  +  +L+   
Sbjct: 239 MRLCWKERPEDRPTFDYLRSVLEDFF 264

>pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263

Iteration: 1
 Score =  152 bits (385), Expect = 2e-37,   Method: Compositional matrix adjust.
 Identities = 83/265 (31%), Positives = 145/265 (54%), Gaps = 12/265 (4%)
Query: 113 IDAKQLKIECKVASGSYGDLYKGTYCSQ-EVAIKVLKPECVNTEMLKEFSQEVYIMRKIR 171
           ID K L    ++ +G +G +  G +  Q +VAIK++K   ++ +   EF +E  +M  + 
Sbjct: 1   IDPKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSED---EFIEEAKVMMNLS 57
Query: 172 HKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLH 231
           H+ +VQ  G CT+   + I+TE+MA G + ++L + +  FQ   LL++  DV + M YL 
Sbjct: 58  HEKLVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLE 117
Query: 232 QNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAETGTY--RWMAPEVIEHKP 289
               +HRDL   N L+++ GVVKV+DFG++R        ++    +  RW  PEV+ +  
Sbjct: 118 SKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMYSK 177
Query: 290 YDYKADVFSFGIALWELLT-GELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRLAELLER 348
           +  K+D+++FG+ +WE+ + G++PY   T  + A  + Q  LR   P  A  ++  ++  
Sbjct: 178 FSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQ-GLRLYRPHLASEKVYTIMYS 236
Query: 349 CWQHDPTQRPNF----SQITDILKQ 369
           CW     +RP F    S I D++ +
Sbjct: 237 CWHEKADERPTFKILLSNILDVMDE 261

>pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373

Iteration: 1
 Score =  152 bits (385), Expect = 3e-37,   Method: Compositional matrix adjust.
 Identities = 94/291 (32%), Positives = 147/291 (50%), Gaps = 14/291 (4%)
Query: 98  PNCIEIPTDGTDVW--EIDAKQLKIECKVASGSYGDLYKG-----TYCSQEVAIKVLKPE 150
           P+  E PT     +  E+DA  + I+  V +G +G++  G     +     VAIK LK  
Sbjct: 25  PHTFEDPTQTVHEFAKELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVG 84
Query: 151 CVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGV 210
               +  ++F  E  IM +  H N+++  G  T+   + IVTE+M  GS+  FL K    
Sbjct: 85  YTEKQR-RDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQ 143
Query: 211 FQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARV--QAQSG 268
           F +  L+ +   ++ GM YL     +HRDL   N+L++ N V KV+DFG++RV       
Sbjct: 144 FTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEA 203
Query: 269 VMTAETGT--YRWMAPEVIEHKPYDYKADVFSFGIALWELLT-GELPYAGLTPLQAAVGV 325
             T   G    RW +PE I ++ +   +DV+S+GI LWE+++ GE PY  ++  Q  +  
Sbjct: 204 AYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSN-QDVIKA 262
Query: 326 VQKSLRPTIPKHAHPRLAELLERCWQHDPTQRPNFSQITDILKQMMKEVAS 376
           V +  R   P      L +L+  CWQ D   RP F QI  IL ++++   S
Sbjct: 263 VDEGYRLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKLIRNPGS 313

>pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373

Iteration: 1
 Score =  152 bits (385), Expect = 3e-37,   Method: Compositional matrix adjust.
 Identities = 94/291 (32%), Positives = 147/291 (50%), Gaps = 14/291 (4%)
Query: 98  PNCIEIPTDGTDVW--EIDAKQLKIECKVASGSYGDLYKG-----TYCSQEVAIKVLKPE 150
           P+  E PT     +  E+DA  + I+  V +G +G++  G     +     VAIK LK  
Sbjct: 25  PHTFEDPTQTVHEFAKELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVG 84
Query: 151 CVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGV 210
               +  ++F  E  IM +  H N+++  G  T+   + IVTE+M  GS+  FL K    
Sbjct: 85  YTEKQR-RDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQ 143
Query: 211 FQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARV--QAQSG 268
           F +  L+ +   ++ GM YL     +HRDL   N+L++ N V KV+DFG++RV       
Sbjct: 144 FTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEA 203
Query: 269 VMTAETGT--YRWMAPEVIEHKPYDYKADVFSFGIALWELLT-GELPYAGLTPLQAAVGV 325
             T   G    RW +PE I ++ +   +DV+S+GI LWE+++ GE PY  ++  Q  +  
Sbjct: 204 AYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSN-QDVIKA 262
Query: 326 VQKSLRPTIPKHAHPRLAELLERCWQHDPTQRPNFSQITDILKQMMKEVAS 376
           V +  R   P      L +L+  CWQ D   RP F QI  IL ++++   S
Sbjct: 263 VDEGYRLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKLIRNPGS 313

>pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373

Iteration: 1
 Score =  152 bits (384), Expect = 3e-37,   Method: Compositional matrix adjust.
 Identities = 94/291 (32%), Positives = 146/291 (50%), Gaps = 14/291 (4%)
Query: 98  PNCIEIPTDGTDVW--EIDAKQLKIECKVASGSYGDLYKG-----TYCSQEVAIKVLKPE 150
           P+  E PT     +  E+DA  + I+  V +G +G++  G     +     VAIK LK  
Sbjct: 25  PHTFEDPTQTVHEFAKELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVG 84
Query: 151 CVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGV 210
               +  ++F  E  IM +  H N+++  G  T+   + IVTE+M  GS+  FL K    
Sbjct: 85  YTEKQR-RDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQ 143
Query: 211 FQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARV--QAQSG 268
           F +  L+ +   ++ GM YL     +HRDL   N+L++ N V KV+DFG+ RV       
Sbjct: 144 FTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILINSNLVCKVSDFGLGRVLEDDPEA 203
Query: 269 VMTAETGT--YRWMAPEVIEHKPYDYKADVFSFGIALWELLT-GELPYAGLTPLQAAVGV 325
             T   G    RW +PE I ++ +   +DV+S+GI LWE+++ GE PY  ++  Q  +  
Sbjct: 204 AYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSN-QDVIKA 262
Query: 326 VQKSLRPTIPKHAHPRLAELLERCWQHDPTQRPNFSQITDILKQMMKEVAS 376
           V +  R   P      L +L+  CWQ D   RP F QI  IL ++++   S
Sbjct: 263 VDEGYRLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKLIRNPGS 313

>pdb|2Y4I|B Chain B, Ksr2-Mek1 Heterodimer Length = 319

Iteration: 1
 Score =  152 bits (383), Expect = 4e-37,   Method: Compositional matrix adjust.
 Identities = 92/296 (31%), Positives = 155/296 (52%), Gaps = 25/296 (8%)
Query: 111 WEIDAKQLKIECKVASGSYGDLYKGTYCSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKI 170
           W+I  +QL+I   +  G +G +Y G +   EVAI+++  E  N + LK F +EV   R+ 
Sbjct: 28  WDIPFEQLEIGELIGKGRFGQVYHGRWHG-EVAIRLIDIERDNEDQLKAFKREVMAYRQT 86
Query: 171 RHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYL 230
           RH+NVV F+GAC  PP+L I+T      ++Y  +   K V  +    ++A ++ KGM YL
Sbjct: 87  RHENVVLFMGACMSPPHLAIITSLCKGRTLYSVVRDAKIVLDVNKTRQIAQEIVKGMGYL 146
Query: 231 HQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTA---------ETGTYRWMA 281
           H   I+H+DLK+ N+  D NG V + DFG+  +   SGV+ A         + G    +A
Sbjct: 147 HAKGILHKDLKSKNVFYD-NGKVVITDFGLFSI---SGVLQAGRREDKLRIQNGWLCHLA 202
Query: 282 PEVI---------EHKPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKSLRP 332
           PE+I         +  P+   +DVF+ G   +EL   E P+    P +A +  +   ++P
Sbjct: 203 PEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFK-TQPAEAIIWQMGTGMKP 261
Query: 333 TIPKHAHPR-LAELLERCWQHDPTQRPNFSQITDILKQMMKEVASEGENNHSNKSA 387
            + +    + ++++L  CW  +  +RP F+++ D+L+++ K         H  KSA
Sbjct: 262 NLSQIGMGKEISDILLFCWAFEQEERPTFTKLMDMLEKLPKRNRRLSHPGHFWKSA 317

>pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325

Iteration: 1
 Score =  152 bits (383), Expect = 4e-37,   Method: Compositional matrix adjust.
 Identities = 96/275 (34%), Positives = 137/275 (49%), Gaps = 12/275 (4%)
Query: 112 EIDAKQLKIECKVASGS-----YGDLYKGTYCSQEVAIKVLKPECVNTEMLKEFSQEVYI 166
           EI+A ++ IE  + SG      YG L         VAIK LK      +  ++F  E  I
Sbjct: 45  EIEASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQR-RDFLSEASI 103
Query: 167 MRKIRHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKG 226
           M +  H N+++  G  TR     IVTE+M  GS+  FL    G F +  L+ +   V  G
Sbjct: 104 MGQFDHPNIIRLEGVVTRGRLAMIVTEYMENGSLDTFLRTHDGQFTIMQLVGMLRGVGAG 163
Query: 227 MNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARV-QAQSGVMTAETG---TYRWMAP 282
           M YL     +HRDL   N+L+D N V KV+DFG++RV +         TG     RW AP
Sbjct: 164 MRYLSDLGYVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDAAXTTTGGKIPIRWTAP 223
Query: 283 EVIEHKPYDYKADVFSFGIALWELLT-GELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPR 341
           E I  + +   +DV+SFG+ +WE+L  GE PY  +T  +  +  V++  R   P      
Sbjct: 224 EAIAFRTFSSASDVWSFGVVMWEVLAYGERPYWNMTN-RDVISSVEEGYRLPAPMGCPHA 282
Query: 342 LAELLERCWQHDPTQRPNFSQITDILKQMMKEVAS 376
           L +L+  CW  D  QRP FSQI  +L  +++   S
Sbjct: 283 LHQLMLDCWHKDRAQRPRFSQIVSVLDALIRSPES 317

>pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373

Iteration: 1
 Score =  152 bits (383), Expect = 4e-37,   Method: Compositional matrix adjust.
 Identities = 94/291 (32%), Positives = 147/291 (50%), Gaps = 14/291 (4%)
Query: 98  PNCIEIPTDGTDVW--EIDAKQLKIECKVASGSYGDLYKG-----TYCSQEVAIKVLKPE 150
           P+  E PT     +  E+DA  + I+  V +G +G++  G     +     VAIK LK  
Sbjct: 25  PHTYEDPTQTVHEFAKELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVG 84
Query: 151 CVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGV 210
               +  ++F  E  IM +  H N+++  G  T+   + IVTE+M  GS+  FL K    
Sbjct: 85  YTEKQR-RDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQ 143
Query: 211 FQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARV--QAQSG 268
           F +  L+ +   ++ GM YL     +HRDL   N+L++ N V KV+DFG++RV       
Sbjct: 144 FTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEA 203
Query: 269 VMTAETGT--YRWMAPEVIEHKPYDYKADVFSFGIALWELLT-GELPYAGLTPLQAAVGV 325
             T   G    RW +PE I ++ +   +DV+S+GI LWE+++ GE PY  ++  Q  +  
Sbjct: 204 AYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSN-QDVIKA 262
Query: 326 VQKSLRPTIPKHAHPRLAELLERCWQHDPTQRPNFSQITDILKQMMKEVAS 376
           V +  R   P      L +L+  CWQ D   RP F QI  IL ++++   S
Sbjct: 263 VDEGYRLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKLIRNPGS 313

>pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373

Iteration: 1
 Score =  152 bits (383), Expect = 4e-37,   Method: Compositional matrix adjust.
 Identities = 94/291 (32%), Positives = 147/291 (50%), Gaps = 14/291 (4%)
Query: 98  PNCIEIPTDGTDVW--EIDAKQLKIECKVASGSYGDLYKG-----TYCSQEVAIKVLKPE 150
           P+  E PT     +  E+DA  + I+  V +G +G++  G     +     VAIK LK  
Sbjct: 25  PHTYEDPTQTVHEFAKELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVG 84
Query: 151 CVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGV 210
               +  ++F  E  IM +  H N+++  G  T+   + IVTE+M  GS+  FL K    
Sbjct: 85  YTEKQR-RDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQ 143
Query: 211 FQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARV--QAQSG 268
           F +  L+ +   ++ GM YL     +HRDL   N+L++ N V KV+DFG++RV       
Sbjct: 144 FTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEA 203
Query: 269 VMTAETGT--YRWMAPEVIEHKPYDYKADVFSFGIALWELLT-GELPYAGLTPLQAAVGV 325
             T   G    RW +PE I ++ +   +DV+S+GI LWE+++ GE PY  ++  Q  +  
Sbjct: 204 AYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSN-QDVIKA 262
Query: 326 VQKSLRPTIPKHAHPRLAELLERCWQHDPTQRPNFSQITDILKQMMKEVAS 376
           V +  R   P      L +L+  CWQ D   RP F QI  IL ++++   S
Sbjct: 263 VDEGYRLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKLIRNPGS 313

>pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285

Iteration: 1
 Score =  152 bits (383), Expect = 4e-37,   Method: Compositional matrix adjust.
 Identities = 94/288 (32%), Positives = 151/288 (52%), Gaps = 19/288 (6%)
Query: 112 EIDAKQLKIECKVASGSYGDLYKGTY---CSQE--VAIKVLKPECVNTEMLKEFSQEVYI 166
           EIDA  +KIE  +  G +G++  G       +E  VAIK LK    + +  ++F  E  I
Sbjct: 4   EIDASCIKIEKVIGVGEFGEVCSGRLKVPGKREICVAIKTLKAGYTDKQR-RDFLSEASI 62
Query: 167 MRKIRHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKG 226
           M +  H N++   G  T+   + I+TE+M  GS+  FL K  G F +  L+ +   +  G
Sbjct: 63  MGQFDHPNIIHLEGVVTKCKPVMIITEYMENGSLDAFLRKNDGRFTVIQLVGMLRGIGSG 122
Query: 227 MNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARV--QAQSGVMTAETGT--YRWMAP 282
           M YL   + +HRDL   N+L++ N V KV+DFG++RV         T   G    RW AP
Sbjct: 123 MKYLSDMSYVHRDLAARNILVNSNLVCKVSDFGMSRVLEDDPEAAYTTRGGKIPIRWTAP 182
Query: 283 EVIEHKPYDYKADVFSFGIALWELLT-GELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPR 341
           E I ++ +   +DV+S+GI +WE+++ GE PY  ++  Q  +  +++  R   P      
Sbjct: 183 EAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSN-QDVIKAIEEGYRLPPPMDCPIA 241
Query: 342 LAELLERCWQHDPTQRPNFSQITDILKQMMKEVASEGENNHSNKSAGS 389
           L +L+  CWQ + + RP F QI ++L ++++       N +S K  GS
Sbjct: 242 LHQLMLDCWQKERSDRPKFGQIVNMLDKLIR-------NPNSLKRTGS 282

>pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371

Iteration: 1
 Score =  152 bits (383), Expect = 4e-37,   Method: Compositional matrix adjust.
 Identities = 94/291 (32%), Positives = 147/291 (50%), Gaps = 14/291 (4%)
Query: 98  PNCIEIPTDGTDVW--EIDAKQLKIECKVASGSYGDLYKG-----TYCSQEVAIKVLKPE 150
           P+  E PT     +  E+DA  + I+  V +G +G++  G     +     VAIK LK  
Sbjct: 23  PHTYEDPTQTVHEFAKELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVG 82
Query: 151 CVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGV 210
               +  ++F  E  IM +  H N+++  G  T+   + IVTE+M  GS+  FL K    
Sbjct: 83  YTEKQR-RDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQ 141
Query: 211 FQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARV--QAQSG 268
           F +  L+ +   ++ GM YL     +HRDL   N+L++ N V KV+DFG++RV       
Sbjct: 142 FTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEA 201
Query: 269 VMTAETGT--YRWMAPEVIEHKPYDYKADVFSFGIALWELLT-GELPYAGLTPLQAAVGV 325
             T   G    RW +PE I ++ +   +DV+S+GI LWE+++ GE PY  ++  Q  +  
Sbjct: 202 AYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSN-QDVIKA 260
Query: 326 VQKSLRPTIPKHAHPRLAELLERCWQHDPTQRPNFSQITDILKQMMKEVAS 376
           V +  R   P      L +L+  CWQ D   RP F QI  IL ++++   S
Sbjct: 261 VDEGYRLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKLIRNPGS 311

>pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344

Iteration: 1
 Score =  152 bits (383), Expect = 5e-37,   Method: Compositional matrix adjust.
 Identities = 90/275 (32%), Positives = 141/275 (51%), Gaps = 12/275 (4%)
Query: 112 EIDAKQLKIECKVASGSYGDLYKG-----TYCSQEVAIKVLKPECVNTEMLKEFSQEVYI 166
           E+DA  + I+  V +G +G++  G     +     VAIK LK      +  ++F  E  I
Sbjct: 12  ELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQR-RDFLGEASI 70
Query: 167 MRKIRHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKG 226
           M +  H N+++  G  T+   + IVTE+M  GS+  FL K    F +  L+ +   ++ G
Sbjct: 71  MGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASG 130
Query: 227 MNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARV--QAQSGVMTAETGT--YRWMAP 282
           M YL     +HRDL   N+L++ N V KV+DFG++RV         T   G    RW +P
Sbjct: 131 MKYLSDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSP 190
Query: 283 EVIEHKPYDYKADVFSFGIALWELLT-GELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPR 341
           E I ++ +   +DV+S+GI LWE+++ GE PY  ++  Q  +  V +  R   P      
Sbjct: 191 EAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSN-QDVIKAVDEGYRLPPPMDCPAA 249
Query: 342 LAELLERCWQHDPTQRPNFSQITDILKQMMKEVAS 376
           L +L+  CWQ D   RP F QI  IL ++++   S
Sbjct: 250 LYQLMLDCWQKDRNNRPKFEQIVSILDKLIRNPGS 284

>pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325

Iteration: 1
 Score =  151 bits (382), Expect = 5e-37,   Method: Compositional matrix adjust.
 Identities = 96/275 (34%), Positives = 137/275 (49%), Gaps = 12/275 (4%)
Query: 112 EIDAKQLKIECKVASGS-----YGDLYKGTYCSQEVAIKVLKPECVNTEMLKEFSQEVYI 166
           EI+A ++ IE  + SG      YG L         VAIK LK      +  ++F  E  I
Sbjct: 45  EIEASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQR-RDFLSEASI 103
Query: 167 MRKIRHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKG 226
           M +  H N+++  G  TR     IVTE+M  GS+  FL    G F +  L+ +   V  G
Sbjct: 104 MGQFDHPNIIRLEGVVTRGRLAMIVTEYMENGSLDTFLRTHDGQFTIMQLVGMLRGVGAG 163
Query: 227 MNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARV-QAQSGVMTAETG---TYRWMAP 282
           M YL     +HRDL   N+L+D N V KV+DFG++RV +         TG     RW AP
Sbjct: 164 MRYLSDLGYVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDAAYTTTGGKIPIRWTAP 223
Query: 283 EVIEHKPYDYKADVFSFGIALWELLT-GELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPR 341
           E I  + +   +DV+SFG+ +WE+L  GE PY  +T  +  +  V++  R   P      
Sbjct: 224 EAIAFRTFSSASDVWSFGVVMWEVLAYGERPYWNMTN-RDVISSVEEGYRLPAPMGCPHA 282
Query: 342 LAELLERCWQHDPTQRPNFSQITDILKQMMKEVAS 376
           L +L+  CW  D  QRP FSQI  +L  +++   S
Sbjct: 283 LHQLMLDCWHKDRAQRPRFSQIVSVLDALIRSPES 317

>pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291

Iteration: 1
 Score =  151 bits (382), Expect = 5e-37,   Method: Compositional matrix adjust.
 Identities = 94/288 (32%), Positives = 151/288 (52%), Gaps = 19/288 (6%)
Query: 112 EIDAKQLKIECKVASGSYGDLYKGTY---CSQE--VAIKVLKPECVNTEMLKEFSQEVYI 166
           EIDA  +KIE  +  G +G++  G       +E  VAIK LK    + +  ++F  E  I
Sbjct: 10  EIDASCIKIEKVIGVGEFGEVCSGRLKVPGKREICVAIKTLKAGYTDKQR-RDFLSEASI 68
Query: 167 MRKIRHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKG 226
           M +  H N++   G  T+   + I+TE+M  GS+  FL K  G F +  L+ +   +  G
Sbjct: 69  MGQFDHPNIIHLEGVVTKCKPVMIITEYMENGSLDAFLRKNDGRFTVIQLVGMLRGIGSG 128
Query: 227 MNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARV--QAQSGVMTAETGT--YRWMAP 282
           M YL   + +HRDL   N+L++ N V KV+DFG++RV         T   G    RW AP
Sbjct: 129 MKYLSDMSYVHRDLAARNILVNSNLVCKVSDFGMSRVLEDDPEAAYTTRGGKIPIRWTAP 188
Query: 283 EVIEHKPYDYKADVFSFGIALWELLT-GELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPR 341
           E I ++ +   +DV+S+GI +WE+++ GE PY  ++  Q  +  +++  R   P      
Sbjct: 189 EAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSN-QDVIKAIEEGYRLPPPMDCPIA 247
Query: 342 LAELLERCWQHDPTQRPNFSQITDILKQMMKEVASEGENNHSNKSAGS 389
           L +L+  CWQ + + RP F QI ++L ++++       N +S K  GS
Sbjct: 248 LHQLMLDCWQKERSDRPKFGQIVNMLDKLIR-------NPNSLKRTGS 288

>pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361

Iteration: 1
 Score =  151 bits (382), Expect = 6e-37,   Method: Compositional matrix adjust.
 Identities = 90/275 (32%), Positives = 141/275 (51%), Gaps = 12/275 (4%)
Query: 112 EIDAKQLKIECKVASGSYGDLYKG-----TYCSQEVAIKVLKPECVNTEMLKEFSQEVYI 166
           E+DA  + I+  V +G +G++  G     +     VAIK LK      +  ++F  E  I
Sbjct: 29  ELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQR-RDFLGEASI 87
Query: 167 MRKIRHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKG 226
           M +  H N+++  G  T+   + IVTE+M  GS+  FL K    F +  L+ +   ++ G
Sbjct: 88  MGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASG 147
Query: 227 MNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARV--QAQSGVMTAETGT--YRWMAP 282
           M YL     +HRDL   N+L++ N V KV+DFG++RV         T   G    RW +P
Sbjct: 148 MKYLSDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSP 207
Query: 283 EVIEHKPYDYKADVFSFGIALWELLT-GELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPR 341
           E I ++ +   +DV+S+GI LWE+++ GE PY  ++  Q  +  V +  R   P      
Sbjct: 208 EAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSN-QDVIKAVDEGYRLPPPMDCPAA 266
Query: 342 LAELLERCWQHDPTQRPNFSQITDILKQMMKEVAS 376
           L +L+  CWQ D   RP F QI  IL ++++   S
Sbjct: 267 LYQLMLDCWQKDRNNRPKFEQIVSILDKLIRNPGS 301

>pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306

Iteration: 1
 Score =  151 bits (382), Expect = 6e-37,   Method: Compositional matrix adjust.
 Identities = 94/288 (32%), Positives = 151/288 (52%), Gaps = 19/288 (6%)
Query: 112 EIDAKQLKIECKVASGSYGDLYKGTY---CSQE--VAIKVLKPECVNTEMLKEFSQEVYI 166
           EIDA  +KIE  +  G +G++  G       +E  VAIK LK    + +  ++F  E  I
Sbjct: 25  EIDASCIKIEKVIGVGEFGEVCSGRLKVPGKREICVAIKTLKAGYTDKQR-RDFLSEASI 83
Query: 167 MRKIRHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKG 226
           M +  H N++   G  T+   + I+TE+M  GS+  FL K  G F +  L+ +   +  G
Sbjct: 84  MGQFDHPNIIHLEGVVTKCKPVMIITEYMENGSLDAFLRKNDGRFTVIQLVGMLRGIGSG 143
Query: 227 MNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARV--QAQSGVMTAETGT--YRWMAP 282
           M YL   + +HRDL   N+L++ N V KV+DFG++RV         T   G    RW AP
Sbjct: 144 MKYLSDMSAVHRDLAARNILVNSNLVCKVSDFGMSRVLEDDPEAAYTTRGGKIPIRWTAP 203
Query: 283 EVIEHKPYDYKADVFSFGIALWELLT-GELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPR 341
           E I ++ +   +DV+S+GI +WE+++ GE PY  ++  Q  +  +++  R   P      
Sbjct: 204 EAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSN-QDVIKAIEEGYRLPPPMDCPIA 262
Query: 342 LAELLERCWQHDPTQRPNFSQITDILKQMMKEVASEGENNHSNKSAGS 389
           L +L+  CWQ + + RP F QI ++L ++++       N +S K  GS
Sbjct: 263 LHQLMLDCWQKERSDRPKFGQIVNMLDKLIR-------NPNSLKRTGS 303

>pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287

Iteration: 1
 Score =  151 bits (381), Expect = 6e-37,   Method: Compositional matrix adjust.
 Identities = 93/274 (33%), Positives = 154/274 (56%), Gaps = 26/274 (9%)
Query: 117 QLKIECKVASGSYGDLYKGTYCSQE--VAIKVL-----KPECVNTEMLKEFSQEVYIMRK 169
           +++ E ++  G +G ++KG     +  VAIK L     + E    E  +EF +EV+IM  
Sbjct: 20  EIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSN 79
Query: 170 IRHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNY 229
           + H N+V+  G    PP +  V EF+  G +Y  L  +    + +  L++ +D++ G+ Y
Sbjct: 80  LNHPNIVKLYGLMHNPPRM--VMEFVPCGDLYHRLLDKAHPIKWSVKLRLMLDIALGIEY 137
Query: 230 LHQNN--IIHRDLKTANLLM---DENGVV--KVADFGVAR--VQAQSGVMTAETGTYRWM 280
           +   N  I+HRDL++ N+ +   DEN  V  KVADF +++  V + SG++    G ++WM
Sbjct: 138 MQNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFSLSQQSVHSVSGLL----GNFQWM 193
Query: 281 APEVI--EHKPYDYKADVFSFGIALWELLTGELPYAGLT--PLQAAVGVVQKSLRPTIPK 336
           APE I  E + Y  KAD +SF + L+ +LTGE P+   +   ++    + ++ LRPTIP+
Sbjct: 194 APETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKIKFINMIREEGLRPTIPE 253
Query: 337 HAHPRLAELLERCWQHDPTQRPNFSQITDILKQM 370
              PRL  ++E CW  DP +RP+FS I   L ++
Sbjct: 254 DCPPRLRNVIELCWSGDPKKRPHFSYIVKELSEL 287

>pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291

Iteration: 1
 Score =  151 bits (381), Expect = 8e-37,   Method: Compositional matrix adjust.
 Identities = 86/266 (32%), Positives = 141/266 (53%), Gaps = 12/266 (4%)
Query: 113 IDAKQLKIECKVASGSYGDLYKGTYCSQE-----VAIKVLKPECVNT-EMLKEFSQEVYI 166
           I  K L++  K+  GS+G + +G + +       VA+K LKP+ ++  E + +F +EV  
Sbjct: 15  IGEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNA 74
Query: 167 MRKIRHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKG 226
           M  + H+N+++  G    PP + +VTE    GS+ D L K +G F L +L + A+ V++G
Sbjct: 75  MHSLDHRNLIRLYGVVLTPP-MKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEG 133
Query: 227 MNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSG---VMTAETGT-YRWMAP 282
           M YL     IHRDL   NLL+    +VK+ DFG+ R   Q+    VM       + W AP
Sbjct: 134 MGYLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAP 193
Query: 283 EVIEHKPYDYKADVFSFGIALWELLT-GELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPR 341
           E ++ + + + +D + FG+ LWE+ T G+ P+ GL   Q    + ++  R   P+     
Sbjct: 194 ESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERLPRPEDCPQD 253
Query: 342 LAELLERCWQHDPTQRPNFSQITDIL 367
           +  ++ +CW H P  RP F  + D L
Sbjct: 254 IYNVMVQCWAHKPEDRPTFVALRDFL 279

>pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291

Iteration: 1
 Score =  150 bits (380), Expect = 8e-37,   Method: Compositional matrix adjust.
 Identities = 87/277 (31%), Positives = 143/277 (51%), Gaps = 14/277 (5%)
Query: 112 EIDAKQLKIECKVASGSYGDLYKGTYCSQE-----VAIKVLKPECVNTEMLKEFSQEVYI 166
           EID   +KIE  + +G +G++ +G   +       VAIK LK      +  +EF  E  I
Sbjct: 10  EIDVSYVKIEEVIGAGEFGEVCRGRLKAPGKKESCVAIKTLKGGYTERQR-REFLSEASI 68
Query: 167 MRKIRHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKG 226
           M +  H N+++  G  T    + I+TEFM  G++  FL    G F +  L+ +   ++ G
Sbjct: 69  MGQFEHPNIIRLEGVVTNSMPVMILTEFMENGALDSFLRLNDGQFTVIQLVGMLRGIASG 128
Query: 227 MNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAETGTY------RWM 280
           M YL + + +HRDL   N+L++ N V KV+DFG++R   ++      T +       RW 
Sbjct: 129 MRYLAEMSYVHRDLAARNILVNSNLVCKVSDFGLSRFLEENSSDPTYTSSLGGKIPIRWT 188
Query: 281 APEVIEHKPYDYKADVFSFGIALWELLT-GELPYAGLTPLQAAVGVVQKSLRPTIPKHAH 339
           APE I  + +   +D +S+GI +WE+++ GE PY  ++  Q  +  +++  R   P    
Sbjct: 189 APEAIAFRKFTSASDAWSYGIVMWEVMSFGERPYWDMSN-QDVINAIEQDYRLPPPPDCP 247
Query: 340 PRLAELLERCWQHDPTQRPNFSQITDILKQMMKEVAS 376
             L +L+  CWQ D   RP F Q+   L +M++  AS
Sbjct: 248 TSLHQLMLDCWQKDRNARPRFPQVVSALDKMIRNPAS 284

>pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373

Iteration: 1
 Score =  150 bits (380), Expect = 8e-37,   Method: Compositional matrix adjust.
 Identities = 94/291 (32%), Positives = 146/291 (50%), Gaps = 14/291 (4%)
Query: 98  PNCIEIPTDGTDVW--EIDAKQLKIECKVASGSYGDLYKG-----TYCSQEVAIKVLKPE 150
           P+  E PT     +  E+DA  + I+  V +G +G++  G     +     VAIK LK  
Sbjct: 25  PHTFEDPTQTVHEFAKELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVG 84
Query: 151 CVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGV 210
               +  ++F  E  IM +  H N+++  G  T+   + IVTE M  GS+  FL K    
Sbjct: 85  YTEKQR-RDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEXMENGSLDSFLRKHDAQ 143
Query: 211 FQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARV--QAQSG 268
           F +  L+ +   ++ GM YL     +HRDL   N+L++ N V KV+DFG++RV       
Sbjct: 144 FTVIQLVGMLRGIASGMKYLSDMGAVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEA 203
Query: 269 VMTAETGT--YRWMAPEVIEHKPYDYKADVFSFGIALWELLT-GELPYAGLTPLQAAVGV 325
             T   G    RW +PE I ++ +   +DV+S+GI LWE+++ GE PY  ++  Q  +  
Sbjct: 204 AYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSN-QDVIKA 262
Query: 326 VQKSLRPTIPKHAHPRLAELLERCWQHDPTQRPNFSQITDILKQMMKEVAS 376
           V +  R   P      L +L+  CWQ D   RP F QI  IL ++++   S
Sbjct: 263 VDEGYRLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKLIRNPGS 313

>pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291

Iteration: 1
 Score =  150 bits (380), Expect = 8e-37,   Method: Compositional matrix adjust.
 Identities = 86/266 (32%), Positives = 141/266 (53%), Gaps = 12/266 (4%)
Query: 113 IDAKQLKIECKVASGSYGDLYKGTYCSQE-----VAIKVLKPECVNT-EMLKEFSQEVYI 166
           I  K L++  K+  GS+G + +G + +       VA+K LKP+ ++  E + +F +EV  
Sbjct: 15  IGEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNA 74
Query: 167 MRKIRHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKG 226
           M  + H+N+++  G    PP + +VTE    GS+ D L K +G F L +L + A+ V++G
Sbjct: 75  MHSLDHRNLIRLYGVVLTPP-MKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEG 133
Query: 227 MNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSG---VMTAETGT-YRWMAP 282
           M YL     IHRDL   NLL+    +VK+ DFG+ R   Q+    VM       + W AP
Sbjct: 134 MGYLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHXVMQEHRKVPFAWCAP 193
Query: 283 EVIEHKPYDYKADVFSFGIALWELLT-GELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPR 341
           E ++ + + + +D + FG+ LWE+ T G+ P+ GL   Q    + ++  R   P+     
Sbjct: 194 ESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERLPRPEDCPQD 253
Query: 342 LAELLERCWQHDPTQRPNFSQITDIL 367
           +  ++ +CW H P  RP F  + D L
Sbjct: 254 IYNVMVQCWAHKPEDRPTFVALRDFL 279

>pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277

Iteration: 1
 Score =  150 bits (380), Expect = 9e-37,   Method: Compositional matrix adjust.
 Identities = 86/266 (32%), Positives = 141/266 (53%), Gaps = 12/266 (4%)
Query: 113 IDAKQLKIECKVASGSYGDLYKGTYCSQE-----VAIKVLKPECVNT-EMLKEFSQEVYI 166
           I  K L++  K+  GS+G + +G + +       VA+K LKP+ ++  E + +F +EV  
Sbjct: 9   IGEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNA 68
Query: 167 MRKIRHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKG 226
           M  + H+N+++  G    PP + +VTE    GS+ D L K +G F L +L + A+ V++G
Sbjct: 69  MHSLDHRNLIRLYGVVLTPP-MKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEG 127
Query: 227 MNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSG---VMTAETGT-YRWMAP 282
           M YL     IHRDL   NLL+    +VK+ DFG+ R   Q+    VM       + W AP
Sbjct: 128 MGYLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAP 187
Query: 283 EVIEHKPYDYKADVFSFGIALWELLT-GELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPR 341
           E ++ + + + +D + FG+ LWE+ T G+ P+ GL   Q    + ++  R   P+     
Sbjct: 188 ESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERLPRPEDCPQD 247
Query: 342 LAELLERCWQHDPTQRPNFSQITDIL 367
           +  ++ +CW H P  RP F  + D L
Sbjct: 248 IYNVMVQCWAHKPEDRPTFVALRDFL 273

>pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341

Iteration: 1
 Score =  150 bits (380), Expect = 9e-37,   Method: Compositional matrix adjust.
 Identities = 86/266 (32%), Positives = 141/266 (53%), Gaps = 12/266 (4%)
Query: 113 IDAKQLKIECKVASGSYGDLYKGTYCSQE-----VAIKVLKPECVNT-EMLKEFSQEVYI 166
           I  K L++  K+  GS+G + +G + +       VA+K LKP+ ++  E + +F +EV  
Sbjct: 9   IGEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNA 68
Query: 167 MRKIRHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKG 226
           M  + H+N+++  G    PP + +VTE    GS+ D L K +G F L +L + A+ V++G
Sbjct: 69  MHSLDHRNLIRLYGVVLTPP-MKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEG 127
Query: 227 MNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSG---VMTAETGT-YRWMAP 282
           M YL     IHRDL   NLL+    +VK+ DFG+ R   Q+    VM       + W AP
Sbjct: 128 MGYLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAP 187
Query: 283 EVIEHKPYDYKADVFSFGIALWELLT-GELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPR 341
           E ++ + + + +D + FG+ LWE+ T G+ P+ GL   Q    + ++  R   P+     
Sbjct: 188 ESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERLPRPEDCPQD 247
Query: 342 LAELLERCWQHDPTQRPNFSQITDIL 367
           +  ++ +CW H P  RP F  + D L
Sbjct: 248 IYNVMVQCWAHKPEDRPTFVALRDFL 273

>pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276

Iteration: 1
 Score =  150 bits (380), Expect = 9e-37,   Method: Compositional matrix adjust.
 Identities = 86/266 (32%), Positives = 141/266 (53%), Gaps = 12/266 (4%)
Query: 113 IDAKQLKIECKVASGSYGDLYKGTYCSQE-----VAIKVLKPECVNT-EMLKEFSQEVYI 166
           I  K L++  K+  GS+G + +G + +       VA+K LKP+ ++  E + +F +EV  
Sbjct: 5   IGEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNA 64
Query: 167 MRKIRHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKG 226
           M  + H+N+++  G    PP + +VTE    GS+ D L K +G F L +L + A+ V++G
Sbjct: 65  MHSLDHRNLIRLYGVVLTPP-MKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEG 123
Query: 227 MNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSG---VMTAETGT-YRWMAP 282
           M YL     IHRDL   NLL+    +VK+ DFG+ R   Q+    VM       + W AP
Sbjct: 124 MGYLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAP 183
Query: 283 EVIEHKPYDYKADVFSFGIALWELLT-GELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPR 341
           E ++ + + + +D + FG+ LWE+ T G+ P+ GL   Q    + ++  R   P+     
Sbjct: 184 ESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERLPRPEDCPQD 243
Query: 342 LAELLERCWQHDPTQRPNFSQITDIL 367
           +  ++ +CW H P  RP F  + D L
Sbjct: 244 IYNVMVQCWAHKPEDRPTFVALRDFL 269

>pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273

Iteration: 1
 Score =  150 bits (379), Expect = 1e-36,   Method: Compositional matrix adjust.
 Identities = 86/266 (32%), Positives = 141/266 (53%), Gaps = 12/266 (4%)
Query: 113 IDAKQLKIECKVASGSYGDLYKGTYCSQE-----VAIKVLKPECVNT-EMLKEFSQEVYI 166
           I  K L++  K+  GS+G + +G + +       VA+K LKP+ ++  E + +F +EV  
Sbjct: 5   IGEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNA 64
Query: 167 MRKIRHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKG 226
           M  + H+N+++  G    PP + +VTE    GS+ D L K +G F L +L + A+ V++G
Sbjct: 65  MHSLDHRNLIRLYGVVLTPP-MKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEG 123
Query: 227 MNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSG---VMTAETGT-YRWMAP 282
           M YL     IHRDL   NLL+    +VK+ DFG+ R   Q+    VM       + W AP
Sbjct: 124 MGYLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAP 183
Query: 283 EVIEHKPYDYKADVFSFGIALWELLT-GELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPR 341
           E ++ + + + +D + FG+ LWE+ T G+ P+ GL   Q    + ++  R   P+     
Sbjct: 184 ESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERLPRPEDCPQD 243
Query: 342 LAELLERCWQHDPTQRPNFSQITDIL 367
           +  ++ +CW H P  RP F  + D L
Sbjct: 244 IYNVMVQCWAHKPEDRPTFVALRDFL 269

>pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275

Iteration: 1
 Score =  150 bits (379), Expect = 1e-36,   Method: Compositional matrix adjust.
 Identities = 86/266 (32%), Positives = 141/266 (53%), Gaps = 12/266 (4%)
Query: 113 IDAKQLKIECKVASGSYGDLYKGTYCSQE-----VAIKVLKPECVNT-EMLKEFSQEVYI 166
           I  K L++  K+  GS+G + +G + +       VA+K LKP+ ++  E + +F +EV  
Sbjct: 5   IGEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNA 64
Query: 167 MRKIRHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKG 226
           M  + H+N+++  G    PP + +VTE    GS+ D L K +G F L +L + A+ V++G
Sbjct: 65  MHSLDHRNLIRLYGVVLTPP-MKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEG 123
Query: 227 MNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSG---VMTAETGT-YRWMAP 282
           M YL     IHRDL   NLL+    +VK+ DFG+ R   Q+    VM       + W AP
Sbjct: 124 MGYLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHXVMQEHRKVPFAWCAP 183
Query: 283 EVIEHKPYDYKADVFSFGIALWELLT-GELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPR 341
           E ++ + + + +D + FG+ LWE+ T G+ P+ GL   Q    + ++  R   P+     
Sbjct: 184 ESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERLPRPEDCPQD 243
Query: 342 LAELLERCWQHDPTQRPNFSQITDIL 367
           +  ++ +CW H P  RP F  + D L
Sbjct: 244 IYNVMVQCWAHKPEDRPTFVALRDFL 269

>pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344

Iteration: 1
 Score =  150 bits (378), Expect = 1e-36,   Method: Compositional matrix adjust.
 Identities = 90/275 (32%), Positives = 140/275 (50%), Gaps = 12/275 (4%)
Query: 112 EIDAKQLKIECKVASGSYGDLYKG-----TYCSQEVAIKVLKPECVNTEMLKEFSQEVYI 166
           E+DA  + I+  V +G +G++  G     +     VAIK LK      +  ++F  E  I
Sbjct: 12  ELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQR-RDFLGEASI 70
Query: 167 MRKIRHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKG 226
           M +  H N+++  G  T+   + IVTE M  GS+  FL K    F +  L+ +   ++ G
Sbjct: 71  MGQFDHPNIIRLEGVVTKSKPVMIVTEXMENGSLDSFLRKHDAQFTVIQLVGMLRGIASG 130
Query: 227 MNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARV--QAQSGVMTAETGT--YRWMAP 282
           M YL     +HRDL   N+L++ N V KV+DFG++RV         T   G    RW +P
Sbjct: 131 MKYLSDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSP 190
Query: 283 EVIEHKPYDYKADVFSFGIALWELLT-GELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPR 341
           E I ++ +   +DV+S+GI LWE+++ GE PY  ++  Q  +  V +  R   P      
Sbjct: 191 EAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSN-QDVIKAVDEGYRLPPPMDCPAA 249
Query: 342 LAELLERCWQHDPTQRPNFSQITDILKQMMKEVAS 376
           L +L+  CWQ D   RP F QI  IL ++++   S
Sbjct: 250 LYQLMLDCWQKDRNNRPKFEQIVSILDKLIRNPGS 284

>pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373

Iteration: 1
 Score =  150 bits (378), Expect = 2e-36,   Method: Compositional matrix adjust.
 Identities = 94/291 (32%), Positives = 146/291 (50%), Gaps = 14/291 (4%)
Query: 98  PNCIEIPTDGTDVW--EIDAKQLKIECKVASGSYGDLYKG-----TYCSQEVAIKVLKPE 150
           P+  E PT     +  E+DA  + I+  V +G +G++  G     +     VAIK LK  
Sbjct: 25  PHTYEDPTQTVHEFAKELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVG 84
Query: 151 CVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGV 210
               +  ++F  E  IM +  H N+++  G  T+   + IVTE M  GS+  FL K    
Sbjct: 85  YTEKQR-RDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEXMENGSLDSFLRKHDAQ 143
Query: 211 FQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARV--QAQSG 268
           F +  L+ +   ++ GM YL     +HRDL   N+L++ N V KV+DFG++RV       
Sbjct: 144 FTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEA 203
Query: 269 VMTAETGT--YRWMAPEVIEHKPYDYKADVFSFGIALWELLT-GELPYAGLTPLQAAVGV 325
             T   G    RW +PE I ++ +   +DV+S+GI LWE+++ GE PY  ++  Q  +  
Sbjct: 204 AYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSN-QDVIKA 262
Query: 326 VQKSLRPTIPKHAHPRLAELLERCWQHDPTQRPNFSQITDILKQMMKEVAS 376
           V +  R   P      L +L+  CWQ D   RP F QI  IL ++++   S
Sbjct: 263 VDEGYRLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKLIRNPGS 313

>pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333

Iteration: 1
 Score =  149 bits (376), Expect = 3e-36,   Method: Compositional matrix adjust.
 Identities = 82/260 (31%), Positives = 138/260 (53%), Gaps = 13/260 (5%)
Query: 124 VASGSYGDLYKGTYCSQE------VAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQ 177
           + +G +G++YKG   +        VAIK LK      + + +F  E  IM +  H N+++
Sbjct: 52  IGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRV-DFLGEAGIMGQFSHHNIIR 110
Query: 178 FIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIH 237
             G  ++   + I+TE+M  G++  FL ++ G F +  L+ +   ++ GM YL   N +H
Sbjct: 111 LEGVISKYKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANMNYVH 170
Query: 238 RDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAETG----TYRWMAPEVIEHKPYDYK 293
           RDL   N+L++ N V KV+DFG++RV       T  T       RW APE I ++ +   
Sbjct: 171 RDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPEAISYRKFTSA 230
Query: 294 ADVFSFGIALWELLT-GELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRLAELLERCWQH 352
           +DV+SFGI +WE++T GE PY  L+     +  +    R   P      + +L+ +CWQ 
Sbjct: 231 SDVWSFGIVMWEVMTYGERPYWELSN-HEVMKAINDGFRLPTPMDCPSAIYQLMMQCWQQ 289
Query: 353 DPTQRPNFSQITDILKQMMK 372
           +  +RP F+ I  IL ++++
Sbjct: 290 ERARRPKFADIVSILDKLIR 309

>pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295

Iteration: 1
 Score =  147 bits (372), Expect = 9e-36,   Method: Compositional matrix adjust.
 Identities = 90/274 (32%), Positives = 141/274 (51%), Gaps = 12/274 (4%)
Query: 112 EIDAKQLKIECKVASGSYGDLYKGTYC-----SQEVAIKVLKPECVNTEMLKEFSQEVYI 166
           EI+A  + IE  + +G +G++  G           VAIK LK      +  ++F  E  I
Sbjct: 18  EIEASCITIERVIGAGEFGEVCSGRLKLPGKRELPVAIKTLKVGYTEKQR-RDFLGEASI 76
Query: 167 MRKIRHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKG 226
           M +  H N++   G  T+   + IVTE+M  GS+  FL K  G F +  L+ +   +S G
Sbjct: 77  MGQFDHPNIIHLEGVVTKSKPVMIVTEYMENGSLDTFLKKNDGQFTVIQLVGMLRGISAG 136
Query: 227 MNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARV--QAQSGVMTAETGT--YRWMAP 282
           M YL     +HRDL   N+L++ N V KV+DFG++RV         T   G    RW AP
Sbjct: 137 MKYLSDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTAP 196
Query: 283 EVIEHKPYDYKADVFSFGIALWELLT-GELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPR 341
           E I  + +   +DV+S+GI +WE+++ GE PY  +T  Q  +  V++  R   P      
Sbjct: 197 EAIAFRKFTSASDVWSYGIVMWEVVSYGERPYWEMTN-QDVIKAVEEGYRLPSPMDCPAA 255
Query: 342 LAELLERCWQHDPTQRPNFSQITDILKQMMKEVA 375
           L +L+  CWQ +   RP F +I ++L ++++  A
Sbjct: 256 LYQLMLDCWQKERNSRPKFDEIVNMLDKLIRNPA 289

>pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316

Iteration: 1
 Score =  145 bits (367), Expect = 3e-35,   Method: Compositional matrix adjust.
 Identities = 88/304 (28%), Positives = 151/304 (49%), Gaps = 26/304 (8%)
Query: 99  NCIEIPTDGTDVWEIDAKQLKIECKVASGSYGDLYKG-------TYCSQEVAIKVLKPEC 151
           +C  +P D +  WE    +LK+   +  G++G + +        T   + VA+K+LK   
Sbjct: 13  HCERLPYDASK-WEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATXRTVAVKMLKEGA 71
Query: 152 VNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPN-LCIVTEFMARGSIYDFLHKQKGV 210
            ++E     S+   ++    H NVV  +GACT+P   L ++ EF   G++  +L  ++  
Sbjct: 72  THSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNE 131
Query: 211 F-------------QLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVAD 257
           F              L  L+  +  V+KGM +L     IHRDL   N+L+ E  VVK+ D
Sbjct: 132 FVPYKPEDLYKDFLTLEHLIXYSFQVAKGMEFLASRKXIHRDLAARNILLSEKNVVKICD 191
Query: 258 FGVAR--VQAQSGVMTAETG-TYRWMAPEVIEHKPYDYKADVFSFGIALWELLT-GELPY 313
           FG+AR   +    V   +     +WMAPE I  + Y  ++DV+SFG+ LWE+ + G  PY
Sbjct: 192 FGLARDIXKDPDXVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPY 251
Query: 314 AGLTPLQAAVGVVQKSLRPTIPKHAHPRLAELLERCWQHDPTQRPNFSQITDILKQMMKE 373
            G+   +     +++  R   P +  P + + +  CW  +P+QRP FS++ + L  +++ 
Sbjct: 252 PGVKIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQA 311
Query: 374 VASE 377
            A +
Sbjct: 312 NAQQ 315

>pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314

Iteration: 1
 Score =  145 bits (365), Expect = 5e-35,   Method: Compositional matrix adjust.
 Identities = 89/306 (29%), Positives = 152/306 (49%), Gaps = 28/306 (9%)
Query: 99  NCIEIPTDGTDVWEIDAKQLKIECKVASGSYGDLYKG-------TYCSQEVAIKVLKPEC 151
           +C  +P D +  WE    +LK+   +  G++G + +        T   + VA+K+LK   
Sbjct: 2   HCERLPYDASK-WEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA 60
Query: 152 VNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPN-LCIVTEFMARGSIYDFLHKQKGV 210
            ++E     S+   ++    H NVV  +GACT+P   L ++TEF   G++  +L  ++  
Sbjct: 61  THSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVITEFCKFGNLSTYLRSKRNE 120
Query: 211 F---------------QLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKV 255
           F                L  L+  +  V+KGM +L     IHRDL   N+L+ E  VVK+
Sbjct: 121 FVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKI 180
Query: 256 ADFGVAR--VQAQSGVMTAETG-TYRWMAPEVIEHKPYDYKADVFSFGIALWELLT-GEL 311
            DFG+AR   +    V   +     +WMAPE I  + Y  ++DV+SFG+ LWE+ + G  
Sbjct: 181 CDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGAS 240
Query: 312 PYAGLTPLQAAVGVVQKSLRPTIPKHAHPRLAELLERCWQHDPTQRPNFSQITDILKQMM 371
           PY G+   +     +++  R   P +  P + + +  CW  +P+QRP FS++ + L  ++
Sbjct: 241 PYPGVKIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLL 300
Query: 372 KEVASE 377
           +  A +
Sbjct: 301 QANAQQ 306

>pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316

Iteration: 1
 Score =  143 bits (361), Expect = 1e-34,   Method: Compositional matrix adjust.
 Identities = 88/306 (28%), Positives = 151/306 (49%), Gaps = 28/306 (9%)
Query: 99  NCIEIPTDGTDVWEIDAKQLKIECKVASGSYGDLYKG-------TYCSQEVAIKVLKPEC 151
           +C  +P D +  WE    +LK+   +  G++G + +        T   + VA+K+LK   
Sbjct: 11  HCERLPYDASK-WEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA 69
Query: 152 VNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPN-LCIVTEFMARGSIYDFLHKQKGV 210
            ++E     S+   ++    H NVV  +GACT+P   L ++ EF   G++  +L  ++  
Sbjct: 70  THSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNE 129
Query: 211 F---------------QLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKV 255
           F                L  L+  +  V+KGM +L     IHRDL   N+L+ E  VVK+
Sbjct: 130 FVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKI 189
Query: 256 ADFGVAR--VQAQSGVMTAETG-TYRWMAPEVIEHKPYDYKADVFSFGIALWELLT-GEL 311
            DFG+AR   +    V   +     +WMAPE I  + Y  ++DV+SFG+ LWE+ + G  
Sbjct: 190 CDFGLARDIXKDPDXVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGAS 249
Query: 312 PYAGLTPLQAAVGVVQKSLRPTIPKHAHPRLAELLERCWQHDPTQRPNFSQITDILKQMM 371
           PY G+   +     +++  R   P +  P + + +  CW  +P+QRP FS++ + L  ++
Sbjct: 250 PYPGVKIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLL 309
Query: 372 KEVASE 377
           +  A +
Sbjct: 310 QANAQQ 315

>pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316

Iteration: 1
 Score =  143 bits (361), Expect = 1e-34,   Method: Compositional matrix adjust.
 Identities = 88/306 (28%), Positives = 151/306 (49%), Gaps = 28/306 (9%)
Query: 99  NCIEIPTDGTDVWEIDAKQLKIECKVASGSYGDLYKG-------TYCSQEVAIKVLKPEC 151
           +C  +P D +  WE    +LK+   +  G++G + +        T   + VA+K+LK   
Sbjct: 11  HCERLPYDASK-WEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA 69
Query: 152 VNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPN-LCIVTEFMARGSIYDFLHKQKGV 210
            ++E     S+   ++    H NVV  +GACT+P   L ++ EF   G++  +L  ++  
Sbjct: 70  THSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNE 129
Query: 211 F---------------QLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKV 255
           F                L  L+  +  V+KGM +L     IHRDL   N+L+ E  VVK+
Sbjct: 130 FVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKI 189
Query: 256 ADFGVAR--VQAQSGVMTAETG-TYRWMAPEVIEHKPYDYKADVFSFGIALWELLT-GEL 311
            DFG+AR   +    V   +     +WMAPE I  + Y  ++DV+SFG+ LWE+ + G  
Sbjct: 190 CDFGLARDIYKDPDXVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGAS 249
Query: 312 PYAGLTPLQAAVGVVQKSLRPTIPKHAHPRLAELLERCWQHDPTQRPNFSQITDILKQMM 371
           PY G+   +     +++  R   P +  P + + +  CW  +P+QRP FS++ + L  ++
Sbjct: 250 PYPGVKIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLL 309
Query: 372 KEVASE 377
           +  A +
Sbjct: 310 QANAQQ 315

>pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309

Iteration: 1
 Score =  143 bits (361), Expect = 1e-34,   Method: Compositional matrix adjust.
 Identities = 87/300 (29%), Positives = 149/300 (49%), Gaps = 24/300 (8%)
Query: 99  NCIEIPTDGTDVWEIDAKQLKIECKVASGSYGDLYKG-------TYCSQEVAIKVLKPEC 151
           +C  +P D +  WE    +L +   +  G++G + +        T   + VA+K+LK   
Sbjct: 11  HCERLPYDASK-WEFPRDRLNLGKPLGRGAFGQVIEADAFGIDKTATXRTVAVKMLKEGA 69
Query: 152 VNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPN-LCIVTEFMARGSIYDFLHKQKGV 210
            ++E     S+   ++    H NVV  +GACT+P   L ++ EF   G++  +L  ++  
Sbjct: 70  THSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNE 129
Query: 211 F-----------QLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFG 259
           F            L  L+  +  V+KGM +L     IHRDL   N+L+ E  VVK+ DFG
Sbjct: 130 FVPYKDLYKDFLTLEHLIXYSFQVAKGMEFLASRKXIHRDLAARNILLSEKNVVKIXDFG 189
Query: 260 VAR--VQAQSGVMTAETG-TYRWMAPEVIEHKPYDYKADVFSFGIALWELLT-GELPYAG 315
           +AR   +    V   +     +WMAPE I  + Y  ++DV+SFG+ LWE+ + G  PY G
Sbjct: 190 LARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPG 249
Query: 316 LTPLQAAVGVVQKSLRPTIPKHAHPRLAELLERCWQHDPTQRPNFSQITDILKQMMKEVA 375
           +   +     +++  R   P +  P + + +  CW  +P+QRP FS++ + L  +++  A
Sbjct: 250 VKIDEEFXRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQANA 309

>pdb|3KMU|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Apo) Length = 271

Iteration: 1
 Score =  143 bits (361), Expect = 2e-34,   Method: Compositional matrix adjust.
 Identities = 84/265 (31%), Positives = 139/265 (52%), Gaps = 12/265 (4%)
Query: 113 IDAKQLKIECKVASGSYGDLYKGTYCSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRH 172
           ID KQL    K+     G+L+KG +   ++ +KVLK    +T   ++F++E   +R   H
Sbjct: 7   IDFKQLNFLTKLNENHSGELWKGRWQGNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSH 66
Query: 173 KNVVQFIGACTRPP--NLCIVTEFMARGSIYDFLHKQKG-VFQLTSLLKVAIDVSKGMNY 229
            NV+  +GAC  PP  +  ++T +   GS+Y+ LH+    V   +  +K A+D ++G  +
Sbjct: 67  PNVLPVLGACQSPPAPHPTLITHWXPYGSLYNVLHEGTNFVVDQSQAVKFALDXARGXAF 126
Query: 230 LH--QNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAETGTYRWMAPEVIEH 287
           LH  +  I    L + ++ +DE+   +++   V       G   A      W+APE ++ 
Sbjct: 127 LHTLEPLIPRHALNSRSVXIDEDXTARISXADVKFSFQSPGRXYAPA----WVAPEALQK 182
Query: 288 KPYDYK---ADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRLAE 344
           KP D     AD +SF + LWEL+T E+P+A L+  +    V  + LRPTIP    P +++
Sbjct: 183 KPEDTNRRSADXWSFAVLLWELVTREVPFADLSNXEIGXKVALEGLRPTIPPGISPHVSK 242
Query: 345 LLERCWQHDPTQRPNFSQITDILKQ 369
           L + C   DP +RP F  I  IL++
Sbjct: 243 LXKICXNEDPAKRPKFDXIVPILEK 267

>pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316

Iteration: 1
 Score =  143 bits (360), Expect = 2e-34,   Method: Compositional matrix adjust.
 Identities = 88/306 (28%), Positives = 151/306 (49%), Gaps = 28/306 (9%)
Query: 99  NCIEIPTDGTDVWEIDAKQLKIECKVASGSYGDLYKG-------TYCSQEVAIKVLKPEC 151
           +C  +P D +  WE    +LK+   +  G++G + +        T   + VA+K+LK   
Sbjct: 11  HCERLPYDASK-WEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA 69
Query: 152 VNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPN-LCIVTEFMARGSIYDFLHKQKGV 210
            ++E     S+   ++    H NVV  +GACT+P   L ++ EF   G++  +L  ++  
Sbjct: 70  THSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNE 129
Query: 211 F---------------QLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKV 255
           F                L  L+  +  V+KGM +L     IHRDL   N+L+ E  VVK+
Sbjct: 130 FVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKI 189
Query: 256 ADFGVAR--VQAQSGVMTAETG-TYRWMAPEVIEHKPYDYKADVFSFGIALWELLT-GEL 311
            DFG+AR   +    V   +     +WMAPE I  + Y  ++DV+SFG+ LWE+ + G  
Sbjct: 190 CDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGAS 249
Query: 312 PYAGLTPLQAAVGVVQKSLRPTIPKHAHPRLAELLERCWQHDPTQRPNFSQITDILKQMM 371
           PY G+   +     +++  R   P +  P + + +  CW  +P+QRP FS++ + L  ++
Sbjct: 250 PYPGVKIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLL 309
Query: 372 KEVASE 377
           +  A +
Sbjct: 310 QANAQQ 315

>pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353

Iteration: 1
 Score =  143 bits (360), Expect = 2e-34,   Method: Compositional matrix adjust.
 Identities = 88/306 (28%), Positives = 151/306 (49%), Gaps = 28/306 (9%)
Query: 99  NCIEIPTDGTDVWEIDAKQLKIECKVASGSYGDLYKG-------TYCSQEVAIKVLKPEC 151
           +C  +P D +  WE    +LK+   +  G++G + +        T   + VA+K+LK   
Sbjct: 48  HCERLPYDASK-WEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA 106
Query: 152 VNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPN-LCIVTEFMARGSIYDFLHKQKGV 210
            ++E     S+   ++    H NVV  +GACT+P   L ++ EF   G++  +L  ++  
Sbjct: 107 THSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNE 166
Query: 211 F---------------QLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKV 255
           F                L  L+  +  V+KGM +L     IHRDL   N+L+ E  VVK+
Sbjct: 167 FVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKI 226
Query: 256 ADFGVAR--VQAQSGVMTAETG-TYRWMAPEVIEHKPYDYKADVFSFGIALWELLT-GEL 311
            DFG+AR   +    V   +     +WMAPE I  + Y  ++DV+SFG+ LWE+ + G  
Sbjct: 227 CDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGAS 286
Query: 312 PYAGLTPLQAAVGVVQKSLRPTIPKHAHPRLAELLERCWQHDPTQRPNFSQITDILKQMM 371
           PY G+   +     +++  R   P +  P + + +  CW  +P+QRP FS++ + L  ++
Sbjct: 287 PYPGVKIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLL 346
Query: 372 KEVASE 377
           +  A +
Sbjct: 347 QANAQQ 352

>pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318

Iteration: 1
 Score =  143 bits (360), Expect = 2e-34,   Method: Compositional matrix adjust.
 Identities = 88/306 (28%), Positives = 151/306 (49%), Gaps = 28/306 (9%)
Query: 99  NCIEIPTDGTDVWEIDAKQLKIECKVASGSYGDLYKG-------TYCSQEVAIKVLKPEC 151
           +C  +P D +  WE    +LK+   +  G++G + +        T   + VA+K+LK   
Sbjct: 13  HCERLPYDASK-WEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA 71
Query: 152 VNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPN-LCIVTEFMARGSIYDFLHKQKGV 210
            ++E     S+   ++    H NVV  +GACT+P   L ++ EF   G++  +L  ++  
Sbjct: 72  THSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNE 131
Query: 211 F---------------QLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKV 255
           F                L  L+  +  V+KGM +L     IHRDL   N+L+ E  VVK+
Sbjct: 132 FVPYKEAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKI 191
Query: 256 ADFGVAR--VQAQSGVMTAETG-TYRWMAPEVIEHKPYDYKADVFSFGIALWELLT-GEL 311
            DFG+AR   +    V   +     +WMAPE I  + Y  ++DV+SFG+ LWE+ + G  
Sbjct: 192 CDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGAS 251
Query: 312 PYAGLTPLQAAVGVVQKSLRPTIPKHAHPRLAELLERCWQHDPTQRPNFSQITDILKQMM 371
           PY G+   +     +++  R   P +  P + + +  CW  +P+QRP FS++ + L  ++
Sbjct: 252 PYPGVKIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLL 311
Query: 372 KEVASE 377
           +  A +
Sbjct: 312 QANAQQ 317

>pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314

Iteration: 1
 Score =  143 bits (360), Expect = 2e-34,   Method: Compositional matrix adjust.
 Identities = 88/302 (29%), Positives = 150/302 (49%), Gaps = 28/302 (9%)
Query: 103 IPTDGTDVWEIDAKQLKIECKVASGSYGDLYKG-------TYCSQEVAIKVLKPECVNTE 155
           +P D +  WE    +LK+   +  G++G + +        T   + VA+K+LK    ++E
Sbjct: 6   LPYDASK-WEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSE 64
Query: 156 MLKEFSQEVYIMRKIRHKNVVQFIGACTRPPN-LCIVTEFMARGSIYDFLHKQKGVF--- 211
                S+   ++    H NVV  +GACT+P   L ++TEF   G++  +L  ++  F   
Sbjct: 65  HRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVITEFCKFGNLSTYLRSKRNEFVPY 124
Query: 212 ------------QLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFG 259
                        L  L+  +  V+KGM +L     IHRDL   N+L+ E  VVK+ DFG
Sbjct: 125 KVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFG 184
Query: 260 VAR--VQAQSGVMTAETG-TYRWMAPEVIEHKPYDYKADVFSFGIALWELLT-GELPYAG 315
           +AR   +    V   +     +WMAPE I  + Y  ++DV+SFG+ LWE+ + G  PY G
Sbjct: 185 LARDIXKDPDXVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPG 244
Query: 316 LTPLQAAVGVVQKSLRPTIPKHAHPRLAELLERCWQHDPTQRPNFSQITDILKQMMKEVA 375
           +   +     +++  R   P +  P + + +  CW  +P+QRP FS++ + L  +++  A
Sbjct: 245 VKIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQANA 304
Query: 376 SE 377
            +
Sbjct: 305 QQ 306

>pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309

Iteration: 1
 Score =  142 bits (359), Expect = 3e-34,   Method: Compositional matrix adjust.
 Identities = 87/300 (29%), Positives = 149/300 (49%), Gaps = 24/300 (8%)
Query: 99  NCIEIPTDGTDVWEIDAKQLKIECKVASGSYGDLYKG-------TYCSQEVAIKVLKPEC 151
           +C  +P D +  WE    +L +   +  G++G + +        T   + VA+K+LK   
Sbjct: 11  HCERLPYDASK-WEFPRDRLNLGKPLGRGAFGQVIEADAFGIDKTATXRTVAVKMLKEGA 69
Query: 152 VNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPN-LCIVTEFMARGSIYDFLHKQKGV 210
            ++E     S+   ++    H NVV  +GACT+P   L ++ EF   G++  +L  ++  
Sbjct: 70  THSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNE 129
Query: 211 F-----------QLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFG 259
           F            L  L+  +  V+KGM +L     IHRDL   N+L+ E  VVK+ DFG
Sbjct: 130 FVPYKDLYKDFLTLEHLICYSFQVAKGMEFLASRKXIHRDLAARNILLSEKNVVKICDFG 189
Query: 260 VAR--VQAQSGVMTAETG-TYRWMAPEVIEHKPYDYKADVFSFGIALWELLT-GELPYAG 315
           +AR   +    V   +     +WMAPE I  + Y  ++DV+SFG+ LWE+ + G  PY G
Sbjct: 190 LARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPG 249
Query: 316 LTPLQAAVGVVQKSLRPTIPKHAHPRLAELLERCWQHDPTQRPNFSQITDILKQMMKEVA 375
           +   +     +++  R   P +  P + + +  CW  +P+QRP FS++ + L  +++  A
Sbjct: 250 VKIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQANA 309

>pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314

Iteration: 1
 Score =  142 bits (358), Expect = 3e-34,   Method: Compositional matrix adjust.
 Identities = 88/302 (29%), Positives = 150/302 (49%), Gaps = 28/302 (9%)
Query: 103 IPTDGTDVWEIDAKQLKIECKVASGSYGDLYKG-------TYCSQEVAIKVLKPECVNTE 155
           +P D +  WE    +LK+   +  G++G + +        T   + VA+K+LK    ++E
Sbjct: 6   LPYDASK-WEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSE 64
Query: 156 MLKEFSQEVYIMRKIRHKNVVQFIGACTRPPN-LCIVTEFMARGSIYDFLHKQKGVF--- 211
                S+   ++    H NVV  +GACT+P   L ++TEF   G++  +L  ++  F   
Sbjct: 65  HRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVITEFCKFGNLSTYLRSKRNEFVPY 124
Query: 212 ------------QLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFG 259
                        L  L+  +  V+KGM +L     IHRDL   N+L+ E  VVK+ DFG
Sbjct: 125 KVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFG 184
Query: 260 VAR--VQAQSGVMTAETG-TYRWMAPEVIEHKPYDYKADVFSFGIALWELLT-GELPYAG 315
           +AR   +    V   +     +WMAPE I  + Y  ++DV+SFG+ LWE+ + G  PY G
Sbjct: 185 LARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPG 244
Query: 316 LTPLQAAVGVVQKSLRPTIPKHAHPRLAELLERCWQHDPTQRPNFSQITDILKQMMKEVA 375
           +   +     +++  R   P +  P + + +  CW  +P+QRP FS++ + L  +++  A
Sbjct: 245 VKIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQANA 304
Query: 376 SE 377
            +
Sbjct: 305 QQ 306

>pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317

Iteration: 1
 Score =  142 bits (358), Expect = 3e-34,   Method: Compositional matrix adjust.
 Identities = 86/282 (30%), Positives = 144/282 (51%), Gaps = 23/282 (8%)
Query: 113 IDAKQLKIECKVASGSYGDLYKGTY----CSQEVAIKVLKPECVNTEMLKEFSQEVYIMR 168
           +D   +K +  +  G++G + K          + AIK +K E  + +  ++F+ E+ ++ 
Sbjct: 12  LDWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMK-EYASKDDHRDFAGELEVLC 70
Query: 169 KI-RHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQK---------------GVFQ 212
           K+  H N++  +GAC     L +  E+   G++ DFL K +                   
Sbjct: 71  KLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLS 130
Query: 213 LTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTA 272
              LL  A DV++GM+YL Q   IHRDL   N+L+ EN V K+ADFG++R Q      T 
Sbjct: 131 SQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKKTM 190
Query: 273 ETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLT-GELPYAGLTPLQAAVGVVQKSLR 331
                RWMA E + +  Y   +DV+S+G+ LWE+++ G  PY G+T  +    + Q   R
Sbjct: 191 GRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQ-GYR 249
Query: 332 PTIPKHAHPRLAELLERCWQHDPTQRPNFSQITDILKQMMKE 373
              P +    + +L+ +CW+  P +RP+F+QI   L +M++E
Sbjct: 250 LEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEE 291

>pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327

Iteration: 1
 Score =  142 bits (358), Expect = 4e-34,   Method: Compositional matrix adjust.
 Identities = 86/282 (30%), Positives = 144/282 (51%), Gaps = 23/282 (8%)
Query: 113 IDAKQLKIECKVASGSYGDLYKGTY----CSQEVAIKVLKPECVNTEMLKEFSQEVYIMR 168
           +D   +K +  +  G++G + K          + AIK +K E  + +  ++F+ E+ ++ 
Sbjct: 22  LDWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMK-EYASKDDHRDFAGELEVLC 80
Query: 169 KI-RHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQK---------------GVFQ 212
           K+  H N++  +GAC     L +  E+   G++ DFL K +                   
Sbjct: 81  KLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLS 140
Query: 213 LTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTA 272
              LL  A DV++GM+YL Q   IHRDL   N+L+ EN V K+ADFG++R Q      T 
Sbjct: 141 SQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKKTM 200
Query: 273 ETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLT-GELPYAGLTPLQAAVGVVQKSLR 331
                RWMA E + +  Y   +DV+S+G+ LWE+++ G  PY G+T  +    + Q   R
Sbjct: 201 GRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQ-GYR 259
Query: 332 PTIPKHAHPRLAELLERCWQHDPTQRPNFSQITDILKQMMKE 373
              P +    + +L+ +CW+  P +RP+F+QI   L +M++E
Sbjct: 260 LEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEE 301

>pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316

Iteration: 1
 Score =  142 bits (357), Expect = 4e-34,   Method: Compositional matrix adjust.
 Identities = 87/305 (28%), Positives = 150/305 (49%), Gaps = 27/305 (8%)
Query: 99  NCIEIPTDGTDVWEIDAKQLKIECKVASGSYGDLYKG-------TYCSQEVAIKVLKPEC 151
           +C  +P D +  WE    +L +   +  G++G + +        T   + VA+K+LK   
Sbjct: 12  HCERLPYDASK-WEFPRDRLNLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA 70
Query: 152 VNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPN-LCIVTEFMARGSIYDFLHKQKGV 210
            ++E     S+   ++    H NVV  +GACT+P   L ++ EF   G++  +L  ++  
Sbjct: 71  THSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNE 130
Query: 211 F--------------QLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVA 256
           F               L  L+  +  V+KGM +L     IHRDL   N+L+ E  VVK+ 
Sbjct: 131 FVPYKTPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKIC 190
Query: 257 DFGVAR--VQAQSGVMTAETG-TYRWMAPEVIEHKPYDYKADVFSFGIALWELLT-GELP 312
           DFG+AR   +    V   +     +WMAPE I  + Y  ++DV+SFG+ LWE+ + G  P
Sbjct: 191 DFGLARDIXKDPDXVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASP 250
Query: 313 YAGLTPLQAAVGVVQKSLRPTIPKHAHPRLAELLERCWQHDPTQRPNFSQITDILKQMMK 372
           Y G+   +     +++  R   P +  P + + +  CW  +P+QRP FS++ + L  +++
Sbjct: 251 YPGVKIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQ 310
Query: 373 EVASE 377
             A +
Sbjct: 311 ANAQQ 315

>pdb|1T46|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C-kit Tyrosine Kinase Length = 313

Iteration: 1
 Score =  142 bits (357), Expect = 4e-34,   Method: Compositional matrix adjust.
 Identities = 85/291 (29%), Positives = 143/291 (49%), Gaps = 28/291 (9%)
Query: 111 WEIDAKQLKIECKVASGSYGDLYKGTY-------CSQEVAIKVLKPECVNTEMLKEFSQE 163
           WE    +L     + +G++G + + T         +  VA+K+LKP    TE     S+ 
Sbjct: 18  WEFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSEL 77
Query: 164 VYIMRKIRHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVF------------ 211
             +     H N+V  +GACT      ++TE+   G + +FL +++  F            
Sbjct: 78  KVLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMED 137
Query: 212 -----QLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVAR-VQA 265
                 L  LL  +  V+KGM +L   N IHRDL   N+L+    + K+ DFG+AR ++ 
Sbjct: 138 DELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLTHGRITKICDFGLARDIKN 197
Query: 266 QSGVMTAETGTY--RWMAPEVIEHKPYDYKADVFSFGIALWELLT-GELPYAGLTPLQAA 322
            S  +         +WMAPE I +  Y +++DV+S+GI LWEL + G  PY G+      
Sbjct: 198 DSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKF 257
Query: 323 VGVVQKSLRPTIPKHAHPRLAELLERCWQHDPTQRPNFSQITDILKQMMKE 373
             ++++  R   P+HA   + ++++ CW  DP +RP F QI  ++++ + E
Sbjct: 258 YKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQISE 308

>pdb|1T45|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C- Kit Tyrosine Kinase Length = 331

Iteration: 1
 Score =  141 bits (356), Expect = 5e-34,   Method: Compositional matrix adjust.
 Identities = 87/300 (29%), Positives = 147/300 (49%), Gaps = 30/300 (10%)
Query: 102 EIPTDGTDVWEIDAKQLKIECKVASGSYGDLYKGTY-------CSQEVAIKVLKPECVNT 154
           ++P D    WE    +L     + +G++G + + T         +  VA+K+LKP    T
Sbjct: 29  QLPYDHK--WEFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLT 86
Query: 155 EMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVF--- 211
           E     S+   +     H N+V  +GACT      ++TE+   G + +FL +++  F   
Sbjct: 87  EREALMSELKVLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICS 146
Query: 212 --------------QLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVAD 257
                          L  LL  +  V+KGM +L   N IHRDL   N+L+    + K+ D
Sbjct: 147 KTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLTHGRITKICD 206
Query: 258 FGVAR-VQAQSGVMTAETGTY--RWMAPEVIEHKPYDYKADVFSFGIALWELLT-GELPY 313
           FG+AR ++  S  +         +WMAPE I +  Y +++DV+S+GI LWEL + G  PY
Sbjct: 207 FGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPY 266
Query: 314 AGLTPLQAAVGVVQKSLRPTIPKHAHPRLAELLERCWQHDPTQRPNFSQITDILKQMMKE 373
            G+        ++++  R   P+HA   + ++++ CW  DP +RP F QI  ++++ + E
Sbjct: 267 PGMPVDSKFYKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQISE 326

>pdb|1PKG|A Chain A, Structure Of A C-kit Kinase Product Complex Length = 329

Iteration: 1
 Score =  141 bits (356), Expect = 6e-34,   Method: Compositional matrix adjust.
 Identities = 85/291 (29%), Positives = 143/291 (49%), Gaps = 28/291 (9%)
Query: 111 WEIDAKQLKIECKVASGSYGDLYKGTY-------CSQEVAIKVLKPECVNTEMLKEFSQE 163
           WE    +L     + +G++G + + T         +  VA+K+LKP    TE     S+ 
Sbjct: 34  WEFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSEL 93
Query: 164 VYIMRKIRHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVF------------ 211
             +     H N+V  +GACT      ++TE+   G + +FL +++  F            
Sbjct: 94  KVLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMED 153
Query: 212 -----QLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVAR-VQA 265
                 L  LL  +  V+KGM +L   N IHRDL   N+L+    + K+ DFG+AR ++ 
Sbjct: 154 DELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLTHGRITKICDFGLARDIKN 213
Query: 266 QSGVMTAETGTY--RWMAPEVIEHKPYDYKADVFSFGIALWELLT-GELPYAGLTPLQAA 322
            S  +         +WMAPE I +  Y +++DV+S+GI LWEL + G  PY G+      
Sbjct: 214 DSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKF 273
Query: 323 VGVVQKSLRPTIPKHAHPRLAELLERCWQHDPTQRPNFSQITDILKQMMKE 373
             ++++  R   P+HA   + ++++ CW  DP +RP F QI  ++++ + E
Sbjct: 274 YKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQISE 324

>pdb|3G0E|A Chain A, Kit Kinase Domain In Complex With Sunitinib Length = 336

Iteration: 1
 Score =  141 bits (356), Expect = 6e-34,   Method: Compositional matrix adjust.
 Identities = 87/300 (29%), Positives = 147/300 (49%), Gaps = 30/300 (10%)
Query: 102 EIPTDGTDVWEIDAKQLKIECKVASGSYGDLYKGTY-------CSQEVAIKVLKPECVNT 154
           ++P D    WE    +L     + +G++G + + T         +  VA+K+LKP    T
Sbjct: 34  QLPYDHK--WEFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLT 91
Query: 155 EMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVF--- 211
           E     S+   +     H N+V  +GACT      ++TE+   G + +FL +++  F   
Sbjct: 92  EREALMSELKVLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICS 151
Query: 212 --------------QLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVAD 257
                          L  LL  +  V+KGM +L   N IHRDL   N+L+    + K+ D
Sbjct: 152 KTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLTHGRITKICD 211
Query: 258 FGVAR-VQAQSGVMTAETGTY--RWMAPEVIEHKPYDYKADVFSFGIALWELLT-GELPY 313
           FG+AR ++  S  +         +WMAPE I +  Y +++DV+S+GI LWEL + G  PY
Sbjct: 212 FGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPY 271
Query: 314 AGLTPLQAAVGVVQKSLRPTIPKHAHPRLAELLERCWQHDPTQRPNFSQITDILKQMMKE 373
            G+        ++++  R   P+HA   + ++++ CW  DP +RP F QI  ++++ + E
Sbjct: 272 PGMPVDSKFYKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQISE 331

>pdb|3G0F|A Chain A, Kit Kinase Domain Mutant D816h In Complex With Sunitinib Length = 336

Iteration: 1
 Score =  141 bits (355), Expect = 6e-34,   Method: Compositional matrix adjust.
 Identities = 87/300 (29%), Positives = 147/300 (49%), Gaps = 30/300 (10%)
Query: 102 EIPTDGTDVWEIDAKQLKIECKVASGSYGDLYKGTY-------CSQEVAIKVLKPECVNT 154
           ++P D    WE    +L     + +G++G + + T         +  VA+K+LKP    T
Sbjct: 34  QLPYDHK--WEFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLT 91
Query: 155 EMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVF--- 211
           E     S+   +     H N+V  +GACT      ++TE+   G + +FL +++  F   
Sbjct: 92  EREALMSELKVLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICS 151
Query: 212 --------------QLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVAD 257
                          L  LL  +  V+KGM +L   N IHRDL   N+L+    + K+ D
Sbjct: 152 KTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLTHGRITKICD 211
Query: 258 FGVAR-VQAQSGVMTAETGTY--RWMAPEVIEHKPYDYKADVFSFGIALWELLT-GELPY 313
           FG+AR ++  S  +         +WMAPE I +  Y +++DV+S+GI LWEL + G  PY
Sbjct: 212 FGLARHIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPY 271
Query: 314 AGLTPLQAAVGVVQKSLRPTIPKHAHPRLAELLERCWQHDPTQRPNFSQITDILKQMMKE 373
            G+        ++++  R   P+HA   + ++++ CW  DP +RP F QI  ++++ + E
Sbjct: 272 PGMPVDSKFYKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQISE 331

>pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268

Iteration: 1
 Score =  141 bits (355), Expect = 7e-34,   Method: Compositional matrix adjust.
 Identities = 79/256 (30%), Positives = 141/256 (55%), Gaps = 8/256 (3%)
Query: 112 EIDAKQLKIECKVASGSYGDLYKGTYCSQ-EVAIKVLKPECVNTEMLKEFSQEVYIMRKI 170
           E+  +++ +  ++ SG +G +  G +  Q +VA+K++K   ++ +   EF QE   M K+
Sbjct: 4   ELKREEITLLKELGSGQFGVVKLGKWKGQYDVAVKMIKEGSMSED---EFFQEAQTMMKL 60
Query: 171 RHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYL 230
            H  +V+F G C++   + IVTE+++ G + ++L       + + LL++  DV +GM +L
Sbjct: 61  SHPKLVKFYGVCSKEYPIYIVTEYISNGCLLNYLRSHGKGLEPSQLLEMCYDVCEGMAFL 120
Query: 231 HQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAETGTY--RWMAPEVIEHK 288
             +  IHRDL   N L+D +  VKV+DFG+ R       +++    +  +W APEV  + 
Sbjct: 121 ESHQFIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQYVSSVGTKFPVKWSAPEVFHYF 180
Query: 289 PYDYKADVFSFGIALWELLT-GELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRLAELLE 347
            Y  K+DV++FGI +WE+ + G++PY   T  +  + V Q   R   P  A   + +++ 
Sbjct: 181 KYSSKSDVWAFGILMWEVFSLGKMPYDLYTNSEVVLKVSQGH-RLYRPHLASDTIYQIMY 239
Query: 348 RCWQHDPTQRPNFSQI 363
            CW   P +RP F Q+
Sbjct: 240 SCWHELPEKRPTFQQL 255

>pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314

Iteration: 1
 Score =  141 bits (355), Expect = 8e-34,   Method: Compositional matrix adjust.
 Identities = 87/302 (28%), Positives = 149/302 (49%), Gaps = 28/302 (9%)
Query: 103 IPTDGTDVWEIDAKQLKIECKVASGSYGDLYKG-------TYCSQEVAIKVLKPECVNTE 155
           +P D +  WE    +LK+   +  G++G + +        T   + VA+K+LK    ++E
Sbjct: 6   LPYDASK-WEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSE 64
Query: 156 MLKEFSQEVYIMRKIRHKNVVQFIGACTRPPN-LCIVTEFMARGSIYDFLHKQKGVF--- 211
                S+   ++    H NVV  +GACT+P   L ++ EF   G++  +L  ++  F   
Sbjct: 65  HRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPY 124
Query: 212 ------------QLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFG 259
                        L  L+  +  V+KGM +L     IHRDL   N+L+ E  VVK+ DFG
Sbjct: 125 KVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFG 184
Query: 260 VAR--VQAQSGVMTAETG-TYRWMAPEVIEHKPYDYKADVFSFGIALWELLT-GELPYAG 315
           +AR   +    V   +     +WMAPE I  + Y  ++DV+SFG+ LWE+ + G  PY G
Sbjct: 185 LARDIXKDPDXVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPG 244
Query: 316 LTPLQAAVGVVQKSLRPTIPKHAHPRLAELLERCWQHDPTQRPNFSQITDILKQMMKEVA 375
           +   +     +++  R   P +  P + + +  CW  +P+QRP FS++ + L  +++  A
Sbjct: 245 VKIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQANA 304
Query: 376 SE 377
            +
Sbjct: 305 QQ 306

>pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324

Iteration: 1
 Score =  140 bits (353), Expect = 1e-33,   Method: Compositional matrix adjust.
 Identities = 85/282 (30%), Positives = 144/282 (51%), Gaps = 23/282 (8%)
Query: 113 IDAKQLKIECKVASGSYGDLYKGTY----CSQEVAIKVLKPECVNTEMLKEFSQEVYIMR 168
           +D   +K +  +  G++G + K          + AIK +K E  + +  ++F+ E+ ++ 
Sbjct: 19  LDWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMK-EYASKDDHRDFAGELEVLC 77
Query: 169 KI-RHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQK---------------GVFQ 212
           K+  H N++  +GAC     L +  E+   G++ DFL K +                   
Sbjct: 78  KLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLS 137
Query: 213 LTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTA 272
              LL  A DV++GM+YL Q   IHR+L   N+L+ EN V K+ADFG++R Q      T 
Sbjct: 138 SQQLLHFAADVARGMDYLSQKQFIHRNLAARNILVGENYVAKIADFGLSRGQEVYVKKTM 197
Query: 273 ETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLT-GELPYAGLTPLQAAVGVVQKSLR 331
                RWMA E + +  Y   +DV+S+G+ LWE+++ G  PY G+T  +    + Q   R
Sbjct: 198 GRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQ-GYR 256
Query: 332 PTIPKHAHPRLAELLERCWQHDPTQRPNFSQITDILKQMMKE 373
              P +    + +L+ +CW+  P +RP+F+QI   L +M++E
Sbjct: 257 LEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEE 298

>pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326

Iteration: 1
 Score =  139 bits (351), Expect = 2e-33,   Method: Compositional matrix adjust.
 Identities = 87/299 (29%), Positives = 155/299 (51%), Gaps = 33/299 (11%)
Query: 102 EIPTDGTDVWEIDAKQLKIECKVASGSYGDLYKGTYCS---------QEVAIKVLKPECV 152
           E+P D    WE+   +L +   +  G++G +                 +VA+K+LK +  
Sbjct: 16  ELPEDPR--WELPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDAT 73
Query: 153 NTEMLKEFSQEVYIMRKI-RHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVF 211
             + L +   E+ +M+ I +HKN++  +GACT+   L ++ E+ ++G++ ++L  ++   
Sbjct: 74  EKD-LSDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPG 132
Query: 212 -------------QLTS--LLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVA 256
                        QL+S  L+  A  V++GM YL     IHRDL   N+L+ E+ V+K+A
Sbjct: 133 LEFSFNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIA 192
Query: 257 DFGVARVQAQSGVMTAETG---TYRWMAPEVIEHKPYDYKADVFSFGIALWELLT-GELP 312
           DFG+AR           T      +WMAPE +  + Y +++DV+SFG+ LWE+ T G  P
Sbjct: 193 DFGLARDIHHIDXXKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSP 252
Query: 313 YAGLTPLQAAVGVVQKSLRPTIPKHAHPRLAELLERCWQHDPTQRPNFSQITDILKQMM 371
           Y G+ P++    ++++  R   P +    L  ++  CW   P+QRP F Q+ + L +++
Sbjct: 253 YPGV-PVEELFKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIV 310

>pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326

Iteration: 1
 Score =  139 bits (349), Expect = 4e-33,   Method: Compositional matrix adjust.
 Identities = 87/299 (29%), Positives = 155/299 (51%), Gaps = 33/299 (11%)
Query: 102 EIPTDGTDVWEIDAKQLKIECKVASGSYGDLYKGTYCS---------QEVAIKVLKPECV 152
           E+P D    WE+   +L +   +  G++G +                 +VA+K+LK +  
Sbjct: 16  ELPEDPR--WELPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDAT 73
Query: 153 NTEMLKEFSQEVYIMRKI-RHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVF 211
             + L +   E+ +M+ I +HKN++  +GACT+   L ++ E+ ++G++ ++L  ++   
Sbjct: 74  EKD-LSDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPG 132
Query: 212 -------------QLTS--LLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVA 256
                        QL+S  L+  A  V++GM YL     IHRDL   N+L+ E+ V+K+A
Sbjct: 133 LEYCYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIA 192
Query: 257 DFGVARVQAQSGVMTAETG---TYRWMAPEVIEHKPYDYKADVFSFGIALWELLT-GELP 312
           DFG+AR           T      +WMAPE +  + Y +++DV+SFG+ LWE+ T G  P
Sbjct: 193 DFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSP 252
Query: 313 YAGLTPLQAAVGVVQKSLRPTIPKHAHPRLAELLERCWQHDPTQRPNFSQITDILKQMM 371
           Y G+ P++    ++++  R   P +    L  ++  CW   P+QRP F Q+ + L +++
Sbjct: 253 YPGV-PVEELFKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIV 310

>pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309

Iteration: 1
 Score =  139 bits (349), Expect = 4e-33,   Method: Compositional matrix adjust.
 Identities = 87/299 (29%), Positives = 155/299 (51%), Gaps = 33/299 (11%)
Query: 102 EIPTDGTDVWEIDAKQLKIECKVASGSYGDLYKGTYCS---------QEVAIKVLKPECV 152
           E+P D    WE+   +L +   +  G++G +                 +VA+K+LK +  
Sbjct: 8   ELPEDPR--WELPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDAT 65
Query: 153 NTEMLKEFSQEVYIMRKI-RHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVF 211
             + L +   E+ +M+ I +HKN++  +GACT+   L ++ E+ ++G++ ++L  ++   
Sbjct: 66  EKD-LSDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPG 124
Query: 212 -------------QLTS--LLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVA 256
                        QL+S  L+  A  V++GM YL     IHRDL   N+L+ E+ V+K+A
Sbjct: 125 LEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIA 184
Query: 257 DFGVARVQAQSGVMTAETG---TYRWMAPEVIEHKPYDYKADVFSFGIALWELLT-GELP 312
           DFG+AR           T      +WMAPE +  + Y +++DV+SFG+ LWE+ T G  P
Sbjct: 185 DFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSP 244
Query: 313 YAGLTPLQAAVGVVQKSLRPTIPKHAHPRLAELLERCWQHDPTQRPNFSQITDILKQMM 371
           Y G+ P++    ++++  R   P +    L  ++  CW   P+QRP F Q+ + L +++
Sbjct: 245 YPGV-PVEELFKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIV 302

>pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302

Iteration: 1
 Score =  138 bits (348), Expect = 4e-33,   Method: Compositional matrix adjust.
 Identities = 87/299 (29%), Positives = 155/299 (51%), Gaps = 33/299 (11%)
Query: 102 EIPTDGTDVWEIDAKQLKIECKVASGSYGDLYKGTYCS---------QEVAIKVLKPECV 152
           E+P D    WE+   +L +   +  G++G +                 +VA+K+LK +  
Sbjct: 1   ELPEDPR--WELPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDAT 58
Query: 153 NTEMLKEFSQEVYIMRKI-RHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVF 211
             + L +   E+ +M+ I +HKN++  +GACT+   L ++ E+ ++G++ ++L  ++   
Sbjct: 59  EKD-LSDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPG 117
Query: 212 -------------QLTS--LLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVA 256
                        QL+S  L+  A  V++GM YL     IHRDL   N+L+ E+ V+K+A
Sbjct: 118 LEYCYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIA 177
Query: 257 DFGVARVQAQSGVMTAETG---TYRWMAPEVIEHKPYDYKADVFSFGIALWELLT-GELP 312
           DFG+AR           T      +WMAPE +  + Y +++DV+SFG+ LWE+ T G  P
Sbjct: 178 DFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSP 237
Query: 313 YAGLTPLQAAVGVVQKSLRPTIPKHAHPRLAELLERCWQHDPTQRPNFSQITDILKQMM 371
           Y G+ P++    ++++  R   P +    L  ++  CW   P+QRP F Q+ + L +++
Sbjct: 238 YPGV-PVEELFKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIV 295

>pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317

Iteration: 1
 Score =  138 bits (348), Expect = 4e-33,   Method: Compositional matrix adjust.
 Identities = 87/299 (29%), Positives = 155/299 (51%), Gaps = 33/299 (11%)
Query: 102 EIPTDGTDVWEIDAKQLKIECKVASGSYGDLYKGTYCS---------QEVAIKVLKPECV 152
           E+P D    WE+   +L +   +  G++G +                 +VA+K+LK +  
Sbjct: 16  ELPEDPR--WELPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDAT 73
Query: 153 NTEMLKEFSQEVYIMRKI-RHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVF 211
             + L +   E+ +M+ I +HKN++  +GACT+   L ++ E+ ++G++ ++L  ++   
Sbjct: 74  EKD-LSDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPG 132
Query: 212 -------------QLTS--LLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVA 256
                        QL+S  L+  A  V++GM YL     IHRDL   N+L+ E+ V+K+A
Sbjct: 133 LEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIA 192
Query: 257 DFGVARVQAQSGVMTAETG---TYRWMAPEVIEHKPYDYKADVFSFGIALWELLT-GELP 312
           DFG+AR           T      +WMAPE +  + Y +++DV+SFG+ LWE+ T G  P
Sbjct: 193 DFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSP 252
Query: 313 YAGLTPLQAAVGVVQKSLRPTIPKHAHPRLAELLERCWQHDPTQRPNFSQITDILKQMM 371
           Y G+ P++    ++++  R   P +    L  ++  CW   P+QRP F Q+ + L +++
Sbjct: 253 YPGV-PVEELFKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIV 310

>pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310

Iteration: 1
 Score =  138 bits (348), Expect = 5e-33,   Method: Compositional matrix adjust.
 Identities = 87/299 (29%), Positives = 155/299 (51%), Gaps = 33/299 (11%)
Query: 102 EIPTDGTDVWEIDAKQLKIECKVASGSYGDLYKGTYCS---------QEVAIKVLKPECV 152
           E+P D    WE+   +L +   +  G++G +                 +VA+K+LK +  
Sbjct: 9   ELPEDPR--WELPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDAT 66
Query: 153 NTEMLKEFSQEVYIMRKI-RHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVF 211
             + L +   E+ +M+ I +HKN++  +GACT+   L ++ E+ ++G++ ++L  ++   
Sbjct: 67  EKD-LSDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPG 125
Query: 212 -------------QLTS--LLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVA 256
                        QL+S  L+  A  V++GM YL     IHRDL   N+L+ E+ V+K+A
Sbjct: 126 LEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIA 185
Query: 257 DFGVARVQAQSGVMTAETG---TYRWMAPEVIEHKPYDYKADVFSFGIALWELLT-GELP 312
           DFG+AR           T      +WMAPE +  + Y +++DV+SFG+ LWE+ T G  P
Sbjct: 186 DFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSP 245
Query: 313 YAGLTPLQAAVGVVQKSLRPTIPKHAHPRLAELLERCWQHDPTQRPNFSQITDILKQMM 371
           Y G+ P++    ++++  R   P +    L  ++  CW   P+QRP F Q+ + L +++
Sbjct: 246 YPGV-PVEELFKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIV 303

>pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317

Iteration: 1
 Score =  138 bits (348), Expect = 5e-33,   Method: Compositional matrix adjust.
 Identities = 85/299 (28%), Positives = 151/299 (50%), Gaps = 33/299 (11%)
Query: 102 EIPTDGTDVWEIDAKQLKIECKVASGSYGDLYKGTYCS---------QEVAIKVLKPECV 152
           E+P D    WE+   +L +   +  G++G +                 +VA+K+LK +  
Sbjct: 16  ELPEDPR--WELPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDAT 73
Query: 153 NTEMLKEFSQEVYIMRKI-RHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFL------- 204
             + L +   E+ +M+ I +HKN++  +GACT+   L ++ E+ ++G++ ++L       
Sbjct: 74  EKD-LSDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQAREPPG 132
Query: 205 --------HKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVA 256
                   H  +       L+  A  V++GM YL     IHRDL   N+L+ E+ V+K+A
Sbjct: 133 LEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIA 192
Query: 257 DFGVARVQAQSGVMTAETG---TYRWMAPEVIEHKPYDYKADVFSFGIALWELLT-GELP 312
           DFG+AR           T      +WMAPE +  + Y +++DV+SFG+ LWE+ T G  P
Sbjct: 193 DFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSP 252
Query: 313 YAGLTPLQAAVGVVQKSLRPTIPKHAHPRLAELLERCWQHDPTQRPNFSQITDILKQMM 371
           Y G+ P++    ++++  R   P +    L  ++  CW   P+QRP F Q+ + L +++
Sbjct: 253 YPGV-PVEELFKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIV 310

>pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382

Iteration: 1
 Score =  138 bits (348), Expect = 5e-33,   Method: Compositional matrix adjust.
 Identities = 87/299 (29%), Positives = 155/299 (51%), Gaps = 33/299 (11%)
Query: 102 EIPTDGTDVWEIDAKQLKIECKVASGSYGDLYKGTYCS---------QEVAIKVLKPECV 152
           E+P D    WE+   +L +   +  G++G +                 +VA+K+LK +  
Sbjct: 57  ELPEDPR--WELPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDAT 114
Query: 153 NTEMLKEFSQEVYIMRKI-RHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVF 211
             + L +   E+ +M+ I +HKN++  +GACT+   L ++ E+ ++G++ ++L  ++   
Sbjct: 115 EKD-LSDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPG 173
Query: 212 -------------QLTS--LLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVA 256
                        QL+S  L+  A  V++GM YL     IHRDL   N+L+ E+ V+K+A
Sbjct: 174 LEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIA 233
Query: 257 DFGVARVQAQSGVMTAETG---TYRWMAPEVIEHKPYDYKADVFSFGIALWELLT-GELP 312
           DFG+AR           T      +WMAPE +  + Y +++DV+SFG+ LWE+ T G  P
Sbjct: 234 DFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSP 293
Query: 313 YAGLTPLQAAVGVVQKSLRPTIPKHAHPRLAELLERCWQHDPTQRPNFSQITDILKQMM 371
           Y G+ P++    ++++  R   P +    L  ++  CW   P+QRP F Q+ + L +++
Sbjct: 294 YPGV-PVEELFKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIV 351

>pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306

Iteration: 1
 Score =  138 bits (348), Expect = 5e-33,   Method: Compositional matrix adjust.
 Identities = 87/299 (29%), Positives = 155/299 (51%), Gaps = 33/299 (11%)
Query: 102 EIPTDGTDVWEIDAKQLKIECKVASGSYGDLYKGTYCS---------QEVAIKVLKPECV 152
           E+P D    WE+   +L +   +  G++G +                 +VA+K+LK +  
Sbjct: 5   ELPEDPR--WELPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDAT 62
Query: 153 NTEMLKEFSQEVYIMRKI-RHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVF 211
             + L +   E+ +M+ I +HKN++  +GACT+   L ++ E+ ++G++ ++L  ++   
Sbjct: 63  EKD-LSDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPG 121
Query: 212 -------------QLTS--LLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVA 256
                        QL+S  L+  A  V++GM YL     IHRDL   N+L+ E+ V+K+A
Sbjct: 122 LEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIA 181
Query: 257 DFGVARVQAQSGVMTAETG---TYRWMAPEVIEHKPYDYKADVFSFGIALWELLT-GELP 312
           DFG+AR           T      +WMAPE +  + Y +++DV+SFG+ LWE+ T G  P
Sbjct: 182 DFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSP 241
Query: 313 YAGLTPLQAAVGVVQKSLRPTIPKHAHPRLAELLERCWQHDPTQRPNFSQITDILKQMM 371
           Y G+ P++    ++++  R   P +    L  ++  CW   P+QRP F Q+ + L +++
Sbjct: 242 YPGV-PVEELFKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIV 299

>pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334

Iteration: 1
 Score =  138 bits (347), Expect = 6e-33,   Method: Compositional matrix adjust.
 Identities = 83/305 (27%), Positives = 151/305 (49%), Gaps = 33/305 (10%)
Query: 102 EIPTDGTDVWEIDAKQLKIECKVASGSYGDLYKGTYCSQE---------VAIKVLKPECV 152
           E+P D    WE    +L +   +  G++G +        +         VA+K+LK +  
Sbjct: 23  ELPEDPK--WEFPRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDAT 80
Query: 153 NTEMLKEFSQEVYIMRKI-RHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGV- 210
             + L +   E+ +M+ I +HKN++  +GACT+   L ++ E+ ++G++ ++L  ++   
Sbjct: 81  EKD-LSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPG 139
Query: 211 --------------FQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVA 256
                              L+     +++GM YL     IHRDL   N+L+ EN V+K+A
Sbjct: 140 MEXSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIA 199
Query: 257 DFGVARVQAQSGVMTAETG---TYRWMAPEVIEHKPYDYKADVFSFGIALWELLT-GELP 312
           DFG+AR           T      +WMAPE +  + Y +++DV+SFG+ +WE+ T G  P
Sbjct: 200 DFGLARDINNIDXXKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSP 259
Query: 313 YAGLTPLQAAVGVVQKSLRPTIPKHAHPRLAELLERCWQHDPTQRPNFSQITDILKQMMK 372
           Y G+ P++    ++++  R   P +    L  ++  CW   P+QRP F Q+ + L +++ 
Sbjct: 260 YPGI-PVEELFKLLKEGHRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILT 318
Query: 373 EVASE 377
              +E
Sbjct: 319 LTTNE 323

>pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324

Iteration: 1
 Score =  138 bits (347), Expect = 6e-33,   Method: Compositional matrix adjust.
 Identities = 85/305 (27%), Positives = 153/305 (50%), Gaps = 33/305 (10%)
Query: 102 EIPTDGTDVWEIDAKQLKIECKVASGSYGDLYKGTYCSQE---------VAIKVLKPECV 152
           E+P D    WE    +L +   +  G++G +        +         VA+K+LK +  
Sbjct: 23  ELPEDPK--WEFPRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDAT 80
Query: 153 NTEMLKEFSQEVYIMRKI-RHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQK--G 209
             E L +   E+ +M+ I +HKN++  +GACT+   L ++ E+ ++G++ ++L  ++  G
Sbjct: 81  E-EDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPG 139
Query: 210 V-------------FQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVA 256
           +                  L+     +++GM YL     IHRDL   N+L+ EN V+K+A
Sbjct: 140 MEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIA 199
Query: 257 DFGVARVQAQSGVMTAETG---TYRWMAPEVIEHKPYDYKADVFSFGIALWELLT-GELP 312
           DFG+AR           T      +WMAPE +  + Y +++DV+SFG+ +WE+ T G  P
Sbjct: 200 DFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSP 259
Query: 313 YAGLTPLQAAVGVVQKSLRPTIPKHAHPRLAELLERCWQHDPTQRPNFSQITDILKQMMK 372
           Y G+ P++    ++++  R   P +    L  ++  CW   P+QRP F Q+ + L +++ 
Sbjct: 260 YPGI-PVEELFKLLKEGHRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILT 318
Query: 373 EVASE 377
              +E
Sbjct: 319 LTTNE 323

>pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334

Iteration: 1
 Score =  138 bits (347), Expect = 6e-33,   Method: Compositional matrix adjust.
 Identities = 83/305 (27%), Positives = 151/305 (49%), Gaps = 33/305 (10%)
Query: 102 EIPTDGTDVWEIDAKQLKIECKVASGSYGDLYKGTYCSQE---------VAIKVLKPECV 152
           E+P D    WE    +L +   +  G++G +        +         VA+K+LK +  
Sbjct: 23  ELPEDPK--WEFPRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDAT 80
Query: 153 NTEMLKEFSQEVYIMRKI-RHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGV- 210
             + L +   E+ +M+ I +HKN++  +GACT+   L ++ E+ ++G++ ++L  ++   
Sbjct: 81  EKD-LSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPG 139
Query: 211 --------------FQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVA 256
                              L+     +++GM YL     IHRDL   N+L+ EN V+K+A
Sbjct: 140 MEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIA 199
Query: 257 DFGVARVQAQSGVMTAETG---TYRWMAPEVIEHKPYDYKADVFSFGIALWELLT-GELP 312
           DFG+AR           T      +WMAPE +  + Y +++DV+SFG+ +WE+ T G  P
Sbjct: 200 DFGLARDINNIDXXKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSP 259
Query: 313 YAGLTPLQAAVGVVQKSLRPTIPKHAHPRLAELLERCWQHDPTQRPNFSQITDILKQMMK 372
           Y G+ P++    ++++  R   P +    L  ++  CW   P+QRP F Q+ + L +++ 
Sbjct: 260 YPGI-PVEELFKLLKEGHRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILT 318
Query: 373 EVASE 377
              +E
Sbjct: 319 LTTNE 323

>pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324

Iteration: 1
 Score =  137 bits (346), Expect = 7e-33,   Method: Compositional matrix adjust.
 Identities = 84/305 (27%), Positives = 153/305 (50%), Gaps = 33/305 (10%)
Query: 102 EIPTDGTDVWEIDAKQLKIECKVASGSYGDLYKGTYCSQE---------VAIKVLKPECV 152
           E+P D    WE    +L +   +  G++G +        +         VA+K+LK +  
Sbjct: 23  ELPEDPK--WEFPRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDAT 80
Query: 153 NTEMLKEFSQEVYIMRKI-RHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQK--G 209
             + L +   E+ +M+ I +HKN++  +GACT+   L ++ E+ ++G++ ++L  ++  G
Sbjct: 81  EKD-LSDLVSEMEMMKMIGKHKNIIHLLGACTQDGPLYVIVEYASKGNLREYLRARRPPG 139
Query: 210 V-------------FQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVA 256
           +                  L+     +++GM YL     IHRDL   N+L+ EN V+K+A
Sbjct: 140 MEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIA 199
Query: 257 DFGVARVQAQSGVMTAETG---TYRWMAPEVIEHKPYDYKADVFSFGIALWELLT-GELP 312
           DFG+AR           T      +WMAPE +  + Y +++DV+SFG+ +WE+ T G  P
Sbjct: 200 DFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSP 259
Query: 313 YAGLTPLQAAVGVVQKSLRPTIPKHAHPRLAELLERCWQHDPTQRPNFSQITDILKQMMK 372
           Y G+ P++    ++++  R   P +    L  ++  CW   P+QRP F Q+ + L +++ 
Sbjct: 260 YPGI-PVEELFKLLKEGHRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILT 318
Query: 373 EVASE 377
              +E
Sbjct: 319 LTTNE 323

>pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324

Iteration: 1
 Score =  137 bits (346), Expect = 9e-33,   Method: Compositional matrix adjust.
 Identities = 84/305 (27%), Positives = 153/305 (50%), Gaps = 33/305 (10%)
Query: 102 EIPTDGTDVWEIDAKQLKIECKVASGSYGDLYKGTYCSQE---------VAIKVLKPECV 152
           E+P D    WE    +L +   +  G++G +        +         VA+K+LK +  
Sbjct: 23  ELPEDPK--WEFPRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDAT 80
Query: 153 NTEMLKEFSQEVYIMRKI-RHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQK--G 209
             + L +   E+ +M+ I +HKN++  +GACT+   L ++ E+ ++G++ ++L  ++  G
Sbjct: 81  EKD-LSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPG 139
Query: 210 V-------------FQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVA 256
           +                  L+     +++GM YL     IHRDL   N+L+ EN V+K+A
Sbjct: 140 MEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIA 199
Query: 257 DFGVARVQAQSGVMTAETG---TYRWMAPEVIEHKPYDYKADVFSFGIALWELLT-GELP 312
           DFG+AR           T      +WMAPE +  + Y +++DV+SFG+ +WE+ T G  P
Sbjct: 200 DFGLARDINNIDYYKNTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSP 259
Query: 313 YAGLTPLQAAVGVVQKSLRPTIPKHAHPRLAELLERCWQHDPTQRPNFSQITDILKQMMK 372
           Y G+ P++    ++++  R   P +    L  ++  CW   P+QRP F Q+ + L +++ 
Sbjct: 260 YPGI-PVEELFKLLKEGHRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILT 318
Query: 373 EVASE 377
              +E
Sbjct: 319 LTTNE 323

>pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294

Iteration: 1
 Score =  137 bits (345), Expect = 9e-33,   Method: Compositional matrix adjust.
 Identities = 83/245 (33%), Positives = 136/245 (55%), Gaps = 9/245 (3%)
Query: 123 KVASGSYGDLYKG--TYCSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIG 180
           ++  GS+G++YKG   +  + VAIK++  E    E+     QE+ ++ +     + ++ G
Sbjct: 26  RIGKGSFGEVYKGIDNHTKEVVAIKIIDLEEAEDEIEDI-QQEITVLSQCDSPYITRYFG 84
Query: 181 ACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDL 240
           +  +   L I+ E++  GS  D L  + G  + T +  +  ++ KG++YLH    IHRD+
Sbjct: 85  SYLKSTKLWIIMEYLGGGSALDLL--KPGPLEETYIATILREILKGLDYLHSERKIHRDI 142
Query: 241 KTANLLMDENGVVKVADFGVARVQAQSGVMTAE-TGTYRWMAPEVIEHKPYDYKADVFSF 299
           K AN+L+ E G VK+ADFGVA     + +      GT  WMAPEVI+   YD+KAD++S 
Sbjct: 143 KAANVLLSEQGDVKLADFGVAGQLTDTQIKRNXFVGTPFWMAPEVIKQSAYDFKADIWSL 202
Query: 300 GIALWELLTGELPYAGLTPLQAAVGVVQKSLRPTIP-KHAHPRLAELLERCWQHDPTQRP 358
           GI   EL  GE P + L P++  + ++ K+  PT+  +H+ P   E +E C   DP  RP
Sbjct: 203 GITAIELAKGEPPNSDLHPMR-VLFLIPKNSPPTLEGQHSKP-FKEFVEACLNKDPRFRP 260
Query: 359 NFSQI 363
              ++
Sbjct: 261 TAKEL 265

>pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score =  137 bits (345), Expect = 1e-32,   Method: Compositional matrix adjust.
 Identities = 84/305 (27%), Positives = 153/305 (50%), Gaps = 33/305 (10%)
Query: 102 EIPTDGTDVWEIDAKQLKIECKVASGSYGDLYKGTYCSQE---------VAIKVLKPECV 152
           E+P D    WE    +L +   +  G++G +        +         VA+K+LK +  
Sbjct: 23  ELPEDPK--WEFPRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDAT 80
Query: 153 NTEMLKEFSQEVYIMRKI-RHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQK--G 209
             + L +   E+ +M+ I +HKN++  +GACT+   L ++ E+ ++G++ ++L  ++  G
Sbjct: 81  EKD-LSDLVSEMEMMKMIGKHKNIITLLGACTQDGPLYVIVEYASKGNLREYLRARRPPG 139
Query: 210 V-------------FQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVA 256
           +                  L+     +++GM YL     IHRDL   N+L+ EN V+K+A
Sbjct: 140 MEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIA 199
Query: 257 DFGVARVQAQSGVMTAETG---TYRWMAPEVIEHKPYDYKADVFSFGIALWELLT-GELP 312
           DFG+AR           T      +WMAPE +  + Y +++DV+SFG+ +WE+ T G  P
Sbjct: 200 DFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSP 259
Query: 313 YAGLTPLQAAVGVVQKSLRPTIPKHAHPRLAELLERCWQHDPTQRPNFSQITDILKQMMK 372
           Y G+ P++    ++++  R   P +    L  ++  CW   P+QRP F Q+ + L +++ 
Sbjct: 260 YPGI-PVEELFKLLKEGHRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILT 318
Query: 373 EVASE 377
              +E
Sbjct: 319 LTTNE 323

>pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321

Iteration: 1
 Score =  137 bits (345), Expect = 1e-32,   Method: Compositional matrix adjust.
 Identities = 81/272 (29%), Positives = 145/272 (53%), Gaps = 16/272 (5%)
Query: 112 EIDAKQLKIECKVASGSYGDLYKGTYCSQ------EVAIKVLKPECVNTEMLKEFSQEVY 165
           E + K++K+   + SG++G +YKG +  +       VAIK+L  E    +   EF  E  
Sbjct: 37  ETELKRVKV---LGSGAFGTVYKGIWVPEGETVKIPVAIKILN-ETTGPKANVEFMDEAL 92
Query: 166 IMRKIRHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSK 225
           IM  + H ++V+ +G C  P  + +VT+ M  G + +++H+ K       LL   + ++K
Sbjct: 93  IMASMDHPHLVRLLGVCLSP-TIQLVTQLMPHGCLLEYVHEHKDNIGSQLLLNWCVQIAK 151
Query: 226 GMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVAR-VQAQSGVMTAETGTY--RWMAP 282
           GM YL +  ++HRDL   N+L+     VK+ DFG+AR ++       A+ G    +WMA 
Sbjct: 152 GMMYLEERRLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGGKMPIKWMAL 211
Query: 283 EVIEHKPYDYKADVFSFGIALWELLT-GELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPR 341
           E I ++ + +++DV+S+G+ +WEL+T G  PY G+ P +    +++K  R   P      
Sbjct: 212 ECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGI-PTREIPDLLEKGERLPQPPICTID 270
Query: 342 LAELLERCWQHDPTQRPNFSQITDILKQMMKE 373
           +  ++ +CW  D   RP F ++     +M ++
Sbjct: 271 VYMVMVKCWMIDADSRPKFKELAAEFSRMARD 302

>pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301

Iteration: 1
 Score =  137 bits (345), Expect = 1e-32,   Method: Compositional matrix adjust.
 Identities = 87/271 (32%), Positives = 144/271 (53%), Gaps = 10/271 (3%)
Query: 97  SPNCIEIPTDGTDVWEIDAKQLKIECKVASGSYGDLYKG--TYCSQEVAIKVLKPECVNT 154
           SP  +++P    ++ + +    K+E ++  GS+G+++KG      Q VAIK++  E    
Sbjct: 5   SPVAVQVPGMQNNIADPEELFTKLE-RIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAED 63
Query: 155 EMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQK-GVFQL 213
           E+     QE+ ++ +     V ++ G+  +   L I+ E++  GS  D L       FQ+
Sbjct: 64  EIEDI-QQEITVLSQCDSSYVTKYYGSYLKGSKLWIIMEYLGGGSALDLLRAGPFDEFQI 122
Query: 214 TSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGV-MTA 272
            ++LK   ++ KG++YLH    IHRD+K AN+L+ E G VK+ADFGVA     + +    
Sbjct: 123 ATMLK---EILKGLDYLHSEKKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNT 179
Query: 273 ETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKSLRP 332
             GT  WMAPEVI+   YD KAD++S GI   EL  GE P + + P++    ++ K+  P
Sbjct: 180 FVGTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKGEPPNSDMHPMRVLF-LIPKNNPP 238
Query: 333 TIPKHAHPRLAELLERCWQHDPTQRPNFSQI 363
           T+         E ++ C   DP+ RP   ++
Sbjct: 239 TLVGDFTKSFKEFIDACLNKDPSFRPTAKEL 269

>pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328

Iteration: 1
 Score =  137 bits (344), Expect = 1e-32,   Method: Compositional matrix adjust.
 Identities = 81/272 (29%), Positives = 145/272 (53%), Gaps = 16/272 (5%)
Query: 112 EIDAKQLKIECKVASGSYGDLYKGTYCSQ------EVAIKVLKPECVNTEMLKEFSQEVY 165
           E + K++K+   + SG++G +YKG +  +       VAIK+L  E    +   EF  E  
Sbjct: 14  ETELKRVKV---LGSGAFGTVYKGIWVPEGETVKIPVAIKILN-ETTGPKANVEFMDEAL 69
Query: 166 IMRKIRHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSK 225
           IM  + H ++V+ +G C  P  + +VT+ M  G + +++H+ K       LL   + ++K
Sbjct: 70  IMASMDHPHLVRLLGVCLSP-TIQLVTQLMPHGCLLEYVHEHKDNIGSQLLLNWCVQIAK 128
Query: 226 GMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVAR-VQAQSGVMTAETGTY--RWMAP 282
           GM YL +  ++HRDL   N+L+     VK+ DFG+AR ++       A+ G    +WMA 
Sbjct: 129 GMMYLEERRLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGGKMPIKWMAL 188
Query: 283 EVIEHKPYDYKADVFSFGIALWELLT-GELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPR 341
           E I ++ + +++DV+S+G+ +WEL+T G  PY G+ P +    +++K  R   P      
Sbjct: 189 ECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGI-PTREIPDLLEKGERLPQPPICTID 247
Query: 342 LAELLERCWQHDPTQRPNFSQITDILKQMMKE 373
           +  ++ +CW  D   RP F ++     +M ++
Sbjct: 248 VYMVMVKCWMIDADSRPKFKELAAEFSRMARD 279

>pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293

Iteration: 1
 Score =  137 bits (344), Expect = 1e-32,   Method: Compositional matrix adjust.
 Identities = 78/265 (29%), Positives = 137/265 (51%), Gaps = 14/265 (5%)
Query: 124 VASGSYGDLYKGTYCSQE-----VAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQF 178
           +  G +G++Y+G Y + +     VA+K  K +C   +  ++F  E  IM+ + H ++V+ 
Sbjct: 32  LGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDC-TLDNKEKFMSEAVIMKNLDHPHIVKL 90
Query: 179 IGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHR 238
           IG     P   I+ E    G +  +L + K   ++ +L+  ++ + K M YL   N +HR
Sbjct: 91  IGIIEEEPTW-IIMELYPYGELGHYLERNKNSLKVLTLVLYSLQICKAMAYLESINCVHR 149
Query: 239 DLKTANLLMDENGVVKVADFGVARVQAQSGVMTAETGTY--RWMAPEVIEHKPYDYKADV 296
           D+   N+L+     VK+ DFG++R         A       +WM+PE I  + +   +DV
Sbjct: 150 DIAVRNILVASPECVKLGDFGLSRYIEDEDYYKASVTRLPIKWMSPESINFRRFTTASDV 209
Query: 297 FSFGIALWELLT-GELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRLAELLERCWQHDPT 355
           + F + +WE+L+ G+ P+  L   +  +GV++K  R   P    P L  L+ RCW +DP+
Sbjct: 210 WMFAVCMWEILSFGKQPFFWLEN-KDVIGVLEKGDRLPKPDLCPPVLYTLMTRCWDYDPS 268
Query: 356 QRPNFSQITDILK---QMMKEVASE 377
            RP F+++   L    QM K++A E
Sbjct: 269 DRPRFTELVCSLSDVYQMEKDIAME 293

>pdb|1OEC|A Chain A, Fgfr2 Kinase Domain Length = 316

Iteration: 1
 Score =  137 bits (344), Expect = 1e-32,   Method: Compositional matrix adjust.
 Identities = 84/305 (27%), Positives = 152/305 (49%), Gaps = 33/305 (10%)
Query: 102 EIPTDGTDVWEIDAKQLKIECKVASGSYGDLYKGTYCSQE---------VAIKVLKPECV 152
           E+P D    WE    +L +   +  G +G +        +         VA+K+LK +  
Sbjct: 15  ELPEDPK--WEFPRDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDAT 72
Query: 153 NTEMLKEFSQEVYIMRKI-RHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQK--G 209
             + L +   E+ +M+ I +HKN++  +GACT+   L ++ E+ ++G++ ++L  ++  G
Sbjct: 73  EKD-LSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPG 131
Query: 210 V-------------FQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVA 256
           +                  L+     +++GM YL     IHRDL   N+L+ EN V+K+A
Sbjct: 132 MEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIA 191
Query: 257 DFGVARVQAQSGVMTAETG---TYRWMAPEVIEHKPYDYKADVFSFGIALWELLT-GELP 312
           DFG+AR           T      +WMAPE +  + Y +++DV+SFG+ +WE+ T G  P
Sbjct: 192 DFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSP 251
Query: 313 YAGLTPLQAAVGVVQKSLRPTIPKHAHPRLAELLERCWQHDPTQRPNFSQITDILKQMMK 372
           Y G+ P++    ++++  R   P +    L  ++  CW   P+QRP F Q+ + L +++ 
Sbjct: 252 YPGI-PVEELFKLLKEGHRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILT 310
Query: 373 EVASE 377
              +E
Sbjct: 311 LTTNE 315

>pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277

Iteration: 1
 Score =  137 bits (344), Expect = 1e-32,   Method: Compositional matrix adjust.
 Identities = 78/265 (29%), Positives = 137/265 (51%), Gaps = 14/265 (5%)
Query: 124 VASGSYGDLYKGTYCSQE-----VAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQF 178
           +  G +G++Y+G Y + +     VA+K  K +C   +  ++F  E  IM+ + H ++V+ 
Sbjct: 16  LGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDC-TLDNKEKFMSEAVIMKNLDHPHIVKL 74
Query: 179 IGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHR 238
           IG     P   I+ E    G +  +L + K   ++ +L+  ++ + K M YL   N +HR
Sbjct: 75  IGIIEEEPTW-IIMELYPYGELGHYLERNKNSLKVLTLVLYSLQICKAMAYLESINCVHR 133
Query: 239 DLKTANLLMDENGVVKVADFGVARVQAQSGVMTAETGTY--RWMAPEVIEHKPYDYKADV 296
           D+   N+L+     VK+ DFG++R         A       +WM+PE I  + +   +DV
Sbjct: 134 DIAVRNILVASPECVKLGDFGLSRYIEDEDYYKASVTRLPIKWMSPESINFRRFTTASDV 193
Query: 297 FSFGIALWELLT-GELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRLAELLERCWQHDPT 355
           + F + +WE+L+ G+ P+  L   +  +GV++K  R   P    P L  L+ RCW +DP+
Sbjct: 194 WMFAVCMWEILSFGKQPFFWLEN-KDVIGVLEKGDRLPKPDLCPPVLYTLMTRCWDYDPS 252
Query: 356 QRPNFSQITDILK---QMMKEVASE 377
            RP F+++   L    QM K++A E
Sbjct: 253 DRPRFTELVCSLSDVYQMEKDIAME 277

>pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score =  137 bits (344), Expect = 1e-32,   Method: Compositional matrix adjust.
 Identities = 83/305 (27%), Positives = 153/305 (50%), Gaps = 33/305 (10%)
Query: 102 EIPTDGTDVWEIDAKQLKIECKVASGSYGDLYKGTYCSQE---------VAIKVLKPECV 152
           E+P D    WE    +L +   +  G++G +        +         VA+K+LK +  
Sbjct: 23  ELPEDPK--WEFPRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDAT 80
Query: 153 NTEMLKEFSQEVYIMRKI-RHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQK--G 209
             + L +   E+ +M+ I +HKN++  +GACT+   L ++ E+ ++G++ ++L  ++  G
Sbjct: 81  EKD-LSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPG 139
Query: 210 V-------------FQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVA 256
           +                  L+     +++GM YL     IHRDL   N+L+ EN V+++A
Sbjct: 140 MEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMRIA 199
Query: 257 DFGVARVQAQSGVMTAETG---TYRWMAPEVIEHKPYDYKADVFSFGIALWELLT-GELP 312
           DFG+AR           T      +WMAPE +  + Y +++DV+SFG+ +WE+ T G  P
Sbjct: 200 DFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSP 259
Query: 313 YAGLTPLQAAVGVVQKSLRPTIPKHAHPRLAELLERCWQHDPTQRPNFSQITDILKQMMK 372
           Y G+ P++    ++++  R   P +    L  ++  CW   P+QRP F Q+ + L +++ 
Sbjct: 260 YPGI-PVEELFKLLKEGHRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILT 318
Query: 373 EVASE 377
              +E
Sbjct: 319 LTTNE 323

>pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281

Iteration: 1
 Score =  137 bits (344), Expect = 1e-32,   Method: Compositional matrix adjust.
 Identities = 78/265 (29%), Positives = 137/265 (51%), Gaps = 14/265 (5%)
Query: 124 VASGSYGDLYKGTYCSQE-----VAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQF 178
           +  G +G++Y+G Y + +     VA+K  K +C   +  ++F  E  IM+ + H ++V+ 
Sbjct: 20  LGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDC-TLDNKEKFMSEAVIMKNLDHPHIVKL 78
Query: 179 IGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHR 238
           IG     P   I+ E    G +  +L + K   ++ +L+  ++ + K M YL   N +HR
Sbjct: 79  IGIIEEEPTW-IIMELYPYGELGHYLERNKNSLKVLTLVLYSLQICKAMAYLESINCVHR 137
Query: 239 DLKTANLLMDENGVVKVADFGVARVQAQSGVMTAETGTY--RWMAPEVIEHKPYDYKADV 296
           D+   N+L+     VK+ DFG++R         A       +WM+PE I  + +   +DV
Sbjct: 138 DIAVRNILVASPECVKLGDFGLSRYIEDEDYYKASVTRLPIKWMSPESINFRRFTTASDV 197
Query: 297 FSFGIALWELLT-GELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRLAELLERCWQHDPT 355
           + F + +WE+L+ G+ P+  L   +  +GV++K  R   P    P L  L+ RCW +DP+
Sbjct: 198 WMFAVCMWEILSFGKQPFFWLEN-KDVIGVLEKGDRLPKPDLCPPVLYTLMTRCWDYDPS 256
Query: 356 QRPNFSQITDILK---QMMKEVASE 377
            RP F+++   L    QM K++A E
Sbjct: 257 DRPRFTELVCSLSDVYQMEKDIAME 281

>pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313

Iteration: 1
 Score =  137 bits (344), Expect = 1e-32,   Method: Compositional matrix adjust.
 Identities = 83/305 (27%), Positives = 150/305 (49%), Gaps = 33/305 (10%)
Query: 102 EIPTDGTDVWEIDAKQLKIECKVASGSYGDLYKGTYCSQE---------VAIKVLKPECV 152
           E+P D    WE    +L +   +  G +G +        +         VA+K+LK +  
Sbjct: 12  ELPEDPK--WEFPRDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDAT 69
Query: 153 NTEMLKEFSQEVYIMRKI-RHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGV- 210
             + L +   E+ +M+ I +HKN++  +GACT+   L ++ E+ ++G++ ++L  ++   
Sbjct: 70  EKD-LSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPG 128
Query: 211 --------------FQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVA 256
                              L+     +++GM YL     IHRDL   N+L+ EN V+K+A
Sbjct: 129 MEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIA 188
Query: 257 DFGVARVQAQSGVMTAETG---TYRWMAPEVIEHKPYDYKADVFSFGIALWELLT-GELP 312
           DFG+AR           T      +WMAPE +  + Y +++DV+SFG+ +WE+ T G  P
Sbjct: 189 DFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSP 248
Query: 313 YAGLTPLQAAVGVVQKSLRPTIPKHAHPRLAELLERCWQHDPTQRPNFSQITDILKQMMK 372
           Y G+ P++    ++++  R   P +    L  ++  CW   P+QRP F Q+ + L +++ 
Sbjct: 249 YPGI-PVEELFKLLKEGHRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILT 307
Query: 373 EVASE 377
              +E
Sbjct: 308 LTTNE 312

>pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370

Iteration: 1
 Score =  136 bits (343), Expect = 2e-32,   Method: Compositional matrix adjust.
 Identities = 83/305 (27%), Positives = 150/305 (49%), Gaps = 33/305 (10%)
Query: 102 EIPTDGTDVWEIDAKQLKIECKVASGSYGDLYKGTYCSQE---------VAIKVLKPECV 152
           E+P D    WE    +L +   +  G +G +        +         VA+K+LK +  
Sbjct: 69  ELPEDPK--WEFPRDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDAT 126
Query: 153 NTEMLKEFSQEVYIMRKI-RHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGV- 210
             + L +   E+ +M+ I +HKN++  +GACT+   L ++ E+ ++G++ ++L  ++   
Sbjct: 127 EKD-LSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPG 185
Query: 211 --------------FQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVA 256
                              L+     +++GM YL     IHRDL   N+L+ EN V+K+A
Sbjct: 186 MEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIA 245
Query: 257 DFGVARVQAQSGVMTAETG---TYRWMAPEVIEHKPYDYKADVFSFGIALWELLT-GELP 312
           DFG+AR           T      +WMAPE +  + Y +++DV+SFG+ +WE+ T G  P
Sbjct: 246 DFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSP 305
Query: 313 YAGLTPLQAAVGVVQKSLRPTIPKHAHPRLAELLERCWQHDPTQRPNFSQITDILKQMMK 372
           Y G+ P++    ++++  R   P +    L  ++  CW   P+QRP F Q+ + L +++ 
Sbjct: 306 YPGI-PVEELFKLLKEGHRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILT 364
Query: 373 EVASE 377
              +E
Sbjct: 365 LTTNE 369

>pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311

Iteration: 1
 Score =  136 bits (342), Expect = 3e-32,   Method: Compositional matrix adjust.
 Identities = 82/299 (27%), Positives = 148/299 (49%), Gaps = 33/299 (11%)
Query: 102 EIPTDGTDVWEIDAKQLKIECKVASGSYGDLYKGTYCSQE---------VAIKVLKPECV 152
           E+P D    WE    +L +   +  G +G +        +         VA+K+LK +  
Sbjct: 10  ELPEDPK--WEFPRDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDAT 67
Query: 153 NTEMLKEFSQEVYIMRKI-RHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGV- 210
             + L +   E+ +M+ I +HKN++  +GACT+   L ++ E+ ++G++ ++L  ++   
Sbjct: 68  EKD-LSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPG 126
Query: 211 --------------FQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVA 256
                              L+     +++GM YL     IHRDL   N+L+ EN V+K+A
Sbjct: 127 MEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLTARNVLVTENNVMKIA 186
Query: 257 DFGVARVQAQSGVMTAETG---TYRWMAPEVIEHKPYDYKADVFSFGIALWELLT-GELP 312
           DFG+AR           T      +WMAPE +  + Y +++DV+SFG+ +WE+ T G  P
Sbjct: 187 DFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSP 246
Query: 313 YAGLTPLQAAVGVVQKSLRPTIPKHAHPRLAELLERCWQHDPTQRPNFSQITDILKQMM 371
           Y G+ P++    ++++  R   P +    L  ++  CW   P+QRP F Q+ + L +++
Sbjct: 247 YPGI-PVEELFKLLKEGHRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIL 304

>pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294

Iteration: 1
 Score =  135 bits (341), Expect = 3e-32,   Method: Compositional matrix adjust.
 Identities = 87/268 (32%), Positives = 146/268 (54%), Gaps = 10/268 (3%)
Query: 101 IEIPTDGTDVWEIDAKQL--KIECKVASGSYGDLYKG--TYCSQEVAIKVLKPECVNTEM 156
           +++ T+      +D ++L  K+E K+  GS+G+++KG      + VAIK++  E    E+
Sbjct: 11  VDLGTENLYFQSMDPEELFTKLE-KIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEI 69
Query: 157 LKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSL 216
                QE+ ++ +     V ++ G+  +   L I+ E++  GS  D L  + G    T +
Sbjct: 70  EDI-QQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYLGGGSALDLL--EPGPLDETQI 126
Query: 217 LKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGV-MTAETG 275
             +  ++ KG++YLH    IHRD+K AN+L+ E+G VK+ADFGVA     + +      G
Sbjct: 127 ATILREILKGLDYLHSEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNTFVG 186
Query: 276 TYRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKSLRPTIP 335
           T  WMAPEVI+   YD KAD++S GI   EL  GE P++ L P++    ++ K+  PT+ 
Sbjct: 187 TPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSELHPMKVLF-LIPKNNPPTLE 245
Query: 336 KHAHPRLAELLERCWQHDPTQRPNFSQI 363
            +    L E +E C   +P+ RP   ++
Sbjct: 246 GNYSKPLKEFVEACLNKEPSFRPTAKEL 273

>pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score =  135 bits (341), Expect = 3e-32,   Method: Compositional matrix adjust.
 Identities = 83/305 (27%), Positives = 152/305 (49%), Gaps = 33/305 (10%)
Query: 102 EIPTDGTDVWEIDAKQLKIECKVASGSYGDLYKGTYCSQE---------VAIKVLKPECV 152
           E+P D    WE    +L +   +  G++G +        +         VA+K+LK +  
Sbjct: 23  ELPEDPK--WEFPRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDAT 80
Query: 153 NTEMLKEFSQEVYIMRKI-RHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQK--G 209
             + L +   E+ +M+ I +HKN++  +GACT+   L ++  + ++G++ ++L  ++  G
Sbjct: 81  EKD-LSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVAYASKGNLREYLRARRPPG 139
Query: 210 V-------------FQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVA 256
           +                  L+     +++GM YL     IHRDL   N+L+ EN V+K+A
Sbjct: 140 MEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIA 199
Query: 257 DFGVARVQAQSGVMTAETG---TYRWMAPEVIEHKPYDYKADVFSFGIALWELLT-GELP 312
           DFG+AR           T      +WMAPE +  + Y +++DV+SFG+ +WE+ T G  P
Sbjct: 200 DFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSP 259
Query: 313 YAGLTPLQAAVGVVQKSLRPTIPKHAHPRLAELLERCWQHDPTQRPNFSQITDILKQMMK 372
           Y G+ P++    ++++  R   P +    L  ++  CW   P+QRP F Q+ + L +++ 
Sbjct: 260 YPGI-PVEELFKLLKEGHRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILT 318
Query: 373 EVASE 377
              +E
Sbjct: 319 LTTNE 323

>pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303

Iteration: 1
 Score =  135 bits (340), Expect = 4e-32,   Method: Compositional matrix adjust.
 Identities = 80/244 (32%), Positives = 134/244 (54%), Gaps = 7/244 (2%)
Query: 123 KVASGSYGDLYKG--TYCSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIG 180
           K+  GS+G+++KG      + VAIK++       + +++  QE+ ++ +     V ++ G
Sbjct: 29  KIGKGSFGEVFKGIDNRTQKVVAIKIID-LEEAEDEIEDIQQEITVLSQCDSPYVTKYYG 87
Query: 181 ACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDL 240
           +  +   L I+ E++  GS  D L  + G    T +  +  ++ KG++YLH    IHRD+
Sbjct: 88  SYLKDTKLWIIMEYLGGGSALDLL--EPGPLDETQIATILREILKGLDYLHSEKKIHRDI 145
Query: 241 KTANLLMDENGVVKVADFGVARVQAQSGVMTAE-TGTYRWMAPEVIEHKPYDYKADVFSF 299
           K AN+L+ E+G VK+ADFGVA     + +      GT  WMAPEVI+   YD KAD++S 
Sbjct: 146 KAANVLLSEHGEVKLADFGVAGQLTDTQIKRNXFVGTPFWMAPEVIKQSAYDSKADIWSL 205
Query: 300 GIALWELLTGELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRLAELLERCWQHDPTQRPN 359
           GI   EL  GE P++ L P++    ++ K+  PT+  +    L E +E C   +P+ RP 
Sbjct: 206 GITAIELARGEPPHSELHPMKVLF-LIPKNNPPTLEGNYSKPLKEFVEACLNKEPSFRPT 264
Query: 360 FSQI 363
             ++
Sbjct: 265 AKEL 268

>pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304

Iteration: 1
 Score =  135 bits (340), Expect = 4e-32,   Method: Compositional matrix adjust.
 Identities = 82/244 (33%), Positives = 134/244 (54%), Gaps = 7/244 (2%)
Query: 123 KVASGSYGDLYKG--TYCSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIG 180
           K+  GS+G+++KG      + VAIK++  E    E+     QE+ ++ +     V ++ G
Sbjct: 14  KIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDI-QQEITVLSQCDSPYVTKYYG 72
Query: 181 ACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDL 240
           +  +   L I+ E++  GS  D L  + G    T +  +  ++ KG++YLH    IHRD+
Sbjct: 73  SYLKDTKLWIIMEYLGGGSALDLL--EPGPLDETQIATILREILKGLDYLHSEKKIHRDI 130
Query: 241 KTANLLMDENGVVKVADFGVARVQAQSGV-MTAETGTYRWMAPEVIEHKPYDYKADVFSF 299
           K AN+L+ E+G VK+ADFGVA     + +      GT  WMAPEVI+   YD KAD++S 
Sbjct: 131 KAANVLLSEHGEVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIKQSAYDSKADIWSL 190
Query: 300 GIALWELLTGELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRLAELLERCWQHDPTQRPN 359
           GI   EL  GE P++ L P++  + ++ K+  PT+  +    L E +E C   +P+ RP 
Sbjct: 191 GITAIELARGEPPHSELHPMK-VLFLIPKNNPPTLEGNYSKPLKEFVEACLNKEPSFRPT 249
Query: 360 FSQI 363
             ++
Sbjct: 250 AKEL 253

>pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304

Iteration: 1
 Score =  135 bits (339), Expect = 5e-32,   Method: Compositional matrix adjust.
 Identities = 82/244 (33%), Positives = 133/244 (54%), Gaps = 7/244 (2%)
Query: 123 KVASGSYGDLYKG--TYCSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIG 180
           K+  GS+G+++KG      + VAIK++  E    E+     QE+ ++ +     V ++ G
Sbjct: 14  KIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDI-QQEITVLSQCDSPYVTKYYG 72
Query: 181 ACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDL 240
           +  +   L I+ E++  GS  D L  + G    T +  +  ++ KG++YLH    IHRD+
Sbjct: 73  SYLKDTKLWIIMEYLGGGSALDLL--EPGPLDETQIATILREILKGLDYLHSEKKIHRDI 130
Query: 241 KTANLLMDENGVVKVADFGVARVQAQSGVMTAE-TGTYRWMAPEVIEHKPYDYKADVFSF 299
           K AN+L+ E+G VK+ADFGVA     + +      GT  WMAPEVI+   YD KAD++S 
Sbjct: 131 KAANVLLSEHGEVKLADFGVAGQLTDTQIKRNXFVGTPFWMAPEVIKQSAYDSKADIWSL 190
Query: 300 GIALWELLTGELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRLAELLERCWQHDPTQRPN 359
           GI   EL  GE P++ L P++    ++ K+  PT+  +    L E +E C   +P+ RP 
Sbjct: 191 GITAIELARGEPPHSELHPMKVLF-LIPKNNPPTLEGNYSKPLKEFVEACLNKEPSFRPT 249
Query: 360 FSQI 363
             ++
Sbjct: 250 AKEL 253

>pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score =  135 bits (339), Expect = 5e-32,   Method: Compositional matrix adjust.
 Identities = 83/305 (27%), Positives = 152/305 (49%), Gaps = 33/305 (10%)
Query: 102 EIPTDGTDVWEIDAKQLKIECKVASGSYGDLYKGTYCSQE---------VAIKVLKPECV 152
           E+P D    WE    +L +   +  G++G +        +         VA+K+LK +  
Sbjct: 23  ELPEDPK--WEFPRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDAT 80
Query: 153 NTEMLKEFSQEVYIMRKI-RHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQK--G 209
             + L +   E+ +M+ I +HKN++  +GACT+   L ++  + ++G++ ++L  ++  G
Sbjct: 81  EKD-LSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVGYASKGNLREYLRARRPPG 139
Query: 210 V-------------FQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVA 256
           +                  L+     +++GM YL     IHRDL   N+L+ EN V+K+A
Sbjct: 140 MEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIA 199
Query: 257 DFGVARVQAQSGVMTAETG---TYRWMAPEVIEHKPYDYKADVFSFGIALWELLT-GELP 312
           DFG+AR           T      +WMAPE +  + Y +++DV+SFG+ +WE+ T G  P
Sbjct: 200 DFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSP 259
Query: 313 YAGLTPLQAAVGVVQKSLRPTIPKHAHPRLAELLERCWQHDPTQRPNFSQITDILKQMMK 372
           Y G+ P++    ++++  R   P +    L  ++  CW   P+QRP F Q+ + L +++ 
Sbjct: 260 YPGI-PVEELFKLLKEGHRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILT 318
Query: 373 EVASE 377
              +E
Sbjct: 319 LTTNE 323

>pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303

Iteration: 1
 Score =  134 bits (337), Expect = 9e-32,   Method: Compositional matrix adjust.
 Identities = 87/279 (31%), Positives = 144/279 (51%), Gaps = 29/279 (10%)
Query: 111 WEIDAKQLKIECKVASGSYGDLYKGTYCS---QEVAIKVLKPECVNTEMLKEFSQEVYIM 167
           W I+    +++  + SG+   + +  YC+   ++VAIK +  E   T M  E  +E+  M
Sbjct: 10  WSINRDDYELQEVIGSGATA-VVQAAYCAPKKEKVAIKRINLEKCQTSM-DELLKEIQAM 67
Query: 168 RKIRHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFL--------HKQKGVFQLTSLLKV 219
            +  H N+V +  +      L +V + ++ GS+ D +        HK  GV   +++  +
Sbjct: 68  SQCHHPNIVSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKS-GVLDESTIATI 126
Query: 220 AIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAE------ 273
             +V +G+ YLH+N  IHRD+K  N+L+ E+G V++ADFGV+   A  G +T        
Sbjct: 127 LREVLEGLEYLHKNGQIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTF 186
Query: 274 TGTYRWMAPEVIEH-KPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQK---S 329
            GT  WMAPEV+E  + YD+KAD++SFGI   EL TG  PY    P++  +  +Q    S
Sbjct: 187 VGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMKVLMLTLQNDPPS 246
Query: 330 LRPTIP-----KHAHPRLAELLERCWQHDPTQRPNFSQI 363
           L   +      K       +++  C Q DP +RP  +++
Sbjct: 247 LETGVQDKEMLKKYGKSFRKMISLCLQKDPEKRPTAAEL 285

>pdb|2ZM3|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor And Isoquinolinedione Inhibitor Length = 308

Iteration: 1
 Score =  134 bits (337), Expect = 9e-32,   Method: Compositional matrix adjust.
 Identities = 81/284 (28%), Positives = 143/284 (50%), Gaps = 22/284 (7%)
Query: 109 DVWEIDAKQLKIECKVASGSYGDLYKGTY-------CSQEVAIKVLKPECVNTEMLKEFS 161
           D WE+  +++ +  ++  GS+G +Y+G             VAIK +       E + EF 
Sbjct: 12  DEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERI-EFL 70
Query: 162 QEVYIMRKIRHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQ--------- 212
            E  +M++    +VV+ +G  ++     ++ E M RG +  +L   +   +         
Sbjct: 71  NEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPS 130
Query: 213 LTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVAR-VQAQSGVMT 271
           L+ ++++A +++ GM YL+ N  +HRDL   N ++ E+  VK+ DFG+ R +        
Sbjct: 131 LSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIXETDXXRK 190
Query: 272 AETG--TYRWMAPEVIEHKPYDYKADVFSFGIALWELLT-GELPYAGLTPLQAAVGVVQK 328
              G    RWM+PE ++   +   +DV+SFG+ LWE+ T  E PY GL+  Q    V++ 
Sbjct: 191 GGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVMEG 250
Query: 329 SLRPTIPKHAHPRLAELLERCWQHDPTQRPNFSQITDILKQMMK 372
            L    P +    L EL+  CWQ++P  RP+F +I   +K+ M+
Sbjct: 251 GLLDK-PDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEME 293

>pdb|1K3A|A Chain A, Structure Of The Insulin-Like Growth Factor 1 Receptor Kinase Length = 299

Iteration: 1
 Score =  134 bits (337), Expect = 1e-31,   Method: Compositional matrix adjust.
 Identities = 81/284 (28%), Positives = 143/284 (50%), Gaps = 22/284 (7%)
Query: 109 DVWEIDAKQLKIECKVASGSYGDLYKGTY-------CSQEVAIKVLKPECVNTEMLKEFS 161
           D WE+  +++ +  ++  GS+G +Y+G             VAIK +       E + EF 
Sbjct: 3   DEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERI-EFL 61
Query: 162 QEVYIMRKIRHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQ--------- 212
            E  +M++    +VV+ +G  ++     ++ E M RG +  +L   +   +         
Sbjct: 62  NEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPS 121
Query: 213 LTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVAR-VQAQSGVMT 271
           L+ ++++A +++ GM YL+ N  +HRDL   N ++ E+  VK+ DFG+ R +        
Sbjct: 122 LSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIXETDXXRK 181
Query: 272 AETG--TYRWMAPEVIEHKPYDYKADVFSFGIALWELLT-GELPYAGLTPLQAAVGVVQK 328
              G    RWM+PE ++   +   +DV+SFG+ LWE+ T  E PY GL+  Q    V++ 
Sbjct: 182 GGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVMEG 241
Query: 329 SLRPTIPKHAHPRLAELLERCWQHDPTQRPNFSQITDILKQMMK 372
            L    P +    L EL+  CWQ++P  RP+F +I   +K+ M+
Sbjct: 242 GLLDK-PDNCPDMLLELMRMCWQYNPKMRPSFLEIISSIKEEME 284

>pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290

Iteration: 1
 Score =  134 bits (337), Expect = 1e-31,   Method: Compositional matrix adjust.
 Identities = 85/278 (30%), Positives = 143/278 (51%), Gaps = 27/278 (9%)
Query: 111 WEIDAKQLKIECKVASGSYGDLYKGTYCS---QEVAIKVLKPECVNTEMLKEFSQEVYIM 167
           W I+    +++  + SG+   + +  YC+   ++VAIK +  E   T M  E  +E+  M
Sbjct: 5   WSINRDDYELQEVIGSGATA-VVQAAYCAPKKEKVAIKRINLEKCQTSM-DELLKEIQAM 62
Query: 168 RKIRHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFL-------HKQKGVFQLTSLLKVA 220
            +  H N+V +  +      L +V + ++ GS+ D +         + GV   +++  + 
Sbjct: 63  SQCHHPNIVSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATIL 122
Query: 221 IDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAE------T 274
            +V +G+ YLH+N  IHRD+K  N+L+ E+G V++ADFGV+   A  G +T         
Sbjct: 123 REVLEGLEYLHKNGQIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFV 182
Query: 275 GTYRWMAPEVIEH-KPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQK---SL 330
           GT  WMAPEV+E  + YD+KAD++SFGI   EL TG  PY    P++  +  +Q    SL
Sbjct: 183 GTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMKVLMLTLQNDPPSL 242
Query: 331 RPTIP-----KHAHPRLAELLERCWQHDPTQRPNFSQI 363
              +      K       +++  C Q DP +RP  +++
Sbjct: 243 ETGVQDKEMLKKYGKSFRKMISLCLQKDPEKRPTAAEL 280

>pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330

Iteration: 1
 Score =  133 bits (335), Expect = 1e-31,   Method: Compositional matrix adjust.
 Identities = 82/272 (30%), Positives = 144/272 (52%), Gaps = 16/272 (5%)
Query: 112 EIDAKQLKIECKVASGSYGDLYKGTYCSQ------EVAIKVLKPECVNTEMLKEFSQEVY 165
           E + K++K+   + SG++G +YKG +  +       VAIK L+ E  + +  KE   E Y
Sbjct: 17  ETEFKKIKV---LGSGAFGTVYKGLWIPEGEKVKIPVAIKELR-EATSPKANKEILDEAY 72
Query: 166 IMRKIRHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSK 225
           +M  + + +V + +G C     + ++T+ M  G + D++ + K       LL   + ++K
Sbjct: 73  VMASVDNPHVCRLLGICLTS-TVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAK 131
Query: 226 GMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVAR-VQAQSGVMTAETGTY--RWMAP 282
           GMNYL    ++HRDL   N+L+     VK+ DFG+A+ + A+     AE G    +WMA 
Sbjct: 132 GMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMAL 191
Query: 283 EVIEHKPYDYKADVFSFGIALWELLT-GELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPR 341
           E I H+ Y +++DV+S+G+ +WEL+T G  PY G+ P      +++K  R   P      
Sbjct: 192 ESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGI-PASEISSILEKGERLPQPPICTID 250
Query: 342 LAELLERCWQHDPTQRPNFSQITDILKQMMKE 373
           +  ++ +CW  D   RP F ++     +M ++
Sbjct: 251 VYMIMRKCWMIDADSRPKFRELIIEFSKMARD 282

>pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337

Iteration: 1
 Score =  133 bits (335), Expect = 1e-31,   Method: Compositional matrix adjust.
 Identities = 82/272 (30%), Positives = 144/272 (52%), Gaps = 16/272 (5%)
Query: 112 EIDAKQLKIECKVASGSYGDLYKGTYCSQ------EVAIKVLKPECVNTEMLKEFSQEVY 165
           E + K++K+   + SG++G +YKG +  +       VAIK L+ E  + +  KE   E Y
Sbjct: 24  ETEFKKIKV---LGSGAFGTVYKGLWIPEGEKVKIPVAIKELR-EATSPKANKEILDEAY 79
Query: 166 IMRKIRHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSK 225
           +M  + + +V + +G C     + ++T+ M  G + D++ + K       LL   + ++K
Sbjct: 80  VMASVDNPHVCRLLGICLTS-TVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAK 138
Query: 226 GMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVAR-VQAQSGVMTAETGTY--RWMAP 282
           GMNYL    ++HRDL   N+L+     VK+ DFG+A+ + A+     AE G    +WMA 
Sbjct: 139 GMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMAL 198
Query: 283 EVIEHKPYDYKADVFSFGIALWELLT-GELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPR 341
           E I H+ Y +++DV+S+G+ +WEL+T G  PY G+ P      +++K  R   P      
Sbjct: 199 ESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGI-PASEISSILEKGERLPQPPICTID 257
Query: 342 LAELLERCWQHDPTQRPNFSQITDILKQMMKE 373
           +  ++ +CW  D   RP F ++     +M ++
Sbjct: 258 VYMIMRKCWMIDADSRPKFRELIIEFSKMARD 289

>pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327

Iteration: 1
 Score =  133 bits (335), Expect = 2e-31,   Method: Compositional matrix adjust.
 Identities = 82/272 (30%), Positives = 144/272 (52%), Gaps = 16/272 (5%)
Query: 112 EIDAKQLKIECKVASGSYGDLYKGTYCSQ------EVAIKVLKPECVNTEMLKEFSQEVY 165
           E + K++K+   + SG++G +YKG +  +       VAIK L+ E  + +  KE   E Y
Sbjct: 14  ETEFKKIKV---LGSGAFGTVYKGLWIPEGEKVKIPVAIKELR-EATSPKANKEILDEAY 69
Query: 166 IMRKIRHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSK 225
           +M  + + +V + +G C     + ++T+ M  G + D++ + K       LL   + ++K
Sbjct: 70  VMASVDNPHVCRLLGICLTS-TVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAK 128
Query: 226 GMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVAR-VQAQSGVMTAETGTY--RWMAP 282
           GMNYL    ++HRDL   N+L+     VK+ DFG+A+ + A+     AE G    +WMA 
Sbjct: 129 GMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMAL 188
Query: 283 EVIEHKPYDYKADVFSFGIALWELLT-GELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPR 341
           E I H+ Y +++DV+S+G+ +WEL+T G  PY G+ P      +++K  R   P      
Sbjct: 189 ESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGI-PASEISSILEKGERLPQPPICTID 247
Query: 342 LAELLERCWQHDPTQRPNFSQITDILKQMMKE 373
           +  ++ +CW  D   RP F ++     +M ++
Sbjct: 248 VYMIMRKCWMIDADSRPKFRELIIEFSKMARD 279

>pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334

Iteration: 1
 Score =  133 bits (334), Expect = 2e-31,   Method: Compositional matrix adjust.
 Identities = 82/272 (30%), Positives = 145/272 (53%), Gaps = 16/272 (5%)
Query: 112 EIDAKQLKIECKVASGSYGDLYKGTYCSQ------EVAIKVLKPECVNTEMLKEFSQEVY 165
           E + K++K+   ++SG++G +YKG +  +       VAIK L+ E  + +  KE   E Y
Sbjct: 21  ETEFKKIKV---LSSGAFGTVYKGLWIPEGEKVKIPVAIKELR-EATSPKANKEILDEAY 76
Query: 166 IMRKIRHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSK 225
           +M  + + +V + +G C     + ++T+ M  G + D++ + K       LL   + ++K
Sbjct: 77  VMASVDNPHVCRLLGICLTS-TVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAK 135
Query: 226 GMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVAR-VQAQSGVMTAETGTY--RWMAP 282
           GMNYL    ++HRDL   N+L+     VK+ DFG+A+ + A+     AE G    +WMA 
Sbjct: 136 GMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMAL 195
Query: 283 EVIEHKPYDYKADVFSFGIALWELLT-GELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPR 341
           E I H+ Y +++DV+S+G+ +WEL+T G  PY G+ P      +++K  R   P      
Sbjct: 196 ESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGI-PASEISSILEKGERLPQPPICTID 254
Query: 342 LAELLERCWQHDPTQRPNFSQITDILKQMMKE 373
           +  ++ +CW  D   RP F ++     +M ++
Sbjct: 255 VYMIMVKCWMIDADSRPKFRELIIEFSKMARD 286

>pdb|1JQH|A Chain A, Igf-1 Receptor Kinase Domain Length = 308

Iteration: 1
 Score =  133 bits (334), Expect = 2e-31,   Method: Compositional matrix adjust.
 Identities = 81/289 (28%), Positives = 145/289 (50%), Gaps = 32/289 (11%)
Query: 109 DVWEIDAKQLKIECKVASGSYGDLYKGTY-------CSQEVAIKVLKPECVNTEMLKEFS 161
           D WE+  +++ +  ++  GS+G +Y+G             VAIK +       E + EF 
Sbjct: 12  DEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERI-EFL 70
Query: 162 QEVYIMRKIRHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQ--------- 212
            E  +M++    +VV+ +G  ++     ++ E M RG +  +L   +   +         
Sbjct: 71  NEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPS 130
Query: 213 LTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVAR--------VQ 264
           L+ ++++A +++ GM YL+ N  +HRDL   N ++ E+  VK+ DFG+ R         +
Sbjct: 131 LSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRK 190
Query: 265 AQSGVMTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLT-GELPYAGLTPLQAAV 323
              G++       RWM+PE ++   +   +DV+SFG+ LWE+ T  E PY GL+  Q   
Sbjct: 191 GGKGLLPV-----RWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLR 245
Query: 324 GVVQKSLRPTIPKHAHPRLAELLERCWQHDPTQRPNFSQITDILKQMMK 372
            V++  L    P +    L EL+  CWQ++P  RP+F +I   +K+ M+
Sbjct: 246 FVMEGGLLDK-PDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEME 293

>pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex With An Hydantoin Inhibitor Length = 305

Iteration: 1
 Score =  133 bits (334), Expect = 2e-31,   Method: Compositional matrix adjust.
 Identities = 81/289 (28%), Positives = 145/289 (50%), Gaps = 32/289 (11%)
Query: 109 DVWEIDAKQLKIECKVASGSYGDLYKGTY-------CSQEVAIKVLKPECVNTEMLKEFS 161
           D WE+  +++ +  ++  GS+G +Y+G             VAIK +       E + EF 
Sbjct: 9   DEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERI-EFL 67
Query: 162 QEVYIMRKIRHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQ--------- 212
            E  +M++    +VV+ +G  ++     ++ E M RG +  +L   +   +         
Sbjct: 68  NEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPS 127
Query: 213 LTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVAR--------VQ 264
           L+ ++++A +++ GM YL+ N  +HRDL   N ++ E+  VK+ DFG+ R         +
Sbjct: 128 LSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRK 187
Query: 265 AQSGVMTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLT-GELPYAGLTPLQAAV 323
              G++       RWM+PE ++   +   +DV+SFG+ LWE+ T  E PY GL+  Q   
Sbjct: 188 GGKGLLPV-----RWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLR 242
Query: 324 GVVQKSLRPTIPKHAHPRLAELLERCWQHDPTQRPNFSQITDILKQMMK 372
            V++  L    P +    L EL+  CWQ++P  RP+F +I   +K+ M+
Sbjct: 243 FVMEGGLLDK-PDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEME 290

>pdb|2OJ9|A Chain A, Structure Of Igf-1r Kinase Domain Complexed With A Benzimidazole Inhibitor Length = 307

Iteration: 1
 Score =  133 bits (334), Expect = 2e-31,   Method: Compositional matrix adjust.
 Identities = 81/289 (28%), Positives = 145/289 (50%), Gaps = 32/289 (11%)
Query: 109 DVWEIDAKQLKIECKVASGSYGDLYKGTY-------CSQEVAIKVLKPECVNTEMLKEFS 161
           D WE+  +++ +  ++  GS+G +Y+G             VAIK +       E + EF 
Sbjct: 11  DEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERI-EFL 69
Query: 162 QEVYIMRKIRHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQ--------- 212
            E  +M++    +VV+ +G  ++     ++ E M RG +  +L   +   +         
Sbjct: 70  NEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPS 129
Query: 213 LTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVAR--------VQ 264
           L+ ++++A +++ GM YL+ N  +HRDL   N ++ E+  VK+ DFG+ R         +
Sbjct: 130 LSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRK 189
Query: 265 AQSGVMTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLT-GELPYAGLTPLQAAV 323
              G++       RWM+PE ++   +   +DV+SFG+ LWE+ T  E PY GL+  Q   
Sbjct: 190 GGKGLLPV-----RWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLR 244
Query: 324 GVVQKSLRPTIPKHAHPRLAELLERCWQHDPTQRPNFSQITDILKQMMK 372
            V++  L    P +    L EL+  CWQ++P  RP+F +I   +K+ M+
Sbjct: 245 FVMEGGLLDK-PDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEME 292

>pdb|3QQU|A Chain A, Cocrystal Structure Of Unphosphorylated Igf With Pyrimidine 8 Length = 301

Iteration: 1
 Score =  133 bits (334), Expect = 2e-31,   Method: Compositional matrix adjust.
 Identities = 81/289 (28%), Positives = 145/289 (50%), Gaps = 32/289 (11%)
Query: 109 DVWEIDAKQLKIECKVASGSYGDLYKGTY-------CSQEVAIKVLKPECVNTEMLKEFS 161
           D WE+  +++ +  ++  GS+G +Y+G             VAIK +       E + EF 
Sbjct: 5   DEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERI-EFL 63
Query: 162 QEVYIMRKIRHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQ--------- 212
            E  +M++    +VV+ +G  ++     ++ E M RG +  +L   +   +         
Sbjct: 64  NEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPS 123
Query: 213 LTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVAR--------VQ 264
           L+ ++++A +++ GM YL+ N  +HRDL   N ++ E+  VK+ DFG+ R         +
Sbjct: 124 LSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRK 183
Query: 265 AQSGVMTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLT-GELPYAGLTPLQAAV 323
              G++       RWM+PE ++   +   +DV+SFG+ LWE+ T  E PY GL+  Q   
Sbjct: 184 GGKGLLPV-----RWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLR 238
Query: 324 GVVQKSLRPTIPKHAHPRLAELLERCWQHDPTQRPNFSQITDILKQMMK 372
            V++  L    P +    L EL+  CWQ++P  RP+F +I   +K+ M+
Sbjct: 239 FVMEGGLLDK-PDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEME 286

>pdb|3I81|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor (Igf-1r-Wt) Complex With Bms-754807 [1-(4-((5-Cyclopropyl- 1h-Pyrazol-3-Yl)amino)pyrrolo[2,1-F][1,2, 4]triazin-2-Yl)-N- (6-Fluoro-3-Pyridinyl)-2-Methyl-L-Prolinamide] Length = 315

Iteration: 1
 Score =  133 bits (334), Expect = 2e-31,   Method: Compositional matrix adjust.
 Identities = 81/289 (28%), Positives = 145/289 (50%), Gaps = 32/289 (11%)
Query: 109 DVWEIDAKQLKIECKVASGSYGDLYKGTY-------CSQEVAIKVLKPECVNTEMLKEFS 161
           D WE+  +++ +  ++  GS+G +Y+G             VAIK +       E + EF 
Sbjct: 11  DEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERI-EFL 69
Query: 162 QEVYIMRKIRHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQ--------- 212
            E  +M++    +VV+ +G  ++     ++ E M RG +  +L   +   +         
Sbjct: 70  NEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPS 129
Query: 213 LTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVAR--------VQ 264
           L+ ++++A +++ GM YL+ N  +HRDL   N ++ E+  VK+ DFG+ R         +
Sbjct: 130 LSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRK 189
Query: 265 AQSGVMTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLT-GELPYAGLTPLQAAV 323
              G++       RWM+PE ++   +   +DV+SFG+ LWE+ T  E PY GL+  Q   
Sbjct: 190 GGKGLLPV-----RWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLR 244
Query: 324 GVVQKSLRPTIPKHAHPRLAELLERCWQHDPTQRPNFSQITDILKQMMK 372
            V++  L    P +    L EL+  CWQ++P  RP+F +I   +K+ M+
Sbjct: 245 FVMEGGLLDK-PDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEME 292

>pdb|3LVP|A Chain A, Crystal Structure Of Bisphosphorylated Igf1-R Kinase Domain (2p) In Complex With A Bis-Azaindole Inhibitor Length = 336

Iteration: 1
 Score =  133 bits (334), Expect = 2e-31,   Method: Compositional matrix adjust.
 Identities = 81/289 (28%), Positives = 145/289 (50%), Gaps = 32/289 (11%)
Query: 109 DVWEIDAKQLKIECKVASGSYGDLYKGTY-------CSQEVAIKVLKPECVNTEMLKEFS 161
           D WE+  +++ +  ++  GS+G +Y+G             VAIK +       E + EF 
Sbjct: 40  DEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERI-EFL 98
Query: 162 QEVYIMRKIRHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQ--------- 212
            E  +M++    +VV+ +G  ++     ++ E M RG +  +L   +   +         
Sbjct: 99  NEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPS 158
Query: 213 LTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVAR--------VQ 264
           L+ ++++A +++ GM YL+ N  +HRDL   N ++ E+  VK+ DFG+ R         +
Sbjct: 159 LSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRK 218
Query: 265 AQSGVMTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLT-GELPYAGLTPLQAAV 323
              G++       RWM+PE ++   +   +DV+SFG+ LWE+ T  E PY GL+  Q   
Sbjct: 219 GGKGLLPV-----RWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLR 273
Query: 324 GVVQKSLRPTIPKHAHPRLAELLERCWQHDPTQRPNFSQITDILKQMMK 372
            V++  L    P +    L EL+  CWQ++P  RP+F +I   +K+ M+
Sbjct: 274 FVMEGGLLDK-PDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEME 321

>pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327

Iteration: 1
 Score =  132 bits (333), Expect = 2e-31,   Method: Compositional matrix adjust.
 Identities = 82/272 (30%), Positives = 145/272 (53%), Gaps = 16/272 (5%)
Query: 112 EIDAKQLKIECKVASGSYGDLYKGTYCSQ------EVAIKVLKPECVNTEMLKEFSQEVY 165
           E + K++K+   ++SG++G +YKG +  +       VAIK L+ E  + +  KE   E Y
Sbjct: 14  ETEFKKIKV---LSSGAFGTVYKGLWIPEGEKVKIPVAIKELR-EATSPKANKEILDEAY 69
Query: 166 IMRKIRHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSK 225
           +M  + + +V + +G C     + ++T+ M  G + D++ + K       LL   + ++K
Sbjct: 70  VMASVDNPHVCRLLGICLTS-TVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAK 128
Query: 226 GMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVAR-VQAQSGVMTAETGTY--RWMAP 282
           GMNYL    ++HRDL   N+L+     VK+ DFG+A+ + A+     AE G    +WMA 
Sbjct: 129 GMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMAL 188
Query: 283 EVIEHKPYDYKADVFSFGIALWELLT-GELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPR 341
           E I H+ Y +++DV+S+G+ +WEL+T G  PY G+ P      +++K  R   P      
Sbjct: 189 ESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGI-PASEISSILEKGERLPQPPICTID 247
Query: 342 LAELLERCWQHDPTQRPNFSQITDILKQMMKE 373
           +  ++ +CW  D   RP F ++     +M ++
Sbjct: 248 VYMIMVKCWMIDADSRPKFRELIIEFSKMARD 279

>pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a Resolution. Length = 322

Iteration: 1
 Score =  132 bits (333), Expect = 3e-31,   Method: Compositional matrix adjust.
 Identities = 81/289 (28%), Positives = 144/289 (49%), Gaps = 32/289 (11%)
Query: 109 DVWEIDAKQLKIECKVASGSYGDLYKGTY-------CSQEVAIKVLKPECVNTEMLKEFS 161
           D WE+  +++ +  ++  GS+G +Y+G             VAIK +  E  +     EF 
Sbjct: 18  DEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVN-EAASMRERIEFL 76
Query: 162 QEVYIMRKIRHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVF---------Q 212
            E  +M++    +VV+ +G  ++     ++ E M RG +  +L   +             
Sbjct: 77  NEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPS 136
Query: 213 LTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVAR--------VQ 264
           L+ ++++A +++ GM YL+ N  +HRDL   N ++ E+  VK+ DFG+ R         +
Sbjct: 137 LSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRK 196
Query: 265 AQSGVMTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLT-GELPYAGLTPLQAAV 323
              G++       RWM+PE ++   +   +DV+SFG+ LWE+ T  E PY GL+  Q   
Sbjct: 197 GGKGLLPV-----RWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLR 251
Query: 324 GVVQKSLRPTIPKHAHPRLAELLERCWQHDPTQRPNFSQITDILKQMMK 372
            V++  L    P +    L EL+  CWQ++P  RP+F +I   +K+ M+
Sbjct: 252 FVMEGGLLDK-PDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEME 299

>pdb|3LW0|A Chain A, Igf-1rk In Complex With Ligand Msc1609119a-1 Length = 304

Iteration: 1
 Score =  132 bits (333), Expect = 3e-31,   Method: Compositional matrix adjust.
 Identities = 81/289 (28%), Positives = 144/289 (49%), Gaps = 32/289 (11%)
Query: 109 DVWEIDAKQLKIECKVASGSYGDLYKGTY-------CSQEVAIKVLKPECVNTEMLKEFS 161
           D WE+  +++ +  ++  GS+G +Y+G             VAIK +       E + EF 
Sbjct: 8   DEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERI-EFL 66
Query: 162 QEVYIMRKIRHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVF---------Q 212
            E  +M++    +VV+ +G  ++     ++ E M RG +  +L   +             
Sbjct: 67  NEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPS 126
Query: 213 LTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVAR--------VQ 264
           L+ ++++A +++ GM YL+ N  +HRDL   N ++ E+  VK+ DFG+ R         +
Sbjct: 127 LSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRK 186
Query: 265 AQSGVMTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLT-GELPYAGLTPLQAAV 323
              G++       RWM+PE ++   +   +DV+SFG+ LWE+ T  E PY GL+  Q   
Sbjct: 187 GGKGLLPV-----RWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLR 241
Query: 324 GVVQKSLRPTIPKHAHPRLAELLERCWQHDPTQRPNFSQITDILKQMMK 372
            V++  L    P +    L EL+  CWQ++P  RP+F +I   +K+ M+
Sbjct: 242 FVMEGGLLDK-PDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEME 289

>pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329

Iteration: 1
 Score =  132 bits (333), Expect = 3e-31,   Method: Compositional matrix adjust.
 Identities = 82/272 (30%), Positives = 144/272 (52%), Gaps = 16/272 (5%)
Query: 112 EIDAKQLKIECKVASGSYGDLYKGTYCSQ------EVAIKVLKPECVNTEMLKEFSQEVY 165
           E + K++K+   + SG++G +YKG +  +       VAIK L+ E  + +  KE   E Y
Sbjct: 16  ETEFKKIKV---LGSGAFGTVYKGLWIPEGEKVKIPVAIKELR-EATSPKANKEILDEAY 71
Query: 166 IMRKIRHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSK 225
           +M  + + +V + +G C     + ++T+ M  G + D++ + K       LL   + ++K
Sbjct: 72  VMASVDNPHVCRLLGICLTS-TVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAK 130
Query: 226 GMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVAR-VQAQSGVMTAETGTY--RWMAP 282
           GMNYL    ++HRDL   N+L+     VK+ DFG+A+ + A+     AE G    +WMA 
Sbjct: 131 GMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMAL 190
Query: 283 EVIEHKPYDYKADVFSFGIALWELLT-GELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPR 341
           E I H+ Y +++DV+S+G+ +WEL+T G  PY G+ P      +++K  R   P      
Sbjct: 191 ESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGI-PASEISSILEKGERLPQPPICTID 249
Query: 342 LAELLERCWQHDPTQRPNFSQITDILKQMMKE 373
           +  ++ +CW  D   RP F ++     +M ++
Sbjct: 250 VYMIMVKCWMIDADSRPKFRELIIEFSKMARD 281

>pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334

Iteration: 1
 Score =  132 bits (333), Expect = 3e-31,   Method: Compositional matrix adjust.
 Identities = 82/272 (30%), Positives = 144/272 (52%), Gaps = 16/272 (5%)
Query: 112 EIDAKQLKIECKVASGSYGDLYKGTYCSQ------EVAIKVLKPECVNTEMLKEFSQEVY 165
           E + K++K+   + SG++G +YKG +  +       VAIK L+ E  + +  KE   E Y
Sbjct: 21  ETEFKKIKV---LGSGAFGTVYKGLWIPEGEKVKIPVAIKELR-EATSPKANKEILDEAY 76
Query: 166 IMRKIRHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSK 225
           +M  + + +V + +G C     + ++T+ M  G + D++ + K       LL   + ++K
Sbjct: 77  VMASVDNPHVCRLLGICLTS-TVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAK 135
Query: 226 GMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVAR-VQAQSGVMTAETGTY--RWMAP 282
           GMNYL    ++HRDL   N+L+     VK+ DFG+A+ + A+     AE G    +WMA 
Sbjct: 136 GMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMAL 195
Query: 283 EVIEHKPYDYKADVFSFGIALWELLT-GELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPR 341
           E I H+ Y +++DV+S+G+ +WEL+T G  PY G+ P      +++K  R   P      
Sbjct: 196 ESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGI-PASEISSILEKGERLPQPPICTID 254
Query: 342 LAELLERCWQHDPTQRPNFSQITDILKQMMKE 373
           +  ++ +CW  D   RP F ++     +M ++
Sbjct: 255 VYMIMVKCWMIDADSRPKFRELIIEFSKMARD 286

>pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth Factor-1 Receptor Kinase Domain Length = 322

Iteration: 1
 Score =  132 bits (333), Expect = 3e-31,   Method: Compositional matrix adjust.
 Identities = 81/289 (28%), Positives = 145/289 (50%), Gaps = 32/289 (11%)
Query: 109 DVWEIDAKQLKIECKVASGSYGDLYKGTY-------CSQEVAIKVLKPECVNTEMLKEFS 161
           D WE+  +++ +  ++  GS+G +Y+G             VAIK +  E  +     EF 
Sbjct: 18  DEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVN-EAASMRERIEFL 76
Query: 162 QEVYIMRKIRHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQ--------- 212
            E  +M++    +VV+ +G  ++     ++ E M RG +  +L   +   +         
Sbjct: 77  NEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPS 136
Query: 213 LTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVAR--------VQ 264
           L+ ++++A +++ GM YL+ N  +HRDL   N ++ E+  VK+ DFG+ R         +
Sbjct: 137 LSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRK 196
Query: 265 AQSGVMTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLT-GELPYAGLTPLQAAV 323
              G++       RWM+PE ++   +   +DV+SFG+ LWE+ T  E PY GL+  Q   
Sbjct: 197 GGKGLLPV-----RWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLR 251
Query: 324 GVVQKSLRPTIPKHAHPRLAELLERCWQHDPTQRPNFSQITDILKQMMK 372
            V++  L    P +    L EL+  CWQ++P  RP+F +I   +K+ M+
Sbjct: 252 FVMEGGLLDK-PDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEME 299

>pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327

Iteration: 1
 Score =  132 bits (333), Expect = 3e-31,   Method: Compositional matrix adjust.
 Identities = 82/272 (30%), Positives = 144/272 (52%), Gaps = 16/272 (5%)
Query: 112 EIDAKQLKIECKVASGSYGDLYKGTYCSQ------EVAIKVLKPECVNTEMLKEFSQEVY 165
           E + K++K+   + SG++G +YKG +  +       VAIK L+ E  + +  KE   E Y
Sbjct: 14  ETEFKKIKV---LGSGAFGTVYKGLWIPEGEKVKIPVAIKELR-EATSPKANKEILDEAY 69
Query: 166 IMRKIRHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSK 225
           +M  + + +V + +G C     + ++T+ M  G + D++ + K       LL   + ++K
Sbjct: 70  VMASVDNPHVCRLLGICLTS-TVQLITQLMPFGXLLDYVREHKDNIGSQYLLNWCVQIAK 128
Query: 226 GMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVAR-VQAQSGVMTAETGTY--RWMAP 282
           GMNYL    ++HRDL   N+L+     VK+ DFG+A+ + A+     AE G    +WMA 
Sbjct: 129 GMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMAL 188
Query: 283 EVIEHKPYDYKADVFSFGIALWELLT-GELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPR 341
           E I H+ Y +++DV+S+G+ +WEL+T G  PY G+ P      +++K  R   P      
Sbjct: 189 ESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGI-PASEISSILEKGERLPQPPICTID 247
Query: 342 LAELLERCWQHDPTQRPNFSQITDILKQMMKE 373
           +  ++ +CW  D   RP F ++     +M ++
Sbjct: 248 VYMIMVKCWMIDADSRPKFRELIIEFSKMARD 279

>pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333

Iteration: 1
 Score =  132 bits (333), Expect = 3e-31,   Method: Compositional matrix adjust.
 Identities = 82/272 (30%), Positives = 144/272 (52%), Gaps = 16/272 (5%)
Query: 112 EIDAKQLKIECKVASGSYGDLYKGTYCSQ------EVAIKVLKPECVNTEMLKEFSQEVY 165
           E + K++K+   + SG++G +YKG +  +       VAIK L+ E  + +  KE   E Y
Sbjct: 20  ETEFKKIKV---LGSGAFGTVYKGLWIPEGEKVKIPVAIKELR-EATSPKANKEILDEAY 75
Query: 166 IMRKIRHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSK 225
           +M  + + +V + +G C     + ++T+ M  G + D++ + K       LL   + ++K
Sbjct: 76  VMASVDNPHVCRLLGICLTS-TVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAK 134
Query: 226 GMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVAR-VQAQSGVMTAETGTY--RWMAP 282
           GMNYL    ++HRDL   N+L+     VK+ DFG+A+ + A+     AE G    +WMA 
Sbjct: 135 GMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMAL 194
Query: 283 EVIEHKPYDYKADVFSFGIALWELLT-GELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPR 341
           E I H+ Y +++DV+S+G+ +WEL+T G  PY G+ P      +++K  R   P      
Sbjct: 195 ESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGI-PASEISSILEKGERLPQPPICTID 253
Query: 342 LAELLERCWQHDPTQRPNFSQITDILKQMMKE 373
           +  ++ +CW  D   RP F ++     +M ++
Sbjct: 254 VYMIMVKCWMIDADSRPKFRELIIEFSKMARD 285

>pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315

Iteration: 1
 Score =  132 bits (333), Expect = 3e-31,   Method: Compositional matrix adjust.
 Identities = 82/272 (30%), Positives = 144/272 (52%), Gaps = 16/272 (5%)
Query: 112 EIDAKQLKIECKVASGSYGDLYKGTYCSQ------EVAIKVLKPECVNTEMLKEFSQEVY 165
           E + K++K+   + SG++G +YKG +  +       VAIK L+ E  + +  KE   E Y
Sbjct: 8   ETEFKKIKV---LGSGAFGTVYKGLWIPEGEKVKIPVAIKELR-EATSPKANKEILDEAY 63
Query: 166 IMRKIRHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSK 225
           +M  + + +V + +G C     + ++T+ M  G + D++ + K       LL   + ++K
Sbjct: 64  VMASVDNPHVCRLLGICLTS-TVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAK 122
Query: 226 GMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVAR-VQAQSGVMTAETGTY--RWMAP 282
           GMNYL    ++HRDL   N+L+     VK+ DFG+A+ + A+     AE G    +WMA 
Sbjct: 123 GMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMAL 182
Query: 283 EVIEHKPYDYKADVFSFGIALWELLT-GELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPR 341
           E I H+ Y +++DV+S+G+ +WEL+T G  PY G+ P      +++K  R   P      
Sbjct: 183 ESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGI-PASEISSILEKGERLPQPPICTID 241
Query: 342 LAELLERCWQHDPTQRPNFSQITDILKQMMKE 373
           +  ++ +CW  D   RP F ++     +M ++
Sbjct: 242 VYMIMVKCWMIDADSRPKFRELIIEFSKMARD 273

>pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330

Iteration: 1
 Score =  132 bits (333), Expect = 3e-31,   Method: Compositional matrix adjust.
 Identities = 82/272 (30%), Positives = 144/272 (52%), Gaps = 16/272 (5%)
Query: 112 EIDAKQLKIECKVASGSYGDLYKGTYCSQ------EVAIKVLKPECVNTEMLKEFSQEVY 165
           E + K++K+   + SG++G +YKG +  +       VAIK L+ E  + +  KE   E Y
Sbjct: 17  ETEFKKIKV---LGSGAFGTVYKGLWIPEGEKVKIPVAIKELR-EATSPKANKEILDEAY 72
Query: 166 IMRKIRHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSK 225
           +M  + + +V + +G C     + ++T+ M  G + D++ + K       LL   + ++K
Sbjct: 73  VMASVDNPHVCRLLGICLTS-TVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAK 131
Query: 226 GMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVAR-VQAQSGVMTAETGTY--RWMAP 282
           GMNYL    ++HRDL   N+L+     VK+ DFG+A+ + A+     AE G    +WMA 
Sbjct: 132 GMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMAL 191
Query: 283 EVIEHKPYDYKADVFSFGIALWELLT-GELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPR 341
           E I H+ Y +++DV+S+G+ +WEL+T G  PY G+ P      +++K  R   P      
Sbjct: 192 ESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGI-PASEISSILEKGERLPQPPICTID 250
Query: 342 LAELLERCWQHDPTQRPNFSQITDILKQMMKE 373
           +  ++ +CW  D   RP F ++     +M ++
Sbjct: 251 VYMIMVKCWMIDADSRPKFRELIIEFSKMARD 282

>pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330

Iteration: 1
 Score =  132 bits (333), Expect = 3e-31,   Method: Compositional matrix adjust.
 Identities = 82/272 (30%), Positives = 144/272 (52%), Gaps = 16/272 (5%)
Query: 112 EIDAKQLKIECKVASGSYGDLYKGTYCSQ------EVAIKVLKPECVNTEMLKEFSQEVY 165
           E + K++K+   + SG++G +YKG +  +       VAIK L+ E  + +  KE   E Y
Sbjct: 17  ETEFKKIKV---LGSGAFGTVYKGLWIPEGEKVKIPVAIKELR-EATSPKANKEILDEAY 72
Query: 166 IMRKIRHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSK 225
           +M  + + +V + +G C     + ++T+ M  G + D++ + K       LL   + ++K
Sbjct: 73  VMASVDNPHVCRLLGICLTS-TVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAK 131
Query: 226 GMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVAR-VQAQSGVMTAETGTY--RWMAP 282
           GMNYL    ++HRDL   N+L+     VK+ DFG+A+ + A+     AE G    +WMA 
Sbjct: 132 GMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMAL 191
Query: 283 EVIEHKPYDYKADVFSFGIALWELLT-GELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPR 341
           E I H+ Y +++DV+S+G+ +WEL+T G  PY G+ P      +++K  R   P      
Sbjct: 192 ESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGI-PASEISSILEKGERLPQPPICTID 250
Query: 342 LAELLERCWQHDPTQRPNFSQITDILKQMMKE 373
           +  ++ +CW  D   RP F ++     +M ++
Sbjct: 251 VYMIMVKCWMIDADSRPKFRELIIEFSKMARD 282

>pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329

Iteration: 1
 Score =  132 bits (332), Expect = 3e-31,   Method: Compositional matrix adjust.
 Identities = 82/272 (30%), Positives = 143/272 (52%), Gaps = 16/272 (5%)
Query: 112 EIDAKQLKIECKVASGSYGDLYKGTYCSQ------EVAIKVLKPECVNTEMLKEFSQEVY 165
           E + K++K+   + SG++G +YKG +  +       VAIK L+ E  + +  KE   E Y
Sbjct: 16  ETEFKKIKV---LGSGAFGTVYKGLWIPEGEKVKIPVAIKELR-EATSPKANKEILDEAY 71
Query: 166 IMRKIRHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSK 225
           +M  + + +V + +G C     + ++T+ M  G + D++ + K       LL   + ++K
Sbjct: 72  VMASVDNPHVCRLLGICLTS-TVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAK 130
Query: 226 GMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVAR-VQAQSGVMTAETGTY--RWMAP 282
           GMNYL    ++HRDL   N+L+     VK+ DFG A+ + A+     AE G    +WMA 
Sbjct: 131 GMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGKVPIKWMAL 190
Query: 283 EVIEHKPYDYKADVFSFGIALWELLT-GELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPR 341
           E I H+ Y +++DV+S+G+ +WEL+T G  PY G+ P      +++K  R   P      
Sbjct: 191 ESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGI-PASEISSILEKGERLPQPPICTID 249
Query: 342 LAELLERCWQHDPTQRPNFSQITDILKQMMKE 373
           +  ++ +CW  D   RP F ++     +M ++
Sbjct: 250 VYMIMRKCWMIDADSRPKFRELIIEFSKMARD 281

>pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327

Iteration: 1
 Score =  132 bits (332), Expect = 3e-31,   Method: Compositional matrix adjust.
 Identities = 82/272 (30%), Positives = 144/272 (52%), Gaps = 16/272 (5%)
Query: 112 EIDAKQLKIECKVASGSYGDLYKGTYCSQ------EVAIKVLKPECVNTEMLKEFSQEVY 165
           E + K++K+   + SG++G +YKG +  +       VAIK L+ E  + +  KE   E Y
Sbjct: 14  ETEFKKIKV---LGSGAFGTVYKGLWIPEGEKVKIPVAIKELR-EATSPKANKEILDEAY 69
Query: 166 IMRKIRHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSK 225
           +M  + + +V + +G C     + ++T+ M  G + D++ + K       LL   + ++K
Sbjct: 70  VMASVDNPHVCRLLGICLTS-TVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAK 128
Query: 226 GMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVAR-VQAQSGVMTAETGTY--RWMAP 282
           GMNYL    ++HRDL   N+L+     VK+ DFG+A+ + A+     AE G    +WMA 
Sbjct: 129 GMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMAL 188
Query: 283 EVIEHKPYDYKADVFSFGIALWELLT-GELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPR 341
           E I H+ Y +++DV+S+G+ +WEL+T G  PY G+ P      +++K  R   P      
Sbjct: 189 ESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGI-PASEISSILEKGERLPQPPICTID 247
Query: 342 LAELLERCWQHDPTQRPNFSQITDILKQMMKE 373
           +  ++ +CW  D   RP F ++     +M ++
Sbjct: 248 VYMIMVKCWMIDADSRPKFRELIIEFSKMARD 279

>pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352

Iteration: 1
 Score =  132 bits (332), Expect = 3e-31,   Method: Compositional matrix adjust.
 Identities = 82/272 (30%), Positives = 144/272 (52%), Gaps = 16/272 (5%)
Query: 112 EIDAKQLKIECKVASGSYGDLYKGTYCSQ------EVAIKVLKPECVNTEMLKEFSQEVY 165
           E + K++K+   + SG++G +YKG +  +       VAIK L+ E  + +  KE   E Y
Sbjct: 39  ETEFKKIKV---LGSGAFGTVYKGLWIPEGEKVKIPVAIKELR-EATSPKANKEILDEAY 94
Query: 166 IMRKIRHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSK 225
           +M  + + +V + +G C     + ++T+ M  G + D++ + K       LL   + ++K
Sbjct: 95  VMASVDNPHVCRLLGICLTS-TVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAK 153
Query: 226 GMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVAR-VQAQSGVMTAETGTY--RWMAP 282
           GMNYL    ++HRDL   N+L+     VK+ DFG+A+ + A+     AE G    +WMA 
Sbjct: 154 GMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMAL 213
Query: 283 EVIEHKPYDYKADVFSFGIALWELLT-GELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPR 341
           E I H+ Y +++DV+S+G+ +WEL+T G  PY G+ P      +++K  R   P      
Sbjct: 214 ESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGI-PASEISSILEKGERLPQPPICTID 272
Query: 342 LAELLERCWQHDPTQRPNFSQITDILKQMMKE 373
           +  ++ +CW  D   RP F ++     +M ++
Sbjct: 273 VYMIMVKCWMIDADSRPKFRELIIEFSKMARD 304

>pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314

Iteration: 1
 Score =  132 bits (331), Expect = 5e-31,   Method: Compositional matrix adjust.
 Identities = 81/295 (27%), Positives = 148/295 (50%), Gaps = 36/295 (12%)
Query: 111 WEIDAKQLKIECKVASGSYGDLYKGTYCSQE-------VAIKVLKPECVNTEMLKEFSQE 163
           WE   K L +   +  G +G + K T    +       VA+K+LK     +E L++   E
Sbjct: 18  WEFPRKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSE-LRDLLSE 76
Query: 164 VYIMRKIRHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGV------------- 210
             +++++ H +V++  GAC++   L ++ E+   GS+  FL + + V             
Sbjct: 77  FNVLKQVNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNS 136
Query: 211 ----------FQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGV 260
                       +  L+  A  +S+GM YL + +++HRDL   N+L+ E   +K++DFG+
Sbjct: 137 SSLDHPDERALTMGDLISFAWQISQGMQYLAEMSLVHRDLAARNILVAEGRKMKISDFGL 196
Query: 261 AR-VQAQSGVMTAETGT--YRWMAPEVIEHKPYDYKADVFSFGIALWELLT-GELPYAGL 316
           +R V  +   +    G    +WMA E +    Y  ++DV+SFG+ LWE++T G  PY G+
Sbjct: 197 SRDVYEEDSXVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGI 256
Query: 317 TPLQAAVGVVQKSLRPTIPKHAHPRLAELLERCWQHDPTQRPNFSQITDILKQMM 371
            P +    +++   R   P +    +  L+ +CW+ +P +RP F+ I+  L++MM
Sbjct: 257 PP-ERLFNLLKTGHRMERPDNCSEEMYRLMLQCWKQEPDKRPVFADISKDLEKMM 310

>pdb|3D94|A Chain A, Crystal Structure Of The Insulin-Like Growth Factor-1 Receptor Kinase In Complex With Pqip Length = 301

Iteration: 1
 Score =  132 bits (331), Expect = 5e-31,   Method: Compositional matrix adjust.
 Identities = 81/289 (28%), Positives = 144/289 (49%), Gaps = 32/289 (11%)
Query: 109 DVWEIDAKQLKIECKVASGSYGDLYKGTY-------CSQEVAIKVLKPECVNTEMLKEFS 161
           D WE+  +++ +  ++  GS+G +Y+G             VAIK +       E + EF 
Sbjct: 5   DEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERI-EFL 63
Query: 162 QEVYIMRKIRHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQ--------- 212
            E  +M++    +VV+ +G  ++     ++ E M RG +  +L   +   +         
Sbjct: 64  NEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPS 123
Query: 213 LTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVAR--------VQ 264
           L+ ++++A +++ GM YL+ N  +HRDL   N  + E+  VK+ DFG+ R         +
Sbjct: 124 LSKMIQMAGEIADGMAYLNANKFVHRDLAARNCXVAEDFTVKIGDFGMTRDIYETDYYRK 183
Query: 265 AQSGVMTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLT-GELPYAGLTPLQAAV 323
              G++       RWM+PE ++   +   +DV+SFG+ LWE+ T  E PY GL+  Q   
Sbjct: 184 GGKGLLPV-----RWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLR 238
Query: 324 GVVQKSLRPTIPKHAHPRLAELLERCWQHDPTQRPNFSQITDILKQMMK 372
            V++  L    P +    L EL+  CWQ++P  RP+F +I   +K+ M+
Sbjct: 239 FVMEGGLLDK-PDNCPDMLLELMRMCWQYNPKMRPSFLEIISSIKEEME 286

>pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314

Iteration: 1
 Score =  131 bits (330), Expect = 6e-31,   Method: Compositional matrix adjust.
 Identities = 81/295 (27%), Positives = 147/295 (49%), Gaps = 36/295 (12%)
Query: 111 WEIDAKQLKIECKVASGSYGDLYKGTYCSQE-------VAIKVLKPECVNTEMLKEFSQE 163
           WE   K L +   +  G +G + K T    +       VA+K+LK     +E L++   E
Sbjct: 18  WEFPRKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSE-LRDLLSE 76
Query: 164 VYIMRKIRHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGV------------- 210
             +++++ H +V++  GAC++   L ++ E+   GS+  FL + + V             
Sbjct: 77  FNVLKQVNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNS 136
Query: 211 ----------FQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGV 260
                       +  L+  A  +S+GM YL +  ++HRDL   N+L+ E   +K++DFG+
Sbjct: 137 SSLDHPDERALTMGDLISFAWQISQGMQYLAEMKLVHRDLAARNILVAEGRKMKISDFGL 196
Query: 261 AR-VQAQSGVMTAETGT--YRWMAPEVIEHKPYDYKADVFSFGIALWELLT-GELPYAGL 316
           +R V  +   +    G    +WMA E +    Y  ++DV+SFG+ LWE++T G  PY G+
Sbjct: 197 SRDVYEEDSXVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGI 256
Query: 317 TPLQAAVGVVQKSLRPTIPKHAHPRLAELLERCWQHDPTQRPNFSQITDILKQMM 371
            P +    +++   R   P +    +  L+ +CW+ +P +RP F+ I+  L++MM
Sbjct: 257 PP-ERLFNLLKTGHRMERPDNCSEEMYRLMLQCWKQEPDKRPVFADISKDLEKMM 310

>pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314

Iteration: 1
 Score =  131 bits (330), Expect = 6e-31,   Method: Compositional matrix adjust.
 Identities = 81/295 (27%), Positives = 147/295 (49%), Gaps = 36/295 (12%)
Query: 111 WEIDAKQLKIECKVASGSYGDLYKGTYCSQE-------VAIKVLKPECVNTEMLKEFSQE 163
           WE   K L +   +  G +G + K T    +       VA+K+LK     +E L++   E
Sbjct: 18  WEFPRKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSE-LRDLLSE 76
Query: 164 VYIMRKIRHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGV------------- 210
             +++++ H +V++  GAC++   L ++ E+   GS+  FL + + V             
Sbjct: 77  FNVLKQVNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNS 136
Query: 211 ----------FQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGV 260
                       +  L+  A  +S+GM YL +  ++HRDL   N+L+ E   +K++DFG+
Sbjct: 137 SSLDHPDERALTMGDLISFAWQISQGMQYLAEMKLVHRDLAARNILVAEGRKMKISDFGL 196
Query: 261 AR-VQAQSGVMTAETGT--YRWMAPEVIEHKPYDYKADVFSFGIALWELLT-GELPYAGL 316
           +R V  +   +    G    +WMA E +    Y  ++DV+SFG+ LWE++T G  PY G+
Sbjct: 197 SRDVYEEDSYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGI 256
Query: 317 TPLQAAVGVVQKSLRPTIPKHAHPRLAELLERCWQHDPTQRPNFSQITDILKQMM 371
            P +    +++   R   P +    +  L+ +CW+ +P +RP F+ I+  L++MM
Sbjct: 257 PP-ERLFNLLKTGHRMERPDNCSEEMYRLMLQCWKQEPDKRPVFADISKDLEKMM 310

>pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In Complex With Aee788 Length = 327

Iteration: 1
 Score =  131 bits (330), Expect = 6e-31,   Method: Compositional matrix adjust.
 Identities = 82/272 (30%), Positives = 143/272 (52%), Gaps = 16/272 (5%)
Query: 112 EIDAKQLKIECKVASGSYGDLYKGTYCSQ------EVAIKVLKPECVNTEMLKEFSQEVY 165
           E + K++K+   + SG++G +YKG +  +       VAIK L+ E  + +  KE   E Y
Sbjct: 14  ETEFKKIKV---LGSGAFGTVYKGLWIPEGEKVKIPVAIKELR-EATSPKANKEILDEAY 69
Query: 166 IMRKIRHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSK 225
           +M  + + +V + +G C     + ++T+ M  G + D++ + K       LL   + ++K
Sbjct: 70  VMASVDNPHVCRLLGICLTS-TVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAK 128
Query: 226 GMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVAR-VQAQSGVMTAETGTY--RWMAP 282
           GMNYL    ++HRDL   N+L+     VK+ DFG A+ + A+     AE G    +WMA 
Sbjct: 129 GMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGKVPIKWMAL 188
Query: 283 EVIEHKPYDYKADVFSFGIALWELLT-GELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPR 341
           E I H+ Y +++DV+S+G+ +WEL+T G  PY G+ P      +++K  R   P      
Sbjct: 189 ESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGI-PASEISSILEKGERLPQPPICTID 247
Query: 342 LAELLERCWQHDPTQRPNFSQITDILKQMMKE 373
           +  ++ +CW  D   RP F ++     +M ++
Sbjct: 248 VYMIMVKCWMIDADSRPKFRELIIEFSKMARD 279

>pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In Complex With Amppnp Length = 334

Iteration: 1
 Score =  131 bits (329), Expect = 7e-31,   Method: Compositional matrix adjust.
 Identities = 82/272 (30%), Positives = 143/272 (52%), Gaps = 16/272 (5%)
Query: 112 EIDAKQLKIECKVASGSYGDLYKGTYCSQ------EVAIKVLKPECVNTEMLKEFSQEVY 165
           E + K++K+   + SG++G +YKG +  +       VAIK L+ E  + +  KE   E Y
Sbjct: 21  ETEFKKIKV---LGSGAFGTVYKGLWIPEGEKVKIPVAIKELR-EATSPKANKEILDEAY 76
Query: 166 IMRKIRHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSK 225
           +M  + + +V + +G C     + ++T+ M  G + D++ + K       LL   + ++K
Sbjct: 77  VMASVDNPHVCRLLGICLTS-TVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAK 135
Query: 226 GMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVAR-VQAQSGVMTAETGTY--RWMAP 282
           GMNYL    ++HRDL   N+L+     VK+ DFG A+ + A+     AE G    +WMA 
Sbjct: 136 GMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGKVPIKWMAL 195
Query: 283 EVIEHKPYDYKADVFSFGIALWELLT-GELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPR 341
           E I H+ Y +++DV+S+G+ +WEL+T G  PY G+ P      +++K  R   P      
Sbjct: 196 ESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGI-PASEISSILEKGERLPQPPICTID 254
Query: 342 LAELLERCWQHDPTQRPNFSQITDILKQMMKE 373
           +  ++ +CW  D   RP F ++     +M ++
Sbjct: 255 VYMIMVKCWMIDADSRPKFRELIIEFSKMARD 286

>pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317

Iteration: 1
 Score =  131 bits (329), Expect = 7e-31,   Method: Compositional matrix adjust.
 Identities = 81/284 (28%), Positives = 139/284 (48%), Gaps = 22/284 (7%)
Query: 111 WEIDAKQLKIECKVASGSYGDLYKGTYCSQ-------EVAIKVLKPECVNTEMLKEFSQE 163
           WE     L+    + +G++G + + T           +VA+K+LK    + +  +    E
Sbjct: 33  WEFPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLK-STAHADEKEALMSE 91
Query: 164 VYIMRKI-RHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGV---------FQL 213
           + IM  + +H+N+V  +GACT    + ++TE+   G + +FL ++             +L
Sbjct: 92  LKIMSHLGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKAEADLDKEDGRPLEL 151
Query: 214 TSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVAR-VQAQSGVMTA 272
             LL  +  V++GM +L   N IHRD+   N+L+    V K+ DFG+AR +   S  +  
Sbjct: 152 RDLLHFSSQVAQGMAFLASKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIVK 211
Query: 273 ETGTY--RWMAPEVIEHKPYDYKADVFSFGIALWELLT-GELPYAGLTPLQAAVGVVQKS 329
                  +WMAPE I    Y  ++DV+S+GI LWE+ + G  PY G+        +V+  
Sbjct: 212 GNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGILVNSKFYKLVKDG 271
Query: 330 LRPTIPKHAHPRLAELLERCWQHDPTQRPNFSQITDILKQMMKE 373
            +   P  A   +  +++ CW  +PT RP F QI   L++  +E
Sbjct: 272 YQMAQPAFAPKNIYSIMQACWALEPTHRPTFQQICSFLQEQAQE 315

>pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324

Iteration: 1
 Score =  130 bits (328), Expect = 9e-31,   Method: Compositional matrix adjust.
 Identities = 81/272 (29%), Positives = 144/272 (52%), Gaps = 16/272 (5%)
Query: 112 EIDAKQLKIECKVASGSYGDLYKGTYCSQ------EVAIKVLKPECVNTEMLKEFSQEVY 165
           E + K++K+   + SG++G +YKG +  +       VAIK L+ E  + +  KE   E Y
Sbjct: 11  ETEFKKIKV---LGSGAFGTVYKGLWIPEGEKVKIPVAIKELR-EATSPKANKEILDEAY 66
Query: 166 IMRKIRHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSK 225
           +M  + + +V + +G C     + ++T+ M  G + D++ + K       LL   + +++
Sbjct: 67  VMASVDNPHVCRLLGICLTS-TVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAE 125
Query: 226 GMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVAR-VQAQSGVMTAETGTY--RWMAP 282
           GMNYL    ++HRDL   N+L+     VK+ DFG+A+ + A+     AE G    +WMA 
Sbjct: 126 GMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMAL 185
Query: 283 EVIEHKPYDYKADVFSFGIALWELLT-GELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPR 341
           E I H+ Y +++DV+S+G+ +WEL+T G  PY G+ P      +++K  R   P      
Sbjct: 186 ESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGI-PASEISSILEKGERLPQPPICTID 244
Query: 342 LAELLERCWQHDPTQRPNFSQITDILKQMMKE 373
           +  ++ +CW  D   RP F ++     +M ++
Sbjct: 245 VYMIMVKCWMIDADSRPKFRELIIEFSKMARD 276

>pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334

Iteration: 1
 Score =  130 bits (328), Expect = 9e-31,   Method: Compositional matrix adjust.
 Identities = 81/272 (29%), Positives = 144/272 (52%), Gaps = 16/272 (5%)
Query: 112 EIDAKQLKIECKVASGSYGDLYKGTYCSQ------EVAIKVLKPECVNTEMLKEFSQEVY 165
           E + K++K+   ++SG++G +YKG +  +       VAIK L+ E  + +  KE   E Y
Sbjct: 21  ETEFKKIKV---LSSGAFGTVYKGLWIPEGEKVKIPVAIKELR-EATSPKANKEILDEAY 76
Query: 166 IMRKIRHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSK 225
           +M  + + +V + +G C     + ++ + M  G + D++ + K       LL   + ++K
Sbjct: 77  VMASVDNPHVCRLLGICLTS-TVQLIMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAK 135
Query: 226 GMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVAR-VQAQSGVMTAETGTY--RWMAP 282
           GMNYL    ++HRDL   N+L+     VK+ DFG+A+ + A+     AE G    +WMA 
Sbjct: 136 GMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMAL 195
Query: 283 EVIEHKPYDYKADVFSFGIALWELLT-GELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPR 341
           E I H+ Y +++DV+S+G+ +WEL+T G  PY G+ P      +++K  R   P      
Sbjct: 196 ESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGI-PASEISSILEKGERLPQPPICTID 254
Query: 342 LAELLERCWQHDPTQRPNFSQITDILKQMMKE 373
           +  ++ +CW  D   RP F ++     +M ++
Sbjct: 255 VYMIMVKCWMIDADSRPKFRELIIEFSKMARD 286

>pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329

Iteration: 1
 Score =  130 bits (328), Expect = 1e-30,   Method: Compositional matrix adjust.
 Identities = 82/288 (28%), Positives = 140/288 (48%), Gaps = 22/288 (7%)
Query: 111 WEIDAKQLKIECKVASGSYGDLYKGTYCSQ-------EVAIKVLKPECVNTEMLKEFSQE 163
           WE     L+    + +G++G + + T           +VA+K+LK    + +  +    E
Sbjct: 41  WEFPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLK-STAHADEKEALMSE 99
Query: 164 VYIMRKI-RHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGV---------FQL 213
           + IM  + +H+N+V  +GACT    + ++TE+   G + +FL ++             +L
Sbjct: 100 LKIMSHLGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKAEADLDKEDGRPLEL 159
Query: 214 TSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVAR-VQAQSGVMTA 272
             LL  +  V++GM +L   N IHRD+   N+L+    V K+ DFG+AR +   S  +  
Sbjct: 160 RDLLHFSSQVAQGMAFLASKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIVK 219
Query: 273 ETGTY--RWMAPEVIEHKPYDYKADVFSFGIALWELLT-GELPYAGLTPLQAAVGVVQKS 329
                  +WMAPE I    Y  ++DV+S+GI LWE+ + G  PY G+        +V+  
Sbjct: 220 GNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGILVNSKFYKLVKDG 279
Query: 330 LRPTIPKHAHPRLAELLERCWQHDPTQRPNFSQITDILKQMMKEVASE 377
            +   P  A   +  +++ CW  +PT RP F QI   L++  +E   E
Sbjct: 280 YQMAQPAFAPKNIYSIMQACWALEPTHRPTFQQICSFLQEQAQEDRRE 327

>pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329

Iteration: 1
 Score =  130 bits (327), Expect = 1e-30,   Method: Compositional matrix adjust.
 Identities = 81/272 (29%), Positives = 143/272 (52%), Gaps = 16/272 (5%)
Query: 112 EIDAKQLKIECKVASGSYGDLYKGTYCSQ------EVAIKVLKPECVNTEMLKEFSQEVY 165
           E + K++K+   + SG++G +YKG +  +       VAIK L+ E  + +  KE   E Y
Sbjct: 16  ETEFKKIKV---LGSGAFGTVYKGLWIPEGEKVKIPVAIKELR-EATSPKANKEILDEAY 71
Query: 166 IMRKIRHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSK 225
           +M  + + +V + +G C     + ++ + M  G + D++ + K       LL   + ++K
Sbjct: 72  VMASVDNPHVCRLLGICLTS-TVQLIMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAK 130
Query: 226 GMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVAR-VQAQSGVMTAETGTY--RWMAP 282
           GMNYL    ++HRDL   N+L+     VK+ DFG+A+ + A+     AE G    +WMA 
Sbjct: 131 GMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMAL 190
Query: 283 EVIEHKPYDYKADVFSFGIALWELLT-GELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPR 341
           E I H+ Y +++DV+S+G+ +WEL+T G  PY G+ P      +++K  R   P      
Sbjct: 191 ESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGI-PASEISSILEKGERLPQPPICTID 249
Query: 342 LAELLERCWQHDPTQRPNFSQITDILKQMMKE 373
           +  ++ +CW  D   RP F ++     +M ++
Sbjct: 250 VYMIMVKCWMIDADSRPKFRELIIEFSKMARD 281

>pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331

Iteration: 1
 Score =  130 bits (327), Expect = 1e-30,   Method: Compositional matrix adjust.
 Identities = 81/272 (29%), Positives = 143/272 (52%), Gaps = 16/272 (5%)
Query: 112 EIDAKQLKIECKVASGSYGDLYKGTYCSQ------EVAIKVLKPECVNTEMLKEFSQEVY 165
           E + K++K+   + SG++G +YKG +  +       VAIK L+ E  + +  KE   E Y
Sbjct: 18  ETEFKKIKV---LGSGAFGTVYKGLWIPEGEKVKIPVAIKELR-EATSPKANKEILDEAY 73
Query: 166 IMRKIRHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSK 225
           +M  + + +V + +G C     + ++ + M  G + D++ + K       LL   + ++K
Sbjct: 74  VMASVDNPHVCRLLGICLTS-TVQLIMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAK 132
Query: 226 GMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVAR-VQAQSGVMTAETGTY--RWMAP 282
           GMNYL    ++HRDL   N+L+     VK+ DFG+A+ + A+     AE G    +WMA 
Sbjct: 133 GMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMAL 192
Query: 283 EVIEHKPYDYKADVFSFGIALWELLT-GELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPR 341
           E I H+ Y +++DV+S+G+ +WEL+T G  PY G+ P      +++K  R   P      
Sbjct: 193 ESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGI-PASEISSILEKGERLPQPPICTID 251
Query: 342 LAELLERCWQHDPTQRPNFSQITDILKQMMKE 373
           +  ++ +CW  D   RP F ++     +M ++
Sbjct: 252 VYMIMVKCWMIDADSRPKFRELIIEFSKMARD 283

>pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330

Iteration: 1
 Score =  130 bits (327), Expect = 1e-30,   Method: Compositional matrix adjust.
 Identities = 81/272 (29%), Positives = 143/272 (52%), Gaps = 16/272 (5%)
Query: 112 EIDAKQLKIECKVASGSYGDLYKGTYCSQ------EVAIKVLKPECVNTEMLKEFSQEVY 165
           E + K++K+   + SG++G +YKG +  +       VAIK L+ E  + +  KE   E Y
Sbjct: 17  ETEFKKIKV---LGSGAFGTVYKGLWIPEGEKVKIPVAIKELR-EATSPKANKEILDEAY 72
Query: 166 IMRKIRHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSK 225
           +M  + + +V + +G C     + ++ + M  G + D++ + K       LL   + ++K
Sbjct: 73  VMASVDNPHVCRLLGICLTS-TVQLIMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAK 131
Query: 226 GMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVAR-VQAQSGVMTAETGTY--RWMAP 282
           GMNYL    ++HRDL   N+L+     VK+ DFG+A+ + A+     AE G    +WMA 
Sbjct: 132 GMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMAL 191
Query: 283 EVIEHKPYDYKADVFSFGIALWELLT-GELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPR 341
           E I H+ Y +++DV+S+G+ +WEL+T G  PY G+ P      +++K  R   P      
Sbjct: 192 ESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGI-PASEISSILEKGERLPQPPICTID 250
Query: 342 LAELLERCWQHDPTQRPNFSQITDILKQMMKE 373
           +  ++ +CW  D   RP F ++     +M ++
Sbjct: 251 VYMIMVKCWMIDADSRPKFRELIIEFSKMARD 282

>pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328

Iteration: 1
 Score =  130 bits (327), Expect = 1e-30,   Method: Compositional matrix adjust.
 Identities = 81/272 (29%), Positives = 143/272 (52%), Gaps = 16/272 (5%)
Query: 112 EIDAKQLKIECKVASGSYGDLYKGTYCSQ------EVAIKVLKPECVNTEMLKEFSQEVY 165
           E + K++K+   + SG++G +YKG +  +       VAIK L+ E  + +  KE   E Y
Sbjct: 15  ETEFKKIKV---LGSGAFGTVYKGLWIPEGEKVKIPVAIKELR-EATSPKANKEILDEAY 70
Query: 166 IMRKIRHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSK 225
           +M  + + +V + +G C     + ++ + M  G + D++ + K       LL   + ++K
Sbjct: 71  VMASVDNPHVCRLLGICLTS-TVQLIMQLMPFGXLLDYVREHKDNIGSQYLLNWCVQIAK 129
Query: 226 GMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVAR-VQAQSGVMTAETGTY--RWMAP 282
           GMNYL    ++HRDL   N+L+     VK+ DFG+A+ + A+     AE G    +WMA 
Sbjct: 130 GMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMAL 189
Query: 283 EVIEHKPYDYKADVFSFGIALWELLT-GELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPR 341
           E I H+ Y +++DV+S+G+ +WEL+T G  PY G+ P      +++K  R   P      
Sbjct: 190 ESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGI-PASEISSILEKGERLPQPPICTID 248
Query: 342 LAELLERCWQHDPTQRPNFSQITDILKQMMKE 373
           +  ++ +CW  D   RP F ++     +M ++
Sbjct: 249 VYMIMVKCWMIDADSRPKFRELIIEFSKMARD 280

>pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328

Iteration: 1
 Score =  130 bits (327), Expect = 1e-30,   Method: Compositional matrix adjust.
 Identities = 81/272 (29%), Positives = 143/272 (52%), Gaps = 16/272 (5%)
Query: 112 EIDAKQLKIECKVASGSYGDLYKGTYCSQ------EVAIKVLKPECVNTEMLKEFSQEVY 165
           E + K++K+   + SG++G +YKG +  +       VAIK L+ E  + +  KE   E Y
Sbjct: 15  ETEFKKIKV---LGSGAFGTVYKGLWIPEGEKVKIPVAIKELR-EATSPKANKEILDEAY 70
Query: 166 IMRKIRHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSK 225
           +M  + + +V + +G C     + ++ + M  G + D++ + K       LL   + ++K
Sbjct: 71  VMASVDNPHVCRLLGICLTS-TVQLIMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAK 129
Query: 226 GMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVAR-VQAQSGVMTAETGTY--RWMAP 282
           GMNYL    ++HRDL   N+L+     VK+ DFG+A+ + A+     AE G    +WMA 
Sbjct: 130 GMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMAL 189
Query: 283 EVIEHKPYDYKADVFSFGIALWELLT-GELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPR 341
           E I H+ Y +++DV+S+G+ +WEL+T G  PY G+ P      +++K  R   P      
Sbjct: 190 ESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGI-PASEISSILEKGERLPQPPICTID 248
Query: 342 LAELLERCWQHDPTQRPNFSQITDILKQMMKE 373
           +  ++ +CW  D   RP F ++     +M ++
Sbjct: 249 VYMIMVKCWMIDADSRPKFRELIIEFSKMARD 280

>pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329

Iteration: 1
 Score =  130 bits (327), Expect = 1e-30,   Method: Compositional matrix adjust.
 Identities = 81/272 (29%), Positives = 142/272 (52%), Gaps = 16/272 (5%)
Query: 112 EIDAKQLKIECKVASGSYGDLYKGTYCSQ------EVAIKVLKPECVNTEMLKEFSQEVY 165
           E + K++K+   + SG++G +YKG +  +       VAIK L+ E  + +  KE   E Y
Sbjct: 16  ETEFKKIKV---LGSGAFGTVYKGLWIPEGEKVKIPVAIKELR-EATSPKANKEILDEAY 71
Query: 166 IMRKIRHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSK 225
           +M  + + +V + +G C     + ++ + M  G + D++ + K       LL   + ++K
Sbjct: 72  VMASVDNPHVCRLLGICLTS-TVQLIMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAK 130
Query: 226 GMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVAR-VQAQSGVMTAETGTY--RWMAP 282
           GMNYL    ++HRDL   N+L+     VK+ DFG A+ + A+     AE G    +WMA 
Sbjct: 131 GMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGKVPIKWMAL 190
Query: 283 EVIEHKPYDYKADVFSFGIALWELLT-GELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPR 341
           E I H+ Y +++DV+S+G+ +WEL+T G  PY G+ P      +++K  R   P      
Sbjct: 191 ESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGI-PASEISSILEKGERLPQPPICTID 249
Query: 342 LAELLERCWQHDPTQRPNFSQITDILKQMMKE 373
           +  ++ +CW  D   RP F ++     +M ++
Sbjct: 250 VYMIMRKCWMIDADSRPKFRELIIEFSKMARD 281

>pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327

Iteration: 1
 Score =  130 bits (327), Expect = 1e-30,   Method: Compositional matrix adjust.
 Identities = 81/272 (29%), Positives = 143/272 (52%), Gaps = 16/272 (5%)
Query: 112 EIDAKQLKIECKVASGSYGDLYKGTYCSQ------EVAIKVLKPECVNTEMLKEFSQEVY 165
           E + K++K+   + SG++G +YKG +  +       VAIK L+ E  + +  KE   E Y
Sbjct: 14  ETEFKKIKV---LGSGAFGTVYKGLWIPEGEKVKIPVAIKELR-EATSPKANKEILDEAY 69
Query: 166 IMRKIRHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSK 225
           +M  + + +V + +G C     + ++ + M  G + D++ + K       LL   + ++K
Sbjct: 70  VMASVDNPHVCRLLGICLTS-TVQLIMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAK 128
Query: 226 GMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVAR-VQAQSGVMTAETGTY--RWMAP 282
           GMNYL    ++HRDL   N+L+     VK+ DFG+A+ + A+     AE G    +WMA 
Sbjct: 129 GMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMAL 188
Query: 283 EVIEHKPYDYKADVFSFGIALWELLT-GELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPR 341
           E I H+ Y +++DV+S+G+ +WEL+T G  PY G+ P      +++K  R   P      
Sbjct: 189 ESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGI-PASEISSILEKGERLPQPPICTID 247
Query: 342 LAELLERCWQHDPTQRPNFSQITDILKQMMKE 373
           +  ++ +CW  D   RP F ++     +M ++
Sbjct: 248 VYMIMVKCWMIDADSRPKFRELIIEFSKMARD 279

>pdb|3LCT|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 344

Iteration: 1
 Score =  130 bits (326), Expect = 2e-30,   Method: Compositional matrix adjust.
 Identities = 89/298 (29%), Positives = 143/298 (47%), Gaps = 24/298 (8%)
Query: 90  SKLLIESSPN-CIEIPTDG-TDVWEIDAKQLKIECKVASGSYGDLYKGTYCSQ------- 140
           S ++ + +PN C    T   +D+ E+  K + +   +  G++G++Y+G            
Sbjct: 20  STIMTDYNPNYCFAGKTSSISDLKEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPL 79
Query: 141 EVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVTEFMARGSI 200
           +VA+K L   C   + L +F  E  I+ K  H+N+V+ IG   +     I+ E MA G +
Sbjct: 80  QVAVKTLPEVCSEQDEL-DFLMEALIISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDL 138
Query: 201 YDFLHK------QKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENG--- 251
             FL +      Q     +  LL VA D++ G  YL +N+ IHRD+   N L+   G   
Sbjct: 139 KSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGR 198
Query: 252 VVKVADFGVARVQAQSGVMTAETGTY---RWMAPEVIEHKPYDYKADVFSFGIALWELLT 308
           V K+ DFG+AR   ++G            +WM PE      +  K D +SFG+ LWE+ +
Sbjct: 199 VAKIGDFGMARDIYRAGYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS 258
Query: 309 -GELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRLAELLERCWQHDPTQRPNFSQITD 365
            G +PY   +  Q  +  V    R   PK+    +  ++ +CWQH P  RPNF+ I +
Sbjct: 259 LGYMPYPSKS-NQEVLEFVTSGGRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILE 315

>pdb|3L9P|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 367

Iteration: 1
 Score =  130 bits (326), Expect = 2e-30,   Method: Compositional matrix adjust.
 Identities = 89/298 (29%), Positives = 143/298 (47%), Gaps = 24/298 (8%)
Query: 90  SKLLIESSPN-CIEIPTDG-TDVWEIDAKQLKIECKVASGSYGDLYKGTYCSQ------- 140
           S ++ + +PN C    T   +D+ E+  K + +   +  G++G++Y+G            
Sbjct: 43  STIMTDYNPNYCFAGKTSSISDLKEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPL 102
Query: 141 EVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVTEFMARGSI 200
           +VA+K L   C   + L +F  E  I+ K  H+N+V+ IG   +     I+ E MA G +
Sbjct: 103 QVAVKTLPEVCSEQDEL-DFLMEALIISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDL 161
Query: 201 YDFLHK------QKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENG--- 251
             FL +      Q     +  LL VA D++ G  YL +N+ IHRD+   N L+   G   
Sbjct: 162 KSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGR 221
Query: 252 VVKVADFGVARVQAQSGVMTAETGTY---RWMAPEVIEHKPYDYKADVFSFGIALWELLT 308
           V K+ DFG+AR   ++G            +WM PE      +  K D +SFG+ LWE+ +
Sbjct: 222 VAKIGDFGMARDIYRAGYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS 281
Query: 309 -GELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRLAELLERCWQHDPTQRPNFSQITD 365
            G +PY   +  Q  +  V    R   PK+    +  ++ +CWQH P  RPNF+ I +
Sbjct: 282 LGYMPYPSKS-NQEVLEFVTSGGRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILE 338

>pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361

Iteration: 1
 Score =  129 bits (325), Expect = 2e-30,   Method: Compositional matrix adjust.
 Identities = 81/272 (29%), Positives = 143/272 (52%), Gaps = 16/272 (5%)
Query: 112 EIDAKQLKIECKVASGSYGDLYKGTYCSQ------EVAIKVLKPECVNTEMLKEFSQEVY 165
           E + K++K+   + SG++G +YKG +  +       VAI  L+ E  + +  KE   E Y
Sbjct: 48  ETEFKKIKV---LGSGAFGTVYKGLWIPEGEKVKIPVAIMELR-EATSPKANKEILDEAY 103
Query: 166 IMRKIRHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSK 225
           +M  + + +V + +G C     + ++T+ M  G + D++ + K       LL   + ++K
Sbjct: 104 VMASVDNPHVCRLLGICLTS-TVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAK 162
Query: 226 GMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVAR-VQAQSGVMTAETGT--YRWMAP 282
           GMNYL    ++HRDL   N+L+     VK+ DFG+A+ + A+     AE G    +WMA 
Sbjct: 163 GMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMAL 222
Query: 283 EVIEHKPYDYKADVFSFGIALWELLT-GELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPR 341
           E I H+ Y +++DV+S+G+ +WEL+T G  PY G+ P      +++K  R   P      
Sbjct: 223 ESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGI-PASEISSILEKGERLPQPPICTID 281
Query: 342 LAELLERCWQHDPTQRPNFSQITDILKQMMKE 373
           +  ++ +CW  D   RP F ++     +M ++
Sbjct: 282 VYMIMVKCWMIDADSRPKFRELIIEFSKMARD 313

>pdb|2YJR|A Chain A, Structure Of F1174l Mutant Anaplastic Lymphoma Kinase Length = 342

Iteration: 1
 Score =  129 bits (325), Expect = 2e-30,   Method: Compositional matrix adjust.
 Identities = 91/304 (29%), Positives = 145/304 (47%), Gaps = 25/304 (8%)
Query: 85  GVPMHSKLLIE-SSPN-CIEIPTDG-TDVWEIDAKQLKIECKVASGSYGDLYKGTYCSQ- 140
           G+P    L  + S+PN C    T   +D+ E+  K + +   +  G++G++Y+G      
Sbjct: 11  GIPTTENLYFQGSNPNYCFAGKTSSISDLKEVPRKNITLIRGLGHGAFGEVYEGQVSGMP 70
Query: 141 ------EVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVTEF 194
                 +VA+K L   C   + L +F  E  I+ K+ H+N+V+ IG   +     I+ E 
Sbjct: 71  NDPSPLQVAVKTLPEVCSEQDEL-DFLMEALIISKLNHQNIVRCIGVSLQSLPRFILLEL 129
Query: 195 MARGSIYDFLHK------QKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMD 248
           MA G +  FL +      Q     +  LL VA D++ G  YL +N+ IHRD+   N L+ 
Sbjct: 130 MAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLT 189
Query: 249 ENG---VVKVADFGVARVQAQSGVMT---AETGTYRWMAPEVIEHKPYDYKADVFSFGIA 302
             G   V K+ DFG+AR   ++             +WM PE      +  K D +SFG+ 
Sbjct: 190 CPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVL 249
Query: 303 LWELLT-GELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRLAELLERCWQHDPTQRPNFS 361
           LWE+ + G +PY   +  Q  +  V    R   PK+    +  ++ +CWQH P  RPNF+
Sbjct: 250 LWEIFSLGYMPYPSKS-NQEVLEFVTSGGRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFA 308
Query: 362 QITD 365
            I +
Sbjct: 309 IILE 312

>pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333

Iteration: 1
 Score =  129 bits (324), Expect = 3e-30,   Method: Compositional matrix adjust.
 Identities = 81/288 (28%), Positives = 139/288 (48%), Gaps = 26/288 (9%)
Query: 111 WEIDAKQLKIECKVASGSYGDLYKGTYCSQ-------EVAIKVLKPECVNTEMLKEFSQE 163
           WE     L+    + +G++G + + T           +VA+K+LK    + +  +    E
Sbjct: 41  WEFPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLK-STAHADEKEALMSE 99
Query: 164 VYIMRKI-RHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQL--------- 213
           + IM  + +H+N+V  +GACT    + ++TE+   G + +FL ++  V +          
Sbjct: 100 LKIMSHLGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANS 159
Query: 214 ----TSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVAR-VQAQSG 268
                 LL  +  V++GM +L   N IHRD+   N+L+    V K+ DFG+AR +   S 
Sbjct: 160 TLSTRDLLHFSSQVAQGMAFLASKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSN 219
Query: 269 VMTAETGTY--RWMAPEVIEHKPYDYKADVFSFGIALWELLT-GELPYAGLTPLQAAVGV 325
            +         +WMAPE I    Y  ++DV+S+GI LWE+ + G  PY G+        +
Sbjct: 220 YIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGILVNSKFYKL 279
Query: 326 VQKSLRPTIPKHAHPRLAELLERCWQHDPTQRPNFSQITDILKQMMKE 373
           V+   +   P  A   +  +++ CW  +PT RP F QI   L++  +E
Sbjct: 280 VKDGYQMAQPAFAPKNIYSIMQACWALEPTHRPTFQQICSFLQEQAQE 327

>pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333

Iteration: 1
 Score =  129 bits (324), Expect = 3e-30,   Method: Compositional matrix adjust.
 Identities = 81/288 (28%), Positives = 139/288 (48%), Gaps = 26/288 (9%)
Query: 111 WEIDAKQLKIECKVASGSYGDLYKGTYCSQ-------EVAIKVLKPECVNTEMLKEFSQE 163
           WE     L+    + +G++G + + T           +VA+K+LK    + +  +    E
Sbjct: 41  WEFPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLK-STAHADEKEALMSE 99
Query: 164 VYIMRKI-RHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQL--------- 213
           + IM  + +H+N+V  +GACT    + ++TE+   G + +FL ++  V +          
Sbjct: 100 LKIMSHLGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANS 159
Query: 214 ----TSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVAR-VQAQSG 268
                 LL  +  V++GM +L   N IHRD+   N+L+    V K+ DFG+AR +   S 
Sbjct: 160 TASTRDLLHFSSQVAQGMAFLASKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSN 219
Query: 269 VMTAETGTY--RWMAPEVIEHKPYDYKADVFSFGIALWELLT-GELPYAGLTPLQAAVGV 325
            +         +WMAPE I    Y  ++DV+S+GI LWE+ + G  PY G+        +
Sbjct: 220 YIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGILVNSKFYKL 279
Query: 326 VQKSLRPTIPKHAHPRLAELLERCWQHDPTQRPNFSQITDILKQMMKE 373
           V+   +   P  A   +  +++ CW  +PT RP F QI   L++  +E
Sbjct: 280 VKDGYQMAQPAFAPKNIYSIMQACWALEPTHRPTFQQICSFLQEQAQE 327

>pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329

Iteration: 1
 Score =  129 bits (324), Expect = 3e-30,   Method: Compositional matrix adjust.
 Identities = 81/272 (29%), Positives = 142/272 (52%), Gaps = 16/272 (5%)
Query: 112 EIDAKQLKIECKVASGSYGDLYKGTYCSQ------EVAIKVLKPECVNTEMLKEFSQEVY 165
           E + K++K+   + SG++G +YKG +  +       VAIK L+ E  + +  KE   E Y
Sbjct: 16  ETEFKKIKV---LGSGAFGTVYKGLWIPEGEKVKIPVAIKELR-EATSPKANKEILDEAY 71
Query: 166 IMRKIRHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSK 225
           +M  + + +V + +G C     + ++ + M  G + D++ + K       LL   + ++K
Sbjct: 72  VMASVDNPHVCRLLGICLTS-TVQLIMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAK 130
Query: 226 GMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVAR-VQAQSGVMTAETGTY--RWMAP 282
           GMNYL    ++HRDL   N+L+     VK+ DFG A+ + A+     AE G    +WMA 
Sbjct: 131 GMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGKVPIKWMAL 190
Query: 283 EVIEHKPYDYKADVFSFGIALWELLT-GELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPR 341
           E I H+ Y +++DV+S+G+ +WEL+T G  PY G+ P      +++K  R   P      
Sbjct: 191 ESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGI-PASEISSILEKGERLPQPPICTID 249
Query: 342 LAELLERCWQHDPTQRPNFSQITDILKQMMKE 373
           +  ++ +CW  D   RP F ++     +M ++
Sbjct: 250 VYMIMVKCWMIDADSRPKFRELIIEFSKMARD 281

>pdb|2YHV|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase Length = 342

Iteration: 1
 Score =  129 bits (324), Expect = 3e-30,   Method: Compositional matrix adjust.
 Identities = 91/304 (29%), Positives = 144/304 (47%), Gaps = 25/304 (8%)
Query: 85  GVPMHSKLLIE-SSPN-CIEIPTDG-TDVWEIDAKQLKIECKVASGSYGDLYKGTYCSQ- 140
           G+P    L  + S+PN C    T   +D+ E+  K + +   +  G++G++Y+G      
Sbjct: 11  GIPTTENLYFQGSNPNYCFAGKTSSISDLKEVPRKNITLIRGLGHGAFGEVYEGQVSGMP 70
Query: 141 ------EVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVTEF 194
                 +VA+K L   C   + L +F  E  I+ K  H+N+V+ IG   +     I+ E 
Sbjct: 71  NDPSPLQVAVKTLPEVCSEQDEL-DFLMEALIISKFNHQNIVRCIGVSLQSLPRFILMEL 129
Query: 195 MARGSIYDFLHK------QKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMD 248
           MA G +  FL +      Q     +  LL VA D++ G  YL +N+ IHRD+   N L+ 
Sbjct: 130 MAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLT 189
Query: 249 ENG---VVKVADFGVARVQAQSGVMT---AETGTYRWMAPEVIEHKPYDYKADVFSFGIA 302
             G   V K+ DFG+AR   ++             +WM PE      +  K D +SFG+ 
Sbjct: 190 CPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVL 249
Query: 303 LWELLT-GELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRLAELLERCWQHDPTQRPNFS 361
           LWE+ + G +PY   +  Q  +  V    R   PK+    +  ++ +CWQH P  RPNF+
Sbjct: 250 LWEIFSLGYMPYPSKS-NQEVLEFVTSGGRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFA 308
Query: 362 QITD 365
            I +
Sbjct: 309 IILE 312

>pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331

Iteration: 1
 Score =  129 bits (324), Expect = 3e-30,   Method: Compositional matrix adjust.
 Identities = 81/272 (29%), Positives = 142/272 (52%), Gaps = 16/272 (5%)
Query: 112 EIDAKQLKIECKVASGSYGDLYKGTYCSQ------EVAIKVLKPECVNTEMLKEFSQEVY 165
           E + K++K+   + SG++G +YKG +  +       VAIK L+ E  + +  KE   E Y
Sbjct: 18  ETEFKKIKV---LGSGAFGTVYKGLWIPEGEKVKIPVAIKELR-EATSPKANKEILDEAY 73
Query: 166 IMRKIRHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSK 225
           +M  + + +V + +G C     + ++ + M  G + D++ + K       LL   + ++K
Sbjct: 74  VMASVDNPHVCRLLGICLTS-TVQLIMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAK 132
Query: 226 GMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVAR-VQAQSGVMTAETGTY--RWMAP 282
           GMNYL    ++HRDL   N+L+     VK+ DFG A+ + A+     AE G    +WMA 
Sbjct: 133 GMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGKVPIKWMAL 192
Query: 283 EVIEHKPYDYKADVFSFGIALWELLT-GELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPR 341
           E I H+ Y +++DV+S+G+ +WEL+T G  PY G+ P      +++K  R   P      
Sbjct: 193 ESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGI-PASEISSILEKGERLPQPPICTID 251
Query: 342 LAELLERCWQHDPTQRPNFSQITDILKQMMKE 373
           +  ++ +CW  D   RP F ++     +M ++
Sbjct: 252 VYMIMVKCWMIDADSRPKFRELIIEFSKMARD 283

>pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307

Iteration: 1
 Score =  129 bits (323), Expect = 3e-30,   Method: Compositional matrix adjust.
 Identities = 77/199 (38%), Positives = 122/199 (61%), Gaps = 13/199 (6%)
Query: 123 KVASGSYGDLYKGTYCSQEVAIKVLKPEC-VNTEMLKE-FSQEVYIMRKIRHKNVVQFIG 180
           K+  G +G +YKG   +  VA+K L     + TE LK+ F QE+ +M K +H+N+V+ +G
Sbjct: 38  KMGEGGFGVVYKGYVNNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHENLVELLG 97
Query: 181 ACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLL--KVAIDVSKGMNYLHQNNIIHR 238
             +   +LC+V  +M  GS+ D L    G   L+  +  K+A   + G+N+LH+N+ IHR
Sbjct: 98  FSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHENHHIHR 157
Query: 239 DLKTANLLMDENGVVKVADFGVARVQ---AQSGVMTAETGTYRWMAPEVI--EHKPYDYK 293
           D+K+AN+L+DE    K++DFG+AR     AQ+ + +   GT  +MAPE +  E  P   K
Sbjct: 158 DIKSANILLDEAFTAKISDFGLARASEKFAQTVMXSRIVGTTAYMAPEALRGEITP---K 214
Query: 294 ADVFSFGIALWELLTGELP 312
           +D++SFG+ L E++TG LP
Sbjct: 215 SDIYSFGVVLLEIITG-LP 232

>pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298

Iteration: 1
 Score =  128 bits (322), Expect = 5e-30,   Method: Compositional matrix adjust.
 Identities = 77/266 (28%), Positives = 132/266 (49%), Gaps = 14/266 (5%)
Query: 124 VASGSYGDLYKGTYCSQ-----EVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQF 178
           +  G +G +Y G Y  Q     + AIK L       + ++ F +E  +MR + H NV+  
Sbjct: 29  IGKGHFGVVYHGEYIDQAQNRIQCAIKSLS-RITEMQQVEAFLREGLLMRGLNHPNVLAL 87
Query: 179 IGACTRPPNLC-IVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIH 237
           IG    P  L  ++  +M  G +  F+   +    +  L+   + V++GM YL +   +H
Sbjct: 88  IGIMLPPEGLPHVLLPYMCHGDLLQFIRSPQRNPTVKDLISFGLQVARGMEYLAEQKFVH 147
Query: 238 RDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAETGTY-----RWMAPEVIEHKPYDY 292
           RDL   N ++DE+  VKVADFG+AR        + +   +     +W A E ++   +  
Sbjct: 148 RDLAARNCMLDESFTVKVADFGLARDILDREYYSVQQHRHARLPVKWTALESLQTYRFTT 207
Query: 293 KADVFSFGIALWELLT-GELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRLAELLERCWQ 351
           K+DV+SFG+ LWELLT G  PY  + P      + Q    P  P++    L +++++CW+
Sbjct: 208 KSDVWSFGVLLWELLTRGAPPYRHIDPFDLTHFLAQGRRLPQ-PEYCPDSLYQVMQQCWE 266
Query: 352 HDPTQRPNFSQITDILKQMMKEVASE 377
            DP  RP F  +   ++Q++  +  +
Sbjct: 267 ADPAVRPTFRVLVGEVEQIVSALLGD 292

>pdb|2YJS|A Chain A, Structure Of C1156y Mutant Anaplastic Lymphoma Kinase Length = 342

Iteration: 1
 Score =  128 bits (322), Expect = 5e-30,   Method: Compositional matrix adjust.
 Identities = 91/304 (29%), Positives = 145/304 (47%), Gaps = 25/304 (8%)
Query: 85  GVPMHSKLLIE-SSPN-CIEIPTDG-TDVWEIDAKQLKIECKVASGSYGDLYKGTYCSQ- 140
           G+P    L  + S+PN C    T   +D+ E+  K + +   +  G++G++Y+G      
Sbjct: 11  GIPTTENLYFQGSNPNYCFAGKTSSISDLKEVPRKNITLIRGLGHGAFGEVYEGQVSGMP 70
Query: 141 ------EVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVTEF 194
                 +VA+K L PE  + +   +F  E  I+ K  H+N+V+ IG   +     I+ E 
Sbjct: 71  NDPSPLQVAVKTL-PEVYSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPRFILLEL 129
Query: 195 MARGSIYDFLHK------QKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMD 248
           MA G +  FL +      Q     +  LL VA D++ G  YL +N+ IHRD+   N L+ 
Sbjct: 130 MAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLT 189
Query: 249 ENG---VVKVADFGVARVQAQSGVMT---AETGTYRWMAPEVIEHKPYDYKADVFSFGIA 302
             G   V K+ DFG+AR   ++             +WM PE      +  K D +SFG+ 
Sbjct: 190 CPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVL 249
Query: 303 LWELLT-GELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRLAELLERCWQHDPTQRPNFS 361
           LWE+ + G +PY   +  Q  +  V    R   PK+    +  ++ +CWQH P  RPNF+
Sbjct: 250 LWEIFSLGYMPYPSKS-NQEVLEFVTSGGRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFA 308
Query: 362 QITD 365
            I +
Sbjct: 309 IILE 312

>pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307

Iteration: 1
 Score =  128 bits (321), Expect = 6e-30,   Method: Compositional matrix adjust.
 Identities = 77/199 (38%), Positives = 121/199 (60%), Gaps = 13/199 (6%)
Query: 123 KVASGSYGDLYKGTYCSQEVAIKVLKPEC-VNTEMLKE-FSQEVYIMRKIRHKNVVQFIG 180
           K+  G +G +YKG   +  VA+K L     + TE LK+ F QE+ +M K +H+N+V+ +G
Sbjct: 38  KMGEGGFGVVYKGYVNNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHENLVELLG 97
Query: 181 ACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLL--KVAIDVSKGMNYLHQNNIIHR 238
             +   +LC+V  +M  GS+ D L    G   L+  +  K+A   + G+N+LH+N+ IHR
Sbjct: 98  FSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHENHHIHR 157
Query: 239 DLKTANLLMDENGVVKVADFGVARVQ---AQSGVMTAETGTYRWMAPEVI--EHKPYDYK 293
           D+K+AN+L+DE    K++DFG+AR     AQ+ +     GT  +MAPE +  E  P   K
Sbjct: 158 DIKSANILLDEAFTAKISDFGLARASEKFAQTVMXXRIVGTTAYMAPEALRGEITP---K 214
Query: 294 ADVFSFGIALWELLTGELP 312
           +D++SFG+ L E++TG LP
Sbjct: 215 SDIYSFGVVLLEIITG-LP 232

>pdb|3AOX|A Chain A, X-Ray Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Ch5424802 Length = 344

Iteration: 1
 Score =  127 bits (319), Expect = 1e-29,   Method: Compositional matrix adjust.
 Identities = 88/298 (29%), Positives = 142/298 (47%), Gaps = 24/298 (8%)
Query: 90  SKLLIESSPN-CIEIPTDG-TDVWEIDAKQLKIECKVASGSYGDLYKGTYCSQ------- 140
           S ++ + +PN C    T   +D+ E+  K + +   +  G++G++Y+G            
Sbjct: 19  STIMTDYNPNYCFAGKTSSISDLKEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPL 78
Query: 141 EVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVTEFMARGSI 200
           +VA+K L   C   + L +F  E  I+ K  H+N+V+ IG   +     I+ E MA G +
Sbjct: 79  QVAVKTLPEVCSEQDEL-DFLMEALIISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDL 137
Query: 201 YDFLHK------QKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENG--- 251
             FL +      Q     +  LL VA D++ G  YL +N+ IHRD+   N L+   G   
Sbjct: 138 KSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGR 197
Query: 252 VVKVADFGVARVQAQSGVMT---AETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLT 308
           V K+ DFG+AR   ++             +WM PE      +  K D +SFG+ LWE+ +
Sbjct: 198 VAKIGDFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS 257
Query: 309 -GELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRLAELLERCWQHDPTQRPNFSQITD 365
            G +PY   +  Q  +  V    R   PK+    +  ++ +CWQH P  RPNF+ I +
Sbjct: 258 LGYMPYPSKSN-QEVLEFVTSGGRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILE 314

>pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335

Iteration: 1
 Score =  127 bits (319), Expect = 1e-29,   Method: Compositional matrix adjust.
 Identities = 84/294 (28%), Positives = 143/294 (48%), Gaps = 28/294 (9%)
Query: 111 WEIDAKQLKIECKVASGSYGDLYKGTYCSQ-------EVAIKVLKPECVNTEMLKEFSQE 163
           WE     L+    + +G++G + + T           +VA+K+LK    + +  +    E
Sbjct: 41  WEFPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLK-STAHADEKEALMSE 99
Query: 164 VYIMRKI-RHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVF----------- 211
           + IM  + +H+N+V  +GACT    + ++TE+   G + +FL +++              
Sbjct: 100 LKIMSHLGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKRPPGLEYSYNPSHNP 159
Query: 212 --QLTS--LLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVAR-VQAQ 266
             QL+S  LL  +  V++GM +L   N IHRD+   N+L+    V K+ DFG+AR +   
Sbjct: 160 EEQLSSRDLLHFSSQVAQGMAFLASKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMND 219
Query: 267 SGVMTAETGTY--RWMAPEVIEHKPYDYKADVFSFGIALWELLT-GELPYAGLTPLQAAV 323
           S  +         +WMAPE I    Y  ++DV+S+GI LWE+ + G  PY G+       
Sbjct: 220 SNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGILVNSKFY 279
Query: 324 GVVQKSLRPTIPKHAHPRLAELLERCWQHDPTQRPNFSQITDILKQMMKEVASE 377
            +V+   +   P  A   +  +++ CW  +PT RP F QI   L++  +E   E
Sbjct: 280 KLVKDGYQMAQPAFAPKNIYSIMQACWALEPTHRPTFQQICSFLQEQAQEDRRE 333

>pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297

Iteration: 1
 Score =  127 bits (318), Expect = 1e-29,   Method: Compositional matrix adjust.
 Identities = 84/295 (28%), Positives = 145/295 (49%), Gaps = 35/295 (11%)
Query: 107 GTDVWEIDAKQLKIECKVASGSYGDLYKG-------TYCSQEVAIKVLKPECVNTEMLKE 159
           G  V  I  + + ++ ++  G++G ++         T     VA+K LK   +     K+
Sbjct: 6   GIHVQHIKRRDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAAR--KD 63
Query: 160 FSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLH-------------- 205
           F +E  ++  ++H+++V+F G C     L +V E+M  G +  FL               
Sbjct: 64  FQREAELLTNLQHEHIVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQP 123
Query: 206 -KQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQ 264
            + KG   L+ +L +A  ++ GM YL   + +HRDL T N L+  N +VK+ DFG++R  
Sbjct: 124 RQAKGELGLSQMLHIASQIASGMVYLASQHFVHRDLATRNCLVGANLLVKIGDFGMSRDV 183
Query: 265 AQSGVMTAETGTY---RWMAPEVIEHKPYDYKADVFSFGIALWELLT-GELPYAGLTPLQ 320
             +        T    RWM PE I ++ +  ++DV+SFG+ LWE+ T G+ P+  L+  +
Sbjct: 184 YSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSNTE 243
Query: 321 AAVGVVQKSL--RPTI-PKHAHPRLAELLERCWQHDPTQRPNFSQITDILKQMMK 372
               + Q  +  RP + PK  +    +++  CWQ +P QR N  +I  IL  + K
Sbjct: 244 VIECITQGRVLERPRVCPKEVY----DVMLGCWQREPQQRLNIKEIYKILHALGK 294

>pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301

Iteration: 1
 Score =  127 bits (318), Expect = 1e-29,   Method: Compositional matrix adjust.
 Identities = 77/199 (38%), Positives = 120/199 (60%), Gaps = 13/199 (6%)
Query: 123 KVASGSYGDLYKGTYCSQEVAIKVLKPEC-VNTEMLKE-FSQEVYIMRKIRHKNVVQFIG 180
           K+  G +G +YKG   +  VA+K L     + TE LK+ F QE+ +M K +H+N+V+ +G
Sbjct: 32  KMGEGGFGVVYKGYVNNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHENLVELLG 91
Query: 181 ACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLL--KVAIDVSKGMNYLHQNNIIHR 238
             +   +LC+V  +M  GS+ D L    G   L+  +  K+A   + G+N+LH+N+ IHR
Sbjct: 92  FSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHENHHIHR 151
Query: 239 DLKTANLLMDENGVVKVADFGVARVQ---AQSGVMTAETGTYRWMAPEVI--EHKPYDYK 293
           D+K+AN+L+DE    K++DFG+AR     AQ  +     GT  +MAPE +  E  P   K
Sbjct: 152 DIKSANILLDEAFTAKISDFGLARASEKFAQXVMXXRIVGTTAYMAPEALRGEITP---K 208
Query: 294 ADVFSFGIALWELLTGELP 312
           +D++SFG+ L E++TG LP
Sbjct: 209 SDIYSFGVVLLEIITG-LP 226

>pdb|4FNW|A Chain A, Crystal Structure Of The Apo F1174l Anaplastic Lymphoma Kinase Catalytic Domain Length = 327

Iteration: 1
 Score =  127 bits (318), Expect = 1e-29,   Method: Compositional matrix adjust.
 Identities = 83/278 (29%), Positives = 134/278 (48%), Gaps = 22/278 (7%)
Query: 108 TDVWEIDAKQLKIECKVASGSYGDLYKGTYCSQ-------EVAIKVLKPECVNTEMLKEF 160
           +D+ E+  K + +   +  G++G++Y+G            +VA+K L   C   + L +F
Sbjct: 23  SDLKEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDEL-DF 81
Query: 161 SQEVYIMRKIRHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHK------QKGVFQLT 214
             E  I+ K+ H+N+V+ IG   +     I+ E MA G +  FL +      Q     + 
Sbjct: 82  LMEALIISKLNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAML 141
Query: 215 SLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENG---VVKVADFGVARVQAQSGVMT 271
            LL VA D++ G  YL +N+ IHRD+   N L+   G   V K+ DFG+AR   ++    
Sbjct: 142 DLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYR 201
Query: 272 ---AETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLT-GELPYAGLTPLQAAVGVVQ 327
                    +WM PE      +  K D +SFG+ LWE+ + G +PY   +  Q  +  V 
Sbjct: 202 KGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKS-NQEVLEFVT 260
Query: 328 KSLRPTIPKHAHPRLAELLERCWQHDPTQRPNFSQITD 365
              R   PK+    +  ++ +CWQH P  RPNF+ I +
Sbjct: 261 SGGRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILE 298

>pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324

Iteration: 1
 Score =  126 bits (317), Expect = 2e-29,   Method: Compositional matrix adjust.
 Identities = 81/297 (27%), Positives = 139/297 (46%), Gaps = 35/297 (11%)
Query: 111 WEIDAKQLKIECKVASGSYGDLYKGTYCSQ-------EVAIKVLKPECVNTEMLKEFSQE 163
           WE     L+    + +G++G + + T           +VA+K+LK    + +  +    E
Sbjct: 26  WEFPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLK-STAHADEKEALMSE 84
Query: 164 VYIMRKI-RHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGV------------ 210
           + IM  + +H+N+V  +GACT    + ++TE+   G + +FL ++               
Sbjct: 85  LKIMSHLGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKAEAMLGPSLAPGQDP 144
Query: 211 ----------FQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGV 260
                      +L  LL  +  V++GM +L   N IHRD+   N+L+    V K+ DFG+
Sbjct: 145 EGLDKEDGRPLELRDLLHFSSQVAQGMAFLASKNCIHRDVAARNVLLTNGHVAKIGDFGL 204
Query: 261 AR-VQAQSGVMTAETGTY--RWMAPEVIEHKPYDYKADVFSFGIALWELLT-GELPYAGL 316
           AR +   S  +         +WMAPE I    Y  ++DV+S+GI LWE+ + G  PY G+
Sbjct: 205 ARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGI 264
Query: 317 TPLQAAVGVVQKSLRPTIPKHAHPRLAELLERCWQHDPTQRPNFSQITDILKQMMKE 373
                   +V+   +   P  A   +  +++ CW  +PT RP F QI   L++  +E
Sbjct: 265 LVNSKFYKLVKDGYQMAQPAFAPKNIYSIMQACWALEPTHRPTFQQICSFLQEQAQE 321

>pdb|2YFX|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase In Complex With Crizotinib Length = 327

Iteration: 1
 Score =  126 bits (317), Expect = 2e-29,   Method: Compositional matrix adjust.
 Identities = 83/278 (29%), Positives = 133/278 (47%), Gaps = 22/278 (7%)
Query: 108 TDVWEIDAKQLKIECKVASGSYGDLYKGTYCSQ-------EVAIKVLKPECVNTEMLKEF 160
           +D+ E+  K + +   +  G++G++Y+G            +VA+K L   C   + L +F
Sbjct: 22  SDLKEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDEL-DF 80
Query: 161 SQEVYIMRKIRHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHK------QKGVFQLT 214
             E  I+ K  H+N+V+ IG   +     I+ E MA G +  FL +      Q     + 
Sbjct: 81  LMEALIISKFNHQNIVRCIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAML 140
Query: 215 SLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENG---VVKVADFGVARVQAQSGVMT 271
            LL VA D++ G  YL +N+ IHRD+   N L+   G   V K+ DFG+AR   ++    
Sbjct: 141 DLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYR 200
Query: 272 ---AETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLT-GELPYAGLTPLQAAVGVVQ 327
                    +WM PE      +  K D +SFG+ LWE+ + G +PY   +  Q  +  V 
Sbjct: 201 KGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKS-NQEVLEFVT 259
Query: 328 KSLRPTIPKHAHPRLAELLERCWQHDPTQRPNFSQITD 365
              R   PK+    +  ++ +CWQH P  RPNF+ I +
Sbjct: 260 SGGRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILE 297

>pdb|4DCE|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With A Piperidine-Carboxamide Inhibitor Length = 333

Iteration: 1
 Score =  126 bits (316), Expect = 2e-29,   Method: Compositional matrix adjust.
 Identities = 83/278 (29%), Positives = 133/278 (47%), Gaps = 22/278 (7%)
Query: 108 TDVWEIDAKQLKIECKVASGSYGDLYKGTYCSQ-------EVAIKVLKPECVNTEMLKEF 160
           +D+ E+  K + +   +  G++G++Y+G            +VA+K L   C   + L +F
Sbjct: 29  SDLKEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDEL-DF 87
Query: 161 SQEVYIMRKIRHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHK------QKGVFQLT 214
             E  I+ K  H+N+V+ IG   +     I+ E MA G +  FL +      Q     + 
Sbjct: 88  LMEALIISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAML 147
Query: 215 SLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENG---VVKVADFGVARVQAQSGVMT 271
            LL VA D++ G  YL +N+ IHRD+   N L+   G   V K+ DFG+AR   ++    
Sbjct: 148 DLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYR 207
Query: 272 ---AETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLT-GELPYAGLTPLQAAVGVVQ 327
                    +WM PE      +  K D +SFG+ LWE+ + G +PY   +  Q  +  V 
Sbjct: 208 KGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKS-NQEVLEFVT 266
Query: 328 KSLRPTIPKHAHPRLAELLERCWQHDPTQRPNFSQITD 365
              R   PK+    +  ++ +CWQH P  RPNF+ I +
Sbjct: 267 SGGRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILE 304

>pdb|2XB7|A Chain A, Structure Of Human Anaplastic Lymphoma Kinase In Complex With Nvp- Tae684 Length = 315

Iteration: 1
 Score =  126 bits (316), Expect = 2e-29,   Method: Compositional matrix adjust.
 Identities = 83/278 (29%), Positives = 133/278 (47%), Gaps = 22/278 (7%)
Query: 108 TDVWEIDAKQLKIECKVASGSYGDLYKGTYCSQ-------EVAIKVLKPECVNTEMLKEF 160
           +D+ E+  K + +   +  G++G++Y+G            +VA+K L   C   + L +F
Sbjct: 14  SDLKEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDEL-DF 72
Query: 161 SQEVYIMRKIRHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHK------QKGVFQLT 214
             E  I+ K  H+N+V+ IG   +     I+ E MA G +  FL +      Q     + 
Sbjct: 73  LMEALIISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAML 132
Query: 215 SLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENG---VVKVADFGVARVQAQSGVMT 271
            LL VA D++ G  YL +N+ IHRD+   N L+   G   V K+ DFG+AR   ++    
Sbjct: 133 DLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYR 192
Query: 272 ---AETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLT-GELPYAGLTPLQAAVGVVQ 327
                    +WM PE      +  K D +SFG+ LWE+ + G +PY   +  Q  +  V 
Sbjct: 193 KGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKS-NQEVLEFVT 251
Query: 328 KSLRPTIPKHAHPRLAELLERCWQHDPTQRPNFSQITD 365
              R   PK+    +  ++ +CWQH P  RPNF+ I +
Sbjct: 252 SGGRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILE 289

>pdb|2XP2|A Chain A, Structure Of The Human Anaplastic Lymphoma Kinase In Complex With Crizotinib (Pf-02341066) Length = 327

Iteration: 1
 Score =  126 bits (316), Expect = 2e-29,   Method: Compositional matrix adjust.
 Identities = 83/278 (29%), Positives = 133/278 (47%), Gaps = 22/278 (7%)
Query: 108 TDVWEIDAKQLKIECKVASGSYGDLYKGTYCSQ-------EVAIKVLKPECVNTEMLKEF 160
           +D+ E+  K + +   +  G++G++Y+G            +VA+K L   C   + L +F
Sbjct: 22  SDLKEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDEL-DF 80
Query: 161 SQEVYIMRKIRHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHK------QKGVFQLT 214
             E  I+ K  H+N+V+ IG   +     I+ E MA G +  FL +      Q     + 
Sbjct: 81  LMEALIISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAML 140
Query: 215 SLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENG---VVKVADFGVARVQAQSGVMT 271
            LL VA D++ G  YL +N+ IHRD+   N L+   G   V K+ DFG+AR   ++    
Sbjct: 141 DLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYR 200
Query: 272 ---AETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLT-GELPYAGLTPLQAAVGVVQ 327
                    +WM PE      +  K D +SFG+ LWE+ + G +PY   +  Q  +  V 
Sbjct: 201 KGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKS-NQEVLEFVT 259
Query: 328 KSLRPTIPKHAHPRLAELLERCWQHDPTQRPNFSQITD 365
              R   PK+    +  ++ +CWQH P  RPNF+ I +
Sbjct: 260 SGGRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILE 297

>pdb|4FNZ|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Piperidine-Carboxamide Inhibitor 2 Length = 327

Iteration: 1
 Score =  126 bits (316), Expect = 2e-29,   Method: Compositional matrix adjust.
 Identities = 83/278 (29%), Positives = 133/278 (47%), Gaps = 22/278 (7%)
Query: 108 TDVWEIDAKQLKIECKVASGSYGDLYKGTYCSQ-------EVAIKVLKPECVNTEMLKEF 160
           +D+ E+  K + +   +  G++G++Y+G            +VA+K L   C   + L +F
Sbjct: 23  SDLKEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDEL-DF 81
Query: 161 SQEVYIMRKIRHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHK------QKGVFQLT 214
             E  I+ K  H+N+V+ IG   +     I+ E MA G +  FL +      Q     + 
Sbjct: 82  LMEALIISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAML 141
Query: 215 SLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENG---VVKVADFGVARVQAQSGVMT 271
            LL VA D++ G  YL +N+ IHRD+   N L+   G   V K+ DFG+AR   ++    
Sbjct: 142 DLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYR 201
Query: 272 ---AETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLT-GELPYAGLTPLQAAVGVVQ 327
                    +WM PE      +  K D +SFG+ LWE+ + G +PY   +  Q  +  V 
Sbjct: 202 KGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKS-NQEVLEFVT 260
Query: 328 KSLRPTIPKHAHPRLAELLERCWQHDPTQRPNFSQITD 365
              R   PK+    +  ++ +CWQH P  RPNF+ I +
Sbjct: 261 SGGRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILE 298

>pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326

Iteration: 1
 Score =  126 bits (316), Expect = 2e-29,   Method: Compositional matrix adjust.
 Identities = 86/265 (32%), Positives = 136/265 (51%), Gaps = 37/265 (13%)
Query: 124 VASGSYGDLYKGTY--CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKI-RHKNVVQFIG 180
           V +G+YG +YKG +    Q  AIKV+    V  +  +E  QE+ +++K   H+N+  + G
Sbjct: 32  VGNGTYGQVYKGRHVKTGQLAAIKVMD---VTGDEEEEIKQEINMLKKYSHHRNIATYYG 88
Query: 181 ACTR--PP----NLCIVTEFMARGSIYDFLHKQKG-VFQLTSLLKVAIDVSKGMNYLHQN 233
           A  +  PP     L +V EF   GS+ D +   KG   +   +  +  ++ +G+++LHQ+
Sbjct: 89  AFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQH 148
Query: 234 NIIHRDLKTANLLMDENGVVKVADFGV-ARVQAQSGVMTAETGTYRWMAPEVI--EHKP- 289
            +IHRD+K  N+L+ EN  VK+ DFGV A++    G      GT  WMAPEVI  +  P 
Sbjct: 149 KVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFIGTPYWMAPEVIACDENPD 208
Query: 290 --YDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRLA---- 343
             YD+K+D++S GI   E+  G  P   + P++A            IP++  PRL     
Sbjct: 209 ATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALF---------LIPRNPAPRLKSKKW 259
Query: 344 -----ELLERCWQHDPTQRPNFSQI 363
                  +E C   + +QRP   Q+
Sbjct: 260 SKKFQSFIESCLVKNHSQRPATEQL 284

>pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302

Iteration: 1
 Score =  126 bits (316), Expect = 2e-29,   Method: Compositional matrix adjust.
 Identities = 78/268 (29%), Positives = 127/268 (47%), Gaps = 14/268 (5%)
Query: 124 VASGSYGDLYKGTYCSQE-----VAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQF 178
           +  G +G +Y GT    +      A+K L     +   + +F  E  IM+   H NV+  
Sbjct: 36  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLN-RITDIGEVSQFLTEGIIMKDFSHPNVLSL 94
Query: 179 IGACTRPP-NLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIH 237
           +G C R   +  +V  +M  G + +F+  +     +  L+   + V+KGM YL     +H
Sbjct: 95  LGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLASKKFVH 154
Query: 238 RDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAETGT-----YRWMAPEVIEHKPYDY 292
           RDL   N ++DE   VKVADFG+AR        +    T      +WMA E ++ + +  
Sbjct: 155 RDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQTQKFTT 214
Query: 293 KADVFSFGIALWELLT-GELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRLAELLERCWQ 351
           K+DV+SFG+ LWEL+T G  PY  +      V ++Q   R   P++    L E++ +CW 
Sbjct: 215 KSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGR-RLLQPEYCPDPLYEVMLKCWH 273
Query: 352 HDPTQRPNFSQITDILKQMMKEVASEGE 379
                RP+FS++   +  +      E E
Sbjct: 274 PKAEMRPSFSELVSRISAIFSTFIGEHE 301

>pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306

Iteration: 1
 Score =  126 bits (316), Expect = 2e-29,   Method: Compositional matrix adjust.
 Identities = 78/291 (26%), Positives = 140/291 (48%), Gaps = 26/291 (8%)
Query: 98  PNCIEIPTDGTDVWEIDAKQLKIECKVASGSYGDLYKGTY-------CSQEVAIKVLKPE 150
           P+ + +P    D WE+  +++ +  ++  GS+G +Y+G             VA+K +   
Sbjct: 3   PSSVYVP----DEWEVSREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNES 58
Query: 151 CVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGV 210
               E + EF  E  +M+     +VV+ +G  ++     +V E MA G +  +L   +  
Sbjct: 59  ASLRERI-EFLNEASVMKGFTCHHVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPE 117
Query: 211 FQ---------LTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVA 261
            +         L  ++++A +++ GM YL+    +HRDL   N ++  +  VK+ DFG+ 
Sbjct: 118 AENNPGRPPPTLQEMIQMAAEIADGMAYLNAKKFVHRDLAARNCMVAHDFTVKIGDFGMT 177
Query: 262 R-VQAQSGVMTAETG--TYRWMAPEVIEHKPYDYKADVFSFGIALWELLT-GELPYAGLT 317
           R +           G    RWMAPE ++   +   +D++SFG+ LWE+ +  E PY GL+
Sbjct: 178 RDIXETDXXRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLS 237
Query: 318 PLQAAVGVVQKSLRPTIPKHAHPRLAELLERCWQHDPTQRPNFSQITDILK 368
             Q    V+        P +   R+ +L+  CWQ +P  RP F +I ++LK
Sbjct: 238 NEQVLKFVMDGGYLDQ-PDNCPERVTDLMRMCWQFNPNMRPTFLEIVNLLK 287

>pdb|4FOB|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Acyliminobenzimidazole Inhibitor 1 Length = 353

Iteration: 1
 Score =  126 bits (316), Expect = 2e-29,   Method: Compositional matrix adjust.
 Identities = 83/278 (29%), Positives = 133/278 (47%), Gaps = 22/278 (7%)
Query: 108 TDVWEIDAKQLKIECKVASGSYGDLYKGTYCSQ-------EVAIKVLKPECVNTEMLKEF 160
           +D+ E+  K + +   +  G++G++Y+G            +VA+K L   C   + L +F
Sbjct: 49  SDLKEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDEL-DF 107
Query: 161 SQEVYIMRKIRHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHK------QKGVFQLT 214
             E  I+ K  H+N+V+ IG   +     I+ E MA G +  FL +      Q     + 
Sbjct: 108 LMEALIISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAML 167
Query: 215 SLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENG---VVKVADFGVARVQAQSGVMT 271
            LL VA D++ G  YL +N+ IHRD+   N L+   G   V K+ DFG+AR   ++    
Sbjct: 168 DLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYR 227
Query: 272 ---AETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLT-GELPYAGLTPLQAAVGVVQ 327
                    +WM PE      +  K D +SFG+ LWE+ + G +PY   +  Q  +  V 
Sbjct: 228 KGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSN-QEVLEFVT 286
Query: 328 KSLRPTIPKHAHPRLAELLERCWQHDPTQRPNFSQITD 365
              R   PK+    +  ++ +CWQH P  RPNF+ I +
Sbjct: 287 SGGRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILE 324

>pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310

Iteration: 1
 Score =  125 bits (315), Expect = 3e-29,   Method: Compositional matrix adjust.
 Identities = 83/271 (30%), Positives = 131/271 (48%), Gaps = 20/271 (7%)
Query: 124 VASGSYGDLYKGTYCSQEVAIKVLKPECV--NTEMLKEFSQEVYIMRKIRHKNVVQFIGA 181
           +  G +G   K T+  +E    ++  E +  + E  + F +EV +MR + H NV++FIG 
Sbjct: 18  LGKGCFGQAIKVTH--RETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGV 75
Query: 182 CTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLK 241
             +   L  +TE++  G++   +      +  +  +  A D++ GM YLH  NIIHRDL 
Sbjct: 76  LYKDKRLNFITEYIKGGTLRGIIKSMDSQYPWSQRVSFAKDIASGMAYLHSMNIIHRDLN 135
Query: 242 TANLLMDENGVVKVADFGVARVQAQ-----SGVMTAE----------TGTYRWMAPEVIE 286
           + N L+ EN  V VADFG+AR+         G+ + +           G   WMAPE+I 
Sbjct: 136 SHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVGNPYWMAPEMIN 195
Query: 287 HKPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGV-VQKSLRPTIPKHAHPRLAEL 345
            + YD K DVFSFGI L E++          P     G+ V+  L    P +  P    +
Sbjct: 196 GRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDFGLNVRGFLDRYCPPNCPPSFFPI 255
Query: 346 LERCWQHDPTQRPNFSQITDILKQMMKEVAS 376
             RC   DP +RP+F ++   L+ +   +A 
Sbjct: 256 TVRCCDLDPEKRPSFVKLEHWLETLRMHLAG 286

>pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344

Iteration: 1
 Score =  125 bits (315), Expect = 3e-29,   Method: Compositional matrix adjust.
 Identities = 76/273 (27%), Positives = 146/273 (53%), Gaps = 18/273 (6%)
Query: 112 EIDAKQLKIECKVASGSYGDLYKGTYCSQEVAIKVLKPECVNT-------EMLKEFSQEV 164
           E + ++LK+   + SG +G ++KG +  +  +IK+  P C+         +  +  +  +
Sbjct: 30  ETELRKLKV---LGSGVFGTVHKGVWIPEGESIKI--PVCIKVIEDKSGRQSFQAVTDHM 84
Query: 165 YIMRKIRHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVS 224
             +  + H ++V+ +G C    +L +VT+++  GS+ D + + +G      LL   + ++
Sbjct: 85  LAIGSLDHAHIVRLLGLCPGS-SLQLVTQYLPLGSLLDHVRQHRGALGPQLLLNWGVQIA 143
Query: 225 KGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSG--VMTAETGT-YRWMA 281
           KGM YL ++ ++HR+L   N+L+     V+VADFGVA +       ++ +E  T  +WMA
Sbjct: 144 KGMYYLEEHGMVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLYSEAKTPIKWMA 203
Query: 282 PEVIEHKPYDYKADVFSFGIALWELLT-GELPYAGLTPLQAAVGVVQKSLRPTIPKHAHP 340
            E I    Y +++DV+S+G+ +WEL+T G  PYAGL  L     +++K  R   P+    
Sbjct: 204 LESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGLR-LAEVPDLLEKGERLAQPQICTI 262
Query: 341 RLAELLERCWQHDPTQRPNFSQITDILKQMMKE 373
            +  ++ +CW  D   RP F ++ +   +M ++
Sbjct: 263 DVYMVMVKCWMIDENIRPTFKELANEFTRMARD 295

>pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325

Iteration: 1
 Score =  125 bits (315), Expect = 3e-29,   Method: Compositional matrix adjust.
 Identities = 76/273 (27%), Positives = 146/273 (53%), Gaps = 18/273 (6%)
Query: 112 EIDAKQLKIECKVASGSYGDLYKGTYCSQEVAIKVLKPECVNT-------EMLKEFSQEV 164
           E + ++LK+   + SG +G ++KG +  +  +IK+  P C+         +  +  +  +
Sbjct: 12  ETELRKLKV---LGSGVFGTVHKGVWIPEGESIKI--PVCIKVIEDKSGRQSFQAVTDHM 66
Query: 165 YIMRKIRHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVS 224
             +  + H ++V+ +G C    +L +VT+++  GS+ D + + +G      LL   + ++
Sbjct: 67  LAIGSLDHAHIVRLLGLCPGS-SLQLVTQYLPLGSLLDHVRQHRGALGPQLLLNWGVQIA 125
Query: 225 KGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSG--VMTAETGT-YRWMA 281
           KGM YL ++ ++HR+L   N+L+     V+VADFGVA +       ++ +E  T  +WMA
Sbjct: 126 KGMYYLEEHGMVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLYSEAKTPIKWMA 185
Query: 282 PEVIEHKPYDYKADVFSFGIALWELLT-GELPYAGLTPLQAAVGVVQKSLRPTIPKHAHP 340
            E I    Y +++DV+S+G+ +WEL+T G  PYAGL  L     +++K  R   P+    
Sbjct: 186 LESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGLR-LAEVPDLLEKGERLAQPQICTI 244
Query: 341 RLAELLERCWQHDPTQRPNFSQITDILKQMMKE 373
            +  ++ +CW  D   RP F ++ +   +M ++
Sbjct: 245 DVYMVMVKCWMIDENIRPTFKELANEFTRMARD 277

>pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306

Iteration: 1
 Score =  125 bits (315), Expect = 3e-29,   Method: Compositional matrix adjust.
 Identities = 78/291 (26%), Positives = 140/291 (48%), Gaps = 26/291 (8%)
Query: 98  PNCIEIPTDGTDVWEIDAKQLKIECKVASGSYGDLYKGTY-------CSQEVAIKVLKPE 150
           P+ + +P    D WE+  +++ +  ++  GS+G +Y+G             VA+K +   
Sbjct: 3   PSSVFVP----DEWEVSREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNES 58
Query: 151 CVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGV 210
               E + EF  E  +M+     +VV+ +G  ++     +V E MA G +  +L   +  
Sbjct: 59  ASLRERI-EFLNEASVMKGFTCHHVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPE 117
Query: 211 FQ---------LTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVA 261
            +         L  ++++A +++ GM YL+    +HRDL   N ++  +  VK+ DFG+ 
Sbjct: 118 AENNPGRPPPTLQEMIQMAAEIADGMAYLNAKKFVHRDLAARNCMVAHDFTVKIGDFGMT 177
Query: 262 R-VQAQSGVMTAETG--TYRWMAPEVIEHKPYDYKADVFSFGIALWELLT-GELPYAGLT 317
           R +           G    RWMAPE ++   +   +D++SFG+ LWE+ +  E PY GL+
Sbjct: 178 RDIXETDXXRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLS 237
Query: 318 PLQAAVGVVQKSLRPTIPKHAHPRLAELLERCWQHDPTQRPNFSQITDILK 368
             Q    V+        P +   R+ +L+  CWQ +P  RP F +I ++LK
Sbjct: 238 NEQVLKFVMDGGYLDQ-PDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLK 287

>pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307

Iteration: 1
 Score =  125 bits (314), Expect = 4e-29,   Method: Compositional matrix adjust.
 Identities = 77/266 (28%), Positives = 126/266 (47%), Gaps = 14/266 (5%)
Query: 124 VASGSYGDLYKGTYCSQE-----VAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQF 178
           +  G +G +Y GT    +      A+K L     +   + +F  E  IM+   H NV+  
Sbjct: 37  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLN-RITDIGEVSQFLTEGIIMKDFSHPNVLSL 95
Query: 179 IGACTRPP-NLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIH 237
           +G C R   +  +V  +M  G + +F+  +     +  L+   + V+KGM YL     +H
Sbjct: 96  LGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLASKKFVH 155
Query: 238 RDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAETGT-----YRWMAPEVIEHKPYDY 292
           RDL   N ++DE   VKVADFG+AR        +    T      +WMA E ++ + +  
Sbjct: 156 RDLAARNCMLDEKFTVKVADFGLARDMYDKEXXSVHNKTGAKLPVKWMALESLQTQKFTT 215
Query: 293 KADVFSFGIALWELLT-GELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRLAELLERCWQ 351
           K+DV+SFG+ LWEL+T G  PY  +      V ++Q   R   P++    L E++ +CW 
Sbjct: 216 KSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGR-RLLQPEYCPDPLYEVMLKCWH 274
Query: 352 HDPTQRPNFSQITDILKQMMKEVASE 377
                RP+FS++   +  +      E
Sbjct: 275 PKAEMRPSFSELVSRISAIFSTFIGE 300

>pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343

Iteration: 1
 Score =  125 bits (314), Expect = 4e-29,   Method: Compositional matrix adjust.
 Identities = 77/256 (30%), Positives = 124/256 (48%), Gaps = 29/256 (11%)
Query: 142 VAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVTEFMARGSIY 201
           VA+K+LK E  + +M  +F +E  +M +  + N+V+ +G C     +C++ E+MA G + 
Sbjct: 80  VAVKMLKEE-ASADMQADFQREAALMAEFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLN 138
Query: 202 DFLHKQKG-----------------------VFQLTSLLKVAIDVSKGMNYLHQNNIIHR 238
           +FL                                   L +A  V+ GM YL +   +HR
Sbjct: 139 EFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHR 198
Query: 239 DLKTANLLMDENGVVKVADFGVARVQAQSGVMTAETG---TYRWMAPEVIEHKPYDYKAD 295
           DL T N L+ EN VVK+ADFG++R    +    A+       RWM PE I +  Y  ++D
Sbjct: 199 DLATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESD 258
Query: 296 VFSFGIALWELLT-GELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRLAELLERCWQHDP 354
           V+++G+ LWE+ + G  PY G+   +  +  V+       P++    L  L+  CW   P
Sbjct: 259 VWAYGVVLWEIFSYGLQPYYGMA-HEEVIYYVRDGNILACPENCPLELYNLMRLCWSKLP 317
Query: 355 TQRPNFSQITDILKQM 370
             RP+F  I  IL++M
Sbjct: 318 ADRPSFCSIHRILQRM 333

>pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308

Iteration: 1
 Score =  125 bits (313), Expect = 5e-29,   Method: Compositional matrix adjust.
 Identities = 77/266 (28%), Positives = 126/266 (47%), Gaps = 14/266 (5%)
Query: 124 VASGSYGDLYKGTYCSQE-----VAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQF 178
           +  G +G +Y GT    +      A+K L     +   + +F  E  IM+   H NV+  
Sbjct: 38  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLN-RITDIGEVSQFLTEGIIMKDFSHPNVLSL 96
Query: 179 IGACTRPP-NLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIH 237
           +G C R   +  +V  +M  G + +F+  +     +  L+   + V+KGM YL     +H
Sbjct: 97  LGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLASKKFVH 156
Query: 238 RDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAETGT-----YRWMAPEVIEHKPYDY 292
           RDL   N ++DE   VKVADFG+AR        +    T      +WMA E ++ + +  
Sbjct: 157 RDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQTQKFTT 216
Query: 293 KADVFSFGIALWELLT-GELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRLAELLERCWQ 351
           K+DV+SFG+ LWEL+T G  PY  +      V ++Q   R   P++    L E++ +CW 
Sbjct: 217 KSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGR-RLLQPEYCPDPLYEVMLKCWH 275
Query: 352 HDPTQRPNFSQITDILKQMMKEVASE 377
                RP+FS++   +  +      E
Sbjct: 276 PKAEMRPSFSELVSRISAIFSTFIGE 301

>pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310

Iteration: 1
 Score =  125 bits (313), Expect = 5e-29,   Method: Compositional matrix adjust.
 Identities = 77/266 (28%), Positives = 126/266 (47%), Gaps = 14/266 (5%)
Query: 124 VASGSYGDLYKGTYCSQE-----VAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQF 178
           +  G +G +Y GT    +      A+K L     +   + +F  E  IM+   H NV+  
Sbjct: 38  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLN-RITDIGEVSQFLTEGIIMKDFSHPNVLSL 96
Query: 179 IGACTRPP-NLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIH 237
           +G C R   +  +V  +M  G + +F+  +     +  L+   + V+KGM YL     +H
Sbjct: 97  LGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLASKKFVH 156
Query: 238 RDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAETGT-----YRWMAPEVIEHKPYDY 292
           RDL   N ++DE   VKVADFG+AR        +    T      +WMA E ++ + +  
Sbjct: 157 RDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQTQKFTT 216
Query: 293 KADVFSFGIALWELLT-GELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRLAELLERCWQ 351
           K+DV+SFG+ LWEL+T G  PY  +      V ++Q   R   P++    L E++ +CW 
Sbjct: 217 KSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGR-RLLQPEYCPDPLYEVMLKCWH 275
Query: 352 HDPTQRPNFSQITDILKQMMKEVASE 377
                RP+FS++   +  +      E
Sbjct: 276 PKAEMRPSFSELVSRISAIFSTFIGE 301

>pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298

Iteration: 1
 Score =  125 bits (313), Expect = 5e-29,   Method: Compositional matrix adjust.
 Identities = 77/266 (28%), Positives = 126/266 (47%), Gaps = 14/266 (5%)
Query: 124 VASGSYGDLYKGTYCSQE-----VAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQF 178
           +  G +G +Y GT    +      A+K L     +   + +F  E  IM+   H NV+  
Sbjct: 33  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLN-RITDIGEVSQFLTEGIIMKDFSHPNVLSL 91
Query: 179 IGACTRPP-NLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIH 237
           +G C R   +  +V  +M  G + +F+  +     +  L+   + V+KGM YL     +H
Sbjct: 92  LGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLASKKFVH 151
Query: 238 RDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAETGT-----YRWMAPEVIEHKPYDY 292
           RDL   N ++DE   VKVADFG+AR        +    T      +WMA E ++ + +  
Sbjct: 152 RDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQTQKFTT 211
Query: 293 KADVFSFGIALWELLT-GELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRLAELLERCWQ 351
           K+DV+SFG+ LWEL+T G  PY  +      V ++Q   R   P++    L E++ +CW 
Sbjct: 212 KSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGR-RLLQPEYCPDPLYEVMLKCWH 270
Query: 352 HDPTQRPNFSQITDILKQMMKEVASE 377
                RP+FS++   +  +      E
Sbjct: 271 PKAEMRPSFSELVSRISAIFSTFIGE 296

>pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306

Iteration: 1
 Score =  125 bits (313), Expect = 5e-29,   Method: Compositional matrix adjust.
 Identities = 77/266 (28%), Positives = 126/266 (47%), Gaps = 14/266 (5%)
Query: 124 VASGSYGDLYKGTYCSQE-----VAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQF 178
           +  G +G +Y GT    +      A+K L     +   + +F  E  IM+   H NV+  
Sbjct: 35  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLN-RITDIGEVSQFLTEGIIMKDFSHPNVLSL 93
Query: 179 IGACTRPP-NLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIH 237
           +G C R   +  +V  +M  G + +F+  +     +  L+   + V+KGM YL     +H
Sbjct: 94  LGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLASKKFVH 153
Query: 238 RDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAETGT-----YRWMAPEVIEHKPYDY 292
           RDL   N ++DE   VKVADFG+AR        +    T      +WMA E ++ + +  
Sbjct: 154 RDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQTQKFTT 213
Query: 293 KADVFSFGIALWELLT-GELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRLAELLERCWQ 351
           K+DV+SFG+ LWEL+T G  PY  +      V ++Q   R   P++    L E++ +CW 
Sbjct: 214 KSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGR-RLLQPEYCPDPLYEVMLKCWH 272
Query: 352 HDPTQRPNFSQITDILKQMMKEVASE 377
                RP+FS++   +  +      E
Sbjct: 273 PKAEMRPSFSELVSRISAIFSTFIGE 298

>pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303

Iteration: 1
 Score =  125 bits (313), Expect = 6e-29,   Method: Compositional matrix adjust.
 Identities = 76/280 (27%), Positives = 135/280 (48%), Gaps = 22/280 (7%)
Query: 109 DVWEIDAKQLKIECKVASGSYGDLYKGTY-------CSQEVAIKVLKPECVNTEMLKEFS 161
           D WE+  +++ +  ++  GS+G +Y+G             VA+K +       E + EF 
Sbjct: 7   DEWEVSREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERI-EFL 65
Query: 162 QEVYIMRKIRHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQ--------- 212
            E  +M+     +VV+ +G  ++     +V E MA G +  +L   +   +         
Sbjct: 66  NEASVMKGFTCHHVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPT 125
Query: 213 LTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVAR-VQAQSGVMT 271
           L  ++++A +++ GM YL+    +HRDL   N ++  +  VK+ DFG+ R +        
Sbjct: 126 LQEMIQMAAEIADGMAYLNAKKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIXETDXXRK 185
Query: 272 AETG--TYRWMAPEVIEHKPYDYKADVFSFGIALWELLT-GELPYAGLTPLQAAVGVVQK 328
              G    RWMAPE ++   +   +D++SFG+ LWE+ +  E PY GL+  Q    V+  
Sbjct: 186 GGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVLKFVMDG 245
Query: 329 SLRPTIPKHAHPRLAELLERCWQHDPTQRPNFSQITDILK 368
                 P +   R+ +L+  CWQ +P  RP F +I ++LK
Sbjct: 246 GYLDQ-PDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLK 284

>pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319

Iteration: 1
 Score =  125 bits (313), Expect = 6e-29,   Method: Compositional matrix adjust.
 Identities = 76/252 (30%), Positives = 123/252 (48%), Gaps = 14/252 (5%)
Query: 124 VASGSYGDLYKGTYCSQE-----VAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQF 178
           +  G +G +Y GT    +      A+K L     +   + +F  E  IM+   H NV+  
Sbjct: 57  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLN-RITDIGEVSQFLTEGIIMKDFSHPNVLSL 115
Query: 179 IGACTRPP-NLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIH 237
           +G C R   +  +V  +M  G + +F+  +     +  L+   + V+KGM YL     +H
Sbjct: 116 LGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLASKKFVH 175
Query: 238 RDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAETGT-----YRWMAPEVIEHKPYDY 292
           RDL   N ++DE   VKVADFG+AR        +    T      +WMA E ++ + +  
Sbjct: 176 RDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQTQKFTT 235
Query: 293 KADVFSFGIALWELLT-GELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRLAELLERCWQ 351
           K+DV+SFG+ LWEL+T G  PY  +      V ++Q   R   P++    L E++ +CW 
Sbjct: 236 KSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGR-RLLQPEYCPDPLYEVMLKCWH 294
Query: 352 HDPTQRPNFSQI 363
                RP+FS++
Sbjct: 295 PKAEMRPSFSEL 306

>pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306

Iteration: 1
 Score =  124 bits (312), Expect = 6e-29,   Method: Compositional matrix adjust.
 Identities = 81/309 (26%), Positives = 147/309 (47%), Gaps = 26/309 (8%)
Query: 98  PNCIEIPTDGTDVWEIDAKQLKIECKVASGSYGDLYKGTY-------CSQEVAIKVLKPE 150
           P+ + +P    D WE+  +++ +  ++  GS+G +Y+G             VA+K +   
Sbjct: 3   PSSVFVP----DEWEVSREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNES 58
Query: 151 CVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGV 210
               E + EF  E  +M+     +VV+ +G  ++     +V E MA G +  +L   +  
Sbjct: 59  ASLRERI-EFLNEASVMKGFTCHHVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPE 117
Query: 211 FQ---------LTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVA 261
            +         L  ++++A +++ GM YL+    +HRDL   N ++  +  VK+ DFG+ 
Sbjct: 118 AENNPGRPPPTLQEMIQMAAEIADGMAYLNAKKFVHRDLAARNCMVAHDFTVKIGDFGMT 177
Query: 262 R-VQAQSGVMTAETG--TYRWMAPEVIEHKPYDYKADVFSFGIALWELLT-GELPYAGLT 317
           R +   +       G    RWMAPE ++   +   +D++SFG+ LWE+ +  E PY GL+
Sbjct: 178 RDIYETAYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLS 237
Query: 318 PLQAAVGVVQKSLRPTIPKHAHPRLAELLERCWQHDPTQRPNFSQITDILKQMMKEVASE 377
             Q    V+        P +   R+ +L+  CWQ +P  RP F +I ++LK  +     E
Sbjct: 238 NEQVLKFVMDGGYLDQ-PDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKDDLHPSFPE 296
Query: 378 GENNHSNKS 386
               HS ++
Sbjct: 297 VSFFHSEEN 305

>pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309

Iteration: 1
 Score =  124 bits (312), Expect = 6e-29,   Method: Compositional matrix adjust.
 Identities = 77/266 (28%), Positives = 126/266 (47%), Gaps = 14/266 (5%)
Query: 124 VASGSYGDLYKGTYCSQE-----VAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQF 178
           +  G +G +Y GT    +      A+K L     +   + +F  E  IM+   H NV+  
Sbjct: 37  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLN-RITDIGEVSQFLTEGIIMKDFSHPNVLSL 95
Query: 179 IGACTRPP-NLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIH 237
           +G C R   +  +V  +M  G + +F+  +     +  L+   + V+KGM YL     +H
Sbjct: 96  LGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLASKKFVH 155
Query: 238 RDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAETGT-----YRWMAPEVIEHKPYDY 292
           RDL   N ++DE   VKVADFG+AR        +    T      +WMA E ++ + +  
Sbjct: 156 RDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQTQKFTT 215
Query: 293 KADVFSFGIALWELLT-GELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRLAELLERCWQ 351
           K+DV+SFG+ LWEL+T G  PY  +      V ++Q   R   P++    L E++ +CW 
Sbjct: 216 KSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGR-RLLQPEYCPDPLYEVMLKCWH 274
Query: 352 HDPTQRPNFSQITDILKQMMKEVASE 377
                RP+FS++   +  +      E
Sbjct: 275 PKAEMRPSFSELVSRISAIFSTFIGE 300

>pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318

Iteration: 1
 Score =  124 bits (312), Expect = 7e-29,   Method: Compositional matrix adjust.
 Identities = 76/252 (30%), Positives = 123/252 (48%), Gaps = 14/252 (5%)
Query: 124 VASGSYGDLYKGTYCSQE-----VAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQF 178
           +  G +G +Y GT    +      A+K L     +   + +F  E  IM+   H NV+  
Sbjct: 56  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLN-RITDIGEVSQFLTEGIIMKDFSHPNVLSL 114
Query: 179 IGACTRPP-NLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIH 237
           +G C R   +  +V  +M  G + +F+  +     +  L+   + V+KGM YL     +H
Sbjct: 115 LGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLASKKFVH 174
Query: 238 RDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAETGT-----YRWMAPEVIEHKPYDY 292
           RDL   N ++DE   VKVADFG+AR        +    T      +WMA E ++ + +  
Sbjct: 175 RDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQTQKFTT 234
Query: 293 KADVFSFGIALWELLT-GELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRLAELLERCWQ 351
           K+DV+SFG+ LWEL+T G  PY  +      V ++Q   R   P++    L E++ +CW 
Sbjct: 235 KSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGR-RLLQPEYCPDPLYEVMLKCWH 293
Query: 352 HDPTQRPNFSQI 363
                RP+FS++
Sbjct: 294 PKAEMRPSFSEL 305

>pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292

Iteration: 1
 Score =  124 bits (312), Expect = 7e-29,   Method: Compositional matrix adjust.
 Identities = 76/253 (30%), Positives = 123/253 (48%), Gaps = 14/253 (5%)
Query: 124 VASGSYGDLYKGTYCSQE-----VAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQF 178
           +  G +G +Y GT    +      A+K L     +   + +F  E  IM+   H NV+  
Sbjct: 30  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLN-RITDIGEVSQFLTEGIIMKDFSHPNVLSL 88
Query: 179 IGACTRPP-NLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIH 237
           +G C R   +  +V  +M  G + +F+  +     +  L+   + V+KGM YL     +H
Sbjct: 89  LGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLASKKFVH 148
Query: 238 RDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAETGT-----YRWMAPEVIEHKPYDY 292
           RDL   N ++DE   VKVADFG+AR        +    T      +WMA E ++ + +  
Sbjct: 149 RDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQTQKFTT 208
Query: 293 KADVFSFGIALWELLT-GELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRLAELLERCWQ 351
           K+DV+SFG+ LWEL+T G  PY  +      V ++Q   R   P++    L E++ +CW 
Sbjct: 209 KSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGR-RLLQPEYCPDPLYEVMLKCWH 267
Query: 352 HDPTQRPNFSQIT 364
                RP+FS++ 
Sbjct: 268 PKAEMRPSFSELV 280

>pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344

Iteration: 1
 Score =  124 bits (312), Expect = 8e-29,   Method: Compositional matrix adjust.
 Identities = 79/290 (27%), Positives = 136/290 (46%), Gaps = 33/290 (11%)
Query: 111 WEIDAKQLKIECKVASGSYGDLYKGTY-------CSQEVAIKVLKPECVNTEMLKEFSQE 163
           WE   + L+    + SG++G +   T         S +VA+K+LK +  ++E     S+ 
Sbjct: 40  WEFPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSEL 99
Query: 164 VYIMRKIRHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQK--------------- 208
             + +   H+N+V  +GACT    + ++ E+   G + ++L  ++               
Sbjct: 100 KMMTQLGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKR 159
Query: 209 -------GVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVA 261
                   V     LL  A  V+KGM +L   + +HRDL   N+L+    VVK+ DFG+A
Sbjct: 160 LEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAARNVLVTHGKVVKICDFGLA 219
Query: 262 R-VQAQSGVMTAETGTY--RWMAPEVIEHKPYDYKADVFSFGIALWELLT-GELPYAGLT 317
           R + + S  +         +WMAPE +    Y  K+DV+S+GI LWE+ + G  PY G+ 
Sbjct: 220 RDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIP 279
Query: 318 PLQAAVGVVQKSLRPTIPKHAHPRLAELLERCWQHDPTQRPNFSQITDIL 367
                  ++Q   +   P +A   +  +++ CW  D  +RP+F  +T  L
Sbjct: 280 VDANFYKLIQNGFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFL 329

>pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306

Iteration: 1
 Score =  124 bits (312), Expect = 8e-29,   Method: Compositional matrix adjust.
 Identities = 81/314 (25%), Positives = 148/314 (47%), Gaps = 36/314 (11%)
Query: 98  PNCIEIPTDGTDVWEIDAKQLKIECKVASGSYGDLYKGTY-------CSQEVAIKVLKPE 150
           P+ + +P    D WE+  +++ +  ++  GS+G +Y+G             VA+K +   
Sbjct: 3   PSSVFVP----DEWEVSREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNES 58
Query: 151 CVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGV 210
               E + EF  E  +M+     +VV+ +G  ++     +V E MA G +  +L   +  
Sbjct: 59  ASLRERI-EFLNEASVMKGFTCHHVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPE 117
Query: 211 FQ---------LTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVA 261
            +         L  ++++A +++ GM YL+    +HRDL   N ++  +  VK+ DFG+ 
Sbjct: 118 AENNPGRPPPTLQEMIQMAAEIADGMAYLNAKKFVHRDLAARNCMVAHDFTVKIGDFGMT 177
Query: 262 R--------VQAQSGVMTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLT-GELP 312
           R         +   G++       RWMAPE ++   +   +D++SFG+ LWE+ +  E P
Sbjct: 178 RDIYETDYYRKGGKGLLPV-----RWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQP 232
Query: 313 YAGLTPLQAAVGVVQKSLRPTIPKHAHPRLAELLERCWQHDPTQRPNFSQITDILKQMMK 372
           Y GL+  Q    V+        P +   R+ +L+  CWQ +P  RP F +I ++LK  + 
Sbjct: 233 YQGLSNEQVLKFVMDGGYLDQ-PDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKDDLH 291
Query: 373 EVASEGENNHSNKS 386
               E    HS ++
Sbjct: 292 PSFPEVSFFHSEEN 305

>pdb|4FNX|A Chain A, Crystal Structure Of The Apo R1275q Anaplastic Lymphoma Kinase Catalytic Domain Length = 327

Iteration: 1
 Score =  124 bits (311), Expect = 8e-29,   Method: Compositional matrix adjust.
 Identities = 82/278 (29%), Positives = 133/278 (47%), Gaps = 22/278 (7%)
Query: 108 TDVWEIDAKQLKIECKVASGSYGDLYKGTYCSQ-------EVAIKVLKPECVNTEMLKEF 160
           +D+ E+  K + +   +  G++G++Y+G            +VA+K L   C   + L +F
Sbjct: 23  SDLKEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDEL-DF 81
Query: 161 SQEVYIMRKIRHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHK------QKGVFQLT 214
             E  I+ K  H+N+V+ IG   +     I+ E MA G +  FL +      Q     + 
Sbjct: 82  LMEALIISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAML 141
Query: 215 SLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENG---VVKVADFGVARVQAQSGVMT 271
            LL VA D++ G  YL +N+ IHRD+   N L+   G   V K+ DFG+A+   ++    
Sbjct: 142 DLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMAQDIYRASYYR 201
Query: 272 ---AETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLT-GELPYAGLTPLQAAVGVVQ 327
                    +WM PE      +  K D +SFG+ LWE+ + G +PY   +  Q  +  V 
Sbjct: 202 KGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKS-NQEVLEFVT 260
Query: 328 KSLRPTIPKHAHPRLAELLERCWQHDPTQRPNFSQITD 365
              R   PK+    +  ++ +CWQH P  RPNF+ I +
Sbjct: 261 SGGRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILE 298

>pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317

Iteration: 1
 Score =  124 bits (310), Expect = 1e-28,   Method: Compositional matrix adjust.
 Identities = 77/266 (28%), Positives = 130/266 (48%), Gaps = 14/266 (5%)
Query: 124 VASGSYGDLYKGTYCSQE-----VAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQF 178
           +  G +G +Y GT    +      A+K L     +   + +F  E  IM+   H NV+  
Sbjct: 39  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLN-RITDIGEVSQFLTEGIIMKDFSHPNVLSL 97
Query: 179 IGACTRPP-NLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIH 237
           +G C R   +  +V  +M  G + +F+  +     +  L+   + V+KGM +L     +H
Sbjct: 98  LGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKKFVH 157
Query: 238 RDLKTANLLMDENGVVKVADFGVAR--VQAQSGVMTAETGT---YRWMAPEVIEHKPYDY 292
           RDL   N ++DE   VKVADFG+AR  +  +   +  +TG     +WMA E ++ + +  
Sbjct: 158 RDLAARNCMLDEKFTVKVADFGLARDMLDKEFDSVHNKTGAKLPVKWMALESLQTQKFTT 217
Query: 293 KADVFSFGIALWELLT-GELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRLAELLERCWQ 351
           K+DV+SFG+ LWEL+T G  PY  +      V ++Q   R   P++    L E++ +CW 
Sbjct: 218 KSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGR-RLLQPEYCPDPLYEVMLKCWH 276
Query: 352 HDPTQRPNFSQITDILKQMMKEVASE 377
                RP+FS++   +  +      E
Sbjct: 277 PKAEMRPSFSELVSRISAIFSTFIGE 302

>pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor Length = 307

Iteration: 1
 Score =  123 bits (309), Expect = 1e-28,   Method: Compositional matrix adjust.
 Identities = 77/296 (26%), Positives = 142/296 (47%), Gaps = 36/296 (12%)
Query: 98  PNCIEIPTDGTDVWEIDAKQLKIECKVASGSYGDLYKGTY-------CSQEVAIKVLKPE 150
           P+ + +P    D WE+  +++ +  ++  GS+G +Y+G             VA+K +   
Sbjct: 4   PSSVYVP----DEWEVSREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNES 59
Query: 151 CVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGV 210
               E + EF  E  +M+     +VV+ +G  ++     +V E MA G +  +L   +  
Sbjct: 60  ASLRERI-EFLNEASVMKGFTCHHVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPE 118
Query: 211 FQ---------LTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVA 261
            +         L  ++++A +++ GM YL+    +HR+L   N ++  +  VK+ DFG+ 
Sbjct: 119 AENNPGRPPPTLQEMIQMAAEIADGMAYLNAKKFVHRNLAARNCMVAHDFTVKIGDFGMT 178
Query: 262 R--------VQAQSGVMTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLT-GELP 312
           R         +   G++       RWMAPE ++   +   +D++SFG+ LWE+ +  E P
Sbjct: 179 RDIYETDYYRKGGKGLLPV-----RWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQP 233
Query: 313 YAGLTPLQAAVGVVQKSLRPTIPKHAHPRLAELLERCWQHDPTQRPNFSQITDILK 368
           Y GL+  Q    V+        P +   R+ +L+  CWQ +P  RP F +I ++LK
Sbjct: 234 YQGLSNEQVLKFVMDGGYLDQ-PDNCPERVTDLMRMCWQFNPNMRPTFLEIVNLLK 288

>pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306

Iteration: 1
 Score =  123 bits (309), Expect = 2e-28,   Method: Compositional matrix adjust.
 Identities = 77/296 (26%), Positives = 142/296 (47%), Gaps = 36/296 (12%)
Query: 98  PNCIEIPTDGTDVWEIDAKQLKIECKVASGSYGDLYKGTY-------CSQEVAIKVLKPE 150
           P+ + +P    D WE+  +++ +  ++  GS+G +Y+G             VA+K +   
Sbjct: 3   PSSVYVP----DEWEVSREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNES 58
Query: 151 CVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGV 210
               E + EF  E  +M+     +VV+ +G  ++     +V E MA G +  +L   +  
Sbjct: 59  ASLRERI-EFLNEASVMKGFTCHHVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPE 117
Query: 211 FQ---------LTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVA 261
            +         L  ++++A +++ GM YL+    +HR+L   N ++  +  VK+ DFG+ 
Sbjct: 118 AENNPGRPPPTLQEMIQMAAEIADGMAYLNAKKFVHRNLAARNCMVAHDFTVKIGDFGMT 177
Query: 262 R--------VQAQSGVMTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLT-GELP 312
           R         +   G++       RWMAPE ++   +   +D++SFG+ LWE+ +  E P
Sbjct: 178 RDIYETDYYRKGGKGLLPV-----RWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQP 232
Query: 313 YAGLTPLQAAVGVVQKSLRPTIPKHAHPRLAELLERCWQHDPTQRPNFSQITDILK 368
           Y GL+  Q    V+        P +   R+ +L+  CWQ +P  RP F +I ++LK
Sbjct: 233 YQGLSNEQVLKFVMDGGYLDQ-PDNCPERVTDLMRMCWQFNPNMRPTFLEIVNLLK 287

>pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373

Iteration: 1
 Score =  123 bits (309), Expect = 2e-28,   Method: Compositional matrix adjust.
 Identities = 77/266 (28%), Positives = 129/266 (48%), Gaps = 14/266 (5%)
Query: 124 VASGSYGDLYKGTYCSQE-----VAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQF 178
           +  G +G +Y GT    +      A+K L     +   + +F  E  IM+   H NV+  
Sbjct: 97  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLN-RITDIGEVSQFLTEGIIMKDFSHPNVLSL 155
Query: 179 IGACTRPP-NLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIH 237
           +G C R   +  +V  +M  G + +F+  +     +  L+   + V+KGM +L     +H
Sbjct: 156 LGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKKFVH 215
Query: 238 RDLKTANLLMDENGVVKVADFGVAR--VQAQSGVMTAETGT---YRWMAPEVIEHKPYDY 292
           RDL   N ++DE   VKVADFG+AR     +   +  +TG     +WMA E ++ + +  
Sbjct: 216 RDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQKFTT 275
Query: 293 KADVFSFGIALWELLT-GELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRLAELLERCWQ 351
           K+DV+SFG+ LWEL+T G  PY  +      V ++Q   R   P++    L E++ +CW 
Sbjct: 276 KSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGR-RLLQPEYCPDPLYEVMLKCWH 334
Query: 352 HDPTQRPNFSQITDILKQMMKEVASE 377
                RP+FS++   +  +      E
Sbjct: 335 PKAEMRPSFSELVSRISAIFSTFIGE 360

>pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317

Iteration: 1
 Score =  123 bits (308), Expect = 2e-28,   Method: Compositional matrix adjust.
 Identities = 77/266 (28%), Positives = 129/266 (48%), Gaps = 14/266 (5%)
Query: 124 VASGSYGDLYKGTYCSQE-----VAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQF 178
           +  G +G +Y GT    +      A+K L     +   + +F  E  IM+   H NV+  
Sbjct: 39  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLN-RITDIGEVSQFLTEGIIMKDFSHPNVLSL 97
Query: 179 IGACTRPP-NLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIH 237
           +G C R   +  +V  +M  G + +F+  +     +  L+   + V+KGM +L     +H
Sbjct: 98  LGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKKFVH 157
Query: 238 RDLKTANLLMDENGVVKVADFGVAR--VQAQSGVMTAETGT---YRWMAPEVIEHKPYDY 292
           RDL   N ++DE   VKVADFG+AR     +   +  +TG     +WMA E ++ + +  
Sbjct: 158 RDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQKFTT 217
Query: 293 KADVFSFGIALWELLT-GELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRLAELLERCWQ 351
           K+DV+SFG+ LWEL+T G  PY  +      V ++Q   R   P++    L E++ +CW 
Sbjct: 218 KSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGR-RLLQPEYCPDPLYEVMLKCWH 276
Query: 352 HDPTQRPNFSQITDILKQMMKEVASE 377
                RP+FS++   +  +      E
Sbjct: 277 PKAEMRPSFSELVSRISAIFSTFIGE 302

>pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312

Iteration: 1
 Score =  123 bits (308), Expect = 2e-28,   Method: Compositional matrix adjust.
 Identities = 77/266 (28%), Positives = 129/266 (48%), Gaps = 14/266 (5%)
Query: 124 VASGSYGDLYKGTYCSQE-----VAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQF 178
           +  G +G +Y GT    +      A+K L     +   + +F  E  IM+   H NV+  
Sbjct: 36  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLN-RITDIGEVSQFLTEGIIMKDFSHPNVLSL 94
Query: 179 IGACTRPP-NLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIH 237
           +G C R   +  +V  +M  G + +F+  +     +  L+   + V+KGM +L     +H
Sbjct: 95  LGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKKFVH 154
Query: 238 RDLKTANLLMDENGVVKVADFGVAR--VQAQSGVMTAETGT---YRWMAPEVIEHKPYDY 292
           RDL   N ++DE   VKVADFG+AR     +   +  +TG     +WMA E ++ + +  
Sbjct: 155 RDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQKFTT 214
Query: 293 KADVFSFGIALWELLT-GELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRLAELLERCWQ 351
           K+DV+SFG+ LWEL+T G  PY  +      V ++Q   R   P++    L E++ +CW 
Sbjct: 215 KSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGR-RLLQPEYCPDPLYEVMLKCWH 273
Query: 352 HDPTQRPNFSQITDILKQMMKEVASE 377
                RP+FS++   +  +      E
Sbjct: 274 PKAEMRPSFSELVSRISAIFSTFIGE 299

>pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325

Iteration: 1
 Score =  123 bits (308), Expect = 2e-28,   Method: Compositional matrix adjust.
 Identities = 81/263 (30%), Positives = 130/263 (49%), Gaps = 16/263 (6%)
Query: 109 DVWEIDAKQLKIECKVASGSYGDLYKGTYCSQEVAIKVLKPECVNTEMLKEFSQEVYIMR 168
           D WEI  +       +  G++G +YK       V       +  + E L+++  E+ I+ 
Sbjct: 37  DFWEIIGE-------LGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILA 89
Query: 169 KIRHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMN 228
              H N+V+ + A     NL I+ EF A G++   + + +     + +  V       +N
Sbjct: 90  SCDHPNIVKLLDAFYYENNLWILIEFCAGGAVDAVMLELERPLTESQIQVVCKQTLDALN 149
Query: 229 YLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQS-GVMTAETGTYRWMAPEVI-- 285
           YLH N IIHRDLK  N+L   +G +K+ADFGV+    ++     +  GT  WMAPEV+  
Sbjct: 150 YLHDNKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDSFIGTPYWMAPEVVMC 209
Query: 286 ---EHKPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKSLRPTI--PKHAHP 340
              + +PYDYKADV+S GI L E+   E P+  L P++  + +  KS  PT+  P     
Sbjct: 210 ETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVLLKIA-KSEPPTLAQPSRWSS 268
Query: 341 RLAELLERCWQHDPTQRPNFSQI 363
              + L++C + +   R   SQ+
Sbjct: 269 NFKDFLKKCLEKNVDARWTTSQL 291

>pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314

Iteration: 1
 Score =  123 bits (308), Expect = 2e-28,   Method: Compositional matrix adjust.
 Identities = 77/266 (28%), Positives = 129/266 (48%), Gaps = 14/266 (5%)
Query: 124 VASGSYGDLYKGTYCSQE-----VAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQF 178
           +  G +G +Y GT    +      A+K L     +   + +F  E  IM+   H NV+  
Sbjct: 38  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLN-RITDIGEVSQFLTEGIIMKDFSHPNVLSL 96
Query: 179 IGACTRPP-NLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIH 237
           +G C R   +  +V  +M  G + +F+  +     +  L+   + V+KGM +L     +H
Sbjct: 97  LGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKKFVH 156
Query: 238 RDLKTANLLMDENGVVKVADFGVAR--VQAQSGVMTAETGT---YRWMAPEVIEHKPYDY 292
           RDL   N ++DE   VKVADFG+AR     +   +  +TG     +WMA E ++ + +  
Sbjct: 157 RDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQKFTT 216
Query: 293 KADVFSFGIALWELLT-GELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRLAELLERCWQ 351
           K+DV+SFG+ LWEL+T G  PY  +      V ++Q   R   P++    L E++ +CW 
Sbjct: 217 KSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGR-RLLQPEYCPDPLYEVMLKCWH 275
Query: 352 HDPTQRPNFSQITDILKQMMKEVASE 377
                RP+FS++   +  +      E
Sbjct: 276 PKAEMRPSFSELVSRISAIFSTFIGE 301

>pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314

Iteration: 1
 Score =  123 bits (308), Expect = 2e-28,   Method: Compositional matrix adjust.
 Identities = 77/266 (28%), Positives = 129/266 (48%), Gaps = 14/266 (5%)
Query: 124 VASGSYGDLYKGTYCSQE-----VAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQF 178
           +  G +G +Y GT    +      A+K L     +   + +F  E  IM+   H NV+  
Sbjct: 38  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLN-RITDIGEVSQFLTEGIIMKDFSHPNVLSL 96
Query: 179 IGACTRPP-NLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIH 237
           +G C R   +  +V  +M  G + +F+  +     +  L+   + V+KGM +L     +H
Sbjct: 97  LGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKKFVH 156
Query: 238 RDLKTANLLMDENGVVKVADFGVAR--VQAQSGVMTAETGT---YRWMAPEVIEHKPYDY 292
           RDL   N ++DE   VKVADFG+AR     +   +  +TG     +WMA E ++ + +  
Sbjct: 157 RDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQKFTT 216
Query: 293 KADVFSFGIALWELLT-GELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRLAELLERCWQ 351
           K+DV+SFG+ LWEL+T G  PY  +      V ++Q   R   P++    L E++ +CW 
Sbjct: 217 KSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGR-RLLQPEYCPDPLYEVMLKCWH 275
Query: 352 HDPTQRPNFSQITDILKQMMKEVASE 377
                RP+FS++   +  +      E
Sbjct: 276 PKAEMRPSFSELVSRISAIFSTFIGE 301

>pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319

Iteration: 1
 Score =  123 bits (308), Expect = 2e-28,   Method: Compositional matrix adjust.
 Identities = 77/266 (28%), Positives = 129/266 (48%), Gaps = 14/266 (5%)
Query: 124 VASGSYGDLYKGTYCSQE-----VAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQF 178
           +  G +G +Y GT    +      A+K L     +   + +F  E  IM+   H NV+  
Sbjct: 43  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLN-RITDIGEVSQFLTEGIIMKDFSHPNVLSL 101
Query: 179 IGACTRPP-NLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIH 237
           +G C R   +  +V  +M  G + +F+  +     +  L+   + V+KGM +L     +H
Sbjct: 102 LGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKKFVH 161
Query: 238 RDLKTANLLMDENGVVKVADFGVAR--VQAQSGVMTAETGT---YRWMAPEVIEHKPYDY 292
           RDL   N ++DE   VKVADFG+AR     +   +  +TG     +WMA E ++ + +  
Sbjct: 162 RDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQKFTT 221
Query: 293 KADVFSFGIALWELLT-GELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRLAELLERCWQ 351
           K+DV+SFG+ LWEL+T G  PY  +      V ++Q   R   P++    L E++ +CW 
Sbjct: 222 KSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGR-RLLQPEYCPDPLYEVMLKCWH 280
Query: 352 HDPTQRPNFSQITDILKQMMKEVASE 377
                RP+FS++   +  +      E
Sbjct: 281 PKAEMRPSFSELVSRISAIFSTFIGE 306

>pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338

Iteration: 1
 Score =  123 bits (308), Expect = 2e-28,   Method: Compositional matrix adjust.
 Identities = 79/272 (29%), Positives = 140/272 (51%), Gaps = 16/272 (5%)
Query: 112 EIDAKQLKIECKVASGSYGDLYKGTYCSQ------EVAIKVLKPECVNTEMLKEFSQEVY 165
           E + +++K+   + SG++G +YKG +          VAIKVL+ E  + +  KE   E Y
Sbjct: 16  ETELRKVKV---LGSGAFGTVYKGIWIPDGENVKIPVAIKVLR-ENTSPKANKEILDEAY 71
Query: 166 IMRKIRHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSK 225
           +M  +    V + +G C     + +VT+ M  G + D + + +G      LL   + ++K
Sbjct: 72  VMAGVGSPYVSRLLGICLTS-TVQLVTQLMPYGCLLDHVRENRGRLGSQDLLNWCMQIAK 130
Query: 226 GMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVAR-VQAQSGVMTAETGTY--RWMAP 282
           GM+YL    ++HRDL   N+L+     VK+ DFG+AR +        A+ G    +WMA 
Sbjct: 131 GMSYLEDVRLVHRDLAARNVLVKSPNHVKITDFGLARLLDIDETEYHADGGKVPIKWMAL 190
Query: 283 EVIEHKPYDYKADVFSFGIALWELLT-GELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPR 341
           E I  + + +++DV+S+G+ +WEL+T G  PY G+ P +    +++K  R   P      
Sbjct: 191 ESILRRRFTHQSDVWSYGVTVWELMTFGAKPYDGI-PAREIPDLLEKGERLPQPPICTID 249
Query: 342 LAELLERCWQHDPTQRPNFSQITDILKQMMKE 373
           +  ++ +CW  D   RP F ++     +M ++
Sbjct: 250 VYMIMVKCWMIDSECRPRFRELVSEFSRMARD 281

>pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325

Iteration: 1
 Score =  122 bits (307), Expect = 2e-28,   Method: Compositional matrix adjust.
 Identities = 82/267 (30%), Positives = 131/267 (49%), Gaps = 24/267 (8%)
Query: 109 DVWEIDAKQLKIECKVASGSYGDLYKGTYCSQEVAIKVLKPECVNTEMLKEFSQEVYIMR 168
           D WEI  +       +  G++G +YK       V       +  + E L+++  E+ I+ 
Sbjct: 37  DFWEIIGE-------LGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILA 89
Query: 169 KIRHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMN 228
              H N+V+ + A     NL I+ EF A G++   + + +     + +  V       +N
Sbjct: 90  SCDHPNIVKLLDAFYYENNLWILIEFCAGGAVDAVMLELERPLTESQIQVVCKQTLDALN 149
Query: 229 YLHQNNIIHRDLKTANLLMDENGVVKVADFGVA-----RVQAQSGVMTAETGTYRWMAPE 283
           YLH N IIHRDLK  N+L   +G +K+ADFGV+      +Q +   +    GT  WMAPE
Sbjct: 150 YLHDNKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRXIQRRDSFI----GTPYWMAPE 205
Query: 284 VI-----EHKPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKSLRPTI--PK 336
           V+     + +PYDYKADV+S GI L E+   E P+  L P++  + +  KS  PT+  P 
Sbjct: 206 VVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVLLKIA-KSEPPTLAQPS 264
Query: 337 HAHPRLAELLERCWQHDPTQRPNFSQI 363
                  + L++C + +   R   SQ+
Sbjct: 265 RWSSNFKDFLKKCLEKNVDARWTTSQL 291

>pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299

Iteration: 1
 Score =  122 bits (307), Expect = 3e-28,   Method: Compositional matrix adjust.
 Identities = 86/291 (29%), Positives = 145/291 (49%), Gaps = 32/291 (10%)
Query: 108 TDVWEIDAKQLKIECKVASGSYGDLYKG---TYCSQE----VAIKVLKPECVNTEMLKEF 160
           T V  I    + ++ ++  G++G ++       C ++    VA+K LK    N    K+F
Sbjct: 5   TFVQHIKRHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNAR--KDF 62
Query: 161 SQEVYIMRKIRHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFL--HKQKGVF------- 211
            +E  ++  ++H+++V+F G C     L +V E+M  G +  FL  H    V        
Sbjct: 63  HREAELLTNLQHEHIVKFYGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNPP 122
Query: 212 -QLTS--LLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSG 268
            +LT   +L +A  ++ GM YL   + +HRDL T N L+ EN +VK+ DFG++R    + 
Sbjct: 123 TELTQSQMLHIAQQIAAGMVYLASQHFVHRDLATRNCLVGENLLVKIGDFGMSRDVYSTD 182
Query: 269 VMTAETGTY---RWMAPEVIEHKPYDYKADVFSFGIALWELLT-GELPYAGLTPLQAAVG 324
                  T    RWM PE I ++ +  ++DV+S G+ LWE+ T G+ P+  L+  +    
Sbjct: 183 YYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNEVIEC 242
Query: 325 VVQKSL--RP-TIPKHAHPRLAELLERCWQHDPTQRPNFSQITDILKQMMK 372
           + Q  +  RP T P+  +    EL+  CWQ +P  R N   I  +L+ + K
Sbjct: 243 ITQGRVLQRPRTCPQEVY----ELMLGCWQREPHMRKNIKGIHTLLQNLAK 289

>pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273

Iteration: 1
 Score =  122 bits (306), Expect = 4e-28,   Method: Compositional matrix adjust.
 Identities = 81/276 (29%), Positives = 148/276 (53%), Gaps = 13/276 (4%)
Query: 113 IDAKQLKIECK-VASGSYGDLYKGTY----CSQEVAIKVLKPECVNTEMLKEFSQEVYIM 167
           +D K L +E K + SG++G + KG Y      + VA+K+LK E  +  +  E   E  +M
Sbjct: 1   LDRKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVM 60
Query: 168 RKIRHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGM 227
           +++ +  +V+ IG C    +  +V E    G +  +L + + V +  +++++   VS GM
Sbjct: 61  QQLDNPYIVRMIGIC-EAESWMLVMEMAELGPLNKYLQQNRHV-KDKNIIELVHQVSMGM 118
Query: 228 NYLHQNNIIHRDLKTANLLMDENGVVKVADFGVAR-VQAQSGVMTAET-GTY--RWMAPE 283
            YL ++N +HRDL   N+L+      K++DFG+++ ++A      A+T G +  +W APE
Sbjct: 119 KYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPE 178
Query: 284 VIEHKPYDYKADVFSFGIALWELLT-GELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRL 342
            I +  +  K+DV+SFG+ +WE  + G+ PY G+   +    +++K  R   P      +
Sbjct: 179 CINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSE-VTAMLEKGERMGCPAGCPREM 237
Query: 343 AELLERCWQHDPTQRPNFSQITDILKQMMKEVASEG 378
            +L+  CW +D   RP F+ +   L+    +V +EG
Sbjct: 238 YDLMNLCWTYDVENRPGFAAVELRLRNYYYDVVNEG 273

>pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302

Iteration: 1
 Score =  122 bits (306), Expect = 4e-28,   Method: Compositional matrix adjust.
 Identities = 72/261 (27%), Positives = 126/261 (48%), Gaps = 25/261 (9%)
Query: 134 KGTYCSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRP--PNLCIV 191
           +G    ++VA+K LKPE      + +  +E+ I+R + H+N+V++ G CT      + ++
Sbjct: 45  EGDNTGEQVAVKSLKPESGGNH-IADLKKEIEILRNLYHENIVKYKGICTEDGGNGIKLI 103
Query: 192 TEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENG 251
            EF+  GS+ ++L K K    L   LK A+ + KGM+YL     +HRDL   N+L++   
Sbjct: 104 MEFLPSGSLKEYLPKNKNKINLKQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLVESEH 163
Query: 252 VVKVADFGVARV----QAQSGVMTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELL 307
            VK+ DFG+ +     +    V         W APE +    +   +DV+SFG+ L ELL
Sbjct: 164 QVKIGDFGLTKAIETDKEXXTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELL 223
Query: 308 T----------------GELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRLAELLERCWQ 351
           T                G  P  G   +   V  +++  R   P +    + +L+ +CW+
Sbjct: 224 TYCDSDSSPMALFLKMIG--PTHGQMTVTRLVNTLKEGKRLPCPPNCPDEVYQLMRKCWE 281
Query: 352 HDPTQRPNFSQITDILKQMMK 372
             P+ R +F  + +  + ++K
Sbjct: 282 FQPSNRTSFQNLIEGFEALLK 302

>pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291

Iteration: 1
 Score =  122 bits (306), Expect = 4e-28,   Method: Compositional matrix adjust.
 Identities = 81/276 (29%), Positives = 148/276 (53%), Gaps = 13/276 (4%)
Query: 113 IDAKQLKIECK-VASGSYGDLYKGTY----CSQEVAIKVLKPECVNTEMLKEFSQEVYIM 167
           +D K L +E K + SG++G + KG Y      + VA+K+LK E  +  +  E   E  +M
Sbjct: 13  LDRKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVM 72
Query: 168 RKIRHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGM 227
           +++ +  +V+ IG C    +  +V E    G +  +L + + V +  +++++   VS GM
Sbjct: 73  QQLDNPYIVRMIGIC-EAESWMLVMEMAELGPLNKYLQQNRHV-KDKNIIELVHQVSMGM 130
Query: 228 NYLHQNNIIHRDLKTANLLMDENGVVKVADFGVAR-VQAQSGVMTAET-GTY--RWMAPE 283
            YL ++N +HRDL   N+L+      K++DFG+++ ++A      A+T G +  +W APE
Sbjct: 131 KYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPE 190
Query: 284 VIEHKPYDYKADVFSFGIALWELLT-GELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRL 342
            I +  +  K+DV+SFG+ +WE  + G+ PY G+   +    +++K  R   P      +
Sbjct: 191 CINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSE-VTAMLEKGERMGCPAGCPREM 249
Query: 343 AELLERCWQHDPTQRPNFSQITDILKQMMKEVASEG 378
            +L+  CW +D   RP F+ +   L+    +V +EG
Sbjct: 250 YDLMNLCWTYDVENRPGFAAVELRLRNYYYDVVNEG 285

>pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325

Iteration: 1
 Score =  122 bits (305), Expect = 4e-28,   Method: Compositional matrix adjust.
 Identities = 82/267 (30%), Positives = 131/267 (49%), Gaps = 24/267 (8%)
Query: 109 DVWEIDAKQLKIECKVASGSYGDLYKGTYCSQEVAIKVLKPECVNTEMLKEFSQEVYIMR 168
           D WEI  +       +  G++G +YK       V       +  + E L+++  E+ I+ 
Sbjct: 37  DFWEIIGE-------LGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILA 89
Query: 169 KIRHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMN 228
              H N+V+ + A     NL I+ EF A G++   + + +     + +  V       +N
Sbjct: 90  SCDHPNIVKLLDAFYYENNLWILIEFCAGGAVDAVMLELERPLTESQIQVVCKQTLDALN 149
Query: 229 YLHQNNIIHRDLKTANLLMDENGVVKVADFGVA-----RVQAQSGVMTAETGTYRWMAPE 283
           YLH N IIHRDLK  N+L   +G +K+ADFGV+      +Q +   +    GT  WMAPE
Sbjct: 150 YLHDNKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRXIQRRDXFI----GTPYWMAPE 205
Query: 284 VI-----EHKPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKSLRPTI--PK 336
           V+     + +PYDYKADV+S GI L E+   E P+  L P++  + +  KS  PT+  P 
Sbjct: 206 VVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVLLKIA-KSEPPTLAQPS 264
Query: 337 HAHPRLAELLERCWQHDPTQRPNFSQI 363
                  + L++C + +   R   SQ+
Sbjct: 265 RWSSNFKDFLKKCLEKNVDARWTTSQL 291

>pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290

Iteration: 1
 Score =  122 bits (305), Expect = 4e-28,   Method: Compositional matrix adjust.
 Identities = 72/261 (27%), Positives = 126/261 (48%), Gaps = 25/261 (9%)
Query: 134 KGTYCSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRP--PNLCIV 191
           +G    ++VA+K LKPE      + +  +E+ I+R + H+N+V++ G CT      + ++
Sbjct: 33  EGDNTGEQVAVKSLKPESGGNH-IADLKKEIEILRNLYHENIVKYKGICTEDGGNGIKLI 91
Query: 192 TEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENG 251
            EF+  GS+ ++L K K    L   LK A+ + KGM+YL     +HRDL   N+L++   
Sbjct: 92  MEFLPSGSLKEYLPKNKNKINLKQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLVESEH 151
Query: 252 VVKVADFGVARV----QAQSGVMTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELL 307
            VK+ DFG+ +     +    V         W APE +    +   +DV+SFG+ L ELL
Sbjct: 152 QVKIGDFGLTKAIETDKEXXTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELL 211
Query: 308 T----------------GELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRLAELLERCWQ 351
           T                G  P  G   +   V  +++  R   P +    + +L+ +CW+
Sbjct: 212 TYCDSDSSPMALFLKMIG--PTHGQMTVTRLVNTLKEGKRLPCPPNCPDEVYQLMRKCWE 269
Query: 352 HDPTQRPNFSQITDILKQMMK 372
             P+ R +F  + +  + ++K
Sbjct: 270 FQPSNRTSFQNLIEGFEALLK 290

>pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314

Iteration: 1
 Score =  122 bits (305), Expect = 5e-28,   Method: Compositional matrix adjust.
 Identities = 79/246 (32%), Positives = 127/246 (51%), Gaps = 10/246 (4%)
Query: 123 KVASGSYGDLYKGTY--CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIG 180
           K+  GSYG +YK  +    Q VAIK +  E    E++KE S    IM++    +VV++ G
Sbjct: 36  KLGEGSYGSVYKAIHKETGQIVAIKQVPVESDLQEIIKEIS----IMQQCDSPHVVKYYG 91
Query: 181 ACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDL 240
           +  +  +L IV E+   GS+ D +  +        +  +     KG+ YLH    IHRD+
Sbjct: 92  SYFKNTDLWIVMEYCGAGSVSDIIRLRNKTLTEDEIATILQSTLKGLEYLHFMRKIHRDI 151
Query: 241 KTANLLMDENGVVKVADFGVA-RVQAQSGVMTAETGTYRWMAPEVIEHKPYDYKADVFSF 299
           K  N+L++  G  K+ADFGVA ++           GT  WMAPEVI+   Y+  AD++S 
Sbjct: 152 KAGNILLNTEGHAKLADFGVAGQLTDXMAKRNXVIGTPFWMAPEVIQEIGYNCVADIWSL 211
Query: 300 GIALWELLTGELPYAGLTPLQAAVGVVQKSLRPTI--PKHAHPRLAELLERCWQHDPTQR 357
           GI   E+  G+ PYA + P++ A+ ++  +  PT   P+       + +++C    P QR
Sbjct: 212 GITAIEMAEGKPPYADIHPMR-AIFMIPTNPPPTFRKPELWSDNFTDFVKQCLVKSPEQR 270
Query: 358 PNFSQI 363
              +Q+
Sbjct: 271 ATATQL 276

>pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329

Iteration: 1
 Score =  120 bits (302), Expect = 1e-27,   Method: Compositional matrix adjust.
 Identities = 83/301 (27%), Positives = 146/301 (48%), Gaps = 30/301 (9%)
Query: 99  NCIEIPTDGTD--VWEIDAKQLKIECKVASGSYGDLY----KGTYCSQE---VAIKVLKP 149
           + IE P   +D  V  I  + + ++ ++  G++G ++          Q+   VA+K LK 
Sbjct: 22  HIIENPQYFSDACVHHIKRRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKE 81
Query: 150 ECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQ-- 207
              +    ++F +E  ++  ++H+++V+F G CT    L +V E+M  G +  FL     
Sbjct: 82  ASESAR--QDFQREAELLTMLQHQHIVRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGP 139
Query: 208 ------------KGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKV 255
                        G   L  LL VA  V+ GM YL   + +HRDL T N L+ +  VVK+
Sbjct: 140 DAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLHFVHRDLATRNCLVGQGLVVKI 199
Query: 256 ADFGVARVQAQSGVMTAETGTY---RWMAPEVIEHKPYDYKADVFSFGIALWELLT-GEL 311
            DFG++R    +        T    RWM PE I ++ +  ++DV+SFG+ LWE+ T G+ 
Sbjct: 200 GDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQ 259
Query: 312 PYAGLTPLQAAVGVVQKSLRPTIPKHAHPRLAELLERCWQHDPTQRPNFSQITDILKQMM 371
           P+  L+  + A+  + +      P+   P +  ++  CWQ +P QR +   +   L+ + 
Sbjct: 260 PWYQLSNTE-AIDCITQGRELERPRACPPEVYAIMRGCWQREPQQRHSIKDVHARLQALA 318
Query: 372 K 372
           +
Sbjct: 319 Q 319

>pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300

Iteration: 1
 Score =  120 bits (301), Expect = 1e-27,   Method: Compositional matrix adjust.
 Identities = 74/249 (29%), Positives = 124/249 (49%), Gaps = 21/249 (8%)
Query: 142 VAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVTEFMARGSIY 201
           VA+K LK    +    ++F +E  ++  ++H+++V+F G CT    L +V E+M  G + 
Sbjct: 45  VAVKALKEASESAR--QDFQREAELLTMLQHQHIVRFFGVCTEGRPLLMVFEYMRHGDLN 102
Query: 202 DFLHKQ--------------KGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLM 247
            FL                  G   L  LL VA  V+ GM YL   + +HRDL T N L+
Sbjct: 103 RFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLHFVHRDLATRNCLV 162
Query: 248 DENGVVKVADFGVARVQAQSGVMTAETGTY---RWMAPEVIEHKPYDYKADVFSFGIALW 304
            +  VVK+ DFG++R    +        T    RWM PE I ++ +  ++DV+SFG+ LW
Sbjct: 163 GQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLW 222
Query: 305 ELLT-GELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRLAELLERCWQHDPTQRPNFSQI 363
           E+ T G+ P+  L+  + A+  + +      P+   P +  ++  CWQ +P QR +   +
Sbjct: 223 EIFTYGKQPWYQLSNTE-AIDCITQGRELERPRACPPEVYAIMRGCWQREPQQRHSIKDV 281
Query: 364 TDILKQMMK 372
              L+ + +
Sbjct: 282 HARLQALAQ 290

>pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The Murine Receptor Tyrosine Kinase Tyro3 (Sky) Length = 323

Iteration: 1
 Score =  120 bits (301), Expect = 1e-27,   Method: Compositional matrix adjust.
 Identities = 75/270 (27%), Positives = 135/270 (50%), Gaps = 23/270 (8%)
Query: 113 IDAKQLKIECKVASGSYGDLYKGTYCSQE-----VAIKVLKPECVNTEMLKEFSQEVYIM 167
           I  +Q  +   +  G +G + +     ++     VA+K+LK + + +  ++EF +E   M
Sbjct: 20  IPEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACM 79
Query: 168 RKIRHKNVVQFIGACTRP------PNLCIVTEFMARGSIYDFLHKQK-----GVFQLTSL 216
           ++  H +V + +G   R       P   ++  FM  G ++ FL   +         L +L
Sbjct: 80  KEFDHPHVAKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTL 139
Query: 217 LKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVM----TA 272
           ++  +D++ GM YL   N IHRDL   N ++ E+  V VADFG++R +  SG       A
Sbjct: 140 VRFMVDIACGMEYLSSRNFIHRDLAARNCMLAEDMTVCVADFGLSR-KIYSGDYYRQGCA 198
Query: 273 ETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLT-GELPYAGLTPLQAAVGVVQKSLR 331
                +W+A E +    Y   +DV++FG+ +WE++T G+ PYAG+   +    ++  + R
Sbjct: 199 SKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGIENAEIYNYLIGGN-R 257
Query: 332 PTIPKHAHPRLAELLERCWQHDPTQRPNFS 361
              P      + +L+ +CW  DP QRP+F+
Sbjct: 258 LKQPPECMEEVYDLMYQCWSADPKQRPSFT 287

>pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306

Iteration: 1
 Score =  120 bits (301), Expect = 1e-27,   Method: Compositional matrix adjust.
 Identities = 74/249 (29%), Positives = 124/249 (49%), Gaps = 21/249 (8%)
Query: 142 VAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVTEFMARGSIY 201
           VA+K LK    +    ++F +E  ++  ++H+++V+F G CT    L +V E+M  G + 
Sbjct: 51  VAVKALKEASESAR--QDFQREAELLTMLQHQHIVRFFGVCTEGRPLLMVFEYMRHGDLN 108
Query: 202 DFLHKQ--------------KGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLM 247
            FL                  G   L  LL VA  V+ GM YL   + +HRDL T N L+
Sbjct: 109 RFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLHFVHRDLATRNCLV 168
Query: 248 DENGVVKVADFGVARVQAQSGVMTAETGTY---RWMAPEVIEHKPYDYKADVFSFGIALW 304
            +  VVK+ DFG++R    +        T    RWM PE I ++ +  ++DV+SFG+ LW
Sbjct: 169 GQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLW 228
Query: 305 ELLT-GELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRLAELLERCWQHDPTQRPNFSQI 363
           E+ T G+ P+  L+  + A+  + +      P+   P +  ++  CWQ +P QR +   +
Sbjct: 229 EIFTYGKQPWYQLSNTE-AIDCITQGRELERPRACPPEVYAIMRGCWQREPQQRHSIKDV 287
Query: 364 TDILKQMMK 372
              L+ + +
Sbjct: 288 HARLQALAQ 296

>pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287

Iteration: 1
 Score =  120 bits (300), Expect = 2e-27,   Method: Compositional matrix adjust.
 Identities = 76/271 (28%), Positives = 140/271 (51%), Gaps = 16/271 (5%)
Query: 121 ECKVASGSYGDLYKGTYCSQ----EVAIKVLK--PECVNTEMLKEFSQEVYIMRKIRHKN 174
           + ++  G++G + +G Y  +    +VAIKVLK   E  +TE   E  +E  IM ++ +  
Sbjct: 15  DIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTE---EMMREAQIMHQLDNPY 71
Query: 175 VVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNN 234
           +V+ IG C +   L +V E    G ++ FL  ++    ++++ ++   VS GM YL + N
Sbjct: 72  IVRLIGVC-QAEALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKN 130
Query: 235 IIHRDLKTANLLMDENGVVKVADFGVAR-VQAQSGVMTAETG---TYRWMAPEVIEHKPY 290
            +HRDL   N+L+      K++DFG+++ + A     TA +      +W APE I  + +
Sbjct: 131 FVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRKF 190
Query: 291 DYKADVFSFGIALWELLT-GELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRLAELLERC 349
             ++DV+S+G+ +WE L+ G+ PY  +   +  +  +++  R   P    P L  L+  C
Sbjct: 191 SSRSDVWSYGVTMWEALSYGQKPYKKMKGPE-VMAFIEQGKRMECPPECPPELYALMSDC 249
Query: 350 WQHDPTQRPNFSQITDILKQMMKEVASEGEN 380
           W +    RP+F  +   ++     +AS+ E 
Sbjct: 250 WIYKWEDRPDFLTVEQRMRACYYSLASKVEG 280

>pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274

Iteration: 1
 Score =  119 bits (299), Expect = 2e-27,   Method: Compositional matrix adjust.
 Identities = 80/275 (29%), Positives = 147/275 (53%), Gaps = 13/275 (4%)
Query: 113 IDAKQLKIECK-VASGSYGDLYKGTY----CSQEVAIKVLKPECVNTEMLKEFSQEVYIM 167
           +D K L +E K + SG++G + KG Y      + VA+K+LK E  +  +  E   E  +M
Sbjct: 3   LDRKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVM 62
Query: 168 RKIRHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGM 227
           +++ +  +V+ IG C    +  +V E    G +  +L + + V +  +++++   VS GM
Sbjct: 63  QQLDNPYIVRMIGIC-EAESWMLVMEMAELGPLNKYLQQNRHV-KDKNIIELVHQVSMGM 120
Query: 228 NYLHQNNIIHRDLKTANLLMDENGVVKVADFGVAR-VQAQSGVMTAET-GTY--RWMAPE 283
            YL ++N +HRDL   N+L+      K++DFG+++ ++A      A+T G +  +W APE
Sbjct: 121 KYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPE 180
Query: 284 VIEHKPYDYKADVFSFGIALWELLT-GELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRL 342
            I +  +  K+DV+SFG+ +WE  + G+ PY G+   +    +++K  R   P      +
Sbjct: 181 CINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSE-VTAMLEKGERMGCPAGCPREM 239
Query: 343 AELLERCWQHDPTQRPNFSQITDILKQMMKEVASE 377
            +L+  CW +D   RP F+ +   L+    +V +E
Sbjct: 240 YDLMNLCWTYDVENRPGFAAVELRLRNYYYDVVNE 274

>pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298

Iteration: 1
 Score =  119 bits (299), Expect = 2e-27,   Method: Compositional matrix adjust.
 Identities = 71/199 (35%), Positives = 114/199 (57%), Gaps = 13/199 (6%)
Query: 123 KVASGSYGDLYKGTYCSQEVAIKVLKP--ECVNTEMLKEFSQEVYIMRKIRHKNVVQFIG 180
           K   G +G +YKG   +  VA+K L    +    E+ ++F QE+ +  K +H+N+V+ +G
Sbjct: 29  KXGEGGFGVVYKGYVNNTTVAVKKLAAMVDITTEELKQQFDQEIKVXAKCQHENLVELLG 88
Query: 181 ACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLT--SLLKVAIDVSKGMNYLHQNNIIHR 238
             +   +LC+V  +   GS+ D L    G   L+     K+A   + G+N+LH+N+ IHR
Sbjct: 89  FSSDGDDLCLVYVYXPNGSLLDRLSCLDGTPPLSWHXRCKIAQGAANGINFLHENHHIHR 148
Query: 239 DLKTANLLMDENGVVKVADFGVARVQ---AQSGVMTAETGTYRWMAPEVI--EHKPYDYK 293
           D+K+AN+L+DE    K++DFG+AR     AQ    +   GT  + APE +  E  P   K
Sbjct: 149 DIKSANILLDEAFTAKISDFGLARASEKFAQXVXXSRIVGTTAYXAPEALRGEITP---K 205
Query: 294 ADVFSFGIALWELLTGELP 312
           +D++SFG+ L E++TG LP
Sbjct: 206 SDIYSFGVVLLEIITG-LP 223

>pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295

Iteration: 1
 Score =  119 bits (298), Expect = 3e-27,   Method: Compositional matrix adjust.
 Identities = 80/296 (27%), Positives = 141/296 (47%), Gaps = 29/296 (9%)
Query: 107 GTDVWEIDAKQLKIECKVASGSYGDLYKGTY------CSQEVAIKVLKPECVNTEMLKEF 160
           G+D  + + + LK   ++  G++G +    Y        + VA+K L+      E L++F
Sbjct: 1   GSDPTQFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHST--EEHLRDF 58
Query: 161 SQEVYIMRKIRHKNVVQFIGACTRP--PNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLK 218
            +E+ I++ ++H N+V++ G C      NL ++ E++  GS+ D+L K K       LL+
Sbjct: 59  EREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQ 118
Query: 219 VAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARV--QAQSGVMTAETGT 276
               + KGM YL     IHRDL T N+L++    VK+ DFG+ +V  Q +      E G 
Sbjct: 119 YTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGE 178
Query: 277 YR--WMAPEVIEHKPYDYKADVFSFGIALWELLT----GELPYA-----------GLTPL 319
               W APE +    +   +DV+SFG+ L+EL T     + P A           G   +
Sbjct: 179 SPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIV 238
Query: 320 QAAVGVVQKSLRPTIPKHAHPRLAELLERCWQHDPTQRPNFSQITDILKQMMKEVA 375
              + +++ + R   P      +  ++  CW ++  QRP+F  +   + Q+   +A
Sbjct: 239 FHLIELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRDNMA 294

>pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350

Iteration: 1
 Score =  119 bits (298), Expect = 3e-27,   Method: Compositional matrix adjust.
 Identities = 67/247 (27%), Positives = 136/247 (55%), Gaps = 5/247 (2%)
Query: 123 KVASGSYGD--LYKGTYCSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIG 180
           K+  GS+G   L K T   ++  IK +    ++++  +E  +EV ++  ++H N+VQ+  
Sbjct: 31  KIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRE 90
Query: 181 ACTRPPNLCIVTEFMARGSIYDFLHKQKGV-FQLTSLLKVAIDVSKGMNYLHQNNIIHRD 239
           +     +L IV ++   G ++  ++ QKGV FQ   +L   + +   + ++H   I+HRD
Sbjct: 91  SFEENGSLYIVMDYCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHVHDRKILHRD 150
Query: 240 LKTANLLMDENGVVKVADFGVARV-QAQSGVMTAETGTYRWMAPEVIEHKPYDYKADVFS 298
           +K+ N+ + ++G V++ DFG+ARV  +   +  A  GT  +++PE+ E+KPY+ K+D+++
Sbjct: 151 IKSQNIFLTKDGTVQLGDFGIARVLNSTVELARACIGTPYYLSPEICENKPYNNKSDIWA 210
Query: 299 FGIALWELLTGELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRLAELLERCWQHDPTQRP 358
            G  L+EL T +  +   +     + ++  S  P +  H    L  L+ + ++ +P  RP
Sbjct: 211 LGCVLYELCTLKHAFEAGSMKNLVLKIISGSF-PPVSLHYSYDLRSLVSQLFKRNPRDRP 269
Query: 359 NFSQITD 365
           + + I +
Sbjct: 270 SVNSILE 276

>pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295

Iteration: 1
 Score =  119 bits (297), Expect = 4e-27,   Method: Compositional matrix adjust.
 Identities = 80/296 (27%), Positives = 141/296 (47%), Gaps = 29/296 (9%)
Query: 107 GTDVWEIDAKQLKIECKVASGSYGDLYKGTY------CSQEVAIKVLKPECVNTEMLKEF 160
           G+D  + + + LK   ++  G++G +    Y        + VA+K L+      E L++F
Sbjct: 1   GSDPTQFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHST--EEHLRDF 58
Query: 161 SQEVYIMRKIRHKNVVQFIGACTRP--PNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLK 218
            +E+ I++ ++H N+V++ G C      NL ++ E++  GS+ D+L K K       LL+
Sbjct: 59  EREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQ 118
Query: 219 VAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARV--QAQSGVMTAETGT 276
               + KGM YL     IHRDL T N+L++    VK+ DFG+ +V  Q +      E G 
Sbjct: 119 YTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEFFKVKEPGE 178
Query: 277 --YRWMAPEVIEHKPYDYKADVFSFGIALWELLT----GELPYA-----------GLTPL 319
               W APE +    +   +DV+SFG+ L+EL T     + P A           G   +
Sbjct: 179 SPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIV 238
Query: 320 QAAVGVVQKSLRPTIPKHAHPRLAELLERCWQHDPTQRPNFSQITDILKQMMKEVA 375
              + +++ + R   P      +  ++  CW ++  QRP+F  +   + Q+   +A
Sbjct: 239 FHLIELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRDNMA 294

>pdb|3IOK|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313

Iteration: 1
 Score =  118 bits (295), Expect = 6e-27,   Method: Compositional matrix adjust.
 Identities = 79/301 (26%), Positives = 142/301 (47%), Gaps = 29/301 (9%)
Query: 103 IPTDGTDVWEIDAKQLKIECKVASGSYGDLYKGTY------CSQEVAIKVLKPECVNTEM 156
           +P    ++ + + + LK   ++  G++G +    Y        + VA+K L+      E 
Sbjct: 15  VPRGSHNMTQFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHST--EEH 72
Query: 157 LKEFSQEVYIMRKIRHKNVVQFIGACTRP--PNLCIVTEFMARGSIYDFLHKQKGVFQLT 214
           L++F +E+ I++ ++H N+V++ G C      NL ++ E++  GS+ D+L K K      
Sbjct: 73  LRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHI 132
Query: 215 SLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARV--QAQSGVMTA 272
            LL+    + KGM YL     IHRDL T N+L++    VK+ DFG+ +V  Q +      
Sbjct: 133 KLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVK 192
Query: 273 ETGTYR--WMAPEVIEHKPYDYKADVFSFGIALWELLT----GELPYA-----------G 315
           E G     W APE +    +   +DV+SFG+ L+EL T     + P A           G
Sbjct: 193 EPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQG 252
Query: 316 LTPLQAAVGVVQKSLRPTIPKHAHPRLAELLERCWQHDPTQRPNFSQITDILKQMMKEVA 375
              +   + +++ + R   P      +  ++  CW ++  QRP+F  +   + Q+   +A
Sbjct: 253 QMIVFHLIELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRDNMA 312
Query: 376 S 376
Sbjct: 313 G 313

>pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317

Iteration: 1
 Score =  118 bits (295), Expect = 6e-27,   Method: Compositional matrix adjust.
 Identities = 74/282 (26%), Positives = 135/282 (47%), Gaps = 32/282 (11%)
Query: 112 EIDAKQLKIECKVASGSYGDLYKGTY-------CSQEVAIKVLKPECVNTEMLKEFSQEV 164
           E+  +++ +  ++  GS+G +Y+G             VA+K +       E + EF  E 
Sbjct: 12  EVSREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERI-EFLNEA 70
Query: 165 YIMRKIRHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQ---------LTS 215
            +M+     +VV+ +G  ++     +V E MA G +  +L   +   +         L  
Sbjct: 71  SVMKGFTCHHVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQE 130
Query: 216 LLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVAR--------VQAQS 267
           ++++A +++ GM YL+    +HRDL   N ++  +  VK+ DFG+ R         +   
Sbjct: 131 MIQMAAEIADGMAYLNAKKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGGK 190
Query: 268 GVMTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLT-GELPYAGLTPLQAAVGVV 326
           G++       RWMAPE ++   +   +D++SFG+ LWE+ +  E PY GL+  Q    V+
Sbjct: 191 GLLPV-----RWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVLKFVM 245
Query: 327 QKSLRPTIPKHAHPRLAELLERCWQHDPTQRPNFSQITDILK 368
                   P +   R+ +L+  CWQ +P  RP F +I ++LK
Sbjct: 246 DGGYLDQ-PDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLK 286

>pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277

Iteration: 1
 Score =  118 bits (295), Expect = 7e-27,   Method: Compositional matrix adjust.
 Identities = 79/274 (28%), Positives = 146/274 (53%), Gaps = 13/274 (4%)
Query: 113 IDAKQLKIECK-VASGSYGDLYKGTY----CSQEVAIKVLKPECVNTEMLKEFSQEVYIM 167
           +D K L +E K + SG++G + KG Y      + VA+K+LK E  +  +  E   E  +M
Sbjct: 7   LDRKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVM 66
Query: 168 RKIRHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGM 227
           +++ +  +V+ IG C    +  +V E    G +  +L + + V +  +++++   VS GM
Sbjct: 67  QQLDNPYIVRMIGIC-EAESWMLVMEMAELGPLNKYLQQNRHV-KDKNIIELVHQVSMGM 124
Query: 228 NYLHQNNIIHRDLKTANLLMDENGVVKVADFGVAR-VQAQSGVMTAET-GTY--RWMAPE 283
            YL ++N +HRDL   N+L+      K++DFG+++ ++A      A+T G +  +W APE
Sbjct: 125 KYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPE 184
Query: 284 VIEHKPYDYKADVFSFGIALWELLT-GELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRL 342
            I +  +  K+DV+SFG+ +WE  + G+ PY G+   +    +++K  R   P      +
Sbjct: 185 CINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSE-VTAMLEKGERMGCPAGCPREM 243
Query: 343 AELLERCWQHDPTQRPNFSQITDILKQMMKEVAS 376
            +L+  CW +D   RP F+ +   L+    +V +
Sbjct: 244 YDLMNLCWTYDVENRPGFAAVELRLRNYYYDVVN 277

>pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277

Iteration: 1
 Score =  118 bits (295), Expect = 7e-27,   Method: Compositional matrix adjust.
 Identities = 79/274 (28%), Positives = 146/274 (53%), Gaps = 13/274 (4%)
Query: 113 IDAKQLKIECK-VASGSYGDLYKGTY----CSQEVAIKVLKPECVNTEMLKEFSQEVYIM 167
           +D K L +E K + SG++G + KG Y      + VA+K+LK E  +  +  E   E  +M
Sbjct: 7   LDRKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVM 66
Query: 168 RKIRHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGM 227
           +++ +  +V+ IG C    +  +V E    G +  +L + + V +  +++++   VS GM
Sbjct: 67  QQLDNPYIVRMIGIC-EAESWMLVMEMAELGPLNKYLQQNRHV-KDKNIIELVHQVSMGM 124
Query: 228 NYLHQNNIIHRDLKTANLLMDENGVVKVADFGVAR-VQAQSGVMTAET-GTY--RWMAPE 283
            YL ++N +HRDL   N+L+      K++DFG+++ ++A      A+T G +  +W APE
Sbjct: 125 KYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENXYKAQTHGKWPVKWYAPE 184
Query: 284 VIEHKPYDYKADVFSFGIALWELLT-GELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRL 342
            I +  +  K+DV+SFG+ +WE  + G+ PY G+   +    +++K  R   P      +
Sbjct: 185 CINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSE-VTAMLEKGERMGCPAGCPREM 243
Query: 343 AELLERCWQHDPTQRPNFSQITDILKQMMKEVAS 376
            +L+  CW +D   RP F+ +   L+    +V +
Sbjct: 244 YDLMNLCWTYDVENRPGFAAVELRLRNYYYDVVN 277

>pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293

Iteration: 1
 Score =  117 bits (294), Expect = 9e-27,   Method: Compositional matrix adjust.
 Identities = 79/274 (28%), Positives = 146/274 (53%), Gaps = 13/274 (4%)
Query: 113 IDAKQLKIECK-VASGSYGDLYKGTY----CSQEVAIKVLKPECVNTEMLKEFSQEVYIM 167
           +D K L +E K + SG++G + KG Y      + VA+K+LK E  +  +  E   E  +M
Sbjct: 23  LDRKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVM 82
Query: 168 RKIRHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGM 227
           +++ +  +V+ IG C    +  +V E    G +  +L + + V +  +++++   VS GM
Sbjct: 83  QQLDNPYIVRMIGIC-EAESWMLVMEMAELGPLNKYLQQNRHV-KDKNIIELVHQVSMGM 140
Query: 228 NYLHQNNIIHRDLKTANLLMDENGVVKVADFGVAR-VQAQSGVMTAET-GTY--RWMAPE 283
            YL ++N +HRDL   N+L+      K++DFG+++ ++A      A+T G +  +W APE
Sbjct: 141 KYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPE 200
Query: 284 VIEHKPYDYKADVFSFGIALWELLT-GELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRL 342
            I +  +  K+DV+SFG+ +WE  + G+ PY G+   +    +++K  R   P      +
Sbjct: 201 CINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSE-VTAMLEKGERMGCPAGCPREM 259
Query: 343 AELLERCWQHDPTQRPNFSQITDILKQMMKEVAS 376
            +L+  CW +D   RP F+ +   L+    +V +
Sbjct: 260 YDLMNLCWTYDVENRPGFAAVELRLRNYYYDVVN 293

>pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299

Iteration: 1
 Score =  117 bits (294), Expect = 9e-27,   Method: Compositional matrix adjust.
 Identities = 79/274 (28%), Positives = 146/274 (53%), Gaps = 13/274 (4%)
Query: 113 IDAKQLKIECK-VASGSYGDLYKGTY----CSQEVAIKVLKPECVNTEMLKEFSQEVYIM 167
           +D K L +E K + SG++G + KG Y      + VA+K+LK E  +  +  E   E  +M
Sbjct: 23  LDRKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVM 82
Query: 168 RKIRHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGM 227
           +++ +  +V+ IG C    +  +V E    G +  +L + + V +  +++++   VS GM
Sbjct: 83  QQLDNPYIVRMIGIC-EAESWMLVMEMAELGPLNKYLQQNRHV-KDKNIIELVHQVSMGM 140
Query: 228 NYLHQNNIIHRDLKTANLLMDENGVVKVADFGVAR-VQAQSGVMTAET-GTY--RWMAPE 283
            YL ++N +HRDL   N+L+      K++DFG+++ ++A      A+T G +  +W APE
Sbjct: 141 KYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPE 200
Query: 284 VIEHKPYDYKADVFSFGIALWELLT-GELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRL 342
            I +  +  K+DV+SFG+ +WE  + G+ PY G+   +    +++K  R   P      +
Sbjct: 201 CINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSE-VTAMLEKGERMGCPAGCPREM 259
Query: 343 AELLERCWQHDPTQRPNFSQITDILKQMMKEVAS 376
            +L+  CW +D   RP F+ +   L+    +V +
Sbjct: 260 YDLMNLCWTYDVENRPGFAAVELRLRNYYYDVVN 293

>pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291

Iteration: 1
 Score =  117 bits (294), Expect = 9e-27,   Method: Compositional matrix adjust.
 Identities = 79/274 (28%), Positives = 146/274 (53%), Gaps = 13/274 (4%)
Query: 113 IDAKQLKIECK-VASGSYGDLYKGTY----CSQEVAIKVLKPECVNTEMLKEFSQEVYIM 167
           +D K L +E K + SG++G + KG Y      + VA+K+LK E  +  +  E   E  +M
Sbjct: 21  LDRKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVM 80
Query: 168 RKIRHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGM 227
           +++ +  +V+ IG C    +  +V E    G +  +L + + V +  +++++   VS GM
Sbjct: 81  QQLDNPYIVRMIGIC-EAESWMLVMEMAELGPLNKYLQQNRHV-KDKNIIELVHQVSMGM 138
Query: 228 NYLHQNNIIHRDLKTANLLMDENGVVKVADFGVAR-VQAQSGVMTAET-GTY--RWMAPE 283
            YL ++N +HRDL   N+L+      K++DFG+++ ++A      A+T G +  +W APE
Sbjct: 139 KYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPE 198
Query: 284 VIEHKPYDYKADVFSFGIALWELLT-GELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRL 342
            I +  +  K+DV+SFG+ +WE  + G+ PY G+   +    +++K  R   P      +
Sbjct: 199 CINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSE-VTAMLEKGERMGCPAGCPREM 257
Query: 343 AELLERCWQHDPTQRPNFSQITDILKQMMKEVAS 376
            +L+  CW +D   RP F+ +   L+    +V +
Sbjct: 258 YDLMNLCWTYDVENRPGFAAVELRLRNYYYDVVN 291

>pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613

Iteration: 1
 Score =  117 bits (294), Expect = 9e-27,   Method: Compositional matrix adjust.
 Identities = 76/277 (27%), Positives = 142/277 (51%), Gaps = 16/277 (5%)
Query: 118 LKIECKVASGSYGDLYKGTYCSQ----EVAIKVLK--PECVNTEMLKEFSQEVYIMRKIR 171
           L  + ++  G++G + +G Y  +    +VAIKVLK   E  +TE   E  +E  IM ++ 
Sbjct: 338 LIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTE---EMMREAQIMHQLD 394
Query: 172 HKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLH 231
           +  +V+ IG C +   L +V E    G ++ FL  ++    ++++ ++   VS GM YL 
Sbjct: 395 NPYIVRLIGVC-QAEALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLE 453
Query: 232 QNNIIHRDLKTANLLMDENGVVKVADFGVAR-VQAQSGVMTAETG---TYRWMAPEVIEH 287
           + N +HR+L   N+L+      K++DFG+++ + A     TA +      +W APE I  
Sbjct: 454 EKNFVHRNLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINF 513
Query: 288 KPYDYKADVFSFGIALWELLT-GELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRLAELL 346
           + +  ++DV+S+G+ +WE L+ G+ PY  +   +  +  +++  R   P    P L  L+
Sbjct: 514 RKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPE-VMAFIEQGKRMECPPECPPELYALM 572
Query: 347 ERCWQHDPTQRPNFSQITDILKQMMKEVASEGENNHS 383
             CW +    RP+F  +   ++     +AS+ E   +
Sbjct: 573 SDCWIYKWEDRPDFLTVEQRMRACYYSLASKVEGGSA 609

>pdb|2P0C|A Chain A, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein Kina Length = 313

Iteration: 1
 Score =  117 bits (294), Expect = 9e-27,   Method: Compositional matrix adjust.
 Identities = 77/282 (27%), Positives = 138/282 (48%), Gaps = 22/282 (7%)
Query: 113 IDAKQLKIECKVASGSYGDLYKGTY-----CSQEVAIKVLKPECVNTEMLKEFSQEVYIM 167
           ID   L +   +  G +G + +G        S +VA+K +K +  +   ++EF  E   M
Sbjct: 31  IDRNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACM 90
Query: 168 RKIRHKNVVQFIGACTRP-----PNLCIVTEFMARGSIYDFLHKQK-----GVFQLTSLL 217
           +   H NV++ +G C        P   ++  FM  G ++ +L   +         L +LL
Sbjct: 91  KDFSHPNVIRLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLL 150
Query: 218 KVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAETGT- 276
           K  +D++ GM YL   N +HRDL   N ++ ++  V VADFG+++ +  SG    +    
Sbjct: 151 KFMVDIALGMEYLSNRNFLHRDLAARNCMLRDDMTVCVADFGLSK-KIYSGDYYRQGRIA 209
Query: 277 ---YRWMAPEVIEHKPYDYKADVFSFGIALWELLT-GELPYAGLTPLQAAVGVVQKSLRP 332
               +W+A E +  + Y  K+DV++FG+ +WE+ T G  PY G+   +    ++    R 
Sbjct: 210 KMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTPYPGVQNHEMYDYLLHGH-RL 268
Query: 333 TIPKHAHPRLAELLERCWQHDPTQRPNFSQITDILKQMMKEV 374
             P+     L E++  CW+ DP  RP FS +   L+++++ +
Sbjct: 269 KQPEDCLDELYEIMYSCWRTDPLDRPTFSVLRLQLEKLLESL 310

>pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311

Iteration: 1
 Score =  117 bits (293), Expect = 1e-26,   Method: Compositional matrix adjust.
 Identities = 77/289 (26%), Positives = 137/289 (47%), Gaps = 29/289 (10%)
Query: 103 IPTDGTDVWEIDAKQLKIECKVASGSYGDLYKGTY------CSQEVAIKVLKPECVNTEM 156
           +P    ++ + + + LK   ++  G++G +    Y        + VA+K L+      E 
Sbjct: 15  VPRGSHNMTQFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHST--EEH 72
Query: 157 LKEFSQEVYIMRKIRHKNVVQFIGACTRP--PNLCIVTEFMARGSIYDFLHKQKGVFQLT 214
           L++F +E+ I++ ++H N+V++ G C      NL ++ E++  GS+ D+L K K      
Sbjct: 73  LRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHI 132
Query: 215 SLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARV--QAQSGVMTA 272
            LL+    + KGM YL     IHRDL T N+L++    VK+ DFG+ +V  Q +      
Sbjct: 133 KLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVK 192
Query: 273 ETGT--YRWMAPEVIEHKPYDYKADVFSFGIALWELLT----GELPYA-----------G 315
           E G     W APE +    +   +DV+SFG+ L+EL T     + P A           G
Sbjct: 193 EPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQG 252
Query: 316 LTPLQAAVGVVQKSLRPTIPKHAHPRLAELLERCWQHDPTQRPNFSQIT 364
              +   + +++ + R   P      +  ++  CW ++  QRP+F  + 
Sbjct: 253 QMIVFHLIELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLA 301

>pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636

Iteration: 1
 Score =  117 bits (292), Expect = 2e-26,   Method: Compositional matrix adjust.
 Identities = 79/274 (28%), Positives = 146/274 (53%), Gaps = 13/274 (4%)
Query: 113 IDAKQLKIECK-VASGSYGDLYKGTY----CSQEVAIKVLKPECVNTEMLKEFSQEVYIM 167
           +D K L +E K + SG++G + KG Y      + VA+K+LK E  +  +  E   E  +M
Sbjct: 366 LDRKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVM 425
Query: 168 RKIRHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGM 227
           +++ +  +V+ IG C    +  +V E    G +  +L + + V +  +++++   VS GM
Sbjct: 426 QQLDNPYIVRMIGIC-EAESWMLVMEMAELGPLNKYLQQNRHV-KDKNIIELVHQVSMGM 483
Query: 228 NYLHQNNIIHRDLKTANLLMDENGVVKVADFGVAR-VQAQSGVMTAET-GTY--RWMAPE 283
            YL ++N +HRDL   N+L+      K++DFG+++ ++A      A+T G +  +W APE
Sbjct: 484 KYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPE 543
Query: 284 VIEHKPYDYKADVFSFGIALWELLT-GELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRL 342
            I +  +  K+DV+SFG+ +WE  + G+ PY G+   +    +++K  R   P      +
Sbjct: 544 CINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSE-VTAMLEKGERMGCPAGCPREM 602
Query: 343 AELLERCWQHDPTQRPNFSQITDILKQMMKEVAS 376
            +L+  CW +D   RP F+ +   L+    +V +
Sbjct: 603 YDLMNLCWTYDVENRPGFAAVELRLRNYYYDVVN 636

>pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635

Iteration: 1
 Score =  116 bits (291), Expect = 2e-26,   Method: Compositional matrix adjust.
 Identities = 79/274 (28%), Positives = 146/274 (53%), Gaps = 13/274 (4%)
Query: 113 IDAKQLKIECK-VASGSYGDLYKGTY----CSQEVAIKVLKPECVNTEMLKEFSQEVYIM 167
           +D K L +E K + SG++G + KG Y      + VA+K+LK E  +  +  E   E  +M
Sbjct: 365 LDRKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVM 424
Query: 168 RKIRHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGM 227
           +++ +  +V+ IG C    +  +V E    G +  +L + + V +  +++++   VS GM
Sbjct: 425 QQLDNPYIVRMIGIC-EAESWMLVMEMAELGPLNKYLQQNRHV-KDKNIIELVHQVSMGM 482
Query: 228 NYLHQNNIIHRDLKTANLLMDENGVVKVADFGVAR-VQAQSGVMTAET-GTY--RWMAPE 283
            YL ++N +HRDL   N+L+      K++DFG+++ ++A      A+T G +  +W APE
Sbjct: 483 KYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPE 542
Query: 284 VIEHKPYDYKADVFSFGIALWELLT-GELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRL 342
            I +  +  K+DV+SFG+ +WE  + G+ PY G+   +    +++K  R   P      +
Sbjct: 543 CINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSE-VTAMLEKGERMGCPAGCPREM 601
Query: 343 AELLERCWQHDPTQRPNFSQITDILKQMMKEVAS 376
            +L+  CW +D   RP F+ +   L+    +V +
Sbjct: 602 YDLMNLCWTYDVENRPGFAAVELRLRNYYYDVVN 635

>pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326

Iteration: 1
 Score =  116 bits (291), Expect = 2e-26,   Method: Compositional matrix adjust.
 Identities = 79/294 (26%), Positives = 140/294 (47%), Gaps = 29/294 (9%)
Query: 109 DVWEIDAKQLKIECKVASGSYGDLYKGTY------CSQEVAIKVLKPECVNTEMLKEFSQ 162
           D  + + + LK   ++  G++G +    Y        + VA+K L+      E L++F +
Sbjct: 34  DPTQFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHST--EEHLRDFER 91
Query: 163 EVYIMRKIRHKNVVQFIGACTRP--PNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVA 220
           E+ I++ ++H N+V++ G C      NL ++ E++  GS+ D+L K K       LL+  
Sbjct: 92  EIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYT 151
Query: 221 IDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARV--QAQSGVMTAETGTYR 278
             + KGM YL     IHRDL T N+L++    VK+ DFG+ +V  Q +      E G   
Sbjct: 152 SQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESP 211
Query: 279 --WMAPEVIEHKPYDYKADVFSFGIALWELLT----GELPYA-----------GLTPLQA 321
             W APE +    +   +DV+SFG+ L+EL T     + P A           G   +  
Sbjct: 212 IFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFH 271
Query: 322 AVGVVQKSLRPTIPKHAHPRLAELLERCWQHDPTQRPNFSQITDILKQMMKEVA 375
            + +++ + R   P      +  ++  CW ++  QRP+F  +   + Q+  ++A
Sbjct: 272 LIELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRDQMA 325

>pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298

Iteration: 1
 Score =  116 bits (291), Expect = 2e-26,   Method: Compositional matrix adjust.
 Identities = 79/298 (26%), Positives = 141/298 (47%), Gaps = 29/298 (9%)
Query: 105 TDGTDVWEIDAKQLKIECKVASGSYGDLYKGTY------CSQEVAIKVLKPECVNTEMLK 158
           ++  D  + + + LK   ++  G++G +    Y        + VA+K L+      E L+
Sbjct: 2   SEDRDPTQFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHST--EEHLR 59
Query: 159 EFSQEVYIMRKIRHKNVVQFIGACTRP--PNLCIVTEFMARGSIYDFLHKQKGVFQLTSL 216
           +F +E+ I++ ++H N+V++ G C      NL ++ E++  GS+ D+L K K       L
Sbjct: 60  DFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKL 119
Query: 217 LKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARV--QAQSGVMTAET 274
           L+    + KGM YL     IHRDL T N+L++    VK+ DFG+ +V  Q +      E 
Sbjct: 120 LQYTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEP 179
Query: 275 GTYR--WMAPEVIEHKPYDYKADVFSFGIALWELLT----GELPYA-----------GLT 317
           G     W APE +    +   +DV+SFG+ L+EL T     + P A           G  
Sbjct: 180 GESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQM 239
Query: 318 PLQAAVGVVQKSLRPTIPKHAHPRLAELLERCWQHDPTQRPNFSQITDILKQMMKEVA 375
            +   + +++ + R   P      +  ++  CW ++  QRP+F  +   + Q+   +A
Sbjct: 240 IVFHLIELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRDNMA 297

>pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293

Iteration: 1
 Score =  116 bits (291), Expect = 2e-26,   Method: Compositional matrix adjust.
 Identities = 79/294 (26%), Positives = 140/294 (47%), Gaps = 29/294 (9%)
Query: 109 DVWEIDAKQLKIECKVASGSYGDLYKGTY------CSQEVAIKVLKPECVNTEMLKEFSQ 162
           D  + + + LK   ++  G++G +    Y        + VA+K L+      E L++F +
Sbjct: 1   DPTQFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHST--EEHLRDFER 58
Query: 163 EVYIMRKIRHKNVVQFIGACTRP--PNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVA 220
           E+ I++ ++H N+V++ G C      NL ++ E++  GS+ D+L K K       LL+  
Sbjct: 59  EIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYT 118
Query: 221 IDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARV--QAQSGVMTAETGTYR 278
             + KGM YL     IHRDL T N+L++    VK+ DFG+ +V  Q +      E G   
Sbjct: 119 SQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESP 178
Query: 279 --WMAPEVIEHKPYDYKADVFSFGIALWELLT----GELPYA-----------GLTPLQA 321
             W APE +    +   +DV+SFG+ L+EL T     + P A           G   +  
Sbjct: 179 IFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFH 238
Query: 322 AVGVVQKSLRPTIPKHAHPRLAELLERCWQHDPTQRPNFSQITDILKQMMKEVA 375
            + +++ + R   P      +  ++  CW ++  QRP+F  +   + Q+  ++A
Sbjct: 239 LIELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRDQMA 292

>pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295

Iteration: 1
 Score =  116 bits (291), Expect = 2e-26,   Method: Compositional matrix adjust.
 Identities = 71/243 (29%), Positives = 132/243 (54%), Gaps = 11/243 (4%)
Query: 124 VASGSYGDLYKGTYCSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACT 183
           +  G+YG +Y G   S +V I + +    ++   +   +E+ + + ++HKN+VQ++G+ +
Sbjct: 30  LGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSFS 89
Query: 184 RPPNLCIVTEFMARGSIYDFLHKQKGVFQLT--SLLKVAIDVSKGMNYLHQNNIIHRDLK 241
               + I  E +  GS+   L  + G  +    ++      + +G+ YLH N I+HRD+K
Sbjct: 90  ENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDNQIVHRDIK 149
Query: 242 TANLLMDE-NGVVKVADFGVA-RVQAQSGVMTAETGTYRWMAPEVIEHKPYDY--KADVF 297
             N+L++  +GV+K++DFG + R+   +      TGT ++MAPE+I+  P  Y   AD++
Sbjct: 150 GDNVLINTYSGVLKISDFGTSKRLAGINPCTETFTGTLQYMAPEIIDKGPRGYGKAADIW 209
Query: 298 SFGIALWELLTGELPYAGLTPLQAA---VGVVQKSLRPTIPKHAHPRLAELLERCWQHDP 354
           S G  + E+ TG+ P+  L   QAA   VG+ +  + P IP+         + +C++ DP
Sbjct: 210 SLGCTIIEMATGKPPFYELGEPQAAMFKVGMFK--VHPEIPESMSAEAKAFILKCFEPDP 267
Query: 355 TQR 357
            +R
Sbjct: 268 DKR 270

>pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302

Iteration: 1
 Score =  116 bits (290), Expect = 2e-26,   Method: Compositional matrix adjust.
 Identities = 79/294 (26%), Positives = 139/294 (47%), Gaps = 29/294 (9%)
Query: 109 DVWEIDAKQLKIECKVASGSYGDLYKGTY------CSQEVAIKVLKPECVNTEMLKEFSQ 162
           D  + + + LK   ++  G++G +    Y        + VA+K L+      E L++F +
Sbjct: 10  DPTQFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHST--EEHLRDFER 67
Query: 163 EVYIMRKIRHKNVVQFIGACTRP--PNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVA 220
           E+ I++ ++H N+V++ G C      NL ++ E++  GS+ D+L K K       LL+  
Sbjct: 68  EIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYT 127
Query: 221 IDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARV--QAQSGVMTAETGTYR 278
             + KGM YL     IHRDL T N+L++    VK+ DFG+ +V  Q +      E G   
Sbjct: 128 SQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESP 187
Query: 279 --WMAPEVIEHKPYDYKADVFSFGIALWELLT----GELPYA-----------GLTPLQA 321
             W APE +    +   +DV+SFG+ L+EL T     + P A           G   +  
Sbjct: 188 IFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFH 247
Query: 322 AVGVVQKSLRPTIPKHAHPRLAELLERCWQHDPTQRPNFSQITDILKQMMKEVA 375
            + +++ + R   P      +  ++  CW ++  QRP+F  +   + Q+   +A
Sbjct: 248 LIELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRDNMA 301

>pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348

Iteration: 1
 Score =  116 bits (290), Expect = 2e-26,   Method: Compositional matrix adjust.
 Identities = 77/243 (31%), Positives = 115/243 (47%), Gaps = 10/243 (4%)
Query: 123 KVASGSYGDLY--KGTYCSQEVAIKVLKPECVNT-EMLKEFSQEVYIMRKIRHKNVVQFI 179
           ++  GS+G +Y  +    S+ VAIK +      + E  ++  +EV  ++K+RH N +Q+ 
Sbjct: 61  EIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYR 120
Query: 180 GACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRD 239
           G   R     +V E+   GS  D L   K   Q   +  V     +G+ YLH +N+IHRD
Sbjct: 121 GCYLREHTAWLVMEY-CLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRD 179
Query: 240 LKTANLLMDENGVVKVADFGVARVQAQSGVMTAETGTYRWMAPEVI---EHKPYDYKADV 296
           +K  N+L+ E G+VK+ DFG A + A +       GT  WMAPEVI   +   YD K DV
Sbjct: 180 VKAGNILLSEPGLVKLGDFGSASIMAPANXF---VGTPYWMAPEVILAMDEGQYDGKVDV 236
Query: 297 FSFGIALWELLTGELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRLAELLERCWQHDPTQ 356
           +S GI   EL   + P   +  + A   + Q         H        ++ C Q  P  
Sbjct: 237 WSLGITCIELAERKPPLFNMNAMSALYHIAQNESPALQSGHWSEYFRNFVDSCLQKIPQD 296
Query: 357 RPN 359
           RP 
Sbjct: 297 RPT 299

>pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309

Iteration: 1
 Score =  116 bits (290), Expect = 2e-26,   Method: Compositional matrix adjust.
 Identities = 77/242 (31%), Positives = 115/242 (47%), Gaps = 10/242 (4%)
Query: 123 KVASGSYGDLY--KGTYCSQEVAIKVLKPECVNT-EMLKEFSQEVYIMRKIRHKNVVQFI 179
           ++  GS+G +Y  +    S+ VAIK +      + E  ++  +EV  ++K+RH N +Q+ 
Sbjct: 22  EIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYR 81
Query: 180 GACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRD 239
           G   R     +V E+   GS  D L   K   Q   +  V     +G+ YLH +N+IHRD
Sbjct: 82  GCYLREHTAWLVMEY-CLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRD 140
Query: 240 LKTANLLMDENGVVKVADFGVARVQAQSGVMTAETGTYRWMAPEVI---EHKPYDYKADV 296
           +K  N+L+ E G+VK+ DFG A + A +       GT  WMAPEVI   +   YD K DV
Sbjct: 141 VKAGNILLSEPGLVKLGDFGSASIMAPANXF---VGTPYWMAPEVILAMDEGQYDGKVDV 197
Query: 297 FSFGIALWELLTGELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRLAELLERCWQHDPTQ 356
           +S GI   EL   + P   +  + A   + Q         H        ++ C Q  P  
Sbjct: 198 WSLGITCIELAERKPPLFNMNAMSALYHIAQNESPALQSGHWSEYFRNFVDSCLQKIPQD 257
Query: 357 RP 358
           RP
Sbjct: 258 RP 259

>pdb|3MDY|A Chain A, Crystal Structure Of The Cytoplasmic Domain Of The Bone Morp Protein Receptor Type-1b (Bmpr1b) In Complex With Fkbp12 An 193189 Length = 337

Iteration: 1
 Score =  116 bits (290), Expect = 3e-26,   Method: Compositional matrix adjust.
 Identities = 88/301 (29%), Positives = 147/301 (48%), Gaps = 52/301 (17%)
Query: 115 AKQLKIECKVASGSYGDLYKGTYCSQEVAIKVLKPECVNTEMLKEFSQ-EVYIMRKIRHK 173
           AKQ+++  ++  G YG+++ G +  ++VA+KV       TE    F + E+Y    +RH+
Sbjct: 36  AKQIQMVKQIGKGRYGEVWMGKWRGEKVAVKVF----FTTEEASWFRETEIYQTVLMRHE 91
Query: 174 NVVQFIGACTRPP----NLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNY 229
           N++ FI A  +       L ++T++   GS+YD+L  +       S+LK+A     G+ +
Sbjct: 92  NILGFIAADIKGTGSWTQLYLITDYHENGSLYDYL--KSTTLDAKSMLKLAYSSVSGLCH 149
Query: 230 LH--------QNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAE------TG 275
           LH        +  I HRDLK+ N+L+ +NG   +AD G+A V+  S     +       G
Sbjct: 150 LHTEIFSTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLA-VKFISDTNEVDIPPNTRVG 208
Query: 276 TYRWMAPEVIE------HKPYDYKADVFSFGIALWEL----LTG------ELPYAGLTPL 319
           T R+M PEV++      H      AD++SFG+ LWE+    ++G      +LPY  L P 
Sbjct: 209 TKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQLPYHDLVPS 268
Query: 320 QAAVG-----VVQKSLRPTIPKHAHP-----RLAELLERCWQHDPTQRPNFSQITDILKQ 369
             +       V  K LRP+ P          ++ +L+  CW H+P  R    ++   L +
Sbjct: 269 DPSYEDMREIVCIKKLRPSFPNRWSSDECLRQMGKLMTECWAHNPASRLTALRVKKTLAK 328
Query: 370 M 370
           M
Sbjct: 329 M 329

>pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293

Iteration: 1
 Score =  116 bits (290), Expect = 3e-26,   Method: Compositional matrix adjust.
 Identities = 79/294 (26%), Positives = 139/294 (47%), Gaps = 29/294 (9%)
Query: 109 DVWEIDAKQLKIECKVASGSYGDLYKGTY------CSQEVAIKVLKPECVNTEMLKEFSQ 162
           D  + + + LK   ++  G++G +    Y        + VA+K L+      E L++F +
Sbjct: 2   DPTQFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHST--EEHLRDFER 59
Query: 163 EVYIMRKIRHKNVVQFIGACTRP--PNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVA 220
           E+ I++ ++H N+V++ G C      NL ++ E++  GS+ D+L K K       LL+  
Sbjct: 60  EIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYT 119
Query: 221 IDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARV--QAQSGVMTAETGTYR 278
             + KGM YL     IHRDL T N+L++    VK+ DFG+ +V  Q +      E G   
Sbjct: 120 SQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESP 179
Query: 279 --WMAPEVIEHKPYDYKADVFSFGIALWELLT----GELPYA-----------GLTPLQA 321
             W APE +    +   +DV+SFG+ L+EL T     + P A           G   +  
Sbjct: 180 IFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFH 239
Query: 322 AVGVVQKSLRPTIPKHAHPRLAELLERCWQHDPTQRPNFSQITDILKQMMKEVA 375
            + +++ + R   P      +  ++  CW ++  QRP+F  +   + Q+   +A
Sbjct: 240 LIELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRDNMA 293

>pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300

Iteration: 1
 Score =  116 bits (290), Expect = 3e-26,   Method: Compositional matrix adjust.
 Identities = 79/294 (26%), Positives = 139/294 (47%), Gaps = 29/294 (9%)
Query: 109 DVWEIDAKQLKIECKVASGSYGDLYKGTY------CSQEVAIKVLKPECVNTEMLKEFSQ 162
           D  + + + LK   ++  G++G +    Y        + VA+K L+      E L++F +
Sbjct: 8   DPTQFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHST--EEHLRDFER 65
Query: 163 EVYIMRKIRHKNVVQFIGACTRP--PNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVA 220
           E+ I++ ++H N+V++ G C      NL ++ E++  GS+ D+L K K       LL+  
Sbjct: 66  EIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYT 125
Query: 221 IDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARV--QAQSGVMTAETGTYR 278
             + KGM YL     IHRDL T N+L++    VK+ DFG+ +V  Q +      E G   
Sbjct: 126 SQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESP 185
Query: 279 --WMAPEVIEHKPYDYKADVFSFGIALWELLT----GELPYA-----------GLTPLQA 321
             W APE +    +   +DV+SFG+ L+EL T     + P A           G   +  
Sbjct: 186 IFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFH 245
Query: 322 AVGVVQKSLRPTIPKHAHPRLAELLERCWQHDPTQRPNFSQITDILKQMMKEVA 375
            + +++ + R   P      +  ++  CW ++  QRP+F  +   + Q+   +A
Sbjct: 246 LIELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRDNMA 299

>pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301

Iteration: 1
 Score =  116 bits (290), Expect = 3e-26,   Method: Compositional matrix adjust.
 Identities = 79/294 (26%), Positives = 139/294 (47%), Gaps = 29/294 (9%)
Query: 109 DVWEIDAKQLKIECKVASGSYGDLYKGTY------CSQEVAIKVLKPECVNTEMLKEFSQ 162
           D  + + + LK   ++  G++G +    Y        + VA+K L+      E L++F +
Sbjct: 3   DPTQFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHST--EEHLRDFER 60
Query: 163 EVYIMRKIRHKNVVQFIGACTRP--PNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVA 220
           E+ I++ ++H N+V++ G C      NL ++ E++  GS+ D+L K K       LL+  
Sbjct: 61  EIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYT 120
Query: 221 IDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARV--QAQSGVMTAETGTYR 278
             + KGM YL     IHRDL T N+L++    VK+ DFG+ +V  Q +      E G   
Sbjct: 121 SQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESP 180
Query: 279 --WMAPEVIEHKPYDYKADVFSFGIALWELLT----GELPYA-----------GLTPLQA 321
             W APE +    +   +DV+SFG+ L+EL T     + P A           G   +  
Sbjct: 181 IFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFH 240
Query: 322 AVGVVQKSLRPTIPKHAHPRLAELLERCWQHDPTQRPNFSQITDILKQMMKEVA 375
            + +++ + R   P      +  ++  CW ++  QRP+F  +   + Q+   +A
Sbjct: 241 LIELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRDNMA 294

>pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301

Iteration: 1
 Score =  115 bits (289), Expect = 3e-26,   Method: Compositional matrix adjust.
 Identities = 79/294 (26%), Positives = 139/294 (47%), Gaps = 29/294 (9%)
Query: 109 DVWEIDAKQLKIECKVASGSYGDLYKGTY------CSQEVAIKVLKPECVNTEMLKEFSQ 162
           D  + + + LK   ++  G++G +    Y        + VA+K L+      E L++F +
Sbjct: 9   DPTQFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHST--EEHLRDFER 66
Query: 163 EVYIMRKIRHKNVVQFIGACTRP--PNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVA 220
           E+ I++ ++H N+V++ G C      NL ++ E++  GS+ D+L K K       LL+  
Sbjct: 67  EIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYT 126
Query: 221 IDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARV--QAQSGVMTAETGTYR 278
             + KGM YL     IHRDL T N+L++    VK+ DFG+ +V  Q +      E G   
Sbjct: 127 SQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESP 186
Query: 279 --WMAPEVIEHKPYDYKADVFSFGIALWELLT----GELPYA-----------GLTPLQA 321
             W APE +    +   +DV+SFG+ L+EL T     + P A           G   +  
Sbjct: 187 IFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFH 246
Query: 322 AVGVVQKSLRPTIPKHAHPRLAELLERCWQHDPTQRPNFSQITDILKQMMKEVA 375
            + +++ + R   P      +  ++  CW ++  QRP+F  +   + Q+   +A
Sbjct: 247 LIELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRDNMA 300

>pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269

Iteration: 1
 Score =  115 bits (289), Expect = 3e-26,   Method: Compositional matrix adjust.
 Identities = 71/243 (29%), Positives = 132/243 (54%), Gaps = 11/243 (4%)
Query: 124 VASGSYGDLYKGTYCSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACT 183
           +  G+YG +Y G   S +V I + +    ++   +   +E+ + + ++HKN+VQ++G+ +
Sbjct: 16  LGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSFS 75
Query: 184 RPPNLCIVTEFMARGSIYDFLHKQKGVFQLT--SLLKVAIDVSKGMNYLHQNNIIHRDLK 241
               + I  E +  GS+   L  + G  +    ++      + +G+ YLH N I+HRD+K
Sbjct: 76  ENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDNQIVHRDIK 135
Query: 242 TANLLMDE-NGVVKVADFGVA-RVQAQSGVMTAETGTYRWMAPEVIEHKPYDY--KADVF 297
             N+L++  +GV+K++DFG + R+   +      TGT ++MAPE+I+  P  Y   AD++
Sbjct: 136 GDNVLINTYSGVLKISDFGTSKRLAGINPCTETFTGTLQYMAPEIIDKGPRGYGKAADIW 195
Query: 298 SFGIALWELLTGELPYAGLTPLQAA---VGVVQKSLRPTIPKHAHPRLAELLERCWQHDP 354
           S G  + E+ TG+ P+  L   QAA   VG+ +  + P IP+         + +C++ DP
Sbjct: 196 SLGCTIIEMATGKPPFYELGEPQAAMFKVGMFK--VHPEIPESMSAEAKAFILKCFEPDP 253
Query: 355 TQR 357
            +R
Sbjct: 254 DKR 256

>pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303

Iteration: 1
 Score =  115 bits (289), Expect = 3e-26,   Method: Compositional matrix adjust.
 Identities = 79/294 (26%), Positives = 139/294 (47%), Gaps = 29/294 (9%)
Query: 109 DVWEIDAKQLKIECKVASGSYGDLYKGTY------CSQEVAIKVLKPECVNTEMLKEFSQ 162
           D  + + + LK   ++  G++G +    Y        + VA+K L+      E L++F +
Sbjct: 7   DPTQFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHST--EEHLRDFER 64
Query: 163 EVYIMRKIRHKNVVQFIGACTRP--PNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVA 220
           E+ I++ ++H N+V++ G C      NL ++ E++  GS+ D+L K K       LL+  
Sbjct: 65  EIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYT 124
Query: 221 IDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARV--QAQSGVMTAETGTYR 278
             + KGM YL     IHRDL T N+L++    VK+ DFG+ +V  Q +      E G   
Sbjct: 125 SQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESP 184
Query: 279 --WMAPEVIEHKPYDYKADVFSFGIALWELLT----GELPYA-----------GLTPLQA 321
             W APE +    +   +DV+SFG+ L+EL T     + P A           G   +  
Sbjct: 185 IFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFH 244
Query: 322 AVGVVQKSLRPTIPKHAHPRLAELLERCWQHDPTQRPNFSQITDILKQMMKEVA 375
            + +++ + R   P      +  ++  CW ++  QRP+F  +   + Q+   +A
Sbjct: 245 LIELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRDNMA 298

>pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298

Iteration: 1
 Score =  115 bits (288), Expect = 4e-26,   Method: Compositional matrix adjust.
 Identities = 79/296 (26%), Positives = 140/296 (47%), Gaps = 29/296 (9%)
Query: 109 DVWEIDAKQLKIECKVASGSYGDLYKGTY------CSQEVAIKVLKPECVNTEMLKEFSQ 162
           D  + + + LK   ++  G++G +    Y        + VA+K L+      E L++F +
Sbjct: 4   DPTQFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHST--EEHLRDFER 61
Query: 163 EVYIMRKIRHKNVVQFIGACTRP--PNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVA 220
           E+ I++ ++H N+V++ G C      NL ++ E++  GS+ D+L K K       LL+  
Sbjct: 62  EIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYT 121
Query: 221 IDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARV--QAQSGVMTAETGTYR 278
             + KGM YL     IHR+L T N+L++    VK+ DFG+ +V  Q +      E G   
Sbjct: 122 SQICKGMEYLGTKRYIHRNLATRNILVENENRVKIGDFGLTKVLPQDKEYYKVKEPGESP 181
Query: 279 --WMAPEVIEHKPYDYKADVFSFGIALWELLT----GELPYA-----------GLTPLQA 321
             W APE +    +   +DV+SFG+ L+EL T     + P A           G   +  
Sbjct: 182 IFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFH 241
Query: 322 AVGVVQKSLRPTIPKHAHPRLAELLERCWQHDPTQRPNFSQITDILKQMMKEVASE 377
            + +++ + R   P      +  ++  CW ++  QRP+F  +   + Q+   +A E
Sbjct: 242 LIELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRDNMAGE 297

>pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298

Iteration: 1
 Score =  115 bits (288), Expect = 4e-26,   Method: Compositional matrix adjust.
 Identities = 79/294 (26%), Positives = 139/294 (47%), Gaps = 29/294 (9%)
Query: 109 DVWEIDAKQLKIECKVASGSYGDLYKGTY------CSQEVAIKVLKPECVNTEMLKEFSQ 162
           D  + + + LK   ++  G++G +    Y        + VA+K L+      E L++F +
Sbjct: 6   DPTQFEERHLKFLRQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHST--EEHLRDFER 63
Query: 163 EVYIMRKIRHKNVVQFIGACTRP--PNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVA 220
           E+ I++ ++H N+V++ G C      NL ++ EF+  GS+ ++L K K       LL+  
Sbjct: 64  EIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEFLPYGSLREYLQKHKERIDHIKLLQYT 123
Query: 221 IDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARV--QAQSGVMTAETGTYR 278
             + KGM YL     IHRDL T N+L++    VK+ DFG+ +V  Q +      E G   
Sbjct: 124 SQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESP 183
Query: 279 --WMAPEVIEHKPYDYKADVFSFGIALWELLT----GELPYA-----------GLTPLQA 321
             W APE +    +   +DV+SFG+ L+EL T     + P A           G   +  
Sbjct: 184 IFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFH 243
Query: 322 AVGVVQKSLRPTIPKHAHPRLAELLERCWQHDPTQRPNFSQITDILKQMMKEVA 375
            + +++ + R   P      +  ++  CW ++  QRP+F  +   + Q+   +A
Sbjct: 244 LIELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRDNMA 297

>pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296

Iteration: 1
 Score =  115 bits (287), Expect = 5e-26,   Method: Compositional matrix adjust.
 Identities = 77/246 (31%), Positives = 129/246 (52%), Gaps = 10/246 (4%)
Query: 123 KVASGSYGDLYKGTYCSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGAC 182
           K+  GS G +   T  S    + V K +    +  +    EV IMR  +H+NVV+   + 
Sbjct: 31  KIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSY 90
Query: 183 TRPPNLCIVTEFMARGSIYDFL-HKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLK 241
                L +V EF+  G++ D + H +    Q+ +   V + V + ++ LH   +IHRD+K
Sbjct: 91  LVGDELWVVMEFLEGGALTDIVTHTRMNEEQIAA---VCLAVLQALSVLHAQGVIHRDIK 147
Query: 242 TANLLMDENGVVKVADFGV-ARVQAQSGVMTAETGTYRWMAPEVIEHKPYDYKADVFSFG 300
           + ++L+  +G VK++DFG  A+V  +        GT  WMAPE+I   PY  + D++S G
Sbjct: 148 SDSILLTHDGRVKLSDFGFCAQVSKEVPRRKXLVGTPYWMAPELISRLPYGPEVDIWSLG 207
Query: 301 IALWELLTGELPYAGLTPLQAAVGVVQKSLRPTIPKHAH---PRLAELLERCWQHDPTQR 357
           I + E++ GE PY    PL+ A+ +++ +L P + K+ H   P L   L+R    DP QR
Sbjct: 208 IMVIEMVDGEPPYFNEPPLK-AMKMIRDNLPPRL-KNLHKVSPSLKGFLDRLLVRDPAQR 265
Query: 358 PNFSQI 363
              +++
Sbjct: 266 ATAAEL 271

>pdb|3HNG|A Chain A, Crystal Structure Of Vegfr1 In Complex With N-(4-chlorophenyl)-2- ((pyridin-4-ylmethyl)amino)benzamide Length = 360

Iteration: 1
 Score =  115 bits (287), Expect = 5e-26,   Method: Compositional matrix adjust.
 Identities = 54/163 (33%), Positives = 94/163 (57%), Gaps = 4/163 (2%)
Query: 213 LTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTA 272
           +  L+  +  V++GM +L     IHRDL   N+L+ EN VVK+ DFG+AR   ++     
Sbjct: 198 MEDLISYSFQVARGMEFLSSRKCIHRDLAARNILLSENNVVKICDFGLARDIYKNPDYVR 257
Query: 273 ETGT---YRWMAPEVIEHKPYDYKADVFSFGIALWELLT-GELPYAGLTPLQAAVGVVQK 328
           +  T    +WMAPE I  K Y  K+DV+S+G+ LWE+ + G  PY G+   +     +++
Sbjct: 258 KGDTRLPLKWMAPESIFDKIYSTKSDVWSYGVLLWEIFSLGGSPYPGVQMDEDFCSRLRE 317
Query: 329 SLRPTIPKHAHPRLAELLERCWQHDPTQRPNFSQITDILKQMM 371
            +R   P+++ P + +++  CW  DP +RP F+++ + L  ++
Sbjct: 318 GMRMRAPEYSTPEIYQIMLDCWHRDPKERPRFAELVEKLGDLL 360

>pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292

Iteration: 1
 Score =  115 bits (287), Expect = 6e-26,   Method: Compositional matrix adjust.
 Identities = 77/246 (31%), Positives = 129/246 (52%), Gaps = 10/246 (4%)
Query: 123 KVASGSYGDLYKGTYCSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGAC 182
           K+  GS G +   T  S    + V K +    +  +    EV IMR  +H+NVV+   + 
Sbjct: 27  KIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSY 86
Query: 183 TRPPNLCIVTEFMARGSIYDFL-HKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLK 241
                L +V EF+  G++ D + H +    Q+ +   V + V + ++ LH   +IHRD+K
Sbjct: 87  LVGDELWVVMEFLEGGALTDIVTHTRMNEEQIAA---VCLAVLQALSVLHAQGVIHRDIK 143
Query: 242 TANLLMDENGVVKVADFGV-ARVQAQSGVMTAETGTYRWMAPEVIEHKPYDYKADVFSFG 300
           + ++L+  +G VK++DFG  A+V  +        GT  WMAPE+I   PY  + D++S G
Sbjct: 144 SDSILLTHDGRVKLSDFGFCAQVSKEVPRRKXLVGTPYWMAPELISRLPYGPEVDIWSLG 203
Query: 301 IALWELLTGELPYAGLTPLQAAVGVVQKSLRPTIPKHAH---PRLAELLERCWQHDPTQR 357
           I + E++ GE PY    PL+ A+ +++ +L P + K+ H   P L   L+R    DP QR
Sbjct: 204 IMVIEMVDGEPPYFNEPPLK-AMKMIRDNLPPRL-KNLHKVSPSLKGFLDRLLVRDPAQR 261
Query: 358 PNFSQI 363
              +++
Sbjct: 262 ATAAEL 267

>pdb|2QLU|A Chain A, Crystal Structure Of Activin Receptor Type Ii Kinase Domain From Human Length = 314

Iteration: 1
 Score =  114 bits (286), Expect = 7e-26,   Method: Compositional matrix adjust.
 Identities = 83/278 (29%), Positives = 139/278 (50%), Gaps = 51/278 (18%)
Query: 125 ASGSYGDLYKGTYCSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTR 184
           A G +G ++K    +  VA+K+     +  +   +  +E++    ++H+N++QFI A  R
Sbjct: 24  ARGRFGCVWKAQLMNDFVAVKIFP---LQDKQSWQSEREIFSTPGMKHENLLQFIAAEKR 80
Query: 185 PPNL----CIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQN------- 233
             NL     ++T F  +GS+ D+L  +  +     L  VA  +S+G++YLH++       
Sbjct: 81  GSNLEVELWLITAFHDKGSLTDYL--KGNIITWNELCHVAETMSRGLSYLHEDVPWCRGE 138
Query: 234 ----NIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAET----GTYRWMAPEVI 285
               +I HRD K+ N+L+  +    +ADFG+A V+ + G    +T    GT R+MAPEV+
Sbjct: 139 GHKPSIAHRDFKSKNVLLKSDLTAVLADFGLA-VRFEPGKPPGDTHGQVGTRRYMAPEVL 197
Query: 286 E-----HKPYDYKADVFSFGIALWELLTGELPYAG-----LTPLQAAVG----------- 324
           E      +    + D+++ G+ LWEL++      G     + P +  +G           
Sbjct: 198 EGAINFQRDAFLRIDMYAMGLVLWELVSRCKAADGPVDEYMLPFEEEIGQHPSLEELQEV 257
Query: 325 VVQKSLRPTIPKH--AHPRLAEL---LERCWQHDPTQR 357
           VV K +RPTI  H   HP LA+L   +E CW HD   R
Sbjct: 258 VVHKKMRPTIKDHWLKHPGLAQLCVTIEECWDHDAEAR 295

>pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302

Iteration: 1
 Score =  114 bits (286), Expect = 7e-26,   Method: Compositional matrix adjust.
 Identities = 78/266 (29%), Positives = 131/266 (49%), Gaps = 25/266 (9%)
Query: 123 KVASGSYGDLYKGTYCSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGAC 182
           KV+   Y     GT   + VA+K LK +C   +    + QE+ I+R + H++++++ G C
Sbjct: 29  KVSLYCYDPTNDGT--GEMVAVKALKADC-GPQHRSGWKQEIDILRTLYHEHIIKYKGCC 85
Query: 183 TR--PPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDL 240
                 +L +V E++  GS+ D+L +      L  LL  A  + +GM YLH  + IHR+L
Sbjct: 86  EDQGEKSLQLVMEYVPLGSLRDYLPRHS--IGLAQLLLFAQQICEGMAYLHSQHYIHRNL 143
Query: 241 KTANLLMDENGVVKVADFGVARV--QAQSGVMTAETGTYR--WMAPEVIEHKPYDYKADV 296
              N+L+D + +VK+ DFG+A+   +        E G     W APE ++   + Y +DV
Sbjct: 144 AARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAPECLKEYKFYYASDV 203
Query: 297 FSFGIALWELLTG-ELPYAGLTPLQAAVGVVQKSL-------------RPTIPKHAHPRL 342
           +SFG+ L+ELLT  +   +  T     +G+ Q  +             R   P      +
Sbjct: 204 WSFGVTLYELLTHCDSSQSPPTKFLELIGIAQGQMTVLRLTELLERGERLPRPDKCPCEV 263
Query: 343 AELLERCWQHDPTQRPNFSQITDILK 368
             L++ CW+ + + RP F  +  ILK
Sbjct: 264 YHLMKNCWETEASFRPTFENLIPILK 289

>pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303

Iteration: 1
 Score =  114 bits (286), Expect = 7e-26,   Method: Compositional matrix adjust.
 Identities = 77/246 (31%), Positives = 129/246 (52%), Gaps = 10/246 (4%)
Query: 123 KVASGSYGDLYKGTYCSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGAC 182
           K+  GS G +   T  S    + V K +    +  +    EV IMR  +H+NVV+   + 
Sbjct: 38  KIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSY 97
Query: 183 TRPPNLCIVTEFMARGSIYDFL-HKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLK 241
                L +V EF+  G++ D + H +    Q+ +   V + V + ++ LH   +IHRD+K
Sbjct: 98  LVGDELWVVMEFLEGGALTDIVTHTRMNEEQIAA---VCLAVLQALSVLHAQGVIHRDIK 154
Query: 242 TANLLMDENGVVKVADFGV-ARVQAQSGVMTAETGTYRWMAPEVIEHKPYDYKADVFSFG 300
           + ++L+  +G VK++DFG  A+V  +        GT  WMAPE+I   PY  + D++S G
Sbjct: 155 SDSILLTHDGRVKLSDFGFCAQVSKEVPRRKXLVGTPYWMAPELISRLPYGPEVDIWSLG 214
Query: 301 IALWELLTGELPYAGLTPLQAAVGVVQKSLRPTIPKHAH---PRLAELLERCWQHDPTQR 357
           I + E++ GE PY    PL+ A+ +++ +L P + K+ H   P L   L+R    DP QR
Sbjct: 215 IMVIEMVDGEPPYFNEPPLK-AMKMIRDNLPPRL-KNLHKVSPSLKGFLDRLLVRDPAQR 272
Query: 358 PNFSQI 363
              +++
Sbjct: 273 ATAAEL 278

>pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301

Iteration: 1
 Score =  114 bits (286), Expect = 8e-26,   Method: Compositional matrix adjust.
 Identities = 77/246 (31%), Positives = 129/246 (52%), Gaps = 10/246 (4%)
Query: 123 KVASGSYGDLYKGTYCSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGAC 182
           K+  GS G +   T  S    + V K +    +  +    EV IMR  +H+NVV+   + 
Sbjct: 36  KIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSY 95
Query: 183 TRPPNLCIVTEFMARGSIYDFL-HKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLK 241
                L +V EF+  G++ D + H +    Q+ +   V + V + ++ LH   +IHRD+K
Sbjct: 96  LVGDELWVVMEFLEGGALTDIVTHTRMNEEQIAA---VCLAVLQALSVLHAQGVIHRDIK 152
Query: 242 TANLLMDENGVVKVADFGV-ARVQAQSGVMTAETGTYRWMAPEVIEHKPYDYKADVFSFG 300
           + ++L+  +G VK++DFG  A+V  +        GT  WMAPE+I   PY  + D++S G
Sbjct: 153 SDSILLTHDGRVKLSDFGFCAQVSKEVPRRKXLVGTPYWMAPELISRLPYGPEVDIWSLG 212
Query: 301 IALWELLTGELPYAGLTPLQAAVGVVQKSLRPTIPKHAH---PRLAELLERCWQHDPTQR 357
           I + E++ GE PY    PL+ A+ +++ +L P + K+ H   P L   L+R    DP QR
Sbjct: 213 IMVIEMVDGEPPYFNEPPLK-AMKMIRDNLPPRL-KNLHKVSPSLKGFLDRLLVRDPAQR 270
Query: 358 PNFSQI 363
              +++
Sbjct: 271 ATAAEL 276

>pdb|3Q4T|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a) Kinase Domain In Complex With Dorsomorphin Length = 322

Iteration: 1
 Score =  114 bits (286), Expect = 8e-26,   Method: Compositional matrix adjust.
 Identities = 83/291 (28%), Positives = 139/291 (47%), Gaps = 48/291 (16%)
Query: 125 ASGSYGDLYKGTYCSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTR 184
           A G +G ++K    ++ VA+K+     +  +   +   EVY +  ++H+N++QFIGA  R
Sbjct: 33  ARGRFGCVWKAQLLNEYVAVKIFP---IQDKQSWQNEYEVYSLPGMKHENILQFIGAEKR 89
Query: 185 PP----NLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQN------- 233
                 +L ++T F  +GS+ DFL  +  V     L  +A  +++G+ YLH++       
Sbjct: 90  GTSVDVDLWLITAFHEKGSLSDFL--KANVVSWNELCHIAETMARGLAYLHEDIPGLKDG 147
Query: 234 ---NIIHRDLKTANLLMDENGVVKVADFGVA---RVQAQSGVMTAETGTYRWMAPEVIE- 286
               I HRD+K+ N+L+  N    +ADFG+A        +G    + GT R+MAPEV+E 
Sbjct: 148 HKPAISHRDIKSKNVLLKNNLTACIADFGLALKFEAGKSAGDTHGQVGTRRYMAPEVLEG 207
Query: 287 ----HKPYDYKADVFSFGIALWELLTGELPYAG-----LTPLQAAVG-----------VV 326
                +    + D+++ G+ LWEL +      G     + P +  +G           VV
Sbjct: 208 AINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYMLPFEEEIGQHPSLEDMQEVVV 267
Query: 327 QKSLRPTI----PKHA-HPRLAELLERCWQHDPTQRPNFSQITDILKQMMK 372
            K  RP +     KHA    L E +E CW HD   R +   + + + QM +
Sbjct: 268 HKKKRPVLRDYWQKHAGMAMLCETIEECWDHDAEARLSAGCVGERITQMQR 318

>pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302

Iteration: 1
 Score =  114 bits (285), Expect = 9e-26,   Method: Compositional matrix adjust.
 Identities = 78/266 (29%), Positives = 131/266 (49%), Gaps = 25/266 (9%)
Query: 123 KVASGSYGDLYKGTYCSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGAC 182
           KV+   Y     GT   + VA+K LK +C   +    + QE+ I+R + H++++++ G C
Sbjct: 29  KVSLYCYDPTNDGT--GEMVAVKALKADC-GPQHRSGWKQEIDILRTLYHEHIIKYKGCC 85
Query: 183 TR--PPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDL 240
                 +L +V E++  GS+ D+L +      L  LL  A  + +GM YLH  + IHR+L
Sbjct: 86  EDQGEKSLQLVMEYVPLGSLRDYLPRHS--IGLAQLLLFAQQICEGMAYLHAQHYIHRNL 143
Query: 241 KTANLLMDENGVVKVADFGVARV--QAQSGVMTAETGTYR--WMAPEVIEHKPYDYKADV 296
              N+L+D + +VK+ DFG+A+   +        E G     W APE ++   + Y +DV
Sbjct: 144 AARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAPECLKEYKFYYASDV 203
Query: 297 FSFGIALWELLTG-ELPYAGLTPLQAAVGVVQKSL-------------RPTIPKHAHPRL 342
           +SFG+ L+ELLT  +   +  T     +G+ Q  +             R   P      +
Sbjct: 204 WSFGVTLYELLTHCDSSQSPPTKFLELIGIAQGQMTVLRLTELLERGERLPRPDKCPCEV 263
Query: 343 AELLERCWQHDPTQRPNFSQITDILK 368
             L++ CW+ + + RP F  +  ILK
Sbjct: 264 YHLMKNCWETEASFRPTFENLIPILK 289

>pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318

Iteration: 1
 Score =  114 bits (285), Expect = 1e-25,   Method: Compositional matrix adjust.
 Identities = 78/266 (29%), Positives = 130/266 (48%), Gaps = 25/266 (9%)
Query: 123 KVASGSYGDLYKGTYCSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGAC 182
           KV+   Y     GT   + VA+K LK +    +    + QE+ I+R + H++++++ G C
Sbjct: 46  KVSLYCYDPTNDGT--GEMVAVKALKAD-AGPQHRSGWKQEIDILRTLYHEHIIKYKGCC 102
Query: 183 --TRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDL 240
                 +L +V E++  GS+ D+L +      L  LL  A  + +GM YLH  + IHRDL
Sbjct: 103 EDAGAASLQLVMEYVPLGSLRDYLPRHS--IGLAQLLLFAQQICEGMAYLHAQHYIHRDL 160
Query: 241 KTANLLMDENGVVKVADFGVARV--QAQSGVMTAETGTYR--WMAPEVIEHKPYDYKADV 296
              N+L+D + +VK+ DFG+A+   +        E G     W APE ++   + Y +DV
Sbjct: 161 AARNVLLDNDRLVKIGDFGLAKAVPEGHEXYRVREDGDSPVFWYAPECLKEYKFYYASDV 220
Query: 297 FSFGIALWELLTG-ELPYAGLTPLQAAVGVVQKSL-------------RPTIPKHAHPRL 342
           +SFG+ L+ELLT  +   +  T     +G+ Q  +             R   P      +
Sbjct: 221 WSFGVTLYELLTHCDSSQSPPTKFLELIGIAQGQMTVLRLTELLERGERLPRPDKCPAEV 280
Query: 343 AELLERCWQHDPTQRPNFSQITDILK 368
             L++ CW+ + + RP F  +  ILK
Sbjct: 281 YHLMKNCWETEASFRPTFENLIPILK 306

>pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346

Iteration: 1
 Score =  114 bits (284), Expect = 1e-25,   Method: Compositional matrix adjust.
 Identities = 77/246 (31%), Positives = 129/246 (52%), Gaps = 10/246 (4%)
Query: 123 KVASGSYGDLYKGTYCSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGAC 182
           K+  GS G +   T  S    + V K +    +  +    EV IMR  +H+NVV+   + 
Sbjct: 81  KIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSY 140
Query: 183 TRPPNLCIVTEFMARGSIYDFL-HKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLK 241
                L +V EF+  G++ D + H +    Q+ +   V + V + ++ LH   +IHRD+K
Sbjct: 141 LVGDELWVVMEFLEGGALTDIVTHTRMNEEQIAA---VCLAVLQALSVLHAQGVIHRDIK 197
Query: 242 TANLLMDENGVVKVADFGV-ARVQAQSGVMTAETGTYRWMAPEVIEHKPYDYKADVFSFG 300
           + ++L+  +G VK++DFG  A+V  +        GT  WMAPE+I   PY  + D++S G
Sbjct: 198 SDSILLTHDGRVKLSDFGFCAQVSKEVPRRKXLVGTPYWMAPELISRLPYGPEVDIWSLG 257
Query: 301 IALWELLTGELPYAGLTPLQAAVGVVQKSLRPTIPKHAH---PRLAELLERCWQHDPTQR 357
           I + E++ GE PY    PL+ A+ +++ +L P + K+ H   P L   L+R    DP QR
Sbjct: 258 IMVIEMVDGEPPYFNEPPLK-AMKMIRDNLPPRL-KNLHKVSPSLKGFLDRLLVRDPAQR 315
Query: 358 PNFSQI 363
              +++
Sbjct: 316 ATAAEL 321

>pdb|1B6C|B Chain B, Crystal Structure Of The Cytoplasmic Domain Of The Type I Tgf-Beta Receptor In Complex With Fkbp12 Length = 342

Iteration: 1
 Score =  114 bits (284), Expect = 1e-25,   Method: Compositional matrix adjust.
 Identities = 80/304 (26%), Positives = 149/304 (49%), Gaps = 52/304 (17%)
Query: 115 AKQLKIECKVASGSYGDLYKGTYCSQEVAIKVLKPECVNTEMLKEFSQ-EVYIMRKIRHK 173
           A+ + ++  +  G +G++++G +  +EVA+K+      + E    F + E+Y    +RH+
Sbjct: 41  ARTIVLQESIGKGRFGEVWRGKWRGEEVAVKIFS----SREERSWFREAEIYQTVMLRHE 96
Query: 174 NVVQFIGACTRP----PNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNY 229
           N++ FI A  +       L +V+++   GS++D+L++      +  ++K+A+  + G+ +
Sbjct: 97  NILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRY--TVTVEGMIKLALSTASGLAH 154
Query: 230 LHQN--------NIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAE------TG 275
           LH           I HRDLK+ N+L+ +NG   +AD G+A V+  S   T +       G
Sbjct: 155 LHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLA-VRHDSATDTIDIAPNHRVG 213
Query: 276 TYRWMAPEVIE------HKPYDYKADVFSFGIALWELLTG----------ELPYAGLTPL 319
           T R+MAPEV++      H     +AD+++ G+  WE+             +LPY  L P 
Sbjct: 214 TKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPS 273
Query: 320 QAAVG-----VVQKSLRPTIPKH-----AHPRLAELLERCWQHDPTQRPNFSQITDILKQ 369
             +V      V ++ LRP IP       A   +A+++  CW  +   R    +I   L Q
Sbjct: 274 DPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQ 333
Query: 370 MMKE 373
           + ++
Sbjct: 334 LSQQ 337

>pdb|3TZM|A Chain A, Tgf-Beta Receptor Type 1 In Complex With Sb431542 Length = 309

Iteration: 1
 Score =  114 bits (284), Expect = 1e-25,   Method: Compositional matrix adjust.
 Identities = 80/304 (26%), Positives = 149/304 (49%), Gaps = 52/304 (17%)
Query: 115 AKQLKIECKVASGSYGDLYKGTYCSQEVAIKVLKPECVNTEMLKEFSQ-EVYIMRKIRHK 173
           A+ + ++  +  G +G++++G +  +EVA+K+      + E    F + E+Y    +RH+
Sbjct: 8   ARTIVLQESIGKGRFGEVWRGKWRGEEVAVKIFS----SREERSWFREAEIYQTVMLRHE 63
Query: 174 NVVQFIGACTRP----PNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNY 229
           N++ FI A  +       L +V+++   GS++D+L++      +  ++K+A+  + G+ +
Sbjct: 64  NILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRY--TVTVEGMIKLALSTASGLAH 121
Query: 230 LHQN--------NIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAE------TG 275
           LH           I HRDLK+ N+L+ +NG   +AD G+A V+  S   T +       G
Sbjct: 122 LHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLA-VRHDSATDTIDIAPNHRVG 180
Query: 276 TYRWMAPEVIE------HKPYDYKADVFSFGIALWELLTG----------ELPYAGLTPL 319
           T R+MAPEV++      H     +AD+++ G+  WE+             +LPY  L P 
Sbjct: 181 TKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPS 240
Query: 320 QAAVG-----VVQKSLRPTIPKH-----AHPRLAELLERCWQHDPTQRPNFSQITDILKQ 369
             +V      V ++ LRP IP       A   +A+++  CW  +   R    +I   L Q
Sbjct: 241 DPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQ 300
Query: 370 MMKE 373
           + ++
Sbjct: 301 LSQQ 304

>pdb|1PY5|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Inhibitor Length = 326

Iteration: 1
 Score =  114 bits (284), Expect = 1e-25,   Method: Compositional matrix adjust.
 Identities = 80/304 (26%), Positives = 149/304 (49%), Gaps = 52/304 (17%)
Query: 115 AKQLKIECKVASGSYGDLYKGTYCSQEVAIKVLKPECVNTEMLKEFSQ-EVYIMRKIRHK 173
           A+ + ++  +  G +G++++G +  +EVA+K+      + E    F + E+Y    +RH+
Sbjct: 28  ARTIVLQESIGKGRFGEVWRGKWRGEEVAVKIFS----SREERSWFREAEIYQTVMLRHE 83
Query: 174 NVVQFIGACTRP----PNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNY 229
           N++ FI A  +       L +V+++   GS++D+L++      +  ++K+A+  + G+ +
Sbjct: 84  NILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRY--TVTVEGMIKLALSTASGLAH 141
Query: 230 LHQN--------NIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAE------TG 275
           LH           I HRDLK+ N+L+ +NG   +AD G+A V+  S   T +       G
Sbjct: 142 LHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLA-VRHDSATDTIDIAPNHRVG 200
Query: 276 TYRWMAPEVIE------HKPYDYKADVFSFGIALWELLTG----------ELPYAGLTPL 319
           T R+MAPEV++      H     +AD+++ G+  WE+             +LPY  L P 
Sbjct: 201 TKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPS 260
Query: 320 QAAVG-----VVQKSLRPTIPKH-----AHPRLAELLERCWQHDPTQRPNFSQITDILKQ 369
             +V      V ++ LRP IP       A   +A+++  CW  +   R    +I   L Q
Sbjct: 261 DPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQ 320
Query: 370 MMKE 373
           + ++
Sbjct: 321 LSQQ 324

>pdb|1RW8|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Atp Site Inhibitor Length = 301

Iteration: 1
 Score =  114 bits (284), Expect = 1e-25,   Method: Compositional matrix adjust.
 Identities = 80/304 (26%), Positives = 149/304 (49%), Gaps = 52/304 (17%)
Query: 115 AKQLKIECKVASGSYGDLYKGTYCSQEVAIKVLKPECVNTEMLKEFSQ-EVYIMRKIRHK 173
           A+ + ++  +  G +G++++G +  +EVA+K+      + E    F + E+Y    +RH+
Sbjct: 3   ARTIVLQESIGKGRFGEVWRGKWRGEEVAVKIFS----SREERSWFREAEIYQTVMLRHE 58
Query: 174 NVVQFIGACTRP----PNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNY 229
           N++ FI A  +       L +V+++   GS++D+L++      +  ++K+A+  + G+ +
Sbjct: 59  NILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRY--TVTVEGMIKLALSTASGLAH 116
Query: 230 LHQN--------NIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAE------TG 275
           LH           I HRDLK+ N+L+ +NG   +AD G+A V+  S   T +       G
Sbjct: 117 LHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLA-VRHDSATDTIDIAPNHRVG 175
Query: 276 TYRWMAPEVIE------HKPYDYKADVFSFGIALWELLTG----------ELPYAGLTPL 319
           T R+MAPEV++      H     +AD+++ G+  WE+             +LPY  L P 
Sbjct: 176 TKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPS 235
Query: 320 QAAVG-----VVQKSLRPTIPKH-----AHPRLAELLERCWQHDPTQRPNFSQITDILKQ 369
             +V      V ++ LRP IP       A   +A+++  CW  +   R    +I   L Q
Sbjct: 236 DPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQ 295
Query: 370 MMKE 373
           + ++
Sbjct: 296 LSQQ 299

>pdb|2WOT|A Chain A, Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)-3- Pyridyl)oxy)-N-(3,4,5-Trimethoxyphenyl)pyridin-2-Amine Length = 306

Iteration: 1
 Score =  114 bits (284), Expect = 1e-25,   Method: Compositional matrix adjust.
 Identities = 80/304 (26%), Positives = 149/304 (49%), Gaps = 52/304 (17%)
Query: 115 AKQLKIECKVASGSYGDLYKGTYCSQEVAIKVLKPECVNTEMLKEFSQ-EVYIMRKIRHK 173
           A+ + ++  +  G +G++++G +  +EVA+K+      + E    F + E+Y    +RH+
Sbjct: 5   ARTIVLQESIGKGRFGEVWRGKWRGEEVAVKIFS----SREERSWFREAEIYQTVMLRHE 60
Query: 174 NVVQFIGACTRP----PNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNY 229
           N++ FI A  +       L +V+++   GS++D+L++      +  ++K+A+  + G+ +
Sbjct: 61  NILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRY--TVTVEGMIKLALSTASGLAH 118
Query: 230 LHQN--------NIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAE------TG 275
           LH           I HRDLK+ N+L+ +NG   +AD G+A V+  S   T +       G
Sbjct: 119 LHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLA-VRHDSATDTIDIAPNHRVG 177
Query: 276 TYRWMAPEVIE------HKPYDYKADVFSFGIALWELLTG----------ELPYAGLTPL 319
           T R+MAPEV++      H     +AD+++ G+  WE+             +LPY  L P 
Sbjct: 178 TKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPS 237
Query: 320 QAAVG-----VVQKSLRPTIPKH-----AHPRLAELLERCWQHDPTQRPNFSQITDILKQ 369
             +V      V ++ LRP IP       A   +A+++  CW  +   R    +I   L Q
Sbjct: 238 DPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQ 297
Query: 370 MMKE 373
           + ++
Sbjct: 298 LSQQ 301

>pdb|1VJY|A Chain A, Crystal Structure Of A Naphthyridine Inhibitor Of Human Tgf- Beta Type I Receptor Length = 303

Iteration: 1
 Score =  113 bits (283), Expect = 1e-25,   Method: Compositional matrix adjust.
 Identities = 80/304 (26%), Positives = 149/304 (49%), Gaps = 52/304 (17%)
Query: 115 AKQLKIECKVASGSYGDLYKGTYCSQEVAIKVLKPECVNTEMLKEFSQ-EVYIMRKIRHK 173
           A+ + ++  +  G +G++++G +  +EVA+K+      + E    F + E+Y    +RH+
Sbjct: 2   ARTIVLQESIGKGRFGEVWRGKWRGEEVAVKIFS----SREERSWFREAEIYQTVMLRHE 57
Query: 174 NVVQFIGACTRP----PNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNY 229
           N++ FI A  +       L +V+++   GS++D+L++      +  ++K+A+  + G+ +
Sbjct: 58  NILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRY--TVTVEGMIKLALSTASGLAH 115
Query: 230 LHQN--------NIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAE------TG 275
           LH           I HRDLK+ N+L+ +NG   +AD G+A V+  S   T +       G
Sbjct: 116 LHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLA-VRHDSATDTIDIAPNHRVG 174
Query: 276 TYRWMAPEVIE------HKPYDYKADVFSFGIALWELLTG----------ELPYAGLTPL 319
           T R+MAPEV++      H     +AD+++ G+  WE+             +LPY  L P 
Sbjct: 175 TKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPS 234
Query: 320 QAAVG-----VVQKSLRPTIPKH-----AHPRLAELLERCWQHDPTQRPNFSQITDILKQ 369
             +V      V ++ LRP IP       A   +A+++  CW  +   R    +I   L Q
Sbjct: 235 DPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQ 294
Query: 370 MMKE 373
           + ++
Sbjct: 295 LSQQ 298

>pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423

Iteration: 1
 Score =  113 bits (283), Expect = 2e-25,   Method: Compositional matrix adjust.
 Identities = 77/246 (31%), Positives = 129/246 (52%), Gaps = 10/246 (4%)
Query: 123 KVASGSYGDLYKGTYCSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGAC 182
           K+  GS G +   T  S    + V K +    +  +    EV IMR  +H+NVV+   + 
Sbjct: 158 KIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSY 217
Query: 183 TRPPNLCIVTEFMARGSIYDFL-HKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLK 241
                L +V EF+  G++ D + H +    Q+ +   V + V + ++ LH   +IHRD+K
Sbjct: 218 LVGDELWVVMEFLEGGALTDIVTHTRMNEEQIAA---VCLAVLQALSVLHAQGVIHRDIK 274
Query: 242 TANLLMDENGVVKVADFGV-ARVQAQSGVMTAETGTYRWMAPEVIEHKPYDYKADVFSFG 300
           + ++L+  +G VK++DFG  A+V  +        GT  WMAPE+I   PY  + D++S G
Sbjct: 275 SDSILLTHDGRVKLSDFGFCAQVSKEVPRRKXLVGTPYWMAPELISRLPYGPEVDIWSLG 334
Query: 301 IALWELLTGELPYAGLTPLQAAVGVVQKSLRPTIPKHAH---PRLAELLERCWQHDPTQR 357
           I + E++ GE PY    PL+ A+ +++ +L P + K+ H   P L   L+R    DP QR
Sbjct: 335 IMVIEMVDGEPPYFNEPPLK-AMKMIRDNLPPRL-KNLHKVSPSLKGFLDRLLVRDPAQR 392
Query: 358 PNFSQI 363
              +++
Sbjct: 393 ATAAEL 398

>pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306

Iteration: 1
 Score =  112 bits (280), Expect = 3e-25,   Method: Compositional matrix adjust.
 Identities = 79/277 (28%), Positives = 137/277 (49%), Gaps = 23/277 (8%)
Query: 123 KVASGSYGDLYKG--TYCSQEVAIKVLKPECVNTEMLKEFS-QEVYIMRKIRHKNVVQFI 179
           K+  G+ G +Y        QEVAI+ +    +  +  KE    E+ +MR+ ++ N+V ++
Sbjct: 28  KIGQGASGTVYTAMDVATGQEVAIRQMN---LQQQPKKELIINEILVMRENKNPNIVNYL 84
Query: 180 GACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRD 239
            +      L +V E++A GS+ D + +         +  V  +  + + +LH N +IHRD
Sbjct: 85  DSYLVGDELWVVMEYLAGGSLTDVVTET--CMDEGQIAAVCRECLQALEFLHSNQVIHRD 142
Query: 240 LKTANLLMDENGVVKVADFGV-ARVQAQSGVMTAETGTYRWMAPEVIEHKPYDYKADVFS 298
           +K+ N+L+  +G VK+ DFG  A++  +    +   GT  WMAPEV+  K Y  K D++S
Sbjct: 143 IKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSXMVGTPYWMAPEVVTRKAYGPKVDIWS 202
Query: 299 FGIALWELLTGELPYAGLTPLQAAVGVVQKSLRPTI--PKHAHPRLAELLERCWQHDPTQ 356
            GI   E++ GE PY    PL+ A+ ++  +  P +  P+       + L RC + D  +
Sbjct: 203 LGIMAIEMIEGEPPYLNENPLR-ALYLIATNGTPELQNPEKLSAIFRDFLNRCLEMDVEK 261
Query: 357 RPN--------FSQITDILKQMMKEVASEGE---NNH 382
           R +        F +I   L  +   +A+  E   NNH
Sbjct: 262 RGSAKELIQHQFLKIAKPLSSLTPLIAAAKEATKNNH 298

>pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291

Iteration: 1
 Score =  112 bits (280), Expect = 3e-25,   Method: Compositional matrix adjust.
 Identities = 78/266 (29%), Positives = 133/266 (50%), Gaps = 25/266 (9%)
Query: 123 KVASGSYGDLYKGTYCSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGAC 182
           KV+   Y     GT   + VA+K LK  C   ++   + +E+ I+R + H+++V++ G C
Sbjct: 24  KVSLYCYDPTNDGT--GEMVAVKALKEGC-GPQLRSGWQREIEILRTLYHEHIVKYKGCC 80
Query: 183 TR--PPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDL 240
                 ++ +V E++  GS+ D+L +      L  LL  A  + +GM YLH  + IHR L
Sbjct: 81  EDQGEKSVQLVMEYVPLGSLRDYLPRH--CVGLAQLLLFAQQICEGMAYLHAQHYIHRAL 138
Query: 241 KTANLLMDENGVVKVADFGVARV--QAQSGVMTAETGT--YRWMAPEVIEHKPYDYKADV 296
              N+L+D + +VK+ DFG+A+   +        E G     W APE ++   + Y +DV
Sbjct: 139 AARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAPECLKECKFYYASDV 198
Query: 297 FSFGIALWELLT----GELPYAGLTPL----QAAVGV------VQKSLRPTIPKHAHPRL 342
           +SFG+ L+ELLT     + P+   T L    Q  + V      +++  R   P      +
Sbjct: 199 WSFGVTLYELLTYCDSNQSPHTKFTELIGHTQGQMTVLRLTELLERGERLPRPDRCPCEI 258
Query: 343 AELLERCWQHDPTQRPNFSQITDILK 368
             L++ CW+ + + RP F  +  IL+
Sbjct: 259 YHLMKNCWETEASFRPTFQNLVPILQ 284

>pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290

Iteration: 1
 Score =  112 bits (280), Expect = 4e-25,   Method: Compositional matrix adjust.
 Identities = 78/266 (29%), Positives = 133/266 (50%), Gaps = 25/266 (9%)
Query: 123 KVASGSYGDLYKGTYCSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGAC 182
           KV+   Y     GT   + VA+K LK  C   ++   + +E+ I+R + H+++V++ G C
Sbjct: 23  KVSLYCYDPTNDGT--GEMVAVKALKEGC-GPQLRSGWQREIEILRTLYHEHIVKYKGCC 79
Query: 183 TR--PPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDL 240
                 ++ +V E++  GS+ D+L +      L  LL  A  + +GM YLH  + IHR L
Sbjct: 80  EDQGEKSVQLVMEYVPLGSLRDYLPRH--CVGLAQLLLFAQQICEGMAYLHAQHYIHRAL 137
Query: 241 KTANLLMDENGVVKVADFGVARV--QAQSGVMTAETGT--YRWMAPEVIEHKPYDYKADV 296
              N+L+D + +VK+ DFG+A+   +        E G     W APE ++   + Y +DV
Sbjct: 138 AARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAPECLKECKFYYASDV 197
Query: 297 FSFGIALWELLT----GELPYAGLTPL----QAAVGV------VQKSLRPTIPKHAHPRL 342
           +SFG+ L+ELLT     + P+   T L    Q  + V      +++  R   P      +
Sbjct: 198 WSFGVTLYELLTYCDSNQSPHTKFTELIGHTQGQMTVLRLTELLERGERLPRPDRCPCEI 257
Query: 343 AELLERCWQHDPTQRPNFSQITDILK 368
             L++ CW+ + + RP F  +  IL+
Sbjct: 258 YHLMKNCWETEASFRPTFQNLVPILQ 283

>pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297

Iteration: 1
 Score =  112 bits (280), Expect = 4e-25,   Method: Compositional matrix adjust.
 Identities = 79/277 (28%), Positives = 137/277 (49%), Gaps = 23/277 (8%)
Query: 123 KVASGSYGDLYKG--TYCSQEVAIKVLKPECVNTEMLKEFS-QEVYIMRKIRHKNVVQFI 179
           K+  G+ G +Y        QEVAI+ +    +  +  KE    E+ +MR+ ++ N+V ++
Sbjct: 27  KIGQGASGTVYTAMDVATGQEVAIRQMN---LQQQPKKELIINEILVMRENKNPNIVNYL 83
Query: 180 GACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRD 239
            +      L +V E++A GS+ D + +         +  V  +  + + +LH N +IHRD
Sbjct: 84  DSYLVGDELWVVMEYLAGGSLTDVVTET--CMDEGQIAAVCRECLQALEFLHSNQVIHRD 141
Query: 240 LKTANLLMDENGVVKVADFGV-ARVQAQSGVMTAETGTYRWMAPEVIEHKPYDYKADVFS 298
           +K+ N+L+  +G VK+ DFG  A++  +    +   GT  WMAPEV+  K Y  K D++S
Sbjct: 142 IKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSXMVGTPYWMAPEVVTRKAYGPKVDIWS 201
Query: 299 FGIALWELLTGELPYAGLTPLQAAVGVVQKSLRPTI--PKHAHPRLAELLERCWQHDPTQ 356
            GI   E++ GE PY    PL+ A+ ++  +  P +  P+       + L RC + D  +
Sbjct: 202 LGIMAIEMIEGEPPYLNENPLR-ALYLIATNGTPELQNPEKLSAIFRDFLNRCLEMDVEK 260
Query: 357 RPN--------FSQITDILKQMMKEVASEGE---NNH 382
           R +        F +I   L  +   +A+  E   NNH
Sbjct: 261 RGSAKELLQHQFLKIAKPLSSLTPLIAAAKEATKNNH 297

>pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302

Iteration: 1
 Score =  112 bits (279), Expect = 4e-25,   Method: Compositional matrix adjust.
 Identities = 80/270 (29%), Positives = 132/270 (48%), Gaps = 20/270 (7%)
Query: 106 DGTDVWEIDAKQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVNTEMLKEFSQE 163
           D  +VWEI  +       +  G++G +YK          A KV+  E  + E L+++  E
Sbjct: 16  DPNEVWEIVGE-------LGDGAFGKVYKAKNKETGALAAAKVI--ETKSEEELEDYIVE 66
Query: 164 VYIMRKIRHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDV 223
           + I+    H  +V+ +GA      L I+ EF   G++   + +         +  V   +
Sbjct: 67  IEILATCDHPYIVKLLGAYYHDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVVCRQM 126
Query: 224 SKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQS-GVMTAETGTYRWMAP 282
            + +N+LH   IIHRDLK  N+LM   G +++ADFGV+    ++     +  GT  WMAP
Sbjct: 127 LEALNFLHSKRIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQKRDSFIGTPYWMAP 186
Query: 283 EVI-----EHKPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKSLRPTI--P 335
           EV+     +  PYDYKAD++S GI L E+   E P+  L P++  + +  KS  PT+  P
Sbjct: 187 EVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIA-KSDPPTLLTP 245
Query: 336 KHAHPRLAELLERCWQHDPTQRPNFSQITD 365
                   + L+     +P  RP+ +Q+ +
Sbjct: 246 SKWSVEFRDFLKIALDKNPETRPSAAQLLE 275

>pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293

Iteration: 1
 Score =  112 bits (279), Expect = 4e-25,   Method: Compositional matrix adjust.
 Identities = 80/270 (29%), Positives = 132/270 (48%), Gaps = 20/270 (7%)
Query: 106 DGTDVWEIDAKQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVNTEMLKEFSQE 163
           D  +VWEI  +       +  G++G +YK          A KV+  E  + E L+++  E
Sbjct: 8   DPNEVWEIVGE-------LGDGAFGKVYKAKNKETGALAAAKVI--ETKSEEELEDYIVE 58
Query: 164 VYIMRKIRHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDV 223
           + I+    H  +V+ +GA      L I+ EF   G++   + +         +  V   +
Sbjct: 59  IEILATCDHPYIVKLLGAYYHDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVVCRQM 118
Query: 224 SKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQS-GVMTAETGTYRWMAP 282
            + +N+LH   IIHRDLK  N+LM   G +++ADFGV+    ++     +  GT  WMAP
Sbjct: 119 LEALNFLHSKRIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQKRDSFIGTPYWMAP 178
Query: 283 EVI-----EHKPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKSLRPTI--P 335
           EV+     +  PYDYKAD++S GI L E+   E P+  L P++  + +  KS  PT+  P
Sbjct: 179 EVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIA-KSDPPTLLTP 237
Query: 336 KHAHPRLAELLERCWQHDPTQRPNFSQITD 365
                   + L+     +P  RP+ +Q+ +
Sbjct: 238 SKWSVEFRDFLKIALDKNPETRPSAAQLLE 267

>pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298

Iteration: 1
 Score =  112 bits (279), Expect = 5e-25,   Method: Compositional matrix adjust.
 Identities = 77/294 (26%), Positives = 137/294 (46%), Gaps = 29/294 (9%)
Query: 109 DVWEIDAKQLKIECKVASGSYGDLYKGTY------CSQEVAIKVLKPECVNTEMLKEFSQ 162
           D  + + + LK   ++  G++G +    Y        + VA+K L+      E L++F +
Sbjct: 6   DPTQFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHST--EEHLRDFER 63
Query: 163 EVYIMRKIRHKNVVQFIGACTRP--PNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVA 220
           E+ I++ ++H N+V++ G C      NL ++ E++  GS+ D+L           LL+  
Sbjct: 64  EIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQAHAERIDHIKLLQYT 123
Query: 221 IDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARV--QAQSGVMTAETGTYR 278
             + KGM YL     IHRDL T N+L++    VK+ DFG+ +V  Q +      E G   
Sbjct: 124 SQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESP 183
Query: 279 --WMAPEVIEHKPYDYKADVFSFGIALWELLT----GELPYA-----------GLTPLQA 321
             W APE +    +   +DV+SFG+ L+EL T     + P A           G   +  
Sbjct: 184 IFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFH 243
Query: 322 AVGVVQKSLRPTIPKHAHPRLAELLERCWQHDPTQRPNFSQITDILKQMMKEVA 375
            + +++ + R   P      +  ++  CW ++  QRP+F  +   + Q+   +A
Sbjct: 244 LIELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRDNMA 297

>pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297

Iteration: 1
 Score =  112 bits (279), Expect = 5e-25,   Method: Compositional matrix adjust.
 Identities = 79/277 (28%), Positives = 136/277 (49%), Gaps = 23/277 (8%)
Query: 123 KVASGSYGDLYKG--TYCSQEVAIKVLKPECVNTEMLKEFS-QEVYIMRKIRHKNVVQFI 179
           K+  G+ G +Y        QEVAI+ +    +  +  KE    E+ +MR+ ++ N+V ++
Sbjct: 27  KIGQGASGTVYTAMDVATGQEVAIRQMN---LQQQPKKELIINEILVMRENKNPNIVNYL 83
Query: 180 GACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRD 239
            +      L +V E++A GS+ D + +         +  V  +  + + +LH N +IHRD
Sbjct: 84  DSYLVGDELWVVMEYLAGGSLTDVVTET--CMDEGQIAAVCRECLQALEFLHSNQVIHRD 141
Query: 240 LKTANLLMDENGVVKVADFGV-ARVQAQSGVMTAETGTYRWMAPEVIEHKPYDYKADVFS 298
           +K+ N+L+  +G VK+ DFG  A++  +    +   GT  WMAPEV+  K Y  K D++S
Sbjct: 142 IKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWS 201
Query: 299 FGIALWELLTGELPYAGLTPLQAAVGVVQKSLRPTI--PKHAHPRLAELLERCWQHDPTQ 356
            GI   E++ GE PY    PL+ A+ ++  +  P +  P+       + L RC   D  +
Sbjct: 202 LGIMAIEMIEGEPPYLNENPLR-ALYLIATNGTPELQNPEKLSAIFRDFLNRCLDMDVEK 260
Query: 357 RPN--------FSQITDILKQMMKEVASEGE---NNH 382
           R +        F +I   L  +   +A+  E   NNH
Sbjct: 261 RGSAKELLQHQFLKIAKPLSSLTPLIAAAKEATKNNH 297

>pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328

Iteration: 1
 Score =  112 bits (279), Expect = 5e-25,   Method: Compositional matrix adjust.
 Identities = 72/243 (29%), Positives = 122/243 (50%), Gaps = 6/243 (2%)
Query: 124 VASGSYGD--LYKGTYCSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGA 181
           +  G++    L +     +EVAIK++    +N   L++  +EV IM+ + H N+V+    
Sbjct: 23  IGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEV 82
Query: 182 CTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLK 241
                 L ++ E+ + G ++D+L     + +  +  K    VS  + Y HQ  I+HRDLK
Sbjct: 83  IETEKTLYLIMEYASGGEVFDYLVAHGRMKEKEARSKFRQIVS-AVQYCHQKRIVHRDLK 141
Query: 242 TANLLMDENGVVKVADFGVARVQAQSGVMTAETGTYRWMAPEVIEHKPYDY-KADVFSFG 300
             NLL+D +  +K+ADFG +      G + A  G   + APE+ + K YD  + DV+S G
Sbjct: 142 AENLLLDADMNIKIADFGFSNEFTVGGKLDAFCGAPPYAAPELFQGKKYDGPEVDVWSLG 201
Query: 301 IALWELLTGELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRLAELLERCWQHDPTQRPNF 360
           + L+ L++G LP+ G    +    V++   R  IP +       LL+R    +P +R   
Sbjct: 202 VILYTLVSGSLPFDGQNLKELRERVLRGKYR--IPFYMSTDCENLLKRFLVLNPIKRGTL 259
Query: 361 SQI 363
            QI
Sbjct: 260 EQI 262

>pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297

Iteration: 1
 Score =  111 bits (278), Expect = 6e-25,   Method: Compositional matrix adjust.
 Identities = 79/277 (28%), Positives = 136/277 (49%), Gaps = 23/277 (8%)
Query: 123 KVASGSYGDLYKG--TYCSQEVAIKVLKPECVNTEMLKEFS-QEVYIMRKIRHKNVVQFI 179
           K+  G+ G +Y        QEVAI+ +    +  +  KE    E+ +MR+ ++ N+V ++
Sbjct: 27  KIGQGASGTVYTAMDVATGQEVAIRQMN---LQQQPKKELIINEILVMRENKNPNIVNYL 83
Query: 180 GACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRD 239
            +      L +V E++A GS+ D + +         +  V  +  + + +LH N +IHRD
Sbjct: 84  DSYLVGDELWVVMEYLAGGSLTDVVTET--CMDEGQIAAVCRECLQALEFLHSNQVIHRD 141
Query: 240 LKTANLLMDENGVVKVADFGV-ARVQAQSGVMTAETGTYRWMAPEVIEHKPYDYKADVFS 298
           +K+ N+L+  +G VK+ DFG  A++  +    +   GT  WMAPEV+  K Y  K D++S
Sbjct: 142 IKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSEMVGTPYWMAPEVVTRKAYGPKVDIWS 201
Query: 299 FGIALWELLTGELPYAGLTPLQAAVGVVQKSLRPTI--PKHAHPRLAELLERCWQHDPTQ 356
            GI   E++ GE PY    PL+ A+ ++  +  P +  P+       + L RC   D  +
Sbjct: 202 LGIMAIEMIEGEPPYLNENPLR-ALYLIATNGTPELQNPEKLSAIFRDFLNRCLDMDVEK 260
Query: 357 RPN--------FSQITDILKQMMKEVASEGE---NNH 382
           R +        F +I   L  +   +A+  E   NNH
Sbjct: 261 RGSAKELLQHQFLKIAKPLSSLTPLIAAAKEATKNNH 297

>pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306

Iteration: 1
 Score =  110 bits (276), Expect = 1e-24,   Method: Compositional matrix adjust.
 Identities = 78/277 (28%), Positives = 137/277 (49%), Gaps = 23/277 (8%)
Query: 123 KVASGSYGDLYKG--TYCSQEVAIKVLKPECVNTEMLKEFS-QEVYIMRKIRHKNVVQFI 179
           K+  G+ G +Y        QEVAI+ +    +  +  KE    E+ +MR+ ++ N+V ++
Sbjct: 28  KIGQGASGTVYTAMDVATGQEVAIRQMN---LQQQPKKELIINEILVMRENKNPNIVNYL 84
Query: 180 GACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRD 239
            +      L +V E++A GS+ D + +         +  V  +  + + +LH N +IHR+
Sbjct: 85  DSYLVGDELWVVMEYLAGGSLTDVVTET--CMDEGQIAAVCRECLQALEFLHSNQVIHRN 142
Query: 240 LKTANLLMDENGVVKVADFGV-ARVQAQSGVMTAETGTYRWMAPEVIEHKPYDYKADVFS 298
           +K+ N+L+  +G VK+ DFG  A++  +    +   GT  WMAPEV+  K Y  K D++S
Sbjct: 143 IKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWS 202
Query: 299 FGIALWELLTGELPYAGLTPLQAAVGVVQKSLRPTI--PKHAHPRLAELLERCWQHDPTQ 356
            GI   E++ GE PY    PL+ A+ ++  +  P +  P+       + L RC + D  +
Sbjct: 203 LGIMAIEMIEGEPPYLNENPLR-ALYLIATNGTPELQNPEKLSAIFRDFLNRCLEMDVEK 261
Query: 357 RPN--------FSQITDILKQMMKEVASEGE---NNH 382
           R +        F +I   L  +   +A+  E   NNH
Sbjct: 262 RGSAKELIQHQFLKIAKPLSSLTPLIAAAKEATKNNH 298

>pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328

Iteration: 1
 Score =  110 bits (276), Expect = 1e-24,   Method: Compositional matrix adjust.
 Identities = 71/243 (29%), Positives = 122/243 (50%), Gaps = 6/243 (2%)
Query: 124 VASGSYGD--LYKGTYCSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGA 181
           +  G++    L +     +EVAIK++    +N   L++  +EV IM+ + H N+V+    
Sbjct: 20  IGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEV 79
Query: 182 CTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLK 241
                 L ++ E+ + G ++D+L     + +  +  K    VS  + Y HQ  I+HRDLK
Sbjct: 80  IETEKTLYLIMEYASGGEVFDYLVAHGRMKEKEARSKFRQIVS-AVQYCHQKRIVHRDLK 138
Query: 242 TANLLMDENGVVKVADFGVARVQAQSGVMTAETGTYRWMAPEVIEHKPYDY-KADVFSFG 300
             NLL+D +  +K+ADFG +      G +    G+  + APE+ + K YD  + DV+S G
Sbjct: 139 AENLLLDADMNIKIADFGFSNEFTVGGKLDTFCGSPPYAAPELFQGKKYDGPEVDVWSLG 198
Query: 301 IALWELLTGELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRLAELLERCWQHDPTQRPNF 360
           + L+ L++G LP+ G    +    V++   R  IP +       LL+R    +P +R   
Sbjct: 199 VILYTLVSGSLPFDGQNLKELRERVLRGKYR--IPFYMSTDCENLLKRFLVLNPIKRGTL 256
Query: 361 SQI 363
            QI
Sbjct: 257 EQI 259

>pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321

Iteration: 1
 Score =  110 bits (276), Expect = 1e-24,   Method: Compositional matrix adjust.
 Identities = 77/252 (30%), Positives = 128/252 (50%), Gaps = 18/252 (7%)
Query: 123 KVASGSYGD--LYKGTYCSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIG 180
           K+  GS G   L +  +  ++VA+K++  +    +  +    EV IMR  +H NVV+   
Sbjct: 52  KIGEGSTGIVCLAREKHSGRQVAVKMM--DLRKQQRRELLFNEVVIMRDYQHFNVVEMYK 109
Query: 181 ACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDL 240
           +      L ++ EF+  G++ D + + +       +  V   V + + YLH   +IHRD+
Sbjct: 110 SYLVGEELWVLMEFLQGGALTDIVSQVR--LNEEQIATVCEAVLQALAYLHAQGVIHRDI 167
Query: 241 KTANLLMDENGVVKVADFGV-ARVQAQSGVMTAETGTYRWMAPEVIEHKPYDYKADVFSF 299
           K+ ++L+  +G VK++DFG  A++           GT  WMAPEVI    Y  + D++S 
Sbjct: 168 KSDSILLTLDGRVKLSDFGFCAQISKDVPKRKXLVGTPYWMAPEVISRSLYATEVDIWSL 227
Query: 300 GIALWELLTGELPYAGLTPLQAAVGVVQKSLRPTIP---KHAH---PRLAELLERCWQHD 353
           GI + E++ GE PY   +P+QA      K LR + P   K++H   P L + LER    D
Sbjct: 228 GIMVIEMVDGEPPYFSDSPVQA-----MKRLRDSPPPKLKNSHKVSPVLRDFLERMLVRD 282
Query: 354 PTQRPNFSQITD 365
           P +R    ++ D
Sbjct: 283 PQERATAQELLD 294

>pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317

Iteration: 1
 Score =  110 bits (275), Expect = 1e-24,   Method: Compositional matrix adjust.
 Identities = 73/227 (32%), Positives = 119/227 (52%), Gaps = 18/227 (7%)
Query: 123 KVASGSYGDLYKGT--YCSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIG 180
           K+  GS G +   T  +  ++VA+K  K +    +  +    EV IMR   H NVV    
Sbjct: 52  KIGEGSTGIVCIATEKHTGKQVAVK--KMDLRKQQRRELLFNEVVIMRDYHHDNVVDMYS 109
Query: 181 ACTRPPNLCIVTEFMARGSIYDFL-HKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRD 239
           +      L +V EF+  G++ D + H +    Q+ +   V + V + ++YLH   +IHRD
Sbjct: 110 SYLVGDELWVVMEFLEGGALTDIVTHTRMNEEQIAT---VCLSVLRALSYLHNQGVIHRD 166
Query: 240 LKTANLLMDENGVVKVADFGV-ARVQAQSGVMTAETGTYRWMAPEVIEHKPYDYKADVFS 298
           +K+ ++L+  +G +K++DFG  A+V  +        GT  WMAPEVI   PY  + D++S
Sbjct: 167 IKSDSILLTSDGRIKLSDFGFCAQVSKEVPKRKXLVGTPYWMAPEVISRLPYGTEVDIWS 226
Query: 299 FGIALWELLTGELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRLAEL 345
            GI + E++ GE PY    PLQA      + +R ++P    PR+ +L
Sbjct: 227 LGIMVIEMIDGEPPYFNEPPLQA-----MRRIRDSLP----PRVKDL 264

>pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294

Iteration: 1
 Score =  110 bits (275), Expect = 1e-24,   Method: Compositional matrix adjust.
 Identities = 67/209 (32%), Positives = 114/209 (54%), Gaps = 4/209 (1%)
Query: 158 KEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLL 217
           ++ S E+ I R + H++VV F G       + +V E   R S+ + LHK++         
Sbjct: 60  EKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVVLELCRRRSLLE-LHKRRKALTEPEAR 118
Query: 218 KVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVA-RVQAQSGVMTAETGT 276
                +  G  YLH+N +IHRDLK  NL ++E+  VK+ DFG+A +V+          GT
Sbjct: 119 YYLRQIVLGCQYLHRNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKVLCGT 178
Query: 277 YRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKSLRPTIPK 336
             ++APEV+  K + ++ DV+S G  ++ LL G+ P+   + L+     ++K+   +IPK
Sbjct: 179 PNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFET-SCLKETYLRIKKN-EYSIPK 236
Query: 337 HAHPRLAELLERCWQHDPTQRPNFSQITD 365
           H +P  A L+++  Q DPT RP  +++ +
Sbjct: 237 HINPVAASLIQKMLQTDPTARPTINELLN 265

>pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311

Iteration: 1
 Score =  110 bits (275), Expect = 1e-24,   Method: Compositional matrix adjust.
 Identities = 65/209 (31%), Positives = 111/209 (53%), Gaps = 4/209 (1%)
Query: 158 KEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLL 217
           ++ S E+ I R + H++VV F G       + +V E   R S+ + LHK++         
Sbjct: 62  EKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVVLELCRRRSLLE-LHKRRKALTEPEAR 120
Query: 218 KVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVA-RVQAQSGVMTAETGT 276
                +  G  YLH+N +IHRDLK  NL ++E+  VK+ DFG+A +V+          GT
Sbjct: 121 YYLRQIVLGCQYLHRNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKTLCGT 180
Query: 277 YRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKSLRPTIPK 336
             ++APEV+  K + ++ DV+S G  ++ LL G+ P+      +  + + +     +IPK
Sbjct: 181 PNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKNEY--SIPK 238
Query: 337 HAHPRLAELLERCWQHDPTQRPNFSQITD 365
           H +P  A L+++  Q DPT RP  +++ +
Sbjct: 239 HINPVAASLIQKMLQTDPTARPTINELLN 267

>pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310

Iteration: 1
 Score =  110 bits (275), Expect = 1e-24,   Method: Compositional matrix adjust.
 Identities = 67/271 (24%), Positives = 135/271 (49%), Gaps = 9/271 (3%)
Query: 118 LKIECKVASGSYGDLYKGTYCSQEVAI---KVLKPECVNTEMLKEFSQEVYIMRKIRHKN 174
            +IE K+  G + ++Y+       V +   KV   + ++ +   +  +E+ +++++ H N
Sbjct: 34  FRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPN 93
Query: 175 VVQFIGACTRPPNLCIVTEFMARGSIYDFLH---KQKGVFQLTSLLKVAIDVSKGMNYLH 231
           V+++  +      L IV E    G +   +    KQK +    ++ K  + +   + ++H
Sbjct: 94  VIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMH 153
Query: 232 QNNIIHRDLKTANLLMDENGVVKVADFGVAR-VQAQSGVMTAETGTYRWMAPEVIEHKPY 290
              ++HRD+K AN+ +   GVVK+ D G+ R   +++    +  GT  +M+PE I    Y
Sbjct: 154 SRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPERIHENGY 213
Query: 291 DYKADVFSFGIALWELLTGELPYAG-LTPLQAAVGVVQKSLRPTIPK-HAHPRLAELLER 348
           ++K+D++S G  L+E+   + P+ G    L +    +++   P +P  H    L +L+  
Sbjct: 214 NFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQCDYPPLPSDHYSEELRQLVNM 273
Query: 349 CWQHDPTQRPNFSQITDILKQMMKEVASEGE 379
           C   DP +RP+ + + D+ K+M    AS  E
Sbjct: 274 CINPDPEKRPDVTYVYDVAKRMHACTASSLE 304

>pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311

Iteration: 1
 Score =  110 bits (274), Expect = 2e-24,   Method: Compositional matrix adjust.
 Identities = 65/209 (31%), Positives = 111/209 (53%), Gaps = 4/209 (1%)
Query: 158 KEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLL 217
           ++ S E+ I R + H++VV F G       + +V E   R S+ + LHK++         
Sbjct: 62  EKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVVLELCRRRSLLE-LHKRRKALTEPEAR 120
Query: 218 KVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVA-RVQAQSGVMTAETGT 276
                +  G  YLH+N +IHRDLK  NL ++E+  VK+ DFG+A +V+          GT
Sbjct: 121 YYLRQIVLGCQYLHRNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKTLCGT 180
Query: 277 YRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKSLRPTIPK 336
             ++APEV+  K + ++ DV+S G  ++ LL G+ P+      +  + + +     +IPK
Sbjct: 181 PNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKNEY--SIPK 238
Query: 337 HAHPRLAELLERCWQHDPTQRPNFSQITD 365
           H +P  A L+++  Q DPT RP  +++ +
Sbjct: 239 HINPVAASLIQKMLQTDPTARPTINELLN 267

>pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311

Iteration: 1
 Score =  110 bits (274), Expect = 2e-24,   Method: Compositional matrix adjust.
 Identities = 67/207 (32%), Positives = 107/207 (51%), Gaps = 10/207 (4%)
Query: 140 QEVAIKVLKPECV-NTEMLKEFSQEVYIMRKIRHKNVVQF--IGACTRP--PNLCIVTEF 194
           ++VA+KVL+ +   +      F +E      + H  +V     G    P  P   IV E+
Sbjct: 38  RDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPLPYIVMEY 97
Query: 195 MARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVK 254
           +   ++ D +H + G       ++V  D  + +N+ HQN IIHRD+K AN+L+     VK
Sbjct: 98  VDGVTLRDIVHTE-GPMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANILISATNAVK 156
Query: 255 VADFGVARVQAQSGVMTAET----GTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTGE 310
           V DFG+AR  A SG    +T    GT ++++PE       D ++DV+S G  L+E+LTGE
Sbjct: 157 VVDFGIARAIADSGNSVXQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGE 216
Query: 311 LPYAGLTPLQAAVGVVQKSLRPTIPKH 337
            P+ G +P+  A   V++   P   +H
Sbjct: 217 PPFTGDSPVSVAYQHVREDPIPPSARH 243

>pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315

Iteration: 1
 Score =  110 bits (274), Expect = 2e-24,   Method: Compositional matrix adjust.
 Identities = 65/209 (31%), Positives = 111/209 (53%), Gaps = 4/209 (1%)
Query: 158 KEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLL 217
           ++ S E+ I R + H++VV F G       + +V E   R S+ + LHK++         
Sbjct: 66  EKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVVLELCRRRSLLE-LHKRRKALTEPEAR 124
Query: 218 KVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVA-RVQAQSGVMTAETGT 276
                +  G  YLH+N +IHRDLK  NL ++E+  VK+ DFG+A +V+          GT
Sbjct: 125 YYLRQIVLGCQYLHRNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKTLCGT 184
Query: 277 YRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKSLRPTIPK 336
             ++APEV+  K + ++ DV+S G  ++ LL G+ P+      +  + + +     +IPK
Sbjct: 185 PNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKNEY--SIPK 242
Query: 337 HAHPRLAELLERCWQHDPTQRPNFSQITD 365
           H +P  A L+++  Q DPT RP  +++ +
Sbjct: 243 HINPVAASLIQKMLQTDPTARPTINELLN 271

>pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308

Iteration: 1
 Score =  110 bits (274), Expect = 2e-24,   Method: Compositional matrix adjust.
 Identities = 75/283 (26%), Positives = 134/283 (47%), Gaps = 28/283 (9%)
Query: 112 EIDAKQLKIECKVASGSYGDLYKGTYC-------SQEVAIKVLKPECVNTEMLKEFSQEV 164
           EI    ++   ++    +G +YKG          +Q VAIK LK +     + +EF  E 
Sbjct: 22  EISLSAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKA-EGPLREEFRHEA 80
Query: 165 YIMRKIRHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFL-----HKQKGVFQLTSLLKV 219
            +  +++H NVV  +G  T+   L ++  + + G +++FL     H   G       +K 
Sbjct: 81  MLRARLQHPNVVCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKS 140
Query: 220 AID----------VSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVAR-VQAQS- 267
           A++          ++ GM YL  ++++H+DL T N+L+ +   VK++D G+ R V A   
Sbjct: 141 ALEPPDFVHLVAQIAAGMEYLSSHHVVHKDLATRNVLVYDKLNVKISDLGLFREVYAADY 200
Query: 268 -GVMTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLT-GELPYAGLTPLQAAVGV 325
             ++       RWMAPE I +  +   +D++S+G+ LWE+ + G  PY G +       +
Sbjct: 201 YKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDVVEMI 260
Query: 326 VQKSLRPTIPKHAHPRLAELLERCWQHDPTQRPNFSQITDILK 368
             + + P  P      +  L+  CW   P++RP F  I   L+
Sbjct: 261 RNRQVLPC-PDDCPAWVYALMIECWNEFPSRRPRFKDIHSRLR 302

>pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289

Iteration: 1
 Score =  110 bits (274), Expect = 2e-24,   Method: Compositional matrix adjust.
 Identities = 75/283 (26%), Positives = 134/283 (47%), Gaps = 28/283 (9%)
Query: 112 EIDAKQLKIECKVASGSYGDLYKGTYC-------SQEVAIKVLKPECVNTEMLKEFSQEV 164
           EI    ++   ++    +G +YKG          +Q VAIK LK +     + +EF  E 
Sbjct: 5   EISLSAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKA-EGPLREEFRHEA 63
Query: 165 YIMRKIRHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFL-----HKQKGVFQLTSLLKV 219
            +  +++H NVV  +G  T+   L ++  + + G +++FL     H   G       +K 
Sbjct: 64  MLRARLQHPNVVCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKS 123
Query: 220 AID----------VSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVAR-VQAQS- 267
           A++          ++ GM YL  ++++H+DL T N+L+ +   VK++D G+ R V A   
Sbjct: 124 ALEPPDFVHLVAQIAAGMEYLSSHHVVHKDLATRNVLVYDKLNVKISDLGLFREVYAADY 183
Query: 268 -GVMTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLT-GELPYAGLTPLQAAVGV 325
             ++       RWMAPE I +  +   +D++S+G+ LWE+ + G  PY G +       +
Sbjct: 184 YKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDVVEMI 243
Query: 326 VQKSLRPTIPKHAHPRLAELLERCWQHDPTQRPNFSQITDILK 368
             + + P  P      +  L+  CW   P++RP F  I   L+
Sbjct: 244 RNRQVLPC-PDDCPAWVYALMIECWNEFPSRRPRFKDIHSRLR 285

>pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335

Iteration: 1
 Score =  110 bits (274), Expect = 2e-24,   Method: Compositional matrix adjust.
 Identities = 65/209 (31%), Positives = 111/209 (53%), Gaps = 4/209 (1%)
Query: 158 KEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLL 217
           ++ S E+ I R + H++VV F G       + +V E   R S+ + LHK++         
Sbjct: 86  EKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVVLELCRRRSLLE-LHKRRKALTEPEAR 144
Query: 218 KVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVA-RVQAQSGVMTAETGT 276
                +  G  YLH+N +IHRDLK  NL ++E+  VK+ DFG+A +V+          GT
Sbjct: 145 YYLRQIVLGCQYLHRNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKVLCGT 204
Query: 277 YRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKSLRPTIPK 336
             ++APEV+  K + ++ DV+S G  ++ LL G+ P+      +  + + +     +IPK
Sbjct: 205 PNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKNEY--SIPK 262
Query: 337 HAHPRLAELLERCWQHDPTQRPNFSQITD 365
           H +P  A L+++  Q DPT RP  +++ +
Sbjct: 263 HINPVAASLIQKMLQTDPTARPTINELLN 291

>pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333

Iteration: 1
 Score =  110 bits (274), Expect = 2e-24,   Method: Compositional matrix adjust.
 Identities = 65/209 (31%), Positives = 111/209 (53%), Gaps = 4/209 (1%)
Query: 158 KEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLL 217
           ++ S E+ I R + H++VV F G       + +V E   R S+ + LHK++         
Sbjct: 84  EKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVVLELCRRRSLLE-LHKRRKALTEPEAR 142
Query: 218 KVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVA-RVQAQSGVMTAETGT 276
                +  G  YLH+N +IHRDLK  NL ++E+  VK+ DFG+A +V+          GT
Sbjct: 143 YYLRQIVLGCQYLHRNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKVLCGT 202
Query: 277 YRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKSLRPTIPK 336
             ++APEV+  K + ++ DV+S G  ++ LL G+ P+      +  + + +     +IPK
Sbjct: 203 PNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKNEY--SIPK 260
Query: 337 HAHPRLAELLERCWQHDPTQRPNFSQITD 365
           H +P  A L+++  Q DPT RP  +++ +
Sbjct: 261 HINPVAASLIQKMLQTDPTARPTINELLN 289

>pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285

Iteration: 1
 Score =  109 bits (273), Expect = 2e-24,   Method: Compositional matrix adjust.
 Identities = 73/269 (27%), Positives = 129/269 (47%), Gaps = 10/269 (3%)
Query: 124 VASGSYGDLYKGTYCSQE--VAIKVL-KPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIG 180
           +  G +G++Y       +  +A+KVL K +     +  +  +EV I   +RH N+++  G
Sbjct: 21  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 80
Query: 181 ACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDL 240
                  + ++ E+  RG +Y  L K    F          +++  ++Y H   +IHRD+
Sbjct: 81  YFHDATRVYLILEYAPRGEVYKELQKL-SKFDEQRTATYITELANALSYCHSKRVIHRDI 139
Query: 241 KTANLLMDENGVVKVADFGVARVQAQSGVMTAETGTYRWMAPEVIEHKPYDYKADVFSFG 300
           K  NLL+   G +K+ADFG + V A S   T   GT  ++ PE+IE + +D K D++S G
Sbjct: 140 KPENLLLGSAGELKIADFGWS-VHAPSSRRTTLCGTLDYLPPEMIEGRMHDEKVDLWSLG 198
Query: 301 IALWELLTGELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRLAELLERCWQHDPTQRPNF 360
           +  +E L G+ P+   T  +    + +     T P        +L+ R  +H+P+QRP  
Sbjct: 199 VLCYEFLVGKPPFEANTYQETYKRISRVEF--TFPDFVTEGARDLISRLLKHNPSQRP-- 254
Query: 361 SQITDILKQMMKEVASEGENNHSNKSAGS 389
             + ++L+       S   +N  NK + S
Sbjct: 255 -MLREVLEHPWITANSSKPSNCQNKESAS 282

>pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311

Iteration: 1
 Score =  109 bits (272), Expect = 3e-24,   Method: Compositional matrix adjust.
 Identities = 66/207 (31%), Positives = 107/207 (51%), Gaps = 10/207 (4%)
Query: 140 QEVAIKVLKPECV-NTEMLKEFSQEVYIMRKIRHKNVVQF--IGACTRP--PNLCIVTEF 194
           ++VA+KVL+ +   +      F +E      + H  +V     G    P  P   IV E+
Sbjct: 38  RDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPLPYIVMEY 97
Query: 195 MARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVK 254
           +   ++ D +H + G       ++V  D  + +N+ HQN IIHRD+K AN+++     VK
Sbjct: 98  VDGVTLRDIVHTE-GPMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMISATNAVK 156
Query: 255 VADFGVARVQAQSGVMTAET----GTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTGE 310
           V DFG+AR  A SG    +T    GT ++++PE       D ++DV+S G  L+E+LTGE
Sbjct: 157 VMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGE 216
Query: 311 LPYAGLTPLQAAVGVVQKSLRPTIPKH 337
            P+ G +P+  A   V++   P   +H
Sbjct: 217 PPFTGDSPVSVAYQHVREDPIPPSARH 243

>pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311

Iteration: 1
 Score =  108 bits (271), Expect = 4e-24,   Method: Compositional matrix adjust.
 Identities = 66/207 (31%), Positives = 107/207 (51%), Gaps = 10/207 (4%)
Query: 140 QEVAIKVLKPECV-NTEMLKEFSQEVYIMRKIRHKNVVQF--IGACTRP--PNLCIVTEF 194
           ++VA+KVL+ +   +      F +E      + H  +V     G    P  P   IV E+
Sbjct: 38  RDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPLPYIVMEY 97
Query: 195 MARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVK 254
           +   ++ D +H + G       ++V  D  + +N+ HQN IIHRD+K AN+++     VK
Sbjct: 98  VDGVTLRDIVHTE-GPMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMISATNAVK 156
Query: 255 VADFGVARVQAQSGVMTAET----GTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTGE 310
           V DFG+AR  A SG    +T    GT ++++PE       D ++DV+S G  L+E+LTGE
Sbjct: 157 VMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGE 216
Query: 311 LPYAGLTPLQAAVGVVQKSLRPTIPKH 337
            P+ G +P+  A   V++   P   +H
Sbjct: 217 PPFTGDSPVSVAYQHVREDPIPPSARH 243

>pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311

Iteration: 1
 Score =  108 bits (271), Expect = 4e-24,   Method: Compositional matrix adjust.
 Identities = 66/207 (31%), Positives = 107/207 (51%), Gaps = 10/207 (4%)
Query: 140 QEVAIKVLKPECV-NTEMLKEFSQEVYIMRKIRHKNVVQF--IGACTRP--PNLCIVTEF 194
           ++VA+KVL+ +   +      F +E      + H  +V     G    P  P   IV E+
Sbjct: 38  RDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYATGEAETPAGPLPYIVMEY 97
Query: 195 MARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVK 254
           +   ++ D +H + G       ++V  D  + +N+ HQN IIHRD+K AN+++     VK
Sbjct: 98  VDGVTLRDIVHTE-GPMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMISATNAVK 156
Query: 255 VADFGVARVQAQSGVMTAET----GTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTGE 310
           V DFG+AR  A SG    +T    GT ++++PE       D ++DV+S G  L+E+LTGE
Sbjct: 157 VMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGE 216
Query: 311 LPYAGLTPLQAAVGVVQKSLRPTIPKH 337
            P+ G +P+  A   V++   P   +H
Sbjct: 217 PPFTGDSPVSVAYQHVREDPIPPSARH 243

>pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327

Iteration: 1
 Score =  108 bits (271), Expect = 4e-24,   Method: Compositional matrix adjust.
 Identities = 75/267 (28%), Positives = 126/267 (47%), Gaps = 14/267 (5%)
Query: 111 WEIDAKQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVNTEMLKEFSQEVYIMR 168
           W+  A+ LK   ++  G+YG + K  +    Q +A+K ++      E  +       +MR
Sbjct: 17  WDFTAEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMR 76
Query: 169 KIRHKNVVQFIGACTRPPNLCIVTEFMARG--SIYDFLHK-QKGVFQLTSLLKVAIDVSK 225
                 +VQF GA  R  +  I  E M+      Y +++     V     L K+ +   K
Sbjct: 77  SSDCPYIVQFYGALFREGDCWICMELMSTSFDKFYKYVYSVLDDVIPEEILGKITLATVK 136
Query: 226 GMNYLHQN-NIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAETGTYRWMAPEV 284
            +N+L +N  IIHRD+K +N+L+D +G +K+ DFG++     S   T + G   +MAPE 
Sbjct: 137 ALNHLKENLKIIHRDIKPSNILLDRSGNIKLCDFGISGQLVDSIAKTRDAGCRPYMAPER 196
Query: 285 IE----HKPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKSLRPTIP----K 336
           I+     + YD ++DV+S GI L+EL TG  PY     +   +  V K   P +     +
Sbjct: 197 IDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVFDQLTQVVKGDPPQLSNSEER 256
Query: 337 HAHPRLAELLERCWQHDPTQRPNFSQI 363
              P     +  C   D ++RP + ++
Sbjct: 257 EFSPSFINFVNLCLTKDESKRPKYKEL 283

>pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494

Iteration: 1
 Score =  108 bits (270), Expect = 5e-24,   Method: Compositional matrix adjust.
 Identities = 74/248 (29%), Positives = 126/248 (50%), Gaps = 11/248 (4%)
Query: 123 KVASGSYGD--LYKGTYCSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIG 180
           K+ SG+YG+  L +      E AIK+++   V+T    +  +EV +++ + H N+++   
Sbjct: 44  KLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYD 103
Query: 181 ACTRPPNLCIVTEFMARGSIYD-FLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRD 239
                 N  +V E    G ++D  +H+ K  F       +   V  G+ YLH++NI+HRD
Sbjct: 104 FFEDKRNYYLVMECYKGGELFDEIIHRMK--FNEVDAAVIIKQVLSGVTYLHKHNIVHRD 161
Query: 240 LKTANLLM---DENGVVKVADFGVARVQAQSGVMTAETGTYRWMAPEVIEHKPYDYKADV 296
           LK  NLL+   +++ ++K+ DFG++ V      M    GT  ++APEV+  K YD K DV
Sbjct: 162 LKPENLLLESKEKDALIKIVDFGLSAVFENQKKMKERLGTAYYIAPEVL-RKKYDEKCDV 220
Query: 297 FSFGIALWELLTGELPYAGLTPLQAAVGVVQKSLRPTIP--KHAHPRLAELLERCWQHDP 354
           +S G+ L+ LL G  P+ G T  +    V +       P  K+      +L+++  Q D 
Sbjct: 221 WSIGVILFILLAGYPPFGGQTDQEILRKVEKGKYTFDSPEWKNVSEGAKDLIKQMLQFDS 280
Query: 355 TQRPNFSQ 362
            +R +  Q
Sbjct: 281 QRRISAQQ 288

>pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299

Iteration: 1
 Score =  108 bits (270), Expect = 5e-24,   Method: Compositional matrix adjust.
 Identities = 66/207 (31%), Positives = 107/207 (51%), Gaps = 10/207 (4%)
Query: 140 QEVAIKVLKPECV-NTEMLKEFSQEVYIMRKIRHKNVVQF--IGACTRP--PNLCIVTEF 194
           ++VA+KVL+ +   +      F +E      + H  +V     G    P  P   IV E+
Sbjct: 55  RDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPLPYIVMEY 114
Query: 195 MARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVK 254
           +   ++ D +H + G       ++V  D  + +N+ HQN IIHRD+K AN+++     VK
Sbjct: 115 VDGVTLRDIVHTE-GPMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMISATNAVK 173
Query: 255 VADFGVARVQAQSGVMTAET----GTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTGE 310
           V DFG+AR  A SG    +T    GT ++++PE       D ++DV+S G  L+E+LTGE
Sbjct: 174 VMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGE 233
Query: 311 LPYAGLTPLQAAVGVVQKSLRPTIPKH 337
            P+ G +P+  A   V++   P   +H
Sbjct: 234 PPFTGDSPVSVAYQHVREDPIPPSARH 260

>pdb|1Y6A|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 2-Anilino-5-Aryl-Oxazole Inhibitor Length = 366

Iteration: 1
 Score =  108 bits (270), Expect = 5e-24,   Method: Compositional matrix adjust.
 Identities = 57/174 (32%), Positives = 93/174 (53%), Gaps = 4/174 (2%)
Query: 208 KGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVAR--VQA 265
           K    L  L+  +  V+KGM +L     IHRDL   N+L+ E  VVK+ DFG+AR   + 
Sbjct: 192 KDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKD 251
Query: 266 QSGVMTAETG-TYRWMAPEVIEHKPYDYKADVFSFGIALWELLT-GELPYAGLTPLQAAV 323
              V   +     +WMAPE I  + Y  ++DV+SFG+ LWE+ + G  PY G+   +   
Sbjct: 252 PDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFC 311
Query: 324 GVVQKSLRPTIPKHAHPRLAELLERCWQHDPTQRPNFSQITDILKQMMKEVASE 377
             +++  R   P +  P + + +  CW  +P+QRP FS++ + L  +++  A +
Sbjct: 312 RRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQANAQQ 365

>pdb|3VHK|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Back Pocket Binder Length = 368

Iteration: 1
 Score =  108 bits (270), Expect = 6e-24,   Method: Compositional matrix adjust.
 Identities = 57/174 (32%), Positives = 93/174 (53%), Gaps = 4/174 (2%)
Query: 208 KGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVAR--VQA 265
           K    L  L+  +  V+KGM +L     IHRDL   N+L+ E  VVK+ DFG+AR   + 
Sbjct: 194 KDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKD 253
Query: 266 QSGVMTAETG-TYRWMAPEVIEHKPYDYKADVFSFGIALWELLT-GELPYAGLTPLQAAV 323
              V   +     +WMAPE I  + Y  ++DV+SFG+ LWE+ + G  PY G+   +   
Sbjct: 254 PDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFC 313
Query: 324 GVVQKSLRPTIPKHAHPRLAELLERCWQHDPTQRPNFSQITDILKQMMKEVASE 377
             +++  R   P +  P + + +  CW  +P+QRP FS++ + L  +++  A +
Sbjct: 314 RRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQANAQQ 367

>pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327

Iteration: 1
 Score =  108 bits (269), Expect = 6e-24,   Method: Compositional matrix adjust.
 Identities = 68/227 (29%), Positives = 117/227 (51%), Gaps = 4/227 (1%)
Query: 138 CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVTEFMAR 197
             +EVA+K++    +N+  L++  +EV IM+ + H N+V+          L +V E+ + 
Sbjct: 38  TGKEVAVKIIDKTQLNSSSLQKLFREVRIMKVLNHPNIVKLFEVIETEKTLYLVMEYASG 97
Query: 198 GSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVAD 257
           G ++D+L     + +  +  K    VS  + Y HQ  I+HRDLK  NLL+D +  +K+AD
Sbjct: 98  GEVFDYLVAHGRMKEKEARAKFRQIVS-AVQYCHQKFIVHRDLKAENLLLDADMNIKIAD 156
Query: 258 FGVARVQAQSGVMTAETGTYRWMAPEVIEHKPYDY-KADVFSFGIALWELLTGELPYAGL 316
           FG +        + A  G   + APE+ + K YD  + DV+S G+ L+ L++G LP+ G 
Sbjct: 157 FGFSNEFTFGNKLDAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQ 216
Query: 317 TPLQAAVGVVQKSLRPTIPKHAHPRLAELLERCWQHDPTQRPNFSQI 363
              +    V++   R  IP +       LL++    +P++R    QI
Sbjct: 217 NLKELRERVLRGKYR--IPFYMSTDCENLLKKFLILNPSKRGTLEQI 261

>pdb|3VHE|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With A Novel Pyrrolopyrimidine Inhibitor Length = 359

Iteration: 1
 Score =  108 bits (269), Expect = 6e-24,   Method: Compositional matrix adjust.
 Identities = 57/172 (33%), Positives = 92/172 (53%), Gaps = 4/172 (2%)
Query: 208 KGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVAR--VQA 265
           K    L  L+  +  V+KGM +L     IHRDL   N+L+ E  VVK+ DFG+AR   + 
Sbjct: 187 KDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKD 246
Query: 266 QSGVMTAETG-TYRWMAPEVIEHKPYDYKADVFSFGIALWELLT-GELPYAGLTPLQAAV 323
              V   +     +WMAPE I  + Y  ++DV+SFG+ LWE+ + G  PY G+   +   
Sbjct: 247 PDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFC 306
Query: 324 GVVQKSLRPTIPKHAHPRLAELLERCWQHDPTQRPNFSQITDILKQMMKEVA 375
             +++  R   P +  P + + +  CW  +P+QRP FS++ + L  +++  A
Sbjct: 307 RRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQANA 358

>pdb|3VID|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With Compound A Length = 356

Iteration: 1
 Score =  108 bits (269), Expect = 7e-24,   Method: Compositional matrix adjust.
 Identities = 57/172 (33%), Positives = 92/172 (53%), Gaps = 4/172 (2%)
Query: 208 KGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVAR--VQA 265
           K    L  L+  +  V+KGM +L     IHRDL   N+L+ E  VVK+ DFG+AR   + 
Sbjct: 185 KDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKD 244
Query: 266 QSGVMTAETG-TYRWMAPEVIEHKPYDYKADVFSFGIALWELLT-GELPYAGLTPLQAAV 323
              V   +     +WMAPE I  + Y  ++DV+SFG+ LWE+ + G  PY G+   +   
Sbjct: 245 PDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFC 304
Query: 324 GVVQKSLRPTIPKHAHPRLAELLERCWQHDPTQRPNFSQITDILKQMMKEVA 375
             +++  R   P +  P + + +  CW  +P+QRP FS++ + L  +++  A
Sbjct: 305 RRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQANA 356

>pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283

Iteration: 1
 Score =  108 bits (269), Expect = 7e-24,   Method: Compositional matrix adjust.
 Identities = 75/286 (26%), Positives = 136/286 (47%), Gaps = 12/286 (4%)
Query: 107 GTDVWEIDAKQLKIECKVASGSYGDLYKGTYCSQE--VAIKVL-KPECVNTEMLKEFSQE 163
           G+  W ++    +I   +  G +G++Y       +  +A+KVL K +     +  +  +E
Sbjct: 4   GSRQWALE--DFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRRE 61
Query: 164 VYIMRKIRHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDV 223
           V I   +RH N+++  G       + ++ E+   G++Y  L K    F          ++
Sbjct: 62  VEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK-FDEQRTATYITEL 120
Query: 224 SKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAETGTYRWMAPE 283
           +  ++Y H   +IHRD+K  NLL+   G +K+ADFG + V A S    A  GT  ++ PE
Sbjct: 121 ANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWS-VHAPSSRRAALCGTLDYLPPE 179
Query: 284 VIEHKPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRLA 343
           +IE + +D K D++S G+  +E L G+ P+   T  +    + +     T P        
Sbjct: 180 MIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEF--TFPDFVTEGAR 237
Query: 344 ELLERCWQHDPTQRPNFSQITDILKQMMKEVASEGENNHSNKSAGS 389
           +L+ R  +H+P+QRP    + ++L+       S   +N  NK + S
Sbjct: 238 DLISRLLKHNPSQRP---MLREVLEHPWITANSSKPSNCQNKESAS 280

>pdb|3H9R|A Chain A, Crystal Structure Of The Kinase Domain Of Type I Activin Receptor (Acvr1) In Complex With Fkbp12 And Dorsomorphin Length = 330

Iteration: 1
 Score =  108 bits (269), Expect = 7e-24,   Method: Compositional matrix adjust.
 Identities = 86/302 (28%), Positives = 151/302 (50%), Gaps = 54/302 (17%)
Query: 115 AKQLKI-ECKVASGSYGDLYKGTYCSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHK 173
           A+Q+ + EC V  G YG++++G++  + VA+K+           +E   E+Y    +RH+
Sbjct: 36  ARQITLLEC-VGKGRYGEVWRGSWQGENVAVKIFSSR-DEKSWFRE--TELYNTVMLRHE 91
Query: 174 NVVQFIGA--CTR--PPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNY 229
           N++ FI +   +R     L ++T +   GS+YD+L  Q       S L++ + ++ G+ +
Sbjct: 92  NILGFIASDMTSRHSSTQLWLITHYHEMGSLYDYL--QLTTLDTVSCLRIVLSIASGLAH 149
Query: 230 LH--------QNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVM-----TAETGT 276
           LH        +  I HRDLK+ N+L+ +NG   +AD G+A + +QS            GT
Sbjct: 150 LHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGT 209
Query: 277 YRWMAPEVIEH----KPYD-YK-ADVFSFGIALWELLTGEL----------PYAGLTP-- 318
            R+MAPEV++       +D YK  D+++FG+ LWE+    +          P+  + P  
Sbjct: 210 KRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYDVVPND 269
Query: 319 -----LQAAVGVVQKSLRPTIPKH--AHP---RLAELLERCWQHDPTQRPNFSQITDILK 368
                ++  V V Q+  RP IP    + P    LA+L++ CW  +P+ R    +I   L 
Sbjct: 270 PSFEDMRKVVCVDQQ--RPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKKTLT 327
Query: 369 QM 370
           ++
Sbjct: 328 KI 329

>pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311

Iteration: 1
 Score =  107 bits (268), Expect = 9e-24,   Method: Compositional matrix adjust.
 Identities = 66/207 (31%), Positives = 106/207 (51%), Gaps = 10/207 (4%)
Query: 140 QEVAIKVLKPECV-NTEMLKEFSQEVYIMRKIRHKNVVQF--IGACTRP--PNLCIVTEF 194
           ++VA+KVL+ +   +      F +E      + H  +V     G    P  P   IV E+
Sbjct: 38  RDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPLPYIVMEY 97
Query: 195 MARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVK 254
           +   ++ D +H + G       ++V  D  + +N+ HQN IIHRD+K AN+++     VK
Sbjct: 98  VDGVTLRDIVHTE-GPMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMISATNAVK 156
Query: 255 VADFGVARVQAQSGVMTAET----GTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTGE 310
           V DFG+AR  A SG    +T    GT ++++PE       D ++DV+S G  L+E+LTGE
Sbjct: 157 VMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGE 216
Query: 311 LPYAGLTPLQAAVGVVQKSLRPTIPKH 337
            P+ G +P   A   V++   P   +H
Sbjct: 217 PPFTGDSPDSVAYQHVREDPIPPSARH 243

>pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280

Iteration: 1
 Score =  107 bits (267), Expect = 1e-23,   Method: Compositional matrix adjust.
 Identities = 75/286 (26%), Positives = 135/286 (47%), Gaps = 12/286 (4%)
Query: 107 GTDVWEIDAKQLKIECKVASGSYGDLYKGTYCSQE--VAIKVL-KPECVNTEMLKEFSQE 163
           G   W ++    +I   +  G +G++Y       +  +A+KVL K +     +  +  +E
Sbjct: 1   GPRQWALE--DFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRRE 58
Query: 164 VYIMRKIRHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDV 223
           V I   +RH N+++  G       + ++ E+   G++Y  L K    F          ++
Sbjct: 59  VEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK-FDEQRTATYITEL 117
Query: 224 SKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAETGTYRWMAPE 283
           +  ++Y H   +IHRD+K  NLL+   G +K+ADFG + V A S   T   GT  ++ PE
Sbjct: 118 ANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWS-VHAPSSRRTTLCGTLDYLPPE 176
Query: 284 VIEHKPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRLA 343
           +IE + +D K D++S G+  +E L G+ P+   T  +    + +     T P        
Sbjct: 177 MIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEF--TFPDFVTEGAR 234
Query: 344 ELLERCWQHDPTQRPNFSQITDILKQMMKEVASEGENNHSNKSAGS 389
           +L+ R  +H+P+QRP    + ++L+       S   +N  NK + S
Sbjct: 235 DLISRLLKHNPSQRP---MLREVLEHPWITANSSKPSNCQNKESAS 277

>pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285

Iteration: 1
 Score =  107 bits (267), Expect = 1e-23,   Method: Compositional matrix adjust.
 Identities = 72/269 (26%), Positives = 128/269 (47%), Gaps = 10/269 (3%)
Query: 124 VASGSYGDLYKGTYCSQE--VAIKVL-KPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIG 180
           +  G +G++Y       +  +A+KVL K +     +  +  +EV I   +RH N+++  G
Sbjct: 21  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 80
Query: 181 ACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDL 240
                  + ++ E+  RG +Y  L K    F          +++  ++Y H   +IHRD+
Sbjct: 81  YFHDATRVYLILEYAPRGEVYKELQKL-SKFDEQRTATYITELANALSYCHSKRVIHRDI 139
Query: 241 KTANLLMDENGVVKVADFGVARVQAQSGVMTAETGTYRWMAPEVIEHKPYDYKADVFSFG 300
           K  NLL+   G +K+ADFG + V A S       GT  ++ PE+IE + +D K D++S G
Sbjct: 140 KPENLLLGSAGELKIADFGWS-VHAPSSRRXXLXGTLDYLPPEMIEGRMHDEKVDLWSLG 198
Query: 301 IALWELLTGELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRLAELLERCWQHDPTQRPNF 360
           +  +E L G+ P+   T  +    + +     T P        +L+ R  +H+P+QRP  
Sbjct: 199 VLCYEFLVGKPPFEANTYQETYKRISRVEF--TFPDFVTEGARDLISRLLKHNPSQRP-- 254
Query: 361 SQITDILKQMMKEVASEGENNHSNKSAGS 389
             + ++L+       S   +N  NK + S
Sbjct: 255 -MLREVLEHPWITANSSKPSNCQNKESAS 282

>pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327

Iteration: 1
 Score =  107 bits (267), Expect = 1e-23,   Method: Compositional matrix adjust.
 Identities = 67/227 (29%), Positives = 117/227 (51%), Gaps = 4/227 (1%)
Query: 138 CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVTEFMAR 197
             +EVA+K++    +N+  L++  +EV IM+ + H N+V+          L +V E+ + 
Sbjct: 38  TGKEVAVKIIDKTQLNSSSLQKLFREVRIMKVLNHPNIVKLFEVIETEKTLYLVMEYASG 97
Query: 198 GSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVAD 257
           G ++D+L     + +  +  K    VS  + Y HQ  I+HRDLK  NLL+D +  +K+AD
Sbjct: 98  GEVFDYLVAHGRMKEKEARAKFRQIVS-AVQYCHQKFIVHRDLKAENLLLDADMNIKIAD 156
Query: 258 FGVARVQAQSGVMTAETGTYRWMAPEVIEHKPYDY-KADVFSFGIALWELLTGELPYAGL 316
           FG +        +    G+  + APE+ + K YD  + DV+S G+ L+ L++G LP+ G 
Sbjct: 157 FGFSNEFTFGNKLDTFCGSPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQ 216
Query: 317 TPLQAAVGVVQKSLRPTIPKHAHPRLAELLERCWQHDPTQRPNFSQI 363
              +    V++   R  IP +       LL++    +P++R    QI
Sbjct: 217 NLKELRERVLRGKYR--IPFYMSTDCENLLKKFLILNPSKRGTLEQI 261

>pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327

Iteration: 1
 Score =  107 bits (267), Expect = 1e-23,   Method: Compositional matrix adjust.
 Identities = 67/227 (29%), Positives = 117/227 (51%), Gaps = 4/227 (1%)
Query: 138 CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVTEFMAR 197
             +EVA+K++    +N+  L++  +EV IM+ + H N+V+          L +V E+ + 
Sbjct: 38  TGKEVAVKIIDKTQLNSSSLQKLFREVRIMKVLNHPNIVKLFEVIETEKTLYLVMEYASG 97
Query: 198 GSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVAD 257
           G ++D+L     + +  +  K    VS  + Y HQ  I+HRDLK  NLL+D +  +K+AD
Sbjct: 98  GEVFDYLVAHGRMKEKEARAKFRQIVS-AVQYCHQKFIVHRDLKAENLLLDADMNIKIAD 156
Query: 258 FGVARVQAQSGVMTAETGTYRWMAPEVIEHKPYDY-KADVFSFGIALWELLTGELPYAGL 316
           FG +        +    G+  + APE+ + K YD  + DV+S G+ L+ L++G LP+ G 
Sbjct: 157 FGFSNEFTFGNKLDTFCGSPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQ 216
Query: 317 TPLQAAVGVVQKSLRPTIPKHAHPRLAELLERCWQHDPTQRPNFSQI 363
              +    V++   R  IP +       LL++    +P++R    QI
Sbjct: 217 NLKELRERVLRGKYR--IPFYMSTDCENLLKKFLILNPSKRGTLEQI 261

>pdb|3MTF|A Chain A, Crystal Structure Of The Acvr1 Kinase In Complex With A 2- Aminopyridine Inhibitor Length = 301

Iteration: 1
 Score =  107 bits (267), Expect = 1e-23,   Method: Compositional matrix adjust.
 Identities = 84/296 (28%), Positives = 147/296 (49%), Gaps = 53/296 (17%)
Query: 120 IECKVASGSYGDLYKGTYCSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFI 179
           +EC V  G YG++++G++  + VA+K+           +E   E+Y    +RH+N++ FI
Sbjct: 13  LEC-VGKGRYGEVWRGSWQGENVAVKIFSSR-DEKSWFRE--TELYNTVMLRHENILGFI 68
Query: 180 GA--CTR--PPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLH---- 231
            +   +R     L ++T +   GS+YD+L  Q       S L++ + ++ G+ +LH    
Sbjct: 69  ASDMTSRHSSTQLWLITHYHEMGSLYDYL--QLTTLDTVSCLRIVLSIASGLAHLHIEIF 126
Query: 232 ----QNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVM-----TAETGTYRWMAP 282
               +  I HRDLK+ N+L+ +NG   +AD G+A + +QS            GT R+MAP
Sbjct: 127 GTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAP 186
Query: 283 EVIEH----KPYD-YK-ADVFSFGIALWELLTGEL----------PYAGLTP-------L 319
           EV++       +D YK  D+++FG+ LWE+    +          P+  + P       +
Sbjct: 187 EVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYDVVPNDPSFEDM 246
Query: 320 QAAVGVVQKSLRPTIPKH--AHP---RLAELLERCWQHDPTQRPNFSQITDILKQM 370
           +  V V Q+  RP IP    + P    LA+L++ CW  +P+ R    +I   L ++
Sbjct: 247 RKVVCVDQQ--RPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKKTLTKI 300

>pdb|4DYM|A Chain A, Crystal Structure Of The Acvr1 Kinase Domain In Complex With The Imidazo[1,2-B]pyridazine Inhibitor K00135 Length = 301

Iteration: 1
 Score =  107 bits (266), Expect = 1e-23,   Method: Compositional matrix adjust.
 Identities = 84/296 (28%), Positives = 147/296 (49%), Gaps = 53/296 (17%)
Query: 120 IECKVASGSYGDLYKGTYCSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFI 179
           +EC V  G YG++++G++  + VA+K+           +E   E+Y    +RH+N++ FI
Sbjct: 13  LEC-VGKGRYGEVWRGSWQGENVAVKIFSSR-DEKSWFRE--TELYNTVMLRHENILGFI 68
Query: 180 GA--CTR--PPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLH---- 231
            +   +R     L ++T +   GS+YD+L  Q       S L++ + ++ G+ +LH    
Sbjct: 69  ASDMTSRHSSTQLWLITHYHEMGSLYDYL--QLTTLDTVSCLRIVLSIASGLAHLHIEIF 126
Query: 232 ----QNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVM-----TAETGTYRWMAP 282
               +  I HRDLK+ N+L+ +NG   +AD G+A + +QS            GT R+MAP
Sbjct: 127 GTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAP 186
Query: 283 EVIEH----KPYD-YK-ADVFSFGIALWELLTGEL----------PYAGLTP-------L 319
           EV++       +D YK  D+++FG+ LWE+    +          P+  + P       +
Sbjct: 187 EVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYDVVPNDPSFEDM 246
Query: 320 QAAVGVVQKSLRPTIPKH--AHP---RLAELLERCWQHDPTQRPNFSQITDILKQM 370
           +  V V Q+  RP IP    + P    LA+L++ CW  +P+ R    +I   L ++
Sbjct: 247 RKVVCVDQQ--RPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKKTLTKI 300

>pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280

Iteration: 1
 Score =  107 bits (266), Expect = 1e-23,   Method: Compositional matrix adjust.
 Identities = 75/286 (26%), Positives = 135/286 (47%), Gaps = 12/286 (4%)
Query: 107 GTDVWEIDAKQLKIECKVASGSYGDLYKGTYCSQE--VAIKVL-KPECVNTEMLKEFSQE 163
           G   W ++    +I   +  G +G++Y       +  +A+KVL K +     +  +  +E
Sbjct: 1   GPRQWALE--DFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRRE 58
Query: 164 VYIMRKIRHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDV 223
           V I   +RH N+++  G       + ++ E+   G++Y  L K    F          ++
Sbjct: 59  VEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK-FDEQRTATYITEL 117
Query: 224 SKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAETGTYRWMAPE 283
           +  ++Y H   +IHRD+K  NLL+   G +K+ADFG + V A S   T   GT  ++ PE
Sbjct: 118 ANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWS-VHAPSSRRTELCGTLDYLPPE 176
Query: 284 VIEHKPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRLA 343
           +IE + +D K D++S G+  +E L G+ P+   T  +    + +     T P        
Sbjct: 177 MIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEF--TFPDFVTEGAR 234
Query: 344 ELLERCWQHDPTQRPNFSQITDILKQMMKEVASEGENNHSNKSAGS 389
           +L+ R  +H+P+QRP    + ++L+       S   +N  NK + S
Sbjct: 235 DLISRLLKHNPSQRP---MLREVLEHPWITANSSKPSNCQNKESAS 277

>pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319

Iteration: 1
 Score =  107 bits (266), Expect = 1e-23,   Method: Compositional matrix adjust.
 Identities = 67/227 (29%), Positives = 117/227 (51%), Gaps = 4/227 (1%)
Query: 138 CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVTEFMAR 197
             +EVA+K++    +N+  L++  +EV IM+ + H N+V+          L +V E+ + 
Sbjct: 31  TGKEVAVKIIDKTQLNSSSLQKLFREVRIMKVLNHPNIVKLFEVIETEKTLYLVMEYASG 90
Query: 198 GSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVAD 257
           G ++D+L     + +  +  K    VS  + Y HQ  I+HRDLK  NLL+D +  +K+AD
Sbjct: 91  GEVFDYLVAHGWMKEKEARAKFRQIVS-AVQYCHQKFIVHRDLKAENLLLDADMNIKIAD 149
Query: 258 FGVARVQAQSGVMTAETGTYRWMAPEVIEHKPYDY-KADVFSFGIALWELLTGELPYAGL 316
           FG +        +    G+  + APE+ + K YD  + DV+S G+ L+ L++G LP+ G 
Sbjct: 150 FGFSNEFTFGNKLDTFCGSPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQ 209
Query: 317 TPLQAAVGVVQKSLRPTIPKHAHPRLAELLERCWQHDPTQRPNFSQI 363
              +    V++   R  IP +       LL++    +P++R    QI
Sbjct: 210 NLKELRERVLRGKYR--IPFYMSTDCENLLKKFLILNPSKRGTLEQI 254

>pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281

Iteration: 1
 Score =  107 bits (266), Expect = 2e-23,   Method: Compositional matrix adjust.
 Identities = 71/269 (26%), Positives = 129/269 (47%), Gaps = 10/269 (3%)
Query: 124 VASGSYGDLYKGTYCSQE--VAIKVL-KPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIG 180
           +  G +G++Y       +  +A+KVL K +     +  +  +EV I   +RH N+++  G
Sbjct: 17  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 76
Query: 181 ACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDL 240
                  + ++ E+   G++Y  L K    F          +++  ++Y H   +IHRD+
Sbjct: 77  YFHDATRVYLILEYAPLGTVYRELQKLSK-FDEQRTATYITELANALSYCHSKRVIHRDI 135
Query: 241 KTANLLMDENGVVKVADFGVARVQAQSGVMTAETGTYRWMAPEVIEHKPYDYKADVFSFG 300
           K  NLL+   G +K+ADFG +   A S   T  +GT  ++ PE+IE + +D K D++S G
Sbjct: 136 KPENLLLGSAGELKIADFGWS-CHAPSSRRTTLSGTLDYLPPEMIEGRMHDEKVDLWSLG 194
Query: 301 IALWELLTGELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRLAELLERCWQHDPTQRPNF 360
           +  +E L G+ P+   T  +    + +     T P        +L+ R  +H+P+QRP  
Sbjct: 195 VLCYEFLVGKPPFEANTYQETYKRISRVEF--TFPDFVTEGARDLISRLLKHNPSQRP-- 250
Query: 361 SQITDILKQMMKEVASEGENNHSNKSAGS 389
             + ++L+       S   +N  NK + S
Sbjct: 251 -MLREVLEHPWITANSSKPSNSQNKESAS 278

>pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285

Iteration: 1
 Score =  107 bits (266), Expect = 2e-23,   Method: Compositional matrix adjust.
 Identities = 72/269 (26%), Positives = 129/269 (47%), Gaps = 10/269 (3%)
Query: 124 VASGSYGDLYKGTYCSQE--VAIKVL-KPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIG 180
           +  G +G++Y       +  +A+KVL K +     +  +  +EV I   +RH N+++  G
Sbjct: 21  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 80
Query: 181 ACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDL 240
                  + ++ E+   G++Y  L K    F          +++  ++Y H   +IHRD+
Sbjct: 81  YFHDATRVYLILEYAPLGTVYRELQKLSK-FDEQRTATYITELANALSYCHSKRVIHRDI 139
Query: 241 KTANLLMDENGVVKVADFGVARVQAQSGVMTAETGTYRWMAPEVIEHKPYDYKADVFSFG 300
           K  NLL+   G +K+ADFG + V A S   T   GT  ++ PE+IE + +D K D++S G
Sbjct: 140 KPENLLLGSAGELKIADFGWS-VHAPSSRRTTLCGTLDYLPPEMIEGRMHDEKVDLWSLG 198
Query: 301 IALWELLTGELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRLAELLERCWQHDPTQRPNF 360
           +  +E L G+ P+   T  +    + +     T P        +L+ R  +H+P+QRP  
Sbjct: 199 VLCYEFLVGKPPFEANTYQETYKRISRVEF--TFPDFVTEGARDLISRLLKHNPSQRP-- 254
Query: 361 SQITDILKQMMKEVASEGENNHSNKSAGS 389
             + ++L+       S   +N  NK + S
Sbjct: 255 -MLREVLEHPWITANSSKPSNCQNKESAS 282

>pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283

Iteration: 1
 Score =  106 bits (265), Expect = 2e-23,   Method: Compositional matrix adjust.
 Identities = 72/269 (26%), Positives = 129/269 (47%), Gaps = 10/269 (3%)
Query: 124 VASGSYGDLYKGTYCSQE--VAIKVL-KPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIG 180
           +  G +G++Y       +  +A+KVL K +     +  +  +EV I   +RH N+++  G
Sbjct: 19  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 78
Query: 181 ACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDL 240
                  + ++ E+   G++Y  L K    F          +++  ++Y H   +IHRD+
Sbjct: 79  YFHDATRVYLILEYAPLGTVYRELQKLSK-FDEQRTATYITELANALSYCHSKRVIHRDI 137
Query: 241 KTANLLMDENGVVKVADFGVARVQAQSGVMTAETGTYRWMAPEVIEHKPYDYKADVFSFG 300
           K  NLL+   G +K+ADFG + V A S   T   GT  ++ PE+IE + +D K D++S G
Sbjct: 138 KPENLLLGSAGELKIADFGWS-VHAPSSRRTTLCGTLDYLPPEMIEGRMHDEKVDLWSLG 196
Query: 301 IALWELLTGELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRLAELLERCWQHDPTQRPNF 360
           +  +E L G+ P+   T  +    + +     T P        +L+ R  +H+P+QRP  
Sbjct: 197 VLCYEFLVGKPPFEANTYQETYKRISRVEF--TFPDFVTEGARDLISRLLKHNPSQRP-- 252
Query: 361 SQITDILKQMMKEVASEGENNHSNKSAGS 389
             + ++L+       S   +N  NK + S
Sbjct: 253 -MLREVLEHPWITANSSKPSNCQNKESAS 280

>pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297

Iteration: 1
 Score =  106 bits (265), Expect = 2e-23,   Method: Compositional matrix adjust.
 Identities = 72/269 (26%), Positives = 129/269 (47%), Gaps = 10/269 (3%)
Query: 124 VASGSYGDLYKGTYCSQE--VAIKVL-KPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIG 180
           +  G +G++Y       +  +A+KVL K +     +  +  +EV I   +RH N+++  G
Sbjct: 33  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 92
Query: 181 ACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDL 240
                  + ++ E+   G++Y  L K    F          +++  ++Y H   +IHRD+
Sbjct: 93  YFHDATRVYLILEYAPLGTVYRELQKL-SKFDEQRTATYITELANALSYCHSKRVIHRDI 151
Query: 241 KTANLLMDENGVVKVADFGVARVQAQSGVMTAETGTYRWMAPEVIEHKPYDYKADVFSFG 300
           K  NLL+   G +K+ADFG + V A S   T   GT  ++ PE+IE + +D K D++S G
Sbjct: 152 KPENLLLGSAGELKIADFGWS-VHAPSSRRTTLCGTLDYLPPEMIEGRMHDEKVDLWSLG 210
Query: 301 IALWELLTGELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRLAELLERCWQHDPTQRPNF 360
           +  +E L G+ P+   T  +    + +     T P        +L+ R  +H+P+QRP  
Sbjct: 211 VLCYEFLVGKPPFEANTYQETYKRISRVEF--TFPDFVTEGARDLISRLLKHNPSQRP-- 266
Query: 361 SQITDILKQMMKEVASEGENNHSNKSAGS 389
             + ++L+       S   +N  NK + S
Sbjct: 267 -MLREVLEHPWITANSSKPSNCQNKESAS 294

>pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285

Iteration: 1
 Score =  106 bits (265), Expect = 2e-23,   Method: Compositional matrix adjust.
 Identities = 72/269 (26%), Positives = 128/269 (47%), Gaps = 10/269 (3%)
Query: 124 VASGSYGDLYKGTYCSQE--VAIKVL-KPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIG 180
           +  G +G++Y       +  +A+KVL K +     +  +  +EV I   +RH N+++  G
Sbjct: 21  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 80
Query: 181 ACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDL 240
                  + ++ E+   G++Y  L K    F          +++  ++Y H   +IHRD+
Sbjct: 81  YFHDATRVYLILEYAPLGTVYRELQKLSK-FDEQRTATYITELANALSYCHSKRVIHRDI 139
Query: 241 KTANLLMDENGVVKVADFGVARVQAQSGVMTAETGTYRWMAPEVIEHKPYDYKADVFSFG 300
           K  NLL+   G +K+ADFG + V A S   T   GT  ++ PE IE + +D K D++S G
Sbjct: 140 KPENLLLGSAGELKIADFGWS-VHAPSSRRTTLCGTLDYLPPEXIEGRXHDEKVDLWSLG 198
Query: 301 IALWELLTGELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRLAELLERCWQHDPTQRPNF 360
           +  +E L G+ P+   T  +    + +     T P        +L+ R  +H+P+QRP  
Sbjct: 199 VLCYEFLVGKPPFEANTYQETYKRISRVEF--TFPDFVTEGARDLISRLLKHNPSQRP-- 254
Query: 361 SQITDILKQMMKEVASEGENNHSNKSAGS 389
             + ++L+       S   +N  NK + S
Sbjct: 255 -XLREVLEHPWITANSSKPSNCQNKESAS 282

>pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306

Iteration: 1
 Score =  106 bits (265), Expect = 2e-23,   Method: Compositional matrix adjust.
 Identities = 72/269 (26%), Positives = 129/269 (47%), Gaps = 10/269 (3%)
Query: 124 VASGSYGDLYKGTYCSQE--VAIKVL-KPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIG 180
           +  G +G++Y       +  +A+KVL K +     +  +  +EV I   +RH N+++  G
Sbjct: 42  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 101
Query: 181 ACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDL 240
                  + ++ E+   G++Y  L K    F          +++  ++Y H   +IHRD+
Sbjct: 102 YFHDATRVYLILEYAPLGTVYRELQKL-SKFDEQRTATYITELANALSYCHSKRVIHRDI 160
Query: 241 KTANLLMDENGVVKVADFGVARVQAQSGVMTAETGTYRWMAPEVIEHKPYDYKADVFSFG 300
           K  NLL+   G +K+ADFG + V A S   T   GT  ++ PE+IE + +D K D++S G
Sbjct: 161 KPENLLLGSAGELKIADFGWS-VHAPSSRRTTLCGTLDYLPPEMIEGRMHDEKVDLWSLG 219
Query: 301 IALWELLTGELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRLAELLERCWQHDPTQRPNF 360
           +  +E L G+ P+   T  +    + +     T P        +L+ R  +H+P+QRP  
Sbjct: 220 VLCYEFLVGKPPFEANTYQETYKRISRVEF--TFPDFVTEGARDLISRLLKHNPSQRP-- 275
Query: 361 SQITDILKQMMKEVASEGENNHSNKSAGS 389
             + ++L+       S   +N  NK + S
Sbjct: 276 -MLREVLEHPWITANSSKPSNCQNKESAS 303

>pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327

Iteration: 1
 Score =  106 bits (264), Expect = 2e-23,   Method: Compositional matrix adjust.
 Identities = 66/227 (29%), Positives = 117/227 (51%), Gaps = 4/227 (1%)
Query: 138 CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVTEFMAR 197
             +EVA++++    +N+  L++  +EV IM+ + H N+V+          L +V E+ + 
Sbjct: 38  TGKEVAVRIIDKTQLNSSSLQKLFREVRIMKVLNHPNIVKLFEVIETEKTLYLVMEYASG 97
Query: 198 GSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVAD 257
           G ++D+L     + +  +  K    VS  + Y HQ  I+HRDLK  NLL+D +  +K+AD
Sbjct: 98  GEVFDYLVAHGRMKEKEARAKFRQIVS-AVQYCHQKFIVHRDLKAENLLLDADMNIKIAD 156
Query: 258 FGVARVQAQSGVMTAETGTYRWMAPEVIEHKPYDY-KADVFSFGIALWELLTGELPYAGL 316
           FG +        +    G+  + APE+ + K YD  + DV+S G+ L+ L++G LP+ G 
Sbjct: 157 FGFSNEFTFGNKLDTFCGSPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQ 216
Query: 317 TPLQAAVGVVQKSLRPTIPKHAHPRLAELLERCWQHDPTQRPNFSQI 363
              +    V++   R  IP +       LL++    +P++R    QI
Sbjct: 217 NLKELRERVLRGKYR--IPFYMSTDCENLLKKFLILNPSKRGTLEQI 261

>pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279

Iteration: 1
 Score =  106 bits (264), Expect = 2e-23,   Method: Compositional matrix adjust.
 Identities = 72/269 (26%), Positives = 129/269 (47%), Gaps = 10/269 (3%)
Query: 124 VASGSYGDLYKGTYCSQE--VAIKVL-KPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIG 180
           +  G +G++Y       +  +A+KVL K +     +  +  +EV I   +RH N+++  G
Sbjct: 17  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 76
Query: 181 ACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDL 240
                  + ++ E+   G++Y  L K    F          +++  ++Y H   +IHRD+
Sbjct: 77  YFHDATRVYLILEYAPLGTVYRELQKLSK-FDEQRTATYITELANALSYCHSKRVIHRDI 135
Query: 241 KTANLLMDENGVVKVADFGVARVQAQSGVMTAETGTYRWMAPEVIEHKPYDYKADVFSFG 300
           K  NLL+   G +K+ADFG + V A S   T   GT  ++ PE+IE + +D K D++S G
Sbjct: 136 KPENLLLGSAGELKIADFGWS-VHAPSSRRTDLCGTLDYLPPEMIEGRMHDEKVDLWSLG 194
Query: 301 IALWELLTGELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRLAELLERCWQHDPTQRPNF 360
           +  +E L G+ P+   T  +    + +     T P        +L+ R  +H+P+QRP  
Sbjct: 195 VLCYEFLVGKPPFEANTYQETYKRISRVEF--TFPDFVTEGARDLISRLLKHNPSQRP-- 250
Query: 361 SQITDILKQMMKEVASEGENNHSNKSAGS 389
             + ++L+       S   +N  NK + S
Sbjct: 251 -MLREVLEHPWITANSSKPSNCQNKESAS 278

>pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327

Iteration: 1
 Score =  106 bits (264), Expect = 3e-23,   Method: Compositional matrix adjust.
 Identities = 67/227 (29%), Positives = 115/227 (50%), Gaps = 4/227 (1%)
Query: 138 CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVTEFMAR 197
             +EVA+K++    +N+  L++  +EV I + + H N+V+          L +V E+ + 
Sbjct: 38  TGKEVAVKIIDKTQLNSSSLQKLFREVRIXKVLNHPNIVKLFEVIETEKTLYLVXEYASG 97
Query: 198 GSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVAD 257
           G ++D+L       +  +  K    VS  + Y HQ  I+HRDLK  NLL+D +  +K+AD
Sbjct: 98  GEVFDYLVAHGRXKEKEARAKFRQIVS-AVQYCHQKFIVHRDLKAENLLLDADXNIKIAD 156
Query: 258 FGVARVQAQSGVMTAETGTYRWMAPEVIEHKPYDY-KADVFSFGIALWELLTGELPYAGL 316
           FG +        + A  G   + APE+ + K YD  + DV+S G+ L+ L++G LP+ G 
Sbjct: 157 FGFSNEFTFGNKLDAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQ 216
Query: 317 TPLQAAVGVVQKSLRPTIPKHAHPRLAELLERCWQHDPTQRPNFSQI 363
              +    V++   R  IP +       LL++    +P++R    QI
Sbjct: 217 NLKELRERVLRGKYR--IPFYXSTDCENLLKKFLILNPSKRGTLEQI 261

>pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283

Iteration: 1
 Score =  106 bits (264), Expect = 3e-23,   Method: Compositional matrix adjust.
 Identities = 72/269 (26%), Positives = 129/269 (47%), Gaps = 10/269 (3%)
Query: 124 VASGSYGDLYKGTYCSQE--VAIKVL-KPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIG 180
           +  G +G++Y       +  +A+KVL K +     +  +  +EV I   +RH N+++  G
Sbjct: 21  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 80
Query: 181 ACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDL 240
                  + ++ E+   G++Y  L K    F          +++  ++Y H   +IHRD+
Sbjct: 81  YFHDATRVYLILEYAPLGTVYRELQKLSK-FDEQRTATYITELANALSYCHSKRVIHRDI 139
Query: 241 KTANLLMDENGVVKVADFGVARVQAQSGVMTAETGTYRWMAPEVIEHKPYDYKADVFSFG 300
           K  NLL+   G +K+ADFG + V A S   T   GT  ++ PE+IE + +D K D++S G
Sbjct: 140 KPENLLLGSAGELKIADFGWS-VHAPSSRRTDLCGTLDYLPPEMIEGRMHDEKVDLWSLG 198
Query: 301 IALWELLTGELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRLAELLERCWQHDPTQRPNF 360
           +  +E L G+ P+   T  +    + +     T P        +L+ R  +H+P+QRP  
Sbjct: 199 VLCYEFLVGKPPFEANTYQETYKRISRVEF--TFPDFVTEGARDLISRLLKHNPSQRP-- 254
Query: 361 SQITDILKQMMKEVASEGENNHSNKSAGS 389
             + ++L+       S   +N  NK + S
Sbjct: 255 -MLREVLEHPWITANSSKPSNCQNKESAS 282

>pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327

Iteration: 1
 Score =  106 bits (264), Expect = 3e-23,   Method: Compositional matrix adjust.
 Identities = 66/227 (29%), Positives = 117/227 (51%), Gaps = 4/227 (1%)
Query: 138 CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVTEFMAR 197
             +EVA++++    +N+  L++  +EV IM+ + H N+V+          L +V E+ + 
Sbjct: 38  TGKEVAVRIIDKTQLNSSSLQKLFREVRIMKVLNHPNIVKLFEVIETEKTLYLVMEYASG 97
Query: 198 GSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVAD 257
           G ++D+L     + +  +  K    VS  + Y HQ  I+HRDLK  NLL+D +  +K+AD
Sbjct: 98  GEVFDYLVAHGRMKEKEARAKFRQIVS-AVQYCHQKFIVHRDLKAENLLLDADMNIKIAD 156
Query: 258 FGVARVQAQSGVMTAETGTYRWMAPEVIEHKPYDY-KADVFSFGIALWELLTGELPYAGL 316
           FG +        +    G+  + APE+ + K YD  + DV+S G+ L+ L++G LP+ G 
Sbjct: 157 FGFSNEFTFGNKLDEFCGSPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQ 216
Query: 317 TPLQAAVGVVQKSLRPTIPKHAHPRLAELLERCWQHDPTQRPNFSQI 363
              +    V++   R  IP +       LL++    +P++R    QI
Sbjct: 217 NLKELRERVLRGKYR--IPFYMSTDCENLLKKFLILNPSKRGTLEQI 261

>pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262

Iteration: 1
 Score =  105 bits (263), Expect = 3e-23,   Method: Compositional matrix adjust.
 Identities = 66/245 (26%), Positives = 121/245 (49%), Gaps = 7/245 (2%)
Query: 124 VASGSYGDLYKGTYCSQE--VAIKVL-KPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIG 180
           +  G +G++Y      ++  +A+KVL K +     +  +  +EV I   +RH N+++  G
Sbjct: 13  LGKGKFGNVYLAREKQRKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 72
Query: 181 ACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDL 240
                  + ++ E+   G++Y  L K    F          +++  ++Y H   +IHRD+
Sbjct: 73  YFHDATRVYLILEYAPLGTVYRELQKLSK-FDEQRTATYITELANALSYCHSKRVIHRDI 131
Query: 241 KTANLLMDENGVVKVADFGVARVQAQSGVMTAETGTYRWMAPEVIEHKPYDYKADVFSFG 300
           K  NLL+   G +K+ADFG + V A S   T   GT  ++ PE+IE + +D K D++S G
Sbjct: 132 KPENLLLGSAGELKIADFGWS-VHAPSSRRTTLCGTLDYLPPEMIEGRMHDEKVDLWSLG 190
Query: 301 IALWELLTGELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRLAELLERCWQHDPTQRPNF 360
           +  +E L G+ P+   T  +    + +     T P        +L+ R  +H+P+QRP  
Sbjct: 191 VLCYEFLVGKPPFEANTYQETYKRISRVEF--TFPDFVTEGARDLISRLLKHNPSQRPML 248
Query: 361 SQITD 365
            ++ +
Sbjct: 249 REVLE 253

>pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268

Iteration: 1
 Score =  105 bits (263), Expect = 3e-23,   Method: Compositional matrix adjust.
 Identities = 69/262 (26%), Positives = 126/262 (48%), Gaps = 9/262 (3%)
Query: 107 GTDVWEIDAKQLKIECKVASGSYGDLYKGTYCSQE--VAIKVL-KPECVNTEMLKEFSQE 163
           G   W ++    +I   +  G +G++Y       +  +A+KVL K +     +  +  +E
Sbjct: 1   GKRQWALE--DFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRRE 58
Query: 164 VYIMRKIRHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDV 223
           V I   +RH N+++  G       + ++ E+   G++Y  L K    F          ++
Sbjct: 59  VEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK-FDEQRTATYITEL 117
Query: 224 SKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAETGTYRWMAPE 283
           +  ++Y H   +IHRD+K  NLL+   G +K+ADFG + V A S   T   GT  ++ PE
Sbjct: 118 ANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWS-VHAPSSRRTXLCGTLDYLPPE 176
Query: 284 VIEHKPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRLA 343
           +IE + +D K D++S G+  +E L G+ P+   T  +    + +     T P        
Sbjct: 177 MIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEF--TFPDFVTEGAR 234
Query: 344 ELLERCWQHDPTQRPNFSQITD 365
           +L+ R  +H+P+QRP   ++ +
Sbjct: 235 DLISRLLKHNPSQRPMLREVLE 256

>pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486

Iteration: 1
 Score =  105 bits (263), Expect = 4e-23,   Method: Compositional matrix adjust.
 Identities = 63/206 (30%), Positives = 110/206 (53%), Gaps = 7/206 (3%)
Query: 115 AKQLKIECKVASGSYGDLYK--GTYCSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRH 172
           A++  I C +  GS+G++ K       QE A+KV+       +      +EV +++K+ H
Sbjct: 21  AERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDH 80
Query: 173 KNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQ 232
            N+++         +  IV E    G ++D + K+K  F      ++   V  G+ Y+H+
Sbjct: 81  PNIMKLFEILEDSSSFYIVGELYTGGELFDEIIKRKR-FSEHDAARIIKQVFSGITYMHK 139
Query: 233 NNIIHRDLKTANLLM---DENGVVKVADFGVARVQAQSGVMTAETGTYRWMAPEVIEHKP 289
           +NI+HRDLK  N+L+   +++  +K+ DFG++    Q+  M    GT  ++APEV+    
Sbjct: 140 HNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDRIGTAYYIAPEVL-RGT 198
Query: 290 YDYKADVFSFGIALWELLTGELPYAG 315
           YD K DV+S G+ L+ LL+G  P+ G
Sbjct: 199 YDEKCDVWSAGVILYILLSGTPPFYG 224

>pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294

Iteration: 1
 Score =  105 bits (262), Expect = 4e-23,   Method: Compositional matrix adjust.
 Identities = 71/277 (25%), Positives = 137/277 (49%), Gaps = 18/277 (6%)
Query: 110 VWEIDAKQLKIECKVASGSYGDLY--KGTYCSQEVAIK-VLKPECVNTEMLKEFSQEVYI 166
           + +I  ++ KI  K+  G    +Y  + T  + +VAIK +  P     E LK F +EV+ 
Sbjct: 5   IGKIINERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHN 64
Query: 167 MRKIRHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKG 226
             ++ H+N+V  I          +V E++   ++ +++ +  G   + + +     +  G
Sbjct: 65  SSQLSHQNIVSMIDVDEEDDCYYLVMEYIEGPTLSEYI-ESHGPLSVDTAINFTNQILDG 123
Query: 227 MNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAE--TGTYRWMAPEV 284
           + + H   I+HRD+K  N+L+D N  +K+ DFG+A+  +++ +       GT ++ +PE 
Sbjct: 124 IKHAHDMRIVHRDIKPQNILIDSNKTLKIFDFGIAKALSETSLTQTNHVLGTVQYFSPEQ 183
Query: 285 IEHKPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKS-------LRPTIPKH 337
            + +  D   D++S GI L+E+L GE P+ G T +  A+  +Q S       +R  IP+ 
Sbjct: 184 AKGEATDECTDIYSIGIVLYEMLVGEPPFNGETAVSIAIKHIQDSVPNVTTDVRKDIPQ- 242
Query: 338 AHPRLAELLERCWQHDPTQR-PNFSQITDILKQMMKE 373
               L+ ++ R  + D   R     ++ D L  ++ E
Sbjct: 243 ---SLSNVILRATEKDKANRYKTIQEMKDDLSSVLHE 276

>pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275

Iteration: 1
 Score =  105 bits (262), Expect = 4e-23,   Method: Compositional matrix adjust.
 Identities = 66/245 (26%), Positives = 120/245 (48%), Gaps = 7/245 (2%)
Query: 124 VASGSYGDLYKGTYCSQE--VAIKVL-KPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIG 180
           +  G +G++Y       +  +A+KVL K +     +  +  +EV I   +RH N+++  G
Sbjct: 19  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 78
Query: 181 ACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDL 240
                  + ++ E+   G++Y  L K    F          +++  ++Y H   +IHRD+
Sbjct: 79  YFHDATRVYLILEYAPLGTVYRELQKLSK-FDEQRTATYITELANALSYCHSKRVIHRDI 137
Query: 241 KTANLLMDENGVVKVADFGVARVQAQSGVMTAETGTYRWMAPEVIEHKPYDYKADVFSFG 300
           K  NLL+   G +K+ADFG + V A S   T   GT  ++ PE+IE + +D K D++S G
Sbjct: 138 KPENLLLGSAGELKIADFGWS-VHAPSSRRTTLCGTLDYLPPEMIEGRMHDEKVDLWSLG 196
Query: 301 IALWELLTGELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRLAELLERCWQHDPTQRPNF 360
           +  +E L G+ P+   T  +    + +     T P        +L+ R  +H+P+QRP  
Sbjct: 197 VLCYEFLVGKPPFEANTYQETYKRISRVEF--TFPDFVTEGARDLISRLLKHNPSQRPML 254
Query: 361 SQITD 365
            ++ +
Sbjct: 255 REVLE 259

>pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318

Iteration: 1
 Score =  105 bits (262), Expect = 5e-23,   Method: Compositional matrix adjust.
 Identities = 67/245 (27%), Positives = 123/245 (50%), Gaps = 8/245 (3%)
Query: 116 KQLKIECKVASGSYG--DLYKGTYCSQEVAIKVLKPE-CVNTEMLKEFSQEVYIMRKIRH 172
           +  +I   + +GS+G   L +  +  +  A+KVLK E  V  + ++  + E  ++  + H
Sbjct: 6   QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTH 65
Query: 173 KNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQ 232
             +++  G       + ++ +++  G ++  L K +      +    A +V   + YLH 
Sbjct: 66  PFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAA-EVCLALEYLHS 124
Query: 233 NNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAETGTYRWMAPEVIEHKPYDY 292
            +II+RDLK  N+L+D+NG +K+ DFG A+      V     GT  ++APEV+  KPY+ 
Sbjct: 125 KDIIYRDLKPENILLDKNGHIKITDFGFAKYVPD--VTYXLCGTPDYIAPEVVSTKPYNK 182
Query: 293 KADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRLAELLERCWQH 352
             D +SFGI ++E+L G  P+     ++    ++   LR   P   +  + +LL R    
Sbjct: 183 SIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNAELR--FPPFFNEDVKDLLSRLITR 240
Query: 353 DPTQR 357
           D +QR
Sbjct: 241 DLSQR 245

>pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272

Iteration: 1
 Score =  105 bits (262), Expect = 5e-23,   Method: Compositional matrix adjust.
 Identities = 66/245 (26%), Positives = 120/245 (48%), Gaps = 7/245 (2%)
Query: 124 VASGSYGDLYKGTYCSQE--VAIKVL-KPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIG 180
           +  G +G++Y       +  +A+KVL K +     +  +  +EV I   +RH N+++  G
Sbjct: 20  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 79
Query: 181 ACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDL 240
                  + ++ E+   G++Y  L K    F          +++  ++Y H   +IHRD+
Sbjct: 80  YFHDATRVYLILEYAPLGTVYRELQKLSK-FDEQRTATYITELANALSYCHSKRVIHRDI 138
Query: 241 KTANLLMDENGVVKVADFGVARVQAQSGVMTAETGTYRWMAPEVIEHKPYDYKADVFSFG 300
           K  NLL+   G +K+ADFG + V A S   T   GT  ++ PE+IE + +D K D++S G
Sbjct: 139 KPENLLLGSAGELKIADFGWS-VHAPSSRRTTLCGTLDYLPPEMIEGRMHDEKVDLWSLG 197
Query: 301 IALWELLTGELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRLAELLERCWQHDPTQRPNF 360
           +  +E L G+ P+   T  +    + +     T P        +L+ R  +H+P+QRP  
Sbjct: 198 VLCYEFLVGKPPFEANTYQETYKRISRVEF--TFPDFVTEGARDLISRLLKHNPSQRPML 255
Query: 361 SQITD 365
            ++ +
Sbjct: 256 REVLE 260

>pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267

Iteration: 1
 Score =  105 bits (262), Expect = 5e-23,   Method: Compositional matrix adjust.
 Identities = 66/245 (26%), Positives = 120/245 (48%), Gaps = 7/245 (2%)
Query: 124 VASGSYGDLYKGTYCSQE--VAIKVL-KPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIG 180
           +  G +G++Y       +  +A+KVL K +     +  +  +EV I   +RH N+++  G
Sbjct: 15  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 74
Query: 181 ACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDL 240
                  + ++ E+   G++Y  L K    F          +++  ++Y H   +IHRD+
Sbjct: 75  YFHDATRVYLILEYAPLGTVYRELQKLSK-FDEQRTATYITELANALSYCHSKRVIHRDI 133
Query: 241 KTANLLMDENGVVKVADFGVARVQAQSGVMTAETGTYRWMAPEVIEHKPYDYKADVFSFG 300
           K  NLL+   G +K+ADFG + V A S   T   GT  ++ PE+IE + +D K D++S G
Sbjct: 134 KPENLLLGSAGELKIADFGWS-VHAPSSRRTTLCGTLDYLPPEMIEGRMHDEKVDLWSLG 192
Query: 301 IALWELLTGELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRLAELLERCWQHDPTQRPNF 360
           +  +E L G+ P+   T  +    + +     T P        +L+ R  +H+P+QRP  
Sbjct: 193 VLCYEFLVGKPPFEANTYQETYKRISRVEF--TFPDFVTEGARDLISRLLKHNPSQRPML 250
Query: 361 SQITD 365
            ++ +
Sbjct: 251 REVLE 255

>pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287

Iteration: 1
 Score =  105 bits (261), Expect = 5e-23,   Method: Compositional matrix adjust.
 Identities = 71/269 (26%), Positives = 129/269 (47%), Gaps = 10/269 (3%)
Query: 124 VASGSYGDLYKGTYCSQE--VAIKVL-KPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIG 180
           +  G +G++Y       +  +A+KVL K +     +  +  +EV I   +RH N+++  G
Sbjct: 16  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 75
Query: 181 ACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDL 240
                  + ++ E+   G++Y  L K    F          +++  ++Y H   +IHRD+
Sbjct: 76  YFHDATRVYLILEYAPLGTVYRELQKLSK-FDEQRTATYITELANALSYCHSKRVIHRDI 134
Query: 241 KTANLLMDENGVVKVADFGVARVQAQSGVMTAETGTYRWMAPEVIEHKPYDYKADVFSFG 300
           K  NLL+   G +K+ADFG + V A S   T   GT  ++ PE+IE + +D K D++S G
Sbjct: 135 KPENLLLGSAGELKIADFGWS-VHAPSSRRTDLCGTLDYLPPEMIEGRMHDEKVDLWSLG 193
Query: 301 IALWELLTGELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRLAELLERCWQHDPTQRPNF 360
           +  +E L G+ P+   T  +    + +     T P        +L+ R  +H+P+QRP  
Sbjct: 194 VLCYEFLVGKPPFEANTYQETYKRISRVEF--TFPDFVTEGARDLISRLLKHNPSQRP-- 249
Query: 361 SQITDILKQMMKEVASEGENNHSNKSAGS 389
             + ++L+       S   +N  NK + +
Sbjct: 250 -MLREVLEHPWITANSSKPSNCQNKESAA 277

>pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268

Iteration: 1
 Score =  105 bits (261), Expect = 6e-23,   Method: Compositional matrix adjust.
 Identities = 66/245 (26%), Positives = 120/245 (48%), Gaps = 7/245 (2%)
Query: 124 VASGSYGDLYKGTYCSQE--VAIKVL-KPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIG 180
           +  G +G++Y       +  +A+KVL K +     +  +  +EV I   +RH N+++  G
Sbjct: 16  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 75
Query: 181 ACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDL 240
                  + ++ E+   G++Y  L K    F          +++  ++Y H   +IHRD+
Sbjct: 76  YFHDATRVYLILEYAPLGTVYRELQKLSK-FDEQRTATYITELANALSYCHSKRVIHRDI 134
Query: 241 KTANLLMDENGVVKVADFGVARVQAQSGVMTAETGTYRWMAPEVIEHKPYDYKADVFSFG 300
           K  NLL+   G +K+ADFG + V A S    A  GT  ++ PE+IE + +D K D++S G
Sbjct: 135 KPENLLLGSAGELKIADFGWS-VHAPSSRRAALCGTLDYLPPEMIEGRMHDEKVDLWSLG 193
Query: 301 IALWELLTGELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRLAELLERCWQHDPTQRPNF 360
           +  +E L G+ P+   T  +    + +     T P        +L+ R  +H+P+QRP  
Sbjct: 194 VLCYEFLVGKPPFEANTYQETYKRISRVEF--TFPDFVTEGARDLISRLLKHNPSQRPML 251
Query: 361 SQITD 365
            ++ +
Sbjct: 252 REVLE 256

>pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282

Iteration: 1
 Score =  105 bits (261), Expect = 6e-23,   Method: Compositional matrix adjust.
 Identities = 71/269 (26%), Positives = 129/269 (47%), Gaps = 10/269 (3%)
Query: 124 VASGSYGDLYKGTYCSQE--VAIKVL-KPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIG 180
           +  G +G++Y       +  +A+KVL K +     +  +  +EV I   +RH N+++  G
Sbjct: 18  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 77
Query: 181 ACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDL 240
                  + ++ E+   G++Y  L K    F          +++  ++Y H   +IHRD+
Sbjct: 78  YFHDATRVYLILEYAPLGTVYRELQKLSK-FDEQRTATYITELANALSYCHSKRVIHRDI 136
Query: 241 KTANLLMDENGVVKVADFGVARVQAQSGVMTAETGTYRWMAPEVIEHKPYDYKADVFSFG 300
           K  NLL+   G +K+A+FG + V A S   T   GT  ++ PE+IE + +D K D++S G
Sbjct: 137 KPENLLLGSAGELKIANFGWS-VHAPSSRRTTLCGTLDYLPPEMIEGRMHDEKVDLWSLG 195
Query: 301 IALWELLTGELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRLAELLERCWQHDPTQRPNF 360
           +  +E L G+ P+   T  +    + +     T P        +L+ R  +H+P+QRP  
Sbjct: 196 VLCYEFLVGKPPFEANTYQETYKRISRVEF--TFPDFVTEGARDLISRLLKHNPSQRP-- 251
Query: 361 SQITDILKQMMKEVASEGENNHSNKSAGS 389
             + ++L+       S   +N  NK + S
Sbjct: 252 -MLREVLEHPWITANSSKPSNCQNKESAS 279

>pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275

Iteration: 1
 Score =  105 bits (261), Expect = 6e-23,   Method: Compositional matrix adjust.
 Identities = 66/245 (26%), Positives = 120/245 (48%), Gaps = 7/245 (2%)
Query: 124 VASGSYGDLYKGTYCSQE--VAIKVL-KPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIG 180
           +  G +G++Y       +  +A+KVL K +     +  +  +EV I   +RH N+++  G
Sbjct: 16  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 75
Query: 181 ACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDL 240
                  + ++ E+   G++Y  L K    F          +++  ++Y H   +IHRD+
Sbjct: 76  YFHDATRVYLILEYAPLGTVYRELQKLSK-FDEQRTATYITELANALSYCHSKRVIHRDI 134
Query: 241 KTANLLMDENGVVKVADFGVARVQAQSGVMTAETGTYRWMAPEVIEHKPYDYKADVFSFG 300
           K  NLL+   G +K+ADFG + V A S   T   GT  ++ PE+IE + +D K D++S G
Sbjct: 135 KPENLLLGSAGELKIADFGWS-VHAPSSRRTDLCGTLDYLPPEMIEGRMHDEKVDLWSLG 193
Query: 301 IALWELLTGELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRLAELLERCWQHDPTQRPNF 360
           +  +E L G+ P+   T  +    + +     T P        +L+ R  +H+P+QRP  
Sbjct: 194 VLCYEFLVGKPPFEANTYQETYKRISRVEF--TFPDFVTEGARDLISRLLKHNPSQRPML 251
Query: 361 SQITD 365
            ++ +
Sbjct: 252 REVLE 256

>pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268

Iteration: 1
 Score =  104 bits (260), Expect = 7e-23,   Method: Compositional matrix adjust.
 Identities = 66/245 (26%), Positives = 120/245 (48%), Gaps = 7/245 (2%)
Query: 124 VASGSYGDLYKGTYCSQE--VAIKVL-KPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIG 180
           +  G +G++Y     + +  +A+KVL K +     +  +  +EV I   +RH N+++  G
Sbjct: 16  LGKGKFGNVYLAREKNSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 75
Query: 181 ACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDL 240
                  + ++ E+   G++Y  L K    F          +++  ++Y H   +IHRD+
Sbjct: 76  YFHDSTRVYLILEYAPLGTVYRELQKLSK-FDEQRTATYITELANALSYCHSKKVIHRDI 134
Query: 241 KTANLLMDENGVVKVADFGVARVQAQSGVMTAETGTYRWMAPEVIEHKPYDYKADVFSFG 300
           K  NLL+   G +K+ADFG + V A S    A  GT  ++ PE+IE + +D K D++S G
Sbjct: 135 KPENLLLGSAGELKIADFGWS-VHAPSSRRAALCGTLDYLPPEMIEGRMHDEKVDLWSLG 193
Query: 301 IALWELLTGELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRLAELLERCWQHDPTQRPNF 360
           +  +E L G+ P+   T       + +     T P        +L+ R  +H+P+QRP  
Sbjct: 194 VLCYEFLVGKPPFEANTYQDTYKRISRVEF--TFPDFVTEGARDLISRLLKHNPSQRPML 251
Query: 361 SQITD 365
            ++ +
Sbjct: 252 REVLE 256

>pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287

Iteration: 1
 Score =  104 bits (260), Expect = 7e-23,   Method: Compositional matrix adjust.
 Identities = 63/206 (30%), Positives = 110/206 (53%), Gaps = 7/206 (3%)
Query: 115 AKQLKIECKVASGSYGDLYK--GTYCSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRH 172
           A++  I C +  GS+G++ K       QE A+KV+       +      +EV +++K+ H
Sbjct: 21  AERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDH 80
Query: 173 KNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQ 232
            N+++         +  IV E    G ++D + K+K  F      ++   V  G+ Y+H+
Sbjct: 81  PNIMKLFEILEDSSSFYIVGELYTGGELFDEIIKRKR-FSEHDAARIIKQVFSGITYMHK 139
Query: 233 NNIIHRDLKTANLLM---DENGVVKVADFGVARVQAQSGVMTAETGTYRWMAPEVIEHKP 289
           +NI+HRDLK  N+L+   +++  +K+ DFG++    Q+  M    GT  ++APEV+    
Sbjct: 140 HNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDRIGTAYYIAPEVL-RGT 198
Query: 290 YDYKADVFSFGIALWELLTGELPYAG 315
           YD K DV+S G+ L+ LL+G  P+ G
Sbjct: 199 YDEKCDVWSAGVILYILLSGTPPFYG 224

>pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279

Iteration: 1
 Score =  104 bits (260), Expect = 8e-23,   Method: Compositional matrix adjust.
 Identities = 71/269 (26%), Positives = 128/269 (47%), Gaps = 10/269 (3%)
Query: 124 VASGSYGDLYKGTYCSQE--VAIKVL-KPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIG 180
           +  G +G++Y       +  +A+KVL K +     +  +  +EV I   +RH N+++  G
Sbjct: 17  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 76
Query: 181 ACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDL 240
                  + ++ E+   G++Y  L K    F          +++  ++Y H   +IHRD+
Sbjct: 77  YFHDATRVYLILEYAPLGTVYRELQKLSK-FDEQRTATYITELANALSYCHSKRVIHRDI 135
Query: 241 KTANLLMDENGVVKVADFGVARVQAQSGVMTAETGTYRWMAPEVIEHKPYDYKADVFSFG 300
           K  NLL+   G +K+ADFG + V A S       GT  ++ PE+IE + +D K D++S G
Sbjct: 136 KPENLLLGSAGELKIADFGWS-VHAPSSRRDTLCGTLDYLPPEMIEGRMHDEKVDLWSLG 194
Query: 301 IALWELLTGELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRLAELLERCWQHDPTQRPNF 360
           +  +E L G+ P+   T  +    + +     T P        +L+ R  +H+P+QRP  
Sbjct: 195 VLCYEFLVGKPPFEANTYQETYKRISRVEF--TFPDFVTEGARDLISRLLKHNPSQRP-- 250
Query: 361 SQITDILKQMMKEVASEGENNHSNKSAGS 389
             + ++L+       S   +N  NK + S
Sbjct: 251 -MLREVLEHPWITANSSKPSNCQNKESAS 278

>pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286

Iteration: 1
 Score =  104 bits (260), Expect = 8e-23,   Method: Compositional matrix adjust.
 Identities = 63/206 (30%), Positives = 110/206 (53%), Gaps = 7/206 (3%)
Query: 115 AKQLKIECKVASGSYGDLYK--GTYCSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRH 172
           A++  I C +  GS+G++ K       QE A+KV+       +      +EV +++K+ H
Sbjct: 21  AERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDH 80
Query: 173 KNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQ 232
            N+++         +  IV E    G ++D + K+K  F      ++   V  G+ Y+H+
Sbjct: 81  PNIMKLFEILEDSSSFYIVGELYTGGELFDEIIKRKR-FSEHDAARIIKQVFSGITYMHK 139
Query: 233 NNIIHRDLKTANLLM---DENGVVKVADFGVARVQAQSGVMTAETGTYRWMAPEVIEHKP 289
           +NI+HRDLK  N+L+   +++  +K+ DFG++    Q+  M    GT  ++APEV+    
Sbjct: 140 HNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDRIGTAYYIAPEVL-RGT 198
Query: 290 YDYKADVFSFGIALWELLTGELPYAG 315
           YD K DV+S G+ L+ LL+G  P+ G
Sbjct: 199 YDEKCDVWSAGVILYILLSGTPPFYG 224

>pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282

Iteration: 1
 Score =  104 bits (260), Expect = 8e-23,   Method: Compositional matrix adjust.
 Identities = 71/269 (26%), Positives = 128/269 (47%), Gaps = 10/269 (3%)
Query: 124 VASGSYGDLYKGTYCSQE--VAIKVL-KPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIG 180
           +  G +G++Y       +  +A+KVL K +     +  +  +EV I   +RH N+++  G
Sbjct: 18  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 77
Query: 181 ACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDL 240
                  + ++ E+   G++Y  L K    F          +++  ++Y H   +IHRD+
Sbjct: 78  YFHDATRVYLILEYAPLGTVYRELQKLSK-FDEQRTATYITELANALSYCHSKRVIHRDI 136
Query: 241 KTANLLMDENGVVKVADFGVARVQAQSGVMTAETGTYRWMAPEVIEHKPYDYKADVFSFG 300
           K  NLL+   G +K+ADFG + V A S       GT  ++ PE+IE + +D K D++S G
Sbjct: 137 KPENLLLGSAGELKIADFGWS-VHAPSSRRXXLCGTLDYLPPEMIEGRMHDEKVDLWSLG 195
Query: 301 IALWELLTGELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRLAELLERCWQHDPTQRPNF 360
           +  +E L G+ P+   T  +    + +     T P        +L+ R  +H+P+QRP  
Sbjct: 196 VLCYEFLVGKPPFEANTYQETYKRISRVEF--TFPDFVTEGARDLISRLLKHNPSQRP-- 251
Query: 361 SQITDILKQMMKEVASEGENNHSNKSAGS 389
             + ++L+       S   +N  NK + S
Sbjct: 252 -MLREVLEHPWITANSSKPSNCQNKESAS 279

>pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271

Iteration: 1
 Score =  104 bits (259), Expect = 9e-23,   Method: Compositional matrix adjust.
 Identities = 68/262 (25%), Positives = 126/262 (48%), Gaps = 9/262 (3%)
Query: 107 GTDVWEIDAKQLKIECKVASGSYGDLYKGTYCSQE--VAIKVL-KPECVNTEMLKEFSQE 163
           G+  W ++    +I   +  G +G++Y       +  +A+KVL K +     +  +  +E
Sbjct: 4   GSRQWALE--DFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRRE 61
Query: 164 VYIMRKIRHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDV 223
           V I   +RH N+++  G       + ++ E+   G++Y  L K    F          ++
Sbjct: 62  VEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK-FDEQRTATYITEL 120
Query: 224 SKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAETGTYRWMAPE 283
           +  ++Y H   +IHRD+K  NLL+   G +K+ADFG + V A S       GT  ++ PE
Sbjct: 121 ANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWS-VHAPSSRRDDLCGTLDYLPPE 179
Query: 284 VIEHKPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRLA 343
           +IE + +D K D++S G+  +E L G+ P+   T  +    + +     T P        
Sbjct: 180 MIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEF--TFPDFVTEGAR 237
Query: 344 ELLERCWQHDPTQRPNFSQITD 365
           +L+ R  +H+P+QRP   ++ +
Sbjct: 238 DLISRLLKHNPSQRPMLREVLE 259

>pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290

Iteration: 1
 Score =  104 bits (259), Expect = 1e-22,   Method: Compositional matrix adjust.
 Identities = 74/281 (26%), Positives = 125/281 (44%), Gaps = 36/281 (12%)
Query: 113 IDAKQLKIECKVASGSYGDLYKGTY------CSQEVAIKVLKPECVNTEMLKEFSQEVYI 166
            + + LK   ++  G++G +    Y          VA+K L+      +  ++F +E+ I
Sbjct: 4   FEERHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHS--GPDQQRDFQREIQI 61
Query: 167 MRKIRHKNVVQFIGACTRP--PNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVS 224
           ++ +    +V++ G    P  P L +V E++  G + DFL + +     + LL  +  + 
Sbjct: 62  LKALHSDFIVKYRGVSYGPGRPELRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQIC 121
Query: 225 KGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQA--QSGVMTAETGTYR--WM 280
           KGM YL     +HRDL   N+L++    VK+ADFG+A++    +   +  E G     W 
Sbjct: 122 KGMEYLGSRRCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDXXVVREPGQSPIFWY 181
Query: 281 APEVIEHKPYDYKADVFSFGIALWELLT----GELPYAGLTPLQAAVGVVQKSLR----- 331
           APE +    +  ++DV+SFG+ L+EL T       P A    +      V    R     
Sbjct: 182 APESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGCERDVPALCRLLELL 241
Query: 332 ---------PTIPKHAHPRLAELLERCWQHDPTQRPNFSQI 363
                    P  P   H    EL++ CW   P  RP+FS +
Sbjct: 242 EEGQRLPAPPACPAEVH----ELMKLCWAPSPQDRPSFSAL 278

>pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268

Iteration: 1
 Score =  103 bits (258), Expect = 1e-22,   Method: Compositional matrix adjust.
 Identities = 68/262 (25%), Positives = 125/262 (47%), Gaps = 9/262 (3%)
Query: 107 GTDVWEIDAKQLKIECKVASGSYGDLYKGTYCSQE--VAIKVL-KPECVNTEMLKEFSQE 163
           G   W ++    +I   +  G +G++Y       +  +A+KVL K +     +  +  +E
Sbjct: 1   GKRQWALE--DFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRRE 58
Query: 164 VYIMRKIRHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDV 223
           V I   +RH N+++  G       + ++ E+   G++Y  L K    F          ++
Sbjct: 59  VEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK-FDEQRTATYITEL 117
Query: 224 SKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAETGTYRWMAPE 283
           +  ++Y H   +IHRD+K  NLL+   G +K+ADFG + V A S       GT  ++ PE
Sbjct: 118 ANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWS-VHAPSSRRXXLCGTLDYLPPE 176
Query: 284 VIEHKPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRLA 343
           +IE + +D K D++S G+  +E L G+ P+   T  +    + +     T P        
Sbjct: 177 MIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEF--TFPDFVTEGAR 234
Query: 344 ELLERCWQHDPTQRPNFSQITD 365
           +L+ R  +H+P+QRP   ++ +
Sbjct: 235 DLISRLLKHNPSQRPMLREVLE 256

>pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272

Iteration: 1
 Score =  103 bits (257), Expect = 2e-22,   Method: Compositional matrix adjust.
 Identities = 65/245 (26%), Positives = 120/245 (48%), Gaps = 7/245 (2%)
Query: 124 VASGSYGDLYKGTYCSQE--VAIKVL-KPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIG 180
           +  G +G++Y       +  +A+KVL K +     +  +  +EV I   +RH N+++  G
Sbjct: 19  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 78
Query: 181 ACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDL 240
                  + ++ E+   G++Y  L K    F          +++  ++Y H   +IHRD+
Sbjct: 79  YFHDATRVYLILEYAPLGTVYRELQKLSK-FDEQRTATYITELANALSYCHSKRVIHRDI 137
Query: 241 KTANLLMDENGVVKVADFGVARVQAQSGVMTAETGTYRWMAPEVIEHKPYDYKADVFSFG 300
           K  NLL+   G +K+A+FG + V A S   T   GT  ++ PE+IE + +D K D++S G
Sbjct: 138 KPENLLLGSAGELKIANFGWS-VHAPSSRRTTLCGTLDYLPPEMIEGRMHDEKVDLWSLG 196
Query: 301 IALWELLTGELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRLAELLERCWQHDPTQRPNF 360
           +  +E L G+ P+   T  +    + +     T P        +L+ R  +H+P+QRP  
Sbjct: 197 VLCYEFLVGKPPFEANTYQETYKRISRVEF--TFPDFVTEGARDLISRLLKHNPSQRPML 254
Query: 361 SQITD 365
            ++ +
Sbjct: 255 REVLE 259

>pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349

Iteration: 1
 Score =  103 bits (257), Expect = 2e-22,   Method: Compositional matrix adjust.
 Identities = 76/271 (28%), Positives = 124/271 (45%), Gaps = 27/271 (9%)
Query: 124 VASGSYGDLYKGTYCSQE-VAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGAC 182
           +  G +G +YKG       VA+K LK E      L +F  EV ++    H+N+++  G C
Sbjct: 46  LGRGGFGKVYKGRLADGTLVAVKRLKEERXQGGEL-QFQTEVEMISMAVHRNLLRLRGFC 104
Query: 183 TRPPNLCIVTEFMARGSIYDFLHKQ---KGVFQLTSLLKVAIDVSKGMNYLHQN---NII 236
             P    +V  +MA GS+   L ++   +         ++A+  ++G+ YLH +    II
Sbjct: 105 MTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKII 164
Query: 237 HRDLKTANLLMDENGVVKVADFGVARVQ--AQSGVMTAETGTYRWMAPEVIEHKPYDYKA 294
           HRD+K AN+L+DE     V DFG+A++       V  A  GT   +APE +       K 
Sbjct: 165 HRDVKAANILLDEEFEAVVGDFGLAKLMDYKDXHVXXAVRGTIGHIAPEYLSTGKSSEKT 224
Query: 295 DVFSFGIALWELLTGELPY-----------------AGLTPLQAAVGVVQKSLRPTIPKH 337
           DVF +G+ L EL+TG+  +                  GL   +    +V   L+      
Sbjct: 225 DVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEALVDVDLQGNYKDE 284
Query: 338 AHPRLAELLERCWQHDPTQRPNFSQITDILK 368
              +L ++   C Q  P +RP  S++  +L+
Sbjct: 285 EVEQLIQVALLCTQSSPMERPKMSEVVRMLE 315

>pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306

Iteration: 1
 Score =  103 bits (257), Expect = 2e-22,   Method: Compositional matrix adjust.
 Identities = 71/269 (26%), Positives = 128/269 (47%), Gaps = 10/269 (3%)
Query: 124 VASGSYGDLYKGTYCSQE--VAIKVL-KPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIG 180
           +  G +G++Y       +  +A+KVL K +     +  +  +EV I   +RH N+++  G
Sbjct: 42  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 101
Query: 181 ACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDL 240
                  + ++ E+   G++Y  L K    F          +++  ++Y H   +IHRD+
Sbjct: 102 YFHDATRVYLILEYAPLGTVYRELQKL-SKFDEQRTATYITELANALSYCHSKRVIHRDI 160
Query: 241 KTANLLMDENGVVKVADFGVARVQAQSGVMTAETGTYRWMAPEVIEHKPYDYKADVFSFG 300
           K  NLL+   G +K+ADFG + V A S       GT  ++ PE+IE + +D K D++S G
Sbjct: 161 KPENLLLGSAGELKIADFGWS-VHAPSSRRDDLCGTLDYLPPEMIEGRMHDEKVDLWSLG 219
Query: 301 IALWELLTGELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRLAELLERCWQHDPTQRPNF 360
           +  +E L G+ P+   T  +    + +     T P        +L+ R  +H+P+QRP  
Sbjct: 220 VLCYEFLVGKPPFEANTYQETYKRISRVEF--TFPDFVTEGARDLISRLLKHNPSQRP-- 275
Query: 361 SQITDILKQMMKEVASEGENNHSNKSAGS 389
             + ++L+       S   +N  NK + S
Sbjct: 276 -MLREVLEHPWITANSSKPSNCQNKESAS 303

>pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275

Iteration: 1
 Score =  103 bits (256), Expect = 2e-22,   Method: Compositional matrix adjust.
 Identities = 65/245 (26%), Positives = 119/245 (48%), Gaps = 7/245 (2%)
Query: 124 VASGSYGDLYKGTYCSQE--VAIKVL-KPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIG 180
           +  G +G++Y       +  +A+KVL K +     +  +  +EV I   +RH N+++  G
Sbjct: 19  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 78
Query: 181 ACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDL 240
                  + ++ E+   G++Y  L K    F          +++  ++Y H   +IHRD+
Sbjct: 79  YFHDATRVYLILEYAPLGTVYRELQKLSK-FDEQRTATYITELANALSYCHSKRVIHRDI 137
Query: 241 KTANLLMDENGVVKVADFGVARVQAQSGVMTAETGTYRWMAPEVIEHKPYDYKADVFSFG 300
           K  NLL+   G +K+ADFG + V A S       GT  ++ PE+IE + +D K D++S G
Sbjct: 138 KPENLLLGSAGELKIADFGWS-VHAPSSRRXXLCGTLDYLPPEMIEGRMHDEKVDLWSLG 196
Query: 301 IALWELLTGELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRLAELLERCWQHDPTQRPNF 360
           +  +E L G+ P+   T  +    + +     T P        +L+ R  +H+P+QRP  
Sbjct: 197 VLCYEFLVGKPPFEANTYQETYKRISRVEF--TFPDFVTEGARDLISRLLKHNPSQRPML 254
Query: 361 SQITD 365
            ++ +
Sbjct: 255 REVLE 259

>pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467

Iteration: 1
 Score =  103 bits (256), Expect = 2e-22,   Method: Compositional matrix adjust.
 Identities = 79/257 (30%), Positives = 126/257 (49%), Gaps = 33/257 (12%)
Query: 123 KVASGSYGD--LYKGTYCSQEVAIKVLKPECVNTEMLK-EFSQEVYIMRKIRHKNVVQFI 179
           K+ SG+YG+  L K      E AIK++K   V T         EV +++++ H N+++  
Sbjct: 11  KLGSGAYGEVLLCKDKLTGAERAIKIIKKSSVTTTSNSGALLDEVAVLKQLDHPNIMKLY 70
Query: 180 GACTRPPNLCIVTEFMARGSIYD-FLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHR 238
                  N  +V E    G ++D  + +QK  F       +   V  G  YLH++NI+HR
Sbjct: 71  EFFEDKRNYYLVMEVYRGGELFDEIILRQK--FSEVDAAVIMKQVLSGTTYLHKHNIVHR 128
Query: 239 DLKTANLLMD---ENGVVKVADFGVARVQAQSGVMTAETGTYRWMAPEVIEHKPYDYKAD 295
           DLK  NLL++    + ++K+ DFG++      G M    GT  ++APEV+  K YD K D
Sbjct: 129 DLKPENLLLESKSRDALIKIVDFGLSAHFEVGGKMKERLGTAYYIAPEVL-RKKYDEKCD 187
Query: 296 VFSFGIALWELLTGELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRLAELLERCWQHDPT 355
           V+S G+ L+ LL G  P+ G T  Q  +  V+K                     +  DP 
Sbjct: 188 VWSCGVILYILLCGYPPFGGQTD-QEILKRVEKGK-------------------FSFDP- 226
Query: 356 QRPNFSQITDILKQMMK 372
             P+++Q++D  KQ++K
Sbjct: 227 --PDWTQVSDEAKQLVK 241

>pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326

Iteration: 1
 Score =  102 bits (254), Expect = 3e-22,   Method: Compositional matrix adjust.
 Identities = 75/271 (27%), Positives = 123/271 (45%), Gaps = 27/271 (9%)
Query: 124 VASGSYGDLYKGTYCSQE-VAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGAC 182
           +  G +G +YKG       VA+K LK E      L +F  EV ++    H+N+++  G C
Sbjct: 38  LGRGGFGKVYKGRLADGXLVAVKRLKEERTQGGEL-QFQTEVEMISMAVHRNLLRLRGFC 96
Query: 183 TRPPNLCIVTEFMARGSIYDFLHKQ---KGVFQLTSLLKVAIDVSKGMNYLHQN---NII 236
             P    +V  +MA GS+   L ++   +         ++A+  ++G+ YLH +    II
Sbjct: 97  MTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKII 156
Query: 237 HRDLKTANLLMDENGVVKVADFGVARVQ--AQSGVMTAETGTYRWMAPEVIEHKPYDYKA 294
           HRD+K AN+L+DE     V DFG+A++       V  A  G    +APE +       K 
Sbjct: 157 HRDVKAANILLDEEFEAVVGDFGLAKLMDYKDXHVXXAVRGXIGHIAPEYLSTGKSSEKT 216
Query: 295 DVFSFGIALWELLTGELPY-----------------AGLTPLQAAVGVVQKSLRPTIPKH 337
           DVF +G+ L EL+TG+  +                  GL   +    +V   L+      
Sbjct: 217 DVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEALVDVDLQGNYKDE 276
Query: 338 AHPRLAELLERCWQHDPTQRPNFSQITDILK 368
              +L ++   C Q  P +RP  S++  +L+
Sbjct: 277 EVEQLIQVALLCTQSSPMERPKMSEVVRMLE 307

>pdb|3MY0|A Chain A, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound To Ldn- 193189 Length = 305

Iteration: 1
 Score =  102 bits (254), Expect = 3e-22,   Method: Compositional matrix adjust.
 Identities = 84/302 (27%), Positives = 144/302 (47%), Gaps = 54/302 (17%)
Query: 115 AKQLK-IECKVASGSYGDLYKGTYCSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHK 173
           A+Q+  +EC V  G YG++++G +  + VA+K+        E       E+Y    +RH 
Sbjct: 7   ARQVALVEC-VGKGRYGEVWRGLWHGESVAVKIFSSR---DEQSWFRETEIYNTVLLRHD 62
Query: 174 NVVQFIGACTRPPN----LCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNY 229
           N++ FI +     N    L ++T +   GS+YDFL +Q     L   L++A+  + G+ +
Sbjct: 63  NILGFIASDMTSRNSSTQLWLITHYHEHGSLYDFLQRQTLEPHLA--LRLAVSAACGLAH 120
Query: 230 LH--------QNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVM-----TAETGT 276
           LH        +  I HRD K+ N+L+  N    +AD G+A + +Q             GT
Sbjct: 121 LHVEIFGTQGKPAIAHRDFKSRNVLVKSNLQCCIADLGLAVMHSQGSDYLDIGNNPRVGT 180
Query: 277 YRWMAPEVIEHKPY-----DYK-ADVFSFGIALWELLTGEL----------PYAGLTP-- 318
            R+MAPEV++ +        YK  D+++FG+ LWE+    +          P+  + P  
Sbjct: 181 KRYMAPEVLDEQIRTDCFESYKWTDIWAFGLVLWEIARRTIVNGIVEDYRPPFYDVVPND 240
Query: 319 -----LQAAVGVVQKSLRPTIPKH--AHP---RLAELLERCWQHDPTQRPNFSQITDILK 368
                ++  V V Q++  PTIP    A P    LA+++  CW  +P+ R    +I   L+
Sbjct: 241 PSFEDMKKVVCVDQQT--PTIPNRLAADPVLSGLAQMMRECWYPNPSARLTALRIKKTLQ 298
Query: 369 QM 370
           ++
Sbjct: 299 KI 300

>pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336

Iteration: 1
 Score =  102 bits (254), Expect = 4e-22,   Method: Compositional matrix adjust.
 Identities = 69/246 (28%), Positives = 125/246 (50%), Gaps = 12/246 (4%)
Query: 124 VASGSYGDLYKGTY--CSQEVAIKVLKPECVN-TEMLKEFSQEVYIMRKIRHKNVVQFIG 180
           +  GS+G +   T+    Q+VA+K +  + +  ++M     +E+  ++ +RH ++++   
Sbjct: 17  LGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYD 76
Query: 181 ACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDL 240
             T P ++ +V E+ A G ++D++ ++K + +     +    +   + Y H++ I+HRDL
Sbjct: 77  VITTPTDIVMVIEY-AGGELFDYIVEKKRMTEDEGR-RFFQQIICAIEYCHRHKIVHRDL 134
Query: 241 KTANLLMDENGVVKVADFGVARVQAQSGVMTAETGTYRWMAPEVIEHKPY-DYKADVFSF 299
           K  NLL+D+N  VK+ADFG++ +      +    G+  + APEVI  K Y   + DV+S 
Sbjct: 135 KPENLLLDDNLNVKIADFGLSNIMTDGNFLKTSCGSPNYAAPEVINGKLYAGPEVDVWSC 194
Query: 300 GIALWELLTGELPYAG--LTPLQAAVGVVQKSLRPTIPKHAHPRLAELLERCWQHDPTQR 357
           GI L+ +L G LP+    +  L   V     S    +P    P    L+ R    DP QR
Sbjct: 195 GIVLYVMLVGRLPFDDEFIPNLFKKVN----SCVYVMPDFLSPGAQSLIRRMIVADPMQR 250
Query: 358 PNFSQI 363
               +I
Sbjct: 251 ITIQEI 256

>pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287

Iteration: 1
 Score =  102 bits (254), Expect = 4e-22,   Method: Compositional matrix adjust.
 Identities = 79/257 (30%), Positives = 126/257 (49%), Gaps = 33/257 (12%)
Query: 123 KVASGSYGD--LYKGTYCSQEVAIKVLKPECVNTEMLK-EFSQEVYIMRKIRHKNVVQFI 179
           K+ SG+YG+  L K      E AIK++K   V T         EV +++++ H N+++  
Sbjct: 28  KLGSGAYGEVLLCKDKLTGAERAIKIIKKSSVTTTSNSGALLDEVAVLKQLDHPNIMKLY 87
Query: 180 GACTRPPNLCIVTEFMARGSIYD-FLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHR 238
                  N  +V E    G ++D  + +QK  F       +   V  G  YLH++NI+HR
Sbjct: 88  EFFEDKRNYYLVMEVYRGGELFDEIILRQK--FSEVDAAVIMKQVLSGTTYLHKHNIVHR 145
Query: 239 DLKTANLLMD---ENGVVKVADFGVARVQAQSGVMTAETGTYRWMAPEVIEHKPYDYKAD 295
           DLK  NLL++    + ++K+ DFG++      G M    GT  ++APEV+  K YD K D
Sbjct: 146 DLKPENLLLESKSRDALIKIVDFGLSAHFEVGGKMKERLGTAYYIAPEVL-RKKYDEKCD 204
Query: 296 VFSFGIALWELLTGELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRLAELLERCWQHDPT 355
           V+S G+ L+ LL G  P+ G T  Q  +  V+K                     +  DP 
Sbjct: 205 VWSCGVILYILLCGYPPFGGQTD-QEILKRVEKGK-------------------FSFDP- 243
Query: 356 QRPNFSQITDILKQMMK 372
             P+++Q++D  KQ++K
Sbjct: 244 --PDWTQVSDEAKQLVK 258

>pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304

Iteration: 1
 Score =  102 bits (253), Expect = 5e-22,   Method: Compositional matrix adjust.
 Identities = 66/250 (26%), Positives = 123/250 (49%), Gaps = 9/250 (3%)
Query: 114 DAKQLKIECKVASGSYGDLY-----KGTYCSQEVAIKVLKPECVNTEMLKEFSQEVYIMR 168
           D  Q ++   +  GS+G ++      G+   Q  A+KVLK   +          E  I+ 
Sbjct: 22  DPSQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILV 81
Query: 169 KIRHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMN 228
           ++ H  +V+   A      L ++ +F+  G ++  L K+  +F    +     +++  ++
Sbjct: 82  EVNHPFIVKLHYAFQTEGKLYLILDFLRGGDLFTRLSKEV-MFTEEDVKFYLAELALALD 140
Query: 229 YLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQA-QSGVMTAETGTYRWMAPEVIEH 287
           +LH   II+RDLK  N+L+DE G +K+ DFG+++          +  GT  +MAPEV+  
Sbjct: 141 HLHSLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYSFCGTVEYMAPEVVNR 200
Query: 288 KPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRLAELLE 347
           + +   AD +SFG+ ++E+LTG LP+ G    +    +++  L   +P+   P    LL 
Sbjct: 201 RGHTQSADWWSFGVLMFEMLTGTLPFQGKDRKETMTMILKAKL--GMPQFLSPEAQSLLR 258
Query: 348 RCWQHDPTQR 357
             ++ +P  R
Sbjct: 259 MLFKRNPANR 268

>pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305

Iteration: 1
 Score =  102 bits (253), Expect = 6e-22,   Method: Compositional matrix adjust.
 Identities = 66/250 (26%), Positives = 123/250 (49%), Gaps = 9/250 (3%)
Query: 114 DAKQLKIECKVASGSYGDLY-----KGTYCSQEVAIKVLKPECVNTEMLKEFSQEVYIMR 168
           D  Q ++   +  GS+G ++      G+   Q  A+KVLK   +          E  I+ 
Sbjct: 23  DPSQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILV 82
Query: 169 KIRHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMN 228
           ++ H  +V+   A      L ++ +F+  G ++  L K+  +F    +     +++  ++
Sbjct: 83  EVNHPFIVKLHYAFQTEGKLYLILDFLRGGDLFTRLSKEV-MFTEEDVKFYLAELALALD 141
Query: 229 YLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQA-QSGVMTAETGTYRWMAPEVIEH 287
           +LH   II+RDLK  N+L+DE G +K+ DFG+++          +  GT  +MAPEV+  
Sbjct: 142 HLHSLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYSFCGTVEYMAPEVVNR 201
Query: 288 KPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRLAELLE 347
           + +   AD +SFG+ ++E+LTG LP+ G    +    +++  L   +P+   P    LL 
Sbjct: 202 RGHTQSADWWSFGVLMFEMLTGTLPFQGKDRKETMTMILKAKL--GMPQFLSPEAQSLLR 259
Query: 348 RCWQHDPTQR 357
             ++ +P  R
Sbjct: 260 MLFKRNPANR 269

>pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325

Iteration: 1
 Score =  101 bits (252), Expect = 6e-22,   Method: Compositional matrix adjust.
 Identities = 66/250 (26%), Positives = 123/250 (49%), Gaps = 9/250 (3%)
Query: 114 DAKQLKIECKVASGSYGDLY-----KGTYCSQEVAIKVLKPECVNTEMLKEFSQEVYIMR 168
           D  Q ++   +  GS+G ++      G+   Q  A+KVLK   +          E  I+ 
Sbjct: 22  DPSQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILV 81
Query: 169 KIRHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMN 228
           ++ H  +V+   A      L ++ +F+  G ++  L K+  +F    +     +++  ++
Sbjct: 82  EVNHPFIVKLHYAFQTEGKLYLILDFLRGGDLFTRLSKEV-MFTEEDVKFYLAELALALD 140
Query: 229 YLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQA-QSGVMTAETGTYRWMAPEVIEH 287
           +LH   II+RDLK  N+L+DE G +K+ DFG+++          +  GT  +MAPEV+  
Sbjct: 141 HLHSLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYSFCGTVEYMAPEVVNR 200
Query: 288 KPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRLAELLE 347
           + +   AD +SFG+ ++E+LTG LP+ G    +    +++  L   +P+   P    LL 
Sbjct: 201 RGHTQSADWWSFGVLMFEMLTGTLPFQGKDRKETMTMILKAKL--GMPQFLSPEAQSLLR 258
Query: 348 RCWQHDPTQR 357
             ++ +P  R
Sbjct: 259 MLFKRNPANR 268

>pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328

Iteration: 1
 Score =  101 bits (252), Expect = 7e-22,   Method: Compositional matrix adjust.
 Identities = 59/200 (29%), Positives = 106/200 (53%), Gaps = 4/200 (2%)
Query: 119 KIECKVASGSYGD--LYKGTYCSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVV 176
           +++  +  G++    L +     +EVA+K++    +N   L++  +EV IM+ + H N+V
Sbjct: 18  RLQKTIGKGNFAKVKLARHVLTGREVAVKIIDKTQLNPTSLQKLFREVRIMKILNHPNIV 77
Query: 177 QFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNII 236
           +          L +V E+ + G ++D+L     + +  +  K    VS  + Y HQ  I+
Sbjct: 78  KLFEVIETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFRQIVS-AVQYCHQKYIV 136
Query: 237 HRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAETGTYRWMAPEVIEHKPYDY-KAD 295
           HRDLK  NLL+D +  +K+ADFG +        +    G+  + APE+ + K YD  + D
Sbjct: 137 HRDLKAENLLLDGDMNIKIADFGFSNEFTVGNKLDTFCGSPPYAAPELFQGKKYDGPEVD 196
Query: 296 VFSFGIALWELLTGELPYAG 315
           V+S G+ L+ L++G LP+ G
Sbjct: 197 VWSLGVILYTLVSGSLPFDG 216

>pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272

Iteration: 1
 Score =  101 bits (251), Expect = 9e-22,   Method: Compositional matrix adjust.
 Identities = 65/245 (26%), Positives = 119/245 (48%), Gaps = 7/245 (2%)
Query: 124 VASGSYGDLYKGTYCSQE--VAIKVL-KPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIG 180
           +  G +G++Y       +  +A+KVL K +     +  +  +EV I   +RH N+++  G
Sbjct: 20  LGKGKFGNVYLARERQSKFILALKVLFKTQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 79
Query: 181 ACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDL 240
                  + ++ E+   G++Y  L K    F          +++  ++Y H   +IHRD+
Sbjct: 80  YFHDATRVYLILEYAPLGTVYRELQKL-SRFDEQRTATYITELANALSYCHSKRVIHRDI 138
Query: 241 KTANLLMDENGVVKVADFGVARVQAQSGVMTAETGTYRWMAPEVIEHKPYDYKADVFSFG 300
           K  NLL+  NG +K+ADFG + V A S   T   GT  ++ PE+IE + +D K D++S G
Sbjct: 139 KPENLLLGSNGELKIADFGWS-VHAPSSRRTTLCGTLDYLPPEMIEGRMHDEKVDLWSLG 197
Query: 301 IALWELLTGELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRLAELLERCWQHDPTQRPNF 360
           +  +E L G  P+   T  +    + +     T P        +L+ R  +H+ +QR   
Sbjct: 198 VLCYEFLVGMPPFEAHTYQETYRRISRVEF--TFPDFVTEGARDLISRLLKHNASQRLTL 255
Query: 361 SQITD 365
           +++ +
Sbjct: 256 AEVLE 260

>pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314

Iteration: 1
 Score =  100 bits (250), Expect = 1e-21,   Method: Compositional matrix adjust.
 Identities = 77/301 (25%), Positives = 133/301 (44%), Gaps = 38/301 (12%)
Query: 113 IDAKQLKIECKVASGSYGDLYKGTY------CSQEVAIKVLKPECVNTEMLKEFSQEVYI 166
            + + LK   ++  G++G +    Y          VA+K L+      +  ++F +E+ I
Sbjct: 7   FEERHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHS--GPDQQRDFQREIQI 64
Query: 167 MRKIRHKNVVQFIGACTRP--PNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVS 224
           ++ +    +V++ G    P   +L +V E++  G + DFL + +     + LL  +  + 
Sbjct: 65  LKALHSDFIVKYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQIC 124
Query: 225 KGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQA--QSGVMTAETGTYR--WM 280
           KGM YL     +HRDL   N+L++    VK+ADFG+A++    +   +  E G     W 
Sbjct: 125 KGMEYLGSRRCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQSPIFWY 184
Query: 281 APEVIEHKPYDYKADVFSFGIALWELLT-----------------GELPYAGLTPLQAAV 323
           APE +    +  ++DV+SFG+ L+EL T                  E     L+ L   +
Sbjct: 185 APESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGSERDVPALSRLLELL 244
Query: 324 GVVQK-SLRPTIPKHAHPRLAELLERCWQHDPTQRPNFSQITDILKQMMKEVASEGENNH 382
              Q+    P  P   H    EL++ CW   P  RP+FS +   L  +     S G   H
Sbjct: 245 EEGQRLPAPPACPAEVH----ELMKLCWAPSPQDRPSFSALGPQLDMLWS--GSRGCETH 298
Query: 383 S 383
           +
Sbjct: 299 A 299

>pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315

Iteration: 1
 Score =  100 bits (250), Expect = 1e-21,   Method: Compositional matrix adjust.
 Identities = 77/301 (25%), Positives = 131/301 (43%), Gaps = 38/301 (12%)
Query: 113 IDAKQLKIECKVASGSYGDLYKGTY------CSQEVAIKVLKPECVNTEMLKEFSQEVYI 166
            + + LK   ++  G++G +    Y          VA+K L+      +  ++F +E+ I
Sbjct: 8   FEERHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHS--GPDQQRDFQREIQI 65
Query: 167 MRKIRHKNVVQFIGACTRP--PNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVS 224
           ++ +    +V++ G    P   +L +V E++  G + DFL + +     + LL  +  + 
Sbjct: 66  LKALHSDFIVKYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQIC 125
Query: 225 KGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQA--QSGVMTAETGTYR--WM 280
           KGM YL     +HRDL   N+L++    VK+ADFG+A++    +   +  E G     W 
Sbjct: 126 KGMEYLGSRRCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQSPIFWY 185
Query: 281 APEVIEHKPYDYKADVFSFGIALWELLT----GELPYAGLTPLQAAVGVVQKSLR----- 331
           APE +    +  ++DV+SFG+ L+EL T       P A    +      V    R     
Sbjct: 186 APESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGCERDVPALCRLLELL 245
Query: 332 ---------PTIPKHAHPRLAELLERCWQHDPTQRPNFSQITDILKQMMKEVASEGENNH 382
                    P  P   H    EL++ CW   P  RP+FS +   L  +     S G   H
Sbjct: 246 EEGQRLPAPPACPAEVH----ELMKLCWAPSPQDRPSFSALGPQLDMLWS--GSRGCETH 299
Query: 383 S 383
           +
Sbjct: 300 A 300

>pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327

Iteration: 1
 Score =  100 bits (248), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 77/301 (25%), Positives = 131/301 (43%), Gaps = 38/301 (12%)
Query: 113 IDAKQLKIECKVASGSYGDLYKGTY------CSQEVAIKVLKPECVNTEMLKEFSQEVYI 166
            + + LK   ++  G++G +    Y          VA+K L+      +  ++F +E+ I
Sbjct: 20  FEERHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHS--GPDQQRDFQREIQI 77
Query: 167 MRKIRHKNVVQFIGACTRP--PNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVS 224
           ++ +    +V++ G    P   +L +V E++  G + DFL + +     + LL  +  + 
Sbjct: 78  LKALHSDFIVKYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQIC 137
Query: 225 KGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQA--QSGVMTAETGTYR--WM 280
           KGM YL     +HRDL   N+L++    VK+ADFG+A++    +   +  E G     W 
Sbjct: 138 KGMEYLGSRRCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQSPIFWY 197
Query: 281 APEVIEHKPYDYKADVFSFGIALWELLT----GELPYAGLTPLQAAVGVVQKSLR----- 331
           APE +    +  ++DV+SFG+ L+EL T       P A    +      V    R     
Sbjct: 198 APESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGCERDVPALSRLLELL 257
Query: 332 ---------PTIPKHAHPRLAELLERCWQHDPTQRPNFSQITDILKQMMKEVASEGENNH 382
                    P  P   H    EL++ CW   P  RP+FS +   L  +     S G   H
Sbjct: 258 EEGQRLPAPPACPAEVH----ELMKLCWAPSPQDRPSFSALGPQLDMLWS--GSRGCETH 311
Query: 383 S 383
           +
Sbjct: 312 A 312

>pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290

Iteration: 1
 Score =  100 bits (248), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 76/254 (29%), Positives = 124/254 (48%), Gaps = 13/254 (5%)
Query: 114 DAKQLKIECKVASGSYGDLYKG--TYCSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIR 171
           D + LK + ++  GS+  +YKG  T  + EVA   L+   +     + F +E   ++ ++
Sbjct: 24  DGRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEXLKGLQ 83
Query: 172 HKNVVQFIGA--CTRPPNLCIV--TEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGM 227
           H N+V+F  +   T     CIV  TE    G++  +L + K V ++  L      + KG+
Sbjct: 84  HPNIVRFYDSWESTVKGKKCIVLVTELXTSGTLKTYLKRFK-VXKIKVLRSWCRQILKGL 142
Query: 228 NYLHQNN--IIHRDLKTANLLMD-ENGVVKVADFGVARVQAQSGVMTAETGTYRWMAPEV 284
            +LH     IIHRDLK  N+ +    G VK+ D G+A ++ ++    A  GT  + APE 
Sbjct: 143 QFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLK-RASFAKAVIGTPEFXAPEX 201
Query: 285 IEHKPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKSLRP-TIPKHAHPRLA 343
            E K YD   DV++FG    E  T E PY+           V   ++P +  K A P + 
Sbjct: 202 YEEK-YDESVDVYAFGXCXLEXATSEYPYSECQNAAQIYRRVTSGVKPASFDKVAIPEVK 260
Query: 344 ELLERCWQHDPTQR 357
           E++E C + +  +R
Sbjct: 261 EIIEGCIRQNKDER 274

>pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476

Iteration: 1
 Score =  100 bits (248), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 61/246 (24%), Positives = 130/246 (52%), Gaps = 13/246 (5%)
Query: 127 GSYGDLYKGTY--CSQEVAIKVLKPECVNT-EMLKEFSQEVYIMRKIRHKNVVQFIGACT 183
           G++G +  G +     +VA+K+L  + + + +++ +  +E+  ++  RH ++++     +
Sbjct: 27  GTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQVIS 86
Query: 184 RPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTA 243
            P ++ +V E+++ G ++D++ K  G        ++   +  G++Y H++ ++HRDLK  
Sbjct: 87  TPSDIFMVMEYVSGGELFDYICKN-GRLDEKESRRLFQQILSGVDYCHRHMVVHRDLKPE 145
Query: 244 NLLMDENGVVKVADFGVARVQAQSGVMTAETGTYRWMAPEVIEHKPY-DYKADVFSFGIA 302
           N+L+D +   K+ADFG++ + +    +    G+  + APEVI  + Y   + D++S G+ 
Sbjct: 146 NVLLDAHMNAKIADFGLSNMMSDGEFLRXSCGSPNYAAPEVISGRLYAGPEVDIWSSGVI 205
Query: 303 LWELLTGELPYAGLTPLQAAVGVVQKSLRPTI---PKHAHPRLAELLERCWQHDPTQRPN 359
           L+ LL G LP+         V  + K +   I   P++ +P +  LL+   Q DP +R  
Sbjct: 206 LYALLCGTLPFD-----DDHVPTLFKKICDGIFYTPQYLNPSVISLLKHMLQVDPMKRAT 260
Query: 360 FSQITD 365
              I +
Sbjct: 261 IKDIRE 266

>pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350

Iteration: 1
 Score = 99.8 bits (247), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 71/238 (29%), Positives = 119/238 (50%), Gaps = 10/238 (4%)
Query: 124 VASGSYGD--LYKGTYCSQEVAIKVL-KPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIG 180
           + +GS+G   L K        A+K+L K + V  + ++    E  I++ +    +V+   
Sbjct: 49  IGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEF 108
Query: 181 ACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDL 240
           +     NL +V E+M  G ++  L ++ G F        A  +     YLH  ++I+RDL
Sbjct: 109 SFKDNSNLYMVMEYMPGGDMFSHL-RRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDL 167
Query: 241 KTANLLMDENGVVKVADFGVA-RVQAQSGVMTAETGTYRWMAPEVIEHKPYDYKADVFSF 299
           K  NLL+D+ G +KVADFG A RV+ ++  +    GT  ++APE+I  K Y+   D ++ 
Sbjct: 168 KPENLLIDQQGYIKVADFGFAKRVKGRTWXL---CGTPEYLAPEIILSKGYNKAVDWWAL 224
Query: 300 GIALWELLTGELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRLAELLERCWQHDPTQR 357
           G+ ++E+  G  P+    P+Q    +V   +R   P H    L +LL    Q D T+R
Sbjct: 225 GVLIYEMAAGYPPFFADQPIQIYEKIVSGKVR--FPSHFSSDLKDLLRNLLQVDLTKR 280

>pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276

Iteration: 1
 Score = 99.8 bits (247), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 61/249 (24%), Positives = 132/249 (53%), Gaps = 13/249 (5%)
Query: 124 VASGSYGDLYKGTY--CSQEVAIKVLKPECVNT-EMLKEFSQEVYIMRKIRHKNVVQFIG 180
           +  G++G +  G +     +VA+K+L  + + + +++ +  +E+  ++  RH ++++   
Sbjct: 19  LGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQ 78
Query: 181 ACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDL 240
             + P +  +V E+++ G ++D++ K   V ++ +  ++   +   ++Y H++ ++HRDL
Sbjct: 79  VISTPTDFFMVMEYVSGGELFDYICKHGRVEEMEAR-RLFQQILSAVDYCHRHMVVHRDL 137
Query: 241 KTANLLMDENGVVKVADFGVARVQAQSGVMTAETGTYRWMAPEVIEHKPY-DYKADVFSF 299
           K  N+L+D +   K+ADFG++ + +    +    G+  + APEVI  + Y   + D++S 
Sbjct: 138 KPENVLLDAHMNAKIADFGLSNMMSDGEFLRTSCGSPNYAAPEVISGRLYAGPEVDIWSC 197
Query: 300 GIALWELLTGELPYAGLTPLQAAVGVVQKSLRP---TIPKHAHPRLAELLERCWQHDPTQ 356
           G+ L+ LL G LP+         V  + K +R     IP++ +  +A LL    Q DP +
Sbjct: 198 GVILYALLCGTLPFD-----DEHVPTLFKKIRGGVFYIPEYLNRSVATLLMHMLQVDPLK 252
Query: 357 RPNFSQITD 365
           R     I +
Sbjct: 253 RATIKDIRE 261

>pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350

Iteration: 1
 Score = 99.8 bits (247), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 71/238 (29%), Positives = 119/238 (50%), Gaps = 10/238 (4%)
Query: 124 VASGSYGD--LYKGTYCSQEVAIKVL-KPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIG 180
           + +GS+G   L K        A+K+L K + V  + ++    E  I++ +    +V+   
Sbjct: 49  IGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEF 108
Query: 181 ACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDL 240
           +     NL +V E+M  G ++  L ++ G F        A  +     YLH  ++I+RDL
Sbjct: 109 SFKDNSNLYMVMEYMPGGDMFSHL-RRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDL 167
Query: 241 KTANLLMDENGVVKVADFGVA-RVQAQSGVMTAETGTYRWMAPEVIEHKPYDYKADVFSF 299
           K  NLL+D+ G +KVADFG A RV+ ++  +    GT  ++APE+I  K Y+   D ++ 
Sbjct: 168 KPENLLIDQQGYIKVADFGFAKRVKGRTWXL---CGTPEYLAPEIILSKGYNKAVDWWAL 224
Query: 300 GIALWELLTGELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRLAELLERCWQHDPTQR 357
           G+ ++E+  G  P+    P+Q    +V   +R   P H    L +LL    Q D T+R
Sbjct: 225 GVLIYEMAAGYPPFFADQPIQIYEKIVSGKVR--FPSHFSSDLKDLLRNLLQVDLTKR 280

>pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276

Iteration: 1
 Score = 99.4 bits (246), Expect = 3e-21,   Method: Compositional matrix adjust.
 Identities = 61/249 (24%), Positives = 132/249 (53%), Gaps = 13/249 (5%)
Query: 124 VASGSYGDLYKGTY--CSQEVAIKVLKPECVNT-EMLKEFSQEVYIMRKIRHKNVVQFIG 180
           +  G++G +  G +     +VA+K+L  + + + +++ +  +E+  ++  RH ++++   
Sbjct: 19  LGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQ 78
Query: 181 ACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDL 240
             + P +  +V E+++ G ++D++ K   V ++ +  ++   +   ++Y H++ ++HRDL
Sbjct: 79  VISTPTDFFMVMEYVSGGELFDYICKHGRVEEMEAR-RLFQQILSAVDYCHRHMVVHRDL 137
Query: 241 KTANLLMDENGVVKVADFGVARVQAQSGVMTAETGTYRWMAPEVIEHKPY-DYKADVFSF 299
           K  N+L+D +   K+ADFG++ + +    +    G+  + APEVI  + Y   + D++S 
Sbjct: 138 KPENVLLDAHMNAKIADFGLSNMMSDGEFLRDSCGSPNYAAPEVISGRLYAGPEVDIWSC 197
Query: 300 GIALWELLTGELPYAGLTPLQAAVGVVQKSLRP---TIPKHAHPRLAELLERCWQHDPTQ 356
           G+ L+ LL G LP+         V  + K +R     IP++ +  +A LL    Q DP +
Sbjct: 198 GVILYALLCGTLPFD-----DEHVPTLFKKIRGGVFYIPEYLNRSVATLLMHMLQVDPLK 252
Query: 357 RPNFSQITD 365
           R     I +
Sbjct: 253 RATIKDIRE 261

>pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272

Iteration: 1
 Score = 99.0 bits (245), Expect = 4e-21,   Method: Compositional matrix adjust.
 Identities = 64/245 (26%), Positives = 118/245 (48%), Gaps = 7/245 (2%)
Query: 124 VASGSYGDLYKGTYCSQE--VAIKVL-KPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIG 180
           +  G +G++Y       +  +A+KVL K +     +  +  +EV I   +RH N+++  G
Sbjct: 20  LGKGKFGNVYLARERQSKFILALKVLFKTQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 79
Query: 181 ACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDL 240
                  + ++ E+   G++Y  L K    F          +++  ++Y H   +IHRD+
Sbjct: 80  YFHDATRVYLILEYAPLGTVYRELQKL-SRFDEQRTATYITELANALSYCHSKRVIHRDI 138
Query: 241 KTANLLMDENGVVKVADFGVARVQAQSGVMTAETGTYRWMAPEVIEHKPYDYKADVFSFG 300
           K  NLL+  NG +K+ADFG + V A S       GT  ++ PE+IE + +D K D++S G
Sbjct: 139 KPENLLLGSNGELKIADFGWS-VHAPSSRRDTLCGTLDYLPPEMIEGRMHDEKVDLWSLG 197
Query: 301 IALWELLTGELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRLAELLERCWQHDPTQRPNF 360
           +  +E L G  P+   T  +    + +     T P        +L+ R  +H+ +QR   
Sbjct: 198 VLCYEFLVGMPPFEAHTYQETYRRISRVEF--TFPDFVTEGARDLISRLLKHNASQRLTL 255
Query: 361 SQITD 365
           +++ +
Sbjct: 256 AEVLE 260

>pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334

Iteration: 1
 Score = 99.0 bits (245), Expect = 4e-21,   Method: Compositional matrix adjust.
 Identities = 61/217 (28%), Positives = 111/217 (51%), Gaps = 11/217 (5%)
Query: 106 DGTDVWEIDAKQLK--IECKVASGSYGDLYKGTYCSQEVAIKVLKPECVNTEMLK----E 159
           + +  W+  A+ +K   E K   G+ G   +     ++   K+   +C+  + LK     
Sbjct: 8   ESSSSWKKQAEDIKKIFEFKETLGT-GAFSEVVLAEEKATGKLFAVKCIPKKALKGKESS 66
Query: 160 FSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKV 219
              E+ ++RKI+H+N+V        P +L +V + ++ G ++D +  +KG +       +
Sbjct: 67  IENEIAVLRKIKHENIVALEDIYESPNHLYLVMQLVSGGELFDRI-VEKGFYTEKDASTL 125
Query: 220 AIDVSKGMNYLHQNNIIHRDLKTANLL---MDENGVVKVADFGVARVQAQSGVMTAETGT 276
              V   + YLH+  I+HRDLK  NLL    DE   + ++DFG+++++ +  VM+   GT
Sbjct: 126 IRQVLDAVYYLHRMGIVHRDLKPENLLYYSQDEESKIMISDFGLSKMEGKGDVMSTACGT 185
Query: 277 YRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPY 313
             ++APEV+  KPY    D +S G+  + LL G  P+
Sbjct: 186 PGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPF 222

>pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317

Iteration: 1
 Score = 99.0 bits (245), Expect = 5e-21,   Method: Compositional matrix adjust.
 Identities = 58/207 (28%), Positives = 108/207 (52%), Gaps = 4/207 (1%)
Query: 158 KEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLL 217
           ++ S E+ I + + + +VV F G       + +V E   R S+ + LHK++         
Sbjct: 87  EKMSTEIAIHKSLDNPHVVGFHGFFEDDDFVYVVLEICRRRSLLE-LHKRRKAVTEPEAR 145
Query: 218 KVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVA-RVQAQSGVMTAETGT 276
                  +G+ YLH N +IHRDLK  NL ++++  VK+ DFG+A +++          GT
Sbjct: 146 YFMRQTIQGVQYLHNNRVIHRDLKLGNLFLNDDMDVKIGDFGLATKIEFDGERKKTLCGT 205
Query: 277 YRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKSLRPTIPK 336
             ++APEV+  K + ++ D++S G  L+ LL G+ P+      +  + + +     ++P+
Sbjct: 206 PNYIAPEVLCKKGHSFEVDIWSLGCILYTLLVGKPPFETSCLKETYIRIKKNEY--SVPR 263
Query: 337 HAHPRLAELLERCWQHDPTQRPNFSQI 363
           H +P  + L+ R    DPT RP+ +++
Sbjct: 264 HINPVASALIRRMLHADPTLRPSVAEL 290

>pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317

Iteration: 1
 Score = 98.6 bits (244), Expect = 5e-21,   Method: Compositional matrix adjust.
 Identities = 58/207 (28%), Positives = 108/207 (52%), Gaps = 4/207 (1%)
Query: 158 KEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLL 217
           ++ S E+ I + + + +VV F G       + +V E   R S+ + LHK++         
Sbjct: 87  EKMSTEIAIHKSLDNPHVVGFHGFFEDDDFVYVVLEICRRRSLLE-LHKRRKAVTEPEAR 145
Query: 218 KVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVA-RVQAQSGVMTAETGT 276
                  +G+ YLH N +IHRDLK  NL ++++  VK+ DFG+A +++          GT
Sbjct: 146 YFMRQTIQGVQYLHNNRVIHRDLKLGNLFLNDDMDVKIGDFGLATKIEFDGERKKXLCGT 205
Query: 277 YRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKSLRPTIPK 336
             ++APEV+  K + ++ D++S G  L+ LL G+ P+      +  + + +     ++P+
Sbjct: 206 PNYIAPEVLCKKGHSFEVDIWSLGCILYTLLVGKPPFETSCLKETYIRIKKNEY--SVPR 263
Query: 337 HAHPRLAELLERCWQHDPTQRPNFSQI 363
           H +P  + L+ R    DPT RP+ +++
Sbjct: 264 HINPVASALIRRMLHADPTLRPSVAEL 290

>pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301

Iteration: 1
 Score = 98.6 bits (244), Expect = 6e-21,   Method: Compositional matrix adjust.
 Identities = 58/207 (28%), Positives = 108/207 (52%), Gaps = 4/207 (1%)
Query: 158 KEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLL 217
           ++ S E+ I + + + +VV F G       + +V E   R S+ + LHK++         
Sbjct: 71  EKMSTEIAIHKSLDNPHVVGFHGFFEDDDFVYVVLEICRRRSLLE-LHKRRKAVTEPEAR 129
Query: 218 KVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVA-RVQAQSGVMTAETGT 276
                  +G+ YLH N +IHRDLK  NL ++++  VK+ DFG+A +++          GT
Sbjct: 130 YFMRQTIQGVQYLHNNRVIHRDLKLGNLFLNDDMDVKIGDFGLATKIEFDGERKKDLCGT 189
Query: 277 YRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKSLRPTIPK 336
             ++APEV+  K + ++ D++S G  L+ LL G+ P+      +  + + +     ++P+
Sbjct: 190 PNYIAPEVLCKKGHSFEVDIWSLGCILYTLLVGKPPFETSCLKETYIRIKKNEY--SVPR 247
Query: 337 HAHPRLAELLERCWQHDPTQRPNFSQI 363
           H +P  + L+ R    DPT RP+ +++
Sbjct: 248 HINPVASALIRRMLHADPTLRPSVAEL 274

>pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317

Iteration: 1
 Score = 98.2 bits (243), Expect = 7e-21,   Method: Compositional matrix adjust.
 Identities = 58/207 (28%), Positives = 108/207 (52%), Gaps = 4/207 (1%)
Query: 158 KEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLL 217
           ++ S E+ I + + + +VV F G       + +V E   R S+ + LHK++         
Sbjct: 87  EKMSTEIAIHKSLDNPHVVGFHGFFEDDDFVYVVLEICRRRSLLE-LHKRRKAVTEPEAR 145
Query: 218 KVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVA-RVQAQSGVMTAETGT 276
                  +G+ YLH N +IHRDLK  NL ++++  VK+ DFG+A +++          GT
Sbjct: 146 YFMRQTIQGVQYLHNNRVIHRDLKLGNLFLNDDMDVKIGDFGLATKIEFDGERKKDLCGT 205
Query: 277 YRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKSLRPTIPK 336
             ++APEV+  K + ++ D++S G  L+ LL G+ P+      +  + + +     ++P+
Sbjct: 206 PNYIAPEVLCKKGHSFEVDIWSLGCILYTLLVGKPPFETSCLKETYIRIKKNEY--SVPR 263
Query: 337 HAHPRLAELLERCWQHDPTQRPNFSQI 363
           H +P  + L+ R    DPT RP+ +++
Sbjct: 264 HINPVASALIRRMLHADPTLRPSVAEL 290

>pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350

Iteration: 1
 Score = 97.8 bits (242), Expect = 8e-21,   Method: Compositional matrix adjust.
 Identities = 70/238 (29%), Positives = 119/238 (50%), Gaps = 10/238 (4%)
Query: 124 VASGSYGD--LYKGTYCSQEVAIKVL-KPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIG 180
           + +GS+G   L K        A+K+L K + V  + ++    E  I++ +    +V+   
Sbjct: 49  IGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEF 108
Query: 181 ACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDL 240
           +     NL +V E++  G ++  L ++ G F        A  +     YLH  ++I+RDL
Sbjct: 109 SFKDNSNLYMVMEYVPGGEMFSHL-RRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDL 167
Query: 241 KTANLLMDENGVVKVADFGVA-RVQAQSGVMTAETGTYRWMAPEVIEHKPYDYKADVFSF 299
           K  NLL+D+ G +KVADFG A RV+ ++  +    GT  ++APE+I  K Y+   D ++ 
Sbjct: 168 KPENLLIDQQGYIKVADFGFAKRVKGRTWXL---CGTPEYLAPEIILSKGYNKAVDWWAL 224
Query: 300 GIALWELLTGELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRLAELLERCWQHDPTQR 357
           G+ ++E+  G  P+    P+Q    +V   +R   P H    L +LL    Q D T+R
Sbjct: 225 GVLIYEMAAGYPPFFADQPIQIYEKIVSGKVR--FPSHFSSDLKDLLRNLLQVDLTKR 280

>pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340

Iteration: 1
 Score = 97.8 bits (242), Expect = 9e-21,   Method: Compositional matrix adjust.
 Identities = 89/315 (28%), Positives = 147/315 (46%), Gaps = 30/315 (9%)
Query: 72  MQDQSCSKRQPALGVPMHS--KLLIESSP-------NCIEIPTDGTDVWEIDAKQLKIEC 122
           M      KR P L +P  +  +    S+P        CI I   G   +E+ A  L+   
Sbjct: 1   MSQSKGKKRNPGLKIPKEAFEQPQTSSTPPRDLDSKACISI---GNQNFEVKADDLEPIM 57
Query: 123 KVASGSYGDLYKGTYC--SQEVAIKVLKPECVNTEMLKEFSQEVYI-MRKIRHKNVVQFI 179
           ++  G+YG + K  +    Q +A+K ++   VN++  K    ++ I MR +     V F 
Sbjct: 58  ELGRGAYGVVEKMRHVPSGQIMAVKRIR-ATVNSQEQKRLLMDLDISMRTVDCPFTVTFY 116
Query: 180 GACTRPPNLCIVTEFMARGSIYDFLHKQ---KGVFQLTSLL-KVAIDVSKGMNYLHQN-N 234
           GA  R  ++ I  E M   +  D  +KQ   KG      +L K+A+ + K + +LH   +
Sbjct: 117 GALFREGDVWICMELM--DTSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKLS 174
Query: 235 IIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAETGTYRWMAPEVI----EHKPY 290
           +IHRD+K +N+L++  G VK+ DFG++     S   T + G   +MAPE I      K Y
Sbjct: 175 VIHRDVKPSNVLINALGQVKMCDFGISGYLVDSVAKTIDAGCKPYMAPERINPELNQKGY 234
Query: 291 DYKADVFSFGIALWELLTGELPYAGL-TPLQAAVGVVQKSLRPTIPKHA-HPRLAELLER 348
             K+D++S GI + EL     PY    TP Q    VV++   P +P         +   +
Sbjct: 235 SVKSDIWSLGITMIELAILRFPYDSWGTPFQQLKQVVEEP-SPQLPADKFSAEFVDFTSQ 293
Query: 349 CWQHDPTQRPNFSQI 363
           C + +  +RP + ++
Sbjct: 294 CLKKNSKERPTYPEL 308

>pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337

Iteration: 1
 Score = 97.8 bits (242), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 70/238 (29%), Positives = 119/238 (50%), Gaps = 10/238 (4%)
Query: 124 VASGSYGD--LYKGTYCSQEVAIKVL-KPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIG 180
           + +GS+G   L K        A+K+L K + V  + ++    E  I++ +    +V+   
Sbjct: 36  LGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEF 95
Query: 181 ACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDL 240
           +     NL +V E++A G ++  L ++ G F        A  +     YLH  ++I+RDL
Sbjct: 96  SFKDNSNLYMVMEYVAGGEMFSHL-RRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDL 154
Query: 241 KTANLLMDENGVVKVADFGVA-RVQAQSGVMTAETGTYRWMAPEVIEHKPYDYKADVFSF 299
           K  NLL+DE G ++V DFG A RV+ ++  +    GT  ++APE+I  K Y+   D ++ 
Sbjct: 155 KPENLLIDEQGYIQVTDFGFAKRVKGRTWXL---CGTPEYLAPEIILSKGYNKAVDWWAL 211
Query: 300 GIALWELLTGELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRLAELLERCWQHDPTQR 357
           G+ ++E+  G  P+    P+Q    +V   +R   P H    L +LL    Q D T+R
Sbjct: 212 GVLIYEMAAGYPPFFADQPIQIYEKIVSGKVR--FPSHFSSDLKDLLRNLLQVDLTKR 267

>pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350

Iteration: 1
 Score = 97.1 bits (240), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 69/238 (28%), Positives = 119/238 (50%), Gaps = 10/238 (4%)
Query: 124 VASGSYGD--LYKGTYCSQEVAIKVL-KPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIG 180
           + +GS+G   L K        A+K+L K + V  + ++    E  I++ +    +V+   
Sbjct: 49  LGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEF 108
Query: 181 ACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDL 240
           +     NL +V E++A G ++  L ++ G F        A  +     YLH  ++I+RDL
Sbjct: 109 SFKDNSNLYMVMEYVAGGEMFSHL-RRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDL 167
Query: 241 KTANLLMDENGVVKVADFGVA-RVQAQSGVMTAETGTYRWMAPEVIEHKPYDYKADVFSF 299
           K  NLL+D+ G ++V DFG A RV+ ++  +    GT  ++APE+I  K Y+   D ++ 
Sbjct: 168 KPENLLIDQQGYIQVTDFGFAKRVKGRTWXL---AGTPEYLAPEIILSKGYNKAVDWWAL 224
Query: 300 GIALWELLTGELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRLAELLERCWQHDPTQR 357
           G+ ++E+  G  P+    P+Q    +V   +R   P H    L +LL    Q D T+R
Sbjct: 225 GVLIYEMAAGYPPFFADQPIQIYEKIVSGKVR--FPSHFSSDLKDLLRNLLQVDLTKR 280

>pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350

Iteration: 1
 Score = 96.7 bits (239), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 69/238 (28%), Positives = 119/238 (50%), Gaps = 10/238 (4%)
Query: 124 VASGSYGD--LYKGTYCSQEVAIKVL-KPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIG 180
           + +GS+G   L K        A+K+L K + V  + ++    E  I++ +    +V+   
Sbjct: 49  LGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEF 108
Query: 181 ACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDL 240
           +     NL +V E++A G ++  L ++ G F        A  +     YLH  ++I+RDL
Sbjct: 109 SFKDNSNLYMVMEYVAGGEMFSHL-RRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDL 167
Query: 241 KTANLLMDENGVVKVADFGVA-RVQAQSGVMTAETGTYRWMAPEVIEHKPYDYKADVFSF 299
           K  NLL+D+ G ++V DFG A RV+ ++  +    GT  ++APE+I  K Y+   D ++ 
Sbjct: 168 KPENLLIDQQGYIQVTDFGFAKRVKGRTWXL---XGTPEYLAPEIILSKGYNKAVDWWAL 224
Query: 300 GIALWELLTGELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRLAELLERCWQHDPTQR 357
           G+ ++E+  G  P+    P+Q    +V   +R   P H    L +LL    Q D T+R
Sbjct: 225 GVLIYEMAAGYPPFFADQPIQIYEKIVSGKVR--FPSHFSSDLKDLLRNLLQVDLTKR 280

>pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327

Iteration: 1
 Score = 96.7 bits (239), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 62/235 (26%), Positives = 118/235 (50%), Gaps = 11/235 (4%)
Query: 124 VASGSYGDLYK-----GTYCSQEVAIKVLKPECV--NTEMLKEFSQEVYIMRKIRHKNVV 176
           +  G YG +++     G    +  A+KVLK   +  N +       E  I+ +++H  +V
Sbjct: 25  LGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIV 84
Query: 177 QFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNII 236
             I A      L ++ E+++ G ++  L ++ G+F   +      ++S  + +LHQ  II
Sbjct: 85  DLIYAFQTGGKLYLILEYLSGGELFMQLERE-GIFMEDTACFYLAEISMALGHLHQKGII 143
Query: 237 HRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAE-TGTYRWMAPEVIEHKPYDYKAD 295
           +RDLK  N++++  G VK+ DFG+ +     G +T    GT  +MAPE++    ++   D
Sbjct: 144 YRDLKPENIMLNHQGHVKLTDFGLCKESIHDGTVTHTFCGTIEYMAPEILMRSGHNRAVD 203
Query: 296 VFSFGIALWELLTGELPYAGLTPLQAAVGVVQKSLR--PTIPKHAHPRLAELLER 348
            +S G  ++++LTG  P+ G    +    +++  L   P + + A   L +LL+R
Sbjct: 204 WWSLGALMYDMLTGAPPFTGENRKKTIDKILKCKLNLPPYLTQEARDLLKKLLKR 258

>pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327

Iteration: 1
 Score = 96.7 bits (239), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 62/235 (26%), Positives = 118/235 (50%), Gaps = 11/235 (4%)
Query: 124 VASGSYGDLYK-----GTYCSQEVAIKVLKPECV--NTEMLKEFSQEVYIMRKIRHKNVV 176
           +  G YG +++     G    +  A+KVLK   +  N +       E  I+ +++H  +V
Sbjct: 25  LGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIV 84
Query: 177 QFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNII 236
             I A      L ++ E+++ G ++  L ++ G+F   +      ++S  + +LHQ  II
Sbjct: 85  DLIYAFQTGGKLYLILEYLSGGELFMQLERE-GIFMEDTACFYLAEISMALGHLHQKGII 143
Query: 237 HRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAE-TGTYRWMAPEVIEHKPYDYKAD 295
           +RDLK  N++++  G VK+ DFG+ +     G +T    GT  +MAPE++    ++   D
Sbjct: 144 YRDLKPENIMLNHQGHVKLTDFGLCKESIHDGTVTHXFCGTIEYMAPEILMRSGHNRAVD 203
Query: 296 VFSFGIALWELLTGELPYAGLTPLQAAVGVVQKSLR--PTIPKHAHPRLAELLER 348
            +S G  ++++LTG  P+ G    +    +++  L   P + + A   L +LL+R
Sbjct: 204 WWSLGALMYDMLTGAPPFTGENRKKTIDKILKCKLNLPPYLTQEARDLLKKLLKR 258

>pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350

Iteration: 1
 Score = 96.7 bits (239), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 71/246 (28%), Positives = 122/246 (49%), Gaps = 12/246 (4%)
Query: 124 VASGSYGD--LYKGTYCSQEVAIKVL-KPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIG 180
           + +GS+G   L K        A+K+L K + V  + ++    E  I++ +    +V+   
Sbjct: 49  LGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEF 108
Query: 181 ACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDL 240
           +     NL +V E++A G ++  L ++ G F        A  +     YLH  ++I+RDL
Sbjct: 109 SFKDNSNLYMVMEYVAGGEMFSHL-RRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDL 167
Query: 241 KTANLLMDENGVVKVADFGVA-RVQAQSGVMTAETGTYRWMAPEVIEHKPYDYKADVFSF 299
           K  NLL+D+ G ++V DFG A RV+ ++  +    GT  ++APE+I  K Y+   D ++ 
Sbjct: 168 KPENLLIDQQGYIQVTDFGFAKRVKGRTWXL---CGTPEYLAPEIILSKGYNKAVDWWAL 224
Query: 300 GIALWELLTGELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRLAELLERCWQHDPTQRPN 359
           G+ ++E+  G  P+    P+Q    +V   +R   P H    L +LL    Q D T+R  
Sbjct: 225 GVLIYEMAAGYPPFFADQPIQIYEKIVSGKVR--FPSHFSSDLKDLLRNLLQVDLTKR-- 280
Query: 360 FSQITD 365
           F  + D
Sbjct: 281 FGNLKD 286

>pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350

Iteration: 1
 Score = 96.3 bits (238), Expect = 3e-20,   Method: Compositional matrix adjust.
 Identities = 69/238 (28%), Positives = 119/238 (50%), Gaps = 10/238 (4%)
Query: 124 VASGSYGD--LYKGTYCSQEVAIKVL-KPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIG 180
           + +GS+G   L K        A+K+L K + V  + ++    E  I++ +    +V+   
Sbjct: 49  LGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEF 108
Query: 181 ACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDL 240
           +     NL +V E++A G ++  L ++ G F        A  +     YLH  ++I+RDL
Sbjct: 109 SFKDNSNLYMVMEYVAGGEMFSHL-RRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDL 167
Query: 241 KTANLLMDENGVVKVADFGVA-RVQAQSGVMTAETGTYRWMAPEVIEHKPYDYKADVFSF 299
           K  NLL+D+ G ++V DFG A RV+ ++  +    GT  ++APE+I  K Y+   D ++ 
Sbjct: 168 KPENLLIDQQGYIQVTDFGFAKRVKGRTWXL---CGTPEYLAPEIILSKGYNKAVDWWAL 224
Query: 300 GIALWELLTGELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRLAELLERCWQHDPTQR 357
           G+ ++E+  G  P+    P+Q    +V   +R   P H    L +LL    Q D T+R
Sbjct: 225 GVLIYEMAAGYPPFFADQPIQIYEKIVSGKVR--FPSHFSSDLKDLLRNLLQVDLTKR 280

>pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345

Iteration: 1
 Score = 96.3 bits (238), Expect = 3e-20,   Method: Compositional matrix adjust.
 Identities = 69/238 (28%), Positives = 119/238 (50%), Gaps = 10/238 (4%)
Query: 124 VASGSYGD--LYKGTYCSQEVAIKVL-KPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIG 180
           + +GS+G   L K        A+K+L K + V  + ++    E  I++ +    +V+   
Sbjct: 44  LGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEF 103
Query: 181 ACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDL 240
           +     NL +V E++A G ++  L ++ G F        A  +     YLH  ++I+RDL
Sbjct: 104 SFKDNSNLYMVMEYVAGGEMFSHL-RRIGRFXEPHARFYAAQIVLTFEYLHSLDLIYRDL 162
Query: 241 KTANLLMDENGVVKVADFGVA-RVQAQSGVMTAETGTYRWMAPEVIEHKPYDYKADVFSF 299
           K  NLL+D+ G ++V DFG A RV+ ++  +    GT  ++APE+I  K Y+   D ++ 
Sbjct: 163 KPENLLIDQQGYIQVTDFGFAKRVKGRTWXL---CGTPEYLAPEIILSKGYNKAVDWWAL 219
Query: 300 GIALWELLTGELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRLAELLERCWQHDPTQR 357
           G+ ++E+  G  P+    P+Q    +V   +R   P H    L +LL    Q D T+R
Sbjct: 220 GVLIYEMAAGYPPFFADQPIQIYEKIVSGKVR--FPSHFSSDLKDLLRNLLQVDLTKR 275

>pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351

Iteration: 1
 Score = 96.3 bits (238), Expect = 3e-20,   Method: Compositional matrix adjust.
 Identities = 69/238 (28%), Positives = 119/238 (50%), Gaps = 10/238 (4%)
Query: 124 VASGSYGD--LYKGTYCSQEVAIKVL-KPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIG 180
           + +GS+G   L K        A+K+L K + V  + ++    E  I++ +    +V+   
Sbjct: 50  LGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEF 109
Query: 181 ACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDL 240
           +     NL +V E++A G ++  L ++ G F        A  +     YLH  ++I+RDL
Sbjct: 110 SFKDNSNLYMVMEYVAGGEMFSHL-RRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDL 168
Query: 241 KTANLLMDENGVVKVADFGVA-RVQAQSGVMTAETGTYRWMAPEVIEHKPYDYKADVFSF 299
           K  NLL+D+ G ++V DFG A RV+ ++  +    GT  ++APE+I  K Y+   D ++ 
Sbjct: 169 KPENLLIDQQGYIQVTDFGFAKRVKGRTWXL---CGTPEYLAPEIILSKGYNKAVDWWAL 225
Query: 300 GIALWELLTGELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRLAELLERCWQHDPTQR 357
           G+ ++E+  G  P+    P+Q    +V   +R   P H    L +LL    Q D T+R
Sbjct: 226 GVLIYEMAAGYPPFFADQPIQIYEKIVSGKVR--FPSHFSSDLKDLLRNLLQVDLTKR 281

>pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350

Iteration: 1
 Score = 96.3 bits (238), Expect = 3e-20,   Method: Compositional matrix adjust.
 Identities = 69/238 (28%), Positives = 119/238 (50%), Gaps = 10/238 (4%)
Query: 124 VASGSYGD--LYKGTYCSQEVAIKVL-KPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIG 180
           + +GS+G   L K        A+K+L K + V  + ++    E  I++ +    +V+   
Sbjct: 49  LGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEF 108
Query: 181 ACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDL 240
           +     NL +V E++A G ++  L ++ G F        A  +     YLH  ++I+RDL
Sbjct: 109 SFKDNSNLYMVMEYVAGGEMFSHL-RRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDL 167
Query: 241 KTANLLMDENGVVKVADFGVA-RVQAQSGVMTAETGTYRWMAPEVIEHKPYDYKADVFSF 299
           K  NLL+D+ G ++V DFG A RV+ ++  +    GT  ++APE+I  K Y+   D ++ 
Sbjct: 168 KPENLLIDQQGYIQVTDFGFAKRVKGRTWXL---CGTPEYLAPEIILSKGYNKAVDWWAL 224
Query: 300 GIALWELLTGELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRLAELLERCWQHDPTQR 357
           G+ ++E+  G  P+    P+Q    +V   +R   P H    L +LL    Q D T+R
Sbjct: 225 GVLIYEMAAGYPPFFADEPIQIYEKIVSGKVR--FPSHFSSDLKDLLRNLLQVDLTKR 280

>pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 96.3 bits (238), Expect = 3e-20,   Method: Compositional matrix adjust.
 Identities = 69/238 (28%), Positives = 119/238 (50%), Gaps = 10/238 (4%)
Query: 124 VASGSYGD--LYKGTYCSQEVAIKVL-KPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIG 180
           + +GS+G   L K        A+K+L K + V  + ++    E  I++ +    +V+   
Sbjct: 49  LGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEF 108
Query: 181 ACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDL 240
           +     NL +V E++A G ++  L ++ G F        A  +     YLH  ++I+RDL
Sbjct: 109 SFKDNSNLYMVMEYVAGGEMFSHL-RRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDL 167
Query: 241 KTANLLMDENGVVKVADFGVA-RVQAQSGVMTAETGTYRWMAPEVIEHKPYDYKADVFSF 299
           K  NLL+D+ G ++V DFG A RV+ ++  +    GT  ++APE+I  K Y+   D ++ 
Sbjct: 168 KPENLLIDQQGYIQVTDFGFAKRVKGRTWXL---CGTPEYLAPEIILSKGYNKAVDWWAL 224
Query: 300 GIALWELLTGELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRLAELLERCWQHDPTQR 357
           G+ ++E+  G  P+    P+Q    +V   +R   P H    L +LL    Q D T+R
Sbjct: 225 GVLIYEMAAGYPPFFADQPIQIYEKIVSGKVR--FPSHFSSDLKDLLRNLLQVDLTKR 280

>pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371

Iteration: 1
 Score = 96.3 bits (238), Expect = 3e-20,   Method: Compositional matrix adjust.
 Identities = 69/238 (28%), Positives = 119/238 (50%), Gaps = 10/238 (4%)
Query: 124 VASGSYGD--LYKGTYCSQEVAIKVL-KPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIG 180
           + +GS+G   L K        A+K+L K + V  + ++    E  I++ +    +V+   
Sbjct: 70  LGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEF 129
Query: 181 ACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDL 240
           +     NL +V E++A G ++  L ++ G F        A  +     YLH  ++I+RDL
Sbjct: 130 SFKDNSNLYMVMEYVAGGEMFSHL-RRIGRFXEPHARFYAAQIVLTFEYLHSLDLIYRDL 188
Query: 241 KTANLLMDENGVVKVADFGVA-RVQAQSGVMTAETGTYRWMAPEVIEHKPYDYKADVFSF 299
           K  NLL+D+ G ++V DFG A RV+ ++  +    GT  ++APE+I  K Y+   D ++ 
Sbjct: 189 KPENLLIDQQGYIQVTDFGFAKRVKGRTWXL---CGTPEYLAPEIILSKGYNKAVDWWAL 245
Query: 300 GIALWELLTGELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRLAELLERCWQHDPTQR 357
           G+ ++E+  G  P+    P+Q    +V   +R   P H    L +LL    Q D T+R
Sbjct: 246 GVLIYEMAAGYPPFFADQPIQIYEKIVSGKVR--FPSHFSSDLKDLLRNLLQVDLTKR 301

>pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350

Iteration: 1
 Score = 96.3 bits (238), Expect = 3e-20,   Method: Compositional matrix adjust.
 Identities = 69/238 (28%), Positives = 119/238 (50%), Gaps = 10/238 (4%)
Query: 124 VASGSYGD--LYKGTYCSQEVAIKVL-KPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIG 180
           + +GS+G   L K        A+K+L K + V  + ++    E  I++ +    +V+   
Sbjct: 49  LGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEF 108
Query: 181 ACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDL 240
           +     NL +V E++A G ++  L ++ G F        A  +     YLH  ++I+RDL
Sbjct: 109 SFKDNSNLYMVMEYVAGGEMFSHL-RRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDL 167
Query: 241 KTANLLMDENGVVKVADFGVA-RVQAQSGVMTAETGTYRWMAPEVIEHKPYDYKADVFSF 299
           K  NLL+D+ G ++V DFG A RV+ ++  +    GT  ++APE+I  K Y+   D ++ 
Sbjct: 168 KPENLLIDQQGYIQVTDFGFAKRVKGRTWXL---CGTPEYLAPEIILSKGYNKAVDWWAL 224
Query: 300 GIALWELLTGELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRLAELLERCWQHDPTQR 357
           G+ ++E+  G  P+    P+Q    +V   +R   P H    L +LL    Q D T+R
Sbjct: 225 GVLIYEMAAGYPPFFADQPIQIYEKIVSGKVR--FPSHFSSDLKDLLRNLLQVDLTKR 280

>pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350

Iteration: 1
 Score = 96.3 bits (238), Expect = 3e-20,   Method: Compositional matrix adjust.
 Identities = 69/238 (28%), Positives = 119/238 (50%), Gaps = 10/238 (4%)
Query: 124 VASGSYGD--LYKGTYCSQEVAIKVL-KPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIG 180
           + +GS+G   L K        A+K+L K + V  + ++    E  I++ +    +V+   
Sbjct: 49  LGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEF 108
Query: 181 ACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDL 240
           +     NL +V E++A G ++  L ++ G F        A  +     YLH  ++I+RDL
Sbjct: 109 SFKDNSNLYMVMEYVAGGEMFSHL-RRIGRFXEPHARFYAAQIVLTFEYLHSLDLIYRDL 167
Query: 241 KTANLLMDENGVVKVADFGVA-RVQAQSGVMTAETGTYRWMAPEVIEHKPYDYKADVFSF 299
           K  NLL+D+ G ++V DFG A RV+ ++  +    GT  ++APE+I  K Y+   D ++ 
Sbjct: 168 KPENLLIDQQGYIQVTDFGFAKRVKGRTWXL---CGTPEYLAPEIILSKGYNKAVDWWAL 224
Query: 300 GIALWELLTGELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRLAELLERCWQHDPTQR 357
           G+ ++E+  G  P+    P+Q    +V   +R   P H    L +LL    Q D T+R
Sbjct: 225 GVLIYEMAAGYPPFFADQPIQIYEKIVSGKVR--FPSHFSSDLKDLLRNLLQVDLTKR 280

>pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350

Iteration: 1
 Score = 95.9 bits (237), Expect = 3e-20,   Method: Compositional matrix adjust.
 Identities = 69/238 (28%), Positives = 119/238 (50%), Gaps = 10/238 (4%)
Query: 124 VASGSYGD--LYKGTYCSQEVAIKVL-KPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIG 180
           + +GS+G   L K        A+K+L K + V  + ++    E  I++ +    +V+   
Sbjct: 49  LGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEF 108
Query: 181 ACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDL 240
           +     NL +V E++A G ++  L ++ G F        A  +     YLH  ++I+RDL
Sbjct: 109 SFKDNSNLYMVMEYVAGGEMFSHL-RRIGRFXEPHARFYAAQIVLTFEYLHSLDLIYRDL 167
Query: 241 KTANLLMDENGVVKVADFGVA-RVQAQSGVMTAETGTYRWMAPEVIEHKPYDYKADVFSF 299
           K  NLL+D+ G ++V DFG A RV+ ++  +    GT  ++APE+I  K Y+   D ++ 
Sbjct: 168 KPENLLIDQQGYIQVTDFGFAKRVKGRTWXL---CGTPEYLAPEIILSKGYNKAVDWWAL 224
Query: 300 GIALWELLTGELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRLAELLERCWQHDPTQR 357
           G+ ++E+  G  P+    P+Q    +V   +R   P H    L +LL    Q D T+R
Sbjct: 225 GVLIYEMAAGYPPFFADQPIQIYEKIVSGKVR--FPSHFSSDLKDLLRNLLQVDLTKR 280

>pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350

Iteration: 1
 Score = 95.9 bits (237), Expect = 3e-20,   Method: Compositional matrix adjust.
 Identities = 69/238 (28%), Positives = 119/238 (50%), Gaps = 10/238 (4%)
Query: 124 VASGSYGD--LYKGTYCSQEVAIKVL-KPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIG 180
           + +GS+G   L K        A+K+L K + V  + ++    E  I++ +    +V+   
Sbjct: 49  LGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEF 108
Query: 181 ACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDL 240
           +     NL +V E++A G ++  L ++ G F        A  +     YLH  ++I+RDL
Sbjct: 109 SFKDNSNLYMVMEYVAGGEMFSHL-RRIGRFAEPHARFYAAQIVLTFEYLHSLDLIYRDL 167
Query: 241 KTANLLMDENGVVKVADFGVA-RVQAQSGVMTAETGTYRWMAPEVIEHKPYDYKADVFSF 299
           K  NLL+D+ G ++V DFG A RV+ ++  +    GT  ++APE+I  K Y+   D ++ 
Sbjct: 168 KPENLLIDQQGYIQVTDFGFAKRVKGRTWXL---CGTPEYLAPEIILSKGYNKAVDWWAL 224
Query: 300 GIALWELLTGELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRLAELLERCWQHDPTQR 357
           G+ ++E+  G  P+    P+Q    +V   +R   P H    L +LL    Q D T+R
Sbjct: 225 GVLIYEMAAGYPPFFADQPIQIYEKIVSGKVR--FPSHFSSDLKDLLRNLLQVDLTKR 280

>pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283

Iteration: 1
 Score = 95.9 bits (237), Expect = 3e-20,   Method: Compositional matrix adjust.
 Identities = 66/247 (26%), Positives = 124/247 (50%), Gaps = 14/247 (5%)
Query: 124 VASGSYGD--LYKGTYCSQEVAIKVLKPECV-NTEMLKEFSQEVYIMRKIRHKNVVQFIG 180
           +  GS+G   L   T   Q+VA+K++  + +  ++M     +E+  +R +RH ++++   
Sbjct: 22  LGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYD 81
Query: 181 ACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDL 240
                  + +V E+ A   ++D++  Q+         +    +   + Y H++ I+HRDL
Sbjct: 82  VIKSKDEIIMVIEY-AGNELFDYI-VQRDKMSEQEARRFFQQIISAVEYCHRHKIVHRDL 139
Query: 241 KTANLLMDENGVVKVADFGVARVQAQSGVMTAETGTYRWMAPEVIEHKPY-DYKADVFSF 299
           K  NLL+DE+  VK+ADFG++ +      +    G+  + APEVI  K Y   + DV+S 
Sbjct: 140 KPENLLLDEHLNVKIADFGLSNIMTDGNFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSC 199
Query: 300 GIALWELLTGELPYAGLTPLQAAVGVVQKSLRP---TIPKHAHPRLAELLERCWQHDPTQ 356
           G+ L+ +L   LP+        ++ V+ K++     T+PK   P  A L++R    +P  
Sbjct: 200 GVILYVMLCRRLPFD-----DESIPVLFKNISNGVYTLPKFLSPGAAGLIKRMLIVNPLN 254
Query: 357 RPNFSQI 363
           R +  +I
Sbjct: 255 RISIHEI 261

>pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507

Iteration: 1
 Score = 95.9 bits (237), Expect = 3e-20,   Method: Compositional matrix adjust.
 Identities = 62/198 (31%), Positives = 106/198 (53%), Gaps = 8/198 (4%)
Query: 124 VASGSYGD--LYKGTYCSQEVAIKVLKPECVNTEMLKE-FSQEVYIMRKIRHKNVVQFIG 180
           +  GS+G+  L K     QE A+KV+    V  +  KE   +EV +++++ H N+++   
Sbjct: 57  LGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYE 116
Query: 181 ACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDL 240
                    +V E    G ++D +  +K  F      ++   V  G+ Y+H+N I+HRDL
Sbjct: 117 FFEDKGYFYLVGEVYTGGELFDEIISRK-RFSEVDAARIIRQVLSGITYMHKNKIVHRDL 175
Query: 241 KTANLLMD---ENGVVKVADFGVARVQAQSGVMTAETGTYRWMAPEVIEHKPYDYKADVF 297
           K  NLL++   ++  +++ DFG++     S  M  + GT  ++APEV+ H  YD K DV+
Sbjct: 176 KPENLLLESKSKDANIRIIDFGLSTHFEASKKMKDKIGTAYYIAPEVL-HGTYDEKCDVW 234
Query: 298 SFGIALWELLTGELPYAG 315
           S G+ L+ LL+G  P+ G
Sbjct: 235 STGVILYILLSGCPPFNG 252

>pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 95.9 bits (237), Expect = 3e-20,   Method: Compositional matrix adjust.
 Identities = 69/238 (28%), Positives = 119/238 (50%), Gaps = 10/238 (4%)
Query: 124 VASGSYGD--LYKGTYCSQEVAIKVL-KPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIG 180
           + +GS+G   L K        A+K+L K + V  + ++    E  I++ +    +V+   
Sbjct: 49  LGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEF 108
Query: 181 ACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDL 240
           +     NL +V E++A G ++  L ++ G F        A  +     YLH  ++I+RDL
Sbjct: 109 SFKDNSNLYMVMEYVAGGEMFSHL-RRIGRFXEPHARFYAAQIVLTFEYLHSLDLIYRDL 167
Query: 241 KTANLLMDENGVVKVADFGVA-RVQAQSGVMTAETGTYRWMAPEVIEHKPYDYKADVFSF 299
           K  NLL+D+ G ++V DFG A RV+ ++  +    GT  ++APE+I  K Y+   D ++ 
Sbjct: 168 KPENLLIDQQGYIQVTDFGFAKRVKGRTWXL---CGTPEYLAPEIILSKGYNKAVDWWAL 224
Query: 300 GIALWELLTGELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRLAELLERCWQHDPTQR 357
           G+ ++E+  G  P+    P+Q    +V   +R   P H    L +LL    Q D T+R
Sbjct: 225 GVLIYEMAAGYPPFFADQPIQIYEKIVSGKVR--FPSHFSSDLKDLLRNLLQVDLTKR 280

>pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371

Iteration: 1
 Score = 95.9 bits (237), Expect = 3e-20,   Method: Compositional matrix adjust.
 Identities = 69/238 (28%), Positives = 118/238 (49%), Gaps = 10/238 (4%)
Query: 124 VASGSYGD--LYKGTYCSQEVAIKVL-KPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIG 180
           + +GS+G   L K        A+K+L K + V  + ++    E  I++ +    +V+   
Sbjct: 70  LGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEF 129
Query: 181 ACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDL 240
           +     NL +V E++A G ++  L ++ G F        A  +     YLH  ++I+RDL
Sbjct: 130 SFKDNSNLYMVMEYVAGGEMFSHL-RRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDL 188
Query: 241 KTANLLMDENGVVKVADFGVA-RVQAQSGVMTAETGTYRWMAPEVIEHKPYDYKADVFSF 299
           K  NLL+D+ G ++V DFG A RV+  +  +    GT  ++APE+I  K Y+   D ++ 
Sbjct: 189 KPENLLIDQQGYIQVTDFGFAKRVKGATWTL---CGTPEYLAPEIILSKGYNKAVDWWAL 245
Query: 300 GIALWELLTGELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRLAELLERCWQHDPTQR 357
           G+ ++E+  G  P+    P+Q    +V   +R   P H    L +LL    Q D T+R
Sbjct: 246 GVLIYEMAAGYPPFFADQPIQIYEKIVSGKVR--FPSHFSSDLKDLLRNLLQVDLTKR 301

>pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484

Iteration: 1
 Score = 95.9 bits (237), Expect = 4e-20,   Method: Compositional matrix adjust.
 Identities = 68/242 (28%), Positives = 119/242 (49%), Gaps = 10/242 (4%)
Query: 124 VASGSYGD--LYKGTYCSQEVAIKVLKPECVNTEMLKE-FSQEVYIMRKIRHKNVVQFIG 180
           +  GS+G+  L K     QE A+KV+    V  +  KE   +EV +++++ H N+++   
Sbjct: 34  LGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYE 93
Query: 181 ACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDL 240
                    +V E    G ++D +  +K  F      ++   V  G+ Y+H+N I+HRDL
Sbjct: 94  FFEDKGYFYLVGEVYTGGELFDEIISRKR-FSEVDAARIIRQVLSGITYMHKNKIVHRDL 152
Query: 241 KTANLLMD---ENGVVKVADFGVARVQAQSGVMTAETGTYRWMAPEVIEHKPYDYKADVF 297
           K  NLL++   ++  +++ DFG++     S  M  + GT  ++APEV+ H  YD K DV+
Sbjct: 153 KPENLLLESKSKDANIRIIDFGLSTHFEASKKMKDKIGTAYYIAPEVL-HGTYDEKCDVW 211
Query: 298 SFGIALWELLTGELPYAGLTPLQAAVGVVQKSLRPTIP--KHAHPRLAELLERCWQHDPT 355
           S G+ L+ LL+G  P+ G         V +      +P  K       +L+ +   + P+
Sbjct: 212 STGVILYILLSGCPPFNGANEYDILKKVEKGKYTFELPQWKKVSESAKDLIRKMLTYVPS 271
Query: 356 QR 357
            R
Sbjct: 272 MR 273

>pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275

Iteration: 1
 Score = 95.9 bits (237), Expect = 4e-20,   Method: Compositional matrix adjust.
 Identities = 66/247 (26%), Positives = 124/247 (50%), Gaps = 14/247 (5%)
Query: 124 VASGSYGD--LYKGTYCSQEVAIKVLKPECV-NTEMLKEFSQEVYIMRKIRHKNVVQFIG 180
           +  GS+G   L   T   Q+VA+K++  + +  ++M     +E+  +R +RH ++++   
Sbjct: 21  LGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYD 80
Query: 181 ACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDL 240
                  + +V E+ A   ++D++  Q+         +    +   + Y H++ I+HRDL
Sbjct: 81  VIKSKDEIIMVIEY-AGNELFDYI-VQRDKMSEQEARRFFQQIISAVEYCHRHKIVHRDL 138
Query: 241 KTANLLMDENGVVKVADFGVARVQAQSGVMTAETGTYRWMAPEVIEHKPY-DYKADVFSF 299
           K  NLL+DE+  VK+ADFG++ +      +    G+  + APEVI  K Y   + DV+S 
Sbjct: 139 KPENLLLDEHLNVKIADFGLSNIMTDGNFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSC 198
Query: 300 GIALWELLTGELPYAGLTPLQAAVGVVQKSLRP---TIPKHAHPRLAELLERCWQHDPTQ 356
           G+ L+ +L   LP+        ++ V+ K++     T+PK   P  A L++R    +P  
Sbjct: 199 GVILYVMLCRRLPFD-----DESIPVLFKNISNGVYTLPKFLSPGAAGLIKRMLIVNPLN 253
Query: 357 RPNFSQI 363
           R +  +I
Sbjct: 254 RISIHEI 260

>pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508

Iteration: 1
 Score = 95.9 bits (237), Expect = 4e-20,   Method: Compositional matrix adjust.
 Identities = 62/198 (31%), Positives = 106/198 (53%), Gaps = 8/198 (4%)
Query: 124 VASGSYGD--LYKGTYCSQEVAIKVLKPECVNTEMLKE-FSQEVYIMRKIRHKNVVQFIG 180
           +  GS+G+  L K     QE A+KV+    V  +  KE   +EV +++++ H N+++   
Sbjct: 58  LGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYE 117
Query: 181 ACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDL 240
                    +V E    G ++D +  +K  F      ++   V  G+ Y+H+N I+HRDL
Sbjct: 118 FFEDKGYFYLVGEVYTGGELFDEIISRK-RFSEVDAARIIRQVLSGITYMHKNKIVHRDL 176
Query: 241 KTANLLMD---ENGVVKVADFGVARVQAQSGVMTAETGTYRWMAPEVIEHKPYDYKADVF 297
           K  NLL++   ++  +++ DFG++     S  M  + GT  ++APEV+ H  YD K DV+
Sbjct: 177 KPENLLLESKSKDANIRIIDFGLSTHFEASKKMKDKIGTAYYIAPEVL-HGTYDEKCDVW 235
Query: 298 SFGIALWELLTGELPYAG 315
           S G+ L+ LL+G  P+ G
Sbjct: 236 STGVILYILLSGCPPFNG 253

>pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304

Iteration: 1
 Score = 95.9 bits (237), Expect = 4e-20,   Method: Compositional matrix adjust.
 Identities = 56/196 (28%), Positives = 108/196 (55%), Gaps = 11/196 (5%)
Query: 124 VASGSYGDLYKGTYCSQEVAIKVLKPECVN-TEMLKEFS--QEVYIMRKIRHKNVVQFIG 180
           + SG++ +++      Q +  K+   +C+  +   ++ S   E+ +++KI+H+N+V    
Sbjct: 17  LGSGAFSEVF---LVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTLED 73
Query: 181 ACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDL 240
                 +  +V + ++ G ++D +  ++GV+       V   V   + YLH+N I+HRDL
Sbjct: 74  IYESTTHYYLVMQLVSGGELFDRI-LERGVYTEKDASLVIQQVLSAVKYLHENGIVHRDL 132
Query: 241 KTANLLM---DENGVVKVADFGVARVQAQSGVMTAETGTYRWMAPEVIEHKPYDYKADVF 297
           K  NLL    +EN  + + DFG+++++ Q+G+M+   GT  ++APEV+  KPY    D +
Sbjct: 133 KPENLLYLTPEENSKIMITDFGLSKME-QNGIMSTACGTPGYVAPEVLAQKPYSKAVDCW 191
Query: 298 SFGIALWELLTGELPY 313
           S G+  + LL G  P+
Sbjct: 192 SIGVITYILLCGYPPF 207

>pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274

Iteration: 1
 Score = 95.9 bits (237), Expect = 4e-20,   Method: Compositional matrix adjust.
 Identities = 66/247 (26%), Positives = 124/247 (50%), Gaps = 14/247 (5%)
Query: 124 VASGSYGD--LYKGTYCSQEVAIKVLKPECV-NTEMLKEFSQEVYIMRKIRHKNVVQFIG 180
           +  GS+G   L   T   Q+VA+K++  + +  ++M     +E+  +R +RH ++++   
Sbjct: 16  LGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYD 75
Query: 181 ACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDL 240
                  + +V E+ A   ++D++  Q+         +    +   + Y H++ I+HRDL
Sbjct: 76  VIKSKDEIIMVIEY-AGNELFDYI-VQRDKMSEQEARRFFQQIISAVEYCHRHKIVHRDL 133
Query: 241 KTANLLMDENGVVKVADFGVARVQAQSGVMTAETGTYRWMAPEVIEHKPY-DYKADVFSF 299
           K  NLL+DE+  VK+ADFG++ +      +    G+  + APEVI  K Y   + DV+S 
Sbjct: 134 KPENLLLDEHLNVKIADFGLSNIMTDGNFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSC 193
Query: 300 GIALWELLTGELPYAGLTPLQAAVGVVQKSLRP---TIPKHAHPRLAELLERCWQHDPTQ 356
           G+ L+ +L   LP+        ++ V+ K++     T+PK   P  A L++R    +P  
Sbjct: 194 GVILYVMLCRRLPFD-----DESIPVLFKNISNGVYTLPKFLSPGAAGLIKRMLIVNPLN 248
Query: 357 RPNFSQI 363
           R +  +I
Sbjct: 249 RISIHEI 255

>pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271

Iteration: 1
 Score = 95.5 bits (236), Expect = 4e-20,   Method: Compositional matrix adjust.
 Identities = 66/247 (26%), Positives = 124/247 (50%), Gaps = 14/247 (5%)
Query: 124 VASGSYGD--LYKGTYCSQEVAIKVLKPECV-NTEMLKEFSQEVYIMRKIRHKNVVQFIG 180
           +  GS+G   L   T   Q+VA+K++  + +  ++M     +E+  +R +RH ++++   
Sbjct: 12  LGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYD 71
Query: 181 ACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDL 240
                  + +V E+ A   ++D++  Q+         +    +   + Y H++ I+HRDL
Sbjct: 72  VIKSKDEIIMVIEY-AGNELFDYI-VQRDKMSEQEARRFFQQIISAVEYCHRHKIVHRDL 129
Query: 241 KTANLLMDENGVVKVADFGVARVQAQSGVMTAETGTYRWMAPEVIEHKPY-DYKADVFSF 299
           K  NLL+DE+  VK+ADFG++ +      +    G+  + APEVI  K Y   + DV+S 
Sbjct: 130 KPENLLLDEHLNVKIADFGLSNIMTDGNFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSC 189
Query: 300 GIALWELLTGELPYAGLTPLQAAVGVVQKSLRP---TIPKHAHPRLAELLERCWQHDPTQ 356
           G+ L+ +L   LP+        ++ V+ K++     T+PK   P  A L++R    +P  
Sbjct: 190 GVILYVMLCRRLPFD-----DESIPVLFKNISNGVYTLPKFLSPGAAGLIKRMLIVNPLN 244
Query: 357 RPNFSQI 363
           R +  +I
Sbjct: 245 RISIHEI 251

>pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351

Iteration: 1
 Score = 95.5 bits (236), Expect = 5e-20,   Method: Compositional matrix adjust.
 Identities = 70/238 (29%), Positives = 117/238 (49%), Gaps = 10/238 (4%)
Query: 124 VASGSYGD--LYKGTYCSQEVAIKVL-KPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIG 180
           + +GS+G   L K        A+K+L K + V  + ++    E  I + +    +V+   
Sbjct: 50  LGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRIQQAVNFPFLVKLEF 109
Query: 181 ACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDL 240
           +     NL +V E+   G ++  L ++ G F        A  +     YLH  ++I+RDL
Sbjct: 110 SFKDNSNLYMVLEYAPGGEMFSHL-RRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDL 168
Query: 241 KTANLLMDENGVVKVADFGVA-RVQAQSGVMTAETGTYRWMAPEVIEHKPYDYKADVFSF 299
           K  NLL+D+ G +KVADFG A RV+ ++  +    GT  ++APE+I  K Y+   D ++ 
Sbjct: 169 KPENLLIDQQGYIKVADFGFAKRVKGRTWXL---CGTPEYLAPEIILSKGYNKAVDWWAL 225
Query: 300 GIALWELLTGELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRLAELLERCWQHDPTQR 357
           G+ ++E+  G  P+    P+Q    +V   +R   P H    L +LL    Q D T+R
Sbjct: 226 GVLIYEMAAGYPPFFADQPIQIYEKIVSGKVR--FPSHFSSDLKDLLRNLLQVDLTKR 281

>pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298

Iteration: 1
 Score = 95.1 bits (235), Expect = 5e-20,   Method: Compositional matrix adjust.
 Identities = 62/198 (31%), Positives = 106/198 (53%), Gaps = 8/198 (4%)
Query: 124 VASGSYGD--LYKGTYCSQEVAIKVLKPECVNTEMLKE-FSQEVYIMRKIRHKNVVQFIG 180
           +  GS+G+  L K     QE A+KV+    V  +  KE   +EV +++++ H N+++   
Sbjct: 40  LGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYE 99
Query: 181 ACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDL 240
                    +V E    G ++D +  +K  F      ++   V  G+ Y+H+N I+HRDL
Sbjct: 100 FFEDKGYFYLVGEVYTGGELFDEIISRKR-FSEVDAARIIRQVLSGITYMHKNKIVHRDL 158
Query: 241 KTANLLMD---ENGVVKVADFGVARVQAQSGVMTAETGTYRWMAPEVIEHKPYDYKADVF 297
           K  NLL++   ++  +++ DFG++     S  M  + GT  ++APEV+ H  YD K DV+
Sbjct: 159 KPENLLLESKSKDANIRIIDFGLSTHFEASKKMKDKIGTAYYIAPEVL-HGTYDEKCDVW 217
Query: 298 SFGIALWELLTGELPYAG 315
           S G+ L+ LL+G  P+ G
Sbjct: 218 STGVILYILLSGCPPFNG 235

>pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350

Iteration: 1
 Score = 95.1 bits (235), Expect = 5e-20,   Method: Compositional matrix adjust.
 Identities = 68/238 (28%), Positives = 119/238 (50%), Gaps = 10/238 (4%)
Query: 124 VASGSYGD--LYKGTYCSQEVAIKVL-KPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIG 180
           + +GS+G   L K        A+K+L K + V  + ++    E  I++ +    +V+   
Sbjct: 49  LGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEF 108
Query: 181 ACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDL 240
           +     NL +V E++A G ++  L ++ G F        A  +     YLH  ++I+RDL
Sbjct: 109 SFKDNSNLYMVMEYVAGGEMFSHL-RRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDL 167
Query: 241 KTANLLMDENGVVKVADFGVA-RVQAQSGVMTAETGTYRWMAPEVIEHKPYDYKADVFSF 299
           K  NL++D+ G ++V DFG A RV+ ++  +    GT  ++APE+I  K Y+   D ++ 
Sbjct: 168 KPENLIIDQQGYIQVTDFGFAKRVKGRTWXL---CGTPEYLAPEIIISKGYNKAVDWWAL 224
Query: 300 GIALWELLTGELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRLAELLERCWQHDPTQR 357
           G+ ++E+  G  P+    P+Q    +V   +R   P H    L +LL    Q D T+R
Sbjct: 225 GVLIYEMAAGYPPFFADQPIQIYEKIVSGKVR--FPSHFSSDLKDLLRNLLQVDLTKR 280

>pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336

Iteration: 1
 Score = 95.1 bits (235), Expect = 7e-20,   Method: Compositional matrix adjust.
 Identities = 70/246 (28%), Positives = 121/246 (49%), Gaps = 12/246 (4%)
Query: 124 VASGSYGD--LYKGTYCSQEVAIKVL-KPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIG 180
           + +GS+G   L K        A+K+L K + V  + ++    E  I++ +    +V+   
Sbjct: 35  LGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEF 94
Query: 181 ACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDL 240
           +     NL +V E++  G ++  L ++ G F        A  +     YLH  ++I+RDL
Sbjct: 95  SFKDNSNLYMVMEYVPGGEMFSHL-RRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDL 153
Query: 241 KTANLLMDENGVVKVADFGVA-RVQAQSGVMTAETGTYRWMAPEVIEHKPYDYKADVFSF 299
           K  NLL+D+ G ++V DFG A RV+ ++  +    GT  ++APE+I  K Y+   D ++ 
Sbjct: 154 KPENLLIDQQGYIQVTDFGFAKRVKGRTWTL---CGTPEYLAPEIILSKGYNKAVDWWAL 210
Query: 300 GIALWELLTGELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRLAELLERCWQHDPTQRPN 359
           G+ ++E+  G  P+    P+Q    +V   +R   P H    L +LL    Q D T+R  
Sbjct: 211 GVLIYEMAAGYPPFFADQPIQIYEKIVSGKVR--FPSHFSSDLKDLLRNLLQVDLTKR-- 266
Query: 360 FSQITD 365
           F  + D
Sbjct: 267 FGNLKD 272

>pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350

Iteration: 1
 Score = 95.1 bits (235), Expect = 7e-20,   Method: Compositional matrix adjust.
 Identities = 68/238 (28%), Positives = 119/238 (50%), Gaps = 10/238 (4%)
Query: 124 VASGSYGD--LYKGTYCSQEVAIKVL-KPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIG 180
           + +GS+G   L K        A+K+L K + V  + ++    E  I++ +    +V+   
Sbjct: 49  LGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEF 108
Query: 181 ACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDL 240
           +     NL +V E++A G ++  L ++ G F        A  +     YLH  ++I+RDL
Sbjct: 109 SFKDNSNLYMVMEYVAGGEMFSHL-RRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDL 167
Query: 241 KTANLLMDENGVVKVADFGVA-RVQAQSGVMTAETGTYRWMAPEVIEHKPYDYKADVFSF 299
           K  NLL+D+ G ++V DFG A RV+ ++  +    GT  ++APE+I  K Y+   D ++ 
Sbjct: 168 KPENLLIDQQGYIQVTDFGFAKRVKGRTWXL---CGTPEYLAPEIILSKGYNKAVDWWAL 224
Query: 300 GIALWELLTGELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRLAELLERCWQHDPTQR 357
           G+ ++++  G  P+    P+Q    +V   +R   P H    L +LL    Q D T+R
Sbjct: 225 GVLIYQMAAGYPPFFADQPIQIYEKIVSGKVR--FPSHFSSDLKDLLRNLLQVDLTKR 280

>pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340

Iteration: 1
 Score = 94.7 bits (234), Expect = 7e-20,   Method: Compositional matrix adjust.
 Identities = 62/239 (25%), Positives = 115/239 (48%), Gaps = 8/239 (3%)
Query: 124 VASGSYGD--LYKGTYCSQEVAIKVLKPEC-VNTEMLKEFSQEVYIMRKIRHKNVVQFIG 180
           +  G++G   L K     +  A+K+LK E  V  + +     E  +++  RH  +     
Sbjct: 16  LGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKY 75
Query: 181 ACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLH-QNNIIHRD 239
           +      LC V E+   G ++  L +++ VF          ++   ++YLH + N+++RD
Sbjct: 76  SFQTHDRLCFVMEYANGGELFFHLSRER-VFSEDRARFYGAEIVSALDYLHSEKNVVYRD 134
Query: 240 LKTANLLMDENGVVKVADFGVARVQAQSG-VMTAETGTYRWMAPEVIEHKPYDYKADVFS 298
           LK  NL++D++G +K+ DFG+ +   + G  M    GT  ++APEV+E   Y    D + 
Sbjct: 135 LKLENLMLDKDGHIKITDFGLCKEGIKDGATMKXFCGTPEYLAPEVLEDNDYGRAVDWWG 194
Query: 299 FGIALWELLTGELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRLAELLERCWQHDPTQR 357
            G+ ++E++ G LP+      +    ++ + +R   P+   P    LL    + DP QR
Sbjct: 195 LGVVMYEMMCGRLPFYNQDHEKLFELILMEEIR--FPRTLGPEAKSLLSGLLKKDPKQR 251

>pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350

Iteration: 1
 Score = 94.7 bits (234), Expect = 7e-20,   Method: Compositional matrix adjust.
 Identities = 70/246 (28%), Positives = 121/246 (49%), Gaps = 12/246 (4%)
Query: 124 VASGSYGD--LYKGTYCSQEVAIKVL-KPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIG 180
           + +GS+G   L K        A+K+L K + V  + ++    E  I++ +    +V+   
Sbjct: 49  LGTGSFGRVMLVKHKETGNHFAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEY 108
Query: 181 ACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDL 240
           +     NL +V E++  G ++  L ++ G F        A  +     YLH  ++I+RDL
Sbjct: 109 SFKDNSNLYMVMEYVPGGEMFSHL-RRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDL 167
Query: 241 KTANLLMDENGVVKVADFGVA-RVQAQSGVMTAETGTYRWMAPEVIEHKPYDYKADVFSF 299
           K  NLL+D+ G ++V DFG A RV+ ++  +    GT  ++APE+I  K Y+   D ++ 
Sbjct: 168 KPENLLIDQQGYIQVTDFGFAKRVKGRTWXL---CGTPEYLAPEIILSKGYNKAVDWWAL 224
Query: 300 GIALWELLTGELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRLAELLERCWQHDPTQRPN 359
           G+ ++E+  G  P+    P+Q    +V   +R   P H    L +LL    Q D T+R  
Sbjct: 225 GVLIYEMAAGYPPFFADQPIQIYEKIVSGKVR--FPSHFSSDLKDLLRNLLQVDLTKR-- 280
Query: 360 FSQITD 365
           F  + D
Sbjct: 281 FGNLKD 286

>pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342

Iteration: 1
 Score = 94.7 bits (234), Expect = 7e-20,   Method: Compositional matrix adjust.
 Identities = 58/238 (24%), Positives = 112/238 (47%), Gaps = 7/238 (2%)
Query: 124 VASGSYGD--LYKGTYCSQEVAIKVLKPECV-NTEMLKEFSQEVYIMRKIRHKNVVQFIG 180
           +  G++G   L +     +  A+K+L+ E +   + +     E  +++  RH  +     
Sbjct: 18  LGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKY 77
Query: 181 ACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDL 240
           A      LC V E+   G ++  L +++ VF          ++   + YLH  ++++RD+
Sbjct: 78  AFQTHDRLCFVMEYANGGELFFHLSRER-VFTEERARFYGAEIVSALEYLHSRDVVYRDI 136
Query: 241 KTANLLMDENGVVKVADFGVARVQAQSG-VMTAETGTYRWMAPEVIEHKPYDYKADVFSF 299
           K  NL++D++G +K+ DFG+ +     G  M    GT  ++APEV+E   Y    D +  
Sbjct: 137 KLENLMLDKDGHIKITDFGLCKEGISDGATMKXFCGTPEYLAPEVLEDNDYGRAVDWWGL 196
Query: 300 GIALWELLTGELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRLAELLERCWQHDPTQR 357
           G+ ++E++ G LP+      +    ++ + +R   P+   P    LL    + DP QR
Sbjct: 197 GVVMYEMMCGRLPFYNQDHERLFELILMEEIR--FPRTLSPEAKSLLAGLLKKDPKQR 252

>pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351

Iteration: 1
 Score = 94.7 bits (234), Expect = 8e-20,   Method: Compositional matrix adjust.
 Identities = 68/238 (28%), Positives = 118/238 (49%), Gaps = 10/238 (4%)
Query: 124 VASGSYGD--LYKGTYCSQEVAIKVL-KPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIG 180
           + +GS+G   L K        A+K+L K + V  + ++    E  I++ +    +V+   
Sbjct: 50  LGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEF 109
Query: 181 ACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDL 240
           +     NL +V E++  G ++  L ++ G F        A  +     YLH  ++I+RDL
Sbjct: 110 SFKDNSNLYMVMEYVPGGEMFSHL-RRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDL 168
Query: 241 KTANLLMDENGVVKVADFGVA-RVQAQSGVMTAETGTYRWMAPEVIEHKPYDYKADVFSF 299
           K  NLL+D+ G ++V DFG A RV+ ++  +    GT  ++APE+I  K Y+   D ++ 
Sbjct: 169 KPENLLIDQQGYIQVTDFGFAKRVKGRTWTL---CGTPEYLAPEIILSKGYNKAVDWWAL 225
Query: 300 GIALWELLTGELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRLAELLERCWQHDPTQR 357
           G+ ++E+  G  P+    P+Q    +V   +R   P H    L +LL    Q D T+R
Sbjct: 226 GVLIYEMAAGYPPFFADQPIQIYEKIVSGKVR--FPSHFSSDLKDLLRNLLQVDLTKR 281

>pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350

Iteration: 1
 Score = 94.7 bits (234), Expect = 8e-20,   Method: Compositional matrix adjust.
 Identities = 70/246 (28%), Positives = 121/246 (49%), Gaps = 12/246 (4%)
Query: 124 VASGSYGD--LYKGTYCSQEVAIKVL-KPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIG 180
           + +GS+G   L K        A+K+L K + V  + ++    E  I++ +    +V+   
Sbjct: 49  LGTGSFGRVMLVKHKETGNHFAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEY 108
Query: 181 ACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDL 240
           +     NL +V E++  G ++  L ++ G F        A  +     YLH  ++I+RDL
Sbjct: 109 SFKDNSNLYMVMEYVPGGEMFSHL-RRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDL 167
Query: 241 KTANLLMDENGVVKVADFGVA-RVQAQSGVMTAETGTYRWMAPEVIEHKPYDYKADVFSF 299
           K  NLL+D+ G ++V DFG A RV+ ++  +    GT  ++APE+I  K Y+   D ++ 
Sbjct: 168 KPENLLIDQQGYIQVTDFGFAKRVKGRTWXL---CGTPEYLAPEIILSKGYNKAVDWWAL 224
Query: 300 GIALWELLTGELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRLAELLERCWQHDPTQRPN 359
           G+ ++E+  G  P+    P+Q    +V   +R   P H    L +LL    Q D T+R  
Sbjct: 225 GVLIYEMAAGYPPFFADQPIQIYEKIVSGKVR--FPSHFSSDLKDLLRNLLQVDLTKR-- 280
Query: 360 FSQITD 365
           F  + D
Sbjct: 281 FGNLKD 286

>pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315

Iteration: 1
 Score = 94.7 bits (234), Expect = 8e-20,   Method: Compositional matrix adjust.
 Identities = 58/238 (24%), Positives = 112/238 (47%), Gaps = 7/238 (2%)
Query: 124 VASGSYGD--LYKGTYCSQEVAIKVLKPECV-NTEMLKEFSQEVYIMRKIRHKNVVQFIG 180
           +  G++G   L +     +  A+K+L+ E +   + +     E  +++  RH  +     
Sbjct: 13  LGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKY 72
Query: 181 ACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDL 240
           A      LC V E+   G ++  L +++ VF          ++   + YLH  ++++RD+
Sbjct: 73  AFQTHDRLCFVMEYANGGELFFHLSRER-VFTEERARFYGAEIVSALEYLHSRDVVYRDI 131
Query: 241 KTANLLMDENGVVKVADFGVARVQAQSG-VMTAETGTYRWMAPEVIEHKPYDYKADVFSF 299
           K  NL++D++G +K+ DFG+ +     G  M    GT  ++APEV+E   Y    D +  
Sbjct: 132 KLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGL 191
Query: 300 GIALWELLTGELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRLAELLERCWQHDPTQR 357
           G+ ++E++ G LP+      +    ++ + +R   P+   P    LL    + DP QR
Sbjct: 192 GVVMYEMMCGRLPFYNQDHERLFELILMEEIR--FPRTLSPEAKSLLAGLLKKDPKQR 247

>pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337

Iteration: 1
 Score = 94.7 bits (234), Expect = 8e-20,   Method: Compositional matrix adjust.
 Identities = 58/238 (24%), Positives = 112/238 (47%), Gaps = 7/238 (2%)
Query: 124 VASGSYGD--LYKGTYCSQEVAIKVLKPECV-NTEMLKEFSQEVYIMRKIRHKNVVQFIG 180
           +  G++G   L +     +  A+K+L+ E +   + +     E  +++  RH  +     
Sbjct: 13  LGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKY 72
Query: 181 ACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDL 240
           A      LC V E+   G ++  L +++ VF          ++   + YLH  ++++RD+
Sbjct: 73  AFQTHDRLCFVMEYANGGELFFHLSRER-VFTEERARFYGAEIVSALEYLHSRDVVYRDI 131
Query: 241 KTANLLMDENGVVKVADFGVARVQAQSG-VMTAETGTYRWMAPEVIEHKPYDYKADVFSF 299
           K  NL++D++G +K+ DFG+ +     G  M    GT  ++APEV+E   Y    D +  
Sbjct: 132 KLENLMLDKDGHIKITDFGLCKEGISDGATMKXFCGTPEYLAPEVLEDNDYGRAVDWWGL 191
Query: 300 GIALWELLTGELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRLAELLERCWQHDPTQR 357
           G+ ++E++ G LP+      +    ++ + +R   P+   P    LL    + DP QR
Sbjct: 192 GVVMYEMMCGRLPFYNQDHERLFELILMEEIR--FPRTLSPEAKSLLAGLLKKDPKQR 247

>pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350

Iteration: 1
 Score = 94.7 bits (234), Expect = 8e-20,   Method: Compositional matrix adjust.
 Identities = 68/238 (28%), Positives = 118/238 (49%), Gaps = 10/238 (4%)
Query: 124 VASGSYGD--LYKGTYCSQEVAIKVL-KPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIG 180
           + +GS+G   L K        A+K+L K + V  + ++    E  I++ +    +V+   
Sbjct: 49  LGTGSFGRVMLVKHKETGNHFAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEY 108
Query: 181 ACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDL 240
           +     NL +V E++  G ++  L ++ G F        A  +     YLH  ++I+RDL
Sbjct: 109 SFKDNSNLYMVMEYVPGGEMFSHL-RRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDL 167
Query: 241 KTANLLMDENGVVKVADFGVA-RVQAQSGVMTAETGTYRWMAPEVIEHKPYDYKADVFSF 299
           K  NLL+D+ G ++V DFG A RV+ ++  +    GT  ++APE+I  K Y+   D ++ 
Sbjct: 168 KPENLLIDQQGYIQVTDFGFAKRVKGRTWXL---CGTPEYLAPEIILSKGYNKAVDWWAL 224
Query: 300 GIALWELLTGELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRLAELLERCWQHDPTQR 357
           G+ ++E+  G  P+    P+Q    +V   +R   P H    L +LL    Q D T+R
Sbjct: 225 GVLIYEMAAGYPPFFADQPIQIYEKIVSGKVR--FPSHFSSDLKDLLRNLLQVDLTKR 280

>pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350

Iteration: 1
 Score = 94.7 bits (234), Expect = 8e-20,   Method: Compositional matrix adjust.
 Identities = 70/246 (28%), Positives = 121/246 (49%), Gaps = 12/246 (4%)
Query: 124 VASGSYGD--LYKGTYCSQEVAIKVL-KPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIG 180
           + +GS+G   L K        A+K+L K + V  + ++    E  I++ +    +V+   
Sbjct: 49  LGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEF 108
Query: 181 ACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDL 240
           +     NL +V E++  G ++  L ++ G F        A  +     YLH  ++I+RDL
Sbjct: 109 SFKDNSNLYMVMEYVPGGEMFSHL-RRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDL 167
Query: 241 KTANLLMDENGVVKVADFGVA-RVQAQSGVMTAETGTYRWMAPEVIEHKPYDYKADVFSF 299
           K  NLL+D+ G ++V DFG A RV+ ++  +    GT  ++APE+I  K Y+   D ++ 
Sbjct: 168 KPENLLIDQQGYIQVTDFGFAKRVKGRTWXL---CGTPEYLAPEIILSKGYNKAVDWWAL 224
Query: 300 GIALWELLTGELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRLAELLERCWQHDPTQRPN 359
           G+ ++E+  G  P+    P+Q    +V   +R   P H    L +LL    Q D T+R  
Sbjct: 225 GVLIYEMAAGYPPFFADQPIQIYEKIVSGKVR--FPSHFSSDLKDLLRNLLQVDLTKR-- 280
Query: 360 FSQITD 365
           F  + D
Sbjct: 281 FGNLKD 286

>pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341

Iteration: 1
 Score = 94.7 bits (234), Expect = 8e-20,   Method: Compositional matrix adjust.
 Identities = 62/239 (25%), Positives = 115/239 (48%), Gaps = 8/239 (3%)
Query: 124 VASGSYGD--LYKGTYCSQEVAIKVLKPEC-VNTEMLKEFSQEVYIMRKIRHKNVVQFIG 180
           +  G++G   L K     +  A+K+LK E  V  + +     E  +++  RH  +     
Sbjct: 17  LGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKY 76
Query: 181 ACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLH-QNNIIHRD 239
           +      LC V E+   G ++  L +++ VF          ++   ++YLH + N+++RD
Sbjct: 77  SFQTHDRLCFVMEYANGGELFFHLSRER-VFSEDRARFYGAEIVSALDYLHSEKNVVYRD 135
Query: 240 LKTANLLMDENGVVKVADFGVARVQAQSG-VMTAETGTYRWMAPEVIEHKPYDYKADVFS 298
           LK  NL++D++G +K+ DFG+ +   + G  M    GT  ++APEV+E   Y    D + 
Sbjct: 136 LKLENLMLDKDGHIKITDFGLCKEGIKDGATMKXFCGTPEYLAPEVLEDNDYGRAVDWWG 195
Query: 299 FGIALWELLTGELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRLAELLERCWQHDPTQR 357
            G+ ++E++ G LP+      +    ++ + +R   P+   P    LL    + DP QR
Sbjct: 196 LGVVMYEMMCGRLPFYNQDHEKLFELILMEEIR--FPRTLGPEAKSLLSGLLKKDPKQR 252

>pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335

Iteration: 1
 Score = 94.7 bits (234), Expect = 8e-20,   Method: Compositional matrix adjust.
 Identities = 58/238 (24%), Positives = 112/238 (47%), Gaps = 7/238 (2%)
Query: 124 VASGSYGD--LYKGTYCSQEVAIKVLKPECV-NTEMLKEFSQEVYIMRKIRHKNVVQFIG 180
           +  G++G   L +     +  A+K+L+ E +   + +     E  +++  RH  +     
Sbjct: 13  LGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKY 72
Query: 181 ACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDL 240
           A      LC V E+   G ++  L +++ VF          ++   + YLH  ++++RD+
Sbjct: 73  AFQTHDRLCFVMEYANGGELFFHLSRER-VFTEERARFYGAEIVSALEYLHSRDVVYRDI 131
Query: 241 KTANLLMDENGVVKVADFGVARVQAQSG-VMTAETGTYRWMAPEVIEHKPYDYKADVFSF 299
           K  NL++D++G +K+ DFG+ +     G  M    GT  ++APEV+E   Y    D +  
Sbjct: 132 KLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGL 191
Query: 300 GIALWELLTGELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRLAELLERCWQHDPTQR 357
           G+ ++E++ G LP+      +    ++ + +R   P+   P    LL    + DP QR
Sbjct: 192 GVVMYEMMCGRLPFYNQDHERLFELILMEEIR--FPRTLSPEAKSLLAGLLKKDPKQR 247

>pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339

Iteration: 1
 Score = 94.7 bits (234), Expect = 9e-20,   Method: Compositional matrix adjust.
 Identities = 58/238 (24%), Positives = 112/238 (47%), Gaps = 7/238 (2%)
Query: 124 VASGSYGD--LYKGTYCSQEVAIKVLKPECV-NTEMLKEFSQEVYIMRKIRHKNVVQFIG 180
           +  G++G   L +     +  A+K+L+ E +   + +     E  +++  RH  +     
Sbjct: 16  LGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKY 75
Query: 181 ACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDL 240
           A      LC V E+   G ++  L +++ VF          ++   + YLH  ++++RD+
Sbjct: 76  AFQTHDRLCFVMEYANGGELFFHLSRER-VFTEERARFYGAEIVSALEYLHSRDVVYRDI 134
Query: 241 KTANLLMDENGVVKVADFGVARVQAQSG-VMTAETGTYRWMAPEVIEHKPYDYKADVFSF 299
           K  NL++D++G +K+ DFG+ +     G  M    GT  ++APEV+E   Y    D +  
Sbjct: 135 KLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGL 194
Query: 300 GIALWELLTGELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRLAELLERCWQHDPTQR 357
           G+ ++E++ G LP+      +    ++ + +R   P+   P    LL    + DP QR
Sbjct: 195 GVVMYEMMCGRLPFYNQDHERLFELILMEEIR--FPRTLSPEAKSLLAGLLKKDPKQR 250

>pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343

Iteration: 1
 Score = 94.7 bits (234), Expect = 9e-20,   Method: Compositional matrix adjust.
 Identities = 68/238 (28%), Positives = 118/238 (49%), Gaps = 10/238 (4%)
Query: 124 VASGSYGD--LYKGTYCSQEVAIKVL-KPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIG 180
           + +GS+G   L K        A+K+L K + V  + ++    E  I++ +    +V+   
Sbjct: 42  LGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEF 101
Query: 181 ACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDL 240
           +     NL +V E++  G ++  L ++ G F        A  +     YLH  ++I+RDL
Sbjct: 102 SFKDNSNLYMVMEYVPGGEMFSHL-RRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDL 160
Query: 241 KTANLLMDENGVVKVADFGVA-RVQAQSGVMTAETGTYRWMAPEVIEHKPYDYKADVFSF 299
           K  NLL+D+ G ++V DFG A RV+ ++  +    GT  ++APE+I  K Y+   D ++ 
Sbjct: 161 KPENLLIDQQGYIQVTDFGFAKRVKGRTWXL---CGTPEYLAPEIILSKGYNKAVDWWAL 217
Query: 300 GIALWELLTGELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRLAELLERCWQHDPTQR 357
           G+ ++E+  G  P+    P+Q    +V   +R   P H    L +LL    Q D T+R
Sbjct: 218 GVLIYEMAAGYPPFFADQPIQIYEKIVSGKVR--FPSHFSSDLKDLLRNLLQVDLTKR 273

>pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446

Iteration: 1
 Score = 94.7 bits (234), Expect = 9e-20,   Method: Compositional matrix adjust.
 Identities = 62/239 (25%), Positives = 115/239 (48%), Gaps = 8/239 (3%)
Query: 124 VASGSYGD--LYKGTYCSQEVAIKVLKPEC-VNTEMLKEFSQEVYIMRKIRHKNVVQFIG 180
           +  G++G   L K     +  A+K+LK E  V  + +     E  +++  RH  +     
Sbjct: 159 LGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKY 218
Query: 181 ACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLH-QNNIIHRD 239
           +      LC V E+   G ++  L +++ VF          ++   ++YLH + N+++RD
Sbjct: 219 SFQTHDRLCFVMEYANGGELFFHLSRER-VFSEDRARFYGAEIVSALDYLHSEKNVVYRD 277
Query: 240 LKTANLLMDENGVVKVADFGVARVQAQSG-VMTAETGTYRWMAPEVIEHKPYDYKADVFS 298
           LK  NL++D++G +K+ DFG+ +   + G  M    GT  ++APEV+E   Y    D + 
Sbjct: 278 LKLENLMLDKDGHIKITDFGLCKEGIKDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWG 337
Query: 299 FGIALWELLTGELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRLAELLERCWQHDPTQR 357
            G+ ++E++ G LP+      +    ++ + +R   P+   P    LL    + DP QR
Sbjct: 338 LGVVMYEMMCGRLPFYNQDHEKLFELILMEEIR--FPRTLGPEAKSLLSGLLKKDPKQR 394

>pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343

Iteration: 1
 Score = 94.4 bits (233), Expect = 9e-20,   Method: Compositional matrix adjust.
 Identities = 68/238 (28%), Positives = 118/238 (49%), Gaps = 10/238 (4%)
Query: 124 VASGSYGD--LYKGTYCSQEVAIKVL-KPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIG 180
           + +GS+G   L K        A+K+L K + V  + ++    E  I++ +    +V+   
Sbjct: 42  LGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEF 101
Query: 181 ACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDL 240
           +     NL +V E++  G ++  L ++ G F        A  +     YLH  ++I+RDL
Sbjct: 102 SFKDNSNLYMVMEYVPGGEMFSHL-RRIGRFXEPHARFYAAQIVLTFEYLHSLDLIYRDL 160
Query: 241 KTANLLMDENGVVKVADFGVA-RVQAQSGVMTAETGTYRWMAPEVIEHKPYDYKADVFSF 299
           K  NLL+D+ G ++V DFG A RV+ ++  +    GT  ++APE+I  K Y+   D ++ 
Sbjct: 161 KPENLLIDQQGYIQVTDFGFAKRVKGRTWXL---CGTPEYLAPEIILSKGYNKAVDWWAL 217
Query: 300 GIALWELLTGELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRLAELLERCWQHDPTQR 357
           G+ ++E+  G  P+    P+Q    +V   +R   P H    L +LL    Q D T+R
Sbjct: 218 GVLIYEMAAGYPPFFADQPIQIYEKIVSGKVR--FPSHFSSDLKDLLRNLLQVDLTKR 273

>pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446

Iteration: 1
 Score = 94.4 bits (233), Expect = 9e-20,   Method: Compositional matrix adjust.
 Identities = 62/239 (25%), Positives = 115/239 (48%), Gaps = 8/239 (3%)
Query: 124 VASGSYGD--LYKGTYCSQEVAIKVLKPEC-VNTEMLKEFSQEVYIMRKIRHKNVVQFIG 180
           +  G++G   L K     +  A+K+LK E  V  + +     E  +++  RH  +     
Sbjct: 156 LGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKY 215
Query: 181 ACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLH-QNNIIHRD 239
           +      LC V E+   G ++  L +++ VF          ++   ++YLH + N+++RD
Sbjct: 216 SFQTHDRLCFVMEYANGGELFFHLSRER-VFSEDRARFYGAEIVSALDYLHSEKNVVYRD 274
Query: 240 LKTANLLMDENGVVKVADFGVARVQAQSG-VMTAETGTYRWMAPEVIEHKPYDYKADVFS 298
           LK  NL++D++G +K+ DFG+ +   + G  M    GT  ++APEV+E   Y    D + 
Sbjct: 275 LKLENLMLDKDGHIKITDFGLCKEGIKDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWG 334
Query: 299 FGIALWELLTGELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRLAELLERCWQHDPTQR 357
            G+ ++E++ G LP+      +    ++ + +R   P+   P    LL    + DP QR
Sbjct: 335 LGVVMYEMMCGRLPFYNQDHEKLFELILMEEIR--FPRTLGPEAKSLLSGLLKKDPKQR 391

>pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342

Iteration: 1
 Score = 94.4 bits (233), Expect = 9e-20,   Method: Compositional matrix adjust.
 Identities = 62/239 (25%), Positives = 115/239 (48%), Gaps = 8/239 (3%)
Query: 124 VASGSYGD--LYKGTYCSQEVAIKVLKPEC-VNTEMLKEFSQEVYIMRKIRHKNVVQFIG 180
           +  G++G   L K     +  A+K+LK E  V  + +     E  +++  RH  +     
Sbjct: 18  LGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKY 77
Query: 181 ACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLH-QNNIIHRD 239
           +      LC V E+   G ++  L +++ VF          ++   ++YLH + N+++RD
Sbjct: 78  SFQTHDRLCFVMEYANGGELFFHLSRER-VFSEDRARFYGAEIVSALDYLHSEKNVVYRD 136
Query: 240 LKTANLLMDENGVVKVADFGVARVQAQSG-VMTAETGTYRWMAPEVIEHKPYDYKADVFS 298
           LK  NL++D++G +K+ DFG+ +   + G  M    GT  ++APEV+E   Y    D + 
Sbjct: 137 LKLENLMLDKDGHIKITDFGLCKEGIKDGATMKXFCGTPEYLAPEVLEDNDYGRAVDWWG 196
Query: 299 FGIALWELLTGELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRLAELLERCWQHDPTQR 357
            G+ ++E++ G LP+      +    ++ + +R   P+   P    LL    + DP QR
Sbjct: 197 LGVVMYEMMCGRLPFYNQDHEKLFELILMEEIR--FPRTLGPEAKSLLSGLLKKDPKQR 253

>pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351

Iteration: 1
 Score = 94.4 bits (233), Expect = 9e-20,   Method: Compositional matrix adjust.
 Identities = 68/238 (28%), Positives = 118/238 (49%), Gaps = 10/238 (4%)
Query: 124 VASGSYGD--LYKGTYCSQEVAIKVL-KPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIG 180
           + +GS+G   L K        A+K+L K + V  + ++    E  I++ +    +V+   
Sbjct: 50  LGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEF 109
Query: 181 ACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDL 240
           +     NL +V E++  G ++  L ++ G F        A  +     YLH  ++I+RDL
Sbjct: 110 SFKDNSNLYMVMEYVPGGEMFSHL-RRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDL 168
Query: 241 KTANLLMDENGVVKVADFGVA-RVQAQSGVMTAETGTYRWMAPEVIEHKPYDYKADVFSF 299
           K  NLL+D+ G ++V DFG A RV+ ++  +    GT  ++APE+I  K Y+   D ++ 
Sbjct: 169 KPENLLIDQQGYIQVTDFGFAKRVKGRTWXL---CGTPEYLAPEIILSKGYNKAVDWWAL 225
Query: 300 GIALWELLTGELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRLAELLERCWQHDPTQR 357
           G+ ++E+  G  P+    P+Q    +V   +R   P H    L +LL    Q D T+R
Sbjct: 226 GVLIYEMAAGYPPFFADQPIQIYEKIVSGKVR--FPSHFSSDLKDLLRNLLQVDLTKR 281

>pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373

Iteration: 1
 Score = 94.4 bits (233), Expect = 9e-20,   Method: Compositional matrix adjust.
 Identities = 63/241 (26%), Positives = 118/241 (48%), Gaps = 12/241 (4%)
Query: 124 VASGSYGDLYKGTYCSQEV--AIKVLKPECV--NTEMLKEFSQEVYIMRKIRHKNVVQFI 179
           +  GS+G +    + ++EV  A+KVL+ + +    E     S+   +++ ++H  +V   
Sbjct: 46  IGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLH 105
Query: 180 GACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRD 239
            +      L  V +++  G ++  L +++   +  +    A +++  + YLH  NI++RD
Sbjct: 106 FSFQTADKLYFVLDYINGGELFYHLQRERCFLEPRARFYAA-EIASALGYLHSLNIVYRD 164
Query: 240 LKTANLLMDENGVVKVADFGVARVQAQSGVMTAE-TGTYRWMAPEVIEHKPYDYKADVFS 298
           LK  N+L+D  G + + DFG+ +   +    T+   GT  ++APEV+  +PYD   D + 
Sbjct: 165 LKPENILLDSQGHIVLTDFGLCKENIEHNSTTSTFCGTPEYLAPEVLHKQPYDRTVDWWC 224
Query: 299 FGIALWELLTGELPYAGLTPLQAAVGVVQK--SLRPTIPKHAHPRLAELLERCWQHDPTQ 356
            G  L+E+L G  P+      +    ++ K   L+P I   A      LLE   Q D T+
Sbjct: 225 LGAVLYEMLYGLPPFYSRNTAEMYDNILNKPLQLKPNITNSAR----HLLEGLLQKDRTK 280
Query: 357 R 357
           R
Sbjct: 281 R 281

>pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351

Iteration: 1
 Score = 94.4 bits (233), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 68/238 (28%), Positives = 118/238 (49%), Gaps = 10/238 (4%)
Query: 124 VASGSYGD--LYKGTYCSQEVAIKVL-KPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIG 180
           + +GS+G   L K        A+K+L K + V  + ++    E  I++ +    +V+   
Sbjct: 50  LGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEF 109
Query: 181 ACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDL 240
           +     NL +V E++  G ++  L ++ G F        A  +     YLH  ++I+RDL
Sbjct: 110 SFKDNSNLYMVMEYVPGGEMFSHL-RRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDL 168
Query: 241 KTANLLMDENGVVKVADFGVA-RVQAQSGVMTAETGTYRWMAPEVIEHKPYDYKADVFSF 299
           K  NLL+D+ G ++V DFG A RV+ ++  +    GT  ++APE+I  K Y+   D ++ 
Sbjct: 169 KPENLLIDQQGYIQVTDFGFAKRVKGRTWXL---CGTPEYLAPEIILSKGYNKAVDWWAL 225
Query: 300 GIALWELLTGELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRLAELLERCWQHDPTQR 357
           G+ ++E+  G  P+    P+Q    +V   +R   P H    L +LL    Q D T+R
Sbjct: 226 GVLIYEMAAGYPPFFADQPIQIYEKIVSGKVR--FPSHFSSDLKDLLRNLLQVDLTKR 281

>pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351

Iteration: 1
 Score = 94.4 bits (233), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 68/238 (28%), Positives = 117/238 (49%), Gaps = 10/238 (4%)
Query: 124 VASGSYGD--LYKGTYCSQEVAIKVL-KPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIG 180
           + +GS+G   L K        A+K+L K + V  + ++    E  I++ +    +V+   
Sbjct: 50  LGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEF 109
Query: 181 ACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDL 240
           +     NL +V E+   G ++  L ++ G F        A  +     YLH  ++I+RDL
Sbjct: 110 SFKDNSNLYMVMEYAPGGEMFSHL-RRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDL 168
Query: 241 KTANLLMDENGVVKVADFGVA-RVQAQSGVMTAETGTYRWMAPEVIEHKPYDYKADVFSF 299
           K  NL++D+ G +KV DFG A RV+ ++  +    GT  ++APE+I  K Y+   D ++ 
Sbjct: 169 KPENLMIDQQGYIKVTDFGFAKRVKGRTWXL---CGTPEYLAPEIILSKGYNKAVDWWAL 225
Query: 300 GIALWELLTGELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRLAELLERCWQHDPTQR 357
           G+ ++E+  G  P+    P+Q    +V   +R   P H    L +LL    Q D T+R
Sbjct: 226 GVLIYEMAAGYPPFFADQPIQIYEKIVSGKVR--FPSHFSSDLKDLLRNLLQVDLTKR 281

>pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371

Iteration: 1
 Score = 94.4 bits (233), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 68/238 (28%), Positives = 118/238 (49%), Gaps = 10/238 (4%)
Query: 124 VASGSYGD--LYKGTYCSQEVAIKVL-KPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIG 180
           + +GS+G   L K        A+K+L K + V  + ++    E  I++ +    +V+   
Sbjct: 70  LGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEF 129
Query: 181 ACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDL 240
           +     NL +V E++  G ++  L ++ G F        A  +     YLH  ++I+RDL
Sbjct: 130 SFKDNSNLYMVMEYVPGGEMFSHL-RRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDL 188
Query: 241 KTANLLMDENGVVKVADFGVA-RVQAQSGVMTAETGTYRWMAPEVIEHKPYDYKADVFSF 299
           K  NLL+D+ G ++V DFG A RV+ ++  +    GT  ++APE+I  K Y+   D ++ 
Sbjct: 189 KPENLLIDQQGYIQVTDFGFAKRVKGRTWXL---CGTPEYLAPEIILSKGYNKAVDWWAL 245
Query: 300 GIALWELLTGELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRLAELLERCWQHDPTQR 357
           G+ ++E+  G  P+    P+Q    +V   +R   P H    L +LL    Q D T+R
Sbjct: 246 GVLIYEMAAGYPPFFADQPIQIYEKIVSGKVR--FPSHFSSDLKDLLRNLLQVDLTKR 301

>pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336

Iteration: 1
 Score = 94.4 bits (233), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 58/238 (24%), Positives = 112/238 (47%), Gaps = 7/238 (2%)
Query: 124 VASGSYGD--LYKGTYCSQEVAIKVLKPECV-NTEMLKEFSQEVYIMRKIRHKNVVQFIG 180
           +  G++G   L +     +  A+K+L+ E +   + +     E  +++  RH  +     
Sbjct: 13  LGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKY 72
Query: 181 ACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDL 240
           A      LC V E+   G ++  L +++ VF          ++   + YLH  ++++RD+
Sbjct: 73  AFQTHDRLCFVMEYANGGELFFHLSRER-VFTEERARFYGAEIVSALEYLHSRDVVYRDI 131
Query: 241 KTANLLMDENGVVKVADFGVARVQAQSG-VMTAETGTYRWMAPEVIEHKPYDYKADVFSF 299
           K  NL++D++G +K+ DFG+ +     G  M    GT  ++APEV+E   Y    D +  
Sbjct: 132 KLENLMLDKDGHIKITDFGLCKEGISDGATMKXFCGTPEYLAPEVLEDNDYGRAVDWWGL 191
Query: 300 GIALWELLTGELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRLAELLERCWQHDPTQR 357
           G+ ++E++ G LP+      +    ++ + +R   P+   P    LL    + DP QR
Sbjct: 192 GVVMYEMMCGRLPFYNQDHERLFELILMEEIR--FPRTLSPEAKSLLAGLLKKDPKQR 247

>pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350

Iteration: 1
 Score = 94.4 bits (233), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 68/238 (28%), Positives = 118/238 (49%), Gaps = 10/238 (4%)
Query: 124 VASGSYGD--LYKGTYCSQEVAIKVL-KPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIG 180
           + +GS+G   L K        A+K+L K + V  + ++    E  I++ +    +V+   
Sbjct: 49  LGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEF 108
Query: 181 ACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDL 240
           +     NL +V E++  G ++  L ++ G F        A  +     YLH  ++I+RDL
Sbjct: 109 SFKDNSNLYMVMEYVPGGEMFSHL-RRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDL 167
Query: 241 KTANLLMDENGVVKVADFGVA-RVQAQSGVMTAETGTYRWMAPEVIEHKPYDYKADVFSF 299
           K  NLL+D+ G ++V DFG A RV+ ++  +    GT  ++APE+I  K Y+   D ++ 
Sbjct: 168 KPENLLIDQQGYIQVTDFGFAKRVKGRTWXL---CGTPEYLAPEIILSKGYNKAVDWWAL 224
Query: 300 GIALWELLTGELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRLAELLERCWQHDPTQR 357
           G+ ++E+  G  P+    P+Q    +V   +R   P H    L +LL    Q D T+R
Sbjct: 225 GVLIYEMAAGYPPFFADQPIQIYEKIVSGKVR--FPSHFSSDLKDLLRNLLQVDLTKR 280

>pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350

Iteration: 1
 Score = 94.4 bits (233), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 68/238 (28%), Positives = 117/238 (49%), Gaps = 10/238 (4%)
Query: 124 VASGSYGD--LYKGTYCSQEVAIKVL-KPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIG 180
           + +GS+G   L K        A+K+L K + V  + ++    E  I++ +    +V+   
Sbjct: 49  LGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEF 108
Query: 181 ACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDL 240
           +     NL +V E+   G ++  L ++ G F        A  +     YLH  ++I+RDL
Sbjct: 109 SFKDNSNLYMVMEYAPGGEMFSHL-RRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDL 167
Query: 241 KTANLLMDENGVVKVADFGVA-RVQAQSGVMTAETGTYRWMAPEVIEHKPYDYKADVFSF 299
           K  NL++D+ G +KV DFG A RV+ ++  +    GT  ++APE+I  K Y+   D ++ 
Sbjct: 168 KPENLMIDQQGYIKVTDFGFAKRVKGRTWXL---CGTPEYLAPEIILSKGYNKAVDWWAL 224
Query: 300 GIALWELLTGELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRLAELLERCWQHDPTQR 357
           G+ ++E+  G  P+    P+Q    +V   +R   P H    L +LL    Q D T+R
Sbjct: 225 GVLIYEMAAGYPPFFADQPIQIYEKIVSGKVR--FPSHFSSDLKDLLRNLLQVDLTKR 280

>pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351

Iteration: 1
 Score = 94.4 bits (233), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 68/238 (28%), Positives = 118/238 (49%), Gaps = 10/238 (4%)
Query: 124 VASGSYGD--LYKGTYCSQEVAIKVL-KPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIG 180
           + +GS+G   L K        A+K+L K + V  + ++    E  I++ +    +V+   
Sbjct: 50  LGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEF 109
Query: 181 ACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDL 240
           +     NL +V E++  G ++  L ++ G F        A  +     YLH  ++I+RDL
Sbjct: 110 SFKDNSNLYMVMEYVPGGEMFSHL-RRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDL 168
Query: 241 KTANLLMDENGVVKVADFGVA-RVQAQSGVMTAETGTYRWMAPEVIEHKPYDYKADVFSF 299
           K  NLL+D+ G ++V DFG A RV+ ++  +    GT  ++APE+I  K Y+   D ++ 
Sbjct: 169 KPENLLIDQQGYIQVTDFGFAKRVKGRTWXL---CGTPEYLAPEIILSKGYNKAVDWWAL 225
Query: 300 GIALWELLTGELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRLAELLERCWQHDPTQR 357
           G+ ++E+  G  P+    P+Q    +V   +R   P H    L +LL    Q D T+R
Sbjct: 226 GVLIYEMAAGYPPFFADQPIQIYEKIVSGKVR--FPSHFSSDLKDLLRNLLQVDLTKR 281

>pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351

Iteration: 1
 Score = 94.4 bits (233), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 68/238 (28%), Positives = 118/238 (49%), Gaps = 10/238 (4%)
Query: 124 VASGSYGD--LYKGTYCSQEVAIKVL-KPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIG 180
           + +GS+G   L K        A+K+L K + V  + ++    E  I++ +    +V+   
Sbjct: 50  LGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEF 109
Query: 181 ACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDL 240
           +     NL +V E++  G ++  L ++ G F        A  +     YLH  ++I+RDL
Sbjct: 110 SFKDNSNLYMVMEYVPGGEMFSHL-RRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDL 168
Query: 241 KTANLLMDENGVVKVADFGVA-RVQAQSGVMTAETGTYRWMAPEVIEHKPYDYKADVFSF 299
           K  NLL+D+ G ++V DFG A RV+ ++  +    GT  ++APE+I  K Y+   D ++ 
Sbjct: 169 KPENLLIDQQGYIQVTDFGFAKRVKGRTWXL---CGTPEYLAPEIILSKGYNKAVDWWAL 225
Query: 300 GIALWELLTGELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRLAELLERCWQHDPTQR 357
           G+ ++E+  G  P+    P+Q    +V   +R   P H    L +LL    Q D T+R
Sbjct: 226 GVLIYEMAAGYPPFFADQPIQIYEKIVSGKVR--FPSHFSSDLKDLLRNLLQVDLTKR 281

>pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335

Iteration: 1
 Score = 94.4 bits (233), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 58/238 (24%), Positives = 112/238 (47%), Gaps = 7/238 (2%)
Query: 124 VASGSYGD--LYKGTYCSQEVAIKVLKPECV-NTEMLKEFSQEVYIMRKIRHKNVVQFIG 180
           +  G++G   L +     +  A+K+L+ E +   + +     E  +++  RH  +     
Sbjct: 13  LGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKY 72
Query: 181 ACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDL 240
           A      LC V E+   G ++  L +++ VF          ++   + YLH  ++++RD+
Sbjct: 73  AFQTHDRLCFVMEYANGGELFFHLSRER-VFTEERARFYGAEIVSALEYLHSRDVVYRDI 131
Query: 241 KTANLLMDENGVVKVADFGVARVQAQSG-VMTAETGTYRWMAPEVIEHKPYDYKADVFSF 299
           K  NL++D++G +K+ DFG+ +     G  M    GT  ++APEV+E   Y    D +  
Sbjct: 132 KLENLMLDKDGHIKITDFGLCKEGISDGATMKXFCGTPEYLAPEVLEDNDYGRAVDWWGL 191
Query: 300 GIALWELLTGELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRLAELLERCWQHDPTQR 357
           G+ ++E++ G LP+      +    ++ + +R   P+   P    LL    + DP QR
Sbjct: 192 GVVMYEMMCGRLPFYNQDHERLFELILMEEIR--FPRTLSPEAKSLLAGLLKKDPKQR 247

>pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285

Iteration: 1
 Score = 94.4 bits (233), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 64/237 (27%), Positives = 114/237 (48%), Gaps = 7/237 (2%)
Query: 124 VASGSYGDLYKGTYCSQE--VAIKVLKPECVNTEMLK-EFSQEVYIMRKIRHKNVVQFIG 180
           +  G +G++Y       +  +A+KVL    +  E ++ +  +E+ I   +RH N+++   
Sbjct: 23  LGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYN 82
Query: 181 ACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDL 240
                  + ++ EF  RG +Y  L K  G F          +++  ++Y H+  +IHRD+
Sbjct: 83  YFHDRKRIYLMLEFAPRGELYKELQKH-GRFDEQRSATFMEELADALHYCHERKVIHRDI 141
Query: 241 KTANLLMDENGVVKVADFGVARVQAQSGVMTAETGTYRWMAPEVIEHKPYDYKADVFSFG 300
           K  NLLM   G +K+ADFG + V A S       GT  ++ PE+IE K +D K D++  G
Sbjct: 142 KPENLLMGYKGELKIADFGWS-VHAPSLRRRXMCGTLDYLPPEMIEGKTHDEKVDLWCAG 200
Query: 301 IALWELLTGELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRLAELLERCWQHDPTQR 357
           +  +E L G  P+   +  +    +V   L+   P        +L+ +  ++ P QR
Sbjct: 201 VLCYEFLVGMPPFDSPSHTETHRRIVNVDLK--FPPFLSDGSKDLISKLLRYHPPQR 255

>pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350

Iteration: 1
 Score = 94.4 bits (233), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 68/238 (28%), Positives = 118/238 (49%), Gaps = 10/238 (4%)
Query: 124 VASGSYGD--LYKGTYCSQEVAIKVL-KPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIG 180
           + +GS+G   L K        A+K+L K + V  + ++    E  I++ +    +V+   
Sbjct: 49  LGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKEIEHTLNEKRILQAVNFPFLVKLEF 108
Query: 181 ACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDL 240
           +     NL +V E+   G ++  L ++ G F        A  +     YLH  ++I+RDL
Sbjct: 109 SFKDNSNLYMVMEYAPGGEMFSHL-RRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDL 167
Query: 241 KTANLLMDENGVVKVADFGVA-RVQAQSGVMTAETGTYRWMAPEVIEHKPYDYKADVFSF 299
           K  NL++D+ G +KV DFG+A RV+ ++  +    GT  ++APE+I  K Y+   D ++ 
Sbjct: 168 KPENLMIDQQGYIKVTDFGLAKRVKGRTWXL---CGTPEYLAPEIILSKGYNKAVDWWAL 224
Query: 300 GIALWELLTGELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRLAELLERCWQHDPTQR 357
           G+ ++E+  G  P+    P+Q    +V   +R   P H    L +LL    Q D T+R
Sbjct: 225 GVLIYEMAAGYPPFFADQPIQIYEKIVSGKVR--FPSHFSSDLKDLLRNLLQVDLTKR 280

>pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 94.4 bits (233), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 69/238 (28%), Positives = 118/238 (49%), Gaps = 10/238 (4%)
Query: 124 VASGSYGD--LYKGTYCSQEVAIKVL-KPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIG 180
           + +GS+G   L K        A+K+L K + V  + ++    E  I++ +    +V+   
Sbjct: 49  LGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEF 108
Query: 181 ACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDL 240
           +     NL +V E++A G ++  L ++ G F        A  +     YLH  ++I+RDL
Sbjct: 109 SFKDNSNLYMVMEYVAGGEMFSHL-RRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDL 167
Query: 241 KTANLLMDENGVVKVADFGVA-RVQAQSGVMTAETGTYRWMAPEVIEHKPYDYKADVFSF 299
           K  NLL+D+ G ++V DFG A RV+ ++  +    GT   +APE+I  K Y+   D ++ 
Sbjct: 168 KPENLLIDQQGYIQVTDFGFAKRVKGRTWXL---CGTPEALAPEIILSKGYNKAVDWWAL 224
Query: 300 GIALWELLTGELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRLAELLERCWQHDPTQR 357
           G+ ++E+  G  P+    P+Q    +V   +R   P H    L +LL    Q D T+R
Sbjct: 225 GVLIYEMAAGYPPFFADQPIQIYEKIVSGKVR--FPSHFSSDLKDLLRNLLQVDLTKR 280

>pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351

Iteration: 1
 Score = 94.4 bits (233), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 68/238 (28%), Positives = 118/238 (49%), Gaps = 10/238 (4%)
Query: 124 VASGSYGD--LYKGTYCSQEVAIKVL-KPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIG 180
           + +GS+G   L K        A+K+L K + V  + ++    E  I++ +    +V+   
Sbjct: 50  LGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEF 109
Query: 181 ACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDL 240
           +     NL +V E++  G ++  L ++ G F        A  +     YLH  ++I+RDL
Sbjct: 110 SFKDNSNLYMVMEYVPGGEMFSHL-RRIGRFXEPHARFYAAQIVLTFEYLHSLDLIYRDL 168
Query: 241 KTANLLMDENGVVKVADFGVA-RVQAQSGVMTAETGTYRWMAPEVIEHKPYDYKADVFSF 299
           K  NLL+D+ G ++V DFG A RV+ ++  +    GT  ++APE+I  K Y+   D ++ 
Sbjct: 169 KPENLLIDQQGYIQVTDFGFAKRVKGRTWXL---CGTPEYLAPEIILSKGYNKAVDWWAL 225
Query: 300 GIALWELLTGELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRLAELLERCWQHDPTQR 357
           G+ ++E+  G  P+    P+Q    +V   +R   P H    L +LL    Q D T+R
Sbjct: 226 GVLIYEMAAGYPPFFADQPIQIYEKIVSGKVR--FPSHFSSDLKDLLRNLLQVDLTKR 281

>pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350

Iteration: 1
 Score = 94.0 bits (232), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 68/238 (28%), Positives = 117/238 (49%), Gaps = 10/238 (4%)
Query: 124 VASGSYGD--LYKGTYCSQEVAIKVL-KPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIG 180
           + +GS+G   L K        A+K+L K + V  + ++    E  I++ +    +V+   
Sbjct: 49  LGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEF 108
Query: 181 ACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDL 240
           +     NL +V E+   G ++  L ++ G F        A  +     YLH  ++I+RDL
Sbjct: 109 SFKDNSNLYMVMEYAPGGEMFSHL-RRIGRFXEPHARFYAAQIVLTFEYLHSLDLIYRDL 167
Query: 241 KTANLLMDENGVVKVADFGVA-RVQAQSGVMTAETGTYRWMAPEVIEHKPYDYKADVFSF 299
           K  NL++D+ G +KV DFG A RV+ ++  +    GT  ++APE+I  K Y+   D ++ 
Sbjct: 168 KPENLMIDQQGYIKVTDFGFAKRVKGRTWXL---CGTPEYLAPEIILSKGYNKAVDWWAL 224
Query: 300 GIALWELLTGELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRLAELLERCWQHDPTQR 357
           G+ ++E+  G  P+    P+Q    +V   +R   P H    L +LL    Q D T+R
Sbjct: 225 GVLIYEMAAGYPPFFADQPIQIYEKIVSGKVR--FPSHFSSDLKDLLRNLLQVDLTKR 280

>pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350

Iteration: 1
 Score = 94.0 bits (232), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 68/238 (28%), Positives = 118/238 (49%), Gaps = 10/238 (4%)
Query: 124 VASGSYGD--LYKGTYCSQEVAIKVL-KPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIG 180
           + +GS+G   L K        A+K+L K + V  + ++    E  I++ +    +V+   
Sbjct: 49  LGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEF 108
Query: 181 ACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDL 240
           +     NL +V E++  G ++  L ++ G F        A  +     YLH  ++I+RDL
Sbjct: 109 SFKDNSNLYMVMEYVPGGEMFSHL-RRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDL 167
Query: 241 KTANLLMDENGVVKVADFGVA-RVQAQSGVMTAETGTYRWMAPEVIEHKPYDYKADVFSF 299
           K  NLL+D+ G ++V DFG A RV+ ++  +    GT  ++APE+I  K Y+   D ++ 
Sbjct: 168 KPENLLIDQQGYIQVTDFGFAKRVKGRTWXL---CGTPEYLAPEIILSKGYNKAVDWWAL 224
Query: 300 GIALWELLTGELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRLAELLERCWQHDPTQR 357
           G+ ++E+  G  P+    P+Q    +V   +R   P H    L +LL    Q D T+R
Sbjct: 225 GVLIYEMAAGYPPFFADQPIQIYEKIVSGKVR--FPSHFSSDLKDLLRNLLQVDLTKR 280

>pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284

Iteration: 1
 Score = 94.0 bits (232), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 64/237 (27%), Positives = 114/237 (48%), Gaps = 7/237 (2%)
Query: 124 VASGSYGDLYKGTYCSQE--VAIKVLKPECVNTEMLK-EFSQEVYIMRKIRHKNVVQFIG 180
           +  G +G++Y       +  +A+KVL    +  E ++ +  +E+ I   +RH N+++   
Sbjct: 22  LGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYN 81
Query: 181 ACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDL 240
                  + ++ EF  RG +Y  L K  G F          +++  ++Y H+  +IHRD+
Sbjct: 82  YFHDRKRIYLMLEFAPRGELYKELQKH-GRFDEQRSATFMEELADALHYCHERKVIHRDI 140
Query: 241 KTANLLMDENGVVKVADFGVARVQAQSGVMTAETGTYRWMAPEVIEHKPYDYKADVFSFG 300
           K  NLLM   G +K+ADFG + V A S       GT  ++ PE+IE K +D K D++  G
Sbjct: 141 KPENLLMGYKGELKIADFGWS-VHAPSLRRRXMCGTLDYLPPEMIEGKTHDEKVDLWCAG 199
Query: 301 IALWELLTGELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRLAELLERCWQHDPTQR 357
           +  +E L G  P+   +  +    +V   L+   P        +L+ +  ++ P QR
Sbjct: 200 VLCYEFLVGMPPFDSPSHTETHRRIVNVDLK--FPPFLSDGSKDLISKLLRYHPPQR 254

>pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 94.0 bits (232), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 68/237 (28%), Positives = 118/237 (49%), Gaps = 10/237 (4%)
Query: 124 VASGSYGD--LYKGTYCSQEVAIKVL-KPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIG 180
           + +GS+G   L K        A+K+L K + V  + ++    E  I++ +    +V+   
Sbjct: 49  LGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEF 108
Query: 181 ACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDL 240
           +     NL +V E++A G ++  L ++ G F        A  +     YLH  ++I+RDL
Sbjct: 109 SFKDNSNLYMVMEYVAGGEMFSHL-RRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDL 167
Query: 241 KTANLLMDENGVVKVADFGVA-RVQAQSGVMTAETGTYRWMAPEVIEHKPYDYKADVFSF 299
           K  NLL+D+ G ++V DFG A RV+ ++  +    GT  ++APE+I  K Y+   D ++ 
Sbjct: 168 KPENLLIDQQGYIQVTDFGFAKRVKGRTWXL---CGTPEYLAPEIILSKGYNKAVDWWAL 224
Query: 300 GIALWELLTGELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRLAELLERCWQHDPTQ 356
           G+ ++E+  G  P+    P+Q    +V   +R   P H    L +LL    Q D T+
Sbjct: 225 GVLIYEMAAGYPPFFADQPIQIYEKIVSGKVR--FPSHFSSDLKDLLRNLLQVDLTK 279

>pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350

Iteration: 1
 Score = 94.0 bits (232), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 68/238 (28%), Positives = 118/238 (49%), Gaps = 10/238 (4%)
Query: 124 VASGSYGD--LYKGTYCSQEVAIKVL-KPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIG 180
           + +GS+G   L K        A+K+L K + V  + ++    E  I++ +    +V+   
Sbjct: 49  LGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEF 108
Query: 181 ACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDL 240
           +     NL +V E++  G ++  L ++ G F        A  +     YLH  ++I+RDL
Sbjct: 109 SFKDNSNLYMVMEYVPGGEMFSHL-RRIGRFXEPHARFYAAQIVLTFEYLHSLDLIYRDL 167
Query: 241 KTANLLMDENGVVKVADFGVA-RVQAQSGVMTAETGTYRWMAPEVIEHKPYDYKADVFSF 299
           K  NLL+D+ G ++V DFG A RV+ ++  +    GT  ++APE+I  K Y+   D ++ 
Sbjct: 168 KPENLLIDQQGYIQVTDFGFAKRVKGRTWXL---CGTPEYLAPEIILSKGYNKAVDWWAL 224
Query: 300 GIALWELLTGELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRLAELLERCWQHDPTQR 357
           G+ ++E+  G  P+    P+Q    +V   +R   P H    L +LL    Q D T+R
Sbjct: 225 GVLIYEMAAGYPPFFADQPIQIYEKIVSGKVR--FPSHFSSDLKDLLRNLLQVDLTKR 280

>pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350

Iteration: 1
 Score = 94.0 bits (232), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 68/238 (28%), Positives = 118/238 (49%), Gaps = 10/238 (4%)
Query: 124 VASGSYGD--LYKGTYCSQEVAIKVL-KPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIG 180
           + +GS+G   L K        A+K+L K + V  + ++    E  I++ +    +V+   
Sbjct: 49  LGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEF 108
Query: 181 ACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDL 240
           +     NL +V E++  G ++  L ++ G F        A  +     YLH  ++I+RDL
Sbjct: 109 SFKDNSNLYMVMEYVPGGEMFSHL-RRIGRFXEPHARFYAAQIVLTFEYLHSLDLIYRDL 167
Query: 241 KTANLLMDENGVVKVADFGVA-RVQAQSGVMTAETGTYRWMAPEVIEHKPYDYKADVFSF 299
           K  NLL+D+ G ++V DFG A RV+ ++  +    GT  ++APE+I  K Y+   D ++ 
Sbjct: 168 KPENLLIDQQGYIQVTDFGFAKRVKGRTWXL---CGTPEYLAPEIILSKGYNKAVDWWAL 224
Query: 300 GIALWELLTGELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRLAELLERCWQHDPTQR 357
           G+ ++E+  G  P+    P+Q    +V   +R   P H    L +LL    Q D T+R
Sbjct: 225 GVLIYEMAAGYPPFFADQPIQIYEKIVSGKVR--FPSHFSSDLKDLLRNLLQVDLTKR 280

>pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 94.0 bits (232), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 68/238 (28%), Positives = 118/238 (49%), Gaps = 10/238 (4%)
Query: 124 VASGSYGD--LYKGTYCSQEVAIKVL-KPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIG 180
           + +GS+G   L K        A+K+L K + V  + ++    E  I++ +    +V+   
Sbjct: 49  LGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEF 108
Query: 181 ACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDL 240
           +     NL +V E++A G ++  L ++ G F        A  +     YLH  ++I+RDL
Sbjct: 109 SFKDNSNLYMVMEYVAGGEMFSHL-RRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDL 167
Query: 241 KTANLLMDENGVVKVADFGVA-RVQAQSGVMTAETGTYRWMAPEVIEHKPYDYKADVFSF 299
           K  NLL+D+ G ++V DFG A RV+ ++  +    GT  ++AP +I  K Y+   D ++ 
Sbjct: 168 KPENLLIDQQGYIQVTDFGFAKRVKGRTWXL---CGTPEYLAPAIILSKGYNKAVDWWAL 224
Query: 300 GIALWELLTGELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRLAELLERCWQHDPTQR 357
           G+ ++E+  G  P+    P+Q    +V   +R   P H    L +LL    Q D T+R
Sbjct: 225 GVLIYEMAAGYPPFFADQPIQIYEKIVSGKVR--FPSHFSSDLKDLLRNLLQVDLTKR 280

>pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384

Iteration: 1
 Score = 94.0 bits (232), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 68/264 (25%), Positives = 129/264 (48%), Gaps = 14/264 (5%)
Query: 112 EIDAKQLKIECKVASGSYGD--LYKGTYCSQEVAIKVL-KPECVNTEMLKEFSQEVYIMR 168
           +++    +I   +  GS+G   + +     +  A+K + K +CV    ++   +E+ IM+
Sbjct: 11  DVNFDHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQ 70
Query: 169 KIRHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAI-DVSKGM 227
            + H  +V    +     ++ +V + +  G +    H Q+ V      +K+ I ++   +
Sbjct: 71  GLEHPFLVNLWYSFQDEEDMFMVVDLLLGGDLR--YHLQQNVHFKEETVKLFICELVMAL 128
Query: 228 NYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAETGTYRWMAPEVIEH 287
           +YL    IIHRD+K  N+L+DE+G V + DF +A +  +   +T   GT  +MAPE+   
Sbjct: 129 DYLQNQRIIHRDMKPDNILLDEHGHVHITDFNIAAMLPRETQITTMAGTKPYMAPEMFSS 188
Query: 288 KP---YDYKADVFSFGIALWELLTGELPY--AGLTPLQAAVGVVQKSLRPTIPKHAHPRL 342
           +    Y +  D +S G+  +ELL G  PY     T  +  V   + ++  T P      +
Sbjct: 189 RKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSSKEIVHTFETTV-VTYPSAWSQEM 247
Query: 343 AELLERCWQHDPTQRPNFSQITDI 366
             LL++  + +P QR  FSQ++D+
Sbjct: 248 VSLLKKLLEPNPDQR--FSQLSDV 269

>pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321

Iteration: 1
 Score = 93.6 bits (231), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 65/251 (25%), Positives = 124/251 (49%), Gaps = 11/251 (4%)
Query: 114 DAKQLKIECKVASGSYGDLYKGTYCSQE-----VAIKVLKPECVNTEMLKEFSQEVYIMR 168
           D    ++   +  GS+G ++     ++       A+KVLK   +          E  I+ 
Sbjct: 26  DPSHFELLKVLGQGSFGKVFLVRKVTRPDSGHLYAMKVLKKATLKVRDRVRTKMERDILA 85
Query: 169 KIRHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMN 228
            + H  VV+   A      L ++ +F+  G ++  L K+  +F    +     +++ G++
Sbjct: 86  DVNHPFVVKLHYAFQTEGKLYLILDFLRGGDLFTRLSKEV-MFTEEDVKFYLAELALGLD 144
Query: 229 YLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAET--GTYRWMAPEVIE 286
           +LH   II+RDLK  N+L+DE G +K+ DFG+++ +A      A +  GT  +MAPEV+ 
Sbjct: 145 HLHSLGIIYRDLKPENILLDEEGHIKLTDFGLSK-EAIDHEKKAYSFCGTVEYMAPEVVN 203
Query: 287 HKPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRLAELL 346
            + + + AD +S+G+ ++E+LTG LP+ G    +    +++  L   +P+        LL
Sbjct: 204 RQGHSHSADWWSYGVLMFEMLTGSLPFQGKDRKETMTLILKAKL--GMPQFLSTEAQSLL 261
Query: 347 ERCWQHDPTQR 357
              ++ +P  R
Sbjct: 262 RALFKRNPANR 272

>pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293

Iteration: 1
 Score = 93.2 bits (230), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 50/176 (28%), Positives = 94/176 (53%), Gaps = 8/176 (4%)
Query: 145 KVLKPECVNTEMLK----EFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVTEFMARGSI 200
           K++  +C+  E L+        E+ ++ KI+H N+V          +L ++ + ++ G +
Sbjct: 44  KLVAIKCIAKEALEGKEGSMENEIAVLHKIKHPNIVALDDIYESGGHLYLIMQLVSGGEL 103
Query: 201 YDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLL---MDENGVVKVAD 257
           +D +  +KG +      ++   V   + YLH   I+HRDLK  NLL   +DE+  + ++D
Sbjct: 104 FDRI-VEKGFYTERDASRLIFQVLDAVKYLHDLGIVHRDLKPENLLYYSLDEDSKIMISD 162
Query: 258 FGVARVQAQSGVMTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPY 313
           FG+++++    V++   GT  ++APEV+  KPY    D +S G+  + LL G  P+
Sbjct: 163 FGLSKMEDPGSVLSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPF 218

>pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543

Iteration: 1
 Score = 93.2 bits (230), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 60/205 (29%), Positives = 97/205 (47%), Gaps = 8/205 (3%)
Query: 163 EVYIMRKIRHKNVVQFIGACTRPPNLCIVTEFMARGSI----YDFLHKQKGVFQLTSLLK 218
           E  I+ K+  + +V    A     +LC+V   M  G I    Y+      G FQ    + 
Sbjct: 235 EKKILAKVHSRFIVSLAYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPG-FQEPRAIF 293
Query: 219 VAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVA-RVQAQSGVMTAETGTY 277
               +  G+ +LHQ NII+RDLK  N+L+D++G V+++D G+A  ++A         GT 
Sbjct: 294 YTAQIVSGLEHLHQRNIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTKTKGYAGTP 353
Query: 278 RWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKSLRP--TIP 335
            +MAPE++  + YD+  D F+ G+ L+E++    P+           + Q+ L    T P
Sbjct: 354 GFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRVLEQAVTYP 413
Query: 336 KHAHPRLAELLERCWQHDPTQRPNF 360
               P   +  E   Q DP +R  F
Sbjct: 414 DKFSPASKDFCEALLQKDPEKRLGF 438

>pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331

Iteration: 1
 Score = 92.8 bits (229), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 76/258 (29%), Positives = 126/258 (48%), Gaps = 24/258 (9%)
Query: 124 VASGSYGDLYK--GTYCSQEVAIKVLKPECVNTEMLKEFS-QEVYIMRKIRHKNVVQFIG 180
           V  GSYG + K       + VAIK    E  + +M+K+ + +E+ +++++RH+N+V  + 
Sbjct: 33  VGEGSYGMVMKCRNKDTGRIVAIKKFL-ESDDDKMVKKIAMREIKLLKQLRHENLVNLLE 91
Query: 181 ACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDL 240
            C +     +V EF+   +I D L           + K    +  G+ + H +NIIHRD+
Sbjct: 92  VCKKKKRWYLVFEFVDH-TILDDLELFPNGLDYQVVQKYLFQIINGIGFCHSHNIIHRDI 150
Query: 241 KTANLLMDENGVVKVADFGVARVQAQSG-VMTAETGTYRWMAPE-VIEHKPYDYKADVFS 298
           K  N+L+ ++GVVK+ DFG AR  A  G V   E  T  + APE ++    Y    DV++
Sbjct: 151 KPENILVSQSGVVKLCDFGFARTLAAPGEVYDDEVATRWYRAPELLVGDVKYGKAVDVWA 210
Query: 299 FGIALWELLTGELPYAGLTPLQAAVGVVQKSLRPTIPKH----------AHPRLAELLER 348
            G  + E+  GE  + G + +     ++   L   IP+H          A  RL E+ ER
Sbjct: 211 IGCLVTEMFMGEPLFPGDSDIDQLYHIMM-CLGNLIPRHQELFNKNPVFAGVRLPEIKER 269
Query: 349 CWQHDPTQR--PNFSQIT 364
               +P +R  P  S++ 
Sbjct: 270 ----EPLERRYPKLSEVV 283

>pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543

Iteration: 1
 Score = 92.8 bits (229), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 60/205 (29%), Positives = 97/205 (47%), Gaps = 8/205 (3%)
Query: 163 EVYIMRKIRHKNVVQFIGACTRPPNLCIVTEFMARGSI----YDFLHKQKGVFQLTSLLK 218
           E  I+ K+  + +V    A     +LC+V   M  G I    Y+      G FQ    + 
Sbjct: 235 EKKILAKVHSRFIVSLAYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPG-FQEPRAIF 293
Query: 219 VAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVA-RVQAQSGVMTAETGTY 277
               +  G+ +LHQ NII+RDLK  N+L+D++G V+++D G+A  ++A         GT 
Sbjct: 294 YTAQIVSGLEHLHQRNIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTKTKGYAGTP 353
Query: 278 RWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKSLRP--TIP 335
            +MAPE++  + YD+  D F+ G+ L+E++    P+           + Q+ L    T P
Sbjct: 354 GFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRVLEQAVTYP 413
Query: 336 KHAHPRLAELLERCWQHDPTQRPNF 360
               P   +  E   Q DP +R  F
Sbjct: 414 DKFSPASKDFCEALLQKDPEKRLGF 438

>pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350

Iteration: 1
 Score = 92.8 bits (229), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 67/238 (28%), Positives = 117/238 (49%), Gaps = 10/238 (4%)
Query: 124 VASGSYGD--LYKGTYCSQEVAIKVL-KPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIG 180
           + +GS+G   L K        A+K+L K + V  + ++    E  I++ +    +V+   
Sbjct: 49  LGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEF 108
Query: 181 ACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDL 240
           +     NL +V E+   G ++  L ++ G F        A  +     YLH  ++I+RDL
Sbjct: 109 SFKDNSNLYMVMEYAPGGEMFSHL-RRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDL 167
Query: 241 KTANLLMDENGVVKVADFGVA-RVQAQSGVMTAETGTYRWMAPEVIEHKPYDYKADVFSF 299
           K  NL++D+ G ++V DFG A RV+ ++  +    GT  ++APE+I  K Y+   D ++ 
Sbjct: 168 KPENLMIDQQGYIQVTDFGFAKRVKGRTWXL---CGTPEYLAPEIILSKGYNKAVDWWAL 224
Query: 300 GIALWELLTGELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRLAELLERCWQHDPTQR 357
           G+ ++E+  G  P+    P+Q    +V   +R   P H    L +LL    Q D T+R
Sbjct: 225 GVLIYEMAAGYPPFFADQPIQIYEKIVSGKVR--FPSHFSSDLKDLLRNLLQVDLTKR 280

>pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351

Iteration: 1
 Score = 92.8 bits (229), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 67/238 (28%), Positives = 116/238 (48%), Gaps = 10/238 (4%)
Query: 124 VASGSYGD--LYKGTYCSQEVAIKVL-KPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIG 180
           + +GS+G   L K        A+K+L K + V  + ++    E  I++ +    + +   
Sbjct: 50  LGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLTKLEF 109
Query: 181 ACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDL 240
           +     NL +V E+   G ++  L ++ G F        A  +     YLH  ++I+RDL
Sbjct: 110 SFKDNSNLYMVMEYAPGGEMFSHL-RRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDL 168
Query: 241 KTANLLMDENGVVKVADFGVA-RVQAQSGVMTAETGTYRWMAPEVIEHKPYDYKADVFSF 299
           K  NL++D+ G +KV DFG A RV+ ++  +    GT  ++APE+I  K Y+   D ++ 
Sbjct: 169 KPENLMIDQQGYIKVTDFGFAKRVKGRTWXL---CGTPEYLAPEIILSKGYNKAVDWWAL 225
Query: 300 GIALWELLTGELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRLAELLERCWQHDPTQR 357
           G+ ++E+  G  P+    P+Q    +V   +R   P H    L +LL    Q D T+R
Sbjct: 226 GVLIYEMAAGYPPFFADQPIQIYEKIVSGKVR--FPSHFSSDLKDLLRNLLQVDLTKR 281

>pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6 Length = 317

Iteration: 1
 Score = 92.8 bits (229), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 67/261 (25%), Positives = 128/261 (49%), Gaps = 13/261 (4%)
Query: 114 DAKQLKIECKVASGSYG--DLYKGTYCSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIR 171
           D+ + ++   + +G++G   L +    ++ VA+K ++      ++ +   +E+   R +R
Sbjct: 17  DSDRYELVKDIGAGNFGVARLMRDKQANELVAVKYIE---RGEKIDENVKREIINHRSLR 73
Query: 172 HKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLH 231
           H N+V+F      P +L IV E+ + G +++ +    G F           +  G++Y H
Sbjct: 74  HPNIVRFKEVILTPTHLAIVMEYASGGELFERI-CNAGRFSEDEARFFFQQLISGVSYAH 132
Query: 232 QNNIIHRDLKTANLLMDENGV--VKVADFGVARVQAQSGVMTAETGTYRWMAPEVIEHKP 289
              + HRDLK  N L+D +    +K+ADFG ++         +  GT  ++APEV+  K 
Sbjct: 133 AMQVAHRDLKLENTLLDGSPAPRLKIADFGYSKASVLHSQPKSAVGTPAYIAPEVLLKKE 192
Query: 290 YDYK-ADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQK--SLRPTIPKHAH--PRLAE 344
           YD K ADV+S G+ L+ +L G  P+      +     + +  +++  IP + H  P    
Sbjct: 193 YDGKVADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILNVQYAIPDYVHISPECRH 252
Query: 345 LLERCWQHDPTQRPNFSQITD 365
           L+ R +  DP +R +  +I +
Sbjct: 253 LISRIFVADPAKRISIPEIRN 273

>pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342

Iteration: 1
 Score = 92.8 bits (229), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 61/202 (30%), Positives = 106/202 (52%), Gaps = 11/202 (5%)
Query: 166 IMRKIRHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSK 225
           ++R  +H N++           + +VTE M  G + D + +QK  F       V   ++K
Sbjct: 69  LLRYGQHPNIITLKDVYDDGKYVYVVTELMKGGELLDKILRQK-FFSEREASAVLFTITK 127
Query: 226 GMNYLHQNNIIHRDLKTANLL-MDENG---VVKVADFGVAR-VQAQSGVMTAETGTYRWM 280
            + YLH   ++HRDLK +N+L +DE+G    +++ DFG A+ ++A++G++     T  ++
Sbjct: 128 TVEYLHAQGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAENGLLMTPCYTANFV 187
Query: 281 APEVIEHKPYDYKADVFSFGIALWELLTGELPYAGL---TP--LQAAVGVVQKSLRPTIP 335
           APEV+E + YD   D++S G+ L+ +LTG  P+A     TP  + A +G  + SL     
Sbjct: 188 APEVLERQGYDAACDIWSLGVLLYTMLTGYTPFANGPDDTPEEILARIGSGKFSLSGGYW 247
Query: 336 KHAHPRLAELLERCWQHDPTQR 357
                   +L+ +    DP QR
Sbjct: 248 NSVSDTAKDLVSKMLHVDPHQR 269

>pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543

Iteration: 1
 Score = 92.8 bits (229), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 60/205 (29%), Positives = 97/205 (47%), Gaps = 8/205 (3%)
Query: 163 EVYIMRKIRHKNVVQFIGACTRPPNLCIVTEFMARGSI----YDFLHKQKGVFQLTSLLK 218
           E  I+ K+  + +V    A     +LC+V   M  G I    Y+      G FQ    + 
Sbjct: 235 EKKILAKVHSRFIVSLAYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPG-FQEPRAIF 293
Query: 219 VAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVA-RVQAQSGVMTAETGTY 277
               +  G+ +LHQ NII+RDLK  N+L+D++G V+++D G+A  ++A         GT 
Sbjct: 294 YTAQIVSGLEHLHQRNIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTKTKGYAGTP 353
Query: 278 RWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKSLRP--TIP 335
            +MAPE++  + YD+  D F+ G+ L+E++    P+           + Q+ L    T P
Sbjct: 354 GFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRVLEQAVTYP 413
Query: 336 KHAHPRLAELLERCWQHDPTQRPNF 360
               P   +  E   Q DP +R  F
Sbjct: 414 DKFSPASKDFCEALLQKDPEKRLGF 438

>pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543

Iteration: 1
 Score = 92.8 bits (229), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 60/205 (29%), Positives = 97/205 (47%), Gaps = 8/205 (3%)
Query: 163 EVYIMRKIRHKNVVQFIGACTRPPNLCIVTEFMARGSI----YDFLHKQKGVFQLTSLLK 218
           E  I+ K+  + +V    A     +LC+V   M  G I    Y+      G FQ    + 
Sbjct: 235 EKKILAKVHSRFIVSLAYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPG-FQEPRAIF 293
Query: 219 VAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVA-RVQAQSGVMTAETGTY 277
               +  G+ +LHQ NII+RDLK  N+L+D++G V+++D G+A  ++A         GT 
Sbjct: 294 YTAQIVSGLEHLHQRNIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTKTKGYAGTP 353
Query: 278 RWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKSLRP--TIP 335
            +MAPE++  + YD+  D F+ G+ L+E++    P+           + Q+ L    T P
Sbjct: 354 GFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRVLEQAVTYP 413
Query: 336 KHAHPRLAELLERCWQHDPTQRPNF 360
               P   +  E   Q DP +R  F
Sbjct: 414 DKFSPASKDFCEALLQKDPEKRLGF 438

>pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351

Iteration: 1
 Score = 92.8 bits (229), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 67/238 (28%), Positives = 116/238 (48%), Gaps = 10/238 (4%)
Query: 124 VASGSYGD--LYKGTYCSQEVAIKVL-KPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIG 180
           + +GS+G   L K        A+K+L K + V  + ++    E  I++ +    + +   
Sbjct: 50  LGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLTKLEF 109
Query: 181 ACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDL 240
           +     NL +V E+   G ++  L ++ G F        A  +     YLH  ++I+RDL
Sbjct: 110 SFKDNSNLYMVMEYAPGGEMFSHL-RRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDL 168
Query: 241 KTANLLMDENGVVKVADFGVA-RVQAQSGVMTAETGTYRWMAPEVIEHKPYDYKADVFSF 299
           K  NL++D+ G +KV DFG A RV+ ++  +    GT  ++APE+I  K Y+   D ++ 
Sbjct: 169 KPENLMIDQQGYIKVTDFGFAKRVKGRTWXL---CGTPEYLAPEIILSKGYNKAVDWWAL 225
Query: 300 GIALWELLTGELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRLAELLERCWQHDPTQR 357
           G+ ++E+  G  P+    P+Q    +V   +R   P H    L +LL    Q D T+R
Sbjct: 226 GVLIYEMAAGYPPFFADQPIQIYEKIVSGKVR--FPSHFSSDLKDLLRNLLQVDLTKR 281

>pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350

Iteration: 1
 Score = 92.8 bits (229), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 67/238 (28%), Positives = 118/238 (49%), Gaps = 10/238 (4%)
Query: 124 VASGSYGD--LYKGTYCSQEVAIKVL-KPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIG 180
           + +GS+G   L K        A+K+L K + V  + ++    E  I++ +    +V+   
Sbjct: 49  LGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKEIEHTLNEKRILQAVNFPFLVKLEF 108
Query: 181 ACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDL 240
           +     NL +V E+   G ++  L ++ G F        A  +     YLH  ++I+RDL
Sbjct: 109 SFKDNSNLYMVMEYAPGGEMFSHL-RRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDL 167
Query: 241 KTANLLMDENGVVKVADFGVA-RVQAQSGVMTAETGTYRWMAPEVIEHKPYDYKADVFSF 299
           K  NL++D+ G ++V DFG+A RV+ ++  +    GT  ++APE+I  K Y+   D ++ 
Sbjct: 168 KPENLMIDQQGYIQVTDFGLAKRVKGRTWXL---CGTPEYLAPEIILSKGYNKAVDWWAL 224
Query: 300 GIALWELLTGELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRLAELLERCWQHDPTQR 357
           G+ ++E+  G  P+    P+Q    +V   +R   P H    L +LL    Q D T+R
Sbjct: 225 GVLIYEMAAGYPPFFADQPIQIYEKIVSGKVR--FPSHFSSDLKDLLRNLLQVDLTKR 280

>pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315

Iteration: 1
 Score = 92.8 bits (229), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 50/176 (28%), Positives = 94/176 (53%), Gaps = 8/176 (4%)
Query: 145 KVLKPECVNTEMLK----EFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVTEFMARGSI 200
           K++  +C+  E L+        E+ ++ KI+H N+V          +L ++ + ++ G +
Sbjct: 44  KLVAIKCIAKEALEGKEGSMENEIAVLHKIKHPNIVALDDIYESGGHLYLIMQLVSGGEL 103
Query: 201 YDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLL---MDENGVVKVAD 257
           +D +  +KG +      ++   V   + YLH   I+HRDLK  NLL   +DE+  + ++D
Sbjct: 104 FDRI-VEKGFYTERDASRLIFQVLDAVKYLHDLGIVHRDLKPENLLYYSLDEDSKIMISD 162
Query: 258 FGVARVQAQSGVMTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPY 313
           FG+++++    V++   GT  ++APEV+  KPY    D +S G+  + LL G  P+
Sbjct: 163 FGLSKMEDPGSVLSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPF 218

>pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351

Iteration: 1
 Score = 92.8 bits (229), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 67/238 (28%), Positives = 116/238 (48%), Gaps = 10/238 (4%)
Query: 124 VASGSYGD--LYKGTYCSQEVAIKVL-KPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIG 180
           + +GS+G   L K        A+K+L K + V  + ++    E  I++ +    + +   
Sbjct: 50  LGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLTKLEF 109
Query: 181 ACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDL 240
           +     NL +V E+   G ++  L ++ G F        A  +     YLH  ++I+RDL
Sbjct: 110 SFKDNSNLYMVMEYAPGGEMFSHL-RRIGRFXEPHARFYAAQIVLTFEYLHSLDLIYRDL 168
Query: 241 KTANLLMDENGVVKVADFGVA-RVQAQSGVMTAETGTYRWMAPEVIEHKPYDYKADVFSF 299
           K  NL++D+ G +KV DFG A RV+ ++  +    GT  ++APE+I  K Y+   D ++ 
Sbjct: 169 KPENLMIDQQGYIKVTDFGFAKRVKGRTWXL---CGTPEYLAPEIILSKGYNKAVDWWAL 225
Query: 300 GIALWELLTGELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRLAELLERCWQHDPTQR 357
           G+ ++E+  G  P+    P+Q    +V   +R   P H    L +LL    Q D T+R
Sbjct: 226 GVLIYEMAAGYPPFFADQPIQIYEKIVSGKVR--FPSHFSSDLKDLLRNLLQVDLTKR 281

>pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283

Iteration: 1
 Score = 92.8 bits (229), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 63/241 (26%), Positives = 117/241 (48%), Gaps = 17/241 (7%)
Query: 134 KGTYCSQEVAIKVLKPECVNTEML----KEFSQEVYIMRKIRHKNVVQFIGACTRPPNLC 189
           KGT   +E A K +K   +++       +E  +EV I+R+IRH N++          ++ 
Sbjct: 27  KGT--GKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIFENKTDVV 84
Query: 190 IVTEFMARGSIYDFLHKQKGVFQ--LTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLM 247
           ++ E ++ G ++DFL +++ + +   T  LK  +D   G++YLH   I H DLK  N+++
Sbjct: 85  LILELVSGGELFDFLAEKESLTEDEATQFLKQILD---GVHYLHSKRIAHFDLKPENIML 141
Query: 248 DENGV----VKVADFGVARVQAQSGVMTAETGTYRWMAPEVIEHKPYDYKADVFSFGIAL 303
            +  V    +K+ DFG+A             GT  ++APE++ ++P   +AD++S G+  
Sbjct: 142 LDKNVPNPRIKLIDFGIAHKIEAGNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVIT 201
Query: 304 WELLTGELPYAGLTPLQAAVGV--VQKSLRPTIPKHAHPRLAELLERCWQHDPTQRPNFS 361
           + LL+G  P+ G T  +    +  V          +      + + R    DP +R   +
Sbjct: 202 YILLSGASPFLGETKQETLTNISAVNYDFDEEYFSNTSELAKDFIRRLLVKDPKRRMTIA 261
Query: 362 Q 362
           Q
Sbjct: 262 Q 262

>pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320

Iteration: 1
 Score = 92.4 bits (228), Expect = 4e-19,   Method: Compositional matrix adjust.
 Identities = 50/176 (28%), Positives = 94/176 (53%), Gaps = 8/176 (4%)
Query: 145 KVLKPECVNTEMLK----EFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVTEFMARGSI 200
           K++  +C+  E L+        E+ ++ KI+H N+V          +L ++ + ++ G +
Sbjct: 44  KLVAIKCIAKEALEGKEGSMENEIAVLHKIKHPNIVALDDIYESGGHLYLIMQLVSGGEL 103
Query: 201 YDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLL---MDENGVVKVAD 257
           +D +  +KG +      ++   V   + YLH   I+HRDLK  NLL   +DE+  + ++D
Sbjct: 104 FDRI-VEKGFYTERDASRLIFQVLDAVKYLHDLGIVHRDLKPENLLYYSLDEDSKIMISD 162
Query: 258 FGVARVQAQSGVMTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPY 313
           FG+++++    V++   GT  ++APEV+  KPY    D +S G+  + LL G  P+
Sbjct: 163 FGLSKMEDPGSVLSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPF 218

>pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278

Iteration: 1
 Score = 92.4 bits (228), Expect = 4e-19,   Method: Compositional matrix adjust.
 Identities = 63/241 (26%), Positives = 117/241 (48%), Gaps = 17/241 (7%)
Query: 134 KGTYCSQEVAIKVLKPECVNTEML----KEFSQEVYIMRKIRHKNVVQFIGACTRPPNLC 189
           KGT   +E A K +K   +++       +E  +EV I+R+IRH N++          ++ 
Sbjct: 34  KGT--GKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIFENKTDVV 91
Query: 190 IVTEFMARGSIYDFLHKQKGVFQ--LTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLM 247
           ++ E ++ G ++DFL +++ + +   T  LK  +D   G++YLH   I H DLK  N+++
Sbjct: 92  LILELVSGGELFDFLAEKESLTEDEATQFLKQILD---GVHYLHSKRIAHFDLKPENIML 148
Query: 248 DENGV----VKVADFGVARVQAQSGVMTAETGTYRWMAPEVIEHKPYDYKADVFSFGIAL 303
            +  V    +K+ DFG+A             GT  ++APE++ ++P   +AD++S G+  
Sbjct: 149 LDKNVPNPRIKLIDFGIAHKIEAGNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVIT 208
Query: 304 WELLTGELPYAGLTPLQAAVGV--VQKSLRPTIPKHAHPRLAELLERCWQHDPTQRPNFS 361
           + LL+G  P+ G T  +    +  V          +      + + R    DP +R   +
Sbjct: 209 YILLSGASPFLGETKQETLTNISAVNYDFDEEYFSNTSELAKDFIRRLLVKDPKRRMXIA 268
Query: 362 Q 362
           Q
Sbjct: 269 Q 269

>pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304

Iteration: 1
 Score = 92.4 bits (228), Expect = 4e-19,   Method: Compositional matrix adjust.
 Identities = 63/241 (26%), Positives = 116/241 (48%), Gaps = 17/241 (7%)
Query: 134 KGTYCSQEVAIKVLKPECVNTEML----KEFSQEVYIMRKIRHKNVVQFIGACTRPPNLC 189
           KGT   +E A K +K   + +       +E  +EV I+R+IRH N++          ++ 
Sbjct: 48  KGT--GKEYAAKFIKKRRLXSSRRGVSREEIEREVNILREIRHPNIITLHDIFENKTDVV 105
Query: 190 IVTEFMARGSIYDFLHKQKGVFQ--LTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLM 247
           ++ E ++ G ++DFL +++ + +   T  LK  +D   G++YLH   I H DLK  N+++
Sbjct: 106 LILELVSGGELFDFLAEKESLTEDEATQFLKQILD---GVHYLHSKRIAHFDLKPENIML 162
Query: 248 DENGV----VKVADFGVARVQAQSGVMTAETGTYRWMAPEVIEHKPYDYKADVFSFGIAL 303
            +  V    +K+ DFG+A             GT  ++APE++ ++P   +AD++S G+  
Sbjct: 163 LDKNVPNPRIKLIDFGIAHKIEAGNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVIT 222
Query: 304 WELLTGELPYAGLTPLQAAVGV--VQKSLRPTIPKHAHPRLAELLERCWQHDPTQRPNFS 361
           + LL+G  P+ G T  +    +  V          +      + + R    DP +R   +
Sbjct: 223 YILLSGASPFLGETKQETLTNISAVNYDFDEEYFSNTSELAKDFIRRLLVKDPKRRMXIA 282
Query: 362 Q 362
           Q
Sbjct: 283 Q 283

>pdb|3UC4|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.6 Length = 362

Iteration: 1
 Score = 92.0 bits (227), Expect = 5e-19,   Method: Compositional matrix adjust.
 Identities = 67/261 (25%), Positives = 126/261 (48%), Gaps = 13/261 (4%)
Query: 114 DAKQLKIECKVASGSYG--DLYKGTYCSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIR 171
           D+ + ++   + SG++G   L +    ++ VA+K ++      ++     +E+   R +R
Sbjct: 17  DSDRYELVKDIGSGNFGVARLMRDKQSNELVAVKYIE---RGEKIAANVKREIINHRSLR 73
Query: 172 HKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLH 231
           H N+V+F      P +L IV E+ + G +++ +    G F           +  G++Y H
Sbjct: 74  HPNIVRFKEVILTPTHLAIVMEYASGGELFERI-CNAGRFSEDEARFFFQQLISGVSYCH 132
Query: 232 QNNIIHRDLKTANLLMDENGV--VKVADFGVARVQAQSGVMTAETGTYRWMAPEVIEHKP 289
              + HRDLK  N L+D +    +K+ DFG ++         +  GT  ++APEV+  K 
Sbjct: 133 AMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKE 192
Query: 290 YDYK-ADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQK--SLRPTIPKHAH--PRLAE 344
           YD K ADV+S G+ L+ +L G  P+      +     + +  +++  IP + H  P    
Sbjct: 193 YDGKVADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILNVQYAIPDYVHISPECRH 252
Query: 345 LLERCWQHDPTQRPNFSQITD 365
           L+ R +  DP +R +  +I +
Sbjct: 253 LISRIFVADPAKRISIPEIRN 273

>pdb|3UJG|A Chain A, Crystal Structure Of Snrk2.6 In Complex With Hab1 Length = 361

Iteration: 1
 Score = 91.7 bits (226), Expect = 6e-19,   Method: Compositional matrix adjust.
 Identities = 67/261 (25%), Positives = 127/261 (48%), Gaps = 13/261 (4%)
Query: 114 DAKQLKIECKVASGSYG--DLYKGTYCSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIR 171
           D+ + ++   + SG++G   L +    ++ VA+K ++      ++ +   +E+   R +R
Sbjct: 16  DSDRYELVKDIGSGNFGVARLMRDKQSNELVAVKYIE---RGEKIDENVKREIINHRSLR 72
Query: 172 HKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLH 231
           H N+V+F      P +L IV E+ + G +++ +    G F           +  G++Y H
Sbjct: 73  HPNIVRFKEVILTPTHLAIVMEYASGGELFERI-CNAGRFSEDEARFFFQQLISGVSYCH 131
Query: 232 QNNIIHRDLKTANLLMDENGV--VKVADFGVARVQAQSGVMTAETGTYRWMAPEVIEHKP 289
              + HRDLK  N L+D +    +K+ DFG ++         +  GT  ++APEV+  K 
Sbjct: 132 AMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKE 191
Query: 290 YDYK-ADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQK--SLRPTIPKHAH--PRLAE 344
           YD K ADV+S G+ L+ +L G  P+      +     + +  +++  IP + H  P    
Sbjct: 192 YDGKVADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILNVQYAIPDYVHISPECRH 251
Query: 345 LLERCWQHDPTQRPNFSQITD 365
           L+ R +  DP +R +  +I +
Sbjct: 252 LISRIFVADPAKRISIPEIRN 272

>pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360

Iteration: 1
 Score = 91.7 bits (226), Expect = 6e-19,   Method: Compositional matrix adjust.
 Identities = 61/199 (30%), Positives = 110/199 (55%), Gaps = 10/199 (5%)
Query: 124 VASGSYGDLY----KGTYCSQEVAIKVLKPECVNTEMLKEFSQ-EVYIMRKIRHKNVVQF 178
           +  GS+G +     KGT   +  AIK+LK + V  +   E +  E  ++  +     +  
Sbjct: 27  LGKGSFGKVMLADRKGT--EELYAIKILKKDVVIQDDDVECTMVEKRVLALLDKPPFLTQ 84
Query: 179 IGACTRPPN-LCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIH 237
           + +C +  + L  V E++  G +  +  +Q G F+    +  A ++S G+ +LH+  II+
Sbjct: 85  LHSCFQTVDRLYFVMEYVNGGDLM-YHIQQVGKFKEPQAVFYAAEISIGLFFLHKRGIIY 143
Query: 238 RDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAE-TGTYRWMAPEVIEHKPYDYKADV 296
           RDLK  N+++D  G +K+ADFG+ +     GV T E  GT  ++APE+I ++PY    D 
Sbjct: 144 RDLKLDNVMLDSEGHIKIADFGMCKEHMMDGVTTREFCGTPDYIAPEIIAYQPYGKSVDW 203
Query: 297 FSFGIALWELLTGELPYAG 315
           +++G+ L+E+L G+ P+ G
Sbjct: 204 WAYGVLLYEMLAGQPPFDG 222

>pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484

Iteration: 1
 Score = 91.3 bits (225), Expect = 8e-19,   Method: Compositional matrix adjust.
 Identities = 61/198 (30%), Positives = 103/198 (52%), Gaps = 8/198 (4%)
Query: 124 VASGSYGD--LYKGTYCSQEVAIKVLKPECVNTEMLKE-FSQEVYIMRKIRHKNVVQFIG 180
           +  GS+G+  L K     QE A+KV+    V  +  KE   +EV +++++ H N+ +   
Sbjct: 34  LGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIXKLYE 93
Query: 181 ACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDL 240
                    +V E    G ++D +  +K  F      ++   V  G+ Y H+N I+HRDL
Sbjct: 94  FFEDKGYFYLVGEVYTGGELFDEIISRK-RFSEVDAARIIRQVLSGITYXHKNKIVHRDL 152
Query: 241 KTANLLMD---ENGVVKVADFGVARVQAQSGVMTAETGTYRWMAPEVIEHKPYDYKADVF 297
           K  NLL++   ++  +++ DFG++     S     + GT  ++APEV+ H  YD K DV+
Sbjct: 153 KPENLLLESKSKDANIRIIDFGLSTHFEASKKXKDKIGTAYYIAPEVL-HGTYDEKCDVW 211
Query: 298 SFGIALWELLTGELPYAG 315
           S G+ L+ LL+G  P+ G
Sbjct: 212 STGVILYILLSGCPPFNG 229

>pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332

Iteration: 1
 Score = 91.3 bits (225), Expect = 9e-19,   Method: Compositional matrix adjust.
 Identities = 49/176 (27%), Positives = 94/176 (53%), Gaps = 8/176 (4%)
Query: 145 KVLKPECVNTEMLK----EFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVTEFMARGSI 200
           K++  +C+  + L+        E+ ++ KI+H N+V          +L ++ + ++ G +
Sbjct: 44  KLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIVALDDIYESGGHLYLIMQLVSGGEL 103
Query: 201 YDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLL---MDENGVVKVAD 257
           +D +  +KG +      ++   V   + YLH   I+HRDLK  NLL   +DE+  + ++D
Sbjct: 104 FDRI-VEKGFYTERDASRLIFQVLDAVKYLHDLGIVHRDLKPENLLYYSLDEDSKIMISD 162
Query: 258 FGVARVQAQSGVMTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPY 313
           FG+++++    V++   GT  ++APEV+  KPY    D +S G+  + LL G  P+
Sbjct: 163 FGLSKMEDPGSVLSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPF 218

>pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361

Iteration: 1
 Score = 91.3 bits (225), Expect = 9e-19,   Method: Compositional matrix adjust.
 Identities = 69/259 (26%), Positives = 122/259 (47%), Gaps = 13/259 (5%)
Query: 114 DAKQLKIECKVASGSYG--DLYKGTYCSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIR 171
           D+ +      + SG++G   L +     + VA+K ++      E ++   +E+   R +R
Sbjct: 18  DSDRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGAAIDENVQ---REIINHRSLR 74
Query: 172 HKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLH 231
           H N+V+F      P +L I+ E+ + G +Y+ +    G F           +  G++Y H
Sbjct: 75  HPNIVRFKEVILTPTHLAIIMEYASGGELYERI-CNAGRFSEDEARFFFQQLLSGVSYCH 133
Query: 232 QNNIIHRDLKTANLLMDENGV--VKVADFGVARVQAQSGVMTAETGTYRWMAPEVIEHKP 289
              I HRDLK  N L+D +    +K+ DFG ++         +  GT  ++APEV+  + 
Sbjct: 134 SMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRQE 193
Query: 290 YDYK-ADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQK--SLRPTIPK--HAHPRLAE 344
           YD K ADV+S G+ L+ +L G  P+      +     +Q+  S++ +IP      P    
Sbjct: 194 YDGKIADVWSCGVTLYVMLVGAYPFEDPEEPRDYRKTIQRILSVKYSIPDDIRISPECCH 253
Query: 345 LLERCWQHDPTQRPNFSQI 363
           L+ R +  DP  R +  +I
Sbjct: 254 LISRIFVADPATRISIPEI 272

>pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327

Iteration: 1
 Score = 90.9 bits (224), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 58/191 (30%), Positives = 103/191 (53%), Gaps = 9/191 (4%)
Query: 124 VASGSYGDLYKGTYC-SQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGAC 182
           +  G +G +YKG      +VA+K   PE  +++ ++EF  E+  +   RH ++V  IG C
Sbjct: 47  IGHGVFGKVYKGVLRDGAKVALKRRTPE--SSQGIEEFETEIETLSFCRHPHLVSLIGFC 104
Query: 183 TRPPNLCIVTEFMARGSIYDFLHKQK---GVFQLTSLLKVAIDVSKGMNYLHQNNIIHRD 239
                + ++ ++M  G++   L+              L++ I  ++G++YLH   IIHRD
Sbjct: 105 DERNEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTRAIIHRD 164
Query: 240 LKTANLLMDENGVVKVADFGVARVQAQSG---VMTAETGTYRWMAPEVIEHKPYDYKADV 296
           +K+ N+L+DEN V K+ DFG+++   + G   +     GT  ++ PE         K+DV
Sbjct: 165 VKSINILLDENFVPKITDFGISKKGTELGQTHLXXVVKGTLGYIDPEYFIKGRLTEKSDV 224
Query: 297 FSFGIALWELL 307
           +SFG+ L+E+L
Sbjct: 225 YSFGVVLFEVL 235

>pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504

Iteration: 1
 Score = 90.9 bits (224), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 59/210 (28%), Positives = 111/210 (52%), Gaps = 20/210 (9%)
Query: 123 KVASGSYGD--LYKGTYCSQEVAIKVLKPECVN-------TEMLKEFSQEVY----IMRK 169
           K+ SG+YG+  L K      E AIKV+K    +        + +++F +E+Y    +++ 
Sbjct: 43  KLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKS 102
Query: 170 IRHKNVVQFIGACTRPPNLCIVTEFMARGSIYD-FLHKQKGVFQLTSLLKVAIDVSKGMN 228
           + H N+++            +VTEF   G +++  +++ K  F       +   +  G+ 
Sbjct: 103 LDHPNIIKLFDVFEDKKYFYLVTEFYEGGELFEQIINRHK--FDECDAANIMKQILSGIC 160
Query: 229 YLHQNNIIHRDLKTANLLMDENGV---VKVADFGVARVQAQSGVMTAETGTYRWMAPEVI 285
           YLH++NI+HRD+K  N+L++       +K+ DFG++   ++   +    GT  ++APEV+
Sbjct: 161 YLHKHNIVHRDIKPENILLENKNSLLNIKIVDFGLSSFFSKDYKLRDRLGTAYYIAPEVL 220
Query: 286 EHKPYDYKADVFSFGIALWELLTGELPYAG 315
           + K Y+ K DV+S G+ ++ LL G  P+ G
Sbjct: 221 K-KKYNEKCDVWSCGVIMYILLCGYPPFGG 249

>pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352

Iteration: 1
 Score = 90.5 bits (223), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 62/243 (25%), Positives = 118/243 (48%), Gaps = 16/243 (6%)
Query: 124 VASGSYGDLYKGTY--CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKI-----RHKNVV 176
           +  GS+G ++   +   +Q  AIK LK + V   ++ +  +   + +++      H  + 
Sbjct: 26  LGKGSFGKVFLAEFKKTNQFFAIKALKKDVV---LMDDDVECTMVEKRVLSLAWEHPFLT 82
Query: 177 QFIGACTRPPNLCIVTEFMARGSIYDFLHKQK-GVFQLTSLLKVAIDVSKGMNYLHQNNI 235
                     NL  V E++  G +    H Q    F L+     A ++  G+ +LH   I
Sbjct: 83  HMFCTFQTKENLFFVMEYLNGGDL--MYHIQSCHKFDLSRATFYAAEIILGLQFLHSKGI 140
Query: 236 IHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAE-TGTYRWMAPEVIEHKPYDYKA 294
           ++RDLK  N+L+D++G +K+ADFG+ +        T E  GT  ++APE++  + Y++  
Sbjct: 141 VYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNEFCGTPDYIAPEILLGQKYNHSV 200
Query: 295 DVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRLAELLERCWQHDP 354
           D +SFG+ L+E+L G+ P+ G    +    +   +  P  P+       +LL + +  +P
Sbjct: 201 DWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMDN--PFYPRWLEKEAKDLLVKLFVREP 258
Query: 355 TQR 357
            +R
Sbjct: 259 EKR 261

>pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321

Iteration: 1
 Score = 90.5 bits (223), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 58/191 (30%), Positives = 103/191 (53%), Gaps = 9/191 (4%)
Query: 124 VASGSYGDLYKGTYC-SQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGAC 182
           +  G +G +YKG      +VA+K   PE  +++ ++EF  E+  +   RH ++V  IG C
Sbjct: 47  IGHGVFGKVYKGVLRDGAKVALKRRTPE--SSQGIEEFETEIETLSFCRHPHLVSLIGFC 104
Query: 183 TRPPNLCIVTEFMARGSIYDFLHKQK---GVFQLTSLLKVAIDVSKGMNYLHQNNIIHRD 239
                + ++ ++M  G++   L+              L++ I  ++G++YLH   IIHRD
Sbjct: 105 DERNEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTRAIIHRD 164
Query: 240 LKTANLLMDENGVVKVADFGVARVQA---QSGVMTAETGTYRWMAPEVIEHKPYDYKADV 296
           +K+ N+L+DEN V K+ DFG+++      Q+ +     GT  ++ PE         K+DV
Sbjct: 165 VKSINILLDENFVPKITDFGISKKGTELDQTHLXXVVKGTLGYIDPEYFIKGRLTEKSDV 224
Query: 297 FSFGIALWELL 307
           +SFG+ L+E+L
Sbjct: 225 YSFGVVLFEVL 235

>pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311

Iteration: 1
 Score = 90.5 bits (223), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 60/200 (30%), Positives = 106/200 (53%), Gaps = 8/200 (4%)
Query: 123 KVASGSYGDLYKGTYCSQE-VAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGA 181
           KV  G+YG +YK        VA+K ++ +  +  +     +E+ +++++ H N+V  I  
Sbjct: 28  KVGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDV 87
Query: 182 CTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLK 241
                 L +V EFM +  +   L + K   Q + +      + +G+ + HQ+ I+HRDLK
Sbjct: 88  IHSERCLTLVFEFMEK-DLKKVLDENKTGLQDSQIKIYLYQLLRGVAHCHQHRILHRDLK 146
Query: 242 TANLLMDENGVVKVADFGVAR---VQAQSGVMTAETGTYRWMAPEVI-EHKPYDYKADVF 297
             NLL++ +G +K+ADFG+AR   +  +S   T E  T  + AP+V+   K Y    D++
Sbjct: 147 PQNLLINSDGALKLADFGLARAFGIPVRS--YTHEVVTLWYRAPDVLMGSKKYSTSVDIW 204
Query: 298 SFGIALWELLTGELPYAGLT 317
           S G    E++TG+  + G+T
Sbjct: 205 SIGCIFAEMITGKPLFPGVT 224

>pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313

Iteration: 1
 Score = 90.1 bits (222), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 60/200 (30%), Positives = 106/200 (53%), Gaps = 8/200 (4%)
Query: 123 KVASGSYGDLYKGTYCSQE-VAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGA 181
           KV  G+YG +YK        VA+K ++ +  +  +     +E+ +++++ H N+V  I  
Sbjct: 28  KVGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDV 87
Query: 182 CTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLK 241
                 L +V EFM +  +   L + K   Q + +      + +G+ + HQ+ I+HRDLK
Sbjct: 88  IHSERCLTLVFEFMEK-DLKKVLDENKTGLQDSQIKIYLYQLLRGVAHCHQHRILHRDLK 146
Query: 242 TANLLMDENGVVKVADFGVAR---VQAQSGVMTAETGTYRWMAPEVI-EHKPYDYKADVF 297
             NLL++ +G +K+ADFG+AR   +  +S   T E  T  + AP+V+   K Y    D++
Sbjct: 147 PQNLLINSDGALKLADFGLARAFGIPVRS--YTHEVVTLWYRAPDVLMGSKKYSTSVDIW 204
Query: 298 SFGIALWELLTGELPYAGLT 317
           S G    E++TG+  + G+T
Sbjct: 205 SIGCIFAEMITGKPLFPGVT 224

>pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677

Iteration: 1
 Score = 89.7 bits (221), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 67/241 (27%), Positives = 118/241 (48%), Gaps = 22/241 (9%)
Query: 103 IPTDGTDVWEIDAKQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVNTEMLKEF 160
           +PT     WE+  +       + +G +G + +  +    ++VAIK  + E ++ +  + +
Sbjct: 9   LPTQTCGPWEMKER-------LGTGGFGYVLRWIHQDTGEQVAIKQCRQE-LSPKNRERW 60
Query: 161 SQEVYIMRKIRHKNVVQFI----GACTRPPN--LCIVTEFMARGSIYDFLHKQKGVFQLT 214
             E+ IM+K+ H NVV       G     PN    +  E+   G +  +L++ +    L 
Sbjct: 61  CLEIQIMKKLNHPNVVSAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLK 120
Query: 215 S--LLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMD---ENGVVKVADFGVARVQAQSGV 269
              +  +  D+S  + YLH+N IIHRDLK  N+++    +  + K+ D G A+   Q  +
Sbjct: 121 EGPIRTLLSDISSALRYLHENRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQGEL 180
Query: 270 MTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPY-AGLTPLQAAVGVVQK 328
            T   GT +++APE++E K Y    D +SFG   +E +TG  P+     P+Q    V +K
Sbjct: 181 CTEFVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFLPNWQPVQWHGKVREK 240
Query: 329 S 329
           S
Sbjct: 241 S 241

>pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676

Iteration: 1
 Score = 89.7 bits (221), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 67/241 (27%), Positives = 118/241 (48%), Gaps = 22/241 (9%)
Query: 103 IPTDGTDVWEIDAKQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVNTEMLKEF 160
           +PT     WE+  +       + +G +G + +  +    ++VAIK  + E ++ +  + +
Sbjct: 8   LPTQTCGPWEMKER-------LGTGGFGYVLRWIHQDTGEQVAIKQCRQE-LSPKNRERW 59
Query: 161 SQEVYIMRKIRHKNVVQFI----GACTRPPN--LCIVTEFMARGSIYDFLHKQKGVFQLT 214
             E+ IM+K+ H NVV       G     PN    +  E+   G +  +L++ +    L 
Sbjct: 60  CLEIQIMKKLNHPNVVSAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLK 119
Query: 215 S--LLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMD---ENGVVKVADFGVARVQAQSGV 269
              +  +  D+S  + YLH+N IIHRDLK  N+++    +  + K+ D G A+   Q  +
Sbjct: 120 EGPIRTLLSDISSALRYLHENRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQGEL 179
Query: 270 MTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPY-AGLTPLQAAVGVVQK 328
            T   GT +++APE++E K Y    D +SFG   +E +TG  P+     P+Q    V +K
Sbjct: 180 CTEFVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFLPNWQPVQWHGKVREK 239
Query: 329 S 329
           S
Sbjct: 240 S 240

>pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288

Iteration: 1
 Score = 89.7 bits (221), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 52/179 (29%), Positives = 99/179 (55%), Gaps = 11/179 (6%)
Query: 158 KEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQ--LTS 215
           +E  +EV I+R++ H NV+          ++ ++ E ++ G ++DFL +++ + +   TS
Sbjct: 60  EEIEREVSILRQVLHHNVITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATS 119
Query: 216 LLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGV----VKVADFGVARVQAQSGVMT 271
            +K  +D   G+NYLH   I H DLK  N+++ +  +    +K+ DFG+A  + + GV  
Sbjct: 120 FIKQILD---GVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAH-EIEDGVEF 175
Query: 272 AET-GTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKS 329
               GT  ++APE++ ++P   +AD++S G+  + LL+G  P+ G T  +    +   S
Sbjct: 176 KNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITSVS 234

>pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689

Iteration: 1
 Score = 89.7 bits (221), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 69/245 (28%), Positives = 115/245 (46%), Gaps = 16/245 (6%)
Query: 124 VASGSYGDLYKGTYCSQEVAIKVLKPECVNTEMLKEFSQEVY-----IMRKIRHKNVVQF 178
           +  G +G++Y    C +    K+   +C++ + +K    E       IM  +       F
Sbjct: 197 IGRGGFGEVYG---CRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPF 253
Query: 179 I----GACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNN 234
           I     A   P  L  + + M  G ++  L  Q GVF    +   A ++  G+ ++H   
Sbjct: 254 IVCMSYAFHTPDKLSFILDLMNGGDLHYHL-SQHGVFSEADMRFYAAEIILGLEHMHNRF 312
Query: 235 IIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAETGTYRWMAPEVIEHK-PYDYK 293
           +++RDLK AN+L+DE+G V+++D G+A          A  GT+ +MAPEV++    YD  
Sbjct: 313 VVYRDLKPANILLDEHGHVRISDLGLA-CDFSKKKPHASVGTHGYMAPEVLQKGVAYDSS 371
Query: 294 ADVFSFGIALWELLTGELPY-AGLTPLQAAVGVVQKSLRPTIPKHAHPRLAELLERCWQH 352
           AD FS G  L++LL G  P+    T  +  +  +  ++   +P    P L  LLE   Q 
Sbjct: 372 ADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELPDSFSPELRSLLEGLLQR 431
Query: 353 DPTQR 357
           D  +R
Sbjct: 432 DVNRR 436

>pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321

Iteration: 1
 Score = 89.7 bits (221), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 52/179 (29%), Positives = 99/179 (55%), Gaps = 11/179 (6%)
Query: 158 KEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQ--LTS 215
           +E  +EV I+R++ H NV+          ++ ++ E ++ G ++DFL +++ + +   TS
Sbjct: 60  EEIEREVSILRQVLHHNVITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATS 119
Query: 216 LLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGV----VKVADFGVARVQAQSGVMT 271
            +K  +D   G+NYLH   I H DLK  N+++ +  +    +K+ DFG+A  + + GV  
Sbjct: 120 FIKQILD---GVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAH-EIEDGVEF 175
Query: 272 AET-GTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKS 329
               GT  ++APE++ ++P   +AD++S G+  + LL+G  P+ G T  +    +   S
Sbjct: 176 KNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITSVS 234

>pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688

Iteration: 1
 Score = 89.7 bits (221), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 69/245 (28%), Positives = 115/245 (46%), Gaps = 16/245 (6%)
Query: 124 VASGSYGDLYKGTYCSQEVAIKVLKPECVNTEMLKEFSQEVY-----IMRKIRHKNVVQF 178
           +  G +G++Y    C +    K+   +C++ + +K    E       IM  +       F
Sbjct: 196 IGRGGFGEVYG---CRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPF 252
Query: 179 I----GACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNN 234
           I     A   P  L  + + M  G ++  L  Q GVF    +   A ++  G+ ++H   
Sbjct: 253 IVCMSYAFHTPDKLSFILDLMNGGDLHYHL-SQHGVFSEADMRFYAAEIILGLEHMHNRF 311
Query: 235 IIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAETGTYRWMAPEVIEHK-PYDYK 293
           +++RDLK AN+L+DE+G V+++D G+A          A  GT+ +MAPEV++    YD  
Sbjct: 312 VVYRDLKPANILLDEHGHVRISDLGLA-CDFSKKKPHASVGTHGYMAPEVLQKGVAYDSS 370
Query: 294 ADVFSFGIALWELLTGELPY-AGLTPLQAAVGVVQKSLRPTIPKHAHPRLAELLERCWQH 352
           AD FS G  L++LL G  P+    T  +  +  +  ++   +P    P L  LLE   Q 
Sbjct: 371 ADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELPDSFSPELRSLLEGLLQR 430
Query: 353 DPTQR 357
           D  +R
Sbjct: 431 DVNRR 435

>pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321

Iteration: 1
 Score = 89.4 bits (220), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 52/179 (29%), Positives = 99/179 (55%), Gaps = 11/179 (6%)
Query: 158 KEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQ--LTS 215
           +E  +EV I+R++ H NV+          ++ ++ E ++ G ++DFL +++ + +   TS
Sbjct: 60  EEIEREVSILRQVLHHNVITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATS 119
Query: 216 LLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGV----VKVADFGVARVQAQSGVMT 271
            +K  +D   G+NYLH   I H DLK  N+++ +  +    +K+ DFG+A  + + GV  
Sbjct: 120 FIKQILD---GVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAH-EIEDGVEF 175
Query: 272 AET-GTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKS 329
               GT  ++APE++ ++P   +AD++S G+  + LL+G  P+ G T  +    +   S
Sbjct: 176 KNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITSVS 234

>pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689

Iteration: 1
 Score = 89.4 bits (220), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 69/245 (28%), Positives = 115/245 (46%), Gaps = 16/245 (6%)
Query: 124 VASGSYGDLYKGTYCSQEVAIKVLKPECVNTEMLKEFSQEVY-----IMRKIRHKNVVQF 178
           +  G +G++Y    C +    K+   +C++ + +K    E       IM  +       F
Sbjct: 197 IGRGGFGEVYG---CRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPF 253
Query: 179 I----GACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNN 234
           I     A   P  L  + + M  G ++  L  Q GVF    +   A ++  G+ ++H   
Sbjct: 254 IVCMSYAFHTPDKLSFILDLMNGGDLHYHL-SQHGVFSEADMRFYAAEIILGLEHMHNRF 312
Query: 235 IIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAETGTYRWMAPEVIEHK-PYDYK 293
           +++RDLK AN+L+DE+G V+++D G+A          A  GT+ +MAPEV++    YD  
Sbjct: 313 VVYRDLKPANILLDEHGHVRISDLGLA-CDFSKKKPHASVGTHGYMAPEVLQKGVAYDSS 371
Query: 294 ADVFSFGIALWELLTGELPY-AGLTPLQAAVGVVQKSLRPTIPKHAHPRLAELLERCWQH 352
           AD FS G  L++LL G  P+    T  +  +  +  ++   +P    P L  LLE   Q 
Sbjct: 372 ADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELPDSFSPELRSLLEGLLQR 431
Query: 353 DPTQR 357
           D  +R
Sbjct: 432 DVNRR 436

>pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695

Iteration: 1
 Score = 89.4 bits (220), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 69/245 (28%), Positives = 115/245 (46%), Gaps = 16/245 (6%)
Query: 124 VASGSYGDLYKGTYCSQEVAIKVLKPECVNTEMLKEFSQEVY-----IMRKIRHKNVVQF 178
           +  G +G++Y    C +    K+   +C++ + +K    E       IM  +       F
Sbjct: 197 IGRGGFGEVYG---CRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPF 253
Query: 179 I----GACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNN 234
           I     A   P  L  + + M  G ++  L  Q GVF    +   A ++  G+ ++H   
Sbjct: 254 IVCMSYAFHTPDKLSFILDLMNGGDLHYHL-SQHGVFSEADMRFYAAEIILGLEHMHNRF 312
Query: 235 IIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAETGTYRWMAPEVIEHK-PYDYK 293
           +++RDLK AN+L+DE+G V+++D G+A          A  GT+ +MAPEV++    YD  
Sbjct: 313 VVYRDLKPANILLDEHGHVRISDLGLA-CDFSKKKPHASVGTHGYMAPEVLQKGVAYDSS 371
Query: 294 ADVFSFGIALWELLTGELPY-AGLTPLQAAVGVVQKSLRPTIPKHAHPRLAELLERCWQH 352
           AD FS G  L++LL G  P+    T  +  +  +  ++   +P    P L  LLE   Q 
Sbjct: 372 ADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELPDSFSPELRSLLEGLLQR 431
Query: 353 DPTQR 357
           D  +R
Sbjct: 432 DVNRR 436

>pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2: Se-Met Derivative Length = 342

Iteration: 1
 Score = 89.4 bits (220), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 60/202 (29%), Positives = 104/202 (51%), Gaps = 11/202 (5%)
Query: 166 IMRKIRHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSK 225
           ++R  +H N++           + +VTE    G + D + +QK  F       V   ++K
Sbjct: 69  LLRYGQHPNIITLKDVYDDGKYVYVVTELXKGGELLDKILRQK-FFSEREASAVLFTITK 127
Query: 226 GMNYLHQNNIIHRDLKTANLL-MDENG---VVKVADFGVAR-VQAQSGVMTAETGTYRWM 280
            + YLH   ++HRDLK +N+L +DE+G    +++ DFG A+ ++A++G++     T  ++
Sbjct: 128 TVEYLHAQGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAENGLLXTPCYTANFV 187
Query: 281 APEVIEHKPYDYKADVFSFGIALWELLTGELPYAGL---TP--LQAAVGVVQKSLRPTIP 335
           APEV+E + YD   D++S G+ L+  LTG  P+A     TP  + A +G  + SL     
Sbjct: 188 APEVLERQGYDAACDIWSLGVLLYTXLTGYTPFANGPDDTPEEILARIGSGKFSLSGGYW 247
Query: 336 KHAHPRLAELLERCWQHDPTQR 357
                   +L+ +    DP QR
Sbjct: 248 NSVSDTAKDLVSKXLHVDPHQR 269

>pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346

Iteration: 1
 Score = 89.4 bits (220), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 59/199 (29%), Positives = 109/199 (54%), Gaps = 15/199 (7%)
Query: 124 VASGSYGDLYKGTY--CSQEVAIKVLKPECVNTEMLKEFSQEVYIM-RKIRHKNVVQFIG 180
           +  GSY +  +  +   + E A+KV+       +  ++ S+E+ I+ R  +H N++    
Sbjct: 35  IGVGSYSECKRCVHKATNMEYAVKVID------KSKRDPSEEIEILLRYGQHPNIITLKD 88
Query: 181 ACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDL 240
                 ++ +VTE M  G + D + +QK  F       V   + K + YLH   ++HRDL
Sbjct: 89  VYDDGKHVYLVTELMRGGELLDKILRQK-FFSEREASFVLHTIGKTVEYLHSQGVVHRDL 147
Query: 241 KTANLL-MDENG---VVKVADFGVAR-VQAQSGVMTAETGTYRWMAPEVIEHKPYDYKAD 295
           K +N+L +DE+G    +++ DFG A+ ++A++G++     T  ++APEV++ + YD   D
Sbjct: 148 KPSNILYVDESGNPECLRICDFGFAKQLRAENGLLMTPCYTANFVAPEVLKRQGYDEGCD 207
Query: 296 VFSFGIALWELLTGELPYA 314
           ++S GI L+ +L G  P+A
Sbjct: 208 IWSLGILLYTMLAGYTPFA 226

>pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321

Iteration: 1
 Score = 89.4 bits (220), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 52/179 (29%), Positives = 99/179 (55%), Gaps = 11/179 (6%)
Query: 158 KEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQ--LTS 215
           +E  +EV I+R++ H NV+          ++ ++ E ++ G ++DFL +++ + +   TS
Sbjct: 60  EEIEREVSILRQVLHHNVITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATS 119
Query: 216 LLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGV----VKVADFGVARVQAQSGVMT 271
            +K  +D   G+NYLH   I H DLK  N+++ +  +    +K+ DFG+A  + + GV  
Sbjct: 120 FIKQILD---GVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAH-EIEDGVEF 175
Query: 272 AET-GTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKS 329
               GT  ++APE++ ++P   +AD++S G+  + LL+G  P+ G T  +    +   S
Sbjct: 176 KNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITAVS 234

>pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361

Iteration: 1
 Score = 89.4 bits (220), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 58/222 (26%), Positives = 112/222 (50%), Gaps = 16/222 (7%)
Query: 112 EIDAKQLKIECKVASGSYGDLYKGTYCSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIR 171
           E+ + Q  I  K    S G  Y   +  +  +    +  C      +E  +EV I+R++ 
Sbjct: 19  ELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVC-----REEIEREVSILRQVL 73
Query: 172 HKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQ--LTSLLKVAIDVSKGMNY 229
           H N++          ++ ++ E ++ G ++DFL +++ + +   TS +K  +D   G+NY
Sbjct: 74  HPNIITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILD---GVNY 130
Query: 230 LHQNNIIHRDLKTANLLMDENGV----VKVADFGVARVQAQSGVMTAET-GTYRWMAPEV 284
           LH   I H DLK  N+++ +  +    +K+ DFG+A  + + GV      GT  ++APE+
Sbjct: 131 LHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAH-EIEDGVEFKNIFGTPEFVAPEI 189
Query: 285 IEHKPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVV 326
           + ++P   +AD++S G+  + LL+G  P+ G T  +    + 
Sbjct: 190 VNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANIT 231

>pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330

Iteration: 1
 Score = 89.4 bits (220), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 59/199 (29%), Positives = 109/199 (54%), Gaps = 15/199 (7%)
Query: 124 VASGSYGDLYKGTY--CSQEVAIKVLKPECVNTEMLKEFSQEVYIM-RKIRHKNVVQFIG 180
           +  GSY +  +  +   + E A+KV+       +  ++ S+E+ I+ R  +H N++    
Sbjct: 35  IGVGSYSECKRCVHKATNMEYAVKVID------KSKRDPSEEIEILLRYGQHPNIITLKD 88
Query: 181 ACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDL 240
                 ++ +VTE M  G + D + +QK  F       V   + K + YLH   ++HRDL
Sbjct: 89  VYDDGKHVYLVTELMRGGELLDKILRQK-FFSEREASFVLHTIGKTVEYLHSQGVVHRDL 147
Query: 241 KTANLL-MDENG---VVKVADFGVAR-VQAQSGVMTAETGTYRWMAPEVIEHKPYDYKAD 295
           K +N+L +DE+G    +++ DFG A+ ++A++G++     T  ++APEV++ + YD   D
Sbjct: 148 KPSNILYVDESGNPECLRICDFGFAKQLRAENGLLMTPCYTANFVAPEVLKRQGYDEGCD 207
Query: 296 VFSFGIALWELLTGELPYA 314
           ++S GI L+ +L G  P+A
Sbjct: 208 IWSLGILLYTMLAGYTPFA 226

>pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321

Iteration: 1
 Score = 89.0 bits (219), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 52/179 (29%), Positives = 99/179 (55%), Gaps = 11/179 (6%)
Query: 158 KEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQ--LTS 215
           +E  +EV I+R++ H NV+          ++ ++ E ++ G ++DFL +++ + +   TS
Sbjct: 60  EEIEREVSILRQVLHHNVITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATS 119
Query: 216 LLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGV----VKVADFGVARVQAQSGVMT 271
            +K  +D   G+NYLH   I H DLK  N+++ +  +    +K+ DFG+A  + + GV  
Sbjct: 120 FIKQILD---GVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAH-EIEDGVEF 175
Query: 272 AET-GTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKS 329
               GT  ++APE++ ++P   +AD++S G+  + LL+G  P+ G T  +    +   S
Sbjct: 176 KNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITAVS 234

>pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285

Iteration: 1
 Score = 89.0 bits (219), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 69/255 (27%), Positives = 125/255 (49%), Gaps = 21/255 (8%)
Query: 123 KVASGSYGD--LYKGTYCSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIG 180
           K+ SG++GD  L +      E  IK +  +     M ++   E+ +++ + H N+++   
Sbjct: 29  KLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPM-EQIEAEIEVLKSLDHPNIIKIFE 87
Query: 181 ACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMN---YLHQNNIIH 237
                 N+ IV E    G + + +   +   +  S   VA  + + MN   Y H  +++H
Sbjct: 88  VFEDYHNMYIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQHVVH 147
Query: 238 RDLKTANLLMDE---NGVVKVADFGVARVQAQSGVMTAETGTYRWMAPEVIEHKPYDYKA 294
           +DLK  N+L  +   +  +K+ DFG+A +       T   GT  +MAPEV + +   +K 
Sbjct: 148 KDLKPENILFQDTSPHSPIKIIDFGLAELFKSDEHSTNAAGTALYMAPEVFK-RDVTFKC 206
Query: 295 DVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKSLRPTIPKHA------HPRLAELLER 348
           D++S G+ ++ LLTG LP+ G T L+     VQ+      P +A       P+  +LL++
Sbjct: 207 DIWSAGVVMYFLLTGCLPFTG-TSLEE----VQQKATYKEPNYAVECRPLTPQAVDLLKQ 261
Query: 349 CWQHDPTQRPNFSQI 363
               DP +RP+ +Q+
Sbjct: 262 MLTKDPERRPSAAQV 276

>pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318

Iteration: 1
 Score = 89.0 bits (219), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 72/271 (26%), Positives = 129/271 (47%), Gaps = 15/271 (5%)
Query: 105 TDGTDVWEIDAKQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVNTEMLKEFSQ 162
           T G   ++ +   L+   ++ SG+ G ++K  +      +A+K ++      E  +    
Sbjct: 14  TIGGQRYQAEINDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMD 73
Query: 163 EVYIMRKIRHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQ-KGVFQLTSLLKVAI 221
              +++      +VQ  G      ++ I  E M  G+  + L K+ +G      L K+ +
Sbjct: 74  LDVVLKSHDCPYIVQCFGTFITNTDVFIAMELM--GTCAEKLKKRMQGPIPERILGKMTV 131
Query: 222 DVSKGMNYL-HQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAETGTYRWM 280
            + K + YL  ++ +IHRD+K +N+L+DE G +K+ DFG++             G   +M
Sbjct: 132 AIVKALYYLKEKHGVIHRDVKPSNILLDERGQIKLCDFGISGRLVDDKAKDRSAGCAAYM 191
Query: 281 APEVIE----HKP-YDYKADVFSFGIALWELLTGELPYAGL-TPLQAAVGVVQKSLRPTI 334
           APE I+     KP YD +ADV+S GI+L EL TG+ PY    T  +    V+Q+   P +
Sbjct: 192 APERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKTDFEVLTKVLQEE-PPLL 250
Query: 335 PKHA--HPRLAELLERCWQHDPTQRPNFSQI 363
           P H          ++ C   D  +RP ++++
Sbjct: 251 PGHMGFSGDFQSFVKDCLTKDHRKRPKYNKL 281

>pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351

Iteration: 1
 Score = 89.0 bits (219), Expect = 5e-18,   Method: Compositional matrix adjust.
 Identities = 64/215 (29%), Positives = 109/215 (50%), Gaps = 13/215 (6%)
Query: 152 VNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVTEFMARGSI-YDFLHKQKGV 210
           ++TE LK   +E  I   ++H ++V+ +   +    L +V EFM    + ++ + +    
Sbjct: 68  LSTEDLK---REASICHMLKHPHIVELLETYSSDGMLYMVFEFMDGADLCFEIVKRADAG 124
Query: 211 FQLTSLLKVAI--DVSKGMNYLHQNNIIHRDLKTANLLM---DENGVVKVADFGVARVQA 265
           F  +  +       + + + Y H NNIIHRD+K  N+L+   + +  VK+ DFGVA    
Sbjct: 125 FVYSEAVASHYMRQILEALRYCHDNNIIHRDVKPENVLLASKENSAPVKLGDFGVAIQLG 184
Query: 266 QSG-VMTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVG 324
           +SG V     GT  +MAPEV++ +PY    DV+  G+ L+ LL+G LP+ G T  +   G
Sbjct: 185 ESGLVAGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLPFYG-TKERLFEG 243
Query: 325 VVQK--SLRPTIPKHAHPRLAELLERCWQHDPTQR 357
           +++    + P    H      +L+ R    DP +R
Sbjct: 244 IIKGKYKMNPRQWSHISESAKDLVRRMLMLDPAER 278

>pdb|3ZUT|A Chain A, The Structure Of Ost1 (D160a) Kinase Length = 362

Iteration: 1
 Score = 88.6 bits (218), Expect = 5e-18,   Method: Compositional matrix adjust.
 Identities = 66/261 (25%), Positives = 126/261 (48%), Gaps = 13/261 (4%)
Query: 114 DAKQLKIECKVASGSYG--DLYKGTYCSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIR 171
           D+ + ++   + SG++G   L +    ++ VA+K ++      ++ +   +E+   R +R
Sbjct: 17  DSDRYELVKDIGSGNFGVARLMRDKQSNELVAVKYIE---RGEKIDENVKREIINHRSLR 73
Query: 172 HKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLH 231
           H N+V+F      P +L IV E+ + G +++ +    G F           +  G++Y H
Sbjct: 74  HPNIVRFKEVILTPTHLAIVMEYASGGELFERI-CNAGRFSEDEARFFFQQLISGVSYCH 132
Query: 232 QNNIIHRDLKTANLLMDENGV--VKVADFGVARVQAQSGVMTAETGTYRWMAPEVIEHKP 289
              + HRDLK  N L+D +    +K+  FG ++         +  GT  ++APEV+  K 
Sbjct: 133 AMQVCHRDLKLENTLLDGSPAPRLKICAFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKE 192
Query: 290 YDYK-ADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQK--SLRPTIPKHAH--PRLAE 344
           YD K ADV+S G+ L+ +L G  P+      +     + +  +++  IP + H  P    
Sbjct: 193 YDGKVADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILNVQYAIPDYVHISPECRH 252
Query: 345 LLERCWQHDPTQRPNFSQITD 365
           L+ R +  DP +R +  +I +
Sbjct: 253 LISRIFVADPAKRISIPEIRN 273

>pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290

Iteration: 1
 Score = 88.6 bits (218), Expect = 6e-18,   Method: Compositional matrix adjust.
 Identities = 75/266 (28%), Positives = 128/266 (48%), Gaps = 18/266 (6%)
Query: 112 EIDAKQLKIECKVASGSYGDLYKGTYC--SQEVAIKVLKPECVNTEMLKEFSQEVYI-MR 168
           E+ A  L+   ++  G+YG + K  +    Q +A+K ++   VN++  K    ++ I MR
Sbjct: 3   EVKADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIR-ATVNSQEQKRLLMDLDISMR 61
Query: 169 KIRHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQ---KGVFQLTSLL-KVAIDVS 224
            +     V F GA  R  ++ I  E M   +  D  +KQ   KG      +L K+A+ + 
Sbjct: 62  TVDCPFTVTFYGALFREGDVWICMELM--DTSLDKFYKQVIDKGQTIPEDILGKIAVSIV 119
Query: 225 KGMNYLHQN-NIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAETGTYRWMAPE 283
           K + +LH   ++IHRD+K +N+L++  G VK+ DFG++           + G   +MAPE
Sbjct: 120 KALEHLHSKLSVIHRDVKPSNVLINALGQVKMCDFGISGYLVDDVAKDIDAGCKPYMAPE 179
Query: 284 VI----EHKPYDYKADVFSFGIALWELLTGELPYAGL-TPLQAAVGVVQKSLRPTIPKHA 338
            I      K Y  K+D++S GI + EL     PY    TP Q    VV++   P +P   
Sbjct: 180 RINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTPFQQLKQVVEEP-SPQLPADK 238
Query: 339 -HPRLAELLERCWQHDPTQRPNFSQI 363
                 +   +C + +  +RP + ++
Sbjct: 239 FSAEFVDFTSQCLKKNSKERPTYPEL 264

>pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345

Iteration: 1
 Score = 88.2 bits (217), Expect = 6e-18,   Method: Compositional matrix adjust.
 Identities = 61/243 (25%), Positives = 117/243 (48%), Gaps = 16/243 (6%)
Query: 124 VASGSYGDLYKGTY--CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKI-----RHKNVV 176
           +  GS+G ++   +   +Q  AIK LK + V   ++ +  +   + +++      H  + 
Sbjct: 25  LGKGSFGKVFLAEFKKTNQFFAIKALKKDVV---LMDDDVECTMVEKRVLSLAWEHPFLT 81
Query: 177 QFIGACTRPPNLCIVTEFMARGSIYDFLHKQK-GVFQLTSLLKVAIDVSKGMNYLHQNNI 235
                     NL  V E++  G +    H Q    F L+     A ++  G+ +LH   I
Sbjct: 82  HMFCTFQTKENLFFVMEYLNGGDL--MYHIQSCHKFDLSRATFYAAEIILGLQFLHSKGI 139
Query: 236 IHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAE-TGTYRWMAPEVIEHKPYDYKA 294
           ++RDLK  N+L+D++G +K+ADFG+ +        T    GT  ++APE++  + Y++  
Sbjct: 140 VYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNXFCGTPDYIAPEILLGQKYNHSV 199
Query: 295 DVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRLAELLERCWQHDP 354
           D +SFG+ L+E+L G+ P+ G    +    +   +  P  P+       +LL + +  +P
Sbjct: 200 DWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMDN--PFYPRWLEKEAKDLLVKLFVREP 257
Query: 355 TQR 357
            +R
Sbjct: 258 EKR 260

>pdb|4FVP|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain (Apo Form) Length = 289

Iteration: 1
 Score = 88.2 bits (217), Expect = 8e-18,   Method: Compositional matrix adjust.
 Identities = 72/259 (27%), Positives = 119/259 (45%), Gaps = 31/259 (11%)
Query: 127 GSYGDLYKGTYCSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPP 186
           G YG L++      EV +KVL     N    + F +   +M K+ HK++V   G C    
Sbjct: 33  GDYGQLHE-----TEVLLKVLDKAHRNYS--ESFFEAASMMSKLSHKHLVLNYGVCVCGD 85
Query: 187 NLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLL 246
              +V EF+  GS+  +L K K    +   L+VA  ++  M++L +N +IH ++   N+L
Sbjct: 86  ENILVQEFVKFGSLDTYLKKNKNCINILWKLEVAKQLAAAMHFLEENTLIHGNVCAKNIL 145
Query: 247 M--DEN------GVVKVADFGVARVQAQSGVMTAETGTYRWMAPEVIEH-KPYDYKADVF 297
           +  +E+        +K++D G++       ++        W+ PE IE+ K  +   D +
Sbjct: 146 LIREEDRKTGNPPFIKLSDPGISITVLPKDILQERIP---WVPPECIENPKNLNLATDKW 202
Query: 298 SFGIALWELLTGELPYAGLTPLQAAVGVVQKSL-----RPTIPKHAHPRLAELLERCWQH 352
           SFG  LWE+ +G     G  PL A     Q+ L     R  +P      LA L+  C  +
Sbjct: 203 SFGTTLWEICSG-----GDKPLSALDS--QRKLQFYEDRHQLPAPKAAELANLINNCMDY 255
Query: 353 DPTQRPNFSQITDILKQMM 371
           +P  RP+F  I   L  + 
Sbjct: 256 EPDHRPSFRAIIRDLNSLF 274

>pdb|3ZUU|A Chain A, The Structure Of Ost1 (D160a, S175d) Kinase In Complex With Gold Length = 362

Iteration: 1
 Score = 87.4 bits (215), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 66/261 (25%), Positives = 125/261 (47%), Gaps = 13/261 (4%)
Query: 114 DAKQLKIECKVASGSYG--DLYKGTYCSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIR 171
           D+ + ++   + SG++G   L +    ++ VA+K ++      ++ +   +E+   R +R
Sbjct: 17  DSDRYELVKDIGSGNFGVARLMRDKQSNELVAVKYIE---RGEKIDENVKREIINHRSLR 73
Query: 172 HKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLH 231
           H N+V+F      P +L IV E+ + G +++ +    G F           +  G++Y H
Sbjct: 74  HPNIVRFKEVILTPTHLAIVMEYASGGELFERI-CNAGRFSEDEARFFFQQLISGVSYCH 132
Query: 232 QNNIIHRDLKTANLLMDENGV--VKVADFGVARVQAQSGVMTAETGTYRWMAPEVIEHKP 289
              + HRDLK  N L+D +    +K+  FG ++            GT  ++APEV+  K 
Sbjct: 133 AMQVCHRDLKLENTLLDGSPAPRLKICAFGYSKSSVLHSQPKDTVGTPAYIAPEVLLKKE 192
Query: 290 YDYK-ADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQK--SLRPTIPKHAH--PRLAE 344
           YD K ADV+S G+ L+ +L G  P+      +     + +  +++  IP + H  P    
Sbjct: 193 YDGKVADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILNVQYAIPDYVHISPECRH 252
Query: 345 LLERCWQHDPTQRPNFSQITD 365
           L+ R +  DP +R +  +I +
Sbjct: 253 LISRIFVADPAKRISIPEIRN 273

>pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284

Iteration: 1
 Score = 86.7 bits (213), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 70/277 (25%), Positives = 127/277 (45%), Gaps = 40/277 (14%)
Query: 113 IDAKQLKIECKVASGSYGDLYKGTYCSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRH 172
           +D K++++   + SG +G ++K  +   +    V+K    N E   +  +EV  + K+ H
Sbjct: 11  MDFKEIEL---IGSGGFGQVFKAKH-RIDGKTYVIKRVKYNNE---KAEREVKALAKLDH 63
Query: 173 KNVVQFIGA--------------CTRPPNLC--IVTEFMARGSIYDFLHKQKGVFQLTSL 216
            N+V + G                +R    C  I  EF  +G++  ++ K++G  +L  +
Sbjct: 64  VNIVHYNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGE-KLDKV 122
Query: 217 LKVAI--DVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAET 274
           L + +   ++KG++Y+H   +I+RDLK +N+ + +   VK+ DFG+       G      
Sbjct: 123 LALELFEQITKGVDYIHSKKLINRDLKPSNIFLVDTKQVKIGDFGLVTSLKNDGKRXRSK 182
Query: 275 GTYRWMAPEVIEHKPYDYKADVFSFGIALWELL----TGELPYAGLTPLQAAVGVVQKSL 330
           GT R+M+PE I  + Y  + D+++ G+ L ELL    T        T L+  +       
Sbjct: 183 GTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFETSKFFTDLRDGI------- 235
Query: 331 RPTIPKHAHPRLAELLERCWQHDPTQRPNFSQITDIL 367
              I      +   LL++     P  RPN S+I   L
Sbjct: 236 ---ISDIFDKKEKTLLQKLLSKKPEDRPNTSEILRTL 269

>pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298

Iteration: 1
 Score = 86.7 bits (213), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 62/213 (29%), Positives = 109/213 (51%), Gaps = 20/213 (9%)
Query: 157 LKEFSQEVYIMRKIRHKNVVQFIGACTRP--PNLCIVTEFMARGSIYDF-----LHKQKG 209
           +++  QE+ I++K+ H NVV+ +     P   +L +V E + +G + +      L + + 
Sbjct: 80  IEQVYQEIAILKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPTLKPLSEDQA 139
Query: 210 VFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVA-RVQAQSG 268
            F    L+K       G+ YLH   IIHRD+K +NLL+ E+G +K+ADFGV+   +    
Sbjct: 140 RFYFQDLIK-------GIEYLHYQKIIHRDIKPSNLLVGEDGHIKIADFGVSNEFKGSDA 192
Query: 269 VMTAETGTYRWMAPEVIE--HKPYDYKA-DVFSFGIALWELLTGELPYAGLTPLQAAVGV 325
           +++   GT  +MAPE +    K +  KA DV++ G+ L+  + G+ P+     +     +
Sbjct: 193 LLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMDERIMCLHSKI 252
Query: 326 VQKSLR-PTIPKHAHPRLAELLERCWQHDPTQR 357
             ++L  P  P  A   L +L+ R    +P  R
Sbjct: 253 KSQALEFPDQPDIAE-DLKDLITRMLDKNPESR 284

>pdb|4FVR|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain Mutant V617f (Mg- Atp-Bound Form) Length = 289

Iteration: 1
 Score = 86.7 bits (213), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 72/259 (27%), Positives = 119/259 (45%), Gaps = 31/259 (11%)
Query: 127 GSYGDLYKGTYCSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPP 186
           G YG L++      EV +KVL     N    + F +   +M K+ HK++V   G C    
Sbjct: 33  GDYGQLHE-----TEVLLKVLDKAHRNYS--ESFFEAASMMSKLSHKHLVLNYGVCFCGD 85
Query: 187 NLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLL 246
              +V EF+  GS+  +L K K    +   L+VA  ++  M++L +N +IH ++   N+L
Sbjct: 86  ENILVQEFVKFGSLDTYLKKNKNCINILWKLEVAKQLAWAMHFLEENTLIHGNVCAKNIL 145
Query: 247 M--DEN------GVVKVADFGVARVQAQSGVMTAETGTYRWMAPEVIEH-KPYDYKADVF 297
           +  +E+        +K++D G++       ++        W+ PE IE+ K  +   D +
Sbjct: 146 LIREEDRKTGNPPFIKLSDPGISITVLPKDILQERIP---WVPPECIENPKNLNLATDKW 202
Query: 298 SFGIALWELLTGELPYAGLTPLQAAVGVVQKSL-----RPTIPKHAHPRLAELLERCWQH 352
           SFG  LWE+ +G     G  PL A     Q+ L     R  +P      LA L+  C  +
Sbjct: 203 SFGTTLWEICSG-----GDKPLSALDS--QRKLQFYEDRHQLPAPKAAELANLINNCMDY 255
Query: 353 DPTQRPNFSQITDILKQMM 371
           +P  RP+F  I   L  + 
Sbjct: 256 EPDHRPSFRAIIRDLNSLF 274

>pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674

Iteration: 1
 Score = 86.7 bits (213), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 44/129 (34%), Positives = 76/129 (58%), Gaps = 2/129 (1%)
Query: 188 LCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLM 247
           L  V E++  G +   + +Q G F+    +  A +++ G+ +L    II+RDLK  N+++
Sbjct: 417 LYFVMEYVNGGDLMYHI-QQVGRFKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVML 475
Query: 248 DENGVVKVADFGVARVQAQSGVMTAE-TGTYRWMAPEVIEHKPYDYKADVFSFGIALWEL 306
           D  G +K+ADFG+ +     GV T    GT  ++APE+I ++PY    D ++FG+ L+E+
Sbjct: 476 DSEGHIKIADFGMCKENIWDGVTTKXFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEM 535
Query: 307 LTGELPYAG 315
           L G+ P+ G
Sbjct: 536 LAGQAPFEG 544

>pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364

Iteration: 1
 Score = 85.9 bits (211), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 62/248 (25%), Positives = 126/248 (50%), Gaps = 17/248 (6%)
Query: 124 VASGSYGD--LYKGTYCSQEVAIKVLKPECVNTEMLKEFSQ-EVYIMRKIRHKNVVQFIG 180
           +  GSY    L +     +  A+KV+K E VN +   ++ Q E ++  +  +   +  + 
Sbjct: 28  IGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLH 87
Query: 181 ACTRPPN-LCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRD 239
           +C +  + L  V E++  G +   + +Q+ + +  +    A ++S  +NYLH+  II+RD
Sbjct: 88  SCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSA-EISLALNYLHERGIIYRD 146
Query: 240 LKTANLLMDENGVVKVADFGVARVQAQSGVMTAE-TGTYRWMAPEVIEHKPYDYKADVFS 298
           LK  N+L+D  G +K+ D+G+ +   + G  T+   GT  ++APE++  + Y +  D ++
Sbjct: 147 LKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSXFCGTPNYIAPEILRGEDYGFSVDWWA 206
Query: 299 FGIALWELLTGELPY----AGLTPLQAAVG-----VVQKSLRPTIPKHAHPRLAELLERC 349
            G+ ++E++ G  P+    +   P Q         +++K +R  IP+    + A +L+  
Sbjct: 207 LGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIR--IPRSMSVKAASVLKSF 264
Query: 350 WQHDPTQR 357
              DP +R
Sbjct: 265 LNKDPKER 272

>pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306

Iteration: 1
 Score = 85.9 bits (211), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 72/293 (24%), Positives = 125/293 (42%), Gaps = 67/293 (22%)
Query: 113 IDAKQLKIECKVASGSYGDLYKG-------TYCSQEVAIKVLKPECVNTEMLKEFSQEVY 165
           +D K++++   + SG +G ++K        TY  + V     K E           +EV 
Sbjct: 12  MDFKEIEL---IGSGGFGQVFKAKHRIDGKTYVIRRVKYNNEKAE-----------REVK 57
Query: 166 IMRKIRHKNVVQFIGA---------------------------CTRPPNLC--IVTEFMA 196
            + K+ H N+V + G                             +R    C  I  EF  
Sbjct: 58  ALAKLDHVNIVHYNGCWDGFDYDPETSDDSLESSDYDPENSKNSSRSKTKCLFIQMEFCD 117
Query: 197 RGSIYDFLHKQKGVFQLTSLLKVAI--DVSKGMNYLHQNNIIHRDLKTANLLMDENGVVK 254
           +G++  ++ K++G  +L  +L + +   ++KG++Y+H   +IHRDLK +N+ + +   VK
Sbjct: 118 KGTLEQWIEKRRGE-KLDKVLALELFEQITKGVDYIHSKKLIHRDLKPSNIFLVDTKQVK 176
Query: 255 VADFGVARVQAQSGVMTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELL----TGE 310
           + DFG+       G  T   GT R+M+PE I  + Y  + D+++ G+ L ELL    T  
Sbjct: 177 IGDFGLVTSLKNDGKRTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAF 236
Query: 311 LPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRLAELLERCWQHDPTQRPNFSQI 363
                 T L+  +          I      +   LL++     P  RPN S+I
Sbjct: 237 ETSKFFTDLRDGI----------ISDIFDKKEKTLLQKLLSKKPEDRPNTSEI 279

>pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311

Iteration: 1
 Score = 85.9 bits (211), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 79/304 (25%), Positives = 142/304 (46%), Gaps = 52/304 (17%)
Query: 123 KVASGSYGDLYK--GTYCSQEVAIKVLKPECVNTEMLKEFS-QEVYIMRKIRHKNVVQFI 179
           K+  GSYG ++K       Q VAIK    E  +  ++K+ + +E+ ++++++H N+V  +
Sbjct: 10  KIGEGSYGVVFKCRNRDTGQIVAIKKFL-ESEDDPVIKKIALREIRMLKQLKHPNLVNLL 68
Query: 180 GACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLK-VAIDVSKGMNYLHQNNIIHR 238
               R   L +V E+     +++    Q+GV +   L+K +     + +N+ H++N IHR
Sbjct: 69  EVFRRKRRLHLVFEYCDHTVLHELDRYQRGVPE--HLVKSITWQTLQAVNFCHKHNCIHR 126
Query: 239 DLKTANLLMDENGVVKVADFGVAR-VQAQSGVMTAETGTYRWMAPE-VIEHKPYDYKADV 296
           D+K  N+L+ ++ V+K+ DFG AR +   S     E  T  + +PE ++    Y    DV
Sbjct: 127 DVKPENILITKHSVIKLCDFGFARLLTGPSDYYDDEVATRWYRSPELLVGDTQYGPPVDV 186
Query: 297 FSFGIALWELLTGELPYAGLTPLQAAVGVVQKSLRPTIPKH------------------- 337
           ++ G    ELL+G   + G + +   + +++K+L   IP+H                   
Sbjct: 187 WAIGCVFAELLSGVPLWPGKSDVD-QLYLIRKTLGDLIPRHQQVFSTNQYFSGVKIPDPE 245
Query: 338 ------------AHPRLAELLERCWQHDPTQR---------PNFSQITDILKQMMKEVAS 376
                       ++P L  LL+ C   DPT+R         P F  I +I + + KE   
Sbjct: 246 DMEPLELKFPNISYPALG-LLKGCLHMDPTERLTCEQLLHHPYFENIREI-EDLAKEHDK 303
Query: 377 EGEN 380
             EN
Sbjct: 304 PAEN 307

>pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576

Iteration: 1
 Score = 85.9 bits (211), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 43/152 (28%), Positives = 81/152 (53%), Gaps = 1/152 (0%)
Query: 163 EVYIMRKIRHKNVVQFIGACTRPPNLCIVTEFMARGSI-YDFLHKQKGVFQLTSLLKVAI 221
           E  I+ K+  + VV    A      LC+V   M  G + +   H  +  F     +  A 
Sbjct: 234 EKQILEKVNSRFVVSLAYAYETKDALCLVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAA 293
Query: 222 DVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAETGTYRWMA 281
           ++  G+  LH+  I++RDLK  N+L+D++G ++++D G+A    +   +    GT  +MA
Sbjct: 294 EICCGLEDLHRERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQTIKGRVGTVGYMA 353
Query: 282 PEVIEHKPYDYKADVFSFGIALWELLTGELPY 313
           PEV++++ Y +  D ++ G  L+E++ G+ P+
Sbjct: 354 PEVVKNERYTFSPDWWALGCLLYEMIAGQSPF 385

>pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353

Iteration: 1
 Score = 85.9 bits (211), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 44/129 (34%), Positives = 76/129 (58%), Gaps = 2/129 (1%)
Query: 188 LCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLM 247
           L  V E++  G +  +  +Q G F+    +  A +++ G+ +L    II+RDLK  N+++
Sbjct: 96  LYFVMEYVNGGDLM-YHIQQVGRFKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVML 154
Query: 248 DENGVVKVADFGVARVQAQSGVMTAE-TGTYRWMAPEVIEHKPYDYKADVFSFGIALWEL 306
           D  G +K+ADFG+ +     GV T    GT  ++APE+I ++PY    D ++FG+ L+E+
Sbjct: 155 DSEGHIKIADFGMCKENIWDGVTTKXFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEM 214
Query: 307 LTGELPYAG 315
           L G+ P+ G
Sbjct: 215 LAGQAPFEG 223

>pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576

Iteration: 1
 Score = 85.5 bits (210), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 43/152 (28%), Positives = 81/152 (53%), Gaps = 1/152 (0%)
Query: 163 EVYIMRKIRHKNVVQFIGACTRPPNLCIVTEFMARGSI-YDFLHKQKGVFQLTSLLKVAI 221
           E  I+ K+  + VV    A      LC+V   M  G + +   H  +  F     +  A 
Sbjct: 234 EKQILEKVNSRFVVSLAYAYETKDALCLVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAA 293
Query: 222 DVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAETGTYRWMA 281
           ++  G+  LH+  I++RDLK  N+L+D++G ++++D G+A    +   +    GT  +MA
Sbjct: 294 EICCGLEDLHRERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQTIKGRVGTVGYMA 353
Query: 282 PEVIEHKPYDYKADVFSFGIALWELLTGELPY 313
           PEV++++ Y +  D ++ G  L+E++ G+ P+
Sbjct: 354 PEVVKNERYTFSPDWWALGCLLYEMIAGQSPF 385

>pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349

Iteration: 1
 Score = 85.5 bits (210), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 62/248 (25%), Positives = 126/248 (50%), Gaps = 17/248 (6%)
Query: 124 VASGSYGD--LYKGTYCSQEVAIKVLKPECVNTEMLKEFSQ-EVYIMRKIRHKNVVQFIG 180
           +  GSY    L +     +  A+KV+K E VN +   ++ Q E ++  +  +   +  + 
Sbjct: 13  IGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLH 72
Query: 181 ACTRPPN-LCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRD 239
           +C +  + L  V E++  G +   + +Q+ + +  +    A ++S  +NYLH+  II+RD
Sbjct: 73  SCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSA-EISLALNYLHERGIIYRD 131
Query: 240 LKTANLLMDENGVVKVADFGVARVQAQSGVMTAE-TGTYRWMAPEVIEHKPYDYKADVFS 298
           LK  N+L+D  G +K+ D+G+ +   + G  T+   GT  ++APE++  + Y +  D ++
Sbjct: 132 LKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSXFCGTPNYIAPEILRGEDYGFSVDWWA 191
Query: 299 FGIALWELLTGELPY----AGLTPLQAAVG-----VVQKSLRPTIPKHAHPRLAELLERC 349
            G+ ++E++ G  P+    +   P Q         +++K +R  IP+    + A +L+  
Sbjct: 192 LGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIR--IPRSLSVKAASVLKSF 249
Query: 350 WQHDPTQR 357
              DP +R
Sbjct: 250 LNKDPKER 257

>pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304

Iteration: 1
 Score = 85.5 bits (210), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 56/207 (27%), Positives = 104/207 (50%), Gaps = 7/207 (3%)
Query: 162 QEVYIMRKIRHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAI 221
           +E+ ++ +     +V F GA      + I  E M  GS+ D + K+ G      L KV+I
Sbjct: 72  RELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSL-DQVLKKAGRIPEQILGKVSI 130
Query: 222 DVSKGMNYLHQNN-IIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAETGTYRWM 280
            V KG+ YL + + I+HRD+K +N+L++  G +K+ DFGV+  Q    +  +  GT  +M
Sbjct: 131 AVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSG-QLIDSMANSFVGTRSYM 189
Query: 281 APEVIEHKPYDYKADVFSFGIALWELLTGELPY---AGLTPLQAAVGVVQKSLRPTIPKH 337
           +PE ++   Y  ++D++S G++L E+  G  P    +G   +   +  +     P +P  
Sbjct: 190 SPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIGSGSGSMAIFELLDYIVNEPPPKLPSG 249
Query: 338 AHP-RLAELLERCWQHDPTQRPNFSQI 363
                  + + +C   +P +R +  Q+
Sbjct: 250 VFSLEFQDFVNKCLIKNPAERADLKQL 276

>pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345

Iteration: 1
 Score = 85.5 bits (210), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 62/248 (25%), Positives = 126/248 (50%), Gaps = 17/248 (6%)
Query: 124 VASGSYGD--LYKGTYCSQEVAIKVLKPECVNTEMLKEFSQ-EVYIMRKIRHKNVVQFIG 180
           +  GSY    L +     +  A+KV+K E VN +   ++ Q E ++  +  +   +  + 
Sbjct: 17  IGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLH 76
Query: 181 ACTRPPN-LCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRD 239
           +C +  + L  V E++  G +   + +Q+ + +  +    A ++S  +NYLH+  II+RD
Sbjct: 77  SCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSA-EISLALNYLHERGIIYRD 135
Query: 240 LKTANLLMDENGVVKVADFGVARVQAQSGVMTAE-TGTYRWMAPEVIEHKPYDYKADVFS 298
           LK  N+L+D  G +K+ D+G+ +   + G  T+   GT  ++APE++  + Y +  D ++
Sbjct: 136 LKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSXFCGTPNYIAPEILRGEDYGFSVDWWA 195
Query: 299 FGIALWELLTGELPY----AGLTPLQAAVG-----VVQKSLRPTIPKHAHPRLAELLERC 349
            G+ ++E++ G  P+    +   P Q         +++K +R  IP+    + A +L+  
Sbjct: 196 LGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIR--IPRSLSVKAASVLKSF 253
Query: 350 WQHDPTQR 357
              DP +R
Sbjct: 254 LNKDPKER 261

>pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277

Iteration: 1
 Score = 84.7 bits (208), Expect = 9e-17,   Method: Compositional matrix adjust.
 Identities = 55/208 (26%), Positives = 103/208 (49%), Gaps = 11/208 (5%)
Query: 158 KEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQ--LTS 215
           ++  +EV I+++I+H NV+          ++ ++ E +A G ++DFL +++ + +   T 
Sbjct: 59  EDIEREVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATE 118
Query: 216 LLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGV----VKVADFGVARVQAQSGVMT 271
            LK  ++   G+ YLH   I H DLK  N+++ +  V    +K+ DFG+A          
Sbjct: 119 FLKQILN---GVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFK 175
Query: 272 AETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPYAGLTPLQ--AAVGVVQKS 329
              GT  ++APE++ ++P   +AD++S G+  + LL+G  P+ G T  +  A V  V   
Sbjct: 176 NIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYE 235
Query: 330 LRPTIPKHAHPRLAELLERCWQHDPTQR 357
                  +      + + R    DP +R
Sbjct: 236 FEDEYFSNTSALAKDFIRRLLVKDPKKR 263

>pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396

Iteration: 1
 Score = 84.7 bits (208), Expect = 9e-17,   Method: Compositional matrix adjust.
 Identities = 61/248 (24%), Positives = 126/248 (50%), Gaps = 17/248 (6%)
Query: 124 VASGSYGD--LYKGTYCSQEVAIKVLKPECVNTEMLKEFSQ-EVYIMRKIRHKNVVQFIG 180
           +  GSY    L +     +  A++V+K E VN +   ++ Q E ++  +  +   +  + 
Sbjct: 60  IGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLH 119
Query: 181 ACTRPPN-LCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRD 239
           +C +  + L  V E++  G +   + +Q+ + +  +    A ++S  +NYLH+  II+RD
Sbjct: 120 SCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSA-EISLALNYLHERGIIYRD 178
Query: 240 LKTANLLMDENGVVKVADFGVARVQAQSGVMTAE-TGTYRWMAPEVIEHKPYDYKADVFS 298
           LK  N+L+D  G +K+ D+G+ +   + G  T+   GT  ++APE++  + Y +  D ++
Sbjct: 179 LKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSTFCGTPNYIAPEILRGEDYGFSVDWWA 238
Query: 299 FGIALWELLTGELPY----AGLTPLQAAVG-----VVQKSLRPTIPKHAHPRLAELLERC 349
            G+ ++E++ G  P+    +   P Q         +++K +R  IP+    + A +L+  
Sbjct: 239 LGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIR--IPRSLSVKAASVLKSF 296
Query: 350 WQHDPTQR 357
              DP +R
Sbjct: 297 LNKDPKER 304

>pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285

Iteration: 1
 Score = 84.7 bits (208), Expect = 9e-17,   Method: Compositional matrix adjust.
 Identities = 55/208 (26%), Positives = 103/208 (49%), Gaps = 11/208 (5%)
Query: 158 KEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQ--LTS 215
           ++  +EV I+++I+H NV+          ++ ++ E +A G ++DFL +++ + +   T 
Sbjct: 59  EDIEREVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATE 118
Query: 216 LLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGV----VKVADFGVARVQAQSGVMT 271
            LK  ++   G+ YLH   I H DLK  N+++ +  V    +K+ DFG+A          
Sbjct: 119 FLKQILN---GVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFK 175
Query: 272 AETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPYAGLTPLQ--AAVGVVQKS 329
              GT  ++APE++ ++P   +AD++S G+  + LL+G  P+ G T  +  A V  V   
Sbjct: 176 NIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYE 235
Query: 330 LRPTIPKHAHPRLAELLERCWQHDPTQR 357
                  +      + + R    DP +R
Sbjct: 236 FEDEYFSNTSALAKDFIRRLLVKDPKKR 263

>pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278

Iteration: 1
 Score = 84.7 bits (208), Expect = 9e-17,   Method: Compositional matrix adjust.
 Identities = 55/208 (26%), Positives = 103/208 (49%), Gaps = 11/208 (5%)
Query: 158 KEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQ--LTS 215
           ++  +EV I+++I+H NV+          ++ ++ E +A G ++DFL +++ + +   T 
Sbjct: 59  EDIEREVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATE 118
Query: 216 LLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGV----VKVADFGVARVQAQSGVMT 271
            LK  ++   G+ YLH   I H DLK  N+++ +  V    +K+ DFG+A          
Sbjct: 119 FLKQILN---GVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFK 175
Query: 272 AETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPYAGLTPLQ--AAVGVVQKS 329
              GT  ++APE++ ++P   +AD++S G+  + LL+G  P+ G T  +  A V  V   
Sbjct: 176 NIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYE 235
Query: 330 LRPTIPKHAHPRLAELLERCWQHDPTQR 357
                  +      + + R    DP +R
Sbjct: 236 FEDEYFSNTSALAKDFIRRLLVKDPKKR 263

>pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326

Iteration: 1
 Score = 84.7 bits (208), Expect = 9e-17,   Method: Compositional matrix adjust.
 Identities = 55/208 (26%), Positives = 103/208 (49%), Gaps = 11/208 (5%)
Query: 158 KEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQ--LTS 215
           ++  +EV I+++I+H NV+          ++ ++ E +A G ++DFL +++ + +   T 
Sbjct: 59  EDIEREVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATE 118
Query: 216 LLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGV----VKVADFGVARVQAQSGVMT 271
            LK  ++   G+ YLH   I H DLK  N+++ +  V    +K+ DFG+A          
Sbjct: 119 FLKQILN---GVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFK 175
Query: 272 AETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPYAGLTPLQ--AAVGVVQKS 329
              GT  ++APE++ ++P   +AD++S G+  + LL+G  P+ G T  +  A V  V   
Sbjct: 176 NIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYE 235
Query: 330 LRPTIPKHAHPRLAELLERCWQHDPTQR 357
                  +      + + R    DP +R
Sbjct: 236 FEDEYFSNTSALAKDFIRRLLVKDPKKR 263

>pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301

Iteration: 1
 Score = 84.7 bits (208), Expect = 9e-17,   Method: Compositional matrix adjust.
 Identities = 56/204 (27%), Positives = 103/204 (50%), Gaps = 5/204 (2%)
Query: 162 QEVYIMRKIRHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAI 221
           +E+ ++ +     +V F GA      + I  E M  GS+ D + K+ G      L KV+I
Sbjct: 56  RELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSL-DQVLKKAGRIPEQILGKVSI 114
Query: 222 DVSKGMNYLHQNN-IIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAETGTYRWM 280
            V KG+ YL + + I+HRD+K +N+L++  G +K+ DFGV+  Q    +     GT  +M
Sbjct: 115 AVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSG-QLIDEMANEFVGTRSYM 173
Query: 281 APEVIEHKPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKSLRPTIPKHAHP 340
           +PE ++   Y  ++D++S G++L E+  G  P   +   +    +V +   P +P     
Sbjct: 174 SPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPRPPMAIFELLDYIVNEP-PPKLPSAVFS 232
Query: 341 -RLAELLERCWQHDPTQRPNFSQI 363
               + + +C   +P +R +  Q+
Sbjct: 233 LEFQDFVNKCLIKNPAERADLKQL 256

>pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295

Iteration: 1
 Score = 84.7 bits (208), Expect = 9e-17,   Method: Compositional matrix adjust.
 Identities = 55/208 (26%), Positives = 103/208 (49%), Gaps = 11/208 (5%)
Query: 158 KEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQ--LTS 215
           ++  +EV I+++I+H NV+          ++ ++ E +A G ++DFL +++ + +   T 
Sbjct: 59  EDIEREVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATE 118
Query: 216 LLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGV----VKVADFGVARVQAQSGVMT 271
            LK  ++   G+ YLH   I H DLK  N+++ +  V    +K+ DFG+A          
Sbjct: 119 FLKQILN---GVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFK 175
Query: 272 AETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPYAGLTPLQ--AAVGVVQKS 329
              GT  ++APE++ ++P   +AD++S G+  + LL+G  P+ G T  +  A V  V   
Sbjct: 176 NIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYE 235
Query: 330 LRPTIPKHAHPRLAELLERCWQHDPTQR 357
                  +      + + R    DP +R
Sbjct: 236 FEDEYFSNTSALAKDFIRRLLVKDPKKR 263

>pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334

Iteration: 1
 Score = 84.3 bits (207), Expect = 9e-17,   Method: Compositional matrix adjust.
 Identities = 55/208 (26%), Positives = 103/208 (49%), Gaps = 11/208 (5%)
Query: 158 KEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQ--LTS 215
           ++  +EV I+++I+H NV+          ++ ++ E +A G ++DFL +++ + +   T 
Sbjct: 59  EDIEREVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATE 118
Query: 216 LLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGV----VKVADFGVARVQAQSGVMT 271
            LK  ++   G+ YLH   I H DLK  N+++ +  V    +K+ DFG+A          
Sbjct: 119 FLKQILN---GVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFK 175
Query: 272 AETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPYAGLTPLQ--AAVGVVQKS 329
              GT  ++APE++ ++P   +AD++S G+  + LL+G  P+ G T  +  A V  V   
Sbjct: 176 NIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYE 235
Query: 330 LRPTIPKHAHPRLAELLERCWQHDPTQR 357
                  +      + + R    DP +R
Sbjct: 236 FEDEYFSNTSALAKDFIRRLLVKDPKKR 263

>pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295

Iteration: 1
 Score = 84.3 bits (207), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 55/208 (26%), Positives = 103/208 (49%), Gaps = 11/208 (5%)
Query: 158 KEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQ--LTS 215
           ++  +EV I+++I+H NV+          ++ ++ E +A G ++DFL +++ + +   T 
Sbjct: 59  EDIEREVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATE 118
Query: 216 LLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGV----VKVADFGVARVQAQSGVMT 271
            LK  ++   G+ YLH   I H DLK  N+++ +  V    +K+ DFG+A          
Sbjct: 119 FLKQILN---GVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFK 175
Query: 272 AETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPYAGLTPLQ--AAVGVVQKS 329
              GT  ++APE++ ++P   +AD++S G+  + LL+G  P+ G T  +  A V  V   
Sbjct: 176 NIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYE 235
Query: 330 LRPTIPKHAHPRLAELLERCWQHDPTQR 357
                  +      + + R    DP +R
Sbjct: 236 FEDEYFSNTSALAKDFIRRLLVKDPKKR 263

>pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293

Iteration: 1
 Score = 84.3 bits (207), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 55/208 (26%), Positives = 103/208 (49%), Gaps = 11/208 (5%)
Query: 158 KEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQ--LTS 215
           ++  +EV I+++I+H NV+          ++ ++ E +A G ++DFL +++ + +   T 
Sbjct: 58  EDIEREVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATE 117
Query: 216 LLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGV----VKVADFGVARVQAQSGVMT 271
            LK  ++   G+ YLH   I H DLK  N+++ +  V    +K+ DFG+A          
Sbjct: 118 FLKQILN---GVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFK 174
Query: 272 AETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPYAGLTPLQ--AAVGVVQKS 329
              GT  ++APE++ ++P   +AD++S G+  + LL+G  P+ G T  +  A V  V   
Sbjct: 175 NIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYE 234
Query: 330 LRPTIPKHAHPRLAELLERCWQHDPTQR 357
                  +      + + R    DP +R
Sbjct: 235 FEDEYFSNTSALAKDFIRRLLVKDPKKR 262

>pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294

Iteration: 1
 Score = 84.3 bits (207), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 55/208 (26%), Positives = 103/208 (49%), Gaps = 11/208 (5%)
Query: 158 KEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQ--LTS 215
           ++  +EV I+++I+H NV+          ++ ++ E +A G ++DFL +++ + +   T 
Sbjct: 58  EDIEREVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATE 117
Query: 216 LLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGV----VKVADFGVARVQAQSGVMT 271
            LK  ++   G+ YLH   I H DLK  N+++ +  V    +K+ DFG+A          
Sbjct: 118 FLKQILN---GVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFK 174
Query: 272 AETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPYAGLTPLQ--AAVGVVQKS 329
              GT  ++APE++ ++P   +AD++S G+  + LL+G  P+ G T  +  A V  V   
Sbjct: 175 NIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYE 234
Query: 330 LRPTIPKHAHPRLAELLERCWQHDPTQR 357
                  +      + + R    DP +R
Sbjct: 235 FEDEYFSNTSALAKDFIRRLLVKDPKKR 262

>pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295

Iteration: 1
 Score = 84.3 bits (207), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 55/208 (26%), Positives = 103/208 (49%), Gaps = 11/208 (5%)
Query: 158 KEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQ--LTS 215
           ++  +EV I+++I+H NV+          ++ ++ E +A G ++DFL +++ + +   T 
Sbjct: 59  EDIEREVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATE 118
Query: 216 LLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGV----VKVADFGVARVQAQSGVMT 271
            LK  ++   G+ YLH   I H DLK  N+++ +  V    +K+ DFG+A          
Sbjct: 119 FLKQILN---GVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFK 175
Query: 272 AETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPYAGLTPLQ--AAVGVVQKS 329
              GT  ++APE++ ++P   +AD++S G+  + LL+G  P+ G T  +  A V  V   
Sbjct: 176 NIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYE 235
Query: 330 LRPTIPKHAHPRLAELLERCWQHDPTQR 357
                  +      + + R    DP +R
Sbjct: 236 FEDEYFSNTSALAKDFIRRLLVKDPKKR 263

>pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 In Presence Of Indirubin E804 Length = 277

Iteration: 1
 Score = 84.3 bits (207), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 65/250 (26%), Positives = 121/250 (48%), Gaps = 21/250 (8%)
Query: 120 IECKVASGSYGDL----YKGTYCSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNV 175
           +E  +  GS+G++     KGT   +  A K+ K      E +  F QE+ IM+ + H N+
Sbjct: 13  LENTIGRGSWGEVKIAVQKGTRI-RRAAKKIPK---YFVEDVDRFKQEIEIMKSLDHPNI 68
Query: 176 VQFIGACTRPPNLCIVTEFMARGSIYD-FLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNN 234
           ++         ++ +V E    G +++  +HK+  VF+ +   ++  DV   + Y H+ N
Sbjct: 69  IRLYETFEDNTDIYLVMELCTGGELFERVVHKR--VFRESDAARIMKDVLSAVAYCHKLN 126
Query: 235 IIHRDLKTANLLM---DENGVVKVADFGVARVQAQSGVMTAETGTYRWMAPEVIEHKPYD 291
           + HRDLK  N L      +  +K+ DFG+A       +M  + GT  +++P+V+E   Y 
Sbjct: 127 VAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKMMRTKVGTPYYVSPQVLEGL-YG 185
Query: 292 YKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKSLRPTIPK----HAHPRLAELLE 347
            + D +S G+ ++ LL G  P++  T  +  + + + +   T P+    +  P+   L+ 
Sbjct: 186 PECDEWSAGVMMYVLLCGYPPFSAPTDXEVMLKIREGTF--TFPEKDWLNVSPQAESLIR 243
Query: 348 RCWQHDPTQR 357
           R     P QR
Sbjct: 244 RLLTKSPKQR 253

>pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312

Iteration: 1
 Score = 84.3 bits (207), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 55/208 (26%), Positives = 103/208 (49%), Gaps = 11/208 (5%)
Query: 158 KEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQ--LTS 215
           ++  +EV I+++I+H NV+          ++ ++ E +A G ++DFL +++ + +   T 
Sbjct: 59  EDIEREVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATE 118
Query: 216 LLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGV----VKVADFGVARVQAQSGVMT 271
            LK  ++   G+ YLH   I H DLK  N+++ +  V    +K+ DFG+A          
Sbjct: 119 FLKQILN---GVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFK 175
Query: 272 AETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPYAGLTPLQ--AAVGVVQKS 329
              GT  ++APE++ ++P   +AD++S G+  + LL+G  P+ G T  +  A V  V   
Sbjct: 176 NIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYE 235
Query: 330 LRPTIPKHAHPRLAELLERCWQHDPTQR 357
                  +      + + R    DP +R
Sbjct: 236 FEDEYFSNTSALAKDFIRRLLVKDPKKR 263

>pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295

Iteration: 1
 Score = 84.3 bits (207), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 55/208 (26%), Positives = 103/208 (49%), Gaps = 11/208 (5%)
Query: 158 KEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQ--LTS 215
           ++  +EV I+++I+H NV+          ++ ++ E +A G ++DFL +++ + +   T 
Sbjct: 59  EDIEREVSILKEIQHPNVITLHEVYENKTDVILIGELVAGGELFDFLAEKESLTEEEATE 118
Query: 216 LLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGV----VKVADFGVARVQAQSGVMT 271
            LK  ++   G+ YLH   I H DLK  N+++ +  V    +K+ DFG+A          
Sbjct: 119 FLKQILN---GVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFK 175
Query: 272 AETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPYAGLTPLQ--AAVGVVQKS 329
              GT  ++APE++ ++P   +AD++S G+  + LL+G  P+ G T  +  A V  V   
Sbjct: 176 NIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYE 235
Query: 330 LRPTIPKHAHPRLAELLERCWQHDPTQR 357
                  +      + + R    DP +R
Sbjct: 236 FEDEYFSNTSALAKDFIRRLLVKDPKKR 263

>pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302

Iteration: 1
 Score = 84.3 bits (207), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 55/208 (26%), Positives = 103/208 (49%), Gaps = 11/208 (5%)
Query: 158 KEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQ--LTS 215
           ++  +EV I+++I+H NV+          ++ ++ E +A G ++DFL +++ + +   T 
Sbjct: 59  EDIEREVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATE 118
Query: 216 LLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGV----VKVADFGVARVQAQSGVMT 271
            LK  ++   G+ YLH   I H DLK  N+++ +  V    +K+ DFG+A          
Sbjct: 119 FLKQILN---GVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFK 175
Query: 272 AETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPYAGLTPLQ--AAVGVVQKS 329
              GT  ++APE++ ++P   +AD++S G+  + LL+G  P+ G T  +  A V  V   
Sbjct: 176 NIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYE 235
Query: 330 LRPTIPKHAHPRLAELLERCWQHDPTQR 357
                  +      + + R    DP +R
Sbjct: 236 FEDEYFSNTSALAKDFIRRLLVKDPKKR 263

>pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 Length = 294

Iteration: 1
 Score = 84.0 bits (206), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 65/250 (26%), Positives = 121/250 (48%), Gaps = 21/250 (8%)
Query: 120 IECKVASGSYGDL----YKGTYCSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNV 175
           +E  +  GS+G++     KGT   +  A K+ K      E +  F QE+ IM+ + H N+
Sbjct: 30  LENTIGRGSWGEVKIAVQKGTRI-RRAAKKIPK---YFVEDVDRFKQEIEIMKSLDHPNI 85
Query: 176 VQFIGACTRPPNLCIVTEFMARGSIYD-FLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNN 234
           ++         ++ +V E    G +++  +HK+  VF+ +   ++  DV   + Y H+ N
Sbjct: 86  IRLYETFEDNTDIYLVMELCTGGELFERVVHKR--VFRESDAARIMKDVLSAVAYCHKLN 143
Query: 235 IIHRDLKTANLLM---DENGVVKVADFGVARVQAQSGVMTAETGTYRWMAPEVIEHKPYD 291
           + HRDLK  N L      +  +K+ DFG+A       +M  + GT  +++P+V+E   Y 
Sbjct: 144 VAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKMMRTKVGTPYYVSPQVLEGL-YG 202
Query: 292 YKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKSLRPTIPK----HAHPRLAELLE 347
            + D +S G+ ++ LL G  P++  T  +  + + + +   T P+    +  P+   L+ 
Sbjct: 203 PECDEWSAGVMMYVLLCGYPPFSAPTDXEVMLKIREGTF--TFPEKDWLNVSPQAESLIR 260
Query: 348 RCWQHDPTQR 357
           R     P QR
Sbjct: 261 RLLTKSPKQR 270

>pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334

Iteration: 1
 Score = 84.0 bits (206), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 55/208 (26%), Positives = 103/208 (49%), Gaps = 11/208 (5%)
Query: 158 KEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQ--LTS 215
           ++  +EV I+++I+H NV+          ++ ++ E +A G ++DFL +++ + +   T 
Sbjct: 59  EDIEREVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATE 118
Query: 216 LLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGV----VKVADFGVARVQAQSGVMT 271
            LK  ++   G+ YLH   I H DLK  N+++ +  V    +K+ DFG+A          
Sbjct: 119 FLKQILN---GVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFK 175
Query: 272 AETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPYAGLTPLQ--AAVGVVQKS 329
              GT  ++APE++ ++P   +AD++S G+  + LL+G  P+ G T  +  A V  V   
Sbjct: 176 NIFGTPAFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYE 235
Query: 330 LRPTIPKHAHPRLAELLERCWQHDPTQR 357
                  +      + + R    DP +R
Sbjct: 236 FEDEYFSNTSALAKDFIRRLLVKDPKKR 263

>pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278

Iteration: 1
 Score = 84.0 bits (206), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 61/254 (24%), Positives = 113/254 (44%), Gaps = 6/254 (2%)
Query: 116 KQLKIECKVASGSYGDLYKG--TYCSQEVAIKVL-KPECVNTEMLKEFSQEVYIMRKIRH 172
           +  K+   +  GS+  +Y+    +   EVAIK++ K       M++    EV I  +++H
Sbjct: 11  EDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKH 70
Query: 173 KNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQ 232
            ++++          + +V E    G +  +L  +   F           +  GM YLH 
Sbjct: 71  PSILELYNYFEDSNYVYLVLEMCHNGEMNRYLKNRVKPFSENEARHFMHQIITGMLYLHS 130
Query: 233 NNIIHRDLKTANLLMDENGVVKVADFGVA-RVQAQSGVMTAETGTYRWMAPEVIEHKPYD 291
           + I+HRDL  +NLL+  N  +K+ADFG+A +++          GT  +++PE+     + 
Sbjct: 131 HGILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHEKHYTLCGTPNYISPEIATRSAHG 190
Query: 292 YKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRLAELLERCWQ 351
            ++DV+S G   + LL G  P+   T       VV       +P        +L+ +  +
Sbjct: 191 LESDVWSLGCMFYTLLIGRPPFDTDTVKNTLNKVVLADYE--MPSFLSIEAKDLIHQLLR 248
Query: 352 HDPTQRPNFSQITD 365
            +P  R + S + D
Sbjct: 249 RNPADRLSLSSVLD 262

>pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349

Iteration: 1
 Score = 83.6 bits (205), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 54/204 (26%), Positives = 106/204 (51%), Gaps = 16/204 (7%)
Query: 118 LKIECKVASGSYGDLYKGTYCSQE-----VAIKVLKPECVNTEMLKEFSQEVYIMRKIRH 172
            ++E ++  G+   +Y+   C Q+      A+KVLK + V+ ++++    E+ ++ ++ H
Sbjct: 55  FEVESELGRGATSIVYR---CKQKGTQKPYALKVLK-KTVDKKIVR---TEIGVLLRLSH 107
Query: 173 KNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQ 232
            N+++       P  + +V E +  G ++D +  +KG +           + + + YLH+
Sbjct: 108 PNIIKLKEIFETPTEISLVLELVTGGELFDRI-VEKGYYSERDAADAVKQILEAVAYLHE 166
Query: 233 NNIIHRDLKTANLLMDE---NGVVKVADFGVARVQAQSGVMTAETGTYRWMAPEVIEHKP 289
           N I+HRDLK  NLL      +  +K+ADFG++++     +M    GT  + APE++    
Sbjct: 167 NGIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQVLMKTVCGTPGYCAPEILRGCA 226
Query: 290 YDYKADVFSFGIALWELLTGELPY 313
           Y  + D++S GI  + LL G  P+
Sbjct: 227 YGPEVDMWSVGIITYILLCGFEPF 250

>pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292

Iteration: 1
 Score = 83.2 bits (204), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 63/246 (25%), Positives = 122/246 (49%), Gaps = 11/246 (4%)
Query: 124 VASGSYGDLYKGTYCSQE--VAIKVLKPECVNTEMLK-EFSQEVYIMRKIRHKNVVQFIG 180
           +  G +G++Y          VA+KVL    +  E ++ +  +E+ I   + H N+++   
Sbjct: 31  LGKGKFGNVYLAREKKSHFIVALKVLFKSQIEKEGVEHQLRREIEIQAHLHHPNILRLYN 90
Query: 181 ACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDL 240
                  + ++ E+  RG +Y  L K    F       +  +++  + Y H   +IHRD+
Sbjct: 91  YFYDRRRIYLILEYAPRGELYKELQKS-CTFDEQRTATIMEELADALMYCHGKKVIHRDI 149
Query: 241 KTANLLMDENGVVKVADFGVARVQAQSGVMTAETGTYRWMAPEVIEHKPYDYKADVFSFG 300
           K  NLL+   G +K+ADFG + V A S       GT  ++ PE+IE + ++ K D++  G
Sbjct: 150 KPENLLLGLKGELKIADFGWS-VHAPSLRRKTMCGTLDYLPPEMIEGRMHNEKVDLWCIG 208
Query: 301 IALWELLTGELPYAGLTPLQAAVGVVQKSLR--PTIPKHAHPRLAELLERCWQHDPTQRP 358
           +  +ELL G  P+   +  +    +V+  L+   ++P  A   +++LL    +H+P++R 
Sbjct: 209 VLCYELLVGNPPFESASHNETYRRIVKVDLKFPASVPTGAQDLISKLL----RHNPSERL 264
Query: 359 NFSQIT 364
             +Q++
Sbjct: 265 PLAQVS 270

>pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365

Iteration: 1
 Score = 83.2 bits (204), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 48/180 (26%), Positives = 97/180 (53%), Gaps = 9/180 (5%)
Query: 141 EVAIKVLKPECVNTEMLKEFSQEVYIMRKIR-HKNVVQFIGACTRPPNLCIVTEFMARGS 199
           EV  + L PE +  E+ +   +E +I+R++  H +++  I +      + +V + M +G 
Sbjct: 128 EVTAERLSPEQLE-EVREATRRETHILRQVAGHPHIITLIDSYESSSFMFLVFDLMRKGE 186
Query: 200 IYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFG 259
           ++D+L  +K          +   + + +++LH NNI+HRDLK  N+L+D+N  ++++DFG
Sbjct: 187 LFDYL-TEKVALSEKETRSIMRSLLEAVSFLHANNIVHRDLKPENILLDDNMQIRLSDFG 245
Query: 260 VARVQAQSGVMTAETGTYRWMAPEVIE------HKPYDYKADVFSFGIALWELLTGELPY 313
            +        +    GT  ++APE+++      H  Y  + D+++ G+ L+ LL G  P+
Sbjct: 246 FSCHLEPGEKLRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPF 305

>pdb|4EUT|A Chain A, Structure Of Bx-795 Complexed With Unphosphorylated Human Tbk1 Kinase- Uld Domain Length = 396

Iteration: 1
 Score = 82.8 bits (203), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 80/309 (25%), Positives = 128/309 (41%), Gaps = 64/309 (20%)
Query: 124 VASGSYGDLYKGTY--CSQEVAIKVLKPECVNTEMLKEFS---QEVYIMRKIRHKNVVQF 178
           +  G+  ++++G +       AIKV      N   L+      +E  +++K+ HKN+V+ 
Sbjct: 17  LGQGATANVFRGRHKKTGDLFAIKVFN----NISFLRPVDVQMREFEVLKKLNHKNIVKL 72
Query: 179 --IGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQL--TSLLKVAIDVSKGMNYLHQNN 234
             I   T   +  ++ EF   GS+Y  L +    + L  +  L V  DV  GMN+L +N 
Sbjct: 73  FAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENG 132
Query: 235 IIHRDLKTANLLM----DENGVVKVADFGVARVQAQSGVMTAETGTYRWMAPEVIE---- 286
           I+HR++K  N++     D   V K+ DFG AR         +  GT  ++ P++ E    
Sbjct: 133 IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVSLYGTEEYLHPDMYERAVL 192
Query: 287 ----HKPYDYKADVFSFGIALWELLTGELPYAGL----------------TPLQAAVGV- 325
                K Y    D++S G+  +   TG LP+                    P  A  GV 
Sbjct: 193 RKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITGKPSGAISGVQ 252
Query: 326 --------------VQKSLRPTIPKHAHPRLAELL----ERCWQHDPTQRPNFSQITDIL 367
                         V  SL   +     P LA +L    E+CW  D      F++ +DIL
Sbjct: 253 KAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQF----FAETSDIL 308
Query: 368 KQMMKEVAS 376
            +M+  V S
Sbjct: 309 HRMVIHVFS 317

>pdb|3G2F|A Chain A, Crystal Structure Of The Kinase Domain Of Bone Morphogenetic Protein Receptor Type Ii (Bmpr2) At 2.35 A Resolution Length = 336

Iteration: 1
 Score = 82.8 bits (203), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 77/313 (24%), Positives = 128/313 (40%), Gaps = 59/313 (18%)
Query: 113 IDAKQLKIECKVASGSYGDLYKGTYCSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRH 172
           +D   LK+   +  G YG +YKG+   + VA+KV      N +      + +Y +  + H
Sbjct: 10  LDLDNLKLLELIGRGRYGAVYKGSLDERPVAVKVFS--FANRQNFIN-EKNIYRVPLMEH 66
Query: 173 KNVVQFIGACTRPP-----NLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGM 227
            N+ +FI    R          +V E+   GS+  +L      +   S  ++A  V++G+
Sbjct: 67  DNIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYLSLHTSDW--VSSCRLAHSVTRGL 124
Query: 228 NYLH---------QNNIIHRDLKTANLLMDENGVVKVADFGVA---------RVQAQSGV 269
            YLH         +  I HRDL + N+L+  +G   ++DFG++         R   +   
Sbjct: 125 AYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGNRLVRPGEEDNA 184
Query: 270 MTAETGTYRWMAPEVIE-------HKPYDYKADVFSFGIALWE-------LLTGELPYAG 315
             +E GT R+MAPEV+E        +    + D+++ G+  WE       L  GE     
Sbjct: 185 AISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPGESVPEY 244
Query: 316 LTPLQAAVG-----------VVQKSLRPTIPKH------AHPRLAELLERCWQHDPTQRP 358
               Q  VG           V ++  RP  P+       A   L E +E CW  D   R 
Sbjct: 245 QMAFQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRSLKETIEDCWDQDAEARL 304
Query: 359 NFSQITDILKQMM 371
                 + + ++M
Sbjct: 305 TAQXAEERMAELM 317

>pdb|3TAC|A Chain A, Crystal Structure Of The Liprin-AlphaCASK COMPLEX Length = 361

Iteration: 1
 Score = 82.4 bits (202), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 62/215 (28%), Positives = 107/215 (49%), Gaps = 13/215 (6%)
Query: 152 VNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVTEFMARGSI-YDFLHKQKGV 210
           ++TE LK   +E  I   ++H ++V+ +   +    L +V EFM    + ++ + +    
Sbjct: 70  LSTEDLK---REASICHMLKHPHIVELLETYSSDGMLYMVFEFMDGADLCFEIVKRADAG 126
Query: 211 FQLTSLLKVAI--DVSKGMNYLHQNNIIHRDLKTANLLM---DENGVVKVADFGVARVQA 265
           F  +  +       + + + Y H NNIIHRD+K   +L+   + +  VK+  FGVA    
Sbjct: 127 FVYSEAVASHYMRQILEALRYCHDNNIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLG 186
Query: 266 QSG-VMTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVG 324
           +SG V     GT  +MAPEV++ +PY    DV+  G+ L+ LL+G LP+ G T  +   G
Sbjct: 187 ESGLVAGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLPFYG-TKERLFEG 245
Query: 325 VVQK--SLRPTIPKHAHPRLAELLERCWQHDPTQR 357
           +++    + P    H      +L+ R    DP +R
Sbjct: 246 IIKGKYKMNPRQWSHISESAKDLVRRMLMLDPAER 280

>pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279

Iteration: 1
 Score = 82.4 bits (202), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 56/214 (26%), Positives = 102/214 (47%), Gaps = 12/214 (5%)
Query: 163 EVYIMRKIRHKNVVQFIGACTRPPN--LCIVTEFMARGSIYDFLHK---QKGVFQLTSLL 217
           EV ++R+++H N+V++        N  L IV E+   G +   + K   ++       +L
Sbjct: 55  EVNLLRELKHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVL 114
Query: 218 KVAIDVSKGMNYLHQ-----NNIIHRDLKTANLLMDENGVVKVADFGVARV-QAQSGVMT 271
           +V   ++  +   H+     + ++HRDLK AN+ +D    VK+ DFG+AR+    +    
Sbjct: 115 RVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAK 174
Query: 272 AETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKSLR 331
           A  GT  +M+PE +    Y+ K+D++S G  L+EL     P+   +  + A  + +   R
Sbjct: 175 AFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGKFR 234
Query: 332 PTIPKHAHPRLAELLERCWQHDPTQRPNFSQITD 365
             IP      L E++ R        RP+  +I +
Sbjct: 235 -RIPYRYSDELNEIITRMLNLKDYHRPSVEEILE 267

>pdb|3C0G|A Chain A, Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Length = 351

Iteration: 1
 Score = 82.4 bits (202), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 62/215 (28%), Positives = 107/215 (49%), Gaps = 13/215 (6%)
Query: 152 VNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVTEFMARGSI-YDFLHKQKGV 210
           ++TE LK   +E  I   ++H ++V+ +   +    L +V EFM    + ++ + +    
Sbjct: 68  LSTEDLK---REASICHMLKHPHIVELLETYSSDGMLYMVFEFMDGADLCFEIVKRADAG 124
Query: 211 FQLTSLLKVAI--DVSKGMNYLHQNNIIHRDLKTANLLM---DENGVVKVADFGVARVQA 265
           F  +  +       + + + Y H NNIIHRD+K   +L+   + +  VK+  FGVA    
Sbjct: 125 FVYSEAVASHYMRQILEALRYCHDNNIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLG 184
Query: 266 QSG-VMTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVG 324
           +SG V     GT  +MAPEV++ +PY    DV+  G+ L+ LL+G LP+ G T  +   G
Sbjct: 185 ESGLVAGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLPFYG-TKERLFEG 243
Query: 325 VVQK--SLRPTIPKHAHPRLAELLERCWQHDPTQR 357
           +++    + P    H      +L+ R    DP +R
Sbjct: 244 IIKGKYKMNPRQWSHISESAKDLVRRMLMLDPAER 278

>pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 82.4 bits (202), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 55/196 (28%), Positives = 103/196 (52%), Gaps = 8/196 (4%)
Query: 124 VASGSYGD--LYKGTYCSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGA 181
           +  G+YG+  L       + VA+K++  +    +  +   +E+ I + + H+NVV+F G 
Sbjct: 14  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRA-VDCPENIKKEIXINKMLNHENVVKFYGH 72
Query: 182 CTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLK 241
                   +  E+ + G ++D +    G+ +  +  +    +  G+ YLH   I HRD+K
Sbjct: 73  RREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQ-RFFHQLMAGVVYLHGIGITHRDIK 131
Query: 242 TANLLMDENGVVKVADFGVA---RVQAQSGVMTAETGTYRWMAPEVIEHKPYDYK-ADVF 297
             NLL+DE   +K++DFG+A   R   +  ++    GT  ++APE+++ + +  +  DV+
Sbjct: 132 PENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAPELLKRREFHAEPVDVW 191
Query: 298 SFGIALWELLTGELPY 313
           S GI L  +L GELP+
Sbjct: 192 SCGIVLTAMLAGELPW 207

>pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373

Iteration: 1
 Score = 82.0 bits (201), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 51/198 (25%), Positives = 101/198 (51%), Gaps = 10/198 (5%)
Query: 124 VASGSYGDLYK--GTYCSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGA 181
           +  G +G ++K   T    ++A K++K   +  +  +E   E+ +M ++ H N++Q   A
Sbjct: 97  LGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDK--EEVKNEISVMNQLDHANLIQLYDA 154
Query: 182 CTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAI--DVSKGMNYLHQNNIIHRD 239
                ++ +V E++  G ++D +  +   + LT L  +     + +G+ ++HQ  I+H D
Sbjct: 155 FESKNDIVLVMEYVDGGELFDRIIDES--YNLTELDTILFMKQICEGIRHMHQMYILHLD 212
Query: 240 LKTANLLMDENGV--VKVADFGVARVQAQSGVMTAETGTYRWMAPEVIEHKPYDYKADVF 297
           LK  N+L        +K+ DFG+AR       +    GT  ++APEV+ +    +  D++
Sbjct: 213 LKPENILCVNRDAKQIKIIDFGLARRYKPREKLKVNFGTPEFLAPEVVNYDFVSFPTDMW 272
Query: 298 SFGIALWELLTGELPYAG 315
           S G+  + LL+G  P+ G
Sbjct: 273 SVGVIAYMLLSGLSPFLG 290

>pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276

Iteration: 1
 Score = 82.0 bits (201), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 55/196 (28%), Positives = 103/196 (52%), Gaps = 8/196 (4%)
Query: 124 VASGSYGD--LYKGTYCSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGA 181
           +  G+YG+  L       + VA+K++  +    +  +   +E+ I + + H+NVV+F G 
Sbjct: 15  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRA-VDCPENIKKEIXINKMLNHENVVKFYGH 73
Query: 182 CTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLK 241
                   +  E+ + G ++D +    G+ +  +  +    +  G+ YLH   I HRD+K
Sbjct: 74  RREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQ-RFFHQLMAGVVYLHGIGITHRDIK 132
Query: 242 TANLLMDENGVVKVADFGVA---RVQAQSGVMTAETGTYRWMAPEVIEHKPYDYK-ADVF 297
             NLL+DE   +K++DFG+A   R   +  ++    GT  ++APE+++ + +  +  DV+
Sbjct: 133 PENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAPELLKRREFHAEPVDVW 192
Query: 298 SFGIALWELLTGELPY 313
           S GI L  +L GELP+
Sbjct: 193 SCGIVLTAMLAGELPW 208

>pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 82.0 bits (201), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 55/196 (28%), Positives = 103/196 (52%), Gaps = 8/196 (4%)
Query: 124 VASGSYGD--LYKGTYCSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGA 181
           +  G+YG+  L       + VA+K++  +    +  +   +E+ I + + H+NVV+F G 
Sbjct: 14  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRA-VDCPENIKKEIXINKMLNHENVVKFYGH 72
Query: 182 CTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLK 241
                   +  E+ + G ++D +    G+ +  +  +    +  G+ YLH   I HRD+K
Sbjct: 73  RREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQ-RFFHQLMAGVVYLHGIGITHRDIK 131
Query: 242 TANLLMDENGVVKVADFGVA---RVQAQSGVMTAETGTYRWMAPEVIEHKPYDYK-ADVF 297
             NLL+DE   +K++DFG+A   R   +  ++    GT  ++APE+++ + +  +  DV+
Sbjct: 132 PENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVW 191
Query: 298 SFGIALWELLTGELPY 313
           S GI L  +L GELP+
Sbjct: 192 SCGIVLTAMLAGELPW 207

>pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297

Iteration: 1
 Score = 81.6 bits (200), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 55/196 (28%), Positives = 103/196 (52%), Gaps = 8/196 (4%)
Query: 124 VASGSYGD--LYKGTYCSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGA 181
           +  G+YG+  L       + VA+K++  +    +  +   +E+ I + + H+NVV+F G 
Sbjct: 15  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRA-VDCPENIKKEICINKMLNHENVVKFYGH 73
Query: 182 CTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLK 241
                   +  E+ + G ++D +    G+ +  +  +    +  G+ YLH   I HRD+K
Sbjct: 74  RREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQ-RFFHQLMAGVVYLHGIGITHRDIK 132
Query: 242 TANLLMDENGVVKVADFGVA---RVQAQSGVMTAETGTYRWMAPEVIEHKPYDYK-ADVF 297
             NLL+DE   +K++DFG+A   R   +  ++    GT  ++APE+++ + +  +  DV+
Sbjct: 133 PENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVW 192
Query: 298 SFGIALWELLTGELPY 313
           S GI L  +L GELP+
Sbjct: 193 SCGIVLTAMLAGELPW 208

>pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289

Iteration: 1
 Score = 81.6 bits (200), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 55/196 (28%), Positives = 103/196 (52%), Gaps = 8/196 (4%)
Query: 124 VASGSYGD--LYKGTYCSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGA 181
           +  G+YG+  L       + VA+K++  +    +  +   +E+ I + + H+NVV+F G 
Sbjct: 15  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRA-VDCPENIKKEICINKMLNHENVVKFYGH 73
Query: 182 CTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLK 241
                   +  E+ + G ++D +    G+ +  +  +    +  G+ YLH   I HRD+K
Sbjct: 74  RREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQ-RFFHQLMAGVVYLHGIGITHRDIK 132
Query: 242 TANLLMDENGVVKVADFGVA---RVQAQSGVMTAETGTYRWMAPEVIEHKPYDYK-ADVF 297
             NLL+DE   +K++DFG+A   R   +  ++    GT  ++APE+++ + +  +  DV+
Sbjct: 133 PENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVW 192
Query: 298 SFGIALWELLTGELPY 313
           S GI L  +L GELP+
Sbjct: 193 SCGIVLTAMLAGELPW 208

>pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295

Iteration: 1
 Score = 81.6 bits (200), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 55/196 (28%), Positives = 103/196 (52%), Gaps = 8/196 (4%)
Query: 124 VASGSYGD--LYKGTYCSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGA 181
           +  G+YG+  L       + VA+K++  +    +  +   +E+ I + + H+NVV+F G 
Sbjct: 15  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRA-VDCPENIKKEICINKMLNHENVVKFYGH 73
Query: 182 CTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLK 241
                   +  E+ + G ++D +    G+ +  +  +    +  G+ YLH   I HRD+K
Sbjct: 74  RREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQ-RFFHQLMAGVVYLHGIGITHRDIK 132
Query: 242 TANLLMDENGVVKVADFGVA---RVQAQSGVMTAETGTYRWMAPEVIEHKPYDYK-ADVF 297
             NLL+DE   +K++DFG+A   R   +  ++    GT  ++APE+++ + +  +  DV+
Sbjct: 133 PENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVW 192
Query: 298 SFGIALWELLTGELPY 313
           S GI L  +L GELP+
Sbjct: 193 SCGIVLTAMLAGELPW 208

>pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279

Iteration: 1
 Score = 81.6 bits (200), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 56/214 (26%), Positives = 101/214 (47%), Gaps = 12/214 (5%)
Query: 163 EVYIMRKIRHKNVVQFIGACTRPPN--LCIVTEFMARGSIYDFLHK---QKGVFQLTSLL 217
           EV ++R+++H N+V++        N  L IV E+   G +   + K   ++       +L
Sbjct: 55  EVNLLRELKHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVL 114
Query: 218 KVAIDVSKGMNYLHQ-----NNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTA 272
           +V   ++  +   H+     + ++HRDLK AN+ +D    VK+ DFG+AR+         
Sbjct: 115 RVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDEDFAK 174
Query: 273 E-TGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKSLR 331
           E  GT  +M+PE +    Y+ K+D++S G  L+EL     P+   +  + A  + +   R
Sbjct: 175 EFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGKFR 234
Query: 332 PTIPKHAHPRLAELLERCWQHDPTQRPNFSQITD 365
             IP      L E++ R        RP+  +I +
Sbjct: 235 -RIPYRYSDELNEIITRMLNLKDYHRPSVEEILE 267

>pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323

Iteration: 1
 Score = 81.6 bits (200), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 55/196 (28%), Positives = 103/196 (52%), Gaps = 8/196 (4%)
Query: 124 VASGSYGD--LYKGTYCSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGA 181
           +  G+YG+  L       + VA+K++  +    +  +   +E+ I + + H+NVV+F G 
Sbjct: 15  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRA-VDCPENIKKEICINKMLNHENVVKFYGH 73
Query: 182 CTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLK 241
                   +  E+ + G ++D +    G+ +  +  +    +  G+ YLH   I HRD+K
Sbjct: 74  RREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQ-RFFHQLMAGVVYLHGIGITHRDIK 132
Query: 242 TANLLMDENGVVKVADFGVA---RVQAQSGVMTAETGTYRWMAPEVIEHKPYDYK-ADVF 297
             NLL+DE   +K++DFG+A   R   +  ++    GT  ++APE+++ + +  +  DV+
Sbjct: 133 PENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVW 192
Query: 298 SFGIALWELLTGELPY 313
           S GI L  +L GELP+
Sbjct: 193 SCGIVLTAMLAGELPW 208

>pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322

Iteration: 1
 Score = 81.6 bits (200), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 55/196 (28%), Positives = 103/196 (52%), Gaps = 8/196 (4%)
Query: 124 VASGSYGD--LYKGTYCSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGA 181
           +  G+YG+  L       + VA+K++  +    +  +   +E+ I + + H+NVV+F G 
Sbjct: 14  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRA-VDCPENIKKEICINKMLNHENVVKFYGH 72
Query: 182 CTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLK 241
                   +  E+ + G ++D +    G+ +  +  +    +  G+ YLH   I HRD+K
Sbjct: 73  RREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQ-RFFHQLMAGVVYLHGIGITHRDIK 131
Query: 242 TANLLMDENGVVKVADFGVA---RVQAQSGVMTAETGTYRWMAPEVIEHKPYDYK-ADVF 297
             NLL+DE   +K++DFG+A   R   +  ++    GT  ++APE+++ + +  +  DV+
Sbjct: 132 PENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVW 191
Query: 298 SFGIALWELLTGELPY 313
           S GI L  +L GELP+
Sbjct: 192 SCGIVLTAMLAGELPW 207

>pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269

Iteration: 1
 Score = 81.6 bits (200), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 55/196 (28%), Positives = 103/196 (52%), Gaps = 8/196 (4%)
Query: 124 VASGSYGD--LYKGTYCSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGA 181
           +  G+YG+  L       + VA+K++  +    +  +   +E+ I + + H+NVV+F G 
Sbjct: 14  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRA-VDCPENIKKEICINKMLNHENVVKFYGH 72
Query: 182 CTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLK 241
                   +  E+ + G ++D +    G+ +  +  +    +  G+ YLH   I HRD+K
Sbjct: 73  RREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQ-RFFHQLMAGVVYLHGIGITHRDIK 131
Query: 242 TANLLMDENGVVKVADFGVA---RVQAQSGVMTAETGTYRWMAPEVIEHKPYDYK-ADVF 297
             NLL+DE   +K++DFG+A   R   +  ++    GT  ++APE+++ + +  +  DV+
Sbjct: 132 PENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVW 191
Query: 298 SFGIALWELLTGELPY 313
           S GI L  +L GELP+
Sbjct: 192 SCGIVLTAMLAGELPW 207

>pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269

Iteration: 1
 Score = 81.6 bits (200), Expect = 7e-16,   Method: Compositional matrix adjust.
 Identities = 55/196 (28%), Positives = 102/196 (52%), Gaps = 8/196 (4%)
Query: 124 VASGSYGD--LYKGTYCSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGA 181
           +  G+YG+  L       + VA+K++  +    +  +   +E+ I + + H+NVV+F G 
Sbjct: 14  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRA-VDCPENIKKEICINKMLNHENVVKFYGH 72
Query: 182 CTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLK 241
                   +  E+ + G ++D +    G+ +     +    +  G+ YLH   I HRD+K
Sbjct: 73  RREGNIQYLFLEYCSGGELFDRIEPDIGMPE-PDAQRFFHQLMAGVVYLHGIGITHRDIK 131
Query: 242 TANLLMDENGVVKVADFGVA---RVQAQSGVMTAETGTYRWMAPEVIEHKPYDYK-ADVF 297
             NLL+DE   +K++DFG+A   R   +  ++    GT  ++APE+++ + +  +  DV+
Sbjct: 132 PENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAPELLKRREFHAEPVDVW 191
Query: 298 SFGIALWELLTGELPY 313
           S GI L  +L GELP+
Sbjct: 192 SCGIVLTAMLAGELPW 207

>pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 81.6 bits (200), Expect = 7e-16,   Method: Compositional matrix adjust.
 Identities = 55/196 (28%), Positives = 103/196 (52%), Gaps = 8/196 (4%)
Query: 124 VASGSYGD--LYKGTYCSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGA 181
           +  G+YG+  L       + VA+K++  +    +  +   +E+ I + + H+NVV+F G 
Sbjct: 14  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRA-VDCPENIKKEICINKMLNHENVVKFYGH 72
Query: 182 CTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLK 241
                   +  E+ + G ++D +    G+ +  +  +    +  G+ YLH   I HRD+K
Sbjct: 73  RREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQ-RFFHQLMAGVVYLHGIGITHRDIK 131
Query: 242 TANLLMDENGVVKVADFGVA---RVQAQSGVMTAETGTYRWMAPEVIEHKPYDYK-ADVF 297
             NLL+DE   +K++DFG+A   R   +  ++    GT  ++APE+++ + +  +  DV+
Sbjct: 132 PENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAPELLKRREFHAEPVDVW 191
Query: 298 SFGIALWELLTGELPY 313
           S GI L  +L GELP+
Sbjct: 192 SCGIVLTAMLAGELPW 207

>pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278

Iteration: 1
 Score = 81.6 bits (200), Expect = 7e-16,   Method: Compositional matrix adjust.
 Identities = 55/196 (28%), Positives = 103/196 (52%), Gaps = 8/196 (4%)
Query: 124 VASGSYGD--LYKGTYCSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGA 181
           +  G+YG+  L       + VA+K++  +    +  +   +E+ I + + H+NVV+F G 
Sbjct: 13  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRA-VDCPENIKKEICINKMLNHENVVKFYGH 71
Query: 182 CTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLK 241
                   +  E+ + G ++D +    G+ +  +  +    +  G+ YLH   I HRD+K
Sbjct: 72  RREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQ-RFFHQLMAGVVYLHGIGITHRDIK 130
Query: 242 TANLLMDENGVVKVADFGVA---RVQAQSGVMTAETGTYRWMAPEVIEHKPYDYK-ADVF 297
             NLL+DE   +K++DFG+A   R   +  ++    GT  ++APE+++ + +  +  DV+
Sbjct: 131 PENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVW 190
Query: 298 SFGIALWELLTGELPY 313
           S GI L  +L GELP+
Sbjct: 191 SCGIVLTAMLAGELPW 206

>pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273

Iteration: 1
 Score = 81.6 bits (200), Expect = 7e-16,   Method: Compositional matrix adjust.
 Identities = 55/196 (28%), Positives = 102/196 (52%), Gaps = 8/196 (4%)
Query: 124 VASGSYGD--LYKGTYCSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGA 181
           +  G+YG+  L       + VA+K++  +    +  +   +E+ I + + H+NVV+F G 
Sbjct: 14  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRA-VDCPENIKKEICINKMLNHENVVKFYGH 72
Query: 182 CTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLK 241
                   +  E+ + G ++D +    G+ +     +    +  G+ YLH   I HRD+K
Sbjct: 73  RREGNIQYLFLEYCSGGELFDRIEPDIGMPE-PDAQRFFHQLMAGVVYLHGIGITHRDIK 131
Query: 242 TANLLMDENGVVKVADFGVA---RVQAQSGVMTAETGTYRWMAPEVIEHKPYDYK-ADVF 297
             NLL+DE   +K++DFG+A   R   +  ++    GT  ++APE+++ + +  +  DV+
Sbjct: 132 PENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVW 191
Query: 298 SFGIALWELLTGELPY 313
           S GI L  +L GELP+
Sbjct: 192 SCGIVLTAMLAGELPW 207

>pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269

Iteration: 1
 Score = 81.6 bits (200), Expect = 7e-16,   Method: Compositional matrix adjust.
 Identities = 55/196 (28%), Positives = 102/196 (52%), Gaps = 8/196 (4%)
Query: 124 VASGSYGD--LYKGTYCSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGA 181
           +  G+YG+  L       + VA+K++  +    +  +   +E+ I + + H+NVV+F G 
Sbjct: 15  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRA-VDCPENIKKEICINKMLNHENVVKFYGH 73
Query: 182 CTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLK 241
                   +  E+ + G ++D +    G+ +     +    +  G+ YLH   I HRD+K
Sbjct: 74  RREGNIQYLFLEYCSGGELFDRIEPDIGMPE-PDAQRFFHQLMAGVVYLHGIGITHRDIK 132
Query: 242 TANLLMDENGVVKVADFGVA---RVQAQSGVMTAETGTYRWMAPEVIEHKPYDYK-ADVF 297
             NLL+DE   +K++DFG+A   R   +  ++    GT  ++APE+++ + +  +  DV+
Sbjct: 133 PENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVW 192
Query: 298 SFGIALWELLTGELPY 313
           S GI L  +L GELP+
Sbjct: 193 SCGIVLTAMLAGELPW 208

>pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 81.6 bits (200), Expect = 7e-16,   Method: Compositional matrix adjust.
 Identities = 55/196 (28%), Positives = 103/196 (52%), Gaps = 8/196 (4%)
Query: 124 VASGSYGD--LYKGTYCSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGA 181
           +  G+YG+  L       + VA+K++  +    +  +   +E+ I + + H+NVV+F G 
Sbjct: 14  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRA-VDCPENIKKEICINKMLNHENVVKFYGH 72
Query: 182 CTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLK 241
                   +  E+ + G ++D +    G+ +  +  +    +  G+ YLH   I HRD+K
Sbjct: 73  RREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQ-RFFHQLMAGVVYLHGIGITHRDIK 131
Query: 242 TANLLMDENGVVKVADFGVA---RVQAQSGVMTAETGTYRWMAPEVIEHKPYDYK-ADVF 297
             NLL+DE   +K++DFG+A   R   +  ++    GT  ++APE+++ + +  +  DV+
Sbjct: 132 PENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAPELLKRREFHAEPVDVW 191
Query: 298 SFGIALWELLTGELPY 313
           S GI L  +L GELP+
Sbjct: 192 SCGIVLTAMLAGELPW 207

>pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268

Iteration: 1
 Score = 81.6 bits (200), Expect = 7e-16,   Method: Compositional matrix adjust.
 Identities = 55/196 (28%), Positives = 102/196 (52%), Gaps = 8/196 (4%)
Query: 124 VASGSYGD--LYKGTYCSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGA 181
           +  G+YG+  L       + VA+K++  +    +  +   +E+ I + + H+NVV+F G 
Sbjct: 14  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRA-VDCPENIKKEICINKMLNHENVVKFYGH 72
Query: 182 CTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLK 241
                   +  E+ + G ++D +    G+ +     +    +  G+ YLH   I HRD+K
Sbjct: 73  RREGNIQYLFLEYCSGGELFDRIEPDIGMPE-PDAQRFFHQLMAGVVYLHGIGITHRDIK 131
Query: 242 TANLLMDENGVVKVADFGVA---RVQAQSGVMTAETGTYRWMAPEVIEHKPYDYK-ADVF 297
             NLL+DE   +K++DFG+A   R   +  ++    GT  ++APE+++ + +  +  DV+
Sbjct: 132 PENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVW 191
Query: 298 SFGIALWELLTGELPY 313
           S GI L  +L GELP+
Sbjct: 192 SCGIVLTAMLAGELPW 207

>pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333

Iteration: 1
 Score = 81.6 bits (200), Expect = 7e-16,   Method: Compositional matrix adjust.
 Identities = 49/152 (32%), Positives = 85/152 (55%), Gaps = 3/152 (1%)
Query: 162 QEVYIMRKIRHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAI 221
           +E+ ++ +     +V F GA      + I  E M  GS+ D + K+ G      L KV+I
Sbjct: 53  RELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSL-DQVLKKAGRIPEQILGKVSI 111
Query: 222 DVSKGMNYLHQNN-IIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAETGTYRWM 280
            V KG+ YL + + I+HRD+K +N+L++  G +K+ DFGV+  Q    +  +  GT  +M
Sbjct: 112 AVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSG-QLIDSMANSFVGTRSYM 170
Query: 281 APEVIEHKPYDYKADVFSFGIALWELLTGELP 312
           +PE ++   Y  ++D++S G++L E+  G  P
Sbjct: 171 SPERLQGTHYSVQSDIWSMGLSLVEMAVGRYP 202

>pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271

Iteration: 1
 Score = 81.6 bits (200), Expect = 7e-16,   Method: Compositional matrix adjust.
 Identities = 55/196 (28%), Positives = 103/196 (52%), Gaps = 8/196 (4%)
Query: 124 VASGSYGD--LYKGTYCSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGA 181
           +  G+YG+  L       + VA+K++  +    +  +   +E+ I + + H+NVV+F G 
Sbjct: 14  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRA-VDCPENIKKEICINKMLNHENVVKFYGH 72
Query: 182 CTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLK 241
                   +  E+ + G ++D +    G+ +  +  +    +  G+ YLH   I HRD+K
Sbjct: 73  RREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQ-RFFHQLMAGVVYLHGIGITHRDIK 131
Query: 242 TANLLMDENGVVKVADFGVA---RVQAQSGVMTAETGTYRWMAPEVIEHKPYDYK-ADVF 297
             NLL+DE   +K++DFG+A   R   +  ++    GT  ++APE+++ + +  +  DV+
Sbjct: 132 PENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVW 191
Query: 298 SFGIALWELLTGELPY 313
           S GI L  +L GELP+
Sbjct: 192 SCGIVLTAMLAGELPW 207

>pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276

Iteration: 1
 Score = 81.6 bits (200), Expect = 7e-16,   Method: Compositional matrix adjust.
 Identities = 55/196 (28%), Positives = 103/196 (52%), Gaps = 8/196 (4%)
Query: 124 VASGSYGD--LYKGTYCSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGA 181
           +  G+YG+  L       + VA+K++  +    +  +   +E+ I + + H+NVV+F G 
Sbjct: 15  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRA-VDCPENIKKEICINKMLNHENVVKFYGH 73
Query: 182 CTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLK 241
                   +  E+ + G ++D +    G+ +  +  +    +  G+ YLH   I HRD+K
Sbjct: 74  RREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQ-RFFHQLMAGVVYLHGIGITHRDIK 132
Query: 242 TANLLMDENGVVKVADFGVA---RVQAQSGVMTAETGTYRWMAPEVIEHKPYDYK-ADVF 297
             NLL+DE   +K++DFG+A   R   +  ++    GT  ++APE+++ + +  +  DV+
Sbjct: 133 PENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVW 192
Query: 298 SFGIALWELLTGELPY 313
           S GI L  +L GELP+
Sbjct: 193 SCGIVLTAMLAGELPW 208

>pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 81.6 bits (200), Expect = 7e-16,   Method: Compositional matrix adjust.
 Identities = 55/196 (28%), Positives = 103/196 (52%), Gaps = 8/196 (4%)
Query: 124 VASGSYGD--LYKGTYCSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGA 181
           +  G+YG+  L       + VA+K++  +    +  +   +E+ I + + H+NVV+F G 
Sbjct: 14  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRA-VDCPENIKKEICINKMLNHENVVKFYGH 72
Query: 182 CTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLK 241
                   +  E+ + G ++D +    G+ +  +  +    +  G+ YLH   I HRD+K
Sbjct: 73  RREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQ-RFFHQLMAGVVYLHGIGITHRDIK 131
Query: 242 TANLLMDENGVVKVADFGVA---RVQAQSGVMTAETGTYRWMAPEVIEHKPYDYK-ADVF 297
             NLL+DE   +K++DFG+A   R   +  ++    GT  ++APE+++ + +  +  DV+
Sbjct: 132 PENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVW 191
Query: 298 SFGIALWELLTGELPY 313
           S GI L  +L GELP+
Sbjct: 192 SCGIVLTAMLAGELPW 207

>pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341

Iteration: 1
 Score = 81.6 bits (200), Expect = 8e-16,   Method: Compositional matrix adjust.
 Identities = 49/152 (32%), Positives = 85/152 (55%), Gaps = 3/152 (1%)
Query: 162 QEVYIMRKIRHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAI 221
           +E+ ++ +     +V F GA      + I  E M  GS+ D + K+ G      L KV+I
Sbjct: 53  RELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSL-DQVLKKAGRIPEQILGKVSI 111
Query: 222 DVSKGMNYLHQNN-IIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAETGTYRWM 280
            V KG+ YL + + I+HRD+K +N+L++  G +K+ DFGV+  Q    +  +  GT  +M
Sbjct: 112 AVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSG-QLIDSMANSFVGTRSYM 170
Query: 281 APEVIEHKPYDYKADVFSFGIALWELLTGELP 312
           +PE ++   Y  ++D++S G++L E+  G  P
Sbjct: 171 SPERLQGTHYSVQSDIWSMGLSLVEMAVGRYP 202

>pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387

Iteration: 1
 Score = 81.6 bits (200), Expect = 8e-16,   Method: Compositional matrix adjust.
 Identities = 46/208 (22%), Positives = 108/208 (51%), Gaps = 8/208 (3%)
Query: 123 KVASGSYGDLYKGTYCSQEVAIKVLKPECVNTEM-LKEFS--QEVYIMRKIRHKNVVQFI 179
           ++ SG++G +++   C ++   +V   + +NT   L +++   E+ IM ++ H  ++   
Sbjct: 58  ELGSGAFGVVHR---CVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLH 114
Query: 180 GACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRD 239
            A      + ++ EF++ G ++D +  +        ++       +G+ ++H+++I+H D
Sbjct: 115 DAFEDKYEMVLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHSIVHLD 174
Query: 240 LKTANLLMD--ENGVVKVADFGVARVQAQSGVMTAETGTYRWMAPEVIEHKPYDYKADVF 297
           +K  N++ +  +   VK+ DFG+A       ++   T T  + APE+++ +P  +  D++
Sbjct: 175 IKPENIMCETKKASSVKIIDFGLATKLNPDEIVKVTTATAEFAAPEIVDREPVGFYTDMW 234
Query: 298 SFGIALWELLTGELPYAGLTPLQAAVGV 325
           + G+  + LL+G  P+AG   L+    V
Sbjct: 235 AIGVLGYVLLSGLSPFAGEDDLETLQNV 262

>pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395

Iteration: 1
 Score = 81.6 bits (200), Expect = 8e-16,   Method: Compositional matrix adjust.
 Identities = 49/152 (32%), Positives = 85/152 (55%), Gaps = 3/152 (1%)
Query: 162 QEVYIMRKIRHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAI 221
           +E+ ++ +     +V F GA      + I  E M  GS+ D + K+ G      L KV+I
Sbjct: 115 RELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSL-DQVLKKAGRIPEQILGKVSI 173
Query: 222 DVSKGMNYLHQNN-IIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAETGTYRWM 280
            V KG+ YL + + I+HRD+K +N+L++  G +K+ DFGV+  Q    +  +  GT  +M
Sbjct: 174 AVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSG-QLIDSMANSFVGTRSYM 232
Query: 281 APEVIEHKPYDYKADVFSFGIALWELLTGELP 312
           +PE ++   Y  ++D++S G++L E+  G  P
Sbjct: 233 SPERLQGTHYSVQSDIWSMGLSLVEMAVGRYP 264

>pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328

Iteration: 1
 Score = 81.3 bits (199), Expect = 8e-16,   Method: Compositional matrix adjust.
 Identities = 49/152 (32%), Positives = 85/152 (55%), Gaps = 3/152 (1%)
Query: 162 QEVYIMRKIRHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAI 221
           +E+ ++ +     +V F GA      + I  E M  GS+ D + K+ G      L KV+I
Sbjct: 53  RELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSL-DQVLKKAGRIPEQILGKVSI 111
Query: 222 DVSKGMNYLHQNN-IIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAETGTYRWM 280
            V KG+ YL + + I+HRD+K +N+L++  G +K+ DFGV+  Q    +  +  GT  +M
Sbjct: 112 AVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSG-QLIDSMANSFVGTRSYM 170
Query: 281 APEVIEHKPYDYKADVFSFGIALWELLTGELP 312
           +PE ++   Y  ++D++S G++L E+  G  P
Sbjct: 171 SPERLQGTHYSVQSDIWSMGLSLVEMAVGRYP 202

>pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322

Iteration: 1
 Score = 81.3 bits (199), Expect = 8e-16,   Method: Compositional matrix adjust.
 Identities = 49/152 (32%), Positives = 85/152 (55%), Gaps = 3/152 (1%)
Query: 162 QEVYIMRKIRHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAI 221
           +E+ ++ +     +V F GA      + I  E M  GS+ D + K+ G      L KV+I
Sbjct: 53  RELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSL-DQVLKKAGRIPEQILGKVSI 111
Query: 222 DVSKGMNYLHQNN-IIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAETGTYRWM 280
            V KG+ YL + + I+HRD+K +N+L++  G +K+ DFGV+  Q    +  +  GT  +M
Sbjct: 112 AVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSG-QLIDSMANSFVGTRSYM 170
Query: 281 APEVIEHKPYDYKADVFSFGIALWELLTGELP 312
           +PE ++   Y  ++D++S G++L E+  G  P
Sbjct: 171 SPERLQGTHYSVQSDIWSMGLSLVEMAVGRYP 202

>pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346

Iteration: 1
 Score = 81.3 bits (199), Expect = 8e-16,   Method: Compositional matrix adjust.
 Identities = 59/196 (30%), Positives = 102/196 (52%), Gaps = 18/196 (9%)
Query: 124 VASGSYGDLYKG--TYCSQEVAIKVLK-------PECVNTEMLKEFSQEVYIMRKIRHKN 174
           +  G +  +YK      +Q VAIK +K        + +N   L+E    + +++++ H N
Sbjct: 18  LGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALRE----IKLLQELSHPN 73
Query: 175 VVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVS-KGMNYLHQN 233
           ++  + A     N+ +V +FM   +  + + K   +    S +K  + ++ +G+ YLHQ+
Sbjct: 74  IIGLLDAFGHKSNISLVFDFME--TDLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQH 131
Query: 234 NIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAETGTYRWM-APEVI-EHKPYD 291
            I+HRDLK  NLL+DENGV+K+ADFG+A+               RW  APE++   + Y 
Sbjct: 132 WILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYXHQVVTRWYRAPELLFGARMYG 191
Query: 292 YKADVFSFGIALWELL 307
              D+++ G  L ELL
Sbjct: 192 VGVDMWAVGCILAELL 207

>pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373

Iteration: 1
 Score = 81.3 bits (199), Expect = 9e-16,   Method: Compositional matrix adjust.
 Identities = 61/209 (29%), Positives = 104/209 (49%), Gaps = 29/209 (13%)
Query: 122 CKVASGSYGDLYKGTY--CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFI 179
            K+  G++G+++K  +    Q+VA+K +  E           +E+ I++ ++H+NVV  I
Sbjct: 24  AKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLI 83
Query: 180 GAC---TRPPNLCIVTEFMARGSIY---DFL-HKQKGV-------FQLTSLLKVAIDVSK 225
             C     P N C       +GSIY   DF  H   G+       F L+ + +V   +  
Sbjct: 84  EICRTKASPYNRC-------KGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQMLLN 136
Query: 226 GMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARV-----QAQSGVMTAETGTYRWM 280
           G+ Y+H+N I+HRD+K AN+L+  +GV+K+ADFG+AR       +Q         T  + 
Sbjct: 137 GLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYXNRVVTLWYR 196
Query: 281 APE-VIEHKPYDYKADVFSFGIALWELLT 308
            PE ++  + Y    D++  G  + E+ T
Sbjct: 197 PPELLLGERDYGPPIDLWGAGCIMAEMWT 225

>pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351

Iteration: 1
 Score = 81.3 bits (199), Expect = 9e-16,   Method: Compositional matrix adjust.
 Identities = 61/208 (29%), Positives = 104/208 (50%), Gaps = 29/208 (13%)
Query: 123 KVASGSYGDLYKGTY--CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIG 180
           K+  G++G+++K  +    Q+VA+K +  E           +E+ I++ ++H+NVV  I 
Sbjct: 24  KIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIE 83
Query: 181 AC---TRPPNLCIVTEFMARGSIY---DFL-HKQKGV-------FQLTSLLKVAIDVSKG 226
            C     P N C       +GSIY   DF  H   G+       F L+ + +V   +  G
Sbjct: 84  ICRTKASPYNRC-------KGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQMLLNG 136
Query: 227 MNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARV-----QAQSGVMTAETGTYRWMA 281
           + Y+H+N I+HRD+K AN+L+  +GV+K+ADFG+AR       +Q         T  +  
Sbjct: 137 LYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYXNRVVTLWYRP 196
Query: 282 PE-VIEHKPYDYKADVFSFGIALWELLT 308
           PE ++  + Y    D++  G  + E+ T
Sbjct: 197 PELLLGERDYGPPIDLWGAGCIMAEMWT 224

>pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310

Iteration: 1
 Score = 81.3 bits (199), Expect = 9e-16,   Method: Compositional matrix adjust.
 Identities = 59/227 (25%), Positives = 109/227 (48%), Gaps = 15/227 (6%)
Query: 139 SQEVAIKVL-KPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVTEFMAR 197
           S+E AIK+L K   +    +   ++E  +M ++ H   V+          L     +   
Sbjct: 55  SREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKN 114
Query: 198 GSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVAD 257
           G +  ++ K  G F  T       ++   + YLH   IIHRDLK  N+L++E+  +++ D
Sbjct: 115 GELLKYIRKI-GSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITD 173
Query: 258 FGVARV---QAQSGVMTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPYA 314
           FG A+V   +++     A  GT ++++PE++  K     +D+++ G  +++L+      A
Sbjct: 174 FGTAKVLSPESKQARANAFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLV------A 227
Query: 315 GLTPLQAA--VGVVQK--SLRPTIPKHAHPRLAELLERCWQHDPTQR 357
           GL P +A     + QK   L    P+   P+  +L+E+    D T+R
Sbjct: 228 GLPPFRAGNEYLIFQKIIKLEYDFPEKFFPKARDLVEKLLVLDATKR 274

>pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307

Iteration: 1
 Score = 81.3 bits (199), Expect = 9e-16,   Method: Compositional matrix adjust.
 Identities = 49/152 (32%), Positives = 85/152 (55%), Gaps = 3/152 (1%)
Query: 162 QEVYIMRKIRHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAI 221
           +E+ ++ +     +V F GA      + I  E M  GS+ D + K+ G      L KV+I
Sbjct: 53  RELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSL-DQVLKKAGRIPEQILGKVSI 111
Query: 222 DVSKGMNYLHQNN-IIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAETGTYRWM 280
            V KG+ YL + + I+HRD+K +N+L++  G +K+ DFGV+  Q    +  +  GT  +M
Sbjct: 112 AVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSG-QLIDSMANSFVGTRSYM 170
Query: 281 APEVIEHKPYDYKADVFSFGIALWELLTGELP 312
           +PE ++   Y  ++D++S G++L E+  G  P
Sbjct: 171 SPERLQGTHYSVQSDIWSMGLSLVEMAVGRYP 202

>pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360

Iteration: 1
 Score = 81.3 bits (199), Expect = 9e-16,   Method: Compositional matrix adjust.
 Identities = 49/152 (32%), Positives = 85/152 (55%), Gaps = 3/152 (1%)
Query: 162 QEVYIMRKIRHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAI 221
           +E+ ++ +     +V F GA      + I  E M  GS+ D + K+ G      L KV+I
Sbjct: 80  RELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSL-DQVLKKAGRIPEQILGKVSI 138
Query: 222 DVSKGMNYLHQNN-IIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAETGTYRWM 280
            V KG+ YL + + I+HRD+K +N+L++  G +K+ DFGV+  Q    +  +  GT  +M
Sbjct: 139 AVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSG-QLIDSMANSFVGTRSYM 197
Query: 281 APEVIEHKPYDYKADVFSFGIALWELLTGELP 312
           +PE ++   Y  ++D++S G++L E+  G  P
Sbjct: 198 SPERLQGTHYSVQSDIWSMGLSLVEMAVGRYP 229

>pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311

Iteration: 1
 Score = 81.3 bits (199), Expect = 9e-16,   Method: Compositional matrix adjust.
 Identities = 58/227 (25%), Positives = 109/227 (48%), Gaps = 15/227 (6%)
Query: 139 SQEVAIKVL-KPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVTEFMAR 197
           S+E AIK+L K   +    +   ++E  +M ++ H   V+          L     +   
Sbjct: 57  SREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKN 116
Query: 198 GSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVAD 257
           G +  ++ K  G F  T       ++   + YLH   IIHRDLK  N+L++E+  +++ D
Sbjct: 117 GCLLKYIRKI-GSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITD 175
Query: 258 FGVARV---QAQSGVMTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPYA 314
           FG A+V   +++     +  GT ++++PE++  K     +D+++ G  +++L+      A
Sbjct: 176 FGTAKVLSPESKQARANSFVGTAQYVSPELLTEKSASKSSDLWALGCIIYQLV------A 229
Query: 315 GLTPLQAA--VGVVQK--SLRPTIPKHAHPRLAELLERCWQHDPTQR 357
           GL P +A     + QK   L    P+   P+  +L+E+    D T+R
Sbjct: 230 GLPPFRAGNEYLIFQKIIKLEYDFPEKFFPKARDLVEKLLVLDATKR 276

>pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331

Iteration: 1
 Score = 81.3 bits (199), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 57/205 (27%), Positives = 104/205 (50%), Gaps = 23/205 (11%)
Query: 123 KVASGSYGDLYKGTY--CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIG 180
           K+  G++G+++K  +    Q+VA+K +  E           +E+ I++ ++H+NVV  I 
Sbjct: 25  KIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIE 84
Query: 181 AC---TRPPNLCIVTEFMARGSIYDFL-HKQKGV-------FQLTSLLKVAIDVSKGMNY 229
            C     P N C  + ++    ++DF  H   G+       F L+ + +V   +  G+ Y
Sbjct: 85  ICRTKASPYNRCKASIYL----VFDFCEHDLAGLLSNVLVKFTLSEIKRVMQMLLNGLYY 140
Query: 230 LHQNNIIHRDLKTANLLMDENGVVKVADFGVARV-----QAQSGVMTAETGTYRWMAPE- 283
           +H+N I+HRD+K AN+L+  +GV+K+ADFG+AR       +Q         T  +  PE 
Sbjct: 141 IHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYXNRVVTLWYRPPEL 200
Query: 284 VIEHKPYDYKADVFSFGIALWELLT 308
           ++  + Y    D++  G  + E+ T
Sbjct: 201 LLGERDYGPPIDLWGAGCIMAEMWT 225

>pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331

Iteration: 1
 Score = 81.3 bits (199), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 61/208 (29%), Positives = 104/208 (50%), Gaps = 29/208 (13%)
Query: 123 KVASGSYGDLYKGTY--CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIG 180
           K+  G++G+++K  +    Q+VA+K +  E           +E+ I++ ++H+NVV  I 
Sbjct: 25  KIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIE 84
Query: 181 AC---TRPPNLCIVTEFMARGSIY---DFL-HKQKGV-------FQLTSLLKVAIDVSKG 226
            C     P N C       +GSIY   DF  H   G+       F L+ + +V   +  G
Sbjct: 85  ICRTKASPYNRC-------KGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQMLLNG 137
Query: 227 MNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARV-----QAQSGVMTAETGTYRWMA 281
           + Y+H+N I+HRD+K AN+L+  +GV+K+ADFG+AR       +Q         T  +  
Sbjct: 138 LYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYXNRVVTLWYRP 197
Query: 282 PE-VIEHKPYDYKADVFSFGIALWELLT 308
           PE ++  + Y    D++  G  + E+ T
Sbjct: 198 PELLLGERDYGPPIDLWGAGCIMAEMWT 225

>pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353

Iteration: 1
 Score = 80.9 bits (198), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 55/185 (29%), Positives = 89/185 (48%), Gaps = 9/185 (4%)
Query: 130 GDLYKGTYCSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLC 189
           GDLY      ++V ++    EC  TE      + + + R   H  + Q       P  L 
Sbjct: 48  GDLYAVKVLKKDVILQDDDVECTMTE-----KRILSLARN--HPFLTQLFCCFQTPDRLF 100
Query: 190 IVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDE 249
            V EF+  G +   + K +  F        A ++   + +LH   II+RDLK  N+L+D 
Sbjct: 101 FVMEFVNGGDLMFHIQKSRR-FDEARARFYAAEIISALMFLHDKGIIYRDLKLDNVLLDH 159
Query: 250 NGVVKVADFGVARVQAQSGVMTAE-TGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLT 308
            G  K+ADFG+ +    +GV TA   GT  ++APE+++   Y    D ++ G+ L+E+L 
Sbjct: 160 EGHCKLADFGMCKEGICNGVTTATFCGTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLC 219
Query: 309 GELPY 313
           G  P+
Sbjct: 220 GHAPF 224

>pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317

Iteration: 1
 Score = 80.9 bits (198), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 61/237 (25%), Positives = 121/237 (51%), Gaps = 17/237 (7%)
Query: 115 AKQLKIECKVASGSYGDLYKGTYCSQEVAIKVLKPECVNTEMLKEFS-QEVYIMRKIRHK 173
           + Q K   K+ +G+Y  +YKG   +  V + + + +  + E     + +E+ +M++++H+
Sbjct: 4   SSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKELKHE 63
Query: 174 NVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQ------KGVFQLTSLLKVAIDVSKGM 227
           N+V+          L +V EFM    +  ++  +      +G+ +L  +      + +G+
Sbjct: 64  NIVRLYDVIHTENKLTLVFEFMD-NDLKKYMDSRTVGNTPRGL-ELNLVKYFQWQLLQGL 121
Query: 228 NYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQA-QSGVMTAETGTYRWMAPEVI- 285
            + H+N I+HRDLK  NLL+++ G +K+ DFG+AR         ++E  T  + AP+V+ 
Sbjct: 122 AFCHENKILHRDLKPQNLLINKRGQLKLGDFGLARAFGIPVNTFSSEVVTLWYRAPDVLM 181
Query: 286 EHKPYDYKADVFSFGIALWELLTGELPYAG------LTPLQAAVGVVQKSLRPTIPK 336
             + Y    D++S G  L E++TG+  + G      L  +   +G   +SL P++ K
Sbjct: 182 GSRTYSTSIDIWSCGCILAEMITGKPLFPGTNDEEQLKLIFDIMGTPNESLWPSVTK 238

>pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279

Iteration: 1
 Score = 80.9 bits (198), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 55/214 (25%), Positives = 101/214 (47%), Gaps = 12/214 (5%)
Query: 163 EVYIMRKIRHKNVVQFIGACTRPPN--LCIVTEFMARGSIYDFLHK---QKGVFQLTSLL 217
           EV ++R+++H N+V++        N  L IV E+   G +   + K   ++       +L
Sbjct: 55  EVNLLRELKHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVL 114
Query: 218 KVAIDVSKGMNYLHQ-----NNIIHRDLKTANLLMDENGVVKVADFGVARV-QAQSGVMT 271
           +V   ++  +   H+     + ++HRDLK AN+ +D    VK+ DFG+AR+    +    
Sbjct: 115 RVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAK 174
Query: 272 AETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKSLR 331
              GT  +M+PE +    Y+ K+D++S G  L+EL     P+   +  + A  + +   R
Sbjct: 175 TFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGKFR 234
Query: 332 PTIPKHAHPRLAELLERCWQHDPTQRPNFSQITD 365
             IP      L E++ R        RP+  +I +
Sbjct: 235 -RIPYRYSDELNEIITRMLNLKDYHRPSVEEILE 267

>pdb|4EUU|A Chain A, Structure Of Bx-795 Complexed With Human Tbk1 Kinase Domain Phosphorylated On Ser172 Length = 319

Iteration: 1
 Score = 80.5 bits (197), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 58/211 (27%), Positives = 97/211 (45%), Gaps = 25/211 (11%)
Query: 124 VASGSYGDLYKGTY--CSQEVAIKVLKPECVNTEMLKEFS---QEVYIMRKIRHKNVVQF 178
           +  G+  ++++G +       AIKV      N   L+      +E  +++K+ HKN+V+ 
Sbjct: 17  LGQGATANVFRGRHKKTGDLFAIKVFN----NISFLRPVDVQMREFEVLKKLNHKNIVKL 72
Query: 179 --IGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQL--TSLLKVAIDVSKGMNYLHQNN 234
             I   T   +  ++ EF   GS+Y  L +    + L  +  L V  DV  GMN+L +N 
Sbjct: 73  FAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENG 132
Query: 235 IIHRDLKTANLLM----DENGVVKVADFGVARVQAQSGVMTAETGTYRWMAPEVIE---- 286
           I+HR++K  N++     D   V K+ DFG AR            GT  ++ P++ E    
Sbjct: 133 IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVXLYGTEEYLHPDMYERAVL 192
Query: 287 ----HKPYDYKADVFSFGIALWELLTGELPY 313
                K Y    D++S G+  +   TG LP+
Sbjct: 193 RKDHQKKYGATVDLWSIGVTFYHAATGSLPF 223

>pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491

Iteration: 1
 Score = 80.5 bits (197), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 53/201 (26%), Positives = 99/201 (49%), Gaps = 8/201 (3%)
Query: 120 IECKVASGSYGDLYKGT--YCSQEVAIK-VLKPECVNTEMLKEFSQEVYIMRKIRHKNVV 176
           I  ++ +G++G +++ T        A K V+ P   + E ++   +E+  M  +RH  +V
Sbjct: 55  IHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVR---KEIQTMSVLRHPTLV 111
Query: 177 QFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNII 236
               A      + ++ EFM+ G +++ +  +         ++    V KG+ ++H+NN +
Sbjct: 112 NLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENNYV 171
Query: 237 HRDLKTANLLM--DENGVVKVADFGVARVQAQSGVMTAETGTYRWMAPEVIEHKPYDYKA 294
           H DLK  N++     +  +K+ DFG+         +   TGT  + APEV E KP  Y  
Sbjct: 172 HLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVTTGTAEFAAPEVAEGKPVGYYT 231
Query: 295 DVFSFGIALWELLTGELPYAG 315
           D++S G+  + LL+G  P+ G
Sbjct: 232 DMWSVGVLSYILLSGLSPFGG 252

>pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303

Iteration: 1
 Score = 80.5 bits (197), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 66/270 (24%), Positives = 119/270 (44%), Gaps = 42/270 (15%)
Query: 124 VASGSYGDLYKGTYC--SQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQF--- 178
           +  G++G + K      S+  AIK ++      E L     EV ++  + H+ VV++   
Sbjct: 14  LGQGAFGQVVKARNALDSRYYAIKKIRH---TEEKLSTILSEVMLLASLNHQYVVRYYAA 70
Query: 179 ----------IGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMN 228
                     + A  +   L I  E+   G++YD +H +    Q     ++   + + ++
Sbjct: 71  WLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWRLFRQILEALS 130
Query: 229 YLHQNNIIHRDLKTANLLMDENGVVKVADFGVAR---------------VQAQSGVMTAE 273
           Y+H   IIHRDLK  N+ +DE+  VK+ DFG+A+               +   S  +T+ 
Sbjct: 131 YIHSQGIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQNLPGSSDNLTSA 190
Query: 274 TGTYRWMAPEVIEHKP-YDYKADVFSFGIALWELL----TGELPYAGLTPLQAAVGVVQK 328
            GT  ++A EV++    Y+ K D++S GI  +E++    TG      L  L++    V  
Sbjct: 191 IGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIYPFSTGMERVNILKKLRS----VSI 246
Query: 329 SLRPTIPKHAHPRLAELLERCWQHDPTQRP 358
              P    +      +++     HDP +RP
Sbjct: 247 EFPPDFDDNKMKVEKKIIRLLIDHDPNKRP 276

>pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311

Iteration: 1
 Score = 80.5 bits (197), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 58/227 (25%), Positives = 109/227 (48%), Gaps = 15/227 (6%)
Query: 139 SQEVAIKVL-KPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVTEFMAR 197
           S+E AIK+L K   +    +   ++E  +M ++ H   V+          L     +   
Sbjct: 54  SREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKN 113
Query: 198 GSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVAD 257
           G +  ++ K  G F  T       ++   + YLH   IIHRDLK  N+L++E+  +++ D
Sbjct: 114 GELLKYIRKI-GSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITD 172
Query: 258 FGVARV---QAQSGVMTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPYA 314
           FG A+V   +++     +  GT ++++PE++  K     +D+++ G  +++L+      A
Sbjct: 173 FGTAKVLSPESKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLV------A 226
Query: 315 GLTPLQAA--VGVVQK--SLRPTIPKHAHPRLAELLERCWQHDPTQR 357
           GL P +A     + QK   L    P+   P+  +L+E+    D T+R
Sbjct: 227 GLPPFRAGNEYLIFQKIIKLEYDFPEKFFPKARDLVEKLLVLDATKR 273

>pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573

Iteration: 1
 Score = 80.5 bits (197), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 53/201 (26%), Positives = 99/201 (49%), Gaps = 8/201 (3%)
Query: 120 IECKVASGSYGDLYKGT--YCSQEVAIK-VLKPECVNTEMLKEFSQEVYIMRKIRHKNVV 176
           I  ++ +G++G +++ T        A K V+ P   + E ++   +E+  M  +RH  +V
Sbjct: 161 IHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVR---KEIQTMSVLRHPTLV 217
Query: 177 QFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNII 236
               A      + ++ EFM+ G +++ +  +         ++    V KG+ ++H+NN +
Sbjct: 218 NLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENNYV 277
Query: 237 HRDLKTANLLM--DENGVVKVADFGVARVQAQSGVMTAETGTYRWMAPEVIEHKPYDYKA 294
           H DLK  N++     +  +K+ DFG+         +   TGT  + APEV E KP  Y  
Sbjct: 278 HLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVTTGTAEFAAPEVAEGKPVGYYT 337
Query: 295 DVFSFGIALWELLTGELPYAG 315
           D++S G+  + LL+G  P+ G
Sbjct: 338 DMWSVGVLSYILLSGLSPFGG 358

>pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354

Iteration: 1
 Score = 80.5 bits (197), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 49/152 (32%), Positives = 85/152 (55%), Gaps = 3/152 (1%)
Query: 162 QEVYIMRKIRHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAI 221
           +E+ ++ +     +V F GA      + I  E M  GS+   L + K + +   L KV+I
Sbjct: 63  RELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKEAKRIPE-EILGKVSI 121
Query: 222 DVSKGMNYLHQ-NNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAETGTYRWM 280
            V +G+ YL + + I+HRD+K +N+L++  G +K+ DFGV+  Q    +  +  GT  +M
Sbjct: 122 AVLRGLAYLREKHQIMHRDVKPSNILVNSRGEIKLCDFGVSG-QLIDSMANSFVGTRSYM 180
Query: 281 APEVIEHKPYDYKADVFSFGIALWELLTGELP 312
           APE ++   Y  ++D++S G++L EL  G  P
Sbjct: 181 APERLQGTHYSVQSDIWSMGLSLVELAVGRYP 212

>pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273

Iteration: 1
 Score = 80.5 bits (197), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 55/196 (28%), Positives = 102/196 (52%), Gaps = 8/196 (4%)
Query: 124 VASGSYGD--LYKGTYCSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGA 181
           +  G+YG+  L       + VA+K++  +    +  +   +E+ I   + H+NVV+F G 
Sbjct: 15  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRA-VDCPENIKKEICINAMLNHENVVKFYGH 73
Query: 182 CTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLK 241
                   +  E+ + G ++D +    G+ +  +  +    +  G+ YLH   I HRD+K
Sbjct: 74  RREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQ-RFFHQLMAGVVYLHGIGITHRDIK 132
Query: 242 TANLLMDENGVVKVADFGVA---RVQAQSGVMTAETGTYRWMAPEVIEHKPYDYK-ADVF 297
             NLL+DE   +K++DFG+A   R   +  ++    GT  ++APE+++ + +  +  DV+
Sbjct: 133 PENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVW 192
Query: 298 SFGIALWELLTGELPY 313
           S GI L  +L GELP+
Sbjct: 193 SCGIVLTAMLAGELPW 208

>pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312

Iteration: 1
 Score = 80.1 bits (196), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 58/227 (25%), Positives = 109/227 (48%), Gaps = 15/227 (6%)
Query: 139 SQEVAIKVL-KPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVTEFMAR 197
           S+E AIK+L K   +    +   ++E  +M ++ H   V+          L     +   
Sbjct: 58  SREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKN 117
Query: 198 GSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVAD 257
           G +  ++ K  G F  T       ++   + YLH   IIHRDLK  N+L++E+  +++ D
Sbjct: 118 GELLKYIRKI-GSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITD 176
Query: 258 FGVARV---QAQSGVMTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPYA 314
           FG A+V   +++     +  GT ++++PE++  K     +D+++ G  +++L+      A
Sbjct: 177 FGTAKVLSPESKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLV------A 230
Query: 315 GLTPLQAA--VGVVQK--SLRPTIPKHAHPRLAELLERCWQHDPTQR 357
           GL P +A     + QK   L    P+   P+  +L+E+    D T+R
Sbjct: 231 GLPPFRAGNEYLIFQKIIKLEYDFPEKFFPKARDLVEKLLVLDATKR 277

>pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367

Iteration: 1
 Score = 79.7 bits (195), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 62/215 (28%), Positives = 104/215 (48%), Gaps = 15/215 (6%)
Query: 110 VWEIDAKQLKIECKVASGSYGDLYKG--TYCSQEVAIKVLKPECVNTEMLKEFSQEVYIM 167
           +WE+  +   +   V SG+YG +     T     VA+K L     +    K   +E+ ++
Sbjct: 24  IWEVPERYQNL-SPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLL 82
Query: 168 RKIRHKNVVQFIGACTRPPNL------CIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAI 221
           + ++H+NV+  +   T   +L       +VT  M    + + +  QK        L   I
Sbjct: 83  KHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMG-ADLNNIVKCQKLTDDHVQFLIYQI 141
Query: 222 DVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAETGTYRWMA 281
              +G+ Y+H  +IIHRDLK +NL ++E+  +K+ DFG+AR  A    MT    T  + A
Sbjct: 142 --LRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTADE--MTGYVATRWYRA 197
Query: 282 PEV-IEHKPYDYKADVFSFGIALWELLTGELPYAG 315
           PE+ +    Y+   D++S G  + ELLTG   + G
Sbjct: 198 PEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPG 232

>pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367

Iteration: 1
 Score = 79.7 bits (195), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 62/215 (28%), Positives = 104/215 (48%), Gaps = 15/215 (6%)
Query: 110 VWEIDAKQLKIECKVASGSYGDLYKG--TYCSQEVAIKVLKPECVNTEMLKEFSQEVYIM 167
           +WE+  +   +   V SG+YG +     T     VA+K L     +    K   +E+ ++
Sbjct: 24  IWEVPERYQNL-SPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLL 82
Query: 168 RKIRHKNVVQFIGACTRPPNL------CIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAI 221
           + ++H+NV+  +   T   +L       +VT  M    + + +  QK        L   I
Sbjct: 83  KHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMG-ADLNNIVKCQKLTDDHVQFLIYQI 141
Query: 222 DVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAETGTYRWMA 281
              +G+ Y+H  +IIHRDLK +NL ++E+  +K+ DFG+AR  A    MT    T  + A
Sbjct: 142 --LRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTADE--MTGYVATRWYRA 197
Query: 282 PEV-IEHKPYDYKADVFSFGIALWELLTGELPYAG 315
           PE+ +    Y+   D++S G  + ELLTG   + G
Sbjct: 198 PEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPG 232

>pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367

Iteration: 1
 Score = 79.7 bits (195), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 62/215 (28%), Positives = 104/215 (48%), Gaps = 15/215 (6%)
Query: 110 VWEIDAKQLKIECKVASGSYGDLYKG--TYCSQEVAIKVLKPECVNTEMLKEFSQEVYIM 167
           +WE+  +   +   V SG+YG +     T     VA+K L     +    K   +E+ ++
Sbjct: 24  IWEVPERYQNL-SPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLL 82
Query: 168 RKIRHKNVVQFIGACTRPPNL------CIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAI 221
           + ++H+NV+  +   T   +L       +VT  M    + + +  QK        L   I
Sbjct: 83  KHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMG-ADLNNIVKCQKLTDDHVQFLIYQI 141
Query: 222 DVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAETGTYRWMA 281
              +G+ Y+H  +IIHRDLK +NL ++E+  +K+ DFG+AR  A    MT    T  + A
Sbjct: 142 --LRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTADE--MTGYVATRWYRA 197
Query: 282 PEV-IEHKPYDYKADVFSFGIALWELLTGELPYAG 315
           PE+ +    Y+   D++S G  + ELLTG   + G
Sbjct: 198 PEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPG 232

>pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311

Iteration: 1
 Score = 79.7 bits (195), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 58/227 (25%), Positives = 108/227 (47%), Gaps = 15/227 (6%)
Query: 139 SQEVAIKVL-KPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVTEFMAR 197
           S+E AIK+L K   +    +   ++E  +M ++ H   V+          L     +   
Sbjct: 54  SREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKN 113
Query: 198 GSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVAD 257
           G +  ++ K  G F  T       ++   + YLH   IIHRDLK  N+L++E+  +++ D
Sbjct: 114 GELLKYIRKI-GSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITD 172
Query: 258 FGVARV---QAQSGVMTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPYA 314
           FG A+V   +++        GT ++++PE++  K     +D+++ G  +++L+      A
Sbjct: 173 FGTAKVLSPESKQARANXFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLV------A 226
Query: 315 GLTPLQAA--VGVVQK--SLRPTIPKHAHPRLAELLERCWQHDPTQR 357
           GL P +A     + QK   L    P+   P+  +L+E+    D T+R
Sbjct: 227 GLPPFRAGNEYLIFQKIIKLEYDFPEKFFPKARDLVEKLLVLDATKR 273

>pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292

Iteration: 1
 Score = 79.7 bits (195), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 58/227 (25%), Positives = 108/227 (47%), Gaps = 15/227 (6%)
Query: 139 SQEVAIKVL-KPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVTEFMAR 197
           S+E AIK+L K   +    +   ++E  +M ++ H   V+          L     +   
Sbjct: 39  SREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKN 98
Query: 198 GSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVAD 257
           G +  ++ K  G F  T       ++   + YLH   IIHRDLK  N+L++E+  +++ D
Sbjct: 99  GELLKYIRKI-GSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITD 157
Query: 258 FGVARV---QAQSGVMTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPYA 314
           FG A+V   +++        GT ++++PE++  K     +D+++ G  +++L+      A
Sbjct: 158 FGTAKVLSPESKQARANXFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLV------A 211
Query: 315 GLTPLQAA--VGVVQK--SLRPTIPKHAHPRLAELLERCWQHDPTQR 357
           GL P +A     + QK   L    P+   P+  +L+E+    D T+R
Sbjct: 212 GLPPFRAGNEYLIFQKIIKLEYDFPEKFFPKARDLVEKLLVLDATKR 258

>pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309

Iteration: 1
 Score = 79.7 bits (195), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 58/227 (25%), Positives = 108/227 (47%), Gaps = 15/227 (6%)
Query: 139 SQEVAIKVL-KPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVTEFMAR 197
           S+E AIK+L K   +    +   ++E  +M ++ H   V+          L     +   
Sbjct: 55  SREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKN 114
Query: 198 GSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVAD 257
           G +  ++ K  G F  T       ++   + YLH   IIHRDLK  N+L++E+  +++ D
Sbjct: 115 GELLKYIRKI-GSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITD 173
Query: 258 FGVARV---QAQSGVMTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPYA 314
           FG A+V   +++        GT ++++PE++  K     +D+++ G  +++L+      A
Sbjct: 174 FGTAKVLSPESKQARANXFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLV------A 227
Query: 315 GLTPLQAA--VGVVQK--SLRPTIPKHAHPRLAELLERCWQHDPTQR 357
           GL P +A     + QK   L    P+   P+  +L+E+    D T+R
Sbjct: 228 GLPPFRAGNEYLIFQKIIKLEYDFPEKFFPKARDLVEKLLVLDATKR 274

>pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310

Iteration: 1
 Score = 79.7 bits (195), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 58/227 (25%), Positives = 108/227 (47%), Gaps = 15/227 (6%)
Query: 139 SQEVAIKVL-KPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVTEFMAR 197
           S+E AIK+L K   +    +   ++E  +M ++ H   V+          L     +   
Sbjct: 55  SREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKN 114
Query: 198 GSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVAD 257
           G +  ++ K  G F  T       ++   + YLH   IIHRDLK  N+L++E+  +++ D
Sbjct: 115 GELLKYIRKI-GSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITD 173
Query: 258 FGVARV---QAQSGVMTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPYA 314
           FG A+V   +++        GT ++++PE++  K     +D+++ G  +++L+      A
Sbjct: 174 FGTAKVLSPESKQARANXFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLV------A 227
Query: 315 GLTPLQAA--VGVVQK--SLRPTIPKHAHPRLAELLERCWQHDPTQR 357
           GL P +A     + QK   L    P+   P+  +L+E+    D T+R
Sbjct: 228 GLPPFRAGNEYLIFQKIIKLEYDFPEKFFPKARDLVEKLLVLDATKR 274

>pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309

Iteration: 1
 Score = 79.7 bits (195), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 58/227 (25%), Positives = 108/227 (47%), Gaps = 15/227 (6%)
Query: 139 SQEVAIKVL-KPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVTEFMAR 197
           S+E AIK+L K   +    +   ++E  +M ++ H   V+          L     +   
Sbjct: 55  SREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKN 114
Query: 198 GSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVAD 257
           G +  ++ K  G F  T       ++   + YLH   IIHRDLK  N+L++E+  +++ D
Sbjct: 115 GELLKYIRKI-GSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITD 173
Query: 258 FGVARV---QAQSGVMTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPYA 314
           FG A+V   +++        GT ++++PE++  K     +D+++ G  +++L+      A
Sbjct: 174 FGTAKVLSPESKQARANXFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLV------A 227
Query: 315 GLTPLQAA--VGVVQK--SLRPTIPKHAHPRLAELLERCWQHDPTQR 357
           GL P +A     + QK   L    P+   P+  +L+E+    D T+R
Sbjct: 228 GLPPFRAGNEYLIFQKIIKLEYDFPEKFFPKARDLVEKLLVLDATKR 274

>pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311

Iteration: 1
 Score = 79.7 bits (195), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 58/227 (25%), Positives = 108/227 (47%), Gaps = 15/227 (6%)
Query: 139 SQEVAIKVL-KPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVTEFMAR 197
           S+E AIK+L K   +    +   ++E  +M ++ H   V+          L     +   
Sbjct: 57  SREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKN 116
Query: 198 GSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVAD 257
           G +  ++ K  G F  T       ++   + YLH   IIHRDLK  N+L++E+  +++ D
Sbjct: 117 GELLKYIRKI-GSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITD 175
Query: 258 FGVARV---QAQSGVMTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPYA 314
           FG A+V   +++        GT ++++PE++  K     +D+++ G  +++L+      A
Sbjct: 176 FGTAKVLSPESKQARANXFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLV------A 229
Query: 315 GLTPLQAA--VGVVQK--SLRPTIPKHAHPRLAELLERCWQHDPTQR 357
           GL P +A     + QK   L    P+   P+  +L+E+    D T+R
Sbjct: 230 GLPPFRAGNEYLIFQKIIKLEYDFPEKFFPKARDLVEKLLVLDATKR 276

>pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286

Iteration: 1
 Score = 79.7 bits (195), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 58/227 (25%), Positives = 108/227 (47%), Gaps = 15/227 (6%)
Query: 139 SQEVAIKVL-KPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVTEFMAR 197
           S+E AIK+L K   +    +   ++E  +M ++ H   V+          L     +   
Sbjct: 33  SREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKN 92
Query: 198 GSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVAD 257
           G +  ++ K  G F  T       ++   + YLH   IIHRDLK  N+L++E+  +++ D
Sbjct: 93  GELLKYIRKI-GSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITD 151
Query: 258 FGVARV---QAQSGVMTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPYA 314
           FG A+V   +++        GT ++++PE++  K     +D+++ G  +++L+      A
Sbjct: 152 FGTAKVLSPESKQARANXFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLV------A 205
Query: 315 GLTPLQAA--VGVVQK--SLRPTIPKHAHPRLAELLERCWQHDPTQR 357
           GL P +A     + QK   L    P+   P+  +L+E+    D T+R
Sbjct: 206 GLPPFRAGNEYLIFQKIIKLEYDFPEKFFPKARDLVEKLLVLDATKR 252

>pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311

Iteration: 1
 Score = 79.3 bits (194), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 58/227 (25%), Positives = 108/227 (47%), Gaps = 15/227 (6%)
Query: 139 SQEVAIKVL-KPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVTEFMAR 197
           S+E AIK+L K   +    +   ++E  +M ++ H   V+          L     +   
Sbjct: 57  SREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKN 116
Query: 198 GSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVAD 257
           G +  ++ K  G F  T       ++   + YLH   IIHRDLK  N+L++E+  +++ D
Sbjct: 117 GELLKYIRKI-GSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITD 175
Query: 258 FGVARV---QAQSGVMTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPYA 314
           FG A+V   +++        GT ++++PE++  K     +D+++ G  +++L+      A
Sbjct: 176 FGTAKVLSPESKQARANXFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLV------A 229
Query: 315 GLTPLQAA--VGVVQK--SLRPTIPKHAHPRLAELLERCWQHDPTQR 357
           GL P +A     + QK   L    P+   P+  +L+E+    D T+R
Sbjct: 230 GLPPFRAGNEYLIFQKIIKLEYDFPEKFFPKARDLVEKLLVLDATKR 276

>pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286

Iteration: 1
 Score = 79.3 bits (194), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 58/227 (25%), Positives = 108/227 (47%), Gaps = 15/227 (6%)
Query: 139 SQEVAIKVL-KPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVTEFMAR 197
           S+E AIK+L K   +    +   ++E  +M ++ H   V+          L     +   
Sbjct: 32  SREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKN 91
Query: 198 GSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVAD 257
           G +  ++ K  G F  T       ++   + YLH   IIHRDLK  N+L++E+  +++ D
Sbjct: 92  GELLKYIRKI-GSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITD 150
Query: 258 FGVARV---QAQSGVMTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPYA 314
           FG A+V   +++        GT ++++PE++  K     +D+++ G  +++L+      A
Sbjct: 151 FGTAKVLSPESKQARANXFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLV------A 204
Query: 315 GLTPLQAA--VGVVQK--SLRPTIPKHAHPRLAELLERCWQHDPTQR 357
           GL P +A     + QK   L    P+   P+  +L+E+    D T+R
Sbjct: 205 GLPPFRAGNEYLIFQKIIKLEYDFPEKFFPKARDLVEKLLVLDATKR 251

>pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316

Iteration: 1
 Score = 79.3 bits (194), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 58/227 (25%), Positives = 108/227 (47%), Gaps = 15/227 (6%)
Query: 139 SQEVAIKVL-KPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVTEFMAR 197
           S+E AIK+L K   +    +   ++E  +M ++ H   V+          L     +   
Sbjct: 62  SREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFCFQDDEKLYFGLSYAKN 121
Query: 198 GSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVAD 257
           G +  ++ K  G F  T       ++   + YLH   IIHRDLK  N+L++E+  +++ D
Sbjct: 122 GELLKYIRKI-GSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITD 180
Query: 258 FGVARV---QAQSGVMTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPYA 314
           FG A+V   +++        GT ++++PE++  K     +D+++ G  +++L+      A
Sbjct: 181 FGTAKVLSPESKQARANXFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLV------A 234
Query: 315 GLTPLQAA--VGVVQK--SLRPTIPKHAHPRLAELLERCWQHDPTQR 357
           GL P +A     + QK   L    P+   P+  +L+E+    D T+R
Sbjct: 235 GLPPFRAGNEYLIFQKIIKLEYDFPEKFFPKARDLVEKLLVLDATKR 281

>pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311

Iteration: 1
 Score = 79.3 bits (194), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 58/227 (25%), Positives = 108/227 (47%), Gaps = 15/227 (6%)
Query: 139 SQEVAIKVL-KPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVTEFMAR 197
           S+E AIK+L K   +    +   ++E  +M ++ H   V+          L     +   
Sbjct: 57  SREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKN 116
Query: 198 GSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVAD 257
           G +  ++ K  G F  T       ++   + YLH   IIHRDLK  N+L++E+  +++ D
Sbjct: 117 GELLKYIRKI-GSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITD 175
Query: 258 FGVARV---QAQSGVMTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPYA 314
           FG A+V   +++        GT ++++PE++  K     +D+++ G  +++L+      A
Sbjct: 176 FGTAKVLSPESKQARANXFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLV------A 229
Query: 315 GLTPLQAA--VGVVQK--SLRPTIPKHAHPRLAELLERCWQHDPTQR 357
           GL P +A     + QK   L    P+   P+  +L+E+    D T+R
Sbjct: 230 GLPPFRAGNEYLIFQKIIKLEYDFPEKFFPKARDLVEKLLVLDATKR 276

>pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336

Iteration: 1
 Score = 79.3 bits (194), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 47/179 (26%), Positives = 95/179 (53%), Gaps = 5/179 (2%)
Query: 139 SQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVTEFMARG 198
           +QE A K++  + ++    ++  +E  I R ++H N+V+   + +      +V + +  G
Sbjct: 56  TQEYAAKIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDSISEEGFHYLVFDLVTGG 115
Query: 199 SIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMD---ENGVVKV 255
            +++ +  ++  +           + + +N++HQ++I+HRDLK  NLL+    +   VK+
Sbjct: 116 ELFEDIVARE-YYSEADASHCIHQILESVNHIHQHDIVHRDLKPENLLLASKCKGAAVKL 174
Query: 256 ADFGVA-RVQAQSGVMTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPY 313
           ADFG+A  VQ +        GT  +++PEV+   PY    D+++ G+ L+ LL G  P+
Sbjct: 175 ADFGLAIEVQGEQQAWFGFAGTPGYLSPEVLRKDPYGKPVDIWACGVILYILLVGYPPF 233

>pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326

Iteration: 1
 Score = 79.3 bits (194), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 56/213 (26%), Positives = 107/213 (50%), Gaps = 15/213 (7%)
Query: 116 KQLKIECKVASGSYGDLYKGTYC---SQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIR- 171
           +Q +   ++  G+YG ++K        + VA+K ++ +     M     +EV ++R +  
Sbjct: 11  QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLET 70
Query: 172 --HKNVVQFIGACT-----RPPNLCIVTEFMARGSIYDFLHK--QKGVFQLTSLLKVAID 222
             H NVV+    CT     R   L +V E + +  +  +L K  + GV    ++  +   
Sbjct: 71  FEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQ-DLTTYLDKVPEPGV-PTETIKDMMFQ 128
Query: 223 VSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAETGTYRWMAP 282
           + +G+++LH + ++HRDLK  N+L+  +G +K+ADFG+AR+ +    +T+   T  + AP
Sbjct: 129 LLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTSVVVTLWYRAP 188
Query: 283 EVIEHKPYDYKADVFSFGIALWELLTGELPYAG 315
           EV+    Y    D++S G    E+   +  + G
Sbjct: 189 EVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRG 221

>pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 79.3 bits (194), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 62/236 (26%), Positives = 109/236 (46%), Gaps = 22/236 (9%)
Query: 124 VASGSYGDLYKG--TYCSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGA 181
           + SG+ G +         + VAIK L     N    K   +E+ +M+ + HKN++  +  
Sbjct: 32  IGSGAQGIVVAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKVVNHKNIIGLLNV 91
Query: 182 CTRPPNL------CIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNI 235
            T   +L       IV E M   ++   +  +    +++ LL   +    G+ +LH   I
Sbjct: 92  FTPQKSLEEFQDVYIVMELMD-ANLSQVIQMELDHERMSYLLYQML---VGIKHLHSAGI 147
Query: 236 IHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAETGTYRWMAPEVIEHKPYDYKAD 295
           IHRDLK +N+++  +  +K+ DFG+AR    S +MT    T  + APEVI    Y    D
Sbjct: 148 IHRDLKPSNIVVKSDATLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVD 207
Query: 296 VFSFGIALWELLTGELPYAGLTPLQAAVGVVQ----------KSLRPTIPKHAHPR 341
           ++S G+ + E++ G + + G   +     V++          K L+PT+  +   R
Sbjct: 208 IWSVGVIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPSPEFMKKLQPTVRTYVENR 263

>pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312

Iteration: 1
 Score = 79.3 bits (194), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 58/227 (25%), Positives = 108/227 (47%), Gaps = 15/227 (6%)
Query: 139 SQEVAIKVL-KPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVTEFMAR 197
           S+E AIK+L K   +    +   ++E  +M ++ H   V+          L     +   
Sbjct: 58  SREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKN 117
Query: 198 GSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVAD 257
           G +  ++ K  G F  T       ++   + YLH   IIHRDLK  N+L++E+  +++ D
Sbjct: 118 GELLKYIRKI-GSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITD 176
Query: 258 FGVARV---QAQSGVMTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPYA 314
           FG A+V   +++        GT ++++PE++  K     +D+++ G  +++L+      A
Sbjct: 177 FGTAKVLSPESKQARANXFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLV------A 230
Query: 315 GLTPLQAA--VGVVQK--SLRPTIPKHAHPRLAELLERCWQHDPTQR 357
           GL P +A     + QK   L    P+   P+  +L+E+    D T+R
Sbjct: 231 GLPPFRAGNEYLIFQKIIKLEYDFPEKFFPKARDLVEKLLVLDATKR 277

>pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 79.3 bits (194), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 59/220 (26%), Positives = 103/220 (46%), Gaps = 20/220 (9%)
Query: 138 CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNL------CIV 191
             + VAIK L     N    K   +E+ +M+ + HKN++  +   T   +L       IV
Sbjct: 48  LERNVAIKKLSRPFQNQTHAKRAYRELVLMKVVNHKNIIGLLNVFTPQKSLEEFQDVYIV 107
Query: 192 TEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENG 251
            E M   ++   +  +    +++ LL   +    G+ +LH   IIHRDLK +N+++  + 
Sbjct: 108 MELMD-ANLSQVIQMELDHERMSYLLYQML---VGIKHLHSAGIIHRDLKPSNIVVKSDA 163
Query: 252 VVKVADFGVARVQAQSGVMTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTGEL 311
            +K+ DFG+AR    S +MT    T  + APEVI    Y    D++S G+ + E++ G +
Sbjct: 164 TLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGVIMGEMIKGGV 223
Query: 312 PYAGLTPLQAAVGVVQ----------KSLRPTIPKHAHPR 341
            + G   +     V++          K L+PT+  +   R
Sbjct: 224 LFPGTDHIDQWNKVIEQLGTPSPEFMKKLQPTVRTYVENR 263

>pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286

Iteration: 1
 Score = 79.3 bits (194), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 58/227 (25%), Positives = 108/227 (47%), Gaps = 15/227 (6%)
Query: 139 SQEVAIKVL-KPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVTEFMAR 197
           S+E AIK+L K   +    +   ++E  +M ++ H   V+          L     +   
Sbjct: 34  SREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKN 93
Query: 198 GSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVAD 257
           G +  ++ K  G F  T       ++   + YLH   IIHRDLK  N+L++E+  +++ D
Sbjct: 94  GELLKYIRKI-GSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITD 152
Query: 258 FGVARV---QAQSGVMTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPYA 314
           FG A+V   +++        GT ++++PE++  K     +D+++ G  +++L+      A
Sbjct: 153 FGTAKVLSPESKQARANXFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLV------A 206
Query: 315 GLTPLQAA--VGVVQK--SLRPTIPKHAHPRLAELLERCWQHDPTQR 357
           GL P +A     + QK   L    P+   P+  +L+E+    D T+R
Sbjct: 207 GLPPFRAGNEYLIFQKIIKLEYDFPEKFFPKARDLVEKLLVLDATKR 253

>pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308

Iteration: 1
 Score = 79.3 bits (194), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 56/213 (26%), Positives = 107/213 (50%), Gaps = 15/213 (7%)
Query: 116 KQLKIECKVASGSYGDLYKGTYC---SQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIR- 171
           +Q +   ++  G+YG ++K        + VA+K ++ +     M     +EV ++R +  
Sbjct: 11  QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLET 70
Query: 172 --HKNVVQFIGACT-----RPPNLCIVTEFMARGSIYDFLHK--QKGVFQLTSLLKVAID 222
             H NVV+    CT     R   L +V E + +  +  +L K  + GV    ++  +   
Sbjct: 71  FEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQ-DLTTYLDKVPEPGV-PTETIKDMMFQ 128
Query: 223 VSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAETGTYRWMAP 282
           + +G+++LH + ++HRDLK  N+L+  +G +K+ADFG+AR+ +    +T+   T  + AP
Sbjct: 129 LLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTSVVVTLWYRAP 188
Query: 283 EVIEHKPYDYKADVFSFGIALWELLTGELPYAG 315
           EV+    Y    D++S G    E+   +  + G
Sbjct: 189 EVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRG 221

>pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360

Iteration: 1
 Score = 79.3 bits (194), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 61/215 (28%), Positives = 103/215 (47%), Gaps = 15/215 (6%)
Query: 110 VWEIDAKQLKIECKVASGSYGDLYKG--TYCSQEVAIKVLKPECVNTEMLKEFSQEVYIM 167
           +WE+  +   +   V SG+YG +     T     VA+K L     +    K   +E+ ++
Sbjct: 17  IWEVPERYQNL-SPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLL 75
Query: 168 RKIRHKNVVQFIGACTRPPNL------CIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAI 221
           + ++H+NV+  +   T   +L       +VT  M    + + +  QK        L   I
Sbjct: 76  KHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMG-ADLNNIVKXQKLTDDHVQFLIYQI 134
Query: 222 DVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAETGTYRWMA 281
              +G+ Y+H  +IIHRDLK +NL ++E+  +K+ DFG+AR       MT    T  + A
Sbjct: 135 --LRGLKYIHSADIIHRDLKPSNLAVNEDXELKILDFGLAR--HTDDEMTGYVATRWYRA 190
Query: 282 PEV-IEHKPYDYKADVFSFGIALWELLTGELPYAG 315
           PE+ +    Y+   D++S G  + ELLTG   + G
Sbjct: 191 PEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPG 225

>pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory Dimer Length = 316

Iteration: 1
 Score = 79.3 bits (194), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 72/267 (26%), Positives = 123/267 (46%), Gaps = 18/267 (6%)
Query: 111 WEIDAKQLKIECKVASGSYGDLYKGTYC--SQEVAIKVLKPECVNTEMLKEFSQEVYI-M 167
           +E+ A  L+   ++  G+YG + K  +    Q  A+K ++   VN++  K    ++ I  
Sbjct: 29  FEVKADDLEPIXELGRGAYGVVEKXRHVPSGQIXAVKRIR-ATVNSQEQKRLLXDLDISX 87
Query: 168 RKIRHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQ---KGVFQLTSLL-KVAIDV 223
           R +     V F GA  R  ++ I  E     +  D  +KQ   KG      +L K+A+ +
Sbjct: 88  RTVDCPFTVTFYGALFREGDVWICXELX--DTSLDKFYKQVIDKGQTIPEDILGKIAVSI 145
Query: 224 SKGMNYLHQN-NIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAETGTYRWMAP 282
            K + +LH   ++IHRD+K +N+L++  G VK  DFG++           + G   + AP
Sbjct: 146 VKALEHLHSKLSVIHRDVKPSNVLINALGQVKXCDFGISGYLVDDVAKDIDAGCKPYXAP 205
Query: 283 EVI----EHKPYDYKADVFSFGIALWELLTGELPYAGL-TPLQAAVGVVQKSLRPTIPKH 337
           E I      K Y  K+D++S GI   EL     PY    TP Q    VV++   P +P  
Sbjct: 206 ERINPELNQKGYSVKSDIWSLGITXIELAILRFPYDSWGTPFQQLKQVVEEP-SPQLPAD 264
Query: 338 A-HPRLAELLERCWQHDPTQRPNFSQI 363
                  +   +C + +  +RP + ++
Sbjct: 265 KFSAEFVDFTSQCLKKNSKERPTYPEL 291

>pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289

Iteration: 1
 Score = 79.3 bits (194), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 58/227 (25%), Positives = 108/227 (47%), Gaps = 15/227 (6%)
Query: 139 SQEVAIKVL-KPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVTEFMAR 197
           S+E AIK+L K   +    +   ++E  +M ++ H   V+          L     +   
Sbjct: 35  SREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKN 94
Query: 198 GSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVAD 257
           G +  ++ K  G F  T       ++   + YLH   IIHRDLK  N+L++E+  +++ D
Sbjct: 95  GELLKYIRKI-GSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITD 153
Query: 258 FGVARV---QAQSGVMTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPYA 314
           FG A+V   +++        GT ++++PE++  K     +D+++ G  +++L+      A
Sbjct: 154 FGTAKVLSPESKQARANXFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLV------A 207
Query: 315 GLTPLQAA--VGVVQK--SLRPTIPKHAHPRLAELLERCWQHDPTQR 357
           GL P +A     + QK   L    P+   P+  +L+E+    D T+R
Sbjct: 208 GLPPFRAGNEYLIFQKIIKLEYDFPEKFFPKARDLVEKLLVLDATKR 254

>pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 79.3 bits (194), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 48/158 (30%), Positives = 85/158 (53%), Gaps = 5/158 (3%)
Query: 160 FSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKV 219
             +E+ I + + H+NVV+F G         +  E+ + G ++D +    G+ +     + 
Sbjct: 51  IKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPE-PDAQRF 109
Query: 220 AIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVA---RVQAQSGVMTAETGT 276
              +  G+ YLH   I HRD+K  NLL+DE   +K++DFG+A   R   +  ++    GT
Sbjct: 110 FHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGT 169
Query: 277 YRWMAPEVIEHKPYDYK-ADVFSFGIALWELLTGELPY 313
             ++APE+++ + +  +  DV+S GI L  +L GELP+
Sbjct: 170 LPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPW 207

>pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307

Iteration: 1
 Score = 79.3 bits (194), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 56/213 (26%), Positives = 107/213 (50%), Gaps = 15/213 (7%)
Query: 116 KQLKIECKVASGSYGDLYKGTYC---SQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIR- 171
           +Q +   ++  G+YG ++K        + VA+K ++ +     M     +EV ++R +  
Sbjct: 11  QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLET 70
Query: 172 --HKNVVQFIGACT-----RPPNLCIVTEFMARGSIYDFLHK--QKGVFQLTSLLKVAID 222
             H NVV+    CT     R   L +V E + +  +  +L K  + GV    ++  +   
Sbjct: 71  FEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQ-DLTTYLDKVPEPGV-PTETIKDMMFQ 128
Query: 223 VSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAETGTYRWMAP 282
           + +G+++LH + ++HRDLK  N+L+  +G +K+ADFG+AR+ +    +T+   T  + AP
Sbjct: 129 LLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTSVVVTLWYRAP 188
Query: 283 EVIEHKPYDYKADVFSFGIALWELLTGELPYAG 315
           EV+    Y    D++S G    E+   +  + G
Sbjct: 189 EVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRG 221

>pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366

Iteration: 1
 Score = 79.0 bits (193), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 61/215 (28%), Positives = 103/215 (47%), Gaps = 15/215 (6%)
Query: 110 VWEIDAKQLKIECKVASGSYGDLYKG--TYCSQEVAIKVLKPECVNTEMLKEFSQEVYIM 167
           +WE+  +   +   V SG+YG +     T     VA+K L     +    K   +E+ ++
Sbjct: 23  IWEVPERYQNL-SPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLL 81
Query: 168 RKIRHKNVVQFIGACTRPPNL------CIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAI 221
           + ++H+NV+  +   T   +L       +VT  M    + + +  QK        L   I
Sbjct: 82  KHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMG-ADLNNIVKCQKLTDDHVQFLIYQI 140
Query: 222 DVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAETGTYRWMA 281
              +G+ Y+H  +IIHRDLK +NL ++E+  +K+ DFG+AR       MT    T  + A
Sbjct: 141 --LRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLAR--HTDDEMTGYVATRWYRA 196
Query: 282 PEV-IEHKPYDYKADVFSFGIALWELLTGELPYAG 315
           PE+ +    Y+   D++S G  + ELLTG   + G
Sbjct: 197 PEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPG 231

>pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366

Iteration: 1
 Score = 79.0 bits (193), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 61/215 (28%), Positives = 103/215 (47%), Gaps = 15/215 (6%)
Query: 110 VWEIDAKQLKIECKVASGSYGDLYKG--TYCSQEVAIKVLKPECVNTEMLKEFSQEVYIM 167
           +WE+  +   +   V SG+YG +     T     VA+K L     +    K   +E+ ++
Sbjct: 23  IWEVPERYQNL-SPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLL 81
Query: 168 RKIRHKNVVQFIGACTRPPNL------CIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAI 221
           + ++H+NV+  +   T   +L       +VT  M    + + +  QK        L   I
Sbjct: 82  KHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMG-ADLNNIVKCQKLTDDHVQFLIYQI 140
Query: 222 DVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAETGTYRWMA 281
              +G+ Y+H  +IIHRDLK +NL ++E+  +K+ DFG+AR       MT    T  + A
Sbjct: 141 --LRGLKYIHSADIIHRDLKPSNLAVNEDSELKILDFGLAR--HTDDEMTGYVATRWYRA 196
Query: 282 PEV-IEHKPYDYKADVFSFGIALWELLTGELPYAG 315
           PE+ +    Y+   D++S G  + ELLTG   + G
Sbjct: 197 PEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPG 231

>pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311

Iteration: 1
 Score = 79.0 bits (193), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 57/228 (25%), Positives = 108/228 (47%), Gaps = 15/228 (6%)
Query: 138 CSQEVAIKVL-KPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVTEFMA 196
            S+E AIK+L K   +    +   ++E  +M ++ H   V+          L     +  
Sbjct: 56  TSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAK 115
Query: 197 RGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVA 256
            G +  ++ K  G F  T       ++   + YLH   IIHRDLK  N+L++E+  +++ 
Sbjct: 116 NGELLKYIRKI-GSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQIT 174
Query: 257 DFGVARV---QAQSGVMTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPY 313
           DFG A+V   +++        GT ++++PE++  K     +D+++ G  +++L+      
Sbjct: 175 DFGTAKVLSPESKQARANXFVGTAQYVSPELLTEKSAXKSSDLWALGCIIYQLV------ 228
Query: 314 AGLTPLQAA-VGVVQK---SLRPTIPKHAHPRLAELLERCWQHDPTQR 357
           AGL P +A   G++      L    P+   P+  +L+E+    D T+R
Sbjct: 229 AGLPPFRAGNEGLIFAKIIKLEYDFPEKFFPKARDLVEKLLVLDATKR 276

>pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370

Iteration: 1
 Score = 79.0 bits (193), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 61/215 (28%), Positives = 103/215 (47%), Gaps = 15/215 (6%)
Query: 110 VWEIDAKQLKIECKVASGSYGDLYKG--TYCSQEVAIKVLKPECVNTEMLKEFSQEVYIM 167
           +WE+  +   +   V SG+YG +     T     VA+K L     +    K   +E+ ++
Sbjct: 27  IWEVPERYQNL-APVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLL 85
Query: 168 RKIRHKNVVQFIGACTRPPNL------CIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAI 221
           + ++H+NV+  +   T   +L       +VT  M    + + +  QK        L   I
Sbjct: 86  KHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMG-ADLNNIVKCQKLTDDHVQFLIYQI 144
Query: 222 DVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAETGTYRWMA 281
              +G+ Y+H  +IIHRDLK +NL ++E+  +K+ DFG+AR       MT    T  + A
Sbjct: 145 --LRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLAR--HTDDEMTGYVATRWYRA 200
Query: 282 PEV-IEHKPYDYKADVFSFGIALWELLTGELPYAG 315
           PE+ +    Y+   D++S G  + ELLTG   + G
Sbjct: 201 PEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPG 235

>pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380

Iteration: 1
 Score = 79.0 bits (193), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 61/215 (28%), Positives = 103/215 (47%), Gaps = 15/215 (6%)
Query: 110 VWEIDAKQLKIECKVASGSYGDLYKG--TYCSQEVAIKVLKPECVNTEMLKEFSQEVYIM 167
           +WE+  +   +   V SG+YG +     T     VA+K L     +    K   +E+ ++
Sbjct: 37  IWEVPERYQNL-SPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLL 95
Query: 168 RKIRHKNVVQFIGACTRPPNL------CIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAI 221
           + ++H+NV+  +   T   +L       +VT  M    + + +  QK        L   I
Sbjct: 96  KHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMG-ADLNNIVKCQKLTDDHVQFLIYQI 154
Query: 222 DVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAETGTYRWMA 281
              +G+ Y+H  +IIHRDLK +NL ++E+  +K+ DFG+AR       MT    T  + A
Sbjct: 155 --LRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLAR--HTDDEMTGYVATRWYRA 210
Query: 282 PEV-IEHKPYDYKADVFSFGIALWELLTGELPYAG 315
           PE+ +    Y+   D++S G  + ELLTG   + G
Sbjct: 211 PEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPG 245

>pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360

Iteration: 1
 Score = 79.0 bits (193), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 61/215 (28%), Positives = 103/215 (47%), Gaps = 15/215 (6%)
Query: 110 VWEIDAKQLKIECKVASGSYGDLYKG--TYCSQEVAIKVLKPECVNTEMLKEFSQEVYIM 167
           +WE+  +   +   V SG+YG +     T     VA+K L     +    K   +E+ ++
Sbjct: 17  IWEVPERYQNL-SPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLL 75
Query: 168 RKIRHKNVVQFIGACTRPPNL------CIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAI 221
           + ++H+NV+  +   T   +L       +VT  M    + + +  QK        L   I
Sbjct: 76  KHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMG-ADLNNIVKXQKLTDDHVQFLIYQI 134
Query: 222 DVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAETGTYRWMA 281
              +G+ Y+H  +IIHRDLK +NL ++E+  +K+ DFG+AR       MT    T  + A
Sbjct: 135 --LRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLAR--HTDDEMTGYVATRWYRA 190
Query: 282 PEV-IEHKPYDYKADVFSFGIALWELLTGELPYAG 315
           PE+ +    Y+   D++S G  + ELLTG   + G
Sbjct: 191 PEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPG 225

>pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379

Iteration: 1
 Score = 79.0 bits (193), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 61/215 (28%), Positives = 103/215 (47%), Gaps = 15/215 (6%)
Query: 110 VWEIDAKQLKIECKVASGSYGDLYKG--TYCSQEVAIKVLKPECVNTEMLKEFSQEVYIM 167
           +WE+  +   +   V SG+YG +     T     VA+K L     +    K   +E+ ++
Sbjct: 36  IWEVPERYQNL-SPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLL 94
Query: 168 RKIRHKNVVQFIGACTRPPNL------CIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAI 221
           + ++H+NV+  +   T   +L       +VT  M    + + +  QK        L   I
Sbjct: 95  KHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMG-ADLNNIVKCQKLTDDHVQFLIYQI 153
Query: 222 DVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAETGTYRWMA 281
              +G+ Y+H  +IIHRDLK +NL ++E+  +K+ DFG+AR       MT    T  + A
Sbjct: 154 --LRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLAR--HTDDEMTGYVATRWYRA 209
Query: 282 PEV-IEHKPYDYKADVFSFGIALWELLTGELPYAG 315
           PE+ +    Y+   D++S G  + ELLTG   + G
Sbjct: 210 PEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPG 244

>pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360

Iteration: 1
 Score = 79.0 bits (193), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 61/215 (28%), Positives = 103/215 (47%), Gaps = 15/215 (6%)
Query: 110 VWEIDAKQLKIECKVASGSYGDLYKG--TYCSQEVAIKVLKPECVNTEMLKEFSQEVYIM 167
           +WE+  +   +   V SG+YG +     T     VA+K L     +    K   +E+ ++
Sbjct: 17  IWEVPERYQNL-SPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLL 75
Query: 168 RKIRHKNVVQFIGACTRPPNL------CIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAI 221
           + ++H+NV+  +   T   +L       +VT  M    + + +  QK        L   I
Sbjct: 76  KHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMG-ADLNNIVKCQKLTDDHVQFLIYQI 134
Query: 222 DVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAETGTYRWMA 281
              +G+ Y+H  +IIHRDLK +NL ++E+  +K+ DFG+AR       MT    T  + A
Sbjct: 135 --LRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLAR--HTDDEMTGYVATRWYRA 190
Query: 282 PEV-IEHKPYDYKADVFSFGIALWELLTGELPYAG 315
           PE+ +    Y+   D++S G  + ELLTG   + G
Sbjct: 191 PEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPG 225

>pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348

Iteration: 1
 Score = 78.6 bits (192), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 61/215 (28%), Positives = 103/215 (47%), Gaps = 15/215 (6%)
Query: 110 VWEIDAKQLKIECKVASGSYGDLYKG--TYCSQEVAIKVLKPECVNTEMLKEFSQEVYIM 167
           +WE+  +   +   V SG+YG +     T     VA+K L     +    K   +E+ ++
Sbjct: 13  IWEVPERYQNL-SPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLL 71
Query: 168 RKIRHKNVVQFIGACTRPPNL------CIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAI 221
           + ++H+NV+  +   T   +L       +VT  M    + + +  QK        L   I
Sbjct: 72  KHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMG-ADLNNIVKCQKLTDDHVQFLIYQI 130
Query: 222 DVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAETGTYRWMA 281
              +G+ Y+H  +IIHRDLK +NL ++E+  +K+ DFG+AR       MT    T  + A
Sbjct: 131 --LRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLAR--HTDDEMTGYVATRWYRA 186
Query: 282 PEV-IEHKPYDYKADVFSFGIALWELLTGELPYAG 315
           PE+ +    Y+   D++S G  + ELLTG   + G
Sbjct: 187 PEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPG 221

>pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 78.6 bits (192), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 61/215 (28%), Positives = 103/215 (47%), Gaps = 15/215 (6%)
Query: 110 VWEIDAKQLKIECKVASGSYGDLYKG--TYCSQEVAIKVLKPECVNTEMLKEFSQEVYIM 167
           +WE+  +   +   V SG+YG +     T     VA+K L     +    K   +E+ ++
Sbjct: 19  IWEVPERYQNL-SPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLL 77
Query: 168 RKIRHKNVVQFIGACTRPPNL------CIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAI 221
           + ++H+NV+  +   T   +L       +VT  M    + + +  QK        L   I
Sbjct: 78  KHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMG-ADLNNIVKCQKLTDDHVQFLIYQI 136
Query: 222 DVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAETGTYRWMA 281
              +G+ Y+H  +IIHRDLK +NL ++E+  +K+ DFG+AR       MT    T  + A
Sbjct: 137 --LRGLKYIHSADIIHRDLKPSNLAVNEDSELKILDFGLAR--HTDDEMTGYVATRWYRA 192
Query: 282 PEV-IEHKPYDYKADVFSFGIALWELLTGELPYAG 315
           PE+ +    Y+   D++S G  + ELLTG   + G
Sbjct: 193 PEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPG 227

>pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314

Iteration: 1
 Score = 78.6 bits (192), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 58/227 (25%), Positives = 107/227 (47%), Gaps = 15/227 (6%)
Query: 139 SQEVAIKVL-KPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVTEFMAR 197
           S+E AIK+L K   +    +   ++E  +M ++ H   V+          L     +   
Sbjct: 60  SREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKN 119
Query: 198 GSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVAD 257
           G +  ++ K  G F  T       ++   + YLH   IIHRDLK  N+L++E+  +++ D
Sbjct: 120 GELLKYIRKI-GSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITD 178
Query: 258 FGVARV---QAQSGVMTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPYA 314
           FG A+V   +++        GT ++++PE++  K     +D+++ G  +++L+      A
Sbjct: 179 FGTAKVLSPESKQARANXFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLV------A 232
Query: 315 GLTPLQAA--VGVVQK--SLRPTIPKHAHPRLAELLERCWQHDPTQR 357
           GL P +A     + QK   L    P    P+  +L+E+    D T+R
Sbjct: 233 GLPPFRAGNEYLIFQKIIKLEYDFPAAFFPKARDLVEKLLVLDATKR 279

>pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379

Iteration: 1
 Score = 78.6 bits (192), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 60/218 (27%), Positives = 103/218 (47%), Gaps = 20/218 (9%)
Query: 140 QEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNL------CIVTE 193
           + VAIK L     N    K   +E+ +M+ + HKN++  +   T   +L       IV E
Sbjct: 50  RNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVME 109
Query: 194 FMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVV 253
            M   ++   +  +    +++ LL   +    G+ +LH   IIHRDLK +N+++  +  +
Sbjct: 110 LMD-ANLCQVIQMELDHERMSYLLYQML---CGIKHLHSAGIIHRDLKPSNIVVKSDCTL 165
Query: 254 KVADFGVARVQAQSGVMTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPY 313
           K+ DFG+AR    S +MT E  T  + APEVI    Y    D++S G  + E++ G + +
Sbjct: 166 KILDFGLARTAGTSFMMTPEVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLF 225
Query: 314 AGLTPLQAAVGVVQ----------KSLRPTIPKHAHPR 341
            G   +     V++          K L+PT+  +   R
Sbjct: 226 PGTDHIDQWNKVIEQLGTPCPEFMKKLQPTVRTYVENR 263

>pdb|2BUJ|A Chain A, Crystal Structure Of The Human Serine-Threonine Kinase 16 In Complex With Staurosporine Length = 317

Iteration: 1
 Score = 78.6 bits (192), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 76/283 (26%), Positives = 127/283 (44%), Gaps = 29/283 (10%)
Query: 113 IDAKQLKIECKVASG--SYGDLYKGTYCSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKI 170
           ID K      K+  G  SY DL +G +     A+K +   C   +  +E  +E  + R  
Sbjct: 26  IDNKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRIL--CHEQQDREEAQREADMHRLF 83
Query: 171 RHKNVVQFIGACTRPPNL----CIVTEFMARGSIYDFLH--KQKGVFQLT--SLLKVAID 222
            H N+++ +  C R         ++  F  RG++++ +   K KG F LT   +L + + 
Sbjct: 84  NHPNILRLVAYCLRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNF-LTEDQILWLLLG 142
Query: 223 VSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFG-----VARVQAQSGVMT-----A 272
           + +G+  +H     HRDLK  N+L+ + G   + D G        V+     +T     A
Sbjct: 143 ICRGLEAIHAKGYAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEGSRQALTLQDWAA 202
Query: 273 ETGTYRWMAPEVI---EHKPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGV-VQK 328
           +  T  + APE+     H   D + DV+S G  L+ ++ GE PY  +     +V + VQ 
Sbjct: 203 QRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGDSVALAVQN 262
Query: 329 SLR-PTIPKHAHPRLAELLERCWQHDPTQRPNFSQITDILKQM 370
            L  P  P+H+   L +LL      DP QRP+   +   L+ +
Sbjct: 263 QLSIPQSPRHS-SALWQLLNSMMTVDPHQRPHIPLLLSQLEAL 304

>pdb|2AC5|A Chain A, Structure Of Human Mnk2 Kinase Domain Mutant D228g Length = 316

Iteration: 1
 Score = 78.2 bits (191), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 61/195 (31%), Positives = 101/195 (51%), Gaps = 22/195 (11%)
Query: 139 SQEVAIKVL--KPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVTEFMA 196
           SQE A+K++  +P  + + + +E      + +   H+NV++ I          +V E M 
Sbjct: 38  SQEYAVKIIEKQPGHIRSRVFREVEM---LYQCQGHRNVLELIEFFEEEDRFYLVFEKMR 94
Query: 197 RGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDE-NGV--V 253
            GSI   +HK++   +L + + V  DV+  +++LH   I HRDLK  N+L +  N V  V
Sbjct: 95  GGSILSHIHKRRHFNELEASV-VVQDVASALDFLHNKGIAHRDLKPENILCEHPNQVSPV 153
Query: 254 KVADFGVARVQAQSG----VMTAE----TGTYRWMAPEVI-----EHKPYDYKADVFSFG 300
           K+ DFG+      +G    + T E     G+  +MAPEV+     E   YD + D++S G
Sbjct: 154 KICDFGLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLG 213
Query: 301 IALWELLTGELPYAG 315
           + L+ LL+G  P+ G
Sbjct: 214 VILYILLSGYPPFVG 228

>pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354

Iteration: 1
 Score = 78.2 bits (191), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 61/215 (28%), Positives = 103/215 (47%), Gaps = 15/215 (6%)
Query: 110 VWEIDAKQLKIECKVASGSYGDLYKG--TYCSQEVAIKVLKPECVNTEMLKEFSQEVYIM 167
           +WE+  +   +   V SG+YG +     T     VA+K L     +    K   +E+ ++
Sbjct: 17  IWEVPERYQNL-SPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLL 75
Query: 168 RKIRHKNVVQFIGACTRPPNL------CIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAI 221
           + ++H+NV+  +   T   +L       +VT  M    + + +  QK        L   I
Sbjct: 76  KHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMG-ADLNNIVKCQKLTDDHVQFLIYQI 134
Query: 222 DVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAETGTYRWMA 281
              +G+ Y+H  +IIHRDLK +NL ++E+  +K+ DFG+AR       MT    T  + A
Sbjct: 135 --LRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLAR--HTDDEMTGXVATRWYRA 190
Query: 282 PEV-IEHKPYDYKADVFSFGIALWELLTGELPYAG 315
           PE+ +    Y+   D++S G  + ELLTG   + G
Sbjct: 191 PEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPG 225

>pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360

Iteration: 1
 Score = 78.2 bits (191), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 61/215 (28%), Positives = 103/215 (47%), Gaps = 15/215 (6%)
Query: 110 VWEIDAKQLKIECKVASGSYGDLYKG--TYCSQEVAIKVLKPECVNTEMLKEFSQEVYIM 167
           +WE+  +   +   V SG+YG +     T     VA+K L     +    K   +E+ ++
Sbjct: 17  IWEVPERYQNL-SPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLL 75
Query: 168 RKIRHKNVVQFIGACTRPPNL------CIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAI 221
           + ++H+NV+  +   T   +L       +VT  M    + + +  QK        L   I
Sbjct: 76  KHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMG-ADLNNIVKCQKLTDDHVQFLIYQI 134
Query: 222 DVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAETGTYRWMA 281
              +G+ Y+H  +IIHRDLK +NL ++E+  +K+ DFG+AR       MT    T  + A
Sbjct: 135 --LRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLAR--HTDDEMTGYVATRWYRA 190
Query: 282 PEV-IEHKPYDYKADVFSFGIALWELLTGELPYAG 315
           PE+ +    Y+   D++S G  + ELLTG   + G
Sbjct: 191 PEIMLNAMHYNQTVDIWSVGCIMAELLTGRTLFPG 225

>pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371

Iteration: 1
 Score = 78.2 bits (191), Expect = 8e-15,   Method: Compositional matrix adjust.
 Identities = 61/215 (28%), Positives = 103/215 (47%), Gaps = 15/215 (6%)
Query: 110 VWEIDAKQLKIECKVASGSYGDLYKG--TYCSQEVAIKVLKPECVNTEMLKEFSQEVYIM 167
           +WE+  +   +   V SG+YG +     T     VA+K L     +    K   +E+ ++
Sbjct: 28  IWEVPERYQNL-SPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLL 86
Query: 168 RKIRHKNVVQFIGACTRPPNL------CIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAI 221
           + ++H+NV+  +   T   +L       +VT  M    + + +  QK        L   I
Sbjct: 87  KHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMG-ADLNNIVKCQKLTDDHVQFLIYQI 145
Query: 222 DVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAETGTYRWMA 281
              +G+ Y+H  +IIHRDLK +NL ++E+  +K+ DFG+AR       MT    T  + A
Sbjct: 146 --LRGLKYIHSADIIHRDLKPSNLAVNEDXELKILDFGLAR--HTDDEMTGYVATRWYRA 201
Query: 282 PEV-IEHKPYDYKADVFSFGIALWELLTGELPYAG 315
           PE+ +    Y+   D++S G  + ELLTG   + G
Sbjct: 202 PEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPG 236

>pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298

Iteration: 1
 Score = 78.2 bits (191), Expect = 8e-15,   Method: Compositional matrix adjust.
 Identities = 47/159 (29%), Positives = 84/159 (52%), Gaps = 8/159 (5%)
Query: 162 QEVYIMRKIR-HKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVA 220
           +EV I+RK+  H N++Q            +V + M +G ++D+L  +K         K+ 
Sbjct: 72  KEVDILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYL-TEKVTLSEKETRKIM 130
Query: 221 IDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAETGTYRWM 280
             + + +  LH+ NI+HRDLK  N+L+D++  +K+ DFG +        + +  GT  ++
Sbjct: 131 RALLEVICALHKLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEKLRSVCGTPSYL 190
Query: 281 APEVIE------HKPYDYKADVFSFGIALWELLTGELPY 313
           APE+IE      H  Y  + D++S G+ ++ LL G  P+
Sbjct: 191 APEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPF 229

>pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365

Iteration: 1
 Score = 78.2 bits (191), Expect = 8e-15,   Method: Compositional matrix adjust.
 Identities = 61/215 (28%), Positives = 103/215 (47%), Gaps = 15/215 (6%)
Query: 110 VWEIDAKQLKIECKVASGSYGDLYKG--TYCSQEVAIKVLKPECVNTEMLKEFSQEVYIM 167
           +WE+  +   +   V SG+YG +     T     VA+K L     +    K   +E+ ++
Sbjct: 22  IWEVPERYQNL-SPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLL 80
Query: 168 RKIRHKNVVQFIGACTRPPNL------CIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAI 221
           + ++H+NV+  +   T   +L       +VT  M    + + +  QK        L   I
Sbjct: 81  KHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMG-ADLNNIVKCQKLTDDHVQFLIYQI 139
Query: 222 DVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAETGTYRWMA 281
              +G+ Y+H  +IIHRDLK +NL ++E+  +K+ DFG+AR       MT    T  + A
Sbjct: 140 --LRGLKYIHSADIIHRDLKPSNLAVNEDXELKILDFGLAR--HTDDEMTGYVATRWYRA 195
Query: 282 PEV-IEHKPYDYKADVFSFGIALWELLTGELPYAG 315
           PE+ +    Y+   D++S G  + ELLTG   + G
Sbjct: 196 PEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPG 230

>pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371

Iteration: 1
 Score = 78.2 bits (191), Expect = 8e-15,   Method: Compositional matrix adjust.
 Identities = 80/287 (27%), Positives = 130/287 (45%), Gaps = 39/287 (13%)
Query: 111 WEIDAKQLKIECKVASGSYGDLYKGT--YCSQEVAIKVLKPECVNTEMLKEFSQEVYIMR 168
           WE+  K       V SG+YG +         ++VAIK L     +    K   +E+ +++
Sbjct: 38  WEL-PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLK 96
Query: 169 KIRHKNVVQFIGACTRPPNLCIVTEF-MARGSIYDFLHKQKGV-FQLTSLLKVAIDVSKG 226
            ++H+NV+  +   T   +L    +F +    +   L K  G+ F    +  +   + KG
Sbjct: 97  HMQHENVIGLLDVFTPASSLRNFYDFYLVMPFMQTDLQKIMGMEFSEEKIQYLVYQMLKG 156
Query: 227 MNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAETGTYRWMAPEVI- 285
           + Y+H   ++HRDLK  NL ++E+  +K+ DFG+AR       MT    T  + APEVI 
Sbjct: 157 LKYIHSAGVVHRDLKPGNLAVNEDCELKILDFGLAR--HADAEMTGYVVTRWYRAPEVIL 214
Query: 286 EHKPYDYKADVFSFGIALWELLTGELPYAG------LTPLQAAVGV-----VQK------ 328
               Y+   D++S G  + E+LTG+  + G      LT +    GV     VQK      
Sbjct: 215 SWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFVQKLNDKAA 274
Query: 329 -----SLRPTIPK--------HAHPRLAELLERCWQHDPTQRPNFSQ 362
                SL P  P+         A P+ A+LLE+  + D  +R   +Q
Sbjct: 275 KSYIQSL-PQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQ 320

>pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372

Iteration: 1
 Score = 78.2 bits (191), Expect = 8e-15,   Method: Compositional matrix adjust.
 Identities = 61/215 (28%), Positives = 103/215 (47%), Gaps = 15/215 (6%)
Query: 110 VWEIDAKQLKIECKVASGSYGDLYKG--TYCSQEVAIKVLKPECVNTEMLKEFSQEVYIM 167
           +WE+  +   +   V SG+YG +     T     VA+K L     +    K   +E+ ++
Sbjct: 29  IWEVPERYQNL-SPVGSGAYGSVCAAFDTKTGLRVAVKKLSKPFQSIIHAKRTYRELRLL 87
Query: 168 RKIRHKNVVQFIGACTRPPNL------CIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAI 221
           + ++H+NV+  +   T   +L       +VT  M    + + +  QK        L   I
Sbjct: 88  KHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMG-ADLNNIVKCQKLTDDHVQFLIYQI 146
Query: 222 DVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAETGTYRWMA 281
              +G+ Y+H  +IIHRDLK +NL ++E+  +K+ DFG+AR       MT    T  + A
Sbjct: 147 --LRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLAR--HTDDEMTGYVATRWYRA 202
Query: 282 PEV-IEHKPYDYKADVFSFGIALWELLTGELPYAG 315
           PE+ +    Y+   D++S G  + ELLTG   + G
Sbjct: 203 PEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPG 237

>pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298

Iteration: 1
 Score = 78.2 bits (191), Expect = 8e-15,   Method: Compositional matrix adjust.
 Identities = 50/160 (31%), Positives = 85/160 (53%), Gaps = 10/160 (6%)
Query: 162 QEVYIMRKIR-HKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVA 220
           +EV I+RK+  H N++Q            +V + M +G ++D+L  +K         K+ 
Sbjct: 72  KEVDILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYL-TEKVTLSEKETRKIM 130
Query: 221 IDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAET-GTYRW 279
             + + +  LH+ NI+HRDLK  N+L+D++  +K+ DFG +  Q   G    E  GT  +
Sbjct: 131 RALLEVICALHKLNIVHRDLKPENILLDDDMNIKLTDFGFS-CQLDPGEKLREVCGTPSY 189
Query: 280 MAPEVIE------HKPYDYKADVFSFGIALWELLTGELPY 313
           +APE+IE      H  Y  + D++S G+ ++ LL G  P+
Sbjct: 190 LAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPF 229

>pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360

Iteration: 1
 Score = 78.2 bits (191), Expect = 8e-15,   Method: Compositional matrix adjust.
 Identities = 60/215 (27%), Positives = 102/215 (47%), Gaps = 15/215 (6%)
Query: 110 VWEIDAKQLKIECKVASGSYGDLYKG--TYCSQEVAIKVLKPECVNTEMLKEFSQEVYIM 167
           +WE+  +   +   V SG+YG +     T     VA+K L     +    K   +E+ ++
Sbjct: 17  IWEVPERYQNL-SPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLL 75
Query: 168 RKIRHKNVVQFIGACTRPPNL------CIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAI 221
           + ++H+NV+  +   T   +L       +VT  M    + + +  QK        L   I
Sbjct: 76  KHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMG-ADLNNIVKSQKLTDDHVQFLIYQI 134
Query: 222 DVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAETGTYRWMA 281
              +G+ Y+H  +IIHRDLK +NL ++E+  +K+ DFG+ R       MT    T  + A
Sbjct: 135 --LRGLKYIHSADIIHRDLKPSNLAVNEDSELKILDFGLCR--HTDDEMTGYVATRWYRA 190
Query: 282 PEV-IEHKPYDYKADVFSFGIALWELLTGELPYAG 315
           PE+ +    Y+   D++S G  + ELLTG   + G
Sbjct: 191 PEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPG 225

>pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311

Iteration: 1
 Score = 78.2 bits (191), Expect = 8e-15,   Method: Compositional matrix adjust.
 Identities = 57/227 (25%), Positives = 108/227 (47%), Gaps = 15/227 (6%)
Query: 139 SQEVAIKVL-KPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVTEFMAR 197
           S+E AIK+L K   +    +   ++E  +M ++ H   V+          L     +   
Sbjct: 57  SREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKN 116
Query: 198 GSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVAD 257
           G +  ++ K  G F  T       ++   + YLH   IIHRDLK  N+L++E+  +++ D
Sbjct: 117 GELLKYIRKI-GSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITD 175
Query: 258 FGVARV---QAQSGVMTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPYA 314
           FG A+V   +++        GT ++++PE++  K     +D+++ G  +++L+      A
Sbjct: 176 FGTAKVLSPESKQARANXFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLV------A 229
Query: 315 GLTPLQAA-VGVVQK---SLRPTIPKHAHPRLAELLERCWQHDPTQR 357
           GL P +A   G++      L    P+   P+  +L+E+    D T+R
Sbjct: 230 GLPPFRAGNEGLIFAKIIKLEYDFPEKFFPKARDLVEKLLVLDATKR 276

>pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380

Iteration: 1
 Score = 77.8 bits (190), Expect = 9e-15,   Method: Compositional matrix adjust.
 Identities = 61/215 (28%), Positives = 103/215 (47%), Gaps = 15/215 (6%)
Query: 110 VWEIDAKQLKIECKVASGSYGDLYKG--TYCSQEVAIKVLKPECVNTEMLKEFSQEVYIM 167
           +WE+  +   +   V SG+YG +     T     VA+K L     +    K   +E+ ++
Sbjct: 37  IWEVPERYQNL-SPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLL 95
Query: 168 RKIRHKNVVQFIGACTRPPNL------CIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAI 221
           + ++H+NV+  +   T   +L       +VT  M    + + +  QK        L   I
Sbjct: 96  KHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMG-ADLNNIVKCQKLTDDHVQFLIYQI 154
Query: 222 DVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAETGTYRWMA 281
              +G+ Y+H  +IIHRDLK +NL ++E+  +K+ DFG+AR       MT    T  + A
Sbjct: 155 --LRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLAR--HTDDEMTGYVATRWYRA 210
Query: 282 PEV-IEHKPYDYKADVFSFGIALWELLTGELPYAG 315
           PE+ +    Y+   D++S G  + ELLTG   + G
Sbjct: 211 PEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPG 245

>pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353

Iteration: 1
 Score = 77.8 bits (190), Expect = 9e-15,   Method: Compositional matrix adjust.
 Identities = 80/287 (27%), Positives = 130/287 (45%), Gaps = 39/287 (13%)
Query: 111 WEIDAKQLKIECKVASGSYGDLYKG--TYCSQEVAIKVLKPECVNTEMLKEFSQEVYIMR 168
           WE+  K       V SG+YG +         ++VAIK L     +    K   +E+ +++
Sbjct: 20  WEL-PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLK 78
Query: 169 KIRHKNVVQFIGACTRPPNLCIVTEF-MARGSIYDFLHKQKGV-FQLTSLLKVAIDVSKG 226
            ++H+NV+  +   T   +L    +F +    +   L K  G+ F    +  +   + KG
Sbjct: 79  HMQHENVIGLLDVFTPASSLRNFYDFYLVMPFMQTDLQKIMGLKFSEEKIQYLVYQMLKG 138
Query: 227 MNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAETGTYRWMAPEVI- 285
           + Y+H   ++HRDLK  NL ++E+  +K+ DFG+AR       MT    T  + APEVI 
Sbjct: 139 LKYIHSAGVVHRDLKPGNLAVNEDCELKILDFGLAR--HADAEMTGYVVTRWYRAPEVIL 196
Query: 286 EHKPYDYKADVFSFGIALWELLTGELPYAG------LTPLQAAVGV-----VQK------ 328
               Y+   D++S G  + E+LTG+  + G      LT +    GV     VQK      
Sbjct: 197 SWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFVQKLNDKAA 256
Query: 329 -----SLRPTIPK--------HAHPRLAELLERCWQHDPTQRPNFSQ 362
                SL P  P+         A P+ A+LLE+  + D  +R   +Q
Sbjct: 257 KSYIQSL-PQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQ 302

>pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277

Iteration: 1
 Score = 77.8 bits (190), Expect = 9e-15,   Method: Compositional matrix adjust.
 Identities = 50/160 (31%), Positives = 85/160 (53%), Gaps = 10/160 (6%)
Query: 162 QEVYIMRKIR-HKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVA 220
           +EV I+RK+  H N++Q            +V + M +G ++D+L  +K         K+ 
Sbjct: 59  KEVDILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYL-TEKVTLSEKETRKIM 117
Query: 221 IDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAET-GTYRW 279
             + + +  LH+ NI+HRDLK  N+L+D++  +K+ DFG +  Q   G    E  GT  +
Sbjct: 118 RALLEVICALHKLNIVHRDLKPENILLDDDMNIKLTDFGFS-CQLDPGEKLREVCGTPSY 176
Query: 280 MAPEVIE------HKPYDYKADVFSFGIALWELLTGELPY 313
           +APE+IE      H  Y  + D++S G+ ++ LL G  P+
Sbjct: 177 LAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPF 216

>pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383

Iteration: 1
 Score = 77.8 bits (190), Expect = 9e-15,   Method: Compositional matrix adjust.
 Identities = 61/215 (28%), Positives = 103/215 (47%), Gaps = 15/215 (6%)
Query: 110 VWEIDAKQLKIECKVASGSYGDLYKG--TYCSQEVAIKVLKPECVNTEMLKEFSQEVYIM 167
           +WE+  +   +   V SG+YG +     T     VA+K L     +    K   +E+ ++
Sbjct: 40  IWEVPERYQNL-SPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLL 98
Query: 168 RKIRHKNVVQFIGACTRPPNL------CIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAI 221
           + ++H+NV+  +   T   +L       +VT  M    + + +  QK        L   I
Sbjct: 99  KHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMG-ADLNNIVKCQKLTDDHVQFLIYQI 157
Query: 222 DVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAETGTYRWMA 281
              +G+ Y+H  +IIHRDLK +NL ++E+  +K+ DFG+AR       MT    T  + A
Sbjct: 158 --LRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLAR--HTDDEMTGYVATRWYRA 213
Query: 282 PEV-IEHKPYDYKADVFSFGIALWELLTGELPYAG 315
           PE+ +    Y+   D++S G  + ELLTG   + G
Sbjct: 214 PEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPG 248

>pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360

Iteration: 1
 Score = 77.8 bits (190), Expect = 9e-15,   Method: Compositional matrix adjust.
 Identities = 61/215 (28%), Positives = 103/215 (47%), Gaps = 15/215 (6%)
Query: 110 VWEIDAKQLKIECKVASGSYGDLYKG--TYCSQEVAIKVLKPECVNTEMLKEFSQEVYIM 167
           +WE+  +   +   V SG+YG +     T     VA+K L     +    K   +E+ ++
Sbjct: 17  IWEVPERYQNL-SPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLL 75
Query: 168 RKIRHKNVVQFIGACTRPPNL------CIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAI 221
           + ++H+NV+  +   T   +L       +VT  M    + + +  QK        L   I
Sbjct: 76  KHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMG-ADLNNIVKCQKLTDDHVQFLIYQI 134
Query: 222 DVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAETGTYRWMA 281
              +G+ Y+H  +IIHRDLK +NL ++E+  +K+ DFG+AR       MT    T  + A
Sbjct: 135 --LRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLAR--HTDDEMTGYVATRWYRA 190
Query: 282 PEV-IEHKPYDYKADVFSFGIALWELLTGELPYAG 315
           PE+ +    Y+   D++S G  + ELLTG   + G
Sbjct: 191 PEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPG 225

>pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359

Iteration: 1
 Score = 77.8 bits (190), Expect = 9e-15,   Method: Compositional matrix adjust.
 Identities = 61/215 (28%), Positives = 103/215 (47%), Gaps = 15/215 (6%)
Query: 110 VWEIDAKQLKIECKVASGSYGDLYKG--TYCSQEVAIKVLKPECVNTEMLKEFSQEVYIM 167
           +WE+  +   +   V SG+YG +     T     VA+K L     +    K   +E+ ++
Sbjct: 22  IWEVPERYQNL-SPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLL 80
Query: 168 RKIRHKNVVQFIGACTRPPNL------CIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAI 221
           + ++H+NV+  +   T   +L       +VT  M    + + +  QK        L   I
Sbjct: 81  KHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMG-ADLNNIVKCQKLTDDHVQFLIYQI 139
Query: 222 DVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAETGTYRWMA 281
              +G+ Y+H  +IIHRDLK +NL ++E+  +K+ DFG+AR       MT    T  + A
Sbjct: 140 --LRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLAR--HTDDEMTGYVATRWYRA 195
Query: 282 PEV-IEHKPYDYKADVFSFGIALWELLTGELPYAG 315
           PE+ +    Y+   D++S G  + ELLTG   + G
Sbjct: 196 PEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPG 230

>pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366

Iteration: 1
 Score = 77.8 bits (190), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 61/215 (28%), Positives = 103/215 (47%), Gaps = 15/215 (6%)
Query: 110 VWEIDAKQLKIECKVASGSYGDLYKG--TYCSQEVAIKVLKPECVNTEMLKEFSQEVYIM 167
           +WE+  +   +   V SG+YG +     T     VA+K L     +    K   +E+ ++
Sbjct: 23  IWEVPERYQNL-SPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLL 81
Query: 168 RKIRHKNVVQFIGACTRPPNL------CIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAI 221
           + ++H+NV+  +   T   +L       +VT  M    + + +  QK        L   I
Sbjct: 82  KHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMG-ADLNNIVKCQKLTDDHVQFLIYQI 140
Query: 222 DVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAETGTYRWMA 281
              +G+ Y+H  +IIHRDLK +NL ++E+  +K+ DFG+AR       MT    T  + A
Sbjct: 141 --LRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLAR--HTDDEMTGYVATRWYRA 196
Query: 282 PEV-IEHKPYDYKADVFSFGIALWELLTGELPYAG 315
           PE+ +    Y+   D++S G  + ELLTG   + G
Sbjct: 197 PEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPG 231

>pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372

Iteration: 1
 Score = 77.8 bits (190), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 61/215 (28%), Positives = 103/215 (47%), Gaps = 15/215 (6%)
Query: 110 VWEIDAKQLKIECKVASGSYGDLYKG--TYCSQEVAIKVLKPECVNTEMLKEFSQEVYIM 167
           +WE+  +   +   V SG+YG +     T     VA+K L     +    K   +E+ ++
Sbjct: 29  IWEVPERYQNL-SPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLL 87
Query: 168 RKIRHKNVVQFIGACTRPPNL------CIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAI 221
           + ++H+NV+  +   T   +L       +VT  M    + + +  QK        L   I
Sbjct: 88  KHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMG-ADLNNIVKCQKLTDDHVQFLIYQI 146
Query: 222 DVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAETGTYRWMA 281
              +G+ Y+H  +IIHRDLK +NL ++E+  +K+ DFG+AR       MT    T  + A
Sbjct: 147 --LRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLAR--HTDDEMTGYVATRWYRA 202
Query: 282 PEV-IEHKPYDYKADVFSFGIALWELLTGELPYAG 315
           PE+ +    Y+   D++S G  + ELLTG   + G
Sbjct: 203 PEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPG 237

>pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362

Iteration: 1
 Score = 77.8 bits (190), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 61/215 (28%), Positives = 103/215 (47%), Gaps = 15/215 (6%)
Query: 110 VWEIDAKQLKIECKVASGSYGDLYKG--TYCSQEVAIKVLKPECVNTEMLKEFSQEVYIM 167
           +WE+  +   +   V SG+YG +     T     VA+K L     +    K   +E+ ++
Sbjct: 19  IWEVPERYQNL-SPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLL 77
Query: 168 RKIRHKNVVQFIGACTRPPNL------CIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAI 221
           + ++H+NV+  +   T   +L       +VT  M    + + +  QK        L   I
Sbjct: 78  KHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMG-ADLNNIVKCQKLTDDHVQFLIYQI 136
Query: 222 DVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAETGTYRWMA 281
              +G+ Y+H  +IIHRDLK +NL ++E+  +K+ DFG+AR       MT    T  + A
Sbjct: 137 --LRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLAR--HTDDEMTGYVATRWYRA 192
Query: 282 PEV-IEHKPYDYKADVFSFGIALWELLTGELPYAG 315
           PE+ +    Y+   D++S G  + ELLTG   + G
Sbjct: 193 PEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPG 227

>pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372

Iteration: 1
 Score = 77.8 bits (190), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 61/215 (28%), Positives = 103/215 (47%), Gaps = 15/215 (6%)
Query: 110 VWEIDAKQLKIECKVASGSYGDLYKG--TYCSQEVAIKVLKPECVNTEMLKEFSQEVYIM 167
           +WE+  +   +   V SG+YG +     T     VA+K L     +    K   +E+ ++
Sbjct: 29  IWEVPERYQNL-SPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLL 87
Query: 168 RKIRHKNVVQFIGACTRPPNL------CIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAI 221
           + ++H+NV+  +   T   +L       +VT  M    + + +  QK        L   I
Sbjct: 88  KHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMG-ADLNNIVKCQKLTDDHVQFLIYQI 146
Query: 222 DVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAETGTYRWMA 281
              +G+ Y+H  +IIHRDLK +NL ++E+  +K+ DFG+AR       MT    T  + A
Sbjct: 147 --LRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLAR--HTDDEMTGYVATRWYRA 202
Query: 282 PEV-IEHKPYDYKADVFSFGIALWELLTGELPYAG 315
           PE+ +    Y+   D++S G  + ELLTG   + G
Sbjct: 203 PEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPG 237

>pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371

Iteration: 1
 Score = 77.8 bits (190), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 61/215 (28%), Positives = 103/215 (47%), Gaps = 15/215 (6%)
Query: 110 VWEIDAKQLKIECKVASGSYGDLYKG--TYCSQEVAIKVLKPECVNTEMLKEFSQEVYIM 167
           +WE+  +   +   V SG+YG +     T     VA+K L     +    K   +E+ ++
Sbjct: 28  IWEVPERYQNL-SPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLL 86
Query: 168 RKIRHKNVVQFIGACTRPPNL------CIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAI 221
           + ++H+NV+  +   T   +L       +VT  M    + + +  QK        L   I
Sbjct: 87  KHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMG-ADLNNIVKCQKLTDDHVQFLIYQI 145
Query: 222 DVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAETGTYRWMA 281
              +G+ Y+H  +IIHRDLK +NL ++E+  +K+ DFG+AR       MT    T  + A
Sbjct: 146 --LRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLAR--HTDDEMTGYVATRWYRA 201
Query: 282 PEV-IEHKPYDYKADVFSFGIALWELLTGELPYAG 315
           PE+ +    Y+   D++S G  + ELLTG   + G
Sbjct: 202 PEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPG 236

>pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366

Iteration: 1
 Score = 77.8 bits (190), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 61/215 (28%), Positives = 103/215 (47%), Gaps = 15/215 (6%)
Query: 110 VWEIDAKQLKIECKVASGSYGDLYKG--TYCSQEVAIKVLKPECVNTEMLKEFSQEVYIM 167
           +WE+  +   +   V SG+YG +     T     VA+K L     +    K   +E+ ++
Sbjct: 23  IWEVPERYQNL-SPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLL 81
Query: 168 RKIRHKNVVQFIGACTRPPNL------CIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAI 221
           + ++H+NV+  +   T   +L       +VT  M    + + +  QK        L   I
Sbjct: 82  KHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMG-ADLNNIVKCQKLTDDHVQFLIYQI 140
Query: 222 DVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAETGTYRWMA 281
              +G+ Y+H  +IIHRDLK +NL ++E+  +K+ DFG+AR       MT    T  + A
Sbjct: 141 --LRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLAR--HTDDEMTGYVATRWYRA 196
Query: 282 PEV-IEHKPYDYKADVFSFGIALWELLTGELPYAG 315
           PE+ +    Y+   D++S G  + ELLTG   + G
Sbjct: 197 PEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPG 231

>pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360

Iteration: 1
 Score = 77.8 bits (190), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 61/215 (28%), Positives = 103/215 (47%), Gaps = 15/215 (6%)
Query: 110 VWEIDAKQLKIECKVASGSYGDLYKG--TYCSQEVAIKVLKPECVNTEMLKEFSQEVYIM 167
           +WE+  +   +   V SG+YG +     T     VA+K L     +    K   +E+ ++
Sbjct: 17  IWEVPERYQNL-SPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLL 75
Query: 168 RKIRHKNVVQFIGACTRPPNL------CIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAI 221
           + ++H+NV+  +   T   +L       +VT  M    + + +  QK        L   I
Sbjct: 76  KHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMG-ADLNNIVKCQKLTDDHVQFLIYQI 134
Query: 222 DVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAETGTYRWMA 281
              +G+ Y+H  +IIHRDLK +NL ++E+  +K+ DFG+AR       MT    T  + A
Sbjct: 135 --LRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLAR--HTDDEMTGYVATRWYRA 190
Query: 282 PEV-IEHKPYDYKADVFSFGIALWELLTGELPYAG 315
           PE+ +    Y+   D++S G  + ELLTG   + G
Sbjct: 191 PEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPG 225

>pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379

Iteration: 1
 Score = 77.8 bits (190), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 61/215 (28%), Positives = 103/215 (47%), Gaps = 15/215 (6%)
Query: 110 VWEIDAKQLKIECKVASGSYGDLYKG--TYCSQEVAIKVLKPECVNTEMLKEFSQEVYIM 167
           +WE+  +   +   V SG+YG +     T     VA+K L     +    K   +E+ ++
Sbjct: 36  IWEVPERYQNL-SPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLL 94
Query: 168 RKIRHKNVVQFIGACTRPPNL------CIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAI 221
           + ++H+NV+  +   T   +L       +VT  M    + + +  QK        L   I
Sbjct: 95  KHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMG-ADLNNIVKCQKLTDDHVQFLIYQI 153
Query: 222 DVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAETGTYRWMA 281
              +G+ Y+H  +IIHRDLK +NL ++E+  +K+ DFG+AR       MT    T  + A
Sbjct: 154 --LRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLAR--HTDDEMTGYVATRWYRA 209
Query: 282 PEV-IEHKPYDYKADVFSFGIALWELLTGELPYAG 315
           PE+ +    Y+   D++S G  + ELLTG   + G
Sbjct: 210 PEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPG 244

>pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362

Iteration: 1
 Score = 77.8 bits (190), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 61/215 (28%), Positives = 103/215 (47%), Gaps = 15/215 (6%)
Query: 110 VWEIDAKQLKIECKVASGSYGDLYKG--TYCSQEVAIKVLKPECVNTEMLKEFSQEVYIM 167
           +WE+  +   +   V SG+YG +     T     VA+K L     +    K   +E+ ++
Sbjct: 19  IWEVPERYQNL-SPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLL 77
Query: 168 RKIRHKNVVQFIGACTRPPNL------CIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAI 221
           + ++H+NV+  +   T   +L       +VT  M    + + +  QK        L   I
Sbjct: 78  KHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMG-ADLNNIVKCQKLTDDHVQFLIYQI 136
Query: 222 DVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAETGTYRWMA 281
              +G+ Y+H  +IIHRDLK +NL ++E+  +K+ DFG+AR       MT    T  + A
Sbjct: 137 --LRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLAR--HTDDEMTGYVATRWYRA 192
Query: 282 PEV-IEHKPYDYKADVFSFGIALWELLTGELPYAG 315
           PE+ +    Y+   D++S G  + ELLTG   + G
Sbjct: 193 PEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPG 227

>pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360

Iteration: 1
 Score = 77.8 bits (190), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 61/215 (28%), Positives = 103/215 (47%), Gaps = 15/215 (6%)
Query: 110 VWEIDAKQLKIECKVASGSYGDLYKG--TYCSQEVAIKVLKPECVNTEMLKEFSQEVYIM 167
           +WE+  +   +   V SG+YG +     T     VA+K L     +    K   +E+ ++
Sbjct: 17  IWEVPERYQNL-SPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLL 75
Query: 168 RKIRHKNVVQFIGACTRPPNL------CIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAI 221
           + ++H+NV+  +   T   +L       +VT  M    + + +  QK        L   I
Sbjct: 76  KHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMG-ADLNNIVKCQKLTDDHVQFLIYQI 134
Query: 222 DVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAETGTYRWMA 281
              +G+ Y+H  +IIHRDLK +NL ++E+  +K+ DFG+AR       MT    T  + A
Sbjct: 135 --LRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLAR--HTDDEMTGYVATRWYRA 190
Query: 282 PEV-IEHKPYDYKADVFSFGIALWELLTGELPYAG 315
           PE+ +    Y+   D++S G  + ELLTG   + G
Sbjct: 191 PEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPG 225

>pdb|2WTK|C Chain C, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 305

Iteration: 1
 Score = 77.8 bits (190), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 63/253 (24%), Positives = 112/253 (44%), Gaps = 17/253 (6%)
Query: 124 VASGSYGD----LYKGTYCSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFI 179
           +  GSYG     L   T C + V I   K             +E+ ++R++RHKNV+Q +
Sbjct: 13  LGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLV 72
Query: 180 GAC--TRPPNLCIVTEFMARG--SIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNI 235
                     + +V E+   G   + D + +++  F +         +  G+ YLH   I
Sbjct: 73  DVLYNEEKQKMYMVMEYCVCGMQEMLDSVPEKR--FPVCQAHGYFCQLIDGLEYLHSQGI 130
Query: 236 IHRDLKTANLLMDENGVVKVADFGVARVQ---AQSGVMTAETGTYRWMAPEVIE--HKPY 290
           +H+D+K  NLL+   G +K++  GVA      A         G+  +  PE+        
Sbjct: 131 VHKDIKPGNLLLTTGGTLKISALGVAEALHPFAADDTCRTSQGSPAFQPPEIANGLDTFS 190
Query: 291 DYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRLAELLERCW 350
            +K D++S G+ L+ + TG  P+ G    +    + + S    IP    P L++LL+   
Sbjct: 191 GFKVDIWSAGVTLYNITTGLYPFEGDNIYKLFENIGKGSY--AIPGDCGPPLSDLLKGML 248
Query: 351 QHDPTQRPNFSQI 363
           +++P +R +  QI
Sbjct: 249 EYEPAKRFSIRQI 261

>pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351

Iteration: 1
 Score = 77.8 bits (190), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 61/215 (28%), Positives = 103/215 (47%), Gaps = 15/215 (6%)
Query: 110 VWEIDAKQLKIECKVASGSYGDLYKG--TYCSQEVAIKVLKPECVNTEMLKEFSQEVYIM 167
           +WE+  +   +   V SG+YG +     T     VA+K L     +    K   +E+ ++
Sbjct: 14  IWEVPERYQNL-SPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLL 72
Query: 168 RKIRHKNVVQFIGACTRPPNL------CIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAI 221
           + ++H+NV+  +   T   +L       +VT  M    + + +  QK        L   I
Sbjct: 73  KHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMG-ADLNNIVKCQKLTDDHVQFLIYQI 131
Query: 222 DVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAETGTYRWMA 281
              +G+ Y+H  +IIHRDLK +NL ++E+  +K+ DFG+AR       MT    T  + A
Sbjct: 132 --LRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLAR--HTDDEMTGYVATRWYRA 187
Query: 282 PEV-IEHKPYDYKADVFSFGIALWELLTGELPYAG 315
           PE+ +    Y+   D++S G  + ELLTG   + G
Sbjct: 188 PEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPG 222

>pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354

Iteration: 1
 Score = 77.8 bits (190), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 61/215 (28%), Positives = 103/215 (47%), Gaps = 15/215 (6%)
Query: 110 VWEIDAKQLKIECKVASGSYGDLYKG--TYCSQEVAIKVLKPECVNTEMLKEFSQEVYIM 167
           +WE+  +   +   V SG+YG +     T     VA+K L     +    K   +E+ ++
Sbjct: 17  IWEVPERYQNL-SPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLL 75
Query: 168 RKIRHKNVVQFIGACTRPPNL------CIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAI 221
           + ++H+NV+  +   T   +L       +VT  M    + + +  QK        L   I
Sbjct: 76  KHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMG-ADLNNIVKCQKLTDDHVQFLIYQI 134
Query: 222 DVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAETGTYRWMA 281
              +G+ Y+H  +IIHRDLK +NL ++E+  +K+ DFG+AR       MT    T  + A
Sbjct: 135 --LRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLAR--HTDDEMTGYVATRWYRA 190
Query: 282 PEV-IEHKPYDYKADVFSFGIALWELLTGELPYAG 315
           PE+ +    Y+   D++S G  + ELLTG   + G
Sbjct: 191 PEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPG 225

>pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360

Iteration: 1
 Score = 77.8 bits (190), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 61/215 (28%), Positives = 103/215 (47%), Gaps = 15/215 (6%)
Query: 110 VWEIDAKQLKIECKVASGSYGDLYKG--TYCSQEVAIKVLKPECVNTEMLKEFSQEVYIM 167
           +WE+  +   +   V SG+YG +     T     VA+K L     +    K   +E+ ++
Sbjct: 17  IWEVPERYQNL-SPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLL 75
Query: 168 RKIRHKNVVQFIGACTRPPNL------CIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAI 221
           + ++H+NV+  +   T   +L       +VT  M    + + +  QK        L   I
Sbjct: 76  KHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMG-ADLNNIVKCQKLTDDHVQFLIYQI 134
Query: 222 DVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAETGTYRWMA 281
              +G+ Y+H  +IIHRDLK +NL ++E+  +K+ DFG+AR       MT    T  + A
Sbjct: 135 --LRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLAR--HTDDEMTGYVATRWYRA 190
Query: 282 PEV-IEHKPYDYKADVFSFGIALWELLTGELPYAG 315
           PE+ +    Y+   D++S G  + ELLTG   + G
Sbjct: 191 PEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPG 225

>pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350

Iteration: 1
 Score = 77.8 bits (190), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 61/215 (28%), Positives = 103/215 (47%), Gaps = 15/215 (6%)
Query: 110 VWEIDAKQLKIECKVASGSYGDLYKG--TYCSQEVAIKVLKPECVNTEMLKEFSQEVYIM 167
           +WE+  +   +   V SG+YG +     T     VA+K L     +    K   +E+ ++
Sbjct: 15  IWEVPERYQNL-SPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLL 73
Query: 168 RKIRHKNVVQFIGACTRPPNL------CIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAI 221
           + ++H+NV+  +   T   +L       +VT  M    + + +  QK        L   I
Sbjct: 74  KHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMG-ADLNNIVKCQKLTDDHVQFLIYQI 132
Query: 222 DVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAETGTYRWMA 281
              +G+ Y+H  +IIHRDLK +NL ++E+  +K+ DFG+AR       MT    T  + A
Sbjct: 133 --LRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLAR--HTDDEMTGYVATRWYRA 188
Query: 282 PEV-IEHKPYDYKADVFSFGIALWELLTGELPYAG 315
           PE+ +    Y+   D++S G  + ELLTG   + G
Sbjct: 189 PEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPG 223

>pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348

Iteration: 1
 Score = 77.8 bits (190), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 61/215 (28%), Positives = 103/215 (47%), Gaps = 15/215 (6%)
Query: 110 VWEIDAKQLKIECKVASGSYGDLYKG--TYCSQEVAIKVLKPECVNTEMLKEFSQEVYIM 167
           +WE+  +   +   V SG+YG +     T     VA+K L     +    K   +E+ ++
Sbjct: 13  IWEVPERYQNL-SPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLL 71
Query: 168 RKIRHKNVVQFIGACTRPPNL------CIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAI 221
           + ++H+NV+  +   T   +L       +VT  M    + + +  QK        L   I
Sbjct: 72  KHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMG-ADLNNIVKCQKLTDDHVQFLIYQI 130
Query: 222 DVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAETGTYRWMA 281
              +G+ Y+H  +IIHRDLK +NL ++E+  +K+ DFG+AR       MT    T  + A
Sbjct: 131 --LRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLAR--HTDDEMTGYVATRWYRA 186
Query: 282 PEV-IEHKPYDYKADVFSFGIALWELLTGELPYAG 315
           PE+ +    Y+   D++S G  + ELLTG   + G
Sbjct: 187 PEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPG 221

>pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365

Iteration: 1
 Score = 77.8 bits (190), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 61/215 (28%), Positives = 103/215 (47%), Gaps = 15/215 (6%)
Query: 110 VWEIDAKQLKIECKVASGSYGDLYKG--TYCSQEVAIKVLKPECVNTEMLKEFSQEVYIM 167
           +WE+  +   +   V SG+YG +     T     VA+K L     +    K   +E+ ++
Sbjct: 22  IWEVPERYQNL-SPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLL 80
Query: 168 RKIRHKNVVQFIGACTRPPNL------CIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAI 221
           + ++H+NV+  +   T   +L       +VT  M    + + +  QK        L   I
Sbjct: 81  KHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMG-ADLNNIVKCQKLTDDHVQFLIYQI 139
Query: 222 DVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAETGTYRWMA 281
              +G+ Y+H  +IIHRDLK +NL ++E+  +K+ DFG+AR       MT    T  + A
Sbjct: 140 --LRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLAR--HTDDEMTGYVATRWYRA 195
Query: 282 PEV-IEHKPYDYKADVFSFGIALWELLTGELPYAG 315
           PE+ +    Y+   D++S G  + ELLTG   + G
Sbjct: 196 PEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPG 230

>pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360

Iteration: 1
 Score = 77.8 bits (190), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 61/215 (28%), Positives = 103/215 (47%), Gaps = 15/215 (6%)
Query: 110 VWEIDAKQLKIECKVASGSYGDLYKG--TYCSQEVAIKVLKPECVNTEMLKEFSQEVYIM 167
           +WE+  +   +   V SG+YG +     T     VA+K L     +    K   +E+ ++
Sbjct: 17  IWEVPERYQNL-SPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLL 75
Query: 168 RKIRHKNVVQFIGACTRPPNL------CIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAI 221
           + ++H+NV+  +   T   +L       +VT  M    + + +  QK        L   I
Sbjct: 76  KHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMG-ADLNNIVKCQKLTDDHVQFLIYQI 134
Query: 222 DVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAETGTYRWMA 281
              +G+ Y+H  +IIHRDLK +NL ++E+  +K+ DFG+AR       MT    T  + A
Sbjct: 135 --LRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLAR--HTDDEMTGYVATRWYRA 190
Query: 282 PEV-IEHKPYDYKADVFSFGIALWELLTGELPYAG 315
           PE+ +    Y+   D++S G  + ELLTG   + G
Sbjct: 191 PEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPG 225

>pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362

Iteration: 1
 Score = 77.8 bits (190), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 61/215 (28%), Positives = 103/215 (47%), Gaps = 15/215 (6%)
Query: 110 VWEIDAKQLKIECKVASGSYGDLYKG--TYCSQEVAIKVLKPECVNTEMLKEFSQEVYIM 167
           +WE+  +   +   V SG+YG +     T     VA+K L     +    K   +E+ ++
Sbjct: 19  IWEVPERYQNL-SPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLL 77
Query: 168 RKIRHKNVVQFIGACTRPPNL------CIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAI 221
           + ++H+NV+  +   T   +L       +VT  M    + + +  QK        L   I
Sbjct: 78  KHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMG-ADLNNIVKCQKLTDDHVQFLIYQI 136
Query: 222 DVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAETGTYRWMA 281
              +G+ Y+H  +IIHRDLK +NL ++E+  +K+ DFG+AR       MT    T  + A
Sbjct: 137 --LRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLAR--HTDDEMTGYVATRWYRA 192
Query: 282 PEV-IEHKPYDYKADVFSFGIALWELLTGELPYAG 315
           PE+ +    Y+   D++S G  + ELLTG   + G
Sbjct: 193 PEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPG 227

>pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359

Iteration: 1
 Score = 77.8 bits (190), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 61/215 (28%), Positives = 103/215 (47%), Gaps = 15/215 (6%)
Query: 110 VWEIDAKQLKIECKVASGSYGDLYKG--TYCSQEVAIKVLKPECVNTEMLKEFSQEVYIM 167
           +WE+  +   +   V SG+YG +     T     VA+K L     +    K   +E+ ++
Sbjct: 16  IWEVPERYQNL-SPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLL 74
Query: 168 RKIRHKNVVQFIGACTRPPNL------CIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAI 221
           + ++H+NV+  +   T   +L       +VT  M    + + +  QK        L   I
Sbjct: 75  KHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMG-ADLNNIVKCQKLTDDHVQFLIYQI 133
Query: 222 DVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAETGTYRWMA 281
              +G+ Y+H  +IIHRDLK +NL ++E+  +K+ DFG+AR       MT    T  + A
Sbjct: 134 --LRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLAR--HTDDEMTGYVATRWYRA 189
Query: 282 PEV-IEHKPYDYKADVFSFGIALWELLTGELPYAG 315
           PE+ +    Y+   D++S G  + ELLTG   + G
Sbjct: 190 PEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPG 224

>pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 77.8 bits (190), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 59/218 (27%), Positives = 102/218 (46%), Gaps = 20/218 (9%)
Query: 140 QEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNL------CIVTE 193
           + VAIK L     N    K   +E+ +M+ + HKN++  +   T   +L       IV E
Sbjct: 50  RNVAIKKLSRPFQNQTHAKRAYRELVLMKVVNHKNIIGLLNVFTPQKSLEEFQDVYIVME 109
Query: 194 FMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVV 253
            M   ++   +  +    +++ LL   +    G+ +LH   IIHRDLK +N+++  +  +
Sbjct: 110 LMD-ANLSQVIQMELDHERMSYLLYQML---VGIKHLHSAGIIHRDLKPSNIVVKSDATL 165
Query: 254 KVADFGVARVQAQSGVMTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPY 313
           K+ DFG+AR    S +MT    T  + APEVI    Y    D++S G  + E++ G + +
Sbjct: 166 KILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLF 225
Query: 314 AGLTPLQAAVGVVQ----------KSLRPTIPKHAHPR 341
            G   +     V++          K L+PT+  +   R
Sbjct: 226 PGTDHIDQWNKVIEQLGTPSPEFMKKLQPTVRTYVENR 263

>pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365

Iteration: 1
 Score = 77.8 bits (190), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 60/215 (27%), Positives = 103/215 (47%), Gaps = 15/215 (6%)
Query: 110 VWEIDAKQLKIECKVASGSYGDLYKG--TYCSQEVAIKVLKPECVNTEMLKEFSQEVYIM 167
           +WE+  +   +   + SG+YG +     T     VA+K L     +    K   +E+ ++
Sbjct: 22  IWEVPERYQNL-SPIGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLL 80
Query: 168 RKIRHKNVVQFIGACTRPPNL------CIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAI 221
           + ++H+NV+  +   T   +L       +VT  M    + + +  QK        L   I
Sbjct: 81  KHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMG-ADLNNIVKCQKLTDDHVQFLIYQI 139
Query: 222 DVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAETGTYRWMA 281
              +G+ Y+H  +IIHRDLK +NL ++E+  +K+ DFG+AR       MT    T  + A
Sbjct: 140 --LRGLKYIHSADIIHRDLKPSNLAVNEDXELKILDFGLAR--HTDDEMTGYVATRWYRA 195
Query: 282 PEV-IEHKPYDYKADVFSFGIALWELLTGELPYAG 315
           PE+ +    Y+   D++S G  + ELLTG   + G
Sbjct: 196 PEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPG 230

>pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349

Iteration: 1
 Score = 77.8 bits (190), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 61/215 (28%), Positives = 103/215 (47%), Gaps = 15/215 (6%)
Query: 110 VWEIDAKQLKIECKVASGSYGDLYKG--TYCSQEVAIKVLKPECVNTEMLKEFSQEVYIM 167
           +WE+  +   +   V SG+YG +     T     VA+K L     +    K   +E+ ++
Sbjct: 14  IWEVPERYQNL-SPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLL 72
Query: 168 RKIRHKNVVQFIGACTRPPNL------CIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAI 221
           + ++H+NV+  +   T   +L       +VT  M    + + +  QK        L   I
Sbjct: 73  KHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMG-ADLNNIVKCQKLTDDHVQFLIYQI 131
Query: 222 DVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAETGTYRWMA 281
              +G+ Y+H  +IIHRDLK +NL ++E+  +K+ DFG+AR       MT    T  + A
Sbjct: 132 --LRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLAR--HTDDEMTGYVATRWYRA 187
Query: 282 PEV-IEHKPYDYKADVFSFGIALWELLTGELPYAG 315
           PE+ +    Y+   D++S G  + ELLTG   + G
Sbjct: 188 PEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPG 222

>pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360

Iteration: 1
 Score = 77.8 bits (190), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 61/215 (28%), Positives = 103/215 (47%), Gaps = 15/215 (6%)
Query: 110 VWEIDAKQLKIECKVASGSYGDLYKG--TYCSQEVAIKVLKPECVNTEMLKEFSQEVYIM 167
           +WE+  +   +   V SG+YG +     T     VA+K L     +    K   +E+ ++
Sbjct: 17  IWEVPERYQNL-SPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLL 75
Query: 168 RKIRHKNVVQFIGACTRPPNL------CIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAI 221
           + ++H+NV+  +   T   +L       +VT  M    + + +  QK        L   I
Sbjct: 76  KHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMG-ADLNNIVKCQKLTDDHVQFLIYQI 134
Query: 222 DVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAETGTYRWMA 281
              +G+ Y+H  +IIHRDLK +NL ++E+  +K+ DFG+AR       MT    T  + A
Sbjct: 135 --LRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLAR--HTDDEMTGYVATRWYRA 190
Query: 282 PEV-IEHKPYDYKADVFSFGIALWELLTGELPYAG 315
           PE+ +    Y+   D++S G  + ELLTG   + G
Sbjct: 191 PEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPG 225

>pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367

Iteration: 1
 Score = 77.4 bits (189), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 61/215 (28%), Positives = 103/215 (47%), Gaps = 15/215 (6%)
Query: 110 VWEIDAKQLKIECKVASGSYGDLYKG--TYCSQEVAIKVLKPECVNTEMLKEFSQEVYIM 167
           +WE+  +   +   V SG+YG +     T     VA+K L     +    K   +E+ ++
Sbjct: 24  IWEVPERYQNL-SPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLL 82
Query: 168 RKIRHKNVVQFIGACTRPPNL------CIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAI 221
           + ++H+NV+  +   T   +L       +VT  M    + + +  QK        L   I
Sbjct: 83  KHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMG-ADLNNIVKCQKLTDDHVQFLIYQI 141
Query: 222 DVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAETGTYRWMA 281
              +G+ Y+H  +IIHRDLK +NL ++E+  +K+ DFG+AR       MT    T  + A
Sbjct: 142 --LRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLAR--HTDDEMTGYVATRWYRA 197
Query: 282 PEV-IEHKPYDYKADVFSFGIALWELLTGELPYAG 315
           PE+ +    Y+   D++S G  + ELLTG   + G
Sbjct: 198 PEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPG 232

>pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 77.4 bits (189), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 57/222 (25%), Positives = 102/222 (45%), Gaps = 28/222 (12%)
Query: 140 QEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVTEFMARGS 199
           + VAIK L     N    K   +E+ +M+ + HKN++  +   T   +L    EF     
Sbjct: 50  RNVAIKKLSRPFQNQTHAKRAYRELVLMKVVNHKNIIGLLNVFTPQKSL---EEFQDVYI 106
Query: 200 IYDFLHKQKGVFQLTSLLKVAIDVSK----------GMNYLHQNNIIHRDLKTANLLMDE 249
           + + +        L+ ++++ +D  +          G+ +LH   IIHRDLK +N+++  
Sbjct: 107 VMELMDAN-----LSQVIQMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKS 161
Query: 250 NGVVKVADFGVARVQAQSGVMTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTG 309
           +  +K+ DFG+AR    S +MT    T  + APEVI    Y    D++S G  + E++ G
Sbjct: 162 DATLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKG 221
Query: 310 ELPYAGLTPLQAAVGVVQ----------KSLRPTIPKHAHPR 341
            + + G   +     V++          K L+PT+  +   R
Sbjct: 222 GVLFPGTDHIDQWNKVIEQLGTPSPEFMKKLQPTVRTYVENR 263

>pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380

Iteration: 1
 Score = 77.4 bits (189), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 60/215 (27%), Positives = 102/215 (47%), Gaps = 15/215 (6%)
Query: 110 VWEIDAKQLKIECKVASGSYGDLYKG--TYCSQEVAIKVLKPECVNTEMLKEFSQEVYIM 167
           +WE+  +   +   V SG+YG +     T     VA+K L     +    K   +E+ ++
Sbjct: 37  IWEVPERYQNL-SPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLL 95
Query: 168 RKIRHKNVVQFIGACTRPPNL------CIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAI 221
           + ++H+NV+  +   T   +L       +VT  M    + + +  QK        L   I
Sbjct: 96  KHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMG-ADLNNIVKCQKLTDDHVQFLIYQI 154
Query: 222 DVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAETGTYRWMA 281
              +G+ Y+H  +IIHRDLK +NL ++E+  +K+ DFG+AR       M     T  + A
Sbjct: 155 --LRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLAR--HTDDEMXGXVATRWYRA 210
Query: 282 PEV-IEHKPYDYKADVFSFGIALWELLTGELPYAG 315
           PE+ +    Y+   D++S G  + ELLTG   + G
Sbjct: 211 PEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPG 245

>pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303

Iteration: 1
 Score = 77.4 bits (189), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 65/270 (24%), Positives = 118/270 (43%), Gaps = 42/270 (15%)
Query: 124 VASGSYGDLYKGTYC--SQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQF--- 178
           +  G++G + K      S+  AIK ++      E L     EV ++  + H+ VV++   
Sbjct: 14  LGQGAFGQVVKARNALDSRYYAIKKIRH---TEEKLSTILSEVMLLASLNHQYVVRYYAA 70
Query: 179 ----------IGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMN 228
                     + A  +   L I  E+    ++YD +H +    Q     ++   + + ++
Sbjct: 71  WLERRNFVKPMTAVKKKSTLFIQMEYCENRTLYDLIHSENLNQQRDEYWRLFRQILEALS 130
Query: 229 YLHQNNIIHRDLKTANLLMDENGVVKVADFGVAR---------------VQAQSGVMTAE 273
           Y+H   IIHRDLK  N+ +DE+  VK+ DFG+A+               +   S  +T+ 
Sbjct: 131 YIHSQGIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQNLPGSSDNLTSA 190
Query: 274 TGTYRWMAPEVIEHK-PYDYKADVFSFGIALWELL----TGELPYAGLTPLQAAVGVVQK 328
            GT  ++A EV++    Y+ K D++S GI  +E++    TG      L  L++    V  
Sbjct: 191 IGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIYPFSTGMERVNILKKLRS----VSI 246
Query: 329 SLRPTIPKHAHPRLAELLERCWQHDPTQRP 358
              P    +      +++     HDP +RP
Sbjct: 247 EFPPDFDDNKMKVEKKIIRLLIDHDPNKRP 276

>pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 61/220 (27%), Positives = 104/220 (47%), Gaps = 25/220 (11%)
Query: 110 VWEIDAKQLKIECKVASGSYGDLYKG--TYCSQEVAIKVLKPECVNTEMLKEFSQEVYIM 167
           +WE+  +   +   V SG+YG +     T     VA+K L     +    K   +E+ ++
Sbjct: 13  IWEVPERYQNL-SPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLL 71
Query: 168 RKIRHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVA------- 220
           + ++H+NV+  +   T   +L    EF     +Y   H       L +++K A       
Sbjct: 72  KHMKHENVIGLLDVFTPARSL---EEF---NDVYLVTHLMGA--DLNNIVKCAKLTDDHV 123
Query: 221 ----IDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAETGT 276
                 + +G+ Y+H  +IIHRDLK +NL ++E+  +K+ DFG+AR       MT    T
Sbjct: 124 QFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLAR--HTDDEMTGYVAT 181
Query: 277 YRWMAPEV-IEHKPYDYKADVFSFGIALWELLTGELPYAG 315
             + APE+ +    Y+   D++S G  + ELLTG   + G
Sbjct: 182 RWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPG 221

>pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 61/242 (25%), Positives = 110/242 (45%), Gaps = 14/242 (5%)
Query: 123 KVASGSYGDLYKGTYCSQEV-AIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGA 181
           K+  G+YG +YK      E  A+K ++ E  +  +     +E+ I+++++H N+V+    
Sbjct: 9   KIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDV 68
Query: 182 CTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLK 241
                 L +V E + +  +   L   +G  +  +     + +  G+ Y H   ++HRDLK
Sbjct: 69  IHTKKRLVLVFEHLDQ-DLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRRVLHRDLK 127
Query: 242 TANLLMDENGVVKVADFGVARVQA-QSGVMTAETGTYRWMAPEVI-EHKPYDYKADVFSF 299
             NLL++  G +K+ADFG+AR         T E  T  + AP+V+   K Y    D++S 
Sbjct: 128 PQNLLINREGELKIADFGLARAFGIPVRKYTHEVVTLWYRAPDVLMGSKKYSTTIDIWSV 187
Query: 300 GIALWELLTGELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRLAELLERCWQHDPTQRPN 359
           G    E++ G   + G++     + + +    P       P + EL        P   PN
Sbjct: 188 GCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPN--SKNWPNVTEL--------PKYDPN 237
Query: 360 FS 361
           F+
Sbjct: 238 FT 239

>pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 57/222 (25%), Positives = 102/222 (45%), Gaps = 28/222 (12%)
Query: 140 QEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVTEFMARGS 199
           + VAIK L     N    K   +E+ +M+ + HKN++  +   T   +L    EF     
Sbjct: 50  RNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSL---EEFQDVYI 106
Query: 200 IYDFLHKQKGVFQLTSLLKVAIDVSK----------GMNYLHQNNIIHRDLKTANLLMDE 249
           + + +        L+ ++++ +D  +          G+ +LH   IIHRDLK +N+++  
Sbjct: 107 VMELMDAN-----LSQVIQMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKS 161
Query: 250 NGVVKVADFGVARVQAQSGVMTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTG 309
           +  +K+ DFG+AR    S +MT    T  + APEVI    Y    D++S G  + E++ G
Sbjct: 162 DATLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKG 221
Query: 310 ELPYAGLTPLQAAVGVVQ----------KSLRPTIPKHAHPR 341
            + + G   +     V++          K L+PT+  +   R
Sbjct: 222 GVLFPGTDHIDQWNKVIEQLGTPSPEFMKKLQPTVRTYVENR 263

>pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 61/242 (25%), Positives = 110/242 (45%), Gaps = 14/242 (5%)
Query: 123 KVASGSYGDLYKGTYCSQEV-AIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGA 181
           K+  G+YG +YK      E  A+K ++ E  +  +     +E+ I+++++H N+V+    
Sbjct: 9   KIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDV 68
Query: 182 CTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLK 241
                 L +V E + +  +   L   +G  +  +     + +  G+ Y H   ++HRDLK
Sbjct: 69  IHTKKRLVLVFEHLDQ-DLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRRVLHRDLK 127
Query: 242 TANLLMDENGVVKVADFGVARVQA-QSGVMTAETGTYRWMAPEVI-EHKPYDYKADVFSF 299
             NLL++  G +K+ADFG+AR         T E  T  + AP+V+   K Y    D++S 
Sbjct: 128 PQNLLINREGELKIADFGLARAFGIPVRKYTHEVVTLWYRAPDVLMGSKKYSTTIDIWSV 187
Query: 300 GIALWELLTGELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRLAELLERCWQHDPTQRPN 359
           G    E++ G   + G++     + + +    P       P + EL        P   PN
Sbjct: 188 GCIFAEMVNGAPLFPGVSEADQLMRIFRILGTPN--SKNWPNVTEL--------PKYDPN 237
Query: 360 FS 361
           F+
Sbjct: 238 FT 239

>pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 65/214 (30%), Positives = 105/214 (49%), Gaps = 15/214 (7%)
Query: 111 WEIDAKQLKIECKVASGSYGDLYKGT--YCSQEVAIKVLKPECVNTEMLKEFSQEVYIMR 168
           WE+ A    ++  V SG+YG +          +VAIK L     +    K   +E+ +++
Sbjct: 21  WEVRAVYRDLQ-PVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLK 79
Query: 169 KIRHKNVVQFIGACTRPPNL------CIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAID 222
            +RH+NV+  +   T    L       +V  FM         H++ G  ++  L+   + 
Sbjct: 80  HMRHENVIGLLDVFTPDETLDDFTDFYLVMPFMGTDLGKLMKHEKLGEDRIQFLVYQML- 138
Query: 223 VSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAETGTYRWMAP 282
             KG+ Y+H   IIHRDLK  NL ++E+  +K+ DFG+AR QA S  M     T  + AP
Sbjct: 139 --KGLRYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLAR-QADSE-MXGXVVTRWYRAP 194
Query: 283 EVIEH-KPYDYKADVFSFGIALWELLTGELPYAG 315
           EVI +   Y    D++S G  + E++TG+  + G
Sbjct: 195 EVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKG 228

>pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288

Iteration: 1
 Score = 76.6 bits (187), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 61/242 (25%), Positives = 110/242 (45%), Gaps = 14/242 (5%)
Query: 123 KVASGSYGDLYKGTYCSQEV-AIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGA 181
           K+  G+YG +YK      E  A+K ++ E  +  +     +E+ I+++++H N+V+    
Sbjct: 9   KIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDV 68
Query: 182 CTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLK 241
                 L +V E + +  +   L   +G  +  +     + +  G+ Y H   ++HRDLK
Sbjct: 69  IHTKKRLVLVFEHLDQ-DLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRRVLHRDLK 127
Query: 242 TANLLMDENGVVKVADFGVARVQA-QSGVMTAETGTYRWMAPEVI-EHKPYDYKADVFSF 299
             NLL++  G +K+ADFG+AR         T E  T  + AP+V+   K Y    D++S 
Sbjct: 128 PQNLLINREGELKIADFGLARAFGIPVRKYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSV 187
Query: 300 GIALWELLTGELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRLAELLERCWQHDPTQRPN 359
           G    E++ G   + G++     + + +    P       P + EL        P   PN
Sbjct: 188 GCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPN--SKNWPNVTEL--------PKYDPN 237
Query: 360 FS 361
           F+
Sbjct: 238 FT 239

>pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360

Iteration: 1
 Score = 76.6 bits (187), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 61/215 (28%), Positives = 102/215 (47%), Gaps = 15/215 (6%)
Query: 110 VWEIDAKQLKIECKVASGSYGDLYKG--TYCSQEVAIKVLKPECVNTEMLKEFSQEVYIM 167
           +WE+  +   +   V SG+YG +     T     VA+K L     +    K   +E+ ++
Sbjct: 17  IWEVPERYQNL-SPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLL 75
Query: 168 RKIRHKNVVQFIGACTRPPNL------CIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAI 221
           + ++H+NV+  +   T   +L       +VT  M    + + +  QK        L   I
Sbjct: 76  KHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMG-ADLNNIVKCQKLTDDHVQFLIYQI 134
Query: 222 DVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAETGTYRWMA 281
              +G+ Y+H  +IIHRDLK +NL ++E+  +K+ DFG+AR           T  YR  A
Sbjct: 135 --LRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMAGFVATRWYR--A 190
Query: 282 PEV-IEHKPYDYKADVFSFGIALWELLTGELPYAG 315
           PE+ +    Y+   D++S G  + ELLTG   + G
Sbjct: 191 PEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPG 225

>pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360

Iteration: 1
 Score = 76.6 bits (187), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 61/215 (28%), Positives = 102/215 (47%), Gaps = 15/215 (6%)
Query: 110 VWEIDAKQLKIECKVASGSYGDLYKG--TYCSQEVAIKVLKPECVNTEMLKEFSQEVYIM 167
           +WE+  +   +   V SG+YG +     T     VA+K L     +    K   +E+ ++
Sbjct: 17  IWEVPERYQNL-SPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLL 75
Query: 168 RKIRHKNVVQFIGACTRPPNL------CIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAI 221
           + ++H+NV+  +   T   +L       +VT  M    + + +  QK        L   I
Sbjct: 76  KHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMG-ADLNNIVKCQKLTDDHVQFLIYQI 134
Query: 222 DVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAETGTYRWMA 281
              +G+ Y+H  +IIHRDLK +NL ++E+  +K+ DFG+AR           T  YR  A
Sbjct: 135 --LRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMAGFVATRWYR--A 190
Query: 282 PEV-IEHKPYDYKADVFSFGIALWELLTGELPYAG 315
           PE+ +    Y+   D++S G  + ELLTG   + G
Sbjct: 191 PEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPG 225

>pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348

Iteration: 1
 Score = 76.6 bits (187), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 61/215 (28%), Positives = 102/215 (47%), Gaps = 15/215 (6%)
Query: 110 VWEIDAKQLKIECKVASGSYGDLYKG--TYCSQEVAIKVLKPECVNTEMLKEFSQEVYIM 167
           +WE+  +   +   V SG+YG +     T     VA+K L     +    K   +E+ ++
Sbjct: 13  IWEVPERYQNL-SPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLL 71
Query: 168 RKIRHKNVVQFIGACTRPPNL------CIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAI 221
           + ++H+NV+  +   T   +L       +VT  M    + + +  QK        L   I
Sbjct: 72  KHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMG-ADLNNIVKCQKLTDDHVQFLIYQI 130
Query: 222 DVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAETGTYRWMA 281
              +G+ Y+H  +IIHRDLK +NL ++E+  +K+ DFG+AR           T  YR  A
Sbjct: 131 --LRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMAGFVATRWYR--A 186
Query: 282 PEV-IEHKPYDYKADVFSFGIALWELLTGELPYAG 315
           PE+ +    Y+   D++S G  + ELLTG   + G
Sbjct: 187 PEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPG 221

>pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348

Iteration: 1
 Score = 76.6 bits (187), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 51/166 (30%), Positives = 85/166 (51%), Gaps = 11/166 (6%)
Query: 159 EFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVTEFMARGSIYDF------LHKQKGVFQ 212
           +F  E+ I+  I+++  +   G  T    + I+ E+M   SI  F      L K    F 
Sbjct: 89  DFKNELQIITDIKNEYCLTCEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFI 148
Query: 213 LTSLLKVAI-DVSKGMNYLH-QNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVM 270
              ++K  I  V    +Y+H + NI HRD+K +N+LMD+NG VK++DFG +       + 
Sbjct: 149 PIQVIKCIIKSVLNSFSYIHNEKNICHRDVKPSNILMDKNGRVKLSDFGESEYMVDKKI- 207
Query: 271 TAETGTYRWMAPEVIEHK-PYD-YKADVFSFGIALWELLTGELPYA 314
               GTY +M PE   ++  Y+  K D++S GI L+ +    +P++
Sbjct: 208 KGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFS 253

>pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302

Iteration: 1
 Score = 76.6 bits (187), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 54/202 (26%), Positives = 101/202 (50%), Gaps = 7/202 (3%)
Query: 119 KIECKVASGSYGDLYKG--TYCSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVV 176
           K+E K+  G+YG +YK       + VA+K ++ +     +     +E+ +++++ H N+V
Sbjct: 10  KVE-KIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIV 68
Query: 177 QFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAI-DVSKGMNYLHQNNI 235
           + +        L +V EF++   + DF+           L+K  +  + +G+ + H + +
Sbjct: 69  KLLDVIHTENKLYLVFEFLSM-DLKDFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRV 127
Query: 236 IHRDLKTANLLMDENGVVKVADFGVARV-QAQSGVMTAETGTYRWMAPEVIEH-KPYDYK 293
           +HRDLK  NLL++  G +K+ADFG+AR           E  T  + APE++   K Y   
Sbjct: 128 LHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKYYSTA 187
Query: 294 ADVFSFGIALWELLTGELPYAG 315
            D++S G    E++T    + G
Sbjct: 188 VDIWSLGCIFAEMVTRRALFPG 209

>pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389

Iteration: 1
 Score = 76.6 bits (187), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 65/248 (26%), Positives = 114/248 (45%), Gaps = 31/248 (12%)
Query: 110 VWEIDAKQLKIECKVASGSYGDLYKGTYCSQ-------EVAIKVLKPECVNTEMLKEFSQ 162
           +WE+  ++ +    V SG+YG +     CS        ++A+K L     +    K   +
Sbjct: 46  IWEV-PERYQTLSPVGSGAYGSV-----CSSYDVKSGLKIAVKKLSRPFQSIIHAKRTYR 99
Query: 163 EVYIMRKIRHKNVVQFIGACTRPPNL------CIVTEFMARGSIYDFLHKQKGVFQLTSL 216
           E+ +++ ++H+NV+  +   T   +L       +VT  M    + + +  QK        
Sbjct: 100 ELRLLKHMKHENVIGLLDVFTPATSLEEFNDVYLVTHLMG-ADLNNIVKCQKLTDDHVQF 158
Query: 217 LKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAETGT 276
           L     + +G+ Y+H  +IIHRDLK +NL ++E+  +K+ DFG+AR       MT    T
Sbjct: 159 L--IYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLAR--HTDDEMTGYVAT 214
Query: 277 YRWMAPEV-IEHKPYDYKADVFSFGIALWELLTGELPYAG------LTPLQAAVGVVQKS 329
             + APE+ +    Y+   D++S G  + ELLTG   + G      L  +    G    S
Sbjct: 215 RWYRAPEIMLNWMHYNMTVDIWSVGCIMAELLTGRTLFPGTDHINQLQQIMRLTGTPPAS 274
Query: 330 LRPTIPKH 337
           +   +P H
Sbjct: 275 VISRMPSH 282

>pdb|3LM0|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B (STK17B) Length = 327

Iteration: 1
 Score = 76.3 bits (186), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 48/181 (26%), Positives = 87/181 (48%), Gaps = 5/181 (2%)
Query: 140 QEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRH-KNVVQFIGACTRPPNLCIVTEFMARG 198
           QE A K LK      +   E   E+ ++   +    V+           + ++ E+ A G
Sbjct: 55  QEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHEVYENTSEIILILEYAAGG 114
Query: 199 SIYDF-LHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDEN---GVVK 254
            I+   L +   +     ++++   + +G+ YLHQNNI+H DLK  N+L+      G +K
Sbjct: 115 EIFSLCLPELAEMVSENDVIRLIKQILEGVYYLHQNNIVHLDLKPQNILLSSIYPLGDIK 174
Query: 255 VADFGVARVQAQSGVMTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPYA 314
           + DFG++R    +  +    GT  ++APE++ + P     D+++ GI  + LLT   P+ 
Sbjct: 175 IVDFGMSRKIGHACELREIMGTPEYLAPEILNYDPITTATDMWNIGIIAYMLLTHTSPFV 234
Query: 315 G 315
           G
Sbjct: 235 G 235

>pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360

Iteration: 1
 Score = 76.3 bits (186), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 57/218 (26%), Positives = 104/218 (47%), Gaps = 20/218 (9%)
Query: 142 VAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNL------CIVTEFM 195
           VA+K L     N    K   +E+ +++ + HKN++  +   T    L       +V E M
Sbjct: 50  VAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELM 109
Query: 196 ARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKV 255
              ++   +H +    +++ LL   +    G+ +LH   IIHRDLK +N+++  +  +K+
Sbjct: 110 -DANLCQVIHMELDHERMSYLLYQML---CGIKHLHSAGIIHRDLKPSNIVVKSDCTLKI 165
Query: 256 ADFGVARVQAQSGVMTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPYAG 315
            DFG+AR  + + +MT    T  + APEVI    Y    D++S G  + EL+ G + + G
Sbjct: 166 LDFGLARTASTNFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKGSVIFQG 225
Query: 316 LTPLQAAVGVVQK----------SLRPTIPKHAHPRLA 343
              +     V+++          +L+PT+  +   R A
Sbjct: 226 TDHIDQWNKVIEQLGTPSAEFMAALQPTVRNYVENRPA 263

>pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300

Iteration: 1
 Score = 76.3 bits (186), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 54/202 (26%), Positives = 101/202 (50%), Gaps = 7/202 (3%)
Query: 119 KIECKVASGSYGDLYKG--TYCSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVV 176
           K+E K+  G+YG +YK       + VA+K ++ +     +     +E+ +++++ H N+V
Sbjct: 9   KVE-KIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIV 67
Query: 177 QFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAI-DVSKGMNYLHQNNI 235
           + +        L +V EF++   + DF+           L+K  +  + +G+ + H + +
Sbjct: 68  KLLDVIHTENKLYLVFEFLSM-DLKDFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRV 126
Query: 236 IHRDLKTANLLMDENGVVKVADFGVARV-QAQSGVMTAETGTYRWMAPEVIEH-KPYDYK 293
           +HRDLK  NLL++  G +K+ADFG+AR           E  T  + APE++   K Y   
Sbjct: 127 LHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKYYSTA 186
Query: 294 ADVFSFGIALWELLTGELPYAG 315
            D++S G    E++T    + G
Sbjct: 187 VDIWSLGCIFAEMVTRRALFPG 208

>pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 76.3 bits (186), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 60/215 (27%), Positives = 103/215 (47%), Gaps = 15/215 (6%)
Query: 110 VWEIDAKQLKIECKVASGSYGDLYKG--TYCSQEVAIKVLKPECVNTEMLKEFSQEVYIM 167
           +WE+  +   +   V SG+YG +     T     VA+K L     +    K   +E+ ++
Sbjct: 17  IWEVPERYQNL-SPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLL 75
Query: 168 RKIRHKNVVQFIGACTRPPNL------CIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAI 221
           + ++H+NV+  +   T   +L       +VT  M    + + +  QK        L   I
Sbjct: 76  KHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMG-ADLNNIVKCQKLTDDHVQFLIYQI 134
Query: 222 DVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAETGTYRWMA 281
              +G+ Y+H  +IIHRDLK +NL ++E+  +K+ D+G+AR       MT    T  + A
Sbjct: 135 --LRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDYGLAR--HTDDEMTGYVATRWYRA 190
Query: 282 PEV-IEHKPYDYKADVFSFGIALWELLTGELPYAG 315
           PE+ +    Y+   D++S G  + ELLTG   + G
Sbjct: 191 PEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPG 225

>pdb|4AZF|A Chain A, Human Dyrk2 In Complex With Leucettine L41 Length = 417

Iteration: 1
 Score = 76.3 bits (186), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 59/197 (29%), Positives = 101/197 (51%), Gaps = 17/197 (8%)
Query: 124 VASGSYGDLYKGT--YCSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHK------NV 175
           +  GS+G + K       Q VA+K+++ E       ++ ++E+ I+  +R +      NV
Sbjct: 105 IGKGSFGQVVKAYDHKVHQHVALKMVRNE---KRFHRQAAEEIRILEHLRKQDKDNTMNV 161
Query: 176 VQFIGACTRPPNLCIVTEFMARGSIYDFLHKQK-GVFQLTSLLKVAIDVSKGMNYLHQNN 234
           +  +   T   ++C+  E ++  ++Y+ + K K   F L  + K A  + + ++ LH+N 
Sbjct: 162 IHMLENFTFRNHICMTFELLSM-NLYELIKKNKFQGFSLPLVRKFAHSILQCLDALHKNR 220
Query: 235 IIHRDLKTANLLMDENGV--VKVADFGVARVQAQSGVMTAETGTYRWMAPEVIEHKPYDY 292
           IIH DLK  N+L+ + G   +KV DFG +  + Q      ++  YR  APEVI    Y  
Sbjct: 221 IIHCDLKPENILLKQQGRSGIKVIDFGSSCYEHQRVYTXIQSRFYR--APEVILGARYGM 278
Query: 293 KADVFSFGIALWELLTG 309
             D++S G  L ELLTG
Sbjct: 279 PIDMWSLGCILAELLTG 295

>pdb|2AC3|A Chain A, Structure Of Human Mnk2 Kinase Domain Length = 316

Iteration: 1
 Score = 76.3 bits (186), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 61/195 (31%), Positives = 100/195 (51%), Gaps = 22/195 (11%)
Query: 139 SQEVAIKVL--KPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVTEFMA 196
           SQE A+K++  +P  + + + +E      + +   H+NV++ I          +V E M 
Sbjct: 38  SQEYAVKIIEKQPGHIRSRVFREVEM---LYQCQGHRNVLELIEFFEEEDRFYLVFEKMR 94
Query: 197 RGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDE-NGV--V 253
            GSI   +HK++   +L + + V  DV+  +++LH   I HRDLK  N+L +  N V  V
Sbjct: 95  GGSILSHIHKRRHFNELEASV-VVQDVASALDFLHNKGIAHRDLKPENILCEHPNQVSPV 153
Query: 254 KVADF----GVARVQAQSGVMTAE----TGTYRWMAPEVI-----EHKPYDYKADVFSFG 300
           K+ DF    G+      S + T E     G+  +MAPEV+     E   YD + D++S G
Sbjct: 154 KICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLG 213
Query: 301 IALWELLTGELPYAG 315
           + L+ LL+G  P+ G
Sbjct: 214 VILYILLSGYPPFVG 228

>pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299

Iteration: 1
 Score = 76.3 bits (186), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 54/202 (26%), Positives = 102/202 (50%), Gaps = 7/202 (3%)
Query: 119 KIECKVASGSYGDLYKG--TYCSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVV 176
           K+E K+  G+YG +YK       + VA+K ++ +     +     +E+ +++++ H N+V
Sbjct: 7   KVE-KIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIV 65
Query: 177 QFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAI-DVSKGMNYLHQNNI 235
           + +        L +V EF+ +  +  F+           L+K  +  + +G+++ H + +
Sbjct: 66  KLLDVIHTENKLYLVFEFLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQGLSFCHSHRV 124
Query: 236 IHRDLKTANLLMDENGVVKVADFGVARV-QAQSGVMTAETGTYRWMAPEVIEH-KPYDYK 293
           +HRDLK  NLL++  G +K+ADFG+AR         T E  T  + APE++   K Y   
Sbjct: 125 LHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKYYSTA 184
Query: 294 ADVFSFGIALWELLTGELPYAG 315
            D++S G    E++T    + G
Sbjct: 185 VDIWSLGCIFAEMVTRRALFPG 206

>pdb|3GNI|B Chain B, Structure Of Strad And Mo25 Length = 389

Iteration: 1
 Score = 76.3 bits (186), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 70/304 (23%), Positives = 128/304 (42%), Gaps = 62/304 (20%)
Query: 133 YKGTYCSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVT 192
           YK T   + V ++ +  E  + EM+     E+++ +   H N+V +         L +VT
Sbjct: 48  YKPT--GEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVT 105
Query: 193 EFMARGSIYDFL--HKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDEN 250
            FMA GS  D +  H   G+ +L ++  +   V K ++Y+H    +HR +K +++L+  +
Sbjct: 106 SFMAYGSAKDLICTHFMDGMNEL-AIAYILQGVLKALDYIHHMGYVHRSVKASHILISVD 164
Query: 251 GVVKVADFG-----VARVQAQSGVMTAETGTYR---WMAPEVIEH--KPYDYKADVFSFG 300
           G V ++        ++  Q Q  V      + +   W++PEV++   + YD K+D++S G
Sbjct: 165 GKVYLSGLRSNLSMISHGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVG 224
Query: 301 IALWELLTGELPYAGLTPLQAAV------------------------------------G 324
           I   EL  G +P+  +   Q  +                                     
Sbjct: 225 ITACELANGHVPFKDMPATQMLLEKLNGTVPCLLDTSTIPAEELTMSPSRSVANSGLSDS 284
Query: 325 VVQKSLRPT---IPKHAH-----PRLAELLERCWQHDPTQRPNFSQITD--ILKQMMKEV 374
           +   + RP+    P H +     P     +E+C Q +P  RP+ S + +    KQ +K  
Sbjct: 285 LTTSTPRPSNGDSPSHPYHRTFSPHFHHFVEQCLQRNPDARPSASTLLNHSFFKQ-IKRR 343
Query: 375 ASEG 378
           ASE 
Sbjct: 344 ASEA 347

>pdb|2WTK|B Chain B, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 373

Iteration: 1
 Score = 76.3 bits (186), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 70/304 (23%), Positives = 128/304 (42%), Gaps = 62/304 (20%)
Query: 133 YKGTYCSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVT 192
           YK T   + V ++ +  E  + EM+     E+++ +   H N+V +         L +VT
Sbjct: 32  YKPT--GEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVT 89
Query: 193 EFMARGSIYDFL--HKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDEN 250
            FMA GS  D +  H   G+ +L ++  +   V K ++Y+H    +HR +K +++L+  +
Sbjct: 90  SFMAYGSAKDLICTHFMDGMNEL-AIAYILQGVLKALDYIHHMGYVHRSVKASHILISVD 148
Query: 251 GVVKVADFG-----VARVQAQSGVMTAETGTYR---WMAPEVIEH--KPYDYKADVFSFG 300
           G V ++        ++  Q Q  V      + +   W++PEV++   + YD K+D++S G
Sbjct: 149 GKVYLSGLRSNLSMISHGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVG 208
Query: 301 IALWELLTGELPYAGLTPLQAAV------------------------------------G 324
           I   EL  G +P+  +   Q  +                                     
Sbjct: 209 ITACELANGHVPFKDMPATQMLLEKLNGTVPCLLDTSTIPAEELTMSPSRSVANSGLSDS 268
Query: 325 VVQKSLRPT---IPKHAH-----PRLAELLERCWQHDPTQRPNFSQITD--ILKQMMKEV 374
           +   + RP+    P H +     P     +E+C Q +P  RP+ S + +    KQ +K  
Sbjct: 269 LTTSTPRPSNGDSPSHPYHRTFSPHFHHFVEQCLQRNPDARPSASTLLNHSFFKQ-IKRR 327
Query: 375 ASEG 378
           ASE 
Sbjct: 328 ASEA 331

>pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 76.3 bits (186), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 57/222 (25%), Positives = 102/222 (45%), Gaps = 28/222 (12%)
Query: 140 QEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVTEFMARGS 199
           + VAIK L     N    K   +E+ +M+ + HKN++  +   T   +L    EF     
Sbjct: 50  RNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSL---EEFQDVYI 106
Query: 200 IYDFLHKQKGVFQLTSLLKVAIDVSK----------GMNYLHQNNIIHRDLKTANLLMDE 249
           + + +        L+ ++++ +D  +          G+ +LH   IIHRDLK +N+++  
Sbjct: 107 VMELMDAN-----LSQVIQMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKS 161
Query: 250 NGVVKVADFGVARVQAQSGVMTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTG 309
           +  +K+ DFG+AR    S +MT    T  + APEVI    Y    D++S G  + E++ G
Sbjct: 162 DCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKG 221
Query: 310 ELPYAGLTPLQAAVGVVQ----------KSLRPTIPKHAHPR 341
            + + G   +     V++          K L+PT+  +   R
Sbjct: 222 GVLFPGTDHIDQWNKVIEQLGTPSPEFMKKLQPTVRTYVENR 263

>pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369

Iteration: 1
 Score = 76.3 bits (186), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 59/218 (27%), Positives = 102/218 (46%), Gaps = 20/218 (9%)
Query: 140 QEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNL------CIVTE 193
           + VAIK L     N    K   +E+ +M+ + HKN++  +   T   +L       IV E
Sbjct: 50  RNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVME 109
Query: 194 FMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVV 253
            M   ++   +  +    +++ LL     +  G+ +LH   IIHRDLK +N+++  +  +
Sbjct: 110 LMD-ANLCQVIQMELDHERMSYLL---YQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTL 165
Query: 254 KVADFGVARVQAQSGVMTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPY 313
           K+ DFG+AR    S +MT    T  + APEVI    Y    D++S G  + E++ G + +
Sbjct: 166 KILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLF 225
Query: 314 AGLTPLQAAVGVVQ----------KSLRPTIPKHAHPR 341
            G   +     V++          K L+PT+  +   R
Sbjct: 226 PGTDHIDQWNKVIEQLGTPCPEFMKKLQPTVRTYVENR 263

>pdb|3KVW|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) In Complex With An Indirubin Ligand Length = 429

Iteration: 1
 Score = 76.3 bits (186), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 59/197 (29%), Positives = 101/197 (51%), Gaps = 17/197 (8%)
Query: 124 VASGSYGDLYKGT--YCSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHK------NV 175
           +  GS+G + K       Q VA+K+++ E       ++ ++E+ I+  +R +      NV
Sbjct: 105 IGKGSFGQVVKAYDHKVHQHVALKMVRNE---KRFHRQAAEEIRILEHLRKQDKDNTMNV 161
Query: 176 VQFIGACTRPPNLCIVTEFMARGSIYDFLHKQK-GVFQLTSLLKVAIDVSKGMNYLHQNN 234
           +  +   T   ++C+  E ++  ++Y+ + K K   F L  + K A  + + ++ LH+N 
Sbjct: 162 IHMLENFTFRNHICMTFELLSM-NLYELIKKNKFQGFSLPLVRKFAHSILQCLDALHKNR 220
Query: 235 IIHRDLKTANLLMDENGV--VKVADFGVARVQAQSGVMTAETGTYRWMAPEVIEHKPYDY 292
           IIH DLK  N+L+ + G   +KV DFG +  + Q      ++  YR  APEVI    Y  
Sbjct: 221 IIHCDLKPENILLKQQGRSGIKVIDFGSSCYEHQRVYTXIQSRFYR--APEVILGARYGM 278
Query: 293 KADVFSFGIALWELLTG 309
             D++S G  L ELLTG
Sbjct: 279 PIDMWSLGCILAELLTG 295

>pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299

Iteration: 1
 Score = 76.3 bits (186), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 54/202 (26%), Positives = 101/202 (50%), Gaps = 7/202 (3%)
Query: 119 KIECKVASGSYGDLYKG--TYCSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVV 176
           K+E K+  G+YG +YK       + VA+K ++ +     +     +E+ +++++ H N+V
Sbjct: 7   KVE-KIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIV 65
Query: 177 QFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAI-DVSKGMNYLHQNNI 235
           + +        L +V EF+ +  + DF+           L+K  +  + +G+ + H + +
Sbjct: 66  KLLDVIHTENKLYLVFEFLHQ-DLKDFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRV 124
Query: 236 IHRDLKTANLLMDENGVVKVADFGVARV-QAQSGVMTAETGTYRWMAPEVIEH-KPYDYK 293
           +HRDLK  NLL++  G +K+ADFG+AR           E  T  + APE++   K Y   
Sbjct: 125 LHRDLKPENLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKYYSTA 184
Query: 294 ADVFSFGIALWELLTGELPYAG 315
            D++S G    E++T    + G
Sbjct: 185 VDIWSLGCIFAEMVTRRALFPG 206

>pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380

Iteration: 1
 Score = 76.3 bits (186), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 62/224 (27%), Positives = 103/224 (45%), Gaps = 31/224 (13%)
Query: 124 VASGSYGDLYKGTYCSQ-------EVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVV 176
           +  G+YG       CS         VAIK + P    T   +   +E+ I+ + RH+N++
Sbjct: 51  IGEGAYG-----MVCSAYDNVNKVRVAIKKISPFEHQTYCQRTL-REIKILLRFRHENII 104
Query: 177 QFIGACTRPP------NLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYL 230
             I    R P      ++ +VT  M    +Y  L  Q        +      + +G+ Y+
Sbjct: 105 G-INDIIRAPTIEQMKDVYLVTHLMG-ADLYKLLKTQH--LSNDHICYFLYQILRGLKYI 160
Query: 231 HQNNIIHRDLKTANLLMDENGVVKVADFGVARV----QAQSGVMTAETGTYRWMAPEV-I 285
           H  N++HRDLK +NLL++    +K+ DFG+ARV       +G +T    T  + APE+ +
Sbjct: 161 HSANVLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIML 220
Query: 286 EHKPYDYKADVFSFGIALWELLTGELPYAG---LTPLQAAVGVV 326
             K Y    D++S G  L E+L+    + G   L  L   +G++
Sbjct: 221 NSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGIL 264

>pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371

Iteration: 1
 Score = 76.3 bits (186), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 59/218 (27%), Positives = 102/218 (46%), Gaps = 20/218 (9%)
Query: 140 QEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNL------CIVTE 193
           + VAIK L     N    K   +E+ +M+ + HKN++  +   T   +L       IV E
Sbjct: 51  RNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVME 110
Query: 194 FMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVV 253
            M   ++   +  +    +++ LL   +    G+ +LH   IIHRDLK +N+++  +  +
Sbjct: 111 LMD-ANLCQVIQMELDHERMSYLLYQML---CGIKHLHSAGIIHRDLKPSNIVVKSDCTL 166
Query: 254 KVADFGVARVQAQSGVMTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPY 313
           K+ DFG+AR    S +MT    T  + APEVI    Y    D++S G  + E++ G + +
Sbjct: 167 KILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLF 226
Query: 314 AGLTPLQAAVGVVQ----------KSLRPTIPKHAHPR 341
            G   +     V++          K L+PT+  +   R
Sbjct: 227 PGTDHIDQWNKVIEQLGTPCPEFMKKLQPTVRTYVENR 264

>pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309

Iteration: 1
 Score = 75.9 bits (185), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 53/208 (25%), Positives = 102/208 (49%), Gaps = 6/208 (2%)
Query: 113 IDAKQLKIECKVASGSYGDLYKG--TYCSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKI 170
           +D +  +   K+  G+YG +YK       + VA+K ++ +     +     +E+ +++++
Sbjct: 4   VDMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKEL 63
Query: 171 RHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAI-DVSKGMNY 229
            H N+V+ +        L +V EF+ +  +  F+           L+K  +  + +G+ +
Sbjct: 64  NHPNIVKLLDVIHTENKLYLVFEFLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQGLAF 122
Query: 230 LHQNNIIHRDLKTANLLMDENGVVKVADFGVARV-QAQSGVMTAETGTYRWMAPEVIEH- 287
            H + ++HRDLK  NLL++  G +K+ADFG+AR         T E  T  + APE++   
Sbjct: 123 CHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGC 182
Query: 288 KPYDYKADVFSFGIALWELLTGELPYAG 315
           K Y    D++S G    E++T    + G
Sbjct: 183 KYYSTAVDIWSLGCIFAEMVTRRALFPG 210

>pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306

Iteration: 1
 Score = 75.9 bits (185), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 54/202 (26%), Positives = 101/202 (50%), Gaps = 7/202 (3%)
Query: 119 KIECKVASGSYGDLYKG--TYCSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVV 176
           K+E K+  G+YG +YK       + VA+K ++ +     +     +E+ +++++ H N+V
Sbjct: 14  KVE-KIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIV 72
Query: 177 QFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAI-DVSKGMNYLHQNNI 235
           + +        L +V EF+ +  +  F+           L+K  +  + +G+ + H + +
Sbjct: 73  KLLDVIHTENKLYLVFEFLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRV 131
Query: 236 IHRDLKTANLLMDENGVVKVADFGVARV-QAQSGVMTAETGTYRWMAPEV-IEHKPYDYK 293
           +HRDLK  NLL++  G +K+ADFG+AR         T E  T  + APE+ +  K Y   
Sbjct: 132 LHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGXKYYSTA 191
Query: 294 ADVFSFGIALWELLTGELPYAG 315
            D++S G    E++T    + G
Sbjct: 192 VDIWSLGCIFAEMVTRRALFPG 213

>pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299

Iteration: 1
 Score = 75.9 bits (185), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 54/202 (26%), Positives = 101/202 (50%), Gaps = 7/202 (3%)
Query: 119 KIECKVASGSYGDLYKG--TYCSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVV 176
           K+E K+  G+YG +YK       + VA+K ++ +     +     +E+ +++++ H N+V
Sbjct: 7   KVE-KIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIV 65
Query: 177 QFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAI-DVSKGMNYLHQNNI 235
           + +        L +V EF+ +  +  F+           L+K  +  + +G+ + H + +
Sbjct: 66  KLLDVIHTENKLYLVFEFLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRV 124
Query: 236 IHRDLKTANLLMDENGVVKVADFGVARV-QAQSGVMTAETGTYRWMAPEV-IEHKPYDYK 293
           +HRDLK  NLL++  G +K+ADFG+AR         T E  T  + APE+ +  K Y   
Sbjct: 125 LHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGXKYYSTA 184
Query: 294 ADVFSFGIALWELLTGELPYAG 315
            D++S G    E++T    + G
Sbjct: 185 VDIWSLGCIFAEMVTRRALFPG 206

>pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 75.9 bits (185), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 59/218 (27%), Positives = 102/218 (46%), Gaps = 20/218 (9%)
Query: 140 QEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNL------CIVTE 193
           + VAIK L     N    K   +E+ +M+ + HKN++  +   T   +L       IV E
Sbjct: 50  RNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVME 109
Query: 194 FMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVV 253
            M   ++   +  +    +++ LL   +    G+ +LH   IIHRDLK +N+++  +  +
Sbjct: 110 LMD-ANLCQVIQMELDHERMSYLLYQML---CGIKHLHSAGIIHRDLKPSNIVVKSDCTL 165
Query: 254 KVADFGVARVQAQSGVMTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPY 313
           K+ DFG+AR    S +MT    T  + APEVI    Y    D++S G  + E++ G + +
Sbjct: 166 KILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLF 225
Query: 314 AGLTPLQAAVGVVQ----------KSLRPTIPKHAHPR 341
            G   +     V++          K L+PT+  +   R
Sbjct: 226 PGTDHIDQWNKVIEQLGTPSPEFMKKLQPTVRTYVENR 263

>pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292

Iteration: 1
 Score = 75.9 bits (185), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 52/194 (26%), Positives = 94/194 (48%), Gaps = 5/194 (2%)
Query: 123 KVASGSYGDLYKGTY--CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIG 180
           K+  G+YG ++K       + VA+K ++ +  +  +     +E+ ++++++HKN+V+   
Sbjct: 9   KIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHD 68
Query: 181 ACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDL 240
                  L +V EF  +  +  +     G      +      + KG+ + H  N++HRDL
Sbjct: 69  VLHSDKKLTLVFEFCDQ-DLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSRNVLHRDL 127
Query: 241 KTANLLMDENGVVKVADFGVARVQA-QSGVMTAETGTYRWMAPEVI-EHKPYDYKADVFS 298
           K  NLL++ NG +K+ADFG+AR         +AE  T  +  P+V+   K Y    D++S
Sbjct: 128 KPQNLLINRNGELKLADFGLARAFGIPVRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWS 187
Query: 299 FGIALWELLTGELP 312
            G    EL     P
Sbjct: 188 AGCIFAELANAARP 201

>pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329

Iteration: 1
 Score = 75.9 bits (185), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 47/158 (29%), Positives = 86/158 (54%), Gaps = 8/158 (5%)
Query: 163 EVYIMRKIRHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAID 222
           E+ I++K+ H  +++ I       +  IV E M  G ++D +   K + + T  L     
Sbjct: 71  EIEILKKLNHPCIIK-IKNFFDAEDYYIVLELMEGGELFDKVVGNKRLKEATCKLYF-YQ 128
Query: 223 VSKGMNYLHQNNIIHRDLKTANLLM---DENGVVKVADFGVARVQAQSGVMTAETGTYRW 279
           +   + YLH+N IIHRDLK  N+L+   +E+ ++K+ DFG +++  ++ +M    GT  +
Sbjct: 129 MLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLCGTPTY 188
Query: 280 MAPEV---IEHKPYDYKADVFSFGIALWELLTGELPYA 314
           +APEV   +    Y+   D +S G+ L+  L+G  P++
Sbjct: 189 LAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFS 226

>pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323

Iteration: 1
 Score = 75.9 bits (185), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 47/158 (29%), Positives = 86/158 (54%), Gaps = 8/158 (5%)
Query: 163 EVYIMRKIRHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAID 222
           E+ I++K+ H  +++ I       +  IV E M  G ++D +   K + + T  L     
Sbjct: 65  EIEILKKLNHPCIIK-IKNFFDAEDYYIVLELMEGGELFDKVVGNKRLKEATCKLYF-YQ 122
Query: 223 VSKGMNYLHQNNIIHRDLKTANLLM---DENGVVKVADFGVARVQAQSGVMTAETGTYRW 279
           +   + YLH+N IIHRDLK  N+L+   +E+ ++K+ DFG +++  ++ +M    GT  +
Sbjct: 123 MLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLCGTPTY 182
Query: 280 MAPEV---IEHKPYDYKADVFSFGIALWELLTGELPYA 314
           +APEV   +    Y+   D +S G+ L+  L+G  P++
Sbjct: 183 LAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFS 220

>pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322

Iteration: 1
 Score = 75.9 bits (185), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 47/158 (29%), Positives = 86/158 (54%), Gaps = 8/158 (5%)
Query: 163 EVYIMRKIRHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAID 222
           E+ I++K+ H  +++ I       +  IV E M  G ++D +   K + + T  L     
Sbjct: 64  EIEILKKLNHPCIIK-IKNFFDAEDYYIVLELMEGGELFDKVVGNKRLKEATCKLYF-YQ 121
Query: 223 VSKGMNYLHQNNIIHRDLKTANLLM---DENGVVKVADFGVARVQAQSGVMTAETGTYRW 279
           +   + YLH+N IIHRDLK  N+L+   +E+ ++K+ DFG +++  ++ +M    GT  +
Sbjct: 122 MLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLCGTPTY 181
Query: 280 MAPEV---IEHKPYDYKADVFSFGIALWELLTGELPYA 314
           +APEV   +    Y+   D +S G+ L+  L+G  P++
Sbjct: 182 LAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFS 219

>pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383

Iteration: 1
 Score = 75.9 bits (185), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 60/215 (27%), Positives = 102/215 (47%), Gaps = 15/215 (6%)
Query: 110 VWEIDAKQLKIECKVASGSYGDLYKG--TYCSQEVAIKVLKPECVNTEMLKEFSQEVYIM 167
           +WE+  +   +   V SG+YG +     T     VA+K L     +    K   +E+ ++
Sbjct: 40  IWEVPERYQNL-SPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLL 98
Query: 168 RKIRHKNVVQFIGACTRPPNL------CIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAI 221
           + ++H+NV+  +   T   +L       +VT  M    + + +  QK        L   I
Sbjct: 99  KHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMG-ADLNNIVKCQKLTDDHVQFLIYQI 157
Query: 222 DVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAETGTYRWMA 281
              +G+ Y+H  +IIHRDLK +NL ++E+  +K+ DFG+AR       M     T  + A
Sbjct: 158 --LRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLAR--HTDDEMXGYVATRWYRA 213
Query: 282 PEV-IEHKPYDYKADVFSFGIALWELLTGELPYAG 315
           PE+ +    Y+   D++S G  + ELLTG   + G
Sbjct: 214 PEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPG 248

>pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364

Iteration: 1
 Score = 75.9 bits (185), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 65/255 (25%), Positives = 117/255 (45%), Gaps = 29/255 (11%)
Query: 142 VAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNL------CIVTEFM 195
           VA+K L     N    K   +E+ +++ + HKN++  +   T    L       +V E M
Sbjct: 52  VAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELM 111
Query: 196 ARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKV 255
              ++   +H +    +++ LL     +  G+ +LH   IIHRDLK +N+++  +  +K+
Sbjct: 112 -DANLCQVIHMELDHERMSYLL---YQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKI 167
Query: 256 ADFGVARVQAQSGVMTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPYAG 315
            DFG+AR    + +MT    T  + APEVI    Y    D++S G  + EL+ G + + G
Sbjct: 168 LDFGLARTACTNFMMTPYVVTRYYRAPEVILGMGYAANVDIWSVGCIMGELVKGCVIFQG 227
Query: 316 LTPLQAAVGVVQK----------SLRPTI-------PKHAHPRLAELLERCWQHDPTQRP 358
              +     V+++          +L+PT+       PK+   +  EL         ++R 
Sbjct: 228 TDHIDQWNKVIEQLGTPSAEFMAALQPTVRNYVENRPKYPGIKFEELFPDWIFPSESERD 287
Query: 359 NF--SQITDILKQMM 371
               SQ  D+L +M+
Sbjct: 288 KIKTSQARDLLSKML 302

>pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301

Iteration: 1
 Score = 75.5 bits (184), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 47/178 (26%), Positives = 90/178 (50%), Gaps = 5/178 (2%)
Query: 140 QEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVTEFMARGS 199
           QE A K++  + ++    ++  +E  I R ++H N+V+   + +      +V + +  G 
Sbjct: 30  QEYAAKIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDSISEEGFHYLVFDLVTGGE 89
Query: 200 IYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLM---DENGVVKVA 256
           +++ +  ++  +           + + +N+ H N I+HRDLK  NLL+    +   VK+A
Sbjct: 90  LFEDIVARE-YYSEADASHCIQQILESVNHCHLNGIVHRDLKPENLLLASKSKGAAVKLA 148
Query: 257 DFGVA-RVQAQSGVMTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPY 313
           DFG+A  VQ          GT  +++PEV+   PY    D+++ G+ L+ LL G  P+
Sbjct: 149 DFGLAIEVQGDQQAWFGFAGTPGYLSPEVLRKDPYGKPVDMWACGVILYILLVGYPPF 206

>pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322

Iteration: 1
 Score = 75.5 bits (184), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 47/158 (29%), Positives = 86/158 (54%), Gaps = 8/158 (5%)
Query: 163 EVYIMRKIRHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAID 222
           E+ I++K+ H  +++ I       +  IV E M  G ++D +   K + + T  L     
Sbjct: 65  EIEILKKLNHPCIIK-IKNFFDAEDYYIVLELMEGGELFDKVVGNKRLKEATCKLYF-YQ 122
Query: 223 VSKGMNYLHQNNIIHRDLKTANLLM---DENGVVKVADFGVARVQAQSGVMTAETGTYRW 279
           +   + YLH+N IIHRDLK  N+L+   +E+ ++K+ DFG +++  ++ +M    GT  +
Sbjct: 123 MLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLCGTPTY 182
Query: 280 MAPEV---IEHKPYDYKADVFSFGIALWELLTGELPYA 314
           +APEV   +    Y+   D +S G+ L+  L+G  P++
Sbjct: 183 LAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFS 220

>pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327

Iteration: 1
 Score = 75.5 bits (184), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 47/178 (26%), Positives = 90/178 (50%), Gaps = 5/178 (2%)
Query: 140 QEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVTEFMARGS 199
           QE A K++  + ++    ++  +E  I R ++H N+V+   + +      +V + +  G 
Sbjct: 30  QEYAAKIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDSISEEGFHYLVFDLVTGGE 89
Query: 200 IYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLM---DENGVVKVA 256
           +++ +  ++  +           + + +N+ H N I+HRDLK  NLL+    +   VK+A
Sbjct: 90  LFEDIVARE-YYSEADASHCIQQILESVNHCHLNGIVHRDLKPENLLLASKSKGAAVKLA 148
Query: 257 DFGVA-RVQAQSGVMTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPY 313
           DFG+A  VQ          GT  +++PEV+   PY    D+++ G+ L+ LL G  P+
Sbjct: 149 DFGLAIEVQGDQQAWFGFAGTPGYLSPEVLRKDPYGKPVDMWACGVILYILLVGYPPF 206

>pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323

Iteration: 1
 Score = 75.5 bits (184), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 47/158 (29%), Positives = 86/158 (54%), Gaps = 8/158 (5%)
Query: 163 EVYIMRKIRHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAID 222
           E+ I++K+ H  +++ I       +  IV E M  G ++D +   K + + T  L     
Sbjct: 65  EIEILKKLNHPCIIK-IKNFFDAEDYYIVLELMEGGELFDKVVGNKRLKEATCKLYF-YQ 122
Query: 223 VSKGMNYLHQNNIIHRDLKTANLLM---DENGVVKVADFGVARVQAQSGVMTAETGTYRW 279
           +   + YLH+N IIHRDLK  N+L+   +E+ ++K+ DFG +++  ++ +M    GT  +
Sbjct: 123 MLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLCGTPTY 182
Query: 280 MAPEV---IEHKPYDYKADVFSFGIALWELLTGELPYA 314
           +APEV   +    Y+   D +S G+ L+  L+G  P++
Sbjct: 183 LAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFS 220

>pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306

Iteration: 1
 Score = 75.5 bits (184), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 54/202 (26%), Positives = 101/202 (50%), Gaps = 7/202 (3%)
Query: 119 KIECKVASGSYGDLYKG--TYCSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVV 176
           K+E K+  G+YG +YK       + VA+K ++ +     +     +E+ +++++ H N+V
Sbjct: 14  KVE-KIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIV 72
Query: 177 QFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAI-DVSKGMNYLHQNNI 235
           + +        L +V EF+ +  +  F+           L+K  +  + +G+ + H + +
Sbjct: 73  KLLDVIHTENKLYLVFEFLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRV 131
Query: 236 IHRDLKTANLLMDENGVVKVADFGVARV-QAQSGVMTAETGTYRWMAPEVIEH-KPYDYK 293
           +HRDLK  NLL++  G +K+ADFG+AR         T E  T  + APE++   K Y   
Sbjct: 132 LHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKYYSTA 191
Query: 294 ADVFSFGIALWELLTGELPYAG 315
            D++S G    E++T    + G
Sbjct: 192 VDIWSLGCIFAEMVTRRALFPG 213

>pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308

Iteration: 1
 Score = 75.5 bits (184), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 56/200 (28%), Positives = 96/200 (48%), Gaps = 15/200 (7%)
Query: 122 CKVASGSYGDLYKG--TYCSQEVAIKVLK-PECVNTEMLKEFS--QEVYIMRKIR---HK 173
            ++  G+YG +YK    +    VA+K ++ P           S  +EV ++R++    H 
Sbjct: 15  AEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHP 74
Query: 174 NVVQFIGACT-----RPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLK-VAIDVSKGM 227
           NVV+ +  C      R   + +V E + +  +  +L K          +K +     +G+
Sbjct: 75  NVVRLMDVCATSRTDREIKVTLVFEHVDQ-DLRTYLDKAPPPGLPAETIKDLMRQFLRGL 133
Query: 228 NYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAETGTYRWMAPEVIEH 287
           ++LH N I+HRDLK  N+L+   G VK+ADFG+AR+ +    +T    T  + APEV+  
Sbjct: 134 DFLHANCIVHRDLKPENILVTSGGTVKLADFGLARIYSYQMALTPVVVTLWYRAPEVLLQ 193
Query: 288 KPYDYKADVFSFGIALWELL 307
             Y    D++S G    E+ 
Sbjct: 194 STYATPVDMWSVGCIFAEMF 213

>pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364

Iteration: 1
 Score = 75.5 bits (184), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 57/218 (26%), Positives = 101/218 (46%), Gaps = 20/218 (9%)
Query: 140 QEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNL------CIVTE 193
           + VAIK L     N    K   +E+ +M+ + HKN++  +   T    L       +V E
Sbjct: 50  RNVAIKKLSRPFQNQTHAKRAYRELVLMKXVNHKNIISLLNVFTPQKTLEEFQDVYLVME 109
Query: 194 FMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVV 253
            M   ++   +  +    +++ LL   +    G+ +LH   IIHRDLK +N+++  +  +
Sbjct: 110 LMD-ANLXQVIQMELDHERMSYLLYQML---XGIKHLHSAGIIHRDLKPSNIVVKSDXTL 165
Query: 254 KVADFGVARVQAQSGVMTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPY 313
           K+ DFG+AR    S +MT    T  + APEVI    Y    D++S G  + E++  ++ +
Sbjct: 166 KILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILF 225
Query: 314 AGLTPLQAAVGVVQ----------KSLRPTIPKHAHPR 341
            G   +     V++          K L+PT+  +   R
Sbjct: 226 PGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYVENR 263

>pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300

Iteration: 1
 Score = 75.5 bits (184), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 54/202 (26%), Positives = 101/202 (50%), Gaps = 7/202 (3%)
Query: 119 KIECKVASGSYGDLYKG--TYCSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVV 176
           K+E K+  G+YG +YK       + VA+K ++ +     +     +E+ +++++ H N+V
Sbjct: 8   KVE-KIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIV 66
Query: 177 QFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAI-DVSKGMNYLHQNNI 235
           + +        L +V EF+ +  +  F+           L+K  +  + +G+ + H + +
Sbjct: 67  KLLDVIHTENKLYLVFEFLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRV 125
Query: 236 IHRDLKTANLLMDENGVVKVADFGVARV-QAQSGVMTAETGTYRWMAPEVIEH-KPYDYK 293
           +HRDLK  NLL++  G +K+ADFG+AR         T E  T  + APE++   K Y   
Sbjct: 126 LHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKYYSTA 185
Query: 294 ADVFSFGIALWELLTGELPYAG 315
            D++S G    E++T    + G
Sbjct: 186 VDIWSLGCIFAEMVTRRALFPG 207

>pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299

Iteration: 1
 Score = 75.5 bits (184), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 54/202 (26%), Positives = 101/202 (50%), Gaps = 7/202 (3%)
Query: 119 KIECKVASGSYGDLYKG--TYCSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVV 176
           K+E K+  G+YG +YK       + VA+K ++ +     +     +E+ +++++ H N+V
Sbjct: 7   KVE-KIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIV 65
Query: 177 QFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAI-DVSKGMNYLHQNNI 235
           + +        L +V EF+ +  +  F+           L+K  +  + +G+ + H + +
Sbjct: 66  KLLDVIHTENKLYLVFEFLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRV 124
Query: 236 IHRDLKTANLLMDENGVVKVADFGVARV-QAQSGVMTAETGTYRWMAPEVIEH-KPYDYK 293
           +HRDLK  NLL++  G +K+ADFG+AR         T E  T  + APE++   K Y   
Sbjct: 125 LHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKYYSTA 184
Query: 294 ADVFSFGIALWELLTGELPYAG 315
            D++S G    E++T    + G
Sbjct: 185 VDIWSLGCIFAEMVTRRALFPG 206

>pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298

Iteration: 1
 Score = 75.5 bits (184), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 54/202 (26%), Positives = 101/202 (50%), Gaps = 7/202 (3%)
Query: 119 KIECKVASGSYGDLYKG--TYCSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVV 176
           K+E K+  G+YG +YK       + VA+K ++ +     +     +E+ +++++ H N+V
Sbjct: 6   KVE-KIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIV 64
Query: 177 QFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAI-DVSKGMNYLHQNNI 235
           + +        L +V EF+ +  +  F+           L+K  +  + +G+ + H + +
Sbjct: 65  KLLDVIHTENKLYLVFEFLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRV 123
Query: 236 IHRDLKTANLLMDENGVVKVADFGVARV-QAQSGVMTAETGTYRWMAPEVIEH-KPYDYK 293
           +HRDLK  NLL++  G +K+ADFG+AR         T E  T  + APE++   K Y   
Sbjct: 124 LHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKYYSTA 183
Query: 294 ADVFSFGIALWELLTGELPYAG 315
            D++S G    E++T    + G
Sbjct: 184 VDIWSLGCIFAEMVTRRALFPG 205

>pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299

Iteration: 1
 Score = 75.5 bits (184), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 54/202 (26%), Positives = 101/202 (50%), Gaps = 7/202 (3%)
Query: 119 KIECKVASGSYGDLYKG--TYCSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVV 176
           K+E K+  G+YG +YK       + VA+K ++ +     +     +E+ +++++ H N+V
Sbjct: 7   KVE-KIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIV 65
Query: 177 QFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAI-DVSKGMNYLHQNNI 235
           + +        L +V EF+ +  +  F+           L+K  +  + +G+ + H + +
Sbjct: 66  KLLDVIHTENKLYLVFEFLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRV 124
Query: 236 IHRDLKTANLLMDENGVVKVADFGVARV-QAQSGVMTAETGTYRWMAPEVIEH-KPYDYK 293
           +HRDLK  NLL++  G +K+ADFG+AR         T E  T  + APE++   K Y   
Sbjct: 125 LHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKYYSTA 184
Query: 294 ADVFSFGIALWELLTGELPYAG 315
            D++S G    E++T    + G
Sbjct: 185 VDIWSLGCIFAEMVTRRALFPG 206

>pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298

Iteration: 1
 Score = 75.5 bits (184), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 54/202 (26%), Positives = 101/202 (50%), Gaps = 7/202 (3%)
Query: 119 KIECKVASGSYGDLYKG--TYCSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVV 176
           K+E K+  G+YG +YK       + VA+K ++ +     +     +E+ +++++ H N+V
Sbjct: 6   KVE-KIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIV 64
Query: 177 QFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAI-DVSKGMNYLHQNNI 235
           + +        L +V EF+ +  +  F+           L+K  +  + +G+ + H + +
Sbjct: 65  KLLDVIHTENKLYLVFEFLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRV 123
Query: 236 IHRDLKTANLLMDENGVVKVADFGVARV-QAQSGVMTAETGTYRWMAPEVIEH-KPYDYK 293
           +HRDLK  NLL++  G +K+ADFG+AR         T E  T  + APE++   K Y   
Sbjct: 124 LHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKYYSTA 183
Query: 294 ADVFSFGIALWELLTGELPYAG 315
            D++S G    E++T    + G
Sbjct: 184 VDIWSLGCIFAEMVTRRALFPG 205

>pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355

Iteration: 1
 Score = 75.1 bits (183), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 60/248 (24%), Positives = 116/248 (46%), Gaps = 15/248 (6%)
Query: 124 VASGSYGDLY-----KGTYCSQEVAIKVLKPECV--NTEMLKEFSQEVYIMRKIRHKN-V 175
           + +G+YG ++      G    +  A+KVLK   +    +  +    E  ++  IR    +
Sbjct: 62  LGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFL 121
Query: 176 VQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNI 235
           V    A      L ++ +++  G ++  L +++   +    + V  ++   + +LH+  I
Sbjct: 122 VTLHYAFQTETKLHLILDYINGGELFTHLSQRERFTEHEVQIYVG-EIVLALEHLHKLGI 180
Query: 236 IHRDLKTANLLMDENGVVKVADFGVAR--VQAQSGVMTAETGTYRWMAPEVIE--HKPYD 291
           I+RD+K  N+L+D NG V + DFG+++  V  ++       GT  +MAP+++      +D
Sbjct: 181 IYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYDFCGTIEYMAPDIVRGGDSGHD 240
Query: 292 YKADVFSFGIALWELLTGELPYA--GLTPLQAAVGVVQKSLRPTIPKHAHPRLAELLERC 349
              D +S G+ ++ELLTG  P+   G    QA +        P  P+       +L++R 
Sbjct: 241 KAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPPYPQEMSALAKDLIQRL 300
Query: 350 WQHDPTQR 357
              DP +R
Sbjct: 301 LMKDPKKR 308

>pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360

Iteration: 1
 Score = 75.1 bits (183), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 60/215 (27%), Positives = 102/215 (47%), Gaps = 15/215 (6%)
Query: 110 VWEIDAKQLKIECKVASGSYGDLYKG--TYCSQEVAIKVLKPECVNTEMLKEFSQEVYIM 167
           +WE+  +   +   V SG+YG +     T     VA+K L     +    K   +E+ ++
Sbjct: 17  IWEVPERYQNL-SPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLL 75
Query: 168 RKIRHKNVVQFIGACTRPPNL------CIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAI 221
           + ++H+NV+  +   T   +L       +VT  M    + + +  QK        L   I
Sbjct: 76  KHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMG-ADLNNIVKCQKLTDDHVQFLIYQI 134
Query: 222 DVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAETGTYRWMA 281
              +G+ Y+H  +IIHRDLK +NL ++E+  +K+ DF +AR       MT    T  + A
Sbjct: 135 --LRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFYLAR--HTDDEMTGYVATRWYRA 190
Query: 282 PEV-IEHKPYDYKADVFSFGIALWELLTGELPYAG 315
           PE+ +    Y+   D++S G  + ELLTG   + G
Sbjct: 191 PEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPG 225

>pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284

Iteration: 1
 Score = 75.1 bits (183), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 45/176 (25%), Positives = 88/176 (50%), Gaps = 4/176 (2%)
Query: 141 EVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVTEFMARGSI 200
           E A K++  + ++    ++  +E  I RK++H N+V+   +        +V + +  G +
Sbjct: 33  EFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVFDLVTGGEL 92
Query: 201 YDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMD---ENGVVKVAD 257
           ++ +  ++  +           + + + Y H N I+HR+LK  NLL+    +   VK+AD
Sbjct: 93  FEDIVARE-FYSEADASHCIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLAD 151
Query: 258 FGVARVQAQSGVMTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPY 313
           FG+A     S       GT  +++PEV++  PY    D+++ G+ L+ LL G  P+
Sbjct: 152 FGLAIEVNDSEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPF 207

>pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269

Iteration: 1
 Score = 75.1 bits (183), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 45/176 (25%), Positives = 88/176 (50%), Gaps = 4/176 (2%)
Query: 141 EVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVTEFMARGSI 200
           E A K++  + ++    ++  +E  I RK++H N+V+   +        +V + +  G +
Sbjct: 33  EFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVFDLVTGGEL 92
Query: 201 YDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMD---ENGVVKVAD 257
           ++ +  ++  +           + + + Y H N I+HR+LK  NLL+    +   VK+AD
Sbjct: 93  FEDIVARE-FYSEADASHCIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLAD 151
Query: 258 FGVARVQAQSGVMTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPY 313
           FG+A     S       GT  +++PEV++  PY    D+++ G+ L+ LL G  P+
Sbjct: 152 FGLAIEVNDSEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPF 207

>pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443

Iteration: 1
 Score = 75.1 bits (183), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 47/158 (29%), Positives = 86/158 (54%), Gaps = 8/158 (5%)
Query: 163 EVYIMRKIRHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAID 222
           E+ I++K+ H  +++ I       +  IV E M  G ++D +   K + + T  L     
Sbjct: 204 EIEILKKLNHPCIIK-IKNFFDAEDYYIVLELMEGGELFDKVVGNKRLKEATCKLYF-YQ 261
Query: 223 VSKGMNYLHQNNIIHRDLKTANLLM---DENGVVKVADFGVARVQAQSGVMTAETGTYRW 279
           +   + YLH+N IIHRDLK  N+L+   +E+ ++K+ DFG +++  ++ +M    GT  +
Sbjct: 262 MLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLCGTPTY 321
Query: 280 MAPEV---IEHKPYDYKADVFSFGIALWELLTGELPYA 314
           +APEV   +    Y+   D +S G+ L+  L+G  P++
Sbjct: 322 LAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFS 359

>pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419

Iteration: 1
 Score = 75.1 bits (183), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 47/158 (29%), Positives = 86/158 (54%), Gaps = 8/158 (5%)
Query: 163 EVYIMRKIRHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAID 222
           E+ I++K+ H  +++ I       +  IV E M  G ++D +   K + + T  L     
Sbjct: 190 EIEILKKLNHPCIIK-IKNFFDAEDYYIVLELMEGGELFDKVVGNKRLKEATCKLYF-YQ 247
Query: 223 VSKGMNYLHQNNIIHRDLKTANLLM---DENGVVKVADFGVARVQAQSGVMTAETGTYRW 279
           +   + YLH+N IIHRDLK  N+L+   +E+ ++K+ DFG +++  ++ +M    GT  +
Sbjct: 248 MLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLCGTPTY 307
Query: 280 MAPEV---IEHKPYDYKADVFSFGIALWELLTGELPYA 314
           +APEV   +    Y+   D +S G+ L+  L+G  P++
Sbjct: 308 LAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFS 345

>pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362

Iteration: 1
 Score = 75.1 bits (183), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 45/176 (25%), Positives = 88/176 (50%), Gaps = 4/176 (2%)
Query: 141 EVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVTEFMARGSI 200
           E A K++  + ++    ++  +E  I RK++H N+V+   +        +V + +  G +
Sbjct: 56  EFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVFDLVTGGEL 115
Query: 201 YDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMD---ENGVVKVAD 257
           ++ +  ++  +           + + + Y H N I+HR+LK  NLL+    +   VK+AD
Sbjct: 116 FEDIVARE-FYSEADASHCIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLAD 174
Query: 258 FGVARVQAQSGVMTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPY 313
           FG+A     S       GT  +++PEV++  PY    D+++ G+ L+ LL G  P+
Sbjct: 175 FGLAIEVNDSEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPF 230

>pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282

Iteration: 1
 Score = 75.1 bits (183), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 45/176 (25%), Positives = 88/176 (50%), Gaps = 4/176 (2%)
Query: 141 EVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVTEFMARGSI 200
           E A K++  + ++    ++  +E  I RK++H N+V+   +        +V + +  G +
Sbjct: 32  EFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVFDLVTGGEL 91
Query: 201 YDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMD---ENGVVKVAD 257
           ++ +  ++  +           + + + Y H N I+HR+LK  NLL+    +   VK+AD
Sbjct: 92  FEDIVARE-FYSEADASHCIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLAD 150
Query: 258 FGVARVQAQSGVMTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPY 313
           FG+A     S       GT  +++PEV++  PY    D+++ G+ L+ LL G  P+
Sbjct: 151 FGLAIEVNDSEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPF 206

>pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324

Iteration: 1
 Score = 75.1 bits (183), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 50/199 (25%), Positives = 98/199 (49%), Gaps = 6/199 (3%)
Query: 123 KVASGSYGDLYKGT--YCSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIG 180
           K+  G+Y  +YKG        VA+K ++ E           +EV +++ ++H N+V    
Sbjct: 9   KLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAI-REVSLLKDLKHANIVTLHD 67
Query: 181 ACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDL 240
                 +L +V E++ +  +  +L     +  + ++      + +G+ Y H+  ++HRDL
Sbjct: 68  IIHTEKSLTLVFEYLDK-DLKQYLDDCGNIINMHNVKLFLFQLLRGLAYCHRQKVLHRDL 126
Query: 241 KTANLLMDENGVVKVADFGVARVQA-QSGVMTAETGTYRWMAPEV-IEHKPYDYKADVFS 298
           K  NLL++E G +K+ADFG+AR ++  +     E  T  +  P++ +    Y  + D++ 
Sbjct: 127 KPQNLLINERGELKLADFGLARAKSIPTKTYDNEVVTLWYRPPDILLGSTDYSTQIDMWG 186
Query: 299 FGIALWELLTGELPYAGLT 317
            G   +E+ TG   + G T
Sbjct: 187 VGCIFYEMATGRPLFPGST 205

>pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355

Iteration: 1
 Score = 75.1 bits (183), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 57/218 (26%), Positives = 101/218 (46%), Gaps = 20/218 (9%)
Query: 140 QEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNL------CIVTE 193
           + VAIK L     N    K   +E+ +M+ + HKN++  +   T    L       +V E
Sbjct: 50  RNVAIKKLSRPFQNQTHAKRAYRELVLMKXVNHKNIISLLNVFTPQKTLEEFQDVYLVME 109
Query: 194 FMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVV 253
            M   ++   +  +    +++ LL   +    G+ +LH   IIHRDLK +N+++  +  +
Sbjct: 110 LMD-ANLXQVIQMELDHERMSYLLYQML---CGIKHLHSAGIIHRDLKPSNIVVKSDXTL 165
Query: 254 KVADFGVARVQAQSGVMTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPY 313
           K+ DFG+AR    S +MT    T  + APEVI    Y    D++S G  + E++  ++ +
Sbjct: 166 KILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILF 225
Query: 314 AGLTPLQAAVGVVQ----------KSLRPTIPKHAHPR 341
            G   +     V++          K L+PT+  +   R
Sbjct: 226 PGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYVENR 263

>pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364

Iteration: 1
 Score = 74.7 bits (182), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 62/224 (27%), Positives = 103/224 (45%), Gaps = 31/224 (13%)
Query: 124 VASGSYGDLYKGTYCSQ-------EVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVV 176
           +  G+YG       CS         VAIK + P    T   +   +E+ I+ + RH+N++
Sbjct: 35  IGEGAYG-----MVCSAYDNLNKVRVAIKKISPFEHQTYXQRTL-REIKILLRFRHENII 88
Query: 177 QFIGACTRPP------NLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYL 230
             I    R P      ++ IV + M    +Y  L  Q        +      + +G+ Y+
Sbjct: 89  G-INDIIRAPTIEQMKDVYIVQDLM-ETDLYKLLKTQH--LSNDHICYFLYQILRGLKYI 144
Query: 231 HQNNIIHRDLKTANLLMDENGVVKVADFGVARV----QAQSGVMTAETGTYRWMAPEV-I 285
           H  N++HRDLK +NLL++    +K+ DFG+ARV       +G +T    T  + APE+ +
Sbjct: 145 HSANVLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIML 204
Query: 286 EHKPYDYKADVFSFGIALWELLTGELPYAG---LTPLQAAVGVV 326
             K Y    D++S G  L E+L+    + G   L  L   +G++
Sbjct: 205 NSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGIL 248

>pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370

Iteration: 1
 Score = 74.7 bits (182), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 59/222 (26%), Positives = 106/222 (47%), Gaps = 29/222 (13%)
Query: 110 VWEIDAKQLKIECKVASGSYGDLYKG--TYCSQEVAIKVLKPECVNTEMLKEFSQEVYIM 167
           VWE+  ++L+    V SG+YG +         Q+VA+K L     +    +   +E+ ++
Sbjct: 23  VWEV-PQRLQGLRPVGSGAYGSVCSAYDARLRQKVAVKKLSRPFQSLIHARRTYRELRLL 81
Query: 168 RKIRHKNVVQFIGACTRPPNL------CIVTEFMA-------RGSIYDFLHKQKGVFQLT 214
           + ++H+NV+  +   T   ++       +VT  M        +       H Q  V+QL 
Sbjct: 82  KHLKHENVIGLLDVFTPATSIEDFSEVYLVTTLMGADLNNIVKSQALSDEHVQFLVYQLL 141
Query: 215 SLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAET 274
                     +G+ Y+H   IIHRDLK +N+ ++E+  +++ DFG+AR   +   MT   
Sbjct: 142 ----------RGLKYIHSAGIIHRDLKPSNVAVNEDSELRILDFGLARQADEE--MTGYV 189
Query: 275 GTYRWMAPEV-IEHKPYDYKADVFSFGIALWELLTGELPYAG 315
            T  + APE+ +    Y+   D++S G  + ELL G+  + G
Sbjct: 190 ATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLQGKALFPG 231

>pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 74.7 bits (182), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 53/197 (26%), Positives = 94/197 (47%), Gaps = 12/197 (6%)
Query: 122 CKVASGSYGDLYKG--TYCSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIR---HKNVV 176
            ++  G+YG +YK    +    VA+K ++       +     +EV ++R++    H NVV
Sbjct: 10  AEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGEEGLPISTVREVALLRRLEAFEHPNVV 69
Query: 177 QFIGACT-----RPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLK-VAIDVSKGMNYL 230
           + +  C      R   + +V E + +  +  +L K          +K +     +G+++L
Sbjct: 70  RLMDVCATSRTDREIKVTLVFEHVDQ-DLRTYLDKAPPPGLPAETIKDLMRQFLRGLDFL 128
Query: 231 HQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAETGTYRWMAPEVIEHKPY 290
           H N I+HRDLK  N+L+   G VK+ADFG+AR+ +    +     T  + APEV+    Y
Sbjct: 129 HANCIVHRDLKPENILVTSGGTVKLADFGLARIYSYQMALAPVVVTLWYRAPEVLLQSTY 188
Query: 291 DYKADVFSFGIALWELL 307
               D++S G    E+ 
Sbjct: 189 ATPVDMWSVGCIFAEMF 205

>pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353

Iteration: 1
 Score = 74.7 bits (182), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 56/222 (25%), Positives = 100/222 (45%), Gaps = 28/222 (12%)
Query: 140 QEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVTEFMARGS 199
           + VAIK L     N    K   +E+ +M+ + HKN++  +   T    L    EF     
Sbjct: 50  RNVAIKKLSRPFQNQTHAKRAYRELVLMKXVNHKNIISLLNVFTPQKTL---EEFQDVYL 106
Query: 200 IYDFLHKQKGVFQLTSLLKVAIDVSK----------GMNYLHQNNIIHRDLKTANLLMDE 249
           + + +        L  ++++ +D  +          G+ +LH   IIHRDLK +N+++  
Sbjct: 107 VMELMDAN-----LCQVIQMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKS 161
Query: 250 NGVVKVADFGVARVQAQSGVMTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTG 309
           +  +K+ DFG+AR    S +MT    T  + APEVI    Y    D++S G  + E++  
Sbjct: 162 DXTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRH 221
Query: 310 ELPYAGLTPLQAAVGVVQ----------KSLRPTIPKHAHPR 341
           ++ + G   +     V++          K L+PT+  +   R
Sbjct: 222 KILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYVENR 263

>pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303

Iteration: 1
 Score = 74.7 bits (182), Expect = 9e-14,   Method: Compositional matrix adjust.
 Identities = 64/270 (23%), Positives = 115/270 (42%), Gaps = 42/270 (15%)
Query: 124 VASGSYGDLYKGTYC--SQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGA 181
           +  G++G + K      S+  AIK ++      E L     EV ++  + H+ VV++  A
Sbjct: 14  LGQGAFGQVVKARNALDSRYYAIKKIRH---TEEKLSTILSEVXLLASLNHQYVVRYYAA 70
Query: 182 -------------CTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMN 228
                          +   L I  E+    ++YD +H +    Q     ++   + + ++
Sbjct: 71  WLERRNFVKPXTAVKKKSTLFIQXEYCENRTLYDLIHSENLNQQRDEYWRLFRQILEALS 130
Query: 229 YLHQNNIIHRDLKTANLLMDENGVVKVADFGVAR---------------VQAQSGVMTAE 273
           Y+H   IIHR+LK  N+ +DE+  VK+ DFG+A+               +   S  +T+ 
Sbjct: 131 YIHSQGIIHRNLKPXNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQNLPGSSDNLTSA 190
Query: 274 TGTYRWMAPEVIEHK-PYDYKADVFSFGIALWELL----TGELPYAGLTPLQAAVGVVQK 328
            GT  ++A EV++    Y+ K D +S GI  +E +    TG      L  L++    V  
Sbjct: 191 IGTAXYVATEVLDGTGHYNEKIDXYSLGIIFFEXIYPFSTGXERVNILKKLRS----VSI 246
Query: 329 SLRPTIPKHAHPRLAELLERCWQHDPTQRP 358
              P    +      +++     HDP +RP
Sbjct: 247 EFPPDFDDNKXKVEKKIIRLLIDHDPNKRP 276

>pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360

Iteration: 1
 Score = 74.7 bits (182), Expect = 9e-14,   Method: Compositional matrix adjust.
 Identities = 60/215 (27%), Positives = 102/215 (47%), Gaps = 15/215 (6%)
Query: 110 VWEIDAKQLKIECKVASGSYGDLYKG--TYCSQEVAIKVLKPECVNTEMLKEFSQEVYIM 167
           +WE+  +   +   V SG+YG +     T     VA+K L     +    K   +E+ ++
Sbjct: 17  IWEVPERYQNL-SPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLL 75
Query: 168 RKIRHKNVVQFIGACTRPPNL------CIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAI 221
           + ++H+NV+  +   T   +L       +VT  M    + + +  QK        L   I
Sbjct: 76  KHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMG-ADLNNIVKCQKLTDDHVQFLIYQI 134
Query: 222 DVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAETGTYRWMA 281
              +G+ Y+H  +IIHRDLK +NL ++E+  +K+  FG+AR       MT    T  + A
Sbjct: 135 --LRGLKYIHSADIIHRDLKPSNLAVNEDCELKILGFGLAR--HTDDEMTGYVATRWYRA 190
Query: 282 PEV-IEHKPYDYKADVFSFGIALWELLTGELPYAG 315
           PE+ +    Y+   D++S G  + ELLTG   + G
Sbjct: 191 PEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPG 225

>pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364

Iteration: 1
 Score = 74.7 bits (182), Expect = 9e-14,   Method: Compositional matrix adjust.
 Identities = 62/224 (27%), Positives = 103/224 (45%), Gaps = 31/224 (13%)
Query: 124 VASGSYGDLYKGTYCSQ-------EVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVV 176
           +  G+YG       CS         VAIK + P    T   +   +E+ I+ + RH+N++
Sbjct: 35  IGEGAYG-----MVCSAYDNLNKVRVAIKKISPFEHQTYCQRTL-REIKILLRFRHENII 88
Query: 177 QFIGACTRPP------NLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYL 230
             I    R P      ++ IV + M    +Y  L  Q        +      + +G+ Y+
Sbjct: 89  G-INDIIRAPTIEQMKDVYIVQDLM-ETDLYKLLKTQH--LSNDHICYFLYQILRGLKYI 144
Query: 231 HQNNIIHRDLKTANLLMDENGVVKVADFGVARV----QAQSGVMTAETGTYRWMAPEV-I 285
           H  N++HRDLK +NLL++    +K+ DFG+ARV       +G +T    T  + APE+ +
Sbjct: 145 HSANVLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIML 204
Query: 286 EHKPYDYKADVFSFGIALWELLTGELPYAG---LTPLQAAVGVV 326
             K Y    D++S G  L E+L+    + G   L  L   +G++
Sbjct: 205 NSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGIL 248

>pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Length = 370

Iteration: 1
 Score = 74.7 bits (182), Expect = 9e-14,   Method: Compositional matrix adjust.
 Identities = 58/218 (26%), Positives = 100/218 (45%), Gaps = 20/218 (9%)
Query: 140 QEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNL------CIVTE 193
           + VAIK L     N    K   +E+ +M+ + HKN++  +   T   +L       IV E
Sbjct: 50  RNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVME 109
Query: 194 FMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVV 253
            M   ++   +  +    +++ LL     +  G+ +LH   IIHRDLK +N+++  +  +
Sbjct: 110 LMD-ANLCQVIQMELDHERMSYLL---YQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTL 165
Query: 254 KVADFGVARVQAQSGVMTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPY 313
           K+ DFG+AR    S +M  E  T  + APEVI    Y    D++S G  + E++  ++ +
Sbjct: 166 KILDFGLARTAGTSFMMEPEVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVCHKILF 225
Query: 314 AG----------LTPLQAAVGVVQKSLRPTIPKHAHPR 341
            G          +  L        K L+PT+  +   R
Sbjct: 226 PGRDYIDQWNKVIEQLGTPCPAFMKKLQPTVRNYVENR 263

>pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364

Iteration: 1
 Score = 74.7 bits (182), Expect = 9e-14,   Method: Compositional matrix adjust.
 Identities = 57/218 (26%), Positives = 101/218 (46%), Gaps = 20/218 (9%)
Query: 140 QEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNL------CIVTE 193
           + VAIK L     N    K   +E+ +M+ + HKN++  +   T    L       +V E
Sbjct: 50  RNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVME 109
Query: 194 FMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVV 253
            M   ++   +  +    +++ LL   +    G+ +LH   IIHRDLK +N+++  +  +
Sbjct: 110 LMD-ANLXQVIQMELDHERMSYLLYQML---XGIKHLHSAGIIHRDLKPSNIVVKSDXTL 165
Query: 254 KVADFGVARVQAQSGVMTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPY 313
           K+ DFG+AR    S +MT    T  + APEVI    Y    D++S G  + E++  ++ +
Sbjct: 166 KILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILF 225
Query: 314 AGLTPLQAAVGVVQ----------KSLRPTIPKHAHPR 341
            G   +     V++          K L+PT+  +   R
Sbjct: 226 PGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYVENR 263

>pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360

Iteration: 1
 Score = 74.3 bits (181), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 62/224 (27%), Positives = 103/224 (45%), Gaps = 31/224 (13%)
Query: 124 VASGSYGDLYKGTYCSQ-------EVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVV 176
           +  G+YG       CS         VAIK + P    T   +   +E+ I+ + RH+N++
Sbjct: 31  IGEGAYG-----MVCSAYDNVNKVRVAIKKISPFEHQTYCQRTL-REIKILLRFRHENII 84
Query: 177 QFIGACTRPP------NLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYL 230
             I    R P      ++ IV + M    +Y  L  Q        +      + +G+ Y+
Sbjct: 85  G-INDIIRAPTIEQMKDVYIVQDLM-ETDLYKLLKTQH--LSNDHICYFLYQILRGLKYI 140
Query: 231 HQNNIIHRDLKTANLLMDENGVVKVADFGVARV----QAQSGVMTAETGTYRWMAPEV-I 285
           H  N++HRDLK +NLL++    +K+ DFG+ARV       +G +T    T  + APE+ +
Sbjct: 141 HSANVLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIML 200
Query: 286 EHKPYDYKADVFSFGIALWELLTGELPYAG---LTPLQAAVGVV 326
             K Y    D++S G  L E+L+    + G   L  L   +G++
Sbjct: 201 NSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGIL 244

>pdb|3K2L|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) Length = 429

Iteration: 1
 Score = 74.3 bits (181), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 58/197 (29%), Positives = 100/197 (50%), Gaps = 17/197 (8%)
Query: 124 VASGSYGDLYKGT--YCSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHK------NV 175
           +  G +G + K       Q VA+K+++ E       ++ ++E+ I+  +R +      NV
Sbjct: 105 IGKGXFGQVVKAYDHKVHQHVALKMVRNE---KRFHRQAAEEIRILEHLRKQDKDNTMNV 161
Query: 176 VQFIGACTRPPNLCIVTEFMARGSIYDFLHKQK-GVFQLTSLLKVAIDVSKGMNYLHQNN 234
           +  +   T   ++C+  E ++  ++Y+ + K K   F L  + K A  + + ++ LH+N 
Sbjct: 162 IHMLENFTFRNHICMTFELLSM-NLYELIKKNKFQGFSLPLVRKFAHSILQCLDALHKNR 220
Query: 235 IIHRDLKTANLLMDENGV--VKVADFGVARVQAQSGVMTAETGTYRWMAPEVIEHKPYDY 292
           IIH DLK  N+L+ + G   +KV DFG +  + Q      ++  YR  APEVI    Y  
Sbjct: 221 IIHCDLKPENILLKQQGRSGIKVIDFGSSCYEHQRVYXXIQSRFYR--APEVILGARYGM 278
Query: 293 KADVFSFGIALWELLTG 309
             D++S G  L ELLTG
Sbjct: 279 PIDMWSLGCILAELLTG 295

>pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360

Iteration: 1
 Score = 74.3 bits (181), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 62/224 (27%), Positives = 103/224 (45%), Gaps = 31/224 (13%)
Query: 124 VASGSYGDLYKGTYCSQ-------EVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVV 176
           +  G+YG       CS         VAIK + P    T   +   +E+ I+ + RH+N++
Sbjct: 31  IGEGAYG-----MVCSAYDNVNKVRVAIKKISPFEHQTYCQRTL-REIKILLRFRHENII 84
Query: 177 QFIGACTRPP------NLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYL 230
             I    R P      ++ IV + M    +Y  L  Q        +      + +G+ Y+
Sbjct: 85  G-INDIIRAPTIEQMKDVYIVQDLM-ETDLYKLLKTQH--LSNDHICYFLYQILRGLKYI 140
Query: 231 HQNNIIHRDLKTANLLMDENGVVKVADFGVARV----QAQSGVMTAETGTYRWMAPEV-I 285
           H  N++HRDLK +NLL++    +K+ DFG+ARV       +G +T    T  + APE+ +
Sbjct: 141 HSANVLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIML 200
Query: 286 EHKPYDYKADVFSFGIALWELLTGELPYAG---LTPLQAAVGVV 326
             K Y    D++S G  L E+L+    + G   L  L   +G++
Sbjct: 201 NSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGIL 244

>pdb|3R1N|A Chain A, Mk3 Kinase Bound To Compound 5b Length = 317

Iteration: 1
 Score = 74.3 bits (181), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 53/189 (28%), Positives = 94/189 (49%), Gaps = 13/189 (6%)
Query: 188 LCIVTEFMARGSIYDFLHKQ-KGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLL 246
           L I+ E M  G ++  + ++    F      ++  D+   + +LH +NI HRD+K  NLL
Sbjct: 82  LLIIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAIQFLHSHNIAHRDVKPENLL 141
Query: 247 M---DENGVVKVADFGVARVQAQSGVMTAETGTYRWMAPEVIEHKPYDYKADVFSFGIAL 303
               +++ V+K+ DFG A+   Q+ + T     Y ++APEV+  + YD   D++S G+ +
Sbjct: 142 YTSKEKDAVLKLTDFGFAKETTQNALQTPCYTPY-YVAPEVLGPEKYDKSCDMWSLGVIM 200
Query: 304 WELLTGELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRLAELLERCWQ-------HDPTQ 356
           + LL G  P+   T  QA    +++ +R       +P  +E+ E   Q        DPT+
Sbjct: 201 YILLCGFPPFYSNTG-QAISPGMKRRIRLGQYGFPNPEWSEVSEDAKQLIRLLLKTDPTE 259
Query: 357 RPNFSQITD 365
           R   +Q  +
Sbjct: 260 RLTITQFMN 268

>pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365

Iteration: 1
 Score = 74.3 bits (181), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 62/224 (27%), Positives = 103/224 (45%), Gaps = 31/224 (13%)
Query: 124 VASGSYGDLYKGTYCSQ-------EVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVV 176
           +  G+YG       CS         VAIK + P    T   +   +E+ I+ + RH+N++
Sbjct: 36  IGEGAYG-----MVCSAYDNLNKVRVAIKKISPFEHQTYCQRTL-REIKILLRFRHENII 89
Query: 177 QFIGACTRPP------NLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYL 230
             I    R P      ++ IV + M    +Y  L  Q        +      + +G+ Y+
Sbjct: 90  G-INDIIRAPTIEQMKDVYIVQDLM-ETDLYKLLKTQH--LSNDHICYFLYQILRGLKYI 145
Query: 231 HQNNIIHRDLKTANLLMDENGVVKVADFGVARV----QAQSGVMTAETGTYRWMAPEV-I 285
           H  N++HRDLK +NLL++    +K+ DFG+ARV       +G +T    T  + APE+ +
Sbjct: 146 HSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIML 205
Query: 286 EHKPYDYKADVFSFGIALWELLTGELPYAG---LTPLQAAVGVV 326
             K Y    D++S G  L E+L+    + G   L  L   +G++
Sbjct: 206 NSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGIL 249

>pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360

Iteration: 1
 Score = 74.3 bits (181), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 62/224 (27%), Positives = 103/224 (45%), Gaps = 31/224 (13%)
Query: 124 VASGSYGDLYKGTYCSQ-------EVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVV 176
           +  G+YG       CS         VAIK + P    T   +   +E+ I+ + RH+N++
Sbjct: 31  IGEGAYG-----MVCSAYDNVNKVRVAIKKISPFEHQTYCQRTL-REIKILLRFRHENII 84
Query: 177 QFIGACTRPP------NLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYL 230
             I    R P      ++ IV + M    +Y  L  Q        +      + +G+ Y+
Sbjct: 85  G-INDIIRAPTIEQMKDVYIVQDLM-ETDLYKLLKTQH--LSNDHICYFLYQILRGLKYI 140
Query: 231 HQNNIIHRDLKTANLLMDENGVVKVADFGVARV----QAQSGVMTAETGTYRWMAPEV-I 285
           H  N++HRDLK +NLL++    +K+ DFG+ARV       +G +T    T  + APE+ +
Sbjct: 141 HSANVLHRDLKPSNLLLNTTXDLKIXDFGLARVADPDHDHTGFLTEYVATRWYRAPEIML 200
Query: 286 EHKPYDYKADVFSFGIALWELLTGELPYAG---LTPLQAAVGVV 326
             K Y    D++S G  L E+L+    + G   L  L   +G++
Sbjct: 201 NSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGIL 244

>pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366

Iteration: 1
 Score = 74.3 bits (181), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 62/224 (27%), Positives = 103/224 (45%), Gaps = 31/224 (13%)
Query: 124 VASGSYGDLYKGTYCSQ-------EVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVV 176
           +  G+YG       CS         VAIK + P    T   +   +E+ I+ + RH+N++
Sbjct: 37  IGEGAYG-----MVCSAYDNLNKVRVAIKKISPFEHQTYCQRTL-REIKILLRFRHENII 90
Query: 177 QFIGACTRPP------NLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYL 230
             I    R P      ++ IV + M    +Y  L  Q        +      + +G+ Y+
Sbjct: 91  G-INDIIRAPTIEQMKDVYIVQDLM-ETDLYKLLKTQH--LSNDHICYFLYQILRGLKYI 146
Query: 231 HQNNIIHRDLKTANLLMDENGVVKVADFGVARV----QAQSGVMTAETGTYRWMAPEV-I 285
           H  N++HRDLK +NLL++    +K+ DFG+ARV       +G +T    T  + APE+ +
Sbjct: 147 HSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIML 206
Query: 286 EHKPYDYKADVFSFGIALWELLTGELPYAG---LTPLQAAVGVV 326
             K Y    D++S G  L E+L+    + G   L  L   +G++
Sbjct: 207 NSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGIL 250

>pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357

Iteration: 1
 Score = 74.3 bits (181), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 62/224 (27%), Positives = 103/224 (45%), Gaps = 31/224 (13%)
Query: 124 VASGSYGDLYKGTYCSQ-------EVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVV 176
           +  G+YG       CS         VAIK + P    T   +   +E+ I+ + RH+N++
Sbjct: 28  IGEGAYG-----MVCSAYDNLNKVRVAIKKISPFEHQTYCQRTL-REIKILLRFRHENII 81
Query: 177 QFIGACTRPP------NLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYL 230
             I    R P      ++ IV + M    +Y  L  Q        +      + +G+ Y+
Sbjct: 82  G-INDIIRAPTIEQMKDVYIVQDLM-ETDLYKLLKTQH--LSNDHICYFLYQILRGLKYI 137
Query: 231 HQNNIIHRDLKTANLLMDENGVVKVADFGVARV----QAQSGVMTAETGTYRWMAPEV-I 285
           H  N++HRDLK +NLL++    +K+ DFG+ARV       +G +T    T  + APE+ +
Sbjct: 138 HSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIML 197
Query: 286 EHKPYDYKADVFSFGIALWELLTGELPYAG---LTPLQAAVGVV 326
             K Y    D++S G  L E+L+    + G   L  L   +G++
Sbjct: 198 NSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGIL 241

>pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364

Iteration: 1
 Score = 74.3 bits (181), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 62/224 (27%), Positives = 103/224 (45%), Gaps = 31/224 (13%)
Query: 124 VASGSYGDLYKGTYCSQ-------EVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVV 176
           +  G+YG       CS         VAIK + P    T   +   +E+ I+ + RH+N++
Sbjct: 35  IGEGAYG-----MVCSAYDNLNKVRVAIKKISPFEHQTYCQRTL-REIKILLRFRHENII 88
Query: 177 QFIGACTRPP------NLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYL 230
             I    R P      ++ IV + M    +Y  L  Q        +      + +G+ Y+
Sbjct: 89  G-INDIIRAPTIEQMKDVYIVQDLM-ETDLYKLLKTQH--LSNDHICYFLYQILRGLKYI 144
Query: 231 HQNNIIHRDLKTANLLMDENGVVKVADFGVARV----QAQSGVMTAETGTYRWMAPEV-I 285
           H  N++HRDLK +NLL++    +K+ DFG+ARV       +G +T    T  + APE+ +
Sbjct: 145 HSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIML 204
Query: 286 EHKPYDYKADVFSFGIALWELLTGELPYAG---LTPLQAAVGVV 326
             K Y    D++S G  L E+L+    + G   L  L   +G++
Sbjct: 205 NSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGIL 248

>pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356

Iteration: 1
 Score = 74.3 bits (181), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 57/218 (26%), Positives = 101/218 (46%), Gaps = 20/218 (9%)
Query: 140 QEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNL------CIVTE 193
           + VAIK L     N    K   +E+ +M+ + HKN++  +   T    L       +V E
Sbjct: 43  RNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVME 102
Query: 194 FMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVV 253
            M   ++   +  +    +++ LL   +    G+ +LH   IIHRDLK +N+++  +  +
Sbjct: 103 LMD-ANLXQVIQMELDHERMSYLLYQML---XGIKHLHSAGIIHRDLKPSNIVVKSDXTL 158
Query: 254 KVADFGVARVQAQSGVMTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPY 313
           K+ DFG+AR    S +MT    T  + APEVI    Y    D++S G  + E++  ++ +
Sbjct: 159 KILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILF 218
Query: 314 AGLTPLQAAVGVVQ----------KSLRPTIPKHAHPR 341
            G   +     V++          K L+PT+  +   R
Sbjct: 219 PGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYVENR 256

>pdb|3FHR|A Chain A, High Resolution Crystal Structure Of Mitogen-Activated Protein Kinase-Activated Protein Kinase 3 (Mk3)-Inhibitor Complex Length = 336

Iteration: 1
 Score = 74.3 bits (181), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 53/189 (28%), Positives = 94/189 (49%), Gaps = 13/189 (6%)
Query: 188 LCIVTEFMARGSIYDFLHKQ-KGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLL 246
           L I+ E M  G ++  + ++    F      ++  D+   + +LH +NI HRD+K  NLL
Sbjct: 101 LLIIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAIQFLHSHNIAHRDVKPENLL 160
Query: 247 M---DENGVVKVADFGVARVQAQSGVMTAETGTYRWMAPEVIEHKPYDYKADVFSFGIAL 303
               +++ V+K+ DFG A+   Q+ + T     Y ++APEV+  + YD   D++S G+ +
Sbjct: 161 YTSKEKDAVLKLTDFGFAKETTQNALQTPCYTPY-YVAPEVLGPEKYDKSCDMWSLGVIM 219
Query: 304 WELLTGELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRLAELLERCWQ-------HDPTQ 356
           + LL G  P+   T  QA    +++ +R       +P  +E+ E   Q        DPT+
Sbjct: 220 YILLCGFPPFYSNTG-QAISPGMKRRIRLGQYGFPNPEWSEVSEDAKQLIRLLLKTDPTE 278
Query: 357 RPNFSQITD 365
           R   +Q  +
Sbjct: 279 RLTITQFMN 287

>pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368

Iteration: 1
 Score = 74.3 bits (181), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 62/224 (27%), Positives = 103/224 (45%), Gaps = 31/224 (13%)
Query: 124 VASGSYGDLYKGTYCSQ-------EVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVV 176
           +  G+YG       CS         VAIK + P    T   +   +E+ I+ + RH+N++
Sbjct: 39  IGEGAYG-----MVCSAYDNVNKVRVAIKKISPFEHQTYCQRTL-REIKILLRFRHENII 92
Query: 177 QFIGACTRPP------NLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYL 230
             I    R P      ++ IV + M    +Y  L  Q        +      + +G+ Y+
Sbjct: 93  G-INDIIRAPTIEQMKDVYIVQDLM-ETDLYKLLKTQH--LSNDHICYFLYQILRGLKYI 148
Query: 231 HQNNIIHRDLKTANLLMDENGVVKVADFGVARV----QAQSGVMTAETGTYRWMAPEV-I 285
           H  N++HRDLK +NLL++    +K+ DFG+ARV       +G +T    T  + APE+ +
Sbjct: 149 HSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIML 208
Query: 286 EHKPYDYKADVFSFGIALWELLTGELPYAG---LTPLQAAVGVV 326
             K Y    D++S G  L E+L+    + G   L  L   +G++
Sbjct: 209 NSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGIL 252

>pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368

Iteration: 1
 Score = 74.3 bits (181), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 62/224 (27%), Positives = 103/224 (45%), Gaps = 31/224 (13%)
Query: 124 VASGSYGDLYKGTYCSQ-------EVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVV 176
           +  G+YG       CS         VAIK + P    T   +   +E+ I+ + RH+N++
Sbjct: 31  IGEGAYG-----MVCSAYDNVNKVRVAIKKISPFEHQTYCQRTL-REIKILLRFRHENII 84
Query: 177 QFIGACTRPP------NLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYL 230
             I    R P      ++ IV + M    +Y  L  Q        +      + +G+ Y+
Sbjct: 85  G-INDIIRAPTIEQMKDVYIVQDLM-ETDLYKLLKTQH--LSNDHICYFLYQILRGLKYI 140
Query: 231 HQNNIIHRDLKTANLLMDENGVVKVADFGVARV----QAQSGVMTAETGTYRWMAPEV-I 285
           H  N++HRDLK +NLL++    +K+ DFG+ARV       +G +T    T  + APE+ +
Sbjct: 141 HSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIML 200
Query: 286 EHKPYDYKADVFSFGIALWELLTGELPYAG---LTPLQAAVGVV 326
             K Y    D++S G  L E+L+    + G   L  L   +G++
Sbjct: 201 NSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGIL 244

>pdb|3P23|A Chain A, Crystal Structure Of The Human Kinase And Rnase Domains In Complex With Adp Length = 432

Iteration: 1
 Score = 74.3 bits (181), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 74/261 (28%), Positives = 127/261 (48%), Gaps = 49/261 (18%)
Query: 132 LYKGTYCSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKI-RHKNVVQFIGACTRPPN--- 187
           +Y+G + +++VA+K + PEC +        +EV ++R+   H NV+++   CT       
Sbjct: 41  VYRGMFDNRDVAVKRILPECFSFA-----DREVQLLRESDEHPNVIRYF--CTEKDRQFQ 93
Query: 188 -----LCIVT--EFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDL 240
                LC  T  E++ +    DF H   G+  +T L +     + G+ +LH  NI+HRDL
Sbjct: 94  YIAIELCAATLQEYVEQK---DFAHL--GLEPITLLQQT----TSGLAHLHSLNIVHRDL 144
Query: 241 KTANLLM---DENGVVK--VADFGVARVQA--------QSGVMTAETGTYRWMAPEVIEH 287
           K  N+L+   + +G +K  ++DFG+ +  A        +SGV     GT  W+APE++  
Sbjct: 145 KPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGV----PGTEGWIAPEMLSE 200
Query: 288 KPYD---YKADVFSFGIALWELLT-GELPYAGLTPLQAAVGVVQKSLRPTIP-KHAHPRL 342
              +   Y  D+FS G   + +++ G  P+      QA + +   SL    P KH     
Sbjct: 201 DCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQRQANILLGACSLDCLHPEKHEDVIA 260
Query: 343 AELLERCWQHDPTQRPNFSQI 363
            EL+E+    DP +RP+   +
Sbjct: 261 RELIEKMIAMDPQKRPSAKHV 281

>pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 74.3 bits (181), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 60/215 (27%), Positives = 102/215 (47%), Gaps = 15/215 (6%)
Query: 110 VWEIDAKQLKIECKVASGSYGDLYKG--TYCSQEVAIKVLKPECVNTEMLKEFSQEVYIM 167
           +WE+  +   +   V SG+YG +     T     VA+K L     +    K   +E+ ++
Sbjct: 17  IWEVPERYQNL-SPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLL 75
Query: 168 RKIRHKNVVQFIGACTRPPNL------CIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAI 221
           + ++H+NV+  +   T   +L       +VT  M    + + +  QK        L   I
Sbjct: 76  KHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMG-ADLNNIVKCQKLTDDHVQFLIYQI 134
Query: 222 DVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAETGTYRWMA 281
              +G+ Y+H  +IIHRDLK +NL ++E+  +K+ D G+AR       MT    T  + A
Sbjct: 135 --LRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDAGLAR--HTDDEMTGYVATRWYRA 190
Query: 282 PEV-IEHKPYDYKADVFSFGIALWELLTGELPYAG 315
           PE+ +    Y+   D++S G  + ELLTG   + G
Sbjct: 191 PEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPG 225

>pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358

Iteration: 1
 Score = 74.3 bits (181), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 62/224 (27%), Positives = 103/224 (45%), Gaps = 31/224 (13%)
Query: 124 VASGSYGDLYKGTYCSQ-------EVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVV 176
           +  G+YG       CS         VAIK + P    T   +   +E+ I+ + RH+N++
Sbjct: 29  IGEGAYG-----MVCSAYDNLNKVRVAIKKISPFEHQTYCQRTL-REIKILLRFRHENII 82
Query: 177 QFIGACTRPP------NLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYL 230
             I    R P      ++ IV + M    +Y  L  Q        +      + +G+ Y+
Sbjct: 83  G-INDIIRAPTIEQMKDVYIVQDLM-ETDLYKLLKTQH--LSNDHICYFLYQILRGLKYI 138
Query: 231 HQNNIIHRDLKTANLLMDENGVVKVADFGVARV----QAQSGVMTAETGTYRWMAPEV-I 285
           H  N++HRDLK +NLL++    +K+ DFG+ARV       +G +T    T  + APE+ +
Sbjct: 139 HSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIML 198
Query: 286 EHKPYDYKADVFSFGIALWELLTGELPYAG---LTPLQAAVGVV 326
             K Y    D++S G  L E+L+    + G   L  L   +G++
Sbjct: 199 NSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGIL 242

>pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360

Iteration: 1
 Score = 74.3 bits (181), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 62/224 (27%), Positives = 103/224 (45%), Gaps = 31/224 (13%)
Query: 124 VASGSYGDLYKGTYCSQ-------EVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVV 176
           +  G+YG       CS         VAIK + P    T   +   +E+ I+ + RH+N++
Sbjct: 31  IGEGAYG-----MVCSAYDNVNKVRVAIKKISPFEHQTYCQRTL-REIKILLRFRHENII 84
Query: 177 QFIGACTRPP------NLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYL 230
             I    R P      ++ IV + M    +Y  L  Q        +      + +G+ Y+
Sbjct: 85  G-INDIIRAPTIEQMKDVYIVQDLM-ETDLYKLLKTQH--LSNDHICYFLYQILRGLKYI 140
Query: 231 HQNNIIHRDLKTANLLMDENGVVKVADFGVARV----QAQSGVMTAETGTYRWMAPEV-I 285
           H  N++HRDLK +NLL++    +K+ DFG+ARV       +G +T    T  + APE+ +
Sbjct: 141 HSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIML 200
Query: 286 EHKPYDYKADVFSFGIALWELLTGELPYAG---LTPLQAAVGVV 326
             K Y    D++S G  L E+L+    + G   L  L   +G++
Sbjct: 201 NSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGIL 244

>pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380

Iteration: 1
 Score = 74.3 bits (181), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 62/224 (27%), Positives = 103/224 (45%), Gaps = 31/224 (13%)
Query: 124 VASGSYGDLYKGTYCSQ-------EVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVV 176
           +  G+YG       CS         VAIK + P    T   +   +E+ I+ + RH+N++
Sbjct: 51  IGEGAYG-----MVCSAYDNVNKVRVAIKKISPFEHQTYCQRTL-REIKILLRFRHENII 104
Query: 177 QFIGACTRPP------NLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYL 230
             I    R P      ++ IV + M    +Y  L  Q        +      + +G+ Y+
Sbjct: 105 G-INDIIRAPTIEQMKDVYIVQDLM-ETDLYKLLKTQH--LSNDHICYFLYQILRGLKYI 160
Query: 231 HQNNIIHRDLKTANLLMDENGVVKVADFGVARV----QAQSGVMTAETGTYRWMAPEV-I 285
           H  N++HRDLK +NLL++    +K+ DFG+ARV       +G +T    T  + APE+ +
Sbjct: 161 HSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIML 220
Query: 286 EHKPYDYKADVFSFGIALWELLTGELPYAG---LTPLQAAVGVV 326
             K Y    D++S G  L E+L+    + G   L  L   +G++
Sbjct: 221 NSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGIL 264

>pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358

Iteration: 1
 Score = 74.3 bits (181), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 62/224 (27%), Positives = 103/224 (45%), Gaps = 31/224 (13%)
Query: 124 VASGSYGDLYKGTYCSQ-------EVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVV 176
           +  G+YG       CS         VAIK + P    T   +   +E+ I+ + RH+N++
Sbjct: 29  IGEGAYG-----MVCSAYDNLNKVRVAIKKISPFEHQTYCQRTL-REIKILLRFRHENII 82
Query: 177 QFIGACTRPP------NLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYL 230
             I    R P      ++ IV + M    +Y  L  Q        +      + +G+ Y+
Sbjct: 83  G-INDIIRAPTIEQMKDVYIVQDLM-ETDLYKLLKTQH--LSNDHICYFLYQILRGLKYI 138
Query: 231 HQNNIIHRDLKTANLLMDENGVVKVADFGVARV----QAQSGVMTAETGTYRWMAPEV-I 285
           H  N++HRDLK +NLL++    +K+ DFG+ARV       +G +T    T  + APE+ +
Sbjct: 139 HSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIML 198
Query: 286 EHKPYDYKADVFSFGIALWELLTGELPYAG---LTPLQAAVGVV 326
             K Y    D++S G  L E+L+    + G   L  L   +G++
Sbjct: 199 NSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGIL 242

>pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 74.3 bits (181), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 62/224 (27%), Positives = 103/224 (45%), Gaps = 31/224 (13%)
Query: 124 VASGSYGDLYKGTYCSQ-------EVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVV 176
           +  G+YG       CS         VAIK + P    T   +   +E+ I+ + RH+N++
Sbjct: 33  IGEGAYG-----MVCSAYDNVNKVRVAIKKISPFEHQTYCQRTL-REIKILLRFRHENII 86
Query: 177 QFIGACTRPP------NLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYL 230
             I    R P      ++ IV + M    +Y  L  Q        +      + +G+ Y+
Sbjct: 87  G-INDIIRAPTIEQMKDVYIVQDLM-ETDLYKLLKTQH--LSNDHICYFLYQILRGLKYI 142
Query: 231 HQNNIIHRDLKTANLLMDENGVVKVADFGVARV----QAQSGVMTAETGTYRWMAPEV-I 285
           H  N++HRDLK +NLL++    +K+ DFG+ARV       +G +T    T  + APE+ +
Sbjct: 143 HSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIML 202
Query: 286 EHKPYDYKADVFSFGIALWELLTGELPYAG---LTPLQAAVGVV 326
             K Y    D++S G  L E+L+    + G   L  L   +G++
Sbjct: 203 NSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGIL 246

>pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 74.3 bits (181), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 53/197 (26%), Positives = 94/197 (47%), Gaps = 12/197 (6%)
Query: 122 CKVASGSYGDLYKG--TYCSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIR---HKNVV 176
            ++  G+YG +YK    +    VA+K ++       +     +EV ++R++    H NVV
Sbjct: 10  AEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGEEGLPISTVREVALLRRLEAFEHPNVV 69
Query: 177 QFIGACT-----RPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLK-VAIDVSKGMNYL 230
           + +  C      R   + +V E + +  +  +L K          +K +     +G+++L
Sbjct: 70  RLMDVCATSRTDREIKVTLVFEHVDQ-DLRTYLDKAPPPGLPAETIKDLMRQFLRGLDFL 128
Query: 231 HQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAETGTYRWMAPEVIEHKPY 290
           H N I+HRDLK  N+L+   G VK+ADFG+AR+ +    +     T  + APEV+    Y
Sbjct: 129 HANCIVHRDLKPENILVTSGGTVKLADFGLARIYSYQMALDPVVVTLWYRAPEVLLQSTY 188
Query: 291 DYKADVFSFGIALWELL 307
               D++S G    E+ 
Sbjct: 189 ATPVDMWSVGCIFAEMF 205

>pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 74.3 bits (181), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 60/215 (27%), Positives = 102/215 (47%), Gaps = 15/215 (6%)
Query: 110 VWEIDAKQLKIECKVASGSYGDLYKG--TYCSQEVAIKVLKPECVNTEMLKEFSQEVYIM 167
           +WE+  +   +   V SG+YG +     T     VA+K L     +    K   +E+ ++
Sbjct: 17  IWEVPERYQNL-SPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLL 75
Query: 168 RKIRHKNVVQFIGACTRPPNL------CIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAI 221
           + ++H+NV+  +   T   +L       +VT  M    + + +  QK        L   I
Sbjct: 76  KHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMG-ADLNNIVKCQKLTDDHVQFLIYQI 134
Query: 222 DVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAETGTYRWMA 281
              +G+ Y+H  +IIHRDLK +NL ++E+  +K+ D G+AR       MT    T  + A
Sbjct: 135 --LRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDRGLAR--HTDDEMTGYVATRWYRA 190
Query: 282 PEV-IEHKPYDYKADVFSFGIALWELLTGELPYAG 315
           PE+ +    Y+   D++S G  + ELLTG   + G
Sbjct: 191 PEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPG 225

>pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464

Iteration: 1
 Score = 73.9 bits (180), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 57/235 (24%), Positives = 106/235 (45%), Gaps = 24/235 (10%)
Query: 140 QEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVTEFMARGS 199
           + VAIK L     N    K   +E+ +M+ + HKN++  +   T    L    EF     
Sbjct: 88  RNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTL---EEFQDVYL 144
Query: 200 IYDFLHKQKGVFQLTSLLKVAIDVSK----------GMNYLHQNNIIHRDLKTANLLMDE 249
           + + +        L  ++++ +D  +          G+ +LH   IIHRDLK +N+++  
Sbjct: 145 VMELMDAN-----LCQVIQMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKS 199
Query: 250 NGVVKVADFGVARVQAQSGVMTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTG 309
           +  +K+ DFG+AR    S +MT    T  + APEVI    Y    D++S G  + E++  
Sbjct: 200 DCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRH 259
Query: 310 ELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRLAELLERCWQHDPTQRPNFSQIT 364
           ++ + G   +     V+++   P       P   + L+   ++    RP ++ +T
Sbjct: 260 KILFPGRDYIDQWNKVIEQLGTPC------PEFMKKLQPTVRNYVENRPKYAGLT 308

>pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292

Iteration: 1
 Score = 73.9 bits (180), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 51/198 (25%), Positives = 97/198 (48%), Gaps = 12/198 (6%)
Query: 123 KVASGSYGDLYKGTY--CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIG 180
           K+  G+YG ++K       + VA+K ++ +  +  +     +E+ ++++++HKN+V+   
Sbjct: 9   KIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHD 68
Query: 181 ACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDL 240
                  L +V EF  +  +  +     G      +      + KG+ + H  N++HRDL
Sbjct: 69  VLHSDKKLTLVFEFCDQ-DLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSRNVLHRDL 127
Query: 241 KTANLLMDENGVVKVADFGVARVQA-QSGVMTAETGTYRWMAPEVIEHKPYDYKADVFSF 299
           K  NLL++ NG +K+A+FG+AR         +AE  T  +  P+V+      + A ++S 
Sbjct: 128 KPQNLLINRNGELKLANFGLARAFGIPVRCYSAEVVTLWYRPPDVL------FGAKLYST 181
Query: 300 GIALWE--LLTGELPYAG 315
            I +W    +  EL  AG
Sbjct: 182 SIDMWSAGCIFAELANAG 199

>pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 73.9 bits (180), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 60/215 (27%), Positives = 102/215 (47%), Gaps = 15/215 (6%)
Query: 110 VWEIDAKQLKIECKVASGSYGDLYKG--TYCSQEVAIKVLKPECVNTEMLKEFSQEVYIM 167
           +WE+  +   +   V SG+YG +     T     VA+K L     +    K   +E+ ++
Sbjct: 17  IWEVPERYQNL-SPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLL 75
Query: 168 RKIRHKNVVQFIGACTRPPNL------CIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAI 221
           + ++H+NV+  +   T   +L       +VT  M    + + +  QK        L   I
Sbjct: 76  KHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMG-ADLNNIVKCQKLTDDHVQFLIYQI 134
Query: 222 DVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAETGTYRWMA 281
              +G+ Y+H  +IIHRDLK +NL ++E+  +K+ D G+AR       MT    T  + A
Sbjct: 135 --LRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDGGLAR--HTDDEMTGYVATRWYRA 190
Query: 282 PEV-IEHKPYDYKADVFSFGIALWELLTGELPYAG 315
           PE+ +    Y+   D++S G  + ELLTG   + G
Sbjct: 191 PEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPG 225

>pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 73.9 bits (180), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 62/224 (27%), Positives = 102/224 (45%), Gaps = 31/224 (13%)
Query: 124 VASGSYGDLYKGTYCSQ-------EVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVV 176
           +  G+YG       CS         VAIK + P    T   +   +E+ I+   RH+N++
Sbjct: 33  IGEGAYG-----MVCSAYDNVNKVRVAIKKISPFEHQTYCQRTL-REIKILLAFRHENII 86
Query: 177 QFIGACTRPP------NLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYL 230
             I    R P      ++ IV + M    +Y  L  Q        +      + +G+ Y+
Sbjct: 87  G-INDIIRAPTIEQMKDVYIVQDLM-ETDLYKLLKTQH--LSNDHICYFLYQILRGLKYI 142
Query: 231 HQNNIIHRDLKTANLLMDENGVVKVADFGVARV----QAQSGVMTAETGTYRWMAPEV-I 285
           H  N++HRDLK +NLL++    +K+ DFG+ARV       +G +T    T  + APE+ +
Sbjct: 143 HSANVLHRDLKPSNLLLNTTSDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIML 202
Query: 286 EHKPYDYKADVFSFGIALWELLTGELPYAG---LTPLQAAVGVV 326
             K Y    D++S G  L E+L+    + G   L  L   +G++
Sbjct: 203 NSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGIL 246

>pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 73.9 bits (180), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 53/197 (26%), Positives = 94/197 (47%), Gaps = 12/197 (6%)
Query: 122 CKVASGSYGDLYKG--TYCSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIR---HKNVV 176
            ++  G+YG +YK    +    VA+K ++       +     +EV ++R++    H NVV
Sbjct: 10  AEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGEEGLPISTVREVALLRRLEAFEHPNVV 69
Query: 177 QFIGACT-----RPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLK-VAIDVSKGMNYL 230
           + +  C      R   + +V E + +  +  +L K          +K +     +G+++L
Sbjct: 70  RLMDVCATSRTDREIKVTLVFEHVDQ-DLRTYLDKAPPPGLPAETIKDLMRQFLRGLDFL 128
Query: 231 HQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAETGTYRWMAPEVIEHKPY 290
           H N I+HRDLK  N+L+   G VK+ADFG+AR+ +    +     T  + APEV+    Y
Sbjct: 129 HANCIVHRDLKPENILVTSGGTVKLADFGLARIYSYQMALFPVVVTLWYRAPEVLLQSTY 188
Query: 291 DYKADVFSFGIALWELL 307
               D++S G    E+ 
Sbjct: 189 ATPVDMWSVGCIFAEMF 205

>pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 54/210 (25%), Positives = 98/210 (46%), Gaps = 23/210 (10%)
Query: 119 KIECKVASGSYGDLYKG--TYCSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVV 176
           K+E K+  G+YG +YK       + VA+K ++ +     +     +E+ +++++ H N+V
Sbjct: 10  KVE-KIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIV 68
Query: 177 QFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLL---------KVAIDVSKGM 227
           + +        L +V         ++FLH+    F   S L              + +G+
Sbjct: 69  KLLDVIHTENKLYLV---------FEFLHQDLKTFMDASALTGIPLPLIKSYLFQLLQGL 119
Query: 228 NYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARV-QAQSGVMTAETGTYRWMAPEVIE 286
            + H + ++HRDLK  NLL++  G +K+ADFG+AR           E  T  + APE++ 
Sbjct: 120 AFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILL 179
Query: 287 H-KPYDYKADVFSFGIALWELLTGELPYAG 315
             K Y    D++S G    E++T    + G
Sbjct: 180 GCKYYSTAVDIWSLGCIFAEMVTRRALFPG 209

>pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 53/202 (26%), Positives = 100/202 (49%), Gaps = 7/202 (3%)
Query: 119 KIECKVASGSYGDLYKG--TYCSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVV 176
           K+E K+  G+YG +YK       + VA+K ++ +     +     +E+ +++++ H N+V
Sbjct: 10  KVE-KIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIV 68
Query: 177 QFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAI-DVSKGMNYLHQNNI 235
           + +        L +V EF++   +  F+           L+K  +  + +G+ + H + +
Sbjct: 69  KLLDVIHTENKLYLVFEFLSM-DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRV 127
Query: 236 IHRDLKTANLLMDENGVVKVADFGVARV-QAQSGVMTAETGTYRWMAPEVIEH-KPYDYK 293
           +HRDLK  NLL++  G +K+ADFG+AR           E  T  + APE++   K Y   
Sbjct: 128 LHRDLKPENLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKYYSTA 187
Query: 294 ADVFSFGIALWELLTGELPYAG 315
            D++S G    E++T    + G
Sbjct: 188 VDIWSLGCIFAEMVTRRALFPG 209

>pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 53/202 (26%), Positives = 100/202 (49%), Gaps = 7/202 (3%)
Query: 119 KIECKVASGSYGDLYKG--TYCSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVV 176
           K+E K+  G+YG +YK       + VA+K ++ +     +     +E+ +++++ H N+V
Sbjct: 8   KVE-KIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIV 66
Query: 177 QFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAI-DVSKGMNYLHQNNI 235
           + +        L +V EF++   +  F+           L+K  +  + +G+ + H + +
Sbjct: 67  KLLDVIHTENKLYLVFEFLSM-DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRV 125
Query: 236 IHRDLKTANLLMDENGVVKVADFGVARV-QAQSGVMTAETGTYRWMAPEVIEH-KPYDYK 293
           +HRDLK  NLL++  G +K+ADFG+AR           E  T  + APE++   K Y   
Sbjct: 126 LHRDLKPENLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKYYSTA 185
Query: 294 ADVFSFGIALWELLTGELPYAG 315
            D++S G    E++T    + G
Sbjct: 186 VDIWSLGCIFAEMVTRRALFPG 207

>pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 61/224 (27%), Positives = 103/224 (45%), Gaps = 31/224 (13%)
Query: 124 VASGSYGDLYKGTYCSQ-------EVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVV 176
           +  G+YG       CS         VAI+ + P    T   +   +E+ I+ + RH+N++
Sbjct: 35  IGEGAYG-----MVCSAYDNLNKVRVAIRKISPFEHQTYCQRTL-REIKILLRFRHENII 88
Query: 177 QFIGACTRPP------NLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYL 230
             I    R P      ++ IV + M    +Y  L  Q        +      + +G+ Y+
Sbjct: 89  G-INDIIRAPTIEQMKDVYIVQDLM-ETDLYKLLKTQH--LSNDHICYFLYQILRGLKYI 144
Query: 231 HQNNIIHRDLKTANLLMDENGVVKVADFGVARV----QAQSGVMTAETGTYRWMAPEV-I 285
           H  N++HRDLK +NLL++    +K+ DFG+ARV       +G +T    T  + APE+ +
Sbjct: 145 HSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIML 204
Query: 286 EHKPYDYKADVFSFGIALWELLTGELPYAG---LTPLQAAVGVV 326
             K Y    D++S G  L E+L+    + G   L  L   +G++
Sbjct: 205 NSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGIL 248

>pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 59/222 (26%), Positives = 106/222 (47%), Gaps = 29/222 (13%)
Query: 110 VWEIDAKQLKIECKVASGSYGDLYKG--TYCSQEVAIKVLKPECVNTEMLKEFSQEVYIM 167
           VWE+  ++L+    V SG+YG +         Q+VA+K L     +    +   +E+ ++
Sbjct: 23  VWEV-PQRLQGLRPVGSGAYGSVCSAYDARLRQKVAVKKLSRPFQSLIHARRTYRELRLL 81
Query: 168 RKIRHKNVVQFIGACTRPPNL------CIVTEFMA-------RGSIYDFLHKQKGVFQLT 214
           + ++H+NV+  +   T   ++       +VT  M        +       H Q  V+QL 
Sbjct: 82  KHLKHENVIGLLDVFTPATSIEDFSEVYLVTTLMGADLNNIVKCQALSDEHVQFLVYQLL 141
Query: 215 SLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAET 274
                     +G+ Y+H   IIHRDLK +N+ ++E+  +++ DFG+AR   +   MT   
Sbjct: 142 ----------RGLKYIHSAGIIHRDLKPSNVAVNEDSELRILDFGLARQADEE--MTGYV 189
Query: 275 GTYRWMAPEV-IEHKPYDYKADVFSFGIALWELLTGELPYAG 315
            T  + APE+ +    Y+   D++S G  + ELL G+  + G
Sbjct: 190 ATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLQGKALFPG 231

>pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 57/235 (24%), Positives = 106/235 (45%), Gaps = 24/235 (10%)
Query: 140 QEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVTEFMARGS 199
           + VAIK L     N    K   +E+ +M+ + HKN++  +   T    L    EF     
Sbjct: 88  RNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTL---EEFQDVYL 144
Query: 200 IYDFLHKQKGVFQLTSLLKVAIDVSK----------GMNYLHQNNIIHRDLKTANLLMDE 249
           + + +        L  ++++ +D  +          G+ +LH   IIHRDLK +N+++  
Sbjct: 145 VMELMDAN-----LCQVIQMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKS 199
Query: 250 NGVVKVADFGVARVQAQSGVMTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTG 309
           +  +K+ DFG+AR    S +MT    T  + APEVI    Y    D++S G  + E++  
Sbjct: 200 DCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRH 259
Query: 310 ELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRLAELLERCWQHDPTQRPNFSQIT 364
           ++ + G   +     V+++   P       P   + L+   ++    RP ++ +T
Sbjct: 260 KILFPGRDYIDQWNKVIEQLGTPC------PEFMKKLQPTVRNYVENRPKYAGLT 308

>pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 62/224 (27%), Positives = 103/224 (45%), Gaps = 31/224 (13%)
Query: 124 VASGSYGDLYKGTYCSQ-------EVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVV 176
           +  G+YG       CS         VAIK + P    T   +   +E+ I+ + RH+N++
Sbjct: 35  IGEGAYG-----MVCSAYDNLNKVRVAIKKISPFEHQTYCQRTL-REIKILLRFRHENII 88
Query: 177 QFIGACTRPP------NLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYL 230
             I    R P      ++ IV + M    +Y  L  Q        +      + +G+ Y+
Sbjct: 89  G-INDIIRAPTIEQMKDVYIVQDLM-ETDLYKLLKCQH--LSNDHICYFLYQILRGLKYI 144
Query: 231 HQNNIIHRDLKTANLLMDENGVVKVADFGVARV----QAQSGVMTAETGTYRWMAPEV-I 285
           H  N++HRDLK +NLL++    +K+ DFG+ARV       +G +T    T  + APE+ +
Sbjct: 145 HSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIML 204
Query: 286 EHKPYDYKADVFSFGIALWELLTGELPYAG---LTPLQAAVGVV 326
             K Y    D++S G  L E+L+    + G   L  L   +G++
Sbjct: 205 NSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGIL 248

>pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 53/202 (26%), Positives = 100/202 (49%), Gaps = 7/202 (3%)
Query: 119 KIECKVASGSYGDLYKG--TYCSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVV 176
           K+E K+  G+YG +YK       + VA+K ++ +     +     +E+ +++++ H N+V
Sbjct: 10  KVE-KIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIV 68
Query: 177 QFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAI-DVSKGMNYLHQNNI 235
           + +        L +V EF+ +  +  F+           L+K  +  + +G+ + H + +
Sbjct: 69  KLLDVIHTENKLYLVFEFLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRV 127
Query: 236 IHRDLKTANLLMDENGVVKVADFGVARV-QAQSGVMTAETGTYRWMAPEVIEH-KPYDYK 293
           +HRDLK  NLL++  G +K+ADFG+AR           E  T  + APE++   K Y   
Sbjct: 128 LHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKYYSTA 187
Query: 294 ADVFSFGIALWELLTGELPYAG 315
            D++S G    E++T    + G
Sbjct: 188 VDIWSLGCIFAEMVTRRALFPG 209

>pdb|2G01|A Chain A, Pyrazoloquinolones As Novel, Selective Jnk1 Inhibitors Length = 370

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 58/218 (26%), Positives = 102/218 (46%), Gaps = 20/218 (9%)
Query: 140 QEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNL------CIVTE 193
           + VAIK L     N    K   +E+ +M+ + HKN++  +   T   +L       IV E
Sbjct: 50  RNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVME 109
Query: 194 FMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVV 253
            M   ++   +  +    +++ LL     +  G+ +LH   IIHRDLK +N+++  +  +
Sbjct: 110 LMD-ANLCQVIQMELDHERMSYLL---YQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTL 165
Query: 254 KVADFGVARVQAQSGVMTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPY 313
           K+ DFG+AR    S +M  E  T  + APEVI    Y    D++S G  + E++  ++ +
Sbjct: 166 KILDFGLARTAGTSFMMEPEVVTRYYRAPEVILGMGYKENVDLWSVGCIMGEMVCHKILF 225
Query: 314 AGLTPLQAAVGVVQ----------KSLRPTIPKHAHPR 341
            G   +     V++          K L+PT+  +   R
Sbjct: 226 PGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRTYVENR 263

>pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 53/202 (26%), Positives = 100/202 (49%), Gaps = 7/202 (3%)
Query: 119 KIECKVASGSYGDLYKG--TYCSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVV 176
           K+E K+  G+YG +YK       + VA+K ++ +     +     +E+ +++++ H N+V
Sbjct: 11  KVE-KIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIV 69
Query: 177 QFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAI-DVSKGMNYLHQNNI 235
           + +        L +V EF+ +  +  F+           L+K  +  + +G+ + H + +
Sbjct: 70  KLLDVIHTENKLYLVFEFLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRV 128
Query: 236 IHRDLKTANLLMDENGVVKVADFGVARV-QAQSGVMTAETGTYRWMAPEVIEH-KPYDYK 293
           +HRDLK  NLL++  G +K+ADFG+AR           E  T  + APE++   K Y   
Sbjct: 129 LHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKYYSTA 188
Query: 294 ADVFSFGIALWELLTGELPYAG 315
            D++S G    E++T    + G
Sbjct: 189 VDIWSLGCIFAEMVTRRALFPG 210

>pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 58/218 (26%), Positives = 101/218 (46%), Gaps = 20/218 (9%)
Query: 140 QEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNL------CIVTE 193
           + VAIK L     N    K   +E+ +M+ + HKN++  +   T   +L       IV E
Sbjct: 52  RNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVME 111
Query: 194 FMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVV 253
            M   ++   +  +    +++ LL     +  G+ +LH   IIHRDLK +N+++  +  +
Sbjct: 112 LMD-ANLCQVIQMELDHERMSYLL---YQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTL 167
Query: 254 KVADFGVARVQAQSGVMTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPY 313
           K+ DFG+AR    S +M     T  + APEVI    Y    D++S G  + E++ G + +
Sbjct: 168 KILDFGLARTAGTSFMMVPFVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLF 227
Query: 314 AGLTPLQAAVGVVQ----------KSLRPTIPKHAHPR 341
            G   +     V++          K L+PT+  +   R
Sbjct: 228 PGTDHIDQWNKVIEQLGTPCPEFMKKLQPTVRTYVENR 265

>pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 53/202 (26%), Positives = 100/202 (49%), Gaps = 7/202 (3%)
Query: 119 KIECKVASGSYGDLYKG--TYCSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVV 176
           K+E K+  G+YG +YK       + VA+K ++ +     +     +E+ +++++ H N+V
Sbjct: 10  KVE-KIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIV 68
Query: 177 QFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAI-DVSKGMNYLHQNNI 235
           + +        L +V EF+ +  +  F+           L+K  +  + +G+ + H + +
Sbjct: 69  KLLDVIHTENKLYLVFEFLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRV 127
Query: 236 IHRDLKTANLLMDENGVVKVADFGVARV-QAQSGVMTAETGTYRWMAPEVIEH-KPYDYK 293
           +HRDLK  NLL++  G +K+ADFG+AR           E  T  + APE++   K Y   
Sbjct: 128 LHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKYYSTA 187
Query: 294 ADVFSFGIALWELLTGELPYAG 315
            D++S G    E++T    + G
Sbjct: 188 VDIWSLGCIFAEMVTRRALFPG 209

>pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 53/202 (26%), Positives = 100/202 (49%), Gaps = 7/202 (3%)
Query: 119 KIECKVASGSYGDLYKG--TYCSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVV 176
           K+E K+  G+YG +YK       + VA+K ++ +     +     +E+ +++++ H N+V
Sbjct: 9   KVE-KIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIV 67
Query: 177 QFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAI-DVSKGMNYLHQNNI 235
           + +        L +V EF+ +  +  F+           L+K  +  + +G+ + H + +
Sbjct: 68  KLLDVIHTENKLYLVFEFLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRV 126
Query: 236 IHRDLKTANLLMDENGVVKVADFGVARV-QAQSGVMTAETGTYRWMAPEVIEH-KPYDYK 293
           +HRDLK  NLL++  G +K+ADFG+AR           E  T  + APE++   K Y   
Sbjct: 127 LHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKYYSTA 186
Query: 294 ADVFSFGIALWELLTGELPYAG 315
            D++S G    E++T    + G
Sbjct: 187 VDIWSLGCIFAEMVTRRALFPG 208

>pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 56/222 (25%), Positives = 100/222 (45%), Gaps = 28/222 (12%)
Query: 140 QEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVTEFMARGS 199
           + VAIK L     N    K   +E+ +M+ + HKN++  +   T    L    EF     
Sbjct: 51  RNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTL---EEFQDVYL 107
Query: 200 IYDFLHKQKGVFQLTSLLKVAIDVSK----------GMNYLHQNNIIHRDLKTANLLMDE 249
           + + +        L  ++++ +D  +          G+ +LH   IIHRDLK +N+++  
Sbjct: 108 VMELMDAN-----LCQVIQMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKS 162
Query: 250 NGVVKVADFGVARVQAQSGVMTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTG 309
           +  +K+ DFG+AR    S +MT    T  + APEVI    Y    D++S G  + E++  
Sbjct: 163 DCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRH 222
Query: 310 ELPYAGLTPLQAAVGVVQ----------KSLRPTIPKHAHPR 341
           ++ + G   +     V++          K L+PT+  +   R
Sbjct: 223 KILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYVENR 264

>pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 53/202 (26%), Positives = 100/202 (49%), Gaps = 7/202 (3%)
Query: 119 KIECKVASGSYGDLYKG--TYCSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVV 176
           K+E K+  G+YG +YK       + VA+  ++ +     +     +E+ +++++ H N+V
Sbjct: 7   KVE-KIGEGTYGVVYKARNKLTGEVVALXKIRLDTETEGVPSTAIREISLLKELNHPNIV 65
Query: 177 QFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAI-DVSKGMNYLHQNNI 235
           + +        L +V EF+ +  +  F+           L+K  +  + +G+ + H + +
Sbjct: 66  KLLDVIHTENKLYLVFEFLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRV 124
Query: 236 IHRDLKTANLLMDENGVVKVADFGVARV-QAQSGVMTAETGTYRWMAPEVIEH-KPYDYK 293
           +HRDLK  NLL++  G +K+ADFG+AR         T E  T  + APE++   K Y   
Sbjct: 125 LHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKYYSTA 184
Query: 294 ADVFSFGIALWELLTGELPYAG 315
            D++S G    E++T    + G
Sbjct: 185 VDIWSLGCIFAEMVTRRALFPG 206

>pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 53/202 (26%), Positives = 100/202 (49%), Gaps = 7/202 (3%)
Query: 119 KIECKVASGSYGDLYKG--TYCSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVV 176
           K+E K+  G+YG +YK       + VA+  ++ +     +     +E+ +++++ H N+V
Sbjct: 6   KVE-KIGEGTYGVVYKARNKLTGEVVALXKIRLDTETEGVPSTAIREISLLKELNHPNIV 64
Query: 177 QFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAI-DVSKGMNYLHQNNI 235
           + +        L +V EF+ +  +  F+           L+K  +  + +G+ + H + +
Sbjct: 65  KLLDVIHTENKLYLVFEFLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRV 123
Query: 236 IHRDLKTANLLMDENGVVKVADFGVARV-QAQSGVMTAETGTYRWMAPEVIEH-KPYDYK 293
           +HRDLK  NLL++  G +K+ADFG+AR         T E  T  + APE++   K Y   
Sbjct: 124 LHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKYYSTA 183
Query: 294 ADVFSFGIALWELLTGELPYAG 315
            D++S G    E++T    + G
Sbjct: 184 VDIWSLGCIFAEMVTRRALFPG 205

>pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 56/222 (25%), Positives = 100/222 (45%), Gaps = 28/222 (12%)
Query: 140 QEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVTEFMARGS 199
           + VAIK L     N    K   +E+ +M+ + HKN++  +   T    L    EF     
Sbjct: 49  RNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTL---EEFQDVYL 105
Query: 200 IYDFLHKQKGVFQLTSLLKVAIDVSK----------GMNYLHQNNIIHRDLKTANLLMDE 249
           + + +        L  ++++ +D  +          G+ +LH   IIHRDLK +N+++  
Sbjct: 106 VMELMDAN-----LCQVIQMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKS 160
Query: 250 NGVVKVADFGVARVQAQSGVMTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTG 309
           +  +K+ DFG+AR    S +MT    T  + APEVI    Y    D++S G  + E++  
Sbjct: 161 DCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRH 220
Query: 310 ELPYAGLTPLQAAVGVVQ----------KSLRPTIPKHAHPR 341
           ++ + G   +     V++          K L+PT+  +   R
Sbjct: 221 KILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYVENR 262

>pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 56/222 (25%), Positives = 100/222 (45%), Gaps = 28/222 (12%)
Query: 140 QEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVTEFMARGS 199
           + VAIK L     N    K   +E+ +M+ + HKN++  +   T    L    EF     
Sbjct: 51  RNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTL---EEFQDVYL 107
Query: 200 IYDFLHKQKGVFQLTSLLKVAIDVSK----------GMNYLHQNNIIHRDLKTANLLMDE 249
           + + +        L  ++++ +D  +          G+ +LH   IIHRDLK +N+++  
Sbjct: 108 VMELMDAN-----LCQVIQMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKS 162
Query: 250 NGVVKVADFGVARVQAQSGVMTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTG 309
           +  +K+ DFG+AR    S +MT    T  + APEVI    Y    D++S G  + E++  
Sbjct: 163 DCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRH 222
Query: 310 ELPYAGLTPLQAAVGVVQ----------KSLRPTIPKHAHPR 341
           ++ + G   +     V++          K L+PT+  +   R
Sbjct: 223 KILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYVENR 264

>pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 56/222 (25%), Positives = 100/222 (45%), Gaps = 28/222 (12%)
Query: 140 QEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVTEFMARGS 199
           + VAIK L     N    K   +E+ +M+ + HKN++  +   T    L    EF     
Sbjct: 50  RNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTL---EEFQDVYL 106
Query: 200 IYDFLHKQKGVFQLTSLLKVAIDVSK----------GMNYLHQNNIIHRDLKTANLLMDE 249
           + + +        L  ++++ +D  +          G+ +LH   IIHRDLK +N+++  
Sbjct: 107 VMELMDAN-----LCQVIQMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKS 161
Query: 250 NGVVKVADFGVARVQAQSGVMTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTG 309
           +  +K+ DFG+AR    S +MT    T  + APEVI    Y    D++S G  + E++  
Sbjct: 162 DCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRH 221
Query: 310 ELPYAGLTPLQAAVGVVQ----------KSLRPTIPKHAHPR 341
           ++ + G   +     V++          K L+PT+  +   R
Sbjct: 222 KILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYVENR 263

>pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 53/202 (26%), Positives = 100/202 (49%), Gaps = 7/202 (3%)
Query: 119 KIECKVASGSYGDLYKG--TYCSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVV 176
           K+E K+  G+YG +YK       + VA+K ++ +     +     +E+ +++++ H N+V
Sbjct: 7   KVE-KIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIV 65
Query: 177 QFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAI-DVSKGMNYLHQNNI 235
           + +        L +V EF+ +  +  F+           L+K  +  + +G+ + H + +
Sbjct: 66  KLLDVIHTENKLYLVFEFLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRV 124
Query: 236 IHRDLKTANLLMDENGVVKVADFGVARV-QAQSGVMTAETGTYRWMAPEVIEH-KPYDYK 293
           +HRDLK  NLL++  G +K+ADFG+AR           E  T  + APE++   K Y   
Sbjct: 125 LHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKYYSTA 184
Query: 294 ADVFSFGIALWELLTGELPYAG 315
            D++S G    E++T    + G
Sbjct: 185 VDIWSLGCIFAEMVTRRALFPG 206

>pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 56/222 (25%), Positives = 100/222 (45%), Gaps = 28/222 (12%)
Query: 140 QEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVTEFMARGS 199
           + VAIK L     N    K   +E+ +M+ + HKN++  +   T    L    EF     
Sbjct: 50  RNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTL---EEFQDVYL 106
Query: 200 IYDFLHKQKGVFQLTSLLKVAIDVSK----------GMNYLHQNNIIHRDLKTANLLMDE 249
           + + +        L  ++++ +D  +          G+ +LH   IIHRDLK +N+++  
Sbjct: 107 VMELMDAN-----LCQVIQMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKS 161
Query: 250 NGVVKVADFGVARVQAQSGVMTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTG 309
           +  +K+ DFG+AR    S +MT    T  + APEVI    Y    D++S G  + E++  
Sbjct: 162 DCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRH 221
Query: 310 ELPYAGLTPLQAAVGVVQ----------KSLRPTIPKHAHPR 341
           ++ + G   +     V++          K L+PT+  +   R
Sbjct: 222 KILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYVENR 263

>pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 73.2 bits (178), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 53/202 (26%), Positives = 100/202 (49%), Gaps = 7/202 (3%)
Query: 119 KIECKVASGSYGDLYKG--TYCSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVV 176
           K+E K+  G+YG +YK       + VA+K ++ +     +     +E+ +++++ H N+V
Sbjct: 9   KVE-KIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIV 67
Query: 177 QFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAI-DVSKGMNYLHQNNI 235
           + +        L +V EF+ +  +  F+           L+K  +  + +G+ + H + +
Sbjct: 68  KLLDVIHTENKLYLVFEFLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRV 126
Query: 236 IHRDLKTANLLMDENGVVKVADFGVARV-QAQSGVMTAETGTYRWMAPEVIEH-KPYDYK 293
           +HRDLK  NLL++  G +K+ADFG+AR           E  T  + APE++   K Y   
Sbjct: 127 LHRDLKPENLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKYYSTA 186
Query: 294 ADVFSFGIALWELLTGELPYAG 315
            D++S G    E++T    + G
Sbjct: 187 VDIWSLGCIFAEMVTRRALFPG 208

>pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299

Iteration: 1
 Score = 73.2 bits (178), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 53/202 (26%), Positives = 100/202 (49%), Gaps = 7/202 (3%)
Query: 119 KIECKVASGSYGDLYKG--TYCSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVV 176
           K+E K+  G+YG +YK       + VA+K ++ +     +     +E+ +++++ H N+V
Sbjct: 7   KVE-KIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIV 65
Query: 177 QFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAI-DVSKGMNYLHQNNI 235
           + +        L +V EF+ +  +  F+           L+K  +  + +G+ + H + +
Sbjct: 66  KLLDVIHTENKLYLVFEFLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRV 124
Query: 236 IHRDLKTANLLMDENGVVKVADFGVARV-QAQSGVMTAETGTYRWMAPEVIEH-KPYDYK 293
           +HRDLK  NLL++  G +K+ADFG+AR           E  T  + APE++   K Y   
Sbjct: 125 LHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKYYSTA 184
Query: 294 ADVFSFGIALWELLTGELPYAG 315
            D++S G    E++T    + G
Sbjct: 185 VDIWSLGCIFAEMVTRRALFPG 206

>pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297

Iteration: 1
 Score = 73.2 bits (178), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 53/202 (26%), Positives = 100/202 (49%), Gaps = 7/202 (3%)
Query: 119 KIECKVASGSYGDLYKG--TYCSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVV 176
           K+E K+  G+YG +YK       + VA+K ++ +     +     +E+ +++++ H N+V
Sbjct: 7   KVE-KIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIV 65
Query: 177 QFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAI-DVSKGMNYLHQNNI 235
           + +        L +V EF+ +  +  F+           L+K  +  + +G+ + H + +
Sbjct: 66  KLLDVIHTENKLYLVFEFLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRV 124
Query: 236 IHRDLKTANLLMDENGVVKVADFGVARV-QAQSGVMTAETGTYRWMAPEVIEH-KPYDYK 293
           +HRDLK  NLL++  G +K+ADFG+AR           E  T  + APE++   K Y   
Sbjct: 125 LHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKYYSTA 184
Query: 294 ADVFSFGIALWELLTGELPYAG 315
            D++S G    E++T    + G
Sbjct: 185 VDIWSLGCIFAEMVTRRALFPG 206

>pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299

Iteration: 1
 Score = 73.2 bits (178), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 53/202 (26%), Positives = 100/202 (49%), Gaps = 7/202 (3%)
Query: 119 KIECKVASGSYGDLYKG--TYCSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVV 176
           K+E K+  G+YG +YK       + VA+K ++ +     +     +E+ +++++ H N+V
Sbjct: 8   KVE-KIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIV 66
Query: 177 QFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAI-DVSKGMNYLHQNNI 235
           + +        L +V EF+ +  +  F+           L+K  +  + +G+ + H + +
Sbjct: 67  KLLDVIHTENKLYLVFEFLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRV 125
Query: 236 IHRDLKTANLLMDENGVVKVADFGVARV-QAQSGVMTAETGTYRWMAPEVIEH-KPYDYK 293
           +HRDLK  NLL++  G +K+ADFG+AR           E  T  + APE++   K Y   
Sbjct: 126 LHRDLKPENLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKYYSTA 185
Query: 294 ADVFSFGIALWELLTGELPYAG 315
            D++S G    E++T    + G
Sbjct: 186 VDIWSLGCIFAEMVTRRALFPG 207

>pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296

Iteration: 1
 Score = 73.2 bits (178), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 53/202 (26%), Positives = 100/202 (49%), Gaps = 7/202 (3%)
Query: 119 KIECKVASGSYGDLYKG--TYCSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVV 176
           K+E K+  G+YG +YK       + VA+K ++ +     +     +E+ +++++ H N+V
Sbjct: 6   KVE-KIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIV 64
Query: 177 QFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAI-DVSKGMNYLHQNNI 235
           + +        L +V EF+ +  +  F+           L+K  +  + +G+ + H + +
Sbjct: 65  KLLDVIHTENKLYLVFEFLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRV 123
Query: 236 IHRDLKTANLLMDENGVVKVADFGVARV-QAQSGVMTAETGTYRWMAPEVIEH-KPYDYK 293
           +HRDLK  NLL++  G +K+ADFG+AR           E  T  + APE++   K Y   
Sbjct: 124 LHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKYYSTA 183
Query: 294 ADVFSFGIALWELLTGELPYAG 315
            D++S G    E++T    + G
Sbjct: 184 VDIWSLGCIFAEMVTRRALFPG 205

>pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298

Iteration: 1
 Score = 73.2 bits (178), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 53/202 (26%), Positives = 100/202 (49%), Gaps = 7/202 (3%)
Query: 119 KIECKVASGSYGDLYKG--TYCSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVV 176
           K+E K+  G+YG +YK       + VA+K ++ +     +     +E+ +++++ H N+V
Sbjct: 6   KVE-KIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIV 64
Query: 177 QFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAI-DVSKGMNYLHQNNI 235
           + +        L +V EF+ +  +  F+           L+K  +  + +G+ + H + +
Sbjct: 65  KLLDVIHTENKLYLVFEFLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRV 123
Query: 236 IHRDLKTANLLMDENGVVKVADFGVARV-QAQSGVMTAETGTYRWMAPEVIEH-KPYDYK 293
           +HRDLK  NLL++  G +K+ADFG+AR           E  T  + APE++   K Y   
Sbjct: 124 LHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKYYSTA 183
Query: 294 ADVFSFGIALWELLTGELPYAG 315
            D++S G    E++T    + G
Sbjct: 184 VDIWSLGCIFAEMVTRRALFPG 205

>pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 73.2 bits (178), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 53/202 (26%), Positives = 100/202 (49%), Gaps = 7/202 (3%)
Query: 119 KIECKVASGSYGDLYKG--TYCSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVV 176
           K+E K+  G+YG +YK       + VA+K ++ +     +     +E+ +++++ H N+V
Sbjct: 9   KVE-KIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIV 67
Query: 177 QFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAI-DVSKGMNYLHQNNI 235
           + +        L +V EF+ +  +  F+           L+K  +  + +G+ + H + +
Sbjct: 68  KLLDVIHTENKLYLVFEFLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRV 126
Query: 236 IHRDLKTANLLMDENGVVKVADFGVARV-QAQSGVMTAETGTYRWMAPEVIEH-KPYDYK 293
           +HRDLK  NLL++  G +K+ADFG+AR           E  T  + APE++   K Y   
Sbjct: 127 LHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKYYSTA 186
Query: 294 ADVFSFGIALWELLTGELPYAG 315
            D++S G    E++T    + G
Sbjct: 187 VDIWSLGCIFAEMVTRRALFPG 208

>pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355

Iteration: 1
 Score = 73.2 bits (178), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 56/222 (25%), Positives = 100/222 (45%), Gaps = 28/222 (12%)
Query: 140 QEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVTEFMARGS 199
           + VAIK L     N    K   +E+ +M+ + HKN++  +   T    L    EF     
Sbjct: 43  RNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTL---EEFQDVYL 99
Query: 200 IYDFLHKQKGVFQLTSLLKVAIDVSK----------GMNYLHQNNIIHRDLKTANLLMDE 249
           + + +        L  ++++ +D  +          G+ +LH   IIHRDLK +N+++  
Sbjct: 100 VMELMDAN-----LCQVIQMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKS 154
Query: 250 NGVVKVADFGVARVQAQSGVMTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTG 309
           +  +K+ DFG+AR    S +MT    T  + APEVI    Y    D++S G  + E++  
Sbjct: 155 DCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRH 214
Query: 310 ELPYAGLTPLQAAVGVVQ----------KSLRPTIPKHAHPR 341
           ++ + G   +     V++          K L+PT+  +   R
Sbjct: 215 KILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYVENR 256

>pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300

Iteration: 1
 Score = 73.2 bits (178), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 53/202 (26%), Positives = 100/202 (49%), Gaps = 7/202 (3%)
Query: 119 KIECKVASGSYGDLYKG--TYCSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVV 176
           K+E K+  G+YG +YK       + VA+K ++ +     +     +E+ +++++ H N+V
Sbjct: 8   KVE-KIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIV 66
Query: 177 QFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAI-DVSKGMNYLHQNNI 235
           + +        L +V EF+ +  +  F+           L+K  +  + +G+ + H + +
Sbjct: 67  KLLDVIHTENKLYLVFEFLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRV 125
Query: 236 IHRDLKTANLLMDENGVVKVADFGVARV-QAQSGVMTAETGTYRWMAPEVIEH-KPYDYK 293
           +HRDLK  NLL++  G +K+ADFG+AR           E  T  + APE++   K Y   
Sbjct: 126 LHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKYYSTA 185
Query: 294 ADVFSFGIALWELLTGELPYAG 315
            D++S G    E++T    + G
Sbjct: 186 VDIWSLGCIFAEMVTRRALFPG 207

>pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356

Iteration: 1
 Score = 73.2 bits (178), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 56/222 (25%), Positives = 100/222 (45%), Gaps = 28/222 (12%)
Query: 140 QEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVTEFMARGS 199
           + VAIK L     N    K   +E+ +M+ + HKN++  +   T    L    EF     
Sbjct: 44  RNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTL---EEFQDVYL 100
Query: 200 IYDFLHKQKGVFQLTSLLKVAIDVSK----------GMNYLHQNNIIHRDLKTANLLMDE 249
           + + +        L  ++++ +D  +          G+ +LH   IIHRDLK +N+++  
Sbjct: 101 VMELMDAN-----LCQVIQMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKS 155
Query: 250 NGVVKVADFGVARVQAQSGVMTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTG 309
           +  +K+ DFG+AR    S +MT    T  + APEVI    Y    D++S G  + E++  
Sbjct: 156 DCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRH 215
Query: 310 ELPYAGLTPLQAAVGVVQ----------KSLRPTIPKHAHPR 341
           ++ + G   +     V++          K L+PT+  +   R
Sbjct: 216 KILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYVENR 257

>pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289

Iteration: 1
 Score = 73.2 bits (178), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 53/202 (26%), Positives = 100/202 (49%), Gaps = 7/202 (3%)
Query: 119 KIECKVASGSYGDLYKG--TYCSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVV 176
           K+E K+  G+YG +YK       + VA+K ++ +     +     +E+ +++++ H N+V
Sbjct: 7   KVE-KIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIV 65
Query: 177 QFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAI-DVSKGMNYLHQNNI 235
           + +        L +V EF+ +  +  F+           L+K  +  + +G+ + H + +
Sbjct: 66  KLLDVIHTENKLYLVFEFLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRV 124
Query: 236 IHRDLKTANLLMDENGVVKVADFGVARV-QAQSGVMTAETGTYRWMAPEVIEH-KPYDYK 293
           +HRDLK  NLL++  G +K+ADFG+AR           E  T  + APE++   K Y   
Sbjct: 125 LHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKYYSTA 184
Query: 294 ADVFSFGIALWELLTGELPYAG 315
            D++S G    E++T    + G
Sbjct: 185 VDIWSLGCIFAEMVTRRALFPG 206

>pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298

Iteration: 1
 Score = 73.2 bits (178), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 53/202 (26%), Positives = 100/202 (49%), Gaps = 7/202 (3%)
Query: 119 KIECKVASGSYGDLYKG--TYCSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVV 176
           K+E K+  G+YG +YK       + VA+K ++ +     +     +E+ +++++ H N+V
Sbjct: 8   KVE-KIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIV 66
Query: 177 QFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAI-DVSKGMNYLHQNNI 235
           + +        L +V EF+ +  +  F+           L+K  +  + +G+ + H + +
Sbjct: 67  KLLDVIHTENKLYLVFEFLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRV 125
Query: 236 IHRDLKTANLLMDENGVVKVADFGVARV-QAQSGVMTAETGTYRWMAPEVIEH-KPYDYK 293
           +HRDLK  NLL++  G +K+ADFG+AR           E  T  + APE++   K Y   
Sbjct: 126 LHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKYYSTA 185
Query: 294 ADVFSFGIALWELLTGELPYAG 315
            D++S G    E++T    + G
Sbjct: 186 VDIWSLGCIFAEMVTRRALFPG 207

>pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356

Iteration: 1
 Score = 73.2 bits (178), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 56/223 (25%), Positives = 100/223 (44%), Gaps = 28/223 (12%)
Query: 139 SQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVTEFMARG 198
            + VAIK L     N    K   +E+ +M+ + HKN++  +   T    L    EF    
Sbjct: 43  DRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTL---EEFQDVY 99
Query: 199 SIYDFLHKQKGVFQLTSLLKVAIDVSK----------GMNYLHQNNIIHRDLKTANLLMD 248
            + + +        L  ++++ +D  +          G+ +LH   IIHRDLK +N+++ 
Sbjct: 100 LVMELMDAN-----LCQVIQMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVK 154
Query: 249 ENGVVKVADFGVARVQAQSGVMTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLT 308
            +  +K+ DFG+AR    S +MT    T  + APEVI    Y    D++S G  + E++ 
Sbjct: 155 SDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVR 214
Query: 309 GELPYAGLTPLQAAVGVVQ----------KSLRPTIPKHAHPR 341
            ++ + G   +     V++          K L+PT+  +   R
Sbjct: 215 HKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYVENR 257

>pdb|3LL6|A Chain A, Crystal Structure Of The Human Cyclin G Associated Kinase (gak) Length = 337

Iteration: 1
 Score = 73.2 bits (178), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 80/325 (24%), Positives = 141/325 (43%), Gaps = 51/325 (15%)
Query: 112 EIDAKQLKIECKVASGSYGDLYKG--TYCSQEVAIKVLKPECVNTEMLKEFSQEVYIMRK 169
           E+   +L++   +A G +  +Y+       +E A+K L       E  +   QEV  M+K
Sbjct: 24  ELGELRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSN--EEEKNRAIIQEVCFMKK 81
Query: 170 IR-HKNVVQFIGAC--------TRPPNLCIVTEFMARGSIYDFLHK--QKGVFQLTSLLK 218
           +  H N+VQF  A         T      ++TE + +G + +FL K   +G     ++LK
Sbjct: 82  LSGHPNIVQFCSAASIGKEESDTGQAEFLLLTE-LCKGQLVEFLKKMESRGPLSCDTVLK 140
Query: 219 VAIDVSKGMNYLHQNN--IIHRDLKTANLLMDENGVVKVADFGVARV---------QAQS 267
           +     + + ++H+    IIHRDLK  NLL+   G +K+ DFG A            AQ 
Sbjct: 141 IFYQTCRAVQHMHRQKPPIIHRDLKVENLLLSNQGTIKLCDFGSATTISHYPDYSWSAQR 200
Query: 268 GVMTAE----TGTYRWMAPEVIE---HKPYDYKADVFSFGIALWELLTGELPYAGLTPLQ 320
             +  E      T  +  PE+I+   + P   K D+++ G  L+ L   + P+     L+
Sbjct: 201 RALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDGAKLR 260
Query: 321 AAVGVVQKSLRPTIPKH--AHPRLAELLERCWQHDPTQRPNFSQITDILKQMMKEVASEG 378
              G      + +IP H   +     L+    Q +P +R +   I +++ Q+ +  A+  
Sbjct: 261 IVNG------KYSIPPHDTQYTVFHSLIRAMLQVNPEERLS---IAEVVHQLQEIAAARN 311
Query: 379 ENNHS------NKSAGSFFSSLRRG 397
            N  S       ++ G   ++L RG
Sbjct: 312 VNPKSPITELLEQNGGYGSATLSRG 336

>pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 73.2 bits (178), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 62/224 (27%), Positives = 102/224 (45%), Gaps = 31/224 (13%)
Query: 124 VASGSYGDLYKGTYCSQ-------EVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVV 176
           +  G+YG       CS         VAIK + P    T   +   +E+ I+   RH+N++
Sbjct: 33  IGEGAYG-----MVCSAYDNVNKVRVAIKKISPFEHQTYCQRTL-REIKILLAFRHENII 86
Query: 177 QFIGACTRPP------NLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYL 230
             I    R P      ++ IV + M    +Y  L  Q        +      + +G+ Y+
Sbjct: 87  G-INDIIRAPTIEQMKDVYIVQDLM-ETDLYKLLKTQH--LSNDHICYFLYQILRGLKYI 142
Query: 231 HQNNIIHRDLKTANLLMDENGVVKVADFGVARV----QAQSGVMTAETGTYRWMAPEV-I 285
           H  N++HRDLK +NLL++    +K+ DFG+ARV       +G +T    T  + APE+ +
Sbjct: 143 HSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIML 202
Query: 286 EHKPYDYKADVFSFGIALWELLTGELPYAG---LTPLQAAVGVV 326
             K Y    D++S G  L E+L+    + G   L  L   +G++
Sbjct: 203 NSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGIL 246

>pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382

Iteration: 1
 Score = 73.2 bits (178), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 59/207 (28%), Positives = 101/207 (48%), Gaps = 22/207 (10%)
Query: 124 VASGSYGDLYKGTY---CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVV---Q 177
           +  G+YG +    Y       VAIK + P    T   +   +E+ I+ + RH+NV+    
Sbjct: 51  IGEGAYG-MVSSAYDHVRKTRVAIKKISPFEHQTYCQRTL-REIQILLRFRHENVIGIRD 108
Query: 178 FIGACTRPP--NLCIVTEFMARGSIYDFLHKQKGVFQLTS--LLKVAIDVSKGMNYLHQN 233
            + A T     ++ IV + M    +Y  L  Q    QL++  +      + +G+ Y+H  
Sbjct: 109 ILRASTLEAMRDVYIVQDLM-ETDLYKLLKSQ----QLSNDHICYFLYQILRGLKYIHSA 163
Query: 234 NIIHRDLKTANLLMDENGVVKVADFGVARV----QAQSGVMTAETGTYRWMAPEV-IEHK 288
           N++HRDLK +NLL++    +K+ DFG+AR+       +G +T    T  + APE+ +  K
Sbjct: 164 NVLHRDLKPSNLLINTTCDLKICDFGLARIADPEHDHTGFLTEXVATRWYRAPEIMLNSK 223
Query: 289 PYDYKADVFSFGIALWELLTGELPYAG 315
            Y    D++S G  L E+L+    + G
Sbjct: 224 GYTKSIDIWSVGCILAEMLSNRPIFPG 250

>pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine Inhibitor Length = 369

Iteration: 1
 Score = 72.8 bits (177), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 58/218 (26%), Positives = 102/218 (46%), Gaps = 20/218 (9%)
Query: 140 QEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNL------CIVTE 193
           + VAIK L     N    K   +E+ +M+ + HKN++  +   T   +L       IV E
Sbjct: 55  RNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVME 114
Query: 194 FMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVV 253
            M   ++   +  +    +++ LL     +  G+ +LH   IIHRDLK +N+++  +  +
Sbjct: 115 LMD-ANLCQVIQMELDHERMSYLL---YQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTL 170
Query: 254 KVADFGVARVQAQSGVMTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPY 313
           K+ DFG+AR    S +MT    T  + APEVI    Y    D++S G  + E++  ++ +
Sbjct: 171 KILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDLWSVGCIMGEMVCHKILF 230
Query: 314 AGLTPLQAAVGVVQ----------KSLRPTIPKHAHPR 341
            G   +     V++          K L+PT+  +   R
Sbjct: 231 PGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRTYVENR 268

>pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor Length = 358

Iteration: 1
 Score = 72.8 bits (177), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 58/218 (26%), Positives = 102/218 (46%), Gaps = 20/218 (9%)
Query: 140 QEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNL------CIVTE 193
           + VAIK L     N    K   +E+ +M+ + HKN++  +   T   +L       IV E
Sbjct: 44  RNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVME 103
Query: 194 FMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVV 253
            M   ++   +  +    +++ LL     +  G+ +LH   IIHRDLK +N+++  +  +
Sbjct: 104 LMD-ANLCQVIQMELDHERMSYLL---YQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTL 159
Query: 254 KVADFGVARVQAQSGVMTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPY 313
           K+ DFG+AR    S +MT    T  + APEVI    Y    D++S G  + E++  ++ +
Sbjct: 160 KILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDLWSVGCIMGEMVCHKILF 219
Query: 314 AGLTPLQAAVGVVQ----------KSLRPTIPKHAHPR 341
            G   +     V++          K L+PT+  +   R
Sbjct: 220 PGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRTYVENR 257

>pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364

Iteration: 1
 Score = 72.8 bits (177), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 61/224 (27%), Positives = 102/224 (45%), Gaps = 31/224 (13%)
Query: 124 VASGSYGDLYKGTYCSQ-------EVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVV 176
           +  G+YG       CS         VAIK + P    T   +   +E+ I+ + RH+N++
Sbjct: 35  IGEGAYG-----MVCSAYDNLNKVRVAIKKISPFEHQTYCQRTL-REIKILLRFRHENII 88
Query: 177 QFIGACTRPP------NLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYL 230
             I    R P      ++ IV + M    +Y  L  Q        +      + +G+ Y+
Sbjct: 89  G-INDIIRAPTIEQMKDVYIVQDLM-ETDLYKLLKTQH--LSNDHICYFLYQILRGLKYI 144
Query: 231 HQNNIIHRDLKTANLLMDENGVVKVADFGVARV----QAQSGVMTAETGTYRWMAPEV-I 285
           H  N++HRDLK +NLL++    +K+ DFG+ARV       +G +     T  + APE+ +
Sbjct: 145 HSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLXEXVATRWYRAPEIML 204
Query: 286 EHKPYDYKADVFSFGIALWELLTGELPYAG---LTPLQAAVGVV 326
             K Y    D++S G  L E+L+    + G   L  L   +G++
Sbjct: 205 NSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGIL 248

>pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365

Iteration: 1
 Score = 72.8 bits (177), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 61/224 (27%), Positives = 102/224 (45%), Gaps = 31/224 (13%)
Query: 124 VASGSYGDLYKGTYCSQ-------EVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVV 176
           +  G+YG       CS         VAIK + P    T   +   +E+ I+ + RH+N++
Sbjct: 36  IGEGAYG-----MVCSAYDNLNKVRVAIKKISPFEHQTYCQRTL-REIKILLRFRHENII 89
Query: 177 QFIGACTRPP------NLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYL 230
             I    R P      ++ IV + M    +Y  L  Q        +      + +G+ Y+
Sbjct: 90  G-INDIIRAPTIEQMKDVYIVQDLM-ETDLYKLLKTQH--LSNDHICYFLYQILRGLKYI 145
Query: 231 HQNNIIHRDLKTANLLMDENGVVKVADFGVARV----QAQSGVMTAETGTYRWMAPEV-I 285
           H  N++HRDLK +NLL++    +K+ DFG+ARV       +G +     T  + APE+ +
Sbjct: 146 HSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLXEXVATRWYRAPEIML 205
Query: 286 EHKPYDYKADVFSFGIALWELLTGELPYAG---LTPLQAAVGVV 326
             K Y    D++S G  L E+L+    + G   L  L   +G++
Sbjct: 206 NSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGIL 249

>pdb|3HKO|A Chain A, Crystal Structure Of A Cdpk Kinase Domain From Cryptosporidium Parvum, Cgd7_40 Length = 345

Iteration: 1
 Score = 72.4 bits (176), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 81/324 (25%), Positives = 131/324 (40%), Gaps = 74/324 (22%)
Query: 116 KQLKIECKVASGSYGDLYKGTYCSQEVAIKVLKP------ECVNTEMLKEFSQEVYIMRK 169
           K+  ++  +  GSYG + +    +Q  AI+ +K         +N + ++    EV +M+K
Sbjct: 26  KKYHLKGAIGQGSYG-VVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKK 84
Query: 170 IRHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSK---- 225
           + H N+ +          +C+V E    G + D L+    VF   S  K A+DV K    
Sbjct: 85  LHHPNIARLYEVYEDEQYICLVMELCHGGHLLDKLN----VFIDDSTGKCAMDVVKTQIC 140
Query: 226 ---------------------------------------GMNYLHQNNIIHRDLKTANLL 246
                                                   ++YLH   I HRD+K  N L
Sbjct: 141 PCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHYLHNQGICHRDIKPENFL 200
Query: 247 MDENGV--VKVADFGVAR--VQAQSGV---MTAETGTYRWMAPEVIE--HKPYDYKADVF 297
              N    +K+ DFG+++   +  +G    MT + GT  ++APEV+   ++ Y  K D +
Sbjct: 201 FSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCDAW 260
Query: 298 SFGIALWELLTGELPYAGLTPLQAAVGVVQKSLRPTIPKH------AHPRLAELL----- 346
           S G+ L  LL G +P+ G+        V+ K L    P +      A   L+ LL     
Sbjct: 261 SAGVLLHLLLMGAVPFPGVNDADTISQVLNKKLCFENPNYNVLSPLARDLLSNLLNRNVD 320
Query: 347 ERCWQHDPTQRPNFSQITDILKQM 370
           ER       Q P  SQ +D + +M
Sbjct: 321 ERFDAMRALQHPWISQFSDKIYKM 344

>pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348

Iteration: 1
 Score = 72.4 bits (176), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 59/222 (26%), Positives = 106/222 (47%), Gaps = 29/222 (13%)
Query: 110 VWEIDAKQLKIECKVASGSYGDLYKG--TYCSQEVAIKVLKPECVNTEMLKEFSQEVYIM 167
           VWE+  ++L+    V SG+YG +         Q+VA+K L     +    +   +E+ ++
Sbjct: 15  VWEV-PQRLQGLRPVGSGAYGSVCSAYDARLRQKVAVKKLSRPFQSLIHARRTYRELRLL 73
Query: 168 RKIRHKNVVQFIGACTRPPNL------CIVTEFMA-------RGSIYDFLHKQKGVFQLT 214
           + ++H+NV+  +   T   ++       +VT  M        +       H Q  V+QL 
Sbjct: 74  KHLKHENVIGLLDVFTPATSIEDFSEVYLVTTLMGADLNNIVKCQALSDEHVQFLVYQLL 133
Query: 215 SLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAET 274
                     +G+ Y+H   IIHRDLK +N+ ++E+  +++ DFG+AR   +   MT   
Sbjct: 134 ----------RGLKYIHSAGIIHRDLKPSNVAVNEDCELRILDFGLARQADEE--MTGYV 181
Query: 275 GTYRWMAPEV-IEHKPYDYKADVFSFGIALWELLTGELPYAG 315
            T  + APE+ +    Y+   D++S G  + ELL G+  + G
Sbjct: 182 ATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLQGKALFPG 223

>pdb|3QD2|B Chain B, Crsytal Structure Of Mouse Perk Kinase Domain Length = 332

Iteration: 1
 Score = 71.6 bits (174), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 49/172 (28%), Positives = 85/172 (49%), Gaps = 23/172 (13%)
Query: 217 LKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQS----GVMT- 271
           L + I +++ + +LH   ++HRDLK +N+    + VVKV DFG+     Q      V+T 
Sbjct: 167 LHIFIQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTP 226
Query: 272 --------AETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPYAGLTPLQAA- 322
                    + GT  +M+PE I    Y +K D+FS G+ L+ELL     Y+  T ++   
Sbjct: 227 MPAYATHXGQVGTKLYMSPEQIHGNNYSHKVDIFSLGLILFELL-----YSFSTQMERVR 281
Query: 323 -VGVVQKSLRPTIPKHAHPRLAELLERCWQHDPTQRPNFSQITDILKQMMKE 373
            +  V+    P +    +P+   +++      PT+RP   + TDI++  + E
Sbjct: 282 IITDVRNLKFPLLFTQKYPQEHMMVQDMLSPSPTERP---EATDIIENAIFE 330

>pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298

Iteration: 1
 Score = 71.6 bits (174), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 53/202 (26%), Positives = 100/202 (49%), Gaps = 7/202 (3%)
Query: 119 KIECKVASGSYGDLYKG--TYCSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVV 176
           K+E K+  G+YG +YK       + VA+K ++ +     +     +E+ +++++ H N+V
Sbjct: 6   KVE-KIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIV 64
Query: 177 QFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAI-DVSKGMNYLHQNNI 235
           + +        L +V E + +  +  F+           L+K  +  + +G+ + H + +
Sbjct: 65  KLLDVIHTENKLYLVFEHVHQ-DLKTFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRV 123
Query: 236 IHRDLKTANLLMDENGVVKVADFGVARV-QAQSGVMTAETGTYRWMAPEVIEH-KPYDYK 293
           +HRDLK  NLL++  G +K+ADFG+AR         T E  T  + APE++   K Y   
Sbjct: 124 LHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKYYSTA 183
Query: 294 ADVFSFGIALWELLTGELPYAG 315
            D++S G    E++T    + G
Sbjct: 184 VDIWSLGCIFAEMVTRRALFPG 205

>pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299

Iteration: 1
 Score = 71.6 bits (174), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 51/216 (23%), Positives = 101/216 (46%), Gaps = 29/216 (13%)
Query: 120 IECKVASGSYGDLYKGTYCSQEVAIKVLKPECVNTEMLKE-FSQEVYIMRKIRHKNVVQF 178
           I+C +  G +G +++      +    + +    N E+ +E   +EV  + K+ H  +V++
Sbjct: 10  IQC-LGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRY 68
Query: 179 IGACT--------RPPN----LCIVTEFMARGSIYDFLHKQKGV--FQLTSLLKVAIDVS 224
             A          +P +    L I  +   + ++ D+++ +  +   + +  L + + ++
Sbjct: 69  FNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIA 128
Query: 225 KGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQS-------------GVMT 271
           + + +LH   ++HRDLK +N+    + VVKV DFG+     Q                 T
Sbjct: 129 EAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYARHT 188
Query: 272 AETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELL 307
            + GT  +M+PE I    Y +K D+FS G+ L+ELL
Sbjct: 189 GQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELL 224

>pdb|1YXS|A Chain A, Crystal Structure Of Kinase Pim1 With P123m Mutation Length = 293

Iteration: 1
 Score = 71.6 bits (174), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 61/260 (23%), Positives = 113/260 (43%), Gaps = 21/260 (8%)
Query: 117 QLKIECKVASGSYGDLYKGTYCSQEVAIKVLKPECVNTEMLKEFSQ------EVYIMRKI 170
           Q ++   + SG +G +Y G   S  + + +   E        E         EV +++K+
Sbjct: 9   QYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKV 68
Query: 171 R--HKNVVQFIGACTRPPNLCIVTEFMAR-GSIYDFLHKQKGVFQLTSLLKVAIDVSKGM 227
                 V++ +    RP +  ++ E M     ++DF+  ++G  Q          V + +
Sbjct: 69  SSGFSGVIRLLDWFERPDSFVLILERMEPVQDLFDFI-TERGALQEELARSFFWQVLEAV 127
Query: 228 NYLHQNNIIHRDLKTANLLMDEN-GVVKVADFGVARVQAQSGVMTAETGTYRWMAPEVIE 286
            + H   ++HRD+K  N+L+D N G +K+ DFG   +   + V T   GT  +  PE I 
Sbjct: 128 RHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDT-VYTDFDGTRVYSPPEWIR 186
Query: 287 -HKPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRLAEL 345
            H+ +   A V+S GI L++++ G++P+     +       Q   R  +          L
Sbjct: 187 YHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRG----QVFFRQRVSSECQ----HL 238
Query: 346 LERCWQHDPTQRPNFSQITD 365
           +  C    P+ RP F +I +
Sbjct: 239 IRWCLALRPSDRPTFEEIQN 258

>pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313

Iteration: 1
 Score = 71.2 bits (173), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 43/178 (24%), Positives = 91/178 (51%), Gaps = 5/178 (2%)
Query: 140 QEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVTEFMARGS 199
           QE A K++  + ++    ++  +E  I R ++H N+V+   + +   +  ++ + +  G 
Sbjct: 48  QEYAAKIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDSISEEGHHYLIFDLVTGGE 107
Query: 200 IYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMD---ENGVVKVA 256
           +++ +  ++  +           + + + + HQ  ++HRDLK  NLL+    +   VK+A
Sbjct: 108 LFEDIVARE-YYSEADASHCIQQILEAVLHCHQMGVVHRDLKPENLLLASKLKGAAVKLA 166
Query: 257 DFGVA-RVQAQSGVMTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPY 313
           DFG+A  V+ +        GT  +++PEV+   PY    D+++ G+ L+ LL G  P+
Sbjct: 167 DFGLAIEVEGEQQAWFGFAGTPGYLSPEVLRKDPYGKPVDLWACGVILYILLVGYPPF 224

>pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 56/203 (27%), Positives = 103/203 (50%), Gaps = 19/203 (9%)
Query: 124 VASGSYGD--LYKGTYCSQEVAIKVL-KPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIG 180
           +  G++G+  L +     +  A+K+L K E +       F +E  IM       VVQ   
Sbjct: 83  IGRGAFGEVQLVRHKASQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFC 142
Query: 181 ACTRPPNLCIVTEFMARGSIYDFLHK----QKGVFQLTSLLKVAIDVSKGMNYLHQNNII 236
           A      L +V E+M  G + + +      +K     T+ + +A+D       +H   +I
Sbjct: 143 AFQDDKYLYMVMEYMPGGDLVNLMSNYDVPEKWAKFYTAEVVLALDA------IHSMGLI 196
Query: 237 HRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAET--GTYRWMAPEVIEHKP----Y 290
           HRD+K  N+L+D++G +K+ADFG      ++G++  +T  GT  +++PEV++ +     Y
Sbjct: 197 HRDVKPDNMLLDKHGHLKLADFGTCMKMDETGMVHCDTAVGTPDYISPEVLKSQGGDGYY 256
Query: 291 DYKADVFSFGIALWELLTGELPY 313
             + D +S G+ L+E+L G+ P+
Sbjct: 257 GRECDWWSVGVFLFEMLVGDTPF 279

>pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 56/211 (26%), Positives = 104/211 (49%), Gaps = 41/211 (19%)
Query: 138 CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQF--------------IGACT 183
           C + VAIK  K    + + +K   +E+ I+R++ H N+V+               +G+ T
Sbjct: 35  CDKRVAIK--KIVLTDPQSVKHALREIKIIRRLDHDNIVKVFEILGPSGSQLTDDVGSLT 92
Query: 184 RPPNLCIVTEFMA--------RGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNI 235
              ++ IV E+M         +G + +  H +  ++QL           +G+ Y+H  N+
Sbjct: 93  ELNSVYIVQEYMETDLANVLEQGPLLEE-HARLFMYQLL----------RGLKYIHSANV 141
Query: 236 IHRDLKTANLLMD-ENGVVKVADFGVARVQ----AQSGVMTAETGTYRWMAPE-VIEHKP 289
           +HRDLK ANL ++ E+ V+K+ DFG+AR+     +  G ++    T  + +P  ++    
Sbjct: 142 LHRDLKPANLFINTEDLVLKIGDFGLARIMDPHYSHKGHLSEGLVTKWYRSPRLLLSPNN 201
Query: 290 YDYKADVFSFGIALWELLTGELPYAGLTPLQ 320
           Y    D+++ G    E+LTG+  +AG   L+
Sbjct: 202 YTKAIDMWAAGCIFAEMLTGKTLFAGAHELE 232

>pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325

Iteration: 1
 Score = 69.7 bits (169), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 39/146 (26%), Positives = 77/146 (52%), Gaps = 5/146 (3%)
Query: 172 HKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLH 231
           H N+V+         +  +V E +  G +++ + K+K  F  T    +   +   ++++H
Sbjct: 65  HPNIVKLHEVFHDQLHTFLVMELLNGGELFERIKKKKH-FSETEASYIMRKLVSAVSHMH 123
Query: 232 QNNIIHRDLKTANLLM---DENGVVKVADFGVARVQA-QSGVMTAETGTYRWMAPEVIEH 287
              ++HRDLK  NLL    ++N  +K+ DFG AR++   +  +     T  + APE++  
Sbjct: 124 DVGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQPLKTPCFTLHYAAPELLNQ 183
Query: 288 KPYDYKADVFSFGIALWELLTGELPY 313
             YD   D++S G+ L+ +L+G++P+
Sbjct: 184 NGYDESCDLWSLGVILYTMLSGQVPF 209

>pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302

Iteration: 1
 Score = 69.7 bits (169), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 52/202 (25%), Positives = 99/202 (49%), Gaps = 7/202 (3%)
Query: 119 KIECKVASGSYGDLYKG--TYCSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVV 176
           K+E K+  G+YG +YK       + VA+K ++ +     +     +E+ +++++ H N+V
Sbjct: 10  KVE-KIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIV 68
Query: 177 QFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAI-DVSKGMNYLHQNNI 235
           + +        L +V E + +  +  F+           L+K  +  + +G+ + H + +
Sbjct: 69  KLLDVIHTENKLYLVFEHVDQ-DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRV 127
Query: 236 IHRDLKTANLLMDENGVVKVADFGVARV-QAQSGVMTAETGTYRWMAPEVIEH-KPYDYK 293
           +HRDLK  NLL++  G +K+ADFG+AR           E  T  + APE++   K Y   
Sbjct: 128 LHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKYYSTA 187
Query: 294 ADVFSFGIALWELLTGELPYAG 315
            D++S G    E++T    + G
Sbjct: 188 VDIWSLGCIFAEMVTRRALFPG 209

>pdb|2P3G|X Chain X, Crystal Structure Of A Pyrrolopyridine Inhibitor Bound To Mapkap Kinase-2 Length = 327

Iteration: 1
 Score = 69.3 bits (168), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 49/189 (25%), Positives = 88/189 (46%), Gaps = 12/189 (6%)
Query: 188 LCIVTEFMARGSIYDFLHKQ-KGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLL 246
           L IV E +  G ++  +  +    F      ++   + + + YLH  NI HRD+K  NLL
Sbjct: 90  LLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLL 149
Query: 247 MDE---NGVVKVADFGVARVQAQSGVMTAETGTYRWMAPEVIEHKPYDYKADVFSFGIAL 303
                 N ++K+ DFG A+       +T    T  ++APEV+  + YD   D++S G+ +
Sbjct: 150 YTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIM 209
Query: 304 WELLTGELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRLAE-------LLERCWQHDPTQ 356
           + LL G  P+     L  + G ++  +R    +  +P  +E       L+    + +PTQ
Sbjct: 210 YILLCGYPPFYSNHGLAISPG-MKTRIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQ 268
Query: 357 RPNFSQITD 365
           R   ++  +
Sbjct: 269 RMTITEFMN 277

>pdb|2JBO|A Chain A, Protein Kinase Mk2 In Complex With An Inhibitor (Crystal Form-1, Soaking) Length = 326

Iteration: 1
 Score = 69.3 bits (168), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 49/189 (25%), Positives = 88/189 (46%), Gaps = 12/189 (6%)
Query: 188 LCIVTEFMARGSIYDFLH-KQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLL 246
           L IV E +  G ++  +  +    F      ++   + + + YLH  NI HRD+K  NLL
Sbjct: 96  LLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLL 155
Query: 247 MDE---NGVVKVADFGVARVQAQSGVMTAETGTYRWMAPEVIEHKPYDYKADVFSFGIAL 303
                 N ++K+ DFG A+       +T    T  ++APEV+  + YD   D++S G+ +
Sbjct: 156 YTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIM 215
Query: 304 WELLTGELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRLAE-------LLERCWQHDPTQ 356
           + LL G  P+     L  + G ++  +R    +  +P  +E       L+    + +PTQ
Sbjct: 216 YILLCGYPPFYSNHGLAISPG-MKTRIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQ 274
Query: 357 RPNFSQITD 365
           R   ++  +
Sbjct: 275 RMTITEFMN 283

>pdb|3GOK|A Chain A, Binding Site Mapping Of Protein Ligands Length = 334

Iteration: 1
 Score = 69.3 bits (168), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 49/189 (25%), Positives = 88/189 (46%), Gaps = 12/189 (6%)
Query: 188 LCIVTEFMARGSIYDFLH-KQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLL 246
           L IV E +  G ++  +  +    F      ++   + + + YLH  NI HRD+K  NLL
Sbjct: 104 LLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLL 163
Query: 247 MDE---NGVVKVADFGVARVQAQSGVMTAETGTYRWMAPEVIEHKPYDYKADVFSFGIAL 303
                 N ++K+ DFG A+       +T    T  ++APEV+  + YD   D++S G+ +
Sbjct: 164 YTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIM 223
Query: 304 WELLTGELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRLAE-------LLERCWQHDPTQ 356
           + LL G  P+     L  + G ++  +R    +  +P  +E       L+    + +PTQ
Sbjct: 224 YILLCGYPPFYSNHGLAISPG-MKTRIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQ 282
Query: 357 RPNFSQITD 365
           R   ++  +
Sbjct: 283 RMTITEFMN 291

>pdb|2ONL|C Chain C, Crystal Structure Of The P38a-Mapkap Kinase 2 Heterodimer Length = 406

Iteration: 1
 Score = 69.3 bits (168), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 49/189 (25%), Positives = 88/189 (46%), Gaps = 12/189 (6%)
Query: 188 LCIVTEFMARGSIYDFLHKQ-KGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLL 246
           L IV E +  G ++  +  +    F      ++   + + + YLH  NI HRD+K  NLL
Sbjct: 140 LLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLL 199
Query: 247 MDE---NGVVKVADFGVARVQAQSGVMTAETGTYRWMAPEVIEHKPYDYKADVFSFGIAL 303
                 N ++K+ DFG A+       +T    T  ++APEV+  + YD   D++S G+ +
Sbjct: 200 YTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIM 259
Query: 304 WELLTGELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRLAE-------LLERCWQHDPTQ 356
           + LL G  P+     L  + G ++  +R    +  +P  +E       L+    + +PTQ
Sbjct: 260 YILLCGYPPFYSNHGLAISPG-MKTRIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQ 318
Query: 357 RPNFSQITD 365
           R   ++  +
Sbjct: 319 RMTITEFMN 327

>pdb|3R2Y|A Chain A, Mk2 Kinase Bound To Compound 1 Length = 319

Iteration: 1
 Score = 69.3 bits (168), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 49/189 (25%), Positives = 88/189 (46%), Gaps = 12/189 (6%)
Query: 188 LCIVTEFMARGSIYDFLH-KQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLL 246
           L IV E +  G ++  +  +    F      ++   + + + YLH  NI HRD+K  NLL
Sbjct: 89  LLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLL 148
Query: 247 MDE---NGVVKVADFGVARVQAQSGVMTAETGTYRWMAPEVIEHKPYDYKADVFSFGIAL 303
                 N ++K+ DFG A+       +T    T  ++APEV+  + YD   D++S G+ +
Sbjct: 149 YTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIM 208
Query: 304 WELLTGELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRLAE-------LLERCWQHDPTQ 356
           + LL G  P+     L  + G ++  +R    +  +P  +E       L+    + +PTQ
Sbjct: 209 YILLCGYPPFYSNHGLAISPG-MKTRIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQ 267
Query: 357 RPNFSQITD 365
           R   ++  +
Sbjct: 268 RMTITEFMN 276

>pdb|3R2B|A Chain A, Mk2 Kinase Bound To Compound 5b Length = 318

Iteration: 1
 Score = 69.3 bits (168), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 49/189 (25%), Positives = 88/189 (46%), Gaps = 12/189 (6%)
Query: 188 LCIVTEFMARGSIYDFLH-KQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLL 246
           L IV E +  G ++  +  +    F      ++   + + + YLH  NI HRD+K  NLL
Sbjct: 88  LLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLL 147
Query: 247 MDE---NGVVKVADFGVARVQAQSGVMTAETGTYRWMAPEVIEHKPYDYKADVFSFGIAL 303
                 N ++K+ DFG A+       +T    T  ++APEV+  + YD   D++S G+ +
Sbjct: 148 YTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIM 207
Query: 304 WELLTGELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRLAE-------LLERCWQHDPTQ 356
           + LL G  P+     L  + G ++  +R    +  +P  +E       L+    + +PTQ
Sbjct: 208 YILLCGYPPFYSNHGLAISPG-MKTRIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQ 266
Query: 357 RPNFSQITD 365
           R   ++  +
Sbjct: 267 RMTITEFMN 275

>pdb|2PZY|A Chain A, Structure Of Mk2 Complexed With Compound 76 Length = 324

Iteration: 1
 Score = 69.3 bits (168), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 49/189 (25%), Positives = 88/189 (46%), Gaps = 12/189 (6%)
Query: 188 LCIVTEFMARGSIYDFLH-KQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLL 246
           L IV E +  G ++  +  +    F      ++   + + + YLH  NI HRD+K  NLL
Sbjct: 94  LLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLL 153
Query: 247 MDE---NGVVKVADFGVARVQAQSGVMTAETGTYRWMAPEVIEHKPYDYKADVFSFGIAL 303
                 N ++K+ DFG A+       +T    T  ++APEV+  + YD   D++S G+ +
Sbjct: 154 YTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIM 213
Query: 304 WELLTGELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRLAE-------LLERCWQHDPTQ 356
           + LL G  P+     L  + G ++  +R    +  +P  +E       L+    + +PTQ
Sbjct: 214 YILLCGYPPFYSNHGLAISPG-MKTRIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQ 272
Query: 357 RPNFSQITD 365
           R   ++  +
Sbjct: 273 RMTITEFMN 281

>pdb|3FPM|A Chain A, Crystal Structure Of A Squarate Inhibitor Bound To Mapkap Kinase-2 Length = 325

Iteration: 1
 Score = 69.3 bits (168), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 49/189 (25%), Positives = 88/189 (46%), Gaps = 12/189 (6%)
Query: 188 LCIVTEFMARGSIYDFLH-KQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLL 246
           L IV E +  G ++  +  +    F      ++   + + + YLH  NI HRD+K  NLL
Sbjct: 95  LLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLL 154
Query: 247 MDE---NGVVKVADFGVARVQAQSGVMTAETGTYRWMAPEVIEHKPYDYKADVFSFGIAL 303
                 N ++K+ DFG A+       +T    T  ++APEV+  + YD   D++S G+ +
Sbjct: 155 YTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIM 214
Query: 304 WELLTGELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRLAE-------LLERCWQHDPTQ 356
           + LL G  P+     L  + G ++  +R    +  +P  +E       L+    + +PTQ
Sbjct: 215 YILLCGYPPFYSNHGLAISPG-MKTRIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQ 273
Query: 357 RPNFSQITD 365
           R   ++  +
Sbjct: 274 RMTITEFMN 282

>pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307

Iteration: 1
 Score = 69.3 bits (168), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 53/192 (27%), Positives = 95/192 (49%), Gaps = 18/192 (9%)
Query: 140 QEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVTEFMARGS 199
           +E A+K+++ +  ++   + F +   + +   +KN+++ I          +V E +  GS
Sbjct: 39  KEYAVKIIEKQAGHSRS-RVFREVETLYQCQGNKNILELIEFFEDDTRFYLVFEKLQGGS 97
Query: 200 IYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDEN---GVVKVA 256
           I   + KQK  F      +V  DV+  +++LH   I HRDLK  N+L +       VK+ 
Sbjct: 98  ILAHIQKQKH-FNEREASRVVRDVAAALDFLHTKGIAHRDLKPENILCESPEKVSPVKIC 156
Query: 257 DF----GVARVQAQSGVMTAE----TGTYRWMAPEVIE-----HKPYDYKADVFSFGIAL 303
           DF    G+    + + + T E     G+  +MAPEV+E        YD + D++S G+ L
Sbjct: 157 DFDLGSGMKLNNSCTPITTPELTTPCGSAEYMAPEVVEVFTDQATFYDKRCDLWSLGVVL 216
Query: 304 WELLTGELPYAG 315
           + +L+G  P+ G
Sbjct: 217 YIMLSGYPPFVG 228

>pdb|1KWP|A Chain A, Crystal Structure Of Mapkap2 Length = 400

Iteration: 1
 Score = 68.9 bits (167), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 49/189 (25%), Positives = 88/189 (46%), Gaps = 12/189 (6%)
Query: 188 LCIVTEFMARGSIYDFLHKQ-KGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLL 246
           L IV E +  G ++  +  +    F      ++   + + + YLH  NI HRD+K  NLL
Sbjct: 134 LLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLL 193
Query: 247 MDE---NGVVKVADFGVARVQAQSGVMTAETGTYRWMAPEVIEHKPYDYKADVFSFGIAL 303
                 N ++K+ DFG A+       +T    T  ++APEV+  + YD   D++S G+ +
Sbjct: 194 YTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIM 253
Query: 304 WELLTGELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRLAE-------LLERCWQHDPTQ 356
           + LL G  P+     L  + G ++  +R    +  +P  +E       L+    + +PTQ
Sbjct: 254 YILLCGYPPFYSNHGLAISPG-MKTRIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQ 312
Query: 357 RPNFSQITD 365
           R   ++  +
Sbjct: 313 RMTITEFMN 321

>pdb|2OZA|A Chain A, Structure Of P38alpha Complex Length = 356

Iteration: 1
 Score = 68.9 bits (167), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 49/189 (25%), Positives = 88/189 (46%), Gaps = 12/189 (6%)
Query: 188 LCIVTEFMARGSIYDFLHKQ-KGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLL 246
           L IV E +  G ++  +  +    F      ++   + + + YLH  NI HRD+K  NLL
Sbjct: 90  LLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLL 149
Query: 247 MDE---NGVVKVADFGVARVQAQSGVMTAETGTYRWMAPEVIEHKPYDYKADVFSFGIAL 303
                 N ++K+ DFG A+       +T    T  ++APEV+  + YD   D++S G+ +
Sbjct: 150 YTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIM 209
Query: 304 WELLTGELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRLAE-------LLERCWQHDPTQ 356
           + LL G  P+     L  + G ++  +R    +  +P  +E       L+    + +PTQ
Sbjct: 210 YILLCGYPPFYSNHGLAISPG-MKTRIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQ 268
Query: 357 RPNFSQITD 365
           R   ++  +
Sbjct: 269 RMTITEFMN 277

>pdb|4AS0|A Chain A, Cyclometalated Phthalimides As Protein Kinase Inhibitors Length = 273

Iteration: 1
 Score = 68.9 bits (167), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 60/260 (23%), Positives = 112/260 (43%), Gaps = 21/260 (8%)
Query: 117 QLKIECKVASGSYGDLYKGTYCSQEVAIKVLKPECVNTEMLKEFSQ------EVYIMRKI 170
           Q ++   + SG +G +Y G   S  + + +   E        E         EV +++K+
Sbjct: 5   QYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKV 64
Query: 171 R--HKNVVQFIGACTRPPNLCIVTEFMAR-GSIYDFLHKQKGVFQLTSLLKVAIDVSKGM 227
                 V++ +    RP +  ++ E       ++DF+  ++G  Q          V + +
Sbjct: 65  SSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFI-TERGALQEELARSFFWQVLEAV 123
Query: 228 NYLHQNNIIHRDLKTANLLMDEN-GVVKVADFGVARVQAQSGVMTAETGTYRWMAPEVIE 286
            + H   ++HRD+K  N+L+D N G +K+ DFG   +   + V T   GT  +  PE I 
Sbjct: 124 RHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDT-VYTDFDGTRVYSPPEWIR 182
Query: 287 -HKPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRLAEL 345
            H+ +   A V+S GI L++++ G++P+     +       Q   R  +          L
Sbjct: 183 YHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIGG----QVFFRQRVSSECQ----HL 234
Query: 346 LERCWQHDPTQRPNFSQITD 365
           +  C    P+ RP F +I +
Sbjct: 235 IRWCLALRPSDRPTFEEIQN 254

>pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415

Iteration: 1
 Score = 68.9 bits (167), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 57/212 (26%), Positives = 105/212 (49%), Gaps = 19/212 (8%)
Query: 115 AKQLKIECKVASGSYGD--LYKGTYCSQEVAIKVL-KPECVNTEMLKEFSQEVYIMRKIR 171
           A+  ++   +  G++G+  L +     +  A+K+L K E +       F +E  IM    
Sbjct: 73  AEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFAN 132
Query: 172 HKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHK----QKGVFQLTSLLKVAIDVSKGM 227
              VVQ   A      L +V E+M  G + + +      +K     T+ + +A+D     
Sbjct: 133 SPWVVQLFYAFQDDRYLYMVMEYMPGGDLVNLMSNYDVPEKWARFYTAEVVLALDA---- 188
Query: 228 NYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAET--GTYRWMAPEVI 285
             +H    IHRD+K  N+L+D++G +K+ADFG      + G++  +T  GT  +++PEV+
Sbjct: 189 --IHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAVGTPDYISPEVL 246
Query: 286 EHKP----YDYKADVFSFGIALWELLTGELPY 313
           + +     Y  + D +S G+ L+E+L G+ P+
Sbjct: 247 KSQGGDGYYGRECDWWSVGVFLYEMLVGDTPF 278

>pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410

Iteration: 1
 Score = 68.9 bits (167), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 57/212 (26%), Positives = 105/212 (49%), Gaps = 19/212 (8%)
Query: 115 AKQLKIECKVASGSYGD--LYKGTYCSQEVAIKVL-KPECVNTEMLKEFSQEVYIMRKIR 171
           A+  ++   +  G++G+  L +     +  A+K+L K E +       F +E  IM    
Sbjct: 68  AEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFAN 127
Query: 172 HKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHK----QKGVFQLTSLLKVAIDVSKGM 227
              VVQ   A      L +V E+M  G + + +      +K     T+ + +A+D     
Sbjct: 128 SPWVVQLFYAFQDDRYLYMVMEYMPGGDLVNLMSNYDVPEKWARFYTAEVVLALDA---- 183
Query: 228 NYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAET--GTYRWMAPEVI 285
             +H    IHRD+K  N+L+D++G +K+ADFG      + G++  +T  GT  +++PEV+
Sbjct: 184 --IHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAVGTPDYISPEVL 241
Query: 286 EHKP----YDYKADVFSFGIALWELLTGELPY 313
           + +     Y  + D +S G+ L+E+L G+ P+
Sbjct: 242 KSQGGDGYYGRECDWWSVGVFLYEMLVGDTPF 273

>pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406

Iteration: 1
 Score = 68.9 bits (167), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 57/212 (26%), Positives = 105/212 (49%), Gaps = 19/212 (8%)
Query: 115 AKQLKIECKVASGSYGD--LYKGTYCSQEVAIKVL-KPECVNTEMLKEFSQEVYIMRKIR 171
           A+  ++   +  G++G+  L +     +  A+K+L K E +       F +E  IM    
Sbjct: 73  AEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFAN 132
Query: 172 HKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHK----QKGVFQLTSLLKVAIDVSKGM 227
              VVQ   A      L +V E+M  G + + +      +K     T+ + +A+D     
Sbjct: 133 SPWVVQLFYAFQDDRYLYMVMEYMPGGDLVNLMSNYDVPEKWARFYTAEVVLALDA---- 188
Query: 228 NYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAET--GTYRWMAPEVI 285
             +H    IHRD+K  N+L+D++G +K+ADFG      + G++  +T  GT  +++PEV+
Sbjct: 189 --IHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAVGTPDYISPEVL 246
Query: 286 EHKP----YDYKADVFSFGIALWELLTGELPY 313
           + +     Y  + D +S G+ L+E+L G+ P+
Sbjct: 247 KSQGGDGYYGRECDWWSVGVFLYEMLVGDTPF 278

>pdb|3KA0|A Chain A, Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4-Ylamino)-2- Hydroxyphenyl)-N-Methylbenzo[b]thiophene-2-Carboxamide Length = 320

Iteration: 1
 Score = 68.9 bits (167), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 49/189 (25%), Positives = 88/189 (46%), Gaps = 12/189 (6%)
Query: 188 LCIVTEFMARGSIYDFLHKQ-KGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLL 246
           L IV E +  G ++  +  +    F      ++   + + + YLH  NI HRD+K  NLL
Sbjct: 88  LLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLL 147
Query: 247 MDE---NGVVKVADFGVARVQAQSGVMTAETGTYRWMAPEVIEHKPYDYKADVFSFGIAL 303
                 N ++K+ DFG A+       +T    T  ++APEV+  + YD   D++S G+ +
Sbjct: 148 YTSKRPNAILKLTDFGFAKETTSHNSLTEPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIM 207
Query: 304 WELLTGELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRLAE-------LLERCWQHDPTQ 356
           + LL G  P+     L  + G ++  +R    +  +P  +E       L+    + +PTQ
Sbjct: 208 YILLCGYPPFYSNHGLAISPG-MKTRIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQ 266
Query: 357 RPNFSQITD 365
           R   ++  +
Sbjct: 267 RMTITEFMN 275

>pdb|3JPV|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Pyrrolo[2,3- A]carbazole Ligand Length = 313

Iteration: 1
 Score = 68.9 bits (167), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 60/260 (23%), Positives = 112/260 (43%), Gaps = 21/260 (8%)
Query: 117 QLKIECKVASGSYGDLYKGTYCSQEVAIKVLKPECVNTEMLKEFSQ------EVYIMRKI 170
           Q ++   + SG +G +Y G   S  + + +   E        E         EV +++K+
Sbjct: 38  QYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKV 97
Query: 171 RH--KNVVQFIGACTRPPNLCIVTEFMAR-GSIYDFLHKQKGVFQLTSLLKVAIDVSKGM 227
                 V++ +    RP +  ++ E       ++DF+  ++G  Q          V + +
Sbjct: 98  SSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFI-TERGALQEELARSFFWQVLEAV 156
Query: 228 NYLHQNNIIHRDLKTANLLMDEN-GVVKVADFGVARVQAQSGVMTAETGTYRWMAPEVIE 286
            + H   ++HRD+K  N+L+D N G +K+ DFG   +   + V T   GT  +  PE I 
Sbjct: 157 RHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDT-VYTDFDGTRVYSPPEWIR 215
Query: 287 -HKPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRLAEL 345
            H+ +   A V+S GI L++++ G++P+     +       Q   R  +          L
Sbjct: 216 YHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIGG----QVFFRQRVSSECQ----HL 267
Query: 346 LERCWQHDPTQRPNFSQITD 365
           +  C    P+ RP F +I +
Sbjct: 268 IRWCLALRPSDRPTFEEIQN 287

>pdb|2BIL|B Chain B, The Human Protein Kinase Pim1 In Complex With Its Consensus Peptide Pimtide Length = 313

Iteration: 1
 Score = 68.9 bits (167), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 60/260 (23%), Positives = 112/260 (43%), Gaps = 21/260 (8%)
Query: 117 QLKIECKVASGSYGDLYKGTYCSQEVAIKVLKPECVNTEMLKEFSQ------EVYIMRKI 170
           Q ++   + SG +G +Y G   S  + + +   E        E         EV +++K+
Sbjct: 37  QYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKV 96
Query: 171 RH--KNVVQFIGACTRPPNLCIVTEFMAR-GSIYDFLHKQKGVFQLTSLLKVAIDVSKGM 227
                 V++ +    RP +  ++ E       ++DF+  ++G  Q          V + +
Sbjct: 97  SSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFI-TERGALQEELARSFFWQVLEAV 155
Query: 228 NYLHQNNIIHRDLKTANLLMDEN-GVVKVADFGVARVQAQSGVMTAETGTYRWMAPEVIE 286
            + H   ++HRD+K  N+L+D N G +K+ DFG   +   + V T   GT  +  PE I 
Sbjct: 156 RHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDT-VYTDFDGTRVYSPPEWIR 214
Query: 287 -HKPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRLAEL 345
            H+ +   A V+S GI L++++ G++P+     +       Q   R  +          L
Sbjct: 215 YHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIGG----QVFFRQRVSSECQ----HL 266
Query: 346 LERCWQHDPTQRPNFSQITD 365
           +  C    P+ RP F +I +
Sbjct: 267 IRWCLALRPSDRPTFEEIQN 286

>pdb|2J2I|B Chain B, Crystal Structure Of The Humab Pim1 In Complex With Ly333531 Length = 312

Iteration: 1
 Score = 68.9 bits (167), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 60/260 (23%), Positives = 112/260 (43%), Gaps = 21/260 (8%)
Query: 117 QLKIECKVASGSYGDLYKGTYCSQEVAIKVLKPECVNTEMLKEFSQ------EVYIMRKI 170
           Q ++   + SG +G +Y G   S  + + +   E        E         EV +++K+
Sbjct: 37  QYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKV 96
Query: 171 RH--KNVVQFIGACTRPPNLCIVTEFMAR-GSIYDFLHKQKGVFQLTSLLKVAIDVSKGM 227
                 V++ +    RP +  ++ E       ++DF+  ++G  Q          V + +
Sbjct: 97  SSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFI-TERGALQEELARSFFWQVLEAV 155
Query: 228 NYLHQNNIIHRDLKTANLLMDEN-GVVKVADFGVARVQAQSGVMTAETGTYRWMAPEVIE 286
            + H   ++HRD+K  N+L+D N G +K+ DFG   +   + V T   GT  +  PE I 
Sbjct: 156 RHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDT-VYTDFDGTRVYSPPEWIR 214
Query: 287 -HKPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRLAEL 345
            H+ +   A V+S GI L++++ G++P+     +       Q   R  +          L
Sbjct: 215 YHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIGG----QVFFRQRVSSECQ----HL 266
Query: 346 LERCWQHDPTQRPNFSQITD 365
           +  C    P+ RP F +I +
Sbjct: 267 IRWCLALRPSDRPTFEEIQN 286

>pdb|3CXW|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Beta Carboline Ligand I Length = 314

Iteration: 1
 Score = 68.6 bits (166), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 60/260 (23%), Positives = 112/260 (43%), Gaps = 21/260 (8%)
Query: 117 QLKIECKVASGSYGDLYKGTYCSQEVAIKVLKPECVNTEMLKEFSQ------EVYIMRKI 170
           Q ++   + SG +G +Y G   S  + + +   E        E         EV +++K+
Sbjct: 38  QYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKV 97
Query: 171 RH--KNVVQFIGACTRPPNLCIVTEFMAR-GSIYDFLHKQKGVFQLTSLLKVAIDVSKGM 227
                 V++ +    RP +  ++ E       ++DF+  ++G  Q          V + +
Sbjct: 98  SSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFI-TERGALQEELARSFFWQVLEAV 156
Query: 228 NYLHQNNIIHRDLKTANLLMDEN-GVVKVADFGVARVQAQSGVMTAETGTYRWMAPEVIE 286
            + H   ++HRD+K  N+L+D N G +K+ DFG   +   + V T   GT  +  PE I 
Sbjct: 157 RHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDT-VYTDFDGTRVYSPPEWIR 215
Query: 287 -HKPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRLAEL 345
            H+ +   A V+S GI L++++ G++P+     +       Q   R  +          L
Sbjct: 216 YHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIGG----QVFFRQRVSSECQ----HL 267
Query: 346 LERCWQHDPTQRPNFSQITD 365
           +  C    P+ RP F +I +
Sbjct: 268 IRWCLALRPSDRPTFEEIQN 287

>pdb|1YHS|A Chain A, Crystal Structure Of Pim-1 Bound To Staurosporine Length = 273

Iteration: 1
 Score = 68.6 bits (166), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 60/260 (23%), Positives = 112/260 (43%), Gaps = 21/260 (8%)
Query: 117 QLKIECKVASGSYGDLYKGTYCSQEVAIKVLKPECVNTEMLKEFSQ------EVYIMRKI 170
           Q ++   + SG +G +Y G   S  + + +   E        E         EV +++K+
Sbjct: 5   QYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKV 64
Query: 171 R--HKNVVQFIGACTRPPNLCIVTEFMAR-GSIYDFLHKQKGVFQLTSLLKVAIDVSKGM 227
                 V++ +    RP +  ++ E       ++DF+  ++G  Q          V + +
Sbjct: 65  SSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFI-TERGALQEELARSFFWQVLEAV 123
Query: 228 NYLHQNNIIHRDLKTANLLMDEN-GVVKVADFGVARVQAQSGVMTAETGTYRWMAPEVIE 286
            + H   ++HRD+K  N+L+D N G +K+ DFG   +   + V T   GT  +  PE I 
Sbjct: 124 RHCHNXGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDT-VYTDFDGTRVYSPPEWIR 182
Query: 287 -HKPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRLAEL 345
            H+ +   A V+S GI L++++ G++P+     +       Q   R  +          L
Sbjct: 183 YHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRG----QVFFRQRVSXECQ----HL 234
Query: 346 LERCWQHDPTQRPNFSQITD 365
           +  C    P+ RP F +I +
Sbjct: 235 IRWCLALRPSDRPTFEEIQN 254

>pdb|3CY3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And The Jnk Inhibitor V Length = 314

Iteration: 1
 Score = 68.6 bits (166), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 60/260 (23%), Positives = 112/260 (43%), Gaps = 21/260 (8%)
Query: 117 QLKIECKVASGSYGDLYKGTYCSQEVAIKVLKPECVNTEMLKEFSQ------EVYIMRKI 170
           Q ++   + SG +G +Y G   S  + + +   E        E         EV +++K+
Sbjct: 38  QYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKV 97
Query: 171 RH--KNVVQFIGACTRPPNLCIVTEFMAR-GSIYDFLHKQKGVFQLTSLLKVAIDVSKGM 227
                 V++ +    RP +  ++ E       ++DF+  ++G  Q          V + +
Sbjct: 98  SSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFI-TERGALQEELARSFFWQVLEAV 156
Query: 228 NYLHQNNIIHRDLKTANLLMDEN-GVVKVADFGVARVQAQSGVMTAETGTYRWMAPEVIE 286
            + H   ++HRD+K  N+L+D N G +K+ DFG   +   + V T   GT  +  PE I 
Sbjct: 157 RHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDT-VYTDFDGTRVYSPPEWIR 215
Query: 287 -HKPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRLAEL 345
            H+ +   A V+S GI L++++ G++P+     +       Q   R  +          L
Sbjct: 216 YHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIGG----QVFFRQRVSXECQ----HL 267
Query: 346 LERCWQHDPTQRPNFSQITD 365
           +  C    P+ RP F +I +
Sbjct: 268 IRWCLALRPSDRPTFEEIQN 287

>pdb|3MA3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Naphtho-Difuran Ligand Length = 313

Iteration: 1
 Score = 68.6 bits (166), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 60/260 (23%), Positives = 112/260 (43%), Gaps = 21/260 (8%)
Query: 117 QLKIECKVASGSYGDLYKGTYCSQEVAIKVLKPECVNTEMLKEFSQ------EVYIMRKI 170
           Q ++   + SG +G +Y G   S  + + +   E        E         EV +++K+
Sbjct: 38  QYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKV 97
Query: 171 RH--KNVVQFIGACTRPPNLCIVTEFMAR-GSIYDFLHKQKGVFQLTSLLKVAIDVSKGM 227
                 V++ +    RP +  ++ E       ++DF+  ++G  Q          V + +
Sbjct: 98  SSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFI-TERGALQEELARSFFWQVLEAV 156
Query: 228 NYLHQNNIIHRDLKTANLLMDEN-GVVKVADFGVARVQAQSGVMTAETGTYRWMAPEVIE 286
            + H   ++HRD+K  N+L+D N G +K+ DFG   +   + V T   GT  +  PE I 
Sbjct: 157 RHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDT-VYTDFDGTRVYSPPEWIR 215
Query: 287 -HKPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRLAEL 345
            H+ +   A V+S GI L++++ G++P+     +       Q   R  +          L
Sbjct: 216 YHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIGG----QVFFRQRVSXECQ----HL 267
Query: 346 LERCWQHDPTQRPNFSQITD 365
           +  C    P+ RP F +I +
Sbjct: 268 IRWCLALRPSDRPTFEEIQN 287

>pdb|2BIK|B Chain B, Human Pim1 Phosphorylated On Ser261 Length = 313

Iteration: 1
 Score = 68.6 bits (166), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 60/260 (23%), Positives = 112/260 (43%), Gaps = 21/260 (8%)
Query: 117 QLKIECKVASGSYGDLYKGTYCSQEVAIKVLKPECVNTEMLKEFSQ------EVYIMRKI 170
           Q ++   + SG +G +Y G   S  + + +   E        E         EV +++K+
Sbjct: 37  QYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKV 96
Query: 171 RH--KNVVQFIGACTRPPNLCIVTEFMAR-GSIYDFLHKQKGVFQLTSLLKVAIDVSKGM 227
                 V++ +    RP +  ++ E       ++DF+  ++G  Q          V + +
Sbjct: 97  SSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFI-TERGALQEELARSFFWQVLEAV 155
Query: 228 NYLHQNNIIHRDLKTANLLMDEN-GVVKVADFGVARVQAQSGVMTAETGTYRWMAPEVIE 286
            + H   ++HRD+K  N+L+D N G +K+ DFG   +   + V T   GT  +  PE I 
Sbjct: 156 RHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDT-VYTDFDGTRVYSPPEWIR 214
Query: 287 -HKPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRLAEL 345
            H+ +   A V+S GI L++++ G++P+     +       Q   R  +          L
Sbjct: 215 YHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIGG----QVFFRQRVSXECQ----HL 266
Query: 346 LERCWQHDPTQRPNFSQITD 365
           +  C    P+ RP F +I +
Sbjct: 267 IRWCLALRPSDRPTFEEIQN 286

>pdb|3JXW|A Chain A, Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-Ones As Potent, Highly Selective And Orally Bioavailable Pim Kinases Inhibitors Length = 294

Iteration: 1
 Score = 68.2 bits (165), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 60/260 (23%), Positives = 112/260 (43%), Gaps = 21/260 (8%)
Query: 117 QLKIECKVASGSYGDLYKGTYCSQEVAIKVLKPECVNTEMLKEFSQ------EVYIMRKI 170
           Q ++   + SG +G +Y G   S  + + +   E        E         EV +++K+
Sbjct: 10  QYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKV 69
Query: 171 R--HKNVVQFIGACTRPPNLCIVTEFMAR-GSIYDFLHKQKGVFQLTSLLKVAIDVSKGM 227
                 V++ +    RP +  ++ E       ++DF+  ++G  Q          V + +
Sbjct: 70  SSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFI-TERGALQEELARSFFWQVLEAV 128
Query: 228 NYLHQNNIIHRDLKTANLLMDEN-GVVKVADFGVARVQAQSGVMTAETGTYRWMAPEVIE 286
            + H   ++HRD+K  N+L+D N G +K+ DFG   +   + V T   GT  +  PE I 
Sbjct: 129 RHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDT-VYTDFDGTRVYSPPEWIR 187
Query: 287 -HKPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRLAEL 345
            H+ +   A V+S GI L++++ G++P+     +       Q   R  +          L
Sbjct: 188 YHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRG----QVFFRQRVSSECQ----HL 239
Query: 346 LERCWQHDPTQRPNFSQITD 365
           +  C    P+ RP F +I +
Sbjct: 240 IRWCLALRPSDRPTFEEIQN 259

>pdb|3C4E|A Chain A, Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7- Azaindole Length = 273

Iteration: 1
 Score = 68.2 bits (165), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 60/260 (23%), Positives = 112/260 (43%), Gaps = 21/260 (8%)
Query: 117 QLKIECKVASGSYGDLYKGTYCSQEVAIKVLKPECVNTEMLKEFSQ------EVYIMRKI 170
           Q ++   + SG +G +Y G   S  + + +   E        E         EV +++K+
Sbjct: 5   QYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKV 64
Query: 171 R--HKNVVQFIGACTRPPNLCIVTEFMAR-GSIYDFLHKQKGVFQLTSLLKVAIDVSKGM 227
                 V++ +    RP +  ++ E       ++DF+  ++G  Q          V + +
Sbjct: 65  SSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFI-TERGALQEELARSFFWQVLEAV 123
Query: 228 NYLHQNNIIHRDLKTANLLMDEN-GVVKVADFGVARVQAQSGVMTAETGTYRWMAPEVIE 286
            + H   ++HRD+K  N+L+D N G +K+ DFG   +   + V T   GT  +  PE I 
Sbjct: 124 RHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDT-VYTDFDGTRVYSPPEWIR 182
Query: 287 -HKPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRLAEL 345
            H+ +   A V+S GI L++++ G++P+     +       Q   R  +          L
Sbjct: 183 YHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRG----QVFFRQRVSSECQ----HL 234
Query: 346 LERCWQHDPTQRPNFSQITD 365
           +  C    P+ RP F +I +
Sbjct: 235 IRWCLALRPSDRPTFEEIQN 254

>pdb|1YWV|A Chain A, Crystal Structures Of Proto-Oncogene Kinase Pim1: A Target Of Aberrant Somatic Hypermutations In Diffuse Large Cell Lymphoma Length = 293

Iteration: 1
 Score = 68.2 bits (165), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 60/260 (23%), Positives = 112/260 (43%), Gaps = 21/260 (8%)
Query: 117 QLKIECKVASGSYGDLYKGTYCSQEVAIKVLKPECVNTEMLKEFSQ------EVYIMRKI 170
           Q ++   + SG +G +Y G   S  + + +   E        E         EV +++K+
Sbjct: 9   QYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKV 68
Query: 171 R--HKNVVQFIGACTRPPNLCIVTEFMAR-GSIYDFLHKQKGVFQLTSLLKVAIDVSKGM 227
                 V++ +    RP +  ++ E       ++DF+  ++G  Q          V + +
Sbjct: 69  SSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFI-TERGALQEELARSFFWQVLEAV 127
Query: 228 NYLHQNNIIHRDLKTANLLMDEN-GVVKVADFGVARVQAQSGVMTAETGTYRWMAPEVIE 286
            + H   ++HRD+K  N+L+D N G +K+ DFG   +   + V T   GT  +  PE I 
Sbjct: 128 RHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDT-VYTDFDGTRVYSPPEWIR 186
Query: 287 -HKPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRLAEL 345
            H+ +   A V+S GI L++++ G++P+     +       Q   R  +          L
Sbjct: 187 YHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRG----QVFFRQRVSSECQ----HL 238
Query: 346 LERCWQHDPTQRPNFSQITD 365
           +  C    P+ RP F +I +
Sbjct: 239 IRWCLALRPSDRPTFEEIQN 258

>pdb|1NXK|A Chain A, Crystal Structure Of Staurosporine Bound To Map Kap Kinase 2 Length = 400

Iteration: 1
 Score = 68.2 bits (165), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 49/189 (25%), Positives = 85/189 (44%), Gaps = 12/189 (6%)
Query: 188 LCIVTEFMARGSIYDFLHKQ-KGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLL 246
           L IV E +  G ++  +  +    F      ++   + + + YLH  NI HRD+K  NLL
Sbjct: 134 LLIVXECLDGGELFSRIQDRGDQAFTEREASEIXKSIGEAIQYLHSINIAHRDVKPENLL 193
Query: 247 MDE---NGVVKVADFGVARVQAQSGVMTAETGTYRWMAPEVIEHKPYDYKADVFSFGIAL 303
                 N ++K+ DFG A+       +T    T  ++APEV+  + YD   D +S G+  
Sbjct: 194 YTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEVLGPEKYDKSCDXWSLGVIX 253
Query: 304 WELLTGELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRLAE-------LLERCWQHDPTQ 356
           + LL G  P+     L  + G  +  +R    +  +P  +E       L+    + +PTQ
Sbjct: 254 YILLCGYPPFYSNHGLAISPG-XKTRIRXGQYEFPNPEWSEVSEEVKXLIRNLLKTEPTQ 312
Query: 357 RPNFSQITD 365
           R   ++  +
Sbjct: 313 RXTITEFXN 321

>pdb|4DTK|A Chain A, Novel And Selective Pan-Pim Kinase Inhibitor Length = 276

Iteration: 1
 Score = 68.2 bits (165), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 60/260 (23%), Positives = 112/260 (43%), Gaps = 21/260 (8%)
Query: 117 QLKIECKVASGSYGDLYKGTYCSQEVAIKVLKPECVNTEMLKEFSQ------EVYIMRKI 170
           Q ++   + SG +G +Y G   S  + + +   E        E         EV +++K+
Sbjct: 8   QYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKV 67
Query: 171 R--HKNVVQFIGACTRPPNLCIVTEFMAR-GSIYDFLHKQKGVFQLTSLLKVAIDVSKGM 227
                 V++ +    RP +  ++ E       ++DF+  ++G  Q          V + +
Sbjct: 68  SSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFI-TERGALQEELARSFFWQVLEAV 126
Query: 228 NYLHQNNIIHRDLKTANLLMDEN-GVVKVADFGVARVQAQSGVMTAETGTYRWMAPEVIE 286
            + H   ++HRD+K  N+L+D N G +K+ DFG   +   + V T   GT  +  PE I 
Sbjct: 127 RHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDT-VYTDFDGTRVYSPPEWIR 185
Query: 287 -HKPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRLAEL 345
            H+ +   A V+S GI L++++ G++P+     +       Q   R  +          L
Sbjct: 186 YHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRG----QVFFRQRVSSECQ----HL 237
Query: 346 LERCWQHDPTQRPNFSQITD 365
           +  C    P+ RP F +I +
Sbjct: 238 IRWCLALRPSDRPTFEEIQN 257

>pdb|3R00|A Chain A, The Discovery Of Novel Benzofuran-2-Carboxylic Acids As Potent Pim-1 Inhibitors Length = 299

Iteration: 1
 Score = 68.2 bits (165), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 60/260 (23%), Positives = 112/260 (43%), Gaps = 21/260 (8%)
Query: 117 QLKIECKVASGSYGDLYKGTYCSQEVAIKVLKPECVNTEMLKEFSQ------EVYIMRKI 170
           Q ++   + SG +G +Y G   S  + + +   E        E         EV +++K+
Sbjct: 10  QYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKV 69
Query: 171 R--HKNVVQFIGACTRPPNLCIVTEFMAR-GSIYDFLHKQKGVFQLTSLLKVAIDVSKGM 227
                 V++ +    RP +  ++ E       ++DF+  ++G  Q          V + +
Sbjct: 70  SSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFI-TERGALQEELARSFFWQVLEAV 128
Query: 228 NYLHQNNIIHRDLKTANLLMDEN-GVVKVADFGVARVQAQSGVMTAETGTYRWMAPEVIE 286
            + H   ++HRD+K  N+L+D N G +K+ DFG   +   + V T   GT  +  PE I 
Sbjct: 129 RHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDT-VYTDFDGTRVYSPPEWIR 187
Query: 287 -HKPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRLAEL 345
            H+ +   A V+S GI L++++ G++P+     +       Q   R  +          L
Sbjct: 188 YHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRG----QVFFRQRVSSECQ----HL 239
Query: 346 LERCWQHDPTQRPNFSQITD 365
           +  C    P+ RP F +I +
Sbjct: 240 IRWCLALRPSDRPTFEEIQN 259

>pdb|3UIX|A Chain A, Crystal Structure Of Pim1 Kinase In Complex With Small Molecule Inhibitor Length = 298

Iteration: 1
 Score = 68.2 bits (165), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 60/260 (23%), Positives = 112/260 (43%), Gaps = 21/260 (8%)
Query: 117 QLKIECKVASGSYGDLYKGTYCSQEVAIKVLKPECVNTEMLKEFSQ------EVYIMRKI 170
           Q ++   + SG +G +Y G   S  + + +   E        E         EV +++K+
Sbjct: 10  QYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKV 69
Query: 171 R--HKNVVQFIGACTRPPNLCIVTEFMAR-GSIYDFLHKQKGVFQLTSLLKVAIDVSKGM 227
                 V++ +    RP +  ++ E       ++DF+  ++G  Q          V + +
Sbjct: 70  SSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFI-TERGALQEELARSFFWQVLEAV 128
Query: 228 NYLHQNNIIHRDLKTANLLMDEN-GVVKVADFGVARVQAQSGVMTAETGTYRWMAPEVIE 286
            + H   ++HRD+K  N+L+D N G +K+ DFG   +   + V T   GT  +  PE I 
Sbjct: 129 RHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDT-VYTDFDGTRVYSPPEWIR 187
Query: 287 -HKPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRLAEL 345
            H+ +   A V+S GI L++++ G++P+         +   Q   R  +          L
Sbjct: 188 YHRYHGRSAAVWSLGILLYDMVCGDIPFEH----DEEIIRGQVFFRQRVSSECQ----HL 239
Query: 346 LERCWQHDPTQRPNFSQITD 365
           +  C    P+ RP F +I +
Sbjct: 240 IRWCLALRPSDRPTFEEIQN 259

>pdb|4ALV|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328

Iteration: 1
 Score = 68.2 bits (165), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 60/260 (23%), Positives = 112/260 (43%), Gaps = 21/260 (8%)
Query: 117 QLKIECKVASGSYGDLYKGTYCSQEVAIKVLKPECVNTEMLKEFSQ------EVYIMRKI 170
           Q ++   + SG +G +Y G   S  + + +   E        E         EV +++K+
Sbjct: 52  QYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKV 111
Query: 171 RH--KNVVQFIGACTRPPNLCIVTEFMAR-GSIYDFLHKQKGVFQLTSLLKVAIDVSKGM 227
                 V++ +    RP +  ++ E       ++DF+  ++G  Q          V + +
Sbjct: 112 SSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFI-TERGALQEELARSFFWQVLEAV 170
Query: 228 NYLHQNNIIHRDLKTANLLMDEN-GVVKVADFGVARVQAQSGVMTAETGTYRWMAPEVIE 286
            + H   ++HRD+K  N+L+D N G +K+ DFG   +   + V T   GT  +  PE I 
Sbjct: 171 RHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDT-VYTDFDGTRVYSPPEWIR 229
Query: 287 -HKPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRLAEL 345
            H+ +   A V+S GI L++++ G++P+         +   Q   R  +          L
Sbjct: 230 YHRYHGRSAAVWSLGILLYDMVCGDIPFEH----DEEIIRGQVFFRQRVSSECQ----HL 281
Query: 346 LERCWQHDPTQRPNFSQITD 365
           +  C    P+ RP F +I +
Sbjct: 282 IRWCLALRPSDRPTFEEIQN 301

>pdb|3A99|A Chain A, Structure Of Pim-1 Kinase Crystallized In The Presence Of P27kip1 Carboxy-Terminal Peptide Length = 320

Iteration: 1
 Score = 68.2 bits (165), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 60/260 (23%), Positives = 112/260 (43%), Gaps = 21/260 (8%)
Query: 117 QLKIECKVASGSYGDLYKGTYCSQEVAIKVLKPECVNTEMLKEFSQ------EVYIMRKI 170
           Q ++   + SG +G +Y G   S  + + +   E        E         EV +++K+
Sbjct: 44  QYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKV 103
Query: 171 RH--KNVVQFIGACTRPPNLCIVTEFMAR-GSIYDFLHKQKGVFQLTSLLKVAIDVSKGM 227
                 V++ +    RP +  ++ E       ++DF+  ++G  Q          V + +
Sbjct: 104 SSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFI-TERGALQEELARSFFWQVLEAV 162
Query: 228 NYLHQNNIIHRDLKTANLLMDEN-GVVKVADFGVARVQAQSGVMTAETGTYRWMAPEVIE 286
            + H   ++HRD+K  N+L+D N G +K+ DFG   +   + V T   GT  +  PE I 
Sbjct: 163 RHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDT-VYTDFDGTRVYSPPEWIR 221
Query: 287 -HKPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRLAEL 345
            H+ +   A V+S GI L++++ G++P+         +   Q   R  +          L
Sbjct: 222 YHRYHGRSAAVWSLGILLYDMVCGDIPFEH----DEEIIRGQVFFRQRVSSECQ----HL 273
Query: 346 LERCWQHDPTQRPNFSQITD 365
           +  C    P+ RP F +I +
Sbjct: 274 IRWCLALRPSDRPTFEEIQN 293

>pdb|1XWS|A Chain A, Crystal Structure Of The Human Pim1 Kinase Domain Length = 313

Iteration: 1
 Score = 68.2 bits (165), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 60/260 (23%), Positives = 112/260 (43%), Gaps = 21/260 (8%)
Query: 117 QLKIECKVASGSYGDLYKGTYCSQEVAIKVLKPECVNTEMLKEFSQ------EVYIMRKI 170
           Q ++   + SG +G +Y G   S  + + +   E        E         EV +++K+
Sbjct: 37  QYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKV 96
Query: 171 RH--KNVVQFIGACTRPPNLCIVTEFMAR-GSIYDFLHKQKGVFQLTSLLKVAIDVSKGM 227
                 V++ +    RP +  ++ E       ++DF+  ++G  Q          V + +
Sbjct: 97  SSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFI-TERGALQEELARSFFWQVLEAV 155
Query: 228 NYLHQNNIIHRDLKTANLLMDEN-GVVKVADFGVARVQAQSGVMTAETGTYRWMAPEVIE 286
            + H   ++HRD+K  N+L+D N G +K+ DFG   +   + V T   GT  +  PE I 
Sbjct: 156 RHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDT-VYTDFDGTRVYSPPEWIR 214
Query: 287 -HKPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRLAEL 345
            H+ +   A V+S GI L++++ G++P+         +   Q   R  +          L
Sbjct: 215 YHRYHGRSAAVWSLGILLYDMVCGDIPFEH----DEEIIRGQVFFRQRVSSECQ----HL 266
Query: 346 LERCWQHDPTQRPNFSQITD 365
           +  C    P+ RP F +I +
Sbjct: 267 IRWCLALRPSDRPTFEEIQN 286

>pdb|2XJ0|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-4 From Crystallographic Fragment Screen Length = 301

Iteration: 1
 Score = 68.2 bits (165), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 60/260 (23%), Positives = 112/260 (43%), Gaps = 21/260 (8%)
Query: 117 QLKIECKVASGSYGDLYKGTYCSQEVAIKVLKPECVNTEMLKEFSQ------EVYIMRKI 170
           Q ++   + SG +G +Y G   S  + + +   E        E         EV +++K+
Sbjct: 25  QYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKV 84
Query: 171 RH--KNVVQFIGACTRPPNLCIVTEFMAR-GSIYDFLHKQKGVFQLTSLLKVAIDVSKGM 227
                 V++ +    RP +  ++ E       ++DF+  ++G  Q          V + +
Sbjct: 85  SSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFI-TERGALQEELARSFFWQVLEAV 143
Query: 228 NYLHQNNIIHRDLKTANLLMDEN-GVVKVADFGVARVQAQSGVMTAETGTYRWMAPEVIE 286
            + H   ++HRD+K  N+L+D N G +K+ DFG   +   + V T   GT  +  PE I 
Sbjct: 144 RHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDT-VYTDFDGTRVYSPPEWIR 202
Query: 287 -HKPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRLAEL 345
            H+ +   A V+S GI L++++ G++P+         +   Q   R  +          L
Sbjct: 203 YHRYHGRSAAVWSLGILLYDMVCGDIPFEH----DEEIIRGQVFFRQRVSSECQ----HL 254
Query: 346 LERCWQHDPTQRPNFSQITD 365
           +  C    P+ RP F +I +
Sbjct: 255 IRWCLALRPSDRPTFEEIQN 274

>pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388

Iteration: 1
 Score = 67.8 bits (164), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 59/242 (24%), Positives = 110/242 (45%), Gaps = 48/242 (19%)
Query: 123 KVASGSYGDLYKGT--YCSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIR-HKNVVQFI 179
           K+  G+YG ++K       + VA+K +     N+   +   +E+ I+ ++  H+N+V  +
Sbjct: 16  KLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIVNLL 75
Query: 180 GA--CTRPPNLCIVTEFMA-------RGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYL 230
                    ++ +V ++M        R +I + +HKQ  V+QL  ++K          YL
Sbjct: 76  NVLRADNDRDVYLVFDYMETDLHAVIRANILEPVHKQYVVYQLIKVIK----------YL 125
Query: 231 HQNNIIHRDLKTANLLMDENGVVKVADFGVAR----------------------VQAQSG 268
           H   ++HRD+K +N+L++    VKVADFG++R                            
Sbjct: 126 HSGGLLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVTNNIPLSINENTENFDDDQP 185
Query: 269 VMTAETGTYRWMAPEV-IEHKPYDYKADVFSFGIALWELLTGELPYAG---LTPLQAAVG 324
           ++T    T  + APE+ +    Y    D++S G  L E+L G+  + G   +  L+  +G
Sbjct: 186 ILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFPGSSTMNQLERIIG 245
Query: 325 VV 326
           V+
Sbjct: 246 VI 247

>pdb|1XQZ|A Chain A, Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolution Length = 300

Iteration: 1
 Score = 67.8 bits (164), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 60/260 (23%), Positives = 112/260 (43%), Gaps = 21/260 (8%)
Query: 117 QLKIECKVASGSYGDLYKGTYCSQEVAIKVLKPECVNTEMLKEFSQ------EVYIMRKI 170
           Q ++   + SG +G +Y G   S  + + +   E        E         EV +++K+
Sbjct: 24  QYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKV 83
Query: 171 RH--KNVVQFIGACTRPPNLCIVTEFMAR-GSIYDFLHKQKGVFQLTSLLKVAIDVSKGM 227
                 V++ +    RP +  ++ E       ++DF+  ++G  Q          V + +
Sbjct: 84  SSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFI-TERGALQEELARSFFWQVLEAV 142
Query: 228 NYLHQNNIIHRDLKTANLLMDEN-GVVKVADFGVARVQAQSGVMTAETGTYRWMAPEVIE 286
            + H   ++HRD+K  N+L+D N G +K+ DFG   +   + V T   GT  +  PE I 
Sbjct: 143 RHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDT-VYTDFDGTRVYSPPEWIR 201
Query: 287 -HKPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRLAEL 345
            H+ +   A V+S GI L++++ G++P+         +   Q   R  +          L
Sbjct: 202 YHRYHGRSAAVWSLGILLYDMVCGDIPFEH----DEEIIRGQVFFRQRVSSECQ----HL 253
Query: 346 LERCWQHDPTQRPNFSQITD 365
           +  C    P+ RP F +I +
Sbjct: 254 IRWCLALRPSDRPTFEEIQN 273

>pdb|4A7C|A Chain A, Crystal Structure Of Pim1 Kinase With Etp46546 Length = 308

Iteration: 1
 Score = 67.8 bits (164), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 60/260 (23%), Positives = 112/260 (43%), Gaps = 21/260 (8%)
Query: 117 QLKIECKVASGSYGDLYKGTYCSQEVAIKVLKPECVNTEMLKEFSQ------EVYIMRKI 170
           Q ++   + SG +G +Y G   S  + + +   E        E         EV +++K+
Sbjct: 32  QYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKV 91
Query: 171 R--HKNVVQFIGACTRPPNLCIVTEFMAR-GSIYDFLHKQKGVFQLTSLLKVAIDVSKGM 227
                 V++ +    RP +  ++ E       ++DF+  ++G  Q          V + +
Sbjct: 92  SSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFI-TERGALQEELARSFFWQVLEAV 150
Query: 228 NYLHQNNIIHRDLKTANLLMDEN-GVVKVADFGVARVQAQSGVMTAETGTYRWMAPEVIE 286
            + H   ++HRD+K  N+L+D N G +K+ DFG   +   + V T   GT  +  PE I 
Sbjct: 151 RHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDT-VYTDFDGTRVYSPPEWIR 209
Query: 287 -HKPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRLAEL 345
            H+ +   A V+S GI L++++ G++P+     +       Q   R  +          L
Sbjct: 210 YHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRG----QVFFRQRVSXECQ----HL 261
Query: 346 LERCWQHDPTQRPNFSQITD 365
           +  C    P+ RP F +I +
Sbjct: 262 IRWCLALRPSDRPTFEEIQN 281

>pdb|3DCV|A Chain A, Crystal Structure Of Human Pim1 Kinase Complexed With 4-(4- Hydroxy-3-Methyl-Phenyl)-6-Phenylpyrimidin-2(1h)-One Length = 328

Iteration: 1
 Score = 67.8 bits (164), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 60/260 (23%), Positives = 112/260 (43%), Gaps = 21/260 (8%)
Query: 117 QLKIECKVASGSYGDLYKGTYCSQEVAIKVLKPECVNTEMLKEFSQ------EVYIMRKI 170
           Q ++   + SG +G +Y G   S  + + +   E        E         EV +++K+
Sbjct: 52  QYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKV 111
Query: 171 R--HKNVVQFIGACTRPPNLCIVTEFMAR-GSIYDFLHKQKGVFQLTSLLKVAIDVSKGM 227
                 V++ +    RP +  ++ E       ++DF+  ++G  Q          V + +
Sbjct: 112 SSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFI-TERGALQEELARSFFWQVLEAV 170
Query: 228 NYLHQNNIIHRDLKTANLLMDEN-GVVKVADFGVARVQAQSGVMTAETGTYRWMAPEVIE 286
            + H   ++HRD+K  N+L+D N G +K+ DFG   +   + V T   GT  +  PE I 
Sbjct: 171 RHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDT-VYTDFDGTRVYSPPEWIR 229
Query: 287 -HKPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRLAEL 345
            H+ +   A V+S GI L++++ G++P+         +   Q   R  +          L
Sbjct: 230 YHRYHGRSAAVWSLGILLYDMVCGDIPFEH----DEEIIRGQVFFRQRVSXECQ----HL 281
Query: 346 LERCWQHDPTQRPNFSQITD 365
           +  C    P+ RP F +I +
Sbjct: 282 IRWCLALRPSDRPTFEEIQN 301

>pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 48/199 (24%), Positives = 96/199 (48%), Gaps = 15/199 (7%)
Query: 129 YGDLYKGTY---------CS-QEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQF 178
           Y D+ KG +         C+  E A K++  + ++    ++  +E  I R ++H N+V+ 
Sbjct: 9   YEDIGKGAFSVVRRCVKLCTGHEYAAKIINTKKLSARDHQKLEREARICRLLKHSNIVRL 68
Query: 179 IGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHR 238
             + +      +V + +  G +++ +  ++  +           + + + + HQ  ++HR
Sbjct: 69  HDSISEEGFHYLVFDLVTGGELFEDIVARE-YYSEADASHCIQQILEAVLHCHQMGVVHR 127
Query: 239 DLKTANLLMD---ENGVVKVADFGVA-RVQAQSGVMTAETGTYRWMAPEVIEHKPYDYKA 294
           DLK  NLL+    +   VK+ADFG+A  VQ          GT  +++PEV+  + Y    
Sbjct: 128 DLKPENLLLASKCKGAAVKLADFGLAIEVQGDQQAWFGFAGTPGYLSPEVLRKEAYGKPV 187
Query: 295 DVFSFGIALWELLTGELPY 313
           D+++ G+ L+ LL G  P+
Sbjct: 188 DIWACGVILYILLVGYPPF 206

>pdb|2XIY|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-2 From Crystallographic Fragment Screen Length = 301

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 60/260 (23%), Positives = 112/260 (43%), Gaps = 21/260 (8%)
Query: 117 QLKIECKVASGSYGDLYKGTYCSQEVAIKVLKPECVNTEMLKEFSQ------EVYIMRKI 170
           Q ++   + SG +G +Y G   S  + + +   E        E         EV +++K+
Sbjct: 25  QYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKV 84
Query: 171 RH--KNVVQFIGACTRPPNLCIVTEFMAR-GSIYDFLHKQKGVFQLTSLLKVAIDVSKGM 227
                 V++ +    RP +  ++ E       ++DF+  ++G  Q          V + +
Sbjct: 85  SSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFI-TERGALQEELARSFFWQVLEAV 143
Query: 228 NYLHQNNIIHRDLKTANLLMDEN-GVVKVADFGVARVQAQSGVMTAETGTYRWMAPEVIE 286
            + H   ++HRD+K  N+L+D N G +K+ DFG   +   + V T   GT  +  PE I 
Sbjct: 144 RHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDT-VYTDFDGTRVYSPPEWIR 202
Query: 287 -HKPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRLAEL 345
            H+ +   A V+S GI L++++ G++P+         +   Q   R  +          L
Sbjct: 203 YHRYHGRSAAVWSLGILLYDMVCGDIPFEH----DEEIIRGQVFFRQRVSXECQ----HL 254
Query: 346 LERCWQHDPTQRPNFSQITD 365
           +  C    P+ RP F +I +
Sbjct: 255 IRWCLALRPSDRPTFEEIQN 274

>pdb|2OBJ|A Chain A, Crystal Structure Of Human Pim-1 Kinase In Complex With Inhibitor Length = 333

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 60/260 (23%), Positives = 112/260 (43%), Gaps = 21/260 (8%)
Query: 117 QLKIECKVASGSYGDLYKGTYCSQEVAIKVLKPECVNTEMLKEFSQ------EVYIMRKI 170
           Q ++   + SG +G +Y G   S  + + +   E        E         EV +++K+
Sbjct: 57  QYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKV 116
Query: 171 RH--KNVVQFIGACTRPPNLCIVTEFMAR-GSIYDFLHKQKGVFQLTSLLKVAIDVSKGM 227
                 V++ +    RP +  ++ E       ++DF+  ++G  Q          V + +
Sbjct: 117 SSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFI-TERGALQEELARSFFWQVLEAV 175
Query: 228 NYLHQNNIIHRDLKTANLLMDEN-GVVKVADFGVARVQAQSGVMTAETGTYRWMAPEVIE 286
            + H   ++HRD+K  N+L+D N G +K+ DFG   +   + V T   GT  +  PE I 
Sbjct: 176 RHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDT-VYTDFDGTRVYSPPEWIR 234
Query: 287 -HKPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRLAEL 345
            H+ +   A V+S GI L++++ G++P+         +   Q   R  +          L
Sbjct: 235 YHRYHGRSAAVWSLGILLYDMVCGDIPFEH----DEEIIRGQVFFRQRVSXECQ----HL 286
Query: 346 LERCWQHDPTQRPNFSQITD 365
           +  C    P+ RP F +I +
Sbjct: 287 IRWCLALRPSDRPTFEEIQN 306

>pdb|3F2A|A Chain A, Crystal Structure Of Human Pim-1 In Complex With Dappa Length = 300

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 60/260 (23%), Positives = 112/260 (43%), Gaps = 21/260 (8%)
Query: 117 QLKIECKVASGSYGDLYKGTYCSQEVAIKVLKPECVNTEMLKEFSQ------EVYIMRKI 170
           Q ++   + SG +G +Y G   S  + + +   E        E         EV +++K+
Sbjct: 24  QYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKV 83
Query: 171 R--HKNVVQFIGACTRPPNLCIVTEFMAR-GSIYDFLHKQKGVFQLTSLLKVAIDVSKGM 227
                 V++ +    RP +  ++ E       ++DF+  ++G  Q          V + +
Sbjct: 84  SSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFI-TERGALQEELARSFFWQVLEAV 142
Query: 228 NYLHQNNIIHRDLKTANLLMDEN-GVVKVADFGVARVQAQSGVMTAETGTYRWMAPEVIE 286
            + H   ++HRD+K  N+L+D N G +K+ DFG   +   + V T   GT  +  PE I 
Sbjct: 143 RHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDT-VYTDFDGTRVYSPPEWIR 201
Query: 287 -HKPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRLAEL 345
            H+ +   A V+S GI L++++ G++P+         +   Q   R  +          L
Sbjct: 202 YHRYHGRSAAVWSLGILLYDMVCGDIPFEH----DEEIIRGQVFFRQRVSXECQ----HL 253
Query: 346 LERCWQHDPTQRPNFSQITD 365
           +  C    P+ RP F +I +
Sbjct: 254 IRWCLALRPSDRPTFEEIQN 273

>pdb|3GBZ|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia Length = 329

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 51/198 (25%), Positives = 95/198 (47%), Gaps = 17/198 (8%)
Query: 122 CKVASGSYGDLYKG--TYCSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFI 179
            K+  G+YG++YK   T  ++ VAIK ++ E     +     +EV ++++++H+N+++  
Sbjct: 40  TKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHRNIIELK 99
Query: 180 GACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRD 239
                   L ++ E+ A   +  ++ K   V  +  +      +  G+N+ H    +HRD
Sbjct: 100 SVIHHNHRLHLIFEY-AENDLKKYMDKNPDV-SMRVIKSFLYQLINGVNFCHSRRCLHRD 157
Query: 240 LKTANLLM-----DENGVVKVADFGVARVQAQSGV----MTAETGTYRWMAPEV-IEHKP 289
           LK  NLL+      E  V+K+ DFG+AR     G+     T E  T  +  PE+ +  + 
Sbjct: 158 LKPQNLLLSVSDASETPVLKIGDFGLARA---FGIPIRQFTHEIITLWYRPPEILLGSRH 214
Query: 290 YDYKADVFSFGIALWELL 307
           Y    D++S      E+L
Sbjct: 215 YSTSVDIWSIACIWAEML 232

>pdb|3UYS|A Chain A, Crystal Structure Of Apo Human Ck1d Length = 296

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 71/279 (25%), Positives = 119/279 (42%), Gaps = 29/279 (10%)
Query: 115 AKQLKIECKVASGSYGDLYKGT--YCSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRH 172
             + ++  K+ SGS+GD+Y GT     +EVAIK+   ECV T+   +   E  I + ++ 
Sbjct: 8   GNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKL---ECVKTKH-PQLHIESKIYKMMQG 63
Query: 173 KNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQ 232
              +  I  C    +  ++   +   S+ D  +     F L ++L +A  +   + Y+H 
Sbjct: 64  GVGIPTIRWCGAEGDYNVMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHS 123
Query: 233 NNIIHRDLKTANLLM---DENGVVKVADFGVAR----VQAQSGVMTAE----TGTYRWMA 281
            N IHRD+K  N LM    +  +V + DFG+A+     +    +   E    TGT R+ +
Sbjct: 124 KNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYAS 183
Query: 282 PEV---IEHKPYDYKADVFSFGIALWELLTGELPYAGL---TPLQAAVGVVQKSLRPTIP 335
                 IE    D   D+ S G  L     G LP+ GL   T  Q    + +K +   I 
Sbjct: 184 INTHLGIEQSRRD---DLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIE 240
Query: 336 ---KHAHPRLAELLERCWQHDPTQRPNFSQITDILKQMM 371
              K      A  L  C       +P++S +  + + + 
Sbjct: 241 VLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLF 279

>pdb|4G3F|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) Bound To A 2-(aminothiazoly)phenol (cmp2) Length = 336

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 55/200 (27%), Positives = 88/200 (44%), Gaps = 17/200 (8%)
Query: 123 KVASGSYGDLY--KGTYCSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIG 180
           +V  GS+G+++  K      + A+K ++ E    E       E+     +    +V   G
Sbjct: 65  RVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVFRVE-------ELVACAGLSSPRIVPLYG 117
Query: 181 ACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDL 240
           A    P + I  E +  GS+   + KQ G       L       +G+ YLH   I+H D+
Sbjct: 118 AVREGPWVNIFMELLEGGSLGQLI-KQMGCLPEDRALYYLGQALEGLEYLHTRRILHGDV 176
Query: 241 KTANLLMDENGV-VKVADFGVARVQAQSG----VMTAE--TGTYRWMAPEVIEHKPYDYK 293
           K  N+L+  +G    + DFG A      G    ++T +   GT   MAPEV+  KP D K
Sbjct: 177 KADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPEVVMGKPCDAK 236
Query: 294 ADVFSFGIALWELLTGELPY 313
            D++S    +  +L G  P+
Sbjct: 237 VDIWSSCCMMLHMLNGCHPW 256

>pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 63/258 (24%), Positives = 113/258 (43%), Gaps = 19/258 (7%)
Query: 73  QDQSCSKRQPALGVPMHSKLLIESSPNCIEIPTDGTDVWEIDAKQLKIECKVASGSYGDL 132
           +D S     P    P H+   + ++ N   +     DV      + +I   + +G+YG +
Sbjct: 12  EDGSAEPPGPVKAEPAHTAASV-AAKNLALLKARSFDVTFDVGDEYEIIETIGNGAYGVV 70
Query: 133 --YKGTYCSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPP---- 186
              +     Q+VAIK +          K   +E+ I++  +H N++  I    RP     
Sbjct: 71  SSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHDNIIA-IKDILRPTVPYG 129
Query: 187 ---NLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTA 243
              ++ +V + M    ++  +H  + +  L  +      + +G+ Y+H   +IHRDLK +
Sbjct: 130 EFKSVYVVLDLM-ESDLHQIIHSSQPL-TLEHVRYFLYQLLRGLKYMHSAQVIHRDLKPS 187
Query: 244 NLLMDENGVVKVADFGVARVQAQSGV-----MTAETGTYRWMAPEV-IEHKPYDYKADVF 297
           NLL++EN  +K+ DFG+AR    S       MT    T  + APE+ +    Y    D++
Sbjct: 188 NLLVNENCELKIGDFGMARGLCTSPAEHQYFMTEYVATRWYRAPELMLSLHEYTQAIDLW 247
Query: 298 SFGIALWELLTGELPYAG 315
           S G    E+L     + G
Sbjct: 248 SVGCIFGEMLARRQLFPG 265

>pdb|1CKJ|A Chain A, Casein Kinase I Delta Truncation Mutant Containing Residues 1-317 Complex With Bound Tungstate Length = 317

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 71/279 (25%), Positives = 119/279 (42%), Gaps = 29/279 (10%)
Query: 115 AKQLKIECKVASGSYGDLYKGT--YCSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRH 172
             + ++  K+ SGS+GD+Y GT     +EVAIK+   ECV T+   +   E  I + ++ 
Sbjct: 6   GNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKL---ECVKTKH-PQLHIESKIYKMMQG 61
Query: 173 KNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQ 232
              +  I  C    +  ++   +   S+ D  +     F L ++L +A  +   + Y+H 
Sbjct: 62  GVGIPTIRWCGAEGDYNVMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHS 121
Query: 233 NNIIHRDLKTANLLM---DENGVVKVADFGVAR----VQAQSGVMTAE----TGTYRWMA 281
            N IHRD+K  N LM    +  +V + DFG+A+     +    +   E    TGT R+ +
Sbjct: 122 KNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYAS 181
Query: 282 PEV---IEHKPYDYKADVFSFGIALWELLTGELPYAGL---TPLQAAVGVVQKSLRPTIP 335
                 IE    D   D+ S G  L     G LP+ GL   T  Q    + +K +   I 
Sbjct: 182 INTHLGIEQSRRD---DLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIE 238
Query: 336 ---KHAHPRLAELLERCWQHDPTQRPNFSQITDILKQMM 371
              K      A  L  C       +P++S +  + + + 
Sbjct: 239 VLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLF 277

>pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 47/199 (23%), Positives = 98/199 (49%), Gaps = 15/199 (7%)
Query: 129 YGDLYKGTYCSQEVAIKVLKPE-----CVNTEML-----KEFSQEVYIMRKIRHKNVVQF 178
           + +L KG +      +KVL  +      +NT+ L     ++  +E  I R ++H N+V+ 
Sbjct: 16  FEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRL 75
Query: 179 IGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHR 238
             + +   +  ++ + +  G +++ +  ++  +           + + + + HQ  ++HR
Sbjct: 76  HDSISEEGHHYLIFDLVTGGELFEDIVARE-YYSEADASHCIQQILEAVLHCHQMGVVHR 134
Query: 239 DLKTANLLMD---ENGVVKVADFGVA-RVQAQSGVMTAETGTYRWMAPEVIEHKPYDYKA 294
           +LK  NLL+    +   VK+ADFG+A  V+ +        GT  +++PEV+   PY    
Sbjct: 135 NLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQAWFGFAGTPGYLSPEVLRKDPYGKPV 194
Query: 295 DVFSFGIALWELLTGELPY 313
           D+++ G+ L+ LL G  P+
Sbjct: 195 DLWACGVILYILLVGYPPF 213

>pdb|4G3C|A Chain A, Crystal Structure Of Apo Murine Nf-kappab Inducing Kinase (nik) Length = 352

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 55/200 (27%), Positives = 88/200 (44%), Gaps = 17/200 (8%)
Query: 123 KVASGSYGDLY--KGTYCSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIG 180
           +V  GS+G+++  K      + A+K ++ E    E       E+     +    +V   G
Sbjct: 81  RVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVFRVE-------ELVACAGLSSPRIVPLYG 133
Query: 181 ACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDL 240
           A    P + I  E +  GS+   + KQ G       L       +G+ YLH   I+H D+
Sbjct: 134 AVREGPWVNIFMELLEGGSLGQLI-KQMGCLPEDRALYYLGQALEGLEYLHTRRILHGDV 192
Query: 241 KTANLLMDENGV-VKVADFGVARVQAQSG----VMTAE--TGTYRWMAPEVIEHKPYDYK 293
           K  N+L+  +G    + DFG A      G    ++T +   GT   MAPEV+  KP D K
Sbjct: 193 KADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPEVVMGKPCDAK 252
Query: 294 ADVFSFGIALWELLTGELPY 313
            D++S    +  +L G  P+
Sbjct: 253 VDIWSSCCMMLHMLNGCHPW 272

>pdb|3DLS|A Chain A, Crystal Structure Of Human Pas Kinase Bound To Adp Length = 335

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 61/255 (23%), Positives = 116/255 (45%), Gaps = 24/255 (9%)
Query: 124 VASGSYGDLYKGT--YCSQEVAIKVLKPE-----C-VNTEMLKEFSQEVYIMRKIRHKNV 175
           + SG++G ++       ++EV +K +K E     C +    L + + E+ I+ ++ H N+
Sbjct: 32  LGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANI 91
Query: 176 VQFIGACTRPPNLCIVTEFMARG-SIYDFLHKQKGVFQLTSLLKVAI--DVSKGMNYLHQ 232
           ++ +          +V E    G  ++ F+ +     +L   L   I   +   + YL  
Sbjct: 92  IKVLDIFENQGFFQLVMEKHGSGLDLFAFIDRHP---RLDEPLASYIFRQLVSAVGYLRL 148
Query: 233 NNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAETGTYRWMAPEVIEHKPY-D 291
            +IIHRD+K  N+++ E+  +K+ DFG A    +  +     GT  + APEV+   PY  
Sbjct: 149 KDIIHRDIKDENIVIAEDFTIKLIDFGSAAYLERGKLFYTFCGTIEYCAPEVLMGNPYRG 208
Query: 292 YKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRLAELLERCWQ 351
            + +++S G+ L+ L+  E P+  L         V+ ++ P  P      L  L+    Q
Sbjct: 209 PELEMWSLGVTLYTLVFEENPFCELEE------TVEAAIHP--PYLVSKELMSLVSGLLQ 260
Query: 352 HDPTQRPNFSQ-ITD 365
             P +R    + +TD
Sbjct: 261 PVPERRTTLEKLVTD 275

>pdb|2XIX|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-1 From Crystallographic Fragment Screen Length = 301

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 51/208 (24%), Positives = 97/208 (46%), Gaps = 13/208 (6%)
Query: 117 QLKIECKVASGSYGDLYKGTYCSQEVAIKVLKPECVNTEMLKEFSQ------EVYIMRKI 170
           Q ++   + SG +G +Y G   S  + + +   E        E         EV +++K+
Sbjct: 25  QYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKV 84
Query: 171 R--HKNVVQFIGACTRPPNLCIVTEFMAR-GSIYDFLHKQKGVFQLTSLLKVAIDVSKGM 227
                 V++ +    RP +  ++ E       ++DF+  ++G  Q          V + +
Sbjct: 85  SSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFI-TERGALQEELARSFFWQVLEAV 143
Query: 228 NYLHQNNIIHRDLKTANLLMDEN-GVVKVADFGVARVQAQSGVMTAETGTYRWMAPEVIE 286
            + H   ++HRD+K  N+L+D N G +K+ DFG   +   + V T   GT  +  PE I 
Sbjct: 144 RHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDT-VYTDFDGTRVYSPPEWIR 202
Query: 287 -HKPYDYKADVFSFGIALWELLTGELPY 313
            H+ +   A V+S GI L++++ G++P+
Sbjct: 203 YHRYHGRSAAVWSLGILLYDMVCGDIPF 230

>pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 63/244 (25%), Positives = 116/244 (47%), Gaps = 30/244 (12%)
Query: 122 CKV-ASGSYGDLYKGTYC-SQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFI 179
           CKV  +GS+G +++     S EVAIK    + +  +  K  ++E+ IMR ++H NVV   
Sbjct: 45  CKVIGNGSFGVVFQAKLVESDEVAIK----KVLQDKRFK--NRELQIMRIVKHPNVVDLK 98
Query: 180 ------GACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAI---DVSKGMNYL 230
                 G       L +V E++   ++Y        + Q   +L + +    + + + Y+
Sbjct: 99  AFFYSNGDKKDEVFLNLVLEYVPE-TVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYI 157
Query: 231 HQNNIIHRDLKTANLLMD-ENGVVKVADFGVARVQAQSGVMTAETGTYRWMAPEVI-EHK 288
           H   I HRD+K  NLL+D  +GV+K+ DFG A++        +   +  + APE+I    
Sbjct: 158 HSIGICHRDIKPQNLLLDPPSGVLKLIDFGSAKILIAGEPNVSXICSRYYRAPELIFGAT 217
Query: 289 PYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQ----------KSLRPTIPKHA 338
            Y    D++S G  + EL+ G+  + G + +   V +++          K++ P   +H 
Sbjct: 218 NYTTNIDIWSTGCVMAELMQGQPLFPGESGIDQLVEIIKVLGTPSREQIKTMNPNYMEHK 277
Query: 339 HPRL 342
            P++
Sbjct: 278 FPQI 281

>pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 63/258 (24%), Positives = 113/258 (43%), Gaps = 19/258 (7%)
Query: 73  QDQSCSKRQPALGVPMHSKLLIESSPNCIEIPTDGTDVWEIDAKQLKIECKVASGSYGDL 132
           +D S     P    P H+   + ++ N   +     DV      + +I   + +G+YG +
Sbjct: 13  EDGSAEPPGPVKAEPAHTAASV-AAKNLALLKARSFDVTFDVGDEYEIIETIGNGAYGVV 71
Query: 133 --YKGTYCSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPP---- 186
              +     Q+VAIK +          K   +E+ I++  +H N++  I    RP     
Sbjct: 72  SSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHDNIIA-IKDILRPTVPYG 130
Query: 187 ---NLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTA 243
              ++ +V + M    ++  +H  + +  L  +      + +G+ Y+H   +IHRDLK +
Sbjct: 131 EFKSVYVVLDLM-ESDLHQIIHSSQPL-TLEHVRYFLYQLLRGLKYMHSAQVIHRDLKPS 188
Query: 244 NLLMDENGVVKVADFGVARVQAQSGV-----MTAETGTYRWMAPEV-IEHKPYDYKADVF 297
           NLL++EN  +K+ DFG+AR    S       MT    T  + APE+ +    Y    D++
Sbjct: 189 NLLVNENCELKIGDFGMARGLCTSPAEHQYFMTEYVATRWYRAPELMLSLHEYTQAIDLW 248
Query: 298 SFGIALWELLTGELPYAG 315
           S G    E+L     + G
Sbjct: 249 SVGCIFGEMLARRQLFPG 266

>pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik) Length = 356

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 61/265 (23%), Positives = 114/265 (43%), Gaps = 20/265 (7%)
Query: 123 KVASGSYGDLYK--GTYCSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIG 180
           ++  GS+G++++        + A+K ++ E    E       E+     +    +V   G
Sbjct: 81  RLGRGSFGEVHRMEDKQTGFQCAVKKVRLEVFRAE-------ELMACAGLTSPRIVPLYG 133
Query: 181 ACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDL 240
           A    P + I  E +  GS+   + K++G       L       +G+ YLH   I+H D+
Sbjct: 134 AVREGPWVNIFMELLEGGSLGQLV-KEQGCLPEDRALYYLGQALEGLEYLHSRRILHGDV 192
Query: 241 KTANLLMDENGV-VKVADFGVARVQAQSG----VMTAE--TGTYRWMAPEVIEHKPYDYK 293
           K  N+L+  +G    + DFG A      G    ++T +   GT   MAPEV+  +  D K
Sbjct: 193 KADNVLLSSDGSHAALCDFGHAVCLQPDGLGKDLLTGDYIPGTETHMAPEVVLGRSCDAK 252
Query: 294 ADVFSFGIALWELLTGELPYAGL--TPLQAAVGVVQKSLRPTIPKHAHPRLAELLERCWQ 351
            DV+S    +  +L G  P+      PL   +      +R  IP    P  A+ ++   +
Sbjct: 253 VDVWSSCCMMLHMLNGCHPWTQFFRGPLCLKIASEPPPVR-EIPPSCAPLTAQAIQEGLR 311
Query: 352 HDPTQRPNFSQITDILKQMMKEVAS 376
            +P  R + +++   + + +++V  
Sbjct: 312 KEPIHRVSAAELGGKVNRALQQVGG 336

>pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik) Length = 371

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 61/265 (23%), Positives = 114/265 (43%), Gaps = 20/265 (7%)
Query: 123 KVASGSYGDLYK--GTYCSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIG 180
           ++  GS+G++++        + A+K ++ E    E       E+     +    +V   G
Sbjct: 100 RLGRGSFGEVHRMEDKQTGFQCAVKKVRLEVFRAE-------ELMACAGLTSPRIVPLYG 152
Query: 181 ACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDL 240
           A    P + I  E +  GS+   + K++G       L       +G+ YLH   I+H D+
Sbjct: 153 AVREGPWVNIFMELLEGGSLGQLV-KEQGCLPEDRALYYLGQALEGLEYLHSRRILHGDV 211
Query: 241 KTANLLMDENGV-VKVADFGVARVQAQSG----VMTAE--TGTYRWMAPEVIEHKPYDYK 293
           K  N+L+  +G    + DFG A      G    ++T +   GT   MAPEV+  +  D K
Sbjct: 212 KADNVLLSSDGSHAALCDFGHAVCLQPDGLGKSLLTGDYIPGTETHMAPEVVLGRSCDAK 271
Query: 294 ADVFSFGIALWELLTGELPYAGL--TPLQAAVGVVQKSLRPTIPKHAHPRLAELLERCWQ 351
            DV+S    +  +L G  P+      PL   +      +R  IP    P  A+ ++   +
Sbjct: 272 VDVWSSCCMMLHMLNGCHPWTQFFRGPLCLKIASEPPPVR-EIPPSCAPLTAQAIQEGLR 330
Query: 352 HDPTQRPNFSQITDILKQMMKEVAS 376
            +P  R + +++   + + +++V  
Sbjct: 331 KEPIHRVSAAELGGKVNRALQQVGG 355

>pdb|4G3G|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) V408l Bound To A 2-(aminothiazolyl)phenol (cmp3) Length = 350

Iteration: 1
 Score = 65.9 bits (159), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 54/200 (27%), Positives = 88/200 (44%), Gaps = 17/200 (8%)
Query: 123 KVASGSYGDLY--KGTYCSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIG 180
           ++  GS+G+++  K      + A+K ++ E    E       E+     +    +V   G
Sbjct: 79  RLGRGSFGEVHRMKDKQTGFQCAVKKVRLEVFRVE-------ELVACAGLSSPRIVPLYG 131
Query: 181 ACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDL 240
           A    P + I  E +  GS+   + KQ G       L       +G+ YLH   I+H D+
Sbjct: 132 AVREGPWVNIFMELLEGGSLGQLI-KQMGCLPEDRALYYLGQALEGLEYLHTRRILHGDV 190
Query: 241 KTANLLMDENGV-VKVADFGVARVQAQSG----VMTAE--TGTYRWMAPEVIEHKPYDYK 293
           K  N+L+  +G    + DFG A      G    ++T +   GT   MAPEV+  KP D K
Sbjct: 191 KADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPEVVMGKPCDAK 250
Query: 294 ADVFSFGIALWELLTGELPY 313
            D++S    +  +L G  P+
Sbjct: 251 VDIWSSCCMMLHMLNGCHPW 270

>pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353

Iteration: 1
 Score = 65.5 bits (158), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 58/218 (26%), Positives = 101/218 (46%), Gaps = 19/218 (8%)
Query: 115 AKQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRH 172
           +   +++  +  G+YG +   T+    + VAIK ++P       L+   +E+ I++  +H
Sbjct: 10  SSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTL-REIKILKHFKH 68
Query: 173 KNVVQFIGACTRPPNLCIVTE-FMARGSIYDFLHKQKGVFQLTS--LLKVAIDVSKGMNY 229
           +N++  I    RP +     E ++ +  +   LH+      L+   +        + +  
Sbjct: 69  ENIIT-IFNIQRPDSFENFNEVYIIQELMQTDLHRVISTQMLSDDHIQYFIYQTLRAVKV 127
Query: 230 LHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGV-----------MTAETGTYR 278
           LH +N+IHRDLK +NLL++ N  +KV DFG+AR+  +S             MT    T  
Sbjct: 128 LHGSNVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQSGMTEXVATRW 187
Query: 279 WMAPEV-IEHKPYDYKADVFSFGIALWELLTGELPYAG 315
           + APEV +    Y    DV+S G  L EL      + G
Sbjct: 188 YRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPG 225

>pdb|2IWI|A Chain A, Crystal Structure Of The Human Pim2 In Complex With A Ruthenium Organometallic Ligand Ru1 Length = 312

Iteration: 1
 Score = 65.5 bits (158), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 47/174 (27%), Positives = 78/174 (44%), Gaps = 13/174 (7%)
Query: 223 VSKGMNYLHQNNIIHRDLKTANLLMD-ENGVVKVADFGVARVQAQSGVMTAETGTYRWMA 281
           V   + + H   ++HRD+K  N+L+D   G  K+ DFG   +       T   GT  +  
Sbjct: 148 VVAAIQHCHSRGVVHRDIKDENILIDLRRGCAKLIDFGSGAL-LHDEPYTDFDGTRVYSP 206
Query: 282 PEVI-EHKPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKSLRPTIPKHAHP 340
           PE I  H+ +   A V+S GI L++++ G++P+      +    +++  L    P H  P
Sbjct: 207 PEWISRHQYHALPATVWSLGILLYDMVCGDIPF------ERDQEILEAELH--FPAHVSP 258
Query: 341 RLAELLERCWQHDPTQRPNFSQITDILKQMMKEVASEGENNHSNKSAGSFFSSL 394
               L+ RC    P+ RP+  +I  +L   M+  A +   N S         SL
Sbjct: 259 DCCALIRRCLAPKPSSRPSLEEI--LLDPWMQTPAEDVPLNPSKGGPAPLAWSL 310

>pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353

Iteration: 1
 Score = 65.1 bits (157), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 58/218 (26%), Positives = 101/218 (46%), Gaps = 19/218 (8%)
Query: 115 AKQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRH 172
           +   +++  +  G+YG +   T+    + VAIK ++P       L+   +E+ I++  +H
Sbjct: 10  SSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTL-REIKILKHFKH 68
Query: 173 KNVVQFIGACTRPPNLCIVTE-FMARGSIYDFLHKQKGVFQLTS--LLKVAIDVSKGMNY 229
           +N++  I    RP +     E ++ +  +   LH+      L+   +        + +  
Sbjct: 69  ENIIT-IFNIQRPDSFENFNEVYIIQELMQTDLHRVISTQMLSDDHIQYFIYQTLRAVKV 127
Query: 230 LHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGV-----------MTAETGTYR 278
           LH +N+IHRDLK +NLL++ N  +KV DFG+AR+  +S             MT    T  
Sbjct: 128 LHGSNVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQSGMTEYVATRW 187
Query: 279 WMAPEV-IEHKPYDYKADVFSFGIALWELLTGELPYAG 315
           + APEV +    Y    DV+S G  L EL      + G
Sbjct: 188 YRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPG 225

>pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437

Iteration: 1
 Score = 65.1 bits (157), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 57/233 (24%), Positives = 106/233 (45%), Gaps = 32/233 (13%)
Query: 124 VASGSYGDL--YKGTYCSQEVAIKVLKPECVNTEMLKE-----FSQEVYIMRKIRHKNVV 176
           +  G++G++   K     +  A+K+L       EMLK      F +E  ++     K + 
Sbjct: 82  IGRGAFGEVAVVKLKNADKVFAMKILN----KWEMLKRAETACFREERDVLVNGDSKWIT 137
Query: 177 QFIGACTRPPNLCIVTEFMARGSIYDFLHK-------QKGVFQLTSLLKVAIDVSKGMNY 229
               A     NL +V ++   G +   L K       +   F L  ++ +AID       
Sbjct: 138 TLHYAFQDDNNLYLVMDYYVGGDLLTLLSKFEDRLPEEMARFYLAEMV-IAIDS------ 190
Query: 230 LHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVM--TAETGTYRWMAPEVIE- 286
           +HQ + +HRD+K  N+LMD NG +++ADFG      + G +  +   GT  +++PE+++ 
Sbjct: 191 VHQLHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSVAVGTPDYISPEILQA 250
Query: 287 ----HKPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKSLRPTIP 335
                  Y  + D +S G+ ++E+L GE P+   + ++    ++    R   P
Sbjct: 251 MEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKERFQFP 303

>pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350

Iteration: 1
 Score = 64.7 bits (156), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 74/294 (25%), Positives = 127/294 (43%), Gaps = 33/294 (11%)
Query: 124 VASGSYGDLYKGTYCS--QEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQF--- 178
           + +GS+G +Y+   C   + VAIK    + +  +  K  ++E+ IMRK+ H N+V+    
Sbjct: 29  IGNGSFGVVYQAKLCDSGELVAIK----KVLQDKRFK--NRELQIMRKLDHCNIVRLRYF 82
Query: 179 ---IGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAI---DVSKGMNYLHQ 232
               G       L +V +++   ++Y          Q   ++ V +    + + + Y+H 
Sbjct: 83  FYSSGEKKDEVYLNLVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHS 141
Query: 233 NNIIHRDLKTANLLMD-ENGVVKVADFGVAR--VQAQSGVMTAETGTYRWMAPEVI-EHK 288
             I HRD+K  NLL+D +  V+K+ DFG A+  V+ +  V    +  YR  APE+I    
Sbjct: 142 FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXICSRYYR--APELIFGAT 199
Query: 289 PYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVV-------QKSLRPTIPKHAHPR 341
            Y    DV+S G  L ELL G+  + G + +   V ++       ++ +R   P +   +
Sbjct: 200 DYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFK 259
Query: 342 LAELLERCWQHDPTQRPNFSQITDILKQMMKEVASEGENNHSNKSAGSFFSSLR 395
             ++    W      RP        L   + E             A SFF  LR
Sbjct: 260 FPQIKAHPWTK--VFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDELR 311

>pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350

Iteration: 1
 Score = 64.7 bits (156), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 74/294 (25%), Positives = 127/294 (43%), Gaps = 33/294 (11%)
Query: 124 VASGSYGDLYKGTYCS--QEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQF--- 178
           + +GS+G +Y+   C   + VAIK    + +  +  K  ++E+ IMRK+ H N+V+    
Sbjct: 28  IGNGSFGVVYQAKLCDSGELVAIK----KVLQDKRFK--NRELQIMRKLDHCNIVRLRYF 81
Query: 179 ---IGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAI---DVSKGMNYLHQ 232
               G       L +V +++   ++Y          Q   ++ V +    + + + Y+H 
Sbjct: 82  FYSSGEKKDEVYLNLVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHS 140
Query: 233 NNIIHRDLKTANLLMD-ENGVVKVADFGVAR--VQAQSGVMTAETGTYRWMAPEVI-EHK 288
             I HRD+K  NLL+D +  V+K+ DFG A+  V+ +  V    +  YR  APE+I    
Sbjct: 141 FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXICSRYYR--APELIFGAT 198
Query: 289 PYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVV-------QKSLRPTIPKHAHPR 341
            Y    DV+S G  L ELL G+  + G + +   V ++       ++ +R   P +   +
Sbjct: 199 DYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFK 258
Query: 342 LAELLERCWQHDPTQRPNFSQITDILKQMMKEVASEGENNHSNKSAGSFFSSLR 395
             ++    W      RP        L   + E             A SFF  LR
Sbjct: 259 FPQIKAHPWTK--VFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDELR 310

>pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352

Iteration: 1
 Score = 64.7 bits (156), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 74/294 (25%), Positives = 127/294 (43%), Gaps = 33/294 (11%)
Query: 124 VASGSYGDLYKGTYCS--QEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQF--- 178
           + +GS+G +Y+   C   + VAIK    + +  +  K  ++E+ IMRK+ H N+V+    
Sbjct: 28  IGNGSFGVVYQAKLCDSGELVAIK----KVLQDKRFK--NRELQIMRKLDHCNIVRLRYF 81
Query: 179 ---IGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAI---DVSKGMNYLHQ 232
               G       L +V +++   ++Y          Q   ++ V +    + + + Y+H 
Sbjct: 82  FYSSGEKKDEVYLNLVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHS 140
Query: 233 NNIIHRDLKTANLLMD-ENGVVKVADFGVAR--VQAQSGVMTAETGTYRWMAPEVI-EHK 288
             I HRD+K  NLL+D +  V+K+ DFG A+  V+ +  V    +  YR  APE+I    
Sbjct: 141 FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXICSRYYR--APELIFGAT 198
Query: 289 PYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVV-------QKSLRPTIPKHAHPR 341
            Y    DV+S G  L ELL G+  + G + +   V ++       ++ +R   P +   +
Sbjct: 199 DYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFK 258
Query: 342 LAELLERCWQHDPTQRPNFSQITDILKQMMKEVASEGENNHSNKSAGSFFSSLR 395
             ++    W      RP        L   + E             A SFF  LR
Sbjct: 259 FPQIKAHPWTK--VFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDELR 310

>pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353

Iteration: 1
 Score = 64.7 bits (156), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 74/294 (25%), Positives = 127/294 (43%), Gaps = 33/294 (11%)
Query: 124 VASGSYGDLYKGTYC--SQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQF--- 178
           + +GS+G +Y+   C   + VAIK    + +  +  K  ++E+ IMRK+ H N+V+    
Sbjct: 32  IGNGSFGVVYQAKLCDSGELVAIK----KVLQDKRFK--NRELQIMRKLDHCNIVRLRYF 85
Query: 179 ---IGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAI---DVSKGMNYLHQ 232
               G       L +V +++   ++Y          Q   ++ V +    + + + Y+H 
Sbjct: 86  FYSSGEKKDEVYLNLVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHS 144
Query: 233 NNIIHRDLKTANLLMD-ENGVVKVADFGVAR--VQAQSGVMTAETGTYRWMAPEVI-EHK 288
             I HRD+K  NLL+D +  V+K+ DFG A+  V+ +  V    +  YR  APE+I    
Sbjct: 145 FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXICSRYYR--APELIFGAT 202
Query: 289 PYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVV-------QKSLRPTIPKHAHPR 341
            Y    DV+S G  L ELL G+  + G + +   V ++       ++ +R   P +   +
Sbjct: 203 DYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFK 262
Query: 342 LAELLERCWQHDPTQRPNFSQITDILKQMMKEVASEGENNHSNKSAGSFFSSLR 395
             ++    W      RP        L   + E             A SFF  LR
Sbjct: 263 FPQIKAHPWTK--VFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDELR 314

>pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371

Iteration: 1
 Score = 64.7 bits (156), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 74/294 (25%), Positives = 127/294 (43%), Gaps = 33/294 (11%)
Query: 124 VASGSYGDLYKGTYCS--QEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQF--- 178
           + +GS+G +Y+   C   + VAIK    + +  +  K  ++E+ IMRK+ H N+V+    
Sbjct: 40  IGNGSFGVVYQAKLCDSGELVAIK----KVLQDKRFK--NRELQIMRKLDHCNIVRLRYF 93
Query: 179 ---IGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAI---DVSKGMNYLHQ 232
               G       L +V +++   ++Y          Q   ++ V +    + + + Y+H 
Sbjct: 94  FYSSGEKKDEVYLNLVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHS 152
Query: 233 NNIIHRDLKTANLLMD-ENGVVKVADFGVAR--VQAQSGVMTAETGTYRWMAPEVI-EHK 288
             I HRD+K  NLL+D +  V+K+ DFG A+  V+ +  V    +  YR  APE+I    
Sbjct: 153 FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXICSRYYR--APELIFGAT 210
Query: 289 PYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVV-------QKSLRPTIPKHAHPR 341
            Y    DV+S G  L ELL G+  + G + +   V ++       ++ +R   P +   +
Sbjct: 211 DYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFK 270
Query: 342 LAELLERCWQHDPTQRPNFSQITDILKQMMKEVASEGENNHSNKSAGSFFSSLR 395
             ++    W      RP        L   + E             A SFF  LR
Sbjct: 271 FPQIKAHPWTK--VFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDELR 322

>pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 74/294 (25%), Positives = 127/294 (43%), Gaps = 33/294 (11%)
Query: 124 VASGSYGDLYKGTYCS--QEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQF--- 178
           + +GS+G +Y+   C   + VAIK    + +  +  K  ++E+ IMRK+ H N+V+    
Sbjct: 47  IGNGSFGVVYQAKLCDSGELVAIK----KVLQDKRFK--NRELQIMRKLDHCNIVRLRYF 100
Query: 179 ---IGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAI---DVSKGMNYLHQ 232
               G       L +V +++   ++Y          Q   ++ V +    + + + Y+H 
Sbjct: 101 FYSSGEKKDEVYLNLVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHS 159
Query: 233 NNIIHRDLKTANLLMD-ENGVVKVADFGVAR--VQAQSGVMTAETGTYRWMAPEVI-EHK 288
             I HRD+K  NLL+D +  V+K+ DFG A+  V+ +  V    +  YR  APE+I    
Sbjct: 160 FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXICSRYYR--APELIFGAT 217
Query: 289 PYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVV-------QKSLRPTIPKHAHPR 341
            Y    DV+S G  L ELL G+  + G + +   V ++       ++ +R   P +   +
Sbjct: 218 DYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFK 277
Query: 342 LAELLERCWQHDPTQRPNFSQITDILKQMMKEVASEGENNHSNKSAGSFFSSLR 395
             ++    W      RP        L   + E             A SFF  LR
Sbjct: 278 FPQIKAHPWTK--VFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDELR 329

>pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 74/294 (25%), Positives = 127/294 (43%), Gaps = 33/294 (11%)
Query: 124 VASGSYGDLYKGTYCS--QEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQF--- 178
           + +GS+G +Y+   C   + VAIK    + +  +  K  ++E+ IMRK+ H N+V+    
Sbjct: 36  IGNGSFGVVYQAKLCDSGELVAIK----KVLQDKRFK--NRELQIMRKLDHCNIVRLRYF 89
Query: 179 ---IGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAI---DVSKGMNYLHQ 232
               G       L +V +++   ++Y          Q   ++ V +    + + + Y+H 
Sbjct: 90  FYSSGEKKDEVYLNLVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHS 148
Query: 233 NNIIHRDLKTANLLMD-ENGVVKVADFGVAR--VQAQSGVMTAETGTYRWMAPEVI-EHK 288
             I HRD+K  NLL+D +  V+K+ DFG A+  V+ +  V    +  YR  APE+I    
Sbjct: 149 FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXICSRYYR--APELIFGAT 206
Query: 289 PYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVV-------QKSLRPTIPKHAHPR 341
            Y    DV+S G  L ELL G+  + G + +   V ++       ++ +R   P +   +
Sbjct: 207 DYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFK 266
Query: 342 LAELLERCWQHDPTQRPNFSQITDILKQMMKEVASEGENNHSNKSAGSFFSSLR 395
             ++    W      RP        L   + E             A SFF  LR
Sbjct: 267 FPQIKAHPWTK--VFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDELR 318

>pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 74/294 (25%), Positives = 129/294 (43%), Gaps = 33/294 (11%)
Query: 124 VASGSYGDLYKGTYCS--QEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQ---F 178
           + +GS+G +Y+   C   + VAIK    + +  +  K  ++E+ IMRK+ H N+V+   F
Sbjct: 28  IGNGSFGVVYQAKLCDSGELVAIK----KVLQDKRFK--NRELQIMRKLDHCNIVRLRYF 81
Query: 179 IGACTRPPN---LCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAI---DVSKGMNYLHQ 232
             +     +   L +V +++   ++Y          Q   ++ V +    + + + Y+H 
Sbjct: 82  FYSSGEKKDVVYLNLVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHS 140
Query: 233 NNIIHRDLKTANLLMD-ENGVVKVADFGVAR--VQAQSGVMTAETGTYRWMAPEVI-EHK 288
             I HRD+K  NLL+D +  V+K+ DFG A+  V+ +  V    +  YR  APE+I    
Sbjct: 141 FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXICSRYYR--APELIFGAT 198
Query: 289 PYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVV-------QKSLRPTIPKHAHPR 341
            Y    DV+S G  L ELL G+  + G + +   V ++       ++ +R   P +   +
Sbjct: 199 DYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFK 258
Query: 342 LAELLERCWQHDPTQRPNFSQITDILKQMMKEVASEGENNHSNKSAGSFFSSLR 395
             ++    W      RP        L   + E             A SFF  LR
Sbjct: 259 FPQIKAHPWTK--VFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDELR 310

>pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 74/294 (25%), Positives = 127/294 (43%), Gaps = 33/294 (11%)
Query: 124 VASGSYGDLYKGTYCS--QEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQF--- 178
           + +GS+G +Y+   C   + VAIK    + +  +  K  ++E+ IMRK+ H N+V+    
Sbjct: 40  IGNGSFGVVYQAKLCDSGELVAIK----KVLQDKRFK--NRELQIMRKLDHCNIVRLRYF 93
Query: 179 ---IGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAI---DVSKGMNYLHQ 232
               G       L +V +++   ++Y          Q   ++ V +    + + + Y+H 
Sbjct: 94  FYSSGEKKDEVYLNLVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHS 152
Query: 233 NNIIHRDLKTANLLMD-ENGVVKVADFGVAR--VQAQSGVMTAETGTYRWMAPEVI-EHK 288
             I HRD+K  NLL+D +  V+K+ DFG A+  V+ +  V    +  YR  APE+I    
Sbjct: 153 FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXICSRYYR--APELIFGAT 210
Query: 289 PYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVV-------QKSLRPTIPKHAHPR 341
            Y    DV+S G  L ELL G+  + G + +   V ++       ++ +R   P +   +
Sbjct: 211 DYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFK 270
Query: 342 LAELLERCWQHDPTQRPNFSQITDILKQMMKEVASEGENNHSNKSAGSFFSSLR 395
             ++    W      RP        L   + E             A SFF  LR
Sbjct: 271 FPQIKAHPWTK--VFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDELR 322

>pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 74/294 (25%), Positives = 127/294 (43%), Gaps = 33/294 (11%)
Query: 124 VASGSYGDLYKGTYCS--QEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQF--- 178
           + +GS+G +Y+   C   + VAIK    + +  +  K  ++E+ IMRK+ H N+V+    
Sbjct: 28  IGNGSFGVVYQAKLCDSGELVAIK----KVLQDKRFK--NRELQIMRKLDHCNIVRLRYF 81
Query: 179 ---IGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAI---DVSKGMNYLHQ 232
               G       L +V +++   ++Y          Q   ++ V +    + + + Y+H 
Sbjct: 82  FYSSGEKKDEVYLNLVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHS 140
Query: 233 NNIIHRDLKTANLLMD-ENGVVKVADFGVAR--VQAQSGVMTAETGTYRWMAPEVI-EHK 288
             I HRD+K  NLL+D +  V+K+ DFG A+  V+ +  V    +  YR  APE+I    
Sbjct: 141 FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRYYR--APELIFGAT 198
Query: 289 PYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVV-------QKSLRPTIPKHAHPR 341
            Y    DV+S G  L ELL G+  + G + +   V ++       ++ +R   P +   +
Sbjct: 199 DYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFK 258
Query: 342 LAELLERCWQHDPTQRPNFSQITDILKQMMKEVASEGENNHSNKSAGSFFSSLR 395
             ++    W      RP        L   + E             A SFF  LR
Sbjct: 259 FPQIKAHPWTK--VFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDELR 310

>pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 74/294 (25%), Positives = 127/294 (43%), Gaps = 33/294 (11%)
Query: 124 VASGSYGDLYKGTYC--SQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQF--- 178
           + +GS+G +Y+   C   + VAIK    + +  +  K  ++E+ IMRK+ H N+V+    
Sbjct: 28  IGNGSFGVVYQAKLCDSGELVAIK----KVLQGKAFK--NRELQIMRKLDHCNIVRLRYF 81
Query: 179 ---IGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAI---DVSKGMNYLHQ 232
               G       L +V +++   ++Y          Q   ++ V +    + + + Y+H 
Sbjct: 82  FYSSGEKKDEVYLNLVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHS 140
Query: 233 NNIIHRDLKTANLLMD-ENGVVKVADFGVAR--VQAQSGVMTAETGTYRWMAPEVI-EHK 288
             I HRD+K  NLL+D +  V+K+ DFG A+  V+ +  V    +  YR  APE+I    
Sbjct: 141 FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRYYR--APELIFGAT 198
Query: 289 PYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVV-------QKSLRPTIPKHAHPR 341
            Y    DV+S G  L ELL G+  + G + +   V ++       ++ +R   P +   +
Sbjct: 199 DYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFK 258
Query: 342 LAELLERCWQHDPTQRPNFSQITDILKQMMKEVASEGENNHSNKSAGSFFSSLR 395
             ++    W      RP        L   + E             A SFF  LR
Sbjct: 259 FPQIKAHPWTK--VFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDELR 310
  Database: pdbaa

Structure Templates Detected by RPS-BLAST

Original result of RPS-BLAST against PDB70 database

ID	Length	Definition	E-value
Query	399
3p86_A	309	Serine/threonine-protein kinase CTR1; ETR1, ERS1,	1e-159
3og7_A	289	AKAP9-BRAF fusion protein; proto-oncogene, V600E,	1e-147
3lb7_A	307	RAF proto-oncogene serine/threonine-protein kinas;	1e-146
3kmu_A	271	ILK, integrin-linked kinase; cell adhesion, ANK re	1e-146
3dtc_A	271	Mitogen-activated protein kinase kinase kinase 9;	1e-146
2y4i_B	319	KSR2, HKSR2, kinase suppressor of RAS 2; transfera	1e-145
3s95_A	310	LIMK-1, LIM domain kinase 1; structural genomics,	1e-144
4f0f_A	287	Serine/threonine-protein kinase ROCO4; LRRK2, ATP-	1e-141
2eva_A	307	TAK1 kinase - TAB1 chimera fusion protein; transfe	1e-139
3mdy_A	337	Bone morphogenetic protein receptor type-1B; compl	1e-120
3q4u_A	301	Activin receptor type-1; structural genomics conso	1e-118
3gxj_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	1e-115
1b6c_B	342	TGF-B superfamily receptor type I; complex (isomer	1e-114
3soc_A	322	Activin receptor type-2A; structural genomics cons	1e-111
3g2f_A	336	Bone morphogenetic protein receptor type-2; kinase	1e-102
3cbl_A	377	C-FES, proto-oncogene tyrosine-protein kinase FES/	2e-92
3t9t_A	267	Tyrosine-protein kinase ITK/TSK; kinase domain, al	3e-89
3gen_A	283	Tyrosine-protein kinase BTK; bruton'S tyrosine kin	4e-89
1byg_A	278	CSK, protein (C-terminal SRC kinase); protein kina	7e-89
1k9a_A	450	Carboxyl-terminal SRC kinase; COOH-terminal SRC ki	9e-89
3sxs_A	268	Cytoplasmic tyrosine-protein kinase BMX; transfera	6e-88
1opk_A	495	P150, C-ABL, proto-oncogene tyrosine-protein kinas	6e-88
1xbb_A	291	Tyrosine-protein kinase SYK; gleevec, STI-571, ima	6e-88
3kfa_A	288	Tyrosine-protein kinase ABL1; CML, drug resistance	9e-88
1u46_A	291	ACK-1, activated CDC42 kinase 1; tyrosine kinase,	3e-87
3cc6_A	281	Protein tyrosine kinase 2 beta; focal adhesion kin	1e-86
1mp8_A	281	Focal adhesion kinase 1; tyrosine protein kinase,	4e-86
1u59_A	287	Tyrosine-protein kinase ZAP-70; transferase; HET:	6e-86
1qpc_A	279	LCK kinase; alpha beta fold, transferase; HET: PTR	7e-86
3kul_A	325	Ephrin type-A receptor 8; ATP-binding, kinase, nuc	1e-85
1mqb_A	333	Ephrin type-A receptor 2; tyrosine protein kinase,	2e-85
3kex_A	325	Receptor tyrosine-protein kinase ERBB-3; kinase do	8e-85
3lzb_A	327	Epidermal growth factor receptor; epidermal growth	1e-84
2qol_A	373	Ephrin receptor; receptor tyrosine kinase, juxtame	6e-84
1qcf_A	454	Haematopoetic cell kinase (HCK); tyrosine kinase-i	3e-83
3ugc_A	295	Tyrosine-protein kinase JAK2; small molecule inhib	8e-83
1fmk_A	452	C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros	2e-82
2h8h_A	535	Proto-oncogene tyrosine-protein kinase SRC; SRC ki	3e-82
2w1i_A	326	JAK2; chromosomal rearrangement, nucleotide-bindin	3e-82
3lxl_A	327	Tyrosine-protein kinase JAK3; TYK2, inflammation,	5e-82
2j0j_A	656	Focal adhesion kinase 1; cell migration, FERM, tra	2e-81
4fvq_A	289	Tyrosine-protein kinase JAK2; janus protein kinase	5e-81
4e5w_A	302	Tyrosine-protein kinase JAK1; kinase domain, trans	9e-81
3qup_A	323	Tyrosine-protein kinase receptor TYRO3; protein ki	3e-80
1t46_A	313	HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom	6e-80
3brb_A	313	Proto-oncogene tyrosine-protein kinase MER; ATP-bi	6e-80
3poz_A	327	Epidermal growth factor receptor; kinase domain, a	7e-80
3f66_A	298	Hepatocyte growth factor receptor; C-Met, protein	3e-79
3lxp_A	318	Non-receptor tyrosine-protein kinase TYK2; JAK3, i	5e-79
1p4o_A	322	Insulin-like growth factor I receptor protein; IGF	7e-79
2ivs_A	314	Proto-oncogene tyrosine-protein kinase receptor RE	1e-78
3pls_A	298	Macrophage-stimulating protein receptor; protein k	1e-78
3c1x_A	373	Hepatocyte growth factor receptor; receptor tyrosi	3e-78
2xir_A	316	Vascular endothelial growth factor receptor 2; ang	4e-78
3v5q_A	297	NT-3 growth factor receptor; kinase domain, kinase	5e-78
2psq_A	370	Fibroblast growth factor receptor 2; kinase domain	5e-78
2pvf_A	334	Fibroblast growth factor receptor 2; kinase domain	7e-78
2i1m_A	333	Macrophage colony-stimulating factor 1 receptor; k	9e-78
4aoj_A	329	High affinity nerve growth factor receptor; transf	1e-77
2ozo_A	613	Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t	2e-77
2yfx_A	327	Tyrosine-protein kinase receptor; nucleotide-bindi	2e-77
3zzw_A	289	Tyrosine-protein kinase transmembrane receptor RO;	3e-77
1rjb_A	344	FL cytokine receptor; kinase, structure, autoinhib	3e-77
3tt0_A	382	Basic fibroblast growth factor receptor 1; kinase	3e-77
1fvr_A	327	Tyrosine-protein kinase TIE-2; tyrosine kinase, tr	7e-77
3l9p_A	367	Anaplastic lymphoma kinase; kinase domain, ATP-bin	1e-76
1luf_A	343	Muscle-specific tyrosine kinase receptor MUSK; pho	1e-74
1t4h_A	290	Serine/threonine-protein kinase WNK1; protein seri	1e-69
4apc_A	350	Serine/threonine-protein kinase NEK1; transferase;	5e-65
3p1a_A	311	MYT1 kinase, membrane-associated tyrosine- and thr	4e-63
2clq_A	295	Mitogen-activated protein kinase kinase kinase 5;	4e-63
2vwi_A	303	Serine/threonine-protein kinase OSR1; STE kinase,	7e-63
3a7i_A	303	MST3 kinase, serine/threonine kinase 24 (STE20 hom	7e-63
4g3f_A	336	NF-kappa-beta-inducing kinase; non-RD kinase, prot	3e-62
2wqm_A	310	Serine/threonine-protein kinase NEK7; ATP-binding,	4e-62
2a19_B	284	Interferon-induced, double-stranded RNA-activated	4e-62
3fxz_A	297	Serine/threonine-protein kinase PAK 1; transferase	3e-60
3an0_A	340	Dual specificity mitogen-activated protein kinase;	6e-60
3com_A	314	Serine/threonine-protein kinase 4; MST1, STE20-lik	7e-60
2c30_A	321	Serine/threonine-protein kinase PAK 6; CRIB domain	3e-59
1x8b_A	289	WEE1HU, WEE1-like protein kinase; cell cycle, tran	5e-59
2j7t_A	302	Serine/threonine-protein kinase 10; transferase, A	1e-58
3aln_A	327	Dual specificity mitogen-activated protein kinase;	1e-58
3fme_A	290	Dual specificity mitogen-activated protein kinase;	2e-58
3dbq_A	343	Dual specificity protein kinase TTK; MPS1 structur	3e-57
2buj_A	317	Serine/threonine-protein kinase 16; transferase, A	3e-57
3gni_B	389	Strad alpha; kinase fold, pseudokinase, alpha heli	3e-57
1u5q_A	348	Serine/threonine protein kinase TAO2; transferase;	3e-57
2zmd_A	390	Dual specificity protein kinase TTK; MPS1, T686A,	5e-57
2dyl_A	318	Dual specificity mitogen-activated protein kinase	1e-56
3cek_A	313	Dual specificity protein kinase TTK; HMPS1, PYT, E	1e-56
4g31_A	299	Eukaryotic translation initiation factor 2-alpha;	2e-56
3eqc_A	360	Dual specificity mitogen-activated protein kinase;	6e-55
2w5a_A	279	Serine/threonine-protein kinase NEK2; Ser/Thr prot	9e-55
1zy4_A	303	Serine/threonine-protein kinase GCN2; translation	2e-54
2x7f_A	326	TRAF2 and NCK-interacting protein kinase; serine/t	3e-54
2nru_A	307	Interleukin-1 receptor-associated kinase 4; inhibi	5e-52
2qkw_B	321	Protein kinase; three-helix bundle motif, AVRPTO-P	3e-50
3cok_A	278	Serine/threonine-protein kinase PLK4; POLO-like ki	7e-48
3fdn_A	279	Serine/threonine-protein kinase 6; aurora kinase i	4e-47
4euu_A	319	Serine/threonine-protein kinase TBK1; ATP binding,	4e-47
2rku_A	294	Serine/threonine-protein kinase PLK1; structure of	5e-47
2owb_A	335	Serine/threonine-protein kinase PLK1; catalytic do	5e-47
3ll6_A	337	Cyclin G-associated kinase; transferase, protein k	6e-47
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	8e-47
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	1e-19
2vgo_A	284	Serine/threonine-protein kinase 12-A; nucleotide-b	3e-46
3qd2_B	332	Eukaryotic translation initiation factor 2-alpha;	1e-45
3p23_A	432	Serine/threonine-protein kinase/endoribonuclease;	1e-45
3uim_A	326	Brassinosteroid insensitive 1-associated receptor;	3e-45
4eut_A	396	Serine/threonine-protein kinase TBK1; ATP binding,	4e-45
3qa8_A	676	MGC80376 protein; kinase ubiquitin-like domain, ph	9e-45
4eqm_A	294	Protein kinase; transferase; HET: ANP; 3.00A {Stap	9e-44
2pml_X	348	PFPK7, Ser/Thr protein kinase; phosphorylati trans	2e-43
3ork_A	311	Serine/threonine protein kinase; structural genomi	1e-42
3fe3_A	328	MAP/microtubule affinity-regulating kinase 3; seri	9e-42
3e7e_A	365	HBUB1, BUB1A, mitotic checkpoint serine/threonine-	1e-41
3q60_A	371	ROP5B; pseudokinase, transferase; HET: ATP; 1.72A	7e-41
3dls_A	335	PAS domain-containing serine/threonine-protein KI;	3e-40
2h6d_A	276	5'-AMP-activated protein kinase catalytic subunit	5e-39
2zv2_A	298	Calcium/calmodulin-dependent protein kinase kinas;	1e-38
2h34_A	309	Serine/threonine-protein kinase PKNE; apoenzyme, t	2e-38
2rio_A	434	Serine/threonine-protein kinase/endoribonuclease I	3e-38
2yex_A	276	Serine/threonine-protein kinase CHK1; transferase,	5e-38
2eue_A	275	Carbon catabolite derepressing protein kinase; kin	1e-37
3h4j_B	336	AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin	4e-37
3lij_A	494	Calcium/calmodulin dependent protein kinase with A	4e-37
2y94_A	476	5'-AMP-activated protein kinase catalytic subunit;	7e-37
3tki_A	323	Serine/threonine-protein kinase CHK1; cell checkpo	7e-37
2iwi_A	312	Serine/threonine-protein kinase PIM-2; nucleotide-	7e-37
3mwu_A	486	Calmodulin-domain protein kinase 1; serine/threoni	1e-36
3nyv_A	484	Calmodulin-domain protein kinase 1; serine/threoni	1e-36
3a99_A	320	Proto-oncogene serine/threonine-protein kinase PI;	2e-36
3uc3_A	361	Serine/threonine-protein kinase SRK2I; SNRK2, ABA	3e-36
2wtk_C	305	Serine/threonine-protein kinase 11; transferase-me	4e-36
3byv_A	377	Rhoptry kinase; malaria, transferase, structural g	5e-36
2wei_A	287	Calmodulin-domain protein kinase 1, putative; nucl	2e-35
3kk8_A	284	Calcium/calmodulin dependent protein kinase II; AT	2e-35
3f3z_A	277	Calcium/calmodulin-dependent protein kinase with d	1e-34
3hko_A	345	Calcium/calmodulin-dependent protein kinase with d	1e-34
1tki_A	321	Titin; serine kinase, muscle, autoinhibition; 2.00	1e-34
2pzi_A	681	Probable serine/threonine-protein kinase PKNG; ATP	2e-34
2jam_A	304	Calcium/calmodulin-dependent protein kinase type 1	2e-34
1kob_A	387	Twitchin; kinase, intrasteric regulation; 2.30A {A	2e-34
3i6u_A	419	CDS1, serine/threonine-protein kinase CHK2; Ser/Th	3e-34
3dzo_A	413	Rhoptry kinase domain; parasitic disease, transfer	5e-34
2bdw_A	362	Hypothetical protein K11E8.1D; kinase, calmodulin	7e-34
3lm5_A	327	Serine/threonine-protein kinase 17B; STK17B, serin	7e-34
3uto_A	573	Twitchin; kinase, muscle sarcomere, transferase; H	2e-33
3c0i_A	351	Peripheral plasma membrane protein CASK; neurexin,	2e-33
3bhy_A	283	Death-associated protein kinase 3; death associate	2e-33
3is5_A	285	Calcium-dependent protein kinase; CDPK, structural	2e-33
2a2a_A	321	Death-associated protein kinase 2; autoinhibition,	5e-33
2yab_A	361	Death-associated protein kinase 2; apoptosis, tran	5e-33
3q5i_A	504	Protein kinase; CDPK, malaria, phosphotransferase,	1e-32
3soa_A	444	Calcium/calmodulin-dependent protein kinase type a	1e-32
2ycf_A	322	Serine/threonine-protein kinase CHK2; transferase,	1e-32
2y0a_A	326	Death-associated protein kinase 1; transferase, ca	2e-32
1uu3_A	310	HPDK1, 3-phosphoinositide dependent protein kinase	4e-32
2w4o_A	349	Calcium/calmodulin-dependent protein kinase type I	1e-31
2x4f_A	373	Myosin light chain kinase family member 4; LUNG, b	1e-31
2y7j_A	365	Phosphorylase B kinase gamma catalytic chain, test	2e-31
4fr4_A	384	YANK1, serine/threonine-protein kinase 32A; struct	2e-31
1phk_A	298	Phosphorylase kinase; glycogen metabolism, transfe	2e-31
3kn6_A	325	Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1	2e-31
4aaa_A	331	Cyclin-dependent kinase-like 2; transferase, phosp	3e-31
1rdq_E	350	PKA C-alpha, CAMP-dependent protein kinase, alpha-	2e-30
4agu_A	311	Cyclin-dependent kinase-like 1; transferase, phosp	2e-30
3pg1_A	362	Mitogen-activated protein kinase, putative (MAP K	1e-29
3fhr_A	336	MAP kinase-activated protein kinase 3; kinase-inhi	2e-29
2qr7_A	342	Ribosomal protein S6 kinase alpha-3; kinase domain	5e-29
1ob3_A	288	PFPK5, cell division control protein 2 homolog; tr	6e-29
3niz_A	311	Rhodanese family protein; structural genomics, str	2e-28
1fot_A	318	TPK1 delta, CAMP-dependent protein kinase type 1;	2e-28
3o0g_A	292	Cell division protein kinase 5; kinase activator c	4e-28
4e7w_A	394	Glycogen synthase kinase 3; GSK3, PTyr195, transfe	4e-28
1ua2_A	346	CAK, cell division protein kinase 7; cell cycle, p	4e-28
2ac3_A	316	MAP kinase-interacting serine/threonine kinase 2;	4e-28
1cm8_A	367	Phosphorylated MAP kinase P38-gamma; phosphorylati	6e-28
3c4z_A	543	Rhodopsin kinase; Ser/Thr kinase, RGS homology dom	7e-28
1nxk_A	400	MAP kinase-activated protein kinase 2; MK2, phosph	9e-28
2r3i_A	299	Cell division protein kinase 2; serine/threonine-p	9e-28
3mtl_A	324	Cell division protein kinase 16; pctaire1, indirub	1e-27
2acx_A	576	G protein-coupled receptor kinase 6; GRK, G transf	2e-27
1o6l_A	337	RAC-beta serine/threonine protein kinase; protein	2e-27
2fst_X	367	Mitogen-activated protein kinase 14; active mutant	4e-27
3nsz_A	330	CK II alpha, casein kinase II subunit alpha; inhib	6e-27
3a8x_A	345	Protein kinase C IOTA type; transferase; HET: TPO;	6e-27
2pmi_A	317	Negative RE, cyclin-dependent protein kinase PHO85	7e-27
3rgf_A	405	Cyclin-dependent kinase 8; protein kinase complex,	8e-27
3coi_A	353	Mitogen-activated protein kinase 13; P38D, P38delt	8e-27
3uqc_A	286	Probable conserved transmembrane protein; structur	9e-27
4dc2_A	396	Protein kinase C IOTA type; kinase, substrate, cel	9e-27
3qyz_A	364	Mitogen-activated protein kinase 1; transferase, s	2e-26
3mi9_A	351	Cell division protein kinase 9; P-TEFB, HIV-1, pro	3e-26
3pvu_A	695	Beta-adrenergic receptor kinase 1; transferase, se	3e-26
3g51_A	325	Ribosomal protein S6 kinase alpha-3; N-terminal ki	3e-26
4ejn_A	446	RAC-alpha serine/threonine-protein kinase; AKT1, a	4e-26
1j1b_A	420	Glycogen synthase kinase-3 beta; complex, TAU, AMP	4e-26
2xrw_A	371	Mitogen-activated protein kinase 8; transcription,	7e-26
1xjd_A	345	Protein kinase C, theta type; PKC-theta, ATP, AMP,	7e-26
4aw2_A	437	Serine/threonine-protein kinase MRCK alpha; transf	8e-26
3ttj_A	464	Mitogen-activated protein kinase 10; JNK3, protein	9e-26
3g33_A	308	Cell division protein kinase 4; Ser/Thr protein ki	9e-26
3txo_A	353	PKC-L, NPKC-ETA, protein kinase C ETA type; phosph	1e-25
3a62_A	327	Ribosomal protein S6 kinase beta-1; kinase domain,	2e-25
3gbz_A	329	Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-	2e-25
1blx_A	326	Cyclin-dependent kinase 6; inhibitor protein, cycl	3e-25
3pfq_A	674	PKC-B, PKC-beta, protein kinase C beta type; phosp	3e-25
2r5t_A	373	Serine/threonine-protein kinase SGK1; AGC protein	4e-25
2i0e_A	353	Protein kinase C-beta II; serine/threonine protein	6e-25
2vd5_A	412	DMPK protein; serine/threonine-protein kinase, kin	1e-24
1q8y_A	373	SR protein kinase; transferase; HET: ADP ADE; 2.05	2e-24
2i6l_A	320	Mitogen-activated protein kinase 6; MAPK6, ERK3, e	2e-24
1vzo_A	355	Ribosomal protein S6 kinase alpha 5; protein kinas	3e-24
3v8s_A	410	RHO-associated protein kinase 1; dimerization, myo	5e-24
3e3p_A	360	Protein kinase, putative glycogen synthase kinase;	7e-24
2b9h_A	353	MAP kinase FUS3, mitogen-activated protein kinase	8e-24
3m2w_A	299	MAP kinase-activated protein kinase 2; small molec	1e-22
3eb0_A	383	Putative uncharacterized protein; kinase cryptospo	2e-22
3kvw_A	429	DYRK2, dual specificity tyrosine-phosphorylation-r	3e-22
3rp9_A	458	Mitogen-activated protein kinase; structural genom	1e-21
3n9x_A	432	Phosphotransferase; malaria kinase, structural gen	2e-21
3oz6_A	388	Mitogen-activated protein kinase 1, serine/threon	1e-20
1wak_A	397	Serine/threonine-protein kinase SPRK1; SRPK, trans	5e-20
2vx3_A	382	Dual specificity tyrosine-phosphorylation- regula	6e-20
2eu9_A	355	Dual specificity protein kinase CLK3; kinase domai	4e-19
1z57_A	339	Dual specificity protein kinase CLK1; protein tyro	9e-19
3llt_A	360	Serine/threonine kinase-1, pflammer; lammer kinase	5e-18
3uzp_A	296	CKI-delta, CKID, casein kinase I isoform delta; CK	4e-17
2izr_A	330	Casein kinase I isoform gamma-3; serine/threonine-	9e-16
2v62_A	345	Serine/threonine-protein kinase VRK2; transferase,	3e-15
1csn_A	298	Casein kinase-1; phosphotransferase; HET: ATP; 2.0	1e-14
3sv0_A	483	Casein kinase I-like; typical kinase domain fold,	2e-14
3op5_A	364	Serine/threonine-protein kinase VRK1; adenosine tr	2e-12
2jii_A	352	Serine/threonine-protein kinase VRK3 molecule: VA	2e-12
2vuw_A	336	Serine/threonine-protein kinase haspin; cell cycle	3e-11
1vt4_I	1221	APAF-1 related killer DARK; drosophila apoptosome,	3e-06
1vt4_I	1221	APAF-1 related killer DARK; drosophila apoptosome,	1e-05

>3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309

 Score =  449 bits (1157), Expect = e-159
 Identities = 120/300 (40%), Positives = 187/300 (62%), Gaps = 7/300 (2%)

Query: 90  SKLLIESSPNCIEIPTDGTDVWEIDAKQLKIECKVASGSYGDLYKGTYCSQEVAIKVLKP 149
           S   I ++ N         D  +I    L I+ K+ +GS+G +++  +   +VA+K+L  
Sbjct: 11  SDYDIPTTENLYFQGAMDGDDMDIPWCDLNIKEKIGAGSFGTVHRAEWHGSDVAVKILME 70

Query: 150 ECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKG 209
           +  + E + EF +EV IM+++RH N+V F+GA T+PPNL IVTE+++RGS+Y  LHK   
Sbjct: 71  QDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKSGA 130

Query: 210 VFQLT--SLLKVAIDVSKGMNYLHQNN--IIHRDLKTANLLMDENGVVKVADFGVARVQA 265
             QL     L +A DV+KGMNYLH  N  I+HR+LK+ NLL+D+   VKV DFG++R++A
Sbjct: 131 REQLDERRRLSMAYDVAKGMNYLHNRNPPIVHRNLKSPNLLVDKKYTVKVCDFGLSRLKA 190

Query: 266 QSGV-MTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVG 324
            + +   +  GT  WMAPEV+  +P + K+DV+SFG+ LWEL T + P+  L P Q    
Sbjct: 191 STFLSSKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPWGNLNPAQVVAA 250

Query: 325 VVQKSLRPTIPKHAHPRLAELLERCWQHDPTQRPNFSQITDILKQMMKEVASEGENNHSN 384
           V  K  R  IP++ +P++A ++E CW ++P +RP+F+ I D+L+ ++K        N S+
Sbjct: 251 VGFKCKRLEIPRNLNPQVAAIIEGCWTNEPWKRPSFATIMDLLRPLIKSAVP--PPNRSD 308

>3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289

 Score =  417 bits (1073), Expect = e-147
 Identities = 94/282 (33%), Positives = 161/282 (57%), Gaps = 12/282 (4%)

Query: 102 EIPTDGTDVWEIDAKQLKIECKVASGSYGDLYKGTYCSQEVAIKVLKPECVNTEMLKEFS 161
               D  D WEI   Q+ +  ++ SGS+G +YKG +   +VA+K+L       + L+ F 
Sbjct: 10  HGSRDAADDWEIPDGQITVGQRIGSGSFGTVYKGKWH-GDVAVKMLNVTAPTPQQLQAFK 68

Query: 162 QEVYIMRKIRHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAI 221
            EV ++RK RH N++ F+G  T P  L IVT++    S+Y  LH  +  F++  L+ +A 
Sbjct: 69  NEVGVLRKTRHVNILLFMGYSTAPQ-LAIVTQWCEGSSLYHHLHASETKFEMKKLIDIAR 127

Query: 222 DVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQ---SGVMTAETGTYR 278
             ++GM+YLH  +IIHRDLK+ N+ + E+  VK+ DFG+A  +++   S      +G+  
Sbjct: 128 QTARGMDYLHAKSIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSIL 187

Query: 279 WMAPEVI---EHKPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKSLR---- 331
           WMAPEVI   +  PY +++DV++FGI L+EL+TG+LPY+ +      + +V +       
Sbjct: 188 WMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIEMVGRGSLSPDL 247

Query: 332 PTIPKHAHPRLAELLERCWQHDPTQRPNFSQITDILKQMMKE 373
             +  +   R+  L+  C +    +RP+F +I   ++++ +E
Sbjct: 248 SKVRSNCPKRMKRLMAECLKKKRDERPSFPRILAEIEELARE 289

>3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271

 Score =  414 bits (1067), Expect = e-146
 Identities = 85/271 (31%), Positives = 147/271 (54%), Gaps = 12/271 (4%)

Query: 111 WEIDAKQLKIECKVASGSYGDLYKGTYCSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKI 170
             ID KQL    K+     G+L+KG +   ++ +KVLK    +T   ++F++E   +R  
Sbjct: 5   SGIDFKQLNFLTKLNENHSGELWKGRWQGNDIVVKVLKVRDWSTRKSRDFNEECPRLRIF 64

Query: 171 RHKNVVQFIGACTRPP--NLCIVTEFMARGSIYDFLHKQKG-VFQLTSLLKVAIDVSKGM 227
            H NV+  +GAC  PP  +  ++T +M  GS+Y+ LH+    V   +  +K A+D+++GM
Sbjct: 65  SHPNVLPVLGACQSPPAPHPTLITHWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGM 124

Query: 228 NYLH--QNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAETGTYRWMAPEVI 285
            +LH  +  I    L + ++++DE+   +++   V                  W+APE +
Sbjct: 125 AFLHTLEPLIPRHALNSRSVMIDEDMTARISMADVKFSF----QSPGRMYAPAWVAPEAL 180

Query: 286 EHKPYDY---KADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRL 342
           + KP D     AD++SF + LWEL+T E+P+A L+ ++  + V  + LRPTIP    P +
Sbjct: 181 QKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSNMEIGMKVALEGLRPTIPPGISPHV 240

Query: 343 AELLERCWQHDPTQRPNFSQITDILKQMMKE 373
           ++L++ C   DP +RP F  I  IL++M  +
Sbjct: 241 SKLMKICMNEDPAKRPKFDMIVPILEKMQDK 271

>3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271

 Score =  414 bits (1066), Expect = e-146
 Identities = 96/274 (35%), Positives = 151/274 (55%), Gaps = 16/274 (5%)

Query: 110 VWEIDAKQLKIECKVASGSYGDLYKGTYCSQEVAIKVLKPECVN--TEMLKEFSQEVYIM 167
           + EID  +L +E  +  G +G +Y+  +   EVA+K  + +     ++ ++   QE  + 
Sbjct: 1   LLEIDFAELTLEEIIGIGGFGKVYRAFWIGDEVAVKAARHDPDEDISQTIENVRQEAKLF 60

Query: 168 RKIRHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGM 227
             ++H N++   G C + PNLC+V EF   G +   L  ++       L+  A+ +++GM
Sbjct: 61  AMLKHPNIIALRGVCLKEPNLCLVMEFARGGPLNRVLSGKR--IPPDILVNWAVQIARGM 118

Query: 228 NYLHQNN---IIHRDLKTANLLMDE--------NGVVKVADFGVARVQAQSGVMTAETGT 276
           NYLH      IIHRDLK++N+L+ +        N ++K+ DFG+AR   ++  M+A  G 
Sbjct: 119 NYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAREWHRTTKMSA-AGA 177

Query: 277 YRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKSLRPTIPK 336
           Y WMAPEVI    +   +DV+S+G+ LWELLTGE+P+ G+  L  A GV    L   IP 
Sbjct: 178 YAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGIDGLAVAYGVAMNKLALPIPS 237

Query: 337 HAHPRLAELLERCWQHDPTQRPNFSQITDILKQM 370
                 A+L+E CW  DP  RP+F+ I D L  +
Sbjct: 238 TCPEPFAKLMEDCWNPDPHSRPSFTNILDQLTTI 271

>2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319

 Score =  413 bits (1064), Expect = e-145
 Identities = 88/308 (28%), Positives = 152/308 (49%), Gaps = 19/308 (6%)

Query: 96  SSPNCIEIPTDGTDVWEIDAKQLKIECKVASGSYGDLYKGTYCSQEVAIKVLKPECVNTE 155
           S P      +     W+I  +QL+I   +  G +G +Y G +   EVAI+++  E  N +
Sbjct: 13  SFPRKASQTSIFLQEWDIPFEQLEIGELIGKGRFGQVYHGRWH-GEVAIRLIDIERDNED 71

Query: 156 MLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTS 215
            LK F +EV   R+ RH+NVV F+GAC  PP+L I+T      ++Y  +   K V  +  
Sbjct: 72  QLKAFKREVMAYRQTRHENVVLFMGACMSPPHLAIITSLCKGRTLYSVVRDAKIVLDVNK 131

Query: 216 LLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQA------QSGV 269
             ++A ++ KGM YLH   I+H+DLK+ N+  D NG V + DFG+  +        +   
Sbjct: 132 TRQIAQEIVKGMGYLHAKGILHKDLKSKNVFYD-NGKVVITDFGLFSISGVLQAGRREDK 190

Query: 270 MTAETGTYRWMAPEVI---------EHKPYDYKADVFSFGIALWELLTGELPYAGLTPLQ 320
           +  + G    +APE+I         +  P+   +DVF+ G   +EL   E P+       
Sbjct: 191 LRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPAEA 250

Query: 321 AAVGVVQKSLRPTIPKHAHPR-LAELLERCWQHDPTQRPNFSQITDILKQMMKEVASEGE 379
             +  +   ++P + +    + ++++L  CW  +  +RP F+++ D+L+++ K       
Sbjct: 251 -IIWQMGTGMKPNLSQIGMGKEISDILLFCWAFEQEERPTFTKLMDMLEKLPKRNRRLSH 309

Query: 380 NNHSNKSA 387
             H  KSA
Sbjct: 310 PGHFWKSA 317

>3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310

 Score =  412 bits (1060), Expect = e-144
 Identities = 85/304 (27%), Positives = 132/304 (43%), Gaps = 17/304 (5%)

Query: 111 WEIDAKQLKIECKVASGSYGDLYKGTYCSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKI 170
                  L     +  G +G   K T+      + + +    + E  + F +EV +MR +
Sbjct: 5   RIFRPSDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCL 64

Query: 171 RHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYL 230
            H NV++FIG   +   L  +TE++  G++   +      +  +  +  A D++ GM YL
Sbjct: 65  EHPNVLKFIGVLYKDKRLNFITEYIKGGTLRGIIKSMDSQYPWSQRVSFAKDIASGMAYL 124

Query: 231 HQNNIIHRDLKTANLLMDENGVVKVADFGVARVQA---------------QSGVMTAETG 275
           H  NIIHRDL + N L+ EN  V VADFG+AR+                          G
Sbjct: 125 HSMNIIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVG 184

Query: 276 TYRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGV-VQKSLRPTI 334
              WMAPE+I  + YD K DVFSFGI L E++          P     G+ V+  L    
Sbjct: 185 NPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDFGLNVRGFLDRYC 244

Query: 335 PKHAHPRLAELLERCWQHDPTQRPNFSQITDILKQMMKEVASEGEN-NHSNKSAGSFFSS 393
           P +  P    +  RC   DP +RP+F ++   L+ +   +A          +    F+ +
Sbjct: 245 PPNCPPSFFPITVRCCDLDPEKRPSFVKLEHWLETLRMHLAGHLPLGPQLEQLDRGFWET 304

Query: 394 LRRG 397
            RRG
Sbjct: 305 YRRG 308

>4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287

 Score =  401 bits (1033), Expect = e-141
 Identities = 87/285 (30%), Positives = 147/285 (51%), Gaps = 22/285 (7%)

Query: 104 PTDGTDVWEIDAKQLKIECKVASGSYGDLYKGTYCS--QEVAIKVLKPECVN-----TEM 156
               + +  +   +++ E ++  G +G ++KG        VAIK L            E 
Sbjct: 7   EFPKSRLPTLADNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEK 66

Query: 157 LKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSL 216
            +EF +EV+IM  + H N+V+  G    PP   +V EF+  G +Y  L  +    + +  
Sbjct: 67  FQEFQREVFIMSNLNHPNIVKLYGLMHNPP--RMVMEFVPCGDLYHRLLDKAHPIKWSVK 124

Query: 217 LKVAIDVSKGMNYLHQNN--IIHRDLKTANLLMDENG-----VVKVADFGVARVQAQSGV 269
           L++ +D++ G+ Y+   N  I+HRDL++ N+ +           KVADFG+++    S  
Sbjct: 125 LRLMLDIALGIEYMQNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQQSVHS-- 182

Query: 270 MTAETGTYRWMAPEVI--EHKPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAV--GV 325
           ++   G ++WMAPE I  E + Y  KAD +SF + L+ +LTGE P+   +  +      +
Sbjct: 183 VSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKIKFINMI 242

Query: 326 VQKSLRPTIPKHAHPRLAELLERCWQHDPTQRPNFSQITDILKQM 370
            ++ LRPTIP+   PRL  ++E CW  DP +RP+FS I   L ++
Sbjct: 243 REEGLRPTIPEDCPPRLRNVIELCWSGDPKKRPHFSYIVKELSEL 287

>2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307

 Score =  397 bits (1022), Expect = e-139
 Identities = 94/277 (33%), Positives = 146/277 (52%), Gaps = 15/277 (5%)

Query: 110 VWEIDAKQLKIECKVASGSYGDLYKGTYCSQEVAIKVLKPECVNTEMLKEFSQEVYIMRK 169
           +  ID K++++E  V  G++G + K  + +++VAIK ++ E       K F  E+  + +
Sbjct: 2   LHMIDYKEIEVEEVVGRGAFGVVCKAKWRAKDVAIKQIESE----SERKAFIVELRQLSR 57

Query: 170 IRHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLT--SLLKVAIDVSKGM 227
           + H N+V+  GAC  P  +C+V E+   GS+Y+ LH  + +   T    +   +  S+G+
Sbjct: 58  VNHPNIVKLYGACLNP--VCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGV 115

Query: 228 NYLHQ---NNIIHRDLKTANLLMDENG-VVKVADFGVARVQAQSGVMTAETGTYRWMAPE 283
            YLH      +IHRDLK  NLL+   G V+K+ DFG A        MT   G+  WMAPE
Sbjct: 116 AYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQTH--MTNNKGSAAWMAPE 173

Query: 284 VIEHKPYDYKADVFSFGIALWELLTGELPYAGL-TPLQAAVGVVQKSLRPTIPKHAHPRL 342
           V E   Y  K DVFS+GI LWE++T   P+  +  P    +  V    RP + K+    +
Sbjct: 174 VFEGSNYSEKCDVFSWGIILWEVITRRKPFDEIGGPAFRIMWAVHNGTRPPLIKNLPKPI 233

Query: 343 AELLERCWQHDPTQRPNFSQITDILKQMMKEVASEGE 379
             L+ RCW  DP+QRP+  +I  I+  +M+      E
Sbjct: 234 ESLMTRCWSKDPSQRPSMEEIVKIMTHLMRYFPGADE 270

>3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337

 Score =  352 bits (905), Expect = e-120
 Identities = 90/333 (27%), Positives = 147/333 (44%), Gaps = 50/333 (15%)

Query: 86  VPMHSKL--LIESSPNCIEIPTDGTDVWEIDAKQLKIECKVASGSYGDLYKGTYCSQEVA 143
           +P    L  LIE S +          V    AKQ+++  ++  G YG+++ G +  ++VA
Sbjct: 5   IPPGESLRDLIEQSQSSGSGSGLPLLVQRTIAKQIQMVKQIGKGRYGEVWMGKWRGEKVA 64

Query: 144 IKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRP----PNLCIVTEFMARGS 199
           +KV           +E   E+Y    +RH+N++ FI A  +       L ++T++   GS
Sbjct: 65  VKVFFTTEEA-SWFRE--TEIYQTVLMRHENILGFIAADIKGTGSWTQLYLITDYHENGS 121

Query: 200 IYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLH--------QNNIIHRDLKTANLLMDENG 251
           +YD+L          S+LK+A     G+ +LH        +  I HRDLK+ N+L+ +NG
Sbjct: 122 LYDYLKSTT--LDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNG 179

Query: 252 VVKVADFGVARVQAQSG-----VMTAETGTYRWMAPEVIE------HKPYDYKADVFSFG 300
              +AD G+A                  GT R+M PEV++      H      AD++SFG
Sbjct: 180 TCCIADLGLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFG 239

Query: 301 IALWELLTG----------ELPYAGLTPLQAAVG-----VVQKSLRPTIPKH-----AHP 340
           + LWE+             +LPY  L P   +       V  K LRP+ P          
Sbjct: 240 LILWEVARRCVSGGIVEEYQLPYHDLVPSDPSYEDMREIVCIKKLRPSFPNRWSSDECLR 299

Query: 341 RLAELLERCWQHDPTQRPNFSQITDILKQMMKE 373
           ++ +L+  CW H+P  R    ++   L +M + 
Sbjct: 300 QMGKLMTECWAHNPASRLTALRVKKTLAKMSES 332

>3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301

 Score =  344 bits (885), Expect = e-118
 Identities = 75/299 (25%), Positives = 136/299 (45%), Gaps = 48/299 (16%)

Query: 115 AKQLKIECKVASGSYGDLYKGTYCSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKN 174
           A+ + +   V  G YG++++G++  + VA+K+           +E   E+Y    +RH+N
Sbjct: 7   ARDITLLECVGKGRYGEVWRGSWQGENVAVKIFSSRDEK-SWFRE--TELYNTVMLRHEN 63

Query: 175 VVQFIGACTR----PPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYL 230
           ++ FI +          L ++T +   GS+YD+L          S L++ + ++ G+ +L
Sbjct: 64  ILGFIASDMTSRHSSTQLWLITHYHEMGSLYDYLQLTT--LDTVSCLRIVLSIASGLAHL 121

Query: 231 H--------QNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVM-----TAETGTY 277
           H        +  I HRDLK+ N+L+ +NG   +AD G+A + +QS            GT 
Sbjct: 122 HIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTK 181

Query: 278 RWMAPEVIEHKP------YDYKADVFSFGIALWELLTG----------ELPYAGLTPLQA 321
           R+MAPEV++            + D+++FG+ LWE+             + P+  + P   
Sbjct: 182 RYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYDVVPNDP 241

Query: 322 AV-----GVVQKSLRPTIPKH-----AHPRLAELLERCWQHDPTQRPNFSQITDILKQM 370
           +       V     RP IP           LA+L++ CW  +P+ R    +I   L ++
Sbjct: 242 SFEDMRKVVCVDQQRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKKTLTKI 300

>1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342

 Score =  336 bits (864), Expect = e-114
 Identities = 77/307 (25%), Positives = 144/307 (46%), Gaps = 48/307 (15%)

Query: 110 VWEIDAKQLKIECKVASGSYGDLYKGTYCSQEVAIKVLKPECVNTEMLKEFSQEVYIMRK 169
           V    A+ + ++  +  G +G++++G +  +EVA+K+           +E   E+Y    
Sbjct: 36  VQRTIARTIVLQESIGKGRFGEVWRGKWRGEEVAVKIFSSREER-SWFRE--AEIYQTVM 92

Query: 170 IRHKNVVQFIGACTR----PPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSK 225
           +RH+N++ FI A  +       L +V+++   GS++D+L++      +  ++K+A+  + 
Sbjct: 93  LRHENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYT--VTVEGMIKLALSTAS 150

Query: 226 GMNYLHQN--------NIIHRDLKTANLLMDENGVVKVADFGVARVQAQSG-----VMTA 272
           G+ +LH           I HRDLK+ N+L+ +NG   +AD G+A     +          
Sbjct: 151 GLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNH 210

Query: 273 ETGTYRWMAPEVIE------HKPYDYKADVFSFGIALWELLTG----------ELPYAGL 316
             GT R+MAPEV++      H     +AD+++ G+  WE+             +LPY  L
Sbjct: 211 RVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDL 270

Query: 317 TPLQAAVG-----VVQKSLRPTIPKH-----AHPRLAELLERCWQHDPTQRPNFSQITDI 366
            P   +V      V ++ LRP IP       A   +A+++  CW  +   R    +I   
Sbjct: 271 VPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKT 330

Query: 367 LKQMMKE 373
           L Q+ ++
Sbjct: 331 LSQLSQQ 337

>3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322

 Score =  327 bits (841), Expect = e-111
 Identities = 83/309 (26%), Positives = 143/309 (46%), Gaps = 48/309 (15%)

Query: 107 GTDVWEIDAKQLKIECKVASGSYGDLYKGTYCSQEVAIKVLKPECVNTEMLKEFSQEVYI 166
           GT+     +  L++    A G +G ++K    ++ VA+K+   +    +   +   EVY 
Sbjct: 15  GTENLYFQSMPLQLLEVKARGRFGCVWKAQLLNEYVAVKIFPIQD---KQSWQNEYEVYS 71

Query: 167 MRKIRHKNVVQFIGACTRPPN----LCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAID 222
           +  ++H+N++QFIGA  R  +    L ++T F  +GS+ DFL     V     L  +A  
Sbjct: 72  LPGMKHENILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFLKAN--VVSWNELCHIAET 129

Query: 223 VSKGMNYLHQN----------NIIHRDLKTANLLMDENGVVKVADFGVARVQ---AQSGV 269
           +++G+ YLH++           I HRD+K+ N+L+  N    +ADFG+A        +G 
Sbjct: 130 MARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLALKFEAGKSAGD 189

Query: 270 MTAETGTYRWMAPEVIEH-----KPYDYKADVFSFGIALWELLTGELPYAG-----LTPL 319
              + GT R+MAPEV+E      +    + D+++ G+ LWEL +      G     + P 
Sbjct: 190 THGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYMLPF 249

Query: 320 QAAVG-----------VVQKSLRPTIPKHAHP-----RLAELLERCWQHDPTQRPNFSQI 363
           +  +G           VV K  RP +  +         L E +E CW HD   R +   +
Sbjct: 250 EEEIGQHPSLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEECWDHDAEARLSAGCV 309

Query: 364 TDILKQMMK 372
            + + QM +
Sbjct: 310 GERITQMQR 318

>3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336

 Score =  304 bits (780), Expect = e-102
 Identities = 75/318 (23%), Positives = 127/318 (39%), Gaps = 59/318 (18%)

Query: 111 WEIDAKQLKIECKVASGSYGDLYKGTYCSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKI 170
             +D   LK+   +  G YG +YKG+   + VA+KV          + E  + +Y +  +
Sbjct: 8   PSLDLDNLKLLELIGRGRYGAVYKGSLDERPVAVKVFSFANRQ-NFINE--KNIYRVPLM 64

Query: 171 RHKNVVQFIGACTRPP-----NLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSK 225
            H N+ +FI    R          +V E+   GS+  +L          S  ++A  V++
Sbjct: 65  EHDNIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYLSLHT--SDWVSSCRLAHSVTR 122

Query: 226 GMNYLH---------QNNIIHRDLKTANLLMDENGVVKVADFGVARVQA---------QS 267
           G+ YLH         +  I HRDL + N+L+  +G   ++DFG++             + 
Sbjct: 123 GLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGNRLVRPGEED 182

Query: 268 GVMTAETGTYRWMAPEVIE-------HKPYDYKADVFSFGIALWELL---TGELPYAGLT 317
               +E GT R+MAPEV+E        +    + D+++ G+  WE+    T   P   + 
Sbjct: 183 NAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPGESVP 242

Query: 318 PLQAA---------------VGVVQKSLRPTIPKH------AHPRLAELLERCWQHDPTQ 356
             Q A               V V ++  RP  P+       A   L E +E CW  D   
Sbjct: 243 EYQMAFQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRSLKETIEDCWDQDAEA 302

Query: 357 RPNFSQITDILKQMMKEV 374
           R       + + ++M   
Sbjct: 303 RLTAQXAEERMAELMMIW 320

>3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377

 Score =  281 bits (722), Expect = 2e-92
 Identities = 87/272 (31%), Positives = 143/272 (52%), Gaps = 10/272 (3%)

Query: 109 DVWEIDAKQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVNTEMLKEFSQEVYI 166
           D W ++ + L +  ++  G++G+++ G     +  VA+K  +      ++  +F QE  I
Sbjct: 107 DKWVLNHEDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETL-PPDLKAKFLQEARI 165

Query: 167 MRKIRHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKG 226
           +++  H N+V+ IG CT+   + IV E +  G    FL  +    ++ +LL++  D + G
Sbjct: 166 LKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDFLTFLRTEGARLRVKTLLQMVGDAAAG 225

Query: 227 MNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAETGT----YRWMAP 282
           M YL     IHRDL   N L+ E  V+K++DFG++R     GV  A  G      +W AP
Sbjct: 226 MEYLESKCCIHRDLAARNCLVTEKNVLKISDFGMSRE-EADGVYAASGGLRQVPVKWTAP 284

Query: 283 EVIEHKPYDYKADVFSFGIALWELLT-GELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPR 341
           E + +  Y  ++DV+SFGI LWE  + G  PY  L+  Q     V+K  R   P+     
Sbjct: 285 EALNYGRYSSESDVWSFGILLWETFSLGASPYPNLSNQQ-TREFVEKGGRLPCPELCPDA 343

Query: 342 LAELLERCWQHDPTQRPNFSQITDILKQMMKE 373
           +  L+E+CW ++P QRP+FS I   L+ + K 
Sbjct: 344 VFRLMEQCWAYEPGQRPSFSTIYQELQSIRKR 375

>3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267

 Score =  269 bits (691), Expect = 3e-89
 Identities = 90/267 (33%), Positives = 149/267 (55%), Gaps = 10/267 (3%)

Query: 111 WEIDAKQLKIECKVASGSYGDLYKGTYCSQ-EVAIKVLKPECVNTEMLKEFSQEVYIMRK 169
           W ID  +L    ++ SG +G ++ G + ++ +VAIK ++   ++ E   +F +E  +M K
Sbjct: 3   WVIDPSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSEE---DFIEEAEVMMK 59

Query: 170 IRHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNY 229
           + H  +VQ  G C     +C+VTEFM  G + D+L  Q+G+F   +LL + +DV +GM Y
Sbjct: 60  LSHPKLVQLYGVCLEQAPICLVTEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAY 119

Query: 230 LHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAETGT---YRWMAPEVIE 286
           L +  +IHRDL   N L+ EN V+KV+DFG+ R        T+ TGT    +W +PEV  
Sbjct: 120 LEEACVIHRDLAARNCLVGENQVIKVSDFGMTRF-VLDDQYTSSTGTKFPVKWASPEVFS 178

Query: 287 HKPYDYKADVFSFGIALWELLT-GELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRLAEL 345
              Y  K+DV+SFG+ +WE+ + G++PY   +     V  +    R   P+ A   + ++
Sbjct: 179 FSRYSSKSDVWSFGVLMWEVFSEGKIPYENRS-NSEVVEDISTGFRLYKPRLASTHVYQI 237

Query: 346 LERCWQHDPTQRPNFSQITDILKQMMK 372
           +  CW+  P  RP FS++   L ++ +
Sbjct: 238 MNHCWRERPEDRPAFSRLLRQLAEIAE 264

>3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283

 Score =  269 bits (691), Expect = 4e-89
 Identities = 84/270 (31%), Positives = 145/270 (53%), Gaps = 10/270 (3%)

Query: 109 DVWEIDAKQLKIECKVASGSYGDLYKGTYCSQ-EVAIKVLKPECVNTEMLKEFSQEVYIM 167
             WEID K L    ++ +G +G +  G +  Q +VAIK++K   ++ +   EF +E  +M
Sbjct: 17  GSWEIDPKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSED---EFIEEAKVM 73

Query: 168 RKIRHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGM 227
             + H+ +VQ  G CT+   + I+TE+MA G + ++L + +  FQ   LL++  DV + M
Sbjct: 74  MNLSHEKLVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAM 133

Query: 228 NYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAETGT---YRWMAPEV 284
            YL     +HRDL   N L+++ GVVKV+DFG++R        T+  G+    RW  PEV
Sbjct: 134 EYLESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRY-VLDDEYTSSVGSKFPVRWSPPEV 192

Query: 285 IEHKPYDYKADVFSFGIALWELLT-GELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRLA 343
           + +  +  K+D+++FG+ +WE+ + G++PY   T        + + LR   P  A  ++ 
Sbjct: 193 LMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFT-NSETAEHIAQGLRLYRPHLASEKVY 251

Query: 344 ELLERCWQHDPTQRPNFSQITDILKQMMKE 373
            ++  CW     +RP F  +   +  +M E
Sbjct: 252 TIMYSCWHEKADERPTFKILLSNILDVMDE 281

>1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278

 Score =  269 bits (689), Expect = 7e-89
 Identities = 90/271 (33%), Positives = 146/271 (53%), Gaps = 16/271 (5%)

Query: 109 DVWEIDAKQLKIECKVASGSYGDLYKGTYCSQEVAIKVLKPECVNTEMLKEFSQEVYIMR 168
             W ++ K+LK+   +  G +GD+  G Y   +VA+K +K +       + F  E  +M 
Sbjct: 14  SGWALNMKELKLLQTIGKGEFGDVMLGDYRGNKVAVKCIKNDA----TAQAFLAEASVMT 69

Query: 169 KIRHKNVVQFIGACTR-PPNLCIVTEFMARGSIYDFLHKQKG-VFQLTSLLKVAIDVSKG 226
           ++RH N+VQ +G        L IVTE+MA+GS+ D+L  +   V     LLK ++DV + 
Sbjct: 70  QLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEA 129

Query: 227 MNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAETGT---YRWMAPE 283
           M YL  NN +HRDL   N+L+ E+ V KV+DFG+ +  +     + +       +W APE
Sbjct: 130 MEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEAS-----STQDTGKLPVKWTAPE 184

Query: 284 VIEHKPYDYKADVFSFGIALWELLT-GELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRL 342
            +  K +  K+DV+SFGI LWE+ + G +PY  +  L+  V  V+K  +   P    P +
Sbjct: 185 ALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIP-LKDVVPRVEKGYKMDAPDGCPPAV 243

Query: 343 AELLERCWQHDPTQRPNFSQITDILKQMMKE 373
            E+++ CW  D   RP+F Q+ + L+ +   
Sbjct: 244 YEVMKNCWHLDAAMRPSFLQLREQLEHIKTH 274

>1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450

 Score =  274 bits (703), Expect = 9e-89
 Identities = 91/297 (30%), Positives = 148/297 (49%), Gaps = 16/297 (5%)

Query: 83  ALGVPMHSKLLIESSPNCIEIPTDGTDVWEIDAKQLKIECKVASGSYGDLYKGTYCSQEV 142
           A G+                        W ++ K+LK+   +  G +GD+  G Y   +V
Sbjct: 160 ADGLCTRLIKPKVMEGTVAAQDEFYRSGWALNMKELKLLQTIGKGEFGDVMLGDYRGNKV 219

Query: 143 AIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTR-PPNLCIVTEFMARGSIY 201
           A+K +K +       + F  E  +M ++RH N+VQ +G        L IVTE+MA+GS+ 
Sbjct: 220 AVKCIKNDA----TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLV 275

Query: 202 DFLHKQKG-VFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGV 260
           D+L  +   V     LLK ++DV + M YL  NN +HRDL   N+L+ E+ V KV+DFG+
Sbjct: 276 DYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGL 335

Query: 261 ARVQAQSGVMTAETGT---YRWMAPEVIEHKPYDYKADVFSFGIALWELLT-GELPYAGL 316
            +  +     + +       +W APE +  K +  K+DV+SFGI LWE+ + G +PY  +
Sbjct: 336 TKEAS-----STQDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRI 390

Query: 317 TPLQAAVGVVQKSLRPTIPKHAHPRLAELLERCWQHDPTQRPNFSQITDILKQMMKE 373
             L+  V  V+K  +   P    P + ++++ CW  D   RP F Q+ + L+ +   
Sbjct: 391 P-LKDVVPRVEKGYKMDAPDGCPPAVYDVMKNCWHLDAATRPTFLQLREQLEHIRTH 446

>3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268

 Score =  266 bits (682), Expect = 6e-88
 Identities = 81/268 (30%), Positives = 144/268 (53%), Gaps = 10/268 (3%)

Query: 111 WEIDAKQLKIECKVASGSYGDLYKGTYCSQ-EVAIKVLKPECVNTEMLKEFSQEVYIMRK 169
            E+  +++ +  ++ SG +G +  G +  Q +VA+K++K   ++ +   EF QE   M K
Sbjct: 3   MELKREEITLLKELGSGQFGVVKLGKWKGQYDVAVKMIKEGSMSED---EFFQEAQTMMK 59

Query: 170 IRHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNY 229
           + H  +V+F G C++   + IVTE+++ G + ++L       + + LL++  DV +GM +
Sbjct: 60  LSHPKLVKFYGVCSKEYPIYIVTEYISNGCLLNYLRSHGKGLEPSQLLEMCYDVCEGMAF 119

Query: 230 LHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAETGT---YRWMAPEVIE 286
           L  +  IHRDL   N L+D +  VKV+DFG+ R         +  GT    +W APEV  
Sbjct: 120 LESHQFIHRDLAARNCLVDRDLCVKVSDFGMTRY-VLDDQYVSSVGTKFPVKWSAPEVFH 178

Query: 287 HKPYDYKADVFSFGIALWELLT-GELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRLAEL 345
           +  Y  K+DV++FGI +WE+ + G++PY   T     V  V +  R   P  A   + ++
Sbjct: 179 YFKYSSKSDVWAFGILMWEVFSLGKMPYDLYT-NSEVVLKVSQGHRLYRPHLASDTIYQI 237

Query: 346 LERCWQHDPTQRPNFSQITDILKQMMKE 373
           +  CW   P +RP F Q+   ++ + ++
Sbjct: 238 MYSCWHELPEKRPTFQQLLSSIEPLREK 265

>1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495

 Score =  273 bits (701), Expect = 6e-88
 Identities = 100/290 (34%), Positives = 162/290 (55%), Gaps = 12/290 (4%)

Query: 97  SPNCIEIPTDGTDVWEIDAKQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVNT 154
           +   I   +   D WE++   + ++ K+  G YG++Y+G +   S  VA+K LK    +T
Sbjct: 201 NKPTIYGVSPNYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKE---DT 257

Query: 155 EMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKG-VFQL 213
             ++EF +E  +M++I+H N+VQ +G CTR P   I+TEFM  G++ D+L +        
Sbjct: 258 MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSA 317

Query: 214 TSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAE 273
             LL +A  +S  M YL + N IHR+L   N L+ EN +VKVADFG++R+       TA 
Sbjct: 318 VVLLYMATQISSAMEYLEKKNFIHRNLAARNCLVGENHLVKVADFGLSRL-MTGDTYTAH 376

Query: 274 TGT---YRWMAPEVIEHKPYDYKADVFSFGIALWELLT-GELPYAGLTPLQAAVGVVQKS 329
            G     +W APE + +  +  K+DV++FG+ LWE+ T G  PY G+  L     +++K 
Sbjct: 377 AGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGID-LSQVYELLEKD 435

Query: 330 LRPTIPKHAHPRLAELLERCWQHDPTQRPNFSQITDILKQMMKEVASEGE 379
            R   P+    ++ EL+  CWQ +P+ RP+F++I    + M +E +   E
Sbjct: 436 YRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQESSISDE 485

>1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291

 Score =  267 bits (684), Expect = 6e-88
 Identities = 80/284 (28%), Positives = 145/284 (51%), Gaps = 13/284 (4%)

Query: 109 DVWEIDAKQLKIECKV-ASGSYGDLYKGTY----CSQEVAIKVLKPECVNTEMLKEFSQE 163
               +D K L +E K   SG++G + KG Y      + VA+K+LK E  +  +  E   E
Sbjct: 9   KEVYLDRKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAE 68

Query: 164 VYIMRKIRHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDV 223
             +M+++ +  +V+ IG C       +V E    G +  +L + +   +  +++++   V
Sbjct: 69  ANVMQQLDNPYIVRMIGICEAES-WMLVMEMAELGPLNKYLQQNRH-VKDKNIIELVHQV 126

Query: 224 SKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVAR-VQAQSGVMTAETGT---YRW 279
           S GM YL ++N +HRDL   N+L+      K++DFG+++ ++A      A+T      +W
Sbjct: 127 SMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKW 186

Query: 280 MAPEVIEHKPYDYKADVFSFGIALWELLT-GELPYAGLTPLQAAVGVVQKSLRPTIPKHA 338
            APE I +  +  K+DV+SFG+ +WE  + G+ PY G+        +++K  R   P   
Sbjct: 187 YAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMK-GSEVTAMLEKGERMGCPAGC 245

Query: 339 HPRLAELLERCWQHDPTQRPNFSQITDILKQMMKEVASEGENNH 382
              + +L+  CW +D   RP F+ +   L+    +V +EG ++H
Sbjct: 246 PREMYDLMNLCWTYDVENRPGFAAVELRLRNYYYDVVNEGHHHH 289

>3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288

 Score =  266 bits (683), Expect = 9e-88
 Identities = 100/289 (34%), Positives = 159/289 (55%), Gaps = 12/289 (4%)

Query: 108 TDVWEIDAKQLKIECKVASGSYGDLYKGTYCSQE--VAIKVLKPECVNTEMLKEFSQEVY 165
            D WE++   + ++ K+  G YG++Y+G +      VA+K LK + +  E   EF +E  
Sbjct: 5   YDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE---EFLKEAA 61

Query: 166 IMRKIRHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKG-VFQLTSLLKVAIDVS 224
           +M++I+H N+VQ +G CTR P   I+TEFM  G++ D+L +          LL +A  +S
Sbjct: 62  VMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQIS 121

Query: 225 KGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAETGT---YRWMA 281
             M YL + N IHRDL   N L+ EN +VKVADFG++R+       TA  G     +W A
Sbjct: 122 SAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRL-MTGDTYTAHAGAKFPIKWTA 180

Query: 282 PEVIEHKPYDYKADVFSFGIALWELLT-GELPYAGLTPLQAAVGVVQKSLRPTIPKHAHP 340
           PE + +  +  K+DV++FG+ LWE+ T G  PY G+   Q    +++K  R   P+    
Sbjct: 181 PESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQ-VYELLEKDYRMERPEGCPE 239

Query: 341 RLAELLERCWQHDPTQRPNFSQITDILKQMMKEVASEGENNHSNKSAGS 389
           ++ EL+  CWQ +P+ RP+F++I    + M +E +   E        G+
Sbjct: 240 KVYELMRACWQWNPSDRPSFAEIHQAFETMFQESSISDEVEKELGKRGT 288

>1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291

 Score =  265 bits (680), Expect = 3e-87
 Identities = 83/277 (29%), Positives = 141/277 (50%), Gaps = 12/277 (4%)

Query: 108 TDVWEIDAKQLKIECKVASGSYGDLYKGTYCSQE-----VAIKVLKPECVNT-EMLKEFS 161
           +    I  K L++  K+  GS+G + +G + +       VA+K LKP+ ++  E + +F 
Sbjct: 10  SLTCLIGEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFI 69

Query: 162 QEVYIMRKIRHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAI 221
           +EV  M  + H+N+++  G    PP + +VTE    GS+ D L K +G F L +L + A+
Sbjct: 70  REVNAMHSLDHRNLIRLYGVVLTPP-MKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAV 128

Query: 222 DVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVAR-VQAQSGVMTAETGT---Y 277
            V++GM YL     IHRDL   NLL+    +VK+ DFG+ R +         +      +
Sbjct: 129 QVAEGMGYLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPF 188

Query: 278 RWMAPEVIEHKPYDYKADVFSFGIALWELLT-GELPYAGLTPLQAAVGVVQKSLRPTIPK 336
            W APE ++ + + + +D + FG+ LWE+ T G+ P+ GL   Q    + ++  R   P+
Sbjct: 189 AWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERLPRPE 248

Query: 337 HAHPRLAELLERCWQHDPTQRPNFSQITDILKQMMKE 373
                +  ++ +CW H P  RP F  + D L +    
Sbjct: 249 DCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEAQPT 285

>3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281

 Score =  263 bits (675), Expect = 1e-86
 Identities = 75/278 (26%), Positives = 136/278 (48%), Gaps = 11/278 (3%)

Query: 107 GTDVWEIDAKQLKIECKVASGSYGDLYKGTYCSQE-----VAIKVLKPECVNTEMLKEFS 161
           G   + I  + + +   +  G +G++Y+G Y + +     VA+K  K +C      ++F 
Sbjct: 3   GGPQYGIAREDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNK-EKFM 61

Query: 162 QEVYIMRKIRHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAI 221
            E  IM+ + H ++V+ IG     P   I+ E    G +  +L + K   ++ +L+  ++
Sbjct: 62  SEAVIMKNLDHPHIVKLIGIIEEEP-TWIIMELYPYGELGHYLERNKNSLKVLTLVLYSL 120

Query: 222 DVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAETGTY--RW 279
            + K M YL   N +HRD+   N+L+     VK+ DFG++R         A       +W
Sbjct: 121 QICKAMAYLESINCVHRDIAVRNILVASPECVKLGDFGLSRYIEDEDYYKASVTRLPIKW 180

Query: 280 MAPEVIEHKPYDYKADVFSFGIALWELLT-GELPYAGLTPLQAAVGVVQKSLRPTIPKHA 338
           M+PE I  + +   +DV+ F + +WE+L+ G+ P+  L      +GV++K  R   P   
Sbjct: 181 MSPESINFRRFTTASDVWMFAVCMWEILSFGKQPFFWLENKD-VIGVLEKGDRLPKPDLC 239

Query: 339 HPRLAELLERCWQHDPTQRPNFSQITDILKQMMKEVAS 376
            P L  L+ RCW +DP+ RP F+++   L  + +    
Sbjct: 240 PPVLYTLMTRCWDYDPSDRPRFTELVCSLSDVYQMEKD 277

>1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281

 Score =  262 bits (671), Expect = 4e-86
 Identities = 85/275 (30%), Positives = 144/275 (52%), Gaps = 11/275 (4%)

Query: 107 GTDVWEIDAKQLKIECKVASGSYGDLYKGTYCSQE-----VAIKVLKPECVNTEMLKEFS 161
            T  +EI  +++++   +  G +GD+++G Y S E     VAIK  K    +  + ++F 
Sbjct: 6   STRDYEIQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCT-SDSVREKFL 64

Query: 162 QEVYIMRKIRHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAI 221
           QE   MR+  H ++V+ IG  T  P + I+ E    G +  FL  +K    L SL+  A 
Sbjct: 65  QEALTMRQFDHPHIVKLIGVITENP-VWIIMELCTLGELRSFLQVRKYSLDLASLILYAY 123

Query: 222 DVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAETGTY--RW 279
            +S  + YL     +HRD+   N+L+  N  VK+ DFG++R    S    A  G    +W
Sbjct: 124 QLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKW 183

Query: 280 MAPEVIEHKPYDYKADVFSFGIALWELLT-GELPYAGLTPLQAAVGVVQKSLRPTIPKHA 338
           MAPE I  + +   +DV+ FG+ +WE+L  G  P+ G+      +G ++   R  +P + 
Sbjct: 184 MAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVK-NNDVIGRIENGERLPMPPNC 242

Query: 339 HPRLAELLERCWQHDPTQRPNFSQITDILKQMMKE 373
            P L  L+ +CW +DP++RP F+++   L  +++E
Sbjct: 243 PPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILEE 277

>1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287

 Score =  262 bits (671), Expect = 6e-86
 Identities = 76/284 (26%), Positives = 141/284 (49%), Gaps = 13/284 (4%)

Query: 109 DVWEIDAKQLKI-ECKVASGSYGDLYKGTYCSQ----EVAIKVLKPECVNTEMLKEFSQE 163
               +    L I + ++  G++G + +G Y  +    +VAIKVLK      +  +E  +E
Sbjct: 2   KKLFLKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADT-EEMMRE 60

Query: 164 VYIMRKIRHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDV 223
             IM ++ +  +V+ IG C     L +V E    G ++ FL  ++    ++++ ++   V
Sbjct: 61  AQIMHQLDNPYIVRLIGVCQAEA-LMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQV 119

Query: 224 SKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVAR-VQAQSGVMTAETGT---YRW 279
           S GM YL + N +HRDL   N+L+      K++DFG+++ + A     TA +      +W
Sbjct: 120 SMGMKYLEEKNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKW 179

Query: 280 MAPEVIEHKPYDYKADVFSFGIALWELLT-GELPYAGLTPLQAAVGVVQKSLRPTIPKHA 338
            APE I  + +  ++DV+S+G+ +WE L+ G+ PY  +      +  +++  R   P   
Sbjct: 180 YAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMK-GPEVMAFIEQGKRMECPPEC 238

Query: 339 HPRLAELLERCWQHDPTQRPNFSQITDILKQMMKEVASEGENNH 382
            P L  L+  CW +    RP+F  +   ++     +AS+ E +H
Sbjct: 239 PPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSLASKVEGHH 282

>1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279

 Score =  261 bits (669), Expect = 7e-86
 Identities = 86/275 (31%), Positives = 151/275 (54%), Gaps = 12/275 (4%)

Query: 109 DVWEIDAKQLKIECKVASGSYGDLYKGTYCSQ-EVAIKVLKPECVNTEMLKEFSQEVYIM 167
           D WE+  + LK+  ++ +G +G+++ G Y    +VA+K LK   ++ +    F  E  +M
Sbjct: 6   DEWEVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPD---AFLAEANLM 62

Query: 168 RKIRHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKG-VFQLTSLLKVAIDVSKG 226
           ++++H+ +V+     T+ P + I+TE+M  GS+ DFL    G    +  LL +A  +++G
Sbjct: 63  KQLQHQRLVRLYAVVTQEP-IYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEG 121

Query: 227 MNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAETGT---YRWMAPE 283
           M ++ + N IHRDL+ AN+L+ +    K+ADFG+AR+  +    TA  G     +W APE
Sbjct: 122 MAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARL-IEDNEYTAREGAKFPIKWTAPE 180

Query: 284 VIEHKPYDYKADVFSFGIALWELLT-GELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRL 342
            I +  +  K+DV+SFGI L E++T G +PY G+T     +  +++  R   P +    L
Sbjct: 181 AINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMT-NPEVIQNLERGYRMVRPDNCPEEL 239

Query: 343 AELLERCWQHDPTQRPNFSQITDILKQMMKEVASE 377
            +L+  CW+  P  RP F  +  +L+        +
Sbjct: 240 YQLMRLCWKERPEDRPTFDYLRSVLEDFFTATEGQ 274

>3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325

 Score =  262 bits (672), Expect = 1e-85
 Identities = 93/274 (33%), Positives = 137/274 (50%), Gaps = 12/274 (4%)

Query: 109 DVWEIDAKQLKIECKVASGSYGDLYKGTYC-----SQEVAIKVLKPECVNTEMLKEFSQE 163
              EI+A ++ IE  + SG  G++  G           VAIK LK      +  ++F  E
Sbjct: 42  FTREIEASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQ-RRDFLSE 100

Query: 164 VYIMRKIRHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDV 223
             IM +  H N+++  G  TR     IVTE+M  GS+  FL    G F +  L+ +   V
Sbjct: 101 ASIMGQFDHPNIIRLEGVVTRGRLAMIVTEYMENGSLDTFLRTHDGQFTIMQLVGMLRGV 160

Query: 224 SKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVAR-VQAQSGVMTAETGT---YRW 279
             GM YL     +HRDL   N+L+D N V KV+DFG++R ++         TG     RW
Sbjct: 161 GAGMRYLSDLGYVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDAAYTTTGGKIPIRW 220

Query: 280 MAPEVIEHKPYDYKADVFSFGIALWELLT-GELPYAGLTPLQAAVGVVQKSLRPTIPKHA 338
            APE I  + +   +DV+SFG+ +WE+L  GE PY  +T  +  +  V++  R   P   
Sbjct: 221 TAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERPYWNMT-NRDVISSVEEGYRLPAPMGC 279

Query: 339 HPRLAELLERCWQHDPTQRPNFSQITDILKQMMK 372
              L +L+  CW  D  QRP FSQI  +L  +++
Sbjct: 280 PHALHQLMLDCWHKDRAQRPRFSQIVSVLDALIR 313

>1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333

 Score =  262 bits (671), Expect = 2e-85
 Identities = 85/307 (27%), Positives = 145/307 (47%), Gaps = 17/307 (5%)

Query: 79  KRQPALGVPMHSKLLIESSPNCIEIPTDGT--DVWEIDAKQLKIECKVASGSYGDLYKGT 136
                  +P    L           P         EI    +  +  + +G +G++YKG 
Sbjct: 7   HHHHDYDIPTTENLYF--QGAMGSDPNQAVLKFTTEIHPSCVTRQKVIGAGEFGEVYKGM 64

Query: 137 Y------CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCI 190
                      VAIK LK      +   +F  E  IM +  H N+++  G  ++   + I
Sbjct: 65  LKTSSGKKEVPVAIKTLKAGYTEKQR-VDFLGEAGIMGQFSHHNIIRLEGVISKYKPMMI 123

Query: 191 VTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDEN 250
           +TE+M  G++  FL ++ G F +  L+ +   ++ GM YL   N +HRDL   N+L++ N
Sbjct: 124 ITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANMNYVHRDLAARNILVNSN 183

Query: 251 GVVKVADFGVAR-VQAQSGVMTAETGT---YRWMAPEVIEHKPYDYKADVFSFGIALWEL 306
            V KV+DFG++R ++         +G     RW APE I ++ +   +DV+SFGI +WE+
Sbjct: 184 LVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEV 243

Query: 307 LT-GELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRLAELLERCWQHDPTQRPNFSQITD 365
           +T GE PY  L+     +  +    R   P      + +L+ +CWQ +  +RP F+ I  
Sbjct: 244 MTYGERPYWELS-NHEVMKAINDGFRLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVS 302

Query: 366 ILKQMMK 372
           IL ++++
Sbjct: 303 ILDKLIR 309

>3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325

 Score =  260 bits (666), Expect = 8e-85
 Identities = 71/273 (26%), Positives = 137/273 (50%), Gaps = 13/273 (4%)

Query: 111 WEIDAKQLKIECKVASGSYGDLYKGTYCSQ------EVAIKVLKPECVNTEMLKEFSQEV 164
                 +L+    + SG +G ++KG +  +       V IKV++ +    +  +  +  +
Sbjct: 8   RIFKETELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKS-GRQSFQAVTDHM 66

Query: 165 YIMRKIRHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVS 224
             +  + H ++V+ +G C     L +VT+++  GS+ D + + +G      LL   + ++
Sbjct: 67  LAIGSLDHAHIVRLLGLCPGSS-LQLVTQYLPLGSLLDHVRQHRGALGPQLLLNWGVQIA 125

Query: 225 KGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAETGT---YRWMA 281
           KGM YL ++ ++HR+L   N+L+     V+VADFGVA +          +      +WMA
Sbjct: 126 KGMYYLEEHGMVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLYSEAKTPIKWMA 185

Query: 282 PEVIEHKPYDYKADVFSFGIALWELLT-GELPYAGLTPLQAAVGVVQKSLRPTIPKHAHP 340
            E I    Y +++DV+S+G+ +WEL+T G  PYAGL   +    +++K  R   P+    
Sbjct: 186 LESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGLRLAE-VPDLLEKGERLAQPQICTI 244

Query: 341 RLAELLERCWQHDPTQRPNFSQITDILKQMMKE 373
            +  ++ +CW  D   RP F ++ +   +M ++
Sbjct: 245 DVYMVMVKCWMIDENIRPTFKELANEFTRMARD 277

>3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327

 Score =  259 bits (665), Expect = 1e-84
 Identities = 78/271 (28%), Positives = 137/271 (50%), Gaps = 13/271 (4%)

Query: 113 IDAKQLKIECKVASGSYGDLYKGTYCSQ------EVAIKVLKPECVNTEMLKEFSQEVYI 166
           +   + K    + SG++G +YKG +  +       VAIK L+         KE   E Y+
Sbjct: 12  LKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKAN-KEILDEAYV 70

Query: 167 MRKIRHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKG 226
           M  + + +V + +G C     + ++T+ M  G + D++ + K       LL   + ++KG
Sbjct: 71  MASVDNPHVCRLLGICLTST-VQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKG 129

Query: 227 MNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVAR-VQAQSGVMTAETGTY--RWMAPE 283
           MNYL    ++HRDL   N+L+     VK+ DFG+A+ + A+     AE G    +WMA E
Sbjct: 130 MNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALE 189

Query: 284 VIEHKPYDYKADVFSFGIALWELLT-GELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRL 342
            I H+ Y +++DV+S+G+ +WEL+T G  PY G+   +    +++K  R   P      +
Sbjct: 190 SILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE-ISSILEKGERLPQPPICTIDV 248

Query: 343 AELLERCWQHDPTQRPNFSQITDILKQMMKE 373
             ++ +CW  D   RP F ++     +M ++
Sbjct: 249 YMIMRKCWMIDADSRPKFRELIIEFSKMARD 279

>2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373

 Score =  259 bits (664), Expect = 6e-84
 Identities = 88/278 (31%), Positives = 139/278 (50%), Gaps = 12/278 (4%)

Query: 109 DVWEIDAKQLKIECKVASGSYGDLYKGTY-----CSQEVAIKVLKPECVNTEMLKEFSQE 163
              E+DA  + I+  V +G +G++  G           VAIK LK      +  ++F  E
Sbjct: 38  FAKELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQ-RRDFLGE 96

Query: 164 VYIMRKIRHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDV 223
             IM +  H N+++  G  T+   + IVTE+M  GS+  FL K    F +  L+ +   +
Sbjct: 97  ASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGI 156

Query: 224 SKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVAR-VQAQSGVMTAETGT---YRW 279
           + GM YL     +HRDL   N+L++ N V KV+DFG+ R ++          G     RW
Sbjct: 157 ASGMKYLSDMGYVHRDLAARNILINSNLVCKVSDFGLGRVLEDDPEAAYTTRGGKIPIRW 216

Query: 280 MAPEVIEHKPYDYKADVFSFGIALWELLT-GELPYAGLTPLQAAVGVVQKSLRPTIPKHA 338
            +PE I ++ +   +DV+S+GI LWE+++ GE PY  ++  Q  +  V +  R   P   
Sbjct: 217 TSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMS-NQDVIKAVDEGYRLPPPMDC 275

Query: 339 HPRLAELLERCWQHDPTQRPNFSQITDILKQMMKEVAS 376
              L +L+  CWQ D   RP F QI  IL ++++   S
Sbjct: 276 PAALYQLMLDCWQKDRNNRPKFEQIVSILDKLIRNPGS 313

>1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454

 Score =  260 bits (666), Expect = 3e-83
 Identities = 94/275 (34%), Positives = 156/275 (56%), Gaps = 12/275 (4%)

Query: 109 DVWEIDAKQLKIECKVASGSYGDLYKGTY-CSQEVAIKVLKPECVNTEMLKEFSQEVYIM 167
           D WEI  + LK+E K+ +G +G+++  TY    +VA+K +KP    +  ++ F  E  +M
Sbjct: 181 DAWEIPRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKP---GSMSVEAFLAEANVM 237

Query: 168 RKIRHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKG-VFQLTSLLKVAIDVSKG 226
           + ++H  +V+     T+ P + I+TEFMA+GS+ DFL   +G    L  L+  +  +++G
Sbjct: 238 KTLQHDKLVKLHAVVTKEP-IYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEG 296

Query: 227 MNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAETGT---YRWMAPE 283
           M ++ Q N IHRDL+ AN+L+  + V K+ADFG+ARV  +    TA  G     +W APE
Sbjct: 297 MAFIEQRNYIHRDLRAANILVSASLVCKIADFGLARV-IEDNEYTAREGAKFPIKWTAPE 355

Query: 284 VIEHKPYDYKADVFSFGIALWELLT-GELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRL 342
            I    +  K+DV+SFGI L E++T G +PY G++     +  +++  R   P++    L
Sbjct: 356 AINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMS-NPEVIRALERGYRMPRPENCPEEL 414

Query: 343 AELLERCWQHDPTQRPNFSQITDILKQMMKEVASE 377
             ++ RCW++ P +RP F  I  +L        S+
Sbjct: 415 YNIMMRCWKNRPEERPTFEYIQSVLDDFYTATESQ 449

>3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295

 Score =  254 bits (650), Expect = 8e-83
 Identities = 72/297 (24%), Positives = 133/297 (44%), Gaps = 31/297 (10%)

Query: 107 GTDVWEIDAKQLKIECKVASGSYGDLYKGTY------CSQEVAIKVLKPECVNTEMLKEF 160
           G+D  + + + LK   ++  G++G +    Y        + VA+K L+        L++F
Sbjct: 1   GSDPTQFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEH--LRDF 58

Query: 161 SQEVYIMRKIRHKNVVQFIGACTRPPN--LCIVTEFMARGSIYDFLHKQKGVFQLTSLLK 218
            +E+ I++ ++H N+V++ G C       L ++ E++  GS+ D+L K K       LL+
Sbjct: 59  EREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQ 118

Query: 219 VAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVAR-VQAQSGVMTAETGT- 276
               + KGM YL     IHRDL T N+L++    VK+ DFG+ + +         +    
Sbjct: 119 YTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEFFKVKEPGE 178

Query: 277 --YRWMAPEVIEHKPYDYKADVFSFGIALWELLT----------------GELPYAGLTP 318
               W APE +    +   +DV+SFG+ L+EL T                G      +  
Sbjct: 179 SPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIV 238

Query: 319 LQAAVGVVQKSLRPTIPKHAHPRLAELLERCWQHDPTQRPNFSQITDILKQMMKEVA 375
               + +++ + R   P      +  ++  CW ++  QRP+F  +   + Q+   +A
Sbjct: 239 FH-LIELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRDNMA 294

>1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452

 Score =  258 bits (662), Expect = 2e-82
 Identities = 99/271 (36%), Positives = 154/271 (56%), Gaps = 12/271 (4%)

Query: 109 DVWEIDAKQLKIECKVASGSYGDLYKGTYCSQ-EVAIKVLKPECVNTEMLKEFSQEVYIM 167
           D WEI  + L++E K+  G +G+++ GT+     VAIK LKP    T   + F QE  +M
Sbjct: 177 DAWEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKP---GTMSPEAFLQEAQVM 233

Query: 168 RKIRHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKG-VFQLTSLLKVAIDVSKG 226
           +K+RH+ +VQ     +  P + IVTE+M++GS+ DFL  + G   +L  L+ +A  ++ G
Sbjct: 234 KKLRHEKLVQLYAVVSEEP-IYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASG 292

Query: 227 MNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAETGT---YRWMAPE 283
           M Y+ + N +HRDL+ AN+L+ EN V KVADFG+AR+  +    TA  G     +W APE
Sbjct: 293 MAYVERMNYVHRDLRAANILVGENLVCKVADFGLARL-IEDNEYTARQGAKFPIKWTAPE 351

Query: 284 VIEHKPYDYKADVFSFGIALWELLT-GELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRL 342
              +  +  K+DV+SFGI L EL T G +PY G+   +  +  V++  R   P      L
Sbjct: 352 AALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMV-NREVLDQVERGYRMPCPPECPESL 410

Query: 343 AELLERCWQHDPTQRPNFSQITDILKQMMKE 373
            +L+ +CW+ +P +RP F  +   L+     
Sbjct: 411 HDLMCQCWRKEPEERPTFEYLQAFLEDYFTS 441

>2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535

 Score =  260 bits (666), Expect = 3e-82
 Identities = 99/271 (36%), Positives = 154/271 (56%), Gaps = 12/271 (4%)

Query: 109 DVWEIDAKQLKIECKVASGSYGDLYKGTYCSQ-EVAIKVLKPECVNTEMLKEFSQEVYIM 167
           D WEI  + L++E K+  G +G+++ GT+     VAIK LKP    T   + F QE  +M
Sbjct: 260 DAWEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKP---GTMSPEAFLQEAQVM 316

Query: 168 RKIRHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKG-VFQLTSLLKVAIDVSKG 226
           +K+RH+ +VQ     +  P + IVTE+M++GS+ DFL  + G   +L  L+ +A  ++ G
Sbjct: 317 KKLRHEKLVQLYAVVSEEP-IYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASG 375

Query: 227 MNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAETGT---YRWMAPE 283
           M Y+ + N +HRDL+ AN+L+ EN V KVADFG+AR+  +    TA  G     +W APE
Sbjct: 376 MAYVERMNYVHRDLRAANILVGENLVCKVADFGLARL-IEDNEYTARQGAKFPIKWTAPE 434

Query: 284 VIEHKPYDYKADVFSFGIALWELLT-GELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRL 342
              +  +  K+DV+SFGI L EL T G +PY G+   +  +  V++  R   P      L
Sbjct: 435 AALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMV-NREVLDQVERGYRMPCPPECPESL 493

Query: 343 AELLERCWQHDPTQRPNFSQITDILKQMMKE 373
            +L+ +CW+ +P +RP F  +   L+     
Sbjct: 494 HDLMCQCWRKEPEERPTFEYLQAFLEDYFTS 524

>2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326

 Score =  253 bits (649), Expect = 3e-82
 Identities = 71/306 (23%), Positives = 134/306 (43%), Gaps = 31/306 (10%)

Query: 98  PNCIEIPTDGTDVWEIDAKQLKIECKVASGSYGDLYKGTY------CSQEVAIKVLKPEC 151
              +    +  D  + + + LK   ++  G++G +    Y        + VA+K L+   
Sbjct: 23  QGAMGSAFEDRDPTQFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHST 82

Query: 152 VNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPN--LCIVTEFMARGSIYDFLHKQKG 209
                L++F +E+ I++ ++H N+V++ G C       L ++ E++  GS+ D+L K K 
Sbjct: 83  EEH--LRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKE 140

Query: 210 VFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVAR-VQAQSG 268
                 LL+    + KGM YL     IHRDL T N+L++    VK+ DFG+ + +     
Sbjct: 141 RIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKE 200

Query: 269 VMTAETGT---YRWMAPEVIEHKPYDYKADVFSFGIALWELLT----------------G 309
               +        W APE +    +   +DV+SFG+ L+EL T                G
Sbjct: 201 YYKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIG 260

Query: 310 ELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRLAELLERCWQHDPTQRPNFSQITDILKQ 369
                 +      + +++ + R   P      +  ++  CW ++  QRP+F  +   + Q
Sbjct: 261 NDKQGQMIVFH-LIELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQ 319

Query: 370 MMKEVA 375
           +  ++A
Sbjct: 320 IRDQMA 325

>3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327

 Score =  253 bits (648), Expect = 5e-82
 Identities = 68/291 (23%), Positives = 124/291 (42%), Gaps = 28/291 (9%)

Query: 109 DVWEIDAKQLKIECKVASGSYGDLYKGTY------CSQEVAIKVLKPECVNTEMLKEFSQ 162
           D    + + LK   ++  G++G +    Y          VA+K L+      +  ++F +
Sbjct: 16  DPTIFEERHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSG--PDQQRDFQR 73

Query: 163 EVYIMRKIRHKNVVQFIGACTRP--PNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVA 220
           E+ I++ +    +V++ G    P   +L +V E++  G + DFL + +     + LL  +
Sbjct: 74  EIQILKALHSDFIVKYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRARLDASRLLLYS 133

Query: 221 IDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVAR-VQAQSGVMTAETGT--- 276
             + KGM YL     +HRDL   N+L++    VK+ADFG+A+ +                
Sbjct: 134 SQICKGMEYLGSRRCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQSP 193

Query: 277 YRWMAPEVIEHKPYDYKADVFSFGIALWELLT-GELPYAGLTPLQAAVGVVQKSLRPTI- 334
             W APE +    +  ++DV+SFG+ L+EL T  +   +        +G  +     +  
Sbjct: 194 IFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGCERDVPALSRL 253

Query: 335 ------------PKHAHPRLAELLERCWQHDPTQRPNFSQITDILKQMMKE 373
                       P      + EL++ CW   P  RP+FS +   L  +   
Sbjct: 254 LELLEEGQRLPAPPACPAEVHELMKLCWAPSPQDRPSFSALGPQLDMLWSG 304

>2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656

 Score =  261 bits (669), Expect = 2e-81
 Identities = 87/309 (28%), Positives = 154/309 (49%), Gaps = 15/309 (4%)

Query: 73  QDQSCSKRQPALGVPMHSKLLIESSPNCIEIPTDGTDVWEIDAKQLKIECKVASGSYGDL 132
           +    S          +++++ E       +P+     +EI  +++++   +  G +GD+
Sbjct: 351 KQGVRSHTVSVSETDDYAEIIDEEDTY--TMPST--RDYEIQRERIELGRCIGEGQFGDV 406

Query: 133 YKGTYCSQE-----VAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPN 187
           ++G Y S E     VAIK  K    +  + ++F QE   MR+  H ++V+ IG  T  P 
Sbjct: 407 HQGIYMSPENPAMAVAIKTCKNCT-SDSVREKFLQEALTMRQFDHPHIVKLIGVITENP- 464

Query: 188 LCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLM 247
           + I+ E    G +  FL  +K    L SL+  A  +S  + YL     +HRD+   N+L+
Sbjct: 465 VWIIMELCTLGELRSFLQVRKFSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLV 524

Query: 248 DENGVVKVADFGVARVQAQSGVMTAETGTY--RWMAPEVIEHKPYDYKADVFSFGIALWE 305
             N  VK+ DFG++R    S    A  G    +WMAPE I  + +   +DV+ FG+ +WE
Sbjct: 525 SSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWE 584

Query: 306 LLT-GELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRLAELLERCWQHDPTQRPNFSQIT 364
           +L  G  P+ G+      +G ++   R  +P +  P L  L+ +CW +DP++RP F+++ 
Sbjct: 585 ILMHGVKPFQGVKNND-VIGRIENGERLPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELK 643

Query: 365 DILKQMMKE 373
             L  +++E
Sbjct: 644 AQLSTILEE 652

>4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289

 Score =  249 bits (638), Expect = 5e-81
 Identities = 69/296 (23%), Positives = 123/296 (41%), Gaps = 35/296 (11%)

Query: 111 WEIDAKQLKIECKVASGSYGDLYKGTY---------CSQEVAIKVLKPECVNTEMLKEFS 161
            +I  + L     +  G++  ++KG              EV +KVL     N    + F 
Sbjct: 3   HKIRNEDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYS--ESFF 60

Query: 162 QEVYIMRKIRHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAI 221
           +   +M K+ HK++V   G C       +V EF+  GS+  +L K K    +   L+VA 
Sbjct: 61  EAASMMSKLSHKHLVLNYGVCVCGDENILVQEFVKFGSLDTYLKKNKNCINILWKLEVAK 120

Query: 222 DVSKGMNYLHQNNIIHRDLKTANLLMD--------ENGVVKVADFGVARVQAQSGVMTAE 273
            ++  M++L +N +IH ++   N+L+             +K++D G++            
Sbjct: 121 QLAAAMHFLEENTLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISIT-------VLP 173

Query: 274 TGTY----RWMAPEVIEH-KPYDYKADVFSFGIALWELLT-GELPYAGLTPLQAAVGVVQ 327
                    W+ PE IE+ K  +   D +SFG  LWE+ + G+ P + L   Q  +   +
Sbjct: 174 KDILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALD-SQRKLQFYE 232

Query: 328 KSLRPTIPKHAHPRLAELLERCWQHDPTQRPNFSQITDILKQMMKEVASEGENNHS 383
              +  +P      LA L+  C  ++P  RP+F  I   L  +         ++H 
Sbjct: 233 DRHQ--LPAPKAAELANLINNCMDYEPDHRPSFRAIIRDLNSLFTPDLVPRGSHHH 286

>4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302

 Score =  249 bits (637), Expect = 9e-81
 Identities = 76/296 (25%), Positives = 138/296 (46%), Gaps = 29/296 (9%)

Query: 104 PTDGTDVWEIDAKQLKIECKVASGSYGDLYKGTY------CSQEVAIKVLKPECVNTEML 157
           P    D    + + LK    +  G +G +    Y        ++VA+K LKPE      +
Sbjct: 9   PATEVDPTHFEKRFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPES-GGNHI 67

Query: 158 KEFSQEVYIMRKIRHKNVVQFIGACTRPPN--LCIVTEFMARGSIYDFLHKQKGVFQLTS 215
            +  +E+ I+R + H+N+V++ G CT      + ++ EF+  GS+ ++L K K    L  
Sbjct: 68  ADLKKEIEILRNLYHENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPKNKNKINLKQ 127

Query: 216 LLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVAR-VQAQSGVMTAET 274
            LK A+ + KGM+YL     +HRDL   N+L++    VK+ DFG+ + ++      T + 
Sbjct: 128 QLKYAVQICKGMDYLGSRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKD 187

Query: 275 GT---YRWMAPEVIEHKPYDYKADVFSFGIALWELLT---------------GELPYAGL 316
                  W APE +    +   +DV+SFG+ L ELLT                   +  +
Sbjct: 188 DRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTHGQM 247

Query: 317 TPLQAAVGVVQKSLRPTIPKHAHPRLAELLERCWQHDPTQRPNFSQITDILKQMMK 372
           T  +  V  +++  R   P +    + +L+ +CW+  P+ R +F  + +  + ++K
Sbjct: 248 TVTR-LVNTLKEGKRLPCPPNCPDEVYQLMRKCWEFQPSNRTSFQNLIEGFEALLK 302

>3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323

 Score =  248 bits (635), Expect = 3e-80
 Identities = 73/293 (24%), Positives = 138/293 (47%), Gaps = 21/293 (7%)

Query: 109 DVWEIDAKQLKIECKVASGSYGDLYKGTY-----CSQEVAIKVLKPECVNTEMLKEFSQE 163
           +   I  +Q  +   +  G +G + +           +VA+K+LK + + +  ++EF +E
Sbjct: 16  EDVLIPEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLRE 75

Query: 164 VYIMRKIRHKNVVQFIGACTR------PPNLCIVTEFMARGSIYDFL-----HKQKGVFQ 212
              M++  H +V + +G   R       P   ++  FM  G ++ FL      +      
Sbjct: 76  AACMKEFDHPHVAKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLP 135

Query: 213 LTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTA 272
           L +L++  +D++ GM YL   N IHRDL   N ++ E+  V VADFG++R          
Sbjct: 136 LQTLVRFMVDIACGMEYLSSRNFIHRDLAARNCMLAEDMTVCVADFGLSRKIYSGDYYRQ 195

Query: 273 ETGT---YRWMAPEVIEHKPYDYKADVFSFGIALWELLT-GELPYAGLTPLQAAVGVVQK 328
              +    +W+A E +    Y   +DV++FG+ +WE++T G+ PYAG+   +     +  
Sbjct: 196 GCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGIENAE-IYNYLIG 254

Query: 329 SLRPTIPKHAHPRLAELLERCWQHDPTQRPNFSQITDILKQMMKEVASEGENN 381
             R   P      + +L+ +CW  DP QRP+F+ +   L+ ++  ++    + 
Sbjct: 255 GNRLKQPPECMEEVYDLMYQCWSADPKQRPSFTCLRMELENILGHLSVLSTSQ 307

>1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313

 Score =  247 bits (633), Expect = 6e-80
 Identities = 85/308 (27%), Positives = 146/308 (47%), Gaps = 32/308 (10%)

Query: 99  NCIEIPTDGTDVWEIDAKQLKIECKVASGSYGDLYKGTYC-------SQEVAIKVLKPEC 151
           +  ++P D    WE    +L     + +G++G + + T         +  VA+K+LKP  
Sbjct: 8   DPTQLPYD--HKWEFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSA 65

Query: 152 VNTEMLKEFSQEVYIMRKI-RHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFL------ 204
             TE  +    E+ ++  +  H N+V  +GACT      ++TE+   G + +FL      
Sbjct: 66  HLTER-EALMSELKVLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDS 124

Query: 205 -----------HKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVV 253
                         +    L  LL  +  V+KGM +L   N IHRDL   N+L+    + 
Sbjct: 125 FICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLTHGRIT 184

Query: 254 KVADFGVARVQAQSGVMTAETGT---YRWMAPEVIEHKPYDYKADVFSFGIALWELLT-G 309
           K+ DFG+AR          +       +WMAPE I +  Y +++DV+S+GI LWEL + G
Sbjct: 185 KICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLG 244

Query: 310 ELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRLAELLERCWQHDPTQRPNFSQITDILKQ 369
             PY G+        ++++  R   P+HA   + ++++ CW  DP +RP F QI  ++++
Sbjct: 245 SSPYPGMPVDSKFYKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEK 304

Query: 370 MMKEVASE 377
            + E  + 
Sbjct: 305 QISESTNH 312

>3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313

 Score =  247 bits (633), Expect = 6e-80
 Identities = 75/283 (26%), Positives = 132/283 (46%), Gaps = 20/283 (7%)

Query: 109 DVWEIDAKQLKIECKVASGSYGDLYKGTY-----CSQEVAIKVLKPECVNTEMLKEFSQE 163
           +   ID   L +   +  G +G + +G        S +VA+K +K +  +   ++EF  E
Sbjct: 27  EDVVIDRNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSE 86

Query: 164 VYIMRKIRHKNVVQFIGACTR-----PPNLCIVTEFMARGSIYDFL-----HKQKGVFQL 213
              M+   H NV++ +G C        P   ++  FM  G ++ +L             L
Sbjct: 87  AACMKDFSHPNVIRLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPL 146

Query: 214 TSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAE 273
            +LLK  +D++ GM YL   N +HRDL   N ++ ++  V VADFG+++           
Sbjct: 147 QTLLKFMVDIALGMEYLSNRNFLHRDLAARNCMLRDDMTVCVADFGLSKKIYSGDYYRQG 206

Query: 274 TGT---YRWMAPEVIEHKPYDYKADVFSFGIALWELLT-GELPYAGLTPLQAAVGVVQKS 329
                  +W+A E +  + Y  K+DV++FG+ +WE+ T G  PY G+   +     +   
Sbjct: 207 RIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTPYPGVQNHE-MYDYLLHG 265

Query: 330 LRPTIPKHAHPRLAELLERCWQHDPTQRPNFSQITDILKQMMK 372
            R   P+     L E++  CW+ DP  RP FS +   L+++++
Sbjct: 266 HRLKQPEDCLDELYEIMYSCWRTDPLDRPTFSVLRLQLEKLLE 308

>3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327

 Score =  248 bits (634), Expect = 7e-80
 Identities = 80/283 (28%), Positives = 140/283 (49%), Gaps = 16/283 (5%)

Query: 102 EIPTDGTDVWE-IDAKQLKIECKVASGSYGDLYKGTYCSQ------EVAIKVLKPECVNT 154
           E P     +   +   + K    + SG++G +YKG +  +       VAIK L+      
Sbjct: 2   EAPNQA--LLRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPK 59

Query: 155 EMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLT 214
              KE   E Y+M  + + +V + +G C     + ++T+ M  G + D++ + K      
Sbjct: 60  AN-KEILDEAYVMASVDNPHVCRLLGICLTST-VQLITQLMPFGCLLDYVREHKDNIGSQ 117

Query: 215 SLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVAR-VQAQSGVMTAE 273
            LL   + ++KGMNYL    ++HRDL   N+L+     VK+ DFG+A+ + A+     AE
Sbjct: 118 YLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAE 177

Query: 274 TGTY--RWMAPEVIEHKPYDYKADVFSFGIALWELLT-GELPYAGLTPLQAAVGVVQKSL 330
            G    +WMA E I H+ Y +++DV+S+G+ +WEL+T G  PY G+   +    +++K  
Sbjct: 178 GGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE-ISSILEKGE 236

Query: 331 RPTIPKHAHPRLAELLERCWQHDPTQRPNFSQITDILKQMMKE 373
           R   P      +  ++ +CW  D   RP F ++     +M ++
Sbjct: 237 RLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARD 279

>3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298

 Score =  245 bits (627), Expect = 3e-79
 Identities = 76/280 (27%), Positives = 126/280 (45%), Gaps = 14/280 (5%)

Query: 110 VWEIDAKQLKIECKVASGSYGDLYKGTYCS-----QEVAIKVLKPECVNTEMLKEFSQEV 164
           V    +  +     +  G +G +Y GT           A+K L     +   + +F  E 
Sbjct: 19  VIGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRIT-DIGEVSQFLTEG 77

Query: 165 YIMRKIRHKNVVQFIGACTRP-PNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDV 223
            IM+   H NV+  +G C R   +  +V  +M  G + +F+  +     +  L+   + V
Sbjct: 78  IIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQV 137

Query: 224 SKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAETGTY-----R 278
           +KGM YL     +HRDL   N ++DE   VKVADFG+AR        +    T      +
Sbjct: 138 AKGMKYLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVK 197

Query: 279 WMAPEVIEHKPYDYKADVFSFGIALWELLT-GELPYAGLTPLQAAVGVVQKSLRPTIPKH 337
           WMA E ++ + +  K+DV+SFG+ LWEL+T G  PY  +         + +  R   P++
Sbjct: 198 WMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFD-ITVYLLQGRRLLQPEY 256

Query: 338 AHPRLAELLERCWQHDPTQRPNFSQITDILKQMMKEVASE 377
               L E++ +CW      RP+FS++   +  +      E
Sbjct: 257 CPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTFIGE 296

>3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318

 Score =  245 bits (627), Expect = 5e-79
 Identities = 77/310 (24%), Positives = 138/310 (44%), Gaps = 31/310 (10%)

Query: 95  ESSPNCIEIPTDGTDVWEIDAKQLKIECKVASGSYGDLYKGTY------CSQEVAIKVLK 148
                   +     D      + LK    +  G +G +    Y        + VA+K LK
Sbjct: 10  HHHGALEVLFQGPGDPTVFHKRYLKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALK 69

Query: 149 PECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRP--PNLCIVTEFMARGSIYDFLHK 206
            +    +    + QE+ I+R + H++++++ G C      +L +V E++  GS+ D+L +
Sbjct: 70  ADA-GPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDAGAASLQLVMEYVPLGSLRDYLPR 128

Query: 207 QKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVAR-VQA 265
                 L  LL  A  + +GM YLH  + IHRDL   N+L+D + +VK+ DFG+A+ V  
Sbjct: 129 HS--IGLAQLLLFAQQICEGMAYLHAQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPE 186

Query: 266 QSGVMTAETGT---YRWMAPEVIEHKPYDYKADVFSFGIALWELLT-------------- 308
                           W APE ++   + Y +DV+SFG+ L+ELLT              
Sbjct: 187 GHEYYRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLE 246

Query: 309 -GELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRLAELLERCWQHDPTQRPNFSQITDIL 367
              +    +T L+    ++++  R   P      +  L++ CW+ + + RP F  +  IL
Sbjct: 247 LIGIAQGQMTVLR-LTELLERGERLPRPDKCPAEVYHLMKNCWETEASFRPTFENLIPIL 305

Query: 368 KQMMKEVASE 377
           K + ++   +
Sbjct: 306 KTVHEKYQGQ 315

>1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322

 Score =  245 bits (627), Expect = 7e-79
 Identities = 80/295 (27%), Positives = 143/295 (48%), Gaps = 22/295 (7%)

Query: 109 DVWEIDAKQLKIECKVASGSYGDLYKGTY-------CSQEVAIKVLKPECVNTEMLKEFS 161
           D WE+  +++ +  ++  GS+G +Y+G             VAIK +     +     EF 
Sbjct: 18  DEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAA-SMRERIEFL 76

Query: 162 QEVYIMRKIRHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFL---------HKQKGVFQ 212
            E  +M++    +VV+ +G  ++     ++ E M RG +  +L         +       
Sbjct: 77  NEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPS 136

Query: 213 LTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTA 272
           L+ ++++A +++ GM YL+ N  +HRDL   N ++ E+  VK+ DFG+ R   ++     
Sbjct: 137 LSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRK 196

Query: 273 ETGTY---RWMAPEVIEHKPYDYKADVFSFGIALWELLT-GELPYAGLTPLQAAVGVVQK 328
                   RWM+PE ++   +   +DV+SFG+ LWE+ T  E PY GL+  Q  +  V +
Sbjct: 197 GGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQ-VLRFVME 255

Query: 329 SLRPTIPKHAHPRLAELLERCWQHDPTQRPNFSQITDILKQMMKEVASEGENNHS 383
                 P +    L EL+  CWQ++P  RP+F +I   +K+ M+    E    +S
Sbjct: 256 GGLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEMEPGFREVSFYYS 310

>2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314

 Score =  244 bits (625), Expect = 1e-78
 Identities = 81/311 (26%), Positives = 149/311 (47%), Gaps = 38/311 (12%)

Query: 97  SPNCIEIPTDGTDVWEIDAKQLKIECKVASGSYGDLYKGTYC-------SQEVAIKVLKP 149
           S +  +I  D    WE   K L +   +  G +G + K T            VA+K+LK 
Sbjct: 6   SVDAFKILED--PKWEFPRKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKE 63

Query: 150 ECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFL----- 204
               +E+ ++   E  +++++ H +V++  GAC++   L ++ E+   GS+  FL     
Sbjct: 64  NASPSEL-RDLLSEFNVLKQVNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRK 122

Query: 205 ------------------HKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLL 246
                             H  +    +  L+  A  +S+GM YL +  ++HRDL   N+L
Sbjct: 123 VGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEMKLVHRDLAARNIL 182

Query: 247 MDENGVVKVADFGVARVQAQSGVMTAETGT---YRWMAPEVIEHKPYDYKADVFSFGIAL 303
           + E   +K++DFG++R   +       +      +WMA E +    Y  ++DV+SFG+ L
Sbjct: 183 VAEGRKMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLL 242

Query: 304 WELLT-GELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRLAELLERCWQHDPTQRPNFSQ 362
           WE++T G  PY G+ P +    +++   R   P +    +  L+ +CW+ +P +RP F+ 
Sbjct: 243 WEIVTLGGNPYPGIPPER-LFNLLKTGHRMERPDNCSEEMYRLMLQCWKQEPDKRPVFAD 301

Query: 363 ITDILKQMMKE 373
           I+  L++MM +
Sbjct: 302 ISKDLEKMMVK 312

>3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298

 Score =  243 bits (623), Expect = 1e-78
 Identities = 75/281 (26%), Positives = 133/281 (47%), Gaps = 16/281 (5%)

Query: 111 WEI--DAKQLKIECKVASGSYGDLYKGTYC-----SQEVAIKVLKPECVNTEMLKEFSQE 163
             I  +      +  +  G +G +Y G Y        + AIK L       ++ + F +E
Sbjct: 14  VLIPHERVVTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQV-EAFLRE 72

Query: 164 VYIMRKIRHKNVVQFIGACTRP-PNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAID 222
             +MR + H NV+  IG    P     ++  +M  G +  F+   +    +  L+   + 
Sbjct: 73  GLLMRGLNHPNVLALIGIMLPPEGLPHVLLPYMCHGDLLQFIRSPQRNPTVKDLISFGLQ 132

Query: 223 VSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAETGTY----- 277
           V++GM YL +   +HRDL   N ++DE+  VKVADFG+AR        + +   +     
Sbjct: 133 VARGMEYLAEQKFVHRDLAARNCMLDESFTVKVADFGLARDILDREYYSVQQHRHARLPV 192

Query: 278 RWMAPEVIEHKPYDYKADVFSFGIALWELLT-GELPYAGLTPLQAAVGVVQKSLRPTIPK 336
           +W A E ++   +  K+DV+SFG+ LWELLT G  PY  + P       + +  R   P+
Sbjct: 193 KWTALESLQTYRFTTKSDVWSFGVLLWELLTRGAPPYRHIDPFD-LTHFLAQGRRLPQPE 251

Query: 337 HAHPRLAELLERCWQHDPTQRPNFSQITDILKQMMKEVASE 377
           +    L +++++CW+ DP  RP F  +   ++Q++  +  +
Sbjct: 252 YCPDSLYQVMQQCWEADPAVRPTFRVLVGEVEQIVSALLGD 292

>3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373

 Score =  245 bits (627), Expect = 3e-78
 Identities = 80/319 (25%), Positives = 138/319 (43%), Gaps = 16/319 (5%)

Query: 71  AMQDQSCSKRQPALGVPMHSKLLIESSPNCIEIPTDGTDVWEIDAKQLKIECKVASGSYG 130
           ++  ++ S+     G       L   +P  ++       V    +  +     +  G +G
Sbjct: 46  SLYKKAGSENLYFQGANTVHIDLSALNPELVQAVQH--VVIGPSSLIVHFNEVIGRGHFG 103

Query: 131 DLYKGTYCS-----QEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRP 185
            +Y GT           A+K L       E+  +F  E  IM+   H NV+  +G C R 
Sbjct: 104 CVYHGTLLDNDGKKIHCAVKSLNRITDIGEV-SQFLTEGIIMKDFSHPNVLSLLGICLRS 162

Query: 186 -PNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTAN 244
             +  +V  +M  G + +F+  +     +  L+   + V+KGM +L     +HRDL   N
Sbjct: 163 EGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARN 222

Query: 245 LLMDENGVVKVADFGVARVQAQSGVMTAETGTY-----RWMAPEVIEHKPYDYKADVFSF 299
            ++DE   VKVADFG+AR        +    T      +WMA E ++ + +  K+DV+SF
Sbjct: 223 CMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSF 282

Query: 300 GIALWELLT-GELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRLAELLERCWQHDPTQRP 358
           G+ LWEL+T G  PY  +         + +  R   P++    L E++ +CW      RP
Sbjct: 283 GVLLWELMTRGAPPYPDVNTFD-ITVYLLQGRRLLQPEYCPDPLYEVMLKCWHPKAEMRP 341

Query: 359 NFSQITDILKQMMKEVASE 377
           +FS++   +  +      E
Sbjct: 342 SFSELVSRISAIFSTFIGE 360

>2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316

 Score =  242 bits (621), Expect = 4e-78
 Identities = 87/312 (27%), Positives = 146/312 (46%), Gaps = 30/312 (9%)

Query: 94  IESSPNCIEIPTDGTDVWEIDAKQLKIECKVASGSYGDLYKGTY-------CSQEVAIKV 146
           +    +C  +P D    WE    +LK+   +  G++G + +            + VA+K+
Sbjct: 6   LPLDEHCERLPYD-ASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKM 64

Query: 147 LKPECVNTEMLKEFSQEVYIMRKI-RHKNVVQFIGACTRPPN-LCIVTEFMARGSIYDFL 204
           LK         +    E+ I+  I  H NVV  +GACT+P   L ++ EF   G++  +L
Sbjct: 65  LKEGA-THSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYL 123

Query: 205 ---------------HKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDE 249
                             K    L  L+  +  V+KGM +L     IHRDL   N+L+ E
Sbjct: 124 RSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSE 183

Query: 250 NGVVKVADFGVARVQAQSGVMTAETGT---YRWMAPEVIEHKPYDYKADVFSFGIALWEL 306
             VVK+ DFG+AR   +      +       +WMAPE I  + Y  ++DV+SFG+ LWE+
Sbjct: 184 KNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEI 243

Query: 307 LT-GELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRLAELLERCWQHDPTQRPNFSQITD 365
            + G  PY G+   +     +++  R   P +  P + + +  CW  +P+QRP FS++ +
Sbjct: 244 FSLGASPYPGVKIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVE 303

Query: 366 ILKQMMKEVASE 377
            L  +++  A +
Sbjct: 304 HLGNLLQANAQQ 315

>3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297

 Score =  242 bits (619), Expect = 5e-78
 Identities = 79/293 (26%), Positives = 141/293 (48%), Gaps = 29/293 (9%)

Query: 106 DGTDVWEIDAKQLKIECKVASGSYGDLYKGTY-------CSQEVAIKVLKPECVNTEMLK 158
            G  V  I  + + ++ ++  G++G ++               VA+K LK   +     K
Sbjct: 5   SGIHVQHIKRRDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAAR--K 62

Query: 159 EFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFL-------------- 204
           +F +E  ++  ++H+++V+F G C     L +V E+M  G +  FL              
Sbjct: 63  DFQREAELLTNLQHEHIVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQ 122

Query: 205 -HKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARV 263
             + KG   L+ +L +A  ++ GM YL   + +HRDL T N L+  N +VK+ DFG++R 
Sbjct: 123 PRQAKGELGLSQMLHIASQIASGMVYLASQHFVHRDLATRNCLVGANLLVKIGDFGMSRD 182

Query: 264 QAQSGVMTAETGTY---RWMAPEVIEHKPYDYKADVFSFGIALWELLT-GELPYAGLTPL 319
              +        T    RWM PE I ++ +  ++DV+SFG+ LWE+ T G+ P+  L+  
Sbjct: 183 VYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSNT 242

Query: 320 QAAVGVVQKSLRPTIPKHAHPRLAELLERCWQHDPTQRPNFSQITDILKQMMK 372
           +  +  + +      P+     + +++  CWQ +P QR N  +I  IL  + K
Sbjct: 243 E-VIECITQGRVLERPRVCPKEVYDVMLGCWQREPQQRLNIKEIYKILHALGK 294

>2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370

 Score =  244 bits (625), Expect = 5e-78
 Identities = 82/305 (26%), Positives = 147/305 (48%), Gaps = 33/305 (10%)

Query: 102 EIPTDGTDVWEIDAKQLKIECKVASGSYGDLYKGTYC---------SQEVAIKVLKPECV 152
           E+P D    WE    +L +   +  G +G +               +  VA+K+LK +  
Sbjct: 69  ELPED--PKWEFPRDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDA- 125

Query: 153 NTEMLKEFSQEVYIMRKI-RHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFL------- 204
             + L +   E+ +M+ I +HKN++  +GACT+   L ++ E+ ++G++ ++L       
Sbjct: 126 TEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPG 185

Query: 205 --------HKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVA 256
                      +       L+     +++GM YL     IHRDL   N+L+ EN V+K+A
Sbjct: 186 MEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIA 245

Query: 257 DFGVARVQAQSGVMTAETGT---YRWMAPEVIEHKPYDYKADVFSFGIALWELLT-GELP 312
           DFG+AR           T      +WMAPE +  + Y +++DV+SFG+ +WE+ T G  P
Sbjct: 246 DFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSP 305

Query: 313 YAGLTPLQAAVGVVQKSLRPTIPKHAHPRLAELLERCWQHDPTQRPNFSQITDILKQMMK 372
           Y G+   +    ++++  R   P +    L  ++  CW   P+QRP F Q+ + L +++ 
Sbjct: 306 YPGIPVEE-LFKLLKEGHRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILT 364

Query: 373 EVASE 377
              +E
Sbjct: 365 LTTNE 369

>2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334

 Score =  242 bits (621), Expect = 7e-78
 Identities = 82/305 (26%), Positives = 148/305 (48%), Gaps = 33/305 (10%)

Query: 102 EIPTDGTDVWEIDAKQLKIECKVASGSYGDLYKGTYC---------SQEVAIKVLKPECV 152
           E+P D    WE    +L +   +  G++G +               +  VA+K+LK +  
Sbjct: 23  ELPED--PKWEFPRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDA- 79

Query: 153 NTEMLKEFSQEVYIMRKI-RHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFL------- 204
             + L +   E+ +M+ I +HKN++  +GACT+   L ++ E+ ++G++ ++L       
Sbjct: 80  TEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPG 139

Query: 205 --------HKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVA 256
                      +       L+     +++GM YL     IHRDL   N+L+ EN V+K+A
Sbjct: 140 MEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIA 199

Query: 257 DFGVARVQAQSGVMTAETGT---YRWMAPEVIEHKPYDYKADVFSFGIALWELLT-GELP 312
           DFG+AR           T      +WMAPE +  + Y +++DV+SFG+ +WE+ T G  P
Sbjct: 200 DFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSP 259

Query: 313 YAGLTPLQAAVGVVQKSLRPTIPKHAHPRLAELLERCWQHDPTQRPNFSQITDILKQMMK 372
           Y G+   +    ++++  R   P +    L  ++  CW   P+QRP F Q+ + L +++ 
Sbjct: 260 YPGIPVEE-LFKLLKEGHRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILT 318

Query: 373 EVASE 377
              +E
Sbjct: 319 LTTNE 323

>2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333

 Score =  242 bits (620), Expect = 9e-78
 Identities = 83/304 (27%), Positives = 143/304 (47%), Gaps = 28/304 (9%)

Query: 99  NCIEIPTDGTDVWEIDAKQLKIECKVASGSYGDLYKGTY-------CSQEVAIKVLKPEC 151
           +  ++P +  + WE     L+    + +G++G + + T           +VA+K+LK   
Sbjct: 31  DPTQLPYN--EKWEFPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTA 88

Query: 152 VNTEMLKEFSQEVYIMRKI-RHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGV 210
              E  +    E+ IM  + +H+N+V  +GACT    + ++TE+   G + +FL ++  V
Sbjct: 89  HADEK-EALMSELKIMSHLGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRV 147

Query: 211 FQ-------------LTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVAD 257
            +                LL  +  V++GM +L   N IHRD+   N+L+    V K+ D
Sbjct: 148 LETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASKNCIHRDVAARNVLLTNGHVAKIGD 207

Query: 258 FGVARVQAQSGVMTAETGT---YRWMAPEVIEHKPYDYKADVFSFGIALWELLT-GELPY 313
           FG+AR          +       +WMAPE I    Y  ++DV+S+GI LWE+ + G  PY
Sbjct: 208 FGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPY 267

Query: 314 AGLTPLQAAVGVVQKSLRPTIPKHAHPRLAELLERCWQHDPTQRPNFSQITDILKQMMKE 373
            G+        +V+   +   P  A   +  +++ CW  +PT RP F QI   L++  +E
Sbjct: 268 PGILVNSKFYKLVKDGYQMAQPAFAPKNIYSIMQACWALEPTHRPTFQQICSFLQEQAQE 327

Query: 374 VASE 377
              E
Sbjct: 328 DRRE 331

>4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329

 Score =  242 bits (619), Expect = 1e-77
 Identities = 84/322 (26%), Positives = 145/322 (45%), Gaps = 32/322 (9%)

Query: 76  SCSKRQPALGVPMHSKLLIESSPNCIEIPTDGTDVWEIDAKQLKIECKVASGSYGDLYKG 135
           S S   P  G     +  I  +P           V  I  + + ++ ++  G++G ++  
Sbjct: 5   SGSSLSPTEGKGSGLQGHIIENPQYFSDA----CVHHIKRRDIVLKWELGEGAFGKVFLA 60

Query: 136 TY-------CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNL 188
                        VA+K LK         ++F +E  ++  ++H+++V+F G CT    L
Sbjct: 61  ECHNLLPEQDKMLVAVKALKEAS--ESARQDFQREAELLTMLQHQHIVRFFGVCTEGRPL 118

Query: 189 CIVTEFMARGSIYDFL--------------HKQKGVFQLTSLLKVAIDVSKGMNYLHQNN 234
            +V E+M  G +  FL                  G   L  LL VA  V+ GM YL   +
Sbjct: 119 LMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLH 178

Query: 235 IIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAETGTY---RWMAPEVIEHKPYD 291
            +HRDL T N L+ +  VVK+ DFG++R    +        T    RWM PE I ++ + 
Sbjct: 179 FVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFT 238

Query: 292 YKADVFSFGIALWELLT-GELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRLAELLERCW 350
            ++DV+SFG+ LWE+ T G+ P+  L+  + A+  + +      P+   P +  ++  CW
Sbjct: 239 TESDVWSFGVVLWEIFTYGKQPWYQLSNTE-AIDCITQGRELERPRACPPEVYAIMRGCW 297

Query: 351 QHDPTQRPNFSQITDILKQMMK 372
           Q +P QR +   +   L+ + +
Sbjct: 298 QREPQQRHSIKDVHARLQALAQ 319

>2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613

 Score =  249 bits (638), Expect = 2e-77
 Identities = 77/320 (24%), Positives = 146/320 (45%), Gaps = 20/320 (6%)

Query: 77  CSKRQPALGVPMHSKLLIESSPNCIEIPTDGTDVWEIDAKQLKI--------ECKVASGS 128
                P                +     +  +D  E+  K+L +        + ++  G+
Sbjct: 289 SDGYTPEPARITSPDKPRPMPMDTSVFESPFSDPEELKDKKLFLKRDNLLIADIELGCGN 348

Query: 129 YGDLYKGTYCSQ----EVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTR 184
           +G + +G Y  +    +VAIKVLK         +E  +E  IM ++ +  +V+ IG C  
Sbjct: 349 FGSVRQGVYRMRKKQIDVAIKVLKQGTEK-ADTEEMMREAQIMHQLDNPYIVRLIGVCQA 407

Query: 185 PPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTAN 244
              L +V E    G ++ FL  ++    ++++ ++   VS GM YL + N +HR+L   N
Sbjct: 408 EA-LMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRNLAARN 466

Query: 245 LLMDENGVVKVADFGVAR-VQAQSGVMTAETGT---YRWMAPEVIEHKPYDYKADVFSFG 300
           +L+      K++DFG+++ + A     TA +      +W APE I  + +  ++DV+S+G
Sbjct: 467 VLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYG 526

Query: 301 IALWELLT-GELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRLAELLERCWQHDPTQRPN 359
           + +WE L+ G+ PY  +      +  +++  R   P    P L  L+  CW +    RP+
Sbjct: 527 VTMWEALSYGQKPYKKMK-GPEVMAFIEQGKRMECPPECPPELYALMSDCWIYKWEDRPD 585

Query: 360 FSQITDILKQMMKEVASEGE 379
           F  +   ++     +AS+ E
Sbjct: 586 FLTVEQRMRACYYSLASKVE 605

>2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327

 Score =  241 bits (617), Expect = 2e-77
 Identities = 80/285 (28%), Positives = 134/285 (47%), Gaps = 22/285 (7%)

Query: 109 DVWEIDAKQLKIECKVASGSYGDLYKGTY-------CSQEVAIKVLKPECVNTEMLKEFS 161
           D+ E+  K + +   +  G++G++Y+G            +VA+K L   C + +   +F 
Sbjct: 23  DLKEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVC-SEQDELDFL 81

Query: 162 QEVYIMRKIRHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFL------HKQKGVFQLTS 215
            E  I+ K  H+N+V+ IG   +     I+ E MA G +  FL        Q     +  
Sbjct: 82  MEALIISKFNHQNIVRCIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLD 141

Query: 216 LLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMD---ENGVVKVADFGVARVQAQSGVMTA 272
           LL VA D++ G  YL +N+ IHRD+   N L+       V K+ DFG+AR   ++     
Sbjct: 142 LLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRK 201

Query: 273 ETGTY---RWMAPEVIEHKPYDYKADVFSFGIALWELLT-GELPYAGLTPLQAAVGVVQK 328
                   +WM PE      +  K D +SFG+ LWE+ + G +PY   +  +  +  V  
Sbjct: 202 GGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQE-VLEFVTS 260

Query: 329 SLRPTIPKHAHPRLAELLERCWQHDPTQRPNFSQITDILKQMMKE 373
             R   PK+    +  ++ +CWQH P  RPNF+ I + ++   ++
Sbjct: 261 GGRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQD 305

>3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289

 Score =  239 bits (613), Expect = 3e-77
 Identities = 70/287 (24%), Positives = 130/287 (45%), Gaps = 28/287 (9%)

Query: 110 VWEIDAKQLKIECKVASGSYGDLYKGTY-------CSQEVAIKVLKPECVNTEMLKEFSQ 162
           + EI    ++   ++    +G +YKG          +Q VAIK LK +     + +EF  
Sbjct: 3   LKEISLSAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKA-EGPLREEFRH 61

Query: 163 EVYIMRKIRHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFL---------------HKQ 207
           E  +  +++H NVV  +G  T+   L ++  + + G +++FL                  
Sbjct: 62  EAMLRARLQHPNVVCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTV 121

Query: 208 KGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQS 267
           K   +    + +   ++ GM YL  ++++H+DL T N+L+ +   VK++D G+ R    +
Sbjct: 122 KSALEPPDFVHLVAQIAAGMEYLSSHHVVHKDLATRNVLVYDKLNVKISDLGLFREVYAA 181

Query: 268 GVMTAETGTY---RWMAPEVIEHKPYDYKADVFSFGIALWELLT-GELPYAGLTPLQAAV 323
                   +    RWMAPE I +  +   +D++S+G+ LWE+ + G  PY G +     V
Sbjct: 182 DYYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQD-VV 240

Query: 324 GVVQKSLRPTIPKHAHPRLAELLERCWQHDPTQRPNFSQITDILKQM 370
            +++       P      +  L+  CW   P++RP F  I   L+  
Sbjct: 241 EMIRNRQVLPCPDDCPAWVYALMIECWNEFPSRRPRFKDIHSRLRAW 287

>1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344

 Score =  241 bits (618), Expect = 3e-77
 Identities = 83/315 (26%), Positives = 142/315 (45%), Gaps = 37/315 (11%)

Query: 97  SPNCIEIPTDGTDVWEIDAKQLKIECKVASGSYGDLYKGTYC-------SQEVAIKVLKP 149
             +  E   D    WE   + L+    + SG++G +   T         S +VA+K+LK 
Sbjct: 28  YVDFREYEYD--LKWEFPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKE 85

Query: 150 ECVNTEMLKEFSQEVYIMRKI-RHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQK 208
           +  ++E  +    E+ +M ++  H+N+V  +GACT    + ++ E+   G + ++L  ++
Sbjct: 86  KADSSER-EALMSELKMMTQLGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKR 144

Query: 209 GVF--------------------QLTS--LLKVAIDVSKGMNYLHQNNIIHRDLKTANLL 246
             F                     LT   LL  A  V+KGM +L   + +HRDL   N+L
Sbjct: 145 EKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAARNVL 204

Query: 247 MDENGVVKVADFGVARVQAQSGVMTAETGT---YRWMAPEVIEHKPYDYKADVFSFGIAL 303
           +    VVK+ DFG+AR                  +WMAPE +    Y  K+DV+S+GI L
Sbjct: 205 VTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILL 264

Query: 304 WELLT-GELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRLAELLERCWQHDPTQRPNFSQ 362
           WE+ + G  PY G+        ++Q   +   P +A   +  +++ CW  D  +RP+F  
Sbjct: 265 WEIFSLGVNPYPGIPVDANFYKLIQNGFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPN 324

Query: 363 ITDILKQMMKEVASE 377
           +T  L   + +    
Sbjct: 325 LTSFLGCQLADAEEA 339

>3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382

 Score =  243 bits (621), Expect = 3e-77
 Identities = 84/329 (25%), Positives = 155/329 (47%), Gaps = 33/329 (10%)

Query: 78  SKRQPALGVPMHSKLLIESSPNCIEIPTDGTDVWEIDAKQLKIECKVASGSYGDLYKGTY 137
                           + +  +  E+P D    WE+   +L +   +  G++G +     
Sbjct: 33  HHDYDIPTTENLYFQGMLAGVSEYELPED--PRWELPRDRLVLGKPLGEGAFGQVVLAEA 90

Query: 138 ---------CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKI-RHKNVVQFIGACTRPPN 187
                       +VA+K+LK +    + L +   E+ +M+ I +HKN++  +GACT+   
Sbjct: 91  IGLDKDKPNRVTKVAVKMLKSDATEKD-LSDLISEMEMMKMIGKHKNIINLLGACTQDGP 149

Query: 188 LCIVTEFMARGSIYDFL---------------HKQKGVFQLTSLLKVAIDVSKGMNYLHQ 232
           L ++ E+ ++G++ ++L               H  +       L+  A  V++GM YL  
Sbjct: 150 LYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLAS 209

Query: 233 NNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAETGT---YRWMAPEVIEHKP 289
              IHRDL   N+L+ E+ V+K+ADFG+AR           T      +WMAPE +  + 
Sbjct: 210 KKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRI 269

Query: 290 YDYKADVFSFGIALWELLT-GELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRLAELLER 348
           Y +++DV+SFG+ LWE+ T G  PY G+   +    ++++  R   P +    L  ++  
Sbjct: 270 YTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEE-LFKLLKEGHRMDKPSNCTNELYMMMRD 328

Query: 349 CWQHDPTQRPNFSQITDILKQMMKEVASE 377
           CW   P+QRP F Q+ + L +++   +++
Sbjct: 329 CWHAVPSQRPTFKQLVEDLDRIVALTSNQ 357

>1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327

 Score =  240 bits (614), Expect = 7e-77
 Identities = 85/295 (28%), Positives = 144/295 (48%), Gaps = 29/295 (9%)

Query: 106 DGTDVWEIDAKQLKIECKVASGSYGDLYKGTYC----SQEVAIKVLKPECVNTEMLKEFS 161
           D T    +D   +K +  +  G++G + K          + AIK +K      +  ++F+
Sbjct: 15  DPTIYPVLDWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDH-RDFA 73

Query: 162 QEVYIMRKI-RHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFL---------------H 205
            E+ ++ K+  H N++  +GAC     L +  E+   G++ DFL               +
Sbjct: 74  GELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIAN 133

Query: 206 KQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQA 265
                     LL  A DV++GM+YL Q   IHRDL   N+L+ EN V K+ADFG++R   
Sbjct: 134 STASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSR--- 190

Query: 266 QSGVMTAETGT---YRWMAPEVIEHKPYDYKADVFSFGIALWELLT-GELPYAGLTPLQA 321
              V   +T      RWMA E + +  Y   +DV+S+G+ LWE+++ G  PY G+T    
Sbjct: 191 GQEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTC-AE 249

Query: 322 AVGVVQKSLRPTIPKHAHPRLAELLERCWQHDPTQRPNFSQITDILKQMMKEVAS 376
               + +  R   P +    + +L+ +CW+  P +RP+F+QI   L +M++E  +
Sbjct: 250 LYEKLPQGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEERKT 304

>3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367

 Score =  241 bits (616), Expect = 1e-76
 Identities = 82/285 (28%), Positives = 137/285 (48%), Gaps = 22/285 (7%)

Query: 109 DVWEIDAKQLKIECKVASGSYGDLYKGTY-------CSQEVAIKVLKPECVNTEMLKEFS 161
           D+ E+  K + +   +  G++G++Y+G            +VA+K L   C + +   +F 
Sbjct: 64  DLKEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVC-SEQDELDFL 122

Query: 162 QEVYIMRKIRHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHK------QKGVFQLTS 215
            E  I+ K  H+N+V+ IG   +     I+ E MA G +  FL +      Q     +  
Sbjct: 123 MEALIISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLD 182

Query: 216 LLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENG---VVKVADFGVARVQAQSGVMTA 272
           LL VA D++ G  YL +N+ IHRD+   N L+   G   V K+ DFG+AR   ++G    
Sbjct: 183 LLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRAGYYRK 242

Query: 273 ETGTY---RWMAPEVIEHKPYDYKADVFSFGIALWELLT-GELPYAGLTPLQAAVGVVQK 328
                   +WM PE      +  K D +SFG+ LWE+ + G +PY   +  +  +  V  
Sbjct: 243 GGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQE-VLEFVTS 301

Query: 329 SLRPTIPKHAHPRLAELLERCWQHDPTQRPNFSQITDILKQMMKE 373
             R   PK+    +  ++ +CWQH P  RPNF+ I + ++   ++
Sbjct: 302 GGRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQD 346

>1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343

 Score =  235 bits (601), Expect = 1e-74
 Identities = 80/306 (26%), Positives = 137/306 (44%), Gaps = 36/306 (11%)

Query: 102 EIPTDGTDVWEIDAKQLKIECKVASGSYGDLYKGTY-------CSQEVAIKVLKPECVNT 154
            +        E     ++    +  G++G +++              VA+K+LK E  + 
Sbjct: 33  LLLNPKLLSLEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEA-SA 91

Query: 155 EMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFL---------- 204
           +M  +F +E  +M +  + N+V+ +G C     +C++ E+MA G + +FL          
Sbjct: 92  DMQADFQREAALMAEFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCS 151

Query: 205 -------------HKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENG 251
                                    L +A  V+ GM YL +   +HRDL T N L+ EN 
Sbjct: 152 LSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLATRNCLVGENM 211

Query: 252 VVKVADFGVARVQAQSGVMTAETGTY---RWMAPEVIEHKPYDYKADVFSFGIALWELLT 308
           VVK+ADFG++R    +    A+       RWM PE I +  Y  ++DV+++G+ LWE+ +
Sbjct: 212 VVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFS 271

Query: 309 -GELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRLAELLERCWQHDPTQRPNFSQITDIL 367
            G  PY G+   +  +  V+       P++    L  L+  CW   P  RP+F  I  IL
Sbjct: 272 YGLQPYYGMAHEE-VIYYVRDGNILACPENCPLELYNLMRLCWSKLPADRPSFCSIHRIL 330

Query: 368 KQMMKE 373
           ++M + 
Sbjct: 331 QRMCER 336

>1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290

 Score =  219 bits (561), Expect = 1e-69
 Identities = 76/280 (27%), Positives = 133/280 (47%), Gaps = 15/280 (5%)

Query: 95  ESSPNCIEIPTDGTDVWEID--AKQLKIECKVASGSYGDLYKG--TYCSQEVAIKVLKPE 150
           E +    +I    T    +    + LK + ++  GS+  +YKG  T  + EVA   L+  
Sbjct: 3   ERNQQQDDIEELETKAVGMSNDGRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDR 62

Query: 151 CVNTEMLKEFSQEVYIMRKIRHKNVVQFIGA----CTRPPNLCIVTEFMARGSIYDFLHK 206
            +     + F +E  +++ ++H N+V+F  +          + +VTE M  G++  +L +
Sbjct: 63  KLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVTELMTSGTLKTYLKR 122

Query: 207 QKGVFQLTSLLKVAIDVSKGMNYLHQNN--IIHRDLKTANLLMD-ENGVVKVADFGVARV 263
              V ++  L      + KG+ +LH     IIHRDLK  N+ +    G VK+ D G+A +
Sbjct: 123 F-KVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATL 181

Query: 264 QAQSGVMTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAV 323
           +  S       GT  +MAPE+ E K YD   DV++FG+ + E+ T E PY+         
Sbjct: 182 KRASFAKA-VIGTPEFMAPEMYEEK-YDESVDVYAFGMCMLEMATSEYPYSECQNAAQIY 239

Query: 324 GVVQKSLRP-TIPKHAHPRLAELLERCWQHDPTQRPNFSQ 362
             V   ++P +  K A P + E++E C + +  +R +   
Sbjct: 240 RRVTSGVKPASFDKVAIPEVKEIIEGCIRQNKDERYSIKD 279

>4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350

 Score =  210 bits (536), Expect = 5e-65
 Identities = 67/259 (25%), Positives = 137/259 (52%), Gaps = 9/259 (3%)

Query: 126 SGSYGDLYKG--TYCSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACT 183
            GS+G       T   ++  IK +    ++++  +E  +EV ++  ++H N+VQ+  +  
Sbjct: 34  EGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRESFE 93

Query: 184 RPPNLCIVTEFMARGSIYDFLHKQKGV-FQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKT 242
              +L IV ++   G ++  ++ QKGV FQ   +L   + +   + ++H   I+HRD+K+
Sbjct: 94  ENGSLYIVMDYCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHVHDRKILHRDIKS 153

Query: 243 ANLLMDENGVVKVADFGVARVQAQSGVMTAET--GTYRWMAPEVIEHKPYDYKADVFSFG 300
            N+ + ++G V++ DFG+ARV   S V  A    GT  +++PE+ E+KPY+ K+D+++ G
Sbjct: 154 QNIFLTKDGTVQLGDFGIARV-LNSTVELARACIGTPYYLSPEICENKPYNNKSDIWALG 212

Query: 301 IALWELLTGELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRLAELLERCWQHDPTQRPNF 360
             L+EL T +  +   +     + ++  S  P +  H    L  L+ + ++ +P  RP+ 
Sbjct: 213 CVLYELCTLKHAFEAGSMKNLVLKIISGSFPP-VSLHYSYDLRSLVSQLFKRNPRDRPSV 271

Query: 361 SQI--TDILKQMMKEVASE 377
           + I     + + +++  S 
Sbjct: 272 NSILEKGFIAKRIEKFLSP 290

>3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311

 Score =  204 bits (520), Expect = 4e-63
 Identities = 59/280 (21%), Positives = 99/280 (35%), Gaps = 8/280 (2%)

Query: 87  PMHSKLLIESSPNCIEIPTDGTDVWEIDAKQLKIECKVASGSYGDLYKGTY--CSQEVAI 144
           P       E+S        D +       +  +   ++  GSYG+++K       +  A+
Sbjct: 28  PRRVSFRGEASETLQSPGYDPSRPESFFQQSFQRLSRLGHGSYGEVFKVRSKEDGRLYAV 87

Query: 145 KVLKPECVNTEMLKEFSQEVYIMRKI-RHKNVVQFIGACTRPPNLCIVTEFMARGSIYDF 203
           K         +       EV    K+ +H   V+   A      L + TE     S+   
Sbjct: 88  KRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAWEEGGILYLQTEL-CGPSLQQH 146

Query: 204 LHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARV 263
                       +     D    + +LH   ++H D+K AN+ +   G  K+ DFG+   
Sbjct: 147 CEAWGASLPEAQVWGYLRDTLLALAHLHSQGLVHLDVKPANIFLGPRGRCKLGDFGLLVE 206

Query: 264 QAQSGVMTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAV 323
              +G    + G  R+MAPE+++   Y   ADVFS G+ + E+        G    Q   
Sbjct: 207 LGTAGAGEVQEGDPRYMAPELLQ-GSYGTAADVFSLGLTILEVACNMELPHGGEGWQQ-- 263

Query: 324 GVVQKSLRPTIPKHAHPRLAELLERCWQHDPTQRPNFSQI 363
            + Q  L P         L  +L    + DP  R     +
Sbjct: 264 -LRQGYLPPEFTAGLSSELRSVLVMMLEPDPKLRATAEAL 302

>2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295

 Score =  203 bits (519), Expect = 4e-63
 Identities = 70/242 (28%), Positives = 126/242 (52%), Gaps = 11/242 (4%)

Query: 126 SGSYGDLYKGTYCS--QEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACT 183
            G+YG +Y G   S    +AIK +     ++   +   +E+ + + ++HKN+VQ++G+ +
Sbjct: 32  KGTYGIVYAGRDLSNQVRIAIKEIPER--DSRYSQPLHEEIALHKHLKHKNIVQYLGSFS 89

Query: 184 RPPNLCIVTEFMARGSIYDFLHKQKGVFQLT-SLLKV-AIDVSKGMNYLHQNNIIHRDLK 241
               + I  E +  GS+   L  + G  +     +      + +G+ YLH N I+HRD+K
Sbjct: 90  ENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDNQIVHRDIK 149

Query: 242 TANLLMD-ENGVVKVADFGVA-RVQAQSGVMTAETGTYRWMAPEVIEHKP--YDYKADVF 297
             N+L++  +GV+K++DFG + R+   +      TGT ++MAPE+I+  P  Y   AD++
Sbjct: 150 GDNVLINTYSGVLKISDFGTSKRLAGINPCTETFTGTLQYMAPEIIDKGPRGYGKAADIW 209

Query: 298 SFGIALWELLTGELPYAGLT-PLQAAVGVVQKSLRPTIPKHAHPRLAELLERCWQHDPTQ 356
           S G  + E+ TG+ P+  L  P  A   V    + P IP+         + +C++ DP +
Sbjct: 210 SLGCTIIEMATGKPPFYELGEPQAAMFKVGMFKVHPEIPESMSAEAKAFILKCFEPDPDK 269

Query: 357 RP 358
           R 
Sbjct: 270 RA 271

>2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303

 Score =  203 bits (518), Expect = 7e-63
 Identities = 82/281 (29%), Positives = 132/281 (46%), Gaps = 43/281 (15%)

Query: 111 WEIDAKQLKIECKVASGSYGDLYKGTYCS--QEVAIKVLKPECVNTEMLKEFSQEVYIMR 168
           W I+    +++  + SG+   +         ++VAIK +  E   T  + E  +E+  M 
Sbjct: 10  WSINRDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTS-MDELLKEIQAMS 68

Query: 169 KIRHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFL--HKQKGVFQLTSLLKVAI----- 221
           +  H N+V +  +      L +V + ++ GS+ D +     KG  +   L +  I     
Sbjct: 69  QCHHPNIVSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILR 128

Query: 222 DVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAET------G 275
           +V +G+ YLH+N  IHRD+K  N+L+ E+G V++ADFGV+   A  G +T         G
Sbjct: 129 EVLEGLEYLHKNGQIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFVG 188

Query: 276 TYRWMAPEVIE-HKPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKSLRPTI 334
           T  WMAPEV+E  + YD+KAD++SFGI   EL TG  PY    P++              
Sbjct: 189 TPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMKVL---------MLT 239

Query: 335 PKHAHPRLA-----------------ELLERCWQHDPTQRP 358
            ++  P L                  +++  C Q DP +RP
Sbjct: 240 LQNDPPSLETGVQDKEMLKKYGKSFRKMISLCLQKDPEKRP 280

>3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303

 Score =  203 bits (518), Expect = 7e-63
 Identities = 87/275 (31%), Positives = 143/275 (52%), Gaps = 16/275 (5%)

Query: 88  MHSKLLIESSPNCIEIPTDGTDVWEIDAKQLKIECKVASGSYGDLYKGTYCS--QEVAIK 145
           M    +    P    +  D  +++           K+  GS+G+++KG      + VAIK
Sbjct: 1   MAHSPVQSGLPGMQNLKADPEELFTK-------LEKIGKGSFGEVFKGIDNRTQKVVAIK 53

Query: 146 VLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLH 205
           ++  E    E +++  QE+ ++ +     V ++ G+  +   L I+ E++  GS  D L 
Sbjct: 54  IIDLEEAEDE-IEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYLGGGSALDLL- 111

Query: 206 KQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQA 265
            + G    T +  +  ++ KG++YLH    IHRD+K AN+L+ E+G VK+ADFGVA  Q 
Sbjct: 112 -EPGPLDETQIATILREILKGLDYLHSEKKIHRDIKAANVLLSEHGEVKLADFGVA-GQL 169

Query: 266 QSGVMTAET--GTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAV 323
               +   T  GT  WMAPEVI+   YD KAD++S GI   EL  GE P++ L P++  +
Sbjct: 170 TDTQIKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSELHPMK-VL 228

Query: 324 GVVQKSLRPTIPKHAHPRLAELLERCWQHDPTQRP 358
            ++ K+  PT+  +    L E +E C   +P+ RP
Sbjct: 229 FLIPKNNPPTLEGNYSKPLKEFVEACLNKEPSFRP 263

>4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336

 Score =  202 bits (516), Expect = 3e-62
 Identities = 57/243 (23%), Positives = 98/243 (40%), Gaps = 18/243 (7%)

Query: 126 SGSYGDLYKGTYCS--QEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACT 183
            GS+G++++        + A+K ++ E           +E+     +    +V   GA  
Sbjct: 68  RGSFGEVHRMKDKQTGFQCAVKKVRLEVFR-------VEELVACAGLSSPRIVPLYGAVR 120

Query: 184 RPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTA 243
             P + I  E +  GS+   + KQ G       L       +G+ YLH   I+H D+K  
Sbjct: 121 EGPWVNIFMELLEGGSLGQLI-KQMGCLPEDRALYYLGQALEGLEYLHTRRILHGDVKAD 179

Query: 244 NLLMDENGV-VKVADFGVARVQAQSGVMTAET------GTYRWMAPEVIEHKPYDYKADV 296
           N+L+  +G    + DFG A      G+  +        GT   MAPEV+  KP D K D+
Sbjct: 180 NVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPEVVMGKPCDAKVDI 239

Query: 297 FSFGIALWELLTGELPYAGLTPLQAAVGVVQKS-LRPTIPKHAHPRLAELLERCWQHDPT 355
           +S    +  +L G  P+         + +  +      IP    P  A+ ++   + +P 
Sbjct: 240 WSSCCMMLHMLNGCHPWTQYFRGPLCLKIASEPPPIREIPPSCAPLTAQAIQEGLRKEPV 299

Query: 356 QRP 358
            R 
Sbjct: 300 HRA 302

>2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310

 Score =  201 bits (514), Expect = 4e-62
 Identities = 62/268 (23%), Positives = 130/268 (48%), Gaps = 9/268 (3%)

Query: 126 SGSYGDLYKG--TYCSQEVAIKVLK-PECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGAC 182
            G + ++Y+         VA+K ++  + ++ +   +  +E+ +++++ H NV+++  + 
Sbjct: 42  RGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASF 101

Query: 183 TRPPNLCIVTEFMARGSIYDFLHKQK---GVFQLTSLLKVAIDVSKGMNYLHQNNIIHRD 239
                L IV E    G +   +   K    +    ++ K  + +   + ++H   ++HRD
Sbjct: 102 IEDNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSRRVMHRD 161

Query: 240 LKTANLLMDENGVVKVADFGVARV-QAQSGVMTAETGTYRWMAPEVIEHKPYDYKADVFS 298
           +K AN+ +   GVVK+ D G+ R   +++    +  GT  +M+PE I    Y++K+D++S
Sbjct: 162 IKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPERIHENGYNFKSDIWS 221

Query: 299 FGIALWELLTGELPYAG--LTPLQAAVGVVQKSLRPTIPKHAHPRLAELLERCWQHDPTQ 356
            G  L+E+   + P+ G  +        + Q    P    H    L +L+  C   DP +
Sbjct: 222 LGCLLYEMAALQSPFYGDKMNLYSLCKKIEQCDYPPLPSDHYSEELRQLVNMCINPDPEK 281

Query: 357 RPNFSQITDILKQMMKEVASEGENNHSN 384
           RP+ + + D+ K+M    AS  E++H +
Sbjct: 282 RPDVTYVYDVAKRMHACTASSLEHHHHH 309

>2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284

 Score =  200 bits (511), Expect = 4e-62
 Identities = 66/276 (23%), Positives = 116/276 (42%), Gaps = 33/276 (11%)

Query: 119 KIECKVASGSYGDLYKGTYCS--QEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVV 176
           K    + SG +G ++K  +    +   IK +K      E      +EV  + K+ H N+V
Sbjct: 14  KEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNNEKAE------REVKALAKLDHVNIV 67

Query: 177 QFIGA----------------CTRPPNLCIVTEFMARGSIYDFLHKQKGV-FQLTSLLKV 219
            + G                  ++   L I  EF  +G++  ++ K++G        L++
Sbjct: 68  HYNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALEL 127

Query: 220 AIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAETGTYRW 279
              ++KG++Y+H   +I+RDLK +N+ + +   VK+ DFG+       G  T   GT R+
Sbjct: 128 FEQITKGVDYIHSKKLINRDLKPSNIFLVDTKQVKIGDFGLVTSLKNDGKRTRSKGTLRY 187

Query: 280 MAPEVIEHKPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKSLRPTIPKHAH 339
           M+PE I  + Y  + D+++ G+ L ELL                          I     
Sbjct: 188 MSPEQISSQDYGKEVDLYALGLILAELLHVC------DTAFETSKFFTDLRDGIISDIFD 241

Query: 340 PRLAELLERCWQHDPTQRPNFSQI--TDILKQMMKE 373
            +   LL++     P  RPN S+I  T  + +   E
Sbjct: 242 KKEKTLLQKLLSKKPEDRPNTSEILRTLTVWKKSPE 277

>3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297

 Score =  196 bits (500), Expect = 3e-60
 Identities = 75/284 (26%), Positives = 131/284 (46%), Gaps = 23/284 (8%)

Query: 116 KQLKIECKVASGSYGDLYKGTYCS--QEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHK 173
           K+     K+  G+ G +Y     +  QEVAI+ +  +       +    E+ +MR+ ++ 
Sbjct: 20  KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQ--QQPKKELIINEILVMRENKNP 77

Query: 174 NVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQN 233
           N+V ++ +      L +V E++A GS+ D + +         +  V  +  + + +LH N
Sbjct: 78  NIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTE--TCMDEGQIAAVCRECLQALEFLHSN 135

Query: 234 NIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAET--GTYRWMAPEVIEHKPYD 291
            +IHRD+K+ N+L+  +G VK+ DFG    Q         T  GT  WMAPEV+  K Y 
Sbjct: 136 QVIHRDIKSDNILLGMDGSVKLTDFGFC-AQITPEQSKRSTMVGTPYWMAPEVVTRKAYG 194

Query: 292 YKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKSLRPTI--PKHAHPRLAELLERC 349
            K D++S GI   E++ GE PY    PL+A   ++  +  P +  P+       + L RC
Sbjct: 195 PKVDIWSLGIMAIEMIEGEPPYLNENPLRALY-LIATNGTPELQNPEKLSAIFRDFLNRC 253

Query: 350 WQHDPTQRPNFSQI-----------TDILKQMMKEVASEGENNH 382
            + D  +R +  ++              L  ++       +NNH
Sbjct: 254 LEMDVEKRGSAKELLQHQFLKIAKPLSSLTPLIAAAKEATKNNH 297

>3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314

 Score =  195 bits (498), Expect = 7e-60
 Identities = 80/272 (29%), Positives = 127/272 (46%), Gaps = 35/272 (12%)

Query: 101 IEIPTDGTDVWEIDAKQLKIECKVASGSYGDLYKGTYCS--QEVAIKVLKPECVNTEMLK 158
             +     +V+++         K+  GSYG +YK  +    Q VAIK +  E      L+
Sbjct: 21  DSLTKQPEEVFDV-------LEKLGEGSYGSVYKAIHKETGQIVAIKQVPVE----SDLQ 69

Query: 159 EFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLK 218
           E  +E+ IM++    +VV++ G+  +  +L IV E+   GS+ D +  +        +  
Sbjct: 70  EIIKEISIMQQCDSPHVVKYYGSYFKNTDLWIVMEYCGAGSVSDIIRLRNKTLTEDEIAT 129

Query: 219 VAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAET--GT 276
           +     KG+ YLH    IHRD+K  N+L++  G  K+ADFGVA  Q    +    T  GT
Sbjct: 130 ILQSTLKGLEYLHFMRKIHRDIKAGNILLNTEGHAKLADFGVA-GQLTDTMAKRNTVIGT 188

Query: 277 YRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKSLRPTIPK 336
             WMAPEVI+   Y+  AD++S GI   E+  G+ PYA + P++A            IP 
Sbjct: 189 PFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGKPPYADIHPMRAIF---------MIPT 239

Query: 337 HAHPRLA----------ELLERCWQHDPTQRP 358
           +  P             + +++C    P QR 
Sbjct: 240 NPPPTFRKPELWSDNFTDFVKQCLVKSPEQRA 271

>2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321

 Score =  194 bits (494), Expect = 3e-59
 Identities = 73/249 (29%), Positives = 119/249 (47%), Gaps = 12/249 (4%)

Query: 116 KQLKIECKVASGSYGDLYKGTYCS--QEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHK 173
             L    K+  GS G +         ++VA+K++       +  +    EV IMR  +H 
Sbjct: 45  LLLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLR--KQQRRELLFNEVVIMRDYQHF 102

Query: 174 NVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQN 233
           NVV+   +      L ++ EF+  G++ D + +         +  V   V + + YLH  
Sbjct: 103 NVVEMYKSYLVGEELWVLMEFLQGGALTDIVSQ--VRLNEEQIATVCEAVLQALAYLHAQ 160

Query: 234 NIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAET--GTYRWMAPEVIEHKPYD 291
            +IHRD+K+ ++L+  +G VK++DFG    Q    V   ++  GT  WMAPEVI    Y 
Sbjct: 161 GVIHRDIKSDSILLTLDGRVKLSDFGFC-AQISKDVPKRKSLVGTPYWMAPEVISRSLYA 219

Query: 292 YKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKSLRPTI--PKHAHPRLAELLERC 349
            + D++S GI + E++ GE PY   +P+QA    ++ S  P +       P L + LER 
Sbjct: 220 TEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMK-RLRDSPPPKLKNSHKVSPVLRDFLERM 278

Query: 350 WQHDPTQRP 358
              DP +R 
Sbjct: 279 LVRDPQERA 287

>1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289

 Score =  192 bits (491), Expect = 5e-59
 Identities = 56/271 (20%), Positives = 108/271 (39%), Gaps = 33/271 (12%)

Query: 119 KIECKVASGSYGDLYKGTYCS--QEVAIKVLKPECVNTEMLKEFSQEVYIMRKI-RHKNV 175
               K+ SG +G ++K          AIK  K     +   +   +EVY    + +H +V
Sbjct: 14  HELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHV 73

Query: 176 VQFIGACTRPPNLCIVTEFMARGSIYDFL---HKQKGVFQLTSLLKVAIDVSKGMNYLHQ 232
           V++  A     ++ I  E+   GS+ D +   ++    F+   L  + + V +G+ Y+H 
Sbjct: 74  VRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHS 133

Query: 233 NNIIHRDLKTANLLMDENGV-------------------VKVADFGVARVQAQSGVMTAE 273
            +++H D+K +N+ +    +                    K+ D G      +      E
Sbjct: 134 MSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHV---TRISSPQVE 190

Query: 274 TGTYRWMAPEVI-EHKPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKSLRP 332
            G  R++A EV+ E+  +  KAD+F+  + +      E               +++   P
Sbjct: 191 EGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRNGDQWHE----IRQGRLP 246

Query: 333 TIPKHAHPRLAELLERCWQHDPTQRPNFSQI 363
            IP+       ELL+     DP +RP+   +
Sbjct: 247 RIPQVLSQEFTELLKVMIHPDPERRPSAMAL 277

>2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302

 Score =  192 bits (489), Expect = 1e-58
 Identities = 77/269 (28%), Positives = 129/269 (47%), Gaps = 22/269 (8%)

Query: 101 IEIPTDGTDVWEIDAKQLKIECKVASGSYGDLYKGTYCS--QEVAIKVLKPECVNTEMLK 158
           +    D  +VWEI         ++  G++G +YK          A KV++ +  + E L+
Sbjct: 11  VRRDLDPNEVWEI-------VGELGDGAFGKVYKAKNKETGALAAAKVIETK--SEEELE 61

Query: 159 EFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLK 218
           ++  E+ I+    H  +V+ +GA      L I+ EF   G++   + +         +  
Sbjct: 62  DYIVEIEILATCDHPYIVKLLGAYYHDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQV 121

Query: 219 VAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAET--GT 276
           V   + + +N+LH   IIHRDLK  N+LM   G +++ADFGV+  +    +   ++  GT
Sbjct: 122 VCRQMLEALNFLHSKRIIHRDLKAGNVLMTLEGDIRLADFGVS-AKNLKTLQKRDSFIGT 180

Query: 277 YRWMAPEVIEH-----KPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKSLR 331
             WMAPEV+        PYDYKAD++S GI L E+   E P+  L P++  +  + KS  
Sbjct: 181 PYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLL-KIAKSDP 239

Query: 332 PTIPKHAH--PRLAELLERCWQHDPTQRP 358
           PT+   +       + L+     +P  RP
Sbjct: 240 PTLLTPSKWSVEFRDFLKIALDKNPETRP 268

>3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327

 Score =  192 bits (491), Expect = 1e-58
 Identities = 82/301 (27%), Positives = 138/301 (45%), Gaps = 23/301 (7%)

Query: 93  LIESSPNCIEIPTDGTDVWEIDAKQLKIECKVASGSYGDLYKGTYC--SQEVAIKVLKPE 150
           +   S   ++I  +    W+  A+ LK   ++  G+YG + K  +    Q +A+K ++  
Sbjct: 1   MSIESSGKLKISPE--QHWDFTAEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRST 58

Query: 151 CVNTEMLKEFSQEVYI-MRKIRHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHK--- 206
            V+ +  K+   ++ + MR      +VQF GA  R  +  I  E M+  S   F      
Sbjct: 59  -VDEKEQKQLLMDLDVVMRSSDCPYIVQFYGALFREGDCWICMELMS-TSFDKFYKYVYS 116

Query: 207 -QKGVFQLTSLLKVAIDVSKGMNYLHQN-NIIHRDLKTANLLMDENGVVKVADFGVARVQ 264
               V     L K+ +   K +N+L +N  IIHRD+K +N+L+D +G +K+ DFG++   
Sbjct: 117 VLDDVIPEEILGKITLATVKALNHLKENLKIIHRDIKPSNILLDRSGNIKLCDFGISGQL 176

Query: 265 AQSGVMTAETGTYRWMAPEVIE----HKPYDYKADVFSFGIALWELLTGELPYAGLTPLQ 320
             S   T + G   +MAPE I+     + YD ++DV+S GI L+EL TG  PY     + 
Sbjct: 177 VDSIAKTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVF 236

Query: 321 AAVGVVQKSLRPTIPKHAH----PRLAELLERCWQHDPTQRPNFSQITD---ILKQMMKE 373
             +  V K   P +         P     +  C   D ++RP + ++     IL    + 
Sbjct: 237 DQLTQVVKGDPPQLSNSEEREFSPSFINFVNLCLTKDESKRPKYKELLKHPFILMYEERA 296

Query: 374 V 374
           V
Sbjct: 297 V 297

>3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290

 Score =  190 bits (486), Expect = 2e-58
 Identities = 69/278 (24%), Positives = 121/278 (43%), Gaps = 17/278 (6%)

Query: 112 EIDAKQLKIECKVASGSYGDLYKGTYC--SQEVAIKVLKPECVNTEMLKEFSQEVYI-MR 168
           E+ A  L+   ++  G+YG + K  +    Q +A+K ++   VN++  K    ++ I MR
Sbjct: 3   EVKADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRAT-VNSQEQKRLLMDLDISMR 61

Query: 169 KIRHKNVVQFIGACTRPPNLCIVTEFMARGS---IYDFLHKQKGVFQLTSLLKVAIDVSK 225
            +     V F GA  R  ++ I  E M   S    Y  +  +        L K+A+ + K
Sbjct: 62  TVDCPFTVTFYGALFREGDVWICMELMD-TSLDKFYKQVIDKGQTIPEDILGKIAVSIVK 120

Query: 226 GMNYLHQN-NIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAETGTYRWMAPEV 284
            + +LH   ++IHRD+K +N+L++  G VK+ DFG++           + G   +MAPE 
Sbjct: 121 ALEHLHSKLSVIHRDVKPSNVLINALGQVKMCDFGISGYLVDDVAKDIDAGCKPYMAPER 180

Query: 285 IE----HKPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKSLRPTIPKHAH- 339
           I      K Y  K+D++S GI + EL     PY         +  V +   P +P     
Sbjct: 181 INPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTPFQQLKQVVEEPSPQLPADKFS 240

Query: 340 PRLAELLERCWQHDPTQRPNFSQITD---ILKQMMKEV 374
               +   +C + +  +RP + ++           K  
Sbjct: 241 AEFVDFTSQCLKKNSKERPTYPELMQHPFFTLHESKGT 278

>3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343

 Score =  189 bits (483), Expect = 3e-57
 Identities = 54/256 (21%), Positives = 113/256 (44%), Gaps = 21/256 (8%)

Query: 126 SGSYGDLYKGTYCS-QEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKN--VVQFIGAC 182
           SG    +++      Q  AIK +  E  + + L  +  E+  + K++  +  +++     
Sbjct: 19  SGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYE 78

Query: 183 TRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKT 242
                + +V E      +  +L K+K             ++ + ++ +HQ+ I+H DLK 
Sbjct: 79  ITDQYIYMVMEC-GNIDLNSWL-KKKKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKP 136

Query: 243 ANLLMDENGVVKVADFGVAR-VQAQSGVMTAET--GTYRWMAPEVIEHKP---------- 289
           AN L+  +G++K+ DFG+A  +Q  +  +  ++  GT  +M PE I+             
Sbjct: 137 ANFLIV-DGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKS 195

Query: 290 -YDYKADVFSFGIALWELLTGELPYAGLT-PLQAAVGVVQKSLRPTIPKHAHPRLAELLE 347
               K+DV+S G  L+ +  G+ P+  +   +     ++  +     P      L ++L+
Sbjct: 196 KISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHEIEFPDIPEKDLQDVLK 255

Query: 348 RCWQHDPTQRPNFSQI 363
            C + DP QR +  ++
Sbjct: 256 CCLKRDPKQRISIPEL 271

>2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317

 Score =  189 bits (481), Expect = 3e-57
 Identities = 63/286 (22%), Positives = 111/286 (38%), Gaps = 29/286 (10%)

Query: 107 GTDVWEIDAKQLKIECKVASGSYGDLY--KGTYCSQEVAIKVLKPECVNTEMLKEFSQEV 164
           G  V  ID K      K+  G +  +   +G +     A+K +   C   +  +E  +E 
Sbjct: 21  GHMVI-IDNKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRIL--CHEQQDREEAQREA 77

Query: 165 YIMRKIRHKNVVQFIGACTRPPN----LCIVTEFMARGSIYDFL---HKQKGVFQLTSLL 217
            + R   H N+++ +  C R         ++  F  RG++++ +     +        +L
Sbjct: 78  DMHRLFNHPNILRLVAYCLRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQIL 137

Query: 218 KVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQ----------AQS 267
            + + + +G+  +H     HRDLK  N+L+ + G   + D G                  
Sbjct: 138 WLLLGICRGLEAIHAKGYAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEGSRQALTL 197

Query: 268 GVMTAETGTYRWMAPEVIEHKPY---DYKADVFSFGIALWELLTGELPY-AGLTPLQAAV 323
               A+  T  + APE+   + +   D + DV+S G  L+ ++ GE PY        +  
Sbjct: 198 QDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGDSVA 257

Query: 324 GVVQKSLRPTIPKHAHPRLAELLERCWQHDPTQRPNFSQITDILKQ 369
             VQ  L           L +LL      DP QRP+   I  +L Q
Sbjct: 258 LAVQNQLSIPQSPRHSSALWQLLNSMMTVDPHQRPH---IPLLLSQ 300

>3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389

 Score =  191 bits (486), Expect = 3e-57
 Identities = 50/297 (16%), Positives = 105/297 (35%), Gaps = 24/297 (8%)

Query: 111 WEIDAKQLKIECKVASG--SYGDLYKGTYCS--QEVAIKVLKPECVNTEMLKEFSQEVYI 166
           +  +    ++   +  G      +    Y    + V ++ +  E  + EM+     E+++
Sbjct: 20  FLPEGGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHV 79

Query: 167 MRKIRHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFL-HKQKGVFQLTSLLKVAIDVSK 225
            +   H N+V +         L +VT FMA GS  D +           ++  +   V K
Sbjct: 80  SKLFNHPNIVPYRATFIADNELWVVTSFMAYGSAKDLICTHFMDGMNELAIAYILQGVLK 139

Query: 226 GMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVA--------RVQAQSGVMTAETGTY 277
            ++Y+H    +HR +K +++L+  +G V ++             R +             
Sbjct: 140 ALDYIHHMGYVHRSVKASHILISVDGKVYLSGLRSNLSMISHGQRQRVVHDFPKYSVKVL 199

Query: 278 RWMAPEVIEH--KPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKSLRPTIP 335
            W++PEV++   + YD K+D++S GI   EL  G +P+  +   Q  +            
Sbjct: 200 PWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLL---------EKL 250

Query: 336 KHAHPRLAELLERCWQHDPTQRPNFSQITDILKQMMKEVASEGENNHSNKSAGSFFS 392
               P L +      +            + +   +          +  +      FS
Sbjct: 251 NGTVPCLLDTSTIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFS 307

>1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348

 Score =  189 bits (483), Expect = 3e-57
 Identities = 76/255 (29%), Positives = 114/255 (44%), Gaps = 28/255 (10%)

Query: 119 KIECKVASGSYGDLYKGTYCS--QEVAIKVLKPECVNT-EMLKEFSQEVYIMRKIRHKNV 175
               ++  GS+G +Y        + VAIK +      + E  ++  +EV  ++K+RH N 
Sbjct: 57  SDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNT 116

Query: 176 VQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNI 235
           +Q+ G   R     +V E+   GS  D L   K   Q   +  V     +G+ YLH +N+
Sbjct: 117 IQYRGCYLREHTAWLVMEYCL-GSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNM 175

Query: 236 IHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAETGTYRWMAPEVI---EHKPYDY 292
           IHRD+K  N+L+ E G+VK+ DFG A   +      +  GT  WMAPEVI   +   YD 
Sbjct: 176 IHRDVKAGNILLSEPGLVKLGDFGSA---SIMAPANSFVGTPYWMAPEVILAMDEGQYDG 232

Query: 293 KADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRLA--------- 343
           K DV+S GI   EL   + P   +  + A            I ++  P L          
Sbjct: 233 KVDVWSLGITCIELAERKPPLFNMNAMSALY---------HIAQNESPALQSGHWSEYFR 283

Query: 344 ELLERCWQHDPTQRP 358
             ++ C Q  P  RP
Sbjct: 284 NFVDSCLQKIPQDRP 298

>2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390

 Score =  190 bits (485), Expect = 5e-57
 Identities = 53/256 (20%), Positives = 112/256 (43%), Gaps = 21/256 (8%)

Query: 126 SGSYGDLYKGTYCS-QEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKN--VVQFIGAC 182
           SG    +++      Q  AIK +  E  + + L  +  E+  + K++  +  +++     
Sbjct: 66  SGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYE 125

Query: 183 TRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKT 242
                + +V E      +  +L K+K             ++ + ++ +HQ+ I+H DLK 
Sbjct: 126 ITDQYIYMVMEC-GNIDLNSWL-KKKKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKP 183

Query: 243 ANLLMDENGVVKVADFGVAR-VQAQSGVMTAET--GTYRWMAPEVIEHKP---------- 289
           AN L+  +G++K+ DFG+A  +Q  +  +  ++  G   +M PE I+             
Sbjct: 184 ANFLIV-DGMLKLIDFGIANQMQPDTTSVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKS 242

Query: 290 -YDYKADVFSFGIALWELLTGELPYAGLT-PLQAAVGVVQKSLRPTIPKHAHPRLAELLE 347
               K+DV+S G  L+ +  G+ P+  +   +     ++  +     P      L ++L+
Sbjct: 243 KISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHEIEFPDIPEKDLQDVLK 302

Query: 348 RCWQHDPTQRPNFSQI 363
            C + DP QR +  ++
Sbjct: 303 CCLKRDPKQRISIPEL 318

>2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318

 Score =  187 bits (477), Expect = 1e-56
 Identities = 70/284 (24%), Positives = 127/284 (44%), Gaps = 16/284 (5%)

Query: 105 TDGTDVWEIDAKQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVNTEMLKEFSQ 162
           T G   ++ +   L+   ++ SG+ G ++K  +      +A+K ++    N E  K    
Sbjct: 14  TIGGQRYQAEINDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRS-GNKEENKRILM 72

Query: 163 EVYI-MRKIRHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAI 221
           ++ + ++      +VQ  G      ++ I  E M          + +G      L K+ +
Sbjct: 73  DLDVVLKSHDCPYIVQCFGTFITNTDVFIAMELMG-TCAEKLKKRMQGPIPERILGKMTV 131

Query: 222 DVSKGMNYLH-QNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAETGTYRWM 280
            + K + YL  ++ +IHRD+K +N+L+DE G +K+ DFG++             G   +M
Sbjct: 132 AIVKALYYLKEKHGVIHRDVKPSNILLDERGQIKLCDFGISGRLVDDKAKDRSAGCAAYM 191

Query: 281 APEVIE-----HKPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKSLRPTIP 335
           APE I+        YD +ADV+S GI+L EL TG+ PY         +  V +   P +P
Sbjct: 192 APERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKTDFEVLTKVLQEEPPLLP 251

Query: 336 KHAH--PRLAELLERCWQHDPTQRPNFSQITD---ILKQMMKEV 374
            H          ++ C   D  +RP ++++ +   I +    EV
Sbjct: 252 GHMGFSGDFQSFVKDCLTKDHRKRPKYNKLLEHSFIKRYETLEV 295

>3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313

 Score =  187 bits (476), Expect = 1e-56
 Identities = 54/256 (21%), Positives = 113/256 (44%), Gaps = 21/256 (8%)

Query: 126 SGSYGDLYKGTYCS-QEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKN--VVQFIGAC 182
           SG    +++      Q  AIK +  E  + + L  +  E+  + K++  +  +++     
Sbjct: 38  SGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYE 97

Query: 183 TRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKT 242
                + +V E      +  +L K+K             ++ + ++ +HQ+ I+H DLK 
Sbjct: 98  ITDQYIYMVMEC-GNIDLNSWL-KKKKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKP 155

Query: 243 ANLLMDENGVVKVADFGVAR-VQAQSGVMTAET--GTYRWMAPEVIEHKP---------- 289
           AN L+  +G++K+ DFG+A  +Q  +  +  ++  GT  +M PE I+             
Sbjct: 156 ANFLIV-DGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKS 214

Query: 290 -YDYKADVFSFGIALWELLTGELPYAGLT-PLQAAVGVVQKSLRPTIPKHAHPRLAELLE 347
               K+DV+S G  L+ +  G+ P+  +   +     ++  +     P      L ++L+
Sbjct: 215 KISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHEIEFPDIPEKDLQDVLK 274

Query: 348 RCWQHDPTQRPNFSQI 363
            C + DP QR +  ++
Sbjct: 275 CCLKRDPKQRISIPEL 290

>4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299

 Score =  186 bits (474), Expect = 2e-56
 Identities = 55/267 (20%), Positives = 111/267 (41%), Gaps = 33/267 (12%)

Query: 126 SGSYGDLYKGT--YCSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGAC- 182
            G +G +++          AIK ++         ++  +EV  + K+ H  +V++  A  
Sbjct: 15  RGGFGVVFEAKNKVDDCNYAIKRIRLP-NRELAREKVMREVKALAKLEHPGIVRYFNAWL 73

Query: 183 -----------TRPPNLCIVTEFMARGSIYDFLHKQKGVFQL--TSLLKVAIDVSKGMNY 229
                      +    L I  +   + ++ D+++ +  + +   +  L + + +++ + +
Sbjct: 74  EKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEF 133

Query: 230 LHQNNIIHRDLKTANLLMDENGVVKVADFGVARV-------------QAQSGVMTAETGT 276
           LH   ++HRDLK +N+    + VVKV DFG+                       T + GT
Sbjct: 134 LHSKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYARHTGQVGT 193

Query: 277 YRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKSLRPTIPK 336
             +M+PE I    Y +K D+FS G+ L+ELL    P++        +  V+    P +  
Sbjct: 194 KLYMSPEQIHGNSYSHKVDIFSLGLILFELLY---PFSTQMERVRTLTDVRNLKFPPLFT 250

Query: 337 HAHPRLAELLERCWQHDPTQRPNFSQI 363
             +P    +++      P +RP    I
Sbjct: 251 QKYPCEYVMVQDMLSPSPMERPEAINI 277

>3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360

 Score =  184 bits (468), Expect = 6e-55
 Identities = 63/272 (23%), Positives = 119/272 (43%), Gaps = 7/272 (2%)

Query: 102 EIPTDGTDVWEIDAKQLKIECKVASGSYGDLYKGTYC--SQEVAIKVLKPECVNTEMLKE 159
              T    V E+     +   ++ +G+ G ++K ++      +A K++  E +   +  +
Sbjct: 19  AFLTQKQKVGELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLE-IKPAIRNQ 77

Query: 160 FSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKV 219
             +E+ ++ +     +V F GA      + I  E M  GS+   L K+ G      L KV
Sbjct: 78  IIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVL-KKAGRIPEQILGKV 136

Query: 220 AIDVSKGMNYLHQN-NIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAETGTYR 278
           +I V KG+ YL +   I+HRD+K +N+L++  G +K+ DFGV+     S   +   GT  
Sbjct: 137 SIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSF-VGTRS 195

Query: 279 WMAPEVIEHKPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKSLRPTIPKHA 338
           +M+PE ++   Y  ++D++S G++L E+  G  P       +  +    +          
Sbjct: 196 YMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPP 255

Query: 339 HPRLAELLERCWQHDPTQRPN-FSQITDILKQ 369
            PR        +  D       F  +  I+ +
Sbjct: 256 RPRTPGRPLNKFGMDSRPPMAIFELLDYIVNE 287

>2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279

 Score =  181 bits (461), Expect = 9e-55
 Identities = 63/252 (25%), Positives = 114/252 (45%), Gaps = 16/252 (6%)

Query: 126 SGSYGDLYKGTYCS--QEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACT 183
           +GSYG   K    S  + +  K L    +     +    EV ++R+++H N+V++     
Sbjct: 16  TGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRII 75

Query: 184 RPPN--LCIVTEFMARGSIYDFL--HKQKGV-FQLTSLLKVAIDVSKGMNYLHQ-----N 233
              N  L IV E+   G +   +    ++        +L+V   ++  +   H+     +
Sbjct: 76  DRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGH 135

Query: 234 NIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAET--GTYRWMAPEVIEHKPYD 291
            ++HRDLK AN+ +D    VK+ DFG+AR+        A+T  GT  +M+PE +    Y+
Sbjct: 136 TVLHRDLKPANVFLDGKQNVKLGDFGLARI-LNHDTSFAKTFVGTPYYMSPEQMNRMSYN 194

Query: 292 YKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRLAELLERCWQ 351
            K+D++S G  L+EL     P+   +  +   G +++     IP      L E++ R   
Sbjct: 195 EKSDIWSLGCLLYELCALMPPFTAFS-QKELAGKIREGKFRRIPYRYSDELNEIITRMLN 253

Query: 352 HDPTQRPNFSQI 363
                RP+  +I
Sbjct: 254 LKDYHRPSVEEI 265

>1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303

 Score =  181 bits (461), Expect = 2e-54
 Identities = 62/269 (23%), Positives = 112/269 (41%), Gaps = 34/269 (12%)

Query: 126 SGSYGDLYKGTYCS--QEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACT 183
            G++G + K       +  AIK ++      E L     EV ++  + H+ VV++  A  
Sbjct: 16  QGAFGQVVKARNALDSRYYAIKKIR---HTEEKLSTILSEVMLLASLNHQYVVRYYAAWL 72

Query: 184 RPPN-------------LCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYL 230
              N             L I  E+   G++YD +H +    Q     ++   + + ++Y+
Sbjct: 73  ERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWRLFRQILEALSYI 132

Query: 231 HQNNIIHRDLKTANLLMDENGVVKVADFGVARV---------------QAQSGVMTAETG 275
           H   IIHRDLK  N+ +DE+  VK+ DFG+A+                   S  +T+  G
Sbjct: 133 HSQGIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQNLPGSSDNLTSAIG 192

Query: 276 TYRWMAPEVIEHKP-YDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKSLRPTI 334
           T  ++A EV++    Y+ K D++S GI  +E++           +   +  V     P  
Sbjct: 193 TAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIYPFSTGMERVNILKKLRSVSIEFPPDF 252

Query: 335 PKHAHPRLAELLERCWQHDPTQRPNFSQI 363
             +      +++     HDP +RP    +
Sbjct: 253 DDNKMKVEKKIIRLLIDHDPNKRPGARTL 281

>2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326

 Score =  181 bits (461), Expect = 3e-54
 Identities = 79/258 (30%), Positives = 131/258 (50%), Gaps = 23/258 (8%)

Query: 119 KIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKI-RHKNV 175
           ++   V +G+YG +YKG +    Q  AIKV+    V  +  +E  QE+ +++K   H+N+
Sbjct: 27  ELVELVGNGTYGQVYKGRHVKTGQLAAIKVMD---VTGDEEEEIKQEINMLKKYSHHRNI 83

Query: 176 VQFIGA------CTRPPNLCIVTEFMARGSIYDFLHKQK-GVFQLTSLLKVAIDVSKGMN 228
             + GA            L +V EF   GS+ D +   K    +   +  +  ++ +G++
Sbjct: 84  ATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLS 143

Query: 229 YLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAET--GTYRWMAPEVIE 286
           +LHQ+ +IHRD+K  N+L+ EN  VK+ DFGV+  Q    V    T  GT  WMAPEVI 
Sbjct: 144 HLHQHKVIHRDIKGQNVLLTENAEVKLVDFGVSA-QLDRTVGRRNTFIGTPYWMAPEVIA 202

Query: 287 HK-----PYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKSLRPTI-PKHAHP 340
                   YD+K+D++S GI   E+  G  P   + P++A   ++ ++  P +  K    
Sbjct: 203 CDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALF-LIPRNPAPRLKSKKWSK 261

Query: 341 RLAELLERCWQHDPTQRP 358
           +    +E C   + +QRP
Sbjct: 262 KFQSFIESCLVKNHSQRP 279

>2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307

 Score =  175 bits (445), Expect = 5e-52
 Identities = 75/264 (28%), Positives = 134/264 (50%), Gaps = 21/264 (7%)

Query: 127 GSYGDLYKGTYCSQEVAIKVLKPECVNTEM--LKEFSQEVYIMRKIRHKNVVQFIGACTR 184
           G +G +YKG   +  VA+K L      T     ++F QE+ +M K +H+N+V+ +G  + 
Sbjct: 42  GGFGVVYKGYVNNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHENLVELLGFSSD 101

Query: 185 PPNLCIVTEFMARGSIYDFLHKQKGVFQL--TSLLKVAIDVSKGMNYLHQNNIIHRDLKT 242
             +LC+V  +M  GS+ D L    G   L      K+A   + G+N+LH+N+ IHRD+K+
Sbjct: 102 GDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHENHHIHRDIKS 161

Query: 243 ANLLMDENGVVKVADFGVAR---VQAQSGVMTAETGTYRWMAPEVIEHKPYDYKADVFSF 299
           AN+L+DE    K++DFG+AR     AQ+ + +   GT  +MAPE +  +    K+D++SF
Sbjct: 162 ANILLDEAFTAKISDFGLARASEKFAQTVMTSRIVGTTAYMAPEALRGEITP-KSDIYSF 220

Query: 300 GIALWELLTGELPYAGLTPLQAAVGVVQKSLR----------PTI---PKHAHPRLAELL 346
           G+ L E++TG          Q  + + ++               +      +   +  + 
Sbjct: 221 GVVLLEIITGLPAVDEHREPQLLLDIKEEIEDEEKTIEDYIDKKMNDADSTSVEAMYSVA 280

Query: 347 ERCWQHDPTQRPNFSQITDILKQM 370
            +C      +RP+  ++  +L++M
Sbjct: 281 SQCLHEKKNKRPDIKKVQQLLQEM 304

>2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321

 Score =  171 bits (435), Expect = 3e-50
 Identities = 67/275 (24%), Positives = 130/275 (47%), Gaps = 26/275 (9%)

Query: 121 ECKVASGSYGDLYKGTYCS-QEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFI 179
           +  +  G +G +YKG      +VA+K   PE  +++ ++EF  E+  +   RH ++V  I
Sbjct: 44  KFLIGHGVFGKVYKGVLRDGAKVALKRRTPE--SSQGIEEFETEIETLSFCRHPHLVSLI 101

Query: 180 GACTRPPNLCIVTEFMARGSIYDFLH-KQKGVFQLT--SLLKVAIDVSKGMNYLHQNNII 236
           G C     + ++ ++M  G++   L+        ++    L++ I  ++G++YLH   II
Sbjct: 102 GFCDERNEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTRAII 161

Query: 237 HRDLKTANLLMDENGVVKVADFGVARVQAQSG---VMTAETGTYRWMAPE-VIEHKPYDY 292
           HRD+K+ N+L+DEN V K+ DFG+++   +     + T   GT  ++ PE  I+ +  + 
Sbjct: 162 HRDVKSINILLDENFVPKITDFGISKKGTELDQTHLSTVVKGTLGYIDPEYFIKGRLTE- 220

Query: 293 KADVFSFGIALWELLTGELPYAGLTPLQAA---------------VGVVQKSLRPTIPKH 337
           K+DV+SFG+ L+E+L          P +                   +V  +L   I   
Sbjct: 221 KSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVESHNNGQLEQIVDPNLADKIRPE 280

Query: 338 AHPRLAELLERCWQHDPTQRPNFSQITDILKQMMK 372
           +  +  +   +C       RP+   +   L+  ++
Sbjct: 281 SLRKFGDTAVKCLALSSEDRPSMGDVLWKLEYALR 315

>3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278

 Score =  163 bits (415), Expect = 7e-48
 Identities = 63/272 (23%), Positives = 114/272 (41%), Gaps = 35/272 (12%)

Query: 127 GSYGDLYKGTYCS--QEVAIKVL-KPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACT 183
           GS+  +Y+        EVAIK++ K       M++    EV I  +++H ++++      
Sbjct: 22  GSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYNYFE 81

Query: 184 RPPNLCIVTEFMARGSIYDFLHKQKGVF----------QLTSLLKVAIDVSKGMNYLHQN 233
               + +V E    G +  +L  +   F          Q+ +          GM YLH +
Sbjct: 82  DSNYVYLVLEMCHNGEMNRYLKNRVKPFSENEARHFMHQIIT----------GMLYLHSH 131

Query: 234 NIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAET--GTYRWMAPEVIEHKPYD 291
            I+HRDL  +NLL+  N  +K+ADFG+A  Q +       T  GT  +++PE+     + 
Sbjct: 132 GILHRDLTLSNLLLTRNMNIKIADFGLA-TQLKMPHEKHYTLCGTPNYISPEIATRSAHG 190

Query: 292 YKADVFSFGIALWELLTGELPY--AGLTPLQAAVGVVQKSLRPTIPKHAHPRLAELLERC 349
            ++DV+S G   + LL G  P+    +      V          +P        +L+ + 
Sbjct: 191 LESDVWSLGCMFYTLLIGRPPFDTDTVKNTLNKV----VLADYEMPSFLSIEAKDLIHQL 246

Query: 350 WQHDPTQRPNFSQITD---ILKQMMKEVASEG 378
            + +P  R + S + D   + +    +   EG
Sbjct: 247 LRRNPADRLSLSSVLDHPFMSRNSSTKSKDEG 278

>3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279

 Score =  161 bits (410), Expect = 4e-47
 Identities = 67/263 (25%), Positives = 125/263 (47%), Gaps = 10/263 (3%)

Query: 127 GSYGDLY--KGTYCSQEVAIKVL-KPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACT 183
           G +G++Y  +       +A+KVL K +     +  +  +EV I   +RH N+++  G   
Sbjct: 20  GKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFH 79

Query: 184 RPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTA 243
               + ++ E+   G++Y  L ++   F          +++  ++Y H   +IHRD+K  
Sbjct: 80  DATRVYLILEYAPLGTVYREL-QKLSKFDEQRTATYITELANALSYCHSKRVIHRDIKPE 138

Query: 244 NLLMDENGVVKVADFGVARVQAQSGVMTAETGTYRWMAPEVIEHKPYDYKADVFSFGIAL 303
           NLL+   G +K+ADFG + V A S   T   GT  ++ PE+IE + +D K D++S G+  
Sbjct: 139 NLLLGSAGELKIADFGWS-VHAPSSRRTDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLC 197

Query: 304 WELLTGELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRLAELLERCWQHDPTQRPNFSQI 363
           +E L G+ P+   T  +    + +       P        +L+ R  +H+P+QRP   ++
Sbjct: 198 YEFLVGKPPFEANTYQETYKRISRVEFT--FPDFVTEGARDLISRLLKHNPSQRPMLREV 255

Query: 364 TD---ILKQMMKEVASEGENNHS 383
            +   I     K    + + + S
Sbjct: 256 LEHPWITANSSKPSNCQNKESAS 278

>4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319

 Score =  162 bits (412), Expect = 4e-47
 Identities = 62/283 (21%), Positives = 109/283 (38%), Gaps = 46/283 (16%)

Query: 126 SGSYGDLYKGTYCS--QEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGA-- 181
            G+  ++++G +       AIKV          +    +E  +++K+ HKN+V+      
Sbjct: 19  QGATANVFRGRHKKTGDLFAIKVFNNISFL-RPVDVQMREFEVLKKLNHKNIVKLFAIEE 77

Query: 182 CTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLT--SLLKVAIDVSKGMNYLHQNNIIHRD 239
            T   +  ++ EF   GS+Y  L +    + L     L V  DV  GMN+L +N I+HR+
Sbjct: 78  ETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENGIVHRN 137

Query: 240 LKTANLLM----DENGVVKVADFGVARVQAQSGVMTAETGTYRWMAPEVIE--------H 287
           +K  N++     D   V K+ DFG AR         +  GT  ++ P++ E         
Sbjct: 138 IKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVSLYGTEEYLHPDMYERAVLRKDHQ 197

Query: 288 KPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKSLR---------------- 331
           K Y    D++S G+  +   TG LP+      +    V+ K +                 
Sbjct: 198 KKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITGKPSGAISGVQKAENG 257

Query: 332 -----------PTIPKHAHPRLAELLERCWQHDPTQRPNFSQI 363
                       ++ +     L  +L    + D  +   F Q 
Sbjct: 258 PIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQF 300

>2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294

 Score =  161 bits (410), Expect = 5e-47
 Identities = 72/253 (28%), Positives = 123/253 (48%), Gaps = 31/253 (12%)

Query: 127 GSYGDLYKGT--YCSQEVAIKVL-KPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACT 183
           G +   ++ +     +  A K++ K   +     ++ S E+ I R + H++VV F G   
Sbjct: 26  GGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFE 85

Query: 184 RPPNLCIVTEFMARGSIYDFLHKQKGVF----------QLTSLLKVAIDVSKGMNYLHQN 233
               + +V E   R S+ + LHK++             Q+            G  YLH+N
Sbjct: 86  DNDFVFVVLELCRRRSLLE-LHKRRKALTEPEARYYLRQIVL----------GCQYLHRN 134

Query: 234 NIIHRDLKTANLLMDENGVVKVADFGVA-RVQAQSGVMTAETGTYRWMAPEVIEHKPYDY 292
            +IHRDLK  NL ++E+  VK+ DFG+A +V+          GT  ++APEV+  K + +
Sbjct: 135 RVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKVLCGTPNYIAPEVLSKKGHSF 194

Query: 293 KADVFSFGIALWELLTGELPY--AGLTPLQAAVGVVQKSLRPTIPKHAHPRLAELLERCW 350
           + DV+S G  ++ LL G+ P+  + L      +    K    +IPKH +P  A L+++  
Sbjct: 195 EVDVWSIGCIMYTLLVGKPPFETSCLKETYLRI----KKNEYSIPKHINPVAASLIQKML 250

Query: 351 QHDPTQRPNFSQI 363
           Q DPT RP  +++
Sbjct: 251 QTDPTARPTINEL 263

>2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335

 Score =  162 bits (413), Expect = 5e-47
 Identities = 72/253 (28%), Positives = 123/253 (48%), Gaps = 31/253 (12%)

Query: 127 GSYGDLYKGT--YCSQEVAIKVL-KPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACT 183
           G +   ++ +     +  A K++ K   +     ++ S E+ I R + H++VV F G   
Sbjct: 52  GGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFE 111

Query: 184 RPPNLCIVTEFMARGSIYDFLHKQKGVF----------QLTSLLKVAIDVSKGMNYLHQN 233
               + +V E   R S+ + LHK++             Q+            G  YLH+N
Sbjct: 112 DNDFVFVVLELCRRRSLLE-LHKRRKALTEPEARYYLRQIVL----------GCQYLHRN 160

Query: 234 NIIHRDLKTANLLMDENGVVKVADFGVA-RVQAQSGVMTAETGTYRWMAPEVIEHKPYDY 292
            +IHRDLK  NL ++E+  VK+ DFG+A +V+          GT  ++APEV+  K + +
Sbjct: 161 RVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKVLCGTPNYIAPEVLSKKGHSF 220

Query: 293 KADVFSFGIALWELLTGELPY--AGLTPLQAAVGVVQKSLRPTIPKHAHPRLAELLERCW 350
           + DV+S G  ++ LL G+ P+  + L      +    K    +IPKH +P  A L+++  
Sbjct: 221 EVDVWSIGCIMYTLLVGKPPFETSCLKETYLRI----KKNEYSIPKHINPVAASLIQKML 276

Query: 351 QHDPTQRPNFSQI 363
           Q DPT RP  +++
Sbjct: 277 QTDPTARPTINEL 289

>3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337

 Score =  162 bits (412), Expect = 6e-47
 Identities = 69/299 (23%), Positives = 127/299 (42%), Gaps = 43/299 (14%)

Query: 107 GTDVWEIDAKQLKIECKVASGSYGDLY--KGTYCSQEVAIKVLKPECVNTEMLKEFSQEV 164
           G  V E+   +L++   +A G +  +Y  +     +E A+K L       E  +   QEV
Sbjct: 20  GQTV-ELGELRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLL--SNEEEKNRAIIQEV 76

Query: 165 YIMRKIR-HKNVVQFIGACTRPPN--------LCIVTEFMARGSIYDFL--HKQKGVFQL 213
             M+K+  H N+VQF  A +              ++TE   +G + +FL   + +G    
Sbjct: 77  CFMKKLSGHPNIVQFCSAASIGKEESDTGQAEFLLLTEL-CKGQLVEFLKKMESRGPLSC 135

Query: 214 TSLLKVAIDVSKGMNYLHQNN--IIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMT 271
            ++LK+     + + ++H+    IIHRDLK  NLL+   G +K+ DFG A   +     +
Sbjct: 136 DTVLKIFYQTCRAVQHMHRQKPPIIHRDLKVENLLLSNQGTIKLCDFGSATTISHYPDYS 195

Query: 272 AET-------------GTYRWMAPEVIE---HKPYDYKADVFSFGIALWELLTGELPYAG 315
                            T  +  PE+I+   + P   K D+++ G  L+ L   + P+  
Sbjct: 196 WSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFED 255

Query: 316 LTPLQAAVGVVQKSLRPTIPKHAH--PRLAELLERCWQHDPTQRPNFSQITDILKQMMK 372
              L+   G      + +IP H         L+    Q +P +R + +++   L+++  
Sbjct: 256 GAKLRIVNG------KYSIPPHDTQYTVFHSLIRAMLQVNPEERLSIAEVVHQLQEIAA 308

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359

 Score =  163 bits (413), Expect = 8e-47
 Identities = 63/250 (25%), Positives = 113/250 (45%), Gaps = 7/250 (2%)

Query: 128 SYGDLYKGTYCSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPN 187
            +G+L      S+       K +       K++   + +  K R  ++     + +    
Sbjct: 110 KFGNLST-YLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFV 168

Query: 188 LCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLM 247
                  +      + L+K      L  L+  +  V+KGM +L     IHRDL   N+L+
Sbjct: 169 EEKSLSDVEEEEAPEDLYK--DFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILL 226

Query: 248 DENGVVKVADFGVARVQAQSGVMTAETGT---YRWMAPEVIEHKPYDYKADVFSFGIALW 304
            E  VVK+ DFG+AR   +      +       +WMAPE I  + Y  ++DV+SFG+ LW
Sbjct: 227 SEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLW 286

Query: 305 ELLT-GELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRLAELLERCWQHDPTQRPNFSQI 363
           E+ + G  PY G+   +     +++  R   P +  P + + +  CW  +P+QRP FS++
Sbjct: 287 EIFSLGASPYPGVKIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSEL 346

Query: 364 TDILKQMMKE 373
            + L  +++ 
Sbjct: 347 VEHLGNLLQA 356

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359

 Score = 88.8 bits (220), Expect = 1e-19
 Identities = 39/151 (25%), Positives = 67/151 (44%), Gaps = 16/151 (10%)

Query: 100 CIEIPTDGTDVWEIDAKQLKIECKVASGSYGDLYKGTY-------CSQEVAIKVLKPECV 152
           C  +P D    WE    +LK+   +  G++G + +            + VA+K+LK    
Sbjct: 7   CERLPYD-ASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGAT 65

Query: 153 NTEMLKEFSQEVYIMRKI-RHKNVVQFIGACTRPPN-LCIVTEFMARGSIYDFLHKQKGV 210
           ++E  +    E+ I+  I  H NVV  +GACT+P   L ++ EF   G++  +L  ++  
Sbjct: 66  HSEH-RALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNE 124

Query: 211 FQLTSLLKVAIDVSKGMNYLHQNNIIHRDLK 241
           F             +G +Y+     I  DLK
Sbjct: 125 FVPYKTKGA--RFRQGKDYV---GAIPVDLK 150

>2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284

 Score =  159 bits (404), Expect = 3e-46
 Identities = 63/240 (26%), Positives = 114/240 (47%), Gaps = 7/240 (2%)

Query: 127 GSYGDLY--KGTYCSQEVAIKVL-KPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACT 183
           G +G++Y  +       +A+KVL K +     +  +  +E+ I   +RH N+++      
Sbjct: 25  GKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYNYFH 84

Query: 184 RPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTA 243
               + ++ EF  RG +Y  L ++ G F          +++  ++Y H+  +IHRD+K  
Sbjct: 85  DRKRIYLMLEFAPRGELYKEL-QKHGRFDEQRSATFMEELADALHYCHERKVIHRDIKPE 143

Query: 244 NLLMDENGVVKVADFGVARVQAQSGVMTAETGTYRWMAPEVIEHKPYDYKADVFSFGIAL 303
           NLLM   G +K+ADFG + V A S       GT  ++ PE+IE K +D K D++  G+  
Sbjct: 144 NLLMGYKGELKIADFGWS-VHAPSLRRRTMCGTLDYLPPEMIEGKTHDEKVDLWCAGVLC 202

Query: 304 WELLTGELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRLAELLERCWQHDPTQRPNFSQI 363
           +E L G  P+   +  +    +V   L+   P        +L+ +  ++ P QR     +
Sbjct: 203 YEFLVGMPPFDSPSHTETHRRIVNVDLK--FPPFLSDGSKDLISKLLRYHPPQRLPLKGV 260

>3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332

 Score =  159 bits (403), Expect = 1e-45
 Identities = 52/251 (20%), Positives = 104/251 (41%), Gaps = 21/251 (8%)

Query: 133 YKGTYCSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVT 192
           ++       +  +       +   +   S ++  M     KN V  +   +    L I  
Sbjct: 81  WQEEMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQM 140

Query: 193 EFMARGSIYDFLHKQKGVFQL--TSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDEN 250
           +   + ++ D+++++  +        L + I +++ + +LH   ++HRDLK +N+    +
Sbjct: 141 QLCRKENLKDWMNRRCSLEDREHGVCLHIFIQIAEAVEFLHSKGLMHRDLKPSNIFFTMD 200

Query: 251 GVVKVADFGVARV-------------QAQSGVMTAETGTYRWMAPEVIEHKPYDYKADVF 297
            VVKV DFG+                       T + GT  +M+PE I    Y +K D+F
Sbjct: 201 DVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKLYMSPEQIHGNNYSHKVDIF 260

Query: 298 SFGIALWELLTGELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRLAELLERCWQHDPTQR 357
           S G+ L+ELL     ++        +  V+    P +    +P+   +++      PT+R
Sbjct: 261 SLGLILFELLY---SFSTQMERVRIITDVRNLKFPLLFTQKYPQEHMMVQDMLSPSPTER 317

Query: 358 PNFSQITDILK 368
           P     TDI++
Sbjct: 318 PE---ATDIIE 325

>3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432

 Score =  161 bits (409), Expect = 1e-45
 Identities = 60/254 (23%), Positives = 114/254 (44%), Gaps = 22/254 (8%)

Query: 126 SGSYGD-LYKGTYCSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKI-RHKNVVQFIGACT 183
            G+ G  +Y+G + +++VA+K + PEC          +EV ++R+   H NV+++     
Sbjct: 34  HGAEGTIVYRGMFDNRDVAVKRILPEC-----FSFADREVQLLRESDEHPNVIRYFCTEK 88

Query: 184 RPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTA 243
                 I  E  A  ++ +++ ++         + +    + G+ +LH  NI+HRDLK  
Sbjct: 89  DRQFQYIAIELCA-ATLQEYVEQKDFAHLGLEPITLLQQTTSGLAHLHSLNIVHRDLKPH 147

Query: 244 NLLMDENG-----VVKVADFGVARV----QAQSGVMTAETGTYRWMAPEVIE---HKPYD 291
           N+L+            ++DFG+ +     +      +   GT  W+APE++     +   
Sbjct: 148 NILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVPGTEGWIAPEMLSEDCKENPT 207

Query: 292 YKADVFSFGIALWELLT-GELPYAGLTPLQAAVGVVQKSL-RPTIPKHAHPRLAELLERC 349
           Y  D+FS G   + +++ G  P+      QA + +   SL      KH      EL+E+ 
Sbjct: 208 YTVDIFSAGCVFYYVISEGSHPFGKSLQRQANILLGACSLDCLHPEKHEDVIARELIEKM 267

Query: 350 WQHDPTQRPNFSQI 363
              DP +RP+   +
Sbjct: 268 IAMDPQKRPSAKHV 281

>3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326

 Score =  158 bits (401), Expect = 3e-45
 Identities = 75/274 (27%), Positives = 123/274 (44%), Gaps = 27/274 (9%)

Query: 121 ECKVASGSYGDLYKGTYCS-QEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFI 179
           +  +  G +G +YKG       VA+K LK E        +F  EV ++    H+N+++  
Sbjct: 35  KNILGRGGFGKVYKGRLADGTLVAVKRLKEER-TQGGELQFQTEVEMISMAVHRNLLRLR 93

Query: 180 GACTRPPNLCIVTEFMARGSIYDFLH-KQKGVFQLT--SLLKVAIDVSKGMNYLHQN--- 233
           G C  P    +V  +MA GS+   L  + +    L      ++A+  ++G+ YLH +   
Sbjct: 94  GFCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDP 153

Query: 234 NIIHRDLKTANLLMDENGVVKVADFGVARVQ--AQSGVMTAETGTYRWMAPEVIEHKPYD 291
            IIHRD+K AN+L+DE     V DFG+A++     + V TA  GT   +APE +      
Sbjct: 154 KIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSS 213

Query: 292 YKADVFSFGIALWELLTGELPYAGLTPLQA-----------------AVGVVQKSLRPTI 334
            K DVF +G+ L EL+TG+  +                            +V   L+   
Sbjct: 214 EKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEALVDVDLQGNY 273

Query: 335 PKHAHPRLAELLERCWQHDPTQRPNFSQITDILK 368
                 +L ++   C Q  P +RP  S++  +L+
Sbjct: 274 KDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLE 307

>4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396

 Score =  159 bits (403), Expect = 4e-45
 Identities = 62/294 (21%), Positives = 112/294 (38%), Gaps = 46/294 (15%)

Query: 126 SGSYGDLYKGTYCS--QEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGA-- 181
            G+  ++++G +       AIKV          +    +E  +++K+ HKN+V+      
Sbjct: 19  QGATANVFRGRHKKTGDLFAIKVFNNISFL-RPVDVQMREFEVLKKLNHKNIVKLFAIEE 77

Query: 182 CTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLT--SLLKVAIDVSKGMNYLHQNNIIHRD 239
            T   +  ++ EF   GS+Y  L +    + L     L V  DV  GMN+L +N I+HR+
Sbjct: 78  ETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENGIVHRN 137

Query: 240 LKTANLLM----DENGVVKVADFGVARVQAQSGVMTAETGTYRWMAPEVIE--------H 287
           +K  N++     D   V K+ DFG AR         +  GT  ++ P++ E         
Sbjct: 138 IKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVSLYGTEEYLHPDMYERAVLRKDHQ 197

Query: 288 KPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKSLR---------------- 331
           K Y    D++S G+  +   TG LP+      +    V+ K +                 
Sbjct: 198 KKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITGKPSGAISGVQKAENG 257

Query: 332 -----------PTIPKHAHPRLAELLERCWQHDPTQRPNFSQITDILKQMMKEV 374
                       ++ +     L  +L    + D  +   F Q       ++  +
Sbjct: 258 PIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDILHRM 311

>3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676

 Score =  163 bits (413), Expect = 9e-45
 Identities = 69/274 (25%), Positives = 113/274 (41%), Gaps = 38/274 (13%)

Query: 126 SGSYGDLYKGT--YCSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFI---- 179
           +G +G + +       ++VAIK  + E ++ +  + +  E+ IM+K+ H NVV       
Sbjct: 24  TGGFGYVLRWIHQDTGEQVAIKQCRQE-LSPKNRERWCLEIQIMKKLNHPNVVSAREVPD 82

Query: 180 --GACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLT--SLLKVAIDVSKGMNYLHQNNI 235
                       +  E+   G +  +L++ +    L    +  +  D+S  + YLH+N I
Sbjct: 83  GLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLHENRI 142

Query: 236 IHRDLKTANLLMDENG---VVKVADFGVARVQAQSGVMTAETGTYRWMAPEVIEHKPYDY 292
           IHRDLK  N+++       + K+ D G A+   Q  + T   GT +++APE++E K Y  
Sbjct: 143 IHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQGELCTEFVGTLQYLAPELLEQKKYTV 202

Query: 293 KADVFSFGIALWELLTGELPYAGLTP------------------LQAAVGVVQKSLRPTI 334
             D +SFG   +E +TG  P+                            G V+ S     
Sbjct: 203 TVDYWSFGTLAFECITGFRPFLPNWQPVQWHGKVREKSNEHIVVYDDLTGAVKFSSVLPT 262

Query: 335 PKHAHPRLAELLERCW-----QHDPTQRPNFSQI 363
           P H    LA  LER W          QR    Q 
Sbjct: 263 PNHLSGILAGKLER-WLQCMLMWHQRQRGTDPQN 295

>4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294

 Score =  153 bits (388), Expect = 9e-44
 Identities = 64/249 (25%), Positives = 119/249 (47%), Gaps = 11/249 (4%)

Query: 119 KIECKVASGSYGDLYKG--TYCSQEVAIKVLKPE-CVNTEMLKEFSQEVYIMRKIRHKNV 175
           KI  K+  G    +Y    T  + +VAIK +        E LK F +EV+   ++ H+N+
Sbjct: 14  KIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNI 73

Query: 176 VQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNI 235
           V  I          +V E++   ++ +++    G   + + +     +  G+ + H   I
Sbjct: 74  VSMIDVDEEDDCYYLVMEYIEGPTLSEYIE-SHGPLSVDTAINFTNQILDGIKHAHDMRI 132

Query: 236 IHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAET--GTYRWMAPEVIEHKPYDYK 293
           +HRD+K  N+L+D N  +K+ DFG+A+  +++ +       GT ++ +PE  + +  D  
Sbjct: 133 VHRDIKPQNILIDSNKTLKIFDFGIAKALSETSLTQTNHVLGTVQYFSPEQAKGEATDEC 192

Query: 294 ADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRLAELLE----RC 349
            D++S GI L+E+L GE P+ G T +  A+  +Q S+ P +       + + L     R 
Sbjct: 193 TDIYSIGIVLYEMLVGEPPFNGETAVSIAIKHIQDSV-PNVTTDVRKDIPQSLSNVILRA 251

Query: 350 WQHDPTQRP 358
            + D   R 
Sbjct: 252 TEKDKANRY 260

>2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348

 Score =  154 bits (390), Expect = 2e-43
 Identities = 55/281 (19%), Positives = 101/281 (35%), Gaps = 46/281 (16%)

Query: 127 GSYGDLYKGTYCSQEVAIKVLK---------------PECVNTEMLKEFSQEVYIMRKIR 171
           G +  +      ++  A+K  +                +        +F  E+ I+  I+
Sbjct: 42  GKFNKIILCEKDNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIK 101

Query: 172 HKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSK------ 225
           ++  +   G  T    + I+ E+M   SI  F      V        + I V K      
Sbjct: 102 NEYCLTCEGIITNYDEVYIIYEYMENDSILKFDEY-FFVLDKNYTCFIPIQVIKCIIKSV 160

Query: 226 --GMNYLH-QNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAETGTYRWMAP 282
               +Y+H + NI HRD+K +N+LMD+NG VK++DFG +        +    GTY +M P
Sbjct: 161 LNSFSYIHNEKNICHRDVKPSNILMDKNGRVKLSDFGES-EYMVDKKIKGSRGTYEFMPP 219

Query: 283 EVIEHKP--YDYKADVFSFGIALWELLTGELPYAGLTPLQA------------------A 322
           E   ++      K D++S GI L+ +    +P++    L                     
Sbjct: 220 EFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKISLVELFNNIRTKNIEYPLDRNHF 279

Query: 323 VGVVQKSLRPTIPKHAHPRLAELLERCWQHDPTQRPNFSQI 363
           +  +                 + L+   + +P +R      
Sbjct: 280 LYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERITSEDA 320

>3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311

 Score =  150 bits (381), Expect = 1e-42
 Identities = 67/257 (26%), Positives = 118/257 (45%), Gaps = 22/257 (8%)

Query: 119 KIECKVASGSYGDLYKG--TYCSQEVAIKVLKPE-CVNTEMLKEFSQEVYIMRKIRHKNV 175
           ++   +  G   +++        ++VA+KVL+ +   +      F +E      + H  +
Sbjct: 15  ELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAI 74

Query: 176 VQF--IGACTRPPNLC--IVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLH 231
           V     G    P      IV E++   ++ D +H  +G       ++V  D  + +N+ H
Sbjct: 75  VAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVH-TEGPMTPKRAIEVIADACQALNFSH 133

Query: 232 QNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAET----GTYRWMAPEVIEH 287
           QN IIHRD+K AN+++     VKV DFG+AR  A SG    +T    GT ++++PE    
Sbjct: 134 QNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARG 193

Query: 288 KPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQ------KSLRPTIPKHAHPR 341
              D ++DV+S G  L+E+LTGE P+ G +P+  A   V+       +    +       
Sbjct: 194 DSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPPSARHEGLS----AD 249

Query: 342 LAELLERCWQHDPTQRP 358
           L  ++ +    +P  R 
Sbjct: 250 LDAVVLKALAKNPENRY 266

>3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328

 Score =  148 bits (376), Expect = 9e-42
 Identities = 71/236 (30%), Positives = 115/236 (48%), Gaps = 26/236 (11%)

Query: 140 QEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVTEFMARGS 199
           +EVAIK++    +N   L++  +EV IM+ + H N+V+          L ++ E+ + G 
Sbjct: 41  REVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEVIETEKTLYLIMEYASGGE 100

Query: 200 IYDFLHKQKGV--------F-QLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDEN 250
           ++D+L     +        F Q+ S           + Y HQ  I+HRDLK  NLL+D +
Sbjct: 101 VFDYLVAHGRMKEKEARSKFRQIVS----------AVQYCHQKRIVHRDLKAENLLLDAD 150

Query: 251 GVVKVADFGVARVQAQSGVMTAETGTYRWMAPEVIEHKPYD-YKADVFSFGIALWELLTG 309
             +K+ADFG +      G + A  G   + APE+ + K YD  + DV+S G+ L+ L++G
Sbjct: 151 MNIKIADFGFSNEFTVGGKLDAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSG 210

Query: 310 ELPYAG--LTPLQAAVGVVQKSLRPTIPKHAHPRLAELLERCWQHDPTQRPNFSQI 363
            LP+ G  L  L+  V       +  IP +       LL+R    +P +R    QI
Sbjct: 211 SLPFDGQNLKELRERV----LRGKYRIPFYMSTDCENLLKRFLVLNPIKRGTLEQI 262

>3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365

 Score =  149 bits (377), Expect = 1e-41
 Identities = 48/300 (16%), Positives = 108/300 (36%), Gaps = 38/300 (12%)

Query: 112 EIDAKQLKIECKVASGSYGDLYKGTY-------CSQEVAIKVLKPECVNTEMLKEFSQEV 164
           ++ +K + +   +  G++  +Y+ T          Q+  +KV KP     E      Q +
Sbjct: 61  QLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPW-EFYIGT-QLM 118

Query: 165 YIMRKIRHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQK----GVFQLTSLLKVA 220
             ++       ++F  A        +V E  + G++ + ++  K     V     ++  A
Sbjct: 119 ERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFA 178

Query: 221 IDVSKGMNYLHQNNIIHRDLKTANLLM-----------DENGVVKVADFGVA---RVQAQ 266
           + +   +  +H   IIH D+K  N ++           D +  + + D G +   ++  +
Sbjct: 179 MRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPK 238

Query: 267 SGVMTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVV 326
             + TA+  T  +   E++ +KP++Y+ D F     ++ +L G                 
Sbjct: 239 GTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEG-------G 291

Query: 327 QKSLRPTIPKHAHPRL-AELLERCWQHDPTQRPNFSQITDILKQMMKEVASEGENNHSNK 385
           +        +  H  +  E                    D+L+Q +K+V  +   N    
Sbjct: 292 ECKPEGLFRRLPHLDMWNEFFHVMLNIPDCHHL---PSLDLLRQKLKKVFQQHYTNKIRA 348

>3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371

 Score =  147 bits (372), Expect = 7e-41
 Identities = 37/306 (12%), Positives = 93/306 (30%), Gaps = 47/306 (15%)

Query: 116 KQLKIECKVASGSYGDLYKGTYCS--QEVAIKVL-KPECVNTEMLKEFSQEVYIMRKIRH 172
           ++LK+   +  G    ++        ++ A+KV       +   L+   +  +   ++  
Sbjct: 62  RKLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLG 121

Query: 173 KNVVQFIGAC--------------------------TRPPNLCIVTEFMAR-----GSIY 201
           ++  +                                   N  ++    +       S  
Sbjct: 122 ESPEEARDRRRLLLPSDAVAVQSQPPFAQLSPGQDDYAVANYLLLMPAASVDLELLFSTL 181

Query: 202 DFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVA 261
           DF++  +G   + +L  +   + +    L    ++H      NL +  +G + + D    
Sbjct: 182 DFVYVFRGDEGILALHILTAQLIRLAANLQSKGLVHGHFTPDNLFIMPDGRLMLGDVSAL 241

Query: 262 RVQAQSGVMTAETGTYRWMAPEVIEHK--PYDYKADVFSFGIALWELLTGELPYAGLTPL 319
                 G  ++   TY     E +      + +  + +  G++++ +    LP+  +TP 
Sbjct: 242 WKVGTRGPASSVPVTY--APREFLNASTATFTHALNAWQLGLSIYRVWCLFLPFGLVTPG 299

Query: 320 QAAVGVVQKSLRPTIP-------KHAHPRLAELLERCWQHDPTQRPNFSQI--TDILKQM 370
                       P                +  L+ R    D  +R    +   T    Q+
Sbjct: 300 IKGSWKRPSLRVPGTDSLAFGSCTPLPDFVKTLIGRFLNFDRRRRLLPLEAMETPEFLQL 359

Query: 371 MKEVAS 376
             E++S
Sbjct: 360 QNEISS 365

>3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335

 Score =  144 bits (366), Expect = 3e-40
 Identities = 57/257 (22%), Positives = 107/257 (41%), Gaps = 37/257 (14%)

Query: 126 SGSYGDLYKGTYCS--QEVAIKVL------KPECVNTEMLKEFSQEVYIMRKIRHKNVVQ 177
           SG++G ++        +EV +K +      +   +    L + + E+ I+ ++ H N+++
Sbjct: 34  SGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIK 93

Query: 178 FIGACTRPPNLCIVTEFMARGS-IYDFLHKQ--------KGVF-QLTSLLKVAIDVSKGM 227
            +          +V E    G  ++ F+ +           +F QL S    A+      
Sbjct: 94  VLDIFENQGFFQLVMEKHGSGLDLFAFIDRHPRLDEPLASYIFRQLVS----AVG----- 144

Query: 228 NYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAETGTYRWMAPEVIEH 287
            YL   +IIHRD+K  N+++ E+  +K+ DFG A    +  +     GT  + APEV+  
Sbjct: 145 -YLRLKDIIHRDIKDENIVIAEDFTIKLIDFGSAAYLERGKLFYTFCGTIEYCAPEVLMG 203

Query: 288 KPYD-YKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRLAELL 346
            PY   + +++S G+ L+ L+  E P+  L     A            P      L  L+
Sbjct: 204 NPYRGPELEMWSLGVTLYTLVFEENPFCELEETVEA--------AIHPPYLVSKELMSLV 255

Query: 347 ERCWQHDPTQRPNFSQI 363
               Q  P +R    ++
Sbjct: 256 SGLLQPVPERRTTLEKL 272

>2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276

 Score =  140 bits (354), Expect = 5e-39
 Identities = 62/252 (24%), Positives = 127/252 (50%), Gaps = 29/252 (11%)

Query: 127 GSYGDLYKGTYCS--QEVAIKVL-KPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACT 183
           G++G +  G +     +VA+K+L + +  + +++ +  +E+  ++  RH ++++     +
Sbjct: 22  GTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVIS 81

Query: 184 RPPNLCIVTEFMARGSIYDFLHKQKGV--------F-QLTSLLKVAIDVSKGMNYLHQNN 234
            P +  +V E+++ G ++D++ K   V        F Q+ S           ++Y H++ 
Sbjct: 82  TPTDFFMVMEYVSGGELFDYICKHGRVEEMEARRLFQQILS----------AVDYCHRHM 131

Query: 235 IIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAETGTYRWMAPEVIEHKPYD-YK 293
           ++HRDLK  N+L+D +   K+ADFG++ + +    +    G+  + APEVI  + Y   +
Sbjct: 132 VVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRTSCGSPNYAAPEVISGRLYAGPE 191

Query: 294 ADVFSFGIALWELLTGELPYAG--LTPLQAAVGVVQKSLRPTIPKHAHPRLAELLERCWQ 351
            D++S G+ L+ LL G LP+    +  L   +    +     IP++ +  +A LL    Q
Sbjct: 192 VDIWSCGVILYALLCGTLPFDDEHVPTLFKKI----RGGVFYIPEYLNRSVATLLMHMLQ 247

Query: 352 HDPTQRPNFSQI 363
            DP +R     I
Sbjct: 248 VDPLKRATIKDI 259

>2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298

 Score =  139 bits (353), Expect = 1e-38
 Identities = 70/281 (24%), Positives = 117/281 (41%), Gaps = 58/281 (20%)

Query: 127 GSYGDLYKGT--YCSQEVAIKVL------------------------KPECVNTEMLKEF 160
           GSYG +        +   A+KVL                                 +++ 
Sbjct: 24  GSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQV 83

Query: 161 SQEVYIMRKIRHKNVVQF---IGACTRPPNLCIVTEFMARGSIYDFLHKQK-------GV 210
            QE+ I++K+ H NVV+    +       +L +V E + +G + +    +          
Sbjct: 84  YQEIAILKKLDHPNVVKLVEVLDDPNED-HLYMVFELVNQGPVMEVPTLKPLSEDQARFY 142

Query: 211 FQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVM 270
           FQ         D+ KG+ YLH   IIHRD+K +NLL+ E+G +K+ADFGV+     S  +
Sbjct: 143 FQ---------DLIKGIEYLHYQKIIHRDIKPSNLLVGEDGHIKIADFGVSNEFKGSDAL 193

Query: 271 TAET-GTYRWMAPEVI--EHKPYD-YKADVFSFGIALWELLTGELPYAG--LTPLQAAVG 324
            + T GT  +MAPE +    K +     DV++ G+ L+  + G+ P+    +  L + + 
Sbjct: 194 LSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMDERIMCLHSKI- 252

Query: 325 VVQKSLRPTIPKHAH--PRLAELLERCWQHDPTQRPNFSQI 363
              KS     P        L +L+ R    +P  R    +I
Sbjct: 253 ---KSQALEFPDQPDIAEDLKDLITRMLDKNPESRIVVPEI 290

>2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309

 Score =  139 bits (352), Expect = 2e-38
 Identities = 51/251 (20%), Positives = 97/251 (38%), Gaps = 17/251 (6%)

Query: 119 KIECKVASGSYGDLYKG--TYCSQEVAIKVLKPECVNTEMLKE-FSQEVYIMRKIRHKNV 175
           ++   V  G  GD+Y+   T   + VA+K++     +  + +    +E     +++  +V
Sbjct: 37  RLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHV 96

Query: 176 VQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNI 235
           V           L +    +    +   L +++G       + +   +   ++  H    
Sbjct: 97  VPIHDFGEIDGQLYVDMRLINGVDLAAML-RRQGPLAPPRAVAIVRQIGSALDAAHAAGA 155

Query: 236 IHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAET--GTYRWMAPEVIEHKPYDYK 293
            HRD+K  N+L+  +    + DFG+A       +       GT  +MAPE        Y+
Sbjct: 156 THRDVKPENILVSADDFAYLVDFGIASATTDEKLTQLGNTVGTLYYMAPERFSESHATYR 215

Query: 294 ADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQ------KSLRPTIPKHAHPRLAELLE 347
           AD+++    L+E LTG  PY G   L      +        ++RP IP         ++ 
Sbjct: 216 ADIYALTCVLYECLTGSPPYQG-DQLSVMGAHINQAIPRPSTVRPGIP----VAFDAVIA 270

Query: 348 RCWQHDPTQRP 358
           R    +P  R 
Sbjct: 271 RGMAKNPEDRY 281

>2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434

 Score =  141 bits (358), Expect = 3e-38
 Identities = 57/276 (20%), Positives = 114/276 (41%), Gaps = 45/276 (16%)

Query: 126 SGSYGDL-YKGTYCSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKI-RHKNVVQFIGACT 183
            GS G + ++G++  + VA+K +  +            E+ ++ +   H NV+++  + T
Sbjct: 25  YGSSGTVVFQGSFQGRPVAVKRMLIDFC-----DIALMEIKLLTESDDHPNVIRYYCSET 79

Query: 184 RPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSK-------GMNYLHQNNII 236
               L I  E     ++ D + + K V      L+   +          G+ +LH   II
Sbjct: 80  TDRFLYIALELCN-LNLQDLV-ESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSLKII 137

Query: 237 HRDLKTANLLMD-------------ENGVVKVADFGVARV-----QAQSGVMTAETGTYR 278
           HRDLK  N+L+              EN  + ++DFG+ +       +    +   +GT  
Sbjct: 138 HRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQSSFRTNLNNPSGTSG 197

Query: 279 WMAPEVIE-------HKPYDYKADVFSFGIALWELLT-GELPYAGLTPLQAAV--GVVQ- 327
           W APE++E        +      D+FS G   + +L+ G+ P+      ++ +  G+   
Sbjct: 198 WRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYSRESNIIRGIFSL 257

Query: 328 KSLRPTIPKHAHPRLAELLERCWQHDPTQRPNFSQI 363
             ++    +       +L+ +   HDP +RP   ++
Sbjct: 258 DEMKCLHDRSLIAEATDLISQMIDHDPLKRPTAMKV 293

>2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276

 Score =  137 bits (347), Expect = 5e-38
 Identities = 64/254 (25%), Positives = 113/254 (44%), Gaps = 27/254 (10%)

Query: 126 SGSYGDLYKGTYCS--QEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACT 183
            G+YG++         + VA+K++  +    +  +   +E+ I + + H+NVV+F G   
Sbjct: 17  EGAYGEVQLAVNRVTEEAVAVKIVDMKRA-VDCPENIKKEICINKMLNHENVVKFYGHRR 75

Query: 184 RPPNLCIVTEFMARGSIYDFLHKQKGV--------F-QLTSLLKVAIDVSKGMNYLHQNN 234
                 +  E+ + G ++D +    G+        F QL +          G+ YLH   
Sbjct: 76  EGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMA----------GVVYLHGIG 125

Query: 235 IIHRDLKTANLLMDENGVVKVADFG---VARVQAQSGVMTAETGTYRWMAPEVIEHKPYD 291
           I HRD+K  NLL+DE   +K++DFG   V R   +  ++    GT  ++APE+++ + + 
Sbjct: 126 ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFH 185

Query: 292 -YKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKSLRPTIP-KHAHPRLAELLERC 349
               DV+S GI L  +L GELP+   +         ++      P K        LL + 
Sbjct: 186 AEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLALLHKI 245

Query: 350 WQHDPTQRPNFSQI 363
              +P+ R     I
Sbjct: 246 LVENPSARITIPDI 259

>3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336

 Score =  136 bits (345), Expect = 4e-37
 Identities = 71/252 (28%), Positives = 123/252 (48%), Gaps = 30/252 (11%)

Query: 127 GSYGDLYKGTYCS--QEVAIKVL-KPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACT 183
           GS+G +   T+    Q+VA+K + +     ++M     +E+  ++ +RH ++++     T
Sbjct: 20  GSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYDVIT 79

Query: 184 RPPNLCIVTEFMARGSIYDFLHKQKGV--------F-QLTSLLKVAIDVSKGMNYLHQNN 234
            P ++ +V E+ A G ++D++ ++K +        F Q+             + Y H++ 
Sbjct: 80  TPTDIVMVIEY-AGGELFDYIVEKKRMTEDEGRRFFQQIIC----------AIEYCHRHK 128

Query: 235 IIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAETGTYRWMAPEVIEHKPYD-YK 293
           I+HRDLK  NLL+D+N  VK+ADFG++ +      +    G+  + APEVI  K Y   +
Sbjct: 129 IVHRDLKPENLLLDDNLNVKIADFGLSNIMTDGNFLKTSCGSPNYAAPEVINGKLYAGPE 188

Query: 294 ADVFSFGIALWELLTGELPYAG--LTPLQAAVGVVQKSLRPTIPKHAHPRLAELLERCWQ 351
            DV+S GI L+ +L G LP+    +  L   V     S    +P    P    L+ R   
Sbjct: 189 VDVWSCGIVLYVMLVGRLPFDDEFIPNLFKKV----NSCVYVMPDFLSPGAQSLIRRMIV 244

Query: 352 HDPTQRPNFSQI 363
            DP QR    +I
Sbjct: 245 ADPMQRITIQEI 256

>3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494

 Score =  139 bits (353), Expect = 4e-37
 Identities = 77/290 (26%), Positives = 140/290 (48%), Gaps = 21/290 (7%)

Query: 119 KIECKVASGSYGDLYKGTYCS--QEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVV 176
           +   K+ SG+YG++          E AIK+++   V+T    +  +EV +++ + H N++
Sbjct: 40  QRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIM 99

Query: 177 QFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNII 236
           +         N  +V E    G ++D +   +  F       +   V  G+ YLH++NI+
Sbjct: 100 KLYDFFEDKRNYYLVMECYKGGELFDEI-IHRMKFNEVDAAVIIKQVLSGVTYLHKHNIV 158

Query: 237 HRDLKTANLLM---DENGVVKVADFGVARVQAQSGVMTAETGTYRWMAPEVIEHKPYDYK 293
           HRDLK  NLL+   +++ ++K+ DFG++ V      M    GT  ++APEV+  K YD K
Sbjct: 159 HRDLKPENLLLESKEKDALIKIVDFGLSAVFENQKKMKERLGTAYYIAPEVL-RKKYDEK 217

Query: 294 ADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKSLR------PTIPKHAHPRLAELLE 347
            DV+S G+ L+ LL G  P+ G T  +    V +            + + A     +L++
Sbjct: 218 CDVWSIGVILFILLAGYPPFGGQTDQEILRKVEKGKYTFDSPEWKNVSEGA----KDLIK 273

Query: 348 RCWQHDPTQRPNFSQITDILK-QMMKEVASEGENNHSNKSAGSFFSSLRR 396
           +  Q D  +R +  Q    L+   +KE+ S+ E+     S  +   ++R+
Sbjct: 274 QMLQFDSQRRISAQQ---ALEHPWIKEMCSKKESGIELPSLANAIENMRK 320

>2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476

 Score =  138 bits (350), Expect = 7e-37
 Identities = 61/252 (24%), Positives = 128/252 (50%), Gaps = 29/252 (11%)

Query: 127 GSYGDLYKGTYCS--QEVAIKVL-KPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACT 183
           G++G +  G +     +VA+K+L + +  + +++ +  +E+  ++  RH ++++     +
Sbjct: 27  GTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQVIS 86

Query: 184 RPPNLCIVTEFMARGSIYDFLHKQKGV--------F-QLTSLLKVAIDVSKGMNYLHQNN 234
            P ++ +V E+++ G ++D++ K   +        F Q+ S          G++Y H++ 
Sbjct: 87  TPSDIFMVMEYVSGGELFDYICKNGRLDEKESRRLFQQILS----------GVDYCHRHM 136

Query: 235 IIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAETGTYRWMAPEVIEHKPYD-YK 293
           ++HRDLK  N+L+D +   K+ADFG++ + +    +    G+  + APEVI  + Y   +
Sbjct: 137 VVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRTSCGSPNYAAPEVISGRLYAGPE 196

Query: 294 ADVFSFGIALWELLTGELPYAG--LTPLQAAVGVVQKSLRPTIPKHAHPRLAELLERCWQ 351
            D++S G+ L+ LL G LP+    +  L   +           P++ +P +  LL+   Q
Sbjct: 197 VDIWSSGVILYALLCGTLPFDDDHVPTLFKKI----CDGIFYTPQYLNPSVISLLKHMLQ 252

Query: 352 HDPTQRPNFSQI 363
            DP +R     I
Sbjct: 253 VDPMKRATIKDI 264

>3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323

 Score =  135 bits (342), Expect = 7e-37
 Identities = 64/254 (25%), Positives = 113/254 (44%), Gaps = 27/254 (10%)

Query: 126 SGSYGDLYKGTYCS--QEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACT 183
            G+YG++         + VA+K++  +    +  +   +E+ I + + H+NVV+F G   
Sbjct: 17  EGAYGEVQLAVNRVTEEAVAVKIVDMKRA-VDCPENIKKEICINKMLNHENVVKFYGHRR 75

Query: 184 RPPNLCIVTEFMARGSIYDFLHKQKGV--------F-QLTSLLKVAIDVSKGMNYLHQNN 234
                 +  E+ + G ++D +    G+        F QL +          G+ YLH   
Sbjct: 76  EGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMA----------GVVYLHGIG 125

Query: 235 IIHRDLKTANLLMDENGVVKVADFG---VARVQAQSGVMTAETGTYRWMAPEVIEHKPYD 291
           I HRD+K  NLL+DE   +K++DFG   V R   +  ++    GT  ++APE+++ + + 
Sbjct: 126 ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFH 185

Query: 292 -YKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKSLRPTIP-KHAHPRLAELLERC 349
               DV+S GI L  +L GELP+   +         ++      P K        LL + 
Sbjct: 186 AEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLALLHKI 245

Query: 350 WQHDPTQRPNFSQI 363
              +P+ R     I
Sbjct: 246 LVENPSARITIPDI 259

>2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312

 Score =  135 bits (341), Expect = 7e-37
 Identities = 61/262 (23%), Positives = 105/262 (40%), Gaps = 45/262 (17%)

Query: 126 SGSYGDLYKGTYCS--QEVAIKVLKPECVNT----EMLKEFSQEVYIMRKIR----HKNV 175
            G +G ++ G   +   +VAIKV+    V              EV ++ K+     H  V
Sbjct: 41  KGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGV 100

Query: 176 VQFIGACTRPPNLCIVTEFMARGS-IYDFLHKQ--------KGVF-QLTSLLKVAIDVSK 225
           ++ +          +V E       ++D++ ++        +  F Q+ +    AI    
Sbjct: 101 IRLLDWFETQEGFMLVLERPLPAQDLFDYITEKGPLGEGPSRCFFGQVVA----AIQ--- 153

Query: 226 GMNYLHQNNIIHRDLKTANLLMD-ENGVVKVADFGVARVQAQSGVMTAETGTYRWMAPEV 284
              + H   ++HRD+K  N+L+D   G  K+ DFG   +       T   GT  +  PE 
Sbjct: 154 ---HCHSRGVVHRDIKDENILIDLRRGCAKLIDFGSGALL-HDEPYTDFDGTRVYSPPEW 209

Query: 285 IEHKPYD-YKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKSLR--PTIPKHAHPR 341
           I    Y    A V+S GI L++++ G++P+             Q+ L      P H  P 
Sbjct: 210 ISRHQYHALPATVWSLGILLYDMVCGDIPFER----------DQEILEAELHFPAHVSPD 259

Query: 342 LAELLERCWQHDPTQRPNFSQI 363
              L+ RC    P+ RP+  +I
Sbjct: 260 CCALIRRCLAPKPSSRPSLEEI 281

>3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486

 Score =  138 bits (349), Expect = 1e-36
 Identities = 74/290 (25%), Positives = 134/290 (46%), Gaps = 21/290 (7%)

Query: 119 KIECKVASGSYGDLYKGTYCS--QEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVV 176
            I C +  GS+G++ K       QE A+KV+       +      +EV +++K+ H N++
Sbjct: 25  NIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIM 84

Query: 177 QFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNII 236
           +         +  IV E    G ++D +  ++  F      ++   V  G+ Y+H++NI+
Sbjct: 85  KLFEILEDSSSFYIVGELYTGGELFDEI-IKRKRFSEHDAARIIKQVFSGITYMHKHNIV 143

Query: 237 HRDLKTANLLM---DENGVVKVADFGVARVQAQSGVMTAETGTYRWMAPEVIEHKPYDYK 293
           HRDLK  N+L+   +++  +K+ DFG++    Q+  M    GT  ++APEV+    YD K
Sbjct: 144 HRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDRIGTAYYIAPEVL-RGTYDEK 202

Query: 294 ADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKSLR------PTIPKHAHPRLAELLE 347
            DV+S G+ L+ LL+G  P+ G         V             TI   A     +L+ 
Sbjct: 203 CDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGKYAFDLPQWRTISDDA----KDLIR 258

Query: 348 RCWQHDPTQRPNFSQITDILK-QMMKEVASEGENNHSNKSAGSFFSSLRR 396
           +     P+ R   +Q    L+   +++ +SE        S  S  +++R+
Sbjct: 259 KMLTFHPSLRITATQ---CLEHPWIQKYSSETPTISDLPSLESAMTNIRQ 305

>3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484

 Score =  137 bits (348), Expect = 1e-36
 Identities = 63/257 (24%), Positives = 118/257 (45%), Gaps = 18/257 (7%)

Query: 119 KIECKVASGSYGDLYKGTYCS--QEVAIKVL-KPECVNTEMLKEFSQEVYIMRKIRHKNV 175
           K +  +  GS+G++         QE A+KV+ K +       +   +EV +++++ H N+
Sbjct: 29  KGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNI 88

Query: 176 VQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNI 235
           ++            +V E    G ++D +   +  F      ++   V  G+ Y+H+N I
Sbjct: 89  MKLYEFFEDKGYFYLVGEVYTGGELFDEI-ISRKRFSEVDAARIIRQVLSGITYMHKNKI 147

Query: 236 IHRDLKTANLLM---DENGVVKVADFGVARVQAQSGVMTAETGTYRWMAPEVIEHKPYDY 292
           +HRDLK  NLL+    ++  +++ DFG++     S  M  + GT  ++APEV+ H  YD 
Sbjct: 148 VHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKMKDKIGTAYYIAPEVL-HGTYDE 206

Query: 293 KADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKSLR------PTIPKHAHPRLAELL 346
           K DV+S G+ L+ LL+G  P+ G         V +            + + A     +L+
Sbjct: 207 KCDVWSTGVILYILLSGCPPFNGANEYDILKKVEKGKYTFELPQWKKVSESA----KDLI 262

Query: 347 ERCWQHDPTQRPNFSQI 363
            +   + P+ R +    
Sbjct: 263 RKMLTYVPSMRISARDA 279

>3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320

 Score =  134 bits (339), Expect = 2e-36
 Identities = 59/258 (22%), Positives = 110/258 (42%), Gaps = 39/258 (15%)

Query: 126 SGSYGDLYKGTYCS--QEVAIKVLKPECVNT----EMLKEFSQEVYIMRKIRHK--NVVQ 177
           SG +G +Y G   S    VAIK ++ + ++             EV +++K+      V++
Sbjct: 53  SGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIR 112

Query: 178 FIGACTRPPNLCIVTEFMA-RGSIYDFLHKQ--------KGVF-QLTSLLKVAIDVSKGM 227
            +    RP +  ++ E       ++DF+ ++        +  F Q+      A+      
Sbjct: 113 LLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLE----AVR----- 163

Query: 228 NYLHQNNIIHRDLKTANLLMDEN-GVVKVADFGVARVQAQSGVMTAETGTYRWMAPEVIE 286
            + H   ++HRD+K  N+L+D N G +K+ DFG   +  +  V T   GT  +  PE I 
Sbjct: 164 -HCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALL-KDTVYTDFDGTRVYSPPEWIR 221

Query: 287 HKPYD-YKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRLAEL 345
           +  Y    A V+S GI L++++ G++P+     +           +    +        L
Sbjct: 222 YHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRG--------QVFFRQRVSSECQHL 273

Query: 346 LERCWQHDPTQRPNFSQI 363
           +  C    P+ RP F +I
Sbjct: 274 IRWCLALRPSDRPTFEEI 291

>3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361

 Score =  135 bits (341), Expect = 3e-36
 Identities = 68/257 (26%), Positives = 113/257 (43%), Gaps = 33/257 (12%)

Query: 126 SGSYGDLYKGTYCS--QEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACT 183
           SG++G           + VA+K ++      E ++   +E+   R +RH N+V+F     
Sbjct: 30  SGNFGVARLMRDKLTKELVAVKYIERGAAIDENVQ---REIINHRSLRHPNIVRFKEVIL 86

Query: 184 RPPNLCIVTEFMARGSIYDFLHKQKGVF----------QLTSLLKVAIDVSKGMNYLHQN 233
            P +L I+ E+ + G +Y+ +    G F          QL S          G++Y H  
Sbjct: 87  TPTHLAIIMEYASGGELYERI-CNAGRFSEDEARFFFQQLLS----------GVSYCHSM 135

Query: 234 NIIHRDLKTANLLMDENGV--VKVADFGVARVQAQSGVMTAETGTYRWMAPEVIEHKPYD 291
            I HRDLK  N L+D +    +K+ DFG ++         +  GT  ++APEV+  + YD
Sbjct: 136 QICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRQEYD 195

Query: 292 -YKADVFSFGIALWELLTGELPYAG--LTPLQAAVGVVQKSLRPTIPKHAH--PRLAELL 346
              ADV+S G+ L+ +L G  P+                 S++ +IP      P    L+
Sbjct: 196 GKIADVWSCGVTLYVMLVGAYPFEDPEEPRDYRKTIQRILSVKYSIPDDIRISPECCHLI 255

Query: 347 ERCWQHDPTQRPNFSQI 363
            R +  DP  R +  +I
Sbjct: 256 SRIFVADPATRISIPEI 272

>2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305

 Score =  133 bits (336), Expect = 4e-36
 Identities = 64/261 (24%), Positives = 115/261 (44%), Gaps = 39/261 (14%)

Query: 127 GSYGDLYKGTYCS--QEVAIKVLKPECVNT--EMLKEFSQEVYIMRKIRHKNVVQF---I 179
           GSYG + +          A+K+LK + +           +E+ ++R++RHKNV+Q    +
Sbjct: 16  GSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLVDVL 75

Query: 180 GACTRPPNLCIVTEFMARGS--IYDFLHKQK-------GVF-QLTSLLKVAIDVSKGMNY 229
                   + +V E+   G   + D + +++       G F QL            G+ Y
Sbjct: 76  YNEE-KQKMYMVMEYCVCGMQEMLDSVPEKRFPVCQAHGYFCQLID----------GLEY 124

Query: 230 LHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQ---AQSGVMTAETGTYRWMAPEVIE 286
           LH   I+H+D+K  NLL+   G +K++  GVA      A         G+  +  PE+  
Sbjct: 125 LHSQGIVHKDIKPGNLLLTTGGTLKISALGVAEALHPFAADDTCRTSQGSPAFQPPEIAN 184

Query: 287 -HKPYD-YKADVFSFGIALWELLTGELPYAG--LTPLQAAVGVVQKSLRPTIPKHAHPRL 342
               +  +K D++S G+ L+ + TG  P+ G  +  L   +          IP    P L
Sbjct: 185 GLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDNIYKLFENI----GKGSYAIPGDCGPPL 240

Query: 343 AELLERCWQHDPTQRPNFSQI 363
           ++LL+   +++P +R +  QI
Sbjct: 241 SDLLKGMLEYEPAKRFSIRQI 261

>3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377

 Score =  134 bits (338), Expect = 5e-36
 Identities = 42/301 (13%), Positives = 96/301 (31%), Gaps = 61/301 (20%)

Query: 126 SGSYGDLYKGTYCS--QEVAIKVL-KPECVNTEMLKEFSQEVYIMRKIR----------- 171
                   + T     +   + V    E   +  +K+  +EV  +R +R           
Sbjct: 83  QEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVH 142

Query: 172 --------------HKNVVQFIGACTRPPNLCIVTEFM-ARGSIYDFLH------KQKGV 210
                          K +++          L     +   + ++  F             
Sbjct: 143 LRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTHKS 202

Query: 211 FQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVM 270
               + L++ + V + +  LH   ++H  L+  ++++D+ G V +  F       + G  
Sbjct: 203 LVHHARLQLTLQVIRLLASLHHYGLVHTYLRPVDIVLDQRGGVFLTGFEHLV---RDGAR 259

Query: 271 TAETGTYRWMAPEVI-----------EHKPYDYKADVFSFGIALWELLTGELPYAGLTPL 319
              + +  +  PE+                  +  D ++ G+ ++ +   +LP       
Sbjct: 260 VVSSVSRGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIYWIWCADLPITK---- 315

Query: 320 QAAVGVVQKSLR--PTIPKHAHPRLAELLERCWQHDPTQRPNFSQI--TDILKQMMKEVA 375
            AA+G  +   R    IP+        LLE   ++    R    Q   T   +Q+  E++
Sbjct: 316 DAALGGSEWIFRSCKNIPQPVR----ALLEGFLRYPKEDRLLPLQAMETPEYEQLRTELS 371

Query: 376 S 376
           +
Sbjct: 372 A 372

>2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287

 Score =  130 bits (330), Expect = 2e-35
 Identities = 57/192 (29%), Positives = 101/192 (52%), Gaps = 7/192 (3%)

Query: 126 SGSYGDLYKGTYCS--QEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACT 183
            GS+G++ K       QE A+KV+       +      +EV +++K+ H N+++      
Sbjct: 32  KGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILE 91

Query: 184 RPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTA 243
              +  IV E    G ++D +  ++  F      ++   V  G+ Y+H++NI+HRDLK  
Sbjct: 92  DSSSFYIVGELYTGGELFDEI-IKRKRFSEHDAARIIKQVFSGITYMHKHNIVHRDLKPE 150

Query: 244 NLLM---DENGVVKVADFGVARVQAQSGVMTAETGTYRWMAPEVIEHKPYDYKADVFSFG 300
           N+L+   +++  +K+ DFG++    Q+  M    GT  ++APEV+    YD K DV+S G
Sbjct: 151 NILLESKEKDCDIKIIDFGLSTCFQQNTKMKDRIGTAYYIAPEVL-RGTYDEKCDVWSAG 209

Query: 301 IALWELLTGELP 312
           + L+ LL+G  P
Sbjct: 210 VILYILLSGTPP 221

>3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284

 Score =  130 bits (329), Expect = 2e-35
 Identities = 46/192 (23%), Positives = 93/192 (48%), Gaps = 6/192 (3%)

Query: 126 SGSYGDLYKGTYCS--QEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACT 183
            G++  + +  + +   E A K++  + ++    ++  +E  I RK++H N+V+   +  
Sbjct: 16  KGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQ 75

Query: 184 RPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTA 243
                 +V + +  G +++ +   +  +           + + + Y H N I+HR+LK  
Sbjct: 76  EESFHYLVFDLVTGGELFEDI-VAREFYSEADASHCIQQILESIAYCHSNGIVHRNLKPE 134

Query: 244 NLLM---DENGVVKVADFGVARVQAQSGVMTAETGTYRWMAPEVIEHKPYDYKADVFSFG 300
           NLL+    +   VK+ADFG+A     S       GT  +++PEV++  PY    D+++ G
Sbjct: 135 NLLLASKAKGAAVKLADFGLAIEVNDSEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACG 194

Query: 301 IALWELLTGELP 312
           + L+ LL G  P
Sbjct: 195 VILYILLVGYPP 206

>3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277

 Score =  128 bits (324), Expect = 1e-34
 Identities = 49/193 (25%), Positives = 91/193 (47%), Gaps = 11/193 (5%)

Query: 126 SGSYGDLYKGTYCS--QEVAIKVL-KPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGAC 182
            GS+G++            A K + K    + +  K   QE+ IM+ + H N+++     
Sbjct: 19  RGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFK---QEIEIMKSLDHPNIIRLYETF 75

Query: 183 TRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKT 242
               ++ +V E    G +++ +   K VF+ +   ++  DV   + Y H+ N+ HRDLK 
Sbjct: 76  EDNTDIYLVMELCTGGELFERV-VHKRVFRESDAARIMKDVLSAVAYCHKLNVAHRDLKP 134

Query: 243 ANLLM---DENGVVKVADFGVARVQAQSGVMTAETGTYRWMAPEVIEHKPYDYKADVFSF 299
            N L      +  +K+ DFG+A       +M  + GT  +++P+V+    Y  + D +S 
Sbjct: 135 ENFLFLTDSPDSPLKLIDFGLAARFKPGKMMRTKVGTPYYVSPQVL-EGLYGPECDEWSA 193

Query: 300 GIALWELLTGELP 312
           G+ ++ LL G  P
Sbjct: 194 GVMMYVLLCGYPP 206

>3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345

 Score =  130 bits (328), Expect = 1e-34
 Identities = 61/297 (20%), Positives = 110/297 (37%), Gaps = 63/297 (21%)

Query: 126 SGSYGDLYKGTYCS--QEVAIKVL---KPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIG 180
            GSYG +            AIK++   K   +N + ++    EV +M+K+ H N+ +   
Sbjct: 36  QGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYE 95

Query: 181 ACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLL----------------------- 217
                  +C+V E    G + D L+           +                       
Sbjct: 96  VYEDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIH 155

Query: 218 ----------------KVAIDVSKGMNYLHQNNIIHRDLKTANLLM--DENGVVKVADFG 259
                            +   +   ++YLH   I HRD+K  N L   +++  +K+ DFG
Sbjct: 156 GFRESLDFVQREKLISNIMRQIFSALHYLHNQGICHRDIKPENFLFSTNKSFEIKLVDFG 215

Query: 260 VARV-----QAQSGVMTAETGTYRWMAPEVIE--HKPYDYKADVFSFGIALWELLTGELP 312
           +++        +   MT + GT  ++APEV+   ++ Y  K D +S G+ L  LL G +P
Sbjct: 216 LSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCDAWSAGVLLHLLLMGAVP 275

Query: 313 YAGLTPLQAAVGVVQKSLR------PTIPKHAHPRLAELLERCWQHDPTQRPNFSQI 363
           + G+        V+ K L         +   A     +LL      +  +R +  + 
Sbjct: 276 FPGVNDADTISQVLNKKLCFENPNYNVLSPLAR----DLLSNLLNRNVDERFDAMRA 328

>1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321

 Score =  129 bits (327), Expect = 1e-34
 Identities = 41/201 (20%), Positives = 89/201 (44%), Gaps = 7/201 (3%)

Query: 119 KIECKVASGSYGDLYKGTYCS--QEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVV 176
            I   +  G +G +++    S  +    K +K +  +  ++K   +E+ I+   RH+N++
Sbjct: 8   MIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVLVK---KEISILNIARHRNIL 64

Query: 177 QFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNII 236
               +      L ++ EF++   I++ ++          ++     V + + +LH +NI 
Sbjct: 65  HLHESFESMEELVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSHNIG 124

Query: 237 HRDLKTANLLM--DENGVVKVADFGVARVQAQSGVMTAETGTYRWMAPEVIEHKPYDYKA 294
           H D++  N++     +  +K+ +FG AR                + APEV +H       
Sbjct: 125 HFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRLLFTAPEYYAPEVHQHDVVSTAT 184

Query: 295 DVFSFGIALWELLTGELPYAG 315
           D++S G  ++ LL+G  P+  
Sbjct: 185 DMWSLGTLVYVLLSGINPFLA 205

>2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681

 Score =  134 bits (338), Expect = 2e-34
 Identities = 48/248 (19%), Positives = 89/248 (35%), Gaps = 25/248 (10%)

Query: 119 KIECKVASGSYGDLYKGT---YCSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNV 175
           +++  +A G  G +Y         + V +K L     + E       E   + ++ H ++
Sbjct: 83  EVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHS-GDAEAQAMAMAERQFLAEVVHPSI 141

Query: 176 VQFI-----GACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYL 230
           VQ             P   IV E++   S+            +   +   +++   ++YL
Sbjct: 142 VQIFNFVEHTDRHGDPVGYIVMEYVGGQSLKRSK---GQKLPVAEAIAYLLEILPALSYL 198

Query: 231 HQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAETGTYRWMAPEVIEHKPY 290
           H   +++ DLK  N+++ E   +K+ D G        G +    GT  + APE++   P 
Sbjct: 199 HSIGLVYNDLKPENIMLTEEQ-LKLIDLGAVSRINSFGYL---YGTPGFQAPEIVRTGPT 254

Query: 291 DYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRLAELLERCW 350
               D+++ G  L  L        G    +   G+ +                 LL R  
Sbjct: 255 V-ATDIYTVGRTLAALTLDLPTRNG----RYVDGLPEDDPVLKTY----DSYGRLLRRAI 305

Query: 351 QHDPTQRP 358
             DP QR 
Sbjct: 306 DPDPRQRF 313

>2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304

 Score =  128 bits (324), Expect = 2e-34
 Identities = 56/193 (29%), Positives = 103/193 (53%), Gaps = 11/193 (5%)

Query: 126 SGSYGDLYKGTYCS--QEVAIKVL-KPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGAC 182
           SG++ +++        +  A+K + K        L+    E+ +++KI+H+N+V      
Sbjct: 19  SGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLE---NEIAVLKKIKHENIVTLEDIY 75

Query: 183 TRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKT 242
               +  +V + ++ G ++D +  ++GV+       V   V   + YLH+N I+HRDLK 
Sbjct: 76  ESTTHYYLVMQLVSGGELFDRI-LERGVYTEKDASLVIQQVLSAVKYLHENGIVHRDLKP 134

Query: 243 ANLL---MDENGVVKVADFGVARVQAQSGVMTAETGTYRWMAPEVIEHKPYDYKADVFSF 299
            NLL    +EN  + + DFG+++++ Q+G+M+   GT  ++APEV+  KPY    D +S 
Sbjct: 135 ENLLYLTPEENSKIMITDFGLSKME-QNGIMSTACGTPGYVAPEVLAQKPYSKAVDCWSI 193

Query: 300 GIALWELLTGELP 312
           G+  + LL G  P
Sbjct: 194 GVITYILLCGYPP 206

>1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387

 Score =  130 bits (328), Expect = 2e-34
 Identities = 43/205 (20%), Positives = 104/205 (50%), Gaps = 14/205 (6%)

Query: 119 KIECKVASGSYGDLYKGTYCS--QEVAIKVL-KPECVNTEMLKEFSQEVYIMRKIRHKNV 175
            I  ++ SG++G +++    +  +    K +  P  ++   +K    E+ IM ++ H  +
Sbjct: 54  DILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVK---NEISIMNQLHHPKL 110

Query: 176 VQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVF---QLTSLLKVAIDVSKGMNYLHQ 232
           +    A      + ++ EF++ G ++D +  +       ++ + ++      +G+ ++H+
Sbjct: 111 INLHDAFEDKYEMVLILEFLSGGELFDRIAAEDYKMSEAEVINYMR---QACEGLKHMHE 167

Query: 233 NNIIHRDLKTANLLM--DENGVVKVADFGVARVQAQSGVMTAETGTYRWMAPEVIEHKPY 290
           ++I+H D+K  N++    +   VK+ DFG+A       ++   T T  + APE+++ +P 
Sbjct: 168 HSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVKVTTATAEFAAPEIVDREPV 227

Query: 291 DYKADVFSFGIALWELLTGELPYAG 315
            +  D+++ G+  + LL+G  P+AG
Sbjct: 228 GFYTDMWAIGVLGYVLLSGLSPFAG 252

>3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419

 Score =  130 bits (329), Expect = 3e-34
 Identities = 56/263 (21%), Positives = 111/263 (42%), Gaps = 35/263 (13%)

Query: 126 SGSYGDLYKGTYCS--QEVAIKVLK------PECVNTEMLKEFSQEVYIMRKIRHKNVVQ 177
           SG+ G++         ++VAI+++             +       E+ I++K+ H  +++
Sbjct: 145 SGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIK 204

Query: 178 FIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIH 237
                    +  IV E M  G ++D +       +  +       +   + YLH+N IIH
Sbjct: 205 IKNFFD-AEDYYIVLELMEGGELFDKV-VGNKRLKEATCKLYFYQMLLAVQYLHENGIIH 262

Query: 238 RDLKTANLLM---DENGVVKVADFGVARVQAQSGVMTAETGTYRWMAPEVIE---HKPYD 291
           RDLK  N+L+   +E+ ++K+ DFG +++  ++ +M    GT  ++APEV+       Y+
Sbjct: 263 RDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLCGTPTYLAPEVLVSVGTAGYN 322

Query: 292 YKADVFSFGIALWELLTGELP-YAGLTPLQAAVGVVQKSLR----------PTIPKHAHP 340
              D +S G+ L+  L+G  P     T     V +  +               + + A  
Sbjct: 323 RAVDCWSLGVILFICLSGYPPFSEHRTQ----VSLKDQITSGKYNFIPEVWAEVSEKA-- 376

Query: 341 RLAELLERCWQHDPTQRPNFSQI 363
              +L+++    DP  R    + 
Sbjct: 377 --LDLVKKLLVVDPKARFTTEEA 397

>3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413

 Score =  130 bits (327), Expect = 5e-34
 Identities = 35/283 (12%), Positives = 89/283 (31%), Gaps = 50/283 (17%)

Query: 126 SGSYGDLYKGTYCS--QEVAIKVL-KPECVNTEMLKEFSQEVYIMRKIR----------- 171
                   + T     +   + V    E   +  +K+  +EV  +R +R           
Sbjct: 88  QEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVH 147

Query: 172 -----------HKNVVQFIGACTRPPNLCIVTEFM----ARGSIYDFLH------KQKGV 210
                           + I       ++ +++ F      + ++  F             
Sbjct: 148 LRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTHKS 207

Query: 211 FQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVM 270
               + L++ + V + +  LH   ++H  L+  ++++D+ G V +  F        +  +
Sbjct: 208 LVHHARLQLTLQVIRLLASLHHYGLVHTYLRPVDIVLDQRGGVFLTGFEHLVR-DGASAV 266

Query: 271 TAETGTY---RWMAPEVIEHKP-----YDYKADVFSFGIALWELLTGELPYAGLTPLQAA 322
           +     +      A  ++           +  D ++ G+A++ +   +LP      L  +
Sbjct: 267 SPIGRGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWCADLPNTDDAALGGS 326

Query: 323 VGVVQKSLRPTIPKHAHPRLAELLERCWQHDPTQRPNFSQITD 365
             + +      IP      +  LLE   ++    R    Q  +
Sbjct: 327 EWIFRSC--KNIP----QPVRALLEGFLRYPKEDRLLPLQAME 363

>2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362

 Score =  128 bits (324), Expect = 7e-34
 Identities = 46/192 (23%), Positives = 93/192 (48%), Gaps = 6/192 (3%)

Query: 126 SGSYGDLYKGTYCS--QEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACT 183
            G++  + +  + +   E A K++  + ++    ++  +E  I RK++H N+V+   +  
Sbjct: 39  KGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQ 98

Query: 184 RPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTA 243
                 +V + +  G +++ +   +  +           + + + Y H N I+HR+LK  
Sbjct: 99  EESFHYLVFDLVTGGELFEDI-VAREFYSEADASHCIQQILESIAYCHSNGIVHRNLKPE 157

Query: 244 NLLM---DENGVVKVADFGVARVQAQSGVMTAETGTYRWMAPEVIEHKPYDYKADVFSFG 300
           NLL+    +   VK+ADFG+A     S       GT  +++PEV++  PY    D+++ G
Sbjct: 158 NLLLASKAKGAAVKLADFGLAIEVNDSEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACG 217

Query: 301 IALWELLTGELP 312
           + L+ LL G  P
Sbjct: 218 VILYILLVGYPP 229

>3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327

 Score =  127 bits (321), Expect = 7e-34
 Identities = 53/218 (24%), Positives = 98/218 (44%), Gaps = 19/218 (8%)

Query: 108 TDVWEIDAKQLKIECKVASGSYGDLYKGTYCS--QEVAIKVLKPECVNTEMLKEFSQEVY 165
            + + + +K+L        G +  + +    S  QE A K LK      +   E   E+ 
Sbjct: 27  NNFYILTSKEL------GRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIA 80

Query: 166 IMRKIRH-KNVVQFIGACTRPPNLCIVTEFMARGSIYDFL-HKQKGVF---QLTSLLKVA 220
           ++   +    V+           + ++ E+ A G I+     +   +     +  L+K  
Sbjct: 81  VLELAKSCPRVINLHEVYENTSEIILILEYAAGGEIFSLCLPELAEMVSENDVIRLIK-- 138

Query: 221 IDVSKGMNYLHQNNIIHRDLKTANLLM---DENGVVKVADFGVARVQAQSGVMTAETGTY 277
             + +G+ YLHQNNI+H DLK  N+L+      G +K+ DFG++R    +  +    GT 
Sbjct: 139 -QILEGVYYLHQNNIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIGHACELREIMGTP 197

Query: 278 RWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPYAG 315
            ++APE++ + P     D+++ GI  + LLT   P+ G
Sbjct: 198 EYLAPEILNYDPITTATDMWNIGIIAYMLLTHTSPFVG 235

>3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573

 Score =  130 bits (329), Expect = 2e-33
 Identities = 52/202 (25%), Positives = 99/202 (49%), Gaps = 8/202 (3%)

Query: 119 KIECKVASGSYGDLYKGTYCS--QEVAIKVL-KPECVNTEMLKEFSQEVYIMRKIRHKNV 175
            I  ++ +G++G +++ T  +     A K +  P   + E ++   +E+  M  +RH  +
Sbjct: 160 DIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVR---KEIQTMSVLRHPTL 216

Query: 176 VQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNI 235
           V    A      + ++ EFM+ G +++ +  +         ++    V KG+ ++H+NN 
Sbjct: 217 VNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENNY 276

Query: 236 IHRDLKTANLLM--DENGVVKVADFGVARVQAQSGVMTAETGTYRWMAPEVIEHKPYDYK 293
           +H DLK  N++     +  +K+ DFG+         +   TGT  + APEV E KP  Y 
Sbjct: 277 VHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVTTGTAEFAAPEVAEGKPVGYY 336

Query: 294 ADVFSFGIALWELLTGELPYAG 315
            D++S G+  + LL+G  P+ G
Sbjct: 337 TDMWSVGVLSYILLSGLSPFGG 358

>3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351

 Score =  127 bits (320), Expect = 2e-33
 Identities = 53/201 (26%), Positives = 95/201 (47%), Gaps = 16/201 (7%)

Query: 126 SGSYGDLYKGTYCS--QEVAIKVL-KPECVNTEML--KEFSQEVYIMRKIRHKNVVQFIG 180
            G +  + +       Q+ A+K++   +  ++  L  ++  +E  I   ++H ++V+ + 
Sbjct: 34  KGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLE 93

Query: 181 ACTRPPNLCIVTEFMARGSIYDFL-HKQKGVFQLTSLLKVAIDVSK----GMNYLHQNNI 235
             +    L +V EFM    +   +  +    F  +    VA    +     + Y H NNI
Sbjct: 94  TYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSE--AVASHYMRQILEALRYCHDNNI 151

Query: 236 IHRDLKTANLLM---DENGVVKVADFGVAR-VQAQSGVMTAETGTYRWMAPEVIEHKPYD 291
           IHRD+K   +L+   + +  VK+  FGVA  +     V     GT  +MAPEV++ +PY 
Sbjct: 152 IHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESGLVAGGRVGTPHFMAPEVVKREPYG 211

Query: 292 YKADVFSFGIALWELLTGELP 312
              DV+  G+ L+ LL+G LP
Sbjct: 212 KPVDVWGCGVILFILLSGCLP 232

>3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283

 Score =  125 bits (316), Expect = 2e-33
 Identities = 56/210 (26%), Positives = 102/210 (48%), Gaps = 17/210 (8%)

Query: 119 KIECKVASGSYGDLYKGTYCS--QEVAIKVLK----PECVNTEMLKEFSQEVYIMRKIRH 172
           ++  ++ SG +  + K       +E A K +K             +E  +EV I+R+IRH
Sbjct: 8   EMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRH 67

Query: 173 KNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVF---QLTSLLKVAIDVSKGMNY 229
            N++          ++ ++ E ++ G ++DFL  +K      + T  LK    +  G++Y
Sbjct: 68  PNIITLHDIFENKTDVVLILELVSGGELFDFL-AEKESLTEDEATQFLK---QILDGVHY 123

Query: 230 LHQNNIIHRDLKTANLLM----DENGVVKVADFGVARVQAQSGVMTAETGTYRWMAPEVI 285
           LH   I H DLK  N+++      N  +K+ DFG+A             GT  ++APE++
Sbjct: 124 LHSKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEFKNIFGTPEFVAPEIV 183

Query: 286 EHKPYDYKADVFSFGIALWELLTGELPYAG 315
            ++P   +AD++S G+  + LL+G  P+ G
Sbjct: 184 NYEPLGLEADMWSIGVITYILLSGASPFLG 213

>3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285

 Score =  125 bits (315), Expect = 2e-33
 Identities = 57/247 (23%), Positives = 114/247 (46%), Gaps = 11/247 (4%)

Query: 126 SGSYGDLYKGTYCS--QEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACT 183
           SG++GD++     S   E  IK +  +      +++   E+ +++ + H N+++      
Sbjct: 32  SGAFGDVHLVEERSSGLERVIKTINKDRSQ-VPMEQIEAEIEVLKSLDHPNIIKIFEVFE 90

Query: 184 RPPNLCIVTEFMARGSIYDFL---HKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDL 240
              N+ IV E    G + + +     +        + ++   +   + Y H  +++H+DL
Sbjct: 91  DYHNMYIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQHVVHKDL 150

Query: 241 KTANLLM---DENGVVKVADFGVARVQAQSGVMTAETGTYRWMAPEVIEHKPYDYKADVF 297
           K  N+L      +  +K+ DFG+A +       T   GT  +MAPEV   +   +K D++
Sbjct: 151 KPENILFQDTSPHSPIKIIDFGLAELFKSDEHSTNAAGTALYMAPEVF-KRDVTFKCDIW 209

Query: 298 SFGIALWELLTGELPYAGLTPLQAAVGVVQKSLR-PTIPKHAHPRLAELLERCWQHDPTQ 356
           S G+ ++ LLTG LP+ G +  +       K        +   P+  +LL++    DP +
Sbjct: 210 SAGVVMYFLLTGCLPFTGTSLEEVQQKATYKEPNYAVECRPLTPQAVDLLKQMLTKDPER 269

Query: 357 RPNFSQI 363
           RP+ +Q+
Sbjct: 270 RPSAAQV 276

>2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321

 Score =  125 bits (315), Expect = 5e-33
 Identities = 54/200 (27%), Positives = 92/200 (46%), Gaps = 11/200 (5%)

Query: 126 SGSYGDLYKGTYCS--QEVAIKVLK----PECVNTEMLKEFSQEVYIMRKIRHKNVVQFI 179
           SG +  + K    S   E A K +K             +E  +EV I+R++ H NV+   
Sbjct: 22  SGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLH 81

Query: 180 GACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRD 239
                  ++ ++ E ++ G ++DFL  QK              +  G+NYLH   I H D
Sbjct: 82  DVYENRTDVVLILELVSGGELFDFL-AQKESLSEEEATSFIKQILDGVNYLHTKKIAHFD 140

Query: 240 LKTANLLM----DENGVVKVADFGVARVQAQSGVMTAETGTYRWMAPEVIEHKPYDYKAD 295
           LK  N+++         +K+ DFG+A             GT  ++APE++ ++P   +AD
Sbjct: 141 LKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIFGTPEFVAPEIVNYEPLGLEAD 200

Query: 296 VFSFGIALWELLTGELPYAG 315
           ++S G+  + LL+G  P+ G
Sbjct: 201 MWSIGVITYILLSGASPFLG 220

>2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361

 Score =  125 bits (317), Expect = 5e-33
 Identities = 53/200 (26%), Positives = 92/200 (46%), Gaps = 11/200 (5%)

Query: 126 SGSYGDLYKGTYCS--QEVAIKVLK----PECVNTEMLKEFSQEVYIMRKIRHKNVVQFI 179
           SG +  + K    S   E A K +K             +E  +EV I+R++ H N++   
Sbjct: 22  SGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLH 81

Query: 180 GACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRD 239
                  ++ ++ E ++ G ++DFL  QK              +  G+NYLH   I H D
Sbjct: 82  DVYENRTDVVLILELVSGGELFDFL-AQKESLSEEEATSFIKQILDGVNYLHTKKIAHFD 140

Query: 240 LKTANLLM----DENGVVKVADFGVARVQAQSGVMTAETGTYRWMAPEVIEHKPYDYKAD 295
           LK  N+++         +K+ DFG+A             GT  ++APE++ ++P   +AD
Sbjct: 141 LKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIFGTPEFVAPEIVNYEPLGLEAD 200

Query: 296 VFSFGIALWELLTGELPYAG 315
           ++S G+  + LL+G  P+ G
Sbjct: 201 MWSIGVITYILLSGASPFLG 220

>3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504

 Score =  127 bits (321), Expect = 1e-32
 Identities = 61/260 (23%), Positives = 114/260 (43%), Gaps = 28/260 (10%)

Query: 126 SGSYGDLYKGTYCS--QEVAIKVLK-----------PECVNTEMLKEFSQEVYIMRKIRH 172
           SG+YG++      +   E AIKV+K                 +  +E   E+ +++ + H
Sbjct: 46  SGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDH 105

Query: 173 KNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQ 232
            N+++            +VTEF   G +++ +   +  F       +   +  G+ YLH+
Sbjct: 106 PNIIKLFDVFEDKKYFYLVTEFYEGGELFEQI-INRHKFDECDAANIMKQILSGICYLHK 164

Query: 233 NNIIHRDLKTANLLM---DENGVVKVADFGVARVQAQSGVMTAETGTYRWMAPEVIEHKP 289
           +NI+HRD+K  N+L+   +    +K+ DFG++   ++   +    GT  ++APEV+  K 
Sbjct: 165 HNIVHRDIKPENILLENKNSLLNIKIVDFGLSSFFSKDYKLRDRLGTAYYIAPEVL-KKK 223

Query: 290 YDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKSLR------PTIPKHAHPRLA 343
           Y+ K DV+S G+ ++ LL G  P+ G         V +            I   A     
Sbjct: 224 YNEKCDVWSCGVIMYILLCGYPPFGGQNDQDIIKKVEKGKYYFDFNDWKNISDEA----K 279

Query: 344 ELLERCWQHDPTQRPNFSQI 363
           EL++    +D  +R    + 
Sbjct: 280 ELIKLMLTYDYNKRCTAEEA 299

>3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444

 Score =  126 bits (319), Expect = 1e-32
 Identities = 42/193 (21%), Positives = 93/193 (48%), Gaps = 7/193 (3%)

Query: 126 SGSYGDLYKGTYCS--QEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACT 183
            G++  + +       QE A  ++  + ++    ++  +E  I R ++H N+V+   + +
Sbjct: 21  KGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDSIS 80

Query: 184 RPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTA 243
              +  ++ + +  G +++ +   +  +           + + + + HQ  ++HR+LK  
Sbjct: 81  EEGHHYLIFDLVTGGELFEDI-VAREYYSEADASHCIQQILEAVLHCHQMGVVHRNLKPE 139

Query: 244 NLLM---DENGVVKVADFGVAR-VQAQSGVMTAETGTYRWMAPEVIEHKPYDYKADVFSF 299
           NLL+    +   VK+ADFG+A  V+ +        GT  +++PEV+   PY    D+++ 
Sbjct: 140 NLLLASKLKGAAVKLADFGLAIEVEGEQQAWFGFAGTPGYLSPEVLRKDPYGKPVDLWAC 199

Query: 300 GIALWELLTGELP 312
           G+ L+ LL G  P
Sbjct: 200 GVILYILLVGYPP 212

>2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322

 Score =  124 bits (313), Expect = 1e-32
 Identities = 51/208 (24%), Positives = 96/208 (46%), Gaps = 17/208 (8%)

Query: 126 SGSYGDLYKGTYCS--QEVAIKVLK------PECVNTEMLKEFSQEVYIMRKIRHKNVVQ 177
           SG+ G++         ++VAIK++             +       E+ I++K+ H  +++
Sbjct: 20  SGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIK 79

Query: 178 FIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIH 237
                    +  IV E M  G ++D +       +  +       +   + YLH+N IIH
Sbjct: 80  IKNFFD-AEDYYIVLELMEGGELFDKV-VGNKRLKEATCKLYFYQMLLAVQYLHENGIIH 137

Query: 238 RDLKTANLLM---DENGVVKVADFGVARVQAQSGVMTAETGTYRWMAPEVIE---HKPYD 291
           RDLK  N+L+   +E+ ++K+ DFG +++  ++ +M    GT  ++APEV+       Y+
Sbjct: 138 RDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLCGTPTYLAPEVLVSVGTAGYN 197

Query: 292 YKADVFSFGIALWELLTGELP-YAGLTP 318
              D +S G+ L+  L+G  P     T 
Sbjct: 198 RAVDCWSLGVILFICLSGYPPFSEHRTQ 225

>2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326

 Score =  123 bits (311), Expect = 2e-32
 Identities = 54/203 (26%), Positives = 98/203 (48%), Gaps = 17/203 (8%)

Query: 126 SGSYGDLYKGTYCS--QEVAIKVL---KPECVNTEMLKE-FSQEVYIMRKIRHKNVVQFI 179
           SG +  + K    S   + A K +   + +     + +E   +EV I+++I+H NV+   
Sbjct: 21  SGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLH 80

Query: 180 GACTRPPNLCIVTEFMARGSIYDFLHKQKGVF---QLTSLLKVAIDVSKGMNYLHQNNII 236
                  ++ ++ E +A G ++DFL  +K      + T  LK    +  G+ YLH   I 
Sbjct: 81  EVYENKTDVILILELVAGGELFDFL-AEKESLTEEEATEFLK---QILNGVYYLHSLQIA 136

Query: 237 HRDLKTANLLM----DENGVVKVADFGVARVQAQSGVMTAETGTYRWMAPEVIEHKPYDY 292
           H DLK  N+++         +K+ DFG+A             GT  ++APE++ ++P   
Sbjct: 137 HFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPEIVNYEPLGL 196

Query: 293 KADVFSFGIALWELLTGELPYAG 315
           +AD++S G+  + LL+G  P+ G
Sbjct: 197 EADMWSIGVITYILLSGASPFLG 219

>1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310

 Score =  122 bits (308), Expect = 4e-32
 Identities = 58/249 (23%), Positives = 109/249 (43%), Gaps = 33/249 (13%)

Query: 127 GSYGDLY----KGTYCSQEVAIKVL-KPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGA 181
           GS+  +       T  S+E AIK+L K   +    +   ++E  +M ++ H   V+    
Sbjct: 41  GSFSTVVLARELAT--SREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFT 98

Query: 182 CTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSK--------GMNYLHQN 233
                 L     +   G +  ++ K  G F            ++         + YLH  
Sbjct: 99  FQDDEKLYFGLSYAKNGELLKYIRKI-GSFD--------ETCTRFYTAEIVSALEYLHGK 149

Query: 234 NIIHRDLKTANLLMDENGVVKVADFGVA-RVQAQSGVMTAET--GTYRWMAPEVIEHKPY 290
            IIHRDLK  N+L++E+  +++ DFG A  +  +S    A +  GT ++++PE++  K  
Sbjct: 150 GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTEKSA 209

Query: 291 DYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQK--SLRPTIPKHAHPRLAELLER 348
              +D+++ G  +++L+ G  P+           + QK   L    P+   P+  +L+E+
Sbjct: 210 CKSSDLWALGCIIYQLVAGLPPFRAGNEYL----IFQKIIKLEYDFPEKFFPKARDLVEK 265

Query: 349 CWQHDPTQR 357
               D T+R
Sbjct: 266 LLVLDATKR 274

>2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349

 Score =  122 bits (307), Expect = 1e-31
 Identities = 50/189 (26%), Positives = 97/189 (51%), Gaps = 10/189 (5%)

Query: 126 SGSYGDLYKGTYCS--QEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACT 183
            G+   +Y+       +  A+KVLK + V+ ++++    E+ ++ ++ H N+++      
Sbjct: 63  RGATSIVYRCKQKGTQKPYALKVLK-KTVDKKIVR---TEIGVLLRLSHPNIIKLKEIFE 118

Query: 184 RPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTA 243
            P  + +V E +  G ++D +  +KG +           + + + YLH+N I+HRDLK  
Sbjct: 119 TPTEISLVLELVTGGELFDRI-VEKGYYSERDAADAVKQILEAVAYLHENGIVHRDLKPE 177

Query: 244 NLLM---DENGVVKVADFGVARVQAQSGVMTAETGTYRWMAPEVIEHKPYDYKADVFSFG 300
           NLL      +  +K+ADFG++++     +M    GT  + APE++    Y  + D++S G
Sbjct: 178 NLLYATPAPDAPLKIADFGLSKIVEHQVLMKTVCGTPGYCAPEILRGCAYGPEVDMWSVG 237

Query: 301 IALWELLTG 309
           I  + LL G
Sbjct: 238 IITYILLCG 246

>2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373

 Score =  122 bits (309), Expect = 1e-31
 Identities = 48/198 (24%), Positives = 97/198 (48%), Gaps = 14/198 (7%)

Query: 126 SGSYGDLYKGTYCS--QEVAIKVL-KPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGAC 182
            G +G ++K    +   ++A K++      + E +K    E+ +M ++ H N++Q   A 
Sbjct: 99  GGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVK---NEISVMNQLDHANLIQLYDAF 155

Query: 183 TRPPNLCIVTEFMARGSIYDFLHKQKGVF---QLTSLLKVAIDVSKGMNYLHQNNIIHRD 239
               ++ +V E++  G ++D +  +            +K    + +G+ ++HQ  I+H D
Sbjct: 156 ESKNDIVLVMEYVDGGELFDRIIDESYNLTELDTILFMK---QICEGIRHMHQMYILHLD 212

Query: 240 LKTANLLM--DENGVVKVADFGVARVQAQSGVMTAETGTYRWMAPEVIEHKPYDYKADVF 297
           LK  N+L    +   +K+ DFG+AR       +    GT  ++APEV+ +    +  D++
Sbjct: 213 LKPENILCVNRDAKQIKIIDFGLARRYKPREKLKVNFGTPEFLAPEVVNYDFVSFPTDMW 272

Query: 298 SFGIALWELLTGELPYAG 315
           S G+  + LL+G  P+ G
Sbjct: 273 SVGVIAYMLLSGLSPFLG 290

>2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365

 Score =  122 bits (307), Expect = 2e-31
 Identities = 47/202 (23%), Positives = 101/202 (50%), Gaps = 16/202 (7%)

Query: 126 SGSYGDLYKGTYCS--QEVAIKVLK------PECVNTEMLKEFSQEVYIMRKIR-HKNVV 176
            G    + +  + +   E A+K+++            E+ +   +E +I+R++  H +++
Sbjct: 104 RGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHII 163

Query: 177 QFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNII 236
             I +      + +V + M +G ++D+L  +K          +   + + +++LH NNI+
Sbjct: 164 TLIDSYESSSFMFLVFDLMRKGELFDYL-TEKVALSEKETRSIMRSLLEAVSFLHANNIV 222

Query: 237 HRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAETGTYRWMAPEVIE------HKPY 290
           HRDLK  N+L+D+N  ++++DFG +        +    GT  ++APE+++      H  Y
Sbjct: 223 HRDLKPENILLDDNMQIRLSDFGFSCHLEPGEKLRELCGTPGYLAPEILKCSMDETHPGY 282

Query: 291 DYKADVFSFGIALWELLTGELP 312
             + D+++ G+ L+ LL G  P
Sbjct: 283 GKEVDLWACGVILFTLLAGSPP 304

>4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384

 Score =  122 bits (308), Expect = 2e-31
 Identities = 59/230 (25%), Positives = 105/230 (45%), Gaps = 26/230 (11%)

Query: 143 AIKVL-KPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVTEFMARGSIY 201
           A+K + K +CV    ++   +E+ IM+ + H  +V    +     ++ +V + +  G + 
Sbjct: 44  AMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWYSFQDEEDMFMVVDLLLGGDL- 102

Query: 202 DFLH-KQKGVFQLTSLLKVAIDVSK--------GMNYLHQNNIIHRDLKTANLLMDENGV 252
              H +Q   F+         +  K         ++YL    IIHRD+K  N+L+DE+G 
Sbjct: 103 -RYHLQQNVHFK--------EETVKLFICELVMALDYLQNQRIIHRDMKPDNILLDEHGH 153

Query: 253 VKVADFGVARVQAQSGVMTAETGTYRWMAPEVIEHKP---YDYKADVFSFGIALWELLTG 309
           V + DF +A +  +   +T   GT  +MAPE+   +    Y +  D +S G+  +ELL G
Sbjct: 154 VHITDFNIAAMLPRETQITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRG 213

Query: 310 ELPYAGL--TPLQAAVGVVQKSLRPTIPKHAHPRLAELLERCWQHDPTQR 357
             PY     T  +  V   + +   T P      +  LL++  + +P QR
Sbjct: 214 RRPYHIRSSTSSKEIVHTFETT-VVTYPSAWSQEMVSLLKKLLEPNPDQR 262

>1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298

 Score =  120 bits (302), Expect = 2e-31
 Identities = 53/203 (26%), Positives = 98/203 (48%), Gaps = 17/203 (8%)

Query: 126 SGSYGDLYKGTYCS--QEVAIKVL---KPECVNTEMLKE----FSQEVYIMRKI-RHKNV 175
            G    + +  +    +E A+K++        + E ++E      +EV I+RK+  H N+
Sbjct: 27  RGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNI 86

Query: 176 VQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNI 235
           +Q            +V + M +G ++D+L  +K         K+   + + +  LH+ NI
Sbjct: 87  IQLKDTYETNTFFFLVFDLMKKGELFDYL-TEKVTLSEKETRKIMRALLEVICALHKLNI 145

Query: 236 IHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAETGTYRWMAPEVIE------HKP 289
           +HRDLK  N+L+D++  +K+ DFG +        +    GT  ++APE+IE      H  
Sbjct: 146 VHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEKLREVCGTPSYLAPEIIECSMNDNHPG 205

Query: 290 YDYKADVFSFGIALWELLTGELP 312
           Y  + D++S G+ ++ LL G  P
Sbjct: 206 YGKEVDMWSTGVIMYTLLAGSPP 228

>3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325

 Score =  120 bits (304), Expect = 2e-31
 Identities = 46/200 (23%), Positives = 95/200 (47%), Gaps = 19/200 (9%)

Query: 126 SGSYGDLYKGTYCS--QEVAIKVLKPECVNTEMLKEFSQEVYIMRKIR-HKNVVQFIGAC 182
            GS+    K  +    Q  A+K      ++  M     +E+  ++    H N+V+     
Sbjct: 21  EGSFSICRKCVHKKSNQAFAVK-----IISKRMEANTQKEITALKLCEGHPNIVKLHEVF 75

Query: 183 TRPPNLCIVTEFMARGSIYDFLHKQKGVF---QLTSLLKVAIDVSKGMNYLHQNNIIHRD 239
               +  +V E +  G +++ + K+K  F   + + +++    +   ++++H   ++HRD
Sbjct: 76  HDQLHTFLVMELLNGGELFERI-KKKKHFSETEASYIMR---KLVSAVSHMHDVGVVHRD 131

Query: 240 LKTANLLM---DENGVVKVADFGVAR-VQAQSGVMTAETGTYRWMAPEVIEHKPYDYKAD 295
           LK  NLL    ++N  +K+ DFG AR     +  +     T  + APE++    YD   D
Sbjct: 132 LKPENLLFTDENDNLEIKIIDFGFARLKPPDNQPLKTPCFTLHYAAPELLNQNGYDESCD 191

Query: 296 VFSFGIALWELLTGELPYAG 315
           ++S G+ L+ +L+G++P+  
Sbjct: 192 LWSLGVILYTMLSGQVPFQS 211

>4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331

 Score =  120 bits (303), Expect = 3e-31
 Identities = 71/277 (25%), Positives = 116/277 (41%), Gaps = 43/277 (15%)

Query: 119 KIECKVASGSYGDLYKGTYCS--QEVAIKVLKPECVNTEMLKEFSQ-EVYIMRKIRHKNV 175
            +   V  GSYG + K       + VAIK       + +M+K+ +  E+ +++++RH+N+
Sbjct: 29  NLG-LVGEGSYGMVMKCRNKDTGRIVAIKKFLES-DDDKMVKKIAMREIKLLKQLRHENL 86

Query: 176 VQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNI 235
           V  +  C +     +V EF+   +I D L           + K    +  G+ + H +NI
Sbjct: 87  VNLLEVCKKKKRWYLVFEFVDH-TILDDLELFPNGLDYQVVQKYLFQIINGIGFCHSHNI 145

Query: 236 IHRDLKTANLLMDENGVVKVADFGVARV-QAQSGVMTAETGT--YRWMAPEVI-EHKPYD 291
           IHRD+K  N+L+ ++GVVK+ DFG AR   A   V   E  T  YR  APE++     Y 
Sbjct: 146 IHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYDDEVATRWYR--APELLVGDVKYG 203

Query: 292 YKADVFSFGIALWELLTGELPY-------------------------AGLTPLQAAVGVV 326
              DV++ G  + E+  GE P                                    GV 
Sbjct: 204 KAVDVWAIGCLVTEMFMGE-PLFPGDSDIDQLYHIMMCLGNLIPRHQELFNKNPVFAGVR 262

Query: 327 QKSLRPTIP-----KHAHPRLAELLERCWQHDPTQRP 358
              ++   P           + +L ++C   DP +RP
Sbjct: 263 LPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRP 299

>1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350

 Score =  118 bits (299), Expect = 2e-30
 Identities = 63/218 (28%), Positives = 105/218 (48%), Gaps = 10/218 (4%)

Query: 143 AIKVL-KPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVTEFMARGSIY 201
           A+K+L K + V  + ++    E  I++ +    +V+   +     NL +V E++A G ++
Sbjct: 70  AMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMF 129

Query: 202 DFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVA 261
             L +  G F        A  +     YLH  ++I+RDLK  NLL+D+ G ++V DFG A
Sbjct: 130 SHLRRI-GRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFA 188

Query: 262 RVQAQSGVMTAET--GTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPYAGLTPL 319
           +           T  GT   +APE+I  K Y+   D ++ G+ ++E+  G  P+    P+
Sbjct: 189 KRVKG----RTWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPI 244

Query: 320 QAAVGVVQKSLRPTIPKHAHPRLAELLERCWQHDPTQR 357
           Q    +V   +R   P H    L +LL    Q D T+R
Sbjct: 245 QIYEKIVSGKVR--FPSHFSSDLKDLLRNLLQVDLTKR 280

>4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311

 Score =  117 bits (296), Expect = 2e-30
 Identities = 67/277 (24%), Positives = 115/277 (41%), Gaps = 43/277 (15%)

Query: 119 KIECKVASGSYGDLYKGTYCS--QEVAIKVLKPECVNTEMLKEFSQ-EVYIMRKIRHKNV 175
           KI  K+  GSYG ++K       Q VAIK       +  ++K+ +  E+ ++++++H N+
Sbjct: 7   KIG-KIGEGSYGVVFKCRNRDTGQIVAIKKFLES-EDDPVIKKIALREIRMLKQLKHPNL 64

Query: 176 VQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNI 235
           V  +    R   L +V E+    ++   L + +       +  +     + +N+ H++N 
Sbjct: 65  VNLLEVFRRKRRLHLVFEYCDH-TVLHELDRYQRGVPEHLVKSITWQTLQAVNFCHKHNC 123

Query: 236 IHRDLKTANLLMDENGVVKVADFGVARV-QAQSGVMTAETGT--YRWMAPEVIEH-KPYD 291
           IHRD+K  N+L+ ++ V+K+ DFG AR+    S     E  T  YR  +PE++     Y 
Sbjct: 124 IHRDVKPENILITKHSVIKLCDFGFARLLTGPSDYYDDEVATRWYR--SPELLVGDTQYG 181

Query: 292 YKADVFSFGIALWELLTGELPY-------------------------AGLTPLQAAVGVV 326
              DV++ G    ELL+G  P                             +  Q   GV 
Sbjct: 182 PPVDVWAIGCVFAELLSGV-PLWPGKSDVDQLYLIRKTLGDLIPRHQQVFSTNQYFSGVK 240

Query: 327 QKSLRPTIP-----KHAHPRLAELLERCWQHDPTQRP 358
                   P      +       LL+ C   DPT+R 
Sbjct: 241 IPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERL 277

>3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362

 Score =  117 bits (294), Expect = 1e-29
 Identities = 55/312 (17%), Positives = 109/312 (34%), Gaps = 82/312 (26%)

Query: 110 VWEIDAKQLKIECKVASGSYGDLYKGTYCS------QEVAIKVLKPECVNTEMLKEFSQ- 162
           +  + +    ++  ++SGSYG       C+        VAIK +     +   +   S  
Sbjct: 17  LHAMQSPY-TVQRFISSGSYG-----AVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDS 70

Query: 163 --------EVYIMRKIRHKNVVQFIGACTRPPNLC------IVTEFM---------ARGS 199
                   E+ ++    H N++  +                +VTE M          +  
Sbjct: 71  FLCKRVLREIRLLNHFHHPNILG-LRDIFVHFEEPAMHKLYLVTELMRTDLAQVIHDQRI 129

Query: 200 IYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFG 259
           +    H Q  ++ +            G++ LH+  ++HRDL   N+L+ +N  + + DF 
Sbjct: 130 VISPQHIQYFMYHIL----------LGLHVLHEAGVVHRDLHPGNILLADNNDITICDFN 179

Query: 260 VARVQAQSGVMTAETGT--YRWMAPEVI-EHKPYDYKADVFSFGIALWELLTGELPYAGL 316
           +AR        T       YR  APE++ + K +    D++S G  + E+   +  + G 
Sbjct: 180 LAREDTADANKTHYVTHRWYR--APELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGS 237

Query: 317 --------------TPLQAAVGVVQ--------KSLRPTIPK--------HAHPRLAELL 346
                         TP    V +          ++    +P          A P   +L+
Sbjct: 238 TFYNQLNKIVEVVGTPKIEDVVMFSSPSARDYLRNSLSNVPARAWTAVVPTADPVALDLI 297

Query: 347 ERCWQHDPTQRP 358
            +  + +P +R 
Sbjct: 298 AKMLEFNPQRRI 309

>3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336

 Score =  115 bits (291), Expect = 2e-29
 Identities = 58/263 (22%), Positives = 112/263 (42%), Gaps = 41/263 (15%)

Query: 126 SGSYGDLYKGTYCS--QEVAIKVLKPECVNTEMLKEFSQEVYIMRKI-RHKNVVQFIGAC 182
            G  G + +  +    Q+ A+K+L           +  QEV    +     ++V  +   
Sbjct: 39  LGVNGKVLECFHRRTGQKCALKLLYDS-------PKARQEVDHHWQASGGPHIVCILDVY 91

Query: 183 ----TRPPNLCIVTEFMARGSIYDFLHKQKGVFQLT-----SLLKVAIDVSKGMNYLHQN 233
                    L I+ E M  G ++  + + +G    T      +++   D+   + +LH +
Sbjct: 92  ENMHHGKRCLLIIMECMEGGELFSRIQE-RGDQAFTEREAAEIMR---DIGTAIQFLHSH 147

Query: 234 NIIHRDLKTANLLM---DENGVVKVADFGVARVQAQSGVMTAETGTYRWMAPEVIEHKPY 290
           NI HRD+K  NLL    +++ V+K+ DFG A+ +     +     T  ++APEV+  + Y
Sbjct: 148 NIAHRDVKPENLLYTSKEKDAVLKLTDFGFAK-ETTQNALQTPCYTPYYVAPEVLGPEKY 206

Query: 291 DYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKSLR----------PTIPKHAHP 340
           D   D++S G+ ++ LL G  P+   T    + G+ ++               + + A  
Sbjct: 207 DKSCDMWSLGVIMYILLCGFPPFYSNTGQAISPGMKRRIRLGQYGFPNPEWSEVSEDA-- 264

Query: 341 RLAELLERCWQHDPTQRPNFSQI 363
              +L+    + DPT+R   +Q 
Sbjct: 265 --KQLIRLLLKTDPTERLTITQF 285

>2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342

 Score =  114 bits (288), Expect = 5e-29
 Identities = 52/201 (25%), Positives = 103/201 (51%), Gaps = 21/201 (10%)

Query: 126 SGSYGDLYKGTYCS--QEVAIKVLKPECVNTEMLKEFSQEVYIMRK-IRHKNVVQFIGAC 182
            GSY    +  + +   E A+K      ++       ++E+ I+ +  +H N++      
Sbjct: 32  VGSYSVCKRCIHKATNMEFAVK-----IIDKSKRDP-TEEIEILLRYGQHPNIITLKDVY 85

Query: 183 TRPPNLCIVTEFMARGSIYDFLHKQKGVF---QLTSLLKVAIDVSKGMNYLHQNNIIHRD 239
                + +VTE M  G + D + + +  F   + +++L     ++K + YLH   ++HRD
Sbjct: 86  DDGKYVYVVTELMKGGELLDKILR-QKFFSEREASAVLF---TITKTVEYLHAQGVVHRD 141

Query: 240 LKTANLLM----DENGVVKVADFGVAR-VQAQSGVMTAETGTYRWMAPEVIEHKPYDYKA 294
           LK +N+L          +++ DFG A+ ++A++G++     T  ++APEV+E + YD   
Sbjct: 142 LKPSNILYVDESGNPESIRICDFGFAKQLRAENGLLMTPCYTANFVAPEVLERQGYDAAC 201

Query: 295 DVFSFGIALWELLTGELPYAG 315
           D++S G+ L+ +LTG  P+A 
Sbjct: 202 DIWSLGVLLYTMLTGYTPFAN 222

>1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288

 Score =  113 bits (285), Expect = 6e-29
 Identities = 57/205 (27%), Positives = 95/205 (46%), Gaps = 25/205 (12%)

Query: 119 KIECKVASGSYGDLYKGTYCSQE-VAIKVLKPECVNTEMLKE---FS--QEVYIMRKIRH 172
            +E K+  G+YG +YK      E  A+K ++      E   E    +  +E+ I+++++H
Sbjct: 6   GLE-KIGEGTYGVVYKAQNNYGETFALKKIR-----LEKEDEGIPSTTIREISILKELKH 59

Query: 173 KNVVQFIGACTRPPNLCIVTEFMARGSIYD---FLHKQKGVFQLTSLLKVAIDVSKGMNY 229
            N+V+          L +V E +      D    L   +G  +  +     + +  G+ Y
Sbjct: 60  SNIVKLYDVIHTKKRLVLVFEHLD----QDLKKLLDVCEGGLESVTAKSFLLQLLNGIAY 115

Query: 230 LHQNNIIHRDLKTANLLMDENGVVKVADFGVARV-QAQSGVMTAETGT--YRWMAPEVI- 285
            H   ++HRDLK  NLL++  G +K+ADFG+AR         T E  T  YR  AP+V+ 
Sbjct: 116 CHDRRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEIVTLWYR--APDVLM 173

Query: 286 EHKPYDYKADVFSFGIALWELLTGE 310
             K Y    D++S G    E++ G 
Sbjct: 174 GSKKYSTTIDIWSVGCIFAEMVNGT 198

>3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311

 Score =  112 bits (283), Expect = 2e-28
 Identities = 63/205 (30%), Positives = 102/205 (49%), Gaps = 25/205 (12%)

Query: 119 KIECKVASGSYGDLYKGTYCSQE-VAIKVLKPECVNTEMLKE---FS--QEVYIMRKIRH 172
           K+E KV  G+YG +YK        VA+K ++      +   E    +  +E+ +++++ H
Sbjct: 25  KLE-KVGEGTYGVVYKAKDSQGRIVALKRIR-----LDAEDEGIPSTAIREISLLKELHH 78

Query: 173 KNVVQFIGACTRPPNLCIVTEFMARGSIYD---FLHKQKGVFQLTSLLKVAIDVSKGMNY 229
            N+V  I        L +V EFM      D    L + K   Q + +      + +G+ +
Sbjct: 79  PNIVSLIDVIHSERCLTLVFEFME----KDLKKVLDENKTGLQDSQIKIYLYQLLRGVAH 134

Query: 230 LHQNNIIHRDLKTANLLMDENGVVKVADFGVARV-QAQSGVMTAETGT--YRWMAPEVI- 285
            HQ+ I+HRDLK  NLL++ +G +K+ADFG+AR         T E  T  YR  AP+V+ 
Sbjct: 135 CHQHRILHRDLKPQNLLINSDGALKLADFGLARAFGIPVRSYTHEVVTLWYR--APDVLM 192

Query: 286 EHKPYDYKADVFSFGIALWELLTGE 310
             K Y    D++S G    E++TG+
Sbjct: 193 GSKKYSTSVDIWSIGCIFAEMITGK 217

>1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318

 Score =  112 bits (282), Expect = 2e-28
 Identities = 62/227 (27%), Positives = 108/227 (47%), Gaps = 28/227 (12%)

Query: 143 AIKVL-KPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVTEFMARGSIY 201
           A+KVL K   V  + ++  + E  ++  + H  +++  G       + ++ +++  G + 
Sbjct: 35  AMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIMDYIEGGEL- 93

Query: 202 DFLHKQK-GVFQLTSLLKVAIDVSK--------GMNYLHQNNIIHRDLKTANLLMDENGV 252
            F   +K   F           V+K         + YLH  +II+RDLK  N+L+D+NG 
Sbjct: 94  -FSLLRKSQRF--------PNPVAKFYAAEVCLALEYLHSKDIIYRDLKPENILLDKNGH 144

Query: 253 VKVADFGVARVQAQSGVMTAET--GTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTGE 310
           +K+ DFG A+           T  GT  ++APEV+  KPY+   D +SFGI ++E+L G 
Sbjct: 145 IKITDFGFAKYVPD----VTYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGY 200

Query: 311 LPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRLAELLERCWQHDPTQR 357
            P+     ++    ++   LR   P   +  + +LL R    D +QR
Sbjct: 201 TPFYDSNTMKTYEKILNAELR--FPPFFNEDVKDLLSRLITRDLSQR 245

>3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292

 Score =  111 bits (279), Expect = 4e-28
 Identities = 58/209 (27%), Positives = 97/209 (46%), Gaps = 26/209 (12%)

Query: 119 KIECKVASGSYGDLYKGTYCS--QEVAIKVLKPECVNTEMLKE---FS--QEVYIMRKIR 171
           K+E K+  G+YG ++K       + VA+K ++      +   E    S  +E+ ++++++
Sbjct: 6   KLE-KIGEGTYGTVFKAKNRETHEIVALKRVR-----LDDDDEGVPSSALREICLLKELK 59

Query: 172 HKNVVQFIGACTRPPNLCIVTEFMARGSIYD---FLHKQKGVFQLTSLLKVAIDVSKGMN 228
           HKN+V+          L +V EF       D   +     G      +      + KG+ 
Sbjct: 60  HKNIVRLHDVLHSDKKLTLVFEFCD----QDLKKYFDSCNGDLDPEIVKSFLFQLLKGLG 115

Query: 229 YLHQNNIIHRDLKTANLLMDENGVVKVADFGVARV-QAQSGVMTAETGT--YRWMAPEVI 285
           + H  N++HRDLK  NLL++ NG +K+A+FG+AR         +AE  T  YR   P+V+
Sbjct: 116 FCHSRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSAEVVTLWYR--PPDVL 173

Query: 286 -EHKPYDYKADVFSFGIALWELLTGELPY 313
              K Y    D++S G    EL     P 
Sbjct: 174 FGAKLYSTSIDMWSAGCIFAELANAGRPL 202

>4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394

 Score =  113 bits (284), Expect = 4e-28
 Identities = 67/310 (21%), Positives = 118/310 (38%), Gaps = 73/310 (23%)

Query: 101 IEIPTDGTDVWEIDAKQLKIECKVASGSYGDLYKGTYC-SQEVAIKVLKPECVNTEMLKE 159
             + +DG    + +      +  + +GS+G +++     S EVAIK +  +       K 
Sbjct: 26  KVLASDGKTGEQREIAYTNCK-VIGNGSFGVVFQAKLVESDEVAIKKVLQD-------KR 77

Query: 160 F-SQEVYIMRKIRHKNVVQFIGACTRPPN-------LCIVTEFM------------ARGS 199
           F ++E+ IMR ++H NVV  + A             L +V E++                
Sbjct: 78  FKNRELQIMRIVKHPNVVD-LKAFFYSNGDKKDEVFLNLVLEYVPETVYRASRHYAKLKQ 136

Query: 200 IYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDEN-GVVKVADF 258
               L  +  ++QL           + + Y+H   I HRD+K  NLL+D   GV+K+ DF
Sbjct: 137 TMPMLLIKLYMYQLL----------RSLAYIHSIGICHRDIKPQNLLLDPPSGVLKLIDF 186

Query: 259 GVARVQAQSGVMTAE--TGTYRWMAPEVI-EHKPYDYKADVFSFGIALWELLTGELPYAG 315
           G A++        +   +  YR  APE+I     Y    D++S G  + EL+ G+  + G
Sbjct: 187 GSAKILIAGEPNVSYICSRYYR--APELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPG 244

Query: 316 L--------------TPLQAAVGVVQ-------------KSLRPTIPKHAHPRLAELLER 348
                          TP +  +  +                          P   +L+ R
Sbjct: 245 ESGIDQLVEIIKVLGTPSREQIKTMNPNYMEHKFPQIRPHPFSKVFRPRTPPDAIDLISR 304

Query: 349 CWQHDPTQRP 358
             ++ P+ R 
Sbjct: 305 LLEYTPSARL 314

>1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346

 Score =  112 bits (282), Expect = 4e-28
 Identities = 69/288 (23%), Positives = 120/288 (41%), Gaps = 63/288 (21%)

Query: 119 KIECKVASGSYGDLYKG--TYCSQEVAIKVLKPECVNTEMLKE---FS--QEVYIMRKIR 171
           K++  +  G +  +YK      +Q VAIK +K    +    K+    +  +E+ +++++ 
Sbjct: 14  KLD-FLGEGQFATVYKARDKNTNQIVAIKKIKLG--HRSEAKDGINRTALREIKLLQELS 70

Query: 172 HKNVVQFIGACTRPPNLCIVTEFM---------ARGSIYDFLHKQKGVFQLTSLLKVAID 222
           H N++  + A     N+ +V +FM             +    H +  +            
Sbjct: 71  HPNIIGLLDAFGHKSNISLVFDFMETDLEVIIKDNSLVLTPSHIKAYMLMTL-------- 122

Query: 223 VSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARV-QAQSGVMTAETGT--YRW 279
             +G+ YLHQ+ I+HRDLK  NLL+DENGV+K+ADFG+A+   + +   T +  T  YR 
Sbjct: 123 --QGLEYLHQHWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYTHQVVTRWYR- 179

Query: 280 MAPEVIEH-KPYDYKADVFSFGIALWELLTGE--LP----------------------YA 314
            APE++   + Y    D+++ G  L ELL     LP                      + 
Sbjct: 180 -APELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWP 238

Query: 315 GLTPLQAAVGVVQ---KSLRPTIPKHAHPRLAELLERCWQHDPTQRPN 359
            +  L   V         L       A   L +L++  +  +P  R  
Sbjct: 239 DMCSLPDYVTFKSFPGIPLHHIFS-AAGDDLLDLIQGLFLFNPCARIT 285

>2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316

 Score =  111 bits (280), Expect = 4e-28
 Identities = 56/210 (26%), Positives = 95/210 (45%), Gaps = 24/210 (11%)

Query: 126 SGSYGDLYKGTYCS--QEVAIKVL-KPECVNTEMLKEFSQEVYIMRKIR-HKNVVQFIGA 181
            G++  +         QE A+K++ K        +    +EV ++ + + H+NV++ I  
Sbjct: 23  EGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVF---REVEMLYQCQGHRNVLELIEF 79

Query: 182 CTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLK 241
                   +V E M  GSI   +HK +  F       V  DV+  +++LH   I HRDLK
Sbjct: 80  FEEEDRFYLVFEKMRGGSILSHIHK-RRHFNELEASVVVQDVASALDFLHNKGIAHRDLK 138

Query: 242 TANLLM---DENGVVKVADFGVARV--------QAQSGVMTAETGTYRWMAPEVIE---- 286
             N+L    ++   VK+ DF +              +  +    G+  +MAPEV+E    
Sbjct: 139 PENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSE 198

Query: 287 -HKPYDYKADVFSFGIALWELLTGELPYAG 315
               YD + D++S G+ L+ LL+G  P+ G
Sbjct: 199 EASIYDKRCDLWSLGVILYILLSGYPPFVG 228

>1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367

 Score =  112 bits (281), Expect = 6e-28
 Identities = 80/295 (27%), Positives = 118/295 (40%), Gaps = 60/295 (20%)

Query: 110 VWEIDAKQLKIECKVASGSYGDLYKGTYC--SQEVAIKVLKPECVNTEMLKEFSQEVYIM 167
            WE+ A    ++  V SG+YG +          +VAIK L     +    K   +E+ ++
Sbjct: 20  AWEVRAVYRDLQ-PVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLL 78

Query: 168 RKIRHKNVVQFIGACTRPPNLC------IVTEFMA-------RGSIYDFLHKQKGVFQLT 214
           + +RH+NV+  +   T    L       +V  FM        +         Q  V+Q+ 
Sbjct: 79  KHMRHENVIGLLDVFTPDETLDDFTDFYLVMPFMGTDLGKLMKHEKLGEDRIQFLVYQML 138

Query: 215 SLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAET 274
                     KG+ Y+H   IIHRDLK  NL ++E+  +K+ DFG+AR       MT   
Sbjct: 139 ----------KGLRYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQADSE--MTGYV 186

Query: 275 GTYRWM-APEVI-EHKPYDYKADVFSFGIALWELLTGELPYAGL--------------TP 318
            T RW  APEVI     Y    D++S G  + E++TG+  + G               TP
Sbjct: 187 VT-RWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTP 245

Query: 319 LQAAVGVVQ--------KSLRPTIPK-------HAHPRLAELLERCWQHDPTQRP 358
               V  +Q        K L     K       +A P    LLE+    D  QR 
Sbjct: 246 PAEFVQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRV 300

>3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543

 Score =  114 bits (286), Expect = 7e-28
 Identities = 66/248 (26%), Positives = 113/248 (45%), Gaps = 25/248 (10%)

Query: 127 GSYGDLY----KGTYCSQEVAIKVLKPECV----NTEMLKEFSQEVYIMRKIRHKNVVQF 178
           G +G+++    K T   +  A K L  + +      +       E  I+ K+  + +V  
Sbjct: 196 GGFGEVFACQMKAT--GKLYACKKLNKKRLKKRKGYQGAM---VEKKILAKVHSRFIVSL 250

Query: 179 IGACTRPPNLCIVTEFMARGSIYDFLH-----KQKGVFQLTSLLKVAIDVSKGMNYLHQN 233
             A     +LC+V   M  G I    H     +    FQ    +     +  G+ +LHQ 
Sbjct: 251 AYAFETKTDLCLVMTIMNGGDI--RYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQR 308

Query: 234 NIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAET--GTYRWMAPEVIEHKPYD 291
           NII+RDLK  N+L+D++G V+++D G+A V+ ++G    +   GT  +MAPE++  + YD
Sbjct: 309 NIIYRDLKPENVLLDDDGNVRISDLGLA-VELKAGQTKTKGYAGTPGFMAPELLLGEEYD 367

Query: 292 YKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKSLR--PTIPKHAHPRLAELLERC 349
           +  D F+ G+ L+E++    P+           + Q+ L    T P    P   +  E  
Sbjct: 368 FSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRVLEQAVTYPDKFSPASKDFCEAL 427

Query: 350 WQHDPTQR 357
            Q DP +R
Sbjct: 428 LQKDPEKR 435

>1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400

 Score =  112 bits (281), Expect = 9e-28
 Identities = 56/264 (21%), Positives = 106/264 (40%), Gaps = 42/264 (15%)

Query: 126 SGSYGDLYKGTYCS--QEVAIKVL-KPECVNTEMLKEFSQEVYIMRKI-RHKNVVQFIGA 181
            G  G + +       ++ A+K+L               +EV +  +  +  ++V+ +  
Sbjct: 72  LGINGKVLQIFNKRTQEKFALKMLQDCPKA--------RREVELHWRASQCPHIVRIVDV 123

Query: 182 C----TRPPNLCIVTEFMARGSIYDFLHKQKGVFQLT-----SLLKVAIDVSKGMNYLHQ 232
                     L IV E +  G ++  +   +G    T      ++K    + + + YLH 
Sbjct: 124 YENLYAGRKCLLIVMECLDGGELFSRIQ-DRGDQAFTEREASEIMK---SIGEAIQYLHS 179

Query: 233 NNIIHRDLKTANLLM---DENGVVKVADFGVARVQAQSGVMTAETGTYRWMAPEVIEHKP 289
            NI HRD+K  NLL      N ++K+ DFG A+       +T    T  ++APEV+  + 
Sbjct: 180 INIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEVLGPEK 239

Query: 290 YDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKSLR----------PTIPKHAH 339
           YD   D++S G+ ++ LL G  P+     L  + G+  +               + +   
Sbjct: 240 YDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEVSEEV- 298

Query: 340 PRLAELLERCWQHDPTQRPNFSQI 363
                L+    + +PTQR   ++ 
Sbjct: 299 ---KMLIRNLLKTEPTQRMTITEF 319

>3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324

 Score =  110 bits (277), Expect = 1e-27
 Identities = 55/210 (26%), Positives = 99/210 (47%), Gaps = 35/210 (16%)

Query: 119 KIECKVASGSYGDLYKGTYCS--QEVAIKVLKPEC---VNTEMLKEFSQEVYIMRKIRHK 173
           K++ K+  G+Y  +YKG        VA+K ++ E         ++E S    +++ ++H 
Sbjct: 6   KLD-KLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVS----LLKDLKHA 60

Query: 174 NVVQFIGACTRPPNLCIVTEFM---------ARGSIYDFLHKQKGVFQLTSLLKVAIDVS 224
           N+V          +L +V E++           G+I +  + +  +FQL           
Sbjct: 61  NIVTLHDIIHTEKSLTLVFEYLDKDLKQYLDDCGNIINMHNVKLFLFQLL---------- 110

Query: 225 KGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARV-QAQSGVMTAETGT--YRWMA 281
           +G+ Y H+  ++HRDLK  NLL++E G +K+ADFG+AR     +     E  T  YR   
Sbjct: 111 RGLAYCHRQKVLHRDLKPQNLLINERGELKLADFGLARAKSIPTKTYDNEVVTLWYR--P 168

Query: 282 PEVI-EHKPYDYKADVFSFGIALWELLTGE 310
           P+++     Y  + D++  G   +E+ TG 
Sbjct: 169 PDILLGSTDYSTQIDMWGVGCIFYEMATGR 198

>2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576

 Score =  113 bits (284), Expect = 2e-27
 Identities = 56/244 (22%), Positives = 106/244 (43%), Gaps = 20/244 (8%)

Query: 127 GSYGDLY----KGTYCSQEVAIKVLKPECV----NTEMLKEFSQEVYIMRKIRHKNVVQF 178
           G +G++     + T   +  A K L+ + +       M      E  I+ K+  + VV  
Sbjct: 195 GGFGEVCACQVRAT--GKMYACKKLEKKRIKKRKGEAMAL---NEKQILEKVNSRFVVSL 249

Query: 179 IGACTRPPNLCIVTEFMARGSIYDFLHKQ---KGVFQLTSLLKVAIDVSKGMNYLHQNNI 235
             A      LC+V   M  G +    H     +  F     +  A ++  G+  LH+  I
Sbjct: 250 AYAYETKDALCLVLTLMNGGDL--KFHIYHMGQAGFPEARAVFYAAEICCGLEDLHRERI 307

Query: 236 IHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAETGTYRWMAPEVIEHKPYDYKAD 295
           ++RDLK  N+L+D++G ++++D G+A    +   +    GT  +MAPEV++++ Y +  D
Sbjct: 308 VYRDLKPENILLDDHGHIRISDLGLAVHVPEGQTIKGRVGTVGYMAPEVVKNERYTFSPD 367

Query: 296 VFSFGIALWELLTGELPYAGLTPLQAAVGVVQKSLR--PTIPKHAHPRLAELLERCWQHD 353
            ++ G  L+E++ G+ P+           V +          +   P+   L  +    D
Sbjct: 368 WWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEVPEEYSERFSPQARSLCSQLLCKD 427

Query: 354 PTQR 357
           P +R
Sbjct: 428 PAER 431

>1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337

 Score =  110 bits (276), Expect = 2e-27
 Identities = 62/241 (25%), Positives = 112/241 (46%), Gaps = 19/241 (7%)

Query: 127 GSYGDL----YKGTYCSQEVAIKVL-KPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGA 181
           G++G +     K T   +  A+K+L K   +  + +     E  +++  RH  +     A
Sbjct: 16  GTFGKVILVREKAT--GRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYA 73

Query: 182 CTRPPNLCIVTEFMARGSIYDFLHKQK-GVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDL 240
                 LC V E+   G +  F H  +  VF          ++   + YLH  ++++RD+
Sbjct: 74  FQTHDRLCFVMEYANGGEL--FFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYRDI 131

Query: 241 KTANLLMDENGVVKVADFGVARVQAQSGVMTAET--GTYRWMAPEVIEHKPYDYKADVFS 298
           K  NL++D++G +K+ DFG+ +     G     T  GT  ++APEV+E   Y    D + 
Sbjct: 132 KLENLMLDKDGHIKITDFGLCKEGISDGATMK-TFCGTPEYLAPEVLEDNDYGRAVDWWG 190

Query: 299 FGIALWELLTGELPYAGLTPLQAAVGVVQKSLR--PTIPKHAHPRLAELLERCWQHDPTQ 356
            G+ ++E++ G LP+      +    ++ + +R   T+   A   LA LL++    DP Q
Sbjct: 191 LGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFPRTLSPEAKSLLAGLLKK----DPKQ 246

Query: 357 R 357
           R
Sbjct: 247 R 247

>2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367

 Score =  110 bits (276), Expect = 4e-27
 Identities = 73/295 (24%), Positives = 123/295 (41%), Gaps = 60/295 (20%)

Query: 110 VWEIDAKQLKIECKVASGSYGDLYK--GTYCSQEVAIKVLKPECVNTEMLKEFSQEVYIM 167
           +WE+  +   +   V SG+YG +     T     VA+K L     +    K   +E+ ++
Sbjct: 24  IWEVPERYQNLSP-VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLL 82

Query: 168 RKIRHKNVVQFIGACTRPPNLC------IVTEFMA-------RGSIYDFLHKQKGVFQLT 214
           + ++H+NV+  +   T   +L       +VT  M        +       H Q  ++Q+ 
Sbjct: 83  KHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQIL 142

Query: 215 SLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAET 274
                     +G+ Y+H  +IIHRDLK +NL ++E+  +K+ DFG+AR    +  MT   
Sbjct: 143 ----------RGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARH--TADEMTGYV 190

Query: 275 GTYRW-MAPEVI-EHKPYDYKADVFSFGIALWELLTGELPYAGL--------------TP 318
            T RW  APE++     Y+   D++S G  + ELLTG   + G               TP
Sbjct: 191 AT-RWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTP 249

Query: 319 LQAAVGVVQ--------KSLRPTIPK-------HAHPRLAELLERCWQHDPTQRP 358
               +  +         +SL              A+P   +LLE+    D  +R 
Sbjct: 250 GAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRI 304

>3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330

 Score =  108 bits (273), Expect = 6e-27
 Identities = 42/217 (19%), Positives = 93/217 (42%), Gaps = 31/217 (14%)

Query: 110 VWEIDAKQLKIECKVASGSYGDLYKGTYCS--QEVAIKVLKPECVNTEMLKEFSQEVYIM 167
            W        +  K+  G Y ++++    +  ++V +K+LKP        K+  +E+ I+
Sbjct: 31  EWGNQDDYQLVR-KLGRGKYSEVFEAINITNNEKVVVKILKPV-----KKKKIKREIKIL 84

Query: 168 RKIR-HKNVVQFIGACTRPPNLC---IVTEFMAR--GSIYDFL---HKQKGVFQLTSLLK 218
             +R   N++        P +     +           +Y  L     +  ++++     
Sbjct: 85  ENLRGGPNIITLADIVKDPVSRTPALVFEHVNNTDFKQLYQTLTDYDIRFYMYEIL---- 140

Query: 219 VAIDVSKGMNYLHQNNIIHRDLKTANLLMD-ENGVVKVADFGVARVQAQSGVMTAETGTY 277
                 K ++Y H   I+HRD+K  N+++D E+  +++ D+G+A              + 
Sbjct: 141 ------KALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVAS- 193

Query: 278 RWM-APEVI-EHKPYDYKADVFSFGIALWELLTGELP 312
           R+   PE++ +++ YDY  D++S G  L  ++  + P
Sbjct: 194 RYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEP 230

>3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345

 Score =  108 bits (273), Expect = 6e-27
 Identities = 46/180 (25%), Positives = 87/180 (48%), Gaps = 13/180 (7%)

Query: 188 LCIVTEFMARGSIYDFLHKQK-GVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLL 246
           L  V E++  G +    H Q+            + ++S  +NYLH+  II+RDLK  N+L
Sbjct: 85  LFFVIEYVNGGDL--MFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVL 142

Query: 247 MDENGVVKVADFGVARVQAQSGVMTAET--GTYRWMAPEVIEHKPYDYKADVFSFGIALW 304
           +D  G +K+ D+G+ +   + G  T+ T  GT  ++APE++  + Y +  D ++ G+ ++
Sbjct: 143 LDSEGHIKLTDYGMCKEGLRPGDTTS-TFCGTPNYIAPEILRGEDYGFSVDWWALGVLMF 201

Query: 305 ELLTGELPYAGLTPLQAAVGVVQKSL-------RPTIPKHAHPRLAELLERCWQHDPTQR 357
           E++ G  P+  +          +  L       +  IP+    + A +L+     DP +R
Sbjct: 202 EMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIPRSLSVKAASVLKSFLNKDPKER 261

>2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317

 Score =  108 bits (271), Expect = 7e-27
 Identities = 70/285 (24%), Positives = 123/285 (43%), Gaps = 52/285 (18%)

Query: 119 KIECKVASGSYGDLYKGTYCS--QEVAIKVLKPEC---VNTEMLKEFSQEVYIMRKIRHK 173
           ++E K+ +G+Y  +YKG   +    VA+K +K +      +  ++E S    +M++++H+
Sbjct: 9   QLE-KLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREIS----LMKELKHE 63

Query: 174 NVVQFIGACTRPPNLCIVTEFMA---RGSIYDFLHKQKGVFQLTSLLK-VAIDVSKGMNY 229
           N+V+          L +V EFM    +  +              +L+K     + +G+ +
Sbjct: 64  NIVRLYDVIHTENKLTLVFEFMDNDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAF 123

Query: 230 LHQNNIIHRDLKTANLLMDENGVVKVADFGVARV-QAQSGVMTAETGT--YRWMAPEVI- 285
            H+N I+HRDLK  NLL+++ G +K+ DFG+AR         ++E  T  YR  AP+V+ 
Sbjct: 124 CHENKILHRDLKPQNLLINKRGQLKLGDFGLARAFGIPVNTFSSEVVTLWYR--APDVLM 181

Query: 286 EHKPYDYKADVFSFGIALWELLTG------------------------ELPYAGLTPLQA 321
             + Y    D++S G  L E++TG                        E  +  +T L  
Sbjct: 182 GSRTYSTSIDIWSCGCILAEMITGKPLFPGTNDEEQLKLIFDIMGTPNESLWPSVTKLPK 241

Query: 322 AVGVVQK----SLRPTIPKHAHPRLAE----LLERCWQHDPTQRP 358
               +Q+     LR  +  H    L       L    Q +P  R 
Sbjct: 242 YNPNIQQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQLNPDMRL 286

>3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405

 Score =  109 bits (275), Expect = 8e-27
 Identities = 54/240 (22%), Positives = 100/240 (41%), Gaps = 43/240 (17%)

Query: 101 IEIPTDGTDVWEIDAKQLKIECKVASGSYGDLYKG----TYCSQEVAIKVLKPECVNTEM 156
            ++          D       CKV  G+YG +YK         ++ A+K ++   ++   
Sbjct: 7   FKVKLSSERERVED-LFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGISMSA 65

Query: 157 LKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCI--VTEFMARGSIYD---FLHKQKGVF 211
            +E    + ++R+++H NV+          +  +  + ++      +D    +   +   
Sbjct: 66  CRE----IALLRELKHPNVISLQKVFLSHADRKVWLLFDYAE----HDLWHIIKFHRASK 117

Query: 212 QLTSLLKVAIDVSK--------GMNYLHQNNIIHRDLKTANLLM----DENGVVKVADFG 259
                +++   + K        G++YLH N ++HRDLK AN+L+     E G VK+AD G
Sbjct: 118 ANKKPVQLPRGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMG 177

Query: 260 VARV-QAQSGVMTAETGT-----YRWMAPEVI---EHKPYDYKADVFSFGIALWELLTGE 310
            AR+  +    +           YR  APE++    H  Y    D+++ G    ELLT E
Sbjct: 178 FARLFNSPLKPLADLDPVVVTFWYR--APELLLGARH--YTKAIDIWAIGCIFAELLTSE 233

>3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353

 Score =  108 bits (273), Expect = 8e-27
 Identities = 76/295 (25%), Positives = 121/295 (41%), Gaps = 61/295 (20%)

Query: 110 VWEIDAKQLKIECKVASGSYGDLYKGTYC--SQEVAIKVLKPECVNTEMLKEFSQEVYIM 167
            WE+          V SG+YG +         ++VAIK L     +    K   +E+ ++
Sbjct: 19  AWELPKT-YVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLL 77

Query: 168 RKIRHKNVVQFIGACTRPPNLC------IVTEFMA-------RGSIYDFLHKQKGVFQLT 214
           + ++H+NV+  +   T   +L       +V  FM             +    Q  V+Q+ 
Sbjct: 78  KHMQHENVIGLLDVFTPASSLRNFYDFYLVMPFMQTDLQKIMGLKFSEE-KIQYLVYQML 136

Query: 215 SLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAET 274
                     KG+ Y+H   ++HRDLK  NL ++E+  +K+ DFG+AR       MT   
Sbjct: 137 ----------KGLKYIHSAGVVHRDLKPGNLAVNEDCELKILDFGLARHADAE--MTGYV 184

Query: 275 GTYRW-MAPEVI-EHKPYDYKADVFSFGIALWELLTGELPYAGL--------------TP 318
            T RW  APEVI     Y+   D++S G  + E+LTG+  + G                P
Sbjct: 185 VT-RWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVP 243

Query: 319 LQAAVGVVQ--------KSLRPTIPK-------HAHPRLAELLERCWQHDPTQRP 358
               V  +         +SL  T  K        A P+ A+LLE+  + D  +R 
Sbjct: 244 GTEFVQKLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRL 298

>3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286

 Score =  107 bits (268), Expect = 9e-27
 Identities = 29/251 (11%), Positives = 72/251 (28%), Gaps = 45/251 (17%)

Query: 120 IECKVASGSYGDLYKG--TYCSQEVAIKVLKPECVNTE-MLKEFSQEVYIMRKIRHKNVV 176
           +            ++   T   ++VA+  + P+ V  + +L+E       + +I    V 
Sbjct: 35  LLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVA 94

Query: 177 QFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNII 236
           + +          +V E++  GS+ +              ++    ++   +  H+  + 
Sbjct: 95  RVLDVVHTRAGGLVVAEWIRGGSLQEVADTSPSPVGA---IRAMQSLAAAADAAHRAGVA 151

Query: 237 HRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAETGTYRWMAPEVIEHKPYDYKADV 296
                 + + +  +G V +A                                  + + D+
Sbjct: 152 LSIDHPSRVRVSIDGDVVLAYPATMP--------------------------DANPQDDI 185

Query: 297 FSFGIALWELLTGELPYAGLTPLQAAVGVVQ---------KSLRPTIPKHAHPRLAELLE 347
              G +L+ LL    P              +           +   IP     +++ +  
Sbjct: 186 RGIGASLYALLVNRWPLPEAGVRSGLAPAERDTAGQPIEPADIDRDIP----FQISAVAA 241

Query: 348 RCWQHDPTQRP 358
           R  Q D   R 
Sbjct: 242 RSVQGDGGIRS 252

>4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396

 Score =  109 bits (274), Expect = 9e-27
 Identities = 46/180 (25%), Positives = 87/180 (48%), Gaps = 13/180 (7%)

Query: 188 LCIVTEFMARGSIYDFLHKQK-GVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLL 246
           L  V E++  G +    H Q+            + ++S  +NYLH+  II+RDLK  N+L
Sbjct: 128 LFFVIEYVNGGDL--MFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVL 185

Query: 247 MDENGVVKVADFGVARVQAQSGVMTAET--GTYRWMAPEVIEHKPYDYKADVFSFGIALW 304
           +D  G +K+ D+G+ +   + G  T+ T  GT  ++APE++  + Y +  D ++ G+ ++
Sbjct: 186 LDSEGHIKLTDYGMCKEGLRPGDTTS-TFCGTPNYIAPEILRGEDYGFSVDWWALGVLMF 244

Query: 305 ELLTGELPYAGLTPLQAAVGVVQKSL-------RPTIPKHAHPRLAELLERCWQHDPTQR 357
           E++ G  P+  +          +  L       +  IP+    + A +L+     DP +R
Sbjct: 245 EMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIPRSLSVKAASVLKSFLNKDPKER 304

>3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364

 Score =  107 bits (270), Expect = 2e-26
 Identities = 68/301 (22%), Positives = 121/301 (40%), Gaps = 68/301 (22%)

Query: 110 VWEIDAKQLKIECKVASGSYGDLYKG--TYCSQEVAIKVLKP-ECVNTEMLKEFSQEVYI 166
           V+++  +       +  G+YG +           VAIK + P E  +    +   +E+ I
Sbjct: 22  VFDVGPR-YTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFE--HQTYCQRTLREIKI 78

Query: 167 MRKIRHKNVVQFIGACTRPPNLC------IVTEFMA-------RGSIYDFLHKQKGVFQL 213
           + + RH+N++  I    R P +       IV + M        +       H    ++Q+
Sbjct: 79  LLRFRHENIIG-INDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQI 137

Query: 214 TSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARV----QAQSGV 269
                      +G+ Y+H  N++HRDLK +NLL++    +K+ DFG+ARV       +G 
Sbjct: 138 L----------RGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGF 187

Query: 270 MTAETGT--YRWMAPEVI-EHKPYDYKADVFSFGIALWELLTGELPYAGL---------- 316
           +T    T  YR  APE++   K Y    D++S G  L E+L+    + G           
Sbjct: 188 LTEYVATRWYR--APEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHIL 245

Query: 317 ----TPLQAAVGVVQ--------KSLRPTIPK-------HAHPRLAELLERCWQHDPTQR 357
               +P Q  +  +          SL             +A  +  +LL++    +P +R
Sbjct: 246 GILGSPSQEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKR 305

Query: 358 P 358
            
Sbjct: 306 I 306

>3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351

 Score =  107 bits (269), Expect = 3e-26
 Identities = 69/301 (22%), Positives = 127/301 (42%), Gaps = 76/301 (25%)

Query: 119 KIECKVASGSYGDLYKG--TYCSQEVAIKVLKPECVNTEMLKE-F----SQEVYIMRKIR 171
           K+  K+  G++G+++K       Q+VA+K +       E  KE F     +E+ I++ ++
Sbjct: 21  KLA-KIGQGTFGEVFKARHRKTGQKVALKKVL-----MENEKEGFPITALREIKILQLLK 74

Query: 172 HKNVVQFIGACT--------RPPNLCIVTEFMARGSIYD---FLHKQKGVFQLTSLLKVA 220
           H+NVV  I  C            ++ +V +F      +D    L      F L+ + +V 
Sbjct: 75  HENVVNLIEICRTKASPYNRCKGSIYLVFDFCE----HDLAGLLSNVLVKFTLSEIKRVM 130

Query: 221 IDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVAR-----VQAQSGVMTAETG 275
             +  G+ Y+H+N I+HRD+K AN+L+  +GV+K+ADFG+AR       +Q    T    
Sbjct: 131 QMLLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRVV 190

Query: 276 T--YRWMAPEVI-EHKPYDYKADVFSFGIALWELLTG----------------------- 309
           T  YR   PE++   + Y    D++  G  + E+ T                        
Sbjct: 191 TLWYR--PPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSI 248

Query: 310 ---------ELP-YAGLTPLQAAVGVVQKSLRPTIPKHAHPRLA-ELLERCWQHDPTQRP 358
                        Y  L  ++      ++ ++  +  +     A +L+++    DP QR 
Sbjct: 249 TPEVWPNVDNYELYEKLELVKGQ----KRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRI 304

Query: 359 N 359
           +
Sbjct: 305 D 305

>3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695

 Score =  109 bits (275), Expect = 3e-26
 Identities = 64/228 (28%), Positives = 101/228 (44%), Gaps = 22/228 (9%)

Query: 143 AIKVLKPECVNTEMLKEFSQEVYIM--RKI-------RHKNVVQFIGACTRPPNLCIVTE 193
           A+K L       + +K    E   +  R +           +V    A   P  L  + +
Sbjct: 218 AMKCLD-----KKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILD 272

Query: 194 FMARGSIYDFLH-KQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGV 252
            M  G +    H  Q GVF    +   A ++  G+ ++H   +++RDLK AN+L+DE+G 
Sbjct: 273 LMNGGDL--HYHLSQHGVFSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGH 330

Query: 253 VKVADFGVARVQAQSGVMTAETGTYRWMAPEVIEHK-PYDYKADVFSFGIALWELLTGEL 311
           V+++D G+A          A  GT+ +MAPEV++    YD  AD FS G  L++LL G  
Sbjct: 331 VRISDLGLA-CDFSKKKPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHS 389

Query: 312 PYAGLTPLQAAVGVVQKSLR--PTIPKHAHPRLAELLERCWQHDPTQR 357
           P+           + + +L     +P    P L  LLE   Q D  +R
Sbjct: 390 PFRQHKTKDKHE-IDRMTLTMAVELPDSFSPELRSLLEGLLQRDVNRR 436

>3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325

 Score =  106 bits (267), Expect = 3e-26
 Identities = 60/228 (26%), Positives = 103/228 (45%), Gaps = 28/228 (12%)

Query: 143 AIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVTEFMARGSIYD 202
           A+KVLK   +          E  I+ ++ H  +V+   A      L ++ +F+  G +  
Sbjct: 56  AMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKLHYAFQTEGKLYLILDFLRGGDL-- 113

Query: 203 FLHKQK-GVFQLTSLLKVAIDVSK--------GMNYLHQNNIIHRDLKTANLLMDENGVV 253
           F    K  +F          +  K         +++LH   II+RDLK  N+L+DE G +
Sbjct: 114 FTRLSKEVMFTE--------EDVKFYLAELALALDHLHSLGIIYRDLKPENILLDEEGHI 165

Query: 254 KVADFGVARVQAQSGVMTAET--GTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTGEL 311
           K+ DFG+++           +  GT  +MAPEV+  + +   AD +SFG+ ++E+LTG L
Sbjct: 166 KLTDFGLSKESIDHEKKAY-SFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTL 224

Query: 312 PYAGLTPLQAAVGVVQKSLR--PTIPKHAHPRLAELLERCWQHDPTQR 357
           P+ G    +    +++  L     +   A   L  L +R    +P  R
Sbjct: 225 PFQGKDRKETMTMILKAKLGMPQFLSPEAQSLLRMLFKR----NPANR 268

>4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446

 Score =  108 bits (271), Expect = 4e-26
 Identities = 63/242 (26%), Positives = 115/242 (47%), Gaps = 20/242 (8%)

Query: 127 GSYGDLY----KGTYCSQEVAIKVL-KPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGA 181
           G++G +     K T   +  A+K+L K   V  + +     E  +++  RH  +     +
Sbjct: 159 GTFGKVILVKEKAT--GRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYS 216

Query: 182 CTRPPNLCIVTEFMARGSIYDFLHKQK-GVFQLTSLLKVAIDVSKGMNYLH-QNNIIHRD 239
                 LC V E+   G +  F H  +  VF          ++   ++YLH + N+++RD
Sbjct: 217 FQTHDRLCFVMEYANGGEL--FFHLSRERVFSEDRARFYGAEIVSALDYLHSEKNVVYRD 274

Query: 240 LKTANLLMDENGVVKVADFGVARVQAQSGVMTAET--GTYRWMAPEVIEHKPYDYKADVF 297
           LK  NL++D++G +K+ DFG+ +   + G     T  GT  ++APEV+E   Y    D +
Sbjct: 275 LKLENLMLDKDGHIKITDFGLCKEGIKDGATMK-TFCGTPEYLAPEVLEDNDYGRAVDWW 333

Query: 298 SFGIALWELLTGELPYAGLTPLQAAVGVVQKSLR--PTIPKHAHPRLAELLERCWQHDPT 355
             G+ ++E++ G LP+      +    ++ + +R   T+   A   L+ LL++    DP 
Sbjct: 334 GLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFPRTLGPEAKSLLSGLLKK----DPK 389

Query: 356 QR 357
           QR
Sbjct: 390 QR 391

>1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420

 Score =  107 bits (270), Expect = 4e-26
 Identities = 71/341 (20%), Positives = 118/341 (34%), Gaps = 79/341 (23%)

Query: 74  DQSCSKRQPALGVPMHSKLLIESSPNCIEIPTDGTDVWEIDAKQL---KIECKVASGSYG 130
           +     +QP+      S  +              T     D  Q         + +GS+G
Sbjct: 12  ESCKPVQQPS---AFGSMKVSRDKDGSKVTTVVATPGQGPDRPQEVSYTDTKVIGNGSFG 68

Query: 131 DLYKGTYCS--QEVAIKVLKPECVNTEMLKEFSQ-EVYIMRKIRHKNVVQFIGACTRPPN 187
            +Y+   C   + VAIK +  +       K F   E+ IMRK+ H N+V+ +        
Sbjct: 69  VVYQAKLCDSGELVAIKKVLQD-------KRFKNRELQIMRKLDHCNIVR-LRYFFYSSG 120

Query: 188 -------LCIVTEFM------------ARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMN 228
                  L +V +++                    ++ +  ++QL           + + 
Sbjct: 121 EKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLF----------RSLA 170

Query: 229 YLHQNNIIHRDLKTANLLMDEN-GVVKVADFGVARVQAQSGVMTAETGT--YRWMAPEVI 285
           Y+H   I HRD+K  NLL+D +  V+K+ DFG A+   +     +   +  YR  APE+I
Sbjct: 171 YIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRYYR--APELI 228

Query: 286 -EHKPYDYKADVFSFGIALWELLTGELPYAGL--------------TPLQAAVGVVQ--- 327
                Y    DV+S G  L ELL G+  + G               TP +  +  +    
Sbjct: 229 FGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPNY 288

Query: 328 ----------KSLRPTIPKHAHPRLAELLERCWQHDPTQRP 358
                                 P    L  R  ++ PT R 
Sbjct: 289 TEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARL 329

>2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371

 Score =  106 bits (266), Expect = 7e-26
 Identities = 67/305 (21%), Positives = 115/305 (37%), Gaps = 69/305 (22%)

Query: 110 VWEIDAKQLKIECKVASGSYGDLYKG--TYCSQEVAIKVLKPECVNTEMLKEFSQEVYIM 167
            + +  +   ++  + SG+ G +         + VAIK L     N    K   +E+ +M
Sbjct: 20  TFTVLKRYQNLK-PIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLM 78

Query: 168 RKIRHKNVVQFIGACTRPPNLC------IVTEFMA-------RGSIYDFLHKQKGVFQLT 214
           + + HKN++  +   T   +L       IV E M        +  +         ++Q+ 
Sbjct: 79  KCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQMELDH-ERMSYLLYQML 137

Query: 215 SLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAET 274
                      G+ +LH   IIHRDLK +N+++  +  +K+ DFG+AR    S +MT   
Sbjct: 138 ----------CGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYV 187

Query: 275 GTYRWM-APEVIEHKPYDYKADVFSFGIALWELLTGELPYAGL--------------TPL 319
            T R+  APEVI    Y    D++S G  + E++ G + + G               TP 
Sbjct: 188 VT-RYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPC 246

Query: 320 QAAVGVVQ---------------KSLRPTIPKHAHPRLAE-----------LLERCWQHD 353
              +  +Q                S     P    P  +E           LL +    D
Sbjct: 247 PEFMKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVID 306

Query: 354 PTQRP 358
            ++R 
Sbjct: 307 ASKRI 311

>1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345

 Score =  105 bits (265), Expect = 7e-26
 Identities = 66/249 (26%), Positives = 112/249 (44%), Gaps = 34/249 (13%)

Query: 127 GSYGDL----YKGTYCSQEVAIKVLK---------PECVNTE--MLKEFSQEVYIMRKIR 171
           GS+G +    +K T  +Q  AIK LK          EC   E  +L              
Sbjct: 28  GSFGKVFLAEFKKT--NQFFAIKALKKDVVLMDDDVECTMVEKRVLS---------LAWE 76

Query: 172 HKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQK-GVFQLTSLLKVAIDVSKGMNYL 230
           H  +           NL  V E++  G +    H Q    F L+     A ++  G+ +L
Sbjct: 77  HPFLTHMFCTFQTKENLFFVMEYLNGGDL--MYHIQSCHKFDLSRATFYAAEIILGLQFL 134

Query: 231 HQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAET--GTYRWMAPEVIEHK 288
           H   I++RDLK  N+L+D++G +K+ADFG+ +        T  T  GT  ++APE++  +
Sbjct: 135 HSKGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTN-TFCGTPDYIAPEILLGQ 193

Query: 289 PYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRLAELLER 348
            Y++  D +SFG+ L+E+L G+ P+ G    +    +   +     P+       +LL +
Sbjct: 194 KYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMDNPF--YPRWLEKEAKDLLVK 251

Query: 349 CWQHDPTQR 357
            +  +P +R
Sbjct: 252 LFVREPEKR 260

>4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437

 Score =  107 bits (268), Expect = 8e-26
 Identities = 51/205 (24%), Positives = 95/205 (46%), Gaps = 26/205 (12%)

Query: 127 GSYGDLY----KGTYCSQEVAIKVL-KPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGA 181
           G++G++     K     +  A+K+L K E +       F +E  ++     K +     A
Sbjct: 85  GAFGEVAVVKLKNA--DKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLHYA 142

Query: 182 CTRPPNLCIVTEFMARGSIYDFLHKQKGVFQL------TSLLKVAIDVSKGMNYLHQNNI 235
                NL +V ++   G +   L K +            + + +AID       +HQ + 
Sbjct: 143 FQDDNNLYLVMDYYVGGDLLTLLSKFEDRLPEEMARFYLAEMVIAID------SVHQLHY 196

Query: 236 IHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAET--GTYRWMAPEVIEHKP---- 289
           +HRD+K  N+LMD NG +++ADFG      + G + +    GT  +++PE+++       
Sbjct: 197 VHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSVAVGTPDYISPEILQAMEGGKG 256

Query: 290 -YDYKADVFSFGIALWELLTGELPY 313
            Y  + D +S G+ ++E+L GE P+
Sbjct: 257 RYGPECDWWSLGVCMYEMLYGETPF 281

>3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464

 Score =  107 bits (268), Expect = 9e-26
 Identities = 54/218 (24%), Positives = 93/218 (42%), Gaps = 31/218 (14%)

Query: 110 VWEIDAKQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVNTEMLKEFSQEVYIM 167
            + +  +  +    + SG+ G +         + VAIK L     N    K   +E+ +M
Sbjct: 57  TFTVLKR-YQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLM 115

Query: 168 RKIRHKNVVQFIGACTRPPNLC------IVTEFMA-------RGSIYDFLHKQKGVFQLT 214
           + + HKN++  +   T    L       +V E M        +  +         ++Q+ 
Sbjct: 116 KCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDH-ERMSYLLYQML 174

Query: 215 SLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAET 274
                      G+ +LH   IIHRDLK +N+++  +  +K+ DFG+AR    S +MT   
Sbjct: 175 ----------CGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYV 224

Query: 275 GT--YRWMAPEVIEHKPYDYKADVFSFGIALWELLTGE 310
            T  YR  APEVI    Y    D++S G  + E++  +
Sbjct: 225 VTRYYR--APEVILGMGYKENVDIWSVGCIMGEMVRHK 260

>3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308

 Score =  104 bits (263), Expect = 9e-26
 Identities = 66/292 (22%), Positives = 110/292 (37%), Gaps = 67/292 (22%)

Query: 119 KIECKVASGSYGDLYKG--TYCSQEVAIKVLKPECVNTEMLKEFSQ----EVYIMRKIR- 171
            +  ++  G+YG +YK    +    VA+K ++                  EV ++R++  
Sbjct: 13  PVA-EIGVGAYGTVYKARDPHSGHFVALKSVRVP-NGGGGGGGLPISTVREVALLRRLEA 70

Query: 172 --HKNVVQFIGACT-----RPPNLCIVTEFMARGSIYD---FLHKQKGVFQLTSLLK-VA 220
             H NVV+ +  C      R   + +V E +      D   +L K          +K + 
Sbjct: 71  FEHPNVVRLMDVCATSRTDREIKVTLVFEHVD----QDLRTYLDKAPPPGLPAETIKDLM 126

Query: 221 IDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAETGT--YR 278
               +G+++LH N I+HRDLK  N+L+   G VK+ADFG+AR+ +    +T    T  YR
Sbjct: 127 RQFLRGLDFLHANCIVHRDLKPENILVTSGGTVKLADFGLARIYSYQMALTPVVVTLWYR 186

Query: 279 WMAPEVIEHKPYDYKADVFSFGIALWELLTG----------------------------- 309
             APEV+    Y    D++S G    E+                                
Sbjct: 187 --APEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDWP 244

Query: 310 ---ELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRLAELLERCWQHDPTQRP 358
               LP     P         + ++  +P       A+LL      +P +R 
Sbjct: 245 RDVSLPRGAFPPRGP------RPVQSVVP-EMEESGAQLLLEMLTFNPHKRI 289

>3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353

 Score =  105 bits (264), Expect = 1e-25
 Identities = 69/252 (27%), Positives = 105/252 (41%), Gaps = 40/252 (15%)

Query: 127 GSYGDLY----KGTYCSQEVAIKVLK---------PECVNTEMLKEFSQEVYIMRKI--- 170
           GS+G +     K T      A+KVLK          EC  TE            ++I   
Sbjct: 34  GSFGKVMLARVKET--GDLYAVKVLKKDVILQDDDVECTMTE------------KRILSL 79

Query: 171 --RHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQK-GVFQLTSLLKVAIDVSKGM 227
              H  + Q       P  L  V EF+  G +    H QK   F        A ++   +
Sbjct: 80  ARNHPFLTQLFCCFQTPDRLFFVMEFVNGGDL--MFHIQKSRRFDEARARFYAAEIISAL 137

Query: 228 NYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAET--GTYRWMAPEVI 285
            +LH   II+RDLK  N+L+D  G  K+ADFG+ +    +GV TA T  GT  ++APE++
Sbjct: 138 MFLHDKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGICNGVTTA-TFCGTPDYIAPEIL 196

Query: 286 EHKPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRLAEL 345
           +   Y    D ++ G+ L+E+L G  P+           ++   +    P   H     +
Sbjct: 197 QEMLYGPAVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILNDEVV--YPTWLHEDATGI 254

Query: 346 LERCWQHDPTQR 357
           L+     +PT R
Sbjct: 255 LKSFMTKNPTMR 266

>3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327

 Score =  104 bits (262), Expect = 2e-25
 Identities = 64/254 (25%), Positives = 116/254 (45%), Gaps = 41/254 (16%)

Query: 127 GSYG-------DLYKGTYCSQEVAIKVLKPECVNTEMLKEFSQ---EVYIMRKIRHKNVV 176
           G YG            T   +  A+KVLK   +     K+ +    E  I+ +++H  +V
Sbjct: 28  GGYGKVFQVRKVTGANT--GKIFAMKVLKKAMI-VRNAKDTAHTKAERNILEEVKHPFIV 84

Query: 177 QFIGACTRPPNLCIVTEFMARGSIYDFLHKQK-GVFQLTSLLKVAIDVSK--------GM 227
             I A      L ++ E+++ G +  F+  ++ G+F          D +          +
Sbjct: 85  DLIYAFQTGGKLYLILEYLSGGEL--FMQLEREGIFME--------DTACFYLAEISMAL 134

Query: 228 NYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAET--GTYRWMAPEVI 285
            +LHQ  II+RDLK  N++++  G VK+ DFG+ +     G +T  T  GT  +MAPE++
Sbjct: 135 GHLHQKGIIYRDLKPENIMLNHQGHVKLTDFGLCKESIHDGTVT-HTFCGTIEYMAPEIL 193

Query: 286 EHKPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKSLR--PTIPKHAHPRLA 343
               ++   D +S G  ++++LTG  P+ G    +    +++  L   P + + A   L 
Sbjct: 194 MRSGHNRAVDWWSLGALMYDMLTGAPPFTGENRKKTIDKILKCKLNLPPYLTQEARDLLK 253

Query: 344 ELLERCWQHDPTQR 357
           +LL+R    +   R
Sbjct: 254 KLLKR----NAASR 263

>3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329

 Score =  104 bits (261), Expect = 2e-25
 Identities = 62/296 (20%), Positives = 109/296 (36%), Gaps = 78/296 (26%)

Query: 119 KIECKVASGSYGDLYKGTYCS--QEVAIKVLKPEC----VNTEMLKEFSQEVYIMRKIRH 172
           +I  K+  G+YG++YK       + VAIK ++ E     V    ++E S    ++++++H
Sbjct: 38  RIT-KLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVS----LLKELQH 92

Query: 173 KNVVQFIGACTRPPNLCIVTEFMA--------RGSIYDFLHKQKGVFQLTSLLKVAIDVS 224
           +N+++          L ++ E+          +         +  ++QL           
Sbjct: 93  RNIIELKSVIHHNHRLHLIFEYAENDLKKYMDKNPDVSMRVIKSFLYQLI---------- 142

Query: 225 KGMNYLHQNNIIHRDLKTANLLMD-----ENGVVKVADFGVARV-QAQSGVMTAETGT-- 276
            G+N+ H    +HRDLK  NLL+      E  V+K+ DFG+AR         T E  T  
Sbjct: 143 NGVNFCHSRRCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAFGIPIRQFTHEIITLW 202

Query: 277 YRWMAPEVI-EHKPYDYKADVFSFGIALWELLTG-------------------------- 309
           YR   PE++   + Y    D++S      E+L                            
Sbjct: 203 YR--PPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDSEIDQLFKIFEVLGLPDDT 260

Query: 310 ------ELP-YAGLTPLQAAVGVVQKSLRPTIPKHAHPRLAELLERCWQHDPTQRP 358
                  LP +    P         K+L+  +         +LL    + DP +R 
Sbjct: 261 TWPGVTALPDWKQSFPKFRG-----KTLKRVLGALLDDEGLDLLTAMLEMDPVKRI 311

>1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326

 Score =  103 bits (260), Expect = 3e-25
 Identities = 53/218 (24%), Positives = 96/218 (44%), Gaps = 42/218 (19%)

Query: 119 KIECKVASGSYGDLYKGTYCS---QEVAIKVLKPECVNTE------------MLKEFSQE 163
            +  ++  G+YG ++K        + VA+K ++ +    E            +L+     
Sbjct: 15  CVA-EIGEGAYGKVFKARDLKNGGRFVALKRVRVQ--TGEEGMPLSTIREVAVLRH---- 67

Query: 164 VYIMRKIRHKNVVQFI-----GACTRPPNLCIVTEFMARGSIYD---FLHKQKGVFQLTS 215
              +    H NVV+           R   L +V E +      D   +L K       T 
Sbjct: 68  ---LETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVD----QDLTTYLDKVPEPGVPTE 120

Query: 216 LLK-VAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAET 274
            +K +   + +G+++LH + ++HRDLK  N+L+  +G +K+ADFG+AR+ +    +T+  
Sbjct: 121 TIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTSVV 180

Query: 275 GT--YRWMAPEVIEHKPYDYKADVFSFGIALWELLTGE 310
            T  YR  APEV+    Y    D++S G    E+   +
Sbjct: 181 VTLWYR--APEVLLQSSYATPVDLWSVGCIFAEMFRRK 216

>3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674

 Score =  107 bits (267), Expect = 3e-25
 Identities = 65/254 (25%), Positives = 117/254 (46%), Gaps = 44/254 (17%)

Query: 127 GSYGDL----YKGTYCSQEVAIKVLK---------PECVNTEMLKEFSQEVYIMRKI--- 170
           GS+G +     KGT   +  A+K+LK          EC   E            +++   
Sbjct: 352 GSFGKVMLSERKGT--DELYAVKILKKDVVIQDDDVECTMVE------------KRVLAL 397

Query: 171 --RHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQK-GVFQLTSLLKVAIDVSKGM 227
             +   + Q          L  V E++  G +    H Q+ G F+    +  A +++ G+
Sbjct: 398 PGKPPFLTQLHSCFQTMDRLYFVMEYVNGGDL--MYHIQQVGRFKEPHAVFYAAEIAIGL 455

Query: 228 NYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAET--GTYRWMAPEVI 285
            +L    II+RDLK  N+++D  G +K+ADFG+ +     GV T  T  GT  ++APE+I
Sbjct: 456 FFLQSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGVTTK-TFCGTPDYIAPEII 514

Query: 286 EHKPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKSLR--PTIPKHAHPRLA 343
            ++PY    D ++FG+ L+E+L G+ P+ G    +    +++ ++    ++ K A     
Sbjct: 515 AYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNVAYPKSMSKEAVAICK 574

Query: 344 ELLERCWQHDPTQR 357
            L+ +     P +R
Sbjct: 575 GLMTK----HPGKR 584

>2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373

 Score =  104 bits (261), Expect = 4e-25
 Identities = 70/284 (24%), Positives = 124/284 (43%), Gaps = 31/284 (10%)

Query: 93  LIESSPNCIEIPTDGTDVWEIDAKQLKIEC----KV-ASGSYGDLY----KGTYCSQEVA 143
           L+ ++P     P+   ++        K       KV   GS+G +     K        A
Sbjct: 10  LMNANPAPPPAPSQQINLGPSSNPHAKPSDFHFLKVIGKGSFGKVLLARHKAE--EVFYA 67

Query: 144 IKVLKPECVNTEMLKEFSQEVYIM-------RKIRHKNVVQFIGACTRPPNLCIVTEFMA 196
           +KVL+      + + +  +E +IM       + ++H  +V    +      L  V +++ 
Sbjct: 68  VKVLQ-----KKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYIN 122

Query: 197 RGSIYDFLHKQK-GVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKV 255
            G +  F H Q+   F        A +++  + YLH  NI++RDLK  N+L+D  G + +
Sbjct: 123 GGEL--FYHLQRERCFLEPRARFYAAEIASALGYLHSLNIVYRDLKPENILLDSQGHIVL 180

Query: 256 ADFGVARVQAQSGVMTAET--GTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPY 313
            DFG+ +   +    T+ T  GT  ++APEV+  +PYD   D +  G  L+E+L G  P+
Sbjct: 181 TDFGLCKENIEHNSTTS-TFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPF 239

Query: 314 AGLTPLQAAVGVVQKSLRPTIPKHAHPRLAELLERCWQHDPTQR 357
                 +    ++ K L+  +  +       LLE   Q D T+R
Sbjct: 240 YSRNTAEMYDNILNKPLQ--LKPNITNSARHLLEGLLQKDRTKR 281

>2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353

 Score =  103 bits (259), Expect = 6e-25
 Identities = 64/252 (25%), Positives = 114/252 (45%), Gaps = 40/252 (15%)

Query: 127 GSYGDL----YKGTYCSQEVAIKVLK---------PECVNTEMLKEFSQEVYIMRKI--- 170
           GS+G +     KGT   +  A+K+LK          EC   E            +++   
Sbjct: 31  GSFGKVMLSERKGT--DELYAVKILKKDVVIQDDDVECTMVE------------KRVLAL 76

Query: 171 --RHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQK-GVFQLTSLLKVAIDVSKGM 227
             +   + Q          L  V E++  G +    H Q+ G F+    +  A +++ G+
Sbjct: 77  PGKPPFLTQLHSCFQTMDRLYFVMEYVNGGDL--MYHIQQVGRFKEPHAVFYAAEIAIGL 134

Query: 228 NYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAET--GTYRWMAPEVI 285
            +L    II+RDLK  N+++D  G +K+ADFG+ +     GV T  T  GT  ++APE+I
Sbjct: 135 FFLQSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGVTTK-TFCGTPDYIAPEII 193

Query: 286 EHKPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRLAEL 345
            ++PY    D ++FG+ L+E+L G+ P+ G    +    +++ ++    PK        +
Sbjct: 194 AYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNVA--YPKSMSKEAVAI 251

Query: 346 LERCWQHDPTQR 357
            +      P +R
Sbjct: 252 CKGLMTKHPGKR 263

>2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412

 Score =  103 bits (259), Expect = 1e-24
 Identities = 50/258 (19%), Positives = 103/258 (39%), Gaps = 40/258 (15%)

Query: 127 GSYGDLY----KGTYCSQEVAIKVL-KPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGA 181
           G++ ++     K T   Q  A+K++ K + +    +  F +E  ++     + + Q   A
Sbjct: 72  GAFSEVAVVKMKQT--GQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLHFA 129

Query: 182 CTRPPNLCIVTEFMARGSIYDFLHKQKGVFQL------TSLLKVAIDVSKGMNYLHQNNI 235
                 L +V E+   G +   L K              + + +AID       +H+   
Sbjct: 130 FQDENYLYLVMEYYVGGDLLTLLSKFGERIPAEMARFYLAEIVMAID------SVHRLGY 183

Query: 236 IHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAET--GTYRWMAPEVIE------- 286
           +HRD+K  N+L+D  G +++ADFG        G + +    GT  +++PE+++       
Sbjct: 184 VHRDIKPDNILLDRCGHIRLADFGSCLKLRADGTVRSLVAVGTPDYLSPEILQAVGGGPG 243

Query: 287 HKPYDYKADVFSFGIALWELLTGELPYAGLTP-------LQAAVGVVQKSLRPTIPKHAH 339
              Y  + D ++ G+  +E+  G+ P+   +        +     +    +   +P+ A 
Sbjct: 244 TGSYGPECDWWALGVFAYEMFYGQTPFYADSTAETYGKIVHYKEHLSLPLVDEGVPEEAR 303

Query: 340 PRLAELLERCWQHDPTQR 357
             +  LL       P  R
Sbjct: 304 DFIQRLL-----CPPETR 316

>1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373

 Score =  102 bits (256), Expect = 2e-24
 Identities = 47/221 (21%), Positives = 104/221 (47%), Gaps = 39/221 (17%)

Query: 119 KIECKVASGSYG------DLYKGTYCSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIR- 171
            +  K+  G +       D+   T+    VA+K+++ + V TE  ++   E+ +++++  
Sbjct: 22  ILVRKLGWGHFSTVWLAKDMVNNTH----VAMKIVRGDKVYTEAAED---EIKLLQRVND 74

Query: 172 ----------HKNVVQFIGACT-RPPN---LCIVTEFMARGSIYDFLHKQKGV-FQLTSL 216
                       ++++ +     + PN   + +V E +   ++   + K +     L  +
Sbjct: 75  ADNTKEDSMGANHILKLLDHFNHKGPNGVHVVMVFEVL-GENLLALIKKYEHRGIPLIYV 133

Query: 217 LKVAIDVSKGMNYLHQN-NIIHRDLKTANLLMDE------NGVVKVADFGVARVQAQSGV 269
            +++  +  G++Y+H+   IIH D+K  N+LM+          +K+AD G A    +   
Sbjct: 134 KQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYT 193

Query: 270 MTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTGE 310
            + +T  YR  +PEV+   P+   AD++S    ++EL+TG+
Sbjct: 194 NSIQTREYR--SPEVLLGAPWGCGADIWSTACLIFELITGD 232

>2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320

 Score =  101 bits (254), Expect = 2e-24
 Identities = 62/309 (20%), Positives = 116/309 (37%), Gaps = 76/309 (24%)

Query: 110 VWEIDAKQLKIECKVASGSYGDLYKG--TYCSQEVAIKVLKPECVNTEMLKEFSQEVYIM 167
            +++ ++       +  G  G ++      C + VAIK +     + + +K   +E+ I+
Sbjct: 6   GFDLGSR-YMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLT--DPQSVKHALREIKII 62

Query: 168 RKIRHKNVVQFIGACTRPPNLC---------------IVTEFMA-------RGSIYDFLH 205
           R++ H N+V+ +     P                   IV E+M                H
Sbjct: 63  RRLDHDNIVK-VFEILGPSGSQLTDDVGSLTELNSVYIVQEYMETDLANVLEQGPLLEEH 121

Query: 206 KQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMD-ENGVVKVADFGVARV- 263
            +  ++QL           +G+ Y+H  N++HRDLK ANL ++ E+ V+K+ DFG+AR+ 
Sbjct: 122 ARLFMYQLL----------RGLKYIHSANVLHRDLKPANLFINTEDLVLKIGDFGLARIM 171

Query: 264 ---QAQSGVMTAETGT--YRWMAPEVI-EHKPYDYKADVFSFGIALWELLTGELPYAGL- 316
               +  G ++    T  YR  +P ++     Y    D+++ G    E+LTG+  +AG  
Sbjct: 172 DPHYSHKGHLSEGLVTKWYR--SPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAH 229

Query: 317 -------------TPLQAAVGVVQKSLR------PTIPK--------HAHPRLAELLERC 349
                           +     +   +        T P                + LE+ 
Sbjct: 230 ELEQMQLILESIPVVHEEDRQELLSVIPVYIRNDMTEPHKPLTQLLPGISREAVDFLEQI 289

Query: 350 WQHDPTQRP 358
               P  R 
Sbjct: 290 LTFSPMDRL 298

>1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355

 Score =  101 bits (253), Expect = 3e-24
 Identities = 54/233 (23%), Positives = 100/233 (42%), Gaps = 28/233 (12%)

Query: 143 AIKVLKPECV--NTEMLKEFSQEVYIMRKIRHKN-VVQFIGACTRPPNLCIVTEFMARGS 199
           A+KVLK   +    +  +    E  ++  IR    +V    A      L ++ +++  G 
Sbjct: 86  AMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETKLHLILDYINGGE 145

Query: 200 IYDFLHKQK-GVFQLTSLLKVAIDVSK--------GMNYLHQNNIIHRDLKTANLLMDEN 250
           +  F H  +   F             +         + +LH+  II+RD+K  N+L+D N
Sbjct: 146 L--FTHLSQRERFTE--------HEVQIYVGEIVLALEHLHKLGIIYRDIKLENILLDSN 195

Query: 251 GVVKVADFGVARVQAQSGVMTAET--GTYRWMAPEVIEHKPYDYKADV--FSFGIALWEL 306
           G V + DFG+++         A    GT  +MAP+++      +   V  +S G+ ++EL
Sbjct: 196 GHVVLTDFGLSKEFVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYEL 255

Query: 307 LTGELPYAGLTPLQAAVGVVQKSLR--PTIPKHAHPRLAELLERCWQHDPTQR 357
           LTG  P+       +   + ++ L+  P  P+       +L++R    DP +R
Sbjct: 256 LTGASPFTVDGEKNSQAEISRRILKSEPPYPQEMSALAKDLIQRLLMKDPKKR 308

>3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410

 Score =  101 bits (254), Expect = 5e-24
 Identities = 54/198 (27%), Positives = 94/198 (47%), Gaps = 15/198 (7%)

Query: 127 GSYGDLY----KGTYCSQEVAIKVL-KPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGA 181
           G++G++     K T   +  A+K+L K E +       F +E  IM       VVQ   A
Sbjct: 80  GAFGEVQLVRHKST--RKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYA 137

Query: 182 CTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLK 241
                 L +V E+M  G +                     +V   ++ +H    IHRD+K
Sbjct: 138 FQDDRYLYMVMEYMPGGDL--VNLMSNYDVPEKWARFYTAEVVLALDAIHSMGFIHRDVK 195

Query: 242 TANLLMDENGVVKVADFGVARVQAQSGVMTAET--GTYRWMAPEVIEHKP----YDYKAD 295
             N+L+D++G +K+ADFG      + G++  +T  GT  +++PEV++ +     Y  + D
Sbjct: 196 PDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECD 255

Query: 296 VFSFGIALWELLTGELPY 313
            +S G+ L+E+L G+ P+
Sbjct: 256 WWSVGVFLYEMLVGDTPF 273

>3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360

 Score =  100 bits (251), Expect = 7e-24
 Identities = 62/301 (20%), Positives = 107/301 (35%), Gaps = 80/301 (26%)

Query: 119 KIECKVASGSYGDLYKGTYCS--QEVAIK--VLKPECVNTEMLKEFSQEVYIMRKIRHKN 174
           ++E     G++G +  G   S    VAIK  +  P   N E+     Q +  +  + H N
Sbjct: 26  QVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPRFRNREL-----QIMQDLAVLHHPN 80

Query: 175 VVQFIGACTRPPN--------LCIVTEFM------------ARGSIYDFLHKQKGVFQLT 214
           +VQ + +              L +V E++             R      +  +  +FQL 
Sbjct: 81  IVQ-LQSYFYTLGERDRRDIYLNVVMEYVPDTLHRCCRNYYRRQVAPPPILIKVFLFQLI 139

Query: 215 SLLKVAIDVSKGMNYLHQN--NIIHRDLKTANLLMD-ENGVVKVADFGVARVQAQSGVMT 271
                     + +  LH    N+ HRD+K  N+L++  +G +K+ DFG A+  + S    
Sbjct: 140 ----------RSIGCLHLPSVNVCHRDIKPHNVLVNEADGTLKLCDFGSAKKLSPSEPNV 189

Query: 272 AETGT--YRWMAPEVI-EHKPYDYKADVFSFGIALWELLTGELPYAGL------------ 316
           A   +  YR  APE+I  ++ Y    D++S G    E++ GE  + G             
Sbjct: 190 AYICSRYYR--APELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSAGQLHEIVRV 247

Query: 317 --TPLQAAV-----GVVQKSLRPTIPKH------------AHPRLAELLERCWQHDPTQR 357
              P +  +           L                         +LL    Q+ P +R
Sbjct: 248 LGCPSREVLRKLNPSHTDVDL-YNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLPEER 306

Query: 358 P 358
            
Sbjct: 307 M 307

>2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353

 Score =  100 bits (251), Expect = 8e-24
 Identities = 72/309 (23%), Positives = 118/309 (38%), Gaps = 76/309 (24%)

Query: 110 VWEIDAKQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKP-ECVNTEMLKEFSQEVYI 166
           V+ I +   +++  +  G+YG +   T+    + VAIK ++P +           +E+ I
Sbjct: 6   VYNISSD-FQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFD--KPLFALRTLREIKI 62

Query: 167 MRKIRHKNVVQFIGACTRPPNLC------IVTEFMA-------RGSIYDFLHKQKGVFQL 213
           ++  +H+N++  I    RP +        I+ E M           +    H Q  ++Q 
Sbjct: 63  LKHFKHENIIT-IFNIQRPDSFENFNEVYIIQELMQTDLHRVISTQMLSDDHIQYFIYQT 121

Query: 214 TSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARV---------- 263
                      + +  LH +N+IHRDLK +NLL++ N  +KV DFG+AR+          
Sbjct: 122 L----------RAVKVLHGSNVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSE 171

Query: 264 -QAQSGVMTAETGT--YRWMAPEVI-EHKPYDYKADVFSFGIALWELLTGE--------- 310
              Q   M     T  YR  APEV+     Y    DV+S G  L EL             
Sbjct: 172 PTGQQSGMVEFVATRWYR--APEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYR 229

Query: 311 ------LPYAGLTPLQAAVGVVQ--------KSLRPTIPK-------HAHPRLAELLERC 349
                     G       +  ++        KSL               +P+  +LL+R 
Sbjct: 230 HQLLLIFGIIGTPHSDNDLRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRM 289

Query: 350 WQHDPTQRP 358
              DP +R 
Sbjct: 290 LVFDPAKRI 298

>3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299

 Score = 96.2 bits (240), Expect = 1e-22
 Identities = 51/263 (19%), Positives = 99/263 (37%), Gaps = 61/263 (23%)

Query: 126 SGSYGDLYKGTYCS--QEVAIKVLKPECVNTEMLKEFSQEVYIMRKI-RHKNVVQFIGAC 182
            G  G + +       ++ A+K+L+    +    +    EV +  +  +  ++V+ +   
Sbjct: 28  LGINGKVLQIFNKRTQEKFALKMLQ----DCPKARR---EVELHWRASQCPHIVRIVDVY 80

Query: 183 ----TRPPNLCIVTEFMARGSIYDFLHKQKGVFQLT-----SLLKVAIDVSKGMNYLHQN 233
                    L IV E +  G ++  + + +G    T      ++K    + + + YLH  
Sbjct: 81  ENLYAGRKCLLIVMECLDGGELFSRI-QDRGDQAFTEREASEIMK---SIGEAIQYLHSI 136

Query: 234 NIIHRDLKTANLLM---DENGVVKVADFGVARVQAQSGVMTAETGTYRWMAPEVIEHKPY 290
           NI HRD+K  NLL      N ++K+ DFG                     A E    + Y
Sbjct: 137 NIAHRDVKPENLLYTSKRPNAILKLTDFG--------------------FAKETT-GEKY 175

Query: 291 DYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKSLR----------PTIPKHAHP 340
           D   D++S G+ ++ LL G  P+     L  + G+  +               + +    
Sbjct: 176 DKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEVSEEVK- 234

Query: 341 RLAELLERCWQHDPTQRPNFSQI 363
               L+    + +PTQR   ++ 
Sbjct: 235 ---MLIRNLLKTEPTQRMTITEF 254

>3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383

 Score = 97.1 bits (242), Expect = 2e-22
 Identities = 60/333 (18%), Positives = 118/333 (35%), Gaps = 107/333 (32%)

Query: 112 EIDAKQLKIECKVASGSYGDLYKGTYCS--QEVAIKVLKPECVNTEMLKEFSQ-EVYIMR 168
           E  +K+  +   + +GS+G + +       +  A+K +  +         +   E+ IM+
Sbjct: 3   ETSSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQD-------PRYKNRELDIMK 55

Query: 169 KIRHKNVVQ--------------------------------FIGACTRPPN------LCI 190
            + H N+++                                     +   N      L +
Sbjct: 56  VLDHVNIIKLVDYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNV 115

Query: 191 VTEFM-------------ARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIH 237
           + E++             +  SI         ++QL           + + ++H   I H
Sbjct: 116 IMEYVPDTLHKVLKSFIRSGRSIPM-NLISIYIYQLF----------RAVGFIHSLGICH 164

Query: 238 RDLKTANLLMD-ENGVVKVADFGVARVQAQSGVMTAETGT--YRWMAPEVI-EHKPYDYK 293
           RD+K  NLL++ ++  +K+ DFG A+    S    A   +  YR  APE++     Y   
Sbjct: 165 RDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSEPSVAYICSRFYR--APELMLGATEYTPS 222

Query: 294 ADVFSFGIALWELLTGELPYAGL--------------TPLQAAVGVV-----QKSLRPTI 334
            D++S G    EL+ G+  ++G               TP +  +  +     +    PT+
Sbjct: 223 IDLWSIGCVFGELILGKPLFSGETSIDQLVRIIQIMGTPTKEQMIRMNPHYTEVRF-PTL 281

Query: 335 PKH--------AHPRLA-ELLERCWQHDPTQRP 358
                        P LA +LLE+  +++P  R 
Sbjct: 282 KAKDWRKILPEGTPSLAIDLLEQILRYEPDLRI 314

>3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429

 Score = 96.7 bits (241), Expect = 3e-22
 Identities = 59/204 (28%), Positives = 100/204 (49%), Gaps = 23/204 (11%)

Query: 126 SGSYGDLYKGTYC-----SQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHK------N 174
            GS+G + K          Q VA+K+++         ++ ++E+ I+  +R +      N
Sbjct: 107 KGSFGQVVK---AYDHKVHQHVALKMVRN---EKRFHRQAAEEIRILEHLRKQDKDNTMN 160

Query: 175 VVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGV-FQLTSLLKVAIDVSKGMNYLHQN 233
           V+  +   T   ++C+  E ++  ++Y+ + K K   F L  + K A  + + ++ LH+N
Sbjct: 161 VIHMLENFTFRNHICMTFELLSM-NLYELIKKNKFQGFSLPLVRKFAHSILQCLDALHKN 219

Query: 234 NIIHRDLKTANLLMDENG--VVKVADFGVARVQAQSGVMTAETGTYRWMAPEVIEHKPYD 291
            IIH DLK  N+L+ + G   +KV DFG +  + Q      ++  YR  APEVI    Y 
Sbjct: 220 RIIHCDLKPENILLKQQGRSGIKVIDFGSSCYEHQRVYTYIQSRFYR--APEVILGARYG 277

Query: 292 YKADVFSFGIALWELLTGELPYAG 315
              D++S G  L ELLTG     G
Sbjct: 278 MPIDMWSLGCILAELLTGYPLLPG 301

>3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458

 Score = 95.3 bits (237), Expect = 1e-21
 Identities = 65/307 (21%), Positives = 109/307 (35%), Gaps = 73/307 (23%)

Query: 110 VWEIDAKQLKIECKVASGSYGDLYKG--TYCSQEVAIKVLKPECVNTEMLKEFSQEVYIM 167
            W+I  +  +I   + +GSYG + +       + VAIK +     +    K   +E+ I+
Sbjct: 48  DWQIPDR-YEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAIL 106

Query: 168 RKIRHKNVVQFIGACTRPPNLC------IVTEFM---------ARGSIYDFLHKQKGVFQ 212
            ++ H +VV+ +     P ++       +V E               + +  H +  ++ 
Sbjct: 107 NRLNHDHVVK-VLDIVIPKDVEKFDELYVVLEIADSDFKKLFRTPVYLTEL-HIKTLLYN 164

Query: 213 LTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARV--------- 263
           L            G+ Y+H   I+HRDLK AN L++++  VKV DFG+AR          
Sbjct: 165 LL----------VGVKYVHSAGILHRDLKPANCLVNQDCSVKVCDFGLARTVDYPENGNS 214

Query: 264 -------------------QAQSGVMTAETGT--YRWMAPEVI-EHKPYDYKADVFSFGI 301
                              +     +T    T  YR  APE+I   + Y    DV+S G 
Sbjct: 215 QLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYR--APELILLQENYTEAIDVWSIGC 272

Query: 302 ALWELLTGELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRLAELLERCWQHDPTQRPNFS 361
              ELL            +           P  P  +   L+   +         R N  
Sbjct: 273 IFAELLNMIKENVAYHADR----------GPLFPGSSCFPLSPDQKAGNDFKFHTRGNRD 322

Query: 362 QITDILK 368
           Q+  I  
Sbjct: 323 QLNVIFN 329

>3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432

 Score = 94.4 bits (235), Expect = 2e-21
 Identities = 56/245 (22%), Positives = 94/245 (38%), Gaps = 58/245 (23%)

Query: 111 WEIDAKQLKIECKVASGSYGDLYKG--TYCSQEVAIKVLKPECVNTEMLKEFSQEVYIMR 168
             +      I+  +  GSYG +Y        + VAIK +     +    K   +E+ I+ 
Sbjct: 22  VHVPDN-YIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILN 80

Query: 169 KIRHKNVVQFIGACTRPPNLC------IVTEFM---------ARGSIYDFLHKQKGVFQL 213
           +++   +++       P +L       IV E               + +  H +  ++ L
Sbjct: 81  RLKSDYIIRLYDLI-IPDDLLKFDELYIVLEIADSDLKKLFKTPIFLTEE-HIKTILYNL 138

Query: 214 TSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARV---------- 263
                       G N++H++ IIHRDLK AN L++++  VKV DFG+AR           
Sbjct: 139 L----------LGENFIHESGIIHRDLKPANCLLNQDCSVKVCDFGLARTINSEKDTNIV 188

Query: 264 -------------QAQSGVMTAETGT--YRWMAPEVI-EHKPYDYKADVFSFGIALWELL 307
                        +     +T+   T  YR  APE+I   + Y    D++S G    ELL
Sbjct: 189 NDLEENEEPGPHNKNLKKQLTSHVVTRWYR--APELILLQENYTKSIDIWSTGCIFAELL 246

Query: 308 TGELP 312
                
Sbjct: 247 NMLQS 251

>3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388

 Score = 92.1 bits (229), Expect = 1e-20
 Identities = 59/242 (24%), Positives = 102/242 (42%), Gaps = 62/242 (25%)

Query: 111 WEIDAKQLKIECKVASGSYGDLYKGTYCS-------QEVAIKVLKPECVNTEMLKEFSQE 163
             +  K  ++  K+  G+YG                + VA+K +     N+   +   +E
Sbjct: 5   RHVLRK-YELVKKLGKGAYG-----IVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFRE 58

Query: 164 VYIMRKIR-HKNVVQFIGACTRPPN---LCIVTEFMA-------RGSIYDFLHKQKGVFQ 212
           + I+ ++  H+N+V  +    R  N   + +V ++M        R +I + +HKQ  V+Q
Sbjct: 59  IMILTELSGHENIVNLLNVL-RADNDRDVYLVFDYMETDLHAVIRANILEPVHKQYVVYQ 117

Query: 213 LTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARV--------- 263
           L           K + YLH   ++HRD+K +N+L++    VKVADFG++R          
Sbjct: 118 LI----------KVIKYLHSGGLLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVTN 167

Query: 264 -------------QAQSGVMTAETGT--YRWMAPEVI-EHKPYDYKADVFSFGIALWELL 307
                             ++T    T  YR  APE++     Y    D++S G  L E+L
Sbjct: 168 NIPLSINENTENFDDDQPILTDYVATRWYR--APEILLGSTKYTKGIDMWSLGCILGEIL 225

Query: 308 TG 309
            G
Sbjct: 226 CG 227

>1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397

 Score = 90.0 bits (223), Expect = 5e-20
 Identities = 54/261 (20%), Positives = 94/261 (36%), Gaps = 79/261 (30%)

Query: 119 KIECKVASGSYG------DLYKGTYCSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIR- 171
            +  K+  G +       D+    +    VA+KV+K     TE   +   E+ +++ +R 
Sbjct: 40  HVIRKLGWGHFSTVWLSWDIQGKKF----VAMKVVKSAEHYTETALD---EIRLLKSVRN 92

Query: 172 -------HKNVVQFIGACT-RPPN---LCIVTEFMARGSIYDFLHKQK-GVFQLTSLLKV 219
                   + VVQ +        N   +C+V E +    +  ++ K       L  + K+
Sbjct: 93  SDPNDPNREMVVQLLDDFKISGVNGTHICMVFEVL-GHHLLKWIIKSNYQGLPLPCVKKI 151

Query: 220 AIDVSKGMNYLH-QNNIIHRDLKTANLLM------------------------------- 247
              V +G++YLH +  IIH D+K  N+L+                               
Sbjct: 152 IQQVLQGLDYLHTKCRIIHTDIKPENILLSVNEQYIRRLAAEATEWQRSGAPPPSGSAVS 211

Query: 248 ------------------DENGVVKVADFGVARVQAQSGVMTAETGTYRWMAPEVIEHKP 289
                              E   VK+AD G A    +      +T  YR  + EV+    
Sbjct: 212 TAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKHFTEDIQTRQYR--SLEVLIGSG 269

Query: 290 YDYKADVFSFGIALWELLTGE 310
           Y+  AD++S     +EL TG+
Sbjct: 270 YNTPADIWSTACMAFELATGD 290

>2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382

 Score = 89.8 bits (223), Expect = 6e-20
 Identities = 55/213 (25%), Positives = 93/213 (43%), Gaps = 25/213 (11%)

Query: 119 KIECKVASGSYGDLYKGTYC-----SQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRH- 172
           +I+  +  GS+G + K          + VAIK++K        L +   EV ++  +   
Sbjct: 57  EIDSLIGKGSFGQVVK---AYDRVEQEWVAIKIIKN---KKAFLNQAQIEVRLLELMNKH 110

Query: 173 -----KNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGV-FQLTSLLKVAIDVSKG 226
                  +V          +LC+V E ++  ++YD L         L    K A  +   
Sbjct: 111 DTEMKYYIVHLKRHFMFRNHLCLVFEMLSY-NLYDLLRNTNFRGVSLNLTRKFAQQMCTA 169

Query: 227 MNYLHQN--NIIHRDLKTANLLM--DENGVVKVADFGVARVQAQSGVMTAETGTYRWMAP 282
           + +L     +IIH DLK  N+L+   +   +K+ DFG +    Q      ++  YR  +P
Sbjct: 170 LLFLATPELSIIHCDLKPENILLCNPKRSAIKIVDFGSSCQLGQRIYQYIQSRFYR--SP 227

Query: 283 EVIEHKPYDYKADVFSFGIALWELLTGELPYAG 315
           EV+   PYD   D++S G  L E+ TGE  ++G
Sbjct: 228 EVLLGMPYDLAIDMWSLGCILVEMHTGEPLFSG 260

>2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355

 Score = 87.0 bits (216), Expect = 4e-19
 Identities = 47/210 (22%), Positives = 84/210 (40%), Gaps = 48/210 (22%)

Query: 140 QEVAIKVLKPECVNTEMLKEFSQ-EVYIMRKIRHK------NVVQFIGACTRPPNLCIVT 192
            +VA+K+++    N    +E ++ E+ +++KI+ K        V          ++CI  
Sbjct: 46  SQVALKIIR----NVGKYREAARLEINVLKKIKEKDKENKFLCVLMSDWFNFHGHMCIAF 101

Query: 193 EFMARGSIYDFLHKQKGV-FQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENG 251
           E + + + ++FL +     + L  +  +A  +   + +LH+N + H DLK  N+L   + 
Sbjct: 102 ELLGK-NTFEFLKENNFQPYPLPHVRHMAYQLCHALRFLHENQLTHTDLKPENILFVNSE 160

Query: 252 V-------------------VKVADFGVARVQAQSGVMTAETGT-------YRWMAPEVI 285
                               ++VADFG       S     E  T       YR   PEVI
Sbjct: 161 FETLYNEHKSCEEKSVKNTSIRVADFG-------SATFDHEHHTTIVATRHYR--PPEVI 211

Query: 286 EHKPYDYKADVFSFGIALWELLTGELPYAG 315
               +    DV+S G  L+E   G   +  
Sbjct: 212 LELGWAQPCDVWSIGCILFEYYRGFTLFQT 241

>1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339

 Score = 85.4 bits (212), Expect = 9e-19
 Identities = 53/204 (25%), Positives = 86/204 (42%), Gaps = 34/204 (16%)

Query: 139 SQEVAIKVLKPECVNTEMLKEFSQ-EVYIMRKIRHK------NVVQFIGACTRPPNLCIV 191
            + VA+K++K    N +   E ++ E+ ++  +           VQ +       ++CIV
Sbjct: 40  GRHVAVKIVK----NVDRYCEAARSEIQVLEHLNTTDPNSTFRCVQMLEWFEHHGHICIV 95

Query: 192 TEFMARGSIYDFLHKQKGV-FQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDEN 250
            E +   S YDF+ +   + F+L  + K+A  + K +N+LH N + H DLK  N+L  ++
Sbjct: 96  FELLGL-STYDFIKENGFLPFRLDHIRKMAYQICKSVNFLHSNKLTHTDLKPENILFVQS 154

Query: 251 GV-------------------VKVADFGVARVQAQSGVMTAETGTYRWMAPEVIEHKPYD 291
                                +KV DFG A    +       T  YR  APEVI    + 
Sbjct: 155 DYTEAYNPKIKRDERTLINPDIKVVDFGSATYDDEHHSTLVSTRHYR--APEVILALGWS 212

Query: 292 YKADVFSFGIALWELLTGELPYAG 315
              DV+S G  L E   G   +  
Sbjct: 213 QPCDVWSIGCILIEYYLGFTVFPT 236

>3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360

 Score = 83.5 bits (207), Expect = 5e-18
 Identities = 50/211 (23%), Positives = 93/211 (44%), Gaps = 55/211 (26%)

Query: 140 QEVAIKVLKPECVNTEMLKEFSQ-EVYIMRKIRH-----KNVVQFIGACTRPPNLCIVTE 193
           +  A+KV++    N +     ++ E  I++KI++      N+V++ G      ++C++ E
Sbjct: 61  KYYAVKVVR----NIKKYTRSAKIEADILKKIQNDDINNNNIVKYHGKFMYYDHMCLIFE 116

Query: 194 FMARGSIYDFL--HKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENG 251
            +   S+Y+ +  +   G F +  +    I++ K +NYL + ++ H DLK  N+L+D+  
Sbjct: 117 PLGP-SLYEIITRNNYNG-FHIEDIKLYCIEILKALNYLRKMSLTHTDLKPENILLDDPY 174

Query: 252 V-------------------------VKVADFGVARVQAQSGVMTAETGT-------YRW 279
                                     +K+ DFG            ++          YR 
Sbjct: 175 FEKSLITVRRVTDGKKIQIYRTKSTGIKLIDFG-------CATFKSDYHGSIINTRQYR- 226

Query: 280 MAPEVIEHKPYDYKADVFSFGIALWELLTGE 310
            APEVI +  +D  +D++SFG  L EL TG 
Sbjct: 227 -APEVILNLGWDVSSDMWSFGCVLAELYTGS 256

>3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296

 Score = 80.5 bits (199), Expect = 4e-17
 Identities = 72/280 (25%), Positives = 116/280 (41%), Gaps = 35/280 (12%)

Query: 119 KIECKVASGSYGDLYKGTYCS--QEVAIKVLKPECVNTE--MLKEFSQEVYIMRKIRH-K 173
           ++  K+ SGS+GD+Y GT  +  +EVAIK+   ECV T+   L     E  I + ++   
Sbjct: 12  RLGRKIGSGSFGDIYLGTDIAAGEEVAIKL---ECVKTKHPQLH---IESKIYKMMQGGV 65

Query: 174 NVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQN 233
            +              +V E +   S+ D  +     F L ++L +A  +   + Y+H  
Sbjct: 66  GIPTIRWCGAEGDYNVMVMELLGP-SLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSK 124

Query: 234 NIIHRDLKTANLLM---DENGVVKVADFGVAR--VQAQSGVMTAE------TGTYRWM-- 280
           N IHRD+K  N LM    +  +V + DFG+A+    A++            TGT R+   
Sbjct: 125 NFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASI 184

Query: 281 -APEVIEHKPYDYKADVFSFGIALWELLTGELPYAGL---TPLQAAVGVVQKSLRPTIP- 335
                IE    D   D+ S G  L     G LP+ GL   T  Q    + +K +   I  
Sbjct: 185 NTHLGIEQSRRD---DLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEV 241

Query: 336 --KHAHPRLAELLERCWQHDPTQRPNFSQITDILKQMMKE 373
             K      A  L  C       +P++S +  + + +   
Sbjct: 242 LCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHR 281

>2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330

 Score = 76.6 bits (189), Expect = 9e-16
 Identities = 58/276 (21%), Positives = 110/276 (39%), Gaps = 26/276 (9%)

Query: 119 KIECKVASGSYGDLYKGTYCS--QEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRH-KNV 175
           ++  K+  G++G+L  G      + VAIK+   E + +    +   E    +++     +
Sbjct: 12  RVGKKIGCGNFGELRLGKNLYTNEYVAIKL---EPMKSRA-PQLHLEYRFYKQLGSGDGI 67

Query: 176 VQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNI 235
            Q            +V E +   S+ D        F L ++L +AI +   M Y+H  N+
Sbjct: 68  PQVYYFGPCGKYNAMVLELLGP-SLEDLFDLCDRTFSLKTVLMIAIQLISRMEYVHSKNL 126

Query: 236 IHRDLKTANLLMDENG-----VVKVADFGVAR--VQAQSG--VMTAE----TGTYRWMAP 282
           I+RD+K  N L+   G     V+ + DF +A+  +  ++   +   E    TGT R+M+ 
Sbjct: 127 IYRDVKPENFLIGRPGNKTQQVIHIIDFALAKEYIDPETKKHIPYREHKSLTGTARYMSI 186

Query: 283 EVIEHKPYDYKADVFSFGIALWELLTGELPYAGL---TPLQAAVGVVQKSLRPTIPK--H 337
                K    + D+ + G      L G LP+ GL   T  +    +        I     
Sbjct: 187 NTHLGKEQSRRDDLEALGHMFMYFLRGSLPWQGLKADTLKERYQKIGDTKRATPIEVLCE 246

Query: 338 AHPRLAELLERCWQHDPTQRPNFSQITDILKQMMKE 373
             P +A  L    + D  ++P++  +  +   +   
Sbjct: 247 NFPEMATYLRYVRRLDFFEKPDYDYLRKLFTDLFDR 282

>2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345

 Score = 75.2 bits (185), Expect = 3e-15
 Identities = 60/307 (19%), Positives = 118/307 (38%), Gaps = 45/307 (14%)

Query: 106 DGTDVWEIDAKQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVNTEMLKEFSQE 163
           +G  + +++  Q  +  K+ SG +G +Y        ++ A  V+K E      L     E
Sbjct: 27  EGKVLDDMEGNQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLF---SE 83

Query: 164 VYIMRKIRHKNVVQFIGACTRPPNLCIVT-----EFMARGSIYDF------------LHK 206
           +   +++  K+ ++      +   L I           +G  Y F            +  
Sbjct: 84  LKFYQRVAKKDCIKKWIERKQLDYLGIPLFYGSGLTEFKGRSYRFMVMERLGIDLQKISG 143

Query: 207 QKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKV--ADFGVARVQ 264
           Q G F+ +++L++ I +   + Y+H+N  +H D+K ANLL+      +V  AD+G++   
Sbjct: 144 QNGTFKKSTVLQLGIRMLDVLEYIHENEYVHGDIKAANLLLGYKNPDQVYLADYGLSYRY 203

Query: 265 AQSGVM--------TAETGTYRWMAPEVIEHKPYDY--KADVFSFGIALWELLTGELPYA 314
             +G              GT  + +  +  HK      ++DV   G  +   L G+LP+ 
Sbjct: 204 CPNGNHKQYQENPRKGHNGTIEFTS--LDAHKGVALSRRSDVEILGYCMLRWLCGKLPWE 261

Query: 315 GLTPLQAAV--------GVVQKSLRPTIPKHAHPR-LAELLERCWQHDPTQRPNFSQITD 365
                  AV          + +S+    P  +    +A+ L         ++PN+  +  
Sbjct: 262 QNLKDPVAVQTAKTNLLDELPQSVLKWAPSGSSCCEIAQFLVCAHSLAYDEKPNYQALKK 321

Query: 366 ILKQMMK 372
           IL     
Sbjct: 322 ILNPHGI 328

>1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298

 Score = 72.8 bits (179), Expect = 1e-14
 Identities = 46/277 (16%), Positives = 105/277 (37%), Gaps = 27/277 (9%)

Query: 119 KIECKVASGSYGDLYKGTYCS--QEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRH-KNV 175
           K+  ++  GS+G +++GT     Q+VAIK    E   ++   +   E    + +     +
Sbjct: 13  KVGRRIGEGSFGVIFEGTNLLNNQQVAIKF---EPRRSDA-PQLRDEYRTYKLLAGCTGI 68

Query: 176 VQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNI 235
                      +  +V + +   S+ D L      F + ++   A  +   +  +H+ ++
Sbjct: 69  PNVYYFGQEGLHNVLVIDLLGP-SLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKSL 127

Query: 236 IHRDLKTANLLMDENG-----VVKVADFGVAR--VQAQSGVMTAE------TGTYRWMAP 282
           ++RD+K  N L+         ++ V DFG+ +      +            +GT R+M+ 
Sbjct: 128 VYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARYMSI 187

Query: 283 EVIEHKPYDYKADVFSFGIALWELLTGELPYAGL---TPLQAAVGVVQKSLRPTIPK--H 337
                +    + D+ + G      L G LP+ GL   T  Q    + +K     + +   
Sbjct: 188 NTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQSTPLRELCA 247

Query: 338 AHPR-LAELLERCWQHDPTQRPNFSQITDILKQMMKE 373
             P    + +           P++  +  +  ++++ 
Sbjct: 248 GFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKVLER 284

>3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483

 Score = 73.9 bits (181), Expect = 2e-14
 Identities = 64/285 (22%), Positives = 113/285 (39%), Gaps = 45/285 (15%)

Query: 119 KIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVNTE--MLKEFSQEVYIMRKIR-HK 173
           ++  K+ SGS+G++Y GT    ++EVAIK+   E V T+   L     E  I R ++   
Sbjct: 10  RLGRKIGSGSFGEIYLGTNIQTNEEVAIKL---ENVKTKHPQLL---YESKIYRILQGGT 63

Query: 174 NVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQN 233
            +              +V + +   S+ D  +       L ++L +A  +   + ++H  
Sbjct: 64  GIPNVRWFGVEGDYNVLVMDLLGP-SLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSK 122

Query: 234 NIIHRDLKTANLLMDENG---VVKVADFGVARV-------------QAQSGVMTAETGTY 277
           + +HRD+K  N LM        V + DFG+A+              + ++      TGT 
Sbjct: 123 SFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNL-----TGTA 177

Query: 278 RWM---APEVIEHKPYDYKADVFSFGIALWELLTGELPYAGL---TPLQAAVGVVQKSLR 331
           R+        IE    D   D+ S G  L   L G LP+ GL   T  Q    + +K + 
Sbjct: 178 RYASVNTHLGIEQSRRD---DLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVA 234

Query: 332 PTIP---KHAHPRLAELLERCWQHDPTQRPNFSQITDILKQMMKE 373
            +I    +      A     C       +P++S +  + + +   
Sbjct: 235 TSIEALCRGYPTEFASYFHYCRSLRFDDKPDYSYLKRLFRDLFIR 279

>3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364

 Score = 67.1 bits (164), Expect = 2e-12
 Identities = 54/309 (17%), Positives = 115/309 (37%), Gaps = 44/309 (14%)

Query: 106 DGTDVWEIDAKQLKIECKVASGSYGDLYKGTYCS-------QEVAIKVLKPEC--VNTEM 156
            G  + ++ A   K+   +  G +G +Y     S           +KV   +   + TE+
Sbjct: 25  VGEIITDMAAAAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTEL 84

Query: 157 --LKEFSQEVYIMRKIRHKNV-------VQFIGACTRPPNL--CIVTEFMARGSIYDFLH 205
              +  ++   I + IR + +           G   +       ++ +      +     
Sbjct: 85  KFYQRAAKPEQIQKWIRTRKLKYLGVPKYWGSGLHDKNGKSYRFMIMDRFGS-DLQKIYE 143

Query: 206 KQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKV--ADFGVARV 263
                F   ++L++++ +   + Y+H++  +H D+K +NLL++     +V   D+G+A  
Sbjct: 144 ANAKRFSRKTVLQLSLRILDILEYIHEHEYVHGDIKASNLLLNYKNPDQVYLVDYGLAYR 203

Query: 264 QAQSGVMTAE--------TGTYRWMAPEVIEHKPYDY--KADVFSFGIALWELLTGELPY 313
               GV  A          GT  + +  +  H       + D+   G  + + LTG LP+
Sbjct: 204 YCPEGVHKAYAADPKRCHDGTIEFTS--IDAHNGVAPSRRGDLEILGYCMIQWLTGHLPW 261

Query: 314 AGLTPLQAAVG---VVQKSLRPTIPKHAHPR------LAELLERCWQHDPTQRPNFSQIT 364
                    V    +  +    ++     P       +A+ +E     D T++P +  + 
Sbjct: 262 EDNLKDPKYVRDSKIRYRENIASLMDKCFPAANAPGEIAKYMETVKLLDYTEKPLYENLR 321

Query: 365 DILKQMMKE 373
           DIL Q +K 
Sbjct: 322 DILLQGLKA 330

>2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352

 Score = 67.1 bits (164), Expect = 2e-12
 Identities = 48/312 (15%), Positives = 108/312 (34%), Gaps = 50/312 (16%)

Query: 106 DGTDVWEIDAKQLKIECKVASGSYGDLYKGT----------YCSQEVAIKVLKPECVNTE 155
            GT + +   +Q K++      + G LY+               Q+ ++K+   +  +  
Sbjct: 32  TGTVLTDKSGRQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKL---DAKDGR 88

Query: 156 MLKEFS-----------QEVYIMRKIRHKNVVQFIGACTRPPNL-CIVTEFMARGSIYDF 203
           +  E +            +   +       +   +G          +V   + R S+   
Sbjct: 89  LFNEQNFFQRAAKPLQVNKWKKLYSTPLLAIPTCMGFGVHQDKYRFLVLPSLGR-SLQSA 147

Query: 204 LHKQ-KGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKV--ADFGV 260
           L    K V    S+L+VA  +   + +LH+N  +H ++   N+ +D     +V  A +G 
Sbjct: 148 LDVSPKHVLSERSVLQVACRLLDALEFLHENEYVHGNVTAENIFVDPEDQSQVTLAGYGF 207

Query: 261 AR--------VQAQSGVMTAETGTYRWMAPEVIEHKPYDY--KADVFSFGIALWELLTGE 310
           A         V    G  +   G   +++  +  HK      ++D+ S G  + + L G 
Sbjct: 208 AFRYCPSGKHVAYVEGSRSPHEGDLEFIS--MDLHKGCGPSRRSDLQSLGYCMLKWLYGF 265

Query: 311 LPYAGLTPLQAAVG---VVQKSLRPTI-----PKHAHPR-LAELLERCWQHDPTQRPNFS 361
           LP+    P    +                           L + L+        ++P ++
Sbjct: 266 LPWTNCLPNTEDIMKQKQKFVDKPGPFVGPCGHWIRPSETLQKYLKVVMALTYEEKPPYA 325

Query: 362 QITDILKQMMKE 373
            + + L+ ++++
Sbjct: 326 MLRNNLEALLQD 337

>2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336

 Score = 63.4 bits (153), Expect = 3e-11
 Identities = 32/192 (16%), Positives = 65/192 (33%), Gaps = 48/192 (25%)

Query: 117 QLKIECKVASGSYGDLYKGTYCSQEVAIKVL---KPECVNTEM---LKEFSQEVYIMRKI 170
           +L+   K+  G +G++++       VAIK++    P+ VN       +E   E+ I +++
Sbjct: 21  KLQRCEKIGEGVFGEVFQTIADHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKEL 80

Query: 171 ---------RHKNVVQFIGAC----TRPPNLC--------------------------IV 191
                    R +  +          + PP L                           IV
Sbjct: 81  SLLSGEVCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIV 140

Query: 192 TEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQN-NIIHRDLKTANLLMDEN 250
            EF   G   D    +  +  L +   +   ++  +     +    HRDL   N+L+ + 
Sbjct: 141 LEFEFGGI--DLEQMRTKLSSLATAKSILHQLTASLAVAEASLRFEHRDLHWGNVLLKKT 198

Query: 251 GVVKVADFGVAR 262
            + K+      +
Sbjct: 199 SLKKLHYTLNGK 210

>1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221

 Score = 48.7 bits (115), Expect = 3e-06
 Identities = 54/390 (13%), Positives = 110/390 (28%), Gaps = 100/390 (25%)

Query: 39  LDVFVVDGWPYDETEDLKNVLAKEILKSKFLIAMQDQSCSKRQPALGVPMHSKLLIESSP 98
            D FV +    D  +  K++L+KE +     I M   + S              L+    
Sbjct: 26  EDAFVDNFDCKDVQDMPKSILSKEEIDH---IIMSKDAVSGTLRLFW------TLLSKQE 76

Query: 99  NCIEIPTDGTDVWEID----AKQLKIECKVASG---SYGDLYKGTYCSQEVAIK--VLKP 149
             ++   +  +V  I+       +K E +  S     Y +     Y   +V  K  V + 
Sbjct: 77  EMVQKFVE--EVLRINYKFLMSPIKTEQRQPSMMTRMYIEQRDRLYNDNQVFAKYNVSRL 134

Query: 150 ECVNT--EMLKEFSQEVYI----MR---K-------IRHKNVVQF---------IGACTR 184
           +      + L E      +    +    K            V            +  C  
Sbjct: 135 QPYLKLRQALLELRPAKNVLIDGVLGSGKTWVALDVCLSYKVQCKMDFKIFWLNLKNCNS 194

Query: 185 PP-------NLC--IVTEFMARGSIYD--FLHKQKGVFQLTSLLKVAIDVSKGMNYLHQN 233
           P         L   I   + +R        L       +L  LLK               
Sbjct: 195 PETVLEMLQKLLYQIDPNWTSRSDHSSNIKLRIHSIQAELRRLLK--------------- 239

Query: 234 NIIHRDLKTANLLMDE---NGVVKVADFGVARVQAQSGVMTAETGTYRWMAPEVIEHKPY 290
               +  +   L++            +    ++     + T       +++     H   
Sbjct: 240 ---SKPYENCLLVLLNVQNAKAWNAFNLS-CKIL----LTTRFKQVTDFLSAATTTHISL 291

Query: 291 DYKADVF----SFGI-ALW-ELLTGELPYAGLT--PLQAAVGVVQKSLRPTIP-----KH 337
           D+ +          +   + +    +LP   LT  P    + ++ +S+R  +      KH
Sbjct: 292 DHHSMTLTPDEVKSLLLKYLDCRPQDLPREVLTTNPR--RLSIIAESIRDGLATWDNWKH 349

Query: 338 -AHPRLAELLERCWQH-DPT-QRPNFSQIT 364
               +L  ++E      +P   R  F +++
Sbjct: 350 VNCDKLTTIIESSLNVLEPAEYRKMFDRLS 379

>1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221

 Score = 46.4 bits (109), Expect = 1e-05
 Identities = 52/298 (17%), Positives = 92/298 (30%), Gaps = 93/298 (31%)

Query: 6   WVLMKVGELTSLLGEIGLNIQEA----HAFSTVDGFSLDVFVVDG----------WPYDE 51
           W  +   +LT+++ E  LN+ E       F       L VF              W    
Sbjct: 347 WKHVNCDKLTTII-ESSLNVLEPAEYRKMF-----DRLSVFPPSAHIPTILLSLIWFDVI 400

Query: 52  TEDLKNVLAKEILKSKFLIAMQ---------DQSCSKRQPALGVP-MHSKLLIESSPNCI 101
             D+  V+ K  L    L+  Q               +        +H  ++     +  
Sbjct: 401 KSDVMVVVNK--LHKYSLVEKQPKESTISIPSIYLELKVKLENEYALHRSIV-----DHY 453

Query: 102 EIPTDGTDVWEIDAKQLKIECKVASGSYGDLYKGTYCSQEVAIKVLKPECVNTEMLKEFS 161
            IP    D  ++    L            D Y  ++         LK    + E +  F 
Sbjct: 454 NIP-KTFDSDDLIPPYL------------DQYFYSHIGHH-----LK-NIEHPERMTLFR 494

Query: 162 QEVY-----IMRKIRHKNVVQFIGACTRPPNLCIVTEFMARGSIY-DFLHKQKGVF-QLT 214
             V+     + +KIRH +      A     N     +F      Y  ++      + +L 
Sbjct: 495 M-VFLDFRFLEQKIRHDSTAW--NASGSILNTLQQLKF------YKPYICDNDPKYERLV 545

Query: 215 SLLKVAIDVSKGMNYLHQ--NNII---HRDL-KTANLLMDENGVVKVADFGVARVQAQ 266
           + +         +++L +   N+I   + DL + A  LM E+  +    F  A  Q Q
Sbjct: 546 NAI---------LDFLPKIEENLICSKYTDLLRIA--LMAEDEAI----FEEAHKQVQ 588

Structure Templates Detected by HHsearch

Original result of HHsearch against PDB70 database

ID	Length	Definition	Probability
Query	399
3omv_A	307	RAF proto-oncogene serine/threonine-protein kinas;	100.0
4asz_A	299	BDNF/NT-3 growth factors receptor; transferase, TR	100.0
4aoj_A	329	High affinity nerve growth factor receptor; transf	100.0
4gt4_A	308	Tyrosine-protein kinase transmembrane receptor RO;	100.0
4b9d_A	350	Serine/threonine-protein kinase NEK1; transferase,	100.0
4ase_A	353	Vascular endothelial growth factor receptor 2; tra	100.0
4g3f_A	336	NF-kappa-beta-inducing kinase; non-RD kinase, prot	100.0
3fpq_A	290	Serine/threonine-protein kinase WNK1; protein seri	100.0
3hyh_A	275	Carbon catabolite-derepressing protein kinase; kin	100.0
4aw0_A	311	HPDK1, 3-phosphoinositide-dependent protein kinase	100.0
4fih_A	346	Serine/threonine-protein kinase PAK 4; kinase doma	100.0
3ubd_A	304	Ribosomal protein S6 kinase alpha-3; kinase-inhibi	100.0
4fie_A	423	Serine/threonine-protein kinase PAK 4; kinase doma	100.0
3hmm_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	100.0
4g31_A	299	Eukaryotic translation initiation factor 2-alpha;	100.0
4b99_A	398	Mitogen-activated protein kinase 7; transferase, i	100.0
3p86_A	309	Serine/threonine-protein kinase CTR1; ETR1, ERS1,	100.0
3uto_A	573	Twitchin; kinase, muscle sarcomere, transferase; H	100.0
4f9c_A	361	Cell division cycle 7-related protein kinase; Ser/	100.0
3v5w_A	689	G-protein coupled receptor kinase 2; inhibitor com	100.0
2psq_A	370	Fibroblast growth factor receptor 2; kinase domain	100.0
4hcu_A	269	Tyrosine-protein kinase ITK/TSK; transferase-trans	100.0
3fe3_A	328	MAP/microtubule affinity-regulating kinase 3; seri	100.0
3kmu_A	271	ILK, integrin-linked kinase; cell adhesion, ANK re	100.0
3cbl_A	377	C-FES, proto-oncogene tyrosine-protein kinase FES/	100.0
3kul_A	325	Ephrin type-A receptor 8; ATP-binding, kinase, nuc	100.0
3lb7_A	307	RAF proto-oncogene serine/threonine-protein kinas;	100.0
3gen_A	283	Tyrosine-protein kinase BTK; bruton'S tyrosine kin	100.0
3ugc_A	295	Tyrosine-protein kinase JAK2; small molecule inhib	100.0
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	100.0
1k9a_A	450	Carboxyl-terminal SRC kinase; COOH-terminal SRC ki	100.0
3s95_A	310	LIMK-1, LIM domain kinase 1; structural genomics,	100.0
3og7_A	289	AKAP9-BRAF fusion protein; proto-oncogene, V600E,	100.0
3tt0_A	382	Basic fibroblast growth factor receptor 1; kinase	100.0
1t46_A	313	HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom	100.0
1mp8_A	281	Focal adhesion kinase 1; tyrosine protein kinase,	100.0
3dtc_A	271	Mitogen-activated protein kinase kinase kinase 9;	100.0
3sxs_A	268	Cytoplasmic tyrosine-protein kinase BMX; transfera	100.0
3zgw_A	347	Maternal embryonic leucine zipper kinase; transfer	100.0
1rjb_A	344	FL cytokine receptor; kinase, structure, autoinhib	100.0
1luf_A	343	Muscle-specific tyrosine kinase receptor MUSK; pho	100.0
1u59_A	287	Tyrosine-protein kinase ZAP-70; transferase; HET:	100.0
3fxz_A	297	Serine/threonine-protein kinase PAK 1; transferase	100.0
3t9t_A	267	Tyrosine-protein kinase ITK/TSK; kinase domain, al	100.0
2bdw_A	362	Hypothetical protein K11E8.1D; kinase, calmodulin	100.0
2qol_A	373	Ephrin receptor; receptor tyrosine kinase, juxtame	100.0
3soc_A	322	Activin receptor type-2A; structural genomics cons	100.0
1xbb_A	291	Tyrosine-protein kinase SYK; gleevec, STI-571, ima	100.0
2i1m_A	333	Macrophage colony-stimulating factor 1 receptor; k	100.0
1o6l_A	337	RAC-beta serine/threonine protein kinase; protein	100.0
2ivs_A	314	Proto-oncogene tyrosine-protein kinase receptor RE	100.0
1tki_A	321	Titin; serine kinase, muscle, autoinhibition; 2.00	100.0
2yab_A	361	Death-associated protein kinase 2; apoptosis, tran	100.0
3l9p_A	367	Anaplastic lymphoma kinase; kinase domain, ATP-bin	100.0
4eqm_A	294	Protein kinase; transferase; HET: ANP; 3.00A {Stap	100.0
3qup_A	323	Tyrosine-protein kinase receptor TYRO3; protein ki	100.0
4e5w_A	302	Tyrosine-protein kinase JAK1; kinase domain, trans	100.0
1qcf_A	454	Haematopoetic cell kinase (HCK); tyrosine kinase-i	100.0
4f0f_A	287	Serine/threonine-protein kinase ROCO4; LRRK2, ATP-	100.0
3soa_A	444	Calcium/calmodulin-dependent protein kinase type a	100.0
3niz_A	311	Rhodanese family protein; structural genomics, str	100.0
1mqb_A	333	Ephrin type-A receptor 2; tyrosine protein kinase,	100.0
3kfa_A	288	Tyrosine-protein kinase ABL1; CML, drug resistance	100.0
3cc6_A	281	Protein tyrosine kinase 2 beta; focal adhesion kin	100.0
2pvf_A	334	Fibroblast growth factor receptor 2; kinase domain	100.0
2xir_A	316	Vascular endothelial growth factor receptor 2; ang	100.0
3kk8_A	284	Calcium/calmodulin dependent protein kinase II; AT	100.0
2y0a_A	326	Death-associated protein kinase 1; transferase, ca	100.0
3p1a_A	311	MYT1 kinase, membrane-associated tyrosine- and thr	100.0
1ob3_A	288	PFPK5, cell division control protein 2 homolog; tr	100.0
3o0g_A	292	Cell division protein kinase 5; kinase activator c	100.0
3poz_A	327	Epidermal growth factor receptor; kinase domain, a	100.0
3gni_B	389	Strad alpha; kinase fold, pseudokinase, alpha heli	100.0
3brb_A	313	Proto-oncogene tyrosine-protein kinase MER; ATP-bi	100.0
1csn_A	298	Casein kinase-1; phosphotransferase; HET: ATP; 2.0	100.0
1opk_A	495	P150, C-ABL, proto-oncogene tyrosine-protein kinas	100.0
3op5_A	364	Serine/threonine-protein kinase VRK1; adenosine tr	100.0
3lxl_A	327	Tyrosine-protein kinase JAK3; TYK2, inflammation,	100.0
1byg_A	278	CSK, protein (C-terminal SRC kinase); protein kina	100.0
1qpc_A	279	LCK kinase; alpha beta fold, transferase; HET: PTR	100.0
3txo_A	353	PKC-L, NPKC-ETA, protein kinase C ETA type; phosph	100.0
4ejn_A	446	RAC-alpha serine/threonine-protein kinase; AKT1, a	100.0
1kob_A	387	Twitchin; kinase, intrasteric regulation; 2.30A {A	100.0
3a62_A	327	Ribosomal protein S6 kinase beta-1; kinase domain,	100.0
1fmk_A	452	C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros	100.0
2zv2_A	298	Calcium/calmodulin-dependent protein kinase kinas;	100.0
3lxp_A	318	Non-receptor tyrosine-protein kinase TYK2; JAK3, i	100.0
1p4o_A	322	Insulin-like growth factor I receptor protein; IGF	100.0
1fot_A	318	TPK1 delta, CAMP-dependent protein kinase type 1;	100.0
4fr4_A	384	YANK1, serine/threonine-protein kinase 32A; struct	100.0
3a8x_A	345	Protein kinase C IOTA type; transferase; HET: TPO;	100.0
2x4f_A	373	Myosin light chain kinase family member 4; LUNG, b	100.0
4dc2_A	396	Protein kinase C IOTA type; kinase, substrate, cel	100.0
2eva_A	307	TAK1 kinase - TAB1 chimera fusion protein; transfe	100.0
3fme_A	290	Dual specificity mitogen-activated protein kinase;	100.0
1fvr_A	327	Tyrosine-protein kinase TIE-2; tyrosine kinase, tr	100.0
4fvq_A	289	Tyrosine-protein kinase JAK2; janus protein kinase	100.0
3pls_A	298	Macrophage-stimulating protein receptor; protein k	100.0
1u5q_A	348	Serine/threonine protein kinase TAO2; transferase;	100.0
2wqm_A	310	Serine/threonine-protein kinase NEK7; ATP-binding,	100.0
2w1i_A	326	JAK2; chromosomal rearrangement, nucleotide-bindin	100.0
3uc3_A	361	Serine/threonine-protein kinase SRK2I; SNRK2, ABA	100.0
1rdq_E	350	PKA C-alpha, CAMP-dependent protein kinase, alpha-	100.0
2eue_A	275	Carbon catabolite derepressing protein kinase; kin	100.0
1xjd_A	345	Protein kinase C, theta type; PKC-theta, ATP, AMP,	100.0
2ozo_A	613	Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t	100.0
3an0_A	340	Dual specificity mitogen-activated protein kinase;	100.0
3q4u_A	301	Activin receptor type-1; structural genomics conso	100.0
3dbq_A	343	Dual specificity protein kinase TTK; MPS1 structur	100.0
1u46_A	291	ACK-1, activated CDC42 kinase 1; tyrosine kinase,	100.0
2izr_A	330	Casein kinase I isoform gamma-3; serine/threonine-	100.0
3f66_A	298	Hepatocyte growth factor receptor; C-Met, protein	100.0
2i0e_A	353	Protein kinase C-beta II; serine/threonine protein	100.0
2w4o_A	349	Calcium/calmodulin-dependent protein kinase type I	100.0
3kex_A	325	Receptor tyrosine-protein kinase ERBB-3; kinase do	100.0
3c0i_A	351	Peripheral plasma membrane protein CASK; neurexin,	100.0
4aw2_A	437	Serine/threonine-protein kinase MRCK alpha; transf	100.0
2r5t_A	373	Serine/threonine-protein kinase SGK1; AGC protein	100.0
3tki_A	323	Serine/threonine-protein kinase CHK1; cell checkpo	100.0
4euu_A	319	Serine/threonine-protein kinase TBK1; ATP binding,	100.0
3lzb_A	327	Epidermal growth factor receptor; epidermal growth	100.0
3ork_A	311	Serine/threonine protein kinase; structural genomi	100.0
4fl3_A	635	Tyrosine-protein kinase SYK; transferase; HET: ANP	100.0
2y4i_B	319	KSR2, HKSR2, kinase suppressor of RAS 2; transfera	100.0
4agu_A	311	Cyclin-dependent kinase-like 1; transferase, phosp	100.0
2a2a_A	321	Death-associated protein kinase 2; autoinhibition,	100.0
2c30_A	321	Serine/threonine-protein kinase PAK 6; CRIB domain	100.0
3f3z_A	277	Calcium/calmodulin-dependent protein kinase with d	100.0
3h4j_B	336	AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin	100.0
3oz6_A	388	Mitogen-activated protein kinase 1, serine/threon	100.0
2h8h_A	535	Proto-oncogene tyrosine-protein kinase SRC; SRC ki	100.0
3v8s_A	410	RHO-associated protein kinase 1; dimerization, myo	100.0
2qkw_B	321	Protein kinase; three-helix bundle motif, AVRPTO-P	100.0
2pmi_A	317	Negative RE, cyclin-dependent protein kinase PHO85	100.0
2yfx_A	327	Tyrosine-protein kinase receptor; nucleotide-bindi	100.0
3lij_A	494	Calcium/calmodulin dependent protein kinase with A	100.0
2zmd_A	390	Dual specificity protein kinase TTK; MPS1, T686A,	100.0
2y94_A	476	5'-AMP-activated protein kinase catalytic subunit;	100.0
3is5_A	285	Calcium-dependent protein kinase; CDPK, structural	100.0
3g33_A	308	Cell division protein kinase 4; Ser/Thr protein ki	100.0
3mwu_A	486	Calmodulin-domain protein kinase 1; serine/threoni	100.0
3c1x_A	373	Hepatocyte growth factor receptor; receptor tyrosi	100.0
2vd5_A	412	DMPK protein; serine/threonine-protein kinase, kin	100.0
3nyv_A	484	Calmodulin-domain protein kinase 1; serine/threoni	100.0
3gbz_A	329	Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-	100.0
3fdn_A	279	Serine/threonine-protein kinase 6; aurora kinase i	100.0
3qd2_B	332	Eukaryotic translation initiation factor 2-alpha;	100.0
2w5a_A	279	Serine/threonine-protein kinase NEK2; Ser/Thr prot	100.0
3uzp_A	296	CKI-delta, CKID, casein kinase I isoform delta; CK	100.0
2buj_A	317	Serine/threonine-protein kinase 16; transferase, A	100.0
3q5i_A	504	Protein kinase; CDPK, malaria, phosphotransferase,	100.0
4hgt_A	296	Casein kinase I isoform delta; CK1D, inhibitor, tr	100.0
1t4h_A	290	Serine/threonine-protein kinase WNK1; protein seri	100.0
3rp9_A	458	Mitogen-activated protein kinase; structural genom	100.0
3bhy_A	283	Death-associated protein kinase 3; death associate	100.0
3ttj_A	464	Mitogen-activated protein kinase 10; JNK3, protein	100.0
1x8b_A	289	WEE1HU, WEE1-like protein kinase; cell cycle, tran	100.0
2h34_A	309	Serine/threonine-protein kinase PKNE; apoenzyme, t	100.0
3ll6_A	337	Cyclin G-associated kinase; transferase, protein k	100.0
1cm8_A	367	Phosphorylated MAP kinase P38-gamma; phosphorylati	100.0
3hko_A	345	Calcium/calmodulin-dependent protein kinase with d	100.0
3mtl_A	324	Cell division protein kinase 16; pctaire1, indirub	100.0
2v62_A	345	Serine/threonine-protein kinase VRK2; transferase,	100.0
2rku_A	294	Serine/threonine-protein kinase PLK1; structure of	100.0
2dyl_A	318	Dual specificity mitogen-activated protein kinase	100.0
3llt_A	360	Serine/threonine kinase-1, pflammer; lammer kinase	100.0
2owb_A	335	Serine/threonine-protein kinase PLK1; catalytic do	100.0
3eqc_A	360	Dual specificity mitogen-activated protein kinase;	100.0
2jam_A	304	Calcium/calmodulin-dependent protein kinase type 1	100.0
3g2f_A	336	Bone morphogenetic protein receptor type-2; kinase	100.0
2h6d_A	276	5'-AMP-activated protein kinase catalytic subunit	100.0
3dls_A	335	PAS domain-containing serine/threonine-protein KI;	100.0
1nxk_A	400	MAP kinase-activated protein kinase 2; MK2, phosph	100.0
2y7j_A	365	Phosphorylase B kinase gamma catalytic chain, test	100.0
3cok_A	278	Serine/threonine-protein kinase PLK4; POLO-like ki	100.0
2jii_A	352	Serine/threonine-protein kinase VRK3 molecule: VA	100.0
3lm5_A	327	Serine/threonine-protein kinase 17B; STK17B, serin	100.0
3mdy_A	337	Bone morphogenetic protein receptor type-1B; compl	100.0
4aaa_A	331	Cyclin-dependent kinase-like 2; transferase, phosp	100.0
2a19_B	284	Interferon-induced, double-stranded RNA-activated	100.0
3a7i_A	303	MST3 kinase, serine/threonine kinase 24 (STE20 hom	100.0
2vgo_A	284	Serine/threonine-protein kinase 12-A; nucleotide-b	100.0
2nru_A	307	Interleukin-1 receptor-associated kinase 4; inhibi	100.0
2x7f_A	326	TRAF2 and NCK-interacting protein kinase; serine/t	100.0
2xrw_A	371	Mitogen-activated protein kinase 8; transcription,	100.0
1ua2_A	346	CAK, cell division protein kinase 7; cell cycle, p	100.0
3mi9_A	351	Cell division protein kinase 9; P-TEFB, HIV-1, pro	100.0
1phk_A	298	Phosphorylase kinase; glycogen metabolism, transfe	100.0
1b6c_B	342	TGF-B superfamily receptor type I; complex (isomer	100.0
3com_A	314	Serine/threonine-protein kinase 4; MST1, STE20-lik	100.0
3eb0_A	383	Putative uncharacterized protein; kinase cryptospo	100.0
2acx_A	576	G protein-coupled receptor kinase 6; GRK, G transf	100.0
2wei_A	287	Calmodulin-domain protein kinase 1, putative; nucl	100.0
2r3i_A	299	Cell division protein kinase 2; serine/threonine-p	100.0
3uim_A	326	Brassinosteroid insensitive 1-associated receptor;	100.0
2j0j_A	656	Focal adhesion kinase 1; cell migration, FERM, tra	100.0
2vwi_A	303	Serine/threonine-protein kinase OSR1; STE kinase,	100.0
2j7t_A	302	Serine/threonine-protein kinase 10; transferase, A	100.0
4eut_A	396	Serine/threonine-protein kinase TBK1; ATP binding,	100.0
3aln_A	327	Dual specificity mitogen-activated protein kinase;	100.0
2qr7_A	342	Ribosomal protein S6 kinase alpha-3; kinase domain	100.0
3n9x_A	432	Phosphotransferase; malaria kinase, structural gen	100.0
2clq_A	295	Mitogen-activated protein kinase kinase kinase 5;	100.0
2fst_X	367	Mitogen-activated protein kinase 14; active mutant	100.0
3kn6_A	325	Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1	100.0
2yex_A	276	Serine/threonine-protein kinase CHK1; transferase,	100.0
3e7e_A	365	HBUB1, BUB1A, mitotic checkpoint serine/threonine-	100.0
3c4z_A	543	Rhodopsin kinase; Ser/Thr kinase, RGS homology dom	100.0
2ac3_A	316	MAP kinase-interacting serine/threonine kinase 2;	100.0
1blx_A	326	Cyclin-dependent kinase 6; inhibitor protein, cycl	100.0
2ycf_A	322	Serine/threonine-protein kinase CHK2; transferase,	100.0
4exu_A	371	Mitogen-activated protein kinase 13; P38 kinase, t	100.0
3i6u_A	419	CDS1, serine/threonine-protein kinase CHK2; Ser/Th	100.0
3kvw_A	429	DYRK2, dual specificity tyrosine-phosphorylation-r	100.0
3cek_A	313	Dual specificity protein kinase TTK; HMPS1, PYT, E	100.0
3byv_A	377	Rhoptry kinase; malaria, transferase, structural g	100.0
3nsz_A	330	CK II alpha, casein kinase II subunit alpha; inhib	100.0
3pg1_A	362	Mitogen-activated protein kinase, putative (MAP K	100.0
1vzo_A	355	Ribosomal protein S6 kinase alpha 5; protein kinas	100.0
3pfq_A	674	PKC-B, PKC-beta, protein kinase C beta type; phosp	100.0
3gxj_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	100.0
1j1b_A	420	Glycogen synthase kinase-3 beta; complex, TAU, AMP	100.0
3qyz_A	364	Mitogen-activated protein kinase 1; transferase, s	100.0
3q60_A	371	ROP5B; pseudokinase, transferase; HET: ATP; 1.72A	100.0
2wtk_C	305	Serine/threonine-protein kinase 11; transferase-me	100.0
4e7w_A	394	Glycogen synthase kinase 3; GSK3, PTyr195, transfe	100.0
2pml_X	348	PFPK7, Ser/Thr protein kinase; phosphorylati trans	100.0
1z57_A	339	Dual specificity protein kinase CLK1; protein tyro	100.0
3coi_A	353	Mitogen-activated protein kinase 13; P38D, P38delt	100.0
2b9h_A	353	MAP kinase FUS3, mitogen-activated protein kinase	100.0
1wak_A	397	Serine/threonine-protein kinase SPRK1; SRPK, trans	100.0
3sv0_A	483	Casein kinase I-like; typical kinase domain fold,	100.0
1zy4_A	303	Serine/threonine-protein kinase GCN2; translation	100.0
2i6l_A	320	Mitogen-activated protein kinase 6; MAPK6, ERK3, e	100.0
3e3p_A	360	Protein kinase, putative glycogen synthase kinase;	100.0
2eu9_A	355	Dual specificity protein kinase CLK3; kinase domai	100.0
2vx3_A	382	Dual specificity tyrosine-phosphorylation- regula	100.0
3rgf_A	405	Cyclin-dependent kinase 8; protein kinase complex,	100.0
3a99_A	320	Proto-oncogene serine/threonine-protein kinase PI;	100.0
2iwi_A	312	Serine/threonine-protein kinase PIM-2; nucleotide-	100.0
1q8y_A	373	SR protein kinase; transferase; HET: ADP ADE; 2.05	100.0
3fhr_A	336	MAP kinase-activated protein kinase 3; kinase-inhi	100.0
3p23_A	432	Serine/threonine-protein kinase/endoribonuclease;	100.0
3uqc_A	286	Probable conserved transmembrane protein; structur	100.0
2rio_A	434	Serine/threonine-protein kinase/endoribonuclease I	100.0
3qa8_A	676	MGC80376 protein; kinase ubiquitin-like domain, ph	100.0
3m2w_A	299	MAP kinase-activated protein kinase 2; small molec	100.0
3dzo_A	413	Rhoptry kinase domain; parasitic disease, transfer	100.0
2pzi_A	681	Probable serine/threonine-protein kinase PKNG; ATP	100.0
2vuw_A	336	Serine/threonine-protein kinase haspin; cell cycle	100.0
4azs_A	569	Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15	99.98
3en9_A	540	Glycoprotease, O-sialoglycoprotein endopeptidase/p	99.95
1zar_A	282	RIO2 kinase; serine kinase, winged-helix, RIO doma	99.92
1zth_A	258	RIO1 serine protein kinase; ribosome biogenesis, r	99.85
4gyi_A	397	RIO2 kinase; protein kinase, ADP complex, phosphoa	99.74
3tm0_A	263	Aminoglycoside 3'-phosphotransferase; protein kina	99.46
1nd4_A	264	Aminoglycoside 3'-phosphotransferase; protein kina	99.27
3dxp_A	359	Putative acyl-COA dehydrogenase; protein kinase-li	99.26
3sg8_A	304	APH(2'')-ID; antibiotic resistance enzyme, transfe	99.14
3r70_A	320	Aminoglycoside phosphotransferase; structural geno	98.94
3tdw_A	306	Gentamicin resistance protein; kinase, phosphoryl	98.77
3ovc_A	362	Hygromycin-B 4-O-kinase; aminoglycoside phosphotra	98.67
4gkh_A	272	Aminoglycoside 3'-phosphotransferase APHA1-IAB; py	98.64
3ats_A	357	Putative uncharacterized protein; hypothetical pro	98.42
2q83_A	346	YTAA protein; 2635576, structural genomics, joint	98.41
3d1u_A	288	Putative fructosamine-3-kinase; YP_290396.1, struc	98.4
2olc_A	397	MTR kinase, methylthioribose kinase; kinase ADP-2H	98.34
2yle_A	229	Protein spire homolog 1; actin-binding protein, ac	98.16
3jr1_A	312	Putative fructosamine-3-kinase; YP_719053.1, struc	98.0
2pyw_A	420	Uncharacterized protein; 5-methylthioribose kinase	97.89
3dxq_A	301	Choline/ethanolamine kinase family protein; NP_106	97.78
3csv_A	333	Aminoglycoside phosphotransferase; YP_614837.1, ph	97.74
2ppq_A	322	HSK, HK, homoserine kinase; structural genomics, M	97.63
3f7w_A	288	Putative fructosamine-3-kinase; YP_290396.1, struc	97.61
1nw1_A	429	Choline kinase (49.2 KD); phospholipid synthesis,	97.44
3c5i_A	369	Choline kinase; choline, kinase, malaria, transfer	97.19
1zyl_A	328	Hypothetical protein YIHE; putative protein kinase	97.15
3feg_A	379	Choline/ethanolamine kinase; non-protein kinase, c	97.12
3i1a_A	339	Spectinomycin phosphotransferase; protein kinase,	97.06
2qg7_A	458	Ethanolamine kinase PV091845; malaria, SGC, struct	96.94
3f2s_A	401	CK, chetk-alpha, choline kinase alpha; non-protein	96.47
3mes_A	424	Choline kinase; malaria, structural genomics, stru	96.21
1u8s_A	192	Glycine cleavage system transcriptional repressor,	94.91
3g15_A	401	CK, chetk-alpha, choline kinase alpha; non-protein	94.05
2nyi_A	195	Unknown protein; protein structure initiative, PSI	93.69
1zpv_A	91	ACT domain protein; structural genomics, PSI, prot	93.33
3cxl_A	463	N-chimerin; SH2, RHO-GAP, structural genomics cons	91.99
2ko1_A	88	CTR148A, GTP pyrophosphokinase; homodimer, alpha+b	91.04
4ann_A	215	ESSB; membrane protein, membrane secretion, ESS ty	84.34
2f1f_A	164	Acetolactate synthase isozyme III small subunit; f	83.29
4ano_A	219	ESSB; membrane protein, membrane secretion, ESS ty	80.74

>3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens}

Probab=100.00  E-value=3e-61  Score=459.25  Aligned_cols=263  Identities=37%  Similarity=0.689  Sum_probs=228.8

Q ss_pred             CCCceeecccccceeceeceeCceEEEEEEECCeeEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCceeeEEeEEecCC
Q 015868          107 GTDVWEIDAKQLKIECKVASGSYGDLYKGTYCSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPP  186 (399)
Q Consensus       107 ~~~~~~i~~~~~~i~~~lg~G~~g~Vy~~~~~~~~vAvK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~nIv~~~~~~~~~~  186 (399)
                      ....|+|+.+++++.++||+|+||.||+|++.+ .||||+++....+.+..+.|.+|+.+|++++|||||++++++.+ +
T Consensus        27 ~~~~Wei~~~~l~l~~~iG~G~fG~Vy~~~~~~-~vAvK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~-~  104 (307)
T 3omv_A           27 SSYYWEIEASEVMLSTRIGSGSFGTVYKGKWHG-DVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTK-D  104 (307)
T ss_dssp             --CCCBCCTTSCCEEEECCCCSSSEEEEEESSS-EEEEEECCCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS-S
T ss_pred             CCcCcEEcHHHeEEeeEEeeCCCcEEEEEEECC-cEEEEEEEecCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEC-C
Confidence            346799999999999999999999999998754 69999998776677888899999999999999999999998865 4


Q ss_pred             cEEEEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceeecCCCcEEEeeccceeeccC
Q 015868          187 NLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQ  266 (399)
Q Consensus       187 ~~~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~giiHrDlkp~NILl~~~~~vkl~DFG~a~~~~~  266 (399)
                      .+|||||||+||+|.++|+.....+++..+..++.||+.||+|||+++||||||||+|||+++++.+||+|||+|+....
T Consensus       105 ~~~iVmEy~~gGsL~~~l~~~~~~l~~~~~~~i~~qia~gL~yLH~~~IiHRDlKp~NILl~~~~~~Ki~DFGla~~~~~  184 (307)
T 3omv_A          105 NLAIVTQWCEGSSLYKHLHVQETKFQMFQLIDIARQTAQGMDYLHAKNIIHRDMKSNNIFLHEGLTVKIGDFGLATVKSR  184 (307)
T ss_dssp             SCEEEEECCSSCBHHHHHHTSCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCCSSSEEEETTEEEEECCCSSCBC---
T ss_pred             eEEEEEEcCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccCCccCHHHEEECCCCcEEEeeccCceeccc
Confidence            68999999999999999988778899999999999999999999999999999999999999999999999999986543


Q ss_pred             C---CccccCCCCcccccccccCC---CCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhccCC----CCCCC
Q 015868          267 S---GVMTAETGTYRWMAPEVIEH---KPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKSLR----PTIPK  336 (399)
Q Consensus       267 ~---~~~~~~~gt~~y~aPE~l~~---~~~~~~~Dv~slG~vl~elltg~~P~~~~~~~~~~~~~~~~~~~----~~~~~  336 (399)
                      .   .......||+.|||||++.+   .+|+.++|||||||++|||+||+.||.+.++.......+.....    +.++.
T Consensus       185 ~~~~~~~~~~~GT~~ymAPE~l~~~~~~~y~~ksDVwS~Gvvl~Elltg~~Pf~~~~~~~~~~~~~~~~~~~p~~~~~~~  264 (307)
T 3omv_A          185 WSGSQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNRDQIIFMVGRGYASPDLSKLYK  264 (307)
T ss_dssp             ---------CCCCTTSCCHHHHHCCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHTTCCCCCSTTSCT
T ss_pred             CCcceeecccccCCCccCHHHhhccCCCCCCcHHHhHhHHHHHHHHHHCCCCCCCCChHHHHHHHHhcCCCCCCcccccc
Confidence            2   23445689999999999964   46999999999999999999999999988876666655554432    24567


Q ss_pred             CCcHHHHHHHHHHhhhcCCCCCCHHHHHHHHHHHH
Q 015868          337 HAHPRLAELLERCWQHDPTQRPNFSQITDILKQMM  371 (399)
Q Consensus       337 ~~~~~l~~ll~~cl~~dP~~Rps~~ell~~L~~l~  371 (399)
                      .+++++.+|+.+||+.||++|||+.|+++.|+.+.
T Consensus       265 ~~~~~l~~li~~cl~~dP~~RPs~~ei~~~Le~l~  299 (307)
T 3omv_A          265 NCPKAMKRLVADCVKKVKEERPLFPQILSSIELLQ  299 (307)
T ss_dssp             TSCHHHHHHHHHHTCSSSTTSCCHHHHHHHHHHHH
T ss_pred             cchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHh
Confidence            79999999999999999999999999999998774

>4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A*

Probab=100.00  E-value=7.1e-61  Score=455.95  Aligned_cols=260  Identities=28%  Similarity=0.560  Sum_probs=231.4

Q ss_pred             ceeecccccceeceeceeCceEEEEEEEC-------CeeEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCceeeEEeEE
Q 015868          110 VWEIDAKQLKIECKVASGSYGDLYKGTYC-------SQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGAC  182 (399)
Q Consensus       110 ~~~i~~~~~~i~~~lg~G~~g~Vy~~~~~-------~~~vAvK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~nIv~~~~~~  182 (399)
                      +.+|+.++|.+.++||+|+||.||+|++.       +..||||+++..  +....++|.+|+.+|++++|||||+++|+|
T Consensus         7 ~~~I~r~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~--~~~~~~~f~~E~~il~~l~HpnIV~l~g~~   84 (299)
T 4asz_A            7 VQHIKRHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDA--SDNARKDFHREAELLTNLQHEHIVKFYGVC   84 (299)
T ss_dssp             CCBCCGGGEEEEEEEEC--CCCEEEEEECSCC----CEEEEEEEECSC--CHHHHHHHHHHHHHHTTCCCTTBCCEEEEE
T ss_pred             hcccCHHHeEEeeEEeeCCCcEEEEEEECCcccCCCCEEEEEEEeCCC--ChHHHHHHHHHHHHHHhCCCCCCccEEEEE
Confidence            45788899999999999999999999863       578999999865  566678899999999999999999999999


Q ss_pred             ecCCcEEEEEecCCCCCHHHHHHhc------------CCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceeecCC
Q 015868          183 TRPPNLCIVTEFMARGSIYDFLHKQ------------KGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDEN  250 (399)
Q Consensus       183 ~~~~~~~lV~E~~~ggsL~~~l~~~------------~~~l~~~~~~~i~~~i~~~L~~LH~~giiHrDlkp~NILl~~~  250 (399)
                      .+++.+|||||||++|+|.++|+..            ...+++..+..++.||+.||+|||+++||||||||+|||++++
T Consensus        85 ~~~~~~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDlKp~NILl~~~  164 (299)
T 4asz_A           85 VEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLASQHFVHRDLATRNCLVGEN  164 (299)
T ss_dssp             CSSSSEEEEEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGG
T ss_pred             eeCCEEEEEEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCccCHhhEEECCC
Confidence            9999999999999999999999764            2469999999999999999999999999999999999999999


Q ss_pred             CcEEEeeccceeeccCCCcc---ccCCCCcccccccccCCCCCCChhhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHH
Q 015868          251 GVVKVADFGVARVQAQSGVM---TAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLT-GELPYAGLTPLQAAVGVV  326 (399)
Q Consensus       251 ~~vkl~DFG~a~~~~~~~~~---~~~~gt~~y~aPE~l~~~~~~~~~Dv~slG~vl~ellt-g~~P~~~~~~~~~~~~~~  326 (399)
                      +.+||+|||+|+........   ....||++|||||++.+..|+.++|||||||++|||+| |+.||.+.++.+....+.
T Consensus       165 ~~~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~k~DVwS~Gvvl~Ellt~G~~Pf~~~~~~~~~~~i~  244 (299)
T 4asz_A          165 LLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNEVIECIT  244 (299)
T ss_dssp             GCEEECCCSCHHHHTGGGCEEETTTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHH
T ss_pred             CcEEECCcccceecCCCCceeecCceecChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHH
Confidence            99999999999865443221   22358999999999999999999999999999999999 899999999887666544


Q ss_pred             hccCCCCCCCCCcHHHHHHHHHHhhhcCCCCCCHHHHHHHHHHHHH
Q 015868          327 QKSLRPTIPKHAHPRLAELLERCWQHDPTQRPNFSQITDILKQMMK  372 (399)
Q Consensus       327 ~~~~~~~~~~~~~~~l~~ll~~cl~~dP~~Rps~~ell~~L~~l~~  372 (399)
                       .+.++..|..+++++.+|+.+||+.||++|||+.||.+.|+++.+
T Consensus       245 -~~~~~~~p~~~~~~~~~li~~cl~~dP~~RPs~~~i~~~L~~~~~  289 (299)
T 4asz_A          245 -QGRVLQRPRTCPQEVYELMLGCWQREPHMRKNIKGIHTLLQNLAK  289 (299)
T ss_dssp             -HTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             -cCCCCCCCccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHh
Confidence             466778899999999999999999999999999999999988764

>4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens}

Probab=100.00  E-value=3.7e-60  Score=456.92  Aligned_cols=261  Identities=30%  Similarity=0.574  Sum_probs=228.3

Q ss_pred             CceeecccccceeceeceeCceEEEEEEEC-------CeeEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCceeeEEeE
Q 015868          109 DVWEIDAKQLKIECKVASGSYGDLYKGTYC-------SQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGA  181 (399)
Q Consensus       109 ~~~~i~~~~~~i~~~lg~G~~g~Vy~~~~~-------~~~vAvK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~nIv~~~~~  181 (399)
                      ..+.|+.+++.+.++||+|+||.||+|++.       ++.||||+++..  +....++|.+|+.+|++++|||||+++|+
T Consensus        34 ~~~~i~~~d~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~--~~~~~~~f~~E~~il~~l~HpnIV~l~g~  111 (329)
T 4aoj_A           34 CVHHIKRRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEA--SESARQDFQREAELLTMLQHQHIVRFFGV  111 (329)
T ss_dssp             CSCBCCGGGEEEEEEEEECSSEEEEEEEESSSCC---CEEEEEEEESCC--SHHHHHHHHHHHHHHTTCCCTTBCCEEEE
T ss_pred             hhcccCHHHeEEEEEEccCCCcEEEEEEECCcccCCCCeEEEEEEECcC--CHHHHHHHHHHHHHHHhCCCCCCCcEEEE
Confidence            456788899999999999999999999863       578999999864  56667889999999999999999999999


Q ss_pred             EecCCcEEEEEecCCCCCHHHHHHhcC--------------CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceee
Q 015868          182 CTRPPNLCIVTEFMARGSIYDFLHKQK--------------GVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLM  247 (399)
Q Consensus       182 ~~~~~~~~lV~E~~~ggsL~~~l~~~~--------------~~l~~~~~~~i~~~i~~~L~~LH~~giiHrDlkp~NILl  247 (399)
                      |.+++.+|||||||++|+|.++++...              +++++..+..++.||+.||+|||+++||||||||+|||+
T Consensus       112 ~~~~~~~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDLKp~NILl  191 (329)
T 4aoj_A          112 CTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLHFVHRDLATRNCLV  191 (329)
T ss_dssp             ECSSSSEEEEEECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEE
T ss_pred             EEECCEEEEEEEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHhcCCeecccccHhhEEE
Confidence            999999999999999999999997642              468999999999999999999999999999999999999


Q ss_pred             cCCCcEEEeeccceeeccCCC---ccccCCCCcccccccccCCCCCCChhhHHHHHHHHHHHHc-CCCCCCCCCHHHHHH
Q 015868          248 DENGVVKVADFGVARVQAQSG---VMTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLT-GELPYAGLTPLQAAV  323 (399)
Q Consensus       248 ~~~~~vkl~DFG~a~~~~~~~---~~~~~~gt~~y~aPE~l~~~~~~~~~Dv~slG~vl~ellt-g~~P~~~~~~~~~~~  323 (399)
                      ++++.+||+|||+++......   ..+...||+.|||||++.+..|+.++|||||||++|||+| |+.||.+.+..+...
T Consensus       192 ~~~~~~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~~sDvwS~Gvvl~Ellt~G~~Pf~~~~~~~~~~  271 (329)
T 4aoj_A          192 GQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNTEAID  271 (329)
T ss_dssp             ETTTEEEECCCC----------------CCCCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSSCHHHHHH
T ss_pred             CCCCcEEEcccccceeccCCCcceecCcccccccccChhhhcCCCCCccccccchHHHHHHHHcCCCCCCCCCCHHHHHH
Confidence            999999999999998654332   2234568999999999999999999999999999999999 899999999887665


Q ss_pred             HHHhccCCCCCCCCCcHHHHHHHHHHhhhcCCCCCCHHHHHHHHHHHHH
Q 015868          324 GVVQKSLRPTIPKHAHPRLAELLERCWQHDPTQRPNFSQITDILKQMMK  372 (399)
Q Consensus       324 ~~~~~~~~~~~~~~~~~~l~~ll~~cl~~dP~~Rps~~ell~~L~~l~~  372 (399)
                      .+ ..+.++..|..+++++.+|+.+||+.||++|||+.||++.|+.+.+
T Consensus       272 ~i-~~g~~~~~p~~~~~~~~~li~~cl~~dP~~RPs~~ei~~~L~~l~~  319 (329)
T 4aoj_A          272 CI-TQGRELERPRACPPEVYAIMRGCWQREPQQRHSIKDVHARLQALAQ  319 (329)
T ss_dssp             HH-HHTCCCCCCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHHHHHHHHH
T ss_pred             HH-HcCCCCCCcccccHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHhh
Confidence            54 4566788899999999999999999999999999999999998864

>4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A

Probab=100.00  E-value=9.6e-60  Score=450.00  Aligned_cols=260  Identities=27%  Similarity=0.550  Sum_probs=229.2

Q ss_pred             CceeecccccceeceeceeCceEEEEEEE-------CCeeEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCceeeEEeE
Q 015868          109 DVWEIDAKQLKIECKVASGSYGDLYKGTY-------CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGA  181 (399)
Q Consensus       109 ~~~~i~~~~~~i~~~lg~G~~g~Vy~~~~-------~~~~vAvK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~nIv~~~~~  181 (399)
                      ...+|+.+++++.++||+|+||.||+|++       .++.||||+++... .....++|.+|+.+|++++|||||+++|+
T Consensus        19 ~~~ei~~~~~~~~~~lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~~-~~~~~~~f~~E~~il~~l~HpNIV~l~g~   97 (308)
T 4gt4_A           19 KLKEISLSAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKA-EGPLREEFRHEAMLRARLQHPNVVCLLGV   97 (308)
T ss_dssp             CCCBCCGGGEEEEEEEEECSSCEEEEEEEC-------CEEEEEEECCC-C-CC-CHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred             CcccCCHHHCeEeeEeccCCCcEEEEEEEcCCccCCCCeEEEEEEECccc-ChHHHHHHHHHHHHHHhCCCCCCCCcceE
Confidence            34578888999999999999999999986       35789999998653 33445789999999999999999999999


Q ss_pred             EecCCcEEEEEecCCCCCHHHHHHhc---------------CCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcee
Q 015868          182 CTRPPNLCIVTEFMARGSIYDFLHKQ---------------KGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLL  246 (399)
Q Consensus       182 ~~~~~~~~lV~E~~~ggsL~~~l~~~---------------~~~l~~~~~~~i~~~i~~~L~~LH~~giiHrDlkp~NIL  246 (399)
                      |..++.++||||||++|+|.++|..+               ...+++..+..++.||+.||+|||+++||||||||+|||
T Consensus        98 ~~~~~~~~lV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDLK~~NIL  177 (308)
T 4gt4_A           98 VTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSSHHVVHKDLATRNVL  177 (308)
T ss_dssp             ECSSSSCEEEEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEE
T ss_pred             EEECCEEEEEEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCCCccccceE
Confidence            99999999999999999999999653               246899999999999999999999999999999999999


Q ss_pred             ecCCCcEEEeeccceeeccCCC---ccccCCCCcccccccccCCCCCCChhhHHHHHHHHHHHHc-CCCCCCCCCHHHHH
Q 015868          247 MDENGVVKVADFGVARVQAQSG---VMTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLT-GELPYAGLTPLQAA  322 (399)
Q Consensus       247 l~~~~~vkl~DFG~a~~~~~~~---~~~~~~gt~~y~aPE~l~~~~~~~~~Dv~slG~vl~ellt-g~~P~~~~~~~~~~  322 (399)
                      +++++.+||+|||+++......   ..+...||++|||||++.+..|+.++|||||||++|||+| |..||.+.+..+..
T Consensus       178 l~~~~~~Ki~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~~s~ksDVwSfGvvl~El~t~g~~Pf~~~~~~~~~  257 (308)
T 4gt4_A          178 VYDKLNVKISDLGLFREVYAADYYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDVV  257 (308)
T ss_dssp             ECGGGCEEECCSCCBCGGGGGGCBCSSSSSCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTCCHHHHH
T ss_pred             ECCCCCEEECCcccceeccCCCceeEecccccCCcccCHHHHhCCCCCccchhhhHHHHHHHHHhCCCCCCCCCCHHHHH
Confidence            9999999999999998654332   2344578999999999999999999999999999999999 89999999987766


Q ss_pred             HHHHhccCCCCCCCCCcHHHHHHHHHHhhhcCCCCCCHHHHHHHHHHH
Q 015868          323 VGVVQKSLRPTIPKHAHPRLAELLERCWQHDPTQRPNFSQITDILKQM  370 (399)
Q Consensus       323 ~~~~~~~~~~~~~~~~~~~l~~ll~~cl~~dP~~Rps~~ell~~L~~l  370 (399)
                      .. +..+.+++.|..+++++.+|+.+||+.||++||||.||++.|+++
T Consensus       258 ~~-i~~~~~~~~p~~~~~~~~~li~~C~~~dP~~RPs~~ei~~~L~a~  304 (308)
T 4gt4_A          258 EM-IRNRQVLPCPDDCPAWVYALMIECWNEFPSRRPRFKDIHSRLRAW  304 (308)
T ss_dssp             HH-HHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTS
T ss_pred             HH-HHcCCCCCCcccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHhc
Confidence            55 445667778999999999999999999999999999999988753

>4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A*

Probab=100.00  E-value=9.7e-60  Score=455.48  Aligned_cols=250  Identities=24%  Similarity=0.459  Sum_probs=222.1

Q ss_pred             ccccceeceeceeCceEEEEEEE--CCeeEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCceeeEEeEEecCCcEEEEE
Q 015868          115 AKQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVT  192 (399)
Q Consensus       115 ~~~~~i~~~lg~G~~g~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~nIv~~~~~~~~~~~~~lV~  192 (399)
                      .++|++.++||+|+||.||+|++  +++.||||+++....+....+.+.+|+.+|++++|||||++++++.+++.+||||
T Consensus        23 me~Y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~yiVm  102 (350)
T 4b9d_A           23 MEKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRESFEENGSLYIVM  102 (350)
T ss_dssp             CCCEEEEEEC------CEEEEEETTTCCEEEEEEEECTTSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             ccceEEeEEEecCCCeEEEEEEECCCCCEEEEEEEehHHCCHHHHHHHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEE
Confidence            46899999999999999999987  5889999999887777777889999999999999999999999999999999999


Q ss_pred             ecCCCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceeecCCCcEEEeeccceeeccCCC-cc
Q 015868          193 EFMARGSIYDFLHKQK-GVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSG-VM  270 (399)
Q Consensus       193 E~~~ggsL~~~l~~~~-~~l~~~~~~~i~~~i~~~L~~LH~~giiHrDlkp~NILl~~~~~vkl~DFG~a~~~~~~~-~~  270 (399)
                      |||+||+|.++|..+. ..+++..++.++.||+.||+|||++|||||||||+|||++.+|.+||+|||+|+...... ..
T Consensus       103 Ey~~gg~L~~~i~~~~~~~~~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~~~~  182 (350)
T 4b9d_A          103 DYCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHVHDRKILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTVELA  182 (350)
T ss_dssp             ECCTTCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTCEETTCCGGGEEECTTCCEEECSTTEESCCCHHHHHH
T ss_pred             eCCCCCcHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCHHHEEECCCCCEEEcccccceeecCCcccc
Confidence            9999999999997654 457999999999999999999999999999999999999999999999999998765432 23


Q ss_pred             ccCCCCcccccccccCCCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhccCCCCCCCCCcHHHHHHHHHHh
Q 015868          271 TAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRLAELLERCW  350 (399)
Q Consensus       271 ~~~~gt~~y~aPE~l~~~~~~~~~Dv~slG~vl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~cl  350 (399)
                      +..+||+.|||||++.+..|+.++|||||||++|||+||+.||.+.+..+....+... ..+.++..+++++.+||.+||
T Consensus       183 ~~~~GT~~YmAPE~l~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~~~-~~~~~~~~~s~~~~~li~~~L  261 (350)
T 4b9d_A          183 RACIGTPYYLSPEICENKPYNNKSDIWALGCVLYELCTLKHAFEAGSMKNLVLKIISG-SFPPVSLHYSYDLRSLVSQLF  261 (350)
T ss_dssp             HHHHSCCTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHT-CCCCCCTTSCHHHHHHHHHHT
T ss_pred             cccCCCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHcC-CCCCCCccCCHHHHHHHHHHc
Confidence            4457999999999999999999999999999999999999999999988877776654 456678889999999999999


Q ss_pred             hhcCCCCCCHHHHHH
Q 015868          351 QHDPTQRPNFSQITD  365 (399)
Q Consensus       351 ~~dP~~Rps~~ell~  365 (399)
                      +.||++|||++|+++
T Consensus       262 ~~dP~~R~s~~e~l~  276 (350)
T 4b9d_A          262 KRNPRDRPSVNSILE  276 (350)
T ss_dssp             CSSGGGSCCHHHHHT
T ss_pred             cCChhHCcCHHHHhc
Confidence            999999999999976

>4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A*

Probab=100.00  E-value=2.7e-59  Score=454.62  Aligned_cols=265  Identities=31%  Similarity=0.622  Sum_probs=236.4

Q ss_pred             CCceeecccccceeceeceeCceEEEEEEECC-------eeEEEEEecCCCCCHHHHHHHHHHHHHHHhcCC-CceeeEE
Q 015868          108 TDVWEIDAKQLKIECKVASGSYGDLYKGTYCS-------QEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRH-KNVVQFI  179 (399)
Q Consensus       108 ~~~~~i~~~~~~i~~~lg~G~~g~Vy~~~~~~-------~~vAvK~~~~~~~~~~~~~~~~~Ei~~l~~l~h-~nIv~~~  179 (399)
                      .+.|+|+.++|++.++||+|+||.||+|++.+       +.||||+++... .....+.|.+|+.+|++++| ||||+++
T Consensus        56 ~~~wEi~~~~~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~~-~~~~~~~~~~E~~il~~l~hhpnIV~l~  134 (353)
T 4ase_A           56 ASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA-THSEHRALMSELKILIHIGHHLNVVNLL  134 (353)
T ss_dssp             HHHHBCCGGGEEEEEEEEECSSEEEEEEEEETSSSTTCEEEEEEEEECTTC-CHHHHHHHHHHHHHHHHHCCCTTBCCEE
T ss_pred             CcccEecHHHeEEeeEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEcccc-ChHHHHHHHHHHHHHHHcCCCCcEEEEE
Confidence            35699999999999999999999999998743       579999998653 44556789999999999976 9999999


Q ss_pred             eEEecC-CcEEEEEecCCCCCHHHHHHhc---------------CCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCC
Q 015868          180 GACTRP-PNLCIVTEFMARGSIYDFLHKQ---------------KGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTA  243 (399)
Q Consensus       180 ~~~~~~-~~~~lV~E~~~ggsL~~~l~~~---------------~~~l~~~~~~~i~~~i~~~L~~LH~~giiHrDlkp~  243 (399)
                      |+|... ..++||||||++|+|.++|+..               ...+++..+..++.||++||+|||+++||||||||+
T Consensus       135 g~~~~~~~~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH~~~iiHRDLK~~  214 (353)
T 4ase_A          135 GACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAAR  214 (353)
T ss_dssp             EEECCTTSCCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGG
T ss_pred             EEEEecCCEEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHhhCCeecCccCcc
Confidence            999764 5689999999999999999763               235889999999999999999999999999999999


Q ss_pred             ceeecCCCcEEEeeccceeeccCCCc---cccCCCCcccccccccCCCCCCChhhHHHHHHHHHHHHc-CCCCCCCCCHH
Q 015868          244 NLLMDENGVVKVADFGVARVQAQSGV---MTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLT-GELPYAGLTPL  319 (399)
Q Consensus       244 NILl~~~~~vkl~DFG~a~~~~~~~~---~~~~~gt~~y~aPE~l~~~~~~~~~Dv~slG~vl~ellt-g~~P~~~~~~~  319 (399)
                      |||+++++.+||+|||+|+.......   .....||+.|||||++.+..|+.++|||||||++|||+| |+.||.+.+..
T Consensus       215 NILl~~~~~vKi~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~y~~ksDVwS~Gv~l~El~t~G~~Pf~~~~~~  294 (353)
T 4ase_A          215 NILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKID  294 (353)
T ss_dssp             GEEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCS
T ss_pred             ceeeCCCCCEEECcchhhhhcccCCCceeeccccccccccCHHHHhcCCCCCcccEeehHHHHHHHHhCCCCCCCCCCHH
Confidence            99999999999999999986544332   233468999999999999999999999999999999998 99999998877


Q ss_pred             HHHHHHHhccCCCCCCCCCcHHHHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHH
Q 015868          320 QAAVGVVQKSLRPTIPKHAHPRLAELLERCWQHDPTQRPNFSQITDILKQMMKE  373 (399)
Q Consensus       320 ~~~~~~~~~~~~~~~~~~~~~~l~~ll~~cl~~dP~~Rps~~ell~~L~~l~~~  373 (399)
                      +.....+..+.++..|..+++++.++|.+||+.||++|||+.||++.|+++++.
T Consensus       295 ~~~~~~i~~g~~~~~p~~~~~~~~~li~~c~~~dP~~RPt~~eil~~L~~llq~  348 (353)
T 4ase_A          295 EEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQA  348 (353)
T ss_dssp             HHHHHHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             HHHHHHHHcCCCCCCCccCCHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHHHH
Confidence            777777888889999999999999999999999999999999999999999763

>4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A*

Probab=100.00  E-value=1.2e-58  Score=445.70  Aligned_cols=257  Identities=23%  Similarity=0.373  Sum_probs=223.8

Q ss_pred             eecccccceeceeceeCceEEEEEEE--CCeeEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCceeeEEeEEecCCcEE
Q 015868          112 EIDAKQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLC  189 (399)
Q Consensus       112 ~i~~~~~~i~~~lg~G~~g~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~nIv~~~~~~~~~~~~~  189 (399)
                      ....+.|++.++||+|+||.||+|++  +++.||||+++.+...       .+|+.+|++++|||||++++++.+++.+|
T Consensus        54 ~~~~~~~~~~~~lG~G~fG~Vy~a~~~~~g~~vAiK~i~~~~~~-------~~E~~il~~l~HpnIV~l~~~~~~~~~~~  126 (336)
T 4g3f_A           54 REEVHWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVFR-------VEELVACAGLSSPRIVPLYGAVREGPWVN  126 (336)
T ss_dssp             CBTTTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCC-------THHHHTTTTCCCTTBCCEEEEEEETTEEE
T ss_pred             hcchhheEeCcEeccCCCeEEEEEEECCCCCEEEEEEECHHHhH-------HHHHHHHHhCCCCCCCcEEEEEEECCEEE
Confidence            34456799999999999999999997  4789999999865332       46999999999999999999999999999


Q ss_pred             EEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceeecCCC-cEEEeeccceeeccCCC
Q 015868          190 IVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENG-VVKVADFGVARVQAQSG  268 (399)
Q Consensus       190 lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~giiHrDlkp~NILl~~~~-~vkl~DFG~a~~~~~~~  268 (399)
                      ||||||+||+|.+++++ .+.+++..+..++.||+.||+|||++|||||||||+|||++.+| .+||+|||+|+......
T Consensus       127 ivmEy~~gg~L~~~l~~-~~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~~vKl~DFGla~~~~~~~  205 (336)
T 4g3f_A          127 IFMELLEGGSLGQLIKQ-MGCLPEDRALYYLGQALEGLEYLHTRRILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDG  205 (336)
T ss_dssp             EEECCCTTCBHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHTTTEECSCCCGGGEEECTTSCCEEECCCTTCEEC----
T ss_pred             EEEeccCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCceecccCHHHEEEeCCCCEEEEeeCCCCeEccCCC
Confidence            99999999999999976 46799999999999999999999999999999999999999987 69999999998765432


Q ss_pred             c------cccCCCCcccccccccCCCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhccCC-CCCCCCCcHH
Q 015868          269 V------MTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKSLR-PTIPKHAHPR  341 (399)
Q Consensus       269 ~------~~~~~gt~~y~aPE~l~~~~~~~~~Dv~slG~vl~elltg~~P~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~  341 (399)
                      .      ....+||+.|||||++.+.+|+.++|||||||++|||+||+.||.+.+..+....+...... +.+|..++++
T Consensus       206 ~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~s~~  285 (336)
T 4g3f_A          206 LGKSLLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHPWTQYFRGPLCLKIASEPPPIREIPPSCAPL  285 (336)
T ss_dssp             --------CCCCCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSTTTCCSCCHHHHHHSCCGGGGSCTTSCHH
T ss_pred             cccceecCCccccCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHHcCCCCchhcCccCCHH
Confidence            2      12246999999999999999999999999999999999999999987776655555544322 3467889999


Q ss_pred             HHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHh
Q 015868          342 LAELLERCWQHDPTQRPNFSQITDILKQMMKEVAS  376 (399)
Q Consensus       342 l~~ll~~cl~~dP~~Rps~~ell~~L~~l~~~~~~  376 (399)
                      +.+||.+||+.||.+|||+.|+++.|..++++...
T Consensus       286 ~~~li~~~L~~dP~~R~sa~el~~~l~~~l~~~~~  320 (336)
T 4g3f_A          286 TAQAIQEGLRKEPVHRASAMELRRKVGKALQEVGG  320 (336)
T ss_dssp             HHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHTTS
T ss_pred             HHHHHHHHccCCHhHCcCHHHHHHHHHHHHhhhhh
Confidence            99999999999999999999999999999887654

>3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus}

Probab=100.00  E-value=8.7e-58  Score=432.23  Aligned_cols=245  Identities=29%  Similarity=0.533  Sum_probs=214.2

Q ss_pred             cceeceeceeCceEEEEEEE--CCeeEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCceeeEEeEEec----CCcEEEE
Q 015868          118 LKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTR----PPNLCIV  191 (399)
Q Consensus       118 ~~i~~~lg~G~~g~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~nIv~~~~~~~~----~~~~~lV  191 (399)
                      |++.++||+|+||.||+|.+  ++..||+|++..........+.|.+|+.+|++++|||||+++++|..    +..+|||
T Consensus        28 ~~~~~~iG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~lv  107 (290)
T 3fpq_A           28 LKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLV  107 (290)
T ss_dssp             EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEEETTEEEEEEE
T ss_pred             EEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEeeccCCCcEEEEE
Confidence            47888999999999999998  47889999998766677777889999999999999999999999864    3458999


Q ss_pred             EecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCCCceeecC-CCcEEEeeccceeeccCCC
Q 015868          192 TEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNN--IIHRDLKTANLLMDE-NGVVKVADFGVARVQAQSG  268 (399)
Q Consensus       192 ~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~g--iiHrDlkp~NILl~~-~~~vkl~DFG~a~~~~~~~  268 (399)
                      ||||+||+|.+++.+ .+.+++..+..++.||+.||+|||++|  ||||||||+|||++. +|.+||+|||+|+.... .
T Consensus       108 mEy~~gg~L~~~l~~-~~~l~~~~~~~~~~qi~~aL~ylH~~~~~IiHRDlKp~NILl~~~~g~vKl~DFGla~~~~~-~  185 (290)
T 3fpq_A          108 TELMTSGTLKTYLKR-FKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRA-S  185 (290)
T ss_dssp             EECCCSCBHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCCCCCGGGEEESSTTSCEEECCTTGGGGCCT-T
T ss_pred             EeCCCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCCCEEecccChhheeEECCCCCEEEEeCcCCEeCCC-C
Confidence            999999999999976 467999999999999999999999998  999999999999984 79999999999985443 3


Q ss_pred             ccccCCCCcccccccccCCCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhccCC-CCCCCCCcHHHHHHHH
Q 015868          269 VMTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKSLR-PTIPKHAHPRLAELLE  347 (399)
Q Consensus       269 ~~~~~~gt~~y~aPE~l~~~~~~~~~Dv~slG~vl~elltg~~P~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~l~~ll~  347 (399)
                      .....+||+.|||||++.+ +|+.++|||||||++|||+||+.||.+.+........+..... +.++..+++++.+||.
T Consensus       186 ~~~~~~GTp~YmAPE~~~~-~y~~~~DiwSlGvilyelltg~~Pf~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~li~  264 (290)
T 3fpq_A          186 FAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPASFDKVAIPEVKEIIE  264 (290)
T ss_dssp             SBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTTTCCCGGGGGCCCHHHHHHHH
T ss_pred             ccCCcccCccccCHHHcCC-CCCcHHHHHHHHHHHHHHHHCCCCCCCCCcHHHHHHHHHcCCCCCCCCccCCHHHHHHHH
Confidence            4456689999999999876 5999999999999999999999999877665555555544443 3456678899999999


Q ss_pred             HHhhhcCCCCCCHHHHHH
Q 015868          348 RCWQHDPTQRPNFSQITD  365 (399)
Q Consensus       348 ~cl~~dP~~Rps~~ell~  365 (399)
                      +||+.||++|||++|+++
T Consensus       265 ~~L~~dP~~R~s~~e~l~  282 (290)
T 3fpq_A          265 GCIRQNKDERYSIKDLLN  282 (290)
T ss_dssp             HHSCSSGGGSCCHHHHHT
T ss_pred             HHccCChhHCcCHHHHhc
Confidence            999999999999999875

>3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A

Probab=100.00  E-value=1.2e-57  Score=427.78  Aligned_cols=246  Identities=25%  Similarity=0.463  Sum_probs=204.5

Q ss_pred             cccceeceeceeCceEEEEEEE--CCeeEEEEEecCCCC-CHHHHHHHHHHHHHHHhcCCCceeeEEeEEecCCcEEEEE
Q 015868          116 KQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECV-NTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVT  192 (399)
Q Consensus       116 ~~~~i~~~lg~G~~g~Vy~~~~--~~~~vAvK~~~~~~~-~~~~~~~~~~Ei~~l~~l~h~nIv~~~~~~~~~~~~~lV~  192 (399)
                      ++|++.+.||+|+||.||+|++  +++.||||+++.... ..+....+.+|+.+|++++||||+++++++.++..+|+||
T Consensus        13 g~Y~i~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivm   92 (275)
T 3hyh_A           13 GNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDVIKSKDEIIMVI   92 (275)
T ss_dssp             -CCEEEEEEEC---CCEEEEECTTTCCEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             eCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEeHHHcCCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEE
Confidence            5899999999999999999987  589999999976543 3344567999999999999999999999999999999999


Q ss_pred             ecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceeecCCCcEEEeeccceeeccCCCcccc
Q 015868          193 EFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTA  272 (399)
Q Consensus       193 E~~~ggsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~giiHrDlkp~NILl~~~~~vkl~DFG~a~~~~~~~~~~~  272 (399)
                      ||+ +|+|.+++.+ .+.+++..+..++.||+.||+|||++||+||||||+|||+++++.+||+|||+|+..........
T Consensus        93 Ey~-~g~L~~~l~~-~~~l~e~~~~~~~~qi~~al~ylH~~~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~~~~~~~  170 (275)
T 3hyh_A           93 EYA-GNELFDYIVQ-RDKMSEQEARRFFQQIISAVEYCHRHKIVHRDLKPENLLLDEHLNVKIADFGLSNIMTDGNFLKT  170 (275)
T ss_dssp             ECC-CEEHHHHHHH-SCSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCTTTEEECTTCCEEECCSSCC-----------
T ss_pred             eCC-CCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCChHHeEECCCCCEEEeecCCCeecCCCCccCC
Confidence            999 5699999976 56799999999999999999999999999999999999999999999999999987766666667


Q ss_pred             CCCCcccccccccCCCCC-CChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhccCCCCCCCCCcHHHHHHHHHHhh
Q 015868          273 ETGTYRWMAPEVIEHKPY-DYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRLAELLERCWQ  351 (399)
Q Consensus       273 ~~gt~~y~aPE~l~~~~~-~~~~Dv~slG~vl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~cl~  351 (399)
                      .+||+.|||||++.+..| +.++||||+||++|+|+||+.||.+.+..+....+...  .+.+|..+|+++.+||.+||+
T Consensus       171 ~~GT~~Y~APE~~~~~~y~~~~~DiwSlGvily~lltg~~PF~~~~~~~~~~~i~~~--~~~~p~~~s~~~~~li~~~L~  248 (275)
T 3hyh_A          171 SCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFDDESIPVLFKNISNG--VYTLPKFLSPGAAGLIKRMLI  248 (275)
T ss_dssp             ----CTTSCHHHHSSSSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHT--CCCCCTTSCHHHHHHHHHHSC
T ss_pred             eeECcccCChhhhcCCCCCCChhhhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcC--CCCCCCCCCHHHHHHHHHHcc
Confidence            789999999999999887 57999999999999999999999988877665554443  356788899999999999999


Q ss_pred             hcCCCCCCHHHHHH
Q 015868          352 HDPTQRPNFSQITD  365 (399)
Q Consensus       352 ~dP~~Rps~~ell~  365 (399)
                      .||++|||++|+++
T Consensus       249 ~dP~~R~s~~eil~  262 (275)
T 3hyh_A          249 VNPLNRISIHEIMQ  262 (275)
T ss_dssp             SSGGGSCCHHHHHH
T ss_pred             CChhHCcCHHHHHc
Confidence            99999999999976

>4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ...

Probab=100.00  E-value=1.4e-58  Score=440.42  Aligned_cols=249  Identities=22%  Similarity=0.395  Sum_probs=222.2

Q ss_pred             cccccceeceeceeCceEEEEEEE--CCeeEEEEEecCCCC-CHHHHHHHHHHHHHHHhcCCCceeeEEeEEecCCcEEE
Q 015868          114 DAKQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECV-NTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCI  190 (399)
Q Consensus       114 ~~~~~~i~~~lg~G~~g~Vy~~~~--~~~~vAvK~~~~~~~-~~~~~~~~~~Ei~~l~~l~h~nIv~~~~~~~~~~~~~l  190 (399)
                      ..++|++.+.||+|+||.||+|++  +++.||||+++.... +.+..+.+.+|+.+|++++||||+++++++.++..+||
T Consensus        30 ~~~dy~i~~~lG~G~fg~V~~a~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~yi  109 (311)
T 4aw0_A           30 RPEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYF  109 (311)
T ss_dssp             CGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEE
T ss_pred             CccccEEEEEEecccCeEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEE
Confidence            346899999999999999999997  578999999974321 12234678999999999999999999999999999999


Q ss_pred             EEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceeecCCCcEEEeeccceeeccCCC--
Q 015868          191 VTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSG--  268 (399)
Q Consensus       191 V~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~giiHrDlkp~NILl~~~~~vkl~DFG~a~~~~~~~--  268 (399)
                      ||||++||+|.+++.+ .+.+++..+..++.||+.||+|||++||+||||||+|||++.+|.+||+|||+|+......  
T Consensus       110 vmEy~~gG~L~~~i~~-~~~l~e~~~~~~~~qi~~al~ylH~~~IiHRDlKPeNILl~~~g~vKl~DFGla~~~~~~~~~  188 (311)
T 4aw0_A          110 GLSYAKNGELLKYIRK-IGSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQ  188 (311)
T ss_dssp             EECCCTTEEHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEECCTTTTC
T ss_pred             EEecCCCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHeEEcCCCCEEEEEcCCceecCCCCCc
Confidence            9999999999999976 4679999999999999999999999999999999999999999999999999998765332  


Q ss_pred             -ccccCCCCcccccccccCCCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhccCCCCCCCCCcHHHHHHHH
Q 015868          269 -VMTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRLAELLE  347 (399)
Q Consensus       269 -~~~~~~gt~~y~aPE~l~~~~~~~~~Dv~slG~vl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~  347 (399)
                       .....+||+.|||||++.+..|+.++||||+||++|+|+||..||.+.+..+....+...  .+.+|..+++++.+||.
T Consensus       189 ~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~--~~~~p~~~s~~~~dli~  266 (311)
T 4aw0_A          189 ARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEGLIFAKIIKL--EYDFPEKFFPKARDLVE  266 (311)
T ss_dssp             CCBCCCCSCGGGCCHHHHHHSCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHT--CCCCCTTCCHHHHHHHH
T ss_pred             ccccCcccCcccCCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcC--CCCCCcccCHHHHHHHH
Confidence             344568999999999999999999999999999999999999999998888877776654  35678889999999999


Q ss_pred             HHhhhcCCCCCCHHHHHH
Q 015868          348 RCWQHDPTQRPNFSQITD  365 (399)
Q Consensus       348 ~cl~~dP~~Rps~~ell~  365 (399)
                      +||+.||++|||++|++.
T Consensus       267 ~lL~~dp~~R~t~~e~~~  284 (311)
T 4aw0_A          267 KLLVLDATKRLGCEEMEG  284 (311)
T ss_dssp             HHSCSSGGGSTTSGGGTC
T ss_pred             HHccCCHhHCcChHHHcC
Confidence            999999999999999753

>4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A*

Probab=100.00  E-value=4.4e-58  Score=443.20  Aligned_cols=246  Identities=29%  Similarity=0.472  Sum_probs=218.8

Q ss_pred             ccccceeceeceeCceEEEEEEE--CCeeEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCceeeEEeEEecCCcEEEEE
Q 015868          115 AKQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVT  192 (399)
Q Consensus       115 ~~~~~i~~~lg~G~~g~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~nIv~~~~~~~~~~~~~lV~  192 (399)
                      .+.|++.++||+|+||.||+|++  +++.||||+++.....  ..+.+.+|+.+|++++|||||+++++|.+++.+||||
T Consensus        73 ~~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~--~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~ivm  150 (346)
T 4fih_A           73 RSYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQ--RRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVM  150 (346)
T ss_dssp             GGTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCS--SGGGGHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             hHhcEEeEEeecCcCeEEEEEEECCCCCEEEEEEEecCchh--HHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEE
Confidence            35799999999999999999998  5889999999754222  2356889999999999999999999999999999999


Q ss_pred             ecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceeecCCCcEEEeeccceeeccCC-Cccc
Q 015868          193 EFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQS-GVMT  271 (399)
Q Consensus       193 E~~~ggsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~giiHrDlkp~NILl~~~~~vkl~DFG~a~~~~~~-~~~~  271 (399)
                      |||+||+|.+++.+  +.+++..+..++.||+.||+|||++|||||||||+|||++.+|.+||+|||+|+..... ...+
T Consensus       151 Ey~~gg~L~~~l~~--~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~~~~~  228 (346)
T 4fih_A          151 EFLEGGALTDIVTH--TRMNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRK  228 (346)
T ss_dssp             CCCTTEEHHHHHHH--SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSSSCCBC
T ss_pred             eCCCCCcHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEECCCCCEEEecCcCceecCCCCCccc
Confidence            99999999999975  56999999999999999999999999999999999999999999999999999876544 3455


Q ss_pred             cCCCCcccccccccCCCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhccCCCC--CCCCCcHHHHHHHHHH
Q 015868          272 AETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKSLRPT--IPKHAHPRLAELLERC  349 (399)
Q Consensus       272 ~~~gt~~y~aPE~l~~~~~~~~~Dv~slG~vl~elltg~~P~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~l~~ll~~c  349 (399)
                      ..+||+.|||||++.+.+|+.++|||||||++|||++|+.||.+.++.+....+.. ...+.  .+..+++++.+||.+|
T Consensus       229 ~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~-~~~~~~~~~~~~s~~~~dli~~~  307 (346)
T 4fih_A          229 SLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRD-NLPPRLKNLHKVSPSLKGFLDRL  307 (346)
T ss_dssp             CCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHH-SSCCCCSCGGGSCHHHHHHHHHH
T ss_pred             ccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHc-CCCCCCCccccCCHHHHHHHHHH
Confidence            67899999999999999999999999999999999999999999988877665544 33333  3456899999999999


Q ss_pred             hhhcCCCCCCHHHHHH
Q 015868          350 WQHDPTQRPNFSQITD  365 (399)
Q Consensus       350 l~~dP~~Rps~~ell~  365 (399)
                      |+.||++|||++|+++
T Consensus       308 L~~dP~~R~ta~e~l~  323 (346)
T 4fih_A          308 LVRDPAQRATAAELLK  323 (346)
T ss_dssp             SCSSTTTSCCHHHHTT
T ss_pred             cCCChhHCcCHHHHhc
Confidence            9999999999999865

>3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A*

Probab=100.00  E-value=1.5e-58  Score=439.88  Aligned_cols=246  Identities=26%  Similarity=0.440  Sum_probs=212.3

Q ss_pred             eecccccceeceeceeCceEEEEEEE-----CCeeEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCceeeEEeEEecCC
Q 015868          112 EIDAKQLKIECKVASGSYGDLYKGTY-----CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPP  186 (399)
Q Consensus       112 ~i~~~~~~i~~~lg~G~~g~Vy~~~~-----~~~~vAvK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~nIv~~~~~~~~~~  186 (399)
                      .++.++|++.+.||+|+||.||+|+.     +++.||||+++...........+.+|+.+|++++|||||++++++.+++
T Consensus        20 ~~~p~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~   99 (304)
T 3ubd_A           20 KADPSQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKLHYAFQTEG   99 (304)
T ss_dssp             CCCGGGEEEEEEEECGGGCEEEEEEECSSTTTTCEEEEEEEESEEEEEEECC------CCCCCCCCTTEECEEEEEEETT
T ss_pred             cCCccccEEEEEEecCCCeEEEEEEEccCCCCCEEEEEEEEehHHcChHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECC
Confidence            34567899999999999999999987     3578999999754333223346788999999999999999999999999


Q ss_pred             cEEEEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceeecCCCcEEEeeccceeeccC
Q 015868          187 NLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQ  266 (399)
Q Consensus       187 ~~~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~giiHrDlkp~NILl~~~~~vkl~DFG~a~~~~~  266 (399)
                      .+||||||++||+|.+++.+ .+.+++..+..++.||+.||+|||++||+||||||+|||++.+|.+||+|||+|+....
T Consensus       100 ~~~ivmEy~~gg~L~~~l~~-~~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~  178 (304)
T 3ubd_A          100 KLYLILDFLRGGDLFTRLSK-EVMFTEEDVKFYLAELALALDHLHSLGIIYRDLKPENILLDEEGHIKLTDFGLSKESID  178 (304)
T ss_dssp             EEEEEECCCTTCEEHHHHHH-HCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEECTTSCEEEESSEEEEC---
T ss_pred             EEEEEEEcCCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHeEEcCCCCEEecccccceeccC
Confidence            99999999999999999976 46799999999999999999999999999999999999999999999999999986443


Q ss_pred             -CCccccCCCCcccccccccCCCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhccCCCCCCCCCcHHHHHH
Q 015868          267 -SGVMTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRLAEL  345 (399)
Q Consensus       267 -~~~~~~~~gt~~y~aPE~l~~~~~~~~~Dv~slG~vl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l  345 (399)
                       .......+||+.|||||++.+.+|+.++|||||||++|||+||+.||.+.+..+....+.+.  .+.+|..+|+++.+|
T Consensus       179 ~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~~~--~~~~p~~~s~~~~~l  256 (304)
T 3ubd_A          179 HEKKAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGKDRKETMTMILKA--KLGMPQFLSPEAQSL  256 (304)
T ss_dssp             --CCCCSCCCCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHC--CCCCCTTSCHHHHHH
T ss_pred             CCccccccccCcccCCHHHhccCCCCCCCcccchHHHHHHHHhCCCCCCCcCHHHHHHHHHcC--CCCCCCcCCHHHHHH
Confidence             33445678999999999999999999999999999999999999999999988877766654  356788899999999


Q ss_pred             HHHHhhhcCCCCCCH
Q 015868          346 LERCWQHDPTQRPNF  360 (399)
Q Consensus       346 l~~cl~~dP~~Rps~  360 (399)
                      |.+||+.||++|||+
T Consensus       257 i~~~L~~dP~~R~ta  271 (304)
T 3ubd_A          257 LRMLFKRNPANRLGA  271 (304)
T ss_dssp             HHHHTCSSGGGSTTC
T ss_pred             HHHHcccCHHHCCCC
Confidence            999999999999985

>4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens}

Probab=100.00  E-value=8.8e-57  Score=444.47  Aligned_cols=247  Identities=29%  Similarity=0.453  Sum_probs=219.6

Q ss_pred             ccccceeceeceeCceEEEEEEE--CCeeEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCceeeEEeEEecCCcEEEEE
Q 015868          115 AKQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVT  192 (399)
Q Consensus       115 ~~~~~i~~~lg~G~~g~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~nIv~~~~~~~~~~~~~lV~  192 (399)
                      .+.|++.++||+|+||.||+|++  +++.||||++......  ..+.+.+|+.+|++++|||||+++++|..++.+||||
T Consensus       150 ~~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~--~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~iVm  227 (423)
T 4fie_A          150 RSYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQ--RRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVM  227 (423)
T ss_dssp             GGTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEESTTCS--SGGGHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             hHhcEeeeEeccCcCcEEEEEEECCCCCEEEEEEEeccchh--HHHHHHHHHHHHHhCCCCCCCceEEEEEECCEEEEEE
Confidence            35799999999999999999998  5889999999755322  2356889999999999999999999999999999999


Q ss_pred             ecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceeecCCCcEEEeeccceeeccCC-Cccc
Q 015868          193 EFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQS-GVMT  271 (399)
Q Consensus       193 E~~~ggsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~giiHrDlkp~NILl~~~~~vkl~DFG~a~~~~~~-~~~~  271 (399)
                      |||+||+|.+++..  +.+++..+..++.||+.||+|||++|||||||||+|||++.+|.+||+|||+|+..... ....
T Consensus       228 Ey~~gG~L~~~i~~--~~l~e~~~~~~~~qil~aL~ylH~~~IiHRDiKp~NILl~~~g~vKl~DFGla~~~~~~~~~~~  305 (423)
T 4fie_A          228 EFLEGGALTDIVTH--TRMNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRK  305 (423)
T ss_dssp             ECCTTEEHHHHHHH--SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSTTTEEECTTCCEEECCCTTCEECCSSCCCBC
T ss_pred             eCCCCCcHHHHHhc--cCCCHHHHHHHHHHHHHHHHHHHHCCeecccCCHHHEEEcCCCCEEEecCccceECCCCCcccc
Confidence            99999999999965  56999999999999999999999999999999999999999999999999999876544 3455


Q ss_pred             cCCCCcccccccccCCCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhccC-CCCCCCCCcHHHHHHHHHHh
Q 015868          272 AETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKSL-RPTIPKHAHPRLAELLERCW  350 (399)
Q Consensus       272 ~~~gt~~y~aPE~l~~~~~~~~~Dv~slG~vl~elltg~~P~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~l~~ll~~cl  350 (399)
                      ..+||+.|||||++.+..|+.++|||||||++|||++|+.||.+.++.+....+..... ....+..+++++.+||.+||
T Consensus       306 ~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~~~~~~~~~~~s~~~~dli~~~L  385 (423)
T 4fie_A          306 SLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLPPRLKNLHKVSPSLKGFLDRLL  385 (423)
T ss_dssp             CCEECTTTCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCCSCTTSSCHHHHHHHHHHS
T ss_pred             ccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHcCCCCCCcccccCCHHHHHHHHHHc
Confidence            67899999999999999999999999999999999999999999988887766554321 22344678999999999999


Q ss_pred             hhcCCCCCCHHHHHH
Q 015868          351 QHDPTQRPNFSQITD  365 (399)
Q Consensus       351 ~~dP~~Rps~~ell~  365 (399)
                      +.||++|||+.|+++
T Consensus       386 ~~dP~~R~ta~ell~  400 (423)
T 4fie_A          386 VRDPAQRATAAELLK  400 (423)
T ss_dssp             CSSTTTSCCHHHHTT
T ss_pred             CCChhHCcCHHHHhc
Confidence            999999999999875

>3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A*

Probab=100.00  E-value=1e-55  Score=421.85  Aligned_cols=253  Identities=27%  Similarity=0.535  Sum_probs=208.0

Q ss_pred             cccceeceeceeCceEEEEEEECCeeEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCceeeEEeEEecCC----cEEEE
Q 015868          116 KQLKIECKVASGSYGDLYKGTYCSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPP----NLCIV  191 (399)
Q Consensus       116 ~~~~i~~~lg~G~~g~Vy~~~~~~~~vAvK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~nIv~~~~~~~~~~----~~~lV  191 (399)
                      ++|.+.++||+|+||.||+|+++++.||||+++..   ......+..|+..+.+++||||+++++++..+.    .+|||
T Consensus         3 r~i~L~~~iG~G~fG~Vy~~~~~g~~VAvK~l~~~---~~~~~~~e~Ei~~~~~l~HpNIv~l~g~~~~~~~~~~~~~lV   79 (303)
T 3hmm_A            3 RTIVLQESIGKGRFGEVWRGKWRGEEVAVKIFSSR---EERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLV   79 (303)
T ss_dssp             GGEEEEEEEEECSSSEEEEEEETTEEEEEEEECGG---GHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEE
T ss_pred             cEEEEEEEEeeCCCeEEEEEEECCEEEEEEEECcc---chhhHHHHHHHHHHhcCCCCCCCcEEEEEEecCCCceEEEEE
Confidence            57899999999999999999999999999999753   222223345666777899999999999997653    58999


Q ss_pred             EecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC--------CcccCCCCCCceeecCCCcEEEeeccceee
Q 015868          192 TEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQN--------NIIHRDLKTANLLMDENGVVKVADFGVARV  263 (399)
Q Consensus       192 ~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~--------giiHrDlkp~NILl~~~~~vkl~DFG~a~~  263 (399)
                      ||||+||+|.++++.  ..++++.+.+++.|++.||+|||++        +||||||||+|||++.++.+||+|||+|+.
T Consensus        80 ~Ey~~~gsL~~~l~~--~~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl~~~~~~Ki~DFGla~~  157 (303)
T 3hmm_A           80 SDYHEHGSLFDYLNR--YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVR  157 (303)
T ss_dssp             EECCTTCBHHHHHHH--CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEECTTSCEEECCCTTCEE
T ss_pred             ecCCCCCcHHHHHHh--CCCCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEECCCCCEEEEeCCCCcc
Confidence            999999999999976  4589999999999999999999987        999999999999999999999999999987


Q ss_pred             ccCCCc-----cccCCCCcccccccccCCC------CCCChhhHHHHHHHHHHHHcCCCCC----------CCC-----C
Q 015868          264 QAQSGV-----MTAETGTYRWMAPEVIEHK------PYDYKADVFSFGIALWELLTGELPY----------AGL-----T  317 (399)
Q Consensus       264 ~~~~~~-----~~~~~gt~~y~aPE~l~~~------~~~~~~Dv~slG~vl~elltg~~P~----------~~~-----~  317 (399)
                      ......     .....||+.|||||++.+.      .|+.++|||||||++|||+||..||          ...     .
T Consensus       158 ~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~DVwS~Gvvl~El~tg~~~~~~~~~~~~p~~~~~~~~~~  237 (303)
T 3hmm_A          158 HDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPS  237 (303)
T ss_dssp             EETTTTEESCC-----CCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCSSCC
T ss_pred             ccCCCCceeeecccccccccccCHHHhcccccccCCccChhHhhhhHHHHHHHHHHCCCCCCccccccccchhcccccch
Confidence            654432     1234699999999999765      3677999999999999999997654          322     2


Q ss_pred             HHHHHHHHHhccCCCCCCCC-----CcHHHHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHH
Q 015868          318 PLQAAVGVVQKSLRPTIPKH-----AHPRLAELLERCWQHDPTQRPNFSQITDILKQMMKE  373 (399)
Q Consensus       318 ~~~~~~~~~~~~~~~~~~~~-----~~~~l~~ll~~cl~~dP~~Rps~~ell~~L~~l~~~  373 (399)
                      ..+....+.....+|.+|..     +++.+.+|+.+||+.||++|||+.||++.|+++.++
T Consensus       238 ~~~~~~~~~~~~~rp~~p~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~~l~~~  298 (303)
T 3hmm_A          238 VEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQQ  298 (303)
T ss_dssp             HHHHHHHHTTSCCCCCCCGGGGSSHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred             HHHHHHHHhcccCCCCCCccccchHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHHHH
Confidence            23344445566777887754     335789999999999999999999999999988653

>4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A*

Probab=100.00  E-value=5.4e-55  Score=415.77  Aligned_cols=246  Identities=23%  Similarity=0.395  Sum_probs=196.2

Q ss_pred             cccceeceeceeCceEEEEEEE--CCeeEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCceeeEEeEEecCC-------
Q 015868          116 KQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPP-------  186 (399)
Q Consensus       116 ~~~~i~~~lg~G~~g~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~nIv~~~~~~~~~~-------  186 (399)
                      ++|++.+.||+|+||.||+|++  +++.||||+++... .....+.+.+|+.+|++++|||||+++++|...+       
T Consensus         5 ~dy~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~-~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~   83 (299)
T 4g31_A            5 TDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPN-RELAREKVMREVKALAKLEHPGIVRYFNAWLEKNTTEKLQP   83 (299)
T ss_dssp             HHEEEEEEEEECC--EEEEEEETTTCCEEEEEEEEECS-SHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEEC-------
T ss_pred             hhCEEeeEEecCCCeEEEEEEECCCCCEEEEEEEeccC-CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEecCccccccc
Confidence            4689999999999999999997  48899999997543 4555678999999999999999999999986543       


Q ss_pred             -----cEEEEEecCCCCCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceeecCCCcEEEeecc
Q 015868          187 -----NLCIVTEFMARGSIYDFLHKQK--GVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFG  259 (399)
Q Consensus       187 -----~~~lV~E~~~ggsL~~~l~~~~--~~l~~~~~~~i~~~i~~~L~~LH~~giiHrDlkp~NILl~~~~~vkl~DFG  259 (399)
                           .+|||||||+||+|.+++....  ...+...++.++.||+.||+|||++||+||||||+|||++.+|.+||+|||
T Consensus        84 ~~~~~~l~ivmE~~~gg~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~ylH~~~IiHRDlKp~NILl~~~~~vKl~DFG  163 (299)
T 4g31_A           84 SSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDFG  163 (299)
T ss_dssp             ---CEEEEEEEECCCSCCHHHHHHTCCSGGGSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECCCC
T ss_pred             cCCCcEEEEEEecCCCCcHHHHHHhcCCCChhHHHHHHHHHHHHHHHHHHHHHCcCccccCcHHHeEECCCCcEEEccCc
Confidence                 3799999999999999997643  234556788999999999999999999999999999999999999999999


Q ss_pred             ceeeccCCC-------------ccccCCCCcccccccccCCCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHH
Q 015868          260 VARVQAQSG-------------VMTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVV  326 (399)
Q Consensus       260 ~a~~~~~~~-------------~~~~~~gt~~y~aPE~l~~~~~~~~~Dv~slG~vl~elltg~~P~~~~~~~~~~~~~~  326 (399)
                      +|+......             ..+..+||+.|||||++.+.+|+.++|||||||++|||++   ||............+
T Consensus       164 la~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyell~---Pf~~~~~~~~~~~~~  240 (299)
T 4g31_A          164 LVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY---PFSTQMERVRTLTDV  240 (299)
T ss_dssp             CC--------------------------CCCTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHS---CCSSHHHHHHHHHHH
T ss_pred             cceecCCCccccccccccccccccCCcccCccccCHHHHcCCCCCCHHHHHHHHHHHHHHcc---CCCCccHHHHHHHHH
Confidence            998654422             1234579999999999999999999999999999999996   776533322222233


Q ss_pred             hccCCCCCCCCCcHHHHHHHHHHhhhcCCCCCCHHHHHH
Q 015868          327 QKSLRPTIPKHAHPRLAELLERCWQHDPTQRPNFSQITD  365 (399)
Q Consensus       327 ~~~~~~~~~~~~~~~l~~ll~~cl~~dP~~Rps~~ell~  365 (399)
                      .....|..+...++.+.+||.+||+.||.+|||+.|+++
T Consensus       241 ~~~~~p~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~  279 (299)
T 4g31_A          241 RNLKFPPLFTQKYPCEYVMVQDMLSPSPMERPEAINIIE  279 (299)
T ss_dssp             HTTCCCHHHHHHCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             hcCCCCCCCcccCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence            333334344456678899999999999999999999876

>4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens}

Probab=100.00  E-value=2.3e-53  Score=419.47  Aligned_cols=249  Identities=24%  Similarity=0.361  Sum_probs=214.1

Q ss_pred             ccccceeceeceeCceEEEEEEE--CCeeEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCceeeEEeEEec------CC
Q 015868          115 AKQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTR------PP  186 (399)
Q Consensus       115 ~~~~~i~~~lg~G~~g~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~nIv~~~~~~~~------~~  186 (399)
                      .++|++.++||+|+||.||+|++  +++.||||+++.........+.+.+|+.+|++++|||||++++++..      ..
T Consensus        53 ~~~Y~~~~~lG~G~fG~V~~a~~~~t~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~  132 (398)
T 4b99_A           53 GDEYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHDNIIAIKDILRPTVPYGEFK  132 (398)
T ss_dssp             CSSEEEEEEEEECSSCEEEEEEETTTCCEEEEEEETTTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSSCTTTCC
T ss_pred             CCCeEEEEEEecccCeEEEEEEECCCCCEEEEEEECccccchHHHHHHHHHHHHHHhcCCCCcceEeeeeecccccccCC
Confidence            35899999999999999999998  58999999998776667777889999999999999999999998754      35


Q ss_pred             cEEEEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceeecCCCcEEEeeccceeeccC
Q 015868          187 NLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQ  266 (399)
Q Consensus       187 ~~~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~giiHrDlkp~NILl~~~~~vkl~DFG~a~~~~~  266 (399)
                      .+|||||||+ |+|.+++.. .+.+++..+..++.||+.||.|||++|||||||||+|||++.+|.+||+|||+|+....
T Consensus       133 ~~~ivmE~~~-g~L~~~i~~-~~~l~~~~~~~~~~qil~al~ylH~~~iiHRDlKP~NIl~~~~~~~Ki~DFGla~~~~~  210 (398)
T 4b99_A          133 SVYVVLDLME-SDLHQIIHS-SQPLTLEHVRYFLYQLLRGLKYMHSAQVIHRDLKPSNLLVNENCELKIGDFGMARGLCT  210 (398)
T ss_dssp             CEEEEEECCS-EEHHHHHTS-SSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTCCEEECCCTTCBCC--
T ss_pred             EEEEEEeCCC-CCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCcCcCCCcCccccccCCCCCEEEeecceeeeccc
Confidence            7899999996 589999965 56899999999999999999999999999999999999999999999999999986533


Q ss_pred             C-----CccccCCCCcccccccccCCC-CCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhccCCCC-------
Q 015868          267 S-----GVMTAETGTYRWMAPEVIEHK-PYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKSLRPT-------  333 (399)
Q Consensus       267 ~-----~~~~~~~gt~~y~aPE~l~~~-~~~~~~Dv~slG~vl~elltg~~P~~~~~~~~~~~~~~~~~~~~~-------  333 (399)
                      .     ......+||+.|||||++.+. .|+.++||||+||++|||++|++||.+.+..+....+......|.       
T Consensus       211 ~~~~~~~~~~~~~GT~~Y~APEv~~~~~~~~~~~DiWSlG~il~ell~G~~pF~g~~~~~~l~~I~~~~g~p~~~~~~~~  290 (398)
T 4b99_A          211 SPAEHQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPGKNYVHQLQLIMMVLGTPSPAVIQAV  290 (398)
T ss_dssp             -----CCCCCSSCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCCGGGTC--
T ss_pred             CccccccccccceeChHhcCHHHhcCCCCCCChhheehhHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCChHHhhhh
Confidence            2     234567899999999998875 569999999999999999999999999888776655543211111       


Q ss_pred             ----------------------CCCCCcHHHHHHHHHHhhhcCCCCCCHHHHHH
Q 015868          334 ----------------------IPKHAHPRLAELLERCWQHDPTQRPNFSQITD  365 (399)
Q Consensus       334 ----------------------~~~~~~~~l~~ll~~cl~~dP~~Rps~~ell~  365 (399)
                                            +.+.+++++.+||.+||+.||.+|||+.|+++
T Consensus       291 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~  344 (398)
T 4b99_A          291 GAERVRAYIQSLPPRQPVPWETVYPGADRQALSLLGRMLRFEPSARISAAAALR  344 (398)
T ss_dssp             ---CHHHHHHSSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred             hhhhhhhhhhcCCCcCCCCHHHhCCCCCHHHHHHHHHHCcCChhHCcCHHHHhc
Confidence                                  11357899999999999999999999999876

>3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A*

Probab=100.00  E-value=2.5e-51  Score=392.51  Aligned_cols=268  Identities=42%  Similarity=0.767  Sum_probs=232.3

Q ss_pred             CCceeecccccceeceeceeCceEEEEEEECCeeEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCceeeEEeEEecCCc
Q 015868          108 TDVWEIDAKQLKIECKVASGSYGDLYKGTYCSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPN  187 (399)
Q Consensus       108 ~~~~~i~~~~~~i~~~lg~G~~g~Vy~~~~~~~~vAvK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~nIv~~~~~~~~~~~  187 (399)
                      .+.+++...+|++.++||+|+||.||+|++.++.||+|++..........+.+.+|+.++++++||||+++++++...+.
T Consensus        29 ~~~~~i~~~~y~i~~~lG~G~~g~V~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~  108 (309)
T 3p86_A           29 GDDMDIPWCDLNIKEKIGAGSFGTVHRAEWHGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQPPN  108 (309)
T ss_dssp             ---CBCCGGGEEEEEEEEECSSEEEEEEEETTEEEEEEEECCCCCSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTC
T ss_pred             cccccCChhHceeeeEeecCCCeEEEEEEECCCcEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCc
Confidence            35678899999999999999999999999999999999998877777778899999999999999999999999999999


Q ss_pred             EEEEEecCCCCCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCCCceeecCCCcEEEeeccceee
Q 015868          188 LCIVTEFMARGSIYDFLHKQK--GVFQLTSLLKVAIDVSKGMNYLHQNN--IIHRDLKTANLLMDENGVVKVADFGVARV  263 (399)
Q Consensus       188 ~~lV~E~~~ggsL~~~l~~~~--~~l~~~~~~~i~~~i~~~L~~LH~~g--iiHrDlkp~NILl~~~~~vkl~DFG~a~~  263 (399)
                      .++||||+++++|.+++....  ..+++..++.++.|++.||+|||++|  |+||||||+||+++.++.+||+|||+++.
T Consensus       109 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~  188 (309)
T 3p86_A          109 LSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNRNPPIVHRNLKSPNLLVDKKYTVKVCDFGLSRL  188 (309)
T ss_dssp             CEEEEECCTTCBHHHHHHSTTHHHHSCHHHHHHHHHHHHHHHHHHHTSSSCCCCTTCCGGGEEECTTCCEEECCCC----
T ss_pred             eEEEEecCCCCcHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCEECCCCChhhEEEeCCCcEEECCCCCCcc
Confidence            999999999999999997643  23899999999999999999999999  99999999999999999999999999976


Q ss_pred             ccCCC-ccccCCCCcccccccccCCCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhccCCCCCCCCCcHHH
Q 015868          264 QAQSG-VMTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRL  342 (399)
Q Consensus       264 ~~~~~-~~~~~~gt~~y~aPE~l~~~~~~~~~Dv~slG~vl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  342 (399)
                      ..... ......||+.|+|||++.+..++.++||||||+++|+|++|..||...++.+..........+..+|..+++++
T Consensus       189 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  268 (309)
T 3p86_A          189 KASTFLSSKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPWGNLNPAQVVAAVGFKCKRLEIPRNLNPQV  268 (309)
T ss_dssp             -------------CCTTSCHHHHTTCCCCTTHHHHHHHHHHHHHHHCCCTTTTSCHHHHHHHHHHSCCCCCCCTTSCHHH
T ss_pred             ccccccccccCCCCccccChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCCccCCHHH
Confidence            44332 23445789999999999999999999999999999999999999999998887777766777788899999999


Q ss_pred             HHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHH
Q 015868          343 AELLERCWQHDPTQRPNFSQITDILKQMMKEVA  375 (399)
Q Consensus       343 ~~ll~~cl~~dP~~Rps~~ell~~L~~l~~~~~  375 (399)
                      .++|.+||+.||.+|||+.++++.|+.+++...
T Consensus       269 ~~li~~~l~~dP~~Rps~~~ll~~L~~~~~~~~  301 (309)
T 3p86_A          269 AAIIEGCWTNEPWKRPSFATIMDLLRPLIKSAV  301 (309)
T ss_dssp             HHHHHHHTCSSGGGSCCHHHHHHHHHHHHC---
T ss_pred             HHHHHHHccCChhhCcCHHHHHHHHHHHHHhCC
Confidence            999999999999999999999999999986543

>3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A

Probab=100.00  E-value=1e-51  Score=426.05  Aligned_cols=249  Identities=22%  Similarity=0.369  Sum_probs=225.3

Q ss_pred             ccccceeceeceeCceEEEEEEE--CCeeEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCceeeEEeEEecCCcEEEEE
Q 015868          115 AKQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVT  192 (399)
Q Consensus       115 ~~~~~i~~~lg~G~~g~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~nIv~~~~~~~~~~~~~lV~  192 (399)
                      .++|++.+.||+|+||.||+|++  +++.||+|+++..  .....+.+.+|+.+|+.++||||++++++|.+...+||||
T Consensus       156 l~~Y~i~~~lG~G~fg~V~~~~~~~tg~~~AiK~i~~~--~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iv~  233 (573)
T 3uto_A          156 LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTP--HESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIY  233 (573)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC--SHHHHHHHHHHHHHHHHTCCTTBCCEEEEEECSSEEEEEE
T ss_pred             ccccEEEEEEeeccCeEEEEEEECCCCCEEEEEEEecc--chhhHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEE
Confidence            36899999999999999999988  5789999999765  3455678899999999999999999999999999999999


Q ss_pred             ecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceeecCC--CcEEEeeccceeeccCCCcc
Q 015868          193 EFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDEN--GVVKVADFGVARVQAQSGVM  270 (399)
Q Consensus       193 E~~~ggsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~giiHrDlkp~NILl~~~--~~vkl~DFG~a~~~~~~~~~  270 (399)
                      |||+||+|.+++....+.+++..+..++.||+.||.|||++||+||||||+|||++.+  +.+||+|||+|+........
T Consensus       234 E~~~gg~L~~~i~~~~~~l~e~~~~~~~~qi~~al~ylH~~~iiHRDlKp~Nill~~~~~~~vKl~DFG~a~~~~~~~~~  313 (573)
T 3uto_A          234 EFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSV  313 (573)
T ss_dssp             ECCCCCBHHHHHTCTTSCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSCCCEEECCCSSCEECCTTSEE
T ss_pred             eecCCCcHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCChhhccccCCCCCCEEEeeccceeEccCCCce
Confidence            9999999999998777889999999999999999999999999999999999999854  89999999999987776666


Q ss_pred             ccCCCCcccccccccCCCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhccCC--CCCCCCCcHHHHHHHHH
Q 015868          271 TAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKSLR--PTIPKHAHPRLAELLER  348 (399)
Q Consensus       271 ~~~~gt~~y~aPE~l~~~~~~~~~Dv~slG~vl~elltg~~P~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~l~~ll~~  348 (399)
                      ...+||+.|||||++.+.+|+.++|||||||++|+|++|..||.+.+..+....+......  +..+..+++++.+||.+
T Consensus       314 ~~~~GT~~y~APEv~~~~~y~~~~DiWSlGvilyeml~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~dli~~  393 (573)
T 3uto_A          314 KVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMDDSAFSGISEDGKDFIRK  393 (573)
T ss_dssp             EEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHTTCCCCCSGGGTTSCHHHHHHHHT
T ss_pred             eeeEECccccCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHhCCCCCCcccccCCCHHHHHHHHH
Confidence            6778999999999999999999999999999999999999999999988877766554332  23346789999999999


Q ss_pred             HhhhcCCCCCCHHHHHH
Q 015868          349 CWQHDPTQRPNFSQITD  365 (399)
Q Consensus       349 cl~~dP~~Rps~~ell~  365 (399)
                      ||+.||.+|||+.|+++
T Consensus       394 ~L~~dp~~R~t~~e~l~  410 (573)
T 3uto_A          394 LLLADPNTRMTIHQALE  410 (573)
T ss_dssp             TSCSSGGGSCCHHHHHH
T ss_pred             HccCChhHCcCHHHHhc
Confidence            99999999999999976

>4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A*

Probab=100.00  E-value=9e-51  Score=396.56  Aligned_cols=243  Identities=21%  Similarity=0.340  Sum_probs=199.0

Q ss_pred             ccccceeceeceeCceEEEEEEE-----CCeeEEEEEecCCCCCHHHHHHHHHHHHHHHhc-CCCceeeEEeEEecCCcE
Q 015868          115 AKQLKIECKVASGSYGDLYKGTY-----CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKI-RHKNVVQFIGACTRPPNL  188 (399)
Q Consensus       115 ~~~~~i~~~lg~G~~g~Vy~~~~-----~~~~vAvK~~~~~~~~~~~~~~~~~Ei~~l~~l-~h~nIv~~~~~~~~~~~~  188 (399)
                      .++|++.++||+|+||.||+|++     .++.||+|++....    ....+.+|+.+|+.+ +||||+++++++.+.+++
T Consensus        20 ~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~----~~~~~~~E~~~l~~~~~h~nIv~l~~~~~~~~~~   95 (361)
T 4f9c_A           20 SNVFKIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPTS----HPIRIAAELQCLTVAGGQDNVMGVKYCFRKNDHV   95 (361)
T ss_dssp             GGTCEEEEEEEECSSEEEEEEEEEBTTSCEEEEEEEEECTTS----CHHHHHHHHHHHHHTCSBTTBCCCSEEEEETTEE
T ss_pred             cCcEEEEEEEecccCcEEEEEEEcccCCCCCEEEEEEEcccc----CHHHHHHHHHHHHHhcCCCCCceEEEEEEECCEE
Confidence            35799999999999999999976     35789999987542    234678899999998 699999999999999999


Q ss_pred             EEEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceeecCC-CcEEEeeccceeeccCC
Q 015868          189 CIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDEN-GVVKVADFGVARVQAQS  267 (399)
Q Consensus       189 ~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~giiHrDlkp~NILl~~~-~~vkl~DFG~a~~~~~~  267 (399)
                      |+||||++||+|.+++.    .+++..+..++.||+.||+|||++||+||||||+|||++.+ +.+||+|||+|+.....
T Consensus        96 ~lvmE~~~g~~L~~~~~----~l~~~~~~~~~~qll~al~ylH~~gIiHRDiKPeNiLl~~~~~~~kl~DFGla~~~~~~  171 (361)
T 4f9c_A           96 VIAMPYLEHESFLDILN----SLSFQEVREYMLNLFKALKRIHQFGIVHRDVKPSNFLYNRRLKKYALVDFGLAQGTHDT  171 (361)
T ss_dssp             EEEEECCCCCCHHHHHT----TCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEETTTTEEEECCCTTCEECTTC
T ss_pred             EEEEeCCCcccHHHHHc----CCCHHHHHHHHHHHHHHHHHHHHCCeEeCcCCHHHeEEeCCCCeEEECcCCCCcccCCc
Confidence            99999999999999983    48999999999999999999999999999999999999876 89999999999754332


Q ss_pred             C-----------------------------ccccCCCCcccccccccCCC-CCCChhhHHHHHHHHHHHHcCCCCCCCCC
Q 015868          268 G-----------------------------VMTAETGTYRWMAPEVIEHK-PYDYKADVFSFGIALWELLTGELPYAGLT  317 (399)
Q Consensus       268 ~-----------------------------~~~~~~gt~~y~aPE~l~~~-~~~~~~Dv~slG~vl~elltg~~P~~~~~  317 (399)
                      .                             ..+..+||+.|||||++.+. .|+.++||||+||++|||+||+.||...+
T Consensus       172 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~y~~~~DiWSlG~il~ell~G~~Pf~~~~  251 (361)
T 4f9c_A          172 KIELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWSAGVIFLSLLSGRYPFYKAS  251 (361)
T ss_dssp             SCGGGGGC--------------------------CCCCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTCSSSSCCS
T ss_pred             cccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCCccchhhhHHHHHHHHHCCCCCCCCC
Confidence            1                             12345799999999999875 58999999999999999999999995433


Q ss_pred             -HHHHHHHHHhc----------------------------------------------------cCCCCCCCCCcHHHHH
Q 015868          318 -PLQAAVGVVQK----------------------------------------------------SLRPTIPKHAHPRLAE  344 (399)
Q Consensus       318 -~~~~~~~~~~~----------------------------------------------------~~~~~~~~~~~~~l~~  344 (399)
                       ..+....+...                                                    .........+++++.+
T Consensus       252 ~~~~~l~~I~~~~G~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~is~~a~D  331 (361)
T 4f9c_A          252 DDLTALAQIMTIRGSRETIQAAKTFGKSILCSKEVPAQDLRKLCERLRGMDSSTPKLTSDIQGHATNLEGWNEVPDEAYD  331 (361)
T ss_dssp             SHHHHHHHHHHHHCHHHHHHHHHHTTEEEEESSCCCCCCHHHHHHHHC----------------------CTTCCHHHHH
T ss_pred             CHHHHHHHHHHhcCCccchhhhhhccccccccccCcchhhhHHHHhhccccccccccccccccccccccccccCCHHHHH
Confidence             32222211100                                                    0001112457899999


Q ss_pred             HHHHHhhhcCCCCCCHHHHHH
Q 015868          345 LLERCWQHDPTQRPNFSQITD  365 (399)
Q Consensus       345 ll~~cl~~dP~~Rps~~ell~  365 (399)
                      ||.+||+.||.+|||++|+++
T Consensus       332 Ll~~lL~~dP~~R~ta~eaL~  352 (361)
T 4f9c_A          332 LLDKLLDLNPASRITAEEALL  352 (361)
T ss_dssp             HHHHHTCSCTTTSCCHHHHHT
T ss_pred             HHHHHCcCChhHCcCHHHHhc
Confidence            999999999999999999874

>3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A

Probab=100.00  E-value=1.7e-50  Score=417.25  Aligned_cols=249  Identities=25%  Similarity=0.403  Sum_probs=211.4

Q ss_pred             ecccccceeceeceeCceEEEEEEE--CCeeEEEEEecCCC----CCHHHHHHHHHHHHHHHhcCCCceeeEEeEEecCC
Q 015868          113 IDAKQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPEC----VNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPP  186 (399)
Q Consensus       113 i~~~~~~i~~~lg~G~~g~Vy~~~~--~~~~vAvK~~~~~~----~~~~~~~~~~~Ei~~l~~l~h~nIv~~~~~~~~~~  186 (399)
                      +..++|++.+.||+|+||.||+|++  +++.||||+++...    ..........+++.+++.++|||||+++++|.++.
T Consensus       186 ~slddf~i~k~LG~G~fG~V~la~~~~tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~~HP~IV~l~~~f~~~~  265 (689)
T 3v5w_A          186 LTMNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPD  265 (689)
T ss_dssp             CCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSS
T ss_pred             CchHHeEEEEEEecccCeEEEEEEECCCCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhCCCCCEeEEEEEEEECC
Confidence            4467899999999999999999998  67899999996421    12233334445577778889999999999999999


Q ss_pred             cEEEEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceeecCCCcEEEeeccceeeccC
Q 015868          187 NLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQ  266 (399)
Q Consensus       187 ~~~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~giiHrDlkp~NILl~~~~~vkl~DFG~a~~~~~  266 (399)
                      .+||||||++||+|.++|.+ .+.+++..+..++.||+.||+|||++|||||||||+|||++.+|.+||+|||+|+....
T Consensus       266 ~lylVmEy~~GGdL~~~l~~-~~~l~E~~a~~y~~qIl~aL~yLH~~gIiHRDLKPeNILld~~G~vKL~DFGlA~~~~~  344 (689)
T 3v5w_A          266 KLSFILDLMNGGDLHYHLSQ-HGVFSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSK  344 (689)
T ss_dssp             EEEEEECCCCSCBHHHHHHH-HCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEECTTSCEEECCCTTCEECSS
T ss_pred             EEEEEEecCCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCchHHeEEeCCCCEEecccceeeecCC
Confidence            99999999999999999976 46799999999999999999999999999999999999999999999999999987654


Q ss_pred             CCccccCCCCcccccccccC-CCCCCChhhHHHHHHHHHHHHcCCCCCCCCC---HHHHHHHHHhccCCCCCCCCCcHHH
Q 015868          267 SGVMTAETGTYRWMAPEVIE-HKPYDYKADVFSFGIALWELLTGELPYAGLT---PLQAAVGVVQKSLRPTIPKHAHPRL  342 (399)
Q Consensus       267 ~~~~~~~~gt~~y~aPE~l~-~~~~~~~~Dv~slG~vl~elltg~~P~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~l  342 (399)
                      . .....+||+.|||||++. +..|+.++|+|||||++|||++|..||.+.+   ..+......  ...+.+|..+|+++
T Consensus       345 ~-~~~t~~GTp~YmAPEvl~~~~~y~~~vDiWSLGvilYEmLtG~~PF~~~~~~~~~~i~~~i~--~~~~~~p~~~S~~a  421 (689)
T 3v5w_A          345 K-KPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTL--TMAVELPDSFSPEL  421 (689)
T ss_dssp             C-CCCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCTTCGGGCCCHHHHHHHHH--HCCCCCCTTSCHHH
T ss_pred             C-CCCCccCCcCccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhc--CCCCCCCccCCHHH
Confidence            4 345568999999999996 4689999999999999999999999997643   222222222  33456788899999


Q ss_pred             HHHHHHHhhhcCCCCCC-----HHHHHH
Q 015868          343 AELLERCWQHDPTQRPN-----FSQITD  365 (399)
Q Consensus       343 ~~ll~~cl~~dP~~Rps-----~~ell~  365 (399)
                      .+||.+||+.||.+|++     ++||++
T Consensus       422 ~dLI~~lL~~dP~~Rl~~~~~ga~ei~~  449 (689)
T 3v5w_A          422 RSLLEGLLQRDVNRRLGCLGRGAQEVKE  449 (689)
T ss_dssp             HHHHHHHTCSCGGGCTTCSSSTHHHHTT
T ss_pred             HHHHHHHccCCHhHCCCCCCCCHHHHhc
Confidence            99999999999999998     677754

>2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A

Probab=100.00  E-value=3.4e-49  Score=387.13  Aligned_cols=264  Identities=30%  Similarity=0.624  Sum_probs=232.9

Q ss_pred             CceeecccccceeceeceeCceEEEEEEEC---------CeeEEEEEecCCCCCHHHHHHHHHHHHHHHhc-CCCceeeE
Q 015868          109 DVWEIDAKQLKIECKVASGSYGDLYKGTYC---------SQEVAIKVLKPECVNTEMLKEFSQEVYIMRKI-RHKNVVQF  178 (399)
Q Consensus       109 ~~~~i~~~~~~i~~~lg~G~~g~Vy~~~~~---------~~~vAvK~~~~~~~~~~~~~~~~~Ei~~l~~l-~h~nIv~~  178 (399)
                      ..|++..++|++.+.||+|+||.||+|++.         +..||+|+++... .....+.+.+|+.+++.+ +||||+++
T Consensus        74 ~~~~~~~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~~hpnIv~~  152 (370)
T 2psq_A           74 PKWEFPRDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDA-TEKDLSDLVSEMEMMKMIGKHKNIINL  152 (370)
T ss_dssp             TTTBCCGGGEEEEEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTTC-BHHHHHHHHHHHHHHHHSCCCTTBCCE
T ss_pred             ccccccHHHCEeeeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCCc-CHHHHHHHHHHHHHHHHhcCCCCEeeE
Confidence            447788899999999999999999999863         3469999998653 455677899999999999 89999999


Q ss_pred             EeEEecCCcEEEEEecCCCCCHHHHHHhcC---------------CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCC
Q 015868          179 IGACTRPPNLCIVTEFMARGSIYDFLHKQK---------------GVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTA  243 (399)
Q Consensus       179 ~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~---------------~~l~~~~~~~i~~~i~~~L~~LH~~giiHrDlkp~  243 (399)
                      ++++.....+|+||||+++|+|.+++....               ..+++..++.++.||+.||.|||++||+||||||+
T Consensus       153 ~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~  232 (370)
T 2psq_A          153 LGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAAR  232 (370)
T ss_dssp             EEEECSSSSCEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGG
T ss_pred             EEEEccCCCEEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCeeccccchh
Confidence            999999999999999999999999997643               35789999999999999999999999999999999


Q ss_pred             ceeecCCCcEEEeeccceeeccCCC---ccccCCCCcccccccccCCCCCCChhhHHHHHHHHHHHHc-CCCCCCCCCHH
Q 015868          244 NLLMDENGVVKVADFGVARVQAQSG---VMTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLT-GELPYAGLTPL  319 (399)
Q Consensus       244 NILl~~~~~vkl~DFG~a~~~~~~~---~~~~~~gt~~y~aPE~l~~~~~~~~~Dv~slG~vl~ellt-g~~P~~~~~~~  319 (399)
                      |||++.++.+||+|||+++......   ......+|+.|+|||++.+..++.++||||||+++|||+| |..||.+.+..
T Consensus       233 NIll~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~p~~~~~~~  312 (370)
T 2psq_A          233 NVLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVE  312 (370)
T ss_dssp             GEEECTTCCEEECCCSSCEETTCCCTTCTTTTTTSCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGG
T ss_pred             hEEECCCCCEEEccccCCcccCcccceecccCCCcccceECHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCCCCCCHH
Confidence            9999999999999999998655432   2233457889999999999999999999999999999999 99999988776


Q ss_pred             HHHHHHHhccCCCCCCCCCcHHHHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHH
Q 015868          320 QAAVGVVQKSLRPTIPKHAHPRLAELLERCWQHDPTQRPNFSQITDILKQMMKEV  374 (399)
Q Consensus       320 ~~~~~~~~~~~~~~~~~~~~~~l~~ll~~cl~~dP~~Rps~~ell~~L~~l~~~~  374 (399)
                      +... .+....++..|..+++++.++|.+||+.||.+|||+.|+++.|++++...
T Consensus       313 ~~~~-~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~L~~il~~~  366 (370)
T 2psq_A          313 ELFK-LLKEGHRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILTLT  366 (370)
T ss_dssp             GHHH-HHHTTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred             HHHH-HHhcCCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHHh
Confidence            6544 45556677888899999999999999999999999999999999998654

>4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A*

Probab=100.00  E-value=2.7e-49  Score=369.79  Aligned_cols=261  Identities=32%  Similarity=0.678  Sum_probs=231.6

Q ss_pred             CCceeecccccceeceeceeCceEEEEEEE-CCeeEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCceeeEEeEEecCC
Q 015868          108 TDVWEIDAKQLKIECKVASGSYGDLYKGTY-CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPP  186 (399)
Q Consensus       108 ~~~~~i~~~~~~i~~~lg~G~~g~Vy~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~nIv~~~~~~~~~~  186 (399)
                      ...|.++.++|++.+.||+|+||.||+|.+ .++.||+|+++......   +.+.+|+.++++++||||+++++++....
T Consensus         2 ~~~~~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~---~~~~~E~~~l~~l~h~~i~~~~~~~~~~~   78 (269)
T 4hcu_A            2 SGKWVIDPSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSE---EDFIEEAEVMMKLSHPKLVQLYGVCLEQA   78 (269)
T ss_dssp             ---CBCCGGGEEEEEEEEECSSCEEEEEEETTTEEEEEEEECTTSBCH---HHHHHHHHHHHTCCCTTBCCEEEEECSSS
T ss_pred             CccEEeChhhceeeheecCCCccEEEEEEecCCCeEEEEEecccccCH---HHHHHHHHHHHhCCCCCEeeEEEEEecCC
Confidence            356889999999999999999999999998 67889999998764443   56889999999999999999999999999


Q ss_pred             cEEEEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceeecCCCcEEEeeccceeeccC
Q 015868          187 NLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQ  266 (399)
Q Consensus       187 ~~~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~giiHrDlkp~NILl~~~~~vkl~DFG~a~~~~~  266 (399)
                      ..++||||+++++|.+++......+++..++.++.|++.||.|||++||+||||||+||+++.++.+||+|||+++....
T Consensus        79 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~  158 (269)
T 4hcu_A           79 PICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLD  158 (269)
T ss_dssp             SEEEEEECCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECGGGCEEECCTTGGGGBCC
T ss_pred             ceEEEEEeCCCCcHHHHHHhcCcccCHHHHHHHHHHHHHHHHHHHhCCeecCCcchheEEEcCCCCEEeccccccccccc
Confidence            99999999999999999988778899999999999999999999999999999999999999999999999999975543


Q ss_pred             CC--ccccCCCCcccccccccCCCCCCChhhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHHhccCCCCCCCCCcHHHH
Q 015868          267 SG--VMTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLT-GELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRLA  343 (399)
Q Consensus       267 ~~--~~~~~~gt~~y~aPE~l~~~~~~~~~Dv~slG~vl~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~  343 (399)
                      ..  ......+|+.|+|||.+.+..++.++||||||+++|+|++ |..||...+..+..... ....++..+...++++.
T Consensus       159 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~~g~~p~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~  237 (269)
T 4hcu_A          159 DQYTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDI-STGFRLYKPRLASTHVY  237 (269)
T ss_dssp             HHHHSTTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHH-HTTCCCCCCTTSCHHHH
T ss_pred             cccccccCcccccccCCHHHhcCCCCCchhhhHHHHHHHHHHhcCCCCCCCCCCHHHHHHHH-hcCccCCCCCcCCHHHH
Confidence            22  1233456788999999998999999999999999999999 99999998887765554 44566777888999999


Q ss_pred             HHHHHHhhhcCCCCCCHHHHHHHHHHHHH
Q 015868          344 ELLERCWQHDPTQRPNFSQITDILKQMMK  372 (399)
Q Consensus       344 ~ll~~cl~~dP~~Rps~~ell~~L~~l~~  372 (399)
                      +++.+||+.||++|||+.++++.|+++.+
T Consensus       238 ~li~~~l~~~p~~Rps~~~ll~~l~~l~~  266 (269)
T 4hcu_A          238 QIMNHCWRERPEDRPAFSRLLRQLAEIAE  266 (269)
T ss_dssp             HHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             HHHHHHccCCcccCcCHHHHHHHHHHHHH
Confidence            99999999999999999999999999864

>3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A

Probab=100.00  E-value=2e-49  Score=382.59  Aligned_cols=249  Identities=27%  Similarity=0.482  Sum_probs=227.0

Q ss_pred             cccccceeceeceeCceEEEEEEE--CCeeEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCceeeEEeEEecCCcEEEE
Q 015868          114 DAKQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIV  191 (399)
Q Consensus       114 ~~~~~~i~~~lg~G~~g~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~nIv~~~~~~~~~~~~~lV  191 (399)
                      ..++|++.+.||+|+||.||+|++  +++.||||++.....+....+.+.+|+.+++.++||||+++++++......|+|
T Consensus        13 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv   92 (328)
T 3fe3_A           13 HIGNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEVIETEKTLYLI   92 (328)
T ss_dssp             EETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred             ccCCEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhhcCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEE
Confidence            356899999999999999999997  688999999987666777788899999999999999999999999999999999


Q ss_pred             EecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceeecCCCcEEEeeccceeeccCCCccc
Q 015868          192 TEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMT  271 (399)
Q Consensus       192 ~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~giiHrDlkp~NILl~~~~~vkl~DFG~a~~~~~~~~~~  271 (399)
                      |||++|++|.+++... +.+++..++.++.|++.||.|||++||+||||||+|||++.++.+||+|||+++.........
T Consensus        93 ~e~~~~~~L~~~l~~~-~~l~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~  171 (328)
T 3fe3_A           93 MEYASGGEVFDYLVAH-GRMKEKEARSKFRQIVSAVQYCHQKRIVHRDLKAENLLLDADMNIKIADFGFSNEFTVGGKLD  171 (328)
T ss_dssp             ECCCTTCBHHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECSTTCCGGGSSSCGGG
T ss_pred             EECCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCEeccCCCHHHEEEcCCCCEEEeeccCceecCCCCccc
Confidence            9999999999999764 679999999999999999999999999999999999999999999999999998776666667


Q ss_pred             cCCCCcccccccccCCCCCC-ChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhccCCCCCCCCCcHHHHHHHHHHh
Q 015868          272 AETGTYRWMAPEVIEHKPYD-YKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRLAELLERCW  350 (399)
Q Consensus       272 ~~~gt~~y~aPE~l~~~~~~-~~~Dv~slG~vl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~cl  350 (399)
                      ...||+.|+|||++.+..++ .++||||||+++|+|++|..||.+.+..+....+...  ...+|..+++++.+|+.+||
T Consensus       172 ~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~--~~~~p~~~s~~~~~li~~~L  249 (328)
T 3fe3_A          172 AFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERVLRG--KYRIPFYMSTDCENLLKRFL  249 (328)
T ss_dssp             TTSSSGGGCCHHHHHTCCCCSHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHC--CCCCCTTSCHHHHHHHHHHC
T ss_pred             cccCCcceeCcccccCCCcCCchhhhhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhC--CCCCCCCCCHHHHHHHHHHC
Confidence            77899999999999988875 7899999999999999999999999887776665554  34567789999999999999


Q ss_pred             hhcCCCCCCHHHHHH
Q 015868          351 QHDPTQRPNFSQITD  365 (399)
Q Consensus       351 ~~dP~~Rps~~ell~  365 (399)
                      +.||.+|||++|+++
T Consensus       250 ~~dP~~R~t~~eil~  264 (328)
T 3fe3_A          250 VLNPIKRGTLEQIMK  264 (328)
T ss_dssp             CSSTTTSCCHHHHTT
T ss_pred             CCChhHCcCHHHHhc
Confidence            999999999999976

>3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A*

Probab=100.00  E-value=3.4e-49  Score=368.19  Aligned_cols=257  Identities=33%  Similarity=0.620  Sum_probs=234.9

Q ss_pred             eeecccccceeceeceeCceEEEEEEECCeeEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCceeeEEeEEecC--CcE
Q 015868          111 WEIDAKQLKIECKVASGSYGDLYKGTYCSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRP--PNL  188 (399)
Q Consensus       111 ~~i~~~~~~i~~~lg~G~~g~Vy~~~~~~~~vAvK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~nIv~~~~~~~~~--~~~  188 (399)
                      +.++.++|++.+.||+|+||.||+|++.++.||+|+++.........+.+.+|+.++++++||||+++++++..+  ...
T Consensus         5 ~~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~   84 (271)
T 3kmu_A            5 SGIDFKQLNFLTKLNENHSGELWKGRWQGNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGACQSPPAPHP   84 (271)
T ss_dssp             CCCCGGGCEEEEEEEEETTEEEEEEEETTEEEEEEEECCTTCCHHHHHHHHHHGGGGCCCSCTTEECEEEEECTTTSSSC
T ss_pred             CCCCHHHhHHHHHhcCCCcceEEEEEECCeeEEEEEecccccCHHHHHHHHHHHHHHHhcCCCchhheEEEEccCCCCCe
Confidence            567889999999999999999999999999999999998777777788999999999999999999999999887  788


Q ss_pred             EEEEecCCCCCHHHHHHhcCC-CCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCCCceeecCCCcEEEeeccceeecc
Q 015868          189 CIVTEFMARGSIYDFLHKQKG-VFQLTSLLKVAIDVSKGMNYLHQNN--IIHRDLKTANLLMDENGVVKVADFGVARVQA  265 (399)
Q Consensus       189 ~lV~E~~~ggsL~~~l~~~~~-~l~~~~~~~i~~~i~~~L~~LH~~g--iiHrDlkp~NILl~~~~~vkl~DFG~a~~~~  265 (399)
                      ++||||+++++|.+++..... .+++..++.++.|++.||.|||++|  |+||||||+||+++.++.++|+|||++....
T Consensus        85 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~i~H~dikp~Nil~~~~~~~~l~~~~~~~~~~  164 (271)
T 3kmu_A           85 TLITHWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAFLHTLEPLIPRHALNSRSVMIDEDMTARISMADVKFSFQ  164 (271)
T ss_dssp             EEEEECCTTCBHHHHHHSCSSCCCCHHHHHHHHHHHHHHHHHHTTSSSCCTTCCCSGGGEEECTTSCEEEEGGGSCCTTS
T ss_pred             EeeecccCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcCCCceecCCCccceEEEcCCcceeEEeccceeeec
Confidence            999999999999999987543 5899999999999999999999999  9999999999999999999999999875432


Q ss_pred             CCCccccCCCCcccccccccCCCCCCC---hhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhccCCCCCCCCCcHHH
Q 015868          266 QSGVMTAETGTYRWMAPEVIEHKPYDY---KADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRL  342 (399)
Q Consensus       266 ~~~~~~~~~gt~~y~aPE~l~~~~~~~---~~Dv~slG~vl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  342 (399)
                          .....||+.|+|||.+.+..++.   ++||||||+++|+|++|+.||...+..+..........++.++..+++++
T Consensus       165 ----~~~~~~t~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (271)
T 3kmu_A          165 ----SPGRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSNMEIGMKVALEGLRPTIPPGISPHV  240 (271)
T ss_dssp             ----CTTCBSCGGGSCHHHHHSCGGGSCHHHHHHHHHHHHHHHHHHCSCTTTTSCHHHHHHHHHHSCCCCCCCTTCCHHH
T ss_pred             ----ccCccCCccccChhhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCccccChHHHHHHHHhcCCCCCCCCCCCHHH
Confidence                23456899999999998766554   79999999999999999999999999888888888888889999999999


Q ss_pred             HHHHHHHhhhcCCCCCCHHHHHHHHHHHH
Q 015868          343 AELLERCWQHDPTQRPNFSQITDILKQMM  371 (399)
Q Consensus       343 ~~ll~~cl~~dP~~Rps~~ell~~L~~l~  371 (399)
                      .+++.+||+.||++|||+.++++.|+++.
T Consensus       241 ~~li~~~l~~~p~~Rps~~~il~~L~~l~  269 (271)
T 3kmu_A          241 SKLMKICMNEDPAKRPKFDMIVPILEKMQ  269 (271)
T ss_dssp             HHHHHHHTCSSGGGSCCHHHHHHHHHHHC
T ss_pred             HHHHHHHcCCChhhCcCHHHHHHHHHHhh
Confidence            99999999999999999999999999874

>3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A*

Probab=100.00  E-value=1.2e-49  Score=391.10  Aligned_cols=263  Identities=32%  Similarity=0.618  Sum_probs=233.6

Q ss_pred             CceeecccccceeceeceeCceEEEEEEE--CCeeEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCceeeEEeEEecCC
Q 015868          109 DVWEIDAKQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPP  186 (399)
Q Consensus       109 ~~~~i~~~~~~i~~~lg~G~~g~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~nIv~~~~~~~~~~  186 (399)
                      +.|.++.++|++.++||+|+||.||+|++  .++.||||+++.. ...+....+.+|+.+|++++||||+++++++....
T Consensus       107 ~~~~~~~~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~  185 (377)
T 3cbl_A          107 DKWVLNHEDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRET-LPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQ  185 (377)
T ss_dssp             CTTBCCGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEECCTT-SCHHHHTTTTHHHHHHTTCCCTTBCCEEEEECSSS
T ss_pred             cccEEchHHeEEeeEeccCCCCeEEEEEEecCCeEEEEEEcccc-CCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEecCC
Confidence            56899999999999999999999999998  4789999999854 34556678999999999999999999999999999


Q ss_pred             cEEEEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceeecCCCcEEEeeccceeeccC
Q 015868          187 NLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQ  266 (399)
Q Consensus       187 ~~~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~giiHrDlkp~NILl~~~~~vkl~DFG~a~~~~~  266 (399)
                      ..++||||+++|+|.+++......+++..++.++.|++.||+|||++||+||||||+|||++.++.+||+|||+++....
T Consensus       186 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nil~~~~~~~kl~DfG~s~~~~~  265 (377)
T 3cbl_A          186 PIYIVMELVQGGDFLTFLRTEGARLRVKTLLQMVGDAAAGMEYLESKCCIHRDLAARNCLVTEKNVLKISDFGMSREEAD  265 (377)
T ss_dssp             SCEEEEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCGGGCEECTT
T ss_pred             CcEEEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcCCcccCHHHEEEcCCCcEEECcCCCceecCC
Confidence            99999999999999999987767799999999999999999999999999999999999999999999999999986443


Q ss_pred             CCcc---ccCCCCcccccccccCCCCCCChhhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHHhccCCCCCCCCCcHHH
Q 015868          267 SGVM---TAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLT-GELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRL  342 (399)
Q Consensus       267 ~~~~---~~~~gt~~y~aPE~l~~~~~~~~~Dv~slG~vl~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  342 (399)
                      ....   ....++..|+|||.+.+..++.++||||||+++|||++ |..||.+.+..+... .+....++..|..+++++
T Consensus       266 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~t~g~~p~~~~~~~~~~~-~~~~~~~~~~~~~~~~~l  344 (377)
T 3cbl_A          266 GVYAASGGLRQVPVKWTAPEALNYGRYSSESDVWSFGILLWETFSLGASPYPNLSNQQTRE-FVEKGGRLPCPELCPDAV  344 (377)
T ss_dssp             SEEECCSSCCEEEGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCSSTTSCHHHHHH-HHHTTCCCCCCTTCCHHH
T ss_pred             CceeecCCCCCCCcCcCCHhHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHH-HHHcCCCCCCCCCCCHHH
Confidence            3211   11234678999999998889999999999999999998 999999988776544 445566777888899999


Q ss_pred             HHHHHHHhhhcCCCCCCHHHHHHHHHHHHHH
Q 015868          343 AELLERCWQHDPTQRPNFSQITDILKQMMKE  373 (399)
Q Consensus       343 ~~ll~~cl~~dP~~Rps~~ell~~L~~l~~~  373 (399)
                      .++|.+||+.||++|||+.++++.|+++.+.
T Consensus       345 ~~li~~cl~~dP~~Rps~~~i~~~L~~i~~~  375 (377)
T 3cbl_A          345 FRLMEQCWAYEPGQRPSFSTIYQELQSIRKR  375 (377)
T ss_dssp             HHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             HHHHHHHcCCCchhCcCHHHHHHHHHHHHhh
Confidence            9999999999999999999999999998653

>3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens}

Probab=100.00  E-value=4.2e-49  Score=379.63  Aligned_cols=262  Identities=35%  Similarity=0.610  Sum_probs=230.9

Q ss_pred             ceeecccccceeceeceeCceEEEEEEEC-----CeeEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCceeeEEeEEec
Q 015868          110 VWEIDAKQLKIECKVASGSYGDLYKGTYC-----SQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTR  184 (399)
Q Consensus       110 ~~~i~~~~~~i~~~lg~G~~g~Vy~~~~~-----~~~vAvK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~nIv~~~~~~~~  184 (399)
                      ..++..++|++.+.||+|+||.||+|++.     +..||||+++... .....+.+.+|+.++++++||||+++++++..
T Consensus        43 ~~~~~~~~y~i~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~  121 (325)
T 3kul_A           43 TREIEASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGY-TERQRRDFLSEASIMGQFDHPNIIRLEGVVTR  121 (325)
T ss_dssp             CCBCCGGGEEEEEEEEETTTEEEEEEEECCTTSCCEEEEEEEECTTC-CHHHHHHHHHHHHHHTTCCCTTBCCEEEEECG
T ss_pred             ccccChhHeEEeeEEEeCCCcEEEEEEEecCCCCCceEEEEecCCCC-CHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEe
Confidence            35788899999999999999999999873     3469999998653 45566789999999999999999999999999


Q ss_pred             CCcEEEEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceeecCCCcEEEeeccceeec
Q 015868          185 PPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQ  264 (399)
Q Consensus       185 ~~~~~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~giiHrDlkp~NILl~~~~~vkl~DFG~a~~~  264 (399)
                      +...++||||++|++|.+++....+.+++..++.++.|++.||.|||++||+||||||+|||++.++.+||+|||+++..
T Consensus       122 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~  201 (325)
T 3kul_A          122 GRLAMIVTEYMENGSLDTFLRTHDGQFTIMQLVGMLRGVGAGMRYLSDLGYVHRDLAARNVLVDSNLVCKVSDFGLSRVL  201 (325)
T ss_dssp             GGCCEEEEECCTTCBHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCSSCEEC
T ss_pred             CCccEEEeeCCCCCcHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCcceEEECCCCCEEECCCCccccc
Confidence            99999999999999999999877788999999999999999999999999999999999999999999999999999875


Q ss_pred             cCCC----ccccCCCCcccccccccCCCCCCChhhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHHhccCCCCCCCCCc
Q 015868          265 AQSG----VMTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLT-GELPYAGLTPLQAAVGVVQKSLRPTIPKHAH  339 (399)
Q Consensus       265 ~~~~----~~~~~~gt~~y~aPE~l~~~~~~~~~Dv~slG~vl~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~  339 (399)
                      ....    ......+|+.|+|||++.+..++.++||||||+++|+|++ |..||...+..+....+. ...++..+..++
T Consensus       202 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~  280 (325)
T 3kul_A          202 EDDPDAAYTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERPYWNMTNRDVISSVE-EGYRLPAPMGCP  280 (325)
T ss_dssp             C----CCEECC---CCGGGSCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTSCHHHHHHHHH-TTCCCCCCTTCC
T ss_pred             ccCccceeeccCCCCcccccCHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHH-cCCCCCCCCCcC
Confidence            5432    1223346778999999998899999999999999999999 999999988877665544 456677788899


Q ss_pred             HHHHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHH
Q 015868          340 PRLAELLERCWQHDPTQRPNFSQITDILKQMMKE  373 (399)
Q Consensus       340 ~~l~~ll~~cl~~dP~~Rps~~ell~~L~~l~~~  373 (399)
                      +++.+++.+||+.||.+|||+.++++.|+.+++.
T Consensus       281 ~~l~~li~~~l~~dp~~Rps~~eil~~L~~l~~~  314 (325)
T 3kul_A          281 HALHQLMLDCWHKDRAQRPRFSQIVSVLDALIRS  314 (325)
T ss_dssp             HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHS
T ss_pred             HHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhC
Confidence            9999999999999999999999999999998753

>3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A

Probab=100.00  E-value=1.1e-48  Score=368.00  Aligned_cols=262  Identities=31%  Similarity=0.640  Sum_probs=230.1

Q ss_pred             CCceeecccccceeceeceeCceEEEEEEEC-CeeEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCceeeEEeEEecCC
Q 015868          108 TDVWEIDAKQLKIECKVASGSYGDLYKGTYC-SQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPP  186 (399)
Q Consensus       108 ~~~~~i~~~~~~i~~~lg~G~~g~Vy~~~~~-~~~vAvK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~nIv~~~~~~~~~~  186 (399)
                      ...|+++.++|++.+.||+|+||.||++++. +..||+|+++......   +.+.+|+.++++++||||+++++++....
T Consensus        16 ~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~---~~~~~E~~~l~~l~h~~i~~~~~~~~~~~   92 (283)
T 3gen_A           16 YGSWEIDPKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSE---DEFIEEAKVMMNLSHEKLVQLYGVCTKQR   92 (283)
T ss_dssp             CCTTBCCGGGEEEEEECC---CEEEEEEEETTTEEEEEEEECTTSBCH---HHHHHHHHHHHTCCCTTBCCEEEEECSSS
T ss_pred             CCCccCCHHHHHhHhhcCCCCCceEEEEEEcCCCeEEEEEecCCCCCH---HHHHHHHHHHhcCCCCCEeeEEEEEecCC
Confidence            4668999999999999999999999999885 4589999998764443   56889999999999999999999999999


Q ss_pred             cEEEEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceeecCCCcEEEeeccceeeccC
Q 015868          187 NLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQ  266 (399)
Q Consensus       187 ~~~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~giiHrDlkp~NILl~~~~~vkl~DFG~a~~~~~  266 (399)
                      ..++||||+.+++|.+++......+++..++.++.|++.||.|||++||+||||||+||+++.++.+||+|||.++....
T Consensus        93 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~  172 (283)
T 3gen_A           93 PIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLD  172 (283)
T ss_dssp             SEEEEECCCTTCBHHHHHHCGGGCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCSGGGEEECTTSCEEECSTTGGGGBCC
T ss_pred             CeEEEEeccCCCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCccceEEEcCCCCEEEccccccccccc
Confidence            99999999999999999987667899999999999999999999999999999999999999999999999999975543


Q ss_pred             CC--ccccCCCCcccccccccCCCCCCChhhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHHhccCCCCCCCCCcHHHH
Q 015868          267 SG--VMTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLT-GELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRLA  343 (399)
Q Consensus       267 ~~--~~~~~~gt~~y~aPE~l~~~~~~~~~Dv~slG~vl~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~  343 (399)
                      ..  ......+|+.|+|||.+.+..++.++||||||+++|+|+| |..||...+..+..... ....++..+..+++.+.
T Consensus       173 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~t~g~~p~~~~~~~~~~~~~-~~~~~~~~~~~~~~~l~  251 (283)
T 3gen_A          173 DEYTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHI-AQGLRLYRPHLASEKVY  251 (283)
T ss_dssp             HHHHSTTSTTSCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHH-HTTCCCCCCTTCCHHHH
T ss_pred             cccccccCCccCcccCCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCccccChhHHHHHH-hcccCCCCCCcCCHHHH
Confidence            22  1233456788999999998899999999999999999998 99999998887766554 44566677788999999


Q ss_pred             HHHHHHhhhcCCCCCCHHHHHHHHHHHHHH
Q 015868          344 ELLERCWQHDPTQRPNFSQITDILKQMMKE  373 (399)
Q Consensus       344 ~ll~~cl~~dP~~Rps~~ell~~L~~l~~~  373 (399)
                      +++.+||+.||.+|||+.++++.|.+++.+
T Consensus       252 ~li~~~l~~~p~~Rps~~~ll~~L~~~~~~  281 (283)
T 3gen_A          252 TIMYSCWHEKADERPTFKILLSNILDVMDE  281 (283)
T ss_dssp             HHHHHTTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             HHHHHHccCChhHCcCHHHHHHHHHHHhhc
Confidence            999999999999999999999999999864

>3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ...

Probab=100.00  E-value=3.7e-49  Score=373.83  Aligned_cols=263  Identities=28%  Similarity=0.536  Sum_probs=222.4

Q ss_pred             ceeecccccceeceeceeCceEEEEEEE------CCeeEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCceeeEEeEEe
Q 015868          110 VWEIDAKQLKIECKVASGSYGDLYKGTY------CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACT  183 (399)
Q Consensus       110 ~~~i~~~~~~i~~~lg~G~~g~Vy~~~~------~~~~vAvK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~nIv~~~~~~~  183 (399)
                      ..++..++|++.++||+|+||.||+|++      .++.||+|+++..  .....+.+.+|+.++++++||||+++++++.
T Consensus         4 ~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~   81 (295)
T 3ugc_A            4 PTQFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHS--TEEHLRDFEREIEILKSLQHDNIVKYKGVCY   81 (295)
T ss_dssp             --CCCGGGEEEEEEEEECSSEEEEEEEECTTCSSCCEEEEEEEESCC--CHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC
T ss_pred             cCcCCHHHhhhhheeeccCCEEEEEEEEecccCCCCcEEEEEEcccC--CHHHHHHHHHHHHHHHhCCCCCEeeEEEEEe
Confidence            3467789999999999999999999985      5789999999865  5666788999999999999999999999985


Q ss_pred             c--CCcEEEEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceeecCCCcEEEeeccce
Q 015868          184 R--PPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVA  261 (399)
Q Consensus       184 ~--~~~~~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~giiHrDlkp~NILl~~~~~vkl~DFG~a  261 (399)
                      .  ...+++||||+++++|.+++......+++..++.++.|++.||.|||++||+||||||+||+++.++.+||+|||++
T Consensus        82 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~~~~~~kl~Dfg~~  161 (295)
T 3ugc_A           82 SAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLT  161 (295)
T ss_dssp             HHHHTSCEEEEECCTTCBHHHHHHHCGGGCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECCCCSC
T ss_pred             cCCCCceEEEEEeCCCCCHHHHHHhcccccCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHhhEEEcCCCeEEEccCccc
Confidence            4  35689999999999999999887777999999999999999999999999999999999999999999999999999


Q ss_pred             eeccCCC----ccccCCCCcccccccccCCCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHH---------------HHH
Q 015868          262 RVQAQSG----VMTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPYAGLTPL---------------QAA  322 (399)
Q Consensus       262 ~~~~~~~----~~~~~~gt~~y~aPE~l~~~~~~~~~Dv~slG~vl~elltg~~P~~~~~~~---------------~~~  322 (399)
                      +......    ......++..|+|||.+.+..++.++||||||+++|+|+||..||......               ...
T Consensus       162 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~  241 (295)
T 3ugc_A          162 KVLPQDKEFFKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHL  241 (295)
T ss_dssp             C-------------CTTCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTTCTTCSHHHHHHHHHCTTCCTHHHHHHH
T ss_pred             ccccCCcceeeeccCCCCccceeCcHHhcCCCCChHHHHHHHHHHHHHHHhcccccCCChHHHHhhhcCccccchhHHHH
Confidence            8654432    223345677899999999999999999999999999999999998653221               112


Q ss_pred             HHHHhccCCCCCCCCCcHHHHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHH
Q 015868          323 VGVVQKSLRPTIPKHAHPRLAELLERCWQHDPTQRPNFSQITDILKQMMKEV  374 (399)
Q Consensus       323 ~~~~~~~~~~~~~~~~~~~l~~ll~~cl~~dP~~Rps~~ell~~L~~l~~~~  374 (399)
                      ........++..+..+++++.+++.+||+.||++|||+.|+++.|+++.+.+
T Consensus       242 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~el~~~L~~l~~~l  293 (295)
T 3ugc_A          242 IELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRDNM  293 (295)
T ss_dssp             HHHHHTTCCCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHC-
T ss_pred             HHHHhccCcCCCCcCcCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHHhc
Confidence            2334445567778889999999999999999999999999999999997654

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A*

Probab=100.00  E-value=5.6e-49  Score=382.55  Aligned_cols=266  Identities=31%  Similarity=0.621  Sum_probs=234.0

Q ss_pred             CCceeecccccceeceeceeCceEEEEEEEC-------CeeEEEEEecCCCCCHHHHHHHHHHHHHHHhc-CCCceeeEE
Q 015868          108 TDVWEIDAKQLKIECKVASGSYGDLYKGTYC-------SQEVAIKVLKPECVNTEMLKEFSQEVYIMRKI-RHKNVVQFI  179 (399)
Q Consensus       108 ~~~~~i~~~~~~i~~~lg~G~~g~Vy~~~~~-------~~~vAvK~~~~~~~~~~~~~~~~~Ei~~l~~l-~h~nIv~~~  179 (399)
                      ...|++..++|++.++||+|+||.||+|++.       ++.||||+++... .....+.+.+|+.+++++ +||||++++
T Consensus        14 ~~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~~hpniv~~~   92 (359)
T 3vhe_A           14 ASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA-THSEHRALMSELKILIHIGHHLNVVNLL   92 (359)
T ss_dssp             HHHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTC-CHHHHHHHHHHHHHHHHHCCCTTBCCEE
T ss_pred             cccccccccceeeceeecCCCCceEEEEEeccccccccceEEEEEEecCcC-CHHHHHHHHHHHHHHHhhcCCcceeeee
Confidence            4678999999999999999999999999852       3789999998653 455567899999999999 789999999


Q ss_pred             eEEecCCc-EEEEEecCCCCCHHHHHHhcCC-------------------------------------------------
Q 015868          180 GACTRPPN-LCIVTEFMARGSIYDFLHKQKG-------------------------------------------------  209 (399)
Q Consensus       180 ~~~~~~~~-~~lV~E~~~ggsL~~~l~~~~~-------------------------------------------------  209 (399)
                      +++..... +++||||+++|+|.+++.....                                                 
T Consensus        93 ~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  172 (359)
T 3vhe_A           93 GACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEKS  172 (359)
T ss_dssp             EEECSTTSCCEEEEECCTTEEHHHHHHTTTTSBCSCC-------------------------------------------
T ss_pred             eeeecCCCceEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCccccccccccccccc
Confidence            99987654 8999999999999999976432                                                 


Q ss_pred             ----------------CCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceeecCCCcEEEeeccceeeccCCC---cc
Q 015868          210 ----------------VFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSG---VM  270 (399)
Q Consensus       210 ----------------~l~~~~~~~i~~~i~~~L~~LH~~giiHrDlkp~NILl~~~~~vkl~DFG~a~~~~~~~---~~  270 (399)
                                      .+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+++......   ..
T Consensus       173 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~  252 (359)
T 3vhe_A          173 LSDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRK  252 (359)
T ss_dssp             -----------CTTTTCBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCGGGSCTTSCTTCEEC
T ss_pred             cchhhhcccccchhccccCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEEcCCCcEEEEeccceeeecccccchhc
Confidence                            18899999999999999999999999999999999999999999999999998654332   22


Q ss_pred             ccCCCCcccccccccCCCCCCChhhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHHhccCCCCCCCCCcHHHHHHHHHH
Q 015868          271 TAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLT-GELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRLAELLERC  349 (399)
Q Consensus       271 ~~~~gt~~y~aPE~l~~~~~~~~~Dv~slG~vl~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~c  349 (399)
                      ....||+.|+|||++.+..++.++||||||+++|+|+| |..||.+....+...........+..+..+++++.+++.+|
T Consensus       253 ~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~  332 (359)
T 3vhe_A          253 GDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDC  332 (359)
T ss_dssp             --CEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHHHHHHHHHTCCCCCCTTCCHHHHHHHHHH
T ss_pred             cccCCCceeEChhhhcCCCCCchhhhhhHHHHHHHHHhcCCCCCCccchhHHHHHHHHcCCCCCCCCCCCHHHHHHHHHH
Confidence            33457889999999999999999999999999999998 99999988877777777777778888889999999999999


Q ss_pred             hhhcCCCCCCHHHHHHHHHHHHHHH
Q 015868          350 WQHDPTQRPNFSQITDILKQMMKEV  374 (399)
Q Consensus       350 l~~dP~~Rps~~ell~~L~~l~~~~  374 (399)
                      |+.||.+|||+.|+++.|+++++..
T Consensus       333 l~~dP~~Rps~~ell~~L~~~~~~~  357 (359)
T 3vhe_A          333 WHGEPSQRPTFSELVEHLGNLLQAN  357 (359)
T ss_dssp             TCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred             ccCChhhCCCHHHHHHHHHHHHHHh
Confidence            9999999999999999999998643

>1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A

Probab=100.00  E-value=1.3e-48  Score=392.73  Aligned_cols=257  Identities=34%  Similarity=0.680  Sum_probs=228.3

Q ss_pred             CceeecccccceeceeceeCceEEEEEEECCeeEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCceeeEEeEEecCC-c
Q 015868          109 DVWEIDAKQLKIECKVASGSYGDLYKGTYCSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPP-N  187 (399)
Q Consensus       109 ~~~~i~~~~~~i~~~lg~G~~g~Vy~~~~~~~~vAvK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~nIv~~~~~~~~~~-~  187 (399)
                      ..|+++.++|++.++||+|+||.||+|++.++.||||+++...    ..+.|.+|+.+|++++||||+++++++.... .
T Consensus       186 ~~~~i~~~~~~~~~~lG~G~fg~V~~~~~~~~~vavK~~~~~~----~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~  261 (450)
T 1k9a_A          186 SGWALNMKELKLLQTIGKGEFGDVMLGDYRGNKVAVKCIKNDA----TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGG  261 (450)
T ss_dssp             TTCBCCGGGEEEEEEEEECSSEEEEEEEETTEEEEEEEESSCT----TSHHHHHHHHHHHTCCCTTBCCEEEEEECTTSC
T ss_pred             cccccChHHeEEEeeecCcCCeeEEEEEecCCeEEEEEeCCch----HHHHHHHHHHHHHhccCCCEEEEEEEEEcCCCc
Confidence            4589999999999999999999999999999999999998653    3467899999999999999999999987665 7


Q ss_pred             EEEEEecCCCCCHHHHHHhcCC-CCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceeecCCCcEEEeeccceeeccC
Q 015868          188 LCIVTEFMARGSIYDFLHKQKG-VFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQ  266 (399)
Q Consensus       188 ~~lV~E~~~ggsL~~~l~~~~~-~l~~~~~~~i~~~i~~~L~~LH~~giiHrDlkp~NILl~~~~~vkl~DFG~a~~~~~  266 (399)
                      +++||||+++|+|.+++..... .+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+++....
T Consensus       262 ~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~  341 (450)
T 1k9a_A          262 LYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASS  341 (450)
T ss_dssp             EEEEEECCTTCBHHHHHHHHCTTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTSCEEECCCTTCEECC-
T ss_pred             eEEEEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHhhEEECCCCCEEEeeCCCcccccc
Confidence            9999999999999999987544 479999999999999999999999999999999999999999999999999985433


Q ss_pred             CCccccCCCCcccccccccCCCCCCChhhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHHhccCCCCCCCCCcHHHHHH
Q 015868          267 SGVMTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLT-GELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRLAEL  345 (399)
Q Consensus       267 ~~~~~~~~gt~~y~aPE~l~~~~~~~~~Dv~slG~vl~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l  345 (399)
                      .  .....++..|+|||.+.+..++.++||||||+++|||++ |..||...+..+.... +..+.++..|..+++++.++
T Consensus       342 ~--~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~~~~~-i~~~~~~~~p~~~~~~l~~l  418 (450)
T 1k9a_A          342 T--QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPR-VEKGYKMDAPDGCPPAVYDV  418 (450)
T ss_dssp             -------CCCTTTSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTTCCSSTTSCTTTHHHH-HHTTCCCCCCTTCCHHHHHH
T ss_pred             c--ccCCCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHH-HHcCCCCCCCCcCCHHHHHH
Confidence            2  223367889999999999999999999999999999998 9999998877665544 45567778889999999999


Q ss_pred             HHHHhhhcCCCCCCHHHHHHHHHHHHH
Q 015868          346 LERCWQHDPTQRPNFSQITDILKQMMK  372 (399)
Q Consensus       346 l~~cl~~dP~~Rps~~ell~~L~~l~~  372 (399)
                      |.+||+.||.+|||+.++++.|+++..
T Consensus       419 i~~cl~~dp~~Rpt~~~l~~~L~~i~~  445 (450)
T 1k9a_A          419 MKNCWHLDAATRPTFLQLREQLEHIRT  445 (450)
T ss_dssp             HHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             HHHHcCCChhHCcCHHHHHHHHHHHHH
Confidence            999999999999999999999998864

>3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens}

Probab=100.00  E-value=5.8e-49  Score=375.25  Aligned_cols=264  Identities=31%  Similarity=0.505  Sum_probs=225.8

Q ss_pred             eeecccccceeceeceeCceEEEEEEE--CCeeEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCceeeEEeEEecCCcE
Q 015868          111 WEIDAKQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNL  188 (399)
Q Consensus       111 ~~i~~~~~~i~~~lg~G~~g~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~nIv~~~~~~~~~~~~  188 (399)
                      +.+..++|++.+.||+|+||.||+|++  +++.||+|++...  +....+.+.+|+.++++++||||+++++++..+...
T Consensus         5 ~~~~~~~~~~~~~lG~G~~g~V~~~~~~~~~~~va~K~~~~~--~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~   82 (310)
T 3s95_A            5 RIFRPSDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRF--DEETQRTFLKEVKVMRCLEHPNVLKFIGVLYKDKRL   82 (310)
T ss_dssp             EEECGGGEEEEEEEECCSSEEEEEEEETTTCCEEEEEEESCC--CHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEE
T ss_pred             eeeChhHeeccceecCCCCEEEEEEEECCCCcEEEEEEeccC--CHHHHHHHHHHHHHHHhCCCcCcccEEEEEecCCee
Confidence            356778999999999999999999998  4789999998654  567778999999999999999999999999999999


Q ss_pred             EEEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceeecCCCcEEEeeccceeeccCCC
Q 015868          189 CIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSG  268 (399)
Q Consensus       189 ~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~giiHrDlkp~NILl~~~~~vkl~DFG~a~~~~~~~  268 (399)
                      ++||||+++++|.+++......+++..++.++.|++.||+|||++||+||||||+||+++.++.+||+|||+++......
T Consensus        83 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~  162 (310)
T 3s95_A           83 NFITEYIKGGTLRGIIKSMDSQYPWSQRVSFAKDIASGMAYLHSMNIIHRDLNSHNCLVRENKNVVVADFGLARLMVDEK  162 (310)
T ss_dssp             EEEEECCTTCBHHHHHHHCCTTSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEECTTSCEEECCCTTCEECC---
T ss_pred             EEEEEecCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCcCeEEECCCCCEEEeecccceeccccc
Confidence            99999999999999998877889999999999999999999999999999999999999999999999999998654332


Q ss_pred             cc---------------ccCCCCcccccccccCCCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHH-HHhccCCC
Q 015868          269 VM---------------TAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVG-VVQKSLRP  332 (399)
Q Consensus       269 ~~---------------~~~~gt~~y~aPE~l~~~~~~~~~Dv~slG~vl~elltg~~P~~~~~~~~~~~~-~~~~~~~~  332 (399)
                      ..               ....||+.|+|||++.+..++.++||||||+++|+|++|..||....+...... ........
T Consensus       163 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~  242 (310)
T 3s95_A          163 TQPEGLRSLKKPDRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDFGLNVRGFLDR  242 (310)
T ss_dssp             -----------------CCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHTCCSSTTTSCBCTTSSBCHHHHHHH
T ss_pred             ccccccccccccccccccccCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHhcCCCCCcchhhhHHHHhhhhhccccc
Confidence            11               145689999999999999999999999999999999999999876432111000 00111122


Q ss_pred             CCCCCCcHHHHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHh
Q 015868          333 TIPKHAHPRLAELLERCWQHDPTQRPNFSQITDILKQMMKEVAS  376 (399)
Q Consensus       333 ~~~~~~~~~l~~ll~~cl~~dP~~Rps~~ell~~L~~l~~~~~~  376 (399)
                      ..+..+++++.+++.+||+.||++|||+.++++.|+++...+..
T Consensus       243 ~~~~~~~~~l~~li~~~l~~dP~~Rps~~~l~~~L~~l~~~~~~  286 (310)
T 3s95_A          243 YCPPNCPPSFFPITVRCCDLDPEKRPSFVKLEHWLETLRMHLAG  286 (310)
T ss_dssp             TCCTTCCTTHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHHH
T ss_pred             cCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhccC
Confidence            34567888999999999999999999999999999999887764

>3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ...

Probab=100.00  E-value=5.9e-49  Score=371.74  Aligned_cols=264  Identities=35%  Similarity=0.732  Sum_probs=217.1

Q ss_pred             CCCCceeecccccceeceeceeCceEEEEEEECCeeEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCceeeEEeEEecC
Q 015868          106 DGTDVWEIDAKQLKIECKVASGSYGDLYKGTYCSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRP  185 (399)
Q Consensus       106 ~~~~~~~i~~~~~~i~~~lg~G~~g~Vy~~~~~~~~vAvK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~nIv~~~~~~~~~  185 (399)
                      ...+.++|..++|++.++||+|+||.||+|++.+ .||+|+++.........+.+.+|+.++++++||||+++++++ ..
T Consensus        14 ~~~~~~ei~~~~y~~~~~lG~G~~g~Vy~~~~~~-~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-~~   91 (289)
T 3og7_A           14 DAADDWEIPDGQITVGQRIGSGSFGTVYKGKWHG-DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS-TA   91 (289)
T ss_dssp             ----CCBCCTTSCEEEEEEEECSSEEEEEEESSS-EEEEEEESCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEE-CS
T ss_pred             CCCCCCccCccceeeeeEecCCCCeEEEEEEEcC-ceEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCcEEEEEeec-cC
Confidence            4456789999999999999999999999998755 599999988777777888999999999999999999999965 45


Q ss_pred             CcEEEEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceeecCCCcEEEeeccceeecc
Q 015868          186 PNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQA  265 (399)
Q Consensus       186 ~~~~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~giiHrDlkp~NILl~~~~~vkl~DFG~a~~~~  265 (399)
                      +..++||||+.+++|.+++......+++..++.++.|++.||.|||++||+||||||+||+++.++.+||+|||+++...
T Consensus        92 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~  171 (289)
T 3og7_A           92 PQLAIVTQWCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYLHAKSIIHRDLKSNNIFLHEDNTVKIGDFGLATEKS  171 (289)
T ss_dssp             SSCEEEEECCCEEEHHHHHTTC---CCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEETTTEEEECCCC------
T ss_pred             CccEEEEEecCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCccceEEECCCCCEEEccceeccccc
Confidence            56899999999999999998777889999999999999999999999999999999999999999999999999997544


Q ss_pred             C---CCccccCCCCcccccccccC---CCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhccCC-C---CCC
Q 015868          266 Q---SGVMTAETGTYRWMAPEVIE---HKPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKSLR-P---TIP  335 (399)
Q Consensus       266 ~---~~~~~~~~gt~~y~aPE~l~---~~~~~~~~Dv~slG~vl~elltg~~P~~~~~~~~~~~~~~~~~~~-~---~~~  335 (399)
                      .   ........||+.|+|||.+.   +..++.++||||||+++|+|++|+.||......+.....+..... +   ..+
T Consensus       172 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  251 (289)
T 3og7_A          172 RWSGSHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIEMVGRGSLSPDLSKVR  251 (289)
T ss_dssp             ------------CCCTTCCHHHHC----CCSCHHHHHHHHHHHHHHHHHSSCTTSSCCCHHHHHHHHHHTSCCCCTTSSC
T ss_pred             cccccccccccCCCccccCchhhcccCCCCCCcccchHHHHHHHHHHHHCCCCccccchHHHHHHHhcccccCcchhhcc
Confidence            3   22234456899999999997   567889999999999999999999999887766655555444332 2   234


Q ss_pred             CCCcHHHHHHHHHHhhhcCCCCCCHHHHHHHHHHHH
Q 015868          336 KHAHPRLAELLERCWQHDPTQRPNFSQITDILKQMM  371 (399)
Q Consensus       336 ~~~~~~l~~ll~~cl~~dP~~Rps~~ell~~L~~l~  371 (399)
                      ..+++++.+++.+||+.||.+|||+.++++.|+++.
T Consensus       252 ~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~l~  287 (289)
T 3og7_A          252 SNCPKRMKRLMAECLKKKRDERPSFPRILAEIEELA  287 (289)
T ss_dssp             TTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTT
T ss_pred             ccCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHh
Confidence            578899999999999999999999999999999875

>3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens}

Probab=100.00  E-value=3.7e-48  Score=381.18  Aligned_cols=266  Identities=30%  Similarity=0.620  Sum_probs=235.8

Q ss_pred             CceeecccccceeceeceeCceEEEEEEECC---------eeEEEEEecCCCCCHHHHHHHHHHHHHHHhc-CCCceeeE
Q 015868          109 DVWEIDAKQLKIECKVASGSYGDLYKGTYCS---------QEVAIKVLKPECVNTEMLKEFSQEVYIMRKI-RHKNVVQF  178 (399)
Q Consensus       109 ~~~~i~~~~~~i~~~lg~G~~g~Vy~~~~~~---------~~vAvK~~~~~~~~~~~~~~~~~Ei~~l~~l-~h~nIv~~  178 (399)
                      ..|++..++|++.++||+|+||.||+|++.+         ..||+|+++... .....+.+.+|+.+++++ +||||+++
T Consensus        62 ~~~~i~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~~hpnIv~~  140 (382)
T 3tt0_A           62 PRWELPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDA-TEKDLSDLISEMEMMKMIGKHKNIINL  140 (382)
T ss_dssp             TTTBCCGGGEEEEEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTTC-CHHHHHHHHHHHHHHHHHCCCTTBCCE
T ss_pred             cccccchhheEeeeEEecCCCeEEEEEEEccccccccccceEEEEEeecccc-CHHHHHHHHHHHHHHHHhcCCchhhhh
Confidence            5578999999999999999999999998632         579999998653 556678899999999999 89999999


Q ss_pred             EeEEecCCcEEEEEecCCCCCHHHHHHhcC---------------CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCC
Q 015868          179 IGACTRPPNLCIVTEFMARGSIYDFLHKQK---------------GVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTA  243 (399)
Q Consensus       179 ~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~---------------~~l~~~~~~~i~~~i~~~L~~LH~~giiHrDlkp~  243 (399)
                      ++++......++||||+++|+|.+++....               ..+++..++.++.||+.||.|||++||+||||||+
T Consensus       141 ~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~  220 (382)
T 3tt0_A          141 LGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAAR  220 (382)
T ss_dssp             EEEECSSSSCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGG
T ss_pred             eeeeccCCceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCCEecCCCCcc
Confidence            999999999999999999999999998753               35899999999999999999999999999999999


Q ss_pred             ceeecCCCcEEEeeccceeeccCCC---ccccCCCCcccccccccCCCCCCChhhHHHHHHHHHHHHc-CCCCCCCCCHH
Q 015868          244 NLLMDENGVVKVADFGVARVQAQSG---VMTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLT-GELPYAGLTPL  319 (399)
Q Consensus       244 NILl~~~~~vkl~DFG~a~~~~~~~---~~~~~~gt~~y~aPE~l~~~~~~~~~Dv~slG~vl~ellt-g~~P~~~~~~~  319 (399)
                      |||++.++.+||+|||+++......   ......+|+.|+|||++.+..++.++||||||+++|+|++ |..||.+.+..
T Consensus       221 NIll~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~ellt~g~~p~~~~~~~  300 (382)
T 3tt0_A          221 NVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVE  300 (382)
T ss_dssp             GEEECTTCCEEECSCSCCCCSSCCCTTCCCTTCCCGGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHH
T ss_pred             eEEEcCCCcEEEcccCcccccccccccccccCCCCCcceeCHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCHH
Confidence            9999999999999999998654432   2334467889999999999999999999999999999999 99999988876


Q ss_pred             HHHHHHHhccCCCCCCCCCcHHHHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHh
Q 015868          320 QAAVGVVQKSLRPTIPKHAHPRLAELLERCWQHDPTQRPNFSQITDILKQMMKEVAS  376 (399)
Q Consensus       320 ~~~~~~~~~~~~~~~~~~~~~~l~~ll~~cl~~dP~~Rps~~ell~~L~~l~~~~~~  376 (399)
                      +... .+....++..+..+++++.+++.+||+.||++|||+.|+++.|++++.....
T Consensus       301 ~~~~-~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~~~~  356 (382)
T 3tt0_A          301 ELFK-LLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIVALTSN  356 (382)
T ss_dssp             HHHH-HHHTTCCCCCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHSCS
T ss_pred             HHHH-HHHcCCCCCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHHHhc
Confidence            6544 4555667778889999999999999999999999999999999999875543

>1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A*

Probab=100.00  E-value=2.8e-48  Score=370.11  Aligned_cols=265  Identities=31%  Similarity=0.636  Sum_probs=235.9

Q ss_pred             CceeecccccceeceeceeCceEEEEEEE-------CCeeEEEEEecCCCCCHHHHHHHHHHHHHHHhc-CCCceeeEEe
Q 015868          109 DVWEIDAKQLKIECKVASGSYGDLYKGTY-------CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKI-RHKNVVQFIG  180 (399)
Q Consensus       109 ~~~~i~~~~~~i~~~lg~G~~g~Vy~~~~-------~~~~vAvK~~~~~~~~~~~~~~~~~Ei~~l~~l-~h~nIv~~~~  180 (399)
                      ..|++..++|++.+.||+|+||.||+|++       .++.||+|+++... .....+.+.+|+.+++++ +||||+++++
T Consensus        16 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~~h~~i~~~~~   94 (313)
T 1t46_A           16 HKWEFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSA-HLTEREALMSELKVLSYLGNHMNIVNLLG   94 (313)
T ss_dssp             GGGBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTC-CHHHHHHHHHHHHHHHHHCCCTTBCCEEE
T ss_pred             cccccChhhhhHHHhhCccCCcceEEEEEeeccccchhhhhHHHhcCcch-hHHHHHHHHHHHHHHhhcccCCCeeeEEE
Confidence            56889999999999999999999999985       34789999998653 345567899999999999 9999999999


Q ss_pred             EEecCCcEEEEEecCCCCCHHHHHHhcCC-----------------CCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCC
Q 015868          181 ACTRPPNLCIVTEFMARGSIYDFLHKQKG-----------------VFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTA  243 (399)
Q Consensus       181 ~~~~~~~~~lV~E~~~ggsL~~~l~~~~~-----------------~l~~~~~~~i~~~i~~~L~~LH~~giiHrDlkp~  243 (399)
                      ++..++..++||||+++|+|.+++.....                 .+++..++.++.|++.||.|||++||+||||||+
T Consensus        95 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~  174 (313)
T 1t46_A           95 ACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAAR  174 (313)
T ss_dssp             EECSSSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGG
T ss_pred             EEecCCCcEEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCccc
Confidence            99999999999999999999999977543                 4899999999999999999999999999999999


Q ss_pred             ceeecCCCcEEEeeccceeeccCCCc---cccCCCCcccccccccCCCCCCChhhHHHHHHHHHHHHc-CCCCCCCCCHH
Q 015868          244 NLLMDENGVVKVADFGVARVQAQSGV---MTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLT-GELPYAGLTPL  319 (399)
Q Consensus       244 NILl~~~~~vkl~DFG~a~~~~~~~~---~~~~~gt~~y~aPE~l~~~~~~~~~Dv~slG~vl~ellt-g~~P~~~~~~~  319 (399)
                      ||+++.++.+||+|||+++.......   .....+|+.|+|||.+.+..++.++||||||+++|+|+| |..||.+....
T Consensus       175 Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~  254 (313)
T 1t46_A          175 NILLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVD  254 (313)
T ss_dssp             GEEEETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSS
T ss_pred             eEEEcCCCCEEEccccccccccccccceeccCCCCcceeeChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCCcccch
Confidence            99999999999999999986554332   223346788999999999999999999999999999999 99999988776


Q ss_pred             HHHHHHHhccCCCCCCCCCcHHHHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHH
Q 015868          320 QAAVGVVQKSLRPTIPKHAHPRLAELLERCWQHDPTQRPNFSQITDILKQMMKEV  374 (399)
Q Consensus       320 ~~~~~~~~~~~~~~~~~~~~~~l~~ll~~cl~~dP~~Rps~~ell~~L~~l~~~~  374 (399)
                      ...........++..+..+++++.+++.+||+.||.+|||+.|+++.|++++.+.
T Consensus       255 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~  309 (313)
T 1t46_A          255 SKFYKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQISES  309 (313)
T ss_dssp             HHHHHHHHHTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHT
T ss_pred             hHHHHHhccCCCCCCcccCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHHHh
Confidence            6666667777777778889999999999999999999999999999999998754

>1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A*

Probab=100.00  E-value=2.4e-48  Score=365.86  Aligned_cols=264  Identities=30%  Similarity=0.593  Sum_probs=220.5

Q ss_pred             CceeecccccceeceeceeCceEEEEEEEC-----CeeEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCceeeEEeEEe
Q 015868          109 DVWEIDAKQLKIECKVASGSYGDLYKGTYC-----SQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACT  183 (399)
Q Consensus       109 ~~~~i~~~~~~i~~~lg~G~~g~Vy~~~~~-----~~~vAvK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~nIv~~~~~~~  183 (399)
                      ..+++..++|++.+.||+|+||.||+|.+.     +..||+|+++... .....+.+.+|+.++++++||||+++++++.
T Consensus         8 ~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~   86 (281)
T 1mp8_A            8 RDYEIQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCT-SDSVREKFLQEALTMRQFDHPHIVKLIGVIT   86 (281)
T ss_dssp             -CCBCCGGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTT-SHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC
T ss_pred             cceEEehHHeEEEeEeeecCCeeEEEEEEecCCCCceEEEEEeccccC-CHHHHHHHHHHHHHHHhCCCCccceEEEEEc
Confidence            347888999999999999999999999874     3469999987643 4556678999999999999999999999985


Q ss_pred             cCCcEEEEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceeecCCCcEEEeeccceee
Q 015868          184 RPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARV  263 (399)
Q Consensus       184 ~~~~~~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~giiHrDlkp~NILl~~~~~vkl~DFG~a~~  263 (399)
                      . +..++||||+++++|.+++......+++..++.++.|++.||.|||++||+||||||+||+++.++.+||+|||+++.
T Consensus        87 ~-~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~  165 (281)
T 1mp8_A           87 E-NPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRY  165 (281)
T ss_dssp             S-SSCEEEEECCTTEEHHHHHHHTTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECC------
T ss_pred             c-CccEEEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccccHHHEEECCCCCEEECccccccc
Confidence            4 568999999999999999988777899999999999999999999999999999999999999999999999999986


Q ss_pred             ccCCCc--cccCCCCcccccccccCCCCCCChhhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHHhccCCCCCCCCCcH
Q 015868          264 QAQSGV--MTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLT-GELPYAGLTPLQAAVGVVQKSLRPTIPKHAHP  340 (399)
Q Consensus       264 ~~~~~~--~~~~~gt~~y~aPE~l~~~~~~~~~Dv~slG~vl~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~  340 (399)
                      ......  .....+++.|+|||++.+..++.++||||||+++|+|++ |..||.+.+..+....+ ....++..+..+++
T Consensus       166 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~pf~~~~~~~~~~~i-~~~~~~~~~~~~~~  244 (281)
T 1mp8_A          166 MEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRI-ENGERLPMPPNCPP  244 (281)
T ss_dssp             -------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHH-HTTCCCCCCTTCCH
T ss_pred             cCcccccccccCCCcccccChhhcccCCCCCccCchHHHHHHHHHHhcCCCCCCcCCHHHHHHHH-HcCCCCCCCCCCCH
Confidence            554332  233456789999999998899999999999999999997 99999988776655443 34556677888999


Q ss_pred             HHHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHH
Q 015868          341 RLAELLERCWQHDPTQRPNFSQITDILKQMMKEVA  375 (399)
Q Consensus       341 ~l~~ll~~cl~~dP~~Rps~~ell~~L~~l~~~~~  375 (399)
                      ++.+++.+||+.||++|||+.++++.|++++.+..
T Consensus       245 ~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~~~  279 (281)
T 1mp8_A          245 TLYSLMTKCWAYDPSRRPRFTELKAQLSTILEEEK  279 (281)
T ss_dssp             HHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHH
T ss_pred             HHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHhc
Confidence            99999999999999999999999999999987653

>3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0

Probab=100.00  E-value=1.8e-48  Score=364.18  Aligned_cols=256  Identities=37%  Similarity=0.727  Sum_probs=218.1

Q ss_pred             eecccccceeceeceeCceEEEEEEECCeeEEEEEecCCCCC--HHHHHHHHHHHHHHHhcCCCceeeEEeEEecCCcEE
Q 015868          112 EIDAKQLKIECKVASGSYGDLYKGTYCSQEVAIKVLKPECVN--TEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLC  189 (399)
Q Consensus       112 ~i~~~~~~i~~~lg~G~~g~Vy~~~~~~~~vAvK~~~~~~~~--~~~~~~~~~Ei~~l~~l~h~nIv~~~~~~~~~~~~~  189 (399)
                      +++.++|++.+.||+|+||.||+|.+.++.||+|+++.....  ....+.+.+|+.+++.++||||+++++++..++..+
T Consensus         3 ~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~   82 (271)
T 3dtc_A            3 EIDFAELTLEEIIGIGGFGKVYRAFWIGDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGVCLKEPNLC   82 (271)
T ss_dssp             BCCTTSEEEEEEEEEETTEEEEEEEETTEEEEEEEC----------CHHHHHHHHHHHHHCCCTTBCCEEEEECCC--CE
T ss_pred             ccchhheeeeeeeccCCCeEEEEEEEcCCeEEEEEEecCCcccHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCCceE
Confidence            567889999999999999999999999999999998754322  233567899999999999999999999999999999


Q ss_pred             EEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCCCceeecC--------CCcEEEeec
Q 015868          190 IVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNN---IIHRDLKTANLLMDE--------NGVVKVADF  258 (399)
Q Consensus       190 lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~g---iiHrDlkp~NILl~~--------~~~vkl~DF  258 (399)
                      +||||+++++|.+++.  ...+++..++.++.|++.||.|||++|   |+||||||+||+++.        ++.+||+||
T Consensus        83 lv~e~~~~~~L~~~~~--~~~~~~~~~~~i~~~l~~~l~~lH~~~~~~i~H~dikp~Nil~~~~~~~~~~~~~~~kl~Df  160 (271)
T 3dtc_A           83 LVMEFARGGPLNRVLS--GKRIPPDILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDF  160 (271)
T ss_dssp             EEEECCTTEEHHHHHT--SSCCCHHHHHHHHHHHHHHHHHHHHSSSSCCCCSCCSGGGEEESSCCSSSCCSSCCEEECCC
T ss_pred             EEEEcCCCCCHHHHhh--cCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCchHHEEEecccccccccCcceEEccC
Confidence            9999999999999985  457899999999999999999999999   999999999999986        778999999


Q ss_pred             cceeeccCCCccccCCCCcccccccccCCCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhccCCCCCCCCC
Q 015868          259 GVARVQAQSGVMTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKSLRPTIPKHA  338 (399)
Q Consensus       259 G~a~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~Dv~slG~vl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~  338 (399)
                      |.++...... .....||+.|+|||.+.+..++.++||||||+++|+|++|+.||.+.+..............+..+..+
T Consensus       161 g~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (271)
T 3dtc_A          161 GLAREWHRTT-KMSAAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGIDGLAVAYGVAMNKLALPIPSTC  239 (271)
T ss_dssp             CC--------------CCGGGSCHHHHHHCCCSHHHHHHHHHHHHHHHHHCCCTTTTSCHHHHHHHHHTSCCCCCCCTTC
T ss_pred             Cccccccccc-ccCCCCccceeCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHhhhcCCCCCCCCccc
Confidence            9997654432 334578999999999999999999999999999999999999999999888887777777778888999


Q ss_pred             cHHHHHHHHHHhhhcCCCCCCHHHHHHHHHHH
Q 015868          339 HPRLAELLERCWQHDPTQRPNFSQITDILKQM  370 (399)
Q Consensus       339 ~~~l~~ll~~cl~~dP~~Rps~~ell~~L~~l  370 (399)
                      ++++.+++.+||+.||.+|||+.|+++.|+++
T Consensus       240 ~~~~~~li~~~l~~~p~~Rps~~e~l~~L~~l  271 (271)
T 3dtc_A          240 PEPFAKLMEDCWNPDPHSRPSFTNILDQLTTI  271 (271)
T ss_dssp             CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHC-
T ss_pred             CHHHHHHHHHHhcCCcccCcCHHHHHHHHhcC
Confidence            99999999999999999999999999998754

>3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A*

Probab=100.00  E-value=3.6e-48  Score=361.74  Aligned_cols=258  Identities=30%  Similarity=0.582  Sum_probs=228.8

Q ss_pred             ceeecccccceeceeceeCceEEEEEEECC-eeEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCceeeEEeEEecCCcE
Q 015868          110 VWEIDAKQLKIECKVASGSYGDLYKGTYCS-QEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNL  188 (399)
Q Consensus       110 ~~~i~~~~~~i~~~lg~G~~g~Vy~~~~~~-~~vAvK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~nIv~~~~~~~~~~~~  188 (399)
                      .+++..++|++.+.||+|+||.||+|++.+ ..||+|+++......   +.+.+|+.++++++||||+++++++......
T Consensus         2 ~~~l~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~---~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~   78 (268)
T 3sxs_A            2 HMELKREEITLLKELGSGQFGVVKLGKWKGQYDVAVKMIKEGSMSE---DEFFQEAQTMMKLSHPKLVKFYGVCSKEYPI   78 (268)
T ss_dssp             TTBCCGGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECBTTBCH---HHHHHHHHHHHHCCCTTBCCEEEEECSSSSE
T ss_pred             ceEechhheeeeeeeccCCCceEEEEEecCceeEEEEEeccCCCcH---HHHHHHHHHHHhCCCCCEeeEEEEEccCCce
Confidence            357888999999999999999999998854 579999998764433   5688999999999999999999999999999


Q ss_pred             EEEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceeecCCCcEEEeeccceeeccCCC
Q 015868          189 CIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSG  268 (399)
Q Consensus       189 ~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~giiHrDlkp~NILl~~~~~vkl~DFG~a~~~~~~~  268 (399)
                      ++||||+++++|.+++......+++..++.++.|++.||.|||++||+||||||+||+++.++.+||+|||.++......
T Consensus        79 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~  158 (268)
T 3sxs_A           79 YIVTEYISNGCLLNYLRSHGKGLEPSQLLEMCYDVCEGMAFLESHQFIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQ  158 (268)
T ss_dssp             EEEEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTTEEESSCSGGGEEECTTCCEEECCTTCEEECCTTC
T ss_pred             EEEEEccCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCcCcceEEECCCCCEEEccCccceecchhh
Confidence            99999999999999998876779999999999999999999999999999999999999999999999999998665443


Q ss_pred             c--cccCCCCcccccccccCCCCCCChhhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHHhccCCCCCCCCCcHHHHHH
Q 015868          269 V--MTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLT-GELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRLAEL  345 (399)
Q Consensus       269 ~--~~~~~gt~~y~aPE~l~~~~~~~~~Dv~slG~vl~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l  345 (399)
                      .  .....+|+.|+|||.+.+..++.++||||||+++|+|++ |..||...+..+...... ....+..|..+++++.++
T Consensus       159 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~~~l~~l  237 (268)
T 3sxs_A          159 YVSSVGTKFPVKWSAPEVFHYFKYSSKSDVWAFGILMWEVFSLGKMPYDLYTNSEVVLKVS-QGHRLYRPHLASDTIYQI  237 (268)
T ss_dssp             EEECCSCCCCGGGCCHHHHHHSEEETTHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHH-TTCCCCCCTTSCHHHHHH
T ss_pred             hhcccCCCcCcccCCHHHHhccCCchhhhhHHHHHHHHHHHcCCCCCccccChHHHHHHHH-cCCCCCCCCcChHHHHHH
Confidence            2  223345778999999999889999999999999999999 999999988877665544 455666777889999999


Q ss_pred             HHHHhhhcCCCCCCHHHHHHHHHHHH
Q 015868          346 LERCWQHDPTQRPNFSQITDILKQMM  371 (399)
Q Consensus       346 l~~cl~~dP~~Rps~~ell~~L~~l~  371 (399)
                      +.+||+.||.+|||+.++++.|+.+.
T Consensus       238 i~~~l~~~p~~Rps~~~ll~~L~~l~  263 (268)
T 3sxs_A          238 MYSCWHELPEKRPTFQQLLSSIEPLR  263 (268)
T ss_dssp             HHHTTCSSGGGSCCHHHHHHHHGGGC
T ss_pred             HHHHcCCChhhCcCHHHHHHHHHHhh
Confidence            99999999999999999999998774

>1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=1.5e-48  Score=377.55  Aligned_cols=266  Identities=29%  Similarity=0.576  Sum_probs=230.4

Q ss_pred             CceeecccccceeceeceeCceEEEEEEE-------CCeeEEEEEecCCCCCHHHHHHHHHHHHHHHhc-CCCceeeEEe
Q 015868          109 DVWEIDAKQLKIECKVASGSYGDLYKGTY-------CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKI-RHKNVVQFIG  180 (399)
Q Consensus       109 ~~~~i~~~~~~i~~~lg~G~~g~Vy~~~~-------~~~~vAvK~~~~~~~~~~~~~~~~~Ei~~l~~l-~h~nIv~~~~  180 (399)
                      ..|++..++|++.+.||+|+||.||+|++       .+..||+|+++... .....+.+.+|+.+++++ +||||+++++
T Consensus        38 ~~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~~hp~iv~~~~  116 (344)
T 1rjb_A           38 LKWEFPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKA-DSSEREALMSELKMMTQLGSHENIVNLLG  116 (344)
T ss_dssp             GGGBCCGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC-------CHHHHHHHHHHHHHCCCTTBCCEEE
T ss_pred             cCcccCHHHceeeeeecCCCCceeEEeeeeccccCCcceEEEEEeccccc-CHHHHHHHHHHHHHHHhhcCCCCeeeEEE
Confidence            46899999999999999999999999987       34679999998543 334457899999999999 8999999999


Q ss_pred             EEecCCcEEEEEecCCCCCHHHHHHhcCC----------------------CCCHHHHHHHHHHHHHHHHHHHHCCcccC
Q 015868          181 ACTRPPNLCIVTEFMARGSIYDFLHKQKG----------------------VFQLTSLLKVAIDVSKGMNYLHQNNIIHR  238 (399)
Q Consensus       181 ~~~~~~~~~lV~E~~~ggsL~~~l~~~~~----------------------~l~~~~~~~i~~~i~~~L~~LH~~giiHr  238 (399)
                      ++...+..++||||+++|+|.+++.....                      .+++..++.++.||+.||.|||++||+||
T Consensus       117 ~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~  196 (344)
T 1rjb_A          117 ACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHR  196 (344)
T ss_dssp             EECSSSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTTEEET
T ss_pred             EEeeCCccEEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHHhCCcccC
Confidence            99999999999999999999999976543                      37899999999999999999999999999


Q ss_pred             CCCCCceeecCCCcEEEeeccceeeccCCCc---cccCCCCcccccccccCCCCCCChhhHHHHHHHHHHHHc-CCCCCC
Q 015868          239 DLKTANLLMDENGVVKVADFGVARVQAQSGV---MTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLT-GELPYA  314 (399)
Q Consensus       239 Dlkp~NILl~~~~~vkl~DFG~a~~~~~~~~---~~~~~gt~~y~aPE~l~~~~~~~~~Dv~slG~vl~ellt-g~~P~~  314 (399)
                      ||||+||+++.++.+||+|||+++.......   .....+|+.|+|||.+.+..++.++||||||+++|+|+| |..||.
T Consensus       197 Dikp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~  276 (344)
T 1rjb_A          197 DLAARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYP  276 (344)
T ss_dssp             TCSGGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSST
T ss_pred             CCChhhEEEcCCCcEEeCCCccCcccccCccceeccCccCccCccCHHHhccCCCChhHhHHHHHHHHHHHHcCCCCCcc
Confidence            9999999999999999999999986544322   223346789999999999999999999999999999998 999999


Q ss_pred             CCCHHHHHHHHHhccCCCCCCCCCcHHHHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHH
Q 015868          315 GLTPLQAAVGVVQKSLRPTIPKHAHPRLAELLERCWQHDPTQRPNFSQITDILKQMMKEVA  375 (399)
Q Consensus       315 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~cl~~dP~~Rps~~ell~~L~~l~~~~~  375 (399)
                      +..........+.....+..+..+++++.+++.+||+.||.+|||+.++++.|+.++....
T Consensus       277 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~~~~~~  337 (344)
T 1rjb_A          277 GIPVDANFYKLIQNGFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLGCQLADAE  337 (344)
T ss_dssp             TCCCSHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC----
T ss_pred             cCCcHHHHHHHHhcCCCCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHHHHH
Confidence            8877776777777777888888999999999999999999999999999999999876543

>1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7

Probab=100.00  E-value=3.2e-48  Score=374.64  Aligned_cols=263  Identities=30%  Similarity=0.579  Sum_probs=230.0

Q ss_pred             ceeecccccceeceeceeCceEEEEEEECC-------eeEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCceeeEEeEE
Q 015868          110 VWEIDAKQLKIECKVASGSYGDLYKGTYCS-------QEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGAC  182 (399)
Q Consensus       110 ~~~i~~~~~~i~~~lg~G~~g~Vy~~~~~~-------~~vAvK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~nIv~~~~~~  182 (399)
                      .+++..++|++.+.||+|+||.||+|++.+       +.||+|+++... .....+.+.+|+.++++++||||+++++++
T Consensus        41 ~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~  119 (343)
T 1luf_A           41 SLEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEA-SADMQADFQREAALMAEFDNPNIVKLLGVC  119 (343)
T ss_dssp             HTBCCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTC-CHHHHHHHHHHHHHHHTCCCTTBCCEEEEE
T ss_pred             eeEecHHHCeeeeeeeecCCeeEEEEEecCcCCCCCceeEEEEEecccc-CHHHHHHHHHHHHHHHhCCCCCEEEEEEEE
Confidence            357788999999999999999999999854       789999998653 455677899999999999999999999999


Q ss_pred             ecCCcEEEEEecCCCCCHHHHHHhcC-----------------------CCCCHHHHHHHHHHHHHHHHHHHHCCcccCC
Q 015868          183 TRPPNLCIVTEFMARGSIYDFLHKQK-----------------------GVFQLTSLLKVAIDVSKGMNYLHQNNIIHRD  239 (399)
Q Consensus       183 ~~~~~~~lV~E~~~ggsL~~~l~~~~-----------------------~~l~~~~~~~i~~~i~~~L~~LH~~giiHrD  239 (399)
                      ......++||||+++++|.+++....                       ..+++..++.++.||+.||.|||++||+|||
T Consensus       120 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~D  199 (343)
T 1luf_A          120 AVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRD  199 (343)
T ss_dssp             CSSSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSC
T ss_pred             ccCCceEEEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCC
Confidence            99999999999999999999997642                       5789999999999999999999999999999


Q ss_pred             CCCCceeecCCCcEEEeeccceeeccCCC---ccccCCCCcccccccccCCCCCCChhhHHHHHHHHHHHHc-CCCCCCC
Q 015868          240 LKTANLLMDENGVVKVADFGVARVQAQSG---VMTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLT-GELPYAG  315 (399)
Q Consensus       240 lkp~NILl~~~~~vkl~DFG~a~~~~~~~---~~~~~~gt~~y~aPE~l~~~~~~~~~Dv~slG~vl~ellt-g~~P~~~  315 (399)
                      |||+||+++.++.+||+|||+++......   ......+|+.|+|||.+.+..++.++||||||+++|+|++ |..||.+
T Consensus       200 lkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~  279 (343)
T 1luf_A          200 LATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYG  279 (343)
T ss_dssp             CSGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTT
T ss_pred             CCcceEEECCCCeEEEeecCCCcccccCccccccCCCcccceecChhhhccCCcCcccccHHHHHHHHHHHhcCCCcCCC
Confidence            99999999999999999999997544322   2234567889999999998899999999999999999999 9999999


Q ss_pred             CCHHHHHHHHHhccCCCCCCCCCcHHHHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHH
Q 015868          316 LTPLQAAVGVVQKSLRPTIPKHAHPRLAELLERCWQHDPTQRPNFSQITDILKQMMKEV  374 (399)
Q Consensus       316 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~cl~~dP~~Rps~~ell~~L~~l~~~~  374 (399)
                      .+..+....+ .....+..+..+++++.+++.+||+.||.+|||+.++++.|+++....
T Consensus       280 ~~~~~~~~~~-~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~L~~~~~~~  337 (343)
T 1luf_A          280 MAHEEVIYYV-RDGNILACPENCPLELYNLMRLCWSKLPADRPSFCSIHRILQRMCERA  337 (343)
T ss_dssp             SCHHHHHHHH-HTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTC--
T ss_pred             CChHHHHHHH-hCCCcCCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHHHHHHhhh
Confidence            8877665544 445556778889999999999999999999999999999999886543

>1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=1.3e-47  Score=361.87  Aligned_cols=269  Identities=27%  Similarity=0.542  Sum_probs=235.4

Q ss_pred             ceeecccccceec-eeceeCceEEEEEEE----CCeeEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCceeeEEeEEec
Q 015868          110 VWEIDAKQLKIEC-KVASGSYGDLYKGTY----CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTR  184 (399)
Q Consensus       110 ~~~i~~~~~~i~~-~lg~G~~g~Vy~~~~----~~~~vAvK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~nIv~~~~~~~~  184 (399)
                      .+.+..++|.+.+ .||+|+||.||+|.+    .+..||+|+++... .....+.+.+|+.++++++||||+++++++. 
T Consensus         3 ~~~~~~~~~~i~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-   80 (287)
T 1u59_A            3 KLFLKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGT-EKADTEEMMREAQIMHQLDNPYIVRLIGVCQ-   80 (287)
T ss_dssp             CCBCCGGGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSC-CHHHHHHHHHHHHHHHHCCCTTBCCEEEEEE-
T ss_pred             cccccHHHhhhhhccccccCceeEEEeEeccCCCcceEEEEecCCcc-chhHHHHHHHHHHHHHhCCCCCEeEEEEEec-
Confidence            3667788998887 999999999999986    46789999998753 4566788999999999999999999999994 


Q ss_pred             CCcEEEEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceeecCCCcEEEeeccceeec
Q 015868          185 PPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQ  264 (399)
Q Consensus       185 ~~~~~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~giiHrDlkp~NILl~~~~~vkl~DFG~a~~~  264 (399)
                      .+..++||||+++++|.+++......+++..++.++.|++.||.|||++||+||||||+||+++.++.+||+|||+++..
T Consensus        81 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~  160 (287)
T 1u59_A           81 AEALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRDLAARNVLLVNRHYAKISDFGLSKAL  160 (287)
T ss_dssp             SSSEEEEEECCTTEEHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEEETTEEEECCCTTCEEC
T ss_pred             CCCcEEEEEeCCCCCHHHHHHhCCccCCHHHHHHHHHHHHHHHHHHHHCCEeeCCCchheEEEcCCCCEEECcccceeee
Confidence            45699999999999999999877778999999999999999999999999999999999999999999999999999876


Q ss_pred             cCCCc----cccCCCCcccccccccCCCCCCChhhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHHhccCCCCCCCCCc
Q 015868          265 AQSGV----MTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLT-GELPYAGLTPLQAAVGVVQKSLRPTIPKHAH  339 (399)
Q Consensus       265 ~~~~~----~~~~~gt~~y~aPE~l~~~~~~~~~Dv~slG~vl~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~  339 (399)
                      .....    .....+|+.|+|||.+.+..++.++||||||+++|+|++ |..||...+..+... .+....++..+..++
T Consensus       161 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~-~i~~~~~~~~~~~~~  239 (287)
T 1u59_A          161 GADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMA-FIEQGKRMECPPECP  239 (287)
T ss_dssp             TTCSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHHHHH-HHHTTCCCCCCTTCC
T ss_pred             ccCcceeeccccccccccccCHHHhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCHHHHHH-HHhcCCcCCCCCCcC
Confidence            54322    223346889999999998889999999999999999998 999999887766544 344566777888999


Q ss_pred             HHHHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHhcccCC
Q 015868          340 PRLAELLERCWQHDPTQRPNFSQITDILKQMMKEVASEGENN  381 (399)
Q Consensus       340 ~~l~~ll~~cl~~dP~~Rps~~ell~~L~~l~~~~~~~~~~~  381 (399)
                      +++.+++.+||+.||.+||++.++++.|+++..+........
T Consensus       240 ~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~~~~~~~~~  281 (287)
T 1u59_A          240 PELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSLASKVEGH  281 (287)
T ss_dssp             HHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHHHHTTCSSC
T ss_pred             HHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhcCCcccCC
Confidence            999999999999999999999999999999998887654433

>3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A*

Probab=100.00  E-value=4.6e-48  Score=367.66  Aligned_cols=247  Identities=28%  Similarity=0.488  Sum_probs=217.8

Q ss_pred             ccccceeceeceeCceEEEEEEE--CCeeEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCceeeEEeEEecCCcEEEEE
Q 015868          115 AKQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVT  192 (399)
Q Consensus       115 ~~~~~i~~~lg~G~~g~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~nIv~~~~~~~~~~~~~lV~  192 (399)
                      .++|++.++||+|+||.||+|.+  .++.||+|++.......  .+.+.+|+.+++.++||||+++++++..++.+++||
T Consensus        19 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~--~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~   96 (297)
T 3fxz_A           19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPK--KELIINEILVMRENKNPNIVNYLDSYLVGDELWVVM   96 (297)
T ss_dssp             GGTBCCCEEEEEETTEEEEEEEBTTTCCEEEEEEEEGGGCSC--HHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             hhceeeeeeeccCCCeEEEEEEECCCCcEEEEEEeecccccH--HHHHHHHHHHHhcCCCCCCCeEeEEEEECCEEEEEE
Confidence            46899999999999999999976  67899999997543222  356889999999999999999999999999999999


Q ss_pred             ecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceeecCCCcEEEeeccceeeccCCC-ccc
Q 015868          193 EFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSG-VMT  271 (399)
Q Consensus       193 E~~~ggsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~giiHrDlkp~NILl~~~~~vkl~DFG~a~~~~~~~-~~~  271 (399)
                      ||+.|++|.+++...  .+++..++.++.|++.||.|||++||+||||||+|||++.++.+||+|||+++...... ...
T Consensus        97 e~~~~~~L~~~~~~~--~~~~~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~  174 (297)
T 3fxz_A           97 EYLAGGSLTDVVTET--CMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRS  174 (297)
T ss_dssp             ECCTTCBHHHHHHHS--CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSTTCCBC
T ss_pred             ECCCCCCHHHHHhhc--CCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCHHHEEECCCCCEEEeeCCCceecCCcccccC
Confidence            999999999999763  58999999999999999999999999999999999999999999999999998655433 344


Q ss_pred             cCCCCcccccccccCCCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhccC-CCCCCCCCcHHHHHHHHHHh
Q 015868          272 AETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKSL-RPTIPKHAHPRLAELLERCW  350 (399)
Q Consensus       272 ~~~gt~~y~aPE~l~~~~~~~~~Dv~slG~vl~elltg~~P~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~l~~ll~~cl  350 (399)
                      ...||+.|+|||++.+..++.++||||||+++|+|++|..||...++............ ....+..+++.+.++|.+||
T Consensus       175 ~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l  254 (297)
T 3fxz_A          175 TMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIFRDFLNRCL  254 (297)
T ss_dssp             CCCSCGGGCCHHHHHCSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHHCSCCCSCGGGSCHHHHHHHHHHS
T ss_pred             CccCCcCccChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCCCccccCHHHHHHHHHHc
Confidence            56799999999999999999999999999999999999999999888776655544332 33446678999999999999


Q ss_pred             hhcCCCCCCHHHHHH
Q 015868          351 QHDPTQRPNFSQITD  365 (399)
Q Consensus       351 ~~dP~~Rps~~ell~  365 (399)
                      +.||++|||+.|+++
T Consensus       255 ~~dp~~Rps~~ell~  269 (297)
T 3fxz_A          255 EMDVEKRGSAKELLQ  269 (297)
T ss_dssp             CSSTTTSCCHHHHTT
T ss_pred             cCChhHCcCHHHHhh
Confidence            999999999999975

>3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A*

Probab=100.00  E-value=1.2e-47  Score=357.63  Aligned_cols=259  Identities=33%  Similarity=0.687  Sum_probs=230.1

Q ss_pred             ceeecccccceeceeceeCceEEEEEEE-CCeeEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCceeeEEeEEecCCcE
Q 015868          110 VWEIDAKQLKIECKVASGSYGDLYKGTY-CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNL  188 (399)
Q Consensus       110 ~~~i~~~~~~i~~~lg~G~~g~Vy~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~nIv~~~~~~~~~~~~  188 (399)
                      .|.++.++|++.+.||+|+||.||++.+ .++.||+|+++......   +.+.+|+.++++++||||+++++++......
T Consensus         2 ~~~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~~~---~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~   78 (267)
T 3t9t_A            2 KWVIDPSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSE---EDFIEEAEVMMKLSHPKLVQLYGVCLEQAPI   78 (267)
T ss_dssp             -CBCCGGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTTBCH---HHHHHHHHHHHTCCCTTBCCEEEEECSSSSC
T ss_pred             ceEEchhheeeeeEecCCCceeEEEEEecCCCeEEEEEccccCCCH---HHHHHHHHHHHhCCCCCEeeEEEEEccCCCe
Confidence            4788999999999999999999999998 56789999998764333   5788999999999999999999999999999


Q ss_pred             EEEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceeecCCCcEEEeeccceeeccCCC
Q 015868          189 CIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSG  268 (399)
Q Consensus       189 ~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~giiHrDlkp~NILl~~~~~vkl~DFG~a~~~~~~~  268 (399)
                      ++||||+++++|.+++......+++..++.++.|++.||.|||++|++||||||+||+++.++.+||+|||.++......
T Consensus        79 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~  158 (267)
T 3t9t_A           79 CLVTEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQ  158 (267)
T ss_dssp             EEEECCCTTCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEECGGGCEEECCTTGGGGBCCHH
T ss_pred             EEEEeCCCCCcHHHHHhhCcccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCchheEEECCCCCEEEccccccccccccc
Confidence            99999999999999998877789999999999999999999999999999999999999999999999999997543321


Q ss_pred             --ccccCCCCcccccccccCCCCCCChhhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHHhccCCCCCCCCCcHHHHHH
Q 015868          269 --VMTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLT-GELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRLAEL  345 (399)
Q Consensus       269 --~~~~~~gt~~y~aPE~l~~~~~~~~~Dv~slG~vl~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l  345 (399)
                        ......++..|+|||++.+..++.++||||||+++|+|++ |..||...+..+....+ ....++..+..+++++.++
T Consensus       159 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~i-~~~~~~~~~~~~~~~l~~l  237 (267)
T 3t9t_A          159 YTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDI-STGFRLYKPRLASTHVYQI  237 (267)
T ss_dssp             HHSTTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHH-HTTCCCCCCTTSCHHHHHH
T ss_pred             ccccccccccccccChhhhcCCCccchhchhhhHHHHHHHhccCCCCCCCCCHHHHHHHH-hcCCcCCCCccCcHHHHHH
Confidence              1233456788999999998899999999999999999999 89999988877665543 4455666778899999999


Q ss_pred             HHHHhhhcCCCCCCHHHHHHHHHHHHH
Q 015868          346 LERCWQHDPTQRPNFSQITDILKQMMK  372 (399)
Q Consensus       346 l~~cl~~dP~~Rps~~ell~~L~~l~~  372 (399)
                      +.+||+.||.+|||+.++++.|+++.+
T Consensus       238 i~~~l~~~p~~Rps~~~ll~~L~~l~~  264 (267)
T 3t9t_A          238 MNHCWRERPEDRPAFSRLLRQLAEIAE  264 (267)
T ss_dssp             HHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             HHHHccCChhhCcCHHHHHHHHHHHHh
Confidence            999999999999999999999999864

>2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B

Probab=100.00  E-value=1.6e-47  Score=374.24  Aligned_cols=250  Identities=21%  Similarity=0.393  Sum_probs=222.0

Q ss_pred             ccccceeceeceeCceEEEEEEE--CCeeEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCceeeEEeEEecCCcEEEEE
Q 015868          115 AKQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVT  192 (399)
Q Consensus       115 ~~~~~i~~~lg~G~~g~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~nIv~~~~~~~~~~~~~lV~  192 (399)
                      .++|++.+.||+|+||.||+|.+  +++.||+|+++.........+.+.+|+.+++.++||||+++++++......|+||
T Consensus        28 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv~  107 (362)
T 2bdw_A           28 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVF  107 (362)
T ss_dssp             HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             ccCeEEeeEEecCCCeEEEEEEECCCCCEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEE
Confidence            46899999999999999999988  4789999999877667777788999999999999999999999999999999999


Q ss_pred             ecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceeecCCC---cEEEeeccceeeccCCCc
Q 015868          193 EFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENG---VVKVADFGVARVQAQSGV  269 (399)
Q Consensus       193 E~~~ggsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~giiHrDlkp~NILl~~~~---~vkl~DFG~a~~~~~~~~  269 (399)
                      ||+.||+|.+++.. ...+++..++.++.||+.||.|||++||+||||||+|||++.++   .+||+|||+++.......
T Consensus       108 e~~~gg~L~~~l~~-~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~Dlkp~NIll~~~~~~~~~kl~DfG~a~~~~~~~~  186 (362)
T 2bdw_A          108 DLVTGGELFEDIVA-REFYSEADASHCIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEA  186 (362)
T ss_dssp             CCCCSCBHHHHHTT-CSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEESCSSTTCCEEECCCTTCBCCTTCCS
T ss_pred             ecCCCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCchHHEEEecCCCCCCEEEeecCcceEecCCcc
Confidence            99999999999975 46789999999999999999999999999999999999998654   599999999987665555


Q ss_pred             cccCCCCcccccccccCCCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhccCCCCCC--CCCcHHHHHHHH
Q 015868          270 MTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKSLRPTIP--KHAHPRLAELLE  347 (399)
Q Consensus       270 ~~~~~gt~~y~aPE~l~~~~~~~~~Dv~slG~vl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~l~~ll~  347 (399)
                      .....||+.|+|||++.+..|+.++||||||+++|+|++|..||.+.+..+....+.........+  ..+++++.+||.
T Consensus       187 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~  266 (362)
T 2bdw_A          187 WHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKSLID  266 (362)
T ss_dssp             CCCSCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTTGGGGSCHHHHHHHH
T ss_pred             cccCCCCccccCHHHHccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCCcccccCCCHHHHHHHH
Confidence            566789999999999999999999999999999999999999999888777666555443332222  357899999999


Q ss_pred             HHhhhcCCCCCCHHHHHH
Q 015868          348 RCWQHDPTQRPNFSQITD  365 (399)
Q Consensus       348 ~cl~~dP~~Rps~~ell~  365 (399)
                      +||+.||.+|||+.|+++
T Consensus       267 ~~L~~dP~~R~t~~e~l~  284 (362)
T 2bdw_A          267 SMLTVNPKKRITADQALK  284 (362)
T ss_dssp             HHSCSSGGGSCCHHHHTT
T ss_pred             HHcCCChhhCcCHHHHhc
Confidence            999999999999999875

>2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ...

Probab=100.00  E-value=5e-48  Score=379.31  Aligned_cols=263  Identities=33%  Similarity=0.603  Sum_probs=221.0

Q ss_pred             ceeecccccceeceeceeCceEEEEEEEC-----CeeEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCceeeEEeEEec
Q 015868          110 VWEIDAKQLKIECKVASGSYGDLYKGTYC-----SQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTR  184 (399)
Q Consensus       110 ~~~i~~~~~~i~~~lg~G~~g~Vy~~~~~-----~~~vAvK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~nIv~~~~~~~~  184 (399)
                      ..+++.++|++.+.||+|+||.||+|++.     +..||||+++... .....+.+.+|+.++++++||||+++++++..
T Consensus        39 ~~~~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~  117 (373)
T 2qol_A           39 AKELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGY-TEKQRRDFLGEASIMGQFDHPNIIRLEGVVTK  117 (373)
T ss_dssp             SCBCCGGGCCCCEEEEECSSSEEEEC-CBCTTSCBCCEEEEECCTTC-CHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS
T ss_pred             HhhcCHhhceeeeEEeeCCCeEEEEEEEecCCCCceeEEEEEecCcc-CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEee
Confidence            34678889999999999999999999863     5679999998653 55667789999999999999999999999999


Q ss_pred             CCcEEEEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceeecCCCcEEEeeccceeec
Q 015868          185 PPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQ  264 (399)
Q Consensus       185 ~~~~~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~giiHrDlkp~NILl~~~~~vkl~DFG~a~~~  264 (399)
                      ....++||||+++++|.+++......+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++..
T Consensus       118 ~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~  197 (373)
T 2qol_A          118 SKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILINSNLVCKVSDFGLGRVL  197 (373)
T ss_dssp             SSSCEEEEECCTTCBHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCC------
T ss_pred             CCceEEEEeCCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCcceEEEcCCCCEEECcCcccccc
Confidence            99999999999999999999887778999999999999999999999999999999999999999999999999999865


Q ss_pred             cCCCc----cccCCCCcccccccccCCCCCCChhhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHHhccCCCCCCCCCc
Q 015868          265 AQSGV----MTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLT-GELPYAGLTPLQAAVGVVQKSLRPTIPKHAH  339 (399)
Q Consensus       265 ~~~~~----~~~~~gt~~y~aPE~l~~~~~~~~~Dv~slG~vl~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~  339 (399)
                      .....    .....++..|+|||.+.+..++.++||||||+++|||++ |+.||...+..+....+ ....++..+..++
T Consensus       198 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~SlG~il~ellt~g~~P~~~~~~~~~~~~i-~~~~~~~~~~~~~  276 (373)
T 2qol_A          198 EDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAV-DEGYRLPPPMDCP  276 (373)
T ss_dssp             ----------------CTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTC-CTTTTCCHHHHHHHH-HTTEECCCCTTCB
T ss_pred             ccCCccceeccCCCcCCCccChhhhccCCcCchhcHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHH-HcCCCCCCCcccc
Confidence            54321    112235778999999999999999999999999999998 99999988877665543 4445566677899


Q ss_pred             HHHHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHH
Q 015868          340 PRLAELLERCWQHDPTQRPNFSQITDILKQMMKEV  374 (399)
Q Consensus       340 ~~l~~ll~~cl~~dP~~Rps~~ell~~L~~l~~~~  374 (399)
                      .++.+++.+||+.||.+||++.++++.|+++++..
T Consensus       277 ~~l~~li~~cl~~dp~~RPs~~~i~~~L~~~~~~~  311 (373)
T 2qol_A          277 AALYQLMLDCWQKDRNNRPKFEQIVSILDKLIRNP  311 (373)
T ss_dssp             HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHCG
T ss_pred             HHHHHHHHHHhCcChhhCcCHHHHHHHHHHHHhCc
Confidence            99999999999999999999999999999998654

>3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A*

Probab=100.00  E-value=3e-48  Score=372.98  Aligned_cols=262  Identities=31%  Similarity=0.508  Sum_probs=219.4

Q ss_pred             CCCCceeecccccceeceeceeCceEEEEEEECCeeEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCceeeEEeEEecC
Q 015868          106 DGTDVWEIDAKQLKIECKVASGSYGDLYKGTYCSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRP  185 (399)
Q Consensus       106 ~~~~~~~i~~~~~~i~~~lg~G~~g~Vy~~~~~~~~vAvK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~nIv~~~~~~~~~  185 (399)
                      +++..+.+..++|++.++||+|+||.||+|++.++.||||+++..   ......+.+|+.++++++||||+++++++...
T Consensus        14 ~~~~n~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~vavK~~~~~---~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~   90 (322)
T 3soc_A           14 LGTENLYFQSMPLQLLEVKARGRFGCVWKAQLLNEYVAVKIFPIQ---DKQSWQNEYEVYSLPGMKHENILQFIGAEKRG   90 (322)
T ss_dssp             CCCCCEEETTEEEEEEEEEECSTTCEEEEEEETTEEEEEEEECGG---GHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEE
T ss_pred             cCccccccchhhchhhheecccCceEEEEEEECCCEEEEEEeecC---chHHHHHHHHHHHHhcCCCCCchhhcceeccC
Confidence            344567899999999999999999999999999999999999753   33345667799999999999999999999875


Q ss_pred             C----cEEEEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC----------CcccCCCCCCceeecCCC
Q 015868          186 P----NLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQN----------NIIHRDLKTANLLMDENG  251 (399)
Q Consensus       186 ~----~~~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~----------giiHrDlkp~NILl~~~~  251 (399)
                      .    .+++||||+++|+|.+++..  ..+++..++.++.|++.||.|||+.          ||+||||||+|||++.++
T Consensus        91 ~~~~~~~~lv~e~~~~g~L~~~l~~--~~~~~~~~~~i~~qi~~al~~LH~~~~~l~~~~~~~ivH~Dlkp~Nill~~~~  168 (322)
T 3soc_A           91 TSVDVDLWLITAFHEKGSLSDFLKA--NVVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNL  168 (322)
T ss_dssp             CSSSEEEEEEEECCTTCBHHHHHHH--CCBCHHHHHHHHHHHHHHHHHHTCCEEEETTEEECEEECSCCSGGGEEECTTC
T ss_pred             CCCCceEEEEEecCCCCCHHHHHHh--cCCCHHHHHHHHHHHHHHHHHHHhhccccccccCCCEEeCCCChHhEEECCCC
Confidence            4    37999999999999999976  4589999999999999999999999          999999999999999999


Q ss_pred             cEEEeeccceeeccCCCc---cccCCCCcccccccccCCC-----CCCChhhHHHHHHHHHHHHcCCCCCCCCC------
Q 015868          252 VVKVADFGVARVQAQSGV---MTAETGTYRWMAPEVIEHK-----PYDYKADVFSFGIALWELLTGELPYAGLT------  317 (399)
Q Consensus       252 ~vkl~DFG~a~~~~~~~~---~~~~~gt~~y~aPE~l~~~-----~~~~~~Dv~slG~vl~elltg~~P~~~~~------  317 (399)
                      .+||+|||+++.......   .....||+.|+|||++.+.     .++.++||||||+++|+|+||+.||.+..      
T Consensus       169 ~~kL~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~  248 (322)
T 3soc_A          169 TACIADFGLALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYMLP  248 (322)
T ss_dssp             CEEECCCTTCEEECTTSCCCCCTTCCCCGGGCCHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHTTBTTSSSCCCCCCCT
T ss_pred             eEEEccCCcccccccccCccccccCccCccccCHhhcccccccCcCCCccchhHHHHHHHHHHHhCCCCCCCCcchhccc
Confidence            999999999986554322   3335789999999999873     45678899999999999999999996532      


Q ss_pred             ----------HHHHHHHHHhccCCCCCCCC-----CcHHHHHHHHHHhhhcCCCCCCHHHHHHHHHHHHH
Q 015868          318 ----------PLQAAVGVVQKSLRPTIPKH-----AHPRLAELLERCWQHDPTQRPNFSQITDILKQMMK  372 (399)
Q Consensus       318 ----------~~~~~~~~~~~~~~~~~~~~-----~~~~l~~ll~~cl~~dP~~Rps~~ell~~L~~l~~  372 (399)
                                .............++.++..     .++++.+||.+||+.||++|||+.|+++.|+++.+
T Consensus       249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~l~~  318 (322)
T 3soc_A          249 FEEEIGQHPSLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEECWDHDAEARLSAGCVGERITQMQR  318 (322)
T ss_dssp             THHHHCSSCCHHHHHHHHTTSCCCCCCCGGGGSSHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             hhhhhccCCchhhhhhhhhcccCCCCccccccccchHHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHH
Confidence                      22223333344444544432     34569999999999999999999999999999865

>1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A*

Probab=100.00  E-value=1.2e-47  Score=362.88  Aligned_cols=267  Identities=28%  Similarity=0.562  Sum_probs=229.0

Q ss_pred             Cceeecccccceec-eeceeCceEEEEEEE----CCeeEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCceeeEEeEEe
Q 015868          109 DVWEIDAKQLKIEC-KVASGSYGDLYKGTY----CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACT  183 (399)
Q Consensus       109 ~~~~i~~~~~~i~~-~lg~G~~g~Vy~~~~----~~~~vAvK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~nIv~~~~~~~  183 (399)
                      ..+.++.++|++.+ .||+|+||.||+|.+    .++.||+|+++.........+.+.+|+.+++.++||||+++++++ 
T Consensus         9 ~~~~~~~~~y~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-   87 (291)
T 1xbb_A            9 KEVYLDRKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGIC-   87 (291)
T ss_dssp             --CBCCGGGEEEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEE-
T ss_pred             ceeeecchhhhhccCccccccCeeeEeeeecCCCceeeEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEE-
Confidence            34567888999998 999999999999965    357899999987655556678899999999999999999999999 


Q ss_pred             cCCcEEEEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceeecCCCcEEEeeccceee
Q 015868          184 RPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARV  263 (399)
Q Consensus       184 ~~~~~~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~giiHrDlkp~NILl~~~~~vkl~DFG~a~~  263 (399)
                      ..+..++||||+++++|.+++.. ...+++..++.++.|++.||.|||++||+||||||+||+++.++.+||+|||+++.
T Consensus        88 ~~~~~~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~  166 (291)
T 1xbb_A           88 EAESWMLVMEMAELGPLNKYLQQ-NRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKA  166 (291)
T ss_dssp             ESSSEEEEEECCTTEEHHHHHHH-CTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECCCTTCEE
T ss_pred             CCCCcEEEEEeCCCCCHHHHHHh-CcCCCHHHHHHHHHHHHHHHHHHHhCCeEcCCCCcceEEEeCCCcEEEccCCccee
Confidence            55678999999999999999976 45689999999999999999999999999999999999999999999999999986


Q ss_pred             ccCCCc----cccCCCCcccccccccCCCCCCChhhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHHhccCCCCCCCCC
Q 015868          264 QAQSGV----MTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLT-GELPYAGLTPLQAAVGVVQKSLRPTIPKHA  338 (399)
Q Consensus       264 ~~~~~~----~~~~~gt~~y~aPE~l~~~~~~~~~Dv~slG~vl~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~  338 (399)
                      ......    .....+++.|+|||.+.+..++.++||||||+++|+|++ |..||...+..+... .+....++..+..+
T Consensus       167 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~-~~~~~~~~~~~~~~  245 (291)
T 1xbb_A          167 LRADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTA-MLEKGERMGCPAGC  245 (291)
T ss_dssp             CCTTCSEEEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHH-HHHTTCCCCCCTTC
T ss_pred             eccCCCcccccccCCCCceeeChHHhccCCCChhhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHH-HHHcCCCCCCCCCC
Confidence            654322    222346788999999998889999999999999999999 999999988766544 34456677788899


Q ss_pred             cHHHHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHhcc
Q 015868          339 HPRLAELLERCWQHDPTQRPNFSQITDILKQMMKEVASEG  378 (399)
Q Consensus       339 ~~~l~~ll~~cl~~dP~~Rps~~ell~~L~~l~~~~~~~~  378 (399)
                      ++++.+++.+||+.||.+|||+.++++.|+++......++
T Consensus       246 ~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~~~~~~~  285 (291)
T 1xbb_A          246 PREMYDLMNLCWTYDVENRPGFAAVELRLRNYYYDVVNEG  285 (291)
T ss_dssp             CHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHHHHHHH
T ss_pred             CHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHHHhhcc
Confidence            9999999999999999999999999999999998886554

>2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A*

Probab=100.00  E-value=1.2e-47  Score=369.61  Aligned_cols=267  Identities=30%  Similarity=0.587  Sum_probs=235.2

Q ss_pred             CceeecccccceeceeceeCceEEEEEEECC-------eeEEEEEecCCCCCHHHHHHHHHHHHHHHhc-CCCceeeEEe
Q 015868          109 DVWEIDAKQLKIECKVASGSYGDLYKGTYCS-------QEVAIKVLKPECVNTEMLKEFSQEVYIMRKI-RHKNVVQFIG  180 (399)
Q Consensus       109 ~~~~i~~~~~~i~~~lg~G~~g~Vy~~~~~~-------~~vAvK~~~~~~~~~~~~~~~~~Ei~~l~~l-~h~nIv~~~~  180 (399)
                      ..|++..++|++.+.||+|+||.||+|++.+       ..||+|+++... .....+.+.+|+.+++++ +||||+++++
T Consensus        39 ~~~~~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~~h~~iv~~~~  117 (333)
T 2i1m_A           39 EKWEFPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTA-HADEKEALMSELKIMSHLGQHENIVNLLG  117 (333)
T ss_dssp             GGGBCCTTSEEEEEEEEECSSEEEEEEEETTCSSSCCCCEEEEEEECTTC-CHHHHHHHHHHHHHHHHHCCCTTBCCEEE
T ss_pred             ccccCCHHHceeeeEeccCCCcceEEEEecCCCcccchhHHHHHhccccc-ChHHHHHHHHHHHHHHhhcCCCCeeeEEE
Confidence            4688999999999999999999999998743       479999998653 445567899999999999 8999999999


Q ss_pred             EEecCCcEEEEEecCCCCCHHHHHHhc-------------CCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceee
Q 015868          181 ACTRPPNLCIVTEFMARGSIYDFLHKQ-------------KGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLM  247 (399)
Q Consensus       181 ~~~~~~~~~lV~E~~~ggsL~~~l~~~-------------~~~l~~~~~~~i~~~i~~~L~~LH~~giiHrDlkp~NILl  247 (399)
                      ++......++||||+++|+|.+++...             ...+++..++.++.|++.||.|||++||+||||||+||++
T Consensus       118 ~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~NIl~  197 (333)
T 2i1m_A          118 ACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASKNCIHRDVAARNVLL  197 (333)
T ss_dssp             EECSSSSCEEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGCEE
T ss_pred             EEecCCceEEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCCcccCCcccceEEE
Confidence            999999999999999999999999753             3468999999999999999999999999999999999999


Q ss_pred             cCCCcEEEeeccceeeccCCCc---cccCCCCcccccccccCCCCCCChhhHHHHHHHHHHHHc-CCCCCCCCCHHHHHH
Q 015868          248 DENGVVKVADFGVARVQAQSGV---MTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLT-GELPYAGLTPLQAAV  323 (399)
Q Consensus       248 ~~~~~vkl~DFG~a~~~~~~~~---~~~~~gt~~y~aPE~l~~~~~~~~~Dv~slG~vl~ellt-g~~P~~~~~~~~~~~  323 (399)
                      +.++.+||+|||+++.......   .....+|+.|+|||++.+..++.++||||||+++|+|+| |..||.+........
T Consensus       198 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~  277 (333)
T 2i1m_A          198 TNGHVAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGILVNSKFY  277 (333)
T ss_dssp             EGGGEEEBCCCGGGCCGGGCTTSEECSSCEECGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCSSHHHH
T ss_pred             CCCCeEEECccccccccccccceeecCCCCCCccccCHHHhccCCCChHHHHHHHHHHHHHHHcCCCCCCcccchhHHHH
Confidence            9999999999999986543322   223346788999999999899999999999999999999 999999887766666


Q ss_pred             HHHhccCCCCCCCCCcHHHHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHh
Q 015868          324 GVVQKSLRPTIPKHAHPRLAELLERCWQHDPTQRPNFSQITDILKQMMKEVAS  376 (399)
Q Consensus       324 ~~~~~~~~~~~~~~~~~~l~~ll~~cl~~dP~~Rps~~ell~~L~~l~~~~~~  376 (399)
                      ........+..+..+++++.+++.+||+.||.+|||+.++++.|+++..+...
T Consensus       278 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~~~~~~~  330 (333)
T 2i1m_A          278 KLVKDGYQMAQPAFAPKNIYSIMQACWALEPTHRPTFQQICSFLQEQAQEDRR  330 (333)
T ss_dssp             HHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHHH
T ss_pred             HHHhcCCCCCCCCCCCHHHHHHHHHHhccChhhCcCHHHHHHHHHHHHHhhhc
Confidence            67777777778888999999999999999999999999999999999876543

>1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ...

Probab=100.00  E-value=7.9e-48  Score=372.87  Aligned_cols=250  Identities=22%  Similarity=0.440  Sum_probs=219.8

Q ss_pred             ecccccceeceeceeCceEEEEEEE--CCeeEEEEEecCCCC-CHHHHHHHHHHHHHHHhcCCCceeeEEeEEecCCcEE
Q 015868          113 IDAKQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECV-NTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLC  189 (399)
Q Consensus       113 i~~~~~~i~~~lg~G~~g~Vy~~~~--~~~~vAvK~~~~~~~-~~~~~~~~~~Ei~~l~~l~h~nIv~~~~~~~~~~~~~  189 (399)
                      +..++|++.+.||+|+||.||+++.  +++.||+|+++.... .......+.+|+.+++.++||||+++++++.....+|
T Consensus         2 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~   81 (337)
T 1o6l_A            2 VTMNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLC   81 (337)
T ss_dssp             CCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEE
T ss_pred             CChHHeEEEEEEecCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhCCCCcCcceEEEEEeCCEEE
Confidence            4567999999999999999999988  578999999974311 1123457889999999999999999999999999999


Q ss_pred             EEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceeecCCCcEEEeeccceeeccC-CC
Q 015868          190 IVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQ-SG  268 (399)
Q Consensus       190 lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~giiHrDlkp~NILl~~~~~vkl~DFG~a~~~~~-~~  268 (399)
                      +||||++||+|.+++.. .+.+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||+++.... ..
T Consensus        82 lv~E~~~gg~L~~~l~~-~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~~~  160 (337)
T 1o6l_A           82 FVMEYANGGELFFHLSR-ERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGA  160 (337)
T ss_dssp             EEEECCTTCBHHHHHHH-HSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCSCCTTC
T ss_pred             EEEeCCCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCeecCcCCHHHEEECCCCCEEEeeccchhhcccCCC
Confidence            99999999999999976 46789999999999999999999999999999999999999999999999999986433 23


Q ss_pred             ccccCCCCcccccccccCCCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhccCCCCCCCCCcHHHHHHHHH
Q 015868          269 VMTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRLAELLER  348 (399)
Q Consensus       269 ~~~~~~gt~~y~aPE~l~~~~~~~~~Dv~slG~vl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~  348 (399)
                      ......||+.|+|||++.+..|+.++|+||||+++|||++|..||.+.+..+....+...  ...+|..+++++.++|.+
T Consensus       161 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~--~~~~p~~~s~~~~~li~~  238 (337)
T 1o6l_A          161 TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILME--EIRFPRTLSPEAKSLLAG  238 (337)
T ss_dssp             CBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHC--CCCCCTTSCHHHHHHHHH
T ss_pred             cccccccChhhCChhhhcCCCCCchhhcccchhHHHHHhcCCCCCCCCCHHHHHHHHHcC--CCCCCCCCCHHHHHHHHH
Confidence            345567999999999999999999999999999999999999999988887766665543  345778899999999999


Q ss_pred             HhhhcCCCCC-----CHHHHHH
Q 015868          349 CWQHDPTQRP-----NFSQITD  365 (399)
Q Consensus       349 cl~~dP~~Rp-----s~~ell~  365 (399)
                      ||+.||.+||     ++.|+++
T Consensus       239 lL~~dP~~R~g~~~~~~~ei~~  260 (337)
T 1o6l_A          239 LLKKDPKQRLGGGPSDAKEVME  260 (337)
T ss_dssp             HTCSSTTTSTTCSTTTHHHHHT
T ss_pred             HhhcCHHHhcCCCCCCHHHHHc
Confidence            9999999999     8998876

>2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A*

Probab=100.00  E-value=1e-47  Score=366.31  Aligned_cols=262  Identities=29%  Similarity=0.609  Sum_probs=231.4

Q ss_pred             CceeecccccceeceeceeCceEEEEEEE-------CCeeEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCceeeEEeE
Q 015868          109 DVWEIDAKQLKIECKVASGSYGDLYKGTY-------CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGA  181 (399)
Q Consensus       109 ~~~~i~~~~~~i~~~lg~G~~g~Vy~~~~-------~~~~vAvK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~nIv~~~~~  181 (399)
                      ..|++..++|++.+.||+|+||.||+|++       .++.||+|+++... .....+.+.+|+.++++++||||++++++
T Consensus        16 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~hp~iv~~~~~   94 (314)
T 2ivs_A           16 PKWEFPRKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENA-SPSELRDLLSEFNVLKQVNHPHVIKLYGA   94 (314)
T ss_dssp             TTTBCCGGGEEEEEEEEECSSSEEEEEEEETGGGCSSEEEEEEEECCTTC-CHHHHHHHHHHHHHHTTCCCTTBCCEEEE
T ss_pred             cccccchhheeeeeeecccCCeeEEEEEEeccCcccCcceEEEEeccCCC-CHHHHHHHHHHHHHHhhCCCCceeeEEEE
Confidence            45788899999999999999999999986       23789999998653 55667889999999999999999999999


Q ss_pred             EecCCcEEEEEecCCCCCHHHHHHhcC-----------------------CCCCHHHHHHHHHHHHHHHHHHHHCCcccC
Q 015868          182 CTRPPNLCIVTEFMARGSIYDFLHKQK-----------------------GVFQLTSLLKVAIDVSKGMNYLHQNNIIHR  238 (399)
Q Consensus       182 ~~~~~~~~lV~E~~~ggsL~~~l~~~~-----------------------~~l~~~~~~~i~~~i~~~L~~LH~~giiHr  238 (399)
                      +......++||||+++++|.+++....                       ..+++..++.++.||+.||.|||++||+||
T Consensus        95 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~  174 (314)
T 2ivs_A           95 CSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEMKLVHR  174 (314)
T ss_dssp             ECSSSSCEEEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHHHTTEECC
T ss_pred             EecCCceEEEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHHHCCCccc
Confidence            999999999999999999999997643                       238899999999999999999999999999


Q ss_pred             CCCCCceeecCCCcEEEeeccceeeccCCCc---cccCCCCcccccccccCCCCCCChhhHHHHHHHHHHHHc-CCCCCC
Q 015868          239 DLKTANLLMDENGVVKVADFGVARVQAQSGV---MTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLT-GELPYA  314 (399)
Q Consensus       239 Dlkp~NILl~~~~~vkl~DFG~a~~~~~~~~---~~~~~gt~~y~aPE~l~~~~~~~~~Dv~slG~vl~ellt-g~~P~~  314 (399)
                      ||||+||+++.++.+||+|||+++.......   .....+|+.|+|||.+.+..++.++||||||+++|+|++ |..||.
T Consensus       175 dikp~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~  254 (314)
T 2ivs_A          175 DLAARNILVAEGRKMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYP  254 (314)
T ss_dssp             CCSGGGEEEETTTEEEECCCTTCEECTTTSCEECSSCCCSCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSST
T ss_pred             ccchheEEEcCCCCEEEccccccccccccccceeccCCCCcccccChhhhcCCCcCchhhHHHHHHHHHHHHhCCCCCCC
Confidence            9999999999999999999999986544322   233456888999999998889999999999999999999 999999


Q ss_pred             CCCHHHHHHHHHhccCCCCCCCCCcHHHHHHHHHHhhhcCCCCCCHHHHHHHHHHHHH
Q 015868          315 GLTPLQAAVGVVQKSLRPTIPKHAHPRLAELLERCWQHDPTQRPNFSQITDILKQMMK  372 (399)
Q Consensus       315 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~cl~~dP~~Rps~~ell~~L~~l~~  372 (399)
                      +.+..+... .+.....+..+..+++++.+++.+||+.||.+|||+.++++.|++++.
T Consensus       255 ~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~l~~~l~~~~~  311 (314)
T 2ivs_A          255 GIPPERLFN-LLKTGHRMERPDNCSEEMYRLMLQCWKQEPDKRPVFADISKDLEKMMV  311 (314)
T ss_dssp             TCCGGGHHH-HHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             CCCHHHHHH-HhhcCCcCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence            888766544 344556677888899999999999999999999999999999999875

>1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=8.2e-48  Score=370.15  Aligned_cols=248  Identities=18%  Similarity=0.288  Sum_probs=221.4

Q ss_pred             ccccceeceeceeCceEEEEEEE--CCeeEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCceeeEEeEEecCCcEEEEE
Q 015868          115 AKQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVT  192 (399)
Q Consensus       115 ~~~~~i~~~lg~G~~g~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~nIv~~~~~~~~~~~~~lV~  192 (399)
                      .++|++.+.||+|+||.||++.+  +++.||+|+++..   ......+.+|+.+++.++||||+++++++.....+++||
T Consensus         4 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~a~K~~~~~---~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~   80 (321)
T 1tki_A            4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVK---GTDQVLVKKEISILNIARHRNILHLHESFESMEELVMIF   80 (321)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCC---THHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEE
T ss_pred             hhceEeeeEEecCCCeEEEEEEECCCCcEEEEEEEecC---cccHHHHHHHHHHHHhCCCCCCCeEeEEEecCCEEEEEE
Confidence            46899999999999999999988  4789999999754   334567889999999999999999999999999999999


Q ss_pred             ecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceeecC--CCcEEEeeccceeeccCCCcc
Q 015868          193 EFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDE--NGVVKVADFGVARVQAQSGVM  270 (399)
Q Consensus       193 E~~~ggsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~giiHrDlkp~NILl~~--~~~vkl~DFG~a~~~~~~~~~  270 (399)
                      ||++|++|.+++......+++..++.++.|++.||.|||++||+||||||+|||++.  ++.+||+|||+++........
T Consensus        81 e~~~g~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~givH~Dlkp~NIl~~~~~~~~~kl~Dfg~a~~~~~~~~~  160 (321)
T 1tki_A           81 EFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNF  160 (321)
T ss_dssp             CCCCCCBHHHHHTSSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSCCCEEECCCTTCEECCTTCEE
T ss_pred             EeCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCCcCCCCHHHEEEccCCCCCEEEEECCCCeECCCCCcc
Confidence            999999999999876678999999999999999999999999999999999999987  789999999999887665555


Q ss_pred             ccCCCCcccccccccCCCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhccCCCC--CCCCCcHHHHHHHHH
Q 015868          271 TAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKSLRPT--IPKHAHPRLAELLER  348 (399)
Q Consensus       271 ~~~~gt~~y~aPE~l~~~~~~~~~Dv~slG~vl~elltg~~P~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~l~~ll~~  348 (399)
                      ....||+.|+|||++.+..++.++||||||+++|+|++|..||.+.+..+....+........  ....+++++.+++.+
T Consensus       161 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~  240 (321)
T 1tki_A          161 RLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFDEEAFKEISIEAMDFVDR  240 (321)
T ss_dssp             EEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCCCHHHHTTSCHHHHHHHHT
T ss_pred             ccccCChhhcCcHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCcCCCHHHHHHHHHcCCCCCChhhhccCCHHHHHHHHH
Confidence            666799999999999999899999999999999999999999999888777766655433221  124689999999999


Q ss_pred             HhhhcCCCCCCHHHHHH
Q 015868          349 CWQHDPTQRPNFSQITD  365 (399)
Q Consensus       349 cl~~dP~~Rps~~ell~  365 (399)
                      ||..||.+|||+.|+++
T Consensus       241 ~L~~dp~~Rpt~~e~l~  257 (321)
T 1tki_A          241 LLVKERKSRMTASEALQ  257 (321)
T ss_dssp             TSCSSGGGSCCHHHHHH
T ss_pred             HcCCChhHCcCHHHHhc
Confidence            99999999999999987

>2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A*

Probab=100.00  E-value=1.5e-47  Score=374.25  Aligned_cols=250  Identities=22%  Similarity=0.383  Sum_probs=219.7

Q ss_pred             ccccceeceeceeCceEEEEEEE--CCeeEEEEEecCCCCCH----HHHHHHHHHHHHHHhcCCCceeeEEeEEecCCcE
Q 015868          115 AKQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVNT----EMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNL  188 (399)
Q Consensus       115 ~~~~~i~~~lg~G~~g~Vy~~~~--~~~~vAvK~~~~~~~~~----~~~~~~~~Ei~~l~~l~h~nIv~~~~~~~~~~~~  188 (399)
                      .+.|++.+.||+|+||.||+++.  +++.||+|+++......    ...+.+.+|+.++++++||||+++++++.....+
T Consensus        11 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~   90 (361)
T 2yab_A           11 EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLHDVYENRTDV   90 (361)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEE
T ss_pred             hhceEEeeEEeeCcCEEEEEEEECCCCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhCCCcCCCcEEEEEEeCCEE
Confidence            46799999999999999999998  47899999997653321    1346788999999999999999999999999999


Q ss_pred             EEEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceeecCCC----cEEEeeccceeec
Q 015868          189 CIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENG----VVKVADFGVARVQ  264 (399)
Q Consensus       189 ~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~giiHrDlkp~NILl~~~~----~vkl~DFG~a~~~  264 (399)
                      ++||||++||+|.+++.. .+.+++..++.++.||+.||.|||++||+||||||+|||++.++    .+||+|||+++..
T Consensus        91 ~lv~e~~~gg~L~~~l~~-~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~~~~~vkl~DFG~a~~~  169 (361)
T 2yab_A           91 VLILELVSGGELFDFLAQ-KESLSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEI  169 (361)
T ss_dssp             EEEEECCCSCBHHHHHTT-CSCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCTTSSSCCEEECCCSSCEEC
T ss_pred             EEEEEcCCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEeCCCCCccCEEEEecCCceEc
Confidence            999999999999999965 46799999999999999999999999999999999999998877    7999999999877


Q ss_pred             cCCCccccCCCCcccccccccCCCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhccCC--CCCCCCCcHHH
Q 015868          265 AQSGVMTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKSLR--PTIPKHAHPRL  342 (399)
Q Consensus       265 ~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~Dv~slG~vl~elltg~~P~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~l  342 (399)
                      ..........||+.|+|||++.+..|+.++||||||+++|+|++|..||.+.+..+....+......  +..+..+++++
T Consensus       170 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~  249 (361)
T 2yab_A          170 EDGVEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITAVSYDFDEEFFSQTSELA  249 (361)
T ss_dssp             CTTCCCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHTTCCCCCHHHHTTSCHHH
T ss_pred             CCCCccccCCCCccEECchHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCchhccCCCHHH
Confidence            6655556678999999999999999999999999999999999999999998887766655443222  12235688999


Q ss_pred             HHHHHHHhhhcCCCCCCHHHHHH
Q 015868          343 AELLERCWQHDPTQRPNFSQITD  365 (399)
Q Consensus       343 ~~ll~~cl~~dP~~Rps~~ell~  365 (399)
                      .+||.+||..||.+|||+.|+++
T Consensus       250 ~~li~~~L~~dP~~R~t~~e~l~  272 (361)
T 2yab_A          250 KDFIRKLLVKETRKRLTIQEALR  272 (361)
T ss_dssp             HHHHHHHSCSSTTTSCCHHHHHT
T ss_pred             HHHHHHHCCCChhHCcCHHHHhc
Confidence            99999999999999999999975

>3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens}

Probab=100.00  E-value=1.4e-47  Score=375.17  Aligned_cols=265  Identities=30%  Similarity=0.564  Sum_probs=230.0

Q ss_pred             CceeecccccceeceeceeCceEEEEEEE-------CCeeEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCceeeEEeE
Q 015868          109 DVWEIDAKQLKIECKVASGSYGDLYKGTY-------CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGA  181 (399)
Q Consensus       109 ~~~~i~~~~~~i~~~lg~G~~g~Vy~~~~-------~~~~vAvK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~nIv~~~~~  181 (399)
                      +.+++..++|++.++||+|+||.||+|++       .++.||||+++... .......+.+|+.++++++||||++++++
T Consensus        64 ~~~~~~~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~hpnIv~~~~~  142 (367)
T 3l9p_A           64 DLKEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVC-SEQDELDFLMEALIISKFNHQNIVRCIGV  142 (367)
T ss_dssp             GSCBCCGGGEEEEEECCCCSSSCEEEEEECC-----CCEEEEEEECCSSC-CHHHHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred             chhhcCHhHeEEeeEeeeCCCEEEEEEEEccCCCCCcceeEEEEeccccc-ChhhHHHHHHHHHHHHhCCCCCCCeEEEE
Confidence            44677889999999999999999999985       34679999997543 45556789999999999999999999999


Q ss_pred             EecCCcEEEEEecCCCCCHHHHHHhcC------CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceeecCCC---c
Q 015868          182 CTRPPNLCIVTEFMARGSIYDFLHKQK------GVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENG---V  252 (399)
Q Consensus       182 ~~~~~~~~lV~E~~~ggsL~~~l~~~~------~~l~~~~~~~i~~~i~~~L~~LH~~giiHrDlkp~NILl~~~~---~  252 (399)
                      +......++||||+.||+|.+++....      ..+++..++.++.||+.||+|||++||+||||||+|||++.++   .
T Consensus       143 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~~~  222 (367)
T 3l9p_A          143 SLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRV  222 (367)
T ss_dssp             ECSSSSCEEEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSSTTCC
T ss_pred             EecCCCCEEEEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHHhCCeeCCCCChhhEEEecCCCCce
Confidence            999999999999999999999997643      4589999999999999999999999999999999999999555   5


Q ss_pred             EEEeeccceeeccCC---CccccCCCCcccccccccCCCCCCChhhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHHhc
Q 015868          253 VKVADFGVARVQAQS---GVMTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLT-GELPYAGLTPLQAAVGVVQK  328 (399)
Q Consensus       253 vkl~DFG~a~~~~~~---~~~~~~~gt~~y~aPE~l~~~~~~~~~Dv~slG~vl~ellt-g~~P~~~~~~~~~~~~~~~~  328 (399)
                      +||+|||+++.....   .......+|+.|+|||++.+..++.++|||||||++|+|++ |..||...+..+.... +..
T Consensus       223 ~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~pf~~~~~~~~~~~-i~~  301 (367)
T 3l9p_A          223 AKIGDFGMARDIYRAGYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEF-VTS  301 (367)
T ss_dssp             EEECCCHHHHHHHHHSSCTTCCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHH-HHT
T ss_pred             EEECCCccccccccccccccCCCcCCcccEECHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHH-HHc
Confidence            999999999754322   12233467899999999999999999999999999999998 9999999887765554 444


Q ss_pred             cCCCCCCCCCcHHHHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHH
Q 015868          329 SLRPTIPKHAHPRLAELLERCWQHDPTQRPNFSQITDILKQMMKEVA  375 (399)
Q Consensus       329 ~~~~~~~~~~~~~l~~ll~~cl~~dP~~Rps~~ell~~L~~l~~~~~  375 (399)
                      ..++..+..+++++.+++.+||+.||.+|||+.++++.|+.+.+...
T Consensus       302 ~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~l~~~~~~~~  348 (367)
T 3l9p_A          302 GGRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQDPD  348 (367)
T ss_dssp             TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHCHH
T ss_pred             CCCCCCCccCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhhChh
Confidence            55667788899999999999999999999999999999999876554

>4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp}

Probab=100.00  E-value=1e-47  Score=364.53  Aligned_cols=260  Identities=25%  Similarity=0.455  Sum_probs=222.4

Q ss_pred             eecccccceeceeceeCceEEEEEEE--CCeeEEEEEecCC-CCCHHHHHHHHHHHHHHHhcCCCceeeEEeEEecCCcE
Q 015868          112 EIDAKQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPE-CVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNL  188 (399)
Q Consensus       112 ~i~~~~~~i~~~lg~G~~g~Vy~~~~--~~~~vAvK~~~~~-~~~~~~~~~~~~Ei~~l~~l~h~nIv~~~~~~~~~~~~  188 (399)
                      .+-.++|++.+.||+|+||.||+|++  .++.||+|++... .......+.+.+|+.++++++||||+++++++..++.+
T Consensus         7 ~~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~   86 (294)
T 4eqm_A            7 KIINERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMIDVDEEDDCY   86 (294)
T ss_dssp             SCEETTEEEEEEEEEETTEEEEEEEETTTCSEEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCBTTBCCEEEEEECSSEE
T ss_pred             hHhhccEEEEEEEccCCCEEEEEEEECCCCCeEEEEEeccCccccHHHHHHHHHHHHHHhcCCCCCCceEEEeeeeCCeE
Confidence            34467999999999999999999987  5789999998643 33566678899999999999999999999999999999


Q ss_pred             EEEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceeecCCCcEEEeeccceeeccCCC
Q 015868          189 CIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSG  268 (399)
Q Consensus       189 ~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~giiHrDlkp~NILl~~~~~vkl~DFG~a~~~~~~~  268 (399)
                      ++||||++|++|.+++... +.+++..++.++.|++.||.|||++||+||||||+||+++.++.+||+|||+++......
T Consensus        87 ~lv~e~~~g~~L~~~l~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~  165 (294)
T 4eqm_A           87 YLVMEYIEGPTLSEYIESH-GPLSVDTAINFTNQILDGIKHAHDMRIVHRDIKPQNILIDSNKTLKIFDFGIAKALSETS  165 (294)
T ss_dssp             EEEEECCCSCBHHHHHHHH-CSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCSSSTTC----
T ss_pred             EEEEeCCCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEEeCCCcccccccc
Confidence            9999999999999999764 579999999999999999999999999999999999999999999999999997654332


Q ss_pred             c--cccCCCCcccccccccCCCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhccCC---CCCCCCCcHHHH
Q 015868          269 V--MTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKSLR---PTIPKHAHPRLA  343 (399)
Q Consensus       269 ~--~~~~~gt~~y~aPE~l~~~~~~~~~Dv~slG~vl~elltg~~P~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~l~  343 (399)
                      .  .....||+.|+|||.+.+..++.++||||||+++|+|+||+.||.+.+..............   ...+..+++.+.
T Consensus       166 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~  245 (294)
T 4eqm_A          166 LTQTNHVLGTVQYFSPEQAKGEATDECTDIYSIGIVLYEMLVGEPPFNGETAVSIAIKHIQDSVPNVTTDVRKDIPQSLS  245 (294)
T ss_dssp             ---------CCSSCCHHHHHTCCCCTTHHHHHHHHHHHHHHHSSCSSCSSCHHHHHHHHHSSCCCCHHHHSCTTSCHHHH
T ss_pred             ccccCccccCccccCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhhccCCCcchhcccCCCHHHH
Confidence            1  23346899999999999999999999999999999999999999999887776665554332   123567899999


Q ss_pred             HHHHHHhhhcCCCCC-CHHHHHHHHHHHHH
Q 015868          344 ELLERCWQHDPTQRP-NFSQITDILKQMMK  372 (399)
Q Consensus       344 ~ll~~cl~~dP~~Rp-s~~ell~~L~~l~~  372 (399)
                      +++.+||+.||.+|| +++++.+.|.+++.
T Consensus       246 ~li~~~l~~dp~~R~~~~~~l~~~l~~~~~  275 (294)
T 4eqm_A          246 NVILRATEKDKANRYKTIQEMKDDLSSVLH  275 (294)
T ss_dssp             HHHHHHSCSSGGGSCSSHHHHHHHHHTSSS
T ss_pred             HHHHHHhcCCHhHccccHHHHHHHHHHHHh
Confidence            999999999999998 89999888887653

>3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus}

Probab=100.00  E-value=9e-48  Score=368.92  Aligned_cols=267  Identities=27%  Similarity=0.531  Sum_probs=213.9

Q ss_pred             ceeecccccceeceeceeCceEEEEEEECCe-----eEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCceeeEEeEEec
Q 015868          110 VWEIDAKQLKIECKVASGSYGDLYKGTYCSQ-----EVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTR  184 (399)
Q Consensus       110 ~~~i~~~~~~i~~~lg~G~~g~Vy~~~~~~~-----~vAvK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~nIv~~~~~~~~  184 (399)
                      .+.+..++|++.+.||+|+||.||+|++...     .||+|+++.........+.+.+|+.++++++||||+++++++..
T Consensus        17 ~~~i~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~   96 (323)
T 3qup_A           17 DVLIPEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAKLVGVSLR   96 (323)
T ss_dssp             TTBCC---CEEEEEEEEETTEEEEEEEC-------CEEEEEEC------CHHHHHHHHHHHHHTTCCCTTBCCCCEEEEC
T ss_pred             hcccChhHeEEeceecccCCeEEEEEEEcccCCcceeEEEEEecccccCHHHHHHHHHHHHHHHHCCCCceehhhceeec
Confidence            3567788999999999999999999986432     79999998766556667889999999999999999999999987


Q ss_pred             CCcE------EEEEecCCCCCHHHHHHhcC-----CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceeecCCCcE
Q 015868          185 PPNL------CIVTEFMARGSIYDFLHKQK-----GVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVV  253 (399)
Q Consensus       185 ~~~~------~lV~E~~~ggsL~~~l~~~~-----~~l~~~~~~~i~~~i~~~L~~LH~~giiHrDlkp~NILl~~~~~v  253 (399)
                      ....      ++||||+.+++|.+++....     ..+++..++.++.|++.||.|||++||+||||||+||++++++.+
T Consensus        97 ~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~ivH~Dikp~NIli~~~~~~  176 (323)
T 3qup_A           97 SRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSSRNFIHRDLAARNCMLAEDMTV  176 (323)
T ss_dssp             C-------CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTSCE
T ss_pred             cccccCCCccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHHcCCcccCCCCcceEEEcCCCCE
Confidence            7654      99999999999999996532     258999999999999999999999999999999999999999999


Q ss_pred             EEeeccceeeccCCCc---cccCCCCcccccccccCCCCCCChhhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHHhcc
Q 015868          254 KVADFGVARVQAQSGV---MTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLT-GELPYAGLTPLQAAVGVVQKS  329 (399)
Q Consensus       254 kl~DFG~a~~~~~~~~---~~~~~gt~~y~aPE~l~~~~~~~~~Dv~slG~vl~ellt-g~~P~~~~~~~~~~~~~~~~~  329 (399)
                      ||+|||+++.......   .....+++.|+|||.+.+..++.++||||||+++|+|++ |..||.+.+..+...... ..
T Consensus       177 kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~~-~~  255 (323)
T 3qup_A          177 CVADFGLSRKIYSGDYYRQGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGIENAEIYNYLI-GG  255 (323)
T ss_dssp             EECCCCC-----------------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHH-TT
T ss_pred             EEeeccccccccccccccccccccCcccccCchhhcCCCCCCccchhhHHHHHHHHHhCCCCCccccChHHHHHHHh-cC
Confidence            9999999986544322   223456788999999999999999999999999999999 999999988777655544 34


Q ss_pred             CCCCCCCCCcHHHHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHhc
Q 015868          330 LRPTIPKHAHPRLAELLERCWQHDPTQRPNFSQITDILKQMMKEVASE  377 (399)
Q Consensus       330 ~~~~~~~~~~~~l~~ll~~cl~~dP~~Rps~~ell~~L~~l~~~~~~~  377 (399)
                      ..+..+..+++++.+++.+||+.||.+|||+.++++.|++++......
T Consensus       256 ~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~l~~~~~~  303 (323)
T 3qup_A          256 NRLKQPPECMEEVYDLMYQCWSADPKQRPSFTCLRMELENILGHLSVL  303 (323)
T ss_dssp             CCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHC----
T ss_pred             CCCCCCCccCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHhhhc
Confidence            456677889999999999999999999999999999999998766543

>4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A*

Probab=100.00  E-value=1.6e-47  Score=363.36  Aligned_cols=261  Identities=27%  Similarity=0.543  Sum_probs=223.2

Q ss_pred             ceeecccccceeceeceeCceEEEEEEE------CCeeEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCceeeEEeEEe
Q 015868          110 VWEIDAKQLKIECKVASGSYGDLYKGTY------CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACT  183 (399)
Q Consensus       110 ~~~i~~~~~~i~~~lg~G~~g~Vy~~~~------~~~~vAvK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~nIv~~~~~~~  183 (399)
                      ...+..+.|++.++||+|+||.||+|++      .++.||+|+++... .....+.+.+|+.+++.++||||+++++++.
T Consensus        15 ~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~   93 (302)
T 4e5w_A           15 PTHFEKRFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPES-GGNHIADLKKEIEILRNLYHENIVKYKGICT   93 (302)
T ss_dssp             TTBCCGGGEEEEEEEEECSSEEEEEEEECTTSSSCSEEEEEEEEC------CCHHHHHHHHHHHHTCCCTTBCCEEEEEE
T ss_pred             hhhhhhhhhhhhhccCCCCceEEEEEEEccccCccCeEEEEEEecccc-cchhHHHHHHHHHHHHhCCCCCeeeeeeEEe
Confidence            3456678899999999999999999985      57899999998653 2233567899999999999999999999998


Q ss_pred             cC--CcEEEEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceeecCCCcEEEeeccce
Q 015868          184 RP--PNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVA  261 (399)
Q Consensus       184 ~~--~~~~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~giiHrDlkp~NILl~~~~~vkl~DFG~a  261 (399)
                      ..  ..+++||||+++++|.+++......+++..++.++.|++.||.|||++||+||||||+||+++.++.+||+|||.+
T Consensus        94 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~  173 (302)
T 4e5w_A           94 EDGGNGIKLIMEFLPSGSLKEYLPKNKNKINLKQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLVESEHQVKIGDFGLT  173 (302)
T ss_dssp             C---CCEEEEEECCTTCBHHHHHHHHTTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECCCTTC
T ss_pred             cCCCceEEEEEEeCCCCcHHHHHHhccccCCHHHHHHHHHHHHHHHHHhhcCCcccCCCchheEEEcCCCCEEECccccc
Confidence            76  6689999999999999999877788999999999999999999999999999999999999999999999999999


Q ss_pred             eeccCCCc----cccCCCCcccccccccCCCCCCChhhHHHHHHHHHHHHcCCCCCCC--------------CCHHHHHH
Q 015868          262 RVQAQSGV----MTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPYAG--------------LTPLQAAV  323 (399)
Q Consensus       262 ~~~~~~~~----~~~~~gt~~y~aPE~l~~~~~~~~~Dv~slG~vl~elltg~~P~~~--------------~~~~~~~~  323 (399)
                      +.......    .....+|..|+|||.+.+..++.++||||||+++|+|++|..|+..              ........
T Consensus       174 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~  253 (302)
T 4e5w_A          174 KAIETDKEYYTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTHGQMTVTRLV  253 (302)
T ss_dssp             EECCTTCCEEECCCCTTCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCGGGHHHHHH
T ss_pred             ccccCCCcceeccCCCCCCccccCCeeecCCCCCcchhHHHHHHHHHHHHHccCCCcchhhHHhhccCCcccccCHHHHH
Confidence            87654432    2344678889999999998899999999999999999999887532              22333344


Q ss_pred             HHHhccCCCCCCCCCcHHHHHHHHHHhhhcCCCCCCHHHHHHHHHHHH
Q 015868          324 GVVQKSLRPTIPKHAHPRLAELLERCWQHDPTQRPNFSQITDILKQMM  371 (399)
Q Consensus       324 ~~~~~~~~~~~~~~~~~~l~~ll~~cl~~dP~~Rps~~ell~~L~~l~  371 (399)
                      .......+...+..+++++.+++.+||+.||.+|||+.++++.|++++
T Consensus       254 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~ll  301 (302)
T 4e5w_A          254 NTLKEGKRLPCPPNCPDEVYQLMRKCWEFQPSNRTSFQNLIEGFEALL  301 (302)
T ss_dssp             HHHHTTCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             HHHhccCCCCCCCCCCHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHh
Confidence            445556677788899999999999999999999999999999999886

>1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B

Probab=100.00  E-value=1.5e-47  Score=385.28  Aligned_cols=260  Identities=34%  Similarity=0.688  Sum_probs=228.5

Q ss_pred             CCceeecccccceeceeceeCceEEEEEEEC-CeeEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCceeeEEeEEecCC
Q 015868          108 TDVWEIDAKQLKIECKVASGSYGDLYKGTYC-SQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPP  186 (399)
Q Consensus       108 ~~~~~i~~~~~~i~~~lg~G~~g~Vy~~~~~-~~~vAvK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~nIv~~~~~~~~~~  186 (399)
                      .+.|++..++|++.++||+|+||.||+|++. +..||||+++.....   .+.+.+|+.+|++++||||+++++++. ..
T Consensus       180 ~~~~~i~~~~~~~~~~lG~G~fg~V~~~~~~~~~~vavK~~~~~~~~---~~~~~~E~~~l~~l~h~~iv~l~~~~~-~~  255 (454)
T 1qcf_A          180 KDAWEIPRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGSMS---VEAFLAEANVMKTLQHDKLVKLHAVVT-KE  255 (454)
T ss_dssp             TTCSBCCGGGEEEEEEEECCSSEEEEEEEETTTEEEEEEEECTTSBC---HHHHHHHHHHHTTCCCTTBCCEEEEEC-SS
T ss_pred             ccceeechHHeEEEEEcccCCceEEEEEEECCccEEEEEEecCCCcc---HHHHHHHHHHHhhCCCCCEeeEEEEEe-CC
Confidence            3668999999999999999999999999985 678999999875432   468999999999999999999999987 55


Q ss_pred             cEEEEEecCCCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceeecCCCcEEEeeccceeecc
Q 015868          187 NLCIVTEFMARGSIYDFLHKQK-GVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQA  265 (399)
Q Consensus       187 ~~~lV~E~~~ggsL~~~l~~~~-~~l~~~~~~~i~~~i~~~L~~LH~~giiHrDlkp~NILl~~~~~vkl~DFG~a~~~~  265 (399)
                      ..++||||+.+|+|.+++.... ..+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+++...
T Consensus       256 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kl~DFG~a~~~~  335 (454)
T 1qcf_A          256 PIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDLRAANILVSASLVCKIADFGLARVIE  335 (454)
T ss_dssp             SCEEEECCCTTCBHHHHHHSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCSGGGEEECTTCCEEECSTTGGGGBC
T ss_pred             ccEEEEeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCHHHEEECCCCcEEEeeCCCceEcC
Confidence            6899999999999999997543 368899999999999999999999999999999999999999999999999998654


Q ss_pred             CCCc--cccCCCCcccccccccCCCCCCChhhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHHhccCCCCCCCCCcHHH
Q 015868          266 QSGV--MTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLT-GELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRL  342 (399)
Q Consensus       266 ~~~~--~~~~~gt~~y~aPE~l~~~~~~~~~Dv~slG~vl~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  342 (399)
                      ....  .....++..|+|||++.+..++.++||||||+++|||+| |+.||.+.+..+....+ ....++..|..+++++
T Consensus       336 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t~g~~P~~~~~~~~~~~~i-~~~~~~~~~~~~~~~l  414 (454)
T 1qcf_A          336 DNEYTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRAL-ERGYRMPRPENCPEEL  414 (454)
T ss_dssp             CHHHHTTCSSSSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHH-HHTCCCCCCTTSCHHH
T ss_pred             CCceeccCCCcccccccCHHHhccCCCCcHHHHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHH-HcCCCCCCCCCCCHHH
Confidence            3211  223346788999999998899999999999999999999 99999999887766554 4456777788999999


Q ss_pred             HHHHHHHhhhcCCCCCCHHHHHHHHHHHHH
Q 015868          343 AELLERCWQHDPTQRPNFSQITDILKQMMK  372 (399)
Q Consensus       343 ~~ll~~cl~~dP~~Rps~~ell~~L~~l~~  372 (399)
                      .++|.+||+.||++|||+.+|++.|+++..
T Consensus       415 ~~li~~cl~~dp~~RPt~~~i~~~L~~~~~  444 (454)
T 1qcf_A          415 YNIMMRCWKNRPEERPTFEYIQSVLDDFYT  444 (454)
T ss_dssp             HHHHHHHTCSSGGGSCCHHHHHHHHHTSSS
T ss_pred             HHHHHHHccCChhHCcCHHHHHHHHHHHHh
Confidence            999999999999999999999999988753

>4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A*

Probab=100.00  E-value=2.5e-47  Score=359.58  Aligned_cols=255  Identities=34%  Similarity=0.655  Sum_probs=221.3

Q ss_pred             eecccccceeceeceeCceEEEEEEE--CCeeEEEEEecCCCCCH--HHH---HHHHHHHHHHHhcCCCceeeEEeEEec
Q 015868          112 EIDAKQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVNT--EML---KEFSQEVYIMRKIRHKNVVQFIGACTR  184 (399)
Q Consensus       112 ~i~~~~~~i~~~lg~G~~g~Vy~~~~--~~~~vAvK~~~~~~~~~--~~~---~~~~~Ei~~l~~l~h~nIv~~~~~~~~  184 (399)
                      .+..++|++.+.||+|+||.||+|++  +++.||+|++.......  ...   +.+.+|+.++++++||||+++++++..
T Consensus        15 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~   94 (287)
T 4f0f_A           15 TLADNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLMHN   94 (287)
T ss_dssp             BCCSTTEEEEEECCCCSSSCEEEEEETTTCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTCCCTTBCCEEEEETT
T ss_pred             hhhhccceehhccccCCceeEEEEEEcCCceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhCCCCCchhhheeecC
Confidence            45678999999999999999999998  57899999997543322  222   678999999999999999999999976


Q ss_pred             CCcEEEEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCCCceeecCCCc-----EEEee
Q 015868          185 PPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNN--IIHRDLKTANLLMDENGV-----VKVAD  257 (399)
Q Consensus       185 ~~~~~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~g--iiHrDlkp~NILl~~~~~-----vkl~D  257 (399)
                      ..  ++||||+++++|.+++......+++..++.++.|++.||.|||++|  |+||||||+||+++.++.     +||+|
T Consensus        95 ~~--~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~ivH~dikp~Nil~~~~~~~~~~~~kl~D  172 (287)
T 4f0f_A           95 PP--RMVMEFVPCGDLYHRLLDKAHPIKWSVKLRLMLDIALGIEYMQNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVAD  172 (287)
T ss_dssp             TT--EEEEECCTTCBHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHTSSSCCBCSCCSGGGEEESCCCTTCSCCEEECC
T ss_pred             CC--eEEEEecCCCCHHHHHhcccCCccHHHHHHHHHHHHHHHHHHHhCCCCeecCCCCcceEEEeccCCCCceeEEeCC
Confidence            65  6999999999999999887788999999999999999999999999  999999999999988776     99999


Q ss_pred             ccceeeccCCCccccCCCCcccccccccC--CCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHH--HHHHHHhccCCCC
Q 015868          258 FGVARVQAQSGVMTAETGTYRWMAPEVIE--HKPYDYKADVFSFGIALWELLTGELPYAGLTPLQ--AAVGVVQKSLRPT  333 (399)
Q Consensus       258 FG~a~~~~~~~~~~~~~gt~~y~aPE~l~--~~~~~~~~Dv~slG~vl~elltg~~P~~~~~~~~--~~~~~~~~~~~~~  333 (399)
                      ||+++....  ......||+.|+|||++.  ...++.++||||||+++|+|++|..||...+...  ..........++.
T Consensus       173 fg~~~~~~~--~~~~~~g~~~y~aPE~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~  250 (287)
T 4f0f_A          173 FGLSQQSVH--SVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKIKFINMIREEGLRPT  250 (287)
T ss_dssp             CTTCBCCSS--CEECCCCCCTTSCGGGSSCSSCEECHHHHHHHHHHHHHHHHHSSCTTTTCCCCHHHHHHHHHHSCCCCC
T ss_pred             CCccccccc--cccccCCCccccCchhhccCCCCcCchhhHHHHHHHHHHHHcCCCCCccccccHHHHHHHHhccCCCCC
Confidence            999975433  345567899999999994  4567899999999999999999999998765433  3445556677788


Q ss_pred             CCCCCcHHHHHHHHHHhhhcCCCCCCHHHHHHHHHHH
Q 015868          334 IPKHAHPRLAELLERCWQHDPTQRPNFSQITDILKQM  370 (399)
Q Consensus       334 ~~~~~~~~l~~ll~~cl~~dP~~Rps~~ell~~L~~l  370 (399)
                      ++..+++++.+++.+||+.||.+|||+.++++.|+++
T Consensus       251 ~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~l  287 (287)
T 4f0f_A          251 IPEDCPPRLRNVIELCWSGDPKKRPHFSYIVKELSEL  287 (287)
T ss_dssp             CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTC
T ss_pred             CCcccCHHHHHHHHHHhcCChhhCcCHHHHHHHHHhC
Confidence            8999999999999999999999999999999998753

>3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens}

Probab=100.00  E-value=5.9e-47  Score=379.72  Aligned_cols=250  Identities=18%  Similarity=0.332  Sum_probs=220.5

Q ss_pred             ccccceeceeceeCceEEEEEEE--CCeeEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCceeeEEeEEecCCcEEEEE
Q 015868          115 AKQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVT  192 (399)
Q Consensus       115 ~~~~~i~~~lg~G~~g~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~nIv~~~~~~~~~~~~~lV~  192 (399)
                      .++|++.+.||+|+||.||+|.+  +++.||+|++..........+.+.+|+.+++.++||||+++++++......|+||
T Consensus        10 ~~~Y~i~~~LG~G~fg~V~~~~~~~~~~~~a~K~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lv~   89 (444)
T 3soa_A           10 TEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDSISEEGHHYLIF   89 (444)
T ss_dssp             HHHEEEEEEEEEC--CEEEEEEETTTTEEEEEEEEESCSCHHHHHHHHHHHHHHHHHCCBTTBCCEEEEEECSSEEEEEE
T ss_pred             cCCeEEEEEeccCCCeEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCcCCCeEEEEEEECCEEEEEE
Confidence            46899999999999999999987  6889999999877666666788999999999999999999999999999999999


Q ss_pred             ecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceeec---CCCcEEEeeccceeeccCCC-
Q 015868          193 EFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMD---ENGVVKVADFGVARVQAQSG-  268 (399)
Q Consensus       193 E~~~ggsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~giiHrDlkp~NILl~---~~~~vkl~DFG~a~~~~~~~-  268 (399)
                      ||+.||+|.+.+.. .+.+++..+..++.||+.||.|||++||+||||||+|||++   .++.+||+|||+++...... 
T Consensus        90 E~~~gg~L~~~i~~-~~~~~e~~~~~i~~qil~aL~~lH~~givHrDlKp~NIll~~~~~~~~vkL~DFG~a~~~~~~~~  168 (444)
T 3soa_A           90 DLVTGGELFEDIVA-REYYSEADASHCIQQILEAVLHCHQMGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQ  168 (444)
T ss_dssp             CCCBCCBHHHHHHH-CSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSSTTEEESBSSTTCCEEECCCSSCBCCCTTCC
T ss_pred             EeCCCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEeccCCCCcEEEccCceeEEecCCCc
Confidence            99999999999976 46799999999999999999999999999999999999998   46889999999997655432 


Q ss_pred             ccccCCCCcccccccccCCCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhccCCCCC--CCCCcHHHHHHH
Q 015868          269 VMTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKSLRPTI--PKHAHPRLAELL  346 (399)
Q Consensus       269 ~~~~~~gt~~y~aPE~l~~~~~~~~~Dv~slG~vl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~l~~ll  346 (399)
                      ......||+.|+|||++.+..|+.++||||||+++|+|++|..||.+.+..+....+.........  ...+++++.+||
T Consensus       169 ~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li  248 (444)
T 3soa_A          169 AWFGFAGTPGYLSPEVLRKDPYGKPVDLWACGVILYILLVGYPPFWDEDQHRLYQQIKAGAYDFPSPEWDTVTPEAKDLI  248 (444)
T ss_dssp             BCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTCCCCCTTTTTTSCHHHHHHH
T ss_pred             eeecccCCcccCCHHHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhCCCCCCccccccCCHHHHHHH
Confidence            234567999999999999999999999999999999999999999998887776666554433222  246899999999


Q ss_pred             HHHhhhcCCCCCCHHHHHH
Q 015868          347 ERCWQHDPTQRPNFSQITD  365 (399)
Q Consensus       347 ~~cl~~dP~~Rps~~ell~  365 (399)
                      .+||+.||.+|||+.|+++
T Consensus       249 ~~~L~~dP~~Rpta~e~L~  267 (444)
T 3soa_A          249 NKMLTINPSKRITAAEALK  267 (444)
T ss_dssp             HHHSCSSTTTSCCHHHHHH
T ss_pred             HHHcCCChhHCCCHHHHhc
Confidence            9999999999999999986

>3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A*

Probab=100.00  E-value=3.9e-47  Score=363.56  Aligned_cols=253  Identities=26%  Similarity=0.387  Sum_probs=212.6

Q ss_pred             eecccccceeceeceeCceEEEEEEE-CCeeEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCceeeEEeEEecCCcEEE
Q 015868          112 EIDAKQLKIECKVASGSYGDLYKGTY-CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCI  190 (399)
Q Consensus       112 ~i~~~~~~i~~~lg~G~~g~Vy~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~nIv~~~~~~~~~~~~~l  190 (399)
                      +.-.++|++.++||+|+||.||+|++ .++.||+|+++...........+.+|+.++++++||||+++++++..+...++
T Consensus        17 q~l~~~y~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~l   96 (311)
T 3niz_A           17 QGLMEKYQKLEKVGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDVIHSERCLTL   96 (311)
T ss_dssp             ECSSCEEEEEEEEEECSSCEEEEEEETTSCEEEEEEEC------CHHHHHHHHHHHHHHCCCTTBCCEEEEECCSSCEEE
T ss_pred             cchHhhhHhhhhccCCCCeEEEEEEECCCCEEEEEEEecccccchhhHHHHHHHHHHHHcCCCCEeeeeeEEccCCEEEE
Confidence            44467999999999999999999998 67889999998665455556788999999999999999999999999999999


Q ss_pred             EEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceeecCCCcEEEeeccceeeccCC-Cc
Q 015868          191 VTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQS-GV  269 (399)
Q Consensus       191 V~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~giiHrDlkp~NILl~~~~~vkl~DFG~a~~~~~~-~~  269 (399)
                      ||||+++ +|.+++......+++..++.++.|++.||.|||++||+||||||+|||++.++.+||+|||+++..... ..
T Consensus        97 v~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~~~  175 (311)
T 3niz_A           97 VFEFMEK-DLKKVLDENKTGLQDSQIKIYLYQLLRGVAHCHQHRILHRDLKPQNLLINSDGALKLADFGLARAFGIPVRS  175 (311)
T ss_dssp             EEECCSE-EHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEETTSCCC-
T ss_pred             EEcCCCC-CHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCchHhEEECCCCCEEEccCcCceecCCCccc
Confidence            9999986 899999887778999999999999999999999999999999999999999999999999999876533 23


Q ss_pred             cccCCCCcccccccccCC-CCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhccCCCC---------------
Q 015868          270 MTAETGTYRWMAPEVIEH-KPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKSLRPT---------------  333 (399)
Q Consensus       270 ~~~~~gt~~y~aPE~l~~-~~~~~~~Dv~slG~vl~elltg~~P~~~~~~~~~~~~~~~~~~~~~---------------  333 (399)
                      .....+|+.|+|||++.+ ..++.++||||||+++|+|++|+.||.+.+..+...........+.               
T Consensus       176 ~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~  255 (311)
T 3niz_A          176 YTHEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQLPKIFSILGTPNPREWPQVQELPLWKQ  255 (311)
T ss_dssp             --CCCCCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSTTTHHHHHHHHHCCCCTTTSGGGTTSHHHHS
T ss_pred             ccCCcccCCcCCHHHhcCCCCCCchHHhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHCCCChHHhhhhhccchhhh
Confidence            455678999999999976 5689999999999999999999999988776555444332111110               


Q ss_pred             -------------CCCCCcHHHHHHHHHHhhhcCCCCCCHHHHHH
Q 015868          334 -------------IPKHAHPRLAELLERCWQHDPTQRPNFSQITD  365 (399)
Q Consensus       334 -------------~~~~~~~~l~~ll~~cl~~dP~~Rps~~ell~  365 (399)
                                   +...+++++.+||.+||+.||.+|||++|+++
T Consensus       256 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~  300 (311)
T 3niz_A          256 RTFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISARDAMN  300 (311)
T ss_dssp             CCCCCCCCCCHHHHSTTCCHHHHHHHHHHSCSCTTTSCCHHHHHT
T ss_pred             cccccccCCcHHHhCcccCHHHHHHHHHHcCCChhHCCCHHHHhc
Confidence                         12346789999999999999999999999875

>1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=8.3e-47  Score=364.71  Aligned_cols=264  Identities=31%  Similarity=0.602  Sum_probs=226.8

Q ss_pred             eeecccccceeceeceeCceEEEEEEECC------eeEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCceeeEEeEEec
Q 015868          111 WEIDAKQLKIECKVASGSYGDLYKGTYCS------QEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTR  184 (399)
Q Consensus       111 ~~i~~~~~~i~~~lg~G~~g~Vy~~~~~~------~~vAvK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~nIv~~~~~~~~  184 (399)
                      +++..++|++.+.||+|+||.||+|.+..      ..||+|+++... .......+.+|+.++++++||||+++++++..
T Consensus        39 ~~i~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~  117 (333)
T 1mqb_A           39 TEIHPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGY-TEKQRVDFLGEAGIMGQFSHHNIIRLEGVISK  117 (333)
T ss_dssp             CBCCTTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTC-CHHHHHHHHHHHHHHHTCCCTTBCCEEEEECS
T ss_pred             ccCChHHhhcccEEecCCCeEEEEEEEecCCCCccccEEEEEcCCCC-CHHHHHHHHHHHHHHHhCCCCCCCcEEEEEec
Confidence            57888999999999999999999998642      359999998653 45556789999999999999999999999999


Q ss_pred             CCcEEEEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceeecCCCcEEEeeccceeec
Q 015868          185 PPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQ  264 (399)
Q Consensus       185 ~~~~~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~giiHrDlkp~NILl~~~~~vkl~DFG~a~~~  264 (399)
                      ....++||||+++++|.+++......+++..++.++.||+.||.|||++||+||||||+||+++.++.+||+|||+++..
T Consensus       118 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~  197 (333)
T 1mqb_A          118 YKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVL  197 (333)
T ss_dssp             SSSEEEEEECCTTEEHHHHHHHTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCCCC----
T ss_pred             CCCcEEEEeCCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChheEEECCCCcEEECCCCcchhh
Confidence            99999999999999999999887788999999999999999999999999999999999999999999999999999865


Q ss_pred             cCCCc----cccCCCCcccccccccCCCCCCChhhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHHhccCCCCCCCCCc
Q 015868          265 AQSGV----MTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLT-GELPYAGLTPLQAAVGVVQKSLRPTIPKHAH  339 (399)
Q Consensus       265 ~~~~~----~~~~~gt~~y~aPE~l~~~~~~~~~Dv~slG~vl~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~  339 (399)
                      .....    .....+|+.|+|||++.+..++.++||||||+++|+|++ |..||...+..+.... +....++..+..++
T Consensus       198 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~~~~~~-~~~~~~~~~~~~~~  276 (333)
T 1mqb_A          198 EDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKA-INDGFRLPTPMDCP  276 (333)
T ss_dssp             -------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHH-HHTTCCCCCCTTCB
T ss_pred             ccccccccccCCCCccccccCchhcccCCCCchhhhHHHHHHHHHHHcCCCCCcccCCHHHHHHH-HHCCCcCCCcccCC
Confidence            43321    122345788999999999999999999999999999999 9999998887665544 44455666778899


Q ss_pred             HHHHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHh
Q 015868          340 PRLAELLERCWQHDPTQRPNFSQITDILKQMMKEVAS  376 (399)
Q Consensus       340 ~~l~~ll~~cl~~dP~~Rps~~ell~~L~~l~~~~~~  376 (399)
                      +++.+++.+||+.||.+||++.++++.|+++++....
T Consensus       277 ~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~~~~~~~  313 (333)
T 1mqb_A          277 SAIYQLMMQCWQQERARRPKFADIVSILDKLIRAPDS  313 (333)
T ss_dssp             HHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHSGGG
T ss_pred             HHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhcchh
Confidence            9999999999999999999999999999999875543

>3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ...

Probab=100.00  E-value=1.6e-47  Score=360.79  Aligned_cols=264  Identities=36%  Similarity=0.706  Sum_probs=233.8

Q ss_pred             CceeecccccceeceeceeCceEEEEEEEC--CeeEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCceeeEEeEEecCC
Q 015868          109 DVWEIDAKQLKIECKVASGSYGDLYKGTYC--SQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPP  186 (399)
Q Consensus       109 ~~~~i~~~~~~i~~~lg~G~~g~Vy~~~~~--~~~vAvK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~nIv~~~~~~~~~~  186 (399)
                      +.|++..++|++.++||+|+||.||+|.+.  +..||+|+++..   ....+.+.+|+.++++++||||+++++++....
T Consensus         6 ~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~---~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~   82 (288)
T 3kfa_A            6 DKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED---TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREP   82 (288)
T ss_dssp             CTTBCCGGGEEEEEESGGGTTCSEEEEEEGGGTEEEEEEEECSC---STHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred             hcccccccceeEEeecCCCCceeEEEeEecCCCEEEEEEecCcC---HHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCC
Confidence            568999999999999999999999999985  789999999864   234577899999999999999999999999999


Q ss_pred             cEEEEEecCCCCCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceeecCCCcEEEeeccceeecc
Q 015868          187 NLCIVTEFMARGSIYDFLHKQ-KGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQA  265 (399)
Q Consensus       187 ~~~lV~E~~~ggsL~~~l~~~-~~~l~~~~~~~i~~~i~~~L~~LH~~giiHrDlkp~NILl~~~~~vkl~DFG~a~~~~  265 (399)
                      ..++||||+.|++|.+++... ...+++..++.++.|++.||.|||++||+||||||+||+++.++.+||+|||.++...
T Consensus        83 ~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~  162 (288)
T 3kfa_A           83 PFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMT  162 (288)
T ss_dssp             SEEEEEECCTTEEHHHHHHHCCTTTSCHHHHHHHHHHHHHHHHHHHHHTCCCSCCSGGGEEECGGGCEEECCCCGGGTSC
T ss_pred             CEEEEEEcCCCCcHHHHHHhcccCCccHhHHHHHHHHHHHHHHHHHHCCccCCCCCcceEEEcCCCCEEEccCccceecc
Confidence            999999999999999999774 3568999999999999999999999999999999999999999999999999997655


Q ss_pred             CCCc--cccCCCCcccccccccCCCCCCChhhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHHhccCCCCCCCCCcHHH
Q 015868          266 QSGV--MTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLT-GELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRL  342 (399)
Q Consensus       266 ~~~~--~~~~~gt~~y~aPE~l~~~~~~~~~Dv~slG~vl~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  342 (399)
                      ....  .....+|+.|+|||.+.+..++.++||||||+++|+|++ |..||...+..+.... +....++..+..+++++
T Consensus       163 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~~g~~p~~~~~~~~~~~~-~~~~~~~~~~~~~~~~l  241 (288)
T 3kfa_A          163 GDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYEL-LEKDYRMERPEGCPEKV  241 (288)
T ss_dssp             SSSSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHH-HHTTCCCCCCTTCCHHH
T ss_pred             CCccccccCCccccCcCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHH-HhccCCCCCCCCCCHHH
Confidence            4322  223346788999999999999999999999999999999 9999998877665443 44556677788899999


Q ss_pred             HHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHh
Q 015868          343 AELLERCWQHDPTQRPNFSQITDILKQMMKEVAS  376 (399)
Q Consensus       343 ~~ll~~cl~~dP~~Rps~~ell~~L~~l~~~~~~  376 (399)
                      .+++.+||+.||.+|||+.++++.|+++..+...
T Consensus       242 ~~li~~~l~~dp~~Rps~~~~~~~l~~~~~~~~~  275 (288)
T 3kfa_A          242 YELMRACWQWNPSDRPSFAEIHQAFETMFQESSI  275 (288)
T ss_dssp             HHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHHH
T ss_pred             HHHHHHHhCCChhhCcCHHHHHHHHHHHHHhccc
Confidence            9999999999999999999999999999887654

>3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A*

Probab=100.00  E-value=4e-47  Score=357.34  Aligned_cols=263  Identities=27%  Similarity=0.560  Sum_probs=226.1

Q ss_pred             CceeecccccceeceeceeCceEEEEEEECC-----eeEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCceeeEEeEEe
Q 015868          109 DVWEIDAKQLKIECKVASGSYGDLYKGTYCS-----QEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACT  183 (399)
Q Consensus       109 ~~~~i~~~~~~i~~~lg~G~~g~Vy~~~~~~-----~~vAvK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~nIv~~~~~~~  183 (399)
                      ..+.+..++|++.+.||+|+||.||+|++.+     ..||+|+++... .....+.+.+|+.+++.++||||+++++++.
T Consensus         5 ~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~   83 (281)
T 3cc6_A            5 PQYGIAREDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDC-TLDNKEKFMSEAVIMKNLDHPHIVKLIGIIE   83 (281)
T ss_dssp             CCCSCCGGGEEEEEEEEECSSSEEEEEEEECTTCCEEEEEEEECCTTS-CHHHHHHHHHHHHHHHHHCCTTBCCEEEEEC
T ss_pred             ccceecccceEEEEEEEecCCeeEEEeEEcCCCCCcceEEEEeccccc-CchHHHHHHHHHHHHHhCCCCCcceEEEEEc
Confidence            3467788999999999999999999998632     359999998653 4556688999999999999999999999987


Q ss_pred             cCCcEEEEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceeecCCCcEEEeeccceee
Q 015868          184 RPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARV  263 (399)
Q Consensus       184 ~~~~~~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~giiHrDlkp~NILl~~~~~vkl~DFG~a~~  263 (399)
                      .+ ..++||||+++++|.+++......+++..++.++.|++.||.|||++||+||||||+||+++.++.+||+|||.++.
T Consensus        84 ~~-~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~  162 (281)
T 3cc6_A           84 EE-PTWIIMELYPYGELGHYLERNKNSLKVLTLVLYSLQICKAMAYLESINCVHRDIAVRNILVASPECVKLGDFGLSRY  162 (281)
T ss_dssp             SS-SCEEEEECCTTCBHHHHHHHHTTTCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEEEETTEEEECCCCGGGC
T ss_pred             CC-CCEEEEecCCCCCHHHHHHhccccCCHHHHHHHHHHHHHHHHHHHHCCcccCCCccceEEECCCCcEEeCccCCCcc
Confidence            65 57899999999999999988777899999999999999999999999999999999999999999999999999976


Q ss_pred             ccCCCc--cccCCCCcccccccccCCCCCCChhhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHHhccCCCCCCCCCcH
Q 015868          264 QAQSGV--MTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLT-GELPYAGLTPLQAAVGVVQKSLRPTIPKHAHP  340 (399)
Q Consensus       264 ~~~~~~--~~~~~gt~~y~aPE~l~~~~~~~~~Dv~slG~vl~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~  340 (399)
                      ......  .....+++.|+|||.+.+..++.++||||||+++|+|++ |+.||...+..+.... +.....+..+..+++
T Consensus       163 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~llt~g~~p~~~~~~~~~~~~-~~~~~~~~~~~~~~~  241 (281)
T 3cc6_A          163 IEDEDYYKASVTRLPIKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQPFFWLENKDVIGV-LEKGDRLPKPDLCPP  241 (281)
T ss_dssp             C---------CCCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCGGGHHHH-HHHTCCCCCCTTCCH
T ss_pred             cccccccccccCCCCcceeCchhhccCCCCchhccHHHHHHHHHHHhCCCCCcccCChHHHHHH-HhcCCCCCCCCCCCH
Confidence            544321  233456889999999998899999999999999999998 9999987776654433 444556667788999


Q ss_pred             HHHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHH
Q 015868          341 RLAELLERCWQHDPTQRPNFSQITDILKQMMKEV  374 (399)
Q Consensus       341 ~l~~ll~~cl~~dP~~Rps~~ell~~L~~l~~~~  374 (399)
                      .+.+++.+||..||.+|||+.++++.|+++.+..
T Consensus       242 ~l~~li~~~l~~~p~~Rps~~ell~~L~~~~~~~  275 (281)
T 3cc6_A          242 VLYTLMTRCWDYDPSDRPRFTELVCSLSDVYQME  275 (281)
T ss_dssp             HHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred             HHHHHHHHHccCCchhCcCHHHHHHHHHHHHHhh
Confidence            9999999999999999999999999999987643

>2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ...

Probab=100.00  E-value=7.1e-47  Score=364.91  Aligned_cols=265  Identities=29%  Similarity=0.617  Sum_probs=232.9

Q ss_pred             CceeecccccceeceeceeCceEEEEEEEC---------CeeEEEEEecCCCCCHHHHHHHHHHHHHHHhc-CCCceeeE
Q 015868          109 DVWEIDAKQLKIECKVASGSYGDLYKGTYC---------SQEVAIKVLKPECVNTEMLKEFSQEVYIMRKI-RHKNVVQF  178 (399)
Q Consensus       109 ~~~~i~~~~~~i~~~lg~G~~g~Vy~~~~~---------~~~vAvK~~~~~~~~~~~~~~~~~Ei~~l~~l-~h~nIv~~  178 (399)
                      ..|++..++|++.+.||+|+||.||+|++.         +..||+|+++... .....+.+.+|+.+++++ +||||+++
T Consensus        28 ~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~~hp~iv~~  106 (334)
T 2pvf_A           28 PKWEFPRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDA-TEKDLSDLVSEMEMMKMIGKHKNIINL  106 (334)
T ss_dssp             TTTBCCGGGEEEEEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTTC-CHHHHHHHHHHHHHHHHHCCCTTBCCE
T ss_pred             ccccCCHhHeEEeeEEeecCceeEEEeEeccccccccccceEEEEeeeccCC-cHHHHHHHHHHHHHHHHhhcCCCEeeE
Confidence            458899999999999999999999999863         4679999998653 455677899999999999 89999999


Q ss_pred             EeEEecCCcEEEEEecCCCCCHHHHHHhcC---------------CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCC
Q 015868          179 IGACTRPPNLCIVTEFMARGSIYDFLHKQK---------------GVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTA  243 (399)
Q Consensus       179 ~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~---------------~~l~~~~~~~i~~~i~~~L~~LH~~giiHrDlkp~  243 (399)
                      ++++......++||||+++++|.+++....               ..+++..++.++.||+.||.|||++||+||||||+
T Consensus       107 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~  186 (334)
T 2pvf_A          107 LGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAAR  186 (334)
T ss_dssp             EEEECSSSCCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGG
T ss_pred             EEEEccCCceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCccc
Confidence            999999999999999999999999997643               24889999999999999999999999999999999


Q ss_pred             ceeecCCCcEEEeeccceeeccCCCc---cccCCCCcccccccccCCCCCCChhhHHHHHHHHHHHHc-CCCCCCCCCHH
Q 015868          244 NLLMDENGVVKVADFGVARVQAQSGV---MTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLT-GELPYAGLTPL  319 (399)
Q Consensus       244 NILl~~~~~vkl~DFG~a~~~~~~~~---~~~~~gt~~y~aPE~l~~~~~~~~~Dv~slG~vl~ellt-g~~P~~~~~~~  319 (399)
                      ||+++.++.+||+|||+++.......   .....+|+.|+|||++.+..++.++||||||+++|+|++ |..||.+.+..
T Consensus       187 NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~  266 (334)
T 2pvf_A          187 NVLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVE  266 (334)
T ss_dssp             GEEECTTCCEEECCCTTCEECTTTSSEECCSCCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCHH
T ss_pred             eEEEcCCCCEEEccccccccccccccccccCCCCcccceeChHHhcCCCcChHHHHHHHHHHHHHHHhCCCCCcCcCCHH
Confidence            99999999999999999986654322   233456889999999998889999999999999999999 99999988876


Q ss_pred             HHHHHHHhccCCCCCCCCCcHHHHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHH
Q 015868          320 QAAVGVVQKSLRPTIPKHAHPRLAELLERCWQHDPTQRPNFSQITDILKQMMKEVA  375 (399)
Q Consensus       320 ~~~~~~~~~~~~~~~~~~~~~~l~~ll~~cl~~dP~~Rps~~ell~~L~~l~~~~~  375 (399)
                      +.... +....++..+..+++++.+++.+||+.||.+|||+.++++.|++++....
T Consensus       267 ~~~~~-~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~l~~~~~  321 (334)
T 2pvf_A          267 ELFKL-LKEGHRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILTLTT  321 (334)
T ss_dssp             HHHHH-HHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHC
T ss_pred             HHHHH-HhcCCCCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhccc
Confidence            65544 44455677788899999999999999999999999999999999987654

>2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ...

Probab=100.00  E-value=2.3e-47  Score=364.33  Aligned_cols=265  Identities=31%  Similarity=0.618  Sum_probs=232.0

Q ss_pred             CceeecccccceeceeceeCceEEEEEEE-------CCeeEEEEEecCCCCCHHHHHHHHHHHHHHHhc-CCCceeeEEe
Q 015868          109 DVWEIDAKQLKIECKVASGSYGDLYKGTY-------CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKI-RHKNVVQFIG  180 (399)
Q Consensus       109 ~~~~i~~~~~~i~~~lg~G~~g~Vy~~~~-------~~~~vAvK~~~~~~~~~~~~~~~~~Ei~~l~~l-~h~nIv~~~~  180 (399)
                      ..|++..++|++.+.||+|+||.||+|++       .++.||+|+++... .....+.+.+|+.+++++ +||||+++++
T Consensus        20 ~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~~hp~iv~~~~   98 (316)
T 2xir_A           20 SKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA-THSEHRALMSELKILIHIGHHLNVVNLLG   98 (316)
T ss_dssp             HHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTC-CHHHHHHHHHHHHHHHHHCCCTTBCCEEE
T ss_pred             cceecchhheeeeeEEcCCCceeEEEEEEecCCccccceEEEEEecccCC-CcHHHHHHHHHHHHHHhcccCCCeeeEEE
Confidence            56788899999999999999999999985       34789999998653 455567899999999999 6899999999


Q ss_pred             EEecCC-cEEEEEecCCCCCHHHHHHhcCCC---------------CCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCc
Q 015868          181 ACTRPP-NLCIVTEFMARGSIYDFLHKQKGV---------------FQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTAN  244 (399)
Q Consensus       181 ~~~~~~-~~~lV~E~~~ggsL~~~l~~~~~~---------------l~~~~~~~i~~~i~~~L~~LH~~giiHrDlkp~N  244 (399)
                      ++...+ .+++||||+++++|.+++......               +++..++.++.|++.||.|||++||+||||||+|
T Consensus        99 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dikp~N  178 (316)
T 2xir_A           99 ACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARN  178 (316)
T ss_dssp             EECCTTSCCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGG
T ss_pred             EEecCCCceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHHhCCcccccCccce
Confidence            987754 489999999999999999765432               7899999999999999999999999999999999


Q ss_pred             eeecCCCcEEEeeccceeeccCCCc---cccCCCCcccccccccCCCCCCChhhHHHHHHHHHHHHc-CCCCCCCCCHHH
Q 015868          245 LLMDENGVVKVADFGVARVQAQSGV---MTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLT-GELPYAGLTPLQ  320 (399)
Q Consensus       245 ILl~~~~~vkl~DFG~a~~~~~~~~---~~~~~gt~~y~aPE~l~~~~~~~~~Dv~slG~vl~ellt-g~~P~~~~~~~~  320 (399)
                      |+++.++.+||+|||+++.......   .....+|+.|+|||++.+..++.++||||||+++|+|+| |..||.+.+..+
T Consensus       179 il~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~  258 (316)
T 2xir_A          179 ILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDE  258 (316)
T ss_dssp             EEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCCSH
T ss_pred             EEECCCCCEEECCCccccccccCccceeccCCCcceeecCchhhccccccchhHHHHHHHHHHHHHhCCCCCCcccchhH
Confidence            9999999999999999986543322   223456889999999999999999999999999999998 999999877666


Q ss_pred             HHHHHHhccCCCCCCCCCcHHHHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHH
Q 015868          321 AAVGVVQKSLRPTIPKHAHPRLAELLERCWQHDPTQRPNFSQITDILKQMMKEV  374 (399)
Q Consensus       321 ~~~~~~~~~~~~~~~~~~~~~l~~ll~~cl~~dP~~Rps~~ell~~L~~l~~~~  374 (399)
                      .....+....++..+..+++++.+++.+||+.||.+|||+.++++.|+++++..
T Consensus       259 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~  312 (316)
T 2xir_A          259 EFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQAN  312 (316)
T ss_dssp             HHHHHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred             HHHHHhccCccCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhhh
Confidence            666666666777788889999999999999999999999999999999998654

>3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A*

Probab=100.00  E-value=1.2e-46  Score=354.26  Aligned_cols=250  Identities=20%  Similarity=0.372  Sum_probs=223.9

Q ss_pred             ccccceeceeceeCceEEEEEEE--CCeeEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCceeeEEeEEecCCcEEEEE
Q 015868          115 AKQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVT  192 (399)
Q Consensus       115 ~~~~~i~~~lg~G~~g~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~nIv~~~~~~~~~~~~~lV~  192 (399)
                      .++|++.++||+|+||.||+|.+  .++.||+|++..........+.+.+|+.++++++||||+++++++..+...++||
T Consensus         5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~   84 (284)
T 3kk8_A            5 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVF   84 (284)
T ss_dssp             TTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             hhhhhhhhhhcCcCCeEEEEEEEcCCCceEEEEEeecccCCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEcCCEEEEEE
Confidence            46899999999999999999987  4789999999877667777788999999999999999999999999999999999


Q ss_pred             ecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceeecCCCc---EEEeeccceeeccCCCc
Q 015868          193 EFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGV---VKVADFGVARVQAQSGV  269 (399)
Q Consensus       193 E~~~ggsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~giiHrDlkp~NILl~~~~~---vkl~DFG~a~~~~~~~~  269 (399)
                      ||+.+++|.+.+... ..+++..++.++.|++.||.|||++||+||||||+||+++.++.   +||+|||.+........
T Consensus        85 e~~~~~~l~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~~~~kl~Dfg~~~~~~~~~~  163 (284)
T 3kk8_A           85 DLVTGGELFEDIVAR-EFYSEADASHCIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEA  163 (284)
T ss_dssp             CCCCSCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESSSSTTCCEEECCCTTCEECCSSCB
T ss_pred             ecCCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCcCcCCCCHHHEEEecCCCCCcEEEeeceeeEEcccCcc
Confidence            999999999998764 66899999999999999999999999999999999999986655   99999999987776665


Q ss_pred             cccCCCCcccccccccCCCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhccCCCCC--CCCCcHHHHHHHH
Q 015868          270 MTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKSLRPTI--PKHAHPRLAELLE  347 (399)
Q Consensus       270 ~~~~~gt~~y~aPE~l~~~~~~~~~Dv~slG~vl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~l~~ll~  347 (399)
                      .....||+.|+|||.+.+..++.++||||||+++|+|++|..||...+..+..............  ...+++++.+++.
T Consensus       164 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~  243 (284)
T 3kk8_A          164 WHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKSLID  243 (284)
T ss_dssp             CCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTTTTTTSCHHHHHHHH
T ss_pred             ccCCCCCcCCcCchhhcCCCCCcccchHHHHHHHHHHHHCCCCCCCCchhHHHHHHHhccccCCchhhcccCHHHHHHHH
Confidence            66678999999999999999999999999999999999999999998887776665554433222  2468999999999


Q ss_pred             HHhhhcCCCCCCHHHHHH
Q 015868          348 RCWQHDPTQRPNFSQITD  365 (399)
Q Consensus       348 ~cl~~dP~~Rps~~ell~  365 (399)
                      +||+.||++|||+.|+++
T Consensus       244 ~~l~~dp~~Rps~~~~l~  261 (284)
T 3kk8_A          244 SMLTVNPKKRITADQALK  261 (284)
T ss_dssp             HHSCSSTTTSCCHHHHTT
T ss_pred             HHcccChhhCCCHHHHhc
Confidence            999999999999999977

>2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens}

Probab=100.00  E-value=4.8e-47  Score=365.40  Aligned_cols=250  Identities=22%  Similarity=0.382  Sum_probs=219.1

Q ss_pred             ccccceeceeceeCceEEEEEEE--CCeeEEEEEecCCCCCH----HHHHHHHHHHHHHHhcCCCceeeEEeEEecCCcE
Q 015868          115 AKQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVNT----EMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNL  188 (399)
Q Consensus       115 ~~~~~i~~~lg~G~~g~Vy~~~~--~~~~vAvK~~~~~~~~~----~~~~~~~~Ei~~l~~l~h~nIv~~~~~~~~~~~~  188 (399)
                      .+.|++.+.||+|+||.||+|+.  +++.||+|+++......    ...+.+.+|+.++++++||||+++++++......
T Consensus        10 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~   89 (326)
T 2y0a_A           10 DDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDV   89 (326)
T ss_dssp             HHHEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred             ccceEeceEEeeCCCeEEEEEEECCCCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEE
Confidence            46799999999999999999998  47899999997643221    1346788999999999999999999999999999


Q ss_pred             EEEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceeecCCC----cEEEeeccceeec
Q 015868          189 CIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENG----VVKVADFGVARVQ  264 (399)
Q Consensus       189 ~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~giiHrDlkp~NILl~~~~----~vkl~DFG~a~~~  264 (399)
                      ++||||++|++|.+++.. ...+++..++.++.||+.||.|||++||+||||||+||+++.++    .+||+|||+++..
T Consensus        90 ~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~NIll~~~~~~~~~~kl~Dfg~a~~~  168 (326)
T 2y0a_A           90 ILILELVAGGELFDFLAE-KESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKI  168 (326)
T ss_dssp             EEEEECCCSCBHHHHHTT-SSCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESCSSSSSCCEEECCCTTCEEC
T ss_pred             EEEEEcCCCCCHHHHHHh-cCCcCHHHHHHHHHHHHHHHHHHHHCCeEcCCCCHHHEEEecCCCCCCCEEEEECCCCeEC
Confidence            999999999999999965 46799999999999999999999999999999999999999887    8999999999877


Q ss_pred             cCCCccccCCCCcccccccccCCCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhccCC--CCCCCCCcHHH
Q 015868          265 AQSGVMTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKSLR--PTIPKHAHPRL  342 (399)
Q Consensus       265 ~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~Dv~slG~vl~elltg~~P~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~l  342 (399)
                      ..........||+.|+|||++.+..++.++||||||+++|+|++|..||.+.+..+....+......  +..+..+++.+
T Consensus       169 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  248 (326)
T 2y0a_A          169 DFGNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFSNTSALA  248 (326)
T ss_dssp             CTTSCCCCCCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHTCCCCCHHHHTTSCHHH
T ss_pred             CCCCccccccCCcCcCCceeecCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHHhcCCCcCccccccCCHHH
Confidence            6555556678999999999999999999999999999999999999999988877766555443222  11225688999


Q ss_pred             HHHHHHHhhhcCCCCCCHHHHHH
Q 015868          343 AELLERCWQHDPTQRPNFSQITD  365 (399)
Q Consensus       343 ~~ll~~cl~~dP~~Rps~~ell~  365 (399)
                      .+||.+||+.||.+|||+.|+++
T Consensus       249 ~~li~~~L~~dP~~Rpt~~e~l~  271 (326)
T 2y0a_A          249 KDFIRRLLVKDPKKRMTIQDSLQ  271 (326)
T ss_dssp             HHHHHHHSCSSGGGSCCHHHHHH
T ss_pred             HHHHHHHccCChhhCCCHHHHhc
Confidence            99999999999999999999986

>3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens}

Probab=100.00  E-value=6.8e-47  Score=361.75  Aligned_cols=249  Identities=22%  Similarity=0.267  Sum_probs=209.3

Q ss_pred             eecccccceeceeceeCceEEEEEEE--CCeeEEEEEecCCCCCHHHHHHHHHHHHHHHhc-CCCceeeEEeEEecCCcE
Q 015868          112 EIDAKQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKI-RHKNVVQFIGACTRPPNL  188 (399)
Q Consensus       112 ~i~~~~~~i~~~lg~G~~g~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~Ei~~l~~l-~h~nIv~~~~~~~~~~~~  188 (399)
                      .+..++|++.++||+|+||.||+|++  .++.||||++............+..|+..+.++ +||||+++++++..+...
T Consensus        53 ~~~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~~~~~~~h~~iv~l~~~~~~~~~~  132 (311)
T 3p1a_A           53 SFFQQSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAWEEGGIL  132 (311)
T ss_dssp             CHHHHHEEEEEEEEEETTEEEEEEEETTTSCEEEEEEESSSCCSHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEE
T ss_pred             chhhhheeeeheeccCCCeEEEEEEECCCCeEEEEEEecccccChHHHHHHHHHHHHHHHhcCCCcEEEEEEEEEeCCEE
Confidence            44457899999999999999999998  478999999987655566556666676666665 899999999999999999


Q ss_pred             EEEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceeecCCCcEEEeeccceeeccCCC
Q 015868          189 CIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSG  268 (399)
Q Consensus       189 ~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~giiHrDlkp~NILl~~~~~vkl~DFG~a~~~~~~~  268 (399)
                      ++||||+ +++|.+++......+++..++.++.|++.||+|||++||+||||||+|||++.++.+||+|||+++......
T Consensus       133 ~lv~e~~-~~~L~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIll~~~~~~kl~DFG~a~~~~~~~  211 (311)
T 3p1a_A          133 YLQTELC-GPSLQQHCEAWGASLPEAQVWGYLRDTLLALAHLHSQGLVHLDVKPANIFLGPRGRCKLGDFGLLVELGTAG  211 (311)
T ss_dssp             EEEEECC-CCBHHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECGGGCEEECCCTTCEECC---
T ss_pred             EEEEecc-CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEECCCCCEEEccceeeeecccCC
Confidence            9999999 569999998877789999999999999999999999999999999999999999999999999998776665


Q ss_pred             ccccCCCCcccccccccCCCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhccCCCCCCCCCcHHHHHHHHH
Q 015868          269 VMTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRLAELLER  348 (399)
Q Consensus       269 ~~~~~~gt~~y~aPE~l~~~~~~~~~Dv~slG~vl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~  348 (399)
                      ......||+.|+|||++.+ .++.++||||||+++|+|++|..|+.....   ..........+..+..+++++.+++.+
T Consensus       212 ~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~el~~g~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~l~~li~~  287 (311)
T 3p1a_A          212 AGEVQEGDPRYMAPELLQG-SYGTAADVFSLGLTILEVACNMELPHGGEG---WQQLRQGYLPPEFTAGLSSELRSVLVM  287 (311)
T ss_dssp             ---CCCCCGGGCCGGGGGT-CCSTHHHHHHHHHHHHHHHHTCCCCSSHHH---HHHHTTTCCCHHHHTTSCHHHHHHHHH
T ss_pred             CCcccCCCccccCHhHhcC-CCCchhhHHHHHHHHHHHHhCCCCCCCccH---HHHHhccCCCcccccCCCHHHHHHHHH
Confidence            5566679999999999987 699999999999999999999766544322   222233333444566789999999999


Q ss_pred             HhhhcCCCCCCHHHHHH
Q 015868          349 CWQHDPTQRPNFSQITD  365 (399)
Q Consensus       349 cl~~dP~~Rps~~ell~  365 (399)
                      ||+.||++|||+.|+++
T Consensus       288 ~L~~dP~~Rpt~~ell~  304 (311)
T 3p1a_A          288 MLEPDPKLRATAEALLA  304 (311)
T ss_dssp             HSCSSTTTSCCHHHHHT
T ss_pred             HcCCChhhCcCHHHHHh
Confidence            99999999999999975

>1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A

Probab=100.00  E-value=3.2e-47  Score=359.61  Aligned_cols=249  Identities=24%  Similarity=0.410  Sum_probs=210.6

Q ss_pred             cccceeceeceeCceEEEEEEEC-CeeEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCceeeEEeEEecCCcEEEEEec
Q 015868          116 KQLKIECKVASGSYGDLYKGTYC-SQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVTEF  194 (399)
Q Consensus       116 ~~~~i~~~lg~G~~g~Vy~~~~~-~~~vAvK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~nIv~~~~~~~~~~~~~lV~E~  194 (399)
                      ++|++.++||+|+||.||+|+.. ++.||+|+++...........+.+|+.++++++||||+++++++......++||||
T Consensus         2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~   81 (288)
T 1ob3_A            2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEH   81 (288)
T ss_dssp             CSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred             ccchhhhhcccCCCEEEEEEEcCCCCEEEEEEEeccccccccchhHHHHHHHHHhcCCCCEeeeeeEEccCCeEEEEEEe
Confidence            57999999999999999999984 78999999976543333446788999999999999999999999999999999999


Q ss_pred             CCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceeecCCCcEEEeeccceeeccCC-CccccC
Q 015868          195 MARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQS-GVMTAE  273 (399)
Q Consensus       195 ~~ggsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~giiHrDlkp~NILl~~~~~vkl~DFG~a~~~~~~-~~~~~~  273 (399)
                      +++ +|.+++....+.+++..++.++.|++.||.|||++||+||||||+||+++.++.+||+|||+++..... ......
T Consensus        82 ~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~  160 (288)
T 1ob3_A           82 LDQ-DLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHE  160 (288)
T ss_dssp             CSE-EHHHHHHTSTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC--------
T ss_pred             cCC-CHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCCEEEeECccccccCccccccccc
Confidence            986 999999887788999999999999999999999999999999999999999999999999999765432 233455


Q ss_pred             CCCcccccccccCCC-CCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhccCC----------------C----
Q 015868          274 TGTYRWMAPEVIEHK-PYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKSLR----------------P----  332 (399)
Q Consensus       274 ~gt~~y~aPE~l~~~-~~~~~~Dv~slG~vl~elltg~~P~~~~~~~~~~~~~~~~~~~----------------~----  332 (399)
                      .+|+.|+|||++.+. .++.++||||||+++|+|++|..||.+.+..+...........                +    
T Consensus       161 ~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (288)
T 1ob3_A          161 IVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYDPNFTV  240 (288)
T ss_dssp             -CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTTCCTTCCC
T ss_pred             cccccccCchheeCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHHCCCChhhchhhhccccccccccc
Confidence            789999999999764 5899999999999999999999999998876665554331110                0    


Q ss_pred             -------CCCCCCcHHHHHHHHHHhhhcCCCCCCHHHHHH
Q 015868          333 -------TIPKHAHPRLAELLERCWQHDPTQRPNFSQITD  365 (399)
Q Consensus       333 -------~~~~~~~~~l~~ll~~cl~~dP~~Rps~~ell~  365 (399)
                             .....+++++.+||.+||+.||++|||+.|+++
T Consensus       241 ~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~  280 (288)
T 1ob3_A          241 YEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALE  280 (288)
T ss_dssp             CCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             ccCccHHHHhhhcCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence                   112457899999999999999999999999875

>3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A

Probab=100.00  E-value=1.1e-46  Score=356.49  Aligned_cols=249  Identities=22%  Similarity=0.380  Sum_probs=212.9

Q ss_pred             cccceeceeceeCceEEEEEEE--CCeeEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCceeeEEeEEecCCcEEEEEe
Q 015868          116 KQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVTE  193 (399)
Q Consensus       116 ~~~~i~~~lg~G~~g~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~nIv~~~~~~~~~~~~~lV~E  193 (399)
                      ++|++.++||+|+||.||+|++  +++.||+|+++...........+.+|+.++++++||||+++++++..+..+++|||
T Consensus         2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e   81 (292)
T 3o0g_A            2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE   81 (292)
T ss_dssp             CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             CCceeeeEecCCCCeEEEEEEECCCCceEEEEeeeccCCcCCcchHHHHHHHHHhcCCCCCEeeEEeEEEeCCEEEEEEe
Confidence            5799999999999999999998  57889999998766666667889999999999999999999999999999999999


Q ss_pred             cCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceeecCCCcEEEeeccceeeccCC-Ccccc
Q 015868          194 FMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQS-GVMTA  272 (399)
Q Consensus       194 ~~~ggsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~giiHrDlkp~NILl~~~~~vkl~DFG~a~~~~~~-~~~~~  272 (399)
                      |+++ ++.+.+....+.+++..++.++.|++.||+|||++||+||||||+||+++.++.+||+|||+++..... .....
T Consensus        82 ~~~~-~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~  160 (292)
T 3o0g_A           82 FCDQ-DLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSA  160 (292)
T ss_dssp             CCSE-EHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECCSCCSCCCS
T ss_pred             cCCC-CHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEeecccceecCCccccccC
Confidence            9976 777777776788999999999999999999999999999999999999999999999999999876533 23455


Q ss_pred             CCCCcccccccccCCCC-CCChhhHHHHHHHHHHHHcCCCC-CCCCCHHHHHHHHHhccCC-------------------
Q 015868          273 ETGTYRWMAPEVIEHKP-YDYKADVFSFGIALWELLTGELP-YAGLTPLQAAVGVVQKSLR-------------------  331 (399)
Q Consensus       273 ~~gt~~y~aPE~l~~~~-~~~~~Dv~slG~vl~elltg~~P-~~~~~~~~~~~~~~~~~~~-------------------  331 (399)
                      ..||+.|+|||++.+.. ++.++||||||+++|+|++|..| |.+.+..+....+......                   
T Consensus       161 ~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~~~~p~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~  240 (292)
T 3o0g_A          161 EVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDYKPYP  240 (292)
T ss_dssp             CCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTCTTGGGSTTCCCCC
T ss_pred             CccccCCcChHHHcCCCCcCchHHHHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCCCChhhhhhhcccccccccc
Confidence            67899999999998765 89999999999999999987766 5565555544443321111                   


Q ss_pred             --------CCCCCCCcHHHHHHHHHHhhhcCCCCCCHHHHHH
Q 015868          332 --------PTIPKHAHPRLAELLERCWQHDPTQRPNFSQITD  365 (399)
Q Consensus       332 --------~~~~~~~~~~l~~ll~~cl~~dP~~Rps~~ell~  365 (399)
                              ......+++++.+||.+||+.||++|||++|+++
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~  282 (292)
T 3o0g_A          241 MYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQ  282 (292)
T ss_dssp             CCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             cccCCcchhhcccccChHHHHHHHHHhccChhhCCCHHHHhc
Confidence                    1122357899999999999999999999999875

>3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ...

Probab=100.00  E-value=3.9e-47  Score=365.99  Aligned_cols=260  Identities=28%  Similarity=0.584  Sum_probs=221.4

Q ss_pred             eecccccceeceeceeCceEEEEEEEC--Ce----eEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCceeeEEeEEecC
Q 015868          112 EIDAKQLKIECKVASGSYGDLYKGTYC--SQ----EVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRP  185 (399)
Q Consensus       112 ~i~~~~~~i~~~lg~G~~g~Vy~~~~~--~~----~vAvK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~nIv~~~~~~~~~  185 (399)
                      .+..++|++.+.||+|+||.||+|++.  ++    .||+|.++... .....+.+.+|+.++++++||||+++++++..+
T Consensus        11 ~l~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~   89 (327)
T 3poz_A           11 ILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREAT-SPKANKEILDEAYVMASVDNPHVCRLLGICLTS   89 (327)
T ss_dssp             ECCGGGEEEEEEEEEETTEEEEEEEECC----CCEEEEEEEC--------CHHHHHHHHHHHHHCCBTTBCCEEEEEESS
T ss_pred             hcCHHHcccceEEeeCCCeEEEEEEEcCCCceEEEEEEEeeccccc-CHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecC
Confidence            456789999999999999999999873  33    36888876432 334457899999999999999999999999876


Q ss_pred             CcEEEEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceeecCCCcEEEeeccceeecc
Q 015868          186 PNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQA  265 (399)
Q Consensus       186 ~~~~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~giiHrDlkp~NILl~~~~~vkl~DFG~a~~~~  265 (399)
                      . .++|+||+.+|+|.+++......+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++...
T Consensus        90 ~-~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~  168 (327)
T 3poz_A           90 T-VQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLG  168 (327)
T ss_dssp             S-EEEEEECCTTCBHHHHHHHSTTSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEETTEEEECCTTHHHHHT
T ss_pred             C-eEEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCChheEEECCCCCEEEccCcceeEcc
Confidence            5 789999999999999998878889999999999999999999999999999999999999999999999999998655


Q ss_pred             CCCc---cccCCCCcccccccccCCCCCCChhhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHHhccCCCCCCCCCcHH
Q 015868          266 QSGV---MTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLT-GELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPR  341 (399)
Q Consensus       266 ~~~~---~~~~~gt~~y~aPE~l~~~~~~~~~Dv~slG~vl~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  341 (399)
                      ....   .....+|+.|+|||.+.+..++.++||||||+++|+|+| |..||.+.+..+.. ..+....++..+..++.+
T Consensus       169 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~-~~~~~~~~~~~~~~~~~~  247 (327)
T 3poz_A          169 AEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEIS-SILEKGERLPQPPICTID  247 (327)
T ss_dssp             TTCC-------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHH-HHHHTTCCCCCCTTBCHH
T ss_pred             CCcccccccCCCccccccChHHhccCCCCchhhhhhhHHHHHHHHhcCCCCccCCCHHHHH-HHHHcCCCCCCCccCCHH
Confidence            4332   223456889999999999999999999999999999999 99999988776644 345555666778889999


Q ss_pred             HHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHH
Q 015868          342 LAELLERCWQHDPTQRPNFSQITDILKQMMKEV  374 (399)
Q Consensus       342 l~~ll~~cl~~dP~~Rps~~ell~~L~~l~~~~  374 (399)
                      +.+++.+||+.||.+|||+.++++.|+.+.+..
T Consensus       248 ~~~li~~~l~~~p~~Rps~~ell~~l~~~~~~~  280 (327)
T 3poz_A          248 VYMIMVKCWMIDADSRPKFRELIIEFSKMARDP  280 (327)
T ss_dssp             HHHHHHHHTCSCGGGSCCHHHHHHHHHHHHTSH
T ss_pred             HHHHHHHHcCCChhhCCCHHHHHHHHHHHHhhh
Confidence            999999999999999999999999999987654

>3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B*

Probab=100.00  E-value=7.7e-47  Score=372.29  Aligned_cols=257  Identities=21%  Similarity=0.410  Sum_probs=217.0

Q ss_pred             Cceeecccccceeceecee--CceEEEEEEEC--CeeEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCceeeEEeEEec
Q 015868          109 DVWEIDAKQLKIECKVASG--SYGDLYKGTYC--SQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTR  184 (399)
Q Consensus       109 ~~~~i~~~~~~i~~~lg~G--~~g~Vy~~~~~--~~~vAvK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~nIv~~~~~~~~  184 (399)
                      ..+....++|++.++||+|  +||.||+|++.  ++.||||+++.........+.+.+|+.+++.++||||+++++++..
T Consensus        18 s~~~~~~~~y~~~~~lG~G~~~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~   97 (389)
T 3gni_B           18 SSFLPEGGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYRATFIA   97 (389)
T ss_dssp             CCCCCCGGGEEEEEEEEEETTTTEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEE
T ss_pred             hcccCCCCcEEEEecccCCcCCceEEEEEEEcCCCCEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCCCcEeEEEEE
Confidence            3455678899999999999  99999999984  8899999998776677778889999999999999999999999999


Q ss_pred             CCcEEEEEecCCCCCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceeecCCCcEEEeeccceee
Q 015868          185 PPNLCIVTEFMARGSIYDFLHKQ-KGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARV  263 (399)
Q Consensus       185 ~~~~~lV~E~~~ggsL~~~l~~~-~~~l~~~~~~~i~~~i~~~L~~LH~~giiHrDlkp~NILl~~~~~vkl~DFG~a~~  263 (399)
                      +..+++||||+++++|.+++... ...+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||.+..
T Consensus        98 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~NIll~~~~~~kl~dfg~~~~  177 (389)
T 3gni_B           98 DNELWVVTSFMAYGSAKDLICTHFMDGMNELAIAYILQGVLKALDYIHHMGYVHRSVKASHILISVDGKVYLSGLRSNLS  177 (389)
T ss_dssp             TTEEEEEEECCTTCBHHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCGGGCEE
T ss_pred             CCEEEEEEEccCCCCHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEccccccee
Confidence            99999999999999999999764 36699999999999999999999999999999999999999999999999999865


Q ss_pred             ccCCC--------ccccCCCCcccccccccCC--CCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhccC---
Q 015868          264 QAQSG--------VMTAETGTYRWMAPEVIEH--KPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKSL---  330 (399)
Q Consensus       264 ~~~~~--------~~~~~~gt~~y~aPE~l~~--~~~~~~~Dv~slG~vl~elltg~~P~~~~~~~~~~~~~~~~~~---  330 (399)
                      ....+        ......||+.|+|||++.+  ..|+.++|||||||++|+|++|+.||.+.+..+..........   
T Consensus       178 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~  257 (389)
T 3gni_B          178 MISHGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVPCL  257 (389)
T ss_dssp             CEETTEECSCBCCCCTTCTTTGGGSCHHHHSTTSSCBCTHHHHHHHHHHHHHHHHSSCTTTTCCSTTHHHHC--------
T ss_pred             eccccccccccccccccccccccccCHHHHhccCCCCCcHhHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhcCCCCcc
Confidence            33221        1223468999999999987  6799999999999999999999999987665554433222111   


Q ss_pred             -----------------------------------------CCCCCCCCcHHHHHHHHHHhhhcCCCCCCHHHHHH
Q 015868          331 -----------------------------------------RPTIPKHAHPRLAELLERCWQHDPTQRPNFSQITD  365 (399)
Q Consensus       331 -----------------------------------------~~~~~~~~~~~l~~ll~~cl~~dP~~Rps~~ell~  365 (399)
                                                               ....+..+++++.+||.+||+.||.+|||+.|+++
T Consensus       258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~ell~  333 (389)
T 3gni_B          258 LDTSTIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHFVEQCLQRNPDARPSASTLLN  333 (389)
T ss_dssp             ------------------------------------------------CCHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred             ccccccccccccccccccccccccccccccCccccccCCCCCCccccccCHHHHHHHHHHhhcCcccCCCHHHHhc
Confidence                                                     11234567899999999999999999999999985

>3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A*

Probab=100.00  E-value=7.6e-47  Score=360.90  Aligned_cols=266  Identities=28%  Similarity=0.527  Sum_probs=222.8

Q ss_pred             CCceeecccccceeceeceeCceEEEEEEEC-----CeeEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCceeeEEeEE
Q 015868          108 TDVWEIDAKQLKIECKVASGSYGDLYKGTYC-----SQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGAC  182 (399)
Q Consensus       108 ~~~~~i~~~~~~i~~~lg~G~~g~Vy~~~~~-----~~~vAvK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~nIv~~~~~~  182 (399)
                      ...+.++.++|++.+.||+|+||.||+|+..     +..||+|+++.........+.+.+|+.++++++||||+++++++
T Consensus        26 ~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~  105 (313)
T 3brb_A           26 LEDVVIDRNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRLLGVC  105 (313)
T ss_dssp             TTTTBCCGGGEEEEEEEEC-CCCCEEEEEEECTTSCEEEEEEEEC---CCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEE
T ss_pred             HHhcccCHHHeeeccceeecCCeEEEEEEEeccCCceeEEEEEEEeccccchhHHHHHHHHHHHHhcCCCCCeeeeeEEE
Confidence            3556788999999999999999999999763     34799999987766777788999999999999999999999999


Q ss_pred             ecCC-----cEEEEEecCCCCCHHHHHHh-----cCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceeecCCCc
Q 015868          183 TRPP-----NLCIVTEFMARGSIYDFLHK-----QKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGV  252 (399)
Q Consensus       183 ~~~~-----~~~lV~E~~~ggsL~~~l~~-----~~~~l~~~~~~~i~~~i~~~L~~LH~~giiHrDlkp~NILl~~~~~  252 (399)
                      ....     ..++||||+++++|.+++..     ....+++..++.++.||+.||.|||++||+||||||+||+++.++.
T Consensus       106 ~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dikp~NIli~~~~~  185 (313)
T 3brb_A          106 IEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSNRNFLHRDLAARNCMLRDDMT  185 (313)
T ss_dssp             EC-------CEEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHHTTTCCCCCCSGGGEEECTTSC
T ss_pred             eeccccCCcccEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEEcCCCc
Confidence            7754     35999999999999999953     2356999999999999999999999999999999999999999999


Q ss_pred             EEEeeccceeeccCCC---ccccCCCCcccccccccCCCCCCChhhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHHhc
Q 015868          253 VKVADFGVARVQAQSG---VMTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLT-GELPYAGLTPLQAAVGVVQK  328 (399)
Q Consensus       253 vkl~DFG~a~~~~~~~---~~~~~~gt~~y~aPE~l~~~~~~~~~Dv~slG~vl~ellt-g~~P~~~~~~~~~~~~~~~~  328 (399)
                      +||+|||+++......   ......+++.|+|||.+.+..++.++||||||+++|+|++ |..||...+..+..... ..
T Consensus       186 ~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~-~~  264 (313)
T 3brb_A          186 VCVADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTPYPGVQNHEMYDYL-LH  264 (313)
T ss_dssp             EEECSCSCC----------------CCGGGSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHH-HT
T ss_pred             EEEeecCcceecccccccCcccccCCCccccCchhhcCCCccchhhhHHHHHHHHHHHhcCCCCCccCCHHHHHHHH-Hc
Confidence            9999999997654332   1233456889999999999999999999999999999999 99999988776655543 34


Q ss_pred             cCCCCCCCCCcHHHHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHH
Q 015868          329 SLRPTIPKHAHPRLAELLERCWQHDPTQRPNFSQITDILKQMMKEV  374 (399)
Q Consensus       329 ~~~~~~~~~~~~~l~~ll~~cl~~dP~~Rps~~ell~~L~~l~~~~  374 (399)
                      ..++..+..+++++.+++.+||+.||.+|||+.++++.|+++++.+
T Consensus       265 ~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~l~~~l  310 (313)
T 3brb_A          265 GHRLKQPEDCLDELYEIMYSCWRTDPLDRPTFSVLRLQLEKLLESL  310 (313)
T ss_dssp             TCCCCCBTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHHC
T ss_pred             CCCCCCCccccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhc
Confidence            5567778889999999999999999999999999999999998764

>1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A*

Probab=100.00  E-value=3.6e-47  Score=359.97  Aligned_cols=260  Identities=17%  Similarity=0.275  Sum_probs=221.3

Q ss_pred             eecccccceeceeceeCceEEEEEEE--CCeeEEEEEecCCCCCHHHHHHHHHHHHHHHhc-CCCceeeEEeEEecCCcE
Q 015868          112 EIDAKQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKI-RHKNVVQFIGACTRPPNL  188 (399)
Q Consensus       112 ~i~~~~~~i~~~lg~G~~g~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~Ei~~l~~l-~h~nIv~~~~~~~~~~~~  188 (399)
                      .+..++|++.+.||+|+||.||+|++  .++.||+|+++....    ...+.+|+.+++.+ +|+|++++++++......
T Consensus         6 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~----~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~   81 (298)
T 1csn_A            6 NVVGVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSD----APQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHN   81 (298)
T ss_dssp             CEETTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTT----SCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEE
T ss_pred             cccccceEEEEEEeecCCEEEEEEEECCCCcEEEEEEeccCCc----cHHHHHHHHHHHHHhcCCCCCeEEeecCCCcee
Confidence            45577999999999999999999995  689999999875432    23577899999999 799999999999999999


Q ss_pred             EEEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceeecCCCc-----EEEeeccceee
Q 015868          189 CIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGV-----VKVADFGVARV  263 (399)
Q Consensus       189 ~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~giiHrDlkp~NILl~~~~~-----vkl~DFG~a~~  263 (399)
                      ++||||+ +++|.+++......+++..++.++.||+.||.|||++||+||||||+||+++.++.     +||+|||+++.
T Consensus        82 ~lv~e~~-~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~~~~~~kl~Dfg~~~~  160 (298)
T 1csn_A           82 VLVIDLL-GPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKF  160 (298)
T ss_dssp             EEEEECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECCSSSTTTTCEEECCCTTCEE
T ss_pred             EEEEEec-CCCHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEeccCCCCCCCeEEEEECccccc
Confidence            9999999 88999999887777999999999999999999999999999999999999987776     99999999987


Q ss_pred             ccCCCc--------cccCCCCcccccccccCCCCCCChhhHHHHHHHHHHHHcCCCCCCCCC---HHHHHHHHHhccC--
Q 015868          264 QAQSGV--------MTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPYAGLT---PLQAAVGVVQKSL--  330 (399)
Q Consensus       264 ~~~~~~--------~~~~~gt~~y~aPE~l~~~~~~~~~Dv~slG~vl~elltg~~P~~~~~---~~~~~~~~~~~~~--  330 (399)
                      ......        .....||+.|+|||++.+..++.++||||||+++|+|++|+.||.+.+   ..+..........  
T Consensus       161 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~  240 (298)
T 1csn_A          161 YRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQST  240 (298)
T ss_dssp             SBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHHHHS
T ss_pred             cccccccccccccCccCCCCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHcCCCCcchhhccccHHHHHHHHhhccCc
Confidence            654322        234568999999999999999999999999999999999999998743   3333332222211  


Q ss_pred             -CCCCCCCCcHHHHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHh
Q 015868          331 -RPTIPKHAHPRLAELLERCWQHDPTQRPNFSQITDILKQMMKEVAS  376 (399)
Q Consensus       331 -~~~~~~~~~~~l~~ll~~cl~~dP~~Rps~~ell~~L~~l~~~~~~  376 (399)
                       .+.....+++++.+++.+||+.||++|||+.++++.|+++++....
T Consensus       241 ~~~~~~~~~~~~l~~li~~~l~~dp~~RP~~~~l~~~l~~~~~~~~~  287 (298)
T 1csn_A          241 PLRELCAGFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKVLERLNT  287 (298)
T ss_dssp             CHHHHTTTSCHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHHTTC
T ss_pred             cHHHHHhhCcHHHHHHHHHHhcCCcccCCCHHHHHHHHHHHHHhcCC
Confidence             1223457889999999999999999999999999999999876643

>1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A

Probab=100.00  E-value=2.5e-47  Score=387.76  Aligned_cols=260  Identities=36%  Similarity=0.719  Sum_probs=231.0

Q ss_pred             CCceeecccccceeceeceeCceEEEEEEEC--CeeEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCceeeEEeEEecC
Q 015868          108 TDVWEIDAKQLKIECKVASGSYGDLYKGTYC--SQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRP  185 (399)
Q Consensus       108 ~~~~~i~~~~~~i~~~lg~G~~g~Vy~~~~~--~~~vAvK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~nIv~~~~~~~~~  185 (399)
                      .+.|++..++|++.++||+|+||.||+|.+.  +..||||+++.....   .+.|.+|+.+|++++||||+++++++...
T Consensus       212 ~~~~~~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~---~~~~~~E~~~l~~l~hpniv~l~~~~~~~  288 (495)
T 1opk_A          212 YDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME---VEEFLKEAAVMKEIKHPNLVQLLGVCTRE  288 (495)
T ss_dssp             SSCCBCCGGGEEEEEESGGGTTSSEEEEEEGGGTEEEEEEECCSSSSC---HHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred             ccccccCHHHceeeeEecCCCCeEEEEEEEcCCCeEEEEEEecCcccc---hHHHHHHHHHHHhcCCCCEeeEEEEEecC
Confidence            3568999999999999999999999999985  789999999865433   46799999999999999999999999999


Q ss_pred             CcEEEEEecCCCCCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceeecCCCcEEEeeccceeec
Q 015868          186 PNLCIVTEFMARGSIYDFLHKQ-KGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQ  264 (399)
Q Consensus       186 ~~~~lV~E~~~ggsL~~~l~~~-~~~l~~~~~~~i~~~i~~~L~~LH~~giiHrDlkp~NILl~~~~~vkl~DFG~a~~~  264 (399)
                      ..+++||||+.+|+|.+++... ...+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+++..
T Consensus       289 ~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~  368 (495)
T 1opk_A          289 PPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRNLAARNCLVGENHLVKVADFGLSRLM  368 (495)
T ss_dssp             SSCEEEEECCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECGGGCEEECCTTCEECC
T ss_pred             CcEEEEEEccCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChhhEEECCCCcEEEeecccceec
Confidence            9999999999999999999864 356899999999999999999999999999999999999999999999999999875


Q ss_pred             cCCCc--cccCCCCcccccccccCCCCCCChhhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHHhccCCCCCCCCCcHH
Q 015868          265 AQSGV--MTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLT-GELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPR  341 (399)
Q Consensus       265 ~~~~~--~~~~~gt~~y~aPE~l~~~~~~~~~Dv~slG~vl~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  341 (399)
                      .....  .....++..|+|||++.+..++.++||||||+++|||+| |..||.+.+..+... .+....+...|..++++
T Consensus       369 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlG~~l~el~t~g~~p~~~~~~~~~~~-~~~~~~~~~~~~~~~~~  447 (495)
T 1opk_A          369 TGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYE-LLEKDYRMERPEGCPEK  447 (495)
T ss_dssp             TTCCEECCTTCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHH-HHHTTCCCCCCTTCCHH
T ss_pred             cCCceeecCCCcCCcceeCHhHHhcCCCCcHHhHHhHHHHHHHHHhCCCCCCCCCCHHHHHH-HHHcCCCCCCCCCCCHH
Confidence            44322  122345778999999998899999999999999999999 999999988766544 45556777888899999


Q ss_pred             HHHHHHHHhhhcCCCCCCHHHHHHHHHHHH
Q 015868          342 LAELLERCWQHDPTQRPNFSQITDILKQMM  371 (399)
Q Consensus       342 l~~ll~~cl~~dP~~Rps~~ell~~L~~l~  371 (399)
                      +.+||.+||+.||.+|||+.++++.|+.+.
T Consensus       448 l~~li~~cl~~dP~~RPs~~el~~~L~~~~  477 (495)
T 1opk_A          448 VYELMRACWQWNPSDRPSFAEIHQAFETMF  477 (495)
T ss_dssp             HHHHHHHHTCSSGGGSCCHHHHHHHHHTSC
T ss_pred             HHHHHHHHcCcChhHCcCHHHHHHHHHHHH
Confidence            999999999999999999999999998774

>3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A

Probab=100.00  E-value=2.6e-47  Score=372.57  Aligned_cols=268  Identities=19%  Similarity=0.296  Sum_probs=215.7

Q ss_pred             CceeecccccceeceeceeCceEEEEEEEC-------CeeEEEEEecCCCCCHHH---------HHHHHHHHHHHHhcCC
Q 015868          109 DVWEIDAKQLKIECKVASGSYGDLYKGTYC-------SQEVAIKVLKPECVNTEM---------LKEFSQEVYIMRKIRH  172 (399)
Q Consensus       109 ~~~~i~~~~~~i~~~lg~G~~g~Vy~~~~~-------~~~vAvK~~~~~~~~~~~---------~~~~~~Ei~~l~~l~h  172 (399)
                      ...++..++|++.++||+|+||.||+|.+.       ++.||||++.........         ...+.+|+..++.++|
T Consensus        28 ~i~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h  107 (364)
T 3op5_A           28 IITDMAAAAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKY  107 (364)
T ss_dssp             EEECTTCCEEEEEEECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTCHHHHHHHHHHHHHCCHHHHHHHHHHTTCSC
T ss_pred             EeeccCCCeEEEEEEEecCCCeEEEEeeecCccccccccceEEEEeeccchhHHHHHHHHHhhhhhHHHHHHHHHhhccC
Confidence            344466789999999999999999999873       478999999765311100         0123456667778889


Q ss_pred             CceeeEEeEEecC----CcEEEEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceeec
Q 015868          173 KNVVQFIGACTRP----PNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMD  248 (399)
Q Consensus       173 ~nIv~~~~~~~~~----~~~~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~giiHrDlkp~NILl~  248 (399)
                      |||+++++++...    ...++||||+ |++|.+++......+++..++.++.||+.||.|||++||+||||||+|||++
T Consensus       108 ~~iv~~~~~~~~~~~~~~~~~lv~e~~-g~~L~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~iiHrDlkp~Nill~  186 (364)
T 3op5_A          108 LGVPKYWGSGLHDKNGKSYRFMIMDRF-GSDLQKIYEANAKRFSRKTVLQLSLRILDILEYIHEHEYVHGDIKASNLLLN  186 (364)
T ss_dssp             CCSCCEEEEEEEEETTEEEEEEEEECE-EEEHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEE
T ss_pred             CCCCeEEeeeeeccCCcceEEEEEeCC-CCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeEEecCCHHHEEEe
Confidence            9999999998764    4589999999 8999999988778899999999999999999999999999999999999999


Q ss_pred             --CCCcEEEeeccceeeccCCCcc--------ccCCCCcccccccccCCCCCCChhhHHHHHHHHHHHHcCCCCCCCCCH
Q 015868          249 --ENGVVKVADFGVARVQAQSGVM--------TAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPYAGLTP  318 (399)
Q Consensus       249 --~~~~vkl~DFG~a~~~~~~~~~--------~~~~gt~~y~aPE~l~~~~~~~~~Dv~slG~vl~elltg~~P~~~~~~  318 (399)
                        .++.+||+|||+++........        ....||+.|+|||++.+..++.++||||||+++|+|+||+.||.+...
T Consensus       187 ~~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~Pf~~~~~  266 (364)
T 3op5_A          187 YKNPDQVYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNGVAPSRRGDLEILGYCMIQWLTGHLPWEDNLK  266 (364)
T ss_dssp             SSCTTCEEECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGGGTT
T ss_pred             cCCCCeEEEEECCcceecccCCcccccccCcccccCCCCCccCHHHhCCCCCCchhhHHHHHHHHHHHHhCCCCcccccc
Confidence              8899999999999865443211        233499999999999999999999999999999999999999986433


Q ss_pred             HHHHHHHHhccCCCC---------CCCCCcHHHHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHhc
Q 015868          319 LQAAVGVVQKSLRPT---------IPKHAHPRLAELLERCWQHDPTQRPNFSQITDILKQMMKEVASE  377 (399)
Q Consensus       319 ~~~~~~~~~~~~~~~---------~~~~~~~~l~~ll~~cl~~dP~~Rps~~ell~~L~~l~~~~~~~  377 (399)
                      .............+.         .+..+++++.+++.+||+.+|.+||++.+|++.|+++++.....
T Consensus       267 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RP~~~~l~~~l~~~~~~~~~~  334 (364)
T 3op5_A          267 DPKYVRDSKIRYRENIASLMDKCFPAANAPGEIAKYMETVKLLDYTEKPLYENLRDILLQGLKAIGSK  334 (364)
T ss_dssp             CHHHHHHHHHHHHHCHHHHHHHHSCTTCCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHHTTCC
T ss_pred             CHHHHHHHHHHhhhhHHHHHHHhcccccCHHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHcCCC
Confidence            222222111111111         12567899999999999999999999999999999999877543

>3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A*

Probab=100.00  E-value=7.4e-47  Score=363.54  Aligned_cols=262  Identities=26%  Similarity=0.506  Sum_probs=225.4

Q ss_pred             eecccccceeceeceeCceEEEEEEE------CCeeEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCceeeEEeEEe--
Q 015868          112 EIDAKQLKIECKVASGSYGDLYKGTY------CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACT--  183 (399)
Q Consensus       112 ~i~~~~~~i~~~lg~G~~g~Vy~~~~------~~~~vAvK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~nIv~~~~~~~--  183 (399)
                      -++.++|++.+.||+|+||.||++++      .++.||+|++...  .....+.+.+|+.++++++||||+++++++.  
T Consensus        19 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~   96 (327)
T 3lxl_A           19 IFEERHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHS--GPDQQRDFQREIQILKALHSDFIVKYRGVSYGP   96 (327)
T ss_dssp             BCCGGGEEEEEEEEEETTEEEEEEEECTTSSSCSEEEEEEEESSC--CHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECS
T ss_pred             hhchhhhhhhhhccCCCCeEEEEEEeccCCCCcceEEEEEEeccC--CHHHHHHHHHHHHHHHhcCCCceeEEEEEEecC
Confidence            36678999999999999999999985      5788999999865  4666678999999999999999999999986  


Q ss_pred             cCCcEEEEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceeecCCCcEEEeeccceee
Q 015868          184 RPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARV  263 (399)
Q Consensus       184 ~~~~~~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~giiHrDlkp~NILl~~~~~vkl~DFG~a~~  263 (399)
                      .....++||||+++++|.+++......+++..++.++.|++.||.|||++||+||||||+||+++.++.+||+|||.++.
T Consensus        97 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~  176 (327)
T 3lxl_A           97 GRQSLRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKGMEYLGSRRCVHRDLAARNILVESEAHVKIADFGLAKL  176 (327)
T ss_dssp             SSCEEEEEEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECCGGGCEE
T ss_pred             CCceEEEEEeecCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCChhhEEECCCCCEEEccccccee
Confidence            45568999999999999999987667799999999999999999999999999999999999999999999999999987


Q ss_pred             ccCCCc----cccCCCCcccccccccCCCCCCChhhHHHHHHHHHHHHcCCCCCCCCCH--------------HHHHHHH
Q 015868          264 QAQSGV----MTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPYAGLTP--------------LQAAVGV  325 (399)
Q Consensus       264 ~~~~~~----~~~~~gt~~y~aPE~l~~~~~~~~~Dv~slG~vl~elltg~~P~~~~~~--------------~~~~~~~  325 (399)
                      ......    .....+|+.|+|||++.+..++.++||||||+++|+|++|..||.....              .......
T Consensus       177 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  256 (327)
T 3lxl_A          177 LPLDKDYYVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGCERDVPALSRLLEL  256 (327)
T ss_dssp             CCTTCSEEECSSCCCSCGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHCC----CCHHHHHHHH
T ss_pred             cccCCccceeeccCCccccccCHHHhccCCCChHHhHHHHHHHHHHHHhCCCCCccccchhhhhcccccccccHHHHHHH
Confidence            654332    2334578889999999998899999999999999999999999854332              2333444


Q ss_pred             HhccCCCCCCCCCcHHHHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHH
Q 015868          326 VQKSLRPTIPKHAHPRLAELLERCWQHDPTQRPNFSQITDILKQMMKEVA  375 (399)
Q Consensus       326 ~~~~~~~~~~~~~~~~l~~ll~~cl~~dP~~Rps~~ell~~L~~l~~~~~  375 (399)
                      .....++..+..+++++.+++.+||+.||.+|||+.++++.|+.+.....
T Consensus       257 ~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~~~  306 (327)
T 3lxl_A          257 LEEGQRLPAPPACPAEVHELMKLCWAPSPQDRPSFSALGPQLDMLWSGSR  306 (327)
T ss_dssp             HHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHC-----
T ss_pred             hhcccCCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhhhc
Confidence            55666777888999999999999999999999999999999999876554

>1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A*

Probab=100.00  E-value=3.8e-47  Score=356.96  Aligned_cols=257  Identities=34%  Similarity=0.680  Sum_probs=219.1

Q ss_pred             CceeecccccceeceeceeCceEEEEEEECCeeEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCceeeEEeEEecC-Cc
Q 015868          109 DVWEIDAKQLKIECKVASGSYGDLYKGTYCSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRP-PN  187 (399)
Q Consensus       109 ~~~~i~~~~~~i~~~lg~G~~g~Vy~~~~~~~~vAvK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~nIv~~~~~~~~~-~~  187 (399)
                      ..|.++.++|++.+.||+|+||.||++++.++.||+|+++...    ..+.+.+|+.++++++||||+++++++... ..
T Consensus        14 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~vavK~~~~~~----~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~   89 (278)
T 1byg_A           14 SGWALNMKELKLLQTIGKGEFGDVMLGDYRGNKVAVKCIKNDA----TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGG   89 (278)
T ss_dssp             -CCBCCGGGEEEEEEEEECSSCEEEEEEETTEEEEEEECCCCC------HHHHHTHHHHTTCCCTTBCCEEEEECCC--C
T ss_pred             ccccCChhhceEEeEEecCCCceEEEEEEcCCEEEEEEecchh----HHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCCc
Confidence            4578889999999999999999999999999999999998542    346788999999999999999999997554 47


Q ss_pred             EEEEEecCCCCCHHHHHHhcCC-CCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceeecCCCcEEEeeccceeeccC
Q 015868          188 LCIVTEFMARGSIYDFLHKQKG-VFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQ  266 (399)
Q Consensus       188 ~~lV~E~~~ggsL~~~l~~~~~-~l~~~~~~~i~~~i~~~L~~LH~~giiHrDlkp~NILl~~~~~vkl~DFG~a~~~~~  266 (399)
                      .++||||+++++|.+++..... .+++..++.++.|++.||.|||++||+||||||+||+++.++.+||+|||.++....
T Consensus        90 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~  169 (278)
T 1byg_A           90 LYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASS  169 (278)
T ss_dssp             CEEEECCCTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTSCEEECCCCC------
T ss_pred             eEEEEecCCCCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHhCCccccCCCcceEEEeCCCcEEEeeccccccccc
Confidence            8999999999999999976432 378999999999999999999999999999999999999999999999999975443


Q ss_pred             CCccccCCCCcccccccccCCCCCCChhhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHHhccCCCCCCCCCcHHHHHH
Q 015868          267 SGVMTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLT-GELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRLAEL  345 (399)
Q Consensus       267 ~~~~~~~~gt~~y~aPE~l~~~~~~~~~Dv~slG~vl~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l  345 (399)
                      .  .....+++.|+|||.+.+..++.++||||||+++|+|+| |..||...+..+.... +....++..+..+++++.++
T Consensus       170 ~--~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~~~-~~~~~~~~~~~~~~~~l~~l  246 (278)
T 1byg_A          170 T--QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPR-VEKGYKMDAPDGCPPAVYEV  246 (278)
T ss_dssp             --------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGGHHHH-HTTTCCCCCCTTCCHHHHHH
T ss_pred             c--ccCCCccccccCHHHhCCCCCCchhcHHHHHHHHHHHHhCCCCCCCCCCHHHHHHH-HhcCCCCCCcccCCHHHHHH
Confidence            2  233467889999999999899999999999999999998 9999988776655443 44456677888899999999


Q ss_pred             HHHHhhhcCCCCCCHHHHHHHHHHHHH
Q 015868          346 LERCWQHDPTQRPNFSQITDILKQMMK  372 (399)
Q Consensus       346 l~~cl~~dP~~Rps~~ell~~L~~l~~  372 (399)
                      +.+||+.||.+|||+.++++.|+++..
T Consensus       247 i~~~l~~~p~~Rps~~~l~~~L~~i~~  273 (278)
T 1byg_A          247 MKNCWHLDAAMRPSFLQLREQLEHIKT  273 (278)
T ss_dssp             HHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             HHHHhcCChhhCCCHHHHHHHHHHHHh
Confidence            999999999999999999999999864

>1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ...

Probab=100.00  E-value=1.3e-46  Score=353.24  Aligned_cols=261  Identities=31%  Similarity=0.643  Sum_probs=228.3

Q ss_pred             CceeecccccceeceeceeCceEEEEEEEC-CeeEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCceeeEEeEEecCCc
Q 015868          109 DVWEIDAKQLKIECKVASGSYGDLYKGTYC-SQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPN  187 (399)
Q Consensus       109 ~~~~i~~~~~~i~~~lg~G~~g~Vy~~~~~-~~~vAvK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~nIv~~~~~~~~~~~  187 (399)
                      +.|++..++|++.+.||+|+||.||+|... ++.||+|+++.....   .+.+.+|+.++++++||||+++++++.. +.
T Consensus         6 ~~~~v~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~---~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~   81 (279)
T 1qpc_A            6 DEWEVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMS---PDAFLAEANLMKQLQHQRLVRLYAVVTQ-EP   81 (279)
T ss_dssp             CTTBCCGGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTSSC---HHHHHHHHHHHHHCCCTTBCCEEEEECS-SS
T ss_pred             hhcccCHHhhhheeeecCCCCeEEEEEEEcCCcEEEEEEecCCccc---HHHHHHHHHHHHhCCCcCcceEEEEEcC-CC
Confidence            568999999999999999999999999985 468999999865433   3578899999999999999999999875 45


Q ss_pred             EEEEEecCCCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceeecCCCcEEEeeccceeeccC
Q 015868          188 LCIVTEFMARGSIYDFLHKQK-GVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQ  266 (399)
Q Consensus       188 ~~lV~E~~~ggsL~~~l~~~~-~~l~~~~~~~i~~~i~~~L~~LH~~giiHrDlkp~NILl~~~~~vkl~DFG~a~~~~~  266 (399)
                      .++||||+++++|.+++.... ..+++..++.++.|++.||.|||++||+||||||+||++++++.+||+|||.++....
T Consensus        82 ~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~  161 (279)
T 1qpc_A           82 IYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIED  161 (279)
T ss_dssp             CEEEEECCTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEECSS
T ss_pred             cEEEEecCCCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHhhEEEcCCCCEEECCCcccccccC
Confidence            899999999999999996532 3689999999999999999999999999999999999999999999999999987654


Q ss_pred             CCc--cccCCCCcccccccccCCCCCCChhhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHHhccCCCCCCCCCcHHHH
Q 015868          267 SGV--MTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLT-GELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRLA  343 (399)
Q Consensus       267 ~~~--~~~~~gt~~y~aPE~l~~~~~~~~~Dv~slG~vl~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~  343 (399)
                      ...  .....++..|+|||.+.+..++.++||||||+++|+|++ |..||.+.+..+.... +....++..+..+++++.
T Consensus       162 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~-~~~~~~~~~~~~~~~~l~  240 (279)
T 1qpc_A          162 NEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQN-LERGYRMVRPDNCPEELY  240 (279)
T ss_dssp             SCEECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHH-HHTTCCCCCCTTCCHHHH
T ss_pred             cccccccCCCCccCccChhhhccCCCCchhhhHHHHHHHHHHHhCCCCCCcccCHHHHHHH-HhcccCCCCcccccHHHH
Confidence            332  223356788999999998889999999999999999999 9999998887765544 444556677888999999


Q ss_pred             HHHHHHhhhcCCCCCCHHHHHHHHHHHHHHH
Q 015868          344 ELLERCWQHDPTQRPNFSQITDILKQMMKEV  374 (399)
Q Consensus       344 ~ll~~cl~~dP~~Rps~~ell~~L~~l~~~~  374 (399)
                      +++.+||+.||++|||+.++++.|+++....
T Consensus       241 ~li~~~l~~~p~~Rps~~~l~~~l~~~~~~~  271 (279)
T 1qpc_A          241 QLMRLCWKERPEDRPTFDYLRSVLEDFFTAT  271 (279)
T ss_dssp             HHHHHHTCSSGGGSCCHHHHHHHHHHHHHHC
T ss_pred             HHHHHHhccChhhCCCHHHHHHHHHHHHHhc
Confidence            9999999999999999999999999998654

>3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens}

Probab=100.00  E-value=1.7e-47  Score=372.83  Aligned_cols=251  Identities=23%  Similarity=0.376  Sum_probs=213.9

Q ss_pred             eecccccceeceeceeCceEEEEEEE--CCeeEEEEEecCCCC-CHHHHHHHHHHHHHHHhc-CCCceeeEEeEEecCCc
Q 015868          112 EIDAKQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECV-NTEMLKEFSQEVYIMRKI-RHKNVVQFIGACTRPPN  187 (399)
Q Consensus       112 ~i~~~~~~i~~~lg~G~~g~Vy~~~~--~~~~vAvK~~~~~~~-~~~~~~~~~~Ei~~l~~l-~h~nIv~~~~~~~~~~~  187 (399)
                      .+..++|++.+.||+|+||.||+|++  +++.||+|+++.... .......+.+|..+++.+ +||||+++++++.....
T Consensus        19 ~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AvK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~   98 (353)
T 3txo_A           19 RLGIDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCFQTPDR   98 (353)
T ss_dssp             ----CCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHHTTHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSE
T ss_pred             CCchhheEEEEEEeeCCCEEEEEEEEcCCCCEEEEEEEEHHHhcchhHHHHHHHHHHHHHhccCCCceeeEEEEEEeCCE
Confidence            45667999999999999999999988  478999999974311 122345688999999988 69999999999999999


Q ss_pred             EEEEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceeecCCCcEEEeeccceeeccCC
Q 015868          188 LCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQS  267 (399)
Q Consensus       188 ~~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~giiHrDlkp~NILl~~~~~vkl~DFG~a~~~~~~  267 (399)
                      +|+||||++||+|.+++... +.+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||+++.....
T Consensus        99 ~~lv~E~~~gg~L~~~l~~~-~~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~g~ikL~DFG~a~~~~~~  177 (353)
T 3txo_A           99 LFFVMEFVNGGDLMFHIQKS-RRFDEARARFYAAEIISALMFLHDKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGICN  177 (353)
T ss_dssp             EEEEEECCCSCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCSCC-
T ss_pred             EEEEEeCCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCHHHEEECCCCCEEEccccceeecccC
Confidence            99999999999999999764 67999999999999999999999999999999999999999999999999999854332


Q ss_pred             -CccccCCCCcccccccccCCCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhccCCCCCCCCCcHHHHHHH
Q 015868          268 -GVMTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRLAELL  346 (399)
Q Consensus       268 -~~~~~~~gt~~y~aPE~l~~~~~~~~~Dv~slG~vl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll  346 (399)
                       ......+||+.|+|||++.+..|+.++|||||||++|+|++|..||.+.+..+....+...  ...+|..+++++.++|
T Consensus       178 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~--~~~~p~~~~~~~~~li  255 (353)
T 3txo_A          178 GVTTATFCGTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILND--EVVYPTWLHEDATGIL  255 (353)
T ss_dssp             --------CCGGGCCHHHHHHHHCTTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHC--CCCCCTTSCHHHHHHH
T ss_pred             CccccccCCCcCeEChhhcCCCCcCCccCCCcchHHHHHHHhCCCCCCCCCHHHHHHHHHcC--CCCCCCCCCHHHHHHH
Confidence             2344567999999999999999999999999999999999999999999888877766654  3456778999999999


Q ss_pred             HHHhhhcCCCCCCH------HHHHH
Q 015868          347 ERCWQHDPTQRPNF------SQITD  365 (399)
Q Consensus       347 ~~cl~~dP~~Rps~------~ell~  365 (399)
                      .+||+.||.+||++      .++++
T Consensus       256 ~~lL~~dP~~R~~~~~~~~~~~il~  280 (353)
T 3txo_A          256 KSFMTKNPTMRLGSLTQGGEHAILR  280 (353)
T ss_dssp             HHHTCSSGGGSTTSGGGTCTHHHHT
T ss_pred             HHHhhhCHHHccCCcccCCHHHHhh
Confidence            99999999999998      66654

>4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A*

Probab=100.00  E-value=2.3e-47  Score=383.08  Aligned_cols=252  Identities=23%  Similarity=0.438  Sum_probs=212.1

Q ss_pred             eeecccccceeceeceeCceEEEEEEE--CCeeEEEEEecCCC-CCHHHHHHHHHHHHHHHhcCCCceeeEEeEEecCCc
Q 015868          111 WEIDAKQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPEC-VNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPN  187 (399)
Q Consensus       111 ~~i~~~~~~i~~~lg~G~~g~Vy~~~~--~~~~vAvK~~~~~~-~~~~~~~~~~~Ei~~l~~l~h~nIv~~~~~~~~~~~  187 (399)
                      +.+..++|++.+.||+|+||.||+|..  +++.||||+++... ........+.+|+.+++.++||||+++++++...+.
T Consensus       143 ~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~  222 (446)
T 4ejn_A          143 HRVTMNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDR  222 (446)
T ss_dssp             -CCCGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHC-------------CCCCCSCTTSCCEEEEEEETTE
T ss_pred             cCCChHHcEEeEEEeeCcCEEEEEEEEcCCCCEEEEEEEEhhhhhhhHHHHHHHHHHHHHHhCCCCeEeeEEEEEeeCCE
Confidence            456678999999999999999999987  57899999997532 123345678899999999999999999999999999


Q ss_pred             EEEEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH-CCcccCCCCCCceeecCCCcEEEeeccceeeccC
Q 015868          188 LCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQ-NNIIHRDLKTANLLMDENGVVKVADFGVARVQAQ  266 (399)
Q Consensus       188 ~~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~-~giiHrDlkp~NILl~~~~~vkl~DFG~a~~~~~  266 (399)
                      +|+||||++||+|.+++.. ...+++..+..++.||+.||+|||+ +||+||||||+|||++.++.+||+|||+++....
T Consensus       223 ~~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~~~~qi~~aL~~LH~~~giiHrDlkp~NIll~~~~~~kl~DFG~a~~~~~  301 (446)
T 4ejn_A          223 LCFVMEYANGGELFFHLSR-ERVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIK  301 (446)
T ss_dssp             EEEEECCCSSCBHHHHHHH-HSCCCHHHHHHHHHHHHHHHHHHHHHTCCCCCCCCGGGEEECSSSCEEECCCCCCCTTCC
T ss_pred             EEEEEeeCCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHhhcCCEEECCCCHHHEEECCCCCEEEccCCCceeccC
Confidence            9999999999999999976 4578999999999999999999998 9999999999999999999999999999975433


Q ss_pred             -CCccccCCCCcccccccccCCCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhccCCCCCCCCCcHHHHHH
Q 015868          267 -SGVMTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRLAEL  345 (399)
Q Consensus       267 -~~~~~~~~gt~~y~aPE~l~~~~~~~~~Dv~slG~vl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l  345 (399)
                       ........||+.|+|||++.+..|+.++||||||+++|+|++|+.||.+.+..+....+....  ..+|..+++++.+|
T Consensus       302 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~~--~~~p~~~~~~~~~l  379 (446)
T 4ejn_A          302 DGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEE--IRFPRTLGPEAKSL  379 (446)
T ss_dssp             -----CCSSSCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCC--CCCCTTSCHHHHHH
T ss_pred             CCcccccccCCccccCHhhcCCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHHHHHHHHHhCC--CCCCccCCHHHHHH
Confidence             233455689999999999999999999999999999999999999999988877776665543  45678899999999


Q ss_pred             HHHHhhhcCCCCC-----CHHHHHH
Q 015868          346 LERCWQHDPTQRP-----NFSQITD  365 (399)
Q Consensus       346 l~~cl~~dP~~Rp-----s~~ell~  365 (399)
                      |.+||+.||.+||     +++|+++
T Consensus       380 i~~~L~~dP~~R~~~~~~t~~ell~  404 (446)
T 4ejn_A          380 LSGLLKKDPKQRLGGGSEDAKEIMQ  404 (446)
T ss_dssp             HHHHTCSSTTTSTTCSTTTHHHHHT
T ss_pred             HHHHcccCHHHhCCCCCCCHHHHHh
Confidence            9999999999999     9999976

>1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7

Probab=100.00  E-value=8.8e-47  Score=372.14  Aligned_cols=249  Identities=19%  Similarity=0.378  Sum_probs=221.1

Q ss_pred             ccccceeceeceeCceEEEEEEE--CCeeEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCceeeEEeEEecCCcEEEEE
Q 015868          115 AKQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVT  192 (399)
Q Consensus       115 ~~~~~i~~~lg~G~~g~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~nIv~~~~~~~~~~~~~lV~  192 (399)
                      .++|++.+.||+|+||.||+|..  +++.||+|++...  .......+.+|+.+++.++||||+++++++.....+++||
T Consensus        50 ~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~~a~K~~~~~--~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv~  127 (387)
T 1kob_A           50 YDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTP--YPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLIL  127 (387)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC--SHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEE
T ss_pred             ccceEEEEEEecCCCEEEEEEEECCCCCEEEEEEeccc--chhhHHHHHHHHHHHHhCCCcCCCeEEEEEEeCCEEEEEE
Confidence            36899999999999999999988  5788999999765  3444567899999999999999999999999999999999


Q ss_pred             ecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceeecC--CCcEEEeeccceeeccCCCcc
Q 015868          193 EFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDE--NGVVKVADFGVARVQAQSGVM  270 (399)
Q Consensus       193 E~~~ggsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~giiHrDlkp~NILl~~--~~~vkl~DFG~a~~~~~~~~~  270 (399)
                      ||+.|++|.+++......+++..++.++.||+.||.|||++||+||||||+|||++.  ++.+||+|||+++........
T Consensus       128 E~~~gg~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~~~vkL~DFG~a~~~~~~~~~  207 (387)
T 1kob_A          128 EFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIV  207 (387)
T ss_dssp             ECCCCCBHHHHTTCTTCCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSTTCCCEEECCCTTCEECCTTSCE
T ss_pred             EcCCCCcHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccchHHeEEecCCCCceEEEecccceecCCCcce
Confidence            999999999999876668999999999999999999999999999999999999974  578999999999877665555


Q ss_pred             ccCCCCcccccccccCCCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhccC--CCCCCCCCcHHHHHHHHH
Q 015868          271 TAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKSL--RPTIPKHAHPRLAELLER  348 (399)
Q Consensus       271 ~~~~gt~~y~aPE~l~~~~~~~~~Dv~slG~vl~elltg~~P~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~l~~ll~~  348 (399)
                      ....||+.|+|||++.+..++.++|||||||++|+|++|..||.+.+..+....+.....  .+.....+++++.+||.+
T Consensus       208 ~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~  287 (387)
T 1kob_A          208 KVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEFDEDAFSSVSPEAKDFIKN  287 (387)
T ss_dssp             EEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHCCCCCCSSTTTTSCHHHHHHHHT
T ss_pred             eeeccCCCccCchhccCCCCCCcccEeeHhHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCccccccCCHHHHHHHHH
Confidence            566899999999999999999999999999999999999999999888776665554332  233445789999999999


Q ss_pred             HhhhcCCCCCCHHHHHH
Q 015868          349 CWQHDPTQRPNFSQITD  365 (399)
Q Consensus       349 cl~~dP~~Rps~~ell~  365 (399)
                      ||+.||.+|||+.|+++
T Consensus       288 ~L~~dP~~Rpt~~ell~  304 (387)
T 1kob_A          288 LLQKEPRKRLTVHDALE  304 (387)
T ss_dssp             TSCSSGGGSCCHHHHHT
T ss_pred             HcCCChhHCcCHHHHhh
Confidence            99999999999999986

>3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A*

Probab=100.00  E-value=1.5e-46  Score=362.10  Aligned_cols=252  Identities=23%  Similarity=0.435  Sum_probs=210.3

Q ss_pred             eeecccccceeceeceeCceEEEEEEE-----CCeeEEEEEecCCCC--CHHHHHHHHHHHHHHHhcCCCceeeEEeEEe
Q 015868          111 WEIDAKQLKIECKVASGSYGDLYKGTY-----CSQEVAIKVLKPECV--NTEMLKEFSQEVYIMRKIRHKNVVQFIGACT  183 (399)
Q Consensus       111 ~~i~~~~~~i~~~lg~G~~g~Vy~~~~-----~~~~vAvK~~~~~~~--~~~~~~~~~~Ei~~l~~l~h~nIv~~~~~~~  183 (399)
                      ..+..++|++.+.||+|+||.||+++.     .++.||+|+++....  +......+.+|+.+++.++||||+++++++.
T Consensus        12 ~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~   91 (327)
T 3a62_A           12 EKIRPECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIVDLIYAFQ   91 (327)
T ss_dssp             -CCCGGGEEEEEEEEEETTEEEEEEEECSSTTTTCEEEEEEECCC--------------HHHHHHHCCCTTBCCEEEEEE
T ss_pred             CCCCHHHeEEEEEEEeCCCEEEEEEEEeccCCCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhCCCCCccceeEEEE
Confidence            356678999999999999999999987     578999999986532  2334567889999999999999999999999


Q ss_pred             cCCcEEEEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceeecCCCcEEEeeccceee
Q 015868          184 RPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARV  263 (399)
Q Consensus       184 ~~~~~~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~giiHrDlkp~NILl~~~~~vkl~DFG~a~~  263 (399)
                      ....+|+||||++|++|.+++.. .+.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.
T Consensus        92 ~~~~~~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~  170 (327)
T 3a62_A           92 TGGKLYLILEYLSGGELFMQLER-EGIFMEDTACFYLAEISMALGHLHQKGIIYRDLKPENIMLNHQGHVKLTDFGLCKE  170 (327)
T ss_dssp             CSSCEEEEEECCTTEEHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCTTTEEECTTSCEEECCCSCC--
T ss_pred             cCCEEEEEEeCCCCCcHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCEEcccCCHHHeEECCCCcEEEEeCCcccc
Confidence            99999999999999999999976 45689999999999999999999999999999999999999999999999999975


Q ss_pred             ccCCC-ccccCCCCcccccccccCCCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhccCCCCCCCCCcHHH
Q 015868          264 QAQSG-VMTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRL  342 (399)
Q Consensus       264 ~~~~~-~~~~~~gt~~y~aPE~l~~~~~~~~~Dv~slG~vl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  342 (399)
                      ..... ......||+.|+|||++.+..++.++||||||+++|+|++|..||.+.+..+....+...  ...+|..+++++
T Consensus       171 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~--~~~~p~~~~~~~  248 (327)
T 3a62_A          171 SIHDGTVTHTFCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPFTGENRKKTIDKILKC--KLNLPPYLTQEA  248 (327)
T ss_dssp             --------CTTSSCCTTSCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHT--CCCCCTTSCHHH
T ss_pred             cccCCccccccCCCcCccCHhhCcCCCCCCcccchhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhC--CCCCCCCCCHHH
Confidence            43332 234457899999999999999999999999999999999999999998887766665543  345677899999


Q ss_pred             HHHHHHHhhhcCCCCC-----CHHHHHH
Q 015868          343 AELLERCWQHDPTQRP-----NFSQITD  365 (399)
Q Consensus       343 ~~ll~~cl~~dP~~Rp-----s~~ell~  365 (399)
                      .++|.+||+.||.+||     ++.|+++
T Consensus       249 ~~li~~~L~~dp~~R~~~~~~~~~e~l~  276 (327)
T 3a62_A          249 RDLLKKLLKRNAASRLGAGPGDAGEVQA  276 (327)
T ss_dssp             HHHHHHHSCSCGGGSTTSSTTTHHHHHH
T ss_pred             HHHHHHHHhcCHhhccCCCCCCHHHHHc
Confidence            9999999999999999     6777765

>1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ...

Probab=100.00  E-value=6.6e-47  Score=380.48  Aligned_cols=260  Identities=36%  Similarity=0.679  Sum_probs=224.8

Q ss_pred             CCceeecccccceeceeceeCceEEEEEEECC-eeEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCceeeEEeEEecCC
Q 015868          108 TDVWEIDAKQLKIECKVASGSYGDLYKGTYCS-QEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPP  186 (399)
Q Consensus       108 ~~~~~i~~~~~~i~~~lg~G~~g~Vy~~~~~~-~~vAvK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~nIv~~~~~~~~~~  186 (399)
                      .+.|++..++|++.++||+|+||.||+|++.+ ..||||+++.....   .+.|.+|+.+|++++||||+++++++.. .
T Consensus       176 ~~~~~i~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~---~~~~~~E~~~l~~l~hp~iv~~~~~~~~-~  251 (452)
T 1fmk_A          176 KDAWEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMS---PEAFLQEAQVMKKLRHEKLVQLYAVVSE-E  251 (452)
T ss_dssp             TTCSBCCGGGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTTSSC---HHHHHHHHHHHHHCCCTTBCCEEEEECS-S
T ss_pred             ccccccChhHceeeeeecCCCCeEEEEEEECCCceEEEEEeccCCCC---HHHHHHHHHHHHhCCCCCEeeEEEEEcC-C
Confidence            36699999999999999999999999999864 67999999875433   3578999999999999999999999877 5


Q ss_pred             cEEEEEecCCCCCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceeecCCCcEEEeeccceeecc
Q 015868          187 NLCIVTEFMARGSIYDFLHKQ-KGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQA  265 (399)
Q Consensus       187 ~~~lV~E~~~ggsL~~~l~~~-~~~l~~~~~~~i~~~i~~~L~~LH~~giiHrDlkp~NILl~~~~~vkl~DFG~a~~~~  265 (399)
                      ..++||||+++|+|.+++... ...+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+++...
T Consensus       252 ~~~iv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~  331 (452)
T 1fmk_A          252 PIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIE  331 (452)
T ss_dssp             SCEEEECCCTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCCTTC---
T ss_pred             ceEEEehhhcCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChhhEEECCCCCEEECCCccceecC
Confidence            689999999999999999753 3568999999999999999999999999999999999999999999999999998654


Q ss_pred             CCCc--cccCCCCcccccccccCCCCCCChhhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHHhccCCCCCCCCCcHHH
Q 015868          266 QSGV--MTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLT-GELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRL  342 (399)
Q Consensus       266 ~~~~--~~~~~gt~~y~aPE~l~~~~~~~~~Dv~slG~vl~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  342 (399)
                      ....  .....++..|+|||.+.+..++.++||||||+++|||++ |..||.+.+..+....+ ....++..|..+++++
T Consensus       332 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~~~~~i-~~~~~~~~~~~~~~~l  410 (452)
T 1fmk_A          332 DNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQV-ERGYRMPCPPECPESL  410 (452)
T ss_dssp             -----------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHH-HTTCCCCCCTTSCHHH
T ss_pred             CCceecccCCcccccccCHhHHhcCCCCccccHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHH-HcCCCCCCCCCCCHHH
Confidence            3321  223346789999999998899999999999999999999 99999999887765544 4566777888999999


Q ss_pred             HHHHHHHhhhcCCCCCCHHHHHHHHHHHHH
Q 015868          343 AELLERCWQHDPTQRPNFSQITDILKQMMK  372 (399)
Q Consensus       343 ~~ll~~cl~~dP~~Rps~~ell~~L~~l~~  372 (399)
                      .++|.+||+.||++|||++++++.|+++..
T Consensus       411 ~~li~~cl~~dP~~Rpt~~~l~~~L~~~~~  440 (452)
T 1fmk_A          411 HDLMCQCWRKEPEERPTFEYLQAFLEDYFT  440 (452)
T ss_dssp             HHHHHHHTCSSGGGSCCHHHHHHHHHTTTS
T ss_pred             HHHHHHHccCChhhCcCHHHHHHHHHHHhc
Confidence            999999999999999999999999988763

>2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens}

Probab=100.00  E-value=8.1e-47  Score=358.42  Aligned_cols=251  Identities=25%  Similarity=0.405  Sum_probs=210.6

Q ss_pred             ecccccceeceeceeCceEEEEEEE--CCeeEEEEEecCCCCC------------------------HHHHHHHHHHHHH
Q 015868          113 IDAKQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVN------------------------TEMLKEFSQEVYI  166 (399)
Q Consensus       113 i~~~~~~i~~~lg~G~~g~Vy~~~~--~~~~vAvK~~~~~~~~------------------------~~~~~~~~~Ei~~  166 (399)
                      +..++|++.+.||+|+||.||+|+.  +++.||+|+++.....                        ....+.+.+|+.+
T Consensus        10 ~~~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~   89 (298)
T 2zv2_A           10 VQLNQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIAI   89 (298)
T ss_dssp             CEETTEEEEEEEEC--CCEEEEEEETTTTEEEEEEEEECC-------------------------------CHHHHHHHH
T ss_pred             eeecceEEEeEEeecCCEEEEEEEECCCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHHHHH
Confidence            4467999999999999999999987  5789999999754321                        1124578999999


Q ss_pred             HHhcCCCceeeEEeEEec--CCcEEEEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCc
Q 015868          167 MRKIRHKNVVQFIGACTR--PPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTAN  244 (399)
Q Consensus       167 l~~l~h~nIv~~~~~~~~--~~~~~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~giiHrDlkp~N  244 (399)
                      +++++||||+++++++..  ...+++||||+++++|.+++.  ...+++..++.++.||+.||.|||++||+||||||+|
T Consensus        90 l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~--~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~N  167 (298)
T 2zv2_A           90 LKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPT--LKPLSEDQARFYFQDLIKGIEYLHYQKIIHRDIKPSN  167 (298)
T ss_dssp             HHTCCCTTBCCEEEEEECSSSSEEEEEEECCTTCBSCCSSC--SSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGG
T ss_pred             HHhCCCCCCCeEEEEEEcCCCCEEEEEEecCCCCcHHHHhh--cCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHH
Confidence            999999999999999986  567999999999999988653  4579999999999999999999999999999999999


Q ss_pred             eeecCCCcEEEeeccceeeccCCC-ccccCCCCcccccccccCCCC---CCChhhHHHHHHHHHHHHcCCCCCCCCCHHH
Q 015868          245 LLMDENGVVKVADFGVARVQAQSG-VMTAETGTYRWMAPEVIEHKP---YDYKADVFSFGIALWELLTGELPYAGLTPLQ  320 (399)
Q Consensus       245 ILl~~~~~vkl~DFG~a~~~~~~~-~~~~~~gt~~y~aPE~l~~~~---~~~~~Dv~slG~vl~elltg~~P~~~~~~~~  320 (399)
                      |+++.++.+||+|||+++...... ......||+.|+|||++.+..   ++.++||||||+++|+|++|..||.......
T Consensus       168 il~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~  247 (298)
T 2zv2_A          168 LLVGEDGHIKIADFGVSNEFKGSDALLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMDERIMC  247 (298)
T ss_dssp             EEECTTSCEEECCCTTCEECSSSSCEECCCCSCGGGCCGGGCCTTCCCEESHHHHHHHHHHHHHHHHHSSCSSCCSSHHH
T ss_pred             EEECCCCCEEEecCCCccccccccccccCCcCCccccChhhhccCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCccHHH
Confidence            999999999999999998765432 344567999999999998765   3778999999999999999999999887766


Q ss_pred             HHHHHHhccCCCCCCCCCcHHHHHHHHHHhhhcCCCCCCHHHHHH
Q 015868          321 AAVGVVQKSLRPTIPKHAHPRLAELLERCWQHDPTQRPNFSQITD  365 (399)
Q Consensus       321 ~~~~~~~~~~~~~~~~~~~~~l~~ll~~cl~~dP~~Rps~~ell~  365 (399)
                      ..............+..+++++.++|.+||+.||++|||+.|+++
T Consensus       248 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~R~s~~e~l~  292 (298)
T 2zv2_A          248 LHSKIKSQALEFPDQPDIAEDLKDLITRMLDKNPESRIVVPEIKL  292 (298)
T ss_dssp             HHHHHHHCCCCCCSSSCCCHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred             HHHHHhcccCCCCCccccCHHHHHHHHHHhhcChhhCCCHHHHhc
Confidence            655555444444444578999999999999999999999999864

>3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A*

Probab=100.00  E-value=1.5e-46  Score=360.34  Aligned_cols=263  Identities=28%  Similarity=0.541  Sum_probs=224.6

Q ss_pred             eecccccceeceeceeCceEEEEEEE------CCeeEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCceeeEEeEEecC
Q 015868          112 EIDAKQLKIECKVASGSYGDLYKGTY------CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRP  185 (399)
Q Consensus       112 ~i~~~~~~i~~~lg~G~~g~Vy~~~~------~~~~vAvK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~nIv~~~~~~~~~  185 (399)
                      .++.+.|++.++||+|+||.||++.+      .++.||||+++... .....+.+.+|+.++++++||||+++++++...
T Consensus        27 ~~~~r~~~~~~~lG~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~  105 (318)
T 3lxp_A           27 VFHKRYLKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADA-GPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDA  105 (318)
T ss_dssp             BCCGGGEEEEEEEEECSSEEEEEEEECSCC--CCEEEEEEEECTTC-CHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEET
T ss_pred             eecHHHHhhhheecCCCCeEEEEEEEccCCCCCCcEEEEEEecccc-ChHHHHHHHHHHHHHHhCCCcchhhEEEEEecC
Confidence            34555569999999999999999876      57889999998653 456677899999999999999999999999874


Q ss_pred             --CcEEEEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceeecCCCcEEEeeccceee
Q 015868          186 --PNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARV  263 (399)
Q Consensus       186 --~~~~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~giiHrDlkp~NILl~~~~~vkl~DFG~a~~  263 (399)
                        ..+++||||+++++|.+++...  .+++..++.++.|++.||.|||++||+||||||+||+++.++.+||+|||.++.
T Consensus       106 ~~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~i~~~l~~~l~~LH~~~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~  183 (318)
T 3lxp_A          106 GAASLQLVMEYVPLGSLRDYLPRH--SIGLAQLLLFAQQICEGMAYLHAQHYIHRDLAARNVLLDNDRLVKIGDFGLAKA  183 (318)
T ss_dssp             TTTEEEEEECCCTTCBHHHHGGGS--CCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCGGGCEE
T ss_pred             CCceEEEEEecccCCcHHHHHhhC--CCCHHHHHHHHHHHHHHHHHHHhCCccCCCCchheEEEcCCCCEEECCcccccc
Confidence              5789999999999999999663  489999999999999999999999999999999999999999999999999987


Q ss_pred             ccCCCc----cccCCCCcccccccccCCCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHH--------------HHHHHH
Q 015868          264 QAQSGV----MTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPYAGLTPL--------------QAAVGV  325 (399)
Q Consensus       264 ~~~~~~----~~~~~gt~~y~aPE~l~~~~~~~~~Dv~slG~vl~elltg~~P~~~~~~~--------------~~~~~~  325 (399)
                      ......    .....+|..|+|||.+.+..++.++||||||+++|+|+||..||......              ......
T Consensus       184 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  263 (318)
T 3lxp_A          184 VPEGHEYYRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQGQMTVLRLTEL  263 (318)
T ss_dssp             CCTTCSEEEC---CCCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCHHHHHHHHHHH
T ss_pred             ccccccccccccCCCCCceeeChHHhcCCCCCcHHHHHHHHHHHHHHHhCCCcccccchhhhhhhcccccchhHHHHHHH
Confidence            654432    23345788899999999988999999999999999999999998653221              112233


Q ss_pred             HhccCCCCCCCCCcHHHHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHhc
Q 015868          326 VQKSLRPTIPKHAHPRLAELLERCWQHDPTQRPNFSQITDILKQMMKEVASE  377 (399)
Q Consensus       326 ~~~~~~~~~~~~~~~~l~~ll~~cl~~dP~~Rps~~ell~~L~~l~~~~~~~  377 (399)
                      +....++..+..+++++.++|.+||+.||.+|||+.++++.|+.+.+.....
T Consensus       264 ~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l~~~~~~~  315 (318)
T 3lxp_A          264 LERGERLPRPDKCPAEVYHLMKNCWETEASFRPTFENLIPILKTVHEKYQGQ  315 (318)
T ss_dssp             HHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHHC-
T ss_pred             HhcccCCCCCccccHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHHhhccC
Confidence            4556667778889999999999999999999999999999999998877643

>1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ...

Probab=100.00  E-value=1.3e-46  Score=360.57  Aligned_cols=263  Identities=30%  Similarity=0.561  Sum_probs=229.5

Q ss_pred             CCceeecccccceeceeceeCceEEEEEEEC-------CeeEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCceeeEEe
Q 015868          108 TDVWEIDAKQLKIECKVASGSYGDLYKGTYC-------SQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIG  180 (399)
Q Consensus       108 ~~~~~i~~~~~~i~~~lg~G~~g~Vy~~~~~-------~~~vAvK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~nIv~~~~  180 (399)
                      .+.|++..++|++.+.||+|+||.||+|++.       ++.||+|+++... .......+.+|+.+++.++||||+++++
T Consensus        17 ~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~i~~~~~   95 (322)
T 1p4o_A           17 PDEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAA-SMRERIEFLNEASVMKEFNCHHVVRLLG   95 (322)
T ss_dssp             CCTTBCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTS-CHHHHHHHHHHHHHGGGCCCTTBCCEEE
T ss_pred             hhhhcchhhheeeeeEeccCCceEEEeeeecCccCCCCceEEEEEeccccc-CHHHHHHHHHHHHHHHhcCCCCEeeeEE
Confidence            3568899999999999999999999999764       5789999998543 4455678999999999999999999999


Q ss_pred             EEecCCcEEEEEecCCCCCHHHHHHhcC---------CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceeecCCC
Q 015868          181 ACTRPPNLCIVTEFMARGSIYDFLHKQK---------GVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENG  251 (399)
Q Consensus       181 ~~~~~~~~~lV~E~~~ggsL~~~l~~~~---------~~l~~~~~~~i~~~i~~~L~~LH~~giiHrDlkp~NILl~~~~  251 (399)
                      ++......++||||+++++|.+++....         ..+++..++.++.|++.||.|||++||+||||||+||+++.++
T Consensus        96 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~NIli~~~~  175 (322)
T 1p4o_A           96 VVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDF  175 (322)
T ss_dssp             EECSSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCSGGGEEECTTC
T ss_pred             EEccCCccEEEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHHHCCCccCCCccceEEEcCCC
Confidence            9999999999999999999999997532         4578999999999999999999999999999999999999999


Q ss_pred             cEEEeeccceeeccCCCc---cccCCCCcccccccccCCCCCCChhhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHHh
Q 015868          252 VVKVADFGVARVQAQSGV---MTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLT-GELPYAGLTPLQAAVGVVQ  327 (399)
Q Consensus       252 ~vkl~DFG~a~~~~~~~~---~~~~~gt~~y~aPE~l~~~~~~~~~Dv~slG~vl~ellt-g~~P~~~~~~~~~~~~~~~  327 (399)
                      .+||+|||+++.......   .....+|+.|+|||.+.+..++.++||||||+++|+|++ |..||.+.+..+....+..
T Consensus       176 ~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~  255 (322)
T 1p4o_A          176 TVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVME  255 (322)
T ss_dssp             CEEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHHHHHHHHHT
T ss_pred             eEEECcCccccccccccccccccCCCCCCCccChhhhccCCCCchhhHHHHHHHHHHHHhcCCCccccCCHHHHHHHHHc
Confidence            999999999975543321   223356889999999999999999999999999999999 8999999888776555443


Q ss_pred             ccCCCCCCCCCcHHHHHHHHHHhhhcCCCCCCHHHHHHHHHHHHH
Q 015868          328 KSLRPTIPKHAHPRLAELLERCWQHDPTQRPNFSQITDILKQMMK  372 (399)
Q Consensus       328 ~~~~~~~~~~~~~~l~~ll~~cl~~dP~~Rps~~ell~~L~~l~~  372 (399)
                       ...+..+..+++++.+++.+||+.||.+|||+.|+++.|++++.
T Consensus       256 -~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~e~l~~L~~~~~  299 (322)
T 1p4o_A          256 -GGLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEME  299 (322)
T ss_dssp             -TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGSC
T ss_pred             -CCcCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHhhc
Confidence             44556778899999999999999999999999999999988754

>1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7

Probab=100.00  E-value=9.2e-47  Score=362.50  Aligned_cols=248  Identities=26%  Similarity=0.467  Sum_probs=219.2

Q ss_pred             ecccccceeceeceeCceEEEEEEE--CCeeEEEEEecCCCC-CHHHHHHHHHHHHHHHhcCCCceeeEEeEEecCCcEE
Q 015868          113 IDAKQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECV-NTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLC  189 (399)
Q Consensus       113 i~~~~~~i~~~lg~G~~g~Vy~~~~--~~~~vAvK~~~~~~~-~~~~~~~~~~Ei~~l~~l~h~nIv~~~~~~~~~~~~~  189 (399)
                      +..++|++.+.||+|+||.||+++.  +++.||+|+++.... .....+.+.+|+.+++.++||||+++++++.+...+|
T Consensus         3 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~   82 (318)
T 1fot_A            3 YSLQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIF   82 (318)
T ss_dssp             CCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEE
T ss_pred             CChHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhhCCCCCCceEeEEEEeCCEEE
Confidence            3467899999999999999999988  578999999974311 1122456788999999999999999999999999999


Q ss_pred             EEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceeecCCCcEEEeeccceeeccCCCc
Q 015868          190 IVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGV  269 (399)
Q Consensus       190 lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~giiHrDlkp~NILl~~~~~vkl~DFG~a~~~~~~~~  269 (399)
                      +||||++||+|.+++.. ...+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||+++.....  
T Consensus        83 lv~e~~~gg~L~~~l~~-~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~~kL~Dfg~a~~~~~~--  159 (318)
T 1fot_A           83 MIMDYIEGGELFSLLRK-SQRFPNPVAKFYAAEVCLALEYLHSKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPDV--  159 (318)
T ss_dssp             EEECCCCSCBHHHHHHH-TSSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECTTSCEEECCCSSCEECSSC--
T ss_pred             EEEeCCCCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChheEEEcCCCCEEEeecCcceecCCc--
Confidence            99999999999999976 467999999999999999999999999999999999999999999999999999865432  


Q ss_pred             cccCCCCcccccccccCCCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhccCCCCCCCCCcHHHHHHHHHH
Q 015868          270 MTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRLAELLERC  349 (399)
Q Consensus       270 ~~~~~gt~~y~aPE~l~~~~~~~~~Dv~slG~vl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~c  349 (399)
                      .....||+.|+|||++.+..++.++|+||||+++|+|++|..||...+..+....+....  ..+|..+++++.++|.+|
T Consensus       160 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~--~~~p~~~~~~~~~li~~l  237 (318)
T 1fot_A          160 TYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNAE--LRFPPFFNEDVKDLLSRL  237 (318)
T ss_dssp             BCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHCC--CCCCTTSCHHHHHHHHHH
T ss_pred             cccccCCccccCHhHhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhCC--CCCCCCCCHHHHHHHHHH
Confidence            345679999999999999999999999999999999999999999988877776666543  456788999999999999


Q ss_pred             hhhcCCCCC-----CHHHHHH
Q 015868          350 WQHDPTQRP-----NFSQITD  365 (399)
Q Consensus       350 l~~dP~~Rp-----s~~ell~  365 (399)
                      |+.||.+||     +++++++
T Consensus       238 L~~dp~~R~~~~~~~~~~i~~  258 (318)
T 1fot_A          238 ITRDLSQRLGNLQNGTEDVKN  258 (318)
T ss_dssp             TCSCTTTCTTSSTTTTHHHHT
T ss_pred             hccCHHHcCCCcCCCHHHHhc
Confidence            999999999     8888874

>4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens}

Probab=100.00  E-value=3.7e-47  Score=374.18  Aligned_cols=252  Identities=23%  Similarity=0.417  Sum_probs=216.6

Q ss_pred             eeecccccceeceeceeCceEEEEEEE--CCeeEEEEEecCCCC-CHHHHHHHHHHHHHHHhcCCCceeeEEeEEecCCc
Q 015868          111 WEIDAKQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECV-NTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPN  187 (399)
Q Consensus       111 ~~i~~~~~~i~~~lg~G~~g~Vy~~~~--~~~~vAvK~~~~~~~-~~~~~~~~~~Ei~~l~~l~h~nIv~~~~~~~~~~~  187 (399)
                      ..+..++|++.+.||+|+||.||++++  +++.||+|+++.... .....+.+.+|+.+++.++||||+++++++.....
T Consensus        10 ~~v~~~~y~i~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~   89 (384)
T 4fr4_A           10 EDVNFDHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWYSFQDEED   89 (384)
T ss_dssp             CCCCGGGEEEEEEEECCTTCCEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSE
T ss_pred             CCCChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehhhcccHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCE
Confidence            467788999999999999999999988  467899999864311 11224678899999999999999999999999999


Q ss_pred             EEEEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceeecCCCcEEEeeccceeeccCC
Q 015868          188 LCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQS  267 (399)
Q Consensus       188 ~~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~giiHrDlkp~NILl~~~~~vkl~DFG~a~~~~~~  267 (399)
                      +|+||||+.||+|.+++.. ...+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||+++.....
T Consensus        90 ~~lv~e~~~gg~L~~~l~~-~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~  168 (384)
T 4fr4_A           90 MFMVVDLLLGGDLRYHLQQ-NVHFKEETVKLFICELVMALDYLQNQRIIHRDMKPDNILLDEHGHVHITDFNIAAMLPRE  168 (384)
T ss_dssp             EEEEECCCTTEEHHHHHHT-TCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECCTT
T ss_pred             EEEEEecCCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCcHHHeEECCCCCEEEeccceeeeccCC
Confidence            9999999999999999976 567999999999999999999999999999999999999999999999999999987666


Q ss_pred             CccccCCCCcccccccccCC---CCCCChhhHHHHHHHHHHHHcCCCCCCCCCH---HHHHHHHHhccCCCCCCCCCcHH
Q 015868          268 GVMTAETGTYRWMAPEVIEH---KPYDYKADVFSFGIALWELLTGELPYAGLTP---LQAAVGVVQKSLRPTIPKHAHPR  341 (399)
Q Consensus       268 ~~~~~~~gt~~y~aPE~l~~---~~~~~~~Dv~slG~vl~elltg~~P~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~  341 (399)
                      .......||+.|+|||++.+   ..|+.++|||||||++|+|++|..||.....   .+.... .. ......|..++++
T Consensus       169 ~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~-~~-~~~~~~p~~~s~~  246 (384)
T 4fr4_A          169 TQITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSSKEIVHT-FE-TTVVTYPSAWSQE  246 (384)
T ss_dssp             CCBCCCCSCGGGCCGGGTCCCSSCCBCTTHHHHHHHHHHHHHHHSSCSSCCCTTSCHHHHHHH-HH-HCCCCCCTTSCHH
T ss_pred             CceeccCCCccccCCeeeccCCCCCCCccceeechHHHHHHHHhCCCCCCCCCCccHHHHHHH-Hh-hcccCCCCcCCHH
Confidence            66677789999999999974   4689999999999999999999999975432   222222 22 2345677889999


Q ss_pred             HHHHHHHHhhhcCCCCCC-HHHHHH
Q 015868          342 LAELLERCWQHDPTQRPN-FSQITD  365 (399)
Q Consensus       342 l~~ll~~cl~~dP~~Rps-~~ell~  365 (399)
                      +.+||.+||+.||.+||+ ++++++
T Consensus       247 ~~~li~~lL~~dP~~R~s~~~~l~~  271 (384)
T 4fr4_A          247 MVSLLKKLLEPNPDQRFSQLSDVQN  271 (384)
T ss_dssp             HHHHHHHHSCSSGGGSCCSHHHHHT
T ss_pred             HHHHHHHHhcCCHhHhcccHHHHHc
Confidence            999999999999999998 666653

>3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A*

Probab=100.00  E-value=3.5e-46  Score=362.44  Aligned_cols=245  Identities=22%  Similarity=0.404  Sum_probs=212.5

Q ss_pred             ecccccceeceeceeCceEEEEEEE--CCeeEEEEEecCCCC-CHHHHHHHHHHHHHHHhc-CCCceeeEEeEEecCCcE
Q 015868          113 IDAKQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECV-NTEMLKEFSQEVYIMRKI-RHKNVVQFIGACTRPPNL  188 (399)
Q Consensus       113 i~~~~~~i~~~lg~G~~g~Vy~~~~--~~~~vAvK~~~~~~~-~~~~~~~~~~Ei~~l~~l-~h~nIv~~~~~~~~~~~~  188 (399)
                      +..++|++.+.||+|+||.||++++  +++.||+|+++.... .....+.+.+|..+++++ +||||+++++++.....+
T Consensus         6 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~   85 (345)
T 3a8x_A            6 LGLQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRL   85 (345)
T ss_dssp             CCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGSCSHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEE
T ss_pred             CchhheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEhHHhcchHHHHHHHHHHHHHHhcCCCCccCeEEEEEEeCCEE
Confidence            4567899999999999999999998  478999999986533 455667889999999988 899999999999999999


Q ss_pred             EEEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceeecCCCcEEEeeccceeeccC-C
Q 015868          189 CIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQ-S  267 (399)
Q Consensus       189 ~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~giiHrDlkp~NILl~~~~~vkl~DFG~a~~~~~-~  267 (399)
                      |+||||++||+|.+++... +.+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||+++.... .
T Consensus        86 ~lv~e~~~gg~L~~~l~~~-~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~~kL~DFG~a~~~~~~~  164 (345)
T 3a8x_A           86 FFVIEYVNGGDLMFHMQRQ-RKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPG  164 (345)
T ss_dssp             EEEECCCCSCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCGGGCBCSCCTT
T ss_pred             EEEEeCCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEECCCCCEEEEeccccccccCCC
Confidence            9999999999999999763 5799999999999999999999999999999999999999999999999999986432 2


Q ss_pred             CccccCCCCcccccccccCCCCCCChhhHHHHHHHHHHHHcCCCCCCCC---------CHHHHHHHHHhccCCCCCCCCC
Q 015868          268 GVMTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPYAGL---------TPLQAAVGVVQKSLRPTIPKHA  338 (399)
Q Consensus       268 ~~~~~~~gt~~y~aPE~l~~~~~~~~~Dv~slG~vl~elltg~~P~~~~---------~~~~~~~~~~~~~~~~~~~~~~  338 (399)
                      .......||+.|+|||++.+..|+.++|+|||||++|||++|..||...         ...........  ....+|..+
T Consensus       165 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~i~~--~~~~~p~~~  242 (345)
T 3a8x_A          165 DTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILE--KQIRIPRSL  242 (345)
T ss_dssp             CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTTTC-------CHHHHHHHHHH--CCCCCCTTS
T ss_pred             CcccccCCCccccCccccCCCCCChHHhHHHHHHHHHHHHhCCCCcCCcccccccccccHHHHHHHHHc--CCCCCCCCC
Confidence            3345568999999999999999999999999999999999999999752         22222222222  245678889


Q ss_pred             cHHHHHHHHHHhhhcCCCCCCH
Q 015868          339 HPRLAELLERCWQHDPTQRPNF  360 (399)
Q Consensus       339 ~~~l~~ll~~cl~~dP~~Rps~  360 (399)
                      ++++.++|.+||+.||.+||++
T Consensus       243 s~~~~~li~~lL~~dP~~R~~~  264 (345)
T 3a8x_A          243 SVKAASVLKSFLNKDPKERLGC  264 (345)
T ss_dssp             CHHHHHHHHHHTCSSTTTSTTC
T ss_pred             CHHHHHHHHHHhcCCHhHCCCC
Confidence            9999999999999999999996

>2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens}

Probab=100.00  E-value=2.1e-46  Score=367.79  Aligned_cols=252  Identities=20%  Similarity=0.345  Sum_probs=216.4

Q ss_pred             ccce--eceeceeCceEEEEEEE--CCeeEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCceeeEEeEEecCCcEEEEE
Q 015868          117 QLKI--ECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVT  192 (399)
Q Consensus       117 ~~~i--~~~lg~G~~g~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~nIv~~~~~~~~~~~~~lV~  192 (399)
                      .|.+  .+.||+|+||.||+|+.  .++.||+|+++..  .....+.+.+|+.++++++||||+++++++......++||
T Consensus        88 ~~~~~~~~~lG~G~~g~Vy~a~~~~~g~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~  165 (373)
T 2x4f_A           88 FYTVSKTEILGGGRFGQVHKCEETATGLKLAAKIIKTR--GMKDKEEVKNEISVMNQLDHANLIQLYDAFESKNDIVLVM  165 (373)
T ss_dssp             TEEEEEEEECC-----CEEEEEETTTCCEEEEEEEECC--SHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             ceeeecceEEecCcCEEEEEEEEcCCCcEEEEEEEccc--ccccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEE
Confidence            3444  67899999999999987  5789999999865  3455678999999999999999999999999999999999


Q ss_pred             ecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceee--cCCCcEEEeeccceeeccCCCcc
Q 015868          193 EFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLM--DENGVVKVADFGVARVQAQSGVM  270 (399)
Q Consensus       193 E~~~ggsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~giiHrDlkp~NILl--~~~~~vkl~DFG~a~~~~~~~~~  270 (399)
                      ||+++++|.+++......+++..++.++.||+.||.|||++||+||||||+|||+  +.++.+||+|||+++........
T Consensus       166 E~~~~~~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~~~kl~DFG~a~~~~~~~~~  245 (373)
T 2x4f_A          166 EYVDGGELFDRIIDESYNLTELDTILFMKQICEGIRHMHQMYILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPREKL  245 (373)
T ss_dssp             ECCTTCEEHHHHHHTGGGCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEETTTTEEEECCCSSCEECCTTCBC
T ss_pred             eCCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEEecCCCCcEEEEeCCCceecCCcccc
Confidence            9999999999998766779999999999999999999999999999999999999  56789999999999887666555


Q ss_pred             ccCCCCcccccccccCCCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhccCCC--CCCCCCcHHHHHHHHH
Q 015868          271 TAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKSLRP--TIPKHAHPRLAELLER  348 (399)
Q Consensus       271 ~~~~gt~~y~aPE~l~~~~~~~~~Dv~slG~vl~elltg~~P~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~l~~ll~~  348 (399)
                      ....||+.|+|||++.+..++.++||||||+++|+|++|..||.+.+..+....+.......  .....+++++.+||.+
T Consensus       246 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~  325 (373)
T 2x4f_A          246 KVNFGTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSGLSPFLGDNDAETLNNILACRWDLEDEEFQDISEEAKEFISK  325 (373)
T ss_dssp             CCCCSSCTTCCHHHHTTCBCCHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCSCSGGGTTSCHHHHHHHHT
T ss_pred             ccccCCCcEeChhhccCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCChhhhccCCHHHHHHHHH
Confidence            66679999999999999999999999999999999999999999988877776666543322  2235689999999999


Q ss_pred             HhhhcCCCCCCHHHHHH--HHHHH
Q 015868          349 CWQHDPTQRPNFSQITD--ILKQM  370 (399)
Q Consensus       349 cl~~dP~~Rps~~ell~--~L~~l  370 (399)
                      ||+.||.+|||+.|+++  .+.+.
T Consensus       326 ~L~~dp~~Rps~~e~l~hp~~~~~  349 (373)
T 2x4f_A          326 LLIKEKSWRISASEALKHPWLSDH  349 (373)
T ss_dssp             TSCSSGGGSCCHHHHHHSHHHHCH
T ss_pred             HcCCChhhCCCHHHHhcCcCcCCC
Confidence            99999999999999987  55544

>4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus}

Probab=100.00  E-value=1e-46  Score=372.36  Aligned_cols=247  Identities=21%  Similarity=0.385  Sum_probs=210.3

Q ss_pred             eeecccccceeceeceeCceEEEEEEE--CCeeEEEEEecCCCC-CHHHHHHHHHHHHHHHhc-CCCceeeEEeEEecCC
Q 015868          111 WEIDAKQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECV-NTEMLKEFSQEVYIMRKI-RHKNVVQFIGACTRPP  186 (399)
Q Consensus       111 ~~i~~~~~~i~~~lg~G~~g~Vy~~~~--~~~~vAvK~~~~~~~-~~~~~~~~~~Ei~~l~~l-~h~nIv~~~~~~~~~~  186 (399)
                      ..+..++|++.+.||+|+||.||+|+.  +++.||+|+++.... .....+.+.+|..+++++ +||||+++++++....
T Consensus        47 ~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AvK~~~k~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~  126 (396)
T 4dc2_A           47 SSLGLQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTES  126 (396)
T ss_dssp             --CCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGTC----CCHHHHHHHHHHHHTTCTTBCCEEEEEECSS
T ss_pred             cCCChhHcEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhcCCCCCcCeeEEEEEECC
Confidence            456678999999999999999999988  478899999986533 233445688899999887 8999999999999999


Q ss_pred             cEEEEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceeecCCCcEEEeeccceeecc-
Q 015868          187 NLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQA-  265 (399)
Q Consensus       187 ~~~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~giiHrDlkp~NILl~~~~~vkl~DFG~a~~~~-  265 (399)
                      .+|+||||++||+|.+++.. .+.+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||+++... 
T Consensus       127 ~~~lV~E~~~gg~L~~~l~~-~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDLKp~NILl~~~g~ikL~DFGla~~~~~  205 (396)
T 4dc2_A          127 RLFFVIEYVNGGDLMFHMQR-QRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLR  205 (396)
T ss_dssp             EEEEEEECCTTCBHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCC
T ss_pred             EEEEEEEcCCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCEEeccCCHHHEEECCCCCEEEeecceeeeccc
Confidence            99999999999999999976 4679999999999999999999999999999999999999999999999999998633 


Q ss_pred             CCCccccCCCCcccccccccCCCCCCChhhHHHHHHHHHHHHcCCCCCCCCC---------HHHHHHHHHhccCCCCCCC
Q 015868          266 QSGVMTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPYAGLT---------PLQAAVGVVQKSLRPTIPK  336 (399)
Q Consensus       266 ~~~~~~~~~gt~~y~aPE~l~~~~~~~~~Dv~slG~vl~elltg~~P~~~~~---------~~~~~~~~~~~~~~~~~~~  336 (399)
                      ........+||+.|+|||++.+..|+.++|+|||||++|||++|+.||....         .........  .....+|.
T Consensus       206 ~~~~~~~~~gt~~Y~aPE~l~~~~~~~~~DiwslGvllyell~G~~Pf~~~~~~~~~~~~~~~~~~~~i~--~~~~~~p~  283 (396)
T 4dc2_A          206 PGDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVIL--EKQIRIPR  283 (396)
T ss_dssp             TTCCBCCCCBCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSTTTTC------CCHHHHHHHHH--HCCCCCCT
T ss_pred             CCCccccccCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCcccccccccchhhHHHHHHHHh--ccccCCCC
Confidence            3334556689999999999999999999999999999999999999996432         111222222  23456788


Q ss_pred             CCcHHHHHHHHHHhhhcCCCCCCH
Q 015868          337 HAHPRLAELLERCWQHDPTQRPNF  360 (399)
Q Consensus       337 ~~~~~l~~ll~~cl~~dP~~Rps~  360 (399)
                      .+++++.+||.+||+.||.+||++
T Consensus       284 ~~s~~~~~li~~lL~~dP~~R~~~  307 (396)
T 4dc2_A          284 SLSVKAASVLKSFLNKDPKERLGC  307 (396)
T ss_dssp             TSCHHHHHHHHHHTCSCTTTSTTC
T ss_pred             cCCHHHHHHHHHHhcCCHhHcCCC
Confidence            899999999999999999999996

>2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens}

Probab=100.00  E-value=1.3e-46  Score=359.09  Aligned_cols=256  Identities=35%  Similarity=0.668  Sum_probs=216.0

Q ss_pred             eecccccceeceeceeCceEEEEEEECCeeEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCceeeEEeEEecCCcEEEE
Q 015868          112 EIDAKQLKIECKVASGSYGDLYKGTYCSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIV  191 (399)
Q Consensus       112 ~i~~~~~~i~~~lg~G~~g~Vy~~~~~~~~vAvK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~nIv~~~~~~~~~~~~~lV  191 (399)
                      .++.++|++.+.||+|+||.||+|++.++.||+|++...    ...+.+.+|+.++++++||||+++++++.+  ..++|
T Consensus         4 ~i~~~~~~~~~~lg~G~~g~V~~~~~~~~~vavK~~~~~----~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~--~~~lv   77 (307)
T 2eva_A            4 MIDYKEIEVEEVVGRGAFGVVCKAKWRAKDVAIKQIESE----SERKAFIVELRQLSRVNHPNIVKLYGACLN--PVCLV   77 (307)
T ss_dssp             BCCGGGEEEEEEEECCSSSEEEEEEETTEEEEEEECSST----THHHHHHHHHHHHHHCCCTTBCCEEEBCTT--TTEEE
T ss_pred             cCCHhHeeeeeEeecCCCceEEEEEECCeeEEEEEecCh----hHHHHHHHHHHHHhcCCCCCcCeEEEEEcC--CcEEE
Confidence            467889999999999999999999999999999999743    345788999999999999999999998874  47999


Q ss_pred             EecCCCCCHHHHHHhcCC--CCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCCCceeecCCCc-EEEeeccceeecc
Q 015868          192 TEFMARGSIYDFLHKQKG--VFQLTSLLKVAIDVSKGMNYLHQ---NNIIHRDLKTANLLMDENGV-VKVADFGVARVQA  265 (399)
Q Consensus       192 ~E~~~ggsL~~~l~~~~~--~l~~~~~~~i~~~i~~~L~~LH~---~giiHrDlkp~NILl~~~~~-vkl~DFG~a~~~~  265 (399)
                      |||++|++|.+++.....  .++...++.++.|+++||.|||+   +||+||||||+||+++.++. +||+|||+++...
T Consensus        78 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~~kl~Dfg~~~~~~  157 (307)
T 2eva_A           78 MEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQ  157 (307)
T ss_dssp             EECCTTCBHHHHHHCSSSEECCCHHHHHHHHHHHHHHHHHHHTCSSSCCCCCCCSGGGEEEETTTTEEEECCCCC-----
T ss_pred             EEcCCCCCHHHHHhccCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeecCCCChhHEEEeCCCCEEEEcccccccccc
Confidence            999999999999976432  47889999999999999999999   89999999999999998886 7999999997544


Q ss_pred             CCCccccCCCCcccccccccCCCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHH-HHHHHHHhccCCCCCCCCCcHHHHH
Q 015868          266 QSGVMTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPYAGLTPL-QAAVGVVQKSLRPTIPKHAHPRLAE  344 (399)
Q Consensus       266 ~~~~~~~~~gt~~y~aPE~l~~~~~~~~~Dv~slG~vl~elltg~~P~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~l~~  344 (399)
                      ..  .....||+.|+|||++.+..++.++||||||+++|+|++|+.||...... ...........++..+..+++.+.+
T Consensus       158 ~~--~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~  235 (307)
T 2eva_A          158 TH--MTNNKGSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPFDEIGGPAFRIMWAVHNGTRPPLIKNLPKPIES  235 (307)
T ss_dssp             ---------CCTTSSCHHHHTCCCCCTHHHHHHHHHHHHHHHHTCCTTTTTCSSHHHHHHHHHTTCCCCCBTTCCHHHHH
T ss_pred             cc--cccCCCCCceEChhhhCCCCCCcHHHHHHHHHHHHHHHHCCCCchhhCccHHHHHHHHhcCCCCCcccccCHHHHH
Confidence            32  33456899999999999999999999999999999999999999865432 2223334455667778889999999


Q ss_pred             HHHHHhhhcCCCCCCHHHHHHHHHHHHHHHH
Q 015868          345 LLERCWQHDPTQRPNFSQITDILKQMMKEVA  375 (399)
Q Consensus       345 ll~~cl~~dP~~Rps~~ell~~L~~l~~~~~  375 (399)
                      ++.+||+.||.+|||+.++++.|+++.+...
T Consensus       236 li~~~l~~dp~~Rps~~ell~~L~~~~~~~~  266 (307)
T 2eva_A          236 LMTRCWSKDPSQRPSMEEIVKIMTHLMRYFP  266 (307)
T ss_dssp             HHHHHTCSSGGGSCCHHHHHHHHHHHGGGCC
T ss_pred             HHHHHhcCChhhCcCHHHHHHHHHHHHHhcc
Confidence            9999999999999999999999999876553

>3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A

Probab=100.00  E-value=1.6e-46  Score=354.08  Aligned_cols=254  Identities=26%  Similarity=0.436  Sum_probs=205.5

Q ss_pred             eeecccccceeceeceeCceEEEEEEE--CCeeEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCceeeEEeEEecCCcE
Q 015868          111 WEIDAKQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNL  188 (399)
Q Consensus       111 ~~i~~~~~~i~~~lg~G~~g~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~nIv~~~~~~~~~~~~  188 (399)
                      +++..++|++.++||+|+||.||+|++  .++.||+|+++.........+.+.++...++.++||||+++++++..+...
T Consensus         2 ~~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~~~~~~   81 (290)
T 3fme_A            2 MEVKADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGALFREGDV   81 (290)
T ss_dssp             CCCCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEC---CHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSSE
T ss_pred             CcccHHhhhhHHhcCCCCCeEEEEEEecCCCeEEEEEEeecccCcHHHHHHHHHHHHHHHhCCCCeEEEEeeeeeccCCE
Confidence            467789999999999999999999998  788999999987654455555666677778889999999999999999999


Q ss_pred             EEEEecCCCCCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHC-CcccCCCCCCceeecCCCcEEEeeccceeec
Q 015868          189 CIVTEFMARGSIYDFLHK---QKGVFQLTSLLKVAIDVSKGMNYLHQN-NIIHRDLKTANLLMDENGVVKVADFGVARVQ  264 (399)
Q Consensus       189 ~lV~E~~~ggsL~~~l~~---~~~~l~~~~~~~i~~~i~~~L~~LH~~-giiHrDlkp~NILl~~~~~vkl~DFG~a~~~  264 (399)
                      ++||||++| +|.+++..   ....+++..++.++.|++.||.|||++ ||+||||||+||+++.++.+||+|||.++..
T Consensus        82 ~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~  160 (290)
T 3fme_A           82 WICMELMDT-SLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKLSVIHRDVKPSNVLINALGQVKMCDFGISGYL  160 (290)
T ss_dssp             EEEEECCSE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHSCCCCCCCSGGGCEECTTCCEEBCCC------
T ss_pred             EEEEehhcc-chHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCeecCCCCHHHEEECCCCCEEEeecCCcccc
Confidence            999999975 88887754   457899999999999999999999998 9999999999999999999999999999876


Q ss_pred             cCCCccccCCCCccccccccc----CCCCCCChhhHHHHHHHHHHHHcCCCCCCC-CCHHHHHHHHHhccCCCCCCCCCc
Q 015868          265 AQSGVMTAETGTYRWMAPEVI----EHKPYDYKADVFSFGIALWELLTGELPYAG-LTPLQAAVGVVQKSLRPTIPKHAH  339 (399)
Q Consensus       265 ~~~~~~~~~~gt~~y~aPE~l----~~~~~~~~~Dv~slG~vl~elltg~~P~~~-~~~~~~~~~~~~~~~~~~~~~~~~  339 (399)
                      ..........||+.|+|||.+    .+..++.++||||||+++|+|++|..||.. ..+................+..++
T Consensus       161 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (290)
T 3fme_A          161 VDDVAKDIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTPFQQLKQVVEEPSPQLPADKFS  240 (290)
T ss_dssp             ---------CCCCCCSCHHHHSCCTTC--CCHHHHHHHHHHHHHHHHHTSCSSCCCSCHHHHHHHHHHSCCCCCCTTTSC
T ss_pred             cccccccccCCCccccChhhcChhhcCcCCCcHHHHHHHHHHHHHHHHCCCCccccCchHHHHHHHhccCCCCcccccCC
Confidence            655555556799999999996    566789999999999999999999999987 344555555555444444456789


Q ss_pred             HHHHHHHHHHhhhcCCCCCCHHHHHH
Q 015868          340 PRLAELLERCWQHDPTQRPNFSQITD  365 (399)
Q Consensus       340 ~~l~~ll~~cl~~dP~~Rps~~ell~  365 (399)
                      +++.+++.+||+.||++|||+.|+++
T Consensus       241 ~~~~~li~~~l~~~p~~Rpt~~e~l~  266 (290)
T 3fme_A          241 AEFVDFTSQCLKKNSKERPTYPELMQ  266 (290)
T ss_dssp             HHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred             HHHHHHHHHHhhcChhhCcCHHHHHh
Confidence            99999999999999999999999987

>1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A*

Probab=100.00  E-value=1.3e-46  Score=361.84  Aligned_cols=261  Identities=32%  Similarity=0.607  Sum_probs=223.9

Q ss_pred             eecccccceeceeceeCceEEEEEEE--CCee--EEEEEecCCCCCHHHHHHHHHHHHHHHhc-CCCceeeEEeEEecCC
Q 015868          112 EIDAKQLKIECKVASGSYGDLYKGTY--CSQE--VAIKVLKPECVNTEMLKEFSQEVYIMRKI-RHKNVVQFIGACTRPP  186 (399)
Q Consensus       112 ~i~~~~~~i~~~lg~G~~g~Vy~~~~--~~~~--vAvK~~~~~~~~~~~~~~~~~Ei~~l~~l-~h~nIv~~~~~~~~~~  186 (399)
                      .++.++|++.+.||+|+||.||+|++  .+..  +|+|.++... .....+.+.+|+.+++++ +||||+++++++....
T Consensus        21 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~v~iK~~~~~~-~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~   99 (327)
T 1fvr_A           21 VLDWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYA-SKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRG   99 (327)
T ss_dssp             BCCGGGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC-------CHHHHHHHHHTTCCCCTTBCCEEEEEEETT
T ss_pred             cccHHHccceeeeecCCCceEEEEEEccCCcccceeeeeecccc-chHHHHHHHHHHHHHHhccCCCchhhhceeeeeCC
Confidence            46778999999999999999999986  4554  4999987542 334456789999999999 8999999999999999


Q ss_pred             cEEEEEecCCCCCHHHHHHhcC---------------CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceeecCCC
Q 015868          187 NLCIVTEFMARGSIYDFLHKQK---------------GVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENG  251 (399)
Q Consensus       187 ~~~lV~E~~~ggsL~~~l~~~~---------------~~l~~~~~~~i~~~i~~~L~~LH~~giiHrDlkp~NILl~~~~  251 (399)
                      ..++||||+++++|.+++....               ..+++..++.++.||+.||.|||++||+||||||+||+++.++
T Consensus       100 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~~~~~  179 (327)
T 1fvr_A          100 YLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENY  179 (327)
T ss_dssp             EEEEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECGGG
T ss_pred             ceEEEEecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCccCCCCccceEEEcCCC
Confidence            9999999999999999997643               4789999999999999999999999999999999999999999


Q ss_pred             cEEEeeccceeeccCCCccccCCCCcccccccccCCCCCCChhhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHHhccC
Q 015868          252 VVKVADFGVARVQAQSGVMTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLT-GELPYAGLTPLQAAVGVVQKSL  330 (399)
Q Consensus       252 ~vkl~DFG~a~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~Dv~slG~vl~ellt-g~~P~~~~~~~~~~~~~~~~~~  330 (399)
                      .+||+|||+++............+++.|+|||.+.+..++.++||||||+++|+|++ |..||.+.+..+.... +....
T Consensus       180 ~~kL~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~~~~~~-~~~~~  258 (327)
T 1fvr_A          180 VAKIADFGLSRGQEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEK-LPQGY  258 (327)
T ss_dssp             CEEECCTTCEESSCEECCC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHH-GGGTC
T ss_pred             eEEEcccCcCccccccccccCCCCCccccChhhhccccCCchhcchHHHHHHHHHHcCCCCCCCCCcHHHHHHH-hhcCC
Confidence            999999999975443333444567889999999998889999999999999999998 9999999887765544 44455


Q ss_pred             CCCCCCCCcHHHHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHH
Q 015868          331 RPTIPKHAHPRLAELLERCWQHDPTQRPNFSQITDILKQMMKEV  374 (399)
Q Consensus       331 ~~~~~~~~~~~l~~ll~~cl~~dP~~Rps~~ell~~L~~l~~~~  374 (399)
                      ++..+..+++++.+++.+||+.||.+|||+.++++.|.+++.+.
T Consensus       259 ~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~  302 (327)
T 1fvr_A          259 RLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEER  302 (327)
T ss_dssp             CCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSS
T ss_pred             CCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhh
Confidence            66778889999999999999999999999999999999998643

>4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A*

Probab=100.00  E-value=2e-47  Score=360.34  Aligned_cols=257  Identities=26%  Similarity=0.473  Sum_probs=218.2

Q ss_pred             eeecccccceeceeceeCceEEEEEEECC---------eeEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCceeeEEeE
Q 015868          111 WEIDAKQLKIECKVASGSYGDLYKGTYCS---------QEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGA  181 (399)
Q Consensus       111 ~~i~~~~~~i~~~lg~G~~g~Vy~~~~~~---------~~vAvK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~nIv~~~~~  181 (399)
                      .++..++|++.+.||+|+||.||+|++..         ..||+|+++..  .....+.+.+|+.++++++||||++++++
T Consensus         3 ~~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~   80 (289)
T 4fvq_A            3 HKIRNEDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKA--HRNYSESFFEAASMMSKLSHKHLVLNYGV   80 (289)
T ss_dssp             CBCCGGGEEEEEEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECGG--GGGGHHHHHHHHHHHHTSCCTTBCCEEEE
T ss_pred             EEechhHeeeeeeeccCCCceEEEEEEecccccccccchhhhhhhcccc--cHHHHHHHHHHHHHHHhCCCCCEeEEEEE
Confidence            35778899999999999999999997643         56999999754  33445789999999999999999999999


Q ss_pred             EecCCcEEEEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceeecCCCc--------E
Q 015868          182 CTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGV--------V  253 (399)
Q Consensus       182 ~~~~~~~~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~giiHrDlkp~NILl~~~~~--------v  253 (399)
                      +..++..++||||++|++|.+++......+++..++.++.||+.||.|||++||+||||||+||+++.++.        +
T Consensus        81 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~~~~~  160 (289)
T 4fvq_A           81 CVCGDENILVQEFVKFGSLDTYLKKNKNCINILWKLEVAKQLAAAMHFLEENTLIHGNVCAKNILLIREEDRKTGNPPFI  160 (289)
T ss_dssp             ECCTTCCEEEEECCTTCBHHHHHHHTGGGCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEEECCBGGGTBCCEE
T ss_pred             EEeCCCCEEEEECCCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHhhCCeECCCcCcceEEEecCCccccccccee
Confidence            99999999999999999999999887666999999999999999999999999999999999999998887        9


Q ss_pred             EEeeccceeeccCCCccccCCCCcccccccccCC-CCCCChhhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHHhccCC
Q 015868          254 KVADFGVARVQAQSGVMTAETGTYRWMAPEVIEH-KPYDYKADVFSFGIALWELLT-GELPYAGLTPLQAAVGVVQKSLR  331 (399)
Q Consensus       254 kl~DFG~a~~~~~~~~~~~~~gt~~y~aPE~l~~-~~~~~~~Dv~slG~vl~ellt-g~~P~~~~~~~~~~~~~~~~~~~  331 (399)
                      ||+|||.+......   ....+|+.|+|||++.+ ..++.++||||||+++|+|++ +.+||........... ..  ..
T Consensus       161 kl~Dfg~~~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~~~~~~~~~~~~~~-~~--~~  234 (289)
T 4fvq_A          161 KLSDPGISITVLPK---DILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDSQRKLQF-YE--DR  234 (289)
T ss_dssp             EECCCCSCTTTSCH---HHHHHTTTTSCHHHHHCGGGCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHH-HH--TT
T ss_pred             eeccCcccccccCc---cccCCcCcccCHHHhCCCCCCCchhHHHHHHHHHHHHHcCCCCCccccchHHHHHH-hh--cc
Confidence            99999998644322   23357889999999987 678999999999999999999 5567766665544332 22  24


Q ss_pred             CCCCCCCcHHHHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHH
Q 015868          332 PTIPKHAHPRLAELLERCWQHDPTQRPNFSQITDILKQMMKEVA  375 (399)
Q Consensus       332 ~~~~~~~~~~l~~ll~~cl~~dP~~Rps~~ell~~L~~l~~~~~  375 (399)
                      +.++...++++.+++.+||+.||.+|||+.++++.|++++..-.
T Consensus       235 ~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~l~~p~~  278 (289)
T 4fvq_A          235 HQLPAPKAAELANLINNCMDYEPDHRPSFRAIIRDLNSLFTPDL  278 (289)
T ss_dssp             CCCCCCSSCTTHHHHHHHSCSSGGGSCCHHHHHHHHHTCC----
T ss_pred             CCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcCCCC
Confidence            55667778899999999999999999999999999999876443

>3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=4.3e-46  Score=352.56  Aligned_cols=258  Identities=29%  Similarity=0.573  Sum_probs=221.9

Q ss_pred             ccceeceeceeCceEEEEEEEC--C---eeEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCceeeEEeEEecCCcE-EE
Q 015868          117 QLKIECKVASGSYGDLYKGTYC--S---QEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNL-CI  190 (399)
Q Consensus       117 ~~~i~~~lg~G~~g~Vy~~~~~--~---~~vAvK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~nIv~~~~~~~~~~~~-~l  190 (399)
                      .|++.+.||+|+||.||+|++.  +   ..||+|+++... .....+.+.+|+.++++++||||+++++++...... ++
T Consensus        22 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~  100 (298)
T 3pls_A           22 VTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRIT-EMQQVEAFLREGLLMRGLNHPNVLALIGIMLPPEGLPHV  100 (298)
T ss_dssp             EEEEEEEEEEETTEEEEEEEEECSSSCEEEEEEEEETTCC-SHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCEE
T ss_pred             EEccCceeccCCCceEEEEEEecCCCceeeeeeeeccccc-cHHHHHHHHHHHHHHHhCCCCCeeeEEEEEecCCCCcEE
Confidence            5667799999999999999862  2   269999997643 455678899999999999999999999999776655 99


Q ss_pred             EEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceeecCCCcEEEeeccceeeccCCC--
Q 015868          191 VTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSG--  268 (399)
Q Consensus       191 V~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~giiHrDlkp~NILl~~~~~vkl~DFG~a~~~~~~~--  268 (399)
                      ||||+.+++|.+++......+++..++.++.|++.||.|||++||+||||||+||+++.++.+||+|||+++......  
T Consensus       101 v~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~~  180 (298)
T 3pls_A          101 LLPYMCHGDLLQFIRSPQRNPTVKDLISFGLQVARGMEYLAEQKFVHRDLAARNCMLDESFTVKVADFGLARDILDREYY  180 (298)
T ss_dssp             EECCCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTCCEEECCTTSSCTTTTGGGG
T ss_pred             EEecccCCCHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEEcCCCcEEeCcCCCcccccCCccc
Confidence            999999999999998877889999999999999999999999999999999999999999999999999997543321  


Q ss_pred             ---ccccCCCCcccccccccCCCCCCChhhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHHhccCCCCCCCCCcHHHHH
Q 015868          269 ---VMTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLT-GELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRLAE  344 (399)
Q Consensus       269 ---~~~~~~gt~~y~aPE~l~~~~~~~~~Dv~slG~vl~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~  344 (399)
                         ......+++.|+|||.+.+..++.++||||||+++|+|++ +.+||...++.+... .......+..+..+++++.+
T Consensus       181 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~l~~  259 (298)
T 3pls_A          181 SVQQHRHARLPVKWTALESLQTYRFTTKSDVWSFGVLLWELLTRGAPPYRHIDPFDLTH-FLAQGRRLPQPEYCPDSLYQ  259 (298)
T ss_dssp             CSCCSSCTTCGGGGSCHHHHTTCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCGGGHHH-HHHTTCCCCCCTTCCHHHHH
T ss_pred             ccccCcCCCCCccccChhhhccCCCChhhchhhHHHHHHHHhhCCCCCCccCCHHHHHH-HhhcCCCCCCCccchHHHHH
Confidence               2234467889999999999999999999999999999999 556676666655443 34455566778889999999


Q ss_pred             HHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHh
Q 015868          345 LLERCWQHDPTQRPNFSQITDILKQMMKEVAS  376 (399)
Q Consensus       345 ll~~cl~~dP~~Rps~~ell~~L~~l~~~~~~  376 (399)
                      ++.+||+.||.+|||+.++++.|++++..+..
T Consensus       260 li~~~l~~~p~~Rps~~~ll~~l~~~~~~l~~  291 (298)
T 3pls_A          260 VMQQCWEADPAVRPTFRVLVGEVEQIVSALLG  291 (298)
T ss_dssp             HHHHHTCSSGGGSCCHHHHHHHHHHHHHHCCS
T ss_pred             HHHHHccCChhhCcCHHHHHHHHHHHHHHHhc
Confidence            99999999999999999999999999887643

>1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A*

Probab=100.00  E-value=2.8e-46  Score=363.50  Aligned_cols=247  Identities=31%  Similarity=0.480  Sum_probs=219.2

Q ss_pred             ccccceeceeceeCceEEEEEEE--CCeeEEEEEecCCCC-CHHHHHHHHHHHHHHHhcCCCceeeEEeEEecCCcEEEE
Q 015868          115 AKQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECV-NTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIV  191 (399)
Q Consensus       115 ~~~~~i~~~lg~G~~g~Vy~~~~--~~~~vAvK~~~~~~~-~~~~~~~~~~Ei~~l~~l~h~nIv~~~~~~~~~~~~~lV  191 (399)
                      .+.|++.+.||+|+||.||+|+.  .++.||||++..... .....+.+.+|+.++++++||||+++++++..+...++|
T Consensus        53 ~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv  132 (348)
T 1u5q_A           53 EKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLV  132 (348)
T ss_dssp             HHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEESCSSCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEE
T ss_pred             hhheeeeeEEccCCCEEEEEEEEccCCeEEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCeEEEE
Confidence            35699999999999999999986  688999999976543 344557899999999999999999999999999999999


Q ss_pred             EecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceeecCCCcEEEeeccceeeccCCCccc
Q 015868          192 TEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMT  271 (399)
Q Consensus       192 ~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~giiHrDlkp~NILl~~~~~vkl~DFG~a~~~~~~~~~~  271 (399)
                      |||+.| +|.+++......+++..++.++.|++.||.|||++||+||||||+|||++.++.+||+|||+++....   ..
T Consensus       133 ~e~~~g-~l~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~---~~  208 (348)
T 1u5q_A          133 MEYCLG-SASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAP---AN  208 (348)
T ss_dssp             EECCSE-EHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEETTTEEEECCCTTCBSSSS---BC
T ss_pred             EecCCC-CHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEECCCCCEEEeeccCceecCC---CC
Confidence            999974 89999877778899999999999999999999999999999999999999999999999999976543   23


Q ss_pred             cCCCCcccccccccC---CCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhccCCCCCCCCCcHHHHHHHHH
Q 015868          272 AETGTYRWMAPEVIE---HKPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRLAELLER  348 (399)
Q Consensus       272 ~~~gt~~y~aPE~l~---~~~~~~~~Dv~slG~vl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~  348 (399)
                      ...||+.|+|||++.   +..++.++||||||+++|+|++|..||...+.................+..+++.+.++|.+
T Consensus       209 ~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~  288 (348)
T 1u5q_A          209 SFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPALQSGHWSEYFRNFVDS  288 (348)
T ss_dssp             CCCSCGGGCCHHHHHTTSSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCCCCTTSCHHHHHHHHH
T ss_pred             cccCCcceeCHhhhccccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCCCCCCHHHHHHHHH
Confidence            457999999999984   56789999999999999999999999999888777766666555555567789999999999


Q ss_pred             HhhhcCCCCCCHHHHHH
Q 015868          349 CWQHDPTQRPNFSQITD  365 (399)
Q Consensus       349 cl~~dP~~Rps~~ell~  365 (399)
                      ||+.||++|||++++++
T Consensus       289 ~l~~dP~~Rps~~~ll~  305 (348)
T 1u5q_A          289 CLQKIPQDRPTSEVLLK  305 (348)
T ss_dssp             HTCSSGGGSCCHHHHTT
T ss_pred             HcccChhhCcCHHHHhh
Confidence            99999999999999975

>2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A*

Probab=100.00  E-value=1.1e-45  Score=352.43  Aligned_cols=264  Identities=24%  Similarity=0.462  Sum_probs=212.5

Q ss_pred             cccccceeceeceeCceEEEEEEE--CCeeEEEEEecCCC-CCHHHHHHHHHHHHHHHhcCCCceeeEEeEEecCCcEEE
Q 015868          114 DAKQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPEC-VNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCI  190 (399)
Q Consensus       114 ~~~~~~i~~~lg~G~~g~Vy~~~~--~~~~vAvK~~~~~~-~~~~~~~~~~~Ei~~l~~l~h~nIv~~~~~~~~~~~~~l  190 (399)
                      ..++|++.+.||+|+||.||+|..  .++.||+|+++... .+......+.+|+.++++++||||+++++++...+..++
T Consensus        30 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~l  109 (310)
T 2wqm_A           30 TLANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNI  109 (310)
T ss_dssp             SGGGEEEEEEEECC--CEEEEEEETTTCCEEEEEEECTTSSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEE
T ss_pred             cccceEEEEeecCCCCceEEEEEEcCCCceEEEEeeehhhccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCcEEE
Confidence            456899999999999999999987  57899999998643 356667889999999999999999999999999999999


Q ss_pred             EEecCCCCCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceeecCCCcEEEeeccceeeccCC
Q 015868          191 VTEFMARGSIYDFLHK---QKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQS  267 (399)
Q Consensus       191 V~E~~~ggsL~~~l~~---~~~~l~~~~~~~i~~~i~~~L~~LH~~giiHrDlkp~NILl~~~~~vkl~DFG~a~~~~~~  267 (399)
                      ||||+.+++|.+++..   ....+++..++.++.|++.||.|||++||+||||||+||+++.++.+||+|||+++.....
T Consensus       110 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~NIl~~~~~~~kl~Dfg~~~~~~~~  189 (310)
T 2wqm_A          110 VLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSK  189 (310)
T ss_dssp             EEECCCSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCC---------
T ss_pred             EEecCCCCCHHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCcHHHEEEcCCCCEEEEeccceeeecCC
Confidence            9999999999999864   3567899999999999999999999999999999999999999999999999999765443


Q ss_pred             C-ccccCCCCcccccccccCCCCCCChhhHHHHHHHHHHHHcCCCCCCCCC--HHHHHHHHHhccCCCCCCCCCcHHHHH
Q 015868          268 G-VMTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPYAGLT--PLQAAVGVVQKSLRPTIPKHAHPRLAE  344 (399)
Q Consensus       268 ~-~~~~~~gt~~y~aPE~l~~~~~~~~~Dv~slG~vl~elltg~~P~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~l~~  344 (399)
                      . ......|++.|+|||.+.+..++.++||||||+++|+|++|..||.+..  .......+......+..+..+++++.+
T Consensus       190 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~  269 (310)
T 2wqm_A          190 TTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQCDYPPLPSDHYSEELRQ  269 (310)
T ss_dssp             ---------CCSSCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTC---CCHHHHHHHHHTTCSCCCCTTTSCHHHHH
T ss_pred             CccccccCCCeeEeChHHhCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchhHHHHHHHhhcccCCCCcccccCHHHHH
Confidence            2 2234568999999999999999999999999999999999999997643  223333333333333334678999999


Q ss_pred             HHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHhc
Q 015868          345 LLERCWQHDPTQRPNFSQITDILKQMMKEVASE  377 (399)
Q Consensus       345 ll~~cl~~dP~~Rps~~ell~~L~~l~~~~~~~  377 (399)
                      ++.+||..||.+|||+.++++.|+++.......
T Consensus       270 li~~~l~~dp~~Rps~~~il~~l~~l~~~~~~~  302 (310)
T 2wqm_A          270 LVNMCINPDPEKRPDVTYVYDVAKRMHACTASS  302 (310)
T ss_dssp             HHHHHTCSSGGGSCCHHHHHHHHHHHHHHHC--
T ss_pred             HHHHHcCCChhhCCCHHHHHHHHHHHHHhhhhh
Confidence            999999999999999999999999997766543

>2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens}

Probab=100.00  E-value=1.8e-46  Score=360.80  Aligned_cols=264  Identities=28%  Similarity=0.532  Sum_probs=225.1

Q ss_pred             ceeecccccceeceeceeCceEEEEEEE------CCeeEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCceeeEEeEEe
Q 015868          110 VWEIDAKQLKIECKVASGSYGDLYKGTY------CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACT  183 (399)
Q Consensus       110 ~~~i~~~~~~i~~~lg~G~~g~Vy~~~~------~~~~vAvK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~nIv~~~~~~~  183 (399)
                      ...+..++|++.+.||+|+||.||++++      .++.||+|+++..  .....+.+.+|+.++++++||||+++++++.
T Consensus        35 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~  112 (326)
T 2w1i_A           35 PTQFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHS--TEEHLRDFEREIEILKSLQHDNIVKYKGVCY  112 (326)
T ss_dssp             --CCCGGGEEEEEEEECCSSEEEEEEEECTTSSSCCEEEEEEEESSC--CSHHHHHHHHHHHHHHTCCCTTBCCEEEEEC
T ss_pred             ccccCHHHceeeeeeccCCCeEEEEEEeccccCCCceEEEEEEeccC--CHHHHHHHHHHHHHHHhCCCCCeeeEEEEEE
Confidence            3456778999999999999999999985      5789999999865  4556678999999999999999999999986


Q ss_pred             cCC--cEEEEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceeecCCCcEEEeeccce
Q 015868          184 RPP--NLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVA  261 (399)
Q Consensus       184 ~~~--~~~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~giiHrDlkp~NILl~~~~~vkl~DFG~a  261 (399)
                      ...  .+++||||+++++|.+++......+++..++.++.|++.||.|||++||+||||||+||+++.++.+||+|||.+
T Consensus       113 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dikp~NIli~~~~~~kL~Dfg~~  192 (326)
T 2w1i_A          113 SAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLT  192 (326)
T ss_dssp             C----CCEEEECCCTTCBHHHHHHHSTTSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEEETTEEEECCCTTC
T ss_pred             ecCCCceEEEEECCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCEeccCCCcceEEEcCCCcEEEecCcch
Confidence            644  689999999999999999887778999999999999999999999999999999999999999999999999999


Q ss_pred             eeccCCCc----cccCCCCcccccccccCCCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHH---------------HHH
Q 015868          262 RVQAQSGV----MTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPYAGLTPL---------------QAA  322 (399)
Q Consensus       262 ~~~~~~~~----~~~~~gt~~y~aPE~l~~~~~~~~~Dv~slG~vl~elltg~~P~~~~~~~---------------~~~  322 (399)
                      +.......    .....++..|+|||.+.+..++.++||||||+++|+|+||..||......               ...
T Consensus       193 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~  272 (326)
T 2w1i_A          193 KVLPQDKEYYKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHL  272 (326)
T ss_dssp             EECCSSCSEEECSSCCSCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHHTTCGGGSHHHHHHHHHCTTCCTHHHHHHH
T ss_pred             hhccccccccccccCCCCceeEECchhhcCCCCCchhhHHHHHHHHHHHHhcCCCCCCCHHHHHHhhccccchhhhHHHH
Confidence            87654432    22345677899999999888999999999999999999999988642110               112


Q ss_pred             HHHHhccCCCCCCCCCcHHHHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHH
Q 015868          323 VGVVQKSLRPTIPKHAHPRLAELLERCWQHDPTQRPNFSQITDILKQMMKEVA  375 (399)
Q Consensus       323 ~~~~~~~~~~~~~~~~~~~l~~ll~~cl~~dP~~Rps~~ell~~L~~l~~~~~  375 (399)
                      ...+....++..+..+++++.++|.+||+.||.+|||+.++++.|+++.+++.
T Consensus       273 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~el~~~L~~l~~~l~  325 (326)
T 2w1i_A          273 IELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRDQMA  325 (326)
T ss_dssp             HHHHHTTCCCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHHHH
T ss_pred             HHHhhcCCCCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHHhc
Confidence            23344455666788899999999999999999999999999999999987764

>3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A

Probab=100.00  E-value=2e-46  Score=366.31  Aligned_cols=249  Identities=25%  Similarity=0.427  Sum_probs=201.0

Q ss_pred             ecccccceeceeceeCceEEEEEEE--CCeeEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCceeeEEeEEecCCcEEE
Q 015868          113 IDAKQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCI  190 (399)
Q Consensus       113 i~~~~~~i~~~lg~G~~g~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~nIv~~~~~~~~~~~~~l  190 (399)
                      .+.++|++.++||+|+||.||+++.  +++.||+|++.......   +.+.+|+.+++.++||||+++++++..+..+++
T Consensus        17 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~---~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~l   93 (361)
T 3uc3_A           17 HDSDRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGAAID---ENVQREIINHRSLRHPNIVRFKEVILTPTHLAI   93 (361)
T ss_dssp             CCTTTEEEEEEESSSTTSSEEEEEETTTCCEEEEEEEESSTTSC---HHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEE
T ss_pred             CCCCcEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEecCcccc---HHHHHHHHHHHhCCCCCCCcEEEEEeeCCEEEE
Confidence            4567999999999999999999998  57899999998653322   457799999999999999999999999999999


Q ss_pred             EEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceeecCCCc--EEEeeccceeeccCCC
Q 015868          191 VTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGV--VKVADFGVARVQAQSG  268 (399)
Q Consensus       191 V~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~giiHrDlkp~NILl~~~~~--vkl~DFG~a~~~~~~~  268 (399)
                      ||||+.||+|.+++.. .+.+++..++.++.|++.||.|||++||+||||||+||+++.++.  +||+|||+++......
T Consensus        94 v~e~~~~~~L~~~l~~-~~~~~~~~~~~i~~ql~~~L~~LH~~~ivH~Dlkp~Nill~~~~~~~~kl~Dfg~a~~~~~~~  172 (361)
T 3uc3_A           94 IMEYASGGELYERICN-AGRFSEDEARFFFQQLLSGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS  172 (361)
T ss_dssp             EEECCCSCBHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHHTTCCSCCCCGGGEEECSSSSCCEEECCCCCC-------
T ss_pred             EEEeCCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEcCCCCceEEEeecCccccccccC
Confidence            9999999999999976 457999999999999999999999999999999999999987765  9999999998655444


Q ss_pred             ccccCCCCcccccccccCCCCCCCh-hhHHHHHHHHHHHHcCCCCCCCCCH----HHHHHHHHhccCCCCCCCCCcHHHH
Q 015868          269 VMTAETGTYRWMAPEVIEHKPYDYK-ADVFSFGIALWELLTGELPYAGLTP----LQAAVGVVQKSLRPTIPKHAHPRLA  343 (399)
Q Consensus       269 ~~~~~~gt~~y~aPE~l~~~~~~~~-~Dv~slG~vl~elltg~~P~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~l~  343 (399)
                      ......||+.|+|||++.+..++.+ +||||||+++|+|++|+.||.+...    ...................+++++.
T Consensus       173 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~  252 (361)
T 3uc3_A          173 QPKSTVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPRDYRKTIQRILSVKYSIPDDIRISPECC  252 (361)
T ss_dssp             --------CTTSCHHHHHCSSCCHHHHHHHHHHHHHHHHHHSSCSCC----CCCHHHHHHHHHTTCCCCCTTSCCCHHHH
T ss_pred             CCCCCcCCCCcCChhhhcCCCCCCCeeeeehhHHHHHHHHhCCCCCCCCccHHHHHHHHHHHhcCCCCCCCcCCCCHHHH
Confidence            4556679999999999988888766 8999999999999999999987544    2222333333323333346899999


Q ss_pred             HHHHHHhhhcCCCCCCHHHHHH
Q 015868          344 ELLERCWQHDPTQRPNFSQITD  365 (399)
Q Consensus       344 ~ll~~cl~~dP~~Rps~~ell~  365 (399)
                      +||.+||+.||.+|||+.|+++
T Consensus       253 ~li~~~L~~dP~~Rps~~ell~  274 (361)
T 3uc3_A          253 HLISRIFVADPATRISIPEIKT  274 (361)
T ss_dssp             HHHHHHSCSCTTTSCCHHHHHT
T ss_pred             HHHHHHccCChhHCcCHHHHHh
Confidence            9999999999999999999976

>1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ...

Probab=100.00  E-value=1.3e-46  Score=366.14  Aligned_cols=247  Identities=26%  Similarity=0.410  Sum_probs=218.6

Q ss_pred             cccccceeceeceeCceEEEEEEE--CCeeEEEEEecCCCC-CHHHHHHHHHHHHHHHhcCCCceeeEEeEEecCCcEEE
Q 015868          114 DAKQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECV-NTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCI  190 (399)
Q Consensus       114 ~~~~~~i~~~lg~G~~g~Vy~~~~--~~~~vAvK~~~~~~~-~~~~~~~~~~Ei~~l~~l~h~nIv~~~~~~~~~~~~~l  190 (399)
                      ..++|++.+.||+|+||.||++++  +++.||+|+++.... .....+.+.+|+.+++.++||||+++++++.....+|+
T Consensus        39 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~l  118 (350)
T 1rdq_E           39 QLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYM  118 (350)
T ss_dssp             CGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEE
T ss_pred             CHHHCEEEEEeecCcCcEEEEEEECCCCCEEEEEEEEhHHhccHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEEEE
Confidence            357899999999999999999998  578999999964311 11224678899999999999999999999999999999


Q ss_pred             EEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceeecCCCcEEEeeccceeeccCCCcc
Q 015868          191 VTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVM  270 (399)
Q Consensus       191 V~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~giiHrDlkp~NILl~~~~~vkl~DFG~a~~~~~~~~~  270 (399)
                      ||||++||+|.+++... +.+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||+++.....  .
T Consensus       119 v~e~~~gg~L~~~l~~~-~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~~kL~DFg~a~~~~~~--~  195 (350)
T 1rdq_E          119 VMEYVAGGEMFSHLRRI-GRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR--T  195 (350)
T ss_dssp             EEECCTTCBHHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECSSC--B
T ss_pred             EEcCCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCcccccCccceEEECCCCCEEEcccccceeccCC--c
Confidence            99999999999999764 56999999999999999999999999999999999999999999999999999865432  3


Q ss_pred             ccCCCCcccccccccCCCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhccCCCCCCCCCcHHHHHHHHHHh
Q 015868          271 TAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRLAELLERCW  350 (399)
Q Consensus       271 ~~~~gt~~y~aPE~l~~~~~~~~~Dv~slG~vl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~cl  350 (399)
                      ....||+.|+|||++.+..++.++||||||+++|+|++|..||.+.+..+....+...  ...+|..+++++.++|.+||
T Consensus       196 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~--~~~~p~~~~~~~~~li~~lL  273 (350)
T 1rdq_E          196 WTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSG--KVRFPSHFSSDLKDLLRNLL  273 (350)
T ss_dssp             CCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHC--CCCCCTTCCHHHHHHHHHHS
T ss_pred             ccccCCccccCHHHhcCCCCCCcCCEecccHhHhHHhhCCCCCCCCCHHHHHHHHHcC--CCCCCCCCCHHHHHHHHHHh
Confidence            4557899999999999999999999999999999999999999998888777666554  34567889999999999999


Q ss_pred             hhcCCCCCC-----HHHHHH
Q 015868          351 QHDPTQRPN-----FSQITD  365 (399)
Q Consensus       351 ~~dP~~Rps-----~~ell~  365 (399)
                      +.||.+||+     ++++++
T Consensus       274 ~~dp~~R~~~~~~~~~ei~~  293 (350)
T 1rdq_E          274 QVDLTKRFGNLKNGVNDIKN  293 (350)
T ss_dssp             CSCTTTCTTSSTTTTHHHHT
T ss_pred             hcCHHhccCCccCCHHHHHh
Confidence            999999998     777765

>1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A*

Probab=100.00  E-value=5.8e-47  Score=367.92  Aligned_cols=250  Identities=24%  Similarity=0.446  Sum_probs=216.6

Q ss_pred             eecccccceeceeceeCceEEEEEEE--CCeeEEEEEecCCCC-CHHHHHHHHHHHHHHHhc-CCCceeeEEeEEecCCc
Q 015868          112 EIDAKQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECV-NTEMLKEFSQEVYIMRKI-RHKNVVQFIGACTRPPN  187 (399)
Q Consensus       112 ~i~~~~~~i~~~lg~G~~g~Vy~~~~--~~~~vAvK~~~~~~~-~~~~~~~~~~Ei~~l~~l-~h~nIv~~~~~~~~~~~  187 (399)
                      .+..++|++.+.||+|+||.||+|++  +++.||+|+++.... ..+....+..|..+++.+ +||||+++++++.....
T Consensus        13 ~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~iv~l~~~~~~~~~   92 (345)
T 1xjd_A           13 KLKIEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKEN   92 (345)
T ss_dssp             ---CTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSE
T ss_pred             CCChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhHHhhhhhhHHHHHHHHHHHHhcCCCCCCCcEEEEEEeCCE
Confidence            45678999999999999999999998  478999999974311 112245677899999887 89999999999999999


Q ss_pred             EEEEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceeecCCCcEEEeeccceeeccC-
Q 015868          188 LCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQ-  266 (399)
Q Consensus       188 ~~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~giiHrDlkp~NILl~~~~~vkl~DFG~a~~~~~-  266 (399)
                      +|+||||++||+|.+++.. .+.+++..+..++.||+.||.|||++||+||||||+|||++.+|.+||+|||+++.... 
T Consensus        93 ~~lv~E~~~gg~L~~~l~~-~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~  171 (345)
T 1xjd_A           93 LFFVMEYLNGGDLMYHIQS-CHKFDLSRATFYAAEIILGLQFLHSKGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLG  171 (345)
T ss_dssp             EEEEEECCTTCBHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCT
T ss_pred             EEEEEeCCCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCChhhEEECCCCCEEEeEChhhhhcccC
Confidence            9999999999999999976 35789999999999999999999999999999999999999999999999999985432 


Q ss_pred             CCccccCCCCcccccccccCCCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhccCCCCCCCCCcHHHHHHH
Q 015868          267 SGVMTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRLAELL  346 (399)
Q Consensus       267 ~~~~~~~~gt~~y~aPE~l~~~~~~~~~Dv~slG~vl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll  346 (399)
                      ........||+.|+|||++.+..|+.++|+||||+++|+|++|..||.+.+..+....+...  .+.+|..+++++.++|
T Consensus       172 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~--~~~~p~~~s~~~~~li  249 (345)
T 1xjd_A          172 DAKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMD--NPFYPRWLEKEAKDLL  249 (345)
T ss_dssp             TCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHC--CCCCCTTSCHHHHHHH
T ss_pred             CCcccCCCCCcccCChhhhcCCCCCChhhhHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHhC--CCCCCcccCHHHHHHH
Confidence            22345567999999999999999999999999999999999999999998887766655543  4567788999999999


Q ss_pred             HHHhhhcCCCCCCHH-HHH
Q 015868          347 ERCWQHDPTQRPNFS-QIT  364 (399)
Q Consensus       347 ~~cl~~dP~~Rps~~-ell  364 (399)
                      .+||+.||.+||++. +++
T Consensus       250 ~~lL~~dp~~R~~~~~~i~  268 (345)
T 1xjd_A          250 VKLFVREPEKRLGVRGDIR  268 (345)
T ss_dssp             HHHSCSSGGGSBTTBSCGG
T ss_pred             HHHhcCCHhHcCCChHHHH
Confidence            999999999999997 664

>2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens}

Probab=100.00  E-value=3.2e-46  Score=388.78  Aligned_cols=265  Identities=27%  Similarity=0.537  Sum_probs=227.0

Q ss_pred             ceeecccccceec-eeceeCceEEEEEEE----CCeeEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCceeeEEeEEec
Q 015868          110 VWEIDAKQLKIEC-KVASGSYGDLYKGTY----CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTR  184 (399)
Q Consensus       110 ~~~i~~~~~~i~~-~lg~G~~g~Vy~~~~----~~~~vAvK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~nIv~~~~~~~~  184 (399)
                      .+.+..+++.+.+ +||+|+||.||+|.+    .+..||||+++... .....+.+.+|+.+|++++||||+++++++..
T Consensus       329 ~~~~~~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~-~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~  407 (613)
T 2ozo_A          329 KLFLKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGT-EKADTEEMMREAQIMHQLDNPYIVRLIGVCQA  407 (613)
T ss_dssp             CSBCCTTSEEEEEEEEEECSSSEEEEEEEECSSCEEEEEEEECCCCC-SSTTHHHHHHHHHHHTTCCCTTBCCEEEEEES
T ss_pred             ceeccccceeEcCcEEecCCCcEEEEEEEecCCCcEEEEEEEcCCCC-ChHHHHHHHHHHHHHHhCCCCCEeeEEEEecc
Confidence            3556667777777 899999999999987    34579999998653 23345789999999999999999999999987


Q ss_pred             CCcEEEEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceeecCCCcEEEeeccceeec
Q 015868          185 PPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQ  264 (399)
Q Consensus       185 ~~~~~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~giiHrDlkp~NILl~~~~~vkl~DFG~a~~~  264 (399)
                       +.+++||||+.+|+|.+++......+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+++..
T Consensus       408 -~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~vkL~DFGla~~~  486 (613)
T 2ozo_A          408 -EALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRNLAARNVLLVNRHYAKISDFGLSKAL  486 (613)
T ss_dssp             -SSEEEEEECCTTCBHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECCCSTTTTC
T ss_pred             -CCeEEEEEeCCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCEEcCcCCHHHEEEcCCCcEEEeeccCcccc
Confidence             4699999999999999999877778999999999999999999999999999999999999999999999999999865


Q ss_pred             cCCCc----cccCCCCcccccccccCCCCCCChhhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHHhccCCCCCCCCCc
Q 015868          265 AQSGV----MTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLT-GELPYAGLTPLQAAVGVVQKSLRPTIPKHAH  339 (399)
Q Consensus       265 ~~~~~----~~~~~gt~~y~aPE~l~~~~~~~~~Dv~slG~vl~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~  339 (399)
                      .....    .....+++.|+|||++.+..++.++||||||+++|||++ |+.||.+.+..+.... +..+.++..|..++
T Consensus       487 ~~~~~~~~~~~~~~~~~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~~~~~-i~~~~~~~~p~~~~  565 (613)
T 2ozo_A          487 GADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAF-IEQGKRMECPPECP  565 (613)
T ss_dssp             C--------------CCTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCSHHHHHH-HHTTCCCCCCTTCC
T ss_pred             cCCCceeeeccCCCCccceeCHhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHH-HHcCCCCCCCCcCC
Confidence            43221    122345689999999999999999999999999999998 9999999887765544 45566778888999


Q ss_pred             HHHHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHhc
Q 015868          340 PRLAELLERCWQHDPTQRPNFSQITDILKQMMKEVASE  377 (399)
Q Consensus       340 ~~l~~ll~~cl~~dP~~Rps~~ell~~L~~l~~~~~~~  377 (399)
                      +++.++|.+||+.||++||++.++++.|+++.......
T Consensus       566 ~~l~~li~~cl~~dP~~RPs~~~l~~~L~~~~~~~~~~  603 (613)
T 2ozo_A          566 PELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSLASK  603 (613)
T ss_dssp             HHHHHHHHHTTCSSTTTSCCHHHHHHHHHHHHHHHSCS
T ss_pred             HHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHHHhccc
Confidence            99999999999999999999999999999998877543

>3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A*

Probab=100.00  E-value=1.8e-46  Score=355.59  Aligned_cols=251  Identities=29%  Similarity=0.591  Sum_probs=207.6

Q ss_pred             ecccccceeceeceeCceEEEEEEECCeeEEEEEecCCCCCHHHHHHHHHHHHHHHh--cCCCceeeEEeEEec----CC
Q 015868          113 IDAKQLKIECKVASGSYGDLYKGTYCSQEVAIKVLKPECVNTEMLKEFSQEVYIMRK--IRHKNVVQFIGACTR----PP  186 (399)
Q Consensus       113 i~~~~~~i~~~lg~G~~g~Vy~~~~~~~~vAvK~~~~~~~~~~~~~~~~~Ei~~l~~--l~h~nIv~~~~~~~~----~~  186 (399)
                      +..++|++.+.||+|+||.||+|++.++.||||++...     ....+.+|.+++..  ++||||+++++++..    ..
T Consensus         5 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~vavK~~~~~-----~~~~~~~e~~~~~~~~l~h~niv~~~~~~~~~~~~~~   79 (301)
T 3q4u_A            5 TVARDITLLECVGKGRYGEVWRGSWQGENVAVKIFSSR-----DEKSWFRETELYNTVMLRHENILGFIASDMTSRHSST   79 (301)
T ss_dssp             CCGGGCEEEEEEEECSSEEEEEEEETTEEEEEEEECGG-----GHHHHHHHHHHHHHTCCCCTTBCCEEEEEEEEETTEE
T ss_pred             cccCcEEEEEeeccCCCcEEEEEEECCEEEEEEEeccc-----cchhhHHHHHHHHHhhccCcCeeeEEEeeccccCCCc
Confidence            44679999999999999999999999999999999743     23456667777776  799999999998654    34


Q ss_pred             cEEEEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH--------HCCcccCCCCCCceeecCCCcEEEeec
Q 015868          187 NLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLH--------QNNIIHRDLKTANLLMDENGVVKVADF  258 (399)
Q Consensus       187 ~~~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH--------~~giiHrDlkp~NILl~~~~~vkl~DF  258 (399)
                      .+++||||+++|+|.++++.  ..+++..++.++.|++.||+|||        ++||+||||||+|||++.++.+||+||
T Consensus        80 ~~~lv~e~~~~g~L~~~l~~--~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~Nill~~~~~~kl~Df  157 (301)
T 3q4u_A           80 QLWLITHYHEMGSLYDYLQL--TTLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADL  157 (301)
T ss_dssp             EEEEEECCCTTCBHHHHHTT--CCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCC
T ss_pred             eeEEehhhccCCCHHHHHhh--cccCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCeecCCCChHhEEEcCCCCEEEeeC
Confidence            58999999999999999954  57899999999999999999999        999999999999999999999999999


Q ss_pred             cceeeccCCCc-----cccCCCCcccccccccCCC------CCCChhhHHHHHHHHHHHHcC----------CCCCCCCC
Q 015868          259 GVARVQAQSGV-----MTAETGTYRWMAPEVIEHK------PYDYKADVFSFGIALWELLTG----------ELPYAGLT  317 (399)
Q Consensus       259 G~a~~~~~~~~-----~~~~~gt~~y~aPE~l~~~------~~~~~~Dv~slG~vl~elltg----------~~P~~~~~  317 (399)
                      |+++.......     .....||+.|+|||++.+.      .++.++||||||+++|+|+||          ..||....
T Consensus       158 g~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~pf~~~~  237 (301)
T 3q4u_A          158 GLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYDVV  237 (301)
T ss_dssp             TTCEEEETTTTEEECCCCCCCCCGGGCCHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTTS
T ss_pred             CCeeecccccccccccccccccccceeChhhhcCcCCCCcccCCchhhHHHHHHHHHHHHhhhcCccccccccccccccC
Confidence            99986554332     2234789999999999877      445789999999999999999          88886532


Q ss_pred             H-----HHHHHHHHhccCCCCCCC-----CCcHHHHHHHHHHhhhcCCCCCCHHHHHHHHHHH
Q 015868          318 P-----LQAAVGVVQKSLRPTIPK-----HAHPRLAELLERCWQHDPTQRPNFSQITDILKQM  370 (399)
Q Consensus       318 ~-----~~~~~~~~~~~~~~~~~~-----~~~~~l~~ll~~cl~~dP~~Rps~~ell~~L~~l  370 (399)
                      +     ............++.++.     .+++++.+++.+||+.||.+|||+.++++.|+++
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~i  300 (301)
T 3q4u_A          238 PNDPSFEDMRKVVCVDQQRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKKTLTKI  300 (301)
T ss_dssp             CSSCCHHHHHHHHTTSCCCCCCCGGGGGSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHHHHH
T ss_pred             CCCcchhhhhHHHhccCCCCCCChhhccCccHHHHHHHHHHHhhcChhhCCCHHHHHHHHhcc
Confidence            2     222222233344455543     2567899999999999999999999999999876

>3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens}

Probab=100.00  E-value=3.9e-46  Score=361.35  Aligned_cols=252  Identities=22%  Similarity=0.389  Sum_probs=214.8

Q ss_pred             eeecccccceeceeceeCceEEEEEEE-CCeeEEEEEecCCCCCHHHHHHHHHHHHHHHhcCC--CceeeEEeEEecCCc
Q 015868          111 WEIDAKQLKIECKVASGSYGDLYKGTY-CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRH--KNVVQFIGACTRPPN  187 (399)
Q Consensus       111 ~~i~~~~~~i~~~lg~G~~g~Vy~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~Ei~~l~~l~h--~nIv~~~~~~~~~~~  187 (399)
                      ..+..++|++.+.||+|+||.||++.. .++.||||+++.........+.+.+|+.++++++|  |||+++++++.....
T Consensus         4 i~~~~~~y~i~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~   83 (343)
T 3dbq_A            4 ISVKGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQY   83 (343)
T ss_dssp             EESSSCEEEEEEEESCCSSEEEEEEECTTSCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSE
T ss_pred             eeeecCEEEEEEEEecCCCeEEEEEEeCCCCEEEEEEeeccccchHHHHHHHHHHHHHHhhhhcCCceEEEeeeEeeCCE
Confidence            467788999999999999999999987 56789999998777777778899999999999987  999999999999999


Q ss_pred             EEEEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceeecCCCcEEEeeccceeeccCC
Q 015868          188 LCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQS  267 (399)
Q Consensus       188 ~~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~giiHrDlkp~NILl~~~~~vkl~DFG~a~~~~~~  267 (399)
                      +++||| +.+++|.+++.. ...+++..+..++.||+.||.|||++||+||||||+|||++ ++.+||+|||+++.....
T Consensus        84 ~~lv~e-~~~~~L~~~l~~-~~~~~~~~~~~i~~qi~~al~~lH~~~iiHrDikp~NIll~-~~~~kl~DFG~a~~~~~~  160 (343)
T 3dbq_A           84 IYMVME-CGNIDLNSWLKK-KKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPD  160 (343)
T ss_dssp             EEEEEC-CCSEEHHHHHHH-SCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEE-TTEEEECCCSSSCCC---
T ss_pred             EEEEEe-CCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCcceEEEE-CCcEEEeecccccccCcc
Confidence            999999 557799999977 46789999999999999999999999999999999999996 688999999999865433


Q ss_pred             C---ccccCCCCcccccccccCC-----------CCCCChhhHHHHHHHHHHHHcCCCCCCCCCH-HHHHHHHHhccCCC
Q 015868          268 G---VMTAETGTYRWMAPEVIEH-----------KPYDYKADVFSFGIALWELLTGELPYAGLTP-LQAAVGVVQKSLRP  332 (399)
Q Consensus       268 ~---~~~~~~gt~~y~aPE~l~~-----------~~~~~~~Dv~slG~vl~elltg~~P~~~~~~-~~~~~~~~~~~~~~  332 (399)
                      .   ......||+.|+|||++.+           ..++.++||||||+++|+|++|..||..... ..............
T Consensus       161 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~  240 (343)
T 3dbq_A          161 TTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHEI  240 (343)
T ss_dssp             ---------CCCCSSCCHHHHHHCC-----------CCHHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHHHHCTTSCC
T ss_pred             cccccCCCCcCCcCcCCHHHHhhccccccccccccCCCchhhHHHHHHHHHHHHhCCCcchhhhhHHHHHHHHhcCCccc
Confidence            2   2334579999999999864           6789999999999999999999999987543 34444445555566


Q ss_pred             CCCCCCcHHHHHHHHHHhhhcCCCCCCHHHHHH
Q 015868          333 TIPKHAHPRLAELLERCWQHDPTQRPNFSQITD  365 (399)
Q Consensus       333 ~~~~~~~~~l~~ll~~cl~~dP~~Rps~~ell~  365 (399)
                      ..|...++++.+|+.+||+.||.+|||+.|+++
T Consensus       241 ~~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~  273 (343)
T 3dbq_A          241 EFPDIPEKDLQDVLKCCLKRDPKQRISIPELLA  273 (343)
T ss_dssp             CCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             CCcccCCHHHHHHHHHHcCCChhHCCCHHHHHh
Confidence            777888899999999999999999999999975

>1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B*

Probab=100.00  E-value=1.2e-46  Score=355.15  Aligned_cols=261  Identities=32%  Similarity=0.639  Sum_probs=220.0

Q ss_pred             eeecccccceeceeceeCceEEEEEEEC---C--eeEEEEEecCCCC-CHHHHHHHHHHHHHHHhcCCCceeeEEeEEec
Q 015868          111 WEIDAKQLKIECKVASGSYGDLYKGTYC---S--QEVAIKVLKPECV-NTEMLKEFSQEVYIMRKIRHKNVVQFIGACTR  184 (399)
Q Consensus       111 ~~i~~~~~~i~~~lg~G~~g~Vy~~~~~---~--~~vAvK~~~~~~~-~~~~~~~~~~Ei~~l~~l~h~nIv~~~~~~~~  184 (399)
                      ..+..++|++.+.||+|+||.||+|++.   +  ..||+|+++.... .....+.+.+|+.++++++||||+++++++..
T Consensus        13 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~   92 (291)
T 1u46_A           13 CLIGEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLT   92 (291)
T ss_dssp             EECCGGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred             cccchhHeeeeeeecCCCceeEEEEEeccCCCceeEEEEEEEccCccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEcc
Confidence            4677889999999999999999999862   2  2689999986532 34556789999999999999999999999987


Q ss_pred             CCcEEEEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceeecCCCcEEEeeccceeec
Q 015868          185 PPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQ  264 (399)
Q Consensus       185 ~~~~~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~giiHrDlkp~NILl~~~~~vkl~DFG~a~~~  264 (399)
                      +. .++||||+++++|.+++......+++..++.++.|++.||.|||++||+||||||+||+++.++.+||+|||.++..
T Consensus        93 ~~-~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~  171 (291)
T 1u46_A           93 PP-MKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRAL  171 (291)
T ss_dssp             SS-CEEEEECCTTCBHHHHHHHHGGGSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEEETTEEEECCCTTCEEC
T ss_pred             CC-ceeeEecccCCCHHHHHHhccCCcCHHHHHHHHHHHHHHHHHHHhCCcccCCCchheEEEcCCCCEEEccccccccc
Confidence            65 89999999999999999887778999999999999999999999999999999999999999999999999999876


Q ss_pred             cCCCc----cccCCCCcccccccccCCCCCCChhhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHHhccCCCCCCCCCc
Q 015868          265 AQSGV----MTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLT-GELPYAGLTPLQAAVGVVQKSLRPTIPKHAH  339 (399)
Q Consensus       265 ~~~~~----~~~~~gt~~y~aPE~l~~~~~~~~~Dv~slG~vl~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~  339 (399)
                      .....    .....+|+.|+|||.+.+..++.++||||||+++|+|++ |..||...+..+..........++..+..++
T Consensus       172 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  251 (291)
T 1u46_A          172 PQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERLPRPEDCP  251 (291)
T ss_dssp             CC-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTSCCCCCCCTTCC
T ss_pred             cccccchhhhccCCCCceeeCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCcccCCHHHHHHHHHccCCCCCCCcCcC
Confidence            54332    223456888999999998889999999999999999999 9999999998887777776666777788899


Q ss_pred             HHHHHHHHHHhhhcCCCCCCHHHHHHHHHHHHH
Q 015868          340 PRLAELLERCWQHDPTQRPNFSQITDILKQMMK  372 (399)
Q Consensus       340 ~~l~~ll~~cl~~dP~~Rps~~ell~~L~~l~~  372 (399)
                      +++.+++.+||..||.+|||+.++++.|+++..
T Consensus       252 ~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~  284 (291)
T 1u46_A          252 QDIYNVMVQCWAHKPEDRPTFVALRDFLLEAQP  284 (291)
T ss_dssp             HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC-
T ss_pred             HHHHHHHHHHccCCcccCcCHHHHHHHHHHhCc
Confidence            999999999999999999999999999988753

>2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A*

Probab=100.00  E-value=2.9e-46  Score=360.03  Aligned_cols=257  Identities=20%  Similarity=0.330  Sum_probs=216.5

Q ss_pred             ecccccceeceeceeCceEEEEEEE--CCeeEEEEEecCCCCCHHHHHHHHHHHHHHHhc-CCCceeeEEeEEecCCcEE
Q 015868          113 IDAKQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKI-RHKNVVQFIGACTRPPNLC  189 (399)
Q Consensus       113 i~~~~~~i~~~lg~G~~g~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~Ei~~l~~l-~h~nIv~~~~~~~~~~~~~  189 (399)
                      +..++|++.+.||+|+||.||+|+.  +++.||||++.....    ...+.+|+.+++++ +||||+++++++......+
T Consensus         6 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~----~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~   81 (330)
T 2izr_A            6 MVGPNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSR----APQLHLEYRFYKQLGSGDGIPQVYYFGPCGKYNA   81 (330)
T ss_dssp             EETTTEEEEEECCC-CTTSEEEEEETTTTEEEEEEEEETTCS----SCCHHHHHHHHHHHCSCTTSCCEEEEEEETTEEE
T ss_pred             EEcCCeEEEEEeeccCCceEEEEEECCCCcEEEEEEeccccc----hHHHHHHHHHHHHhhCCCCCCEEEEEEecCCccE
Confidence            3457899999999999999999996  688999999975432    23578899999999 9999999999999999999


Q ss_pred             EEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceeecCCCc-----EEEeeccceeec
Q 015868          190 IVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGV-----VKVADFGVARVQ  264 (399)
Q Consensus       190 lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~giiHrDlkp~NILl~~~~~-----vkl~DFG~a~~~  264 (399)
                      +||||+ +++|.+++......+++..++.++.|++.||+|||++||+||||||+|||++.++.     +||+|||+++..
T Consensus        82 lv~e~~-~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~Nill~~~~~~~~~~~kl~DFg~a~~~  160 (330)
T 2izr_A           82 MVLELL-GPSLEDLFDLCDRTFSLKTVLMIAIQLISRMEYVHSKNLIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKEY  160 (330)
T ss_dssp             EEEECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECCGGGTCTTSEEECCCTTCEES
T ss_pred             EEEEeC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeeeccCCCCCCceEEEEEcccceee
Confidence            999999 88999999877778999999999999999999999999999999999999998887     999999999865


Q ss_pred             cCCCc--------cccCCCCcccccccccCCCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHH---HHHHHHHhccCCC-
Q 015868          265 AQSGV--------MTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPYAGLTPL---QAAVGVVQKSLRP-  332 (399)
Q Consensus       265 ~~~~~--------~~~~~gt~~y~aPE~l~~~~~~~~~Dv~slG~vl~elltg~~P~~~~~~~---~~~~~~~~~~~~~-  332 (399)
                      .....        .....||+.|+|||++.+..++.++||||||+++|+|++|..||.+.+..   +....+....... 
T Consensus       161 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~Pf~~~~~~~~~~~~~~i~~~~~~~~  240 (330)
T 2izr_A          161 IDPETKKHIPYREHKSLTGTARYMSINTHLGKEQSRRDDLEALGHMFMYFLRGSLPWQGLKADTLKERYQKIGDTKRATP  240 (330)
T ss_dssp             BCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCSSHHHHHHHHHHHHHHSC
T ss_pred             ecCCCCccccccccCCcCCCccccChHHHcCCCCCchhHHHHHHHHHHHHhcCCCCccccccccHHHHHHHHHhhhccCC
Confidence            44322        23557899999999999999999999999999999999999999875432   2222221111111 


Q ss_pred             --CCCCCCcHHHHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHH
Q 015868          333 --TIPKHAHPRLAELLERCWQHDPTQRPNFSQITDILKQMMKEVA  375 (399)
Q Consensus       333 --~~~~~~~~~l~~ll~~cl~~dP~~Rps~~ell~~L~~l~~~~~  375 (399)
                        .....++ ++.+++.+||+.||.+||++.+|.+.|+++.+...
T Consensus       241 ~~~~~~~~p-~~~~li~~~l~~~p~~RP~~~~l~~~l~~~~~~~~  284 (330)
T 2izr_A          241 IEVLCENFP-EMATYLRYVRRLDFFEKPDYDYLRKLFTDLFDRKG  284 (330)
T ss_dssp             HHHHTTTCH-HHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHHTT
T ss_pred             HHHHhccCh-HHHHHHHHHHhCCCCCCCCHHHHHHHHHHHHHHcC
Confidence              1112344 99999999999999999999999999999987664

>3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ...

Probab=100.00  E-value=3.4e-46  Score=353.67  Aligned_cols=258  Identities=29%  Similarity=0.543  Sum_probs=221.1

Q ss_pred             ccccceeceeceeCceEEEEEEECC-----eeEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCceeeEEeEEe-cCCcE
Q 015868          115 AKQLKIECKVASGSYGDLYKGTYCS-----QEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACT-RPPNL  188 (399)
Q Consensus       115 ~~~~~i~~~lg~G~~g~Vy~~~~~~-----~~vAvK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~nIv~~~~~~~-~~~~~  188 (399)
                      ..+|++.+.||+|+||.||+|++..     ..||+|.++... .....+.+.+|+.++++++||||+++++++. .+...
T Consensus        24 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~avk~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~  102 (298)
T 3f66_A           24 SLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRIT-DIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSP  102 (298)
T ss_dssp             GEEEEEEEEEEEETTEEEEEEEEC-----CEEEEEEEETTCC-SHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCC
T ss_pred             ceehhhcceeeecCCceEEEEEEecCCCceeEEEEEecccCC-CHHHHHHHHHHHHHHHhCCCCCEeeeeeEEEcCCCce
Confidence            4578999999999999999998632     358999998643 5566788999999999999999999999864 45678


Q ss_pred             EEEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceeecCCCcEEEeeccceeeccCCC
Q 015868          189 CIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSG  268 (399)
Q Consensus       189 ~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~giiHrDlkp~NILl~~~~~vkl~DFG~a~~~~~~~  268 (399)
                      ++||||+++++|.+++......+++..++.++.|++.||.|||++||+||||||+||+++.++.+||+|||.++......
T Consensus       103 ~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~a~~~~~~~  182 (298)
T 3f66_A          103 LVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKE  182 (298)
T ss_dssp             EEEEECCTTCBHHHHHHCTTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTCCEEECSCGGGCCCSCGG
T ss_pred             EEEEeCCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCchheEEECCCCCEEECcccccccccccc
Confidence            99999999999999998777789999999999999999999999999999999999999999999999999998654322


Q ss_pred             -----ccccCCCCcccccccccCCCCCCChhhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHHhccCCCCCCCCCcHHH
Q 015868          269 -----VMTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLT-GELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRL  342 (399)
Q Consensus       269 -----~~~~~~gt~~y~aPE~l~~~~~~~~~Dv~slG~vl~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  342 (399)
                           ......+|+.|+|||.+.+..++.++||||||+++|+|++ |.+||...+..+..... ....++..+..+++++
T Consensus       183 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~l  261 (298)
T 3f66_A          183 YYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYL-LQGRRLLQPEYCPDPL  261 (298)
T ss_dssp             GCBC-----CCBCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTSCTTTHHHHH-HTTCCCCCCTTCCHHH
T ss_pred             hhccccccCCCCCccccChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCccCCHHHHHHHH-hcCCCCCCCccCCHHH
Confidence                 2233456789999999999999999999999999999999 67788777666554443 3445566678899999


Q ss_pred             HHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHH
Q 015868          343 AELLERCWQHDPTQRPNFSQITDILKQMMKEV  374 (399)
Q Consensus       343 ~~ll~~cl~~dP~~Rps~~ell~~L~~l~~~~  374 (399)
                      .+++.+||+.||.+|||+.++++.|+++++..
T Consensus       262 ~~li~~~l~~~p~~Rps~~ell~~L~~~~~~~  293 (298)
T 3f66_A          262 YEVMLKCWHPKAEMRPSFSELVSRISAIFSTF  293 (298)
T ss_dssp             HHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTS
T ss_pred             HHHHHHHcCCChhhCcCHHHHHHHHHHHHHhh
Confidence            99999999999999999999999999998754

>2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A*

Probab=100.00  E-value=1.6e-46  Score=365.87  Aligned_cols=251  Identities=22%  Similarity=0.391  Sum_probs=216.5

Q ss_pred             eecccccceeceeceeCceEEEEEEEC--CeeEEEEEecCCCC-CHHHHHHHHHHHHHHHhc-CCCceeeEEeEEecCCc
Q 015868          112 EIDAKQLKIECKVASGSYGDLYKGTYC--SQEVAIKVLKPECV-NTEMLKEFSQEVYIMRKI-RHKNVVQFIGACTRPPN  187 (399)
Q Consensus       112 ~i~~~~~~i~~~lg~G~~g~Vy~~~~~--~~~vAvK~~~~~~~-~~~~~~~~~~Ei~~l~~l-~h~nIv~~~~~~~~~~~  187 (399)
                      .+..++|++.+.||+|+||.||+|+..  ++.||+|+++.... .....+.+.+|..++..+ +||||+++++++.....
T Consensus        16 ~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~   95 (353)
T 2i0e_A           16 RMKLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDR   95 (353)
T ss_dssp             ---CTTEEEEEEEEEETTEEEEEEEETTEEEEEEEEEEEHHHHHHTTCHHHHHHHHHHHTCTTCCTTBCCEEEEEECSSE
T ss_pred             CCchHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhcchHHHHHHHHHHHHHhcCCCCEEeeEEEEEEcCCE
Confidence            455679999999999999999999985  57899999974311 112245678899999988 79999999999999999


Q ss_pred             EEEEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceeecCCCcEEEeeccceeeccCC
Q 015868          188 LCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQS  267 (399)
Q Consensus       188 ~~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~giiHrDlkp~NILl~~~~~vkl~DFG~a~~~~~~  267 (399)
                      +|+||||++||+|.+++... +.+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||+++.....
T Consensus        96 ~~lv~E~~~gg~L~~~l~~~-~~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~  174 (353)
T 2i0e_A           96 LYFVMEYVNGGDLMYHIQQV-GRFKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWD  174 (353)
T ss_dssp             EEEEEECCCSCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCT
T ss_pred             EEEEEeCCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCEEeccCCHHHEEEcCCCcEEEEeCCcccccccC
Confidence            99999999999999999763 56999999999999999999999999999999999999999999999999999864332


Q ss_pred             -CccccCCCCcccccccccCCCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhccCCCCCCCCCcHHHHHHH
Q 015868          268 -GVMTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRLAELL  346 (399)
Q Consensus       268 -~~~~~~~gt~~y~aPE~l~~~~~~~~~Dv~slG~vl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll  346 (399)
                       .......||+.|+|||++.+..++.++|+||||+++|||++|+.||.+.+..+....+...  .+.+|..+++++.+||
T Consensus       175 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~--~~~~p~~~s~~~~~li  252 (353)
T 2i0e_A          175 GVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEH--NVAYPKSMSKEAVAIC  252 (353)
T ss_dssp             TCCBCCCCSCGGGCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHC--CCCCCTTSCHHHHHHH
T ss_pred             CcccccccCCccccChhhhcCCCcCCcccccchHHHHHHHHcCCCCCCCCCHHHHHHHHHhC--CCCCCCCCCHHHHHHH
Confidence             2344567999999999999999999999999999999999999999998887777666654  3457788999999999


Q ss_pred             HHHhhhcCCCCCC-----HHHHHH
Q 015868          347 ERCWQHDPTQRPN-----FSQITD  365 (399)
Q Consensus       347 ~~cl~~dP~~Rps-----~~ell~  365 (399)
                      .+||+.||.+||+     ++++++
T Consensus       253 ~~lL~~dP~~R~~~~~~~~~~i~~  276 (353)
T 2i0e_A          253 KGLMTKHPGKRLGCGPEGERDIKE  276 (353)
T ss_dssp             HHHTCSCTTSCTTCSTTHHHHHHT
T ss_pred             HHHhhcCHHHcCCCCCCCHHHHhc
Confidence            9999999999996     466654

>2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens}

Probab=100.00  E-value=4e-46  Score=362.48  Aligned_cols=248  Identities=23%  Similarity=0.376  Sum_probs=197.8

Q ss_pred             ecccccceeceeceeCceEEEEEEEC--CeeEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCceeeEEeEEecCCcEEE
Q 015868          113 IDAKQLKIECKVASGSYGDLYKGTYC--SQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCI  190 (399)
Q Consensus       113 i~~~~~~i~~~lg~G~~g~Vy~~~~~--~~~vAvK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~nIv~~~~~~~~~~~~~l  190 (399)
                      ...++|++.+.||+|+||.||+|++.  ++.||||+++...    ..+.+.+|+.++++++||||+++++++..+...++
T Consensus        50 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~----~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l  125 (349)
T 2w4o_A           50 ALSDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTV----DKKIVRTEIGVLLRLSHPNIIKLKEIFETPTEISL  125 (349)
T ss_dssp             CGGGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEC--------------CHHHHHCCCTTBCCEEEEEECSSEEEE
T ss_pred             cccCcEEEeeEEeeCCCEEEEEEEECCCCcEEEEEEeccch----hHHHHHHHHHHHHhCCCCCCcceeeeEecCCeEEE
Confidence            34568999999999999999999984  6789999998542    23568899999999999999999999999999999


Q ss_pred             EEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceeecC---CCcEEEeeccceeeccCC
Q 015868          191 VTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDE---NGVVKVADFGVARVQAQS  267 (399)
Q Consensus       191 V~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~giiHrDlkp~NILl~~---~~~vkl~DFG~a~~~~~~  267 (399)
                      ||||+++++|.+++.. .+.+++..++.++.|++.||.|||++||+||||||+|||++.   ++.+||+|||+++.....
T Consensus       126 v~e~~~~~~L~~~l~~-~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dikp~NIll~~~~~~~~~kl~Dfg~a~~~~~~  204 (349)
T 2w4o_A          126 VLELVTGGELFDRIVE-KGYYSERDAADAVKQILEAVAYLHENGIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQ  204 (349)
T ss_dssp             EECCCCSCBHHHHHTT-CSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEESSSSTTCCEEECCCC--------
T ss_pred             EEEeCCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCcccEEEecCCCCCCEEEccCccccccCcc
Confidence            9999999999999976 466899999999999999999999999999999999999975   889999999999876655


Q ss_pred             CccccCCCCcccccccccCCCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhccCC---CCCCCCCcHHHHH
Q 015868          268 GVMTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKSLR---PTIPKHAHPRLAE  344 (399)
Q Consensus       268 ~~~~~~~gt~~y~aPE~l~~~~~~~~~Dv~slG~vl~elltg~~P~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~l~~  344 (399)
                      .......||+.|+|||++.+..++.++||||||+++|+|++|..||......+.....+.....   +.....++.++.+
T Consensus       205 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~  284 (349)
T 2w4o_A          205 VLMKTVCGTPGYCAPEILRGCAYGPEVDMWSVGIITYILLCGFEPFYDERGDQFMFRRILNCEYYFISPWWDEVSLNAKD  284 (349)
T ss_dssp             --------CGGGSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCTTCHHHHHHHHHTTCCCCCTTTTTTSCHHHHH
T ss_pred             cccccccCCCCccCHHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCcccHHHHHHHHhCCCccCCchhhhCCHHHHH
Confidence            4455667999999999999999999999999999999999999999877665533333332222   2223568999999


Q ss_pred             HHHHHhhhcCCCCCCHHHHHH
Q 015868          345 LLERCWQHDPTQRPNFSQITD  365 (399)
Q Consensus       345 ll~~cl~~dP~~Rps~~ell~  365 (399)
                      ||.+||+.||++|||+.|+++
T Consensus       285 li~~~L~~dP~~Rpt~~e~l~  305 (349)
T 2w4o_A          285 LVRKLIVLDPKKRLTTFQALQ  305 (349)
T ss_dssp             HHHTTSCSSGGGSCCHHHHHH
T ss_pred             HHHHHccCChhhCcCHHHHhc
Confidence            999999999999999999875

>3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A*

Probab=100.00  E-value=3.5e-47  Score=365.84  Aligned_cols=261  Identities=27%  Similarity=0.576  Sum_probs=221.2

Q ss_pred             eecccccceeceeceeCceEEEEEEEC--Cee----EEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCceeeEEeEEecC
Q 015868          112 EIDAKQLKIECKVASGSYGDLYKGTYC--SQE----VAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRP  185 (399)
Q Consensus       112 ~i~~~~~~i~~~lg~G~~g~Vy~~~~~--~~~----vAvK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~nIv~~~~~~~~~  185 (399)
                      .+..++|++.+.||+|+||.||+|++.  ++.    ||+|++.... .......+.+|+.++++++||||+++++++.. 
T Consensus         9 ~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~~K~~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-   86 (325)
T 3kex_A            9 IFKETELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKS-GRQSFQAVTDHMLAIGSLDHAHIVRLLGLCPG-   86 (325)
T ss_dssp             BCCTTTEEEEEEEECCSSCEEEEEEECCTTCSCCEEEEEEEECCTT-SCSCBCSCCHHHHHHHTCCCTTBCCEEEEECB-
T ss_pred             hcCHhHceeeeeeeecCCceEEEEEEcCCCceEEEEEEEEeccccc-cHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcC-
Confidence            355779999999999999999999873  333    7888876432 12223567789999999999999999998864 


Q ss_pred             CcEEEEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceeecCCCcEEEeeccceeecc
Q 015868          186 PNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQA  265 (399)
Q Consensus       186 ~~~~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~giiHrDlkp~NILl~~~~~vkl~DFG~a~~~~  265 (399)
                      ...++||||+.+|+|.+++....+.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++...
T Consensus        87 ~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~~  166 (325)
T 3kex_A           87 SSLQLVTQYLPLGSLLDHVRQHRGALGPQLLLNWGVQIAKGMYYLEEHGMVHRNLAARNVLLKSPSQVQVADFGVADLLP  166 (325)
T ss_dssp             SSEEEEEECCTTCBSHHHHHSSGGGSCTTHHHHHHHHHHHHHHHHHHTTCCCSCCSSTTEEESSSSCEEECSCSGGGGSC
T ss_pred             CccEEEEEeCCCCCHHHHHHHccccCCHHHHHHHHHHHHHHHHHHHhCCCCCCccchheEEECCCCeEEECCCCcccccC
Confidence            56899999999999999998776789999999999999999999999999999999999999999999999999998654


Q ss_pred             CCC---ccccCCCCcccccccccCCCCCCChhhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHHhccCCCCCCCCCcHH
Q 015868          266 QSG---VMTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLT-GELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPR  341 (399)
Q Consensus       266 ~~~---~~~~~~gt~~y~aPE~l~~~~~~~~~Dv~slG~vl~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  341 (399)
                      ...   ......+|..|+|||.+.+..++.++||||||+++|+|+| |..||.+.+..+.... +....++..+..++++
T Consensus       167 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~-~~~~~~~~~~~~~~~~  245 (325)
T 3kex_A          167 PDDKQLLYSEAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGLRLAEVPDL-LEKGERLAQPQICTID  245 (325)
T ss_dssp             CCTTCCC-----CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCTTHHHHH-HHTTCBCCCCTTBCTT
T ss_pred             cccccccccCCCCcccccChHHhccCCCChhhHhHHhHHHHHHHHhCCCCCccccCHHHHHHH-HHcCCCCCCCCcCcHH
Confidence            432   2234457889999999998999999999999999999999 9999998776665443 4455566777889999


Q ss_pred             HHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHH
Q 015868          342 LAELLERCWQHDPTQRPNFSQITDILKQMMKEVA  375 (399)
Q Consensus       342 l~~ll~~cl~~dP~~Rps~~ell~~L~~l~~~~~  375 (399)
                      +.+++.+||+.||.+|||+.++++.|+++.+...
T Consensus       246 ~~~li~~~l~~dp~~Rps~~el~~~l~~~~~~~~  279 (325)
T 3kex_A          246 VYMVMVKCWMIDENIRPTFKELANEFTRMARDPP  279 (325)
T ss_dssp             TTHHHHHHTCSCTTTSCCHHHHHHHHHHHTTSHH
T ss_pred             HHHHHHHHcCCChhhCcCHHHHHHHHHHHHhcch
Confidence            9999999999999999999999999999876543

>3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A

Probab=100.00  E-value=1.2e-46  Score=366.30  Aligned_cols=250  Identities=24%  Similarity=0.389  Sum_probs=210.4

Q ss_pred             ccccceeceeceeCceEEEEEEE--CCeeEEEEEecCCC---CCHHHHHHHHHHHHHHHhcCCCceeeEEeEEecCCcEE
Q 015868          115 AKQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPEC---VNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLC  189 (399)
Q Consensus       115 ~~~~~i~~~lg~G~~g~Vy~~~~--~~~~vAvK~~~~~~---~~~~~~~~~~~Ei~~l~~l~h~nIv~~~~~~~~~~~~~  189 (399)
                      .++|++.+.||+|+||.||+|.+  +++.||||+++...   ......+.+.+|+.+++.++||||+++++++.....+|
T Consensus        23 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~  102 (351)
T 3c0i_A           23 EDVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETYSSDGMLY  102 (351)
T ss_dssp             HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEE
T ss_pred             ccceEEeeEEeeCCCEEEEEEEECCCCCEEEEEEEEhhhccccccchHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEE
Confidence            56899999999999999999987  57899999986321   01112467899999999999999999999999999999


Q ss_pred             EEEecCCCCCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceeecCCCc---EEEeeccceee
Q 015868          190 IVTEFMARGSIYDFLHKQ---KGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGV---VKVADFGVARV  263 (399)
Q Consensus       190 lV~E~~~ggsL~~~l~~~---~~~l~~~~~~~i~~~i~~~L~~LH~~giiHrDlkp~NILl~~~~~---vkl~DFG~a~~  263 (399)
                      +||||++|++|.+++...   ...+++..++.++.||+.||.|||++||+||||||+|||++.++.   +||+|||+++.
T Consensus       103 lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivHrDlkp~NIl~~~~~~~~~vkl~Dfg~a~~  182 (351)
T 3c0i_A          103 MVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDNNIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQ  182 (351)
T ss_dssp             EEEECCSSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECSSSTTCCEEECCCTTCEE
T ss_pred             EEEeCCCCCCHHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCChHHeEEecCCCCCcEEEecCcceeE
Confidence            999999999999888653   345899999999999999999999999999999999999987654   99999999987


Q ss_pred             ccCCCc-cccCCCCcccccccccCCCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhccCCC--CCCCCCcH
Q 015868          264 QAQSGV-MTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKSLRP--TIPKHAHP  340 (399)
Q Consensus       264 ~~~~~~-~~~~~gt~~y~aPE~l~~~~~~~~~Dv~slG~vl~elltg~~P~~~~~~~~~~~~~~~~~~~~--~~~~~~~~  340 (399)
                      ...... .....||+.|+|||++.+..++.++||||||+++|+|++|..||.+.. .+....+.......  .....+++
T Consensus       183 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~-~~~~~~i~~~~~~~~~~~~~~~s~  261 (351)
T 3c0i_A          183 LGESGLVAGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLPFYGTK-ERLFEGIIKGKYKMNPRQWSHISE  261 (351)
T ss_dssp             CCTTSCBCCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCSSH-HHHHHHHHHTCCCCCHHHHTTSCH
T ss_pred             ecCCCeeecCCcCCcCccCHHHHcCCCCCchHhhHHHHHHHHHHHHCCCCCCCcH-HHHHHHHHcCCCCCCccccccCCH
Confidence            665433 345679999999999999999999999999999999999999998753 33333333322211  11246889


Q ss_pred             HHHHHHHHHhhhcCCCCCCHHHHHH
Q 015868          341 RLAELLERCWQHDPTQRPNFSQITD  365 (399)
Q Consensus       341 ~l~~ll~~cl~~dP~~Rps~~ell~  365 (399)
                      ++.+||.+||+.||++|||+.|+++
T Consensus       262 ~~~~li~~~L~~dP~~R~s~~e~l~  286 (351)
T 3c0i_A          262 SAKDLVRRMLMLDPAERITVYEALN  286 (351)
T ss_dssp             HHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             HHHHHHHHHCCCChhHCcCHHHHhc
Confidence            9999999999999999999999975

>4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A*

Probab=100.00  E-value=2.2e-46  Score=374.62  Aligned_cols=255  Identities=20%  Similarity=0.341  Sum_probs=218.9

Q ss_pred             eeecccccceeceeceeCceEEEEEEEC--CeeEEEEEecCCCC-CHHHHHHHHHHHHHHHhcCCCceeeEEeEEecCCc
Q 015868          111 WEIDAKQLKIECKVASGSYGDLYKGTYC--SQEVAIKVLKPECV-NTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPN  187 (399)
Q Consensus       111 ~~i~~~~~~i~~~lg~G~~g~Vy~~~~~--~~~vAvK~~~~~~~-~~~~~~~~~~Ei~~l~~l~h~nIv~~~~~~~~~~~  187 (399)
                      ..+..++|++.++||+|+||.||+|++.  ++.||+|+++.... .......+.+|+.++..++||||++++++|.+...
T Consensus        69 ~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~~~~  148 (437)
T 4aw2_A           69 MRLHREDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLHYAFQDDNN  148 (437)
T ss_dssp             HSCCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTTTCCHHHHHHHHHHSCTTTBCCEEEEEECSSE
T ss_pred             ccCChhheEEEEEEEeCCCEEEEEEEEcCCCcEEEEEEEEHHHhhhHHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCE
Confidence            3556789999999999999999999984  68899999964210 00112238899999999999999999999999999


Q ss_pred             EEEEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceeecCCCcEEEeeccceeeccCC
Q 015868          188 LCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQS  267 (399)
Q Consensus       188 ~~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~giiHrDlkp~NILl~~~~~vkl~DFG~a~~~~~~  267 (399)
                      +|+||||++||+|.+++....+.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.....
T Consensus       149 ~~lV~Ey~~gg~L~~~l~~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKp~NILl~~~g~vkL~DFGla~~~~~~  228 (437)
T 4aw2_A          149 LYLVMDYYVGGDLLTLLSKFEDRLPEEMARFYLAEMVIAIDSVHQLHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMED  228 (437)
T ss_dssp             EEEEECCCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECCTT
T ss_pred             EEEEEecCCCCcHHHHHHHccCCCCHHHHHHHHHHHHHHHHHHHhCCeEecccCHHHeeEcCCCCEEEcchhhhhhcccC
Confidence            99999999999999999876788999999999999999999999999999999999999999999999999999866544


Q ss_pred             Cc--cccCCCCcccccccccC-----CCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhccCC---CCCCCC
Q 015868          268 GV--MTAETGTYRWMAPEVIE-----HKPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKSLR---PTIPKH  337 (399)
Q Consensus       268 ~~--~~~~~gt~~y~aPE~l~-----~~~~~~~~Dv~slG~vl~elltg~~P~~~~~~~~~~~~~~~~~~~---~~~~~~  337 (399)
                      ..  .....||+.|+|||++.     +..|+.++|||||||++|||++|+.||.+.+..+....+......   |.....
T Consensus       229 ~~~~~~~~~GT~~Y~APE~l~~~~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~  308 (437)
T 4aw2_A          229 GTVQSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKERFQFPTQVTD  308 (437)
T ss_dssp             SCEECCSCCSCGGGCCHHHHHHHHTSCCEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHHHHCCCCSSCCC
T ss_pred             CCcccccccCCcCeeChHHHhhcccCCCCCCCcCeeHHHHHHHHHHHhCCCCCCCCChhHHHHhhhhccccccCCccccc
Confidence            33  23457999999999997     567899999999999999999999999999888877766543322   333355


Q ss_pred             CcHHHHHHHHHHhhhcCCC--CCCHHHHHH
Q 015868          338 AHPRLAELLERCWQHDPTQ--RPNFSQITD  365 (399)
Q Consensus       338 ~~~~l~~ll~~cl~~dP~~--Rps~~ell~  365 (399)
                      +++++.+||++||+.+|+.  ||+++|+++
T Consensus       309 ~s~~~~dLi~~lL~~~~~r~~r~~~~eil~  338 (437)
T 4aw2_A          309 VSENAKDLIRRLICSREHRLGQNGIEDFKK  338 (437)
T ss_dssp             SCHHHHHHHHTTSSCGGGCTTTTTTHHHHT
T ss_pred             CCHHHHHHHHHHhcccccccCCCCHHHHhC
Confidence            8999999999999888888  999999876

>2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A*

Probab=100.00  E-value=1.8e-46  Score=368.18  Aligned_cols=249  Identities=23%  Similarity=0.395  Sum_probs=209.3

Q ss_pred             eecccccceeceeceeCceEEEEEEE--CCeeEEEEEecCCCC-CHHHHHHHHHHHHH-HHhcCCCceeeEEeEEecCCc
Q 015868          112 EIDAKQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECV-NTEMLKEFSQEVYI-MRKIRHKNVVQFIGACTRPPN  187 (399)
Q Consensus       112 ~i~~~~~~i~~~lg~G~~g~Vy~~~~--~~~~vAvK~~~~~~~-~~~~~~~~~~Ei~~-l~~l~h~nIv~~~~~~~~~~~  187 (399)
                      .+..++|++.+.||+|+||.||+|++  +++.||+|+++.... .......+.+|..+ ++.++||||+++++++.....
T Consensus        34 ~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~e~~~ll~~~~hp~Iv~l~~~~~~~~~  113 (373)
T 2r5t_A           34 HAKPSDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADK  113 (373)
T ss_dssp             TCCGGGEEEEEEEECCTTCEEEEEEETTTCCEEEEEEEEGGGBC-------------CCBCCCCCTTBCCEEEEEECSSE
T ss_pred             CCChhheEEEEEEeeCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHHhCCCCCCCCEEEEEEeCCE
Confidence            35567999999999999999999998  467899999976432 23344566777776 577899999999999999999


Q ss_pred             EEEEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceeecCCCcEEEeeccceeeccC-
Q 015868          188 LCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQ-  266 (399)
Q Consensus       188 ~~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~giiHrDlkp~NILl~~~~~vkl~DFG~a~~~~~-  266 (399)
                      +|+||||++||+|.+++.. .+.+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||+++.... 
T Consensus       114 ~~lv~E~~~gg~L~~~l~~-~~~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll~~~g~ikL~DFG~a~~~~~~  192 (373)
T 2r5t_A          114 LYFVLDYINGGELFYHLQR-ERCFLEPRARFYAAEIASALGYLHSLNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEH  192 (373)
T ss_dssp             EEEEEECCCSCBHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCCBCGGGBCC
T ss_pred             EEEEEeCCCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEECCCCCEEEeeCccccccccC
Confidence            9999999999999999976 45789999999999999999999999999999999999999999999999999985333 


Q ss_pred             CCccccCCCCcccccccccCCCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhccCCCCCCCCCcHHHHHHH
Q 015868          267 SGVMTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRLAELL  346 (399)
Q Consensus       267 ~~~~~~~~gt~~y~aPE~l~~~~~~~~~Dv~slG~vl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll  346 (399)
                      ........||+.|+|||++.+..|+.++|+||||+++|||++|..||.+.+..+....+...  ...++..+++++.+||
T Consensus       193 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~--~~~~~~~~~~~~~~li  270 (373)
T 2r5t_A          193 NSTTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNILNK--PLQLKPNITNSARHLL  270 (373)
T ss_dssp             CCCCCSBSCCCCCCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSBHHHHHHHHHHS--CCCCCSSSCHHHHHHH
T ss_pred             CCccccccCCccccCHHHhCCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhc--ccCCCCCCCHHHHHHH
Confidence            23345567999999999999999999999999999999999999999998888777666654  3456778999999999


Q ss_pred             HHHhhhcCCCCCCHHHH
Q 015868          347 ERCWQHDPTQRPNFSQI  363 (399)
Q Consensus       347 ~~cl~~dP~~Rps~~el  363 (399)
                      .+||+.||.+||++.+.
T Consensus       271 ~~lL~~dp~~R~~~~~~  287 (373)
T 2r5t_A          271 EGLLQKDRTKRLGAKDD  287 (373)
T ss_dssp             HHHTCSSGGGSTTTTTT
T ss_pred             HHHcccCHHhCCCCCCC
Confidence            99999999999998643

>3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A*

Probab=100.00  E-value=1.1e-46  Score=362.56  Aligned_cols=249  Identities=24%  Similarity=0.402  Sum_probs=209.1

Q ss_pred             ccccceeceeceeCceEEEEEEE--CCeeEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCceeeEEeEEecCCcEEEEE
Q 015868          115 AKQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVT  192 (399)
Q Consensus       115 ~~~~~i~~~lg~G~~g~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~nIv~~~~~~~~~~~~~lV~  192 (399)
                      .++|++.+.||+|+||.||+|.+  .++.||+|++..... ....+.+.+|+.+++.++||||+++++++..+...|+||
T Consensus         6 ~~~y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~   84 (323)
T 3tki_A            6 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRA-VDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFL   84 (323)
T ss_dssp             TTCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC--------CHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             hhhceeeeEEecCCCEEEEEEEECCCCcEEEEEEEEcccc-cchHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEEE
Confidence            36899999999999999999987  578999999975432 233467889999999999999999999999999999999


Q ss_pred             ecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceeecCCCcEEEeeccceeeccCCC---c
Q 015868          193 EFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSG---V  269 (399)
Q Consensus       193 E~~~ggsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~giiHrDlkp~NILl~~~~~vkl~DFG~a~~~~~~~---~  269 (399)
                      ||++|++|.+++.. ...+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+++......   .
T Consensus        85 e~~~~~~L~~~l~~-~~~~~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~  163 (323)
T 3tki_A           85 EYCSGGELFDRIEP-DIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERL  163 (323)
T ss_dssp             ECCTTEEGGGGSBT-TTBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEECEETTEECC
T ss_pred             EcCCCCcHHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHHCCccccccchHHEEEeCCCCEEEEEeeccceeccCCcccc
Confidence            99999999999865 4569999999999999999999999999999999999999999999999999998654322   2


Q ss_pred             cccCCCCcccccccccCCCCC-CChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHH-HHHhccCCCCCCCCCcHHHHHHHH
Q 015868          270 MTAETGTYRWMAPEVIEHKPY-DYKADVFSFGIALWELLTGELPYAGLTPLQAAV-GVVQKSLRPTIPKHAHPRLAELLE  347 (399)
Q Consensus       270 ~~~~~gt~~y~aPE~l~~~~~-~~~~Dv~slG~vl~elltg~~P~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~l~~ll~  347 (399)
                      .....||+.|+|||++.+..+ +.++||||||+++|+|++|..||.......... ..............+++++.+||.
T Consensus       164 ~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~  243 (323)
T 3tki_A          164 LNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLALLH  243 (323)
T ss_dssp             BCSCCSCGGGSCHHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSCTTSHHHHHHHTTCTTSTTGGGSCHHHHHHHH
T ss_pred             cCCCccCcCccCcHHhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHhcccccCCccccCCHHHHHHHH
Confidence            345679999999999988775 778999999999999999999998766543222 222222222333568999999999


Q ss_pred             HHhhhcCCCCCCHHHHHH
Q 015868          348 RCWQHDPTQRPNFSQITD  365 (399)
Q Consensus       348 ~cl~~dP~~Rps~~ell~  365 (399)
                      +||+.||.+|||+.|+++
T Consensus       244 ~~L~~dP~~R~t~~eil~  261 (323)
T 3tki_A          244 KILVENPSARITIPDIKK  261 (323)
T ss_dssp             HHSCSSTTTSCCHHHHTT
T ss_pred             HHccCChhhCcCHHHHhh
Confidence            999999999999999865

>4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens}

Probab=100.00  E-value=1.8e-46  Score=359.58  Aligned_cols=257  Identities=23%  Similarity=0.380  Sum_probs=213.9

Q ss_pred             ecccccceeceeceeCceEEEEEEEC--CeeEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCceeeEEeEEecCC--cE
Q 015868          113 IDAKQLKIECKVASGSYGDLYKGTYC--SQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPP--NL  188 (399)
Q Consensus       113 i~~~~~~i~~~lg~G~~g~Vy~~~~~--~~~vAvK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~nIv~~~~~~~~~~--~~  188 (399)
                      +..++|++.+.||+|+||.||+|++.  ++.||||+++.... ....+.+.+|+.++++++||||+++++++....  ..
T Consensus         6 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~   84 (319)
T 4euu_A            6 TSNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISF-LRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHK   84 (319)
T ss_dssp             CSSEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGG-GSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCE
T ss_pred             CCCCCEEEEEEecCCCCeEEEEEEECCCCcEEEEEEeccccc-cchHHHHHHHHHHHHhcCCCCcceEEEEeecCCCceE
Confidence            44678999999999999999999985  78999999975321 222467789999999999999999999997665  78


Q ss_pred             EEEEecCCCCCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceee----cCCCcEEEeecccee
Q 015868          189 CIVTEFMARGSIYDFLHKQK--GVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLM----DENGVVKVADFGVAR  262 (399)
Q Consensus       189 ~lV~E~~~ggsL~~~l~~~~--~~l~~~~~~~i~~~i~~~L~~LH~~giiHrDlkp~NILl----~~~~~vkl~DFG~a~  262 (399)
                      ++||||+++++|.+++....  ..+++..++.++.||+.||.|||++||+||||||+||++    +.++.+||+|||+++
T Consensus        85 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~kL~Dfg~a~  164 (319)
T 4euu_A           85 VLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAAR  164 (319)
T ss_dssp             EEEEECCTTCBHHHHHHSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEECTTSCEEEEECCCTTCE
T ss_pred             EEEEeCCCCCCHHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEEeccCCCCceEEEccCCCce
Confidence            99999999999999997643  338999999999999999999999999999999999999    788889999999998


Q ss_pred             eccCCCccccCCCCcccccccccC--------CCCCCChhhHHHHHHHHHHHHcCCCCCCCCCH----HHHHHHHHhccC
Q 015868          263 VQAQSGVMTAETGTYRWMAPEVIE--------HKPYDYKADVFSFGIALWELLTGELPYAGLTP----LQAAVGVVQKSL  330 (399)
Q Consensus       263 ~~~~~~~~~~~~gt~~y~aPE~l~--------~~~~~~~~Dv~slG~vl~elltg~~P~~~~~~----~~~~~~~~~~~~  330 (399)
                      ............||+.|+|||++.        +..++.++||||||+++|+|++|+.||.....    .+..........
T Consensus       165 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~p  244 (319)
T 4euu_A          165 ELEDDEQFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITGKP  244 (319)
T ss_dssp             ECCTTCCBCCCCSCGGGCCHHHHHHHTSCCCCCCCBCTTHHHHHHHHHHHHHHHSSCSEECTTCGGGCHHHHHHHHHHCC
T ss_pred             ecCCCCceeecccCCCccCHHHhhhccccccccCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCccchhHHHHHHHhcCCC
Confidence            877666566678999999999986        57789999999999999999999999975432    222223222111


Q ss_pred             -----------------------CCCCCCCCcHHHHHHHHHHhhhcCCCCCCHHHHHHHHHHH
Q 015868          331 -----------------------RPTIPKHAHPRLAELLERCWQHDPTQRPNFSQITDILKQM  370 (399)
Q Consensus       331 -----------------------~~~~~~~~~~~l~~ll~~cl~~dP~~Rps~~ell~~L~~l  370 (399)
                                             ...++..+++.+.++|.+||+.||++|||+.|+++...+.
T Consensus       245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~R~s~~ell~h~~d~  307 (319)
T 4euu_A          245 SGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDI  307 (319)
T ss_dssp             TTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHHH
T ss_pred             cccchhhhcccCCccccCccCCcccccchhHHHHhHHHHHHhccCChhhhccHHHhhhccHHH
Confidence                                   0122234567899999999999999999999998877754

>3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens}

Probab=100.00  E-value=2.3e-46  Score=360.84  Aligned_cols=260  Identities=28%  Similarity=0.585  Sum_probs=219.4

Q ss_pred             eecccccceeceeceeCceEEEEEEE--CCee----EEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCceeeEEeEEecC
Q 015868          112 EIDAKQLKIECKVASGSYGDLYKGTY--CSQE----VAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRP  185 (399)
Q Consensus       112 ~i~~~~~~i~~~lg~G~~g~Vy~~~~--~~~~----vAvK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~nIv~~~~~~~~~  185 (399)
                      .+..++|++.++||+|+||.||+|.+  .++.    ||+|.++... .....+.+.+|+.++++++||||+++++++..+
T Consensus        11 ~l~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~iK~~~~~~-~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~   89 (327)
T 3lzb_A           11 ILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREAT-SPKANKEILDEAYVMASVDNPHVCRLLGICLTS   89 (327)
T ss_dssp             ECCTTTEEEEEEEEECSSEEEEEEEECCTTCSCCEEEEEEEECCCS-SCCCHHHHHHHHHHHTTCCBTTBCCCCEEEESS
T ss_pred             ccCHhHceEEEEeeeCCCeEEEEEEEcCCCceEEEEEEEEeecccc-CHHHHHHHHHHHHHHHhCCCCCeeEEEEEEecC
Confidence            45678999999999999999999987  3444    5777776432 233457889999999999999999999999876


Q ss_pred             CcEEEEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceeecCCCcEEEeeccceeecc
Q 015868          186 PNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQA  265 (399)
Q Consensus       186 ~~~~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~giiHrDlkp~NILl~~~~~vkl~DFG~a~~~~  265 (399)
                      . .++|+|++.+|+|.+++......+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++...
T Consensus        90 ~-~~~v~~~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~~kL~DfG~a~~~~  168 (327)
T 3lzb_A           90 T-VQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLG  168 (327)
T ss_dssp             S-EEEEECCCSSCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEETTEEEECCTTC-----
T ss_pred             C-ceEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCCCcCCCCCHHHEEEcCCCCEEEccCcceeEcc
Confidence            5 889999999999999998878889999999999999999999999999999999999999999999999999998654


Q ss_pred             CCCc---cccCCCCcccccccccCCCCCCChhhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHHhccCCCCCCCCCcHH
Q 015868          266 QSGV---MTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLT-GELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPR  341 (399)
Q Consensus       266 ~~~~---~~~~~gt~~y~aPE~l~~~~~~~~~Dv~slG~vl~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  341 (399)
                      ....   .....+|+.|+|||.+.+..++.++||||||+++|+|++ |..||.+.+..+... .+.....+..+..++++
T Consensus       169 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~-~~~~~~~~~~~~~~~~~  247 (327)
T 3lzb_A          169 AEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISS-ILEKGERLPQPPICTID  247 (327)
T ss_dssp             -----------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHH-HHHTTCCCCCCTTBCHH
T ss_pred             CccccccccCCCccccccCHHHHcCCCCChHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHH-HHHcCCCCCCCccCCHH
Confidence            3322   233456788999999999999999999999999999999 999999887766544 44455667778889999


Q ss_pred             HHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHH
Q 015868          342 LAELLERCWQHDPTQRPNFSQITDILKQMMKEV  374 (399)
Q Consensus       342 l~~ll~~cl~~dP~~Rps~~ell~~L~~l~~~~  374 (399)
                      +.+++.+||+.||.+|||+.|+++.|+.+.+..
T Consensus       248 l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~  280 (327)
T 3lzb_A          248 VYMIMRKCWMIDADSRPKFRELIIEFSKMARDP  280 (327)
T ss_dssp             HHHHHHHHTCSSGGGSCCHHHHHHHHHHHHTSH
T ss_pred             HHHHHHHHcCCChhHCcCHHHHHHHHHHHHhCc
Confidence            999999999999999999999999999997543

>3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A*

Probab=100.00  E-value=1.2e-46  Score=359.80  Aligned_cols=257  Identities=26%  Similarity=0.427  Sum_probs=212.0

Q ss_pred             cccccceeceeceeCceEEEEEEE--CCeeEEEEEecCCCC-CHHHHHHHHHHHHHHHhcCCCceeeEEeEEecCCc---
Q 015868          114 DAKQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECV-NTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPN---  187 (399)
Q Consensus       114 ~~~~~~i~~~lg~G~~g~Vy~~~~--~~~~vAvK~~~~~~~-~~~~~~~~~~Ei~~l~~l~h~nIv~~~~~~~~~~~---  187 (399)
                      -.++|++.+.||+|+||.||+|++  .++.||+|+++.... +......+.+|+.++++++||||+++++++.....   
T Consensus        10 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~   89 (311)
T 3ork_A           10 LSDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGP   89 (311)
T ss_dssp             ETTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECTTTTTSHHHHHHHHHHHTTCCCCCCTTBCCEEEEEEEEETTEE
T ss_pred             ecCcEEEEEEEccCCCEEEEEEEECCCCceEEEEEeCccccCCHHHHHHHHHHHHHHHcCCCCCcceEEEeeeccCCCCc
Confidence            357899999999999999999996  678999999987543 45566789999999999999999999999876543   


Q ss_pred             -EEEEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceeecCCCcEEEeeccceeeccC
Q 015868          188 -LCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQ  266 (399)
Q Consensus       188 -~~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~giiHrDlkp~NILl~~~~~vkl~DFG~a~~~~~  266 (399)
                       .|+||||++|++|.+++... +.+++..++.++.|++.||.|||++||+||||||+||+++.++.+||+|||+++....
T Consensus        90 ~~~lv~e~~~g~~L~~~l~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~  168 (311)
T 3ork_A           90 LPYIVMEYVDGVTLRDIVHTE-GPMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIAD  168 (311)
T ss_dssp             EEEEEEECCCEEEHHHHHHHH-CSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEETTSCEEECCCSCC-----
T ss_pred             ccEEEEecCCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCCcCCCCHHHEEEcCCCCEEEeeccCcccccc
Confidence             49999999999999999764 5789999999999999999999999999999999999999999999999999986544


Q ss_pred             CC----ccccCCCCcccccccccCCCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhccCCCC--CCCCCcH
Q 015868          267 SG----VMTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKSLRPT--IPKHAHP  340 (399)
Q Consensus       267 ~~----~~~~~~gt~~y~aPE~l~~~~~~~~~Dv~slG~vl~elltg~~P~~~~~~~~~~~~~~~~~~~~~--~~~~~~~  340 (399)
                      ..    ......||+.|+|||++.+..++.++||||||+++|+|++|+.||.+.++.+...........+.  .+..+++
T Consensus       169 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  248 (311)
T 3ork_A          169 SGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPPSARHEGLSA  248 (311)
T ss_dssp             -------------CCTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHCCCCCHHHHSTTCCH
T ss_pred             cccccccccccCcCcccCCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhcCCCCCcccccCCCCH
Confidence            32    12234689999999999999999999999999999999999999999988877666665443322  1345889


Q ss_pred             HHHHHHHHHhhhcCCCCCCHHHH-HHHHHHHH
Q 015868          341 RLAELLERCWQHDPTQRPNFSQI-TDILKQMM  371 (399)
Q Consensus       341 ~l~~ll~~cl~~dP~~Rps~~el-l~~L~~l~  371 (399)
                      ++.++|.+||+.||.+||+..++ ...+.++.
T Consensus       249 ~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~~  280 (311)
T 3ork_A          249 DLDAVVLKALAKNPENRYQTAAEMRADLVRVH  280 (311)
T ss_dssp             HHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHH
T ss_pred             HHHHHHHHHHhcCHhhChhhHHHHHHHHHHHh
Confidence            99999999999999999966554 44554443

>4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A*

Probab=100.00  E-value=5.6e-46  Score=388.17  Aligned_cols=262  Identities=28%  Similarity=0.553  Sum_probs=225.6

Q ss_pred             ceeecccccceec-eeceeCceEEEEEEE----CCeeEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCceeeEEeEEec
Q 015868          110 VWEIDAKQLKIEC-KVASGSYGDLYKGTY----CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTR  184 (399)
Q Consensus       110 ~~~i~~~~~~i~~-~lg~G~~g~Vy~~~~----~~~~vAvK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~nIv~~~~~~~~  184 (399)
                      .|.++...+.+.. +||+|+||.||+|.+    .++.||||+++....+....+.+.+|+.+|++++||||+++++++..
T Consensus       362 ~~~~~~~~~~l~~~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~  441 (635)
T 4fl3_A          362 EVYLDRKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA  441 (635)
T ss_dssp             SSBCCGGGEEEEEEEEEECSSEEEEEEEEECSSCEEEEEEEEECGGGGCGGGHHHHHHHHHHHHHCCCTTBCCEEEEEES
T ss_pred             cccccchhccccCCEeccCCCEEEEEEEEcCCCcceEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec
Confidence            4566666676654 899999999999966    35789999998765555567889999999999999999999999975


Q ss_pred             CCcEEEEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceeecCCCcEEEeeccceeec
Q 015868          185 PPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQ  264 (399)
Q Consensus       185 ~~~~~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~giiHrDlkp~NILl~~~~~vkl~DFG~a~~~  264 (399)
                      + ..++||||+.+|+|.+++.. ...+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++..
T Consensus       442 ~-~~~lv~E~~~~g~L~~~l~~-~~~l~~~~~~~i~~qi~~~L~yLH~~~iiHrDLkp~NILl~~~~~~kL~DFGla~~~  519 (635)
T 4fl3_A          442 E-SWMLVMEMAELGPLNKYLQQ-NRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKAL  519 (635)
T ss_dssp             S-SEEEEEECCTTEEHHHHHHH-CTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECCTTHHHHT
T ss_pred             C-CEEEEEEccCCCCHHHHHhh-CCCCCHHHHHHHHHHHHHHHHHHHHCCEeCCCCChHhEEEeCCCCEEEEEcCCcccc
Confidence            4 58999999999999999976 467899999999999999999999999999999999999999999999999999865


Q ss_pred             cCCC----ccccCCCCcccccccccCCCCCCChhhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHHhccCCCCCCCCCc
Q 015868          265 AQSG----VMTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLT-GELPYAGLTPLQAAVGVVQKSLRPTIPKHAH  339 (399)
Q Consensus       265 ~~~~----~~~~~~gt~~y~aPE~l~~~~~~~~~Dv~slG~vl~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~  339 (399)
                      ....    ..+...+|+.|+|||++.+..++.++||||||+++|||++ |+.||.+.+..+.... +....++..|..++
T Consensus       520 ~~~~~~~~~~~~~~~t~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~~~~~-i~~~~~~~~p~~~~  598 (635)
T 4fl3_A          520 RADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAM-LEKGERMGCPAGCP  598 (635)
T ss_dssp             TC-------------CGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHH-HHTTCCCCCCTTCC
T ss_pred             ccCccccccccCCCCceeeeChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHH-HHcCCCCCCCCCCC
Confidence            4332    1233456789999999999999999999999999999998 9999999988775544 45566778888999


Q ss_pred             HHHHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHH
Q 015868          340 PRLAELLERCWQHDPTQRPNFSQITDILKQMMKEV  374 (399)
Q Consensus       340 ~~l~~ll~~cl~~dP~~Rps~~ell~~L~~l~~~~  374 (399)
                      +++.++|.+||+.||++||++.++++.|+++..++
T Consensus       599 ~~l~~li~~cl~~dP~~RPs~~~l~~~L~~~~~~l  633 (635)
T 4fl3_A          599 REMYDLMNLCWTYDVENRPGFAAVELRLRNYYYDV  633 (635)
T ss_dssp             HHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHHH
T ss_pred             HHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHHh
Confidence            99999999999999999999999999999998765

>2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens}

Probab=100.00  E-value=1.8e-47  Score=365.75  Aligned_cols=265  Identities=31%  Similarity=0.585  Sum_probs=222.6

Q ss_pred             CCceeecccccceeceeceeCceEEEEEEECCeeEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCceeeEEeEEecCCc
Q 015868          108 TDVWEIDAKQLKIECKVASGSYGDLYKGTYCSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPN  187 (399)
Q Consensus       108 ~~~~~i~~~~~~i~~~lg~G~~g~Vy~~~~~~~~vAvK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~nIv~~~~~~~~~~~  187 (399)
                      ...|++..++|++.+.||+|+||.||+|++.+ .||+|+++....+....+.+.+|+.++++++||||+++++++...+.
T Consensus        25 ~~~~~i~~~~~~~~~~lg~G~~g~V~~~~~~~-~~avk~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~  103 (319)
T 2y4i_B           25 LQEWDIPFEQLEIGELIGKGRFGQVYHGRWHG-EVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGACMSPPH  103 (319)
T ss_dssp             GGGSSSCCSCEECCCBCCCSSSSEEEEEEESS-SEEEEECCCCSCCCCCCCCCCTTGGGGTTCCCTTBCCCCEEEECSSC
T ss_pred             cccccCCHHHeEEeeEeccCCceEEEEEEEcC-eEEEEEeecCCCCHHHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCc
Confidence            35688999999999999999999999999865 59999998655444445667889999999999999999999999999


Q ss_pred             EEEEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceeecCCCcEEEeeccceeeccCC
Q 015868          188 LCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQS  267 (399)
Q Consensus       188 ~~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~giiHrDlkp~NILl~~~~~vkl~DFG~a~~~~~~  267 (399)
                      .++||||++|++|.+++......+++..++.++.||+.||.|||++||+||||||+||+++ ++.+||+|||+++.....
T Consensus       104 ~~iv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dlkp~NIl~~-~~~~~l~Dfg~~~~~~~~  182 (319)
T 2y4i_B          104 LAIITSLCKGRTLYSVVRDAKIVLDVNKTRQIAQEIVKGMGYLHAKGILHKDLKSKNVFYD-NGKVVITDFGLFSISGVL  182 (319)
T ss_dssp             EEEECBCCCSEEHHHHTTSSCCCCCSHHHHHHHHHHHHHHHHHHHTTCCCCCCCSTTEEEC---CCEECCCSCCC-----
T ss_pred             eEEEeecccCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCChhhEEEe-CCCEEEeecCCccccccc
Confidence            9999999999999999987666899999999999999999999999999999999999998 689999999998754321


Q ss_pred             ------CccccCCCCcccccccccCC---------CCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhccCCC
Q 015868          268 ------GVMTAETGTYRWMAPEVIEH---------KPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKSLRP  332 (399)
Q Consensus       268 ------~~~~~~~gt~~y~aPE~l~~---------~~~~~~~Dv~slG~vl~elltg~~P~~~~~~~~~~~~~~~~~~~~  332 (399)
                            .......|++.|+|||.+.+         ..++.++||||||+++|+|++|..||...+...............
T Consensus       183 ~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~  262 (319)
T 2y4i_B          183 QAGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPAEAIIWQMGTGMKPN  262 (319)
T ss_dssp             -----CCSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHHHHHHHHHSSCSSSSCCHHHHHHHHHTTCCCC
T ss_pred             cccccccccccCCCcccccChHHhhhccccccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhccCCCCC
Confidence                  12334468999999999975         457889999999999999999999999988877665554433333


Q ss_pred             CCCCCCcHHHHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHH
Q 015868          333 TIPKHAHPRLAELLERCWQHDPTQRPNFSQITDILKQMMKEV  374 (399)
Q Consensus       333 ~~~~~~~~~l~~ll~~cl~~dP~~Rps~~ell~~L~~l~~~~  374 (399)
                      ..+..++.++.+++.+||..||.+|||+.++++.|+++.+..
T Consensus       263 ~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~l~~~~  304 (319)
T 2y4i_B          263 LSQIGMGKEISDILLFCWAFEQEERPTFTKLMDMLEKLPKRN  304 (319)
T ss_dssp             CCCSSCCTTHHHHHHHHHCSSTTTSCCHHHHHHHHTTC----
T ss_pred             CCcCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHhh
Confidence            334468899999999999999999999999999999987644

>4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens}

Probab=100.00  E-value=8e-46  Score=353.26  Aligned_cols=249  Identities=23%  Similarity=0.360  Sum_probs=209.2

Q ss_pred             cccceeceeceeCceEEEEEEEC--CeeEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCceeeEEeEEecCCcEEEEEe
Q 015868          116 KQLKIECKVASGSYGDLYKGTYC--SQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVTE  193 (399)
Q Consensus       116 ~~~~i~~~lg~G~~g~Vy~~~~~--~~~vAvK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~nIv~~~~~~~~~~~~~lV~E  193 (399)
                      ++|++.++||+|+||.||+|++.  ++.||+|++..........+.+.+|+.++++++||||+++++++......++|||
T Consensus         3 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   82 (311)
T 4agu_A            3 EKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLEVFRRKRRLHLVFE   82 (311)
T ss_dssp             CCEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCCCC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             ccceEeeEEeecCCeEEEEEEeCCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhCCCCCccchhheeecCCeEEEEEE
Confidence            58999999999999999999984  7899999998776666777889999999999999999999999999999999999


Q ss_pred             cCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceeecCCCcEEEeeccceeeccCCC-cccc
Q 015868          194 FMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSG-VMTA  272 (399)
Q Consensus       194 ~~~ggsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~giiHrDlkp~NILl~~~~~vkl~DFG~a~~~~~~~-~~~~  272 (399)
                      |+++++|.+++.. ...+++..+..++.|++.||.|||++||+||||||+||+++.++.+||+|||.++...... ....
T Consensus        83 ~~~~~~l~~~~~~-~~~~~~~~~~~i~~~l~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~  161 (311)
T 4agu_A           83 YCDHTVLHELDRY-QRGVPEHLVKSITWQTLQAVNFCHKHNCIHRDVKPENILITKHSVIKLCDFGFARLLTGPSDYYDD  161 (311)
T ss_dssp             CCSEEHHHHHHHT-SSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECC--------
T ss_pred             eCCCchHHHHHhh-hcCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCChhhEEEcCCCCEEEeeCCCchhccCcccccCC
Confidence            9999999988765 4679999999999999999999999999999999999999999999999999998765332 3345


Q ss_pred             CCCCcccccccccCC-CCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcc-------------------CCC
Q 015868          273 ETGTYRWMAPEVIEH-KPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKS-------------------LRP  332 (399)
Q Consensus       273 ~~gt~~y~aPE~l~~-~~~~~~~Dv~slG~vl~elltg~~P~~~~~~~~~~~~~~~~~-------------------~~~  332 (399)
                      ..||+.|+|||.+.+ ..++.++||||||+++|+|++|..||.+.+..+.........                   ...
T Consensus       162 ~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  241 (311)
T 4agu_A          162 EVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGKSDVDQLYLIRKTLGDLIPRHQQVFSTNQYFSGVKI  241 (311)
T ss_dssp             ----GGGCCHHHHHTCSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHHTCGGGTTCCC
T ss_pred             CcCCccccChHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhcccccccccccccccccccCcC
Confidence            678999999999976 678999999999999999999999999888766554432210                   000


Q ss_pred             CC----------CCCCcHHHHHHHHHHhhhcCCCCCCHHHHHH
Q 015868          333 TI----------PKHAHPRLAELLERCWQHDPTQRPNFSQITD  365 (399)
Q Consensus       333 ~~----------~~~~~~~l~~ll~~cl~~dP~~Rps~~ell~  365 (399)
                      ..          ...+++++.+|+.+||+.||.+|||++|+++
T Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~  284 (311)
T 4agu_A          242 PDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQLLH  284 (311)
T ss_dssp             CCCSSCCCHHHHCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHT
T ss_pred             CCccccchhhhhcccccHHHHHHHHHHccCChhhcCCHHHHhc
Confidence            00          1357889999999999999999999999975

>2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A

Probab=100.00  E-value=6.1e-46  Score=356.40  Aligned_cols=250  Identities=23%  Similarity=0.391  Sum_probs=218.9

Q ss_pred             ccccceeceeceeCceEEEEEEE--CCeeEEEEEecCCCCCH----HHHHHHHHHHHHHHhcCCCceeeEEeEEecCCcE
Q 015868          115 AKQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVNT----EMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNL  188 (399)
Q Consensus       115 ~~~~~i~~~lg~G~~g~Vy~~~~--~~~~vAvK~~~~~~~~~----~~~~~~~~Ei~~l~~l~h~nIv~~~~~~~~~~~~  188 (399)
                      .++|++.+.||+|+||.||+|++  +++.||+|+++......    ...+.+.+|+.++++++||||+++++++.....+
T Consensus        11 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~   90 (321)
T 2a2a_A           11 EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYENRTDV   90 (321)
T ss_dssp             HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred             hccEEEeeEeeecCCEEEEEEEECCCCeEEEEEEEecccccccccchhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEE
Confidence            56899999999999999999998  47899999997643221    1356789999999999999999999999999999


Q ss_pred             EEEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceeecCCC----cEEEeeccceeec
Q 015868          189 CIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENG----VVKVADFGVARVQ  264 (399)
Q Consensus       189 ~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~giiHrDlkp~NILl~~~~----~vkl~DFG~a~~~  264 (399)
                      ++||||+++++|.+++.. ...+++..++.++.|++.||.|||++||+||||||+||+++.++    .+||+|||+++..
T Consensus        91 ~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~i~~qi~~aL~~lH~~~ivH~dikp~NIl~~~~~~~~~~~kl~Dfg~~~~~  169 (321)
T 2a2a_A           91 VLILELVSGGELFDFLAQ-KESLSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEI  169 (321)
T ss_dssp             EEEECCCCSCBHHHHHHT-CSCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCTTSSSCCEEECCCTTCEEC
T ss_pred             EEEEEcCCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCChHHEEEecCCCCcCCEEEccCccceec
Confidence            999999999999999976 46789999999999999999999999999999999999999888    7999999999877


Q ss_pred             cCCCccccCCCCcccccccccCCCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhccCC--CCCCCCCcHHH
Q 015868          265 AQSGVMTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKSLR--PTIPKHAHPRL  342 (399)
Q Consensus       265 ~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~Dv~slG~vl~elltg~~P~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~l  342 (399)
                      ..........||+.|+|||++.+..++.++||||||+++|+|++|..||.+.+..+...........  +..+..+++.+
T Consensus       170 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~  249 (321)
T 2a2a_A          170 EDGVEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITSVSYDFDEEFFSHTSELA  249 (321)
T ss_dssp             CTTCCCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHTTCCCCCHHHHTTCCHHH
T ss_pred             CccccccccCCCCCccCcccccCCCCCCccccHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcccccChhhhcccCHHH
Confidence            6655556667999999999999999999999999999999999999999988877766554432221  12235688999


Q ss_pred             HHHHHHHhhhcCCCCCCHHHHHH
Q 015868          343 AELLERCWQHDPTQRPNFSQITD  365 (399)
Q Consensus       343 ~~ll~~cl~~dP~~Rps~~ell~  365 (399)
                      .++|.+||+.||.+|||+.|+++
T Consensus       250 ~~li~~~l~~dp~~Rps~~e~l~  272 (321)
T 2a2a_A          250 KDFIRKLLVKETRKRLTIQEALR  272 (321)
T ss_dssp             HHHHHTTSCSSTTTSCCHHHHHH
T ss_pred             HHHHHHHcCCChhhCcCHHHHhc
Confidence            99999999999999999999986

>2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A*

Probab=100.00  E-value=1e-45  Score=355.35  Aligned_cols=244  Identities=29%  Similarity=0.474  Sum_probs=213.6

Q ss_pred             ccceeceeceeCceEEEEEEE--CCeeEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCceeeEEeEEecCCcEEEEEec
Q 015868          117 QLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVTEF  194 (399)
Q Consensus       117 ~~~i~~~lg~G~~g~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~nIv~~~~~~~~~~~~~lV~E~  194 (399)
                      .|...++||+|+||.||+|+.  .++.||||+++.....  ..+.+.+|+.++++++||||+++++++......++||||
T Consensus        46 ~~~~~~~lg~G~~g~V~~a~~~~~g~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  123 (321)
T 2c30_A           46 LLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQ--RRELLFNEVVIMRDYQHFNVVEMYKSYLVGEELWVLMEF  123 (321)
T ss_dssp             HEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCC--SHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEECC
T ss_pred             hhhccEEeccCCCeEEEEEEECCCCcEEEEEEEeccchh--HHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEec
Confidence            477788999999999999987  5889999999865322  346788999999999999999999999999999999999


Q ss_pred             CCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceeecCCCcEEEeeccceeeccCCC-ccccC
Q 015868          195 MARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSG-VMTAE  273 (399)
Q Consensus       195 ~~ggsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~giiHrDlkp~NILl~~~~~vkl~DFG~a~~~~~~~-~~~~~  273 (399)
                      ++|++|.+++..  ..+++..+..++.|++.||.|||++||+||||||+||+++.++.+||+|||+++...... .....
T Consensus       124 ~~~~~L~~~l~~--~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~~  201 (321)
T 2c30_A          124 LQGGALTDIVSQ--VRLNEEQIATVCEAVLQALAYLHAQGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKSL  201 (321)
T ss_dssp             CCSCBHHHHHTT--CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSSSCCBCCC
T ss_pred             CCCCCHHHHHHh--cCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCcEEEeeeeeeeecccCccccccc
Confidence            999999999864  568999999999999999999999999999999999999999999999999998665432 23456


Q ss_pred             CCCcccccccccCCCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhccCCCCC--CCCCcHHHHHHHHHHhh
Q 015868          274 TGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKSLRPTI--PKHAHPRLAELLERCWQ  351 (399)
Q Consensus       274 ~gt~~y~aPE~l~~~~~~~~~Dv~slG~vl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~l~~ll~~cl~  351 (399)
                      .||+.|+|||++.+..++.++||||||+++|+|++|..||...++.+........ ..+..  +..+++++.+++.+||+
T Consensus       202 ~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~pf~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~l~~li~~~l~  280 (321)
T 2c30_A          202 VGTPYWMAPEVISRSLYATEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRLRDS-PPPKLKNSHKVSPVLRDFLERMLV  280 (321)
T ss_dssp             CSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHS-SCCCCTTGGGSCHHHHHHHHHHSC
T ss_pred             cCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcC-CCCCcCccccCCHHHHHHHHHHcc
Confidence            7999999999999999999999999999999999999999988887765554432 23322  34578999999999999


Q ss_pred             hcCCCCCCHHHHHH
Q 015868          352 HDPTQRPNFSQITD  365 (399)
Q Consensus       352 ~dP~~Rps~~ell~  365 (399)
                      .||++|||+.|+++
T Consensus       281 ~dp~~Rps~~ell~  294 (321)
T 2c30_A          281 RDPQERATAQELLD  294 (321)
T ss_dssp             SSTTTSCCHHHHHT
T ss_pred             CChhhCcCHHHHhc
Confidence            99999999999976

>3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A*

Probab=100.00  E-value=5.4e-46  Score=348.69  Aligned_cols=247  Identities=24%  Similarity=0.405  Sum_probs=216.3

Q ss_pred             ccccceeceeceeCceEEEEEEEC--CeeEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCceeeEEeEEecCCcEEEEE
Q 015868          115 AKQLKIECKVASGSYGDLYKGTYC--SQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVT  192 (399)
Q Consensus       115 ~~~~~i~~~lg~G~~g~Vy~~~~~--~~~vAvK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~nIv~~~~~~~~~~~~~lV~  192 (399)
                      .++|++.+.||+|+||.||+|.+.  +..||+|++......  ..+.+.+|+.++++++||||+++++++......++||
T Consensus         8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~--~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   85 (277)
T 3f3z_A            8 NQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVE--DVDRFKQEIEIMKSLDHPNIIRLYETFEDNTDIYLVM   85 (277)
T ss_dssp             HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCS--CHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             hhhEEeeeEEeecCCEEEEEEEeCCCCcEEEEEeehhhccc--hHHHHHHHHHHHHhCCCCCEeeEEEEEecCCeEEEEE
Confidence            468999999999999999999984  568999998754322  2467889999999999999999999999999999999


Q ss_pred             ecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceee---cCCCcEEEeeccceeeccCCCc
Q 015868          193 EFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLM---DENGVVKVADFGVARVQAQSGV  269 (399)
Q Consensus       193 E~~~ggsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~giiHrDlkp~NILl---~~~~~vkl~DFG~a~~~~~~~~  269 (399)
                      ||+++++|.+++.. ...+++..++.++.|++.||.|||++||+||||||+||++   +.++.+||+|||.+........
T Consensus        86 e~~~~~~L~~~~~~-~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~~~~l~Dfg~~~~~~~~~~  164 (277)
T 3f3z_A           86 ELCTGGELFERVVH-KRVFRESDAARIMKDVLSAVAYCHKLNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKM  164 (277)
T ss_dssp             ECCCSCBHHHHHHH-HCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSTTCCEEECCCTTCEECCTTSC
T ss_pred             eccCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCCHHHEEEecCCCCCcEEEEecccceeccCccc
Confidence            99999999999876 4568999999999999999999999999999999999999   7889999999999987766666


Q ss_pred             cccCCCCcccccccccCCCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhccCCCCC--CCCCcHHHHHHHH
Q 015868          270 MTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKSLRPTI--PKHAHPRLAELLE  347 (399)
Q Consensus       270 ~~~~~gt~~y~aPE~l~~~~~~~~~Dv~slG~vl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~l~~ll~  347 (399)
                      .....||+.|+|||.+.+. ++.++||||||+++|+|++|+.||...+..+..............  ...+++++.+++.
T Consensus       165 ~~~~~~t~~y~aPE~~~~~-~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~  243 (277)
T 3f3z_A          165 MRTKVGTPYYVSPQVLEGL-YGPECDEWSAGVMMYVLLCGYPPFSAPTDSEVMLKIREGTFTFPEKDWLNVSPQAESLIR  243 (277)
T ss_dssp             BCCCCSCTTTCCHHHHTTC-BCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCHHHHTTSCHHHHHHHH
T ss_pred             hhccCCCCCccChHHhccc-CCchhhehhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCCchhhhcCCHHHHHHHH
Confidence            6667899999999999765 899999999999999999999999998887766665544322111  1268899999999


Q ss_pred             HHhhhcCCCCCCHHHHHH
Q 015868          348 RCWQHDPTQRPNFSQITD  365 (399)
Q Consensus       348 ~cl~~dP~~Rps~~ell~  365 (399)
                      +||+.||.+|||+.++++
T Consensus       244 ~~l~~dp~~R~s~~~~l~  261 (277)
T 3f3z_A          244 RLLTKSPKQRITSLQALE  261 (277)
T ss_dssp             HHTCSSTTTSCCHHHHTT
T ss_pred             HHccCChhhCcCHHHHhc
Confidence            999999999999999976

>3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe}

Probab=100.00  E-value=2.5e-47  Score=369.22  Aligned_cols=247  Identities=28%  Similarity=0.482  Sum_probs=212.3

Q ss_pred             ccccceeceeceeCceEEEEEEE--CCeeEEEEEecCCCCC-HHHHHHHHHHHHHHHhcCCCceeeEEeEEecCCcEEEE
Q 015868          115 AKQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVN-TEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIV  191 (399)
Q Consensus       115 ~~~~~i~~~lg~G~~g~Vy~~~~--~~~~vAvK~~~~~~~~-~~~~~~~~~Ei~~l~~l~h~nIv~~~~~~~~~~~~~lV  191 (399)
                      .++|++.+.||+|+||.||+|++  +++.||+|++...... .+....+.+|+.+++.++||||+++++++..+...++|
T Consensus         8 i~~Y~i~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv   87 (336)
T 3h4j_B            8 IGPYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYDVITTPTDIVMV   87 (336)
T ss_dssp             ETTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCSHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             cCCEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEehHHccchhHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEE
Confidence            46899999999999999999998  6789999998642111 11134688999999999999999999999999999999


Q ss_pred             EecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceeecCCCcEEEeeccceeeccCCCccc
Q 015868          192 TEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMT  271 (399)
Q Consensus       192 ~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~giiHrDlkp~NILl~~~~~vkl~DFG~a~~~~~~~~~~  271 (399)
                      |||+ +|+|.+++.. .+.+++..++.++.|++.||.|||++||+||||||+|||+++++.+||+|||+++.........
T Consensus        88 ~E~~-~g~l~~~l~~-~~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~~~~~~kl~DFG~s~~~~~~~~~~  165 (336)
T 3h4j_B           88 IEYA-GGELFDYIVE-KKRMTEDEGRRFFQQIICAIEYCHRHKIVHRDLKPENLLLDDNLNVKIADFGLSNIMTDGNFLK  165 (336)
T ss_dssp             ECCC-CEEHHHHHHH-HCSCCHHHHHHHHHHHHHHHHHHHHHTCCCCCCSTTTEEECTTCCEEECCSSCTBTTTTSBTTC
T ss_pred             EECC-CCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCchhhEEEcCCCCEEEEEeccceeccCCcccc
Confidence            9999 6799999876 3679999999999999999999999999999999999999999999999999998766665566


Q ss_pred             cCCCCcccccccccCCCCC-CChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhccCCCCCCCCCcHHHHHHHHHHh
Q 015868          272 AETGTYRWMAPEVIEHKPY-DYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRLAELLERCW  350 (399)
Q Consensus       272 ~~~gt~~y~aPE~l~~~~~-~~~~Dv~slG~vl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~cl  350 (399)
                      ...||+.|+|||++.+..+ +.++||||||+++|+|++|..||.+.........+  ......+|..+++++.+||.+||
T Consensus       166 ~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~i--~~~~~~~p~~~s~~~~~li~~~L  243 (336)
T 3h4j_B          166 TSCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPNLFKKV--NSCVYVMPDFLSPGAQSLIRRMI  243 (336)
T ss_dssp             CCTTSTTTSCGGGSCCSGGGCHHHHHHHHHHHHHHHHHSSCSSBCSSSTTCBCCC--CSSCCCCCTTSCHHHHHHHHTTS
T ss_pred             cccCCcCcCCHHHHcCCCCCCCccchhHHHHHHHHHHhCCCCCCCccHHHHHHHH--HcCCCCCcccCCHHHHHHHHHHc
Confidence            6789999999999998876 68999999999999999999999875433221111  11234567789999999999999


Q ss_pred             hhcCCCCCCHHHHHH
Q 015868          351 QHDPTQRPNFSQITD  365 (399)
Q Consensus       351 ~~dP~~Rps~~ell~  365 (399)
                      +.||.+|||++|+++
T Consensus       244 ~~dP~~Rpt~~eil~  258 (336)
T 3h4j_B          244 VADPMQRITIQEIRR  258 (336)
T ss_dssp             CSSGGGSCCHHHHTT
T ss_pred             CCChhHCcCHHHHHh
Confidence            999999999999976

>3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=9.4e-46  Score=364.55  Aligned_cols=249  Identities=22%  Similarity=0.393  Sum_probs=203.0

Q ss_pred             ccccceeceeceeCceEEEEEEE--CCeeEEEEEecCCCCCHHHHHHHHHHHHHHHhcC-CCceeeEEeEEecCC--cEE
Q 015868          115 AKQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIR-HKNVVQFIGACTRPP--NLC  189 (399)
Q Consensus       115 ~~~~~i~~~lg~G~~g~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~Ei~~l~~l~-h~nIv~~~~~~~~~~--~~~  189 (399)
                      .++|++.+.||+|+||.||+|.+  +++.||||++.....+......+.+|+.+++++. ||||+++++++....  .+|
T Consensus         8 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~   87 (388)
T 3oz6_A            8 LRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIVNLLNVLRADNDRDVY   87 (388)
T ss_dssp             HTTEEEEEC-------CEEEEEETTTCCEEEEEEECC--CCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECTTSSCEE
T ss_pred             cCceEEEEEeeeCCCeEEEEEEECCCCCEEEEEEecccccChHHHHHHHHHHHHHHhccCCCCCCeeeeEEecCCCCEEE
Confidence            46899999999999999999987  5789999999876667777788999999999997 999999999997544  689


Q ss_pred             EEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceeecCCCcEEEeeccceeeccC---
Q 015868          190 IVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQ---  266 (399)
Q Consensus       190 lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~giiHrDlkp~NILl~~~~~vkl~DFG~a~~~~~---  266 (399)
                      +||||+++ +|.+++..  ..+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+++....   
T Consensus        88 lv~e~~~~-~L~~~~~~--~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~  164 (388)
T 3oz6_A           88 LVFDYMET-DLHAVIRA--NILEPVHKQYVVYQLIKVIKYLHSGGLLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRR  164 (388)
T ss_dssp             EEEECCSE-EHHHHHHH--TCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEESSSCCC
T ss_pred             EEecccCc-CHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHeEEcCCCCEEecCCccccccccccc
Confidence            99999985 99999976  4689999999999999999999999999999999999999999999999999986432   


Q ss_pred             -------------------CCccccCCCCcccccccccCC-CCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHH
Q 015868          267 -------------------SGVMTAETGTYRWMAPEVIEH-KPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVV  326 (399)
Q Consensus       267 -------------------~~~~~~~~gt~~y~aPE~l~~-~~~~~~~Dv~slG~vl~elltg~~P~~~~~~~~~~~~~~  326 (399)
                                         ....+...||+.|+|||++.+ ..|+.++|||||||++|||++|++||.+.+.......+.
T Consensus       165 ~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~  244 (388)
T 3oz6_A          165 VTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFPGSSTMNQLERII  244 (388)
T ss_dssp             CCCCGGGCCC---------------CCCGGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHH
T ss_pred             ccccccccccccccccccccccccCCcccCCcCCHHHhcCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Confidence                               112344579999999999987 678999999999999999999999999988766655544


Q ss_pred             hccCCCC---------------------------------------------CCCCCcHHHHHHHHHHhhhcCCCCCCHH
Q 015868          327 QKSLRPT---------------------------------------------IPKHAHPRLAELLERCWQHDPTQRPNFS  361 (399)
Q Consensus       327 ~~~~~~~---------------------------------------------~~~~~~~~l~~ll~~cl~~dP~~Rps~~  361 (399)
                      .....|.                                             .+..+++++.+||.+||+.||.+|||++
T Consensus       245 ~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~dP~~R~t~~  324 (388)
T 3oz6_A          245 GVIDFPSNEDVESIQSPFAKTMIESLKEKVEIRQSNKRDIFTKWKNLLLKINPKADCNEEALDLLDKLLQFNPNKRISAN  324 (388)
T ss_dssp             HHHCCCCHHHHHTSCCSSHHHHHHHHHHHCC-----CCCCHHHHHHHHHHHCTTCCCCHHHHHHHHHHCCSSGGGSCCHH
T ss_pred             HhcCCCCHHHHHhccCHHHHHHHHhCcccccccCCCHHHhCcchhhhcccccccccCCHHHHHHHHHhhccCcccCCCHH
Confidence            2211111                                             1126789999999999999999999999


Q ss_pred             HHHHH
Q 015868          362 QITDI  366 (399)
Q Consensus       362 ell~~  366 (399)
                      |+++.
T Consensus       325 e~l~H  329 (388)
T 3oz6_A          325 DALKH  329 (388)
T ss_dssp             HHTTS
T ss_pred             HHhCC
Confidence            98763

>2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7

Probab=100.00  E-value=2.2e-46  Score=384.24  Aligned_cols=260  Identities=36%  Similarity=0.681  Sum_probs=228.5

Q ss_pred             CCceeecccccceeceeceeCceEEEEEEECC-eeEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCceeeEEeEEecCC
Q 015868          108 TDVWEIDAKQLKIECKVASGSYGDLYKGTYCS-QEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPP  186 (399)
Q Consensus       108 ~~~~~i~~~~~~i~~~lg~G~~g~Vy~~~~~~-~~vAvK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~nIv~~~~~~~~~~  186 (399)
                      .+.|++..++|++.++||+|+||.||+|++.+ ..||||+++.....   .+.|.+|+.+|++++||||+++++++.. .
T Consensus       259 ~~~~~i~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~---~~~~~~E~~~l~~l~hpniv~~~~~~~~-~  334 (535)
T 2h8h_A          259 KDAWEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMS---PEAFLQEAQVMKKLRHEKLVQLYAVVSE-E  334 (535)
T ss_dssp             TTCSBCCGGGEEEEEEEEECSSEEEEEEEETTTEEEEEEEECTTSSC---HHHHHHHHHHHHHCCCTTBCCEEEEECS-S
T ss_pred             ccceecchhhhhhheecccCCCeEEEEEEECCCceEEEEEeCCCCCC---HHHHHHHHHHHHhCCCCCEeeEEEEEee-c
Confidence            36699999999999999999999999999964 67999999875433   3578999999999999999999999877 5


Q ss_pred             cEEEEEecCCCCCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceeecCCCcEEEeeccceeecc
Q 015868          187 NLCIVTEFMARGSIYDFLHKQ-KGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQA  265 (399)
Q Consensus       187 ~~~lV~E~~~ggsL~~~l~~~-~~~l~~~~~~~i~~~i~~~L~~LH~~giiHrDlkp~NILl~~~~~vkl~DFG~a~~~~  265 (399)
                      ..++||||+.+|+|.+++... ...+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++...
T Consensus       335 ~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~  414 (535)
T 2h8h_A          335 PIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIE  414 (535)
T ss_dssp             SCEEEECCCTTEEHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCTTSTTTCC
T ss_pred             cceEeeehhcCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHhhEEEcCCCcEEEcccccceecC
Confidence            689999999999999999753 3568999999999999999999999999999999999999999999999999997654


Q ss_pred             CCC--ccccCCCCcccccccccCCCCCCChhhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHHhccCCCCCCCCCcHHH
Q 015868          266 QSG--VMTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLT-GELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRL  342 (399)
Q Consensus       266 ~~~--~~~~~~gt~~y~aPE~l~~~~~~~~~Dv~slG~vl~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  342 (399)
                      ...  ......++..|+|||++.+..++.++||||||+++|||++ |..||.+.+..+.... +....+...+..+++++
T Consensus       415 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlGv~l~el~t~g~~P~~~~~~~~~~~~-i~~~~~~~~~~~~~~~l  493 (535)
T 2h8h_A          415 DNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQ-VERGYRMPCPPECPESL  493 (535)
T ss_dssp             CHHHHTTCSTTSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTTCCSSTTCCHHHHHHH-HHTTCCCCCCTTCCHHH
T ss_pred             CCceecccCCcCcccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHH-HHcCCCCCCCCCCCHHH
Confidence            321  1123346788999999998899999999999999999999 9999999888776554 44566777788999999


Q ss_pred             HHHHHHHhhhcCCCCCCHHHHHHHHHHHHH
Q 015868          343 AELLERCWQHDPTQRPNFSQITDILKQMMK  372 (399)
Q Consensus       343 ~~ll~~cl~~dP~~Rps~~ell~~L~~l~~  372 (399)
                      .+||.+||+.||++|||+.+|++.|+++..
T Consensus       494 ~~li~~cl~~dP~~RPt~~~l~~~L~~~~~  523 (535)
T 2h8h_A          494 HDLMCQCWRKEPEERPTFEYLQAFLEDYFT  523 (535)
T ss_dssp             HHHHHHHTCSSGGGSCCHHHHHHHHHTSSC
T ss_pred             HHHHHHHcCCChhHCcCHHHHHHHHHHHhh
Confidence            999999999999999999999999988753

>3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A*

Probab=100.00  E-value=4.6e-46  Score=369.47  Aligned_cols=253  Identities=21%  Similarity=0.323  Sum_probs=217.1

Q ss_pred             eeecccccceeceeceeCceEEEEEEE--CCeeEEEEEecCCCC-CHHHHHHHHHHHHHHHhcCCCceeeEEeEEecCCc
Q 015868          111 WEIDAKQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECV-NTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPN  187 (399)
Q Consensus       111 ~~i~~~~~~i~~~lg~G~~g~Vy~~~~--~~~~vAvK~~~~~~~-~~~~~~~~~~Ei~~l~~l~h~nIv~~~~~~~~~~~  187 (399)
                      ..+..++|++.+.||+|+||.||+|++  +++.||+|+++.... .......+.+|+.+++.++||||+++++++.+...
T Consensus        64 ~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~  143 (410)
T 3v8s_A           64 LRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRY  143 (410)
T ss_dssp             HSCCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTCCCSTHHHHHHHHHHCCCTTBCCEEEEEECSSE
T ss_pred             cccCccccEEEEEEEcCCCEEEEEEEECCCCcEEEEEEEehhhhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEECCE
Confidence            345678999999999999999999998  478899999864210 00112347889999999999999999999999999


Q ss_pred             EEEEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceeecCCCcEEEeeccceeeccCC
Q 015868          188 LCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQS  267 (399)
Q Consensus       188 ~~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~giiHrDlkp~NILl~~~~~vkl~DFG~a~~~~~~  267 (399)
                      +|+||||++||+|.+++..  ..+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||+++.....
T Consensus       144 ~~lV~E~~~gg~L~~~l~~--~~~~e~~~~~~~~qi~~aL~~LH~~givHrDLKp~NILl~~~g~ikL~DFG~a~~~~~~  221 (410)
T 3v8s_A          144 LYMVMEYMPGGDLVNLMSN--YDVPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKE  221 (410)
T ss_dssp             EEEEECCCTTEEHHHHHHH--CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECCTT
T ss_pred             EEEEEeCCCCCcHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeeECCCCCEEEeccceeEeeccC
Confidence            9999999999999999975  46899999999999999999999999999999999999999999999999999876554


Q ss_pred             Cc--cccCCCCcccccccccCCCC----CCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhccCCCCC--CCCCc
Q 015868          268 GV--MTAETGTYRWMAPEVIEHKP----YDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKSLRPTI--PKHAH  339 (399)
Q Consensus       268 ~~--~~~~~gt~~y~aPE~l~~~~----~~~~~Dv~slG~vl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~--~~~~~  339 (399)
                      ..  .....||+.|+|||++.+..    |+.++||||||+++|||++|+.||.+.+..+....+.........  ...++
T Consensus       222 ~~~~~~~~~gt~~Y~APE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~s  301 (410)
T 3v8s_A          222 GMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKNSLTFPDDNDIS  301 (410)
T ss_dssp             SEEECCSCCSCGGGCCHHHHHTTTTTCEEETHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHHHHCCCCTTCCCC
T ss_pred             CcccccCCcCCccccCHHHhhccCCCcCCCCcceEecchHHHHHHHhCCCCCCCCChhhHHHHHHhccccccCCCccccc
Confidence            32  33567999999999998765    789999999999999999999999998888777766654322223  34689


Q ss_pred             HHHHHHHHHHhhhcCCC--CCCHHHHHH
Q 015868          340 PRLAELLERCWQHDPTQ--RPNFSQITD  365 (399)
Q Consensus       340 ~~l~~ll~~cl~~dP~~--Rps~~ell~  365 (399)
                      +++.+||.+||+.+|.+  ||+++|+++
T Consensus       302 ~~~~~li~~lL~~~~~rlgR~~~~ei~~  329 (410)
T 3v8s_A          302 KEAKNLICAFLTDREVRLGRNGVEEIKR  329 (410)
T ss_dssp             HHHHHHHHHHSSCGGGCTTSSCHHHHHT
T ss_pred             HHHHHHHHHHccChhhhCCCCCHHHHhc
Confidence            99999999999999988  999999875

>2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A*

Probab=100.00  E-value=6.2e-47  Score=363.15  Aligned_cols=258  Identities=26%  Similarity=0.482  Sum_probs=216.6

Q ss_pred             ecccccceeceeceeCceEEEEEEEC-CeeEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCceeeEEeEEecCCcEEEE
Q 015868          113 IDAKQLKIECKVASGSYGDLYKGTYC-SQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIV  191 (399)
Q Consensus       113 i~~~~~~i~~~lg~G~~g~Vy~~~~~-~~~vAvK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~nIv~~~~~~~~~~~~~lV  191 (399)
                      ...++|++.+.||+|+||.||+|++. ++.||+|++....  ....+.+.+|+.+++.++||||+++++++...+..++|
T Consensus        36 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv  113 (321)
T 2qkw_B           36 EATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPES--SQGIEEFETEIETLSFCRHPHLVSLIGFCDERNEMILI  113 (321)
T ss_dssp             CCCCCCSCCCCSCBCSSSEEEEEECTTCCEEEEEECCSCC--SSHHHHHHHHHHGGGSCCCTTBCCEEEECCCTTCCEEE
T ss_pred             HHHhccCccceeecCCCeeEEEEEECCCCEEEEEEecccC--hHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEEE
Confidence            34679999999999999999999874 7899999988653  33457899999999999999999999999999999999


Q ss_pred             EecCCCCCHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceeecCCCcEEEeeccceeeccCCC
Q 015868          192 TEFMARGSIYDFLHKQK---GVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSG  268 (399)
Q Consensus       192 ~E~~~ggsL~~~l~~~~---~~l~~~~~~~i~~~i~~~L~~LH~~giiHrDlkp~NILl~~~~~vkl~DFG~a~~~~~~~  268 (399)
                      |||+++++|.+++....   ..+++..++.++.|++.||.|||++||+||||||+||+++.++.+||+|||+++......
T Consensus       114 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~  193 (321)
T 2qkw_B          114 YKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTRAIIHRDVKSINILLDENFVPKITDFGISKKGTELD  193 (321)
T ss_dssp             EECCTTCBTGGGSSSSCCCSCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCSTTEEECTTCCEEECCCTTCEECSSSS
T ss_pred             EEcCCCCcHHHHHhccCCCccccCHHHHHHHHHHHHHHHHHhcCCCeecCCCCHHHEEECCCCCEEEeeccccccccccc
Confidence            99999999999986543   358999999999999999999999999999999999999999999999999998644322


Q ss_pred             ---ccccCCCCcccccccccCCCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHH------HHHHHh---------ccC
Q 015868          269 ---VMTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPYAGLTPLQA------AVGVVQ---------KSL  330 (399)
Q Consensus       269 ---~~~~~~gt~~y~aPE~l~~~~~~~~~Dv~slG~vl~elltg~~P~~~~~~~~~------~~~~~~---------~~~  330 (399)
                         ......||+.|+|||++.+..++.++||||||+++|+|++|+.||....+.+.      ......         ...
T Consensus       194 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  273 (321)
T 2qkw_B          194 QTHLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVESHNNGQLEQIVDPNL  273 (321)
T ss_dssp             CCCCBCCCEEETTTCCHHHHHHCBCCTHHHHHHHHHHHHHHHHCCTTCSCSSSSSCCCHHHHTHHHHTTTCCCSSSSSSC
T ss_pred             ccccccccCCCccccCHHHhcCCCCCcccchHhHHHHHHHHHhCCCcccccCcHHHHHHHHHhhhccccccHHHhcChhh
Confidence               22334589999999999988999999999999999999999999976543211      111110         111


Q ss_pred             CCCCCCCCcHHHHHHHHHHhhhcCCCCCCHHHHHHHHHHHHH
Q 015868          331 RPTIPKHAHPRLAELLERCWQHDPTQRPNFSQITDILKQMMK  372 (399)
Q Consensus       331 ~~~~~~~~~~~l~~ll~~cl~~dP~~Rps~~ell~~L~~l~~  372 (399)
                      ...++...+..+.+++.+||+.||++|||+.|+++.|+.+++
T Consensus       274 ~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~l~  315 (321)
T 2qkw_B          274 ADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKLEYALR  315 (321)
T ss_dssp             TTCSCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             ccccCHHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHhh
Confidence            222334466789999999999999999999999999998875

>2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A*

Probab=100.00  E-value=4.8e-46  Score=356.78  Aligned_cols=249  Identities=25%  Similarity=0.427  Sum_probs=197.6

Q ss_pred             ccccceeceeceeCceEEEEEEE--CCeeEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCceeeEEeEEecCCcEEEEE
Q 015868          115 AKQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVT  192 (399)
Q Consensus       115 ~~~~~i~~~lg~G~~g~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~nIv~~~~~~~~~~~~~lV~  192 (399)
                      .++|++.++||+|+||.||+|.+  +++.||+|+++... .......+.+|+.++++++||||+++++++..++..++||
T Consensus         4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~   82 (317)
T 2pmi_A            4 SSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDS-EEGTPSTAIREISLMKELKHENIVRLYDVIHTENKLTLVF   82 (317)
T ss_dssp             ---------------CEEEEEECSSSCCEEEEEEEECCS-TTCSCHHHHHHHHHHTTCCBTTBCCEEEEECCTTEEEEEE
T ss_pred             ccceeEeeEECCCCCEEEEEEEECCCCcEEEEEEeeccc-ccccHHHHHHHHHHHHhcCCCCcceEEEEEEECCeEEEEE
Confidence            45899999999999999999987  47899999997543 2222356789999999999999999999999999999999


Q ss_pred             ecCCCCCHHHHHHhcC-----CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceeecCCCcEEEeeccceeeccCC
Q 015868          193 EFMARGSIYDFLHKQK-----GVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQS  267 (399)
Q Consensus       193 E~~~ggsL~~~l~~~~-----~~l~~~~~~~i~~~i~~~L~~LH~~giiHrDlkp~NILl~~~~~vkl~DFG~a~~~~~~  267 (399)
                      ||+++ +|.+++....     ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.....
T Consensus        83 e~~~~-~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~  161 (317)
T 2pmi_A           83 EFMDN-DLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHENKILHRDLKPQNLLINKRGQLKLGDFGLARAFGIP  161 (317)
T ss_dssp             ECCCC-BHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCSSCEETTSC
T ss_pred             EecCC-CHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCChHHeEEcCCCCEEECcCccceecCCC
Confidence            99985 9999986542     46899999999999999999999999999999999999999999999999999876533


Q ss_pred             -CccccCCCCcccccccccCC-CCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhccC---------------
Q 015868          268 -GVMTAETGTYRWMAPEVIEH-KPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKSL---------------  330 (399)
Q Consensus       268 -~~~~~~~gt~~y~aPE~l~~-~~~~~~~Dv~slG~vl~elltg~~P~~~~~~~~~~~~~~~~~~---------------  330 (399)
                       .......||+.|+|||++.+ ..++.++||||||+++|+|++|+.||.+.+..+....+.....               
T Consensus       162 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~  241 (317)
T 2pmi_A          162 VNTFSSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTNDEEQLKLIFDIMGTPNESLWPSVTKLPK  241 (317)
T ss_dssp             CCCCCCCCSCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCTTTCGGGGGCTT
T ss_pred             cccCCCCcccccccCchHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhHhhhhhhhhh
Confidence             23445678999999999976 4689999999999999999999999999887665554432110               


Q ss_pred             -----------------CCCCCCCCcHHHHHHHHHHhhhcCCCCCCHHHHHH
Q 015868          331 -----------------RPTIPKHAHPRLAELLERCWQHDPTQRPNFSQITD  365 (399)
Q Consensus       331 -----------------~~~~~~~~~~~l~~ll~~cl~~dP~~Rps~~ell~  365 (399)
                                       .+..+..+++++.+||.+||+.||++|||+.|+++
T Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~e~l~  293 (317)
T 2pmi_A          242 YNPNIQQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQLNPDMRLSAKQALH  293 (317)
T ss_dssp             CCTTCCCCCCCCSHHHHGGGCSSCCCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred             cccccccccchhHHHhhcccccccCCHHHHHHHHHHCCCCcccCCCHHHHhC
Confidence                             01122357889999999999999999999999875

>2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A*

Probab=100.00  E-value=1.3e-45  Score=354.84  Aligned_cols=265  Identities=30%  Similarity=0.559  Sum_probs=225.4

Q ss_pred             CceeecccccceeceeceeCceEEEEEEE-------CCeeEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCceeeEEeE
Q 015868          109 DVWEIDAKQLKIECKVASGSYGDLYKGTY-------CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGA  181 (399)
Q Consensus       109 ~~~~i~~~~~~i~~~lg~G~~g~Vy~~~~-------~~~~vAvK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~nIv~~~~~  181 (399)
                      +..++..++|++.+.||+|+||.||+|++       .++.||+|++.... .......+.+|+.++++++||||++++++
T Consensus        23 ~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~  101 (327)
T 2yfx_A           23 DLKEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVC-SEQDELDFLMEALIISKFNHQNIVRCIGV  101 (327)
T ss_dssp             GSCBCCGGGCEEEEECC--CSSCEEEEEC--------CCEEEEEECCSSC-CHHHHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred             hcccCChhheEEEEEEcCCCCeeEEEEEEcCCCCCCccceEEEEEecccc-chhhHHHHHHHHHHHhhCCCCCCCeEEEE
Confidence            34567889999999999999999999984       45679999997543 45556789999999999999999999999


Q ss_pred             EecCCcEEEEEecCCCCCHHHHHHhcC------CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceeecC---CCc
Q 015868          182 CTRPPNLCIVTEFMARGSIYDFLHKQK------GVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDE---NGV  252 (399)
Q Consensus       182 ~~~~~~~~lV~E~~~ggsL~~~l~~~~------~~l~~~~~~~i~~~i~~~L~~LH~~giiHrDlkp~NILl~~---~~~  252 (399)
                      +......++||||+++++|.+++....      ..+++..++.++.|++.||.|||++||+||||||+||+++.   +..
T Consensus       102 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~dlkp~NIli~~~~~~~~  181 (327)
T 2yfx_A          102 SLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRV  181 (327)
T ss_dssp             ECSSSSCEEEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSSTTCC
T ss_pred             EcCCCCcEEEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHhhCCeecCcCCHhHEEEecCCCcce
Confidence            999999999999999999999998754      45889999999999999999999999999999999999984   446


Q ss_pred             EEEeeccceeeccCCC---ccccCCCCcccccccccCCCCCCChhhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHHhc
Q 015868          253 VKVADFGVARVQAQSG---VMTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLT-GELPYAGLTPLQAAVGVVQK  328 (399)
Q Consensus       253 vkl~DFG~a~~~~~~~---~~~~~~gt~~y~aPE~l~~~~~~~~~Dv~slG~vl~ellt-g~~P~~~~~~~~~~~~~~~~  328 (399)
                      +||+|||+++......   ......+|+.|+|||.+.+..++.++||||||+++|+|+| |..||...+..+.... +..
T Consensus       182 ~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~-~~~  260 (327)
T 2yfx_A          182 AKIGDFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEF-VTS  260 (327)
T ss_dssp             EEECCCHHHHHHHC------CCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHH-HHT
T ss_pred             EEECccccccccccccccccCCCcCCCcceeCHhHhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCcCHHHHHHH-Hhc
Confidence            9999999997543322   1233457889999999998899999999999999999998 9999998877665444 444


Q ss_pred             cCCCCCCCCCcHHHHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHH
Q 015868          329 SLRPTIPKHAHPRLAELLERCWQHDPTQRPNFSQITDILKQMMKEVA  375 (399)
Q Consensus       329 ~~~~~~~~~~~~~l~~ll~~cl~~dP~~Rps~~ell~~L~~l~~~~~  375 (399)
                      ..++..+..+++.+.+++.+||+.||.+|||+.++++.|..+.....
T Consensus       261 ~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~~~~~  307 (327)
T 2yfx_A          261 GGRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQDPD  307 (327)
T ss_dssp             TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHCHH
T ss_pred             CCCCCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHhcCHH
Confidence            55667788899999999999999999999999999999998876443

>3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A*

Probab=100.00  E-value=7.6e-46  Score=376.74  Aligned_cols=255  Identities=28%  Similarity=0.460  Sum_probs=217.2

Q ss_pred             ccccceeceeceeCceEEEEEEE--CCeeEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCceeeEEeEEecCCcEEEEE
Q 015868          115 AKQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVT  192 (399)
Q Consensus       115 ~~~~~i~~~lg~G~~g~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~nIv~~~~~~~~~~~~~lV~  192 (399)
                      .++|++.++||+|+||.||+|++  ++..||+|+++...........+.+|+.+++.++||||+++++++.....+|+||
T Consensus        36 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~  115 (494)
T 3lij_A           36 SEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNYYLVM  115 (494)
T ss_dssp             HHHEEEEEEEECC---EEEEEEETTTCCEEEEEEEEC-----CTTHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             hcCeEEeeEEecCCCEEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEE
Confidence            45799999999999999999998  5788999999865443444567899999999999999999999999999999999


Q ss_pred             ecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceeecCC---CcEEEeeccceeeccCCCc
Q 015868          193 EFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDEN---GVVKVADFGVARVQAQSGV  269 (399)
Q Consensus       193 E~~~ggsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~giiHrDlkp~NILl~~~---~~vkl~DFG~a~~~~~~~~  269 (399)
                      ||+.||+|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++..   +.+||+|||+++.......
T Consensus       116 e~~~~g~L~~~~~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~DfG~a~~~~~~~~  194 (494)
T 3lij_A          116 ECYKGGELFDEIIHR-MKFNEVDAAVIIKQVLSGVTYLHKHNIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQKK  194 (494)
T ss_dssp             ECCCSCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSTTCCEEECCCTTCEECBTTBC
T ss_pred             ecCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCChhhEEEeCCCCCCcEEEEECCCCeECCCCcc
Confidence            999999999998764 668999999999999999999999999999999999999764   5599999999988776666


Q ss_pred             cccCCCCcccccccccCCCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhccCCCCCC--CCCcHHHHHHHH
Q 015868          270 MTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKSLRPTIP--KHAHPRLAELLE  347 (399)
Q Consensus       270 ~~~~~gt~~y~aPE~l~~~~~~~~~Dv~slG~vl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~l~~ll~  347 (399)
                      .....||+.|+|||++.+ .|+.++|||||||++|+|++|..||.+.+..+....+.........+  ..+++++.+||.
T Consensus       195 ~~~~~gt~~y~aPE~l~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~  273 (494)
T 3lij_A          195 MKERLGTAYYIAPEVLRK-KYDEKCDVWSIGVILFILLAGYPPFGGQTDQEILRKVEKGKYTFDSPEWKNVSEGAKDLIK  273 (494)
T ss_dssp             BCCCCSCTTTCCHHHHTT-CBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCSGGGTTSCHHHHHHHH
T ss_pred             ccccCCCcCeeCHHHHcc-cCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCchhcccCCHHHHHHHH
Confidence            667789999999999874 69999999999999999999999999998887776666544433222  468999999999


Q ss_pred             HHhhhcCCCCCCHHHHHH--HHHHHH
Q 015868          348 RCWQHDPTQRPNFSQITD--ILKQMM  371 (399)
Q Consensus       348 ~cl~~dP~~Rps~~ell~--~L~~l~  371 (399)
                      +||+.||.+|||+.|+++  .+.+..
T Consensus       274 ~~L~~dp~~R~s~~e~l~hp~~~~~~  299 (494)
T 3lij_A          274 QMLQFDSQRRISAQQALEHPWIKEMC  299 (494)
T ss_dssp             HHTCSSTTTSCCHHHHHTCHHHHHHH
T ss_pred             HHCCCChhhCccHHHHhcCcccccCc
Confidence            999999999999999986  355543

>2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A*

Probab=100.00  E-value=1.5e-45  Score=363.85  Aligned_cols=253  Identities=21%  Similarity=0.381  Sum_probs=215.2

Q ss_pred             ceeecccccceeceeceeCceEEEEEEE-CCeeEEEEEecCCCCCHHHHHHHHHHHHHHHhcC--CCceeeEEeEEecCC
Q 015868          110 VWEIDAKQLKIECKVASGSYGDLYKGTY-CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIR--HKNVVQFIGACTRPP  186 (399)
Q Consensus       110 ~~~i~~~~~~i~~~lg~G~~g~Vy~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~Ei~~l~~l~--h~nIv~~~~~~~~~~  186 (399)
                      ...+..++|++.+.||+|+||.||++.. .++.||||++.....+....+.+.+|+.++++++  ||||+++++++....
T Consensus        50 ~~~~~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~~~~  129 (390)
T 2zmd_A           50 CISVKGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQ  129 (390)
T ss_dssp             CEEETTEEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSS
T ss_pred             cccccCCceEEEEEEccCCCeEEEEEEcCCCCEEEEEEEecccccHHHHHHHHHHHHHHHHcccCCCeEEEEEEEEecCC
Confidence            3456677899999999999999999987 4778999999877667777889999999999997  599999999999999


Q ss_pred             cEEEEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceeecCCCcEEEeeccceeeccC
Q 015868          187 NLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQ  266 (399)
Q Consensus       187 ~~~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~giiHrDlkp~NILl~~~~~vkl~DFG~a~~~~~  266 (399)
                      .+|+||| +.+++|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++ ++.+||+|||+++....
T Consensus       130 ~~~lv~E-~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~aL~~lH~~~ivHrDlkp~NIll~-~~~~kl~DFG~a~~~~~  206 (390)
T 2zmd_A          130 YIYMVME-CGNIDLNSWLKKK-KSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQP  206 (390)
T ss_dssp             EEEEEEE-CCSEEHHHHHHHC-SSCCHHHHHHHHHHHHHHHHHHHTTTCCCCCCCGGGEEES-SSCEEECCCSSSCCC--
T ss_pred             EEEEEEe-cCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHEEEE-CCeEEEEecCccccccC
Confidence            9999999 5677999999774 5789999999999999999999999999999999999995 68999999999986543


Q ss_pred             CC---ccccCCCCcccccccccCC-----------CCCCChhhHHHHHHHHHHHHcCCCCCCCCCH-HHHHHHHHhccCC
Q 015868          267 SG---VMTAETGTYRWMAPEVIEH-----------KPYDYKADVFSFGIALWELLTGELPYAGLTP-LQAAVGVVQKSLR  331 (399)
Q Consensus       267 ~~---~~~~~~gt~~y~aPE~l~~-----------~~~~~~~Dv~slG~vl~elltg~~P~~~~~~-~~~~~~~~~~~~~  331 (399)
                      ..   ......||+.|+|||++.+           ..++.++|||||||++|+|++|+.||..... ......++.....
T Consensus       207 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~~~~~  286 (390)
T 2zmd_A          207 DTTSVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHE  286 (390)
T ss_dssp             -------CCSCCCGGGCCHHHHHCC------------CCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHCTTSC
T ss_pred             CCccccCCCCCcCCCccChHHhhhccccccccccccCCCChhhHHHHHHHHHHHHHCCCcchhhhHHHHHHHHHhCcccc
Confidence            32   2345579999999999865           3688999999999999999999999987643 3444445554555


Q ss_pred             CCCCCCCcHHHHHHHHHHhhhcCCCCCCHHHHHH
Q 015868          332 PTIPKHAHPRLAELLERCWQHDPTQRPNFSQITD  365 (399)
Q Consensus       332 ~~~~~~~~~~l~~ll~~cl~~dP~~Rps~~ell~  365 (399)
                      ...|...++++.+||.+||+.||.+|||+.|+++
T Consensus       287 ~~~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~  320 (390)
T 2zmd_A          287 IEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLA  320 (390)
T ss_dssp             CCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             CCCCccchHHHHHHHHHHcccChhhCCCHHHHhh
Confidence            6677778899999999999999999999999975

>2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus}

Probab=100.00  E-value=2.9e-46  Score=377.47  Aligned_cols=251  Identities=23%  Similarity=0.488  Sum_probs=221.1

Q ss_pred             eecccccceeceeceeCceEEEEEEE--CCeeEEEEEecCCCCC-HHHHHHHHHHHHHHHhcCCCceeeEEeEEecCCcE
Q 015868          112 EIDAKQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVN-TEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNL  188 (399)
Q Consensus       112 ~i~~~~~~i~~~lg~G~~g~Vy~~~~--~~~~vAvK~~~~~~~~-~~~~~~~~~Ei~~l~~l~h~nIv~~~~~~~~~~~~  188 (399)
                      .+..++|++.+.||+|+||.||+|++  +++.||||+++..... .+....+.+|+.+++.++||||+++++++..+..+
T Consensus        12 ~~~~~~Y~l~~~LG~G~fg~V~~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~   91 (476)
T 2y94_A           12 RVKIGHYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQVISTPSDI   91 (476)
T ss_dssp             CCEETTEEEEEEEECCSSSCEEEEEETTTCCEEEEEEEEHHHHHHTTTHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEE
T ss_pred             CceecCEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEE
Confidence            34567999999999999999999998  5889999999743111 12246789999999999999999999999999999


Q ss_pred             EEEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceeecCCCcEEEeeccceeeccCCC
Q 015868          189 CIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSG  268 (399)
Q Consensus       189 ~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~giiHrDlkp~NILl~~~~~vkl~DFG~a~~~~~~~  268 (399)
                      ++||||++||+|.+++.. .+.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++......
T Consensus        92 ~lv~E~~~gg~L~~~l~~-~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDLkp~NIll~~~~~vkL~DFG~a~~~~~~~  170 (476)
T 2y94_A           92 FMVMEYVSGGELFDYICK-NGRLDEKESRRLFQQILSGVDYCHRHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGE  170 (476)
T ss_dssp             EEEEECCSSEEHHHHTTS-SSSCCHHHHHHHHHHHHHHHHHHHTTTEECSCCSGGGEEECTTCCEEECCCSSCEECCTTC
T ss_pred             EEEEeCCCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCCCcccccHHHEEEecCCCeEEEeccchhhccccc
Confidence            999999999999999965 5679999999999999999999999999999999999999999999999999998876655


Q ss_pred             ccccCCCCcccccccccCCCCC-CChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhccCCCCCCCCCcHHHHHHHH
Q 015868          269 VMTAETGTYRWMAPEVIEHKPY-DYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRLAELLE  347 (399)
Q Consensus       269 ~~~~~~gt~~y~aPE~l~~~~~-~~~~Dv~slG~vl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~  347 (399)
                      ......||+.|+|||++.+..+ +.++||||||+++|+|++|..||.+.+.......+...  ....|..+++++.+||.
T Consensus       171 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~--~~~~p~~~s~~~~~Li~  248 (476)
T 2y94_A          171 FLRTSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDDDHVPTLFKKICDG--IFYTPQYLNPSVISLLK  248 (476)
T ss_dssp             CBCCCCSCSTTCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSSCCSSSHHHHHHHHTT--CCCCCTTCCHHHHHHHH
T ss_pred             cccccCCCcCeEChhhccCCCCCCCcceehhhHHHHHHHhhCCCCCCCCCHHHHHHHHhcC--CcCCCccCCHHHHHHHH
Confidence            5666789999999999998876 68999999999999999999999988776665554443  23467779999999999


Q ss_pred             HHhhhcCCCCCCHHHHHH
Q 015868          348 RCWQHDPTQRPNFSQITD  365 (399)
Q Consensus       348 ~cl~~dP~~Rps~~ell~  365 (399)
                      +||+.||.+|||+.|+++
T Consensus       249 ~~L~~dP~~Rpt~~eil~  266 (476)
T 2y94_A          249 HMLQVDPMKRATIKDIRE  266 (476)
T ss_dssp             HHTCSSTTTSCCHHHHHT
T ss_pred             HHcCCCchhCcCHHHHHh
Confidence            999999999999999986

>3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii}

Probab=100.00  E-value=1e-45  Score=349.02  Aligned_cols=249  Identities=23%  Similarity=0.418  Sum_probs=207.5

Q ss_pred             ccccceeceeceeCceEEEEEEE--CCeeEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCceeeEEeEEecCCcEEEEE
Q 015868          115 AKQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVT  192 (399)
Q Consensus       115 ~~~~~i~~~lg~G~~g~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~nIv~~~~~~~~~~~~~lV~  192 (399)
                      .++|.+.++||+|+||.||+++.  .+..||+|++..... ....+.+.+|+.++++++||||+++++++......++||
T Consensus        21 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~-~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~   99 (285)
T 3is5_A           21 DDLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRS-QVPMEQIEAEIEVLKSLDHPNIIKIFEVFEDYHNMYIVM   99 (285)
T ss_dssp             HHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGC-CSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             hhheeecceeccCCCeEEEEEEEccCCceEEEEEeecccc-chhHHHHHHHHHHHHhCCCchHHhHHHheecCCeEEEEE
Confidence            36899999999999999999987  478999999875432 222467889999999999999999999999999999999


Q ss_pred             ecCCCCCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceee---cCCCcEEEeeccceeeccC
Q 015868          193 EFMARGSIYDFLHKQ---KGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLM---DENGVVKVADFGVARVQAQ  266 (399)
Q Consensus       193 E~~~ggsL~~~l~~~---~~~l~~~~~~~i~~~i~~~L~~LH~~giiHrDlkp~NILl---~~~~~vkl~DFG~a~~~~~  266 (399)
                      ||+++++|.+++...   ...+++..++.++.|++.||.|||++||+||||||+||++   +.++.+||+|||+++....
T Consensus       100 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~dikp~NIl~~~~~~~~~~kl~Dfg~a~~~~~  179 (285)
T 3is5_A          100 ETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQHVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKS  179 (285)
T ss_dssp             CCCSCCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEESSSSTTCCEEECCCCCCCC---
T ss_pred             EeCCCCcHHHHHHhhhhcccCCCHHHHHHHHHHHHHHHHHHHhCCEEECCCCHHHEEEecCCCCCCEEEEeeecceecCC
Confidence            999999999998543   4679999999999999999999999999999999999999   4568899999999987665


Q ss_pred             CCccccCCCCcccccccccCCCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhccCCCC-CCCCCcHHHHHH
Q 015868          267 SGVMTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKSLRPT-IPKHAHPRLAEL  345 (399)
Q Consensus       267 ~~~~~~~~gt~~y~aPE~l~~~~~~~~~Dv~slG~vl~elltg~~P~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~l~~l  345 (399)
                      ........||+.|+|||.+. ..++.++||||||+++|+|++|+.||.+.+..+............. ....+++++.++
T Consensus       180 ~~~~~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  258 (285)
T 3is5_A          180 DEHSTNAAGTALYMAPEVFK-RDVTFKCDIWSAGVVMYFLLTGCLPFTGTSLEEVQQKATYKEPNYAVECRPLTPQAVDL  258 (285)
T ss_dssp             -------CTTGGGCCHHHHT-TCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCC--CCCCHHHHHH
T ss_pred             cccCcCcccccCcCChHHhc-cCCCcccCeehHHHHHHHHHhCCCCCCCCCHHHHHhhhccCCcccccccCcCCHHHHHH
Confidence            55556677999999999986 4689999999999999999999999999887766554443322222 223478999999


Q ss_pred             HHHHhhhcCCCCCCHHHHHH
Q 015868          346 LERCWQHDPTQRPNFSQITD  365 (399)
Q Consensus       346 l~~cl~~dP~~Rps~~ell~  365 (399)
                      +.+||+.||.+|||+.|+++
T Consensus       259 i~~~L~~dP~~Rps~~e~l~  278 (285)
T 3is5_A          259 LKQMLTKDPERRPSAAQVLH  278 (285)
T ss_dssp             HHHHTCSCTTTSCCHHHHHT
T ss_pred             HHHHccCChhhCcCHHHHhc
Confidence            99999999999999999975

>3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens}

Probab=100.00  E-value=4.4e-46  Score=355.04  Aligned_cols=253  Identities=23%  Similarity=0.391  Sum_probs=208.8

Q ss_pred             eecccccceeceeceeCceEEEEEEE--CCeeEEEEEecCCCC---CHHHHHHHHHHHHHHHhc---CCCceeeEEeEEe
Q 015868          112 EIDAKQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECV---NTEMLKEFSQEVYIMRKI---RHKNVVQFIGACT  183 (399)
Q Consensus       112 ~i~~~~~~i~~~lg~G~~g~Vy~~~~--~~~~vAvK~~~~~~~---~~~~~~~~~~Ei~~l~~l---~h~nIv~~~~~~~  183 (399)
                      .+..++|++.++||+|+||.||+|++  +++.||+|+++....   .......+.+|+.+++.+   +||||+++++++.
T Consensus         5 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv~~~~~~~   84 (308)
T 3g33_A            5 SMATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMDVCA   84 (308)
T ss_dssp             -----CCEEEEEECCSSSCCEEEEECTTTCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBCCEEEEEE
T ss_pred             cccccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeEEeeeeee
Confidence            34467999999999999999999995  678999999874321   111123556677777766   4999999999997


Q ss_pred             cCC-----cEEEEEecCCCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceeecCCCcEEEee
Q 015868          184 RPP-----NLCIVTEFMARGSIYDFLHKQK-GVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVAD  257 (399)
Q Consensus       184 ~~~-----~~~lV~E~~~ggsL~~~l~~~~-~~l~~~~~~~i~~~i~~~L~~LH~~giiHrDlkp~NILl~~~~~vkl~D  257 (399)
                      ...     .+++||||+.+ +|.+++.... ..+++..++.++.||+.||+|||++||+||||||+||+++.++.+||+|
T Consensus        85 ~~~~~~~~~~~lv~e~~~~-~L~~~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nil~~~~~~~kl~D  163 (308)
T 3g33_A           85 TSRTDREIKVTLVFEHVDQ-DLRTYLDKAPPPGLPAETIKDLMRQFLRGLDFLHANCIVHRDLKPENILVTSGGTVKLAD  163 (308)
T ss_dssp             ECCSSSEEEEEEEEECCCC-BHHHHHHTCCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCTTTEEECTTSCEEECS
T ss_pred             ccCCCCceeEEEEehhhhc-CHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEcCCCCEEEee
Confidence            765     48999999975 9999997754 3499999999999999999999999999999999999999999999999


Q ss_pred             ccceeeccCCCccccCCCCcccccccccCCCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhccCCCC----
Q 015868          258 FGVARVQAQSGVMTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKSLRPT----  333 (399)
Q Consensus       258 FG~a~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~Dv~slG~vl~elltg~~P~~~~~~~~~~~~~~~~~~~~~----  333 (399)
                      ||+++............||+.|+|||++.+..++.++||||||+++|+|++|..||.+.+..+....+......+.    
T Consensus       164 fg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~  243 (308)
T 3g33_A          164 FGLARIYSYQMALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDW  243 (308)
T ss_dssp             CSCTTTSTTCCCSGGGGCCCSSCCHHHHHTSCCCSTHHHHHHHHHHHHTTTSSCSCCCSSHHHHHHHHHHHHCCCCTTTS
T ss_pred             CccccccCCCcccCCccccccccCchHHcCCCCCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhc
Confidence            9999876655555667899999999999999999999999999999999999999999888776665543211110    


Q ss_pred             ---------------------CCCCCcHHHHHHHHHHhhhcCCCCCCHHHHHH
Q 015868          334 ---------------------IPKHAHPRLAELLERCWQHDPTQRPNFSQITD  365 (399)
Q Consensus       334 ---------------------~~~~~~~~l~~ll~~cl~~dP~~Rps~~ell~  365 (399)
                                           ..+.+++++.+||.+||+.||.+|||+.|+++
T Consensus       244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~  296 (308)
T 3g33_A          244 PRDVSLPRGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQ  296 (308)
T ss_dssp             CSSCSSCGGGSCCCCCCCHHHHSCSCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             cchhhccccccCCCCCCcHHHhCccccHHHHHHHHHHhcCCCccCCCHHHHhc
Confidence                                 12357899999999999999999999999875

>3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A*

Probab=100.00  E-value=3.8e-46  Score=378.14  Aligned_cols=249  Identities=27%  Similarity=0.493  Sum_probs=215.7

Q ss_pred             ccccceeceeceeCceEEEEEEE--CCeeEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCceeeEEeEEecCCcEEEEE
Q 015868          115 AKQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVT  192 (399)
Q Consensus       115 ~~~~~i~~~lg~G~~g~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~nIv~~~~~~~~~~~~~lV~  192 (399)
                      .++|++.++||+|+||.||+|++  +++.||||+++...........+.+|+.++++++||||+++++++.....+++||
T Consensus        21 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~  100 (486)
T 3mwu_A           21 AERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIVG  100 (486)
T ss_dssp             HHHEEEEEEEECCSSSEEEEEEETTTCCEEEEEEEEHHHHBCSCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             hcceEEeEEEeecCCEEEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHHHhCCCCCcCeEEEEEEcCCEEEEEE
Confidence            46899999999999999999998  4789999998643212223467889999999999999999999999999999999


Q ss_pred             ecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceeec---CCCcEEEeeccceeeccCCCc
Q 015868          193 EFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMD---ENGVVKVADFGVARVQAQSGV  269 (399)
Q Consensus       193 E~~~ggsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~giiHrDlkp~NILl~---~~~~vkl~DFG~a~~~~~~~~  269 (399)
                      ||+.|++|.+.+... ..+++..++.++.||+.||.|||++||+||||||+|||++   .++.+||+|||+++.......
T Consensus       101 e~~~~~~L~~~~~~~-~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~~~~~  179 (486)
T 3mwu_A          101 ELYTGGELFDEIIKR-KRFSEHDAARIIKQVFSGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTK  179 (486)
T ss_dssp             CCCCSCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEESSSSTTCCEEECSCSCTTTBCCC--
T ss_pred             EcCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCchHHEEEecCCCCCCEEEEECCcCeECCCCCc
Confidence            999999999998764 5799999999999999999999999999999999999995   456799999999987666555


Q ss_pred             cccCCCCcccccccccCCCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhccCCCCCC--CCCcHHHHHHHH
Q 015868          270 MTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKSLRPTIP--KHAHPRLAELLE  347 (399)
Q Consensus       270 ~~~~~gt~~y~aPE~l~~~~~~~~~Dv~slG~vl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~l~~ll~  347 (399)
                      .....||+.|+|||++.+ .|+.++|||||||++|+|++|..||.+.+..+....+.........|  ..+++++.+||.
T Consensus       180 ~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~  258 (486)
T 3mwu_A          180 MKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGKYAFDLPQWRTISDDAKDLIR  258 (486)
T ss_dssp             --CCTTGGGGCCGGGGGS-CCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCSCSGGGGGSCHHHHHHHH
T ss_pred             cCCCcCCCCCCCHHHhCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCCcccCCCCHHHHHHHH
Confidence            666789999999999986 49999999999999999999999999998887776666554443333  468999999999


Q ss_pred             HHhhhcCCCCCCHHHHHH
Q 015868          348 RCWQHDPTQRPNFSQITD  365 (399)
Q Consensus       348 ~cl~~dP~~Rps~~ell~  365 (399)
                      +||+.||.+|||+.|+++
T Consensus       259 ~~L~~dp~~R~t~~~~l~  276 (486)
T 3mwu_A          259 KMLTFHPSLRITATQCLE  276 (486)
T ss_dssp             HHTCSSTTTSCCHHHHHH
T ss_pred             HHcCCChhhCcCHHHHhc
Confidence            999999999999999986

>3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=1.9e-46  Score=368.10  Aligned_cols=258  Identities=29%  Similarity=0.543  Sum_probs=214.1

Q ss_pred             cccceeceeceeCceEEEEEEEC-----CeeEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCceeeEEeEEec-CCcEE
Q 015868          116 KQLKIECKVASGSYGDLYKGTYC-----SQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTR-PPNLC  189 (399)
Q Consensus       116 ~~~~i~~~lg~G~~g~Vy~~~~~-----~~~vAvK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~nIv~~~~~~~~-~~~~~  189 (399)
                      ..|++.+.||+|+||.||+|++.     ...||+|.++... .....+.+.+|+.++++++||||+++++++.. .+..+
T Consensus        89 ~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~  167 (373)
T 3c1x_A           89 LIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRIT-DIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPL  167 (373)
T ss_dssp             EEEEEEEEEECCSSSEEEEEEEEETTTEEEEEEEEECCSCS-CSHHHHHHHHHHTTSTTCCCTTBCCCCEEECCCSSCCE
T ss_pred             ceeecCcEeeeCCCeEEEEEEEECCCCcEEEEEEEEcCCCC-CHHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCCCeE
Confidence            45788999999999999999862     2358999987543 44556889999999999999999999998754 45789


Q ss_pred             EEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceeecCCCcEEEeeccceeeccCCC-
Q 015868          190 IVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSG-  268 (399)
Q Consensus       190 lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~giiHrDlkp~NILl~~~~~vkl~DFG~a~~~~~~~-  268 (399)
                      +||||+++|+|.+++......+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++...... 
T Consensus       168 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~~~~~  247 (373)
T 3c1x_A          168 VVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEF  247 (373)
T ss_dssp             EEEECCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCC-----------
T ss_pred             EEEECCCCCCHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHHCCEecCccchheEEECCCCCEEEeecccccccccccc
Confidence            9999999999999998777788999999999999999999999999999999999999999999999999998543322 


Q ss_pred             ----ccccCCCCcccccccccCCCCCCChhhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHHhccCCCCCCCCCcHHHH
Q 015868          269 ----VMTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLT-GELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRLA  343 (399)
Q Consensus       269 ----~~~~~~gt~~y~aPE~l~~~~~~~~~Dv~slG~vl~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~  343 (399)
                          ......+|+.|+|||.+.+..++.++||||||+++|+|+| |.+||...+..+.... +....++..|..+++++.
T Consensus       248 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt~~~~p~~~~~~~~~~~~-~~~~~~~~~p~~~~~~l~  326 (373)
T 3c1x_A          248 DSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVY-LLQGRRLLQPEYCPDPLY  326 (373)
T ss_dssp             ----------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCSSCHHHH-HHTTCCCCCCTTCCHHHH
T ss_pred             ccccccCCCCCcccccChHHhcCCCCCcHHHHHHHHHHHHHHHhCcCCCCCCCCHHHHHHH-HHcCCCCCCCCCCCHHHH
Confidence                1233456789999999999999999999999999999999 7889988766554443 344556677888999999


Q ss_pred             HHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHH
Q 015868          344 ELLERCWQHDPTQRPNFSQITDILKQMMKEVA  375 (399)
Q Consensus       344 ~ll~~cl~~dP~~Rps~~ell~~L~~l~~~~~  375 (399)
                      +++.+||+.||++|||+.++++.|++++....
T Consensus       327 ~li~~cl~~dp~~RPs~~ell~~L~~i~~~~~  358 (373)
T 3c1x_A          327 EVMLKCWHPKAEMRPSFSELVSRISAIFSTFI  358 (373)
T ss_dssp             HHHHHHTCSSGGGSCCHHHHHHHHHHHHHTCC
T ss_pred             HHHHHHcCCChhhCcCHHHHHHHHHHHHHhcc
Confidence            99999999999999999999999999987554

>2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens}

Probab=100.00  E-value=8.5e-46  Score=367.76  Aligned_cols=254  Identities=17%  Similarity=0.301  Sum_probs=216.1

Q ss_pred             eeecccccceeceeceeCceEEEEEEE--CCeeEEEEEecCCCC-CHHHHHHHHHHHHHHHhcCCCceeeEEeEEecCCc
Q 015868          111 WEIDAKQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECV-NTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPN  187 (399)
Q Consensus       111 ~~i~~~~~~i~~~lg~G~~g~Vy~~~~--~~~~vAvK~~~~~~~-~~~~~~~~~~Ei~~l~~l~h~nIv~~~~~~~~~~~  187 (399)
                      ..+..++|++.+.||+|+||.||+++.  +++.||+|+++.... .......+.+|..++..++||||+++++++.+...
T Consensus        56 ~~~~~~~f~~~~~lG~G~fG~V~~~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~~~~  135 (412)
T 2vd5_A           56 VRLQRDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLHFAFQDENY  135 (412)
T ss_dssp             HSCCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHGGGCCHHHHHHHHHHSCTTTBCCEEEEEECSSE
T ss_pred             ccCChhhEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCE
Confidence            345678999999999999999999998  588999999974211 11122358899999999999999999999999999


Q ss_pred             EEEEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceeecCCCcEEEeeccceeeccCC
Q 015868          188 LCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQS  267 (399)
Q Consensus       188 ~~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~giiHrDlkp~NILl~~~~~vkl~DFG~a~~~~~~  267 (399)
                      +|+||||++||+|.+++.+....+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||+++.....
T Consensus       136 ~~lVmE~~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~aL~~LH~~giiHrDLKp~NILld~~g~vkL~DFGla~~~~~~  215 (412)
T 2vd5_A          136 LYLVMEYYVGGDLLTLLSKFGERIPAEMARFYLAEIVMAIDSVHRLGYVHRDIKPDNILLDRCGHIRLADFGSCLKLRAD  215 (412)
T ss_dssp             EEEEECCCCSCBHHHHHHHHSSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECCTT
T ss_pred             EEEEEcCCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecccCHHHeeecCCCCEEEeechhheeccCC
Confidence            99999999999999999876668999999999999999999999999999999999999999999999999999876554


Q ss_pred             Cc--cccCCCCcccccccccC-------CCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcc---CCCCCC
Q 015868          268 GV--MTAETGTYRWMAPEVIE-------HKPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKS---LRPTIP  335 (399)
Q Consensus       268 ~~--~~~~~gt~~y~aPE~l~-------~~~~~~~~Dv~slG~vl~elltg~~P~~~~~~~~~~~~~~~~~---~~~~~~  335 (399)
                      ..  .....||+.|+|||++.       +..|+.++|+|||||++|||++|+.||.+.+..+....+....   ..|..+
T Consensus       216 ~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~  295 (412)
T 2vd5_A          216 GTVRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADSTAETYGKIVHYKEHLSLPLVD  295 (412)
T ss_dssp             SCEECSSCCSCGGGCCHHHHHHHHTCTTCSEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHHHHCCCC---
T ss_pred             CccccceeccccCcCCHHHHhhcccCcCCCCCChHHhhhHHhHHHHHHHhCCCCCCCCCHHHHHHHHHhcccCcCCCccc
Confidence            33  23457999999999997       4578999999999999999999999999988877766665432   234445


Q ss_pred             CCCcHHHHHHHHHHhhhcCCCC---CCHHHHHH
Q 015868          336 KHAHPRLAELLERCWQHDPTQR---PNFSQITD  365 (399)
Q Consensus       336 ~~~~~~l~~ll~~cl~~dP~~R---ps~~ell~  365 (399)
                      ..+++++.+||.+||+ +|.+|   |+++|+++
T Consensus       296 ~~~s~~~~dli~~lL~-~p~~Rlgr~~~~ei~~  327 (412)
T 2vd5_A          296 EGVPEEARDFIQRLLC-PPETRLGRGGAGDFRT  327 (412)
T ss_dssp             -CCCHHHHHHHHTTSS-CGGGCTTTTTHHHHHT
T ss_pred             cCCCHHHHHHHHHHcC-ChhhcCCCCCHHHHhc
Confidence            6799999999999999 99998   58888864

>3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A*

Probab=100.00  E-value=5.4e-46  Score=376.70  Aligned_cols=251  Identities=26%  Similarity=0.437  Sum_probs=222.0

Q ss_pred             ecccccceeceeceeCceEEEEEEE--CCeeEEEEEecCCCCC-HHHHHHHHHHHHHHHhcCCCceeeEEeEEecCCcEE
Q 015868          113 IDAKQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVN-TEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLC  189 (399)
Q Consensus       113 i~~~~~~i~~~lg~G~~g~Vy~~~~--~~~~vAvK~~~~~~~~-~~~~~~~~~Ei~~l~~l~h~nIv~~~~~~~~~~~~~  189 (399)
                      +-.++|++.+.||+|+||.||+|+.  +++.||||++...... ......+.+|+.++++++||||+++++++.....++
T Consensus        23 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~  102 (484)
T 3nyv_A           23 IFSDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGYFY  102 (484)
T ss_dssp             CHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCBSSCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEE
T ss_pred             cccCceEEeeEEecCCCEEEEEEEECCCCCEEEEEEEEhhhcccchHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEE
Confidence            3457899999999999999999988  5789999999754332 334577899999999999999999999999999999


Q ss_pred             EEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceee---cCCCcEEEeeccceeeccC
Q 015868          190 IVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLM---DENGVVKVADFGVARVQAQ  266 (399)
Q Consensus       190 lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~giiHrDlkp~NILl---~~~~~vkl~DFG~a~~~~~  266 (399)
                      +||||+.|++|.+++.. ...+++..++.++.||+.||.|||++||+||||||+|||+   +.++.+||+|||+++....
T Consensus       103 lv~e~~~~~~L~~~~~~-~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~~  181 (484)
T 3nyv_A          103 LVGEVYTGGELFDEIIS-RKRFSEVDAARIIRQVLSGITYMHKNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEA  181 (484)
T ss_dssp             EEECCCCSCBHHHHHHT-CSCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSTTCCEEECCTTHHHHBCC
T ss_pred             EEEecCCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEEecCCCCCcEEEEeeeeeEEccc
Confidence            99999999999999976 4679999999999999999999999999999999999999   5678999999999987666


Q ss_pred             CCccccCCCCcccccccccCCCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhccCCCCCC--CCCcHHHHH
Q 015868          267 SGVMTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKSLRPTIP--KHAHPRLAE  344 (399)
Q Consensus       267 ~~~~~~~~gt~~y~aPE~l~~~~~~~~~Dv~slG~vl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~l~~  344 (399)
                      ........||+.|+|||++.+ .|+.++||||||+++|+|++|..||.+.+..+....+.........|  ..+++++.+
T Consensus       182 ~~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~  260 (484)
T 3nyv_A          182 SKKMKDKIGTAYYIAPEVLHG-TYDEKCDVWSTGVILYILLSGCPPFNGANEYDILKKVEKGKYTFELPQWKKVSESAKD  260 (484)
T ss_dssp             CCSHHHHTTGGGTCCHHHHHT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCSGGGGGSCHHHHH
T ss_pred             ccccccCCCCccccCceeecC-CCCCcceeHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCCCCCCcccccCCHHHHH
Confidence            655666789999999999976 69999999999999999999999999999888777766655444433  468999999


Q ss_pred             HHHHHhhhcCCCCCCHHHHHH
Q 015868          345 LLERCWQHDPTQRPNFSQITD  365 (399)
Q Consensus       345 ll~~cl~~dP~~Rps~~ell~  365 (399)
                      ||.+||+.||.+|||+.|+++
T Consensus       261 li~~~L~~dp~~R~s~~e~l~  281 (484)
T 3nyv_A          261 LIRKMLTYVPSMRISARDALD  281 (484)
T ss_dssp             HHHHHTCSSGGGSCCHHHHHT
T ss_pred             HHHHHCCCChhHCcCHHHHhh
Confidence            999999999999999999986

>3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A*

Probab=100.00  E-value=9.7e-46  Score=356.51  Aligned_cols=250  Identities=22%  Similarity=0.365  Sum_probs=203.3

Q ss_pred             cccccceeceeceeCceEEEEEEE--CCeeEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCceeeEEeEEecCCcEEEE
Q 015868          114 DAKQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIV  191 (399)
Q Consensus       114 ~~~~~~i~~~lg~G~~g~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~nIv~~~~~~~~~~~~~lV  191 (399)
                      ..++|++.++||+|+||.||+|.+  .++.||||+++...........+.+|+.++++++||||+++++++..+..+++|
T Consensus        32 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv  111 (329)
T 3gbz_A           32 SIDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHRNIIELKSVIHHNHRLHLI  111 (329)
T ss_dssp             CGGGEEEEEEEEECSSSEEEEEEETTTTEEEEEEECCCCC--------CHHHHHHGGGCCCTTBCCEEEEEEETTEEEEE
T ss_pred             chhhEEEEEEEEecCCeEEEEEEECCCCceEEEEEEcccccccccchhHHHHHHHHHHcCCCCcceEEEEEecCCEEEEE
Confidence            356899999999999999999986  578999999987655555667888999999999999999999999999999999


Q ss_pred             EecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceeec-----CCCcEEEeeccceeeccC
Q 015868          192 TEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMD-----ENGVVKVADFGVARVQAQ  266 (399)
Q Consensus       192 ~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~giiHrDlkp~NILl~-----~~~~vkl~DFG~a~~~~~  266 (399)
                      |||++| +|.+++.. ...+++..++.++.||+.||.|||++||+||||||+|||++     .++.+||+|||+++....
T Consensus       112 ~e~~~~-~L~~~~~~-~~~~~~~~~~~i~~ql~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~~kl~Dfg~a~~~~~  189 (329)
T 3gbz_A          112 FEYAEN-DLKKYMDK-NPDVSMRVIKSFLYQLINGVNFCHSRRCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAFGI  189 (329)
T ss_dssp             EECCSE-EHHHHHHH-CTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEC-----CCEEEECCTTHHHHHC-
T ss_pred             EecCCC-CHHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHhCCEECCCCCHHHEEEecCCCCccceEEECcCCCccccCC
Confidence            999986 99999976 45699999999999999999999999999999999999994     555699999999976543


Q ss_pred             C-CccccCCCCcccccccccCCC-CCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhccCCCCC----------
Q 015868          267 S-GVMTAETGTYRWMAPEVIEHK-PYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKSLRPTI----------  334 (399)
Q Consensus       267 ~-~~~~~~~gt~~y~aPE~l~~~-~~~~~~Dv~slG~vl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~----------  334 (399)
                      . .......||+.|+|||++.+. .++.++||||||+++|+|++|..||.+.+..+...........+..          
T Consensus       190 ~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  269 (329)
T 3gbz_A          190 PIRQFTHEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDSEIDQLFKIFEVLGLPDDTTWPGVTALP  269 (329)
T ss_dssp             ----------CCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSTTGGGST
T ss_pred             cccccCCCcCCccccCHHHhcCCCCCCcHHHHHHHHHHHHHHHHCCCCcCCCCHHHHHHHHHHHhCCCchhhhhhhhhhh
Confidence            3 234455789999999999874 5899999999999999999999999998887766655432211110          


Q ss_pred             ------------------CCCCcHHHHHHHHHHhhhcCCCCCCHHHHHH
Q 015868          335 ------------------PKHAHPRLAELLERCWQHDPTQRPNFSQITD  365 (399)
Q Consensus       335 ------------------~~~~~~~l~~ll~~cl~~dP~~Rps~~ell~  365 (399)
                                        +..+++++.+||.+||+.||.+|||+.|+++
T Consensus       270 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~  318 (329)
T 3gbz_A          270 DWKQSFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRISAKNALE  318 (329)
T ss_dssp             TCCTTCCCCCCCCHHHHHGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             hhhhhhhhhccccHhhhcccccCHHHHHHHHHHccCChhhCCCHHHHhC
Confidence                              1126789999999999999999999999875

>3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ...

Probab=100.00  E-value=1.1e-45  Score=347.09  Aligned_cols=251  Identities=25%  Similarity=0.462  Sum_probs=215.1

Q ss_pred             eecccccceeceeceeCceEEEEEEEC--CeeEEEEEecCCCCC-HHHHHHHHHHHHHHHhcCCCceeeEEeEEecCCcE
Q 015868          112 EIDAKQLKIECKVASGSYGDLYKGTYC--SQEVAIKVLKPECVN-TEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNL  188 (399)
Q Consensus       112 ~i~~~~~~i~~~lg~G~~g~Vy~~~~~--~~~vAvK~~~~~~~~-~~~~~~~~~Ei~~l~~l~h~nIv~~~~~~~~~~~~  188 (399)
                      +...++|++.+.||+|+||.||+|.+.  ++.||+|++...... ......+.+|+.++++++||||+++++++......
T Consensus         5 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~   84 (279)
T 3fdn_A            5 QWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRV   84 (279)
T ss_dssp             CCCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEE
T ss_pred             eeecccEEEeeEEecCCCeEEEEEEEccCCcEEEEEEEeccccchhhHHHHHHHHHHHHHcCCCCCCcchhheEecCCEE
Confidence            345679999999999999999999884  568999998643211 11245688999999999999999999999999999


Q ss_pred             EEEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceeecCCCcEEEeeccceeeccCCC
Q 015868          189 CIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSG  268 (399)
Q Consensus       189 ~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~giiHrDlkp~NILl~~~~~vkl~DFG~a~~~~~~~  268 (399)
                      ++||||+++++|.+++... ..+++..++.++.|++.||.|||++||+||||||+||+++.++.+||+|||++...... 
T Consensus        85 ~lv~e~~~~~~l~~~l~~~-~~~~~~~~~~~~~qi~~~l~~LH~~~i~H~dlkp~Nili~~~~~~~l~Dfg~~~~~~~~-  162 (279)
T 3fdn_A           85 YLILEYAPLGTVYRELQKL-SKFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSS-  162 (279)
T ss_dssp             EEEECCCTTEEHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHTTTCEECCCCGGGEEECTTSCEEECSCCEESCC----
T ss_pred             EEEEecCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCEecccCChHhEEEcCCCCEEEEeccccccCCcc-
Confidence            9999999999999999764 56899999999999999999999999999999999999999999999999998654433 


Q ss_pred             ccccCCCCcccccccccCCCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhccCCCCCCCCCcHHHHHHHHH
Q 015868          269 VMTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRLAELLER  348 (399)
Q Consensus       269 ~~~~~~gt~~y~aPE~l~~~~~~~~~Dv~slG~vl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~  348 (399)
                      ......|++.|+|||.+.+..++.++||||||+++|+|++|..||...+..+.......  .....|..+++++.+||.+
T Consensus       163 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~li~~  240 (279)
T 3fdn_A          163 RRTDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISR--VEFTFPDFVTEGARDLISR  240 (279)
T ss_dssp             -----CCCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHH--TCCCCCTTSCHHHHHHHHH
T ss_pred             cccccCCCCCccCHhHhccCCCCccchhHhHHHHHHHHHHCCCCCCCCcHHHHHHHHHh--CCCCCCCcCCHHHHHHHHH
Confidence            23455789999999999999999999999999999999999999998887766555443  3445677899999999999


Q ss_pred             HhhhcCCCCCCHHHHHHH
Q 015868          349 CWQHDPTQRPNFSQITDI  366 (399)
Q Consensus       349 cl~~dP~~Rps~~ell~~  366 (399)
                      ||+.||.+|||+.|+++.
T Consensus       241 ~l~~~p~~Rps~~e~l~h  258 (279)
T 3fdn_A          241 LLKHNPSQRPMLREVLEH  258 (279)
T ss_dssp             HCCSSGGGSCCHHHHHHC
T ss_pred             HhccChhhCCCHHHHhhC
Confidence            999999999999999874

>3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus}

Probab=100.00  E-value=5.1e-46  Score=356.86  Aligned_cols=247  Identities=23%  Similarity=0.396  Sum_probs=202.7

Q ss_pred             ccccceeceeceeCceEEEEEEE--CCeeEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCceeeEEeEEecCC------
Q 015868          115 AKQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPP------  186 (399)
Q Consensus       115 ~~~~~i~~~lg~G~~g~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~nIv~~~~~~~~~~------  186 (399)
                      .++|++.+.||+|+||.||+|++  +++.||||+++... .....+.+.+|+.++++++||||+++++++...+      
T Consensus         5 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~   83 (332)
T 3qd2_B            5 LTDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPN-RELAREKVMREVKALAKLEHPGIVRYFNAWLETPPEKWQE   83 (332)
T ss_dssp             HHHEEEEEEEECC-CSEEEEEEETTTCCEEEEEEEECCS-TTTHHHHHHHHHHHHTSCCCTTBCCEEEEEEECCSCHHHH
T ss_pred             hhcCceeeEecCCCCeEEEEEEEcCCCcEEEEEEeecCC-chhHHHHHHHHHHHHHhCCCCCEeeEEEEEEEeccchhhh
Confidence            35799999999999999999998  57899999997653 3345678999999999999999999999986543      


Q ss_pred             ---------------------------------------------------cEEEEEecCCCCCHHHHHHhcC--CCCCH
Q 015868          187 ---------------------------------------------------NLCIVTEFMARGSIYDFLHKQK--GVFQL  213 (399)
Q Consensus       187 ---------------------------------------------------~~~lV~E~~~ggsL~~~l~~~~--~~l~~  213 (399)
                                                                         ..++||||++|++|.+++....  ...+.
T Consensus        84 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~  163 (332)
T 3qd2_B           84 EMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREH  163 (332)
T ss_dssp             HHHC--------------------------------------------CCCEEEEEEECCCSSCHHHHHHTCCSGGGSCH
T ss_pred             hhhhhhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhcccCccchhh
Confidence                                                               2899999999999999997643  23456


Q ss_pred             HHHHHHHHHHHHHHHHHHHCCcccCCCCCCceeecCCCcEEEeeccceeeccCCC-------------ccccCCCCcccc
Q 015868          214 TSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSG-------------VMTAETGTYRWM  280 (399)
Q Consensus       214 ~~~~~i~~~i~~~L~~LH~~giiHrDlkp~NILl~~~~~vkl~DFG~a~~~~~~~-------------~~~~~~gt~~y~  280 (399)
                      ..++.++.||+.||.|||++||+||||||+||+++.++.+||+|||+++......             ......||+.|+
T Consensus       164 ~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~  243 (332)
T 3qd2_B          164 GVCLHIFIQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKLYM  243 (332)
T ss_dssp             HHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECSCC--------------CCCSCC-CGGGS
T ss_pred             HHHHHHHHHHHHHHHHHHhCCeeecCCCcccEEEeCCCCEEEeecCcccccccchhhccccccccccccccccCCCcCcc
Confidence            6789999999999999999999999999999999999999999999998765432             223456899999


Q ss_pred             cccccCCCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhccCCCCCCCCCcHHHHHHHHHHhhhcCCCCCCH
Q 015868          281 APEVIEHKPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRLAELLERCWQHDPTQRPNF  360 (399)
Q Consensus       281 aPE~l~~~~~~~~~Dv~slG~vl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~cl~~dP~~Rps~  360 (399)
                      |||++.+..++.++||||||+++|+|++|..|+..   .............+..+...++++.+++.+||+.||.+|||+
T Consensus       244 aPE~~~~~~~~~~~Di~slG~il~el~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~  320 (332)
T 3qd2_B          244 SPEQIHGNNYSHKVDIFSLGLILFELLYSFSTQME---RVRIITDVRNLKFPLLFTQKYPQEHMMVQDMLSPSPTERPEA  320 (332)
T ss_dssp             CHHHHHCCCCCTHHHHHHHHHHHHHHHSCCCCHHH---HHHHHHHHHTTCCCHHHHHHCHHHHHHHHHHHCSSGGGSCCH
T ss_pred             ChHHhcCCCCcchhhHHHHHHHHHHHHHcCCChhH---HHHHHHHhhccCCCcccccCChhHHHHHHHHccCCCCcCCCH
Confidence            99999999999999999999999999998766422   112222223333333334567889999999999999999999


Q ss_pred             HHHHH
Q 015868          361 SQITD  365 (399)
Q Consensus       361 ~ell~  365 (399)
                      .|+++
T Consensus       321 ~~~l~  325 (332)
T 3qd2_B          321 TDIIE  325 (332)
T ss_dssp             HHHHH
T ss_pred             HHHhh
Confidence            99975

>2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A*

Probab=100.00  E-value=6.5e-46  Score=348.27  Aligned_cols=252  Identities=24%  Similarity=0.404  Sum_probs=218.7

Q ss_pred             ccccceeceeceeCceEEEEEEE--CCeeEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCceeeEEeEEe--cCCcEEE
Q 015868          115 AKQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACT--RPPNLCI  190 (399)
Q Consensus       115 ~~~~~i~~~lg~G~~g~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~nIv~~~~~~~--~~~~~~l  190 (399)
                      .++|++.+.||+|+||.||+++.  .++.||+|++..........+.+.+|+.++++++||||+++++++.  .....++
T Consensus         5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~l   84 (279)
T 2w5a_A            5 AEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYI   84 (279)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEEGGGTEEEE
T ss_pred             hhheeeehhccCCCCcEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhcCCCCCCeEEEEEecCCCceEEE
Confidence            46899999999999999999998  5789999999877667777889999999999999999999999874  4567999


Q ss_pred             EEecCCCCCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHCC-----cccCCCCCCceeecCCCcEEEeecccee
Q 015868          191 VTEFMARGSIYDFLHKQ---KGVFQLTSLLKVAIDVSKGMNYLHQNN-----IIHRDLKTANLLMDENGVVKVADFGVAR  262 (399)
Q Consensus       191 V~E~~~ggsL~~~l~~~---~~~l~~~~~~~i~~~i~~~L~~LH~~g-----iiHrDlkp~NILl~~~~~vkl~DFG~a~  262 (399)
                      ||||+++++|.+++...   ...+++..++.++.|++.||.|||++|     |+||||||+||+++.++.+||+|||.++
T Consensus        85 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~ivH~dl~p~NIl~~~~~~~kl~dfg~~~  164 (279)
T 2w5a_A           85 VMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLAR  164 (279)
T ss_dssp             EEECCTTEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHC------CCCCCSGGGEEECSSSCEEECCCCHHH
T ss_pred             EEeCCCCCCHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcccCCCCeeEEeccchhhEEEcCCCCEEEecCchhe
Confidence            99999999999999753   345899999999999999999999999     9999999999999999999999999997


Q ss_pred             eccCCCc-cccCCCCcccccccccCCCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhccCCCCCCCCCcHH
Q 015868          263 VQAQSGV-MTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPR  341 (399)
Q Consensus       263 ~~~~~~~-~~~~~gt~~y~aPE~l~~~~~~~~~Dv~slG~vl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  341 (399)
                      ....... .....|++.|+|||.+.+..++.++||||||+++|+|++|..||...+..+.... +.....+.++..++++
T Consensus       165 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~-i~~~~~~~~~~~~~~~  243 (279)
T 2w5a_A          165 ILNHDTSFAKTFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGK-IREGKFRRIPYRYSDE  243 (279)
T ss_dssp             HC---CHHHHHHHSCCTTCCHHHHHCC-CCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHH-HHHTCCCCCCTTSCHH
T ss_pred             eeccccccccccCCCccccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCcccCHHHHHHH-HhhcccccCCcccCHH
Confidence            6543321 2334689999999999999999999999999999999999999998887665444 4445566788889999


Q ss_pred             HHHHHHHHhhhcCCCCCCHHHHHHHH
Q 015868          342 LAELLERCWQHDPTQRPNFSQITDIL  367 (399)
Q Consensus       342 l~~ll~~cl~~dP~~Rps~~ell~~L  367 (399)
                      +.+++.+||+.||.+|||+.|+++.+
T Consensus       244 l~~li~~~l~~~p~~Rps~~~ll~~~  269 (279)
T 2w5a_A          244 LNEIITRMLNLKDYHRPSVEEILENP  269 (279)
T ss_dssp             HHHHHHHHTCSSGGGSCCHHHHHTST
T ss_pred             HHHHHHHHcCCCcccCCCHHHHHhCh
Confidence            99999999999999999999998743

>3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A

Probab=100.00  E-value=3.2e-45  Score=346.25  Aligned_cols=257  Identities=25%  Similarity=0.383  Sum_probs=214.2

Q ss_pred             ccccceeceeceeCceEEEEEEE--CCeeEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCceeeEEeEE-ecCCcEEEE
Q 015868          115 AKQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGAC-TRPPNLCIV  191 (399)
Q Consensus       115 ~~~~~i~~~lg~G~~g~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~nIv~~~~~~-~~~~~~~lV  191 (399)
                      .++|++.+.||+|+||.||+|++  .++.||+|++......    ..+.+|+.+++.++|++++..+..+ ......++|
T Consensus         8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~----~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv   83 (296)
T 3uzp_A            8 GNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH----PQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMV   83 (296)
T ss_dssp             TTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEESCSSC----CHHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEE
T ss_pred             ccEEEEEEEEccCCCeEEEEEEEcCCCcEEEEEEecCCcch----hHHHHHHHHHHHhhcCCCCCccccccCCCCceEEE
Confidence            46899999999999999999996  6899999998765322    3578899999999988766555555 666778999


Q ss_pred             EecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceee---cCCCcEEEeeccceeeccCCC
Q 015868          192 TEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLM---DENGVVKVADFGVARVQAQSG  268 (399)
Q Consensus       192 ~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~giiHrDlkp~NILl---~~~~~vkl~DFG~a~~~~~~~  268 (399)
                      |||+ +++|.+++......+++..++.++.|++.||.|||++||+||||||+||++   +.++.+||+|||.++......
T Consensus        84 ~e~~-~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~~~~~~  162 (296)
T 3uzp_A           84 MELL-GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDAR  162 (296)
T ss_dssp             EECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECCGGGTTCEEECCCTTCEECBCTT
T ss_pred             EEec-CCCHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHeEEecCCCCCeEEEeeCCCcccccccc
Confidence            9999 889999998777789999999999999999999999999999999999999   488999999999998755432


Q ss_pred             c--------cccCCCCcccccccccCCCCCCChhhHHHHHHHHHHHHcCCCCCCCCCH---HHHHHHHHhccCC---CCC
Q 015868          269 V--------MTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPYAGLTP---LQAAVGVVQKSLR---PTI  334 (399)
Q Consensus       269 ~--------~~~~~gt~~y~aPE~l~~~~~~~~~Dv~slG~vl~elltg~~P~~~~~~---~~~~~~~~~~~~~---~~~  334 (399)
                      .        .....||+.|+|||.+.+..++.++||||||+++|+|++|+.||.....   .+...........   +..
T Consensus       163 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  242 (296)
T 3uzp_A          163 THQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEVL  242 (296)
T ss_dssp             TCCBCCCCCSCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHHSCHHHH
T ss_pred             cccccccccccccccccccCChhhhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCcCchhhhhhhhhhcccccCCchHHH
Confidence            2        2345789999999999999999999999999999999999999987432   1222222211111   123


Q ss_pred             CCCCcHHHHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHh
Q 015868          335 PKHAHPRLAELLERCWQHDPTQRPNFSQITDILKQMMKEVAS  376 (399)
Q Consensus       335 ~~~~~~~l~~ll~~cl~~dP~~Rps~~ell~~L~~l~~~~~~  376 (399)
                      +..+++++.+++.+||+.||.+|||+.++++.|+++......
T Consensus       243 ~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~~~~~~~  284 (296)
T 3uzp_A          243 CKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGF  284 (296)
T ss_dssp             TTTSCHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHHHHHTTC
T ss_pred             HhhCCHHHHHHHHHHHhcCcCcCCCHHHHHHHHHHHHHhcCC
Confidence            467889999999999999999999999999999999876543

>2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens}

Probab=100.00  E-value=4e-46  Score=356.28  Aligned_cols=262  Identities=21%  Similarity=0.343  Sum_probs=216.2

Q ss_pred             CCceeecccccceeceeceeCceEEEEEEE--CCeeEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCceeeEEeEEe--
Q 015868          108 TDVWEIDAKQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACT--  183 (399)
Q Consensus       108 ~~~~~i~~~~~~i~~~lg~G~~g~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~nIv~~~~~~~--  183 (399)
                      ...+.++.++|++.+.||+|+||.||+++.  .++.||+|++...  .....+.+.+|+.+++.++||||+++++++.  
T Consensus        21 g~~~~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~   98 (317)
T 2buj_A           21 GHMVIIDNKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCH--EQQDREEAQREADMHRLFNHPNILRLVAYCLRE   98 (317)
T ss_dssp             EEEEEETTEEEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEES--SHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEEE
T ss_pred             ccEEEECCeEEEEEEEecCCCCeEEEEEEecCCCcEEEEEEEecC--CHHHHHHHHHHHHHHhhcCCCCeeeEEEEEEec
Confidence            356778899999999999999999999996  6789999998754  4566788999999999999999999999986  


Q ss_pred             --cCCcEEEEEecCCCCCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceeecCCCcEEEeec
Q 015868          184 --RPPNLCIVTEFMARGSIYDFLHK---QKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADF  258 (399)
Q Consensus       184 --~~~~~~lV~E~~~ggsL~~~l~~---~~~~l~~~~~~~i~~~i~~~L~~LH~~giiHrDlkp~NILl~~~~~vkl~DF  258 (399)
                        .....++||||+.+++|.+++..   ....+++..++.++.|++.||.|||++||+||||||+||+++.++.+||+||
T Consensus        99 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~dlkp~NIl~~~~~~~kl~df  178 (317)
T 2buj_A           99 RGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHAKGYAHRDLKPTNILLGDEGQPVLMDL  178 (317)
T ss_dssp             ETTEEEEEEEEECCTTCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCEEECCC
T ss_pred             cCCCceeEEEEEeCCCCcHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEcCCCCEEEEec
Confidence              34478999999999999999976   3577999999999999999999999999999999999999999999999999


Q ss_pred             cceeeccCCCc----------cccCCCCcccccccccCCCC---CCChhhHHHHHHHHHHHHcCCCCCCCCCHH-HHHHH
Q 015868          259 GVARVQAQSGV----------MTAETGTYRWMAPEVIEHKP---YDYKADVFSFGIALWELLTGELPYAGLTPL-QAAVG  324 (399)
Q Consensus       259 G~a~~~~~~~~----------~~~~~gt~~y~aPE~l~~~~---~~~~~Dv~slG~vl~elltg~~P~~~~~~~-~~~~~  324 (399)
                      |.++.......          .....||+.|+|||.+.+..   ++.++||||||+++|+|++|+.||...... .....
T Consensus       179 g~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~  258 (317)
T 2buj_A          179 GSMNQACIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGDSVAL  258 (317)
T ss_dssp             SSCEESCEEEESHHHHHHHHHHHHHHSCGGGCCGGGSSCCSEEEECTHHHHHHHHHHHHHHHHSSCTTHHHHHTTSCHHH
T ss_pred             CcchhcccccccccccccccccccccCCcccCCHhHhccCCCcCCCchhhHHHHHHHHHHHHhCCCChhhhhcccchhhH
Confidence            99875432111          12335799999999997654   689999999999999999999999542110 01112


Q ss_pred             HHhccCCCCCCCCCcHHHHHHHHHHhhhcCCCCCCHHHHHHHHHHHH
Q 015868          325 VVQKSLRPTIPKHAHPRLAELLERCWQHDPTQRPNFSQITDILKQMM  371 (399)
Q Consensus       325 ~~~~~~~~~~~~~~~~~l~~ll~~cl~~dP~~Rps~~ell~~L~~l~  371 (399)
                      ..........+..+++++.++|.+||+.||.+|||+.++++.|+++.
T Consensus       259 ~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~~~  305 (317)
T 2buj_A          259 AVQNQLSIPQSPRHSSALWQLLNSMMTVDPHQRPHIPLLLSQLEALQ  305 (317)
T ss_dssp             HHHCC--CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTC
T ss_pred             HhhccCCCCccccCCHHHHHHHHHHhhcChhhCCCHHHHHHHhhhcC
Confidence            22333344455678999999999999999999999999999998763

>3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei}

Probab=100.00  E-value=2.1e-45  Score=374.42  Aligned_cols=249  Identities=24%  Similarity=0.424  Sum_probs=215.7

Q ss_pred             ccccceeceeceeCceEEEEEEE--CCeeEEEEEecCCCCCH-----------HHHHHHHHHHHHHHhcCCCceeeEEeE
Q 015868          115 AKQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVNT-----------EMLKEFSQEVYIMRKIRHKNVVQFIGA  181 (399)
Q Consensus       115 ~~~~~i~~~lg~G~~g~Vy~~~~--~~~~vAvK~~~~~~~~~-----------~~~~~~~~Ei~~l~~l~h~nIv~~~~~  181 (399)
                      .++|++.++||+|+||.||+|+.  +++.||+|+++......           ...+.+.+|+.++++++||||++++++
T Consensus        35 ~~~Y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~  114 (504)
T 3q5i_A           35 GESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFDV  114 (504)
T ss_dssp             GGTEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEC----------------CTHHHHHHHHHHHHTCCCTTBCCEEEE
T ss_pred             ccceEEEeEecccCCeEEEEEEECCCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCCCCCCCeEEEE
Confidence            57899999999999999999998  46889999997653221           234678999999999999999999999


Q ss_pred             EecCCcEEEEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceeecCCC---cEEEeec
Q 015868          182 CTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENG---VVKVADF  258 (399)
Q Consensus       182 ~~~~~~~~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~giiHrDlkp~NILl~~~~---~vkl~DF  258 (399)
                      +..+..+|+||||++||+|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++.++   .+||+||
T Consensus       115 ~~~~~~~~lv~e~~~gg~L~~~l~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~Df  193 (504)
T 3q5i_A          115 FEDKKYFYLVTEFYEGGELFEQIINR-HKFDECDAANIMKQILSGICYLHKHNIVHRDIKPENILLENKNSLLNIKIVDF  193 (504)
T ss_dssp             EECSSEEEEEEECCTTCBHHHHHHHH-SCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESSTTCCSSEEECCC
T ss_pred             EEcCCEEEEEEecCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCcHHHEEEecCCCCccEEEEEC
Confidence            99999999999999999999999764 6799999999999999999999999999999999999998776   6999999


Q ss_pred             cceeeccCCCccccCCCCcccccccccCCCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhccCCCCC--CC
Q 015868          259 GVARVQAQSGVMTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKSLRPTI--PK  336 (399)
Q Consensus       259 G~a~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~Dv~slG~vl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~--~~  336 (399)
                      |+++............||+.|+|||++.+ .|+.++||||||+++|+|++|..||.+.+..+....+.........  ..
T Consensus       194 g~a~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~  272 (504)
T 3q5i_A          194 GLSSFFSKDYKLRDRLGTAYYIAPEVLKK-KYNEKCDVWSCGVIMYILLCGYPPFGGQNDQDIIKKVEKGKYYFDFNDWK  272 (504)
T ss_dssp             TTCEECCTTSCBCCCCSCTTTCCHHHHTT-CBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCHHHHT
T ss_pred             CCCEEcCCCCccccccCCcCCCCHHHhcc-CCCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCccccC
Confidence            99988776666667789999999999875 5899999999999999999999999999888777666554333222  25


Q ss_pred             CCcHHHHHHHHHHhhhcCCCCCCHHHHHH
Q 015868          337 HAHPRLAELLERCWQHDPTQRPNFSQITD  365 (399)
Q Consensus       337 ~~~~~l~~ll~~cl~~dP~~Rps~~ell~  365 (399)
                      .+++++.+||.+||+.||.+|||++|+++
T Consensus       273 ~~s~~~~~li~~~L~~dp~~R~t~~e~l~  301 (504)
T 3q5i_A          273 NISDEAKELIKLMLTYDYNKRCTAEEALN  301 (504)
T ss_dssp             TSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             CCCHHHHHHHHHHcCCChhHCCCHHHHhc
Confidence            68999999999999999999999999975

>4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A

Probab=100.00  E-value=1.6e-45  Score=347.93  Aligned_cols=257  Identities=25%  Similarity=0.381  Sum_probs=211.4

Q ss_pred             ccccceeceeceeCceEEEEEEE--CCeeEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCceeeEEeEE-ecCCcEEEE
Q 015868          115 AKQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGAC-TRPPNLCIV  191 (399)
Q Consensus       115 ~~~~~i~~~lg~G~~g~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~nIv~~~~~~-~~~~~~~lV  191 (399)
                      .++|++.+.||+|+||.||+|++  .++.||+|++....    ....+.+|+.+++.++|++++..+..+ ......++|
T Consensus         8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~----~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv   83 (296)
T 4hgt_A            8 GNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKT----KHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMV   83 (296)
T ss_dssp             ---CEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEC-------CCCHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEE
T ss_pred             CCceEEeeeecCCCCeEEEEEEEcCCCceEEEEeecccc----cchHHHHHHHHHHHhcCCCCCCeeeeecCCCCceEEE
Confidence            46899999999999999999996  67899999976432    223578899999999987766666655 667778999


Q ss_pred             EecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceee---cCCCcEEEeeccceeeccCCC
Q 015868          192 TEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLM---DENGVVKVADFGVARVQAQSG  268 (399)
Q Consensus       192 ~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~giiHrDlkp~NILl---~~~~~vkl~DFG~a~~~~~~~  268 (399)
                      |||+ +++|.+++......+++..++.++.|++.||.|||++||+||||||+||++   +.++.+||+|||+++......
T Consensus        84 ~e~~-~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIl~~~~~~~~~~kL~Dfg~a~~~~~~~  162 (296)
T 4hgt_A           84 MELL-GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDAR  162 (296)
T ss_dssp             EECC-CCBHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECCGGGTTCEEECCCTTCEECBCTT
T ss_pred             EEcc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeeeeccCCCCeEEEecCccceeccCcc
Confidence            9999 889999998777789999999999999999999999999999999999999   788999999999998755432


Q ss_pred             c--------cccCCCCcccccccccCCCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHH---HHHHHHHhccCC---CCC
Q 015868          269 V--------MTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPYAGLTPL---QAAVGVVQKSLR---PTI  334 (399)
Q Consensus       269 ~--------~~~~~gt~~y~aPE~l~~~~~~~~~Dv~slG~vl~elltg~~P~~~~~~~---~~~~~~~~~~~~---~~~  334 (399)
                      .        .....||+.|+|||.+.+..++.++||||||+++|+|++|+.||.+.+..   +...........   +..
T Consensus       163 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  242 (296)
T 4hgt_A          163 THQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEVL  242 (296)
T ss_dssp             TCCBCCCCCSCCCCSCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHHSCHHHH
T ss_pred             cCccCCCCcccccCCCccccchHHhcCCCCCchhHHHHHHHHHHHHhcCCCCCcccchhhhhhhhhhhhcccccchhhhh
Confidence            2        23457899999999999999999999999999999999999999875331   222222211111   122


Q ss_pred             CCCCcHHHHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHh
Q 015868          335 PKHAHPRLAELLERCWQHDPTQRPNFSQITDILKQMMKEVAS  376 (399)
Q Consensus       335 ~~~~~~~l~~ll~~cl~~dP~~Rps~~ell~~L~~l~~~~~~  376 (399)
                      ...+++++.+++.+||+.||++|||+.++++.|++++.+...
T Consensus       243 ~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~~~~~~~~  284 (296)
T 4hgt_A          243 CKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGF  284 (296)
T ss_dssp             TTTSCHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHHHHHHTC
T ss_pred             hccCCHHHHHHHHHHHhcCCCCCCCHHHHHHHHHHHHHHhCC
Confidence            356789999999999999999999999999999999887653

>1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A

Probab=100.00  E-value=3.2e-45  Score=345.85  Aligned_cols=251  Identities=29%  Similarity=0.518  Sum_probs=215.5

Q ss_pred             eecccccceeceeceeCceEEEEEEE--CCeeEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCceeeEEeEEec----C
Q 015868          112 EIDAKQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTR----P  185 (399)
Q Consensus       112 ~i~~~~~~i~~~lg~G~~g~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~nIv~~~~~~~~----~  185 (399)
                      ..+...|++.+.||+|+||.||+|.+  ++..||+|++.....+....+.+.+|+.++++++||||+++++++..    .
T Consensus        22 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~va~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~  101 (290)
T 1t4h_A           22 SNDGRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGK  101 (290)
T ss_dssp             CTTSCEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSC
T ss_pred             ccCceeEEeeeeccCCCCeEEEEeEecCCceEEEEEEecchhhCHHHHHHHHHHHHHHHhCCCCCeeeeeeeeccccCCC
Confidence            34566799999999999999999988  46789999998776677778899999999999999999999999865    3


Q ss_pred             CcEEEEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCCCceeec-CCCcEEEeecccee
Q 015868          186 PNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNN--IIHRDLKTANLLMD-ENGVVKVADFGVAR  262 (399)
Q Consensus       186 ~~~~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~g--iiHrDlkp~NILl~-~~~~vkl~DFG~a~  262 (399)
                      ..+++||||+++++|.+++... ..+++..++.++.|++.||.|||++|  |+||||||+||+++ .++.+||+|||++.
T Consensus       102 ~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~~~i~H~dikp~Nil~~~~~~~~kl~Dfg~~~  180 (290)
T 1t4h_A          102 KCIVLVTELMTSGTLKTYLKRF-KVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLAT  180 (290)
T ss_dssp             EEEEEEEECCCSCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCSCCCGGGEEESSTTSCEEECCTTGGG
T ss_pred             ceEEEEEEecCCCCHHHHHHHc-cCCCHHHHHHHHHHHHHHHHHHHcCCCCEEECCCCHHHEEEECCCCCEEEeeCCCcc
Confidence            5589999999999999999763 66899999999999999999999999  99999999999997 78999999999997


Q ss_pred             eccCCCccccCCCCcccccccccCCCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcc-CCCCCCCCCcHH
Q 015868          263 VQAQSGVMTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKS-LRPTIPKHAHPR  341 (399)
Q Consensus       263 ~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~Dv~slG~vl~elltg~~P~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~  341 (399)
                      ..... ......||+.|+|||++.+ .++.++||||||+++|+|++|..||................ ..+..+...+++
T Consensus       181 ~~~~~-~~~~~~~t~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  258 (290)
T 1t4h_A          181 LKRAS-FAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPASFDKVAIPE  258 (290)
T ss_dssp             GCCTT-SBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTTTCCCGGGGGCCCHH
T ss_pred             ccccc-ccccccCCcCcCCHHHHhc-cCCCcchHHHHHHHHHHHHhCCCCCCCcCcHHHHHHHHhccCCccccCCCCCHH
Confidence            54433 3345578999999999875 48999999999999999999999998866555444444433 333455667899


Q ss_pred             HHHHHHHHhhhcCCCCCCHHHHHH
Q 015868          342 LAELLERCWQHDPTQRPNFSQITD  365 (399)
Q Consensus       342 l~~ll~~cl~~dP~~Rps~~ell~  365 (399)
                      +.++|.+||+.||.+|||+.++++
T Consensus       259 l~~li~~~l~~dp~~Rps~~ell~  282 (290)
T 1t4h_A          259 VKEIIEGCIRQNKDERYSIKDLLN  282 (290)
T ss_dssp             HHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             HHHHHHHHccCChhhCCCHHHHhh
Confidence            999999999999999999999875

>3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii}

Probab=100.00  E-value=3.2e-45  Score=368.50  Aligned_cols=253  Identities=24%  Similarity=0.360  Sum_probs=193.7

Q ss_pred             ceeecccccceeceeceeCceEEEEEEE--CCeeEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCceeeEEeEEecC--
Q 015868          110 VWEIDAKQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRP--  185 (399)
Q Consensus       110 ~~~i~~~~~~i~~~lg~G~~g~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~nIv~~~~~~~~~--  185 (399)
                      .|.+ .++|++.+.||+|+||.||+|.+  +++.||||++.....+....+.+.+|+.+|++++||||+++++++...  
T Consensus        48 ~~~~-~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~  126 (458)
T 3rp9_A           48 DWQI-PDRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDV  126 (458)
T ss_dssp             SCCS-CTTEEECCC-------CEEEEEECC--CEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCT
T ss_pred             cCcc-CCCeEEeeEeeecCCeEEEEEEECCCCcEEEEEEechhhcCHHHHHHHHHHHHHHHhCCCCCCCceEEEEecCCc
Confidence            3444 36899999999999999999976  578999999987666677778899999999999999999999998433  


Q ss_pred             ---CcEEEEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceeecCCCcEEEeecccee
Q 015868          186 ---PNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVAR  262 (399)
Q Consensus       186 ---~~~~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~giiHrDlkp~NILl~~~~~vkl~DFG~a~  262 (399)
                         ..+|+||||+. ++|.+++.. ...+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++
T Consensus       127 ~~~~~~~lv~e~~~-~~L~~~~~~-~~~l~~~~~~~~~~qi~~aL~~LH~~~iiHrDlKp~NILl~~~~~~kl~DFGla~  204 (458)
T 3rp9_A          127 EKFDELYVVLEIAD-SDFKKLFRT-PVYLTELHIKTLLYNLLVGVKYVHSAGILHRDLKPANCLVNQDCSVKVCDFGLAR  204 (458)
T ss_dssp             TTCCCEEEEECCCS-EEHHHHHHS-SCCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTCCEEECCCTTCB
T ss_pred             ccCceEEEEEeccc-cchhhhccc-CCCCCHHHHHHHHHHHHHHHHHHHhCCcCCCCCChhhEEECCCCCEeecccccch
Confidence               56999999985 599999865 5679999999999999999999999999999999999999999999999999998


Q ss_pred             eccCCC----------------------------ccccCCCCccccccccc-CCCCCCChhhHHHHHHHHHHHHc-----
Q 015868          263 VQAQSG----------------------------VMTAETGTYRWMAPEVI-EHKPYDYKADVFSFGIALWELLT-----  308 (399)
Q Consensus       263 ~~~~~~----------------------------~~~~~~gt~~y~aPE~l-~~~~~~~~~Dv~slG~vl~ellt-----  308 (399)
                      ......                            ..+...||+.|+|||++ .+..|+.++|||||||++|||++     
T Consensus       205 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~DiwSlG~il~elltg~~~~  284 (458)
T 3rp9_A          205 TVDYPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNMIKEN  284 (458)
T ss_dssp             CTTSCTTCCCCCC---------------------------CCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHTTSTTT
T ss_pred             hccCccccccccccCccccccccccccccccccccccCCcccccccChHHhhCCCCCCcHhHHHHHHHHHHHHHHhcccc
Confidence            654221                            23445789999999986 56679999999999999999999     


Q ss_pred             ------CCCCCCCCCHH--------------------HHHHHHHh----------------------ccCC-------CC
Q 015868          309 ------GELPYAGLTPL--------------------QAAVGVVQ----------------------KSLR-------PT  333 (399)
Q Consensus       309 ------g~~P~~~~~~~--------------------~~~~~~~~----------------------~~~~-------~~  333 (399)
                            |+++|.+.+..                    .....+..                      ....       ..
T Consensus       285 ~~~~~~~~p~f~g~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  364 (458)
T 3rp9_A          285 VAYHADRGPLFPGSSCFPLSPDQKAGNDFKFHTRGNRDQLNVIFNILGTPSEEDIEALEKEDAKRYIRIFPKREGTDLAE  364 (458)
T ss_dssp             CSSGGGCCCSCC--------------------CHHHHHHHHHHHHHHCCCCHHHHHTSSCHHHHHHHTTSCCCCCCCGGG
T ss_pred             ccccccccccCCCCccccccccccccccccccccCCHHHHHHHHHHcCCCCHHHHhhcCCHHHHHHHHhcCCCCCCCHHH
Confidence                  67777664421                    00000000                      0000       01


Q ss_pred             CCCCCcHHHHHHHHHHhhhcCCCCCCHHHHHH
Q 015868          334 IPKHAHPRLAELLERCWQHDPTQRPNFSQITD  365 (399)
Q Consensus       334 ~~~~~~~~l~~ll~~cl~~dP~~Rps~~ell~  365 (399)
                      ..+.+++++.+||.+||+.||.+|||++|+++
T Consensus       365 ~~~~~s~~~~dLl~~mL~~dP~~R~t~~e~L~  396 (458)
T 3rp9_A          365 RFPASSADAIHLLKRMLVFNPNKRITINECLA  396 (458)
T ss_dssp             GSTTSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred             HCCCCCHHHHHHHHHHhccCccccCCHHHHhc
Confidence            12456899999999999999999999999876

>3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ...

Probab=100.00  E-value=2.3e-45  Score=345.16  Aligned_cols=250  Identities=23%  Similarity=0.424  Sum_probs=213.3

Q ss_pred             ccccceeceeceeCceEEEEEEEC--CeeEEEEEecCCCCCH----HHHHHHHHHHHHHHhcCCCceeeEEeEEecCCcE
Q 015868          115 AKQLKIECKVASGSYGDLYKGTYC--SQEVAIKVLKPECVNT----EMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNL  188 (399)
Q Consensus       115 ~~~~~i~~~lg~G~~g~Vy~~~~~--~~~vAvK~~~~~~~~~----~~~~~~~~Ei~~l~~l~h~nIv~~~~~~~~~~~~  188 (399)
                      .++|++.+.||+|+||.||++++.  ++.||+|+++......    ...+.+.+|+.++++++||||+++++++......
T Consensus         4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~   83 (283)
T 3bhy_A            4 EDHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIFENKTDV   83 (283)
T ss_dssp             HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred             hhhhhhHHhhcccCceEEEEEEEcCCCCeeehHHhhhccccccccchHHHHHHHHHHHHHhCCCCCeeehhheecCCCeE
Confidence            467999999999999999999984  7899999997653221    1356789999999999999999999999999999


Q ss_pred             EEEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceeecCCC----cEEEeeccceeec
Q 015868          189 CIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENG----VVKVADFGVARVQ  264 (399)
Q Consensus       189 ~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~giiHrDlkp~NILl~~~~----~vkl~DFG~a~~~  264 (399)
                      ++||||+++++|.+++.. ...+++..++.++.|++.||.|||++||+||||||+||+++.++    .+||+|||.+...
T Consensus        84 ~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~~~~kl~dfg~~~~~  162 (283)
T 3bhy_A           84 VLILELVSGGELFDFLAE-KESLTEDEATQFLKQILDGVHYLHSKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKI  162 (283)
T ss_dssp             EEEEECCCSCBHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSSSSCCEEECCCTTCEEC
T ss_pred             EEEEeecCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCChHHEEEecCCCCCCceEEEecccceec
Confidence            999999999999999976 45789999999999999999999999999999999999998877    8999999999876


Q ss_pred             cCCCccccCCCCcccccccccCCCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhccCC--CCCCCCCcHHH
Q 015868          265 AQSGVMTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKSLR--PTIPKHAHPRL  342 (399)
Q Consensus       265 ~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~Dv~slG~vl~elltg~~P~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~l  342 (399)
                      ..........+++.|+|||.+.+..++.++||||||+++|+|++|..||.+.+..+...........  +..+..+++.+
T Consensus       163 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  242 (283)
T 3bhy_A          163 EAGNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGETKQETLTNISAVNYDFDEEYFSNTSELA  242 (283)
T ss_dssp             C--------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTCCCCCHHHHTTCCHHH
T ss_pred             cCCCcccccCCCcCccCcceecCCCCCcchhhhhHHHHHHHHHHCCCCCCCcchHHHHHHhHhcccCCcchhcccCCHHH
Confidence            6555555567899999999999999999999999999999999999999998877665544332221  12235688999


Q ss_pred             HHHHHHHhhhcCCCCCCHHHHHH
Q 015868          343 AELLERCWQHDPTQRPNFSQITD  365 (399)
Q Consensus       343 ~~ll~~cl~~dP~~Rps~~ell~  365 (399)
                      .+++.+||+.||.+|||+.++++
T Consensus       243 ~~li~~~l~~dp~~Rps~~~~l~  265 (283)
T 3bhy_A          243 KDFIRRLLVKDPKRRMTIAQSLE  265 (283)
T ss_dssp             HHHHHTTSCSSGGGSCCHHHHHH
T ss_pred             HHHHHHHccCCHhHCcCHHHHHh
Confidence            99999999999999999999987

>3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A*

Probab=100.00  E-value=1.5e-45  Score=371.83  Aligned_cols=247  Identities=24%  Similarity=0.360  Sum_probs=205.8

Q ss_pred             ccccceeceeceeCceEEEEEEE--CCeeEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCceeeEEeEEecCC------
Q 015868          115 AKQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPP------  186 (399)
Q Consensus       115 ~~~~~i~~~lg~G~~g~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~nIv~~~~~~~~~~------  186 (399)
                      .++|++.++||+|+||.||+|.+  +++.||||++.....+....+.+.+|+.+++.++||||+++++++....      
T Consensus        61 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~  140 (464)
T 3ttj_A           61 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQ  140 (464)
T ss_dssp             ETTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEESGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCC
T ss_pred             cCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEECccccChHHHHHHHHHHHHHHhCCCCCCCcEEEEEccCCccccCC
Confidence            57899999999999999999987  5789999999876556677788999999999999999999999996553      


Q ss_pred             cEEEEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceeecCCCcEEEeeccceeeccC
Q 015868          187 NLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQ  266 (399)
Q Consensus       187 ~~~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~giiHrDlkp~NILl~~~~~vkl~DFG~a~~~~~  266 (399)
                      .+|+||||+++ +|.+.+.   ..+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+++....
T Consensus       141 ~~~lv~E~~~~-~l~~~~~---~~l~~~~~~~~~~qil~aL~~lH~~~iiHrDlkp~NIll~~~~~~kl~DFG~a~~~~~  216 (464)
T 3ttj_A          141 DVYLVMELMDA-NLCQVIQ---MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGT  216 (464)
T ss_dssp             EEEEEEECCSE-EHHHHHT---SCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCCCC-----
T ss_pred             eEEEEEeCCCC-CHHHHHh---hcCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChHhEEEeCCCCEEEEEEEeeeecCC
Confidence            57999999987 5777764   3489999999999999999999999999999999999999999999999999987776


Q ss_pred             CCccccCCCCcccccccccCCCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhccCCC--------------
Q 015868          267 SGVMTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKSLRP--------------  332 (399)
Q Consensus       267 ~~~~~~~~gt~~y~aPE~l~~~~~~~~~Dv~slG~vl~elltg~~P~~~~~~~~~~~~~~~~~~~~--------------  332 (399)
                      ....+...||+.|+|||++.+..|+.++|||||||++|+|++|+.||.+.+..+....+......|              
T Consensus       217 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pF~g~~~~~~~~~i~~~lg~p~~~~~~~~~~~~~~  296 (464)
T 3ttj_A          217 SFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRN  296 (464)
T ss_dssp             CCCC----CCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHHHTTSCHHHHH
T ss_pred             CcccCCCcccccccCHHHHcCCCCCHHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHcchhhhh
Confidence            656677789999999999999999999999999999999999999999988766555443321111              


Q ss_pred             ------CC---------CC-----------CCcHHHHHHHHHHhhhcCCCCCCHHHHHH
Q 015868          333 ------TI---------PK-----------HAHPRLAELLERCWQHDPTQRPNFSQITD  365 (399)
Q Consensus       333 ------~~---------~~-----------~~~~~l~~ll~~cl~~dP~~Rps~~ell~  365 (399)
                            ..         +.           ..++++.+||.+||+.||.+|||++|+++
T Consensus       297 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~  355 (464)
T 3ttj_A          297 YVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQ  355 (464)
T ss_dssp             HHTTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred             HhhcccccCCCChHHhCcccccccccccccccCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence                  00         00           01678999999999999999999999975

>1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A*

Probab=100.00  E-value=3.9e-45  Score=343.35  Aligned_cols=244  Identities=23%  Similarity=0.367  Sum_probs=212.4

Q ss_pred             ccccceeceeceeCceEEEEEEE--CCeeEEEEEecCCCCCHHHHHHHHHHHHHHHhc-CCCceeeEEeEEecCCcEEEE
Q 015868          115 AKQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKI-RHKNVVQFIGACTRPPNLCIV  191 (399)
Q Consensus       115 ~~~~~i~~~lg~G~~g~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~Ei~~l~~l-~h~nIv~~~~~~~~~~~~~lV  191 (399)
                      .++|++.+.||+|+||.||+|.+  +++.||+|+++...........+.+|+..+..+ +||||+++++++..++..++|
T Consensus        10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~~h~~iv~~~~~~~~~~~~~lv   89 (289)
T 1x8b_A           10 TTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRYFSAWAEDDHMLIQ   89 (289)
T ss_dssp             HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCCTTSHHHHHHHHHHHHHHHSCSCTTBCCEEEEEEETTEEEEE
T ss_pred             cchhhhhhhhcCCCceEEEEEEEcCCCceEEEEEecccccccHHHHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEE
Confidence            46899999999999999999998  589999999987665666678899999999999 899999999999999999999


Q ss_pred             EecCCCCCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceeecCC------------------
Q 015868          192 TEFMARGSIYDFLHKQ---KGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDEN------------------  250 (399)
Q Consensus       192 ~E~~~ggsL~~~l~~~---~~~l~~~~~~~i~~~i~~~L~~LH~~giiHrDlkp~NILl~~~------------------  250 (399)
                      |||++|++|.+++...   ...+++..++.++.||+.||.|||++||+||||||+||+++.+                  
T Consensus        90 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dikp~NIl~~~~~~~~~~~~~~~~~~~~~~  169 (289)
T 1x8b_A           90 NEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSMSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASN  169 (289)
T ss_dssp             EECCTTCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEC--------------------
T ss_pred             EEecCCCcHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHHhCCEeecCCCHHHEEEcCCCCCcccccccccccccCC
Confidence            9999999999999764   2678999999999999999999999999999999999999844                  


Q ss_pred             -CcEEEeeccceeeccCCCccccCCCCcccccccccCCC-CCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhc
Q 015868          251 -GVVKVADFGVARVQAQSGVMTAETGTYRWMAPEVIEHK-PYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQK  328 (399)
Q Consensus       251 -~~vkl~DFG~a~~~~~~~~~~~~~gt~~y~aPE~l~~~-~~~~~~Dv~slG~vl~elltg~~P~~~~~~~~~~~~~~~~  328 (399)
                       ..+||+|||.+......   ....||+.|+|||.+.+. .++.++||||||+++|+|++|.+|+......    ..+..
T Consensus       170 ~~~~kl~Dfg~~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~~----~~~~~  242 (289)
T 1x8b_A          170 KVMFKIGDLGHVTRISSP---QVEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRNGDQW----HEIRQ  242 (289)
T ss_dssp             CCCEEECCCTTCEETTCS---CCCCCCGGGCCHHHHTTCCTTHHHHHHHHHHHHHHHHTTCCCCCSSSHHH----HHHHT
T ss_pred             ceEEEEcccccccccCCc---cccCCCccccChhHhcCCCCCCchhhHHHHHHHHHHHhcCCCCCcchhHH----HHHHc
Confidence             48999999999876543   234689999999999876 5668999999999999999998877554332    22344


Q ss_pred             cCCCCCCCCCcHHHHHHHHHHhhhcCCCCCCHHHHHH
Q 015868          329 SLRPTIPKHAHPRLAELLERCWQHDPTQRPNFSQITD  365 (399)
Q Consensus       329 ~~~~~~~~~~~~~l~~ll~~cl~~dP~~Rps~~ell~  365 (399)
                      ...+.++..+++++.+++.+||+.||++|||+.|+++
T Consensus       243 ~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~  279 (289)
T 1x8b_A          243 GRLPRIPQVLSQEFTELLKVMIHPDPERRPSAMALVK  279 (289)
T ss_dssp             TCCCCCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             CCCCCCCcccCHHHHHHHHHHhCCCcccCCCHHHHhh
Confidence            5567788899999999999999999999999999875

>2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis}

Probab=100.00  E-value=1.5e-45  Score=352.02  Aligned_cols=258  Identities=18%  Similarity=0.331  Sum_probs=211.1

Q ss_pred             ccccceeceeceeCceEEEEEEE--CCeeEEEEEecCCCC-CHHHHHHHHHHHHHHHhcCCCceeeEEeEEecCCcEEEE
Q 015868          115 AKQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECV-NTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIV  191 (399)
Q Consensus       115 ~~~~~i~~~lg~G~~g~Vy~~~~--~~~~vAvK~~~~~~~-~~~~~~~~~~Ei~~l~~l~h~nIv~~~~~~~~~~~~~lV  191 (399)
                      .++|++.+.||+|+||.||+|++  .++.||+|+++.... .....+.+.+|+.++++++||||+++++++...+..++|
T Consensus        33 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv  112 (309)
T 2h34_A           33 FGPYRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIHDFGEIDGQLYVD  112 (309)
T ss_dssp             -CCEEEEEEEEECSSSEEEEEEETTTTEEEEEEECGGGGGGSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEE
T ss_pred             eccEEEEEEEcCCCCeeEEEEEEcCCCeEEEEEecCcccccCHHHHHHHHHHHHHHhhcCCCCeeEEEEEEeeCCeEEEE
Confidence            57899999999999999999987  578999999975432 345567899999999999999999999999999999999


Q ss_pred             EecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceeecCCCcEEEeeccceeeccCCC--c
Q 015868          192 TEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSG--V  269 (399)
Q Consensus       192 ~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~giiHrDlkp~NILl~~~~~vkl~DFG~a~~~~~~~--~  269 (399)
                      |||++|++|.+++... +.+++..++.++.|++.||.|||++||+||||||+||+++.++.+||+|||++.......  .
T Consensus       113 ~e~~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~  191 (309)
T 2h34_A          113 MRLINGVDLAAMLRRQ-GPLAPPRAVAIVRQIGSALDAAHAAGATHRDVKPENILVSADDFAYLVDFGIASATTDEKLTQ  191 (309)
T ss_dssp             EECCCCEEHHHHHHHH-CSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECSCCC-----------
T ss_pred             EEecCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCcCCcCCCChHHEEEcCCCCEEEecCccCcccccccccc
Confidence            9999999999999763 578999999999999999999999999999999999999999999999999997654432  2


Q ss_pred             cccCCCCcccccccccCCCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhccCC--CCCCCCCcHHHHHHHH
Q 015868          270 MTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKSLR--PTIPKHAHPRLAELLE  347 (399)
Q Consensus       270 ~~~~~gt~~y~aPE~l~~~~~~~~~Dv~slG~vl~elltg~~P~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~l~~ll~  347 (399)
                      .....|++.|+|||.+.+..++.++||||||+++|+|++|+.||...+..... ..+.....  ...+..+++++.+++.
T Consensus       192 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~l~~li~  270 (309)
T 2h34_A          192 LGNTVGTLYYMAPERFSESHATYRADIYALTCVLYECLTGSPPYQGDQLSVMG-AHINQAIPRPSTVRPGIPVAFDAVIA  270 (309)
T ss_dssp             -----CCGGGCCGGGTCC----CCCHHHHHHHHHHHHHHSSCSSCSCHHHHHH-HHHHSCCCCGGGTSTTCCTHHHHHHH
T ss_pred             ccccCCCcCccCHHHHcCCCCCchHhHHHHHHHHHHHHHCCCCCCCchHHHHH-HHhccCCCCccccCCCCCHHHHHHHH
Confidence            23456899999999999999999999999999999999999999887655332 22322221  2345678999999999


Q ss_pred             HHhhhcCCCCC-CHHHHHHHHHHHHHHH
Q 015868          348 RCWQHDPTQRP-NFSQITDILKQMMKEV  374 (399)
Q Consensus       348 ~cl~~dP~~Rp-s~~ell~~L~~l~~~~  374 (399)
                      +||+.||++|| +++++++.|++++...
T Consensus       271 ~~l~~dP~~Rp~s~~~l~~~l~~~l~~~  298 (309)
T 2h34_A          271 RGMAKNPEDRYVTCGDLSAAAHAALATA  298 (309)
T ss_dssp             HHTCSSGGGSCSSHHHHHHHHHHTCC--
T ss_pred             HhccCCHHHHHHhHHHHHHHHHHHHHhh
Confidence            99999999999 9999999999886544

>3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens}

Probab=100.00  E-value=2.3e-45  Score=353.05  Aligned_cols=260  Identities=25%  Similarity=0.427  Sum_probs=202.8

Q ss_pred             CceeecccccceeceeceeCceEEEEEEE--CCeeEEEEEecCCCCCHHHHHHHHHHHHHHHhcC-CCceeeEEeEEe--
Q 015868          109 DVWEIDAKQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIR-HKNVVQFIGACT--  183 (399)
Q Consensus       109 ~~~~i~~~~~~i~~~lg~G~~g~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~Ei~~l~~l~-h~nIv~~~~~~~--  183 (399)
                      ..+++...+|++.+.||+|+||.||+|++  .++.||+|++...  .....+.+.+|+.+++++. ||||+++++++.  
T Consensus        21 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~   98 (337)
T 3ll6_A           21 QTVELGELRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSN--EEEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIG   98 (337)
T ss_dssp             CEEEETTEEEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEES--SHHHHHHHHHHHHHHHHHTTSTTBCCEEEEEEEC
T ss_pred             ceeeccCceEEEEEEEccCCceEEEEEEECCCCcEEEEEEecCC--chHHHHHHHHHHHHHHHhccCCChhhcccccccc
Confidence            56788889999999999999999999998  6889999998654  4566678999999999996 999999999994  


Q ss_pred             ------cCCcEEEEEecCCCCCHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCCCceeecCCCcE
Q 015868          184 ------RPPNLCIVTEFMARGSIYDFLHK--QKGVFQLTSLLKVAIDVSKGMNYLHQNN--IIHRDLKTANLLMDENGVV  253 (399)
Q Consensus       184 ------~~~~~~lV~E~~~ggsL~~~l~~--~~~~l~~~~~~~i~~~i~~~L~~LH~~g--iiHrDlkp~NILl~~~~~v  253 (399)
                            ....+++||||+. |+|.+++..  ..+.+++..++.++.||+.||.|||++|  |+||||||+|||++.++.+
T Consensus        99 ~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~Dikp~NIl~~~~~~~  177 (337)
T 3ll6_A           99 KEESDTGQAEFLLLTELCK-GQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMHRQKPPIIHRDLKVENLLLSNQGTI  177 (337)
T ss_dssp             TTTSTTSSEEEEEEEECCS-EEHHHHHHHHHTTCSCCHHHHHHHHHHHHHHHHHHHTSSSCCBCCCCCGGGCEECTTSCE
T ss_pred             ccccccCCceEEEEEEecC-CCHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEEccCCcccEEECCCCCE
Confidence                  3345899999996 599999865  3567999999999999999999999999  9999999999999999999


Q ss_pred             EEeeccceeeccCCCcc-------------ccCCCCccccccccc---CCCCCCChhhHHHHHHHHHHHHcCCCCCCCCC
Q 015868          254 KVADFGVARVQAQSGVM-------------TAETGTYRWMAPEVI---EHKPYDYKADVFSFGIALWELLTGELPYAGLT  317 (399)
Q Consensus       254 kl~DFG~a~~~~~~~~~-------------~~~~gt~~y~aPE~l---~~~~~~~~~Dv~slG~vl~elltg~~P~~~~~  317 (399)
                      ||+|||+++........             ....||+.|+|||++   .+..++.++||||||+++|+|++|+.||....
T Consensus       178 kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~  257 (337)
T 3ll6_A          178 KLCDFGSATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDGA  257 (337)
T ss_dssp             EBCCCTTCBCCSSCC-------------------------------CCTTSCSSHHHHHHHHHHHHHHHHHSSCCC----
T ss_pred             EEecCccceeccccCcccccccccccchhhccccCCCCcCChhhhhccccCCCChHHhHHHHHHHHHHHHhCCCCCcchh
Confidence            99999999865543211             134589999999998   56778999999999999999999999997755


Q ss_pred             HHHHHHHHHhccCCCCCCCCCcHHHHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHH
Q 015868          318 PLQAAVGVVQKSLRPTIPKHAHPRLAELLERCWQHDPTQRPNFSQITDILKQMMKEVA  375 (399)
Q Consensus       318 ~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~cl~~dP~~Rps~~ell~~L~~l~~~~~  375 (399)
                      .....    ........+...++.+.+++.+||+.||.+|||+.|+++.|+++.....
T Consensus       258 ~~~~~----~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~~~~~~~~  311 (337)
T 3ll6_A          258 KLRIV----NGKYSIPPHDTQYTVFHSLIRAMLQVNPEERLSIAEVVHQLQEIAAARN  311 (337)
T ss_dssp             ------------CCCCTTCCSSGGGHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHHTT
T ss_pred             HHHhh----cCcccCCcccccchHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhccC
Confidence            44332    2233334456677889999999999999999999999999999876543

>1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=3.7e-45  Score=358.11  Aligned_cols=251  Identities=27%  Similarity=0.415  Sum_probs=210.2

Q ss_pred             CceeecccccceeceeceeCceEEEEEEE--CCeeEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCceeeEEeEEecCC
Q 015868          109 DVWEIDAKQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPP  186 (399)
Q Consensus       109 ~~~~i~~~~~~i~~~lg~G~~g~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~nIv~~~~~~~~~~  186 (399)
                      ..|++ .++|++.+.||+|+||.||+|.+  +++.||||++.....+....+.+.+|+.+++.++||||+++++++....
T Consensus        19 ~~~~~-~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~   97 (367)
T 1cm8_A           19 TAWEV-RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDE   97 (367)
T ss_dssp             SEECC-BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCS
T ss_pred             ceeee-cceEEEeEEeeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCcCCCCceeeEecCC
Confidence            34555 46899999999999999999987  5789999999776666777788999999999999999999999997653


Q ss_pred             ------cEEEEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceeecCCCcEEEeeccc
Q 015868          187 ------NLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGV  260 (399)
Q Consensus       187 ------~~~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~giiHrDlkp~NILl~~~~~vkl~DFG~  260 (399)
                            .+|+||||+ +++|.+++..  ..+++..+..++.||+.||.|||++||+||||||+||+++.++.+||+|||+
T Consensus        98 ~~~~~~~~~lv~e~~-~~~L~~~~~~--~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~  174 (367)
T 1cm8_A           98 TLDDFTDFYLVMPFM-GTDLGKLMKH--EKLGEDRIQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAVNEDCELKILDFGL  174 (367)
T ss_dssp             STTTCCCCEEEEECC-SEEHHHHHHH--CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTT
T ss_pred             ccccCceEEEEEecC-CCCHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCccccCcCHHHEEEcCCCCEEEEeeec
Confidence                  469999999 7799999976  5689999999999999999999999999999999999999999999999999


Q ss_pred             eeeccCCCccccCCCCcccccccccCC-CCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhccCC--------
Q 015868          261 ARVQAQSGVMTAETGTYRWMAPEVIEH-KPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKSLR--------  331 (399)
Q Consensus       261 a~~~~~~~~~~~~~gt~~y~aPE~l~~-~~~~~~~Dv~slG~vl~elltg~~P~~~~~~~~~~~~~~~~~~~--------  331 (399)
                      ++....  ..+...+|+.|+|||++.+ ..++.++||||+||++|+|++|+.||.+.+..+....+......        
T Consensus       175 a~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~~~~~~~~~  252 (367)
T 1cm8_A          175 ARQADS--EMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQR  252 (367)
T ss_dssp             CEECCS--SCCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHT
T ss_pred             cccccc--ccCcCcCCCCcCCHHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHH
Confidence            987543  3456688999999999877 67999999999999999999999999988776554443321110        


Q ss_pred             ---------------------CCCCCCCcHHHHHHHHHHhhhcCCCCCCHHHHHH
Q 015868          332 ---------------------PTIPKHAHPRLAELLERCWQHDPTQRPNFSQITD  365 (399)
Q Consensus       332 ---------------------~~~~~~~~~~l~~ll~~cl~~dP~~Rps~~ell~  365 (399)
                                           ..+....++++.+|+.+||+.||.+|||+.|+++
T Consensus       253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~mL~~dP~~R~t~~e~l~  307 (367)
T 1cm8_A          253 LQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALA  307 (367)
T ss_dssp             CSCHHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred             hhhHHHHHHHHhCCCCCCCCHHHHCCCCCHHHHHHHHHHccCChhHCCCHHHHhc
Confidence                                 1123467899999999999999999999999977

>3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=7.8e-46  Score=358.43  Aligned_cols=251  Identities=25%  Similarity=0.421  Sum_probs=211.4

Q ss_pred             ccccceeceeceeCceEEEEEEE--CCeeEEEEEecCCC---CCHHHHHHHHHHHHHHHhcCCCceeeEEeEEecCCcEE
Q 015868          115 AKQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPEC---VNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLC  189 (399)
Q Consensus       115 ~~~~~i~~~lg~G~~g~Vy~~~~--~~~~vAvK~~~~~~---~~~~~~~~~~~Ei~~l~~l~h~nIv~~~~~~~~~~~~~  189 (399)
                      .++|++.+.||+|+||.||+|.+  .++.||+|+++...   .+....+.+.+|+.++++++||||+++++++......+
T Consensus        25 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~  104 (345)
T 3hko_A           25 QKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEVYEDEQYIC  104 (345)
T ss_dssp             HHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred             hhheeecceeeecCCeEEEEEEECCCCceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhCCCCCcceeehhhccCCeEE
Confidence            57899999999999999999987  56789999986431   13344578999999999999999999999999999999


Q ss_pred             EEEecCCCCCHHHHHHhc---------------------------------------CCCCCHHHHHHHHHHHHHHHHHH
Q 015868          190 IVTEFMARGSIYDFLHKQ---------------------------------------KGVFQLTSLLKVAIDVSKGMNYL  230 (399)
Q Consensus       190 lV~E~~~ggsL~~~l~~~---------------------------------------~~~l~~~~~~~i~~~i~~~L~~L  230 (399)
                      +||||++||+|.+++...                                       ...+++..++.++.||+.||+||
T Consensus       105 lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~L  184 (345)
T 3hko_A          105 LVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHYL  184 (345)
T ss_dssp             EEEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHHHHHHHHHHHH
T ss_pred             EEEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHHHHHHHHH
Confidence            999999999999998521                                       11235778899999999999999


Q ss_pred             HHCCcccCCCCCCceeecCCC--cEEEeeccceeeccCCC-----ccccCCCCcccccccccCC--CCCCChhhHHHHHH
Q 015868          231 HQNNIIHRDLKTANLLMDENG--VVKVADFGVARVQAQSG-----VMTAETGTYRWMAPEVIEH--KPYDYKADVFSFGI  301 (399)
Q Consensus       231 H~~giiHrDlkp~NILl~~~~--~vkl~DFG~a~~~~~~~-----~~~~~~gt~~y~aPE~l~~--~~~~~~~Dv~slG~  301 (399)
                      |++||+||||||+||+++.++  .+||+|||+++......     ......||+.|+|||++.+  ..++.++||||||+
T Consensus       185 H~~~ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~  264 (345)
T 3hko_A          185 HNQGICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCDAWSAGV  264 (345)
T ss_dssp             HHTTEECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTCC--------CCCGGGCCHHHHTCSSSCCCTHHHHHHHHH
T ss_pred             HHCCccccCCChhhEEEecCCCceEEEeeccccccccccCccccccccccCCCccccCchhhccCCCCCCcHHHHHHHHH
Confidence            999999999999999998777  89999999998654321     2345578999999999975  67899999999999


Q ss_pred             HHHHHHcCCCCCCCCCHHHHHHHHHhccCCCCCC--CCCcHHHHHHHHHHhhhcCCCCCCHHHHHH
Q 015868          302 ALWELLTGELPYAGLTPLQAAVGVVQKSLRPTIP--KHAHPRLAELLERCWQHDPTQRPNFSQITD  365 (399)
Q Consensus       302 vl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~l~~ll~~cl~~dP~~Rps~~ell~  365 (399)
                      ++|+|++|+.||.+.+..+..............+  ..+++++.++|.+||+.||.+|||+.++++
T Consensus       265 il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~  330 (345)
T 3hko_A          265 LLHLLLMGAVPFPGVNDADTISQVLNKKLCFENPNYNVLSPLARDLLSNLLNRNVDERFDAMRALQ  330 (345)
T ss_dssp             HHHHHHHSSCSSCCSSHHHHHHHHHHCCCCTTSGGGGGSCHHHHHHHHHHSCSCTTTSCCHHHHHH
T ss_pred             HHHHHHHCCCCCCCCChHHHHHHHHhcccccCCcccccCCHHHHHHHHHHcCCChhHCCCHHHHhc
Confidence            9999999999999999888777777655443333  247899999999999999999999999976

>3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens}

Probab=100.00  E-value=6.7e-46  Score=356.88  Aligned_cols=248  Identities=23%  Similarity=0.396  Sum_probs=205.0

Q ss_pred             cccceeceeceeCceEEEEEEE--CCeeEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCceeeEEeEEecCCcEEEEEe
Q 015868          116 KQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVTE  193 (399)
Q Consensus       116 ~~~~i~~~lg~G~~g~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~nIv~~~~~~~~~~~~~lV~E  193 (399)
                      ++|++.++||+|+||.||+|++  +++.||+|+++... .......+.+|+.+++.++||||+++++++......++|||
T Consensus         2 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e   80 (324)
T 3mtl_A            2 ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEH-EEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFE   80 (324)
T ss_dssp             CSEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECC-------CCCCCCCHHHHSCCCCTTBCCEEEEEECSSCEEEEEE
T ss_pred             CceEEEEEEcCCCCEEEEEEEECCCCcEEEEEEEeccc-ccccchhHHHHHHHHHhcCCCCCCeeeeEEeeCCEEEEEec
Confidence            5799999999999999999998  47889999997543 12222345679999999999999999999999999999999


Q ss_pred             cCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceeecCCCcEEEeeccceeeccCCC-cccc
Q 015868          194 FMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSG-VMTA  272 (399)
Q Consensus       194 ~~~ggsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~giiHrDlkp~NILl~~~~~vkl~DFG~a~~~~~~~-~~~~  272 (399)
                      |+++ +|.+++......+++..++.++.||+.||.|||++||+||||||+||+++.++.+||+|||+++...... ....
T Consensus        81 ~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~~~~~~  159 (324)
T 3mtl_A           81 YLDK-DLKQYLDDCGNIINMHNVKLFLFQLLRGLAYCHRQKVLHRDLKPQNLLINERGELKLADFGLARAKSIPTKTYDN  159 (324)
T ss_dssp             CCSE-EHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEEESSCCGGGEEECTTCCEEECSSSEEECC---------
T ss_pred             cccc-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccCCCcCHHHEEECCCCCEEEccCcccccccCCcccccc
Confidence            9975 9999998877789999999999999999999999999999999999999999999999999998654332 3344


Q ss_pred             CCCCcccccccccCC-CCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhccCCCC------------------
Q 015868          273 ETGTYRWMAPEVIEH-KPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKSLRPT------------------  333 (399)
Q Consensus       273 ~~gt~~y~aPE~l~~-~~~~~~~Dv~slG~vl~elltg~~P~~~~~~~~~~~~~~~~~~~~~------------------  333 (399)
                      ..||+.|+|||++.+ ..++.++||||||+++|+|++|+.||.+.+..+....+......+.                  
T Consensus       160 ~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (324)
T 3mtl_A          160 EVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSNEEFKTYNY  239 (324)
T ss_dssp             ---CGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGCHHHHHTCC
T ss_pred             ccCcccccChhhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHhchhhhcchhhccccc
Confidence            578999999999976 5789999999999999999999999999887766555443211111                  


Q ss_pred             ----------CCCCCcHHHHHHHHHHhhhcCCCCCCHHHHHH
Q 015868          334 ----------IPKHAHPRLAELLERCWQHDPTQRPNFSQITD  365 (399)
Q Consensus       334 ----------~~~~~~~~l~~ll~~cl~~dP~~Rps~~ell~  365 (399)
                                .+..+++++.+||.+||+.||.+|||++|+++
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~  281 (324)
T 3mtl_A          240 PKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISAEDAMK  281 (324)
T ss_dssp             CCCCCCCHHHHCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred             ccccchhhhhhcCCCCHHHHHHHHHHcCcCcccCCCHHHHhc
Confidence                      11347889999999999999999999999976

>2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens}

Probab=100.00  E-value=2.9e-46  Score=362.53  Aligned_cols=260  Identities=20%  Similarity=0.294  Sum_probs=206.8

Q ss_pred             CceeecccccceeceeceeCceEEEEEEE-----CCeeEEEEEecCCCCCHH---------HHHHHHHHHHHHHhcCCCc
Q 015868          109 DVWEIDAKQLKIECKVASGSYGDLYKGTY-----CSQEVAIKVLKPECVNTE---------MLKEFSQEVYIMRKIRHKN  174 (399)
Q Consensus       109 ~~~~i~~~~~~i~~~lg~G~~g~Vy~~~~-----~~~~vAvK~~~~~~~~~~---------~~~~~~~Ei~~l~~l~h~n  174 (399)
                      ...++..++|++.+.||+|+||.||+|++     .+..||+|+.........         ....+.+|+..++.++|||
T Consensus        30 ~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~n  109 (345)
T 2v62_A           30 VLDDMEGNQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLG  109 (345)
T ss_dssp             EEECTTSCEEEEEEEC------CEEEEEESSSCGGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTCSCCC
T ss_pred             eeccccCceEEEEeeEeecCCeEEEEEEecCCCCccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhccccccC
Confidence            33456678999999999999999999998     457899999986532111         1124667889999999999


Q ss_pred             eeeEEeEEec----CCcEEEEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceeecCC
Q 015868          175 VVQFIGACTR----PPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDEN  250 (399)
Q Consensus       175 Iv~~~~~~~~----~~~~~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~giiHrDlkp~NILl~~~  250 (399)
                      |+++++++..    ....|+||||+ |++|.+++.... .+++..++.++.||+.||+|||++||+||||||+|||++.+
T Consensus       110 i~~~~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~-~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~  187 (345)
T 2v62_A          110 IPLFYGSGLTEFKGRSYRFMVMERL-GIDLQKISGQNG-TFKKSTVLQLGIRMLDVLEYIHENEYVHGDIKAANLLLGYK  187 (345)
T ss_dssp             CCCEEEEEEEESSSCEEEEEEEECE-EEEHHHHCBGGG-BCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEESS
T ss_pred             cceeecccccccCCCcEEEEEEecc-CCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCeeCCCcCHHHEEEccC
Confidence            9999999987    67899999999 889999997643 79999999999999999999999999999999999999988


Q ss_pred             C--cEEEeeccceeeccCCC--------ccccCCCCcccccccccCCCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHH
Q 015868          251 G--VVKVADFGVARVQAQSG--------VMTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPYAGLTPLQ  320 (399)
Q Consensus       251 ~--~vkl~DFG~a~~~~~~~--------~~~~~~gt~~y~aPE~l~~~~~~~~~Dv~slG~vl~elltg~~P~~~~~~~~  320 (399)
                      +  .+||+|||+++......        ......||+.|+|||++.+..++.++||||||+++|+|++|+.||.......
T Consensus       188 ~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~  267 (345)
T 2v62_A          188 NPDQVYLADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHKGVALSRRSDVEILGYCMLRWLCGKLPWEQNLKDP  267 (345)
T ss_dssp             STTSEEECCCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCTTGGGTTCH
T ss_pred             CCCcEEEEeCCCceecccccccccchhccccccCCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCcccccccc
Confidence            7  99999999998654322        1244578999999999999999999999999999999999999996532222


Q ss_pred             HHHHHHhccCCCCCCC---------CCcHHHHHHHHHHhhhcCCCCCCHHHHHHHHHHH
Q 015868          321 AAVGVVQKSLRPTIPK---------HAHPRLAELLERCWQHDPTQRPNFSQITDILKQM  370 (399)
Q Consensus       321 ~~~~~~~~~~~~~~~~---------~~~~~l~~ll~~cl~~dP~~Rps~~ell~~L~~l  370 (399)
                      ...........+.++.         .+++++.+++.+||+.||++|||+.++++.|+++
T Consensus       268 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~  326 (345)
T 2v62_A          268 VAVQTAKTNLLDELPQSVLKWAPSGSSCCEIAQFLVCAHSLAYDEKPNYQALKKILNPH  326 (345)
T ss_dssp             HHHHHHHHHHHHTTTHHHHHHSCTTSCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHCTT
T ss_pred             HHHHHHHHhhcccccHHHHhhccccccHHHHHHHHHHHhhcCcccCCCHHHHHHHHhcc
Confidence            1111121122222222         6889999999999999999999999999998875

>2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A*

Probab=100.00  E-value=7.2e-45  Score=344.15  Aligned_cols=250  Identities=26%  Similarity=0.436  Sum_probs=220.6

Q ss_pred             cccccceeceeceeCceEEEEEEEC--CeeEEEEEecCCC-CCHHHHHHHHHHHHHHHhcCCCceeeEEeEEecCCcEEE
Q 015868          114 DAKQLKIECKVASGSYGDLYKGTYC--SQEVAIKVLKPEC-VNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCI  190 (399)
Q Consensus       114 ~~~~~~i~~~lg~G~~g~Vy~~~~~--~~~vAvK~~~~~~-~~~~~~~~~~~Ei~~l~~l~h~nIv~~~~~~~~~~~~~l  190 (399)
                      ..++|++.+.||+|+||.||++.+.  ++.||+|++.... ......+.+.+|+.+++.++||||+++++++......++
T Consensus        13 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l   92 (294)
T 2rku_A           13 SRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFV   92 (294)
T ss_dssp             TTEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEE
T ss_pred             cccceEEEEEEeecCCEEEEEEEECCCCceEEEEEechhhccCHHHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCEEEE
Confidence            3568999999999999999999984  7889999987543 345566789999999999999999999999999999999


Q ss_pred             EEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceeecCCCcEEEeeccceeeccCCC-c
Q 015868          191 VTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSG-V  269 (399)
Q Consensus       191 V~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~giiHrDlkp~NILl~~~~~vkl~DFG~a~~~~~~~-~  269 (399)
                      ||||+++++|.+++.. ...+++..++.++.|++.||.|||++||+||||||+||+++.++.+||+|||.++...... .
T Consensus        93 v~e~~~~~~L~~~~~~-~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~  171 (294)
T 2rku_A           93 VLELCRRRSLLELHKR-RKALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGER  171 (294)
T ss_dssp             EEECCTTCBHHHHHHH-HCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECCSTTCC
T ss_pred             EEecCCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChHhEEEcCCCCEEEEeccCceecccCccc
Confidence            9999999999999866 4578999999999999999999999999999999999999999999999999998755332 2


Q ss_pred             cccCCCCcccccccccCCCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhccCCCCCCCCCcHHHHHHHHHH
Q 015868          270 MTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRLAELLERC  349 (399)
Q Consensus       270 ~~~~~gt~~y~aPE~l~~~~~~~~~Dv~slG~vl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~c  349 (399)
                      .....||+.|+|||.+.+..++.++||||||+++|+|++|+.||......+........  ...+|..+++.+.+++.+|
T Consensus       172 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~li~~~  249 (294)
T 2rku_A          172 KKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKN--EYSIPKHINPVAASLIQKM  249 (294)
T ss_dssp             BCCCCSCCSSCCHHHHTTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTT--CCCCCTTSCHHHHHHHHHH
T ss_pred             cccccCCCCcCCcchhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhhc--cCCCccccCHHHHHHHHHH
Confidence            34457899999999999999999999999999999999999999988876655544432  3456778999999999999


Q ss_pred             hhhcCCCCCCHHHHHHH
Q 015868          350 WQHDPTQRPNFSQITDI  366 (399)
Q Consensus       350 l~~dP~~Rps~~ell~~  366 (399)
                      |+.||++|||+.|+++.
T Consensus       250 l~~~p~~Rps~~~ll~~  266 (294)
T 2rku_A          250 LQTDPTARPTINELLND  266 (294)
T ss_dssp             TCSSGGGSCCGGGGGGS
T ss_pred             cccChhhCcCHHHHhhC
Confidence            99999999999999873

>2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens}

Probab=100.00  E-value=6.1e-45  Score=347.78  Aligned_cols=256  Identities=24%  Similarity=0.449  Sum_probs=200.5

Q ss_pred             CceeecccccceeceeceeCceEEEEEEE--CCeeEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCceeeEEeEEecCC
Q 015868          109 DVWEIDAKQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPP  186 (399)
Q Consensus       109 ~~~~i~~~~~~i~~~lg~G~~g~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~nIv~~~~~~~~~~  186 (399)
                      ..+.+..++|++.+.||+|+||.||+|++  .++.||||+++.........+.+.++..+++.++||||+++++++..+.
T Consensus        18 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~   97 (318)
T 2dyl_A           18 QRYQAEINDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGTFITNT   97 (318)
T ss_dssp             SEEECCGGGEEEEEEC------CEEEEEETTTCCEEEEEEEETTSCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSS
T ss_pred             hhhhhhhccccccceeeecCCeeEEEEEEecCCeEEEEEEecccccchHHHHHHHHHHHHHHhcCCCceeeEEEEEecCC
Confidence            55778889999999999999999999998  4889999999876544555556666677888899999999999999999


Q ss_pred             cEEEEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC-CcccCCCCCCceeecCCCcEEEeeccceeecc
Q 015868          187 NLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQN-NIIHRDLKTANLLMDENGVVKVADFGVARVQA  265 (399)
Q Consensus       187 ~~~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~-giiHrDlkp~NILl~~~~~vkl~DFG~a~~~~  265 (399)
                      ..++||||+ ++.+..+.......+++..++.++.|++.||.|||++ ||+||||||+||+++.++.+||+|||+++...
T Consensus        98 ~~~lv~e~~-~~~~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~  176 (318)
T 2dyl_A           98 DVFIAMELM-GTCAEKLKKRMQGPIPERILGKMTVAIVKALYYLKEKHGVIHRDVKPSNILLDERGQIKLCDFGISGRLV  176 (318)
T ss_dssp             EEEEEECCC-SEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHHHCCCCCCCCGGGEEECTTSCEEECCCTTC----
T ss_pred             cEEEEEecc-CCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhhCCEEeCCCCHHHEEECCCCCEEEEECCCchhcc
Confidence            999999999 5577777666567899999999999999999999996 99999999999999999999999999997665


Q ss_pred             CCCccccCCCCcccccccccC-----CCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhccCCCCCC--CCC
Q 015868          266 QSGVMTAETGTYRWMAPEVIE-----HKPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKSLRPTIP--KHA  338 (399)
Q Consensus       266 ~~~~~~~~~gt~~y~aPE~l~-----~~~~~~~~Dv~slG~vl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~--~~~  338 (399)
                      .........+++.|+|||++.     +..++.++||||||+++|+|++|+.||..................+..+  ..+
T Consensus       177 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  256 (318)
T 2dyl_A          177 DDKAKDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKTDFEVLTKVLQEEPPLLPGHMGF  256 (318)
T ss_dssp             ----------CCTTCCHHHHC--------CCTHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHHHHHSCCCCCCSSSCC
T ss_pred             CCccccccCCCccccChhhcccccccccCCccccchhhHHHHHHHHHhCCCCCCCCCccHHHHHHHhccCCCCCCccCCC
Confidence            554455567899999999994     5568899999999999999999999998754433333333334444444  358


Q ss_pred             cHHHHHHHHHHhhhcCCCCCCHHHHHH
Q 015868          339 HPRLAELLERCWQHDPTQRPNFSQITD  365 (399)
Q Consensus       339 ~~~l~~ll~~cl~~dP~~Rps~~ell~  365 (399)
                      ++++.++|.+||+.||.+|||+.++++
T Consensus       257 ~~~l~~li~~~l~~dp~~Rps~~~ll~  283 (318)
T 2dyl_A          257 SGDFQSFVKDCLTKDHRKRPKYNKLLE  283 (318)
T ss_dssp             CHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred             CHHHHHHHHHHccCChhHCcCHHHHhh
Confidence            999999999999999999999999986

>3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7}

Probab=100.00  E-value=7.6e-45  Score=353.93  Aligned_cols=249  Identities=24%  Similarity=0.403  Sum_probs=211.7

Q ss_pred             eeecccccceeceeceeCceEEEEEEE--CCeeEEEEEecCCCCCHHHHHHHHHHHHHHHhcC-----CCceeeEEeEEe
Q 015868          111 WEIDAKQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIR-----HKNVVQFIGACT  183 (399)
Q Consensus       111 ~~i~~~~~~i~~~lg~G~~g~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~Ei~~l~~l~-----h~nIv~~~~~~~  183 (399)
                      ..+-.++|++.++||+|+||.||+|++  .++.||||+++.   .....+.+..|+.+++.+.     ||||+++++++.
T Consensus        30 g~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~---~~~~~~~~~~e~~~l~~l~~~~~~h~~iv~~~~~~~  106 (360)
T 3llt_A           30 GMLLNNAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRN---IKKYTRSAKIEADILKKIQNDDINNNNIVKYHGKFM  106 (360)
T ss_dssp             TCEETTTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECS---CHHHHHHHHHHHHHHHHTCCCSTTGGGBCCEEEEEE
T ss_pred             ceEecCEEEEEEEEcccCCeEEEEEEECCCCeEEEEEEecc---chhhhhhhHHHHHHHHHhcccCCCCCCeecccceee
Confidence            345578999999999999999999998  678899999975   3555677888999999996     999999999999


Q ss_pred             cCCcEEEEEecCCCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceeecC-------------
Q 015868          184 RPPNLCIVTEFMARGSIYDFLHKQK-GVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDE-------------  249 (399)
Q Consensus       184 ~~~~~~lV~E~~~ggsL~~~l~~~~-~~l~~~~~~~i~~~i~~~L~~LH~~giiHrDlkp~NILl~~-------------  249 (399)
                      .....++||||+ +++|.+++.... ..+++..++.++.||+.||+|||++||+||||||+|||++.             
T Consensus       107 ~~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~~~~~~~~~~  185 (360)
T 3llt_A          107 YYDHMCLIFEPL-GPSLYEIITRNNYNGFHIEDIKLYCIEILKALNYLRKMSLTHTDLKPENILLDDPYFEKSLITVRRV  185 (360)
T ss_dssp             ETTEEEEEECCC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCTTCCEEEEEEECT
T ss_pred             ECCeeEEEEcCC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCcccEEEccccccccccchhcc
Confidence            999999999999 889999997654 46999999999999999999999999999999999999975             


Q ss_pred             ------------CCcEEEeeccceeeccCCCccccCCCCcccccccccCCCCCCChhhHHHHHHHHHHHHcCCCCCCCCC
Q 015868          250 ------------NGVVKVADFGVARVQAQSGVMTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPYAGLT  317 (399)
Q Consensus       250 ------------~~~vkl~DFG~a~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~Dv~slG~vl~elltg~~P~~~~~  317 (399)
                                  ++.+||+|||+++.....  .....||+.|+|||++.+..++.++|||||||++|+|++|+.||...+
T Consensus       186 ~~~~~~~~~~~~~~~~kl~DFG~a~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~  263 (360)
T 3llt_A          186 TDGKKIQIYRTKSTGIKLIDFGCATFKSDY--HGSIINTRQYRAPEVILNLGWDVSSDMWSFGCVLAELYTGSLLFRTHE  263 (360)
T ss_dssp             TTCCEEEEEEESCCCEEECCCTTCEETTSC--CCSCCSCGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSCCCSS
T ss_pred             cccccccccccCCCCEEEEeccCceecCCC--CcCccCcccccCcHHHcCCCCCCccchHHHHHHHHHHHHCCCCCCCCc
Confidence                        789999999999865432  345678999999999999999999999999999999999999999877


Q ss_pred             HHHHHHHHHhccCC--------------------------------------------CCCCCCCcHHHHHHHHHHhhhc
Q 015868          318 PLQAAVGVVQKSLR--------------------------------------------PTIPKHAHPRLAELLERCWQHD  353 (399)
Q Consensus       318 ~~~~~~~~~~~~~~--------------------------------------------~~~~~~~~~~l~~ll~~cl~~d  353 (399)
                      ..+...........                                            +..+...++.+.+||.+||+.|
T Consensus       264 ~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~d  343 (360)
T 3llt_A          264 HMEHLAMMESIIQPIPKNMLYEATKTNGSKYVNKDELKLAWPENASSINSIKHVKKCLPLYKIIKHELFCDFLYSILQID  343 (360)
T ss_dssp             HHHHHHHHHHHTCCCCHHHHHHHTTSGGGGGEETTTTEECTTTTCSCHHHHHHHHTCCCHHHHCCCHHHHHHHHHHCCSS
T ss_pred             HHHHHHHHHHhcCCCCHHHHhhhhhccCccccCcccceecCcccccchhhhhhhhhcccccccchHHHHHHHHHHHhcCC
Confidence            66554433221100                                            0001112377889999999999


Q ss_pred             CCCCCCHHHHHH
Q 015868          354 PTQRPNFSQITD  365 (399)
Q Consensus       354 P~~Rps~~ell~  365 (399)
                      |.+|||+.|+++
T Consensus       344 P~~Rpta~elL~  355 (360)
T 3llt_A          344 PTLRPSPAELLK  355 (360)
T ss_dssp             GGGSCCHHHHTT
T ss_pred             hhhCCCHHHHhc
Confidence            999999999874

>2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A*

Probab=100.00  E-value=6.6e-45  Score=351.53  Aligned_cols=249  Identities=26%  Similarity=0.442  Sum_probs=220.5

Q ss_pred             cccccceeceeceeCceEEEEEEE--CCeeEEEEEecCCC-CCHHHHHHHHHHHHHHHhcCCCceeeEEeEEecCCcEEE
Q 015868          114 DAKQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPEC-VNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCI  190 (399)
Q Consensus       114 ~~~~~~i~~~lg~G~~g~Vy~~~~--~~~~vAvK~~~~~~-~~~~~~~~~~~Ei~~l~~l~h~nIv~~~~~~~~~~~~~l  190 (399)
                      ..++|++.+.||+|+||.||++++  .++.||+|++.... ......+.+.+|+.+++.++||||+++++++......++
T Consensus        39 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l  118 (335)
T 2owb_A           39 SRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFV  118 (335)
T ss_dssp             TTEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEE
T ss_pred             cCCceEEEEEEeeCCCeEEEEEEECCCCCEEEEEEechhhhcCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEE
Confidence            357899999999999999999998  46789999987543 345567789999999999999999999999999999999


Q ss_pred             EEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceeecCCCcEEEeeccceeeccCCC-c
Q 015868          191 VTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSG-V  269 (399)
Q Consensus       191 V~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~giiHrDlkp~NILl~~~~~vkl~DFG~a~~~~~~~-~  269 (399)
                      ||||+.+++|.+++.. ...+++..++.++.||+.||.|||++||+||||||+||+++.++.+||+|||+++...... .
T Consensus       119 v~e~~~~~~L~~~~~~-~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~  197 (335)
T 2owb_A          119 VLELCRRRSLLELHKR-RKALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGER  197 (335)
T ss_dssp             EECCCTTCBHHHHHHH-HCSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCCTTCEECCSTTCC
T ss_pred             EEecCCCCCHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHHHCCCEecCCCchhEEEcCCCCEEEeeccCceecccCccc
Confidence            9999999999999876 4678999999999999999999999999999999999999999999999999998765332 3


Q ss_pred             cccCCCCcccccccccCCCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhccCCCCCCCCCcHHHHHHHHHH
Q 015868          270 MTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRLAELLERC  349 (399)
Q Consensus       270 ~~~~~gt~~y~aPE~l~~~~~~~~~Dv~slG~vl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~c  349 (399)
                      .....||+.|+|||++.+..++.++||||||+++|+|++|+.||......+........  ...++..+++++.++|.+|
T Consensus       198 ~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~li~~~  275 (335)
T 2owb_A          198 KKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKN--EYSIPKHINPVAASLIQKM  275 (335)
T ss_dssp             BCCCCSCCSSCCHHHHHTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHT--CCCCCTTSCHHHHHHHHHH
T ss_pred             ccccCCCccccCHHHhccCCCCchhhHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHhcC--CCCCCccCCHHHHHHHHHH
Confidence            34457899999999999999999999999999999999999999988776655554433  3456778999999999999


Q ss_pred             hhhcCCCCCCHHHHHH
Q 015868          350 WQHDPTQRPNFSQITD  365 (399)
Q Consensus       350 l~~dP~~Rps~~ell~  365 (399)
                      |+.||++|||+.|+++
T Consensus       276 l~~dp~~Rps~~ell~  291 (335)
T 2owb_A          276 LQTDPTARPTINELLN  291 (335)
T ss_dssp             TCSSGGGSCCGGGGGG
T ss_pred             ccCChhHCcCHHHHhc
Confidence            9999999999999986

>3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ...

Probab=100.00  E-value=3.7e-45  Score=356.28  Aligned_cols=252  Identities=24%  Similarity=0.434  Sum_probs=214.9

Q ss_pred             eeecccccceeceeceeCceEEEEEEEC--CeeEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCceeeEEeEEecCCcE
Q 015868          111 WEIDAKQLKIECKVASGSYGDLYKGTYC--SQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNL  188 (399)
Q Consensus       111 ~~i~~~~~~i~~~lg~G~~g~Vy~~~~~--~~~vAvK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~nIv~~~~~~~~~~~~  188 (399)
                      .++..++|++.++||+|+||.||++++.  ++.||+|+++... .....+.+.+|+.++++++||||+++++++..+...
T Consensus        28 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~  106 (360)
T 3eqc_A           28 GELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEI-KPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEI  106 (360)
T ss_dssp             CCCCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECCC-CHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEETTEE
T ss_pred             cccccccceeeeeecCCCCeEEEEEEECCCCcEEEEEEecccc-CHHHHHHHHHHHHHHHHCCCCCEEEEeEEEEECCEE
Confidence            3566789999999999999999999985  7899999998653 556678899999999999999999999999999999


Q ss_pred             EEEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC-CcccCCCCCCceeecCCCcEEEeeccceeeccCC
Q 015868          189 CIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQN-NIIHRDLKTANLLMDENGVVKVADFGVARVQAQS  267 (399)
Q Consensus       189 ~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~-giiHrDlkp~NILl~~~~~vkl~DFG~a~~~~~~  267 (399)
                      ++||||++|++|.+++... +.+++..+..++.+++.||.|||++ ||+||||||+||+++.++.+||+|||+++.....
T Consensus       107 ~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~i~~~i~~~l~~lh~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~  185 (360)
T 3eqc_A          107 SICMEHMDGGSLDQVLKKA-GRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS  185 (360)
T ss_dssp             EEEECCCTTCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHHHCCCCSCCSGGGEEECTTCCEEECCCCCCHHHHHH
T ss_pred             EEEEECCCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHhCCEEcCCccHHHEEECCCCCEEEEECCCCcccccc
Confidence            9999999999999999764 5689999999999999999999996 9999999999999999999999999998754332


Q ss_pred             CccccCCCCcccccccccCCCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHH----------------------
Q 015868          268 GVMTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGV----------------------  325 (399)
Q Consensus       268 ~~~~~~~gt~~y~aPE~l~~~~~~~~~Dv~slG~vl~elltg~~P~~~~~~~~~~~~~----------------------  325 (399)
                       ......||+.|+|||++.+..++.++||||||+++|+|++|..||...+..+.....                      
T Consensus       186 -~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  264 (360)
T 3eqc_A          186 -MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPL  264 (360)
T ss_dssp             -C----CCCCTTCCHHHHTTCCCSHHHHHHHHHHHHHHHHHTSCCSSCCCHHHHHHHHC---------------------
T ss_pred             -cccCCCCCCCeECHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccccccCCCCCCCcccCCCcc
Confidence             234457899999999999999999999999999999999999999876654432111                      


Q ss_pred             -------------------HhccCCCCC-CCCCcHHHHHHHHHHhhhcCCCCCCHHHHHH
Q 015868          326 -------------------VQKSLRPTI-PKHAHPRLAELLERCWQHDPTQRPNFSQITD  365 (399)
Q Consensus       326 -------------------~~~~~~~~~-~~~~~~~l~~ll~~cl~~dP~~Rps~~ell~  365 (399)
                                         ......+.. +..++.++.+||.+||+.||++|||+.|+++
T Consensus       265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~  324 (360)
T 3eqc_A          265 NKFGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMV  324 (360)
T ss_dssp             ---------CCCHHHHHHHHHHSCCCCCCTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHT
T ss_pred             cccccCCCCcccchhhhhHHhccCCCCCCcccccHHHHHHHHHHhhcChhhCCCHHHHhh
Confidence                               111222222 3457899999999999999999999999987

>2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A

Probab=100.00  E-value=6e-45  Score=346.51  Aligned_cols=247  Identities=23%  Similarity=0.428  Sum_probs=214.0

Q ss_pred             ccccceeceeceeCceEEEEEEE--CCeeEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCceeeEEeEEecCCcEEEEE
Q 015868          115 AKQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVT  192 (399)
Q Consensus       115 ~~~~~i~~~lg~G~~g~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~nIv~~~~~~~~~~~~~lV~  192 (399)
                      .++|++.+.||+|+||.||+++.  .++.||+|+++...  ......+.+|+.++++++||||+++++++......++||
T Consensus         8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   85 (304)
T 2jam_A            8 RKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSP--AFRDSSLENEIAVLKKIKHENIVTLEDIYESTTHYYLVM   85 (304)
T ss_dssp             HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECC--------HHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             hccceeeeeccCCCCceEEEEEECCCCCEEEEEEEeccc--ccchHHHHHHHHHHHhCCCCCeeehhhhcccCCEEEEEE
Confidence            46899999999999999999998  58899999998642  223457889999999999999999999999999999999


Q ss_pred             ecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceee---cCCCcEEEeeccceeeccCCCc
Q 015868          193 EFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLM---DENGVVKVADFGVARVQAQSGV  269 (399)
Q Consensus       193 E~~~ggsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~giiHrDlkp~NILl---~~~~~vkl~DFG~a~~~~~~~~  269 (399)
                      ||+++++|.+++... +.+++..++.++.|++.||.|||++||+||||||+||++   +.++.+||+|||.++..... .
T Consensus        86 e~~~~~~L~~~l~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dikp~NIl~~~~~~~~~~kl~Dfg~~~~~~~~-~  163 (304)
T 2jam_A           86 QLVSGGELFDRILER-GVYTEKDASLVIQQVLSAVKYLHENGIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQNG-I  163 (304)
T ss_dssp             CCCCSCBHHHHHHHH-SCCCHHHHHHHHHHHHHHHHHHHHTTCCCCSCCGGGCEESSSSTTCCEEBCSCSTTCCCCCB-T
T ss_pred             EcCCCccHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEecCCCCCCEEEccCCcceecCCC-c
Confidence            999999999999763 568999999999999999999999999999999999999   78899999999999754332 2


Q ss_pred             cccCCCCcccccccccCCCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhccCC--CCCCCCCcHHHHHHHH
Q 015868          270 MTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKSLR--PTIPKHAHPRLAELLE  347 (399)
Q Consensus       270 ~~~~~gt~~y~aPE~l~~~~~~~~~Dv~slG~vl~elltg~~P~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~l~~ll~  347 (399)
                      .....||+.|+|||.+.+..++.++||||||+++|+|++|..||...+..+....+......  ...+..+++++.++|.
T Consensus       164 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~  243 (304)
T 2jam_A          164 MSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVITYILLCGYPPFYEETESKLFEKIKEGYYEFESPFWDDISESAKDFIC  243 (304)
T ss_dssp             THHHHSCCCBCCTTTBSSCSCCHHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHCCCCCCTTTTTTSCHHHHHHHH
T ss_pred             cccccCCCCccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCCCCCccccccCCHHHHHHHH
Confidence            34456899999999999999999999999999999999999999988877766555544322  2344678999999999


Q ss_pred             HHhhhcCCCCCCHHHHHH
Q 015868          348 RCWQHDPTQRPNFSQITD  365 (399)
Q Consensus       348 ~cl~~dP~~Rps~~ell~  365 (399)
                      +||+.||.+|||+.|+++
T Consensus       244 ~~l~~dp~~Rps~~~~l~  261 (304)
T 2jam_A          244 HLLEKDPNERYTCEKALS  261 (304)
T ss_dssp             HHHCSSTTTSCCHHHHHT
T ss_pred             HHcCCChhHCcCHHHHhc
Confidence            999999999999999976

>3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens}

Probab=100.00  E-value=5e-46  Score=358.48  Aligned_cols=259  Identities=28%  Similarity=0.477  Sum_probs=206.2

Q ss_pred             eeecccccceeceeceeCceEEEEEEECCeeEEEEEecCCCCCHHHHHHHHHHHHH--HHhcCCCceeeEEeEEec----
Q 015868          111 WEIDAKQLKIECKVASGSYGDLYKGTYCSQEVAIKVLKPECVNTEMLKEFSQEVYI--MRKIRHKNVVQFIGACTR----  184 (399)
Q Consensus       111 ~~i~~~~~~i~~~lg~G~~g~Vy~~~~~~~~vAvK~~~~~~~~~~~~~~~~~Ei~~--l~~l~h~nIv~~~~~~~~----  184 (399)
                      +.++.++|++.+.||+|+||.||+|+..++.||||+++..   .  ...+..|..+  +..++||||+++++.+..    
T Consensus         8 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~vavK~~~~~---~--~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~   82 (336)
T 3g2f_A            8 PSLDLDNLKLLELIGRGRYGAVYKGSLDERPVAVKVFSFA---N--RQNFINEKNIYRVPLMEHDNIARFIVGDERVTAD   82 (336)
T ss_dssp             -CCCTTSEEEEEEEEECSSEEEEEEEETTEEEEEEEEEGG---G--HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECTT
T ss_pred             CCcChHHhheeeecccCCCeEEEEEEECCeEEEEEEeecc---c--hhhHHHHHHHHHHHhccCcchhhheecccccccC
Confidence            4577889999999999999999999999999999999743   1  2333444444  455899999999986532    


Q ss_pred             -CCcEEEEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC---------CcccCCCCCCceeecCCCcEE
Q 015868          185 -PPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQN---------NIIHRDLKTANLLMDENGVVK  254 (399)
Q Consensus       185 -~~~~~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~---------giiHrDlkp~NILl~~~~~vk  254 (399)
                       ...+++||||+++|+|.+++...  ..++..++.++.||+.||.|||++         ||+||||||+|||++.++.+|
T Consensus        83 ~~~~~~lv~e~~~~g~L~~~l~~~--~~~~~~~~~i~~qi~~~L~~LH~~~~~~~~~~~~ivH~Dikp~Nill~~~~~~k  160 (336)
T 3g2f_A           83 GRMEYLLVMEYYPNGSLXKYLSLH--TSDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCV  160 (336)
T ss_dssp             SCEEEEEEECCCTTCBHHHHHHHC--CBCHHHHHHHHHHHHHHHHHHHCCBCCGGGCBCCEECSSCSGGGEEECTTSCEE
T ss_pred             CCceEEEEEecCCCCcHHHHHhhc--ccchhHHHHHHHHHHHHHHHHHhhhccccccccceeecccccceEEEcCCCcEE
Confidence             23578999999999999999763  358899999999999999999999         999999999999999999999


Q ss_pred             EeeccceeeccCCC---------ccccCCCCcccccccccCC-------CCCCChhhHHHHHHHHHHHHcCCCCCCC-CC
Q 015868          255 VADFGVARVQAQSG---------VMTAETGTYRWMAPEVIEH-------KPYDYKADVFSFGIALWELLTGELPYAG-LT  317 (399)
Q Consensus       255 l~DFG~a~~~~~~~---------~~~~~~gt~~y~aPE~l~~-------~~~~~~~Dv~slG~vl~elltg~~P~~~-~~  317 (399)
                      |+|||+++......         ......||+.|+|||++.+       ..++.++||||||+++|||++|..||.. ..
T Consensus       161 L~DFG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~  240 (336)
T 3g2f_A          161 ISDFGLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPGES  240 (336)
T ss_dssp             ECCCTTCEECSSSSCC---------CCTTSCGGGCCHHHHTTCCCGGGHHHHHHHHHHHHHHHHHHHHHTTBGGGSTTSC
T ss_pred             EeeccceeecccccccCccccccccccCCCccceeCchhhcCCcccccccccccccchHHHHHHHHHHHhcCCcCCCccc
Confidence            99999998654321         2234468999999999987       4566789999999999999999766522 11


Q ss_pred             -----------------HHHHHHHHHhccCCCCCCCC------CcHHHHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHH
Q 015868          318 -----------------PLQAAVGVVQKSLRPTIPKH------AHPRLAELLERCWQHDPTQRPNFSQITDILKQMMKEV  374 (399)
Q Consensus       318 -----------------~~~~~~~~~~~~~~~~~~~~------~~~~l~~ll~~cl~~dP~~Rps~~ell~~L~~l~~~~  374 (399)
                                       .............++.+|..      +++++.++|.+||+.||++|||+.|+++.|++++...
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~e~l~~L~~ll~~~  320 (336)
T 3g2f_A          241 VPEYQMAFQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRSLKETIEDCWDQDAEARLTAQXAEERMAELMMIW  320 (336)
T ss_dssp             CCCCCCTTHHHHCSSCCHHHHHHHHTTSCCCCCCCTTCCCCSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHCC
T ss_pred             hhHHHHhhhcccCCCchHHHHHhhhcccccCCCCCcccccccchHHHHHHHHHHHhcCChhhCcchHHHHHHHHHHHHHH
Confidence                             11222222334445555544      4558999999999999999999999999999998765


Q ss_pred             Hh
Q 015868          375 AS  376 (399)
Q Consensus       375 ~~  376 (399)
                      ..
T Consensus       321 ~~  322 (336)
T 3g2f_A          321 ER  322 (336)
T ss_dssp             CC
T ss_pred             Hh
Confidence            43

>2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A*

Probab=100.00  E-value=2.2e-45  Score=344.05  Aligned_cols=251  Identities=23%  Similarity=0.471  Sum_probs=209.7

Q ss_pred             eecccccceeceeceeCceEEEEEEE--CCeeEEEEEecCCCC-CHHHHHHHHHHHHHHHhcCCCceeeEEeEEecCCcE
Q 015868          112 EIDAKQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECV-NTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNL  188 (399)
Q Consensus       112 ~i~~~~~~i~~~lg~G~~g~Vy~~~~--~~~~vAvK~~~~~~~-~~~~~~~~~~Ei~~l~~l~h~nIv~~~~~~~~~~~~  188 (399)
                      .+..++|++.+.||+|+||.||+|++  .++.||+|+++.... ..+..+.+.+|+.+++.++||||+++++++..+...
T Consensus         7 ~~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~   86 (276)
T 2h6d_A            7 RVKIGHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVISTPTDF   86 (276)
T ss_dssp             CCEETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEE
T ss_pred             cceeccEEEEeeecCCCCeEEEEEEECCCCceEEEEEeccccccchhHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCeE
Confidence            45678999999999999999999988  488999999874311 112245788999999999999999999999999999


Q ss_pred             EEEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceeecCCCcEEEeeccceeeccCCC
Q 015868          189 CIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSG  268 (399)
Q Consensus       189 ~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~giiHrDlkp~NILl~~~~~vkl~DFG~a~~~~~~~  268 (399)
                      ++||||+++++|.+++... ..+++..++.++.|++.||.|||++||+|+||||+||+++.++.+||+|||.+.......
T Consensus        87 ~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~  165 (276)
T 2h6d_A           87 FMVMEYVSGGELFDYICKH-GRVEEMEARRLFQQILSAVDYCHRHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGE  165 (276)
T ss_dssp             EEEEECCCSCBHHHHHHHH-CSCCHHHHHHHHHHHHHHHHHHHHHCSSCCCCCGGGEEECTTSCEEECCCCGGGCCCC--
T ss_pred             EEEEeccCCCcHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCChhhEEECCCCCEEEeecccccccCCCc
Confidence            9999999999999999764 568999999999999999999999999999999999999999999999999998765554


Q ss_pred             ccccCCCCcccccccccCCCCC-CChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhccCCCCCCCCCcHHHHHHHH
Q 015868          269 VMTAETGTYRWMAPEVIEHKPY-DYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRLAELLE  347 (399)
Q Consensus       269 ~~~~~~gt~~y~aPE~l~~~~~-~~~~Dv~slG~vl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~  347 (399)
                      ......+++.|+|||.+.+..+ +.++||||||+++|+|++|..||...+..+........  ...+|..++.++.+++.
T Consensus       166 ~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~--~~~~~~~~~~~l~~li~  243 (276)
T 2h6d_A          166 FLRTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDEHVPTLFKKIRGG--VFYIPEYLNRSVATLLM  243 (276)
T ss_dssp             -----------CCTGGGTTSCCCHHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHC--CCCCCTTSCHHHHHHHH
T ss_pred             ceecccCCccccCHHHHcCCCCCCccchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHhhcC--cccCchhcCHHHHHHHH
Confidence            4455678999999999998776 58999999999999999999999988776655444332  34567788999999999


Q ss_pred             HHhhhcCCCCCCHHHHHH
Q 015868          348 RCWQHDPTQRPNFSQITD  365 (399)
Q Consensus       348 ~cl~~dP~~Rps~~ell~  365 (399)
                      +||+.||.+|||+.++++
T Consensus       244 ~~l~~~p~~Rps~~~~l~  261 (276)
T 2h6d_A          244 HMLQVDPLKRATIKDIRE  261 (276)
T ss_dssp             HHTCSSGGGSCCHHHHHH
T ss_pred             HHccCChhhCCCHHHHHh
Confidence            999999999999999986

>3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens}

Probab=100.00  E-value=5.6e-46  Score=359.43  Aligned_cols=243  Identities=23%  Similarity=0.403  Sum_probs=212.0

Q ss_pred             ccccceeceeceeCceEEEEEEE--CCeeEEEEEecCCCCCHH------HHHHHHHHHHHHHhcCCCceeeEEeEEecCC
Q 015868          115 AKQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVNTE------MLKEFSQEVYIMRKIRHKNVVQFIGACTRPP  186 (399)
Q Consensus       115 ~~~~~i~~~lg~G~~g~Vy~~~~--~~~~vAvK~~~~~~~~~~------~~~~~~~Ei~~l~~l~h~nIv~~~~~~~~~~  186 (399)
                      .++|++.+.||+|+||.||+|++  +++.||||+++.......      ....+.+|+.++++++||||+++++++....
T Consensus        23 ~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~  102 (335)
T 3dls_A           23 SQKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDIFENQG  102 (335)
T ss_dssp             HHHEEEEEECSSSSSCSEEEEEETTTTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTCCCTTBCCEEEEEECSS
T ss_pred             ccceEEEeEEEecCCEEEEEEEECCCCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEeeCC
Confidence            46899999999999999999986  678999999986543221      3446778999999999999999999999999


Q ss_pred             cEEEEEecCCCC-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceeecCCCcEEEeeccceeecc
Q 015868          187 NLCIVTEFMARG-SIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQA  265 (399)
Q Consensus       187 ~~~lV~E~~~gg-sL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~giiHrDlkp~NILl~~~~~vkl~DFG~a~~~~  265 (399)
                      .+++||||+.+| +|.+++.. ...+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++...
T Consensus       103 ~~~lv~e~~~~g~~l~~~~~~-~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~  181 (335)
T 3dls_A          103 FFQLVMEKHGSGLDLFAFIDR-HPRLDEPLASYIFRQLVSAVGYLRLKDIIHRDIKDENIVIAEDFTIKLIDFGSAAYLE  181 (335)
T ss_dssp             EEEEEEECCTTSCBHHHHHHT-CCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEECC
T ss_pred             EEEEEEEeCCCCccHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCeEEeccCHHHEEEcCCCcEEEeecccceECC
Confidence            999999998766 99999976 4579999999999999999999999999999999999999999999999999998776


Q ss_pred             CCCccccCCCCcccccccccCCCCC-CChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhccCCCCCCCCCcHHHHH
Q 015868          266 QSGVMTAETGTYRWMAPEVIEHKPY-DYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRLAE  344 (399)
Q Consensus       266 ~~~~~~~~~gt~~y~aPE~l~~~~~-~~~~Dv~slG~vl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~  344 (399)
                      .........||+.|+|||++.+..+ +.++||||||+++|+|++|..||......      .  ......|..+++++.+
T Consensus       182 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~------~--~~~~~~~~~~~~~l~~  253 (335)
T 3dls_A          182 RGKLFYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCELEET------V--EAAIHPPYLVSKELMS  253 (335)
T ss_dssp             TTCCBCEECSCGGGCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSCSSGGGG------T--TTCCCCSSCCCHHHHH
T ss_pred             CCCceeccCCCccccChhhhcCCCCCCCcccchhHHHHHHHHHhCCCchhhHHHH------H--hhccCCCcccCHHHHH
Confidence            6655566779999999999998877 78899999999999999999999764321      1  1223445668999999


Q ss_pred             HHHHHhhhcCCCCCCHHHHHHH
Q 015868          345 LLERCWQHDPTQRPNFSQITDI  366 (399)
Q Consensus       345 ll~~cl~~dP~~Rps~~ell~~  366 (399)
                      ||.+||+.||++|||+.++++.
T Consensus       254 li~~~L~~dP~~Rps~~ell~h  275 (335)
T 3dls_A          254 LVSGLLQPVPERRTTLEKLVTD  275 (335)
T ss_dssp             HHHHHTCSSGGGSCCHHHHHHC
T ss_pred             HHHHHccCChhhCcCHHHHhcC
Confidence            9999999999999999999873

>1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C

Probab=100.00  E-value=4.8e-45  Score=361.38  Aligned_cols=244  Identities=22%  Similarity=0.365  Sum_probs=196.2

Q ss_pred             cccccee-ceeceeCceEEEEEEE--CCeeEEEEEecCCCCCHHHHHHHHHHHHHHH-hcCCCceeeEEeEEec----CC
Q 015868          115 AKQLKIE-CKVASGSYGDLYKGTY--CSQEVAIKVLKPECVNTEMLKEFSQEVYIMR-KIRHKNVVQFIGACTR----PP  186 (399)
Q Consensus       115 ~~~~~i~-~~lg~G~~g~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~Ei~~l~-~l~h~nIv~~~~~~~~----~~  186 (399)
                      .++|.+. +.||.|+||.||++.+  +++.||||+++..       ..+.+|+.++. ..+||||+++++++..    ..
T Consensus        60 ~~~y~~~~~~LG~G~~g~V~~~~~~~~~~~vAiK~~~~~-------~~~~~E~~~~~~~~~hp~iv~l~~~~~~~~~~~~  132 (400)
T 1nxk_A           60 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-------PKARREVELHWRASQCPHIVRIVDVYENLYAGRK  132 (400)
T ss_dssp             GGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS-------HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEE
T ss_pred             cccceeccceeeeccCeEEEEEEECCCCCEEEEEEeCcc-------hhHHHHHHHHHHhcCCCCcceEeEEEeecccCCc
Confidence            3567776 6899999999999988  4788999999742       35667888874 4589999999999865    56


Q ss_pred             cEEEEEecCCCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceeecC---CCcEEEeecccee
Q 015868          187 NLCIVTEFMARGSIYDFLHKQK-GVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDE---NGVVKVADFGVAR  262 (399)
Q Consensus       187 ~~~lV~E~~~ggsL~~~l~~~~-~~l~~~~~~~i~~~i~~~L~~LH~~giiHrDlkp~NILl~~---~~~vkl~DFG~a~  262 (399)
                      .+|+||||+.||+|.+++.... ..+++..++.++.||+.||.|||++||+||||||+|||++.   ++.+||+|||+++
T Consensus       133 ~~~lv~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~~~~kl~DFG~a~  212 (400)
T 1nxk_A          133 CLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAK  212 (400)
T ss_dssp             EEEEEEECCCSEEHHHHHHCC---CCBHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSTTCCEEECCCTTCE
T ss_pred             EEEEEEEeCCCCcHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCcCcceEEEecCCCCccEEEEeccccc
Confidence            7899999999999999997653 46999999999999999999999999999999999999997   7899999999998


Q ss_pred             eccCCCccccCCCCcccccccccCCCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHH----HHHHHHhccCC--CCCCC
Q 015868          263 VQAQSGVMTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPYAGLTPLQ----AAVGVVQKSLR--PTIPK  336 (399)
Q Consensus       263 ~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~Dv~slG~vl~elltg~~P~~~~~~~~----~~~~~~~~~~~--~~~~~  336 (399)
                      ............||+.|+|||++.+..|+.++|||||||++|+|++|..||.+.+...    ....+......  .....
T Consensus       213 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~i~~~~~~~~~~~~~  292 (400)
T 1nxk_A          213 ETTSHNSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWS  292 (400)
T ss_dssp             ECC-----------CTTCCGGGSCCCCSSSHHHHHHHHHHHHHHHHSSCSCCCCTTCSSCCSHHHHHHHTCCCCCTTTTT
T ss_pred             ccCCCCccccCCCCCCccCHhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCccccccHHHHHHHHcCcccCCCcccc
Confidence            7665555566789999999999999999999999999999999999999997654321    11122222221  11225


Q ss_pred             CCcHHHHHHHHHHhhhcCCCCCCHHHHHH
Q 015868          337 HAHPRLAELLERCWQHDPTQRPNFSQITD  365 (399)
Q Consensus       337 ~~~~~l~~ll~~cl~~dP~~Rps~~ell~  365 (399)
                      .+++++.+||.+||+.||++|||+.|+++
T Consensus       293 ~~s~~~~~li~~~L~~dP~~Rpt~~eil~  321 (400)
T 1nxk_A          293 EVSEEVKMLIRNLLKTEPTQRMTITEFMN  321 (400)
T ss_dssp             TSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred             cCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence            68999999999999999999999999986

>2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A

Probab=100.00  E-value=8.8e-45  Score=355.09  Aligned_cols=249  Identities=22%  Similarity=0.423  Sum_probs=216.6

Q ss_pred             cccceeceeceeCceEEEEEEE--CCeeEEEEEecCCCC--C----HHHHHHHHHHHHHHHhc-CCCceeeEEeEEecCC
Q 015868          116 KQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECV--N----TEMLKEFSQEVYIMRKI-RHKNVVQFIGACTRPP  186 (399)
Q Consensus       116 ~~~~i~~~lg~G~~g~Vy~~~~--~~~~vAvK~~~~~~~--~----~~~~~~~~~Ei~~l~~l-~h~nIv~~~~~~~~~~  186 (399)
                      ++|++.+.||+|+||.||+|+.  +++.||||+++....  .    ....+.+.+|+.+++++ +||||+++++++....
T Consensus        94 ~~y~~~~~lg~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~  173 (365)
T 2y7j_A           94 QKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDSYESSS  173 (365)
T ss_dssp             HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEBSS
T ss_pred             hhcccceEEecCCCEEEEEEEECCCCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeEEEEEEeeCC
Confidence            5799999999999999999998  488999999976532  2    22346788999999999 7999999999999999


Q ss_pred             cEEEEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceeecCCCcEEEeeccceeeccC
Q 015868          187 NLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQ  266 (399)
Q Consensus       187 ~~~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~giiHrDlkp~NILl~~~~~vkl~DFG~a~~~~~  266 (399)
                      ..++||||++|++|.+++.. ...+++..+..++.||+.||.|||+.||+||||||+||+++.++.+||+|||++.....
T Consensus       174 ~~~lv~e~~~g~~L~~~l~~-~~~l~~~~~~~i~~qi~~~L~~LH~~gi~H~Dlkp~NIl~~~~~~ikl~DfG~~~~~~~  252 (365)
T 2y7j_A          174 FMFLVFDLMRKGELFDYLTE-KVALSEKETRSIMRSLLEAVSFLHANNIVHRDLKPENILLDDNMQIRLSDFGFSCHLEP  252 (365)
T ss_dssp             EEEEEECCCTTCBHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEECCT
T ss_pred             EEEEEEEeCCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEEEecCcccccCC
Confidence            99999999999999999976 45789999999999999999999999999999999999999999999999999987766


Q ss_pred             CCccccCCCCcccccccccC------CCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhccCCCCCC--CCC
Q 015868          267 SGVMTAETGTYRWMAPEVIE------HKPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKSLRPTIP--KHA  338 (399)
Q Consensus       267 ~~~~~~~~gt~~y~aPE~l~------~~~~~~~~Dv~slG~vl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~--~~~  338 (399)
                      ........||+.|+|||++.      ...++.++||||||+++|+|++|..||...+.......+.........+  ..+
T Consensus       253 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~  332 (365)
T 2y7j_A          253 GEKLRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRRQILMLRMIMEGQYQFSSPEWDDR  332 (365)
T ss_dssp             TCCBCCCCSCGGGCCHHHHHHTTCTTSCCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCHHHHSSS
T ss_pred             CcccccCCCCCCccChhhccccccccCcCCCchhhHHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCCCcccccC
Confidence            55566678999999999985      3468899999999999999999999999888776655554433332222  467


Q ss_pred             cHHHHHHHHHHhhhcCCCCCCHHHHHH
Q 015868          339 HPRLAELLERCWQHDPTQRPNFSQITD  365 (399)
Q Consensus       339 ~~~l~~ll~~cl~~dP~~Rps~~ell~  365 (399)
                      ++++.++|.+||+.||++|||+.++++
T Consensus       333 ~~~~~~li~~~L~~dP~~Rps~~ell~  359 (365)
T 2y7j_A          333 SSTVKDLISRLLQVDPEARLTAEQALQ  359 (365)
T ss_dssp             CHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred             CHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence            889999999999999999999999975

>3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens}

Probab=100.00  E-value=4.8e-46  Score=349.21  Aligned_cols=249  Identities=24%  Similarity=0.420  Sum_probs=192.9

Q ss_pred             ccccceeceeceeCceEEEEEEE--CCeeEEEEEecCCCC-CHHHHHHHHHHHHHHHhcCCCceeeEEeEEecCCcEEEE
Q 015868          115 AKQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECV-NTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIV  191 (399)
Q Consensus       115 ~~~~~i~~~lg~G~~g~Vy~~~~--~~~~vAvK~~~~~~~-~~~~~~~~~~Ei~~l~~l~h~nIv~~~~~~~~~~~~~lV  191 (399)
                      .++|++.+.||+|+||.||+|+.  .++.||+|++..... .....+.+.+|+.++++++||||+++++++......++|
T Consensus        10 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   89 (278)
T 3cok_A           10 IEDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYNYFEDSNYVYLV   89 (278)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTBCCTTBCCEEEEEECSSEEEEE
T ss_pred             cccceeeeeecCCCceEEEEEEEccCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHhCCCCCeEeEEEEEccCCeEEEE
Confidence            46899999999999999999997  678999999964211 111236789999999999999999999999999999999


Q ss_pred             EecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceeecCCCcEEEeeccceeeccCCC-cc
Q 015868          192 TEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSG-VM  270 (399)
Q Consensus       192 ~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~giiHrDlkp~NILl~~~~~vkl~DFG~a~~~~~~~-~~  270 (399)
                      |||+++++|.+++......+++..++.++.|++.||.|||++||+||||||+||+++.++.+||+|||.+....... ..
T Consensus        90 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~~~~  169 (278)
T 3cok_A           90 LEMCHNGEMNRYLKNRVKPFSENEARHFMHQIITGMLYLHSHGILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHEKH  169 (278)
T ss_dssp             EECCTTEEHHHHHHTCSSCCCHHHHHHHHHHHHHHHHHHHHTTEECSSCCGGGEEECTTCCEEECCCTTCEECC------
T ss_pred             EecCCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCCEEEEeecceeeccCCCCcc
Confidence            99999999999998877789999999999999999999999999999999999999999999999999998654322 22


Q ss_pred             ccCCCCcccccccccCCCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhccCCCCCCCCCcHHHHHHHHHHh
Q 015868          271 TAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRLAELLERCW  350 (399)
Q Consensus       271 ~~~~gt~~y~aPE~l~~~~~~~~~Dv~slG~vl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~cl  350 (399)
                      ....||+.|+|||.+.+..++.++||||||+++|+|++|+.||...+..+.......  .....|..++.++.++|.+||
T Consensus       170 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~li~~~l  247 (278)
T 3cok_A          170 YTLCGTPNYISPEIATRSAHGLESDVWSLGCMFYTLLIGRPPFDTDTVKNTLNKVVL--ADYEMPSFLSIEAKDLIHQLL  247 (278)
T ss_dssp             ----------------------CTHHHHHHHHHHHHHHSSCSSCCCSCC-----CCS--SCCCCCTTSCHHHHHHHHHHS
T ss_pred             eeccCCCCcCCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCChhHHHHHHHHhh--cccCCccccCHHHHHHHHHHc
Confidence            345689999999999999999999999999999999999999987665444333222  223466778999999999999


Q ss_pred             hhcCCCCCCHHHHHH
Q 015868          351 QHDPTQRPNFSQITD  365 (399)
Q Consensus       351 ~~dP~~Rps~~ell~  365 (399)
                      +.||++|||+.++++
T Consensus       248 ~~dp~~Rps~~~~l~  262 (278)
T 3cok_A          248 RRNPADRLSLSSVLD  262 (278)
T ss_dssp             CSSGGGSCCHHHHTT
T ss_pred             ccCHhhCCCHHHHhc
Confidence            999999999999875

>2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens}

Probab=100.00  E-value=1.6e-45  Score=358.20  Aligned_cols=258  Identities=17%  Similarity=0.275  Sum_probs=213.9

Q ss_pred             eeecccccceeceeceeCceEEEEEEEC----------CeeEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCceee---
Q 015868          111 WEIDAKQLKIECKVASGSYGDLYKGTYC----------SQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQ---  177 (399)
Q Consensus       111 ~~i~~~~~~i~~~lg~G~~g~Vy~~~~~----------~~~vAvK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~nIv~---  177 (399)
                      .....++|++.+.||+|+||.||+|++.          ++.||+|+++..       ..+.+|+.++++++||||++   
T Consensus        37 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~-------~~~~~E~~~l~~l~h~niv~~~~  109 (352)
T 2jii_A           37 TDKSGRQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKD-------GRLFNEQNFFQRAAKPLQVNKWK  109 (352)
T ss_dssp             ECTTSCEEEEEEEEEEETTEEEEEEEECC-----------CEEEEEEETT-------STHHHHHHHHHHHCCHHHHHHHH
T ss_pred             ecccCCeEEEEEEecCCCCeEEEEEeecCCccccccccCceEEEEEeccc-------chHHHHHHHHHHhcccchhhhhh
Confidence            3445689999999999999999999874          678999999754       46789999999999999887   


Q ss_pred             ------------EEeEEec-CCcEEEEEecCCCCCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCC
Q 015868          178 ------------FIGACTR-PPNLCIVTEFMARGSIYDFLHKQ-KGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTA  243 (399)
Q Consensus       178 ------------~~~~~~~-~~~~~lV~E~~~ggsL~~~l~~~-~~~l~~~~~~~i~~~i~~~L~~LH~~giiHrDlkp~  243 (399)
                                  +++++.. ....++||||+ +++|.+++... ...+++..++.++.||+.||.|||++||+||||||+
T Consensus       110 ~~~~~~~~~i~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dikp~  188 (352)
T 2jii_A          110 KLYSTPLLAIPTCMGFGVHQDKYRFLVLPSL-GRSLQSALDVSPKHVLSERSVLQVACRLLDALEFLHENEYVHGNVTAE  188 (352)
T ss_dssp             HHTTCTTCSCCCCCEEEEETTTEEEEEEECC-CEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCCGG
T ss_pred             hhccCCccCccchhhccccCCcEEEEEecCC-CcCHHHHHHhCCcCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCHH
Confidence                        6677765 67889999999 88999999875 367999999999999999999999999999999999


Q ss_pred             ceeecCCC--cEEEeeccceeeccCCC--------ccccCCCCcccccccccCCCCCCChhhHHHHHHHHHHHHcCCCCC
Q 015868          244 NLLMDENG--VVKVADFGVARVQAQSG--------VMTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPY  313 (399)
Q Consensus       244 NILl~~~~--~vkl~DFG~a~~~~~~~--------~~~~~~gt~~y~aPE~l~~~~~~~~~Dv~slG~vl~elltg~~P~  313 (399)
                      ||+++.++  .+||+|||+++......        ......||+.|+|||.+.+..++.++||||||+++|+|++|+.||
T Consensus       189 NIl~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf  268 (352)
T 2jii_A          189 NIFVDPEDQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHKGCGPSRRSDLQSLGYCMLKWLYGFLPW  268 (352)
T ss_dssp             GEEEETTEEEEEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTT
T ss_pred             HEEEcCCCCceEEEecCcceeeccCCCccccccccccccccCCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCc
Confidence            99999998  99999999997654322        123347899999999999999999999999999999999999999


Q ss_pred             CCCCH-HHHHHHHHh--ccCCCCCC------CCCcHHHHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHh
Q 015868          314 AGLTP-LQAAVGVVQ--KSLRPTIP------KHAHPRLAELLERCWQHDPTQRPNFSQITDILKQMMKEVAS  376 (399)
Q Consensus       314 ~~~~~-~~~~~~~~~--~~~~~~~~------~~~~~~l~~ll~~cl~~dP~~Rps~~ell~~L~~l~~~~~~  376 (399)
                      ....+ .........  ....+.++      ..+++++.+++.+||+.||.+|||+.++++.|+++++....
T Consensus       269 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~~~~~  340 (352)
T 2jii_A          269 TNCLPNTEDIMKQKQKFVDKPGPFVGPCGHWIRPSETLQKYLKVVMALTYEEKPPYAMLRNNLEALLQDLRV  340 (352)
T ss_dssp             GGGTTCHHHHHHHHHHHHHSCCCEECTTSCEECCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHHTTC
T ss_pred             ccCCcCHHHHHHHHHhccCChhhhhhhccccCCCcHHHHHHHHHHHhCChhhCCCHHHHHHHHHHHHHhcCC
Confidence            87642 222222221  11112121      24689999999999999999999999999999999876653

>3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A*

Probab=100.00  E-value=1.8e-45  Score=354.41  Aligned_cols=252  Identities=21%  Similarity=0.369  Sum_probs=215.1

Q ss_pred             ccccccee-ceeceeCceEEEEEEEC--CeeEEEEEecCCCCCHHHHHHHHHHHHHHHhcC-CCceeeEEeEEecCCcEE
Q 015868          114 DAKQLKIE-CKVASGSYGDLYKGTYC--SQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIR-HKNVVQFIGACTRPPNLC  189 (399)
Q Consensus       114 ~~~~~~i~-~~lg~G~~g~Vy~~~~~--~~~vAvK~~~~~~~~~~~~~~~~~Ei~~l~~l~-h~nIv~~~~~~~~~~~~~  189 (399)
                      -.++|.+. +.||+|+||.||+|...  ++.||+|+++...........+.+|+.+++.+. ||||+++++++......+
T Consensus        26 ~~~~y~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~iv~~~~~~~~~~~~~  105 (327)
T 3lm5_A           26 FNNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHEVYENTSEII  105 (327)
T ss_dssp             HHHHEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESEETTEECHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEE
T ss_pred             hhhEEeeccceeCCCCCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHhccCCCCEEEEEEEEEeCCeEE
Confidence            35677777 88999999999999884  789999999865544555678899999999995 699999999999999999


Q ss_pred             EEEecCCCCCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceeecC---CCcEEEeeccceeecc
Q 015868          190 IVTEFMARGSIYDFLHKQ-KGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDE---NGVVKVADFGVARVQA  265 (399)
Q Consensus       190 lV~E~~~ggsL~~~l~~~-~~~l~~~~~~~i~~~i~~~L~~LH~~giiHrDlkp~NILl~~---~~~vkl~DFG~a~~~~  265 (399)
                      +||||+.+++|.+++... ...+++..++.++.|++.||+|||++||+||||||+||+++.   ++.+||+|||+++...
T Consensus       106 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~L~~LH~~givH~Dikp~NIl~~~~~~~~~~kL~Dfg~a~~~~  185 (327)
T 3lm5_A          106 LILEYAAGGEIFSLCLPELAEMVSENDVIRLIKQILEGVYYLHQNNIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIG  185 (327)
T ss_dssp             EEEECCTTEEGGGGGSSCC-CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESCBTTBCCEEECCGGGCEEC-
T ss_pred             EEEEecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeecCcCChHHEEEecCCCCCcEEEeeCccccccC
Confidence            999999999999998543 467999999999999999999999999999999999999987   7899999999998776


Q ss_pred             CCCccccCCCCcccccccccCCCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhccC--CCCCCCCCcHHHH
Q 015868          266 QSGVMTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKSL--RPTIPKHAHPRLA  343 (399)
Q Consensus       266 ~~~~~~~~~gt~~y~aPE~l~~~~~~~~~Dv~slG~vl~elltg~~P~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~l~  343 (399)
                      .........||+.|+|||++.+..++.++||||||+++|+|++|..||...+..+..........  ....+..+++.+.
T Consensus       186 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~  265 (327)
T 3lm5_A          186 HACELREIMGTPEYLAPEILNYDPITTATDMWNIGIIAYMLLTHTSPFVGEDNQETYLNISQVNVDYSEETFSSVSQLAT  265 (327)
T ss_dssp             --------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTTTTTTSCHHHH
T ss_pred             CccccccccCCcCccCCeeecCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHhcccccCchhhcccCHHHH
Confidence            65555566899999999999999999999999999999999999999999888776665554332  2334467899999


Q ss_pred             HHHHHHhhhcCCCCCCHHHHHH
Q 015868          344 ELLERCWQHDPTQRPNFSQITD  365 (399)
Q Consensus       344 ~ll~~cl~~dP~~Rps~~ell~  365 (399)
                      ++|.+||+.||.+|||++++++
T Consensus       266 ~li~~~L~~dP~~Rpt~~~ll~  287 (327)
T 3lm5_A          266 DFIQSLLVKNPEKRPTAEICLS  287 (327)
T ss_dssp             HHHHHHSCSSGGGSCCHHHHTT
T ss_pred             HHHHHHcCCChhhCcCHHHHhC
Confidence            9999999999999999999975

>3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=5.4e-45  Score=350.94  Aligned_cols=253  Identities=32%  Similarity=0.606  Sum_probs=208.6

Q ss_pred             cccccceeceeceeCceEEEEEEECCeeEEEEEecCCCCCHHHHHHHHHHHHHHHhc--CCCceeeEEeEEecC----Cc
Q 015868          114 DAKQLKIECKVASGSYGDLYKGTYCSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKI--RHKNVVQFIGACTRP----PN  187 (399)
Q Consensus       114 ~~~~~~i~~~lg~G~~g~Vy~~~~~~~~vAvK~~~~~~~~~~~~~~~~~Ei~~l~~l--~h~nIv~~~~~~~~~----~~  187 (399)
                      -.++|++.++||+|+||.||+|++.++.||||++...   .  ...+.+|..++...  +||||+++++++...    ..
T Consensus        35 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~vavK~~~~~---~--~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~  109 (337)
T 3mdy_A           35 IAKQIQMVKQIGKGRYGEVWMGKWRGEKVAVKVFFTT---E--EASWFRETEIYQTVLMRHENILGFIAADIKGTGSWTQ  109 (337)
T ss_dssp             HHHHCEEEEEEEEETTEEEEEEEETTEEEEEEEEEGG---G--HHHHHHHHHHHTSTTCCCTTBCCEEEEEEESCGGGCE
T ss_pred             cccceEEEeEeecCCCeEEEEEEECCceEEEEEEecc---c--cchhhhHHHHHHHHhhcCCCeeeEEEEEccCCCCCCc
Confidence            3579999999999999999999999999999999643   2  23444555665554  899999999999877    67


Q ss_pred             EEEEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC--------CcccCCCCCCceeecCCCcEEEeecc
Q 015868          188 LCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQN--------NIIHRDLKTANLLMDENGVVKVADFG  259 (399)
Q Consensus       188 ~~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~--------giiHrDlkp~NILl~~~~~vkl~DFG  259 (399)
                      .++||||+++|+|.+++..  ..+++..++.++.|++.||.|||++        ||+||||||+|||++.++.+||+|||
T Consensus       110 ~~lv~e~~~~g~L~~~l~~--~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfg  187 (337)
T 3mdy_A          110 LYLITDYHENGSLYDYLKS--TTLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGTCCIADLG  187 (337)
T ss_dssp             EEEEECCCTTCBHHHHHHH--CCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCCEECSCCCGGGEEECTTSCEEECCCT
T ss_pred             eEEEEeccCCCcHHHHhhc--cCCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCEEecccchHHEEECCCCCEEEEeCC
Confidence            9999999999999999966  4689999999999999999999999        99999999999999999999999999


Q ss_pred             ceeeccCCCc-----cccCCCCcccccccccCCCCCCCh------hhHHHHHHHHHHHHcC----------CCCCCCCCH
Q 015868          260 VARVQAQSGV-----MTAETGTYRWMAPEVIEHKPYDYK------ADVFSFGIALWELLTG----------ELPYAGLTP  318 (399)
Q Consensus       260 ~a~~~~~~~~-----~~~~~gt~~y~aPE~l~~~~~~~~------~Dv~slG~vl~elltg----------~~P~~~~~~  318 (399)
                      +++.......     .....||+.|+|||++.+..+..+      +||||||+++|||+||          +.||....+
T Consensus       188 ~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~~~~~~~~~~~p~~~~~~  267 (337)
T 3mdy_A          188 LAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQLPYHDLVP  267 (337)
T ss_dssp             TCEECC---------CCSSCSCGGGCCHHHHTTCCCTTCTHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTTSC
T ss_pred             CceeeccccccccCCCCCCccCcceeChhhcccccCCccccCccccchHHHHHHHHHHHhccCcccccccccccHhhhcC
Confidence            9976544322     124578999999999988776665      9999999999999999          777765422


Q ss_pred             -----HHHHHHHHhccCCCCCCC-----CCcHHHHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHH
Q 015868          319 -----LQAAVGVVQKSLRPTIPK-----HAHPRLAELLERCWQHDPTQRPNFSQITDILKQMMKE  373 (399)
Q Consensus       319 -----~~~~~~~~~~~~~~~~~~-----~~~~~l~~ll~~cl~~dP~~Rps~~ell~~L~~l~~~  373 (399)
                           ............++..+.     .+++++.+++.+||+.||.+|||+.++++.|+++.++
T Consensus       268 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l~~~  332 (337)
T 3mdy_A          268 SDPSYEDMREIVCIKKLRPSFPNRWSSDECLRQMGKLMTECWAHNPASRLTALRVKKTLAKMSES  332 (337)
T ss_dssp             SSCCHHHHHHHHTTSCCCCCCCGGGGGSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHT
T ss_pred             CCCchhhhHHHHhhhccCccccccchhhHHHHHHHHHHHHhhhhChhhCCCHHHHHHHHHHHHhh
Confidence                 222222333444555554     4677899999999999999999999999999998764

>4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A*

Probab=100.00  E-value=2.3e-45  Score=353.83  Aligned_cols=256  Identities=25%  Similarity=0.416  Sum_probs=214.2

Q ss_pred             CceeecccccceeceeceeCceEEEEEEEC--CeeEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCceeeEEeEEecCC
Q 015868          109 DVWEIDAKQLKIECKVASGSYGDLYKGTYC--SQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPP  186 (399)
Q Consensus       109 ~~~~i~~~~~~i~~~lg~G~~g~Vy~~~~~--~~~vAvK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~nIv~~~~~~~~~~  186 (399)
                      ..+....++|++.+.||+|+||.||+|++.  ++.||+|++..........+.+.+|+.++++++||||+++++++....
T Consensus        18 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~   97 (331)
T 4aaa_A           18 NLYFQSMEKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLLEVCKKKK   97 (331)
T ss_dssp             -CCCBCGGGEEEEEEGGGGTTSSEEEEEETTTCCEEEEEEEESCSSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETT
T ss_pred             hhhhhhhhhheeeeEEeecCCEEEEEEEECCCCceEEEEEEecCCCchHHHHHHHHHHHHHhhCCCCCEeeEEEEeecCC
Confidence            344556789999999999999999999984  789999999877667777788999999999999999999999999999


Q ss_pred             cEEEEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceeecCCCcEEEeeccceeeccC
Q 015868          187 NLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQ  266 (399)
Q Consensus       187 ~~~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~giiHrDlkp~NILl~~~~~vkl~DFG~a~~~~~  266 (399)
                      ..++||||+++++|.+++.. ...+++..++.++.|++.||.|||++||+||||||+||+++.++.+||+|||.++....
T Consensus        98 ~~~lv~e~~~~~~l~~~~~~-~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~  176 (331)
T 4aaa_A           98 RWYLVFEFVDHTILDDLELF-PNGLDYQVVQKYLFQIINGIGFCHSHNIIHRDIKPENILVSQSGVVKLCDFGFARTLAA  176 (331)
T ss_dssp             EEEEEEECCSEEHHHHHHHS-TTCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCTTC-----
T ss_pred             EEEEEEecCCcchHHHHHhh-ccCCCHHHHHHHHHHHHHHHHHHHHCCEEccCcChheEEEcCCCcEEEEeCCCceeecC
Confidence            99999999999888887654 56799999999999999999999999999999999999999999999999999976544


Q ss_pred             C-CccccCCCCcccccccccCCC-CCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcc---------------
Q 015868          267 S-GVMTAETGTYRWMAPEVIEHK-PYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKS---------------  329 (399)
Q Consensus       267 ~-~~~~~~~gt~~y~aPE~l~~~-~~~~~~Dv~slG~vl~elltg~~P~~~~~~~~~~~~~~~~~---------------  329 (399)
                      . .......||+.|+|||.+.+. .++.++||||||+++|+|++|..||.+.+..+.........               
T Consensus       177 ~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  256 (331)
T 4aaa_A          177 PGEVYDDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQLYHIMMCLGNLIPRHQELFNKNP  256 (331)
T ss_dssp             -------CCCCCTTCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHHHCG
T ss_pred             CccccCCCcCCccccCcccccCCCCcchHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhHhhhcc
Confidence            3 233456789999999999875 78999999999999999999999999888766554433210               


Q ss_pred             -----CCCCC---------CCCCcHHHHHHHHHHhhhcCCCCCCHHHHHH
Q 015868          330 -----LRPTI---------PKHAHPRLAELLERCWQHDPTQRPNFSQITD  365 (399)
Q Consensus       330 -----~~~~~---------~~~~~~~l~~ll~~cl~~dP~~Rps~~ell~  365 (399)
                           ..+.+         ...+++++.+||.+||+.||.+|||+.|+++
T Consensus       257 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~  306 (331)
T 4aaa_A          257 VFAGVRLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELLH  306 (331)
T ss_dssp             GGTTCCCCCCSSCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCGGGGGG
T ss_pred             ccccccCccccccchhhhcccchhHHHHHHHHHHhccCcccCCCHHHHhc
Confidence                 00111         1357899999999999999999999999976

>2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B*

Probab=100.00  E-value=2.4e-45  Score=344.82  Aligned_cols=248  Identities=26%  Similarity=0.412  Sum_probs=213.9

Q ss_pred             ccccceeceeceeCceEEEEEEEC--CeeEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCceeeEEeEEec--------
Q 015868          115 AKQLKIECKVASGSYGDLYKGTYC--SQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTR--------  184 (399)
Q Consensus       115 ~~~~~i~~~lg~G~~g~Vy~~~~~--~~~vAvK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~nIv~~~~~~~~--------  184 (399)
                      ..+|++.+.||+|+||.||+|.+.  ++.||+|+++...      ..+.+|+.++++++||||+++++++..        
T Consensus        10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~------~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~   83 (284)
T 2a19_B           10 GMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN------EKAEREVKALAKLDHVNIVHYNGCWDGFDYDPETS   83 (284)
T ss_dssp             HHHEEEEEEEECSSSCCEEEEEETTTCCEEEEEEEECCS------GGGHHHHHHHHHCCCTTBCCEEEEEEEEEEC----
T ss_pred             ccccceeeeeccCCceEEEEEEEcCCCeEEEEEEecccc------HHHHHHHHHHHhCCCCCEEEEeeeEeccccCcccc
Confidence            568999999999999999999984  8899999998652      356789999999999999999998854        


Q ss_pred             --------CCcEEEEEecCCCCCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceeecCCCcEEE
Q 015868          185 --------PPNLCIVTEFMARGSIYDFLHKQ-KGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKV  255 (399)
Q Consensus       185 --------~~~~~lV~E~~~ggsL~~~l~~~-~~~l~~~~~~~i~~~i~~~L~~LH~~giiHrDlkp~NILl~~~~~vkl  255 (399)
                              ...+++||||+++++|.+++... ...+++..++.++.|++.||.|||++||+||||||+||+++.++.+||
T Consensus        84 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl  163 (284)
T 2a19_B           84 SKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQITKGVDYIHSKKLINRDLKPSNIFLVDTKQVKI  163 (284)
T ss_dssp             -----CCEEEEEEEEECCCCSCBHHHHHHHGGGSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEE
T ss_pred             cccccccCcceEEEEEeccCCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCHHHEEEcCCCCEEE
Confidence                    34589999999999999999764 367899999999999999999999999999999999999999999999


Q ss_pred             eeccceeeccCCCccccCCCCcccccccccCCCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhccCCCCCC
Q 015868          256 ADFGVARVQAQSGVMTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKSLRPTIP  335 (399)
Q Consensus       256 ~DFG~a~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~Dv~slG~vl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~  335 (399)
                      +|||+++............|++.|+|||.+.+..++.++||||||+++|+|++|..|+....  . .....   ....++
T Consensus       164 ~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~--~-~~~~~---~~~~~~  237 (284)
T 2a19_B          164 GDFGLVTSLKNDGKRTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFETS--K-FFTDL---RDGIIS  237 (284)
T ss_dssp             CCCTTCEESSCCSCCCCCCSCCTTSCHHHHHCSCCCTHHHHHHHHHHHHHHHSCCSSHHHHH--H-HHHHH---HTTCCC
T ss_pred             CcchhheeccccccccccCCcccccChhhhccCCCcchhhhHHHHHHHHHHHhcCCcchhHH--H-HHHHh---hccccc
Confidence            99999987766555566679999999999999999999999999999999999998874321  1 11112   233456


Q ss_pred             CCCcHHHHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHH
Q 015868          336 KHAHPRLAELLERCWQHDPTQRPNFSQITDILKQMMKEV  374 (399)
Q Consensus       336 ~~~~~~l~~ll~~cl~~dP~~Rps~~ell~~L~~l~~~~  374 (399)
                      ..+++++.+++.+||+.||.+|||+.|+++.|..+.+..
T Consensus       238 ~~~~~~~~~li~~~l~~dp~~Rps~~e~l~~l~~~~~~~  276 (284)
T 2a19_B          238 DIFDKKEKTLLQKLLSKKPEDRPNTSEILRTLTVWKKSP  276 (284)
T ss_dssp             TTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHTC--
T ss_pred             ccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHhhCC
Confidence            778999999999999999999999999999998885433

>3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A*

Probab=100.00  E-value=8.7e-45  Score=345.03  Aligned_cols=249  Identities=33%  Similarity=0.572  Sum_probs=220.7

Q ss_pred             cccccceeceeceeCceEEEEEEE--CCeeEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCceeeEEeEEecCCcEEEE
Q 015868          114 DAKQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIV  191 (399)
Q Consensus       114 ~~~~~~i~~~lg~G~~g~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~nIv~~~~~~~~~~~~~lV  191 (399)
                      ..+.|++.++||+|+||.||+|.+  .++.||+|+++.... ....+.+.+|+.+++.++||||+++++++......++|
T Consensus        20 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   98 (303)
T 3a7i_A           20 PEELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEA-EDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWII   98 (303)
T ss_dssp             GGGTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEETTTC-STTHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEE
T ss_pred             hHHHHHHhhhhcccCCeEEEEEEECCCCcEEEEEEeccccc-HHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEE
Confidence            346799999999999999999987  578999999976542 23457899999999999999999999999999999999


Q ss_pred             EecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceeecCCCcEEEeeccceeeccCCC-cc
Q 015868          192 TEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSG-VM  270 (399)
Q Consensus       192 ~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~giiHrDlkp~NILl~~~~~vkl~DFG~a~~~~~~~-~~  270 (399)
                      |||+++++|.+++..  +.+++..++.++.|++.||.|||++||+||||||+||+++.++.+||+|||.+....... ..
T Consensus        99 ~e~~~~~~L~~~~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~  176 (303)
T 3a7i_A           99 MEYLGGGSALDLLEP--GPLDETQIATILREILKGLDYLHSEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKR  176 (303)
T ss_dssp             EECCTTEEHHHHHTT--SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECBTTBCCB
T ss_pred             EEeCCCCcHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCChheEEECCCCCEEEeecccceecCcccccc
Confidence            999999999999864  578999999999999999999999999999999999999999999999999998655433 23


Q ss_pred             ccCCCCcccccccccCCCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhccCCCCCCCCCcHHHHHHHHHHh
Q 015868          271 TAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRLAELLERCW  350 (399)
Q Consensus       271 ~~~~gt~~y~aPE~l~~~~~~~~~Dv~slG~vl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~cl  350 (399)
                      ....|++.|+|||.+.+..++.++||||||+++|+|++|..||....+.+..... .....+.++..++..+.+++.+||
T Consensus       177 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~-~~~~~~~~~~~~~~~l~~li~~~l  255 (303)
T 3a7i_A          177 NTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSELHPMKVLFLI-PKNNPPTLEGNYSKPLKEFVEACL  255 (303)
T ss_dssp             CCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHH-HHSCCCCCCSSCCHHHHHHHHHHC
T ss_pred             CccCCCcCccCHHHHhcCCCCchhhhHHHHHHHHHHccCCCCCCCcCHHHHHHHh-hcCCCCCCccccCHHHHHHHHHHc
Confidence            4457899999999999999999999999999999999999999988877655443 345566778889999999999999


Q ss_pred             hhcCCCCCCHHHHHHH
Q 015868          351 QHDPTQRPNFSQITDI  366 (399)
Q Consensus       351 ~~dP~~Rps~~ell~~  366 (399)
                      +.||.+|||+.++++.
T Consensus       256 ~~dp~~Rps~~~ll~~  271 (303)
T 3a7i_A          256 NKEPSFRPTAKELLKH  271 (303)
T ss_dssp             CSSGGGSCCHHHHTTC
T ss_pred             CCChhhCcCHHHHhhC
Confidence            9999999999999773

>2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ...

Probab=100.00  E-value=4.1e-45  Score=344.11  Aligned_cols=250  Identities=24%  Similarity=0.434  Sum_probs=218.2

Q ss_pred             eecccccceeceeceeCceEEEEEEE--CCeeEEEEEecCCCCC-HHHHHHHHHHHHHHHhcCCCceeeEEeEEecCCcE
Q 015868          112 EIDAKQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVN-TEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNL  188 (399)
Q Consensus       112 ~i~~~~~~i~~~lg~G~~g~Vy~~~~--~~~~vAvK~~~~~~~~-~~~~~~~~~Ei~~l~~l~h~nIv~~~~~~~~~~~~  188 (399)
                      .+..++|++.+.||+|+||.||+|+.  .++.||+|++...... ......+.+|+.+++.++||||+++++++......
T Consensus        10 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~   89 (284)
T 2vgo_A           10 KFTIDDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYNYFHDRKRI   89 (284)
T ss_dssp             CCCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEE
T ss_pred             chhhhhceeeheecCCCCeEEEEEEEcCCCcEEEEEEEcccccchHHHHHHHHHHHHHHhcCCCCCEeeEEEEEEcCCEE
Confidence            34567999999999999999999998  4678999998642111 11235788999999999999999999999999999


Q ss_pred             EEEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceeecCCCcEEEeeccceeeccCCC
Q 015868          189 CIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSG  268 (399)
Q Consensus       189 ~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~giiHrDlkp~NILl~~~~~vkl~DFG~a~~~~~~~  268 (399)
                      ++||||+++++|.+++... +.+++..++.++.|++.||.|||++||+||||||+||+++.++.+||+|||.+...... 
T Consensus        90 ~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~-  167 (284)
T 2vgo_A           90 YLMLEFAPRGELYKELQKH-GRFDEQRSATFMEELADALHYCHERKVIHRDIKPENLLMGYKGELKIADFGWSVHAPSL-  167 (284)
T ss_dssp             EEEECCCTTEEHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEECTTCCEEECCCTTCEECSSS-
T ss_pred             EEEEEeCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEEcCCCCEEEecccccccCccc-
Confidence            9999999999999999764 56899999999999999999999999999999999999999999999999999765432 


Q ss_pred             ccccCCCCcccccccccCCCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhccCCCCCCCCCcHHHHHHHHH
Q 015868          269 VMTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRLAELLER  348 (399)
Q Consensus       269 ~~~~~~gt~~y~aPE~l~~~~~~~~~Dv~slG~vl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~  348 (399)
                      ......|++.|+|||.+.+..++.++||||||+++|+|++|..||...+..+.......  ....+|..++.++.++|.+
T Consensus       168 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~li~~  245 (284)
T 2vgo_A          168 RRRTMCGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFDSPSHTETHRRIVN--VDLKFPPFLSDGSKDLISK  245 (284)
T ss_dssp             CBCCCCSCGGGCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHT--TCCCCCTTSCHHHHHHHHH
T ss_pred             ccccccCCCCcCCHHHhccCCCCcccchhhHHHHHHHHHHCCCCCCCCCHhHHHHHHhc--cccCCCCcCCHHHHHHHHH
Confidence            23456789999999999999999999999999999999999999998887666555443  2345677899999999999


Q ss_pred             HhhhcCCCCCCHHHHHH
Q 015868          349 CWQHDPTQRPNFSQITD  365 (399)
Q Consensus       349 cl~~dP~~Rps~~ell~  365 (399)
                      ||+.||.+|||+.++++
T Consensus       246 ~l~~~p~~Rps~~~ll~  262 (284)
T 2vgo_A          246 LLRYHPPQRLPLKGVME  262 (284)
T ss_dssp             HSCSSGGGSCCHHHHHT
T ss_pred             HhhcCHhhCCCHHHHhh
Confidence            99999999999999986

>2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A*

Probab=100.00  E-value=2.1e-45  Score=349.72  Aligned_cols=254  Identities=28%  Similarity=0.495  Sum_probs=212.3

Q ss_pred             ccceeceeceeCceEEEEEEECCeeEEEEEecCCC--CCHHHHHHHHHHHHHHHhcCCCceeeEEeEEecCCcEEEEEec
Q 015868          117 QLKIECKVASGSYGDLYKGTYCSQEVAIKVLKPEC--VNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVTEF  194 (399)
Q Consensus       117 ~~~i~~~lg~G~~g~Vy~~~~~~~~vAvK~~~~~~--~~~~~~~~~~~Ei~~l~~l~h~nIv~~~~~~~~~~~~~lV~E~  194 (399)
                      .|...++||+|+||.||+|.+.++.||+|++....  ......+.+.+|+.++++++||||+++++++......++||||
T Consensus        32 ~~~~~~~lg~G~~g~Vy~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~  111 (307)
T 2nru_A           32 ISVGGNKMGEGGFGVVYKGYVNNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVY  111 (307)
T ss_dssp             TTTTCCEEEECSSEEEEEEESSSCEEEEEEECCCTTSCTTTHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEEC
T ss_pred             ccccCCccccCCCeEEEEEEECCceEEEEEEecccCcchHHHHHHHHHHHHHHHhcCCCCeEEEEEEEecCCceEEEEEe
Confidence            35556899999999999999999999999997542  2345567899999999999999999999999999999999999


Q ss_pred             CCCCCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceeecCCCcEEEeeccceeeccCCCc---
Q 015868          195 MARGSIYDFLHKQ--KGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGV---  269 (399)
Q Consensus       195 ~~ggsL~~~l~~~--~~~l~~~~~~~i~~~i~~~L~~LH~~giiHrDlkp~NILl~~~~~vkl~DFG~a~~~~~~~~---  269 (399)
                      +++++|.+++...  ...+++..++.++.|++.||.|||++||+||||||+||+++.++.+||+|||+++.......   
T Consensus       112 ~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~  191 (307)
T 2nru_A          112 MPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHENHHIHRDIKSANILLDEAFTAKISDFGLARASEKFAQTVM  191 (307)
T ss_dssp             CTTCBHHHHHHTGGGCCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCCTTCEECCSCSSCEE
T ss_pred             cCCCcHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhcCCeecCCCCHHHEEEcCCCcEEEeeccccccccccccccc
Confidence            9999999999743  35689999999999999999999999999999999999999999999999999986544221   


Q ss_pred             cccCCCCcccccccccCCCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHH---Hh----------ccCCCCCCC
Q 015868          270 MTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGV---VQ----------KSLRPTIPK  336 (399)
Q Consensus       270 ~~~~~gt~~y~aPE~l~~~~~~~~~Dv~slG~vl~elltg~~P~~~~~~~~~~~~~---~~----------~~~~~~~~~  336 (399)
                      .....||+.|+|||.+.+. ++.++||||||+++|+|++|..||......+.....   ..          ....+..+.
T Consensus       192 ~~~~~g~~~y~aPE~~~~~-~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  270 (307)
T 2nru_A          192 TSRIVGTTAYMAPEALRGE-ITPKSDIYSFGVVLLEIITGLPAVDEHREPQLLLDIKEEIEDEEKTIEDYIDKKMNDADS  270 (307)
T ss_dssp             CSSCCSCGGGCCHHHHTTE-ECTHHHHHHHHHHHHHHHHCCCSBCTTBSSSBTTHHHHHHHTTSCCHHHHSCSSCSCCCH
T ss_pred             ccccCCCcCcCChHHhcCC-CCccchhHHHHHHHHHHHHCCCCcccCcchHHHHHHHHHhhhhhhhhhhhccccccccch
Confidence            2334689999999998764 889999999999999999999999875432211111   10          011122344


Q ss_pred             CCcHHHHHHHHHHhhhcCCCCCCHHHHHHHHHHHH
Q 015868          337 HAHPRLAELLERCWQHDPTQRPNFSQITDILKQMM  371 (399)
Q Consensus       337 ~~~~~l~~ll~~cl~~dP~~Rps~~ell~~L~~l~  371 (399)
                      ..+..+.+++.+||+.||.+|||+.++++.|+++.
T Consensus       271 ~~~~~l~~li~~cl~~~p~~Rps~~~l~~~L~~l~  305 (307)
T 2nru_A          271 TSVEAMYSVASQCLHEKKNKRPDIKKVQQLLQEMT  305 (307)
T ss_dssp             HHHHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHC
T ss_pred             HHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHh
Confidence            46678999999999999999999999999999874

>2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens}

Probab=100.00  E-value=9.7e-45  Score=348.04  Aligned_cols=250  Identities=31%  Similarity=0.540  Sum_probs=210.4

Q ss_pred             ecccccceeceeceeCceEEEEEEE--CCeeEEEEEecCCCCCHHHHHHHHHHHHHHHhc-CCCceeeEEeEEec-----
Q 015868          113 IDAKQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKI-RHKNVVQFIGACTR-----  184 (399)
Q Consensus       113 i~~~~~~i~~~lg~G~~g~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~Ei~~l~~l-~h~nIv~~~~~~~~-----  184 (399)
                      ...++|++.+.||+|+||.||+|++  .++.||+|++......   ...+.+|+.+++++ +||||+++++++..     
T Consensus        21 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~---~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~   97 (326)
T 2x7f_A           21 DPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDE---EEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPG   97 (326)
T ss_dssp             CCTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSST---THHHHHHHHHHHHHCCSTTBCCEEEEEEECC--C
T ss_pred             CCCCcEEEEEEeccCCCEEEEEEEECCCCCeEEEEEEecCccc---HHHHHHHHHHHHhccCCCCeeeeeeEEeeccCcc
Confidence            3467899999999999999999998  6889999999765322   35788999999999 79999999999976     


Q ss_pred             -CCcEEEEEecCCCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceeecCCCcEEEeecccee
Q 015868          185 -PPNLCIVTEFMARGSIYDFLHKQK-GVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVAR  262 (399)
Q Consensus       185 -~~~~~lV~E~~~ggsL~~~l~~~~-~~l~~~~~~~i~~~i~~~L~~LH~~giiHrDlkp~NILl~~~~~vkl~DFG~a~  262 (399)
                       ....++||||+++++|.+++.... ..+++..++.++.||+.||.|||++||+||||||+||+++.++.+||+|||++.
T Consensus        98 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~  177 (326)
T 2x7f_A           98 MDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHKVIHRDIKGQNVLLTENAEVKLVDFGVSA  177 (326)
T ss_dssp             CCCEEEEEEECCTTEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEECTTCCEEECCCTTTC
T ss_pred             ccceEEEEEEcCCCCcHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCcHHHEEEcCCCCEEEeeCcCce
Confidence             457899999999999999997643 578999999999999999999999999999999999999999999999999987


Q ss_pred             eccCC-CccccCCCCcccccccccC-----CCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhccCCCCCCC
Q 015868          263 VQAQS-GVMTAETGTYRWMAPEVIE-----HKPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKSLRPTIPK  336 (399)
Q Consensus       263 ~~~~~-~~~~~~~gt~~y~aPE~l~-----~~~~~~~~Dv~slG~vl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~  336 (399)
                      ..... .......|++.|+|||++.     +..++.++||||||+++|+|++|..||.....................+.
T Consensus       178 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~  257 (326)
T 2x7f_A          178 QLDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNPAPRLKSK  257 (326)
T ss_dssp             -------------CCGGGCCHHHHC--------CCTTHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCCSCS
T ss_pred             ecCcCccccccccCCccccChhhhccccccCcCCCccchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHhhcCccccCCcc
Confidence            65432 2234457899999999997     56789999999999999999999999999888776666555544444566


Q ss_pred             CCcHHHHHHHHHHhhhcCCCCCCHHHHHH
Q 015868          337 HAHPRLAELLERCWQHDPTQRPNFSQITD  365 (399)
Q Consensus       337 ~~~~~l~~ll~~cl~~dP~~Rps~~ell~  365 (399)
                      .+++.+.++|.+||..||.+||++.++++
T Consensus       258 ~~~~~l~~li~~~l~~dp~~Rps~~~ll~  286 (326)
T 2x7f_A          258 KWSKKFQSFIESCLVKNHSQRPATEQLMK  286 (326)
T ss_dssp             CSCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred             ccCHHHHHHHHHHhccChhhCCCHHHHhh
Confidence            78999999999999999999999999977

>2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ...

Probab=100.00  E-value=1.2e-44  Score=354.84  Aligned_cols=247  Identities=25%  Similarity=0.363  Sum_probs=202.5

Q ss_pred             ccccceeceeceeCceEEEEEEE--CCeeEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCceeeEEeEEecCC------
Q 015868          115 AKQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPP------  186 (399)
Q Consensus       115 ~~~~~i~~~lg~G~~g~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~nIv~~~~~~~~~~------  186 (399)
                      .++|++.+.||+|+||.||+|.+  .++.||||++.....+....+.+.+|+.+++.++||||+++++++....      
T Consensus        24 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~  103 (371)
T 2xrw_A           24 LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQ  103 (371)
T ss_dssp             ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSCCSTTTCC
T ss_pred             hhheeEeeeeEecCCEEEEEEEECCCCceEEEEEeccccCChHHHHHHHHHHHHHHhcCCCCccceEEeecccccccccc
Confidence            47899999999999999999987  5789999999876666777788999999999999999999999997665      


Q ss_pred             cEEEEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceeecCCCcEEEeeccceeeccC
Q 015868          187 NLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQ  266 (399)
Q Consensus       187 ~~~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~giiHrDlkp~NILl~~~~~vkl~DFG~a~~~~~  266 (399)
                      ..|+||||+.+ +|.+++.   ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++....
T Consensus       104 ~~~lv~e~~~~-~l~~~~~---~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a~~~~~  179 (371)
T 2xrw_A          104 DVYIVMELMDA-NLCQVIQ---MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGT  179 (371)
T ss_dssp             EEEEEEECCSE-EHHHHHH---SCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECCCCC------
T ss_pred             ceEEEEEcCCC-CHHHHHh---hccCHHHHHHHHHHHHHHHHHHHHCCeecccCCHHHEEEcCCCCEEEEEeeccccccc
Confidence            68999999976 8888885   3589999999999999999999999999999999999999999999999999987665


Q ss_pred             CCccccCCCCcccccccccCCCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhccCC---------------
Q 015868          267 SGVMTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKSLR---------------  331 (399)
Q Consensus       267 ~~~~~~~~gt~~y~aPE~l~~~~~~~~~Dv~slG~vl~elltg~~P~~~~~~~~~~~~~~~~~~~---------------  331 (399)
                      ........||+.|+|||++.+..++.++||||||+++|+|++|..||.+.+..+....+......               
T Consensus       180 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~  259 (371)
T 2xrw_A          180 SFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKLQPTVRT  259 (371)
T ss_dssp             ----------CTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHC-CCCCCHHHHTTSCHHHHH
T ss_pred             ccccCCceecCCccCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHHhhhHHHH
Confidence            54555678999999999999999999999999999999999999999998876655554432111               


Q ss_pred             -----CCC--------------CC------CCcHHHHHHHHHHhhhcCCCCCCHHHHHH
Q 015868          332 -----PTI--------------PK------HAHPRLAELLERCWQHDPTQRPNFSQITD  365 (399)
Q Consensus       332 -----~~~--------------~~------~~~~~l~~ll~~cl~~dP~~Rps~~ell~  365 (399)
                           +..              |.      ..++++.+||.+||+.||.+|||++|+++
T Consensus       260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~  318 (371)
T 2xrw_A          260 YVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQ  318 (371)
T ss_dssp             HHHSSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred             HHhhCccccccchhhhcccccCcccccccccccHHHHHHHHHHCcCChhhCCCHHHHhC
Confidence                 110              00      12678999999999999999999999987

>1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=4.4e-45  Score=354.33  Aligned_cols=250  Identities=27%  Similarity=0.393  Sum_probs=207.9

Q ss_pred             ccccceeceeceeCceEEEEEEE--CCeeEEEEEecCCCCCH---HHHHHHHHHHHHHHhcCCCceeeEEeEEecCCcEE
Q 015868          115 AKQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVNT---EMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLC  189 (399)
Q Consensus       115 ~~~~~i~~~lg~G~~g~Vy~~~~--~~~~vAvK~~~~~~~~~---~~~~~~~~Ei~~l~~l~h~nIv~~~~~~~~~~~~~  189 (399)
                      .++|++.+.||+|+||.||+|++  +++.||+|+++......   ...+.+.+|+.+++.++||||+++++++......+
T Consensus         9 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~   88 (346)
T 1ua2_A            9 AKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNIS   88 (346)
T ss_dssp             ----CEEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCE
T ss_pred             hcccEEEeEEeecCCEEEEEEEECCCCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhCCCCCCCeEEEEEeeCCceE
Confidence            56899999999999999999987  47899999997543221   22356889999999999999999999999999999


Q ss_pred             EEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceeecCCCcEEEeeccceeeccCC-C
Q 015868          190 IVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQS-G  268 (399)
Q Consensus       190 lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~giiHrDlkp~NILl~~~~~vkl~DFG~a~~~~~~-~  268 (399)
                      +||||+++ +|.+++......+++..++.++.|++.||.|||++||+||||||+||+++.++.+||+|||+++..... .
T Consensus        89 lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~~  167 (346)
T 1ua2_A           89 LVFDFMET-DLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNR  167 (346)
T ss_dssp             EEEECCSE-EHHHHHTTCCSSCCSSHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECCCGGGSTTTSCCC
T ss_pred             EEEEcCCC-CHHHHHHhcCcCCCHHHHHHHHHHHHHHHHHHHHCCEECCCCCHHHEEEcCCCCEEEEecccceeccCCcc
Confidence            99999987 999999877778999999999999999999999999999999999999999999999999999865433 2


Q ss_pred             ccccCCCCcccccccccCCC-CCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhccCCCC--------------
Q 015868          269 VMTAETGTYRWMAPEVIEHK-PYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKSLRPT--------------  333 (399)
Q Consensus       269 ~~~~~~gt~~y~aPE~l~~~-~~~~~~Dv~slG~vl~elltg~~P~~~~~~~~~~~~~~~~~~~~~--------------  333 (399)
                      ......||+.|+|||++.+. .++.++||||||+++|+|++|.+||.+.+..+....+......+.              
T Consensus       168 ~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~  247 (346)
T 1ua2_A          168 AYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDYV  247 (346)
T ss_dssp             CCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSSSTTSSTTCC
T ss_pred             cCCcccccccccCchHhhCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHcCCCChhhhhhhccCcccc
Confidence            34556789999999999764 589999999999999999999999999888776665544221111              


Q ss_pred             -------C-----CCCCcHHHHHHHHHHhhhcCCCCCCHHHHHH
Q 015868          334 -------I-----PKHAHPRLAELLERCWQHDPTQRPNFSQITD  365 (399)
Q Consensus       334 -------~-----~~~~~~~l~~ll~~cl~~dP~~Rps~~ell~  365 (399)
                             .     ...+++++.+||.+||+.||.+|||+.|+++
T Consensus       248 ~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~  291 (346)
T 1ua2_A          248 TFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALK  291 (346)
T ss_dssp             CCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHT
T ss_pred             cccccCCCChHHhhccCCHHHHHHHHHHhccChhhCCCHHHHhc
Confidence                   1     1456789999999999999999999999976

>3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A*

Probab=100.00  E-value=5.5e-45  Score=353.90  Aligned_cols=250  Identities=25%  Similarity=0.421  Sum_probs=211.0

Q ss_pred             ccccceeceeceeCceEEEEEEE--CCeeEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCceeeEEeEEec--------
Q 015868          115 AKQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTR--------  184 (399)
Q Consensus       115 ~~~~~i~~~lg~G~~g~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~nIv~~~~~~~~--------  184 (399)
                      .++|++.++||+|+||.||+|++  +++.||+|++............+.+|+.+++.++||||+++++++..        
T Consensus        16 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~   95 (351)
T 3mi9_A           16 VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRC   95 (351)
T ss_dssp             GGGEEEEEECSSCSTTSEEEEEETTTCCEEEEEECCCSSCSSSSCHHHHHHHHHHHHCCCTTBCCEEEEEEEC-------
T ss_pred             ccceeEEEEEecCCCcEEEEEEECCCCCEEEEEEEecccccccchHHHHHHHHHHHhccCCCcccHhheeeccccccccC
Confidence            57999999999999999999998  57899999997665444445678899999999999999999999976        


Q ss_pred             CCcEEEEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceeecCCCcEEEeeccceeec
Q 015868          185 PPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQ  264 (399)
Q Consensus       185 ~~~~~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~giiHrDlkp~NILl~~~~~vkl~DFG~a~~~  264 (399)
                      ...+++||||+++ +|.+.+......+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++..
T Consensus        96 ~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a~~~  174 (351)
T 3mi9_A           96 KGSIYLVFDFCEH-DLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAF  174 (351)
T ss_dssp             -CEEEEEEECCSE-EHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEEC
T ss_pred             CceEEEEEeccCC-CHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCHHHEEEcCCCCEEEccchhcccc
Confidence            3468999999986 888888777778999999999999999999999999999999999999999999999999999865


Q ss_pred             cC-----CCccccCCCCcccccccccCC-CCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcc--CCCCCCC
Q 015868          265 AQ-----SGVMTAETGTYRWMAPEVIEH-KPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKS--LRPTIPK  336 (399)
Q Consensus       265 ~~-----~~~~~~~~gt~~y~aPE~l~~-~~~~~~~Dv~slG~vl~elltg~~P~~~~~~~~~~~~~~~~~--~~~~~~~  336 (399)
                      ..     ........||+.|+|||++.+ ..++.++||||||+++|+|++|..||.+.+.......+....  ..+....
T Consensus       175 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~  254 (351)
T 3mi9_A          175 SLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPEVWP  254 (351)
T ss_dssp             CCCSSSSCCCCCSSCSCGGGCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTST
T ss_pred             cccccccccccCCcccccCccCchhhcCCCCCCcHhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhhcc
Confidence            42     223345578999999999976 468999999999999999999999999988766555443321  1111111


Q ss_pred             C----------------------------CcHHHHHHHHHHhhhcCCCCCCHHHHHH
Q 015868          337 H----------------------------AHPRLAELLERCWQHDPTQRPNFSQITD  365 (399)
Q Consensus       337 ~----------------------------~~~~l~~ll~~cl~~dP~~Rps~~ell~  365 (399)
                      .                            .++++.+||.+||+.||.+|||+.|+++
T Consensus       255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~  311 (351)
T 3mi9_A          255 NVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALN  311 (351)
T ss_dssp             TGGGCGGGTSSCCCSSCCCCHHHHHHHHHCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             ccccchhhcccccccccccCHHHHhhhccCChHHHHHHHHHhcCChhhCCCHHHHhC
Confidence            1                            2678999999999999999999999876

>1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A*

Probab=100.00  E-value=2.1e-44  Score=341.16  Aligned_cols=250  Identities=23%  Similarity=0.370  Sum_probs=217.9

Q ss_pred             ccccceeceeceeCceEEEEEEE--CCeeEEEEEecCCCC---C----HHHHHHHHHHHHHHHhcC-CCceeeEEeEEec
Q 015868          115 AKQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECV---N----TEMLKEFSQEVYIMRKIR-HKNVVQFIGACTR  184 (399)
Q Consensus       115 ~~~~~i~~~lg~G~~g~Vy~~~~--~~~~vAvK~~~~~~~---~----~~~~~~~~~Ei~~l~~l~-h~nIv~~~~~~~~  184 (399)
                      .++|++.+.||+|+||.||+|++  +++.||+|+++....   .    ....+.+.+|+.+++++. ||||+++++++..
T Consensus        16 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~   95 (298)
T 1phk_A           16 YENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYET   95 (298)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEC
T ss_pred             hhccceeeeecCCCceEEEEEEEcCcCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeeeeeeecc
Confidence            57899999999999999999998  578999999976531   1    233567889999999996 9999999999999


Q ss_pred             CCcEEEEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceeecCCCcEEEeeccceeec
Q 015868          185 PPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQ  264 (399)
Q Consensus       185 ~~~~~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~giiHrDlkp~NILl~~~~~vkl~DFG~a~~~  264 (399)
                      ....++||||+++++|.+++.. ...+++..++.++.||+.||.|||++||+||||||+||+++.++.+||+|||.+...
T Consensus        96 ~~~~~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~  174 (298)
T 1phk_A           96 NTFFFLVFDLMKKGELFDYLTE-KVTLSEKETRKIMRALLEVICALHKLNIVHRDLKPENILLDDDMNIKLTDFGFSCQL  174 (298)
T ss_dssp             SSEEEEEEECCTTCBHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEEC
T ss_pred             CCeEEEEEeccCCCcHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEEcCCCcEEEecccchhhc
Confidence            9999999999999999999976 467899999999999999999999999999999999999999999999999999876


Q ss_pred             cCCCccccCCCCcccccccccC------CCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhccCCCCCC--C
Q 015868          265 AQSGVMTAETGTYRWMAPEVIE------HKPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKSLRPTIP--K  336 (399)
Q Consensus       265 ~~~~~~~~~~gt~~y~aPE~l~------~~~~~~~~Dv~slG~vl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~--~  336 (399)
                      ..........+++.|+|||++.      ...++.++||||||+++|+|++|..||...+.................+  .
T Consensus       175 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  254 (298)
T 1phk_A          175 DPGEKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNYQFGSPEWD  254 (298)
T ss_dssp             CTTCCBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTTTGG
T ss_pred             CCCcccccccCCccccCHHHhccccccccccCCcccccHhHHHHHHHHHHCCCCCcCccHHHHHHHHhcCCcccCccccc
Confidence            6655556677999999999984      5568899999999999999999999999888776665555443332222  4


Q ss_pred             CCcHHHHHHHHHHhhhcCCCCCCHHHHHH
Q 015868          337 HAHPRLAELLERCWQHDPTQRPNFSQITD  365 (399)
Q Consensus       337 ~~~~~l~~ll~~cl~~dP~~Rps~~ell~  365 (399)
                      .+++++.+++.+||+.||.+|||+.|+++
T Consensus       255 ~~~~~l~~li~~~l~~dp~~Rps~~~ll~  283 (298)
T 1phk_A          255 DYSDTVKDLVSRFLVVQPQKRYTAEEALA  283 (298)
T ss_dssp             GSCHHHHHHHHHHCCSSGGGSCCHHHHTT
T ss_pred             ccCHHHHHHHHHHccCCcccCCCHHHHHh
Confidence            68899999999999999999999999875

>1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A*

Probab=100.00  E-value=7.1e-45  Score=351.07  Aligned_cols=253  Identities=28%  Similarity=0.584  Sum_probs=214.9

Q ss_pred             cccccceeceeceeCceEEEEEEECCeeEEEEEecCCCCCHHHHHHHHHHHHHHHh--cCCCceeeEEeEEecCC----c
Q 015868          114 DAKQLKIECKVASGSYGDLYKGTYCSQEVAIKVLKPECVNTEMLKEFSQEVYIMRK--IRHKNVVQFIGACTRPP----N  187 (399)
Q Consensus       114 ~~~~~~i~~~lg~G~~g~Vy~~~~~~~~vAvK~~~~~~~~~~~~~~~~~Ei~~l~~--l~h~nIv~~~~~~~~~~----~  187 (399)
                      -.++|++.+.||+|+||.||+|++.++.||||+++..     ....+.+|..+++.  ++||||+++++++....    .
T Consensus        40 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~vavK~~~~~-----~~~~~~~e~~~~~~~~l~h~ni~~~~~~~~~~~~~~~~  114 (342)
T 1b6c_B           40 IARTIVLQESIGKGRFGEVWRGKWRGEEVAVKIFSSR-----EERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQ  114 (342)
T ss_dssp             HHHHCEEEEEEEEETTEEEEEEEETTEEEEEEEECGG-----GHHHHHHHHHHHHHSCCCCTTBCCEEEEEECCCSSCCC
T ss_pred             ccccEEEEeeecCCCCcEEEEEEEcCccEEEEEeCch-----hHHHHHHHHHHHHHhhcCCCcEEEEEeeecccCCccce
Confidence            3578999999999999999999999999999999643     23567889999988  78999999999998876    7


Q ss_pred             EEEEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH--------HCCcccCCCCCCceeecCCCcEEEeecc
Q 015868          188 LCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLH--------QNNIIHRDLKTANLLMDENGVVKVADFG  259 (399)
Q Consensus       188 ~~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH--------~~giiHrDlkp~NILl~~~~~vkl~DFG  259 (399)
                      .++||||+++|+|.+++..  ..+++..++.++.|++.||.|||        ++||+||||||+||+++.++.+||+|||
T Consensus       115 ~~lv~e~~~~g~L~~~l~~--~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfg  192 (342)
T 1b6c_B          115 LWLVSDYHEHGSLFDYLNR--YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLG  192 (342)
T ss_dssp             EEEEECCCTTCBHHHHHHH--CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCSGGGEEECTTSCEEECCCT
T ss_pred             eEEEEeecCCCcHHHHHhc--cCccHHHHHHHHHHHHHHHHHHHHHHhhhcccCCeeeCCCCHHHEEECCCCCEEEEECC
Confidence            9999999999999999976  46899999999999999999999        8999999999999999999999999999


Q ss_pred             ceeeccCCCc-----cccCCCCcccccccccCCCC------CCChhhHHHHHHHHHHHHcC----------CCCCCCCC-
Q 015868          260 VARVQAQSGV-----MTAETGTYRWMAPEVIEHKP------YDYKADVFSFGIALWELLTG----------ELPYAGLT-  317 (399)
Q Consensus       260 ~a~~~~~~~~-----~~~~~gt~~y~aPE~l~~~~------~~~~~Dv~slG~vl~elltg----------~~P~~~~~-  317 (399)
                      +++.......     .....||+.|+|||++.+..      ++.++||||||+++|+|+||          ..||.... 
T Consensus       193 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~p~~~~~~  272 (342)
T 1b6c_B          193 LAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVP  272 (342)
T ss_dssp             TCEEEETTTTEEEECCCSCCCCGGGCCHHHHTSCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTTSC
T ss_pred             CceeccccccccccccccCCcCcccCCHhhhcccccccccccCCcccHHHHHHHHHHHHhccCcCCcccccccCccccCc
Confidence            9987654432     24457899999999998763      33689999999999999999          78887653 


Q ss_pred             ----HHHHHHHHHhccCCCCCCC-----CCcHHHHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHH
Q 015868          318 ----PLQAAVGVVQKSLRPTIPK-----HAHPRLAELLERCWQHDPTQRPNFSQITDILKQMMKE  373 (399)
Q Consensus       318 ----~~~~~~~~~~~~~~~~~~~-----~~~~~l~~ll~~cl~~dP~~Rps~~ell~~L~~l~~~  373 (399)
                          .......+.....++.++.     .+++.+.+++.+||+.||++|||+.++++.|+++.++
T Consensus       273 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~i~~~L~~i~~~  337 (342)
T 1b6c_B          273 SDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQQ  337 (342)
T ss_dssp             SSCCHHHHHHHHTTSCCCCCCCGGGGTSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHHHHHHHT
T ss_pred             CcccHHHHHHHHHHHHhCCCCcccccchhHHHHHHHHHHHHhccChhhCCCHHHHHHHHHHHHHH
Confidence                2333333444555666664     3456899999999999999999999999999998753

>3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens}

Probab=100.00  E-value=1e-44  Score=346.13  Aligned_cols=250  Identities=30%  Similarity=0.505  Sum_probs=211.5

Q ss_pred             eecccccceeceeceeCceEEEEEEEC--CeeEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCceeeEEeEEecCCcEE
Q 015868          112 EIDAKQLKIECKVASGSYGDLYKGTYC--SQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLC  189 (399)
Q Consensus       112 ~i~~~~~~i~~~lg~G~~g~Vy~~~~~--~~~vAvK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~nIv~~~~~~~~~~~~~  189 (399)
                      ....++|++.+.||+|+||.||+|.+.  ++.||+|+++....    ...+.+|+.+++.++||||+++++++......+
T Consensus        25 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~----~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~  100 (314)
T 3com_A           25 KQPEEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVESD----LQEIIKEISIMQQCDSPHVVKYYGSYFKNTDLW  100 (314)
T ss_dssp             -----CEEEEEECC----CEEEEEEETTTCCEEEEEEEETTSC----CHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEE
T ss_pred             hcchhhhhhheeeccCCCeEEEEEEECCCCCEEEEEecCchHH----HHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEE
Confidence            445678999999999999999999884  78999999986432    356888999999999999999999999999999


Q ss_pred             EEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceeecCCCcEEEeeccceeeccCCC-
Q 015868          190 IVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSG-  268 (399)
Q Consensus       190 lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~giiHrDlkp~NILl~~~~~vkl~DFG~a~~~~~~~-  268 (399)
                      +||||+++++|.+++......+++..++.++.|++.||.|||++|++|+||||+||+++.++.+||+|||.+....... 
T Consensus       101 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~  180 (314)
T 3com_A          101 IVMEYCGAGSVSDIIRLRNKTLTEDEIATILQSTLKGLEYLHFMRKIHRDIKAGNILLNTEGHAKLADFGVAGQLTDTMA  180 (314)
T ss_dssp             EEEECCTTEEHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECBTTBS
T ss_pred             EEeecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcCCCcCHHHEEECCCCCEEEeecccchhhhhhcc
Confidence            9999999999999998767889999999999999999999999999999999999999999999999999997655432 


Q ss_pred             ccccCCCCcccccccccCCCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhccC-CCCCCCCCcHHHHHHHH
Q 015868          269 VMTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKSL-RPTIPKHAHPRLAELLE  347 (399)
Q Consensus       269 ~~~~~~gt~~y~aPE~l~~~~~~~~~Dv~slG~vl~elltg~~P~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~l~~ll~  347 (399)
                      ......|++.|+|||.+.+..++.++||||||+++|+|++|..||................. ....+..+++++.+++.
T Consensus       181 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~  260 (314)
T 3com_A          181 KRNTVIGTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGKPPYADIHPMRAIFMIPTNPPPTFRKPELWSDNFTDFVK  260 (314)
T ss_dssp             CBCCCCSCGGGCCHHHHSSSCBCTTHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCCSSGGGSCHHHHHHHH
T ss_pred             ccCccCCCCCccChhhcCCCCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhcCCCcccCCcccCCHHHHHHHH
Confidence            23445789999999999999999999999999999999999999998887665544333221 12234567899999999


Q ss_pred             HHhhhcCCCCCCHHHHHH
Q 015868          348 RCWQHDPTQRPNFSQITD  365 (399)
Q Consensus       348 ~cl~~dP~~Rps~~ell~  365 (399)
                      +||..||.+|||+.++++
T Consensus       261 ~~l~~dp~~Rpt~~~ll~  278 (314)
T 3com_A          261 QCLVKSPEQRATATQLLQ  278 (314)
T ss_dssp             HHTCSCTTTSCCHHHHTT
T ss_pred             HHccCChhhCcCHHHHHh
Confidence            999999999999999976

>3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=8.7e-45  Score=357.15  Aligned_cols=252  Identities=21%  Similarity=0.336  Sum_probs=210.4

Q ss_pred             eecccccceeceeceeCceEEEEEEE--CCeeEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCceeeEEeEEec-----
Q 015868          112 EIDAKQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTR-----  184 (399)
Q Consensus       112 ~i~~~~~~i~~~lg~G~~g~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~nIv~~~~~~~~-----  184 (399)
                      +...++|++.+.||+|+||.||+|++  +++.||+|++.....      ...+|+.+++.++||||+++++++..     
T Consensus         3 ~~~~~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~------~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~   76 (383)
T 3eb0_A            3 ETSSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPR------YKNRELDIMKVLDHVNIIKLVDYFYTTGDEE   76 (383)
T ss_dssp             ---CTTEEEEEEEECC-CEEEEEEEETTTCCEEEEEEEECCTT------SCCHHHHHHTTCCCTTBCCEEEEEEEC----
T ss_pred             ccccceEEEEEEEEeccCEEEEEEEECCCCCEEEEEEEecCcc------hHHHHHHHHHHcCCCCccchhheeeecCccc
Confidence            45567999999999999999999987  678999999875422      22369999999999999999999843     


Q ss_pred             ---------------------------------CCcEEEEEecCCCCCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHH
Q 015868          185 ---------------------------------PPNLCIVTEFMARGSIYDFLHK---QKGVFQLTSLLKVAIDVSKGMN  228 (399)
Q Consensus       185 ---------------------------------~~~~~lV~E~~~ggsL~~~l~~---~~~~l~~~~~~~i~~~i~~~L~  228 (399)
                                                       ...+++||||+++ +|.+.+..   ....+++..++.++.||+.||.
T Consensus        77 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~-~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~  155 (383)
T 3eb0_A           77 PKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVPD-TLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVG  155 (383)
T ss_dssp             ---------------------------------CCEEEEEECCCSE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHH
T ss_pred             ccccccccccccccccccccccccccccccCCCceEEEEEEecCCc-cHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHH
Confidence                                             3348999999985 88877753   4577999999999999999999


Q ss_pred             HHHHCCcccCCCCCCceeec-CCCcEEEeeccceeeccCCCccccCCCCcccccccccCCC-CCCChhhHHHHHHHHHHH
Q 015868          229 YLHQNNIIHRDLKTANLLMD-ENGVVKVADFGVARVQAQSGVMTAETGTYRWMAPEVIEHK-PYDYKADVFSFGIALWEL  306 (399)
Q Consensus       229 ~LH~~giiHrDlkp~NILl~-~~~~vkl~DFG~a~~~~~~~~~~~~~gt~~y~aPE~l~~~-~~~~~~Dv~slG~vl~el  306 (399)
                      |||++||+||||||+||+++ .++.+||+|||+++............+|+.|+|||++.+. .++.++||||+||++|+|
T Consensus       156 ~LH~~gi~H~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el  235 (383)
T 3eb0_A          156 FIHSLGICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSEPSVAYICSRFYRAPELMLGATEYTPSIDLWSIGCVFGEL  235 (383)
T ss_dssp             HHHTTTEECSCCCGGGEEEETTTTEEEECCCTTCEECCTTSCCCCCCCCSSCCCHHHHTTCSSCCTHHHHHHHHHHHHHH
T ss_pred             HHHHCcCccCccCHHHEEEcCCCCcEEEEECCCCcccCCCCCCcCcccCCCccCHHHhcCCCCCCcchhhhhHHHHHHHH
Confidence            99999999999999999997 6889999999999977666666677899999999998875 489999999999999999


Q ss_pred             HcCCCCCCCCCHHHHHHHHHhccCC---------------------------CCCCCCCcHHHHHHHHHHhhhcCCCCCC
Q 015868          307 LTGELPYAGLTPLQAAVGVVQKSLR---------------------------PTIPKHAHPRLAELLERCWQHDPTQRPN  359 (399)
Q Consensus       307 ltg~~P~~~~~~~~~~~~~~~~~~~---------------------------~~~~~~~~~~l~~ll~~cl~~dP~~Rps  359 (399)
                      ++|+.||.+.+..+....++.....                           ..++..+++++.+||.+||+.||.+|||
T Consensus       236 l~g~~pf~~~~~~~~~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t  315 (383)
T 3eb0_A          236 ILGKPLFSGETSIDQLVRIIQIMGTPTKEQMIRMNPHYTEVRFPTLKAKDWRKILPEGTPSLAIDLLEQILRYEPDLRIN  315 (383)
T ss_dssp             HHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHCTTC--CCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCC
T ss_pred             HhCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhCcccccccCCccCcccHHhhCCCCCCHHHHHHHHHHccCChhhCCC
Confidence            9999999998887766655432111                           1135568899999999999999999999


Q ss_pred             HHHHHH--HHHHH
Q 015868          360 FSQITD--ILKQM  370 (399)
Q Consensus       360 ~~ell~--~L~~l  370 (399)
                      +.|+++  .++++
T Consensus       316 ~~e~l~hp~f~~~  328 (383)
T 3eb0_A          316 PYEAMAHPFFDHL  328 (383)
T ss_dssp             HHHHHTSGGGHHH
T ss_pred             HHHHhcCHHHHHH
Confidence            999985  44444

>2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A*

Probab=100.00  E-value=2.3e-45  Score=376.92  Aligned_cols=252  Identities=21%  Similarity=0.388  Sum_probs=217.1

Q ss_pred             ecccccceeceeceeCceEEEEEEE--CCeeEEEEEecCCCC-CHHHHHHHHHHHHHHHhcCCCceeeEEeEEecCCcEE
Q 015868          113 IDAKQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECV-NTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLC  189 (399)
Q Consensus       113 i~~~~~~i~~~lg~G~~g~Vy~~~~--~~~~vAvK~~~~~~~-~~~~~~~~~~Ei~~l~~l~h~nIv~~~~~~~~~~~~~  189 (399)
                      +..++|++.+.||+|+||.||+|++  +++.||+|++..... .......+.+|+.+|+.++||||+++++++.....+|
T Consensus       181 ~~~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~  260 (576)
T 2acx_A          181 VTKNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALC  260 (576)
T ss_dssp             CCGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred             ccccceEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhHhhhhhHHHHHHHHHHHHHHHcCCCCEeeEEEEEeeCCEEE
Confidence            5678899999999999999999998  588999999964311 1112356889999999999999999999999999999


Q ss_pred             EEEecCCCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceeecCCCcEEEeeccceeeccCCC
Q 015868          190 IVTEFMARGSIYDFLHKQK-GVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSG  268 (399)
Q Consensus       190 lV~E~~~ggsL~~~l~~~~-~~l~~~~~~~i~~~i~~~L~~LH~~giiHrDlkp~NILl~~~~~vkl~DFG~a~~~~~~~  268 (399)
                      +||||++||+|.+++.... ..+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||+++......
T Consensus       261 lVmEy~~gg~L~~~l~~~~~~~l~e~~~~~i~~qIl~aL~yLH~~gIvHrDLKPeNILld~~g~vKL~DFGla~~~~~~~  340 (576)
T 2acx_A          261 LVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDLHRERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQ  340 (576)
T ss_dssp             EEECCCCSCBHHHHHHSSSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCEEECCCTTCEECCTTC
T ss_pred             EEEEcCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeccCCchheEEEeCCCCeEEEecccceecccCc
Confidence            9999999999999997643 459999999999999999999999999999999999999999999999999998776655


Q ss_pred             ccccCCCCcccccccccCCCCCCChhhHHHHHHHHHHHHcCCCCCCCCCH---HHHHHHHHhccCCCCCCCCCcHHHHHH
Q 015868          269 VMTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPYAGLTP---LQAAVGVVQKSLRPTIPKHAHPRLAEL  345 (399)
Q Consensus       269 ~~~~~~gt~~y~aPE~l~~~~~~~~~Dv~slG~vl~elltg~~P~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~l~~l  345 (399)
                      ......||+.|+|||++.+..|+.++|||||||++|+|++|..||...+.   .......+. .....++..+++++.+|
T Consensus       341 ~~~~~~GT~~Y~APEvl~~~~~~~~~DiwSLGvilyeLltG~~PF~~~~~~~~~~~i~~~i~-~~~~~~p~~~s~~~~dL  419 (576)
T 2acx_A          341 TIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVK-EVPEEYSERFSPQARSL  419 (576)
T ss_dssp             CEECCCSCGGGCCHHHHTTCEESSHHHHHHHHHHHHHHHHSSCSSSCSSSCCCHHHHHHHHH-HCCCCCCTTSCHHHHHH
T ss_pred             cccccCCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCcccccchhHHHHHHHhh-cccccCCccCCHHHHHH
Confidence            55667899999999999999999999999999999999999999987532   122222222 23456778899999999


Q ss_pred             HHHHhhhcCCCCC-----CHHHHHH
Q 015868          346 LERCWQHDPTQRP-----NFSQITD  365 (399)
Q Consensus       346 l~~cl~~dP~~Rp-----s~~ell~  365 (399)
                      |.+||+.||.+||     +++|+++
T Consensus       420 I~~lL~~dP~~R~g~~~~sa~eil~  444 (576)
T 2acx_A          420 CSQLLCKDPAERLGCRGGSAREVKE  444 (576)
T ss_dssp             HHHHTCSSGGGSTTCSSSHHHHHHT
T ss_pred             HHHhccCCHHHcCCCCCCCHHHHHh
Confidence            9999999999999     6788865

>2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A*

Probab=100.00  E-value=7.3e-45  Score=343.12  Aligned_cols=249  Identities=27%  Similarity=0.489  Sum_probs=216.3

Q ss_pred             ccccceeceeceeCceEEEEEEE--CCeeEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCceeeEEeEEecCCcEEEEE
Q 015868          115 AKQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVT  192 (399)
Q Consensus       115 ~~~~~i~~~lg~G~~g~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~nIv~~~~~~~~~~~~~lV~  192 (399)
                      .++|++.+.||+|+||.||+|+.  .++.||+|++............+.+|+.++++++||||+++++++......++||
T Consensus        21 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~  100 (287)
T 2wei_A           21 AERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIVG  100 (287)
T ss_dssp             HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGBSSSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             hhcceeeEEEcCCCCEEEEEEEEcCCCcEEEEEEecccccchHHHHHHHHHHHHHHhccCCCccEEEEEEeCCCeEEEEE
Confidence            56899999999999999999998  5789999999755433444577899999999999999999999999999999999


Q ss_pred             ecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceeecCC---CcEEEeeccceeeccCCCc
Q 015868          193 EFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDEN---GVVKVADFGVARVQAQSGV  269 (399)
Q Consensus       193 E~~~ggsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~giiHrDlkp~NILl~~~---~~vkl~DFG~a~~~~~~~~  269 (399)
                      ||+.+++|.+++... ..+++..++.++.|++.||.|||++||+||||||+||+++.+   +.+||+|||.++.......
T Consensus       101 e~~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~NIlv~~~~~~~~~kL~Dfg~~~~~~~~~~  179 (287)
T 2wei_A          101 ELYTGGELFDEIIKR-KRFSEHDAARIIKQVFSGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTK  179 (287)
T ss_dssp             CCCCSCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSSTTCCEEECSTTGGGTBCCCSS
T ss_pred             EccCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCChhhEEEecCCCcccEEEeccCcceeecCCCc
Confidence            999999999998764 568999999999999999999999999999999999999764   4799999999986655444


Q ss_pred             cccCCCCcccccccccCCCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhccCCCCCC--CCCcHHHHHHHH
Q 015868          270 MTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKSLRPTIP--KHAHPRLAELLE  347 (399)
Q Consensus       270 ~~~~~gt~~y~aPE~l~~~~~~~~~Dv~slG~vl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~l~~ll~  347 (399)
                      .....+++.|+|||.+.+. ++.++||||||+++|+|++|..||.+.+..+....+.........+  ..+++++.++|.
T Consensus       180 ~~~~~~~~~y~aPE~~~~~-~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~  258 (287)
T 2wei_A          180 MKDRIGTAYYIAPEVLRGT-YDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGKYAFDLPQWRTISDDAKDLIR  258 (287)
T ss_dssp             CSCHHHHHTTCCHHHHTTC-CCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCSGGGTTSCHHHHHHHH
T ss_pred             cccccCcccccChHHhcCC-CCCchhhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCchhhhhcCHHHHHHHH
Confidence            4455689999999999765 8999999999999999999999999988877665555443333332  468999999999


Q ss_pred             HHhhhcCCCCCCHHHHHH
Q 015868          348 RCWQHDPTQRPNFSQITD  365 (399)
Q Consensus       348 ~cl~~dP~~Rps~~ell~  365 (399)
                      +||+.||++|||+.|+++
T Consensus       259 ~~l~~dp~~Rps~~ell~  276 (287)
T 2wei_A          259 KMLTFHPSLRITATQCLE  276 (287)
T ss_dssp             HHTCSSGGGSCCHHHHHH
T ss_pred             HHcccChhhCcCHHHHhc
Confidence            999999999999999987

>3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A*

Probab=100.00  E-value=1.9e-46  Score=360.20  Aligned_cols=260  Identities=28%  Similarity=0.470  Sum_probs=212.1

Q ss_pred             CceeecccccceeceeceeCceEEEEEEE-CCeeEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCceeeEEeEEecCCc
Q 015868          109 DVWEIDAKQLKIECKVASGSYGDLYKGTY-CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPN  187 (399)
Q Consensus       109 ~~~~i~~~~~~i~~~lg~G~~g~Vy~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~nIv~~~~~~~~~~~  187 (399)
                      ...++..++|++.+.||+|+||.||+|+. .++.||+|+++..... .....+.+|+.+++.++||||+++++++..+..
T Consensus        23 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~  101 (326)
T 3uim_A           23 RELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERTQ-GGELQFQTEVEMISMAVHRNLLRLRGFCMTPTE  101 (326)
T ss_dssp             HHHHTTTTSSCSTTEEECCSSSEEEEECCSSSCCEEEEECCC------CCCHHHHHHHGGGTCCCTTBCCCCEEECCSSC
T ss_pred             HHHHHHhhccccceeEecCCCcEEEEEEecCCCEEEEEEeccccCc-hHHHHHHHHHHHHHhccCCCccceEEEEecCCc
Confidence            34566678999999999999999999986 4788999999865321 122368899999999999999999999999999


Q ss_pred             EEEEEecCCCCCHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCCCceeecCCCcEEEeeccce
Q 015868          188 LCIVTEFMARGSIYDFLHKQK---GVFQLTSLLKVAIDVSKGMNYLHQN---NIIHRDLKTANLLMDENGVVKVADFGVA  261 (399)
Q Consensus       188 ~~lV~E~~~ggsL~~~l~~~~---~~l~~~~~~~i~~~i~~~L~~LH~~---giiHrDlkp~NILl~~~~~vkl~DFG~a  261 (399)
                      .++||||+.+|+|.+++....   ..+++..++.++.|++.||.|||++   ||+||||||+|||++.++.+||+|||++
T Consensus       102 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~~  181 (326)
T 3uim_A          102 RLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLA  181 (326)
T ss_dssp             CEEEEECCTTCBHHHHHHCCSTTCCCCCHHHHHHHHHHHHHHHHHHHHSSSSCEECCCCSGGGEEECTTCCEEECCCSSC
T ss_pred             eEEEEEeccCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCchhhEEECCCCCEEeccCccc
Confidence            999999999999999997643   3489999999999999999999999   9999999999999999999999999999


Q ss_pred             eeccCCC--ccccCCCCcccccccccCCCCCCChhhHHHHHHHHHHHHcCCCCCCCCC----HHHHHHHHHhc-------
Q 015868          262 RVQAQSG--VMTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPYAGLT----PLQAAVGVVQK-------  328 (399)
Q Consensus       262 ~~~~~~~--~~~~~~gt~~y~aPE~l~~~~~~~~~Dv~slG~vl~elltg~~P~~~~~----~~~~~~~~~~~-------  328 (399)
                      +......  ......||+.|+|||.+.+..++.++||||||+++|+|++|..||....    ........+..       
T Consensus       182 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  261 (326)
T 3uim_A          182 KLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKL  261 (326)
T ss_dssp             EECCSSSSCEECCCCSCGGGCCHHHHHHSEECHHHHHHHHHHHHHHHHHCCCSBCHHHHTTTSCSBHHHHHTTTTSSCCS
T ss_pred             cccCcccccccccccCCcCccCHHHhccCCCCccccchhHHHHHHHHHhCCCcccccccccccchhHHHHHHHHhhchhh
Confidence            8765332  2344568999999999988889999999999999999999999995211    00001111110       


Q ss_pred             ------cCCCCCCCCCcHHHHHHHHHHhhhcCCCCCCHHHHHHHHHH
Q 015868          329 ------SLRPTIPKHAHPRLAELLERCWQHDPTQRPNFSQITDILKQ  369 (399)
Q Consensus       329 ------~~~~~~~~~~~~~l~~ll~~cl~~dP~~Rps~~ell~~L~~  369 (399)
                            ...+..+...++.+.+++.+||+.||.+|||+.|+++.|+.
T Consensus       262 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~  308 (326)
T 3uim_A          262 EALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLEG  308 (326)
T ss_dssp             TTSSCTTCTTSCCHHHHHHHHHHHHHHTCSCGGGSCCHHHHHHHHHT
T ss_pred             hhhcChhhccccCHHHHHHHHHHHHHHhCcCCccCCCHHHHHHHhcC
Confidence                  11122233345789999999999999999999999998875

>2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A*

Probab=100.00  E-value=1.8e-44  Score=378.18  Aligned_cols=263  Identities=30%  Similarity=0.595  Sum_probs=228.2

Q ss_pred             CceeecccccceeceeceeCceEEEEEEEC-----CeeEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCceeeEEeEEe
Q 015868          109 DVWEIDAKQLKIECKVASGSYGDLYKGTYC-----SQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACT  183 (399)
Q Consensus       109 ~~~~i~~~~~~i~~~lg~G~~g~Vy~~~~~-----~~~vAvK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~nIv~~~~~~~  183 (399)
                      ..+++..++|++.+.||+|+||.||+|.+.     +..||+|+++... .....+.+.+|+.++++++||||+++++++.
T Consensus       383 ~~~~i~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~  461 (656)
T 2j0j_A          383 RDYEIQRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCT-SDSVREKFLQEALTMRQFDHPHIVKLIGVIT  461 (656)
T ss_dssp             GGTBCCGGGEEEEEEEECCSSCCEEEEEECCSSSCCEEEEEEECSSTT-CHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred             cccccccccEEEeeEEeeCCCEEEEEEEEecCCCccEEEEEEEecccC-CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEe
Confidence            457788899999999999999999999874     3569999987642 4556678999999999999999999999985


Q ss_pred             cCCcEEEEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceeecCCCcEEEeeccceee
Q 015868          184 RPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARV  263 (399)
Q Consensus       184 ~~~~~~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~giiHrDlkp~NILl~~~~~vkl~DFG~a~~  263 (399)
                      . +..++||||+++|+|.+++......+++..++.++.|++.||.|||++||+||||||+|||++.++.+||+|||+++.
T Consensus       462 ~-~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDikp~NILl~~~~~vkL~DFG~a~~  540 (656)
T 2j0j_A          462 E-NPVWIIMELCTLGELRSFLQVRKFSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRY  540 (656)
T ss_dssp             S-SSCEEEEECCTTCBHHHHHHHTTTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECCCCCCCS
T ss_pred             c-CceEEEEEcCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCccccccchHhEEEeCCCCEEEEecCCCee
Confidence            4 568999999999999999987777899999999999999999999999999999999999999999999999999986


Q ss_pred             ccCCCc--cccCCCCcccccccccCCCCCCChhhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHHhccCCCCCCCCCcH
Q 015868          264 QAQSGV--MTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLT-GELPYAGLTPLQAAVGVVQKSLRPTIPKHAHP  340 (399)
Q Consensus       264 ~~~~~~--~~~~~gt~~y~aPE~l~~~~~~~~~Dv~slG~vl~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~  340 (399)
                      ......  .....+|+.|+|||++.+..++.++||||||+++|||++ |..||.+.+..+....+ ....++..|..+++
T Consensus       541 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~~~~~~i-~~~~~~~~~~~~~~  619 (656)
T 2j0j_A          541 MEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRI-ENGERLPMPPNCPP  619 (656)
T ss_dssp             CCC----------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHH-HHTCCCCCCTTCCH
T ss_pred             cCCCcceeccCCCCCcceeCHHHhcCCCCCchhhHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHH-HcCCCCCCCccccH
Confidence            544322  223456789999999998999999999999999999997 99999998887765544 34556778889999


Q ss_pred             HHHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHH
Q 015868          341 RLAELLERCWQHDPTQRPNFSQITDILKQMMKEV  374 (399)
Q Consensus       341 ~l~~ll~~cl~~dP~~Rps~~ell~~L~~l~~~~  374 (399)
                      ++.++|.+||..||.+|||+.++++.|++++.+.
T Consensus       620 ~l~~li~~~l~~dP~~RPs~~el~~~L~~il~~~  653 (656)
T 2j0j_A          620 TLYSLMTKCWAYDPSRRPRFTELKAQLSTILEEE  653 (656)
T ss_dssp             HHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred             HHHHHHHHHcCCChhHCcCHHHHHHHHHHHHHHh
Confidence            9999999999999999999999999999998654

>2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A*

Probab=100.00  E-value=1.7e-45  Score=348.98  Aligned_cols=256  Identities=31%  Similarity=0.566  Sum_probs=197.6

Q ss_pred             CceeecccccceeceeceeCceEEEEEEE--CCeeEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCceeeEEeEEecCC
Q 015868          109 DVWEIDAKQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPP  186 (399)
Q Consensus       109 ~~~~i~~~~~~i~~~lg~G~~g~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~nIv~~~~~~~~~~  186 (399)
                      ..|.+..++|++.+.||+|+||.||+|.+  .++.||+|++..... ....+.+.+|+.++++++||||+++++++...+
T Consensus         8 ~p~~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~   86 (303)
T 2vwi_A            8 LPWSINRDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKC-QTSMDELLKEIQAMSQCHHPNIVSYYTSFVVKD   86 (303)
T ss_dssp             -----CCCCCEEEEECC---CCCEEEEEC----CEEEEECCC-----------------CCCCCCCTTBCCEEEEEESSS
T ss_pred             cccccchhhhhhhheeccccceEEEEEEECCCCcEEEEEEEEhhhc-chhHHHHHHHHHHHhhcCCCCEeeEEEEEeecC
Confidence            34778899999999999999999999976  678999999875432 334567889999999999999999999999999


Q ss_pred             cEEEEEecCCCCCHHHHHHh-------cCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceeecCCCcEEEeecc
Q 015868          187 NLCIVTEFMARGSIYDFLHK-------QKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFG  259 (399)
Q Consensus       187 ~~~lV~E~~~ggsL~~~l~~-------~~~~l~~~~~~~i~~~i~~~L~~LH~~giiHrDlkp~NILl~~~~~vkl~DFG  259 (399)
                      ..++||||++|++|.+++..       ....+++..++.++.|++.||.|||++||+||||||+||+++.++.+||+|||
T Consensus        87 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg  166 (303)
T 2vwi_A           87 ELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKNGQIHRDVKAGNILLGEDGSVQIADFG  166 (303)
T ss_dssp             CEEEEEECCTTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEECTTCCEEECCCH
T ss_pred             CcEEEehhccCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCCCCChhhEEEcCCCCEEEEecc
Confidence            99999999999999999964       24568999999999999999999999999999999999999999999999999


Q ss_pred             ceeeccCCC------ccccCCCCcccccccccCC-CCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhccCC-
Q 015868          260 VARVQAQSG------VMTAETGTYRWMAPEVIEH-KPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKSLR-  331 (399)
Q Consensus       260 ~a~~~~~~~------~~~~~~gt~~y~aPE~l~~-~~~~~~~Dv~slG~vl~elltg~~P~~~~~~~~~~~~~~~~~~~-  331 (399)
                      .++......      ......||+.|+|||.+.+ ..++.++||||||+++|+|++|..||......+........... 
T Consensus       167 ~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~  246 (303)
T 2vwi_A          167 VSAFLATGGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMKVLMLTLQNDPPS  246 (303)
T ss_dssp             HHHHCC---------------CCCTTCCHHHHHHHHCCCTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHHHHHHTSSCCC
T ss_pred             chheeccCCCccchhhhcccCCCccccCHHHhccccCCCchhhHHHHHHHHHHHHhCCCCCccCchhhHHHHHhccCCCc
Confidence            987544321      1233468999999999976 56899999999999999999999999988776655544432211 


Q ss_pred             -------CCCCCCCcHHHHHHHHHHhhhcCCCCCCHHHHHH
Q 015868          332 -------PTIPKHAHPRLAELLERCWQHDPTQRPNFSQITD  365 (399)
Q Consensus       332 -------~~~~~~~~~~l~~ll~~cl~~dP~~Rps~~ell~  365 (399)
                             +.....+++++.+++.+||+.||.+|||+.++++
T Consensus       247 ~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~  287 (303)
T 2vwi_A          247 LETGVQDKEMLKKYGKSFRKMISLCLQKDPEKRPTAAELLR  287 (303)
T ss_dssp             TTC-----CCCCCCCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred             cccccccchhhhhhhHHHHHHHHHHccCChhhCcCHHHHhh
Confidence                   2234568899999999999999999999999976

>2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A*

Probab=100.00  E-value=6e-45  Score=345.57  Aligned_cols=250  Identities=28%  Similarity=0.501  Sum_probs=211.8

Q ss_pred             cccccceeceeceeCceEEEEEEEC--CeeEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCceeeEEeEEecCCcEEEE
Q 015868          114 DAKQLKIECKVASGSYGDLYKGTYC--SQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIV  191 (399)
Q Consensus       114 ~~~~~~i~~~lg~G~~g~Vy~~~~~--~~~vAvK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~nIv~~~~~~~~~~~~~lV  191 (399)
                      ..++|++.+.||+|+||.||+|++.  ++.||+|++....  ....+.+.+|+.+++.++||||+++++++......++|
T Consensus        17 ~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   94 (302)
T 2j7t_A           17 PNEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKS--EEELEDYIVEIEILATCDHPYIVKLLGAYYHDGKLWIM   94 (302)
T ss_dssp             GGGTEEEEEEEECSTTCCEEEEEETTTCCEEEEEEEC------CCHHHHHHHHHHHHHCCCTTBCCEEEEEECC-CEEEE
T ss_pred             CccceeecceeccCCCeEEEEEEEcCCCcEEEEEEecCCC--HHHHHHHHHHHHHHhcCCCCCEeeeeeeeeeCCeEEEE
Confidence            3578999999999999999999984  7899999997642  33356888999999999999999999999999999999


Q ss_pred             EecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceeecCCCcEEEeeccceeeccCC-Ccc
Q 015868          192 TEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQS-GVM  270 (399)
Q Consensus       192 ~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~giiHrDlkp~NILl~~~~~vkl~DFG~a~~~~~~-~~~  270 (399)
                      |||+++++|.+++......+++..++.++.|++.||.|||++|++||||||+||+++.++.+||+|||++...... ...
T Consensus        95 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~  174 (302)
T 2j7t_A           95 IEFCPGGAVDAIMLELDRGLTEPQIQVVCRQMLEALNFLHSKRIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQKR  174 (302)
T ss_dssp             EECCTTEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEECTTSCEEECCCHHHHHHHHHHHC-
T ss_pred             EEeCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHHHEEECCCCCEEEEECCCCcccccccccc
Confidence            9999999999999877788999999999999999999999999999999999999999999999999987543221 122


Q ss_pred             ccCCCCccccccccc-----CCCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhccCC-CCCCCCCcHHHHH
Q 015868          271 TAETGTYRWMAPEVI-----EHKPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKSLR-PTIPKHAHPRLAE  344 (399)
Q Consensus       271 ~~~~gt~~y~aPE~l-----~~~~~~~~~Dv~slG~vl~elltg~~P~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~l~~  344 (399)
                      ....||+.|+|||.+     .+..++.++||||||+++|+|++|..||...+.............. ...+..++.++.+
T Consensus       175 ~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~  254 (302)
T 2j7t_A          175 DSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSDPPTLLTPSKWSVEFRD  254 (302)
T ss_dssp             ----CCGGGCCHHHHHHHHTTSTTTTTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCCSSGGGSCHHHHH
T ss_pred             ccccCChhhcCCeeeccccCCCCCCchhhhHHHHHHHHHHHhcCCCCCccCCHHHHHHHHhccCCcccCCccccCHHHHH
Confidence            345689999999998     4677899999999999999999999999998887766555443322 2235668999999


Q ss_pred             HHHHHhhhcCCCCCCHHHHHH
Q 015868          345 LLERCWQHDPTQRPNFSQITD  365 (399)
Q Consensus       345 ll~~cl~~dP~~Rps~~ell~  365 (399)
                      ++.+||+.||.+|||+.++++
T Consensus       255 li~~~l~~dp~~Rps~~~ll~  275 (302)
T 2j7t_A          255 FLKIALDKNPETRPSAAQLLE  275 (302)
T ss_dssp             HHHHHSCSCTTTSCCHHHHTT
T ss_pred             HHHHHcccChhhCCCHHHHhc
Confidence            999999999999999999975

>4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens}

Probab=100.00  E-value=4.5e-46  Score=368.09  Aligned_cols=259  Identities=22%  Similarity=0.382  Sum_probs=215.1

Q ss_pred             ecccccceeceeceeCceEEEEEEEC--CeeEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCceeeEEeEEecCC--cE
Q 015868          113 IDAKQLKIECKVASGSYGDLYKGTYC--SQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPP--NL  188 (399)
Q Consensus       113 i~~~~~~i~~~lg~G~~g~Vy~~~~~--~~~vAvK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~nIv~~~~~~~~~~--~~  188 (399)
                      +..++|++.+.||+|+||.||+|++.  ++.||||+++.... ....+.+.+|+.++++++||||+++++++....  ..
T Consensus         6 ~~~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~   84 (396)
T 4eut_A            6 TSNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISF-LRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHK   84 (396)
T ss_dssp             CSSEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGG-GSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCE
T ss_pred             CCCCceEEEEEEEcCCCeEEEEEEECCCCcEEEEEEeccccc-cchHHHHHHHHHHHHhcCCCCCCeEEEeeccCCCCee
Confidence            44678999999999999999999985  78999999975321 222467789999999999999999999998755  78


Q ss_pred             EEEEecCCCCCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceee----cCCCcEEEeecccee
Q 015868          189 CIVTEFMARGSIYDFLHKQK--GVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLM----DENGVVKVADFGVAR  262 (399)
Q Consensus       189 ~lV~E~~~ggsL~~~l~~~~--~~l~~~~~~~i~~~i~~~L~~LH~~giiHrDlkp~NILl----~~~~~vkl~DFG~a~  262 (399)
                      ++||||++||+|.+++....  ..+++..++.++.||+.||+|||++||+||||||+|||+    +.++.+||+|||+++
T Consensus        85 ~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~kL~DFG~a~  164 (396)
T 4eut_A           85 VLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAAR  164 (396)
T ss_dssp             EEEECCCTTEEHHHHTTSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEECTTSCEEEEECCGGGCE
T ss_pred             EEEEecCCCCCHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHHCCEEECCcCHHHEEEeecCCCceeEEEecCCCce
Confidence            99999999999999997643  348999999999999999999999999999999999999    778889999999998


Q ss_pred             eccCCCccccCCCCcccccccccCC--------CCCCChhhHHHHHHHHHHHHcCCCCCCCCC----HHHHHHHHHhccC
Q 015868          263 VQAQSGVMTAETGTYRWMAPEVIEH--------KPYDYKADVFSFGIALWELLTGELPYAGLT----PLQAAVGVVQKSL  330 (399)
Q Consensus       263 ~~~~~~~~~~~~gt~~y~aPE~l~~--------~~~~~~~Dv~slG~vl~elltg~~P~~~~~----~~~~~~~~~~~~~  330 (399)
                      ............||+.|+|||++.+        ..++.++||||||+++|+|++|+.||....    ..+..........
T Consensus       165 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~p  244 (396)
T 4eut_A          165 ELEDDEQFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITGKP  244 (396)
T ss_dssp             ECCCGGGSSCSSSCCTTCCHHHHHHHCC--CHHHHHHHHHHHHHHHHHHHHHHHSSCSEECTTCTTTCHHHHHHHHHSCC
T ss_pred             EccCCCccccccCCccccCHHHhhccccccccccCCCcHHHHHHHHHHHHHHHHCCCCCCCCCcccchHHHHHHHhcCCC
Confidence            7766655566789999999999865        467789999999999999999999996532    2333333332211


Q ss_pred             C-----------------------CCCCCCCcHHHHHHHHHHhhhcCCCCCCHHHHHHHHHHHHH
Q 015868          331 R-----------------------PTIPKHAHPRLAELLERCWQHDPTQRPNFSQITDILKQMMK  372 (399)
Q Consensus       331 ~-----------------------~~~~~~~~~~l~~ll~~cl~~dP~~Rps~~ell~~L~~l~~  372 (399)
                      .                       ..++..+++.+.+++.+||+.||++||++.|+++.+.+++.
T Consensus       245 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~ll~~~L~~dP~~R~s~~e~l~~l~~il~  309 (396)
T 4eut_A          245 SGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDILH  309 (396)
T ss_dssp             TTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHHHHT
T ss_pred             cccchhheeccCCCcccCccCCcccccchHHHhhchHHHHHhhccChhhhccHHHHHHHHHHHhh
Confidence            0                       11223456789999999999999999999999999988875

>3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A*

Probab=100.00  E-value=5.4e-45  Score=350.36  Aligned_cols=257  Identities=30%  Similarity=0.512  Sum_probs=192.3

Q ss_pred             CCCceeecccccceeceeceeCceEEEEEEEC--CeeEEEEEecCCCCCHHHHHHHHHHHH-HHHhcCCCceeeEEeEEe
Q 015868          107 GTDVWEIDAKQLKIECKVASGSYGDLYKGTYC--SQEVAIKVLKPECVNTEMLKEFSQEVY-IMRKIRHKNVVQFIGACT  183 (399)
Q Consensus       107 ~~~~~~i~~~~~~i~~~lg~G~~g~Vy~~~~~--~~~vAvK~~~~~~~~~~~~~~~~~Ei~-~l~~l~h~nIv~~~~~~~  183 (399)
                      ....|.+..++|++.+.||+|+||.||+|.+.  ++.||||+++... .......+.+|+. +++.++||||+++++++.
T Consensus        13 ~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~e~~~~~~~~~h~niv~~~~~~~   91 (327)
T 3aln_A           13 PEQHWDFTAEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTV-DEKEQKQLLMDLDVVMRSSDCPYIVQFYGALF   91 (327)
T ss_dssp             CCEEECCCSCSEEC-CEEEECSSEEEEEEEETTTTEEEEEEEEECCC-CHHHHHHHHHHHHHHHSSCCCTTBCCEEEEEE
T ss_pred             hHHhcccCHHHhhehheeccCCCEEEEEEEEcCCCCEEEEEEeeccc-CchHHHHHHHHHHHHHHcCCCCcEeeeeeEEE
Confidence            34668889999999999999999999999985  8899999998654 3344455556665 778889999999999999


Q ss_pred             cCCcEEEEEecCCCCCHHHHHHh----cCCCCCHHHHHHHHHHHHHHHHHHHHC-CcccCCCCCCceeecCCCcEEEeec
Q 015868          184 RPPNLCIVTEFMARGSIYDFLHK----QKGVFQLTSLLKVAIDVSKGMNYLHQN-NIIHRDLKTANLLMDENGVVKVADF  258 (399)
Q Consensus       184 ~~~~~~lV~E~~~ggsL~~~l~~----~~~~l~~~~~~~i~~~i~~~L~~LH~~-giiHrDlkp~NILl~~~~~vkl~DF  258 (399)
                      .++..++||||+.+ +|.+++..    ....+++..+..++.|++.||.|||++ ||+||||||+||+++.++.+||+||
T Consensus        92 ~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~NIll~~~~~~kl~Df  170 (327)
T 3aln_A           92 REGDCWICMELMST-SFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKENLKIIHRDIKPSNILLDRSGNIKLCDF  170 (327)
T ss_dssp             CSSEEEEEECCCSE-EHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHHHSCCCSCCCGGGEEEETTTEEEECCC
T ss_pred             eCCceEEEEeecCC-ChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHhccCCEeECCCCHHHEEEcCCCCEEEccC
Confidence            99999999999986 88888753    256789999999999999999999999 9999999999999999999999999


Q ss_pred             cceeeccCCCccccCCCCccccccccc----CCCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhccCCCCC
Q 015868          259 GVARVQAQSGVMTAETGTYRWMAPEVI----EHKPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKSLRPTI  334 (399)
Q Consensus       259 G~a~~~~~~~~~~~~~gt~~y~aPE~l----~~~~~~~~~Dv~slG~vl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~  334 (399)
                      |+++............||+.|+|||++    .+..++.++||||||+++|+|++|..||..................+.+
T Consensus       171 g~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~  250 (327)
T 3aln_A          171 GISGQLVDSIAKTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVFDQLTQVVKGDPPQL  250 (327)
T ss_dssp             SSSCC------------------------------CCSHHHHHHHHHHHHHHHHSCCCSSCC-------CCCCCSCCCCC
T ss_pred             CCceecccccccccCCCCccccCceeeccccCcCCCCchhhHHHHHHHHHHHHHCCCCCCCcchHHHHHHHHhcCCCCCC
Confidence            999876555444555799999999999    4667899999999999999999999999876543222222222222333


Q ss_pred             C----CCCcHHHHHHHHHHhhhcCCCCCCHHHHHH
Q 015868          335 P----KHAHPRLAELLERCWQHDPTQRPNFSQITD  365 (399)
Q Consensus       335 ~----~~~~~~l~~ll~~cl~~dP~~Rps~~ell~  365 (399)
                      +    ..+++++.+++.+||+.||.+|||+.++++
T Consensus       251 ~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~  285 (327)
T 3aln_A          251 SNSEEREFSPSFINFVNLCLTKDESKRPKYKELLK  285 (327)
T ss_dssp             CCCSSCCCCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred             CCcccccCCHHHHHHHHHHhhCChhhCcCHHHHHh
Confidence            2    458999999999999999999999999976

>2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A

Probab=100.00  E-value=8.8e-45  Score=352.16  Aligned_cols=244  Identities=24%  Similarity=0.424  Sum_probs=206.8

Q ss_pred             ccccceeceeceeCceEEEEEEE--CCeeEEEEEecCCCCCHHHHHHHHHHHHHHHhc-CCCceeeEEeEEecCCcEEEE
Q 015868          115 AKQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKI-RHKNVVQFIGACTRPPNLCIV  191 (399)
Q Consensus       115 ~~~~~i~~~lg~G~~g~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~Ei~~l~~l-~h~nIv~~~~~~~~~~~~~lV  191 (399)
                      .++|++.+.||+|+||.||++.+  +++.||+|+++....      ...+|+.++.++ +||||+++++++.++...|+|
T Consensus        21 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~------~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv   94 (342)
T 2qr7_A           21 TDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKR------DPTEEIEILLRYGQHPNIITLKDVYDDGKYVYVV   94 (342)
T ss_dssp             HHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTTC------CCHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEE
T ss_pred             cccEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEcccC------ChHHHHHHHHHhcCCCCcCeEEEEEEcCCEEEEE
Confidence            46899999999999999999998  478999999986532      234688888888 799999999999999999999


Q ss_pred             EecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceeecCC----CcEEEeeccceeeccCC
Q 015868          192 TEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDEN----GVVKVADFGVARVQAQS  267 (399)
Q Consensus       192 ~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~giiHrDlkp~NILl~~~----~~vkl~DFG~a~~~~~~  267 (399)
                      |||+.||+|.+++.. .+.+++..+..++.||+.||.|||++||+||||||+|||+.++    +.+||+|||+++.....
T Consensus        95 ~E~~~gg~L~~~i~~-~~~~~~~~~~~~~~qi~~al~~lH~~givHrDlkp~NIl~~~~~~~~~~~kl~Dfg~a~~~~~~  173 (342)
T 2qr7_A           95 TELMKGGELLDKILR-QKFFSEREASAVLFTITKTVEYLHAQGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAE  173 (342)
T ss_dssp             ECCCCSCBHHHHHHT-CTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESSSSCSGGGEEECCCTTCEECBCT
T ss_pred             EeCCCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCcEeccCCHHHEEEecCCCCcCeEEEEECCCcccCcCC
Confidence            999999999999976 4679999999999999999999999999999999999998543    35999999999865443


Q ss_pred             -CccccCCCCcccccccccCCCCCCChhhHHHHHHHHHHHHcCCCCCCCC---CHHHHHHHHHhccCC--CCCCCCCcHH
Q 015868          268 -GVMTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPYAGL---TPLQAAVGVVQKSLR--PTIPKHAHPR  341 (399)
Q Consensus       268 -~~~~~~~gt~~y~aPE~l~~~~~~~~~Dv~slG~vl~elltg~~P~~~~---~~~~~~~~~~~~~~~--~~~~~~~~~~  341 (399)
                       .......||+.|+|||++.+..|+.++||||||+++|+|++|..||...   +..+....+......  ...+..++++
T Consensus       174 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~  253 (342)
T 2qr7_A          174 NGLLMTPCYTANFVAPEVLERQGYDAACDIWSLGVLLYTMLTGYTPFANGPDDTPEEILARIGSGKFSLSGGYWNSVSDT  253 (342)
T ss_dssp             TCCBCCSSCCSSCCCHHHHHHHHHHHHHHHHHHHHHHHHHHHSSCSSCSSTTSCHHHHHHHHHHCCCCCCSTTTTTSCHH
T ss_pred             CCceeccCCCccccCHHHhcCCCCCCccCeeeHhHHHHHHhcCCCCCCCCCcCCHHHHHHHHccCCcccCccccccCCHH
Confidence             3345567899999999999888999999999999999999999999763   444444443332222  2234578999


Q ss_pred             HHHHHHHHhhhcCCCCCCHHHHHH
Q 015868          342 LAELLERCWQHDPTQRPNFSQITD  365 (399)
Q Consensus       342 l~~ll~~cl~~dP~~Rps~~ell~  365 (399)
                      +.+||.+||..||++|||+.++++
T Consensus       254 ~~~li~~~L~~dP~~R~t~~~il~  277 (342)
T 2qr7_A          254 AKDLVSKMLHVDPHQRLTAALVLR  277 (342)
T ss_dssp             HHHHHHHHTCSSTTTSCCHHHHTT
T ss_pred             HHHHHHHHCCCChhHCcCHHHHhc
Confidence            999999999999999999999875

>3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A*

Probab=100.00  E-value=4e-44  Score=358.15  Aligned_cols=249  Identities=24%  Similarity=0.343  Sum_probs=202.4

Q ss_pred             ccccceeceeceeCceEEEEEEE--CCeeEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCceeeEEeEEecC-----Cc
Q 015868          115 AKQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRP-----PN  187 (399)
Q Consensus       115 ~~~~~i~~~lg~G~~g~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~nIv~~~~~~~~~-----~~  187 (399)
                      .++|++.+.||+|+||.||+|.+  +++.||||+++....+....+.+.+|+.+|++++||||+++++++...     ..
T Consensus        25 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~  104 (432)
T 3n9x_A           25 PDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRLKSDYIIRLYDLIIPDDLLKFDE  104 (432)
T ss_dssp             CTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSTTTSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCC
T ss_pred             cCCEEEEEEEeecCCEEEEEEEECCCCcEEEEEEeCchhcChHHHHHHHHHHHHHHHcCCCCcceEEEEEecCCCCcCCe
Confidence            46899999999999999999987  578899999987666677778999999999999999999999999766     56


Q ss_pred             EEEEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceeecCCCcEEEeeccceeeccCC
Q 015868          188 LCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQS  267 (399)
Q Consensus       188 ~~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~giiHrDlkp~NILl~~~~~vkl~DFG~a~~~~~~  267 (399)
                      +|+||||+.+ +|.+++.. ...+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.....
T Consensus       105 ~~lv~e~~~~-~L~~~~~~-~~~l~~~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~~kL~DFGla~~~~~~  182 (432)
T 3n9x_A          105 LYIVLEIADS-DLKKLFKT-PIFLTEEHIKTILYNLLLGENFIHESGIIHRDLKPANCLLNQDCSVKVCDFGLARTINSE  182 (432)
T ss_dssp             EEEEEECCSE-EHHHHHHS-SCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEEC---
T ss_pred             EEEEEecCCc-CHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCHHHeEECCCCCEEEccCCCccccccc
Confidence            9999999975 99999965 567999999999999999999999999999999999999999999999999999865433


Q ss_pred             C-----------------------ccccCCCCccccccccc-CCCCCCChhhHHHHHHHHHHHHcC-----------CCC
Q 015868          268 G-----------------------VMTAETGTYRWMAPEVI-EHKPYDYKADVFSFGIALWELLTG-----------ELP  312 (399)
Q Consensus       268 ~-----------------------~~~~~~gt~~y~aPE~l-~~~~~~~~~Dv~slG~vl~elltg-----------~~P  312 (399)
                      .                       ..+...||+.|+|||++ ....|+.++|||||||++|||++|           .++
T Consensus       183 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~~p~  262 (432)
T 3n9x_A          183 KDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSHINDPTNRFPL  262 (432)
T ss_dssp             ----------------------------CCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHTTCTTTCSSGGGCCCS
T ss_pred             ccccccccccccccccccccchhccccCCCCCccccCHHHHhcCCCCCcccccchHHHHHHHHHhccccccccccccccc
Confidence            2                       23567899999999986 566799999999999999999984           444


Q ss_pred             CCCCCH-----------------HHHHHHH-----------------------Hhc-cCCCCC-----CCCCcHHHHHHH
Q 015868          313 YAGLTP-----------------LQAAVGV-----------------------VQK-SLRPTI-----PKHAHPRLAELL  346 (399)
Q Consensus       313 ~~~~~~-----------------~~~~~~~-----------------------~~~-~~~~~~-----~~~~~~~l~~ll  346 (399)
                      |.+.+.                 ......+                       +.. ......     .+.+++++.+||
T Consensus       263 f~g~~~~~~~~~~~~~~~~~~~~~~ql~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl  342 (432)
T 3n9x_A          263 FPGSSCFPLSPDRNSKKVHEKSNRDQLNIIFNIIGTPTEDDLKNINKPEVIKYIKLFPHRKPINLKQKYPSISDDGINLL  342 (432)
T ss_dssp             CCCSCSCC----------CHHHHHHHHHHHHHHHCSCCHHHHHTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHHHHHHH
T ss_pred             CCCccccccCcccccccccccchHHHHHHHHHhcCCCCHHHHHhccCHHHHHHHHhCCCCCCCCHHHHCCCCCHHHHHHH
Confidence            444321                 0000000                       000 001111     145899999999


Q ss_pred             HHHhhhcCCCCCCHHHHHH
Q 015868          347 ERCWQHDPTQRPNFSQITD  365 (399)
Q Consensus       347 ~~cl~~dP~~Rps~~ell~  365 (399)
                      .+||+.||.+|||++|+++
T Consensus       343 ~~mL~~dP~~R~ta~e~L~  361 (432)
T 3n9x_A          343 ESMLKFNPNKRITIDQALD  361 (432)
T ss_dssp             HHHSCSSTTTSCCHHHHHT
T ss_pred             HHHhcCCcccCCCHHHHhc
Confidence            9999999999999999976

>2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens}

Probab=100.00  E-value=1.7e-44  Score=341.10  Aligned_cols=253  Identities=27%  Similarity=0.499  Sum_probs=212.8

Q ss_pred             eeecccccceeceeceeCceEEEEEEE--CCeeEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCceeeEEeEEecCCcE
Q 015868          111 WEIDAKQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNL  188 (399)
Q Consensus       111 ~~i~~~~~~i~~~lg~G~~g~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~nIv~~~~~~~~~~~~  188 (399)
                      +.+..++|.....||+|+||.||+|++  +++.||+|+++...  ....+.+.+|+.+++.++||||+++++++......
T Consensus        17 ~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~   94 (295)
T 2clq_A           17 YDYEYDENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERD--SRYSQPLHEEIALHKHLKHKNIVQYLGSFSENGFI   94 (295)
T ss_dssp             EEECBCTTSSBCEEEECSSSEEEEEEETTTCCEEEEEEEECCC--C---HHHHHHHHHHHTCCCTTBCCEEEEEEETTEE
T ss_pred             ccccccCCCCcEEEeecCcEEEEEEEECCCCeEEEEEEccCCc--hHHHHHHHHHHHHHHhCCCCCEeeEeeEEEeCCcE
Confidence            455566777777999999999999998  56889999998653  34457799999999999999999999999999999


Q ss_pred             EEEEecCCCCCHHHHHHhcCC--CCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceeecC-CCcEEEeeccceeecc
Q 015868          189 CIVTEFMARGSIYDFLHKQKG--VFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDE-NGVVKVADFGVARVQA  265 (399)
Q Consensus       189 ~lV~E~~~ggsL~~~l~~~~~--~l~~~~~~~i~~~i~~~L~~LH~~giiHrDlkp~NILl~~-~~~vkl~DFG~a~~~~  265 (399)
                      ++||||+++++|.+++....+  .+++..++.++.|++.||.|||++||+||||||+||+++. ++.+||+|||.++...
T Consensus        95 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~kl~Dfg~~~~~~  174 (295)
T 2clq_A           95 KIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDNQIVHRDIKGDNVLINTYSGVLKISDFGTSKRLA  174 (295)
T ss_dssp             EEEEECCSEEEHHHHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTCCEEECCTTTCEESC
T ss_pred             EEEEEeCCCCCHHHHHHhhccCCCccHHHHHHHHHHHHHHHHHHHhCCEEccCCChhhEEEECCCCCEEEeecccccccC
Confidence            999999999999999987533  4568899999999999999999999999999999999987 8999999999998654


Q ss_pred             CCC-ccccCCCCcccccccccCCCC--CCChhhHHHHHHHHHHHHcCCCCCCCCCHHH-HHHHHHhccCCCCCCCCCcHH
Q 015868          266 QSG-VMTAETGTYRWMAPEVIEHKP--YDYKADVFSFGIALWELLTGELPYAGLTPLQ-AAVGVVQKSLRPTIPKHAHPR  341 (399)
Q Consensus       266 ~~~-~~~~~~gt~~y~aPE~l~~~~--~~~~~Dv~slG~vl~elltg~~P~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~  341 (399)
                      ... ......|++.|+|||++.+..  ++.++||||||+++|+|++|+.||....... ...........+.++..++++
T Consensus       175 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  254 (295)
T 2clq_A          175 GINPCTETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGEPQAAMFKVGMFKVHPEIPESMSAE  254 (295)
T ss_dssp             C-----CCCCCCGGGCCHHHHHHGGGGCSHHHHHHHHHHHHHHHHHTSCTTGGGSSHHHHHHHHHHHCCCCCCCTTSCHH
T ss_pred             CCCCcccccCCCccccChhhhcCCCCCCCcHHHHHHHHHHHHHHHHCCCCccCCCchhHHHHhhccccccccccccCCHH
Confidence            432 234457899999999997643  8899999999999999999999997654333 222333345567788899999


Q ss_pred             HHHHHHHHhhhcCCCCCCHHHHHH
Q 015868          342 LAELLERCWQHDPTQRPNFSQITD  365 (399)
Q Consensus       342 l~~ll~~cl~~dP~~Rps~~ell~  365 (399)
                      +.+++.+||+.||++||++.++++
T Consensus       255 ~~~li~~~l~~dp~~Rps~~~ll~  278 (295)
T 2clq_A          255 AKAFILKCFEPDPDKRACANDLLV  278 (295)
T ss_dssp             HHHHHHHTTCSSTTTSCCHHHHHT
T ss_pred             HHHHHHHHccCChhhCCCHHHHhc
Confidence            999999999999999999999864

>2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ...

Probab=100.00  E-value=6.4e-45  Score=356.44  Aligned_cols=251  Identities=25%  Similarity=0.415  Sum_probs=197.0

Q ss_pred             CceeecccccceeceeceeCceEEEEEEE--CCeeEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCceeeEEeEEecC-
Q 015868          109 DVWEIDAKQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRP-  185 (399)
Q Consensus       109 ~~~~i~~~~~~i~~~lg~G~~g~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~nIv~~~~~~~~~-  185 (399)
                      ..|++. ++|++.+.||+|+||.||+|.+  +++.||||++.....+....+.+.+|+.+++.++||||+++++++... 
T Consensus        23 ~~~~~~-~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~  101 (367)
T 2fst_X           23 TIWEVP-ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPAR  101 (367)
T ss_dssp             EEEEEE-TTEEEEEECC----CCEEEEEETTTTEEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCS
T ss_pred             cccCCC-CceEEeeEEeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCC
Confidence            456664 6899999999999999999987  578999999987665667778899999999999999999999999754 


Q ss_pred             -----CcEEEEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceeecCCCcEEEeeccc
Q 015868          186 -----PNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGV  260 (399)
Q Consensus       186 -----~~~~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~giiHrDlkp~NILl~~~~~vkl~DFG~  260 (399)
                           ..+|+|+|++ +++|.+++..  ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+
T Consensus       102 ~~~~~~~~~lv~e~~-~~~L~~~~~~--~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~~~~~~kL~DFG~  178 (367)
T 2fst_X          102 SLEEFNDVYLVTHLM-GADLNNIVKC--QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGL  178 (367)
T ss_dssp             SGGGCCCCEEEEECC-CEECC-------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECC---
T ss_pred             ccccCCeEEEEeccc-CCCHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHhhEEECCCCCEEEeeccc
Confidence                 5689999999 6799999865  5699999999999999999999999999999999999999999999999999


Q ss_pred             eeeccCCCccccCCCCcccccccccCC-CCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhccCC--------
Q 015868          261 ARVQAQSGVMTAETGTYRWMAPEVIEH-KPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKSLR--------  331 (399)
Q Consensus       261 a~~~~~~~~~~~~~gt~~y~aPE~l~~-~~~~~~~Dv~slG~vl~elltg~~P~~~~~~~~~~~~~~~~~~~--------  331 (399)
                      ++....  ..+...||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+.......+......        
T Consensus       179 a~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~p~~~~~~~  256 (367)
T 2fst_X          179 ARHTAD--EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKK  256 (367)
T ss_dssp             --------------CCCTTCCHHHHTTCCSCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHTT
T ss_pred             cccccc--cCCCcCcCcCccChHHHcCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHH
Confidence            986543  2455678999999999987 67899999999999999999999999988876554443321100        


Q ss_pred             -------------CC--------CCCCCcHHHHHHHHHHhhhcCCCCCCHHHHHH
Q 015868          332 -------------PT--------IPKHAHPRLAELLERCWQHDPTQRPNFSQITD  365 (399)
Q Consensus       332 -------------~~--------~~~~~~~~l~~ll~~cl~~dP~~Rps~~ell~  365 (399)
                                   +.        .....++++.+||.+||+.||.+|||+.|+++
T Consensus       257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~t~~e~L~  311 (367)
T 2fst_X          257 ISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALA  311 (367)
T ss_dssp             CCCHHHHHHHHTSCCCCCCCHHHHTTTCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             hhhHHHHHHHhccCCCCCCCHHHHCCCCCHHHHHHHHHhCCCCcccCcCHHHHhc
Confidence                         01        11356889999999999999999999999976

>3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A

Probab=100.00  E-value=6.1e-45  Score=350.67  Aligned_cols=241  Identities=22%  Similarity=0.418  Sum_probs=184.7

Q ss_pred             cccee---ceeceeCceEEEEEEE--CCeeEEEEEecCCCCCHHHHHHHHHHHHHHHhcC-CCceeeEEeEEecCCcEEE
Q 015868          117 QLKIE---CKVASGSYGDLYKGTY--CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIR-HKNVVQFIGACTRPPNLCI  190 (399)
Q Consensus       117 ~~~i~---~~lg~G~~g~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~Ei~~l~~l~-h~nIv~~~~~~~~~~~~~l  190 (399)
                      +|.+.   +.||+|+||.||+|.+  +++.||||++...     ....+.+|+.+++.+. ||||+++++++......|+
T Consensus         9 ~y~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~-----~~~~~~~e~~~l~~l~~h~niv~~~~~~~~~~~~~l   83 (325)
T 3kn6_A            9 HYDLDLKDKPLGEGSFSICRKCVHKKSNQAFAVKIISKR-----MEANTQKEITALKLCEGHPNIVKLHEVFHDQLHTFL   83 (325)
T ss_dssp             HEEECTTSCCSEEETTEEEEEEEETTTCCEEEEEEEEGG-----GHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEE
T ss_pred             ccccccCCCccccCCCeEEEEEEECCCCCEEEEEEEChh-----hhhhHHHHHHHHHHhcCCCCeeEEEEEEEcCCEEEE
Confidence            45543   7899999999999998  4789999999643     3456788999999997 9999999999999999999


Q ss_pred             EEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceeecCCC---cEEEeeccceeeccCC
Q 015868          191 VTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENG---VVKVADFGVARVQAQS  267 (399)
Q Consensus       191 V~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~giiHrDlkp~NILl~~~~---~vkl~DFG~a~~~~~~  267 (399)
                      ||||++|++|.+++.. ...+++..++.++.||+.||.|||++||+||||||+|||++.++   .+||+|||+++.....
T Consensus        84 v~e~~~~~~L~~~l~~-~~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~~kl~Dfg~a~~~~~~  162 (325)
T 3kn6_A           84 VMELLNGGELFERIKK-KKHFSETEASYIMRKLVSAVSHMHDVGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPD  162 (325)
T ss_dssp             EECCCCSCBHHHHHHH-CSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEC----CEEEECCCTTCEECCC-
T ss_pred             EEEccCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCHHHEEEecCCCcccEEEeccccceecCCC
Confidence            9999999999999977 46799999999999999999999999999999999999998766   8999999999865543


Q ss_pred             C-ccccCCCCcccccccccCCCCCCChhhHHHHHHHHHHHHcCCCCCCCCCH-------HHHHHHHHhccCCCCCC----
Q 015868          268 G-VMTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPYAGLTP-------LQAAVGVVQKSLRPTIP----  335 (399)
Q Consensus       268 ~-~~~~~~gt~~y~aPE~l~~~~~~~~~Dv~slG~vl~elltg~~P~~~~~~-------~~~~~~~~~~~~~~~~~----  335 (399)
                      . ......||+.|+|||++.+..++.++||||||+++|+|++|..||...+.       .+.... +..... ..+    
T Consensus       163 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~-i~~~~~-~~~~~~~  240 (325)
T 3kn6_A          163 NQPLKTPCFTLHYAAPELLNQNGYDESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEIMKK-IKKGDF-SFEGEAW  240 (325)
T ss_dssp             ---------------------CCCCHHHHHHHHHHHHHHHHHSSCTTC-------CCCHHHHHHH-HTTTCC-CCCSHHH
T ss_pred             CCcccccCCCcCccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCccccccccHHHHHHH-HHcCCC-CCCcccc
Confidence            2 33456789999999999999999999999999999999999999986543       222222 222211 112    


Q ss_pred             CCCcHHHHHHHHHHhhhcCCCCCCHHHHHH
Q 015868          336 KHAHPRLAELLERCWQHDPTQRPNFSQITD  365 (399)
Q Consensus       336 ~~~~~~l~~ll~~cl~~dP~~Rps~~ell~  365 (399)
                      ..+++++.+||.+||+.||.+|||++|+++
T Consensus       241 ~~~s~~~~~li~~~L~~dP~~Rpt~~ell~  270 (325)
T 3kn6_A          241 KNVSQEAKDLIQGLLTVDPNKRLKMSGLRY  270 (325)
T ss_dssp             HTSCHHHHHHHHHHHCCCTTTCCCTTTSTT
T ss_pred             cCCCHHHHHHHHHHCCCChhHCCCHHHHhc
Confidence            357899999999999999999999999863

>2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ...

Probab=100.00  E-value=7.6e-45  Score=340.18  Aligned_cols=249  Identities=24%  Similarity=0.402  Sum_probs=210.6

Q ss_pred             ccccceeceeceeCceEEEEEEE--CCeeEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCceeeEEeEEecCCcEEEEE
Q 015868          115 AKQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVT  192 (399)
Q Consensus       115 ~~~~~i~~~lg~G~~g~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~nIv~~~~~~~~~~~~~lV~  192 (399)
                      .++|++.+.||+|+||.||+|..  .++.||+|+++.... ....+.+.+|+.+++.++||||+++++++......++||
T Consensus         6 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   84 (276)
T 2yex_A            6 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRA-VDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFL   84 (276)
T ss_dssp             HHHEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGC-TTHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             ecceEEEEEeecCCCcEEEEEEECCCCcEEEEEEeeeccc-hhhhHHHHHHHHHHHhcCCCCceeeeeEEEcCCEEEEEE
Confidence            36899999999999999999988  478999999975432 234578899999999999999999999999999999999


Q ss_pred             ecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceeecCCCcEEEeeccceeeccCCC---c
Q 015868          193 EFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSG---V  269 (399)
Q Consensus       193 E~~~ggsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~giiHrDlkp~NILl~~~~~vkl~DFG~a~~~~~~~---~  269 (399)
                      ||+++++|.+++.. ...+++..++.++.|++.||.|||++||+||||||+||+++.++.+||+|||.+.......   .
T Consensus        85 e~~~~~~L~~~l~~-~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~  163 (276)
T 2yex_A           85 EYCSGGELFDRIEP-DIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERL  163 (276)
T ss_dssp             ECCTTEEGGGGSBT-TTBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEECEETTEECC
T ss_pred             EecCCCcHHHHHhh-ccCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCChHHEEEccCCCEEEeeCCCccccCCCcchhc
Confidence            99999999999865 4568999999999999999999999999999999999999999999999999997654322   2


Q ss_pred             cccCCCCcccccccccCCCCC-CChhhHHHHHHHHHHHHcCCCCCCCCCHHHHH-HHHHhccCCCCCCCCCcHHHHHHHH
Q 015868          270 MTAETGTYRWMAPEVIEHKPY-DYKADVFSFGIALWELLTGELPYAGLTPLQAA-VGVVQKSLRPTIPKHAHPRLAELLE  347 (399)
Q Consensus       270 ~~~~~gt~~y~aPE~l~~~~~-~~~~Dv~slG~vl~elltg~~P~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~l~~ll~  347 (399)
                      .....|++.|+|||.+.+..+ +.++||||||+++|+|++|..||......... ...............+++++.+++.
T Consensus       164 ~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~  243 (276)
T 2yex_A          164 LNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLALLH  243 (276)
T ss_dssp             BCCCCSCGGGCCGGGGTCSSBCHHHHHHHHHHHHHHHHHHSSCCCSCSCTTSHHHHHHHTTCTTSTTGGGSCHHHHHHHH
T ss_pred             ccCCccccCccChHHHhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCchHHHHHHHhhhcccccCchhhcCHHHHHHHH
Confidence            344578999999999988765 77899999999999999999999876543222 2222222222223468999999999


Q ss_pred             HHhhhcCCCCCCHHHHHH
Q 015868          348 RCWQHDPTQRPNFSQITD  365 (399)
Q Consensus       348 ~cl~~dP~~Rps~~ell~  365 (399)
                      +||+.||.+|||+.|+++
T Consensus       244 ~~l~~~p~~Rps~~~il~  261 (276)
T 2yex_A          244 KILVENPSARITIPDIKK  261 (276)
T ss_dssp             HHSCSSTTTSCCHHHHTT
T ss_pred             HHCCCCchhCCCHHHHhc
Confidence            999999999999999865

>3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens}

Probab=100.00  E-value=3e-44  Score=350.79  Aligned_cols=256  Identities=17%  Similarity=0.298  Sum_probs=215.5

Q ss_pred             CCceeecccccceeceeceeCceEEEEEE-------ECCeeEEEEEecCCCCCHHHHHHHHHHHHHHHhcC---CCceee
Q 015868          108 TDVWEIDAKQLKIECKVASGSYGDLYKGT-------YCSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIR---HKNVVQ  177 (399)
Q Consensus       108 ~~~~~i~~~~~~i~~~lg~G~~g~Vy~~~-------~~~~~vAvK~~~~~~~~~~~~~~~~~Ei~~l~~l~---h~nIv~  177 (399)
                      ...+++..++|++.+.||+|+||.||+|.       ..++.||+|+++...     ..++.+|+.+++.++   |+||++
T Consensus        57 ~~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~-----~~~~~~e~~~~~~l~~~~~~~iv~  131 (365)
T 3e7e_A           57 KTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPAN-----PWEFYIGTQLMERLKPSMQHMFMK  131 (365)
T ss_dssp             SCEEECSSSEEEEEEEEEECSSEEEEEEEC-------CCCCEEEEEESSCC-----HHHHHHHHHHHHHSCGGGGGGBCC
T ss_pred             ceeEEECCEEEEEEEEeeccCCEEEEEEEecCCcccccCcEEEEEEeCCCC-----hhHHHHHHHHHHHhhhhhhhhhhh
Confidence            35678888999999999999999999993       367899999998642     346778888888887   899999


Q ss_pred             EEeEEecCCcEEEEEecCCCCCHHHHHHh----cCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceeecC----
Q 015868          178 FIGACTRPPNLCIVTEFMARGSIYDFLHK----QKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDE----  249 (399)
Q Consensus       178 ~~~~~~~~~~~~lV~E~~~ggsL~~~l~~----~~~~l~~~~~~~i~~~i~~~L~~LH~~giiHrDlkp~NILl~~----  249 (399)
                      +++++...+..|+||||++||+|.+++..    ....+++..++.++.||+.||+|||++||+||||||+|||++.    
T Consensus       132 ~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~ivHrDiKp~NIll~~~~~~  211 (365)
T 3e7e_A          132 FYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLE  211 (365)
T ss_dssp             EEEEEECSSCEEEEECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEECGGGTC
T ss_pred             hheeeecCCCcEEEEeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHhhCCeecCCCCHHHEEecccccC
Confidence            99999999999999999999999999975    3467999999999999999999999999999999999999998    


Q ss_pred             -------CCcEEEeeccceeecc---CCCccccCCCCcccccccccCCCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHH
Q 015868          250 -------NGVVKVADFGVARVQA---QSGVMTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPYAGLTPL  319 (399)
Q Consensus       250 -------~~~vkl~DFG~a~~~~---~~~~~~~~~gt~~y~aPE~l~~~~~~~~~Dv~slG~vl~elltg~~P~~~~~~~  319 (399)
                             ++.+||+|||+++...   .........||+.|+|||++.+..|+.++||||||+++|+|+||+.||......
T Consensus       212 ~~~~~~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~  291 (365)
T 3e7e_A          212 QDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGG  291 (365)
T ss_dssp             C------CTTEEECCCTTCEEGGGSCTTEEECCSSCTTSCCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCCCEEEETT
T ss_pred             ccccccccCCEEEeeCchhhhhhccCCCceeeeecCCCCCCChHHhcCCCCCccccHHHHHHHHHHHHhCCCccccCCCC
Confidence                   8999999999997543   233445667999999999999999999999999999999999999998643321


Q ss_pred             HHHHHHHhccCCCCCCCCCcHHHHHHHHHHhhhcCCCC-CCHHHHHHHHHHHHHHH
Q 015868          320 QAAVGVVQKSLRPTIPKHAHPRLAELLERCWQHDPTQR-PNFSQITDILKQMMKEV  374 (399)
Q Consensus       320 ~~~~~~~~~~~~~~~~~~~~~~l~~ll~~cl~~dP~~R-ps~~ell~~L~~l~~~~  374 (399)
                      ...   . ....+.  ...++.+.+++.+||+.+|.+| |++.++.+.|++++...
T Consensus       292 ~~~---~-~~~~~~--~~~~~~~~~~~~~~l~~~p~~r~~~~~~l~~~l~~~l~~~  341 (365)
T 3e7e_A          292 ECK---P-EGLFRR--LPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQH  341 (365)
T ss_dssp             EEE---E-CSCCTT--CSSHHHHHHHHHHHHCCCCTTCCCCHHHHHHHHHHHHHHH
T ss_pred             cee---e-chhccc--cCcHHHHHHHHHHHcCCCCCCcchHHHHHHHHHHHHHHHh
Confidence            100   0 011111  1357789999999999999999 68899999999887653

>3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B

Probab=100.00  E-value=1.2e-44  Score=370.39  Aligned_cols=246  Identities=25%  Similarity=0.402  Sum_probs=212.1

Q ss_pred             ecccccceeceeceeCceEEEEEEE--CCeeEEEEEecCCCCC-HHHHHHHHHHHHHHHhcCCCceeeEEeEEecCCcEE
Q 015868          113 IDAKQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVN-TEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLC  189 (399)
Q Consensus       113 i~~~~~~i~~~lg~G~~g~Vy~~~~--~~~~vAvK~~~~~~~~-~~~~~~~~~Ei~~l~~l~h~nIv~~~~~~~~~~~~~  189 (399)
                      +..++|++.+.||+|+||.||+|+.  +++.||+|+++..... ......+.+|+.++++++||||+++++++.....+|
T Consensus       182 ~~~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~  261 (543)
T 3c4z_A          182 MGEDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAYAFETKTDLC  261 (543)
T ss_dssp             CCGGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred             CChhheEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEEhHHhhhhHHHHHHHHHHHHHHhcCCCCEeeEEEEEeeCCEEE
Confidence            4567899999999999999999998  5889999999643111 112357889999999999999999999999999999


Q ss_pred             EEEecCCCCCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceeecCCCcEEEeeccceeeccC
Q 015868          190 IVTEFMARGSIYDFLHKQ---KGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQ  266 (399)
Q Consensus       190 lV~E~~~ggsL~~~l~~~---~~~l~~~~~~~i~~~i~~~L~~LH~~giiHrDlkp~NILl~~~~~vkl~DFG~a~~~~~  266 (399)
                      +||||++||+|.+++...   ...+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||+++....
T Consensus       262 lVmE~~~gg~L~~~l~~~~~~~~~l~e~~~~~~~~qi~~aL~~LH~~gIvHrDLKP~NILl~~~g~vkL~DFGla~~~~~  341 (543)
T 3c4z_A          262 LVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQRNIIYRDLKPENVLLDDDGNVRISDLGLAVELKA  341 (543)
T ss_dssp             EEECCCTTCBHHHHHHTSSTTSCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCEEECCCTTCEECCT
T ss_pred             EEEEeccCCCHHHHHHHhhcccccccHHHHHHHHHHHHHHHHHHHHcCCcccCCChHHEEEeCCCCEEEeecceeeeccC
Confidence            999999999999999764   34699999999999999999999999999999999999999999999999999987654


Q ss_pred             CCc-cccCCCCcccccccccCCCCCCChhhHHHHHHHHHHHHcCCCCCCCCC----HHHHHHHHHhccCCCCCCCCCcHH
Q 015868          267 SGV-MTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPYAGLT----PLQAAVGVVQKSLRPTIPKHAHPR  341 (399)
Q Consensus       267 ~~~-~~~~~gt~~y~aPE~l~~~~~~~~~Dv~slG~vl~elltg~~P~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~  341 (399)
                      ... .....||+.|+|||++.+..|+.++|+|||||++|||++|..||...+    ..+....+..  .....|..++++
T Consensus       342 ~~~~~~~~~GT~~Y~APE~l~~~~~~~~~DiwSlGvilyelltG~~PF~~~~~~~~~~~~~~~i~~--~~~~~p~~~s~~  419 (543)
T 3c4z_A          342 GQTKTKGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRVLE--QAVTYPDKFSPA  419 (543)
T ss_dssp             TCCCBCCCCSCTTTSCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCTTCCCCHHHHHHHHHH--CCCCCCTTSCHH
T ss_pred             CCcccccccCCccccChhhhcCCCCChHHhcCcchHHHHHHHhCCCCCCCCccchhHHHHHHHHhh--cccCCCcccCHH
Confidence            433 334589999999999999999999999999999999999999998753    3333333333  234567889999


Q ss_pred             HHHHHHHHhhhcCCCCCCH
Q 015868          342 LAELLERCWQHDPTQRPNF  360 (399)
Q Consensus       342 l~~ll~~cl~~dP~~Rps~  360 (399)
                      +.+||.+||+.||.+||++
T Consensus       420 ~~~li~~lL~~dP~~R~~~  438 (543)
T 3c4z_A          420 SKDFCEALLQKDPEKRLGF  438 (543)
T ss_dssp             HHHHHHHHSCSSGGGSCCC
T ss_pred             HHHHHHHhccCCHhHCCCC
Confidence            9999999999999999975

>2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A

Probab=100.00  E-value=9.9e-45  Score=346.47  Aligned_cols=247  Identities=26%  Similarity=0.419  Sum_probs=201.3

Q ss_pred             cccccee-ceeceeCceEEEEEEE--CCeeEEEEEecCCCCCHHHHHHHHHHHHHHHhc-CCCceeeEEeEEecCCcEEE
Q 015868          115 AKQLKIE-CKVASGSYGDLYKGTY--CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKI-RHKNVVQFIGACTRPPNLCI  190 (399)
Q Consensus       115 ~~~~~i~-~~lg~G~~g~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~Ei~~l~~l-~h~nIv~~~~~~~~~~~~~l  190 (399)
                      .+.|++. +.||+|+||.||+|++  .++.||||+++...  ......+.+|+.+++++ +||||+++++++..++.+++
T Consensus        11 ~~~y~i~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~~~~h~~i~~~~~~~~~~~~~~l   88 (316)
T 2ac3_A           11 EDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQP--GHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYL   88 (316)
T ss_dssp             TTSCEECCCCCCCCSSEEEEEEECSSSCCEEEEEEEECCS--SCCHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEE
T ss_pred             ceeEEecCceecCCceEEEEEEEEcCCCcEEEEEEEeeCc--chhHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEEEE
Confidence            4578885 7899999999999986  57899999997653  22346788999999985 79999999999999999999


Q ss_pred             EEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceeecCCCc---EEEeeccceeeccCC
Q 015868          191 VTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGV---VKVADFGVARVQAQS  267 (399)
Q Consensus       191 V~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~giiHrDlkp~NILl~~~~~---vkl~DFG~a~~~~~~  267 (399)
                      ||||++|++|.+++... ..+++..++.++.||+.||.|||++||+||||||+||+++.++.   +||+|||+++.....
T Consensus        89 v~e~~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~~~~kl~Dfg~~~~~~~~  167 (316)
T 2ac3_A           89 VFEKMRGGSILSHIHKR-RHFNELEASVVVQDVASALDFLHNKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLN  167 (316)
T ss_dssp             EEECCTTCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEESCSSSSCSEEECCTTCCC-----
T ss_pred             EEEcCCCCcHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCHHHEEEccCCCcCceEEEEccCccccccC
Confidence            99999999999999764 57899999999999999999999999999999999999998776   999999998754322


Q ss_pred             C--------ccccCCCCcccccccccCC-----CCCCChhhHHHHHHHHHHHHcCCCCCCCCCHH--------------H
Q 015868          268 G--------VMTAETGTYRWMAPEVIEH-----KPYDYKADVFSFGIALWELLTGELPYAGLTPL--------------Q  320 (399)
Q Consensus       268 ~--------~~~~~~gt~~y~aPE~l~~-----~~~~~~~Dv~slG~vl~elltg~~P~~~~~~~--------------~  320 (399)
                      .        ......||+.|+|||++.+     ..++.++||||||+++|+|++|..||.+....              .
T Consensus       168 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~  247 (316)
T 2ac3_A          168 GDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPACQN  247 (316)
T ss_dssp             --------------CCSGGGCCHHHHHHTSHHHHHHTTTHHHHHHHHHHHHHHHSSCSCCCCCCSCSCC----CCHHHHH
T ss_pred             CccccccccccccccCCcCccChHHhhcccccccCCCcccccHhHHHHHHHHHHCCCCCcccccccccccccccchhHHH
Confidence            1        1223458999999999975     55889999999999999999999999875421              1


Q ss_pred             HHHHHHhccCCCCCC----CCCcHHHHHHHHHHhhhcCCCCCCHHHHHH
Q 015868          321 AAVGVVQKSLRPTIP----KHAHPRLAELLERCWQHDPTQRPNFSQITD  365 (399)
Q Consensus       321 ~~~~~~~~~~~~~~~----~~~~~~l~~ll~~cl~~dP~~Rps~~ell~  365 (399)
                      .....+.... ...|    ..+++++.+||.+||+.||.+|||+.|+++
T Consensus       248 ~~~~~i~~~~-~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~  295 (316)
T 2ac3_A          248 MLFESIQEGK-YEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQ  295 (316)
T ss_dssp             HHHHHHHHCC-CCCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred             HHHHHHhccC-cccCchhcccCCHHHHHHHHHHhhCChhhCCCHHHHhc
Confidence            1222222221 2222    458899999999999999999999999976

>1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B

Probab=100.00  E-value=1.5e-44  Score=346.41  Aligned_cols=250  Identities=24%  Similarity=0.411  Sum_probs=210.6

Q ss_pred             ccccceeceeceeCceEEEEEEE---CCeeEEEEEecCCCCCHHHHHHHHHHHHHHHhc---CCCceeeEEeEEe-----
Q 015868          115 AKQLKIECKVASGSYGDLYKGTY---CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKI---RHKNVVQFIGACT-----  183 (399)
Q Consensus       115 ~~~~~i~~~lg~G~~g~Vy~~~~---~~~~vAvK~~~~~~~~~~~~~~~~~Ei~~l~~l---~h~nIv~~~~~~~-----  183 (399)
                      .++|++.+.||+|+||.||+|++   .++.||+|+++...........+.+|+.+++.+   +||||+++++++.     
T Consensus        10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~   89 (326)
T 1blx_A           10 DQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTD   89 (326)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECS
T ss_pred             hhceeeeeeecccccEEEEEEEecCCCCEEEEEEEeccCcccccCCchhhHHHHHHHhhhccCCCCeEeeeeeeeecccC
Confidence            47899999999999999999987   368899999875432222223556777777766   8999999999987     


Q ss_pred             cCCcEEEEEecCCCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceeecCCCcEEEeecccee
Q 015868          184 RPPNLCIVTEFMARGSIYDFLHKQK-GVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVAR  262 (399)
Q Consensus       184 ~~~~~~lV~E~~~ggsL~~~l~~~~-~~l~~~~~~~i~~~i~~~L~~LH~~giiHrDlkp~NILl~~~~~vkl~DFG~a~  262 (399)
                      .....++||||+. ++|.+++.... ..+++..++.++.|++.||.|||++||+||||||+||+++.++.+||+|||.++
T Consensus        90 ~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~gi~H~dlkp~Nili~~~~~~kl~Dfg~~~  168 (326)
T 1blx_A           90 RETKLTLVFEHVD-QDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLAR  168 (326)
T ss_dssp             SEEEEEEEEECCS-CBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECSCCSCC
T ss_pred             CCceEEEEEecCC-CCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCHHHeEEcCCCCEEEecCcccc
Confidence            5567999999998 59999997753 458999999999999999999999999999999999999999999999999998


Q ss_pred             eccCCCccccCCCCcccccccccCCCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhccCC-----------
Q 015868          263 VQAQSGVMTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKSLR-----------  331 (399)
Q Consensus       263 ~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~Dv~slG~vl~elltg~~P~~~~~~~~~~~~~~~~~~~-----------  331 (399)
                      ............||+.|+|||++.+..++.++||||||+++|+|++|+.||.+.+.......+......           
T Consensus       169 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  248 (326)
T 1blx_A          169 IYSFQMALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRDVA  248 (326)
T ss_dssp             CCCGGGGGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCGGGSCTTCS
T ss_pred             cccCCCCccccccccceeCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCCCCcccCccccc
Confidence            765544455667899999999999999999999999999999999999999998876665554431110           


Q ss_pred             --------------CCCCCCCcHHHHHHHHHHhhhcCCCCCCHHHHHH
Q 015868          332 --------------PTIPKHAHPRLAELLERCWQHDPTQRPNFSQITD  365 (399)
Q Consensus       332 --------------~~~~~~~~~~l~~ll~~cl~~dP~~Rps~~ell~  365 (399)
                                    ..++..+++.+.+|+.+||+.||.+|||+.|+++
T Consensus       249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~  296 (326)
T 1blx_A          249 LPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS  296 (326)
T ss_dssp             SCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred             cchhhhcccCcchhhhccccCCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence                          1123568899999999999999999999999974

>2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A*

Probab=100.00  E-value=8.1e-45  Score=348.60  Aligned_cols=249  Identities=21%  Similarity=0.362  Sum_probs=205.1

Q ss_pred             ccccceeceeceeCceEEEEEEE--CCeeEEEEEecCCCC------CHHHHHHHHHHHHHHHhcCCCceeeEEeEEecCC
Q 015868          115 AKQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECV------NTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPP  186 (399)
Q Consensus       115 ~~~~~i~~~lg~G~~g~Vy~~~~--~~~~vAvK~~~~~~~------~~~~~~~~~~Ei~~l~~l~h~nIv~~~~~~~~~~  186 (399)
                      .++|++.+.||+|+||.||+|.+  +++.||||++.....      .......+.+|+.++++++||||+++++++..+.
T Consensus         9 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~   88 (322)
T 2ycf_A            9 RDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDAED   88 (322)
T ss_dssp             HHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECC---------------CHHHHHHHHHHCCCTTBCCEEEEEESSS
T ss_pred             hhceeEeeEEecCCCEEEEEEEEcCCCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhCCCCCCceEeeEEcCCc
Confidence            46899999999999999999988  468999999975432      1223346889999999999999999999987765


Q ss_pred             cEEEEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceeecCCCc---EEEeeccceee
Q 015868          187 NLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGV---VKVADFGVARV  263 (399)
Q Consensus       187 ~~~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~giiHrDlkp~NILl~~~~~---vkl~DFG~a~~  263 (399)
                       .++||||+++++|.+++.. ...+++..++.++.||+.||.|||++||+||||||+||+++.++.   +||+|||+++.
T Consensus        89 -~~lv~e~~~~~~L~~~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~  166 (322)
T 2ycf_A           89 -YYIVLELMEGGELFDKVVG-NKRLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKI  166 (322)
T ss_dssp             -EEEEEECCTTEETHHHHST-TCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSSSCCEEECCCTTCEE
T ss_pred             -eEEEEecCCCCcHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEecCCCCCeEEEccCcccee
Confidence             8999999999999999865 467999999999999999999999999999999999999987664   99999999987


Q ss_pred             ccCCCccccCCCCcccccccccC---CCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhccCCC---CCCCC
Q 015868          264 QAQSGVMTAETGTYRWMAPEVIE---HKPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKSLRP---TIPKH  337 (399)
Q Consensus       264 ~~~~~~~~~~~gt~~y~aPE~l~---~~~~~~~~Dv~slG~vl~elltg~~P~~~~~~~~~~~~~~~~~~~~---~~~~~  337 (399)
                      ...........||+.|+|||++.   +..++.++||||||+++|+|++|..||............+......   ..+..
T Consensus       167 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  246 (322)
T 2ycf_A          167 LGETSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNFIPEVWAE  246 (322)
T ss_dssp             CCCCHHHHHHHSCCTTCCHHHHHHTTTTTCTTHHHHHHHHHHHHHHHHSSCSSCSTTCSSCHHHHHHHTCCCCCHHHHTT
T ss_pred             cccccccccccCCcCccCchhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchHHHHHHHHHhCccccCchhhhh
Confidence            66544444557899999999973   5678999999999999999999999997755432222223222222   22356


Q ss_pred             CcHHHHHHHHHHhhhcCCCCCCHHHHHH
Q 015868          338 AHPRLAELLERCWQHDPTQRPNFSQITD  365 (399)
Q Consensus       338 ~~~~l~~ll~~cl~~dP~~Rps~~ell~  365 (399)
                      +++++.+++.+||+.||.+|||+.++++
T Consensus       247 ~~~~~~~li~~~l~~dP~~Rps~~~~l~  274 (322)
T 2ycf_A          247 VSEKALDLVKKLLVVDPKARFTTEEALR  274 (322)
T ss_dssp             SCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred             cCHHHHHHHHHHcccCHhhCCCHHHHhh
Confidence            8899999999999999999999999974

>4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A

Probab=100.00  E-value=3.5e-44  Score=351.49  Aligned_cols=250  Identities=28%  Similarity=0.456  Sum_probs=211.5

Q ss_pred             CceeecccccceeceeceeCceEEEEEEE--CCeeEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCceeeEEeEEecCC
Q 015868          109 DVWEIDAKQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPP  186 (399)
Q Consensus       109 ~~~~i~~~~~~i~~~lg~G~~g~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~nIv~~~~~~~~~~  186 (399)
                      ..|++. ++|.+.+.||+|+||.||+|.+  +++.||||+++.........+.+.+|+.+++.++||||+++++++....
T Consensus        36 ~~~~l~-~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~  114 (371)
T 4exu_A           36 TAWELP-KTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPAS  114 (371)
T ss_dssp             EEEEEE-TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCS
T ss_pred             ceeccc-ccEEEEeEEecCCCeEEEEEEECCCCCEEEEEEecccccchhHHHHHHHHHHHHHhcCCCCchhhhhheeccC
Confidence            456664 6999999999999999999987  5789999999877667777889999999999999999999999998776


Q ss_pred             cE------EEEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceeecCCCcEEEeeccc
Q 015868          187 NL------CIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGV  260 (399)
Q Consensus       187 ~~------~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~giiHrDlkp~NILl~~~~~vkl~DFG~  260 (399)
                      ..      ++||||+.+ +|.+++.   ..+++..++.++.|++.||.|||++||+||||||+||+++.++.+||+|||+
T Consensus       115 ~~~~~~~~~lv~e~~~~-~l~~~~~---~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIll~~~~~~kL~Dfg~  190 (371)
T 4exu_A          115 SLRNFYDFYLVMPFMQT-DLQKIMG---MEFSEEKIQYLVYQMLKGLKYIHSAGVVHRDLKPGNLAVNEDCELKILDFGL  190 (371)
T ss_dssp             SSTTCCCCEEEEECCCE-EHHHHTT---SCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECSTTC
T ss_pred             CcccceeEEEEEccccc-cHHHHhh---cCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCcCHHHeEECCCCCEEEEecCc
Confidence            54      999999975 8888773   4589999999999999999999999999999999999999999999999999


Q ss_pred             eeeccCCCccccCCCCcccccccccCC-CCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhccCCC-------
Q 015868          261 ARVQAQSGVMTAETGTYRWMAPEVIEH-KPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKSLRP-------  332 (399)
Q Consensus       261 a~~~~~~~~~~~~~gt~~y~aPE~l~~-~~~~~~~Dv~slG~vl~elltg~~P~~~~~~~~~~~~~~~~~~~~-------  332 (399)
                      ++.....  .....||+.|+|||++.+ ..++.++||||||+++|+|++|+.||.+.+..+...........+       
T Consensus       191 a~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~  268 (371)
T 4exu_A          191 ARHADAE--MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFVQK  268 (371)
T ss_dssp             C----------CTTCCCTTSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHTT
T ss_pred             ccccccC--cCCcccCccccCHHHhcCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCcHHHHHH
Confidence            9865432  445678999999999987 689999999999999999999999999988766655543311111       


Q ss_pred             ----------------------CCCCCCcHHHHHHHHHHhhhcCCCCCCHHHHHH
Q 015868          333 ----------------------TIPKHAHPRLAELLERCWQHDPTQRPNFSQITD  365 (399)
Q Consensus       333 ----------------------~~~~~~~~~l~~ll~~cl~~dP~~Rps~~ell~  365 (399)
                                            ..+..+++++.+||.+||+.||.+|||+.|+++
T Consensus       269 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~  323 (371)
T 4exu_A          269 LNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALT  323 (371)
T ss_dssp             CSCHHHHHHHHHSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSCTTTSCCHHHHHT
T ss_pred             hhhhhhhhhhhccCCCcchhHHHhccccChHHHHHHHHHCCCChhhcCCHHHHhc
Confidence                                  112457899999999999999999999999976

>3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A

Probab=100.00  E-value=3.7e-45  Score=364.30  Aligned_cols=249  Identities=21%  Similarity=0.368  Sum_probs=198.9

Q ss_pred             ccccceeceeceeCceEEEEEEE--CCeeEEEEEecCCCC------CHHHHHHHHHHHHHHHhcCCCceeeEEeEEecCC
Q 015868          115 AKQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECV------NTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPP  186 (399)
Q Consensus       115 ~~~~~i~~~lg~G~~g~Vy~~~~--~~~~vAvK~~~~~~~------~~~~~~~~~~Ei~~l~~l~h~nIv~~~~~~~~~~  186 (399)
                      .++|++.+.||+|+||.||+|.+  +++.||+|++.....      .......+.+|+.+|++++||||+++++++..+ 
T Consensus       134 ~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~-  212 (419)
T 3i6u_A          134 RDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDAE-  212 (419)
T ss_dssp             HTTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHCCCTTBCCCCEEEESS-
T ss_pred             hccEEEEeEEeeCCCeEEEEEEECCCCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhCCCCCEeeEEEEEecC-
Confidence            57899999999999999999987  568999999875321      122234588999999999999999999998654 


Q ss_pred             cEEEEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceeecCCC---cEEEeeccceee
Q 015868          187 NLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENG---VVKVADFGVARV  263 (399)
Q Consensus       187 ~~~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~giiHrDlkp~NILl~~~~---~vkl~DFG~a~~  263 (399)
                      ..++||||+++++|.+++.. ...+++..++.++.|++.||+|||++||+||||||+|||++.++   .+||+|||+++.
T Consensus       213 ~~~lv~e~~~~g~L~~~l~~-~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~NIll~~~~~~~~~kl~DFG~a~~  291 (419)
T 3i6u_A          213 DYYIVLELMEGGELFDKVVG-NKRLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKI  291 (419)
T ss_dssp             EEEEEEECCTTCBGGGGTSS-SCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSSSCCEEECCSSTTTS
T ss_pred             ceEEEEEcCCCCcHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChHhEEEecCCCcceEEEeeccccee
Confidence            58999999999999998865 46799999999999999999999999999999999999997544   599999999987


Q ss_pred             ccCCCccccCCCCcccccccccCC---CCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhccCCCC---CCCC
Q 015868          264 QAQSGVMTAETGTYRWMAPEVIEH---KPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKSLRPT---IPKH  337 (399)
Q Consensus       264 ~~~~~~~~~~~gt~~y~aPE~l~~---~~~~~~~Dv~slG~vl~elltg~~P~~~~~~~~~~~~~~~~~~~~~---~~~~  337 (399)
                      ...........||+.|+|||++.+   ..|+.++||||||+++|+|++|..||............+.......   ....
T Consensus       292 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~i~~~~~~~~~~~~~~  371 (419)
T 3i6u_A          292 LGETSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNFIPEVWAE  371 (419)
T ss_dssp             CC-----------CTTCCTTTTC----CTTHHHHHHHHHHHHHHHHHHSSCSSCCCSSSCCHHHHHHTTCCCCCHHHHTT
T ss_pred             cCCCccccccCCCCCccCceeeecCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCcchHHHHHHHhcCCCCCCchhhcc
Confidence            766555566789999999999864   5688899999999999999999999987554333333333332222   2256


Q ss_pred             CcHHHHHHHHHHhhhcCCCCCCHHHHHH
Q 015868          338 AHPRLAELLERCWQHDPTQRPNFSQITD  365 (399)
Q Consensus       338 ~~~~l~~ll~~cl~~dP~~Rps~~ell~  365 (399)
                      +++++.+||.+||+.||.+|||+.|+++
T Consensus       372 ~~~~~~~li~~~L~~dP~~Rps~~e~l~  399 (419)
T 3i6u_A          372 VSEKALDLVKKLLVVDPKARFTTEEALR  399 (419)
T ss_dssp             SCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred             cCHHHHHHHHHHccCChhHCcCHHHHhC
Confidence            8899999999999999999999999976

>3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A*

Probab=100.00  E-value=7.6e-44  Score=355.89  Aligned_cols=246  Identities=27%  Similarity=0.426  Sum_probs=210.3

Q ss_pred             cccccceeceeceeCceEEEEEEE--CCeeEEEEEecCCCCCHHHHHHHHHHHHHHHhc------CCCceeeEEeEEecC
Q 015868          114 DAKQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKI------RHKNVVQFIGACTRP  185 (399)
Q Consensus       114 ~~~~~~i~~~lg~G~~g~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~Ei~~l~~l------~h~nIv~~~~~~~~~  185 (399)
                      ...+|++.+.||+|+||.||+|.+  .++.||||+++..   ....+.+.+|+.+++.+      +|+||+++++++...
T Consensus        95 ~~~ry~~~~~LG~G~fg~V~~a~~~~~~~~vAvK~~~~~---~~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~~~~~~  171 (429)
T 3kvw_A           95 VAYRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNE---KRFHRQAAEEIRILEHLRKQDKDNTMNVIHMLENFTFR  171 (429)
T ss_dssp             ETTTEEEEEEEEESSSEEEEEEEETTTTEEEEEEEECSC---HHHHHHHHHHHHHHHHHHTTCTTSCSCBCCEEEEEEET
T ss_pred             ccCcEEEEEEcccCccEEEEEEEECCCCcEEEEEEECCc---cchHHHHHHHHHHHHHHhhccccCCcCEEEEEeecccC
Confidence            456899999999999999999988  4689999999853   45567788899999887      567999999999999


Q ss_pred             CcEEEEEecCCCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceeecCCCc--EEEeecccee
Q 015868          186 PNLCIVTEFMARGSIYDFLHKQK-GVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGV--VKVADFGVAR  262 (399)
Q Consensus       186 ~~~~lV~E~~~ggsL~~~l~~~~-~~l~~~~~~~i~~~i~~~L~~LH~~giiHrDlkp~NILl~~~~~--vkl~DFG~a~  262 (399)
                      ..+++||||+. ++|.+++.... ..+++..++.++.||+.||+|||++||+||||||+|||++.++.  +||+|||+++
T Consensus       172 ~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlKp~NILl~~~~~~~vkL~DFG~a~  250 (429)
T 3kvw_A          172 NHICMTFELLS-MNLYELIKKNKFQGFSLPLVRKFAHSILQCLDALHKNRIIHCDLKPENILLKQQGRSGIKVIDFGSSC  250 (429)
T ss_dssp             TEEEEEECCCC-CBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHHTEECSCCSGGGEEESSTTSCCEEECCCTTCE
T ss_pred             CeEEEEEeccC-CCHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEEccCCCcceEEeecccce
Confidence            99999999996 59999997754 45999999999999999999999999999999999999999887  9999999997


Q ss_pred             eccCCCccccCCCCcccccccccCCCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhccCCC----------
Q 015868          263 VQAQSGVMTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKSLRP----------  332 (399)
Q Consensus       263 ~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~Dv~slG~vl~elltg~~P~~~~~~~~~~~~~~~~~~~~----------  332 (399)
                      .....  .....||+.|+|||++.+..|+.++|||||||++|+|++|..||.+.+..+....+......|          
T Consensus       251 ~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~l~~i~~~~~~p~~~~~~~~~~  328 (429)
T 3kvw_A          251 YEHQR--VYTYIQSRFYRAPEVILGARYGMPIDMWSLGCILAELLTGYPLLPGEDEGDQLACMIELLGMPSQKLLDASKR  328 (429)
T ss_dssp             ETTCC--CCSSCSCGGGCCHHHHHTBCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHTBTT
T ss_pred             ecCCc--ccccCCCCCccChHHHhCCCCCchHHHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCHHHHHhhhh
Confidence            65432  345678999999999999999999999999999999999999999888766554443211000          


Q ss_pred             -----------------------------------------------CCCCCCcHHHHHHHHHHhhhcCCCCCCHHHHHH
Q 015868          333 -----------------------------------------------TIPKHAHPRLAELLERCWQHDPTQRPNFSQITD  365 (399)
Q Consensus       333 -----------------------------------------------~~~~~~~~~l~~ll~~cl~~dP~~Rps~~ell~  365 (399)
                                                                     .++...++++.+||.+||++||++|||+.|+++
T Consensus       329 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~dli~~~L~~dP~~Rpta~e~L~  408 (429)
T 3kvw_A          329 AKNFVSSKGYPRYCTVTTLSDGSVVLNGGRSRRGKLRGPPESREWGNALKGCDDPLFLDFLKQCLEWDPAVRMTPGQALR  408 (429)
T ss_dssp             HHHHBCTTSCBTTSCEECCCC--CEECCEECTTCCEECSTTCSCHHHHTTTCCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             hhhccCCCCCcccccccccccccccccccccchhhccCCccchhhHhhccccchHHHHHHHHHHCCCChhhCCCHHHHhC
Confidence                                                           011234788999999999999999999999986

>3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A*

Probab=100.00  E-value=5.8e-44  Score=341.12  Aligned_cols=254  Identities=22%  Similarity=0.385  Sum_probs=214.5

Q ss_pred             CceeecccccceeceeceeCceEEEEEEE-CCeeEEEEEecCCCCCHHHHHHHHHHHHHHHhcC--CCceeeEEeEEecC
Q 015868          109 DVWEIDAKQLKIECKVASGSYGDLYKGTY-CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIR--HKNVVQFIGACTRP  185 (399)
Q Consensus       109 ~~~~i~~~~~~i~~~lg~G~~g~Vy~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~Ei~~l~~l~--h~nIv~~~~~~~~~  185 (399)
                      ....+..++|++.+.||+|+||.||++.+ .++.||+|++............+.+|+.++++++  ||||+++++++...
T Consensus        21 ~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~  100 (313)
T 3cek_A           21 QSMSVKGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITD  100 (313)
T ss_dssp             CEEEETTEEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECSSCCHHHHHHHHHHHHHHHHHGGGCTTBCCEEEEEECS
T ss_pred             eeeeeccceEEEEEEecCCCCEEEEEEEcCCCcEEEEEEeccccccccchHHHHHHHHHHHhccccCCceEEEEEEeecC
Confidence            44677888999999999999999999987 4678999999877667777889999999999997  49999999999999


Q ss_pred             CcEEEEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceeecCCCcEEEeeccceeecc
Q 015868          186 PNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQA  265 (399)
Q Consensus       186 ~~~~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~giiHrDlkp~NILl~~~~~vkl~DFG~a~~~~  265 (399)
                      ...++||| +.+++|.+++.. ...+++..++.++.|++.||.|||++||+||||||+||+++ ++.+||+|||+++...
T Consensus       101 ~~~~lv~e-~~~~~L~~~l~~-~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~~-~~~~kL~Dfg~~~~~~  177 (313)
T 3cek_A          101 QYIYMVME-CGNIDLNSWLKK-KKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQ  177 (313)
T ss_dssp             SEEEEEEC-CCSEEHHHHHHH-CSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEE-TTEEEECCCSSSCC--
T ss_pred             CEEEEEEe-cCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcccEEEE-CCeEEEeecccccccc
Confidence            99999999 557799999976 45789999999999999999999999999999999999996 4899999999998654


Q ss_pred             CCC---ccccCCCCcccccccccCC-----------CCCCChhhHHHHHHHHHHHHcCCCCCCCCCH-HHHHHHHHhccC
Q 015868          266 QSG---VMTAETGTYRWMAPEVIEH-----------KPYDYKADVFSFGIALWELLTGELPYAGLTP-LQAAVGVVQKSL  330 (399)
Q Consensus       266 ~~~---~~~~~~gt~~y~aPE~l~~-----------~~~~~~~Dv~slG~vl~elltg~~P~~~~~~-~~~~~~~~~~~~  330 (399)
                      ...   ......|++.|+|||.+.+           ..++.++||||||+++|+|++|..||..... ............
T Consensus       178 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~  257 (313)
T 3cek_A          178 PDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNH  257 (313)
T ss_dssp             ------------CCGGGCCHHHHTTCC----------CCCHHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHHHHCTTS
T ss_pred             CccccccccCCCCCCCcCCHHHHhhcccccccccccccCCchHHHHHHHHHHHHHHhCCCchhhHHHHHHHHHHHHhccc
Confidence            332   1234568999999999976           4688899999999999999999999987643 334444455555


Q ss_pred             CCCCCCCCcHHHHHHHHHHhhhcCCCCCCHHHHHH
Q 015868          331 RPTIPKHAHPRLAELLERCWQHDPTQRPNFSQITD  365 (399)
Q Consensus       331 ~~~~~~~~~~~l~~ll~~cl~~dP~~Rps~~ell~  365 (399)
                      ....+...+.++.+++.+||+.||.+|||+.|+++
T Consensus       258 ~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~  292 (313)
T 3cek_A          258 EIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLA  292 (313)
T ss_dssp             CCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             ccCCcccchHHHHHHHHHHccCCcccCcCHHHHhc
Confidence            56677778999999999999999999999999976

>3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A

Probab=100.00  E-value=1.1e-45  Score=362.85  Aligned_cols=252  Identities=14%  Similarity=0.190  Sum_probs=201.8

Q ss_pred             eecccccceeceeceeCceEEEEEEE--CCeeEEEEEecCCC-CCHHHHHHHHHHH---HHHHhcCCCceeeEE------
Q 015868          112 EIDAKQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPEC-VNTEMLKEFSQEV---YIMRKIRHKNVVQFI------  179 (399)
Q Consensus       112 ~i~~~~~~i~~~lg~G~~g~Vy~~~~--~~~~vAvK~~~~~~-~~~~~~~~~~~Ei---~~l~~l~h~nIv~~~------  179 (399)
                      ....++|++.+.||+|+||.||+|++  +++.||||+++... ......+.+.+|+   .++++++||||++++      
T Consensus        69 ~~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~hpniv~~~~~~~~~  148 (377)
T 3byv_A           69 GERPRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFP  148 (377)
T ss_dssp             SCCCEEEEEEEEEEEETTEEEEEEEC-CCCCEEEEEEEEECC-CCTTHHHHHHHHHHGGGGSTTCCSHHHHHHHHCBCCC
T ss_pred             CCCCceEEEcceeecCCCEEEEEEEECCCCcEEEEEEEeeccccchHHHHHHHHHHHHHHhccccCCHHHHHHHhhhhhh
Confidence            34467899999999999999999985  58899999997542 2444567899999   455556899999998      


Q ss_pred             -eEEecCC-----------------cEEEEEecCCCCCHHHHHHhcCCCCC-------HHHHHHHHHHHHHHHHHHHHCC
Q 015868          180 -GACTRPP-----------------NLCIVTEFMARGSIYDFLHKQKGVFQ-------LTSLLKVAIDVSKGMNYLHQNN  234 (399)
Q Consensus       180 -~~~~~~~-----------------~~~lV~E~~~ggsL~~~l~~~~~~l~-------~~~~~~i~~~i~~~L~~LH~~g  234 (399)
                       +++..++                 ..|+||||+ +|+|.+++... +.++       +..++.++.||+.||+|||++|
T Consensus       149 ~~~~~~~~~~~~~~~~~~~~~~~i~~~~lv~E~~-~g~L~~~l~~~-~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~  226 (377)
T 3byv_A          149 FDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVL-LSHSSTHKSLVHHARLQLTLQVIRLLASLHHYG  226 (377)
T ss_dssp             SEEEECTTSCSEEEC------CEEESEEEEEECC-SEEHHHHHHHH-HHTTTTTHHHHHHHHHHHHHHHHHHHHHHHHTT
T ss_pred             hhhhhccCCccccccccCCCceEEEEEEEEEecc-CCCHHHHHHhc-cccccccccccHHHHHHHHHHHHHHHHHHHhCC
Confidence             6666553                 389999999 56999999764 2234       4788889999999999999999


Q ss_pred             cccCCCCCCceeecCCCcEEEeeccceeeccCCCccccCCCCcccccccccCCC-----------CCCChhhHHHHHHHH
Q 015868          235 IIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAETGTYRWMAPEVIEHK-----------PYDYKADVFSFGIAL  303 (399)
Q Consensus       235 iiHrDlkp~NILl~~~~~vkl~DFG~a~~~~~~~~~~~~~gt~~y~aPE~l~~~-----------~~~~~~Dv~slG~vl  303 (399)
                      |+||||||+|||++.++.+||+|||+++....  ......| +.|+|||++.+.           .++.++||||||+++
T Consensus       227 ivHrDikp~NIll~~~~~~kL~DFG~a~~~~~--~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DvwSlG~il  303 (377)
T 3byv_A          227 LVHTYLRPVDIVLDQRGGVFLTGFEHLVRDGA--RVVSSVS-RGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVI  303 (377)
T ss_dssp             EECSCCCGGGEEECTTCCEEECCGGGCEETTC--EEECCCC-TTCCCHHHHHHHTSTHHHHCCEEECCHHHHHHHHHHHH
T ss_pred             eecCCCCHHHEEEcCCCCEEEEechhheecCC--cccCCCC-cCccChhhhcccccccccccccccCChhhhHHHHHHHH
Confidence            99999999999999999999999999986433  3445567 999999999887           899999999999999


Q ss_pred             HHHHcCCCCCCCCCHHHHHHHHHhccCCCCCCCCCcHHHHHHHHHHhhhcCCCCCCHHHHHH--HHHHHHHHH
Q 015868          304 WELLTGELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRLAELLERCWQHDPTQRPNFSQITD--ILKQMMKEV  374 (399)
Q Consensus       304 ~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~cl~~dP~~Rps~~ell~--~L~~l~~~~  374 (399)
                      |+|++|+.||.+.+..+.....      ...+..+++++.+||.+||+.||++|||+.|+++  .++++....
T Consensus       304 ~elltg~~Pf~~~~~~~~~~~~------~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~f~~~~~~~  370 (377)
T 3byv_A          304 YWIWCADLPITKDAALGGSEWI------FRSCKNIPQPVRALLEGFLRYPKEDRLLPLQAMETPEYEQLRTEL  370 (377)
T ss_dssp             HHHHHSSCCC------CCSGGG------GSSCCCCCHHHHHHHHHHTCSSGGGCCCHHHHHTSHHHHHHHHHH
T ss_pred             HHHHHCCCCCcccccccchhhh------hhhccCCCHHHHHHHHHHcCCCchhCCCHHHHhhChHHHHHHHHH
Confidence            9999999999775543322111      1123568899999999999999999999999986  555554443

>3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ...

Probab=100.00  E-value=8.8e-44  Score=341.96  Aligned_cols=244  Identities=18%  Similarity=0.355  Sum_probs=205.5

Q ss_pred             ecccccceeceeceeCceEEEEEEE--CCeeEEEEEecCCCCCHHHHHHHHHHHHHHHhcC-CCceeeEEeEEec--CCc
Q 015868          113 IDAKQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIR-HKNVVQFIGACTR--PPN  187 (399)
Q Consensus       113 i~~~~~~i~~~lg~G~~g~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~Ei~~l~~l~-h~nIv~~~~~~~~--~~~  187 (399)
                      ...++|++.++||+|+||.||+|.+  .++.||+|+++...     .+.+.+|+.++++++ ||||+++++++..  ...
T Consensus        33 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-----~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~  107 (330)
T 3nsz_A           33 GNQDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVK-----KKKIKREIKILENLRGGPNIITLADIVKDPVSRT  107 (330)
T ss_dssp             EEGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSCC-----HHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCC
T ss_pred             cCCCceEEEEEecccCCeEEEEEEECCCCcEEEEEEecccc-----hHHHHHHHHHHHHcCCCCCEEEeeeeeccCCCCc
Confidence            3467899999999999999999987  67899999998542     357889999999997 9999999999987  667


Q ss_pred             EEEEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceeecCCC-cEEEeeccceeeccC
Q 015868          188 LCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENG-VVKVADFGVARVQAQ  266 (399)
Q Consensus       188 ~~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~giiHrDlkp~NILl~~~~-~vkl~DFG~a~~~~~  266 (399)
                      .++||||+.+++|.+++..    +++..++.++.|++.||.|||++||+||||||+|||++.++ .+||+|||+++....
T Consensus       108 ~~lv~e~~~~~~l~~~~~~----~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~  183 (330)
T 3nsz_A          108 PALVFEHVNNTDFKQLYQT----LTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHP  183 (330)
T ss_dssp             EEEEEECCCCCCHHHHGGG----CCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTTEEEECCCTTCEECCT
T ss_pred             eEEEEeccCchhHHHHHHh----CCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEEcCCCCEEEEEeCCCceEcCC
Confidence            8999999999999998843    78999999999999999999999999999999999999777 899999999987766


Q ss_pred             CCccccCCCCcccccccccCC-CCCCChhhHHHHHHHHHHHHcCCCCCCCC-CHHHHHHHHHh------------c----
Q 015868          267 SGVMTAETGTYRWMAPEVIEH-KPYDYKADVFSFGIALWELLTGELPYAGL-TPLQAAVGVVQ------------K----  328 (399)
Q Consensus       267 ~~~~~~~~gt~~y~aPE~l~~-~~~~~~~Dv~slG~vl~elltg~~P~~~~-~~~~~~~~~~~------------~----  328 (399)
                      ........++..|+|||.+.+ ..++.++||||||+++|+|++|..||... ...+.......            .    
T Consensus       184 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~  263 (330)
T 3nsz_A          184 GQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIE  263 (330)
T ss_dssp             TCCCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHTTCC
T ss_pred             CCccccccccccccChhhhcCCCcCCchhhHHHHHHHHHHHHhCCCCcccCCchHHHHHHHHHhcCCchhhhHHHHhccc
Confidence            655666789999999999987 67899999999999999999999999543 22222211110            0    


Q ss_pred             -------------------cCCCCCCCCCcHHHHHHHHHHhhhcCCCCCCHHHHHH
Q 015868          329 -------------------SLRPTIPKHAHPRLAELLERCWQHDPTQRPNFSQITD  365 (399)
Q Consensus       329 -------------------~~~~~~~~~~~~~l~~ll~~cl~~dP~~Rps~~ell~  365 (399)
                                         ......+..+++++.+||.+||+.||.+|||++|+++
T Consensus       264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~e~l~  319 (330)
T 3nsz_A          264 LDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAME  319 (330)
T ss_dssp             CCTHHHHHHCCCCCCCGGGGCCTTTGGGCCHHHHHHHHTTSCSSGGGSCCHHHHHT
T ss_pred             cccchhhhhhhccccchhhhccccccccCCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence                               0111122337899999999999999999999999976

>3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A*

Probab=100.00  E-value=2e-44  Score=351.20  Aligned_cols=251  Identities=22%  Similarity=0.350  Sum_probs=203.9

Q ss_pred             cccccceeceeceeCceEEEEEEE-CCeeEEEEEecCCCC---------CHHHHHHHHHHHHHHHhcCCCceeeEEeEEe
Q 015868          114 DAKQLKIECKVASGSYGDLYKGTY-CSQEVAIKVLKPECV---------NTEMLKEFSQEVYIMRKIRHKNVVQFIGACT  183 (399)
Q Consensus       114 ~~~~~~i~~~lg~G~~g~Vy~~~~-~~~~vAvK~~~~~~~---------~~~~~~~~~~Ei~~l~~l~h~nIv~~~~~~~  183 (399)
                      ..++|++.+.||+|+||.||+|.. .++.||||++.....         +....+.+.+|+.++++++||||+++++++.
T Consensus        20 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~   99 (362)
T 3pg1_A           20 MQSPYTVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPNILGLRDIFV   99 (362)
T ss_dssp             TTCSCEEEEEEEEETTEEEEEEECTTSCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEEE
T ss_pred             hccceEEeEEeccCCCEEEEEEECCCCCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhCCCcCccceeeeEE
Confidence            357899999999999999999976 578899999864322         2344578999999999999999999999984


Q ss_pred             c-----CCcEEEEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceeecCCCcEEEeec
Q 015868          184 R-----PPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADF  258 (399)
Q Consensus       184 ~-----~~~~~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~giiHrDlkp~NILl~~~~~vkl~DF  258 (399)
                      .     ...+|+||||+.| +|.+++......+++..++.++.||+.||.|||++||+||||||+||+++.++.+||+||
T Consensus       100 ~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~kl~Df  178 (362)
T 3pg1_A          100 HFEEPAMHKLYLVTELMRT-DLAQVIHDQRIVISPQHIQYFMYHILLGLHVLHEAGVVHRDLHPGNILLADNNDITICDF  178 (362)
T ss_dssp             ECCTTTCCEEEEEEECCSE-EHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECCT
T ss_pred             eccCCCcceEEEEEccCCC-CHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCcCEecCCChHHEEEcCCCCEEEEec
Confidence            3     3368999999984 999999877778999999999999999999999999999999999999999999999999


Q ss_pred             cceeeccCCCccccCCCCcccccccccCC-CCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhccCCC-----
Q 015868          259 GVARVQAQSGVMTAETGTYRWMAPEVIEH-KPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKSLRP-----  332 (399)
Q Consensus       259 G~a~~~~~~~~~~~~~gt~~y~aPE~l~~-~~~~~~~Dv~slG~vl~elltg~~P~~~~~~~~~~~~~~~~~~~~-----  332 (399)
                      |+++............+|+.|+|||++.+ ..++.++||||||+++|+|++|+.||.+.+..+....+......+     
T Consensus       179 g~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~  258 (362)
T 3pg1_A          179 NLAREDTADANKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTFYNQLNKIVEVVGTPKIEDV  258 (362)
T ss_dssp             TC---------------CGGGCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHH
T ss_pred             CcccccccccccceecccceecCcHHhcCCCCCCcHhHHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChHHh
Confidence            99986665555566778999999999987 678999999999999999999999999988766655543321111     


Q ss_pred             -------------------------CCCCCCcHHHHHHHHHHhhhcCCCCCCHHHHHH
Q 015868          333 -------------------------TIPKHAHPRLAELLERCWQHDPTQRPNFSQITD  365 (399)
Q Consensus       333 -------------------------~~~~~~~~~l~~ll~~cl~~dP~~Rps~~ell~  365 (399)
                                               ..+...++.+.+||.+||+.||.+|||+.|+++
T Consensus       259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~  316 (362)
T 3pg1_A          259 VMFSSPSARDYLRNSLSNVPARAWTAVVPTADPVALDLIAKMLEFNPQRRISTEQALR  316 (362)
T ss_dssp             HHTSCHHHHHHTTTCCCCCCCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             hhccchhhhHHHHhhcccCChhhHHhhCCCCCHHHHHHHHHHhcCChhhCCCHHHHHc
Confidence                                     112456889999999999999999999999976

>1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=5.9e-45  Score=354.96  Aligned_cols=253  Identities=22%  Similarity=0.386  Sum_probs=211.0

Q ss_pred             eeecccccceeceeceeCceEEEEEEE-----CCeeEEEEEecCCCC--CHHHHHHHHHHHHHHHhc-CCCceeeEEeEE
Q 015868          111 WEIDAKQLKIECKVASGSYGDLYKGTY-----CSQEVAIKVLKPECV--NTEMLKEFSQEVYIMRKI-RHKNVVQFIGAC  182 (399)
Q Consensus       111 ~~i~~~~~~i~~~lg~G~~g~Vy~~~~-----~~~~vAvK~~~~~~~--~~~~~~~~~~Ei~~l~~l-~h~nIv~~~~~~  182 (399)
                      ..+..++|++.+.||+|+||.||+++.     .++.||||+++....  .....+.+.+|+.+++++ .||||+++++++
T Consensus        49 ~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~  128 (355)
T 1vzo_A           49 EKVGIENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAF  128 (355)
T ss_dssp             CCCCGGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEE
T ss_pred             ccccccceEEEEEeccCCCEEEEEEEEcccCCCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHccCCCceeEEEEEE
Confidence            345668999999999999999999988     678999999874321  112234567899999999 699999999999


Q ss_pred             ecCCcEEEEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceeecCCCcEEEeecccee
Q 015868          183 TRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVAR  262 (399)
Q Consensus       183 ~~~~~~~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~giiHrDlkp~NILl~~~~~vkl~DFG~a~  262 (399)
                      .....+++||||+++++|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++
T Consensus       129 ~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~  207 (355)
T 1vzo_A          129 QTETKLHLILDYINGGELFTHLSQR-ERFTEHEVQIYVGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSK  207 (355)
T ss_dssp             EETTEEEEEECCCCSCBHHHHHHHH-SCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEESCSSEEE
T ss_pred             eeCceEEEEeecCCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCcEEEeeCCCCe
Confidence            9999999999999999999999764 578999999999999999999999999999999999999999999999999998


Q ss_pred             eccCCC--ccccCCCCcccccccccCC--CCCCChhhHHHHHHHHHHHHcCCCCCCCCC----HHHHHHHHHhccCCCCC
Q 015868          263 VQAQSG--VMTAETGTYRWMAPEVIEH--KPYDYKADVFSFGIALWELLTGELPYAGLT----PLQAAVGVVQKSLRPTI  334 (399)
Q Consensus       263 ~~~~~~--~~~~~~gt~~y~aPE~l~~--~~~~~~~Dv~slG~vl~elltg~~P~~~~~----~~~~~~~~~~~~~~~~~  334 (399)
                      ......  ......||+.|+|||++.+  ..++.++||||||+++|+|++|..||....    .........  ...+..
T Consensus       208 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~--~~~~~~  285 (355)
T 1vzo_A          208 EFVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRIL--KSEPPY  285 (355)
T ss_dssp             ECCGGGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHHHHHH--HCCCCC
T ss_pred             ecccCCCCcccCcccCcCccChhhhcCCCCCCCchhhHHHHHHHHHHHHHCCCCCccCCccchHHHHHHHHh--ccCCCC
Confidence            654322  2334579999999999986  357899999999999999999999997532    222222222  235667


Q ss_pred             CCCCcHHHHHHHHHHhhhcCCCCC-----CHHHHHHH
Q 015868          335 PKHAHPRLAELLERCWQHDPTQRP-----NFSQITDI  366 (399)
Q Consensus       335 ~~~~~~~l~~ll~~cl~~dP~~Rp-----s~~ell~~  366 (399)
                      +..+++.+.+||.+||+.||.+||     ++.|+++.
T Consensus       286 ~~~~~~~~~~li~~~L~~dP~~R~~~~~~s~~ell~h  322 (355)
T 1vzo_A          286 PQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEH  322 (355)
T ss_dssp             CTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTS
T ss_pred             CcccCHHHHHHHHHHhhhCHHHhcCCCCCCHHHHHcC
Confidence            888999999999999999999999     88988763

>3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A

Probab=100.00  E-value=1.1e-44  Score=380.88  Aligned_cols=247  Identities=22%  Similarity=0.387  Sum_probs=215.1

Q ss_pred             eeecccccceeceeceeCceEEEEEEE--CCeeEEEEEecCCCC-CHHHHHHHHHHHHHHHhc-CCCceeeEEeEEecCC
Q 015868          111 WEIDAKQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECV-NTEMLKEFSQEVYIMRKI-RHKNVVQFIGACTRPP  186 (399)
Q Consensus       111 ~~i~~~~~~i~~~lg~G~~g~Vy~~~~--~~~~vAvK~~~~~~~-~~~~~~~~~~Ei~~l~~l-~h~nIv~~~~~~~~~~  186 (399)
                      ..+..++|++.+.||+|+||.||+|++  +++.||||+++.... .....+.+..|..++..+ +||||+++++++....
T Consensus       336 ~~~~~~~f~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~l~~~~~~~~  415 (674)
T 3pfq_A          336 DRMKLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMD  415 (674)
T ss_dssp             ----CTTEEEEEESSBTTTBCEEEEEESSSCCEEEEEEEEHHHHHHTTTTHHHHHHHHHHTCTTCCTTBCCEEEECBCSS
T ss_pred             ccccccceEEEEEEccCCCEEEEEEEECCCCcEEEEEEEeccccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEEEeCC
Confidence            456678999999999999999999998  467899999974311 112245678899999987 6999999999999999


Q ss_pred             cEEEEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceeecCCCcEEEeeccceeeccC
Q 015868          187 NLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQ  266 (399)
Q Consensus       187 ~~~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~giiHrDlkp~NILl~~~~~vkl~DFG~a~~~~~  266 (399)
                      .+|+||||++||+|.+++... +.+++..++.++.||+.||+|||++||+||||||+|||++.+|.+||+|||+++....
T Consensus       416 ~~~lV~E~~~gg~L~~~l~~~-~~~~~~~~~~~~~qi~~aL~~LH~~gIiHrDLKp~NILl~~~g~ikL~DFGla~~~~~  494 (674)
T 3pfq_A          416 RLYFVMEYVNGGDLMYHIQQV-GRFKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIW  494 (674)
T ss_dssp             EEEEEEECCCSCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTSEECCCCCSTTEEECSSSCEEECCCTTCEECCC
T ss_pred             EEEEEEeCcCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeEeccCChhhEEEcCCCcEEEeecceeecccc
Confidence            999999999999999999764 6799999999999999999999999999999999999999999999999999986433


Q ss_pred             C-CccccCCCCcccccccccCCCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhccCCCCCCCCCcHHHHHH
Q 015868          267 S-GVMTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRLAEL  345 (399)
Q Consensus       267 ~-~~~~~~~gt~~y~aPE~l~~~~~~~~~Dv~slG~vl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l  345 (399)
                      . .......||+.|+|||++.+..|+.++||||||+++|||++|..||.+.+..+....+...  ...+|..+++++.+|
T Consensus       495 ~~~~~~~~~GT~~Y~APE~l~~~~~~~~~DvwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~--~~~~p~~~s~~~~~l  572 (674)
T 3pfq_A          495 DGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEH--NVAYPKSMSKEAVAI  572 (674)
T ss_dssp             TTCCBCCCCSCSSSCCHHHHTCCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHSS--CCCCCTTSCHHHHHH
T ss_pred             CCcccccccCCCcccCHhhhcCCCCCccceEechHHHHHHHHcCCCCCCCCCHHHHHHHHHhC--CCCCCccCCHHHHHH
Confidence            2 3345567999999999999999999999999999999999999999999888877766654  356778899999999


Q ss_pred             HHHHhhhcCCCCCCH
Q 015868          346 LERCWQHDPTQRPNF  360 (399)
Q Consensus       346 l~~cl~~dP~~Rps~  360 (399)
                      |.+||+.||.+||++
T Consensus       573 i~~lL~~dP~~R~~~  587 (674)
T 3pfq_A          573 CKGLMTKHPGKRLGC  587 (674)
T ss_dssp             HHHHSCSSSTTCTTC
T ss_pred             HHHHccCCHHHCCCC
Confidence            999999999999997

>1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ...

Probab=100.00  E-value=3.6e-44  Score=357.23  Aligned_cols=245  Identities=24%  Similarity=0.353  Sum_probs=204.1

Q ss_pred             cccccceeceeceeCceEEEEEEE--CCeeEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCceeeEEeEEecC------
Q 015868          114 DAKQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRP------  185 (399)
Q Consensus       114 ~~~~~~i~~~lg~G~~g~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~nIv~~~~~~~~~------  185 (399)
                      ...+|++.+.||+|+||.||+|++  .++.||||++....      +...+|+.+|+.++||||+++++++...      
T Consensus        52 ~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~------~~~~~E~~il~~l~hpniv~l~~~~~~~~~~~~~  125 (420)
T 1j1b_A           52 QEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDK------RFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDE  125 (420)
T ss_dssp             EEEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECCT------TSCCHHHHHHHTCCCTTBCCEEEEEEEEETTTTE
T ss_pred             ccceEEeeeEEeeCCCEEEEEEEECCCCcEEEEEEecccc------hhHHHHHHHHHHcCCCCccceeeEEeccCCCCcc
Confidence            345799999999999999999998  57899999987542      1234699999999999999999988432      


Q ss_pred             CcEEEEEecCCCCCHHHHHH---hcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceeecCC-CcEEEeeccce
Q 015868          186 PNLCIVTEFMARGSIYDFLH---KQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDEN-GVVKVADFGVA  261 (399)
Q Consensus       186 ~~~~lV~E~~~ggsL~~~l~---~~~~~l~~~~~~~i~~~i~~~L~~LH~~giiHrDlkp~NILl~~~-~~vkl~DFG~a  261 (399)
                      ..+++||||+++ ++.+.+.   .....+++..++.++.||+.||.|||++||+||||||+|||++.+ +.+||+|||++
T Consensus       126 ~~~~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NILl~~~~~~~kl~DFG~a  204 (420)
T 1j1b_A          126 VYLNLVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSA  204 (420)
T ss_dssp             EEEEEEEECCCE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECSCCSGGGEEEETTTTEEEECCCTTC
T ss_pred             eeEEeehhcccc-cHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChhhEEEeCCCCeEEeccchhh
Confidence            236799999986 7776664   345779999999999999999999999999999999999999955 67899999999


Q ss_pred             eeccCCCccccCCCCcccccccccCCC-CCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhccC----------
Q 015868          262 RVQAQSGVMTAETGTYRWMAPEVIEHK-PYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKSL----------  330 (399)
Q Consensus       262 ~~~~~~~~~~~~~gt~~y~aPE~l~~~-~~~~~~Dv~slG~vl~elltg~~P~~~~~~~~~~~~~~~~~~----------  330 (399)
                      +............||+.|+|||++.+. .|+.++|||||||++|||++|+.||.+.+..+....++....          
T Consensus       205 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~~l~~i~~~lg~p~~~~~~~~  284 (420)
T 1j1b_A          205 KQLVRGEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREM  284 (420)
T ss_dssp             EECCTTCCCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHHHHHH
T ss_pred             hhcccCCCceeeeeCCCcCCHHHHcCCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhh
Confidence            876655555667899999999999765 799999999999999999999999999887665554443110          


Q ss_pred             --------CCC---------CCCCCcHHHHHHHHHHhhhcCCCCCCHHHHHH
Q 015868          331 --------RPT---------IPKHAHPRLAELLERCWQHDPTQRPNFSQITD  365 (399)
Q Consensus       331 --------~~~---------~~~~~~~~l~~ll~~cl~~dP~~Rps~~ell~  365 (399)
                              .+.         ++...++++.+||.+||+.||.+|||+.|+++
T Consensus       285 ~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~R~t~~e~l~  336 (420)
T 1j1b_A          285 NPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACA  336 (420)
T ss_dssp             CSCCCCCCCCCCCCCCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             ChhhhhhccCccCCCCHHHhcCCCCCHHHHHHHHHhccCChhHCCCHHHHhC
Confidence                    011         23457899999999999999999999999875

>3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ...

Probab=100.00  E-value=7.5e-44  Score=348.03  Aligned_cols=247  Identities=24%  Similarity=0.405  Sum_probs=209.1

Q ss_pred             ccccceeceeceeCceEEEEEEE--CCeeEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCceeeEEeEEecC-----Cc
Q 015868          115 AKQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRP-----PN  187 (399)
Q Consensus       115 ~~~~~i~~~lg~G~~g~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~nIv~~~~~~~~~-----~~  187 (399)
                      .++|++.+.||+|+||.||+|.+  +++.||+|++.... .....+.+.+|+.++++++||||+++++++...     ..
T Consensus        26 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~  104 (364)
T 3qyz_A           26 GPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFE-HQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKD  104 (364)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCTT-CHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCC
T ss_pred             cccEEEEEEeecCCCeEEEEEEECCCCeEEEEEEecccc-CcHHHHHHHHHHHHHHhcCCCCCccceeEEecCCccccce
Confidence            46899999999999999999987  57889999998543 455667899999999999999999999999655     36


Q ss_pred             EEEEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceeecCCCcEEEeeccceeeccCC
Q 015868          188 LCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQS  267 (399)
Q Consensus       188 ~~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~giiHrDlkp~NILl~~~~~vkl~DFG~a~~~~~~  267 (399)
                      .++||||+.+ +|.+++..  ..+++..++.++.|++.||.|||++||+||||||+||+++.++.+||+|||+++.....
T Consensus       105 ~~iv~e~~~~-~L~~~l~~--~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~  181 (364)
T 3qyz_A          105 VYIVQDLMET-DLYKLLKT--QHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPD  181 (364)
T ss_dssp             EEEEEECCSE-EHHHHHHH--CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECCGG
T ss_pred             EEEEEcccCc-CHHHHHHh--CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCChHhEEECCCCCEEEEeCcceEecCCC
Confidence            8999999975 99999965  46899999999999999999999999999999999999999999999999999865543


Q ss_pred             Cc----cccCCCCcccccccccC-CCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhccCCC----------
Q 015868          268 GV----MTAETGTYRWMAPEVIE-HKPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKSLRP----------  332 (399)
Q Consensus       268 ~~----~~~~~gt~~y~aPE~l~-~~~~~~~~Dv~slG~vl~elltg~~P~~~~~~~~~~~~~~~~~~~~----------  332 (399)
                      ..    .....||+.|+|||++. +..++.++||||||+++|+|++|+.||.+.+..+....+......+          
T Consensus       182 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  261 (364)
T 3qyz_A          182 HDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIIN  261 (364)
T ss_dssp             GCBCCTTCCCCSCGGGCCHHHHHTBCSCSTHHHHHHHHHHHHHHHHSSCSSCCSSGGGHHHHHHHHHCSCCHHHHHTCCC
T ss_pred             CCccccccccccccCCCCCHHhcCCCCCCcchhHHHHHHHHHHHHHCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhhh
Confidence            22    24457899999999865 4568999999999999999999999998877655544433211110          


Q ss_pred             -------------------CCCCCCcHHHHHHHHHHhhhcCCCCCCHHHHHH
Q 015868          333 -------------------TIPKHAHPRLAELLERCWQHDPTQRPNFSQITD  365 (399)
Q Consensus       333 -------------------~~~~~~~~~l~~ll~~cl~~dP~~Rps~~ell~  365 (399)
                                         .....+++++.+||.+||+.||.+|||+.|+++
T Consensus       262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~  313 (364)
T 3qyz_A          262 LKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALA  313 (364)
T ss_dssp             HHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             hhHHHHHHhcCCccCCCHHHhCCCCCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence                               012457899999999999999999999999976

>3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A*

Probab=100.00  E-value=3.2e-45  Score=358.62  Aligned_cols=256  Identities=12%  Similarity=0.133  Sum_probs=193.9

Q ss_pred             cccccceeceeceeCceEEEEEEE--CCeeEEEEEecCCCC-CHHHHHHHHHHHHHHHhc--CCCceeeEE-------eE
Q 015868          114 DAKQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECV-NTEMLKEFSQEVYIMRKI--RHKNVVQFI-------GA  181 (399)
Q Consensus       114 ~~~~~~i~~~lg~G~~g~Vy~~~~--~~~~vAvK~~~~~~~-~~~~~~~~~~Ei~~l~~l--~h~nIv~~~-------~~  181 (399)
                      ...+|++.+.||+|+||.||+|++  +++.||+|+++.... .....+.+.+|+.+++.+  +||||++++       ++
T Consensus        60 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~hp~iv~~~~~~~~p~d~  139 (371)
T 3q60_A           60 GERKLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARDRRRLLLPSDA  139 (371)
T ss_dssp             CEEEEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECCSTTHHHHHHHHHHHHHHHHHHHC----------CBCCCCEE
T ss_pred             CceeeeeeeeccCCCCEEEEEEEECCCCceeEEEEEEecccccccHHHHHHHHHHHHHHhcccChhhhhhceeEEeeehh
Confidence            345699999999999999999997  578999999987654 334556788885555544  699988755       44


Q ss_pred             EecC-----------------CcEEEEEecCCCCCHHHHHHhcCCCCCHHHH------HHHHHHHHHHHHHHHHCCcccC
Q 015868          182 CTRP-----------------PNLCIVTEFMARGSIYDFLHKQKGVFQLTSL------LKVAIDVSKGMNYLHQNNIIHR  238 (399)
Q Consensus       182 ~~~~-----------------~~~~lV~E~~~ggsL~~~l~~~~~~l~~~~~------~~i~~~i~~~L~~LH~~giiHr  238 (399)
                      +..+                 ..+|+||||++ ++|.+++......++...+      ..++.||+.||+|||++||+||
T Consensus       140 ~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~vk~~i~~qi~~aL~~LH~~~ivHr  218 (371)
T 3q60_A          140 VAVQSQPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTLDFVYVFRGDEGILALHILTAQLIRLAANLQSKGLVHG  218 (371)
T ss_dssp             EEETTSCSSSBCSCC---CCEEEEEEEECCCS-EEHHHHHHHHHHSCCCCHHHHHHHHHHHHHHHHHHHHHHHHTTEEET
T ss_pred             eecCCCCCeeeccCCcccceeeeEEEEecCCC-CCHHHHHHHhccccchhhhhhhhhHHHHHHHHHHHHHHHHHCCCccC
Confidence            4332                 23899999998 7999999875555566666      7788999999999999999999


Q ss_pred             CCCCCceeecCCCcEEEeeccceeeccCCCccccCCCCcccccccccCC--CCCCChhhHHHHHHHHHHHHcCCCCCCCC
Q 015868          239 DLKTANLLMDENGVVKVADFGVARVQAQSGVMTAETGTYRWMAPEVIEH--KPYDYKADVFSFGIALWELLTGELPYAGL  316 (399)
Q Consensus       239 Dlkp~NILl~~~~~vkl~DFG~a~~~~~~~~~~~~~gt~~y~aPE~l~~--~~~~~~~Dv~slG~vl~elltg~~P~~~~  316 (399)
                      ||||+|||++.++.+||+|||+++.....  .....+|+.|+|||++.+  ..++.++||||||+++|+|+||+.||...
T Consensus       219 Dikp~NIll~~~~~~kL~DFG~a~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~  296 (371)
T 3q60_A          219 HFTPDNLFIMPDGRLMLGDVSALWKVGTR--GPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFLPFGLV  296 (371)
T ss_dssp             TCSGGGEEECTTSCEEECCGGGEEETTCE--EEGGGSCGGGCCHHHHTCSEEECCHHHHHHHHHHHHHHHHHSSCSTTBC
T ss_pred             cCCHHHEEECCCCCEEEEecceeeecCCC--ccCccCCcCCcChhhccCCCCCcCccccHHHHHHHHHHHHhCCCCCCCc
Confidence            99999999999999999999999865432  224567799999999987  78999999999999999999999999876


Q ss_pred             CHHHHHHH-------HHhccCCCCCCCCCcHHHHHHHHHHhhhcCCCCCCHHHHHH--HHHHHHH
Q 015868          317 TPLQAAVG-------VVQKSLRPTIPKHAHPRLAELLERCWQHDPTQRPNFSQITD--ILKQMMK  372 (399)
Q Consensus       317 ~~~~~~~~-------~~~~~~~~~~~~~~~~~l~~ll~~cl~~dP~~Rps~~ell~--~L~~l~~  372 (399)
                      .+......       ..........+..+++++.+||.+||+.||++|||+.++++  .++++..
T Consensus       297 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~~~  361 (371)
T 3q60_A          297 TPGIKGSWKRPSLRVPGTDSLAFGSCTPLPDFVKTLIGRFLNFDRRRRLLPLEAMETPEFLQLQN  361 (371)
T ss_dssp             CTTCTTCCCBCCTTSCCCCSCCCTTSSCCCHHHHHHHHHHTCSSTTTCCCHHHHTTSHHHHHHHH
T ss_pred             CcccccchhhhhhhhccccccchhhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcCHHHHHHHH
Confidence            54211000       00011112223478999999999999999999999999975  4454443

>2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens}

Probab=100.00  E-value=8.5e-44  Score=338.11  Aligned_cols=248  Identities=24%  Similarity=0.432  Sum_probs=208.7

Q ss_pred             ccccceeceeceeCceEEEEEEE--CCeeEEEEEecCCCC--CHHHHHHHHHHHHHHHhcCCCceeeEEeEE--ecCCcE
Q 015868          115 AKQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECV--NTEMLKEFSQEVYIMRKIRHKNVVQFIGAC--TRPPNL  188 (399)
Q Consensus       115 ~~~~~i~~~lg~G~~g~Vy~~~~--~~~~vAvK~~~~~~~--~~~~~~~~~~Ei~~l~~l~h~nIv~~~~~~--~~~~~~  188 (399)
                      .++|++.+.||+|+||.||++.+  .++.||+|+++....  .......+.+|+.++++++||||+++++++  ......
T Consensus         4 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~   83 (305)
T 2wtk_C            4 IGKYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLVDVLYNEEKQKM   83 (305)
T ss_dssp             -CCBCCCCEEEECSSCEEEEEEBTTTCCEEEEEEECHHHHHHSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECC---CE
T ss_pred             ccceeEeeEEecCCCeEEEEEEECCCCcEEEEEEeccccccccchhHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCeE
Confidence            36899999999999999999987  568999999974311  112356799999999999999999999998  445679


Q ss_pred             EEEEecCCCCCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceeecCCCcEEEeeccceeeccC-
Q 015868          189 CIVTEFMARGSIYDFLHKQ-KGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQ-  266 (399)
Q Consensus       189 ~lV~E~~~ggsL~~~l~~~-~~~l~~~~~~~i~~~i~~~L~~LH~~giiHrDlkp~NILl~~~~~vkl~DFG~a~~~~~-  266 (399)
                      ++||||+.++ |.+++... ...+++..++.++.||+.||.|||++||+||||||+||+++.++.+||+|||.+..... 
T Consensus        84 ~lv~e~~~~~-l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~dlkp~NIl~~~~~~~kl~dfg~~~~~~~~  162 (305)
T 2wtk_C           84 YMVMEYCVCG-MQEMLDSVPEKRFPVCQAHGYFCQLIDGLEYLHSQGIVHKDIKPGNLLLTTGGTLKISALGVAEALHPF  162 (305)
T ss_dssp             EEEEECCSEE-HHHHHHHSTTCSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEECCTT
T ss_pred             EEEehhccCC-HHHHHHhCcccccCHHHHHHHHHHHHHHHHHHHHCCeeecCCCcccEEEcCCCcEEeeccccccccCcc
Confidence            9999999885 77777653 46799999999999999999999999999999999999999999999999999986543 


Q ss_pred             --CCccccCCCCcccccccccCCCCC--CChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhccCCCCCCCCCcHHH
Q 015868          267 --SGVMTAETGTYRWMAPEVIEHKPY--DYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRL  342 (399)
Q Consensus       267 --~~~~~~~~gt~~y~aPE~l~~~~~--~~~~Dv~slG~vl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  342 (399)
                        ........||+.|+|||++.+...  +.++||||||+++|+|++|..||.+.+..+....+...  ...++..+++++
T Consensus       163 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~i~~~--~~~~~~~~~~~l  240 (305)
T 2wtk_C          163 AADDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDNIYKLFENIGKG--SYAIPGDCGPPL  240 (305)
T ss_dssp             CSSCEECCCCSCGGGCCHHHHTCCSCEESHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHC--CCCCCSSSCHHH
T ss_pred             ccccccccCCCCCCCcChhhccCcccCCcchhhHHHHHHHHHHHHhCCCCCCCchHHHHHHHHhcC--CCCCCCccCHHH
Confidence              222345568999999999987543  77999999999999999999999988776655544433  345677899999


Q ss_pred             HHHHHHHhhhcCCCCCCHHHHHH
Q 015868          343 AELLERCWQHDPTQRPNFSQITD  365 (399)
Q Consensus       343 ~~ll~~cl~~dP~~Rps~~ell~  365 (399)
                      .+++.+||+.||.+|||+.|+++
T Consensus       241 ~~li~~~l~~dp~~Rps~~~ll~  263 (305)
T 2wtk_C          241 SDLLKGMLEYEPAKRFSIRQIRQ  263 (305)
T ss_dssp             HHHHHHHTCSSTTTSCCHHHHHH
T ss_pred             HHHHHHHccCChhhCCCHHHHhc
Confidence            99999999999999999999986

>4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis}

Probab=100.00  E-value=7.4e-44  Score=352.08  Aligned_cols=247  Identities=25%  Similarity=0.362  Sum_probs=204.4

Q ss_pred             eecccccceeceeceeCceEEEEEEE-CCeeEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCceeeEEeEEecCC----
Q 015868          112 EIDAKQLKIECKVASGSYGDLYKGTY-CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPP----  186 (399)
Q Consensus       112 ~i~~~~~~i~~~lg~G~~g~Vy~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~nIv~~~~~~~~~~----  186 (399)
                      +....+|++.+.||+|+||.||+|++ .+..||+|.+.....      ...+|+.+++.++||||+++++++....    
T Consensus        36 ~~~~~~Y~~~~~lG~G~~g~V~~a~~~~~~~~aikk~~~~~~------~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~  109 (394)
T 4e7w_A           36 EQREIAYTNCKVIGNGSFGVVFQAKLVESDEVAIKKVLQDKR------FKNRELQIMRIVKHPNVVDLKAFFYSNGDKKD  109 (394)
T ss_dssp             CEEEEEEEEEEEEEEETTEEEEEEEETTTEEEEEEEEECCTT------SCCHHHHHHHTCCCTTBCCEEEEEEEESSSSS
T ss_pred             CcccceEEEeEEEeeCCCeEEEEEEECCCCeEEEEEEecCcc------hHHHHHHHHHhCCCCCcceEEEEEEecCCCCC
Confidence            33456899999999999999999998 456688888764321      1236999999999999999999995443    


Q ss_pred             --cEEEEEecCCCCCHHHHHH---hcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceeec-CCCcEEEeeccc
Q 015868          187 --NLCIVTEFMARGSIYDFLH---KQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMD-ENGVVKVADFGV  260 (399)
Q Consensus       187 --~~~lV~E~~~ggsL~~~l~---~~~~~l~~~~~~~i~~~i~~~L~~LH~~giiHrDlkp~NILl~-~~~~vkl~DFG~  260 (399)
                        .+++||||+++ ++.+.+.   .....+++..++.++.||+.||+|||++||+||||||+|||++ .++.+||+|||+
T Consensus       110 ~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~~kL~DFG~  188 (394)
T 4e7w_A          110 EVFLNLVLEYVPE-TVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHSIGICHRDIKPQNLLLDPPSGVLKLIDFGS  188 (394)
T ss_dssp             CEEEEEEEECCSE-EHHHHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEETTTTEEEECCCTT
T ss_pred             ceEEEEEeeccCc-cHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCCHHHEEEcCCCCcEEEeeCCC
Confidence              38899999987 4444432   2356799999999999999999999999999999999999999 799999999999


Q ss_pred             eeeccCCCccccCCCCcccccccccCCC-CCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhccCC--------
Q 015868          261 ARVQAQSGVMTAETGTYRWMAPEVIEHK-PYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKSLR--------  331 (399)
Q Consensus       261 a~~~~~~~~~~~~~gt~~y~aPE~l~~~-~~~~~~Dv~slG~vl~elltg~~P~~~~~~~~~~~~~~~~~~~--------  331 (399)
                      ++............+|+.|+|||++.+. .|+.++|||||||++|+|++|+.||.+.+..+....+......        
T Consensus       189 a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~p~~~~~~~  268 (394)
T 4e7w_A          189 AKILIAGEPNVSYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGESGIDQLVEIIKVLGTPSREQIKT  268 (394)
T ss_dssp             CEECCTTCCCCSSCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHH
T ss_pred             cccccCCCCCcccccCcCccCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHh
Confidence            9887666566677899999999999765 5899999999999999999999999998876665554432110        


Q ss_pred             ----------C---------CCCCCCcHHHHHHHHHHhhhcCCCCCCHHHHHH
Q 015868          332 ----------P---------TIPKHAHPRLAELLERCWQHDPTQRPNFSQITD  365 (399)
Q Consensus       332 ----------~---------~~~~~~~~~l~~ll~~cl~~dP~~Rps~~ell~  365 (399)
                                +         .++..+++++.+||.+||+.||.+|||+.|+++
T Consensus       269 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~  321 (394)
T 4e7w_A          269 MNPNYMEHKFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLTAIEALC  321 (394)
T ss_dssp             HCGGGSSSCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred             hChhhhhhccccccCCcHHHhccccCCHHHHHHHHHHhCCChhhCCCHHHHhc
Confidence                      1         123458899999999999999999999999976

>2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X*

Probab=100.00  E-value=6.8e-45  Score=352.23  Aligned_cols=250  Identities=22%  Similarity=0.409  Sum_probs=213.5

Q ss_pred             ecccccceeceeceeCceEEEEEEECCeeEEEEEecCCCCCH---------------HHHHHHHHHHHHHHhcCCCceee
Q 015868          113 IDAKQLKIECKVASGSYGDLYKGTYCSQEVAIKVLKPECVNT---------------EMLKEFSQEVYIMRKIRHKNVVQ  177 (399)
Q Consensus       113 i~~~~~~i~~~lg~G~~g~Vy~~~~~~~~vAvK~~~~~~~~~---------------~~~~~~~~Ei~~l~~l~h~nIv~  177 (399)
                      +..++|++.+.||+|+||.||+|++.++.||+|++.......               ...+.+.+|+.++++++||||++
T Consensus        28 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~  107 (348)
T 2pml_X           28 KYINDYRIIRTLNQGKFNKIILCEKDNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEYCLT  107 (348)
T ss_dssp             EEETTEEEEEEEECCSSCCEEEEEETTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTCCCTTBCC
T ss_pred             cccCceEEEEEEcCCCCeEEEEEEcCCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhCCCCCcce
Confidence            446799999999999999999999999999999987431110               11278899999999999999999


Q ss_pred             EEeEEecCCcEEEEEecCCCCCHHHH------HHhc-CCCCCHHHHHHHHHHHHHHHHHHHH-CCcccCCCCCCceeecC
Q 015868          178 FIGACTRPPNLCIVTEFMARGSIYDF------LHKQ-KGVFQLTSLLKVAIDVSKGMNYLHQ-NNIIHRDLKTANLLMDE  249 (399)
Q Consensus       178 ~~~~~~~~~~~~lV~E~~~ggsL~~~------l~~~-~~~l~~~~~~~i~~~i~~~L~~LH~-~giiHrDlkp~NILl~~  249 (399)
                      +++++...+..++||||+++++|.++      +... ...+++..++.++.|++.||.|||+ +||+||||||+||+++.
T Consensus       108 ~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~i~H~dl~p~Nil~~~  187 (348)
T 2pml_X          108 CEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIHNEKNICHRDVKPSNILMDK  187 (348)
T ss_dssp             CSEEEESSSEEEEEEECCTTCBSSEESSSEESSCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTSCEECCCCCGGGEEECT
T ss_pred             EEEEEeeCCeEEEEEeccCCCcHHHHHHHhhhhhhccccCCCHHHHHHHHHHHHHHHHHHhccCCEeecCCChHhEEEcC
Confidence            99999999999999999999999998      5442 5679999999999999999999999 99999999999999999


Q ss_pred             CCcEEEeeccceeeccCCCccccCCCCcccccccccCCC-CCCC-hhhHHHHHHHHHHHHcCCCCCCCCCH-HHHHHHHH
Q 015868          250 NGVVKVADFGVARVQAQSGVMTAETGTYRWMAPEVIEHK-PYDY-KADVFSFGIALWELLTGELPYAGLTP-LQAAVGVV  326 (399)
Q Consensus       250 ~~~vkl~DFG~a~~~~~~~~~~~~~gt~~y~aPE~l~~~-~~~~-~~Dv~slG~vl~elltg~~P~~~~~~-~~~~~~~~  326 (399)
                      ++.+||+|||.++..... ......|++.|+|||++.+. .++. ++||||||+++|+|++|..||...+. .+.... +
T Consensus       188 ~~~~kl~dfg~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~-i  265 (348)
T 2pml_X          188 NGRVKLSDFGESEYMVDK-KIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKISLVELFNN-I  265 (348)
T ss_dssp             TSCEEECCCTTCEECBTT-EECSSCSCGGGCCGGGGSSCCCEEHHHHHHHHHHHHHHHHHHSSCSSCCSSCSHHHHHH-H
T ss_pred             CCcEEEeccccccccccc-cccCCCCCcCccCchhhcCCCCCCcchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHH-H
Confidence            999999999999875443 44556789999999999887 6666 99999999999999999999988776 443333 3


Q ss_pred             hccCCCCCC-------------------CCCcHHHHHHHHHHhhhcCCCCCCHHHHHH
Q 015868          327 QKSLRPTIP-------------------KHAHPRLAELLERCWQHDPTQRPNFSQITD  365 (399)
Q Consensus       327 ~~~~~~~~~-------------------~~~~~~l~~ll~~cl~~dP~~Rps~~ell~  365 (399)
                      ... ....|                   ..+++++.+++.+||+.||.+|||+.|+++
T Consensus       266 ~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~e~l~  322 (348)
T 2pml_X          266 RTK-NIEYPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERITSEDALK  322 (348)
T ss_dssp             TSC-CCCCCCSSSSSTTTTCC--------CCCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred             hcc-CcCCccchhhhhccccccccccchhhcCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence            222 22233                   568999999999999999999999999976

>1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A*

Probab=100.00  E-value=2.1e-43  Score=339.29  Aligned_cols=248  Identities=24%  Similarity=0.379  Sum_probs=209.0

Q ss_pred             eecccccceeceeceeCceEEEEEEE---CCeeEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCc------eeeEEeEE
Q 015868          112 EIDAKQLKIECKVASGSYGDLYKGTY---CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKN------VVQFIGAC  182 (399)
Q Consensus       112 ~i~~~~~~i~~~lg~G~~g~Vy~~~~---~~~~vAvK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~n------Iv~~~~~~  182 (399)
                      ++-.++|++.+.||+|+||.||+|.+   .++.||+|+++..   ....+.+.+|+.+++.++|++      ++++++++
T Consensus        10 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~~~~~~   86 (339)
T 1z57_A           10 DVLSARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNV---DRYCEAARSEIQVLEHLNTTDPNSTFRCVQMLEWF   86 (339)
T ss_dssp             CEETTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSS---HHHHHHHHHHHHHHHHHHHHCTTCTTCBCCEEEEE
T ss_pred             CCccCceEEEEEEecCCCeEEEEEEecCCCCcEEEEEEEecC---CchhHHHHHHHHHHHHhhhcCCCCceeeEeeeccc
Confidence            34467999999999999999999987   5789999999753   455678899999999997654      99999999


Q ss_pred             ecCCcEEEEEecCCCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceeecC------------
Q 015868          183 TRPPNLCIVTEFMARGSIYDFLHKQK-GVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDE------------  249 (399)
Q Consensus       183 ~~~~~~~lV~E~~~ggsL~~~l~~~~-~~l~~~~~~~i~~~i~~~L~~LH~~giiHrDlkp~NILl~~------------  249 (399)
                      ...+..++||||+ +++|.+++.... ..+++..++.++.|++.||+|||++||+||||||+||+++.            
T Consensus        87 ~~~~~~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~~~~~~  165 (339)
T 1z57_A           87 EHHGHICIVFELL-GLSTYDFIKENGFLPFRLDHIRKMAYQICKSVNFLHSNKLTHTDLKPENILFVQSDYTEAYNPKIK  165 (339)
T ss_dssp             EETTEEEEEEECC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESCCCEEEEEC----
T ss_pred             ccCCcEEEEEcCC-CCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHEEEeccccccccCCccc
Confidence            9999999999999 789999997654 36899999999999999999999999999999999999987            


Q ss_pred             -------CCcEEEeeccceeeccCCCccccCCCCcccccccccCCCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHH
Q 015868          250 -------NGVVKVADFGVARVQAQSGVMTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPYAGLTPLQAA  322 (399)
Q Consensus       250 -------~~~vkl~DFG~a~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~Dv~slG~vl~elltg~~P~~~~~~~~~~  322 (399)
                             ++.+||+|||.++.....  .....||+.|+|||++.+..++.++||||||+++|+|++|..||...+..+..
T Consensus       166 ~~~~~~~~~~~kl~Dfg~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~  243 (339)
T 1z57_A          166 RDERTLINPDIKVVDFGSATYDDEH--HSTLVSTRHYRAPEVILALGWSQPCDVWSIGCILIEYYLGFTVFPTHDSKEHL  243 (339)
T ss_dssp             CEEEEESCCCEEECCCSSCEETTSC--CCSSCSCGGGCCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSCHHHHH
T ss_pred             cccccccCCCceEeeCcccccCccc--cccccCCccccChHHhhCCCCCcchhhHHHHHHHHHHHhCCCCCCCCChHHHH
Confidence                   668999999999865432  34557899999999999999999999999999999999999999988766544


Q ss_pred             HHHHhccCC------------------------------------------CCCCCCCcHHHHHHHHHHhhhcCCCCCCH
Q 015868          323 VGVVQKSLR------------------------------------------PTIPKHAHPRLAELLERCWQHDPTQRPNF  360 (399)
Q Consensus       323 ~~~~~~~~~------------------------------------------~~~~~~~~~~l~~ll~~cl~~dP~~Rps~  360 (399)
                      .........                                          ...+...++++.+||.+||+.||.+|||+
T Consensus       244 ~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~  323 (339)
T 1z57_A          244 AMMERILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQDVEHERLFDLIQKMLEYDPAKRITL  323 (339)
T ss_dssp             HHHHHHHCSCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTTTSCCH
T ss_pred             HHHHHHhCCCCHHHHhhccchhHHhhccccccccccccchhhhcCcchhhhcccchhhHHHHHHHHHHHhCcCcccccCH
Confidence            332211000                                          01122346789999999999999999999


Q ss_pred             HHHHH
Q 015868          361 SQITD  365 (399)
Q Consensus       361 ~ell~  365 (399)
                      .|+++
T Consensus       324 ~ell~  328 (339)
T 1z57_A          324 REALK  328 (339)
T ss_dssp             HHHTT
T ss_pred             HHHhc
Confidence            99864

>3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens}

Probab=100.00  E-value=1.6e-43  Score=344.06  Aligned_cols=249  Identities=27%  Similarity=0.445  Sum_probs=209.3

Q ss_pred             ceeecccccceeceeceeCceEEEEEEE--CCeeEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCceeeEEeEEecCCc
Q 015868          110 VWEIDAKQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPN  187 (399)
Q Consensus       110 ~~~i~~~~~~i~~~lg~G~~g~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~nIv~~~~~~~~~~~  187 (399)
                      .|++ .++|.+.+.||+|+||.||+|.+  +++.||||++..........+.+.+|+.+++.++||||+++++++.....
T Consensus        19 ~~~l-~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~   97 (353)
T 3coi_A           19 AWEL-PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASS   97 (353)
T ss_dssp             EEEE-ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEESSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSS
T ss_pred             cccc-CceEEEeeeEecCCCeEEEEEEECCCCCEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCcccHhheEecccc
Confidence            3544 36899999999999999999987  58899999998776667777889999999999999999999999987654


Q ss_pred             ------EEEEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceeecCCCcEEEeeccce
Q 015868          188 ------LCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVA  261 (399)
Q Consensus       188 ------~~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~giiHrDlkp~NILl~~~~~vkl~DFG~a  261 (399)
                            +|+||||+.+ +|.+++.   ..+++..++.++.||+.||.|||++||+||||||+||+++.++.+||+|||++
T Consensus        98 ~~~~~~~~lv~e~~~~-~l~~~~~---~~~~~~~~~~i~~qi~~al~~LH~~~ivH~dlkp~NIl~~~~~~~kl~Dfg~~  173 (353)
T 3coi_A           98 LRNFYDFYLVMPFMQT-DLQKIMG---LKFSEEKIQYLVYQMLKGLKYIHSAGVVHRDLKPGNLAVNEDCELKILDFGLA  173 (353)
T ss_dssp             GGGCCCCEEEEECCSE-EGGGTTT---SCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEECTTCCEEECSTTCT
T ss_pred             cccceeEEEEeccccC-CHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEeECCCCcEEEeecccc
Confidence                  4999999975 8888763   35899999999999999999999999999999999999999999999999999


Q ss_pred             eeccCCCccccCCCCcccccccccCC-CCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcc-----------
Q 015868          262 RVQAQSGVMTAETGTYRWMAPEVIEH-KPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKS-----------  329 (399)
Q Consensus       262 ~~~~~~~~~~~~~gt~~y~aPE~l~~-~~~~~~~Dv~slG~vl~elltg~~P~~~~~~~~~~~~~~~~~-----------  329 (399)
                      +.....  .....+|+.|+|||++.+ ..++.++||||||+++|+|++|..||.+.+..+.........           
T Consensus       174 ~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~  251 (353)
T 3coi_A          174 RHADAE--MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFVQKL  251 (353)
T ss_dssp             TC----------CCSBCCSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSSBSSCHHHHHHHHHHHHCBCCHHHHTTC
T ss_pred             cCCCCC--ccccccCcCcCCHHHHhCcCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHHH
Confidence            764432  345578999999999987 678999999999999999999999999887665544433210           


Q ss_pred             ------------------CCCCCCCCCcHHHHHHHHHHhhhcCCCCCCHHHHHH
Q 015868          330 ------------------LRPTIPKHAHPRLAELLERCWQHDPTQRPNFSQITD  365 (399)
Q Consensus       330 ------------------~~~~~~~~~~~~l~~ll~~cl~~dP~~Rps~~ell~  365 (399)
                                        ..+..+..+++++.+||.+||+.||++|||+.|+++
T Consensus       252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~  305 (353)
T 3coi_A          252 NDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALT  305 (353)
T ss_dssp             SCHHHHHHHHTSCBCSSCCTTTTCTTSCHHHHHHHHHHSCSCTTTSCCHHHHHT
T ss_pred             hhHHHHHHHHhCcCCCCccHHHhcCCcCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence                              012234568999999999999999999999999975

>2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A*

Probab=100.00  E-value=2e-43  Score=342.55  Aligned_cols=247  Identities=24%  Similarity=0.371  Sum_probs=207.1

Q ss_pred             ccccceeceeceeCceEEEEEEEC--CeeEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCceeeEEeEEecC-----Cc
Q 015868          115 AKQLKIECKVASGSYGDLYKGTYC--SQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRP-----PN  187 (399)
Q Consensus       115 ~~~~~i~~~lg~G~~g~Vy~~~~~--~~~vAvK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~nIv~~~~~~~~~-----~~  187 (399)
                      .++|++.+.||+|+||.||+|++.  ++.||||+++... .......+.+|+.++++++||||+++++++...     ..
T Consensus        10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~   88 (353)
T 2b9h_A           10 SSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFD-KPLFALRTLREIKILKHFKHENIITIFNIQRPDSFENFNE   88 (353)
T ss_dssp             CTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCS-SHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCSTTCCC
T ss_pred             ccceEEeeEEcCCCCeEEEEEEECCCCcEEEEEeecccc-cchHHHHHHHHHHHHHhCcCCCcCCeeeeecccccCccce
Confidence            578999999999999999999984  8899999997542 455567889999999999999999999988654     67


Q ss_pred             EEEEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceeecCCCcEEEeeccceeeccCC
Q 015868          188 LCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQS  267 (399)
Q Consensus       188 ~~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~giiHrDlkp~NILl~~~~~vkl~DFG~a~~~~~~  267 (399)
                      .++||||+.+ +|.+++..  ..+++..++.++.|++.||.|||++||+||||||+||+++.++.+||+|||+++.....
T Consensus        89 ~~lv~e~~~~-~L~~~~~~--~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~  165 (353)
T 2b9h_A           89 VYIIQELMQT-DLHRVIST--QMLSDDHIQYFIYQTLRAVKVLHGSNVIHRDLKPSNLLINSNCDLKVCDFGLARIIDES  165 (353)
T ss_dssp             EEEEECCCSE-EHHHHHHH--CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCCTTCEECC--
T ss_pred             EEEEEeccCc-cHHHHHhh--cCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEEcCCCcEEEEecccccccccc
Confidence            8999999975 99999876  56899999999999999999999999999999999999999999999999999865432


Q ss_pred             C-----------ccccCCCCcccccccccCC-CCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhccCCC---
Q 015868          268 G-----------VMTAETGTYRWMAPEVIEH-KPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKSLRP---  332 (399)
Q Consensus       268 ~-----------~~~~~~gt~~y~aPE~l~~-~~~~~~~Dv~slG~vl~elltg~~P~~~~~~~~~~~~~~~~~~~~---  332 (399)
                      .           ......||+.|+|||++.+ ..++.++||||||+++|+|++|..||.+.+..+...........+   
T Consensus       166 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~  245 (353)
T 2b9h_A          166 AADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQLLLIFGIIGTPHSD  245 (353)
T ss_dssp             --------------CCCCCCGGGCCHHHHHSCCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCST
T ss_pred             cccccCccccccchhhccccccccCCeeeccCCCccchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCchh
Confidence            1           1223468999999998754 678999999999999999999999999887655444332211110   


Q ss_pred             ---------------------------CCCCCCcHHHHHHHHHHhhhcCCCCCCHHHHHH
Q 015868          333 ---------------------------TIPKHAHPRLAELLERCWQHDPTQRPNFSQITD  365 (399)
Q Consensus       333 ---------------------------~~~~~~~~~l~~ll~~cl~~dP~~Rps~~ell~  365 (399)
                                                 ..+..+++++.+||.+||+.||.+|||+.|+++
T Consensus       246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~  305 (353)
T 2b9h_A          246 NDLRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRITAKEALE  305 (353)
T ss_dssp             TTTTTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             ccccccccchhhHHhhcccCCCCcchhhhcccCCHHHHHHHHHhcCcCcccCCCHHHHhc
Confidence                                       012468899999999999999999999999976

>1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A*

Probab=100.00  E-value=1.1e-43  Score=349.20  Aligned_cols=247  Identities=21%  Similarity=0.332  Sum_probs=203.3

Q ss_pred             ecccccceeceeceeCceEEEEEEE--CCeeEEEEEecCCCCCHHHHHHHHHHHHHHHhcC--------CCceeeEEeEE
Q 015868          113 IDAKQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIR--------HKNVVQFIGAC  182 (399)
Q Consensus       113 i~~~~~~i~~~lg~G~~g~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~Ei~~l~~l~--------h~nIv~~~~~~  182 (399)
                      +-.++|++.++||+|+||.||+|++  .++.||||+++..   ....+.+.+|+.+++.++        |+||+++++++
T Consensus        34 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~~~E~~~l~~l~~~~~~~~~~~~iv~~~~~~  110 (397)
T 1wak_A           34 LFNGRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSA---EHYTETALDEIRLLKSVRNSDPNDPNREMVVQLLDDF  110 (397)
T ss_dssp             EETTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC---HHHHHHHHHHHHHHHHHHHSCTTCGGGGGBCCEEEEE
T ss_pred             hcCCeEEEEEEeeecCCeeEEEEEecCCCeEEEEEEEecC---CcchHHHHHHHHHHHHHhhcCCCCCCcceeeeeecce
Confidence            3467999999999999999999987  5789999999753   555678899999999995        78899999998


Q ss_pred             e----cCCcEEEEEecCCCCCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHC-CcccCCCCCCceeecCCC-----
Q 015868          183 T----RPPNLCIVTEFMARGSIYDFLHKQ-KGVFQLTSLLKVAIDVSKGMNYLHQN-NIIHRDLKTANLLMDENG-----  251 (399)
Q Consensus       183 ~----~~~~~~lV~E~~~ggsL~~~l~~~-~~~l~~~~~~~i~~~i~~~L~~LH~~-giiHrDlkp~NILl~~~~-----  251 (399)
                      .    ....+|+||||+ +++|.+.+... ...+++..++.++.||+.||.|||++ ||+||||||+|||++.++     
T Consensus       111 ~~~~~~~~~~~lv~e~~-~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~givHrDikp~NIll~~~~~~~~~  189 (397)
T 1wak_A          111 KISGVNGTHICMVFEVL-GHHLLKWIIKSNYQGLPLPCVKKIIQQVLQGLDYLHTKCRIIHTDIKPENILLSVNEQYIRR  189 (397)
T ss_dssp             EEEETTEEEEEEEECCC-CCBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECCCCSGGGEEECCCHHHHHH
T ss_pred             eecCCCCceEEEEEecc-CccHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHeeEeccchhhhh
Confidence            7    566799999999 45776666554 36799999999999999999999999 999999999999999776     


Q ss_pred             --------------------------------------------cEEEeeccceeeccCCCccccCCCCcccccccccCC
Q 015868          252 --------------------------------------------VVKVADFGVARVQAQSGVMTAETGTYRWMAPEVIEH  287 (399)
Q Consensus       252 --------------------------------------------~vkl~DFG~a~~~~~~~~~~~~~gt~~y~aPE~l~~  287 (399)
                                                                  .+||+|||.++.....  .....||+.|+|||++.+
T Consensus       190 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~~--~~~~~gt~~y~aPE~~~~  267 (397)
T 1wak_A          190 LAAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKH--FTEDIQTRQYRSLEVLIG  267 (397)
T ss_dssp             HHHHHC---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTBC--SCSCCSCGGGCCHHHHHT
T ss_pred             hhhhhHHHhhcCCCCCCCCccccCCcccccccccccccccccccceEecccccccccccc--CccCCCCCcccCChhhcC
Confidence                                                        7999999999876543  455678999999999999


Q ss_pred             CCCCChhhHHHHHHHHHHHHcCCCCCCCCCH------HHHHHHHHhc-cC------------------------------
Q 015868          288 KPYDYKADVFSFGIALWELLTGELPYAGLTP------LQAAVGVVQK-SL------------------------------  330 (399)
Q Consensus       288 ~~~~~~~Dv~slG~vl~elltg~~P~~~~~~------~~~~~~~~~~-~~------------------------------  330 (399)
                      ..++.++|||||||++|+|++|..||...+.      .......... +.                              
T Consensus       268 ~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  347 (397)
T 1wak_A          268 SGYNTPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLIVAGKYSKEFFTKKGDLKHITKLKP  347 (397)
T ss_dssp             SCCCTHHHHHHHHHHHHHHHHSSCSCCCCCCSSSCHHHHHHHHHHHHHCSCCHHHHHHCTTGGGTBCTTSSBSSCCCCCC
T ss_pred             CCCCcHHHHHHHHHHHHHHhhCCCCCCCCcccccCchHHHHHHHHHhcCCCChHHhhcccccccccCCccccccccccCC
Confidence            9999999999999999999999999976542      1111111110 00                              


Q ss_pred             ---------CCCCCCCCcHHHHHHHHHHhhhcCCCCCCHHHHHH
Q 015868          331 ---------RPTIPKHAHPRLAELLERCWQHDPTQRPNFSQITD  365 (399)
Q Consensus       331 ---------~~~~~~~~~~~l~~ll~~cl~~dP~~Rps~~ell~  365 (399)
                               ....+...++++.+||.+||+.||++|||+.|+++
T Consensus       348 ~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~  391 (397)
T 1wak_A          348 WGLFEVLVEKYEWSQEEAAGFTDFLLPMLELIPEKRATAAECLR  391 (397)
T ss_dssp             CCHHHHHHHTSCCCHHHHHHHHHHHGGGGCSSGGGSCCHHHHHT
T ss_pred             cchhHhhhhhcccchhhHHHHHHHHHHHhccChhhcCCHHHHhh
Confidence                     00122345678999999999999999999999975

>3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group}

Probab=100.00  E-value=1.9e-43  Score=357.46  Aligned_cols=255  Identities=22%  Similarity=0.360  Sum_probs=214.6

Q ss_pred             ccccceeceeceeCceEEEEEEE--CCeeEEEEEecCCCCCHHHHHHHHHHHHHHHhcCC-CceeeEEeEEecCCcEEEE
Q 015868          115 AKQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRH-KNVVQFIGACTRPPNLCIV  191 (399)
Q Consensus       115 ~~~~~i~~~lg~G~~g~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~Ei~~l~~l~h-~nIv~~~~~~~~~~~~~lV  191 (399)
                      .++|++.++||+|+||.||+|++  .++.||||+++.....    ..+.+|+.+++.+.| ++++.+..++......++|
T Consensus         6 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~----~~~~~E~~il~~L~~~~~i~~i~~~~~~~~~~~lv   81 (483)
T 3sv0_A            6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKH----PQLLYESKIYRILQGGTGIPNVRWFGVEGDYNVLV   81 (483)
T ss_dssp             TTTEECCCCCEECSSCEEEEEEETTTCCEEEEEEEETTCSS----CCHHHHHHHHHHTTTSTTCCCEEEEEEETTEEEEE
T ss_pred             CCcEEEEEEEeeCCCEEEEEEEECCCCcEEEEEEecccccc----HHHHHHHHHHHHhcCCCCCCeEEEEEeeCCEEEEE
Confidence            57899999999999999999997  4889999998754322    347789999999987 6666777777888889999


Q ss_pred             EecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceee---cCCCcEEEeeccceeeccCCC
Q 015868          192 TEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLM---DENGVVKVADFGVARVQAQSG  268 (399)
Q Consensus       192 ~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~giiHrDlkp~NILl---~~~~~vkl~DFG~a~~~~~~~  268 (399)
                      |||+ +++|.+++......+++..++.++.||+.||.|||++||+||||||+|||+   +.++.+||+|||+++......
T Consensus        82 me~~-g~sL~~ll~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~~  160 (483)
T 3sv0_A           82 MDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTS  160 (483)
T ss_dssp             EECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECCGGGTTCEEECCCTTCEECBCTT
T ss_pred             EECC-CCCHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccCcceEEEecCCCCCeEEEEeCCcceeccCCc
Confidence            9999 889999998777889999999999999999999999999999999999999   588999999999998765432


Q ss_pred             c--------cccCCCCcccccccccCCCCCCChhhHHHHHHHHHHHHcCCCCCCCCCH---HHHHHHHHhccCC---CCC
Q 015868          269 V--------MTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPYAGLTP---LQAAVGVVQKSLR---PTI  334 (399)
Q Consensus       269 ~--------~~~~~gt~~y~aPE~l~~~~~~~~~Dv~slG~vl~elltg~~P~~~~~~---~~~~~~~~~~~~~---~~~  334 (399)
                      .        .....||..|+|||.+.+..++.++|||||||++|+|++|+.||.+...   .+....+......   ..+
T Consensus       161 ~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l  240 (483)
T 3sv0_A          161 THQHIPYRENKNLTGTARYASVNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVATSIEAL  240 (483)
T ss_dssp             TCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSHHHHHHHHHHHHHHSCHHHH
T ss_pred             cccccccccccccCCCccccCHHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccchhHHHHHHHHhhccccccHHHH
Confidence            2        1245789999999999999999999999999999999999999987543   2222222222111   122


Q ss_pred             CCCCcHHHHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHH
Q 015868          335 PKHAHPRLAELLERCWQHDPTQRPNFSQITDILKQMMKEV  374 (399)
Q Consensus       335 ~~~~~~~l~~ll~~cl~~dP~~Rps~~ell~~L~~l~~~~  374 (399)
                      +..+++++.++|.+||+.+|++||++.+|++.|++++...
T Consensus       241 ~~~~p~~l~~li~~cl~~dP~~RPs~~el~~~L~~l~~~~  280 (483)
T 3sv0_A          241 CRGYPTEFASYFHYCRSLRFDDKPDYSYLKRLFRDLFIRE  280 (483)
T ss_dssp             HTTSCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHHT
T ss_pred             hcCCcHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHHc
Confidence            3568899999999999999999999999999999997643

>1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A

Probab=100.00  E-value=7.1e-44  Score=337.29  Aligned_cols=245  Identities=26%  Similarity=0.465  Sum_probs=200.3

Q ss_pred             ccccceeceeceeCceEEEEEEE--CCeeEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCceeeEEeEEec--------
Q 015868          115 AKQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTR--------  184 (399)
Q Consensus       115 ~~~~~i~~~lg~G~~g~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~nIv~~~~~~~~--------  184 (399)
                      .++|++.+.||+|+||.||+|+.  .++.||+|+++.   .....+.+.+|+.++++++||||+++++++..        
T Consensus         5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~---~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~   81 (303)
T 1zy4_A            5 ASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRH---TEEKLSTILSEVMLLASLNHQYVVRYYAAWLERRNFVKPM   81 (303)
T ss_dssp             HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEE---EHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEECCCCCC--
T ss_pred             cccchhhheeccCCcEEEEEEEEcCCCeEEEEEEEec---cHHHHHHHHHHHHHHHhcCchHHHHHHHHHHhhcchhhhh
Confidence            35799999999999999999997  578999999964   34556789999999999999999999998864        


Q ss_pred             -----CCcEEEEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceeecCCCcEEEeecc
Q 015868          185 -----PPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFG  259 (399)
Q Consensus       185 -----~~~~~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~giiHrDlkp~NILl~~~~~vkl~DFG  259 (399)
                           ....++||||+++++|.+++......+++..++.++.|++.||.|||++||+||||||+||+++.++.+||+|||
T Consensus        82 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dlkp~Nil~~~~~~~kl~dfg  161 (303)
T 1zy4_A           82 TAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWRLFRQILEALSYIHSQGIIHRDLKPMNIFIDESRNVKIGDFG  161 (303)
T ss_dssp             ----CEEEEEEEEECCCSCBHHHHHHHSCGGGCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECCCC
T ss_pred             cccccCCceEEEEecCCCCCHHHhhhccccccchHHHHHHHHHHHHHHHHHHhCCeecccCCHHhEEEcCCCCEEEeeCc
Confidence                 346899999999999999998766778899999999999999999999999999999999999999999999999


Q ss_pred             ceeeccCC---------------CccccCCCCcccccccccCCC-CCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHH
Q 015868          260 VARVQAQS---------------GVMTAETGTYRWMAPEVIEHK-PYDYKADVFSFGIALWELLTGELPYAGLTPLQAAV  323 (399)
Q Consensus       260 ~a~~~~~~---------------~~~~~~~gt~~y~aPE~l~~~-~~~~~~Dv~slG~vl~elltg~~P~~~~~~~~~~~  323 (399)
                      .++.....               .......||+.|+|||++.+. .++.++||||||+++|+|++   ||..........
T Consensus       162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~---p~~~~~~~~~~~  238 (303)
T 1zy4_A          162 LAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY---PFSTGMERVNIL  238 (303)
T ss_dssp             CCSCTTC-------------------------CTTSCHHHHTSCSCCCTHHHHHHHHHHHHHHHS---CCSSHHHHHHHH
T ss_pred             chhhcccccchhccccccccccccccccCCCcccccCcccccCCCCCcchhhHHHHHHHHHHHHh---ccCCchhHHHHH
Confidence            99765421               122345689999999999865 68999999999999999998   554322222222


Q ss_pred             HHHh---ccCCCCCCCCCcHHHHHHHHHHhhhcCCCCCCHHHHHH
Q 015868          324 GVVQ---KSLRPTIPKHAHPRLAELLERCWQHDPTQRPNFSQITD  365 (399)
Q Consensus       324 ~~~~---~~~~~~~~~~~~~~l~~ll~~cl~~dP~~Rps~~ell~  365 (399)
                      ..+.   ....+..+...++.+.+++.+||+.||.+|||+.++++
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~  283 (303)
T 1zy4_A          239 KKLRSVSIEFPPDFDDNKMKVEKKIIRLLIDHDPNKRPGARTLLN  283 (303)
T ss_dssp             HHHHSTTCCCCTTCCTTTSHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             HhccccccccCccccccchHHHHHHHHHHHhcCcccCcCHHHHhC
Confidence            2222   12334455677889999999999999999999999975

>2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens}

Probab=100.00  E-value=2.3e-43  Score=336.63  Aligned_cols=246  Identities=23%  Similarity=0.395  Sum_probs=201.8

Q ss_pred             ccccceeceeceeCceEEEEEEEC--CeeEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCceeeEEeEEe---------
Q 015868          115 AKQLKIECKVASGSYGDLYKGTYC--SQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACT---------  183 (399)
Q Consensus       115 ~~~~~i~~~lg~G~~g~Vy~~~~~--~~~vAvK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~nIv~~~~~~~---------  183 (399)
                      .++|++.+.||+|+||.||+|.+.  ++.||+|++...  +....+.+.+|+.++++++||||+++++++.         
T Consensus        10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~   87 (320)
T 2i6l_A           10 GSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLT--DPQSVKHALREIKIIRRLDHDNIVKVFEILGPSGSQLTDD   87 (320)
T ss_dssp             TTTEEEEEECC-----CEEEEEETTTTEEEEEEEEECC--SHHHHHHHHHHHHHHHTCCCTTBCCEEEEECTTSCBCCC-
T ss_pred             CCceeEEEEeccCCCeEEEEEEECCCCeEEEEEEEecC--ChHHHHHHHHHHHHHHhcCCCCeeEEEEeccccccccccc
Confidence            578999999999999999999984  789999999765  4666788999999999999999999999874         


Q ss_pred             -----cCCcEEEEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceeec-CCCcEEEee
Q 015868          184 -----RPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMD-ENGVVKVAD  257 (399)
Q Consensus       184 -----~~~~~~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~giiHrDlkp~NILl~-~~~~vkl~D  257 (399)
                           .....++||||+.| +|.+++..  +.+++..++.++.|++.||+|||++||+||||||+||+++ +++.+||+|
T Consensus        88 ~~~~~~~~~~~lv~e~~~~-~L~~~~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~kl~D  164 (320)
T 2i6l_A           88 VGSLTELNSVYIVQEYMET-DLANVLEQ--GPLLEEHARLFMYQLLRGLKYIHSANVLHRDLKPANLFINTEDLVLKIGD  164 (320)
T ss_dssp             ---CCSCSEEEEEEECCSE-EHHHHHTT--CCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEETTTTEEEECC
T ss_pred             cccccccCceeEEeeccCC-CHHHHhhc--CCccHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCeEEEcc
Confidence                 34678999999985 99999854  5689999999999999999999999999999999999997 567999999


Q ss_pred             ccceeeccCC----CccccCCCCcccccccccCC-CCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhccC--
Q 015868          258 FGVARVQAQS----GVMTAETGTYRWMAPEVIEH-KPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKSL--  330 (399)
Q Consensus       258 FG~a~~~~~~----~~~~~~~gt~~y~aPE~l~~-~~~~~~~Dv~slG~vl~elltg~~P~~~~~~~~~~~~~~~~~~--  330 (399)
                      ||.++.....    .......++..|+|||.+.+ ..++.++||||||+++|+|++|+.||.+.+..+..........  
T Consensus       165 fg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~  244 (320)
T 2i6l_A          165 FGLARIMDPHYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHELEQMQLILESIPVV  244 (320)
T ss_dssp             CTTCBCC--------CCCGGGSCCTTCCHHHHHCTTCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHSCCC
T ss_pred             CccccccCCCcccccccccccccccccCcHHhcCcccCCchhhhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCC
Confidence            9999865432    12334457899999998865 6789999999999999999999999998887665544432210  


Q ss_pred             ---------------------CC-----CCCCCCcHHHHHHHHHHhhhcCCCCCCHHHHHH
Q 015868          331 ---------------------RP-----TIPKHAHPRLAELLERCWQHDPTQRPNFSQITD  365 (399)
Q Consensus       331 ---------------------~~-----~~~~~~~~~l~~ll~~cl~~dP~~Rps~~ell~  365 (399)
                                           .+     ..+..+++++.++|.+||+.||.+|||+.|+++
T Consensus       245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~  305 (320)
T 2i6l_A          245 HEEDRQELLSVIPVYIRNDMTEPHKPLTQLLPGISREAVDFLEQILTFSPMDRLTAEEALS  305 (320)
T ss_dssp             CHHHHHHHHTTSCHHHHHHTTSCCCCHHHHSTTCCHHHHHHHHTTSCSSGGGSCCHHHHHT
T ss_pred             chhhhhhhhhcCcccccccccCCCCChhHhcchhhHHHHHHHHHHcCCCccccCCHHHHhC
Confidence                                 01     112468899999999999999999999999976

>3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major}

Probab=100.00  E-value=1.2e-43  Score=345.04  Aligned_cols=250  Identities=21%  Similarity=0.245  Sum_probs=198.0

Q ss_pred             eecccccceeceeceeCceEEEEEEEC--CeeEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCceeeEEeEEecCCc--
Q 015868          112 EIDAKQLKIECKVASGSYGDLYKGTYC--SQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPN--  187 (399)
Q Consensus       112 ~i~~~~~~i~~~lg~G~~g~Vy~~~~~--~~~vAvK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~nIv~~~~~~~~~~~--  187 (399)
                      ....++|++.+.||+|+||.||+|++.  ++.||||++......   ...+.+|+..++.++||||+++++++.....  
T Consensus        19 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~---~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~~   95 (360)
T 3e3p_A           19 RKEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPRF---RNRELQIMQDLAVLHHPNIVQLQSYFYTLGERD   95 (360)
T ss_dssp             HHHHTTEEEC----------CEEEEETTTCCEEEEEEEECCTTC---CCHHHHHHHHHHHHCCTTBCCEEEEEEEECSSC
T ss_pred             hhhccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEecCccc---cHHHHHHHHHHHhcCCCCcccHHHhhhcccccc
Confidence            445679999999999999999999984  789999998654222   2355678888899999999999999965433  


Q ss_pred             -----EEEEEecCCCCCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHH--HCCcccCCCCCCceeecC-CCcEEEe
Q 015868          188 -----LCIVTEFMARGSIYDFLHK---QKGVFQLTSLLKVAIDVSKGMNYLH--QNNIIHRDLKTANLLMDE-NGVVKVA  256 (399)
Q Consensus       188 -----~~lV~E~~~ggsL~~~l~~---~~~~l~~~~~~~i~~~i~~~L~~LH--~~giiHrDlkp~NILl~~-~~~vkl~  256 (399)
                           +++||||+++ +|.+.+..   ....+++..++.++.|++.||.|||  ++||+||||||+|||++. ++.+||+
T Consensus        96 ~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~ivH~Dlkp~NIll~~~~~~~kl~  174 (360)
T 3e3p_A           96 RRDIYLNVVMEYVPD-TLHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLPSVNVCHRDIKPHNVLVNEADGTLKLC  174 (360)
T ss_dssp             TTCEEEEEEEECCSC-BHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHTSTTTCCBCSCCCGGGEEEETTTTEEEEC
T ss_pred             ccceeEEEEeecccc-cHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhCCCCCeecCcCCHHHEEEeCCCCcEEEe
Confidence                 8899999987 66555432   4567899999999999999999999  999999999999999996 8999999


Q ss_pred             eccceeeccCCCccccCCCCcccccccccCCC-CCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhccC-----
Q 015868          257 DFGVARVQAQSGVMTAETGTYRWMAPEVIEHK-PYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKSL-----  330 (399)
Q Consensus       257 DFG~a~~~~~~~~~~~~~gt~~y~aPE~l~~~-~~~~~~Dv~slG~vl~elltg~~P~~~~~~~~~~~~~~~~~~-----  330 (399)
                      |||+++............||+.|+|||++.+. .++.++||||||+++|+|++|+.||.+.+.............     
T Consensus       175 Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~  254 (360)
T 3e3p_A          175 DFGSAKKLSPSEPNVAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSAGQLHEIVRVLGCPSRE  254 (360)
T ss_dssp             CCTTCBCCCTTSCCCSTTSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHH
T ss_pred             eCCCceecCCCCCcccccCCcceeCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCcCCCChHHHHHHHHHHcCCCCHH
Confidence            99999877666556667899999999999765 489999999999999999999999999887766655543211     


Q ss_pred             -------------------------CCCCCCCCcHHHHHHHHHHhhhcCCCCCCHHHHHH
Q 015868          331 -------------------------RPTIPKHAHPRLAELLERCWQHDPTQRPNFSQITD  365 (399)
Q Consensus       331 -------------------------~~~~~~~~~~~l~~ll~~cl~~dP~~Rps~~ell~  365 (399)
                                               .+..+...++++.+||.+||+.||.+|||+.|+++
T Consensus       255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~  314 (360)
T 3e3p_A          255 VLRKLNPSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLPEERMKPYEALC  314 (360)
T ss_dssp             HHHHHCTTCCCGGGGCCCCCCHHHHTTTCCCTTHHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred             HHHhcccchhhccccccccCCcccccchhhccccHHHHHHHHHHhccCccccCCHHHHhc
Confidence                                     11223346789999999999999999999999975

>2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A*

Probab=100.00  E-value=2.5e-42  Score=334.17  Aligned_cols=247  Identities=23%  Similarity=0.379  Sum_probs=206.4

Q ss_pred             ecccccceeceeceeCceEEEEEEEC--C-eeEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCc------eeeEEeEEe
Q 015868          113 IDAKQLKIECKVASGSYGDLYKGTYC--S-QEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKN------VVQFIGACT  183 (399)
Q Consensus       113 i~~~~~~i~~~lg~G~~g~Vy~~~~~--~-~~vAvK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~n------Iv~~~~~~~  183 (399)
                      .-.++|++.+.||+|+||.||+|.+.  + +.||+|+++..   ....+.+.+|+.+++.++|++      ++.+++++.
T Consensus        16 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~   92 (355)
T 2eu9_A           16 WLQERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNV---GKYREAARLEINVLKKIKEKDKENKFLCVLMSDWFN   92 (355)
T ss_dssp             EETTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSC---HHHHHHHHHHHHHHHHHHHHCTTSCSCBCCEEEEEE
T ss_pred             eecccEEEEEEeeccCCeEEEEEEecCCCceEEEEEEEccc---ccchhHHHHHHHHHHHHhhcCCCCceeEEEeeeeee
Confidence            34679999999999999999999873  3 68999999753   455678889999999998766      999999999


Q ss_pred             cCCcEEEEEecCCCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceee---------------
Q 015868          184 RPPNLCIVTEFMARGSIYDFLHKQK-GVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLM---------------  247 (399)
Q Consensus       184 ~~~~~~lV~E~~~ggsL~~~l~~~~-~~l~~~~~~~i~~~i~~~L~~LH~~giiHrDlkp~NILl---------------  247 (399)
                      ..+..++||||+ ++++.+++.... ..+++..++.++.||+.||.|||++||+||||||+|||+               
T Consensus        93 ~~~~~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~ivH~Dlkp~NIll~~~~~~~~~~~~~~~  171 (355)
T 2eu9_A           93 FHGHMCIAFELL-GKNTFEFLKENNFQPYPLPHVRHMAYQLCHALRFLHENQLTHTDLKPENILFVNSEFETLYNEHKSC  171 (355)
T ss_dssp             ETTEEEEEEECC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEESCCCEEEEECCC-CC
T ss_pred             eCCeEEEEEecc-CCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEecccccccccccccc
Confidence            999999999999 557777776543 579999999999999999999999999999999999999               


Q ss_pred             ----cCCCcEEEeeccceeeccCCCccccCCCCcccccccccCCCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHH
Q 015868          248 ----DENGVVKVADFGVARVQAQSGVMTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAV  323 (399)
Q Consensus       248 ----~~~~~vkl~DFG~a~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~Dv~slG~vl~elltg~~P~~~~~~~~~~~  323 (399)
                          +.++.+||+|||+++.....  .....||+.|+|||++.+..++.++||||||+++|+|++|..||...+..+...
T Consensus       172 ~~~~~~~~~~kl~Dfg~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~  249 (355)
T 2eu9_A          172 EEKSVKNTSIRVADFGSATFDHEH--HTTIVATRHYRPPEVILELGWAQPCDVWSIGCILFEYYRGFTLFQTHENREHLV  249 (355)
T ss_dssp             CEEEESCCCEEECCCTTCEETTSC--CCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHH
T ss_pred             cccccCCCcEEEeecCcccccccc--ccCCcCCCcccCCeeeecCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHH
Confidence                56789999999999865432  345679999999999999999999999999999999999999999887665443


Q ss_pred             HHHhccCC-C-----------------------------------------CCCCCCcHHHHHHHHHHhhhcCCCCCCHH
Q 015868          324 GVVQKSLR-P-----------------------------------------TIPKHAHPRLAELLERCWQHDPTQRPNFS  361 (399)
Q Consensus       324 ~~~~~~~~-~-----------------------------------------~~~~~~~~~l~~ll~~cl~~dP~~Rps~~  361 (399)
                      ........ |                                         ......++++.+||.+||+.||.+|||+.
T Consensus       250 ~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~  329 (355)
T 2eu9_A          250 MMEKILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYMLQDSLEHVQLFDLMRRMLEFDPAQRITLA  329 (355)
T ss_dssp             HHHHHHCCCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTTTSCCHH
T ss_pred             HHHHHcCCCcHHHhhhccchhhhcccccccccccchhccccccCCcccccccccchhHHHHHHHHHHHhcCChhhCcCHH
Confidence            32221100 0                                         01122356899999999999999999999


Q ss_pred             HHHH
Q 015868          362 QITD  365 (399)
Q Consensus       362 ell~  365 (399)
                      |+++
T Consensus       330 e~l~  333 (355)
T 2eu9_A          330 EALL  333 (355)
T ss_dssp             HHTT
T ss_pred             HHhc
Confidence            9974

>2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A*

Probab=100.00  E-value=2e-42  Score=340.19  Aligned_cols=245  Identities=25%  Similarity=0.398  Sum_probs=206.2

Q ss_pred             ccccceeceeceeCceEEEEEEE--CCeeEEEEEecCCCCCHHHHHHHHHHHHHHHhcC-CC-----ceeeEEeEEecCC
Q 015868          115 AKQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIR-HK-----NVVQFIGACTRPP  186 (399)
Q Consensus       115 ~~~~~i~~~lg~G~~g~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~Ei~~l~~l~-h~-----nIv~~~~~~~~~~  186 (399)
                      .++|++.+.||+|+||.||+|.+  .++.||||+++..   ......+.+|+.+++.++ |+     +|+++++++....
T Consensus        53 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~---~~~~~~~~~e~~~l~~l~~~~~~~~~~iv~~~~~~~~~~  129 (382)
T 2vx3_A           53 MDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNK---KAFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRHFMFRN  129 (382)
T ss_dssp             TTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSS---HHHHHHHHHHHHHHHHHHHCSSGGGGGBCCEEEEEEETT
T ss_pred             eeeEEEEEEEeecCCEEEEEEEEcCCCcEEEEEEEecc---HHHHHHHHHHHHHHHHHHhcccccceeEEEeeeeeccCC
Confidence            57999999999999999999987  4788999999853   455677888999998885 44     4999999999999


Q ss_pred             cEEEEEecCCCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHH--HCCcccCCCCCCceeec--CCCcEEEeeccce
Q 015868          187 NLCIVTEFMARGSIYDFLHKQK-GVFQLTSLLKVAIDVSKGMNYLH--QNNIIHRDLKTANLLMD--ENGVVKVADFGVA  261 (399)
Q Consensus       187 ~~~lV~E~~~ggsL~~~l~~~~-~~l~~~~~~~i~~~i~~~L~~LH--~~giiHrDlkp~NILl~--~~~~vkl~DFG~a  261 (399)
                      ..|+||||+++ +|.+++.... ..+++..+..++.|++.||.|||  +.||+||||||+|||++  .++.+||+|||++
T Consensus       130 ~~~lv~e~~~~-~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivHrDlkp~NIll~~~~~~~~kL~DFG~a  208 (382)
T 2vx3_A          130 HLCLVFEMLSY-NLYDLLRNTNFRGVSLNLTRKFAQQMCTALLFLATPELSIIHCDLKPENILLCNPKRSAIKIVDFGSS  208 (382)
T ss_dssp             EEEEEEECCCC-BHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHTSTTTCEECCCCSGGGEEESSTTSCCEEECCCTTC
T ss_pred             ceEEEEecCCC-CHHHHHhhcCcCCCCHHHHHHHHHHHHHHHHHhccCCCCEEcCCCCcccEEEecCCCCcEEEEeccCc
Confidence            99999999965 9999998754 56999999999999999999999  57999999999999995  4788999999999


Q ss_pred             eeccCCCccccCCCCcccccccccCCCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhccCCCC--------
Q 015868          262 RVQAQSGVMTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKSLRPT--------  333 (399)
Q Consensus       262 ~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~Dv~slG~vl~elltg~~P~~~~~~~~~~~~~~~~~~~~~--------  333 (399)
                      +.....  .....||+.|+|||++.+..++.++|||||||++|+|+||+.||.+.+..+....+......+.        
T Consensus       209 ~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~  286 (382)
T 2vx3_A          209 CQLGQR--IYQYIQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGEPLFSGANEVDQMNKIVEVLGIPPAHILDQAP  286 (382)
T ss_dssp             EETTCC--CCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHHHTTCT
T ss_pred             eecccc--cccccCCccccChHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhhH
Confidence            876432  3456789999999999999999999999999999999999999999887766555443211100        


Q ss_pred             --------CC------------------C----------------------------CCcHHHHHHHHHHhhhcCCCCCC
Q 015868          334 --------IP------------------K----------------------------HAHPRLAELLERCWQHDPTQRPN  359 (399)
Q Consensus       334 --------~~------------------~----------------------------~~~~~l~~ll~~cl~~dP~~Rps  359 (399)
                              ++                  .                            ..++++.+||.+||+.||++|||
T Consensus       287 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~Rpt  366 (382)
T 2vx3_A          287 KARKFFEKLPDGTWNLKKTKDGKREYKPPGTRKLHNILGVETGGPGGRRAGESGHTVADYLKFKDLILRMLDYDPKTRIQ  366 (382)
T ss_dssp             THHHHEEECTTSCEEECCCCTTCCCSCCTTCSCHHHHHTTTTTSGGGTTTTCTTCCHHHHHHHHHHHHHHTCSCTTTSCC
T ss_pred             HHHHHHHhccccccccccccccccccCCcchhhHHHHhhccccCCCccccccccccchhhHHHHHHHHHhcCCChhhCCC
Confidence                    00                  0                            01147899999999999999999


Q ss_pred             HHHHHH
Q 015868          360 FSQITD  365 (399)
Q Consensus       360 ~~ell~  365 (399)
                      +.|+++
T Consensus       367 a~e~L~  372 (382)
T 2vx3_A          367 PYYALQ  372 (382)
T ss_dssp             HHHHTT
T ss_pred             HHHHhc
Confidence            999875

>3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens}

Probab=100.00  E-value=7.1e-43  Score=346.02  Aligned_cols=245  Identities=23%  Similarity=0.391  Sum_probs=184.5

Q ss_pred             cccce-eceeceeCceEEEEEEEC----CeeEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCceeeEEeEEe--cCCcE
Q 015868          116 KQLKI-ECKVASGSYGDLYKGTYC----SQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACT--RPPNL  188 (399)
Q Consensus       116 ~~~~i-~~~lg~G~~g~Vy~~~~~----~~~vAvK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~nIv~~~~~~~--~~~~~  188 (399)
                      +.|.+ .++||+|+||.||+|++.    ++.||+|+++.....    ..+.+|+.+|++++||||+++++++.  ....+
T Consensus        20 ~~y~~~g~~lG~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~~~----~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~   95 (405)
T 3rgf_A           20 DLFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGIS----MSACREIALLRELKHPNVISLQKVFLSHADRKV   95 (405)
T ss_dssp             HHEECSSCCCC-----EEEEEEESSSSCCCCEEEEECSSSSCC----HHHHHHHHHHHHCCCTTBCCCCEEEEETTTTEE
T ss_pred             hhhhhcCcEeeecCCeEEEEEEEccCCCCeEEEEEEECCCCCC----HHHHHHHHHHHhcCCCCeeeEeeEEecCCCCeE
Confidence            45666 458999999999999964    678999999865433    35778999999999999999999994  46789


Q ss_pred             EEEEecCCCCCHHHHHHhc--------CCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceee----cCCCcEEEe
Q 015868          189 CIVTEFMARGSIYDFLHKQ--------KGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLM----DENGVVKVA  256 (399)
Q Consensus       189 ~lV~E~~~ggsL~~~l~~~--------~~~l~~~~~~~i~~~i~~~L~~LH~~giiHrDlkp~NILl----~~~~~vkl~  256 (399)
                      ++||||+.+ +|.+++...        ...+++..++.++.||+.||.|||++||+||||||+|||+    +.++.+||+
T Consensus        96 ~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~kl~  174 (405)
T 3rgf_A           96 WLLFDYAEH-DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIA  174 (405)
T ss_dssp             EEEEECCSE-EHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECCSSTTTTCEEEC
T ss_pred             EEEEeCCCC-CHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCEeCCCcCHHHeEEecCCCCCCcEEEE
Confidence            999999975 888887532        1258999999999999999999999999999999999999    678899999


Q ss_pred             eccceeeccCC----CccccCCCCcccccccccCCC-CCCChhhHHHHHHHHHHHHcCCCCCCCCCHH---------HHH
Q 015868          257 DFGVARVQAQS----GVMTAETGTYRWMAPEVIEHK-PYDYKADVFSFGIALWELLTGELPYAGLTPL---------QAA  322 (399)
Q Consensus       257 DFG~a~~~~~~----~~~~~~~gt~~y~aPE~l~~~-~~~~~~Dv~slG~vl~elltg~~P~~~~~~~---------~~~  322 (399)
                      |||+++.....    .......||+.|+|||++.+. .++.++|||||||++|+|++|..||.+....         ...
T Consensus       175 Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~l  254 (405)
T 3rgf_A          175 DMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQL  254 (405)
T ss_dssp             CTTCCC----------------CCCTTCCHHHHTTCCSCCHHHHHHHHHHHHHHHHHSSCTTCCCC------CCCCHHHH
T ss_pred             ECCCceecCCCCcccccCCCceecCcccCchhhcCCCcccchhhhHHHHHHHHHHHhCCCCCCCccccccccccchHHHH
Confidence            99999865432    223445789999999999874 5899999999999999999999999765432         112


Q ss_pred             HHHHhccCCCC------------------------------------CCCCCcHHHHHHHHHHhhhcCCCCCCHHHHHH
Q 015868          323 VGVVQKSLRPT------------------------------------IPKHAHPRLAELLERCWQHDPTQRPNFSQITD  365 (399)
Q Consensus       323 ~~~~~~~~~~~------------------------------------~~~~~~~~l~~ll~~cl~~dP~~Rps~~ell~  365 (399)
                      ..+......|.                                    .....++++.+||.+||+.||.+|||++|+++
T Consensus       255 ~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ll~~~L~~dP~~R~ta~e~L~  333 (405)
T 3rgf_A          255 DRIFNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITSEQAMQ  333 (405)
T ss_dssp             HHHHHHHCCCCTTTCGGGGGSTTHHHHHHHCCGGGGTTCCHHHHHHTTTCCTTSHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             HHHHHhhCCCChhhcchhhcCcchhhhhhhccccCCCcchhhhhHhhcCCCCCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence            11111110000                                    01122678999999999999999999999976

>3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ...

Probab=100.00  E-value=1.8e-43  Score=339.35  Aligned_cols=246  Identities=24%  Similarity=0.445  Sum_probs=207.8

Q ss_pred             ceeecccccceeceeceeCceEEEEEEE--CCeeEEEEEecCCCCCH----HHHHHHHHHHHHHHhcC--CCceeeEEeE
Q 015868          110 VWEIDAKQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVNT----EMLKEFSQEVYIMRKIR--HKNVVQFIGA  181 (399)
Q Consensus       110 ~~~i~~~~~~i~~~lg~G~~g~Vy~~~~--~~~~vAvK~~~~~~~~~----~~~~~~~~Ei~~l~~l~--h~nIv~~~~~  181 (399)
                      ..+...++|++.+.||+|+||.||+|.+  .++.||||+++......    .....+.+|+.++++++  |+||++++++
T Consensus        37 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~i~~~~~~  116 (320)
T 3a99_A           37 EKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDW  116 (320)
T ss_dssp             ---CCTTTEEEEEECSSSSSCEEEEEEETTTTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEE
T ss_pred             ccCCccCceEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCCCceEEEEE
Confidence            3455678999999999999999999987  67899999997543221    12245678999999996  5999999999


Q ss_pred             EecCCcEEEEEecCCC-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceeec-CCCcEEEeecc
Q 015868          182 CTRPPNLCIVTEFMAR-GSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMD-ENGVVKVADFG  259 (399)
Q Consensus       182 ~~~~~~~~lV~E~~~g-gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~giiHrDlkp~NILl~-~~~~vkl~DFG  259 (399)
                      +..+...++|||++.+ ++|.+++.. .+.+++..++.++.||+.||.|||++||+||||||+||+++ +++.+||+|||
T Consensus       117 ~~~~~~~~lv~e~~~~~~~L~~~l~~-~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~~kL~Dfg  195 (320)
T 3a99_A          117 FERPDSFVLILERPEPVQDLFDFITE-RGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFG  195 (320)
T ss_dssp             EECSSEEEEEEECCSSEEEHHHHHHH-HCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTTEEEECCCT
T ss_pred             EecCCcEEEEEEcCCCCccHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHHHCCcEeCCCCHHHEEEeCCCCCEEEeeCc
Confidence            9999999999999976 899999976 46789999999999999999999999999999999999999 78999999999


Q ss_pred             ceeeccCCCccccCCCCcccccccccCCCCC-CChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhccCCCCCCCCC
Q 015868          260 VARVQAQSGVMTAETGTYRWMAPEVIEHKPY-DYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKSLRPTIPKHA  338 (399)
Q Consensus       260 ~a~~~~~~~~~~~~~gt~~y~aPE~l~~~~~-~~~~Dv~slG~vl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~  338 (399)
                      +++..... ......||+.|+|||++.+..+ +.++||||||+++|+|++|+.||.....      ...  .....+..+
T Consensus       196 ~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~------~~~--~~~~~~~~~  266 (320)
T 3a99_A          196 SGALLKDT-VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEE------IIR--GQVFFRQRV  266 (320)
T ss_dssp             TCEECCSS-CBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHH------HHH--CCCCCSSCC
T ss_pred             cccccccc-cccCCCCCccCCChHHhccCCCCCccchHHhHHHHHHHHHHCCCCCCChhh------hhc--ccccccccC
Confidence            99876543 3445678999999999987765 6789999999999999999999976321      111  123456778


Q ss_pred             cHHHHHHHHHHhhhcCCCCCCHHHHHH
Q 015868          339 HPRLAELLERCWQHDPTQRPNFSQITD  365 (399)
Q Consensus       339 ~~~l~~ll~~cl~~dP~~Rps~~ell~  365 (399)
                      ++++.++|.+||+.||++|||++|+++
T Consensus       267 ~~~~~~li~~~l~~dp~~Rps~~~ll~  293 (320)
T 3a99_A          267 SSECQHLIRWCLALRPSDRPTFEEIQN  293 (320)
T ss_dssp             CHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             CHHHHHHHHHHccCChhhCcCHHHHhc
Confidence            999999999999999999999999976

>2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens}

Probab=100.00  E-value=3.9e-43  Score=335.05  Aligned_cols=245  Identities=24%  Similarity=0.438  Sum_probs=200.0

Q ss_pred             eeecccccceeceeceeCceEEEEEEE--CCeeEEEEEecCCCCCH----HHHHHHHHHHHHHHhc----CCCceeeEEe
Q 015868          111 WEIDAKQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVNT----EMLKEFSQEVYIMRKI----RHKNVVQFIG  180 (399)
Q Consensus       111 ~~i~~~~~~i~~~lg~G~~g~Vy~~~~--~~~~vAvK~~~~~~~~~----~~~~~~~~Ei~~l~~l----~h~nIv~~~~  180 (399)
                      .+.-.++|++.+.||+|+||.||+|.+  .++.||+|+++......    .....+.+|+.+++++    +||||+++++
T Consensus        26 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~~i~~~~~  105 (312)
T 2iwi_A           26 REAFEAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLLD  105 (312)
T ss_dssp             -------CEEEEEEEEETTEEEEEEECTTTCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCSSBCCEEE
T ss_pred             hhhhhhceEEeeEEEcCCCEEEEEEEEccCCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCCCeeeEEE
Confidence            345567999999999999999999987  57899999997654322    2234567799999999    8999999999


Q ss_pred             EEecCCcEEEEEec-CCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceeec-CCCcEEEeec
Q 015868          181 ACTRPPNLCIVTEF-MARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMD-ENGVVKVADF  258 (399)
Q Consensus       181 ~~~~~~~~~lV~E~-~~ggsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~giiHrDlkp~NILl~-~~~~vkl~DF  258 (399)
                      ++......++|||+ +.+++|.+++.. .+.+++..++.++.||+.||.|||++||+||||||+||+++ .++.+||+||
T Consensus       106 ~~~~~~~~~~v~e~~~~~~~L~~~l~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~kl~df  184 (312)
T 2iwi_A          106 WFETQEGFMLVLERPLPAQDLFDYITE-KGPLGEGPSRCFFGQVVAAIQHCHSRGVVHRDIKDENILIDLRRGCAKLIDF  184 (312)
T ss_dssp             EC-----CEEEEECCSSEEEHHHHHHH-HCSCCHHHHHHHHHHHHHHHHHHHHHTEECCCCSGGGEEEETTTTEEEECCC
T ss_pred             EEecCCeEEEEEEecCCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChhhEEEeCCCCeEEEEEc
Confidence            99998899999999 788999999976 45689999999999999999999999999999999999999 8899999999


Q ss_pred             cceeeccCCCccccCCCCcccccccccCCCCCC-ChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhccCCCCCCCC
Q 015868          259 GVARVQAQSGVMTAETGTYRWMAPEVIEHKPYD-YKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKSLRPTIPKH  337 (399)
Q Consensus       259 G~a~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~-~~~Dv~slG~vl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~  337 (399)
                      |+++..... ......|+..|+|||.+.+..+. .++||||||+++|+|++|+.||.....      ...  ....++..
T Consensus       185 g~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~------~~~--~~~~~~~~  255 (312)
T 2iwi_A          185 GSGALLHDE-PYTDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFERDQE------ILE--AELHFPAH  255 (312)
T ss_dssp             SSCEECCSS-CBCCCCSCTTTSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHH------HHH--TCCCCCTT
T ss_pred             chhhhcccC-cccccCCcccccCceeeecCCCCCccchHHHHHHHHHHHHHCCCCCCChHH------Hhh--hccCCccc
Confidence            999876543 34556789999999999877664 589999999999999999999975321      111  23456778


Q ss_pred             CcHHHHHHHHHHhhhcCCCCCCHHHHHH
Q 015868          338 AHPRLAELLERCWQHDPTQRPNFSQITD  365 (399)
Q Consensus       338 ~~~~l~~ll~~cl~~dP~~Rps~~ell~  365 (399)
                      +++++.++|.+||+.||++|||+.|+++
T Consensus       256 ~~~~~~~li~~~l~~~p~~Rps~~e~l~  283 (312)
T 2iwi_A          256 VSPDCCALIRRCLAPKPSSRPSLEEILL  283 (312)
T ss_dssp             SCHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred             CCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence            9999999999999999999999999976

>1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A

Probab=100.00  E-value=9.6e-43  Score=340.08  Aligned_cols=248  Identities=18%  Similarity=0.360  Sum_probs=203.2

Q ss_pred             eecccccceeceeceeCceEEEEEEE--CCeeEEEEEecCCCCCHHHHHHHHHHHHHHHhcC-----------CCceeeE
Q 015868          112 EIDAKQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIR-----------HKNVVQF  178 (399)
Q Consensus       112 ~i~~~~~~i~~~lg~G~~g~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~Ei~~l~~l~-----------h~nIv~~  178 (399)
                      .+..++|++.+.||+|+||.||+|++  .++.||||+++..   ......+.+|+.++++++           ||||+++
T Consensus        15 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~---~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~i~~~   91 (373)
T 1q8y_A           15 PYKDARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGD---KVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKL   91 (373)
T ss_dssp             EETTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC---HHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCC
T ss_pred             cccCCeEEEEEeeeecCCeEEEEEEecCCCcEEEEEEecCC---ccchhhhhHHHHHHHHhhcccccchhccccchHHHH
Confidence            45667999999999999999999997  6889999999753   445677889999999886           8999999


Q ss_pred             EeEEecCC----cEEEEEecCCCCCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHC-CcccCCCCCCceeec----
Q 015868          179 IGACTRPP----NLCIVTEFMARGSIYDFLHKQ-KGVFQLTSLLKVAIDVSKGMNYLHQN-NIIHRDLKTANLLMD----  248 (399)
Q Consensus       179 ~~~~~~~~----~~~lV~E~~~ggsL~~~l~~~-~~~l~~~~~~~i~~~i~~~L~~LH~~-giiHrDlkp~NILl~----  248 (399)
                      ++++....    .+++|||++ +++|.+++... ...+++..++.++.||+.||.|||++ ||+||||||+|||++    
T Consensus        92 ~~~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~~ivH~Dikp~NIll~~~~~  170 (373)
T 1q8y_A           92 LDHFNHKGPNGVHVVMVFEVL-GENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDS  170 (373)
T ss_dssp             CEEEEEEETTEEEEEEEECCC-CEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECSCCSGGGEEEEEEET
T ss_pred             HHHhhccCCCCceEEEEEecC-CCCHHHHHHHhhccCCcHHHHHHHHHHHHHHHHHHHhcCCEEecCCChHHeEEeccCC
Confidence            99987644    689999999 78999999764 35699999999999999999999998 999999999999994    


Q ss_pred             --CCCcEEEeeccceeeccCCCccccCCCCcccccccccCCCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHH------H
Q 015868          249 --ENGVVKVADFGVARVQAQSGVMTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPYAGLTPL------Q  320 (399)
Q Consensus       249 --~~~~vkl~DFG~a~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~Dv~slG~vl~elltg~~P~~~~~~~------~  320 (399)
                        ..+.+||+|||+++.....  .....||+.|+|||++.+..++.++||||||+++|+|++|..||...+..      .
T Consensus       171 ~~~~~~~kl~Dfg~a~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~  248 (373)
T 1q8y_A          171 PENLIQIKIADLGNACWYDEH--YTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDD  248 (373)
T ss_dssp             TTTEEEEEECCCTTCEETTBC--CCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------CHHH
T ss_pred             CcCcceEEEcccccccccCCC--CCCCCCCccccCcHHHhCCCCCchHhHHHHHHHHHHHHhCCCCCCCCcccccCChHH
Confidence              4458999999999876543  34557899999999999999999999999999999999999999865421      1


Q ss_pred             HHHHHHhc----------------------------------------cCCCCCCCCCcHHHHHHHHHHhhhcCCCCCCH
Q 015868          321 AAVGVVQK----------------------------------------SLRPTIPKHAHPRLAELLERCWQHDPTQRPNF  360 (399)
Q Consensus       321 ~~~~~~~~----------------------------------------~~~~~~~~~~~~~l~~ll~~cl~~dP~~Rps~  360 (399)
                      ........                                        .....++..+++++.+||.+||+.||.+|||+
T Consensus       249 ~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~  328 (373)
T 1q8y_A          249 HIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADA  328 (373)
T ss_dssp             HHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBCH
T ss_pred             HHHHHHHhcCCCCHHHHhccchhhhhcCCcchhcccccccccchhhhhhhcccCCcchHHHHHHHHHHHhccCccccCCH
Confidence            11111110                                        00112344567899999999999999999999


Q ss_pred             HHHHH
Q 015868          361 SQITD  365 (399)
Q Consensus       361 ~ell~  365 (399)
                      .|+++
T Consensus       329 ~ell~  333 (373)
T 1q8y_A          329 GGLVN  333 (373)
T ss_dssp             HHHHT
T ss_pred             HHHhh
Confidence            99977

>3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A*

Probab=100.00  E-value=1.4e-42  Score=335.53  Aligned_cols=244  Identities=22%  Similarity=0.356  Sum_probs=176.9

Q ss_pred             ccccceec-eeceeCceEEEEEEEC--CeeEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCceeeEEeEEec----CCc
Q 015868          115 AKQLKIEC-KVASGSYGDLYKGTYC--SQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTR----PPN  187 (399)
Q Consensus       115 ~~~~~i~~-~lg~G~~g~Vy~~~~~--~~~vAvK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~nIv~~~~~~~~----~~~  187 (399)
                      .++|++.+ .||+|+||.||+|.+.  ++.||||++...   ....   .+....++.++||||+++++++..    ...
T Consensus        27 ~~~y~i~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~---~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~  100 (336)
T 3fhr_A           27 TDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDS---PKAR---QEVDHHWQASGGPHIVCILDVYENMHHGKRC  100 (336)
T ss_dssp             GGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESS---HHHH---HHHHHHHHHTTSTTBCCEEEEEEEEETTEEE
T ss_pred             cceeEecceeeeeCCCeEEEEEEECCCCCEEEEEEecCc---HHHH---HHHHHHHHhcCCCChHHHHHHHhhccCCCce
Confidence            56899865 5999999999999985  889999999753   2222   223344667799999999999875    445


Q ss_pred             EEEEEecCCCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceeecC---CCcEEEeeccceee
Q 015868          188 LCIVTEFMARGSIYDFLHKQK-GVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDE---NGVVKVADFGVARV  263 (399)
Q Consensus       188 ~~lV~E~~~ggsL~~~l~~~~-~~l~~~~~~~i~~~i~~~L~~LH~~giiHrDlkp~NILl~~---~~~vkl~DFG~a~~  263 (399)
                      +++||||++||+|.+++.... ..+++..++.++.||+.||.|||++||+||||||+||+++.   ++.+||+|||+++.
T Consensus       101 ~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~ivH~dlkp~NIll~~~~~~~~~kl~Dfg~~~~  180 (336)
T 3fhr_A          101 LLIIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAIQFLHSHNIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKE  180 (336)
T ss_dssp             EEEEEECCTTEEHHHHHHTC-CCCCBHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSTTCCEEECCCTTCEE
T ss_pred             EEEEEeccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEEecCCCceEEEecccccee
Confidence            899999999999999998754 46999999999999999999999999999999999999986   45699999999986


Q ss_pred             ccCCCccccCCCCcccccccccCCCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHh------ccCCCCCCCC
Q 015868          264 QAQSGVMTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQ------KSLRPTIPKH  337 (399)
Q Consensus       264 ~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~Dv~slG~vl~elltg~~P~~~~~~~~~~~~~~~------~~~~~~~~~~  337 (399)
                      .... ......+|+.|+|||++.+..++.++||||||+++|+|++|..||..............      ..........
T Consensus       181 ~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  259 (336)
T 3fhr_A          181 TTQN-ALQTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAISPGMKRRIRLGQYGFPNPEWSE  259 (336)
T ss_dssp             C-----------------------CHHHHHHHHHHHHHHHHHHHHSSCCC---------------------CCCTTTSTT
T ss_pred             cccc-ccccCCCCcCccChhhhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCccchhhhhhHHHhhhccccccCchhhcc
Confidence            5433 33455789999999999988899999999999999999999999977665443221111      1112223356


Q ss_pred             CcHHHHHHHHHHhhhcCCCCCCHHHHHH
Q 015868          338 AHPRLAELLERCWQHDPTQRPNFSQITD  365 (399)
Q Consensus       338 ~~~~l~~ll~~cl~~dP~~Rps~~ell~  365 (399)
                      +++++.+||.+||+.||.+|||+.|+++
T Consensus       260 ~~~~~~~li~~~L~~dP~~Rpt~~ell~  287 (336)
T 3fhr_A          260 VSEDAKQLIRLLLKTDPTERLTITQFMN  287 (336)
T ss_dssp             CCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred             CCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence            8999999999999999999999999987

>3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens}

Probab=100.00  E-value=9e-43  Score=348.34  Aligned_cols=252  Identities=25%  Similarity=0.410  Sum_probs=200.2

Q ss_pred             CCceeecccccceeceeceeCceE-EEEEEECCeeEEEEEecCCCCCHHHHHHHHHHHHHHHhc-CCCceeeEEeEEecC
Q 015868          108 TDVWEIDAKQLKIECKVASGSYGD-LYKGTYCSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKI-RHKNVVQFIGACTRP  185 (399)
Q Consensus       108 ~~~~~i~~~~~~i~~~lg~G~~g~-Vy~~~~~~~~vAvK~~~~~~~~~~~~~~~~~Ei~~l~~l-~h~nIv~~~~~~~~~  185 (399)
                      ...+.+...+|.+.+.||+|+||. ||++...++.||||++.....     ..+.+|+.+++++ +||||+++++++...
T Consensus        16 ~~~~~i~~~~y~~~~~LG~G~~G~V~~~~~~~~~~vAvK~~~~~~~-----~~~~~E~~~l~~l~~HpnIv~l~~~~~~~   90 (432)
T 3p23_A           16 TSVVIVGKISFCPKDVLGHGAEGTIVYRGMFDNRDVAVKRILPECF-----SFADREVQLLRESDEHPNVIRYFCTEKDR   90 (432)
T ss_dssp             --CEEETTEEEEEEEEEEECGGGCEEEEEESSSSEEEEEEECTTTE-----EECHHHHHHHHHSCCCTTBCCEEEEEEET
T ss_pred             CCcEEEccEEEecCCeeecCcCEEEEEEEEeCCeEEEEEEECHHHH-----HHHHHHHHHHHhccCCCCcCeEEEEEecC
Confidence            355778888999999999999998 566777899999999975432     2356899999999 799999999999999


Q ss_pred             CcEEEEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceeecCC-----CcEEEeeccc
Q 015868          186 PNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDEN-----GVVKVADFGV  260 (399)
Q Consensus       186 ~~~~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~giiHrDlkp~NILl~~~-----~~vkl~DFG~  260 (399)
                      ...|+||||+.| +|.+++......++...++.++.||+.||.|||++||+||||||+|||++.+     ..+||+|||+
T Consensus        91 ~~~~lv~E~~~g-~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlKp~NIll~~~~~~~~~~~kL~DFG~  169 (432)
T 3p23_A           91 QFQYIAIELCAA-TLQEYVEQKDFAHLGLEPITLLQQTTSGLAHLHSLNIVHRDLKPHNILISMPNAHGKIKAMISDFGL  169 (432)
T ss_dssp             TEEEEEEECCSE-EHHHHHHSSSCCCCSSCHHHHHHHHHHHHHHHHHTTCCCCCCSTTSEEECCCBTTTBCCEEECCTTE
T ss_pred             CEEEEEEECCCC-CHHHHHHhcCCCccchhHHHHHHHHHHHHHHHHHCcCEeCCCCHHHEEEecCCCCCceeEEEecccc
Confidence            999999999975 9999998776667777788999999999999999999999999999999532     3688999999


Q ss_pred             eeeccCC----CccccCCCCcccccccccC---CCCCCChhhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHHhccCCC
Q 015868          261 ARVQAQS----GVMTAETGTYRWMAPEVIE---HKPYDYKADVFSFGIALWELLT-GELPYAGLTPLQAAVGVVQKSLRP  332 (399)
Q Consensus       261 a~~~~~~----~~~~~~~gt~~y~aPE~l~---~~~~~~~~Dv~slG~vl~ellt-g~~P~~~~~~~~~~~~~~~~~~~~  332 (399)
                      ++.....    .......||+.|+|||++.   ...++.++|||||||++|+|++ |..||......+............
T Consensus       170 a~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~t~~~DiwSlG~il~ellt~g~~pf~~~~~~~~~~~~~~~~~~~  249 (432)
T 3p23_A          170 CKKLAVGRHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQRQANILLGACSLDC  249 (432)
T ss_dssp             EECC------------CCSCTTSCCGGGTSCC---CCCTHHHHHHHHHHHHHHHTTSCBTTBSTTTHHHHHHTTCCCCTT
T ss_pred             eeeccCCCcceeeccccCCCcCccChhhhhcccccCCCcHHHHHHHHHHHHHHHcCCCCCcchhhHHHHHHHhccCCccc
Confidence            9865533    2234457999999999998   4567889999999999999999 999997765554433222111111


Q ss_pred             -CCCCCCcHHHHHHHHHHhhhcCCCCCCHHHHHH
Q 015868          333 -TIPKHAHPRLAELLERCWQHDPTQRPNFSQITD  365 (399)
Q Consensus       333 -~~~~~~~~~l~~ll~~cl~~dP~~Rps~~ell~  365 (399)
                       ..+...+..+.+||.+||+.||.+|||+.++++
T Consensus       250 ~~~~~~~~~~~~~li~~~L~~dP~~Rps~~evl~  283 (432)
T 3p23_A          250 LHPEKHEDVIARELIEKMIAMDPQKRPSAKHVLK  283 (432)
T ss_dssp             SCTTCHHHHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             cCccccccHHHHHHHHHHHhCCHhhCCCHHHHHh
Confidence             112335677899999999999999999999984

>3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A

Probab=100.00  E-value=2.9e-41  Score=319.34  Aligned_cols=232  Identities=13%  Similarity=0.166  Sum_probs=193.6

Q ss_pred             ecccccceeceeceeCceEEEEEEEC--CeeEEEEEecCCCC-CHHHHHHHHHHHHHHHhcCCCceeeEEeEEecCCcEE
Q 015868          113 IDAKQLKIECKVASGSYGDLYKGTYC--SQEVAIKVLKPECV-NTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLC  189 (399)
Q Consensus       113 i~~~~~~i~~~lg~G~~g~Vy~~~~~--~~~vAvK~~~~~~~-~~~~~~~~~~Ei~~l~~l~h~nIv~~~~~~~~~~~~~  189 (399)
                      +-.++|++.+.||+|+||.||+|++.  ++.||||+++.... +....+.+.+|+.++++++||||+++++++...+..|
T Consensus        28 ~~~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~  107 (286)
T 3uqc_A           28 IANGRYRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVLDVVHTRAGGL  107 (286)
T ss_dssp             ETTTTEEEEEEEEBSTTCEEEEEEETTTTEEEEEEESCTTCCSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEE
T ss_pred             EecCcEEEEEEEcccCCeEEEEEEecCCCceEEEEEECcccccCHHHHHHHHHHHHHHhcCCCCCcceeeEEEEECCcEE
Confidence            44578999999999999999999985  79999999987654 3566788999999999999999999999999999999


Q ss_pred             EEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceeecCCCcEEEeeccceeeccCCCc
Q 015868          190 IVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGV  269 (399)
Q Consensus       190 lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~giiHrDlkp~NILl~~~~~vkl~DFG~a~~~~~~~~  269 (399)
                      +||||++|++|.+++..  + .....+.+++.|++.||.|||++||+||||||+|||++.+|.+||+++|          
T Consensus       108 lv~e~~~g~~L~~~l~~--~-~~~~~~~~i~~ql~~aL~~lH~~givH~Dikp~NIll~~~g~~kl~~~~----------  174 (286)
T 3uqc_A          108 VVAEWIRGGSLQEVADT--S-PSPVGAIRAMQSLAAAADAAHRAGVALSIDHPSRVRVSIDGDVVLAYPA----------  174 (286)
T ss_dssp             EEEECCCEEEHHHHHTT--C-CCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEEETTSCEEECSCC----------
T ss_pred             EEEEecCCCCHHHHHhc--C-CChHHHHHHHHHHHHHHHHHHHCCCccCCCCcccEEEcCCCCEEEEecc----------
Confidence            99999999999999954  2 3566788999999999999999999999999999999999999998543          


Q ss_pred             cccCCCCcccccccccCCCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHH---HHHhccCC--CCCCCCCcHHHHH
Q 015868          270 MTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAV---GVVQKSLR--PTIPKHAHPRLAE  344 (399)
Q Consensus       270 ~~~~~gt~~y~aPE~l~~~~~~~~~Dv~slG~vl~elltg~~P~~~~~~~~~~~---~~~~~~~~--~~~~~~~~~~l~~  344 (399)
                               |++       +++.++||||||+++|+|+||+.||.+.+..+...   ........  ...+..+++++.+
T Consensus       175 ---------~~~-------~~~~~~Di~slG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~  238 (286)
T 3uqc_A          175 ---------TMP-------DANPQDDIRGIGASLYALLVNRWPLPEAGVRSGLAPAERDTAGQPIEPADIDRDIPFQISA  238 (286)
T ss_dssp             ---------CCT-------TCCHHHHHHHHHHHHHHHHHSEECSCCCSBCCCSEECCBCTTSCBCCHHHHCTTSCHHHHH
T ss_pred             ---------ccC-------CCCchhHHHHHHHHHHHHHHCCCCCCcCCcchhhHHHHHHhccCCCChhhcccCCCHHHHH
Confidence                     333       37889999999999999999999998765432110   00111111  0123568899999


Q ss_pred             HHHHHhhhcCCCCCCHHHHHHHHHHHHHHH
Q 015868          345 LLERCWQHDPTQRPNFSQITDILKQMMKEV  374 (399)
Q Consensus       345 ll~~cl~~dP~~Rps~~ell~~L~~l~~~~  374 (399)
                      +|.+||+.||.+| |+.|+++.|+++....
T Consensus       239 li~~~l~~dP~~R-s~~el~~~L~~~~~~~  267 (286)
T 3uqc_A          239 VAARSVQGDGGIR-SASTLLNLMQQATAVA  267 (286)
T ss_dssp             HHHHHHCTTSSCC-CHHHHHHHHHHHHC--
T ss_pred             HHHHHcccCCccC-CHHHHHHHHHHHhccC
Confidence            9999999999999 9999999999886433

>2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A*

Probab=100.00  E-value=4.1e-41  Score=336.59  Aligned_cols=242  Identities=21%  Similarity=0.387  Sum_probs=188.6

Q ss_pred             cccceeceeceeCceEEEE-EEECCeeEEEEEecCCCCCHHHHHHHHHHHHHHHhc-CCCceeeEEeEEecCCcEEEEEe
Q 015868          116 KQLKIECKVASGSYGDLYK-GTYCSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKI-RHKNVVQFIGACTRPPNLCIVTE  193 (399)
Q Consensus       116 ~~~~i~~~lg~G~~g~Vy~-~~~~~~~vAvK~~~~~~~~~~~~~~~~~Ei~~l~~l-~h~nIv~~~~~~~~~~~~~lV~E  193 (399)
                      +.|.+.+.||+|+||+||. +...++.||||++...     ..+.+.+|+.+++++ +||||+++++++..+...|+|||
T Consensus        15 ~~~~~~~~LG~G~~g~V~~~~~~~g~~vAvK~~~~~-----~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~lv~E   89 (434)
T 2rio_A           15 NLVVSEKILGYGSSGTVVFQGSFQGRPVAVKRMLID-----FCDIALMEIKLLTESDDHPNVIRYYCSETTDRFLYIALE   89 (434)
T ss_dssp             SCEEEEEEEEECSTTCEEEEEESSSSEEEEEEEEGG-----GHHHHHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEEC
T ss_pred             heeeccCeEeeCCCeEEEEEEEECCeEEEEEEEcHH-----HHHHHHHHHHHHHhccCCCCcCeEEEEEecCCeEEEEEe
Confidence            4566678899999999964 4557899999998753     235678899999986 89999999999999999999999


Q ss_pred             cCCCCCHHHHHHhcCCC------CCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceeecCC-------------CcEE
Q 015868          194 FMARGSIYDFLHKQKGV------FQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDEN-------------GVVK  254 (399)
Q Consensus       194 ~~~ggsL~~~l~~~~~~------l~~~~~~~i~~~i~~~L~~LH~~giiHrDlkp~NILl~~~-------------~~vk  254 (399)
                      |+. |+|.+++......      .++..++.++.||+.||+|||++||+||||||+|||++.+             +.+|
T Consensus        90 ~~~-gsL~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~~~~~~~~~~~~~~~~~k  168 (434)
T 2rio_A           90 LCN-LNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRIL  168 (434)
T ss_dssp             CCS-EEHHHHHHTC------------CCHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEECCHHHHSCCTTCCCSCEEE
T ss_pred             cCC-CCHHHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHHHCCccccCCChHhEEEecCcccccccccCCCceEEE
Confidence            996 4999999764321      1223457899999999999999999999999999999754             4899


Q ss_pred             EeeccceeeccCCCc-----cccCCCCcccccccccCC-------CCCCChhhHHHHHHHHHHHHc-CCCCCCCCCHHHH
Q 015868          255 VADFGVARVQAQSGV-----MTAETGTYRWMAPEVIEH-------KPYDYKADVFSFGIALWELLT-GELPYAGLTPLQA  321 (399)
Q Consensus       255 l~DFG~a~~~~~~~~-----~~~~~gt~~y~aPE~l~~-------~~~~~~~Dv~slG~vl~ellt-g~~P~~~~~~~~~  321 (399)
                      |+|||+++.......     .....||+.|+|||++.+       ..++.++|||||||++|+|+| |..||......+.
T Consensus       169 L~DFG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~~~  248 (434)
T 2rio_A          169 ISDFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYSRES  248 (434)
T ss_dssp             ECCCTTCEECCC--------------CCTTSCHHHHSCCCTTSCCCCCCTHHHHHHHHHHHHHHHTTSCCTTCSTTTHHH
T ss_pred             EcccccceecCCCCccceeeecCCCCCCCccCHHHhccccccccccCcchhhhhHhHHHHHHHHHhCCCCCCCCchhhHH
Confidence            999999987654321     234579999999999976       678999999999999999999 9999987654442


Q ss_pred             HHHHHhccCC-CCC----CCCCcHHHHHHHHHHhhhcCCCCCCHHHHHH
Q 015868          322 AVGVVQKSLR-PTI----PKHAHPRLAELLERCWQHDPTQRPNFSQITD  365 (399)
Q Consensus       322 ~~~~~~~~~~-~~~----~~~~~~~l~~ll~~cl~~dP~~Rps~~ell~  365 (399)
                        ........ +..    +..+++++.++|.+||+.||.+|||+.++++
T Consensus       249 --~i~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~  295 (434)
T 2rio_A          249 --NIIRGIFSLDEMKCLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLR  295 (434)
T ss_dssp             --HHHHTCCCCCCCTTCCCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             --HHhcCCCCcccccccccccchHHHHHHHHHHhhCChhhCCCHHHHHh
Confidence              22222211 111    1235689999999999999999999999975

>3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A*

Probab=100.00  E-value=1.2e-41  Score=353.41  Aligned_cols=256  Identities=24%  Similarity=0.358  Sum_probs=207.3

Q ss_pred             ccccceeceeceeCceEEEEEEE--CCeeEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCceeeEEeEEec------CC
Q 015868          115 AKQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTR------PP  186 (399)
Q Consensus       115 ~~~~~i~~~lg~G~~g~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~nIv~~~~~~~~------~~  186 (399)
                      .++|++.++||+|+||.||+|.+  .++.||||+++.. ......+.+.+|+.++++++||||+++++++..      +.
T Consensus        13 ~grY~i~~~LG~G~fG~Vyla~~~~tg~~VAVKvi~~~-~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~v~~~~~~~~~~~   91 (676)
T 3qa8_A           13 CGPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQE-LSPKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQKLAPND   91 (676)
T ss_dssp             ----CCCCCCCBCSSSBCCCCCCTTTTCCEEECCCCSC-CCHHHHHHHHHHHHHHHHCCBTTBCCEEECCTTTCCCCTTS
T ss_pred             CCCeEEEEEEeeCCCeEEEEEEECCCCcEEEEEEeccc-CCHHHHHHHHHHHHHHHhCCCCCCCceeeeecccccccCCC
Confidence            36899999999999999999987  5789999999865 356667889999999999999999999998765      66


Q ss_pred             cEEEEEecCCCCCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceeecCCCc---EEEeeccce
Q 015868          187 NLCIVTEFMARGSIYDFLHKQK--GVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGV---VKVADFGVA  261 (399)
Q Consensus       187 ~~~lV~E~~~ggsL~~~l~~~~--~~l~~~~~~~i~~~i~~~L~~LH~~giiHrDlkp~NILl~~~~~---vkl~DFG~a  261 (399)
                      ..++||||++||+|.+++....  ..+++..++.++.|++.||+|||++||+||||||+||+++.++.   +||+|||.+
T Consensus        92 ~~~LVmEy~~ggsL~~~L~~~~~~~~lse~~i~~I~~QLl~aL~yLHs~gIVHrDLKP~NILl~~~g~~~~vKL~DFG~a  171 (676)
T 3qa8_A           92 LPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLHENRIIHRDLKPENIVLQPGPQRLIHKIIDLGYA  171 (676)
T ss_dssp             SCCCEEECCSSCBHHHHHHSSSCTTCCCSSHHHHHHHHHHHHHHHHHHTTBCCCCCCSTTEEEECCSSSCEEEECSCCCC
T ss_pred             eEEEEEEeCCCCCHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHeEeecCCCceeEEEcccccc
Confidence            7899999999999999997643  36899999999999999999999999999999999999997765   999999999


Q ss_pred             eeccCCCccccCCCCcccccccccCCCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHH----------Hhc---
Q 015868          262 RVQAQSGVMTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGV----------VQK---  328 (399)
Q Consensus       262 ~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~Dv~slG~vl~elltg~~P~~~~~~~~~~~~~----------~~~---  328 (399)
                      +............||+.|+|||.+.+..++.++||||||+++|+|++|..||............          ...   
T Consensus       172 ~~~~~~~~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSLGviLyeLltG~~Pf~~~~~~~~~~~~i~~~~~~~~~~~~~l~  251 (676)
T 3qa8_A          172 KELDQGELCTEFVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFLPNWQPVQWHGKVREKSNEHIVVYDDLT  251 (676)
T ss_dssp             CBTTSCCCCCCCCSCCTTCSSCSSCCSCCSTTHHHHHHHHHHHHHHSSCSSCCSSCHHHHSSTTCC------CCSCCCCS
T ss_pred             cccccccccccccCCcccCChHHhccCCCCchhHHHHHHHHHHHHHHCCCCCCcccchhhhhhhhhcccchhhhhhhhhc
Confidence            8776665566678999999999999999999999999999999999999999764332111000          000   


Q ss_pred             ---------cCCCCCCCCCcHHHHHHHHHHhhhcCCCCCCHHHH-----HHHHHHHH
Q 015868          329 ---------SLRPTIPKHAHPRLAELLERCWQHDPTQRPNFSQI-----TDILKQMM  371 (399)
Q Consensus       329 ---------~~~~~~~~~~~~~l~~ll~~cl~~dP~~Rps~~el-----l~~L~~l~  371 (399)
                               .....++..+++.+.++|.+||..||++|||+.|+     .+.+.+++
T Consensus       252 g~~~~~~~lp~p~~l~~~ls~~L~dLI~~mL~~DP~kRPTa~elL~hp~F~~l~~iL  308 (676)
T 3qa8_A          252 GAVKFSSVLPTPNHLSGILAGKLERWLQCMLMWHQRQRGTDPQNPNVGCFQALDSIL  308 (676)
T ss_dssp             SSCCCCSSSCCSCCCCGGGHHHHHHHHHHHSCSSCC---CCTTCCCCTTHHHHHHHH
T ss_pred             cccccccccCCchhhchhhhHHHHHHHHHHccCCHhhCcCHHHHhcCHHHHHHHHHH
Confidence                     00111233477899999999999999999999984     45555554

>3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A*

Probab=100.00  E-value=2.5e-40  Score=314.18  Aligned_cols=223  Identities=23%  Similarity=0.402  Sum_probs=182.5

Q ss_pred             cccccee-ceeceeCceEEEEEEE--CCeeEEEEEecCCCCCHHHHHHHHHHHHHH-HhcCCCceeeEEeEEec----CC
Q 015868          115 AKQLKIE-CKVASGSYGDLYKGTY--CSQEVAIKVLKPECVNTEMLKEFSQEVYIM-RKIRHKNVVQFIGACTR----PP  186 (399)
Q Consensus       115 ~~~~~i~-~~lg~G~~g~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~Ei~~l-~~l~h~nIv~~~~~~~~----~~  186 (399)
                      .++|.+. +.||+|+||.||++.+  +++.||+|+++..       ..+.+|+.++ +..+||||+++++++..    ..
T Consensus        16 ~~~y~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-------~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~   88 (299)
T 3m2w_A           16 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-------PKARREVELHWRASQCPHIVRIVDVYENLYAGRK   88 (299)
T ss_dssp             GGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS-------HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEE
T ss_pred             ccchhhcCcccccCCCeEEEEEEEcCCCcEEEEEEeccc-------HHHHHHHHHHHHhccCCCchhHHhhhhhhcCCCc
Confidence            3567777 7799999999999988  5789999999742       3566888888 56689999999999876    66


Q ss_pred             cEEEEEecCCCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceeecC---CCcEEEeecccee
Q 015868          187 NLCIVTEFMARGSIYDFLHKQK-GVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDE---NGVVKVADFGVAR  262 (399)
Q Consensus       187 ~~~lV~E~~~ggsL~~~l~~~~-~~l~~~~~~~i~~~i~~~L~~LH~~giiHrDlkp~NILl~~---~~~vkl~DFG~a~  262 (399)
                      .+++||||++|++|.+++.... ..+++..++.++.|++.||.|||++||+||||||+||+++.   ++.+||+|||++.
T Consensus        89 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~~~kl~Dfg~a~  168 (299)
T 3m2w_A           89 CLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAK  168 (299)
T ss_dssp             EEEEEECCCCSCBHHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSTTCCEEECCCTTCE
T ss_pred             eEEEEEeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEecCCCCCcEEEecccccc
Confidence            7999999999999999998754 46999999999999999999999999999999999999998   7899999999986


Q ss_pred             eccCCCccccCCCCcccccccccCCCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhccCC--CCCC----C
Q 015868          263 VQAQSGVMTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKSLR--PTIP----K  336 (399)
Q Consensus       263 ~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~Dv~slG~vl~elltg~~P~~~~~~~~~~~~~~~~~~~--~~~~----~  336 (399)
                      ...                     +..++.++||||||+++|+|++|..||..................  ...+    .
T Consensus       169 ~~~---------------------~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  227 (299)
T 3m2w_A          169 ETT---------------------GEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWS  227 (299)
T ss_dssp             ECT---------------------TCGGGGHHHHHHHHHHHHHHHHSSCSCCC-------CCSCCSSCTTCCSSCHHHHT
T ss_pred             ccc---------------------cccCCchhhHHHHHHHHHHHHHCCCCCCCCcchhhhHHHHHHHhhccccCCchhcc
Confidence            432                     234678999999999999999999999876554432221111111  1122    4


Q ss_pred             CCcHHHHHHHHHHhhhcCCCCCCHHHHHH
Q 015868          337 HAHPRLAELLERCWQHDPTQRPNFSQITD  365 (399)
Q Consensus       337 ~~~~~l~~ll~~cl~~dP~~Rps~~ell~  365 (399)
                      .+++++.+++.+||+.||.+|||+.|+++
T Consensus       228 ~~~~~~~~li~~~l~~dP~~Rps~~e~l~  256 (299)
T 3m2w_A          228 EVSEEVKMLIRNLLKTEPTQRMTITEFMN  256 (299)
T ss_dssp             TSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             cCCHHHHHHHHHHcccChhhCCCHHHHhc
Confidence            68999999999999999999999999986

>3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii}

Probab=100.00  E-value=5e-41  Score=333.86  Aligned_cols=243  Identities=16%  Similarity=0.196  Sum_probs=188.5

Q ss_pred             ecccccceeceeceeCceEEEEEEEC--CeeEEEEEecCCC-CCHHHHHHHHHHHHHHHhcCC-Cc--------------
Q 015868          113 IDAKQLKIECKVASGSYGDLYKGTYC--SQEVAIKVLKPEC-VNTEMLKEFSQEVYIMRKIRH-KN--------------  174 (399)
Q Consensus       113 i~~~~~~i~~~lg~G~~g~Vy~~~~~--~~~vAvK~~~~~~-~~~~~~~~~~~Ei~~l~~l~h-~n--------------  174 (399)
                      .....|++.+.||+|+||.||+|++.  ++.||||+++... ......+.+.+|+.+++.++| +|              
T Consensus        75 ~~~~~~~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~~~~~~~~~~~~~~  154 (413)
T 3dzo_A           75 ERPRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPF  154 (413)
T ss_dssp             SCCEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEECCSCC----CCHHHHHHHHGGGGSTTCCSHHHHHHHTCBCCCC
T ss_pred             CCceeEEEecccccCCCEEEEEEEecCCCCceEEEEEecCCCccHHHHHHHHHHHHHHHhhccCCCHHHHHHhcccccch
Confidence            34456889999999999999999985  8999999998432 233345779999999999977 21              


Q ss_pred             -------eeeEEeEEec-----CCcEEEEEecCCCCCHHHHHHh------cCCCCCHHHHHHHHHHHHHHHHHHHHCCcc
Q 015868          175 -------VVQFIGACTR-----PPNLCIVTEFMARGSIYDFLHK------QKGVFQLTSLLKVAIDVSKGMNYLHQNNII  236 (399)
Q Consensus       175 -------Iv~~~~~~~~-----~~~~~lV~E~~~ggsL~~~l~~------~~~~l~~~~~~~i~~~i~~~L~~LH~~gii  236 (399)
                             ...+..++..     ...++++|+.+ +++|.+++..      ....+++..++.++.||+.||+|||++||+
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ii  233 (413)
T 3dzo_A          155 DLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLV  233 (413)
T ss_dssp             EEEECCC---------------CCSEEEEEECC-SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTTEE
T ss_pred             hhcccCCCCccccccCCCccccccceEEEeehh-cCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCcc
Confidence                   1111111111     23478888876 5699999842      244577888999999999999999999999


Q ss_pred             cCCCCCCceeecCCCcEEEeeccceeeccCCCccccCCCCccccccccc----------CCCCCCChhhHHHHHHHHHHH
Q 015868          237 HRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAETGTYRWMAPEVI----------EHKPYDYKADVFSFGIALWEL  306 (399)
Q Consensus       237 HrDlkp~NILl~~~~~vkl~DFG~a~~~~~~~~~~~~~gt~~y~aPE~l----------~~~~~~~~~Dv~slG~vl~el  306 (399)
                      ||||||+|||++.++.+||+|||+++.....  .....| +.|+|||++          .+..++.++|||||||++|+|
T Consensus       234 HrDiKp~NILl~~~~~~kL~DFG~a~~~~~~--~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~DvwSlGvil~el  310 (413)
T 3dzo_A          234 HTYLRPVDIVLDQRGGVFLTGFEHLVRDGAS--AVSPIG-RGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWI  310 (413)
T ss_dssp             CSCCCGGGEEECTTCCEEECCGGGCEETTEE--ECCCCC-TTTCCHHHHHHHTSTTGGGCCEEECHHHHHHHHHHHHHHH
T ss_pred             cCCcccceEEEecCCeEEEEeccceeecCCc--cccCCC-CceeCchhhhccccccccccCcCCCchhhHHHHHHHHHHH
Confidence            9999999999999999999999999865443  455567 999999999          666788999999999999999


Q ss_pred             HcCCCCCCCCCHHHHHHHHHhccCCCCCCCCCcHHHHHHHHHHhhhcCCCCCCHHHHHH
Q 015868          307 LTGELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRLAELLERCWQHDPTQRPNFSQITD  365 (399)
Q Consensus       307 ltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~cl~~dP~~Rps~~ell~  365 (399)
                      +||+.||...+..+.......      ....+++++.+||.+||+.||++||++.++++
T Consensus       311 ltg~~Pf~~~~~~~~~~~~~~------~~~~~~~~~~~li~~~l~~dP~~Rpt~~~~l~  363 (413)
T 3dzo_A          311 WCADLPNTDDAALGGSEWIFR------SCKNIPQPVRALLEGFLRYPKEDRLLPLQAME  363 (413)
T ss_dssp             HHSSCCCCTTGGGSCSGGGGS------SCCCCCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred             HHCCCCCCCcchhhhHHHHHh------hcccCCHHHHHHHHHHccCChhhCcCHHHHHh
Confidence            999999987665432221111      12357899999999999999999999888854

>2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis}

Probab=100.00  E-value=8.1e-41  Score=352.42  Aligned_cols=246  Identities=21%  Similarity=0.268  Sum_probs=203.5

Q ss_pred             eecccccceeceeceeCceEEEEEEE---CCeeEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCceeeEEeEEecCCc-
Q 015868          112 EIDAKQLKIECKVASGSYGDLYKGTY---CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPN-  187 (399)
Q Consensus       112 ~i~~~~~~i~~~lg~G~~g~Vy~~~~---~~~~vAvK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~nIv~~~~~~~~~~~-  187 (399)
                      ++-.++|++.+.||+|+||.||+|.+   .++.||||++.... .......+.+|+.++++++||||+++++++..... 
T Consensus        76 ~~~~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~  154 (681)
T 2pzi_A           76 DIVAGQYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSG-DAEAQAMAMAERQFLAEVVHPSIVQIFNFVEHTDRH  154 (681)
T ss_dssp             CEETTTEEEEEEEEEETTEEEEEEEEGGGTTEEEEEEESCSSC-CHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEEECTT
T ss_pred             CEeCCceEEEEEEeeCCCeEEEEEEEcCCCCcEEEEEEeCccC-CHHHHHHHHHHHHHHHhcCCCCcCeEeeeEeecCCC
Confidence            34468999999999999999999987   47899999987543 45666789999999999999999999999987665 


Q ss_pred             ----EEEEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceeecCCCcEEEeeccceee
Q 015868          188 ----LCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARV  263 (399)
Q Consensus       188 ----~~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~giiHrDlkp~NILl~~~~~vkl~DFG~a~~  263 (399)
                          .|+||||++|++|.+++..   .+++..++.++.||+.||.|||++||+||||||+|||++.+ .+||+|||+++.
T Consensus       155 ~~~~~~lv~E~~~g~~L~~~~~~---~l~~~~~~~~~~qi~~aL~~lH~~giiHrDlkp~NIll~~~-~~kl~DFG~a~~  230 (681)
T 2pzi_A          155 GDPVGYIVMEYVGGQSLKRSKGQ---KLPVAEAIAYLLEILPALSYLHSIGLVYNDLKPENIMLTEE-QLKLIDLGAVSR  230 (681)
T ss_dssp             SCEEEEEEEECCCCEECC----C---CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECSS-CEEECCCTTCEE
T ss_pred             CCceeEEEEEeCCCCcHHHHHhC---CCCHHHHHHHHHHHHHHHHHHHHCCCeecccChHHeEEeCC-cEEEEecccchh
Confidence                7999999999999998743   68999999999999999999999999999999999999875 999999999987


Q ss_pred             ccCCCccccCCCCcccccccccCCCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhccCCCCC-CCCCcHHH
Q 015868          264 QAQSGVMTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKSLRPTI-PKHAHPRL  342 (399)
Q Consensus       264 ~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~Dv~slG~vl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~l  342 (399)
                      ....   ....||+.|+|||++.+. ++.++||||||+++|+|++|..||.+....         ...... ....++.+
T Consensus       231 ~~~~---~~~~gt~~y~aPE~~~~~-~~~~sDi~slG~~l~~l~~g~~~~~~~~~~---------~~~~~~~~~~~~~~l  297 (681)
T 2pzi_A          231 INSF---GYLYGTPGFQAPEIVRTG-PTVATDIYTVGRTLAALTLDLPTRNGRYVD---------GLPEDDPVLKTYDSY  297 (681)
T ss_dssp             TTCC---SCCCCCTTTSCTTHHHHC-SCHHHHHHHHHHHHHHHHSCCCEETTEECS---------SCCTTCHHHHHCHHH
T ss_pred             cccC---CccCCCccccCHHHHcCC-CCCceehhhhHHHHHHHHhCCCCCcccccc---------cccccccccccCHHH
Confidence            6543   455799999999999765 488999999999999999999988652110         000000 01245789


Q ss_pred             HHHHHHHhhhcCCCCC-CHHHHHHHHHHHHHHHH
Q 015868          343 AELLERCWQHDPTQRP-NFSQITDILKQMMKEVA  375 (399)
Q Consensus       343 ~~ll~~cl~~dP~~Rp-s~~ell~~L~~l~~~~~  375 (399)
                      .++|.+||+.||.+|| +++++.+.|..++++..
T Consensus       298 ~~li~~~l~~dP~~R~~~~~~l~~~l~~~~~~~~  331 (681)
T 2pzi_A          298 GRLLRRAIDPDPRQRFTTAEEMSAQLTGVLREVV  331 (681)
T ss_dssp             HHHHHHHTCSSGGGSCSSHHHHHHHHHHHHHHHH
T ss_pred             HHHHhhhccCChhhCCCHHHHHHHHHHHHHHHhh
Confidence            9999999999999999 57778888888876653

>2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A

Probab=100.00  E-value=1.8e-41  Score=327.27  Aligned_cols=240  Identities=15%  Similarity=0.232  Sum_probs=190.3

Q ss_pred             ecccccceeceeceeCceEEEEEEECCeeEEEEEecCCCC------CHHHHHHHHHHHHHHHhcC---------CCceee
Q 015868          113 IDAKQLKIECKVASGSYGDLYKGTYCSQEVAIKVLKPECV------NTEMLKEFSQEVYIMRKIR---------HKNVVQ  177 (399)
Q Consensus       113 i~~~~~~i~~~lg~G~~g~Vy~~~~~~~~vAvK~~~~~~~------~~~~~~~~~~Ei~~l~~l~---------h~nIv~  177 (399)
                      +..++|++.++||+|+||.||+|+++++.||||+++....      .....+.+.+|+.+++.++         ||||++
T Consensus        17 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~niv~   96 (336)
T 2vuw_A           17 LPTEKLQRCEKIGEGVFGEVFQTIADHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFIG   96 (336)
T ss_dssp             SCHHHHHTCEEEEEETTEEEEEEEETTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBCCCBCC
T ss_pred             cccccchheeeecccCceEEEEEEeCCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccccCCchhh
Confidence            4568999999999999999999999999999999986532      2233467889999999886         777777


Q ss_pred             EEeEEe-----------------c-------------CCcEEEEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHH
Q 015868          178 FIGACT-----------------R-------------PPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGM  227 (399)
Q Consensus       178 ~~~~~~-----------------~-------------~~~~~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~~i~~~L  227 (399)
                      +.+++.                 .             ...+|+||||+++|++.+.+.+  ..+++..++.++.||+.||
T Consensus        97 l~~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~~--~~~~~~~~~~i~~qi~~aL  174 (336)
T 2vuw_A           97 LNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRT--KLSSLATAKSILHQLTASL  174 (336)
T ss_dssp             EEEEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGTT--TCCCHHHHHHHHHHHHHHH
T ss_pred             hcceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHHh--cCCCHHHHHHHHHHHHHHH
Confidence            776642                 2             6789999999999977666643  5689999999999999999


Q ss_pred             HHHH-HCCcccCCCCCCceeecCCC--------------------cEEEeeccceeeccCCCccccCCCCcccccccccC
Q 015868          228 NYLH-QNNIIHRDLKTANLLMDENG--------------------VVKVADFGVARVQAQSGVMTAETGTYRWMAPEVIE  286 (399)
Q Consensus       228 ~~LH-~~giiHrDlkp~NILl~~~~--------------------~vkl~DFG~a~~~~~~~~~~~~~gt~~y~aPE~l~  286 (399)
                      .||| ++||+||||||+|||++.++                    .+||+|||+++.....    ...||+.|+|||++.
T Consensus       175 ~~lH~~~~ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~~----~~~gt~~y~aPE~~~  250 (336)
T 2vuw_A          175 AVAEASLRFEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERDG----IVVFCDVSMDEDLFT  250 (336)
T ss_dssp             HHHHHHHCCBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEETT----EEECCCCTTCSGGGC
T ss_pred             HHHHHhCCEeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecCCC----cEEEeecccChhhhc
Confidence            9999 99999999999999999887                    9999999999876532    347899999999999


Q ss_pred             CCCCCChhhHHHHHHH-HHHHHcCCCCCCCCCHHHHHH-HHHhccCCC-----CCCCCCcHHHHHHHHHHhhhcCCCCCC
Q 015868          287 HKPYDYKADVFSFGIA-LWELLTGELPYAGLTPLQAAV-GVVQKSLRP-----TIPKHAHPRLAELLERCWQHDPTQRPN  359 (399)
Q Consensus       287 ~~~~~~~~Dv~slG~v-l~elltg~~P~~~~~~~~~~~-~~~~~~~~~-----~~~~~~~~~l~~ll~~cl~~dP~~Rps  359 (399)
                      +.. +.++||||++++ .+++++|..||.......... ........+     ..+..+++++.+||.+||+.|     |
T Consensus       251 g~~-~~~~Diwsl~~~~~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~d-----s  324 (336)
T 2vuw_A          251 GDG-DYQFDIYRLMKKENNNRWGEYHPYSNVLWLHYLTDKMLKQMTFKTKCNTPAMKQIKRKIQEFHRTMLNFS-----S  324 (336)
T ss_dssp             CCS-SHHHHHHHHHHHHHTTCTTSCCTHHHHHHHHHHHHHHHHTCCCSSCCCSHHHHHHHHHHHHHHHHGGGSS-----S
T ss_pred             CCC-ccceehhhhhCCCCcccccccCCCcchhhhhHHHHhhhhhhccCcccchhhhhhcCHHHHHHHHHHhccC-----C
Confidence            876 889999998877 677888989885432211111 222111111     112357889999999999976     8


Q ss_pred             HHHHH
Q 015868          360 FSQIT  364 (399)
Q Consensus       360 ~~ell  364 (399)
                      ++|++
T Consensus       325 a~e~l  329 (336)
T 2vuw_A          325 ATDLL  329 (336)
T ss_dssp             HHHHH
T ss_pred             HHHHH
Confidence            88887

>4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A*

Probab=99.98  E-value=3.5e-33  Score=287.73  Aligned_cols=182  Identities=12%  Similarity=0.124  Sum_probs=130.7

Q ss_pred             eeceeCceEEEEEE--ECCeeEEEEEecCCCC--------CHHHHHHHHHHHHHHHhc-CCCceeeEEeEEecCCcEEEE
Q 015868          123 KVASGSYGDLYKGT--YCSQEVAIKVLKPECV--------NTEMLKEFSQEVYIMRKI-RHKNVVQFIGACTRPPNLCIV  191 (399)
Q Consensus       123 ~lg~G~~g~Vy~~~--~~~~~vAvK~~~~~~~--------~~~~~~~~~~Ei~~l~~l-~h~nIv~~~~~~~~~~~~~lV  191 (399)
                      ..+.|+.|.+..++  +.++.+|+|++.....        .+...++|.+|+.+|+++ .|+||++++++++++..+|||
T Consensus       241 ~~~~~~~~~h~~~rr~~fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~ed~~~~yLV  320 (569)
T 4azs_A          241 QPYAGAGLAHKRSRRYFFGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAHGENAQSGWLV  320 (569)
T ss_dssp             C-C--------CCEEEEECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEEECSSEEEEE
T ss_pred             ccccCCcccccccccccccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEECCEEEEE
Confidence            45566666665543  4789999999976532        123456799999999999 699999999999999999999


Q ss_pred             EecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceeecCCCcEEEeeccceeeccCCC-cc
Q 015868          192 TEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSG-VM  270 (399)
Q Consensus       192 ~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~giiHrDlkp~NILl~~~~~vkl~DFG~a~~~~~~~-~~  270 (399)
                      |||++|++|.++|.. .+.++..   +|+.||+.||+|+|++|||||||||+|||++++|.+||+|||+|+...... ..
T Consensus       321 MEyv~G~~L~d~i~~-~~~l~~~---~I~~QIl~AL~ylH~~GIIHRDIKPeNILL~~dg~vKL~DFGlAr~~~~~~~~~  396 (569)
T 4azs_A          321 MEKLPGRLLSDMLAA-GEEIDRE---KILGSLLRSLAALEKQGFWHDDVRPWNVMVDARQHARLIDFGSIVTTPQDCSWP  396 (569)
T ss_dssp             EECCCSEEHHHHHHT-TCCCCHH---HHHHHHHHHHHHHHHTTCEESCCCGGGEEECTTSCEEECCCTTEESCC---CCS
T ss_pred             EecCCCCcHHHHHHh-CCCCCHH---HHHHHHHHHHHHHHHCCceeccCchHhEEECCCCCEEEeecccCeeCCCCCccc
Confidence            999999999999976 4667654   578999999999999999999999999999999999999999998665432 34


Q ss_pred             ccCCCCcccccccccCCCCCCChhhHHHHHHHHHHHHcC
Q 015868          271 TAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTG  309 (399)
Q Consensus       271 ~~~~gt~~y~aPE~l~~~~~~~~~Dv~slG~vl~elltg  309 (399)
                      ...+||+.|||||++.+. +..++|+|++|++++++.++
T Consensus       397 ~t~vGTp~YmAPE~l~g~-~~~~~d~~s~g~~~~~l~~~  434 (569)
T 4azs_A          397 TNLVQSFFVFVNELFAEN-KSWNGFWRSAPVHPFNLPQP  434 (569)
T ss_dssp             HHHHHHHHHHHHHHC------------------CCCCTT
T ss_pred             cCceechhhccHHHhCCC-CCCcccccccccchhhhccc
Confidence            456799999999999875 67789999999988776554

>3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A*

Probab=99.95  E-value=2e-29  Score=258.34  Aligned_cols=185  Identities=19%  Similarity=0.230  Sum_probs=147.6

Q ss_pred             ceeceeceeCceEEEEEEECCeeEEEEEecCCCCCHH------HHHHHHHHHHHHHhcCCCceeeEEeEEecCCcEEEEE
Q 015868          119 KIECKVASGSYGDLYKGTYCSQEVAIKVLKPECVNTE------MLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVT  192 (399)
Q Consensus       119 ~i~~~lg~G~~g~Vy~~~~~~~~vAvK~~~~~~~~~~------~~~~~~~Ei~~l~~l~h~nIv~~~~~~~~~~~~~lV~  192 (399)
                      ...+.||+|+||.||+|++.++.+++|..........      ..+.+.+|+.++++++||||+++..++......|+||
T Consensus       339 ~~~~~LG~G~fg~Vy~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~lVm  418 (540)
T 3en9_A          339 IPEHLIGKGAEADIKRDSYLDFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALVKDFGIPAPYIFDVDLDNKRIMM  418 (540)
T ss_dssp             ---------CCEEEEEEECSSCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHGGGGTCCCCCEEEEETTTTEEEE
T ss_pred             CCCCEEeeCCCEEEEEEEECCCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhcCCCCcCceEEEEEeCCccEEEE
Confidence            3366899999999999999999999999765433221      2356899999999999999996665666667789999


Q ss_pred             ecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceeecCCCcEEEeeccceeeccCCCc---
Q 015868          193 EFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGV---  269 (399)
Q Consensus       193 E~~~ggsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~giiHrDlkp~NILl~~~~~vkl~DFG~a~~~~~~~~---  269 (399)
                      ||++|++|.+++..         +..++.|+++||.|||++||+||||||+|||++.  .+||+|||+++.......   
T Consensus       419 E~~~ggsL~~~l~~---------~~~i~~qi~~aL~~LH~~gIiHrDiKp~NILl~~--~~kL~DFGla~~~~~~~~~~~  487 (540)
T 3en9_A          419 SYINGKLAKDVIED---------NLDIAYKIGEIVGKLHKNDVIHNDLTTSNFIFDK--DLYIIDFGLGKISNLDEDKAV  487 (540)
T ss_dssp             ECCCSEEHHHHSTT---------CTHHHHHHHHHHHHHHHTTEECTTCCTTSEEESS--SEEECCCTTCEECCCHHHHHH
T ss_pred             ECCCCCCHHHHHHH---------HHHHHHHHHHHHHHHHHCcCccCCCCHHHEEECC--eEEEEECccCEECCCcccccc
Confidence            99999999999865         5689999999999999999999999999999998  999999999987655322   


Q ss_pred             -----cccCCCCcccccccccCC--CCCCChhhHHHHHHHHHHHHcCCCCCC
Q 015868          270 -----MTAETGTYRWMAPEVIEH--KPYDYKADVFSFGIALWELLTGELPYA  314 (399)
Q Consensus       270 -----~~~~~gt~~y~aPE~l~~--~~~~~~~Dv~slG~vl~elltg~~P~~  314 (399)
                           .....||+.|||||++..  ..|+..+|+|+..+-..+-..++.+|.
T Consensus       488 ~~~~~~~~~~GT~~y~APEv~~~~~~~Y~~~~d~ws~vl~~l~~v~~r~rY~  539 (540)
T 3en9_A          488 DLIVFKKAVLSTHHEKFDEIWERFLEGYKSVYDRWEIILELMKDVERRARYV  539 (540)
T ss_dssp             HHHHHHHHHHHHCGGGHHHHHHHHHHHHHHHCTTHHHHHHHHHHHHTCSCCC
T ss_pred             chhhhhhhhcCCCCcCCHHHHHHHHHHHHHHHhHHHHHHHHHHHHHhccccC
Confidence                 124578999999999987  678888999999888877777666663

>1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A*

Probab=99.92  E-value=1.7e-25  Score=210.81  Aligned_cols=146  Identities=14%  Similarity=0.128  Sum_probs=116.5

Q ss_pred             cccceeceeceeCceEEEEEEE-CCeeEEEEEecCCCCCH----------------HHHHHHHHHHHHHHhcCCCceeeE
Q 015868          116 KQLKIECKVASGSYGDLYKGTY-CSQEVAIKVLKPECVNT----------------EMLKEFSQEVYIMRKIRHKNVVQF  178 (399)
Q Consensus       116 ~~~~i~~~lg~G~~g~Vy~~~~-~~~~vAvK~~~~~~~~~----------------~~~~~~~~Ei~~l~~l~h~nIv~~  178 (399)
                      ..|.+.+.||+|+||.||+|++ .++.||+|+++....+.                .....+.+|+.++++++|   +++
T Consensus        90 ~~~~~~~~iG~G~~g~Vy~~~~~~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~l~~---~~v  166 (282)
T 1zar_A           90 KVDAIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQG---LAV  166 (282)
T ss_dssp             SCSEEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTT---SSS
T ss_pred             eEEEecCEeccCCCceEEEEEeCCCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHhccC---CCc
Confidence            3455679999999999999998 57899999997543211                245679999999999984   555


Q ss_pred             EeEEecCCcEEEEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceeecCCCcEEEeec
Q 015868          179 IGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADF  258 (399)
Q Consensus       179 ~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~giiHrDlkp~NILl~~~~~vkl~DF  258 (399)
                      .+++.. +..|+||||++|++|.+ +..       .....++.|++.||.|||++||+||||||+|||++ ++.+||+||
T Consensus       167 ~~~~~~-~~~~lvmE~~~g~~L~~-l~~-------~~~~~i~~qi~~~l~~lH~~giiHrDlkp~NILl~-~~~vkl~DF  236 (282)
T 1zar_A          167 PKVYAW-EGNAVLMELIDAKELYR-VRV-------ENPDEVLDMILEEVAKFYHRGIVHGDLSQYNVLVS-EEGIWIIDF  236 (282)
T ss_dssp             CCEEEE-ETTEEEEECCCCEEGGG-CCC-------SCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEE-TTEEEECCC
T ss_pred             CeEEec-cceEEEEEecCCCcHHH-cch-------hhHHHHHHHHHHHHHHHHHCCCEeCCCCHHHEEEE-CCcEEEEEC
Confidence            554443 45699999999999988 421       23457999999999999999999999999999999 999999999


Q ss_pred             cceeeccCCCccccCCCCcccccccccC
Q 015868          259 GVARVQAQSGVMTAETGTYRWMAPEVIE  286 (399)
Q Consensus       259 G~a~~~~~~~~~~~~~gt~~y~aPE~l~  286 (399)
                      |+++..            ..++|||.+.
T Consensus       237 G~a~~~------------~~~~a~e~l~  252 (282)
T 1zar_A          237 PQSVEV------------GEEGWREILE  252 (282)
T ss_dssp             TTCEET------------TSTTHHHHHH
T ss_pred             CCCeEC------------CCCCHHHHHH
Confidence            999743            3467888874

>1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A*

Probab=99.85  E-value=5.9e-22  Score=184.06  Aligned_cols=138  Identities=14%  Similarity=0.206  Sum_probs=108.9

Q ss_pred             ccceeceeceeCceEEEEEEE--CCee--EEEEEecCCCCCH----------------------HHHHHHHHHHHHHHhc
Q 015868          117 QLKIECKVASGSYGDLYKGTY--CSQE--VAIKVLKPECVNT----------------------EMLKEFSQEVYIMRKI  170 (399)
Q Consensus       117 ~~~i~~~lg~G~~g~Vy~~~~--~~~~--vAvK~~~~~~~~~----------------------~~~~~~~~Ei~~l~~l  170 (399)
                      -|.+.+.||+|+||.||+|.+  .++.  ||||+++......                      .....+.+|+.+|+.+
T Consensus        48 ~~~i~~~ig~G~~g~Vy~a~~~~~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l  127 (258)
T 1zth_A           48 ITAMGGVISTGKEANVFYADGVFDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFRNLERA  127 (258)
T ss_dssp             EEEEEEEEEECSSEEEEEEEEEETTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHHHHHHHH
T ss_pred             chhhCCEEeecceEEEEEEEEcCCCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHHHHHHHH
Confidence            467889999999999999987  7888  9999987542111                      1123688999999999


Q ss_pred             CCCc--eeeEEeEEecCCcEEEEEecCCC-C----CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH-HCCcccCCCCC
Q 015868          171 RHKN--VVQFIGACTRPPNLCIVTEFMAR-G----SIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLH-QNNIIHRDLKT  242 (399)
Q Consensus       171 ~h~n--Iv~~~~~~~~~~~~~lV~E~~~g-g----sL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH-~~giiHrDlkp  242 (399)
                      .|++  ++.+++.    ...++||||+.+ |    +|.++...    .++..+..++.|++.+|.||| +.||+||||||
T Consensus       128 ~~~~i~~p~~~~~----~~~~lVmE~~g~~g~~~~~L~~~~~~----~~~~~~~~i~~qi~~~l~~lH~~~givHrDlkp  199 (258)
T 1zth_A          128 KEAGVSVPQPYTY----MKNVLLMEFIGEDELPAPTLVELGRE----LKELDVEGIFNDVVENVKRLYQEAELVHADLSE  199 (258)
T ss_dssp             HHTTCCCCCEEEE----ETTEEEEECCEETTEECCBHHHHGGG----GGGSCHHHHHHHHHHHHHHHHHTSCEECSSCST
T ss_pred             HhCCCCCCeEEEc----CCCEEEEEecCCCCCccccHHHHhhc----cChHHHHHHHHHHHHHHHHHHHHCCEEeCCCCH
Confidence            8875  3445542    256899999942 3    67776432    234567889999999999999 99999999999


Q ss_pred             CceeecCCCcEEEeeccceeec
Q 015868          243 ANLLMDENGVVKVADFGVARVQ  264 (399)
Q Consensus       243 ~NILl~~~~~vkl~DFG~a~~~  264 (399)
                      +|||+++  .++|+|||+|...
T Consensus       200 ~NILl~~--~~~liDFG~a~~~  219 (258)
T 1zth_A          200 YNIMYID--KVYFIDMGQAVTL  219 (258)
T ss_dssp             TSEEESS--SEEECCCTTCEET
T ss_pred             HHEEEcC--cEEEEECcccccC
Confidence            9999988  9999999999754

>4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A

Probab=99.74  E-value=2.4e-18  Score=167.44  Aligned_cols=138  Identities=13%  Similarity=0.150  Sum_probs=101.6

Q ss_pred             ccceeceeceeCceEEEEEEE-CCeeEEEEEecCCCCC---------------H-HH----HHHHHHHHHHHHhcCCCce
Q 015868          117 QLKIECKVASGSYGDLYKGTY-CSQEVAIKVLKPECVN---------------T-EM----LKEFSQEVYIMRKIRHKNV  175 (399)
Q Consensus       117 ~~~i~~~lg~G~~g~Vy~~~~-~~~~vAvK~~~~~~~~---------------~-~~----~~~~~~Ei~~l~~l~h~nI  175 (399)
                      -|.+..+||.|++|.||+|.. .|+.||||+++....+               . ..    ......|...|.++.+.++
T Consensus        96 iY~I~~~IG~Gk~a~VY~a~d~~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~nL~rL~~~gv  175 (397)
T 4gyi_A           96 VYSVGSRIGVGKESDIMIVADEKGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFAFMKALYEEGF  175 (397)
T ss_dssp             CSEEEEEEEECSSEEEEEEECTTCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHHHHHHHHHTTC
T ss_pred             EEEecCEeeeCCceEEEEEECCCCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHHhcCC
Confidence            488999999999999999986 6889999998743111               0 00    1123457777777755443


Q ss_pred             --eeEEeEEecCCcEEEEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceeecCCC--
Q 015868          176 --VQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENG--  251 (399)
Q Consensus       176 --v~~~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~giiHrDlkp~NILl~~~~--  251 (399)
                        +..++..    ..+|||||++|++|.++..       .+....++.|++.+|.+||+.|||||||||.|||++++|  
T Consensus       176 ~vp~p~~~~----~~~LVME~i~G~~L~~l~~-------~~~~~~l~~qll~~l~~lH~~gIVHrDLKp~NILl~~dgd~  244 (397)
T 4gyi_A          176 PVPEPIAQS----RHTIVMSLVDALPMRQVSS-------VPDPASLYADLIALILRLAKHGLIHGDFNEFNILIREEKDA  244 (397)
T ss_dssp             SCCCEEEEE----TTEEEEECCSCEEGGGCCC-------CSCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEEEEECS
T ss_pred             CCCeeeecc----CceEEEEecCCccHhhhcc-------cHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHEEEeCCCCc
Confidence              3333321    2379999999988865431       123457889999999999999999999999999998876  


Q ss_pred             --------cEEEeeccceeecc
Q 015868          252 --------VVKVADFGVARVQA  265 (399)
Q Consensus       252 --------~vkl~DFG~a~~~~  265 (399)
                              .+.|+||+.+....
T Consensus       245 ~d~~~~~~~~~iID~~Q~V~~~  266 (397)
T 4gyi_A          245 EDPSSITLTPIIIXFPQMVSMD  266 (397)
T ss_dssp             SCTTSEEEEEEECCCTTCEETT
T ss_pred             ccccccccceEEEEeCCcccCC
Confidence                    38999999886443

>3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A*

Probab=99.46  E-value=1.4e-13  Score=127.19  Aligned_cols=140  Identities=12%  Similarity=0.056  Sum_probs=113.0

Q ss_pred             cccceeceeceeCceEEEEEEECCeeEEEEEecCCCCCHHHHHHHHHHHHHHHhcC-CCceeeEEeEEecCCcEEEEEec
Q 015868          116 KQLKIECKVASGSYGDLYKGTYCSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIR-HKNVVQFIGACTRPPNLCIVTEF  194 (399)
Q Consensus       116 ~~~~i~~~lg~G~~g~Vy~~~~~~~~vAvK~~~~~~~~~~~~~~~~~Ei~~l~~l~-h~nIv~~~~~~~~~~~~~lV~E~  194 (399)
                      ..|++...++.|+.+.||+....++.+++|+.......  ....+.+|+.+++.+. +..++++++++...+..|+|||+
T Consensus        14 ~~~~~~~~~~g~s~~~v~~~~~~~~~~vlK~~~~~~~~--~~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e~   91 (263)
T 3tm0_A           14 EKYRCVKDTEGMSPAKVYKLVGENENLYLKMTDSRYKG--TTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNLLMSE   91 (263)
T ss_dssp             TTSEEEECCSCCSSSEEEEEECSSCEEEEEEECGGGTT--STTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEEC
T ss_pred             ccceeEeeccCCCCCeEEEEECCCCcEEEEeCCcccCC--CHHHHHHHHHHHHHHhcCCCCCeEEEEEecCCceEEEEEe
Confidence            35888888999999999999888899999998752111  1235788999999985 67788999999888889999999


Q ss_pred             CCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH------------------------------------------
Q 015868          195 MARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQ------------------------------------------  232 (399)
Q Consensus       195 ~~ggsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~------------------------------------------  232 (399)
                      ++|.+|.+.+.      +......++.++.+++..||+                                          
T Consensus        92 i~G~~l~~~~~------~~~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  165 (263)
T 3tm0_A           92 ADGVLCSEEYE------DEQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEEDTPFK  165 (263)
T ss_dssp             CSSEEHHHHCC------TTTCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCSGGGGSTTCSSS
T ss_pred             cCCeehhhccC------CcccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHhccccccccccccccccCC
Confidence            99999887631      112234678899999999998                                          


Q ss_pred             -----------------CCcccCCCCCCceeecCCCcEEEeeccceee
Q 015868          233 -----------------NNIIHRDLKTANLLMDENGVVKVADFGVARV  263 (399)
Q Consensus       233 -----------------~giiHrDlkp~NILl~~~~~vkl~DFG~a~~  263 (399)
                                       ..++|+|++|.||++++++.+.|+||+.+..
T Consensus       166 ~~~~l~~~l~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~lIDwe~a~~  213 (263)
T 3tm0_A          166 DPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSGR  213 (263)
T ss_dssp             SHHHHHHHHHHCCCCCCEEEECSSCCTTSEEEETTEEEEECCCTTCEE
T ss_pred             CHHHHHHHHHhcCCCCCceEECCCCCcCcEEEECCcEEEEEEchhccc
Confidence                             4589999999999998766677999998864

>1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6

Probab=99.27  E-value=6.3e-12  Score=115.25  Aligned_cols=133  Identities=11%  Similarity=0.107  Sum_probs=98.6

Q ss_pred             ccceeceeceeCceEEEEEEEC-CeeEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCc--eeeEEeEEecCCcEEEEEe
Q 015868          117 QLKIECKVASGSYGDLYKGTYC-SQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKN--VVQFIGACTRPPNLCIVTE  193 (399)
Q Consensus       117 ~~~i~~~lg~G~~g~Vy~~~~~-~~~vAvK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~n--Iv~~~~~~~~~~~~~lV~E  193 (399)
                      .+.+....+.|+.+.||+.... +..+++|+.....     ...+.+|+.+++.+.+.+  +++++++...++..++|||
T Consensus        21 ~~~~~~~~~gg~~~~v~~~~~~~g~~~vlK~~~~~~-----~~~~~~E~~~l~~l~~~~~~vP~~~~~~~~~~~~~~v~e   95 (264)
T 1nd4_A           21 GYDWAQQTIGCSDAAVFRLSAQGRPVLFVKTDLSGA-----LNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLG   95 (264)
T ss_dssp             TCEEEECSCTTSSCEEEEEECTTSCCEEEEEECSCT-----TSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEE
T ss_pred             CCceEecccCCCCceEEEEecCCCCeEEEEeCCccc-----chhhhHHHHHHHHHHhCCCCCCeEEEeccCCCCCEEEEE
Confidence            3444433346667999999764 5679999987541     245778999999886444  6779998888888999999


Q ss_pred             cCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---------------------------------------
Q 015868          194 FMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNN---------------------------------------  234 (399)
Q Consensus       194 ~~~ggsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~g---------------------------------------  234 (399)
                      |++|.++.  ...    ..   ...++.+++..|..||+..                                       
T Consensus        96 ~i~G~~l~--~~~----~~---~~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  166 (264)
T 1nd4_A           96 EVPGQDLL--SSH----LA---PAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLA  166 (264)
T ss_dssp             CCSSEETT--TSC----CC---HHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCC
T ss_pred             ecCCcccC--cCc----CC---HhHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhcCCccchhhhhhccCcc
Confidence            99998874  211    11   1256677777777787643                                       


Q ss_pred             -------------------cccCCCCCCceeecCCCcEEEeeccceee
Q 015868          235 -------------------IIHRDLKTANLLMDENGVVKVADFGVARV  263 (399)
Q Consensus       235 -------------------iiHrDlkp~NILl~~~~~vkl~DFG~a~~  263 (399)
                                         ++|+|++|.||++++++.+.|+|||.+..
T Consensus       167 ~~~~~~~l~~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~liD~~~a~~  214 (264)
T 1nd4_A          167 PAELFARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLGV  214 (264)
T ss_dssp             HHHHHHHHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCEE
T ss_pred             HHHHHHHHHHhcCCCCCeEEECCCCCCCcEEEECCcEEEEEcchhccc
Confidence                               99999999999998776677999999864

>3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134}

Probab=99.26  E-value=1.9e-11  Score=118.25  Aligned_cols=140  Identities=13%  Similarity=0.207  Sum_probs=107.8

Q ss_pred             eceeceeCceEEEEEEECCeeEEEEEec--CCCCCHHHHHHHHHHHHHHHhcC--CCceeeEEeEEecC---CcEEEEEe
Q 015868          121 ECKVASGSYGDLYKGTYCSQEVAIKVLK--PECVNTEMLKEFSQEVYIMRKIR--HKNVVQFIGACTRP---PNLCIVTE  193 (399)
Q Consensus       121 ~~~lg~G~~g~Vy~~~~~~~~vAvK~~~--~~~~~~~~~~~~~~Ei~~l~~l~--h~nIv~~~~~~~~~---~~~~lV~E  193 (399)
                      .+.++.|.++.||+.+..+..+++|+..  +... ......+.+|..+++.+.  +..+++++.++.+.   +..++|||
T Consensus        43 ~~~l~~G~sn~~y~v~~~~~~~vlr~~~~p~~~~-~~~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~~~~g~~~~vme  121 (359)
T 3dxp_A           43 VEQFKGGQSNPTFKLVTPGQTYVMRAKPGPKSKL-LPSAHAIEREYRVMDALAGTDVPVAKMYALCEDESVIGRAFYIME  121 (359)
T ss_dssp             EEECCC-CCSCEEEEECSSCEEEEECCCC-----------CHHHHHHHHHHHTTSSSCCCCEEEEECCTTTTSSCEEEEE
T ss_pred             EEEcCCcccceEEEEEECCceEEEEeCCCCCCCC-CCcHHHHHHHHHHHHHhhcCCCCCCcEEEECCCCCccCCeEEEEE
Confidence            4578899999999999888899999876  4321 122356888999999997  45688999988776   45899999


Q ss_pred             cCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH-----------------------------------------
Q 015868          194 FMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQ-----------------------------------------  232 (399)
Q Consensus       194 ~~~ggsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~-----------------------------------------  232 (399)
                      |++|..+.+.   ....++......++.+++..|+.||+                                         
T Consensus       122 ~v~G~~l~~~---~~~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  198 (359)
T 3dxp_A          122 FVSGRVLWDQ---SLPGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTKQYKLSETESIPAMD  198 (359)
T ss_dssp             CCCCBCCCCT---TCTTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHHHHHHHCCSCCHHHH
T ss_pred             ecCCeecCCC---ccccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHHHHHhcCCcCChHHH
Confidence            9999877542   12346778888899999999999997                                         


Q ss_pred             -----------------CCcccCCCCCCceeecCCCc--EEEeeccceeec
Q 015868          233 -----------------NNIIHRDLKTANLLMDENGV--VKVADFGVARVQ  264 (399)
Q Consensus       233 -----------------~giiHrDlkp~NILl~~~~~--vkl~DFG~a~~~  264 (399)
                                       .+++|+|++|.||+++.++.  +.|+||+.+...
T Consensus       199 ~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~~g  249 (359)
T 3dxp_A          199 SLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEPRVLAVLDWELSTLG  249 (359)
T ss_dssp             HHHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSSCEEEECCCTTCEEE
T ss_pred             HHHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCCcEEEEECccccccC
Confidence                             36899999999999997753  699999998753

>3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A

Probab=99.14  E-value=6.2e-11  Score=111.94  Aligned_cols=181  Identities=17%  Similarity=0.204  Sum_probs=122.4

Q ss_pred             eeceeCceEEEEEEECCeeEEEEEecCCCCCHHHHHHHHHHHHHHHhcC-CCc--eeeEEeEEecCC---cEEEEEecCC
Q 015868          123 KVASGSYGDLYKGTYCSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIR-HKN--VVQFIGACTRPP---NLCIVTEFMA  196 (399)
Q Consensus       123 ~lg~G~~g~Vy~~~~~~~~vAvK~~~~~~~~~~~~~~~~~Ei~~l~~l~-h~n--Iv~~~~~~~~~~---~~~lV~E~~~  196 (399)
                      .++.|.+..||+..   ..+++|+...    ......+.+|..+|+.+. +..  +++++.......   ..|+|||+++
T Consensus        27 ~~~~G~~n~v~~v~---~~~vlR~~~~----~~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~~~~~~~~~~vm~~i~   99 (304)
T 3sg8_A           27 ISGEGNDCIAYEIN---RDFIFKFPKH----SRGSTNLFNEVNILKRIHNKLPLPIPEVVFTGMPSETYQMSFAGFTKIK   99 (304)
T ss_dssp             EEEECSSEEEEEST---TSEEEEEESS----HHHHHHHHHHHHHHHHHTTSSSSCCCCEEEECCCCSSCSCSCEEEECCC
T ss_pred             ecCCCCcceEEEEC---CEEEEEecCC----cchHHHHHHHHHHHHHHHhcCCCCCCceEeecCCCCCCCcceEEEcccC
Confidence            58899999999864   6799999753    345678899999999884 322  556665544333   3489999999


Q ss_pred             CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH--------------------------------------------
Q 015868          197 RGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQ--------------------------------------------  232 (399)
Q Consensus       197 ggsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~--------------------------------------------  232 (399)
                      |.++.+...   ..++......++.+++..++.||+                                            
T Consensus       100 G~~l~~~~~---~~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~  176 (304)
T 3sg8_A          100 GVPLTPLLL---NNLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSRELKGPQMKKVDDF  176 (304)
T ss_dssp             CEECCHHHH---HTSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTTSCHHHHHHHHHH
T ss_pred             CeECCcccc---ccCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhcccCCcccHHHHHHH
Confidence            988875432   235677777888888888888885                                            


Q ss_pred             --------------CCcccCCCCCCceeecC--CCcEEEeeccceeeccCCCccccCCCCcccccccccC----CCC---
Q 015868          233 --------------NNIIHRDLKTANLLMDE--NGVVKVADFGVARVQAQSGVMTAETGTYRWMAPEVIE----HKP---  289 (399)
Q Consensus       233 --------------~giiHrDlkp~NILl~~--~~~vkl~DFG~a~~~~~~~~~~~~~gt~~y~aPE~l~----~~~---  289 (399)
                                    ..++|+|++|.||++++  .+.+.|+||+.+.................-..|+...    ..+   
T Consensus       177 ~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~~~~~~Dl~~~~~~~~~~~~~~~~~~l~~Y~~~~  256 (304)
T 3sg8_A          177 YRDILENEIYFKYYPCLIHNDFSSDHILFDTEKNTICGIIDFGDAAISDPDNDFISLMEDDEEYGMEFVSKILNHYKHKD  256 (304)
T ss_dssp             HHHHHTCGGGTCCCCEEECSCCCGGGEEEETTTTEEEEECCCTTCEEECTTHHHHTTCCTTTSCCHHHHHHHHHHHTCSC
T ss_pred             HHHHHhccccccCCceeEeCCCCcccEEEeCCCCCEEEEEeCCCCccCChHHHHHHHHhhccccCHHHHHHHHHHcCCCC
Confidence                          13699999999999998  5678999999987654321110000000001222111    000   


Q ss_pred             -------CCChhhHHHHHHHHHHHHcCCCCC
Q 015868          290 -------YDYKADVFSFGIALWELLTGELPY  313 (399)
Q Consensus       290 -------~~~~~Dv~slG~vl~elltg~~P~  313 (399)
                             .....+.|+++.++|.+.+|..+|
T Consensus       257 ~~~~~~r~~~~~~~~~l~~~~~~~~~g~~~~  287 (304)
T 3sg8_A          257 IPTVLEKYRMKEKYWSFEKIIYGKEYGYMDW  287 (304)
T ss_dssp             HHHHHHHHHHHHHHHHHHHHHHHHHTTCHHH
T ss_pred             cHHHHHHHHHHHHHHHHHHHHHHHHcCCHHH
Confidence                   122368999999999999998776

>3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A*

Probab=98.77  E-value=1.3e-07  Score=89.34  Aligned_cols=133  Identities=16%  Similarity=0.145  Sum_probs=95.0

Q ss_pred             ceeceeCceEEEEEEECCeeEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCC---ceeeEEeEEe-cCCcEEEEEecCCC
Q 015868          122 CKVASGSYGDLYKGTYCSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHK---NVVQFIGACT-RPPNLCIVTEFMAR  197 (399)
Q Consensus       122 ~~lg~G~~g~Vy~~~~~~~~vAvK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~---nIv~~~~~~~-~~~~~~lV~E~~~g  197 (399)
                      +.++.|....||+.   +..+++|+..    .......+.+|..+|+.+.+.   .+++++.++. ..+..++|||+++|
T Consensus        25 ~~l~~G~~n~v~~v---g~~~VlR~~~----~~~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~~~~g~~~~v~e~i~G   97 (306)
T 3tdw_A           25 ESLGEGFRNYAILV---NGDWVFRFPK----SQQGADELNKEIQLLPLLVGCVKVNIPQYVYIGKRSDGNPFVGYRKVQG   97 (306)
T ss_dssp             EEEEECSSEEEEEE---TTTEEEEEES----SHHHHHHHHHHHHHHHHHTTTCSSBCCCEEEEEECTTSCEEEEEECCCS
T ss_pred             eecCCCcceeEEEE---CCEEEEEecC----CchHHHHHHHHHHHHHHHHhcCCCCCCCeEeecccCCCceEEEEeccCC
Confidence            35788888899987   6889999954    344567899999999999752   3677777774 44567899999999


Q ss_pred             CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC--------------------------------------------
Q 015868          198 GSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQN--------------------------------------------  233 (399)
Q Consensus       198 gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~--------------------------------------------  233 (399)
                      .++.+..-   ..++......++.++...|+.||+.                                            
T Consensus        98 ~~l~~~~~---~~l~~~~~~~~~~~lg~~La~LH~~~~~~~~~~g~p~~~w~~~~~~~~~~~~~~~~~~l~~~~~~~l~~  174 (306)
T 3tdw_A           98 QILGEDGM---AVLPDDAKDRLALQLAEFMNELSAFPVETAISAGVPVTNLKNKILLLSEAVEDQVFPLLDESLRDYLTL  174 (306)
T ss_dssp             EECHHHHH---TTSCHHHHHHHHHHHHHHHHHHHHSCHHHHHHTTCCBCCHHHHHHHHHHHHHHHTGGGSCHHHHHHHHH
T ss_pred             eECchhhh---hhCCHHHHHHHHHHHHHHHHHHhcCCcccccccCCChHHHHHHHHHHHHHHHHhcccccchhhHHHHHH
Confidence            88766321   1234444444455555555555432                                            


Q ss_pred             ----------------CcccCCCCCCceeecC---CCc-EEEeeccceeec
Q 015868          234 ----------------NIIHRDLKTANLLMDE---NGV-VKVADFGVARVQ  264 (399)
Q Consensus       234 ----------------giiHrDlkp~NILl~~---~~~-vkl~DFG~a~~~  264 (399)
                                      .++|+|++|.||+++.   ++. +.|+||+.+...
T Consensus       175 ~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~~~iD~~~a~~g  225 (306)
T 3tdw_A          175 RFQSYMTHPVYTRYTPRLIHGDLSPDHFLTNLNSRQTPLTGIIDFGDAAIS  225 (306)
T ss_dssp             HHHHHHHCHHHHCCCCEEECSCCSGGGEEECTTCSSCCEEEECCCTTCEEE
T ss_pred             HHHHHHhCcccccCCCeeEeCCCCcccEEEecCCCCCceEEEEehhhcCCC
Confidence                            4589999999999987   355 589999988754

>4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A*

Probab=98.64  E-value=3.9e-07  Score=83.91  Aligned_cols=132  Identities=16%  Similarity=0.212  Sum_probs=95.6

Q ss_pred             eeceeCce-EEEEEEE--CCeeEEEEEecCCCCCHHHHHHHHHHHHHHHhcC-CCceeeEEeEEecCCcEEEEEecCCCC
Q 015868          123 KVASGSYG-DLYKGTY--CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIR-HKNVVQFIGACTRPPNLCIVTEFMARG  198 (399)
Q Consensus       123 ~lg~G~~g-~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~Ei~~l~~l~-h~nIv~~~~~~~~~~~~~lV~E~~~gg  198 (399)
                      .+..|.+| .||+...  .+..+.+|+-...     ....+.+|...|+.+. +--+++++.++..++..++|||+++|.
T Consensus        31 ~~~~G~S~~~v~rl~~~~~~~~~~lk~~~~~-----~~~~~~~E~~~l~~l~~~vPVP~v~~~~~~~~~~~lvme~l~G~  105 (272)
T 4gkh_A           31 RDNVGQSGATIYRLYGKPNAPELFLKHGKGS-----VANDVTDEMVRLNWLTAFMPLPTIKHFIRTPDDAWLLTTAIPGK  105 (272)
T ss_dssp             EEECSSSSCEEEEEECCTTCCCEEEEEEETH-----HHHHHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCCSE
T ss_pred             EccCCCcCCeEEEEEecCCCeEEEEEECCCC-----CHhHHHHHHHHHHHhccCCCcCeEEEEEEECCeEEEEEEeeCCc
Confidence            34445555 6898765  3567999997632     3467888999999885 333788999999888999999999998


Q ss_pred             CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC---------------------------------------------
Q 015868          199 SIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQN---------------------------------------------  233 (399)
Q Consensus       199 sL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~---------------------------------------------  233 (399)
                      ++.+.....     ......+..++...|..||+.                                             
T Consensus       106 ~~~~~~~~~-----~~~~~~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  180 (272)
T 4gkh_A          106 TAFQVLEEY-----PDSGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGLVDASDFDDERNGWPVEQVW  180 (272)
T ss_dssp             EHHHHHHHC-----GGGHHHHHHHHHHHHHHHHTSCGGGCCBBCCHHHHHHHHHHHHHTTCCCGGGCCGGGTTCCHHHHH
T ss_pred             cccccccCC-----HHHHHHHHHHHHHHHHHhcCCCcccCCcCcccccchhhHHHHHHHhhhhhhhccccccchHHHHHH
Confidence            887765431     122234555666666666642                                             


Q ss_pred             -------------CcccCCCCCCceeecCCCcEEEeeccceeec
Q 015868          234 -------------NIIHRDLKTANLLMDENGVVKVADFGVARVQ  264 (399)
Q Consensus       234 -------------giiHrDlkp~NILl~~~~~vkl~DFG~a~~~  264 (399)
                                   .++|+|+.+.||++++++.+-|+||+.+...
T Consensus       181 ~~l~~~~~~~~~~~l~HGDl~~~Nil~~~~~~~~viDwe~a~~g  224 (272)
T 4gkh_A          181 KEMHKLLPFSPDSVVTHGDFSLDNLIFDEGKLIGCIDVGRVGIA  224 (272)
T ss_dssp             HHHHTTCCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCEEE
T ss_pred             HHHHhcccccCCcEEEcCCCCCCeEEEECCeEEEEEECcccccC
Confidence                         1489999999999998877789999988643

>3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A*

Probab=98.42  E-value=2.3e-07  Score=89.12  Aligned_cols=80  Identities=11%  Similarity=0.012  Sum_probs=54.9

Q ss_pred             ecee-ceeCceEEEEEEEC--------CeeEEEEEecCCCC-CHHHHHHHHHHHHHHHhcCC---CceeeEEeEEecC--
Q 015868          121 ECKV-ASGSYGDLYKGTYC--------SQEVAIKVLKPECV-NTEMLKEFSQEVYIMRKIRH---KNVVQFIGACTRP--  185 (399)
Q Consensus       121 ~~~l-g~G~~g~Vy~~~~~--------~~~vAvK~~~~~~~-~~~~~~~~~~Ei~~l~~l~h---~nIv~~~~~~~~~--  185 (399)
                      .+.| +.|....+|+.+..        ++.+++|+...... .......+.+|..+++.+..   -.+++++.++...  
T Consensus        25 ~~~l~~~G~~n~~y~v~~~~~~~~~~~~~~~vlR~~~~~~~~~~~~~~~~~~E~~~l~~L~~~~~vpvP~v~~~~~~~~~  104 (357)
T 3ats_A           25 ESGVDSTGMSSETIILTARWQQDGRSIQQKLVARVAPAAEDVPVFPTYRLDHQFEVIRLVGELTDVPVPRVRWIETTGDV  104 (357)
T ss_dssp             EEEECTTSSEEEEEEEEEEEEETTEEEEEEEEEEECCCGGGCCSSSCCCHHHHHHHHHHHHHHCCSCCCCEEEEECSSTT
T ss_pred             EEECCCCCccceEEEEEEecccCCCCCCceEEEEeCCCCCccccCchhHHHHHHHHHHHHhhcCCCCCCcEEEEccCCCc
Confidence            4567 78888999998765        67899998764320 00001346678888888742   3578888887665  


Q ss_pred             -CcEEEEEecCCCCCH
Q 015868          186 -PNLCIVTEFMARGSI  200 (399)
Q Consensus       186 -~~~~lV~E~~~ggsL  200 (399)
                       +..++|||+++|.++
T Consensus       105 ~g~~~~v~e~l~G~~l  120 (357)
T 3ats_A          105 LGTPFFLMDYVEGVVP  120 (357)
T ss_dssp             TSSCEEEEECCCCBCC
T ss_pred             cCCceEEEEecCCCCh
Confidence             356899999998654

>2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis}

Probab=98.41  E-value=2.2e-06  Score=81.33  Aligned_cols=136  Identities=16%  Similarity=0.154  Sum_probs=80.6

Q ss_pred             ceeceeCceEEEEEEECCeeEEEEEecCCCCCHHHHHHHHHHHHHHHhcCC--CceeeEEe------EEecCCcEEEEEe
Q 015868          122 CKVASGSYGDLYKGTYCSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRH--KNVVQFIG------ACTRPPNLCIVTE  193 (399)
Q Consensus       122 ~~lg~G~~g~Vy~~~~~~~~vAvK~~~~~~~~~~~~~~~~~Ei~~l~~l~h--~nIv~~~~------~~~~~~~~~lV~E  193 (399)
                      +.|+.|..+.||+....+..+++|+....   .   ..+..|..+++.+..  -.+++++.      +....+..+++||
T Consensus        38 ~~l~gG~~n~~~~v~~~~~~~vlk~~~~~---~---~~~~~e~~~l~~L~~~g~~vp~~~~~~~g~~~~~~~~~~~~l~~  111 (346)
T 2q83_A           38 DVIQGNQMALVWKVHTDSGAVCLKRIHRP---E---KKALFSIFAQDYLAKKGMNVPGILPNKKGSLYSKHGSFLFVVYD  111 (346)
T ss_dssp             EECC----CEEEEEEETTEEEEEEEECSC---H---HHHHHHHHHHHHHHHHTCSSCCBCCCTTSCSCEEETTEEEEEEE
T ss_pred             eeccccccCcEEEEEeCCCCEEEEecCCC---H---HHHHHHHHHHHHHHHcCCCCCceeecCCCCEEEEECCEEEEEEE
Confidence            35666778899999887778999999762   2   233345555555531  12344443      1223556899999


Q ss_pred             cCCCCCHH--------------HHHHhcCCCC-------------CHH--------H-----------------------
Q 015868          194 FMARGSIY--------------DFLHKQKGVF-------------QLT--------S-----------------------  215 (399)
Q Consensus       194 ~~~ggsL~--------------~~l~~~~~~l-------------~~~--------~-----------------------  215 (399)
                      |++|.++.              ..++.....+             ...        .                       
T Consensus       112 ~i~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~  191 (346)
T 2q83_A          112 WIEGRPFELTVKQDLEFIMKGLADFHTASVGYQPPNGVPIFTKLGRWPNHYTKRCKQMETWKLMAEAEKEDPFSQLYLQE  191 (346)
T ss_dssp             CCCCBCCCTTSHHHHHHHHHHHHHHHHHHTTCCCCTTCCCCBCTTCHHHHHHHHHHHHHHHHHHHHHCSSCHHHHHHHHH
T ss_pred             eecCccCCCCCHHHHHHHHHHHHHHHHhCCCCCCCccchhcccccchHHHHHHHHHHHHHHHHHHHhccCCcHHHHHHHH
Confidence            99986432              1122211101             010        0                       


Q ss_pred             HHHHHHHHHHHHHHHH-------------HCCcccCCCCCCceeecCCCcEEEeeccceee
Q 015868          216 LLKVAIDVSKGMNYLH-------------QNNIIHRDLKTANLLMDENGVVKVADFGVARV  263 (399)
Q Consensus       216 ~~~i~~~i~~~L~~LH-------------~~giiHrDlkp~NILl~~~~~vkl~DFG~a~~  263 (399)
                      +..+...+..++.+|+             ..+++|+|+.+.||+++.++.+.|+||+.+..
T Consensus       192 ~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDfe~a~~  252 (346)
T 2q83_A          192 IDGFIEDGLRIKDRLLQSTYVPWTEQLKKSPNLCHQDYGTGNTLLGENEQIWVIDLDTVSF  252 (346)
T ss_dssp             HHHHHHHHHHHHHHHHHTTHHHHHHHHHHSCCEECSSCSTTSEEECGGGCEEECCCTTCEE
T ss_pred             HHHHHHHHHHHHHHHHhchHHHHHHhccccCceecCCCCcccEEEeCCCcEEEEehhhccc
Confidence            1111122344566665             25799999999999998888999999998854

>2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A*

Probab=98.34  E-value=2.2e-06  Score=83.59  Aligned_cols=76  Identities=11%  Similarity=0.009  Sum_probs=49.8

Q ss_pred             eceeceeCceEEEEEEE--CCeeEEEEEecCCCC--CH---HHHHHHHHHHHHHHhcCC---CceeeEEeEEecCCcEEE
Q 015868          121 ECKVASGSYGDLYKGTY--CSQEVAIKVLKPECV--NT---EMLKEFSQEVYIMRKIRH---KNVVQFIGACTRPPNLCI  190 (399)
Q Consensus       121 ~~~lg~G~~g~Vy~~~~--~~~~vAvK~~~~~~~--~~---~~~~~~~~Ei~~l~~l~h---~nIv~~~~~~~~~~~~~l  190 (399)
                      .+.+|.|.++.||+++.  .++.+++|...+...  ..   .....+..|..+++.+..   ..+++++.+.  ....++
T Consensus        35 ~~~lg~G~~n~vyrv~~~~~~~~~vvK~~~~~~r~~~~~~~~~~~r~~~E~~~L~~l~~~~~~~vP~~~~~d--~~~~~l  112 (397)
T 2olc_A           35 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYSD--TEMAVT  112 (397)
T ss_dssp             EEECCSSSSEEEEEEEC----CEEEEEEECCC-------CCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEEE--TTTTEE
T ss_pred             EEECCCCceEEEEEEEECCCCcEEEEEecchhhcccCCCCcCcHHHHHHHHHHHHHhhhhCCCCcCeEEEEc--CCccEE
Confidence            34789999999999953  567899998764321  00   112356778888887742   3456676543  345689


Q ss_pred             EEecCCCC
Q 015868          191 VTEFMARG  198 (399)
Q Consensus       191 V~E~~~gg  198 (399)
                      |||+++|.
T Consensus       113 vmE~l~g~  120 (397)
T 2olc_A          113 VMEDLSHL  120 (397)
T ss_dssp             EECCCTTS
T ss_pred             EEEeCCCc
Confidence            99999874

>2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A

Probab=98.16  E-value=2.7e-05  Score=68.93  Aligned_cols=136  Identities=14%  Similarity=0.155  Sum_probs=95.1

Q ss_pred             CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH-CCcccCCCCCCceeecCCCcEEEeeccceeeccCCCccccCCCCc
Q 015868          199 SIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQ-NNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAETGTY  277 (399)
Q Consensus       199 sL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~-~giiHrDlkp~NILl~~~~~vkl~DFG~a~~~~~~~~~~~~~gt~  277 (399)
                      ||.++|...+.+++++++|.++.|.+.+|.-+-. +.-..+=+.|..|++..+|.|-+.+ +.+.           ....
T Consensus        34 SL~eIL~~~~~PlsEEqaWALc~Qc~~~L~~~~~~~~~~~~i~~~~~i~l~~dG~V~f~~-~~s~-----------~~~~  101 (229)
T 2yle_A           34 SLEEILRLYNQPINEEQAWAVCYQCCGSLRAAARRRQPRHRVRSAAQIRVWRDGAVTLAP-AADD-----------AGEP  101 (229)
T ss_dssp             EHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCSGGGEEEETTSCEEECC-C------------------
T ss_pred             cHHHHHHHcCCCcCHHHHHHHHHHHHHHHHhhhhcccCCceecCCcceEEecCCceeccc-cccc-----------cccc
Confidence            8999999999999999999999999999877622 1212333457889999999888774 2111           1122


Q ss_pred             ccccccccCCCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhccCCCCCCCCCcHHHHHHHHHHhhh-----
Q 015868          278 RWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRLAELLERCWQH-----  352 (399)
Q Consensus       278 ~y~aPE~l~~~~~~~~~Dv~slG~vl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~cl~~-----  352 (399)
                      .+.|||... ...+.+.=|||||+++|..+-...                   .+..+..+|+.|.+||..|..-     
T Consensus       102 ~~~~pe~~~-~~~te~~~IysLG~tLY~ALDygL-------------------~e~eE~eLS~~LE~LL~~Mt~~~~d~~  161 (229)
T 2yle_A          102 PPVAGKLGY-SQCMETEVIESLGIIIYKALDYGL-------------------KENEERELSPPLEQLIDHMANTVEADG  161 (229)
T ss_dssp             -----CCSS-SSSCHHHHHHHHHHHHHHHHTTTC-------------------CTTEEECCCHHHHHHHHHHTTCCC---
T ss_pred             CCCChhhcc-ccchHHHHHHHHHHHHHHHhhcCC-------------------CcccchhhCHHHHHHHHHHHhcccccc
Confidence            455787763 345678899999999999886332                   3344566899999999999865     


Q ss_pred             --------------------cCCCCCCHHHHHHH
Q 015868          353 --------------------DPTQRPNFSQITDI  366 (399)
Q Consensus       353 --------------------dP~~Rps~~ell~~  366 (399)
                                          .+..|+++.+|++.
T Consensus       162 ~~DeG~~~~~eg~~d~~~~~~~~~~~sl~~Vi~~  195 (229)
T 2yle_A          162 SNDEGYEAAEEGLGDEDEKRKISAIRSYRDVMKL  195 (229)
T ss_dssp             -----------------CCSCCCCCCSHHHHHHH
T ss_pred             cccccccccccccccccccccccCcCCHHHHHHH
Confidence                                24578888888754

>3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT}

Probab=98.00  E-value=2.4e-05  Score=73.88  Aligned_cols=75  Identities=16%  Similarity=0.136  Sum_probs=61.4

Q ss_pred             eceeceeCceEEEEEEECCeeEEEEEecCCCCCHHHHHHHHHHHHHHHhcC---CCceeeEEeEEecCCcEEEEEecCCC
Q 015868          121 ECKVASGSYGDLYKGTYCSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIR---HKNVVQFIGACTRPPNLCIVTEFMAR  197 (399)
Q Consensus       121 ~~~lg~G~~g~Vy~~~~~~~~vAvK~~~~~~~~~~~~~~~~~Ei~~l~~l~---h~nIv~~~~~~~~~~~~~lV~E~~~g  197 (399)
                      .+.|+.|.+..+|+.+..+..+++|+....     ....+..|...|+.+.   ...+++++.++...+..++|||+++|
T Consensus        41 ~~~l~gG~~n~~y~v~~~~~~~vlK~~~~~-----~~~~~~~E~~~L~~L~~~~~v~VP~vl~~~~~~g~~~lvme~l~G  115 (312)
T 3jr1_A           41 KEKLYSGEMNEIWLINDEVQTVFVKINERS-----YRSMFRAEADQLALLAKTNSINVPLVYGIGNSQGHSFLLLEALNK  115 (312)
T ss_dssp             EEEECCSSSSEEEEEESSSCEEEEEEEEGG-----GHHHHHHHHHHHHHHHHTTSSBCCCEEEEEECSSEEEEEEECCCC
T ss_pred             eEEeCCccceeeeEEEECCCeEEEEeCCcc-----cHHHHHHHHHHHHHHHhhCCCCcceEEEEeecCCceEEEEEeccC
Confidence            456888999999999888889999997643     2456888999998884   36688999988888889999999998


Q ss_pred             CCH
Q 015868          198 GSI  200 (399)
Q Consensus       198 gsL  200 (399)
                      ..+
T Consensus       116 ~~~  118 (312)
T 3jr1_A          116 SKN  118 (312)
T ss_dssp             CCC
T ss_pred             CCC
Confidence            753

>2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana}

Probab=97.89  E-value=5.6e-05  Score=74.25  Aligned_cols=78  Identities=17%  Similarity=0.211  Sum_probs=47.7

Q ss_pred             HHCCcccCCCCCCceeecCCCcEEEeeccceeeccCCCccccCC--CCcccccccccCCCCC---CChhhHHHHHHHHHH
Q 015868          231 HQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAET--GTYRWMAPEVIEHKPY---DYKADVFSFGIALWE  305 (399)
Q Consensus       231 H~~giiHrDlkp~NILl~~~~~vkl~DFG~a~~~~~~~~~~~~~--gt~~y~aPE~l~~~~~---~~~~Dv~slG~vl~e  305 (399)
                      +...++|+|++|.|||++.++ ++|+||+.+.............  -...|++|+......-   ....++......+|+
T Consensus       230 ~~~~liHGDl~~~Nil~~~~~-~~lID~e~a~~G~p~~Dla~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  308 (420)
T 2pyw_A          230 RAQALIHGDLHTGSVMVTQDS-TQVIDPEFSFYGPMGFDIGAYLGNLILAFFAQDGHATQENDRKEYKQWILRTIEQTWN  308 (420)
T ss_dssp             BCCEEECSCCSGGGEEECSSC-EEECCCTTCEEECHHHHHHHHHHHHHHHHHHGGGGCCSSCCSHHHHHHHHHHHHHHHH
T ss_pred             CCCeEEecCCCCCcEEEeCCC-CEEEeCcccccCchHHHHHHHHHHHHHHHHhcccccccccchHHHHHHHHHHHHHHHH
Confidence            456899999999999998776 9999999997644221111000  0234566655532111   123455577777777


Q ss_pred             HHcC
Q 015868          306 LLTG  309 (399)
Q Consensus       306 lltg  309 (399)
                      .+++
T Consensus       309 ~y~~  312 (420)
T 2pyw_A          309 LFNK  312 (420)
T ss_dssp             HHHH
T ss_pred             HHHH
Confidence            6653

>3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti}

Probab=97.78  E-value=6e-05  Score=70.49  Aligned_cols=134  Identities=16%  Similarity=0.204  Sum_probs=76.2

Q ss_pred             eceeceeCceEEEEEEECCeeEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCce-eeEEeEEecCCcEEEEEecC-CCC
Q 015868          121 ECKVASGSYGDLYKGTYCSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNV-VQFIGACTRPPNLCIVTEFM-ARG  198 (399)
Q Consensus       121 ~~~lg~G~~g~Vy~~~~~~~~vAvK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~nI-v~~~~~~~~~~~~~lV~E~~-~gg  198 (399)
                      .+.|+.|....+|+.    ..+++|+.....   .......+|..+++.+...++ +++++..  +..-++|+||+ +|.
T Consensus        23 i~~l~gG~tN~~~~~----~~~vlR~~~~~~---~~~~~r~~E~~~l~~l~~~g~~P~~~~~~--~~~~~~v~e~i~~g~   93 (301)
T 3dxq_A           23 PLERLGGLTNLVFRA----GDLCLRIPGKGT---EEYINRANEAVAAREAAKAGVSPEVLHVD--PATGVMVTRYIAGAQ   93 (301)
T ss_dssp             CEEEESCSSEEEEEE----TTEEEEEECC-------CCCHHHHHHHHHHHHHTTSSCCEEEEC--TTTCCEEEECCTTCE
T ss_pred             eeEcCCcccccccee----eeEEEECCCCCc---cceeCHHHHHHHHHHHHHcCCCCceEEEE--CCCCEEEEeecCCCc
Confidence            567888999999998    779999987531   111123467777777743222 5666543  33457899999 664


Q ss_pred             CHHH------------------HHHhcCCCCC----H-HHHHHHHH--------------HHHHHHHHHH----H----C
Q 015868          199 SIYD------------------FLHKQKGVFQ----L-TSLLKVAI--------------DVSKGMNYLH----Q----N  233 (399)
Q Consensus       199 sL~~------------------~l~~~~~~l~----~-~~~~~i~~--------------~i~~~L~~LH----~----~  233 (399)
                      ++..                  .++.....++    . ..+..+..              .+...+..|.    .    .
T Consensus        94 ~l~~~~~~~~~~~~~~~~~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~l~~~l~~~~~~~  173 (301)
T 3dxq_A           94 TMSPEKFKTRPGSPARAGEAFRKLHGSGAVFPFRFELFAMIDDYLKVLSTKNVTLPAGYHDVVREAGGVRSALAAHPLPL  173 (301)
T ss_dssp             ECCHHHHHHSTTHHHHHHHHHHHHHTSCCCCSSBCCHHHHHHHHHHHHC--CCCCCTTHHHHHHHHHHHHHHHHSSCCCC
T ss_pred             cCCHhhHhhhHHHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHhhcCCCchhhHHHHHHHHHHHHHHHHhcCCCc
Confidence            4321                  0111111111    1 11111111              1111111111    1    2


Q ss_pred             CcccCCCCCCceeecCCCcEEEeeccceeec
Q 015868          234 NIIHRDLKTANLLMDENGVVKVADFGVARVQ  264 (399)
Q Consensus       234 giiHrDlkp~NILl~~~~~vkl~DFG~a~~~  264 (399)
                      .++|+|+.|.||+ .+++.+.++||..+...
T Consensus       174 ~l~HgDl~~~Nil-~~~~~~~lID~e~a~~g  203 (301)
T 3dxq_A          174 AACHCDPLCENFL-DTGERMWIVDWEYSGMN  203 (301)
T ss_dssp             EEECSCCCGGGEE-ECSSCEEECCCTTCEEE
T ss_pred             eeeccCCCcCCEE-ECCCCEEEEecccccCC
Confidence            4899999999999 56778899999988653

>3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP}

Probab=97.74  E-value=7.1e-05  Score=70.96  Aligned_cols=136  Identities=13%  Similarity=0.126  Sum_probs=74.5

Q ss_pred             eeceeCceE-EEEEEEC-CeeEEEEEecCCCCCHHHHHHHHHHHHHHHhcCC--CceeeEEeEEecCCcEEEEEecCCCC
Q 015868          123 KVASGSYGD-LYKGTYC-SQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRH--KNVVQFIGACTRPPNLCIVTEFMARG  198 (399)
Q Consensus       123 ~lg~G~~g~-Vy~~~~~-~~~vAvK~~~~~~~~~~~~~~~~~Ei~~l~~l~h--~nIv~~~~~~~~~~~~~lV~E~~~gg  198 (399)
                      .|+.|.... +|+.+.. +..+++|...+...     ..+..|+.+++.+..  -.+++++.+....+  +++||++.+.
T Consensus        25 ~l~gg~s~~~~~r~~~~~~~~~vlk~~~~~~~-----~~~~~e~~~l~~L~~~g~~vP~v~~~d~~~g--~ll~e~l~~~   97 (333)
T 3csv_A           25 PLAGDASSRRYQRLRSPTGAKAVLMDWSPEEG-----GDTQPFVDLAQYLRNLDISAPEIYAEEHARG--LLLIEDLGDA   97 (333)
T ss_dssp             C--------CCEEEECTTCCEEEEEECCTTTT-----CCSHHHHHHHHHHHHTTCBCCCEEEEETTTT--EEEECCCCSC
T ss_pred             ECCCCCCCceEEEEEcCCCCeEEEEECCCCCC-----ccccHHHHHHHHHHhCCCCCCceeeecCCCC--EEEEeeCCCc
Confidence            344454443 6677653 67788887654320     233456677766642  23667777644333  7899999876


Q ss_pred             CHHHHHHhcC-------------------------CCCCHHHHH-------H-HH------------HHHHHHHHHH---
Q 015868          199 SIYDFLHKQK-------------------------GVFQLTSLL-------K-VA------------IDVSKGMNYL---  230 (399)
Q Consensus       199 sL~~~l~~~~-------------------------~~l~~~~~~-------~-i~------------~~i~~~L~~L---  230 (399)
                      ++.+.+....                         ..+......       . +.            ..+...+..+   
T Consensus        98 ~l~~~l~~~~~~~~~~~~~~~~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~~~~~~l~~~  177 (333)
T 3csv_A           98 LFTEVINNDPAQEMPLYRAAVDLLIHLHDAQTPELARLDPETLSEMTRLAFSEYRYAILGDAAEDNRKRFEHRFAQILSA  177 (333)
T ss_dssp             BHHHHHHHCGGGHHHHHHHHHHHHHHHHTSCCCCCCBCCHHHHHHTTTHHHHTHHHHHHSSCCHHHHHHHHHHHHHHHHH
T ss_pred             chHHHhcCCCccHHHHHHHHHHHHHHHhcCCCccCCccCHHHHHHHHHHHHHHHHHHhcCCCcHHHHHHHHHHHHHHHHh
Confidence            6655442210                         012221110       0 00            1112223333   


Q ss_pred             ---HHCCcccCCCCCCceeecCC----CcEEEeeccceeecc
Q 015868          231 ---HQNNIIHRDLKTANLLMDEN----GVVKVADFGVARVQA  265 (399)
Q Consensus       231 ---H~~giiHrDlkp~NILl~~~----~~vkl~DFG~a~~~~  265 (399)
                         +...++|+|+.+.||+++.+    +.+.|+||+.+....
T Consensus       178 ~~~~~~~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~G~  219 (333)
T 3csv_A          178 QLEGDMVFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKLGH  219 (333)
T ss_dssp             HCCSCCEEECSCCSGGGEEECTTSCGGGGEEECCCTTCEEEC
T ss_pred             cccCCCeeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCcCC
Confidence               23479999999999999875    789999999997544

>2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6

Probab=97.63  E-value=5.2e-05  Score=71.37  Aligned_cols=139  Identities=12%  Similarity=0.132  Sum_probs=80.9

Q ss_pred             eceeceeCceEEEEEEECCeeEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCc--eeeEEeE------EecCCcEEEEE
Q 015868          121 ECKVASGSYGDLYKGTYCSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKN--VVQFIGA------CTRPPNLCIVT  192 (399)
Q Consensus       121 ~~~lg~G~~g~Vy~~~~~~~~vAvK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~n--Iv~~~~~------~~~~~~~~lV~  192 (399)
                      .+.|+.|....+|+.+..+..+++|+.....    ....+..|..+++.+...+  +++++..      ....+..++++
T Consensus        27 ~~~i~~G~~n~~~~v~~~~g~~vlk~~~~~~----~~~~l~~e~~~l~~L~~~g~~vP~~~~~~~g~~~~~~~g~~~~l~  102 (322)
T 2ppq_A           27 YKGIAEGVENSNFLLHTTKDPLILTLYEKRV----EKNDLPFFLGLMQHLAAKGLSCPLPLPRKDGELLGELSGRPAALI  102 (322)
T ss_dssp             EEEECC---EEEEEEEESSCCEEEEEECC-------CCHHHHHHHHHHHHHHTTCCCCCBCCBTTCCSCEEETTEEEEEE
T ss_pred             eeccCCCcccceEEEEeCCccEEEEEeCCCC----CHHHHHHHHHHHHHHHHCCCCCCcccCCCCCCEEEEECCEEEEEE
Confidence            4567778889999998877789999987631    1234556777777764222  3444421      12234578999


Q ss_pred             ecCCCCCHH-----H---------HHHhcCCCC--------CHHHHHH---------------HHHHHHHHHHHHHH---
Q 015868          193 EFMARGSIY-----D---------FLHKQKGVF--------QLTSLLK---------------VAIDVSKGMNYLHQ---  232 (399)
Q Consensus       193 E~~~ggsL~-----~---------~l~~~~~~l--------~~~~~~~---------------i~~~i~~~L~~LH~---  232 (399)
                      ++++|..+.     .         .++.....+        .......               +...+...++.++.   
T Consensus       103 ~~l~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~~~~~l~~~l~~~~~~l~~~~~  182 (322)
T 2ppq_A          103 SFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVEKGLREEIRPEIDYLAAHWP  182 (322)
T ss_dssp             ECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTSTTHHHHHHHHHHHHHHHCC
T ss_pred             EeCCCcCCCCCCHHHHHHHHHHHHHHHHHhccCCCcccCccChHHHHHHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhCc
Confidence            999986431     0         122211111        1110000               00123445555553   


Q ss_pred             ----CCcccCCCCCCceeecCCCcEEEeeccceee
Q 015868          233 ----NNIIHRDLKTANLLMDENGVVKVADFGVARV  263 (399)
Q Consensus       233 ----~giiHrDlkp~NILl~~~~~vkl~DFG~a~~  263 (399)
                          .+++|+|+.+.||++++++.+.|+||+.+..
T Consensus       183 ~~~~~~liHgDl~~~Nil~~~~~~~~lIDf~~a~~  217 (322)
T 2ppq_A          183 KDLPAGVIHADLFQDNVFFLGDELSGLIDFYFACN  217 (322)
T ss_dssp             CSSCEEEECSCCCGGGEEEETTEEEEECCCTTCEE
T ss_pred             ccCCcccCCCCCCccCEEEeCCceEEEecchhccC
Confidence                3699999999999998876668999998864

>3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX}

Probab=97.61  E-value=0.0005  Score=63.70  Aligned_cols=78  Identities=13%  Similarity=0.114  Sum_probs=55.4

Q ss_pred             cccceeceeceeCceEEEEEEE-CCeeEEEEEecCCCCCHHHHHHHHHHHHHHHhcCC---CceeeEEeEEecCCcEEEE
Q 015868          116 KQLKIECKVASGSYGDLYKGTY-CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRH---KNVVQFIGACTRPPNLCIV  191 (399)
Q Consensus       116 ~~~~i~~~lg~G~~g~Vy~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~Ei~~l~~l~h---~nIv~~~~~~~~~~~~~lV  191 (399)
                      .+..-.+.+|.|..+.||+.+. .|+.|.+|+........  ...|..|...|+.+..   --+++++++.    ..++|
T Consensus        15 ~~v~~v~~~g~G~~~~vyrv~l~DG~~~~vK~~~~~~~~~--~~~~~~Ea~~L~~L~~~~~vpvP~v~~~~----~~~lv   88 (288)
T 3f7w_A           15 REVAAVAERGHSHRWHLYRVELADGTPLFVKALPDDAPAL--DGLFRAEALGLDWLGRSFGSPVPQVAGWD----DRTLA   88 (288)
T ss_dssp             CCEEEEEEEEEETTEEEEEEEETTSCEEEEEECCTTCCCC--TTHHHHHHHHHHHHTCSTTCCSCCEEEEE----TTEEE
T ss_pred             CCeEEEEecCCCCCeEEEEEEECCCCEEEEEEeCCCCcch--hhHHHHHHHHHHHHHhhCCCCcceEEecc----CceEE
Confidence            3455567899999999999987 57899999876543221  2457789999998842   2355666543    24789


Q ss_pred             EecCCCCC
Q 015868          192 TEFMARGS  199 (399)
Q Consensus       192 ~E~~~ggs  199 (399)
                      ||++.++.
T Consensus        89 ~e~l~~~~   96 (288)
T 3f7w_A           89 MEWVDERP   96 (288)
T ss_dssp             EECCCCCC
T ss_pred             EEeecccC
Confidence            99998764

>1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8

Probab=97.44  E-value=0.00057  Score=67.37  Aligned_cols=71  Identities=11%  Similarity=0.173  Sum_probs=48.8

Q ss_pred             eceeceeCceEEEEEEEC---------CeeEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCc-eeeEEeEEecCCcEEE
Q 015868          121 ECKVASGSYGDLYKGTYC---------SQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKN-VVQFIGACTRPPNLCI  190 (399)
Q Consensus       121 ~~~lg~G~~g~Vy~~~~~---------~~~vAvK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~n-Iv~~~~~~~~~~~~~l  190 (399)
                      .+.|+.|-...+|+.+..         ++.+.+|+..... .   ...+.+|..+++.+...+ .+++++.+..    .+
T Consensus        78 v~~l~gG~tN~~y~v~~~~~~~~~~~~~~~~vlRi~~~~~-~---~~~li~E~~~l~~L~~~g~~P~l~~~~~~----g~  149 (429)
T 1nw1_A           78 ISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNPE-T---ESHLVAESVIFTLLSERHLGPKLYGIFSG----GR  149 (429)
T ss_dssp             EEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSCC-C---HHHHHHHHHHHHHHHHTTSSSCEEEEETT----EE
T ss_pred             EEEeCCCcccceEEEEeCCCccccCCCCceEEEEEeCCCC-c---HHHHHHHHHHHHHHHhCCCCCcEEEEeCC----CE
Confidence            356788888999999874         4789999985421 1   134447888888885333 3677776543    38


Q ss_pred             EEecCCCCC
Q 015868          191 VTEFMARGS  199 (399)
Q Consensus       191 V~E~~~ggs  199 (399)
                      |+||++|.+
T Consensus       150 v~e~l~G~~  158 (429)
T 1nw1_A          150 LEEYIPSRP  158 (429)
T ss_dssp             EECCCCEEE
T ss_pred             EEEEeCCcc
Confidence            999998743

>3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A*

Probab=97.19  E-value=0.00043  Score=66.56  Aligned_cols=71  Identities=11%  Similarity=0.156  Sum_probs=43.9

Q ss_pred             ceeceeCceEEEEEEECC----------eeEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCc-eeeEEeEEecCCcEEE
Q 015868          122 CKVASGSYGDLYKGTYCS----------QEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKN-VVQFIGACTRPPNLCI  190 (399)
Q Consensus       122 ~~lg~G~~g~Vy~~~~~~----------~~vAvK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~n-Iv~~~~~~~~~~~~~l  190 (399)
                      +.++.|....+|+.+..+          ..+++|+.....   ........|..+++.+...+ ++++++..  .  -++
T Consensus        39 ~~l~~G~~N~~y~v~~~~~~~~~~~~~~~~~vlRi~~~~~---~~~~~~~~E~~~l~~L~~~g~~P~~~~~~--~--~~~  111 (369)
T 3c5i_A           39 KQILSGLTNQLFEVGLKEETANNYNSIRTRVLFRIYGKHV---DELYNTISEFEVYKTMSKYKIAPQLLNTF--N--GGR  111 (369)
T ss_dssp             EEC----CCEEEEEEECHHHHTTCTTSCCEEEEEECCTTG---GGTSCHHHHHHHHHHHHHTTSSCCEEEEE--T--TEE
T ss_pred             EEeCCcccceEEEEEeCCCCcccccCCCceEEEEecCCCc---cceecHHHHHHHHHHHHhcCCCCceEEec--C--CcE
Confidence            456778888999988754          688999876431   11112357888888775333 45777654  2  368


Q ss_pred             EEecCCCCC
Q 015868          191 VTEFMARGS  199 (399)
Q Consensus       191 V~E~~~ggs  199 (399)
                      ||||++|.+
T Consensus       112 v~e~i~G~~  120 (369)
T 3c5i_A          112 IEEWLYGDP  120 (369)
T ss_dssp             EEECCCSEE
T ss_pred             EEEEecCCc
Confidence            999998853

>1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6

Probab=97.15  E-value=0.0028  Score=59.49  Aligned_cols=136  Identities=14%  Similarity=0.142  Sum_probs=78.4

Q ss_pred             eeceeCceEEEEEEEC-CeeEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCc--eeeEEeE-----EecCCcEEEEEec
Q 015868          123 KVASGSYGDLYKGTYC-SQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKN--VVQFIGA-----CTRPPNLCIVTEF  194 (399)
Q Consensus       123 ~lg~G~~g~Vy~~~~~-~~~vAvK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~n--Iv~~~~~-----~~~~~~~~lV~E~  194 (399)
                      .++ |....||+.+.. ++.+++|+..+.....   ..+..|..+++.+...+  +++++..     ....+..+++|++
T Consensus        33 ~l~-g~~n~~y~v~~~~g~~~vlK~~~~~~~~~---~~~~~E~~~~~~L~~~g~~vp~~~~~~g~~~~~~~g~~~~l~~~  108 (328)
T 1zyl_A           33 PLN-SYENRVYQFQDEDRRRFVVKFYRPERWTA---DQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPS  108 (328)
T ss_dssp             EEC-CSSSEEEEECCTTCCCEEEEEECTTTSCH---HHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEEC
T ss_pred             eec-CcccceEEEEcCCCCEEEEEEcCCCCCCH---HHHHHHHHHHHHHHHcCCeecceeecCCcEEEEECCEEEEEEEe
Confidence            455 777889988763 5579999997653333   34556777777774222  4445443     1223456889999


Q ss_pred             CCCCCHH-----H------H---HHhc--C------CCCCHHHH----------------------HHHHHHHHHHHHHH
Q 015868          195 MARGSIY-----D------F---LHKQ--K------GVFQLTSL----------------------LKVAIDVSKGMNYL  230 (399)
Q Consensus       195 ~~ggsL~-----~------~---l~~~--~------~~l~~~~~----------------------~~i~~~i~~~L~~L  230 (399)
                      ++|.++.     .      .   ++..  .      ........                      ...+.+++..+.-+
T Consensus       109 i~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~  188 (328)
T 1zyl_A          109 VGGRQFEADNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIAAVTAH  188 (328)
T ss_dssp             CCCEECCSSCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHHHHHHH
T ss_pred             cCCCCCCCCCHHHHHHHHHHHHHHHHhhccCCCccCCCCCHHHHHhhHHHHHhhcCcCCHHHHHHHHHHHHHHHHHHHHH
Confidence            9885321     1      1   1111  0      01111110                      11111222222222


Q ss_pred             ----HHCCcccCCCCCCceeecCCCcEEEeeccceeec
Q 015868          231 ----HQNNIIHRDLKTANLLMDENGVVKVADFGVARVQ  264 (399)
Q Consensus       231 ----H~~giiHrDlkp~NILl~~~~~vkl~DFG~a~~~  264 (399)
                          ....++|+|+++.||+++ + .+.|+||+.+...
T Consensus       189 ~~~~~~~~l~HgD~~~~Nil~~-~-~~~lIDfe~a~~g  224 (328)
T 1zyl_A          189 WREDFTVLRLHGDCHAGNILWR-D-GPMFVDLDDARNG  224 (328)
T ss_dssp             CCSCSCCEECCSSCSGGGEEES-S-SEEECCCTTCCEE
T ss_pred             hhhcCCeeeeeCCCCcccEeEc-C-CCEEEECCCCCcC
Confidence                234689999999999998 4 8999999988643

>3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A*

Probab=97.12  E-value=0.0017  Score=62.85  Aligned_cols=134  Identities=13%  Similarity=0.195  Sum_probs=79.9

Q ss_pred             eeceeCceEEEEEEEC---------CeeEEEEEecCCCCCHHHHHHHHHHHHHHHhcC-CCceeeEEeEEecCCcEEEEE
Q 015868          123 KVASGSYGDLYKGTYC---------SQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIR-HKNVVQFIGACTRPPNLCIVT  192 (399)
Q Consensus       123 ~lg~G~~g~Vy~~~~~---------~~~vAvK~~~~~~~~~~~~~~~~~Ei~~l~~l~-h~nIv~~~~~~~~~~~~~lV~  192 (399)
                      .|..|-...+|+.+..         ++.+.+|+.....   .....+.+|..+++.+. +.-.+++++.+..    .+||
T Consensus        57 ~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlR~~g~~~---~~~~~~~rE~~vl~~L~~~gv~P~ll~~~~~----g~v~  129 (379)
T 3feg_A           57 PVSGGLSNLLFRCSLPDHLPSVGEEPREVLLRLYGAIL---QGVDSLVLESVMFAILAERSLGPQLYGVFPE----GRLE  129 (379)
T ss_dssp             EC-----CCEEEEECCTTSCCCSSCCSEEEEEECC------CCHHHHHHHHHHHHHHHHTTSSCCEEEEETT----EEEE
T ss_pred             EcCCcccccEEEEEeCCCccccCCCCCeEEEEECCCcc---chHHHHHHHHHHHHHHHhcCCCCeEEEEcCC----ccEE
Confidence            5666777788888763         3678999864321   12345568999998884 3334677776654    3999


Q ss_pred             ecCCCCCHH--------------HH---HHhcCC----CCC--HHHHHHHHHHHHH-------------------HHHHH
Q 015868          193 EFMARGSIY--------------DF---LHKQKG----VFQ--LTSLLKVAIDVSK-------------------GMNYL  230 (399)
Q Consensus       193 E~~~ggsL~--------------~~---l~~~~~----~l~--~~~~~~i~~~i~~-------------------~L~~L  230 (399)
                      ||++|.+|.              +.   ++...-    ...  ..++.++..++-.                   .+..|
T Consensus       130 e~i~G~~l~~~~l~~p~~~~~ia~~La~LH~~~~~~~~~~~~l~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~~~~~~L  209 (379)
T 3feg_A          130 QYIPSRPLKTQELREPVLSAAIATKMAQFHGMEMPFTKEPHWLFGTMERYLKQIQDLPPTGLPEMNLLEMYSLKDEMGNL  209 (379)
T ss_dssp             ECCSEEECCGGGGGCHHHHHHHHHHHHHHHTCCCSSCCSCCHHHHHHHHHHHHHHHCCCCSCCSCCHHHHTTHHHHHHHH
T ss_pred             EEecCccCChhHhCCHHHHHHHHHHHHHHhCCCCCCCCCcccHHHHHHHHHHHHHhccCcccchhhhhhhHHHHHHHHHH
Confidence            999985432              11   122111    111  2445555544322                   23333


Q ss_pred             H----H----CCcccCCCCCCceeecCC----CcEEEeeccceee
Q 015868          231 H----Q----NNIIHRDLKTANLLMDEN----GVVKVADFGVARV  263 (399)
Q Consensus       231 H----~----~giiHrDlkp~NILl~~~----~~vkl~DFG~a~~  263 (399)
                      .    .    ..++|+|+.+.||+++.+    +.+.|+||..+..
T Consensus       210 ~~~L~~~~~~~~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~~  254 (379)
T 3feg_A          210 RKLLESTPSPVVFCHNDIQEGNILLLSEPENADSLMLVDFEYSSY  254 (379)
T ss_dssp             HHHHHTSCCCEEEECSCCCGGGEEEESCC---CCEEECCCTTCEE
T ss_pred             HHHHhhcCCCcEEEcCCCCCCeEEEcCCCCccCcEEEEecccCCc
Confidence            3    2    258999999999999876    7899999998864

>3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A*

Probab=97.06  E-value=0.0022  Score=60.97  Aligned_cols=68  Identities=15%  Similarity=0.036  Sum_probs=44.2

Q ss_pred             ceeCceEEEEEEECCeeEEEEEecCCCCCHHHHHHHHHHHHHHHhcC---CCceeeEEeE------EecCCcEEEEEecC
Q 015868          125 ASGSYGDLYKGTYCSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIR---HKNVVQFIGA------CTRPPNLCIVTEFM  195 (399)
Q Consensus       125 g~G~~g~Vy~~~~~~~~vAvK~~~~~~~~~~~~~~~~~Ei~~l~~l~---h~nIv~~~~~------~~~~~~~~lV~E~~  195 (399)
                      |.|....||+.+..+..+++|+......        ..|..+++.+.   -|++++++..      ....+..++||+|+
T Consensus        32 G~g~~N~vy~v~~~~g~~vLK~~~~~~~--------~~E~~~l~~L~~~g~~~vp~pi~~~~G~~~~~~~g~~~~l~~~i  103 (339)
T 3i1a_A           32 GADTNAFAYQADSESKSYFIKLKYGYHD--------EINLSIIRLLHDSGIKEIIFPIHTLEAKLFQQLKHFKIIAYPFI  103 (339)
T ss_dssp             TSCSSCEEEEEECSSCEEEEEEEECSSC--------CHHHHHHHHHHHTTCCSSCCCCCCTTSCSSEECSSEEEEEEECC
T ss_pred             cCccccceEEEEeCCCCEEEEEecCccc--------hHHHHHHHHHHhcCCcccccceecCCCCEEEEECCEEEEEEecc
Confidence            4455678999987556999999876542        24555565553   2325555532      23346689999999


Q ss_pred             CCCCH
Q 015868          196 ARGSI  200 (399)
Q Consensus       196 ~ggsL  200 (399)
                      +|..+
T Consensus       104 ~G~~~  108 (339)
T 3i1a_A          104 HAPNG  108 (339)
T ss_dssp             CCCBT
T ss_pred             CCCcC
Confidence            98654

>2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax}

Probab=96.94  E-value=0.005  Score=61.05  Aligned_cols=72  Identities=19%  Similarity=0.111  Sum_probs=47.6

Q ss_pred             eceeceeCceEEEEEEECC--eeEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCce-eeEEeEEecCCcEEEEEecCCC
Q 015868          121 ECKVASGSYGDLYKGTYCS--QEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNV-VQFIGACTRPPNLCIVTEFMAR  197 (399)
Q Consensus       121 ~~~lg~G~~g~Vy~~~~~~--~~vAvK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~nI-v~~~~~~~~~~~~~lV~E~~~g  197 (399)
                      .+.|+.|-...+|+.+..+  ..+++|+.......   .-...+|..+++.+...++ +++++.+. +   .+||||++|
T Consensus       113 i~~lsgG~tN~~y~v~~~~~~~~~vLRi~g~~~~~---~idR~~E~~vl~~L~~~gl~P~ll~~~~-~---G~v~e~I~G  185 (458)
T 2qg7_A          113 FQIINGGITNILIKVKDMSKQAKYLIRLYGPKTDE---IINREREKKISCILYNKNIAKKIYVFFT-N---GRIEEFMDG  185 (458)
T ss_dssp             EEEECC--CEEEEEEEETTTTEEEEEEEECC-CCS---CSCHHHHHHHHHHHTTSSSBCCEEEEET-T---EEEEECCCS
T ss_pred             EEEcCCCeEeEEEEEEECCCCceEEEEECCCChhh---hcCHHHHHHHHHHHHhcCCCCCEEEEeC-C---eEEEEeeCC
Confidence            3467778889999999876  88999998543111   0112478889998864444 67777763 2   359999988


Q ss_pred             CC
Q 015868          198 GS  199 (399)
Q Consensus       198 gs  199 (399)
                      .+
T Consensus       186 ~~  187 (458)
T 2qg7_A          186 YA  187 (458)
T ss_dssp             EE
T ss_pred             cc
Confidence            53

>3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum}

Probab=96.21  E-value=0.0076  Score=59.10  Aligned_cols=71  Identities=11%  Similarity=0.157  Sum_probs=46.7

Q ss_pred             ceeceeCceEEEEEEEC---------CeeEEEEEecCCCCCHHHHHHHHHHHHHHHhcC-CCceeeEEeEEecCCcEEEE
Q 015868          122 CKVASGSYGDLYKGTYC---------SQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIR-HKNVVQFIGACTRPPNLCIV  191 (399)
Q Consensus       122 ~~lg~G~~g~Vy~~~~~---------~~~vAvK~~~~~~~~~~~~~~~~~Ei~~l~~l~-h~nIv~~~~~~~~~~~~~lV  191 (399)
                      +.+..|-...+|+.+..         ++.+++++.....   +..-...+|..+++.+. +.-.+++++.+.    -++|
T Consensus        76 ~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlRi~g~~t---~~~idR~~E~~~l~~L~~~gi~P~l~~~~~----~~~I  148 (424)
T 3mes_A           76 KQIFSGLTNQLFVVSIVNESMSLSLKHPRILFRIYGKHV---GKFYDSKVELDVFRYLSNINIAPNIIADFP----EGRI  148 (424)
T ss_dssp             EEECCCSSSEEEEEEECCC-----CCCSEEEEEECCCCC----CCCCHHHHHHHHHHHHHTTSSCCEEEEET----TEEE
T ss_pred             EEcCCCcccceEEEEeCCCcccccCCCCeEEEEECCCCc---chhcCHHHHHHHHHHHHhcCCCCCEEEEcC----CCEE
Confidence            45666888889998876         5789999965431   11112346888888774 333456665442    2789


Q ss_pred             EecCCCCC
Q 015868          192 TEFMARGS  199 (399)
Q Consensus       192 ~E~~~ggs  199 (399)
                      |||++|.+
T Consensus       149 ~efI~G~~  156 (424)
T 3mes_A          149 EEFIDGEP  156 (424)
T ss_dssp             EECCCSEE
T ss_pred             EEEeCCcc
Confidence            99999864

>1u8s_A Glycine cleavage system transcriptional repressor, putative; structural genomics, protein structure initiative (PSI), domain swapping; 2.45A {Vibrio cholerae} SCOP: d.58.18.5 d.58.18.5

Probab=94.91  E-value=0.024  Score=49.06  Aligned_cols=52  Identities=17%  Similarity=0.223  Sum_probs=42.4

Q ss_pred             HHHHHHHHhhhhCCCeeeeceeccCCCceeeEEEecCCCCcchHHHHHHHHHHH
Q 015868           10 KVGELTSLLGEIGLNIQEAHAFSTVDGFSLDVFVVDGWPYDETEDLKNVLAKEI   63 (399)
Q Consensus        10 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~~~~~~l~~~l~~~~   63 (399)
                      +++++|.+|++.|+||.++..|.+.++|.+ .++|++- .+..++|+++|.+..
T Consensus        19 iva~vt~~La~~g~NI~d~~~~~~~~~f~~-~~~v~~~-~~~~~~l~~~L~~~~   70 (192)
T 1u8s_A           19 ICNEVVRLVTQAGCNIIDSRIAMFGKEFTL-LMLISGS-PSNITRVETTLPLLG   70 (192)
T ss_dssp             HHHHHHHHHHHTTCEEEEEEEEEETTEEEE-EEEEEEC-HHHHHHHHHHHHHHH
T ss_pred             HHHHHHHHHHHCCCCEEeeeeeecCCceEE-EEEEecC-CCCHHHHHHHHHHHH
Confidence            688999999999999999999999999999 8888763 245566777776543

>3g15_A CK, chetk-alpha, choline kinase alpha; non-protein kinase, structural genomics CONS SGC, hemicholinium-3, transferase; HET: ADP HC6; 1.70A {Homo sapiens} PDB: 3f2r_A* 2i7q_A 2cko_A 2ckp_A* 2ckq_A*

Probab=94.05  E-value=0.22  Score=48.12  Aligned_cols=29  Identities=24%  Similarity=0.437  Sum_probs=25.3

Q ss_pred             cccCCCCCCceee------cCCCcEEEeeccceee
Q 015868          235 IIHRDLKTANLLM------DENGVVKVADFGVARV  263 (399)
Q Consensus       235 iiHrDlkp~NILl------~~~~~vkl~DFG~a~~  263 (399)
                      ++|+|+.+.|||+      ++++.+.++||..|..
T Consensus       246 fcHnDl~~gNil~~~~~~~~~~~~l~vIDwEya~~  280 (401)
T 3g15_A          246 FCHNDCQEGNILLLEGRENSEKQKLMLIDFEYSSY  280 (401)
T ss_dssp             EECSCCCGGGEEEETTGGGCSSCCEEECCCTTCEE
T ss_pred             eEEecCCCCeEEEecCcccCcCCeEEEechHhccC
Confidence            6799999999999      4567899999998864

>2nyi_A Unknown protein; protein structure initiative, PSI, center for eukaryotic structural genomics, CESG, structural genomics; 1.80A {Galdieria sulphuraria}

Probab=93.69  E-value=0.059  Score=46.76  Aligned_cols=36  Identities=17%  Similarity=0.253  Sum_probs=32.9

Q ss_pred             HHHHHHHHhhhhCCCeeeeceeccCCCceeeEEEecC
Q 015868           10 KVGELTSLLGEIGLNIQEAHAFSTVDGFSLDVFVVDG   46 (399)
Q Consensus        10 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g   46 (399)
                      ++++++..|++.|+||.+|..|.+.++|.+ .|+|+.
T Consensus        18 iva~vs~~La~~g~NI~da~q~~~~~~f~m-~~~v~~   53 (195)
T 2nyi_A           18 IVHDFSWALKNISANVESSRMACLGGDFAM-IVLVSL   53 (195)
T ss_dssp             HHHHHHHHHHHTTCEEEEEEEEEETTEEEE-EEEEEE
T ss_pred             HHHHHHHHHHHCCCCEEEEEeEEECCeEEE-EEEEEe
Confidence            678999999999999999999999999999 777764

>1zpv_A ACT domain protein; structural genomics, PSI, protein structure INIT midwest center for structural genomics, MCSG, unknown funct; 1.90A {Streptococcus pneumoniae} SCOP: d.58.18.7

Probab=93.33  E-value=0.17  Score=37.58  Aligned_cols=54  Identities=19%  Similarity=0.131  Sum_probs=43.6

Q ss_pred             HHHHHHHHhhhhCCCeeeeceeccCCCceeeEEEecCCCCcchHHHHHHHHHHHh
Q 015868           10 KVGELTSLLGEIGLNIQEAHAFSTVDGFSLDVFVVDGWPYDETEDLKNVLAKEIL   64 (399)
Q Consensus        10 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~~~~~~l~~~l~~~~~   64 (399)
                      +|+.+|.+|++.|.||.+.+++... |...=.+.|+.-..++.++|.++|++...
T Consensus        18 ila~vt~~la~~~~NI~~i~~~~~~-~~~~~~i~v~~~~~~~l~~l~~~L~~~~~   71 (91)
T 1zpv_A           18 IVAGVSGKIAELGLNIDDISQTVLD-EYFTMMAVVSSDEKQDFTYLRNEFEAFGQ   71 (91)
T ss_dssp             HHHHHHHHHHHTTCEEEEEEEEEET-TEEEEEEEEEESSCCCHHHHHHHHHHHHH
T ss_pred             HHHHHHHHHHHcCCCEEEEEeEEEc-CEEEEEEEEEeCCCCCHHHHHHHHHHHHH
Confidence            6899999999999999999998775 76666666766556788899999976543

>3cxl_A N-chimerin; SH2, RHO-GAP, structural genomics consortium, SGC, gtpas activation, metal-binding, phorbol-ester binding, SH2 domai finger; 2.60A {Homo sapiens} PDB: 1xa6_A

Probab=91.99  E-value=0.013  Score=58.06  Aligned_cols=62  Identities=11%  Similarity=0.046  Sum_probs=18.1

Q ss_pred             ceeceeceeCceEEEEEEECC--eeEEE------EEecCCCCCHHHHHHHHHHHHHHHhcCCCceeeEEeEEe
Q 015868          119 KIECKVASGSYGDLYKGTYCS--QEVAI------KVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACT  183 (399)
Q Consensus       119 ~i~~~lg~G~~g~Vy~~~~~~--~~vAv------K~~~~~~~~~~~~~~~~~Ei~~l~~l~h~nIv~~~~~~~  183 (399)
                      .+.++||   ||.||+|.+.+  .+||+      |..+......+....+.+|..+++.++|||+++.+++..
T Consensus       145 ~l~~~lG---fG~v~~g~~~~~~~~Vav~~~~~~K~~~~~~~~~e~~~~~~rea~l~~~~~H~niv~~h~f~~  214 (463)
T 3cxl_A          145 PIYEHVG---YTTLNREPAYKKHMPVLKETHDERDSTGQDGVSEKRLTSLVRRATLKENEQIPKYEKIHNFKV  214 (463)
T ss_dssp             CSTTTSS---BCCC---------CCBGGGC-----------------------------------CBCCCEEE
T ss_pred             cccccCC---chhhhcccccccCCchhhhhccCccccccccccccccccccccccccccccccccCCCcceEE
Confidence            3455676   99999998865  47888      777665555566677899999999999999999988753

>2ko1_A CTR148A, GTP pyrophosphokinase; homodimer, alpha+beta, transferase, structural genomics, PSI-2, protein structure initiative; NMR {Chlorobaculum tepidum} PDB: 3ibw_A

Probab=91.04  E-value=0.26  Score=36.16  Aligned_cols=49  Identities=12%  Similarity=0.061  Sum_probs=34.8

Q ss_pred             HHHHHHHHhhhhCCCeeeeceeccCCCceeeEEEecCCCCcchHHHHHHH
Q 015868           10 KVGELTSLLGEIGLNIQEAHAFSTVDGFSLDVFVVDGWPYDETEDLKNVL   59 (399)
Q Consensus        10 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~~~~~~l~~~l   59 (399)
                      +|++++++|++.|.||..+......+ ....+|.++.-..+..+++.++|
T Consensus        18 ~L~~I~~~la~~~inI~~i~~~~~~~-~~~~~i~v~~~~~~~l~~l~~~L   66 (88)
T 2ko1_A           18 MTNQITGVISKFDTNIRTIVLNAKDG-IFTCNLMIFVKNTDKLTTLMDKL   66 (88)
T ss_dssp             HHHHHHHHHTTSSSCEEEEEEEECSS-EEEEEEEEEESSHHHHHHHHHHH
T ss_pred             HHHHHHHHHHHCCCCeEEEEEEEcCC-EEEEEEEEEECCHHHHHHHHHHH
Confidence            68999999999999999999876554 66666766654433334444433

>4ann_A ESSB; membrane protein, membrane secretion, ESS type VII secretion virulence; 1.05A {Staphylococcus aureus subsp}

Probab=84.34  E-value=2.4  Score=37.06  Aligned_cols=115  Identities=9%  Similarity=0.085  Sum_probs=77.9

Q ss_pred             CCCceeeEEeEEecCCcEEEEEecCCC-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceeecC
Q 015868          171 RHKNVVQFIGACTRPPNLCIVTEFMAR-GSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDE  249 (399)
Q Consensus       171 ~h~nIv~~~~~~~~~~~~~lV~E~~~g-gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~giiHrDlkp~NILl~~  249 (399)
                      .||+++.. .+-...+.+.+.++.-+. .++.. +    ...+....++++.+|+....+++  .-+|--+.|+||+++.
T Consensus        43 ~~~~Fl~~-~I~e~eD~v~~~y~~~~~~~~f~~-i----k~~~~~eKlr~l~ni~~l~~~~~--~r~tf~L~P~NL~f~~  114 (215)
T 4ann_A           43 HSPYFIDA-ELTELRDSFQIHYDINDNHTPFDN-I----KSFTKNEKLRYLLNIKNLEEVNR--TRYTFVLAPDELFFTR  114 (215)
T ss_dssp             CCTTBCCE-EEEECSSEEEEEECCCTTSEEGGG-G----GGSCHHHHHHHHHHGGGGGGGGG--SSEECCCSGGGEEECT
T ss_pred             cCCcccce-EEEEcccEEEEEEEcCcccCCHHH-H----HhcCHHHHHHHHHHHHHHHHHhc--CceEEEEecceEEEcC
Confidence            58888876 455666677777775442 23333 3    23578889999999988774443  3467778999999999


Q ss_pred             CCcEEEeeccceeeccCCCccccCCCCcccccccccCCCCCCChhhHHHHHHHHHHHHcCCCCCC
Q 015868          250 NGVVKVADFGVARVQAQSGVMTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPYA  314 (399)
Q Consensus       250 ~~~vkl~DFG~a~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~Dv~slG~vl~elltg~~P~~  314 (399)
                      ++.++++-.|+....                +|.     .++...=.-..=|++..+++++..|.
T Consensus       115 ~~~p~i~~RGik~~l----------------~P~-----~~~ee~fL~qyKAliiall~~K~~Fe  158 (215)
T 4ann_A          115 DGLPIAKTRGLQNVV----------------DPL-----PVSEAEFLTRYKALVICAFNEKQSFD  158 (215)
T ss_dssp             TSCEEESCCEETTTB----------------SCC-----CCCHHHHHHHHHHHHHHHHCTTCCHH
T ss_pred             CCCEEEEEccCccCC----------------CCC-----CCCHHHHHHHHHHHHHHHHcCCCCHH
Confidence            999999988865322                121     12222334466678888999888773

>2f1f_A Acetolactate synthase isozyme III small subunit; ferredoxin fold, ACT domain, transferase; HET: P33 1PE; 1.75A {Escherichia coli} SCOP: d.58.18.6 d.58.18.6

Probab=83.29  E-value=1.9  Score=35.99  Aligned_cols=37  Identities=22%  Similarity=0.253  Sum_probs=33.6

Q ss_pred             HHHHHHHHhhhhCCCeeeeceeccCC-CceeeEEEecC
Q 015868           10 KVGELTSLLGEIGLNIQEAHAFSTVD-GFSLDVFVVDG   46 (399)
Q Consensus        10 ~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~g   46 (399)
                      +|++++.++++-|.||.-..+..|.| |++-=.|+|+|
T Consensus        16 vLarIt~lfs~rg~NI~Sl~v~~t~d~~~sriti~V~~   53 (164)
T 2f1f_A           16 ALSRVIGLFSQRGYNIESLTVAPTDDPTLSRMTIQTVG   53 (164)
T ss_dssp             HHHHHHHHHHTTTCCCSEEEEEECSCSSEEEEEEEEES
T ss_pred             HHHHHHHHHHHCCCCeeeceeeecCCCCEEEEEEEEec
Confidence            68999999999999999999998886 88888889994

>4ano_A ESSB; membrane protein, membrane secretion, ESS type V secretion S; HET: MSE; 1.70A {Geobacillus thermodenitrificans ng80-2organism_taxid}

Probab=80.74  E-value=3.5  Score=36.13  Aligned_cols=113  Identities=12%  Similarity=0.061  Sum_probs=74.6

Q ss_pred             CCCceeeEEeEEecCCcEEEEEecCCCC-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHH-HHHHCCcccCCCCCCceeec
Q 015868          171 RHKNVVQFIGACTRPPNLCIVTEFMARG-SIYDFLHKQKGVFQLTSLLKVAIDVSKGMN-YLHQNNIIHRDLKTANLLMD  248 (399)
Q Consensus       171 ~h~nIv~~~~~~~~~~~~~lV~E~~~gg-sL~~~l~~~~~~l~~~~~~~i~~~i~~~L~-~LH~~giiHrDlkp~NILl~  248 (399)
                      .||++  --.+-...+.+.+.++.-+++ ++. .++    .++....++++.+|+.... ++  ..-+|--+.|+||+++
T Consensus        48 ~~~~f--~~~I~~~eD~~~i~y~~~~~~~~f~-~i~----~~~~~eKlrll~nl~~L~~~~~--~~r~tf~l~P~NL~f~  118 (219)
T 4ano_A           48 VDPCI--VRDIDVSEDEVKVVIKPPSSFLTFA-AIR----KTTLLSRIRAAIHLVSKVKHHS--ARRLIFIVCPENLMFN  118 (219)
T ss_dssp             SCSSS--EEEEEECSSEEEEEEECCTTCEEHH-HHH----TSCHHHHHHHHHHHHHHHSSCC--SSSEECCCCGGGEEEC
T ss_pred             cCCCC--CeEEEEeCCEEEEEEEcCcccCcHH-HHH----hcCHHHHHHHHHHHHHHHHHhh--hCceeEEEeCceEEEe
Confidence            57888  333446677787878765443 444 332    3578888999999887655 44  4456777889999999


Q ss_pred             CCCcEEEeeccceeeccCCCccccCCCCcccccccccCCCCCCChhhHHHHHHHHHHHHcCCCCC
Q 015868          249 ENGVVKVADFGVARVQAQSGVMTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPY  313 (399)
Q Consensus       249 ~~~~vkl~DFG~a~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~Dv~slG~vl~elltg~~P~  313 (399)
                      .++.+++.-.|+-...                +|..+     +...=+-..=|++..++.++..|
T Consensus       119 ~~~~p~i~hRGi~~~l----------------pP~e~-----~ee~fl~qyKali~all~~K~~F  162 (219)
T 4ano_A          119 RALEPFFLHVGVKESL----------------PPDEW-----DDERLLREVKATVLALTEGEYRF  162 (219)
T ss_dssp             TTCCEEESCCEETTTB----------------SSCSC-----CHHHHHHHHHHHHHHHTTCSSCH
T ss_pred             CCCcEEEEEcCCcccC----------------CCCCC-----CHHHHHHHHHHHHHHHHcCCCCH
Confidence            9999999988865432                22221     11122335667777888777766

---

Homologous Structure Domains

Structure Domains Detected by RPS-BLAST

Original result of RPS-BLAST against SCOP70(version1.75) database

ID	Length	Definition	E-value
Query	399
d1uwha_	276	d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens)	1e-89
d1byga_	262	d.144.1.7 (A:) Carboxyl-terminal src kinase (csk)	2e-81
d1xbba_	277	d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human	1e-76
d1u59a_	285	d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum	1e-75
d1qpca_	272	d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom	2e-75
d1fmka3	285	d.144.1.7 (A:249-533) c-src tyrosine kinase {Human	2e-75
d1opja_	287	d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou	3e-74
d1rjba_	325	d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s	7e-74
d1sm2a_	263	d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu	1e-73
d2j4za1	263	d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur	4e-73
d1k2pa_	258	d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum	8e-73
d1u46a_	273	d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum	9e-73
d2jfla1	288	d.144.1.7 (A:21-308) STE20-like serine/threonine-p	4e-72
d1t4ha_	270	d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa	2e-71
d1jpaa_	299	d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou	3e-71
d1mqba_	283	d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum	5e-71
d1u5ra_	309	d.144.1.7 (A:) Serine/threonine protein kinase TAO	7e-71
d1t46a_	311	d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens	1e-70
d1mp8a_	273	d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma	1e-69
d1fvra_	309	d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [	2e-69
d2java1	269	d.144.1.7 (A:3-271) Serine/threonine-protein kinas	7e-69
d1yhwa1	293	d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [	4e-68
d1lufa_	301	d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n	1e-67
d1koaa2	350	d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C	5e-67
d1koba_	352	d.144.1.7 (A:) Twitchin, kinase domain {California	2e-66
d1r0pa_	311	d.144.1.7 (A:) Hepatocyte growth factor receptor,	2e-66
d1xkka_	317	d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-	1e-65
d1nvra_	271	d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {	3e-65
d1s9ja_	322	d.144.1.7 (A:) Dual specificity mitogen-activated	3e-65
d1fgka_	299	d.144.1.7 (A:) Fibroblast growth factor receptor 1	5e-65
d1p4oa_	308	d.144.1.7 (A:) Insulin-like growth factor 1 recept	8e-65
d1ywna1	299	d.144.1.7 (A:818-1166) Vascular endothelial growth	8e-65
d1uu3a_	288	d.144.1.7 (A:) 3-phosphoinositide dependent protei	9e-64
d1tkia_	321	d.144.1.7 (A:) Titin, kinase domain {Human (Homo s	3e-63
d1vjya_	303	d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human	2e-62
d1a06a_	307	d.144.1.7 (A:) Calmodulin-dependent protein kinase	1e-61
d1phka_	277	d.144.1.7 (A:) gamma-subunit of glycogen phosphory	3e-60
d1xjda_	320	d.144.1.7 (A:) Protein kinase C, theta type {Human	7e-60
d1fota_	316	d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni	7e-59
d1jksa_	293	d.144.1.7 (A:) Death-associated protein kinase, Da	4e-57
d1o6ya_	277	d.144.1.7 (A:) Mycobacterial protein kinase PknB,	2e-56
d1ckia_	299	d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n	2e-55
d1omwa3	364	d.144.1.7 (A:186-549) G-protein coupled receptor k	2e-55
d1xwsa_	273	d.144.1.7 (A:) Proto-oncogene serine/threonine-pro	1e-53
d2ozaa1	335	d.144.1.7 (A:51-385) MAP kinase activated protein	2e-53
d1o6la_	337	d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap	2e-53
d1csna_	293	d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast	1e-52
d1blxa_	305	d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H	1e-51
d1ua2a_	299	d.144.1.7 (A:) Cell division protein kinase 7, CDK	8e-51
d1rdqe_	350	d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni	4e-49
d1gz8a_	298	d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H	1e-48
d1ob3a_	286	d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod	4e-48
d1pmea_	345	d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien	1e-46
d1vzoa_	322	d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5	3e-46
d3blha1	318	d.144.1.7 (A:8-325) Cell division protein kinase 9	9e-46
d1cm8a_	346	d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s	1e-44
d1q5ka_	350	d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs	2e-44
d1unla_	292	d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H	8e-44
d2gfsa1	348	d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa	9e-41
d2b1pa1	355	d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3	2e-38
d3bqca1	328	d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu	1e-37
d1q8ya_	362	d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces	2e-28
d1zara2	191	d.144.1.9 (A:91-281) Rio2 serine protein kinase C-	4e-18

>d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: B-Raf kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  269 bits (690), Expect = 1e-89
 Identities = 93/276 (33%), Positives = 158/276 (57%), Gaps = 12/276 (4%)

Query: 109 DVWEIDAKQLKIECKVASGSYGDLYKGTYCSQEVAIKVLKPECVNTEMLKEFSQEVYIMR 168
           D WEI   Q+ +  ++ SGS+G +YKG +   +VA+K+L       + L+ F  EV ++R
Sbjct: 1   DDWEIPDGQITVGQRIGSGSFGTVYKGKW-HGDVAVKMLNVTAPTPQQLQAFKNEVGVLR 59

Query: 169 KIRHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMN 228
           K RH N++ F+G  T P  L IVT++    S+Y  LH  +  F++  L+ +A   ++GM+
Sbjct: 60  KTRHVNILLFMGYSTAP-QLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMD 118

Query: 229 YLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQ---SGVMTAETGTYRWMAPEVI 285
           YLH  +IIHRDLK+ N+ + E+  VK+ DFG+A V+++   S      +G+  WMAPEVI
Sbjct: 119 YLHAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVI 178

Query: 286 EHK---PYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKSLR----PTIPKHA 338
             +   PY +++DV++FGI L+EL+TG+LPY+ +      + +V +         +  + 
Sbjct: 179 RMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPDLSKVRSNC 238

Query: 339 HPRLAELLERCWQHDPTQRPNFSQITDILKQMMKEV 374
              +  L+  C +    +RP F QI   ++ + + +
Sbjct: 239 PKAMKRLMAECLKKKRDERPLFPQILASIELLARSL 274

>d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Carboxyl-terminal src kinase (csk)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  248 bits (634), Expect = 2e-81
 Identities = 92/263 (34%), Positives = 147/263 (55%), Gaps = 10/263 (3%)

Query: 111 WEIDAKQLKIECKVASGSYGDLYKGTYCSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKI 170
           W ++ K+LK+   +  G +GD+  G Y   +VA+K +K    N    + F  E  +M ++
Sbjct: 2   WALNMKELKLLQTIGKGEFGDVMLGDYRGNKVAVKCIK----NDATAQAFLAEASVMTQL 57

Query: 171 RHKNVVQFIGACTRPPN-LCIVTEFMARGSIYDFLHKQ-KGVFQLTSLLKVAIDVSKGMN 228
           RH N+VQ +G        L IVTE+MA+GS+ D+L  + + V     LLK ++DV + M 
Sbjct: 58  RHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAME 117

Query: 229 YLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAETGTYRWMAPEVIEHK 288
           YL  NN +HRDL   N+L+ E+ V KV+DFG+ +  + +          +W APE +  K
Sbjct: 118 YLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASST--QDTGKLPVKWTAPEALREK 175

Query: 289 PYDYKADVFSFGIALWELLT-GELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRLAELLE 347
            +  K+DV+SFGI LWE+ + G +PY  + PL+  V  V+K  +   P    P + E+++
Sbjct: 176 KFSTKSDVWSFGILLWEIYSFGRVPYPRI-PLKDVVPRVEKGYKMDAPDGCPPAVYEVMK 234

Query: 348 RCWQHDPTQRPNFSQITDILKQM 370
            CW  D   RP+F Q+ + L+ +
Sbjct: 235 NCWHLDAAMRPSFLQLREQLEHI 257

>d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase SYK
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  236 bits (604), Expect = 1e-76
 Identities = 77/278 (27%), Positives = 141/278 (50%), Gaps = 13/278 (4%)

Query: 113 IDAKQLKIECKV-ASGSYGDLYKGTY----CSQEVAIKVLKPECVNTEMLKEFSQEVYIM 167
           +D K L +E K   SG++G + KG Y      + VA+K+LK E  +  +  E   E  +M
Sbjct: 3   LDRKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVM 62

Query: 168 RKIRHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGM 227
           +++ +  +V+ IG C    +  +V E    G +  +L + +   +  +++++   VS GM
Sbjct: 63  QQLDNPYIVRMIGICE-AESWMLVMEMAELGPLNKYLQQNRH-VKDKNIIELVHQVSMGM 120

Query: 228 NYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARV----QAQSGVMTAETGTYRWMAPE 283
            YL ++N +HRDL   N+L+      K++DFG+++     +      T      +W APE
Sbjct: 121 KYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPE 180

Query: 284 VIEHKPYDYKADVFSFGIALWELLT-GELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRL 342
            I +  +  K+DV+SFG+ +WE  + G+ PY G+   +    +++K  R   P      +
Sbjct: 181 CINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEV-TAMLEKGERMGCPAGCPREM 239

Query: 343 AELLERCWQHDPTQRPNFSQITDILKQMMKEVASEGEN 380
            +L+  CW +D   RP F+ +   L+    +V +EG +
Sbjct: 240 YDLMNLCWTYDVENRPGFAAVELRLRNYYYDVVNEGHH 277

>d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase ZAP-70
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  234 bits (597), Expect = 1e-75
 Identities = 74/284 (26%), Positives = 140/284 (49%), Gaps = 13/284 (4%)

Query: 111 WEIDAKQLKI-ECKVASGSYGDLYKGTYCS----QEVAIKVLKPECVNTEMLKEFSQEVY 165
             +    L I + ++  G++G + +G Y       +VAIKVLK         +E  +E  
Sbjct: 3   LFLKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQG-TEKADTEEMMREAQ 61

Query: 166 IMRKIRHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSK 225
           IM ++ +  +V+ IG C +   L +V E    G ++ FL  ++    ++++ ++   VS 
Sbjct: 62  IMHQLDNPYIVRLIGVC-QAEALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSM 120

Query: 226 GMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARV----QAQSGVMTAETGTYRWMA 281
           GM YL + N +HRDL   N+L+      K++DFG+++      +     +A     +W A
Sbjct: 121 GMKYLEEKNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYA 180

Query: 282 PEVIEHKPYDYKADVFSFGIALWELLT-GELPYAGLTPLQAAVGVVQKSLRPTIPKHAHP 340
           PE I  + +  ++DV+S+G+ +WE L+ G+ PY  +   +  +  +++  R   P    P
Sbjct: 181 PECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEV-MAFIEQGKRMECPPECPP 239

Query: 341 RLAELLERCWQHDPTQRPNFSQITDILKQMMKEVASEGENNHSN 384
            L  L+  CW +    RP+F  +   ++     +AS+ E +H +
Sbjct: 240 ELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSLASKVEGHHHH 283

>d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Lymphocyte kinase (lck)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  233 bits (595), Expect = 2e-75
 Identities = 80/273 (29%), Positives = 144/273 (52%), Gaps = 10/273 (3%)

Query: 109 DVWEIDAKQLKIECKVASGSYGDLYKGTYCS-QEVAIKVLKPECVNTEMLKEFSQEVYIM 167
           D WE+  + LK+  ++ +G +G+++ G Y    +VA+K LK   ++ +    F  E  +M
Sbjct: 6   DEWEVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPD---AFLAEANLM 62

Query: 168 RKIRHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGV-FQLTSLLKVAIDVSKG 226
           ++++H+ +V+     T+ P + I+TE+M  GS+ DFL    G+   +  LL +A  +++G
Sbjct: 63  KQLQHQRLVRLYAVVTQEP-IYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEG 121

Query: 227 MNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARV--QAQSGVMTAETGTYRWMAPEV 284
           M ++ + N IHRDL+ AN+L+ +    K+ADFG+AR+    +           +W APE 
Sbjct: 122 MAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEA 181

Query: 285 IEHKPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRLAE 344
           I +  +  K+DV+SFGI L E++T              +  +++  R   P +    L +
Sbjct: 182 INYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVRPDNCPEELYQ 241

Query: 345 LLERCWQHDPTQRPNFSQITDILKQMMKEVASE 377
           L+  CW+  P  RP F  +  +L+      A+E
Sbjct: 242 LMRLCWKERPEDRPTFDYLRSVLEDFF--TATE 272

>d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-src tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  233 bits (596), Expect = 2e-75
 Identities = 101/287 (35%), Positives = 158/287 (55%), Gaps = 15/287 (5%)

Query: 104 PTDGT--DVWEIDAKQLKIECKVASGSYGDLYKGTYCS-QEVAIKVLKPECVNTEMLKEF 160
            T G   D WEI  + L++E K+  G +G+++ GT+     VAIK LKP  ++ E    F
Sbjct: 3   QTQGLAKDAWEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPE---AF 59

Query: 161 SQEVYIMRKIRHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKG-VFQLTSLLKV 219
            QE  +M+K+RH+ +VQ     +  P + IVTE+M++GS+ DFL  + G   +L  L+ +
Sbjct: 60  LQEAQVMKKLRHEKLVQLYAVVSEEP-IYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDM 118

Query: 220 AIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARV--QAQSGVMTAETGTY 277
           A  ++ GM Y+ + N +HRDL+ AN+L+ EN V KVADFG+AR+    +           
Sbjct: 119 AAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPI 178

Query: 278 RWMAPEVIEHKPYDYKADVFSFGIALWELLT-GELPYAGLTPLQAAVGVVQKSLRPTIPK 336
           +W APE   +  +  K+DV+SFGI L EL T G +PY G+   +  +  V++  R   P 
Sbjct: 179 KWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVN-REVLDQVERGYRMPCPP 237

Query: 337 HAHPRLAELLERCWQHDPTQRPNFSQITDILKQMMKEVASE---GEN 380
                L +L+ +CW+ +P +RP F  +   L+        +   GEN
Sbjct: 238 ECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTSTEPQYQPGEN 284

>d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Abelsone tyrosine kinase (abl)
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  230 bits (588), Expect = 3e-74
 Identities = 92/270 (34%), Positives = 150/270 (55%), Gaps = 8/270 (2%)

Query: 109 DVWEIDAKQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVNTEMLKEFSQEVYI 166
           D WE++   + ++ K+  G YG++Y+G +   S  VA+K LK    +T  ++EF +E  +
Sbjct: 10  DKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKE---DTMEVEEFLKEAAV 66

Query: 167 MRKIRHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLH-KQKGVFQLTSLLKVAIDVSK 225
           M++I+H N+VQ +G CTR P   I+TEFM  G++ D+L    +       LL +A  +S 
Sbjct: 67  MKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISS 126

Query: 226 GMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSG--VMTAETGTYRWMAPE 283
            M YL + N IHRDL   N L+ EN +VKVADFG++R+                +W APE
Sbjct: 127 AMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPE 186

Query: 284 VIEHKPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRLA 343
            + +  +  K+DV++FG+ LWE+ T  +       L     +++K  R   P+    ++ 
Sbjct: 187 SLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEGCPEKVY 246

Query: 344 ELLERCWQHDPTQRPNFSQITDILKQMMKE 373
           EL+  CWQ +P+ RP+F++I    + M +E
Sbjct: 247 ELMRACWQWNPSDRPSFAEIHQAFETMFQE 276

>d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fl cytokine receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  231 bits (589), Expect = 7e-74
 Identities = 78/295 (26%), Positives = 135/295 (45%), Gaps = 35/295 (11%)

Query: 111 WEIDAKQLKIECKVASGSYGDLYKG-------TYCSQEVAIKVLKPECVNTEMLKEFSQE 163
           WE   + L+    + SG++G +          T  S +VA+K+LK +  ++   +    E
Sbjct: 32  WEFPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEK-ADSSEREALMSE 90

Query: 164 VYIMRKI-RHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQK-------------- 208
           + +M ++  H+N+V  +GACT    + ++ E+   G + ++L  ++              
Sbjct: 91  LKMMTQLGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQK 150

Query: 209 --------GVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGV 260
                    V     LL  A  V+KGM +L   + +HRDL   N+L+    VVK+ DFG+
Sbjct: 151 RLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAARNVLVTHGKVVKICDFGL 210

Query: 261 ARVQAQSGVMTAET---GTYRWMAPEVIEHKPYDYKADVFSFGIALWELLT-GELPYAGL 316
           AR                  +WMAPE +    Y  K+DV+S+GI LWE+ + G  PY G+
Sbjct: 211 ARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGI 270

Query: 317 TPLQAAVGVVQKSLRPTIPKHAHPRLAELLERCWQHDPTQRPNFSQITDILKQMM 371
                   ++Q   +   P +A   +  +++ CW  D  +RP+F  +T  L   +
Sbjct: 271 PVDANFYKLIQNGFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLGCQL 325

>d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase Itk/Tsk
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  228 bits (583), Expect = 1e-73
 Identities = 81/263 (30%), Positives = 137/263 (52%), Gaps = 6/263 (2%)

Query: 113 IDAKQLKIECKVASGSYGDLYKGTYCS-QEVAIKVLKPECVNTEMLKEFSQEVYIMRKIR 171
           ID  +L    ++ SG +G ++ G + +  +VAIK ++   ++ E   +F +E  +M K+ 
Sbjct: 2   IDPSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSEE---DFIEEAEVMMKLS 58

Query: 172 HKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLH 231
           H  +VQ  G C     +C+V EFM  G + D+L  Q+G+F   +LL + +DV +GM YL 
Sbjct: 59  HPKLVQLYGVCLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLE 118

Query: 232 QNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAET--GTYRWMAPEVIEHKP 289
           +  +IHRDL   N L+ EN V+KV+DFG+ R        ++       +W +PEV     
Sbjct: 119 EACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFSR 178

Query: 290 YDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRLAELLERC 349
           Y  K+DV+SFG+ +WE+ +              V  +    R   P+ A   + +++  C
Sbjct: 179 YSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLYKPRLASTHVYQIMNHC 238

Query: 350 WQHDPTQRPNFSQITDILKQMMK 372
           W+  P  RP FS++   L ++ +
Sbjct: 239 WKERPEDRPAFSRLLRQLAEIAE 261

>d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Aurora-related kinase 1 (aurora-2)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  227 bits (579), Expect = 4e-73
 Identities = 66/256 (25%), Positives = 122/256 (47%), Gaps = 9/256 (3%)

Query: 111 WEIDAKQLKIECKVASGSYGDLYKGTYCS--QEVAIKVLKPECVNTE-MLKEFSQEVYIM 167
           W ++    +I   +  G +G++Y          +A+KVL    +    +  +  +EV I 
Sbjct: 3   WALE--DFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQ 60

Query: 168 RKIRHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGM 227
             +RH N+++  G       + ++ E+   G++Y  L K    F          +++  +
Sbjct: 61  SHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKL-SKFDEQRTATYITELANAL 119

Query: 228 NYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAETGTYRWMAPEVIEH 287
           +Y H   +IHRD+K  NLL+   G +K+ADFG +   A S   T   GT  ++ PE+IE 
Sbjct: 120 SYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSV-HAPSSRRTTLCGTLDYLPPEMIEG 178

Query: 288 KPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRLAELLE 347
           + +D K D++S G+  +E L G+ P+   T  +    + +  +  T P        +L+ 
Sbjct: 179 RMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISR--VEFTFPDFVTEGARDLIS 236

Query: 348 RCWQHDPTQRPNFSQI 363
           R  +H+P+QRP   ++
Sbjct: 237 RLLKHNPSQRPMLREV 252

>d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Bruton's tyrosine kinase (Btk)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  226 bits (576), Expect = 8e-73
 Identities = 78/262 (29%), Positives = 138/262 (52%), Gaps = 8/262 (3%)

Query: 113 IDAKQLKIECKVASGSYGDLYKGTYCS-QEVAIKVLKPECVNTEMLKEFSQEVYIMRKIR 171
           ID K L    ++ +G +G +  G +    +VAIK++K   ++ +   EF +E  +M  + 
Sbjct: 1   IDPKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSED---EFIEEAKVMMNLS 57

Query: 172 HKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLH 231
           H+ +VQ  G CT+   + I+TE+MA G + ++L + +  FQ   LL++  DV + M YL 
Sbjct: 58  HEKLVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLE 117

Query: 232 QNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSG--VMTAETGTYRWMAPEVIEHKP 289
               +HRDL   N L+++ GVVKV+DFG++R                 RW  PEV+ +  
Sbjct: 118 SKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMYSK 177

Query: 290 YDYKADVFSFGIALWELLT-GELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRLAELLER 348
           +  K+D+++FG+ +WE+ + G++PY   T  + A   + + LR   P  A  ++  ++  
Sbjct: 178 FSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETA-EHIAQGLRLYRPHLASEKVYTIMYS 236

Query: 349 CWQHDPTQRPNFSQITDILKQM 370
           CW     +RP F  +   +  +
Sbjct: 237 CWHEKADERPTFKILLSNILDV 258

>d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Activated CDC42 kinase 1, ACK1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  226 bits (577), Expect = 9e-73
 Identities = 83/268 (30%), Positives = 139/268 (51%), Gaps = 12/268 (4%)

Query: 113 IDAKQLKIECKVASGSYGDLYKGTYCS-----QEVAIKVLKPECVNT-EMLKEFSQEVYI 166
           I  K L++  K+  GS+G + +G + +       VA+K LKP+ ++  E + +F +EV  
Sbjct: 5   IGEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNA 64

Query: 167 MRKIRHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKG 226
           M  + H+N+++  G    PP + +VTE    GS+ D L K +G F L +L + A+ V++G
Sbjct: 65  MHSLDHRNLIRLYGVVLTPP-MKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEG 123

Query: 227 MNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARV----QAQSGVMTAETGTYRWMAP 282
           M YL     IHRDL   NLL+    +VK+ DFG+ R          +       + W AP
Sbjct: 124 MGYLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAP 183

Query: 283 EVIEHKPYDYKADVFSFGIALWELLT-GELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPR 341
           E ++ + + + +D + FG+ LWE+ T G+ P+ GL   Q    + ++  R   P+     
Sbjct: 184 ESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERLPRPEDCPQD 243

Query: 342 LAELLERCWQHDPTQRPNFSQITDILKQ 369
           +  ++ +CW H P  RP F  + D L +
Sbjct: 244 IYNVMVQCWAHKPEDRPTFVALRDFLLE 271

>d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: STE20-like serine/threonine-protein kinase, SLK
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  225 bits (575), Expect = 4e-72
 Identities = 80/272 (29%), Positives = 133/272 (48%), Gaps = 18/272 (6%)

Query: 101 IEIPTDGTDVWEIDAKQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVNTEMLK 158
           +    +  D WEI  +       +  G++G +YK      S   A KV+  +  + E L+
Sbjct: 4   VTRDLNPEDFWEIIGE-------LGDGAFGKVYKAQNKETSVLAAAKVIDTK--SEEELE 54

Query: 159 EFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLK 218
           ++  E+ I+    H N+V+ + A     NL I+ EF A G++   + + +     + +  
Sbjct: 55  DYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFCAGGAVDAVMLELERPLTESQIQV 114

Query: 219 VAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSG-VMTAETGTY 277
           V       +NYLH N IIHRDLK  N+L   +G +K+ADFGV+    ++     +  GT 
Sbjct: 115 VCKQTLDALNYLHDNKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDSFIGTP 174

Query: 278 RWMAPEVI-----EHKPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQ-KSLR 331
            WMAPEV+     + +PYDYKADV+S GI L E+   E P+  L P++  + + + +   
Sbjct: 175 YWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVLLKIAKSEPPT 234

Query: 332 PTIPKHAHPRLAELLERCWQHDPTQRPNFSQI 363
              P        + L++C + +   R   SQ+
Sbjct: 235 LAQPSRWSSNFKDFLKKCLEKNVDARWTTSQL 266

>d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase wnk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  223 bits (569), Expect = 2e-71
 Identities = 73/261 (27%), Positives = 128/261 (49%), Gaps = 13/261 (4%)

Query: 113 IDAKQLKIECKVASGSYGDLYKGTYCS--QEVAIKVLKPECVNTEMLKEFSQEVYIMRKI 170
            D + LK + ++  GS+  +YKG       EVA   L+   +     + F +E  +++ +
Sbjct: 6   NDGRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGL 65

Query: 171 RHKNVVQFIGAC----TRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKG 226
           +H N+V+F  +          + +VTE M  G++  +L +   V ++  L      + KG
Sbjct: 66  QHPNIVRFYDSWESTVKGKKCIVLVTELMTSGTLKTYLKR-FKVMKIKVLRSWCRQILKG 124

Query: 227 MNYLHQNN--IIHRDLKTAN-LLMDENGVVKVADFGVARVQAQSGVMTAETGTYRWMAPE 283
           + +LH     IIHRDLK  N  +    G VK+ D G+A ++ ++    A  GT  +MAPE
Sbjct: 125 LQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLK-RASFAKAVIGTPEFMAPE 183

Query: 284 VIEHKPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKSLRP-TIPKHAHPRL 342
           + E K YD   DV++FG+ + E+ T E PY+           V   ++P +  K A P +
Sbjct: 184 MYEEK-YDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPASFDKVAIPEV 242

Query: 343 AELLERCWQHDPTQRPNFSQI 363
            E++E C + +  +R +   +
Sbjct: 243 KEIIEGCIRQNKDERYSIKDL 263

>d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: ephb2 receptor tyrosine kinase
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  223 bits (570), Expect = 3e-71
 Identities = 90/274 (32%), Positives = 140/274 (51%), Gaps = 14/274 (5%)

Query: 111 WEIDAKQLKIECKVASGSYGDLYKGTYCS-----QEVAIKVLKPECVNTEMLKEFSQEVY 165
            EID   +KIE  + +G +G++  G           VAIK LK      +  ++F  E  
Sbjct: 21  KEIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSG-YTEKQRRDFLSEAS 79

Query: 166 IMRKIRHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSK 225
           IM +  H NV+   G  T+   + I+TEFM  GS+  FL +  G F +  L+ +   ++ 
Sbjct: 80  IMGQFDHPNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQNDGQFTVIQLVGMLRGIAA 139

Query: 226 GMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAET------GTYRW 279
           GM YL   N +HRDL   N+L++ N V KV+DFG++R           T         RW
Sbjct: 140 GMKYLADMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSALGGKIPIRW 199

Query: 280 MAPEVIEHKPYDYKADVFSFGIALWELLT-GELPYAGLTPLQAAVGVVQKSLRPTIPKHA 338
            APE I+++ +   +DV+S+GI +WE+++ GE PY  +T  Q  +  +++  R   P   
Sbjct: 200 TAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTN-QDVINAIEQDYRLPPPMDC 258

Query: 339 HPRLAELLERCWQHDPTQRPNFSQITDILKQMMK 372
              L +L+  CWQ D   RP F QI + L +M++
Sbjct: 259 PSALHQLMLDCWQKDRNHRPKFGQIVNTLDKMIR 292

>d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: epha2 receptor tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  222 bits (566), Expect = 5e-71
 Identities = 77/272 (28%), Positives = 134/272 (49%), Gaps = 11/272 (4%)

Query: 111 WEIDAKQLKIECKVASGSYGDLYKGTY------CSQEVAIKVLKPECVNTEMLKEFSQEV 164
            EI    +  +  + +G +G++YKG            VAIK LK      +   +F  E 
Sbjct: 2   TEIHPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAG-YTEKQRVDFLGEA 60

Query: 165 YIMRKIRHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVS 224
            IM +  H N+++  G  ++   + I+TE+M  G++  FL ++ G F +  L+ +   ++
Sbjct: 61  GIMGQFSHHNIIRLEGVISKYKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIA 120

Query: 225 KGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARV----QAQSGVMTAETGTYRWM 280
            GM YL   N +HRDL   N+L++ N V KV+DFG++RV       +   +      RW 
Sbjct: 121 AGMKYLANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWT 180

Query: 281 APEVIEHKPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKSLRPTIPKHAHP 340
           APE I ++ +   +DV+SFGI +WE++T              +  +    R   P     
Sbjct: 181 APEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAINDGFRLPTPMDCPS 240

Query: 341 RLAELLERCWQHDPTQRPNFSQITDILKQMMK 372
            + +L+ +CWQ +  +RP F+ I  IL ++++
Sbjct: 241 AIYQLMMQCWQQERARRPKFADIVSILDKLIR 272

>d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine protein kinase TAO2
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  222 bits (568), Expect = 7e-71
 Identities = 74/247 (29%), Positives = 112/247 (45%), Gaps = 10/247 (4%)

Query: 123 KVASGSYGDLYKGTYCS--QEVAIKVLKPECVNT-EMLKEFSQEVYIMRKIRHKNVVQFI 179
           ++  GS+G +Y        + VAIK +      + E  ++  +EV  ++K+RH N +Q+ 
Sbjct: 22  EIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYR 81

Query: 180 GACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRD 239
           G   R     +V E+    +  D L   K   Q   +  V     +G+ YLH +N+IHRD
Sbjct: 82  GCYLREHTAWLVMEYCLGSA-SDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRD 140

Query: 240 LKTANLLMDENGVVKVADFGVARVQAQSGVMTAETGTYRWMAPEVIE---HKPYDYKADV 296
           +K  N+L+ E G+VK+ DFG A + A +       GT  WMAPEVI       YD K DV
Sbjct: 141 VKAGNILLSEPGLVKLGDFGSASIMAPANSF---VGTPYWMAPEVILAMDEGQYDGKVDV 197

Query: 297 FSFGIALWELLTGELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRLAELLERCWQHDPTQ 356
           +S GI   EL   + P   +  + A   + Q         H        ++ C Q  P  
Sbjct: 198 WSLGITCIELAERKPPLFNMNAMSALYHIAQNESPALQSGHWSEYFRNFVDSCLQKIPQD 257

Query: 357 RPNFSQI 363
           RP    +
Sbjct: 258 RPTSEVL 264

>d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-KIT receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  222 bits (567), Expect = 1e-70
 Identities = 83/304 (27%), Positives = 145/304 (47%), Gaps = 32/304 (10%)

Query: 99  NCIEIPTDGTDVWEIDAKQLKIECKVASGSYGDLYKGTYCS-------QEVAIKVLKPEC 151
           +  ++P D    WE    +L     + +G++G + + T            VA+K+LKP  
Sbjct: 8   DPTQLPYD--HKWEFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPS- 64

Query: 152 VNTEMLKEFSQEVYIMRKI-RHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQK-- 208
            +    +    E+ ++  +  H N+V  +GACT      ++TE+   G + +FL +++  
Sbjct: 65  AHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDS 124

Query: 209 ---------------GVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVV 253
                              L  LL  +  V+KGM +L   N IHRDL   N+L+    + 
Sbjct: 125 FICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLTHGRIT 184

Query: 254 KVADFGVARVQAQSGVMTAET---GTYRWMAPEVIEHKPYDYKADVFSFGIALWELLT-G 309
           K+ DFG+AR          +       +WMAPE I +  Y +++DV+S+GI LWEL + G
Sbjct: 185 KICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLG 244

Query: 310 ELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRLAELLERCWQHDPTQRPNFSQITDILKQ 369
             PY G+        ++++  R   P+HA   + ++++ CW  DP +RP F QI  ++++
Sbjct: 245 SSPYPGMPVDSKFYKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEK 304

Query: 370 MMKE 373
            + E
Sbjct: 305 QISE 308

>d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Focal adhesion kinase 1 (fak)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  218 bits (557), Expect = 1e-69
 Identities = 80/270 (29%), Positives = 138/270 (51%), Gaps = 9/270 (3%)

Query: 111 WEIDAKQLKIECKVASGSYGDLYKGTYCSQE-----VAIKVLKPECVNTEMLKEFSQEVY 165
           +EI  +++++   +  G +GD+++G Y S E     VAIK  K  C +  + ++F QE  
Sbjct: 2   YEIQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCK-NCTSDSVREKFLQEAL 60

Query: 166 IMRKIRHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSK 225
            MR+  H ++V+ IG  T    + I+ E    G +  FL  +K    L SL+  A  +S 
Sbjct: 61  TMRQFDHPHIVKLIGVITEN-PVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLST 119

Query: 226 GMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAET--GTYRWMAPE 283
            + YL     +HRD+   N+L+  N  VK+ DFG++R    S    A       +WMAPE
Sbjct: 120 ALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPE 179

Query: 284 VIEHKPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRLA 343
            I  + +   +DV+ FG+ +WE+L   +           +G ++   R  +P +  P L 
Sbjct: 180 SINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLPMPPNCPPTLY 239

Query: 344 ELLERCWQHDPTQRPNFSQITDILKQMMKE 373
            L+ +CW +DP++RP F+++   L  +++E
Sbjct: 240 SLMTKCWAYDPSRRPRFTELKAQLSTILEE 269

>d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tie2 kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  219 bits (558), Expect = 2e-69
 Identities = 84/283 (29%), Positives = 142/283 (50%), Gaps = 23/283 (8%)

Query: 112 EIDAKQLKIECKVASGSYGDLYKGTYCS----QEVAIKVLKPECVNTEMLKEFSQEVYIM 167
            +D   +K +  +  G++G + K          + AIK +K    + +  ++F+ E+ ++
Sbjct: 6   VLDWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEY-ASKDDHRDFAGELEVL 64

Query: 168 RKI-RHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQ---------------KGVF 211
            K+  H N++  +GAC     L +  E+   G++ DFL K                    
Sbjct: 65  CKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTL 124

Query: 212 QLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMT 271
               LL  A DV++GM+YL Q   IHRDL   N+L+ EN V K+ADFG++R Q      T
Sbjct: 125 SSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKKT 184

Query: 272 AETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLT-GELPYAGLTPLQAAVGVVQKSL 330
                 RWMA E + +  Y   +DV+S+G+ LWE+++ G  PY G+T  +     + +  
Sbjct: 185 MGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAEL-YEKLPQGY 243

Query: 331 RPTIPKHAHPRLAELLERCWQHDPTQRPNFSQITDILKQMMKE 373
           R   P +    + +L+ +CW+  P +RP+F+QI   L +M++E
Sbjct: 244 RLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEE 286

>d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine-protein kinase Nek2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  216 bits (551), Expect = 7e-69
 Identities = 64/258 (24%), Positives = 118/258 (45%), Gaps = 14/258 (5%)

Query: 119 KIECKVASGSYGDLYKGTYCS--QEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVV 176
           ++   + +GSYG   K    S  + +  K L    +     +    EV ++R+++H N+V
Sbjct: 7   EVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIV 66

Query: 177 QFIGACTRPPN--LCIVTEFMARGSIYDFLH---KQKGVFQLTSLLKVAIDVSKGMNYLH 231
           ++        N  L IV E+   G +   +    K++       +L+V   ++  +   H
Sbjct: 67  RYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECH 126

Query: 232 Q-----NNIIHRDLKTANLLMDENGVVKVADFGVAR-VQAQSGVMTAETGTYRWMAPEVI 285
           +     + ++HRDLK AN+ +D    VK+ DFG+AR +   +    A  GT  +M+PE +
Sbjct: 127 RRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKAFVGTPYYMSPEQM 186

Query: 286 EHKPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRLAEL 345
               Y+ K+D++S G  L+EL     P+   +  + A G +++     IP      L E+
Sbjct: 187 NRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELA-GKIREGKFRRIPYRYSDELNEI 245

Query: 346 LERCWQHDPTQRPNFSQI 363
           + R        RP+  +I
Sbjct: 246 ITRMLNLKDYHRPSVEEI 263

>d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: pak1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  215 bits (548), Expect = 4e-68
 Identities = 68/252 (26%), Positives = 121/252 (48%), Gaps = 8/252 (3%)

Query: 116 KQLKIECKVASGSYGDLYKGTYCS--QEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHK 173
           K+     K+  G+ G +Y     +  QEVAI+ +  +       +    E+ +MR+ ++ 
Sbjct: 20  KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQ--QQPKKELIINEILVMRENKNP 77

Query: 174 NVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQN 233
           N+V ++ +      L +V E++A GS+ D + +         +  V  +  + + +LH N
Sbjct: 78  NIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETC--MDEGQIAAVCRECLQALEFLHSN 135

Query: 234 NIIHRDLKTANLLMDENGVVKVADFGVAR-VQAQSGVMTAETGTYRWMAPEVIEHKPYDY 292
            +IHRD+K+ N+L+  +G VK+ DFG    +  +    +   GT  WMAPEV+  K Y  
Sbjct: 136 QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGP 195

Query: 293 KADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQK-SLRPTIPKHAHPRLAELLERCWQ 351
           K D++S GI   E++ GE PY    PL+A   +    +     P+       + L RC  
Sbjct: 196 KVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIFRDFLNRCLD 255

Query: 352 HDPTQRPNFSQI 363
            D  +R +  ++
Sbjct: 256 MDVEKRGSAKEL 267

>d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Musk tyrosine kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  214 bits (546), Expect = 1e-67
 Identities = 80/296 (27%), Positives = 136/296 (45%), Gaps = 36/296 (12%)

Query: 111 WEIDAKQLKIECKVASGSYGDLYKGTYCS-------QEVAIKVLKPECVNTEMLKEFSQE 163
            E     ++    +  G++G +++              VA+K+LK E  + +M  +F +E
Sbjct: 8   LEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEE-ASADMQADFQRE 66

Query: 164 VYIMRKIRHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKG-------------- 209
             +M +  + N+V+ +G C     +C++ E+MA G + +FL                   
Sbjct: 67  AALMAEFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTR 126

Query: 210 ---------VFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGV 260
                           L +A  V+ GM YL +   +HRDL T N L+ EN VVK+ADFG+
Sbjct: 127 ARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLATRNCLVGENMVVKIADFGL 186

Query: 261 ARVQAQSGVMTAET---GTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTGEL-PYAGL 316
           +R    +    A+       RWM PE I +  Y  ++DV+++G+ LWE+ +  L PY G+
Sbjct: 187 SRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYGM 246

Query: 317 TPLQAAVGVVQKSLRPTIPKHAHPRLAELLERCWQHDPTQRPNFSQITDILKQMMK 372
              +  +  V+       P++    L  L+  CW   P  RP+F  I  IL++M +
Sbjct: 247 AH-EEVIYYVRDGNILACPENCPLELYNLMRLCWSKLPADRPSFCSIHRILQRMCE 301

>d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: Caenorhabditis elegans, pjk4 [TaxId: 6239]

 Score =  214 bits (546), Expect = 5e-67
 Identities = 55/251 (21%), Positives = 108/251 (43%), Gaps = 8/251 (3%)

Query: 119 KIECKVASGSYGDLYKGTYCS--QEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVV 176
            I  ++ +G++G +++ T  +     A K +     +    +   +E+  M  +RH  +V
Sbjct: 29  DIHEELGTGAFGVVHRVTERATGNNFAAKFVMTP--HESDKETVRKEIQTMSVLRHPTLV 86

Query: 177 QFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNII 236
               A      + ++ EFM+ G +++ +  +         ++    V KG+ ++H+NN +
Sbjct: 87  NLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENNYV 146

Query: 237 HRDLKTANLLM--DENGVVKVADFGVARVQAQSGVMTAETGTYRWMAPEVIEHKPYDYKA 294
           H DLK  N++     +  +K+ DFG+         +   TGT  + APEV E KP  Y  
Sbjct: 147 HLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVTTGTAEFAAPEVAEGKPVGYYT 206

Query: 295 DVFSFGIALWELLTGELPYAGLTPLQAAVGVVQK--SLRPTIPKHAHPRLAELLERCWQH 352
           D++S G+  + LL+G  P+ G    +    V     ++  +          + + +    
Sbjct: 207 DMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMDDSAFSGISEDGKDFIRKLLLA 266

Query: 353 DPTQRPNFSQI 363
           DP  R    Q 
Sbjct: 267 DPNTRMTIHQA 277

>d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]

 Score =  212 bits (542), Expect = 2e-66
 Identities = 47/251 (18%), Positives = 110/251 (43%), Gaps = 8/251 (3%)

Query: 119 KIECKVASGSYGDLYKGTYCS--QEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVV 176
            I  ++ SG++G +++    +  +    K +               E+ IM ++ H  ++
Sbjct: 32  DILEELGSGAFGVVHRCVEKATGRVFVAKFINTP--YPLDKYTVKNEISIMNQLHHPKLI 89

Query: 177 QFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNII 236
               A      + ++ EF++ G ++D +  +        ++       +G+ ++H+++I+
Sbjct: 90  NLHDAFEDKYEMVLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHSIV 149

Query: 237 HRDLKTANLLMD--ENGVVKVADFGVARVQAQSGVMTAETGTYRWMAPEVIEHKPYDYKA 294
           H D+K  N++ +  +   VK+ DFG+A       ++   T T  + APE+++ +P  +  
Sbjct: 150 HLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVKVTTATAEFAAPEIVDREPVGFYT 209

Query: 295 DVFSFGIALWELLTGELPYAGLTPLQAAVGVVQK--SLRPTIPKHAHPRLAELLERCWQH 352
           D+++ G+  + LL+G  P+AG   L+    V +              P   + ++   Q 
Sbjct: 210 DMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEFDEDAFSSVSPEAKDFIKNLLQK 269

Query: 353 DPTQRPNFSQI 363
           +P +R      
Sbjct: 270 EPRKRLTVHDA 280

>d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Hepatocyte growth factor receptor, c-MET
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  211 bits (538), Expect = 2e-66
 Identities = 74/280 (26%), Positives = 121/280 (43%), Gaps = 14/280 (5%)

Query: 111 WEIDAKQLKI--ECKVASGSYGDLYKGTYCS-----QEVAIKVLKPECVNTEMLKEFSQE 163
             I    L +     +  G +G +Y GT           A+K L     +   + +F  E
Sbjct: 20  VVIGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRI-TDIGEVSQFLTE 78

Query: 164 VYIMRKIRHKNVVQFIGACTRPPN-LCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAID 222
             IM+   H NV+  +G C R      +V  +M  G + +F+  +     +  L+   + 
Sbjct: 79  GIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQ 138

Query: 223 VSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSG-----VMTAETGTY 277
           V+KGM +L     +HRDL   N ++DE   VKVADFG+AR             T      
Sbjct: 139 VAKGMKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPV 198

Query: 278 RWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKSLRPTIPKH 337
           +WMA E ++ + +  K+DV+SFG+ LWEL+T   P             + +  R   P++
Sbjct: 199 KWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQPEY 258

Query: 338 AHPRLAELLERCWQHDPTQRPNFSQITDILKQMMKEVASE 377
               L E++ +CW      RP+FS++   +  +      E
Sbjct: 259 CPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTFIGE 298

>d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: EGF receptor tyrosine kinase, Erbb-1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  210 bits (534), Expect = 1e-65
 Identities = 74/271 (27%), Positives = 134/271 (49%), Gaps = 13/271 (4%)

Query: 113 IDAKQLKIECKVASGSYGDLYKGTY------CSQEVAIKVLKPECVNTEMLKEFSQEVYI 166
           +   + K    + SG++G +YKG +          VAIK L+    + +  KE   E Y+
Sbjct: 6   LKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREA-TSPKANKEILDEAYV 64

Query: 167 MRKIRHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKG 226
           M  + + +V + +G C     + ++T+ M  G + D++ + K       LL   + ++KG
Sbjct: 65  MASVDNPHVCRLLGICLTS-TVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKG 123

Query: 227 MNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARV---QAQSGVMTAETGTYRWMAPE 283
           MNYL    ++HRDL   N+L+     VK+ DFG+A++   + +           +WMA E
Sbjct: 124 MNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALE 183

Query: 284 VIEHKPYDYKADVFSFGIALWELLT-GELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRL 342
            I H+ Y +++DV+S+G+ +WEL+T G  PY G+        +++K  R   P      +
Sbjct: 184 SILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPA-SEISSILEKGERLPQPPICTIDV 242

Query: 343 AELLERCWQHDPTQRPNFSQITDILKQMMKE 373
             ++ +CW  D   RP F ++     +M ++
Sbjct: 243 YMIMVKCWMIDADSRPKFRELIIEFSKMARD 273

>d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell cycle checkpoint kinase chk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  207 bits (528), Expect = 3e-65
 Identities = 62/252 (24%), Positives = 113/252 (44%), Gaps = 9/252 (3%)

Query: 119 KIECKVASGSYGDLYKGTYCS--QEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVV 176
            +   +  G+YG++         + VA+K++  +    +  +   +E+ I + + H+NVV
Sbjct: 8   DLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMK-RAVDCPENIKKEICINKMLNHENVV 66

Query: 177 QFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNII 236
           +F G         +  E+ + G ++D +    G        +    +  G+ YLH   I 
Sbjct: 67  KFYGHRREGNIQYLFLEYCSGGELFDRIEPDIG-MPEPDAQRFFHQLMAGVVYLHGIGIT 125

Query: 237 HRDLKTANLLMDENGVVKVADFGVARV---QAQSGVMTAETGTYRWMAPEVIEHKPYD-Y 292
           HRD+K  NLL+DE   +K++DFG+A V     +  ++    GT  ++APE+++ + +   
Sbjct: 126 HRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAE 185

Query: 293 KADVFSFGIALWELLTGELPYAGLTP-LQAAVGVVQKSLRPTIPKHAHPRLAELLERCWQ 351
             DV+S GI L  +L GELP+   +   Q      +K       K        LL +   
Sbjct: 186 PVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLALLHKILV 245

Query: 352 HDPTQRPNFSQI 363
            +P+ R     I
Sbjct: 246 ENPSARITIPDI 257

>d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  208 bits (531), Expect = 3e-65
 Identities = 62/297 (20%), Positives = 123/297 (41%), Gaps = 48/297 (16%)

Query: 112 EIDAKQLKIECKVASGSYGDLYKGTYCS--QEVAIKVLKPECVNTEMLKEFSQEVYIMRK 169
           E+     +   ++ +G+ G ++K ++      +A K++  E +   +  +  +E+ ++ +
Sbjct: 2   ELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLE-IKPAIRNQIIRELQVLHE 60

Query: 170 IRHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNY 229
                +V F GA      + I  E M  GS+   L K  G      L KV+I V KG+ Y
Sbjct: 61  CNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKK-AGRIPEQILGKVSIAVIKGLTY 119

Query: 230 LHQ-NNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAETGTYRWMAPEVIEHK 288
           L + + I+HRD+K +N+L++  G +K+ DFGV+  Q    +  +  GT  +M+PE ++  
Sbjct: 120 LREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSG-QLIDSMANSFVGTRSYMSPERLQGT 178

Query: 289 PYDYKADVFSFGIALWELLTGELPYAGLTP------------------------------ 318
            Y  ++D++S G++L E+  G  P                                    
Sbjct: 179 HYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLS 238

Query: 319 -----------LQAAVGVVQKSLRPTIPKHAHPRLA-ELLERCWQHDPTQRPNFSQI 363
                      +   +  +     P +P         + + +C   +P +R +  Q+
Sbjct: 239 SYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQL 295

>d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fibroblast growth factor receptor 1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  207 bits (527), Expect = 5e-65
 Identities = 82/299 (27%), Positives = 150/299 (50%), Gaps = 33/299 (11%)

Query: 102 EIPTDGTDVWEIDAKQLKIECKVASGSYGDLYKGTYCS---------QEVAIKVLKPECV 152
           E+P D    WE+   +L +   +  G++G +                 +VA+K+LK +  
Sbjct: 1   ELPED--PRWELPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDAT 58

Query: 153 NTEMLKEFSQEVYIMRKI-RHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQK--- 208
             ++  +   E+ +M+ I +HKN++  +GACT+   L ++ E+ ++G++ ++L  ++   
Sbjct: 59  EKDL-SDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPG 117

Query: 209 ------------GVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVA 256
                              L+  A  V++GM YL     IHRDL   N+L+ E+ V+K+A
Sbjct: 118 LEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIA 177

Query: 257 DFGVARVQAQSGVMTA---ETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLT-GELP 312
           DFG+AR                  +WMAPE +  + Y +++DV+SFG+ LWE+ T G  P
Sbjct: 178 DFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSP 237

Query: 313 YAGLTPLQAAVGVVQKSLRPTIPKHAHPRLAELLERCWQHDPTQRPNFSQITDILKQMM 371
           Y G+ P++    ++++  R   P +    L  ++  CW   P+QRP F Q+ + L +++
Sbjct: 238 YPGV-PVEELFKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIV 295

>d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Insulin-like growth factor 1 receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  207 bits (527), Expect = 8e-65
 Identities = 81/296 (27%), Positives = 145/296 (48%), Gaps = 26/296 (8%)

Query: 97  SPNCIEIPTDGTDVWEIDAKQLKIECKVASGSYGDLYKGTYCS-------QEVAIKVLKP 149
           S   + +P    D WE+  +++ +  ++  GS+G +Y+G             VAIK +  
Sbjct: 5   SAADVYVP----DEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNE 60

Query: 150 ECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKG 209
              +     EF  E  +M++    +VV+ +G  ++     ++ E M RG +  +L   + 
Sbjct: 61  A-ASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRP 119

Query: 210 V---------FQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGV 260
                       L+ ++++A +++ GM YL+ N  +HRDL   N ++ E+  VK+ DFG+
Sbjct: 120 AMANNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGM 179

Query: 261 ARVQAQSG---VMTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTG-ELPYAGL 316
            R   ++             RWM+PE ++   +   +DV+SFG+ LWE+ T  E PY GL
Sbjct: 180 TRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGL 239

Query: 317 TPLQAAVGVVQKSLRPTIPKHAHPRLAELLERCWQHDPTQRPNFSQITDILKQMMK 372
           +  Q    V++  L    P +    L EL+  CWQ++P  RP+F +I   +K+ M+
Sbjct: 240 SNEQVLRFVMEGGLLD-KPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEME 294

>d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Vascular endothelial growth factor receptor 2 (kdr)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  207 bits (526), Expect = 8e-65
 Identities = 83/297 (27%), Positives = 142/297 (47%), Gaps = 28/297 (9%)

Query: 103 IPTDGTDVWEIDAKQLKIECKVASGSYGDLYKGTYCS-------QEVAIKVLKPECVNTE 155
           +P D    WE    +LK+   +  G++G + +            + VA+K+LK    ++E
Sbjct: 1   LPYD-ASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSE 59

Query: 156 MLKEFSQEVYIMRKIRHKNVVQFIGACTRPPN-LCIVTEFMARGSIYDFLHKQ------- 207
                S+   ++    H NVV  +GACT+P   L ++ EF   G++  +L  +       
Sbjct: 60  HRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPY 119

Query: 208 --------KGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFG 259
                   K    L  L+  +  V+KGM +L     IHRDL   N+L+ E  VVK+ DFG
Sbjct: 120 KVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFG 179

Query: 260 VARVQAQSGVMTAET---GTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTG-ELPYAG 315
           +AR   +      +       +WMAPE I  + Y  ++DV+SFG+ LWE+ +    PY G
Sbjct: 180 LARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPG 239

Query: 316 LTPLQAAVGVVQKSLRPTIPKHAHPRLAELLERCWQHDPTQRPNFSQITDILKQMMK 372
           +   +     +++  R   P +  P + + +  CW  +P+QRP FS++ + L  +++
Sbjct: 240 VKIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQ 296

>d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: 3-phosphoinositide dependent protein kinase-1 Pdk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  204 bits (519), Expect = 9e-64
 Identities = 55/253 (21%), Positives = 113/253 (44%), Gaps = 9/253 (3%)

Query: 119 KIECKVASGSYGDLYKGTYCS--QEVAIKVLKPECVNTE-MLKEFSQEVYIMRKIRHKNV 175
           K    +  GS+  +      +  +E AIK+L+   +  E  +   ++E  +M ++ H   
Sbjct: 11  KFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFF 70

Query: 176 VQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNI 235
           V+          L     +   G +  ++ K  G F  T       ++   + YLH   I
Sbjct: 71  VKLYFTFQDDEKLYFGLSYAKNGELLKYIRKI-GSFDETCTRFYTAEIVSALEYLHGKGI 129

Query: 236 IHRDLKTANLLMDENGVVKVADFGVARVQAQSG---VMTAETGTYRWMAPEVIEHKPYDY 292
           IHRDLK  N+L++E+  +++ DFG A+V +         +  GT ++++PE++  K    
Sbjct: 130 IHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTEKSACK 189

Query: 293 KADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRLAELLERCWQH 352
            +D+++ G  +++L+ G  P+           +++  L    P+   P+  +L+E+    
Sbjct: 190 SSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIK--LEYDFPEKFFPKARDLVEKLLVL 247

Query: 353 DPTQRPNFSQITD 365
           D T+R    ++  
Sbjct: 248 DATKRLGCEEMEG 260

>d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Titin, kinase domain
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  203 bits (518), Expect = 3e-63
 Identities = 47/251 (18%), Positives = 102/251 (40%), Gaps = 9/251 (3%)

Query: 119 KIECKVASGSYGDLYKGTYCS--QEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVV 176
            I   +  G +G +++    S  +    K +K +  +  ++K   +E+ I+   RH+N++
Sbjct: 8   MIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVLVK---KEISILNIARHRNIL 64

Query: 177 QFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNII 236
               +      L ++ EF++   I++ ++          ++     V + + +LH +NI 
Sbjct: 65  HLHESFESMEELVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSHNIG 124

Query: 237 HRDLKTANLLMD--ENGVVKVADFGVARVQAQSGVMTAETGTYRWMAPEVIEHKPYDYKA 294
           H D++  N++     +  +K+ +FG AR                + APEV +H       
Sbjct: 125 HFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRLLFTAPEYYAPEVHQHDVVSTAT 184

Query: 295 DVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKSLRPT--IPKHAHPRLAELLERCWQH 352
           D++S G  ++ LL+G  P+   T  Q    ++           K       + ++R    
Sbjct: 185 DMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFDEEAFKEISIEAMDFVDRLLVK 244

Query: 353 DPTQRPNFSQI 363
           +   R   S+ 
Sbjct: 245 ERKSRMTASEA 255

>d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Type I TGF-beta receptor R4
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  201 bits (511), Expect = 2e-62
 Identities = 75/302 (24%), Positives = 141/302 (46%), Gaps = 48/302 (15%)

Query: 115 AKQLKIECKVASGSYGDLYKGTYCSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKN 174
           A+ + ++  +  G +G++++G +  +EVA+K+        E       E+Y    +RH+N
Sbjct: 2   ARTIVLQESIGKGRFGEVWRGKWRGEEVAVKIFSSR---EERSWFREAEIYQTVMLRHEN 58

Query: 175 VVQFIGACTRP----PNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYL 230
           ++ FI A  +       L +V+++   GS++D+L++      +  ++K+A+  + G+ +L
Sbjct: 59  ILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYT--VTVEGMIKLALSTASGLAHL 116

Query: 231 HQ--------NNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSG-----VMTAETGTY 277
           H           I HRDLK+ N+L+ +NG   +AD G+A     +            GT 
Sbjct: 117 HMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTK 176

Query: 278 RWMAPEVIE------HKPYDYKADVFSFGIALWELLTG----------ELPYAGLTPLQA 321
           R+MAPEV++      H     +AD+++ G+  WE+             +LPY  L P   
Sbjct: 177 RYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDP 236

Query: 322 AV-----GVVQKSLRPTIPKHAHP-----RLAELLERCWQHDPTQRPNFSQITDILKQMM 371
           +V      V ++ LRP IP           +A+++  CW  +   R    +I   L Q+ 
Sbjct: 237 SVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLS 296

Query: 372 KE 373
           ++
Sbjct: 297 QQ 298

>d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Calmodulin-dependent protein kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  199 bits (506), Expect = 1e-61
 Identities = 56/252 (22%), Positives = 114/252 (45%), Gaps = 9/252 (3%)

Query: 119 KIECKVASGSYGDLYKGTYCS--QEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVV 176
                + +G++ ++         + VAIK +  + +  +       E+ ++ KI+H N+V
Sbjct: 12  DFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGK-EGSMENEIAVLHKIKHPNIV 70

Query: 177 QFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNII 236
                     +L ++ + ++ G ++D + + KG +      ++   V   + YLH   I+
Sbjct: 71  ALDDIYESGGHLYLIMQLVSGGELFDRIVE-KGFYTERDASRLIFQVLDAVKYLHDLGIV 129

Query: 237 HRDLKTANLL---MDENGVVKVADFGVARVQAQSGVMTAETGTYRWMAPEVIEHKPYDYK 293
           HRDLK  NLL   +DE+  + ++DFG+++++    V++   GT  ++APEV+  KPY   
Sbjct: 130 HRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSVLSTACGTPGYVAPEVLAQKPYSKA 189

Query: 294 ADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKSLRPTIPKHAH--PRLAELLERCWQ 351
            D +S G+  + LL G  P+      +    +++       P          + +    +
Sbjct: 190 VDCWSIGVIAYILLCGYPPFYDENDAKLFEQILKAEYEFDSPYWDDISDSAKDFIRHLME 249

Query: 352 HDPTQRPNFSQI 363
            DP +R    Q 
Sbjct: 250 KDPEKRFTCEQA 261

>d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: gamma-subunit of glycogen phosphorylase kinase (Phk)
species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]

 Score =  194 bits (494), Expect = 3e-60
 Identities = 57/263 (21%), Positives = 117/263 (44%), Gaps = 19/263 (7%)

Query: 119 KIECKVASGSYGDLYKGTYCS--QEVAIKVLKPECVNT-------EMLKEFSQEVYIMRK 169
           + +  +  G    + +  +    +E A+K++      +       E+ +   +EV I+RK
Sbjct: 6   EPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRK 65

Query: 170 IR-HKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMN 228
           +  H N++Q            +V + M +G ++D+L + K         K+   + + + 
Sbjct: 66  VSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTE-KVTLSEKETRKIMRALLEVIC 124

Query: 229 YLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAETGTYRWMAPEVIE-- 286
            LH+ NI+HRDLK  N+L+D++  +K+ DFG +        +    GT  ++APE+IE  
Sbjct: 125 ALHKLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEKLREVCGTPSYLAPEIIECS 184

Query: 287 ----HKPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKSLRPTIPKHAH--P 340
               H  Y  + D++S G+ ++ LL G  P+     +     ++  + +   P+      
Sbjct: 185 MNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNYQFGSPEWDDYSD 244

Query: 341 RLAELLERCWQHDPTQRPNFSQI 363
            + +L+ R     P +R    + 
Sbjct: 245 TVKDLVSRFLVVQPQKRYTAEEA 267

>d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase C, theta type
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  194 bits (495), Expect = 7e-60
 Identities = 61/255 (23%), Positives = 115/255 (45%), Gaps = 10/255 (3%)

Query: 119 KIECKVASGSYGDLYKGTYCS--QEVAIKVLKPECVNT-EMLKEFSQEVYIM-RKIRHKN 174
            +   +  GS+G ++   +    Q  AIK LK + V   + ++    E  ++     H  
Sbjct: 5   ILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPF 64

Query: 175 VVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNN 234
           +           NL  V E++  G +   +      F L+     A ++  G+ +LH   
Sbjct: 65  LTHMFCTFQTKENLFFVMEYLNGGDLMYHIQS-CHKFDLSRATFYAAEIILGLQFLHSKG 123

Query: 235 IIHRDLKTANLLMDENGVVKVADFGVAR-VQAQSGVMTAETGTYRWMAPEVIEHKPYDYK 293
           I++RDLK  N+L+D++G +K+ADFG+ +             GT  ++APE++  + Y++ 
Sbjct: 124 IVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNTFCGTPDYIAPEILLGQKYNHS 183

Query: 294 ADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRLAELLERCWQHD 353
            D +SFG+ L+E+L G+ P+ G    +    +      P  P+       +LL + +  +
Sbjct: 184 VDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMD--NPFYPRWLEKEAKDLLVKLFVRE 241

Query: 354 PTQRPNFSQITDILK 368
           P +R       DI +
Sbjct: 242 PEKRLGVRG--DIRQ 254

>d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

 Score =  192 bits (488), Expect = 7e-59
 Identities = 65/258 (25%), Positives = 120/258 (46%), Gaps = 10/258 (3%)

Query: 116 KQLKIECKVASGSYGDLYKGTYCS--QEVAIKVLKPE-CVNTEMLKEFSQEVYIMRKIRH 172
           +  +I   + +GS+G ++        +  A+KVLK E  V  + ++  + E  ++  + H
Sbjct: 4   QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTH 63

Query: 173 KNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQ 232
             +++  G       + ++ +++  G     L ++   F        A +V   + YLH 
Sbjct: 64  PFIIRMWGTFQDAQQIFMIMDYI-EGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLHS 122

Query: 233 NNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAETGTYRWMAPEVIEHKPYDY 292
            +II+RDLK  N+L+D+NG +K+ DFG A+            GT  ++APEV+  KPY+ 
Sbjct: 123 KDIIYRDLKPENILLDKNGHIKITDFGFAKYVPDV--TYTLCGTPDYIAPEVVSTKPYNK 180

Query: 293 KADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRLAELLERCWQH 352
             D +SFGI ++E+L G  P+     ++    ++        P   +  + +LL R    
Sbjct: 181 SIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNA--ELRFPPFFNEDVKDLLSRLITR 238

Query: 353 DPTQRPNFSQIT--DILK 368
           D +QR    Q    D+  
Sbjct: 239 DLSQRLGNLQNGTEDVKN 256

>d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Death-associated protein kinase, Dap
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  186 bits (474), Expect = 4e-57
 Identities = 59/257 (22%), Positives = 110/257 (42%), Gaps = 13/257 (5%)

Query: 119 KIECKVASGSYGDLYKGTYCS--QEVAIKVLKPECVNTE----MLKEFSQEVYIMRKIRH 172
               ++ SG +  + K    S   + A K +K     +       ++  +EV I+++I+H
Sbjct: 13  DTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQH 72

Query: 173 KNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQ 232
            NV+          ++ ++ E +A G ++DF   +K         +    +  G+ YLH 
Sbjct: 73  PNVITLHEVYENKTDVILILELVAGGELFDF-LAEKESLTEEEATEFLKQILNGVYYLHS 131

Query: 233 NNIIHRDLKTANLLMDENGV----VKVADFGVARVQAQSGVMTAETGTYRWMAPEVIEHK 288
             I H DLK  N+++ +  V    +K+ DFG+A             GT  ++APE++ ++
Sbjct: 132 LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPEIVNYE 191

Query: 289 PYDYKADVFSFGIALWELLTGELPYAGLTPLQ--AAVGVVQKSLRPTIPKHAHPRLAELL 346
           P   +AD++S G+  + LL+G  P+ G T  +  A V  V          +      + +
Sbjct: 192 PLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFSNTSALAKDFI 251

Query: 347 ERCWQHDPTQRPNFSQI 363
            R    DP +R      
Sbjct: 252 RRLLVKDPKKRMTIQDS 268

>d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Mycobacterial protein kinase PknB, catalytic domain
species: Mycobacterium tuberculosis [TaxId: 1773]

 Score =  184 bits (468), Expect = 2e-56
 Identities = 68/253 (26%), Positives = 119/253 (47%), Gaps = 14/253 (5%)

Query: 119 KIECKVASGSYGDLYKGTYCS--QEVAIKVLKPECV-NTEMLKEFSQEVYIMRKIRHKNV 175
           ++   +  G   +++        ++VA+KVL+ +   +      F +E      + H  +
Sbjct: 10  ELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAI 69

Query: 176 VQFIGAC----TRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLH 231
           V             P   IV E++   ++ D +H + G       ++V  D  + +N+ H
Sbjct: 70  VAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTE-GPMTPKRAIEVIADACQALNFSH 128

Query: 232 QNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAET----GTYRWMAPEVIEH 287
           QN IIHRD+K AN+++     VKV DFG+AR  A SG    +T    GT ++++PE    
Sbjct: 129 QNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARG 188

Query: 288 KPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKSLRPTIPKHAH--PRLAEL 345
              D ++DV+S G  L+E+LTGE P+ G +P+  A   V++   P   +H      L  +
Sbjct: 189 DSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPPSARHEGLSADLDAV 248

Query: 346 LERCWQHDPTQRP 358
           + +    +P  R 
Sbjct: 249 VLKALAKNPENRY 261

>d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  182 bits (463), Expect = 2e-55
 Identities = 60/274 (21%), Positives = 108/274 (39%), Gaps = 23/274 (8%)

Query: 119 KIECKVASGSYGDLYKGTYCS--QEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVV 176
           ++  K+ SGS+GD+Y GT  +  +EVAIK+   +        +   E  I + ++    +
Sbjct: 10  RLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVK----TKHPQLHIESKIYKMMQGGVGI 65

Query: 177 QFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNII 236
             I  C    +  ++   +   S+ D  +     F L ++L +A  +   + Y+H  N I
Sbjct: 66  PTIRWCGAEGDYNVMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFI 125

Query: 237 HRDLKTANLLM---DENGVVKVADFGVARVQAQSGV--------MTAETGTYRWMAPEVI 285
           HRD+K  N LM    +  +V + DFG+A+    +              TGT R+ +    
Sbjct: 126 HRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTH 185

Query: 286 EHKPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKSLR------PTIPKHAH 339
                  + D+ S G  L     G LP+ GL          + S +        + K   
Sbjct: 186 LGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEVLCKGYP 245

Query: 340 PRLAELLERCWQHDPTQRPNFSQITDILKQMMKE 373
              A  L  C       +P++S +  + + +   
Sbjct: 246 SEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHR 279

>d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: G-protein coupled receptor kinase 2
species: Cow (Bos taurus) [TaxId: 9913]

 Score =  184 bits (468), Expect = 2e-55
 Identities = 62/260 (23%), Positives = 115/260 (44%), Gaps = 12/260 (4%)

Query: 119 KIECKVASGSYGDLYKGTYCS--QEVAIKVLKPECVNTE----MLKEFSQEVYIMRKIRH 172
            +   +  G +G++Y        +  A+K L  + +  +    +       + ++     
Sbjct: 7   SVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDC 66

Query: 173 KNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQ 232
             +V    A   P  L  + + M  G ++  L +  GVF    +   A ++  G+ ++H 
Sbjct: 67  PFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQ-HGVFSEADMRFYAAEIILGLEHMHN 125

Query: 233 NNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAETGTYRWMAPEVIEH-KPYD 291
             +++RDLK AN+L+DE+G V+++D G+A          A  GT+ +MAPEV++    YD
Sbjct: 126 RFVVYRDLKPANILLDEHGHVRISDLGLAC-DFSKKKPHASVGTHGYMAPEVLQKGVAYD 184

Query: 292 YKADVFSFGIALWELLTGELPYAGLTPL-QAAVGVVQKSLRPTIPKHAHPRLAELLERCW 350
             AD FS G  L++LL G  P+       +  +  +  ++   +P    P L  LLE   
Sbjct: 185 SSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELPDSFSPELRSLLEGLL 244

Query: 351 QHDPTQRPNFSQ--ITDILK 368
           Q D  +R         ++ +
Sbjct: 245 QRDVNRRLGCLGRGAQEVKE 264

>d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Proto-oncogene serine/threonine-protein kinase Pim-1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  177 bits (449), Expect = 1e-53
 Identities = 57/255 (22%), Positives = 107/255 (41%), Gaps = 19/255 (7%)

Query: 119 KIECKVASGSYGDLYKGTYCS--QEVAIKVLKPECVNT----EMLKEFSQEVYIMRKIR- 171
           ++   + SG +G +Y G   S    VAIK ++ + ++             EV +++K+  
Sbjct: 7   QVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSS 66

Query: 172 -HKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYL 230
               V++ +    RP +  ++ E             ++G  Q          V + + + 
Sbjct: 67  GFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHC 126

Query: 231 HQNNIIHRDLKTANLLMDEN-GVVKVADFGVARVQAQSGVMTAETGTYRWMAPEVIEHKP 289
           H   ++HRD+K  N+L+D N G +K+ DFG   +   + V T   GT  +  PE I +  
Sbjct: 127 HNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDT-VYTDFDGTRVYSPPEWIRYHR 185

Query: 290 Y-DYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRLAELLER 348
           Y    A V+S GI L++++ G++P+     +           +    +        L+  
Sbjct: 186 YHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRG--------QVFFRQRVSSECQHLIRW 237

Query: 349 CWQHDPTQRPNFSQI 363
           C    P+ RP F +I
Sbjct: 238 CLALRPSDRPTFEEI 252

>d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase activated protein kinase 2, mapkap2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  178 bits (453), Expect = 2e-53
 Identities = 54/261 (20%), Positives = 106/261 (40%), Gaps = 24/261 (9%)

Query: 120 IECKVASGSYGDLYKGTYCS--QEVAIKVLKPECVNTEMLKEFSQEVYIMRKI-RHKNVV 176
               +  G  G + +       ++ A+K+L+          +  +EV +  +  +  ++V
Sbjct: 16  TSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-------PKARREVELHWRASQCPHIV 68

Query: 177 QFIGAC----TRPPNLCIVTEFMARGSIYDFLHKQKG-VFQLTSLLKVAIDVSKGMNYLH 231
           + +            L IV E +  G ++  +  +    F      ++   + + + YLH
Sbjct: 69  RIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLH 128

Query: 232 QNNIIHRDLKTANLLMD---ENGVVKVADFGVARVQAQSGVMTAETGTYRWMAPEVIEHK 288
             NI HRD+K  NLL      N ++K+ DFG A+       +T    T  ++APEV+  +
Sbjct: 129 SINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEVLGPE 188

Query: 289 PYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKSLRPTI------PKHAHPRL 342
            YD   D++S G+ ++ LL G  P+     L  + G+  +                   +
Sbjct: 189 KYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEVSEEV 248

Query: 343 AELLERCWQHDPTQRPNFSQI 363
             L+    + +PTQR   ++ 
Sbjct: 249 KMLIRNLLKTEPTQRMTITEF 269

>d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Pkb kinase (Akt-2)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  178 bits (452), Expect = 2e-53
 Identities = 55/256 (21%), Positives = 113/256 (44%), Gaps = 9/256 (3%)

Query: 119 KIECKVASGSYGDLYKGTYCS--QEVAIKVLKPECVNT-EMLKEFSQEVYIMRKIRHKNV 175
                +  G++G +      +  +  A+K+L+ E +   + +     E  +++  RH  +
Sbjct: 8   DYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFL 67

Query: 176 VQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNI 235
                A      LC V E+   G ++  L +++  F          ++   + YLH  ++
Sbjct: 68  TALKYAFQTHDRLCFVMEYANGGELFFHLSRERV-FTEERARFYGAEIVSALEYLHSRDV 126

Query: 236 IHRDLKTANLLMDENGVVKVADFGVARVQAQSG-VMTAETGTYRWMAPEVIEHKPYDYKA 294
           ++RD+K  NL++D++G +K+ DFG+ +     G  M    GT  ++APEV+E   Y    
Sbjct: 127 VYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLEDNDYGRAV 186

Query: 295 DVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRLAELLERCWQHDP 354
           D +  G+ ++E++ G LP+      +    ++ +      P+   P    LL    + DP
Sbjct: 187 DWWGLGVVMYEMMCGRLPFYNQDHERLFELILME--EIRFPRTLSPEAKSLLAGLLKKDP 244

Query: 355 TQRPNFSQIT--DILK 368
            QR         ++++
Sbjct: 245 KQRLGGGPSDAKEVME 260

>d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

 Score =  175 bits (444), Expect = 1e-52
 Identities = 41/276 (14%), Positives = 96/276 (34%), Gaps = 25/276 (9%)

Query: 119 KIECKVASGSYGDLYKGTYCS--QEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVV 176
           K+  ++  GS+G +++GT     Q+VAIK             +   E    + +     +
Sbjct: 8   KVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRR----SDAPQLRDEYRTYKLLAGCTGI 63

Query: 177 QFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNII 236
             +    +     ++   +   S+ D L      F + ++   A  +   +  +H+ +++
Sbjct: 64  PNVYYFGQEGLHNVLVIDLLGPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKSLV 123

Query: 237 HRDLKTANLLMDE-----NGVVKVADFGVARV--------QAQSGVMTAETGTYRWMAPE 283
           +RD+K  N L+         ++ V DFG+ +                   +GT R+M+  
Sbjct: 124 YRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARYMSIN 183

Query: 284 VIEHKPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVV------QKSLRPTIPKH 337
               +    + D+ + G      L G LP+ GL                Q +    +   
Sbjct: 184 THLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQSTPLRELCAG 243

Query: 338 AHPRLAELLERCWQHDPTQRPNFSQITDILKQMMKE 373
                 + +           P++  +  +  ++++ 
Sbjct: 244 FPEEFYKYMHYARNLAFDATPDYDYLQGLFSKVLER 279

>d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK6
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  173 bits (438), Expect = 1e-51
 Identities = 56/281 (19%), Positives = 113/281 (40%), Gaps = 36/281 (12%)

Query: 119 KIECKVASGSYGDLYKGTYCS---QEVAIKVLKPECVNTEMLKEFSQEVYIMRKI---RH 172
           +   ++  G+YG ++K        + VA+K ++ +     M     +EV ++R +    H
Sbjct: 10  ECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEH 69

Query: 173 KNVVQFIGACTRPPN-----LCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGM 227
            NVV+    CT         L +V E + +          +      ++  +   + +G+
Sbjct: 70  PNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGL 129

Query: 228 NYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAETGTYRWMAPEVIEH 287
           ++LH + ++HRDLK  N+L+  +G +K+ADFG+AR+ +    +T+   T  + APEV+  
Sbjct: 130 DFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTSVVVTLWYRAPEVLLQ 189

Query: 288 KPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKSLRPT-------------- 333
             Y    D++S G    E+   +  + G + +     ++     P               
Sbjct: 190 SSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRDVALPRQA 249

Query: 334 -----------IPKHAHPRLAELLERCWQHDPTQRPNFSQI 363
                                +LL +C   +P +R +    
Sbjct: 250 FHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSA 290

>d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 7, CDK7
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  170 bits (432), Expect = 8e-51
 Identities = 67/278 (24%), Positives = 123/278 (44%), Gaps = 35/278 (12%)

Query: 119 KIECKVASGSYGDLYKGTYCS--QEVAIKVLKPECVNT---EMLKEFSQEVYIMRKIRHK 173
           K++  +  G +  +YK    +  Q VAIK +K    +     + +   +E+ +++++ H 
Sbjct: 2   KLD-FLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHP 60

Query: 174 NVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQN 233
           N++  + A     N+ +V +FM    +   +     V   + +    +   +G+ YLHQ+
Sbjct: 61  NIIGLLDAFGHKSNISLVFDFM-ETDLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQH 119

Query: 234 NIIHRDLKTANLLMDENGVVKVADFGVAR-VQAQSGVMTAETGTYRWMAPEVI-EHKPYD 291
            I+HRDLK  NLL+DENGV+K+ADFG+A+   + +   T +  T  + APE++   + Y 
Sbjct: 120 WILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYTHQVVTRWYRAPELLFGARMYG 179

Query: 292 YKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKSLRPT------------------ 333
              D+++ G  L ELL       G + L     + +    PT                  
Sbjct: 180 VGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDYVTFKS 239

Query: 334 --------IPKHAHPRLAELLERCWQHDPTQRPNFSQI 363
                   I   A   L +L++  +  +P  R   +Q 
Sbjct: 240 FPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQA 277

>d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  167 bits (424), Expect = 4e-49
 Identities = 65/255 (25%), Positives = 113/255 (44%), Gaps = 10/255 (3%)

Query: 119 KIECKVASGSYGDLYKGTYCS--QEVAIKVLKPE-CVNTEMLKEFSQEVYIMRKIRHKNV 175
                + +GS+G +    +       A+K+L  +  V  + ++    E  I++ +    +
Sbjct: 44  DRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFL 103

Query: 176 VQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNI 235
           V+   +     NL +V E++A G ++  L +  G F        A  +     YLH  ++
Sbjct: 104 VKLEFSFKDNSNLYMVMEYVAGGEMFSHLRR-IGRFSEPHARFYAAQIVLTFEYLHSLDL 162

Query: 236 IHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAETGTYRWMAPEVIEHKPYDYKAD 295
           I+RDLK  NLL+D+ G ++V DFG A+            GT   +APE+I  K Y+   D
Sbjct: 163 IYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR--TWTLCGTPEALAPEIILSKGYNKAVD 220

Query: 296 VFSFGIALWELLTGELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRLAELLERCWQHDPT 355
            ++ G+ ++E+  G  P+    P+Q    +V    +   P H    L +LL    Q D T
Sbjct: 221 WWALGVLIYEMAAGYPPFFADQPIQIYEKIVSG--KVRFPSHFSSDLKDLLRNLLQVDLT 278

Query: 356 QRPNFSQIT--DILK 368
           +R    +    DI  
Sbjct: 279 KRFGNLKNGVNDIKN 293

>d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  165 bits (417), Expect = 1e-48
 Identities = 55/276 (19%), Positives = 108/276 (39%), Gaps = 31/276 (11%)

Query: 119 KIECKVASGSYGDLYKGTYCS--QEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVV 176
           +   K+  G+YG +YK       + VA+K ++ +     +     +E+ +++++ H N+V
Sbjct: 5   QKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIV 64

Query: 177 QFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNII 236
           + +        L +V EF+ +               L  +      + +G+ + H + ++
Sbjct: 65  KLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVL 124

Query: 237 HRDLKTANLLMDENGVVKVADFGVARVQAQSG-VMTAETGTYRWMAPEVIEHKPY-DYKA 294
           HRDLK  NLL++  G +K+ADFG+AR         T E  T  + APE++    Y     
Sbjct: 125 HRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKYYSTAV 184

Query: 295 DVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKSLRPT--------------------- 333
           D++S G    E++T    + G + +     + +    P                      
Sbjct: 185 DIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWA 244

Query: 334 ------IPKHAHPRLAELLERCWQHDPTQRPNFSQI 363
                 +          LL +   +DP +R +    
Sbjct: 245 RQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAA 280

>d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: (Plasmodium falciparum) [TaxId: 5833]

 Score =  163 bits (412), Expect = 4e-48
 Identities = 59/275 (21%), Positives = 108/275 (39%), Gaps = 31/275 (11%)

Query: 119 KIECKVASGSYGDLYKGTY-CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQ 177
               K+  G+YG +YK      +  A+K ++ E  +  +     +E+ I+++++H N+V+
Sbjct: 5   HGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVK 64

Query: 178 FIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIH 237
                     L +V E +    +   L   +G  +  +     + +  G+ Y H   ++H
Sbjct: 65  LYDVIHTKKRLVLVFEHL-DQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRRVLH 123

Query: 238 RDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAETGTYRW-MAPEVIE-HKPYDYKAD 295
           RDLK  NLL++  G +K+ADFG+AR                W  AP+V+   K Y    D
Sbjct: 124 RDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEIVTLWYRAPDVLMGSKKYSTTID 183

Query: 296 VFSFGIALWELLTGELPYAGLTPLQAAVGVVQKSLRPT---------------------- 333
           ++S G    E++ G   + G++     + + +    P                       
Sbjct: 184 IWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYDPNFTVYEP 243

Query: 334 -----IPKHAHPRLAELLERCWQHDPTQRPNFSQI 363
                  K       +LL +  + DP QR    Q 
Sbjct: 244 LPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQA 278

>d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase Erk2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  161 bits (407), Expect = 1e-46
 Identities = 59/294 (20%), Positives = 115/294 (39%), Gaps = 44/294 (14%)

Query: 110 VWEIDAKQLKIECKVASGSYGDLYKGTYCS--QEVAIKVLKPECVNTEMLKEFSQEVYIM 167
           V+++  +   +   +  G+YG +           VAIK + P   +    +   +E+ I+
Sbjct: 3   VFDVGPRYTNLS-YIGEGAYGMVCSAYDNVNKVRVAIKKISPF-EHQTYCQRTLREIKIL 60

Query: 168 RKIRHKNVVQFIGACTRPP----NLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDV 223
            + RH+N++        P         +   +    +Y  L  Q        +      +
Sbjct: 61  LRFRHENIIGINDIIRAPTIEQMKDVYLVTHLMGADLYKLLKTQH--LSNDHICYFLYQI 118

Query: 224 SKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARV----QAQSGVMTAETGTYRW 279
            +G+ Y+H  N++HRDLK +NLL++    +K+ DFG+ARV       +G +T    T  +
Sbjct: 119 LRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWY 178

Query: 280 MAPEVIEHK-PYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKSLRPT----- 333
            APE++ +   Y    D++S G  L E+L+    + G   L     ++     P+     
Sbjct: 179 RAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLN 238

Query: 334 ------------------------IPKHAHPRLAELLERCWQHDPTQRPNFSQI 363
                                   +  +A  +  +LL++    +P +R    Q 
Sbjct: 239 CIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQA 292

>d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Ribosomal protein S6 kinase alpha 5, Msk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  159 bits (403), Expect = 3e-46
 Identities = 58/266 (21%), Positives = 121/266 (45%), Gaps = 17/266 (6%)

Query: 119 KIECKVASGSYGDLYKGTYCS-----QEVAIKVLKPECV--NTEMLKEFSQEVYIMRKIR 171
           ++   + +G+YG ++     S     +  A+KVLK   +    +  +    E  ++  IR
Sbjct: 27  ELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIR 86

Query: 172 HK-NVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYL 230
               +V    A      L ++ +++  G ++  L +++  F    +     ++   + +L
Sbjct: 87  QSPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQRER-FTEHEVQIYVGEIVLALEHL 145

Query: 231 HQNNIIHRDLKTANLLMDENGVVKVADFGVAR--VQAQSGVMTAETGTYRWMAPEVIEHK 288
           H+  II+RD+K  N+L+D NG V + DFG+++  V  ++       GT  +MAP+++   
Sbjct: 146 HKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYDFCGTIEYMAPDIVRGG 205

Query: 289 PYDY--KADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKSLR--PTIPKHAHPRLAE 344
              +    D +S G+ ++ELLTG  P+       +   + ++ L+  P  P+       +
Sbjct: 206 DSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPPYPQEMSALAKD 265

Query: 345 LLERCWQHDPTQRPNFSQIT--DILK 368
           L++R    DP +R         +I +
Sbjct: 266 LIQRLLMKDPKKRLGCGPRDADEIKE 291

>d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 9, CDK9
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  158 bits (399), Expect = 9e-46
 Identities = 64/291 (21%), Positives = 116/291 (39%), Gaps = 47/291 (16%)

Query: 119 KIECKVASGSYGDLYKGTYCS--QEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVV 176
           +   K+  G++G+++K  +    Q+VA+K +  E           +E+ I++ ++H+NVV
Sbjct: 13  EKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVV 72

Query: 177 QFIGACTRPP--------NLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMN 228
             I  C            ++ +V +F         L      F L+ + +V   +  G+ 
Sbjct: 73  NLIEICRTKASPYNRCKGSIYLVFDFCEHDL-AGLLSNVLVKFTLSEIKRVMQMLLNGLY 131

Query: 229 YLHQNNIIHRDLKTANLLMDENGVVKVADFGVARV-----QAQSGVMTAETGTYRWMAPE 283
           Y+H+N I+HRD+K AN+L+  +GV+K+ADFG+AR       +Q    T    T  +  PE
Sbjct: 132 YIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRVVTLWYRPPE 191

Query: 284 VI-EHKPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKSLRPT--------- 333
           ++   + Y    D++  G  + E+ T      G T       + Q     T         
Sbjct: 192 LLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPEVWPNVDN 251

Query: 334 ---------------------IPKHAHPRLAELLERCWQHDPTQRPNFSQI 363
                                      P   +L+++    DP QR +    
Sbjct: 252 YELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDA 302

>d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38-gamma
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  155 bits (393), Expect = 1e-44
 Identities = 72/295 (24%), Positives = 117/295 (39%), Gaps = 44/295 (14%)

Query: 107 GTDVWEIDAKQLKIECKVASGSYGDLYKGTYCS--QEVAIKVLKPECVNTEMLKEFSQEV 164
               WE+     +    V SG+YG +          +VAIK L     +    K   +E+
Sbjct: 10  TKTAWEVR-AVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYREL 68

Query: 165 YIMRKIRHKNVVQFIGACTRPP------NLCIVTEFMARGSIYDFLHKQKGVFQLTSLLK 218
            +++ +RH+NV+  +   T         +  +V  FM  G+    L K         +  
Sbjct: 69  RLLKHMRHENVIGLLDVFTPDETLDDFTDFYLVMPFM--GTDLGKLMK-HEKLGEDRIQF 125

Query: 219 VAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAETGTYR 278
           +   + KG+ Y+H   IIHRDLK  NL ++E+  +K+ DFG+AR       MT    T  
Sbjct: 126 LVYQMLKGLRYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQADSE--MTGYVVTRW 183

Query: 279 WMAPEVI-EHKPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKSLRP----- 332
           + APEVI     Y    D++S G  + E++TG+  + G   L     +++ +  P     
Sbjct: 184 YRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFV 243

Query: 333 ------------------------TIPKHAHPRLAELLERCWQHDPTQRPNFSQI 363
                                   +I  +A P    LLE+    D  QR    + 
Sbjct: 244 QRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEA 298

>d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Glycogen synthase kinase-3 beta (Gsk3b)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  154 bits (391), Expect = 2e-44
 Identities = 63/303 (20%), Positives = 114/303 (37%), Gaps = 49/303 (16%)

Query: 101 IEIPTDGTD-VWEIDAKQLKIECKVASGSYGDLYKGTYCS--QEVAIKVLKPECVNTEML 157
           +  P  G D   E+     K+   + +GS+G +Y+   C   + VAIK +  +       
Sbjct: 7   VATPGQGPDRPQEVSYTDTKV---IGNGSFGVVYQAKLCDSGELVAIKKVLQD------K 57

Query: 158 KEFSQEVYIMRKIRHKNVVQFIGACTRP------PNLCIVTEFMARGSIYDFLH--KQKG 209
           +  ++E+ IMRK+ H N+V+                L +V +++         H  + K 
Sbjct: 58  RFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQ 117

Query: 210 VFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENG-VVKVADFGVARVQAQSG 268
              +  +      + + + Y+H   I HRD+K  NLL+D +  V+K+ DFG A+   +  
Sbjct: 118 TLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGE 177

Query: 269 VMTAETGTYRWMAP-EVIEHKPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQ 327
              +   +  + AP  +     Y    DV+S G  L ELL G+  + G + +   V +++
Sbjct: 178 PNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIK 237

Query: 328 ---------------------------KSLRPTIPKHAHPRLAELLERCWQHDPTQRPNF 360
                                                  P    L  R  ++ PT R   
Sbjct: 238 VLGTPTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTP 297

Query: 361 SQI 363
            + 
Sbjct: 298 LEA 300

>d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK5
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  152 bits (383), Expect = 8e-44
 Identities = 60/277 (21%), Positives = 113/277 (40%), Gaps = 33/277 (11%)

Query: 119 KIECKVASGSYGDLYKGTYCS--QEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVV 176
           +   K+  G+YG ++K       + VA+K ++ +  +  +     +E+ ++++++HKN+V
Sbjct: 5   EKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIV 64

Query: 177 QFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNII 236
           +          L +V EF  +     F     G      +      + KG+ + H  N++
Sbjct: 65  RLHDVLHSDKKLTLVFEFCDQDLKKYF-DSCNGDLDPEIVKSFLFQLLKGLGFCHSRNVL 123

Query: 237 HRDLKTANLLMDENGVVKVADFGVARVQAQSG-VMTAETGTYRWMAPEVIE-HKPYDYKA 294
           HRDLK  NLL++ NG +K+A+FG+AR         +AE  T  +  P+V+   K Y    
Sbjct: 124 HRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSAEVVTLWYRPPDVLFGAKLYSTSI 183

Query: 295 DVFSFGIALWELLTGELP-YAGLTPLQAAVGVVQKSLRPT-------------------- 333
           D++S G    EL     P + G         + +    PT                    
Sbjct: 184 DMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDYKPYPMYP 243

Query: 334 -------IPKHAHPRLAELLERCWQHDPTQRPNFSQI 363
                  +    +    +LL+   + +P QR +  + 
Sbjct: 244 ATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEA 280

>d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  145 bits (367), Expect = 9e-41
 Identities = 58/291 (19%), Positives = 114/291 (39%), Gaps = 40/291 (13%)

Query: 109 DVWEIDAKQLKIECKVASGSYGDLYKGTYCS--QEVAIKVLKPECVNTEMLKEFSQEVYI 166
            +WE+  +  +    V SG+YG +           VA+K L     +    K   +E+ +
Sbjct: 12  TIWEVPER-YQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRL 70

Query: 167 MRKIRHKNVVQFIGACTRPP-----NLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAI 221
           ++ ++H+NV+  +   T        N   +   +    + + +  QK       +  +  
Sbjct: 71  LKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQK--LTDDHVQFLIY 128

Query: 222 DVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAETGTYRWMA 281
            + +G+ Y+H  +IIHRDLK +NL ++E+  +K+ DFG+AR      +       +    
Sbjct: 129 QILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLAR-HTDDEMTGYVATRWYRAP 187

Query: 282 PEVIEHKPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKSLRPT-------- 333
             ++    Y+   D++S G  + ELLTG   + G   +     +++    P         
Sbjct: 188 EIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKIS 247

Query: 334 ---------------------IPKHAHPRLAELLERCWQHDPTQRPNFSQI 363
                                +   A+P   +LLE+    D  +R   +Q 
Sbjct: 248 SESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQA 298

>d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-jun N-terminal kinase (jnk3s)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  139 bits (351), Expect = 2e-38
 Identities = 64/301 (21%), Positives = 125/301 (41%), Gaps = 21/301 (6%)

Query: 107 GTDVWEIDAKQLKIECKVASGSYGDLYKGTYCS--QEVAIKVLKPECVNTEMLKEFSQEV 164
           G   + +  K+ +    + SG+ G +         + VAIK L     N    K   +E+
Sbjct: 9   GDSTFTVL-KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYREL 67

Query: 165 YIMRKIRHKNVVQFIGACTRPP------NLCIVTEFMARGSIYDFLHKQKGVFQLTSLLK 218
            +M+ + HKN++  +   T         ++ +V E M            +       +  
Sbjct: 68  VLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDAN----LCQVIQMELDHERMSY 123

Query: 219 VAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAETGTYR 278
           +   +  G+ +LH   IIHRDLK +N+++  +  +K+ DFG+AR    S +MT    T  
Sbjct: 124 LLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRY 183

Query: 279 WMAPEVIEHKPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKSLRPTIPKHA 338
           + APEVI    Y    D++S G  + E++  ++ + G   +     V+++   P      
Sbjct: 184 YRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPC----- 238

Query: 339 HPRLAELLERCWQHDPTQRPNFSQITDILKQMMKEVASEGENNHSNKSAGSFFSSLRRGL 398
            P   + L+   ++    RP ++ +T    ++  +     ++ H+   A      L + L
Sbjct: 239 -PEFMKKLQPTVRNYVENRPKYAGLT--FPKLFPDSLFPADSEHNKLKASQARDLLSKML 295

Query: 399 H 399
            
Sbjct: 296 V 296

>d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase CK2, alpha subunit
species: Rattus norvegicus [TaxId: 10116]

 Score =  136 bits (343), Expect = 1e-37
 Identities = 47/308 (15%), Positives = 111/308 (36%), Gaps = 60/308 (19%)

Query: 107 GTDVWEIDAKQLK--------IECKVASGSYGDLYKGTYCS--QEVAIKVLKPECVNTEM 156
             + W+ ++  ++        +  K+  G Y ++++    +  ++V +K+LKP       
Sbjct: 18  PREYWDYESHVVEWGNQDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPV-----K 72

Query: 157 LKEFSQEVYIMRKIR-HKNVVQFIGACTRPPN--LCIVTEFMARGSIYDFLHKQKGVFQL 213
            K+  +E+ I+  +R   N++        P +    +V E +                  
Sbjct: 73  KKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVFEHVNNTDFKQLYQT----LTD 128

Query: 214 TSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMD-ENGVVKVADFGVARVQAQSGVMTA 272
             +     ++ K ++Y H   I+HRD+K  N+++D E+  +++ D+G+A           
Sbjct: 129 YDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNV 188

Query: 273 ETGTYRWMAPEV-IEHKPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKSL- 330
              +  +  PE+ ++++ YDY  D++S G  L  ++  + P+         +  + K L 
Sbjct: 189 RVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLG 248

Query: 331 -----------------------------------RPTIPKHAHPRLAELLERCWQHDPT 355
                                                       P   + L++  ++D  
Sbjct: 249 TEDLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQ 308

Query: 356 QRPNFSQI 363
            R    + 
Sbjct: 309 SRLTAREA 316

>d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Sky1p
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

 Score =  112 bits (280), Expect = 2e-28
 Identities = 46/315 (14%), Positives = 105/315 (33%), Gaps = 75/315 (23%)

Query: 119 KIECKVASGSYGDLYKGTYCS--QEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVV 176
            +  K+  G +  ++          VA+K+++ + V TE       E+ +++++   +  
Sbjct: 16  ILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTE---AAEDEIKLLQRVNDADNT 72

Query: 177 QFIGACTRPP---------------NLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAI 221
           +                        ++ +V E +    +      +     L  + +++ 
Sbjct: 73  KEDSMGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISK 132

Query: 222 DVSKGMNYLH-QNNIIHRDLKTANLLMDENGV------VKVADFGVARVQAQSGVMTAET 274
            +  G++Y+H +  IIH D+K  N+LM+          +K+AD G A    +    +   
Sbjct: 133 QLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYTNS--I 190

Query: 275 GTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQ------- 327
            T  + +PEV+   P+   AD++S    ++EL+TG+  +                     
Sbjct: 191 QTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQIIEL 250

Query: 328 ---------------------------------------KSLRPTIPKHAHPRLAELLER 348
                                                   + +    K     +++ L  
Sbjct: 251 LGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSP 310

Query: 349 CWQHDPTQRPNFSQI 363
             Q DP +R +   +
Sbjct: 311 MLQLDPRKRADAGGL 325

>d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: RIO1-like kinases
domain: Rio2 serine protein kinase C-terminal domain
species: Archaeoglobus fulgidus [TaxId: 2234]

 Score = 79.4 bits (195), Expect = 4e-18
 Identities = 27/203 (13%), Positives = 62/203 (30%), Gaps = 36/203 (17%)

Query: 113 IDAKQLKIECKVASGSYGDLYKGTYCS-QEVAIKVLKPECVNTEMLK--------EFSQE 163
           +DA    I   +  G    ++        E  +K  K    + + +K         FS  
Sbjct: 1   VDA----IGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVL 56

Query: 164 VYIMRKIRHKNVVQFIGACTRPP----NLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKV 219
                +   + + +  G             ++ E +    +Y    +           +V
Sbjct: 57  AIRSARNEFRALQKLQGLAVPKVYAWEGNAVLMELIDAKELYRVRVENP--------DEV 108

Query: 220 AIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARV----QAQSGVMTAETG 275
              + + +   +   I+H DL   N+L+ E G + + DF  +        +  +      
Sbjct: 109 LDMILEEVAKFYHRGIVHGDLSQYNVLVSEEG-IWIIDFPQSVEVGEEGWREILERDVRN 167

Query: 276 TYRWMAPEVIEHKPYDYKADVFS 298
              + +      + Y  + D+ S
Sbjct: 168 IITYFS------RTYRTEKDINS 184

Homologous Domains Detected by HHsearch

Original result of HHsearch against SCOP70(version1.75) database

ID	Length	Definition	Probability
Query	399
d1uwha_	276	B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]}	100.0
d1opja_	287	Abelsone tyrosine kinase (abl) {Mouse (Mus musculu	100.0
d1sm2a_	263	Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie	100.0
d1jpaa_	299	ephb2 receptor tyrosine kinase {Mouse (Mus musculu	100.0
d1u59a_	285	Tyrosine-protein kinase ZAP-70 {Human (Homo sapien	100.0
d1qpca_	272	Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax	100.0
d1xbba_	277	Tyrosine-protein kinase SYK {Human (Homo sapiens)	100.0
d1rjba_	325	Fl cytokine receptor {Human (Homo sapiens) [TaxId:	100.0
d2java1	269	Serine/threonine-protein kinase Nek2 {Human (Homo	100.0
d2j4za1	263	Aurora-related kinase 1 (aurora-2) {Human (Homo sa	100.0
d1k2pa_	258	Bruton's tyrosine kinase (Btk) {Human (Homo sapien	100.0
d1mqba_	283	epha2 receptor tyrosine kinase {Human (Homo sapien	100.0
d1mp8a_	273	Focal adhesion kinase 1 (fak) {Human (Homo sapiens	100.0
d1yhwa1	293	pak1 {Human (Homo sapiens) [TaxId: 9606]}	100.0
d2jfla1	288	STE20-like serine/threonine-protein kinase, SLK {H	100.0
d1nvra_	271	Cell cycle checkpoint kinase chk1 {Human (Homo sap	100.0
d1t4ha_	270	Protein kinase wnk1 {Human (Homo sapiens) [TaxId:	100.0
d1a06a_	307	Calmodulin-dependent protein kinase {Rat (Rattus n	100.0
d1byga_	262	Carboxyl-terminal src kinase (csk) {Human (Homo sa	100.0
d1u5ra_	309	Serine/threonine protein kinase TAO2 {Rat (Rattus	100.0
d1koaa2	350	Twitchin, kinase domain {Caenorhabditis elegans, p	100.0
d1uu3a_	288	3-phosphoinositide dependent protein kinase-1 Pdk1	100.0
d1u46a_	273	Activated CDC42 kinase 1, ACK1 {Human (Homo sapien	100.0
d1koba_	352	Twitchin, kinase domain {California sea hare (Aply	100.0
d1s9ja_	322	Dual specificity mitogen-activated protein kinase	100.0
d1fmka3	285	c-src tyrosine kinase {Human (Homo sapiens) [TaxId	100.0
d1ywna1	299	Vascular endothelial growth factor receptor 2 (kdr	100.0
d1fgka_	299	Fibroblast growth factor receptor 1 {Human (Homo s	100.0
d1jksa_	293	Death-associated protein kinase, Dap {Human (Homo	100.0
d1lufa_	301	Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax	100.0
d1t46a_	311	c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]	100.0
d1o6la_	337	Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9	100.0
d1xkka_	317	EGF receptor tyrosine kinase, Erbb-1 {Human (Homo	100.0
d1o6ya_	277	Mycobacterial protein kinase PknB, catalytic domai	100.0
d1fvra_	309	Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]}	100.0
d1phka_	277	gamma-subunit of glycogen phosphorylase kinase (Ph	100.0
d1fota_	316	cAMP-dependent PK, catalytic subunit {Baker's yeas	100.0
d1tkia_	321	Titin, kinase domain {Human (Homo sapiens) [TaxId:	100.0
d1p4oa_	308	Insulin-like growth factor 1 receptor {Human (Homo	100.0
d1rdqe_	350	cAMP-dependent PK, catalytic subunit {Mouse (Mus m	100.0
d1r0pa_	311	Hepatocyte growth factor receptor, c-MET {Human (H	100.0
d1xjda_	320	Protein kinase C, theta type {Human (Homo sapiens)	100.0
d1omwa3	364	G-protein coupled receptor kinase 2 {Cow (Bos taur	100.0
d2ozaa1	335	MAP kinase activated protein kinase 2, mapkap2 {Hu	100.0
d1gz8a_	298	Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T	100.0
d1blxa_	305	Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T	100.0
d1ua2a_	299	Cell division protein kinase 7, CDK7 {Human (Homo	100.0
d1vjya_	303	Type I TGF-beta receptor R4 {Human (Homo sapiens)	100.0
d1ob3a_	286	Cyclin-dependent PK, CDK2 {(Plasmodium falciparum)	100.0
d1xwsa_	273	Proto-oncogene serine/threonine-protein kinase Pim	100.0
d1cm8a_	346	MAP kinase p38-gamma {Human (Homo sapiens) [TaxId:	100.0
d1ckia_	299	Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax	100.0
d1csna_	293	Casein kinase-1, CK1 {Fission yeast (Schizosacchar	100.0
d1pmea_	345	MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606	100.0
d3blha1	318	Cell division protein kinase 9, CDK9 {Human (Homo	100.0
d1q5ka_	350	Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho	100.0
d1unla_	292	Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T	100.0
d2gfsa1	348	MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]	100.0
d1vzoa_	322	Ribosomal protein S6 kinase alpha 5, Msk1 {Human (	100.0
d3bqca1	328	Protein kinase CK2, alpha subunit {Rattus norvegic	100.0
d2b1pa1	355	c-jun N-terminal kinase (jnk3s) {Human (Homo sapie	100.0
d1q8ya_	362	Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T	100.0
d1zara2	191	Rio2 serine protein kinase C-terminal domain {Arch	99.93
d1j7la_	263	Type IIIa 3',5"-aminoglycoside phosphotransferase	98.67
d1nd4a_	255	Aminoglycoside 3'-phosphotransferase IIa (Kanamyci	98.12
d2pula1	392	Methylthioribose kinase MtnK {Bacillus subtilis [T	97.71
d1zyla1	325	RdoA {Escherichia coli [TaxId: 562]}	97.13
d1nw1a_	395	Choline kinase {Caenorhabditis elegans [TaxId: 623	96.88
d2ppqa1	316	Homoserine kinase ThrB {Agrobacterium tumefaciens	96.84
d1zpva1	83	UPF0237 protein SP0238 {Streptococcus pneumoniae [	93.94
d1u8sa1	86	putative transcriptional repressor VC2159 {Vibrio	91.9
d1ygya3	78	Phosphoglycerate dehydrogenase, regulatory (C-term	88.84
d2f06a1	71	Hypothetical protein BT0572 {Bacteroides thetaiota	87.54
d1sc6a3	84	Phosphoglycerate dehydrogenase, regulatory (C-term	87.23

>d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: B-Raf kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=7.4e-60  Score=442.41  Aligned_cols=263  Identities=35%  Similarity=0.693  Sum_probs=228.9

Q ss_pred             CceeecccccceeceeceeCceEEEEEEECCeeEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCceeeEEeEEecCCcE
Q 015868          109 DVWEIDAKQLKIECKVASGSYGDLYKGTYCSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNL  188 (399)
Q Consensus       109 ~~~~i~~~~~~i~~~lg~G~~g~Vy~~~~~~~~vAvK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~nIv~~~~~~~~~~~~  188 (399)
                      +.|+|+.++|++.++||+|+||.||+|++.+ .||||+++....+....+.|.+|+.+|++++||||+++++++.. +.+
T Consensus         1 ddwei~~~~~~~~~~lG~G~fg~Vy~~~~~~-~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~-~~~   78 (276)
T d1uwha_           1 DDWEIPDGQITVGQRIGSGSFGTVYKGKWHG-DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTA-PQL   78 (276)
T ss_dssp             CCCBCCTTCCCCCSEEEECSSCEEEEEESSS-EEEEEECCCSSCCTTHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSC
T ss_pred             CCcccccccEEEEEEEeeCCCcEEEEEEECC-EEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeeeEEEec-cEE
Confidence            4699999999999999999999999998654 69999998776667778899999999999999999999998765 468


Q ss_pred             EEEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceeecCCCcEEEeeccceeeccCC-
Q 015868          189 CIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQS-  267 (399)
Q Consensus       189 ~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~giiHrDlkp~NILl~~~~~vkl~DFG~a~~~~~~-  267 (399)
                      ++||||++||+|.+++......+++..+..++.||++||+|||++|||||||||+|||++.++.+||+|||+|+..... 
T Consensus        79 ~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~ivHrDlKp~NiLl~~~~~~Kl~DFGla~~~~~~~  158 (276)
T d1uwha_          79 AIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWS  158 (276)
T ss_dssp             EEEEECCCEEEHHHHHHTSCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEETTSSEEECCCCCSCC-----
T ss_pred             EEEEecCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHhcCCEeccccCHHHEEEcCCCCEEEccccceeeccccC
Confidence            9999999999999999887788999999999999999999999999999999999999999999999999999865432 


Q ss_pred             --CccccCCCCcccccccccCC---CCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhccCCC----CCCCCC
Q 015868          268 --GVMTAETGTYRWMAPEVIEH---KPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKSLRP----TIPKHA  338 (399)
Q Consensus       268 --~~~~~~~gt~~y~aPE~l~~---~~~~~~~Dv~slG~vl~elltg~~P~~~~~~~~~~~~~~~~~~~~----~~~~~~  338 (399)
                        .......||+.|||||++.+   .+|+.++|||||||++|||+||+.||.+.++.......+.....+    .++..+
T Consensus       159 ~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~  238 (276)
T d1uwha_         159 GSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPDLSKVRSNC  238 (276)
T ss_dssp             -------CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHHTSCCCCGGGSCTTC
T ss_pred             CcccccccccCcccCCHHHHhcccCCCCCchhhhhhhHHHHHHHHHCCCCCCCCChHHHHHHHHhcCCCCCcchhccccc
Confidence              22345578999999999964   358999999999999999999999999988776666655554332    356778


Q ss_pred             cHHHHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHH
Q 015868          339 HPRLAELLERCWQHDPTQRPNFSQITDILKQMMKE  373 (399)
Q Consensus       339 ~~~l~~ll~~cl~~dP~~Rps~~ell~~L~~l~~~  373 (399)
                      ++++.+||.+||+.||++|||+.|+++.|+.+.+.
T Consensus       239 ~~~l~~li~~cl~~dp~~RPt~~~il~~Le~l~~~  273 (276)
T d1uwha_         239 PKAMKRLMAECLKKKRDERPLFPQILASIELLARS  273 (276)
T ss_dssp             CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHT
T ss_pred             hHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHc
Confidence            99999999999999999999999999999988753

>d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Abelsone tyrosine kinase (abl)
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=3.5e-58  Score=433.47  Aligned_cols=260  Identities=35%  Similarity=0.713  Sum_probs=229.9

Q ss_pred             CCceeecccccceeceeceeCceEEEEEEE--CCeeEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCceeeEEeEEecC
Q 015868          108 TDVWEIDAKQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRP  185 (399)
Q Consensus       108 ~~~~~i~~~~~~i~~~lg~G~~g~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~nIv~~~~~~~~~  185 (399)
                      .+.|+|+.++|++.++||+|+||.||+|++  +++.||||+++.....   .+.|.+|+.+|++++||||++++++|.++
T Consensus         9 ~~~wei~~~~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~---~~~~~~E~~il~~l~HpnIv~~~~~~~~~   85 (287)
T d1opja_           9 YDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME---VEEFLKEAAVMKEIKHPNLVQLLGVCTRE   85 (287)
T ss_dssp             CCTTBCCGGGEEEEEETTTTTTSSEEEEEEGGGTEEEEEEECCTTCSC---HHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred             CcccEecHHHeEEeeEEeeCCCeEEEEEEECCCCeEEEEEEECCccch---HHHHHHHHHHHHhCCCCCEecCCccEeeC
Confidence            356999999999999999999999999998  4789999999865433   35789999999999999999999999999


Q ss_pred             CcEEEEEecCCCCCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceeecCCCcEEEeeccceeec
Q 015868          186 PNLCIVTEFMARGSIYDFLHKQ-KGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQ  264 (399)
Q Consensus       186 ~~~~lV~E~~~ggsL~~~l~~~-~~~l~~~~~~~i~~~i~~~L~~LH~~giiHrDlkp~NILl~~~~~vkl~DFG~a~~~  264 (399)
                      +.+++||||+++|+|.+++... ...+++..+..++.||+.||+|||++||+||||||+|||+++++.+||+|||+|+..
T Consensus        86 ~~~~iv~E~~~~g~l~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlKp~NILl~~~~~~Kl~DFG~a~~~  165 (287)
T d1opja_          86 PPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLM  165 (287)
T ss_dssp             SSCEEEEECCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCCCTTTC
T ss_pred             CeeEEEeecccCcchHHHhhhccccchHHHHHHHHHHHHHHHHHHHHHCCcccCccccCeEEECCCCcEEEccccceeec
Confidence            9999999999999999999763 467899999999999999999999999999999999999999999999999999865


Q ss_pred             cCCCc--cccCCCCcccccccccCCCCCCChhhHHHHHHHHHHHHcCCCC-CCCCCHHHHHHHHHhccCCCCCCCCCcHH
Q 015868          265 AQSGV--MTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELP-YAGLTPLQAAVGVVQKSLRPTIPKHAHPR  341 (399)
Q Consensus       265 ~~~~~--~~~~~gt~~y~aPE~l~~~~~~~~~Dv~slG~vl~elltg~~P-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  341 (399)
                      .....  .+...|++.|+|||++.+..|+.++|||||||++|||++|..| |.+.+..+ ....+....++..|..++++
T Consensus       166 ~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~k~DiwS~Gv~l~ell~~~~p~~~~~~~~~-~~~~i~~~~~~~~~~~~~~~  244 (287)
T d1opja_         166 TGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQ-VYELLEKDYRMERPEGCPEK  244 (287)
T ss_dssp             CSSSSEEETTEEECGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCSSTTCCHHH-HHHHHHTTCCCCCCTTCCHH
T ss_pred             CCCCceeeccccccccccChHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCcchHHH-HHHHHhcCCCCCCCccchHH
Confidence            54332  2333578999999999999999999999999999999996655 55555444 45566777888999999999


Q ss_pred             HHHHHHHHhhhcCCCCCCHHHHHHHHHHHH
Q 015868          342 LAELLERCWQHDPTQRPNFSQITDILKQMM  371 (399)
Q Consensus       342 l~~ll~~cl~~dP~~Rps~~ell~~L~~l~  371 (399)
                      +.+|+.+||+.||++|||++|+++.|+.+.
T Consensus       245 l~~li~~cl~~dP~~Rps~~ei~~~L~~~~  274 (287)
T d1opja_         245 VYELMRACWQWNPSDRPSFAEIHQAFETMF  274 (287)
T ss_dssp             HHHHHHHHTCSSGGGSCCHHHHHHHHHHTT
T ss_pred             HHHHHHHHcCCCHhHCcCHHHHHHHHHHHH
Confidence            999999999999999999999999888764

>d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase Itk/Tsk
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.5e-57  Score=423.87  Aligned_cols=256  Identities=32%  Similarity=0.675  Sum_probs=219.9

Q ss_pred             ecccccceeceeceeCceEEEEEEE-CCeeEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCceeeEEeEEecCCcEEEE
Q 015868          113 IDAKQLKIECKVASGSYGDLYKGTY-CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIV  191 (399)
Q Consensus       113 i~~~~~~i~~~lg~G~~g~Vy~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~nIv~~~~~~~~~~~~~lV  191 (399)
                      |+.++|++.++||+|+||.||+|.+ +++.||||+++......   ++|.+|+.++++++||||++++|++..++.+++|
T Consensus         2 idp~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~~~---~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~lv   78 (263)
T d1sm2a_           2 IDPSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSE---EDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLV   78 (263)
T ss_dssp             BCCSCEEEEEEEECCSSCCEEEEEETTTEEEEEEECCSSSSCH---HHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEE
T ss_pred             CChHHcEEEEEEeeCCCeEEEEEEECCCCEEEEEEECCCcCcH---HHHHHHHHHHHhcCCCCcccccceeccCCceEEE
Confidence            5678899999999999999999998 46789999998654333   5789999999999999999999999999999999


Q ss_pred             EecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceeecCCCcEEEeeccceeeccCCCc--
Q 015868          192 TEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGV--  269 (399)
Q Consensus       192 ~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~giiHrDlkp~NILl~~~~~vkl~DFG~a~~~~~~~~--  269 (399)
                      |||+++|+|.+++......+++..+..++.||+.||+|||+++|+||||||+|||+++++.+||+|||+++.......  
T Consensus        79 ~E~~~~g~L~~~l~~~~~~~~~~~~~~i~~qia~gl~~lH~~~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~~~  158 (263)
T d1sm2a_          79 FEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTS  158 (263)
T ss_dssp             EECCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCTTCSGGGEEECGGGCEEECSCC------------
T ss_pred             EEecCCCcHHHHhhccccCCCHHHHHHHHHHHHHHHHhhhccceeecccchhheeecCCCCeEecccchheeccCCCcee
Confidence            999999999999988778899999999999999999999999999999999999999999999999999986654332  


Q ss_pred             cccCCCCcccccccccCCCCCCChhhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHHhccCCCCCCCCCcHHHHHHHHH
Q 015868          270 MTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLT-GELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRLAELLER  348 (399)
Q Consensus       270 ~~~~~gt~~y~aPE~l~~~~~~~~~Dv~slG~vl~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~  348 (399)
                      .....||+.|+|||++.+..|+.++||||||+++|||+| |.+||...+..+.... +..+.++..|..+++++.+++.+
T Consensus       159 ~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvil~el~t~~~~~~~~~~~~~~~~~-i~~~~~~~~p~~~~~~l~~li~~  237 (263)
T d1sm2a_         159 STGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVED-ISTGFRLYKPRLASTHVYQIMNH  237 (263)
T ss_dssp             ------CTTSCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSCCHHHHHHH-HHHTCCCCCCTTSCHHHHHHHHH
T ss_pred             ecceecCcccCChHHhcCCCCCchhhhcchHHHHHHHHHCCCCCCCCCCHHHHHHH-HHhcCCCCCccccCHHHHHHHHH
Confidence            233568999999999999999999999999999999999 5777777776665544 55577788889999999999999


Q ss_pred             HhhhcCCCCCCHHHHHHHHHHHHH
Q 015868          349 CWQHDPTQRPNFSQITDILKQMMK  372 (399)
Q Consensus       349 cl~~dP~~Rps~~ell~~L~~l~~  372 (399)
                      ||+.||++|||++|+++.|+++.+
T Consensus       238 cl~~~p~~Rps~~~il~~L~~i~e  261 (263)
T d1sm2a_         238 CWKERPEDRPAFSRLLRQLAEIAE  261 (263)
T ss_dssp             HTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             HccCCHhHCcCHHHHHHHHHHHHh
Confidence            999999999999999999998854

>d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: ephb2 receptor tyrosine kinase
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=3.5e-57  Score=429.02  Aligned_cols=259  Identities=34%  Similarity=0.627  Sum_probs=221.9

Q ss_pred             eecccccceeceeceeCceEEEEEEEC--C---eeEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCceeeEEeEEecCC
Q 015868          112 EIDAKQLKIECKVASGSYGDLYKGTYC--S---QEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPP  186 (399)
Q Consensus       112 ~i~~~~~~i~~~lg~G~~g~Vy~~~~~--~---~~vAvK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~nIv~~~~~~~~~~  186 (399)
                      +++.++|++.+.||+|+||.||+|++.  +   ..||||.+.... .....+.|.+|+.+|++++||||+++++++..++
T Consensus        22 ~i~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~  100 (299)
T d1jpaa_          22 EIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGY-TEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKST  100 (299)
T ss_dssp             BCCGGGEEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCSSC-CHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSS
T ss_pred             hhChhhcEEeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEECccc-CHHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCC
Confidence            567789999999999999999999873  2   258899887653 4556678999999999999999999999999999


Q ss_pred             cEEEEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceeecCCCcEEEeeccceeeccC
Q 015868          187 NLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQ  266 (399)
Q Consensus       187 ~~~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~giiHrDlkp~NILl~~~~~vkl~DFG~a~~~~~  266 (399)
                      .+++||||+++|+|.+++....+.+++..+..++.||++||.|||++||+||||||+|||++.++.+||+|||+++....
T Consensus       101 ~~~iv~Ey~~~g~L~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~~  180 (299)
T d1jpaa_         101 PVMIITEFMENGSLDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLADMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLED  180 (299)
T ss_dssp             SCEEEEECCTTEEHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCC--------
T ss_pred             EEEEEEEecCCCcceeeeccccCCCCHHHHHHHHHHHHHHHHHHhhCCCccCccccceEEECCCCcEEECCcccceEccC
Confidence            99999999999999999988778899999999999999999999999999999999999999999999999999986554


Q ss_pred             CCc------cccCCCCcccccccccCCCCCCChhhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHHhccCCCCCCCCCc
Q 015868          267 SGV------MTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLT-GELPYAGLTPLQAAVGVVQKSLRPTIPKHAH  339 (399)
Q Consensus       267 ~~~------~~~~~gt~~y~aPE~l~~~~~~~~~Dv~slG~vl~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~  339 (399)
                      ...      .....||+.|||||.+.+..|+.++|||||||++|||+| |+.||.+.+..+.... +....++..|..++
T Consensus       181 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~sDvwS~Gvvl~el~t~g~~Pf~~~~~~~~~~~-i~~~~~~~~~~~~~  259 (299)
T d1jpaa_         181 DTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQDVINA-IEQDYRLPPPMDCP  259 (299)
T ss_dssp             ---------------CGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHH-HHTTCCCCCCTTCC
T ss_pred             CCCcceeeecccccCCccccCHHHHhcCCCCcccccccchHHHHHHHhCCCCCCCCCCHHHHHHH-HHcCCCCCCCccch
Confidence            321      122357899999999999999999999999999999998 8999999988776554 45567778888999


Q ss_pred             HHHHHHHHHHhhhcCCCCCCHHHHHHHHHHHHH
Q 015868          340 PRLAELLERCWQHDPTQRPNFSQITDILKQMMK  372 (399)
Q Consensus       340 ~~l~~ll~~cl~~dP~~Rps~~ell~~L~~l~~  372 (399)
                      +++.+|+.+||+.||++|||+.||++.|+++++
T Consensus       260 ~~l~~li~~cl~~~P~~RPs~~ei~~~L~~~l~  292 (299)
T d1jpaa_         260 SALHQLMLDCWQKDRNHRPKFGQIVNTLDKMIR  292 (299)
T ss_dssp             HHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHH
T ss_pred             HHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhc
Confidence            999999999999999999999999999999876

>d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase ZAP-70
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.3e-57  Score=424.73  Aligned_cols=267  Identities=27%  Similarity=0.547  Sum_probs=234.8

Q ss_pred             eeecccccceec-eeceeCceEEEEEEEC----CeeEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCceeeEEeEEecC
Q 015868          111 WEIDAKQLKIEC-KVASGSYGDLYKGTYC----SQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRP  185 (399)
Q Consensus       111 ~~i~~~~~~i~~-~lg~G~~g~Vy~~~~~----~~~vAvK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~nIv~~~~~~~~~  185 (399)
                      +.+..++|.+.+ +||+|+||.||+|.+.    +..||||+++... .....+.|.+|+.+|++++||||+++++++..+
T Consensus         3 l~l~~~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~~-~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~   81 (285)
T d1u59a_           3 LFLKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGT-EKADTEEMMREAQIMHQLDNPYIVRLIGVCQAE   81 (285)
T ss_dssp             CBCCGGGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSC-CHHHHHHHHHHHHHHHHCCCTTBCCEEEEEESS
T ss_pred             eeecccCeEECCcEEecccCeEEEEEEEecCCCcEEEEEEEEChhc-CHHHHHHHHHHHHHHHhCCCCCEeeEeeeeccC
Confidence            456677888888 5999999999999763    4579999998653 556678899999999999999999999999764


Q ss_pred             CcEEEEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceeecCCCcEEEeeccceeecc
Q 015868          186 PNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQA  265 (399)
Q Consensus       186 ~~~~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~giiHrDlkp~NILl~~~~~vkl~DFG~a~~~~  265 (399)
                       .+|+||||+++|+|.+++......+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+++...
T Consensus        82 -~~~lvmE~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~gL~ylH~~~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~  160 (285)
T d1u59a_          82 -ALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRDLAARNVLLVNRHYAKISDFGLSKALG  160 (285)
T ss_dssp             -SEEEEEECCTTEEHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEEETTEEEECCCTTCEECT
T ss_pred             -eEEEEEEeCCCCcHHHHhhccccCCCHHHHHHHHHHHHHHHHHHHhCCeecCcCchhheeeccCCceeeccchhhhccc
Confidence             5899999999999999998777889999999999999999999999999999999999999999999999999998765


Q ss_pred             CCCc----cccCCCCcccccccccCCCCCCChhhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHHhccCCCCCCCCCcH
Q 015868          266 QSGV----MTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLT-GELPYAGLTPLQAAVGVVQKSLRPTIPKHAHP  340 (399)
Q Consensus       266 ~~~~----~~~~~gt~~y~aPE~l~~~~~~~~~Dv~slG~vl~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~  340 (399)
                      ....    .....||+.|+|||++.+..++.++|||||||++|||+| |+.||.+.+..+.. ..+..+.++.+|..+++
T Consensus       161 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gv~l~E~lt~G~~Pf~~~~~~~~~-~~i~~~~~~~~p~~~~~  239 (285)
T d1u59a_         161 ADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVM-AFIEQGKRMECPPECPP  239 (285)
T ss_dssp             TCSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHHHH-HHHHTTCCCCCCTTCCH
T ss_pred             ccccccccccccccCccccChHHHhCCCCCccchhhcchHHHHHHHhCCCCCCCCCCHHHHH-HHHHcCCCCCCCCcCCH
Confidence            4332    233468999999999999999999999999999999998 99999998876654 44566778899999999


Q ss_pred             HHHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHhcccC
Q 015868          341 RLAELLERCWQHDPTQRPNFSQITDILKQMMKEVASEGEN  380 (399)
Q Consensus       341 ~l~~ll~~cl~~dP~~Rps~~ell~~L~~l~~~~~~~~~~  380 (399)
                      ++.+||.+||+.||++|||+.+|.+.|+.+..++......
T Consensus       240 ~l~~li~~cl~~~p~~RPs~~~i~~~L~~~~~~~~~~~~~  279 (285)
T d1u59a_         240 ELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSLASKVEG  279 (285)
T ss_dssp             HHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHHHHTTCSS
T ss_pred             HHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHHhhhccch
Confidence            9999999999999999999999999999988777655443

>d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Lymphocyte kinase (lck)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.2e-57  Score=422.88  Aligned_cols=259  Identities=31%  Similarity=0.635  Sum_probs=227.5

Q ss_pred             CceeecccccceeceeceeCceEEEEEEEC-CeeEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCceeeEEeEEecCCc
Q 015868          109 DVWEIDAKQLKIECKVASGSYGDLYKGTYC-SQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPN  187 (399)
Q Consensus       109 ~~~~i~~~~~~i~~~lg~G~~g~Vy~~~~~-~~~vAvK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~nIv~~~~~~~~~~~  187 (399)
                      +.|+|+.++|++.++||+|+||.||+|++. ++.||||+++.....   .+.|.+|+.+|++++||||+++++++.++ .
T Consensus         6 ~~wei~~~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~~~~~~~~---~~~~~~E~~~l~~l~HpnIv~~~g~~~~~-~   81 (272)
T d1qpca_           6 DEWEVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMS---PDAFLAEANLMKQLQHQRLVRLYAVVTQE-P   81 (272)
T ss_dssp             CTTBCCGGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTSSC---HHHHHHHHHHHHHCCCTTBCCEEEEECSS-S
T ss_pred             CCeecCHHHeEEeEEEecCCCcEEEEEEECCCCEEEEEEEccCcCC---HHHHHHHHHHHHhCCCCCEeEEEeeeccC-C
Confidence            679999999999999999999999999985 578999999865433   35789999999999999999999988654 5


Q ss_pred             EEEEEecCCCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceeecCCCcEEEeeccceeeccC
Q 015868          188 LCIVTEFMARGSIYDFLHKQK-GVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQ  266 (399)
Q Consensus       188 ~~lV~E~~~ggsL~~~l~~~~-~~l~~~~~~~i~~~i~~~L~~LH~~giiHrDlkp~NILl~~~~~vkl~DFG~a~~~~~  266 (399)
                      +++||||+++|+|.+++.... ..+++..+..++.||++||.|||++||+||||||+|||+++++.+||+|||+|+....
T Consensus        82 ~~iv~Ey~~~g~L~~~~~~~~~~~l~~~~~~~i~~qi~~gl~~lH~~~ivHrDiKp~NIll~~~~~~Kl~DFGla~~~~~  161 (272)
T d1qpca_          82 IYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIED  161 (272)
T ss_dssp             CEEEEECCTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEECSS
T ss_pred             eEEEEEeCCCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCccchhheeeecccceeeccccceEEccC
Confidence            799999999999999875433 4689999999999999999999999999999999999999999999999999987655


Q ss_pred             CCc--cccCCCCcccccccccCCCCCCChhhHHHHHHHHHHHHcC-CCCCCCCCHHHHHHHHHhccCCCCCCCCCcHHHH
Q 015868          267 SGV--MTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTG-ELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRLA  343 (399)
Q Consensus       267 ~~~--~~~~~gt~~y~aPE~l~~~~~~~~~Dv~slG~vl~elltg-~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~  343 (399)
                      ...  .....||+.|||||++.+..|+.++|||||||++|||+|| .+||...+..+.. ..+....++..|..+++++.
T Consensus       162 ~~~~~~~~~~gt~~y~APE~~~~~~~~~~sDvwS~Gvvl~ellt~~~~~~~~~~~~~~~-~~i~~~~~~~~p~~~~~~l~  240 (272)
T d1qpca_         162 NEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVI-QNLERGYRMVRPDNCPEELY  240 (272)
T ss_dssp             SCEECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHH-HHHHTTCCCCCCTTCCHHHH
T ss_pred             CccccccccCCcccccChHHHhCCCCCchhhhhhhHHHHHHHHhCCCCCCCCCCHHHHH-HHHHhcCCCCCcccChHHHH
Confidence            432  3445689999999999988999999999999999999995 5566666665544 44566788888999999999


Q ss_pred             HHHHHHhhhcCCCCCCHHHHHHHHHHHHH
Q 015868          344 ELLERCWQHDPTQRPNFSQITDILKQMMK  372 (399)
Q Consensus       344 ~ll~~cl~~dP~~Rps~~ell~~L~~l~~  372 (399)
                      +|+.+||+.||++|||++++++.|+.+..
T Consensus       241 ~li~~cl~~~P~~Rpt~~ei~~~L~~~ft  269 (272)
T d1qpca_         241 QLMRLCWKERPEDRPTFDYLRSVLEDFFT  269 (272)
T ss_dssp             HHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             HHHHHHcCCCHhHCcCHHHHHHHhhhhhh
Confidence            99999999999999999999999998764

>d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase SYK
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=9.3e-57  Score=421.56  Aligned_cols=263  Identities=29%  Similarity=0.575  Sum_probs=224.4

Q ss_pred             eccccccee-ceeceeCceEEEEEEEC----CeeEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCceeeEEeEEecCCc
Q 015868          113 IDAKQLKIE-CKVASGSYGDLYKGTYC----SQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPN  187 (399)
Q Consensus       113 i~~~~~~i~-~~lg~G~~g~Vy~~~~~----~~~vAvK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~nIv~~~~~~~~~~~  187 (399)
                      ++.+.+.+. ++||+|+||.||+|.+.    ++.||||+++....+....+.|.+|+.+|++++||||++++++|..+ .
T Consensus         3 ld~~~~~le~k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~~~-~   81 (277)
T d1xbba_           3 LDRKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEAE-S   81 (277)
T ss_dssp             CCGGGEEEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEEESS-S
T ss_pred             echhhCeecCCCcccCCCeEEEEEEEccCCcCeEEEEEEEChhhCCHHHHHHHHHHHHHHHhCCCCCCceEEEEeccC-C
Confidence            344455555 46999999999999863    36799999987655666678899999999999999999999999764 5


Q ss_pred             EEEEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceeecCCCcEEEeeccceeeccCC
Q 015868          188 LCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQS  267 (399)
Q Consensus       188 ~~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~giiHrDlkp~NILl~~~~~vkl~DFG~a~~~~~~  267 (399)
                      .+|||||+++|+|.+++.. ...+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.....
T Consensus        82 ~~lvmE~~~~g~L~~~l~~-~~~l~~~~~~~i~~qi~~gl~ylH~~~iiHrDlKp~Nill~~~~~~kl~DFGla~~~~~~  160 (277)
T d1xbba_          82 WMLVMEMAELGPLNKYLQQ-NRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRAD  160 (277)
T ss_dssp             EEEEEECCTTEEHHHHHHH-CTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECCCTTCEECCTT
T ss_pred             EEEEEEcCCCCcHHHHHhh-ccCCCHHHHHHHHHHHHHHHhhHHhCCcccCCCcchhhcccccCcccccchhhhhhcccc
Confidence            7899999999999999976 467999999999999999999999999999999999999999999999999999865443


Q ss_pred             Cc----cccCCCCcccccccccCCCCCCChhhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHHhccCCCCCCCCCcHHH
Q 015868          268 GV----MTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLT-GELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRL  342 (399)
Q Consensus       268 ~~----~~~~~gt~~y~aPE~l~~~~~~~~~Dv~slG~vl~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  342 (399)
                      ..    .....||+.|||||++.+..|+.++||||||+++|||+| |+.||.+.+..+... .+..+.++..|..+++++
T Consensus       161 ~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gv~l~ellt~g~~Pf~~~~~~~~~~-~i~~~~~~~~p~~~~~~~  239 (277)
T d1xbba_         161 ENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTA-MLEKGERMGCPAGCPREM  239 (277)
T ss_dssp             CSEEEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHH-HHHTTCCCCCCTTCCHHH
T ss_pred             ccccccccccCCCceecCchhhcCCCCCchhhhccchhhhhHHhhCCCCCCCCCCHHHHHH-HHHcCCCCCCCcccCHHH
Confidence            22    223468999999999999999999999999999999998 899999988876554 455677888999999999


Q ss_pred             HHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHhcc
Q 015868          343 AELLERCWQHDPTQRPNFSQITDILKQMMKEVASEG  378 (399)
Q Consensus       343 ~~ll~~cl~~dP~~Rps~~ell~~L~~l~~~~~~~~  378 (399)
                      .+||.+||+.||++|||+++|.+.|+....++..++
T Consensus       240 ~~li~~cl~~dp~~RPs~~~i~~~L~~~~~~~~~e~  275 (277)
T d1xbba_         240 YDLMNLCWTYDVENRPGFAAVELRLRNYYYDVVNEG  275 (277)
T ss_dssp             HHHHHHHTCSSTTTSCCHHHHHHHHHHHHHHHHHHH
T ss_pred             HHHHHHHcCCCHhHCcCHHHHHHHhhCHHhhcCCCC
Confidence            999999999999999999999999999877665544

>d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fl cytokine receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.9e-57  Score=433.03  Aligned_cols=259  Identities=30%  Similarity=0.588  Sum_probs=228.5

Q ss_pred             CceeecccccceeceeceeCceEEEEEEECC-------eeEEEEEecCCCCCHHHHHHHHHHHHHHHhc-CCCceeeEEe
Q 015868          109 DVWEIDAKQLKIECKVASGSYGDLYKGTYCS-------QEVAIKVLKPECVNTEMLKEFSQEVYIMRKI-RHKNVVQFIG  180 (399)
Q Consensus       109 ~~~~i~~~~~~i~~~lg~G~~g~Vy~~~~~~-------~~vAvK~~~~~~~~~~~~~~~~~Ei~~l~~l-~h~nIv~~~~  180 (399)
                      ..|+|+.++|++.++||+|+||.||+|++.+       ..||+|++.... .......+.+|+.+|+++ +||||+++++
T Consensus        30 ~kwei~~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~~HpnIv~l~~  108 (325)
T d1rjba_          30 LKWEFPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKA-DSSEREALMSELKMMTQLGSHENIVNLLG  108 (325)
T ss_dssp             GGGBCCGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC-------CHHHHHHHHHHHHHCCCTTBCCEEE
T ss_pred             ccccCCHHHeEEeeEEeeCCCeEEEEEEEcCCCcccceeEEEEEEecccc-CHHHHHHHHHHHHHHHHhcCCCcEeEEEE
Confidence            4589999999999999999999999998732       369999987543 334456789999999998 8999999999


Q ss_pred             EEecCCcEEEEEecCCCCCHHHHHHhcC----------------------CCCCHHHHHHHHHHHHHHHHHHHHCCcccC
Q 015868          181 ACTRPPNLCIVTEFMARGSIYDFLHKQK----------------------GVFQLTSLLKVAIDVSKGMNYLHQNNIIHR  238 (399)
Q Consensus       181 ~~~~~~~~~lV~E~~~ggsL~~~l~~~~----------------------~~l~~~~~~~i~~~i~~~L~~LH~~giiHr  238 (399)
                      ++...+.+++||||+++|+|.++++...                      ..+++..++.++.||++||+|||++||+||
T Consensus       109 ~~~~~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~~~IiHR  188 (325)
T d1rjba_         109 ACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHR  188 (325)
T ss_dssp             EECSSSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTTEEET
T ss_pred             EEeeCCeEEEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCCeeec
Confidence            9999999999999999999999997643                      347889999999999999999999999999


Q ss_pred             CCCCCceeecCCCcEEEeeccceeeccCCCc---cccCCCCcccccccccCCCCCCChhhHHHHHHHHHHHHc-CCCCCC
Q 015868          239 DLKTANLLMDENGVVKVADFGVARVQAQSGV---MTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLT-GELPYA  314 (399)
Q Consensus       239 Dlkp~NILl~~~~~vkl~DFG~a~~~~~~~~---~~~~~gt~~y~aPE~l~~~~~~~~~Dv~slG~vl~ellt-g~~P~~  314 (399)
                      ||||+|||++.++.+||+|||+|+.......   .....||+.|||||++.+..|+.++|||||||++|||+| |..||.
T Consensus       189 DlKp~Nill~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwS~Gvil~emlt~g~~Pf~  268 (325)
T d1rjba_         189 DLAARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYP  268 (325)
T ss_dssp             TCSGGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSST
T ss_pred             cCchhccccccCCeEEEeeccccccccCCCceeeeccccCCCccCChHHHcCCCCCcceeccchhHHHHHHHhCCCCCCC
Confidence            9999999999999999999999986554432   233457999999999999999999999999999999998 899999


Q ss_pred             CCCHHHHHHHHHhccCCCCCCCCCcHHHHHHHHHHhhhcCCCCCCHHHHHHHHH
Q 015868          315 GLTPLQAAVGVVQKSLRPTIPKHAHPRLAELLERCWQHDPTQRPNFSQITDILK  368 (399)
Q Consensus       315 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~cl~~dP~~Rps~~ell~~L~  368 (399)
                      +.+..+.....+....++..|..+++++.+||.+||+.||++|||++||++.|.
T Consensus       269 ~~~~~~~~~~~~~~~~~~~~p~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~  322 (325)
T d1rjba_         269 GIPVDANFYKLIQNGFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLG  322 (325)
T ss_dssp             TCCCSHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred             CCCHHHHHHHHHhcCCCCCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHh
Confidence            988877778888888899999999999999999999999999999999999885

>d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine-protein kinase Nek2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=7.9e-57  Score=420.18  Aligned_cols=250  Identities=25%  Similarity=0.417  Sum_probs=212.8

Q ss_pred             ccccceeceeceeCceEEEEEEE--CCeeEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCceeeEEeEEec--CCcEEE
Q 015868          115 AKQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTR--PPNLCI  190 (399)
Q Consensus       115 ~~~~~i~~~lg~G~~g~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~nIv~~~~~~~~--~~~~~l  190 (399)
                      .++|++.+.||+|+||.||+|++  +++.||+|+++....+....+.+.+|+.+|++++||||+++++++.+  ...+|+
T Consensus         3 ~edy~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~i   82 (269)
T d2java1           3 AEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYI   82 (269)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCTTSCHHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC----CEEE
T ss_pred             chhCEEeEEEecCCCeEEEEEEECCCCCEEEEEEEChhhCCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEeCCCCEEEE
Confidence            46899999999999999999988  47899999998877777778889999999999999999999999864  456899


Q ss_pred             EEecCCCCCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHCC-----cccCCCCCCceeecCCCcEEEeecccee
Q 015868          191 VTEFMARGSIYDFLHK---QKGVFQLTSLLKVAIDVSKGMNYLHQNN-----IIHRDLKTANLLMDENGVVKVADFGVAR  262 (399)
Q Consensus       191 V~E~~~ggsL~~~l~~---~~~~l~~~~~~~i~~~i~~~L~~LH~~g-----iiHrDlkp~NILl~~~~~vkl~DFG~a~  262 (399)
                      ||||++||+|.+++.+   ....+++..++.++.||+.||.|||++|     |+||||||+|||++.++.+||+|||+++
T Consensus        83 vmEy~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~~vkl~DFG~a~  162 (269)
T d2java1          83 VMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLAR  162 (269)
T ss_dssp             EEECCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTSCEEECCHHHHH
T ss_pred             EEecCCCCcHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcCCCCcEEEeecccee
Confidence            9999999999999864   3567999999999999999999999976     9999999999999999999999999998


Q ss_pred             eccCCC-ccccCCCCcccccccccCCCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhccCCCCCCCCCcHH
Q 015868          263 VQAQSG-VMTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPR  341 (399)
Q Consensus       263 ~~~~~~-~~~~~~gt~~y~aPE~l~~~~~~~~~Dv~slG~vl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  341 (399)
                      ...... ......||+.|||||++.+..|+.++|||||||++|||+||+.||.+.+..+....+.. ...+.+|..++++
T Consensus       163 ~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyel~tg~~Pf~~~~~~~~~~~i~~-~~~~~~~~~~s~~  241 (269)
T d2java1         163 ILNHDTSFAKAFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIRE-GKFRRIPYRYSDE  241 (269)
T ss_dssp             HC-----------CCCSCCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHH-TCCCCCCTTSCHH
T ss_pred             ecccCCCccccCCCCcccCCHHHHcCCCCChHHHHHhhCHHHHHHhhCCCCCCCCCHHHHHHHHHc-CCCCCCCcccCHH
Confidence            755433 33456799999999999999999999999999999999999999999888776655444 4556788899999


Q ss_pred             HHHHHHHHhhhcCCCCCCHHHHHH
Q 015868          342 LAELLERCWQHDPTQRPNFSQITD  365 (399)
Q Consensus       342 l~~ll~~cl~~dP~~Rps~~ell~  365 (399)
                      +.+||.+||+.||.+|||++|+++
T Consensus       242 l~~li~~~L~~dp~~Rps~~ell~  265 (269)
T d2java1         242 LNEIITRMLNLKDYHRPSVEEILE  265 (269)
T ss_dssp             HHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             HHHHHHHHcCCChhHCcCHHHHHh
Confidence            999999999999999999999875

>d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Aurora-related kinase 1 (aurora-2)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6.1e-57  Score=419.50  Aligned_cols=247  Identities=26%  Similarity=0.473  Sum_probs=219.8

Q ss_pred             ccccceeceeceeCceEEEEEEE--CCeeEEEEEecCCCC-CHHHHHHHHHHHHHHHhcCCCceeeEEeEEecCCcEEEE
Q 015868          115 AKQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECV-NTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIV  191 (399)
Q Consensus       115 ~~~~~i~~~lg~G~~g~Vy~~~~--~~~~vAvK~~~~~~~-~~~~~~~~~~Ei~~l~~l~h~nIv~~~~~~~~~~~~~lV  191 (399)
                      .++|++.+.||+|+||.||+|++  +++.||+|++..... +....+.+.+|+.++++++||||+++++++.++..+|+|
T Consensus         5 l~dy~i~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~iv   84 (263)
T d2j4za1           5 LEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLI   84 (263)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             hhHeEEEEEEecCCCcEEEEEEECCCCcEEEEEEEchHHccChHHHHHHHHHHHHHHhcCCCCCCeEEEEEEECCEEEEE
Confidence            35899999999999999999998  478999999864321 112346788999999999999999999999999999999


Q ss_pred             EecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceeecCCCcEEEeeccceeeccCCCccc
Q 015868          192 TEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMT  271 (399)
Q Consensus       192 ~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~giiHrDlkp~NILl~~~~~vkl~DFG~a~~~~~~~~~~  271 (399)
                      |||++||+|.+++.. .+.+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+|+..... ...
T Consensus        85 mEy~~~g~L~~~l~~-~~~l~e~~~~~i~~qi~~al~~lH~~~ivHrDiKp~Nill~~~~~~kl~DFG~a~~~~~~-~~~  162 (263)
T d2j4za1          85 LEYAPLGTVYRELQK-LSKFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSS-RRT  162 (263)
T ss_dssp             EECCTTCBHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCCSCSCCCCC-CCE
T ss_pred             EeecCCCcHHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHHCCeeeeeeccccceecCCCCEeecccceeeecCCC-ccc
Confidence            999999999999976 457999999999999999999999999999999999999999999999999999765543 345


Q ss_pred             cCCCCcccccccccCCCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhccCCCCCCCCCcHHHHHHHHHHhh
Q 015868          272 AETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRLAELLERCWQ  351 (399)
Q Consensus       272 ~~~gt~~y~aPE~l~~~~~~~~~Dv~slG~vl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~cl~  351 (399)
                      ...||+.|||||++.+.+|+.++|||||||++|+|++|+.||.+.+..+....+.+.  .+.+|..+++++.+||.+||+
T Consensus       163 ~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~--~~~~p~~~s~~~~~li~~~L~  240 (263)
T d2j4za1         163 TLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRV--EFTFPDFVTEGARDLISRLLK  240 (263)
T ss_dssp             ETTEEGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTT--CCCCCTTSCHHHHHHHHHHTC
T ss_pred             ccCCCCcccCHHHHcCCCCCchhhhhhHhHHHHHHhcCCCCCCCCCHHHHHHHHHcC--CCCCCccCCHHHHHHHHHHcc
Confidence            567999999999999999999999999999999999999999998887766655443  456788899999999999999


Q ss_pred             hcCCCCCCHHHHHH
Q 015868          352 HDPTQRPNFSQITD  365 (399)
Q Consensus       352 ~dP~~Rps~~ell~  365 (399)
                      .||++|||++|+++
T Consensus       241 ~dp~~R~t~~eil~  254 (263)
T d2j4za1         241 HNPSQRPMLREVLE  254 (263)
T ss_dssp             SSGGGSCCHHHHHT
T ss_pred             CCHhHCcCHHHHHc
Confidence            99999999999976

>d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Bruton's tyrosine kinase (Btk)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.9e-56  Score=415.09  Aligned_cols=253  Identities=31%  Similarity=0.630  Sum_probs=228.5

Q ss_pred             ecccccceeceeceeCceEEEEEEEC-CeeEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCceeeEEeEEecCCcEEEE
Q 015868          113 IDAKQLKIECKVASGSYGDLYKGTYC-SQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIV  191 (399)
Q Consensus       113 i~~~~~~i~~~lg~G~~g~Vy~~~~~-~~~vAvK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~nIv~~~~~~~~~~~~~lV  191 (399)
                      ++.++|++.++||+|+||+||+|++. ++.||||+++......   ++|.+|+.++++++||||++++|++.++..+++|
T Consensus         1 ~~~~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~l~~~~~~~---~~~~~Ev~~~~~l~HpnIv~~~g~~~~~~~~~iv   77 (258)
T d1k2pa_           1 IDPKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSE---DEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFII   77 (258)
T ss_dssp             CCCCCCCCCCCCCEETTEEEEEEEETTTEEEEEEEEESSSSCH---HHHHHHHHHHHTCCCTTBCCEEEEECCSSSEEEE
T ss_pred             CChHHCEEeEEEecCCCeEEEEEEECCCCEEEEEEECcCcCCH---HHHHHHHHHHHhcCCCceeeEEEEEeeCCceEEE
Confidence            45679999999999999999999994 5689999998764443   5789999999999999999999999999999999


Q ss_pred             EecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceeecCCCcEEEeeccceeeccCCCc--
Q 015868          192 TEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGV--  269 (399)
Q Consensus       192 ~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~giiHrDlkp~NILl~~~~~vkl~DFG~a~~~~~~~~--  269 (399)
                      |||+++|+|.+++......+++..+++++.|+++||+|||++||+||||||+||++++++.+||+|||+++.......  
T Consensus        78 ~Ey~~~g~l~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~~iiH~dlk~~Nill~~~~~~kl~DfG~a~~~~~~~~~~  157 (258)
T d1k2pa_          78 TEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTS  157 (258)
T ss_dssp             EECCTTEEHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTTBCCSCCSGGGEEECTTCCEEECCCSSCCBCSSSSCCC
T ss_pred             EEccCCCcHHHhhhccccCCcHHHHHHHHHHHHHHHHHHhhcCcccccccceeEEEcCCCcEEECcchhheeccCCCcee
Confidence            999999999999888778899999999999999999999999999999999999999999999999999986554332  


Q ss_pred             cccCCCCcccccccccCCCCCCChhhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHHhccCCCCCCCCCcHHHHHHHHH
Q 015868          270 MTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLT-GELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRLAELLER  348 (399)
Q Consensus       270 ~~~~~gt~~y~aPE~l~~~~~~~~~Dv~slG~vl~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~  348 (399)
                      .....||+.|+|||.+.+..|+.++||||||+++|||+| |+.||.+.+..+.... +....++..|..+++++.+||.+
T Consensus       158 ~~~~~~t~~y~aPE~~~~~~~~~ksDiwS~G~~l~el~t~g~~Pf~~~~~~~~~~~-i~~~~~~~~p~~~~~~l~~li~~  236 (258)
T d1k2pa_         158 SVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEH-IAQGLRLYRPHLASEKVYTIMYS  236 (258)
T ss_dssp             CCCSCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCHHHHHHH-HHTTCCCCCCTTCCHHHHHHHHH
T ss_pred             ecccCCCCCcCCcHHhcCCCCCcceeecccchhhHhHHhcCCCCCCCCCHHHHHHH-HHhCCCCCCcccccHHHHHHHHH
Confidence            334678999999999999999999999999999999998 8999999998776654 45577888999999999999999


Q ss_pred             HhhhcCCCCCCHHHHHHHHHH
Q 015868          349 CWQHDPTQRPNFSQITDILKQ  369 (399)
Q Consensus       349 cl~~dP~~Rps~~ell~~L~~  369 (399)
                      ||+.||++|||++++++.|.+
T Consensus       237 cl~~dP~~RPt~~eil~~L~d  257 (258)
T d1k2pa_         237 CWHEKADERPTFKILLSNILD  257 (258)
T ss_dssp             TTCSSGGGSCCHHHHHHHHHC
T ss_pred             HccCCHhHCcCHHHHHHHhhC
Confidence            999999999999999998754

>d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: epha2 receptor tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.7e-56  Score=418.09  Aligned_cols=259  Identities=31%  Similarity=0.610  Sum_probs=223.1

Q ss_pred             eecccccceeceeceeCceEEEEEEECC------eeEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCceeeEEeEEecC
Q 015868          112 EIDAKQLKIECKVASGSYGDLYKGTYCS------QEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRP  185 (399)
Q Consensus       112 ~i~~~~~~i~~~lg~G~~g~Vy~~~~~~------~~vAvK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~nIv~~~~~~~~~  185 (399)
                      +|+.+.|++.+.||+|+||.||+|.+.+      ..||||+++... .......|.+|+.++++++||||++++|++...
T Consensus         3 ei~~~~~~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~-~~~~~~~~~~E~~il~~l~H~nIv~~~g~~~~~   81 (283)
T d1mqba_           3 EIHPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGY-TEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKY   81 (283)
T ss_dssp             BCCTTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTC-CHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSS
T ss_pred             cCCHHHeEeeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEEECccc-ChHHHHHHHHHHHHHHhcCCCCEeeeeEEEecC
Confidence            6778899999999999999999998743      369999997653 455567899999999999999999999999999


Q ss_pred             CcEEEEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceeecCCCcEEEeeccceeecc
Q 015868          186 PNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQA  265 (399)
Q Consensus       186 ~~~~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~giiHrDlkp~NILl~~~~~vkl~DFG~a~~~~  265 (399)
                      ...++||||+.++++.+++......+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++...
T Consensus        82 ~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~~i~~gl~~lH~~~iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~  161 (283)
T d1mqba_          82 KPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLE  161 (283)
T ss_dssp             SSEEEEEECCTTEEHHHHHHHTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCCCC-----
T ss_pred             CceEEEEEecccCcchhhhhcccccccHHHHHHHHHHHHHhhhhccccccccCccccceEEECCCCeEEEcccchhhccc
Confidence            99999999999999999998878889999999999999999999999999999999999999999999999999998654


Q ss_pred             CCC----ccccCCCCcccccccccCCCCCCChhhHHHHHHHHHHHHcC-CCCCCCCCHHHHHHHHHhccCCCCCCCCCcH
Q 015868          266 QSG----VMTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTG-ELPYAGLTPLQAAVGVVQKSLRPTIPKHAHP  340 (399)
Q Consensus       266 ~~~----~~~~~~gt~~y~aPE~l~~~~~~~~~Dv~slG~vl~elltg-~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~  340 (399)
                      ...    ......||+.|||||++.+..|+.++||||||+++|||++| .+|+...+..+ ....+..+.++..|..+++
T Consensus       162 ~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~sDI~S~Gvil~el~t~~~~~~~~~~~~~-~~~~i~~~~~~~~~~~~~~  240 (283)
T d1mqba_         162 DDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHE-VMKAINDGFRLPTPMDCPS  240 (283)
T ss_dssp             ------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHH-HHHHHHTTCCCCCCTTCBH
T ss_pred             CCCccceEeccCCCCccccCHHHHccCCCCCcccccccHHHHHHHHhCCCCccccCCHHH-HHHHHhccCCCCCchhhHH
Confidence            332    12334679999999999999999999999999999999995 45555555555 4455667788889999999


Q ss_pred             HHHHHHHHHhhhcCCCCCCHHHHHHHHHHHHH
Q 015868          341 RLAELLERCWQHDPTQRPNFSQITDILKQMMK  372 (399)
Q Consensus       341 ~l~~ll~~cl~~dP~~Rps~~ell~~L~~l~~  372 (399)
                      ++.+|+.+||+.||++|||+.||++.|+.+++
T Consensus       241 ~l~~li~~cl~~~p~~RPt~~eil~~L~~l~~  272 (283)
T d1mqba_         241 AIYQLMMQCWQQERARRPKFADIVSILDKLIR  272 (283)
T ss_dssp             HHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHH
T ss_pred             HHHHHHHHHCcCCHhHCcCHHHHHHHHHHHhh
Confidence            99999999999999999999999999998875

>d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Focal adhesion kinase 1 (fak)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.3e-56  Score=418.03  Aligned_cols=263  Identities=30%  Similarity=0.597  Sum_probs=224.0

Q ss_pred             ceeecccccceeceeceeCceEEEEEEECC-----eeEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCceeeEEeEEec
Q 015868          110 VWEIDAKQLKIECKVASGSYGDLYKGTYCS-----QEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTR  184 (399)
Q Consensus       110 ~~~i~~~~~~i~~~lg~G~~g~Vy~~~~~~-----~~vAvK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~nIv~~~~~~~~  184 (399)
                      .|+|+.++|++.+.||+|+||.||+|++..     ..||||.++... .....+.+.+|+.+|++++||||+++++++.+
T Consensus         1 ~~ei~~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~~-~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~   79 (273)
T d1mp8a_           1 DYEIQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCT-SDSVREKFLQEALTMRQFDHPHIVKLIGVITE   79 (273)
T ss_dssp             CCBCCGGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTT-SHHHHHHHHHHHHHHHTCCCTTBCCEEEEECS
T ss_pred             CCCcCHHHeEEEEEEeeCCCcEEEEEEEecCCceeEEEEEEEecccc-CHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec
Confidence            489999999999999999999999998742     458899886543 45566789999999999999999999999964


Q ss_pred             CCcEEEEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceeecCCCcEEEeeccceeec
Q 015868          185 PPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQ  264 (399)
Q Consensus       185 ~~~~~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~giiHrDlkp~NILl~~~~~vkl~DFG~a~~~  264 (399)
                       +.+++||||+++|+|.+++......+++..++.++.||++||.|||++||+||||||+||++++++.+||+|||+++..
T Consensus        80 -~~~~iv~E~~~~g~l~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~iiHrDlKp~NIll~~~~~~Kl~DfG~a~~~  158 (273)
T d1mp8a_          80 -NPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYM  158 (273)
T ss_dssp             -SSCEEEEECCTTEEHHHHHHHTTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECC-------
T ss_pred             -CeEEEEEEeccCCcHHhhhhccCCCCCHHHHHHHHHHHHHHhhhhcccCeeccccchhheeecCCCcEEEccchhheec
Confidence             5689999999999999999887888999999999999999999999999999999999999999999999999999865


Q ss_pred             cCCC--ccccCCCCcccccccccCCCCCCChhhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHHhccCCCCCCCCCcHH
Q 015868          265 AQSG--VMTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLT-GELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPR  341 (399)
Q Consensus       265 ~~~~--~~~~~~gt~~y~aPE~l~~~~~~~~~Dv~slG~vl~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  341 (399)
                      ....  ..+...||+.|+|||++.+..|+.++|||||||++|||+| |.+||.+.+..+....+ ..+.++++|..++++
T Consensus       159 ~~~~~~~~~~~~gt~~y~apE~l~~~~~~~~~DiwSlGvil~e~lt~g~~P~~~~~~~~~~~~i-~~~~~~~~~~~~~~~  237 (273)
T d1mp8a_         159 EDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRI-ENGERLPMPPNCPPT  237 (273)
T ss_dssp             ------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHH-HTTCCCCCCTTCCHH
T ss_pred             cCCcceeccceecCcccchhhHhccCCCCCccccccchHHHHHHHhcCCCCCCCCCHHHHHHHH-HcCCCCCCCCCCCHH
Confidence            5432  2344567999999999999999999999999999999998 89999998887766554 456677889999999


Q ss_pred             HHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHH
Q 015868          342 LAELLERCWQHDPTQRPNFSQITDILKQMMKEVA  375 (399)
Q Consensus       342 l~~ll~~cl~~dP~~Rps~~ell~~L~~l~~~~~  375 (399)
                      +.+||.+||+.||++|||+.||++.|++++++..
T Consensus       238 ~~~li~~cl~~dp~~Rps~~ei~~~L~~i~~~~k  271 (273)
T d1mp8a_         238 LYSLMTKCWAYDPSRRPRFTELKAQLSTILEEEK  271 (273)
T ss_dssp             HHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHH
T ss_pred             HHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHHhh
Confidence            9999999999999999999999999999987653

>d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: pak1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.4e-56  Score=421.61  Aligned_cols=246  Identities=28%  Similarity=0.486  Sum_probs=219.3

Q ss_pred             cccceeceeceeCceEEEEEEE--CCeeEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCceeeEEeEEecCCcEEEEEe
Q 015868          116 KQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVTE  193 (399)
Q Consensus       116 ~~~~i~~~lg~G~~g~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~nIv~~~~~~~~~~~~~lV~E  193 (399)
                      ++|++.++||+|+||.||+|++  +++.||||+++.....  ..+.+.+|+.+|++++||||+++++++..++.+|+|||
T Consensus        20 ~~Y~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~~~--~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmE   97 (293)
T d1yhwa1          20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQP--KKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVME   97 (293)
T ss_dssp             TTBCSCEECCCSSSCEEEEEEBTTTCCEEEEEEEEGGGCS--CHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             cccEEEEEEecCcCcEEEEEEECCCCCEEEEEEEecccCh--HHHHHHHHHHHHHhCCCCCEeeEeEEEEECCEEEEEEE
Confidence            4799999999999999999986  5899999999754322  24678999999999999999999999999999999999


Q ss_pred             cCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceeecCCCcEEEeeccceeeccCCC-cccc
Q 015868          194 FMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSG-VMTA  272 (399)
Q Consensus       194 ~~~ggsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~giiHrDlkp~NILl~~~~~vkl~DFG~a~~~~~~~-~~~~  272 (399)
                      |++||+|.+++.+  +.+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||+++...... ....
T Consensus        98 y~~gg~L~~~~~~--~~l~~~~~~~i~~qi~~aL~yLH~~~iiHrDiKp~NILl~~~~~vkl~DFG~a~~~~~~~~~~~~  175 (293)
T d1yhwa1          98 YLAGGSLTDVVTE--TCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRST  175 (293)
T ss_dssp             CCTTCBHHHHHHH--SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSTTCCBCC
T ss_pred             ecCCCcHHHHhhc--cCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCcHHHeEECCCCcEeeccchhheeeccccccccc
Confidence            9999999998865  469999999999999999999999999999999999999999999999999998765433 3455


Q ss_pred             CCCCcccccccccCCCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhccC-CCCCCCCCcHHHHHHHHHHhh
Q 015868          273 ETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKSL-RPTIPKHAHPRLAELLERCWQ  351 (399)
Q Consensus       273 ~~gt~~y~aPE~l~~~~~~~~~Dv~slG~vl~elltg~~P~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~l~~ll~~cl~  351 (399)
                      ..||+.|+|||++.+.+|+.++|||||||++|+|+||+.||.+.+..+.......... ....+..+++++.+||.+||+
T Consensus       176 ~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~  255 (293)
T d1yhwa1         176 MVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIFRDFLNRCLD  255 (293)
T ss_dssp             CCSCGGGCCHHHHSSSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHHCSCCCSSGGGSCHHHHHHHHHHTC
T ss_pred             cccCCCccChhhhcCCCCCchhceehHhHHHHHHhhCCCCCCCCCHHHHHHHHHhCCCCCCCCcccCCHHHHHHHHHHcc
Confidence            6799999999999999999999999999999999999999999888777666555433 344567799999999999999


Q ss_pred             hcCCCCCCHHHHHH
Q 015868          352 HDPTQRPNFSQITD  365 (399)
Q Consensus       352 ~dP~~Rps~~ell~  365 (399)
                      .||.+|||+.|+++
T Consensus       256 ~dP~~R~s~~eil~  269 (293)
T d1yhwa1         256 MDVEKRGSAKELLQ  269 (293)
T ss_dssp             SSTTTSCCHHHHTT
T ss_pred             CChhHCcCHHHHhc
Confidence            99999999999864

>d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: STE20-like serine/threonine-protein kinase, SLK
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.5e-56  Score=422.32  Aligned_cols=248  Identities=31%  Similarity=0.513  Sum_probs=219.5

Q ss_pred             cccceeceeceeCceEEEEEEE--CCeeEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCceeeEEeEEecCCcEEEEEe
Q 015868          116 KQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVTE  193 (399)
Q Consensus       116 ~~~~i~~~lg~G~~g~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~nIv~~~~~~~~~~~~~lV~E  193 (399)
                      +.|++.++||+|+||.||+|++  +++.||+|+++..  +....+.+.+|+.+|++++||||+++++++.+++.+++|||
T Consensus        12 d~Y~i~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~--~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lvmE   89 (288)
T d2jfla1          12 DFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTK--SEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIE   89 (288)
T ss_dssp             GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS--SSGGGGGTHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             cCeEEeEEEeeCCCcEEEEEEECCCCeEEEEEEECcC--CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCeEEEEEe
Confidence            4689999999999999999998  5788999999765  33445788999999999999999999999999999999999


Q ss_pred             cCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceeecCCCcEEEeeccceeeccCCC-cccc
Q 015868          194 FMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSG-VMTA  272 (399)
Q Consensus       194 ~~~ggsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~giiHrDlkp~NILl~~~~~vkl~DFG~a~~~~~~~-~~~~  272 (399)
                      |++||+|.+++.+..+.+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+|+...... ....
T Consensus        90 y~~~g~L~~~~~~~~~~l~e~~~~~i~~qi~~gL~ylH~~~ivHrDiKp~NIll~~~~~~Kl~DFG~a~~~~~~~~~~~~  169 (288)
T d2jfla1          90 FCAGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLHDNKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDS  169 (288)
T ss_dssp             CCTTEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECHHHHHHHTC
T ss_pred             cCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEEEeecChhheeECCCCCEEEEechhhhccCCCcccccc
Confidence            999999999988777789999999999999999999999999999999999999999999999999997654332 2345


Q ss_pred             CCCCcccccccccC-----CCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhccC-CCCCCCCCcHHHHHHH
Q 015868          273 ETGTYRWMAPEVIE-----HKPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKSL-RPTIPKHAHPRLAELL  346 (399)
Q Consensus       273 ~~gt~~y~aPE~l~-----~~~~~~~~Dv~slG~vl~elltg~~P~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~l~~ll  346 (399)
                      ..||+.|+|||++.     +.+|+.++|||||||++|+|+||+.||.+.++.+....+..... ....+..+++++.+||
T Consensus       170 ~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~s~~~~~li  249 (288)
T d2jfla1         170 FIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVLLKIAKSEPPTLAQPSRWSSNFKDFL  249 (288)
T ss_dssp             CCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHHHHHHHSCCCCCSSGGGSCHHHHHHH
T ss_pred             cccccccCCHHHHhhcccCCCCCChhhhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHHcCCCCCCCccccCCHHHHHHH
Confidence            68999999999984     55789999999999999999999999999998887776665432 2334567899999999


Q ss_pred             HHHhhhcCCCCCCHHHHHH
Q 015868          347 ERCWQHDPTQRPNFSQITD  365 (399)
Q Consensus       347 ~~cl~~dP~~Rps~~ell~  365 (399)
                      .+||+.||.+|||++|+++
T Consensus       250 ~~~L~~dp~~R~t~~ell~  268 (288)
T d2jfla1         250 KKCLEKNVDARWTTSQLLQ  268 (288)
T ss_dssp             HHHSCSSTTTSCCHHHHTT
T ss_pred             HHHccCChhHCcCHHHHhc
Confidence            9999999999999999875

>d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell cycle checkpoint kinase chk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.1e-56  Score=417.54  Aligned_cols=248  Identities=24%  Similarity=0.403  Sum_probs=210.3

Q ss_pred             cccceeceeceeCceEEEEEEE--CCeeEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCceeeEEeEEecCCcEEEEEe
Q 015868          116 KQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVTE  193 (399)
Q Consensus       116 ~~~~i~~~lg~G~~g~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~nIv~~~~~~~~~~~~~lV~E  193 (399)
                      ++|++.++||+|+||.||+|++  +++.||||+++... ..+..+.+.+|+.+|++++||||+++++++.+++.+|+|||
T Consensus         5 ~dy~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~-~~~~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~~~~~~ivmE   83 (271)
T d1nvra_           5 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKR-AVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLE   83 (271)
T ss_dssp             TEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC--------CHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             cceEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhh-cchHHHHHHHHHHHHHhCCCCCEeeEeeeeccCceeEEEEe
Confidence            5799999999999999999998  47899999997653 23344678999999999999999999999999999999999


Q ss_pred             cCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceeecCCCcEEEeeccceeeccCCC---cc
Q 015868          194 FMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSG---VM  270 (399)
Q Consensus       194 ~~~ggsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~giiHrDlkp~NILl~~~~~vkl~DFG~a~~~~~~~---~~  270 (399)
                      |++||+|.+++.. .+.+++..++.++.||++||+|||++||+||||||+|||+++++.+||+|||+|+......   ..
T Consensus        84 y~~gg~L~~~l~~-~~~l~e~~~~~i~~qi~~al~ylH~~~IiHrDiKp~NILl~~~~~~KL~DFG~a~~~~~~~~~~~~  162 (271)
T d1nvra_          84 YCSGGELFDRIEP-DIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLL  162 (271)
T ss_dssp             CCTTEEGGGGSBT-TTBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCCTTCEECEETTEECCB
T ss_pred             ccCCCcHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHcCCccCcccHHHEEECCCCCEEEccchhheeeccCCccccc
Confidence            9999999999965 5679999999999999999999999999999999999999999999999999998754332   24


Q ss_pred             ccCCCCcccccccccCCCCC-CChhhHHHHHHHHHHHHcCCCCCCCCCHHHHH-HHHHhccCCCCCCCCCcHHHHHHHHH
Q 015868          271 TAETGTYRWMAPEVIEHKPY-DYKADVFSFGIALWELLTGELPYAGLTPLQAA-VGVVQKSLRPTIPKHAHPRLAELLER  348 (399)
Q Consensus       271 ~~~~gt~~y~aPE~l~~~~~-~~~~Dv~slG~vl~elltg~~P~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~l~~ll~~  348 (399)
                      +...||+.|||||++.+..+ +.++|||||||++|+|+||+.||...+..... ...............+++++.+||.+
T Consensus       163 ~~~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~  242 (271)
T d1nvra_         163 NKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLALLHK  242 (271)
T ss_dssp             CCCCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSSTTSHHHHHHHTTCTTSTTGGGSCHHHHHHHHH
T ss_pred             cceeeCcCccCHhHhcCCCCCCCceeeeHhHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCccccCCHHHHHHHHH
Confidence            45679999999999988876 57899999999999999999999876543322 23333333333345789999999999


Q ss_pred             HhhhcCCCCCCHHHHHH
Q 015868          349 CWQHDPTQRPNFSQITD  365 (399)
Q Consensus       349 cl~~dP~~Rps~~ell~  365 (399)
                      ||+.||++|||++|+++
T Consensus       243 ~L~~dP~~R~t~~eil~  259 (271)
T d1nvra_         243 ILVENPSARITIPDIKK  259 (271)
T ss_dssp             HSCSSTTTSCCHHHHTT
T ss_pred             HcCCChhHCcCHHHHhc
Confidence            99999999999999854

>d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase wnk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.5e-55  Score=411.61  Aligned_cols=247  Identities=29%  Similarity=0.532  Sum_probs=213.7

Q ss_pred             cccceeceeceeCceEEEEEEE--CCeeEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCceeeEEeEEec----CCcEE
Q 015868          116 KQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTR----PPNLC  189 (399)
Q Consensus       116 ~~~~i~~~lg~G~~g~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~nIv~~~~~~~~----~~~~~  189 (399)
                      +-|++.++||+|+||+||+|++  +++.||+|++..........+.+.+|+.+|++++||||+++++++..    ...+|
T Consensus         9 ry~~~~~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~~~   88 (270)
T d1t4ha_           9 RFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIV   88 (270)
T ss_dssp             CEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEE
T ss_pred             CEEEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeccccCCEEE
Confidence            3457888999999999999998  46789999998766667777889999999999999999999999864    34689


Q ss_pred             EEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCCCceeec-CCCcEEEeeccceeeccC
Q 015868          190 IVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNN--IIHRDLKTANLLMD-ENGVVKVADFGVARVQAQ  266 (399)
Q Consensus       190 lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~g--iiHrDlkp~NILl~-~~~~vkl~DFG~a~~~~~  266 (399)
                      +||||++||+|.+++.+ ...+++..+..++.||++||+|||++|  |+||||||+|||++ +++.+||+|||+++....
T Consensus        89 ivmE~~~~g~L~~~l~~-~~~~~~~~~~~~~~qi~~gl~yLH~~~~~IiHrDiKp~NILl~~~~~~~Kl~DFGla~~~~~  167 (270)
T d1t4ha_          89 LVTELMTSGTLKTYLKR-FKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRA  167 (270)
T ss_dssp             EEEECCCSCBHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCSCCCGGGEEESSTTSCEEECCTTGGGGCCT
T ss_pred             EEEeCCCCCcHHHHHhc-cccccHHHHHHHHHHHHHHHHHHHHCCCCEEeCCcChhhceeeCCCCCEEEeecCcceeccC
Confidence            99999999999999976 467999999999999999999999998  99999999999996 578999999999975443


Q ss_pred             CCccccCCCCcccccccccCCCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhccCC-CCCCCCCcHHHHHH
Q 015868          267 SGVMTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKSLR-PTIPKHAHPRLAEL  345 (399)
Q Consensus       267 ~~~~~~~~gt~~y~aPE~l~~~~~~~~~Dv~slG~vl~elltg~~P~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~l~~l  345 (399)
                      . ......||+.|||||++.+ +|+.++|||||||++|||++|+.||.+..........+..... +.++...++++.+|
T Consensus       168 ~-~~~~~~GT~~Y~aPE~~~~-~~~~~~DIwSlGvilyel~~g~~Pf~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~l  245 (270)
T d1t4ha_         168 S-FAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPASFDKVAIPEVKEI  245 (270)
T ss_dssp             T-SBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTTTCCCGGGGGCCCHHHHHH
T ss_pred             C-ccCCcccCccccCHHHhCC-CCCCcCchhhHHHHHHHHHHCCCCCCCcccHHHHHHHHHcCCCCcccCccCCHHHHHH
Confidence            3 3445689999999999976 5999999999999999999999999877665555544444433 44566789999999


Q ss_pred             HHHHhhhcCCCCCCHHHHHH
Q 015868          346 LERCWQHDPTQRPNFSQITD  365 (399)
Q Consensus       346 l~~cl~~dP~~Rps~~ell~  365 (399)
                      |.+||+.||++|||++|+++
T Consensus       246 i~~~l~~dp~~R~s~~ell~  265 (270)
T d1t4ha_         246 IEGCIRQNKDERYSIKDLLN  265 (270)
T ss_dssp             HHHHSCSSGGGSCCHHHHHT
T ss_pred             HHHHccCCHhHCcCHHHHhC
Confidence            99999999999999999975

>d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Calmodulin-dependent protein kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=1.6e-55  Score=418.89  Aligned_cols=249  Identities=22%  Similarity=0.418  Sum_probs=203.5

Q ss_pred             ccccceeceeceeCceEEEEEEE--CCeeEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCceeeEEeEEecCCcEEEEE
Q 015868          115 AKQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVT  192 (399)
Q Consensus       115 ~~~~~i~~~lg~G~~g~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~nIv~~~~~~~~~~~~~lV~  192 (399)
                      .+.|++.+.||+|+||.||+|++  +++.||||++....... ....+.+|+.+|++++||||+++++++.+++.+|+||
T Consensus         8 ~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~-~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lvm   86 (307)
T d1a06a_           8 RDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEG-KEGSMENEIAVLHKIKHPNIVALDDIYESGGHLYLIM   86 (307)
T ss_dssp             GGTEEEEEESBSGGGGGEEEEEETTTCCEEEEEEEEC-----------CHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             ccceEEEEEEeeccCeEEEEEEECCCCCEEEEEEEchHHhhh-HHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEE
Confidence            35699999999999999999998  47899999998654332 3456889999999999999999999999999999999


Q ss_pred             ecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceeec---CCCcEEEeeccceeeccCCCc
Q 015868          193 EFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMD---ENGVVKVADFGVARVQAQSGV  269 (399)
Q Consensus       193 E~~~ggsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~giiHrDlkp~NILl~---~~~~vkl~DFG~a~~~~~~~~  269 (399)
                      ||++||+|.+++.. .+.+++..+..++.||+.||+|||++||+||||||+|||+.   +++.+||+|||+++.......
T Consensus        87 E~~~gg~L~~~l~~-~~~l~e~~~~~~~~qi~~al~ylH~~~iiHrDiKp~Nil~~~~~~~~~vkl~DFG~a~~~~~~~~  165 (307)
T d1a06a_          87 QLVSGGELFDRIVE-KGFYTERDASRLIFQVLDAVKYLHDLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSV  165 (307)
T ss_dssp             CCCCSCBHHHHHHT-CSCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSTTCCEEECCC-----------
T ss_pred             eccCCCcHHHhhhc-ccCCCHHHHHHHHHHHHHHHHhhhhceeeeEEecccceeecccCCCceEEEeccceeEEccCCCe
Confidence            99999999999976 56799999999999999999999999999999999999995   578999999999987766655


Q ss_pred             cccCCCCcccccccccCCCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhccCC--CCCCCCCcHHHHHHHH
Q 015868          270 MTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKSLR--PTIPKHAHPRLAELLE  347 (399)
Q Consensus       270 ~~~~~gt~~y~aPE~l~~~~~~~~~Dv~slG~vl~elltg~~P~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~l~~ll~  347 (399)
                      .....||+.|||||++.+.+|+.++|||||||++|+|++|+.||.+.+..+....+......  +..+..+|+++.+||.
T Consensus       166 ~~~~~GT~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~  245 (307)
T d1a06a_         166 LSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQILKAEYEFDSPYWDDISDSAKDFIR  245 (307)
T ss_dssp             -------CTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHTTCCCCCTTTTTTSCHHHHHHHH
T ss_pred             eeeeeeCccccCcHHHcCCCCCcHHHhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHhccCCCCCCccccCCCHHHHHHHH
Confidence            66678999999999999999999999999999999999999999998888777666654433  2344679999999999


Q ss_pred             HHhhhcCCCCCCHHHHHH
Q 015868          348 RCWQHDPTQRPNFSQITD  365 (399)
Q Consensus       348 ~cl~~dP~~Rps~~ell~  365 (399)
                      +||+.||++|||++|+++
T Consensus       246 ~~L~~dP~~R~s~~eil~  263 (307)
T d1a06a_         246 HLMEKDPEKRFTCEQALQ  263 (307)
T ss_dssp             HHSCSSGGGSCCHHHHHH
T ss_pred             HHccCCHhHCcCHHHHhc
Confidence            999999999999999987

>d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Carboxyl-terminal src kinase (csk)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6.2e-56  Score=412.46  Aligned_cols=255  Identities=35%  Similarity=0.690  Sum_probs=221.6

Q ss_pred             eeecccccceeceeceeCceEEEEEEECCeeEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCceeeEEeEEec-CCcEE
Q 015868          111 WEIDAKQLKIECKVASGSYGDLYKGTYCSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTR-PPNLC  189 (399)
Q Consensus       111 ~~i~~~~~~i~~~lg~G~~g~Vy~~~~~~~~vAvK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~nIv~~~~~~~~-~~~~~  189 (399)
                      |+|+.++|++.++||+|+||.||+|++.+..||||+++.+.    ..+.+.+|+.++++++||||++++|++.+ .+.++
T Consensus         2 w~i~~~~~~~~~~lG~G~fg~Vy~~~~~~~~vAvK~i~~~~----~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~   77 (262)
T d1byga_           2 WALNMKELKLLQTIGKGEFGDVMLGDYRGNKVAVKCIKNDA----TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLY   77 (262)
T ss_dssp             CBCCGGGEEEEEEEEECSSCEEEEEEETTEEEEEEECCCCC------HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCE
T ss_pred             CccCHHHeEEeEEEecCCCeEEEEEEECCeEEEEEEECcHH----HHHHHHHHHHHHHhCCCCCEeeEEEEEEecCCcEE
Confidence            89999999999999999999999999999999999998643    34678999999999999999999999865 45689


Q ss_pred             EEEecCCCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceeecCCCcEEEeeccceeeccCCC
Q 015868          190 IVTEFMARGSIYDFLHKQK-GVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSG  268 (399)
Q Consensus       190 lV~E~~~ggsL~~~l~~~~-~~l~~~~~~~i~~~i~~~L~~LH~~giiHrDlkp~NILl~~~~~vkl~DFG~a~~~~~~~  268 (399)
                      +||||+++|+|.+++.+.. ..+++..+.+++.||+.||.|||+++|+||||||+|||++.++.+|++|||+++..... 
T Consensus        78 lv~ey~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~al~ylH~~~ivH~dlkp~Nil~~~~~~~kl~dfg~s~~~~~~-  156 (262)
T d1byga_          78 IVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASST-  156 (262)
T ss_dssp             EEECCCTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTSCEEECCCCC--------
T ss_pred             EEEeccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHhhccccccCceeccccchHhheecCCCCEeecccccceecCCC-
Confidence            9999999999999997643 45899999999999999999999999999999999999999999999999999865433 


Q ss_pred             ccccCCCCcccccccccCCCCCCChhhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHHhccCCCCCCCCCcHHHHHHHH
Q 015868          269 VMTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLT-GELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRLAELLE  347 (399)
Q Consensus       269 ~~~~~~gt~~y~aPE~l~~~~~~~~~Dv~slG~vl~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~  347 (399)
                       .....+|..|+|||.+.+..++.++||||||+++|||+| |++||...+..+.... +..+.++++|..+++++.+||.
T Consensus       157 -~~~~~~~~~y~aPE~l~~~~~t~~sDIwSfG~il~el~t~~~~p~~~~~~~~~~~~-i~~~~~~~~~~~~~~~~~~li~  234 (262)
T d1byga_         157 -QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPR-VEKGYKMDAPDGCPPAVYEVMK  234 (262)
T ss_dssp             ------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGGHHHH-HTTTCCCCCCTTCCHHHHHHHH
T ss_pred             -CccccccccCCChHHHhCCCCChHHHHHhHHHHHHHHHHCCCCCCCCCCHHHHHHH-HHcCCCCCCCccCCHHHHHHHH
Confidence             344567899999999999999999999999999999998 7999998887776555 5567888999999999999999


Q ss_pred             HHhhhcCCCCCCHHHHHHHHHHHHH
Q 015868          348 RCWQHDPTQRPNFSQITDILKQMMK  372 (399)
Q Consensus       348 ~cl~~dP~~Rps~~ell~~L~~l~~  372 (399)
                      +||+.||.+|||+.++++.|+++..
T Consensus       235 ~cl~~dP~~Rps~~~l~~~L~~i~~  259 (262)
T d1byga_         235 NCWHLDAAMRPSFLQLREQLEHIKT  259 (262)
T ss_dssp             HHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             HHcccCHhHCcCHHHHHHHHHHHHh
Confidence            9999999999999999999998853

>d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine protein kinase TAO2
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=2.7e-55  Score=417.55  Aligned_cols=246  Identities=30%  Similarity=0.454  Sum_probs=220.1

Q ss_pred             cccceeceeceeCceEEEEEEE--CCeeEEEEEecCCCC-CHHHHHHHHHHHHHHHhcCCCceeeEEeEEecCCcEEEEE
Q 015868          116 KQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECV-NTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVT  192 (399)
Q Consensus       116 ~~~~i~~~lg~G~~g~Vy~~~~--~~~~vAvK~~~~~~~-~~~~~~~~~~Ei~~l~~l~h~nIv~~~~~~~~~~~~~lV~  192 (399)
                      +.|++.++||+|+||.||+|++  +++.||||+++.... .....+.+.+|+.+|++++||||+++++++.+++.+|+||
T Consensus        15 ~~y~~l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~iv~   94 (309)
T d1u5ra_          15 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVM   94 (309)
T ss_dssp             HHEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             HhcEeeEEEecCCCeEEEEEEECCCCcEEEEEEEchhhccCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEECCEEEEEE
Confidence            4699999999999999999987  578899999986544 3455678999999999999999999999999999999999


Q ss_pred             ecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceeecCCCcEEEeeccceeeccCCCcccc
Q 015868          193 EFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTA  272 (399)
Q Consensus       193 E~~~ggsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~giiHrDlkp~NILl~~~~~vkl~DFG~a~~~~~~~~~~~  272 (399)
                      ||+.||+|..++.. .+.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+|+....   ...
T Consensus        95 E~~~~g~l~~~~~~-~~~l~e~~~~~i~~qi~~aL~yLH~~~iiHrDiKp~NILl~~~~~~Kl~DFG~a~~~~~---~~~  170 (309)
T d1u5ra_          95 EYCLGSASDLLEVH-KKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAP---ANS  170 (309)
T ss_dssp             ECCSEEHHHHHHHH-TSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEETTTEEEECCCTTCBSSSS---BCC
T ss_pred             EecCCCchHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCEeccCCCcceEEECCCCCEEEeecccccccCC---CCc
Confidence            99999988766654 57799999999999999999999999999999999999999999999999999986543   345


Q ss_pred             CCCCcccccccccCC---CCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhccCCCCCCCCCcHHHHHHHHHH
Q 015868          273 ETGTYRWMAPEVIEH---KPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRLAELLERC  349 (399)
Q Consensus       273 ~~gt~~y~aPE~l~~---~~~~~~~Dv~slG~vl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~c  349 (399)
                      ..||+.|||||++.+   ..|+.++|||||||++|||++|..||.+.+..+....+......+..+..+++++.+||.+|
T Consensus       171 ~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~~~~li~~~  250 (309)
T d1u5ra_         171 FVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPALQSGHWSEYFRNFVDSC  250 (309)
T ss_dssp             CCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCCSCTTSCHHHHHHHHHH
T ss_pred             cccCccccCHHHHhccCCCCcCchhhhhhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCCCCCCCCHHHHHHHHHH
Confidence            679999999999864   46899999999999999999999999999988888777776666666677999999999999


Q ss_pred             hhhcCCCCCCHHHHHH
Q 015868          350 WQHDPTQRPNFSQITD  365 (399)
Q Consensus       350 l~~dP~~Rps~~ell~  365 (399)
                      |+.||.+|||++|+++
T Consensus       251 L~~dP~~Rpt~~ell~  266 (309)
T d1u5ra_         251 LQKIPQDRPTSEVLLK  266 (309)
T ss_dssp             TCSSGGGSCCHHHHTT
T ss_pred             CcCChhHCcCHHHHHh
Confidence            9999999999999975

>d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: Caenorhabditis elegans, pjk4 [TaxId: 6239]

Probab=100.00  E-value=4.8e-55  Score=422.72  Aligned_cols=249  Identities=22%  Similarity=0.369  Sum_probs=224.3

Q ss_pred             ccccceeceeceeCceEEEEEEE--CCeeEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCceeeEEeEEecCCcEEEEE
Q 015868          115 AKQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVT  192 (399)
Q Consensus       115 ~~~~~i~~~lg~G~~g~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~nIv~~~~~~~~~~~~~lV~  192 (399)
                      .++|++.+.||+|+||.||+|++  +++.||||++...  .....+.+.+|+.+|++++||||+++++++.+++.+||||
T Consensus        25 l~~Y~i~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~--~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivm  102 (350)
T d1koaa2          25 LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTP--HESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIY  102 (350)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECCC--SHHHHHHHHHHHHHHHHTCCTTBCCEEEEEEETTEEEEEE
T ss_pred             ccCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEccc--chhhHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEE
Confidence            35899999999999999999988  5889999999765  3455678999999999999999999999999999999999


Q ss_pred             ecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceeecC--CCcEEEeeccceeeccCCCcc
Q 015868          193 EFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDE--NGVVKVADFGVARVQAQSGVM  270 (399)
Q Consensus       193 E~~~ggsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~giiHrDlkp~NILl~~--~~~vkl~DFG~a~~~~~~~~~  270 (399)
                      ||++||+|.+++....+.+++..+..++.||+.||.|||++||+||||||+|||++.  ++.+||+|||+++........
T Consensus       103 E~~~gg~L~~~l~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~iiHrDiKp~NIll~~~~~~~vkL~DFG~a~~~~~~~~~  182 (350)
T d1koaa2         103 EFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSV  182 (350)
T ss_dssp             CCCCSCBHHHHHTCTTSCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSTTSCCEEECCCTTCEECCTTSCE
T ss_pred             EcCCCCCHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCeeeeechhHeeeccCCCCeEEEeecchheeccccccc
Confidence            999999999999776778999999999999999999999999999999999999964  689999999999987776666


Q ss_pred             ccCCCCcccccccccCCCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhccCC--CCCCCCCcHHHHHHHHH
Q 015868          271 TAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKSLR--PTIPKHAHPRLAELLER  348 (399)
Q Consensus       271 ~~~~gt~~y~aPE~l~~~~~~~~~Dv~slG~vl~elltg~~P~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~l~~ll~~  348 (399)
                      ....||+.|||||++.+.+|+.++|||||||++|+|+||+.||.+.+..+....+......  +.....+++++.+||.+
T Consensus       183 ~~~~gT~~Y~aPEv~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~  262 (350)
T d1koaa2         183 KVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMDDSAFSGISEDGKDFIRK  262 (350)
T ss_dssp             EEECSCTTTCCHHHHHTCCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCSCCGGGGGCCHHHHHHHHH
T ss_pred             ceecCcccccCHHHHcCCCCChhHhhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCcccccCCCHHHHHHHHH
Confidence            7778999999999999999999999999999999999999999999888877766654433  22335689999999999


Q ss_pred             HhhhcCCCCCCHHHHHH
Q 015868          349 CWQHDPTQRPNFSQITD  365 (399)
Q Consensus       349 cl~~dP~~Rps~~ell~  365 (399)
                      ||+.||++|||++|+++
T Consensus       263 ~L~~dP~~R~t~~eil~  279 (350)
T d1koaa2         263 LLLADPNTRMTIHQALE  279 (350)
T ss_dssp             HCCSSGGGSCCHHHHHH
T ss_pred             HccCChhHCcCHHHHhc
Confidence            99999999999999976

>d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: 3-phosphoinositide dependent protein kinase-1 Pdk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.6e-56  Score=418.26  Aligned_cols=249  Identities=22%  Similarity=0.399  Sum_probs=218.2

Q ss_pred             cccccceeceeceeCceEEEEEEE--CCeeEEEEEecCCCC-CHHHHHHHHHHHHHHHhcCCCceeeEEeEEecCCcEEE
Q 015868          114 DAKQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECV-NTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCI  190 (399)
Q Consensus       114 ~~~~~~i~~~lg~G~~g~Vy~~~~--~~~~vAvK~~~~~~~-~~~~~~~~~~Ei~~l~~l~h~nIv~~~~~~~~~~~~~l  190 (399)
                      ..++|++.+.||+|+||.||+|++  +++.||||+++.... +....+.+.+|+.+|++++||||+++++++.++..+|+
T Consensus         6 ~p~dy~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~i   85 (288)
T d1uu3a_           6 RPEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYF   85 (288)
T ss_dssp             CGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCSTTBCCEEEEEECSSEEEE
T ss_pred             CCCCCEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccCHHHHHHHHHHHHHHHHcCCCCeeEEEEEEEECCEEEE
Confidence            346899999999999999999988  478999999974321 12234678999999999999999999999999999999


Q ss_pred             EEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceeecCCCcEEEeeccceeeccCCC--
Q 015868          191 VTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSG--  268 (399)
Q Consensus       191 V~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~giiHrDlkp~NILl~~~~~vkl~DFG~a~~~~~~~--  268 (399)
                      ||||++||+|.+++.. .+.+++..++.++.|++.||+|||++||+||||||+|||+++++.+||+|||+|+......  
T Consensus        86 vmEy~~gg~L~~~~~~-~~~l~e~~~~~~~~qi~~al~ylH~~~iiHrDiKp~NIll~~~~~vkl~DFG~a~~~~~~~~~  164 (288)
T d1uu3a_          86 GLSYAKNGELLKYIRK-IGSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQ  164 (288)
T ss_dssp             EECCCTTEEHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEECC-----
T ss_pred             EEEccCCCCHHHhhhc-cCCCCHHHHHHHHHHHHHHHHhhccccEEcCcCCccccccCCCceEEecccccceecccCCcc
Confidence            9999999999999876 4679999999999999999999999999999999999999999999999999998765332  


Q ss_pred             -ccccCCCCcccccccccCCCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhccCCCCCCCCCcHHHHHHHH
Q 015868          269 -VMTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRLAELLE  347 (399)
Q Consensus       269 -~~~~~~gt~~y~aPE~l~~~~~~~~~Dv~slG~vl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~  347 (399)
                       ......||+.|+|||++.+..|+.++|||||||++|+|+||+.||.+.++.+....+.+.  .+.+|..+++++.+||.
T Consensus       165 ~~~~~~~GT~~Y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~~--~~~~p~~~s~~~~~li~  242 (288)
T d1uu3a_         165 ARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKL--EYDFPEKFFPKARDLVE  242 (288)
T ss_dssp             -----CCCCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHTT--CCCCCTTCCHHHHHHHH
T ss_pred             cccccccCCccccCceeeccCCCCcccceehhhHHHHHHhhCCCCCCCcCHHHHHHHHHcC--CCCCCccCCHHHHHHHH
Confidence             234457999999999999999999999999999999999999999998888776665543  35678889999999999


Q ss_pred             HHhhhcCCCCCCHHHHHH
Q 015868          348 RCWQHDPTQRPNFSQITD  365 (399)
Q Consensus       348 ~cl~~dP~~Rps~~ell~  365 (399)
                      +||+.||.+|||++|+++
T Consensus       243 ~~L~~dP~~R~t~~e~~~  260 (288)
T d1uu3a_         243 KLLVLDATKRLGCEEMEG  260 (288)
T ss_dssp             TTSCSSGGGSTTSGGGTC
T ss_pred             HHccCCHhHCcCHHHHcC
Confidence            999999999999999865

>d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Activated CDC42 kinase 1, ACK1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.9e-55  Score=411.71  Aligned_cols=258  Identities=32%  Similarity=0.639  Sum_probs=221.7

Q ss_pred             eecccccceeceeceeCceEEEEEEECC-----eeEEEEEecCCCC-CHHHHHHHHHHHHHHHhcCCCceeeEEeEEecC
Q 015868          112 EIDAKQLKIECKVASGSYGDLYKGTYCS-----QEVAIKVLKPECV-NTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRP  185 (399)
Q Consensus       112 ~i~~~~~~i~~~lg~G~~g~Vy~~~~~~-----~~vAvK~~~~~~~-~~~~~~~~~~Ei~~l~~l~h~nIv~~~~~~~~~  185 (399)
                      -|+.++|++.++||+|+||.||+|++.+     ..||||+++.... ..+..+.|.+|+.+|++++||||++++|++.++
T Consensus         4 ~i~~~d~~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~~~   83 (273)
T d1u46a_           4 LIGEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTP   83 (273)
T ss_dssp             ECCGGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred             EEchHHeEEEEEEecCCCeEEEEEEEECCCCcEEEEEEEEEChhhcCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEeec
Confidence            4778899999999999999999998732     3689999986543 344567899999999999999999999999764


Q ss_pred             CcEEEEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceeecCCCcEEEeeccceeecc
Q 015868          186 PNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQA  265 (399)
Q Consensus       186 ~~~~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~giiHrDlkp~NILl~~~~~vkl~DFG~a~~~~  265 (399)
                       ..++||||+++|++.+++..+.+.+++..+..++.||+.||.|||++||+||||||+||+++.++.+||+|||+++...
T Consensus        84 -~~~lv~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~iiHrDikp~NIll~~~~~vkl~DfGl~~~~~  162 (273)
T d1u46a_          84 -PMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALP  162 (273)
T ss_dssp             -SCEEEEECCTTCBHHHHHHHHGGGSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEEETTEEEECCCTTCEECC
T ss_pred             -chheeeeeecCcchhhhhhcccCCCCHHHHHHHHHHHHHHHHHhhhCCEeeeeecHHHhccccccceeeccchhhhhcc
Confidence             6789999999999999998877889999999999999999999999999999999999999999999999999999765


Q ss_pred             CCCc----cccCCCCcccccccccCCCCCCChhhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHHhccCCCCCCCCCcH
Q 015868          266 QSGV----MTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLT-GELPYAGLTPLQAAVGVVQKSLRPTIPKHAHP  340 (399)
Q Consensus       266 ~~~~----~~~~~gt~~y~aPE~l~~~~~~~~~Dv~slG~vl~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~  340 (399)
                      ....    .....|+..|+|||.+.+..++.++||||||+++|||+| |..||.+.+..+....+.....+++.+..+++
T Consensus       163 ~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~S~Gvil~emlt~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~  242 (273)
T d1u46a_         163 QNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERLPRPEDCPQ  242 (273)
T ss_dssp             C-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTSCCCCCCCTTCCH
T ss_pred             cCCCcceecCccccCcccCCHHHHhCCCCCcchhhhhhHHHHHHHHhCCCCCCCCcCHHHHHHHHHhCCCCCCCcccccH
Confidence            4432    223357889999999999999999999999999999998 89999999999988888888888899999999


Q ss_pred             HHHHHHHHHhhhcCCCCCCHHHHHHHHHHH
Q 015868          341 RLAELLERCWQHDPTQRPNFSQITDILKQM  370 (399)
Q Consensus       341 ~l~~ll~~cl~~dP~~Rps~~ell~~L~~l  370 (399)
                      ++.+|+.+||..||++|||+.||.+.|.++
T Consensus       243 ~l~~li~~cl~~dp~~RPt~~ei~~~L~~~  272 (273)
T d1u46a_         243 DIYNVMVQCWAHKPEDRPTFVALRDFLLEA  272 (273)
T ss_dssp             HHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             HHHHHHHHHcCCChhHCcCHHHHHHHHHhc
Confidence            999999999999999999999999888764

>d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]

Probab=100.00  E-value=8e-55  Score=421.47  Aligned_cols=248  Identities=19%  Similarity=0.385  Sum_probs=224.5

Q ss_pred             cccceeceeceeCceEEEEEEE--CCeeEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCceeeEEeEEecCCcEEEEEe
Q 015868          116 KQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVTE  193 (399)
Q Consensus       116 ~~~~i~~~lg~G~~g~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~nIv~~~~~~~~~~~~~lV~E  193 (399)
                      ++|++.++||+|+||.||+|++  +++.||||+++..  .......+.+|+.+|++++||||+++++++.++..+|+|||
T Consensus        29 d~Y~i~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~--~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivmE  106 (352)
T d1koba_          29 DYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTP--YPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILE  106 (352)
T ss_dssp             GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC--SHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEE
T ss_pred             cceEEEEEEecCCCeEEEEEEECCCCCEEEEEEECCc--chhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEE
Confidence            5799999999999999999997  5889999999865  34445678899999999999999999999999999999999


Q ss_pred             cCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceeec--CCCcEEEeeccceeeccCCCccc
Q 015868          194 FMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMD--ENGVVKVADFGVARVQAQSGVMT  271 (399)
Q Consensus       194 ~~~ggsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~giiHrDlkp~NILl~--~~~~vkl~DFG~a~~~~~~~~~~  271 (399)
                      |++||+|.+++......+++..++.++.||+.||.|||++||+||||||+|||++  .++.+||+|||+|+.........
T Consensus       107 ~~~gg~L~~~~~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~iiHRDiKp~NILl~~~~~~~vkL~DFGla~~~~~~~~~~  186 (352)
T d1koba_         107 FLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVK  186 (352)
T ss_dssp             CCCCCBHHHHTTCTTCCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSTTCCCEEECCCTTCEECCTTSCEE
T ss_pred             cCCCChHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecccccccccccccCCCeEEEeecccceecCCCCcee
Confidence            9999999999877677899999999999999999999999999999999999997  67899999999999877766667


Q ss_pred             cCCCCcccccccccCCCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhccCC--CCCCCCCcHHHHHHHHHH
Q 015868          272 AETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKSLR--PTIPKHAHPRLAELLERC  349 (399)
Q Consensus       272 ~~~gt~~y~aPE~l~~~~~~~~~Dv~slG~vl~elltg~~P~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~l~~ll~~c  349 (399)
                      ...||+.|+|||++.+..|+.++|||||||++|+|+||..||.+.+..+....+......  +..+..+++++.+||.+|
T Consensus       187 ~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~  266 (352)
T d1koba_         187 VTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEFDEDAFSSVSPEAKDFIKNL  266 (352)
T ss_dssp             EECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHCCCCCCSSTTTTSCHHHHHHHHTT
T ss_pred             eccCcccccCHHHHcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCcccccCCCHHHHHHHHHH
Confidence            778999999999999999999999999999999999999999999988877666554332  334567999999999999


Q ss_pred             hhhcCCCCCCHHHHHH
Q 015868          350 WQHDPTQRPNFSQITD  365 (399)
Q Consensus       350 l~~dP~~Rps~~ell~  365 (399)
                      |+.||.+|||+.|+++
T Consensus       267 L~~dp~~R~s~~eil~  282 (352)
T d1koba_         267 LQKEPRKRLTVHDALE  282 (352)
T ss_dssp             SCSSGGGSCCHHHHHT
T ss_pred             ccCChhHCcCHHHHhc
Confidence            9999999999999976

>d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.7e-55  Score=420.34  Aligned_cols=251  Identities=25%  Similarity=0.453  Sum_probs=213.1

Q ss_pred             eecccccceeceeceeCceEEEEEEE--CCeeEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCceeeEEeEEecCCcEE
Q 015868          112 EIDAKQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLC  189 (399)
Q Consensus       112 ~i~~~~~~i~~~lg~G~~g~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~nIv~~~~~~~~~~~~~  189 (399)
                      ++..++|++.++||+|+||+||+|++  +++.||+|+++... .......+.+|+.+|++++||||++++++|.++..+|
T Consensus         2 el~~d~y~~~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~-~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~   80 (322)
T d1s9ja_           2 ELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEI-KPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEIS   80 (322)
T ss_dssp             CCCGGGEEEEEEEECCSSCCEEEEEETTTTEEEEEEEEECCC-CTTHHHHHHHHGGGGGGCCCTTBCCEEEEEECSSEEE
T ss_pred             CCCccCCEEEEEEecCCCeEEEEEEECCCCcEEEEEEEChhh-CHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEE
Confidence            56678999999999999999999998  57899999998653 3344578999999999999999999999999999999


Q ss_pred             EEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH-CCcccCCCCCCceeecCCCcEEEeeccceeeccCCC
Q 015868          190 IVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQ-NNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSG  268 (399)
Q Consensus       190 lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~-~giiHrDlkp~NILl~~~~~vkl~DFG~a~~~~~~~  268 (399)
                      +||||++||+|.+++.+ .+.+++..+..++.|++.||.|||+ +||+||||||+|||++++|.+||+|||+|+..... 
T Consensus        81 iVmEy~~gg~L~~~l~~-~~~l~~~~~~~~~~qil~aL~yLH~~~~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~~-  158 (322)
T d1s9ja_          81 ICMEHMDGGSLDQVLKK-AGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS-  158 (322)
T ss_dssp             EEEECCTTEEHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHHHHCCCCSCCSGGGEEECTTCCEEECCCCCCHHHHHH-
T ss_pred             EEEEcCCCCcHHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHHhCCEEccccCHHHeeECCCCCEEEeeCCCccccCCC-
Confidence            99999999999999976 4579999999999999999999997 49999999999999999999999999999865433 


Q ss_pred             ccccCCCCcccccccccCCCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHH------------------------
Q 015868          269 VMTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVG------------------------  324 (399)
Q Consensus       269 ~~~~~~gt~~y~aPE~l~~~~~~~~~Dv~slG~vl~elltg~~P~~~~~~~~~~~~------------------------  324 (399)
                      ......||+.|+|||++.+.+|+.++||||+||++|||++|+.||.+.+..+....                        
T Consensus       159 ~~~~~~GT~~Y~APEvl~~~~y~~~~DiWSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (322)
T d1s9ja_         159 MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLS  238 (322)
T ss_dssp             TC---CCSSCCCCHHHHHCSCCCTTHHHHHHHHHHHHHHHSSCCSSCCCTTHHHHHC-----------------------
T ss_pred             ccccccCCccccCchHHcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhcCCcccCCccccccccccc
Confidence            23456899999999999999999999999999999999999999976543221110                        


Q ss_pred             -----------------HHhccCCCCCC-CCCcHHHHHHHHHHhhhcCCCCCCHHHHHH
Q 015868          325 -----------------VVQKSLRPTIP-KHAHPRLAELLERCWQHDPTQRPNFSQITD  365 (399)
Q Consensus       325 -----------------~~~~~~~~~~~-~~~~~~l~~ll~~cl~~dP~~Rps~~ell~  365 (399)
                                       .......+.++ ..+++++.+||.+||+.||++|||++|+++
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~ta~e~L~  297 (322)
T d1s9ja_         239 SYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMV  297 (322)
T ss_dssp             -------CCCCHHHHHHHHHTSCCCCCCBTTBCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             ccccccccchhHHHHHhhhhccCCccCccccCCHHHHHHHHHHcCCChhHCcCHHHHhh
Confidence                             01111122233 236899999999999999999999999987

>d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-src tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6.9e-55  Score=410.14  Aligned_cols=260  Identities=35%  Similarity=0.681  Sum_probs=220.7

Q ss_pred             CCceeecccccceeceeceeCceEEEEEEEC-CeeEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCceeeEEeEEecCC
Q 015868          108 TDVWEIDAKQLKIECKVASGSYGDLYKGTYC-SQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPP  186 (399)
Q Consensus       108 ~~~~~i~~~~~~i~~~lg~G~~g~Vy~~~~~-~~~vAvK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~nIv~~~~~~~~~~  186 (399)
                      .+.|+|+.++|++.++||+|+||.||+|++. ++.||||+++....+.   +.|.+|+.+|++++||||+++++++.. +
T Consensus         9 ~~~~~i~~~~~~i~~~iG~G~fg~Vy~~~~~~~~~vAiK~l~~~~~~~---~~~~~E~~~l~~l~h~nIv~~~g~~~~-~   84 (285)
T d1fmka3           9 KDAWEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSP---EAFLQEAQVMKKLRHEKLVQLYAVVSE-E   84 (285)
T ss_dssp             TTCSBCCGGGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTTSSCH---HHHHHHHHHHHHCCCTTBCCEEEEECS-S
T ss_pred             CcceEcCHHHEEEeeEEeeCCCeEEEEEEECCCCEEEEEEECcccCCH---HHHHHHHHHHHhcccCCEeEEEEEEec-C
Confidence            4679999999999999999999999999984 4679999998664443   578999999999999999999999865 4


Q ss_pred             cEEEEEecCCCCCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceeecCCCcEEEeeccceeecc
Q 015868          187 NLCIVTEFMARGSIYDFLHKQ-KGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQA  265 (399)
Q Consensus       187 ~~~lV~E~~~ggsL~~~l~~~-~~~l~~~~~~~i~~~i~~~L~~LH~~giiHrDlkp~NILl~~~~~vkl~DFG~a~~~~  265 (399)
                      .+++||||+++|+|.+++... ...+++..++.++.||+.||+|||++||+||||||+|||+++++.+||+|||+++...
T Consensus        85 ~~~lv~Ey~~~g~l~~~~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~ivH~DlKp~NIll~~~~~~kl~DfGla~~~~  164 (285)
T d1fmka3          85 PIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIE  164 (285)
T ss_dssp             SCEEEECCCTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCCTTC---
T ss_pred             CeEEEEEecCCCchhhhhhhcccccchHHHHHHHHHHHHHHHHHHhhhheecccccceEEEECCCCcEEEcccchhhhcc
Confidence            588999999999999998653 3569999999999999999999999999999999999999999999999999998654


Q ss_pred             CCC--ccccCCCCcccccccccCCCCCCChhhHHHHHHHHHHHHcCC-CCCCCCCHHHHHHHHHhccCCCCCCCCCcHHH
Q 015868          266 QSG--VMTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTGE-LPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRL  342 (399)
Q Consensus       266 ~~~--~~~~~~gt~~y~aPE~l~~~~~~~~~Dv~slG~vl~elltg~-~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  342 (399)
                      ...  ......||+.|+|||.+.+..++.++||||||+++|||+||. +|+......+. ...+....+++++..+++++
T Consensus       165 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~S~Giil~el~t~~~p~~~~~~~~~~-~~~i~~~~~~~~~~~~~~~l  243 (285)
T d1fmka3         165 DNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREV-LDQVERGYRMPCPPECPESL  243 (285)
T ss_dssp             -----------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHH-HHHHHTTCCCCCCTTSCHHH
T ss_pred             CCCceeeccccccccccChHHHhCCCCCcHHhhhcchHHHHHHHhCCCCCCCCCCHHHH-HHHHHhcCCCCCCcccCHHH
Confidence            432  234457899999999999999999999999999999999954 55555555544 44455677788899999999


Q ss_pred             HHHHHHHhhhcCCCCCCHHHHHHHHHHHHH
Q 015868          343 AELLERCWQHDPTQRPNFSQITDILKQMMK  372 (399)
Q Consensus       343 ~~ll~~cl~~dP~~Rps~~ell~~L~~l~~  372 (399)
                      .++|.+||+.||++|||+++|++.|+....
T Consensus       244 ~~li~~cl~~dP~~Rps~~~i~~~L~~~~~  273 (285)
T d1fmka3         244 HDLMCQCWRKEPEERPTFEYLQAFLEDYFT  273 (285)
T ss_dssp             HHHHHHHTCSSGGGSCCHHHHHHHHHTTTS
T ss_pred             HHHHHHHcccCHhHCcCHHHHHHHHhhhhc
Confidence            999999999999999999999988887653

>d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Vascular endothelial growth factor receptor 2 (kdr)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.3e-54  Score=411.38  Aligned_cols=264  Identities=31%  Similarity=0.613  Sum_probs=223.2

Q ss_pred             CCceeecccccceeceeceeCceEEEEEEEC-------CeeEEEEEecCCCCCHHHHHHHHHHHHHHHhc-CCCceeeEE
Q 015868          108 TDVWEIDAKQLKIECKVASGSYGDLYKGTYC-------SQEVAIKVLKPECVNTEMLKEFSQEVYIMRKI-RHKNVVQFI  179 (399)
Q Consensus       108 ~~~~~i~~~~~~i~~~lg~G~~g~Vy~~~~~-------~~~vAvK~~~~~~~~~~~~~~~~~Ei~~l~~l-~h~nIv~~~  179 (399)
                      .+-|+|+.++|++.++||+|+||.||+|++.       ++.||||+++... .....+.+.+|..++.++ +|+||+.++
T Consensus         5 ~~~wei~~~~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~-~~~~~~~~~~e~~~l~~~~~h~~iv~~~   83 (299)
T d1ywna1           5 ASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA-THSEHRALMSELKILIHIGHHLNVVNLL   83 (299)
T ss_dssp             HHHHBCCGGGEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC-----CHHHHHHHHHHHHHHHHHCCCTTBCCEE
T ss_pred             CccccccHHHEEEeeEEeecCCeEEEEEEEcCCCcccCCeEEEEEEEcccc-CcHHHHHHHHHHHHHHhhcCCCeEEEee
Confidence            3568999999999999999999999999873       3679999997543 444567788888888777 689999999


Q ss_pred             eEEecC-CcEEEEEecCCCCCHHHHHHhcC---------------CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCC
Q 015868          180 GACTRP-PNLCIVTEFMARGSIYDFLHKQK---------------GVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTA  243 (399)
Q Consensus       180 ~~~~~~-~~~~lV~E~~~ggsL~~~l~~~~---------------~~l~~~~~~~i~~~i~~~L~~LH~~giiHrDlkp~  243 (399)
                      +++... ..+++||||+++|+|.++++...               ..+++..+..++.||++||.|||++||+||||||+
T Consensus        84 ~~~~~~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~ivHrDlKp~  163 (299)
T d1ywna1          84 GACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAAR  163 (299)
T ss_dssp             EEECSTTSCCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGG
T ss_pred             eeeccCCCeEEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHHhCCCcCCcCCcc
Confidence            998664 46899999999999999997532               35889999999999999999999999999999999


Q ss_pred             ceeecCCCcEEEeeccceeeccCCC---ccccCCCCcccccccccCCCCCCChhhHHHHHHHHHHHHcC-CCCCCCCCHH
Q 015868          244 NLLMDENGVVKVADFGVARVQAQSG---VMTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTG-ELPYAGLTPL  319 (399)
Q Consensus       244 NILl~~~~~vkl~DFG~a~~~~~~~---~~~~~~gt~~y~aPE~l~~~~~~~~~Dv~slG~vl~elltg-~~P~~~~~~~  319 (399)
                      |||+++++.+||+|||+|+......   ......||+.|||||++.+..|+.++|||||||++|||+|| .+||.+....
T Consensus       164 NILl~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gvil~ellt~~~~p~~~~~~~  243 (299)
T d1ywna1         164 NILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKID  243 (299)
T ss_dssp             GEEECGGGCEEECC------CCSCTTSCCTTSCCCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCCS
T ss_pred             ceeECCCCcEEEccCcchhhccccccccccCceeeCccccchhHhhcCCCCcccceeehHHHHHHHHhCCCCCCCCCCHH
Confidence            9999999999999999998654432   23345789999999999999999999999999999999986 5789888777


Q ss_pred             HHHHHHHhccCCCCCCCCCcHHHHHHHHHHhhhcCCCCCCHHHHHHHHHHHHH
Q 015868          320 QAAVGVVQKSLRPTIPKHAHPRLAELLERCWQHDPTQRPNFSQITDILKQMMK  372 (399)
Q Consensus       320 ~~~~~~~~~~~~~~~~~~~~~~l~~ll~~cl~~dP~~Rps~~ell~~L~~l~~  372 (399)
                      +.....+..+.++.+|..+++++.++|.+||+.||++|||++|+++.|+++++
T Consensus       244 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~eil~~L~~ilq  296 (299)
T d1ywna1         244 EEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQ  296 (299)
T ss_dssp             HHHHHHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             HHHHHHHhcCCCCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHh
Confidence            77777788888899999999999999999999999999999999999999975

>d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fibroblast growth factor receptor 1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.9e-54  Score=409.00  Aligned_cols=260  Identities=31%  Similarity=0.639  Sum_probs=228.1

Q ss_pred             eeecccccceeceeceeCceEEEEEEECC---------eeEEEEEecCCCCCHHHHHHHHHHHHHHHhc-CCCceeeEEe
Q 015868          111 WEIDAKQLKIECKVASGSYGDLYKGTYCS---------QEVAIKVLKPECVNTEMLKEFSQEVYIMRKI-RHKNVVQFIG  180 (399)
Q Consensus       111 ~~i~~~~~~i~~~lg~G~~g~Vy~~~~~~---------~~vAvK~~~~~~~~~~~~~~~~~Ei~~l~~l-~h~nIv~~~~  180 (399)
                      |+|+.++|++.+.||+|+||.||+|++.+         ..||||+++... ......++.+|...+.++ +||||+++++
T Consensus         8 ~~i~~~~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~-~~~~~~~~~~e~~~l~~~~~HpnIv~~~~   86 (299)
T d1fgka_           8 WELPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDA-TEKDLSDLISEMEMMKMIGKHKNIINLLG   86 (299)
T ss_dssp             TBCCGGGEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTC-CHHHHHHHHHHHHHHHHHCCCTTBCCEEE
T ss_pred             CcccHHHeEEeeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECccc-ChHHHHHHHHHHHHHHHhcCCCeEEeccc
Confidence            99999999999999999999999998632         369999998754 455567899999999888 7999999999


Q ss_pred             EEecCCcEEEEEecCCCCCHHHHHHhcC---------------CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCce
Q 015868          181 ACTRPPNLCIVTEFMARGSIYDFLHKQK---------------GVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANL  245 (399)
Q Consensus       181 ~~~~~~~~~lV~E~~~ggsL~~~l~~~~---------------~~l~~~~~~~i~~~i~~~L~~LH~~giiHrDlkp~NI  245 (399)
                      +|.+++..++||||+.+|+|.+++....               ..+++..++.++.||+.||.|||++||+||||||+||
T Consensus        87 ~~~~~~~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~~~ivHrDiKp~Ni  166 (299)
T d1fgka_          87 ACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNV  166 (299)
T ss_dssp             EECSSSSCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGE
T ss_pred             ccccCCeEEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhhhCCEEeeeecccce
Confidence            9999999999999999999999997543               4589999999999999999999999999999999999


Q ss_pred             eecCCCcEEEeeccceeeccCCC---ccccCCCCcccccccccCCCCCCChhhHHHHHHHHHHHHc-CCCCCCCCCHHHH
Q 015868          246 LMDENGVVKVADFGVARVQAQSG---VMTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLT-GELPYAGLTPLQA  321 (399)
Q Consensus       246 Ll~~~~~vkl~DFG~a~~~~~~~---~~~~~~gt~~y~aPE~l~~~~~~~~~Dv~slG~vl~ellt-g~~P~~~~~~~~~  321 (399)
                      |++.++.+||+|||+++......   ......+|+.|+|||.+.+..|+.++||||||+++|||++ |.+||.+.+..+.
T Consensus       167 Ll~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~y~~k~DiwS~Gvvl~ell~~g~~p~~~~~~~~~  246 (299)
T d1fgka_         167 LVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEEL  246 (299)
T ss_dssp             EECTTCCEEECSTTCCCCGGGCCTTCCCTTSCCGGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHH
T ss_pred             eecCCCCeEeccchhhccccccccccccccCCCChhhhhhhHhcCCCCCchhhhHHhHHHHHHhccCCCCCCCCCCHHHH
Confidence            99999999999999998665433   2344578999999999999999999999999999999998 7999998887765


Q ss_pred             HHHHHhccCCCCCCCCCcHHHHHHHHHHhhhcCCCCCCHHHHHHHHHHHHH
Q 015868          322 AVGVVQKSLRPTIPKHAHPRLAELLERCWQHDPTQRPNFSQITDILKQMMK  372 (399)
Q Consensus       322 ~~~~~~~~~~~~~~~~~~~~l~~ll~~cl~~dP~~Rps~~ell~~L~~l~~  372 (399)
                      . ..+..+.++..|..+++++.+||.+||+.||.+|||+.||++.|+++++
T Consensus       247 ~-~~i~~~~~~~~p~~~~~~l~~li~~cl~~dP~~Rps~~eil~~L~~i~a  296 (299)
T d1fgka_         247 F-KLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIVA  296 (299)
T ss_dssp             H-HHHHTTCCCCCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             H-HHHHcCCCCCCCccchHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHhh
Confidence            4 4566678889999999999999999999999999999999999999865

>d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Death-associated protein kinase, Dap
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.6e-54  Score=409.60  Aligned_cols=249  Identities=22%  Similarity=0.379  Sum_probs=221.3

Q ss_pred             cccceeceeceeCceEEEEEEE--CCeeEEEEEecCCCCC----HHHHHHHHHHHHHHHhcCCCceeeEEeEEecCCcEE
Q 015868          116 KQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVN----TEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLC  189 (399)
Q Consensus       116 ~~~~i~~~lg~G~~g~Vy~~~~--~~~~vAvK~~~~~~~~----~~~~~~~~~Ei~~l~~l~h~nIv~~~~~~~~~~~~~  189 (399)
                      ++|++.++||+|+||.||+|++  +++.||||+++.....    ....+.+.+|+.+|++++||||+++++++.++..+|
T Consensus        10 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~   89 (293)
T d1jksa_          10 DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVI   89 (293)
T ss_dssp             GTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred             cCEEEeEEEecCCCeEEEEEEECCCCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEE
Confidence            5799999999999999999998  4789999999754322    123578999999999999999999999999999999


Q ss_pred             EEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceeecCCC----cEEEeeccceeecc
Q 015868          190 IVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENG----VVKVADFGVARVQA  265 (399)
Q Consensus       190 lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~giiHrDlkp~NILl~~~~----~vkl~DFG~a~~~~  265 (399)
                      |||||++||+|.+++... +.+++..++.++.|++.||+|||++||+||||||+|||++.++    .+|++|||+++...
T Consensus        90 iv~E~~~gg~L~~~i~~~-~~l~~~~~~~~~~qi~~al~yLH~~~ivHrDiKp~Nill~~~~~~~~~vkl~DfG~a~~~~  168 (293)
T d1jksa_          90 LILELVAGGELFDFLAEK-ESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKID  168 (293)
T ss_dssp             EEEECCCSCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCSSSSSCCEEECCCTTCEECT
T ss_pred             EEEEcCCCccccchhccc-cccchhHHHHHHHHHHHHHHhhhhcceeecccccceEEEecCCCcccceEecchhhhhhcC
Confidence            999999999999999764 5799999999999999999999999999999999999998777    59999999999877


Q ss_pred             CCCccccCCCCcccccccccCCCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhccCC--CCCCCCCcHHHH
Q 015868          266 QSGVMTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKSLR--PTIPKHAHPRLA  343 (399)
Q Consensus       266 ~~~~~~~~~gt~~y~aPE~l~~~~~~~~~Dv~slG~vl~elltg~~P~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~l~  343 (399)
                      .........||+.|+|||++.+..|+.++|||||||++|+|+||+.||.+.+..+....+......  +..+..+|+++.
T Consensus       169 ~~~~~~~~~~t~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~  248 (293)
T d1jksa_         169 FGNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFSNTSALAK  248 (293)
T ss_dssp             TSCBCSCCCCCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHTTCCCCCHHHHTTSCHHHH
T ss_pred             CCccccccCCCCcccCHHHHcCCCCCCcccchhhhHHHHHHHcCCCCCCCCCHHHHHHHHHhcCCCCCchhcCCCCHHHH
Confidence            666667778999999999999999999999999999999999999999999888876665543322  223467899999


Q ss_pred             HHHHHHhhhcCCCCCCHHHHHH
Q 015868          344 ELLERCWQHDPTQRPNFSQITD  365 (399)
Q Consensus       344 ~ll~~cl~~dP~~Rps~~ell~  365 (399)
                      +||.+||+.||++|||++|+++
T Consensus       249 ~li~~~L~~dP~~R~s~~eil~  270 (293)
T d1jksa_         249 DFIRRLLVKDPKKRMTIQDSLQ  270 (293)
T ss_dssp             HHHHTTSCSSGGGSCCHHHHHH
T ss_pred             HHHHHHccCChhHCcCHHHHhc
Confidence            9999999999999999999975

>d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Musk tyrosine kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=2.1e-54  Score=410.37  Aligned_cols=260  Identities=30%  Similarity=0.573  Sum_probs=229.1

Q ss_pred             ceeecccccceeceeceeCceEEEEEEECC-------eeEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCceeeEEeEE
Q 015868          110 VWEIDAKQLKIECKVASGSYGDLYKGTYCS-------QEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGAC  182 (399)
Q Consensus       110 ~~~i~~~~~~i~~~lg~G~~g~Vy~~~~~~-------~~vAvK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~nIv~~~~~~  182 (399)
                      .+++..++|++.++||+|+||.||+|++.+       +.||||+++... ..+..+.|.+|+.+|++++||||+++++++
T Consensus         7 ~~e~p~~~~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~-~~~~~~~~~~E~~il~~l~h~niv~~~~~~   85 (301)
T d1lufa_           7 SLEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEA-SADMQADFQREAALMAEFDNPNIVKLLGVC   85 (301)
T ss_dssp             HTBCCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTC-CHHHHHHHHHHHHHHHTCCCTTBCCEEEEE
T ss_pred             hccCCHHHcEEeEEEeeCCCeEEEEEEECCCccCCCCeEEEEEEEChhc-ChHHHHHHHHHHHHHHhcCCCCcccceeee
Confidence            367788899999999999999999998743       689999998643 556678899999999999999999999999


Q ss_pred             ecCCcEEEEEecCCCCCHHHHHHhcC-----------------------CCCCHHHHHHHHHHHHHHHHHHHHCCcccCC
Q 015868          183 TRPPNLCIVTEFMARGSIYDFLHKQK-----------------------GVFQLTSLLKVAIDVSKGMNYLHQNNIIHRD  239 (399)
Q Consensus       183 ~~~~~~~lV~E~~~ggsL~~~l~~~~-----------------------~~l~~~~~~~i~~~i~~~L~~LH~~giiHrD  239 (399)
                      ......++||||+++|+|.+++....                       ..+++..+..++.|++.||+|||++||||||
T Consensus        86 ~~~~~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~~~ivHrD  165 (301)
T d1lufa_          86 AVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRD  165 (301)
T ss_dssp             CSSSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSC
T ss_pred             ccCCceEEEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhcccCCeEeeE
Confidence            99999999999999999999996532                       2478899999999999999999999999999


Q ss_pred             CCCCceeecCCCcEEEeeccceeeccCCC---ccccCCCCcccccccccCCCCCCChhhHHHHHHHHHHHHcCC-CCCCC
Q 015868          240 LKTANLLMDENGVVKVADFGVARVQAQSG---VMTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTGE-LPYAG  315 (399)
Q Consensus       240 lkp~NILl~~~~~vkl~DFG~a~~~~~~~---~~~~~~gt~~y~aPE~l~~~~~~~~~Dv~slG~vl~elltg~-~P~~~  315 (399)
                      |||+|||++.++.+||+|||+++......   ..+...|++.|+|||.+.+..|+.++|||||||++|||++|. +||.+
T Consensus       166 lKp~NILld~~~~~Kl~DFGls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~t~ksDVwS~Gvvl~ell~~~~~p~~~  245 (301)
T d1lufa_         166 LATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYG  245 (301)
T ss_dssp             CSGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTT
T ss_pred             EcccceEECCCCcEEEccchhheeccCCccccccCCCCcCcCcCCHHHHccCCCChhhhhccchhhHHHHHccCCCCCCC
Confidence            99999999999999999999998554322   233456889999999999999999999999999999999985 68988


Q ss_pred             CCHHHHHHHHHhccCCCCCCCCCcHHHHHHHHHHhhhcCCCCCCHHHHHHHHHHHH
Q 015868          316 LTPLQAAVGVVQKSLRPTIPKHAHPRLAELLERCWQHDPTQRPNFSQITDILKQMM  371 (399)
Q Consensus       316 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~cl~~dP~~Rps~~ell~~L~~l~  371 (399)
                      .+..+.... +..+.++.+|..+++++.+||.+||+.+|++|||+.||.+.|++|+
T Consensus       246 ~~~~e~~~~-v~~~~~~~~p~~~~~~~~~li~~cl~~~P~~RPt~~ev~~~L~~i~  300 (301)
T d1lufa_         246 MAHEEVIYY-VRDGNILACPENCPLELYNLMRLCWSKLPADRPSFCSIHRILQRMC  300 (301)
T ss_dssp             SCHHHHHHH-HHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTT
T ss_pred             CCHHHHHHH-HHcCCCCCCCccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhc
Confidence            888876655 5556688889999999999999999999999999999999999874

>d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-KIT receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=7.3e-54  Score=408.44  Aligned_cols=264  Identities=31%  Similarity=0.640  Sum_probs=237.1

Q ss_pred             CceeecccccceeceeceeCceEEEEEEEC-------CeeEEEEEecCCCCCHHHHHHHHHHHHHHHhc-CCCceeeEEe
Q 015868          109 DVWEIDAKQLKIECKVASGSYGDLYKGTYC-------SQEVAIKVLKPECVNTEMLKEFSQEVYIMRKI-RHKNVVQFIG  180 (399)
Q Consensus       109 ~~~~i~~~~~~i~~~lg~G~~g~Vy~~~~~-------~~~vAvK~~~~~~~~~~~~~~~~~Ei~~l~~l-~h~nIv~~~~  180 (399)
                      ..|+|+.++|++.++||+|+||.||+|++.       ++.||||+++... .......+.+|+.+++++ +||||+++++
T Consensus        16 ~~~~~~~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~-~~~~~~~~~~E~~~~~~l~~HpnIv~~~g   94 (311)
T d1t46a_          16 HKWEFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSA-HLTEREALMSELKVLSYLGNHMNIVNLLG   94 (311)
T ss_dssp             GGGBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTC-CHHHHHHHHHHHHHHHHHCCCTTBCCEEE
T ss_pred             ccccCCHHHeEEeeEEeecCCeEEEEEEEeccccCCCCeEEEEEEECccc-CHHHHHHHHHHHHHHHhccCCCCEEEEEE
Confidence            359999999999999999999999999863       3679999998764 455567899999999999 6999999999


Q ss_pred             EEecCCcEEEEEecCCCCCHHHHHHhcC-----------------CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCC
Q 015868          181 ACTRPPNLCIVTEFMARGSIYDFLHKQK-----------------GVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTA  243 (399)
Q Consensus       181 ~~~~~~~~~lV~E~~~ggsL~~~l~~~~-----------------~~l~~~~~~~i~~~i~~~L~~LH~~giiHrDlkp~  243 (399)
                      ++..++..++||||+++|+|.++++...                 ..+++..+..++.||++||+|||++||+||||||+
T Consensus        95 ~~~~~~~~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~~~ivHrDLKp~  174 (311)
T d1t46a_          95 ACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAAR  174 (311)
T ss_dssp             EECSSSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGG
T ss_pred             EEeeCCEEEEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCeeecccccc
Confidence            9999999999999999999999997643                 25889999999999999999999999999999999


Q ss_pred             ceeecCCCcEEEeeccceeeccCCC---ccccCCCCcccccccccCCCCCCChhhHHHHHHHHHHHHc-CCCCCCCCCHH
Q 015868          244 NLLMDENGVVKVADFGVARVQAQSG---VMTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLT-GELPYAGLTPL  319 (399)
Q Consensus       244 NILl~~~~~vkl~DFG~a~~~~~~~---~~~~~~gt~~y~aPE~l~~~~~~~~~Dv~slG~vl~ellt-g~~P~~~~~~~  319 (399)
                      ||+++.++.+|++|||.++......   ......||+.|+|||.+.+..++.++||||||+++|||+| |.+||...+..
T Consensus       175 NIl~~~~~~~ki~DfG~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwS~G~~l~ellt~g~p~~~~~~~~  254 (311)
T d1t46a_         175 NILLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVD  254 (311)
T ss_dssp             GEEEETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSS
T ss_pred             cccccccCcccccccchheeccCCCcceEeeecccChHHcCHHHhcCCCCCCcccccchHHHHHHHHhCCCCCCCCCCHH
Confidence            9999999999999999998765432   2234568999999999999999999999999999999999 77888888877


Q ss_pred             HHHHHHHhccCCCCCCCCCcHHHHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHH
Q 015868          320 QAAVGVVQKSLRPTIPKHAHPRLAELLERCWQHDPTQRPNFSQITDILKQMMKE  373 (399)
Q Consensus       320 ~~~~~~~~~~~~~~~~~~~~~~l~~ll~~cl~~dP~~Rps~~ell~~L~~l~~~  373 (399)
                      +.....+..+.++..|..+++++.+||.+||+.||++|||++||++.|++++++
T Consensus       255 ~~~~~~i~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~~il~~L~~~i~~  308 (311)
T d1t46a_         255 SKFYKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQISE  308 (311)
T ss_dssp             HHHHHHHHHTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             HHHHHHHhcCCCCCCcccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhhcc
Confidence            777778888899999999999999999999999999999999999999988765

>d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Pkb kinase (Akt-2)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.2e-54  Score=413.85  Aligned_cols=250  Identities=22%  Similarity=0.438  Sum_probs=221.9

Q ss_pred             ecccccceeceeceeCceEEEEEEE--CCeeEEEEEecCCCC-CHHHHHHHHHHHHHHHhcCCCceeeEEeEEecCCcEE
Q 015868          113 IDAKQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECV-NTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLC  189 (399)
Q Consensus       113 i~~~~~~i~~~lg~G~~g~Vy~~~~--~~~~vAvK~~~~~~~-~~~~~~~~~~Ei~~l~~l~h~nIv~~~~~~~~~~~~~  189 (399)
                      |..++|++.+.||+|+||.||+|++  +++.||||+++.... ..+..+.+.+|+.+|++++||||+++++++.++..+|
T Consensus         2 i~l~dy~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~   81 (337)
T d1o6la_           2 VTMNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLC   81 (337)
T ss_dssp             CCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEE
T ss_pred             CchHhcEEEEEEecCcCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhCCCCCEEEEEeeeccccccc
Confidence            4567899999999999999999997  588999999974311 1223567889999999999999999999999999999


Q ss_pred             EEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceeecCCCcEEEeeccceeeccCC-C
Q 015868          190 IVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQS-G  268 (399)
Q Consensus       190 lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~giiHrDlkp~NILl~~~~~vkl~DFG~a~~~~~~-~  268 (399)
                      +||||++||+|.+++.. .+.+++..++.++.||+.||+|||++||+||||||+|||++.+|.+||+|||+|+..... .
T Consensus        82 iv~ey~~gg~L~~~~~~-~~~~~e~~~~~~~~qil~al~ylH~~~iiHRDlKP~NILl~~~g~vkl~DFG~a~~~~~~~~  160 (337)
T d1o6la_          82 FVMEYANGGELFFHLSR-ERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGA  160 (337)
T ss_dssp             EEEECCTTCBHHHHHHH-HSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCSCCTTC
T ss_pred             cceeccCCCchhhhhhc-ccCCcHHHHHHHHHHHhhhhhhhhhcCccccccCHHHeEecCCCCEEEeecccccccccCCc
Confidence            99999999999999976 467899999999999999999999999999999999999999999999999999865443 3


Q ss_pred             ccccCCCCcccccccccCCCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhccCCCCCCCCCcHHHHHHHHH
Q 015868          269 VMTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRLAELLER  348 (399)
Q Consensus       269 ~~~~~~gt~~y~aPE~l~~~~~~~~~Dv~slG~vl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~  348 (399)
                      .....+||+.|+|||++.+.+|+.++|||||||++|||++|+.||.+.+..+........  .+.+|..+|+++.+||.+
T Consensus       161 ~~~~~~GT~~Y~aPE~~~~~~y~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~~i~~~--~~~~p~~~s~~~~dli~~  238 (337)
T d1o6la_         161 TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILME--EIRFPRTLSPEAKSLLAG  238 (337)
T ss_dssp             CBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHC--CCCCCTTSCHHHHHHHHH
T ss_pred             ccccceeCHHHhhhhhccCCCCChhhcccchhhHHHHHHHCCCCCCCcCHHHHHHHHhcC--CCCCCccCCHHHHHHHHh
Confidence            445568999999999999999999999999999999999999999999988776665543  456788999999999999


Q ss_pred             HhhhcCCCCCC-----HHHHHH
Q 015868          349 CWQHDPTQRPN-----FSQITD  365 (399)
Q Consensus       349 cl~~dP~~Rps-----~~ell~  365 (399)
                      ||+.||.+||+     ++|+++
T Consensus       239 ~L~~dP~~R~~~~~~~~~eil~  260 (337)
T d1o6la_         239 LLKKDPKQRLGGGPSDAKEVME  260 (337)
T ss_dssp             HTCSSTTTSTTCSTTTHHHHHT
T ss_pred             hccCCchhhcccccccHHHHHc
Confidence            99999999995     777765

>d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: EGF receptor tyrosine kinase, Erbb-1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.2e-54  Score=410.50  Aligned_cols=260  Identities=28%  Similarity=0.588  Sum_probs=223.9

Q ss_pred             ecccccceeceeceeCceEEEEEEEC--Ce----eEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCceeeEEeEEecCC
Q 015868          113 IDAKQLKIECKVASGSYGDLYKGTYC--SQ----EVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPP  186 (399)
Q Consensus       113 i~~~~~~i~~~lg~G~~g~Vy~~~~~--~~----~vAvK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~nIv~~~~~~~~~~  186 (399)
                      +..++|++.+.||+|+||.||+|++.  ++    .||+|.++... +....+.|.+|+.++++++||||++++++|.++ 
T Consensus         6 ~k~~dy~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~-   83 (317)
T d1xkka_           6 LKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREAT-SPKANKEILDEAYVMASVDNPHVCRLLGICLTS-   83 (317)
T ss_dssp             CCTTTEEEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC-----CTHHHHHHHHHHHHHCCCTTBCCEEEEEESS-
T ss_pred             CCHHHCEEeeEEecCCCeEEEEEEEcCCCCEEEEEEEEEEecccc-CHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecC-
Confidence            34567999999999999999999874  32    58999887542 333467899999999999999999999999875 


Q ss_pred             cEEEEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceeecCCCcEEEeeccceeeccC
Q 015868          187 NLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQ  266 (399)
Q Consensus       187 ~~~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~giiHrDlkp~NILl~~~~~vkl~DFG~a~~~~~  266 (399)
                      ..++++|++.+|+|.+++......+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+++....
T Consensus        84 ~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~iiHrDlKp~NIll~~~~~~kl~DFGla~~~~~  163 (317)
T d1xkka_          84 TVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGA  163 (317)
T ss_dssp             SEEEEEECCTTCBHHHHHHHTSSSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEETTEEEECCCSHHHHTTT
T ss_pred             CeeEEEEeccCCcccccccccccCCCHHHHHHHHHHHHHHHHHHHHcCcccCcchhhcceeCCCCCeEeeccccceeccc
Confidence            57788999999999999988888999999999999999999999999999999999999999999999999999986544


Q ss_pred             CCc---cccCCCCcccccccccCCCCCCChhhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHHhccCCCCCCCCCcHHH
Q 015868          267 SGV---MTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLT-GELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRL  342 (399)
Q Consensus       267 ~~~---~~~~~gt~~y~aPE~l~~~~~~~~~Dv~slG~vl~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  342 (399)
                      ...   .....||+.|+|||++.+..|+.++|||||||++|||+| |.+||.+.+..+.. ..+..+.++..|..+++++
T Consensus       164 ~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDvwS~Gvil~el~t~g~~p~~~~~~~~~~-~~i~~~~~~~~p~~~~~~~  242 (317)
T d1xkka_         164 EEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEIS-SILEKGERLPQPPICTIDV  242 (317)
T ss_dssp             TCC--------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCGGGHH-HHHHHTCCCCCCTTBCHHH
T ss_pred             ccccccccccccCccccChHHHhcCCCChhhhhhhHHHHHHHHHHCCCCCCCCCCHHHHH-HHHHcCCCCCCCcccCHHH
Confidence            322   233468999999999999999999999999999999999 89999988876654 4566677888899999999


Q ss_pred             HHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHH
Q 015868          343 AELLERCWQHDPTQRPNFSQITDILKQMMKEVA  375 (399)
Q Consensus       343 ~~ll~~cl~~dP~~Rps~~ell~~L~~l~~~~~  375 (399)
                      .+|+.+||+.||.+|||+.|+++.|..+.++..
T Consensus       243 ~~li~~cl~~dP~~RPs~~eil~~l~~~~~~~~  275 (317)
T d1xkka_         243 YMIMVKCWMIDADSRPKFRELIIEFSKMARDPQ  275 (317)
T ss_dssp             HHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSHH
T ss_pred             HHHHHHhCCCChhhCcCHHHHHHHHHHHHhChH
Confidence            999999999999999999999999998876543

>d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Mycobacterial protein kinase PknB, catalytic domain
species: Mycobacterium tuberculosis [TaxId: 1773]

Probab=100.00  E-value=2.2e-53  Score=398.54  Aligned_cols=256  Identities=26%  Similarity=0.442  Sum_probs=218.8

Q ss_pred             ccccceeceeceeCceEEEEEEE--CCeeEEEEEecCCCC-CHHHHHHHHHHHHHHHhcCCCceeeEEeEEecCC----c
Q 015868          115 AKQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECV-NTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPP----N  187 (399)
Q Consensus       115 ~~~~~i~~~lg~G~~g~Vy~~~~--~~~~vAvK~~~~~~~-~~~~~~~~~~Ei~~l~~l~h~nIv~~~~~~~~~~----~  187 (399)
                      .++|++.+.||+|+||.||+|++  +++.||||+++.... +......+.+|+.+++.++||||+++++++....    .
T Consensus         6 ~drY~i~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~~~~~~   85 (277)
T d1o6ya_           6 SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPL   85 (277)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEECSSSEE
T ss_pred             cceeEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhcCCCCCCcccceeeeccCCCce
Confidence            46799999999999999999997  589999999987644 4566678999999999999999999999987644    3


Q ss_pred             EEEEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceeecCCCcEEEeeccceeeccCC
Q 015868          188 LCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQS  267 (399)
Q Consensus       188 ~~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~giiHrDlkp~NILl~~~~~vkl~DFG~a~~~~~~  267 (399)
                      +|+||||++|++|.+++.. .+.+++..+..++.||+.||+|||++||+||||||+|||++.++.++++|||.+......
T Consensus        86 ~~lvmE~~~g~~L~~~~~~-~~~l~~~~~~~i~~qi~~al~~lH~~~iiHrDiKP~NIll~~~~~~~l~d~~~~~~~~~~  164 (277)
T d1o6ya_          86 PYIVMEYVDGVTLRDIVHT-EGPMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADS  164 (277)
T ss_dssp             EEEEEECCCEEEHHHHHHH-HCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTSCEEECCCTTCEECC--
T ss_pred             EEEEEECCCCCEehhhhcc-cCCCCHHHHHHHHHHHHHHHHHHHhCCccCccccCcccccCccccceeehhhhhhhhccc
Confidence            8999999999999999876 467999999999999999999999999999999999999999999999999998754432


Q ss_pred             C----ccccCCCCcccccccccCCCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhccCCC--CCCCCCcHH
Q 015868          268 G----VMTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKSLRP--TIPKHAHPR  341 (399)
Q Consensus       268 ~----~~~~~~gt~~y~aPE~l~~~~~~~~~Dv~slG~vl~elltg~~P~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~  341 (399)
                      .    ......||+.|+|||++.+..|+.++|||||||++|+|+||+.||.+.++.+.....+.....+  .....+|++
T Consensus       165 ~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~  244 (277)
T d1o6ya_         165 GNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPPSARHEGLSAD  244 (277)
T ss_dssp             --------------TTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHCCCCCGGGTSSSCCHH
T ss_pred             cccccccccccCcccccCHHHHcCCCCCcceecccchHHHHHHHhCCCCCCCcCHHHHHHHHHhcCCCCCchhccCCCHH
Confidence            2    2344579999999999999999999999999999999999999999999888877777654433  234678999


Q ss_pred             HHHHHHHHhhhcCCCCC-CHHHHHHHHHHHH
Q 015868          342 LAELLERCWQHDPTQRP-NFSQITDILKQMM  371 (399)
Q Consensus       342 l~~ll~~cl~~dP~~Rp-s~~ell~~L~~l~  371 (399)
                      +.++|.+||+.||.+|| |++++++.|.++.
T Consensus       245 l~~li~~~L~~dp~~R~~sa~~l~~~l~r~~  275 (277)
T d1o6ya_         245 LDAVVLKALAKNPENRYQTAAEMRADLVRVH  275 (277)
T ss_dssp             HHHHHHHHTCSSGGGSCSSHHHHHHHHHHHH
T ss_pred             HHHHHHHHccCCHhHCHhHHHHHHHHHHHHh
Confidence            99999999999999999 8999999888764

>d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tie2 kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.1e-54  Score=409.17  Aligned_cols=260  Identities=32%  Similarity=0.597  Sum_probs=225.6

Q ss_pred             eecccccceeceeceeCceEEEEEEE--CCe--eEEEEEecCCCCCHHHHHHHHHHHHHHHhc-CCCceeeEEeEEecCC
Q 015868          112 EIDAKQLKIECKVASGSYGDLYKGTY--CSQ--EVAIKVLKPECVNTEMLKEFSQEVYIMRKI-RHKNVVQFIGACTRPP  186 (399)
Q Consensus       112 ~i~~~~~~i~~~lg~G~~g~Vy~~~~--~~~--~vAvK~~~~~~~~~~~~~~~~~Ei~~l~~l-~h~nIv~~~~~~~~~~  186 (399)
                      .|+.++|++.++||+|+||.||+|++  ++.  .||||.++... ..+..+.|.+|+.+|+++ +||||+++++++..++
T Consensus         6 ~i~~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~   84 (309)
T d1fvra_           6 VLDWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYA-SKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRG   84 (309)
T ss_dssp             BCCGGGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC-------CHHHHHHHHHTTCCCCTTBCCEEEEEEETT
T ss_pred             ccCHHHcEEEEEEeeCCCcEEEEEEECCCCeEEEEEEEEECccc-ChHHHHHHHHHHHHHHhccCCCCEeeEEEEEecCC
Confidence            47889999999999999999999987  343  57888876443 334456899999999999 7999999999999999


Q ss_pred             cEEEEEecCCCCCHHHHHHhc---------------CCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceeecCCC
Q 015868          187 NLCIVTEFMARGSIYDFLHKQ---------------KGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENG  251 (399)
Q Consensus       187 ~~~lV~E~~~ggsL~~~l~~~---------------~~~l~~~~~~~i~~~i~~~L~~LH~~giiHrDlkp~NILl~~~~  251 (399)
                      .+++||||++||+|.++++..               ...+++..+..++.||+.||.|||++||+||||||+|||++.++
T Consensus        85 ~~~iV~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~~~iiHrDlkp~NIL~~~~~  164 (309)
T d1fvra_          85 YLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENY  164 (309)
T ss_dssp             EEEEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECGGG
T ss_pred             eeEEEEEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhhcCCccccccccceEEEcCCC
Confidence            999999999999999999653               36799999999999999999999999999999999999999999


Q ss_pred             cEEEeeccceeeccCCCccccCCCCcccccccccCCCCCCChhhHHHHHHHHHHHHcC-CCCCCCCCHHHHHHHHHhccC
Q 015868          252 VVKVADFGVARVQAQSGVMTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTG-ELPYAGLTPLQAAVGVVQKSL  330 (399)
Q Consensus       252 ~vkl~DFG~a~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~Dv~slG~vl~elltg-~~P~~~~~~~~~~~~~~~~~~  330 (399)
                      .+||+|||+++............||..|+|||.+.+..|+.++||||||+++|||++| .+||.+.+..+.... +..+.
T Consensus       165 ~~kl~DfG~a~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDvwSfGvil~ell~~~~~p~~~~~~~~~~~~-i~~~~  243 (309)
T d1fvra_         165 VAKIADFGLSRGQEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEK-LPQGY  243 (309)
T ss_dssp             CEEECCTTCEESSCEECCC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHH-GGGTC
T ss_pred             ceEEccccccccccccccccceecCCcccchHHhccCCCCccceeehhHHHHHHHHhcCCCCCCCCCHHHHHHH-HHhcC
Confidence            9999999999876655555566789999999999999999999999999999999996 468988887776555 45567


Q ss_pred             CCCCCCCCcHHHHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHH
Q 015868          331 RPTIPKHAHPRLAELLERCWQHDPTQRPNFSQITDILKQMMKE  373 (399)
Q Consensus       331 ~~~~~~~~~~~l~~ll~~cl~~dP~~Rps~~ell~~L~~l~~~  373 (399)
                      ++..|..+++++.+||.+||+.||++|||+.|+++.|++++++
T Consensus       244 ~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~L~~i~~~  286 (309)
T d1fvra_         244 RLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEE  286 (309)
T ss_dssp             CCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHS
T ss_pred             CCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhc
Confidence            8889999999999999999999999999999999999999764

>d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: gamma-subunit of glycogen phosphorylase kinase (Phk)
species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]

Probab=100.00  E-value=5.8e-53  Score=395.46  Aligned_cols=250  Identities=22%  Similarity=0.353  Sum_probs=220.4

Q ss_pred             ccccceeceeceeCceEEEEEEE--CCeeEEEEEecCCCCC-------HHHHHHHHHHHHHHHhcC-CCceeeEEeEEec
Q 015868          115 AKQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVN-------TEMLKEFSQEVYIMRKIR-HKNVVQFIGACTR  184 (399)
Q Consensus       115 ~~~~~i~~~lg~G~~g~Vy~~~~--~~~~vAvK~~~~~~~~-------~~~~~~~~~Ei~~l~~l~-h~nIv~~~~~~~~  184 (399)
                      .++|++.+.||+|+||+||+|++  +++.||||+++.....       ....+.+.+|+.++++++ ||||+++++++.+
T Consensus         2 ~~~y~~~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~   81 (277)
T d1phka_           2 YENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYET   81 (277)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEC
T ss_pred             cccCEEceEEecCcCeEEEEEEECCCCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEEeeccc
Confidence            36899999999999999999998  6799999999765322       223456889999999997 9999999999999


Q ss_pred             CCcEEEEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceeecCCCcEEEeeccceeec
Q 015868          185 PPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQ  264 (399)
Q Consensus       185 ~~~~~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~giiHrDlkp~NILl~~~~~vkl~DFG~a~~~  264 (399)
                      +...||||||++||+|.+++.. .+.+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+++..
T Consensus        82 ~~~~~ivmE~~~~g~L~~~l~~-~~~l~e~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nill~~~~~~kl~DFG~a~~~  160 (277)
T d1phka_          82 NTFFFLVFDLMKKGELFDYLTE-KVTLSEKETRKIMRALLEVICALHKLNIVHRDLKPENILLDDDMNIKLTDFGFSCQL  160 (277)
T ss_dssp             SSEEEEEEECCTTCBHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEEC
T ss_pred             CcceEEEEEcCCCchHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHcCCcccccccceEEEcCCCCeEEccchheeEc
Confidence            9999999999999999999976 467999999999999999999999999999999999999999999999999999987


Q ss_pred             cCCCccccCCCCcccccccccC------CCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhccCCC--CCCC
Q 015868          265 AQSGVMTAETGTYRWMAPEVIE------HKPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKSLRP--TIPK  336 (399)
Q Consensus       265 ~~~~~~~~~~gt~~y~aPE~l~------~~~~~~~~Dv~slG~vl~elltg~~P~~~~~~~~~~~~~~~~~~~~--~~~~  336 (399)
                      ......+...||+.|+|||.+.      ...++.++||||+||++|+|+||+.||.+.++......+......+  ....
T Consensus       161 ~~~~~~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~  240 (277)
T d1phka_         161 DPGEKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNYQFGSPEWD  240 (277)
T ss_dssp             CTTCCBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTTTGG
T ss_pred             cCCCceeeeeccCCCCCHHHhhccccccCCCCCchheEcccchhhhhhccCCCCCCCCCHHHHHHHHHhCCCCCCCcccc
Confidence            7666667778999999999985      3457889999999999999999999999998877766666544332  2334


Q ss_pred             CCcHHHHHHHHHHhhhcCCCCCCHHHHHH
Q 015868          337 HAHPRLAELLERCWQHDPTQRPNFSQITD  365 (399)
Q Consensus       337 ~~~~~l~~ll~~cl~~dP~~Rps~~ell~  365 (399)
                      .+|+++.+|+.+||+.||++|||++|+++
T Consensus       241 ~~s~~~~~li~~~L~~~p~~R~s~~eil~  269 (277)
T d1phka_         241 DYSDTVKDLVSRFLVVQPQKRYTAEEALA  269 (277)
T ss_dssp             GSCHHHHHHHHHHCCSSGGGSCCHHHHTT
T ss_pred             cCCHHHHHHHHHHccCChhHCcCHHHHHc
Confidence            79999999999999999999999999864

>d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

Probab=100.00  E-value=2e-53  Score=406.01  Aligned_cols=246  Identities=26%  Similarity=0.471  Sum_probs=219.4

Q ss_pred             ccccceeceeceeCceEEEEEEE--CCeeEEEEEecCCCC-CHHHHHHHHHHHHHHHhcCCCceeeEEeEEecCCcEEEE
Q 015868          115 AKQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECV-NTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIV  191 (399)
Q Consensus       115 ~~~~~i~~~lg~G~~g~Vy~~~~--~~~~vAvK~~~~~~~-~~~~~~~~~~Ei~~l~~l~h~nIv~~~~~~~~~~~~~lV  191 (399)
                      .++|++.++||+|+||.||+|++  +++.||||+++.... .....+.+.+|+.+|++++||||+++++++.++..+|+|
T Consensus         3 l~dy~i~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~iv   82 (316)
T d1fota_           3 LQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMI   82 (316)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEE
T ss_pred             hhHeEEEEEEecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHhccCcChhheeeeEeeCCeeeeE
Confidence            35799999999999999999997  478999999974321 112346789999999999999999999999999999999


Q ss_pred             EecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceeecCCCcEEEeeccceeeccCCCccc
Q 015868          192 TEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMT  271 (399)
Q Consensus       192 ~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~giiHrDlkp~NILl~~~~~vkl~DFG~a~~~~~~~~~~  271 (399)
                      |||+.||+|..++.. ...+++..+..++.||+.||.|||++||+||||||+|||++.+|.+||+|||+|+.....  ..
T Consensus        83 mE~~~gg~l~~~~~~-~~~~~~~~~~~~~~qi~~al~~lH~~~iiHrDiKp~NILl~~~g~vkL~DFG~a~~~~~~--~~  159 (316)
T d1fota_          83 MDYIEGGELFSLLRK-SQRFPNPVAKFYAAEVCLALEYLHSKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPDV--TY  159 (316)
T ss_dssp             ECCCCSCBHHHHHHH-TSSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECTTSCEEECCCSSCEECSSC--BC
T ss_pred             eeecCCccccccccc-cccccccHHHHHHHHHHHhhhhhccCcEEccccCchheeEcCCCCEEEecCccceEeccc--cc
Confidence            999999999998876 567899999999999999999999999999999999999999999999999999876543  44


Q ss_pred             cCCCCcccccccccCCCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhccCCCCCCCCCcHHHHHHHHHHhh
Q 015868          272 AETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRLAELLERCWQ  351 (399)
Q Consensus       272 ~~~gt~~y~aPE~l~~~~~~~~~Dv~slG~vl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~cl~  351 (399)
                      ...||+.|||||++.+.+|+.++|||||||++|+|+||+.||.+.+..+....+...  ...+|..+++++.+++.+||+
T Consensus       160 ~~~Gt~~Y~APE~l~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~~--~~~~p~~~s~~~~~li~~~L~  237 (316)
T d1fota_         160 TLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNA--ELRFPPFFNEDVKDLLSRLIT  237 (316)
T ss_dssp             CCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHC--CCCCCTTSCHHHHHHHHHHTC
T ss_pred             cccCcccccCHHHHcCCCCCchhhccccchhHHHHHhCCCCCCCcCHHHHHHHHHcC--CCCCCCCCCHHHHHHHHHHhh
Confidence            568999999999999999999999999999999999999999999988877766654  345778899999999999999


Q ss_pred             hcCCCCC-----CHHHHHH
Q 015868          352 HDPTQRP-----NFSQITD  365 (399)
Q Consensus       352 ~dP~~Rp-----s~~ell~  365 (399)
                      .||.+|+     |++++++
T Consensus       238 ~dp~~R~~~~r~t~~~il~  256 (316)
T d1fota_         238 RDLSQRLGNLQNGTEDVKN  256 (316)
T ss_dssp             SCTTTCTTSSTTTTHHHHT
T ss_pred             hCHHhccccchhhHHHHHc
Confidence            9999996     8999876

>d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Titin, kinase domain
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4e-53  Score=404.88  Aligned_cols=248  Identities=18%  Similarity=0.286  Sum_probs=221.0

Q ss_pred             ccccceeceeceeCceEEEEEEE--CCeeEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCceeeEEeEEecCCcEEEEE
Q 015868          115 AKQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVT  192 (399)
Q Consensus       115 ~~~~~i~~~lg~G~~g~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~nIv~~~~~~~~~~~~~lV~  192 (399)
                      .++|++.+.||+|+||.||+|.+  +++.||||+++...   .....+.+|+.+|+.++||||+++++++.++..+||||
T Consensus         4 ~~rY~i~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~~---~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~lvm   80 (321)
T d1tkia_           4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKG---TDQVLVKKEISILNIARHRNILHLHESFESMEELVMIF   80 (321)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCT---HHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEE
T ss_pred             ccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEcCCc---ccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEE
Confidence            36899999999999999999987  57899999998652   23356889999999999999999999999999999999


Q ss_pred             ecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceeecCC--CcEEEeeccceeeccCCCcc
Q 015868          193 EFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDEN--GVVKVADFGVARVQAQSGVM  270 (399)
Q Consensus       193 E~~~ggsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~giiHrDlkp~NILl~~~--~~vkl~DFG~a~~~~~~~~~  270 (399)
                      ||++||+|.+++......+++.+++.++.||+.||.|||++||+||||||+|||++.+  ..+||+|||+++........
T Consensus        81 E~~~gg~L~~~i~~~~~~l~e~~~~~i~~qi~~al~yLH~~~iiHrDlKp~NIll~~~~~~~ikl~DFG~~~~~~~~~~~  160 (321)
T d1tkia_          81 EFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNF  160 (321)
T ss_dssp             CCCCCCBHHHHHTSSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSCCCEEECCCTTCEECCTTCEE
T ss_pred             ecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCCcccccccceeecCCCceEEEEcccchhhccccCCcc
Confidence            9999999999998766789999999999999999999999999999999999999854  48999999999877665556


Q ss_pred             ccCCCCcccccccccCCCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhccCCCC--CCCCCcHHHHHHHHH
Q 015868          271 TAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKSLRPT--IPKHAHPRLAELLER  348 (399)
Q Consensus       271 ~~~~gt~~y~aPE~l~~~~~~~~~Dv~slG~vl~elltg~~P~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~l~~ll~~  348 (399)
                      ....+|+.|+|||.+.+..|+.++|||||||++|+|++|..||.+.+..+....+........  .+..+++++.+||.+
T Consensus       161 ~~~~~t~~y~ape~~~~~~~~~~~DiWSlGvily~ll~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~  240 (321)
T d1tkia_         161 RLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFDEEAFKEISIEAMDFVDR  240 (321)
T ss_dssp             EEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCCCHHHHTTSCHHHHHHHHT
T ss_pred             cccccccccccchhccCCCCCchhhcccHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCChhhccCCCHHHHHHHHH
Confidence            667789999999999999999999999999999999999999999998887776665443221  224689999999999


Q ss_pred             HhhhcCCCCCCHHHHHH
Q 015868          349 CWQHDPTQRPNFSQITD  365 (399)
Q Consensus       349 cl~~dP~~Rps~~ell~  365 (399)
                      ||+.||.+|||+.|+++
T Consensus       241 ~L~~dp~~R~s~~eil~  257 (321)
T d1tkia_         241 LLVKERKSRMTASEALQ  257 (321)
T ss_dssp             TSCSSGGGSCCHHHHHH
T ss_pred             HccCChhHCcCHHHHhc
Confidence            99999999999999987

>d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Insulin-like growth factor 1 receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.7e-53  Score=401.65  Aligned_cols=261  Identities=30%  Similarity=0.557  Sum_probs=231.3

Q ss_pred             CceeecccccceeceeceeCceEEEEEEEC-------CeeEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCceeeEEeE
Q 015868          109 DVWEIDAKQLKIECKVASGSYGDLYKGTYC-------SQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGA  181 (399)
Q Consensus       109 ~~~~i~~~~~~i~~~lg~G~~g~Vy~~~~~-------~~~vAvK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~nIv~~~~~  181 (399)
                      +.|+|+.++|++.++||+|+||.||+|++.       +..||||+++... .......|.+|+.++++++||||++++++
T Consensus        13 ~~~ei~~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~~-~~~~~~~~~~E~~il~~l~h~nIv~~~~~   91 (308)
T d1p4oa_          13 DEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAA-SMRERIEFLNEASVMKEFNCHHVVRLLGV   91 (308)
T ss_dssp             CTTBCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTS-CHHHHHHHHHHHHHGGGCCCTTBCCEEEE
T ss_pred             cceeecHHHeEEeeEEeeCCCeEEEEEEECCcccCCCCcEEEEEEECccc-ChHHHHHHHHHHHHHHHcCCCCEeeeeeE
Confidence            569999999999999999999999999874       3689999998653 55566789999999999999999999999


Q ss_pred             EecCCcEEEEEecCCCCCHHHHHHhcC---------CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceeecCCCc
Q 015868          182 CTRPPNLCIVTEFMARGSIYDFLHKQK---------GVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGV  252 (399)
Q Consensus       182 ~~~~~~~~lV~E~~~ggsL~~~l~~~~---------~~l~~~~~~~i~~~i~~~L~~LH~~giiHrDlkp~NILl~~~~~  252 (399)
                      +..++..++||||+++|+|.+++....         ..++...+.+++.|+++||.|||+++|+||||||+|||++++++
T Consensus        92 ~~~~~~~~lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~~~ivHrDlk~~NiLld~~~~  171 (308)
T d1p4oa_          92 VSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFT  171 (308)
T ss_dssp             ECSSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCSGGGEEECTTCC
T ss_pred             EecCCceeEEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHhhCCeeeceEcCCceeecCCce
Confidence            999999999999999999999986432         34688899999999999999999999999999999999999999


Q ss_pred             EEEeeccceeeccCCCc---cccCCCCcccccccccCCCCCCChhhHHHHHHHHHHHHcC-CCCCCCCCHHHHHHHHHhc
Q 015868          253 VKVADFGVARVQAQSGV---MTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTG-ELPYAGLTPLQAAVGVVQK  328 (399)
Q Consensus       253 vkl~DFG~a~~~~~~~~---~~~~~gt~~y~aPE~l~~~~~~~~~Dv~slG~vl~elltg-~~P~~~~~~~~~~~~~~~~  328 (399)
                      +||+|||+++.......   .....||+.|+|||.+.+..++.++||||||+++|||+|| ..||.+.+..+....+. .
T Consensus       172 ~Kl~DFGla~~~~~~~~~~~~~~~~~t~~y~aPe~l~~~~~~~~~Dv~S~G~il~El~t~~~~p~~~~~~~~~~~~i~-~  250 (308)
T d1p4oa_         172 VKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVM-E  250 (308)
T ss_dssp             EEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHHHHHHHHH-T
T ss_pred             EEEeecccceeccCCcceeeccceecccccCCHHHHccCCCCcccccccHHHHHHHHHhCCCCCCCCCCHHHHHHHHH-h
Confidence            99999999986544322   3344689999999999999999999999999999999997 58999998888766544 5


Q ss_pred             cCCCCCCCCCcHHHHHHHHHHhhhcCCCCCCHHHHHHHHHHHH
Q 015868          329 SLRPTIPKHAHPRLAELLERCWQHDPTQRPNFSQITDILKQMM  371 (399)
Q Consensus       329 ~~~~~~~~~~~~~l~~ll~~cl~~dP~~Rps~~ell~~L~~l~  371 (399)
                      +.++.+|..+++.+.++|.+||+.||++|||+++|++.|++.+
T Consensus       251 ~~~~~~p~~~~~~l~~li~~cl~~~P~~RPs~~~il~~L~~~~  293 (308)
T d1p4oa_         251 GGLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEM  293 (308)
T ss_dssp             TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGS
T ss_pred             CCCCCCcccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhc
Confidence            6678888999999999999999999999999999999887654

>d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=8.5e-53  Score=407.01  Aligned_cols=245  Identities=27%  Similarity=0.412  Sum_probs=218.9

Q ss_pred             cccceeceeceeCceEEEEEEE--CCeeEEEEEecCCCC-CHHHHHHHHHHHHHHHhcCCCceeeEEeEEecCCcEEEEE
Q 015868          116 KQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECV-NTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVT  192 (399)
Q Consensus       116 ~~~~i~~~lg~G~~g~Vy~~~~--~~~~vAvK~~~~~~~-~~~~~~~~~~Ei~~l~~l~h~nIv~~~~~~~~~~~~~lV~  192 (399)
                      ++|++.++||+|+||.||+|++  +++.||||+++.... .....+.+.+|+.+|+.++||||+++++++.....+++||
T Consensus        41 d~y~i~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~v~  120 (350)
T d1rdqe_          41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVM  120 (350)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             cCeEEEEEeecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHHcCCCcEeeccccccccccccccc
Confidence            5899999999999999999998  588999999864311 1223467889999999999999999999999999999999


Q ss_pred             ecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceeecCCCcEEEeeccceeeccCCCcccc
Q 015868          193 EFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTA  272 (399)
Q Consensus       193 E~~~ggsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~giiHrDlkp~NILl~~~~~vkl~DFG~a~~~~~~~~~~~  272 (399)
                      ||+.||+|.+++.+. +.+++..++.++.||+.||.|||++|||||||||+|||++.+|.+||+|||+|+....  ....
T Consensus       121 e~~~~g~l~~~l~~~-~~l~e~~~~~i~~qi~~aL~yLH~~~iiHRDIKP~NILl~~~g~ikL~DFG~a~~~~~--~~~~  197 (350)
T d1rdqe_         121 EYVAGGEMFSHLRRI-GRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG--RTWT  197 (350)
T ss_dssp             ECCTTCBHHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECSS--CBCC
T ss_pred             ccccccchhhhHhhc-CCCCHHHHHHHHHHHHHHHHHHHhCCEecCcCCHHHcccCCCCCEEeeeceeeeeccc--cccc
Confidence            999999999999764 5799999999999999999999999999999999999999999999999999987643  2445


Q ss_pred             CCCCcccccccccCCCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhccCCCCCCCCCcHHHHHHHHHHhhh
Q 015868          273 ETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRLAELLERCWQH  352 (399)
Q Consensus       273 ~~gt~~y~aPE~l~~~~~~~~~Dv~slG~vl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~cl~~  352 (399)
                      ..||+.|||||++.+..|+.++|||||||++|+|+||+.||.+.++.+....+...  .+..|..+++++.+||.+||+.
T Consensus       198 ~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~~--~~~~p~~~s~~~~~li~~~L~~  275 (350)
T d1rdqe_         198 LCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSG--KVRFPSHFSSDLKDLLRNLLQV  275 (350)
T ss_dssp             CEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHC--CCCCCTTCCHHHHHHHHHHSCS
T ss_pred             ccCccccCCHHHHcCCCCCccccccchhHHHHHHHhCCCCCCCcCHHHHHHHHhcC--CCCCCccCCHHHHHHHHHHhhh
Confidence            67999999999999999999999999999999999999999999888877766654  3456788999999999999999


Q ss_pred             cCCCCC-----CHHHHHH
Q 015868          353 DPTQRP-----NFSQITD  365 (399)
Q Consensus       353 dP~~Rp-----s~~ell~  365 (399)
                      ||.+|+     |++++++
T Consensus       276 dP~kR~~~~r~t~~ell~  293 (350)
T d1rdqe_         276 DLTKRFGNLKNGVNDIKN  293 (350)
T ss_dssp             CTTTCTTSSTTTTHHHHT
T ss_pred             CHHhccccccccHHHHHc
Confidence            999994     8999876

>d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Hepatocyte growth factor receptor, c-MET
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.2e-52  Score=395.35  Aligned_cols=255  Identities=28%  Similarity=0.500  Sum_probs=217.7

Q ss_pred             ceeceeceeCceEEEEEEECC-----eeEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCceeeEEeEEec-CCcEEEEE
Q 015868          119 KIECKVASGSYGDLYKGTYCS-----QEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTR-PPNLCIVT  192 (399)
Q Consensus       119 ~i~~~lg~G~~g~Vy~~~~~~-----~~vAvK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~nIv~~~~~~~~-~~~~~lV~  192 (399)
                      .+.++||+|+||+||+|++..     ..||||+++.. .+....++|.+|+.+|++++||||++++|++.. ++.+++||
T Consensus        30 ~~~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~-~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~  108 (311)
T d1r0pa_          30 HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRI-TDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVL  108 (311)
T ss_dssp             EEEEEEEEETTEEEEEEEECC----CEEEEEEEECCC-CCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEETTTEEEEEE
T ss_pred             ccceEEeecCCeEEEEEEEECCCCEEEEEEEEEECcc-cCHHHHHHHHHHHHHHHhCCCCCEeEEeEEEEecCCceEEEE
Confidence            346789999999999998743     35899999753 356667899999999999999999999999865 55799999


Q ss_pred             ecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceeecCCCcEEEeeccceeeccCCC----
Q 015868          193 EFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSG----  268 (399)
Q Consensus       193 E~~~ggsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~giiHrDlkp~NILl~~~~~vkl~DFG~a~~~~~~~----  268 (399)
                      ||+++|+|.+++......+++..+.+++.|++.||.|||+.||+||||||+|||+++++.+||+|||+++......    
T Consensus       109 E~~~~g~l~~~~~~~~~~~~~~~~~~i~~qia~gL~~lH~~~iiHrDLK~~NILl~~~~~~kL~DFG~~~~~~~~~~~~~  188 (311)
T d1r0pa_         109 PYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSV  188 (311)
T ss_dssp             ECCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTCCEEECSSGGGCCTTTTTCCCT
T ss_pred             EEeecCchhhhhccccccchHHHHHHHHHHHHHhhhhhcccCcccCCccHHhEeECCCCCEEEecccchhhccccccccc
Confidence            9999999999998877788899999999999999999999999999999999999999999999999998654432    


Q ss_pred             -ccccCCCCcccccccccCCCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhccCCCCCCCCCcHHHHHHHH
Q 015868          269 -VMTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRLAELLE  347 (399)
Q Consensus       269 -~~~~~~gt~~y~aPE~l~~~~~~~~~Dv~slG~vl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~  347 (399)
                       ......||+.|+|||.+.+..++.++||||||+++|||+||..||............+..+.++..|..+++++.+||.
T Consensus       189 ~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~SfGivl~El~t~~~p~~~~~~~~~~~~~i~~g~~~~~p~~~~~~l~~li~  268 (311)
T d1r0pa_         189 HNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQPEYCPDPLYEVML  268 (311)
T ss_dssp             TCTTCSSCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCC------CHHHHHTTCCCCCCTTCCHHHHHHHH
T ss_pred             eecccccccccccChHHHhcCCCCChhHhhhhHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCCCCCcccCcHHHHHHHH
Confidence             2233468999999999999999999999999999999999776665443333334445566788899999999999999


Q ss_pred             HHhhhcCCCCCCHHHHHHHHHHHHHHH
Q 015868          348 RCWQHDPTQRPNFSQITDILKQMMKEV  374 (399)
Q Consensus       348 ~cl~~dP~~Rps~~ell~~L~~l~~~~  374 (399)
                      +||+.||++||++.||++.|+++++..
T Consensus       269 ~cl~~dP~~RPs~~ei~~~L~~i~~~~  295 (311)
T d1r0pa_         269 KCWHPKAEMRPSFSELVSRISAIFSTF  295 (311)
T ss_dssp             HHTCSSGGGSCCHHHHHHHHHHHHHTC
T ss_pred             HHcCCCHhHCcCHHHHHHHHHHHHHhh
Confidence            999999999999999999999997643

>d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase C, theta type
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.5e-52  Score=400.60  Aligned_cols=247  Identities=24%  Similarity=0.449  Sum_probs=216.0

Q ss_pred             cccceeceeceeCceEEEEEEE--CCeeEEEEEecCCCC-CHHHHHHHHHHHHHHH-hcCCCceeeEEeEEecCCcEEEE
Q 015868          116 KQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECV-NTEMLKEFSQEVYIMR-KIRHKNVVQFIGACTRPPNLCIV  191 (399)
Q Consensus       116 ~~~~i~~~lg~G~~g~Vy~~~~--~~~~vAvK~~~~~~~-~~~~~~~~~~Ei~~l~-~l~h~nIv~~~~~~~~~~~~~lV  191 (399)
                      ++|++.+.||+|+||+||+|++  +++.||||+++.... ..+..+.+..|+.++. .++||||+++++++.+++.+|||
T Consensus         2 ddy~i~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~~~~~yiv   81 (320)
T d1xjda_           2 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFV   81 (320)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEE
T ss_pred             CCeEEeeEEecCCCcEEEEEEECCCCCEEEEEEEchhhccChHHHHHHHHHHHHHHHhCCCCcEEEEEEEEccCCceeEE
Confidence            5799999999999999999998  689999999974211 1122345666766654 68999999999999999999999


Q ss_pred             EecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceeecCCCcEEEeeccceeeccCC-Ccc
Q 015868          192 TEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQS-GVM  270 (399)
Q Consensus       192 ~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~giiHrDlkp~NILl~~~~~vkl~DFG~a~~~~~~-~~~  270 (399)
                      |||++||+|.+++.. ...+++..+..++.||+.||.|||++||+||||||+|||+++++.+||+|||+++..... ...
T Consensus        82 mEy~~~g~L~~~i~~-~~~~~e~~~~~~~~qi~~al~ylH~~~iiHrDikp~NiL~~~~~~~kl~DFG~a~~~~~~~~~~  160 (320)
T d1xjda_          82 MEYLNGGDLMYHIQS-CHKFDLSRATFYAAEIILGLQFLHSKGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKT  160 (320)
T ss_dssp             EECCTTCBHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCTTCCB
T ss_pred             EeecCCCcHHHHhhc-cCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCcccceeecCCCceeccccchhhhcccccccc
Confidence            999999999999976 467899999999999999999999999999999999999999999999999999865433 334


Q ss_pred             ccCCCCcccccccccCCCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhccCCCCCCCCCcHHHHHHHHHHh
Q 015868          271 TAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRLAELLERCW  350 (399)
Q Consensus       271 ~~~~gt~~y~aPE~l~~~~~~~~~Dv~slG~vl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~cl  350 (399)
                      +...||+.|+|||++.+..|+.++|||||||++|+|+||+.||.+.++.+....+...  .+.+|..+|+++.+||.+||
T Consensus       161 ~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~~~--~~~~p~~~s~~~~dli~~~L  238 (320)
T d1xjda_         161 NTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMD--NPFYPRWLEKEAKDLLVKLF  238 (320)
T ss_dssp             CCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHC--CCCCCTTSCHHHHHHHHHHS
T ss_pred             cccCCCCCcCCHHHHcCCCCCchhhhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHcC--CCCCCccCCHHHHHHHHHhc
Confidence            5568999999999999999999999999999999999999999999988876665543  56788899999999999999


Q ss_pred             hhcCCCCCCHH-HHHH
Q 015868          351 QHDPTQRPNFS-QITD  365 (399)
Q Consensus       351 ~~dP~~Rps~~-ell~  365 (399)
                      +.||.+|||+. ++++
T Consensus       239 ~~dP~~R~s~~~~l~~  254 (320)
T d1xjda_         239 VREPEKRLGVRGDIRQ  254 (320)
T ss_dssp             CSSGGGSBTTBSCGGG
T ss_pred             ccCCCCCcCHHHHHHh
Confidence            99999999995 6754

>d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: G-protein coupled receptor kinase 2
species: Cow (Bos taurus) [TaxId: 9913]

Probab=100.00  E-value=1.1e-51  Score=401.36  Aligned_cols=249  Identities=25%  Similarity=0.411  Sum_probs=209.7

Q ss_pred             ccccceeceeceeCceEEEEEEE--CCeeEEEEEecCCCC----CHHHHHHHHHHHHHHHhcCCCceeeEEeEEecCCcE
Q 015868          115 AKQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECV----NTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNL  188 (399)
Q Consensus       115 ~~~~~i~~~lg~G~~g~Vy~~~~--~~~~vAvK~~~~~~~----~~~~~~~~~~Ei~~l~~l~h~nIv~~~~~~~~~~~~  188 (399)
                      .++|++.+.||+|+||.||+|++  +++.||||++.....    .........+|+.+++.++||||+++++++..++.+
T Consensus         3 lddy~i~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~~~~~~~   82 (364)
T d1omwa3           3 MNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKL   82 (364)
T ss_dssp             STTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEE
T ss_pred             HHhCeeeeEEecCCCeEEEEEEECCCCCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcCCCCcEEEEEEEEEECCEE
Confidence            46899999999999999999998  578999999864221    122222334457777888899999999999999999


Q ss_pred             EEEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceeecCCCcEEEeeccceeeccCCC
Q 015868          189 CIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSG  268 (399)
Q Consensus       189 ~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~giiHrDlkp~NILl~~~~~vkl~DFG~a~~~~~~~  268 (399)
                      |+||||++||+|.+++.+ ...+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||+|+..... 
T Consensus        83 ~ivmE~~~gg~L~~~l~~-~~~~~e~~~~~~~~qi~~aL~ylH~~~iiHrDlKP~NILl~~~g~iKl~DFGla~~~~~~-  160 (364)
T d1omwa3          83 SFILDLMNGGDLHYHLSQ-HGVFSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKK-  160 (364)
T ss_dssp             EEEECCCCSCBHHHHHHH-HCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECSSSCEEECCCTTCEECSSS-
T ss_pred             EEEEEecCCCcHHHHHHh-cccccHHHHHHHHHHHHHHHHHHHHCCccceeeccceeEEcCCCcEEEeeeceeeecCCC-
Confidence            999999999999999976 467899999999999999999999999999999999999999999999999999876544 


Q ss_pred             ccccCCCCcccccccccC-CCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHH-HHHHhccCCCCCCCCCcHHHHHHH
Q 015868          269 VMTAETGTYRWMAPEVIE-HKPYDYKADVFSFGIALWELLTGELPYAGLTPLQAA-VGVVQKSLRPTIPKHAHPRLAELL  346 (399)
Q Consensus       269 ~~~~~~gt~~y~aPE~l~-~~~~~~~~Dv~slG~vl~elltg~~P~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~l~~ll  346 (399)
                      ......||+.|+|||++. +..|+.++|||||||++|+|+||+.||.+.+..... .........+.+|..+++++.+||
T Consensus       161 ~~~~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li  240 (364)
T d1omwa3         161 KPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELPDSFSPELRSLL  240 (364)
T ss_dssp             CCCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCSSCSSCSSCHHHHHHHSSSCCCCCCSSSCHHHHHHH
T ss_pred             cccccccccccchhHHhhcCCCCCcccchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccCCCCCCCCCCHHHHHHH
Confidence            345568999999999996 457999999999999999999999999876543222 112223445667788999999999


Q ss_pred             HHHhhhcCCCCCC-----HHHHHH
Q 015868          347 ERCWQHDPTQRPN-----FSQITD  365 (399)
Q Consensus       347 ~~cl~~dP~~Rps-----~~ell~  365 (399)
                      .+||+.||.+|||     ++|+++
T Consensus       241 ~~~L~~dP~~R~t~~~~~a~eil~  264 (364)
T d1omwa3         241 EGLLQRDVNRRLGCLGRGAQEVKE  264 (364)
T ss_dssp             HHHTCSSTTTSTTTSSSTHHHHHT
T ss_pred             HHHcccCHHHhCCCcccCHHHHHc
Confidence            9999999999999     678765

>d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase activated protein kinase 2, mapkap2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.2e-52  Score=399.91  Aligned_cols=244  Identities=23%  Similarity=0.397  Sum_probs=204.7

Q ss_pred             ccccceec-eeceeCceEEEEEEE--CCeeEEEEEecCCCCCHHHHHHHHHHHHHHHh-cCCCceeeEEeEEec----CC
Q 015868          115 AKQLKIEC-KVASGSYGDLYKGTY--CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRK-IRHKNVVQFIGACTR----PP  186 (399)
Q Consensus       115 ~~~~~i~~-~lg~G~~g~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~Ei~~l~~-l~h~nIv~~~~~~~~----~~  186 (399)
                      .++|++.. .||+|+||.||+|++  +++.||||+++..       ..+.+|+.++.+ .+||||++++++|.+    ..
T Consensus        10 ~~~y~i~~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~-------~~~~~E~~~~~~~~~hpnIv~l~~~~~~~~~~~~   82 (335)
T d2ozaa1          10 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-------PKARREVELHWRASQCPHIVRIVDVYENLYAGRK   82 (335)
T ss_dssp             GGTEEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECS-------HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEE
T ss_pred             ccCEEEeeEEeeeccCeEEEEEEECCCCCEEEEEEECCc-------HHHHHHHHHHHHhcCCCCCCeEEEEEeecccCCC
Confidence            35898875 599999999999987  5789999999743       456789988765 489999999999865    45


Q ss_pred             cEEEEEecCCCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceeecC---CCcEEEeecccee
Q 015868          187 NLCIVTEFMARGSIYDFLHKQK-GVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDE---NGVVKVADFGVAR  262 (399)
Q Consensus       187 ~~~lV~E~~~ggsL~~~l~~~~-~~l~~~~~~~i~~~i~~~L~~LH~~giiHrDlkp~NILl~~---~~~vkl~DFG~a~  262 (399)
                      .+|+|||||+||+|.+++.+.. ..+++..++.++.||+.||+|||++||+||||||+|||++.   ++.+||+|||+|+
T Consensus        83 ~~~ivmEy~~gg~L~~~i~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~iiHRDiKp~NIll~~~~~~~~~Kl~DFG~a~  162 (335)
T d2ozaa1          83 CLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAK  162 (335)
T ss_dssp             EEEEEEECCCSEEHHHHHHSCSCCCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCSSTTCCEEECCCTTCE
T ss_pred             EEEEEEECCCCCcHHHHHHhcCCCCcCHHHHHHHHHHHHHHHHHHHHcCCccccccccccccccccccccccccccceee
Confidence            6899999999999999997653 56999999999999999999999999999999999999985   5679999999999


Q ss_pred             eccCCCccccCCCCcccccccccCCCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhccCC--CCCC----C
Q 015868          263 VQAQSGVMTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKSLR--PTIP----K  336 (399)
Q Consensus       263 ~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~Dv~slG~vl~elltg~~P~~~~~~~~~~~~~~~~~~~--~~~~----~  336 (399)
                      ............||+.|||||++.+..|+.++|||||||++|+|+||+.||.+.+..............  ..+|    .
T Consensus       163 ~~~~~~~~~~~~gt~~y~aPE~~~~~~y~~~~DiwSlGvily~lltg~~Pf~~~~~~~~~~~~~~~i~~~~~~~~~~~~~  242 (335)
T d2ozaa1         163 ETTSHNSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWS  242 (335)
T ss_dssp             ECCCCCCCCCCSCCCSSCCCCCCCGGGGSHHHHHHHHHHHHHHHTTSSCSCEETTCC--------CCCSCSSSCCTTHHH
T ss_pred             eccCCCccccccCCcccCCcHHHcCCCCCHHHHHHhhchhHHHHhhCCCCCCCCCHHHHHHHHHHHHhcCCCCCCCcccc
Confidence            877766677788999999999999999999999999999999999999999876654443333222221  1122    2


Q ss_pred             CCcHHHHHHHHHHhhhcCCCCCCHHHHHH
Q 015868          337 HAHPRLAELLERCWQHDPTQRPNFSQITD  365 (399)
Q Consensus       337 ~~~~~l~~ll~~cl~~dP~~Rps~~ell~  365 (399)
                      .+|+++.+||.+||+.||++|||+.|+++
T Consensus       243 ~~s~~~~~li~~~L~~dP~~R~s~~eil~  271 (335)
T d2ozaa1         243 EVSEEVKMLIRNLLKTEPTQRMTITEFMN  271 (335)
T ss_dssp             HSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred             cCCHHHHHHHHHHccCChhHCcCHHHHHc
Confidence            57899999999999999999999999976

>d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.5e-51  Score=390.11  Aligned_cols=249  Identities=22%  Similarity=0.396  Sum_probs=208.0

Q ss_pred             cccceeceeceeCceEEEEEEE--CCeeEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCceeeEEeEEecCCcEEEEEe
Q 015868          116 KQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVTE  193 (399)
Q Consensus       116 ~~~~i~~~lg~G~~g~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~nIv~~~~~~~~~~~~~lV~E  193 (399)
                      ++|++.++||+|+||.||+|++  +++.||||+++....+......+.+|+.+|++++||||+++++++.++..+|+|||
T Consensus         2 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~~~~~~iv~e   81 (298)
T d1gz8a_           2 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFE   81 (298)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEC-------CCHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             CCCEeccEEecCcCeEEEEEEECCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEEeccccccccceeEEEe
Confidence            5899999999999999999998  47899999998665444556789999999999999999999999999999999999


Q ss_pred             cCCCCCHHHHH-HhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceeecCCCcEEEeeccceeeccCCC-ccc
Q 015868          194 FMARGSIYDFL-HKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSG-VMT  271 (399)
Q Consensus       194 ~~~ggsL~~~l-~~~~~~l~~~~~~~i~~~i~~~L~~LH~~giiHrDlkp~NILl~~~~~vkl~DFG~a~~~~~~~-~~~  271 (399)
                      |+.+ ++.+++ ......+++..+..++.||+.||.|||++|||||||||+|||++.++.+||+|||.|+...... ...
T Consensus        82 ~~~~-~~~~~~~~~~~~~l~e~~~~~~~~qil~~L~yLH~~~IiHrDiKpeNIl~~~~~~~kl~DFG~a~~~~~~~~~~~  160 (298)
T d1gz8a_          82 FLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYT  160 (298)
T ss_dssp             CCSE-EHHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECSTTHHHHHCCCSBCTT
T ss_pred             ecCC-chhhhhhhhcccCCCHHHHHHHHHHHHHHHHHhhcCCEEccccCchheeecccCcceeccCCcceeccCCcccce
Confidence            9976 455444 4456779999999999999999999999999999999999999999999999999998765433 344


Q ss_pred             cCCCCcccccccccCCCCC-CChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhccCC----------------CCC
Q 015868          272 AETGTYRWMAPEVIEHKPY-DYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKSLR----------------PTI  334 (399)
Q Consensus       272 ~~~gt~~y~aPE~l~~~~~-~~~~Dv~slG~vl~elltg~~P~~~~~~~~~~~~~~~~~~~----------------~~~  334 (399)
                      ...||+.|+|||++....+ +.++||||+||++|+|++|+.||.+.+..+...........                +..
T Consensus       161 ~~~gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~  240 (298)
T d1gz8a_         161 HEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSF  240 (298)
T ss_dssp             CCBCCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTTCCTTS
T ss_pred             eecccceeeehhhhccccCCCccccccccchhhhHHhhCCCCCCCCCHHHHHHHHHHhcCCCchhhcccccccccccccc
Confidence            5579999999999877664 78999999999999999999999998877665554321110                001


Q ss_pred             -----------CCCCcHHHHHHHHHHhhhcCCCCCCHHHHHH
Q 015868          335 -----------PKHAHPRLAELLERCWQHDPTQRPNFSQITD  365 (399)
Q Consensus       335 -----------~~~~~~~l~~ll~~cl~~dP~~Rps~~ell~  365 (399)
                                 ...+++++.+||.+||+.||++|||+.|+++
T Consensus       241 ~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~t~~ell~  282 (298)
T d1gz8a_         241 PKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALA  282 (298)
T ss_dssp             CCCCCCCHHHHSTTCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             ccccccchhhhccCCCHHHHHHHHHHccCChhHCcCHHHHhC
Confidence                       1356789999999999999999999999976

>d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK6
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=9.7e-52  Score=392.28  Aligned_cols=251  Identities=22%  Similarity=0.376  Sum_probs=212.7

Q ss_pred             ccccceeceeceeCceEEEEEEEC---CeeEEEEEecCCCCCHHHHHHHHHHHHHHHhc---CCCceeeEEeEEec----
Q 015868          115 AKQLKIECKVASGSYGDLYKGTYC---SQEVAIKVLKPECVNTEMLKEFSQEVYIMRKI---RHKNVVQFIGACTR----  184 (399)
Q Consensus       115 ~~~~~i~~~lg~G~~g~Vy~~~~~---~~~vAvK~~~~~~~~~~~~~~~~~Ei~~l~~l---~h~nIv~~~~~~~~----  184 (399)
                      .++|++.++||+|+||+||+|++.   ++.||||+++...........+.+|+.+|+.+   +||||++++++|..    
T Consensus         6 ~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~~~~   85 (305)
T d1blxa_           6 DQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTD   85 (305)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECS
T ss_pred             cCCEEEEEEEecccCeEEEEEEEECCCCEEEEEEEEehhhccchHHHHHHHHHHHHHHHhhcCCCCcceeeeeecccccc
Confidence            468999999999999999999973   56799999975433333334566777777766   79999999999853    


Q ss_pred             -CCcEEEEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceeecCCCcEEEeeccceee
Q 015868          185 -PPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARV  263 (399)
Q Consensus       185 -~~~~~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~giiHrDlkp~NILl~~~~~vkl~DFG~a~~  263 (399)
                       ...++++||++.++++..........+++..++.++.|++.||+|||++||+||||||+|||++.++.+||+|||+++.
T Consensus        86 ~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~ivHrDiKp~NILi~~~~~~kl~dfg~~~~  165 (305)
T d1blxa_          86 RETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLARI  165 (305)
T ss_dssp             SEEEEEEEEECCSCBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECSCCSCCC
T ss_pred             cCceEEEEEEeccCCchhhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEEecCCCccEEEEcCCCCeeecchhhhhh
Confidence             3468999999998777766666677899999999999999999999999999999999999999999999999999987


Q ss_pred             ccCCCccccCCCCcccccccccCCCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhccC-------------
Q 015868          264 QAQSGVMTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKSL-------------  330 (399)
Q Consensus       264 ~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~Dv~slG~vl~elltg~~P~~~~~~~~~~~~~~~~~~-------------  330 (399)
                      ...........||+.|+|||++.+.+|+.++||||+||++|||+||+.||.+.++.+....+.....             
T Consensus       166 ~~~~~~~~~~~gT~~Y~APE~~~~~~y~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~  245 (305)
T d1blxa_         166 YSFQMALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRDVAL  245 (305)
T ss_dssp             CCGGGGGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCGGGSCTTCSS
T ss_pred             hcccccCCCcccChhhcCcchhcCCCCChhehhhchHHHHHHHHHCCCCCCCCCHHHHHHHHHHhhCCCchhcccccccc
Confidence            7666666778899999999999999999999999999999999999999999888776655443110             


Q ss_pred             ------------CCCCCCCCcHHHHHHHHHHhhhcCCCCCCHHHHHH
Q 015868          331 ------------RPTIPKHAHPRLAELLERCWQHDPTQRPNFSQITD  365 (399)
Q Consensus       331 ------------~~~~~~~~~~~l~~ll~~cl~~dP~~Rps~~ell~  365 (399)
                                  .+..+..+++.+.+||.+||+.||++|||+.|+++
T Consensus       246 ~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~sa~e~L~  292 (305)
T d1blxa_         246 PRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS  292 (305)
T ss_dssp             CGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred             hhhhhccccccchhhccccCCHHHHHHHHHHCcCChhHCcCHHHHhc
Confidence                        01234567899999999999999999999999865

>d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 7, CDK7
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1e-50  Score=384.44  Aligned_cols=245  Identities=27%  Similarity=0.373  Sum_probs=202.3

Q ss_pred             eeceeceeCceEEEEEEE--CCeeEEEEEecCCCCC---HHHHHHHHHHHHHHHhcCCCceeeEEeEEecCCcEEEEEec
Q 015868          120 IECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVN---TEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVTEF  194 (399)
Q Consensus       120 i~~~lg~G~~g~Vy~~~~--~~~~vAvK~~~~~~~~---~~~~~~~~~Ei~~l~~l~h~nIv~~~~~~~~~~~~~lV~E~  194 (399)
                      ..+.||+|+||+||+|++  +++.||||+++.....   ....+.+.+|+.+|++++||||+++++++..+..+|+||||
T Consensus         2 ~l~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~~~~~~~ivmE~   81 (299)
T d1ua2a_           2 KLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISLVFDF   81 (299)
T ss_dssp             EEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCEEEEEC
T ss_pred             cceEeccCcCeEEEEEEECCCCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhCCCCCEeEEEeeeccCCceeehhhh
Confidence            357899999999999987  5789999999754322   22235789999999999999999999999999999999999


Q ss_pred             CCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceeecCCCcEEEeeccceeeccCCC-ccccC
Q 015868          195 MARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSG-VMTAE  273 (399)
Q Consensus       195 ~~ggsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~giiHrDlkp~NILl~~~~~vkl~DFG~a~~~~~~~-~~~~~  273 (399)
                      +.++++..+. .....+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||.++...... .....
T Consensus        82 ~~~~~~~~~~-~~~~~l~~~~~~~~~~qil~aL~~lH~~~iiHrDiKp~NIli~~~~~~KL~DFG~a~~~~~~~~~~~~~  160 (299)
T d1ua2a_          82 METDLEVIIK-DNSLVLTPSHIKAYMLMTLQGLEYLHQHWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYTHQ  160 (299)
T ss_dssp             CSEEHHHHHT-TCCSSCCSSHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECCCGGGSTTTSCCCCCCCS
T ss_pred             hcchHHhhhh-hcccCCCHHHHHHHHHHHHHHHHHhhccceecccCCcceEEecCCCccccccCccccccCCCcccccce
Confidence            9886665544 456779999999999999999999999999999999999999999999999999998655433 33445


Q ss_pred             CCCcccccccccCC-CCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhccCCC--------------------
Q 015868          274 TGTYRWMAPEVIEH-KPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKSLRP--------------------  332 (399)
Q Consensus       274 ~gt~~y~aPE~l~~-~~~~~~~Dv~slG~vl~elltg~~P~~~~~~~~~~~~~~~~~~~~--------------------  332 (399)
                      .||+.|+|||++.+ ..|+.++|||||||++|||+||.+||.+.+..+....+......|                    
T Consensus       161 ~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~l~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (299)
T d1ua2a_         161 VVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDYVTFKSF  240 (299)
T ss_dssp             CCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSSSTTSSTTCCCCCCC
T ss_pred             ecChhhccHHHHccCCCCChhhhhhhcchHHHHHHhCcCCCCCCCHHHHHHHHHHhcCCCChhhccchhccchhhhhccC
Confidence            79999999999865 468999999999999999999999999988877665544311100                    


Q ss_pred             -CC-----CCCCcHHHHHHHHHHhhhcCCCCCCHHHHHH
Q 015868          333 -TI-----PKHAHPRLAELLERCWQHDPTQRPNFSQITD  365 (399)
Q Consensus       333 -~~-----~~~~~~~l~~ll~~cl~~dP~~Rps~~ell~  365 (399)
                       ..     .+..++++.+||.+||+.||++|||++|+++
T Consensus       241 ~~~~~~~~~~~~s~~~~dll~~~L~~dP~~R~sa~e~L~  279 (299)
T d1ua2a_         241 PGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALK  279 (299)
T ss_dssp             CCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHT
T ss_pred             CCCChHHhcccCCHHHHHHHHHHccCChhhCcCHHHHhC
Confidence             01     1356889999999999999999999999875

>d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Type I TGF-beta receptor R4
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1e-50  Score=385.06  Aligned_cols=255  Identities=27%  Similarity=0.511  Sum_probs=207.3

Q ss_pred             ccccceeceeceeCceEEEEEEECCeeEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCceeeEEeEEecCC----cEEE
Q 015868          115 AKQLKIECKVASGSYGDLYKGTYCSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPP----NLCI  190 (399)
Q Consensus       115 ~~~~~i~~~lg~G~~g~Vy~~~~~~~~vAvK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~nIv~~~~~~~~~~----~~~l  190 (399)
                      .++|.+.++||+|+||+||+|++.++.||||+++..   .........|+..+.+++||||+++++++....    .+|+
T Consensus         2 ~~~~~l~~~iG~G~fg~Vy~~~~~g~~vAvK~~~~~---~~~~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~~~~~~~~l   78 (303)
T d1vjya_           2 ARTIVLQESIGKGRFGEVWRGKWRGEEVAVKIFSSR---EERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWL   78 (303)
T ss_dssp             GGGEEEEEEEECCSSSEEEEEEETTEEEEEEEECGG---GHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEE
T ss_pred             CcEEEEEEEEeeCCCeEEEEEEECCEEEEEEEECcc---chhHHHHHHHHHHHhhCCCCcCcceEEEEEeCCCcceEEEE
Confidence            357899999999999999999999999999999743   222222334555556789999999999997643    5899


Q ss_pred             EEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH--------CCcccCCCCCCceeecCCCcEEEeecccee
Q 015868          191 VTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQ--------NNIIHRDLKTANLLMDENGVVKVADFGVAR  262 (399)
Q Consensus       191 V~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~--------~giiHrDlkp~NILl~~~~~vkl~DFG~a~  262 (399)
                      ||||+++|+|.+++++  ..+++..+++++.|++.||+|||+        +||+||||||+|||++.++.+||+|||+++
T Consensus        79 v~Ey~~~g~L~~~l~~--~~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~~~Kl~DFGl~~  156 (303)
T d1vjya_          79 VSDYHEHGSLFDYLNR--YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAV  156 (303)
T ss_dssp             EEECCTTCBHHHHHHH--CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCCTTCE
T ss_pred             EEecccCCCHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEcCCCCeEEEecCccc
Confidence            9999999999999976  358999999999999999999996        699999999999999999999999999998


Q ss_pred             eccCCC-----ccccCCCCcccccccccCCCC------CCChhhHHHHHHHHHHHHcCCCCCCC---------------C
Q 015868          263 VQAQSG-----VMTAETGTYRWMAPEVIEHKP------YDYKADVFSFGIALWELLTGELPYAG---------------L  316 (399)
Q Consensus       263 ~~~~~~-----~~~~~~gt~~y~aPE~l~~~~------~~~~~Dv~slG~vl~elltg~~P~~~---------------~  316 (399)
                      ......     ......||+.|+|||.+.+..      ++.++|||||||++|||+||..||..               .
T Consensus       157 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~~~~~~~~~~~~~~~~~~  236 (303)
T d1vjya_         157 RHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDP  236 (303)
T ss_dssp             EEETTTTEECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCSSC
T ss_pred             cccCCCcceeccccceecccCcCChhhccccccccCCCcCcchhhhhhHHHHHHHhhCCCCCCcccccccchhhcccccc
Confidence            765433     223457899999999997653      56789999999999999999877632               1


Q ss_pred             CHHHHHHHHHhccCCCCCCCCC-----cHHHHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHH
Q 015868          317 TPLQAAVGVVQKSLRPTIPKHA-----HPRLAELLERCWQHDPTQRPNFSQITDILKQMMKEV  374 (399)
Q Consensus       317 ~~~~~~~~~~~~~~~~~~~~~~-----~~~l~~ll~~cl~~dP~~Rps~~ell~~L~~l~~~~  374 (399)
                      ..............+|.+|...     ...+.+|+.+||+.||++|||+.||++.|+++.++.
T Consensus       237 ~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ei~~~L~~i~~~~  299 (303)
T d1vjya_         237 SVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQQE  299 (303)
T ss_dssp             CHHHHHHHHTTSCCCCCCCGGGGGCHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred             hHHHHHHHHhccccCCCCCcccCChHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHHHhc
Confidence            2333344445556667766543     346999999999999999999999999999987653

>d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: (Plasmodium falciparum) [TaxId: 5833]

Probab=100.00  E-value=1.7e-50  Score=380.44  Aligned_cols=249  Identities=23%  Similarity=0.376  Sum_probs=209.2

Q ss_pred             cccceeceeceeCceEEEEEEE-CCeeEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCceeeEEeEEecCCcEEEEEec
Q 015868          116 KQLKIECKVASGSYGDLYKGTY-CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVTEF  194 (399)
Q Consensus       116 ~~~~i~~~lg~G~~g~Vy~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~nIv~~~~~~~~~~~~~lV~E~  194 (399)
                      ++|++.++||+|+||.||+|++ +++.||||+++....+....+.+.+|+.+|++++||||+++++++..++..+++||+
T Consensus         2 ~~Y~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~i~~e~   81 (286)
T d1ob3a_           2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEH   81 (286)
T ss_dssp             CSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred             CCceeccEEecCCCcEEEEEEeCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEeeeeecccCCceeEEEEe
Confidence            5899999999999999999988 468999999987654444567899999999999999999999999999999999999


Q ss_pred             CCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceeecCCCcEEEeeccceeeccCCCc-cccC
Q 015868          195 MARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGV-MTAE  273 (399)
Q Consensus       195 ~~ggsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~giiHrDlkp~NILl~~~~~vkl~DFG~a~~~~~~~~-~~~~  273 (399)
                      +.++.+..+ ....+.+++..+..++.||+.||+|||+.||+||||||+|||++.++.+|++|||.+........ ....
T Consensus        82 ~~~~~~~~~-~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~IvHrDiKp~NIll~~~~~~kl~DfG~a~~~~~~~~~~~~~  160 (286)
T d1ob3a_          82 LDQDLKKLL-DVCEGGLESVTAKSFLLQLLNGIAYCHDRRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHE  160 (286)
T ss_dssp             CSEEHHHHH-HTSTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC--------
T ss_pred             ehhhhHHHH-HhhcCCcchhhhHHHHHHHHHHHHHhccCcEEecCCCCceeeEcCCCCEEecccccceecccCcccccee
Confidence            987555554 45568899999999999999999999999999999999999999999999999999987654332 3444


Q ss_pred             CCCcccccccccCCC-CCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhccCC---------------------
Q 015868          274 TGTYRWMAPEVIEHK-PYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKSLR---------------------  331 (399)
Q Consensus       274 ~gt~~y~aPE~l~~~-~~~~~~Dv~slG~vl~elltg~~P~~~~~~~~~~~~~~~~~~~---------------------  331 (399)
                      .+++.|+|||.+.+. .++.++|||||||++|||++|+.||.+.+..+....+......                     
T Consensus       161 ~~~~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (286)
T d1ob3a_         161 IVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYDPNFTV  240 (286)
T ss_dssp             -CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTTCCTTCCC
T ss_pred             cccchhhhHHHHhCCCCCCcceeehhcCcHHHHHHHCCCCCCCCCHHHHHHHHHHhhCCCChhhccchhhhhhccccccc
Confidence            689999999999754 5689999999999999999999999998877765554321110                     


Q ss_pred             ------CCCCCCCcHHHHHHHHHHhhhcCCCCCCHHHHHH
Q 015868          332 ------PTIPKHAHPRLAELLERCWQHDPTQRPNFSQITD  365 (399)
Q Consensus       332 ------~~~~~~~~~~l~~ll~~cl~~dP~~Rps~~ell~  365 (399)
                            +..+..+++++.+||.+||+.||++|||++|+++
T Consensus       241 ~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~s~~ell~  280 (286)
T d1ob3a_         241 YEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALE  280 (286)
T ss_dssp             CCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             ccCcchhhhcccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence                  1123567899999999999999999999999974

>d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Proto-oncogene serine/threonine-protein kinase Pim-1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.6e-51  Score=385.14  Aligned_cols=240  Identities=24%  Similarity=0.463  Sum_probs=204.8

Q ss_pred             cccceeceeceeCceEEEEEEE--CCeeEEEEEecCCCCCH----HHHHHHHHHHHHHHhcC--CCceeeEEeEEecCCc
Q 015868          116 KQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVNT----EMLKEFSQEVYIMRKIR--HKNVVQFIGACTRPPN  187 (399)
Q Consensus       116 ~~~~i~~~lg~G~~g~Vy~~~~--~~~~vAvK~~~~~~~~~----~~~~~~~~Ei~~l~~l~--h~nIv~~~~~~~~~~~  187 (399)
                      ++|++.+.||+|+||.||+|++  +++.||||+++......    .....+.+|+.+|++++  ||||+++++++..+..
T Consensus         4 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~~~~~   83 (273)
T d1xwsa_           4 SQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDS   83 (273)
T ss_dssp             TTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECSSE
T ss_pred             CeEEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEEEEEEeeCCe
Confidence            5899999999999999999998  47899999987542211    11234678999999997  8999999999999999


Q ss_pred             EEEEEecCCC-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceeecC-CCcEEEeeccceeecc
Q 015868          188 LCIVTEFMAR-GSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDE-NGVVKVADFGVARVQA  265 (399)
Q Consensus       188 ~~lV~E~~~g-gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~giiHrDlkp~NILl~~-~~~vkl~DFG~a~~~~  265 (399)
                      .++||||+.+ +++.+++.. ...+++..++.++.||+.||+|||++||+||||||+|||++. ++.+||+|||+|+...
T Consensus        84 ~~lv~e~~~~~~~l~~~~~~-~~~l~e~~~~~~~~qi~~al~~lH~~~iiHrDiKp~NIll~~~~~~vkl~DFG~a~~~~  162 (273)
T d1xwsa_          84 FVLILERPEPVQDLFDFITE-RGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLK  162 (273)
T ss_dssp             EEEEEECCSSEEEHHHHHHH-HCSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEETTTTEEEECCCTTCEECC
T ss_pred             EEEEEEeccCcchHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCcccceEEecCCCeEEECccccceecc
Confidence            9999999976 588888866 467999999999999999999999999999999999999985 4799999999998654


Q ss_pred             CCCccccCCCCcccccccccCCCCC-CChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhccCCCCCCCCCcHHHHH
Q 015868          266 QSGVMTAETGTYRWMAPEVIEHKPY-DYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKSLRPTIPKHAHPRLAE  344 (399)
Q Consensus       266 ~~~~~~~~~gt~~y~aPE~l~~~~~-~~~~Dv~slG~vl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~  344 (399)
                      .. ..+...||+.|+|||++.+..+ +.++|||||||++|+|+||+.||...+.      ...  ....++..+|+++.+
T Consensus       163 ~~-~~~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~------i~~--~~~~~~~~~s~~~~~  233 (273)
T d1xwsa_         163 DT-VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEE------IIR--GQVFFRQRVSSECQH  233 (273)
T ss_dssp             SS-CBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHH------HHH--CCCCCSSCCCHHHHH
T ss_pred             cc-cccccccCCCcCCHHHHcCCCCCCcccccccceeeehhHhhCCCCCCCchH------Hhh--cccCCCCCCCHHHHH
Confidence            43 4556789999999999987765 5678999999999999999999976321      122  234567789999999


Q ss_pred             HHHHHhhhcCCCCCCHHHHHH
Q 015868          345 LLERCWQHDPTQRPNFSQITD  365 (399)
Q Consensus       345 ll~~cl~~dP~~Rps~~ell~  365 (399)
                      ||.+||+.||++|||++|+++
T Consensus       234 li~~~L~~dp~~R~s~~eil~  254 (273)
T d1xwsa_         234 LIRWCLALRPSDRPTFEEIQN  254 (273)
T ss_dssp             HHHHHTCSSGGGSCCHHHHHT
T ss_pred             HHHHHccCCHhHCcCHHHHhc
Confidence            999999999999999999976

>d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38-gamma
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.2e-49  Score=381.59  Aligned_cols=256  Identities=27%  Similarity=0.408  Sum_probs=212.5

Q ss_pred             CceeecccccceeceeceeCceEEEEEEE--CCeeEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCceeeEEeEEecCC
Q 015868          109 DVWEIDAKQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPP  186 (399)
Q Consensus       109 ~~~~i~~~~~~i~~~lg~G~~g~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~nIv~~~~~~~~~~  186 (399)
                      ..|++ .++|++.++||+|+||.||+|++  +++.||||+++....+....+.+.+|+.+|++++||||++++++|...+
T Consensus        12 ~~~~~-~~~Y~~i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~~   90 (346)
T d1cm8a_          12 TAWEV-RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDE   90 (346)
T ss_dssp             SEECC-BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCS
T ss_pred             ceeec-CCcEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEchhhcChHHHHHHHHHHHHHHhcCCCCeeEEEEEeccCc
Confidence            45776 57999999999999999999997  4899999999877667777889999999999999999999999997654


Q ss_pred             ------cEEEEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceeecCCCcEEEeeccc
Q 015868          187 ------NLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGV  260 (399)
Q Consensus       187 ------~~~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~giiHrDlkp~NILl~~~~~vkl~DFG~  260 (399)
                            .+|+||||+ +.+|..+++.  +.+++..++.++.||+.||.|||++||+||||||+|||++.++.+|++|||.
T Consensus        91 ~~~~~~~~~lv~e~~-~~~l~~~~~~--~~l~~~~~~~~~~qi~~aL~~LH~~~IiHrDiKp~NIL~~~~~~~kl~Dfg~  167 (346)
T d1cm8a_          91 TLDDFTDFYLVMPFM-GTDLGKLMKH--EKLGEDRIQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAVNEDCELKILDFGL  167 (346)
T ss_dssp             STTTCCCCEEEEECC-SEEHHHHHHH--CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTT
T ss_pred             cccccceEEEEEecc-cccHHHHHHh--ccccHHHHHHHHHHHHHHHHHHHhCCCcccccCcchhhcccccccccccccc
Confidence                  479999999 5588887754  5699999999999999999999999999999999999999999999999999


Q ss_pred             eeeccCCCccccCCCCcccccccccCC-CCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhccC---------
Q 015868          261 ARVQAQSGVMTAETGTYRWMAPEVIEH-KPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKSL---------  330 (399)
Q Consensus       261 a~~~~~~~~~~~~~gt~~y~aPE~l~~-~~~~~~~Dv~slG~vl~elltg~~P~~~~~~~~~~~~~~~~~~---------  330 (399)
                      ++....  ..+...||+.|+|||++.+ ..++.++||||+||++|+|++|+.||.+.+.............         
T Consensus       168 a~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  245 (346)
T d1cm8a_         168 ARQADS--EMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQR  245 (346)
T ss_dssp             CEECCS--SCCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHT
T ss_pred             eeccCC--ccccccccccccCHHHHcCCCCCCccchhhcchHHHHHHHHCcCCCCCCChHHHHHHHHhccCCCcHHHHhh
Confidence            986544  3566789999999999876 4578999999999999999999999998876655443322110         


Q ss_pred             --------------------CCCCCCCCcHHHHHHHHHHhhhcCCCCCCHHHHHHH--HHHH
Q 015868          331 --------------------RPTIPKHAHPRLAELLERCWQHDPTQRPNFSQITDI--LKQM  370 (399)
Q Consensus       331 --------------------~~~~~~~~~~~l~~ll~~cl~~dP~~Rps~~ell~~--L~~l  370 (399)
                                          .+.+...+++++.+||.+||+.||.+|||+.|+++.  ++++
T Consensus       246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~eiL~Hp~f~~~  307 (346)
T d1cm8a_         246 LQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESL  307 (346)
T ss_dssp             CSCHHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTT
T ss_pred             hcchhhhhhhccCCcccccchHHhccCCCHHHHHHHHHHCcCChhHCcCHHHHhcChhhCcC
Confidence                                112335678999999999999999999999999873  4443

>d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=1e-48  Score=370.55  Aligned_cols=255  Identities=24%  Similarity=0.349  Sum_probs=208.1

Q ss_pred             cccceeceeceeCceEEEEEEE--CCeeEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCc-eeeEEeEEecCCcEEEEE
Q 015868          116 KQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKN-VVQFIGACTRPPNLCIVT  192 (399)
Q Consensus       116 ~~~~i~~~lg~G~~g~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~n-Iv~~~~~~~~~~~~~lV~  192 (399)
                      ++|++.++||+|+||.||+|++  +++.||||++......    .++.+|+.+++.++|+| |+.+.+++..++..++||
T Consensus         7 ~rY~l~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~----~~~~~E~~i~~~l~~~~~i~~~~~~~~~~~~~~ivm   82 (299)
T d1ckia_           7 NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH----PQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVM   82 (299)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEESCTTS----CCHHHHHHHHHHSTTSTTCCCEEEEEEETTEEEEEE
T ss_pred             CEEEEeEEEeeCCCcEEEEEEECCCCCEEEEEEEchhccC----HHHHHHHHHHHHccCCCcccEEEEEEecCCEEEEEE
Confidence            5799999999999999999997  4789999998764322    35778999999998765 555666667888899999


Q ss_pred             ecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceeecC---CCcEEEeeccceeeccCCC-
Q 015868          193 EFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDE---NGVVKVADFGVARVQAQSG-  268 (399)
Q Consensus       193 E~~~ggsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~giiHrDlkp~NILl~~---~~~vkl~DFG~a~~~~~~~-  268 (399)
                      ||+ ++++.+.+......+++..+..++.|++.||+|||++||+||||||+|||++.   +..+||+|||+|+...... 
T Consensus        83 e~~-~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~~~~~~~~  161 (299)
T d1ckia_          83 ELL-GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDART  161 (299)
T ss_dssp             ECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECCGGGTTCEEECCCSSCEECBCTTT
T ss_pred             EEc-CCchhhhhhhccCCCcHHHHHHHHHHHHHHHHHHHHCCeeeccCCHhhccccccCCCceeeeeccCcceecccccc
Confidence            999 45888888777788999999999999999999999999999999999998764   4579999999998765432 


Q ss_pred             -------ccccCCCCcccccccccCCCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHH---hc---cCCCCCC
Q 015868          269 -------VMTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVV---QK---SLRPTIP  335 (399)
Q Consensus       269 -------~~~~~~gt~~y~aPE~l~~~~~~~~~Dv~slG~vl~elltg~~P~~~~~~~~~~~~~~---~~---~~~~~~~  335 (399)
                             ......||+.|||||.+.+.+++.++|||||||++|||+||+.||.............   ..   ...+..+
T Consensus       162 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  241 (299)
T d1ckia_         162 HQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEVLC  241 (299)
T ss_dssp             CCBCCCCBCCSCCCCSSSCCHHHHTTBCCCHHHHHHHHHHHHHHHHHSSCTTCCCC-------HHHHHHHHHHSCHHHHT
T ss_pred             ccceeccccCCcCCCccccCHHHHhCCCCCChhhEEecCHHHHHHHhCCCcccccchHHHHHHHHHhhcccCCCChhHhc
Confidence                   1234479999999999999999999999999999999999999998766544333221   11   1112234


Q ss_pred             CCCcHHHHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHH
Q 015868          336 KHAHPRLAELLERCWQHDPTQRPNFSQITDILKQMMKEVA  375 (399)
Q Consensus       336 ~~~~~~l~~ll~~cl~~dP~~Rps~~ell~~L~~l~~~~~  375 (399)
                      ..+|+++.+++.+||+.+|++||+++++.+.|+++.....
T Consensus       242 ~~~p~~~~~li~~cl~~~p~~RP~~~~i~~~l~~~~~~~~  281 (299)
T d1ckia_         242 KGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQG  281 (299)
T ss_dssp             TTSCHHHHHHHHHHHHSCTTCCCCHHHHHHHHHHHHHHHT
T ss_pred             cCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHHHHcC
Confidence            6789999999999999999999999999999998876443

>d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

Probab=100.00  E-value=8.3e-49  Score=370.24  Aligned_cols=257  Identities=17%  Similarity=0.276  Sum_probs=215.3

Q ss_pred             cccccceeceeceeCceEEEEEEE--CCeeEEEEEecCCCCCHHHHHHHHHHHHHHHhcCC-CceeeEEeEEecCCcEEE
Q 015868          114 DAKQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRH-KNVVQFIGACTRPPNLCI  190 (399)
Q Consensus       114 ~~~~~~i~~~lg~G~~g~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~Ei~~l~~l~h-~nIv~~~~~~~~~~~~~l  190 (399)
                      -.++|++.++||+|+||.||+|++  +++.||||+++.....    ..+.+|++.++.+.| +|++.+++++..+...++
T Consensus         3 ig~~Y~i~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~----~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~~   78 (293)
T d1csna_           3 VGVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDA----PQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVL   78 (293)
T ss_dssp             ETTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTTS----CCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEE
T ss_pred             CCCceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEccccCc----HHHHHHHHHHHHhcCCCCCCEEEEEeecCCccEE
Confidence            357899999999999999999997  5789999998654322    346678899999975 899999999999999999


Q ss_pred             EEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceeecC-----CCcEEEeeccceeecc
Q 015868          191 VTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDE-----NGVVKVADFGVARVQA  265 (399)
Q Consensus       191 V~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~giiHrDlkp~NILl~~-----~~~vkl~DFG~a~~~~  265 (399)
                      ||||+ +++|.+++......++...+..++.|++.||.|||++||+||||||+|||++.     ++.+||+|||+|+...
T Consensus        79 vme~~-~~~l~~~~~~~~~~~~~~~~~~i~~q~~~~l~~lH~~giiHrDiKp~Nili~~~~~~~~~~vkl~DFG~a~~~~  157 (293)
T d1csna_          79 VIDLL-GPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYR  157 (293)
T ss_dssp             EEECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECCSSSTTTTCEEECCCTTCEESB
T ss_pred             EEEec-CCCHHHHHHhhccchhhHHHHHHHHHHHHHHHHHHHCCceeccCCccceeecCcccccCCceEEcccceeEEcc
Confidence            99999 67999999887788999999999999999999999999999999999999974     5789999999998754


Q ss_pred             CCC--------ccccCCCCcccccccccCCCCCCChhhHHHHHHHHHHHHcCCCCCCCCCH---HHHHHHHHhc---cCC
Q 015868          266 QSG--------VMTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPYAGLTP---LQAAVGVVQK---SLR  331 (399)
Q Consensus       266 ~~~--------~~~~~~gt~~y~aPE~l~~~~~~~~~Dv~slG~vl~elltg~~P~~~~~~---~~~~~~~~~~---~~~  331 (399)
                      ...        ......||+.|||||++.+..++.++||||||+++|||+||+.||.+...   .+....+...   ...
T Consensus       158 ~~~~~~~~~~~~~~~~~GT~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~i~~~~~~~~~  237 (293)
T d1csna_         158 DPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQSTPL  237 (293)
T ss_dssp             CTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHHHHSCH
T ss_pred             cCccccceeecccCceEEchhhcCHHHhcCCCCChHHHHHHhhHHHHHHHhCCCcCCCccchhHHHHHHHHHhccCCCCh
Confidence            321        12334699999999999999999999999999999999999999976543   2222222111   112


Q ss_pred             CCCCCCCcHHHHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHH
Q 015868          332 PTIPKHAHPRLAELLERCWQHDPTQRPNFSQITDILKQMMKEVA  375 (399)
Q Consensus       332 ~~~~~~~~~~l~~ll~~cl~~dP~~Rps~~ell~~L~~l~~~~~  375 (399)
                      +.+++.+|+++.+++..|+..+|++||+++.+.+.|+++++...
T Consensus       238 ~~l~~~~p~~l~~ii~~~~~~~~~~rP~y~~l~~~l~~~~~~~~  281 (293)
T d1csna_         238 RELCAGFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKVLERLN  281 (293)
T ss_dssp             HHHTTTSCHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHHTT
T ss_pred             HHhcCCCCHHHHHHHHHHhcCCcccCcCHHHHHHHHHHHHHHcC
Confidence            23446788999999999999999999999999999998876553

>d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase Erk2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.3e-48  Score=375.47  Aligned_cols=251  Identities=24%  Similarity=0.412  Sum_probs=204.6

Q ss_pred             ceeecccccceeceeceeCceEEEEEEE--CCeeEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCceeeEEeEEecCC-
Q 015868          110 VWEIDAKQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPP-  186 (399)
Q Consensus       110 ~~~i~~~~~~i~~~lg~G~~g~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~nIv~~~~~~~~~~-  186 (399)
                      +|+|. ++|++.++||+|+||+||+|.+  +++.||||+++... .....+.+.+|+.+|++++||||+++++++.... 
T Consensus         3 ~~~i~-~rY~~~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~-~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~   80 (345)
T d1pmea_           3 VFDVG-PRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFE-HQTYCQRTLREIKILLRFRHENIIGINDIIRAPTI   80 (345)
T ss_dssp             CCCCC-TTEEEEEECC---CCCEEEEEETTTCSEEEEEEECCTT-CHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSST
T ss_pred             ccCcC-CCeEEEEEEeeccCeEEEEEEECCCCcEEEEEEEehhc-ChHHHHHHHHHHHHHHHcCCCCCCcEEEEEeeccc
Confidence            45554 4699999999999999999987  58999999997643 4556678999999999999999999999996543 


Q ss_pred             ----cEEEEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceeecCCCcEEEeecccee
Q 015868          187 ----NLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVAR  262 (399)
Q Consensus       187 ----~~~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~giiHrDlkp~NILl~~~~~vkl~DFG~a~  262 (399)
                          .+|+++ ++.||+|.+++..  ..+++..++.++.||+.||+|||++|||||||||+|||++.++.+||+|||+++
T Consensus        81 ~~~~~~~l~~-~~~~g~L~~~l~~--~~l~~~~i~~i~~qil~al~yLH~~~iiHRDIKp~NILl~~~~~~kl~DfG~a~  157 (345)
T d1pmea_          81 EQMKDVYLVT-HLMGADLYKLLKT--QHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLAR  157 (345)
T ss_dssp             TTCCCEEEEE-ECCCEEHHHHHHH--CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCE
T ss_pred             cccceEEEEE-eecCCchhhhhhc--CCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCCcceEEECCCCCEEEcccCcee
Confidence                355555 5668899999975  469999999999999999999999999999999999999999999999999998


Q ss_pred             eccCCC----ccccCCCCcccccccccC-CCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhccCCC-----
Q 015868          263 VQAQSG----VMTAETGTYRWMAPEVIE-HKPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKSLRP-----  332 (399)
Q Consensus       263 ~~~~~~----~~~~~~gt~~y~aPE~l~-~~~~~~~~Dv~slG~vl~elltg~~P~~~~~~~~~~~~~~~~~~~~-----  332 (399)
                      ......    ......||+.|+|||++. +..++.++||||+||++|+|++|+.||.+.+..............+     
T Consensus       158 ~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~eml~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~  237 (345)
T d1pmea_         158 VADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDL  237 (345)
T ss_dssp             ECCGGGCBCCTTCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHH
T ss_pred             eccCCCccceeeccccccceechHHHhhcCCCCCchhhhhccCceehHHhhCCCCCCCCCHHHHHHHHhhhccCCChhhh
Confidence            654432    234456899999999985 4567899999999999999999999998877655444332211000     


Q ss_pred             ------------------------CCCCCCcHHHHHHHHHHhhhcCCCCCCHHHHHH
Q 015868          333 ------------------------TIPKHAHPRLAELLERCWQHDPTQRPNFSQITD  365 (399)
Q Consensus       333 ------------------------~~~~~~~~~l~~ll~~cl~~dP~~Rps~~ell~  365 (399)
                                              .....+++++.+|+.+||+.||.+|||++|+++
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~ta~e~L~  294 (345)
T d1pmea_         238 NCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALA  294 (345)
T ss_dssp             HTCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred             hhhhhhhhhcccccCCccCCCCHHHhCCCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence                                    112457889999999999999999999999986

>d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 9, CDK9
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.9e-48  Score=369.55  Aligned_cols=250  Identities=25%  Similarity=0.391  Sum_probs=203.5

Q ss_pred             ccccceeceeceeCceEEEEEEE--CCeeEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCceeeEEeEEec--------
Q 015868          115 AKQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTR--------  184 (399)
Q Consensus       115 ~~~~~i~~~lg~G~~g~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~nIv~~~~~~~~--------  184 (399)
                      .++|++.++||+|+||+||+|++  +++.||||++............+.+|+.+|++++||||+++++++..        
T Consensus         9 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~~~~~~~   88 (318)
T d3blha1           9 VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRC   88 (318)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC----CTTSSCHHHHHHHHHHHHCCCTTBCCEEEEEEC--------
T ss_pred             cCCEEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHHhcCCCccceEeeeeccccccccc
Confidence            57999999999999999999997  57899999987665555556778899999999999999999999855        


Q ss_pred             CCcEEEEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceeecCCCcEEEeeccceeec
Q 015868          185 PPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQ  264 (399)
Q Consensus       185 ~~~~~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~giiHrDlkp~NILl~~~~~vkl~DFG~a~~~  264 (399)
                      ...+|+||||+.++.+. ........+++..++.++.|++.||.|||++||+||||||+|||++.++.+||+|||+++..
T Consensus        89 ~~~~~iv~e~~~~~~~~-~~~~~~~~~~~~~~~~i~~qil~~l~~lH~~~ivHrDlKp~NILl~~~~~~kl~dfg~~~~~  167 (318)
T d3blha1          89 KGSIYLVFDFCEHDLAG-LLSNVLVKFTLSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAF  167 (318)
T ss_dssp             --CEEEEEECCCEEHHH-HHTCTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCEEECCCTTCEEC
T ss_pred             CceEEEEEeccCCCccc-hhhhcccccccHHHHHHHHHHHHHHHHhccCCEEecCcCchheeecCCCcEEeeecceeeec
Confidence            34689999999875544 45455678999999999999999999999999999999999999999999999999999765


Q ss_pred             cCCC-----ccccCCCCcccccccccCCC-CCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhccCC--CCCC-
Q 015868          265 AQSG-----VMTAETGTYRWMAPEVIEHK-PYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKSLR--PTIP-  335 (399)
Q Consensus       265 ~~~~-----~~~~~~gt~~y~aPE~l~~~-~~~~~~Dv~slG~vl~elltg~~P~~~~~~~~~~~~~~~~~~~--~~~~-  335 (399)
                      ....     ......||+.|+|||++.+. .|+.++||||+||++|||++|+.||.+.+..............  +... 
T Consensus       168 ~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGvil~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~  247 (318)
T d3blha1         168 SLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPEVWP  247 (318)
T ss_dssp             CC-----CCCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTST
T ss_pred             ccccccccccccceecCHHHhhHHHHcCCCCCCcHHHcccCCceeeeHhhCCCCCCCCCHHHHHHHHHHhcCCCChhhcc
Confidence            4322     22334689999999999765 6899999999999999999999999988876665544331111  1100 


Q ss_pred             ---------------------------CCCcHHHHHHHHHHhhhcCCCCCCHHHHHH
Q 015868          336 ---------------------------KHAHPRLAELLERCWQHDPTQRPNFSQITD  365 (399)
Q Consensus       336 ---------------------------~~~~~~l~~ll~~cl~~dP~~Rps~~ell~  365 (399)
                                                 ...++++.+||.+||+.||++|||++|+++
T Consensus       248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~sa~elL~  304 (318)
T d3blha1         248 NVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALN  304 (318)
T ss_dssp             TCCCC-------CCSSCCBCHHHHHHHHHCCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred             ccchhhhhhhhcccccccccchhhhccccCCHHHHHHHHHHCcCChhHCcCHHHHHc
Confidence                                       013678899999999999999999999974

>d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Glycogen synthase kinase-3 beta (Gsk3b)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4e-48  Score=374.49  Aligned_cols=243  Identities=25%  Similarity=0.327  Sum_probs=202.9

Q ss_pred             ccceeceeceeCceEEEEEEE--CCeeEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCceeeEEeEEec------CCcE
Q 015868          117 QLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTR------PPNL  188 (399)
Q Consensus       117 ~~~i~~~lg~G~~g~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~nIv~~~~~~~~------~~~~  188 (399)
                      +|+..++||+|+||+||+|++  +++.||||+++....      ...+|+.+|++++||||++++++|..      ..++
T Consensus        21 ~Y~~~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~------~~~~Ei~il~~l~h~niv~~~~~~~~~~~~~~~~~~   94 (350)
T d1q5ka_          21 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR------FKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYL   94 (350)
T ss_dssp             EEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSS------SCCHHHHHHHHCCCTTBCCEEEEEEEC--CCSCCEE
T ss_pred             CcEeeeEEeeCcCeEEEEEEECCCCCEEEEEEECccch------HHHHHHHHHHhcCCCCCCcEEEEEEecCccCCceEE
Confidence            699999999999999999998  578999999976532      23479999999999999999999853      2347


Q ss_pred             EEEEecCCCCCHHHHHH--hcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceeecCCC-cEEEeeccceeecc
Q 015868          189 CIVTEFMARGSIYDFLH--KQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENG-VVKVADFGVARVQA  265 (399)
Q Consensus       189 ~lV~E~~~ggsL~~~l~--~~~~~l~~~~~~~i~~~i~~~L~~LH~~giiHrDlkp~NILl~~~~-~vkl~DFG~a~~~~  265 (399)
                      ||||||++++.+..+..  .....+++..++.++.||+.||+|||++||+||||||+|||++.++ .+||+|||+++...
T Consensus        95 ~lv~Ey~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~yLH~~~IiHrDiKp~NILl~~~~~~~kl~DFG~a~~~~  174 (350)
T d1q5ka_          95 NLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLV  174 (350)
T ss_dssp             EEEEECCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECTTTCCEEECCCTTCEECC
T ss_pred             EEEEeccCCccHHHHHhhhhccCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCcceEEEecCCCceeEecccchhhcc
Confidence            99999998754443332  3456799999999999999999999999999999999999999775 89999999998877


Q ss_pred             CCCccccCCCCcccccccccCC-CCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcc---------------
Q 015868          266 QSGVMTAETGTYRWMAPEVIEH-KPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKS---------------  329 (399)
Q Consensus       266 ~~~~~~~~~gt~~y~aPE~l~~-~~~~~~~Dv~slG~vl~elltg~~P~~~~~~~~~~~~~~~~~---------------  329 (399)
                      .........||+.|+|||.+.+ ..|+.++||||+||++|||++|+.||...+..+....+....               
T Consensus       175 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~el~~g~~pf~~~~~~~~l~~i~~~~g~~~~~~~~~~~~~~  254 (350)
T d1q5ka_         175 RGEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPNY  254 (350)
T ss_dssp             TTSCCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHCC--
T ss_pred             CCcccccccccccccChHHhhcccCCCcceeecccceEEEehhhCCCCCCCCCHHHHHHHHHHHhCCChHHhhhhhccch
Confidence            6666677789999999999875 578999999999999999999999999888766555443210               


Q ss_pred             ---CCC---------CCCCCCcHHHHHHHHHHhhhcCCCCCCHHHHHH
Q 015868          330 ---LRP---------TIPKHAHPRLAELLERCWQHDPTQRPNFSQITD  365 (399)
Q Consensus       330 ---~~~---------~~~~~~~~~l~~ll~~cl~~dP~~Rps~~ell~  365 (399)
                         ..+         ......++++.+||.+||+.||++|||+.|+++
T Consensus       255 ~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~  302 (350)
T d1q5ka_         255 TEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACA  302 (350)
T ss_dssp             -CCCCCCCCCCCGGGTSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             hhccccccccCchhhhcccCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence               001         112457899999999999999999999999985

>d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK5
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=7.5e-48  Score=362.75  Aligned_cols=249  Identities=23%  Similarity=0.349  Sum_probs=211.3

Q ss_pred             cccceeceeceeCceEEEEEEE--CCeeEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCceeeEEeEEecCCcEEEEEe
Q 015868          116 KQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVTE  193 (399)
Q Consensus       116 ~~~~i~~~lg~G~~g~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~nIv~~~~~~~~~~~~~lV~E  193 (399)
                      ++|++.++||+|+||+||+|++  +++.||||+++...........+.+|+.+|++++||||+++++++......++|+|
T Consensus         2 ~ry~~i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~iv~~   81 (292)
T d1unla_           2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE   81 (292)
T ss_dssp             CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred             CCCEeeeEEecCcCeEEEEEEECCCCcEEEEEEEehhhCChHHHHHHHHHHHHHHhcCcCCEEeeccccccccceeEEee
Confidence            5899999999999999999998  57889999998776666677899999999999999999999999999999999999


Q ss_pred             cCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceeecCCCcEEEeeccceeeccCCC-cccc
Q 015868          194 FMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSG-VMTA  272 (399)
Q Consensus       194 ~~~ggsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~giiHrDlkp~NILl~~~~~vkl~DFG~a~~~~~~~-~~~~  272 (399)
                      ++.++++..++.. .+.+++..+..++.|++.||+|||++||+||||||+|||++.++.+||+|||.++...... ....
T Consensus        82 ~~~~~~l~~~~~~-~~~~~~~~~~~~~~q~~~aL~~lH~~~IvHrDiKP~NIli~~~~~~kl~DFG~a~~~~~~~~~~~~  160 (292)
T d1unla_          82 FCDQDLKKYFDSC-NGDLDPEIVKSFLFQLLKGLGFCHSRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSA  160 (292)
T ss_dssp             CCSEEHHHHHHHT-TTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSCCSCCCS
T ss_pred             ecccccccccccc-ccccchhHHHHHHHHHHHHHHHhhcCCEeeecccCcccccccCCceeeeecchhhcccCCCcccee
Confidence            9999888877754 6788999999999999999999999999999999999999999999999999998766543 3344


Q ss_pred             CCCCcccccccccCCCC-CCChhhHHHHHHHHHHHHcCCCCC-CCCCHHHHHHHHHhcc---------------------
Q 015868          273 ETGTYRWMAPEVIEHKP-YDYKADVFSFGIALWELLTGELPY-AGLTPLQAAVGVVQKS---------------------  329 (399)
Q Consensus       273 ~~gt~~y~aPE~l~~~~-~~~~~Dv~slG~vl~elltg~~P~-~~~~~~~~~~~~~~~~---------------------  329 (399)
                      ..+++.|+|||.+.+.. ++.++|||||||++|||++|..|| .+.+..+....+....                     
T Consensus       161 ~~~~~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (292)
T d1unla_         161 EVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDYKPYP  240 (292)
T ss_dssp             CCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTCTTGGGSTTCCCCC
T ss_pred             eccccchhhhhHhccCCCCCchhhccccchHHHHHhhCCCCCCCCCCHHHHHHHHHhhcCCCChhhhhhhhhcccccccc
Confidence            45788899999987665 689999999999999999999885 4444444333322110                     


Q ss_pred             ------CCCCCCCCCcHHHHHHHHHHhhhcCCCCCCHHHHHH
Q 015868          330 ------LRPTIPKHAHPRLAELLERCWQHDPTQRPNFSQITD  365 (399)
Q Consensus       330 ------~~~~~~~~~~~~l~~ll~~cl~~dP~~Rps~~ell~  365 (399)
                            .....+...++++.+||.+||+.||.+|||++|+++
T Consensus       241 ~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~sa~e~L~  282 (292)
T d1unla_         241 MYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQ  282 (292)
T ss_dssp             CCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred             cccccchhhhccccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence                  112233567899999999999999999999999865

>d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6e-48  Score=372.72  Aligned_cols=254  Identities=24%  Similarity=0.391  Sum_probs=211.6

Q ss_pred             CCCceeecccccceeceeceeCceEEEEEEE--CCeeEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCceeeEEeEEec
Q 015868          107 GTDVWEIDAKQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTR  184 (399)
Q Consensus       107 ~~~~~~i~~~~~~i~~~lg~G~~g~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~nIv~~~~~~~~  184 (399)
                      +.++|++ .++|++.++||+|+||+||+|++  +++.||||+++....+....+.+.+|+.+|++++||||+++++++..
T Consensus        10 ~~~~~~~-~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~   88 (348)
T d2gfsa1          10 NKTIWEV-PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTP   88 (348)
T ss_dssp             SSSEEEE-ETTEEEEEECGGGTTSSEEEEEETTTTEEEEEEECSCTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECS
T ss_pred             CCccccC-CCCeEEEEEEecCCCeEEEEEEECCCCCEEEEEEECchhcChHHHHHHHHHHHHHHhcCCCCeeeEEEEEee
Confidence            3467888 46899999999999999999987  58999999998776677777889999999999999999999999864


Q ss_pred             C-----CcEEEEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceeecCCCcEEEeecc
Q 015868          185 P-----PNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFG  259 (399)
Q Consensus       185 ~-----~~~~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~giiHrDlkp~NILl~~~~~vkl~DFG  259 (399)
                      .     ...+++++++.||+|.+++..  +.+++..++.++.||+.||+|||++||+||||||+|||++.++.+|++|||
T Consensus        89 ~~~~~~~~~~~i~~~~~gg~L~~~~~~--~~l~e~~~~~i~~qil~aL~~LH~~giiHrDiKp~NILi~~~~~~kl~dfg  166 (348)
T d2gfsa1          89 ARSLEEFNDVYLVTHLMGADLNNIVKC--QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFG  166 (348)
T ss_dssp             CSSTTTCCCCEEEEECCSEEHHHHHTT--CCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECCC-
T ss_pred             ccccccCceEEEEEeecCCchhhhccc--ccccHHHHHHHHHHHHHHHHHHHhCCCcccccCCccccccccccccccccc
Confidence            3     234566677789999999954  569999999999999999999999999999999999999999999999999


Q ss_pred             ceeeccCCCccccCCCCcccccccccCCC-CCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhccCCC------
Q 015868          260 VARVQAQSGVMTAETGTYRWMAPEVIEHK-PYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKSLRP------  332 (399)
Q Consensus       260 ~a~~~~~~~~~~~~~gt~~y~aPE~l~~~-~~~~~~Dv~slG~vl~elltg~~P~~~~~~~~~~~~~~~~~~~~------  332 (399)
                      .+.....  ......|++.|+|||.+.+. .++.++|||||||++|+|++|+.||.+.+.......+......+      
T Consensus       167 ~a~~~~~--~~~~~~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ll~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~  244 (348)
T d2gfsa1         167 LARHTDD--EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLK  244 (348)
T ss_dssp             ---CCTG--GGSSSCHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHT
T ss_pred             hhcccCc--ccccccccccccCchhhcCCccCCcccchhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChHHhh
Confidence            9975433  34556789999999997765 46899999999999999999999999887766555443321111      


Q ss_pred             ---------------C--------CCCCCcHHHHHHHHHHhhhcCCCCCCHHHHHH
Q 015868          333 ---------------T--------IPKHAHPRLAELLERCWQHDPTQRPNFSQITD  365 (399)
Q Consensus       333 ---------------~--------~~~~~~~~l~~ll~~cl~~dP~~Rps~~ell~  365 (399)
                                     .        ....+++++.+||.+||+.||.+|||+.|+++
T Consensus       245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~elL~  300 (348)
T d2gfsa1         245 KISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALA  300 (348)
T ss_dssp             TCCCHHHHHHHTTSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             hccchhhhhhhhhcccCCCcchhhhcCCCCHHHHHHHHHHCcCChhhCcCHHHHhc
Confidence                           1        11357899999999999999999999999986

>d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Ribosomal protein S6 kinase alpha 5, Msk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1e-48  Score=374.27  Aligned_cols=252  Identities=22%  Similarity=0.393  Sum_probs=210.6

Q ss_pred             ecccccceeceeceeCceEEEEEEE-----CCeeEEEEEecCCCC--CHHHHHHHHHHHHHHHhcCC-CceeeEEeEEec
Q 015868          113 IDAKQLKIECKVASGSYGDLYKGTY-----CSQEVAIKVLKPECV--NTEMLKEFSQEVYIMRKIRH-KNVVQFIGACTR  184 (399)
Q Consensus       113 i~~~~~~i~~~lg~G~~g~Vy~~~~-----~~~~vAvK~~~~~~~--~~~~~~~~~~Ei~~l~~l~h-~nIv~~~~~~~~  184 (399)
                      +..++|++.++||+|+||.||+|..     +++.||||+++....  +....+.+.+|+.+|++++| |||+++++++..
T Consensus        21 ~~l~~y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~~~  100 (322)
T d1vzoa_          21 VGIENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQT  100 (322)
T ss_dssp             CCGGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEE
T ss_pred             cchhceEEEEEEecCCCeEEEEEEECccCCCCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccCCCeEEEeeeeecc
Confidence            3457899999999999999999986     467899999875321  12234568899999999977 899999999999


Q ss_pred             CCcEEEEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceeecCCCcEEEeeccceeec
Q 015868          185 PPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQ  264 (399)
Q Consensus       185 ~~~~~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~giiHrDlkp~NILl~~~~~vkl~DFG~a~~~  264 (399)
                      ...+++||||+.||+|.+++... +.+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++..
T Consensus       101 ~~~~~~v~e~~~~~~L~~~i~~~-~~~~e~~~~~~~~Qi~~al~~lH~~~ivHrDiKp~Nill~~~~~vkL~DFG~a~~~  179 (322)
T d1vzoa_         101 ETKLHLILDYINGGELFTHLSQR-ERFTEHEVQIYVGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEF  179 (322)
T ss_dssp             TTEEEEEECCCCSCBHHHHHHHH-SCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEESCSSEEEEC
T ss_pred             CCceeeeeecccccHHHHHHHhc-ccccHHHHHHHHHHHHHHHHHhhcCCEEeccCCccceeecCCCCEEEeeccchhhh
Confidence            99999999999999999999764 56789999999999999999999999999999999999999999999999999865


Q ss_pred             cCC--CccccCCCCcccccccccCCC--CCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHh--ccCCCCCCCCC
Q 015868          265 AQS--GVMTAETGTYRWMAPEVIEHK--PYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQ--KSLRPTIPKHA  338 (399)
Q Consensus       265 ~~~--~~~~~~~gt~~y~aPE~l~~~--~~~~~~Dv~slG~vl~elltg~~P~~~~~~~~~~~~~~~--~~~~~~~~~~~  338 (399)
                      ...  .......|++.|+|||.+.+.  .++.++|||||||++|+|++|+.||.+.+..........  ....+.+|..+
T Consensus       180 ~~~~~~~~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~~~~~~~~~~~i~~~~~~~~~~~~~~~  259 (322)
T d1vzoa_         180 VADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPPYPQEM  259 (322)
T ss_dssp             CGGGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHHHHHHHCCCCCCTTS
T ss_pred             cccccccccccccccccchhHHhhcCCcCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcccCCCCCcccC
Confidence            432  234456789999999999765  468899999999999999999999977544332222221  23356678889


Q ss_pred             cHHHHHHHHHHhhhcCCCCCC-----HHHHHH
Q 015868          339 HPRLAELLERCWQHDPTQRPN-----FSQITD  365 (399)
Q Consensus       339 ~~~l~~ll~~cl~~dP~~Rps-----~~ell~  365 (399)
                      ++++.+||.+||+.||.+|||     ++|+++
T Consensus       260 s~~~~~li~~~l~~dP~~R~s~~~~t~~eil~  291 (322)
T d1vzoa_         260 SALAKDLIQRLLMKDPKKRLGCGPRDADEIKE  291 (322)
T ss_dssp             CHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHT
T ss_pred             CHHHHHHHHHHcccCHHHcCCCCcccHHHHHc
Confidence            999999999999999999994     788865

>d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase CK2, alpha subunit
species: Rattus norvegicus [TaxId: 10116]

Probab=100.00  E-value=2.6e-47  Score=365.50  Aligned_cols=242  Identities=18%  Similarity=0.344  Sum_probs=202.2

Q ss_pred             ccccceeceeceeCceEEEEEEE--CCeeEEEEEecCCCCCHHHHHHHHHHHHHHHhcC-CCceeeEEeEEec--CCcEE
Q 015868          115 AKQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIR-HKNVVQFIGACTR--PPNLC  189 (399)
Q Consensus       115 ~~~~~i~~~lg~G~~g~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~Ei~~l~~l~-h~nIv~~~~~~~~--~~~~~  189 (399)
                      .++|++.++||+|+||+||+|++  +++.||||+++...     .+.+.+|+.+|+++. ||||+++++++..  ...++
T Consensus        34 ~d~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~-----~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~~~~~~~  108 (328)
T d3bqca1          34 QDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVK-----KKKIKREIKILENLRGGPNIITLADIVKDPVSRTPA  108 (328)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSSC-----HHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCSEE
T ss_pred             CcCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEECHHH-----HHHHHHHHHHHHhccCCCCCcEEEEEEEecCCCcee
Confidence            46899999999999999999997  48899999997542     357889999999995 9999999999974  45699


Q ss_pred             EEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceeecCCC-cEEEeeccceeeccCCC
Q 015868          190 IVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENG-VVKVADFGVARVQAQSG  268 (399)
Q Consensus       190 lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~giiHrDlkp~NILl~~~~-~vkl~DFG~a~~~~~~~  268 (399)
                      +||||+.+++|..+.    ..+++..+..++.||+.||+|||++||+||||||+|||++.++ .+||+|||+|+......
T Consensus       109 ~v~e~~~~~~L~~~~----~~l~e~~i~~i~~qil~aL~~LH~~gIvHrDiKp~NILi~~~~~~vkl~DFG~a~~~~~~~  184 (328)
T d3bqca1         109 LVFEHVNNTDFKQLY----QTLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQ  184 (328)
T ss_dssp             EEEECCCSCBGGGTT----TSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTTEEEECCGGGCEECCTTC
T ss_pred             EEEeecCCCcHHHHh----cCCCHHHHHHHHHHHHHHHHHHhhcccccccccccceEEcCCCCeeeecccccceeccCCC
Confidence            999999999987653    4689999999999999999999999999999999999998655 69999999998877666


Q ss_pred             ccccCCCCcccccccccCCC-CCCChhhHHHHHHHHHHHHcCCCCCCCCCHHH-HHHHHHh-------------------
Q 015868          269 VMTAETGTYRWMAPEVIEHK-PYDYKADVFSFGIALWELLTGELPYAGLTPLQ-AAVGVVQ-------------------  327 (399)
Q Consensus       269 ~~~~~~gt~~y~aPE~l~~~-~~~~~~Dv~slG~vl~elltg~~P~~~~~~~~-~~~~~~~-------------------  327 (399)
                      ......+|+.|+|||.+.+. .++.++||||+||++|+|++|..||....... .......                   
T Consensus       185 ~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~~l~e~~~g~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~  264 (328)
T d3bqca1         185 EYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELD  264 (328)
T ss_dssp             CCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHTTCCCC
T ss_pred             cccccccCccccCcccccCCCCCCcccchhhhhhhhHHhccCCCCCCCCchhHHHHHHHHHHHCCchhhhhhhhcccccC
Confidence            66777899999999998765 57999999999999999999999997654322 1111100                   


Q ss_pred             ----------------ccCCCCCCCCCcHHHHHHHHHHhhhcCCCCCCHHHHHH
Q 015868          328 ----------------KSLRPTIPKHAHPRLAELLERCWQHDPTQRPNFSQITD  365 (399)
Q Consensus       328 ----------------~~~~~~~~~~~~~~l~~ll~~cl~~dP~~Rps~~ell~  365 (399)
                                      ..........+++++.+||++||+.||.+|||++|+++
T Consensus       265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~e~L~  318 (328)
T d3bqca1         265 PRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAME  318 (328)
T ss_dssp             GGGGGTCCCCCCCCGGGGCCTTTGGGCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             cccchhcccccccchhhcccccccccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence                            00111122347899999999999999999999999975

>d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-jun N-terminal kinase (jnk3s)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6.4e-48  Score=373.79  Aligned_cols=246  Identities=24%  Similarity=0.353  Sum_probs=197.9

Q ss_pred             cccceeceeceeCceEEEEEEE--CCeeEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCceeeEEeEEec------CCc
Q 015868          116 KQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTR------PPN  187 (399)
Q Consensus       116 ~~~~i~~~lg~G~~g~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~nIv~~~~~~~~------~~~  187 (399)
                      ++|++.++||+|+||+||+|.+  +++.||||+++....+......+.+|+.++++++||||++++++|..      ...
T Consensus        17 ~~Y~i~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~~~~~~~   96 (355)
T d2b1pa1          17 KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQD   96 (355)
T ss_dssp             TTEEEEEECSCC--CEEEEEEETTTTEEEEEEEEESTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCCE
T ss_pred             CCeEEEEEeecCcCeEEEEEEECCCCCEEEEEEEChhhcCHHHHHHHHHHHHHHHhcCCCCeeEEEEEEecccccccCce
Confidence            5799999999999999999998  48999999998877777778889999999999999999999999964      367


Q ss_pred             EEEEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceeecCCCcEEEeeccceeeccCC
Q 015868          188 LCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQS  267 (399)
Q Consensus       188 ~~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~giiHrDlkp~NILl~~~~~vkl~DFG~a~~~~~~  267 (399)
                      +|+||||+.++ +.+.+   ...+++..++.++.||+.||.|||++||+||||||+|||++.++.+|++|||.++.....
T Consensus        97 ~~iv~Ey~~~~-l~~~~---~~~~~~~~i~~~~~qil~gl~~LH~~giiHrDlKP~Nil~~~~~~~kl~df~~~~~~~~~  172 (355)
T d2b1pa1          97 VYLVMELMDAN-LCQVI---QMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTS  172 (355)
T ss_dssp             EEEEEECCSEE-HHHHH---TSCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCCCC-------
T ss_pred             eEEEEeccchH-HHHhh---hcCCCHHHHHHHHHHHHHHHHHhhhcccccccCCccccccccccceeeechhhhhccccc
Confidence            89999999774 55544   356899999999999999999999999999999999999999999999999999877776


Q ss_pred             CccccCCCCcccccccccCCCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhccCC----------------
Q 015868          268 GVMTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKSLR----------------  331 (399)
Q Consensus       268 ~~~~~~~gt~~y~aPE~l~~~~~~~~~Dv~slG~vl~elltg~~P~~~~~~~~~~~~~~~~~~~----------------  331 (399)
                      ...+...+|+.|+|||++.+..++.++||||+||++|+|++|+.||.+.+.......+......                
T Consensus       173 ~~~~~~~~t~~y~aPE~l~~~~~~~~~DiwSlG~~l~ell~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~  252 (355)
T d2b1pa1         173 FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNY  252 (355)
T ss_dssp             --------CCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHTTSCHHHHHH
T ss_pred             cccccccccccccChhhhcCCCCCCCcccccccchHHHHhhCCCCCCCCCHHHHHHHHHHhccCCCHHHHHHhhhhHHHH
Confidence            6667778999999999999999999999999999999999999999887765544433211100                


Q ss_pred             ----CC--------------C------CCCCcHHHHHHHHHHhhhcCCCCCCHHHHHH
Q 015868          332 ----PT--------------I------PKHAHPRLAELLERCWQHDPTQRPNFSQITD  365 (399)
Q Consensus       332 ----~~--------------~------~~~~~~~l~~ll~~cl~~dP~~Rps~~ell~  365 (399)
                          +.              .      +...++++.+||.+||..||++|||++|+++
T Consensus       253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~ta~elL~  310 (355)
T d2b1pa1         253 VENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQ  310 (355)
T ss_dssp             HHTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred             hhcCccccccccccccccccccccccccccCCHHHHHHHHHHCcCChhHCcCHHHHhc
Confidence                00              0      0124678999999999999999999999975

>d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Sky1p
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

Probab=100.00  E-value=3.3e-41  Score=326.61  Aligned_cols=246  Identities=19%  Similarity=0.362  Sum_probs=189.7

Q ss_pred             ccccceeceeceeCceEEEEEEE--CCeeEEEEEecCCCCCHHHHHHHHHHHHHHHhcC-----------CCceeeEEeE
Q 015868          115 AKQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIR-----------HKNVVQFIGA  181 (399)
Q Consensus       115 ~~~~~i~~~lg~G~~g~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~Ei~~l~~l~-----------h~nIv~~~~~  181 (399)
                      .++|++.++||+|+||+||+|++  +++.||||+++..   ....+.+.+|+.+++.++           |+||++++++
T Consensus        12 ~~rY~i~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~---~~~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~~~   88 (362)
T d1q8ya_          12 DARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGD---KVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDH   88 (362)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC---HHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEE
T ss_pred             CCcEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEecc---ccchHHHHHHHHHHHHhcchhhhhhhhcCcCceEEEEEE
Confidence            35799999999999999999987  5899999999864   444567888999998875           5789999988


Q ss_pred             Eec--CCcEEEEEecCCCCC-H-HHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH-CCcccCCCCCCceeecCCC-----
Q 015868          182 CTR--PPNLCIVTEFMARGS-I-YDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQ-NNIIHRDLKTANLLMDENG-----  251 (399)
Q Consensus       182 ~~~--~~~~~lV~E~~~ggs-L-~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~-~giiHrDlkp~NILl~~~~-----  251 (399)
                      +..  ....+++++++..+. . ..........+++..++.++.||+.||+|||+ .||+||||||+|||++.++     
T Consensus        89 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qil~al~~lh~~~~IvHrDlKp~NIll~~~~~~~~~  168 (362)
T d1q8ya_          89 FNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENL  168 (362)
T ss_dssp             EEEEETTEEEEEEEECCCCEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECSCCSGGGEEEEEEETTTTE
T ss_pred             eeeccccceeeeeeecccccccccccccccccCCcHHHHHHHHHHHHHHHHHHhhhcCcccccCChhHeeeeccCccccc
Confidence            754  345566666654443 2 22233345778999999999999999999998 8999999999999998665     


Q ss_pred             -cEEEeeccceeeccCCCccccCCCCcccccccccCCCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHH------HHHH
Q 015868          252 -VVKVADFGVARVQAQSGVMTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPYAGLTPLQ------AAVG  324 (399)
Q Consensus       252 -~vkl~DFG~a~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~Dv~slG~vl~elltg~~P~~~~~~~~------~~~~  324 (399)
                       .++++|||.+......  .....||+.|+|||++.+..|+.++|+||+||++++|++|+.||.......      ....
T Consensus       169 ~~~kl~dfg~s~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~pF~~~~~~~~~~~~~~~~~  246 (362)
T d1q8ya_         169 IQIKIADLGNACWYDEH--YTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQ  246 (362)
T ss_dssp             EEEEECCCTTCEETTBC--CCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------CHHHHHHH
T ss_pred             ceeeEeecccccccccc--cccccccccccChhhccccCCCccccccchHHHHHHHHHCCCCCCCCccccccchhHHHHH
Confidence             3999999999865443  355679999999999999999999999999999999999999997543211      0000


Q ss_pred             HHh-----------c---------------c--------------CCCCCCCCCcHHHHHHHHHHhhhcCCCCCCHHHHH
Q 015868          325 VVQ-----------K---------------S--------------LRPTIPKHAHPRLAELLERCWQHDPTQRPNFSQIT  364 (399)
Q Consensus       325 ~~~-----------~---------------~--------------~~~~~~~~~~~~l~~ll~~cl~~dP~~Rps~~ell  364 (399)
                      ...           .               .              .....+...++++.+||.+||..||.+|||+.|++
T Consensus       247 ~~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~Rpta~e~L  326 (362)
T d1q8ya_         247 IIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADAGGLV  326 (362)
T ss_dssp             HHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBCHHHHH
T ss_pred             HHHHhCCCCHHHhhcccccccccccchhhhccccccCCchhhhcccccccCcccCHHHHHHHHHHCCCChhHCcCHHHHh
Confidence            000           0               0              01112234568899999999999999999999997


Q ss_pred             H
Q 015868          365 D  365 (399)
Q Consensus       365 ~  365 (399)
                      +
T Consensus       327 ~  327 (362)
T d1q8ya_         327 N  327 (362)
T ss_dssp             T
T ss_pred             c
Confidence            6

>d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: RIO1-like kinases
domain: Rio2 serine protein kinase C-terminal domain
species: Archaeoglobus fulgidus [TaxId: 2234]

Probab=99.93  E-value=6.1e-26  Score=199.30  Aligned_cols=165  Identities=15%  Similarity=0.134  Sum_probs=122.0

Q ss_pred             cceeceeceeCceEEEEEEE-CCeeEEEEEecCCCCC----------------HHHHHHHHHHHHHHHhcCCCceeeEEe
Q 015868          118 LKIECKVASGSYGDLYKGTY-CSQEVAIKVLKPECVN----------------TEMLKEFSQEVYIMRKIRHKNVVQFIG  180 (399)
Q Consensus       118 ~~i~~~lg~G~~g~Vy~~~~-~~~~vAvK~~~~~~~~----------------~~~~~~~~~Ei~~l~~l~h~nIv~~~~  180 (399)
                      +.+.++||+|+||+||+|+. +++.||||+++....+                .........|...+.++.|.+++..++
T Consensus         2 ~~vg~~IG~G~~g~Vy~a~~~~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~~~~   81 (191)
T d1zara2           2 DAIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVYA   81 (191)
T ss_dssp             SEEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCEEE
T ss_pred             chhCCEeeeCcceEEEEEECCCCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHccCCCcceEEE
Confidence            35788999999999999986 6899999998753221                112234567899999999999999887


Q ss_pred             EEecCCcEEEEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceeecCCCcEEEeeccc
Q 015868          181 ACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGV  260 (399)
Q Consensus       181 ~~~~~~~~~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~giiHrDlkp~NILl~~~~~vkl~DFG~  260 (399)
                      +..    .+++|||+++..+.+        ++...+..++.|++.++.|||++||+||||||+|||++++ .++|+|||.
T Consensus        82 ~~~----~~lvme~~~~~~~~~--------l~~~~~~~i~~ql~~~l~~lH~~giiHrDiKP~NILv~~~-~~~liDFG~  148 (191)
T d1zara2          82 WEG----NAVLMELIDAKELYR--------VRVENPDEVLDMILEEVAKFYHRGIVHGDLSQYNVLVSEE-GIWIIDFPQ  148 (191)
T ss_dssp             EET----TEEEEECCCCEEGGG--------CCCSCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEETT-EEEECCCTT
T ss_pred             ecC----CEEEEEeeccccccc--------hhhHHHHHHHHHHHHHHHHHhhCCEEEccCChhheeeeCC-CEEEEECCC
Confidence            542    379999998865432        4455567899999999999999999999999999999865 589999999


Q ss_pred             eeeccCCCccccCCCCcccccc--cc---cCCCCCCChhhHHHHHHH
Q 015868          261 ARVQAQSGVMTAETGTYRWMAP--EV---IEHKPYDYKADVFSFGIA  302 (399)
Q Consensus       261 a~~~~~~~~~~~~~gt~~y~aP--E~---l~~~~~~~~~Dv~slG~v  302 (399)
                      |.....+...       .|...  +.   +-.+.|+.++|+||+.--
T Consensus       149 a~~~~~~~~~-------~~l~rd~~~~~~~f~r~y~~~~d~~s~~~~  188 (191)
T d1zara2         149 SVEVGEEGWR-------EILERDVRNIITYFSRTYRTEKDINSAIDR  188 (191)
T ss_dssp             CEETTSTTHH-------HHHHHHHHHHHHHHHHHHCCCCCHHHHHHH
T ss_pred             cccCCCCCcH-------HHHHHHHHHHHHHHcCCCCCcccHHHHHHH
Confidence            9765433211       11111  00   113567889999996443

>d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Type IIIa 3',5"-aminoglycoside phosphotransferase
species: Enterococcus faecalis [TaxId: 1351]

Probab=98.67  E-value=2.6e-08  Score=89.13  Aligned_cols=140  Identities=12%  Similarity=0.066  Sum_probs=96.0

Q ss_pred             cccceeceeceeCceEEEEEEECCeeEEEEEecCCCCCHHHHHHHHHHHHHHHhcC-CCceeeEEeEEecCCcEEEEEec
Q 015868          116 KQLKIECKVASGSYGDLYKGTYCSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIR-HKNVVQFIGACTRPPNLCIVTEF  194 (399)
Q Consensus       116 ~~~~i~~~lg~G~~g~Vy~~~~~~~~vAvK~~~~~~~~~~~~~~~~~Ei~~l~~l~-h~nIv~~~~~~~~~~~~~lV~E~  194 (399)
                      ..|++.+..+-++.+.||+.+..++.+.+|+.......  ....+.+|...++.+. +--+++++.+...++..++||++
T Consensus        14 ~~~~~~~~~~G~s~~~v~rv~~~~~~~vlk~~~~~~~~--~~~~~~~E~~~l~~l~~~vpvP~vl~~~~~~~~~~lv~~~   91 (263)
T d1j7la_          14 EKYRCVKDTEGMSPAKVYKLVGENENLYLKMTDSRYKG--TTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNLLMSE   91 (263)
T ss_dssp             TTSEEEECSCCCSSSEEEEEECSSCEEEEEEECGGGTT--STTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEEC
T ss_pred             hceEEEEcCCCCCCCcEEEEEeCCCeEEEEEcCCCccc--chhhHHHHHHHHHHHhccCCCCcEEEEEecCCceEEEEEe
Confidence            35666666555556789999888888999998654211  1234667888888774 33367888888888889999999


Q ss_pred             CCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC-----------------------------------------
Q 015868          195 MARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQN-----------------------------------------  233 (399)
Q Consensus       195 ~~ggsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~-----------------------------------------  233 (399)
                      ++|.++.+.....      .....++.++.+.++.||+.                                         
T Consensus        92 l~G~~~~~~~~~~------~~~~~~~~~l~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  165 (263)
T d1j7la_          92 ADGVLCSEEYEDE------QSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEEDTPFK  165 (263)
T ss_dssp             CSSEEHHHHTTTC------SCHHHHHHHHHHHHHHHHTSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCCGGGGSTTCSCS
T ss_pred             ccccccccccccc------ccHHHHHHHHHHHHHHHhccCccccccCcchhhhhhhHHHHHHHHhhhhhhhcccccccch
Confidence            9998776543211      11122333444444444431                                         


Q ss_pred             ------------------CcccCCCCCCceeecCCCcEEEeeccceee
Q 015868          234 ------------------NIIHRDLKTANLLMDENGVVKVADFGVARV  263 (399)
Q Consensus       234 ------------------giiHrDlkp~NILl~~~~~vkl~DFG~a~~  263 (399)
                                        .++|+|+.|.||++++++.+.|+||+.+..
T Consensus       166 ~~~~~~~~l~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDwe~a~~  213 (263)
T d1j7la_         166 DPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSGR  213 (263)
T ss_dssp             SHHHHHHHHHHSCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCEE
T ss_pred             HHHHHHHHHHhcCCcCCcEEEEeeccCcceeecCCceEEEeechhccc
Confidence                              258999999999999877778999998864

>d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase)
species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]

Probab=98.12  E-value=9.6e-06  Score=71.46  Aligned_cols=136  Identities=11%  Similarity=0.132  Sum_probs=82.6

Q ss_pred             eeceeCc-eEEEEEEEC-CeeEEEEEecCCCCCHHHHHHHHHHHHHHHhcCC--CceeeEEeEEecCCcEEEEEecCCCC
Q 015868          123 KVASGSY-GDLYKGTYC-SQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRH--KNVVQFIGACTRPPNLCIVTEFMARG  198 (399)
Q Consensus       123 ~lg~G~~-g~Vy~~~~~-~~~vAvK~~~~~~~~~~~~~~~~~Ei~~l~~l~h--~nIv~~~~~~~~~~~~~lV~E~~~gg  198 (399)
                      .+..|.+ +.||+.+.. +..+.+|+......     ..+..|...++.+..  -.+++++.+...++..++||++++|.
T Consensus        17 ~~~~G~s~~~v~r~~~~~~~~~vlK~~~~~~~-----~~l~~E~~~l~~L~~~gvpvP~v~~~~~~~~~~~~v~~~i~G~   91 (255)
T d1nd4a_          17 QQTIGCSDAAVFRLSAQGRPVLFVKTDLSGAL-----NELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPGQ   91 (255)
T ss_dssp             ECSCTTSSCEEEEEECTTSCCEEEEEECSCTT-----SCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSSE
T ss_pred             EcCCcccCCeEEEEEeCCCCEEEEEeCCccCH-----hHHHHHHHHHHHHHhcCCCCCceeeecccccceEEEEEeeecc
Confidence            3344544 678998875 44578898775532     245667777777643  33678888888888899999999886


Q ss_pred             CHHH--------------HHHh-c-----CCCC--CHHHHHHHH--------------------HHHHHHHHHHHHC---
Q 015868          199 SIYD--------------FLHK-Q-----KGVF--QLTSLLKVA--------------------IDVSKGMNYLHQN---  233 (399)
Q Consensus       199 sL~~--------------~l~~-~-----~~~l--~~~~~~~i~--------------------~~i~~~L~~LH~~---  233 (399)
                      ++.+              .+.+ +     ...+  .......-.                    ......+..+.++   
T Consensus        92 ~~~~~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~  171 (255)
T d1nd4a_          92 DLLSSHLAPAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLAPAELFARLKARMPD  171 (255)
T ss_dssp             ETTTSCCCHHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCCHHHHHHHHHHTCCS
T ss_pred             ccccccccHHHHHHHHHHHHHHHccCChhhCCCcccchhhHHHHHHHHHHhhhccccccchhhhhHHHHHHHHHHHhCCc
Confidence            5422              1111 0     0000  000000000                    0011223333332   


Q ss_pred             ----CcccCCCCCCceeecCCCcEEEeeccceee
Q 015868          234 ----NIIHRDLKTANLLMDENGVVKVADFGVARV  263 (399)
Q Consensus       234 ----giiHrDlkp~NILl~~~~~vkl~DFG~a~~  263 (399)
                          .++|+|+.|.|||+++++.+-|+||+.+..
T Consensus       172 ~~~~~liHgD~~~~Nvl~~~~~~~~iID~~~~~~  205 (255)
T d1nd4a_         172 GEDLVVTHGDACLPNIMVENGRFSGFIDCGRLGV  205 (255)
T ss_dssp             SCCEEEECSSCCGGGEEEETTEEEEECCCTTCEE
T ss_pred             cCCceEEeCCCCCcceEEeCCceEEEEEchhccc
Confidence                369999999999999877778999998864

>d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Methylthioribose kinase MtnK
species: Bacillus subtilis [TaxId: 1423]

Probab=97.71  E-value=4.4e-05  Score=72.13  Aligned_cols=76  Identities=12%  Similarity=0.022  Sum_probs=47.9

Q ss_pred             ceeceeCceEEEEEEE--CCeeEEEEEecCCC-C----CHHHHHHHHHHHHHHHhcC---CCceeeEEeEEecCCcEEEE
Q 015868          122 CKVASGSYGDLYKGTY--CSQEVAIKVLKPEC-V----NTEMLKEFSQEVYIMRKIR---HKNVVQFIGACTRPPNLCIV  191 (399)
Q Consensus       122 ~~lg~G~~g~Vy~~~~--~~~~vAvK~~~~~~-~----~~~~~~~~~~Ei~~l~~l~---h~nIv~~~~~~~~~~~~~lV  191 (399)
                      +.||.|....||+.+.  .++.+++|.-.+.. .    ......+...|...|+.+.   ...+++++.+.  +...++|
T Consensus        32 ~eig~G~~N~vfrV~~~~~~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~~d--~~~~~lv  109 (392)
T d2pula1          32 QEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYSD--TEMAVTV  109 (392)
T ss_dssp             EECCSSSSEEEEEEEC----CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEEE--TTTTEEE
T ss_pred             EEeCCCceEeEEEEEeCCCCeEEEEecCCchhcccCCCCCCCHHHHHHHHHHHHHhhhhCCCCcceEEEEc--CCCCEEE
Confidence            3689999999999865  35688999754311 0    0111233456777777663   24577777653  3456799


Q ss_pred             EecCCCCC
Q 015868          192 TEFMARGS  199 (399)
Q Consensus       192 ~E~~~ggs  199 (399)
                      ||++++..
T Consensus       110 mE~L~~~~  117 (392)
T d2pula1         110 MEDLSHLK  117 (392)
T ss_dssp             ECCCTTSE
T ss_pred             EeccCCcc
Confidence            99998753

>d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: RdoA
species: Escherichia coli [TaxId: 562]

Probab=97.13  E-value=0.00081  Score=61.31  Aligned_cols=129  Identities=15%  Similarity=0.161  Sum_probs=74.3

Q ss_pred             eEEEEEEE-CCeeEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCcee--eEEe-----EEecCCcEEEEEecCCCCCH-
Q 015868          130 GDLYKGTY-CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVV--QFIG-----ACTRPPNLCIVTEFMARGSI-  200 (399)
Q Consensus       130 g~Vy~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~nIv--~~~~-----~~~~~~~~~lV~E~~~ggsL-  200 (399)
                      -.||+++. .|+.|++|+.++...+.   +.+..|...+..|...++.  ..+.     .+...+..+.++++++|..+ 
T Consensus        36 N~vy~v~~~dg~~~VlK~~rp~~~s~---~~i~~E~~~l~~L~~~gipv~~p~~~~g~~~~~~~~~~~~l~~~~~G~~~~  112 (325)
T d1zyla1          36 NRVYQFQDEDRRRFVVKFYRPERWTA---DQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVGGRQFE  112 (325)
T ss_dssp             SEEEEECCTTCCCEEEEEECTTTSCH---HHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCCCEECC
T ss_pred             ceeEEEEcCCCCEEEEEEeCCCCCCH---HHHHHHHHHHHHHHhcCCCCCCceecCCCeeeeeeeEEEEEEeecCCcCCC
Confidence            47999976 67889999998875444   3456688888777532222  1111     12345568899999987421 


Q ss_pred             ----HHH---------HHhc--C------CCCC-------------------HH---HHHHHHHHHHHHHHHHH----HC
Q 015868          201 ----YDF---------LHKQ--K------GVFQ-------------------LT---SLLKVAIDVSKGMNYLH----QN  233 (399)
Q Consensus       201 ----~~~---------l~~~--~------~~l~-------------------~~---~~~~i~~~i~~~L~~LH----~~  233 (399)
                          ..+         ++..  .      ...+                   ..   .....+.++...+.-.-    ..
T Consensus       113 ~~~~~~~~~lG~~LA~lH~~~~~~~~~~r~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~~~~~~~p~  192 (325)
T d1zyla1         113 ADNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIAAVTAHWREDFTV  192 (325)
T ss_dssp             SSCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHHHHHHHCCSCSCC
T ss_pred             CCCHHHHHHHHHHHHHHHhhcccCCccccCCCCHHHHhhhhHHHHHHcCcCCHHHHHHHHHHHHHHHHHHHHhccccCCc
Confidence                111         1110  0      0111                   11   12222233333322221    13


Q ss_pred             CcccCCCCCCceeecCCCcEEEeeccceee
Q 015868          234 NIIHRDLKTANLLMDENGVVKVADFGVARV  263 (399)
Q Consensus       234 giiHrDlkp~NILl~~~~~vkl~DFG~a~~  263 (399)
                      ++||+|+.+.|||+++ + ..++||+.++.
T Consensus       193 ~liHgDlh~~NvL~~~-~-~~~IDFdd~~~  220 (325)
T d1zyla1         193 LRLHGDCHAGNILWRD-G-PMFVDLDDARN  220 (325)
T ss_dssp             EECCSSCSGGGEEESS-S-EEECCCTTCCE
T ss_pred             eeecCCCCcccEEEeC-C-ceEEechhccc
Confidence            6899999999999974 3 45899999875

>d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Choline kinase
domain: Choline kinase
species: Caenorhabditis elegans [TaxId: 6239]

Probab=96.88  E-value=0.0017  Score=60.77  Aligned_cols=70  Identities=14%  Similarity=0.217  Sum_probs=47.1

Q ss_pred             ceeceeCceEEEEEEECC---------eeEEEEEecCCCCCHHHHHHHHHHHHHHHhcC-CCceeeEEeEEecCCcEEEE
Q 015868          122 CKVASGSYGDLYKGTYCS---------QEVAIKVLKPECVNTEMLKEFSQEVYIMRKIR-HKNVVQFIGACTRPPNLCIV  191 (399)
Q Consensus       122 ~~lg~G~~g~Vy~~~~~~---------~~vAvK~~~~~~~~~~~~~~~~~Ei~~l~~l~-h~nIv~~~~~~~~~~~~~lV  191 (399)
                      ++|+.|-.-.+|+.+...         +.|.+++....  ...  ....+|..+++.+. +.-.+++++++..    .+|
T Consensus        48 ~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g~~--~~~--idr~~E~~i~~~ls~~gl~Pkll~~~~~----g~I  119 (395)
T d1nw1a_          48 SRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNP--ETE--SHLVAESVIFTLLSERHLGPKLYGIFSG----GRL  119 (395)
T ss_dssp             EEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSC--CCH--HHHHHHHHHHHHHHHTTSSSCEEEEETT----EEE
T ss_pred             EEcCCccccceEEEEeCCCCccccCCCCcEEEEecCCc--chh--hHHHHHHHHHHHHHhCCCCCeEEEEcCC----ceE
Confidence            467778888899987632         45777776532  121  23457888888885 4334678887753    689


Q ss_pred             EecCCCCC
Q 015868          192 TEFMARGS  199 (399)
Q Consensus       192 ~E~~~ggs  199 (399)
                      +||++|.+
T Consensus       120 ~efi~g~~  127 (395)
T d1nw1a_         120 EEYIPSRP  127 (395)
T ss_dssp             ECCCCEEE
T ss_pred             EEEecccc
Confidence            99998853

>d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Homoserine kinase ThrB
species: Agrobacterium tumefaciens [TaxId: 358]

Probab=96.84  E-value=0.0014  Score=59.09  Aligned_cols=139  Identities=11%  Similarity=0.053  Sum_probs=74.7

Q ss_pred             eceeceeCceEEEEEEECCeeEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCce--eeEEeE------EecCCcEEEEE
Q 015868          121 ECKVASGSYGDLYKGTYCSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNV--VQFIGA------CTRPPNLCIVT  192 (399)
Q Consensus       121 ~~~lg~G~~g~Vy~~~~~~~~vAvK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~nI--v~~~~~------~~~~~~~~lV~  192 (399)
                      .+.|..|---+.|+.+..+..+++|+.....    ...++..|+.++..+...++  +..+..      .........++
T Consensus        23 ~~~i~~G~~N~ny~v~t~~g~yVLri~~~~~----~~~~l~~~~~~l~~L~~~g~pvp~pi~~~~g~~~~~~~~~~~~~~   98 (316)
T d2ppqa1          23 YKGIAEGVENSNFLLHTTKDPLILTLYEKRV----EKNDLPFFLGLMQHLAAKGLSCPLPLPRKDGELLGELSGRPAALI   98 (316)
T ss_dssp             EEEECC---EEEEEEEESSCCEEEEEECC-------CCHHHHHHHHHHHHHHTTCCCCCBCCBTTCCSCEEETTEEEEEE
T ss_pred             eecCCCCcccCeEEEEECCCcEEEEEcCCCC----CHHHHHHHHHHHHhhhhccccccccceecCCCcceeeecccceee
Confidence            3456667777889998888889999986532    12344556777777643222  111110      12223456666


Q ss_pred             ecCCCCCHH--------------HHHHhcCC--------CC------------------CHHHHHHHHHHHHHHHHHHHH
Q 015868          193 EFMARGSIY--------------DFLHKQKG--------VF------------------QLTSLLKVAIDVSKGMNYLHQ  232 (399)
Q Consensus       193 E~~~ggsL~--------------~~l~~~~~--------~l------------------~~~~~~~i~~~i~~~L~~LH~  232 (399)
                      .+..|....              ..++....        ..                  ....+...+..+...+...+.
T Consensus        99 ~~~~g~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~  178 (316)
T d2ppqa1          99 SFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVEKGLREEIRPEIDYLAAHWP  178 (316)
T ss_dssp             ECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTSTTHHHHHHHHHHHHHHHCC
T ss_pred             eecccccccccchhHHHHHHHHHHhhhhhhhhcccccccccchhhcchhhhHHHHhhhhcchhHHHHHHHHHHhhhccCc
Confidence            666653210              01111000        00                  001112222233333333332


Q ss_pred             ----CCcccCCCCCCceeecCCCcEEEeeccceee
Q 015868          233 ----NNIIHRDLKTANLLMDENGVVKVADFGVARV  263 (399)
Q Consensus       233 ----~giiHrDlkp~NILl~~~~~vkl~DFG~a~~  263 (399)
                          .|+||+|+.+.||+++++...-|+||+.+..
T Consensus       179 ~~L~~giIHgDl~~dNvl~~~~~v~gvIDF~~~~~  213 (316)
T d2ppqa1         179 KDLPAGVIHADLFQDNVFFLGDELSGLIDFYFACN  213 (316)
T ss_dssp             CSSCEEEECSCCCGGGEEEETTEEEEECCCTTCEE
T ss_pred             cccccccccCCcchhhhhcccccceeEeccccccc
Confidence                4799999999999999888889999998863

>d1zpva1 d.58.18.7 (A:1-83) UPF0237 protein SP0238 {Streptococcus pneumoniae [TaxId: 1313]}

class: Alpha and beta proteins (a+b)
fold: Ferredoxin-like
superfamily: ACT-like
family: SP0238-like
domain: UPF0237 protein SP0238
species: Streptococcus pneumoniae [TaxId: 1313]

Probab=93.94  E-value=0.032  Score=39.41  Aligned_cols=56  Identities=20%  Similarity=0.163  Sum_probs=42.3

Q ss_pred             HHHHHHHHhhhhCCCeeeeceeccCCCceeeEEEecCCCCcchHHHHHHHHHHHhhh
Q 015868           10 KVGELTSLLGEIGLNIQEAHAFSTVDGFSLDVFVVDGWPYDETEDLKNVLAKEILKS   66 (399)
Q Consensus        10 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~~~~~~l~~~l~~~~~~~   66 (399)
                      +++.+|.+|++.|.||.+.+.+...+-|.+. ++|+.-+..+.++|+++|.+.....
T Consensus        15 iVa~vt~~l~~~g~NI~d~~q~~~~~~f~~~-~~v~~~~~~~~~~l~~~l~~la~~l   70 (83)
T d1zpva1          15 IVAGVSGKIAELGLNIDDISQTVLDEYFTMM-AVVSSDEKQDFTYLRNEFEAFGQTL   70 (83)
T ss_dssp             HHHHHHHHHHHTTCEEEEEEEEEETTEEEEE-EEEEESSCCCHHHHHHHHHHHHHHH
T ss_pred             HHHHHHHHHHHCCCeEEEEEeEEeCCEEEEE-EEEEEecCCCHHHHHHHHHHHHHHc
Confidence            5788999999999999999998877767774 4566333446788888886654443

>d1u8sa1 d.58.18.5 (A:2-87) putative transcriptional repressor VC2159 {Vibrio cholerae [TaxId: 666]}

class: Alpha and beta proteins (a+b)
fold: Ferredoxin-like
superfamily: ACT-like
family: Glycine cleavage system transcriptional repressor
domain: putative transcriptional repressor VC2159
species: Vibrio cholerae [TaxId: 666]

Probab=91.90  E-value=0.066  Score=38.01  Aligned_cols=56  Identities=13%  Similarity=0.080  Sum_probs=42.1

Q ss_pred             HHHHHHHHhhhhCCCeeeeceeccCCCceeeEEEecCCCCcchHHHHHHHHHHHhhhh
Q 015868           10 KVGELTSLLGEIGLNIQEAHAFSTVDGFSLDVFVVDGWPYDETEDLKNVLAKEILKSK   67 (399)
Q Consensus        10 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~~~~~~l~~~l~~~~~~~~   67 (399)
                      +++++|.+|++.|.||.+++-+... |.-.=.+.|++ +....++|+.+|++......
T Consensus        18 iva~vt~~l~~~g~NI~d~~~~~~~-~~~~~~~~v~~-~~~~~~~l~~~L~~l~~~l~   73 (86)
T d1u8sa1          18 ICNEVVRLVTQAGCNIIDSRIAMFG-KEFTLLMLISG-SPSNITRVETTLPLLGQQHD   73 (86)
T ss_dssp             HHHHHHHHHHHTTCEEEEEEEEEET-TEEEEEEEEEE-CHHHHHHHHHHHHHHHHHHT
T ss_pred             HHHHHHHHHHHCCCeEEEeEeEEEC-CeeEEEEEEEc-CcccHHHHHHHHHHHHHHhC
Confidence            5789999999999999999987654 44445666774 44567888888877655443

>d1ygya3 d.58.18.1 (A:452-529) Phosphoglycerate dehydrogenase, regulatory (C-terminal) domain {Mycobacterium tuberculosis [TaxId: 1773]}

class: Alpha and beta proteins (a+b)
fold: Ferredoxin-like
superfamily: ACT-like
family: Phosphoglycerate dehydrogenase, regulatory (C-terminal) domain
domain: Phosphoglycerate dehydrogenase, regulatory (C-terminal) domain
species: Mycobacterium tuberculosis [TaxId: 1773]

Probab=88.84  E-value=0.6  Score=32.10  Aligned_cols=48  Identities=25%  Similarity=0.342  Sum_probs=37.3

Q ss_pred             HHHHHHHHhhhhCCCeeeeceeccC-CCceeeEEEecCCCCcchHHHHHHHH
Q 015868           10 KVGELTSLLGEIGLNIQEAHAFSTV-DGFSLDVFVVDGWPYDETEDLKNVLA   60 (399)
Q Consensus        10 ~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~g~~~~~~~~l~~~l~   60 (399)
                      +|++++++|++-|.||...|+.-+. .|+..=++.||+-..   +++.++|+
T Consensus        16 vi~~I~~~l~~~~iNI~~m~~~~~~~g~~a~~vi~vD~~~~---~~vl~~I~   64 (78)
T d1ygya3          16 ALGKIGTLLGTAGVNIQAAQLSEDAEGPGATILLRLDQDVP---DDVRTAIA   64 (78)
T ss_dssp             HHHHHHHHHHHTTCCEEEEEEEECSSSSCEEEEEEESSCCC---HHHHHHHH
T ss_pred             HHHHHHHHHHhcCcChhhheeeecCCCCeEEEEEEcCCCcc---HHHHHHHH
Confidence            5889999999999999999998654 557888888887443   45555553

>d2f06a1 d.58.18.11 (A:71-141) Hypothetical protein BT0572 {Bacteroides thetaiotaomicron [TaxId: 818]}

class: Alpha and beta proteins (a+b)
fold: Ferredoxin-like
superfamily: ACT-like
family: BT0572-like
domain: Hypothetical protein BT0572
species: Bacteroides thetaiotaomicron [TaxId: 818]

Probab=87.54  E-value=0.68  Score=31.17  Aligned_cols=48  Identities=15%  Similarity=0.179  Sum_probs=40.3

Q ss_pred             HHHHHHHHhhhhCCCeeeeceeccCCCceeeEEEecCCCCcchHHHHHHHHHHH
Q 015868           10 KVGELTSLLGEIGLNIQEAHAFSTVDGFSLDVFVVDGWPYDETEDLKNVLAKEI   63 (399)
Q Consensus        10 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~~~~~~l~~~l~~~~   63 (399)
                      .|.+++++|++-|.||.=.-+|.+. ++..=+|.||     +.++..++|++..
T Consensus        12 ~L~~v~~~L~~~~InI~~~y~~~~~-~~~~~vl~vd-----d~~~a~~~L~~~G   59 (71)
T d2f06a1          12 ALAKVLGFLSAEGVFIEYMYSFANN-NVANVVIRPS-----NMDKCIEVLKEKK   59 (71)
T ss_dssp             HHHHHHHHHHHTTCCEEEEEEEEET-TEEEEEEEES-----CHHHHHHHHHHTT
T ss_pred             HHHHHHHHHHHCCCCEEEEEEEcCC-CcEEEEEEEC-----CHHHHHHHHHHCC
Confidence            4788999999999999999999886 7899999997     5677777776543

>d1sc6a3 d.58.18.1 (A:327-410) Phosphoglycerate dehydrogenase, regulatory (C-terminal) domain {Escherichia coli [TaxId: 562]}

class: Alpha and beta proteins (a+b)
fold: Ferredoxin-like
superfamily: ACT-like
family: Phosphoglycerate dehydrogenase, regulatory (C-terminal) domain
domain: Phosphoglycerate dehydrogenase, regulatory (C-terminal) domain
species: Escherichia coli [TaxId: 562]

Probab=87.23  E-value=0.31  Score=34.14  Aligned_cols=36  Identities=19%  Similarity=0.317  Sum_probs=28.6

Q ss_pred             HHHHHHHHhhhhCCCeeeeceeccCC-CceeeEEEec
Q 015868           10 KVGELTSLLGEIGLNIQEAHAFSTVD-GFSLDVFVVD   45 (399)
Q Consensus        10 ~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~   45 (399)
                      +|++++++|++-|+||...+.-+..+ ||.+=.+.+|
T Consensus        24 vla~I~~~l~~~~iNI~~~~~~~~~~~~~a~~~i~~D   60 (84)
T d1sc6a3          24 VLTALNKIFAEQGVNIAAQYLQTSAQMGYVVIDIEAD   60 (84)
T ss_dssp             HHHHHHHHHHHTTCEEEEEEEEECSSEEEEEEEEECC
T ss_pred             HHHHHHHHHHHcCCCHHHhccccCCCCcEEEEEEECC
Confidence            58899999999999999999988777 5665444333